accession_id
stringlengths
9
11
pmid
stringlengths
1
8
introduction
sequencelengths
0
213
methods
sequencelengths
0
389
results
sequencelengths
0
2.61k
discussion
sequencelengths
0
371
conclusion
sequencelengths
0
229
front
sequencelengths
0
66
body
sequencelengths
0
2.64k
back
sequencelengths
0
550
figure
sequencelengths
0
370
table
sequencelengths
0
999
formula
sequencelengths
0
2.66k
box
sequencelengths
0
58
code
sequencelengths
0
10
quote
sequencelengths
0
105
chemical
sequencelengths
0
0
supplementary
sequencelengths
0
74
footnote
sequencelengths
0
37
graphic
sequencelengths
0
2.41k
media
sequencelengths
0
74
unknown_pub
stringlengths
2
363k
glossary
sequence
n_references
int32
0
1.35k
license
stringclasses
4 values
retracted
stringclasses
2 values
last_updated
stringlengths
19
19
citation
stringlengths
14
89
package_file
stringlengths
0
35
PMC10786743
37086305
[ "<title>Introduction</title>", "<p id=\"Par2\">Borderline personality disorder (BPD) is a severe mental disorder, characterized by pronounced deficits in emotion regulation, inappropriate outbursts of anger, interpersonal instability, suicidal/self-harming and impulsive behaviors. A neurobiological model of BPD has been proposed including genetic and environmental factors that affect brain development [##REF##29182951##1##]. Previous neuroimaging findings highlight the presence of several alterations in this population, especially in prefrontal cortex, limbic system and their connection; however, little is known about the specific contribution of different limbic structures to BPD symptomatology [##REF##34031363##2##].</p>", "<p id=\"Par3\">Previous studies described smaller volumes in the amygdala and hippocampus in adults with BPD compared to healthy controls [##REF##16239012##3##–##REF##19721849##5##]; however, when comparing BPD patients with major depression (MD) to BPD without MD, Zetzsche and colleagues [##REF##16476409##6##] showed that amygdala volumes in both hemispheres were significantly larger. Results concerning the role of amygdala are not as conclusive as the results regarding the hippocampus, especially in patients with BPD and other comorbidities. Still under debate is the impact of comorbid post-traumatic stress disorder (PTSD) on limbic grey matter volumes in patients with BPD. A meta-analysis by de-Almeida and colleagues [##REF##22789064##7##] showed that amygdala volumes are reduced in patients with BPD and this pattern is confirmed in BPD patients without PTSD, but not in BPD patients with PTSD.</p>", "<p id=\"Par4\">In the last years, a wide number of neuroimaging studies have used functional MRI (fMRI) approaches to investigate dynamic interactions between brain areas during experimental conditions (i.e. task) and resting states in patients with BPD [##REF##24492919##8##]. Previous task fMRI studies demonstrate increased activation of amygdala bilaterally in patients with BPD compared to controls in response to aversive stimuli (e.g. violent scenes) [##REF##11483139##9##], and patients with BPD also show higher left amygdala activation in response to expressions of emotion depicted in the Ekman faces [##REF##14643096##10##]; they tend to project negative attributes onto the Ekman faces, especially the ambiguous “neutral” expression, suggesting abnormal amygdala functionality [##REF##19019636##11##]. Moreover, resting-state fMRI studies showed aberrant functional connectivity in the default mode network, central executive and salience network in BPD patients compared to healthy controls [##REF##24198777##12##].</p>", "<p id=\"Par5\">A stronger coupling between the amygdala and a cluster comprising the orbitofrontal cortex, putamen and insula was also found by Krause-Utz and colleagues [##REF##24492919##8##]. Insula contains multiple subregions and, as described in the review of Nieuwenhuys [##REF##22230626##13##], is implicated in a large number of widely different functions, ranging from pain perception to the processing of social emotions. Previous neuroimaging studies showed, in healthy volunteers, the presence of two major complementary networks involving the ventral-anterior and dorsal-posterior insula: the first is primarily related to limbic regions which play a role in emotional aspects; the latter is more involved in sensorimotor integration [##REF##21111053##14##]. Only a few preliminary studies explored the involvement of insula in BPD patients [##REF##27199724##15##]; however, no evidence described the contribution of the different insula subparts to BPD symptomatology.</p>", "<p id=\"Par6\">The aim of this study was to explore structural and functional alterations of amygdala and different insula subregions in a group of young adults newly diagnosed patients with BPD, shedding light on their different contribution to neuropsychiatric symptoms.</p>" ]
[ "<title>Methods</title>", "<title>Participants</title>", "<p id=\"Par7\">Twenty-eight patients with BPD (6 M/22F, mean age = 23.7 ± 3.4 years) and twenty-eight matched healthy controls (6 M/22F, mean age = 24.3 ± 2.8 years) were included in this study. Patients were eligible if they were at least 18 and not over 30 years old and met criteria for BPD at the Structured Clinical Interview for DSM-IV-Axis II (SCID-II) [##UREF##0##16##]. Exclusion criteria for both groups were: presence of neurological disorders or intellectual disabilities, diagnosis of schizophrenia spectrum disorders or of other personality disorder, comorbidity with substance or alcohol use disorders, and continuous use of poly psychopharmacology over the last year. A subgroup of 20 patients underwent pharmacological treatment, specifically antidepressants, mood stabilizers, antipsychotics and/or anxiolytics.</p>", "<p id=\"Par8\">A total of 20 BPD patients showed a moderate level of depression (Beck Depression Inventory, BDI score &gt; 20); however, no patients had comorbidities with ‘major depression’ nor with ‘Post Traumatic Stress Disorder’ (PTSD). The choice to include young adults and exclude cases with comorbidities was made to assess the BPD core, limiting the impact of other clinical factors that often affect the course of the disease and its neurobiology.</p>", "<p id=\"Par9\">The study was approved by the local Ethical Committee (#88866-24/07/2017), and written informed consent was obtained from all participants.</p>", "<title>Neuropsychiatric assessment</title>", "<p id=\"Par10\">All participants underwent an extensive neuropsychiatric assessment that included the following instruments: Difficulties in Emotion Regulation Scale (DERS) [##UREF##1##17##]; Barratt Impulsiveness Scale-11 (BIS-11) [##REF##8778124##18##]; Self Harm Inventory (SHI) [##REF##9811134##19##]; Ruminative Response Scale (RRS) [##REF##1890582##20##]; Anger Rumination Scale (ARS) [##UREF##2##21##]. In addition, the Edinburgh Handedness Inventory [##REF##5146491##22##] was also administrate to evaluate the laterality of each participant; moreover, the Beck Depression Inventory (BDI) was also administrated to the BPD group.</p>", "<title>Brain MR acquisition</title>", "<p id=\"Par11\">Patients and healthy controls underwent a brain MR imaging investigation, within a month after the neuropsychiatric assessment, using a 1.5 T GE scanner (Signa HDx 15) with an 8-channel head coil. The MRI protocol included a 3D high-resolution T1-weighted image acquired using a fast spoiled gradient echo (FSPGR) sequence (pure axial orientation, TR/TE/T1 = 12.3/5.2/600 ms, FOV = 256 mm, 1 mm<sup>3</sup> isotropic resolution) and a 9 min whole brain resting-state fMRI scan acquired with a gradient EPI sequence (pure axial orientation, TR/TE = 3000/40 ms, FOV = 240 mm, 34 slices, 1.875 × 1.875 × 4 mm<sup>3</sup> resolution, 180 volumes). All participants were instructed to remain in a relaxed wakefulness, keeping their eyes closed without falling asleep.</p>", "<title>Volume and cortical thickness analysis</title>", "<p id=\"Par12\">Volumetric and cortical thickness measurements were obtained with FreeSurfer 6.0 image analysis suite (a detailed description of pre-processing and processing of T1-w images is available at <ext-link ext-link-type=\"uri\" xlink:href=\"http://surfer.nmr.mgh.harvard.edu/\">http://surfer.nmr.mgh.harvard.edu/</ext-link>) and normalized by the total intracranial volume (TIV, obtained from FreeSurfer) for each participant. Volume was evaluated for both amygdala and insula, while cortical thickness for insula only. Representative segmentations of amygdala and insula are shown in Fig. ##FIG##0##1##.</p>", "<p id=\"Par13\">Moreover, the insular cortex was parcellated into six subregions (posterior long gyrus, PLG; anterior long gyrus, ALG; posterior short gyrus, PSG; middle short gyrus, MSG; anterior short gyrus, ASG; anterior inferior cortex, AIC) as described in the study of Faillenot and colleagues [##REF##28179166##23##], by aligning the subdivision performed on the MNI template to each insula segmentation on the T1-w image. A representative parcellation of insula is shown in Fig. ##FIG##1##2##.</p>", "<p id=\"Par14\">To explore which specific subregions of the insular cortex were potentially impaired, insula was examined not only as a whole, but also considering the anterior and posterior portions separately (respectively, made of AIC, PSG, MSG, ASG subregions, and ALG, PLG subregions); then, each subregion was also examined individually.</p>", "<title>Resting-state fMRI analysis</title>", "<p id=\"Par15\">Data pre-processing and analysis were conducted using FSL (<ext-link ext-link-type=\"uri\" xlink:href=\"https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/\">https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/</ext-link>). Functional images were corrected for head-motion (MCFLIRT) [##REF##12377157##24##]; spatial smoothing (gaussian kernel FWHM = 5 mm) and high-pass temporal filter (cut-off 100 s) were applied.</p>", "<p id=\"Par16\">Functional images were linearly (FLIRT, with BBR method, Boundary Based Registration) [##REF##19573611##25##] registered to the structural T1-w image, and this was non-linearly warped to the MNI template (FNIRT) [##UREF##3##26##] with a subsequent resample to 2 × 2 × 2 mm<sup>3</sup>.</p>", "<p id=\"Par17\">Single-subject Independent Component Analysis was performed using a probabilistic approach and implemented in MELODIC (multivariate exploratory linear optimized decomposition into Independent components 3.14 FSL tool) with automatically estimated number of components. The obtained components were manually classified between signal and noise, based on knowledge of RSN patterns and of typical artifact characteristics, and data denoising was then performed by regressing out the noise signals [##REF##27989777##27##, ##REF##29527492##28##].</p>", "<p id=\"Par18\">Resting-state data were then analyzed with a seed-based approach, focusing on the amygdala (right and left separately) and the insula (right and left, as a whole, for the posterior and anterior portions separately, and for the PLG part) by aligning the regions of interest used for volumetric analysis to the functional space.</p>", "<p id=\"Par19\">With a dual regression approach between each seed and each subject’s 4D functional dataset, subject-specific spatial maps of functional connectivity were obtained. These maps were aligned to the MNI space and then entered the group-level statistical comparison.</p>", "<title>Statistical analysis</title>", "<p id=\"Par20\">As for clinical and MR volumetric data, parametric t tests were used for group comparisons. The significance threshold was set to <italic>p</italic> &lt; 0.05. Regarding resting-state fMRI data, voxelwise group differences were evaluated with permutation testing (FSL randomize) [##REF##24530839##29##], with 5000 permutations. Age and sex were added as confounding regressors. Statistical significance was set at <italic>p</italic> &lt; 0.05 FWE-corrected for multiple comparisons with TFCE (Threshold-Free Cluster Enhancement). Parameter estimates were extracted from regions that showed significant group differences for correlations.</p>", "<p id=\"Par21\">Group differences were assessed both with whole samples and with sub-groups including only female participants (<italic>N</italic> = 44). Pearson’s correlations were run in the BPD patients’ group between both structural and functional data with the neuropsychiatric scales.</p>" ]
[ "<title>Results</title>", "<title>Demographic and neuropsychiatric results</title>", "<p id=\"Par22\">The two groups did not differ in any of the sociodemographic factors investigated, and as expected, the neuropsychiatric assessment showed worse scores in the BPD group compared with healthy controls that obtained scores within the normal range in all scales. As shown in Table ##TAB##0##1##, our sample of patients presents significant higher scores (<italic>p</italic> &lt; 0.0001) on BPD symptoms domains, measured with specific assessment tools, i.e. DERS for emotion dysregulation, BIS-11 for impulsivity, RRS and ARS for rumination and SHI for self-harm.</p>", "<title>Volume and cortical thickness results</title>", "<p id=\"Par23\">Comparing all patients against controls, no differences were found in amygdala volumes. A focused analysis run with a sub-sample composed only by females (22 BPD and 22 controls) showed a significant reduction of right amygdala volumes (<italic>p</italic> = 0.037) in the BPD group (mean = 1.27 ± 0.18 cm<sup>3</sup>) compared to healthy controls (mean = 1.36 ± 0.10 cm<sup>3</sup>) (Fig. ##FIG##0##1##). Instead, BPD patients group showed significant cortical thickness reduction of the left insula (<italic>p</italic> = 0.027) (mean = 2.88 ± 0.11 mm) compared to the healthy control group (mean = 2.94 ± 0.09 mm). No significant differences were found considering only the sub-sample of females.</p>", "<p id=\"Par24\">Moreover, the insular cortex was parcellated in anterior and posterior subregions, and the left posterior part resulted significantly thinner in the BPD group compared to healthy controls (<italic>p</italic> = 0.039). A deeper analysis showed that the left posterior long gyrus (PLG) was the subpart significantly thinner (<italic>p</italic> = 0.019) in the BPD group (mean = 2.87 ± 0.16 mm) compared to healthy controls (mean = 2.98 ± 0.19 mm) (Fig. ##FIG##1##2##).</p>", "<title>Resting-state fMRI results</title>", "<p id=\"Par25\">The fMRI analysis showed significant reduced functional connectivity in the BPD group compared to healthy controls between the amygdala (right and left) and the frontal pole. In addition, decreased connectivity was also found between amygdala (left) and precuneus and between amygdala (left) and temporal pole (Fig. ##FIG##2##3##).</p>", "<p id=\"Par26\">When considering only the female sub-groups, reduced functional connectivity in the BPD group was confirmed between right amygdala and the frontal pole; instead, decrease connectivity of the left amygdala was only present at a trend level (<italic>p</italic> &lt; 0.1).</p>", "<p id=\"Par27\">No differences in anterior nor posterior insula functional connectivity were found between patients with BPD and healthy controls when considering the whole sample. A focused analysis run only with the female sub-groups showed significantly higher connectivity in subjects with BPD between anterior insula (right and left) and several brain areas (Fig. ##FIG##3##4##).</p>", "<title>Correlations analyses</title>", "<p id=\"Par28\">Negative correlations were found between right amygdala volume and two neuropsychiatric scales, specifically, Difficulties in Emotion Regulation Scale (<italic>p</italic> = 0.031; <italic>r</italic> =  − 0.415) and Ruminative Response Scale (<italic>p</italic> = 0.045; <italic>r</italic> =  − 0.389). Moreover, significant negative correlations were also found in the BPD group between cortical thickness of the left insula and Anger Rumination Scale (ARS) (<italic>p</italic> = 0.019; <italic>r</italic> =  − 0.450). Regarding functional connectivity alterations, significant positive correlations were found between reduced left amygdala connectivity and two neuropsychiatric scales, specifically, Anger Rumination Scale (<italic>p</italic> = 0.009; <italic>r</italic> = 0.491) and Barratt Impulsiveness Scale-11 (<italic>p</italic> = 0.020; <italic>r</italic> = 0.447). Instead, correlations between increase left anterior insula connectivity with the neuropsychiatric scales (i.e. Difficulties in Emotion Regulation Scale) were only present at a trend level (<italic>p</italic> = 0.09; <italic>r</italic> =  − 0.37).</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par29\">The results of this study clearly demonstrate the presence of amygdala and insula structural alterations in a BPD sample, highlighting their association with specific neuropsychiatric symptoms, such as emotion dysregulation, rumination and impulsivity. In addition, reduced functional connectivity between amygdala and different brain areas, mainly frontal areas, was also found in the BPD group compared to healthy controls.</p>", "<p id=\"Par30\">Previous functional brain imaging studies provide an approach in assessing the relationship between prefrontal cortex (PFC) and amygdala function by examining the correlation coefficients between these two structures [##REF##17203018##30##]. Human studies, mainly carried out in healthy subjects, with fMRI and with 18-fluorodeoxyglucose (FDG)-positron emission tomography (PET), showed significant correlation between these two structures; however, the directionality of these correlations was inconsistent. Some studies showed positive correlations between regions of PFC and amygdala [##REF##15880108##31##]; instead, other studies negative correlations [##REF##10683827##32##]. The amygdala has been implicated not only in the processing of negative emotions in general, but also more specifically in the regulation of aggressive behavior. In primates, bilateral ablation of the amygdala leads to increased social affiliation and decreased aggression [##REF##11439444##33##, ##REF##10594668##34##], demonstrating a central role of the amygdala in the processing of aggressive behaviors. Moreover, recent human studies showed that bilateral amygdala radio-frequency ablation improved behavior in patients presenting refractory aggressive behavior [##REF##30690521##35##].</p>", "<p id=\"Par31\">Our data showed in a BPD population the association between functional amygdala alteration and two symptoms related to pathological aggression: impulsivity and anger rumination. The association between impulsivity traits and amygdala in patients with borderline personality disorder has been recently described by Eskander and colleagues [##REF##32923187##36##]; instead, the neural correlates of anger rumination, a poorly studied construct, remain a matter of debate.</p>", "<p id=\"Par32\">In this study, we also found an association between anger rumination and reduced insula cortical thickness, indicating a role played by both limbic structures in this specific trait. These findings contribute to increase the understanding of the neural processes related to the risk of aggressive behavior by specifying that both insula and amygdala are involved in the subjective experience of anger rumination that, as described by Martino and colleagues [##REF##29024226##37##], predicts aggression proneness. As the Emotional Cascades Model (ECM) [##REF##19413411##38##] states that emotional dysregulation is amplified and exacerbated by rumination in a positive feedback loop, which leads to ‘cascades of emotion’ [##REF##29182951##1##], in this study, we showed a strong association between impulsivity and anger rumination, which are both related to limbic structures alterations (i.e. amygdala and insula).</p>", "<p id=\"Par33\">To the best of our knowledge, this is the first study that describes the neural correlates of anger rumination in a BPD population using both structural and functional techniques. In a previous study, Denson and colleagues run an fMRI experiment, with healthy young volunteers, during which participants were insulted and induced to ruminate [##REF##18578600##39##]. Authors found that different neural regions, including insula, have been specifically linked to anger rumination. More recently, an fMRI study with 13 women with BPD, despite limitations related to the small sample size, found increase activation in the insula and in the orbitofrontal cortex in response to negative feedback [##UREF##4##40##]. As the insula regulates affective distress, and its alteration in patients with BPD is involved in reactivity to social rejection, this result was interpreted as contributing to their greater reactivity to criticism and their tendency to put greater efforts to regulate emotional responses [##UREF##4##40##]. Beside these preliminary evidence, we found specific association with functional but also structural alteration of amygdala and insula when considering only the female subgroup of patients with BPD, but also when considering the whole sample. The ratio of males/females of BPD patients recruited in this study is consistent with epidemiological studies and with the routine access to community mental health services, where patients are usually referred [##REF##30306417##41##]. Hence, despite the number of studies in borderline personality disorder patients, gender differences related to symptoms and/or associated with specific brain structural and functional alterations have not been adequately addressed in the literature; therefore, results are still inconclusive.</p>", "<p id=\"Par34\">The results of this study clearly demonstrate the presence of amygdala and insula alterations in a BPD population and these two limbic structures seem to be implicated in different neuropsychiatric symptoms. Further studies with larger and homogeneous samples, controlling for gender and comorbidities, are needed to confirm these preliminary results and to provide additional insights about the association between specific neuropsychiatric symptoms and different brain structures, shedding light on the relevance of neuroimaging biomarkers in borderline personality disorder.</p>" ]
[]
[ "<p id=\"Par1\">Borderline Personality Disorder (BPD) is a severe mental disorder, characterized by deficits in emotion regulation, interpersonal dysfunctions, dissociation and impulsivity. Brain abnormalities have been generally explored; however, the specific contribution of different limbic structures to BPD symptomatology is not described. The aim of this study is to cover this gap, exploring functional and structural alterations of amygdala and insula and to highlight their contribution to neuropsychiatric symptoms. Twenty-eight BPD patients (23.7 ± 3.42 years; 6 M/22F) and twenty-eight matched healthy controls underwent a brain MR protocol (1.5 T, including a 3D T1-weighted sequence and resting-state fMRI) and a complete neuropsychiatric assessment. Volumetry, cortical thickness and functional connectivity of amygdala and insula were evaluated, along with correlations with the neuropsychiatric scales. BPD patients showed a lower cortical thickness of the left insula (<italic>p</italic> = 0.027) that negatively correlated with the Anger Rumination Scale (<italic>p</italic> = 0.019; <italic>r</italic> = − 0.450). A focused analysis on female patients showed a significant reduction of right amygdala volumes in BPD (<italic>p</italic> = 0.037), that correlate with Difficulties in Emotion Regulation Scale (<italic>p</italic> = 0.031; <italic>r</italic> =  − 0.415), Beck Depression Inventory (<italic>p</italic> = 0.009; <italic>r</italic> =  − 0.50) and Ruminative Response Scale (<italic>p</italic> = 0.045; <italic>r</italic> =  − 0.389). Reduced functional connectivity was found in BPD between amygdala and frontal pole, precuneus and temporal pole. This functional connectivity alterations correlated with Anger Rumination Scale (<italic>p</italic> = .009; <italic>r</italic> = − 0.491) and Barratt Impulsiveness Scale (<italic>p</italic> = 0.020; <italic>r</italic> = − 0.447). Amygdala and insula are altered in BPD patients, and these two limbic structures are implicated in specific neuropsychiatric symptoms, such as difficulty in emotion regulation, depression, anger and depressive rumination.</p>", "<title>Keywords</title>", "<p>Open access funding provided by Alma Mater Studiorum - Università di Bologna within the CRUI-CARE Agreement.</p>" ]
[]
[ "<title>Funding</title>", "<p>Open access funding provided by Alma Mater Studiorum - Università di Bologna within the CRUI-CARE Agreement.</p>", "<title>Declarations</title>", "<title>Conflict of interest</title>", "<p id=\"Par35\">The authors have no relevant financial or non-financial interests to disclose.</p>", "<title>Ethical approval</title>", "<p id=\"Par36\">The study was approved by the local Ethical Committee (#88866-24/07/2017), and written informed consent was obtained from all participants.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>Volume and cortical thickness differences between groups (all participants and only females): <bold>a</bold> amygdala volume; <bold>b</bold> insula cortical thickness. Representative axial and coronal T1-images from a healthy control showing, respectively, amygdala segmentation (<bold>a</bold>) and insular (<bold>b</bold>) (FreeSurfer 6.0 analysis). *<italic>p</italic> &lt; 0.05</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>Differences between groups in the cortical thickness of the insula subparts: <bold>a</bold> anterior (orange) and posterior (white) subparts; <bold>b</bold> posterior long gyrus (PLG) (in yellow) obtained from FreeSurfer 6.0 analysis and insula subdivisions (Faillenot et al. 2017); pink: ASG, red: AIC, turquoise: MSG, blue: PSG, green: ALG. *<italic>p</italic> &lt; 0.05</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p>Functional connectivity differences (decreased connectivity) between groups: <bold>a</bold> right amygdala (seed); <bold>b</bold> left amygdala (seed)</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p>Functional connectivity differences (increased connectivity) between the two female sub-groups: <bold>a</bold> right anterior insula (seed); <bold>b</bold> left anterior insula (seed)</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Demographic and clinical features of the study groups</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\"/><th align=\"left\">BPD <italic>N</italic> = 28</th><th align=\"left\">Healthy controls <italic>N</italic> = 28</th><th align=\"left\"><italic>p</italic> value</th></tr></thead><tbody><tr><td align=\"left\">Age (mean ± SD, years)</td><td align=\"left\">23.7 ± 3.4</td><td align=\"left\">24.3 ± 2.8</td><td align=\"left\">0.465</td></tr><tr><td align=\"left\">Gender (M/F)</td><td align=\"left\">6/22</td><td align=\"left\">6/22</td><td align=\"left\">1</td></tr><tr><td align=\"left\">Laterality (R/L)</td><td align=\"left\">25/3</td><td align=\"left\">25/3</td><td align=\"left\">1</td></tr><tr><td align=\"left\">DERS</td><td align=\"left\">121.78 ± 13.96</td><td align=\"left\">65.04 ± 17.73</td><td align=\"left\"> &lt; 0.0001</td></tr><tr><td align=\"left\">BIS -11</td><td align=\"left\">74.63 ± 10.64</td><td align=\"left\">52.89 ± 8.78</td><td align=\"left\"> &lt; 0.0001</td></tr><tr><td align=\"left\">RRS</td><td align=\"left\">62.96 ± 9.03</td><td align=\"left\">39.32 ± 12.04</td><td align=\"left\"> &lt; 0.0001</td></tr><tr><td align=\"left\">ARS</td><td align=\"left\">34.19 ± 7.85</td><td align=\"left\">21.57 ± 7.03</td><td align=\"left\"> &lt; 0.0001</td></tr><tr><td align=\"left\">SHI</td><td align=\"left\">8.11 ± 4.03</td><td align=\"left\">0.79 ± 1.31</td><td align=\"left\"> &lt; 0.0001</td></tr><tr><td align=\"left\">BDI</td><td align=\"left\">25.5 ± 8.54</td><td align=\"left\">–</td><td align=\"left\">–</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[]
[ "<table-wrap-foot><p>Laterality was calculated using Edinburgh Handedness Inventory (Oldfield 1971)</p><p><italic>R</italic> right, <italic>L</italic> left, <italic>DERS</italic> Difficulties in Emotion Regulation Scale, <italic>BIS-11</italic> Barratt Impulsiveness Scale-11, <italic>RRS</italic> Ruminative Response Scale, <italic>ARS</italic> Anger Rumination Scale, <italic>SHI</italic> Self Harm Inventory, <italic>BDI</italic> Beck Depression Inventory</p></table-wrap-foot>", "<fn-group><fn><p>M. Mitolo, F. D’Adda, M. Menchetti and C. Tonon have contributed equally to this work.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"406_2023_1597_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"406_2023_1597_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"406_2023_1597_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"406_2023_1597_Fig4_HTML\" id=\"MO4\"/>" ]
[]
[{"label": ["16."], "surname": ["First", "Gibbon", "Spitzer", "Williams", "Benjamin"], "given-names": ["MB", "M", "RL", "JBW", "LS"], "source": ["Structured clinical interview for DSM-IV axis II personality disorders, (SCID-II)"], "year": ["1997"], "publisher-loc": ["Washington, DC"], "publisher-name": ["American Psychiatric Association"]}, {"label": ["17."], "surname": ["Gratz", "Roemer"], "given-names": ["KL", "L"], "article-title": ["Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale"], "source": ["J Psychopathol Behav Assess"], "year": ["2004"], "volume": ["26"], "fpage": ["41"], "lpage": ["54"], "pub-id": ["10.1023/B:JOBA.0000007455.08539.94"]}, {"label": ["21."], "surname": ["Baldetti", "Bartolozzi", "Fiore"], "given-names": ["M", "C", "F"], "article-title": ["La validazione italiana dell\u2019Anger Rumination Scale"], "source": ["Lavoro presentato al IV Forum sulla formazione in psicoterapia"], "year": ["2011"], "publisher-loc": ["Assisi"], "publisher-name": ["Ottobre 2001"], "fpage": ["14"], "lpage": ["16"]}, {"label": ["26."], "surname": ["Andersson", "Jenkinson", "Smith"], "given-names": ["JLR", "M", "S"], "article-title": ["Non-linear registration aka spatial normalisation"], "source": ["Technical report FMRIB technical report TR07JA2"], "year": ["2007"], "publisher-loc": ["Oxford"], "publisher-name": ["FMRIB Centre"]}, {"label": ["40."], "surname": ["Peters", "Chester", "Walsh", "DeWall", "Baer"], "given-names": ["JR", "DS", "EC", "CN", "RA"], "article-title": ["The rewarding nature of provocation-focused rumination in women with borderline personality disorder: a preliminary fMRI investigation"], "source": ["Borderline Personal Disord Emotion Dysregul"], "year": ["2018"], "volume": ["5"], "fpage": ["1"], "pub-id": ["10.1186/s40479-018-0079-7"]}]
{ "acronym": [], "definition": [] }
41
CC BY
no
2024-01-14 23:40:12
Eur Arch Psychiatry Clin Neurosci. 2024 Apr 22; 274(1):109-116
oa_package/c1/9c/PMC10786743.tar.gz
PMC10786744
38214824
[ "<title>Introduction</title>", "<p id=\"Par2\">Zaraibi goats are considered one of the most important economic sources of livestock to Egyptian peoples till now (Nowier et al. ##REF##31664649##2020##). Egypt has over 4.3 million goats, the majority of which are Baladi and Barki goats raised for meat production (Hassen and Tesfaye ##REF##25326441##2014##) and Zaraibi goats reared for milk production (Galal ##UREF##12##2005##). The Egyptian Nubian goat (E. Nubian), known as the Zaraibi or Nubi goat in Upper Egypt of the Arab Republic of Egypt, Zaraibi goats are one of the main ancestors of the common Anglo-Nubian goat (Aboul-Naga et al. ##UREF##0##2012##).</p>", "<p id=\"Par3\">One of the key components of animal production in Egypt and a significant source of red meat is the goat industry. The amount of goat meat produced in Egypt during the period (2015–2019) was about 30 thousand tons, which represents about 4.14% of the average total production of red meat in Egypt (Hosny et al. ##UREF##19##2022##).</p>", "<p id=\"Par4\">To increase goat production and population, successful reproduction is essential; hence, it is important to have a thorough understanding of animal physiology throughout the various stages of reproduction (Salve et al. ##UREF##29##2016##). Reproductive health issues hinder goat breeding development plans (Haile ##UREF##16##2014##). Reproductive disorders negatively impact goat producers, reducing food production and affecting threatened animal species’ persistence. Major abortions and pregnancy losses due to embryonic mortality constrain gestation in all livestock animals (Yadav et al. ##UREF##38##2021##). Abortion is a multifactorial phenomenon controlled by many factors, including infectious agents (bacterial, viral, fungal, and protozoan agents, etc. and non-infectious factors such as toxicities, malnutrition, stress, maternal endocrine imbalance, and ambient temperature (Hajiabadi et al. ##UREF##17##2022##).</p>", "<p id=\"Par5\">Heavy metals in animal feed and water can harm animal health due to their bioaccumulation (Agbugui and Abe ##UREF##1##2022##; Ghazzal et al. ##UREF##14##2022##). Exposure to sub-lethal quantities of Pb can negatively affect various biochemical and physiological systems (Elarabany and El-Batrawy ##UREF##9##2019##). Ruminants are often exposed to toxic environmental toxins, posing a threat to animal health (Gensa ##UREF##13##2019##; Mridula et al. ##UREF##26##2022##). These toxins affect various organs, like the reproductive, nervous, respiratory, liver, gastrointestinal, and endocrine systems (Volkov and Ezhkova ##UREF##34##2020##; Bíreš et al. ##REF##7865991##1995##). They caused poor body conditions, slowed reproduction rates, and cancer due to their mutagenicity, teratogenicity, and carcinogenicity (Bíreš et al. ##REF##7865991##1995##; Dasharathy et al. ##UREF##8##2022##).</p>", "<p id=\"Par6\">Lead is a reproductive toxin that affects female animals’ reproduction, causing endometritis in ewes (Stoev et al. ##UREF##32##1997##), decreased fertility in cows )McEvoy and McCoy ##UREF##24##1993##), poor conception rates, decreased heat detection, and longer service intervals in buffalo cows (El-Tohamy et al. ##UREF##10##1997##).</p>", "<p id=\"Par7\">Pregnancy detection is crucial for animal production systems to avoid abortion in herds due to unknown causes (Smith et al. ##REF##25727670##2015##). Therefore, the reproductive process for any animal production system must include a crucial stage known as pregnancy detection for decisions on rebreeding or culling non-pregnant females. Early, accurate, and practical methods are needed for reproductive performance improvement (Arashiro et al. ##REF##29096272##2018##). Various methods, including abdominal palpation, radiography, ultrasonography, and hormone detection, are being used in small ruminants with variable diagnostic accuracy. This helps in making informed decisions on rebreeding or culling non-pregnant females.</p>", "<p id=\"Par8\">Numerous methods for small ruminant pregnancy detection have been developed to optimize reproductive performance in goats (Karadaev ##UREF##20##2015##). The ideal pregnancy test should have high sensitivity, specificity, and simplicity in conducting under field conditions (Pohler et al. ##UREF##28##2016##).</p>", "<p id=\"Par9\">Pregnancy-associated glycoproteins (PAG), a large family of inactive aspartic proteinases, are only secreted by mono- and bi-nucleate trophectoderm cells (Xie et al. ##UREF##37##1991##). Since PAG only has ruminant placental origin, it is thought to be a better appropriate biomarker for pregnancy in goats (Roberts et al. ##REF##28043363##2017##). Bovine species have had 22 PAG genes (boPAG-1 to boPAG-22) cloned and fully sequenced (Garbayo et al. ##REF##17204380##2008##). Not all PAGs are detectable at the same period of gestation; some arrive earlier and others later (Green et al. ##REF##10819764##2000##). While some (bPAG-1, bPAG-6, and bPAG-7) are present from the middle to the end of pregnancy, others (bPAG-4, bPAG-5, and bPAG-9) start to appear about day 25 but are missing in the last stages of pregnancy (Green et al. ##REF##10819764##2000##).</p>", "<p id=\"Par10\">Zamfirescu et al. (##UREF##39##2011##) reported that progesterone (P<sub>4</sub>) and pregnancy-associated glycoproteins (PAGs) were considered as laboratory tools for pregnancy detection and observed that the quantitative measurement of (PAGs) can be used to confirm early gestation in goats.</p>", "<p id=\"Par11\">The current study is part of an integrated research project to identify the environmental factors that may be the direct and/or indirect cause of the frequent and noticeable abortion of female goats on many animal farms in Egypt. This resulted in a sharp and noticeable decline in livestock and in the number of goats, resulting in a reduction in the meat of female Zaraibi goats in animal farms. To achieve this goal, physiological parameters of progesterone (P<sub>4</sub>), pregnancy-associated glycoprotein 1 (PAG1), and ambient ionic pollutants of lead (Pb) in the blood were measured in pregnant goats. The regression and correlation analyses were performed to determine the significant relationships and correlation coefficients of ambient Pb ions with gestation stages and serum PAG1 and P<sub>4</sub> levels to clarify their effect on abortion.</p>" ]
[ "<title>Materials and methods</title>", "<title>Management of animals</title>", "<p id=\"Par12\">The animals were kept as part of the flock of the Animal Production Research Institute (APRI) and Agriculture Research Center (ARC) Sakha Experimental Station in Kafr El-Sheikh governorate (31.089°N, 30.951°E). The current study comprised 40 healthy and disease-free multiparous estrous-cycle native Egyptian Zaraibi goats (<italic>C. hircus</italic>). Throughout the trial, the animals were group-housed and maintained in a semi-intensive management system with uniform dietary conditions (65% undercoated cottonseed cake, 11% rice straw, 18% wheat bran, 3% molasses, 2% limestone, and 1% salt), 660 g/head/day and free access to water and salt blocks. This portion of the field study lasted for five months, from May to September 2018.</p>", "<p id=\"Par13\">A single vasectomized male Zaraibi goat (an infertile male) was introduced twice daily at 8 a.m. and 4 p.m. to detect the estrus phase of the does. Five viable mature fertile male Zaraibi goats (bucks) were used for mating estrus females. Mating was allowed to occur spontaneously for 45 days, and pregnant goats were identified using ultrasound and ultrasonography.</p>", "<p id=\"Par14\">Ultrasound investigations were conducted using ultrasound (Renco Preg-Tone), according to Quintela et al. (##REF##22681297##2012##). Transrectal ultrasonography was performed on all animals until the 60th day of pregnancy (ESOATE Pie Medical Aquila Pro-Vet + probe, 6.0 MHz LA Rectal Veterinary Transducer), as described by Padilla-Rivas et al. (##UREF##27##2005##). Ultrasonography of the pregnant uterus revealed an anechoic embryonic vesicle (black) encircling the echoic (white) elongated streak (foetus), which extended across more than half of the fetal fluid. Ultrasonography revealed that 28 of the 40 goats were pregnant, while the remaining 12 did not become pregnant and were therefore excluded from the study. Eight goats aborted during pregnancy, while the remaining 20 goats gave birth to 12 singles and eight twins. As a result, there were 12 single and eight twin pregnancies.</p>", "<p id=\"Par15\">Prior to the trials, all goats had received vaccinations against the most contagious diseases. The Institutional Animal Care and Use Committee (IACUC) of Cairo University authorized the care and handling of animals under the permit CU/I/S/96/17. All measurements performed in compliance with the veterinary standards were approved by the Animal Ethics Committee of the Institute.</p>", "<title>Blood sampling</title>", "<p id=\"Par16\">Blood samples were obtained by jugular venipuncture. The blood was collected in non-heparinized tubes at room temperature and then centrifuged at 3000 × g for 15 min at 4 °C to separate the serum that was stored at − 20°C until measurements of lead (Pb), pregnancy-associated glycoprotein 1 (PAGs), and progesterone (P<sub>4</sub>) levels in the serum of aborted and non-aborted goats.</p>", "<title>Hormone assay</title>", "<title>Pregnancy-associated glycoprotein 1</title>", "<p id=\"Par17\">The estimation of pregnancy-associated glycoproteins (PAGs) levels was quantified by enzyme-linked immunosorbent assay (ELISA) using a bovine pregnancy-associated glycoproteins 1 (PAG1) ELIZA kit using kits from Shanghai Coon Koon Biotec Co., Ltd., Room 1408, 1687 Chang Yang RD, Shanghai, China. Cat No. CK-bio-18624, Standard Curve Range: 1–48 ng/ml; sensitivity: 0.1 ng/ml). The assay was conducted according to the procedures described in the enclosed catalog, and an automatic photometer plate reader was used for readings of absorbencies. The intra-assay precision (CV%) was less than 10%. The inter-assay precision (CV%) was &lt; 15%. The computed level of PGA1 in serum was expressed as nanograms per milliliter (ng/ml).</p>", "<title>Progesterone assay</title>", "<p id=\"Par18\">Serum progesterone (P<sub>4</sub>) levels were measured by radioimmunoassay (RIA) using a DIA source PROG-RIA-CT Kit (KIP1458; DIA source ImmunoAssays S.A., Rue du Bosquet, 2, B-1348 Louvain-la-Neuve, Belgium).the principle of this method was described by (Alper et al. ##REF##3595917##1987##). The computed concentration of progesterone (P4) in serum was expressed as nanograms per milliliter (ng/ml).</p>", "<title>Lead assay</title>", "<p id=\"Par19\">The lead (Pb) ion serum content was estimated using inductively coupled plasma mass spectrometry (ICP-MS), according to(Morsy et al. ##REF##24097360##2016##). The sera were completely digested by concentrated nitric acid that evaporated after complete digestion until yellowish-white ash appeared on the wall of the test tube. The precipitate was dissolved in 3 ml HCl and diluted with deionized water. The estimated lead (Pb) level in the serum was expressed as μg/dl.</p>", "<title>Statistical analysis</title>", "<p id=\"Par20\">The Kolmogorov-Smirnov test confirmed that the current data were normally distributed; hence, a parametric statistical analysis was used. Accordingly, the repeated-measures greenhouse two-way analysis of variance (ANOVA) due to the non-homogeneity of the raw data was applied to clarify the significant changes in the studied dependent variables of Pb, PAGs, and P4 contents as direct responses of the independent variables of the pregnancy intervals (28, 46, 60, 88, 108, 128, and 148 days) and, in turn, the effect of these parameters on cases of birth (abortion and delivery of one or two fetuses). In addition, post hoc analysis of variance (ANOVA) of Schiff’s test was used to compare dependent values.</p>", "<p id=\"Par21\">Regression analysis and correlation coefficients were computed to fit the relationship between the interval pregnancy period (independent variable) and the dependent variables, as well as the association between the levels of Pb ions in the serum and the concentrations of P<sub>4</sub> and PAG1 in the serum of aborted goats. The levels of studied parameters at, above, or below which abortion occurred were identified using diagnostic statistical analysis of receiver operating characteristic (ROC) curves. IBM Statistical Package for the Social Sciences, version 28, was used to analyze the data.</p>" ]
[ "<title>Results</title>", "<p id=\"Par22\">The ultrasonographic images of Zaraibi goats showed that 28 (70%) of the 40 (100%) females were pregnant, while 12 females (30%) were not. On days 30, 39, 52, 63, 72, 76, 90, and 101, respectively, eight of the 28 pregnant goats miscarried and lost their fetuses (28.6%), whereas the other 20 goats (71.4%) carried their pregnancies to term. Of the 20 pregnant goats that were photographed, eight (40%) had uteruses that held twins, while the uteruses of the remaining 12 females (60%) each carried a single kid (Photo ##FIG##0##1##).</p>", "<p id=\"Par23\">Repeated-measures two-way analysis of variance demonstrated that the pregnancy stage had a significant effect on the levels of serum Pb, PAG 1, and P<sub>4</sub> in pregnant Zaraibi goats, which in turn had a substantial effect on abortion and the number of kids born (Table ##TAB##0##1##).\n</p>", "<p id=\"Par24\">According to the post hoc analysis of variance (ANOVA) for Scheffe’s test, the serum Pb content of aborted goats was significantly higher than that of goats that delivered one or two kids throughout all pregnancy periods, whereas in goats that delivered a single kid or twins did not differ (Table ##TAB##1##2##). The gestation stages (28, 46, 60, 88, 108, 128, and 148 days) had a significant direct exponential relationship with the levels of Pb in aborted goats and were accompanied by marked positive correlation coefficients of + 0.98 (Table ##TAB##1##2##).\n</p>", "<p id=\"Par25\">The levels of PAG1 and P<sub>4</sub> in the serum of goats that gave birth to a single kid or twin were substantially greater than those in goats that had an abortion at all corresponding stages of pregnancy (Table ##TAB##1##2##). Additionally, PAG1 and P<sub>4</sub> concentrations in twin-bearing goats were significantly higher than those in single-bearing goats at all stages (Table ##TAB##1##2##). As shown in Table ##TAB##1##2##, according to the regression analysis and correlation coefficient, in aborted goats, the levels of serum PAG1 and P<sub>4</sub> content exhibited a significant inverse power and exponential relationship with the gestational stages and were associated with a significant negative correlation coefficient of − 0.78 and − 0.94, respectively (Table ##TAB##1##2##), that is, the levels of PAG1 and P<sub>4</sub> decreased with increasing gestational stage time.</p>", "<p id=\"Par26\">As shown in Fig. ##FIG##1##1##, the serum Pb content of aborted goats exhibited a significant inverse power relationship with the concentrations of PAG1, and this was accompanied by a significant negative correlation coefficient of − 0.88, whereas with levels of P<sub>4</sub> showed a significant inverse exponential association with a significant correlation coefficient of − 0.77.</p>", "<p id=\"Par27\">As seen in Table ##TAB##2##3##, the receiver operating characteristic (ROC) analysis revealed that the threshold levels of Pb, P<sub>4</sub>, and PAG1 in the serum of aborted goats were ≥ 32.08 μg/dl, ≤ 0.48 ng/ml, and ≤ 0.95 ng/ml, respectively, with a significant area under curves (AUC) of 1.00 (Table ##TAB##2##3##). This means that the serum Pb level of ≥ 32.08 μg/dl will cause abortion, but below this value will not, and vice versa for P<sub>4</sub> and PAG1 ≤ 0.48 ng/ml and ≤ 0.95 ng/ml will induce abortion. In addition, as shown in Fig. ##FIG##2##2##, the threshold values of P<sub>4</sub> and PAG1 required to induce give birth to twins were ≥ 12.34 ng/ml and ≥ 31.52 ng/ml with significant excellent AUC of 0.96 and 0.90, respectively.\n</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par28\">The current findings showed that the bioavailability of blood lead (Pb) levels in aborted goats was significantly higher than that of non-aborted goats at most pregnancy stages. Even though Zaraibi goats were supported by veterinary care under livestock breeding management, laboratory measurements affirmed the presence of Pb in the blood of all non-aborted and aborted goats in varying proportions, indicating that their environment was lead-contaminated. Most toxicologists and environmental pollution experts believe that the presence of Pb in most mammalian tissues, including blood, is normal and not unusual, but in proportions consistent with the permissible limit decided by UNESCO (WHO ##UREF##35##1987##). This clarifies and explains the Pb ion bioaccumulation in most tissues, including blood, of both aborted and non-aborted goats because of Pb environmental exposure (Azeh Engwa et al. ##UREF##2##2019##) as in our current findings.</p>", "<p id=\"Par29\">The route of exposure, the physiochemical characteristics, and the toxicokinetic of the Pb molecule, as well as an individual’s age and nutritional status, all have an impact on how much lead is absorbed (Morrow et al. ##REF##7408808##1980##). The levels of free Pb ions reaching systemic blood circulation, because of their absorption via all routes of exposure, are called bioavailability of Pb. According to previous studies, 40% of Pb that is inhaled is deposited in the lungs, and deposited in the lower respiratory tract absorbs almost entirely (Morrow et al. ##REF##7408808##1980##). The duodenum is where Pb is largely absorbed during digestion; however, age and nutritional state can have a significant impact on how quickly lead is absorbed (Graziano et al. ##REF##8820585##1996##). Pb can also be absorbed via healthy skin (Wright et al. ##UREF##36##2003##). Accordingly, about 95% of the available lead is transported and distributed those ions to all tissues (Stauber et al. ##REF##8016629##1994##) .</p>", "<p id=\"Par30\">In systemic circulation, the bioavailable Pb attaches to hemoglobin in erythrocytes and is then easily transferred to soft tissues such as the kidney, liver, reproductive organs (ovaries, placenta, etc.), and central nervous system (Goutam Mukherjee et al. ##REF##35358731##2022##). Pb accumulates and is stored largely in bones and teeth after redistribution, accounting for up to 90% of the total Pb body burden (Barry ##REF##1131339##1975##). Pb has a half-life of 30 days in blood and most soft tissues, but a half-life of up to 25 years in bone (Hu et al. ##REF##9417769##1998##). Pb produced from bones is a significant endogenous exposure route and/or source that can contribute up to 50% of the blood Pb levels in the absence of exogenous exposure, physiologically, Pb is easily absorbed by the fetus through the placenta and builds up in breast milk (Gulson et al. ##REF##9755144##1998##). On the basis of toxicokinetics, urine and/or biliary clearance are the main pathways by which ingested Pb is expelled from the body via Phase I and II biotransformation; however, in goats and most models of mammalian organisms, biliary clearance outpaces urine excretion of Pb (Rădulescu and Lundgren ##REF##30626917##2019##). Accumulating research also suggests that kids excrete ingested Pb at a slower pace than adults, which may contribute to extended retention durations in kids (Stauber et al. ##REF##8016629##1994##)</p>", "<p id=\"Par31\">Our current data show that the levels of Pb ions in the serum of non-aborted goats were much lower than those of aborted goats. This demonstrates that abortion is entirely reliant on the concentration of Pb ions in goat serum, as well as their bioaccumulation in their tissues, particularly the ovary, placenta, and liver (Canaz et al. ##REF##28551014##2017##). Statistically, the serum Pb concentration threshold value to trigger abortion was ≥ 32.08 μg/dl. This means that the Pb concentration required to induce abortion was ≥ 32.08 μg/dl, implying that Pb concentrations below this level will not cause abortion as demonstrated in our non-aborted goats. This interpretation is reinforced by the fact that blood Pb ion levels in mothers at all stages of pregnancy were substantially below the threshold level and failed to disturb levels of progesterone (P<sub>4</sub>) and pregnancy-associated glycoprotein1 (PAG1) and consequently allowing the pregnancy to continue to term as will discuss below.</p>", "<p id=\"Par32\">In aborted goats, according to the current results, the serum Pb contents were significantly higher than those of non-aborted goats at all the gestation stages. In addition, there was a significant exponential direct relationship between the gestational stages (28, 46, 60, 88, 108, 128, and 148 days), and the levels of Pb ions content, and this was accompanied by a significant positive correlation coefficient. Accordingly, this relationship confirmed the existence of vital continued accumulations of Pb in the serum of aborted goats and consequently in soft tissues of the reproductive system especially the ovaries and placenta (Massányi et al. ##UREF##23##2020##).</p>", "<p id=\"Par33\">Pregnancy-associated glycoproteins (PAGs), in mammals including goats, are a group of glycoproteins mainly produced by the trophoblast cells of the placenta of mammals. PAGs have been shown to be useful for identifying the presence of vital embryos and for pregnancy follow-up monitoring, particularly in bovine, goats, and other dairy animals (Barbato et al. ##UREF##4##2022##; Filho et al. ##REF##31539641##2020##). In ruminants, PAGs are synthesized in the mono- and binucleate cells of the trophectoderm and released into maternal blood circulation where they can be quantified (Zoli et al. ##REF##1547318##1992##). PAG1 have been identified and immunolocalized as part of the discoidal-type placenta in some mammalian species (Panasiewicz et al. ##REF##30616842##2019##).</p>", "<p id=\"Par34\">Several studies on goats have linked high PAG concentrations to a decrease in the activity of polymorphonuclear neutrophils (Dosogne et al. ##REF##9950353##1999##), implying that trophoblast PAG production, influencing maternal immunological status, could be a mechanism by which the conceptus protects itself from rejection. PAGs, as stated by Austin et al. (##REF##9886868##1999##), play a hormonal role in the release of granulocyte chemotactic protein-2 (GCP-2), an α-chemokine whose production is stimulated by interferon-τ (IFN-τ) in early pregnancy (Barbato et al. ##UREF##4##2022##). As a result, IFN-τ and PAGs would play a similar role in the activation of this chemokine, which appears to be implicated in the start of pregnancy. As a result, PAGs have been proposed as a luteotropic component of the placenta (Xie et al. ##REF##7534122##1994##).</p>", "<p id=\"Par35\">Our present results demonstrated that the PAG1 content of goats who gave birth to twins was significantly higher than those who gave birth to a single kid. PAG1 levels in maternal circulation are higher in twin-bearing goats than in single-fetus goats (González et al. ##UREF##15##2000##; Sousa et al. ##UREF##30##1999##), and they are also higher (about ten times) in inter-specific pregnancies than in normal intra-specific gestation (Morecroft et al. ##REF##25576462##2015##), which is consistent with our findings. González et al. (##UREF##15##2000##) found that the goat that delivered twin fetuses had higher PAG concentrations than those that delivered a single fetus. Moreover, in native North Moroccan goats. Chentouf et al. (##REF##18507794##2008##) observed statistical differences between goats carrying one or two fetuses. Vasques et al. (##UREF##33##1995##) proposed the relationship between fetal growth rate and PAGs increase during pregnancy in cows as the important decline in PAG1 was reflected by stopped trophectoderm development. Additionally, the successive monitoring of PAG1 in goats also enables the identification of trophoblastic activity disorders that result in fetal death (Zarrouk et al. ##UREF##40##1999##; Batalha et al. ##UREF##5##2001##; Faye et al. ##REF##15451252##2004##).</p>", "<p id=\"Par36\">As observed in our results, PAG1 are typically detectable in maternal blood starting from around day 28 of pregnancy in cattle (Barbato et al. ##UREF##4##2022##). The levels of PAG1 increase as the pregnancy progresses and can reach peak levels at different time points depending on the species and individual animal. Different goat breeds may have variations in their PAG profiles, and some breeds may have higher or lower levels of PAGs compared to others (Morecroft et al. ##REF##25576462##2015##).</p>", "<p id=\"Par37\">Progesterone (P<sub>4</sub>) is a steroid hormone that plays a crucial role in the regulation of female reproductive physiology, such as ovulation, implantation, pregnancy maintenance, and lactation (Kolatorova et al. ##UREF##21##2022##). It exerts its effects by binding to progesterone receptors (PRs), which are expressed in various tissues, such as the uterus, mammary gland, brain, and bone (Dinny Graham and Clarke ##REF##9267762##1997##). During pregnancy, progesterone production is essential for the maintenance of gestation (Arck et al. ##REF##17681043##2007##). The corpora lutea, formed on the ovary after ovulation, produce progesterone in goats (Gaafar et al. ##UREF##11##2005##). The progesterone levels are highest during mid-pregnancy and gradually decline towards parturition (Convey ##REF##4369168##1974##). It is involved in regulating the estrous cycle and preparing the uterus for pregnancy. It helps to maintain the uterine environment required for successful implantation and embryonic development (Lonergan ##REF##21855985##2011##). Progesterone levels in goats can be used for pregnancy diagnosis and determination. Low progesterone levels can indicate that a doe is not pregnant, while high levels alone do not confirm pregnancy but rather indicate the presence of progesterone (Rawlings and Ward ##REF##892216##1977##). In addition to its role in reproduction, progesterone also plays a crucial role in synchronizing estrus in goats. Progestogens, which are synthetic derivatives of progesterone, have been used for estrus synchronization in goats (Rawlings and Ward ##REF##892216##1977##). They help to regulate and control the timing of estrus, allowing for more controlled breeding practices. P<sub>4</sub> plays an important role in uterine growth promotion and myometrium contractility suppression, oocyte maturation, implantation facilitation, and pregnancy maintenance in the uterus and ovary (Huang et al. ##REF##15793702##2005##). It provided the lobular-alveolar development in the mammary gland to prepare for milk production and reduce milk protein synthesis before parturition (Woo and Shadel ##REF##21215364##2011##).</p>", "<p id=\"Par38\">Our results revealed that the levels of progesterone (P<sub>4</sub>) in the peripheral plasma of pregnant goats increased after mating and remained high from day 28 to day 148 of pregnancy. These findings are consistent with those of Thorburn and Schneider (##REF##5061155##1972##) who found that throughout early pregnancy, plasma progesterone concentrations remain constant from day 8 to day 60, then increase between days 60 and 70, and remain stable until just before parturition. In the pregnant goat, the ovary is the primary location of progesterone production, while production by the placenta is minimal and unlikely to alter the level of this hormone in maternal circulation.</p>", "<p id=\"Par39\">In the present results, levels of PAG1 and P<sub>4</sub> produced and released by the placenta and corpus luteum, respectively, were sufficient for pregnancy maintenance in Zaraibi goats. According to Sawada et al. (##REF##7985207##1994##), the levels of P<sub>4</sub> and PAG1 in the serum began to rise after 10 days of mating and persisted up until 140 days of pregnancy before rapidly declining one day before parturition. This is consistent with our current results, with the difference that each of the PAGs and P<sub>4</sub> reached their highest average on day 88 after mating, then began to decrease slowly and gradually until the date of birth. On the other hand, the PAG and P<sub>4</sub> levels in our data were different from those reported by González et al. (##REF##15289050##2004##) and Chentouf et al. (##REF##18507794##2008##). We attribute this to the homologous or heterologous goat breed variants that affect P<sub>4</sub> synthesis, and this reflects the genetic strategy for maintaining a pregnancy under severe conditions (Sousa et al. ##UREF##30##1999##). PAGs and P<sub>4</sub> synthesis differ by breed, which reflects a genetic strategy for maintaining a pregnancy under the severe conditions of our Egyptian farm, according to their current levels.</p>", "<p id=\"Par40\">Physiologically, the reactive oxygen species (ROS), which are produced during pregnancy because of metabolic changes in the mother and fetus, are required for the proliferation, differentiation, and maturation of developing cells. This is because the development of the fetal organs during pregnancy requires an appropriate supply of nutrients and oxygen (Bak and Roszkowski ##UREF##3##2013##).</p>", "<p id=\"Par41\">The placenta of the mother is dyspeptic with mitochondria, which are the primary source of energy since they create and release pro-oxygenates, earning them the moniker “ROS factories” and/or “powerhouses.” The superoxide anion radical, which is formed in vast amounts, is a generator of more reactive oxygen, such as hydrogen peroxide and hydroxyl free radicals. Their production increases as the pregnancy progresses, which is mostly due to an increase in placental mass (Toboła-Wróbel et al. ##UREF##31##2020##).</p>", "<p id=\"Par42\">During normal pregnancy, the phenomenon of the mother’s immunological tolerance to the fetus’ antigens, which permits the kid to develop in the uterus despite the pregnant female’s ability to reject the foreign antigen, is a crucial factor in a pregnancy that is progressing normally (Toboła-Wróbel et al. ##UREF##31##2020##). The creation of ROS is reduced in a normally functioning pregnant organism due to the reduced activities of the immune system (Moore et al. ##UREF##25##2019##). Low levels of ROS work physiologically as a defensive mechanism against pathogenic pathogens (Puertollano et al. ##REF##21506934##2011##) as in non-aborted goats as mentioned above.</p>", "<p id=\"Par43\">High bioaccumulation of serum Pb content reflects its high concentrations in various tissues; they exacerbate oxidative stress in tissues because of the overproduction of ROS by direct action in the mitochondrial electron transport chain, resulting in cellular peroxidation of lipids, proteins, and DNA (Belyaeva et al. ##REF##18501399##2008##), resulting in a cycle of cellular or molecular damage (Bouayed and Bohn ##REF##20972369##2010##) and inflammation in the placenta, which can affect the synthesis and secretion of PAGs and other hormones Mason et al. ##UREF##22##2014##). On the other hand, Pb accumulates in the tissues of the fetus throughout certain developmental phases of pregnancy, when it then displays its harmful effects (Mason et al. ##UREF##22##2014##). Additionally, abnormal high Pb accumulation can impair the expression and function of placental transporters, such as amino acid transporters and glucose transporters, which are essential for fetal nutrition and development (Collin et al. ##UREF##7##2022##).</p>", "<p id=\"Par44\">As a response to the oxidative stress, it may be suggested that the abortion in goats could be attributed to the reduction of essential elements such as P, Fe, and Zn (Casas and Sordo ##UREF##6##2006##); the reduction of total proteins (Collin et al. ##UREF##7##2022##) required for the synthesis of progesterone (P<sub>4</sub>); and the alteration in gene expression related to enzymatic and hormonal codes because of the overproduction of ROS (Hernández-Coro et al. ##REF##33819547##2021##).</p>", "<p id=\"Par45\">According to the current findings, P<sub>4</sub> levels in the blood of aborted goats were significantly reduced and had an inverse relationship with serum levels of Pb. This may be attributed to the partial or complete block of protein synthesis as shown in current data, which consequently reduces the process of protein synthesis needed for progesterone (P<sub>4</sub>) synthesis. This assumption is confirmed by the severe drop in the level of P<sub>4</sub> in the blood to a level not enough to fix the attachment of embryos to the placenta, causing abortion. This may be attributed to Pb accumulation which might enhance the overproduction of ROS, leading to oxidative damage of the mitochondria and endoplasmic reticulum, which are responsible for energy production and protein synthesis, respectively. In our current data on aborted goats, the threshold level of P<sub>4</sub> to induce abortion was ≤ 0.48 ng/dL. The inhibition of P<sub>4</sub> may also be referred to as the toxicity of Pb that alter and/or disturb the gene expression of endogenous antioxidants (Mao et al. ##REF##29397540##2018##). Hamed et al. (##UREF##18##2012##) reported that Pb caused severe damage to DNA in the brain, liver, kidney, and reproductive tissues, leading to the production of abnormal strands of mRNA that control the synthesis of P<sub>4</sub>, consequently reducing its production. Pb bioaccumulation caused a significant disturbance in DNA molecular structure that, of course, altered the gene expression of mRNA, causing a significant depletion in the synthesis of proteins in the cells and leading to the shortage of protein precursors required for P<sub>4</sub> synthesis.</p>", "<p id=\"Par46\">In conclusion, the current results affirmed the following:<list list-type=\"order\"><list-item><p id=\"Par47\">The lead ions accumulated in the serum of aborted goats were significantly higher than those of non-aborted goats.</p></list-item><list-item><p id=\"Par48\">The levels of PAG1 and P<sub>4</sub> in the blood of goats that gave birth to twins were significantly higher than those of goats that gave birth to single kids, and both were markedly higher than those of aborted goats.</p></list-item><list-item><p id=\"Par49\">In aborted goats, the time of gestation exhibited a significant direct exponential relationship with serum Pb content, accompanied by a significant positive correlation coefficient of + 0.98. In contrast, the levels of serum PAG1 and P<sub>4</sub> showed a significant inverse power and exponential relationship with the time of gestation, with significant negative correlation coefficients of − 0.78 and − 0.94.</p></list-item><list-item><p id=\"Par50\">The serum Pb content in aborted goats exhibited a significant inverse relationship with each of the PAG1 and P<sub>4</sub> levels, and these were associated with significant correlation coefficients of − 0.88 and − 0.77 respectively. This indicates that Pb accumulation is the main dependent factor that severely reduces the levels of serum PAGs and P<sub>4</sub>, which in turn causes abortion.</p></list-item><list-item><p id=\"Par51\">The threshold level of serum Pb content required to cause abortion was ≥ 32.08 μg/dl, whereas serum PAG1 and P<sub>4</sub> were ≤ 0.95 ng/ml and ≤ 0.48 ng/ml, respectively. The threshold levels ≥ 12.34 ng/ml and ≥ 31.52 ng/ml for P<sub>4</sub> and PAG1, respectively, were needed to deliver twins.</p></list-item><list-item><p id=\"Par52\">PAG1 and P<sub>4</sub> levels are also key factors in determining whether Zaraibi goats will give birth to twins.</p></list-item><list-item><p id=\"Par53\">The results of the current study shed light on pollutants and the extent of their impact on livestock in the Arab Republic of Egypt, which requires us to carry out more research that must work to combat pollution in all its forms, biologically and chemically, in order to advance livestock, through which we can fill the food gap as well as limit the economic deterioration of livestock, which is considered the food artery for the masses of Egyptian people who suffer from the deterioration of livestock.</p></list-item></list></p>", "<p id=\"Par54\">Based on our current field studies, we hope that the gentlemen responsible for managing animal farms will follow up on the different kinds of environmental pollution that have horrific effects on the productivity of those farms and work to treat and avoid destructive factors to avoid heavy losses to Egyptian income.</p>" ]
[]
[ "<p id=\"Par1\">This study aimed to investigate the impact of ambient lead (Pb) exposure on progesterone (P<sub>4</sub>) and pregnancy-associated glycoprotein 1 (PAG1) and their relationship with abortion in Egyptian Zaraibi goats (<italic>C. hircus</italic>). To achieve this, 40 female goats (does) were mated with highly fertile male goats, resulting in a total of 28 pregnant goats. Eight of them aborted, and each of the 12 pregnant goats gave birth to one kid, whereas the remaining eight gave birth to twins. The levels of PAG1, P4, and Pb in serum were estimated by enzyme-linked immunosorbent assay (ELISA), radioimmunoassay (RIA), and inductively coupled plasma mass spectrometry (ICP-MS) respectively. Statistically, the repeated measure two-way ANOVA, regression analysis, correlation coefficient, and receiver operating characteristic (ROC) curves were applied. The current data demonstrated that the levels of blood Pb in aborted goats were significantly higher than those in non-aborted goats at the early, mid, and late gestations, and this was followed by significant decreases in serum PAG1 and P<sub>4</sub>. Furthermore, there were substantial inverse associations between blood Pb concentration and levels of PAG1 and P<sub>4</sub>, with markedly negative correlation coefficients of − 0.88 and − 0.77, respectively, in aborted goats. The threshold level of Pb required to cause abortion was ≥ 32.08 μg/dl, but for PAG1 and P<sub>4</sub> were respectively ≤ 0.95 ng/ml and ≤ 0.48 ng/ml. Additionally, threshold levels of ≥ 12.34 ng/ml and ≥ 31.52 ng/ml for P<sub>4</sub> and PAG1, respectively, were needed to deliver twins. In conclusion, pollution-induced increases in Pb bioavailability resulted in dramatic decreases in P<sub>4</sub> and PAG1 levels, leading to abortions. PAG1 and P<sub>4</sub> levels are also key factors in determining whether Zaraibi goats will give birth to twins.</p>", "<title>Keywords</title>", "<p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p>" ]
[]
[ "<title>Author contribution</title>", "<p>The current manuscript is part of a doctoral thesis in the philosophy of science by the student AFM (first author), who carried out all the requirements of the thesis and research practically and in the laboratory under the supervision of professors supervising the manuscript as co-authors, as they participated in the conception and design of the current study to achieve its goal. Accordingly, the student examined the goats’ health, mating, pregnancy, and number of embryos until birth, as well as abortion cases, with the help of Dr. AMS (fourth author). Additionally, the student was sone material preparation, blood collection, and analysis with the aid of Prof. Dr. SME-N (second author) and Prof. Dr. FHAE-R (third author). The results, statistical analysis, data tabulation, and presentation were performed and written under the supervision of Prof. Dr. GMM (sixth author and corresponding author) and Associate Prof. Dr. AA-MA (fifth author). In addition to the above, the student wrote an interpretation of the statistical results with the help of Prof. Dr. SME-N, Dr. AMS, Prof Dr FHAE-R, Associate Prof. Dr. AA-MA, and Prof. Dr. GMM (corresponding author). All the authors have read and approved the final manuscript.</p>", "<title>Funding</title>", "<p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p>", "<title>Data availability</title>", "<p>All data analyzed during the current study are available from the corresponding author on request.</p>", "<title>Declarations</title>", "<title>Ethics approval</title>", "<p id=\"Par55\">An ethical approval was granted by the Institutional Animal Care and Use Committee (IACUC), Faculty of Science, Cairo University, Egypt with permit number: CU/I/S/96/17.</p>", "<title>Consent to participate and consent for publication</title>", "<p id=\"Par56\">All authors approved to participate in this work. Additionally, they gave their approval for the study’s methodology and manuscript’s submission to the journal Tropical Animal Health and Production.</p>", "<title>Conflict of interest</title>", "<p id=\"Par57\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Photo 1</label><caption><p>Transrectal ultrasonographic photos of two pregnant does. One had a single embryo at day 32 while the other had twins embryos at day 26</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 1</label><caption><p>The relationship between levels of lead (Pb, μg/dl) with each of the progesterone (P<sub>4</sub>, ng/ml) and pregnancy-associated glycoprotein (PAG1, ng/ml) content in the sera of aborted Zaraibi goats. The symbol * indicates a significant correlation coefficient between the studied parameters. The letter <italic>x</italic> indicated the levels of Pb ions in sera, whereas the letter <italic>y</italic> is the levels of PAG1 and P<sub>4</sub> throughout the gestation stages</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 2</label><caption><p>The receiver operating characteristic (ROC) curve determines the threshold level of serum P<sub>4</sub> (ng/ml) and PAG1 (ng/ml) required for twin pregnancy. The area under the curve (AUC) and its statistics are represented</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>The repeated measures greenhouse two-way ANOVA table that analyzes the changes of the levels of serum lead (Pb, μg/dl); the pregnancy-associated glycoprotein1 (PAG1, ng/ml), and progesterone (P<sub>4</sub>, ng/ml) contents in pregnant Zaraibi goats as a response to the pregnancy stages and their effect on the birth cases (abortion or non-abortion)</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Parameters</th><th>Source</th><th>SS</th><th>df</th><th>MS</th><th><italic>F</italic><sub>calculated</sub></th><th><italic>P</italic>-values</th></tr></thead><tbody><tr><td rowspan=\"3\">Pb</td><td>PP</td><td>285.851</td><td>3</td><td>89.325</td><td>22.241</td><td><italic>P</italic> &lt; 0.0001</td></tr><tr><td>PP*BC</td><td>633.278</td><td>6</td><td>98.946</td><td>24.637</td><td><italic>P</italic> &lt; 0.0001</td></tr><tr><td>Error</td><td>321.309</td><td>80</td><td>4.016</td><td/><td/></tr><tr><td rowspan=\"3\">PAG1</td><td>PP</td><td>3518.367</td><td>3</td><td>1112.609</td><td>114.180</td><td><italic>P</italic> &lt; 0.0001</td></tr><tr><td>PP*BC</td><td>4001.279</td><td>6</td><td>632.659</td><td>64.926</td><td><italic>P</italic> &lt; 0.0001</td></tr><tr><td>Error</td><td>770.355</td><td>79</td><td>9.744</td><td/><td/></tr><tr><td rowspan=\"3\">P<sub>4</sub></td><td>PP</td><td>38.328</td><td>3</td><td>12.325</td><td>14.729</td><td><italic>P</italic> &lt; 0.0001</td></tr><tr><td>PP*BC</td><td>186.284</td><td>6</td><td>29.951</td><td>35.794</td><td><italic>P</italic> &lt; 0.0001</td></tr><tr><td>Error</td><td>65.053</td><td>78</td><td>0.837</td><td/><td/></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Changes in serum lead (Pb, μg/dl), pregnancy-associated glycoproteins (PAG1, ng/ml), and progesterone (P<sub>4</sub>, ng/ml) contents of Zaraibi goats who aborted and those who gave birth to a single kid or twins during pregnancy stages (28, 46, 60, 88, 108, 128, and 148 days)</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th rowspan=\"2\">Pregnancy stages</th><th colspan=\"3\">Lead (Pb, μg/dl)</th><th colspan=\"3\">PAG1 (ng/ml)</th><th colspan=\"3\">Progesterone (P<sub>4</sub>, ng/ml)</th></tr><tr><th>Aborted</th><th>Single</th><th>Twins</th><th>Aborted</th><th>Single</th><th>Twins</th><th>Aborted</th><th>Single</th><th>Twins</th></tr></thead><tbody><tr><td>28</td><td>33.042 ± 1.242</td><td>9.74 ± 0.992*</td><td>9.02 ± 01.358*</td><td>2.963 ± 0.350</td><td>9.492 ± 0.286*</td><td>27.231 ± 0.638*<sup>■</sup></td><td>3.417 ± 0.322</td><td>8.832 ± 0.263*</td><td>11.024 ± 0.322*<sup>■</sup></td></tr><tr><td>46</td><td>34.681 ± 0.967<sup><bold>a</bold></sup></td><td>9.46 ± 0.991*</td><td>9.74 ± 0.357*</td><td>1.729 ± 0.580</td><td>12.976 ± 1.974*<sup><bold>a</bold></sup></td><td>39.760 ± 1.921*<sup>■<bold>a</bold></sup></td><td>2.598 ± 0.310<sup><bold>a</bold></sup></td><td>10.291 ± 0.253<sup><bold>a</bold></sup><bold>*</bold></td><td>11.258 ± 0.310*<sup>■</sup></td></tr><tr><td>60</td><td>35.962 ± 1.406<sup><bold>ab</bold></sup></td><td>9.14 ± 1.288*</td><td>9.90 ± 0.597*</td><td>1.216 ± 0.601</td><td>19.085 ± 1.307*<sup><bold>ab</bold></sup></td><td>39.939 ± 1.184*<sup><bold>ab</bold>■</sup></td><td>1.759 ± 0.280<sup><bold>ab</bold></sup></td><td>10.729 ± 0.228<sup><bold>a</bold></sup><bold>*</bold></td><td>11.639 ± 0.280*<sup>■</sup></td></tr><tr><td>88</td><td>37.072 ± 1.060<sup><bold>abc</bold></sup></td><td>10.16 ± 0.957*</td><td>8.98 ± 0.859*<sup>■</sup></td><td>0.986 ± 0.197<sup><bold>a</bold></sup></td><td>34.013 ± 2.650*<sup><bold>abc</bold></sup></td><td>44.567 ± 1.813*<sup><bold>abc</bold>■</sup></td><td>0.837 ± 0.214<sup><bold>abc</bold></sup></td><td>10.833 ± 0.338<sup><bold>a</bold></sup><bold>*</bold></td><td>14.735 ± 0.414*<sup><bold>abc</bold>■</sup></td></tr><tr><td>108</td><td>38.665 ± 1.304<sup><bold>abcdc</bold></sup></td><td>9.713 ± 1.182*</td><td>9.95 ± 0.223*</td><td>1.005 ± 0.433<sup><bold>a</bold></sup></td><td>29.782 ± 1.353*<sup><bold>abcd</bold></sup></td><td>46.354 ± 2.582*<sup><bold>abc</bold>■</sup></td><td>0.385 ± 0.186<sup><bold>abcd</bold></sup></td><td>11.183 ± 0.234<sup><bold>ab</bold></sup><bold>*</bold></td><td>14.566 ± 0.286*<sup><bold>abc</bold></sup></td></tr><tr><td>128</td><td>40.332 ± 2.344<sup><bold>abcde</bold></sup></td><td>9.95 ± 0.869*</td><td>9.13 ± 0.661*</td><td>0.999 ± 0.247<sup><bold>a</bold></sup></td><td>28.983 ± 1.610*<sup><bold>abcd</bold></sup></td><td>41.617 ± 1.963*<sup><bold>abcd</bold>■</sup></td><td>0.372 ± 0.110<sup><bold>abc</bold></sup></td><td>10.402 ± 0.172<sup><bold>ae</bold></sup><bold>*</bold></td><td>12.454 ± 0.210*<sup><bold>abcde</bold>■</sup></td></tr><tr><td>148</td><td>44.781 ± 2.606<sup><bold>abcdef</bold></sup></td><td>8.96 ± 1.704*</td><td>9.18 ± 0.862*</td><td>0.961 ± 0.259<sup><bold>a</bold></sup></td><td>28.632 ± 2.538*<sup><bold>abcd</bold></sup></td><td>32.008 ± 1.629*<sup><bold>abcdef</bold>■</sup></td><td>0.345 ± 0.197<sup><bold>abc</bold></sup></td><td>9.572 ± 0.160*<sup><bold>abcdef</bold></sup></td><td>12.734 ± 0.197*<sup><bold>abcde</bold>■</sup></td></tr><tr><td><italic>R</italic></td><td colspan=\"3\"><italic>y</italic> = 25.51<italic>e</italic><sup>0.003<italic>x</italic></sup></td><td colspan=\"3\"><italic>y</italic> = 21.961<italic>x</italic><sup>−0.656</sup></td><td colspan=\"3\"><italic>y</italic> = 6.0642<italic>e</italic><sup>−0.022<italic>x</italic></sup></td></tr><tr><td><italic>r</italic></td><td/><td>+ 0.98*</td><td/><td/><td>− 0.78*</td><td/><td/><td>− 0.94*</td><td/></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Threshold values (threshold values), sensitivity (Sen), specificity (Sp), positive (PPV) and negative (NPV) predictive values, accuracy (%), and area under the curve (AUC) of the blood lead (Pb, μg/dl), pregnancy-associated glycoprotein1 (PAG1, ng/ml), and progesterone (P<sub>4</sub>, ng/ml) contents of aborted Zaraibi goats throughout pregnancy stages</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Parameters</th><th>Threshold values</th><th>Sen (%)</th><th>Sp (%)</th><th>PPV (%)</th><th>NPV (%)</th><th>Se + Sp (%)</th><th>Accuracy (%)</th><th>AUC</th><th><italic>P</italic>-value<sup>■</sup></th></tr></thead><tbody><tr><td>Pb<sup>1</sup></td><td>32.08</td><td>1.0</td><td>1.0</td><td>1.0</td><td>1.0</td><td>2.0</td><td>1.0</td><td>1.0</td><td><italic>P</italic> &lt; 0.001</td></tr><tr><td>PAG1<sup>2</sup></td><td>0.95</td><td>1.0</td><td>0.92</td><td>1.0</td><td>1.0</td><td>2.0</td><td>1.0</td><td>1.0</td><td><italic>P</italic> &lt; 0.001</td></tr><tr><td>P4<sup>2</sup></td><td>0.48</td><td>1.0</td><td>1.0</td><td>0.98</td><td>1.0</td><td>2.0</td><td>1.0</td><td>1.0</td><td><italic>P</italic> &lt; 0.001</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[]
[ "<table-wrap-foot><p><italic>SS</italic> sum of squares, <italic>df</italic> degree of freedom, <italic>MS</italic> mean of squares</p><p><italic>F</italic><sub>calculated</sub>: the computed <italic>F</italic>-value of the data</p><p>PP*BC: interaction of pregnancy period intervals with the birth cases (abortion, single, or twins)</p><p><italic>P</italic> &lt; 0.0001: significant effect at <italic>α</italic> = 0.0001</p></table-wrap-foot>", "<table-wrap-foot><p>Data represented as an average ± SEM</p><p>The symbols * and <sup>■</sup> indicate a significant difference (<italic>P</italic> &lt; 0.05) in comparison with the corresponding aborted goats and those that birth a single kid, respectively</p><p>In the same column, letters a, b, c, d, e, and f indicate a significant difference (<italic>P</italic> &lt; 0.05) in comparison with those at pregnancy stages of 28, 46, 60, 88, 108, 128, and 148 days of gestation, respectively</p><p><italic>R</italic> regression equation</p><p><italic>r</italic>*: indicated the correlation coefficient</p></table-wrap-foot>", "<table-wrap-foot><p><sup>1</sup>The test is positive if the levels of desired parameters are ≥ the threshold value</p><p><sup>2</sup>The test is positive if the levels of desired parameters are ≤ threshold value</p><p><sup>■</sup>Significant effect at <italic>α</italic> = 0.001 (<italic>P</italic> &lt; 0.001)</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher’s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"11250_2023_3877_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"11250_2023_3877_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"11250_2023_3877_Fig3_HTML\" id=\"MO3\"/>" ]
[]
[{"surname": ["Aboul-Naga", "Hamed", "Shaat", "Mabrouk"], "given-names": ["AM", "A", "I", "MMS"], "article-title": ["Genetic improvement of Egyptian Nubian goats as sub-tropical dairy prolific breed"], "source": ["Small Ruminant Research"], "year": ["2012"], "volume": ["102"], "fpage": ["125"], "lpage": ["130"], "pub-id": ["10.1016/j.smallrumres.2011.06.014"]}, {"surname": ["Agbugui", "Abe"], "given-names": ["M", "GO"], "article-title": ["Heavy Metals in Fish"], "source": ["Bioaccumulation and Health British Journal of Earth Sciences Research"], "year": ["2022"], "volume": ["10"], "fpage": ["47"], "lpage": ["66"]}, {"mixed-citation": ["Azeh Engwa, G., Udoka Ferdinand, P., Nweke Nwalo, F. and N. Unachukwu, M., 2019. Mechanism and Health Effects of Heavy Metal Toxicity in Humans. 10.5772/INTECHOPEN.82511"]}, {"surname": ["Bak", "Roszkowski"], "given-names": ["A", "K"], "article-title": ["Oxidative stress in pregnant women"], "source": ["Archives of Perinatal Medicine"], "year": ["2013"], "volume": ["19"], "fpage": ["150"], "lpage": ["155"]}, {"surname": ["Barbato", "Menchetti", "Brecchia", "Barile"], "given-names": ["O", "L", "G", "VL"], "source": ["Using Pregnancy-Associated Glycoproteins (PAGs) to Improve Reproductive Management: From Dairy Cows to Other Dairy Livestock Animals"], "year": ["2022"]}, {"surname": ["Batalha", "Sulon", "Figueiredo", "Beckers", "Espeschit", "Martins", "Silva"], "given-names": ["ES", "J", "JR", "JF", "CJB", "R", "LDM"], "article-title": ["Plasma profile of pregnancy associated glycoprotein (PAG) in pregnant alpine goats using two radioimmunoassay (RIA) systems"], "source": ["Small Ruminant Research"], "year": ["2001"], "volume": ["42"], "fpage": ["111"], "lpage": ["118"], "pub-id": ["10.1016/S0921-4488(01)00243-7"]}, {"mixed-citation": ["Casas, J.A.S. and Sordo, J.A., 2006. Lead Lead, 158\u2013228. 10.1186/s12889-016-3902-3"]}, {"mixed-citation": ["Collin, M.S., Venkatraman, S.K., Vijayakumar, N., Kanimozhi, V., Arbaaz, S.M., Stacey, R.G.S., Anusha, J., Choudhary, R., Lvov, V., Tovar, G.I., Senatov, F., Koppala, S. and Swamiappan, S., 2022. Bioaccumulation of lead (Pb) and its effects on human: A review Journal of Hazardous Materials Advances 10.1016/j.hazl.2022.100064"]}, {"mixed-citation": ["Dasharathy, S., Arjunan, S., Maliyur Basavaraju, A., Murugasen, V., Ramachandran, S., Keshav, R. and Murugan, R., 2022. Mutagenic, Carcinogenic, and Teratogenic Effect of Heavy Metals Evidence-based Complementary and Alternative Medicine, 2022. 10.1155/2022/8011953"]}, {"surname": ["Elarabany", "El-Batrawy"], "given-names": ["N", "O"], "article-title": ["Physiological changes in the Cattle Egret, Bubulcus ibis, as a bioindicator of air pollution in New Damietta City, Egypt African"], "source": ["Journal of Biological Sciences"], "year": ["2019"], "volume": ["15"], "fpage": ["13"], "lpage": ["31"], "pub-id": ["10.21608/AJBS.2019.63379"]}, {"surname": ["El-Tohamy", "Hamam", "Ali"], "given-names": ["MM", "AM", "UA"], "article-title": ["Reproductive efficiency of buffalo-cows and its relationship with some heavy metals in the soil"], "source": ["Egypt. J. Applied Sci."], "year": ["1997"], "volume": ["12"], "fpage": ["75"], "lpage": ["88"]}, {"surname": ["Gaafar", "Gabr", "Teleb"], "given-names": ["KM", "MK", "DF"], "article-title": ["The hormonal profile during the estrous cycle and gestation in Damascus goats"], "source": ["Small Ruminant Research"], "year": ["2005"], "volume": ["57"], "fpage": ["85"], "lpage": ["93"], "pub-id": ["10.1016/j.smallrumres.2004.07.009"]}, {"surname": ["Galal"], "given-names": ["S"], "article-title": ["Biodiversity in goats"], "source": ["Small Ruminant Research - SMALL RUMINANT RES."], "year": ["2005"], "volume": ["60"], "fpage": ["75"], "lpage": ["81"], "pub-id": ["10.1016/j.smallrumres.2005.06.021"]}, {"mixed-citation": ["Gensa, U., 2019. Review on Cyanide Poisoning in Ruminants. Journal of Biology, Agriculture and Healthcare, 9(6), 1\u201312. 10.7176/JBAH"]}, {"mixed-citation": ["Ghazzal, M., Hussain, M.I., Khan, Z.I., Habib ur Rahman, M., El-Habeeb, A.A. and Yang, H.H., 2022. Chromium Poisoning in Buffaloes in the Vicinity of Contaminated Pastureland, Punjab, Pakistan Sustainability (Switzerland), 14; 10.3390/su142215095"]}, {"surname": ["Gonz\u00e1lez", "Sulon", "Garbayo", "Batista", "Cabrera", "Calero", "Gracia", "Beckers"], "given-names": ["F", "J", "JM", "M", "F", "PO", "A", "JF"], "article-title": ["Secretory profiles of pregnancy-associated glycoproteins at different stages of pregnancy in the goat"], "source": ["Reproduction in Domestic Animals"], "year": ["2000"], "volume": ["35"], "fpage": ["79"], "lpage": ["82"], "pub-id": ["10.1046/j.1439-0531.2000.00202.x"]}, {"surname": ["Haile"], "given-names": ["A"], "article-title": ["Assessment of Major Reproductive Disorders of Dairy Cattle in Urban and Per Urban Area of Hosanna"], "source": ["Southern Ethiopia Animal and Veterinary Sciences"], "year": ["2014"], "volume": ["2"], "fpage": ["135"], "pub-id": ["10.11648/j.avs.20140205.11"]}, {"surname": ["Hajiabadi", "Fathi", "Hamli"], "given-names": ["N", "E", "H"], "article-title": ["Relationships between hematological parameters and Cl and Na homeostasis in dairy herds and abortion"], "source": ["International journal of health sciences"], "year": ["2022"], "volume": ["6"], "fpage": ["9341"], "lpage": ["9352"], "pub-id": ["10.53730/ijhs.v6nS3.8159"]}, {"mixed-citation": ["Hamed, M.A., Ali, S.A. and Saba El-Rigal, N., 2012. Therapeutic potential of ginger against renal injury induced by carbon tetrachloride in rats The Scientific World Journal. 10.1100/2012/840421"]}, {"mixed-citation": ["Hosny, H., Aziz, A., Shawky,\u00a0H. and Harby, A.A., 2022. The economics of sheep and goat meat production in Egypt: a case study in Gharbia\u00a0Governorate. IOSR Journal of Economics and Finance (IOSR-JEF), 13(2), 07\u201317."]}, {"surname": ["Karadaev"], "given-names": ["M"], "article-title": ["Pregnancy diagnosis techniques in goats \u2013 A review"], "source": ["Bulgarian Journal of Veterinary Medicine"], "year": ["2015"], "volume": ["18"], "fpage": ["183"], "lpage": ["193"], "pub-id": ["10.15547/bjvm.837"]}, {"mixed-citation": ["Kolatorova, L., Vitku, J., Suchopar, J., Hill, M. and Parizek, A., 2022. Progesterone: A Steroid with Wide Range of Effects in Physiology as Well as Human Medicine International Journal of Molecular Sciences, 23. 10.3390/ijms23147989"]}, {"mixed-citation": ["Mason, L.H., Harp, J.P. and Han, D.Y., 2014. Pb neurotoxicity: Neuropsychological effects of lead toxicity BioMed Research International, 2014. 10.1155/2014/840547"]}, {"surname": ["Mass\u00e1nyi", "Mass\u00e1nyi", "Madeddu", "Stawarz", "Luk\u00e1\u010d"], "given-names": ["P", "M", "R", "R", "N"], "article-title": ["Effects of cadmium, lead, and mercury on the structure and function of reproductive organs"], "source": ["Toxics"], "year": ["2020"], "volume": ["8"], "fpage": ["1"], "lpage": ["31"], "pub-id": ["10.3390/toxics8040094"]}, {"surname": ["McEvoy", "McCoy"], "given-names": ["JD", "M"], "article-title": ["Acute lead poisoning in a beef herd associated with contaminated silage"], "source": ["Veterinary Res."], "year": ["1993"], "volume": ["132"], "fpage": ["89"], "lpage": ["90"]}, {"surname": ["Moore", "Ahmad", "Schmid", "Berger", "Ruiz", "Pickler", "Zimmerman"], "given-names": ["TA", "IM", "KK", "AM", "RJ", "RH", "MC"], "article-title": ["Oxidative Stress Levels Throughout Pregnancy, at Birth, and in the Neonate Biological Research for"], "source": ["Nursing"], "year": ["2019"], "volume": ["21"], "fpage": ["485"], "lpage": ["494"], "pub-id": ["10.1177/1099800419858670"]}, {"surname": ["Mridula", "Guvvala", "Sarathi", "Vinu"], "given-names": ["N", "R", "R"], "article-title": ["Effect of Zeolite Addition on Partial Discharge and Dielectric Behavior of Thermally Aged Synthetic Ester Fluid Under External Magnetic Field"], "source": ["IEEE Access"], "year": ["2022"], "volume": ["10"], "fpage": ["46670"], "lpage": ["46677"], "pub-id": ["10.1109/ACCESS.2022.3171326"]}, {"surname": ["Padilla-Rivas", "Sohnrey", "Holtz"], "given-names": ["GR", "B", "W"], "article-title": ["Early pregnancy detection by real-time ultrasonography in Boer goats"], "source": ["Small Ruminant Research"], "year": ["2005"], "volume": ["58"], "fpage": ["87"], "lpage": ["92"], "pub-id": ["10.1016/j.smallrumres.2004.09.004"]}, {"surname": ["Pohler", "Franco", "Reese", "Dantas", "Ellis", "Payton"], "given-names": ["KG", "GA", "ST", "FG", "MD", "RR"], "article-title": ["Past, present and future of pregnancy detection methods"], "source": ["Applied Reproductive Strategies in Beef Cattle"], "year": ["2016"], "volume": ["7-8"], "fpage": ["251"], "lpage": ["259"]}, {"surname": ["Salve", "Ingole", "Nagvekar", "Bharucha", "Dagli"], "given-names": ["RR", "SD", "AS", "SV", "NR"], "article-title": ["Pregnancy associated protein and progesterone concentrations during early pregnancy in Sirohi goats"], "source": ["Small Ruminant Research"], "year": ["2016"], "volume": ["141"], "fpage": ["45"], "lpage": ["47"], "pub-id": ["10.1016/j.smallrumres.2016.07.003"]}, {"surname": ["Sousa", "Garbayo", "Figueiredo", "Sulon", "Gon\u00e7alves", "Beckers"], "given-names": ["NM", "JM", "JR", "J", "PBD", "JF"], "article-title": ["Pregnancy-associated glycoprotein and progesterone profiles during pregnancy and postpartum in native goats from the north-east of Brazil"], "source": ["Small Ruminant Research"], "year": ["1999"], "volume": ["32"], "fpage": ["137"], "lpage": ["147"], "pub-id": ["10.1016/S0921-4488(98)00171-0"]}, {"mixed-citation": ["Tobo\u0142a-Wr\u00f3bel, K., Pietryga, M., Dydowicz, P., Napiera\u0142a, M., Br\u0105zert, J. and Florek, E., 2020. Association of Oxidative Stress on Pregnancy Oxidative Medicine and Cellular Longevity, 2020. 10.1155/2020/6398520"]}, {"surname": ["Stoev", "Manov", "Vassilev"], "given-names": ["SD", "V", "N"], "article-title": ["Morphological investigation in experimental cases of chronic lead poisoning in pregnant sheep Bulgarian"], "source": ["J. Agric. Sci."], "year": ["1997"], "volume": ["3"], "fpage": ["795"], "lpage": ["801"]}, {"surname": ["Vasques", "Horta", "Marques", "Sasser", "Humblot"], "given-names": ["MI", "AEM", "CC", "RG", "P"], "article-title": ["Levels of bPSPB throughout single and twin pregnancies after AI or transfer of IVM/IVF cattle embryos"], "source": ["Animal Reproduction Science"], "year": ["1995"], "volume": ["38"], "fpage": ["279"], "lpage": ["289"], "pub-id": ["10.1016/0378-4320(94)01373-T"]}, {"surname": ["Volkov", "Ezhkova"], "given-names": ["R", "A"], "article-title": ["Migration of heavy metals in the system \u201csoil-plant-animal-livestock products\u201d"], "source": ["BIO Web of Conferences"], "year": ["2020"], "volume": ["27"], "fpage": ["00068"], "pub-id": ["10.1051/bioconf/20202700068"]}, {"mixed-citation": ["World Health Organization, 1987. WHO advisory committee on variola virus research: report of the seventeenth meeting, Geneva, Switzerland,\u00a012\u201313."]}, {"mixed-citation": ["Wright, R.O., Tsaih, S.W., Schwartz, J., Wright, R.J. and Hu, H., 2003. Association between iron deficiency and blood lead level in a longitudinal analysis of children followed in an urban primary care clinic Journal of Pediatrics, 142, 9\u201314. 10.1067/mpd.2003.mpd0344"]}, {"surname": ["Xie", "Low", "Nagel", "Kramer", "Anthony", "Zoli", "Beckers", "Roberts"], "given-names": ["S", "BG", "RJ", "KK", "RV", "AP", "JF", "RM"], "article-title": ["Identification of the major pregnancy-specific antigens of cattle and sheep as inactive members of the aspartic proteinase family"], "source": ["Proceedings of the National Academy of Sciences of the United States of America"], "year": ["1991"], "fpage": ["10247"], "lpage": ["10251"]}, {"mixed-citation": ["Yadav, R., Yadav, P., Singh, G., Kumar, S., Dutt, R. and Pandey, A., 2021. Non Infectious Causes of Abortion in Livestock Animals -A Review International Journal of Livestock Research, 1. 10.5455/ijlr.20201031"]}, {"surname": ["Zamfirescu", "Anghel", "Nadolu", "Dobrin"], "given-names": ["S", "A", "D", "N"], "article-title": ["Plasmatic profiles of pregnancy-associated glycoprotein and progesterone levels during early pregnancy in carpathian goat"], "source": ["Annals of the Romanian Society for Cell Biology"], "year": ["2011"], "volume": ["16"], "fpage": ["50"], "lpage": ["53"]}, {"mixed-citation": ["Zarrouk, A., Engeland, I. V., Sulon, J. and Beckers, J.F., 1999. Pregnancy-associated glycoprotein levels in pregnant goats inoculated with Toxoplasma gondii OR Listeria monocytogenes: A retrospective study Theriogenology, 52, 1095\u20131104. 10.1016/s0093-691x(99)00197-1"]}]
{ "acronym": [], "definition": [] }
85
CC BY
no
2024-01-14 23:40:12
Trop Anim Health Prod. 2024 Jan 12; 56(1):40
oa_package/d5/6c/PMC10786744.tar.gz
PMC10786746
38214766
[ "<title>Introduction</title>", "<p id=\"Par37\">The morbidity of ischemic cerebrovascular disease increases with age; the elderly over 65-years-old are very prone to cerebral ischemia cognitive decline (Rajeev et al. ##REF##35198062##2022##). Chronic cerebral hypoperfusion (CCH), a hemodynamic feature of ischemic cerebrovascular diseases, including carotid stenosis, atherosclerosis of large or small cerebral vessels, and other cerebral-vascular or senile diseases, is a major cause of cognitive impairment and vascular dementia (VaD) (Ciacciarelli et al. ##REF##31948882##2020##). VaD is the second most common cause of dementia, accounting for approximately 15 − 20% of dementia in North America and Europe, and roughly 30% in Asia (Chan et al. ##REF##23746902##2013##; Wolters and Ikram ##REF##31294622##2019##), which results in a heavy burden to worldwide public health. Because of a lack of unified diagnostic criteria and effective intervention targets, progress in its treatment has been difficult (O’Brien and Thomas ##REF##26595643##2015##). Long-term insufficient cerebral blood flow can activate inflammation, oxidative stress, and neurodegeneration, leading to multiple neurocyte injuries(Kalaria ##REF##29273521##2018##). These cellular injury cascades may trigger or exacerbate homeostatic disturbances between or within cells and organelles, causing subcellular deteriorations and irreversible hippocampal neuronal damage (Rajeev et al. ##REF##37309012##2023##). Therefore, additional effort is still needed to identify the mechanism of CCH-induced memory dysfunction, which will hopefully identify specific intervention targets.</p>", "<p id=\"Par38\">The endocannabinoid system (ECS) is composed of cannabinoid receptors (CBR1 and CBR2), endogenous ligands-anandamides, 2-arachidonic glycerol, and endogenous degrading enzymes (Lu and Mackie ##REF##32980261##2021##). The ECS involves the regulation of numerous pathophysiological processes, such as habituation, neuropathic pain, neuroinflammation, and cognitive deficits (Cristino et al. ##REF##31831863##2020##). The 3´-carbamoylbiphenyl-3-yl cyclohexyl carbamate (URB597), a fatty acid amide hydrolase (FAAH) inhibitor, mediates ECS bioactivities and levels, providing beneficial effects during neurodegeneration, ischemia-reperfusion injury, and oxidative stress (Wang et al. ##REF##34093011##2021b##, ##UREF##2##2022##; Cakir et al. ##REF##36700769##2023##). Mitochondria and the endoplasmic reticulum (ER) are essential organelles that produce reactive oxygen species (ROS) in response to neuronal oxidative stress during cerebral ischemia (Singh-Mallah et al. ##REF##30957515##2019##). Inhibition of excessive hippocampal mitochondria ROS production and mitophagy by URB597 targeting CCH-induced neuroinflammatory responses have been previously reported (Wang et al. ##REF##28501776##2017b##; Su et al. ##REF##29955058##2018##). In contrast, some reports have suggested that URB597 impaired long-term potentiation, learning, and memory (Basavarajappa et al. ##REF##24648181##2014##). Increasing studies have shown that ECS regulated brain energy metabolism, hippocampal neurogenesis, synaptic plasticity, and organogenesis (Forte et al. ##REF##34675233##2021##). More importantly, the effects of URB597 on mitochondria and the ER, as well as the potential molecular mechanisms of neuro-modulation during CCH have not yet been systematically assessed.</p>", "<p id=\"Par39\">To address these issues, in the present study, we determined the effects of URB597 on ER stress and mitochondrial function, as well as the underlying mechanisms associated with its therapeutic potential in brain ischemia treatment.</p>" ]
[ "<title>Materials and Methods</title>", "<title>Materials and Reagents</title>", "<p id=\"Par40\">The FAAH inhibitor (URB597) (No. HY-10,864), the ER stress inhibitor and inducer, [benzenebutyric acid (4-PBA) (No. HY-A0281) and thapsigargin (TG) (No. HY-13,433), respectively], and a selective CB2 antagonist (6-lodopravadoline, AM630) (No. HY-15,421) were all purchased from the Med Chem Express (MCE, Shanghai, China). The drugs were dissolved using 10% dimethyl sulfoxide, 40% polyethylene glycol-300, 5% Tween-80, and 45% saline according to the manufacturer’s instructions for in vivo experiments. The doses of agents were selected as previously reported (Wang et al. ##REF##28042028##2017a##, ##UREF##2##2022##; Reddy et al. ##REF##30980806##2019##; Pawar et al. ##UREF##1##2022##). Briefly, URB597 at a concentration of 2 µM for cell experiments, was administered via intraperitoneal (i.p.) injection at 0.3 mg/kg/day for animal experiments, 4-PBA at a concentration of 4 µM for cell experiments, was administered i.p. to rats at 40 mg/kg/day, and TG was used at a concentration of 0.02 µM for cell experiments. Rabbit monoclonal/polyclonal antibodies against NeuN (24307T), glial fibrillary acidic protein (GFAP, 80788T), caspase-9 (9508T), β-tubulin (2146 S), and phospho-PERK (Thr980, 3179 S) were from Cell Signaling Technology (Danvers, MA, USA). Antibodies against 78-kDa glucose-regulated protein (GRP78) (ab212054), protein kinase R-like ER kinase (PERK) (ab229912), CB2 (ab35601), and GAPDH (ab8245) were from Abcam (Cambridge, MA, USA). Antibodies to Iba-1(DF6642) and C/EBP-homologous protein (CHOP, DF6025) were from Affinity (Cincinnati, OH, USA). Antibody to translocase of the outer mitochondrial membrane 20 (TOMM20) (WH0009804M1) was from Sigma-Aldrich (St. Louis, MO, USA). Antibodies to β-Arrestin-1 (sc-53,780) and cytochrome-c (Cyt-c, sc-13,156) were from Santa Cruz Biotechnology (Shanghai, China). The Alexa 488/594-conjugated goat anti-rabbit/mouse antibody was from Invitrogen (Carlsbad, CA, USA). The antibody to ATF6 (AF6243), the enhanced BCA protein assay kit (P0010), the Annexin V-FITC apoptosis detection kit (C1062), the ATP assay kit (S0026), the total superoxide dismutase (SOD) assay kit (S0109), the catalase assay kit (CAT, S0051), the lipid peroxidation malondialdehyde (MDA) assay kit (MDA, S0131S), and the dihydroethidium (DHE, S0063) and Nissl staining solution (C0117) were from Beyotime Biotechnology (Shanghai, China).</p>", "<title>The CCH Model and Treatment Groups</title>", "<p id=\"Par41\">Sprague-Dawley male rats (1-month-old, 150 − 180 g) were from the experimental animal center of Shanghai Sippr-BK Laboratory Animals (Shanghai, China). They were housed in a SPF animal center with a room temperature of 24 °C and 60% humidity, with free access to food and water during a 12 h light/dark cycle. CCH was induced by bilateral common carotid artery occlusion (BCCAO) as described in our previous studies (Wang et al. ##REF##28042028##2017a##, ##REF##28501776##b##). After 2 weeks of acclimatization, the rats (age, 6-weeks-old; body weight, approximately 200 g) were initially anesthetized with 5% isoflurane in 70% nitrogen and 30% oxygen, then maintained using 2% isoflurane in 0.5 L/min oxygen. A midline cervical incision was performed to expose the bilateral common carotid arteries, which were carefully double-ligated with 5 − 0 silk sutures. Sham-operated animals were not subjected to carotid artery ligation.</p>", "<p id=\"Par42\">CCH rats were then randomly divided into five treatment groups: (1) the BCCAO group (M), (2) the BCCAO + URB597 group (MU), (3) the BCCAO + 4-PBA group (MP), (4) the BCCAO + URB597 + 4-PBA group (MUP), and (5) the BCCAO + URB597 + 4-PBA + AM630 group (MUPA) (<italic>n</italic> = 8 in each group). Four rats were dead after BCCAO surgery. Rats received daily injections of URB597 (0.3 mg/kg/day, i.p.), 4-PBA (40 mg/kg/day, i.p.), and AM630 (1 mg/kg/day, i.p.) for 4 weeks in the MU, MP, MUP, MUPA groups, respectively. Rats in the Sham and M groups (<italic>n</italic> = 8 in each group) received daily injections of an equal amount of vehicle. Rats were decapitated 2 h after the last injection and the brains were immediately removed for experiments, or stored at -80 °C.</p>", "<title>The Oxygen-Glucose Deprivation (OGD) Model and Treatment Groups</title>", "<p id=\"Par43\">The mouse hippocampal neuronal HT22 cell line was purchased from a public cell bank (ATCC, Manassas, VA, USA). The cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Beyotime Biotechnology) supplemented with 10% fetal bovine serum (HyClone, Ogden, UT, USA) and 1% penicillin/streptomycin (HyClone) in an incubator (Heraeus, Hanau, Germany) at 37 °C in 5% CO<sub>2</sub>. For OGD, HT22 cells were seeded in 96-well plates at a density of 1 × 10<sup>5</sup> cells/mL and were cultured in glucose-free DMEM at 37 °C in 0.5% O<sub>2</sub>, 94.5% N<sub>2</sub>, and 5% CO<sub>2</sub> for 4 h. The cells were then incubated in a maintenance medium for 24 h under normal conditions before subsequent experiments.</p>", "<p id=\"Par44\">HT22 cells in the control group were treated identically except that they were not exposed to OGD. Experimental treatment groups were as follows: (1) the control group (Con), (2) the OGD group (OGD), (3) the OGD + 4-PBA (4 µM) treatment group (4-PBA), (4) the OGD + URB597 (2 µM) treatment group (URB), and (6) the OGD + TG (0.02 µM) treatment group (TG).</p>", "<title>Cell Viability Assay</title>", "<p id=\"Par45\">Cell viability was assessed using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay as previously reported (Chang et al. ##REF##33396027##2021##; Wang et al. ##UREF##2##2022##). A solution with 20 µL MTT [5 mg/mL MTT in phosphate-buffered saline (PBS), pH 7.4] was added to each group. Then, neurons were incubated for 4 h at 37 °C in 5% CO<sub>2</sub>. The absorbance (OD) was measured spectrophotometrically at 490 nm on a microplate reader (Epoch; Bio-Tek, Winooski, VT USA).</p>", "<title>Measurement of Oxidative Stress and ATP</title>", "<p id=\"Par46\">Oxidative stress and ATP levels were evaluated by determination of SOD, CAT, MDA, and ATP using commercial kits. All assays were performed using a microplate reader according to the manufacturer’s instructions (manufacturer and address) (Wang et al. ##REF##31808139##2020a##).</p>", "<title>DHE Staining</title>", "<p id=\"Par47\">The intracellular ROS were detected using DHE staining. Cells were plated in 24-well plates, then fixed with formaldehyde for 30 min, stained with 30 µM DHE staining at room temperature for 5 min, then checked with an immunofluorescence assay using ImageJ software (Version 1.46r; National Institutes of Health, Bethesda, MD, USA) (Gao et al. ##REF##31299935##2019##).</p>", "<title>Annexin-V-FITC Flow Cytometry Analysis</title>", "<p id=\"Par48\">Cell apoptosis was quantified using an Annexin V Apoptosis Detection kit according to the manufacturer’s instructions (manufacturer and address). Briefly, 10 µL propidium iodide and 5 µL Annexin-V-FITC solution were added to HT22 cells, followed by incubation for 15 min in the dark at room temperature. Finally, the cells were collected into flow cytometry tubes, and cell apoptosis was measured using a flow cytometer at 488 nm.</p>", "<title>Nissl Staining</title>", "<p id=\"Par49\">Coronal slices (10 μm thick) were used to estimate hippocampal neural tissue damage using Nissl staining as earlier reported (Xu et al. ##REF##30372862##2018##). Briefly, the coronal cryosections of the brain were stained with 0.75% cresyl violet, dehydrated using graded alcohol percentages (70%, 95%, and 100%), and placed in xylene. The slices (<italic>n</italic> = 3) were visualized using a microscope (BX53; Olympus, Tokyo, Japan) at ×200 by an investigator blinded to the identities of the treatments.</p>", "<title>Morris Water Maze (MWM)</title>", "<p id=\"Par50\">The MWM was used to measure hippocampus-dependent learning and memory, as previously described (Wang et al. ##REF##28042028##2017a##, ##REF##33708855##2021c##). Rats were tested in a circular tank, 1.5 m in diameter with a platform of 14 cm in diameter below the water surface (1.5 cm). Animals were trained for 4 days with four trials per day by looking at the platform in the tank with water (25 ± 1 °C) (<italic>n</italic> = 8 rats per group). On day 5, the platform was removed and rats were allowed to swim freely for 60 s in the probe trial. A video camera and Human Visual System Image Software (HVS Image, Hampton, UK) were used to observe and record the times spent in the target quadrant, platform position crossings, and the swimming pattern of each rat.</p>", "<title>Transmission Electron Microscopy (TEM)</title>", "<p id=\"Par51\">Brains were prepared for TEM analysis to determine ultrastructural changes, using previously reported procedures (Wang et al. ##REF##28042028##2017a##, ##REF##28501776##b##). Briefly, tissues were dehydrated by alcohol and embedded with a mixture of acetone and ethoxylate resin (Ladd Research Industries, Burlington, VT). Brain sections, cut to a thickness of 600 nm using the LKB Huxley ultramicrotome, were placed on copper grids, then stained with uranyl acetate and lead citrate (Wang et al. ##REF##28501776##2017b##). Finally, the ultrastructure changes of organelles in the hippocampus CA1 area were observed using a transmission electron microscope (CM-120; Philips, Amsterdam, The Netherlands). The degree of mitochondrial damage and the ultrastructure changes of mitochondria-associated ER membranes (MAMs) were semi-quantitatively analyzed by one investigator, blinded to the identities of the treatment groups, according to published guidelines as shown in Table ##TAB##0##1## (Flameng’s score) (Flameng et al. ##REF##6243726##1980##; Paillusson et al. ##REF##28337542##2017##; Ouyang et al. ##REF##35370565##2022##).</p>", "<p id=\"Par52\">\n\n</p>", "<title>Immunofluorescence Staining</title>", "<p id=\"Par53\">Brain sections or HT22 cells were fixed in precooled 4% paraformaldehyde for 20 min, permeabilized with 0.1% Triton X-100 (Sigma-Aldrich) for 30 min, then blocked with 5% bovine serum albumin (BSA) in PBS for 30 min at room temperature. The fixed tissues and cells were incubated with primary antibodies against GRP78 (1:300), TOMM20 (1:300), NeuN (1:300), Iba-1 (1:300), or GFAP (1:300) in 5% BSA overnight at 4 °C(Jin et al. ##REF##30515081##2018##; Wang et al. ##UREF##2##2022##). Subsequently, samples were counterstained with 4´,6-diamidino-2-phenylindole after incubating with deconjugated secondary antibodies for 2 h in the dark. A fluorescence microscope (Zeiss, Jena, Germany) was used to photograph the immunofluorescent images. Finally, three fields of view in each group were used to estimate the mean fluorescence intensity, by an investigator blinded to the identities of the groups.</p>", "<title>Western Blotting and Immunoprecipitation</title>", "<p id=\"Par54\">Proteins from neuronal tissues in the hippocampus CA1 area were extracted and quantified using a total protein extraction kit (BC3711; Solarbio, Beijing, China) and a BCA protein assay kit (P0012S; Beyotime) according to the manufacturer’s protocols. Equal amounts of protein were separated by SDS-PAGE on a 6 − 12% polyacrylamide gel, then transferred onto polyvinylidene difluoride (PVDF) membranes. The PVDF membranes were subsequently probed with primary antibodies against the following proteins overnight at 4℃: GRP78 (1:1,000), ATF6 (1:500), PERK (1:1,000), p-PERK (1:1,000), CB2 (1:500), β-Arrestin-1(1:500), CHOP (1:500), Cyt-c (1:500), caspase-9 (1:1,000), GAPDH (1:5,000), and β-tubulin (1:5,000) used as an internal loading control. Following washing in PBS, the membranes were incubated with secondary antibodies conjugated with horseradish peroxidase, at room temperature for 1 h. The western blot protein bands were visualized using the enhanced chemiluminescence system (Millipore, Watford, UK) and quantified by ImageJ software.</p>", "<p id=\"Par55\">For immunoprecipitation, 300 µg of protein extract was incubated with the antibodies against CB2, β-Arrestin-1, or unspecific IgG at 4 °C overnight, and protein-A/G agarose was added for another 2–3 h at 4 °C (Wang et al. ##REF##33972548##2021a##). The immune precipitates were centrifuged, washed, suspended, and subjected to western blotting analysis.</p>", "<title>Statistical Analysis</title>", "<p id=\"Par56\">Each experiment was conducted at least in triplicate. The data are presented as the mean ± standard deviation (SD) and were analyzed by SPSS statistical software for Windows, version 20.0 (SPSS, Chicago, IL, USA). The repeated-measures mixed analyses of variance (ANOVA) with Tukey post-hoc test was used to assess group and training day differences. One-way analysis of variance, followed by the Tukey post-hoc test was conducted to evaluate statistical differences among the experimental groups. Significance was defined as <italic>P</italic> &lt; 0.05.</p>" ]
[ "<title>Results</title>", "<title>The FAAH Inhibitor, URB597, Promotes Neuronal Survival in OGD in Hippocampal HT22 Cells</title>", "<p id=\"Par57\">The flow chart for the experimental procedure is shown in Fig. ##FIG##0##1##A. ER stress can be triggered by cerebral ischemia, leading to irreversible neuronal damage. Neuronal survival and apoptosis were estimated using MTT and flow cytometry analyses, respectively (Fig. ##FIG##0##1##B, D). Here, we found that 4-PBA and URB597 improved the survival stage of HT22 neuronal cells, and reduced cell apoptosis following OGD treatment (Fig. ##FIG##0##1##C, E, all, <italic>P</italic> &lt; 0.05 vs. the Con group). Compared with individual intervention with URB597, apoptosis was significantly increased after adding the ER stress agonist, TG (Fig. ##FIG##0##1##E, <italic>P</italic> &lt; 0.05 vs. the URB group), which suggested that activating ERS aggravated neuronal injury. Thus, these results suggested the neuroprotection of URB597 against OGD-induced neuronal apoptosis was associated with suppressing ERS.</p>", "<p id=\"Par58\">\n\n</p>", "<title>The FAAH Inhibitor, URB597, Inhibits OGD-Induced ERS in Hippocampal HT22 Cells</title>", "<p id=\"Par59\">As shown in Fig. ##FIG##1##2##, ERS-related GRP78 labeling with green fluorescence was very significant in the OGD group (<italic>P</italic> &lt; 0.05 vs. Con). While the green intensity was reduced by 4-PBA and URB597 treatments (<italic>P</italic> &lt; 0.05 vs. OGD), this inhibition of GRP78 fluorescence with URB597 was reversed by TG (<italic>P</italic> &lt; 0.05 vs. URB597) (Fig. ##FIG##1##2##A, B). Furthermore, the presence of ERS pathway-related proteins, ATF6, PERK, p-PERK, and CHOP, were determined using western blotting (Fig. ##FIG##1##2##C). The results showed that GRP78, ATF6, PERK, p-PERK, and CHOP levels significantly increased following OGD treatment, relative to the control treatment, whereas 4-PBA and URB597 treatments reduced the expressions of these proteins (all, <italic>P</italic> &lt; 0.05 vs. OGD group). When compared with the URB59 group, TG treatment upregulated the expressions of GRP78, ATF6, PERK, p-PERK, and CHOP (Fig. ##FIG##1##2##D–G), showing that URB597 suppressed the OGD-induced ERS and ER-related apoptosis of CHOP.</p>", "<p id=\"Par60\">\n\n</p>", "<title>The FAAH Inhibitor, URB597, Alleviates OGD-Induced Mitochondrial Injury in Hippocampal HT22 Cells</title>", "<p id=\"Par61\">We further evaluated the effects of these three reagents on mitochondrial structure and function. Double staining with NeuN (red) and TOMM20 (a mitochondrial marker, green) revealed that green fluorescence intensity was enhanced by 4-PBA and URB597 treatment, but not by TG (all, <italic>P</italic> &lt; 0.05 vs. OGD) (Fig. ##FIG##2##3##A, B). The relative fluorescence intensity of TOMM20 decreased after co-treatment with URB597 and TG (<italic>P</italic> &lt; 0.05 vs. URB597), while ATP, 4-PBA, and URB597 treatments promoted ATP production (<italic>P</italic> &lt; 0.05 vs. OGD). However, treatment with the ERS agonist, TG, resulted in a reduction in ATP production. Together, these results confirmed that inhibition of ERS by 4-PBA as well as by URB597 alleviated OGD-induced mitochondrial injury.</p>", "<p id=\"Par62\">\n\n</p>", "<title>The FAAH Inhibitor, URB597, Suppresses OGD-Induced ER and Mitochondrial Stress in Hippocampal HT22 Cells</title>", "<p id=\"Par63\">Mitochondria and the ER are the main organelles that produce ROS. The imbalance between oxidation and antioxidant products causes an oxidative stress response. Various biomarkers, such as ROS, SOD, MDA, and CAT were used to assess the level of oxidative stress in hippocampal HT22 neuronal cells. Immunofluorescent DHE (red fluorescence, Fig. ##FIG##3##4##A) staining of ROS levels was increased after OGD treatment (<italic>P</italic> &lt; 0.05 vs. Con), and the red fluorescence was partially downregulated in the 4-PBA and URB597 treatment groups, when compared with the OGD group (<italic>P</italic> &lt; 0.05 vs. OGD, Fig. ##FIG##3##4##B), indicating URB597 mitigated the ROS levels in OGD neurons. Furthermore, cells in the OGD group showed decreased levels of SOD and CAT (<italic>P</italic> &lt; 0.05, respectively, vs. Con) and increased levels of ROS and MDA (<italic>P</italic> &lt; 0.05, vs. Con). URB597 treatment reversed all of these effects (Fig. ##FIG##3##4##C–F). TG weakened the antioxidant effects of URB597 in OGD (<italic>p</italic> &lt; 0.05 vs. URB597, Fig. ##FIG##3##4##C–F). Together, these results showed that URB597 inhibited OGD-induced ROS production and the resultant oxidative stress response.</p>", "<p id=\"Par64\">\n\n</p>", "<title>The FAAH Inhibitor, URB597, Improves CCH-Induced Cognitive Deficits</title>", "<p id=\"Par65\">We further assessed the effects of URB597 on hippocampal neurons and cognitive ability using Nissl staining and the MWM test, respectively. As shown in Fig. ##FIG##4##5##A, many neurons in the CA1, CA3, and DG regions of the hippocampus in mice of the M group became shrunken with lighter Nissl staining, compared with those in the Sham group (<italic>P</italic> &lt; 0.05 vs. Sham) (Fig. ##FIG##4##5##A–D). The reduced Nissl staining of bodies was increased after URB597 treatment, 4-PBA treatment, and co-treatment (<italic>P</italic> &lt; 0.05 vs. M) (Fig. ##FIG##4##5##B–D), indicating that URB597 and 4-PBA treatments prevented structural damage of neurons in hippocampal regions of mice induced by CCH. In the visible platform trial, the escape latency of CCH mice was significantly improved following URB597 treatment, 4-PBA treatment, and co-treatment, without differences in swimming speeds (Fig. ##FIG##4##5##E–F). In the spatial probe trial, the crossed number of platforms and the time spent in the target quadrant in the M group were significantly lower than in mice in the Sham group (<italic>P</italic> &lt; 0.05 vs. Sham) (Fig. ##FIG##4##5##G–I). However, the number of crossings and the finding times partially increased in mice in the URB597 and 4-PBA treatment groups, when compared with the M group (all, <italic>P</italic> &lt; 0.05 vs. M). Moreover, co-treatment had optimal effectiveness in learning and memory (<italic>P</italic> &lt; 0.05 vs. MUP) (Fig. ##FIG##4##5##H–I). Collectively, these results suggested that URB597 and 4-PBA minimized CCH-induced cognitive impairment in mice.</p>", "<p id=\"Par66\">\n\n</p>", "<title>The FAAH Inhibitor URB597 Alleviates CCH-Induced ER Stress and Mitochondrial Dysfunction</title>", "<p id=\"Par67\">The hippocampus is one of the key brain regions for learning and memory in mammals. Mitochondria and ER are important organelles for the homeostasis and survival of neurons. To expand upon the above findings, the effects of URB597 treatment on ERS and mitochondria in hippocampal neurons in CCH mice were assessed using immunofluorescence staining. First, double staining with GRP78 (red) and different markers of neural cells (green) suggested that a large number of proteins were expressed by neurons (Fig. ##FIG##5##6##A). Compared with the cerebral ischemia group, URB597 not only inhibited ERS but also protected mitochondria in hippocampus CA1 areas (Fig. ##FIG##5##6##B, C). A similar trend was also found in the 4-PBA treatment and the co-treatment groups. Statistical analyses suggested that URB597, 4-PBA, and URB597 combined with 4-PBA significantly reversed the ERS and mitochondrial damage caused by CCH (all, <italic>P</italic> &lt; 0.05 vs. M) (Fig. ##FIG##5##6##D, E). Taken together, in CCH mice, URB597 had the favorable effects of inhibiting ERS and protecting mitochondria.</p>", "<p id=\"Par68\">\n\n</p>", "<title>The FAAH Inhibitor, URB597, Ameliorates CCH-Induced Ultrastructural Injuries of MAMs</title>", "<p id=\"Par69\">MAMs are not only very important for the functions of mitochondria and the ER, but also regulate communication between the two organelles. Ultrastructural changes of mitochondria and the ER were detected by TEM (Fig. ##FIG##6##7##A). Severely swollen and degenerated mitochondria with disrupted crista and large vacuoles were found in the cytoplasm of ischemia neurons. The ER was expanded and the number of residual bodies increased, while some even disappeared. The gap between mitochondria and the ER widened and disappeared. The apoptotic or degenerated neurons with obscured cytoplasm and reduced MAMs were found in the M group. The number of organelles also decreased significantly after CCH. However, morphological defects of the mitochondria, the ER, and MAMs in mice of the MU, MP, and MUP groups were alleviated, when compared with mice in the M group. Specific criteria of neuronal mitochondria injury were used for a more in-depth analysis using Flameng’s score (Table ##TAB##0##1##) The score of neuronal injury was significantly increased in the M group (<italic>P</italic> &lt; 0.05, vs. Sham), which decreased after URB597, 4-PBA, and co-treatments, with improved interactions of five MAMs (all, <italic>P</italic> &lt; 0.05, vs. M) (Fig. ##FIG##6##7##B, C). Together, these results confirmed that URB597 ameliorated MAM impairment induced by CCH.</p>", "<p id=\"Par70\">\n\n</p>", "<title>The FAAH Inhibitor, URB597, Activates CB2/β-Arrestin1/PERK Signaling</title>", "<p id=\"Par71\">ECS functional activities can be regulated by FAAH. It has been reported that the FAAH inhibitor, URB597, has anti-inflammatory and antioxidant effects during ischemic stroke and traumatic brain injury. The β-arrestin1 has also been reported to be involved in regulating mitochondrial damage and ERS. To clarify the mechanism responsible for the effects of URB597, we determined changes in CB2/β-Arrestin1, ERS, and organelle apoptosis-related proteins. First, co-immunoprecipitation (Co-IP) experiments confirmed the interaction between CB2 and β-Arrestin1 (Fig. ##FIG##7##8##A). CB2 and β-Arrestin1 protein levels were significantly increased in the URB597, 4-PBA, and co-treatment groups, when compared with those in the M group (<italic>P</italic> &lt; 0.05, vs. M) (Fig. ##FIG##7##8##B–D). In contrast, the phosphorylation level of PERK (p-PERK) was decreased in mice with CCH (<italic>P</italic> &lt; 0.05, vs. Sham) (Fig. ##FIG##7##8##B, E). CCH increased the levels of organelle-specific apoptosis-related proteins (CHOP, Cyt-c, and caspase-9), which was decreased by URB597 treatment (<italic>P</italic> &lt; 0.05, vs. M) (Fig. ##FIG##7##8##B, F–I). Furthermore, in the CB2 antagonist AM630 group, the above effects were partly reversed (<italic>P</italic> &lt; 0.05, vs. MUP), showing a similar trend compared with those in the M group (Fig. ##FIG##7##8##B, F–I). All of these results indicated that URB597 inhibited ERS and protected mitochondria in the CB2-dependent model.</p>", "<p id=\"Par72\">\n\n</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par73\">Cerebral ischemia is a severe form of stress, causing disturbances in most molecular-biological cellular and organelles processes (Paschen and Doutheil ##REF##9886350##1999##). The ER is a complex, dynamic organelle that mediates numerous responses, such as lipid metabolism, Ca<sup>2+</sup> storage, and protein folding and repair. ER stress is essential to determine the fate of neurons during brain ischemia (Su and Li ##REF##26289799##2016##). Ischemic injury initiates the unfolded protein response (UPR), which is regarded as a protective mechanism (Han et al. ##REF##34408630##2021##). However, an excessive UPR is usually caused by brain trauma, cerebral ischemia-reperfusion, and stroke, leading to irreversible neuronal damage (Guo et al. ##REF##34322090##2021##; Han et al. ##REF##34408630##2021##). In the present study, we found that ER stress was triggered by OGD and was secondary to oxidative stress and mitochondrial damage. Three ER membrane-embedded sensors, GRP78, ATF6, and PERK, were activated by perturbed ER homeostasis. The level of those proteins as well as the phosphorylation of PERK were increased in OGD. In addition, damage to mitochondrial function has also been confirmed with the decrease in TOMM20 fluorescence and ATP. The ER and mitochondria, as key organelles that control intracellular ROS levels, are prone to oxidative stress due to the destruction of their structure and function (Resende et al. ##REF##35369731##2022##). An abnormal increase in ROS and MDA, and a decrease in antioxidant activity (SOD and CAT) indicates that cells are suffering from oxidative stress, which is considered one of the main factors in ischemic cerebral damage and cognitive impairment (Jurcau and Simion ##REF##32124703##2020##; Orellana-Urzua et al. ##REF##32640953##2020##).</p>", "<p id=\"Par74\">URB597 (C<sub>20</sub>H<sub>22</sub>N<sub>2</sub>O<sub>3</sub>) is a highly selective inhibitor of FAAH. It promotes the activities of ECS by enhancing its ligand and receptor. We previously reported the anti-inflammatory and antioxidant effects of URB597 on OGD. URB597 protects primary cultured hippocampal neurons and brain microvascular endothelial cells against OGD-induced oxidative stress and neuroinflammatory injury (Wang et al. ##REF##34093011##2021b##). URB597 also inhibits ischemic cognitive decline by activating CB1/AKT/BDNF signaling in the CCH rat model (Wang et al. ##REF##28042028##2017a##, ##REF##33708855##2021c##). URB597 shows neuroprotective effects on neuropathic pain, addiction, and depression through multiple mechanisms, and prevents dendrite loss, microglia response, and nicotine-dependent behaviors without evoking classical cannabinoid-like effects (e.g. hypothermia, catalepsy, and hyperphagia) (Piomelli et al. ##REF##16834756##2006##; Wang et al. ##REF##28501776##2017b##; Ebrahimi-Ghiri et al. ##REF##33155516##2021##). However, the effects of URB597 on ER stress and the role of ER stress in the process of CCH remain unclear. Here, inhibition of ER stress by 4-PBA and URB597 produced significant neuroprotective effects and was demonstrated in the cerebral ischemia model, both in vivo and in vitro. Water maze test results suggested that inhibition of ER stress improved CCH-induced cognitive impairment. Furthermore, CCH-induced ultrastructural deterioration of ER and mitochondrion, including abundant ER swelling, abnormal mitochondria membrane swelling, and mitochondrial crista rupture, were ameliorated by URB597 treatment. Nissl staining in a single treatment group or co-treatment group also supported these findings. Recently, a study confirmed that drug-targeted restraint of ER stress alleviated CCH-induced synaptic plasticity injury, oxidative stress, and neuronal apoptosis (Thangwong et al. ##REF##35219702##2022##), which is consistent with our findings. In addition, the pH of treatment fluids may affect its efficacy, as the potency of URB597 is pH-dependent (Paylor et al. ##REF##16997568##2006##), which is a very important factor needed to be considered in further studies.</p>", "<p id=\"Par75\">Mitochondria and ER are dynamic organelles that communicate with each other. There are membrane contacts termed MAMs that provide an excellent scaffold for crosstalk between the ER and mitochondria, allowing rapid exchange of biological molecules to maintain cellular health (Missiroli et al. ##REF##29491386##2018##). Dysfunctions in the MAMs are associated with pathological conditions and human diseases, including neurodegenerative diseases, aging, and traumatic brain injury (Veeresh et al. ##REF##31460675##2019##; Markovinovic et al. ##UREF##0##2022##). In CCH, the disintegration of MAM ultrastructure was verified by TEM in our study. Currently, there is controversy about the changes and roles of MAMs in vascular dementia and Alzheimer’s disease (AD) pathology. Some researchers have found that MAM-localized functions are increased significantly in cellular and animal models of AD (Area-Gomez and Schon ##REF##28246299##2017##; Zhao et al. ##REF##35236834##2022##). However, several studies have now reported that MAMs regulate neuronal health and synaptic transmission that are damaged in patients with cognitive dysfunction (Area-Gomez et al. ##REF##22892566##2012##; Markovinovic et al. ##UREF##0##2022##). Such a different conclusion has resulted from the different disease models. The cellar/animal model is different from the chronic pathological changes in humans. In addition, highly activated MAMs may be a compensatory mechanism. Although upregulated MAM function and increased ER-mitochondria communications have been confirmed in AD and ischemic brain injury, mitochondria are extremely susceptible to destruction and reduction in aging, AD, and chronic ischemic cerebrovascular disease (Ham and Raju ##REF##27321753##2017##; Wang et al. ##REF##32471464##2020b##), whose amount directly affects the number and range of MAMs.</p>", "<p id=\"Par76\">CB2 was initially regarded as a peripheral immunomodulation receptor since it was discovered in 1993 (Raitio et al. ##REF##15892633##2005##). However, CB2 has been recently shown to be expressed in both glial cells and neurons, and is involved in multiple functions at cellular and behavioral levels (Jordan and Xi ##REF##30611802##2019##). Brain CB2 is inducible and neuroprotective via up-regulation in response to various insults (Jordan and Xi ##REF##30611802##2019##). In the present study, we found that CCH decreased CB2 expression in the hippocampus, which was associated with CCH-induced neuronal injury. Contartese et al. reported that activation of CB2 protected rat brain cortical slices against OGD and reperfusion injury (Contartese et al. ##REF##23036353##2012##). In a spinal cord ischemia-reperfusion rat model, exogenous activation of CB2 using the agonist, JWH-133, attenuated ischemia-induced neurological deficits (Jing et al. ##REF##32248810##2020##). URB597 can promote the expression of CB2 while inhibiting ER stress, and also upregulates the level of β-Arrestin1. In addition, there is a direct interaction between CB2 and β-Arrestin1, which has been confirmed by Co-IP experiments. The β-Arrestin1 not only directly regulates the expression of PERK, but also activates the Nrf2 pathway and reduces oxidative stress (Liu et al. ##REF##31207192##2019##; Tan et al. ##REF##33897365##2021##). The β-Arrestin1 plays a pivotal role in ER stress signaling pathways that have previously been observed in neurons (Sharma et al. ##REF##34966948##2021##). Here, we also showed that upregulation of CB2 by URB597 was significantly reversed by treatment with the CB2 antagonist, AM630. Interestingly, the expression of PERK protein was elevated following AM630 treatment. One of the potential mechanisms was that AM630 may stimulate microglial accumulation, further aggravating inflammatory responses and ER stress (Tang et al. ##REF##25963415##2015##). Another reason was that PERK can be regulated by the p38 MAPK pathway, which is activated to a certain extent by AM630 (Guo et al. ##REF##34322090##2021##). To the best of our knowledge, these results suggested for the first time that inhibition of ER stress and protection of mitochondria by URB597 was CB2/β-Arrestin1 dependent.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par77\">Taken together, these observations suggest novel mechanisms of URB597 and insights into cognitive impairment during ischemic cerebrovascular diseases, and identify CB2 as a potential target for therapy of ischemic cerebrovascular diseases. Thus, a deeper understanding of how CCH accelerates the vascular-mediated hippocampal neuropathology could potentially provide for preventive interventions, which is vital in developing effective treatments to reverse early symptoms and slow cognitive decline.</p>" ]
[ "<p id=\"Par1\">\nAugmentation of endoplasmic reticulum (ER) stress may trigger excessive oxidative stress, which induces mitochondrial dysfunction. The fatty acid amide hydrolase inhibitor, URB597, shows anti-oxidation characteristics in multiple neurological disorders. The present study aimed to determine whether inhibition of ER stress was involved in the protective effects of URB597 against chronic cerebral hypoperfusion (CCH)-induced cognitive impairment. Hippocampal HT-22 cells were exposed to oxygen-glucose deprivation. The cell viability, apoptosis, ER stress, mitochondrial ATP, and oxidative stress levels were assessed following treatment with URB597, benzenebutyric acid (4-PBA), and thapsigargin (TG). Furthermore, the effects of URB597 on ER stress and related pathways were investigated in the CCH animal model, including Morris water maze testing of cognition, western blotting analysis of ER stress signaling, and transmission electron microscopy of mitochondrial and ER ultrastructure changes. The results suggested that cerebral ischemia caused ER stress with upregulation of ER stress signaling-related proteins, mitochondrial dysfunction, neuronal apoptosis, ultrastructural injuries of mitochondria-associated ER membranes, and cognitive decline. Co-immunoprecipitation experiments confirmed the interaction between CB2 and β-Arrestin1. Inhibiting ER stress by URB597 improved these changes by activating CB2/β-Arrestin1 signaling, which was reversed by the CB2 antagonist, AM630. Together, the results identified a novel mechanism of URB597, involving CCH-induced cognitive impairment alleviation of CB2-dependent ER stress and mitochondrial dysfunction. Furthermore, this study identified CB2 as a potential target for therapy of ischemic cerebrovascular diseases.</p>", "<title>Graphical Abstract</title>", "<p id=\"Par1111\">\n\n</p>", "<title>Keywords</title>" ]
[]
[ "<title>Acknowledgements</title>", "<p>We thank the editor and reviewers for their valuable comments on this study.</p>", "<title>Author Contributions</title>", "<p>Conception and design: D-PW, Q-LL, and JH; administrative support: Q-LL and Z-BW; collection and assembly of data: D-PW, Q-LL, and KK; data analysis and interpretation: Q-LL and KK; manuscript writing: D-PW and KK. Final approval of manuscript: all authors.</p>", "<title>Funding</title>", "<p>This study was supported by the National Nature Science Foundation of China (82001383, 82060680), the China Postdoctoral Science Foundation (2023M732302), and the Shanghai Municipal Health Commission (2022YQ004).</p>", "<title>Data Availability</title>", "<p>Data will be made available upon reasonable request.</p>", "<title>Declarations</title>", "<title>Ethical Approval</title>", "<p id=\"Par80\">The approval number of Shanghai animal center is SCXK2023-0004. All experiments were approved by the Animal Care and Use Committee of Tongji Hospital of Tongji University (No. 2020-DW009) and conducted according to guidelines published by the National Institutes of Health Policies on the Care and Use of Laboratory Animals.</p>", "<title>Consent to Participate</title>", "<p id=\"Par82\">Not applicable.</p>", "<title>Consent for Publication</title>", "<p id=\"Par83\">Not applicable.</p>", "<title>Conflict of Interest</title>", "<p id=\"Par81\">The authors declare no conflict of interest.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>Effects of URB597, 4-PBA, and TG on HT22 cell survival and apoptosis in OGD. <bold>A</bold> An experimental flow chart. <bold>B</bold> Representative NeuN (green) immunofluorescence for HT22 neuronal cells. <bold>C</bold> Statistical analysis of the cell viability using the MTT assay. <bold>D</bold>, <bold>E</bold> Cellular apoptosis was detected by Annexin V-FITC/propidium iodide flow cytometry analysis. <sup>∗</sup><italic>p</italic> &lt; 0.05 νs. Con, <sup>#</sup><italic>p</italic> &lt; 0.05 νs. OGD, <sup>^</sup><italic>p</italic> &lt; 0.05 νs. 4-PBA, <sup>&amp;</sup><italic>p</italic> &lt; 0.05 νs. URB597, (<italic>n</italic> = 4). Magnification: 200×, scale bar: 50 μm</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>Effects of URB597, 4-PBA, and TG on HT22 cell ER stress in OGD. <bold>A</bold> Representative GRP78 (green) and NeuN (red) immunofluorescence. <bold>B</bold> Statistical analysis of the fluorescence intensity of GRP78. <bold>C</bold> The expression of ER stress signaling-related proteins, including GRP78, ATF-6, p-PERK/PERK, and CHOP. <bold>D</bold>–<bold>G</bold> Expression histograms. <sup>∗</sup><italic>p</italic> &lt; 0.05 νs. Con, <sup>#</sup><italic>p</italic> &lt; 0.05 νs. OGD, <sup>^</sup><italic>p</italic> &lt; 0.05 νs. 4-PBA, <sup>&amp;</sup><italic>p</italic> &lt; 0.05 νs. URB597, (<italic>n</italic> = 3)</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p>Effects of URB597, 4-PBA, and TG on HT22 cell mitochondrial function in OGD. <bold>A</bold> Representative TOMM20 (green) and NeuN (red) immunofluorescence. <bold>B</bold> Statistical analysis of fluorescence intensity of TOMM20. <bold>C</bold> Statistical analysis of ATP levels. <sup>∗</sup><italic>p</italic> &lt; 0.05 νs. Con, <sup>#</sup><italic>p</italic> &lt; 0.05 νs. OGD, <sup>^</sup><italic>p</italic> &lt; 0.05 νs. 4-PBA, <sup>&amp;</sup><italic>p</italic> &lt; 0.05 νs. URB597, (<italic>n</italic> = 4)</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p>Effects of URB597, 4-PBA, and TG on ER and mitochondrial oxidative stress in OGD. <bold>A</bold> Immunofluorescent DHE staining of reactive oxygen species (ROS) levels. <bold>B</bold> Quantitative analysis of the DHE signal. <bold>C</bold>–<bold>F</bold> Quantification of ROS, SOD, CAT, and MDA levels in HT22 cells. <sup>∗</sup><italic>p</italic> &lt; 0.05 νs. Con, <sup>#</sup><italic>p</italic> &lt; 0.05 νs. OGD, <sup>^</sup><italic>p</italic> &lt; 0.05 νs. 4-PBA, <sup>&amp;</sup><italic>p</italic> &lt; 0.05 νs. URB597, (<italic>n</italic> = 4). Magnification: 200×, scale bar: 50 μm</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><p>Effects of URB597 and 4-PBA on CCH-induced hippocampal neuronal injury and spatial learning and memory deficits. <bold>A</bold> Representative Nissl staining in hippocampal CA1, CA3, and DG areas. <bold>B</bold>–<bold>D</bold> Quantitative analysis of Nissl-stained cells rate in CA1, CA3, and DG, respectively (<italic>n</italic> = 3). <bold>E</bold> Representative swimming paths of rats in the probe trial. <bold>F</bold> The swimming speed during the probe trial. <bold>G</bold> Escape latencies during the training trials <bold>H</bold>, <bold>I</bold> The time spent in the target quadrant and the platform location crosses from different groups during the probe trial. <sup>*</sup><italic>p</italic> &lt; 0.05 vs. Sham; <sup>#</sup><italic>p</italic> &lt; 0.05 νs. M, ^<italic>p</italic> &lt; 0.05 νs. MP, <sup>&amp;</sup><italic>p</italic> &lt; 0.05 νs. MU, (<italic>n</italic> = 8)</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><p>Effects of URB597 and 4-PBA on CCH-induced ER stress and mitochondrial function. <bold>A</bold> Representative double staining between GRP78 (red) and NeuN, Ibal-1, and GFAP (green) in the hippocampus. <bold>B</bold>, <bold>C</bold> Representative GRP78 and TOMM20 double staining with NeuN immunofluorescence, respectively. <bold>D</bold>, <bold>E</bold> Quantitative analysis of the relative fluorescence intensity. <sup>*</sup><italic>p</italic> &lt; 0.05 vs. Sham; <sup>#</sup><italic>p</italic> &lt; 0.05 νs. M, <sup>^</sup><italic>p</italic> &lt; 0.05 νs. MP, <sup>&amp;</sup><italic>p</italic> &lt; 0.05 νs. MU (<italic>n</italic> = 4)</p></caption></fig>", "<fig id=\"Fig7\"><label>Fig. 7</label><caption><p>Effects of URB597 and 4-PBA on CCH-induced ultrastructural changes of MAMs. <bold>A</bold> Representative ultrastructure of hippocampal neurons in different groups. Neurons with normal neuron nuclei and the ER and mitochondria in the Sham group were found. There were many coupling MAM regions between mitochondria and ER with normal morphology. Ultrastructural deterioration of mitochondria, the ER, and MAM regions were induced by CCH. The number of organelles decreased significantly. Swollen mitochondria and ER with disrupted MAMs. Ultrastructural changes after chronic treatment with URB and 4-PBA involved reduced degenerated organelles, slightly swollen mitochondria, normal ER, and improved MAMs in structure and quantity. <bold>B</bold>–<bold>C</bold> Quantitative analysis of MAMs and mitochondria injury. Nu: nucleus. Red dotted lines: ER; green asterisk: normal mitochondria; red asterisk: abnormal mitochondria. <sup>*</sup><italic>p</italic> &lt; 0.05 vs. Sham; <sup>#</sup><italic>p</italic> &lt; 0.05 νs. M, <sup>^</sup><italic>p</italic> &lt; 0.05 νs. MP, <sup>&amp;</sup><italic>p</italic> &lt; 0.05 νs. MU (<italic>n</italic> = 4)</p></caption></fig>", "<fig id=\"Fig8\"><label>Fig. 8</label><caption><p>Effects of URB597 and 4-PBA on the CB2/β-Arrestin1-dependent ER stress and mitochondrial apoptosis. <bold>A</bold> Immunoprecipitation confirmed the interaction between CB2 and β-Arrestin1. <bold>B</bold> Representative western blots of CB2, β-Arrestin1, p-PERK/PERK, CHOP, Cyt-c, and caspase-9. <bold>C</bold>–<bold>H</bold> Quantitative analysis of protein expression. <sup>*</sup><italic>p</italic> &lt; 0.05 vs. Sham; <sup>#</sup><italic>p</italic> &lt; 0.05 νs. M, <sup>^</sup><italic>p</italic> &lt; 0.05 νs. MP, <sup>&amp;</sup><italic>p</italic> &lt; 0.05 νs. MU, <sup>▽</sup><italic>p</italic> &lt; 0.05 νs. MUP (<italic>n</italic> = 3)</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>The criteria for scoring the neuronal mitochondria injury using TEM (Flameng et al. ##REF##6243726##1980##)</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Scores</th><th align=\"left\">Injurious manifestations and ultrastructural changes</th></tr></thead><tbody><tr><td align=\"left\">0</td><td align=\"left\">Normal structure</td></tr><tr><td align=\"left\">1</td><td align=\"left\">The structure is basically normal, but the matrix particles are lost (slight swelling, matrix density is reduced, cristae separation)</td></tr><tr><td align=\"left\">2</td><td align=\"left\">Mitochondrial swelling (reduced matrix density, cristae separation), the matrix is transparent; cristae are not broken</td></tr><tr><td align=\"left\">3</td><td align=\"left\">Mitochondrial cristae rupture, matrix coagulation (severe swelling)</td></tr><tr><td align=\"left\">4</td><td align=\"left\">Mitochondrial cristae rupture, the integrity of the inner and outer membranes disappear and become vacuolated (severe swelling, rupture of inner and outer membranes)</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[]
[ "<fn-group><fn><p><bold>Publisher’s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Da Peng Wang and Kai Kang contributed equally.</p></fn></fn-group>" ]
[ "<graphic position=\"anchor\" xlink:href=\"11481_2024_10098_Figa_HTML\" id=\"d32e237\"/>", "<graphic xlink:href=\"11481_2024_10098_Fig1_HTML\" id=\"d32e767\"/>", "<graphic xlink:href=\"11481_2024_10098_Fig2_HTML\" id=\"d32e843\"/>", "<graphic xlink:href=\"11481_2024_10098_Fig3_HTML\" id=\"d32e899\"/>", "<graphic xlink:href=\"11481_2024_10098_Fig4_HTML\" id=\"d32e974\"/>", "<graphic xlink:href=\"11481_2024_10098_Fig5_HTML\" id=\"d32e1070\"/>", "<graphic xlink:href=\"11481_2024_10098_Fig6_HTML\" id=\"d32e1133\"/>", "<graphic xlink:href=\"11481_2024_10098_Fig7_HTML\" id=\"d32e1192\"/>", "<graphic xlink:href=\"11481_2024_10098_Fig8_HTML\" id=\"d32e1272\"/>" ]
[]
[{"mixed-citation": ["Markovinovic A, Greig J, Martin-Guerrero SM, Salam S, Paillusson S (2022) Endoplasmic reticulum-mitochondria signaling in neurons and neurodegenerative diseases. J Cell Sci 135"]}, {"mixed-citation": ["Pawar HD, Mahajan UB, Nakhate KT, Agrawal YO, Patil CR, Meeran MFN, Sharma C, Ojha S, Goyal SN (2022) Curcumin protects Diabetic mice against Isoproterenol-Induced myocardial infarction by modulating CB2 cannabinoid receptors. Life (Basel) 12."]}, {"mixed-citation": ["Wang DP, Kang K, Sun J, Lin Q, Lv QL, Hai J (2022) URB597 and Andrographolide Improve Brain Microvascular Endothelial Cell Permeability and Apoptosis by Reducing Oxidative Stress and Inflammation Associated with Activation of Nrf2 Signaling in Oxygen-Glucose Deprivation. Oxid Med Cell Longev 2022:4139330"]}]
{ "acronym": [ "AD", "BCCAO", "BDNF", "CAT", "CBR", "CCH", "Co-IP", "CHOP", "Cyt-c", "DHE", "DMEM", "ECS", "ER", "FAAH", "GFAP", "GRP78", "MDA", "MAMs", "MWM", "OD", "OGD", "PERK", "ROS", "SD", "SOD", "TEM", "TOMM20", "TG", "UPR", "URB597", "VaD", "4-PBA", "MP", "MUP", "MUPA" ], "definition": [ "Alzheimer’s disease", "bilateral common carotid artery occlusion", "brain-derived neurotrophic factor", "catalase", "cannabinoid receptor", "chronic cerebral hypoperfusion", "co-immunoprecipitation", "C/EBP-homologous protein", "cytochrome-c", "dihydroethidium", "Dulbecco’s Modified Eagle Medium", "endocannabinoid system", "endoplasmic reticulum", "fatty acid amide hydrolase", "glial fibrillary acidic protein", "78-kDa glucose-regulated protein", "malondialdehyde", "mitochondria-associated ER membranes", "Morris water maze", "optical density absorbance", "oxygen-glucose deprivation", "protein kinase R-like ER kinase", "reactive oxygen species", "standard deviation", "superoxide dismutase", "transmission electron microscopy", "translocase of outer mitochondrial membrane 20", "thapsigargin", "unfolded protein response", "3´-carbamoylbiphenyl-3-yl cyclohexyl carbamate", "vascular dementia", "benzenebutyric acid. MU,the BCCAO + URB597 group", "the BCCAO + 4-PBA group", "the BCCAO + URB597 + 4-PBA group", "the BCCAO + URB597 + 4-PBA + AM630 group" ] }
57
CC BY
no
2024-01-14 23:40:12
J Neuroimmune Pharmacol. 2024 Jan 12; 19(1):1
oa_package/55/3c/PMC10786746.tar.gz
PMC10786747
38214813
[ "<title>Introduction</title>", "<p id=\"Par2\">Photobiomodulation (PBM) is a promising tool for stimulating, healing, regenerating, and protecting damaged tissues through the use of the red to near-infrared (NIR) spectrum (600–1200 nm) [##UREF##0##1##, ##UREF##1##2##]. Its medical implication was discovered in 1967, when Endre Mester observed that PBM promoted hair regrowth and wound healing in rats [##UREF##2##3##]. Since its discovery, PBM has been recognised by many organisations, researchers, and clinicians in the biomedical field, as this technique can repair damaged tissues, restore brain blood flow, minimise inflammation, stimulate neurogenesis, synaptogenesis, and nerve growth factors [##UREF##3##4##, ##REF##30614743##5##], among other effects. Consequently, it has been employed in a wide range of alterations that affect the nervous system; for example, for the treatment of traumatic events such as stroke, traumatic brain injury, or ischemia, in degenerative diseases and psychological/psychiatric alterations, and even to prevent cognitive decline in healthy ageing [##UREF##0##1##, ##REF##33069687##6##–##REF##37721264##10##].</p>", "<p id=\"Par3\">PBM action mechanism affects an enzyme of the mitochondrial respiratory chain, cytochrome c oxidase (CCO). The CCO enzyme is located in the IV complex of the electron transport chain, in the inner mitochondrial membrane. It catalyses the final reduction of molecular oxygen (O<sub>2</sub>) into two water molecules (H<sub>2</sub>O), using the electrons generated in glucose metabolism, and pumps protons out of the matrix. This pumping, in turn, generates energy that produces ATP synthesis [##REF##2469224##11##]. Brain functioning is critically dependent on oxygen consumption by CCO for ATP production, which can be examined by CCO histochemistry.</p>", "<p id=\"Par4\">Interestingly, the CCO enzyme is the major intracellular photoceptor that can absorb specific wavelengths, leading to molecular and cellular modifications [##UREF##0##1##, ##UREF##7##12##]. The CCO enzyme contains a heme and copper centres with red (620–680 nm) or infrared (760–825 nm) spectral absorption peaks [##UREF##8##13##]. However, CCO’s absorption of light is not limited to these wavelengths, as it has been shown that longer NIR wavelengths, such as 1064, can trigger a hemodynamic response, leading to greater brain oxygenation [##UREF##8##13##, ##REF##33636401##14##]. When CCO absorbs photons derived from a PBM device, ATP synthesis is enhanced due to an increase in the mitochondrial reactive oxygen species (ROS), which activates signalling pathways associated with protective, antioxidant and antiapoptotic effects in the cells. The dissociation of nitric oxide (NO) after light stimulation increases mitochondrial membrane potential, oxygen consumption, and glucose metabolism [##UREF##3##4##, ##UREF##8##13##]. Production of ROS and release of Ca2 + may follow this process, leading to the activation of transcription factors and signalling mediators with long-lasting effects on cells [##REF##30507909##15##]. The signalling pathways can also modulate the long-term expression of various proteins and genes. The stimulation of CCO also induces the replication of mitochondrial DNA, thereby activating early genes [##UREF##3##4##, ##UREF##8##13##]. Therefore, PBM emerges as a novel approach to modulating bioenergetics in the brain [##UREF##7##12##, ##REF##35368252##16##].</p>", "<p id=\"Par5\">Many PBM parameters such as wavelength, wavelength type (continuous or pulsated), frequency, intensity, irradiance, brain target area, and days of application can have different effects [##REF##33069687##6##, ##UREF##9##17##], and need to be considered. In this study, we focused on the wavelength, where 810 nm is thought to be more effective, as it promotes greater light absorption [##REF##29327206##18##]. Specifically, it has been shown that NIR light penetrates tissue more deeply (&gt; 30–40 mm), whereas red light penetrates up to &lt; 10 mm [##REF##27943458##19##]. Therefore, we aim to determine the effect of a single NIR (810 nm) PBM treatment and a combination of NIR (810 nm) and red (660 nm) PBM application on brain oxidative metabolism through COO histochemistry in healthy adult male and female rats.</p>" ]
[ "<title>Material and methods</title>", "<title>Animals</title>", "<p id=\"Par6\">A total of 24 male (275–315 gr at the beginning of the experiment) and 24 female (225–300 gr) Wistar rats were used. All the animals had ad libitum access to food and tap water and were maintained at constant room temperature (20-22ºC), with a relative humidity of 65–70% and an artificial light–dark cycle of 12 h (08:00–20:00/20:00–08:00 h). The animals were caged in groups of four rats in transparent polycarbonate cages.</p>", "<p id=\"Par7\">The procedures and manipulation of the animals followed the European Communities Council Directive (2010/63/UE) and the Spanish legislation on the care and use of animals for experimentation (RD 53/2013). The local committee for animal studies of Oviedo University approved the study (PROAE 23/2021).</p>", "<p id=\"Par8\">We applied PBM for 5 consecutive days with a wavelength of 810 nm (810 male and female groups) and, for 5 consecutive days, a combination of 810 nm and 660 nm, emitting 810 nm on 3 days and 660 nm on 2 days (810 + 660 male and female groups). Male and female rats were randomly split into 6 groups: control male group (CM, <italic>n</italic> = 8), 810 nm PBM male group (810 M, <italic>n</italic> = 8), 810 nm + 660 nm PBM male group (810 + 660 M, <italic>n</italic> = 8), control female group (CF, <italic>n</italic> = 8), 810 nm PBM female group (810 F, <italic>n</italic> = 8), and 810 nm + 660 nm PBM female group (810 + 660 F, <italic>n</italic> = 8).</p>", "<title>Photobiomodulation therapy</title>", "<title>Apparatus</title>", "<p id=\"Par9\">The lasers were adjusted to provide an optical power of 40 mW. The lasers are cased inside a cylinder 45 mm high and 18 mm in diameter. The case also holds the driver for the laser diodes and a 7.50-mm lens. As the devices used produce a dot of 2.43 mm in diameter, the irradiance externally applied externally is 862 mW/cm<sup>2</sup>. Previous experiments have demonstrated than only 0.8% of the external irradiance actually reaches the test animal’s brain. Therefore, only 6.9 mW/cm2 were applied on the area of interest. The lasers were operated in cycles of 40 s ON followed by 10 s OFF to prevent excessive device heating. These cycles were applied at a rate of 14 cycles/day for 5 days, resulting in a total energy delivered of approximately 20 J/cm2. For the 810 nm male and female groups, the energy delivery was 4 J/cm2 each day, leading to 20 J/cm2 for the entire treatment. For the 810 + 660 nm male and female groups, the energy was applied using the 810-nm wave for 3 days (resulting in an energy delivery of 12 J/cm<sup>2</sup>) and the 660-nm wave for 2 days (providing the remaining 8 J/cm<sup>2</sup>). The pattern of the waveforms to be applied is generated by an external microcontroller-based circuit. Table ##TAB##0##1## summarises the parameters employed.\n</p>", "<p id=\"Par10\">The apparatus was previously calibrated using a PM160 optical power meter from Thorlabs. The laser driver was adjusted until the power meter showed that it provided 40 mW. The power meter used was calibrated by the manufacturer (calibration certificate number 15239113314). The 810-nm device has a laser diode with a rated output power of 500 mW at 50 °C maximum (S810500MG, <italic>Roithner Lasertechnik</italic>), and the 660 nm has a laser diode with a rated output power of 100 mW at 85 °C maximum (LNCQ28PS01WW, <italic>Panasonic</italic>).</p>", "<title>Treatment protocol</title>", "<p id=\"Par11\">Before PBM treatment, the rats were habituated to the researcher and the immobilisation required for the treatment for one week. They were shaved across prefrontal areas to maximise light penetration. The target area for PBM was the prefrontal cortex, and the PBM device was transcranially placed at this location (Fig. ##FIG##0##1##).</p>", "<p id=\"Par12\">The therapy lasted for 1 habituation day and 5 consecutive PBM active days. On these days, subjects were immobilised by the researcher on a soft surface while the PMB device was placed on the shaved region. For the 810-nm male and female groups, the treatment began with this immobilised procedure, but the light device was in ON mode. A laser with a continuous wave at 810-nm wavelength was used for these groups for 5 consecutive days. For the 810 + 660 nm male and female groups, immobilisation was carried out identically, but rats received PBM with a laser with a continuous wave at 810 nm for 3 days (days 1, 3, and 5), and at 660 nm for 2 days (days 2 and 5). Control groups were immobilised with the same procedure for 5 consecutive days, but the device was in OFF mode, as in habituation (Fig. ##FIG##1##2##). PBM was administrated in three blocks of 10 min, a total duration of 30 min per day. Intertrial interval (ITI) was 30 min. During habituation, the device was set to OFF mode.</p>", "<title>Tissue processing</title>", "<p id=\"Par13\">The day after finishing the light procedure, the animals were decapitated, and the brains were removed intact, frozen rapidly in isopentane, and stored at -40 ºC. Coronal Sects. (30 µm) of the brain were cut at -20 ºC in a cryostat and mounted on non-gelatinised slides for cytochrome c oxidase (CCO) histochemistry. The regions of interest were anatomically defined according to Paxinos and Watson’s atlas [##UREF##10##20##].</p>", "<title>CCO histochemistry and quantification</title>", "<p id=\"Par14\">Section slides were processed with quantitative CCO histochemistry, described by Gonzalez-Lima and Cada [##REF##7891865##21##].  To quantify enzymatic activity and control staining variability across the baths, sets of tissue homogenate standards from adult Wistar rat brains were cut at different thicknesses. The sections and standards were incubated for 5 min in 0.1 phosphate buffer with 10% sucrose and 0.5 glutaraldehyde, pH 7.6. Afterwards, they were bathed with a 0.1 M phosphate buffer with sucrose performed for 5 min each. Subsequently, 0.05MTris buffer, pH 7.6, with 275 mg/l cobalt chloride, sucrose, and 0.5 dimethylsulfoxide were applied for 10 min. Then, sections and standards were incubated in a solution with 0.0075% cytochrome-c, 0.002% catalase, 5% sucrose, 0.25% dimethylsulfoxide, and 0.05% diaminobenzidine tetrahydrochloride, in 0.1 M phosphate buffer at 37 °C for 1 h. The reaction was interrupted by fixing the tissue in buffered 4% formalin for 30 min at room temperature. Finally, the slides were dehydrated, cleared with xylene, and coverslipped.</p>", "<p id=\"Par15\">The CCO histochemical intensity was quantified by densitometric analysis, using a computer-assisted image analysis workstation (MCID, Interfocus Imaging Ltd., Linton, England) consisting of a high-precision illuminator, a digital camera, and a computer with the specific image analysis software MDCID Core 7.0. The mean optical density (OD) of each region was measured using 3 consecutive sections for each subject. In each section, four non-overlapping readings were taken, using a square-shaped dissector adjusted for each region size. OD values were converted to CCO activity units, determined by the enzymatic activity of the standards measured spectrophotometrically. For CCO histochemistry, the regions studied were included in the bregma coordinates + 3.24 mm for the cingulate cortex (CG), prelimbic cortex (PL), and infralimbic cortex (IL), and in -3.24 mm for the CA1, CA3, and the dentate gyrus (DG) subfields of the dorsal hippocampus, granular retrosplenial cortex (RSG), disgranular retrosplenial cortex (RSD), and parietal cortex (PAR).</p>", "<title>Statistical analysis</title>", "<p id=\"Par16\">All data were analysed with the Sigma-Stat 14 program (Systat, Richmond, USA). The results were considered statistically significant if<italic> P</italic> &lt; 0.05. A two-way analysis of variance (ANOVA) was performed to explore differences between the PBM treatment (control, 810 + 660, 810) and sex (male, female) in each brain region. To assess multiple comparisons, the Holm-Sidak method was employed. When an interaction effect was found, post-hoc multiple comparisons considering the interaction of two factors were performed. When no interaction effect was found, but there were differences in the main effects, post-hoc analysis considering the significant factors was performed. Power analysis (1 – β) was calculated with alpha 0.05 and was described when significant differences were found. Graphic representation of the results was performed with the SigmaPlot 14 software program. Data are expressed as mean ± standard deviation (SD).</p>" ]
[ "<title>Results</title>", "<p id=\"Par17\">The analysis of metabolic brain activity revealed no effect of Treatment x Sex interaction in any brain area: CG (<italic>F</italic><sub>(2, 42) =</sub> 0.114, <italic>P</italic> = 0.892), PL (<italic>F</italic><sub>(2, 38) =</sub> 0.546, <italic>P</italic> = 0.584), IL (<italic>F</italic><sub>(2, 38) =</sub> 0.726, <italic>P</italic> = 0.490), CA1 (<italic>F</italic><sub>(2, 40) =</sub> 0.372, <italic>P</italic> = 0.692), CA3 (<italic>F</italic><sub>(2, 41) =</sub> 0.311, <italic>P</italic> = 0.734), DG (<italic>F</italic><sub>(2, 41) =</sub> 1.453, <italic>P</italic> = 0.246), RSG (<italic>F</italic><sub>(2, 40) =</sub> 2.692, <italic>P</italic> = 0.080), RSD (<italic>F</italic><sub>(2, 41) =</sub> 1.104, <italic>P</italic> = 0.341), PAR (<italic>F</italic><sub>(2, 41) =</sub> 1.552, <italic>P</italic> = 0.224). Thus, considering the main factors, sex differences were revealed regardless of treatment in CG (<italic>F</italic><sub>(2, 42) =</sub> 4.939; <italic>P</italic> = 0.032, β = 0.481), CA1 (<italic>F</italic><sub>(1, 40) =</sub> 14.223; <italic>P</italic> &lt; 0.001, β = 0.959), CA3 (<italic>F</italic><sub>(1, 41) =</sub> 12.220; <italic>P</italic> = 0.001, β = 0.922), RSG (<italic>F</italic><sub>(1, 40) =</sub> 7.555; <italic>P</italic> = 0.009, β = 0.711), RSD (<italic>F</italic><sub>(1, 41) =</sub> 6.595; <italic>P</italic> = 0.014, β = 0.637), and PAR (<italic>F</italic><sub>(1, 42) =</sub> 14.123; <italic>P</italic> &lt; 0.001, β = 0.958). Multiple comparisons revealed a higher brain metabolic activity in male than in female groups (CG: <italic>t</italic> = 2.222, <italic>P</italic> = 0.032; CA1: <italic>t</italic> = 3.771, <italic>P</italic> &lt; 0.001; CA3: <italic>t</italic> = 3.496, <italic>P</italic> = 0.001; RSG: <italic>t</italic> = 2.800, <italic>P</italic> = 0.009; RSG: <italic>t</italic> = 2.568, <italic>P</italic> = 0.014; PAR: <italic>t</italic> = 3.758, <italic>P</italic> &lt; 0.001) (Fig. ##FIG##2##3##).</p>", "<p id=\"Par18\">However, a treatment effect was found in CG (<italic>F</italic><sub>(2, 42) =</sub> 9.668, <italic>P</italic> &lt; 0.001, β = 0.968), PL (<italic>F</italic><sub>(2, 38) =</sub> 8.329, <italic>P</italic> = 0.001, β = 0.931), IL (<italic>F</italic><sub>(2, 38) =</sub> 4.984, <italic>P</italic> = 0.012, β = 0.679), CA1 (<italic>F</italic><sub>(2, 40) =</sub> 6.881, <italic>P</italic> = 0.003, β = 0.860), CA3 (<italic>F</italic><sub>(2, 41) =</sub> 3.864, <italic>P</italic> = 0.029, β = 0.523), DG (<italic>F</italic><sub>(2, 41) =</sub> 5.796, <italic>P</italic> = 0.006, β = 0.772), RSG (<italic>F</italic><sub>(2, 40) =</sub> 17.617, <italic>P</italic> &lt; 0.001, β = 1.000), RSD (<italic>F</italic><sub>(2, 41) =</sub> 18.793, <italic>P</italic> &lt; 0.001, β = 1.000), and PAR (<italic>F</italic><sub>(2, 41) =</sub> 19.3268, <italic>P</italic> &lt; 0.001, β = 1.000). Post-hoc analysis for factor treatment revealed differences in CG, PL, DG, RSG, RSD, and PAR between 810 + 660 (CG: <italic>t</italic> = 4.068, <italic>P</italic> &lt; 0.001; PL:<italic> t</italic> = 4.001, <italic>P</italic> &lt; 0.001; DG:<italic> t</italic> = 3.019, <italic>P</italic> = 0.013; RSG: <italic>t</italic> = 5.216, <italic>P</italic> &lt; 0.001; RSD: <italic>t</italic> = 5.543, <italic>P</italic> &lt; 0.001; PAR: <italic>t</italic> = 5.795, <italic>P</italic> &lt; 0.001) and 810 groups (CG: <italic>t</italic> = 3.486, <italic>P</italic> = 0.002; PL:<italic> t</italic> = 2.669, <italic>P</italic> = 0.022; DG: <italic>t</italic> = 2.805, <italic>P</italic> = 0.013; RSG: <italic>t</italic> = 5.001, <italic>P</italic> &lt; 0.001; RSD: <italic>t</italic> = 5.005, <italic>P</italic> &lt; 0.001; and PAR: <italic>t</italic> = 4.808, <italic>P</italic> &lt; 0.001), compared to controls. Differences were also found between 810 + 660 and controls in IL, CA1 and CA3 (IL: <italic>t</italic> = 3.059, <italic>P</italic> = 0.012; CA1: <italic>t</italic> = 3.696, <italic>P</italic> = 0.002; CA3: <italic>t</italic> = 2.761, <italic>P</italic> = 0.026) (Fig. ##FIG##3##4##).</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par19\">Despite the promising studies on the benefits of PBM on health and disease conditions, its action mechanism is still not completely understood. In the present study, we explored the effect of differential PBM wavelength applications on brain metabolic activity in healthy male and female rats.</p>", "<p id=\"Par20\">PBM action mechanisms are based on light penetration, which depends on the absorption and dispersion of the molecules present in the tissue. Penetration decreases as the wavelength increases, and with 810 nm being considered optimal [##REF##28748217##22##], a wavelength included in both PBM treatments. Brain tissue chromophores can absorb photonic energy, leading to changes in cell metabolism and brain physiology [##UREF##8##13##, ##REF##28735143##23##]. As noted above, the CCO enzyme is composed of 13 protein subunits containing two heme and copper centres with red (620–680 nm) and NIR (760–825 nm) absorption peaks, such that PBM oxidises this enzyme, accelerating and increasing oxygen consumption and ATP synthesis. When light reaches CCO and is absorbed by the enzyme, electrons are excited. It has been suggested that PBM in the red and NIR wavelengths induce NO photodissociation [##REF##30507909##15##]. Thus, PBM can dissociate NO from CCO, leading to an enhancement of CCO activity. It has been reported that NO binds to the heme iron and copper centres of CCO and consequently reverses the inhibition of the electron transport chain [##UREF##11##24##]. This leads to an enhancement of mitochondrial membrane potential and an increase in oxygen consumption, ATP synthesis, and glucose metabolism rate [##UREF##0##1##, ##UREF##8##13##, ##UREF##12##25##]. These events are followed by ROS induction and a release of Ca<sup>2+</sup>, resulting in the activation of transcription factors and signalling pathways associated with cytoprotective, antioxidant and antiapoptotic effects [##UREF##0##1##, ##UREF##8##13##, ##UREF##12##25##].</p>", "<p id=\"Par21\">Previous studies have outlined the need to explore PBM differences regarding sex [##UREF##13##26##–##REF##30851081##29##] because male and female subjects may respond differentially to PBM treatments because of light penetration through the skull [##UREF##13##26##]. It is essential to analyse the effect of PBM including sex as an independent variable, to avoid sex and gender bias in neuroscience research [##UREF##13##26##, ##UREF##14##30##]. To address this issue, analyses were performed considering treatment and sex as the main factors and also the interaction effect between them, aligned with previous studies [##REF##35600629##28##]. No Sex x Treatment interaction effect was found in any brain region, but analyses revealed sex differences, showing that CCO activity in CG, CA1, CA3, RSG, RSD, and PAR is higher in males. This effect includes the controls and both PBM treatments, suggesting that increased metabolic activity across several brain limbic regions in males appears, regardless of treatment. In this line, the study of Mällo et al. (2009) revealed sexual dimorphism, with males displaying a higher CCO activity under control and stress conditions [##REF##19706319##31##], similar to [##UREF##15##32##]. Also, CCO expression has been found to differ between sexes in several behavioural tasks [##REF##35600629##28##, ##REF##19463868##33##–##REF##18583456##35##], emphasising the need to include females in experimental and preclinical studies to determine whether they respond differently.</p>", "<p id=\"Par22\">Regarding treatments, we observed an enhancement of CCO activity using the 810 + 660 nm PBM treatment in prefrontal areas (CG, PL, IL), hippocampus (CA1, CA3, DG), retrosplenial cortex (RSG, RSD), and parietal cortex in the male and female groups, compared to controls. Moreover, higher brain metabolic activity was found with 810 nm in the prefrontal cortex (CG, PL), hippocampus (DG), retrosplenial (RSG, RSD), and parietal cortex. The results reflect that both treatments increased oxidative metabolism in several brain regions, but more brain regions are engaged in the combination of wavelengths, suggesting differential mechanisms. The combination of 660 and 810 nm may result in appropriate neuromodulation of brain oxidative metabolic activity, as CCO activity was up-regulated in a large number of brain areas. This may be attributable to a summative effect across the heme and copper centres of the CCO enzyme by the two wavelengths within the spectrum. When applying only the NIR spectrum, there was also an increase in brain metabolic activity in male and female rats in some areas functionally interconnected with the prefrontal cortex [##REF##29222057##36##]. In this line, it has been shown that the effect observed in the CCO activity due to PBM treatment is not limited to the target area stimulated, but instead spreads over several brain regions interconnected with the target [##UREF##7##12##, ##UREF##16##37##, ##UREF##17##38##]. However, it is important to note that no statistical differences were found between treatments, although there was an increase in 6 brain areas after 810-nm PBM treatment, and in 9 brain areas after a combination of waves.</p>", "<p id=\"Par23\">To our knowledge, there are no animal studies comparing the effect of a single wavelength or a combination of wavelengths that conform the range of red to the NIR spectrum on brain activity in healthy subjects. Under pathological conditions (model of anxiety and depression), one study compared the therapeutic effect of a NIR wave (810 nm) with the red wave (660 nm). They observed that both treatments restored glucose levels (higher under stress), but the NIR light was more effective than the red laser in reducing immobility time in stressed animals [##REF##27367569##39##]. The red light reduced cortisol levels, suggesting that both lights contribute differently at behavioural and molecular levels. We underline that the present study was performed with healthy adult male and female rats whereas [##REF##27367569##39##] applied PBM to rats suffering from chronic stress, which are different from a neurobiological and behavioural perspective. However, stress may mediate the PBM treatment due to immobilisation [##UREF##18##40##], suggesting that the stress associated with the PBM procedure may be modulated by the red wavelength [##REF##27367569##39##], applied only in the 810 + 660 nm groups. In human studies, a PBM device was described with diodes with two different wavelengths, simultaneously applying different waves included within the range of red to the NIR spectrum [##UREF##18##40##–##UREF##20##42##], resulting in cognitive enhancements [##UREF##18##40##] and emotional improvements [##UREF##20##42##]. To note, studies addressing this issue select a device with a higher number of infrared diodes compared with red [##UREF##18##40##, ##UREF##19##41##]. Further research is needed to delve into wavelength interactions and their effect on the nervous system.</p>", "<p id=\"Par24\">Most studies select a single wavelength for the entire treatment (for a review, see [##REF##33069687##6##]). As mentioned, light absorption is possible due to CCO enzyme activity within the mitochondria, observing enhancement of ATP synthesis and of the activity of the complex IV in the prefrontal cortex with 808 nm [##REF##27379735##43##], and enhancement of CCO activity in healthy rats with 670 nm [##UREF##17##38##]. The increased CCO activity marked by histochemistry that we observed in male and female brain areas with a single 810 nm application or combined with a red light (660 nm) is similar to previous studies regarding brain oxidative metabolism. Longer wavelengths can also impact CCO, as it was recently observed that a single 1064-nm treatment leads to an increase of CCO in several brain regions, lasting up to 4 weeks [##UREF##7##12##]. In addition, some human studies have found an increment in the rate of oxygen consumption, attributed to an increase in CCO expression [##REF##22850314##44##], a more efficient prefrontal blood oxygen flux [##REF##28466195##45##], or a brain-wide connectivity enhancement [##UREF##21##46##]. Moreover, it has been shown that PBM (810 nm) applied to healthy young adults can modify the brain activity of functionally active networks, showing the relevance not only of PBM parameters, but also of biological and individual factors [##REF##31682952##47##].</p>", "<p id=\"Par25\">Interestingly, we found increased CCO activity with the treatments in both target and distal brain regions, in line with previous studies reporting modifications of the brain metabolic activity in areas that are distal to the light source and suggesting brain network reorganisation [##REF##35368252##16##, ##UREF##16##37##, ##UREF##17##38##]. We suggest that the changes in CCO activity outside the prefrontal cortex are a consequence of brain interconnections, considering that it is implausible for light penetrance to reach hippocampal areas or other cortical areas distal to the light device. This assumption is based on previous studies, which consider that light penetration depends on both wavelength and type of tissue, with the NIR spectrum achieving the highest penetration through the skull [##REF##28231069##48##]. Some studies reflect that 810 nm can reach percentages of 39% in rats [##REF##26039354##49##], and others report that PBM cannot exceed 10 mm of penetration, but it can affect deeper structures indirectly through pathways such as circulation [##UREF##22##50##].</p>", "<p id=\"Par26\">Most studies are focused on exploring the benefits of PBM in human population. Indeed, it has been found that PBM can improve cognitive and emotional functioning in healthy subjects with 810 nm [##REF##26017772##51##] and 850 nm [##REF##31011865##52##, ##UREF##23##53##], although other studies found no differences from treatment with a single application of 810 nm [##UREF##24##54##]. Regarding brain activity, a 850-nm PBM treatment applied over the prefrontal cortex can change brainwaves, reducing the entire cortical delta waves, which may be linked to improved cognitive performance [##REF##31011865##52##]. However, most of these studies focus on the neurocognitive benefits of PBM, both in healthy and clinical population, and few studies further explore the brain mechanism [##REF##33069687##6##, ##UREF##8##13##]. Therefore, more studies in animals and humans are needed to discover the optimum PBM parameters, including wavelengths, pulse frequency, energy density or sessions, and to personalize PBM treatments [##UREF##25##55##].</p>", "<p id=\"Par27\">One limitation of the study is the absence of a group that only received 660-nm PBM wavelength to contribute more knowledge about the red-light spectrum and its effect on CCO. Also, other parameters apart from wavelength may produce a biological effect. Thus, to better understand the PBM action mechanisms, it is necessary to delve into the type of light emitted, irradiance, frequency, fluency, wave type, and the mode of application (including target area, duration of sessions and treatments).</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par28\">The present findings support PBM as a potential treatment at the cellular level; both single-wave 810-nm treatment or a combination of 810- and 660-nm treatments can increase CCO activity in different brain areas that conform the limbic system of male and female rats. There was a marked effect on brain networks using alternate red (660 nm) and NIR (810 nm) waves across several cortical and subcortical areas, suggesting that a combination of lights of the spectrum may be interesting. The behavioural consequences and the molecular and cellular mechanisms should be explored in greater depth.</p>" ]
[ "<p id=\"Par1\">Photobiomodulation (PBM), an emerging and non-invasive intervention, has been shown to benefit the nervous system by modifying the mitochondrial cytochrome c-oxidase (CCO) enzyme, which has red (620–680 nm) or infrared (760–825 nm) spectral absorption peaks. The effect of a single 810-nm wavelength with a combination of 810 nm and 660 nm lights in the brain metabolic activity of male and female rats was compared. PBM, with a wavelength of 810 nm and a combination of 810 nm and 660 nm, was applied for 5 days on the prefrontal cortex. Then, brain metabolic activity in the prefrontal area, hippocampus, retrosplenial, and parietal cortex was explored. Sex differences were found in cortical and subcortical regions, indicating higher male brain oxidative metabolism, regardless of treatment. CCO activity in the cingulate and prelimbic area, dentate gyrus, retrosplenial and parietal cortex was enhanced in both treatments (810 + 660 nm and 810 nm). Moreover, using the combination of waves, CCO increased in the infralimbic area, and in CA1 and CA3 of the hippocampus. Thus, employment of a single NIR treatment or a combination of red to NIR treatment led to slight differences in CCO activity across the limbic system, suggesting that a combination of lights of the spectrum may be relevant.</p>", "<title>Keywords</title>", "<p>Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature.</p>" ]
[]
[ "<title>Acknowledgements</title>", "<p>We thank the Bioterium of the University of Oviedo Virginia Navascués Howard for reviewing the language, and AINDACE Foundation (Ayuda a la Investigación del Daño y Enfermedades Cerebrales).</p>", "<title>Authors contribution</title>", "<p>CZ delivered the technique, processed the tissue, analyzed the data and redacted the manuscript. LR-F delivered the technique and processed the tissue. JM designed the PBM apparatus. JA designed the study, acquired the funding and corrected the final manuscript.</p>", "<title>Funding</title>", "<p>Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was supported by Projects Grants of Ministry of Economy and Competitivity (PID2020-117259RBI00/AEI/10.13039/501100011033), the Principality of Asturias (FICYT AYUD/2021/51378) and Grant MCINN-23-PLEC2022-009464, by the European Union Next Generation.</p>", "<title>Declarations</title>", "<title>Informed consent</title>", "<p id=\"Par29\">Not applicable.</p>", "<title>Competing interest</title>", "<p id=\"Par30\">No.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>PBM application. (<bold>A</bold>) Immobilisation procedure and PBM application (<bold>B</bold>) Subject’s shaved head. (<bold>C</bold>) Diagram of the diameters of the device and irradiation point (spot). The device is applied directly on the scalp between the ears and eyes </p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>Experimental design of PBM application</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig.3</label><caption><p>CCO activity of male and female rats in prefrontal cortex (<bold>A</bold>, <bold>B</bold>, <bold>C</bold>), hippocampus (<bold>D</bold>, <bold>E</bold>, <bold>F</bold>), retrosplenial (<bold>G</bold>, <bold>H</bold>), and parietal cortex (<bold>I</bold>). * Represents sex differences. There was no Treatment x Sex interaction effect</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig.4</label><caption><p>CCO activity of male and female rats in prefrontal cortex (<bold>A</bold>, <bold>B</bold>, <bold>C</bold>), hippocampus (<bold>D</bold>, <bold>E</bold>, <bold>F</bold>), retrosplenial (<bold>G</bold>, <bold>H</bold>), and parietal cortex (<bold>I</bold>). * Represents treatment differences. Data are expressed as mean ± SD</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>PBM parameters selected for each wavelength </p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\"/><th align=\"left\">810 nm</th><th align=\"left\">660 nm</th></tr></thead><tbody><tr><td align=\"left\">Wave type</td><td align=\"left\" colspan=\"2\">50-s cycles (40 s ON and 10 s OFF)</td></tr><tr><td align=\"left\">Duration</td><td align=\"left\">30 min (3 blocks × 10 min each; ITI 30 min)</td><td align=\"left\">20 min (2 blocks × 10 min each; ITI 20 min)</td></tr><tr><td align=\"left\">Irradiance</td><td align=\"left\" colspan=\"2\">69 W/m<sup>2</sup></td></tr><tr><td align=\"left\">Output optical power</td><td align=\"left\" colspan=\"2\">40 mW</td></tr><tr><td align=\"left\">Fluency</td><td align=\"left\" colspan=\"2\">4 J/cm<sup>2</sup> each day</td></tr><tr><td align=\"left\">Target area</td><td align=\"left\">Prefrontal cortex</td><td align=\"left\">Prefrontal cortex</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[]
[ "<fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"10103_2023_3966_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"10103_2023_3966_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"10103_2023_3966_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"10103_2023_3966_Fig4_HTML\" id=\"MO4\"/>" ]
[]
[{"label": ["1."], "mixed-citation": ["Hamblin MR (2016) Shining light on the head: Photobiomodulation for brain disorders. BBA Clin 6: 113\u2013124. 10.1016/j.bbacli.2016.09.002"]}, {"label": ["2."], "surname": ["Atta", "Elarif", "Al Bahrawy"], "given-names": ["D", "A", "M"], "article-title": ["Reactive oxygen species creation by laser-irradiated indocyanine green as photodynamic therapy modality: an in vitro study"], "source": ["Lasers Med Sci"], "year": ["2023"], "volume": ["38"], "fpage": ["1"], "lpage": ["7"], "pub-id": ["10.1007/s10103-023-03876-1"]}, {"label": ["3."], "mixed-citation": ["Mester E, Lud\u00e1ny G, Selyei M, et al (1968) The stimulating effect of low power laser rays on biological systems. Laser Rev 1:3"]}, {"label": ["4."], "mixed-citation": ["Hamblin MR (2018) Photobiomodulation for traumatic brain injury and stroke. J Neurosci Res 96:731\u2013743. 10.1002/jnr.24190"]}, {"label": ["7."], "surname": ["Montazeri", "Farhadi", "Fekrazad"], "given-names": ["K", "M", "R"], "article-title": ["Transcranial photobiomodulation in the management of brain disorders"], "source": ["J Photochem Photobiol B Biol"], "year": ["2021"], "volume": ["221"], "fpage": ["112207"], "pub-id": ["10.1016/j.jphotobiol.2021.112207"]}, {"label": ["8."], "surname": ["Qu", "Li", "Zhou"], "given-names": ["X", "L", "X"], "article-title": ["Repeated transcranial photobiomodulation improves working memory of healthy older adults: behavioral outcomes of poststimulation including a three-week follow-up"], "source": ["Neurophotonics"], "year": ["2022"], "volume": ["9"], "fpage": ["35005"], "pub-id": ["10.1117/1.NPh.9.3.035005"]}, {"label": ["9."], "surname": ["Cassano", "Petrie", "Hamblin"], "given-names": ["P", "SR", "MR"], "article-title": ["Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis"], "source": ["Neurophotonics"], "year": ["2016"], "volume": ["3"], "fpage": ["31404"], "pub-id": ["10.1117/1.NPh.3.3.031404"]}, {"label": ["12."], "surname": ["Wade", "Barrett", "Davis"], "given-names": ["ZS", "DW", "RE"], "article-title": ["Histochemical mapping of the duration of action of photobiomodulation on cytochrome c oxidase in the rat brain"], "source": ["Front Neurosci"], "year": ["2023"], "volume": ["17"], "fpage": ["1"], "lpage": ["12"], "pub-id": ["10.3389/fnins.2023.1243527"]}, {"label": ["13."], "mixed-citation": ["Cardoso FDS, Gonzalez-Lima F, Gomes da Silva S (2021) Photobiomodulation for the aging brain. Ageing Res Rev 70. 10.1016/j.arr.2021.101415"]}, {"label": ["17."], "surname": ["Dompe", "Moncrieff", "Matys"], "given-names": ["C", "L", "J"], "article-title": ["Photobiomodulation\u2014underlying mechanism and clinical applications"], "source": ["J Clin Med"], "year": ["2020"], "volume": ["9"], "fpage": ["1"], "lpage": ["17"], "pub-id": ["10.3390/jcm9061724"]}, {"label": ["20."], "mixed-citation": ["Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates. Elsevier Academic Press"]}, {"label": ["24."], "mixed-citation": ["Wu C, Yang L, Feng S, et al (2022) Therapeutic non-invasive brain treatments in Alzheimer\u2019s disease: recent advances and challenges. Inflamm Regen 42:31. 10.1186/s41232-022-00216-8"]}, {"label": ["25."], "mixed-citation": ["Hamblin MR (2016) Photobiomodulation or low-level laser therapy. J Biophotonics 9:1122\u20131124. 10.1002/jbio.201670113"]}, {"label": ["26."], "surname": ["Liebert", "Seyedsadjadi", "Pang"], "given-names": ["A", "N", "V"], "article-title": ["Evaluation of Gender Differences in Response to Photobiomodulation Therapy, Including Laser Acupuncture: A Narrative Review and Implication to Precision Medicine"], "source": ["Photobiomodulation, photomedicine, laser Surg"], "year": ["2022"], "volume": ["40"], "fpage": ["78"], "lpage": ["87"], "pub-id": ["10.1089/photob.2021.0066"]}, {"label": ["30."], "surname": ["Will", "Proa\u00f1o", "Thomas"], "given-names": ["TR", "SB", "AM"], "article-title": ["Problems and progress regarding sex bias and omission in neuroscience research"], "source": ["eNeuro"], "year": ["2017"], "volume": ["4"], "fpage": ["1"], "lpage": ["10"], "pub-id": ["10.1523/ENEURO.0278-17.2017"]}, {"label": ["32."], "mixed-citation": ["L\u00f3pez-Taboada I, Sal-Sarria S, Vallejo G, et al (2022) Sexual dimorphism in spatial learning and brain metabolism after exposure to a western diet and early life stress in rats. Physiol Behav 257:113969. 10.1016/j.physbeh.2022.113969"]}, {"label": ["37."], "mixed-citation": ["Guti\u00e9rrez-Men\u00e9ndez A, Cid-Duarte S, Banqueri M, et al (2021) Photobiomodulation effects on active brain networks during a spatial memory task. Physiol 230:1129110.1016/j.physbeh.2020.113291"]}, {"label": ["38."], "surname": ["Arias", "Mendez", "Mart\u00ednez", "Arias"], "given-names": ["JL", "M", "J\u00c1", "N"], "article-title": ["Differential effects of photobiomodulation interval schedules on brain cytochrome c-oxidase and proto-oncogene expression"], "source": ["Neurophotonics"], "year": ["2020"], "volume": ["7"], "fpage": ["1"], "lpage": ["11"], "pub-id": ["10.1117/1.nph.7.4.045011"]}, {"label": ["40."], "surname": ["Chan, "], "article-title": ["Photobiomodulation Improves the Frontal Cognitive Function of Older Adults"], "source": ["Physiol Behav"], "year": ["2019"], "volume": ["176"], "fpage": ["139"], "lpage": ["148"], "pub-id": ["10.1002/gps.5039.Photobiomodulation"]}, {"label": ["41."], "surname": ["Chan", "Yeung", "Lee"], "given-names": ["AS", "MK", "TL"], "article-title": ["Can photobiomodulation enhance brain function in older adults?"], "source": ["Photobiomodulation in the Brain: Low-Level Laser (Light) Therapy in Neurology and Neuroscience"], "year": ["2019"], "publisher-loc": ["Department of Psychology"], "publisher-name": ["The Chinese University of Hong Kong, Hong Kong"], "fpage": ["427"], "lpage": ["446"]}, {"label": ["42."], "mixed-citation": ["Henderson TA, Morries LD (2017) Multi-Watt Near-Infrared Phototherapy for the Treatment of Comorbid Depression: An Open-Label Single-Arm Study. Front Psychiatry 8:187.\u00a010.3389/fpsyt.2017.00187"]}, {"label": ["46."], "mixed-citation": ["Dmochowski GM, Shereen AD, Berisha D, Dmochowski JP (2020) Near-infrared light increases functional connectivity with a non-thermal mechanism. Cereb cortex Commun 1:tgaa004. 10.1093/texcom/tgaa004"]}, {"label": ["50."], "mixed-citation": ["Mitrofanis J, Jeffery G (2018) Does photobiomodulation influence ageing? Aging (Albany. NY). 10:2224\u20132225. 10.18632/aging.101556"]}, {"label": ["53."], "mixed-citation": ["Sabouri Moghadam H, Nazari MA, Jahan A, et al (2017) Beneficial effects of transcranial light emitting diode (LED) therapy on attentional performance: An experimental design. Iran Red Crescent Med J 19:e44513. 10.5812/ircmj.44513"]}, {"label": ["54."], "mixed-citation": ["Heinrich M, Sanguinetti J, Hicks G, et al (2019) Photobiomodulation for cognitive enhancement in healthy adults. Brain Stimulation 12:506. 10.1016/j.brs.2018.12.658"]}, {"label": ["55."], "surname": ["Yuan", "Cassano", "Pias", "Fang"], "given-names": ["Y", "P", "M", "Q"], "article-title": ["Transcranial photobiomodulation with near-infrared light from childhood to elderliness: simulation of dosimetry"], "source": ["Neurophotonics"], "year": ["2020"], "volume": ["7"], "fpage": ["15009"], "pub-id": ["10.1117/1.NPh.7.1.015009"]}]
{ "acronym": [], "definition": [] }
55
CC BY
no
2024-01-14 23:40:13
Lasers Med Sci. 2024 Jan 12; 39(1):26
oa_package/aa/74/PMC10786747.tar.gz
PMC10786749
38214749
[ "<title>Introduction</title>", "<p id=\"Par3\">Para-aminobenzoic acid (also known as aminobenzoic acid or aminobenzoic acid) is an organic molecule with two functional groups: carboxyl and amino. Aminobenzoic acid has essential applications in Biochemistry and Chemistry. Furthermore, it is also used in industry for synthesis. Besides, aminobenzoic acid is a pollutant. Its remediation (or removal) has been the subject of several investigations [##UREF##0##1##–##UREF##4##6##]. Therefore, to understand the adsorption process of aminobenzoic acid, studying its interactions with water molecules surrounding it becomes crucial. Microsolvation of aminobenzoic acid has received little attention. Thus, in this work, we studied the para-aminobenzoic acid-water clusters. This study is performed in a prelude to investigating the adsorption of aminobenzoic acid for wastewater treatment. It is important to note that aminobenzoic acid coexists in water in both the zwitterionic and non-zwitterionic forms. However, the zwitterionic form is more prevalent due to its excellent stability in water. Microsolvation of the zwitterionic and non-zwitterionic forms of aminobenzoic acid has received negligible consideration. This work focuses on the non-zwitterionic form of aminobenzoic acid.</p>", "<p id=\"Par4\">Structures of aminobenzoic acid (or aminobenzoic acid) water clusters (from monomer to trimer) have been investigated by Ghosh and Chaudhuri [##UREF##5##7##] at the B3LYP/aug-cc-pVDZ level of theory. For each cluster size, only one stable configuration is reported. The most stable aminobenzoic acid-water monomer and dimer structure have a cyclic OHO configuration. The most stable structure for the aminobenzoic acid-water trimer has a double cyclic OHO configuration [##UREF##5##7##]. In addition to the structures, NMR spin-spin couplings of the investigated structures have also been reported. Besides, microhydration of aminobenzoic acid in anionic protonated form has been studied by da Silva Olivier and coworkers [##UREF##6##8##]. Microhydration has been studied from one to five explicit water molecules at the B3LYP/TZVP level of theory in implicit solvent (using the polarizable continuum model, PCM). The study has examined the effects of the water molecules on the UV–Vis spectrum of aminobenzoic acid in the anionic protonated form [##UREF##6##8##]. Due to the anionic form, the structures reported by da Silva Olivier and coworkers [##UREF##6##8##] are different from those obtained by Ghosh and Chaudhuri [##UREF##5##7##]. It has been found that the maximum absorption wavelength increases with the number of explicit water molecules [##UREF##6##8##]. Rosbottom et al. [##UREF##7##9##] have studied the interactions of aminobenzoic acid with solvent molecules of water, ethanol, and acetonitrile. They started with molecular dynamics simulations and optimized the structures at the B3LYP/6-31 G(d) level of theory. They identified possible fixation sites of water, ethanol, and acetonitrile molecules on the aminobenzoic acid. They found that the water molecules prefer to be attached to the carboxyl group of aminobenzoic acid [##UREF##7##9##].</p>", "<p id=\"Par5\">In addition to the structures of aminobenzoic acid-water clusters, solvation enthalpy and solvation free energy of the aminobenzoic acid has been reported by a few authors [##UREF##8##10##–##UREF##9##13##]. Turner et al. [##REF##27711471##11##] have reported the solvation enthalpy of the aminobenzoic acid in the water, in ethanol, and in acetonitrile using an experimental approach. They have also calculated the hydration free energy of the aminobenzoic acid in the solvents mentioned above using molecular dynamics simulations. The same authors have reported dissolution enthalpy and dissolution free energies of the aminobenzoic acid [##REF##27711471##11##]. Recently, Li et al. [##UREF##9##13##] have evaluated several thermodynamic properties of the aminobenzoic acid using experimental approaches and molecular dynamics simulations. Using molecular dynamics simulations, the authors calculated the hydration free energy of the aminobenzoic acid in several solvents: methyl acetate, n-propyl acetate, isopropyl acetate, acetone, and water [##UREF##9##13##].</p>", "<p id=\"Par6\">An exploration of the literature shows that very few studies of the aminobenzoic acid-water clusters have been reported. Furthermore, the authors must thoroughly explore the possible structures even for the reported studies. Thus, we explored the potential energy surfaces (PESs) of aminobenzoic acid-water clusters, starting with classical molecular dynamics simulations followed by full optimizations at the PW6B95D3/def2-TZVP level of theory. Quantum theory of atoms in molecules (QTAIM) analysis has been performed to understand the nature of non-covalent interactions. The generated structures have been used to calculate the hydration enthalpy and the hydration free energy of the aminobenzoic acid at different temperatures.</p>" ]
[ "<title>Methodology</title>", "<p id=\"Par7\">We start this section by presenting the cluster continuum solvation model used in this work to compute the solvation free energy and the solvation enthalpy of aminobenzoic acid (see the “Solvation free energy and enthalpy” section). Then, the methodology used to sample initial configurations is presented (see the “Geometry sampling” section). Finally, we present the computational details, including the choice of the computational level of theory, the software used, and details to enhance the accuracy of the calculations (see the “Computational details” section).</p>", "<title>Solvation free energy and enthalpy</title>", "<p id=\"Par8\">The aminobenzoic acid’s solvation free energy and the solvation enthalpy are calculated using the cluster continuum solvation model. A schematic representation of the cluster continuum solvation model is given in Fig. ##FIG##0##1##, which expresses the Eq. ##FORMU##33##1##. The main idea of the cluster continuum solvation model is to adopt a hybrid solvation model. The solvent molecules closer to the solute (aminobenzoic acid) are treated explicitly using quantum mechanics, while solvent molecules far from the solute are considered a continuum medium. The advantage of the model is that only a few explicit water molecules are required to achieve convergence. Therefore, the model will allow a considerable saving of computational time. The cluster continuum solvation model has been successfully applied in the literature to compute the solvation free energy of the proton in solutions [##UREF##10##14##–##UREF##15##23##]. Recently, we applied the cluster continuum solvation model to calculate the solvation free energy and enthalpy of phenol in water at different temperatures [##UREF##16##24##].The solvation free energy and the solvation enthalpy of aminobenzoic acid within the cluster continuum solvation model can be calculated using Eqs. ##FORMU##34##2## and ##FORMU##35##3##, respectively.where AB stands for aminobenzoic acid. The superscript <italic>s</italic> and <italic>g</italic> are solvent and gas phases, respectively. and represent X’s free energy and enthalpy in the solvent phase, respectively. Similar meanings for and .</p>", "<p id=\"Par9\">Examination of Eqs. ##FORMU##34##2## and ##FORMU##35##3## shows that the calculation of the solvation free energy and enthalpy of aminobenzoic acid is subjected to the determination of the structures of as well as the structures of for different values of <italic>n</italic>. The structures of are thoroughly explored in this work. The free energy and the enthalpy of , as required in Eqs. ##FORMU##34##2## and ##FORMU##35##3##, are calculated as Boltzmann average over the free energy and enthalpy of all possible configurations of the cluster. The structures of neutral water clusters, , have been thoroughly explored in our previous works [##UREF##17##25##, ##UREF##18##26##] using ABCluster as described in the “Geometry sampling” section. However, only the most stable structures in our previous works have been re-optimized at the PW6B95D3/def2-TZVP to compute the solvation free energy and enthalpy of aminobenzoic acid in this work. This has been done for tractability and could slightly affect the calculated hydration energies. Consequently, one needs to determine the structures of for different values of <italic>n</italic> to be able to use Eqs. ##FORMU##34##2## and ##FORMU##35##3##. In this work, we have determined different structures of for to . We started this work by sampling different possible configurations for each value of <italic>n</italic>. The sampling has been performed using classical molecular dynamics as implemented in the ABCluster (see the “Geometry sampling” section).</p>", "<title>Geometry sampling</title>", "<p id=\"Par10\">Initial configurations have been sampled using the ABCluster code of Zhang and Dolg [##REF##26327507##27##, ##REF##26738568##28##]. ABCluster samples all possible configurations on a given molecular cluster’s potential energy surface (PES). The sampling is performed using classical molecular dynamics with potential energy constituted of electrostatic and Lenard-Jones interactions. The potential energy parameters are retrieved from the CHARMM force field [##REF##19575467##29##]. The sampling details using ABCluster can be found in our previous works on molecular clusters [##REF##30007393##30##–##UREF##20##34##]. Moreover, more details on the artificial bee colony algorithm (global optimization algorithm used in ABCluster) can be found in the initial papers of Zhang and Dolg [##REF##26327507##27##, ##REF##26738568##28##]. The located configurations of different cluster sizes have been fully optimized at the PW6B95D3/def2-TZVP level of theory (see the “Computational details” section for more details).</p>", "<title>Computational details</title>", "<p id=\"Par11\">The configurations located using ABCluster are fully optimized using the PW6B95D3 DFT functional. Due to non-covalent bondings that stabilize the aminobenzoic acid-water clusters, we had to consider the dispersive nature of the interactions. This dispersive nature justifies the choice of a functional including the third order Grimme’s dispersion corrections [##REF##20423165##35##] (the PW6B95D3 functional). In addition, the PW6B95D3 functional is the most accurate for studying clusters with non-covalent interactions in our previous works [##UREF##21##36##–##UREF##23##39##]. Two different basis sets have been tested to optimize the configurations: cc-pVDZ and def2-TZVP. For the accuracy of the energies, the def2-TZVP (a triple zeta basis set) will be considered in the calculations of the solvation free energy and the solvation enthalpy. Frequency calculations have been systematically performed along with all optimizations. The frequency calculations have been performed to confirm the location of true local minima on the PESs and to calculate the free energy and enthalpy of the corresponding structure. Optimizations and frequency calculations have been performed using the Gaussian 16 suite of codes [##UREF##24##40##]. The <italic>tight</italic> option has been used for accurate optimization, and the <italic>ultrafine</italic> grid has been used for accurate integrals calculations. Optimizations and frequency calculations have been performed in the implicit solvation model. The solvation model based on density (SMD) has been used for the implicit solvation [##REF##19366259##41##]. Thus, the structures of as well as for different values of <italic>n</italic> have been calculated in the implicit solvation model.</p>", "<p id=\"Par12\">The gas phase binding energies of the most stable isomers have been calculated using twelve DFT functionals, including Grimme’s empirical dispersion [##REF##20423165##35##, ##REF##16955487##42##]. The functionals include B3LYP-D3 [##UREF##25##43##], B3PW91-D3 [##UREF##25##43##], M05-D3 [##REF##16268672##44##], M052X-D3 [##UREF##26##45##], M06-D3 [##UREF##27##46##], M062X-D3 [##UREF##27##46##], MN15 [##REF##30155154##47##], PBE1PBE-D3 [##UREF##28##48##], PBEPBE-D3 [##REF##10062328##49##], PW6B95D3 [##REF##16833898##50##], TPSSTPSS-D3 [##UREF##29##51##], and B97XD [##REF##18989472##52##]. The most stable structures located at the PW6B95D3/def2-TZVP level of theory have been fully re-optimized using the above functionals associated with the def2-TZVP basis set. Gaussian 16 suite of codes [##UREF##24##40##] has been used for these calculations along with <italic>tight</italic> and <italic>ultrafine</italic> options as described above. In addition, binding energies are also calculated at the DLPNO-CCSD(T)/CBS level of theory to serve as a benchmark for DFT functionals. Calculations at the DLPNO-CCSD(T)/CBS level of theory have been performed using the Orca program [##UREF##30##53##]. We used <italic>tightpno</italic> and <italic>tightscf</italic> for accuracy. In addition, we used the <italic>AutoAux</italic> option for the automatic generation of auxiliary basis sets [##REF##28005364##54##]. The CBS extrapolation has been performed using the two-point strategy involving electronic energies calculated using the def2-TZVPP and the def2-QZVPP basis sets. Further details on the CBS extrapolation can be found in our previous works [##UREF##22##38##, ##UREF##23##39##].</p>", "<p id=\"Par13\">We performed a quantum theory of atoms in molecules (QTAIM) analysis on the most stable structures to understand the nature of non-covalent bonding in the aminobenzoic acid-water clusters. The QTAIM analysis uses the AIMAll code [##UREF##31##55##]. The QTAIM analysis has been performed only on the most stable configurations obtained at the PW6B95D3/def2-TZVP level of theory. Regarding the relative population, the program TEMPO [##UREF##32##56##, ##UREF##33##57##] has been used to compute the relative population of the clusters at different temperatures.</p>" ]
[ "<title>Results and discussions</title>", "<p id=\"Par14\">In this section, we start by presenting the structures of the aminobenzoic acid-water clusters as optimized at the PW6B95D3/def2-TZVP level of theory. The structures are presented along with their solvent phase relative electronic energies, including zero point energy (ZPE) corrections (see the “Structures and relative energies” section). After presenting the stability, we examine the nature of non-covalent bondings stabilizing the studied clusters in the “Non-covalent bondings in ABW structures” section. Next, we presented the relative population of the clusters to highlight the structures that significantly contribute to the cluster’s population (see the “Relative population of ABW structures” secton). Then, the structures, as well as their free energies and enthalpies, are used to evaluate the absolute hydration free energy and the absolute hydration enthalpy of the aminobenzoic acid for different ranges of temperature (see the “Solvation free energy and solvation enthalpy” section). Finally, we present the binding energies calculated using twelve DFT functionals benchmarked against DLPNO-CCSD(T). These binding energies are calculated to select the most suitable functional for studying the interaction between the aminobenzoic acid and water molecules (see the “Gas phase binding energies and DFT benchmarking” section).</p>", "<title>Structures and relative energies</title>", "<p id=\"Par15\">After complete optimization at the PW6B95D3/def2-TZVP level of theory, the configurations found different from one another have been retained. Four different configurations of the ABW have been located on its PES within the ZPE-corrected electronic energy landscape of 3.2 kcal/mol. The located structures are reported in Fig. ##FIG##1##2##. In Fig. ##FIG##1##2##, the global minimum energy structure is <bold>ABW1_1</bold>. The second most stable isomer of the aminobenzoic acid-water monomer lies 1.6 kcal/mol, <bold>ABW1_2</bold>. In <bold>ABW1_1</bold>, the water monomer is a proton acceptor, while in <bold>ABW1_2</bold>, <bold>ABW1_3</bold>, and <bold>ABW1_4</bold>, the water monomer is a proton donor. In addition, we note that when the water molecule interacts with the amino- group, the generated isomer is less stable than that generated when the water molecule interacts with the carboxyl group (see Fig. ##FIG##1##2##). For ABW, the four structures have been optimized at the same level of theory using the CPCM and the PCM solvation models. The calculated relative energies are reported in Fig. ##SUPPL##0##S1## of the supporting information. It has been found that the structure’s geometry does not considerably change with the solvation model. In addition, all three solvation models (CPCM, PCM, and SMD) predicted the same structure as the most stable. However, the relative energy of the isomers <bold>ABW1_3</bold> and <bold>ABW1_4</bold> are exchanged using CPCM and PCM (see details in the supporting information).</p>", "<p id=\"Par16\">To assess the influence of the computational level of theory on the geometry of the clusters, we optimized all the structures of ABW, ABW, and ABW at the MP2/def2-TZVP level of theory. It has been found that most of the geometries obtained at the MP2 are identical to those obtained at the PW6B95D3. However, there are a few geometries where the water molecules exhibit a slight shift that does not visually change the geometries. Regarding their energies, it has been found that the relative energies at these two levels of theory follow different trends. However, for each cluster size, the most stable and the least stable structures are predicted to be the same at MP2 and PW6B95D3 levels of theory (see Figs. ##SUPPL##0##S2##, ##SUPPL##0##S3##, and ##SUPPL##0##S4## of the supporting information).</p>", "<p id=\"Par17\">For the aminobenzoic acid-(water), nine different isomers are located on the cluster’s PES (see Fig. ##FIG##2##3##). The most stable configuration, <bold>ABW2_1</bold>, has three OHO hydrogen bondings forming a cyclic configuration. The stability of cyclic configurations for small-sized clusters perfectly agrees with the study of neutral water clusters [##UREF##18##26##, ##REF##25341561##58##]. Generally, the isomers where the water molecules are attached to the carboxyl group are among the most stable. In contrast, the isomers where the water molecules are attached to the amino group have lesser stability (see Fig. ##FIG##2##3##). This stability trend is because the carboxyl group is more hydrophilic than the amino group. Consequently, water molecules establish more robust bondings with the carboxyl group than the amino group. This stability trend is also noted in larger-sized aminobenzoic acid-water clusters studied in this work. The relative energies calculated using the two basis sets (cc-pVDZ and def2-TZVP) follow almost the same stability trend (see Fig. ##FIG##2##3##). Both basis sets predicted the same global minimum energy structure and the same least stable structure. The relative energies calculated using the cc-pVDZ basis set are larger than those calculated using the def2-TZVP basis set. This difference highlights the overestimation of the energies calculated using the cc-pVDZ basis set.</p>", "<p id=\"Par18\">Eleven configurations of the aminobenzoic acid-water trimer have been identified on the PES of the cluster at the PW6B95D3/def2-TZVP level of theory. The located isomers and their relative energies are reported in Fig. ##FIG##3##4##. The predicted most stable isomer of the ABW cluster, <bold>ABW3_1</bold>, has a pyramidal configuration of the water molecules and the COOH group. The second most stable isomer, <bold>ABW3_2</bold>, exhibits a folded cyclic configuration. In most of the structures of the ABW cluster, the three water molecules form a cyclic configuration interacting with the aminobenzoic acid (see <bold>ABW3_4</bold> to <bold>ABW3_8</bold> in Fig. ##FIG##3##4##). Similar to the case of ABW and ABW, when the water molecules interact with the carboxyl group, the generated structure is found to be more stable than the structure generated by the interaction with the amino group. Regarding the effect of the basis sets, we noted that both cc-pVDZ and def2-TZVP predicted the same global minimum energy structure. In addition, the stability trend is the same for both basis sets (see Fig. ##FIG##3##4##).</p>", "<p id=\"Par19\">We located seventeen structures on the PES of ABW cluster, reported in Fig. ##FIG##4##5##. In the most stable structure, <bold>ABW4_1</bold>, the water molecules form a chain interacting with the aminobenzoic acid. As seen in the “Non-covalent bondings in ABW structures” section, <bold>ABW4_1</bold> is stabilized by strong OHO hydrogen bondings and OH bonding interactions. <bold>ABW4_1</bold> has five OHO and two OH bonding interactions. There are two degenerate second most stable structures, <bold>ABW4_2</bold> and <bold>ABW4_3</bold>, lying 0.4 kcal/mol above the most stable configuration (see Fig. ##FIG##4##5##). The structures in which the water molecules interact with the carboxyl group are the most stable, while those in which the water molecules interact with the amino group are found to be the least stable. There are structures between these two groups in which the water molecules interact with the carboxyl and amino groups.</p>", "<p id=\"Par20\">The structures of larger clusters of ABW () are reported in Figs. ##FIG##5##6##, ##FIG##6##7##, and ##FIG##7##8##, respectively. Generally, the most stable configurations are the structures where the water molecules establish strong OHO hydrogen bondings with the carboxyl group. However, for the case of ABW cluster, water molecules interact with both carboxyl and amino groups in the most stable configuration (see Fig. ##FIG##7##8##). This is due to the relatively large number of water molecules compared to smaller-sized clusters. It has been noted that the water molecules occupy one side of the aminobenzoic acid in all the studied clusters. This behavior is mainly attributed to the clusters’ stability and the number of explicit water molecules. In this work, we have limited the study to a maximum of ten explicit water molecules. With ten water molecules, if the water molecules were shared on both sides of the aminobenzoic acid, the resulting structure would be less stable than those reported in this work. Therefore, the water molecules prefer to be on one side for these small-sized clusters to enhance stability. Furthermore, even the initial structures generated in the gas phase by the ABCluster have similar behavior. Regarding the basis set effects on larger clusters, it is generally found that the predicted stability trend using these two basis sets (def2-TZVP and cc-pVDZ) is different. This difference could indicate that the cc-pVDZ basis set is not large enough to achieve accuracy. On the other hand, one could also expect that a basis set larger than def2-TZVP could be necessary. However, Grimme and coworkers [##UREF##34##59##] suggested that a basis set larger than a triple zeta is generally excessive for the description of structures and frequencies.</p>", "<title>Non-covalent bondings in ABW structures</title>", "<p id=\"Par21\">Understanding the nature of the interactions that link the water molecules to the aminobenzoic acid is essential to understanding its micro solvation in water. This is also important to understand the stability of the generated clusters. Therefore, QTAIM analysis has been performed on the most stable configurations of ABW based on their structures and their electron densities calculated at the PW6B95D3/def2-TZVP level of theory. Bond paths, bond critical points, and their properties are calculated using the AIMAll program [##UREF##31##55##]. The most stable configurations’ calculated bond paths and critical points are reported Fig. ##FIG##8##9##. For <bold>ABW1_1</bold> and <bold>ABW2_1</bold>, we have also represented the 2D contour map of the electron density in the plane containing the phenyl group. Atomic basins of some atoms in the plane have also been represented. In order to determine the nature of non-covalent bondings, properties of all bond critical points are reported in the supporting information. These properties include the electron density, , the Laplacian of the electron density, , the ellipticity, the kinetic energy, and the difference between the bond path length and the geometrical bond length.</p>", "<p id=\"Par22\">The most stable structure of ABW exhibits a strong OHO hydrogen bonding, where the water molecule acts as a proton acceptor. At the bond critical point of OHO, the electron density is evaluated to be 0.0443ea, while is 1157ea, highlighting a strong hydrogen bonding. Similarly, the <bold>ABW2_1</bold> and <bold>ABW3_1</bold> are stabilized by strong hydrogen bondings. Non-covalent bonding different from OHO appears in <bold>ABW4_1</bold> (the reader is reminded that this analysis applies only to the most stable configurations). <bold>ABW4_1</bold> has five OHO hydrogen bondings and one OH and OC bonding interactions. Previous studies have found that there is a strong relationship between the strength of bonding and the value of the electron density at the corresponding bond critical point [##UREF##35##60##–##UREF##40##67##]. The higher the electron density at a bond critical point, the stronger the corresponding bonding. Thus, based on the value of at the bond critical points, the OH and OC bonding interactions are weaker than the five OHO hydrogen bondings. Similar bonding interactions are found in <bold>ABW6_1</bold>, <bold>ABW8_1</bold>. The isomer <bold>ABW10_1</bold> has all types of non-covalent interactions identified in this work. This can be ascribed to its size as compared to smaller-sized clusters. The water molecules interact both with the surface of the aminobenzoic acid, establishing OHO and OHN hydrogen bondings, and OH and OC bonding interactions (see Fig. ##FIG##8##9##). It is worth noting that similar non-covalent bondings have been recently identified in phenol-water clusters after QTAIM analysis performed at the B97XD/aug-cc-pVDZ level of theory [##UREF##16##24##]. As phenol has no nitrogen atom, the OHN hydrogen bondings have not been identified. Instead, the absence of nitrogen leads to CHO non-covalent bondings, which have been identified as weak hydrogen bondings [##UREF##16##24##].</p>", "<p id=\"Par23\">To have an idea about the strength of non-covalent bondings in ABW, we extracted the minimum and the maximum of the electron density, , and the Laplacian of the electron density, , at bond critical points of non-covalent bondings (see Table ##TAB##0##1##). Based on the value of at bond critical points, it comes out from Table ##TAB##0##1## that the hydrogen bondings are the most robust non-covalent interactions. The OHN hydrogen bonding is less robust than the OHO hydrogen bondings. The results show that the OH bonding interactions are the weakest non-covalent bondings of aminobenzoic acid-water clusters. The bonding strength trend perfectly agrees with our findings in phenol-water clusters [##UREF##16##24##]. The OHO hydrogen bondings are the most robust non-covalent bonding identified in phenol-water clusters.</p>", "<title>Relative population of ABW structures</title>", "<p id=\"Par24\">In order to assess the effects of the temperature on the stability of the located structures, we have calculated their relative population/probability for temperature ranging from 20 to 400 K. The probabilities are calculated using the Boltzmann formula within the canonical distribution. The probability of isomer <italic>k</italic> of the cluster ABW, , can be calculated using Eq. ##FORMU##131##4##.where , is the Boltzmann constant, and is the Gibbs free energy of isomer <italic>i</italic> at temperature <italic>T</italic>. The numerically evaluated relative probabilities of ABW clusters are reported in Fig. ##SUPPL##0##S4## of the supporting information.</p>", "<p id=\"Par25\">The results show that the most stable configurations dominate the population of the clusters, ABW, , and for temperatures ranging from 20 to 400 K. It has been noted that only a few configurations around the most stable one contribute to the population. The results show that for each ABW cluster, more than one isomer contributes to its population. The isomers that contribute to the population of the clusters have their relative energies within 2.0 kcal/mol.</p>", "<title>Solvation free energy and solvation enthalpy</title>", "<p id=\"Par26\">The solvation enthalpy and the solvation free energy of aminobenzoic acid in water are calculated using the cluster continuum solvation model through Eqs. ##FORMU##34##2## and ##FORMU##35##3##. The calculated hydration free energy and enthalpy at room temperature are reported in Fig. ##FIG##9##10## for different cluster sizes <italic>n</italic>.</p>", "<p id=\"Par27\">\n\n</p>", "<p id=\"Par28\">Examination of Fig. ##FIG##9##10## shows that the hydration free energy and enthalpy do not considerably change with the cluster size change. This indicates that one explicit water molecule is enough for the hybrid solvation of aminobenzoic acid. It also indicates that one water molecule is enough in the cluster continuum solvation model. Therefore, we averaged over the estimated values for different cluster sizes to calculate the hydration free energy and the hydration enthalpy. Thus, the hydration enthalpy and the hydration free energy of aminobenzoic acid are numerically estimated to be kcal/mol and kcal/mol, respectively. Previously, Turner and coworkers [##REF##27711471##11##] estimated the solvation enthalpy and the solvation free energy of aminobenzoic acid in ethanol, acetonitrile, and water. The solvation enthalpy is estimated using an experimental technique, while the solvation free energy is calculated using molecular dynamics simulations [##REF##27711471##11##]. Turner and coworkers [##REF##27711471##11##] estimated the hydration enthalpy of aminobenzoic acid to be kcal/mol. Besides, they estimated the hydration free energy (using molecular dynamics) to be kcal/mol. The hydration enthalpy of the aminobenzoic acid estimated in this work is found to be in perfect agreement with the experimental estimate of Turner and coworkers [##REF##27711471##11##]. However, our estimated hydration free energy is found to be underestimated as compared to the reported value of Turner and coworkers [##REF##27711471##11##]. Recently, Li et al. [##UREF##9##13##] estimated the hydration free energy of the aminobenzoic acid in several solvents, including water, using molecular dynamics simulations. They estimated the hydration free energy of aminobenzoic acid in water to be kcal/mol, in perfect agreement with our estimate. Thus, the calculated hydration free energy of Turner and coworkers [##REF##27711471##11##] could be overestimated. Despite the agreement of the calculated hydration enthalpy with the experiment, it is essential to discuss some possibilities that led to the agreement. There is a high probability that the computational methodology used in this work has led to the accuracy of the hydration enthalpy and free energy. However, there is also a chance (that can not be excluded) that the accuracy of the hydration free energy and enthalpy is a result of an error cancellation. As the hydration enthalpy and free energy are calculated using the difference between the energy of ABW, AB, and W, an overestimation or an underestimation of individual energy could cancel each other and lead to the accuracy of the hydration free energy and enthalpy. Regardless of the source of the accuracy of the present results, the credit for the accuracy goes to our methodology. It is important to note that the accuracy is not accidental as this methodology has been successfully used in our previous work to estimate accurately the solvation free energy of the proton in ammonia [##UREF##13##20##], methanol [##REF##30427006##21##], and acetonitrile [##UREF##15##23##].</p>", "<p id=\"Par29\">To assess the effect of the implicit solvation on the calculated hydration free energy and enthalpy, these energies are calculated using two more implicit models: the CPCM and the PCM. The hydration free energy and enthalpy calculated using these models (at room temperature) are reported in Table ##TAB##1##2##. It can be seen that the CPCM and PCM models predicted the same values for the hydration energy and enthalpy of the aminobenzoic acid. In addition, it has been found that the difference between the predicted values using PCM and the ones predicted using the SMD model is considerably important. Moreover, the CPCM and the PCM models predicted a positive value (4.0kcal/mol) of the hydration free energy. In contrast, the previous estimate based on molecular dynamics predicted kcal/mol (as mentioned above). On the other hand, the predicted hydration enthalpy using PCM and CPCM (kcal/mol) is considerably far from the experimental value of kcal/mol. Therefore, the SMD model chosen in this work is better than the CPCM and PCM models for the estimation of the hydration free energy and enthalpy of the aminobenzoic acid.</p>", "<p id=\"Par30\">After establishing the reliability of our estimated hydration free energy and enthalpy at room temperature, we examine the effect of temperature on the calculated values. The aminobenzoic acid’s hydration free energy and enthalpy as a function of temperature are reported in Fig. ##FIG##10##11##. As seen in Fig. ##FIG##10##11##, the hydration enthalpy is less affected and exhibits a minor change with the temperature change. Regarding the hydration free energy of aminobenzoic acid, we noted that it exhibits an almost linear variation with the temperature change (see Fig. ##FIG##10##11##). This behavior of the hydration free energy and enthalpy has been noted in our previous work on the hydration of phenol [##UREF##16##24##]. In agreement with the current results, we have found that phenol’s hydration free energy increases linearly as a temperature function.</p>", "<title>Gas phase binding energies and DFT benchmarking</title>", "<p id=\"Par31\">In order to determine the appropriate DFT functional to study the interaction between the aminobenzoic acid and the water molecules, we calculated the binding energies of the studied ABW clusters. The binding energies are calculated using twelve different DFT functionals, including Grimme’s empirical dispersions (except the MN15). The methodology provides the functionals, and they are reported in Table ##TAB##2##3##. The binding energy of ABW is calculated using Eq. ##FORMU##257##5##.where <italic>E</italic>(<italic>X</italic>) is the electronic energy of the molecule <italic>X</italic>. For each of the functionals, the molecules involved in Eq. ##FORMU##257##5## are fully re-optimized using the functional associated with the def2-TZVP basis set. Basis set superposition error has not been considered in this work. To calculate the binding energies, only the most stable configurations of ABW have been considered. For each DFT functional, and for each cluster size, the most stable structure has been fully re-optimized. After optimization, it has been found that there is no visual difference between the geometries resulting from different functionals. In addition, the binding energies are also calculated at the DLPNO-CCSD(T)/CBS to serve as a benchmark for the DFT functionals. The calculated binding energies using the twelve functionals and the DLPNO-CCSD(T) method are reported in Table ##TAB##2##3##. Statistical descriptors, including the mean absolute deviation (MAD), the maximum deviation (MAX), and the root mean squared error (RMSE), are calculated in reference to the DLPNO-CCSD(T)/CBS binding energies. The statistical descriptors are also reported in Table ##TAB##2##3##.</p>", "<p id=\"Par32\">It comes out from Table ##TAB##2##3## that the MAD varies from 4.8kcal/mol to 11.6kcal/mol, while the RMSE varies from 5.5kcal/mol to 13.3kcal/mol. To easily assess the performance of these functionals, the calculated statistical descriptors are reported in Fig. ##FIG##11##12##. It can be seen that the PW6B95D3 functional has the smallest MAD and the smallest RMSE. Therefore, the PW6B95D3 functional is the most suitable for studying the aminobenzoic acid-water clusters. Besides, we note that the PBEPBE-D3 functional has the highest MAD and RMSE, highlighting the unsuitability of the functional for the aminobenzoic acid-water clusters. The results show that the first three most suitable DFT functionals are classified in the following order: PW6B95D3 &gt; MN15 &gt; B97XD. It is worth mentioning that the most suitable DFT functional, PW6B95D3, has a MAD of 4.8kcal/mol, which is not negligible. This considerable MAD could be ascribed to the basis set superposition error. Therefore, counterpoise corrections should be considered to reduce the basis set superposition error for a more accurate description. The functional PW6B95D3 is the most suitable for studying molecular clusters [##UREF##21##36##–##UREF##23##39##]. Consequently, based on this work and our past investigations, the PW6B95D3 functional is recommended for studying molecular clusters.</p>" ]
[ "<title>Results and discussions</title>", "<p id=\"Par14\">In this section, we start by presenting the structures of the aminobenzoic acid-water clusters as optimized at the PW6B95D3/def2-TZVP level of theory. The structures are presented along with their solvent phase relative electronic energies, including zero point energy (ZPE) corrections (see the “Structures and relative energies” section). After presenting the stability, we examine the nature of non-covalent bondings stabilizing the studied clusters in the “Non-covalent bondings in ABW structures” section. Next, we presented the relative population of the clusters to highlight the structures that significantly contribute to the cluster’s population (see the “Relative population of ABW structures” secton). Then, the structures, as well as their free energies and enthalpies, are used to evaluate the absolute hydration free energy and the absolute hydration enthalpy of the aminobenzoic acid for different ranges of temperature (see the “Solvation free energy and solvation enthalpy” section). Finally, we present the binding energies calculated using twelve DFT functionals benchmarked against DLPNO-CCSD(T). These binding energies are calculated to select the most suitable functional for studying the interaction between the aminobenzoic acid and water molecules (see the “Gas phase binding energies and DFT benchmarking” section).</p>", "<title>Structures and relative energies</title>", "<p id=\"Par15\">After complete optimization at the PW6B95D3/def2-TZVP level of theory, the configurations found different from one another have been retained. Four different configurations of the ABW have been located on its PES within the ZPE-corrected electronic energy landscape of 3.2 kcal/mol. The located structures are reported in Fig. ##FIG##1##2##. In Fig. ##FIG##1##2##, the global minimum energy structure is <bold>ABW1_1</bold>. The second most stable isomer of the aminobenzoic acid-water monomer lies 1.6 kcal/mol, <bold>ABW1_2</bold>. In <bold>ABW1_1</bold>, the water monomer is a proton acceptor, while in <bold>ABW1_2</bold>, <bold>ABW1_3</bold>, and <bold>ABW1_4</bold>, the water monomer is a proton donor. In addition, we note that when the water molecule interacts with the amino- group, the generated isomer is less stable than that generated when the water molecule interacts with the carboxyl group (see Fig. ##FIG##1##2##). For ABW, the four structures have been optimized at the same level of theory using the CPCM and the PCM solvation models. The calculated relative energies are reported in Fig. ##SUPPL##0##S1## of the supporting information. It has been found that the structure’s geometry does not considerably change with the solvation model. In addition, all three solvation models (CPCM, PCM, and SMD) predicted the same structure as the most stable. However, the relative energy of the isomers <bold>ABW1_3</bold> and <bold>ABW1_4</bold> are exchanged using CPCM and PCM (see details in the supporting information).</p>", "<p id=\"Par16\">To assess the influence of the computational level of theory on the geometry of the clusters, we optimized all the structures of ABW, ABW, and ABW at the MP2/def2-TZVP level of theory. It has been found that most of the geometries obtained at the MP2 are identical to those obtained at the PW6B95D3. However, there are a few geometries where the water molecules exhibit a slight shift that does not visually change the geometries. Regarding their energies, it has been found that the relative energies at these two levels of theory follow different trends. However, for each cluster size, the most stable and the least stable structures are predicted to be the same at MP2 and PW6B95D3 levels of theory (see Figs. ##SUPPL##0##S2##, ##SUPPL##0##S3##, and ##SUPPL##0##S4## of the supporting information).</p>", "<p id=\"Par17\">For the aminobenzoic acid-(water), nine different isomers are located on the cluster’s PES (see Fig. ##FIG##2##3##). The most stable configuration, <bold>ABW2_1</bold>, has three OHO hydrogen bondings forming a cyclic configuration. The stability of cyclic configurations for small-sized clusters perfectly agrees with the study of neutral water clusters [##UREF##18##26##, ##REF##25341561##58##]. Generally, the isomers where the water molecules are attached to the carboxyl group are among the most stable. In contrast, the isomers where the water molecules are attached to the amino group have lesser stability (see Fig. ##FIG##2##3##). This stability trend is because the carboxyl group is more hydrophilic than the amino group. Consequently, water molecules establish more robust bondings with the carboxyl group than the amino group. This stability trend is also noted in larger-sized aminobenzoic acid-water clusters studied in this work. The relative energies calculated using the two basis sets (cc-pVDZ and def2-TZVP) follow almost the same stability trend (see Fig. ##FIG##2##3##). Both basis sets predicted the same global minimum energy structure and the same least stable structure. The relative energies calculated using the cc-pVDZ basis set are larger than those calculated using the def2-TZVP basis set. This difference highlights the overestimation of the energies calculated using the cc-pVDZ basis set.</p>", "<p id=\"Par18\">Eleven configurations of the aminobenzoic acid-water trimer have been identified on the PES of the cluster at the PW6B95D3/def2-TZVP level of theory. The located isomers and their relative energies are reported in Fig. ##FIG##3##4##. The predicted most stable isomer of the ABW cluster, <bold>ABW3_1</bold>, has a pyramidal configuration of the water molecules and the COOH group. The second most stable isomer, <bold>ABW3_2</bold>, exhibits a folded cyclic configuration. In most of the structures of the ABW cluster, the three water molecules form a cyclic configuration interacting with the aminobenzoic acid (see <bold>ABW3_4</bold> to <bold>ABW3_8</bold> in Fig. ##FIG##3##4##). Similar to the case of ABW and ABW, when the water molecules interact with the carboxyl group, the generated structure is found to be more stable than the structure generated by the interaction with the amino group. Regarding the effect of the basis sets, we noted that both cc-pVDZ and def2-TZVP predicted the same global minimum energy structure. In addition, the stability trend is the same for both basis sets (see Fig. ##FIG##3##4##).</p>", "<p id=\"Par19\">We located seventeen structures on the PES of ABW cluster, reported in Fig. ##FIG##4##5##. In the most stable structure, <bold>ABW4_1</bold>, the water molecules form a chain interacting with the aminobenzoic acid. As seen in the “Non-covalent bondings in ABW structures” section, <bold>ABW4_1</bold> is stabilized by strong OHO hydrogen bondings and OH bonding interactions. <bold>ABW4_1</bold> has five OHO and two OH bonding interactions. There are two degenerate second most stable structures, <bold>ABW4_2</bold> and <bold>ABW4_3</bold>, lying 0.4 kcal/mol above the most stable configuration (see Fig. ##FIG##4##5##). The structures in which the water molecules interact with the carboxyl group are the most stable, while those in which the water molecules interact with the amino group are found to be the least stable. There are structures between these two groups in which the water molecules interact with the carboxyl and amino groups.</p>", "<p id=\"Par20\">The structures of larger clusters of ABW () are reported in Figs. ##FIG##5##6##, ##FIG##6##7##, and ##FIG##7##8##, respectively. Generally, the most stable configurations are the structures where the water molecules establish strong OHO hydrogen bondings with the carboxyl group. However, for the case of ABW cluster, water molecules interact with both carboxyl and amino groups in the most stable configuration (see Fig. ##FIG##7##8##). This is due to the relatively large number of water molecules compared to smaller-sized clusters. It has been noted that the water molecules occupy one side of the aminobenzoic acid in all the studied clusters. This behavior is mainly attributed to the clusters’ stability and the number of explicit water molecules. In this work, we have limited the study to a maximum of ten explicit water molecules. With ten water molecules, if the water molecules were shared on both sides of the aminobenzoic acid, the resulting structure would be less stable than those reported in this work. Therefore, the water molecules prefer to be on one side for these small-sized clusters to enhance stability. Furthermore, even the initial structures generated in the gas phase by the ABCluster have similar behavior. Regarding the basis set effects on larger clusters, it is generally found that the predicted stability trend using these two basis sets (def2-TZVP and cc-pVDZ) is different. This difference could indicate that the cc-pVDZ basis set is not large enough to achieve accuracy. On the other hand, one could also expect that a basis set larger than def2-TZVP could be necessary. However, Grimme and coworkers [##UREF##34##59##] suggested that a basis set larger than a triple zeta is generally excessive for the description of structures and frequencies.</p>", "<title>Non-covalent bondings in ABW structures</title>", "<p id=\"Par21\">Understanding the nature of the interactions that link the water molecules to the aminobenzoic acid is essential to understanding its micro solvation in water. This is also important to understand the stability of the generated clusters. Therefore, QTAIM analysis has been performed on the most stable configurations of ABW based on their structures and their electron densities calculated at the PW6B95D3/def2-TZVP level of theory. Bond paths, bond critical points, and their properties are calculated using the AIMAll program [##UREF##31##55##]. The most stable configurations’ calculated bond paths and critical points are reported Fig. ##FIG##8##9##. For <bold>ABW1_1</bold> and <bold>ABW2_1</bold>, we have also represented the 2D contour map of the electron density in the plane containing the phenyl group. Atomic basins of some atoms in the plane have also been represented. In order to determine the nature of non-covalent bondings, properties of all bond critical points are reported in the supporting information. These properties include the electron density, , the Laplacian of the electron density, , the ellipticity, the kinetic energy, and the difference between the bond path length and the geometrical bond length.</p>", "<p id=\"Par22\">The most stable structure of ABW exhibits a strong OHO hydrogen bonding, where the water molecule acts as a proton acceptor. At the bond critical point of OHO, the electron density is evaluated to be 0.0443ea, while is 1157ea, highlighting a strong hydrogen bonding. Similarly, the <bold>ABW2_1</bold> and <bold>ABW3_1</bold> are stabilized by strong hydrogen bondings. Non-covalent bonding different from OHO appears in <bold>ABW4_1</bold> (the reader is reminded that this analysis applies only to the most stable configurations). <bold>ABW4_1</bold> has five OHO hydrogen bondings and one OH and OC bonding interactions. Previous studies have found that there is a strong relationship between the strength of bonding and the value of the electron density at the corresponding bond critical point [##UREF##35##60##–##UREF##40##67##]. The higher the electron density at a bond critical point, the stronger the corresponding bonding. Thus, based on the value of at the bond critical points, the OH and OC bonding interactions are weaker than the five OHO hydrogen bondings. Similar bonding interactions are found in <bold>ABW6_1</bold>, <bold>ABW8_1</bold>. The isomer <bold>ABW10_1</bold> has all types of non-covalent interactions identified in this work. This can be ascribed to its size as compared to smaller-sized clusters. The water molecules interact both with the surface of the aminobenzoic acid, establishing OHO and OHN hydrogen bondings, and OH and OC bonding interactions (see Fig. ##FIG##8##9##). It is worth noting that similar non-covalent bondings have been recently identified in phenol-water clusters after QTAIM analysis performed at the B97XD/aug-cc-pVDZ level of theory [##UREF##16##24##]. As phenol has no nitrogen atom, the OHN hydrogen bondings have not been identified. Instead, the absence of nitrogen leads to CHO non-covalent bondings, which have been identified as weak hydrogen bondings [##UREF##16##24##].</p>", "<p id=\"Par23\">To have an idea about the strength of non-covalent bondings in ABW, we extracted the minimum and the maximum of the electron density, , and the Laplacian of the electron density, , at bond critical points of non-covalent bondings (see Table ##TAB##0##1##). Based on the value of at bond critical points, it comes out from Table ##TAB##0##1## that the hydrogen bondings are the most robust non-covalent interactions. The OHN hydrogen bonding is less robust than the OHO hydrogen bondings. The results show that the OH bonding interactions are the weakest non-covalent bondings of aminobenzoic acid-water clusters. The bonding strength trend perfectly agrees with our findings in phenol-water clusters [##UREF##16##24##]. The OHO hydrogen bondings are the most robust non-covalent bonding identified in phenol-water clusters.</p>", "<title>Relative population of ABW structures</title>", "<p id=\"Par24\">In order to assess the effects of the temperature on the stability of the located structures, we have calculated their relative population/probability for temperature ranging from 20 to 400 K. The probabilities are calculated using the Boltzmann formula within the canonical distribution. The probability of isomer <italic>k</italic> of the cluster ABW, , can be calculated using Eq. ##FORMU##131##4##.where , is the Boltzmann constant, and is the Gibbs free energy of isomer <italic>i</italic> at temperature <italic>T</italic>. The numerically evaluated relative probabilities of ABW clusters are reported in Fig. ##SUPPL##0##S4## of the supporting information.</p>", "<p id=\"Par25\">The results show that the most stable configurations dominate the population of the clusters, ABW, , and for temperatures ranging from 20 to 400 K. It has been noted that only a few configurations around the most stable one contribute to the population. The results show that for each ABW cluster, more than one isomer contributes to its population. The isomers that contribute to the population of the clusters have their relative energies within 2.0 kcal/mol.</p>", "<title>Solvation free energy and solvation enthalpy</title>", "<p id=\"Par26\">The solvation enthalpy and the solvation free energy of aminobenzoic acid in water are calculated using the cluster continuum solvation model through Eqs. ##FORMU##34##2## and ##FORMU##35##3##. The calculated hydration free energy and enthalpy at room temperature are reported in Fig. ##FIG##9##10## for different cluster sizes <italic>n</italic>.</p>", "<p id=\"Par27\">\n\n</p>", "<p id=\"Par28\">Examination of Fig. ##FIG##9##10## shows that the hydration free energy and enthalpy do not considerably change with the cluster size change. This indicates that one explicit water molecule is enough for the hybrid solvation of aminobenzoic acid. It also indicates that one water molecule is enough in the cluster continuum solvation model. Therefore, we averaged over the estimated values for different cluster sizes to calculate the hydration free energy and the hydration enthalpy. Thus, the hydration enthalpy and the hydration free energy of aminobenzoic acid are numerically estimated to be kcal/mol and kcal/mol, respectively. Previously, Turner and coworkers [##REF##27711471##11##] estimated the solvation enthalpy and the solvation free energy of aminobenzoic acid in ethanol, acetonitrile, and water. The solvation enthalpy is estimated using an experimental technique, while the solvation free energy is calculated using molecular dynamics simulations [##REF##27711471##11##]. Turner and coworkers [##REF##27711471##11##] estimated the hydration enthalpy of aminobenzoic acid to be kcal/mol. Besides, they estimated the hydration free energy (using molecular dynamics) to be kcal/mol. The hydration enthalpy of the aminobenzoic acid estimated in this work is found to be in perfect agreement with the experimental estimate of Turner and coworkers [##REF##27711471##11##]. However, our estimated hydration free energy is found to be underestimated as compared to the reported value of Turner and coworkers [##REF##27711471##11##]. Recently, Li et al. [##UREF##9##13##] estimated the hydration free energy of the aminobenzoic acid in several solvents, including water, using molecular dynamics simulations. They estimated the hydration free energy of aminobenzoic acid in water to be kcal/mol, in perfect agreement with our estimate. Thus, the calculated hydration free energy of Turner and coworkers [##REF##27711471##11##] could be overestimated. Despite the agreement of the calculated hydration enthalpy with the experiment, it is essential to discuss some possibilities that led to the agreement. There is a high probability that the computational methodology used in this work has led to the accuracy of the hydration enthalpy and free energy. However, there is also a chance (that can not be excluded) that the accuracy of the hydration free energy and enthalpy is a result of an error cancellation. As the hydration enthalpy and free energy are calculated using the difference between the energy of ABW, AB, and W, an overestimation or an underestimation of individual energy could cancel each other and lead to the accuracy of the hydration free energy and enthalpy. Regardless of the source of the accuracy of the present results, the credit for the accuracy goes to our methodology. It is important to note that the accuracy is not accidental as this methodology has been successfully used in our previous work to estimate accurately the solvation free energy of the proton in ammonia [##UREF##13##20##], methanol [##REF##30427006##21##], and acetonitrile [##UREF##15##23##].</p>", "<p id=\"Par29\">To assess the effect of the implicit solvation on the calculated hydration free energy and enthalpy, these energies are calculated using two more implicit models: the CPCM and the PCM. The hydration free energy and enthalpy calculated using these models (at room temperature) are reported in Table ##TAB##1##2##. It can be seen that the CPCM and PCM models predicted the same values for the hydration energy and enthalpy of the aminobenzoic acid. In addition, it has been found that the difference between the predicted values using PCM and the ones predicted using the SMD model is considerably important. Moreover, the CPCM and the PCM models predicted a positive value (4.0kcal/mol) of the hydration free energy. In contrast, the previous estimate based on molecular dynamics predicted kcal/mol (as mentioned above). On the other hand, the predicted hydration enthalpy using PCM and CPCM (kcal/mol) is considerably far from the experimental value of kcal/mol. Therefore, the SMD model chosen in this work is better than the CPCM and PCM models for the estimation of the hydration free energy and enthalpy of the aminobenzoic acid.</p>", "<p id=\"Par30\">After establishing the reliability of our estimated hydration free energy and enthalpy at room temperature, we examine the effect of temperature on the calculated values. The aminobenzoic acid’s hydration free energy and enthalpy as a function of temperature are reported in Fig. ##FIG##10##11##. As seen in Fig. ##FIG##10##11##, the hydration enthalpy is less affected and exhibits a minor change with the temperature change. Regarding the hydration free energy of aminobenzoic acid, we noted that it exhibits an almost linear variation with the temperature change (see Fig. ##FIG##10##11##). This behavior of the hydration free energy and enthalpy has been noted in our previous work on the hydration of phenol [##UREF##16##24##]. In agreement with the current results, we have found that phenol’s hydration free energy increases linearly as a temperature function.</p>", "<title>Gas phase binding energies and DFT benchmarking</title>", "<p id=\"Par31\">In order to determine the appropriate DFT functional to study the interaction between the aminobenzoic acid and the water molecules, we calculated the binding energies of the studied ABW clusters. The binding energies are calculated using twelve different DFT functionals, including Grimme’s empirical dispersions (except the MN15). The methodology provides the functionals, and they are reported in Table ##TAB##2##3##. The binding energy of ABW is calculated using Eq. ##FORMU##257##5##.where <italic>E</italic>(<italic>X</italic>) is the electronic energy of the molecule <italic>X</italic>. For each of the functionals, the molecules involved in Eq. ##FORMU##257##5## are fully re-optimized using the functional associated with the def2-TZVP basis set. Basis set superposition error has not been considered in this work. To calculate the binding energies, only the most stable configurations of ABW have been considered. For each DFT functional, and for each cluster size, the most stable structure has been fully re-optimized. After optimization, it has been found that there is no visual difference between the geometries resulting from different functionals. In addition, the binding energies are also calculated at the DLPNO-CCSD(T)/CBS to serve as a benchmark for the DFT functionals. The calculated binding energies using the twelve functionals and the DLPNO-CCSD(T) method are reported in Table ##TAB##2##3##. Statistical descriptors, including the mean absolute deviation (MAD), the maximum deviation (MAX), and the root mean squared error (RMSE), are calculated in reference to the DLPNO-CCSD(T)/CBS binding energies. The statistical descriptors are also reported in Table ##TAB##2##3##.</p>", "<p id=\"Par32\">It comes out from Table ##TAB##2##3## that the MAD varies from 4.8kcal/mol to 11.6kcal/mol, while the RMSE varies from 5.5kcal/mol to 13.3kcal/mol. To easily assess the performance of these functionals, the calculated statistical descriptors are reported in Fig. ##FIG##11##12##. It can be seen that the PW6B95D3 functional has the smallest MAD and the smallest RMSE. Therefore, the PW6B95D3 functional is the most suitable for studying the aminobenzoic acid-water clusters. Besides, we note that the PBEPBE-D3 functional has the highest MAD and RMSE, highlighting the unsuitability of the functional for the aminobenzoic acid-water clusters. The results show that the first three most suitable DFT functionals are classified in the following order: PW6B95D3 &gt; MN15 &gt; B97XD. It is worth mentioning that the most suitable DFT functional, PW6B95D3, has a MAD of 4.8kcal/mol, which is not negligible. This considerable MAD could be ascribed to the basis set superposition error. Therefore, counterpoise corrections should be considered to reduce the basis set superposition error for a more accurate description. The functional PW6B95D3 is the most suitable for studying molecular clusters [##UREF##21##36##–##UREF##23##39##]. Consequently, based on this work and our past investigations, the PW6B95D3 functional is recommended for studying molecular clusters.</p>" ]
[ "<title>Conclusions</title>", "<p id=\"Par33\">This work thoroughly explored the potential energy surfaces (PESs) of aminobenzoic acid-water clusters, ABW, . The exploration started with classical molecular dynamics, followed by complete optimization at the PW6B95D3/def2-TZVP level of theory. In addition, we performed a quantum theory of atoms in molecules (QTAIM) analysis to understand the nature of non-covalent bonding in the clusters. Relative populations of the clusters as a function of temperature are also reported. Using the located structures of aminobenzoic acid-water clusters, we calculated the hydration enthalpy and the hydration free energy of the aminobenzoic acid using the cluster continuum solvation model. Finally, we calculated the binding energies of the most stable configurations using twelve DFT functionals and DLPNO-CCSD(T), including empirical dispersion. The binding energies are evaluated to benchmark the functionals.</p>", "<p id=\"Par34\">Several stable structures have been located on the PESs of ABW, . We noted that the most stable configurations are obtained when the water molecules establish strong OHO hydrogen bondings. Moreover, it has been found that the structures where the water molecules interact with the carboxyl group are more stable than those in which the water molecules interact with the amino group. The QTAIM analysis reveals that OHO hydrogen bondings (with carboxyl group) are more robust than the OHN hydrogen bonding (with the amino group). In addition to OHO and OHN hydrogen bondings, we have identified two more non-covalent interactions: the OH and the OC bonding interactions. The OHO hydrogen bonding is found to be the most robust non-covalent interactions, while the OH are found to be the weakest. Elsewhere, the study of temperature effects on the population of the ABW clusters shows that the most stable isomers dominate the population of clusters.</p>", "<p id=\"Par35\">The hydration free energy and the hydration enthalpy of the aminobenzoic acid at room temperature are estimated to be kcal/mol and kcal/mol. The estimated hydration enthalpy is found to be in perfect agreement with an experimental estimate. As for the hydration free energy, it agrees with the estimate based on molecular dynamics simulations. Besides, we examined the effects of temperature on the calculated hydration free energy and enthalpy. The results show that the hydration enthalpy is not affected by the change in temperature, while the hydration free energy exhibits a linear variation as a function of temperature.</p>", "<p id=\"Par36\">To recommend the most suitable DFT functional for the study of the aminobenzoic acid-water clusters, we calculated the binding energy of the most stable configurations in the gas phase. The binding energies are calculated using twelve DFT functionals, including empirical dispersion benchmarked to DLPNO-CCSD(T)/CBS. The def2-TZVP basis set was used in association with the functionals. The results show that the PW6B95D3 functional has the smallest mean absolute deviation (MAD) and the slightest root mean squared error (RMSE). In addition, we have found that the three most suitable DFT functionals with negligible differences are PW6B95D3 &gt; MN15 &gt; B97XD. We also noted that the PBEPBE-D3 functional has the highest MAD and RMSE compared to the DLPNO-CCSD(T)/CBS level of theory. Finally, based on the current results and our previous benchmarks on molecular clusters, the PW6B95D3 functional can be considered for studying non-covalent bonding systems.</p>" ]
[ "<title><bold>Context</bold></title>", "<p id=\"Par1\">Micro-hydration of the aminobenzoic acid is essential to understand its interaction with surrounding water molecules. Understanding the micro-hydration of the aminobenzoic acid is also essential to study its remediation from wastewater. Therefore, we explored the potential energy surfaces (PESs) of the para-aminobenzoic acid-water clusters, ABW, , to study the microsolvation of the aminobenzoic acid in water. In addition, we performed a quantum theory of atoms in molecules (QTAIM) analysis to identify the nature of non-covalent bondings in the aminobenzoic acid-water clusters. Furthermore, temperature effects on the stability of the located isomers have been examined. The located structures have been used to calculate the hydration free energy and the hydration enthalpy of the aminobenzoic acid using the cluster continuum solvation model. The hydration free energy and the hydration enthalpy of the aminobenzoic acid at room temperature are evaluated to be −7.0 kcal/mol and −18.1 kcal/mol, respectively. The hydration enthalpy is in perfect agreement with a previous experimental estimate. Besides, temperature effects on the calculated hydration enthalpy and free energy are reported. Finally, we calculated the gas phase binding energies of the most stable structures of the ABW clusters using twelve functionals of density functional theory (DFT), including empirical dispersion. The DFT functionals are benchmarked against the DLPNO-CCSD(T)/CBS. We have found that the three most suitable DFT functionals are classified in the following order: PW6B95D3 &gt; MN15 &gt; B97XD. Therefore, the PW6B95D3 functional is recommended for further study of the aminobenzoic acid-water clusters and similar systems.</p>", "<title><bold>Methods</bold></title>", "<p id=\"Par2\">The exploration started with classical molecular dynamics simulations followed by complete optimization at the PW6B95D3/def2-TZVP level of theory. Optimizations are performed using Gaussian 16 suite of codes. QTAIM analysis is performed using the AIMAll program.</p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s00894-023-05810-2.</p>", "<title>Keywords</title>", "<p>Open access funding provided by University of the Free State.</p>" ]
[ "<title>Supplementary Information</title>", "<p>Below is the link to the electronic supplementary material.</p>" ]
[ "<title>Author contribution</title>", "<p>D.A. and JC.AM performed the calculations, analysed the data, and prepared the figures and tables A.M. proposed the idea, the methodology, performed the QTAIM analysis, wrote the initial draft, and reviewed the manuscript J.C. Writing-review and editing, supervision, funding acquisition, and software.</p>", "<title>Funding</title>", "<p>Open access funding provided by University of the Free State. This work is supported by the South African National Research Foundation (NRF, Grant number 145414), The Central Research Fund of the University of the Free State (Grant number 0000), and The Center for High Performance Computing (CHPC, Grant number CHEM0947) in South Africa.</p>", "<title>Data availability</title>", "<p>The data used in this work is provided in the manuscript or in the supporting information.</p>", "<title>Declarations</title>", "<title>Competing of interest</title>", "<p id=\"Par41\">The authors declare no competing interests.</p>", "<title>Supporting information</title>", "<p id=\"Par42\">A complete list of the structures of ABW for , , and , as well as their relative energies, are reported in Figs. ##SUPPL##0##S1##–##SUPPL##0##S3##, respectively. In addition, the curves of the relative population of the studied clusters are reported in Fig. ##SUPPL##0##S4##.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>Schematic representation of the cluster continuum solvation model used in this work to calculate the solvation free energy and enthalpy of aminobenzoic acid in water. The representation is given for the case of six explicit water molecules</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>Structures and relative energies of ABW as optimized at the PW6B95D3/def2-TZVP level of theory. The relative energies are reported in kcal/mol</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p>Structures and relative energies of ABW as optimized at the PW6B95D3/def2-TZVP level of theory. Numbers are the calculated relative energies (in kcal/mol). Numbers in parenthesis are relative energies calculated at the PW6B95D3/cc-pVDZ level of theory</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p>Structures and relative energies of ABW as optimized at the PW6B95D3/def2-TZVP level of theory. Numbers are the calculated relative energies (in kcal/mol). Numbers in parenthesis are relative energies calculated at the PW6B95D3/cc-pVDZ level of theory</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><p>Structures and relative energies of ABW as optimized at the PW6B95D3/def2-TZVP level of theory. Numbers are the calculated relative energies (in kcal/mol). Numbers in parenthesis are relative energies calculated at the PW6B95D3/cc-pVDZ level of theory</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><p>Structures and relative energies of ABW as optimized at the PW6B95D3/def2-TZVP level of theory. Numbers are the calculated relative energies (in kcal/mol). Numbers in parenthesis are relative energies calculated at the PW6B95D3/cc-pVDZ level of theory. Only the eleven first isomers are reported here. The complete list of the located structures is provided in the supporting information</p></caption></fig>", "<fig id=\"Fig7\"><label>Fig. 7</label><caption><p>Structures and relative energies of ABW as optimized at the PW6B95D3/def2-TZVP level of theory. Numbers are the calculated relative energies (in kcal/mol). Numbers in parenthesis are relative energies calculated at the PW6B95D3/cc-pVDZ level of theory. Only the eleven first isomers are reported here. The complete list of the located structures is provided in the supporting information</p></caption></fig>", "<fig id=\"Fig8\"><label>Fig. 8</label><caption><p>Structures and relative energies of ABW as optimized at the PW6B95D3/def2-TZVP level of theory. Numbers are the calculated relative energies (in kcal/mol). Numbers in parenthesis are relative energies calculated at the PW6B95D3/cc-pVDZ level of theory. Only the ten first isomers are reported here. The complete list of the located structures is provided in the supporting information</p></caption></fig>", "<fig id=\"Fig9\"><label>Fig. 9</label><caption><p>Critical points and bond paths of most stable configurations of the studied ABW. For the ABW and ABW, the atomic basins, as well as the 2D contour map of the electron density, are represented</p></caption></fig>", "<fig id=\"Fig10\"><label>Fig. 10</label><caption><p>Hydration free energy and hydration enthalpy of aminobenzoic acid at room temperature, calculated using the cluster continuum model at the PW6B95D3/def2-TZVP level of theory</p></caption></fig>", "<fig id=\"Fig11\"><label>Fig. 11</label><caption><p>Hydration enthalpy and hydration free energy of aminobenzoic acid calculated for temperatures ranging from 20 to 400 K. The hydration enthalpy and free energy are calculated using the Eqs. ##FORMU##34##2## and ##FORMU##35##3##, respectively</p></caption></fig>", "<fig id=\"Fig12\"><label>Fig. 12</label><caption><p>Calculated statistical descriptors related to the studied functionals, including the mean absolute deviation (MAD), the maximum deviation (MAX), and the root mean squared error (RMSE). These values are reported in kcal/mol</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Minimum and maximum intervals of the electron density, , and the Laplacian of the electron density, , at bond critical points based on the global minima energy structures of the studied clusters</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\"/><th align=\"left\" colspan=\"2\"> ()</th><th align=\"left\" colspan=\"2\"> ()</th></tr><tr><th align=\"left\"> Bonding</th><th align=\"left\">Min</th><th align=\"left\">Max</th><th align=\"left\">Min</th><th align=\"left\">Max</th></tr></thead><tbody><tr><td align=\"left\">OHO</td><td align=\"left\">0.0023</td><td align=\"left\">0.0496</td><td align=\"left\">0.0091</td><td align=\"left\">0.1171</td></tr><tr><td align=\"left\">OHN</td><td align=\"left\">0.0189</td><td align=\"left\">0.0189</td><td align=\"left\">0.0590</td><td align=\"left\">0.0590</td></tr><tr><td align=\"left\">OH</td><td align=\"left\">0.0045</td><td align=\"left\">0.0056</td><td align=\"left\">0.0173</td><td align=\"left\">0.0185</td></tr><tr><td align=\"left\">OC</td><td align=\"left\">0.0030</td><td align=\"left\">0.0062</td><td align=\"left\">0.0107</td><td align=\"left\">0.0253</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Hydration free energy and enthalpy calculated using three implicit solvation models (CPCM, PCM, and SMD) and reported in kcal/mol</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Models</th><th align=\"left\"></th><th align=\"left\"></th></tr></thead><tbody><tr><td align=\"left\">CPCM</td><td align=\"left\">5.6</td><td align=\"left\">4.0</td></tr><tr><td align=\"left\">PCM</td><td align=\"left\">5.6</td><td align=\"left\">4.0</td></tr><tr><td align=\"left\">SMD</td><td align=\"left\">15.1</td><td align=\"left\">6.6</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Binding energies of aminobenzoic acid-water clusters, ABW, calculated using twelve different DFT functionals benchmarked to DLPNO-CCSD(T)</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">ABW</th><th align=\"left\">B3LYP</th><th align=\"left\">B3PW91</th><th align=\"left\">M052X</th><th align=\"left\">M05</th><th align=\"left\">M062X</th><th align=\"left\">M06</th><th align=\"left\">MN15</th><th align=\"left\">PBE0</th><th align=\"left\">PBE</th><th align=\"left\">PW6</th><th align=\"left\">TPSS</th><th align=\"left\">wB97</th><th align=\"left\">DLPNO</th></tr></thead><tbody><tr><td align=\"left\">ABW</td><td align=\"left\">12.3</td><td align=\"left\">11.9</td><td align=\"left\">12.1</td><td align=\"left\">11.7</td><td align=\"left\">12.1</td><td align=\"left\">12.0</td><td align=\"left\">11.8</td><td align=\"left\">12.6</td><td align=\"left\">13.3</td><td align=\"left\">11.4</td><td align=\"left\">12.5</td><td align=\"left\">11.5</td><td align=\"left\">8.5</td></tr><tr><td align=\"left\">ABW</td><td align=\"left\">25.8</td><td align=\"left\">24.7</td><td align=\"left\">24.6</td><td align=\"left\">24.7</td><td align=\"left\">24.5</td><td align=\"left\">24.2</td><td align=\"left\">23.7</td><td align=\"left\">26.2</td><td align=\"left\">27.6</td><td align=\"left\">23.3</td><td align=\"left\">26.0</td><td align=\"left\">24.2</td><td align=\"left\">21.7</td></tr><tr><td align=\"left\">ABW</td><td align=\"left\">36.1</td><td align=\"left\">34.6</td><td align=\"left\">34.8</td><td align=\"left\">34.2</td><td align=\"left\">34.8</td><td align=\"left\">34.1</td><td align=\"left\">33.1</td><td align=\"left\">36.4</td><td align=\"left\">38.6</td><td align=\"left\">32.3</td><td align=\"left\">36.2</td><td align=\"left\">33.4</td><td align=\"left\">28.8</td></tr><tr><td align=\"left\">ABW</td><td align=\"left\">45.1</td><td align=\"left\">43.7</td><td align=\"left\">43.2</td><td align=\"left\">42.9</td><td align=\"left\">43.2</td><td align=\"left\">44.0</td><td align=\"left\">41.7</td><td align=\"left\">45.7</td><td align=\"left\">48.6</td><td align=\"left\">40.5</td><td align=\"left\">45.4</td><td align=\"left\">41.8</td><td align=\"left\">33.7</td></tr><tr><td align=\"left\">ABW</td><td align=\"left\">76.8</td><td align=\"left\">73.5</td><td align=\"left\">73.2</td><td align=\"left\">73.6</td><td align=\"left\">73.0</td><td align=\"left\">72.5</td><td align=\"left\">70.5</td><td align=\"left\">77.3</td><td align=\"left\">82.2</td><td align=\"left\">68.8</td><td align=\"left\">77.1</td><td align=\"left\">70.8</td><td align=\"left\">59.8</td></tr><tr><td align=\"left\">ABW</td><td align=\"left\">106.4</td><td align=\"left\">101.2</td><td align=\"left\">101.2</td><td align=\"left\">102.3</td><td align=\"left\">100.1</td><td align=\"left\">98.8</td><td align=\"left\">95.5</td><td align=\"left\">107.5</td><td align=\"left\">114.6</td><td align=\"left\">94.8</td><td align=\"left\">107.0</td><td align=\"left\">98.3</td><td align=\"left\">—–</td></tr><tr><td align=\"left\">ABW</td><td align=\"left\">131.9</td><td align=\"left\">124.8</td><td align=\"left\">125.4</td><td align=\"left\">127.0</td><td align=\"left\">124.8</td><td align=\"left\">123.2</td><td align=\"left\">118.8</td><td align=\"left\">132.5</td><td align=\"left\">141.5</td><td align=\"left\">117.4</td><td align=\"left\">132.1</td><td align=\"left\">121.9</td><td align=\"left\">—–</td></tr><tr><td align=\"left\">MAD</td><td align=\"left\">8.7</td><td align=\"left\">7.2</td><td align=\"left\">7.1</td><td align=\"left\">6.9</td><td align=\"left\">7.0</td><td align=\"left\">6.9</td><td align=\"left\">5.7</td><td align=\"left\">9.2</td><td align=\"left\">11.6</td><td align=\"left\">4.8</td><td align=\"left\">9.0</td><td align=\"left\">5.9</td><td align=\"left\">0.0</td></tr><tr><td align=\"left\">MAX</td><td align=\"left\">17.0</td><td align=\"left\">13.7</td><td align=\"left\">13.4</td><td align=\"left\">13.8</td><td align=\"left\">13.2</td><td align=\"left\">12.8</td><td align=\"left\">10.7</td><td align=\"left\">17.5</td><td align=\"left\">22.5</td><td align=\"left\">9.0</td><td align=\"left\">17.3</td><td align=\"left\">11.1</td><td align=\"left\">0.0</td></tr><tr><td align=\"left\">RMSE</td><td align=\"left\">10.0</td><td align=\"left\">8.3</td><td align=\"left\">8.1</td><td align=\"left\">8.1</td><td align=\"left\">8.0</td><td align=\"left\">7.9</td><td align=\"left\">6.5</td><td align=\"left\">10.5</td><td align=\"left\">13.3</td><td align=\"left\">5.5</td><td align=\"left\">10.3</td><td align=\"left\">6.7</td><td align=\"left\">0.0</td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=1-10$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mn>10</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega $$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mi>ω</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$4-$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mrow><mml:mn>4</mml:mn><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M20\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq12\"><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M22\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq13\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M24\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq14\"><alternatives><tex-math id=\"M25\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M26\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq15\"><alternatives><tex-math id=\"M27\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M28\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq16\"><alternatives><tex-math id=\"M29\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$o-$$\\end{document}</tex-math><mml:math id=\"M30\"><mml:mrow><mml:mi>o</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq17\"><alternatives><tex-math id=\"M31\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$2-$$\\end{document}</tex-math><mml:math id=\"M32\"><mml:mrow><mml:mn>2</mml:mn><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq18\"><alternatives><tex-math id=\"M33\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$o-$$\\end{document}</tex-math><mml:math id=\"M34\"><mml:mrow><mml:mi>o</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq19\"><alternatives><tex-math id=\"M35\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M36\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq20\"><alternatives><tex-math id=\"M37\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$o-$$\\end{document}</tex-math><mml:math id=\"M38\"><mml:mrow><mml:mi>o</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq21\"><alternatives><tex-math id=\"M39\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M40\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq22\"><alternatives><tex-math id=\"M41\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$o-$$\\end{document}</tex-math><mml:math id=\"M42\"><mml:mrow><mml:mi>o</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq23\"><alternatives><tex-math id=\"M43\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$o-$$\\end{document}</tex-math><mml:math id=\"M44\"><mml:mrow><mml:mi>o</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq24\"><alternatives><tex-math id=\"M45\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M46\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq25\"><alternatives><tex-math id=\"M47\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M48\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq26\"><alternatives><tex-math id=\"M49\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M50\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq27\"><alternatives><tex-math id=\"M51\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M52\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq28\"><alternatives><tex-math id=\"M53\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M54\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq29\"><alternatives><tex-math id=\"M55\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M56\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq30\"><alternatives><tex-math id=\"M57\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M58\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq31\"><alternatives><tex-math id=\"M59\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M60\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq32\"><alternatives><tex-math id=\"M61\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M62\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq33\"><alternatives><tex-math id=\"M63\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M64\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq34\"><alternatives><tex-math id=\"M65\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p-$$\\end{document}</tex-math><mml:math id=\"M66\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M67\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\text {AB}(g)+(\\text {H}_2\\text {O})_n(s)\\longrightarrow \\text {AB}(\\text {H}_2\\text {O})_n(s) \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M68\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mtext>AB</mml:mtext><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>s</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">⟶</mml:mo><mml:mtext>AB</mml:mtext><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>s</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M69\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\Delta G_s(\\text {AB})_n= &amp; {} \\Delta G_s[\\text {AB}(\\text {H}_2\\text {O})_n]-\\Delta G_s[(\\text {H}_2\\text {O})_n]\\nonumber \\\\{} &amp; {} -\\Delta G_{g}[\\text {AB}], \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M70\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>G</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mtext>AB</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>G</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mtext>AB</mml:mtext><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>G</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow/><mml:mrow/></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>G</mml:mi><mml:mi>g</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mtext>AB</mml:mtext><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M71\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\Delta H_s(\\text {AB})_n= &amp; {} \\Delta H_s[\\text {AB}(\\text {H}_2\\text {O})_n]-\\Delta H_s[(\\text {H}_2\\text {O})_n]\\nonumber \\\\{} &amp; {} -\\Delta H_{g}[\\text {AB}], \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M72\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>H</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mtext>AB</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>H</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mtext>AB</mml:mtext><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>H</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow/><mml:mrow/></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>H</mml:mi><mml:mi>g</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mtext>AB</mml:mtext><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq35\"><alternatives><tex-math id=\"M73\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta G_s[X]$$\\end{document}</tex-math><mml:math id=\"M74\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>G</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mi>X</mml:mi><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq36\"><alternatives><tex-math id=\"M75\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta H_s[X]$$\\end{document}</tex-math><mml:math id=\"M76\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>H</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mi>X</mml:mi><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq37\"><alternatives><tex-math id=\"M77\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta G_g[X]$$\\end{document}</tex-math><mml:math id=\"M78\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>G</mml:mi><mml:mi>g</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mi>X</mml:mi><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq38\"><alternatives><tex-math id=\"M79\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta H_g[X]$$\\end{document}</tex-math><mml:math id=\"M80\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>H</mml:mi><mml:mi>g</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mi>X</mml:mi><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq39\"><alternatives><tex-math id=\"M81\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {AB}(\\text {H}_2\\text {O})_n$$\\end{document}</tex-math><mml:math id=\"M82\"><mml:mrow><mml:mtext>AB</mml:mtext><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq40\"><alternatives><tex-math id=\"M83\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(\\text {H}_2\\text {O})_n$$\\end{document}</tex-math><mml:math id=\"M84\"><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq41\"><alternatives><tex-math id=\"M85\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {AB}(\\text {H}_2\\text {O})_n$$\\end{document}</tex-math><mml:math id=\"M86\"><mml:mrow><mml:mtext>AB</mml:mtext><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq42\"><alternatives><tex-math id=\"M87\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {AB}(\\text {H}_2\\text {O})_n$$\\end{document}</tex-math><mml:math id=\"M88\"><mml:mrow><mml:mtext>AB</mml:mtext><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq43\"><alternatives><tex-math id=\"M89\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(\\text {H}_2\\text {O})_n$$\\end{document}</tex-math><mml:math id=\"M90\"><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq44\"><alternatives><tex-math id=\"M91\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {AB}(\\text {H}_2\\text {O})_n$$\\end{document}</tex-math><mml:math id=\"M92\"><mml:mrow><mml:mtext>AB</mml:mtext><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq45\"><alternatives><tex-math id=\"M93\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {AB}(\\text {H}_2\\text {O})_n$$\\end{document}</tex-math><mml:math id=\"M94\"><mml:mrow><mml:mtext>AB</mml:mtext><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq46\"><alternatives><tex-math id=\"M95\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=1$$\\end{document}</tex-math><mml:math id=\"M96\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq47\"><alternatives><tex-math id=\"M97\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=10$$\\end{document}</tex-math><mml:math id=\"M98\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>10</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq48\"><alternatives><tex-math id=\"M99\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {AB}(\\text {H}_2\\text {O})_n$$\\end{document}</tex-math><mml:math id=\"M100\"><mml:mrow><mml:mtext>AB</mml:mtext><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq49\"><alternatives><tex-math id=\"M101\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(\\text {H}_2\\text {O})_n$$\\end{document}</tex-math><mml:math id=\"M102\"><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq50\"><alternatives><tex-math id=\"M103\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega $$\\end{document}</tex-math><mml:math id=\"M104\"><mml:mi>ω</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq51\"><alternatives><tex-math id=\"M105\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M106\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq52\"><alternatives><tex-math id=\"M107\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{n}$$\\end{document}</tex-math><mml:math id=\"M108\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq53\"><alternatives><tex-math id=\"M109\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_1$$\\end{document}</tex-math><mml:math id=\"M110\"><mml:msub><mml:mrow/><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq54\"><alternatives><tex-math id=\"M111\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_2$$\\end{document}</tex-math><mml:math id=\"M112\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq55\"><alternatives><tex-math id=\"M113\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_1$$\\end{document}</tex-math><mml:math id=\"M114\"><mml:msub><mml:mrow/><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq56\"><alternatives><tex-math id=\"M115\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_1$$\\end{document}</tex-math><mml:math id=\"M116\"><mml:msub><mml:mrow/><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq57\"><alternatives><tex-math id=\"M117\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_1$$\\end{document}</tex-math><mml:math id=\"M118\"><mml:msub><mml:mrow/><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq58\"><alternatives><tex-math id=\"M119\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_2$$\\end{document}</tex-math><mml:math id=\"M120\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq59\"><alternatives><tex-math id=\"M121\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_3$$\\end{document}</tex-math><mml:math id=\"M122\"><mml:msub><mml:mrow/><mml:mn>3</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq60\"><alternatives><tex-math id=\"M123\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_2$$\\end{document}</tex-math><mml:math id=\"M124\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq61\"><alternatives><tex-math id=\"M125\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M126\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq62\"><alternatives><tex-math id=\"M127\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_3$$\\end{document}</tex-math><mml:math id=\"M128\"><mml:msub><mml:mrow/><mml:mn>3</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq63\"><alternatives><tex-math id=\"M129\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_4$$\\end{document}</tex-math><mml:math id=\"M130\"><mml:msub><mml:mrow/><mml:mn>4</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq64\"><alternatives><tex-math id=\"M131\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_6$$\\end{document}</tex-math><mml:math id=\"M132\"><mml:msub><mml:mrow/><mml:mn>6</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq65\"><alternatives><tex-math id=\"M133\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_3$$\\end{document}</tex-math><mml:math id=\"M134\"><mml:msub><mml:mrow/><mml:mn>3</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq66\"><alternatives><tex-math id=\"M135\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_3$$\\end{document}</tex-math><mml:math id=\"M136\"><mml:msub><mml:mrow/><mml:mn>3</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq67\"><alternatives><tex-math id=\"M137\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_1$$\\end{document}</tex-math><mml:math id=\"M138\"><mml:msub><mml:mrow/><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq68\"><alternatives><tex-math id=\"M139\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_2$$\\end{document}</tex-math><mml:math id=\"M140\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq69\"><alternatives><tex-math id=\"M141\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_8$$\\end{document}</tex-math><mml:math id=\"M142\"><mml:msub><mml:mrow/><mml:mn>8</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq70\"><alternatives><tex-math id=\"M143\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{10}$$\\end{document}</tex-math><mml:math id=\"M144\"><mml:msub><mml:mrow/><mml:mn>10</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq71\"><alternatives><tex-math id=\"M145\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_4$$\\end{document}</tex-math><mml:math id=\"M146\"><mml:msub><mml:mrow/><mml:mn>4</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq72\"><alternatives><tex-math id=\"M147\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M148\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq73\"><alternatives><tex-math id=\"M149\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M150\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq74\"><alternatives><tex-math id=\"M151\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots \\pi $$\\end{document}</tex-math><mml:math id=\"M152\"><mml:mrow><mml:mo>⋯</mml:mo><mml:mi>π</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq75\"><alternatives><tex-math id=\"M153\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M154\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq76\"><alternatives><tex-math id=\"M155\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots \\pi $$\\end{document}</tex-math><mml:math id=\"M156\"><mml:mrow><mml:mo>⋯</mml:mo><mml:mi>π</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq77\"><alternatives><tex-math id=\"M157\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M158\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq78\"><alternatives><tex-math id=\"M159\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=6-10$$\\end{document}</tex-math><mml:math id=\"M160\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>6</mml:mn><mml:mo>-</mml:mo><mml:mn>10</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq79\"><alternatives><tex-math id=\"M161\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M162\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq80\"><alternatives><tex-math id=\"M163\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{10}$$\\end{document}</tex-math><mml:math id=\"M164\"><mml:msub><mml:mrow/><mml:mn>10</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq81\"><alternatives><tex-math id=\"M165\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M166\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq82\"><alternatives><tex-math id=\"M167\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_1$$\\end{document}</tex-math><mml:math id=\"M168\"><mml:msub><mml:mrow/><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq83\"><alternatives><tex-math id=\"M169\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_2$$\\end{document}</tex-math><mml:math id=\"M170\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq84\"><alternatives><tex-math id=\"M171\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M172\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq85\"><alternatives><tex-math id=\"M173\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M174\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq86\"><alternatives><tex-math id=\"M175\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho $$\\end{document}</tex-math><mml:math id=\"M176\"><mml:mi>ρ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq87\"><alternatives><tex-math id=\"M177\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\nabla ^2\\rho $$\\end{document}</tex-math><mml:math id=\"M178\"><mml:mrow><mml:msup><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>ρ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq88\"><alternatives><tex-math id=\"M179\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_1$$\\end{document}</tex-math><mml:math id=\"M180\"><mml:msub><mml:mrow/><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq89\"><alternatives><tex-math id=\"M181\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M182\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq90\"><alternatives><tex-math id=\"M183\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M184\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq91\"><alternatives><tex-math id=\"M185\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{0}^{-3}$$\\end{document}</tex-math><mml:math id=\"M186\"><mml:msubsup><mml:mrow/><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq92\"><alternatives><tex-math id=\"M187\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\nabla ^2 \\rho $$\\end{document}</tex-math><mml:math id=\"M188\"><mml:mrow><mml:msup><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>ρ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq93\"><alternatives><tex-math id=\"M189\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{0}^{-5}$$\\end{document}</tex-math><mml:math id=\"M190\"><mml:msubsup><mml:mrow/><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq94\"><alternatives><tex-math id=\"M191\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M192\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq95\"><alternatives><tex-math id=\"M193\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M194\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq96\"><alternatives><tex-math id=\"M195\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots \\pi $$\\end{document}</tex-math><mml:math id=\"M196\"><mml:mrow><mml:mo>⋯</mml:mo><mml:mi>π</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq97\"><alternatives><tex-math id=\"M197\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M198\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq98\"><alternatives><tex-math id=\"M199\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho $$\\end{document}</tex-math><mml:math id=\"M200\"><mml:mi>ρ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq99\"><alternatives><tex-math id=\"M201\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots \\pi $$\\end{document}</tex-math><mml:math id=\"M202\"><mml:mrow><mml:mo>⋯</mml:mo><mml:mi>π</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq100\"><alternatives><tex-math id=\"M203\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M204\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq101\"><alternatives><tex-math id=\"M205\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M206\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq102\"><alternatives><tex-math id=\"M207\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M208\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq103\"><alternatives><tex-math id=\"M209\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M210\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq104\"><alternatives><tex-math id=\"M211\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots \\pi $$\\end{document}</tex-math><mml:math id=\"M212\"><mml:mrow><mml:mo>⋯</mml:mo><mml:mi>π</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq105\"><alternatives><tex-math id=\"M213\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M214\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq106\"><alternatives><tex-math id=\"M215\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega $$\\end{document}</tex-math><mml:math id=\"M216\"><mml:mi>ω</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq107\"><alternatives><tex-math id=\"M217\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M218\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq108\"><alternatives><tex-math id=\"M219\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M220\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq109\"><alternatives><tex-math id=\"M221\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M222\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq110\"><alternatives><tex-math id=\"M223\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho $$\\end{document}</tex-math><mml:math id=\"M224\"><mml:mi>ρ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq111\"><alternatives><tex-math id=\"M225\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\nabla ^2 \\rho $$\\end{document}</tex-math><mml:math id=\"M226\"><mml:mrow><mml:msup><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>ρ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq112\"><alternatives><tex-math id=\"M227\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho $$\\end{document}</tex-math><mml:math id=\"M228\"><mml:mi>ρ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq113\"><alternatives><tex-math id=\"M229\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M230\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq114\"><alternatives><tex-math id=\"M231\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M232\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq115\"><alternatives><tex-math id=\"M233\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots \\pi $$\\end{document}</tex-math><mml:math id=\"M234\"><mml:mrow><mml:mo>⋯</mml:mo><mml:mi>π</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq116\"><alternatives><tex-math id=\"M235\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M236\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq117\"><alternatives><tex-math id=\"M237\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho $$\\end{document}</tex-math><mml:math id=\"M238\"><mml:mi>ρ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq118\"><alternatives><tex-math id=\"M239\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\nabla ^2 \\rho $$\\end{document}</tex-math><mml:math id=\"M240\"><mml:mrow><mml:msup><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>ρ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq119\"><alternatives><tex-math id=\"M241\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho $$\\end{document}</tex-math><mml:math id=\"M242\"><mml:mi>ρ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq120\"><alternatives><tex-math id=\"M243\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ea_0^{-3}$$\\end{document}</tex-math><mml:math id=\"M244\"><mml:mrow><mml:mi>e</mml:mi><mml:msubsup><mml:mi>a</mml:mi><mml:mn>0</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq121\"><alternatives><tex-math id=\"M245\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\nabla ^2\\rho $$\\end{document}</tex-math><mml:math id=\"M246\"><mml:mrow><mml:msup><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>ρ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq122\"><alternatives><tex-math id=\"M247\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ea_0^{-5}$$\\end{document}</tex-math><mml:math id=\"M248\"><mml:mrow><mml:mi>e</mml:mi><mml:msubsup><mml:mi>a</mml:mi><mml:mn>0</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq123\"><alternatives><tex-math id=\"M249\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M250\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq124\"><alternatives><tex-math id=\"M251\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M252\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq125\"><alternatives><tex-math id=\"M253\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots \\pi $$\\end{document}</tex-math><mml:math id=\"M254\"><mml:mrow><mml:mo>⋯</mml:mo><mml:mi>π</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq126\"><alternatives><tex-math id=\"M255\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M256\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq127\"><alternatives><tex-math id=\"M257\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{n}$$\\end{document}</tex-math><mml:math id=\"M258\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq128\"><alternatives><tex-math id=\"M259\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M260\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq129\"><alternatives><tex-math id=\"M261\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P_n^k(T)$$\\end{document}</tex-math><mml:math id=\"M262\"><mml:mrow><mml:msubsup><mml:mi>P</mml:mi><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msubsup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ4\"><label>4</label><alternatives><tex-math id=\"M263\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} P_n^k(T)=\\dfrac{1}{\\sum _i \\exp \\left\\{ -\\beta \\left( G_i(T)-G_k(T)\\right) \\right\\} }, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M264\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msubsup><mml:mi>P</mml:mi><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msubsup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mstyle displaystyle=\"true\" scriptlevel=\"0\"><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mo>∑</mml:mo><mml:mi>i</mml:mi></mml:msub><mml:mo>exp</mml:mo><mml:mfenced close=\"}\" open=\"{\"><mml:mo>-</mml:mo><mml:mi>β</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>G</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfenced></mml:mfenced></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq130\"><alternatives><tex-math id=\"M265\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\beta =k_BT$$\\end{document}</tex-math><mml:math id=\"M266\"><mml:mrow><mml:mi>β</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>B</mml:mi></mml:msub><mml:mi>T</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq131\"><alternatives><tex-math id=\"M267\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k_B$$\\end{document}</tex-math><mml:math id=\"M268\"><mml:msub><mml:mi>k</mml:mi><mml:mi>B</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq132\"><alternatives><tex-math id=\"M269\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$G_i(T)$$\\end{document}</tex-math><mml:math id=\"M270\"><mml:mrow><mml:msub><mml:mi>G</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq133\"><alternatives><tex-math id=\"M271\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M272\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq134\"><alternatives><tex-math id=\"M273\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M274\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq135\"><alternatives><tex-math id=\"M275\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=2-10$$\\end{document}</tex-math><mml:math id=\"M276\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mo>-</mml:mo><mml:mn>10</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq136\"><alternatives><tex-math id=\"M277\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M278\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq137\"><alternatives><tex-math id=\"M279\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\sim $$\\end{document}</tex-math><mml:math id=\"M280\"><mml:mo>∼</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq138\"><alternatives><tex-math id=\"M281\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta H_{Solv}$$\\end{document}</tex-math><mml:math id=\"M282\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>H</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">Solv</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq139\"><alternatives><tex-math id=\"M283\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta G_{Solv}$$\\end{document}</tex-math><mml:math id=\"M284\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>G</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">Solv</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq140\"><alternatives><tex-math id=\"M285\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M286\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq141\"><alternatives><tex-math id=\"M287\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M288\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq142\"><alternatives><tex-math id=\"M289\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M290\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq143\"><alternatives><tex-math id=\"M291\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M292\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq144\"><alternatives><tex-math id=\"M293\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${-18.1}$$\\end{document}</tex-math><mml:math id=\"M294\"><mml:mrow><mml:mo>-</mml:mo><mml:mn>18.1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq145\"><alternatives><tex-math id=\"M295\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${-7.0}$$\\end{document}</tex-math><mml:math id=\"M296\"><mml:mrow><mml:mo>-</mml:mo><mml:mn>7.0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq146\"><alternatives><tex-math id=\"M297\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${-17.8}$$\\end{document}</tex-math><mml:math id=\"M298\"><mml:mrow><mml:mo>-</mml:mo><mml:mn>17.8</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq147\"><alternatives><tex-math id=\"M299\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${-10.1}$$\\end{document}</tex-math><mml:math id=\"M300\"><mml:mrow><mml:mo>-</mml:mo><mml:mn>10.1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq148\"><alternatives><tex-math id=\"M301\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${-7.6}$$\\end{document}</tex-math><mml:math id=\"M302\"><mml:mrow><mml:mo>-</mml:mo><mml:mn>7.6</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq149\"><alternatives><tex-math id=\"M303\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M304\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq150\"><alternatives><tex-math id=\"M305\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M306\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq151\"><alternatives><tex-math id=\"M307\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${-10.1}$$\\end{document}</tex-math><mml:math id=\"M308\"><mml:mrow><mml:mo>-</mml:mo><mml:mn>10.1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq152\"><alternatives><tex-math id=\"M309\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${-5.6}$$\\end{document}</tex-math><mml:math id=\"M310\"><mml:mrow><mml:mo>-</mml:mo><mml:mn>5.6</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq153\"><alternatives><tex-math id=\"M311\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${-17.8}$$\\end{document}</tex-math><mml:math id=\"M312\"><mml:mrow><mml:mo>-</mml:mo><mml:mn>17.8</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq154\"><alternatives><tex-math id=\"M313\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M314\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq155\"><alternatives><tex-math id=\"M315\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M316\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq156\"><alternatives><tex-math id=\"M317\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_1$$\\end{document}</tex-math><mml:math id=\"M318\"><mml:msub><mml:mrow/><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq157\"><alternatives><tex-math id=\"M319\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M320\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq158\"><alternatives><tex-math id=\"M321\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M322\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq159\"><alternatives><tex-math id=\"M323\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M324\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq160\"><alternatives><tex-math id=\"M325\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M326\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq161\"><alternatives><tex-math id=\"M327\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M328\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq162\"><alternatives><tex-math id=\"M329\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M330\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq163\"><alternatives><tex-math id=\"M331\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M332\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq164\"><alternatives><tex-math id=\"M333\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M334\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq165\"><alternatives><tex-math id=\"M335\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M336\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq166\"><alternatives><tex-math id=\"M337\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M338\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq167\"><alternatives><tex-math id=\"M339\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M340\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq168\"><alternatives><tex-math id=\"M341\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M342\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq169\"><alternatives><tex-math id=\"M343\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M344\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq170\"><alternatives><tex-math id=\"M345\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_2$$\\end{document}</tex-math><mml:math id=\"M346\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq171\"><alternatives><tex-math id=\"M347\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M348\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq172\"><alternatives><tex-math id=\"M349\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M350\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq173\"><alternatives><tex-math id=\"M351\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M352\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq174\"><alternatives><tex-math id=\"M353\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M354\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq175\"><alternatives><tex-math id=\"M355\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M356\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq176\"><alternatives><tex-math id=\"M357\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M358\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq177\"><alternatives><tex-math id=\"M359\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M360\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq178\"><alternatives><tex-math id=\"M361\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M362\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq179\"><alternatives><tex-math id=\"M363\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M364\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq180\"><alternatives><tex-math id=\"M365\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M366\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq181\"><alternatives><tex-math id=\"M367\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M368\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq182\"><alternatives><tex-math id=\"M369\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M370\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq183\"><alternatives><tex-math id=\"M371\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M372\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq184\"><alternatives><tex-math id=\"M373\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_3$$\\end{document}</tex-math><mml:math id=\"M374\"><mml:msub><mml:mrow/><mml:mn>3</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq185\"><alternatives><tex-math id=\"M375\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M376\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq186\"><alternatives><tex-math id=\"M377\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M378\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq187\"><alternatives><tex-math id=\"M379\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M380\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq188\"><alternatives><tex-math id=\"M381\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M382\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq189\"><alternatives><tex-math id=\"M383\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M384\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq190\"><alternatives><tex-math id=\"M385\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M386\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq191\"><alternatives><tex-math id=\"M387\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M388\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq192\"><alternatives><tex-math id=\"M389\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M390\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq193\"><alternatives><tex-math id=\"M391\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M392\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq194\"><alternatives><tex-math id=\"M393\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M394\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq195\"><alternatives><tex-math id=\"M395\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M396\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq196\"><alternatives><tex-math id=\"M397\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M398\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq197\"><alternatives><tex-math id=\"M399\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M400\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq198\"><alternatives><tex-math id=\"M401\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_4$$\\end{document}</tex-math><mml:math id=\"M402\"><mml:msub><mml:mrow/><mml:mn>4</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq199\"><alternatives><tex-math id=\"M403\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M404\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq200\"><alternatives><tex-math id=\"M405\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M406\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq201\"><alternatives><tex-math id=\"M407\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M408\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq202\"><alternatives><tex-math id=\"M409\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M410\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq203\"><alternatives><tex-math id=\"M411\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M412\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq204\"><alternatives><tex-math id=\"M413\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M414\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq205\"><alternatives><tex-math id=\"M415\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M416\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq206\"><alternatives><tex-math id=\"M417\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M418\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq207\"><alternatives><tex-math id=\"M419\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M420\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq208\"><alternatives><tex-math id=\"M421\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M422\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq209\"><alternatives><tex-math id=\"M423\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M424\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq210\"><alternatives><tex-math id=\"M425\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M426\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq211\"><alternatives><tex-math id=\"M427\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M428\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq212\"><alternatives><tex-math id=\"M429\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_6$$\\end{document}</tex-math><mml:math id=\"M430\"><mml:msub><mml:mrow/><mml:mn>6</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq213\"><alternatives><tex-math id=\"M431\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M432\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq214\"><alternatives><tex-math id=\"M433\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M434\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq215\"><alternatives><tex-math id=\"M435\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M436\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq216\"><alternatives><tex-math id=\"M437\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M438\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq217\"><alternatives><tex-math id=\"M439\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M440\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq218\"><alternatives><tex-math id=\"M441\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M442\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq219\"><alternatives><tex-math id=\"M443\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M444\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq220\"><alternatives><tex-math id=\"M445\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M446\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq221\"><alternatives><tex-math id=\"M447\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M448\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq222\"><alternatives><tex-math id=\"M449\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M450\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq223\"><alternatives><tex-math id=\"M451\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M452\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq224\"><alternatives><tex-math id=\"M453\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M454\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq225\"><alternatives><tex-math id=\"M455\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M456\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq226\"><alternatives><tex-math id=\"M457\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_8$$\\end{document}</tex-math><mml:math id=\"M458\"><mml:msub><mml:mrow/><mml:mn>8</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq227\"><alternatives><tex-math id=\"M459\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M460\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq228\"><alternatives><tex-math id=\"M461\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M462\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq229\"><alternatives><tex-math id=\"M463\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M464\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq230\"><alternatives><tex-math id=\"M465\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M466\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq231\"><alternatives><tex-math id=\"M467\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M468\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq232\"><alternatives><tex-math id=\"M469\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M470\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq233\"><alternatives><tex-math id=\"M471\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M472\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq234\"><alternatives><tex-math id=\"M473\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M474\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq235\"><alternatives><tex-math id=\"M475\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M476\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq236\"><alternatives><tex-math id=\"M477\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M478\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq237\"><alternatives><tex-math id=\"M479\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M480\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq238\"><alternatives><tex-math id=\"M481\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M482\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq239\"><alternatives><tex-math id=\"M483\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{10}$$\\end{document}</tex-math><mml:math id=\"M484\"><mml:msub><mml:mrow/><mml:mn>10</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq240\"><alternatives><tex-math id=\"M485\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M486\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq241\"><alternatives><tex-math id=\"M487\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M488\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq242\"><alternatives><tex-math id=\"M489\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M490\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq243\"><alternatives><tex-math id=\"M491\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M492\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq244\"><alternatives><tex-math id=\"M493\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M494\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq245\"><alternatives><tex-math id=\"M495\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M496\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq246\"><alternatives><tex-math id=\"M497\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M498\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq247\"><alternatives><tex-math id=\"M499\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M500\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq248\"><alternatives><tex-math id=\"M501\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M502\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq249\"><alternatives><tex-math id=\"M503\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M504\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq250\"><alternatives><tex-math id=\"M505\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M506\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq251\"><alternatives><tex-math id=\"M507\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M508\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq252\"><alternatives><tex-math id=\"M509\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega $$\\end{document}</tex-math><mml:math id=\"M510\"><mml:mi>ω</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq253\"><alternatives><tex-math id=\"M511\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M512\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq254\"><alternatives><tex-math id=\"M513\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M514\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ5\"><label>5</label><alternatives><tex-math id=\"M515\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\Delta E_n= E(\\text {ABW}_n)-E(\\text {AB})-nE(\\text {H}_2\\text {O}), \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M516\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>E</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi>E</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>ABW</mml:mtext><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mi>E</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mtext>AB</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mi>n</mml:mi><mml:mi>E</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq255\"><alternatives><tex-math id=\"M517\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M518\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq256\"><alternatives><tex-math id=\"M519\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega $$\\end{document}</tex-math><mml:math id=\"M520\"><mml:mi>ω</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq257\"><alternatives><tex-math id=\"M521\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M522\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq258\"><alternatives><tex-math id=\"M523\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=1-10$$\\end{document}</tex-math><mml:math id=\"M524\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mn>10</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq259\"><alternatives><tex-math id=\"M525\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M526\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq260\"><alternatives><tex-math id=\"M527\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=1-10$$\\end{document}</tex-math><mml:math id=\"M528\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mn>10</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq261\"><alternatives><tex-math id=\"M529\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M530\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq262\"><alternatives><tex-math id=\"M531\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M532\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq263\"><alternatives><tex-math id=\"M533\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M534\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq264\"><alternatives><tex-math id=\"M535\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M536\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq265\"><alternatives><tex-math id=\"M537\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M538\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq266\"><alternatives><tex-math id=\"M539\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots \\pi $$\\end{document}</tex-math><mml:math id=\"M540\"><mml:mrow><mml:mo>⋯</mml:mo><mml:mi>π</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq267\"><alternatives><tex-math id=\"M541\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M542\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq268\"><alternatives><tex-math id=\"M543\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots $$\\end{document}</tex-math><mml:math id=\"M544\"><mml:mo>⋯</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq269\"><alternatives><tex-math id=\"M545\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\cdots \\pi $$\\end{document}</tex-math><mml:math id=\"M546\"><mml:mrow><mml:mo>⋯</mml:mo><mml:mi>π</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq270\"><alternatives><tex-math id=\"M547\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M548\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq271\"><alternatives><tex-math id=\"M549\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${-7.0}$$\\end{document}</tex-math><mml:math id=\"M550\"><mml:mrow><mml:mo>-</mml:mo><mml:mn>7.0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq272\"><alternatives><tex-math id=\"M551\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${-18.1}$$\\end{document}</tex-math><mml:math id=\"M552\"><mml:mrow><mml:mo>-</mml:mo><mml:mn>18.1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq273\"><alternatives><tex-math id=\"M553\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega $$\\end{document}</tex-math><mml:math id=\"M554\"><mml:mi>ω</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq274\"><alternatives><tex-math id=\"M555\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_n$$\\end{document}</tex-math><mml:math id=\"M556\"><mml:msub><mml:mrow/><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq275\"><alternatives><tex-math id=\"M557\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=6$$\\end{document}</tex-math><mml:math id=\"M558\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq276\"><alternatives><tex-math id=\"M559\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=8$$\\end{document}</tex-math><mml:math id=\"M560\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq277\"><alternatives><tex-math id=\"M561\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=10$$\\end{document}</tex-math><mml:math id=\"M562\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>10</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>" ]
[ "<table-wrap-foot><p>The full data of the electron density and its Laplacian at all bond critical points is provided in the supporting information</p></table-wrap-foot>", "<table-wrap-foot><p>For DFT functionals, the basis set used in the calculations is def2-TZVP, while for DLPNO-CCSD(T), we used the two-point strategy complete basis set (CBS) extrapolation. Statistical descriptors, including the mean absolute deviation (MAD), the maximum deviation (MAX), and the root mean squared error (RMSE), are calculated in reference to the DLPNO-CCSD(T)/CBS binding energies. To fit the table on the page, some names have been truncated: PW6=PW6B95D3, wB97=B97XD, DLPNO=DLPNO-CCSD(T)</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Diane Anni and Jean Claude Amika Mbema contributed equally to the manuscript.</p></fn></fn-group>" ]
[ "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq9.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq10.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq11.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq12.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq13.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq14.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq15.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq16.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq17.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq18.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq19.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq20.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq21.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq22.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq23.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq24.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq25.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq26.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq27.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq28.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq29.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq30.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq31.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq32.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq33.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq34.gif\"/>", "<graphic xlink:href=\"894_2023_5810_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"894_2023_5810_Article_Equ1.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"894_2023_5810_Article_Equ2.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"894_2023_5810_Article_Equ3.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq35.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq36.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq37.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq38.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq39.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq40.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq41.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq42.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq43.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq44.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq45.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq46.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq47.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq48.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq49.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq50.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq51.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq52.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq53.gif\"/>", "<graphic xlink:href=\"894_2023_5810_Fig2_HTML\" id=\"MO2\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq54.gif\"/>", "<graphic xlink:href=\"894_2023_5810_Fig3_HTML\" id=\"MO3\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq55.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq56.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq57.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq58.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq59.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq60.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq61.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq62.gif\"/>", "<graphic xlink:href=\"894_2023_5810_Fig4_HTML\" id=\"MO4\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq63.gif\"/>", "<graphic xlink:href=\"894_2023_5810_Fig5_HTML\" id=\"MO5\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq64.gif\"/>", "<graphic xlink:href=\"894_2023_5810_Fig6_HTML\" id=\"MO6\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq65.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq66.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq67.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq68.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq69.gif\"/>", "<graphic xlink:href=\"894_2023_5810_Fig7_HTML\" id=\"MO7\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq70.gif\"/>", "<graphic xlink:href=\"894_2023_5810_Fig8_HTML\" id=\"MO8\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq71.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq72.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq73.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq74.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq75.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq76.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq77.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq78.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq79.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq80.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq81.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq82.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq83.gif\"/>", "<graphic xlink:href=\"894_2023_5810_Fig9_HTML\" id=\"MO9\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq84.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq85.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq86.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq87.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq88.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq89.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq90.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq91.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq92.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq93.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq94.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq95.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq96.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq97.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq98.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq99.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq100.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq101.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq102.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq103.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq104.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq105.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq106.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq107.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq108.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq109.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq110.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq111.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq112.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq113.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq114.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq115.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq116.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq117.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq118.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq119.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq120.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq121.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq122.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq123.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq124.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq125.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq126.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq127.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq128.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq129.gif\"/>", "<graphic xlink:href=\"894_2023_5810_Article_Equ4.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq130.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq131.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq132.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq133.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq134.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq135.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq136.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq137.gif\"/>", "<graphic xlink:href=\"894_2023_5810_Fig10_HTML\" id=\"MO10\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq138.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq139.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq140.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq141.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq142.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq143.gif\"/>", "<graphic xlink:href=\"894_2023_5810_Fig11_HTML\" id=\"MO11\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq144.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq145.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq146.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq147.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq148.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq149.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq150.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq151.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq152.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq153.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq154.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq155.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq156.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq157.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq158.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq159.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq160.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq161.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq162.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq163.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq164.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq165.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq166.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq167.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq168.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq169.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq170.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq171.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq172.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq173.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq174.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq175.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq176.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq177.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq178.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq179.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq180.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq181.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq182.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq183.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq184.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq185.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq186.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq187.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq188.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq189.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq190.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq191.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq192.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq193.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq194.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq195.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq196.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq197.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq198.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq199.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq200.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq201.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq202.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq203.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq204.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq205.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq206.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq207.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq208.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq209.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq210.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq211.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq212.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq213.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq214.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq215.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq216.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq217.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq218.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq219.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq220.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq221.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq222.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq223.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq224.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq225.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq226.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq227.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq228.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq229.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq230.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq231.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq232.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq233.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq234.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq235.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq236.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq237.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq238.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq239.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq240.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq241.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq242.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq243.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq244.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq245.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq246.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq247.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq248.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq249.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq250.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq251.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq252.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq253.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq254.gif\"/>", "<graphic xlink:href=\"894_2023_5810_Article_Equ5.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq255.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq256.gif\"/>", "<graphic xlink:href=\"894_2023_5810_Fig12_HTML\" id=\"MO12\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq257.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq258.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq259.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq260.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq261.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq262.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq263.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq264.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq265.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq266.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq267.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq268.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq269.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq270.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq271.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq272.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq273.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq274.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq275.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq276.gif\"/>", "<inline-graphic xlink:href=\"894_2023_5810_Article_IEq277.gif\"/>" ]
[ "<media xlink:href=\"894_2023_5810_MOESM1_ESM.pdf\"><caption><p>Supplementary file 1 (pdf 5455 KB)</p></caption></media>", "<media xlink:href=\"894_2023_5810_MOESM2_ESM.pdf\"><caption><p>Supplementary file 2 (pdf 31 KB)</p></caption></media>", "<media xlink:href=\"894_2023_5810_MOESM3_ESM.pdf\"><caption><p>Supplementary file 3 (pdf 332 KB)</p></caption></media>" ]
[{"label": ["1."], "surname": ["Wang", "Fei", "Chen", "Zhang"], "given-names": ["H-l", "Z-h", "J-l", "Q-x"], "article-title": ["Effect of pH on the adsorption of p-aminobenzoic acid on polystyrene-based adsorbents"], "source": ["Chinese J Polym Sci"], "year": ["2007"], "volume": ["25"], "fpage": ["235"], "lpage": ["244"], "pub-id": ["10.1142/S0256767907002060"]}, {"label": ["2."], "surname": ["Perry", "Cordova", "Smith", "Son", "Schiefer", "Dervishi", "Watanabe", "Biris"], "given-names": ["DA", "JS", "LG", "H-J", "EM", "E", "F", "AS"], "article-title": ["Study of adsorption of aminobenzoic acid isomers on silver nanostructures by surface-enhanced infrared spectroscopy"], "source": ["J Phys Chem C"], "year": ["2009"], "volume": ["113"], "fpage": ["18304"], "lpage": ["18311"], "pub-id": ["10.1021/jp906871g"]}, {"label": ["4."], "surname": ["Xue", "Dong", "Wang", "Bi", "Zhai", "Li", "Nie"], "given-names": ["Y", "W", "X", "W", "P", "H", "M"], "article-title": ["Degradation of sunscreen agent p-aminobenzoic acid using a combination system of UV irradiation, persulphate and iron (II)"], "source": ["Environ Sci Pollut Res"], "year": ["2016"], "volume": ["23"], "fpage": ["4561"], "lpage": ["4568"], "pub-id": ["10.1007/s11356-015-5631-z"]}, {"label": ["5."], "surname": ["Wu", "Li", "Lu", "Lin", "Wei", "Zhang"], "given-names": ["D", "Y", "G", "Q", "L", "P"], "article-title": ["Removal of aqueous para-aminobenzoic acid using a compartmental electro-peroxone process"], "source": ["Water"], "year": ["2021"], "volume": ["13"], "fpage": ["2961"], "pub-id": ["10.3390/w13212961"]}, {"label": ["6."], "surname": ["Zhang", "Wang", "Fang", "Qin", "Li", "Du"], "given-names": ["Y", "B", "K", "Y", "H", "J"], "article-title": ["Degradation of p-aminobenzoic acid by peroxymonosulfate and evolution of effluent organic matter: The effect of chloride ion"], "source": ["Chem Eng J"], "year": ["2021"], "volume": ["411"], "fpage": ["128462"], "pub-id": ["10.1016/j.cej.2021.128462"]}, {"label": ["7."], "surname": ["Ghosh", "Chaudhuri"], "given-names": ["A", "P"], "article-title": ["NMR spin-spin coupling constants in microhydrated ortho-aminobenzoic acid"], "source": ["Mol Phys"], "year": ["2015"], "volume": ["113"], "fpage": ["497"], "lpage": ["507"], "pub-id": ["10.1080/00268976.2014.955065"]}, {"label": ["8."], "surname": ["da Silva", "Ito", "Galembeck"], "given-names": ["Olivier D", "AS", "SE"], "article-title": ["Microhydration effects on geometric properties and electronic absorption spectra of ortho-aminobenzoic acid"], "source": ["Spectrochim Acta A"], "year": ["2015"], "volume": ["147"], "fpage": ["328"], "lpage": ["333"], "pub-id": ["10.1016/j.saa.2015.03.108"]}, {"label": ["9."], "surname": ["Rosbottom", "Pickering", "Hammond", "Roberts"], "given-names": ["I", "JH", "RB", "KJ"], "article-title": ["A digital workflow supporting the selection of solvents for optimizing the crystallizability of p-aminobenzoic acid"], "source": ["Org Process Res Dev"], "year": ["2020"], "volume": ["24"], "fpage": ["500"], "lpage": ["507"], "pub-id": ["10.1021/acs.oprd.9b00261"]}, {"label": ["10."], "surname": ["Benoit", "Louis", "Fre"], "given-names": ["R", "C", "M"], "article-title": ["Solution and ionization of some carboxylic acids in water and dimethyl sulfoxide"], "source": ["Thermochimica Acta"], "year": ["1991"], "volume": ["176"], "fpage": ["221"], "lpage": ["232"], "pub-id": ["10.1016/0040-6031(91)80277-P"]}, {"label": ["13."], "surname": ["Li", "Jia", "Gao", "Wang", "Hong", "Gao", "Gong"], "given-names": ["Z", "S", "Y", "M", "W", "Z", "J"], "article-title": ["Solid-liquid equilibrium behavior and thermodynamic analysis of p-aminobenzoic acid using experimental measurement and molecular dynamic simulation"], "source": ["J Mol Liq"], "year": ["2021"], "volume": ["323"], "fpage": ["114964"], "pub-id": ["10.1016/j.molliq.2020.114964"]}, {"label": ["14."], "surname": ["Tawa", "Topol", "Burt", "Caldwell", "Rashin"], "given-names": ["G", "I", "S", "R", "A"], "article-title": ["Calculation of the aqueous solvation free energy of the proton"], "source": ["J Chem Phys"], "year": ["1998"], "volume": ["109"], "fpage": ["4852"], "lpage": ["4863"], "pub-id": ["10.1063/1.477096"]}, {"label": ["15."], "mixed-citation": ["Hunenberger P, Reif M (2011) Single-ion solvation; theoretical and computational chemistry series; the royal society of chemistry, pp\u00a0001\u2013664"]}, {"label": ["19."], "surname": ["Ishikawa", "Nakai"], "given-names": ["A", "H"], "article-title": ["Quantum chemical approach for condensed-phase thermochemistry (III): accurate evaluation of proton hydration energy and standard hydrogen electrode potential"], "source": ["Chem Phys Lett"], "year": ["2016"], "volume": ["650"], "fpage": ["159"], "lpage": ["164"], "pub-id": ["10.1016/j.cplett.2016.03.004"]}, {"label": ["20."], "mixed-citation": ["Malloum A, Fifen JJ, Dhaouadi Z, Nana ESG (2017) Jaidane N-D solvation energies of the proton in ammonia explicitly versus temperature. J Chem Phys 146"]}, {"label": ["22."], "surname": ["Malloum", "Fifen", "Conradie"], "given-names": ["A", "JJ", "J"], "article-title": ["Determination of the absolute solvation free energy and enthalpy of the proton in solutions"], "source": ["J Mol Liq"], "year": ["2021"], "volume": ["322"], "fpage": ["114919"], "pub-id": ["10.1016/j.molliq.2020.114919"]}, {"label": ["23."], "surname": ["Malloum", "Conradie"], "given-names": ["A", "J"], "article-title": ["Solvation free energy of the proton in acetonitrile"], "source": ["J Mol Liq"], "year": ["2021"], "volume": ["335"], "fpage": ["116032"], "pub-id": ["10.1016/j.molliq.2021.116032"]}, {"label": ["24."], "surname": ["Malloum", "Conradie"], "given-names": ["A", "J"], "article-title": ["Microsolvation of phenol in water: structures, hydration free energy and enthalpy"], "source": ["Mol Simul"], "year": ["2023"], "volume": ["49"], "fpage": ["403"], "lpage": ["414"], "pub-id": ["10.1080/08927022.2022.2163674"]}, {"label": ["25."], "surname": ["Malloum", "Fifen", "Dhaouadi", "Engo", "Conradie"], "given-names": ["A", "JJ", "Z", "SGN", "J"], "article-title": ["Structures, relative stabilities and binding energies of neutral water clusters, (H"], "tex-math": ["\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_2$$\\end{document}", "\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2-30}$$\\end{document}"], "{http://www.w3.org/1998/Math/MathML}mn": ["2", "2", "30"], "{http://www.w3.org/1998/Math/MathML}mo": ["-"], "source": ["New J Chem"], "year": ["2019"], "volume": ["43"], "fpage": ["13020"], "lpage": ["13037"], "pub-id": ["10.1039/C9NJ01659G"]}, {"label": ["26."], "surname": ["Malloum", "Conradie"], "given-names": ["A", "J"], "article-title": ["Structures of water clusters in the solvent phase and relative stability compared to gas phase"], "source": ["Polyhedron"], "year": ["2021"], "volume": ["193"], "fpage": ["114856"], "pub-id": ["10.1016/j.poly.2020.114856"]}, {"label": ["33."], "surname": ["Malloum", "Fifen", "Conradie"], "given-names": ["A", "JJ", "J"], "article-title": ["Theoretical infrared spectrum of the ethanol hexamer"], "source": ["Int J Quantum Chem"], "year": ["2020"], "volume": ["120"], "fpage": ["e26234"], "pub-id": ["10.1002/qua.26234"]}, {"label": ["34."], "surname": ["Malloum", "Conradie"], "given-names": ["A", "J"], "article-title": ["Global and local minima of protonated acetonitrile clusters"], "source": ["New J Chem"], "year": ["2020"], "volume": ["44"], "fpage": ["17558"], "lpage": ["17569"], "pub-id": ["10.1039/D0NJ03389H"]}, {"label": ["36."], "surname": ["Malloum", "Fifen", "Conradie"], "given-names": ["A", "JJ", "J"], "article-title": ["Binding energies and isomer distribution of neutral acetonitrile clusters"], "source": ["Int J Quantum Chem"], "year": ["2020"], "volume": ["120"], "fpage": ["e26221"], "pub-id": ["10.1002/qua.26222"]}, {"label": ["38."], "surname": ["Malloum", "Conradie"], "given-names": ["A", "J"], "article-title": ["Accurate binding energies of ammonia clusters and benchmarking of hybrid DFT functionals"], "source": ["Comput Theor Chem"], "year": ["2021"], "volume": ["1200"], "fpage": ["113236"], "pub-id": ["10.1016/j.comptc.2021.113236"]}, {"label": ["39."], "mixed-citation": ["Malloum A, Conradie J (2022) Non-covalent interactions in dimethylsulfoxide (DMSO) clusters and DFT benchmarking. J Mol Liq 350"]}, {"label": ["40."], "mixed-citation": ["Frisch MJ, et al (2016) Gaussian"], "tex-math": ["\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{\\sim }$$\\end{document}"], "{http://www.w3.org/1998/Math/MathML}mo": ["\u223c"]}, {"label": ["43."], "surname": ["Becke"], "given-names": ["AD"], "article-title": ["Density-functional thermochemistry. III. The role of exact exchange"], "source": ["J Chem Phys"], "year": ["1993"], "volume": ["98"], "fpage": ["5648"], "lpage": ["5652"], "pub-id": ["10.1063/1.464913"]}, {"label": ["45."], "mixed-citation": ["Zhao Y, Schultz NE, Truhlar DG (2006) Design of density functionals by combining the method of constraint satisfaction with parametrization for thermochemistry, thermochemical kinetics, and noncovalent interactions. J Chem Theory Comput 2:364\u2013 382"]}, {"label": ["46."], "mixed-citation": ["Zhao Y, Truhlar DG (2008) The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals. Theor Chem Acc 120:215\u2013241"]}, {"label": ["48."], "surname": ["Adamo", "Barone"], "given-names": ["C", "V"], "article-title": ["Toward reliable density functional methods without adjustable parameters: the PBE0 model"], "source": ["J Chem Phys"], "year": ["1999"], "volume": ["110"], "fpage": ["6158"], "lpage": ["6170"], "pub-id": ["10.1063/1.478522"]}, {"label": ["51."], "mixed-citation": ["Tao J, Perdew JP, Staroverov VN, Scuseria GE (2003) Climbing the density functional ladder: nonempirical meta-generalized gradient approximation designed for molecules and solids. Phys Rev Lett 91"]}, {"label": ["53."], "surname": ["Neese"], "given-names": ["F"], "article-title": ["The ORCA program system"], "source": ["Wiley Interdiscip Rev Comput Mol Sci"], "year": ["2012"], "volume": ["2"], "fpage": ["73"], "lpage": ["78"], "pub-id": ["10.1002/wcms.81"]}, {"label": ["55."], "mixed-citation": ["Keith TA (2019) TK Gristmill software. Overland Park KS, USA 11:16. ("], "ext-link": ["https://aim.tkgristmill.com"]}, {"label": ["56."], "mixed-citation": ["Fifen JJ, Nsangou M, Dhaouadi Z, Motapon O, Jaidane N-E (2013) Structures of protonated methanol clusters and temperature effects. J Chem Phys 138:184301"]}, {"label": ["57."], "mixed-citation": ["Fifen JJ, Agmon N (2016) Structure and spectroscopy of hydrated sodium ions at different temperatures and the cluster stability rules. J Chem Theory Comput 12:1656\u20131673"]}, {"label": ["59."], "mixed-citation": ["Bursch M, Mewes J-M, Hansen A, Grimme S (2022) Best-practice DFT protocols for basic molecular computational chemistry. Angew Chem Int Ed 61"]}, {"label": ["60."], "surname": ["Boyd", "Choi"], "given-names": ["RJ", "SC"], "article-title": ["Hydrogen bonding between nitriles and hydrogen halides and the topological properties of molecular charge distributions"], "source": ["Chem Phys Lett"], "year": ["1986"], "volume": ["129"], "fpage": ["62"], "lpage": ["65"], "pub-id": ["10.1016/0009-2614(86)80169-5"]}, {"label": ["61."], "surname": ["Carroll", "Bader"], "given-names": ["MT", "RF"], "article-title": ["An analysis of the hydrogen bond in BASE-HF complexes using the theory of atoms in molecules"], "source": ["Mol Phys"], "year": ["1988"], "volume": ["65"], "fpage": ["695"], "lpage": ["722"], "pub-id": ["10.1080/00268978800101351"]}, {"label": ["62."], "surname": ["Espinosa", "Molins", "Lecomte"], "given-names": ["E", "E", "C"], "article-title": ["Hydrogen bond strengths revealed by topological analyses of experimentally observed electron densities"], "source": ["Chem Phys Lett"], "year": ["1998"], "volume": ["285"], "fpage": ["170"], "lpage": ["173"], "pub-id": ["10.1016/S0009-2614(98)00036-0"]}, {"label": ["63."], "surname": ["Grabowski"], "given-names": ["SJ"], "article-title": ["Ab initio calculations on conventional and unconventional hydrogen bonds study of the hydrogen bond strength"], "source": ["J Phys Chem A"], "year": ["2001"], "volume": ["105"], "fpage": ["10739"], "lpage": ["10746"], "pub-id": ["10.1021/jp011819h"]}, {"label": ["64."], "mixed-citation": ["Domaga\u0142a M, Grabowski SJ, Urbaniak K, Mlosto\u0144 G (2003) Role of C-H...S and C-H...N hydrogen bonds in organic crystal structures the crystal and molecular structure of 3-methyl-2,4-diphenyl-(1,3)-thiazolidine-5-spiro-2\u2018-adamantane and 3-methyl-2,4,5,5-tetraphenyl-(1,3)-thiazolidine. J Phys Chem A 107:2730\u20132736"]}, {"label": ["67."], "surname": ["Knop", "Boyd", "Choi"], "given-names": ["O", "RJ", "S"], "article-title": ["Sulfur-sulfur bond lengths, or can a bond length be estimated from a single parameter"], "source": ["J Am Chem Soc"], "year": ["1988"], "volume": ["110"], "fpage": ["7299"], "lpage": ["7301"], "pub-id": ["10.1021/ja00230a005"]}]
{ "acronym": [], "definition": [] }
67
CC BY
no
2024-01-14 23:40:13
J Mol Model. 2024 Jan 12; 30(2):38
oa_package/5d/0b/PMC10786749.tar.gz
PMC10786752
38214802
[ "<title>Introduction</title>", "<p id=\"Par63\">Liver diseases are named based on their etiology. The hepatotoxicity of some drugs causes drug-induced liver diseases (DILI) and alcohol-associated liver disease (ALD) is a harmful consequence that may occur from excessive and chronic alcohol consumption. Liver diseases can also occur from overnutrition and obesity [metabolic dysfunction-associated steatotic liver disease (MASLD)], toxic agents [toxicant-associated fatty liver disease (TAFLD)], and hepatitis viruses (viral hepatitis). However, liver diseases, regardless of the cause, share many pathophysiological features like oxidative stress, post-translational modifications (PTMs), fat accumulation, metabolic signaling alterations, mitochondrial dysfunction, gut barrier dysfunction, inflammation, and hepatocyte apoptosis. Overall, we have reviewed the cellular and molecular pathologies of these liver diseases to derive potential preventions or therapeutic targets against liver diseases [##REF##22700427##1##].</p>", "<title>Oxidative stress in liver diseases</title>", "<p id=\"Par64\">Oxidative stress is an imbalance between pro-oxidants and antioxidants. Usually, the cell can remove reactive oxygen species (ROS) and reactive nitrogen species (RNS) through antioxidant molecules such as reduced glutathione (GSH) and primary defense enzymes such as superoxide dismutase (SOD), catalase (CAT), and glutathione-dependent peroxidases (GPx) [##REF##22700427##1##]. So why has oxidative stress been observed in studies on DILI [##REF##29084443##2##–##REF##35513409##5##], TAFLD [##REF##15925388##6##–##REF##9282839##8##], ALD [##REF##25548474##9##–##REF##35054960##12##], and MASLD [##REF##30617744##13##–##REF##36304513##23##]? When organelles such as mitochondria, endoplasmic reticula (ER), and peroxisomes are damaged and dysfunctional, more ROS are produced [##REF##22700427##1##, ##REF##32156524##18##] in a vicious cycle [##REF##30682878##14##, ##REF##32920226##24##]. Excessive oxidative stress may cause DNA oxidation [##REF##12480607##25##], lipid peroxidation, oxidative protein modifications [##REF##25465468##26##], impaired fat metabolism [##REF##15925388##6##, ##REF##34960036##20##, ##REF##25465468##26##–##REF##8509425##28##], systemic inflammation [##REF##25465468##26##, ##REF##33032084##29##, ##REF##25942353##30##], and tissue damage [##REF##33259796##31##–##REF##34060044##33##], all of which contribute to the progression of liver diseases [##REF##31571145##17##, ##REF##32352946##34##, ##REF##29952268##35##].</p>", "<p id=\"Par65\">Hepatocytes respond to oxidative stress in diverse ways. Hepatic stellate cells (HSCs), when activated by ROS and damage-associated molecular patterns (DAMPs) from injured or necrotic hepatocytes, will produce extracellular matrix components to construct fibrotic tissue [##REF##29728869##36##]. On the other hand, Kupffer cells, upon activation by endotoxins (including lipopolysaccharide, LPS) or superoxide anions (⋅O<sub>2</sub><sup>−</sup>), will then produce more ROS through stimulation of NADPH-dependent oxidases (NOXs), and the redox-sensitive transcription factor nuclear factor-κB (NF-κB)-mediated pro-inflammatory storm of cytokines, chemokines, and cell adhesion molecules (CAMs) [##REF##29728869##36##]. Consequently, in response to oxidative stress, hepatocytes stimulate necrotic and apoptotic pathways, leading to impaired liver function, worsened paracrine inflammation, and fibrogenesis [##REF##29728869##36##].</p>", "<title>Post-translational protein modifications in liver diseases</title>", "<p id=\"Par66\">PTMs regulate the localization, stability, and final activity of virtually all proteins in the context of liver diseases [##REF##36157540##37##, ##REF##30045773##38##]. The proteins involved in promoting various PTMs exist in several subcellular organelles, including the cytoplasm [##REF##21204248##39##], ER [##REF##15554233##40##, ##REF##26278393##41##], mitochondria [##REF##30644754##42##], and nucleus [##REF##28094767##43##]; PTMs may also be observed in the proteomes of the liver [##REF##36157540##37##, ##REF##26767982##44##–##REF##34884899##47##], gut [##REF##16557555##7##], and other peripheral tissues [##REF##33032084##29##]. PTMs found in liver diseases include protein acetylation [##REF##36157540##37##, ##REF##30644754##42##, ##REF##34890308##48##], nitration [##REF##36528936##10##, ##REF##25465468##26##, ##REF##36157540##37##, ##REF##23691267##49##–##REF##23454065##53##], <italic>S</italic>-nitrosylation [##REF##23691267##49##, ##REF##18778711##54##, ##REF##17673211##55##], oxidation [##REF##36157540##37##], phosphorylation [##REF##25465468##26##, ##REF##26491845##56##, ##REF##33214856##57##], succinylation [##UREF##0##58##], ADP-ribosylation [##REF##26767982##44##], ubiquitination [##REF##36157540##37##, ##REF##19660437##59##], SUMOylation [##REF##22407595##60##–##REF##36116159##65##], carbonylation [##REF##30027653##66##–##REF##22668639##68##], <italic>S</italic>-palmitoylation [##REF##28526873##45##–##REF##34884899##47##, ##REF##25839660##69##], glycosylation [##REF##16557555##7##, ##REF##36157540##37##, ##REF##35577141##70##, ##REF##25651996##71##], protein adducts of aldehyde (i.e., acetaldehydes) [##REF##25548474##9##, ##UREF##1##72##], lipid peroxidation products (LPOs), and advanced glycation end products (AGEs) [##REF##15925388##6##, ##REF##30027653##66##, ##REF##9884160##74##–##REF##9029273##79##]. Several studies detail that specific PTMs correlate with exposures to excessive alcohol [##REF##21609791##80##, ##REF##15449375##81##], CCl<sub>4</sub> [##REF##16557555##7##, ##REF##26491845##56##], acetaminophen (APAP) [##REF##23454065##53##, ##REF##35513057##82##], 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) [##REF##21204248##39##], or fructose [##REF##30959577##51##]. In these cases, PTMs accumulate in cells and contribute significantly to fat accumulation [##REF##18778711##54##], hepatocyte apoptosis, inflammation, fibrosis [##REF##30959577##51##], and cirrhosis [##REF##36157540##37##], by altering signaling pathways affiliated with liver disease progression [##REF##28094767##43##, ##REF##30027653##66##, ##REF##20524971##67##] and by targeting proteins for ubiquitin-mediated proteolysis [##REF##19660437##59##]. Overall, PTMs are one of the various ROS-mediated changes that occur on cellular and translational levels [##REF##33032084##29##] to, directly and indirectly, contribute to alcohol-mediated hepatic injuries [##REF##35054960##12##, ##REF##17058263##83##, ##REF##28803762##84##]. The contributing roles of specific PTMs or simple consequences in the disease process can be elucidated by carefully studying their time-dependent events. The functional activities of a specific PTM on a few selected proteins should also be found in disease models to figure out their roles further. Based on the concept and approaches, precisely characterizing the roles of specifically targeted PTMs in designated subcellular organelles or tissues can provide valuable information to understand better the molecular mechanisms of liver diseases or even genetic- and aging-related disorders. For example, in various alcohol exposure models, an elevated intestinal activity or expression of the ethanol-inducible cytochrome P450-2E1 (CYP2E1) contributes to increased ROS/RNS [##REF##35054960##12##, ##REF##29679894##85##], promoting PTMs (e.g., nitration [##REF##25465468##26##, ##REF##30959577##51##, ##REF##21520201##52##, ##REF##19660437##59##, ##REF##22668639##68##, ##REF##29458168##86##]), which structurally alters the intestinal environment creating inflammation, gut tight junction (TJ) and adherens junction (AJ) protein degradation, apoptosis of enterocytes in the intestines [##REF##24064383##11##, ##REF##29458168##86##, ##REF##25462064##87##], systemic endotoxemia, and the progression of ALD  [##REF##30115921##88##, ##REF##19155080##89##].</p>", "<title>Mitochondrial dysfunction in liver diseases</title>", "<p id=\"Par67\">Mitochondria are critical sites of bioenergetics, fat oxidation, intermediary metabolism, apoptosis, mitophagy, and redox homeostasis [##REF##33060165##90##–##REF##32574708##93##]. They are one of the primary sources of oxidative stress involved in fatty liver diseases [##REF##37239997##94##]; α-ketoglutarate dehydrogenase and pyruvate dehydrogenase are involved in redox reactions to generate NADH and FADH<sub>2</sub> in the tricarboxylic acid (TCA) cycle [##REF##33276146##95##], then in the electron transport chain (ETC), complexes I, II, and III perform redox reactions to generate ATP [##REF##32156524##18##]. Thus, to balance out the ROS/RNS generated from these redox reactions, many mitochondrial antioxidants and enzymes exist.</p>", "<p id=\"Par68\">Mitochondrial antioxidant proteins in the first line of defense against ROS/RNS fall into three categories, including non-enzymatic antioxidants (i.e., GSH), direct enzymatic antioxidants (i.e., SOD2 and GPx), and indirect enzymatic antioxidants [i.e., glutathione reductases (GR), peroxiredoxins, and thioredoxins (Trx)] [##REF##30988244##96##, ##REF##32987701##97##]. The transcription of many of these antioxidants is either regulated by peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) [##REF##32215168##98##] or by nuclear factor erythroid 2-related factor (Nrf2) separating from its regulatory binding protein Kelch-like ECH-associated protein (Keap1) [##REF##28899199##99##, ##REF##32640524##100##]. Typically, in the second line of defense, mitochondria trigger mitophagy to restore redox homeostasis and retain the function of other mitochondria and organelles for cellular activities [##REF##30556744##101##]. However, these natural lines of defense in mitochondria can be altered after excessive consumption of or exposure to alcohol (ethanol) [##REF##29679894##85##, ##REF##37239997##94##], drugs [##REF##30027653##66##, ##REF##26461142##102##, ##REF##20420575##103##], viruses [##REF##20002299##104##], and some nutrients, including fructose [##REF##31830478##105##]. Specifically, these exposures can alter mitochondrial redox homeostasis and oxidatively damage DNA [##REF##28618992##106##, ##REF##33435522##107##], RNA [##REF##28618992##106##], lipids, and proteins, through PTMs [##REF##9282839##8##, ##REF##25465468##26##, ##REF##34890308##48##, ##REF##35577141##70##, ##REF##35359990##108##, ##REF##31906014##109##], causing inactivation of their functions and signaling pathways, leading to mitochondrial dysfunction [##REF##25465468##26##, ##REF##23454065##53##, ##REF##22668639##68##, ##REF##17058263##83##], death of hepatocytes, and liver damage [##REF##31571145##17##, ##REF##29867464##110##] or age-related conditions [##REF##30954429##91##, ##REF##32131138##111##–##REF##9714734##113##]. Not only can many types of PTMs accumulate in mitochondria [##REF##29679894##85##], but they can also downregulate the expression of or inactivate mitochondrial deacetylases like sirtuin 3 (SIRT3) [##REF##35902030##114##–##REF##25361925##117##], sirtuin 4 (SIRT4) [##REF##32365537##118##–##REF##36376267##121##], and sirtuin 5 (SIRT5) [##REF##9282839##8##, ##REF##34890308##48####REF##35359990##108##, ##REF##31906014##109##, ##REF##25361925##117##, ##REF##30662803##122##, ##REF##28285806##123##] in the context of ALD [##REF##18555008##124##, ##UREF##2##125##], MASLD [##REF##30959577##51##, ##REF##29331880##126##, ##REF##36615471##127##], and other conditions [##REF##27164052##128##]. Nucleus-localized sirtuin 1 (SIRT1) migrates to mitochondria to exert its effects [##UREF##2##125##] and is another prevalent target in the context of ALD [##UREF##2##125##, ##UREF##3##129##–##REF##28808418##133##] and MASLD [##REF##27732911##22##, ##REF##25361925##117##, ##REF##28808418##133##]. Other than sirtuin pathways, signaling pathways of PGC-1α [##REF##18793633##131##, ##REF##17704301##134##], AMPK [##REF##32029622##135##, ##REF##34592488##136##], as well as Bax and Bcl2 [##UREF##4##132##, ##REF##35369900##137##], are altered to cause mitochondrial dysfunction and apoptosis of hepatocytes in liver diseases [##REF##18793633##131##, ##UREF##4##132##, ##REF##17704301##134##–##REF##35369900##137##]. However, these proteins represent important targets for prevention and therapy [##REF##35879991##75##, ##REF##29679894##85##, ##REF##36615829##138##–##REF##36938442##140##]. Overall, mitochondrial conditions likely provide a more comprehensive picture of the molecular pathology of liver diseases [##REF##35879991##75##, ##REF##36615471##127##, ##REF##29753208##141##, ##REF##27956449##142##].</p>", "<title>Intestinal barrier dysfunction in liver diseases</title>", "<p id=\"Par69\">The gut, like many organs, has multiple barriers; the immunological barrier is composed of gut-associated lymphoid tissue, the physical barrier consists of epithelial TJ/AJ proteins and microbiota, and the chemical barrier is composed of antimicrobial proteins, IgA, and a mucus layer [##REF##33060124##143##]. Gut dysbiosis is a term to describe changes in the relative abundance of beneficial and pathogenic bacteria, where excessive Gram-negative bacteria may stick to and cause perforations in the gut barrier wall (intestinal permeability changes) and “leak” various toxic metabolites [e.g., bile acids, trimethylamine (TMA), and LPS, a cell wall component of Gram-negative bacteria] into systemic circulation [##REF##36552802##144##]. The atypical transmission of pathogenic gut bacteria and toxic metabolites (endotoxemia) acts to permeate the barriers of the liver through the portal vein, enterohepatic circulation, or bile acid secretions [##UREF##5##145##–##REF##29748586##147##]. Gut dysbiosis is inextricably linked to the exacerbation and progression of various liver diseases [##REF##35831502##148##–##REF##33071239##153##]. Altered microbiota compositions have been found in several clinical cases of ALD [##REF##29268595##154##, ##REF##29041989##155##], cirrhosis [##REF##21574172##156##–##REF##25079328##159##], MASLD [##REF##23055155##160##, ##REF##35565740##161##], viral hepatitis including Hepatitis B viral infections (HBV) [##REF##29180991##162##–##REF##28027582##165##] and Hepatitis C viral infections (HCV) [##REF##27625705##166##–##REF##28561276##168##], as well as hepatocellular carcinoma (HCC) [##REF##36943499##158##, ##REF##27496472##169##]. Furthermore, mechanistic animal studies on hepatic endotoxemia have shown it to be positively correlated with intestinal barrier dysfunction; elevated PTMs that disrupt TJ/AJ protein networks allow intestinal contents such as pathogenic bacteria and LPS to leak out into systemic circulation, characteristically manifesting in hepatic nitro-oxidative stress [##REF##22703178##170##–##REF##31382466##172##]. Endotoxemia is also affiliated with mitochondrial dysfunction [##REF##12480607##25##] and systemic inflammation [##REF##31382466##172##] in rodent models of ALD [##REF##24064383##11##, ##REF##29331880##126##, ##REF##29413959##151##, ##REF##34573017##173##] and MASLD [##REF##34960036##20##, ##REF##30959577##51##, ##REF##22668639##68##, ##REF##29413959##151##, ##REF##35736447##174##–##REF##22185839##178##]. Sometimes, the etiology of ALD and MASLD may even overlap; several reports detail several taxa that produce endogenous ethanol, as observed in experimental models [##REF##30959577##51##, ##REF##12016429##179##], adult patients with MASLD [##REF##23055155##160##], and even young children with metabolic dysfunction-associated steatohepatitis (MASH) [##REF##26006114##180##]. Some cases of ALD [##REF##29331880##126##] and MASLD [##REF##32059982##181##–##REF##35010976##183##] may even affect other peripheral organs via the intestinal route.</p>" ]
[]
[]
[]
[]
[ "<p id=\"Par1\">This review provides an update on recent findings from basic, translational, and clinical studies on the molecular mechanisms of mitochondrial dysfunction and apoptosis of hepatocytes in multiple liver diseases, including but not limited to alcohol-associated liver disease (ALD), metabolic dysfunction-associated steatotic liver disease (MASLD), and drug-induced liver injury (DILI). While the ethanol-inducible cytochrome P450-2E1 (CYP2E1) is mainly responsible for oxidizing binge alcohol via the microsomal ethanol oxidizing system, it is also responsible for metabolizing many xenobiotics, including pollutants, chemicals, drugs, and specific diets abundant in n-6 fatty acids, into toxic metabolites in many organs, including the liver, causing pathological insults through organelles such as mitochondria and endoplasmic reticula. Oxidative imbalances (oxidative stress) in mitochondria promote the covalent modifications of lipids, proteins, and nucleic acids through enzymatic and non-enzymatic mechanisms. Excessive changes stimulate various post-translational modifications (PTMs) of mitochondrial proteins, transcription factors, and histones. Increased PTMs of mitochondrial proteins inactivate many enzymes involved in the reduction of oxidative species, fatty acid metabolism, and mitophagy pathways, leading to mitochondrial dysfunction, energy depletion, and apoptosis. Unique from other organelles, mitochondria control many signaling cascades involved in bioenergetics (fat metabolism), inflammation, and apoptosis/necrosis of hepatocytes. When mitochondrial homeostasis is shifted, these pathways become altered or shut down, likely contributing to the death of hepatocytes with activation of inflammation and hepatic stellate cells, causing liver fibrosis and cirrhosis. This review will encapsulate how mitochondrial dysfunction contributes to hepatocyte apoptosis in several types of liver diseases in order to provide recommendations for targeted therapeutics.</p>", "<title>Keywords</title>" ]
[ "<title>The causal roles of oxidative stress, PTMs, mitochondrial dysfunction, and intestinal barrier dysfunction in promoting several chronic and acute liver diseases</title>", "<title>Alcohol-associated liver disease</title>", "<title>Alcohol-mediated oxidative stress and gut barrier dysfunction</title>", "<p id=\"Par70\">Alcohol is first absorbed in the small intestines, then transported to the liver and metabolized mainly by oxidative and non-oxidative metabolism [##REF##29104501##184##–##REF##33568752##186##]. The majority of alcohol is oxidized in the cytosol by aldehyde dehydrogenase (ADH), in peroxisomes by CAT, and in microsomes and mitochondria by CYP2E1 via the microsomal ethanol-oxidizing system (MEOS) before toxic acetaldehyde is further detoxified by mitochondrial aldehyde dehydrogenase 2 (ALDH2) [##REF##23101976##187##, ##REF##31206264##188##]. Liver diseases have been widely studied in the context of these enzymes that either oxidatively metabolize ethanol into toxic metabolites, or detoxify alcohol and are made less effective through genetic polymorphisms. It is known that oxidative damage from NAPDH-dependent CYP2E1 metabolism [##REF##34360999##189##] leads to toxicological damage in ALD [##REF##33711388##190##], causing events such as increased ROS production [##REF##33711388##190##], antioxidant downregulation, mitochondrial dysfunction [##REF##31203697##191##, ##REF##31836462##192##], suppressed fatty acid oxidation, oxidative DNA damage, and protein adduct formation via lipid peroxidation [i.e., acrolein, malondialdehyde (MDA), and 4-hydroxynonenal (4-HNE)] in the liver [##REF##28210688##193##]. In addition, another study showed a crucial role of CYP2E1 in alcohol-mediated oxidative DNA damage in the liver [##REF##15660387##194##].</p>", "<p id=\"Par71\">However, there is evidence that alcohol absorption along with oxidative and non-oxidative metabolism, occurs in the gut [##REF##23101976##187##, ##REF##28988570##195##]. Studies have found the expression of ADH 4 isoform [##REF##10677787##196##], CYP2E1 [##REF##25462064##87##], and ALDH2 in the intestines [##REF##25462064##87##], as well as inactivated ALDH2 [##REF##17673211##55##, ##REF##17058263##83##] and upregulated CYP2E1 [##REF##25462064##87##], acetaldehyde, and LPS [##REF##17673211##55##, ##REF##17058263##83##, ##REF##25462064##87##, ##REF##10677787##196##] in models of ALD. These changes indicate signs of oxidative ethanol metabolism that results in alcohol-induced oxidative stress and intestinal barrier dysfunction. Recently, it has been shown that protective ALDH2 is inactivated through PTMs such as oxidation [##REF##17673211##55##]  and <italic>S</italic>-nitrosylation in ALD [##REF##17673211##55##, ##REF##17058263##83##], nitration in APAP-mediated DILI [##REF##23454065##53##, ##REF##19660437##59##], phosphorylation in CCl<sub>4</sub>-mediated TAFLD [##REF##26491845##56##, ##REF##19922789##197##], oxidation in MDMA-induced TAFLD [##REF##18780394##198##], and lipid peroxidation products in ALD [##REF##16411662##199##]. Some believe that acetaldehyde independently causes alcohol-associated organ damage; one study displayed that it independently disrupted intestinal TJ and AJ protein networks, leading to endotoxemia and liver injury [##REF##25548474##9##]. Similar effects of acetaldehyde have been shown in models of chronic alcohol exposure in <italic>Aldh2</italic>-KO mice, resulting in ALD [##REF##26173414##200##]. Other studies conducted with binge alcohol-exposed <italic>Aldh2</italic>-KO mice suggest that acetaldehyde stimulates intestinal barrier dysfunction, leading to acute liver injury [##REF##36528936##10##].</p>", "<p id=\"Par72\">When ALDH2 activity is depleted in <italic>Aldh2</italic>-KO mice [##REF##15654606##201##], pro-oxidant CYP2E1 has been found to be upregulated in the intestines upon alcohol exposure [##REF##25462064##87##, ##REF##15654606##201##, ##REF##7802633##202##]. Intestinal CYP2E1-mediated oxidative stress can also sensitize the liver to toxicity through endotoxemia and gut-derived TNF-α through the CYP2E1-thioredoxin-ASK1-JNK1 pathway [##REF##22028977##203##]. The effects of intestinal CYP2E1 on gut barrier dysfunction and endotoxemia are worsened with concomitant LPS administration [##REF##24064383##11##]. Hepatic CYP2E1 is also another significant contributor to alcohol-induced oxidative stress and signaling pathway alterations [##REF##25548474##9##], as shown in multiple studies examining the effects of inhibiting or knocking out the <italic>Cyp2e1</italic> gene for [##REF##21525766##204##–##REF##19157621##206##]. For example, polyenyl phosphatidylcholine (PPC) effectively suppressed alcohol-mediated oxidative stress and then was found to be inhibiting CYP2E1 [##REF##15554233##40##, ##REF##10029208##207##]. In another study, transgenic over-expression of CYP2E1 in mice exacerbated the pathogenesis of ALD [##REF##19157621##206##, ##REF##12085356##208##] and MASLD [##REF##19307976##209##, ##REF##20594230##210##]. Perhaps reversing the expression and activities of CYP2E1 and ALDH2 may serve a purpose in protecting against alcohol-induced hepato-intestinal oxidative stress and gut barrier dysfunction. For example, a translational study showed that ALDH2 suppression was protected by physiologically relevant levels of omega-3 polyunsaturated fatty acids [##REF##20420575##103##, ##REF##18571270##211##], and in a recent phase II clinical trial, treatment with clomethiazole (CMZ), an inhibitor of CYP2E1, mitigated the biomarkers of alcohol-induced oxidative stress and ALD progression [##REF##36562601##212##].</p>", "<title>Alcohol-mediated oxidative stress and mitochondrial dysfunction in the fatty liver</title>", "<p id=\"Par73\">Alcohol-mediated steatosis (or fat accumulation) can be induced by activating de novo fat synthesis, blocking fat degradation pathways, or increasing the transport of lipids from other tissues [##REF##33711388##190##]. On a molecular level, this may also occur through mitochondrial dysfunction associated with decreased fat degradation due to PTM-mediated suppression of the enzymes in β-oxidation [##REF##20420575##103##, ##REF##18571270##211##], upregulated immune cell infiltrations, protein adducts, lipid peroxidatifon, and DNA damage [##REF##33711388##190##].Alcohol-mediated ROS and RNS can also downregulate β-oxidation activity by inhibiting peroxisome proliferator-activated receptor-α (PPAR-α) and a lipid catabolism regulator named AMP-activated protein kinase (AMPK) [##REF##25548474##9##, ##REF##29637855##213##] while upregulating sterol regulatory binding protein-1 (SREBP-1) to increase hepatic fatty acid and cholesterol biosynthesis [##REF##25548474##9##, ##REF##29637855##213##]. Furthermore, chronic and binge alcohol models show increased lipid transport to the liver, contributing to fat accumulation in hepatocytes [##REF##19032584##214##, ##REF##34558087##215##]. A study from Ceni et al. theorizes that in cases of ALD, steatosis may happen epigenetically by targeting forkhead box (FoxO3a) and SIRT1, which serve as intermediaries between autophagy and transcriptional lipid metabolism regulation [##REF##25548474##9##].</p>", "<title>The vicious cycle of oxidative stress and inflammation in promoting fibrosis</title>", "<p id=\"Par74\">Oxidative stress and inflammation reciprocally communicate in a positive feedback loop to stimulate fibrosis. The accumulation of ROS and LPOs promotes hepatocyte apoptosis/necrosis, which activates hepatic stellate cells (HSCs) [##REF##33711388##190##]. In an attempt to heal this “wound,” HSCs may promote fibrosis and cirrhosis in an inflammatory signaling response [##REF##33711388##190##]. The ROS-mediated activation of HSCs can be seen through the accumulation of α-smooth muscle actin (α-SMA), vimentin (VIM), and collagen in the extracellular matrices of hepatocytes [##REF##25548474##9##, ##REF##31203697##191##, ##REF##31836462##192##]. Fibrosis may also be stimulated by upregulating the MDA/4-HNE pathway; this pathway will, in turn, upregulate pro-fibrogenic matrix metalloproteinase-2 (MMP2) and downregulate matrix metalloproteinase-1 (MMP1), two enzymes responsible for remodeling the hepatic extracellular matrix [##REF##25548474##9##, ##REF##31203697##191##, ##REF##31836462##192##, ##REF##29234202##216##]. Another method of alcohol-induced ROS-mediated liver fibrosis happens when acetaldehyde and other reactive aldehydes upregulate the expression of fibrogenic transforming-growth-factor-β (TGF-β). This stimulates the production of collagen and α-SMA and decreases interferon-γ signaling in HSCs to cause fibrosis [##REF##25548474##9##]. Other PTMs, such as acetylation and methylation, have been known to contribute to the progression of fibrosis in ALD [##UREF##1##72##, ##REF##28988570##195##, ##REF##8675177##217##, ##REF##29774570##218##]. This accumulated inflammation is worsened by increased intestinal barrier dysfunction [##REF##36552802##144##, ##REF##29083504##219##]. The likely-resulting endotoxemia from intestinal barrier dysfunction stimulates toll-like receptor 4 (TLR4) in Kupffer cells to produce NADPH-oxidase (NOX)-dependent ROS [##REF##29637855##213##] and activate HSCs, leading to fibrosis [##REF##36552802##144##, ##REF##29083504##219##]. Additionally, the efforts of Nrf2 and its downstream antioxidant enzymes and proteins may be exhausted or suppressed, leading to lowered antioxidant levels, in the progression of liver injury to hepatitis and fibrosis [##REF##25278702##220##].</p>", "<title>Metabolic dysfunction-associated steatotic liver disease</title>", "<p id=\"Par75\">MASLD is closely affiliated with obesity [##REF##26707365##221##, ##REF##7382552##222##], type-2 diabetes mellitus (T2DM) [##REF##26707365##221##, ##REF##7382552##222##], hypertension [##REF##26707365##221##], and metabolic syndrome [##REF##26707365##221##]. MASLD may be further specified as TAFLD. However, it should be noted that the overall mechanism of MASLD shares many commonalities with that of ALD. In MASLD and ALD, dysregulated lipid metabolism contributes to lipotoxicity and peroxidation [##REF##31821039##223##], leading to ER stress, mitochondrial dysfunction, and hepatocyte damage. These alterations activate HSCs, leading to inflammation and fibrogenesis [##REF##28210688##193##, ##REF##31821039##223##–##REF##19387919##225##]. Liver insults begin with the phase of steatosis; mitochondrial respiration increases to meet the increased need for energy. As a result, ROS production increases, activating antioxidant responses [##REF##33276146##95##, ##REF##17680645##226##, ##REF##16505490##227##]. Lipid accumulation will develop due to the excess of free fatty acids (FFAs) [##REF##31821039##223##], compromising mitophagy responses through the activation of JNK-dependent apoptosis [##REF##33276146##95##, ##REF##17680645##226##, ##REF##16505490##227##]. In the next stage of MASH, inflammation and oxidative stress occur in a vicious, positive feedback loop [##REF##33406763##228##], triggering apoptosis of hepatocytes [##REF##16505490##227##], and potentially compromising cellular respiration, mitophagy, and antioxidant pathways. Fibrosis is initiated when increased inflammation, oxidative stress, and hepatocyte apoptosis cumulatively stimulate Kupffer cells and HSCs, as well as neutrophil infiltration, to repair the “wounds” [##REF##33276146##95##, ##REF##24298175##229##].</p>", "<p id=\"Par76\">Despite this common pathology of ALD and MASLD, the Multiple-Hit Hypothesis remains a phenomenon more studied in the context of MASH/MASLD. The Multiple-Hit Hypothesis details increased fat accumulation to be the “first hit” [##REF##9547102##230##]. According to Day and James, oxidative stress follows steatosis as the “second hit” [##REF##9547102##230##]. MASLD has many manifestations of metabolic syndrome, from as little as lipid droplets to total systemic inflammation seen in MASH, with the possibility of progression to fibrosis and HCC. Other factors, such as inflammation, altered hepatocyte apoptosis signaling, and activation of HSCs, allow milder cases of MASLD to progress to more severe cases, including MASH [##REF##30682878##14##]. More reports mention the  Three-Hit Hypothesis, involving dysregulated lipid metabolism, mitochondrial dysfunction with decreased fat degradation, and oxidative stress that happens in cycles in the progression of MASLD cases [##REF##34050922##231##, ##REF##28303724##232##]. Additional theories on the Multiple-Hit Hypothesis of MASLD detail the role of lipid and sugar metabolism, gut barrier dysfunction, and systemic inflammation as common factors in metabolic syndrome [##REF##26823198##233##]</p>", "<p id=\"Par77\">MASLD/MASH, caused by non-alcohol substances, such as fructose/sucrose and Western-style high-fat diets (HFDs) (containing high ratios of pro-inflammatory omega-6 fatty acids to anti-inflammatory omega-3 fatty acids), is a hepatic manifestation of metabolic syndrome [##REF##34328248##234##]. Similar to ALD, increased de novo fat synthesis and fat transport from adipose tissue with decreased mitochondrial fat degradation are usually observed in MASLD [##REF##30343320##235##]. Increased oxidative stress and nitrative stress also significantly contribute to the progression of MASLD/MASH. Oxidative stress may happen partly through the involvement of translocation and activation of mitochondrial NOX4 [##REF##30343320##235##], CYP2E1-generated ROS [##REF##22668639##68##, ##REF##20594230##210##, ##REF##21401612##236##], HFD-mediated insulin resistance [##REF##27732911##22##], and various PTMs of mitochondrial proteins, causing mitochondrial dysfunction, decreased fat degradation, and elevated hepatocyte death [##REF##23691267##49##].</p>", "<title>The effect of fat metabolism dysregulation on oxidative stress</title>", "<p id=\"Par78\">Elevated FFAs can be more hepatotoxic than TG accumulation since FFAs can cause JNK-mediated hepatocyte apoptosis [##REF##16505490##227##] and the production of a cytokine storm in the progression of MASLD and MASH [##REF##17680645##226##]. In addition, an increased FFA pool may lead to oxidative stress in cells, altering apoptosis and causing NF-κB-related inflammatory pathways that induce cytokine production and activate HSCs [##REF##30343320##235##]. The specific mechanism of FFA and ROS-related apoptosis of hepatocytes involves the regulation of the mitochondria by Bcl-2 and Bax. For instance, when NOX4 and CYP2E1 oxidize substrates like long-chain FFAs, uncoupled electrons leak from the mitochondrial ETC [##REF##22668639##68##]. When FFAs are oxidized in peroxisomes and the ER, oxidative stress accumulates and activates the Bax/Bcl-2 complex through FoxOa3 and JNK [##REF##34065331##237##]. Bax, when released from Bcl-2, will induce a mitochondrial permeability transition (MPT) in response to this oxidative stress [##REF##11812920##238##], which will trigger cytochrome c to be released from mitochondria, activating caspase-mediated apoptosis [##REF##30343320##235##]. Alternatively, activated JNK can stimulate the phosphorylation of Bax, leading to its translocation to mitochondria to cause mitochondrial permeability changes and hepatocyte apoptosis [##REF##16709574##239##].</p>", "<p id=\"Par79\">Besides the accumulation of FFAs and LPOs, cholesterol (dys)regulation significantly affects the onset and progression of MASLD. One study suggests that the cholesterol-to-bile acid ratio is vital to supporting the homeostatic redox environment of HSCs [##REF##35326188##240##]. One report showed that cholesterol could be a selective inducer of oxidative stress and mitigate fibrosis by inducing HSC apoptosis [##REF##35326188##240##]. A recent genetic study suggested that having a good cholesterol index (i.e., more high-density lipoprotein (HDL) cholesterol and less low-density lipoprotein (LDL) cholesterol) could significantly prevent FLD because HDLs allow LDLs and other fats to be filtered through the liver and excreted rather than accumulating in blood vessels and tissues [##UREF##8##241##].</p>", "<title>The effect of insulinemia on fat metabolism and inflammation</title>", "<p id=\"Par80\">Insulin resistance/insulinemia, genetics, and metabolic syndrome account for most cases of MASLD [##REF##34050922##231##, ##REF##30343320##235##]. Insulinemia has been shown to serve as a cause of FFA accumulation [##REF##33681089##242##]. Mainly, most FFAs in hepatocytes are found in the FFA pool in the liver and transported after lipolysis from other tissues [##REF##33681089##242##]. Insulin typically signals lipolysis of triglycerides (TGs) into FFAs. However, in cases of insulinemia, adipose cells are in constant lipolysis, causing excess FFAs to travel to the liver and lead to fat accumulation [##REF##32156524##18##, ##REF##30343320##235##].</p>", "<p id=\"Par81\">Other studies have detailed an interaction between the NF-κB pathway and insulin resistance to MASLD [##REF##33530432##19##]. Many therapeutic effects against MASLD related to oxidative stress and lipid peroxidation have been explored through this pathway, including normalizing mitochondrial function with proper mitochondrial β-oxidation and ATP synthesis [##REF##33530432##19##]. Inhibiting the redox-sensitive transcription factor NF-κB is also an essential therapy targeting inflammation in MASLD to prevent the progression to worse disease stages such as MASH [##REF##33530432##19##].</p>", "<title>The effect of oxidative stress on fat metabolism and inflammation</title>", "<p id=\"Par82\">Recent reviews suggest that increased oxidative stress may cause de novo lipogenesis through upregulation of SREBP-1 and mitochondrial dysfunction in MASLD [##REF##32920226##24##, ##REF##33406763##228##]. In MASH, ROS primarily come from mitochondrial electron leakage, pro-oxidative enzyme activation (i.e., CYP2E1, NOX4), iron accumulation and Fenton reaction metabolism [##REF##32156524##18##, ##REF##22124850##243##], and antioxidant depletion [##REF##30343320##235##]. While it is well documented that CYP2E1 contributes to oxidative stress pathways in ALD and DILI, many reports have also demonstrated the critical role of CYP2E1 in MASLD through the production of ROS and LPOs; this may represent the second hit in the progression of steatosis to MASH [##REF##25465468##26##, ##REF##26278393##41##, ##REF##22668639##68##, ##REF##22185839##178##, ##REF##28051126##244##]. Thus, this oxidative and lipotoxic stress must be balanced out with the help of various antioxidants.</p>", "<p id=\"Par83\">The Nrf2/ARE pathway is a crucial prevention for MASLD because it counteracts oxidative stress and corrects lipid metabolism [##REF##33530432##19##]. Under physiological states, Nrf2, a transcription factor, is usually bound to Keap1. Under oxidative stress conditions, ROS oxidizes Keap1, which is degraded by ubiquitin-dependent degradation and releases Nrf2. When Nrf2 is released, it travels to the nucleus to bind antioxidant response elements (ARE). Activation of the Nrf2/ARE pathway upregulates the transcription of several antioxidant enzymes, including HO-1, NADPH-dependent quinone reductase, and GSH synthesis enzymes like GR and glutamate-cysteine ligase modifier subunit (GCLM) [##REF##35513409##5##].</p>", "<p id=\"Par84\">Many antioxidants have been known to target MASLD, including vitamins E and C in MASLD patients, caffeine and coffee polyphenols in murine models of Western-style HFDs [##REF##30682878##14##]. Other studies detail the use of metformin and Hesperetin in rat hepatocytes and HepG2 cells, and caffeine in zebrafish [##REF##30682878##14##]. Mitochondria-targeting synthetic and naturally-occurring antioxidants like melatonin have an immense potential to treat or prevent MASLD [##REF##31571145##17##].</p>", "<title>Role of intestinal barrier dysfunction in MASLD</title>", "<p id=\"Par85\">Earlier reports showed that intestinal barrier dysfunction plays a causal role in MASLD [##REF##23055155##160##, ##REF##11054393##245##–##REF##28049662##248##]. In our opinion, intestinal barrier dysfunction in MASLD is caused by increased oxidative stress, which can cause apoptosis of gut epithelial cells (enterocytes), and PTMs of intestinal TJ/AJ proteins that lead to their decrements via ubiquitin-dependent proteolytic degradation [##REF##29458168##86##]. WT mice exposed to a Western-style HFD (containing cholesterol to represent a fast food diet) showed elevated serum LPS within 2 weeks of feeding, indicating gut barrier dysfunction; insulin resistance, hepatic inflammation, and fibrosis followed at 10 and 22 weeks of feeding, suggesting a causal role of gut barrier dysfunction in the progression of liver disease [##REF##28051126##244##]. [CYP2E1 levels may have been induced by endogenous ethanol production by gut microbiota [##REF##26006114##180##, ##REF##26984853##249##]. Although the cell death mechanisms of gut enterocytes in these rodent models of MASLD/MASH were not described, mitochondrial dysfunction may have happened due to elevated oxidative PTMs and Bax-mediated apoptosis. Thus, CYP2E1 may be an essential target to mitigate gut barrier dysfunction in MASLD/MASH [##REF##26278393##41##, ##REF##28303724##232##]. However, NADPH-oxidase may not be as important as CYP2E1 in the development of intestinal barrier dysfunction in MASH, as done in one study using a methionine and choline-deficient diet (MCD) [##REF##17157947##250##].</p>", "<title>Toxicant-associated fatty liver disease</title>", "<title>Carbon tetrachloride</title>", "<p id=\"Par86\">Carbon tetrachloride (CCl<sub>4</sub>) has been widely used as a hepatotoxic agent in experimental models. Since 1924, scientists have understood that CCl<sub>4</sub> causes acute hepatotoxicity, fatty liver, and liver fibrosis, depending on the dosage and treatment duration. In the last hundred years, scientists have understood this mechanism to include lipid peroxidation, hepatotoxicity, and liver damage through CYP2E1-mediated metabolism into toxic trichloromethyl and trichloromethyl peroxyl radicals; these toxic metabolites cause oxidative damage in the mitochondria and ER [##REF##32970608##78##]. CCl<sub>4</sub>-mediated hepatotoxicity is exacerbated by a Western-style HFD [##REF##19972622##251##] and alcohol consumption [##REF##3193297##252##], which both happen to elevate CYP2E1 levels. Previous animal studies also found that <italic>Cyp2e1</italic>-KO mice were relatively resistant to CCl<sub>4</sub>-mediated hepatotoxicity [##REF##34360999##189##, ##REF##9875305##253##].</p>", "<p id=\"Par87\">Despite many reports, the molecular mechanisms of CCl<sub>4</sub>-mediated hepatotoxicity and acute liver injury could be further elucidated. A recent report detailed the time-dependent events of PTMs and hepatotoxicity in WT versus <italic>Cyp2e1</italic>-KO mice [##REF##26491845##56##]. The results showed that JNK-mediated phosphorylation of many mitochondrial proteins occurred 1–8 h in WT mice after CCl<sub>4</sub> treatment [##REF##26491845##56##]. At the same time, acute hepatotoxicity, assessed by serum ALT activity, LPO levels, and H&amp;E-stained liver histology, was observed 24 hours after IP injection of a single toxic dose (50 mg/kg) of CCl<sub>4</sub> [##REF##26491845##56##]. In this model, activated p-JNK translocated to mitochondria at 2 h and phosphorylated many mitochondrial proteins, such as ALDH2, ubiquinone-dependent NADH dehydrogenase (Complex I), and α-ketoglutarate dehydrogenase, decreasing their activities [##REF##26491845##56##]. These changes in protein phosphorylation, decreased activities, and liver injury were markedly prevented when CCl<sub>4</sub>-exposed WT mice were co-treated with a highly selective JNK inhibitor (i.e., SU3327 or BI-78D3) and mitochondria-targeted Mito-TEMPO [##REF##26491845##56##]. This model also demonstrated that <italic>Cyp2e1</italic>-KO mice were protected from CCl<sub>4</sub>-mediated cellular changes, JNK-mediated phosphorylation, mitochondrial dysfunction, and liver injury [##REF##26491845##56##]. Thus, CYP2E1-mediated metabolic activation of CCl<sub>4</sub> was shown to play a significant role in ROS production, and JNK-mediated PTMs in promoting mitochondrial dysfunction and acute liver injury. In fact, increased oxidative stress stimulated the activation of JNK, which translocated to mitochondria and phosphorylated many target proteins ( decreasing their activities), leading to hepatotoxicity at a later time point. These results support the causal role of PTMs in promoting mitochondrial dysfunction and the characteristic hepatotoxicity of TAFLD.</p>", "<title>Thioacetamide</title>", "<p id=\"Par88\">Thioacetamide (TAA) was developed as an anti-fungal agent. However, TAA exposure has caused acute liver injury, cirrhosis, and HCC, in experimental models [##REF##35337166##254##–##REF##32512829##257##] and humans [##REF##32512829##257##], depending on the dosage and TAA exposure duration [##REF##36411771##255##, ##REF##28813612##258##]. TAA-mediated hepatotoxicity and other tissue damage, including renal and cardiac toxicity, are believed to be induced through CYP2E1-mediated TAA metabolism in mammals. In fact, <italic>Cyp2e1</italic>-KO mice were protected from TAA-mediated hepatotoxicity and HCC [##REF##18374380##259##]. A recent report showed that TAA-mediated hepatocyte pyroptosis in mice can be attenuated by administration of an anaerobic bacterial species named <italic>Parabacteroides distasonis</italic> by modulating intestinal bile acid metabolism [##REF##37005411##260##]. In this report, decreased levels of <italic>Parabacteroides distasonis</italic> were observed in people with hepatic fibrosis. Administration of this bacteria inhibited bile salt hydrolase and suppressed intestinal expression of Farnesoid X receptor (FXR) and its signaling [##REF##30617157##261##]. It also reduced hepatic levels of a component of bile acid named taurochenodeoxycholic acid (TCDCA), which typically induces mitochondrial permeability transitions and caspase-11-dependent pyroptosis; therefore, reduction of TCDCA mitigated TAA-mediated liver fibrosis in mice [##REF##30617157##261##]. Additionally, co-administration of the natural compound celastrol increased the relative abundance of <italic>Parabacteroides distasonis,</italic> promoting bile acid excretion and hepatic fibrosis attenuation. Celastrol was also shown to increase SIRT1 expression and FXR signaling to improve cholestatic liver disease [##REF##30617157##261##]. These results suggest the beneficial effects of <italic>Parabacteroides distasonis</italic> and celastrol against liver disease and suggest crosstalk between the gut microbiota and liver disease. Based on these results, more studies detailing gut–liver interactions are needed to improve liver disease prognosis.</p>", "<title>Drug-induced liver injuries</title>", "<p id=\"Par89\">Drug-induced liver injuries (DILI) account for 50% of all acute liver diseases. Of this 50%, 37% of DILI are associated with acetaminophen (APAP, paracetamol) and the other 13% are caused by isoniazid (isonicotinic acid hydrazide, INAH), TAA, erythromycin, diclofenac, and others [##REF##31702487##262##]. DILI cases fall into two major categories: intrinsic/direct hepatotoxicity or idiosyncratic hepatotoxicity, with a third emerging category being indirect mechanisms of hepatotoxicity (that may include gut dysbiosis) [##REF##31307588##263##]. The most common cause of intrinsic DILI is APAP overdose mechanistically through mitochondrial dysfunction and hepatocyte damage [##REF##27861792##4##], and the severity of idiosyncratic DILI varies based on the geographical region of prevalence [##REF##22733303##264##] and environmental factors such as alcohol consumption and other pathological conditions, including obesity, insulin resistance, and (pre)diabetes. For example, the leading cause (45.4% according to the American DILI Network) of idiosyncratic DILI cases in the US and UK were due to antibiotic use, followed by herbal and dietary supplements, whereas, in Korea, herbal and dietary supplements were the cause of 70% of idiosyncratic DILI cases [##REF##27956449##142##, ##REF##22733303##264##]. The National Institutes of Health (NIH) supplies a database named LiverTox (<ext-link ext-link-type=\"uri\" xlink:href=\"http://livertox.nih.gov\">http://livertox.nih.gov</ext-link>) that one meta-analysis [##REF##26517184##265##] grouped into categories based on types of hepatotoxicity and should provide more detailed information on idiosyncratic cases. However, this review will focus on a few models illustrating the mechanisms of intrinsic cases of DILI.</p>", "<title>Over-the-counter pain medicines: acetaminophen</title>", "<p id=\"Par90\">APAP, the active ingredient found in Tylenol, Panamax, Excedrin, and Panadol, is generally prescribed and available as an over-the-counter medicine to treat pain, fever, and inflammation by reducing the production of prostaglandins. However, APAP overdose is the leading cause of acute liver diseases in the UK and USA [##REF##31702487##262##, ##REF##18570942##266##] and is responsible for 50% of acute DILI in the USA [##REF##34232786##267##]. A multitude of investigations have elucidated the critical role of oxidative stress, mitochondrial dysfunction, and hepatocyte death in the mechanism of APAP overdose-induced liver diseases [##REF##29867464##110##, ##REF##34232786##267##–##REF##27744120##270##]. In normal doses, APAP toxicity is not observed because its toxic metabolites are neutralized by GSH. However, after fasting (which decreases GSH), large amounts of APAP rapidly deplete cellular GSH, leading to acute liver injury [##REF##29867464##110##, ##REF##29054140##268##, ##REF##30849782##269##]. In one mechanism, APAP becomes hepatotoxic after its metabolism by CYP2E1 and other P450 isoforms, and produces a reactive metabolite named <italic>N</italic>-acetyl-<italic>p</italic>-benzoquinone imine (NAPQI) [##REF##29867464##110##, ##REF##29632419##271##, ##REF##33042525##272##]. This reactive metabolite produces conjugation adducts for many cellular proteins, including those involved in the mitochondrial ETC and others [##REF##29867464##110##, ##REF##29054140##268##, ##REF##30849782##269##]. These protein-adducts, in turn, create mitochondrial nitro-oxidative stress, likely promoting PTMs of mitochondrial proteins [##REF##25465468##26##, ##REF##26278393##41##, ##REF##22668639##68##, ##REF##22185839##178##, ##REF##28051126##244##], leading to impaired mitochondrial function and energy production. However, the roles of NAPQI-related covalent protein adducts have been challenged with evidence of similar patterns of protein-adducts observed in studies with a non-hepatotoxic structural analog named 3’-hydroxyacetanilide [##REF##25465468##26##, ##REF##26278393##41##, ##REF##22668639##68##, ##REF##22185839##178##, ##REF##28051126##244##, ##REF##9020405##273##]. In one study, pretreatment with gadolinium chloride, a suppressor of Kupffer cells, significantly prevented APAP-mediated liver injury but not NAPQI-protein adducts, suggesting a noncritical role of NAPQI-protein adducts in APAP-related hepatotoxicity [##REF##10385655##274##]. Thus, scientists have explored the role of various PTMs in APAP-mediated acute hepatotoxicity. APAP can trigger a mitogen-activated protein kinase (MAPK) cascade [##REF##30849782##269##], ultimately activating c-Jun N-terminal kinase (JNK) phosphorylation [##REF##34232786##267##, ##REF##29054140##268##, ##REF##29632419##271##]. Phosphorylated JNK travels into the mitochondria to further phosphorylate many mitochondrial proteins, including the mitochondrial ETC, causing even more ROS leakage and oxidative stress by binding to SH3 homology associated BTK binding protein (Sab) [##REF##29867464##110##, ##REF##34331779##275##]. This excessive buildup of ROS causes a mitochondrial permeability change and the release of mitochondrial proteins that induce DNA damage and activate hepatocyte apoptosis [##REF##30849782##269##, ##REF##31307587##276##]. Ultimately, this process also impairs the autophagosome, leading to defective mitophagy [##REF##29867464##110##] and receptor interacting protein (RIP) kinase-mediated necrosis of the cell [##REF##29867464##110##, ##REF##29054140##268##, ##REF##30849782##269##, ##REF##16831600##277##–##REF##18337250##279##].</p>", "<p id=\"Par91\">In addition to JNK-mediated protein phosphorylation, the essential roles of nitrated proteins in mitochondria and cytosol were reported [##REF##23454065##53##, ##REF##19660437##59##]. In these studies, time-dependent events of protein nitration and necrotic cell death were compared after a single toxic dose (350–400 mg/kg) of APAP was administered to WT and <italic>Cyp2e1</italic>-KO mice. Nitrated cytosolic and mitochondrial proteins were observed around 2–4 h, and hepatocyte necrosis and elevated serum ALT levels were noticed 24 hours after APAP exposure in WT mice. Mitochondrial ALDH2, ATP synthetase, GPx, 3-ketoacyl-CoA thiolase (KAT), SOD2, and cytosolic SOD1 were nitrated, and their activities were suppressed at 2–4 hours, suggesting a causal role of protein nitration in promoting mitochondrial dysfunction, leading to apoptosis or necrosis of hepatocytes. Additionally, the non-toxic analog 3’-hydroxyacetanilide did not cause nitration and liver injury in WT mice. In contrast, protein nitration and hepatotoxicity were not seen in the corresponding <italic>Cyp2e1</italic>-KO mice, supporting the vital roles of CYP2E1 and nitration in APAP-mediated DILI [##REF##23454065##53##, ##REF##19660437##59##]. Recent studies suggest that boosting antioxidants in the mitochondria through mitoquinone [##REF##36894071##280##] and others [##REF##27744120##270##] may serve as effective treatments for APAP-induced DILI.</p>", "<p id=\"Par92\">It is also known that APAP toxicity is enhanced by co-existing conditions such as obesity and MASLD [##REF##36713231##281##] and is often potentiated by alcohol intake [##REF##7382090##282##–##REF##10759684##285##]. APAP toxicity is also observed in people with alcohol use disorder (AUD), possibly due to upregulated CYP2E1 activity [##REF##7382090##282##, ##REF##3511825##286##, ##REF##9329933##287##] or a response to fasting [##REF##7990219##288##] (which is known to decrease GSH levels and increase CYP2E1 [##REF##7802633##202##]). Thus, co-administration of excessive alcohol and therapeutic doses of APAP may put individuals at risk of severe liver injury [##REF##33306215##289##].</p>", "<title>Misused substances: cocaine, amphetamines, and MDMA</title>", "<p id=\"Par93\">It has been well-established that many misused substances such as pain-relieving drugs, mood-enhancing drugs, and recreational psychostimulants such as cocaine, amphetamines, and 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy, Molly) are known to cause significant toxicity to the liver as well as many other organs [##REF##24090944##290##]. Cocaine toxicity is mediated by its oxidative metabolism by P450 isozymes, including CYP2B, CYP3a, and CYP2E1. Reactive metabolites of cocaine (i.e., norcocaine and norcocaine nitric oxide) and increased ROS produced during P450-mediated catalysis are known to increase oxidative stress, leading to mitochondrial dysfunction, hepatocyte death, and liver injury [##REF##22856658##77##, ##REF##22856659##291##]. Hepatotoxicity due to cocaine has been significantly worsened in the presence of other agents such as endotoxin [##REF##12933325##292##] and alcohol; co-administration of cocaine and ethanol produces potently toxic cocaethylene [##REF##1440602##293##] and suppresses mitochondrial ALDH2 activity through PTMs [##REF##19446252##294##]. Although the detailed cell death signaling mechanisms are unknown, one recent report showed that cocaine toxicity was attenuated in p53-knockout (p53-KO) mice, suggesting the involvement of the p53-mediated apoptosis pathway [##REF##30576773##295##]. A recent study showed that cocaine caused mitochondrial dysfunction and acute liver injury in WT mice, and hepatotoxicity was prominently observed in <italic>Gpx-1</italic>-KO mice but protected in Gpx1-overexpressing transgenic mice [##REF##30027653##66##]. Based on the importance of PTMs in mitochondrial dysfunction and hepatocyte cell death in DILI, ALD, and MASLD models, the contributing roles of various PTMs in cocaine-mediated mitochondrial dysfunction and hepatotoxicity are expected, although this needs to be verified by future research.</p>", "<p id=\"Par94\">Overdoses of amphetamine-type psychostimulants like amphetamines and MDMA can cause hyperthermia, tissue injury, acute liver failure, and death, depending on their dosage and host conditions (e.g., hepatic GSH levels). MDMA toxicity is thought to occur through the P450-mediated production of its reactive metabolites, which can activate lysosomal functionand increase mitochondrial swelling and dysfunction [##REF##20420575##103##, ##REF##20420570##296##]. Other risk factors, such as hyperthermia,elevated neurotransmitter effluxes, increased LPOs, oxidized biogenic amines, decreased GSH, and dysregulated host environments, have also been suggested [##REF##20420575##103##]. Although the detailed mechanisms of tissue injury are poorly understood, it is widely accepted that increased oxidative stress and nitrative stress play a key role in promoting MDMA-mediated hepatotoxicity. Targeted proteomics approaches revealed that many mitochondrial and cytosolic proteins were oxidatively modified upon exposure to MDMA, and some of them, like mitochondrial ALDH2, 3-ketoacyl-CoA, and ATP synthetase, were inactivated [##REF##18780394##198##]. These reports support the role of oxidatively modified cellular proteins in promoting mitochondrial dysfunction and ER stress, contributing to cell death of hepatocytes and liver injury [##REF##23691267##49##, ##REF##20420570##296##, ##REF##31462520##297##]. Other types of PTMs, such as nitration, JNK-mediated phosphorylation, and acetylation, of proteins, can also take part in the pathology of MDMA-mediated tissue injury, although this area solicits further investigation.</p>", "<title>Anti-cancer agents: cisplatin</title>", "<p id=\"Par95\">Many chemotherapies have been found to cause hepatotoxicity as well as other tissues. Antitumor antibiotics (e.g., dactinomycin, doxorubicin, and mitomycin) and alkylating agents (e.g., Busulfan, Melphalan, and Cyclophosphamide) have been shown to elevate serum ALT and AST activities in liver function tests [##REF##34354855##298##]. Platinum-based agents (e.g., Oxaliplatin, Cisplatin, and Carboplatin) have also been shown to elevate serum levels of liver transaminases to cause steatohepatitis [##REF##34354855##298##]. Cisplatin is a platinum-based chemotherapy drug that was approved by the FDA in 1978 despite its harsh side effects of inducing organ damage (including the liver and kidneys) [##REF##34653753##299##], through oxidative metabolism via CYP2E1 and CYP4A11 [##REF##28612092##300##]. Since then, the effects of cisplatin have been studied and reviewed; cisplatin induces oxidative stress [##REF##33849559##301##–##REF##16251482##303##], inflammation [##REF##34653753##299##, ##REF##33849559##301##, ##REF##34064100##304##], mitochondrial dysfunction [##REF##34064100##304##], apoptosis [##REF##35367536##305##], and DNA damage [##REF##34653753##299##, ##REF##34064100##304##, ##REF##31911150##306##]. Cisplatin causes oxidative stress by increasing MDA and decreasing GSH, GPx, CAT, and SOD [##REF##33945910##307##]. Cisplatin also stimulates apoptotic signaling pathways involving TNF-α, Bax and Bcl-2, cytochrome c, and caspase-3, and stimulates IL-6 related inflammatory pathways [##REF##33945910##307##].</p>", "<p id=\"Par96\">There are also theories on how cisplatin-induced hepatotoxicity happens through the gut–liver axis. One study mentioned that cisplatin-induced liver toxicity is accelerated by inflammation and oxidative stress in the gut through the increased abundance of pathological bacteria like <italic>Escherichia, Parabacteroides,</italic> and <italic>Ruminococcus</italic>, all of which are Gram-negative bacteria [##REF##33849559##301##]. In this study, antibiotic treatment improved liver histology, promoted Nrf2 activation, increased the levels of GSH, and inhibited the JNK- and p38-related cell death signaling pathways [##REF##33849559##301##, ##REF##30031043##308##], demonstrating its significance as an effective treatment for cisplatin-mediated hepatotoxicity.</p>", "<title>Anti-tuberculosis agent: isoniazid</title>", "<p id=\"Par97\">It is known that an anti-tuberculosis agent, isoniazid (isonicotinic acid hydrazide, INAH), can cause hepatitis through CYP2E1-mediated metabolism [##REF##25755470##309##]<bold>.</bold> INAH or INAH metabolites, such as hydrazine, can cause mitochondrial injury, mitochondrial oxidative stress, and impaired metabolic homeostasis [##REF##24783247##310##]. Consequently, these reactive metabolites and ROS will likely promote oxidative PTMs, lipid peroxidation, and cell death pathways. In addition, these reactive metabolites can bind to proteins, lipids, or nucleic acids and inhibit the enzymes in the mitochondrial ETC, resulting in oxidative stress, mitochondrial dysfunction, and hepatotoxicity [##REF##24783247##310##, ##UREF##9##311##].</p>", "<p id=\"Par98\">Like cisplatin, INAH alters CAT activity, GPx activity, and GSH content while increasing ROS and MDA levels. It also decreases the expression of microRNA-122 and PPAR-α and increases AP1 and JNK phosphorylation [##REF##31004821##312##]. It also upregulates the mRNA expression of ER stress-related factors, including glucose-related protein 78 (Grp78), activating-transcription-factor-6 (ATF6), protein kinase RNA-like ER kinase (PERK), inositol-requiring enzyme 1 (IRE1), x-box binding protein 1 (XBP1s), and C/EBP homologous protein (CHOP) [##REF##31004821##312##]. Furthermore, it upregulates apoptotic signaling pathways, including Bax, cytochrome c release from mitochondria, and activation of caspases 3, 8, and 9. Lastly, it suppresses the Nrf2 signaling pathway, including Nrf2 and its downstream targets of heme oxygenase-1 (HO1), NAD(P)H quinone dehydrogenase 1 (NQO1), GCLM, and glutamate-cysteine ligase catalytic subunit (GCLC) [##REF##31004821##312##].</p>", "<title>Anti-depressants and anti-psychotics</title>", "<p id=\"Par99\">Recent reports have shown that many anti-depressant medications clinically used are known to cause side effects of liver toxicity and weight gain [##REF##23914755##313##, ##REF##33398419##314##]. The mechanisms of these undesirable effects are poorly understood. Most of these side effects are idiosyncratic hepatotoxicity, and their symptoms appear as early as 5 days and last up to 3 years. Some severe cases are linked to users’ deaths [##REF##23914755##313##], possibly due to severe drug interactions with other agents or pre-existing conditions like metabolic syndrome, obesity, and diabetes [##REF##28123443##315##]. In contrast, people with MASLD may be prone to developing anxiety and depression [##REF##32923833##316##]. Thus, this newly emerging area with anti-depressants related liver injury needs more studies.</p>", "<p id=\"Par100\">Much of depression, schizophrenia, bipolar disorders, and psychotic disorders are associated with oxidative stress in the brain through the gut–brain axis [##REF##35456041##317##, ##REF##34536490##318##]. However, it is also known that the metabolisms of anti-depressants, including monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs), first-generation anti-psychotics (FGAs), and second-generation anti-psychotics (SGAs), cause oxidative stress which may affect mitochondrial functions [##REF##33398419##314##]. The mechanism by which anti-depressant and anti-psychotic medications induce oxidative stress in hepatocytes begins with their metabolism through cytochrome P450 isoforms, causing reduced GSH to convert to oxidized glutathione disulfide (GSSG), as well as producing ROS and reactive metabolites that covalently bind proteins, lipids, and nucleic acids [##REF##33398419##314##]. These changes affect multiple mitochondrial metabolism pathways, including the proton gradient in oxidative phosphorylation and the proportion of  superoxide anion metabolites leaking from the ETC [##REF##33398419##314##]. These ROS activate apoptotic pathways involving Bax and Bcl-2, cytochrome c release from mitochondria, and activation of caspase-3 cleavage, as well as inducing cell damage and necrosis [##REF##33398419##314##]. They can also decrease the activities of GST, GPx, and CAT [##REF##33398419##314##]. A recent report also showed that a tricyclic anti-depressant named clomipramine caused mitochondrial dysfunction by decreasing ATP production [##REF##37217012##319##]. It is important to note that all anti-depressants and anti-psychotics collectively follow this umbrella mechanism, although there are some subtle differences in individual mechanisms of creating hepatotoxic oxidative stress [##REF##33398419##314##]. Oxidative stress is also produced from inflammatory pathways induced by chronic usage of anti-depressants and anti-psychotics; DAMP signals are likely to stimulate the apoptotic and necrotic pathways [##REF##33398419##314##]. They also activate Kupffer cells through TLRs and inflammatory signaling pathway, including NF-κB, tumor necrosis factor-α (TNF-α), ROS, nitric oxide (NO), and chemokine and cytokine storms [##REF##33398419##314##]. Chemokine and cytokine storms can also recruit circulating lymphocytes, eosinophils, and neutrophils, infiltrating the liver to start further inflammation and hepatotoxicity [##REF##33398419##314##].</p>", "<title>Viral hepatitis</title>", "<p id=\"Par101\">It is also known that infection with hepatitis B (HBV) and C virus (HCV) can cause mitochondrial dysfunction, hepatic inflammation, and chronic liver disease, in people and cell lines, through the hepatitis virus core and other proteins associated with HBV/HCV [##REF##30012333##16##, ##REF##20002299##104##]. For instance, over-expression of the HCV core protein has been shown to induce oxidative stress and mitochondrial depolarization, leading to cell death [##REF##20002299##104##]. These events were Ca<sup>2+</sup>-dependent and could be prevented by Ca<sup>2+</sup> chelation. In addition, chronic infection with HCV increased oxidative DNA damage with high levels of MDA and 4-HNE, which correlated with the degree of liver inflammation and fibrosis [##REF##12385452##320##]. The activity of the mitochondrial complex I enzyme (NADH-ubiquinone oxidoreductase) was suppressed in the genomic HCV replicon cells. This suppression decreased mitochondrial GSH and increased ROS production; these changes were restored by decreasing HCV replication with Fluvastatin [##REF##18410284##321##]. Another study showed that the HCV core protein and CYP2E1, which produces ROS, work additively to decrease mitochondrial GSH and sensitize hepatocytes to ROS-mediated cell death [##REF##15633127##322##]. Furthermore, a retrospective study with HCV-infected patients before and after antiviral treatment revealed that higher levels of serum LPS and intestinal fatty acid binding proteins, markers of intestinal permeability, were observed in patients with fibrosis/cirrhosis than those of patients without fibrosis and healthy volunteers [##REF##21726511##149##] in both HBV [##REF##29180991##162##–##REF##28027582##165##] and HCV infections [##REF##27625705##166##–##REF##28561276##168##]. These studies indicate the importance of intestinal barrier dysfunction in accelerating hepatitis virus-induced liver disease outcomes through the gut–liver axis.</p>", "<title>Hepatocellular carcinoma (HCC)</title>", "<p id=\"Par102\">ALD and MASLD have been known to ultimately progress to HCC; 4.4 per 100,000 people with MASLD were diagnosed with HCC globally from 1989 to 2015 [##REF##26707365##221##]. HCC is highly associated with metabolic risk factors and alcohol consumption [##REF##32319693##323##], and is exacerbated by underlying cirrhosis [##REF##30367835##324##]. Humans with the <italic>ALDH2*2</italic> gene variants are more susceptible to alcohol-induced HCC [##REF##28253921##325##] and esophageal cancers [##REF##22703580##73##, ##REF##19320537##326##]. ALDH2*2 protein variants are also individually-correlated with HCC [##REF##34873463##327##, ##REF##11774273##328##] and are identified as potential biomarkers for HCC [##REF##14625850##329##, ##REF##12481271##330##]. Some believe that accumulated acetaldehyde, LPOs, and ROS are carcinogenic and contribute to HCC through aging; this may allow fibrosis to progress to HCC by modulating various PTMs that increase DNA adducts of liver cells [##REF##25548474##9##, ##REF##33053943##331##]. Alcohol-mediated DNA oxidation, resulting from the polymorphisms of the <italic>ALDH2</italic> gene and activation of CYP2E1, may also partake in the development of HCC and other cancers [##REF##25548474##9##, ##REF##15660387##194##, ##REF##33053943##331##–##REF##9744533##333##]. Overall, excessive alcohol intake induces CYP2E1 and/or inactivates mitochondrial ALDH2; both can lead to oxidative DNA damage, apoptosis, suppressed cell proliferation, and altered inflammatory pathways [##REF##25548474##9##, ##REF##33053943##331##], contributing to the development of tumors. Thus, targeting CYP2E1 or activating ALDH2 with safe chemicals, including naturally occurring dietary supplements [##REF##30603740##334##], is a promising strategy to prevent alcohol-induced HCC. Recent reports showed that CMZ, a specific inhibitor of CYP2E1, was shown to prevent or improve ALD in humans [##REF##33972357##335##] and experimental models of fibrosis and HCC [##REF##31836462##192##]. Oxidative stress and dysbiosis are critical factors contributing to the progression of ALD to HCC [##REF##27496472##169##, ##REF##33053943##331##, ##REF##34068269##336##, ##REF##29665135##337##], and thus serve as important targets to prevent the onset of alcohol-related HCC [##REF##34068269##336##, ##REF##36157148##338##].</p>", "<title>Challenges and opportunities</title>", "<title>Challenges</title>", "<p id=\"Par103\">One challenge is that many overlapping similarities exist between ALD and other liver diseases [##UREF##10##339##], but treatments for each liver disease can differ. A practical guideline for treating ALD patients described the clinical observation that ALD frequently occurred with other liver diseases, including MASLD and HCV [##REF##31314133##340##]. Specific studies have been designed to distinguish the characteristics of ALD and MASLD. However, their histological features and pathological mechanisms are very similar [##REF##10348825##341##]; this is because many metabolic risk factors for MASLD/MASH overlap with those of ALD [##REF##11870378##342##] (and significantly increase the risk of severe liver disease [##REF##29164643##343##]) and patients need to be treated for both types of liver disease.</p>", "<p id=\"Par104\">Another challenge is the additive or synergistic interactions between alcohol intake and many other risk factors for liver diseases. For instance, Åberg et al. showed that mild and moderate consumers of alcohol with obesity, waist circumference, and diabetes may have increased levels of liver disease; in contrast, heavy drinkers with diabetes, large waist circumferences, and high BMIs had elevated risks of severe liver disease [##REF##29164643##343##]. Other studies have detailed that BMI and moderate alcohol intake increase the risk of liver disease [##REF##20223873##344##, ##REF##31325180##345##]. Raynard et al. showed that BMI and blood glucose are independent risk factors for alcohol-associated fibrosis (cirrhosis) [##REF##11870378##342##]. However, more studies are needed to differentiate the risk factors for ALD and MASLD. Due to the synergistic or potentiation effects of concurrent exposures to alcohol, HFDs, smoking, recreational and pharmaceutical drugs, individual mechanisms of liver injury and disease listed in previous sections may not be observed in isolation.</p>", "<p id=\"Par105\">Likewise, a third consideration is that each of these exposures promotes unique patterns of ROS/RNS, inflammation, dysbiosis, and PTMs, and most of these features take place simultaneously. Overlapping pathological risk factors of liver diseases could further increase the difficulty of prognosis and therapeutic benefits unless those multiple interventions target many pathways simultaneously.</p>", "<p id=\"Par106\">A fourth consideration is that the pharmacokinetics, specifically the absorption, distribution, metabolism, excretion, and toxicity (ADME-Tox) properties of hepatotoxic compounds and targeted interventions vary. These complexities present a significant challenge in the context of DILI. However, the Liver Tox Knowledge Base (LTKB) may provide more insight into adverse drug reactions in DILI research [##REF##36411771##255##] and allow medical professionals to distinguish DILI caused by agents with different latencies, symptoms, mechanisms, and responses [##REF##34990036##346##]. An editorial suggests that digitalizing these assessments differentiating DILI from ALD and MASLD  and detecting specific agents of hepatotoxicity with a Revise Electronic Causality Assessment Method (RECAM) may improve the likelihood of treating emergency cases of DILI [##REF##34990036##346##, ##REF##29247356##347##]. Others mention the possibility of artificial intelligence (AI) for DILI predictions [##REF##33937745##348##], but additional research is needed in the emerging field of AI.</p>", "<p id=\"Par107\">The final challenge in liver disease research is establishing the correct diagnosis to differentiate between various liver diseases. Serum enzymes that are elevated in ALD may not necessarily be elevated in DILI diagnoses. Additionally, the current diagnosis of many liver diseases, such as MASLD and MASH, involves invasive access to biomarkers, often requiring biopsy surgeries for targeted interventions [##REF##35740949##349##]. Some studies suggest screening for MASLD using less-invasive procedures (i.e., ultrasounds) [##REF##23175136##350##], but deciding on a screening method may prove complex given the varied cost of diagnosis and treatment under different health insurance plans.</p>", "<title>Opportunities</title>", "<p id=\"Par108\">Fortunately, many preventions and treatments are being investigated for various liver diseases. Other than what has already been mentioned, interventions for MASLD include but are not limited to four main specific targets. The first intervention class targets hepatic fat accumulation by modulating PPARs (i.e., pemafibrate and elafibranor), targeting FXR signaling (i.e., obeticholic acid and celastrol), inhibiting <italic>de novo</italic> lipogenesis (i.e., aramchol and ACC inhibitors), and utilizing fibroblast growth factor analogues [##REF##29247356##347##]. The second intervention class aims to alleviate oxidative stress, inflammation, and apoptosis, including ASK1 and caspase inhibitors (i.e., Emricasan) [##REF##29247356##347##]. The third intervention class targets the intestinal microbiome and metabolic endotoxemia through IMMe124, TLR antagonists, and antibiotics (i.e., solithromycin). The fourth intervention class works to mitigate hepatic fibrosis through antifibrotic agents [i.e., cenicriviroc, (a cysteine-cysteine-motif chemokine receptor-2,5 antagonist) and gelectin-3 antagonists] [##REF##29247356##347##].</p>", "<p id=\"Par109\">Current interventions for ALD include abstinence, nutritional support, glucocorticosteroids, Pentoxifylline, anti-TNF therapy, antioxidants, liver transplantations, probiotics, antibiotics, <italic>S</italic>-adenosyl methionine, betaine, endocannabinoid antagonists, osteopontin inhibitors, and stem cell therapy, as reviewed [##REF##29085205##351##]. To facilitate the development of safe and effective therapeutic drugs for treating ALD patients, the National Institute on Alcoholism and Alcohol Abuse (NIAAA, NIH) supports a multi-center Consortia for drug evaluation studies in double-blind randomized clinical trials. Since the start of the multi-center consortia in the early 2010s, many reports on clinical trials have been published. In addition, the executive summary of many published reports and other information related to various clinical trials by the multi-center Consortia, including DASH (Defeat Alcoholic Steatohepatitis) and TREAT (Translational Research and Evolving Alcoholic Hepatitis Treatment), have been compiled and available in Alcoholic Hepatitis Network (AlcHepNet). Currently, three agents, anakinra as an inhibitor of the IL-1 receptor [##REF##35340032##352##], prednisone [##REF##25945012##353##, ##REF##34166722##354##], zinc sulfate [##REF##29960116##355##], and coffee [##REF##29404510##356##] are being evaluated for their efficacies in phase II clinical studies for alcohol-associated hepatitis. We expect more reports on the clinical trial outcomes to be published by the Consortia in the future. However, the most crucial factor for long-term survival and improvement of ALD patients is abstinence without relapse of AUD. Thus, many scientists proposed that ALD patients be treated with integrated care by preventing AUD [##REF##30080255##357##] and obtaining nutritional support [##REF##36647416##358##–##REF##26764182##361##].</p>", "<p id=\"Par110\">MASLD and ALD prevention may also begin with identifying bacterial signatures that distinguish the two and differentially diagnosing each through fecal samples [##REF##28467925##362##]. Many other natural compounds such as silymarin, resveratrol, curcumin, and berberine have effectively prevented the progression of MASLD and MASH [##REF##31993304##363##, ##REF##30142943##364##]. Some of these naturally occurring compounds function as <italic>antioxidants</italic> and inhibitors of CYP2E1 [##REF##36557984##365##–##REF##8625450##367##] to prevent ALD, MASLD, and DILI. In addition, many naturally occurring antioxidants, including resveratrol, quercetin, and curcumin, are known to activate sirtuins, Nrf2, and PGC1α to improve liver disease outcomes [##REF##29679894##85##, ##REF##36615829##138##, ##REF##33846538##139##, ##REF##31993304##363##, ##REF##30142943##364##, ##REF##35935939##368##]. Based on the previous information regarding the prevalence of sirtuins 3, 4, and 5 in mitochondria and protectors against liver diseases and general age-related diseases, sirtuin activators including naturally occurring polyphenols would exhibit great therapeutic benefits [##REF##29458168##86##, ##REF##29331880##126##, ##REF##29577959##369##]. Additionally, given the plethora of studies suggesting that SIRT1 is a therapeutic target in ALD, SIRT1 is another opportunity for precision medicine and targeted interventions [##REF##27871879##370##]. Lastly, ghrelin has been shown to improve oxidative stress, apoptosis, and inflammation in MASLD development [##REF##22843123##371##].</p>", "<p id=\"Par111\">DILI may be prevented with adequate nutrition and abstinence. It may also be prevented by predicting its onset and type; this may be done by measuring hepatic transporter inhibition, mitochondrial toxicity, reactive metabolite formation, hepatocyte cytotoxicity, as well as the dose and physiochemical properties of the drug ingested [##REF##32511920##372##]. Current interventions for DILI include abstinence, <italic>N</italic>-acetylcysteine, corticosteroids, ursodeoxycholic acid, silymarin, glycyrrhizin, bile acid washouts, and emergency liver transplants [##REF##26633044##373##].</p>", "<title>Modulation of mitochondrial dysfunction, PTMs, and oxidative stress for liver diseases</title>", "<p id=\"Par112\">Overall, mitochondrial dysfunction is associated with decreased function of energy supply, redox homeostasis, fat oxidation, cellular metabolism, and cell survival signals [##REF##30508523##374##]. Webb et al. detailed that targeting mitochondrial dysfunction to prevent liver disease progressions includes altering metabolic signaling cascades to increase energetic efficiency, mitigating ROS/RNS, and restoring mitophagy and other systems to maintain homeostasis within mitochondria [##REF##30954429##91##]. There are many ways to treat mitochondrial dysfunction liver diseases, including the consumption of a less caloric diet, anti-diabetic drugs (i.e., elafibranor, liraglutide, metformin, thiazolidinediones, MSDC 0602K), bile acid regulators (i.e., obeticholic acid, ursodeoxycholic acid), and antioxidants that act on nuclear receptors or mitochondrial metabolism (i.e., vitamin E, tempol, resveratrol) [##REF##30954429##91##, ##REF##31004828##375##]. Other mitochondria-targeted antioxidants, including mitoquinone [##REF##36894071##280##], MitoE [##REF##19076448##376##], mitoquinol mesylate (Mito-MES) [##UREF##11##377##], mitochondria-targeted ubiquinone [##REF##21520201##52##], and quercetin [##REF##36474569##378##] were reported to affect mitophagy and improve liver conditions. Furthermore, silymarin, corilagin, anthocyanins, dihydromyricetin, berberine, hydroxytyrosol, cysteamine, pentoxifylline, avocado oil, and pegbelfermin, mitotherapy, as well as ACC inhibitors, genistein, and aramchol were reported to improve mitochondrial function in MASLD [##REF##34065331##237##]. Naturally occurring terpenoid polyphenols, including capsaicin [##REF##36938442##140##], are excellent liver disease preventions that target mitochondrial dysfunction [##UREF##12##379##, ##REF##34159683##380##] and CYP2E1-induced oxidative stress [##REF##33556870##381##]. <italic>N</italic>-acetylcysteine [##REF##29753208##141##], naturally occurring terpenoid polyphenols, and phenolic acids [##REF##35935939##368##] were reported to minimize oxidative stress and hepatotoxicity by targeting antioxidant enzymes [##REF##34653753##299##]. Melatonin is another promising agent that improves mitochondrial abnormalities in APAP-induced DILI [##REF##16948781##382##, ##REF##23272189##383##], chemotherapies [##REF##25755110##384##], and other liver injuries [##REF##30315933##385##].</p>", "<title>Targeting intestinal barrier dysfunction for liver diseases</title>", "<p id=\"Par113\">Gut dysbiosis is responsible for the exacerbation and progression of various liver diseases [##REF##32102237##386##] through the promotion of toxic metabolites [##REF##31349604##150##]; in fact, targeting gut dysbiosis has the potential to mitigate the onset and progression of liver diseases [##REF##31349604##150##, ##REF##36261549##387##]. Given this information, it is necessary to create intestinal eubiosis or symbiosis to mitigate liver disease development and progression. Many gut bacteria are helpful in their ability to turn toxic compounds into non-toxic compounds; for instance, <italic>B. xylanisolvens</italic> can metabolize nicotine in smokers with MASLD, preventing the progression to MASH [##REF##36261549##387##].</p>", "<p id=\"Par114\">Many reports reviewed different mechanisms by which the gut can be targeted to prevent liver disease or metabolic diseases caused by intestinal barrier disruption and endotoxemia. Considering the critical connection of the gut microbiota and liver, fecal microbiota transplants (FMT), or administering probiotics of <italic>Lactobacillus rhamnosus</italic> GG [##REF##24475018##388##] and <italic>Akkermansia muciniphila</italic> [##REF##28550049##389##] may be used to treat ALD [##REF##33806556##390##] or metabolic disease in general [##REF##36654766##391##]. In addition to probiotics, other gut-targeted treatments include antibiotics, prebiotics, and “postbiotics”. These treatments have various targets, acting on the microbial barrier, physical barrier, or chemical barrier of the intestines [##REF##31622696##152##, ##REF##31707624##392##]. Modulation of the microbial composition of the intestines would decrease the production and release of LPS into serum [##REF##31004166##393##], regulate FXR signaling [##REF##24656817##394##], limit or lower bacterial metabolites such as trimethylamine (TMA) and trimethylamine-<italic>N-</italic>oxide [##REF##27048804##395##, ##REF##34005835##396##], and prevent oxidative stress, inflammation, and gut barrier dysfunction [##REF##31004166##393##] (Table ##TAB##0##1##).</p>", "<title>Concluding remarks</title>", "<p id=\"Par115\">This article briefly reviewed the causes and manifestations of various liver diseases, including ALD, MASLD/MASH, TAFLD, and DILI. We have precisely described the roles of oxidative stress and examples of PTMs (e.g., oxidation, <italic>S</italic>-nitrosylation, JNK-mediated phosphorylation, nitration, acetylation, and adduct formation) of mitochondrial proteins and transcription factors in promoting fat synthesis, mitochondrial dysfunction and apoptosis of hepatocytes, leading to individual liver diseases caused by different etiological agents. We have also explained the causal roles of CYP2E1 and NOXs as initial sources of ROS through the metabolism of many substrates, including alcohol (ethanol), long-chain FFAs, APAP, INAH, cisplatin, CCl<sub>4</sub>, cocaine, MDMA, antidepressants, and TAA. In addition, we have mentioned the protective role of mitochondrial ALDH2 against oxidative stress-mediated mitochondrial dysfunction and hepatotoxicity, apoptosis/necrosis of hepatocytes and gut enterocytes, the production of DAMPs, the activation of Kupffer cells and HSCs, altered inflammation, and fibrosis, leading to cirrhosis and HCC. We have also discussed the role of gut dysbiosis in promoting intestinal barrier dysfunction, endotoxemia, and liver disease through the gut–liver axis. Furthermore, we proposed four challenges regarding the diagnosis and prognosis of several liver diseases. Based on the mechanistic insights and challenges, we have suggested basic and translational research opportunities against liver diseases by listing the benefits of many agents, including naturally occurring antioxidants and synthetic compounds. We hope our review can contribute to developing new and effective preventive or therapeutic agents against individual liver diseases as well as organ damage in other tissues.</p>" ]
[ "<title>Acknowledgements</title>", "<p>Figures ##FIG##0##1## and ##FIG##1##2## were created with a software from Biorender.com.</p>", "<title>Author contributions</title>", "<p>Manuscript conceptualization: KRL, BJS. Literature search and article acquisition: KRL, BJS. Writing drafts and revision: KRL, BJS. Figure drawing and table construction: KRL. Proofreading of the drafts and critical comments: KRL, BJS, WR. Final manuscript review and editing: KRL, WR, BJS. Post-submission review and editing: KRL, BJS, WR.</p>", "<title>Funding</title>", "<p>This research was supported by the Intramural Research Fund (to BJS) from the National Institute on Alcohol Abuse and Alcoholism.</p>", "<title>Availability of data and material</title>", "<p>Not applicable.</p>", "<title>Declarations</title>", "<title>Conflict of interest</title>", "<p id=\"Par116\">All authors read this review article and have declared no conflict of interest.</p>", "<title>Ethics approval and consent to participate</title>", "<p id=\"Par117\">Not applicable.</p>", "<title>Consent for publication</title>", "<p id=\"Par118\">All authors read the current version of this article and agreed to publish it.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>The functional outcomes of oxidative stress in hepatocytes. Oxidative stress in hepatocyte mitochondria may lead to mitochondrial dysfunction by promoting covalent modifications of lipids, proteins, and nucleic acids. These covalent modifications target some proteins for degradation and accumulate oxidized macromolecules in the mitochondria. These events may inactivate mitophagy and autophagy or cause mitochondrial dysfunction, leading to fat accumulation, caspase-mediated apoptosis, and NF-κB-mediated inflammation. These events collectively activate Kupffer and stellate cells in the liver, leading to further damage and dysfunction of liver physiology</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>Mitochondrial function changes from healthy hepatocytes to liver diseases. Normally, mitochondria can clear out mild oxidative stress generated by oxidative phosphorylation and other cellular activities through enzymatic and non-enzymatic ways. They can transcribe new antioxidant enzymes to balance oxidative stress and the cycle of inflammation, and to regulate of metabolic pathways and mitochondrial biogenesis. However, mitochondrial dysfunction is a staple of ALD, MASLD, and other liver diseases due to its contributions to elevated oxidative stress, inflammation, dysfunctional metabolic pathways, and promotion of cellular death pathways</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Opportunities to treat liver diseases through various targets</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Designed to target</th><th align=\"left\">ALD</th><th align=\"left\">MASLD</th><th align=\"left\">DILI</th></tr></thead><tbody><tr><td align=\"left\">Mitochondrial dysfunction</td><td align=\"left\"><p>Abstinence [##REF##29085205##351##]</p><p>Nutritional support:</p><p>Vitamins like folate, vitamin B6, vitamin B12, vitamin A, and thiamine [##REF##29085205##351##]</p><p>Minerals (like selenium, zinc, copper, and magnesium [##REF##29085205##351##]</p><p>Nicotinamide riboside [##REF##29679894##85##]</p><p>Mitochondria-targeted ubiquinone [##REF##21520201##52##]</p></td><td align=\"left\"><p>Silymarin, corilagin, anthocyanins, dihydromyricetin, berberine, hydroxytyrosol, cysteamine, pentoxifylline, avocado oil, and pegbelfermin, mitotherapy, as well as ACC inhibitors, genistein, and aramchol [##REF##34065331##237##]</p><p>Ursodeoxycholic acid [##REF##26633044##373##]</p><p>Less caloric diet, anti-diabetic drugs (i.e., elafibranor, liraglutide, metformin, thiazolidinediones, and MSDC 0602 K) [##REF##30954429##91##, ##REF##31004828##375##]</p><p>MitoE [##REF##19076448##376##]</p><p>Mitoquinol mesylate (Mito-MES) [##UREF##11##377##]</p><p>Capsaicin for septic acute liver injury [##REF##36938442##140##]</p></td><td align=\"left\"><p>Adequate nutrition and abstinence [##REF##32511920##372##]</p><p>Predicting its onset and type by measuring hepatic transporter inhibition, mitochondrial toxicity, reactive metabolite formation, hepatocyte cytotoxicity, as well as the dose and physiochemical properties of the drug ingested [##REF##32511920##372##]</p><p>Melatonin for chemotherapy hepatotoxicity [##REF##16948781##382##]</p><p>[##REF##25755110##384##]</p><p>Mitoquinone for acetaminophen hepatotoxicity [##REF##36894071##280##]</p></td></tr><tr><td align=\"left\">Oxidative stress</td><td align=\"left\"><p>Abstinence [##REF##29085205##351##]</p><p>Nutritional support:</p><p>Vitamins like folate, vitamin B6, vitamin B12, vitamin A, thiamine [##REF##29085205##351##]</p><p>Minerals (like selenium, zinc, copper, and magnesium [##REF##29085205##351##]</p><p>Antioxidants [##REF##29085205##351##]</p><p>Nicotinamide riboside (targets SIRT1)[##REF##33846538##139##]</p><p>Melatonin and <italic>N</italic>-acetylcysteine [##REF##30315933##385##]</p><p>Mitochondria-targeted ubiquinone [##REF##21520201##52##]</p></td><td align=\"left\"><p>ASK1 and caspase inhibitors (i.e., emricasan) [##REF##29247356##347##]</p><p>Silymarin, resveratrol, curcumin, and berberine [##REF##31993304##363##, ##REF##30142943##364##]</p><p>Ghrelin [##REF##22843123##371##]</p><p>Berberine [##REF##31993304##363##]</p><p>Melatonin and <italic>N</italic>-acetylcysteine [##REF##30315933##385##]</p><p>Quercetin [##REF##35935939##368##, ##REF##36474569##378##]</p><p>Various flavonoids for CYP2E1-induced oxidative stress [##REF##33556870##381##]</p></td><td align=\"left\"><p>Adequate nutrition and abstinence [##REF##32511920##372##]</p><p>Predicting its onset and type by measuring hepatic transporter inhibition, mitochondrial toxicity, reactive metabolite formation, hepatocyte cytotoxicity, as well as the dose and physiochemical properties of the drug ingested [##REF##32511920##372##]</p><p><italic>N</italic>-acetylcysteine [##REF##29753208##141##, ##REF##26633044##373##, ##REF##12823615##397##]</p><p>Silymarin [##REF##36557984##365##–##REF##8625450##367##, ##REF##26633044##373##]</p><p>Melatonin for chemotherapy hepatotoxicity [##REF##25755110##384##]</p><p>Melatonin with <italic>N</italic>-acetylcysteine for many types of DILI [##REF##30315933##385##]</p><p>Plant extracts and oil rich in flavonoids, terpenoids, polyphenols, and phenolic acids for cisplatin-mediated hepatoxicity [##REF##34653753##299##]</p></td></tr><tr><td align=\"left\">PTMs</td><td align=\"left\"><p>Abstinence [##REF##29085205##351##]</p><p>Nutritional support:</p><p>Vitamins like folate, vitamin B6, vitamin B12, vitamin A, thiamine [##REF##29085205##351##]</p><p>Minerals (like selenium, zinc, copper, and magnesium [##REF##29085205##351##]</p><p>Naturally occurring polyphenols to target SIRT3, SIRT4, and SIRT5 [##REF##24064383##11##, ##UREF##0##58##, ##REF##29458168##86##, ##REF##29331880##126##, ##REF##29577959##369##]</p><p>SIRT1 targets [##REF##27871879##370##]</p></td><td align=\"left\"/><td align=\"left\"><p>Adequate nutrition and abstinence [##REF##32511920##372##]</p><p>Predicting its onset and type by measuring hepatic transporter inhibition, mitochondrial toxicity, reactive metabolite formation, hepatocyte cytotoxicity, as well as the dose and physiochemical properties of the drug ingested [##REF##32511920##372##]</p></td></tr><tr><td align=\"left\">Apoptosis</td><td align=\"left\"><p>Abstinence [##REF##29085205##351##]</p><p>Nutritional support:</p><p>vitamins like folate, vitamin B6, vitamin B12, vitamin A, thiamine [##REF##29085205##351##]</p><p>Minerals like selenium, zinc, copper, and magnesium [##REF##29085205##351##]</p></td><td align=\"left\"><p>ASK1 and caspase inhibitors (i.e., Emricasan) [##REF##29247356##347##]</p><p>Ghrelin [##REF##22843123##371##]</p><p>Quercetin [##REF##36474569##378##]</p><p>Capsaicin for septic acute liver injury [##REF##36938442##140##]</p></td><td align=\"left\"><p>Adequate nutrition and abstinence [##REF##32511920##372##]</p><p>Predicting its onset and type by measuring hepatic transporter inhibition, mitochondrial toxicity, reactive metabolite formation, hepatocyte cytotoxicity, as well as the dose and physiochemical properties of the drug ingested [##REF##32511920##372##]</p><p>Melatonin for acetaminophen hepatotoxicity [##REF##16948781##382##, ##REF##23272189##383##]</p></td></tr><tr><td align=\"left\">Dysbiosis/intestinal barrier dysfunction/endotoxemia</td><td align=\"left\"><p>Abstinence [##REF##29085205##351##]</p><p>Nutritional support:</p><p>vitamins like folate, vitamin B6, vitamin B12, vitamin A, thiamine [##REF##29085205##351##]</p><p>Minerals (like selenium, zinc, copper, and magnesium [##REF##29085205##351##]</p><p>Probiotics and antibiotics [##REF##29085205##351##]</p><p>Fecal microbiota transplants (FMT), or administering probiotics of <italic>Lactobacillus rhamnosus</italic> GG [##REF##24475018##388##] and <italic>Akkermansia muciniphila</italic> [##REF##28550049##389##, ##REF##33806556##390##]</p><p>Nicotinamide riboside [##REF##36615829##138##]</p></td><td align=\"left\"><p>IMMe124 [##REF##29247356##347##]</p><p>TLR antagonists [##REF##29247356##347##]</p><p>Antibiotics (i.e., solithromycin) [##REF##29247356##347##]</p><p>Fecal samples to identify bacterial signature differences from ALD [##REF##28467925##362##]</p><p><italic>B. xylanisolvens</italic> can metabolize nicotine in smokers with MASLD, preventing progression into MASH [##REF##36261549##387##]</p><p>Resveratrol [##REF##31993304##363##]</p><p>Silymarin, curcumin, and berberine [##REF##31993304##363##, ##REF##30142943##364##]</p></td><td align=\"left\"><p>Adequate nutrition and abstinence [##REF##32511920##372##]</p><p>Predicting its onset and type by measuring hepatic transporter inhibition, mitochondrial toxicity, reactive metabolite formation, hepatocyte cytotoxicity, as well as the dose and physiochemical properties of the drug ingested [##REF##32511920##372##]</p></td></tr><tr><td align=\"left\">Inflammation</td><td align=\"left\"><p>Abstinence [##REF##29085205##351##]</p><p>Nutritional support:</p><p>vitamins like folate, vitamin B6, vitamin B12, vitamin A, thiamine [##REF##29085205##351##]</p><p>Minerals like selenium, zinc, copper, and magnesium [##REF##29085205##351##]</p><p>Glucocorticosteroids [##REF##29085205##351##]</p><p>Pentoxifylline [##REF##29085205##351##]</p><p>Anti-TNF therapy [##REF##29085205##351##]</p><p>Betaine [##REF##29085205##351##]</p><p>Osteopontin inhibition [##REF##29085205##351##]</p><p>Stem cell therapy [##REF##29085205##351##]</p><p>Nicotinamide riboside (targets SIRT1) [##REF##33846538##139##]</p></td><td align=\"left\"><p>ASK1 and caspase inhibitors (i.e., emricasan) [##REF##29247356##347##]</p><p>Ghrelin [##REF##22843123##371##]</p><p>Silymarin [##REF##31993304##363##]</p><p>Resveratrol, curcumin, and berberine [##REF##31993304##363##, ##REF##30142943##364##]</p><p>Quercetin [##REF##36474569##378##]</p></td><td align=\"left\"><p>Adequate nutrition and abstinence [##REF##32511920##372##]</p><p>Predicting its onset and type by measuring hepatic transporter inhibition, mitochondrial toxicity, reactive metabolite formation, hepatocyte cytotoxicity, as well as the dose and physiochemical properties of the drug ingested [##REF##32511920##372##]</p><p>Corticosteroids [##REF##26633044##373##]</p><p>Silymarin [##REF##26633044##373##]</p><p>Glycyrrhizin [##REF##26633044##373##]</p></td></tr><tr><td align=\"left\">Fat accumulation</td><td align=\"left\"><p>Abstinence [##REF##29085205##351##]</p><p>Nutritional support:</p><p>vitamins like folate, vitamin B6, vitamin B12, vitamin A, thiamine [##REF##29085205##351##]</p><p>Minerals like selenium, zinc, copper, and magnesium [##REF##29085205##351##]</p><p>Betaine [##REF##29085205##351##]</p><p>Mitochondria-targeted ubiquinone [##REF##21520201##52##]</p></td><td align=\"left\"><p>Modulating PPARs (i.e., pemafibrate and elafibranor) [##REF##29247356##347##]</p><p>Targeting FXR signaling (i.e., obeticholic acid and celastrol) [##REF##29247356##347##]</p><p>Inhibiting de novo lipogenesis (i.e., aramchol and ACC inhibitors) [##REF##29247356##347##]</p><p>Utilizing fibroblast growth factor analogues [##REF##29247356##347##]</p><p>Bile acid regulators (i.e., obeticholic acid, ursodeoxycholic acid) [##REF##26633044##373##]</p></td><td align=\"left\"><p>Adequate nutrition and abstinence [##REF##32511920##372##]</p><p>Predicting its onset and type by measuring hepatic transporter inhibition, mitochondrial toxicity, reactive metabolite formation, hepatocyte cytotoxicity, as well as the dose and physiochemical properties of the drug ingested [##REF##32511920##372##]</p><p>Bile acid washouts [##REF##26633044##373##]</p></td></tr><tr><td align=\"left\">Fibrosis</td><td align=\"left\"><p>Abstinence [##REF##29085205##351##]</p><p>Nutritional support:</p><p>vitamins like folate, vitamin B6, vitamin B12, vitamin A, thiamine [##REF##29085205##351##]</p><p>Minerals like selenium, zinc, copper, and magnesium [##REF##29085205##351##]</p><p>Pentoxifylline [##REF##29085205##351##]</p><p>Liver transplantation [##REF##29085205##351##]</p><p>Betaine [##REF##29085205##351##]</p><p>Stem cell therapy [##REF##29085205##351##]</p></td><td align=\"left\"><p>Antifibrotic agents (i.e., cenicriviroc, (a cysteine-cysteine-motif chemokine receptor-2,5 antagonist)) [##REF##29247356##347##]</p><p>Gelectin-3 antagonists] [##REF##29247356##347##]</p><p>Less caloric diet, anti-diabetic drugs (i.e., elafibranor, liraglutide, metformin, thiazolidinediones, MSDC 0602 K) [##REF##30954429##91##, ##REF##31004828##375##]</p></td><td align=\"left\"><p>Adequate nutrition and abstinence [##REF##32511920##372##]</p><p>Predicting its onset and type by measuring hepatic transporter inhibition, mitochondrial toxicity, reactive metabolite formation, hepatocyte cytotoxicity, as well as the dose and physiochemical properties of the drug ingested [##REF##32511920##372##]</p><p>Silymarin [##REF##26633044##373##]</p><p>Inhibitors of CYP2E1 [##REF##36557984##365##–##REF##8625450##367##]</p></td></tr><tr><td align=\"left\">Hepatitis</td><td align=\"left\">Anakinra (IL-1 inhibitor) [##REF##35340032##352##], prednisone [##REF##25945012##353##, ##REF##34166722##354##], zinc sulfate [##REF##29960116##355##], and coffee [##REF##29404510##356##] are being evaluated for their efficacies in phase II clinical studies [##REF##35340032##352##–##REF##29404510##356##]</td><td align=\"left\"/><td align=\"left\"><p>Adequate nutrition and abstinence [##REF##32511920##372##]</p><p>Predicting its onset and type by measuring hepatic transporter inhibition, mitochondrial toxicity, reactive metabolite formation, hepatocyte cytotoxicity, as well as the dose and physiochemical properties of the drug ingested [##REF##32511920##372##]</p></td></tr><tr><td align=\"left\">Liver failure</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\">Emergency liver transplants [##REF##26633044##373##]</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[]
[ "<fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"18_2023_5061_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"18_2023_5061_Fig2_HTML\" id=\"MO2\"/>" ]
[]
[{"label": ["58."], "mixed-citation": ["Chen XF et al (2018) SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer. EMBO Rep 19(5):e45124"]}, {"label": ["72."], "mixed-citation": ["Adhikari R et al (2023) Alcohol-induced tubulin post-translational modifications directly alter hepatic protein trafficking. Hepatol Commun 7(4):e0103"]}, {"label": ["125."], "surname": ["You"], "given-names": ["M"], "article-title": ["Sirtuin 1 signaling and alcoholic fatty liver disease"], "source": ["Hepatobil Surg Nutr"], "year": ["2015"], "volume": ["4"], "issue": ["2"], "fpage": ["88"], "lpage": ["100"]}, {"label": ["129."], "mixed-citation": ["Goikoetxea-Usandizaga N et al (2023) The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent. Hepatology 78(3):878-895"]}, {"label": ["132."], "surname": ["Zhu"], "given-names": ["J"], "article-title": ["The combination of blueberry juice and probiotics reduces apoptosis of alcoholic fatty liver of mice by affecting SIRT1 pathway"], "source": ["Drug Des Dev Ther"], "year": ["2016"], "volume": ["10"], "fpage": ["1649"], "lpage": ["1661"]}, {"label": ["145."], "mixed-citation": ["Konturek PC et al (2018) Gut\u2013liver axis: how do gut bacteria influence the liver? Med Sci (Basel) 6(3):79"]}, {"label": ["171."], "mixed-citation": ["(2012) Structure, function and diversity of the healthy human microbiome. Nature. 486(7402):207\u2013214"]}, {"label": ["176."], "mixed-citation": ["Peiseler M et al (2022) Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease\u2014novel insights into cellular communication circuits. J Hepatol"]}, {"label": ["241."], "mixed-citation": ["Xie J et al (2022) The associations between modifiable risk factors and nonalcoholic fatty liver disease: a comprehensive Mendelian randomization study. Hepatology"]}, {"label": ["311."], "mixed-citation": ["Ezhilarasan D (2023) Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms. Drug Metab Rev 1\u201315"]}, {"label": ["339."], "mixed-citation": ["Devarbhavi H et al (2023) Global burden of liver disease: 2023 update. J Hepatol"]}, {"label": ["377."], "mixed-citation": ["Sulaimon LA et al (2021) Molecular mechanism of mitoquinol mesylate in mitigating the progression of hepatocellular carcinoma-in silico and in vivo studies. J Cell Biochem"]}, {"label": ["379."], "mixed-citation": ["Zapata J et al (2022) Targeting mitochondria for the prevention and treatment of nonalcoholic fatty liver disease: polyphenols as a non-pharmacological approach. Curr Med Chem 30(26):2977-2995"]}]
{ "acronym": [ "ADH", "AGE-adduct", "ALD", "AJ", "AMPK", "ALDH2", "APAP", "ARE", "AUD", "CAT", "CYP2E1", "DAMP", "DILI", "ER", "ETC", "FFA", "FLD", "GPx", "GR", "GSH", "GSSG", "HCC", "HBV", "HCV", "HFD", "4-HNE", "HSC", "INAH", "JNK", "Keap1", "KO", "LPO", "LPS", "MAPK", "MASH", "MASLD", "MDA", "MDMA", "MEOS", "NF-κB", "NO", "NOX", "Nrf2", "PARP", "PGC-1α", "PPAR-α", "PTMs", "RNS", "ROS", "α-SMA", "SOD", "SREBP-1", "TAA", "TAFLD", "TG", "TGF-β", "TJ", "TLR4", "TNF-α", "SIRT1", "VIM" ], "definition": [ "Alcohol dehydrogenase", "Advanced glycation end product adduct", "Alcohol-associated liver disease", "Adherens junction", "AMP-activated protein kinase", "Mitochondrial aldehyde dehydrogenase 2", "Acetaminophen", "Antioxidant response element", "Alcohol use disorder", "Catalase", "Ethanol-inducible cytochrome P450-2E1", "Danger-associated molecular pattern", "Drug-induced liver injury", "Endoplasmic reticulum", "Electron transport chain", "Free fatty acid", "Fatty liver disease", "Glutathione peroxidase", "Glutathione reductase", "Reduced glutathione", "Oxidized glutathione", "Hepatocellular carcinoma", "Hepatitis B virus", "Hepatitis C virus", "Western-style high-fat diet", "4-hydroxynonenal", "Hepatic stellate cells", "Isoniazid", "C-Jun N-terminal protein kinase", "Kelch-like ECH-associated protein", "Knockout", "Lipid peroxidation product", "Lipopolysaccharide", "Mitogen-activated protein kinase", "Metabolic dysfunction-associated steatohepatitis", "Metabolic dysfunction-associated steatotic liver disease", "Malondialdehyde", "3,4-methylenedioxy methamphetamine", "Microsomal ethanol-oxidizing system", "Nuclear factor-κB", "Nitric oxide", "NADPH-oxidase", "Nuclear factor erythroid 2-related factor", "Poly ADP-ribose polymerase", "Peroxisomal proliferator-activated receptor-γ coactivator-1α", "Peroxisomal proliferator-activated receptor-α", "Post-translational modifications", "Reactive nitrogen species", "Reactive oxygen species", "α-Smooth muscle actin", "Superoxide dismutase", "Sterol regulatory element-binding protein-1", "Thioacetamide", "Toxicant-associated fatty liver disease", "Triglyceride", "Transforming growth factor-β", "Tight junction", "Toll-like receptor 4", "Tumor necrosis factor-α", "NAD+-dependent deacetylase Sirtuin 1", "Vimentin" ] }
397
CC BY
no
2024-01-14 23:40:13
Cell Mol Life Sci. 2024 Jan 12; 81(1):34
oa_package/d8/d4/PMC10786752.tar.gz
PMC10786771
38214796
[ "<title>Background</title>", "<p id=\"Par5\">The prevalence of obesity in young people is a huge public health concern in the United Kingdom (UK). Although there have been efforts to curtail the rising prevalence of obesity, a World Health Organisation (WHO) report estimated that a third of adolescents in Europe are overweight or obese [##UREF##0##1##]. Additionally, the UK societal costs of overweight and obesity are predicted to reach £49.9 billion per year by 2050 [##UREF##1##2##]. Weight-management interventions targeting obesity in young people are ongoing [##UREF##2##3##] and are an important strategy to reduce the societal burden of obesity. However, policymakers must make resource allocation decisions based on cost-effectiveness evidence to ensure value for money. Furthermore, there is currently no validated weight-specific HRQoL measure for adolescents that can be used in economic evaluation.</p>", "<p id=\"Par6\">As such, the Weight-Specific Adolescent Instrument for Economic Evaluation (WAItE) has been developed for use in adolescence (ages 11–18), consisting of seven dimensions relating to tiredness, walking, participation in sports, concentration, embarrassment, unhappiness, and being treated differently [##UREF##3##4##]. Each dimension is expressed using a 5-level frequency response scale with increasing degrees of severity ranging from “never” to “always”. The WAItE descriptive system is available on request.</p>", "<p id=\"Par7\">During development, the WAItE’s psychometric properties were thoroughly examined, and each dimension was informed by a combination of Rasch analysis, psychometric assessment and re-visiting the qualitative material [##UREF##4##5##]. Additionally, a robust validation of the WAItE has been conducted to provide evidence of its criterion validity and reliability for future use [##UREF##5##6##]. This involved examination of the concurrent validity of the WAItE in comparison to other validated patient-related HRQoL tools and an assessment of the test-retest reliability of the WAItE to explore its consistency.</p>", "<p id=\"Par8\">Despite being specifically designed to be a preference-based measure, the WAItE currently has no associated value set and therefore cannot be used to generate quality-adjusted life years (QALYs), which are the basis of cost-utility analysis (CUA). To address this, an algorithm was developed which mapped responses from the WAItE to the Child Health Utility 9 Dimension (CHU9D) value set [##UREF##6##7##]. However, this is considered to be a second-best approach, with the ‘gold standard’ valuation method being direct elicitation of preference values through a valuation study [##UREF##7##8##].</p>", "<p id=\"Par9\">Given the developmental work already completed on the WAItE, a natural progression is to develop a preference algorithm to generate a set of preference values for the WAItE which are based on direct elicitation of preferences from a valuation study. A discrete choice experiment (DCE) study (a method of eliciting preference by asking participants to make a choice between two or more alternatives) is ongoing to develop a value set for the WAItE classification system [##UREF##8##9##]. The DCE will be delivered to members of the adult general population of the UK using an online survey. There were several reasons for the decision, to use an adult sample, including the fact that adults may have a greater capacity to understand complex preference elicitation tasks. Furthermore, as adult preferences are typically used to generate value sets for adult preference-based measures, using adult preferences to value adolescent preference-based measures provides a comparability in the methods used to value health states for both adolescents and adults. The choice of whose preferences to use in the valuation of child and adolescent health states is a matter of normative debate, and our choice is further discussed in the study protocol [##UREF##8##9##].</p>", "<p id=\"Par10\">A DCE alone is not sufficient to generate a set of preference values, as the results are interpreted on a latent scale rather than the 0 = death, 1 = full health QALY scale. There are a number of options for converting the DCE results onto the 0 = death, 1 = full health QALY scale, and currently there is no standard method of anchoring [##UREF##9##10##].</p>", "<p id=\"Par11\">One method that has previously been used to anchor latent DCE results onto the 0 = death, 1 = full health QALY scale is a standalone TTO study. This anchoring method has been successfully used in both Australia and China [##UREF##10##11##, ##UREF##11##12##] to convert DCE results for the CHU-9D on the latent scale to the 0 = death, 1 = full health QALY scale. By obtaining a value for the lowest WAItE state (the Pits state) relative to death, the latent coefficients obtained in the DCE will be reweighted on the 0 = death, 1 = full health QALY scale by ensuring that 0 represents death, therefore providing the WAItE with an appropriate preference-based value set for use in CUA.</p>", "<p id=\"Par12\">The TTO technique developed by Torrance and colleagues [##UREF##12##13##], presents a simple and intuitive alternative to ensure that health state values are anchored with 0 representing death. This technique presents respondents with two alternative “lives”, either a “life” in full health or a “life” in an impaired health state (both followed by death), and respondents are asked to identify a time spent in full health in which they would consider that “life” to be equivalent to spending a relatively longer, or equal, but fixed amount of time in the impaired health state “life” [##UREF##13##14##].</p>", "<p id=\"Par13\">One limitation the standard TTO methodology presents is the evaluation of states considered worse than being dead. In the standard TTO values are bound between 1 and 0, and no time amount of time can be given up from the full health “life” to avoid the impaired health state that would generate a negative utility value (that can be associated with worse than being dead). To enable states considered better than dead (BTD) and states worse than dead (WTD) to be valued as part of the same valuation exercise, the composite TTO (cTTO) has been developed [##UREF##14##15##]. The cTTO uses the standard TTO for BTD health states and the ‘lead-time’ TTO [##UREF##15##16##] for WTD health states. The lead-time TTO involves giving the respondent a fixed and equal amount of extra time spent in full health to the beginning of both “lives”. Thus, the total length of each live remains equal, and the time spent in the impaired health state also remains fixed and equal to that of the standard TTO, yet the available time in full health that can be given up to avoid the impaired health state is now greater than the time in the impaired health state. Implicitly, this means that health states that are considered WTD can generate negative utility values that are comparable with the positive BTD health state values.</p>", "<p id=\"Par14\">As TTO is traditionally an interviewer-led method of preference elicitation, the use of videoconferencing software for delivering interviews has become an important consideration, particularly when external factors prevent traditional face-to-face interviews being delivered. It has been shown that with several changes to the recruitment and interview process, TTO interviews using videoconferencing software are feasible and yield similar results to traditional face-to-face interviews [##REF##33345290##17##–##UREF##17##19##].</p>", "<p id=\"Par15\">The principal aim of this study was to use the TTO method to obtain a utility value for the WAItE Pits state relative to death, to then anchor the latent coefficients generated from a DCE obtained as part of a UK valuation of the WAItE instrument on to the 0 = death, 1 = full health QALY scale. This will enable QALYs to be directly generated from the WAItE for use in CUAA secondary aim of the study was to assess the feasibility of the use of an online modality of delivering TTO interviews.</p>" ]
[ "<title>Methods</title>", "<title>Ethics</title>", "<p id=\"Par16\">Ethical approval was granted by Newcastle University’s Faculty of Medical Sciences Ethics Board (Reference Number 9978/2020).</p>", "<title>Survey development</title>", "<p id=\"Par17\">A bespoke cTTO survey was designed using the Qualtrics software package [##UREF##18##20##]. In line with the DCE part of the full valuation study, the cTTO was designed to be completed by a sample of the UK adult general population. the TTO methodology is considered overly cognitively demanding for children and adolescents, and ethical concerns have been raised about using techniques that involve consideration of death with children and adolescents [##UREF##19##21##].</p>", "<p id=\"Par18\">The main part of the TTO survey was structured as follows. First, participants were asked to complete the WAItE for themselves to familiarise themselves with the wording, formatting, and descriptive system of the questionnaire. The participants were then asked to read aloud four health states generated from the WAItE descriptive system and rank them from their most preferred to least preferred, including the Pits State, which is defined by the worst level of each dimension. Aside from the Pits state, three WAItE states were chosen to represent ‘mild impairment’, ‘moderate impairment’ and ‘severe impairment’. The health states presented to the participants are shown in Appendix ##SUPPL##0##1##. The respondents were then asked to score each of the WAItE health states on a scale from 0 (‘the worst health you can imagine’) to 100 (‘the best health you can imagine’) using a visual analogue scale (VAS). Before scoring each health state, they were reminded of what position they had ranked the health state in the previous section.</p>", "<p id=\"Par19\">To familiarise themselves with the format and wording of the TTO, in the next section of the interview, the respondents completed two practice TTO tasks. They were first asked to value being ‘In a wheelchair’ and then ‘The worst health state you can imagine’. The inclusion of practice profiles is standard practice in TTO studies, as it is argued that their inclusion improves the participants’ understanding of the exercise and improves data quality [##UREF##20##22##, ##UREF##21##23##].</p>", "<p id=\"Par20\">The respondents then completed the TTO tasks, valuing the moderate impairment state first, the severe impairment state, the mild impairment state, and finally the Pits state. In line with the valuation protocols for the various versions of the EQ-5D [##UREF##22##24##–##UREF##24##26##], a cTTO was used, with the respondents presented with a standard TTO to value health states BTD and a lead-time TTO for any health states they considered WTD. In line with the various EQ-5D protocols, there was a 10-year fixed duration for the impaired health state “life” in the standard TTO (BTD health states) and a 20-year duration in the lead-time TTO “life” (WTD health states), with 10 years of full-health followed by 10 years of impaired health in that sequence [##UREF##14##15##, ##UREF##22##24##]. The iterative procedure followed a ‘ping pong approach’ [##UREF##25##27##], with the length of the time in full health varied until the respondent was indifferent between the two “lives” (full health vs. 10-years in the impaired health state). Respondents were able to reach indifference at a minimum of half year increments.</p>", "<p id=\"Par21\">In the final part of the interview, the respondents completed three post-survey questions, related to their understanding of the survey, their ease in telling the difference between different health states and their difficulty in deciding on their answers.</p>", "<title>Piloting</title>", "<p id=\"Par22\">Following initial survey testing with a convenience sample of Newcastle University colleagues not familiar with the TTO methodology, a round of external pilot testing of the TTO survey was conducted using a convenience sample recruited from a local community group in the North-East of England. The opportunity to pilot the survey was advertised to the group via social media. Individuals responded to the advertisement and were sent a copy of the study information sheet to read before consenting to take part. Pilot interviews were completed by two trained interviewers in August 2021 on the videoconferencing platform Zoom [##UREF##26##28##], and each respondent received a £15 shopping voucher as compensation for their time. Piloting via the community group enabled the survey to be tested on a range of genders, ages, and backgrounds to provide variation in our pilot sample. The interview script (which was based on the valuation protocols for the various versions of the EQ-5D [##UREF##22##24##–##UREF##24##26##]) was followed for each interview to ensure consistency and respondent understanding and to mitigate interviewer bias. No changes were made to the script or cTTO procedure following piloting, so the pilot responses were included in the full estimation sample.</p>", "<title>Recruitment and sampling</title>", "<p id=\"Par23\">The main study sample was gathered with the assistance of the market research company <italic>Dynata</italic> [##UREF##27##29##]. To gather a balanced sample of adults from the general population, potential respondents first completed a screening survey. In this screening survey, sociodemographic information was collected including gender, age band, ethnicity, region, income band, employment status, highest educational qualification, and self-reported weight status. At the end of the screening survey, the participants consented to be contacted via email to take part in the online TTO interview and stated their availability for interview. Quotas implemented by <italic>Dynata</italic> ensured that this sample was nationally representative in terms of gender, age band, and geographical location. Those respondents who reported being from the North-East of England were excluded from this sample to avoid over-representation because the pilot sample was exclusively sampled from this geographical area. Our overall target sample size was 40, like previous studies that have conducted a standalone TTO for the purposes of anchoring the latent coefficients from a DCE in the context of child health [##UREF##9##10##, ##UREF##10##11##].</p>", "<title>Interview procedure</title>", "<p id=\"Par24\">Prior to the interview, the participants were sent a meeting link via email along with a comprehensive participant information sheet which they were asked to read prior to the interview. As with the pilot interviews, an interview script was followed by the trained interviewers to ensure consistency and mitigate interviewer bias. The interviewer shared their screen for the duration of the interview, allowing the respondent to see the online survey on their screen whilst also being able to converse with the interviewer. After being introduced to the survey, having the opportunity to ask any questions related to the participant information sheet and verbally consenting to take part in the online interview, the main part of the survey began, as detailed in the ‘Survey Development’ sub-section. At the conclusion of the survey, the respondents were thanked for their participation in the interview and the interview was ended. Each participant was paid the equivalent of £15 in either panel points or shopping vouchers as a thank you for their time completing the interview.</p>", "<title>Data analysis</title>", "<p id=\"Par25\">For those states considered BTD, the TTO utility scores were calculated as: /10, with representing the number of years at which the respondent was indifferent between the time spent in full health and 10 years in the WAItE health state in question. For those states considered WTD, the TTO utility scores were calculated as ( – 10)/10, bounding these utilities between − 1 and 0. Descriptive summary statistics for the responses to the TTO and VAS were calculated, including the mean, median, standard deviation, and inter-quartile range. The responses to the WAItE were converted to a WAItE total sum score, scored between 7 (the best possible health state) and 35 (the worst possible health state). The participant’s sociodemographic characteristics from the screening survey and their responses to the post-survey questions were presented as frequencies and percentages. The two sets of data were linked using a personalised identifying code. Data were analysed using Stata version 16.0 [##UREF##28##30##].</p>" ]
[ "<title>Results</title>", "<p id=\"Par26\">In the pilot sample, 14 individuals responded to the advertisement, and 7 pilot interviews were completed. In the main sample, 102 adults who completed the initial screening survey were invited to participate in the study via email. Of the potential participants invited to take part in the online interview, 9 (9%) could not be contacted, and a further 5 (50%) did not respond to the emails asking them to participate in the interview (see Appendix ##SUPPL##1##2##). Of those who responded to the email, 4 (4%) declined the invitation, and 3 participants (3%) did not attend. This gave a final sample size of 35 in the main sample.</p>", "<p id=\"Par27\">Combining the pilot sample and the main sample (hereafter the ‘full estimation sample’) gave a final sample size of 42, in line with our target sample size of 40. All participants fully completed the online interview. Table ##TAB##0##1## shows the socio-demographic characteristics of the estimation sample. The full estimation sample was 55% male, 88% white and the modal age category was 25–34 (31%). The sample was relatively evenly spread across the geographical regions of the UK. Most of the participants were either in paid employment or self-employed (62%), and 62% of participants had a degree. The majority (60%) of the participants self-reported as being a normal/healthy weight, with 31% reporting being overweight and 2% being obese.</p>", "<p id=\"Par28\">\n\n</p>", "<p id=\"Par29\">Table ##TAB##1##2## shows the responses to the WAItE. Overall, the respondents reported being in relatively good health, with the modal answer being ‘never’ (the highest level in the WAItE classification system) for five of the seven categories. The exceptions to these were the attributes related to tiredness and concentration. One respondent reported themselves as being in full health, corresponding to the highest level in each of the WAItE attributes.</p>", "<p id=\"Par30\">\n\n</p>", "<p id=\"Par31\">Table ##TAB##2##3## shows the mean (median) values from the TTO and VAS. The mild impairment state was valued the highest 0.95 (1), followed by the moderate impairment state 0.79 (0.80), the severe impairment state 0.39 (0.50) and the Pits State 0.23 (0.33). While no participants valued Health State A or Health State B WTD, 4 participants (10%) valued Health State C WTD, and 7 participants (17%) valued the Pits State WTD. The mean (median) VAS value of Health State A was 85 (88), the value of Health State B was 59 (60), the value of Health State C was 28 (26) and the Pits state was 12 (10).</p>", "<p id=\"Par32\">\n\n</p>", "<p id=\"Par33\">Most of the participants (98%) strongly agreed or agreed that it was easy to understand the questions in the online interview. Similarly, 95% strongly agreed or agreed that it was easy to tell the difference between the health states presented in the online interview. 45% of the participants strongly agreed or agreed that it was difficult to decide on their answers, while 41% of the participants strongly disagreed or disagreed and 14% neither agreed nor disagreed.</p>" ]
[ "<title>Discussion</title>", "<title>WAItE utility values</title>", "<p id=\"Par34\">The mean and median values from the TTO followed the pattern one would expect <italic>a priori</italic>, with the mild impairment state being valued the highest (0.950), followed by the moderate impairment state (0.794), the severe impairment (0.386) and finally the Pits State (0.229). As one may expect given the small sample size and nature of the task, there are large standard deviations around the mean TTO value of both Health State C (0.48) and the PitsState (0.54), indicating a significant level of individual level heterogeneity. Previous work has also found an increased level of heterogeneity in the valuation of more severe states when using the cTTO [##UREF##14##15##]. One reason for this could be the fact that the valuation space for the lead-time TTO (which is more likely to be used for severe health states) is larger (-1 to 1) than that of the standard TTO (0–1). It also could be due to the increased complexity of the lead-time TTO. The mean and median values for the VAS also follow the pattern one would expect <italic>a priori</italic>, with a logical ordering of the health states identical to the TTO responses.</p>", "<p id=\"Par35\">The mean TTO values of the Pits State will be used to anchor the latent estimates from an ongoing DCE study (adult sample, N = 1,005) to provide a scoring algorithm for the WAItE for the UK population, by re-scaling these latent estimates onto the 0 = death, 1 = full health QALY scale needed for CUA. This will allow for the calculation of weight-specific QALYs in the adolescent population.</p>", "<title>Using interviewer assisted digital TTO surveys</title>", "<p id=\"Par36\">As well as contributing to the literature regarding the use of standalone TTO studies as a method of anchoring in valuation studies, this study has also provided further evidence that it is feasible to collect TTO data to an appropriate standard using digital interviews. Although in person TTO interviews have traditionally been the most common used method (although not necessarily seen as the “gold standard” [##UREF##16##18##]), when there are limited resources available (both human and financial) or where physical barriers or external factors exist, digital methods appear to be an acceptable and feasible alternative.</p>", "<p id=\"Par37\">Related to this, it is worthwhile discussing the findings from this study in relation to the points raised by Lipman [##REF##33345290##17##] with regards to the advantages, disadvantages and lessons learnt from interviewer assisted digital TTO interviews. As noted by Lipman [##REF##33345290##17##], there could be a higher chance of respondents cancelling on short notice or not showing up at all when conducting interviewer-assisted remote interviews. In this study, only three respondents did not show up to their online interview, even without the use of reminder emails. As further noted by Lipman [##REF##33345290##17##], there is a possibility that the use of interviewer assisted digital TTO interviews may introduce selection bias, where respondents with certain sociodemographic characteristics are more likely to take part in the interview. There is some evidence of selection bias in this study. As shown in Appendix ##SUPPL##2##3##, there are some differences between the characteristics of individuals who completed the screening survey (which was nationally representative in terms of gender, age band, and geographic area) but did not take part in the online interview, and those individuals who completed the online interview. For instance, those who completed the online interview were less likely to be in the lowest age category (18–24), less likely to be in the lowest income category (&lt;£18,800) and more likely to have a degree level education. However, these differences can be considered relatively small.</p>", "<title>Strengths and limitations</title>", "<p id=\"Par38\">There are several strengths to the study. Firstly, all participants who started the online TTO interview fully completed the interview, indicating that the online interview, and interview process more generally, was fit for purpose. Furthermore, most of the participants indicated that the questions in the survey were easy to understand and that it was easy to tell the difference between health states presented. Although 45% of respondents agreed that it was difficult to decide on their answers, it should be noted that the TTO is a cognitively complex task which requires the careful consideration of health status and time preference, and therefore some level of difficulty is to be expected. It is again worth noting that the mean and median values for the TTO followed a logical pattern that one would expect <italic>a priori</italic>, further indicating that the online interview process was fit for purpose.</p>", "<p id=\"Par39\">However, there are also several limitations to this study that should be considered when interpreting the findings. Firstly, the size of the full estimation sample (n = 42) is low compared with other patient preference studies. However, as stated previously, this sample size is comparable to several other studies in the literature that have conducted a standalone TTO for the purposes of anchoring the latent coefficients from a DCE in the context of child health [##UREF##9##10##, ##UREF##10##11##], both of which had a final sample size of 38. Furthermore, the final sample itself was composed of a larger sample collected through a market research company (n = 35), and a sample gathered from the local area (n = 7). Although the main online survey completed by the participants was identical, the method of collecting the sociodemographic data was slightly different between the two samples, and the two samples of data were collected at different points in time. However, as shown in Appendix ##SUPPL##3##4## the answers to the online interview were very similar between the two samples. Excluding the pilot responses from the full estimation sample made very little difference to the overall results and interpretation of the findings.</p>", "<p id=\"Par40\">Secondly, the TTO survey was completed by a sample of adults rather than adolescents. These valuations from adults may be different to those from adolescents. As previously noted, the choice of whose preferences to use is a normative debate, and there is currently limited guidance on the most appropriate methods to use [31]. Planned future research will investigate whether responses in preference elicitation tasks in the context of the WAItE are comparable between adults and adolescents.</p>", "<p id=\"Par41\">Thirdly, although every effort was made to ensure that the sample was representative of the UK adult population, the sample is slightly unbalanced in some demographic characteristics, including age band, income band, and self-reported weight status. Given the relatively small sample size, the likelihood of an imbalance was expected to be high due to sampling uncertainty.</p>", "<p id=\"Par42\">Fourthly, due to the COVID-19 pandemic, the interviews took place online rather than face-to-face as originally planned. This meant that some of the contextual factors that would be controlled for in an in-person setting could not be addressed. Another consequence of the use of online surveys is that the electronic devices used by the participants may have had heterogeneous size screens, meaning that the VAS presented to the participants may have been displayed in different lengths, which could influence the participant’s response to this task. Finally, there are limitations with the TTO methodology. For instance, the QALY approach assumes that the utility estimates generated are independent from the length of time presented in the questionnaire, and therefore the length of time spent in the impaired health state presented to the respondents may impact the results obtained. The cTTO technique further relies on this assumption as WTD tasks change the duration of the impaired health state by adding extra time in full health. Moreover, the duration of the time spent in full health relative to impaired health and the sequence in which they are presented can introduce new concerns about framing. The literature has advocated for more consistency in the design of TTO and cTTO preference elicitation exercises [##UREF##14##15##].</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par43\">This study used TTO methods to estimate the values of several health states defined by the WAItE descriptive system, a weight-specific patient reported outcome measure for use in adolescence. This included an estimate of the P State, which will be used in an ongoing valuation study of the WAItE in the UK population to anchor the latent coefficients from a DCE study onto the 0 = death, 1 = full health QALY scale. In addition to the contribution to the literature regarding the valuation of weight-specific HRQoL in adolescence, the study also contributes to the growing literature suggesting that collecting TTO data using an interview-assisted digital survey is a feasible alternative to the traditional face-to-face TTO interviews.</p>" ]
[ "<title>Purpose</title>", "<p id=\"Par1\">The Weight-Specific Adolescent Instrument for Economic Evaluation (WAItE) is a physical weight-specific patient reported outcome measure for use in adolescence. The purpose of this study was to use the Time Trade-Off (TTO) methodology, administered using an online interviewer-assisted remote survey, to obtain utility values for several health states from the WAItE descriptive system from a sample of the UK adult general population.</p>", "<title>Methods</title>", "<p id=\"Par2\">The adult sample was gathered using a market research company and a sample of local residents. All participants completed the same interviewer-assisted remote survey, which included rating WAItE states of varying impairment using the TTO.</p>", "<title>Results</title>", "<p id=\"Par3\">42 adults completed the survey. Utility values were gathered for four health states, ranging from low impairment to the most severe health from the WAItE descriptive system (the Pits state). Consistent orderings of the WAItE health states were observed; the health state with the lowest level of impairment was valued highest and the Pits state was valued lowest. Several respondents (n = 7, 17%) considered the Pits state to be worse than death; however, the mean value of this health state was 0.23.</p>", "<title>Conclusions</title>", "<p id=\"Par4\">The utility value of the Pits state relative to death generated from this study will be used to anchor latent values for WAItE health states generated from a Discrete Choice Experiment onto the 0 = death, 1 = full health Quality Adjusted Life Year (QALY) scale as part of a valuation study for the WAItE in the UK population. This study also provides further evidence that interviewer-assisted digital studies are feasible for collecting TTO data.</p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1186/s41687-023-00674-9.</p>", "<title>Keywords</title>" ]
[ "<title>Electronic supplementary material</title>", "<p>Below is the link to the electronic supplementary material.</p>", "<p>\n\n</p>", "<p>\n\n</p>", "<p>\n\n</p>", "<p>\n\n</p>", "<p>\n\n</p>", "<p>\n\n</p>" ]
[ "<title>Acknowledgements</title>", "<p>None.</p>", "<title>Author contributions</title>", "<p>YO acquired the funding. TR, SH, GOL and YO contributed to the design of the study. SH, GOL, WK and AK carried out the interviews. The first draft of the manuscript was written by TR and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.</p>", "<title>Funding</title>", "<p>This study is funded as part of the MapMe2 study. The MapMe2 study is funded by the National Institute for Health and Care Research [NIHR127745] Trial ID: ISRCTN12378125.</p>", "<title>Declarations</title>", "<title>Ethics approval and consent to participate</title>", "<p id=\"Par44\">The Newcastle University Medical School Ethics Committee approved the study (Reference 9978/2020). Informed consent was obtained from all individual participants included in the study.</p>", "<title>Consent for publication</title>", "<p id=\"Par45\">Not applicable.</p>", "<title>Availability of supporting data materials</title>", "<p id=\"Par46\">Data is available from the corresponding author on request.</p>", "<title>Competing interests</title>", "<p id=\"Par47\">The authors have no relevant financial or non-financial interests to disclose.</p>" ]
[]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Participant Characteristics</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Sample</th><th align=\"left\">Full Sample (n = 42)</th><th align=\"left\">Main Sample<break/>(n = 35)</th><th align=\"left\">Pilot Sample<break/>(n = 7)</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"2\">\n<bold>Gender</bold>\n</td><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\">Male</td><td align=\"left\">23 (55%)</td><td align=\"left\">20 (57%)</td><td align=\"left\">3 (43%)</td></tr><tr><td align=\"left\">Female</td><td align=\"left\">19 (45%)</td><td align=\"left\">15 (43%)</td><td align=\"left\">4 (57%)</td></tr><tr><td align=\"left\">\n<bold>Age Band</bold>\n</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\">18–24</td><td align=\"left\">3 (7%)</td><td align=\"left\">2 (6%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">25–34</td><td align=\"left\">13 (31%)</td><td align=\"left\">10 (29%)</td><td align=\"left\">3 (43%)</td></tr><tr><td align=\"left\">35–44</td><td align=\"left\">7 (17%)</td><td align=\"left\">6 (17%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">45–54</td><td align=\"left\">5 (12%)</td><td align=\"left\">5 (14%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">55–64</td><td align=\"left\">9 (21%)</td><td align=\"left\">8 (23%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">65+</td><td align=\"left\">5 (12%)</td><td align=\"left\">4 (11%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">\n<bold>Income band</bold>\n</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\">&lt;£18,800</td><td align=\"left\">2 (5%)</td><td align=\"left\">2 (6%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">£18,801 - £27,162</td><td align=\"left\">10 (24%)</td><td align=\"left\">9 (26%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">£27,163 - £36,731</td><td align=\"left\">5 (12%)</td><td align=\"left\">5 (14%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">£36,732 - £50,798</td><td align=\"left\">8 (19%)</td><td align=\"left\">6 (17%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">&gt; £50,799</td><td align=\"left\">14 (33%)</td><td align=\"left\">11 (31%)</td><td align=\"left\">3 (43%)</td></tr><tr><td align=\"left\">Prefer Not To Say</td><td align=\"left\">3 (7%)</td><td align=\"left\">2 (6%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">\n<bold>Ethnicity</bold>\n</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\">White</td><td align=\"left\">37 (88%)</td><td align=\"left\">31 (89%)</td><td align=\"left\">6 (86%)</td></tr><tr><td align=\"left\">Asian</td><td align=\"left\">1 (3%)</td><td align=\"left\">1 (9%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">Mixed</td><td align=\"left\">3 (7%)</td><td align=\"left\">3 (9%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">Prefer Not To Say</td><td align=\"left\">1 (2%)</td><td align=\"left\">0 (0%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">\n<bold>Region</bold>\n</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\">East Anglia</td><td align=\"left\">1 (2%)</td><td align=\"left\">1 (3%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">East Midlands</td><td align=\"left\">1 (2%)</td><td align=\"left\">1 (3%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">London</td><td align=\"left\">4 (10%)</td><td align=\"left\">4 (11%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">North East</td><td align=\"left\">6 (14%)</td><td align=\"left\">0 (0%)</td><td align=\"left\">6 (86%)</td></tr><tr><td align=\"left\">North West</td><td align=\"left\">7 (17%)</td><td align=\"left\">7 (20%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">Northern Ireland</td><td align=\"left\">1 (2%)</td><td align=\"left\">1 (3%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">Scotland</td><td align=\"left\">5 (12%)</td><td align=\"left\">5 (14%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">South East</td><td align=\"left\">3 (7%)</td><td align=\"left\">3 (9%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">South West</td><td align=\"left\">3 (7%)</td><td align=\"left\">3 (9%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">Wales</td><td align=\"left\">3 (7%)</td><td align=\"left\">3 (9%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">West Midlands</td><td align=\"left\">5 (12%)</td><td align=\"left\">5 (14%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">Yorkshire &amp; Humberside</td><td align=\"left\">3 (7%)</td><td align=\"left\">2 (6%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">\n<bold>Employment</bold>\n</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\">Paid Employment</td><td align=\"left\">24 (57%)</td><td align=\"left\">20 (57%)</td><td align=\"left\">4 (57%)</td></tr><tr><td align=\"left\">Self-Employed</td><td align=\"left\">2 (5%)</td><td align=\"left\">2 (6%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">Unemployed</td><td align=\"left\">2 (5%)</td><td align=\"left\">2 (6%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">Full-Time Student</td><td align=\"left\">2 (5%)</td><td align=\"left\">1 (3%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">Looking After Home / Family</td><td align=\"left\">2 (5%)</td><td align=\"left\">2 (6%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">Retired</td><td align=\"left\">8 (19%)</td><td align=\"left\">7 (20%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">Other</td><td align=\"left\">2 (5%)</td><td align=\"left\">1 (3%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">\n<bold>Highest Educational Qualification</bold>\n</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\">Degree or Equivalent</td><td align=\"left\">26 (62%)</td><td align=\"left\">22 (63%)</td><td align=\"left\">4 (57%)</td></tr><tr><td align=\"left\">Higher Education Below Degree</td><td align=\"left\">3 (7%)</td><td align=\"left\">2 (6%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">A-Level/AS-Level</td><td align=\"left\">4 (10%)</td><td align=\"left\">4 (11%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">GCSE Grade A* - C</td><td align=\"left\">4 (10%)</td><td align=\"left\">4 (11%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">GCSE Grade D – G</td><td align=\"left\">1 (2%)</td><td align=\"left\">1 (3%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">Other</td><td align=\"left\">1 (2%)</td><td align=\"left\">0 (0%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">No Formal Qualification</td><td align=\"left\">3 (7%)</td><td align=\"left\">2 (6%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">\n<bold>Weight Status</bold>\n</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\">Underweight</td><td align=\"left\">2 (5%)</td><td align=\"left\">2 (6%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">Normal/Healthy Weight</td><td align=\"left\">25 (60%)</td><td align=\"left\">19 (54%)</td><td align=\"left\">6 (86%)</td></tr><tr><td align=\"left\">Overweight</td><td align=\"left\">13 (31%)</td><td align=\"left\">12 (34%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">Obese</td><td align=\"left\">1 (2%)</td><td align=\"left\">1 (3%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">Prefer Not To Say</td><td align=\"left\">1 (2%)</td><td align=\"left\">1 (3%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">\n<bold>Easy to Understand the Questions</bold>\n</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\">Strongly Agree</td><td align=\"left\">32 (76%)</td><td align=\"left\">28 (80%)</td><td align=\"left\">4 (57%)</td></tr><tr><td align=\"left\">Agree</td><td align=\"left\">9 (21%)</td><td align=\"left\">7 (20%)</td><td align=\"left\">2 (29%)</td></tr><tr><td align=\"left\">Neither Agree or Disagree</td><td align=\"left\">1 (2%)</td><td align=\"left\">0 (0%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">Disagree</td><td align=\"left\">0 (0%)</td><td align=\"left\">0 (0%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">Strongly Disagree</td><td align=\"left\">0 (0%)</td><td align=\"left\">0 (0%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">\n<bold>Easy to Tell the Difference between the Health States</bold>\n</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\">Strongly Agree</td><td align=\"left\">24 (57%)</td><td align=\"left\">21 (60%)</td><td align=\"left\">3 (43%)</td></tr><tr><td align=\"left\">Agree</td><td align=\"left\">16 (38%)</td><td align=\"left\">13 (37%)</td><td align=\"left\">3 (43%)</td></tr><tr><td align=\"left\">Neither Agree or Disagree</td><td align=\"left\">2 (5%)</td><td align=\"left\">1 (3%)</td><td align=\"left\">1 (14%)</td></tr><tr><td align=\"left\">Disagree</td><td align=\"left\">0 (0%)</td><td align=\"left\">0 (0%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">Strongly Disagree</td><td align=\"left\">0 (0%)</td><td align=\"left\">0 (0%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">\n<bold>Difficult to Decide on Answers</bold>\n</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\">Strongly Agree</td><td align=\"left\">2 (5%)</td><td align=\"left\">2 (6%)</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">Agree</td><td align=\"left\">17 (40%)</td><td align=\"left\">15 (43%)</td><td align=\"left\">2 (29%)</td></tr><tr><td align=\"left\">Neither Agree or Disagree</td><td align=\"left\">6 (14%)</td><td align=\"left\">4 (11%)</td><td align=\"left\">2 (29%)</td></tr><tr><td align=\"left\">Disagree</td><td align=\"left\">13 (31%)</td><td align=\"left\">10 (29%)</td><td align=\"left\">3 (43%)</td></tr><tr><td align=\"left\">Strongly Disagree</td><td align=\"left\">4 (10%)</td><td align=\"left\">4 (11%)</td><td align=\"left\">0 (0%)</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Responses to the WAItE</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Mean WAItE Total Score (SD)</th><th align=\"left\">26.73 (5.27)</th></tr><tr><th align=\"left\">Median WAItE Total Score (IQR)</th><th align=\"left\">28 (23–31)</th></tr><tr><th align=\"left\">WAItE Attributes &amp; Levels</th><th align=\"left\">n (%)</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"2\">\n<bold>I get tired</bold>\n</td></tr><tr><td align=\"left\">\n<italic>Never</italic>\n</td><td align=\"left\">2 (5%)</td></tr><tr><td align=\"left\">\n<italic>Almost Never</italic>\n</td><td align=\"left\">10 (24%)</td></tr><tr><td align=\"left\">\n<italic>Sometimes</italic>\n</td><td align=\"left\">20 (48%)</td></tr><tr><td align=\"left\">\n<italic>Often</italic>\n</td><td align=\"left\">8 (19%)</td></tr><tr><td align=\"left\">\n<italic>Always</italic>\n</td><td align=\"left\">2 (5%)</td></tr><tr><td align=\"left\" colspan=\"2\">\n<bold>I struggle to keep up when walking around with others</bold>\n</td></tr><tr><td align=\"left\">\n<italic>Never</italic>\n</td><td align=\"left\">21 (50%)</td></tr><tr><td align=\"left\">\n<italic>Almost Never</italic>\n</td><td align=\"left\">8 (19%)</td></tr><tr><td align=\"left\">\n<italic>Sometimes</italic>\n</td><td align=\"left\">6 (14%)</td></tr><tr><td align=\"left\">\n<italic>Often</italic>\n</td><td align=\"left\">3 (7%)</td></tr><tr><td align=\"left\">\n<italic>Always</italic>\n</td><td align=\"left\">4 (10%)</td></tr><tr><td align=\"left\" colspan=\"2\">\n<bold>I avoid doing sports</bold>\n</td></tr><tr><td align=\"left\">\n<italic>Never</italic>\n</td><td align=\"left\">13 (31%)</td></tr><tr><td align=\"left\">\n<italic>Almost Never</italic>\n</td><td align=\"left\">10 (24%)</td></tr><tr><td align=\"left\">\n<italic>Sometimes</italic>\n</td><td align=\"left\">6 (14%)</td></tr><tr><td align=\"left\">\n<italic>Often</italic>\n</td><td align=\"left\">4 (10%)</td></tr><tr><td align=\"left\">\n<italic>Always</italic>\n</td><td align=\"left\">9 (21%)</td></tr><tr><td align=\"left\" colspan=\"2\">\n<bold>I struggle to concentration on my work/studies</bold>\n</td></tr><tr><td align=\"left\">\n<italic>Never</italic>\n</td><td align=\"left\">8 (19%)</td></tr><tr><td align=\"left\">\n<italic>Almost Never</italic>\n</td><td align=\"left\">13 (31%)</td></tr><tr><td align=\"left\">\n<italic>Sometimes</italic>\n</td><td align=\"left\">17 (40%)</td></tr><tr><td align=\"left\">\n<italic>Often</italic>\n</td><td align=\"left\">4 (10%)</td></tr><tr><td align=\"left\">\n<italic>Always</italic>\n</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\" colspan=\"2\">\n<bold>I feel embarrassed shopping for clothes</bold>\n</td></tr><tr><td align=\"left\">\n<italic>Never</italic>\n</td><td align=\"left\">28 (67%)</td></tr><tr><td align=\"left\">\n<italic>Almost Never</italic>\n</td><td align=\"left\">9 (21%)</td></tr><tr><td align=\"left\">\n<italic>Sometimes</italic>\n</td><td align=\"left\">1 (2%)</td></tr><tr><td align=\"left\">\n<italic>Often</italic>\n</td><td align=\"left\">2 (5%)</td></tr><tr><td align=\"left\">\n<italic>Always</italic>\n</td><td align=\"left\">2 (5%)</td></tr><tr><td align=\"left\" colspan=\"2\">\n<bold>I feel unhappy because I am unable to do the same things as others</bold>\n</td></tr><tr><td align=\"left\">\n<italic>Never</italic>\n</td><td align=\"left\">20 (48%)</td></tr><tr><td align=\"left\">\n<italic>Almost Never</italic>\n</td><td align=\"left\">7 (17%)</td></tr><tr><td align=\"left\">\n<italic>Sometimes</italic>\n</td><td align=\"left\">9 (21%)</td></tr><tr><td align=\"left\">\n<italic>Often</italic>\n</td><td align=\"left\">6 (14%)</td></tr><tr><td align=\"left\">\n<italic>Always</italic>\n</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\" colspan=\"2\">\n<bold>People treat me differently when I go out</bold>\n</td></tr><tr><td align=\"left\">\n<italic>Never</italic>\n</td><td align=\"left\">25 (60%)</td></tr><tr><td align=\"left\">\n<italic>Almost Never</italic>\n</td><td align=\"left\">11 (26%)</td></tr><tr><td align=\"left\">\n<italic>Sometimes</italic>\n</td><td align=\"left\">5 (14%)</td></tr><tr><td align=\"left\">\n<italic>Often</italic>\n</td><td align=\"left\">0 (0%)</td></tr><tr><td align=\"left\">\n<italic>Always</italic>\n</td><td align=\"left\">0 (0%)</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>TTO and VAS Values for WAItE Health States (N = 42)</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Health State</th><th align=\"left\">Health State A (2,212,122)</th><th align=\"left\">Health State B (2,234,442)</th><th align=\"left\">Health State C (4,445,555)</th><th align=\"left\">Pits State (5,555,555)</th></tr></thead><tbody><tr><td align=\"left\">TTO Mean (SD)</td><td align=\"left\">0.95 (0.09)</td><td align=\"left\">0.79 (0.19)</td><td align=\"left\">0.39 (0.48)</td><td align=\"left\">0.23 (0.54)</td></tr><tr><td align=\"left\">TTO Median (IQR)</td><td align=\"left\">1 (0.95–1)</td><td align=\"left\">0.80 (0.70–0.95)</td><td align=\"left\">0.50 (0.20–0.70)</td><td align=\"left\">0.33 (0.05–0.60)</td></tr><tr><td align=\"left\">Valuing State WTD (%)</td><td align=\"left\">0 (0%)</td><td align=\"left\">0 (0%)</td><td align=\"left\">4 (10%)</td><td align=\"left\">7 (17%)</td></tr><tr><td align=\"left\">VAS Mean (SD)</td><td align=\"left\">84.48 (11.39)</td><td align=\"left\">59.31 (12.89)</td><td align=\"left\">28.45 (15)</td><td align=\"left\">11.50 (11.78)</td></tr><tr><td align=\"left\">VAS Median (IQR)</td><td align=\"left\">87.50 (80–90)</td><td align=\"left\">60 (50–65)</td><td align=\"left\">25.50 (20–40)</td><td align=\"left\">10 (0–20)</td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x$$\\end{document}</tex-math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M2\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x$$\\end{document}</tex-math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x$$\\end{document}</tex-math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM5\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM6\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<inline-graphic xlink:href=\"41687_2023_674_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41687_2023_674_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41687_2023_674_Article_IEq3.gif\"/>" ]
[ "<media xlink:href=\"41687_2023_674_MOESM1_ESM.docx\"><caption><p>Supplementary Material 1</p></caption></media>", "<media xlink:href=\"41687_2023_674_MOESM2_ESM.docx\"><caption><p>Supplementary Material 2</p></caption></media>", "<media xlink:href=\"41687_2023_674_MOESM3_ESM.docx\"><caption><p>Supplementary Material 3</p></caption></media>", "<media xlink:href=\"41687_2023_674_MOESM4_ESM.docx\"><caption><p>Supplementary Material 4</p></caption></media>", "<media xlink:href=\"41687_2023_674_MOESM5_ESM.docx\"><caption><p>Supplementary Material 5</p></caption></media>", "<media xlink:href=\"41687_2023_674_MOESM6_ESM.docx\"><caption><p>Supplementary Material 6</p></caption></media>" ]
[{"label": ["1."], "surname": ["Hern\u00e1ndez-Quevedo", "Gauci", "Rechel"], "given-names": ["C", "C", "B"], "article-title": ["Childhood obesity in Europe and policies to address it"], "source": ["Eurohealth"], "year": ["2019"], "volume": ["25"], "issue": ["1"], "fpage": ["7"], "lpage": ["10"]}, {"label": ["2."], "ext-link": ["https://www.gov.uk/government/publications/health-matters-obesity-and-the-food-environment/health-matters-obesity-and-the-food-environment-2#~:text=The%20overall%20cost%20of%20obesity,%C2%A349.9%20billion%20per%20year"]}, {"label": ["3."], "mixed-citation": ["Jones AR, Tov\u00e9e MJ, Cutler LR, Parkinson KN, Ells LJ, Araujo-Soares V, Pearce MS, Mann KD, Scott D, Harris JM, Adamson AJ (2018) Development of the MapMe intervention body image scales of known weight status for 4\u20135 and 10\u201311 year old children. J Public Health. Sep 1;40(3):582\u2009\u2013\u200990"]}, {"label": ["4."], "surname": ["Oluboyede", "Hulme", "Hill"], "given-names": ["Y", "C", "A"], "article-title": ["Development and refinement of the WAItE: a new obesity-specific quality of life measure for adolescents qual"], "source": ["Life Res Aug"], "year": ["2017"], "volume": ["26"], "fpage": ["2025"], "lpage": ["2039"], "pub-id": ["10.1007/s11136-017-1561-1"]}, {"label": ["5."], "surname": ["Oluboyede", "Smith", "Hill", "Hulme"], "given-names": ["Y", "AB", "A", "C"], "article-title": ["The weight-specific adolescent instrument for economic evaluation (WAItE): psychometric evaluation using a Rasch model approach"], "source": ["Qual Life Res Apr"], "year": ["2019"], "volume": ["15"], "fpage": ["969"], "lpage": ["977"], "pub-id": ["10.1007/s11136-018-2074-2"]}, {"label": ["6."], "mixed-citation": ["Oluboyede Y, Robinson T (2019) Measuring weight-specific quality of life in adolescents: an examination of the concurrent validity and test-retest reliability of the WAItE. Value in Health. Mar 1;22(3):348\u2009\u2013\u200954"]}, {"label": ["7."], "mixed-citation": ["Robinson T, Oluboyede Y (2019) Estimating CHU-9D utility scores from the WAItE: a mapping algorithm for economic evaluation. Value in Health. Feb 1;22(2):239\u2009\u2013\u200946"]}, {"label": ["8."], "mixed-citation": ["Brazier J, Ratcliffe J, Saloman J, Tsuchiya A (2017) Measuring and valuing health benefits for economic evaluation. Oxford University Press;"]}, {"label": ["9."], "mixed-citation": ["Robinson T, Hill S, Oluboyede Y (2021) Developing a preference-based measure for weight-specific health-related quality of life in adolescence: the WAItE UK valuation study protocol. BMJ Open. Nov 1;11(11):e054203"]}, {"label": ["10."], "surname": ["Webb", "O\u2019Dwyer", "Meads", "Kind", "Wright"], "given-names": ["EJ", "J", "D", "P", "P"], "article-title": ["Transforming discrete choice experiment latent scale values for EQ-5D-3L using the visual analogue scale"], "source": ["Eur J Health Econ Jul"], "year": ["2020"], "volume": ["21"], "fpage": ["787"], "lpage": ["800"], "pub-id": ["10.1007/s10198-020-01173-0"]}, {"label": ["11."], "surname": ["Ratcliffe", "Chen", "Stevens", "Bradley", "Couzner", "Brazier", "Sawyer", "Roberts", "Huynh", "Flynn"], "given-names": ["J", "G", "K", "S", "L", "J", "M", "R", "E", "T"], "article-title": ["Valuing Child Health Utility 9D health states with young adults: insights from a time trade off study"], "source": ["Appl Health Econ Health Policy Oct"], "year": ["2015"], "volume": ["13"], "fpage": ["485"], "lpage": ["492"], "pub-id": ["10.1007/s40258-015-0184-3"]}, {"label": ["12."], "surname": ["Chen", "Xu", "Huynh", "Wang", "Stevens", "Ratcliffe"], "given-names": ["G", "F", "E", "Z", "K", "J"], "article-title": ["Scoring the Child Health Utility 9D instrument: estimation of a Chinese child and adolescent-specific tariff"], "source": ["Qual Life Res Jan"], "year": ["2019"], "volume": ["15"], "fpage": ["163"], "lpage": ["176"], "pub-id": ["10.1007/s11136-018-2032-z"]}, {"label": ["13."], "mixed-citation": ["Torrance GW (1976) Social preferences for health states: an empirical evaluation of three measurement techniques. Socio-Econ. Plan. Sci. Jan 1;10(3):129\u2009\u2013\u200936"]}, {"label": ["14."], "mixed-citation": ["Torrance GW (1986) Measurement of health state utilities for economic appraisal: a review. J. Health Econ. Mar 1;5(1):1\u201330"]}, {"label": ["15."], "surname": ["Janssen", "Versteegh", "Stolk"], "given-names": ["BM", "M", "MM"], "article-title": ["Introducing the composite time trade-off: a test of feasibility and face validity"], "source": ["Eur J Health Econ Jul"], "year": ["2013"], "volume": ["14"], "fpage": ["5"], "lpage": ["13"], "pub-id": ["10.1007/s10198-013-0503-2"]}, {"label": ["16."], "mixed-citation": ["Robinson A, Spencer A (2006) Exploring challenges to TTO utilities: valuing states worse than dead Health Econ. 15(4):393\u2013402"]}, {"label": ["18."], "mixed-citation": ["Rowen D, Mukuria C, Bray N, Carlton J, Longworth L, Meads D, O\u2019Neill C, Shah K, Yang Y (2022) Assessing the comparative feasibility, acceptability and equivalence of videoconference interviews and face-to-face interviews using the time trade-off technique. Soc. Sci. Med. Sep 1;309:115227"]}, {"label": ["19."], "mixed-citation": ["Est\u00e9vez-Carrillo A, Dewilde S, Oppe M, Ramos-Go\u00f1i JM (2022) Exploring the comparability of face-to-face versus video conference-based composite time trade-off interviews: insights from EQ-5D-Y-3L valuation studies in Belgium and Spain. Patient. Sep;15(5):521\u2009\u2013\u200935"]}, {"label": ["20."], "mixed-citation": ["Qualtrics, Provo UT USA. "], "ext-link": ["https://www.qualtrics.com"]}, {"label": ["21."], "surname": ["Rogers", "Marshman", "Rodd", "Rowen"], "given-names": ["HJ", "Z", "H", "D"], "article-title": ["Discrete choice experiments or best-worst scaling? A qualitative study to determine the suitability of preference elicitation tasks in research with children and young people"], "source": ["Patient-Rep Outcomes Dec"], "year": ["2021"], "volume": ["5"], "fpage": ["1"], "lpage": ["1"]}, {"label": ["22."], "surname": ["Dolan"], "given-names": ["P"], "article-title": ["Modeling valuations for EuroQol health states"], "source": ["Med Care Nov"], "year": ["1997"], "volume": ["1"], "fpage": ["1095"], "lpage": ["1108"], "pub-id": ["10.1097/00005650-199711000-00002"]}, {"label": ["23."], "surname": ["Shen", "Breckons", "Vale", "Pickard"], "given-names": ["J", "M", "L", "R"], "article-title": ["Using time trade-off methods to elicit short-term utilities associated with treatments for bulbar urethral stricture"], "source": ["PharmacoEconomics-Open Dec"], "year": ["2019"], "volume": ["3"], "fpage": ["551"], "lpage": ["558"], "pub-id": ["10.1007/s41669-019-0133-4"]}, {"label": ["24."], "mixed-citation": ["Oppe M, Devlin NJ, van Hout B, Krabbe PF, de Charro F (2014) A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value in Health Jun 1;17(4):445\u2009\u2013\u200953"]}, {"label": ["25."], "mixed-citation": ["Stolk E, Ludwig K, Rand K, van Hout B, Ramos-Go\u00f1i JM (2019) Overview, update, and lessons learned from the international EQ-5D-5L valuation work: version 2 of the EQ-5D-5L valuation protocol. Value in Health. Jan 1;22(1):23\u201330"]}, {"label": ["26."], "surname": ["Ramos-Go\u00f1i", "Oppe", "Stolk", "Shah", "Kreimeier", "Rivero-Arias", "Devlin"], "given-names": ["JM", "M", "E", "K", "S", "O", "N"], "article-title": ["International valuation protocol for the EQ-5D-Y-3L"], "source": ["Pharmacoeconomics Jul"], "year": ["2020"], "volume": ["38"], "fpage": ["653"], "lpage": ["663"], "pub-id": ["10.1007/s40273-020-00909-3"]}, {"label": ["27."], "surname": ["Attema", "Edelaar-Peeters", "Versteegh", "Stolk"], "given-names": ["AE", "Y", "MM", "EA"], "article-title": ["Time trade-off: one methodology, different methods"], "source": ["Eur J Health Econ Jul"], "year": ["2013"], "volume": ["14"], "fpage": ["53"], "lpage": ["64"], "pub-id": ["10.1007/s10198-013-0508-x"]}, {"label": ["28."], "mixed-citation": ["Zoom S, Joe CA, USA. "], "ext-link": ["https://zoom.us/"]}, {"label": ["29."], "mixed-citation": ["Dynata, Shelton CT USA. "], "ext-link": ["https://www.dynata.com/"]}, {"label": ["30."], "collab": ["StataCorp"], "source": ["Stata Statistical Software: release 16. College Station"], "year": ["2019"], "publisher-loc": ["TX"], "publisher-name": ["StataCorp LLC"]}]
{ "acronym": [], "definition": [] }
30
CC BY
no
2024-01-14 23:40:13
J Patient Rep Outcomes. 2024 Jan 12; 8:6
oa_package/5d/dc/PMC10786771.tar.gz
PMC10786773
0
[ "<title>Introduction</title>", "<p id=\"Par2\">Nanotechnology has attracted the wondrous interest of researchers and scientists globally and that addresses the development of functional materials and devices with a dimensional range of 1–100 nm. Among various classes of these nanomaterials, gold nanoparticles (AuNPs) are highly remarkable due to their unique properties that offer a wide range of biomedical and industrial applications, including cosmetics, chemical sensing, drug carriers, bioimaging, cancer treatment, and gene therapy [##UREF##7##10##].</p>", "<p id=\"Par3\">Despite the huge potential benefits of AuNPs in the areas of biomedical and industrial applications and their reported safety attributed to their inert and non-toxic gold core, there has been an increased interest in studying their possible deleterious effects on biological systems due to their ability to induce oxidative stress. Unfortunately, the results of these studies did not yield univocal reports [##REF##28882675##22##].</p>", "<p id=\"Par4\">Reproductive toxicological studies are mandatory at every stage of the drug approval process. These studies are of fundamental importance as possible defects may not only affect the person or animal directly treated with the drug but also have possible adverse effects on the following generations [##UREF##6##8##]. Exposure to nanoparticles (NPs) may induce different deleterious effects on male reproductive organs, spermatogenesis and hormone levels [##UREF##10##16##].</p>", "<p id=\"Par5\">Previous studies reported that AuNPs exposure led to a decrease in sperm motility, morphology, and fertilizing capability, an increase in the number of abnormal spermatozoa [##REF##27921087##28##, ##REF##24289310##32##, ##REF##18054925##36##], an accumulation of AuNPs in the testes [##UREF##22##35##], a reduction in population of germ cells, degeneration of testicular tissues, detachment of germinal epithelium from the basement membrane [##UREF##7##10##], and a reduction of testosterone production [##UREF##15##21##]. Unfortunately, the reversibility of AuNP-induced reproductive toxicity was not investigated in those studies.</p>", "<p id=\"Par6\">The aim of this work is to evaluate the toxic effect of AuNPs on the reproductive system of adult male Albino rats and to explore the reversibility of AuNP-induced reproductive toxicity after one and two months of withdrawal.</p>" ]
[ "<title>Materials and methods</title>", "<p id=\"Par7\">The current experimental study was conducted on 60 adult male Albino rats weighing between 150 and 200 g purchased from Mansoura Experimental Research Centrer (MERC), Faculty of Medicine, Mansoura University. Rats were housed in clean cages, kept under standard laboratory conditions including good lighting (12 h of light and 12 h of darkness) and good aeration, and fed a standard laboratory diet and tap water ad libitum for 14 days before and during the experiment. The experimental protocol was approved by Mansoura University Institution Research Board (IRB) (Code Number: MD.19.01.124).</p>", "<title>Material</title>", "<title>Chemicals and kits</title>", "<p id=\"Par8\">Gold (III) chloride hydrate purchased from Sigma-Aldrich, USA; trisodium citrate purchased from EL Gomhorya Company, Egypt; deionized water; and a kit for the analysis of serum testosterone purchased from EQUIPAR Diagnostic, Serono, Italy, were used in the current study.</p>", "<title>Methods</title>", "<title>Gold nanoparticles preparation and characterization</title>", "<p id=\"Par9\">Preparation and characterization were performed at Faculty of Science, Mansoura University. Colloidal AuNPs were prepared according to the standard citrate reduction method [##UREF##16##24##]. Then, they were characterized using ultraviolet–visible absorption spectroscopy, transmission electron microscope (TEM), size distribution histogram, and atomic absorption spectrophotometer with the following criteria: dark wine-red colored solution, spherical in shape with an average size 13 ± 4 nm, and 384 mg/L in concentration (Fig. ##FIG##0##1##).</p>", "<title>Study design</title>", "<p id=\"Par10\">Rats were weighted and divided randomly into four groups (15 rats each) as follows:<list list-type=\"alpha-lower\"><list-item><p id=\"Par11\">Control group: rats received deionized water daily IP for 28 days.</p></list-item><list-item><p id=\"Par12\">Test group: rats received a toxic dose of AuNPs (570 μg/kg) daily IP for 28 days [##UREF##22##35##].</p></list-item><list-item><p id=\"Par13\">Withdrawal group I: rats received a toxic dose of AuNPs (570 μg/kg) daily IP for 28 days. Then, they were left with free access to tap water and food to assess the recovery for another 30 days.</p></list-item><list-item><p id=\"Par14\">Withdrawal group II: rats received a toxic dose of AuNPs (570 μg/kg) daily IP for 28 days. Then, they were left with free access to tap water and food to assess the recovery for another 60 days.</p></list-item></list></p>", "<title>Sample collection and preparation</title>", "<p id=\"Par15\">After twenty-four hours from the last dose in both control and test groups and 30 and 60 days from the last dose in both withdrawal groups I and II, respectively, rats were weighted and anaesthetized IP with sodium pentobarbital (40 mg/kg) [##REF##27892724##40##]. From each rat, one ml of blood was obtained from the apex of the heart for determination of testosterone hormone level. The epididymides and testes were dissected out. The epididymis was sharply cut and separated from the testis. Each epididymis was gently squeezed on a slide and then pulled up using the leukocyte pipette of the hemocytometer for calculation of its volume. Then, the viscid epididymal spermatozoan fluid was allowed to liquefy with 0.5 ml of hydroxyethyl piperazineethanesulfonic acid buffered Earle's balanced salt solution and 0.4% human albumin solution for semen analysis as regards count, motility, and morphology [##REF##20384798##9##].</p>", "<p id=\"Par16\">The right testes were weighted in grams to evaluate absolute testicular weights. Then, they were prepared and stained with hematoxylin and eosin (H &amp; E) stain and Masson's trichrome stain for light microscopic histological examination and digital morphometric study. On the other hand, the left testes were prepared and stained with 1% toluidine blue for electron microscopic examination by TEM.</p>", "<title>Light microscopic study</title>", "<p id=\"Par17\">In this study, spermatogenesis and histopathological testicular changes were evaluated. A semi-quantitative evaluation of spermatogenesis was performed using Johnsen’s tubular biopsy score (JTBS) of spermatogenesis in 20 seminiferous tubules from each testicular section. As described by Johnsen, testicular tubular sections in each group were evaluated and given a score from 1 to 10, as shown in Table ##TAB##0##1##. JTBS was calculated by dividing the sum of all scores by the total number of seminiferous tubules examined [##UREF##24##39##].</p>", "<p id=\"Par18\">In addition, a semi-quantitative evaluation of histopathological testicular changes was performed as follows: Testicular sections were examined and scored for the histopathological changes [0 (no injury), 1 (mild injury), 2 (moderate injury), 3 (severe injury)]; thirty seminiferous tubules from each rat were examined randomly; each tubule took a score of (0, 1, 2 or 3); the histopathological changes were categorized into seven parameters: (a) disruption of seminiferous tubules, (b) detachment of spermatogenic cells, (c) inflammation, (d) <italic>edema</italic> of the interstitium, (e) congestion of vessels, (f) degeneration of Sertoli cells, and (g) degeneration of Leydig cells; for each experimental group, the average scores for slides were taken and assessed statistically [##UREF##12##18##].</p>", "<p id=\"Par19\">Moreover, Masson's trichrome-stained slides were photographed using an Olympus® digital camera installed on an Olympus® microscope with a 0.5 X photo adaptor and a 10 or 20 X objective. The resulting images were analyzed on an Intel® Core I7®-based computer using Video Test Morphology® software (Russia) for calibrated distance measurement, area measurement, and descriptive geometric analysis. The digital morphometric study of the thicknesses of tunica albuginea, blood vessel walls, and epithelial lining of the tubules, as well as their mean diameter, was performed as follows: One image was tested for each animal in each group for each parameter; in each image, six measurements for the parameter were taken at different random places using the manual line tool; all measurements were calibrated against a micrometer slide, which was photographed using the same optical system. This process enables the system to measure the distances in (μm) instead of pixels. Then, these measurements were averaged for each image [##UREF##0##1##].</p>", "<title>TEM Study</title>", "<p id=\"Par20\">TEM study was performed at the Electron Microscopy Unit, Faculty of Science, Alexandria University.</p>", "<title>Statistical analysis</title>", "<p id=\"Par21\">The collected data were coded, processed, and analyzed using the computerized Statistical Package for Social Science (SPSS) program (version 22.0). Student t-tests, one-way ANOVA tests, post-hoc Tukey tests, Kruskal–Wallis tests, and Mann–Whitney <italic>U</italic> tests were performed for statistical comparisons. Descriptive statistics were performed only for TEM histopathological images. Qualitative data were described using numbers and percents. While quantitative data were described using the median for non-parametric data and the mean ± standard deviation (SD) for parametric data after testing normality using the Shapiro–Wilk test, The significance of the obtained results was judged when the <italic>p</italic> value was ≤ 0.05.</p>" ]
[ "<title>Results</title>", "<title>Body weight changes in animals</title>", "<p id=\"Par22\">After receiving the toxic dose of AuNPs for 28 days, there was a statistically significant decrease in final body weights in animals of the test group compared to animals of the control group (<italic>p1</italic> = 0.048). Meanwhile, the final body weights of withdrawal group II animals showed a statistically significant increase compared to the test group and withdrawal group I (<italic>p5</italic> = 0.001 and <italic>p6</italic> = 0.01, respectively) (Table ##TAB##1##2##).</p>", "<title>Absolute testicular weights of animals</title>", "<p id=\"Par23\">As regards absolute testicular weights, the test group showed a statistically significant decrease compared to the control group (<italic>p1</italic> = 0.002). However, withdrawal group II showed a statistically significant increase compared to the test group and withdrawal group I (<italic>p5</italic> = 0.001 and <italic>p6</italic> = 0.004, respectively) (Table ##TAB##2##3##).</p>", "<title>Serum testosterone hormone levels</title>", "<p id=\"Par24\">The test group showed a statistically significant decrease in serum testosterone hormone levels compared to the control group (<italic>p1</italic> &lt; 0.001). While, withdrawal groups I and II showed statistically significant increases compared to the test group (<italic>p4</italic> and <italic>p5</italic> &lt; 0.001) (Table ##TAB##3##4##).</p>", "<title>Semen analysis</title>", "<p id=\"Par25\">By comparing semen analysis parameters (sperm count, motility, and abnormal morphology) among all studied groups, the test group showed statistically significant decreases in sperm count and percentage of motile sperms and a statistically significant increase in the percentage of sperms with abnormal morphology compared to the control group (<italic>p1</italic> &lt; 0.001 for all) (Table ##TAB##4##5##).</p>", "<p id=\"Par26\">On the other hand, withdrawal group I showed a statistically significant increase in sperm count and percentage of motile sperms associated with a statistically significant decrease in the percentage of sperms with abnormal morphology compared to the test group (<italic>p4</italic> = 0.003, &lt; 0.001 and &lt; 0.001 respectively).</p>", "<p id=\"Par27\">Moreover, withdrawal group II showed statistically significant increases in sperm count and percentage of motile sperms associated with a statistically significant decrease in the percentage of sperms with abnormal morphology compared to the test group (<italic>p5</italic> &lt; 0.001 for all) and withdrawal group I (<italic>p6</italic> &lt; 0.001 for all).</p>", "<title>Light microscopic results</title>", "<title>Johnsen's tubular biopsy score for spermatogenesis (JTBS)</title>", "<p id=\"Par28\">Spermatogenesis was compared among all studied groups of rats by comparing JTBS, as shown in Table ##TAB##5##6##. The test group shows a statistically significant decrease in JTBS compared to the control group (<italic>p1</italic> &lt; 0.001). While, withdrawal groups I and II showed statistically significant increases in JTBS compared to the test group (<italic>p4</italic> and <italic>p5</italic> &lt; 0.001).</p>", "<title>Testicular histopathological changes</title>", "<p id=\"Par29\">Light microscopic examination of testicular tissue sections from control group rats revealed normal testicular architecture. The testis was surrounded by tunica albuginea, which was formed of connective tissue fibers and fibroblasts (Fig. ##FIG##1##2##a). The testis consisted of seminiferous tubules of variable sizes and shapes separated by interstitial tissue containing small blood vessels and groups of Leydig cells close to them (Figs. ##FIG##1##2##a and ##FIG##2##3##a).</p>", "<p id=\"Par30\">Each seminiferous tubule was surrounded by basement membrane and myoid cells with flat nuclei. Seminiferous tubules were lined with stratified spermatogenic cells and Sertoli cells. Spermatogenic cells included: spermatogonia, primary spermatocytes, secondary spermatocytes, spermatids, and spermatozoa. Spermatogonia were resting on a basement membrane. Spermatocytes are the largest spermatogenic cells. Two forms of spermatids were seen; round (early spermatids) and elongated (late spermatids). Mature spermatozoa were seen filling the lumen of the seminiferous tubules. Sertoli cells appeared near the basement membrane (Figs. ##FIG##1##2##a and ##FIG##2##3##a).</p>", "<p id=\"Par31\">After administration of the toxic dose of AuNPs for 28 days, marked reduction of stratified germinal epithelium lining seminiferous tubules appeared. Most of spermatogenic cells were replaced by vacuoles. The lumens of most of seminiferous tubules were devoid of mature spermatozoa. Sertoli cells and Leydig cells showed marked degeneration. Blood vascular walls appeared thickened. Interstitial inflammation and edema were detected (Figs. ##FIG##1##2##b and ##FIG##2##3##b). Compared to the control group, the test group showed statistically significant disruption of seminiferous tubules, detachment of spermatogenic cells, interstitial inflammation and edema, congestion of vessels, degeneration of Sertoli cells and degeneration of Leydig cells (<italic>p1</italic> &lt; 0.001 for all) (Table ##TAB##6##7##).</p>", "<p id=\"Par32\">After withdrawal of the toxic dose of AuNPs for 30 days and continuing on standard diet and water only, some seminiferous tubules showed preservation of the normal stratified germinal epithelium. Meanwhile, other tubules were lined by vacuolated and degenerated cells (Figs. ##FIG##1##2##c and ##FIG##2##3##c).Compared to the test group, withdrawal group I showed statistically significant decrease in disruption of seminiferous tubules, detachment of spermatogenic cells, interstitial inflammation and edema, congestion of vessels and degeneration of Sertoli cells and Leydig cells (<italic>p4</italic> = 0.001, = 0.002, = 0.001, &lt; 0.001, &lt; 0.001, &lt; 0.001 and &lt; 0.001 respectively) (Table ##TAB##6##7##).</p>", "<p id=\"Par33\">After withdrawal of the toxic dose of AuNPs for 60 days and continuing on standard diet and water only, near normal testicular architecture was observed (Figs. ##FIG##1##2##d and ##FIG##2##3##d). There was statistically significant decrease in disruption of seminiferous tubules, detachment of spermatogenic cells, interstitial inflammation and edema, congestion of vessels and degeneration of Sertoli cells and Leydig cells compared to that of the test group (<italic>p5</italic> &lt; 0.001 for all) (Table ##TAB##6##7##).</p>", "<title>Digital morphometric study (computer assisted digital image analysis)</title>", "<p id=\"Par34\">The test group showed a statistically significant increase in the thicknesses of tunica albuginea and blood vascular walls and the mean diameter of seminiferous tubules and a statistically significant decrease in the thickness of the epithelial lining of the tubule compared to the control group (<italic>p1</italic> &lt; 0.001 for all).</p>", "<p id=\"Par35\">On the other hand, withdrawal groups I and II showed statistically significant decreases in the thicknesses of tunica albuginea and blood vascular walls and a statistically significant increase in the thickness of the epithelial lining of the tubule compared to the test group. In addition, withdrawal group II showed a statistically significant decrease in the mean diameter of seminiferous tubules compared to the test group (Table ##TAB##7##8##).</p>", "<title>Electron microscopic results</title>", "<p id=\"Par36\">The control group showed normal testicular ultrastructural architecture (Fig. ##FIG##3##4##). In comparison, the test group's testicular cells showed vacuolization, mitochondrial degeneration, nuclear membrane disruption, and wide intercellular spaces associated with AuNPs accumulation inside Sertoli cells, spermatognia, spermatocytes, mature sperm heads and tails, and Leydig cells (Fig. ##FIG##4##5##). Furthermore, some testicular cells of withdrawal group I show nuclear membrane irregularity, perinuclear spacing, vacuolization, and mitochondrial degeneration, while other testicular cells are normal (Fig. ##FIG##5##6##). Moreover, most testicular cells in withdrawal group II are normal, with few small vacuoles and few degenerated mitochondria (Fig. ##FIG##6##7##).</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par37\">Nanoparticles are currently utilized in every branch of science and in commercial applications to make products cleaner, lighter, stronger, more precise, more efficient, and more aesthetic [##UREF##3##5##]. Among them, AuNPs are highly remarkable with their unique functional properties and easy synthesis, allowing them to be used in a wide range of medical applications, including biosensing, photothermal therapy, photodynamic therapy, radiotherapy, X-ray imaging, computed tomography, and gene and drug delivery [##REF##32039188##14##]. Due to the fact that NPS may negatively affect male reproductive organs, spermatogenesis, and hormone levels, reproductive toxicity caused by NP exposure is regarded as an essential topic to be researched in general toxicology [##UREF##10##16##].</p>", "<p id=\"Par38\">This study aimed at studying the toxic effects of AuNPs on the reproductive system of adult male Albino rats and assessing their reversibility after 30 and 60 days of withdrawal. To the best of the authors' knowledge, there are no available studies investigating the reversibility of AuNPs-induced reproductive toxicity.</p>", "<p id=\"Par39\">In this experimental study, sixty adult male Albino rats were divided into four groups (fifteen rats each): the control group, the test group, withdrawal group I, and withdrawal group II. Control group rats received deionized water daily through the intraperitoneal route for 28 days. Test group and withdrawal groups I and II rats received 570 μg/kg of AuNPs (13 ± 4 nm) daily through the intraperitoneal route for 28 days. Then, withdrawal groups I and II continued for another thirty and sixty days, respectively, with free access to tap water and food to assess the recovery.</p>", "<p id=\"Par40\">Several researchers have already utilized the animal model used in this study to evaluate the AuNPs induced reproductive toxicity [##UREF##7##10##, ##UREF##9##13##, ##UREF##22##35##]. Regarding the AuNPs dose used in the current study, Zhang et al. [##UREF##25##41##] have used an equivalent dose in mice, and this dose was calculated in rats according to Nair and Jacob [##UREF##18##27##] conversion tables. The same dose was also used in rats by Velikorodnaya et al. [##UREF##22##35##] to evaluate AuNP-induced reproductive toxicity. The intraperitoneal route was preferred due to the dense blood vessels and lymph in the peritoneum, which allow good and rapid drug absorption [##UREF##25##41##].</p>", "<p id=\"Par41\">In the present study, there was statistically significant decrease in final body weights in animals of the test group compared to animals of the control group. Zhang et al. [##UREF##25##41##] obtained a similar result following daily IP injection of mice with AuNPs (13.5 nm) for 28 days. The metabolic effects of AuNPs, which have been reported by Chen et al. [##UREF##4##6##], could be the cause of this outcome. They found that IP injection of AuNPs (20–30 nm) into mice improved lipid and glucose metabolism, decreased fat mass, and aided in weight loss. However, compared to the test group, withdrawal groups I and II showed statistically non-significant and statistically significant increases in final body weights, respectively. When the final body weights of both withdrawal groups were compared, withdrawal group II showed a statistically significant increase. This could be attributed to the gradual recovery from AuNPs-induced toxicity after AuNPs clearance from the body.</p>", "<p id=\"Par42\">Furthermore, the test group showed a statistically significant decrease in absolute testicular weights compared to the control group. Meanwhile, withdrawal groups I and II showed statistically non-significant and statistically significant increases in absolute testicular weights compared to the test group, respectively. The toxic effects of NPs on germ cell mass could be the cause of the test group's decreased absolute testicular weight [##UREF##8##11##]. While, its increase in withdrawal groups I and II indicated gradual regeneration of germ cells and gradual recovery from AuNPs induced spermatogenic defects.</p>", "<p id=\"Par43\">Regarding serum testosterone hormone levels, they were statistically decreased in the test group compared to the control group. This result was in agreement with Behnammorshedi et al. [##UREF##2##4##] who observed that after daily IP injection of different doses of AuNPs for ten days in rats, the mean testosterone level decreased with increasing AuNPs dose. Similarly, Liu et al. [##UREF##15##21##] suggested that after daily intravenous injection of AuNPs (5–10 nm) for 14 days in mice, the testosterone production in Leydig cells reduced due to down regulating of the expression of 17α hydroxylase enzyme, which has crucial importance in androgen synthesis and degeneration of Leydig cells which are responsible for testosterone production.</p>", "<p id=\"Par44\">Meanwhile, withdrawal groups I and II showed statistically significant increases in serum testosterone hormone levels compared to the test group. This result may be attributed to regaining of Leydig cells mitochondrial secretory activity after resolving their degeneration.</p>", "<p id=\"Par45\">As regards semen analysis, the test group displayed statistically significant decreases in sperm count and percentage of motile sperms and a statistically significant increase in the percentage of sperms with abnormal morphology compared to the control group. These results were in accordance with Wiwanitkit et al. [##REF##18054925##36##], who reported the effect of mixing AuNPs (9 nm) with a fresh semen sample from a healthy human male. They observed that after 15 min of exposure to AuNPs, the motility was lost in 25% of the sperms, and some human sperms were clumped and fragmented with an accumulation of AuNPs in the sperm tails and heads. Another study conducted by Taylor et al. [##REF##24289310##32##] on bovine spermatozoa reported detrimental effects on sperm motility, morphology, and fertilizing capability after mixing with AuNPs (10.8 nm in average).</p>", "<p id=\"Par46\">As well, Nazari et al. [##REF##27921087##28##] reported a significant decrease in sperm motility and an increased number of abnormal spermatozoa after repeated IP injection of AuNPs (10–30 nm) in mice. In addition, Liu et al. [##UREF##15##21##] reported sperm malformations (including small heads, large heads, double heads, double tails, and coiled tails) after daily intravenous injection of AuNPs (5–10 nm) for 14 days in mice.</p>", "<p id=\"Par47\">These detrimental effects of AuNPs on sperm quantity and quality were explained by the induction of reactive oxygen species (ROS), resulting in oxidative stress and mitochondrial damage with subsequent metabolic dysfunction [##UREF##8##11##].</p>", "<p id=\"Par48\">Furthermore, withdrawal groups I and II showed statistically significant increases in sperm count and percentage of motile sperms and decrease in the percentage of sperms with abnormal morphology compared to the test group. This result reflected the gradual reversibility of AuNPs-induced damage to the epididymal sperms.</p>", "<p id=\"Par49\">Concerning light microscopic results, the test group showed statistically significant decreases in JTBS for spermatogenesis and the mean thickness of the epithelial lining of the tubules compared to the control group. The negative effect of AuNPs on spermatogenesis in the current study may be attributed to their ability to produce ROS, which leads to formation of oxidative stress and disruption of cellular metabolism associated with inducement or exacerbation of the NPs-related inflammatory response [##REF##28442746##38##], as well as induction of oxidative DNA damage that leads to cell cycle arrest and cytotoxic effects on male germ cells. This explains why sperms and spermatids were rarely seen in the test group [##UREF##8##11##].</p>", "<p id=\"Par50\">Regarding other light microscopic results, the test group showed statistically significant disruption of seminiferous tubules, detachment of spermatogenic cells, interstitial inflammation and edema, congestion of vessels, and degeneration of Sertoli and Leydig cells compared to the control group. The mean thicknesses of tunica albuginea and blood vascular walls and the mean diameter of the seminiferous tubules showed statistically significant increases compared to the control group.</p>", "<p id=\"Par51\">These toxic testicular histopathological changes could be explained by the intracellular leaching of gold ions from AuNPs and their effects on the surrounding biomacromolecules. Consequently, these ions strongly inhibit mitochondrial membrane depolarization and/or inactivation of mitochondrial enzymes, rendering direct or indirect mitochondrial damage, leading to alteration of cellular redox balance and promoting cell necrosis or apoptosis [##REF##27518167##34##].</p>", "<p id=\"Par52\">Furthermore, testicular interstitial inflammation and edema generated in the current study could be explained by AuNPs activation of inflammatory mediators' synthesis by disturbing the normal mechanisms of cell metabolism [##UREF##11##17##]. Additionally, congestion of blood vessels and interstitial edema could be attributed to the induction of nitric oxide production, which is an endothelial relaxing factor [##REF##34345594##23##].</p>", "<p id=\"Par53\">Moreover, the thickening of tunica albuginea, basal lamina, and blood vascular walls observed in the test group of the current study can be attributed to increased production of glycosaminoglycans and proteoglycans, a mechanism that is considered a defense reaction against the damaging activity of the probably induced ROS [##UREF##1##3##].</p>", "<p id=\"Par54\">Although the mean thickness of the epithelial lining of seminiferous tubules was decreased in the test group of the current study, their mean diameters were increased. This could be explained as a result of the detachment of spermatogenic cells into the lumen, leading to blocking of the efferent ducts with subsequent impairment of seminiferous tubule fluid passage from the testis to the epididymis, resulting in increased seminiferous tubule diameter [##REF##17763286##25##].</p>", "<p id=\"Par55\">Regarding the electron microscopic results of the test group, most of the intratubular and interstitial testicular changes could be explained by lipid peroxidation of the cell membranes and organelles. It also destroys the structure of the spermatozoal lipid matrix, which can be associated with loss or affect sperm motility [##UREF##5##7##].</p>", "<p id=\"Par56\">Cytoplasmic vacuolization of testicular cells in the test group of the current study might have arisen from lysosomal membrane damage induced by ROS with subsequent release of lysosomal hydrolases into the cytosol, uncontrolled extra lysosomal proteolysis, and tissue destruction [##REF##32082274##15##]. The clear vacuoles within the cytoplasm might represent distended and pinched-off segments of the endoplasmic reticulum. The cellular swelling might occur as a result of failure of energy-dependent sodium–potassium ion pumps in the plasma membrane, leading to intracellular accumulation of sodium and progressive changes in osmolarity with consequent entry of water into the cells. This pattern of injury could be referred to as hydropic change [##UREF##13##19##].</p>", "<p id=\"Par57\">The accumulation of AuNPs in Sertoli cells, spermatogenic cells, and Leydig cells in the current study was strong evidence of their ability to cross the blood testis barrier (BTB). AuNPs accumulation in Sertoli cells and its associated Sertoli cell degeneration would have altered the structural and functional integrity of testicular tissues, with subsequent disruption of the Sertoli-germ cell interaction leading to the detachment of spermatogenic cells from the seminiferous epithelium. Moreover, Sertoli cell degeneration would have impaired the production of growth factors and nutrients, which would have a harmful impact on the normal maturation of spermatogenic cells at various stages [##UREF##21##33##]. In addition, AuNPs accumulation inside the interstitial Leydig cells and its subsequent degeneration explain the decrease in testosterone levels and impaired sperm production and maturation of the test group rats [##UREF##15##21##].</p>", "<p id=\"Par58\">Mohamed et al. [##UREF##17##26##] also noted the presence of intercellular gaps between the spermatogenic cells as found in the test group of the current study. They attributed this to the disruption of tight junctions in BTB upon exposure to the ROS, leading to the entry of excess water and toxic agents between the spermatogenic cells and widening of intercellular spaces.</p>", "<p id=\"Par59\">Both light and electron microscopic results of the test group came in accordance with Gupta et al. [##UREF##7##10##], who stated that after oral exposure of mice to AuNPs (15 nm) for 90 days, there was considerable accumulation of AuNPs in the testes, degeneration of testicular tissues, detachment of germinal epithelium from the basement membrane, and a reduction in the population of germ cells. Also, these results came in agreement with Liu et al. [##UREF##15##21##], who performed combined in vitro and in vivo studies on Leydig cells and mice and recognized that after AuNPs (5 nm) internalization into Leydig cells lysosomes, they induced the formation of autophagosomes, increased the production of ROS, and arrested the cell cycle in S phase, resulting in concentration-dependent cytotoxicity and DNA damage with a significant reduction of testosterone production. Additionally, after daily intravenous injections of AuNPs for 14 days in mice, they accumulated and were retained in the testes in a dose-dependent manner.</p>", "<p id=\"Par60\">However, the results of the current study were in disagreement with Leclerc et al. [##UREF##14##20##], who reported that after daily intramuscular injection of AuNPs (70 nm) for 45 days, there were neither testicular histopathological toxicity signs nor AuNPs testicular accumulation. This inconsistency of results could be due to different sizes of AuNPs and different routes of their administration.</p>", "<p id=\"Par61\">Both light and electron microscopic results of withdrawal groups I and II of the present study reflected the gradual reversibility of AuNPs-induced damage to the testicular tissues. Similar reversible effects for the damage of the testicular tissues were detected by Bai et al. [##REF##20693989##2##], who used carbon nanotubes, Ren et al. [##UREF##19##30##], who used silica nanoparticles,and Nirmal et al. [##REF##28371123##29##], who used graphene oxide nanoparticles.</p>", "<p id=\"Par62\">In this study, the reversibility of AuNPs-induced male reproductive toxicity may be attributed to: (A) exocytosis of NPs as suggested by Sakhtianchi et al. [##UREF##20##31##], (B) clearance of AuNPs from a variety of body organs as investigated by Han et al. [##REF##24935253##12##], (C) deoxyribonucleic acid repair process as detected by Xu et al. [##UREF##23##37##], and (D) subsidence of AuNPs-induced oxidative stress and lipid peroxidation as concluded from other nanoparticle reversibility studies [##REF##20693989##2##, ##UREF##19##30##].</p>" ]
[]
[ "<p id=\"Par1\">Nanotechnology has become a trending area in science all over the world. Although gold nanoparticles (AuNPs) have been utilized widely in biomedical fields, potential toxicities may arise from their interactions with biological systems. The current study aimed at evaluating the toxic effects of AuNPs on the reproductive system of adult male albino rats and assessing the recovery probability. In this study, AuNPs (13 ± 4 nm in diameter) were synthesized, and the experimental work was conducted on 60 adult male albino rats divided into the following groups: control group (received deionized water daily intraperitoneally (IP) for 28 days), test group, and withdrawal groups I and II (received 570 μg/kg of 13 ± 4 nm AuNPs daily IP for 28 days). Withdrawal groups I and II were left for another 30 and 60 days without sacrification, respectively. The test group showed significant decreases in final body and absolute testicular weights, testosterone hormone level, sperm count and motility, and spermatogenesis score, as well as significant increase in the percentage of sperms of abnormal morphology compared to the control group, associated with significant light and electron microscopic histopathological changes. Partial improvement of all studied reproductive parameters was detected after one month of withdrawal in withdrawal group I, and significant improvement and reversibility of all these parameters were reported after two months of withdrawal in withdrawal group II. So, AuNPs induce male reproductive toxicity, which partially improves after one month of withdrawal and significantly improves and reverses after two months of withdrawal.</p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s43188-023-00203-2.</p>", "<title>Keywords</title>", "<p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p>" ]
[ "<title>Recommendations</title>", "<p id=\"Par63\">Health programs should be conducted to provide the public with information about AuNPs-containing products and their male reproductive toxic effects associated with limiting the use of these products to the necessary ones only. In addition, precautions should be taken when dealing with AuNPs-containing products, especially in terms of occupational work, by wearing gloves and protective clothes. Patients on AuNPs treatment should be reassured that male reproductive toxicity is reversible.</p>", "<title>Supplementary Information</title>", "<p>Below is the link to the electronic supplementary material.</p>" ]
[ "<title>Acknowledgements</title>", "<p>The authors owe deepest gratitude and appreciation to Prof. Dr. Fikri Mohamed Hassan Reicha, Professor of Physics, Faculty of Science, Mansoura University, may God have mercy on him, for his great help and guidance in gold nanoparticles preparation.</p>", "<title>Author contributions</title>", "<p>Study conception and design: NAA, DAE-M, and SAGE-H; Acquisition of data: NAA, and DAE; Analysis and interpretation of data: NAA, DAE, HMAE-A, and DAE-M; Drafting of manuscript: NAA; Critical revision: HMAE-A, DAE-M, and SAGE-H. All authors read and approved the final manuscript.</p>", "<title>Funding</title>", "<p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). The authors received no financial support for the research or authorship of this article.</p>", "<title>Data availability</title>", "<p>All datasets on which the conclusions of the manuscript rely are available.</p>", "<title>Declarations</title>", "<title>Conflict of interest</title>", "<p id=\"Par64\">All authors confirm that there is no conflict of interest.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>Characterization of gold nanoparticles. <bold>a</bold> Ultraviolet–visible spectrum of gold nanoparticles showing sharp absorbance band peaked at wavelength 520 nm. <bold>b</bold> High resolution transmission electron microscope image displaying spherical shape of AuNPs with average size 13 ± 4 nm, scale bar was 50 nm. <bold>c</bold> Histogram representing size distribution of AuNPs analyzed using ImageJ</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>Photomicrographs of paraffin sections in the testes of the control group (<bold>a</bold>) showing normal testicular architecture; the test group (<bold>b</bold>) showing vacuolated tubules separated by interstitial exudate and inflammatory cells (black arrows); withdrawal group I (<bold>c</bold>) showing preservation of the germinal epithelium in some tubules (green arrows), degeneration and vacuolation in other tubules (blue arrows); withdrawal group II (<bold>d</bold>) showing layers of spermatogenic cells lining the tubules, mature spermatozoa in the lumen (red arrows) (H &amp; E stain X100). Scale bar: 100 μm</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p>Photomicrographs of paraffin sections in the testes of the control group (<bold>a</bold>) showing seminiferous tubules lined by layers of spermatogenic cells separated by interstitium containing blood vessels (red arrow) and normal Leydig cells (green arrow); the test group (<bold>b</bold>) showing marked reduction of stratified germinal epithelium in the tubules, most of spermatogenic cells are replaced by vacuoles, the lumen of the tubule is devoid of mature spermatozoa, tubules are lined by degenerated Sertoli cells and separated by interstitium containing thickened blood vessels (red arrow), degenerated Leydig cell (green arrow), exudate and inflammatory cells (black arrows); withdrawal group I (<bold>c</bold>) showing tubules lined by degenerated cells, no mature spermatozoa are present in the lumen of seminiferous tubules, some Leydig cells are normal with rounded to oval nuclei and prominent nucleoli (yellow arrow), others are degenerated with pyknotic nuclei (blue arrow); withdrawal group II (<bold>d</bold>) showing preservation of germinal epithelium in most of tubules, mature spermatozoa are seen in the lumen (black arrows) (H &amp; E stain X400). Scale bar: 25 μm</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p>Electron micrographs of the testicular cells of the control group showing Sertoli cell resting on basal lamina (<bold>a</bold>), spermatogonium resting on basal lamina (<bold>b</bold>), primary spermatocytes (<bold>c</bold>), round spermatids (<bold>d</bold> and <bold>e</bold>), head of mature sperm (<bold>f</bold>), longitudinal section of mature sperm tail (<bold>g</bold>), transverse section of mature sperm tail (<bold>h</bold>) and normal interstitial Leydig cell (i). Scale bar: 2 μm (<bold>a</bold>, <bold>b</bold>, <bold>c</bold>, <bold>d</bold>, <bold>e</bold> and <bold>i</bold>), 1 μm (<bold>g</bold> and <bold>h</bold>) and 500 nm (<bold>f</bold>). Number of observations: 5 images per each testicular cell type</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><p>Electron micrographs of the testicular cells of the test group revealing seminiferous tubules bounded by thick wavy basal lamina (<bold>a</bold> and <bold>b</bold>). a + , b + , c + and g + are more magnified photos of a, b, c and g photos to show AuNPs accumulation inside Sertoli cell, spermatogonium, primary spermatocyte, mature sperm head and tail and Leydig cell (a + , b + , c + , e, f and g + respectively). Wide intercellular spaces are shown between Sertoli cell, spermatogonium and their adjacent cells (<bold>a</bold> and <bold>b</bold>). Spermatogonium and primary spermatocyte show disrupted nuclear membrane (<bold>b</bold> and <bold>c</bold> respectively). Round spermatid shows peripherally arranged vaculated mitochondria (<bold>d</bold>). Leydig cells show shrunken nucleus and excess lipid droplets (<bold>g</bold>). Cytoplasmic vacuolization and mitochondrial degeneration are present in almost all testicular cells. Scale bar: 2 μm (a, b, c, d and g) and 500 nm (a<sup>+</sup>, b<sup>+</sup>, c<sup>+</sup>, e, f and g<sup>+</sup>). Number of observations: 5 images per each testicular cell type</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><p>Electron micrographs of the testicular cells of withdrawal group I showing Sertoli cell with normal indented nuclear membrane, vacuolization and mitochondrial degeneration (<bold>a</bold>), spermatogonium and primary spermatocyte with irregular nuclear membranes, perinuclear spaces, vacuolization and mitochondrial degeneration (<bold>b</bold> and <bold>c</bold> respectively), normal round spermatid (<bold>d</bold>), heads and tails of mature sperms with vaculated mitochondria (<bold>e</bold> and <bold>f</bold> respectively). Leydig cell with degenerated mitochondria and excess lipid droplets (<bold>g</bold>). Scale bar: 2 μm (<bold>a</bold>, <bold>b</bold>, <bold>c</bold>, <bold>d</bold>, <bold>e</bold> and <bold>g</bold>) and 1 μm (<bold>f</bold>). Number of observations: 5 images per each testicular cell type</p></caption></fig>", "<fig id=\"Fig7\"><label>Fig. 7</label><caption><p>Electron micrographs of the testicular cells of withdrawal group II showing near normal thickness basal lamina (<bold>a</bold> and <bold>b</bold>), Sertoli cell with normal indented nuclei and prominent nucleoli, its cytoplasm contains mitochondria and small vacuoles (<bold>a</bold>), normal spermatogonium (<bold>b</bold>), primary spermatocyte with few vaculated mitochondria (<bold>c</bold>), normal round spermatids (<bold>d</bold>), normal transverse sections of mature sperm tails (<bold>e</bold>), normal Leydig cell (f). Scale bar: 2 μm (<bold>a</bold>, <bold>b</bold>, <bold>c</bold> and <bold>d</bold>) and 1 μm (<bold>e</bold> and <bold>f</bold>). Number of observations: 5 images per each testicular cell type</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Johnsen’s tubular biopsy score according to histologic criteria of spermatogenic cells</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Score</th><th align=\"left\">Histologic criteria of spermatogenic cells</th></tr></thead><tbody><tr><td align=\"left\">10</td><td align=\"left\">Complete spermatogenesis, numerous spermatozoa, germinal epithelium of regular height and tubular lumen of normal diameter</td></tr><tr><td align=\"left\">9</td><td align=\"left\">Numerous spermatozoa, germinal epithelium disorganized with sequestration of germinal cells and tubular lumen obturated</td></tr><tr><td align=\"left\">8</td><td align=\"left\">Less than 5 ± 10 spermatozoa per tubular cross-section</td></tr><tr><td align=\"left\">7</td><td align=\"left\">No spermatozoa, but numerous spermatids, spermatocytes and spermatogonia</td></tr><tr><td align=\"left\">6</td><td align=\"left\">No spermatozoa, 5 ± 20 spermatids and numerous spermatocytes and spermatogonia per cross-section</td></tr><tr><td align=\"left\">5</td><td align=\"left\">No spermatozoa and spermatids, but numerous spermatocytes and spermatogonia</td></tr><tr><td align=\"left\">4</td><td align=\"left\">No spermatozoa and spermatids, less than 5 spermatocytes, but numerous spermatogonia per cross-section</td></tr><tr><td align=\"left\">3</td><td align=\"left\">Only spermatogonia</td></tr><tr><td align=\"left\">2</td><td align=\"left\">No germinal cells, only Sertoli cells (Sertoli-cell-only syndrome)</td></tr><tr><td align=\"left\">1</td><td align=\"left\">No cells at all within the tubules</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Comparisons between initial and final body weights (g) and percentage of weight change among all studied groups (n = 60)</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Groups<break/>(n = 15 for each)</th><th align=\"left\">Initial body weight (g)<break/>Mean ± SD</th><th align=\"left\">Final body weight (g)<break/>Mean ± SD</th><th align=\"left\">Comparison between initial and final body weights</th><th align=\"left\">Percentage of weight change</th></tr></thead><tbody><tr><td align=\"left\">Control group</td><td align=\"left\">166.5 ± 9.44</td><td align=\"left\">210.6 ± 32.5</td><td align=\"left\"> &lt; 0.001*</td><td char=\".\" align=\"char\">26.5%</td></tr><tr><td align=\"left\">Test group</td><td align=\"left\">170.70 ± 16.45</td><td align=\"left\">181 ± 17.99</td><td align=\"left\">0.087</td><td char=\".\" align=\"char\">9.0%</td></tr><tr><td align=\"left\">Withdrawal group I</td><td align=\"left\">158.6 ± 10.58</td><td align=\"left\">197.1 ± 4.80</td><td align=\"left\">0.024*</td><td char=\".\" align=\"char\">24.3%</td></tr><tr><td align=\"left\">Withdrawal group II</td><td align=\"left\">171.40 ± 15.03</td><td align=\"left\">236.1 ± 24.71</td><td align=\"left\"> &lt; 0.001*</td><td char=\".\" align=\"char\">37.7%</td></tr><tr><td align=\"left\" rowspan=\"7\">Comparison of final body weights among all studied groups</td><td align=\"left\" colspan=\"2\">Test of significance</td><td align=\"left\" colspan=\"2\">Paired comparison</td></tr><tr><td align=\"left\" rowspan=\"6\" colspan=\"2\"><p>F = 5.2</p><p><italic>p</italic> = 0.004*</p></td><td align=\"left\" colspan=\"2\"><italic>p1</italic> = 0.048*</td></tr><tr><td align=\"left\" colspan=\"2\"><italic>p2</italic> = 0.357</td></tr><tr><td align=\"left\" colspan=\"2\"><italic>p3</italic> = 0.086</td></tr><tr><td align=\"left\" colspan=\"2\"><italic>p4</italic> = 0.273</td></tr><tr><td align=\"left\" colspan=\"2\"><italic>p5</italic> = 0.001*</td></tr><tr><td align=\"left\" colspan=\"2\"><italic>p6</italic> = 0.01*</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Comparisons of absolute testicular weights (g) among all studied groups of rats (n = 60)</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Groups<break/>(n = 15 for each)</th><th align=\"left\">Absolute testicular weights (g)<break/>Mean ± SD</th><th align=\"left\">Test of significance</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"2\">Control group</td><td align=\"left\" rowspan=\"2\">1.37 ± 0.15</td><td align=\"left\">F = 7.32</td></tr><tr><td align=\"left\"><italic>p</italic> = 0.001*</td></tr><tr><td align=\"left\">Test group</td><td align=\"left\">1.08 ± 0.21</td><td align=\"left\">Paired comparison</td></tr><tr><td align=\"left\" rowspan=\"6\">Withdrawal group I</td><td align=\"left\" rowspan=\"6\">1.15 ± 0.13</td><td align=\"left\"><italic>p1</italic> = 0.002*</td></tr><tr><td align=\"left\"><italic>p2</italic> = 0.014*</td></tr><tr><td align=\"left\"><italic>p3</italic> = 0.635</td></tr><tr><td align=\"left\"><italic>p4</italic> = 0.408</td></tr><tr><td align=\"left\"><italic>p5</italic> = 0.001*</td></tr><tr><td align=\"left\" rowspan=\"2\"><italic>p6</italic> = 0.004*</td></tr><tr><td align=\"left\">Withdrawal group II</td><td align=\"left\">1.40 ± <italic>0.2</italic>4</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab4\"><label>Table 4</label><caption><p>Comparison of serum testosterone hormone levels (ng/dL) among all studied groups of rats (n = 60)</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Groups<break/>(n = 15 for each)</th><th align=\"left\">Serum testosterone hormone levels (ng/dL)<break/>Mean ± SD</th><th align=\"left\">Test of significance</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"2\">Control group</td><td align=\"left\" rowspan=\"2\">190.06 ± 30.58</td><td align=\"left\">F = 49.69</td></tr><tr><td align=\"left\"><italic>p</italic> &lt; 0.001*</td></tr><tr><td align=\"left\">Test group</td><td align=\"left\">84.79 ± 20.74</td><td align=\"left\">Paired comparison</td></tr><tr><td align=\"left\" rowspan=\"4\">Withdrawal group I</td><td align=\"left\" rowspan=\"4\">161.40 ± 20.91</td><td align=\"left\"><italic>p1</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p2</italic> = 0.01*</td></tr><tr><td align=\"left\"><italic>p3</italic> = 0.20</td></tr><tr><td align=\"left\"><italic>p4</italic> &lt; 0.001*</td></tr><tr><td align=\"left\" rowspan=\"2\">Withdrawal group II</td><td align=\"left\" rowspan=\"2\">203.97 ± 21.84</td><td align=\"left\"><italic>p5</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p6</italic> &lt; 0.001*</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab5\"><label>Table 5</label><caption><p>Comparison of semen analysis parameters (sperm count, motility and abnormal morphology) among all studied groups of rats (n = 60)</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Groups<break/>(n = 15 for each)</th><th align=\"left\">Sperm count<break/>(10<sup>6</sup>/ mL)<break/>Mean ± SD</th><th align=\"left\">Sperm motility<break/>(%)<break/>Mean ± SD</th><th align=\"left\">Abnormal sperm morphology<break/>(%)<break/>Median (min—max)</th></tr></thead><tbody><tr><td align=\"left\">Control group</td><td align=\"left\">111.68 ± 9.06</td><td align=\"left\">93.0 ± 2.58</td><td align=\"left\">4 (0—6)</td></tr><tr><td align=\"left\">Test group</td><td align=\"left\">56.54 ± 12.97</td><td align=\"left\">52.50 ± 6.34</td><td align=\"left\">20 (10—25)</td></tr><tr><td align=\"left\">Withdrawal group I</td><td align=\"left\">76.52 ± 14.72</td><td align=\"left\">77.5 ± 9.20</td><td align=\"left\">10 (5—15)</td></tr><tr><td align=\"left\">Withdrawal group II</td><td align=\"left\">112.26 ± 17.26</td><td align=\"left\">85.50 ± 8.32</td><td align=\"left\">5 (0—10)</td></tr><tr><td align=\"left\" rowspan=\"2\">Test of significance</td><td align=\"left\">F = 39.47</td><td align=\"left\">F = 61.66</td><td align=\"left\">KW</td></tr><tr><td align=\"left\"><italic>p</italic> &lt; 0.001*</td><td align=\"left\"><italic>p</italic> &lt; 0.001*</td><td align=\"left\"><italic>p</italic> &lt; 0.001*</td></tr><tr><td align=\"left\" rowspan=\"6\">Paired comparison</td><td align=\"left\"><italic>p1</italic> &lt; 0.001*</td><td align=\"left\"><italic>p1</italic> &lt; 0.001*</td><td align=\"left\"><italic>p1</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p2</italic> &lt; 0.001*</td><td align=\"left\"><italic>p2</italic> &lt; 0.001*</td><td align=\"left\"><italic>p2</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p3</italic> = 0.926</td><td align=\"left\"><italic>p3</italic> = 0.069</td><td align=\"left\"><italic>p3</italic> = 0.284</td></tr><tr><td align=\"left\"><italic>p4</italic> = 0.003*</td><td align=\"left\"><italic>p4</italic> &lt; 0.001*</td><td align=\"left\"><italic>p4</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p5</italic> &lt; 0.001*</td><td align=\"left\"><italic>p5</italic> &lt; 0.001*</td><td align=\"left\"><italic>p5</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p6</italic> &lt; 0.001*</td><td align=\"left\"><italic>p6</italic> = 0.002*</td><td align=\"left\"><italic>p6</italic> = 0.008*</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab6\"><label>Table 6</label><caption><p>Comparison of Johnsen's tubular biopsy scores for spermatogenesis among all studied groups of rats (<italic>n</italic> = 60)</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Groups<break/>(n = 15 for each)</th><th align=\"left\">Johnsen's tubular biopsy score for spermatogenesis (ng/dL)<break/>Mean ± SD</th><th align=\"left\">Test of significance</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"2\">Control group</td><td align=\"left\" rowspan=\"2\">9.46 ± 0.11</td><td align=\"left\">F = 31.41</td></tr><tr><td align=\"left\"><italic>p</italic> &lt; 0.001*</td></tr><tr><td align=\"left\">Test group</td><td align=\"left\">3.76 ± 2.69</td><td align=\"left\">Paired comparison</td></tr><tr><td align=\"left\" rowspan=\"3\">Withdrawal group I</td><td align=\"left\" rowspan=\"3\">7.74 ± 1.10</td><td align=\"left\"><italic>p1</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p2</italic> = 0.014*</td></tr><tr><td align=\"left\"><italic>p3</italic> = 0.675</td></tr><tr><td align=\"left\" rowspan=\"3\">Withdrawal group II</td><td align=\"left\" rowspan=\"3\">9.18 ± 0.59</td><td align=\"left\"><italic>p4</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p5</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p6</italic> = 0.037*</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab7\"><label>Table 7</label><caption><p>Comparison of testicular histopathological score results among all studied groups of rats (n = 60)</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Groups<break/>(n = 15 for each)</th><th align=\"left\">Control group</th><th align=\"left\">Test group</th><th align=\"left\">Withdrawal group I</th><th align=\"left\">Withdrawal group II</th><th align=\"left\">Test of significance</th><th align=\"left\">Paired comparison</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"6\"><p>Disruption of seminiferous tubules</p><p>Median</p><p>(min- max)</p></td><td align=\"left\" rowspan=\"6\"><p>0</p><p>(0–0)</p></td><td align=\"left\" rowspan=\"6\"><p>2.25</p><p>(1–3)</p></td><td align=\"left\" rowspan=\"6\"><p>0.85</p><p>(0.2–1.7)</p></td><td align=\"left\" rowspan=\"6\"><p>0.005</p><p>(0–0.04)</p></td><td align=\"left\" rowspan=\"6\"><p>KW</p><p><italic>p</italic> &lt; 0.001*</p></td><td align=\"left\"><italic>p1</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p2</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p3</italic> = 0.063</td></tr><tr><td align=\"left\"><italic>p4</italic> = 0.001*</td></tr><tr><td align=\"left\"><italic>p5</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p6</italic> = 0.001*</td></tr><tr><td align=\"left\" rowspan=\"6\"><p>Detachment of spermatogenic cells</p><p>Median</p><p>(min- max)</p></td><td align=\"left\" rowspan=\"6\"><p>0</p><p>(0–0)</p></td><td align=\"left\" rowspan=\"6\"><p>2.85</p><p>(1–3)</p></td><td align=\"left\" rowspan=\"6\"><p>0.95</p><p>(0.5–1.7)</p></td><td align=\"left\" rowspan=\"6\"><p>0</p><p>(0–0.3)</p></td><td align=\"left\" rowspan=\"6\"><p>KW</p><p><italic>p</italic> &lt; 0.001*</p></td><td align=\"left\"><italic>p1</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p2</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p3</italic> = 0.068</td></tr><tr><td align=\"left\"><italic>p4</italic> = 0.002*</td></tr><tr><td align=\"left\"><italic>p5</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p6</italic> &lt; 0.001*</td></tr><tr><td align=\"left\" rowspan=\"6\"><p>Inflammation</p><p>Median</p><p>(min- max)</p></td><td align=\"left\" rowspan=\"6\"><p>0</p><p>(0–0)</p></td><td align=\"left\" rowspan=\"6\"><p>1.35</p><p>(1–3)</p></td><td align=\"left\" rowspan=\"6\"><p>0</p><p>(0–0.5)</p></td><td align=\"left\" rowspan=\"6\"><p>0</p><p>(0–0.8)</p></td><td align=\"left\" rowspan=\"6\"><p>KW</p><p><italic>p</italic> &lt; 0.001*</p></td><td align=\"left\"><italic>p1</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p2</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p3</italic> = 0.147</td></tr><tr><td align=\"left\"><italic>p4</italic> = 0.001*</td></tr><tr><td align=\"left\"><italic>p5</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p6</italic> = 0.691</td></tr><tr><td align=\"left\" rowspan=\"6\"><p>Edema of interstitium</p><p>Median</p><p>(min- max)</p></td><td align=\"left\" rowspan=\"6\"><p>0</p><p>(0–0)</p></td><td align=\"left\" rowspan=\"6\"><p>2.65</p><p>(1–3)</p></td><td align=\"left\" rowspan=\"6\"><p>0.75</p><p>(0.3–1.3)</p></td><td align=\"left\" rowspan=\"6\"><p>0</p><p>(0–0.1)</p></td><td align=\"left\" rowspan=\"6\"><p>KW</p><p><italic>p</italic> &lt; 0.001*</p></td><td align=\"left\"><italic>p1</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p2</italic> = 0.001*</td></tr><tr><td align=\"left\"><italic>p3</italic> = 0.317</td></tr><tr><td align=\"left\"><italic>p4</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p5</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p6</italic> = 0.013*</td></tr><tr><td align=\"left\" rowspan=\"6\"><p>Congestion of vessels</p><p>Median</p><p>(min- max)</p></td><td align=\"left\" rowspan=\"6\"><p>0</p><p>(0–0)</p></td><td align=\"left\" rowspan=\"6\"><p>1.75</p><p>(1–3)</p></td><td align=\"left\" rowspan=\"6\"><p>0.15</p><p>(0–0.5)</p></td><td align=\"left\" rowspan=\"6\"><p>0</p><p>(0–0.1)</p></td><td align=\"left\" rowspan=\"6\"><p>KW</p><p><italic>p</italic> &lt; 0.001*</p></td><td align=\"left\"><italic>p1</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p2</italic> = 0.005*</td></tr><tr><td align=\"left\"><italic>p3</italic> = 0.063</td></tr><tr><td align=\"left\"><italic>p4</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p5</italic> &lt; 0.001</td></tr><tr><td align=\"left\"><italic>p6</italic> = 0.481</td></tr><tr><td align=\"left\" rowspan=\"6\"><p>Sertoli cells degeneration</p><p>Median</p><p>(min- max)</p></td><td align=\"left\" rowspan=\"6\"><p>0</p><p>(0–0)</p></td><td align=\"left\" rowspan=\"6\"><p>2.75</p><p>(1–3)</p></td><td align=\"left\" rowspan=\"6\"><p>0.75</p><p>(0.4–1.5)</p></td><td align=\"left\" rowspan=\"6\"><p>0</p><p>(0–0.2)</p></td><td align=\"left\" rowspan=\"6\"><p>KW</p><p><italic>p</italic> &lt; 0.001*</p></td><td align=\"left\"><italic>p1</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p2</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p3</italic> = 0.147</td></tr><tr><td align=\"left\"><italic>p4</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p5</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p6</italic> = 0.001*</td></tr><tr><td align=\"left\" rowspan=\"6\"><p>Leydig cells degeneration</p><p>Median</p><p>(min- max)</p></td><td align=\"left\" rowspan=\"6\"><p>0</p><p>(0–0)</p></td><td align=\"left\" rowspan=\"6\"><p>2.25</p><p>(1–3)</p></td><td align=\"left\" rowspan=\"6\"><p>0.15</p><p>(0–0.5)</p></td><td align=\"left\" rowspan=\"6\"><p>0</p><p>(0–0.8)</p></td><td align=\"left\" rowspan=\"6\"><p>KW</p><p><italic>p</italic> &lt; 0.001*</p></td><td align=\"left\"><italic>p1</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p2</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p3</italic> = 0.147</td></tr><tr><td align=\"left\"><italic>p4</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p5</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p6</italic> = 0.008*</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab8\"><label>Table 8</label><caption><p>Comparisons of digital image analysis results among all studied groups of rats (n = 60)</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Groups<break/>(n = 15 for each)</th><th align=\"left\">Thickness of tunica albuginea (μm)<break/>Mean ± SD</th><th align=\"left\">Thickness of the blood vascular walls (μm)<break/>Mean ± SD</th><th align=\"left\">Thickness of the epithelial lining of the tubule (μm) Mean ± SD</th><th align=\"left\">Diameters of seminiferous tubules (μm) Mean ± SD</th></tr></thead><tbody><tr><td align=\"left\">Control group</td><td align=\"left\">8.46 ± 1.41</td><td align=\"left\">5.98 ± 2.91</td><td align=\"left\">41.71 ± 9.38</td><td align=\"left\">140.83 ± 23.16</td></tr><tr><td align=\"left\">Test group</td><td align=\"left\">40.08 ± 8.47</td><td align=\"left\">18.36 ± 8.48</td><td align=\"left\">15.56 ± 5.39</td><td align=\"left\">234.32 ± 87.45</td></tr><tr><td align=\"left\">Withdrawal group I</td><td align=\"left\">18.57 ± 4.28</td><td align=\"left\">8.66 ± 1.65</td><td align=\"left\">26.43 ± 5.33</td><td align=\"left\">197.67 ± 67.05</td></tr><tr><td align=\"left\">Withdrawal group II</td><td align=\"left\">10.27 ± 1.41</td><td align=\"left\">7.62 ± 1.75</td><td align=\"left\">37.39 ± 7.21</td><td align=\"left\">169.09 ± 17.46</td></tr><tr><td align=\"left\" rowspan=\"2\">Test of significance</td><td align=\"left\">F = 161.08</td><td align=\"left\">F = 26.02</td><td align=\"left\">F = 50.18</td><td align=\"left\">F = 8.87</td></tr><tr><td align=\"left\"><italic>p</italic> &lt; 0.001*</td><td align=\"left\"><italic>p</italic> &lt; 0.001*</td><td align=\"left\"><italic>p</italic> &lt; 0.001*</td><td align=\"left\"><italic>p</italic> &lt; 0.001*</td></tr><tr><td align=\"left\" rowspan=\"6\">Paired comparison</td><td align=\"left\"><italic>p1</italic> &lt; 0.001*</td><td align=\"left\"><italic>p1</italic> &lt; 0.001*</td><td align=\"left\"><italic>p1</italic> &lt; 0.001*</td><td align=\"left\"><italic>p1</italic> &lt; 0.001*</td></tr><tr><td align=\"left\"><italic>p2</italic> &lt; 0.001*</td><td align=\"left\"><italic>p2</italic> = 0.09</td><td align=\"left\"><italic>p2</italic> &lt; 0.001*</td><td align=\"left\"><italic>p2</italic> = 0.004*</td></tr><tr><td align=\"left\"><italic>p3</italic> = 0.264</td><td align=\"left\"><italic>p3</italic> = 0.293</td><td align=\"left\"><italic>p3</italic> = 0.147</td><td align=\"left\"><italic>p3</italic> = 0.141</td></tr><tr><td align=\"left\"><italic>p4</italic> = 0.001*</td><td align=\"left\"><italic>p4</italic> = 0.001*</td><td align=\"left\"><italic>p4</italic> = 0.001*</td><td align=\"left\"><italic>p4</italic> = 0.058</td></tr><tr><td align=\"left\"><italic>p5</italic> &lt; 0.001*</td><td align=\"left\"><italic>p5</italic> &lt; 0.001*</td><td align=\"left\"><italic>p5</italic> &lt; 0.001*</td><td align=\"left\"><italic>p5</italic> = 0.001*</td></tr><tr><td align=\"left\"><italic>p6</italic> &lt; 0.001*</td><td align=\"left\"><italic>p6</italic> = 0.504</td><td align=\"left\"><italic>p6</italic> = 0.691</td><td align=\"left\"><italic>p6</italic> = 0.137</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p><italic>n</italic> number, <italic>g</italic> gram, <italic>SD</italic> standard deviation, <italic>p</italic> comparison among all studied groups, <italic>p1</italic> comparison between control group and test group, <italic>p2</italic> comparison between control group and withdrawal group I, <italic>p3</italic> comparison between control group and withdrawal group II, <italic>p4</italic> comparison between test group and withdrawal group I, <italic>p5</italic> comparison between test group and withdrawal group II, <italic>p6</italic> comparison between withdrawal groups I and II, <italic>F</italic> One Way ANOVA test, *<italic>p</italic> is significant</p></table-wrap-foot>", "<table-wrap-foot><p><italic>n</italic> number, <italic>g</italic> gram, <italic>SD</italic> standard deviation, <italic>p</italic> comparison among all studied groups, <italic>p1</italic> comparison between control group and test group, <italic>p2</italic> comparison between control group and withdrawal group I, <italic>p3</italic> comparison between control group and withdrawal group II, <italic>p4</italic> comparison between test group and withdrawal group I, <italic>p5</italic> comparison between test group and withdrawal group II, <italic>p6</italic> comparison between withdrawal groups I and II, <italic>F</italic> One Way ANOVA test, *<italic>p</italic> is significant</p></table-wrap-foot>", "<table-wrap-foot><p><italic>n</italic> number, <italic>ng</italic> nanogram, <italic>dL</italic> deciliter, <italic>SD</italic> standard deviation, <italic>p</italic>: comparison among all studied groups, <italic>p1</italic> comparison between control group and test group, <italic>p2</italic> comparison between control group and withdrawal group I, <italic>p3</italic> comparison between control group and withdrawal group II, <italic>p4</italic> comparison between test group and withdrawal group I, <italic>p5</italic> comparison between test group and withdrawal group II, <italic>p6</italic> comparison between withdrawal groups I and II, <italic>F</italic> One Way ANOVA test, *<italic>p</italic> is significant</p></table-wrap-foot>", "<table-wrap-foot><p><italic>n</italic> number, <italic>mL</italic> milliliter, <italic>SD</italic> standard deviation, <italic>min</italic> minimum, <italic>max</italic> maximum. <italic>p</italic> comparison among all studied groups. <italic>p1</italic> comparison between control group and test group. <italic>p2</italic> comparison between control group and withdrawal group I, <italic>p3</italic> comparison between control group and withdrawal group II. <italic>p4</italic> comparison between test group and withdrawal group I. <italic>p5</italic> comparison between test group and withdrawal group II, <italic>p6</italic> comparison between withdrawal groups I and II. <italic>F</italic> One Way ANOVA test, <italic>KW</italic> Kruskal Wallis test, *<italic>p</italic> is significant</p></table-wrap-foot>", "<table-wrap-foot><p><italic>n</italic> number, <italic>SD</italic> standard deviation, <italic>p</italic> comparison among all studied groups, <italic>p1</italic> comparison between control group and test group, <italic>p2</italic> comparison between control group and withdrawal group I, <italic>p3</italic> comparison between control group and withdrawal group II, <italic>p4</italic> comparison between test group and withdrawal group I, <italic>p5</italic> comparison between test group and withdrawal group II, <italic>p6</italic> comparison between withdrawal groups I and II, <italic>F</italic> One Way ANOVA test, *<italic>p</italic> is significant</p></table-wrap-foot>", "<table-wrap-foot><p><italic>n</italic> number, <italic>min</italic> minimum, <italic>max</italic> maximum, <italic>p</italic> comparison among all studied groups, <italic>p1</italic> comparison between control group and test group, <italic>p2</italic> comparison between control group and withdrawal group I, <italic>p3</italic> comparison between control group and withdrawal group II, <italic>p4</italic> comparison between test group and withdrawal group I, <italic>p5</italic> comparison between test group and withdrawal group II, <italic>p6</italic> comparison between withdrawal groups I and II, <italic>KW</italic> Kruskal Wallis test. *<italic>p</italic> is significant</p></table-wrap-foot>", "<table-wrap-foot><p><italic>n</italic> number, <italic>μm</italic> micrometer, <italic>SD</italic> standard deviation, <italic>p</italic> comparison among all studied groups, <italic>p1</italic> comparison between control group and test group, <italic>p2</italic> comparison between control group and withdrawal group I, <italic>p3</italic> comparison between control group and withdrawal group II, <italic>p4</italic> comparison between test group and withdrawal group I, <italic>p5</italic> comparison between test group and withdrawal group II, <italic>p6</italic> comparison between withdrawal groups I and II, <italic>F</italic> One Way ANOVA test. *<italic>p</italic> is significant</p></table-wrap-foot>" ]
[ "<graphic xlink:href=\"43188_2023_203_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"43188_2023_203_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"43188_2023_203_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"43188_2023_203_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"43188_2023_203_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"43188_2023_203_Fig6_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"43188_2023_203_Fig7_HTML\" id=\"MO7\"/>" ]
[ "<media xlink:href=\"43188_2023_203_MOESM1_ESM.xlsx\"><caption><p>Supplementary file1 (XLSX 19 KB)</p></caption></media>" ]
[{"label": ["1."], "surname": ["Ahmed", "Elsheikh", "Attia", "Ali"], "given-names": ["SI", "AS", "GA", "TO"], "article-title": ["Prenatal progesterone exposure of male rats induces morphometric and histological changes in testes"], "source": ["Asian Pac J Reprod"], "year": ["2016"], "volume": ["5"], "fpage": ["204"], "lpage": ["209"], "pub-id": ["10.1016/j.apjr.2016.04.015"]}, {"label": ["3."], "surname": ["Bayomy", "Sarhan", "Abdel-Razek"], "given-names": ["NA", "NI", "KM"], "article-title": ["Effect of an experimental left varicocele on the bilateral testes of adult rats: a histological and immunohistochemical study"], "source": ["Egyp J Histol"], "year": ["2012"], "volume": ["35"], "fpage": ["509"], "lpage": ["519"], "pub-id": ["10.1097/01.EHX.0000418065.13002.11"]}, {"label": ["4."], "surname": ["Behnammorshedi", "Nazem", "Moghadam"], "given-names": ["M", "H", "MS"], "article-title": ["The effect of gold nanoparticle on luteinizing hormone, follicle stimulating hormone, testosterone and testis in male rat"], "source": ["Biomed Res"], "year": ["2015"], "volume": ["26"], "fpage": ["48"], "lpage": ["352"]}, {"label": ["5."], "surname": ["Bratovcic"], "given-names": ["A"], "article-title": ["Different applications of nanomaterials and their impact on the environment"], "source": ["Int J Mater Sci Eng"], "year": ["2019"], "volume": ["5"], "fpage": ["1"], "lpage": ["7"], "pub-id": ["10.14445/23948884/IJMSE-V5I1P101"]}, {"label": ["6."], "surname": ["Chen", "Ng", "Bishop"], "given-names": ["H", "JP", "DP"], "article-title": ["Gold nanoparticles as cell regulators: beneficial effects of gold nanoparticles on the metabolic profile of mice with pre-existing obesity"], "source": ["J Nanobiotechnol"], "year": ["2018"], "volume": ["16"], "fpage": ["1"], "lpage": ["13"], "pub-id": ["10.1186/s12951-018-0414-6"]}, {"label": ["7."], "surname": ["Chianese", "Pierantoni"], "given-names": ["R", "R"], "article-title": ["Mitochondrial reactive oxygen species (ROS) production alters sperm quality"], "source": ["Antioxidants"], "year": ["2021"], "volume": ["10"], "fpage": ["1"], "lpage": ["19"], "pub-id": ["10.3390/antiox10010092"]}, {"label": ["8."], "mixed-citation": ["Dayal N, Singh D, Patil P et al (2017) Effect of bioaccumulation of gold nanoparticles on ovarian morphology of female Zebrafish (Danio rerio). World J Pathol 6:1\u201312. "], "ext-link": ["http://www.npplweb.com/wjp/content/6/1"]}, {"label": ["10."], "mixed-citation": ["Gupta H, Singh D, Vanage G et al (2018) Evaluation of histopathological and ultrastructural changes in the testicular cells of Wistar rats post chronic exposure to gold nanoparticles. Indian J Biotechnol 17:9\u201315. "], "ext-link": ["http://nopr.niscpr.res.in/handle/123456789/44831"]}, {"label": ["11."], "surname": ["Habas", "Demir", "Guo"], "given-names": ["K", "E", "C"], "article-title": ["Toxicity mechanisms of nanoparticles in the male reproductive system"], "source": ["Drug Metab Rev"], "year": ["2021"], "volume": ["1"], "fpage": ["1"], "lpage": ["14"], "pub-id": ["10.1080/03602532.2021.1917597"]}, {"label": ["13."], "surname": ["Hassan", "Abdoon", "Elsheikh", "Khairy", "Gamaleldin", "Elnabtity"], "given-names": ["AA", "ASS", "SM", "MH", "AA", "SM"], "article-title": ["Effect of acute gold nanorods on reproductive function in male albino rats: histological, morphometric, hormonal, and redox balance parameters"], "source": ["Environ Sci Pollut Res"], "year": ["2019"], "volume": ["26"], "fpage": ["15816"], "lpage": ["15827"], "pub-id": ["10.1007/s11356-019-04884-x"]}, {"label": ["16."], "surname": ["Iftikhar", "Noureen", "Uzair"], "given-names": ["M", "A", "M"], "article-title": ["Perspectives of nanoparticles in male infertility: evidence for induced abnormalities in sperm production"], "source": ["Int J Environ Res Public Health"], "year": ["2021"], "volume": ["18"], "fpage": ["1"], "lpage": ["19"], "pub-id": ["10.3390/ijerph18041758"]}, {"label": ["17."], "surname": ["Jia", "Ma", "Wei"], "given-names": ["YP", "BY", "XW"], "article-title": ["The in vitro and in vivo toxicity of gold nanoparticles"], "source": ["Chin Chem Lett"], "year": ["2017"], "volume": ["28"], "fpage": ["691"], "lpage": ["702"], "pub-id": ["10.1016/j.cclet.2017.01.021"]}, {"label": ["18."], "surname": ["Kamel", "Mohammad", "Maurice"], "given-names": ["ME", "HM", "C"], "article-title": ["Ginseng nanoparticles protect against methotrexate-induced testicular toxicity in rats"], "source": ["Egypt J Basic Clin Pharmacol"], "year": ["2019"], "volume": ["9"], "fpage": ["1"], "lpage": ["14"], "pub-id": ["10.32527/2019/101397"]}, {"label": ["19."], "surname": ["Kumar", "Abbas", "Aster"], "given-names": ["V", "AK", "JC"], "source": ["Robbins basic pathology e-book"], "year": ["2017"], "edition": ["10"], "publisher-loc": ["Philadelphia, Pensylvania"], "publisher-name": ["Elsevier Health Sciences"], "fpage": ["31"], "lpage": ["53"]}, {"label": ["20."], "surname": ["Leclerc", "Klein", "Forest"], "given-names": ["L", "JP", "V"], "article-title": ["Testicular biodistribution of silica-gold nanoparticles after intramuscular injection in mice"], "source": ["Biomed Microdevice"], "year": ["2015"], "volume": ["17"], "fpage": ["1"], "lpage": ["11"], "pub-id": ["10.1007/s10544-015-9968-3"]}, {"label": ["21."], "surname": ["Liu", "Li", "Xiao"], "given-names": ["Y", "X", "S"], "article-title": ["The effects of gold nanoparticles on Leydig cells and male reproductive function in mice"], "source": ["Int J Nanomed"], "year": ["2020"], "volume": ["15"], "fpage": ["1"], "lpage": ["26"], "pub-id": ["10.2147/IJN.S276606"]}, {"label": ["24."], "surname": ["Merza", "Al-Attabi", "Abbas"], "given-names": ["KS", "HD", "ZM"], "article-title": ["Comparative study on methods for preparation of gold nanoparticles"], "source": ["Green Sustain Chem"], "year": ["2012"], "volume": ["2"], "fpage": ["26"], "lpage": ["28"], "pub-id": ["10.4236/gsc.2012.21005"]}, {"label": ["26."], "surname": ["Mohamed", "Saber", "Omar"], "given-names": ["D", "A", "A"], "article-title": ["Effect of cadmium on the testes of adult albino rats and the ameliorating effect of zinc and vitamin E"], "source": ["Br J Sci"], "year": ["2014"], "volume": ["11"], "fpage": ["72"], "lpage": ["95"]}, {"label": ["27."], "surname": ["Nair", "Jacob"], "given-names": ["AB", "S"], "article-title": ["A simple practice guide for dose conversion between animals and human"], "source": ["J Basic Clin Pharmacy"], "year": ["2016"], "volume": ["7"], "fpage": ["27"], "pub-id": ["10.4103/0976-0105.177703"]}, {"label": ["30."], "surname": ["Ren", "Zhang", "Zou"], "given-names": ["L", "J", "Y"], "article-title": ["Silica nanoparticles induce reversible damage of spermatogenic cells via RIPK1 signal pathways in C57 mice"], "source": ["Int J Nanomed"], "year": ["2016"], "volume": ["11"], "fpage": ["2251"], "lpage": ["2264"], "pub-id": ["10.2147/IJN.S102268"]}, {"label": ["31."], "surname": ["Sakhtianchi", "Minchin", "Lee"], "given-names": ["R", "RF", "KB"], "article-title": ["Exocytosis of nanoparticles from cells: role in cellular retention and toxicity"], "source": ["Adv Coll Interface Sci"], "year": ["2013"], "volume": ["201"], "fpage": ["18"], "lpage": ["29"], "pub-id": ["10.1016/j.cis.2013.10.013"]}, {"label": ["33."], "surname": ["Thakur", "Gupta", "Singh"], "given-names": ["M", "H", "D"], "article-title": ["Histopathological and ultrastructural effects of nanoparticles on rat testis following 90 days (chronic study) of repeated oral administration"], "source": ["J Nanobiotechnol"], "year": ["2014"], "volume": ["12"], "fpage": ["1"], "lpage": ["13"], "pub-id": ["10.1186/s12951-014-0042-8"]}, {"label": ["35."], "surname": ["Velikorodnaya", "Pocheptsov", "Sokolov"], "given-names": ["YI", "AY", "OI"], "article-title": ["Effect of gold nanoparticles on proliferation and apoptosis during spermatogenesis in rats"], "source": ["Nanotechnol Russ"], "year": ["2015"], "volume": ["10"], "fpage": ["814"], "lpage": ["819"], "pub-id": ["10.1134/S1995078015050201"]}, {"label": ["37."], "surname": ["Xu", "Wang", "Yu"], "given-names": ["Y", "N", "Y"], "article-title": ["Exposure to silica nanoparticles causes reversible damage of the spermatogenic process in mice"], "source": ["PLoS ONE"], "year": ["2014"], "volume": ["9"], "fpage": ["1"], "lpage": ["11"], "pub-id": ["10.1371/journal.pone.0101572"]}, {"label": ["39."], "surname": ["Yulu\u011f", "T\u00fcredi", "Alver"], "given-names": ["E", "S", "A"], "article-title": ["Effects of resveratrol on methotrexate-induced testicular damage in rats"], "source": ["Sci World J"], "year": ["2013"], "volume": ["8"], "fpage": ["1"], "lpage": ["12"], "pub-id": ["10.1155/2013/489659"]}, {"label": ["41."], "surname": ["Zhang", "Wu", "Wu"], "given-names": ["XD", "HY", "D"], "article-title": ["Toxicologic effects of gold nanoparticles in vivo by different administration routes"], "source": ["Int J Nanomed"], "year": ["2010"], "volume": ["5"], "fpage": ["771"], "lpage": ["781"], "pub-id": ["10.2147/IJN.S8428"]}]
{ "acronym": [], "definition": [] }
41
CC BY
no
2024-01-14 23:40:13
Toxicol Res. 2023 Aug 23; 40(1):57-72
oa_package/da/13/PMC10786773.tar.gz
PMC10786774
38214765
[ "<title>Introduction</title>", "<p id=\"Par7\">In recent years, interest in 2D materials, especially MXenes, has grown due to their unique properties and applications in electronics, energy storage, and sensors [##UREF##0##1##–##UREF##2##3##]. MXenes, derived from MAX phases, exhibit exceptional properties, including high electrical conductivity, large surface area, and tailorable functional groups [##UREF##3##4##, ##REF##35989101##5##]. The key to obtaining high-quality MXenes lies in the selective etching of the A-layer, resulting in surface functional groups such as –O, –OH, and –F [##UREF##4##6##].</p>", "<p id=\"Par8\">Since the discovery of MXene, hydrofluoric acid (HF) has remained the most commonly employed etching method because of its exceptional selectivity in etching the A-layer from the MAX phases. Naguib et al. played a pioneering role in developing this method, marking a significant milestone in the field [##REF##21861270##7##]. However, owing to the hazardous nature of HF, researchers explored alternative etchants, like lithium fluoride (LiF), sodium fluoride (NaF), potassium fluoride (KF), and ammonium fluoride (NH<sub>4</sub>F) salts in hydrochloric acid (HCl) [##UREF##5##8##]. Although this approach mitigates the direct use of HF, it is essential to note that it still carries inherent risks, as the reaction with HCl can lead to the release of toxic HF gas. Consequently, efforts focused on more safer approaches. Halim et al. substituted HF with NH<sub>4</sub>HF<sub>2</sub> [##REF##24741204##9##], while Libo et al. employed a hydrothermal method with NH<sub>4</sub>F (pressurization technique) [##UREF##6##10##]. Xie et al. utilized NaOH and hydrothermal treatments [##REF##25142728##11##], Aihu et al. employed NH<sub>4</sub>HF<sub>2</sub> [##UREF##7##12##], and Biao et al. used water-assisted potassium hydroxide for MXene production [##UREF##8##13##].</p>", "<p id=\"Par9\">Despite much progress in etching methods, achieving successful MXene preparation remains a challenge, especially for researchers without a material or chemical background. Existing methods may require multiple attempts, making it uncertain to obtain high-quality products. One limitation of the stirred-based methods is the incomplete penetration of the etchant between the stacked layers, which can result in residual Al. Similarly, the autoclave treatments may suffer from incomplete etching due to a lack of stirring. To address these issues, a new approach combining simultaneous stirring and pressurizing is needed for effective etching. This ensures proper interaction with each flake and the production of high-quality MXenes. Furthermore, Precise control over MXene thickness and size is crucial for enhancing their properties, including electrical conductivity, optical characteristics, surface catalysis and overall performances [##REF##30705273##14##–##REF##29118368##17##]. This control is often achieved through exfoliation processes, such as tip-sonication of MXene in various exfoliating solvents, such as dimethyl sulfoxide (DMSO) and <italic>N</italic>-methyl-2-pyrrolidone (NMP) [##UREF##10##18##]. However, it's important to note that exfoliation is a secondary process in MXene synthesis, with etching being the primary factor that determines thickness and size control. Skillful etching allows successful exfoliation, resulting in MXenes with various thicknesses and sizes to meet specific application requirements.</p>", "<p id=\"Par10\">To further improve properties of MXene or based materials, such as electrical conductivity, optical characteristics, and stability, control over surface functional groups (–O, –OH, –F) is crucial [##REF##30705273##14##, ##UREF##11##19##, ##UREF##12##20##]. While defunctionalization can improve conductivity [##REF##30705273##14##], the ambient reattachment of –O and –OH groups degrade their stability and performance. To improve the characteristics of MXenes, various approaches have been proposed, including incorporating metal oxides, defect control, polymer composites, and optimizing storage environments [##UREF##1##2##, ##REF##33723803##21##–##UREF##14##24##]. However, studies on the surface engineering of effective protective layers that enhance the characteristics of MXenes is still limited. Previous studies have explored surface engineering using solution-based techniques. For instance, functionalizing MXenes with fluoroalkylsilane (FOTS) molecules resulted in a superhydrophobic surface, improved stability, and enhanced gas-sensing performance [##REF##32857499##25##]. Similarly, Jingjing et al. functionalized MXenes with (3-Aminopropyl)triethoxysilane for efficient stabilization [##UREF##15##26##]. Lim et al. utilized alkylsilane coupling agents to increase the surface hydrophobicity of Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> MXenes, enabling their dispersibility in nonpolar solvents such as hexane [##UREF##16##27##]. Similarly, Xin et al. introduced hydrocarbon termination to reduce the hydrophilicity of Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> MXene and improve its sensitivity to volatile organic compounds [##UREF##17##28##]. Prior work improved MXene stability and sensing performance despite unwanted functional groups (–O/–OH and –F), which negatively impact conductivity and overall performance, hindering comprehensive understanding of new functional groups' effects. This emphasizes the need for a cleaning step before introducing desired functional groups to study their impact. Current solution-based methods have limitations, necessitating a liquid-free technique to remove unwanted functional groups and graft target ones. This approach could substantially enhance MXene properties and performance for broader applications, such as gas sensing performances.</p>", "<p id=\"Par11\">Previous MXene research mainly utilized molecular functional groups [##REF##33723803##21##, ##UREF##13##22##, ##UREF##14##24##], limiting direct comparison with elemental MXene functional groups (–O/–OH and –F) in terms of fundamental characteristics (electronegativity, atomic size, shielding effect, and hydrophilicity) [##REF##32857499##25##, ##UREF##15##26##, ##UREF##17##28##]. Investigating the elemental forms of these functional groups is essential for comprehensive understanding. Some studies explored elemental functional groups to enhance MXene properties. For example, Shi et al. enhanced ambient stability by replacing –F with –I [##UREF##18##29##], and Wang et al. effectively tuned the work function of Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> MXene using oxygen plasma treatment to enhance electron transport in perovskite solar cells [##REF##34185990##30##]. Although halogenated functional groups (such as –I, –Br, and –IBr) [##REF##33502839##31##, ##REF##33415973##32##] have been studied in energy storage, their role in gas sensing is underexplored. Additionally, MXenes possess inherent metallic properties, allowing efficient electron donation to adsorbed gas molecules, regardless of whether they are oxidizing or reducing gases [##REF##32857499##25##, ##REF##29368519##33##]. However, the high electronegativity and shielding effect of –O/–OH and –F result in prolonged response and recovery times. Also, the smaller atomic size of –O/–OH and –F reduces interlayer space and specific surface area. Therefore, exploring substitutions of –O/–OH and –F functional groups with other elements provides insights into their effects on MXene properties in gas sensing.</p>", "<p id=\"Par12\">Herein, we implemented a comprehensive approach to achieve precise control over the thickness of MXene flakes within the MXene film. Additionally, we developed a unique gas-phase method, conducted in an isolated environment, to defunctionalize and functionalize MXenes with elemental forms of functional groups (–I and –Br). This research sheds light on the fundamental characteristics of these functional groups and their interplay with the metallic nature of MXenes, particularly in gas-sensing applications. We found that iodine, serving as a hydrophobic terminal (contact angle: 99°) on the Ti<sub>3</sub>C<sub>2</sub> MXene surface, effectively counteracts oxidative instability. Furthermore, the larger atomic size of iodine, lower electronegativity, and lower shielding effect significantly increased the specific surface area of MXene (36.2 cm<sup>2</sup> g<sup>−1</sup>), conductivity (749 S m<sup>−1</sup>), sensitivity (0.1119 Ω ppm<sup>−1</sup>), linear detection limit (0.05–200 ppm), and the adsorption/desorption efficiency (100/112 s). These advancements position MXenes as highly promising for advanced gas-sensing applications.</p>" ]
[]
[ "<title>Results and Discussion</title>", "<title>Structural and Morphological Investigation</title>", "<p id=\"Par23\">The XRD patterns shown in Figs. ##FIG##1##1##a and S10a reveal the partial etching of Al from the Ti<sub>3</sub>AlC<sub>2</sub> powder. In the sample stirred in HF and exfoliated in DMSO for 7 h, we observe a slight shift of the (002) peak from 13.92° to 11.76°, accompanied by the appearance of the (104) peak at 41.92° which exhibits a 74% reduction in intensity compared to the MAX phase sample [##REF##32616671##38##, ##UREF##22##39##]. These findings suggest that stirring the MAX phase in HF alone had limited success in etching Al, thus impeding its conversion into smaller MXene flakes. In contrast, through a hybrid HF-hydrothermal treatment involving pressurization of partially etched Ti<sub>3</sub>AlC<sub>2</sub> powder within an advanced high-pressure autoclave reactor, successful etching of Al was achieved even prior to the initiation of the exfoliation process. Therefore, its XRD pattern reveals a downward shift from 11.76° to 8.84° for the (002) peak and the appearance of the (104) peak with a reduced intensity of approximately 80%. This suggests that the pressurization and stirring processes are more effective in eliminating Al content than the bare HF stirring process. Furthermore, through a prolonged tip-sonication process, the (002) peak of Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> experiences an additional shift from 8.84° to 7.82°, indicating an increase in interplanar distance that reduces the stacked-layer and flake thickness: &lt; 100–600 nm and ~ 1 µm (Figs. ##SUPPL##0##S1##j and##SUPPL##0## S10##a). Finally, the I-MXene XRD revealed a further downward shift of the (002) peak from 7.82° to 7.50°, indicating an increased interlayer spacing owing to steric hindrance caused by the larger iodine atoms.</p>", "<p id=\"Par24\">SEM images in Figs. ##SUPPL##0##S1##a, g–j and 1b illustrate the partially etched Ti<sub>3</sub>AlC<sub>2</sub> after 7 h exfoliation (stacked-layer and flake thickness: ~ 500 nm and 10 µm prepared via HF-stirred method), highly etched Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> prior the exfoliation, and fully etched Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> after 7 h exfoliation, respectively. These images clearly demonstrate the successful transformation of bulk Ti<sub>3</sub>AlC<sub>2</sub> to fully etched Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub>. EDS mapping of fully etched Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> was performed, as presented in Fig. ##SUPPL##0##S1##j, k, confirming that C, Ti, F, and –O/–OH were its elemental constituents. Moreover, the tenfold diluted sample was spin-coated onto a Si wafer at 3000 rpm, resulting in a MXene flakes with thickness of 200–600 nm, as shown in Fig. S5e, f. The observed thickness validates the effective removal of thicker MXene flakes (fully etched MXene flakes: 1 µm) by means of dilution. Dilution enables self-assembly of sub-100 nm MXene flakes at the immiscible solvent interface on the Si substrate to form the film. Consequently, the thicknesses of the few-layer MXene on the Si wafer were measured using an AFM as 9, 18, and 63 nm, as depicted in Figs. ##FIG##1##1##c–e and ##SUPPL##0##S4##d, e, ##SUPPL##0##S5##b, c. Furthermore, HRTEM analysis of the few-layer MXene, was performed, along with EDS mapping that confirmed the presence of C, Ti, –F, and –O/–OH as its elemental constituents (Fig. ##FIG##1##1##f–h). The observed copper (Cu) peak originated from the Cu grid used as the substrate. Notably, the distribution of Ti appears non-uniform in the summed EDS image (Fig. ##FIG##1##1##g). This non-uniformity arises because the EDS analysis was conducted on the MXene flake enclosed within the blue dashed rectangle in Fig. ##FIG##1##1##f, where a few more MXene flakes exist at the lower edge of the analyzed flake. Consequently, the EDS analysis reflects a higher Ti content at the lower edge side than in the individual flakes analyzed. Additionally, the presence of white squares in Fig. ##FIG##1##1##c, d, and g indicated the agglomerated MXene nanoparticles, as confirmed through SEM images of fully etched MXene flakes with thickness ranging from 1 to 2 µm (Fig.##SUPPL##0## S4##a–c). Moreover, the AFM images of few-layer MXene (Fig. ##SUPPL##0## S4##d, e) further provide a comprehensive view of these MXene nanoparticles. BET analysis was performed to assess the impact of thickness and functionalization on the specific surface areas of Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> MXene (Figs. ##FIG##1##1##i and ##SUPPL##0## S10##b). The results revealed that the specific surface areas of the MAX phase, fully-etched MXene, few-layer MXene, few-layer I-MXene, and few-layer Br-MXene are 3.8, 14.9, 24.6, 31.7, and 36.2 m<sup>2</sup> g<sup>−1</sup>, respectively, confirming successful exfoliation during the selective etching process. Notably, I-MXene exhibited a higher specific surface area of 36.2 m<sup>2</sup> g<sup>−1</sup>, which was attributed to the increased interplanar distance resulting from the intercalation of larger iodine atoms than oxygen and fluorine, as observed in the XRD analysis. Moreover, water contact angle measurements revealed that the wettability of the Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> nanosheets was modified by –I and –Br terminal groups. The as-prepared Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> with –OH, –O, and –F functional groups exhibited a hydrophilic surface with a water contact angle (<italic>θ</italic>) of 39° (Fig. ##SUPPL##0##S11##a). However, upon functionalization with bromine and iodine, the contact angle increased significantly to 77° and 99°, respectively, indicating a more hydrophobic nature (Fig. ##SUPPL##0##S11##b, c). This hydrophobicity arose from the direct and firm interaction of the iodine and or bromine terminals with the Ti or C atoms of Ti<sub>3</sub>C<sub>2</sub>, which was achieved using a unique gas-phase approach. Owing to the firm attachment of less hydrophilic functional groups, Ti<sub>3</sub>C<sub>2</sub> exhibits remarkable moisture protection over extended periods. For the I-MXene-based sample, we observed a substantial increase in resistance compared to the initial value in both ambient (2,412%) and aqueous (255,766%) environments on the 21<sup>st</sup> and 80<sup>th</sup> days, respectively (Fig. ##SUPPL##0##S12##a–c). Notably, on the 28<sup>th</sup> day, the sample (I-MXene) submerged in the aqueous medium showed no response, while the sample (I-MXene) exposed to the ambient environment displayed a resistance increase of 203,653% of the initial value on 150<sup>th</sup> day. These results convincingly demonstrate the outstanding stability of I-MXene in both aqueous and ambient environments compared to the as-prepared MXene-based sample, which exhibited no response on the 21<sup>st</sup> day in an aqueous medium and on the 110<sup>th</sup> day in the ambient environment.</p>", "<title>Elemental Analysis and Functional Groups Confirmation</title>", "<p id=\"Par25\">FTIR, XPS, and SEM with EDS analyses were performed to investigate the elemental composition and functional groups of MXene, as depicted in Figs. ##FIG##2##2## and ##SUPPL##0##S13##. The FTIR spectrum of the fully etched as-prepared MXene exhibited characteristic peaks corresponding to the –OH, C–O, Ti–OH, Ti–F, and Ti–O bonds at 3434, 1635, 1480, 950, and 642 cm<sup>−1</sup>, respectively (Fig. ##FIG##2##2##a) [##UREF##15##26##, ##UREF##23##40##, ##UREF##24##41##]. In fully etched I– and Br–MXene, a reduction in the transmittance of –OH and –F functional groups, as well as Ti–O peaks, compared to as-prepared MXene confirmed the removal of –O and –F functional groups and the attachment of Br and I functional groups, as indicated by the observed peaks at 757 cm<sup>−1</sup> (C–Ti–I) and 659 cm<sup>−1</sup> (C–Ti–Br) [##REF##32616671##38##, ##UREF##25##42##, ##UREF##26##43##].</p>", "<p id=\"Par26\">The XPS survey spectra in Fig. ##FIG##2##2##b reveal distinct peaks for the –I and –Br functional groups with minimal oxygen content and the absence of–F in I– and Br–MXene, confirming the successful elimination of the –O/–OH and –F functional groups and the introduction of –I and –Br-based functional groups. The lower intensity (at%: 7.06) of the O 1<italic>s</italic> spectra in I–MXene and Br–MXene (at%: 9.09%) compared to that of the as-prepared MXene (at%: 32.08%) suggests the minimal presence of water/oxygen molecules, potentially influenced by ambient environmental factors (Figs. ##FIG##2##2##c, d and S13a). In addition, the Ti 2<italic>p</italic> spectra of each sample (Figs. ##FIG##2##2##e, f and S13b) were fitted with four doublets of Ti 2<italic>p</italic><sub>3/2</sub> and Ti 2<italic>p</italic><sub>1/2</sub> corresponding to Ti–C, Ti<sup>2+</sup>, Ti<sup>3+</sup>, and Ti–O [##REF##32857499##25##, ##UREF##27##44##]. The existence of T–O/TiO<sub>2</sub> peaks with high intensity in the as-prepared MXene confirmed a higher oxygen content than those of I–MXene and Br–MXene. The C 1<italic> s</italic> spectra for each sample were also analyzed, revealing lower intensity peaks corresponding to C–Ti–T<sub><italic>x</italic></sub>, C–C, CH<sub>x</sub>/CO, and COO in I–MXene and Br–MXene than in the as-prepared MXene (Fig. ##SUPPL##0##S13##c–e) [##UREF##17##28##]. Furthermore, Figs. ##FIG##3##3##g and ##SUPPL##0##S13##f displayed the I 3<italic>d</italic> spectrum (at%: 23.05) of I–MXene and the Br 3<italic>d</italic> spectrum (at%: 21.27) of Br–MXene, confirming the successful functionalization of MXene with –I and –Br. Additionally, SEM with EDS analysis confirmed that both I and Br were successfully attached to MXene as functional groups (Figs. ##FIG##2##2##h, i and ##SUPPL##0##S14##a–d).</p>", "<title>Role of Functionalization on Oxidation Stability of MXene</title>", "<p id=\"Par27\">The oxidation stability of MXene was investigated by immersing the as-prepared I- and Br-MXene samples in DI water for one week, followed by FTIR and XPS analyses (Fig. ##FIG##3##3##). The FTIR spectra (Fig. ##FIG##3##3##a) revealed an increased transmittance of the –OH- and –O-related peaks for the immersed MXene compared to the as-prepared MXene (Fig. ##FIG##2##2##a), indicating the occurrence of oxidation. In contrast, I– and Br–MXene exhibited lower transmittances for these peaks, suggesting hindered interactions between the water molecules and Ti atoms. Similarly, the XPS survey spectrum revealed the origination of the O 1<italic>s</italic> peaks in both the immersed Br– and I–MXenes (Fig. ##FIG##3##3##b), indicating oxidation. The high resolution O 1<italic>s</italic> XPS spectra (Fig. ##FIG##3##3##c–e) further support these observations, showing significant adsorption of –O, –OH, and H<sub>2</sub>O molecules on the as-prepared MXene surface (at%: 64.26), leading to high-intensity peaks associated with T–O, Ti–O–C, Ti–OH, and water molecule adsorption. In contrast, I–MXene (27.18%) and Br–MXene (40.39%) demonstrated lower levels of oxidation. Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> MXenes undergo complete oxidation to TiO<sub>2</sub> when exposed to water molecules for an extended period. To confirm this concept, the Ti<sub>2<italic>p</italic></sub> spectra of each sample were obtained (Figs. ##FIG##3##3##e, f and ##SUPPL##0##S15##a), revealing a higher intensity of the Ti–O/TiO<sub>2</sub> peak in the immersed as-prepared MXene, indicating the conversion of Ti (at% 13.75 in the freshly prepared MXene) to TiO<sub>2</sub> (at% 8.89 in the immersed as-prepared MXene). In contrast, both I–MXene and Br–MXene retained a significant amount of Ti, as I–MXene exhibited Ti of at% of 12.8 and 9.89 in fresh I–MXene and immersed I–MXene, respectively (Fig. ##FIG##3##3##f). The Br–MXene exhibited Ti of at% of 16.51 and 12.26 in fresh Br–MXene and immersed Br–MXene, respectively (Fig. S15a). Additionally, the C 1<italic>s</italic> spectra exhibited higher-intensity peaks corresponding to COO and CH<sub><italic>x</italic></sub>/CO in the as-prepared MXene, whereas I–MXene and Br–MXene exhibited lower intensities (Figs. ##FIG##3##3##h, i and ##SUPPL##0##S15##These findings suggest that the presence of I and Br functional groups reduces the susceptibility of MXene to oxidation because the COO and CH<sub><italic>x</italic></sub>/CO groups are associated with oxidation-related processes. The overall results indicate that the highly hydrophobic nature of the I and Br functional groups compared to the –O/–OH and –F functional groups effectively protects MXene from complete oxidation, contributing to improved oxidation stability.</p>", "<title>Role of Thickness and Functional Groups on the Gas Sensing Performance of MXene</title>", "<p id=\"Par28\">Gas sensing experiments were conducted using Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> flakes of varying thicknesses and functionalizations to evaluate their impact on the gas sensing performance of MXene. For the thickness analysis, we employed three distinct sensors: highly etched as-prepared MXene, fully etched as-prepared MXene, and few-layer as-prepared MXene. To assess their gas-sensing capabilities, each sensor was exposed to NO<sub>2</sub> gas at room temperature at a concentration of 50 ppm (Figs. ##FIG##4##4##a and ##SUPPL##0##S17##). Remarkably, the few-layer MXene exhibited a significantly superior gas response of ~ 4%, outperforming the thicker flakes, which demonstrated responses of ~ 3.1% and ~ 2%, respectively (Fig. ##FIG##4##4##a). We also examined the response and recovery properties of the samples (Fig. ##SUPPL##0##S17##). The results revealed that the few-layer MXene-based samples exhibited shorter response and recovery times of 195 and 214 s, respectively. In contrast, the fully and highly etched MXene-based sensors exhibited relatively long response/recovery times of 237/253 s and 301/297 s, respectively. The response time refers to the time required to reach 90% of the maximum response during exposure to the target gas, whereas the recovery time indicates the time taken to return to a baseline level, typically 10% of the maximum response, after the gas was removed. The enhanced gas response observed in few-layer MXene can be attributed to its high surface area (24.6 m<sup>2</sup> g<sup>−1</sup>), providing a greater number of active sites for gas interaction. This finding highlights the significance of the thin-layered structure of MXene in improving its gas-sensing performance, making it a promising material for future gas-sensing applications. Moreover, to investigate the dose-concentration vs gas response calibration analysis, we tested different dose concentrations (5, 10, and 20 mg mL<sup>−1</sup>) of MXene and then diluted them tenfold for few-layer MXene film preparation using the immiscible approach. This calibration demonstrated that the tenfold diluted sample from the 10 mg mL<sup>−1</sup> concentration exhibited a higher response compared to the 5 and 20 mg mL<sup>−1</sup> counterparts (Fig. ##SUPPL##0##S19##c).</p>", "<p id=\"Par29\">Based on the exceptional gas-sensing performance of the few-layer MXene, we extended the investigation to explore its gas-sensing capabilities with I– and Br– terminations, as depicted in Fig. ##FIG##4##4##b–f. The fabricated sensors were exposed to NO<sub>2</sub> gas at room temperature, covering concentrations ranging from 0.05 to 500 ppm (Figs. ##FIG##4##4##b, d and S18a). The gas-sensing responses as a function of NO<sub>2</sub> concentration of all the three sensors are plotted in Figs. ##FIG##4##4##c, e and S18b, demonstrating excellent reproducibility with a relative standard deviation (RSD) of less than 5% for the average responses. In Fig. ##FIG##4##4##c, it may appear that as-prepared MXene exhibits a negative response at 250 ppb. However, the actual response of as-prepared MXene initiates at 500 ppb, with no response observed at 200 ppb. To clarify this potential confusion, we have added a red-dashed arrow in the figure, extending from zero to the point where the misunderstanding may arise. To enhance the robustness and reliability of the sensor fabrication approach using an immiscible solution, an RSD assessment was performed using two separate devices (<italic>n</italic> = 2) for each sensor type. Remarkably, I–MXene demonstrated outstanding responses of 0.20% and 23% toward 50 ppb and 200 ppm NO<sub>2</sub>, respectively, surpassing those of Br–MXene (0.23% and 17.35% for 250 ppb and 200 ppm) and the as-prepared MXene (0% and 11.38% for 250 ppb and 200 ppm) sensors. The sensitivity of a gas sensor, which is represented by the slope of its response, plays a pivotal role in determining its overall performance. For I–MXene, Br–MXene, and as-prepared MXene, the slope values within their linear detection range were determined as 0.1119 Ω ppm<sup>−1</sup> (0.05 to 200 ppm), 0.0839 Ω ppm<sup>−1</sup> (0.25 to 200 ppm), and 0.0603 Ω ppm<sup>−1</sup> (0.50 to 200 ppm), respectively. Moreover, I–MXene exhibits significantly faster response times of ~ 90 s and recovery times of ~ 100 s (Figs. ##FIG##4##4##f and ##SUPPL##0##S18##).</p>", "<p id=\"Par30\">Moreover, for selectivity analysis, all the sensors were exposed to five different gases (NO<sub>2</sub>, NH<sub>3</sub>, acetone, ethanol, and H<sub>2</sub>) at a concentration of 50 ppm. The response plot in Figs. ##FIG##4##4##g and ##SUPPL##0##S19##a demonstrate that both I– and Br–MXene-based sensors exhibited the highest response changes in the presence of NO<sub>2</sub>, indicating a high selectivity toward NO<sub>2</sub> among the polar gases. Furthermore, to assess the repeatability and stability of the fabricated gas sensors during dynamic operation, we performed extensive tests by subjecting each sensor to multiple pulses of 90 ppm NO<sub>2</sub> at three-day intervals for 30 days, as illustrated in Figs. ##FIG##4##4##h, i and ##SUPPL##0##S20##a, b. The results indicated that the I–MXene-based sensor exhibited repeatable and stable dynamic responses over four consecutive cycles within the first nine days compared to Br– and the as-prepared MXene. Further analysis was performed for the full 30-day period to assess the degradation in response to each sensor. The results revealed that the I–MXene- and Br–MXene-based sensors displayed smaller changes in response, with RSD values of 4.6% and 36.4%, respectively. In contrast, the as-prepared MXene sensor exhibited no response after 15 days and had a significantly higher RSD value of 130.6%. This finding is consistent with that of our previous analysis (Fig. ##SUPPL##0##S12##), further highlighting the excellent long-term stability and durability of I–MXene compared to those of the as-prepared MXene. Additionally, the dynamic response of the I-MXene-based sensor to 50 ppm of NO<sub>2</sub> was examined across a humidity range started from vacuum-environment (dry) till 80% RH. The results, shown in Fig. ##SUPPL##0##S19##b, indicate a response decrease from 7.4% to 1.05% with increase of humidity. This highlights the sensor's effectiveness even in high humidity, but the response reduction in humid conditions can be attributed to water molecules occupying the sensing channel's active surface, affecting its performance.</p>", "<title>Gas Sensing Process and I–MXene Performances</title>", "<p id=\"Par31\">The gas sensing mechanism of the developed MXene-based sensors is illustrated in Fig. ##FIG##5##5##. These sensors operate based on changes in the electrical resistance resulting from the adsorption of gas molecules onto the surface of the sensor [##UREF##28##45##]. Unlike traditional semiconductor sensors, where the resistance varies based on the oxidizing or reducing gases, MXene-based sensors, owing to their inherent metallic properties, efficiently donate electrons to adsorbed gases regardless of their nature [##REF##32857499##25##]. For instance, in the context of MXene gas sensors, the adsorbed gas molecules (NO<sub>2</sub> or others) acquire electrons from the MXene surface during adsorption (Eq. ##FORMU##1##2##), leading to an increase in resistance.</p>", "<p id=\"Par32\">However, the presence of –O/–OH and –F functional groups, characterized by their elevated electronegativity and robust electron shielding owing to their smaller atomic sizes, hinders rapid electron exchange with gas molecules. This resulted in extended response times for gas-sensing applications (Fig. ##FIG##5##5##a(i)). Similarly, upon stopping the NO<sub>2</sub> gas injection and introducing N<sub>2</sub> gas, a concentration gradient emerged between the densely adsorbed NO<sub>2</sub><sup>−</sup><sub>(ads)</sub> on the MXene surface and the less concentrated NO<sub>2</sub> gas phase within the chamber. Driven by this gradient, a shift toward equilibrium occurred, leading to the detachment of NO<sub>2</sub><sup>−</sup><sub>(ads)</sub> from the MXene surface. N<sub>2</sub> gas collisions play a pivotal role in transferring energy, thereby disrupting the adsorption forces and inducing detachment. The resulting NO<sub>2</sub><sup>−</sup><sub>(ads)</sub> shifts to NO<sub>2</sub> gas, causing desorption, as shown in Eq. (##FORMU##2##3##):</p>", "<p id=\"Par33\">Notably, gases with high electron affinities bonded to the –O/–OH and –F functional groups required more energy for detachment, leading to longer desorption times (Fig. ##FIG##5##5##a(ii)). Conversely, when the MXene terminals exhibited lower electronegativity and reduced shielding effects owing to larger atomic sizes (Fig. ##FIG##5##5##c), faster adsorption and desorption occurred (Fig. ##FIG##5##5##b). Therefore, the excellent selectivity of I–MXene toward NO<sub>2</sub> is attributed to the high electron affinity of NO<sub>2</sub>, which enables stable bonds for faster charge transport with I–MXene owing to the presence of an unpaired electron in its molecular orbital. In contrast, NH<sub>3</sub> has a lone pair of electrons available for donation, leading to lower electron affinity. Similarly, acetone and ethanol have lower electron affinities owing to the partial positive charge on the carbon atom caused by the electronegativity difference with the oxygen atom. These lower electron affinities result in weaker electronic interactions with the I–MXene surface, leading to lower sensor responses. Non-polar gases such as H<sub>2</sub> have symmetrical electron density distributions that weaken their interactions with the MXene surface, resulting in lower sensor responses.</p>", "<p id=\"Par34\">Moreover, the faster response time of I–MXene is attributed to the larger atomic size of iodine, which reduces the shielding effect on the outermost electrons and promotes enhanced electron transfer between gas molecules with high electron affinity and I–MXene. Therefore, the NO<sub>2</sub> sensor required a shorter response/recovery time (90/122 s) than NH<sub>3</sub> (90/122 s), ethanol (121/159 s), acetone (114/161 s), and H<sub>2</sub> (147/142 s) (Figs. ##FIG##4##4##g and ##FIG##5##5##b). Furthermore, the exceptional sensitivity and wide detection range arise from the larger atomic size of iodine, which enhances the interlayer spacing for greater gas adsorption (Fig. ##FIG##5##5##d), and its lower electronegativity, which promotes efficient electron exchange even at low concentrations (50 ppb). These attributes collectively bestow I–MXene with remarkable sensitivity across a broad concentration range (50–200 ppm), distinguishing it from the as-prepared and Br–MXenes. Furthermore, a comparison with previously published studies revealed that I–MXene exhibited remarkable improvements in the recovery time and a wide linear dynamic range, as summarized in Table ##TAB##0##1##. These findings elucidate the crucial role of terminal functionalization in enhancing the gas-sensing performance of MXenes, providing valuable insights for the development of highly sensitive and faster-responsive gas sensors.</p>" ]
[ "<title>Results and Discussion</title>", "<title>Structural and Morphological Investigation</title>", "<p id=\"Par23\">The XRD patterns shown in Figs. ##FIG##1##1##a and S10a reveal the partial etching of Al from the Ti<sub>3</sub>AlC<sub>2</sub> powder. In the sample stirred in HF and exfoliated in DMSO for 7 h, we observe a slight shift of the (002) peak from 13.92° to 11.76°, accompanied by the appearance of the (104) peak at 41.92° which exhibits a 74% reduction in intensity compared to the MAX phase sample [##REF##32616671##38##, ##UREF##22##39##]. These findings suggest that stirring the MAX phase in HF alone had limited success in etching Al, thus impeding its conversion into smaller MXene flakes. In contrast, through a hybrid HF-hydrothermal treatment involving pressurization of partially etched Ti<sub>3</sub>AlC<sub>2</sub> powder within an advanced high-pressure autoclave reactor, successful etching of Al was achieved even prior to the initiation of the exfoliation process. Therefore, its XRD pattern reveals a downward shift from 11.76° to 8.84° for the (002) peak and the appearance of the (104) peak with a reduced intensity of approximately 80%. This suggests that the pressurization and stirring processes are more effective in eliminating Al content than the bare HF stirring process. Furthermore, through a prolonged tip-sonication process, the (002) peak of Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> experiences an additional shift from 8.84° to 7.82°, indicating an increase in interplanar distance that reduces the stacked-layer and flake thickness: &lt; 100–600 nm and ~ 1 µm (Figs. ##SUPPL##0##S1##j and##SUPPL##0## S10##a). Finally, the I-MXene XRD revealed a further downward shift of the (002) peak from 7.82° to 7.50°, indicating an increased interlayer spacing owing to steric hindrance caused by the larger iodine atoms.</p>", "<p id=\"Par24\">SEM images in Figs. ##SUPPL##0##S1##a, g–j and 1b illustrate the partially etched Ti<sub>3</sub>AlC<sub>2</sub> after 7 h exfoliation (stacked-layer and flake thickness: ~ 500 nm and 10 µm prepared via HF-stirred method), highly etched Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> prior the exfoliation, and fully etched Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> after 7 h exfoliation, respectively. These images clearly demonstrate the successful transformation of bulk Ti<sub>3</sub>AlC<sub>2</sub> to fully etched Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub>. EDS mapping of fully etched Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> was performed, as presented in Fig. ##SUPPL##0##S1##j, k, confirming that C, Ti, F, and –O/–OH were its elemental constituents. Moreover, the tenfold diluted sample was spin-coated onto a Si wafer at 3000 rpm, resulting in a MXene flakes with thickness of 200–600 nm, as shown in Fig. S5e, f. The observed thickness validates the effective removal of thicker MXene flakes (fully etched MXene flakes: 1 µm) by means of dilution. Dilution enables self-assembly of sub-100 nm MXene flakes at the immiscible solvent interface on the Si substrate to form the film. Consequently, the thicknesses of the few-layer MXene on the Si wafer were measured using an AFM as 9, 18, and 63 nm, as depicted in Figs. ##FIG##1##1##c–e and ##SUPPL##0##S4##d, e, ##SUPPL##0##S5##b, c. Furthermore, HRTEM analysis of the few-layer MXene, was performed, along with EDS mapping that confirmed the presence of C, Ti, –F, and –O/–OH as its elemental constituents (Fig. ##FIG##1##1##f–h). The observed copper (Cu) peak originated from the Cu grid used as the substrate. Notably, the distribution of Ti appears non-uniform in the summed EDS image (Fig. ##FIG##1##1##g). This non-uniformity arises because the EDS analysis was conducted on the MXene flake enclosed within the blue dashed rectangle in Fig. ##FIG##1##1##f, where a few more MXene flakes exist at the lower edge of the analyzed flake. Consequently, the EDS analysis reflects a higher Ti content at the lower edge side than in the individual flakes analyzed. Additionally, the presence of white squares in Fig. ##FIG##1##1##c, d, and g indicated the agglomerated MXene nanoparticles, as confirmed through SEM images of fully etched MXene flakes with thickness ranging from 1 to 2 µm (Fig.##SUPPL##0## S4##a–c). Moreover, the AFM images of few-layer MXene (Fig. ##SUPPL##0## S4##d, e) further provide a comprehensive view of these MXene nanoparticles. BET analysis was performed to assess the impact of thickness and functionalization on the specific surface areas of Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> MXene (Figs. ##FIG##1##1##i and ##SUPPL##0## S10##b). The results revealed that the specific surface areas of the MAX phase, fully-etched MXene, few-layer MXene, few-layer I-MXene, and few-layer Br-MXene are 3.8, 14.9, 24.6, 31.7, and 36.2 m<sup>2</sup> g<sup>−1</sup>, respectively, confirming successful exfoliation during the selective etching process. Notably, I-MXene exhibited a higher specific surface area of 36.2 m<sup>2</sup> g<sup>−1</sup>, which was attributed to the increased interplanar distance resulting from the intercalation of larger iodine atoms than oxygen and fluorine, as observed in the XRD analysis. Moreover, water contact angle measurements revealed that the wettability of the Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> nanosheets was modified by –I and –Br terminal groups. The as-prepared Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> with –OH, –O, and –F functional groups exhibited a hydrophilic surface with a water contact angle (<italic>θ</italic>) of 39° (Fig. ##SUPPL##0##S11##a). However, upon functionalization with bromine and iodine, the contact angle increased significantly to 77° and 99°, respectively, indicating a more hydrophobic nature (Fig. ##SUPPL##0##S11##b, c). This hydrophobicity arose from the direct and firm interaction of the iodine and or bromine terminals with the Ti or C atoms of Ti<sub>3</sub>C<sub>2</sub>, which was achieved using a unique gas-phase approach. Owing to the firm attachment of less hydrophilic functional groups, Ti<sub>3</sub>C<sub>2</sub> exhibits remarkable moisture protection over extended periods. For the I-MXene-based sample, we observed a substantial increase in resistance compared to the initial value in both ambient (2,412%) and aqueous (255,766%) environments on the 21<sup>st</sup> and 80<sup>th</sup> days, respectively (Fig. ##SUPPL##0##S12##a–c). Notably, on the 28<sup>th</sup> day, the sample (I-MXene) submerged in the aqueous medium showed no response, while the sample (I-MXene) exposed to the ambient environment displayed a resistance increase of 203,653% of the initial value on 150<sup>th</sup> day. These results convincingly demonstrate the outstanding stability of I-MXene in both aqueous and ambient environments compared to the as-prepared MXene-based sample, which exhibited no response on the 21<sup>st</sup> day in an aqueous medium and on the 110<sup>th</sup> day in the ambient environment.</p>", "<title>Elemental Analysis and Functional Groups Confirmation</title>", "<p id=\"Par25\">FTIR, XPS, and SEM with EDS analyses were performed to investigate the elemental composition and functional groups of MXene, as depicted in Figs. ##FIG##2##2## and ##SUPPL##0##S13##. The FTIR spectrum of the fully etched as-prepared MXene exhibited characteristic peaks corresponding to the –OH, C–O, Ti–OH, Ti–F, and Ti–O bonds at 3434, 1635, 1480, 950, and 642 cm<sup>−1</sup>, respectively (Fig. ##FIG##2##2##a) [##UREF##15##26##, ##UREF##23##40##, ##UREF##24##41##]. In fully etched I– and Br–MXene, a reduction in the transmittance of –OH and –F functional groups, as well as Ti–O peaks, compared to as-prepared MXene confirmed the removal of –O and –F functional groups and the attachment of Br and I functional groups, as indicated by the observed peaks at 757 cm<sup>−1</sup> (C–Ti–I) and 659 cm<sup>−1</sup> (C–Ti–Br) [##REF##32616671##38##, ##UREF##25##42##, ##UREF##26##43##].</p>", "<p id=\"Par26\">The XPS survey spectra in Fig. ##FIG##2##2##b reveal distinct peaks for the –I and –Br functional groups with minimal oxygen content and the absence of–F in I– and Br–MXene, confirming the successful elimination of the –O/–OH and –F functional groups and the introduction of –I and –Br-based functional groups. The lower intensity (at%: 7.06) of the O 1<italic>s</italic> spectra in I–MXene and Br–MXene (at%: 9.09%) compared to that of the as-prepared MXene (at%: 32.08%) suggests the minimal presence of water/oxygen molecules, potentially influenced by ambient environmental factors (Figs. ##FIG##2##2##c, d and S13a). In addition, the Ti 2<italic>p</italic> spectra of each sample (Figs. ##FIG##2##2##e, f and S13b) were fitted with four doublets of Ti 2<italic>p</italic><sub>3/2</sub> and Ti 2<italic>p</italic><sub>1/2</sub> corresponding to Ti–C, Ti<sup>2+</sup>, Ti<sup>3+</sup>, and Ti–O [##REF##32857499##25##, ##UREF##27##44##]. The existence of T–O/TiO<sub>2</sub> peaks with high intensity in the as-prepared MXene confirmed a higher oxygen content than those of I–MXene and Br–MXene. The C 1<italic> s</italic> spectra for each sample were also analyzed, revealing lower intensity peaks corresponding to C–Ti–T<sub><italic>x</italic></sub>, C–C, CH<sub>x</sub>/CO, and COO in I–MXene and Br–MXene than in the as-prepared MXene (Fig. ##SUPPL##0##S13##c–e) [##UREF##17##28##]. Furthermore, Figs. ##FIG##3##3##g and ##SUPPL##0##S13##f displayed the I 3<italic>d</italic> spectrum (at%: 23.05) of I–MXene and the Br 3<italic>d</italic> spectrum (at%: 21.27) of Br–MXene, confirming the successful functionalization of MXene with –I and –Br. Additionally, SEM with EDS analysis confirmed that both I and Br were successfully attached to MXene as functional groups (Figs. ##FIG##2##2##h, i and ##SUPPL##0##S14##a–d).</p>", "<title>Role of Functionalization on Oxidation Stability of MXene</title>", "<p id=\"Par27\">The oxidation stability of MXene was investigated by immersing the as-prepared I- and Br-MXene samples in DI water for one week, followed by FTIR and XPS analyses (Fig. ##FIG##3##3##). The FTIR spectra (Fig. ##FIG##3##3##a) revealed an increased transmittance of the –OH- and –O-related peaks for the immersed MXene compared to the as-prepared MXene (Fig. ##FIG##2##2##a), indicating the occurrence of oxidation. In contrast, I– and Br–MXene exhibited lower transmittances for these peaks, suggesting hindered interactions between the water molecules and Ti atoms. Similarly, the XPS survey spectrum revealed the origination of the O 1<italic>s</italic> peaks in both the immersed Br– and I–MXenes (Fig. ##FIG##3##3##b), indicating oxidation. The high resolution O 1<italic>s</italic> XPS spectra (Fig. ##FIG##3##3##c–e) further support these observations, showing significant adsorption of –O, –OH, and H<sub>2</sub>O molecules on the as-prepared MXene surface (at%: 64.26), leading to high-intensity peaks associated with T–O, Ti–O–C, Ti–OH, and water molecule adsorption. In contrast, I–MXene (27.18%) and Br–MXene (40.39%) demonstrated lower levels of oxidation. Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> MXenes undergo complete oxidation to TiO<sub>2</sub> when exposed to water molecules for an extended period. To confirm this concept, the Ti<sub>2<italic>p</italic></sub> spectra of each sample were obtained (Figs. ##FIG##3##3##e, f and ##SUPPL##0##S15##a), revealing a higher intensity of the Ti–O/TiO<sub>2</sub> peak in the immersed as-prepared MXene, indicating the conversion of Ti (at% 13.75 in the freshly prepared MXene) to TiO<sub>2</sub> (at% 8.89 in the immersed as-prepared MXene). In contrast, both I–MXene and Br–MXene retained a significant amount of Ti, as I–MXene exhibited Ti of at% of 12.8 and 9.89 in fresh I–MXene and immersed I–MXene, respectively (Fig. ##FIG##3##3##f). The Br–MXene exhibited Ti of at% of 16.51 and 12.26 in fresh Br–MXene and immersed Br–MXene, respectively (Fig. S15a). Additionally, the C 1<italic>s</italic> spectra exhibited higher-intensity peaks corresponding to COO and CH<sub><italic>x</italic></sub>/CO in the as-prepared MXene, whereas I–MXene and Br–MXene exhibited lower intensities (Figs. ##FIG##3##3##h, i and ##SUPPL##0##S15##These findings suggest that the presence of I and Br functional groups reduces the susceptibility of MXene to oxidation because the COO and CH<sub><italic>x</italic></sub>/CO groups are associated with oxidation-related processes. The overall results indicate that the highly hydrophobic nature of the I and Br functional groups compared to the –O/–OH and –F functional groups effectively protects MXene from complete oxidation, contributing to improved oxidation stability.</p>", "<title>Role of Thickness and Functional Groups on the Gas Sensing Performance of MXene</title>", "<p id=\"Par28\">Gas sensing experiments were conducted using Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> flakes of varying thicknesses and functionalizations to evaluate their impact on the gas sensing performance of MXene. For the thickness analysis, we employed three distinct sensors: highly etched as-prepared MXene, fully etched as-prepared MXene, and few-layer as-prepared MXene. To assess their gas-sensing capabilities, each sensor was exposed to NO<sub>2</sub> gas at room temperature at a concentration of 50 ppm (Figs. ##FIG##4##4##a and ##SUPPL##0##S17##). Remarkably, the few-layer MXene exhibited a significantly superior gas response of ~ 4%, outperforming the thicker flakes, which demonstrated responses of ~ 3.1% and ~ 2%, respectively (Fig. ##FIG##4##4##a). We also examined the response and recovery properties of the samples (Fig. ##SUPPL##0##S17##). The results revealed that the few-layer MXene-based samples exhibited shorter response and recovery times of 195 and 214 s, respectively. In contrast, the fully and highly etched MXene-based sensors exhibited relatively long response/recovery times of 237/253 s and 301/297 s, respectively. The response time refers to the time required to reach 90% of the maximum response during exposure to the target gas, whereas the recovery time indicates the time taken to return to a baseline level, typically 10% of the maximum response, after the gas was removed. The enhanced gas response observed in few-layer MXene can be attributed to its high surface area (24.6 m<sup>2</sup> g<sup>−1</sup>), providing a greater number of active sites for gas interaction. This finding highlights the significance of the thin-layered structure of MXene in improving its gas-sensing performance, making it a promising material for future gas-sensing applications. Moreover, to investigate the dose-concentration vs gas response calibration analysis, we tested different dose concentrations (5, 10, and 20 mg mL<sup>−1</sup>) of MXene and then diluted them tenfold for few-layer MXene film preparation using the immiscible approach. This calibration demonstrated that the tenfold diluted sample from the 10 mg mL<sup>−1</sup> concentration exhibited a higher response compared to the 5 and 20 mg mL<sup>−1</sup> counterparts (Fig. ##SUPPL##0##S19##c).</p>", "<p id=\"Par29\">Based on the exceptional gas-sensing performance of the few-layer MXene, we extended the investigation to explore its gas-sensing capabilities with I– and Br– terminations, as depicted in Fig. ##FIG##4##4##b–f. The fabricated sensors were exposed to NO<sub>2</sub> gas at room temperature, covering concentrations ranging from 0.05 to 500 ppm (Figs. ##FIG##4##4##b, d and S18a). The gas-sensing responses as a function of NO<sub>2</sub> concentration of all the three sensors are plotted in Figs. ##FIG##4##4##c, e and S18b, demonstrating excellent reproducibility with a relative standard deviation (RSD) of less than 5% for the average responses. In Fig. ##FIG##4##4##c, it may appear that as-prepared MXene exhibits a negative response at 250 ppb. However, the actual response of as-prepared MXene initiates at 500 ppb, with no response observed at 200 ppb. To clarify this potential confusion, we have added a red-dashed arrow in the figure, extending from zero to the point where the misunderstanding may arise. To enhance the robustness and reliability of the sensor fabrication approach using an immiscible solution, an RSD assessment was performed using two separate devices (<italic>n</italic> = 2) for each sensor type. Remarkably, I–MXene demonstrated outstanding responses of 0.20% and 23% toward 50 ppb and 200 ppm NO<sub>2</sub>, respectively, surpassing those of Br–MXene (0.23% and 17.35% for 250 ppb and 200 ppm) and the as-prepared MXene (0% and 11.38% for 250 ppb and 200 ppm) sensors. The sensitivity of a gas sensor, which is represented by the slope of its response, plays a pivotal role in determining its overall performance. For I–MXene, Br–MXene, and as-prepared MXene, the slope values within their linear detection range were determined as 0.1119 Ω ppm<sup>−1</sup> (0.05 to 200 ppm), 0.0839 Ω ppm<sup>−1</sup> (0.25 to 200 ppm), and 0.0603 Ω ppm<sup>−1</sup> (0.50 to 200 ppm), respectively. Moreover, I–MXene exhibits significantly faster response times of ~ 90 s and recovery times of ~ 100 s (Figs. ##FIG##4##4##f and ##SUPPL##0##S18##).</p>", "<p id=\"Par30\">Moreover, for selectivity analysis, all the sensors were exposed to five different gases (NO<sub>2</sub>, NH<sub>3</sub>, acetone, ethanol, and H<sub>2</sub>) at a concentration of 50 ppm. The response plot in Figs. ##FIG##4##4##g and ##SUPPL##0##S19##a demonstrate that both I– and Br–MXene-based sensors exhibited the highest response changes in the presence of NO<sub>2</sub>, indicating a high selectivity toward NO<sub>2</sub> among the polar gases. Furthermore, to assess the repeatability and stability of the fabricated gas sensors during dynamic operation, we performed extensive tests by subjecting each sensor to multiple pulses of 90 ppm NO<sub>2</sub> at three-day intervals for 30 days, as illustrated in Figs. ##FIG##4##4##h, i and ##SUPPL##0##S20##a, b. The results indicated that the I–MXene-based sensor exhibited repeatable and stable dynamic responses over four consecutive cycles within the first nine days compared to Br– and the as-prepared MXene. Further analysis was performed for the full 30-day period to assess the degradation in response to each sensor. The results revealed that the I–MXene- and Br–MXene-based sensors displayed smaller changes in response, with RSD values of 4.6% and 36.4%, respectively. In contrast, the as-prepared MXene sensor exhibited no response after 15 days and had a significantly higher RSD value of 130.6%. This finding is consistent with that of our previous analysis (Fig. ##SUPPL##0##S12##), further highlighting the excellent long-term stability and durability of I–MXene compared to those of the as-prepared MXene. Additionally, the dynamic response of the I-MXene-based sensor to 50 ppm of NO<sub>2</sub> was examined across a humidity range started from vacuum-environment (dry) till 80% RH. The results, shown in Fig. ##SUPPL##0##S19##b, indicate a response decrease from 7.4% to 1.05% with increase of humidity. This highlights the sensor's effectiveness even in high humidity, but the response reduction in humid conditions can be attributed to water molecules occupying the sensing channel's active surface, affecting its performance.</p>", "<title>Gas Sensing Process and I–MXene Performances</title>", "<p id=\"Par31\">The gas sensing mechanism of the developed MXene-based sensors is illustrated in Fig. ##FIG##5##5##. These sensors operate based on changes in the electrical resistance resulting from the adsorption of gas molecules onto the surface of the sensor [##UREF##28##45##]. Unlike traditional semiconductor sensors, where the resistance varies based on the oxidizing or reducing gases, MXene-based sensors, owing to their inherent metallic properties, efficiently donate electrons to adsorbed gases regardless of their nature [##REF##32857499##25##]. For instance, in the context of MXene gas sensors, the adsorbed gas molecules (NO<sub>2</sub> or others) acquire electrons from the MXene surface during adsorption (Eq. ##FORMU##1##2##), leading to an increase in resistance.</p>", "<p id=\"Par32\">However, the presence of –O/–OH and –F functional groups, characterized by their elevated electronegativity and robust electron shielding owing to their smaller atomic sizes, hinders rapid electron exchange with gas molecules. This resulted in extended response times for gas-sensing applications (Fig. ##FIG##5##5##a(i)). Similarly, upon stopping the NO<sub>2</sub> gas injection and introducing N<sub>2</sub> gas, a concentration gradient emerged between the densely adsorbed NO<sub>2</sub><sup>−</sup><sub>(ads)</sub> on the MXene surface and the less concentrated NO<sub>2</sub> gas phase within the chamber. Driven by this gradient, a shift toward equilibrium occurred, leading to the detachment of NO<sub>2</sub><sup>−</sup><sub>(ads)</sub> from the MXene surface. N<sub>2</sub> gas collisions play a pivotal role in transferring energy, thereby disrupting the adsorption forces and inducing detachment. The resulting NO<sub>2</sub><sup>−</sup><sub>(ads)</sub> shifts to NO<sub>2</sub> gas, causing desorption, as shown in Eq. (##FORMU##2##3##):</p>", "<p id=\"Par33\">Notably, gases with high electron affinities bonded to the –O/–OH and –F functional groups required more energy for detachment, leading to longer desorption times (Fig. ##FIG##5##5##a(ii)). Conversely, when the MXene terminals exhibited lower electronegativity and reduced shielding effects owing to larger atomic sizes (Fig. ##FIG##5##5##c), faster adsorption and desorption occurred (Fig. ##FIG##5##5##b). Therefore, the excellent selectivity of I–MXene toward NO<sub>2</sub> is attributed to the high electron affinity of NO<sub>2</sub>, which enables stable bonds for faster charge transport with I–MXene owing to the presence of an unpaired electron in its molecular orbital. In contrast, NH<sub>3</sub> has a lone pair of electrons available for donation, leading to lower electron affinity. Similarly, acetone and ethanol have lower electron affinities owing to the partial positive charge on the carbon atom caused by the electronegativity difference with the oxygen atom. These lower electron affinities result in weaker electronic interactions with the I–MXene surface, leading to lower sensor responses. Non-polar gases such as H<sub>2</sub> have symmetrical electron density distributions that weaken their interactions with the MXene surface, resulting in lower sensor responses.</p>", "<p id=\"Par34\">Moreover, the faster response time of I–MXene is attributed to the larger atomic size of iodine, which reduces the shielding effect on the outermost electrons and promotes enhanced electron transfer between gas molecules with high electron affinity and I–MXene. Therefore, the NO<sub>2</sub> sensor required a shorter response/recovery time (90/122 s) than NH<sub>3</sub> (90/122 s), ethanol (121/159 s), acetone (114/161 s), and H<sub>2</sub> (147/142 s) (Figs. ##FIG##4##4##g and ##FIG##5##5##b). Furthermore, the exceptional sensitivity and wide detection range arise from the larger atomic size of iodine, which enhances the interlayer spacing for greater gas adsorption (Fig. ##FIG##5##5##d), and its lower electronegativity, which promotes efficient electron exchange even at low concentrations (50 ppb). These attributes collectively bestow I–MXene with remarkable sensitivity across a broad concentration range (50–200 ppm), distinguishing it from the as-prepared and Br–MXenes. Furthermore, a comparison with previously published studies revealed that I–MXene exhibited remarkable improvements in the recovery time and a wide linear dynamic range, as summarized in Table ##TAB##0##1##. These findings elucidate the crucial role of terminal functionalization in enhancing the gas-sensing performance of MXenes, providing valuable insights for the development of highly sensitive and faster-responsive gas sensors.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par35\">In conclusion, we developed a new high-pressure autoclave reactor approach for MXene synthesis and the collection of MXene flakes with a thickness of less than 100 nm over an Si substrate through the interface between two immiscible solvents. Additionally, a unique gas-phase method was employed to eliminate undesired functional groups (–O, –OH, and –F) and introduce I and Br functional groups. The introduction of an iodine termination, characterized by its larger atomic size, reduced shielding effect, and lower electronegativity, played a pivotal role in significantly increasing the surface area, stability, and gas-sensing performance of MXenes. While achieving these advancements, we also identified challenges to improve MXene synthesis, including streamlining the etching process using a Teflon-based high-pressure reactor instead of stainless steel. This adjustment was necessary because HF cannot be treated in a stainless-steel autoclave. In future studies, we intend to optimize the conditions for MXene synthesis using HF-free etchants in a Teflon-based high-pressure reactor. Additionally, we intend to investigate 12 different surface terminations (O, OH, N, NH, NH<sub>2</sub>, S, SH, H, F, Cl, Br, and I) on various carbide-based MXenes to gain valuable insights into the influence of different functional groups and MXene materials on their electrical, environmental, and gas sensing properties. Notably, the proposed methods hold promise for application to other MXene structures and compositions, offering versatility and the potential for further advancements in MXene research across various fields.</p>" ]
[ "<title> Highlights</title>", "<p id=\"Par1\">\n<list list-type=\"bullet\"><list-item><p id=\"Par2\">Gas-phase functionalization of X-MXene (X = –F, –OH, –O, –Br, –I) films crafted from sub-100 nm thin MXene flakes for highly sensitive NO<sub>2</sub> sensors.</p></list-item><list-item><p id=\"Par3\">I-MXene-based senor exhibited significant sensing performances toward trace NO<sub>2</sub> at room temperature.</p></list-item><list-item><p id=\"Par4\">The hydrophobicity, larger atomic size, lower electronegativity, and reduced shielding of -I contribute to the excellent sensing enhancement of I-MXene. </p></list-item></list></p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s40820-023-01316-x.</p>", "<p id=\"Par5\">In this study, precise control over the thickness and termination of Ti<sub>3</sub>C<sub>2</sub>T<sub>X</sub> MXene flakes is achieved to enhance their electrical properties, environmental stability, and gas-sensing performance. Utilizing a hybrid method involving high-pressure processing, stirring, and immiscible solutions, sub-100 nm MXene flake thickness is achieved within the MXene film on the Si-wafer. Functionalization control is achieved by defunctionalizing MXene at 650 °C under vacuum and H<sub>2</sub> gas in a CVD furnace, followed by refunctionalization with iodine and bromine vaporization from a bubbler attached to the CVD. Notably, the introduction of iodine, which has a larger atomic size, lower electronegativity, reduce shielding effect, and lower hydrophilicity (contact angle: 99°), profoundly affecting MXene. It improves the surface area (36.2 cm<sup>2</sup> g<sup>−1</sup>), oxidation stability in aqueous/ambient environments (21 days/80 days), and film conductivity (749 S m<sup>−1</sup>). Additionally, it significantly enhances the gas-sensing performance, including the sensitivity (0.1119 Ω ppm<sup>−1</sup>), response (0.2% and 23% to 50 ppb and 200 ppm NO<sub>2</sub>), and response/recovery times (90/100 s). The reduced shielding effect of the –I-terminals and the metallic characteristics of MXene enhance the selectivity of I-MXene toward NO<sub>2</sub>. This approach paves the way for the development of stable and high-performance gas-sensing two-dimensional materials with promising prospects for future studies.</p>", "<p id=\"Par6\">\n</p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s40820-023-01316-x.</p>", "<title>Keywords</title>" ]
[ "<title>Experimental Section</title>", "<title>Materials</title>", "<p id=\"Par13\">All chemicals used in this study were obtained from various suppliers. Ti<sub>3</sub>AlC<sub>2</sub> MAX phase was purchased from Nanochemazone (Canada). Sigma-Aldrich provided HF (48%), HCl (37%), LiF, NaF, NH<sub>4</sub>F, and DMSO. Iodine and Bromine were obtained from Samchun Pure Chemical Co., Ltd.</p>", "<title>Synthesis of Few-layer Ti<sub>3</sub>C<sub>2</sub>T<sub><bold><italic>x</italic></bold></sub> MXene Flakes within MXene Film</title>", "<p id=\"Par14\">The optimized hybrid HF-Hydrothermal synthesis conditions for few-layer MXene preparation, as discussed below, were determined through a series of experimental attempts (Table SI 1–16). This involved the initial stirring of 1.0 g of Ti<sub>3</sub>AlC<sub>2</sub> powder (Scheme ##FIG##0##1##a, b and Table S16) at 200 rpm for 36 h at room temperature in 20 mL HF (48%). The choice of etchant concentrations (HF, 48 wt% and HCl, 37 wt% as described in the Supporting Information) was based on a previous study [##UREF##19##34##], where these concentrations were found to effectively modulate MXene size. This process was followed by washing and collecting product with centrifugation using deionized (DI) water and vacuum filtration until the pH of the supernatant reached approximately 6.0.</p>", "<p id=\"Par15\">The obtained product was transferred to a high-pressure autoclave reactor containing a 120 mL solution prepared by dissolving 5 g of NH<sub>4</sub>F in 120 mL of DI water. The solution was pressurized to 22 MPa for 36 h with a constant flow of Ar gas at 150 °C while stirring at 200 rpm (Scheme ##FIG##0##1##c). Subsequently, the resulting product was washed by filtration and centrifugation until the pH reached ~ 6.50 and then freeze-dried for 48 h.</p>", "<p id=\"Par16\">The dried product was then introduced into a double-walled beaker containing DMSO and subjected to 7 h of tip sonication. The tip sonicator was equipped with a water-chiller system to maintain a constant temperature of 15 °C. Subsequently, the sample was washed by centrifugation, and the sediment was collected from two parts of the centrifuge tube (Fig. ##SUPPL##0##S3##i), that is, bottom (flake thickness ~ 1 µm: Fig. ##SUPPL##0##S1##j) and top (flake thickness &lt; 100–600 nm: Fig. ##SUPPL##0##S5##d–f), and then freeze-dried (Scheme ##FIG##0##1##d). The sediment collected from the upper part of the centrifuge tube was dispersed in water at concentrations of 5, 10, and 20 mg mL<sup>−1</sup>. Subsequently, these suspensions were further diluted by a factor of 10 relative to the initial sediment concentration, as illustrated in Fig. ##SUPPL##0##S7##a [##REF##33405898##35##]. The diluted MXene sample was mixed with methanol and carefully transferred dropwise into a beaker containing chloroform solvent, with a Si wafer positioned at the bottom (Scheme ##FIG##0##1##e). The immiscibility of methanol and chloroform creates an interface where few-layer MXene flakes, with stacked layers and flake thicknesses of less than 80 nm and approximately 600 nm, self-assemble (Few-layer MXene: Figs. ##FIG##1##1##c–g and ##SUPPL##0##S5##a–.c). This assembly results in the formation of an MXene film (Fig. ##SUPPL##0##S8## and ##SUPPL##0##S9##) that aligns with the substrate size on the upper surface of the chloroform solvent (Fig. ##SUPPL##0##S7##b). Subsequently, excess chloroform is removed, and the film level is adjusted to match the substrate. Finally, the substrate is lifted and subjected to a drying process at 100 °C for approximately 30 min to ensure complete dryness of the film (Scheme ##FIG##0##1##f). Notably, achieving few-layer MXene films is a challenge yet essential task, particularly for analyzing gas sensing performance. Traditional methods like spin-coating or drop-casting often result in non-uniform and thick films, limiting sensing capabilities. In contrast, the immiscible approach for film formation, validated by SEM (Fig. ##SUPPL##0##S8##) and TEM (Fig. ##SUPPL##0##S9##) analysis, offers distinct advantages. This technique surpasses other methods, such as spin-coating (Fig. ##SUPPL##0##S5##d) and drop-casting (Fig. ##SUPPL##0##S16##c), by consistently producing films composed of few-layer MXene flakes on a scale Si-wafer. This enhances the specific surface area and active sites available for gas adsorption.</p>", "<title>Functionalization of Few-Layer Ti<sub>3</sub>C<sub>2</sub>T<sub><bold><italic>x</italic></bold></sub> MXene</title>", "<p id=\"Par17\">For the precise surface modification of few-layer MXenes, a gas-phase approach utilizing a CVD furnace with a bubbler system was employed (Scheme ##FIG##0##1##g). The obtained few-layer MXene film on the Si-wafer underwent heating at 650 °C under vacuum and H<sub>2</sub> gas environment for 2 h in each case. This thermal treatment effectively eliminated –O, –F, and –OH functional groups, resulting in a clean MXene surface. The integrated bubbler system in the CVD furnace contained I– and Br– as the desired termination elements. Vaporized iodine was introduced into the furnace using Ar gas flow at 50 °C for 30 min, selectively attaching to the clean surface of MXene. Similarly, Bromine vapor was introduced at room temperature for 30 min under Ar gas flow. The diluted MXene powder was spread over a Si wafer and subjected to a similar functionalization process, which was then characterized by Brunauer–Emmett–Teller (BET), X-ray photoelectron spectroscopy (XPS), and Fourier transform infrared (FTIR) analyses.</p>", "<p id=\"Par18\">To fully validate the role of halogenated functional groups on electrical properties and gas sensing performances, it is essential to explore Cl-MXene as a gas sensing element. Our preferred approach for MXene functionalization involves starting with the precursor material in its elemental form. However, during the course of this study, elemental chlorine in any suitable form (liquid/solid/gas) was not available, which temporarily limited our ability to explore Cl-MXene under these specific conditions. In contrast, we explored the synthesis of Cl-MXene using a CuCl<sub>2</sub> molten salt approach [##REF##33415973##32##]. Unlike the high-pressure and stirring treatments involved in our as-prepared MXene synthesis, this method resulted in a reduced interlayer separation, as shown in Fig. ##SUPPL##0##S6##a, b. Due to the minimal interlayer spacing, Cl-MXene exhibited higher resistance and poorer gas-sensing performance compared to our as-prepared MXene (Fig. ##SUPPL##0##S21##a, b). Additionally, the Cl-MXene was not transformed into few-layer MXene to compare its role with few-layer I- and Br-MXene. As preparation of few-layer from multi-layer Cl-MXene, need to underwent prolonged exfoliation process. This exfoliation process would effectively alter its functional group composition, leading to changes in its properties and performance. As a result, our chosen functionalization approach involves first preparing MXene with fewer stacked layers and then functionalizing it in a controlled gaseous phase environment, allowing for the versatile production of few-layer MXene with various functional groups. Further details regarding Cl-MXene synthesis, characteristics, and gas-sensing performances are discussed in the Supporting Information.</p>", "<title>Characterization</title>", "<p id=\"Par19\">The surface morphologies, microstructures, and crystallinities of different Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub> MXene products were analyzed using various characterization techniques. Scanning electron microscopy (SEM) was performed using a JEOL-7800F instrument, whereas transmission electron microscopy (TEM) was performed using a JEM-ARM 200F instrument (NEOARM) equipped with a high-angle annular dark-field scanning electron microscope (HAADF-STEM) and energy-dispersive spectrometer (EDS). The thicknesses of the few-layer MXene samples were determined by atomic force microscopy (AFM, Model: NX-10, Park System). X-ray diffraction (XRD) measurements were performed using an Ultima IV instrument (Rigaku, Japan). The chemical components and bonding structures resulting from the iodine and bromine functionalization were investigated using X-ray photoelectron spectroscopy (XPS (mono) (Model: K-alpha)) and FTIR analysis (FT-IR Spectrometer, Model: Cary670). BET analysis was performed using an Autosorb IQ instrument to determine the specific surface area of each prepared sample. The optical absorbance was measured using a V-750 UV–visible spectrofluorometer equipped with a diffuse reflectance and fluorescence detector (JASCO FP-8600).</p>", "<title>Gas Sensing Device Preparation and Measurement Process</title>", "<p id=\"Par20\">In the preparation of gas sensing devices, two different scenarios were used based on the MXene film preparation and functionalization mythology. Firstly, we considered two MXene samples, including as-prepared MXene flakes-with stacked layers and flake thicknesses of approximately 100 nm and 10 µm (highly etched as-prepared MXene) and -with stacked layers and flake thicknesses ranging from &lt; 100 to 600 nm and approximately 1 µm (fully etched as-prepared MXene). Both samples underwent a common device preparation process, which included drop-casting from a 2 mg mL<sup>−1</sup> stack solution onto interdigitated gold (Au) electrodes coated over a Si-wafer. (Fig. ##SUPPL##0##S16##c). To ensure the quality of the interdigitated electrode structure, we used the shadow mask pattern with length, width, and spacing of 8.641, 3.281, and 0.188 mm, respectively (Fig. ##SUPPL##0##S16##a). The optical image of the device (Fig. ##SUPPL##0##S16##b) clearly shows that MXene was drop-casted onto the Au-electrode pattern, ensuring the ohmic contacts, as MXene behaves also like a metal. This is further confirmed by the ohmic response obtained in the I–V curve (Fig. ##SUPPL##0##S16##d). The completed sensor devices were then placed within a 5 cm<sup>3</sup> chamber and connected to the signal acquisition system via slender gold wires using silver paste (Fig. ##SUPPL##0##S16##e).</p>", "<p id=\"Par21\">On the other hand, we produced the few-layer MXene film using an immiscible solution approach with a tenfold diluted sample of 10 mg mL<sup>−1</sup> MXene sediment from the upper part of a centrifuge tube (Fig. ##SUPPL##0##S3##i). SEM and TEM images of this MXene-based film (obtained among films prepared via the tenfold dilution of 5, 10, and 20 mg mL<sup>−1</sup>) are provided in Figs. ##SUPPL##0##S8## and ##SUPPL##0##S9##. This film was then functionalized with I- and Br-. Subsequently, the same process of thermal evaporation and gold wire soldering, with silver paste, was applied to establish a connection with the signal acquisition system.</p>", "<p id=\"Par22\">To carry out the gas sensing experiments, the mass flow meters and controllers (MFC, Tylan 2900), were used to precisely dilute the target gases, including NO<sub>2</sub>, NH<sub>3</sub>, H<sub>2</sub>, ethanol and acetone (Deahan Gas Co., Ltd), by N<sub>2</sub> gas (Daehan Gas Co., Ltd). These gases were dynamically mixed to achieve the desired gas concentrations. Prior to introducing the target gas, the chamber was evacuated to maintain vacuum conditions and minimize the influence of humidity. Electrical conductance signals of the sensors were recorded using a data acquisition system (Agilent 34970A). The response sensitivity (S%) of the sensors was calculated using the following equation:where <italic>R</italic><sub>a</sub> and <italic>R</italic><sub>g</sub> denote the resistance of the sensors upon exposure to N<sub>2</sub> and the target gases, respectively [##UREF##20##36##, ##UREF##21##37##].</p>", "<title>Supplementary Information</title>", "<p>Below is the link to the electronic supplementary material.</p>" ]
[ "<title>Acknowledgements</title>", "<p>This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2021R1I1A1A0105621313, No. 2022R1F1A1074441, No. 2022K1A3A1A20014496, and No. 2022R1F1A1074083). Additionally, this work was supported by the Ministry of Education Funding (No. RIS 2021-004). Furthermore, this work was supported by the Brain Pool program funded by the Ministry of Science and ICT through the National Research Foundation of Korea (RS-2023-00284318). The authors would like to thank Kehui Han from Shiyanjia Lab (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.shiyanjia.com\">www.shiyanjia.com</ext-link>) for the xrd analysis.</p>", "<title>Declarations</title>", "<title>Conflict of interest</title>", "<p id=\"Par36\">The authors declare no interest conflict. They have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p>" ]
[ "<fig id=\"Sch1\"><label>Scheme 1</label><caption><p>Steps involved in the <bold>a–f</bold> preparation and <bold>g</bold> functionalization of few-layer MXene</p></caption></fig>", "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p><bold>a</bold> XRD of MAX phase, fully etched as-prepared, and fully etched I-MXene. <bold>b</bold> MXene SEM image of the diluted MXene powder. <bold>c</bold> 2D and <bold>d</bold> 3D AFM images of the few-layered MXene with correspondence <bold>e</bold> line-profile of the thickness. <bold>f</bold> HRTEM image of few-layer MXene with <bold>g</bold> SUM EDS mapping and corresponding <bold>h</bold> elemental compositions. <bold>i</bold> BET analysis of MAX phase, few-layer as-prepared MXene, and few-layer I-MXene</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p><bold>a</bold> FTIR and <bold>b</bold> XPS survey spectra of as-prepared-, I– and Br–MXene. High resolution XPS O 1<italic>s</italic> spectra of <bold>c</bold> as-prepared MXene and <bold>d</bold> I–MXene. Ti 2<italic>p</italic> spectra of <bold>e</bold> as-prepared MXene and <bold>f</bold> I–MXene. <bold>g</bold> I 3<italic>d</italic> spectrum of I–MXene. Sum EDS images of <bold>h</bold> I–MXene and corresponding <bold>i</bold> elemental composition</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p>Characterization of MXene samples after one week immersion in DI water: <bold>a</bold> FTIR and <bold>b</bold> XPS survey spectra of as-prepared-, I–, and Br–MXene. <bold>c–e</bold> High-resolution XPS O 1<italic>s</italic> spectra of as-prepared, I–, and Br–MXene. Ti 2<italic>p</italic> spectra of <bold>f</bold> as-prepared-MXene and <bold>g</bold> I–MXene C 1<italic>s</italic> spectra of <bold>h</bold> as-prepared-MXene and <bold>i</bold> I–MXene</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p><bold>a</bold> Gas sensing capabilities based on different thicknesses of MXene toward 50 ppm of NO<sub>2</sub>. Dynamic response curves of as-prepared-, I–, and Br–MXene-based sensors to <bold>b</bold> lower (0.05 ppb–1 ppm) and <bold>d</bold> higher (5–200 ppm) NO<sub>2</sub> concentrations with their corresponding <bold>c</bold> response versus NO<sub>2</sub> concentration. <bold>f</bold> Sensing response and recovery time of as-prepared- and I–MXene-based sensors to NO<sub>2</sub> concentrations ranging from 5 to 500 ppm. <bold>g</bold> Selectivity and <bold>h</bold> stability performances of I–MXene toward four pulses of NO<sub>2</sub>. <bold>i</bold> Long-term stability evaluation of all sensors over a 30-day period</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><p><bold>a, b</bold> Schematics depicting the influence of electronegativity and shielding effects of functional groups (–O/–F/–OH and –I/–Br) on the (i) response and (ii) recovery times when detecting high electron affinity gases <bold>c</bold> Comparison of atomic sizes (–F and –I) indicating differing shielding effects. <bold>d</bold> Enhanced interlayer-spacing of MXene nanosheets achieved via iodine terminals (calculated using Bragg's law) for optimized NO<sub>2</sub> absorption. <bold>e</bold> Symbol and emoji annotations elucidating essential components within the schematic illustration</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Comparison of I–MXene with previous studies on functionalized and composite-based MXene gas sensors at room temperature</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Material</th><th align=\"left\">Type of gas</th><th align=\"left\">Concentration (PPM)</th><th align=\"left\">Response (%)</th><th align=\"left\">Linear range (ppm)</th><th align=\"left\">Res/rec time (s)</th><th align=\"left\">References</th></tr></thead><tbody><tr><td align=\"left\">-FOTS functionalized Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub></td><td align=\"left\">Ethanol</td><td align=\"left\">120</td><td align=\"left\">14.1</td><td char=\"–\" align=\"char\">5–120</td><td align=\"left\">39/139</td><td align=\"left\">[##REF##32857499##25##]</td></tr><tr><td align=\"left\">CPTMS functionalized Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub></td><td align=\"left\">Ethanol</td><td align=\"left\">120</td><td align=\"left\">10.1</td><td char=\"–\" align=\"char\">5–120</td><td align=\"left\">120/332</td><td align=\"left\">[##REF##32857499##25##]</td></tr><tr><td align=\"left\">Hydrocarbon functionalized Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub></td><td align=\"left\">Ethanol</td><td align=\"left\">100</td><td align=\"left\">14.3</td><td char=\"–\" align=\"char\">20–500</td><td align=\"left\">14.3/37.5</td><td align=\"left\">[##UREF##17##28##]</td></tr><tr><td align=\"left\">Oxygen-functionalized MXene</td><td align=\"left\">NO<sub>2</sub></td><td align=\"left\">10</td><td align=\"left\">13.8</td><td char=\"–\" align=\"char\">1–10</td><td align=\"left\">–/–</td><td align=\"left\">[##REF##36812910##46##]</td></tr><tr><td align=\"left\">Alkalized organ-like MXene</td><td align=\"left\">NH<sub>3</sub></td><td align=\"left\">100</td><td align=\"left\">28.87</td><td char=\"–\" align=\"char\">10–500</td><td align=\"left\">1/201</td><td align=\"left\">[##REF##30990023##47##]</td></tr><tr><td align=\"left\">Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub>/PDS-Cl Composite</td><td align=\"left\">H<sub>2</sub>S</td><td align=\"left\">5</td><td align=\"left\">2</td><td char=\"–\" align=\"char\">0.5–5</td><td align=\"left\">–/–</td><td align=\"left\">[##REF##36694305##48##]</td></tr><tr><td align=\"left\">Sulfur-doped Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub></td><td align=\"left\">Toluene</td><td align=\"left\">50</td><td align=\"left\">79.5</td><td char=\"–\" align=\"char\">1–50</td><td align=\"left\">~ 60/ ~ 350</td><td align=\"left\">[##REF##32786375##49##]</td></tr><tr><td align=\"left\">3D MXene framework</td><td align=\"left\">Acetone</td><td align=\"left\">5</td><td align=\"left\">0.75</td><td char=\"–\" align=\"char\">0.05–30</td><td align=\"left\">90/110</td><td align=\"left\">[##UREF##29##50##]</td></tr><tr><td align=\"left\">Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub>/CuO</td><td align=\"left\">NO<sub>2</sub></td><td align=\"left\">50</td><td align=\"left\">56.99</td><td char=\"–\" align=\"char\">1–50</td><td align=\"left\">13.5/20.9</td><td align=\"left\">[##UREF##30##51##]</td></tr><tr><td align=\"left\">Ti<sub>3</sub>C<sub>2</sub>T<sub><italic>x</italic></sub></td><td align=\"left\">NO<sub>2</sub></td><td align=\"left\">50</td><td align=\"left\">11.91</td><td char=\"–\" align=\"char\">1–50</td><td align=\"left\">40.4/60.9</td><td align=\"left\">[##UREF##30##51##]</td></tr><tr><td align=\"left\">Ti<sub>3</sub>C<sub>2</sub>-I</td><td align=\"left\">NO<sub>2</sub></td><td align=\"left\">120</td><td align=\"left\">14.50</td><td char=\"–\" align=\"char\">0.05–50</td><td align=\"left\">90/105</td><td align=\"left\">This work</td></tr></tbody></table></table-wrap>" ]
[ "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{S}}\\% \\, = \\, \\Delta R/R_{{\\text{a}}} \\times { 1}00 \\, = \\, \\left( {R_{{\\text{g}}} - R_{{\\text{a}}} } \\right)/R_{{\\text{a}}} \\times { 1}00$$\\end{document}</tex-math><mml:math id=\"M2\" display=\"block\"><mml:mrow><mml:mtext>S</mml:mtext><mml:mo>%</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mo>=</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>R</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mtext>a</mml:mtext></mml:msub><mml:mo>×</mml:mo><mml:mn>100</mml:mn><mml:mspace width=\"0.166667em\"/><mml:mo>=</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mtext>g</mml:mtext></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mtext>a</mml:mtext></mml:msub></mml:mrow></mml:mfenced><mml:mo stretchy=\"false\">/</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mtext>a</mml:mtext></mml:msub><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{NO}}_{{2}} \\left( {{\\text{gas}}} \\right) \\, + {\\text{ e}}^{ - } \\to {\\text{ NO}}_{{2}}^{-} \\left( {{\\text{ads}}} \\right)$$\\end{document}</tex-math><mml:math id=\"M4\" display=\"block\"><mml:mrow><mml:msub><mml:mtext>NO</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mtext>gas</mml:mtext></mml:mfenced><mml:mspace width=\"0.166667em\"/><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>e</mml:mtext></mml:mrow><mml:mo>-</mml:mo></mml:msup><mml:mo stretchy=\"false\">→</mml:mo><mml:msubsup><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>NO</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mo>-</mml:mo></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mtext>ads</mml:mtext></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{NO}}_{{2}}^{-} \\left( {{\\text{gas}}} \\right) \\, + {\\text{N}}_{{2}} \\left( {\\text{purging gas}} \\right) \\, \\to {\\text{ NO}}_{{2}} \\left( {{\\text{ads}}} \\right) \\, + {\\text{ e}}^{ - }$$\\end{document}</tex-math><mml:math id=\"M6\" display=\"block\"><mml:mrow><mml:msubsup><mml:mtext>NO</mml:mtext><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mo>-</mml:mo></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mtext>gas</mml:mtext></mml:mfenced><mml:mspace width=\"0.166667em\"/><mml:mo>+</mml:mo><mml:msub><mml:mtext>N</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtext>purging gas</mml:mtext></mml:mrow></mml:mfenced><mml:mspace width=\"0.166667em\"/><mml:mo stretchy=\"false\">→</mml:mo><mml:msub><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>NO</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mtext>ads</mml:mtext></mml:mfenced><mml:mspace width=\"0.166667em\"/><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>e</mml:mtext></mml:mrow><mml:mo>-</mml:mo></mml:msup></mml:mrow></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[]
[ "<graphic position=\"anchor\" xlink:href=\"40820_2023_1316_Figa_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"40820_2023_1316_Sch1_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"40820_2023_1316_Fig1_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"40820_2023_1316_Article_Equ1.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"40820_2023_1316_Fig2_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"40820_2023_1316_Fig3_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"40820_2023_1316_Fig4_HTML\" id=\"MO7\"/>", "<graphic xlink:href=\"40820_2023_1316_Article_Equ2.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"40820_2023_1316_Fig5_HTML\" id=\"MO8\"/>", "<graphic xlink:href=\"40820_2023_1316_Article_Equ3.gif\" position=\"anchor\"/>" ]
[ "<media xlink:href=\"40820_2023_1316_MOESM1_ESM.pdf\"><caption><p>Supplementary file1 (PDF 3063 kb)</p></caption></media>" ]
[{"label": ["1."], "surname": ["Wang", "Pang", "Cheng", "Han", "Li"], "given-names": ["Y", "J", "Q", "L", "Y"], "article-title": ["Applications of 2D-layered palladium diselenide and its van der waals heterostructures in electronics and optoelectronics"], "source": ["Nano-Micro Lett."], "year": ["2021"], "volume": ["13"], "fpage": ["143"], "pub-id": ["10.1007/s40820-021-00660-0"]}, {"label": ["2."], "surname": ["Yang", "Lv", "Zhang", "Wang", "Jiang"], "given-names": ["Z", "S", "Y", "J", "L"], "article-title": ["Self-assembly 3D porous crumpled MXene spheres as efficient gas and pressure sensing material for transient all-MXene sensors"], "source": ["Nano-Micro Lett."], "year": ["2022"], "volume": ["14"], "fpage": ["56"], "pub-id": ["10.1007/s40820-022-00796-7"]}, {"label": ["3."], "surname": ["Sardana", "Singh", "Sharma", "Kaur", "Pati"], "given-names": ["S", "Z", "AK", "N", "PK"], "article-title": ["Self-powered biocompatible humidity sensor based on anelectrospun anisotropic triboelectric nanogenerator for non-invasive diagnostic applications"], "source": ["Sens. Actuat. B Chem."], "year": ["2022"], "volume": ["371"], "fpage": ["132507"], "pub-id": ["10.1016/j.snb.2022.132507"]}, {"label": ["4."], "surname": ["Rasheed"], "given-names": ["T"], "article-title": ["MXenes as an emerging class of two-dimensional materials for advanced energy storage devices"], "source": ["J. Mater. Chem. A"], "year": ["2022"], "volume": ["10"], "fpage": ["4558"], "lpage": ["4584"], "pub-id": ["10.1039/d1ta10083a"]}, {"label": ["6."], "surname": ["Bashir", "Ismail", "Wang", "Zhu", "Zhao"], "given-names": ["T", "SA", "J", "W", "J"], "article-title": ["MXene terminating groups O, \u2013F or\u2013OH, \u2013F or O, \u2013OH, \u2013F, or O, \u2013OH, \u2013Cl?"], "source": ["J. Energy Chem."], "year": ["2023"], "volume": ["76"], "fpage": ["90"], "lpage": ["104"], "pub-id": ["10.1016/j.jechem.2022.08.032"]}, {"label": ["8."], "surname": ["Liu", "Zhou", "Chen", "Jia", "Zhou"], "given-names": ["F", "A", "J", "J", "W"], "article-title": ["Preparation of Ti"], "sub": ["3", "2", "2"], "source": ["Appl. Surf. Sci."], "year": ["2017"], "volume": ["416"], "fpage": ["781"], "lpage": ["789"], "pub-id": ["10.1016/j.apsusc.2017.04.239"]}, {"label": ["10."], "surname": ["Wang", "Zhang", "Wang", "Shen", "Zhang"], "given-names": ["L", "H", "B", "C", "C"], "article-title": ["Synthesis and electrochemical performance of Ti"], "sub": ["3", "2"], "italic": ["x"], "source": ["Electron. Mater. Lett."], "year": ["2016"], "volume": ["12"], "fpage": ["702"], "lpage": ["710"], "pub-id": ["10.1007/s13391-016-6088-z"]}, {"label": ["12."], "surname": ["Feng", "Yu", "Jiang", "Wang", "Mi"], "given-names": ["A", "Y", "F", "Y", "L"], "article-title": ["Fabrication and thermal stability of NH"], "sub": ["4", "2", "3", "2"], "source": ["Ceram. Int."], "year": ["2017"], "volume": ["43"], "fpage": ["6322"], "lpage": ["6328"], "pub-id": ["10.1016/j.ceramint.2017.02.039"]}, {"label": ["13."], "surname": ["Zhang", "Zhu", "Shi", "Wu", "Wang"], "given-names": ["B", "J", "P", "W", "F"], "article-title": ["Fluoride-free synthesis and microstructure evolution of novel two-dimensional Ti"], "sub": ["3", "2", "2"], "source": ["Ceram. Int."], "year": ["2019"], "volume": ["45"], "fpage": ["8395"], "lpage": ["8405"], "pub-id": ["10.1016/j.ceramint.2019.01.148"]}, {"label": ["15."], "surname": ["Liu", "Li", "Cui", "Yan", "Zhang"], "given-names": ["M-Z", "X-H", "X-H", "H-T", "R-Z"], "article-title": ["The influence of different functional groups on quantum capacitance, electronic and optical properties of Hf"], "sub": ["2"], "source": ["Appl. Surf. Sci."], "year": ["2022"], "volume": ["605"], "fpage": ["154830"], "pub-id": ["10.1016/j.apsusc.2022.154830"]}, {"label": ["18."], "surname": ["Parihar", "Singhal", "Kumar", "Khan", "Khan"], "given-names": ["A", "A", "N", "R", "MA"], "article-title": ["Next-generation intelligent MXene-based electrochemical aptasensors for point-of-care cancer diagnostics"], "source": ["Nano-Micro Lett."], "year": ["2022"], "volume": ["14"], "fpage": ["100"], "pub-id": ["10.1007/s40820-022-00845-1"]}, {"label": ["19."], "surname": ["Soomro", "Zhang", "Fan", "Wei", "Xu"], "given-names": ["RA", "P", "B", "Y", "B"], "article-title": ["Progression in the oxidation stability of MXenes"], "source": ["Nano-Micro Lett."], "year": ["2023"], "volume": ["15"], "fpage": ["108"], "pub-id": ["10.1007/s40820-023-01069-7"]}, {"label": ["20."], "surname": ["Zhao", "Hu", "Shi", "Fu", "Chen"], "given-names": ["SF", "FX", "ZZ", "JJ", "Y"], "article-title": ["2-D/2-D heterostructured biomimetic enzyme by interfacial assembling Mn"], "sub": ["3", "4", "2"], "source": ["Nano Res."], "year": ["2021"], "volume": ["14"], "fpage": ["879"], "lpage": ["886"], "pub-id": ["10.1007/s12274-020-3130-0"]}, {"label": ["22."], "surname": ["Sardana", "Debnath", "Aswal", "Mahajan"], "given-names": ["S", "AK", "DK", "A"], "article-title": ["WS"], "sub": ["2", "3", "2"], "source": ["Sens. Actuat. B Chem."], "year": ["2023"], "volume": ["394"], "fpage": ["134352"], "pub-id": ["10.1016/j.snb.2023.134352"]}, {"label": ["24."], "surname": ["Xu", "Song", "Liu", "Liu", "Pan"], "given-names": ["T", "Q", "K", "H", "J"], "article-title": ["Nanocellulose-assisted construction of multifunctional MXene-based aerogels with engineering biomimetic texture for pressure sensor and compressible electrode"], "source": ["Nano-Micro Lett."], "year": ["2023"], "volume": ["15"], "fpage": ["98"], "pub-id": ["10.1007/s40820-023-01073-x"]}, {"label": ["26."], "surname": ["Ji", "Zhao", "Shen", "Liu", "Zhang"], "given-names": ["J", "L", "Y", "S", "Y"], "article-title": ["Covalent stabilization and functionalization of MXene via silylation reactions with improved surface properties"], "source": ["FlatChem"], "year": ["2019"], "volume": ["17"], "fpage": ["100128"], "pub-id": ["10.1016/j.flatc.2019.100128"]}, {"label": ["27."], "surname": ["Lim", "Park", "Yang", "Kwak", "Lee"], "given-names": ["S", "H", "J", "C", "J"], "article-title": ["Stable colloidal dispersion of octylated Ti3C2-MXenes in a nonpolar solvent"], "source": ["Colloids Surf. A Physicochem. Eng. Aspects"], "year": ["2019"], "volume": ["579"], "fpage": ["123648"], "pub-id": ["10.1016/j.colsurfa.2019.123648"]}, {"label": ["28."], "surname": ["Li", "An", "Lu", "Shan", "Xing"], "given-names": ["X", "Z", "Y", "J", "H"], "article-title": ["Room temperature VOCs sensing with termination-modified Ti"], "sub": ["3", "2"], "italic": ["x"], "source": ["Adv. Mater. Technol."], "year": ["2022"], "volume": ["7"], "fpage": ["2100872"], "pub-id": ["10.1002/admt.202100872"]}, {"label": ["29."], "surname": ["Shi", "Zhang", "Liu", "Park", "Lohe"], "given-names": ["H", "P", "Z", "S", "MR"], "article-title": ["Ambient-stable two-dimensional titanium carbide (MXene) enabled by iodine etching"], "source": ["Angew. Chem. Int. Ed."], "year": ["2021"], "volume": ["60"], "fpage": ["8689"], "lpage": ["8693"], "pub-id": ["10.1002/anie.202015627"]}, {"label": ["34."], "surname": ["Alhabeb", "Maleski", "Anasori", "Lelyukh", "Clark"], "given-names": ["M", "K", "B", "P", "L"], "source": ["Guidelines for synthesis and processing of two-dimensional titanium carbide (Ti3C2Tx MXene)"], "year": ["2023"], "publisher-loc": ["New York"], "publisher-name": ["MXenes. Jenny Stanford Publishing"], "fpage": ["415"], "lpage": ["449"]}, {"label": ["36."], "surname": ["Han", "Han", "Zhang", "Wang", "Li"], "given-names": ["D", "X", "X", "W", "D"], "article-title": ["Highly sensitive and rapidly responding room-temperature NH"], "sub": ["3"], "source": ["Sens. Actuat. B Chem."], "year": ["2022"], "volume": ["367"], "fpage": ["132038"], "pub-id": ["10.1016/j.snb.2022.132038"]}, {"label": ["37."], "surname": ["Sardana", "Mahajan"], "given-names": ["S", "A"], "article-title": ["Edge-site-enriched Ti"], "sub": ["3", "2", "2"], "italic": ["x"], "source": ["ACS Appl. Nano Mater."], "year": ["2023"], "volume": ["6"], "fpage": ["469"], "lpage": ["481"], "pub-id": ["10.1021/acsanm.2c04581"]}, {"label": ["39."], "surname": ["Wu", "Tu", "Dai", "Tang", "Zhang"], "given-names": ["X", "T", "Y", "P", "Y"], "article-title": ["Direct ink writing of highly conductive MXene frames for tunable electromagnetic interference shielding and electromagnetic wave-induced thermochromism"], "source": ["Nano-Micro Lett."], "year": ["2021"], "volume": ["13"], "fpage": ["148"], "pub-id": ["10.1007/s40820-021-00665-9"]}, {"label": ["40."], "surname": ["Riazi", "Anayee", "Hantanasirisakul", "Shamsabadi", "Anasori"], "given-names": ["H", "M", "K", "AA", "B"], "article-title": ["Surface modification of a MXene by an aminosilane coupling agent"], "source": ["Adv. Mater. Interfaces"], "year": ["2020"], "volume": ["7"], "fpage": ["1902008"], "pub-id": ["10.1002/admi.201902008"]}, {"label": ["41."], "surname": ["Xu", "Zheng", "Liu", "Li", "Lin"], "given-names": ["H", "D", "F", "W", "J"], "article-title": ["Synthesis of an MXene/polyaniline composite with excellent electrochemical properties"], "source": ["J. Mater. Chem. A"], "year": ["2020"], "volume": ["8"], "fpage": ["5853"], "lpage": ["5858"], "pub-id": ["10.1039/D0TA00572J"]}, {"label": ["42."], "surname": ["Liu", "Jian", "Fang", "Xu", "Zhu"], "given-names": ["Z", "Z", "J", "X", "X"], "article-title": ["Low-temperature reverse microemulsion synthesis, characterization, and photocatalytic performance of nanocrystalline titanium dioxide"], "source": ["Int. J. Photoenergy"], "year": ["2012"], "volume": ["2012"], "fpage": ["702503"], "pub-id": ["10.1155/2012/702503"]}, {"label": ["43."], "surname": ["Wu", "Li", "Liu", "Wang", "Li"], "given-names": ["Z", "S", "M", "Z", "J"], "article-title": ["Synthesis and characterization of a liquid oxygen-compatible epoxy resin"], "source": ["High Perform. Polym."], "year": ["2015"], "volume": ["27"], "fpage": ["74"], "lpage": ["84"], "pub-id": ["10.1177/0954008314539359"]}, {"label": ["44."], "surname": ["Zhang", "Pinilla", "McEvoy", "Cullen", "Anasori"], "given-names": ["CJ", "S", "N", "CP", "B"], "article-title": ["Oxidation stability of colloidal two-dimensional titanium carbides (MXenes)"], "source": ["Chem. Mater."], "year": ["2017"], "volume": ["29"], "fpage": ["4848"], "lpage": ["4856"], "pub-id": ["10.1021/acs.chemmater.7b00745"]}, {"label": ["45."], "surname": ["Saruhan", "Lontio Fomekong", "Nahirniak"], "given-names": ["B", "R", "S"], "article-title": ["Review: influences of semiconductor metal oxide properties on gas sensing characteristics"], "source": ["Front. Sens."], "year": ["2021"], "volume": ["2"], "fpage": ["657931"], "pub-id": ["10.3389/fsens.2021.657931"]}, {"label": ["50."], "surname": ["Yuan", "Yang", "Peng", "Li", "Yin"], "given-names": ["W", "K", "H", "F", "F"], "article-title": ["A flexible VOCs sensor based on a 3D MXene framework with a high sensing performance"], "source": ["J. Mater. Chem. A"], "year": ["2018"], "volume": ["6"], "fpage": ["18116"], "lpage": ["18124"], "pub-id": ["10.1039/C8TA06928J"]}, {"label": ["51."], "surname": ["Guo", "Feng", "Zhang", "Zhang", "Xu"], "given-names": ["F", "C", "Z", "L", "C"], "article-title": ["A room-temperature NO"], "sub": ["2", "3", "2", "X"], "source": ["Sens. Actuat. B Chem."], "year": ["2023"], "volume": ["375"], "fpage": ["132885"], "pub-id": ["10.1016/j.snb.2022.132885"]}]
{ "acronym": [], "definition": [] }
51
CC BY
no
2024-01-14 23:40:13
Nanomicro Lett. 2024 Jan 12; 16:84
oa_package/f3/09/PMC10786774.tar.gz
PMC10786775
38214840
[ "<title>Introduction</title>", "<p id=\"Par6\">Stretchable electronics featuring compliant mechanical properties are disruptive innovations for next-generation wearables [##REF##20339064##1##–##UREF##0##3##]. An attractive platform, called epidermal electronics, is established through the direct lamination of stretchable devices on the skin [##REF##21836009##4##, ##REF##31538370##5##], achieving robust body integration for emerging areas in health monitoring [##REF##30819934##6##–##REF##35353566##8##], wearable therapy [##REF##26999482##9##], and human–machine interfaces [##UREF##1##10##, ##UREF##2##11##]. Compliant conductors are critical components of stretchable electronics to build functional electrodes and electrical interconnects. As an attractive class of material candidates, stretchable nanocomposites are formed by dispersing metallic nanostructures into elastomeric matrices, including carbon nanotubes [##REF##26179120##12##, ##REF##29608857##13##], metal nanoparticles [##REF##28504674##14##, ##REF##23863931##15##], metal nanowires [##REF##22786752##16##–##REF##34446604##19##], and metal nanoflakes [##REF##30729786##20##, ##REF##35723443##21##]. These nanofillers establish an electrically conductive and intrinsically stretchable percolation network. Despite the excellent electrical and mechanical properties, stretchable nanocomposites may not perfectly follow the textured skin with microwrinkles and hairs [##REF##23440975##22##–##REF##37072159##24##]. Air pockets developed at the tissue-device interface may affect the sensing performance by attenuating valuable biological signals [##REF##33962955##25##]. In addition, stretchable nanocomposites lack the natural adhesion to biological tissues. These devices still require mechanical compression or bioadhesives to mount on the moving body [##UREF##5##26##–##UREF##6##28##]. These practical wearable issues largely limit the widespread implementation of stretchable electronic devices and systems.</p>", "<p id=\"Par7\">Hydrogels are skin-like solids comprising crosslinked, water-filled polymeric networks. In biomedical fields, hydrogels have found a wide range of applications in contact lenses [##UREF##7##29##, ##REF##11700799##30##], wound dressings [##REF##34374515##31##–##REF##28751604##33##], cell culture [##UREF##8##34##], and drug delivery [##UREF##9##35##, ##REF##29657852##36##]. The ionic conductivity and mechanical stretchability render hydrogels attractive candidates for epidermal electronics [##UREF##10##37##, ##UREF##11##38##]. The extreme softness allows them to achieve conformal contact with the irregular surface of the skin [##REF##33962955##25##]. In addition, the polymeric network can incorporate functional groups with cellular affinity for selective adhesion to biological tissues [##UREF##12##39##]. A stable and seamless interface is readily established by the tissue-adhesive hydrogel on highly textured skin, providing an ideal opportunity to collect physiological information and apply electrical/chemical simulations [##UREF##13##40##, ##REF##36739173##41##]. Despite their excellent performance as epidermal interfaces, the limited conductivity of hydrogels from dissociated ions still restricts the expansion of application scopes toward various devices and systems.</p>", "<p id=\"Par8\">A promising architecture of epidermal electronics involves heterogeneously integrated conductive nanocomposite and hydrogel hybrids to combine the best of both worlds. Directly bonding hydrogels to polymers is often challenging due to their distinctive surface energies [##REF##26573427##42##]. As a straightforward approach, hydrogels and polymers are modified in bulk with silane coupling agents to achieve a strong bond at the interface [##REF##29487342##43##]. The main drawback is the potential changes in the mechanical and electrical properties of nanocomposites when they are mixed with silanes [##UREF##14##44##]. Alternatively, the polymers are surface modified with reactive groups for hydrogels through oxygen plasma exposure [##REF##30462477##45##], benzophenone-based photograph treatment [##REF##27345380##46##, ##REF##29761554##47##], and cyanoacrylate polymerizations [##REF##28691092##48##]. The surface treatment may easily damage the conductive nanocomposites. In contrast to the molecular modifications, a macroscopically mechanical interlock strategy relies on geometric designs to achieve physical adhesion between polymers and hydrogels [##UREF##15##49##]. Although highly roughened interfaces are known for improved adhesion [##UREF##16##50##], this common surface engineering approach leads to small adhesion forces for hydrogels due to their inherent softness for easy separation through elastic deformations [##REF##26573427##42##]. A porous elastomer web has been employed as the matrix to load conductive nanofilm electrodes and lock with the hydrogels [##UREF##17##51##]. This interpenetrating elastomer/hydrogel network can only be separated through rupture, which substantially increases the interfacial toughness [##REF##19887124##52##]. Unfortunately, this attractive design relies on the porous microstructure of the substrates and cannot be directly applied to regular devices constructed on elastomer films. An effective approach to firmly combine conductive nanocomposite with hydrogels is therefore urgently required for epidermal devices.</p>", "<p id=\"Par9\">In this study, we report a generic strategy to build mechanically interlocked conductive nanocomposite/hydrogel hybrid electrodes. Silver nanowire (Ag NW)/elastomer nanocomposites are spray deposited on the styrene-ethylene-butylene-styrene (SEBS) substrate to create patterned conductive features. A stretchable and porous SEBS microfoam is then thermally laminated to the Ag NW nanocomposite for mechanical interlock with the hydrogel. The resulting interlocked hybrid electrodes exhibited a high interfacial toughness of 158.2 J m<sup>−2</sup>, representing a notable improvement over directly stacked hybrids by a factor of 28. In addition to the SEBS substrate, a tackified microfoam is readily bonded with different substrates to construct robust hydrogel/polymer hybrids, including ethylene–vinyl acetate copolymer (EVA) elastomer, poly(methyl methacrylate)–poly(n-butyl acrylate) (PMMA-PnBA) elastomer, and polyethylene terephthalate (PET) plastic. After attaching the porous microfoam, the conductive nanocomposite still makes contact with the hydrogel through the porous microstructure, enabling interlocked hybrid electrodes to be electrically connected. The hybrid electrodes based on polydopamine–polyacrylamide (PDA-PAM) hydrogels exhibit conformal contact and strong adhesion to the skin, achieving low contact impedance better than state-of-the-art Ag/AgCl gel electrodes. The corresponding epidermal sensors can be mounted on the curvilinear body to record electrocardiogram (ECG) and electromyogram (EMG) signals without additional adhesive. Additionally, an integrated epidermal sleeve has been created composed of interlocked hybrid sensing electrodes and Ag NW nanocomposite electrical interconnects, functioning as a human–machine interface to distinguish different gestures by recording muscle contractions. The design and fabrication of mechanically interlocked hybrid electrodes are well-compatible with existing epidermal devices. The robust combination of conductive nanocomposites and hydrogels demonstrated here marks a significant step forward in the field of stretchable and wearable electronics.</p>" ]
[]
[ "<title>Results and Discussion</title>", "<title>Design and Fabrication of Interlocked Hybrid Electrodes</title>", "<p id=\"Par17\">As schematically illustrated in Fig. ##FIG##0##1##a, a representative epidermal electronic device is composed of Ag NW nanocomposite/hydrogel hybrid electrodes and Ag NW nanocomposite interconnects. Tissue-adhesive hydrogels are exploited in these hybrid electrodes to establish strong and conformal electronic interfaces with the skin. An interpenetrating hydrogel/polymer layer provides a robust interlocking mechanism for reliable attachment to the sensing device. Highly conductive Ag NW nanocomposites are used to construct electrical interconnects for external equipment. Figure ##FIG##0##1##b reveals the critical steps involved in preparing the polymer/hydrogel hybrids. Polyol-reduction synthesized Ag NWs are uniformly dispersed in a SEBS elastomer solution and spray deposited on the stretchable substrate as the conductive nanocomposite [##REF##36520145##53##]. Conductive features are readily defined with shadow masks, as exemplified by the cow cartoon pattern. Soft microfoams are produced through a sacrificial template approach. Salicylic acid (SA) microrods through antisolvent synthesis are blended with SEBS elastomer to form a composite film (Fig. ##SUPPL##0##S1##) [##UREF##18##54##, ##REF##35262322##55##]. This composite film is physically attached to the conductive features in a vacuum laminator, in which the combined heat and pressure promote the interdiffusion of polymer chains for a strong bond [##UREF##19##56##, ##REF##30484303##57##]. The embedded SA microrods are removed by dissolving ethanol to form the porous microstructure. The interlocked hybrids are realized by infiltrating the hydrogel precursor into porous microfoam and crosslinking under ambient conditions. Notice that mussel-inspired PDA–PAM hydrogel is adopted here for its excellent tissue affinity [##UREF##12##39##].</p>", "<title>Characterizations of the Bonding Mechanism</title>", "<p id=\"Par18\">The composite film is self-supporting and convenient to handle, as shown in Fig. ##FIG##1##2##a. In Fig. ##SUPPL##1##S2##, the uniaxial stress–strain curve confirms its decent modulus of 4.73 MPa. In contrast, the SEBS microfoam is soft, porous, and easily deformable. The SEM image reveals the microstructure containing interconnected pores in dozens of micrometers (Fig. ##FIG##1##2##b). The microfoam has a low modulus of 0.15 MPa and a large fracture strain of 598% (Fig. ##SUPPL##1##S2##). These distinctive mechanical properties are exploited to enable the physical bonding process. The composite film is stiff enough to facilitate the transfer and thermal lamination onto other substrates without any surface wrinkles. The porous microfoam is then formed by dissolving the embedded SA microrods. Strong attachment manifests with interfacial toughness of 1776.5 J m<sup>−2</sup> (Fig. S3). In contrast, the soft microfoam is easily compressed and loses its porosity during thermal bonding, thereby eliminating the practical feasibility of direct transfer.</p>", "<p id=\"Par19\">The PDA-PAM hydrogel has been synthesized by a free radical polymerization method. According to Fig. S4, the uniaxial stress–strain curve reveals its modulus of 0.54 kPa, fracture strain of 952%, and toughness of ~ 1.063 MJ m<sup>−3</sup>. To form the interlocked hybrid, the hydrogel precursor is drop cast onto the microfoam-attached substrate. An anionic surfactant has been added to the standard precursor for improved wettability, facilitating full infiltration into the porous microfoam. A cross-sectional optical image in Fig. ##FIG##1##2##c reveals a trilayer structure of the elastomer-hydrogel hybrid, with the interpenetrating hydrogel and SEBS elastomer as the intermediate bonding layer. Additionally, the SEM images in Fig. S5 further confirm that the hydrogel has completely infiltrated the porous microfoam. This ideal microstructure is attributed to the capillary action of the porous microfoam that facilitates the absorption of the hydrogel precursor.</p>", "<p id=\"Par20\">The interlocked hybrid retains structural stability under large tensile deformations. The hydrogel is not peeled off from SEBS at 300% strain (Fig. ##FIG##1##2##d). The standard 180°-peeling test is carried out to evaluate the robustness of hydrogel–elastomer hybrids. Stiff backing layers are laminated on hydrogels and elastomers to constrain their elongations [##REF##27345380##46##]. Directly stacked hydrogel–SEBS film hybrids show obvious interfacial crack propagation (Fig. ##FIG##1##2##e). A steady peeling force is measured as 2.5 N m<sup>−1</sup>, corresponding to an interfacial toughness of 5.6 J m<sup>−2</sup> (Fig. ##FIG##1##2##f). In contrast, the hydrogel of the interlocked hybrid produces a brushed hair pattern near the interpenetrating bonding layer, as the characteristic signature of cohesive failures [##REF##27345380##46##, ##REF##30484303##57##]. The peeling force initially increases and approaches a stable value of ~ 78 N m<sup>−1</sup>. The interfacial toughness of 158.2 J m<sup>−2</sup> represents a marked improvement over stacked hybrids by ~ 28 times. Instead of simply increasing the interface roughness, the hydrogel has been infiltrated into the open pores of the microfoams. This unique topological feature ensures the separation through rupture, leading to substantially enhanced interfacial interactions [##REF##19887124##52##]. As the hydrogel has significantly lower toughness than the elastomer, the crack interface is expected to be confined within the hydrogel and has been confirmed in Supporting Video ##SUPPL##0##S1##. According to SEM images in Fig. S6, the residual surface of the interlocked hybrid after peeling off the hydrogel layer reveals intact microfoam partially filled with the hydrogel. As a result, the microfoam establishes an interpenetrating interface with the hydrogel to achieve strong adhesion. On the other hand, the interfacial toughness value may not necessarily be the highest among recent reports. The PDA-PAM hydrogel used here is well recognized for its tissue affinity rather than its mechanical properties. Alternative toughened hydrogels can be used to augment the adhesion levels.</p>", "<p id=\"Par21\">We have further investigated the influence of the microfoam on the mechanical interlocking effect. The porosity of the microfoam increases by raising the SA microrod loading, as shown in Fig. S7. The pore size remains relatively consistent despite some aggregations at high SA microrod loading. According to Figs. ##FIG##1##2##g and S8, the softness of the microfoam improves with its porosity, as reflected in reduced modulus and increased fracture strain. The robustness of the corresponding interlocked hybrids is characterized by 180°-peeling tests, as summarized in Fig. ##FIG##1##2##h. The interfacial toughness shows a slight initial increase with porosity before declining significantly at high porosity. A weight ratio of 4:1 between SA microrods and SEBS is found to be the optimal composition to attain strong adhesion. In addition, the interfacial toughness also depends on the microfoam thickness, as depicted in Fig. ##FIG##1##2##i. A thin microfoam has weak adhesion, likely associated with its soft mechanical properties. A decent thickness of 140 µm is still needed for robust attachments.</p>", "<title>Generalization to Other Polymers</title>", "<p id=\"Par22\">Bonding hydrogels to different polymer substrates is a widely recognized challenge. Here, the mechanical interlock utilizes the microfoam to form an interpenetrating interface with the hydrogel. To expand the range of compatible polymers, a petroleum resin is mixed with the SEBS elastomer during microfoam preparation to act as the tackifier [##REF##33236828##58##]. The resulting microfoam can be easily laminated to various substrates through thermal bonding, including EVA, PMMA-PnBA elastomers, and PET plastics. According to Fig. S9, the interfacial toughness for EVA, PMMA-PnBA, and PET is 490.8, 660.6, and 195.2 J m<sup>−2</sup>, respectively. As shown in Fig. ##FIG##2##3##a, these microfoams allow the facile preparation of interlocked hydrogel/polymer hybrids, in which the hydrogels are firmly adhered to these polymers. Figure ##FIG##2##3##b shows the 180°-peeling tests on PET/hydrogel hybrids. The peeling force is ~ 75 N m<sup>−1</sup> for the interlocked hybrid and ~ 3.6 N m<sup>−1</sup> for the regularly stacked hybrid. In Fig. ##FIG##2##3##c, the interfacial toughness of the three interlocked hybrids is quite high and consistent with the interlocked hydrogel/SEBS hybrid. This mechanical interlocking strategy has shown significant improvements over regularly stacked hybrids, demonstrating its generic suitability for different substrates.</p>", "<p id=\"Par23\">In addition to SEBS-based elastomers, the material choice for the microfoams can be replaced with other polymers. For instance, we have prepared EVA microfoams using a similar sacrificial template approach. These EVA microfoams have the ability to bond with EVA and SEBS substrates, consequently creating interlocked elastomer/hydrogel hybrids, as shown in Fig. S10. The results suggest the soft microfoam as a versatile intermediate layer that can be used for rugged integration with hydrogels.</p>", "<title>Electrical Properties and Body Conformability of Interlocked Hybrid Electrodes</title>", "<p id=\"Par24\">Ag NW nanocomposites are a prototypical form of compliant conductors [##REF##22786752##16##, ##UREF##3##18##]. In the inset of Fig. ##FIG##3##4##a, SEM image reveals randomly oriented Ag NWs in the SEBS elastomer matrix. The percolation network of high–aspect–ratio Ag NWs is responsible for the excellent electrical conductivity of ~ 11,000 S cm<sup>−1</sup>. Abundant Ag NWs are exposed on nanocomposite for convenient contact with other conductors. The stretchability of Ag NW nanocomposites is evaluated by measuring their electrical properties under uniaxial tensile deformations, as shown in Fig. ##FIG##3##4##a. The normalized resistance is 4.74 at 20% strain, 13.53 at 50% strain, and 54.08 at 100% strain, respectively. The decent deformability is a notable attribute of nanowire percolation networks [##REF##22786752##16##, ##REF##30104619##17##]. In Fig. ##FIG##3##4##b, the Ag NW nanocomposites exhibit limited resistance changes during 1000 stretch-relaxation cycles to 50% strain, which demonstrates excellent electromechanical durability for wearable applications. Unlike continuous metal films, the nanocomposite relies on the exposed Ag NWs for external contact, as illustrated in Fig. ##FIG##3##4##c. To estimate the actual surface area, the double-layer capacitance of the nanocomposite electrode submerged in PBS electrolyte is measured with cyclic voltammetry (Fig. ##FIG##3##4##d) [##UREF##20##59##, ##REF##24628572##60##]. The capacitance of the pristine Ag NW nanocomposite is determined as 0.22 mF cm<sup>−2</sup> (Figs. ##FIG##3##4##e and S11). After microfoam attachment, the capacitance shows a certain decrease to 0.16 mF cm<sup>−2</sup>, suggesting a slightly reduced surface area by 27.3%. The nanocomposite electrode is still largely exposed for reliable contact with the hydrogel, thanks to the highly porous structure of the microfoam (Fig. ##FIG##1##2##b).</p>", "<p id=\"Par25\">Interlocked nanocomposite/hydrogel hybrid electrodes are created for epidermal sensing. The attached microfoam and hydrogel have minor influences on the electrode durability, as confirmed by the tensile fatigue test presented in Fig. S12. In Fig. ##FIG##3##4##f, we can observe that the interlocked electrode has achieved firm attachment to the skin. According to 180°-peeling tests conducted on porcine skin, the interfacial adhesion toughness of our PDA–PAM hydrogel is determined as ~ 20 J m<sup>−2</sup> (Fig. S13). This excellent tissue adhesion of the hydrogel is consistent with previous studies due to the abundant catechol groups with high cellular affinity [##UREF##21##61##]. The mechanically interlocked interface further allows the convenient removal of electrodes without accidental delamination. In hybrid electrodes, Ag NW nanocomposites and hydrogels are also electrically connected through the porous locking layer. Figure ##FIG##3##4##g shows the skin–electrode contact impedance as a function of the frequency. The hybrid electrodes exhibit lower contact impedance than commercial Ag/AgCl gel electrodes. Since the conformability of epidermal electrodes is directly correlated with their bending stiffness [##UREF##4##23##, ##UREF##22##62##], the hydrogels have a much lower modulus than regular elastomers, allowing them to make better contact with the textured skin surface through deformations. The exceptional contact impedance of the interlocked hybrid electrodes is attributed to the high ionic conductivity, low modulus, and strong tissue affinity of the PDA-PAM hydrogel layer to interface with the skin. On the other hand, traditional nanocomposite electrodes cannot be directly mounted on the curvilinear human body. An applied pressure of 4 kPa is required to compress the Ag NW nanocomposite electrode onto the textured skin surface. However, the contact impedance is still significantly inferior to the hybrid electrodes. The ordering of the contact impedance has been confirmed by additional measurements from five individuals, as summarized in Fig. S14. Therefore, the interlocked nanocomposite/hydrogel hybrid electrodes are considered an attractive mechanical and electrical interface for epidermal electronics.</p>", "<title>Epidermal Biopotential Detection</title>", "<p id=\"Par26\">Encouraged by the above results, we construct epidermal electronic patches with interlocked hybrid electrodes for biopotential recordings. A typical patch is composed of three interlocked electrodes and corresponding interconnects (Fig. ##FIG##4##5##a). An epidermal sensing patch with linearly arranged electrodes was placed on the right flexor carpi radialis for EMG recording. The hydrogel electrodes exhibit firm adhesion to the skin due to polydopamine. Likewise, a sensing patch with triangularly arranged electrodes was attached to the left chest for ECG recording (Fig. ##FIG##4##5##b). Raw biopotentials were conditioned with a preamplifier and sampled with a data acquisition card. In Fig. ##FIG##4##5##c, the EMG signals reveal the contraction of muscle fibers corresponding to open and closed hand motions. The signal-to-noise ratio (SNR) is 29.0 dB for interlocking electrodes and 26.2 dB for commercial gel electrodes. In addition, ECG waveforms reveal clear P, Q, R, S, and T signatures critical for the diagnosis of cardiovascular diseases, as shown in Fig. ##FIG##4##5##d [##REF##31706789##63##, ##REF##33328095##64##]. The SNR by interlocking electrodes (38.7 dB) is also higher than that by commercial gel electrodes (33.9 dB). The improved signal quality of interlocking electrodes is consistent with their low skin contact impedance. In addition, the self-adhesive hydrogel electrodes can be painlessly peeled off from the skin due to their strong adhesion to the underlying substrate. The as-prepared conductive composites are therefore well suited for robust epidermal electronics.</p>", "<title>Fabrication and Application of Integrated Epidermal Sensing Systems</title>", "<p id=\"Par27\">An integrated epidermal sensing system is fabricated as a human–machine interface. Figure ##FIG##5##6##a shows the integrated sensing system as a soft armband composed of twelve sensing electrodes. Each set of three electrodes makes up an independent EMG channel designed to monitor the activity of an individual muscle. The sensing electrodes and electrical interconnects are spatially separated to avoid crosstalk among the channels. Individual sensing channels are strategically positioned along the primary muscles of the forearm, including brachioradialis, flexor carpi radialis, flexor carpi ulnaris, and extensor digitorum. The self-adhesive hydrogel electrodes exhibit conformal and intimate attachment to the curvilinear human body, establishing a stable interface for high-fidelity electrophysiological recording. In Fig. S15, the conditioned EMG waveforms are simultaneously recorded for different hand gestures. Common hand gestures are readily identified with root-mean-square voltage amplitudes reflecting muscle contraction levels, as shown in Fig. ##FIG##5##6##b. The entire system essentially represents an epidermal human–machine interface to decipher the gestures into four channels of analog signals, which is attractive for robotic control, advanced prosthetics, and virtual reality.</p>" ]
[ "<title>Results and Discussion</title>", "<title>Design and Fabrication of Interlocked Hybrid Electrodes</title>", "<p id=\"Par17\">As schematically illustrated in Fig. ##FIG##0##1##a, a representative epidermal electronic device is composed of Ag NW nanocomposite/hydrogel hybrid electrodes and Ag NW nanocomposite interconnects. Tissue-adhesive hydrogels are exploited in these hybrid electrodes to establish strong and conformal electronic interfaces with the skin. An interpenetrating hydrogel/polymer layer provides a robust interlocking mechanism for reliable attachment to the sensing device. Highly conductive Ag NW nanocomposites are used to construct electrical interconnects for external equipment. Figure ##FIG##0##1##b reveals the critical steps involved in preparing the polymer/hydrogel hybrids. Polyol-reduction synthesized Ag NWs are uniformly dispersed in a SEBS elastomer solution and spray deposited on the stretchable substrate as the conductive nanocomposite [##REF##36520145##53##]. Conductive features are readily defined with shadow masks, as exemplified by the cow cartoon pattern. Soft microfoams are produced through a sacrificial template approach. Salicylic acid (SA) microrods through antisolvent synthesis are blended with SEBS elastomer to form a composite film (Fig. ##SUPPL##0##S1##) [##UREF##18##54##, ##REF##35262322##55##]. This composite film is physically attached to the conductive features in a vacuum laminator, in which the combined heat and pressure promote the interdiffusion of polymer chains for a strong bond [##UREF##19##56##, ##REF##30484303##57##]. The embedded SA microrods are removed by dissolving ethanol to form the porous microstructure. The interlocked hybrids are realized by infiltrating the hydrogel precursor into porous microfoam and crosslinking under ambient conditions. Notice that mussel-inspired PDA–PAM hydrogel is adopted here for its excellent tissue affinity [##UREF##12##39##].</p>", "<title>Characterizations of the Bonding Mechanism</title>", "<p id=\"Par18\">The composite film is self-supporting and convenient to handle, as shown in Fig. ##FIG##1##2##a. In Fig. ##SUPPL##1##S2##, the uniaxial stress–strain curve confirms its decent modulus of 4.73 MPa. In contrast, the SEBS microfoam is soft, porous, and easily deformable. The SEM image reveals the microstructure containing interconnected pores in dozens of micrometers (Fig. ##FIG##1##2##b). The microfoam has a low modulus of 0.15 MPa and a large fracture strain of 598% (Fig. ##SUPPL##1##S2##). These distinctive mechanical properties are exploited to enable the physical bonding process. The composite film is stiff enough to facilitate the transfer and thermal lamination onto other substrates without any surface wrinkles. The porous microfoam is then formed by dissolving the embedded SA microrods. Strong attachment manifests with interfacial toughness of 1776.5 J m<sup>−2</sup> (Fig. S3). In contrast, the soft microfoam is easily compressed and loses its porosity during thermal bonding, thereby eliminating the practical feasibility of direct transfer.</p>", "<p id=\"Par19\">The PDA-PAM hydrogel has been synthesized by a free radical polymerization method. According to Fig. S4, the uniaxial stress–strain curve reveals its modulus of 0.54 kPa, fracture strain of 952%, and toughness of ~ 1.063 MJ m<sup>−3</sup>. To form the interlocked hybrid, the hydrogel precursor is drop cast onto the microfoam-attached substrate. An anionic surfactant has been added to the standard precursor for improved wettability, facilitating full infiltration into the porous microfoam. A cross-sectional optical image in Fig. ##FIG##1##2##c reveals a trilayer structure of the elastomer-hydrogel hybrid, with the interpenetrating hydrogel and SEBS elastomer as the intermediate bonding layer. Additionally, the SEM images in Fig. S5 further confirm that the hydrogel has completely infiltrated the porous microfoam. This ideal microstructure is attributed to the capillary action of the porous microfoam that facilitates the absorption of the hydrogel precursor.</p>", "<p id=\"Par20\">The interlocked hybrid retains structural stability under large tensile deformations. The hydrogel is not peeled off from SEBS at 300% strain (Fig. ##FIG##1##2##d). The standard 180°-peeling test is carried out to evaluate the robustness of hydrogel–elastomer hybrids. Stiff backing layers are laminated on hydrogels and elastomers to constrain their elongations [##REF##27345380##46##]. Directly stacked hydrogel–SEBS film hybrids show obvious interfacial crack propagation (Fig. ##FIG##1##2##e). A steady peeling force is measured as 2.5 N m<sup>−1</sup>, corresponding to an interfacial toughness of 5.6 J m<sup>−2</sup> (Fig. ##FIG##1##2##f). In contrast, the hydrogel of the interlocked hybrid produces a brushed hair pattern near the interpenetrating bonding layer, as the characteristic signature of cohesive failures [##REF##27345380##46##, ##REF##30484303##57##]. The peeling force initially increases and approaches a stable value of ~ 78 N m<sup>−1</sup>. The interfacial toughness of 158.2 J m<sup>−2</sup> represents a marked improvement over stacked hybrids by ~ 28 times. Instead of simply increasing the interface roughness, the hydrogel has been infiltrated into the open pores of the microfoams. This unique topological feature ensures the separation through rupture, leading to substantially enhanced interfacial interactions [##REF##19887124##52##]. As the hydrogel has significantly lower toughness than the elastomer, the crack interface is expected to be confined within the hydrogel and has been confirmed in Supporting Video ##SUPPL##0##S1##. According to SEM images in Fig. S6, the residual surface of the interlocked hybrid after peeling off the hydrogel layer reveals intact microfoam partially filled with the hydrogel. As a result, the microfoam establishes an interpenetrating interface with the hydrogel to achieve strong adhesion. On the other hand, the interfacial toughness value may not necessarily be the highest among recent reports. The PDA-PAM hydrogel used here is well recognized for its tissue affinity rather than its mechanical properties. Alternative toughened hydrogels can be used to augment the adhesion levels.</p>", "<p id=\"Par21\">We have further investigated the influence of the microfoam on the mechanical interlocking effect. The porosity of the microfoam increases by raising the SA microrod loading, as shown in Fig. S7. The pore size remains relatively consistent despite some aggregations at high SA microrod loading. According to Figs. ##FIG##1##2##g and S8, the softness of the microfoam improves with its porosity, as reflected in reduced modulus and increased fracture strain. The robustness of the corresponding interlocked hybrids is characterized by 180°-peeling tests, as summarized in Fig. ##FIG##1##2##h. The interfacial toughness shows a slight initial increase with porosity before declining significantly at high porosity. A weight ratio of 4:1 between SA microrods and SEBS is found to be the optimal composition to attain strong adhesion. In addition, the interfacial toughness also depends on the microfoam thickness, as depicted in Fig. ##FIG##1##2##i. A thin microfoam has weak adhesion, likely associated with its soft mechanical properties. A decent thickness of 140 µm is still needed for robust attachments.</p>", "<title>Generalization to Other Polymers</title>", "<p id=\"Par22\">Bonding hydrogels to different polymer substrates is a widely recognized challenge. Here, the mechanical interlock utilizes the microfoam to form an interpenetrating interface with the hydrogel. To expand the range of compatible polymers, a petroleum resin is mixed with the SEBS elastomer during microfoam preparation to act as the tackifier [##REF##33236828##58##]. The resulting microfoam can be easily laminated to various substrates through thermal bonding, including EVA, PMMA-PnBA elastomers, and PET plastics. According to Fig. S9, the interfacial toughness for EVA, PMMA-PnBA, and PET is 490.8, 660.6, and 195.2 J m<sup>−2</sup>, respectively. As shown in Fig. ##FIG##2##3##a, these microfoams allow the facile preparation of interlocked hydrogel/polymer hybrids, in which the hydrogels are firmly adhered to these polymers. Figure ##FIG##2##3##b shows the 180°-peeling tests on PET/hydrogel hybrids. The peeling force is ~ 75 N m<sup>−1</sup> for the interlocked hybrid and ~ 3.6 N m<sup>−1</sup> for the regularly stacked hybrid. In Fig. ##FIG##2##3##c, the interfacial toughness of the three interlocked hybrids is quite high and consistent with the interlocked hydrogel/SEBS hybrid. This mechanical interlocking strategy has shown significant improvements over regularly stacked hybrids, demonstrating its generic suitability for different substrates.</p>", "<p id=\"Par23\">In addition to SEBS-based elastomers, the material choice for the microfoams can be replaced with other polymers. For instance, we have prepared EVA microfoams using a similar sacrificial template approach. These EVA microfoams have the ability to bond with EVA and SEBS substrates, consequently creating interlocked elastomer/hydrogel hybrids, as shown in Fig. S10. The results suggest the soft microfoam as a versatile intermediate layer that can be used for rugged integration with hydrogels.</p>", "<title>Electrical Properties and Body Conformability of Interlocked Hybrid Electrodes</title>", "<p id=\"Par24\">Ag NW nanocomposites are a prototypical form of compliant conductors [##REF##22786752##16##, ##UREF##3##18##]. In the inset of Fig. ##FIG##3##4##a, SEM image reveals randomly oriented Ag NWs in the SEBS elastomer matrix. The percolation network of high–aspect–ratio Ag NWs is responsible for the excellent electrical conductivity of ~ 11,000 S cm<sup>−1</sup>. Abundant Ag NWs are exposed on nanocomposite for convenient contact with other conductors. The stretchability of Ag NW nanocomposites is evaluated by measuring their electrical properties under uniaxial tensile deformations, as shown in Fig. ##FIG##3##4##a. The normalized resistance is 4.74 at 20% strain, 13.53 at 50% strain, and 54.08 at 100% strain, respectively. The decent deformability is a notable attribute of nanowire percolation networks [##REF##22786752##16##, ##REF##30104619##17##]. In Fig. ##FIG##3##4##b, the Ag NW nanocomposites exhibit limited resistance changes during 1000 stretch-relaxation cycles to 50% strain, which demonstrates excellent electromechanical durability for wearable applications. Unlike continuous metal films, the nanocomposite relies on the exposed Ag NWs for external contact, as illustrated in Fig. ##FIG##3##4##c. To estimate the actual surface area, the double-layer capacitance of the nanocomposite electrode submerged in PBS electrolyte is measured with cyclic voltammetry (Fig. ##FIG##3##4##d) [##UREF##20##59##, ##REF##24628572##60##]. The capacitance of the pristine Ag NW nanocomposite is determined as 0.22 mF cm<sup>−2</sup> (Figs. ##FIG##3##4##e and S11). After microfoam attachment, the capacitance shows a certain decrease to 0.16 mF cm<sup>−2</sup>, suggesting a slightly reduced surface area by 27.3%. The nanocomposite electrode is still largely exposed for reliable contact with the hydrogel, thanks to the highly porous structure of the microfoam (Fig. ##FIG##1##2##b).</p>", "<p id=\"Par25\">Interlocked nanocomposite/hydrogel hybrid electrodes are created for epidermal sensing. The attached microfoam and hydrogel have minor influences on the electrode durability, as confirmed by the tensile fatigue test presented in Fig. S12. In Fig. ##FIG##3##4##f, we can observe that the interlocked electrode has achieved firm attachment to the skin. According to 180°-peeling tests conducted on porcine skin, the interfacial adhesion toughness of our PDA–PAM hydrogel is determined as ~ 20 J m<sup>−2</sup> (Fig. S13). This excellent tissue adhesion of the hydrogel is consistent with previous studies due to the abundant catechol groups with high cellular affinity [##UREF##21##61##]. The mechanically interlocked interface further allows the convenient removal of electrodes without accidental delamination. In hybrid electrodes, Ag NW nanocomposites and hydrogels are also electrically connected through the porous locking layer. Figure ##FIG##3##4##g shows the skin–electrode contact impedance as a function of the frequency. The hybrid electrodes exhibit lower contact impedance than commercial Ag/AgCl gel electrodes. Since the conformability of epidermal electrodes is directly correlated with their bending stiffness [##UREF##4##23##, ##UREF##22##62##], the hydrogels have a much lower modulus than regular elastomers, allowing them to make better contact with the textured skin surface through deformations. The exceptional contact impedance of the interlocked hybrid electrodes is attributed to the high ionic conductivity, low modulus, and strong tissue affinity of the PDA-PAM hydrogel layer to interface with the skin. On the other hand, traditional nanocomposite electrodes cannot be directly mounted on the curvilinear human body. An applied pressure of 4 kPa is required to compress the Ag NW nanocomposite electrode onto the textured skin surface. However, the contact impedance is still significantly inferior to the hybrid electrodes. The ordering of the contact impedance has been confirmed by additional measurements from five individuals, as summarized in Fig. S14. Therefore, the interlocked nanocomposite/hydrogel hybrid electrodes are considered an attractive mechanical and electrical interface for epidermal electronics.</p>", "<title>Epidermal Biopotential Detection</title>", "<p id=\"Par26\">Encouraged by the above results, we construct epidermal electronic patches with interlocked hybrid electrodes for biopotential recordings. A typical patch is composed of three interlocked electrodes and corresponding interconnects (Fig. ##FIG##4##5##a). An epidermal sensing patch with linearly arranged electrodes was placed on the right flexor carpi radialis for EMG recording. The hydrogel electrodes exhibit firm adhesion to the skin due to polydopamine. Likewise, a sensing patch with triangularly arranged electrodes was attached to the left chest for ECG recording (Fig. ##FIG##4##5##b). Raw biopotentials were conditioned with a preamplifier and sampled with a data acquisition card. In Fig. ##FIG##4##5##c, the EMG signals reveal the contraction of muscle fibers corresponding to open and closed hand motions. The signal-to-noise ratio (SNR) is 29.0 dB for interlocking electrodes and 26.2 dB for commercial gel electrodes. In addition, ECG waveforms reveal clear P, Q, R, S, and T signatures critical for the diagnosis of cardiovascular diseases, as shown in Fig. ##FIG##4##5##d [##REF##31706789##63##, ##REF##33328095##64##]. The SNR by interlocking electrodes (38.7 dB) is also higher than that by commercial gel electrodes (33.9 dB). The improved signal quality of interlocking electrodes is consistent with their low skin contact impedance. In addition, the self-adhesive hydrogel electrodes can be painlessly peeled off from the skin due to their strong adhesion to the underlying substrate. The as-prepared conductive composites are therefore well suited for robust epidermal electronics.</p>", "<title>Fabrication and Application of Integrated Epidermal Sensing Systems</title>", "<p id=\"Par27\">An integrated epidermal sensing system is fabricated as a human–machine interface. Figure ##FIG##5##6##a shows the integrated sensing system as a soft armband composed of twelve sensing electrodes. Each set of three electrodes makes up an independent EMG channel designed to monitor the activity of an individual muscle. The sensing electrodes and electrical interconnects are spatially separated to avoid crosstalk among the channels. Individual sensing channels are strategically positioned along the primary muscles of the forearm, including brachioradialis, flexor carpi radialis, flexor carpi ulnaris, and extensor digitorum. The self-adhesive hydrogel electrodes exhibit conformal and intimate attachment to the curvilinear human body, establishing a stable interface for high-fidelity electrophysiological recording. In Fig. S15, the conditioned EMG waveforms are simultaneously recorded for different hand gestures. Common hand gestures are readily identified with root-mean-square voltage amplitudes reflecting muscle contraction levels, as shown in Fig. ##FIG##5##6##b. The entire system essentially represents an epidermal human–machine interface to decipher the gestures into four channels of analog signals, which is attractive for robotic control, advanced prosthetics, and virtual reality.</p>" ]
[ "<title>Conclusions</title>", "<p id=\"Par28\">In conclusion, we have presented a convenient fabrication approach for conductive nanocomposite/hydrogel hybrid electrodes with a mechanically interlocked design. Soft microfoams thermally bonded to the conductive nanocomposite establish an interpenetrating network with the hydrogel. These interlocked hybrids exhibit a high interfacial toughness of 158.2 J m<sup>−2</sup>, surpassing the directly stacked hybrid by 28 times. Ag NW nanocomposites and hydrogels are found to be electrically connected through the porous microfoams. Interlocked hybrid exploits PDA-PAM hydrogel to establish a conformal and self-adhesive interface with the skin, achieving lower contact impedance than commercial Ag/AgCl gel electrodes. These properties make them attractive epidermal electrodes to capture high-quality EMG and ECG signals. An integrated epidermal sleeve is created as a human–machine interface to distinguish hand gestures through recorded muscle contractions. The microfoam-enabled bonding strategy is generally applicable to various substrates, including EVA, PMMA-PnBA, and PET, and different microfoam materials. The mechanically interlocked hybrid electrodes merge the attributes of nanocomposites and hydrogels, making them attractive candidates for emerging applications in epidermal devices and systems.</p>" ]
[ "<title>Highlights</title>", "<p id=\"Par1\">\n<list list-type=\"bullet\"><list-item><p id=\"Par2\">Nanocomposite/hydrogel hybrid electrodes are created with high interfacial toughness by introducing soft microfoams as the mechanically interlocking layer. </p></list-item><list-item><p id=\"Par3\">In the hybrid electrodes, silver nanowires and hydrogels are electrically connected through the porous microfoams, achieving high conductivity and low contact impedance for high-quality biopotential recordings. </p></list-item><list-item><p id=\"Par4\">The microfoam-enabled bonding strategy is generally applicable to diverse polymer substrates.</p></list-item></list></p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s40820-023-01314-z.</p>", "<p id=\"Par5\">Stretchable electronics are crucial enablers for next-generation wearables intimately integrated into the human body. As the primary compliant conductors used in these devices, metallic nanostructure/elastomer composites often struggle to form conformal contact with the textured skin. Hybrid electrodes have been consequently developed based on conductive nanocomposite and soft hydrogels to establish seamless skin-device interfaces. However, chemical modifications are typically needed for reliable bonding, which can alter their original properties. To overcome this limitation, this study presents a facile fabrication approach for mechanically interlocked nanocomposite/hydrogel hybrid electrodes. In this physical process, soft microfoams are thermally laminated on silver nanowire nanocomposites as a porous interface, which forms an interpenetrating network with the hydrogel. The microfoam-enabled bonding strategy is generally compatible with various polymers. The resulting interlocked hybrids have a 28-fold improved interfacial toughness compared to directly stacked hybrids. These electrodes achieve firm attachment to the skin and low contact impedance using tissue-adhesive hydrogels. They have been successfully integrated into an epidermal sleeve to distinguish hand gestures by sensing muscle contractions. Interlocked nanocomposite/hydrogel hybrids reported here offer a promising platform to combine the benefits of both materials for epidermal devices and systems.</p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s40820-023-01314-z.</p>", "<title>Keywords</title>" ]
[ "<title>Experimental Section</title>", "<title>Materials</title>", "<p id=\"Par10\">All thermoplastic elastomers are commercially available, including hydrogenated styrene–ethylene–butylene–styrene elastomer (SEBS, Tuftec H1221) from Asahi Kasei Corporation, poly (methyl methacrylate)–poly (n-butyl acrylate) (PMMA–PnBA, Kurarity LA2140e) from Kuraray Co., Ltd., and EVA (Elvax 40W) from DuPont de Nemours, Inc. All other chemical reagents were purchased from Shanghai Macklin Biochemical Co., Ltd. Ag NWs of ∼80 μm in length were synthesized in a polyol-reduction process [##REF##36520145##53##]. Salicylic acid microrods were synthesized through an antisolvent crystallization process according to the reported formulation [##UREF##18##54##]. The polydopamine-polyacrylamide (PDA–PAM) was synthesized following a reported method with slight modifications [##UREF##12##39##]. Briefly, a mixture of 5 g acrylamide, 15 mg bisacrylamide, 500 mg ammonium persulfate, 20 mg dopamine, and 100 mg Aerosol OT-75 surfactant was thoroughly dissolved in 15 mL H<sub>2</sub>O under vigorous stirring inside an ice bath. After adding 60 μL tetramethylethylenediamine, the precursor solution was stirred for 2 min and then injected into a mold. The hydrogel was obtained after crosslinking at room temperature for 2 h. To prepare stretchable substrates, the thermoplastic elastomer pellets were dissolved in toluene and then drop cast onto non-sticky glass wafers with octadecyl trichlorosilane (OTS) functionalization, followed by thorough evaporation under ambient conditions.</p>", "<title>Preparation of Microfoams, Ag NW Nanocomposites, and Interlocked Hydrogel–Polymer Hybrids</title>", "<title>Composite Films and Corresponding Microfoams</title>", "<p id=\"Par11\">Salicylic acid microrods and a SEBS solution (20 w/w% in toluene) were mixed thoroughly in a laboratory blender (FS400-ST, Shanghai Lichen-BX Instrument Technology Co., Ltd.). The mass ratio between salicylic acid microrods and the SEBS elastomer varied and was typically set at 4:1. The viscous mixture was drop cast onto an OTS-modified glass wafer and dried under ambient conditions to obtain the composite film. The porous microfoam was formed by dissolving salicylic acid microrods in ethanol and then drying under ambient conditions. EVA-based composite films and corresponding microfoams were prepared in a similar procedure using EVA solution in toluene.</p>", "<title>Patterned Ag NW Nanocomposites</title>", "<p id=\"Par12\">As-synthesized Ag NWs were redispersed in chloroform at 1.0 mg mL<sup>−1</sup>. SEBS elastomer was thoroughly dissolved at 5.67 mg mL<sup>−1</sup> in this Ag NW organic dispersion. The mixture was spray deposited into the conductive nanocomposite as described previously [##REF##36520145##53##]. During deposition, stainless shadow masks defined the patterned features comprising sensing electrodes and electrical interconnects. An additional ∼20 μm-thick SEBS elastomer layer was spray deposited onto the interconnect regions for encapsulation. A flexible flat polyimide cable with copper wires was bonded to the interconnect ends as the interface with external recording equipment.</p>", "<title>Mechanically Interlocked Hydrogel–Polymer Hybrids</title>", "<p id=\"Par13\">Salicylic acid/SEBS composite films were thermally bonded to SEBS substrates in an automatic vacuum laminator (temperature = 80 °C, pressure = 70 kPa, and duration = 3 min). The embedded salicylic acid microrods were removed in an ethanol bath to produce the porous microstructure. Inside a mold, the hydrogel precursor was cast onto the microfoam-attached substrate. The anionic surfactant allowed the precursor to infiltrate the porous microstructure. The interlocked hydrogel–SEBS hybrid was obtained by curing in ambient conditions. To generalize the design for different substrates, a petroleum resin was added to the SEBS elastomer as the tackifier. A mixed solution was prepared by dissolving 2 g SEBS and 1 g petroleum resin in 12 g toluene. The resulting composite film exhibits firm adhesion to other substrates (Fig. S9). Interlocked hydrogel/polymer hybrids were prepared following similar procedures. Alternatively, salicylic acid/EVA composite films were created and thermally bonded with targeted polymer substrates, producing porous microfoams to interlock with the hydrogels.</p>", "<title>Material Characterizations</title>", "<p id=\"Par14\">Optical microscopy images were collected with a Keyence VHX-6000 digital microscope. Scanning electron microscopy (SEM) images were acquired using a Zeiss GeminiSEM 500 field emission scanning electron microscope. Optical images were taken with a Fujifilm X-T10 camera. Optical topographical images were obtained using a Keyence VK-K1000 laser scanning microscope. The sample thickness was determined with the corresponding height profiles. All mechanical measurements were carried out using a Shimadzu AGS-X universal testing machine with a 50 N load cell. Uniaxial stress–strain curves were obtained from rectangular samples (20 mm length, 9.5 mm width, and 140 μm thickness) at a constant speed of 20 mm min<sup>−1</sup>. Interfacial toughness was determined from standard 180°-peeling tests at a constant speed of 50 mm min<sup>−1</sup>. All samples were cut into rectangular shapes with 20 mm in width and 80 mm in length. A 90 µm-thick polyimide film was glued to the hydrogel using cyanoacrylate adhesive as a stiff backing layer. An 80 µm-thick polyethylene terephthalate (PET) film was bonded to elastomer substrates as a stiff backing layer. The electrical resistance of conductive nanocomposites was measured under a four-probe configuration using a Keithley 2110 digital multimeter. All tensile strains were applied with a homemade motorized translational stage. Cyclic voltammetry was performed in 0.1 M PBS solution using a CHI 660E electrochemical workstation. A three-electrode setup was used with an Ag/AgCl reference electrode, a carbon rod counter electrode, and the working electrode.</p>", "<title>Impedance Measurement and Electrophysiological Signal Detection</title>", "<p id=\"Par15\">A pair of electrodes were attached to the forearm. Skin–electrode contact impedance was acquired using the electrochemical workstation. Interlocking hybrid electrodes and commercial Ag/AgCl gel electrodes (2223CN, 3 M Co.) were measured separately for comparison. The EMG sensing patch was attached to the right flexor carpi radialis, whereas the ECG sensing patch was attached to the chest. All biopotential signals were conditioned with a preamplifier from Nanjing Zijin Electronics Studio and recorded at a rate of 2 kHz by a USB3202 data acquisition card from Beijing Art Technology Development Co., Ltd.</p>", "<title>Fabrication and Operation of Integrated Epidermal Sensing Sleeve</title>", "<p id=\"Par16\">The integrated epidermal sensing system was composed of four channels of epidermal sensing electrodes. Each channel has three 1 cm electrodes spaced 2.7 cm apart. The epidermal sensing device was attached to the forearm with sensing electrodes along the key muscles. All channels were conditioned with an Intan RHD2000 amplifier and simultaneously sampled at 5 kHz with an Intan RHD USB interface board.</p>", "<title>Supplementary Information</title>", "<p>Below is the link to the electronic supplementary material.</p>" ]
[ "<title>Acknowledgements</title>", "<p>We acknowledge the support from the National Key Research and Development Program of China (Grant No. 2022YFA1405000), the Natural Science Foundation of Jiangsu Province, Major Project (Grant No. BK20212004), the National Natural Science Foundation of China (Grant No. 62374083), and the State Key Laboratory of Analytical Chemistry for Life Science (Grant No. 5431ZZXM2205).</p>", "<title>Declarations</title>", "<title>Conflict of Interest</title>", "<p id=\"Par29\">The authors declare no interest conflict. They have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Desheng Kong is a youth editorial board member for Nano-Micro Letters and was not involved in the editorial review or the decision to publish this article. All authors declare that there are no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>Design and fabrication of mechanically interlocked nanocomposite/hydrogel hybrid electrodes. <bold>a</bold> Schematic illustration of an epidermal sensing device comprising Ag NW nanocomposite/hydrogel hybrid electrodes and Ag NW nanocomposite interconnects. <bold>b</bold> Optical images of the process flow to create an interlocked elastomer/hydrogel hybrid involving spray depositing silver nanowire nanocomposites, attaching salicylic acid/elastomer film, dissolving embedded SA microrods, and infiltrating the hydrogel</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>Mechanical characterizations of interlocked hybrid electrodes. <bold>a</bold> Optical images showing a self-supporting composite (top) and a soft SEBS microfoam (bottom). <bold>b</bold> SEM image of the microfoam with interconnected micropores. <bold>c</bold> Optical microscopy images revealing the cross-section of the interlocked hydrogel-elastomer hybrid. <bold>d</bold> Images of the interlocked hydrogel-elastomer hybrid under uniaxial tensile deformations. <bold>e</bold> 180°-peeling tests with optical images (left) and force <italic>versus</italic> displacement curves (right) for elastomer/hydrogel hybrids. Interlocked and stacked hybrids have been measured for comparison. <bold>f</bold> Corresponding interfacial toughness of the hybrids. <bold>g</bold> Uniaxial stress–strain curve of SEBS microfoam with different porosity, in which the porosity is modulated by the weight ratio (ϕ) between salicylic acid and SEBS elastomer. <bold>h</bold> Interfacial toughness as a function of microfoam porosity for ~ 150 μm-thick interlocked SEBS/hydrogel hybrids. <bold>i</bold> Interfacial toughness <italic>versus</italic> microfoam thickness (<italic>ϕ</italic> = 4:1)</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p>Interlocking hybrids on different substrates. <bold>a</bold> Optical images showing interlocking hybrids and corresponding manual peeling processes on EVA (left), PMMA-PnBA (middle), and PET (right) substrates. <bold>b</bold> Measured forces <italic>versus</italic> displacement during 180°-peeling tests for regular hydrogel-PET film hybrid and interlocked hydrogel-PET hybrid. <bold>c</bold> Interfacial toughness of three regular hybrids and corresponding interlocked hybrids</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p>Electrical properties of interlocked hybrid electrodes. <bold>a</bold> Normalized resistance of the Ag NW nanocomposite as a function of the tensile strain. Inset: SEM image showing randomly oriented Ag NWs embedded in the SEBS elastomer matrix. Scale bars: 2 μm. <bold>b</bold> Change in the resistance of Ag NW nanocomposites during 1000 stretch–relaxation cycles to 50% strain. <bold>c</bold> Schematic diagram illustrating the pristine (left) and microfoam-attached (right) Ag NW nanocomposites. <bold>d</bold> Cyclic voltammetry curves of bare and microfoam-attached nanocomposite electrodes at a scan rate of 0.9 V s<sup>−1</sup>. <bold>e</bold> Corresponding double-layer capacitance values. <bold>f</bold> Optical image shows a representative hybrid electrode firmly attached to the skin. <bold>g</bold> Skin–electrode contact impedance as a function of frequency for epidermal electrodes. Commercial Ag/AgCl gel electrodes establish the baseline for comparison. Ag NW nanocomposite electrodes are applied with 4 kPa pressure through a compression wrap for reliable skin contact</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><p>Interlocked hybrid electrodes for biopotential recordings. <bold>a</bold> Images of an epidermal sensing patch fixed on the forearm to record EMG signals. Inset: an epidermal EMG sensing patch comprised of three sensing electrodes and interconnects. <bold>b</bold> Optical image showing an epidermal patch mounted on the left chest to record ECG signals. Inset: an epidermal ECG sensing patch. <bold>c</bold> Recorded EMG waveforms with interlocked hybrid electrodes (top) and commercial Ag/AgCl gel electrodes (bottom) corresponding to several muscle contraction-relaxation cycles. <bold>d</bold> Recorded ECG signals (left) exhibiting characteristic P, Q, R, S, and T signatures (right)</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><p>Integrated epidermal electronic sleeve as a human–machine interface. <bold>a</bold> Optical images showing an epidermal electronic sleeve wrapping over the forearm (left) and the integrated four-channel EMG sensing system (right). <bold>b</bold> Voltage amplitude of each sensing channels (bottom) for different hand gestures (top)</p></caption></fig>" ]
[]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>" ]
[]
[ "<graphic position=\"anchor\" xlink:href=\"40820_2023_1314_Figa_HTML\" id=\"MO100\"/>", "<graphic xlink:href=\"40820_2023_1314_Fig1_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"40820_2023_1314_Fig2_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"40820_2023_1314_Fig3_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"40820_2023_1314_Fig4_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"40820_2023_1314_Fig5_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"40820_2023_1314_Fig6_HTML\" id=\"MO7\"/>" ]
[ "<media xlink:href=\"40820_2023_1314_MOESM1_ESM.mov\"><caption><p>Supplementary file1 (MOV 13137 kb)</p></caption></media>", "<media xlink:href=\"40820_2023_1314_MOESM2_ESM.pdf\"><caption><p>Supplementary file2 (PDF 1123 kb)</p></caption></media>" ]
[{"label": ["3."], "surname": ["Ma", "Kong", "Pan", "Bao"], "given-names": ["Z", "D", "L", "Z"], "article-title": ["Skin-inspired electronics: emerging semiconductor devices and systems"], "source": ["J. Semicond."], "year": ["2020"], "volume": ["41"], "fpage": ["041601"], "pub-id": ["10.1088/1674-4926/41/4/041601"]}, {"label": ["10."], "surname": ["Wang", "Yan", "Wang", "Cai", "Gao"], "given-names": ["M", "Z", "T", "P", "S"], "article-title": ["Gesture recognition using a bioinspired learning architecture that integrates visual data with somatosensory data from stretchable sensors"], "source": ["Nat. Electron."], "year": ["2020"], "volume": ["3"], "fpage": ["563"], "lpage": ["570"], "pub-id": ["10.1038/s41928-020-0422-z"]}, {"label": ["11."], "surname": ["Zhao", "Zhou", "Cao", "Wang", "Zhang"], "given-names": ["H", "Y", "S", "Y", "J"], "article-title": ["Ultrastretchable and washable conductive microtextiles by coassembly of silver nanowires and elastomeric microfibers for epidermal human\u2013machine interfaces"], "source": ["ACS Mater. Lett."], "year": ["2021"], "volume": ["3"], "fpage": ["912"], "lpage": ["920"], "pub-id": ["10.1021/acsmaterialslett.1c00128"]}, {"label": ["18."], "surname": ["Liang", "Li", "Niu", "Yu", "Pei"], "given-names": ["J", "L", "X", "Z", "Q"], "article-title": ["Elastomeric polymer light-emitting devices and displays"], "source": ["Nat. Photon."], "year": ["2013"], "volume": ["7"], "fpage": ["817"], "lpage": ["824"], "pub-id": ["10.1038/nphoton.2013.242"]}, {"label": ["23."], "surname": ["Liu", "Rao", "Jang", "Tan", "Lu"], "given-names": ["S", "Y", "H", "P", "N"], "article-title": ["Strategies for body-conformable electronics"], "source": ["Matter"], "year": ["2022"], "volume": ["5"], "fpage": ["1104"], "lpage": ["1136"], "pub-id": ["10.1016/j.matt.2022.02.006"]}, {"label": ["26."], "surname": ["Jin", "Matsuhisa", "Lee", "Abbas", "Yokota"], "given-names": ["H", "N", "S", "M", "T"], "article-title": ["Enhancing the performance of stretchable conductors for E-textiles by controlled ink permeation"], "source": ["Adv. Mater."], "year": ["2017"], "volume": ["29"], "fpage": ["1605848"], "pub-id": ["10.1002/adma.201605848"]}, {"label": ["28."], "surname": ["Zhou", "Zhao", "Wang", "Li", "Li"], "given-names": ["Y", "C", "J", "Y", "C"], "article-title": ["Stretchable high-permittivity nanocomposites for epidermal alternating-current electroluminescent displays"], "source": ["ACS Mater. Lett."], "year": ["2019"], "volume": ["1"], "fpage": ["511"], "lpage": ["518"], "pub-id": ["10.1021/acsmaterialslett.9b00376"]}, {"label": ["29."], "surname": ["Wichterle", "L\u00edm"], "given-names": ["O", "D"], "article-title": ["Hydrophilic gels for biological use"], "source": ["Nature"], "year": ["1960"], "volume": ["185"], "fpage": ["117"], "lpage": ["118"], "pub-id": ["10.1038/185117a0"]}, {"label": ["34."], "surname": ["Caliari", "Burdick"], "given-names": ["SR", "JA"], "article-title": ["A practical guide to hydrogels for cell culture"], "source": ["Nat. Meth."], "year": ["2016"], "volume": ["13"], "fpage": ["405"], "lpage": ["414"], "pub-id": ["10.1038/nmeth.3839"]}, {"label": ["35."], "surname": ["Peppas", "Hilt", "Khademhosseini", "Langer"], "given-names": ["N", "J", "A", "R"], "article-title": ["Hydrogels in biology and medicine: from molecular principles to bionanotechnology"], "source": ["Adv. Mater."], "year": ["2006"], "volume": ["18"], "fpage": ["1345"], "lpage": ["1360"], "pub-id": ["10.1002/adma.200501612"]}, {"label": ["37."], "surname": ["Hu", "Chee", "Sugiarto", "Yu", "Shi"], "given-names": ["L", "PL", "S", "Y", "C"], "article-title": ["Hydrogel-based flexible electronics"], "source": ["Adv. Mater."], "year": ["2023"], "volume": ["35"], "fpage": ["2205326"], "pub-id": ["10.1002/adma.202205326"]}, {"label": ["38."], "surname": ["Yuk", "Wu", "Zhao"], "given-names": ["H", "J", "X"], "article-title": ["Hydrogel interfaces for merging humans and machines"], "source": ["Nat. Rev. Mater."], "year": ["2022"], "volume": ["7"], "fpage": ["935"], "lpage": ["952"], "pub-id": ["10.1038/s41578-022-00483-4"]}, {"label": ["39."], "surname": ["Han", "Yan", "Wang", "Fang", "Zhang"], "given-names": ["L", "L", "K", "L", "H"], "article-title": ["Tough, self-healable and tissue-adhesive hydrogel with tunable multifunctionality"], "source": ["NPG Asia Mater."], "year": ["2017"], "volume": ["9"], "fpage": ["e372"], "pub-id": ["10.1038/am.2017.33"]}, {"label": ["40."], "surname": ["Xie", "Wang", "He", "Ding", "Lu"], "given-names": ["C", "X", "H", "Y", "X"], "article-title": ["Mussel-inspired hydrogels for self-adhesive bioelectronics"], "source": ["Adv. Funct. Mater."], "year": ["2020"], "volume": ["30"], "fpage": ["1909954"], "pub-id": ["10.1002/adfm.201909954"]}, {"label": ["44."], "surname": ["Yang", "Bai", "Chen", "Suo"], "given-names": ["J", "R", "B", "Z"], "article-title": ["Hydrogel adhesion: a supramolecular synergy of chemistry, topology, and mechanics"], "source": ["Adv. Funct. Mater."], "year": ["2020"], "volume": ["30"], "fpage": ["1901693"], "pub-id": ["10.1002/adfm.201901693"]}, {"label": ["49."], "surname": ["Zhu", "Zhang", "Chen"], "given-names": ["M", "F", "X"], "article-title": ["Bioinspired mechanically interlocking structures"], "source": ["Small Struct."], "year": ["2020"], "volume": ["1"], "fpage": ["2000045"], "pub-id": ["10.1002/sstr.202000045"]}, {"label": ["50."], "surname": ["Jennings"], "given-names": ["CW"], "article-title": ["Surface roughness and bond strength of adhesives"], "source": ["J. Adhes."], "year": ["1972"], "volume": ["4"], "fpage": ["25"], "lpage": ["38"], "pub-id": ["10.1080/00218467208072208"]}, {"label": ["51."], "surname": ["Pan", "Zhang", "Cai", "Wang", "He"], "given-names": ["S", "F", "P", "M", "K"], "article-title": ["Mechanically interlocked hydrogel\u2013elastomer hybrids for on-skin electronics"], "source": ["Adv. Funct. Mater."], "year": ["2020"], "volume": ["30"], "fpage": ["1909540"], "pub-id": ["10.1002/adfm.201909540"]}, {"label": ["54."], "surname": ["Tierney", "Rasmuson", "Hudson"], "given-names": ["TB", "\u00c5C", "SP"], "article-title": ["Size and shape control of micron-sized salicylic acid crystals during antisolvent crystallization"], "source": ["Org. Process Res. Dev."], "year": ["2017"], "volume": ["21"], "fpage": ["1732"], "lpage": ["1740"], "pub-id": ["10.1021/acs.oprd.7b00181"]}, {"label": ["56."], "surname": ["Tsao", "DeVoe"], "given-names": ["C-W", "DL"], "article-title": ["Bonding of thermoplastic polymer microfluidics"], "source": ["Microfluid. Nanofluid."], "year": ["2009"], "volume": ["6"], "fpage": ["1"], "lpage": ["16"], "pub-id": ["10.1007/s10404-008-0361-x"]}, {"label": ["59."], "surname": ["Trasatti", "Petrii"], "given-names": ["S", "OA"], "article-title": ["Real surface area measurements in electrochemistry"], "source": ["J. Electroanal. Chem."], "year": ["1992"], "volume": ["327"], "fpage": ["353"], "lpage": ["376"], "pub-id": ["10.1016/0022-0728(92)80162-w"]}, {"label": ["61."], "surname": ["Jung", "Kim", "Lee", "Choi", "Kim"], "given-names": ["H", "MK", "JY", "SW", "J"], "article-title": ["Adhesive hydrogel patch with enhanced strength and adhesiveness to skin for transdermal drug delivery"], "source": ["Adv. Funct. Mater."], "year": ["2020"], "volume": ["30"], "fpage": ["2004407"], "pub-id": ["10.1002/adfm.202004407"]}, {"label": ["62."], "surname": ["Wang", "Lu"], "given-names": ["L", "N"], "article-title": ["Conformability of a thin elastic membrane laminated on a soft substrate with slightly wavy surface"], "source": ["J. Appl. Mech."], "year": ["2016"], "volume": ["83"], "fpage": ["041007"], "pub-id": ["10.1115/1.4032466"]}]
{ "acronym": [], "definition": [] }
64
CC BY
no
2024-01-14 23:40:13
Nanomicro Lett. 2024 Jan 12; 16:87
oa_package/da/da/PMC10786775.tar.gz
PMC10786779
38214843
[ "<title>Introduction</title>", "<p id=\"Par6\">The advancements of electric vehicles and smart grids technologies will call for higher demands on lithium-ion batteries (LIBs) with enhanced energy density and safety features [##REF##18256660##1##–##REF##15669156##3##]. However, the conventional use of organic liquid electrolytes in LIBs, while showing improvements, presents inherent issues such as leakage, instability, and flammability, posing safety concerns [##REF##26713396##4##]. Consequently, all-solid-state lithium metal batteries (ASSLMBs) have emerged as ideal candidates due to their high energy density, long cycle life, and especially better safety [##UREF##0##5##–##REF##29468745##7##], to substitute liquid-electrolyte LIBs and address the growing demands. The energy density of ASSLMBs can be significantly enhanced by employing a lithium metal anode. This is attributed to its exceptionally low working voltage (0 V vs. Li<sup>+</sup>/Li) and remarkable theoretical capacity (3860 mAh g<sup>−1</sup>) [##REF##30302834##8##–##UREF##1##10##]. Furthermore, the solid electrolytes employed in ASSLMBs are nonflammable, stable in the air (except for halides and sulfides), and less reactive with Li metal anode, indicating their suitability with highly safe Li metal batteries [##REF##32603100##11##].</p>", "<p id=\"Par7\">However, the realization of ASSLMBs is an overwhelming challenge for serious interfacial issues, both Li/electrolyte and electrolyte/cathode interfaces [##UREF##2##12##, ##UREF##3##13##]. Regarding the Li metal anode, it's important to note that the Li/electrolyte interface tends to deteriorate with repeated cycling. This degradation occurs due to the stripping and plating of lithium, which disrupts the continuous pathways for both electron and ion conduction. Consequently, this disruption leads to uneven lithium deposition and the formation of dendrites at the Li/electrolyte interface. These dendrites can further exacerbate the issue by causing a loss of interfacial contact and an increase in resistance [##UREF##4##14##]. For the cathode electrode, due to tortuous and lengthy ionic diffusion paths within electrodes, ASSLMBs typically have low active mass loading (&lt; 1 mg cm<sup>−2</sup>), which is much lower than the requirements for commercial batteries, which call for 12 mg cm<sup>−2</sup> for LiCoO<sub>2</sub> cathode. This issue results in low energy density and poor ion transport as well as increased interfacial resistance [##REF##32857517##15##, ##UREF##5##16##]. Hence, there is a strong desire to develop multifunctional electrolytes that possess several key attributes. These include excellent compatibility with lithium anodes, the capability to accommodate high mass loadings of cathode materials, the ability to establish robust interface contacts, and the provision of substantial mechanical strength.</p>", "<p id=\"Par8\">One effective strategy to mitigate critical interface-related issues is to increase the contact area by incorporating 3D-structured components within batteries [##REF##34632638##17##–##UREF##6##19##]. For Li metal, various 3D architectures (carbon-based [##UREF##7##20##], metal [##UREF##8##21##], alloy [##REF##27219349##22##], etc.) featuring well-ordered micro- or nanostructures have been proven highly advantageous. These structures are instrumental in lowering local current densities, accommodating significant volumetric changes, and facilitating more uniform lithium plating and stripping. This is achieved by augmenting the electroactive surface area. Indeed, achieving high energy density in cathode materials is not as simple as merely increasing the thickness of the active materials. This approach faces challenges related to poor charge transport kinetics and compromised mechanical stability in thick electrode configurations [##REF##29543991##23##, ##UREF##9##24##]. Simultaneously, electrodes featuring high mass loadings through conventional slurry-coating techniques often encounter challenges such as inadequate interfacial adhesion, sluggish chemical kinetics, and disruptions in electrical contact, all of which stem from the volumetric changes that occur during cycling [##UREF##10##25##]. Likewise, within ASSLMBs, the pursuit of both high energy density and robust safety features calls for the integration of versatile 3D architectures. These architectures are crucial for developing electrolytes that possess superior mechanical properties and exceptional ionic conductivity [##REF##29575234##26##, ##REF##36007199##27##]. In turn, these characteristics play a pivotal role in enhancing the overall stability of the interfaces, including the Li/electrolyte and electrolyte/cathode interfaces. Various approaches have been proposed to fabricate 3D frameworks, including template method [##UREF##11##28##], electrospinning [##UREF##12##29##], hydrogel-derived method [##UREF##13##30##] and 3D printing [##REF##32857517##15##]. For example, Hu’s group [##UREF##14##31##] proposed a well-organized Li<sub>7</sub>La<sub>3</sub>Zr<sub>2</sub>O<sub>12</sub> (LLZO) skeletons using bacteria cellulose as template, demonstrating the continuous Li<sup>+</sup> transport paths and enhanced ionic conductivity. Yu’s group [##UREF##13##30##] transformed randomly dispersed Li<sub>3<italic>x</italic></sub>La<sub>2/3−<italic>x</italic></sub>TiO<sub>3</sub> (LLTO) particles into a continuous 3D framework, and the composite polymer electrolyte delivered an ionic conductivity of 8.8 × 10<sup>–5</sup> S cm<sup>−1</sup> at room temperature. Bruce’s group [##UREF##15##32##] created the structural hybrid electrolytes with 3D bi-continuous ordered ceramic electrolyte and polymer matrix via the 3D printing, further exhibiting superior mechanical properties without significantly compromising ionic conductivity. Nevertheless, while previous studies have primarily focused on addressing issues such as the suppression of lithium dendrite growth and enhancement of ionic conductivity in solid electrolytes, there has been limited exploration into strategies for bolstering the interface between solid electrolytes and cathode materials, improving the reaction kinetics of cathode materials, and ultimately elevating the energy density of the entire cell. Furthermore, it's worth noting that many 3D solid electrolytes come with substantial costs and involve intricate synthesis processes, which pose challenges for mass production and practical applications. To date, there have been relatively few reports on the direct fabrication of electrolyte films that combine a 3D architecture with high ionic conductivity and excellent flexibility. This represents an area with substantial untapped potential.</p>", "<p id=\"Par9\">Composite polymer electrolytes (CPEs), as a prominent type of electrolyte, typically showcase a combination of advantageous characteristics. These include remarkable flexibility, moderate ionic conductivity, and effective contact with electrode materials, with a particular emphasis on processability [##UREF##16##33##, ##UREF##17##34##]. Yang’s group [##UREF##18##35##] reported a 3D CPEs consist of vertically aligned Li<sub>1.5</sub>Al<sub>0.5</sub>Ge<sub>1.5</sub>(PO<sub>4</sub>)<sub>3</sub> (LAGP) skeletons and polyethylene oxide (Poly(PEGDA))-based polymer matrix via simple ice template method. 2D vermiculite sheets (VAVS) were also used as raw materials to fabricate the 3D vertically aligned network by Luo’s group [##UREF##19##36##]. Inspired by the microstructure of biomass wood, Hu’s group [##UREF##20##37##] developed a vertical garnet framework by wood template, Cui’s group [##REF##29727578##38##] explored AlF<sub>3</sub>-modified AAO with a vertically aligned structure as a 3D framework for polymer electrolytes. There have also been some other noteworthy reports on electrolytes with vertical orientations [##UREF##21##39##, ##UREF##22##40##], such as perovskite membranes with vertically aligned microchannels and inorganic-polymer nanocomposites channels [##UREF##23##41##]. Hence, the establishment of a continuous and well-structured ion-conducting network emerges as a pivotal strategy in augmenting the overall performance of ASSLMBs.</p>", "<p id=\"Par10\">Herein, we demonstrate a novel 3D-micropatterned composite polymer electrolyte with a vertically aligned 3D ion transport network by direct 3D-printing technology, which can form a morphologically stable interface with electrode material. Specifically, the 3D-printed electrolyte slurry with adjustable viscosity and excellent rheological properties consisted of well-dispersed nanoscale Ta-doped LLZO and PEGDA matrix. The resulting 3D solid electrolytes with spiral (s-3DSE) or pillared (p-3DSE) architecture possess 3D interconnected conductive and porous frameworks, which greatly reduce the resistance and polarization during the repeated cycling process. This 3DSE architecture possesses two critical effects compared to the conventional planar CPEs. On one side, the 3DSE with the increased effective surface area can lower the local current density to retard the Li stripping and stripping at the Li/electrolyte interface, and further maintain strong contact after certain cycles. On the other side, it introduces a thick-independent effect to facilitate ion transport beyond the electrolyte/cathode interface, which improves the mass loading of active materials and reinforces the interfacial adhesion by 3D architecture. Attributing to these two effects, we demonstrate that the Li symmetric cell using a p-3DSE exhibits a high critical current density (CCD) of 1.92 mA cm<sup>−2</sup> and can stably operate over 2600 h under 0.5 mA cm<sup>−2</sup> at room temperature without significant interfacial degradation and early short circuit. The optimized all-solid-state Li/LFP and Li/NCM811 cells based on p-3DSE with a high mass loading of 20 mg cm<sup>−2</sup> (LFP) and 22 mg cm<sup>−2</sup> (NCM811) deliver a high areal capacity of 2.75 mAh cm<sup>−2</sup> (LFP) and 3.92 mAh cm<sup>−2</sup> (NCM811) at room temperature.</p>" ]
[]
[ "<title>Results and Discussion</title>", "<title>3D Printing Fabrication 3DSE</title>", "<p id=\"Par15\">The digital light processing (DLP) 3D printing fabrication of 3DSE, including the nanoscale Li<sub>6.5</sub>La<sub>3</sub>Zr<sub>1.5</sub>Ta<sub>0.5</sub>O<sub>12</sub> (nano-LLZTO), lithium bis(trifluoromethane sulfonyl)imide (LiTFSI), polyethyleneglycol diacrylate (PEGDA 1000) monomer, and photoinitiator (TPO) is schematically illustrated in Fig. ##FIG##0##1##a. The spiral and pillar-structured 3DSE were designed and fabricated in this study. PEGDA monomers were crosslinked via precise light exposure and then produced Poly(PEGDA) polymer electrolyte with high ionic conductivity. Specifically, PEGDA monomer with 0.5 wt% TPO, the inorganic electrolyte (nano-LLZTO), and lithium salt (LiTFSI) with different weight ratio was mixed (Fig. ##SUPPL##0##S1##). A planar substrate was printed first, followed by a spiral structure of a vertically oriented cylindrical structure. More details can be found in Materials and Methods part in supporting information. After a two-step curing process, 3D composite electrolytes with symmetrical structures on both sides were obtained, whose structural factors were independently controlled. During printing, the 405 nm wavelength LED was projected to the resin surface according to the designed model, followed by a layer-by-layer stacking process. The obtained 3DSE with rational design affords critical advantages for cathode active materials and Li metal anode. For the cathode materials, vertically aligned 3DSE with low tortuosity provides short and direct ion transport pathways and mechanical support due to their highly ordered structure and channels; high mass loading of cathodes can be achieved due to the 3D space, which contributes to high energy and power density; and strong adhering of active materials and highly efficient ion transport network enable fast kinetics and stable contact interfaces. For the Li anode, enlarged specific area can promote uniformly Li plating/stripping; polymer network with uniformly distributed inorganic electrolyte powder enables a high ionic conductivity; and the remarkable mechanical properties play a vital role in suppressing Li dendrite growth and ensure the structural integrity after cell assemble. As a result, the micro-CT image of the p-3DSE that assembled by curing two pieces of the printed parts, shows the structural characteristics of the symmetrical vertically aligned pillars (Fig. ##FIG##0##1##b) and distribution of nano-LLZTO ceramic electrolyte in 3D architecture (Fig. ##FIG##0##1##c), which contributes to the enhanced ion conductivity. Figure ##FIG##0##1##d shows the viscosity of the composite printing slurry, which exhibit a typical shear thinning phenomenon. The viscosity of the slurry is about 2000 cps at shear rate of 1/s, which provides a suitable release force during printing process and guarantee the completeness of the microstructures. The insets are optical pictures of the slurry at different stages.</p>", "<title>Structure and Properties Characterizations</title>", "<p id=\"Par16\">The various 3DSE were successfully prepared via the 3D-printing method, and its detailed characterization results can be seen in Fig. ##FIG##1##2##. Based on the above-mentioned printable slurry, we first printed two kinds of electrolyte with 3D architecture, including 3D spiral structure (s-3DSE) and 3D pillared structure (p-3DSE). Figure ##FIG##1##2##a shows a flexible electrolyte film with large-size, which can be made of PEGDA matrix and nanosize LLZTO electrolyte. The planar structure served as the control group (noted as f-SE, Fig. S2). A series of optical images demonstrated that 3D-printed electrolytes possess excellent flexibility and good mechanical strength for f-SE, s-3DSE and p-3DSE, including bending, twisting and rolling repeatedly (Fig. S3). The inorganic electrolyte LLZTO used in these electrolytes was prepared by a high-energy ball mill. The particle size distribution was 200–500 nm from SEM images (Fig. S4) and TEM images (Fig. S5), which is beneficial to evenly disperse in EO and improve ionic conductivity. Scanning electron microscopy (SEM) images further exhibited 3D architectural structural details of the printed electrolyte. The p-3DSE duplicated the designed geometry with a pillared structure of 100 μm width, 150 μm height, and 200 μm spacing on a planar substrate of 75 μm thickness (Fig. ##FIG##1##2##b, c). Figure ##FIG##1##2##d–f exhibits good flexibility and functionality at different states of free, bending, and twisting for p-3DSE electrolyte. The insets are optical images of large-sized p-3DSE electrolyte films under different bending states. The enlarged SEM images revealed the morphologies of a single pillar and its surface, which shows the complete vertically aligned framework and smooth surface features (Fig. ##FIG##1##2##i, j). The same characteristics occurred in both planar electrolytes and s-3DSE electrolytes from SEM images (Figs. S2c, d and S6). The thickness of the plane electrolyte is 75 μm, which is consistent with the design thickness (Figs. S2a and S6a, e). The s-3DSE with the spiral microstructure of 100 μm width and 150 μm height was also successfully printed, which formed a continuous support structure (Fig. S6c, d). The flat morphology of the s-3DSE surface and planar structure indicates that the LLZTO remained immobilized in the structure of the PEGDA matrix. In order to further improve the effective contact area between the electrolyte surface and electrodes, we have further optimized the vertically oriented pillared structure. From 3D and 2D laser scanning confocal microscopy (LSCM) images, vertically oriented 3D electrolytes with different sizes can be visually compared, especially with respect to the diameter and density of the pillars (Figs. ##FIG##1##2##g, h and S7). In detail, a series of p-3DSE with different sizes were obtained by varying the height (50, 100, 150, 200 μm) and diameter (200, 300 μm) of the pillars, with the spacing between the pillars remaining constant at 200 μm throughout the printing process. The thickness of the planar substrate was maintained at 75 μm (Fig. S8).</p>", "<p id=\"Par17\">The cross-sectional morphology of the symmetrical p-3DSE was evaluated by the micro-CT and SEM. As shown in Fig. ##FIG##1##2##k, l, the p-3DSE films could keep flat after the post-curing process, which is vital for ASSLMBs assembly. The EDS mappings in Fig. ##FIG##1##2##m reveal that the p-3DSE was successfully integrated with the PEGDA, LiTFSI and LLZTO. X-ray diffraction (XRD) patterns of the various electrolytes are shown in Fig. ##FIG##1##2##n. The diffraction patterns match well with the standard pattern of LLZTO ceramics electrolyte, which indicates well-maintained CPEs after incorporating with the PEGDA matrix. Thermogravimetric analysis (TGA) curves are shown in Fig. ##FIG##1##2##o to evaluate the thermal stability of the CPEs. It is clarified that the p-3DSE exhibits enhanced thermal stability due to the introduction of nano-LLZTO. The mechanical properties of the obtained 3D electrolytes were characterized by the tensile test at room temperature. The p-3DSE exhibited high mechanical strengths of 3.25 MPa, which is robust enough for using in coin cells and pouch cells (Fig. ##FIG##1##2##p). The introduction of nano-LLZTO and vertically aligned pillared structure does not greatly sacrifice the mechanical properties of electrolyte, which was ascribed to the good adhesion between the PEGDA matrix and nanoscale LLZTO ceramic.</p>", "<p id=\"Par18\">Fourier transform infrared (FTIR) were performed to investigate the interaction between the nano-LLZTO ceramic and Poly(PEGDA) matrix (Fig. ##FIG##2##3##a). Poly(PEGDA)-based electrolytes clearly display the typical bands of C–O–C stretching (1132, 1086, 1053, and 952 cm<sup>−1</sup>), attributing to the ether oxygen in PEGDA, as well as S=O stretching (654 cm<sup>−1</sup>) and LiTFSI aggregation (1634 cm<sup>−1</sup>) attributing to the Li salts. The peak for LiTFSI aggregation in the s-3DSE electrolyte shifts from 1634 to 1654 cm<sup>−1</sup> when compared to the Poly(PEGDA) electrolyte, and its intensity decreases. This is also consistent for the p-3DSE electrolyte, which suggests that the addition of LLZTO garnet ceramic electrolyte can promote the LiTFSI dissociation and thus free more Li<sup>+</sup>. The Li ionic conductivity of as-obtained electrolyte films was determined by electrochemical impedance spectroscopy (EIS) using symmetric stainless steel/electrolyte/stainless steel (SS/electrolyte/SS) cells. The Nyquist plots of the SS/p-3DSE/SS cell in a temperature range of 20–100 °C are shown in Fig. ##FIG##2##3##b. The enlarged Nyquist plot of SS/p-3DSE/SS cell at the high-frequency region is shown in Fig. ##FIG##2##3##c. It is obvious that the resistance of the p-3DSE is much lower than that of other 3D-printed electrolytes (Figs. S9 and S10). Temperature-dependent ionic conductivity (<italic>σ</italic>) curves (Fig. ##FIG##2##3##d) reveal that the ionic conductivity can be improved with elevated temperature. Compared with the Poly(PEGDA)/LiTFSI solid electrolyte, the conductivity of the p-3DSE is as high as 3.15 × 10<sup>–4</sup> S cm<sup>−1</sup> at 30 °C, which meets the room temperature requirements of ASSLMBs. The <italic>σ</italic> of p-3DSE reaches 1.05 × 10<sup>–3</sup> S cm<sup>−1</sup> at 60 °C, which is two orders of magnitude higher than Poly(PEGDA)/LiTFSI electrolyte (2.41 × 10<sup>–5</sup> S cm<sup>−1</sup>) at the same temperature. The activation energy (<italic>E</italic><sub>a</sub>) of the p-3DSE (0.25 eV) is lower than that of the s-3DSE (0.36 eV), f-SE (0.49 eV) and Poly(PEGDA)/LiTFSI electrolyte (0.70 eV), indicating a low activation barrier for the dissociation of ion pairs and local ion hopping. The Li-ion transference number (<italic>t</italic><sub>Li</sub><sup>+</sup>) of p-3DSE, s-3DSE, f-SE, and Poly(PEGDA)/LiTFSI electrolyte is 0.68, 0.61, 0.42, and 0.34, respectively (Figs. ##FIG##2##3##e and S11). Obviously, the <italic>t</italic><sub>Li</sub><sup>+</sup> of all printed electrolytes with LLZTO ceramic is higher than that of the Poly(PEGDA)/LiTFSI electrolyte. In particular, p-3DSE possesses an optimized Li-ion transference number of 0.71, which is ascribed to the 3D architecture with vertically aligned lithium-ion channels and the interaction between the LLZTO particles and Poly(PEGDA) matrix (Table ##SUPPL##0##S1##). Linear sweep voltammetry (LSV) curves clearly show the current value of Poly(PEGDA)/LiTFSI electrolyte suddenly rising at 4.32 V, indicating that the electrolyte has begun to decompose, while the p-3DSE and s-3DSE maintains a stable value until approximately 5.26 and 4.85 V, indicating that the printed 3DSEs are more capable of supporting high-voltage cathodes. These results demonstrate that the 3D-printed p-3DSE with low tortuosity and low activation energy can contribute to lowering the overpotential by promoting the Li<sup>+</sup> transport within the electrodes.</p>", "<title>Electrochemical Performance</title>", "<p id=\"Par19\">The critical current density (CCD) testing with Li/p-3DSE/Li, Li/s-3DSE/Li, Li/f-SE/Li, and Li/Poly(PEGDA)/LiTFSI/Li cells was performed first. During the testing, the current density increased stepwise from 0.2 to 2.0 mA cm<sup>−2</sup>. As shown in Fig. ##FIG##3##4##a, the CCD for p-3DSE, s-3DSE, f-SE and Poly(PEGDA)/LiTFSI electrolyte is 1.92, 1.32, 0.95, and 0.61 mA cm<sup>−2</sup>, respectively (Fig. S12). For p-3DSE, even at a high current density of 1.92 mA cm<sup>−2</sup>, a polarization voltage of 275 mV is obtained (Fig. ##FIG##3##4##b), which is indicative of the improved CCD performed as compared with other reported electrolytes [##UREF##24##42##–##UREF##26##46##] This reveals that 3DSE with highly ordered microstructure can lower the local current density and suppress Li dendrite growth at the Li/3DSE interface. The EIS spectra for the Li symmetrical cells with p-3DSE, s-3DSE, f-SE and Poly(PEGDA)/LiTFSI electrolyte after different cycles are shown in Figs. ##FIG##3##4##c, S13 and Table S2. The reduced semicircle in the low-frequency region shows that the charge transfer resistance (<italic>R</italic><sub>ct</sub>) decreases ascribed to the gradually optimized Li/electrolyte interfaces after repeated cycling. In addition, the starting point of the high-frequency region also decreases gradually, indicating the reduction of the bulk resistance of the solid electrolyte (<italic>R</italic><sub>s</sub>). In contrast, the cells with Poly(PEGDA)/LiTFSI electrolyte exhibits an increasing interface resistance from 1st cycle to the 50th cycle, corresponding to 1762.0 and 2160.0 Ω. Interestingly, the Li/p-3DSE/Li cells reveal a lower initial interface resistance of 287.8 Ω compared with Li/Poly(PEGDA)/LiTFSI/Li cells, while the interface impedance is only 199.2 Ω after 20 cycles of activation, especially after 50 cycles, the interface impedance maintained to be 90.97 Ω. The excellent interfacial compatibility of the Li/p-3DSE/Li cells can be attributed to the 3DSE with enlarged surface areas and highly efficient ion transport channels.</p>", "<p id=\"Par20\">Meanwhile, the Li/p-3DSE/Li cells deliver excellent rate performance in the symmetric cell at room temperature (Fig. ##FIG##3##4##d). In detail, the cells show low voltage polarizations of 55, 65, 75, 86, 100, 115, 124, and 150 mV at current densities of 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.5, and 1 mA cm<sup>−2</sup>, respectively. However, the Li/ Poly(PEGDA)/LiTFSI/Li cells and Li/f-SE/Li cells display more serious voltage polarizations, especially at high current densities (Fig. S14). The Li/p-3DSE/Li cells remain stable within 600 h of cycling under room temperature at 1 mA cm<sup>−2</sup> and a capacity of 1 mAh cm<sup>−2</sup> (Figs. ##FIG##3##4##f and S15). No short circuit occurs after 600 h and the polarization voltage remains stable at approximately 80 mV. This indicates good interface stability between the p-3DSE and Li metal. However, the Li/s-3DSE/Li cells assembled with the f-SE exhibit abrupt changes in voltage only within 50 h, and the cells show significant initial voltage changes and subsequent stabilization as well as the increasing voltage over 400 h of Li plating/stripping, demonstrating the continuous growth of Li dendrites during uneven Li plating/stripping process. Figure ##FIG##3##4##f shows the long-term cycling performance of Li/p-3DSE/Li cells at room temperature. At a current density of 0.5 mA cm<sup>−2</sup>, the cells are stable, and continuously cycled beyond 2600 h without short-circuiting, which indisputably demonstrates an exceptional cycling stability. Furthermore, the Li/p-3DSE/Li cells demonstrate outstanding cycle capability under different temperatures from 40 to 100 °C, and showed excellent long-term cycling stability beyond 1250, 1400, 1750, and 2000 h, respectively (Fig. ##FIG##3##4##g). The insets detailed exhibit the plating/stripping curves of the cells with different electrolytes at different stages. The voltage hysteresis curves clearly indicated that the Li/p-3DSE/Li cells exhibited the most stable polarization voltage and interface stability (Fig. ##FIG##3##4##h). The EIS profiles under different temperatures after certain cycles at 1 mA cm<sup>−2</sup> are shown in Fig. ##FIG##3##4##i, indicating fast ion transport and a stale solid–solid interface. These results present significant improvements in terms of CCD and long-lifespan under room temperature among the previously reported 3D electrolytes in terms of cycling lifespan and current density (Fig. ##FIG##3##4##j, Tables S4).</p>", "<p id=\"Par21\">In ASSLMBs, electrodes under high mass loadings, to enhance areal capacities, are necessary. However, sluggish ions transport and poor electrode flexibility could occur when blindly increasing the thickness of the electrode. In this regard, we skillfully designed 3D electrolyte architectures, especially for cathode materials. SEM images indicate the optimized p-3DSE/LFP electrodes by a simple spraying process (Fig. S16). It is obvious that the LFP material is uniformly and firmly attached to the 3D electrolyte frameworks, as shown in Fig. ##FIG##4##5##a. The enlarged SEM images from the top and cross-sectional show a smooth surface and strong contact. Through the LCSM image, it can be further proved that the LFP active materials are uniformly distributed in the 3D electrolyte skeletons and remain over 100 μm thickness (Fig. ##FIG##4##5##b). By controlling the spraying time, the cathode electrodes with different mass loadings can be prepared (Fig. S17). In particular, a composite p-3DSE/LFP electrode with a loading beyond 15 mg cm<sup>−2</sup> can be obtained (Fig. ##FIG##4##5##c). Strong adhesion between cathode material and p-3DSE can be found through the cross-sectional SEM images (Fig. S18a, b), compared with the electrodes fabricated by the traditional method (Fig. S18c, d). In order to investigate the relationship between the thickness of active materials and ion transport, two commercial materials, LFP and NCM811, were selected as the cathode materials, and a series of thickness electrodes were fabricated. The galvanostatic charge–discharge of Li/p-3DSE/LFP and Li/f-SE/LFP full cells at 0.1C-rate from 2.5 to 4.2 V was performed. As shown in Fig. ##FIG##4##5##d, after 100 cycles, there is a capacity retention of 97% for the Li/p-3DSE/LFP cells. However, the capacity retention of the Li/f-SE/LFP cell drops to 83.1%. While the cycling stability of Li/p-3DSE/LFP is improved, a capacity retention of 89% after 600 cycles at 1C-rate is obtained (Fig. ##FIG##4##5##e). Figure ##FIG##4##5##f illustrates the rate performance under different rates (Fig. S19), and the Li/p-3DSE/LFP cells show improved cyclic stability and rate performance than the Li/ Poly(PEGDA)/LiTFSI/LFP (Fig. S20). The Li/p-3DSE/LFP cells assembled with different mass loadings exhibit superior cycling capacities, indicating that high Li-ion transport expressways are formed in the cells. Figure ##FIG##4##5##g indicates the cycling performance of Li/p-3DSE/LFP cells at 0.5C-rate under different loadings. With the mass loadings of 3.5, 6.2, 8.5 10, 12.7, 15.5, and 20 mg cm<sup>−2</sup>, the reversible capacities of these cells are 0.576, 0.94, 1.227, 1.426, 1.872, 2.203, and 2.754 mAh cm<sup>−2</sup>, respectively. This result indicates that p-3DSE with enlarged surface area and high ion-conducting frameworks can still maintain stability, provide Li<sup>+</sup> transport pathways and improve the contact between the electrolyte and electrode. After 300 cycles, the Li/p-3DSE/LFP cells with the mass loading of 15.5 mg cm<sup>−2</sup> possess a higher capacity retention of 92.48% compared with the Li/p-3DSE/LFP cells with the loading of 20 mg cm<sup>−2</sup>, indicating that interface failure may occur when the electrode thickness exceeds 150 μm. Moreover, the Li/p-3DSE/NCM811 cells exhibit excellent rate performance from 0.05C-rate to 5C-rate, as shown in Figs. ##FIG##4##5##i and S21. The Li/p-3DSE/NCM811 cells provide capacities of 208.3, 189.2, 156.8, 108.3, and 100.0 mAh g<sup>−1</sup> at 0.1, 0.2, 0.5, 1, and 2C-rate, respectively. Even at 5C-rate, the cell still delivers a reversible capacity of 76.23 mAh g<sup>−1</sup>. The long-term cycling performance of the Li/p-3DSE/NCM811 cells under the loading of 22 mg cm<sup>−2</sup> at 0.2C-rate is shown in Fig. ##FIG##4##5##j, and the high reversible capacity of 3.19 mAh cm<sup>−2</sup> can be obtained even after 300 cycles with a high capacity retention of 84.8%, which is ascribed to lower interfacial resistance and shorter ion transport pathway within electrodes. The EIS spectra of Li/p-3DSE/NCM cells after different cycles were tested. As shown in Fig. ##FIG##4##5##k, it is noted that the semicircle gradually decreases as the cycle number increases, indicating an activation process between the electrolyte/electrode interfaces in initial cycles and enhanced Li<sup>+</sup> ion transfer. The stable electrolyte/electrode interfaces can be established over time (Table S5). To verify the practicality of 3D printing electrolytes, the LFP/Li pouch cells were assembled to test the practicality of the p-3DSE electrolyte in ASSLMBs. The LFP/Li cells can light on the LED under bending, folding, and after recovery (Fig. S22), indicating good flexibility and functionality at different states of the 3D-printed p-3DSE electrolyte (Fig. ##FIG##1##2##c–f).</p>", "<title>Interfacial Evolution of Morphologies and Chemistries</title>", "<p id=\"Par22\">The morphological evolution at Li/SE, Li/f-SE, and Li/p-3DSE interfaces during galvanostatic cycling under 0.1 mA cm<sup>−2</sup> (0.5 mAh cm<sup>−2</sup>) was tracked by post-mortem analysis. A schematic illustration was established to understand the electrolyte/Li interface interaction (Fig. ##FIG##5##6##a). In Li/electrolyte/Li cells, significant damage of the interface occurred in less than 50 h for the bare Poly(PEGDA)/LiTFSI electrolyte, and pores and voids were extensively detected not only at the surface of Li metal (Fig. S23) but also in the solid electrolyte film (Fig. S24). In contrast, the Li/p-3DSE/Li cells steadily maintained the stripping and deposition processes due to increased effective active area with Li. The nucleation and penetration of Li dendrites from the interface can be efficiently suppressed, as confirmed by the clean SEM images of the cycled p-3DSE at different stages. At the initial stage of cycles, the pillar arrays of p-3DSE were still clearly visible due to the small-capacity Li deposition (Fig. S25a). The enlarged SEM images show that the Li metal is uniformly and tightly deposited on the surface of the electrolyte pillar. A dense and smooth Li/electrolyte composite was formed within 20 h when the capacity of Li increased with cycling, indicating a stable and robust interface (Figs. S25b and 6c). The surface of Li metal with p-3DSE electrolyte also showed uniform and dense Li, without Li dendrite growth (Figs. ##FIG##5##6##e and S26), compared with the f-SE (Fig. ##FIG##5##6##d). From the optical images, the Li metal after cycles was flat and shiny (Fig. S27a). In contrast, the surface of lithium metal with bare Poly(PEGDA)/LiTFSI electrolyte showed black spots, and massive dendrites and pits (Fig. S27b). The p-3DSE film also delivered dense and smooth morphology after repeated cycles (Fig. S28). The results show serious interface degradation in the Li/SE and Li/f-SE cells. However, the Li flux toward the interface can become sufficient to replenish the Li loss at p-3DSE areas, which prevents interfacial degradation. Multiphysics simulation was conducted to monitor ions distribution at the Li/electrolyte interfaces (Fig. S29). As shown in Fig. ##FIG##5##6##b, the Li symmetric cell with p-3DSE electrolyte possesses low Li<sup>+</sup> concentration gradient, which clarifies fast ion conduction and reaction kinetics occurred at the Li/p-3DSE interface tended toward a uniform Li deposition, instead of forming dendritic Li at initial lithium plating stages. Nevertheless, severe Li<sup>+</sup> concentration gradient and fluctuations can be observed at the Li/f-SE and Li/s-3DSE interfaces, meaning that unavailing Li<sup>+</sup> depletion or Li dendrites would occur at interfaces due to the locally fluctuated Li<sup>+</sup> flux.</p>", "<p id=\"Par23\">In order to probe the reasons for the good compatibility of the Li metal anode interface in different electrolytes, X-ray photoelectron spectroscopy (XPS) depth profiling, with the assistance of Ar ion etching, was employed to analyze the cycled electrolytes and Li anodes. In Fig. ##FIG##5##6##f, the chemical speciation of C 1<italic>s</italic> in p-3DSE within the solid electrolyte interface (SEI) shows minimal variation. However, there is a notable enhancement in the intensity of Li<sub>2</sub>O species as the sputtering time is extended. This observation serves as compelling evidence that the Li<sub>2</sub>CO<sub>3</sub> species undergo decomposition, transitioning into the more stable Li<sub>2</sub>O structure at the interface between Li and p-3DSE. This phenomenon is essentially consistent across the PEGDA/LiTFSI (Fig. S30), f-SE (Fig. S31), and s-3DSE (Fig. S32). An obvious LiF peak emerges at the cycled p-3DSE and s-3DSE electrolytes, producing LiF-rich SEI (Figs. ##FIG##5##6##h and S32). In general, LiF is considered to be an important component in facilitating fast and uniform Li<sup>+</sup> transportation in SEI, which would also promote uniform Li deposition [##UREF##26##46##]. In the S 2<italic>p</italic> and N 1<italic>s</italic> spectra, S 2<italic>p</italic> peak at 167.8 eV and N 1<italic>s</italic> peak at 398.6 eV corresponded to LiTFSI (Figs. ##FIG##5##6##i, k and S31, S32). The peak of ionic conductor Li<sub>3</sub>N at 397.4 eV in N 1<italic>s</italic> spectra is also considered to be an ideal component of SEI due to its ability to reduce the interfacial resistance and suppress the growth of Li dendrites [##UREF##27##47##]. In the PEGDA/LiTFSI and f-SE systems, F elements are primarily attributed to the LiTFSI component, and there is no distinct signal of LiF. As shown in Fig. ##FIG##5##6##l, there is a noticeable reduction in the intensity of C 1<italic>s</italic> as the sputtering time increases, accompanied by an enhancement in the intensities of F 1<italic>s</italic> and N 1<italic>s</italic>. This observation suggests the formation of an SEI film rich in LiF and Li<sub>3</sub>N species on the surface of p-3DSE/s-3DSE. Consequently, the establishment of a stable interface between Li metal and p-3DSE/s-3DSE is achieved, resulting in enhanced kinetics and the capability for long-term operation.</p>", "<p id=\"Par24\">The positive effect of the p-3DSE electrolyte on the NCM811 and LFP cathodes in terms of thier rate and long-term electrochemical performance was pronounced in coin full cells featuring with Li metal anode. The cross-sectional SEM image of the cycled NCM811 cathode with p-3DSE electrolyte showed their microstructural characteristics in the mechanical stability. As shown in Fig. ##FIG##6##7##a, the secondary particles of a cycled NCM811 cathode contain no visible microcracks, while those of a cycled NCM811 cathode with Poly(PEGDA)/LiTFSI electrolyte are nearly fractured and contained extensive networks of wide microcracks (Fig. S33). SEM–EDS analysis revealed the uniform distribution of O, Ni, Co and Mn elements from the surface to the bulk of cycled NCM811 particles. Furthermore, the crystal structure of NCM811 cathode after 300 cycles at 0.2C was investigated by the atomic resolution Z-contrast STEM-HAADF imaging. As shown in Fig. S34, the NCM811 cathode with Poly(PEGDA)/LiTFSI electrolyte is accompanied by a large amount of cation mixing and NiO phase near the crack, which greatly inhibited the transport of Li<sup>+</sup> and rapidly increased the electrochemical impedance (Fig. S35). On the contrary, the layered structure with R-3 m space group was well retained in the bulk of cycled NCM811 cathode with p-3DSE electrolyte (Fig. ##FIG##6##7##b, c), and the stable layered structure can provide a stable diffusion channel for Li<sup>+</sup> in the electrochemical performance, which demonstrated fast kinetics and electrochemical cycle stability, which can be demonstrated by CV curves using different electrolytes (Fig. S36). Electron energy loss spectroscopy (EELS) spectra were tested to reveal the electronic structure evolution of Ni, Co, Mn and O elements. The line in Fig. ##FIG##6##7##d indicates the measurement position of EELS. The chemical shift of the Ni L-edges, Co L-edges, and Mn L-edges of the NCM811 cathode with Poly(PEGDA)/LiTFSI electrolyte to the position with low energy loss, especially the Ni, indicated the reduction of the valence state of the metal element. In addition, the O K-edges strength decreases gradually from the bulk to the surface, indicating the formation of oxygen vacancy and promoting the migration of transition metal ions to the Li<sup>+</sup> sites, exacerbating the structural transformation (Fig. S37). However, the Ni L-edges, Co L-edges, Mn L-edges, and O K-edges of NCM811 cathode with p-3DSE electrolyte show almost no chemical shift, which is indicative of the structure stability. All these findings contribute to the enhanced compatibility of p-3DSE electrolytes with the high-voltage cathode (NCM811). Such superior full cells performances can be ascribed to the high oxidation stability of p-3DSE due to the addition of LLZTO inorganic networks, the high Li<sup>+</sup> conductivity at room temperature and the intimate contact between Li metal anode and p-3DSE (Fig. ##FIG##6##7##i).</p>", "<p id=\"Par25\">To elucidate the origin of the enhanced interfacial Li<sup>+</sup> transportation by the introduction of vertical-aligned ion-conducting network on cathodes, Multiphysics simulation were performed to analyze the ion distribution (Fig. S38). The Li<sup>+</sup> concentration distribution under two cathode/electrolyte models were simulated, as shown in Fig. ##FIG##6##7##g. The results show that a more homogeneous Li<sup>+</sup> distribution and negligible Li<sup>+</sup> concentration polarization in the p-3DSE/cathode are achieved compared with that of the Poly(PEGDA)/LiTFSI/cathode. From the f-SE/cathode model, large concentration gradients are observed due to the long transport pathway of Li<sup>+</sup> which is unfavorable for efficient Li<sup>+</sup> migration and diffusion, especially under high-load electrodes. The p-3DSE case with micro-pillars provides a facile pathway for Li<sup>+</sup> transport which minimize the transport length resulting in enhanced Li<sup>+</sup> transport performance. Therefore, these achievements result in a low concentration gradient, and hence low concentration polarization, which leads to the optimized rates performance. The relationship between Li<sup>+</sup> concentration and electrode thickness along the vertical direction is shown in Fig. ##FIG##6##7##h. The local Li<sup>+</sup> concentration is larger in the p-3DSE/cathode electrode with the increasing thickness of integrated electrodes than that of the f-SE/cathode electrode when the electrode thickness is larger than 62 μm. This indicates a better Li<sup>+</sup> transfer and lower Li<sup>+</sup> diffusion resistance for the p-3DSE/cathode electrode. Thus, high capacity can be achieved by loading cathode materials on the as-designed 3D electrolyte with pillared-structure arrays. This structure enables a continuous Li<sup>+</sup> conduction network, which demonstrates rapid and stable Li<sup>+</sup> transfer within the electrolyte/cathode (Fig. ##FIG##6##7##i).</p>" ]
[ "<title>Results and Discussion</title>", "<title>3D Printing Fabrication 3DSE</title>", "<p id=\"Par15\">The digital light processing (DLP) 3D printing fabrication of 3DSE, including the nanoscale Li<sub>6.5</sub>La<sub>3</sub>Zr<sub>1.5</sub>Ta<sub>0.5</sub>O<sub>12</sub> (nano-LLZTO), lithium bis(trifluoromethane sulfonyl)imide (LiTFSI), polyethyleneglycol diacrylate (PEGDA 1000) monomer, and photoinitiator (TPO) is schematically illustrated in Fig. ##FIG##0##1##a. The spiral and pillar-structured 3DSE were designed and fabricated in this study. PEGDA monomers were crosslinked via precise light exposure and then produced Poly(PEGDA) polymer electrolyte with high ionic conductivity. Specifically, PEGDA monomer with 0.5 wt% TPO, the inorganic electrolyte (nano-LLZTO), and lithium salt (LiTFSI) with different weight ratio was mixed (Fig. ##SUPPL##0##S1##). A planar substrate was printed first, followed by a spiral structure of a vertically oriented cylindrical structure. More details can be found in Materials and Methods part in supporting information. After a two-step curing process, 3D composite electrolytes with symmetrical structures on both sides were obtained, whose structural factors were independently controlled. During printing, the 405 nm wavelength LED was projected to the resin surface according to the designed model, followed by a layer-by-layer stacking process. The obtained 3DSE with rational design affords critical advantages for cathode active materials and Li metal anode. For the cathode materials, vertically aligned 3DSE with low tortuosity provides short and direct ion transport pathways and mechanical support due to their highly ordered structure and channels; high mass loading of cathodes can be achieved due to the 3D space, which contributes to high energy and power density; and strong adhering of active materials and highly efficient ion transport network enable fast kinetics and stable contact interfaces. For the Li anode, enlarged specific area can promote uniformly Li plating/stripping; polymer network with uniformly distributed inorganic electrolyte powder enables a high ionic conductivity; and the remarkable mechanical properties play a vital role in suppressing Li dendrite growth and ensure the structural integrity after cell assemble. As a result, the micro-CT image of the p-3DSE that assembled by curing two pieces of the printed parts, shows the structural characteristics of the symmetrical vertically aligned pillars (Fig. ##FIG##0##1##b) and distribution of nano-LLZTO ceramic electrolyte in 3D architecture (Fig. ##FIG##0##1##c), which contributes to the enhanced ion conductivity. Figure ##FIG##0##1##d shows the viscosity of the composite printing slurry, which exhibit a typical shear thinning phenomenon. The viscosity of the slurry is about 2000 cps at shear rate of 1/s, which provides a suitable release force during printing process and guarantee the completeness of the microstructures. The insets are optical pictures of the slurry at different stages.</p>", "<title>Structure and Properties Characterizations</title>", "<p id=\"Par16\">The various 3DSE were successfully prepared via the 3D-printing method, and its detailed characterization results can be seen in Fig. ##FIG##1##2##. Based on the above-mentioned printable slurry, we first printed two kinds of electrolyte with 3D architecture, including 3D spiral structure (s-3DSE) and 3D pillared structure (p-3DSE). Figure ##FIG##1##2##a shows a flexible electrolyte film with large-size, which can be made of PEGDA matrix and nanosize LLZTO electrolyte. The planar structure served as the control group (noted as f-SE, Fig. S2). A series of optical images demonstrated that 3D-printed electrolytes possess excellent flexibility and good mechanical strength for f-SE, s-3DSE and p-3DSE, including bending, twisting and rolling repeatedly (Fig. S3). The inorganic electrolyte LLZTO used in these electrolytes was prepared by a high-energy ball mill. The particle size distribution was 200–500 nm from SEM images (Fig. S4) and TEM images (Fig. S5), which is beneficial to evenly disperse in EO and improve ionic conductivity. Scanning electron microscopy (SEM) images further exhibited 3D architectural structural details of the printed electrolyte. The p-3DSE duplicated the designed geometry with a pillared structure of 100 μm width, 150 μm height, and 200 μm spacing on a planar substrate of 75 μm thickness (Fig. ##FIG##1##2##b, c). Figure ##FIG##1##2##d–f exhibits good flexibility and functionality at different states of free, bending, and twisting for p-3DSE electrolyte. The insets are optical images of large-sized p-3DSE electrolyte films under different bending states. The enlarged SEM images revealed the morphologies of a single pillar and its surface, which shows the complete vertically aligned framework and smooth surface features (Fig. ##FIG##1##2##i, j). The same characteristics occurred in both planar electrolytes and s-3DSE electrolytes from SEM images (Figs. S2c, d and S6). The thickness of the plane electrolyte is 75 μm, which is consistent with the design thickness (Figs. S2a and S6a, e). The s-3DSE with the spiral microstructure of 100 μm width and 150 μm height was also successfully printed, which formed a continuous support structure (Fig. S6c, d). The flat morphology of the s-3DSE surface and planar structure indicates that the LLZTO remained immobilized in the structure of the PEGDA matrix. In order to further improve the effective contact area between the electrolyte surface and electrodes, we have further optimized the vertically oriented pillared structure. From 3D and 2D laser scanning confocal microscopy (LSCM) images, vertically oriented 3D electrolytes with different sizes can be visually compared, especially with respect to the diameter and density of the pillars (Figs. ##FIG##1##2##g, h and S7). In detail, a series of p-3DSE with different sizes were obtained by varying the height (50, 100, 150, 200 μm) and diameter (200, 300 μm) of the pillars, with the spacing between the pillars remaining constant at 200 μm throughout the printing process. The thickness of the planar substrate was maintained at 75 μm (Fig. S8).</p>", "<p id=\"Par17\">The cross-sectional morphology of the symmetrical p-3DSE was evaluated by the micro-CT and SEM. As shown in Fig. ##FIG##1##2##k, l, the p-3DSE films could keep flat after the post-curing process, which is vital for ASSLMBs assembly. The EDS mappings in Fig. ##FIG##1##2##m reveal that the p-3DSE was successfully integrated with the PEGDA, LiTFSI and LLZTO. X-ray diffraction (XRD) patterns of the various electrolytes are shown in Fig. ##FIG##1##2##n. The diffraction patterns match well with the standard pattern of LLZTO ceramics electrolyte, which indicates well-maintained CPEs after incorporating with the PEGDA matrix. Thermogravimetric analysis (TGA) curves are shown in Fig. ##FIG##1##2##o to evaluate the thermal stability of the CPEs. It is clarified that the p-3DSE exhibits enhanced thermal stability due to the introduction of nano-LLZTO. The mechanical properties of the obtained 3D electrolytes were characterized by the tensile test at room temperature. The p-3DSE exhibited high mechanical strengths of 3.25 MPa, which is robust enough for using in coin cells and pouch cells (Fig. ##FIG##1##2##p). The introduction of nano-LLZTO and vertically aligned pillared structure does not greatly sacrifice the mechanical properties of electrolyte, which was ascribed to the good adhesion between the PEGDA matrix and nanoscale LLZTO ceramic.</p>", "<p id=\"Par18\">Fourier transform infrared (FTIR) were performed to investigate the interaction between the nano-LLZTO ceramic and Poly(PEGDA) matrix (Fig. ##FIG##2##3##a). Poly(PEGDA)-based electrolytes clearly display the typical bands of C–O–C stretching (1132, 1086, 1053, and 952 cm<sup>−1</sup>), attributing to the ether oxygen in PEGDA, as well as S=O stretching (654 cm<sup>−1</sup>) and LiTFSI aggregation (1634 cm<sup>−1</sup>) attributing to the Li salts. The peak for LiTFSI aggregation in the s-3DSE electrolyte shifts from 1634 to 1654 cm<sup>−1</sup> when compared to the Poly(PEGDA) electrolyte, and its intensity decreases. This is also consistent for the p-3DSE electrolyte, which suggests that the addition of LLZTO garnet ceramic electrolyte can promote the LiTFSI dissociation and thus free more Li<sup>+</sup>. The Li ionic conductivity of as-obtained electrolyte films was determined by electrochemical impedance spectroscopy (EIS) using symmetric stainless steel/electrolyte/stainless steel (SS/electrolyte/SS) cells. The Nyquist plots of the SS/p-3DSE/SS cell in a temperature range of 20–100 °C are shown in Fig. ##FIG##2##3##b. The enlarged Nyquist plot of SS/p-3DSE/SS cell at the high-frequency region is shown in Fig. ##FIG##2##3##c. It is obvious that the resistance of the p-3DSE is much lower than that of other 3D-printed electrolytes (Figs. S9 and S10). Temperature-dependent ionic conductivity (<italic>σ</italic>) curves (Fig. ##FIG##2##3##d) reveal that the ionic conductivity can be improved with elevated temperature. Compared with the Poly(PEGDA)/LiTFSI solid electrolyte, the conductivity of the p-3DSE is as high as 3.15 × 10<sup>–4</sup> S cm<sup>−1</sup> at 30 °C, which meets the room temperature requirements of ASSLMBs. The <italic>σ</italic> of p-3DSE reaches 1.05 × 10<sup>–3</sup> S cm<sup>−1</sup> at 60 °C, which is two orders of magnitude higher than Poly(PEGDA)/LiTFSI electrolyte (2.41 × 10<sup>–5</sup> S cm<sup>−1</sup>) at the same temperature. The activation energy (<italic>E</italic><sub>a</sub>) of the p-3DSE (0.25 eV) is lower than that of the s-3DSE (0.36 eV), f-SE (0.49 eV) and Poly(PEGDA)/LiTFSI electrolyte (0.70 eV), indicating a low activation barrier for the dissociation of ion pairs and local ion hopping. The Li-ion transference number (<italic>t</italic><sub>Li</sub><sup>+</sup>) of p-3DSE, s-3DSE, f-SE, and Poly(PEGDA)/LiTFSI electrolyte is 0.68, 0.61, 0.42, and 0.34, respectively (Figs. ##FIG##2##3##e and S11). Obviously, the <italic>t</italic><sub>Li</sub><sup>+</sup> of all printed electrolytes with LLZTO ceramic is higher than that of the Poly(PEGDA)/LiTFSI electrolyte. In particular, p-3DSE possesses an optimized Li-ion transference number of 0.71, which is ascribed to the 3D architecture with vertically aligned lithium-ion channels and the interaction between the LLZTO particles and Poly(PEGDA) matrix (Table ##SUPPL##0##S1##). Linear sweep voltammetry (LSV) curves clearly show the current value of Poly(PEGDA)/LiTFSI electrolyte suddenly rising at 4.32 V, indicating that the electrolyte has begun to decompose, while the p-3DSE and s-3DSE maintains a stable value until approximately 5.26 and 4.85 V, indicating that the printed 3DSEs are more capable of supporting high-voltage cathodes. These results demonstrate that the 3D-printed p-3DSE with low tortuosity and low activation energy can contribute to lowering the overpotential by promoting the Li<sup>+</sup> transport within the electrodes.</p>", "<title>Electrochemical Performance</title>", "<p id=\"Par19\">The critical current density (CCD) testing with Li/p-3DSE/Li, Li/s-3DSE/Li, Li/f-SE/Li, and Li/Poly(PEGDA)/LiTFSI/Li cells was performed first. During the testing, the current density increased stepwise from 0.2 to 2.0 mA cm<sup>−2</sup>. As shown in Fig. ##FIG##3##4##a, the CCD for p-3DSE, s-3DSE, f-SE and Poly(PEGDA)/LiTFSI electrolyte is 1.92, 1.32, 0.95, and 0.61 mA cm<sup>−2</sup>, respectively (Fig. S12). For p-3DSE, even at a high current density of 1.92 mA cm<sup>−2</sup>, a polarization voltage of 275 mV is obtained (Fig. ##FIG##3##4##b), which is indicative of the improved CCD performed as compared with other reported electrolytes [##UREF##24##42##–##UREF##26##46##] This reveals that 3DSE with highly ordered microstructure can lower the local current density and suppress Li dendrite growth at the Li/3DSE interface. The EIS spectra for the Li symmetrical cells with p-3DSE, s-3DSE, f-SE and Poly(PEGDA)/LiTFSI electrolyte after different cycles are shown in Figs. ##FIG##3##4##c, S13 and Table S2. The reduced semicircle in the low-frequency region shows that the charge transfer resistance (<italic>R</italic><sub>ct</sub>) decreases ascribed to the gradually optimized Li/electrolyte interfaces after repeated cycling. In addition, the starting point of the high-frequency region also decreases gradually, indicating the reduction of the bulk resistance of the solid electrolyte (<italic>R</italic><sub>s</sub>). In contrast, the cells with Poly(PEGDA)/LiTFSI electrolyte exhibits an increasing interface resistance from 1st cycle to the 50th cycle, corresponding to 1762.0 and 2160.0 Ω. Interestingly, the Li/p-3DSE/Li cells reveal a lower initial interface resistance of 287.8 Ω compared with Li/Poly(PEGDA)/LiTFSI/Li cells, while the interface impedance is only 199.2 Ω after 20 cycles of activation, especially after 50 cycles, the interface impedance maintained to be 90.97 Ω. The excellent interfacial compatibility of the Li/p-3DSE/Li cells can be attributed to the 3DSE with enlarged surface areas and highly efficient ion transport channels.</p>", "<p id=\"Par20\">Meanwhile, the Li/p-3DSE/Li cells deliver excellent rate performance in the symmetric cell at room temperature (Fig. ##FIG##3##4##d). In detail, the cells show low voltage polarizations of 55, 65, 75, 86, 100, 115, 124, and 150 mV at current densities of 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.5, and 1 mA cm<sup>−2</sup>, respectively. However, the Li/ Poly(PEGDA)/LiTFSI/Li cells and Li/f-SE/Li cells display more serious voltage polarizations, especially at high current densities (Fig. S14). The Li/p-3DSE/Li cells remain stable within 600 h of cycling under room temperature at 1 mA cm<sup>−2</sup> and a capacity of 1 mAh cm<sup>−2</sup> (Figs. ##FIG##3##4##f and S15). No short circuit occurs after 600 h and the polarization voltage remains stable at approximately 80 mV. This indicates good interface stability between the p-3DSE and Li metal. However, the Li/s-3DSE/Li cells assembled with the f-SE exhibit abrupt changes in voltage only within 50 h, and the cells show significant initial voltage changes and subsequent stabilization as well as the increasing voltage over 400 h of Li plating/stripping, demonstrating the continuous growth of Li dendrites during uneven Li plating/stripping process. Figure ##FIG##3##4##f shows the long-term cycling performance of Li/p-3DSE/Li cells at room temperature. At a current density of 0.5 mA cm<sup>−2</sup>, the cells are stable, and continuously cycled beyond 2600 h without short-circuiting, which indisputably demonstrates an exceptional cycling stability. Furthermore, the Li/p-3DSE/Li cells demonstrate outstanding cycle capability under different temperatures from 40 to 100 °C, and showed excellent long-term cycling stability beyond 1250, 1400, 1750, and 2000 h, respectively (Fig. ##FIG##3##4##g). The insets detailed exhibit the plating/stripping curves of the cells with different electrolytes at different stages. The voltage hysteresis curves clearly indicated that the Li/p-3DSE/Li cells exhibited the most stable polarization voltage and interface stability (Fig. ##FIG##3##4##h). The EIS profiles under different temperatures after certain cycles at 1 mA cm<sup>−2</sup> are shown in Fig. ##FIG##3##4##i, indicating fast ion transport and a stale solid–solid interface. These results present significant improvements in terms of CCD and long-lifespan under room temperature among the previously reported 3D electrolytes in terms of cycling lifespan and current density (Fig. ##FIG##3##4##j, Tables S4).</p>", "<p id=\"Par21\">In ASSLMBs, electrodes under high mass loadings, to enhance areal capacities, are necessary. However, sluggish ions transport and poor electrode flexibility could occur when blindly increasing the thickness of the electrode. In this regard, we skillfully designed 3D electrolyte architectures, especially for cathode materials. SEM images indicate the optimized p-3DSE/LFP electrodes by a simple spraying process (Fig. S16). It is obvious that the LFP material is uniformly and firmly attached to the 3D electrolyte frameworks, as shown in Fig. ##FIG##4##5##a. The enlarged SEM images from the top and cross-sectional show a smooth surface and strong contact. Through the LCSM image, it can be further proved that the LFP active materials are uniformly distributed in the 3D electrolyte skeletons and remain over 100 μm thickness (Fig. ##FIG##4##5##b). By controlling the spraying time, the cathode electrodes with different mass loadings can be prepared (Fig. S17). In particular, a composite p-3DSE/LFP electrode with a loading beyond 15 mg cm<sup>−2</sup> can be obtained (Fig. ##FIG##4##5##c). Strong adhesion between cathode material and p-3DSE can be found through the cross-sectional SEM images (Fig. S18a, b), compared with the electrodes fabricated by the traditional method (Fig. S18c, d). In order to investigate the relationship between the thickness of active materials and ion transport, two commercial materials, LFP and NCM811, were selected as the cathode materials, and a series of thickness electrodes were fabricated. The galvanostatic charge–discharge of Li/p-3DSE/LFP and Li/f-SE/LFP full cells at 0.1C-rate from 2.5 to 4.2 V was performed. As shown in Fig. ##FIG##4##5##d, after 100 cycles, there is a capacity retention of 97% for the Li/p-3DSE/LFP cells. However, the capacity retention of the Li/f-SE/LFP cell drops to 83.1%. While the cycling stability of Li/p-3DSE/LFP is improved, a capacity retention of 89% after 600 cycles at 1C-rate is obtained (Fig. ##FIG##4##5##e). Figure ##FIG##4##5##f illustrates the rate performance under different rates (Fig. S19), and the Li/p-3DSE/LFP cells show improved cyclic stability and rate performance than the Li/ Poly(PEGDA)/LiTFSI/LFP (Fig. S20). The Li/p-3DSE/LFP cells assembled with different mass loadings exhibit superior cycling capacities, indicating that high Li-ion transport expressways are formed in the cells. Figure ##FIG##4##5##g indicates the cycling performance of Li/p-3DSE/LFP cells at 0.5C-rate under different loadings. With the mass loadings of 3.5, 6.2, 8.5 10, 12.7, 15.5, and 20 mg cm<sup>−2</sup>, the reversible capacities of these cells are 0.576, 0.94, 1.227, 1.426, 1.872, 2.203, and 2.754 mAh cm<sup>−2</sup>, respectively. This result indicates that p-3DSE with enlarged surface area and high ion-conducting frameworks can still maintain stability, provide Li<sup>+</sup> transport pathways and improve the contact between the electrolyte and electrode. After 300 cycles, the Li/p-3DSE/LFP cells with the mass loading of 15.5 mg cm<sup>−2</sup> possess a higher capacity retention of 92.48% compared with the Li/p-3DSE/LFP cells with the loading of 20 mg cm<sup>−2</sup>, indicating that interface failure may occur when the electrode thickness exceeds 150 μm. Moreover, the Li/p-3DSE/NCM811 cells exhibit excellent rate performance from 0.05C-rate to 5C-rate, as shown in Figs. ##FIG##4##5##i and S21. The Li/p-3DSE/NCM811 cells provide capacities of 208.3, 189.2, 156.8, 108.3, and 100.0 mAh g<sup>−1</sup> at 0.1, 0.2, 0.5, 1, and 2C-rate, respectively. Even at 5C-rate, the cell still delivers a reversible capacity of 76.23 mAh g<sup>−1</sup>. The long-term cycling performance of the Li/p-3DSE/NCM811 cells under the loading of 22 mg cm<sup>−2</sup> at 0.2C-rate is shown in Fig. ##FIG##4##5##j, and the high reversible capacity of 3.19 mAh cm<sup>−2</sup> can be obtained even after 300 cycles with a high capacity retention of 84.8%, which is ascribed to lower interfacial resistance and shorter ion transport pathway within electrodes. The EIS spectra of Li/p-3DSE/NCM cells after different cycles were tested. As shown in Fig. ##FIG##4##5##k, it is noted that the semicircle gradually decreases as the cycle number increases, indicating an activation process between the electrolyte/electrode interfaces in initial cycles and enhanced Li<sup>+</sup> ion transfer. The stable electrolyte/electrode interfaces can be established over time (Table S5). To verify the practicality of 3D printing electrolytes, the LFP/Li pouch cells were assembled to test the practicality of the p-3DSE electrolyte in ASSLMBs. The LFP/Li cells can light on the LED under bending, folding, and after recovery (Fig. S22), indicating good flexibility and functionality at different states of the 3D-printed p-3DSE electrolyte (Fig. ##FIG##1##2##c–f).</p>", "<title>Interfacial Evolution of Morphologies and Chemistries</title>", "<p id=\"Par22\">The morphological evolution at Li/SE, Li/f-SE, and Li/p-3DSE interfaces during galvanostatic cycling under 0.1 mA cm<sup>−2</sup> (0.5 mAh cm<sup>−2</sup>) was tracked by post-mortem analysis. A schematic illustration was established to understand the electrolyte/Li interface interaction (Fig. ##FIG##5##6##a). In Li/electrolyte/Li cells, significant damage of the interface occurred in less than 50 h for the bare Poly(PEGDA)/LiTFSI electrolyte, and pores and voids were extensively detected not only at the surface of Li metal (Fig. S23) but also in the solid electrolyte film (Fig. S24). In contrast, the Li/p-3DSE/Li cells steadily maintained the stripping and deposition processes due to increased effective active area with Li. The nucleation and penetration of Li dendrites from the interface can be efficiently suppressed, as confirmed by the clean SEM images of the cycled p-3DSE at different stages. At the initial stage of cycles, the pillar arrays of p-3DSE were still clearly visible due to the small-capacity Li deposition (Fig. S25a). The enlarged SEM images show that the Li metal is uniformly and tightly deposited on the surface of the electrolyte pillar. A dense and smooth Li/electrolyte composite was formed within 20 h when the capacity of Li increased with cycling, indicating a stable and robust interface (Figs. S25b and 6c). The surface of Li metal with p-3DSE electrolyte also showed uniform and dense Li, without Li dendrite growth (Figs. ##FIG##5##6##e and S26), compared with the f-SE (Fig. ##FIG##5##6##d). From the optical images, the Li metal after cycles was flat and shiny (Fig. S27a). In contrast, the surface of lithium metal with bare Poly(PEGDA)/LiTFSI electrolyte showed black spots, and massive dendrites and pits (Fig. S27b). The p-3DSE film also delivered dense and smooth morphology after repeated cycles (Fig. S28). The results show serious interface degradation in the Li/SE and Li/f-SE cells. However, the Li flux toward the interface can become sufficient to replenish the Li loss at p-3DSE areas, which prevents interfacial degradation. Multiphysics simulation was conducted to monitor ions distribution at the Li/electrolyte interfaces (Fig. S29). As shown in Fig. ##FIG##5##6##b, the Li symmetric cell with p-3DSE electrolyte possesses low Li<sup>+</sup> concentration gradient, which clarifies fast ion conduction and reaction kinetics occurred at the Li/p-3DSE interface tended toward a uniform Li deposition, instead of forming dendritic Li at initial lithium plating stages. Nevertheless, severe Li<sup>+</sup> concentration gradient and fluctuations can be observed at the Li/f-SE and Li/s-3DSE interfaces, meaning that unavailing Li<sup>+</sup> depletion or Li dendrites would occur at interfaces due to the locally fluctuated Li<sup>+</sup> flux.</p>", "<p id=\"Par23\">In order to probe the reasons for the good compatibility of the Li metal anode interface in different electrolytes, X-ray photoelectron spectroscopy (XPS) depth profiling, with the assistance of Ar ion etching, was employed to analyze the cycled electrolytes and Li anodes. In Fig. ##FIG##5##6##f, the chemical speciation of C 1<italic>s</italic> in p-3DSE within the solid electrolyte interface (SEI) shows minimal variation. However, there is a notable enhancement in the intensity of Li<sub>2</sub>O species as the sputtering time is extended. This observation serves as compelling evidence that the Li<sub>2</sub>CO<sub>3</sub> species undergo decomposition, transitioning into the more stable Li<sub>2</sub>O structure at the interface between Li and p-3DSE. This phenomenon is essentially consistent across the PEGDA/LiTFSI (Fig. S30), f-SE (Fig. S31), and s-3DSE (Fig. S32). An obvious LiF peak emerges at the cycled p-3DSE and s-3DSE electrolytes, producing LiF-rich SEI (Figs. ##FIG##5##6##h and S32). In general, LiF is considered to be an important component in facilitating fast and uniform Li<sup>+</sup> transportation in SEI, which would also promote uniform Li deposition [##UREF##26##46##]. In the S 2<italic>p</italic> and N 1<italic>s</italic> spectra, S 2<italic>p</italic> peak at 167.8 eV and N 1<italic>s</italic> peak at 398.6 eV corresponded to LiTFSI (Figs. ##FIG##5##6##i, k and S31, S32). The peak of ionic conductor Li<sub>3</sub>N at 397.4 eV in N 1<italic>s</italic> spectra is also considered to be an ideal component of SEI due to its ability to reduce the interfacial resistance and suppress the growth of Li dendrites [##UREF##27##47##]. In the PEGDA/LiTFSI and f-SE systems, F elements are primarily attributed to the LiTFSI component, and there is no distinct signal of LiF. As shown in Fig. ##FIG##5##6##l, there is a noticeable reduction in the intensity of C 1<italic>s</italic> as the sputtering time increases, accompanied by an enhancement in the intensities of F 1<italic>s</italic> and N 1<italic>s</italic>. This observation suggests the formation of an SEI film rich in LiF and Li<sub>3</sub>N species on the surface of p-3DSE/s-3DSE. Consequently, the establishment of a stable interface between Li metal and p-3DSE/s-3DSE is achieved, resulting in enhanced kinetics and the capability for long-term operation.</p>", "<p id=\"Par24\">The positive effect of the p-3DSE electrolyte on the NCM811 and LFP cathodes in terms of thier rate and long-term electrochemical performance was pronounced in coin full cells featuring with Li metal anode. The cross-sectional SEM image of the cycled NCM811 cathode with p-3DSE electrolyte showed their microstructural characteristics in the mechanical stability. As shown in Fig. ##FIG##6##7##a, the secondary particles of a cycled NCM811 cathode contain no visible microcracks, while those of a cycled NCM811 cathode with Poly(PEGDA)/LiTFSI electrolyte are nearly fractured and contained extensive networks of wide microcracks (Fig. S33). SEM–EDS analysis revealed the uniform distribution of O, Ni, Co and Mn elements from the surface to the bulk of cycled NCM811 particles. Furthermore, the crystal structure of NCM811 cathode after 300 cycles at 0.2C was investigated by the atomic resolution Z-contrast STEM-HAADF imaging. As shown in Fig. S34, the NCM811 cathode with Poly(PEGDA)/LiTFSI electrolyte is accompanied by a large amount of cation mixing and NiO phase near the crack, which greatly inhibited the transport of Li<sup>+</sup> and rapidly increased the electrochemical impedance (Fig. S35). On the contrary, the layered structure with R-3 m space group was well retained in the bulk of cycled NCM811 cathode with p-3DSE electrolyte (Fig. ##FIG##6##7##b, c), and the stable layered structure can provide a stable diffusion channel for Li<sup>+</sup> in the electrochemical performance, which demonstrated fast kinetics and electrochemical cycle stability, which can be demonstrated by CV curves using different electrolytes (Fig. S36). Electron energy loss spectroscopy (EELS) spectra were tested to reveal the electronic structure evolution of Ni, Co, Mn and O elements. The line in Fig. ##FIG##6##7##d indicates the measurement position of EELS. The chemical shift of the Ni L-edges, Co L-edges, and Mn L-edges of the NCM811 cathode with Poly(PEGDA)/LiTFSI electrolyte to the position with low energy loss, especially the Ni, indicated the reduction of the valence state of the metal element. In addition, the O K-edges strength decreases gradually from the bulk to the surface, indicating the formation of oxygen vacancy and promoting the migration of transition metal ions to the Li<sup>+</sup> sites, exacerbating the structural transformation (Fig. S37). However, the Ni L-edges, Co L-edges, Mn L-edges, and O K-edges of NCM811 cathode with p-3DSE electrolyte show almost no chemical shift, which is indicative of the structure stability. All these findings contribute to the enhanced compatibility of p-3DSE electrolytes with the high-voltage cathode (NCM811). Such superior full cells performances can be ascribed to the high oxidation stability of p-3DSE due to the addition of LLZTO inorganic networks, the high Li<sup>+</sup> conductivity at room temperature and the intimate contact between Li metal anode and p-3DSE (Fig. ##FIG##6##7##i).</p>", "<p id=\"Par25\">To elucidate the origin of the enhanced interfacial Li<sup>+</sup> transportation by the introduction of vertical-aligned ion-conducting network on cathodes, Multiphysics simulation were performed to analyze the ion distribution (Fig. S38). The Li<sup>+</sup> concentration distribution under two cathode/electrolyte models were simulated, as shown in Fig. ##FIG##6##7##g. The results show that a more homogeneous Li<sup>+</sup> distribution and negligible Li<sup>+</sup> concentration polarization in the p-3DSE/cathode are achieved compared with that of the Poly(PEGDA)/LiTFSI/cathode. From the f-SE/cathode model, large concentration gradients are observed due to the long transport pathway of Li<sup>+</sup> which is unfavorable for efficient Li<sup>+</sup> migration and diffusion, especially under high-load electrodes. The p-3DSE case with micro-pillars provides a facile pathway for Li<sup>+</sup> transport which minimize the transport length resulting in enhanced Li<sup>+</sup> transport performance. Therefore, these achievements result in a low concentration gradient, and hence low concentration polarization, which leads to the optimized rates performance. The relationship between Li<sup>+</sup> concentration and electrode thickness along the vertical direction is shown in Fig. ##FIG##6##7##h. The local Li<sup>+</sup> concentration is larger in the p-3DSE/cathode electrode with the increasing thickness of integrated electrodes than that of the f-SE/cathode electrode when the electrode thickness is larger than 62 μm. This indicates a better Li<sup>+</sup> transfer and lower Li<sup>+</sup> diffusion resistance for the p-3DSE/cathode electrode. Thus, high capacity can be achieved by loading cathode materials on the as-designed 3D electrolyte with pillared-structure arrays. This structure enables a continuous Li<sup>+</sup> conduction network, which demonstrates rapid and stable Li<sup>+</sup> transfer within the electrolyte/cathode (Fig. ##FIG##6##7##i).</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par26\">In summary, 3D composite solid electrolytes with highly efficient ion-conducting networks are developed using 3D printing technologies. Multiple-type electrolyte films with vertical-aligned micro-pillar (p-3DSE) and spiral (s-3DSE) structures were rationally designed and fabricated. The results demonstrates that p-3DSE homogenized the Li<sup>+</sup> ion concentration at the electrolyte/Li interfaces, reinforce the electrolyte/cathode interfacial adhesion, and improve the loading of cathode materials. The 3D-printed p-3DSE delivered robust long-term cycle life of up to 2600 cycles at 1 mA cm<sup>−2</sup> and a high critical current density of 1.92 mA cm<sup>−2</sup>. The optimized 3D electrolyte structure could realize all-solid-state Li metal batteries with a dramatically superior full-cell areal capacity of 2.75 mAh cm<sup>−2</sup> (LFP) and 3.92 mAh cm<sup>−2</sup> (NCM811) at the room temperature. The novel design of 3D-printed electrolytes showed excellent interfacial stability with Li anode and LFP (NCM811) cathode, thus preventing interfacial degradation induced by the dendrite growth and the contact loss. Our study describes a highly efficient Li<sup>+</sup> transport mode of CSEs for advanced solid-state lithium metal batteries.</p>" ]
[ "<title>Highlights</title>", "<p id=\"Par100\">\n<list list-type=\"bullet\"><list-item><p id=\"Par400\">This study introduces an innovative 3D-printed electrolyte with vertically aligned ion transport network, which contains well-dispersed nanoscale Ta-doped Li<sub>7</sub>La<sub>3</sub>Zr<sub>2</sub>O<sub>12</sub> in a poly(ethylene glycol) diacrylate matrix.</p></list-item><list-item><p id=\"Par500\">The 3DSE architecture enables efficient ion transport across the Li/electrolyte and electrolyte/cathode interfaces, which allows for increased active material mass loading and enhanced interfacial adhesion.</p></list-item><list-item><p>The p-3DSE Li symmetric cell displays an impressive critical current density value of 1.92 mA cm<sup>−2</sup> and stable operation for 2600 h at room temperature. Full cells using p-3DSE achieve notable areal capacities.</p></list-item></list></p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s40820-023-01301-4.</p>", "<p id=\"Par1\">Improving the long-term cycling stability and energy density of all-solid-state lithium (Li)-metal batteries (ASSLMBs) at room temperature is a severe challenge because of the notorious solid–solid interfacial contact loss and sluggish ion transport. Solid electrolytes are generally studied as two-dimensional (2D) structures with planar interfaces, showing limited interfacial contact and further resulting in unstable Li/electrolyte and cathode/electrolyte interfaces. Herein, three-dimensional (3D) architecturally designed composite solid electrolytes are developed with independently controlled structural factors using 3D printing processing and post-curing treatment. Multiple-type electrolyte films with vertical-aligned micro-pillar (p-3DSE) and spiral (s-3DSE) structures are rationally designed and developed, which can be employed for both Li metal anode and cathode in terms of accelerating the Li<sup>+</sup> transport within electrodes and reinforcing the interfacial adhesion. The printed p-3DSE delivers robust long-term cycle life of up to 2600 cycles and a high critical current density of 1.92 mA cm<sup>−2</sup>. The optimized electrolyte structure could lead to ASSLMBs with a superior full-cell areal capacity of 2.75 mAh cm<sup>−2</sup> (LFP) and 3.92 mAh cm<sup>−2</sup> (NCM811). This unique design provides enhancements for both anode and cathode electrodes, thereby alleviating interfacial degradation induced by dendrite growth and contact loss. The approach in this study opens a new design strategy for advanced composite solid polymer electrolytes in ASSLMBs operating under high rates/capacities and room temperature. </p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s40820-023-01301-4.</p>", "<title>Keywords</title>" ]
[ "<title>Experimental Section</title>", "<title>Materials</title>", "<p id=\"Par11\">Li<sub>2</sub>CO<sub>3</sub> (99.9%, Sigma-Aldrich), La<sub>2</sub>O<sub>3</sub> (99.9%, Sigma-Aldrich), ZrO<sub>2</sub> (99.9%, Sigma-Aldrich), Ta<sub>2</sub>O<sub>5</sub> (99.9%, Sigma-Aldrich), were purchased from Sigma-Aldrich. Poly(ethylene glycol) diacrylate (PEGDA, Aladdin, Mv ≈ 1000) phenylbis (2,4,6-trimethylbenzoyl)-phosphine oxide (Aladdin), succinonitrile (Aladdin), and LiTFSI (Sigma-Aldrich) were also purchased. Lithium iron phosphate (LiFePO<sub>4</sub>), Ni-rich layered oxides LiNi<sub>0.8</sub>Co<sub>0.1</sub>Mn<sub>0.1</sub>O<sub>2</sub> (NCM811), conductive carbon black (Super-P), Li foil (0.45 mm, 99.9%), Al foil (20 μm, 99.99%), polyvinylidene fluoride (PVDF) were purchased from MTI Corporation. Aluminum plastic film, tab and sealing machine were purchased from Guangdong Canrd New Energy Technology Co., Ltd.</p>", "<title>Preparation of Nanoscale LLZTO, 3D Composite Electrolytes and 3D Cathodes</title>", "<title>Preparations of the Nanoscale LLZTO Powder</title>", "<p id=\"Par12\">The Li<sub>6.5</sub>La<sub>3</sub>Zr<sub>1.5</sub>Ta<sub>0.5</sub>O<sub>12</sub> (LLZTO) garnet electrolyte was synthesized using a solid-state reaction method. Li<sub>2</sub>CO<sub>3</sub>, La<sub>2</sub>O<sub>3</sub>, Ta<sub>2</sub>O<sub>5</sub>, and ZrO<sub>2</sub> were used as precursors. To compensate for Li volatilization, an excess amount of Li<sub>2</sub>CO<sub>3</sub> by 15% was added. Raw materials with isopropanol as a solvent were mixed through ball milling at 600 rpm for 8 h with zirconium oxide balls and then dried at 80 °C for 6 h. The dried material was sintered at 900 °C for 6 h. The final sintering step was conducted at 1200 °C for 24 h. The as-synthesized LLZTO sample was ground at 600 rpm for 2 h to obtain LLZTO powders. All of the powders were stored in an Ar-filled glovebox (H<sub>2</sub>O &lt; 0.01 ppm, O<sub>2</sub> &lt; 0.01 ppm).</p>", "<title>Fabrication of 3D-printed LLZTO/Poly(PEGDA) Composite Polymer Electrolytes</title>", "<p id=\"Par13\">Poly(ethylene glycol) diacrylate (PEGDA, Aladdin, Mv ≈ 1000), LiTFSI (99%, Sigma-Aldrich), self-synthesized LLZTO and photoinitiator phenylbis (2,4,6-trimethyl benzoyl)-phosphine oxide (TPO, 97%, Macklin) were mixed in weight ratios of 1.5:1:0.10:0.0075, 1.5:1:0.15:0.0075, and 1.5:1:0.20:0.0075 under a 45 °C water bath using magnetic stirring at speed of 400 rpm for overnight. The SEs were then printed with a 405 nm LED printer (Asiga Max, ASIGA) by exposing the prepared precursor 6 s at a power of 9 W cm<sup>−2</sup> with a layer thickness of 50 μm in a humidity below 30%, under the designed geometry (three types, including planar, spiral and pillar structures). Anhydrous ethanol (99.7%, Energy Chemical) was then used to wash away the uncured precursor. Fully photopolymerized CPEs were dried in a vacuum oven at 25 °C for 2 h, followed by further drying in an Ar-filled glovebox with &lt; 0.01 ppm H<sub>2</sub>O level for at least 48 h. After the printing process, three-type composite polymer electrolytes were successfully fabricated in a direct 3D printing technology.</p>", "<title>Preparation of LFP/3DSE and NCM811/3DSE Cathodes</title>", "<p id=\"Par14\">The cathode electrodes were prepared by mixing LFP or NCM811 powder (70 wt%), super-P (10 wt%), and CPE (20 wt%, as the binder) in acetonitrile and vigorously stirred overnight. The slurry was then sprayed onto three-type CPEs, followed by drying in vacuum ovens at 30 °C overnight and further drying in an Ar-filled glovebox (H<sub>2</sub>O &lt; 0.01 ppm, O<sub>2</sub> &lt; 0.01 ppm) for at least 24 h. In these experiments, LFP/3DSE and NCM811/3DSE composite cathodes with different mass loadings were obtained by controlling the spray time from 5 to 30 min, thus achieving integrated cathode/electrolyte varying the thickness between 20 and 160 μm.</p>", "<title>Supplementary Information</title>", "<p>Below is the link to the electronic supplementary material.</p>" ]
[ "<title>Acknowledgements</title>", "<p>This work was financially supported by Stable Support Plan Program for Higher Education Institutions (20220815094504001), and Shenzhen Key Laboratory of Advanced Energy Storage (ZDSYS20220401141000001). This work was also financially supported by the Shenzhen Science and Technology Innovation Commission (GJHZ20200731095606021; 20200925155544005) and the Project of Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone (HZQB-KCZYB-2020083). The authors would also like to acknowledge the technical support from SUSTech Core Research Facilities.</p>", "<title>Declarations</title>", "<title>Conflict of Interests</title>", "<p id=\"Par27\">The authors declare no interest conflict. They have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p><bold>a</bold> Schematic illustration of the fabrication of 3D printing 3DSE and structure-property relationships. <bold>b</bold> Micro-CT image of the symmetric p-3DSE and <bold>c</bold> distribution of nano-LLZTO ceramic electrolyte in 3D architecture. <bold>d</bold> The viscosity of the as-obtained printed slurry (The insets are optical pictures of the slurry at different stages)</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p><bold>a</bold> Optical images and SEM images of <bold>b, i, j </bold>top and <bold>c</bold> front view of p-3DSE. SEM images of p-3DSE electrolyte at different states of <bold>d</bold> free, <bold>e</bold> bending, and <bold>f</bold> twisting (The inset images are optical images of large-scale p-3DSE film under different states). <bold>g, h</bold> Typical LCSM images of p-3DSE with different sizes. <bold>k</bold> Micro-CT image and l SEM image of cross-sectional and m corresponding EDS mapping data of p-3DSE. <bold>n</bold> XRD patterns, <bold>o</bold> TGA curves and <bold>p</bold> stress-strain curves of various electrolyte examples</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p><bold>a</bold> FTIR spectra for Poly(PEGDA)/LiTFSI electrolyte, f-SE, S-3DSE and p-3DSE electrolytes. <bold>b</bold>, <bold>c</bold> Impedance spectra for p-3DSE electrolytes from 20 to 100 °C. <bold>d</bold> Arrhenius plots of p-3DSE electrolyte. <bold>e</bold> Chronoamperometry curves of p-3DSE electrolytes (the inset image is the EIS curves of p-3DSE before and after polarization) and <bold>f</bold> LSV curves of Poly(PEGDA)/LiTFSI, s-3DSE, and p-3DSE electrolytes</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p><bold>a</bold> CCD testing on the Li/p-3DSE/Li cells with current steps from 0.05 to 2.0 mA cm<sup>−2</sup>. <bold>b</bold> Comparison of the CCD of various electrolytes. <bold>c</bold> EIS spectra of the Li/f-SE/Li and Li/p-3DSE/Li cells cycled after different cycles. The symmetrical cells performance<bold> d</bold> rate capability, cycling <bold>e</bold> at 30 °C under 1 mA cm<sup>−2</sup>/mAh cm<sup>−2</sup> and <bold>f</bold> 0.5 mA cm<sup>−2</sup>/mAh cm<sup>−2</sup>. <bold>g</bold> Long-term cycling of Li/p-3DSE/Li cells under varying temperatures from 40 to 100 °C and <bold>h</bold> the corresponding tendency of polarization voltage. Insets in <bold>g</bold> show an enlarged view of the voltage profiles in 6–10 h, 596–600 h, 1250–1255 h, and 1700–1705 h. <bold>i</bold> EIS spectra of the Li/p-3DSE/Li cells at different temperatures. <bold>j</bold> Comparison of the cycling current density and lifespan of Li symmetric cells with previously reported 3D electrolytes</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><p><bold>a</bold> SEM images of p-3DSE/LFP cathode from the top and cross-sectional views. <bold>b</bold> LCSM images of p-3DSE/LFP cathode. <bold>c</bold> The curve of mass loading of LFP cathode and spraying time. Cycling performance of cells using LFP cathode at <bold>d</bold> 0.1C, <bold>e</bold> 1.0C, and <bold>f</bold> typical charge/discharge profiles at various rates. <bold>g</bold> Cycling life of LFP cathode with different mass loadings and <bold>h</bold> the corresponding capacity retention. <bold>i</bold> Rate performance, <bold>j</bold> cycling lifespan under high mass loading and <bold>k</bold> EIS spectra of Li/p-3DSE/NCM811 cells</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><p><bold>a</bold> Schematic illustration of the plating process of Li metal with the p-3DSE. <bold>b</bold> Li<sup>+</sup> concentration distribution ascends along the Li anodes interface and three-type electrolytes based on simulation. SEM images of <bold>c</bold> p-3DSE after cycles from top-view, Li metal cycled beyond 1000 times under <bold>d</bold> f-SE electrolyte and <bold>e</bold> p-3DSE electrolyte after FIB cutting from cross-sectional view (Insets are enlarged SEM images). Sputter-down XPS spectra of <bold>f</bold> C 1<italic>s</italic>, <bold>g</bold> O 1<italic>s</italic>, <bold>h</bold> F 1<italic>s</italic>, <bold>i</bold> S 1<italic>s</italic>, <bold>j</bold> Li 1<italic>s</italic>, and <bold>k</bold> N 1<italic>s</italic> spectra of p-3DSE interfaces. <bold>l</bold> Bar charts showing the atomic concentrations of different sputtering times in the electrolyte interface</p></caption></fig>", "<fig id=\"Fig7\"><label>Fig. 7</label><caption><p><bold>a</bold> Cross-sectional image of FIB-SEM and line-scan of O, Ni, Co, and Mn elements of NCM811 cathode after cycles with p-3DSE. <bold>b</bold>, <bold>c</bold> HAADF-STEM images of the interior region for FIB-prepared NCM811. <bold>d</bold>–<bold>f</bold> High-resolution STEM image, and the corresponding EELS spectra of Co, Ni, Mn L-edge, and O K-edge. <bold>g</bold> Li<sup>+</sup> concentration distribution of the integrated electrolyte/cathode at 200 μm for f-SE and p-3DSE electrolytes, and <bold>h</bold> the corresponding relationship between Li<sup>+</sup> concentration and electrode thickness along the vertical direction (the line in Fig. 7 g). <bold>i</bold> Schematic illustration of the Li<sup>+</sup> transport mechanism between p-3DSE and cathode materials</p></caption></fig>" ]
[]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<fn-group><fn><p>Yongbiao Mu, Shixiang Yu, Yuzhu Chen and Youqi Chu have contributed equally to this work.</p></fn></fn-group>" ]
[ "<graphic position=\"anchor\" xlink:href=\"40820_2023_1301_Figa_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"40820_2023_1301_Fig1_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"40820_2023_1301_Fig2_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"40820_2023_1301_Fig3_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"40820_2023_1301_Fig4_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"40820_2023_1301_Fig5_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"40820_2023_1301_Fig6_HTML\" id=\"MO7\"/>", "<graphic xlink:href=\"40820_2023_1301_Fig7_HTML\" id=\"MO8\"/>" ]
[ "<media xlink:href=\"40820_2023_1301_MOESM1_ESM.pdf\"><caption><p>Supplementary file1 (PDF 2732 kb)</p></caption></media>" ]
[{"label": ["5."], "surname": ["Dirican", "Yan", "Zhu", "Zhang"], "given-names": ["M", "C", "P", "X"], "article-title": ["Composite solid electrolytes for all-solid-state lithium batteries"], "source": ["Mater. Sci. Eng. R. Rep."], "year": ["2019"], "volume": ["136"], "fpage": ["27"], "lpage": ["46"], "pub-id": ["10.1016/j.mser.2018.10.004"]}, {"label": ["10."], "surname": ["Liu", "Zhang", "Xu"], "given-names": ["B", "J-G", "W"], "article-title": ["Advancing lithium metal batteries"], "source": ["Joule"], "year": ["2018"], "volume": ["2"], "fpage": ["833"], "lpage": ["845"], "pub-id": ["10.1016/j.joule.2018.03.008"]}, {"label": ["12."], "surname": ["Xiao", "Wang", "Bo", "Kim", "Miara"], "given-names": ["Y", "Y", "S-H", "JC", "LJ"], "article-title": ["Understanding interface stability in solid-state batteries"], "source": ["Nat. Rev. Mater."], "year": ["2020"], "volume": ["5"], "fpage": ["105"], "lpage": ["126"], "pub-id": ["10.1038/s41578-019-0157-5"]}, {"label": ["13."], "surname": ["Miao", "Guan", "Ma", "Li", "Nan"], "given-names": ["X", "S", "C", "L", "C-W"], "article-title": ["Role of interfaces in solid-state batteries"], "source": ["Adv. Mater."], "year": ["2022"], "volume": ["35"], "issue": ["50"], "fpage": ["e2206402"], "pub-id": ["10.1002/adma.202206402"]}, {"label": ["14."], "surname": ["Du", "Liao", "Lu", "Shao"], "given-names": ["M", "K", "Q", "Z"], "article-title": ["Recent advances in the interface engineering of solid-state Li-ion batteries with artificial buffer layers: challenges, materials, construction, and characterization"], "source": ["Energy Environ. Sci."], "year": ["2019"], "volume": ["12"], "fpage": ["1780"], "lpage": ["1804"], "pub-id": ["10.1039/C9EE00515C"]}, {"label": ["16."], "surname": ["Dong", "Mayer", "Liu", "Passerini", "Bresser"], "given-names": ["X", "A", "X", "S", "D"], "article-title": ["Single-ion conducting multi-block copolymer electrolyte for lithium-metal batteries with high mass loading NCM"], "sub": ["811"], "source": ["ACS Energy Lett."], "year": ["2023"], "volume": ["8"], "fpage": ["1114"], "lpage": ["1121"], "pub-id": ["10.1021/acsenergylett.2c02806"]}, {"label": ["19."], "surname": ["Mu", "Chen", "Wu", "Zhang", "Lin"], "given-names": ["Y", "Y", "B", "Q", "M"], "article-title": ["Dual vertically aligned electrode-inspired high-capacity lithium batteries"], "source": ["Adv. Sci."], "year": ["2022"], "volume": ["9"], "fpage": ["e2203321"], "pub-id": ["10.1002/advs.202203321"]}, {"label": ["20."], "surname": ["Zuo", "Wu", "Yang", "Yin", "Ye"], "given-names": ["T-T", "X-W", "C-P", "Y-X", "H"], "article-title": ["Graphitized carbon fibers as multifunctional 3D current collectors for high areal capacity Li anodes"], "source": ["Adv. Mater."], "year": ["2017"], "volume": ["29"], "fpage": ["1700389"], "pub-id": ["10.1002/adma.201700389"]}, {"label": ["21."], "surname": ["Zhang", "Wen", "Wang", "Qin", "Liu"], "given-names": ["R", "S", "N", "K", "E"], "article-title": ["N-doped graphene modified 3D porous Cu current collector toward microscale homogeneous Li deposition for Li metal anodes"], "source": ["Adv. Energy Mater."], "year": ["2018"], "volume": ["8"], "fpage": ["1800914"], "pub-id": ["10.1002/aenm.201800914"]}, {"label": ["24."], "surname": ["Park", "King", "Tian", "Boland", "Coelho"], "given-names": ["S-H", "PJ", "R", "CS", "J"], "article-title": ["High areal capacity battery electrodes enabled by segregated nanotube networks"], "source": ["Nat. Energy"], "year": ["2019"], "volume": ["4"], "fpage": ["560"], "lpage": ["567"], "pub-id": ["10.1038/s41560-019-0398-y"]}, {"label": ["25."], "surname": ["Chen", "Zhang", "Li", "Kuang", "Song"], "given-names": ["C", "Y", "Y", "Y", "J"], "article-title": ["Highly conductive, lightweight, low-tortuosity carbon frameworks as ultrathick 3D current collectors"], "source": ["Adv. Energy Mater."], "year": ["2017"], "volume": ["7"], "fpage": ["1700595"], "pub-id": ["10.1002/aenm.201700595"]}, {"label": ["28."], "surname": ["Elango", "Demorti\u00e8re", "De Andrade", "Morcrette", "Seznec"], "given-names": ["R", "A", "V", "M", "V"], "article-title": ["Thick binder-free electrodes for Li\u2013ion battery fabricated using templating approach and spark plasma sintering reveals high areal capacity"], "source": ["Adv. Energy Mater."], "year": ["2018"], "volume": ["8"], "fpage": ["1703031"], "pub-id": ["10.1002/aenm.201703031"]}, {"label": ["29."], "surname": ["Kang", "Yan", "Gao", "Zhang", "Liu"], "given-names": ["J", "Z", "L", "Y", "W"], "article-title": ["Improved ionic conductivity and enhancedinterfacial stability of solid polymer electrolytes with porous ferroelectric ceramic nanofibers"], "source": ["Energy Storage Mater."], "year": ["2022"], "volume": ["53"], "fpage": ["192"], "lpage": ["203"], "pub-id": ["10.1016/j.ensm.2022.09.005"]}, {"label": ["30."], "surname": ["Bae", "Li", "Zhang", "Zhou", "Zhao"], "given-names": ["J", "Y", "J", "X", "F"], "article-title": ["Cover picture: a 3D nanostructured hydrogel-framework-derived high-performance composite polymer lithium-ion electrolyte"], "source": ["Angew. Chem. Int. Ed."], "year": ["2018"], "volume": ["57"], "fpage": ["2007"], "pub-id": ["10.1002/anie.201800929"]}, {"label": ["31."], "surname": ["Xie", "Yang", "Fu", "Yao", "Jiang"], "given-names": ["H", "C", "KK", "Y", "F"], "article-title": ["Flexible, scalable, and highly conductive garnet-polymer solid electrolyte templated by bacterial cellulose"], "source": ["Adv. Energy Mater."], "year": ["2018"], "volume": ["8"], "fpage": ["1703474"], "pub-id": ["10.1002/aenm.201703474"]}, {"label": ["32."], "surname": ["Zekoll", "Marriner-Edwards", "Ola Hekselman", "Kasemchainan", "Kuss"], "given-names": ["S", "C", "AK", "J", "C"], "article-title": ["Hybrid electrolytes with 3D bicontinuous ordered ceramic and polymer microchannels for all-solid-state batteries"], "source": ["Energy Environ. Sci."], "year": ["2018"], "volume": ["11"], "fpage": ["185"], "lpage": ["201"], "pub-id": ["10.1039/c7ee02723k"]}, {"label": ["33."], "surname": ["Tang", "Guo", "Fu"], "given-names": ["S", "W", "Y"], "article-title": ["Advances in composite polymer electrolytes for lithium batteries and beyond"], "source": ["Adv. Energy Mater."], "year": ["2021"], "volume": ["11"], "fpage": ["2000802"], "pub-id": ["10.1002/aenm.202000802"]}, {"label": ["34."], "surname": ["Pan", "Zhao", "Wang", "Huang", "Dou"], "given-names": ["J", "P", "N", "F", "S"], "article-title": ["Research progress in stable interfacial constructions between composite polymer electrolytes and electrodes"], "source": ["Energy Environ. Sci."], "year": ["2022"], "volume": ["15"], "fpage": ["2753"], "lpage": ["2775"], "pub-id": ["10.1039/d1ee03466a"]}, {"label": ["35."], "surname": ["Wang", "Zhai", "Qie", "Cheng", "Li"], "given-names": ["X", "H", "B", "Q", "A"], "article-title": ["Rechargeable solid-state lithium metal batteries with vertically aligned ceramic nanoparticle/polymer composite electrolyte"], "source": ["Nano Energy"], "year": ["2019"], "volume": ["60"], "fpage": ["205"], "lpage": ["212"], "pub-id": ["10.1016/j.nanoen.2019.03.051"]}, {"label": ["36."], "surname": ["Tang", "Tang", "Guan", "Zhang", "Xiang"], "given-names": ["W", "S", "X", "X", "Q"], "article-title": ["High-performance solid polymer electrolytes filled with vertically aligned 2D materials"], "source": ["Adv. Funct. Mater."], "year": ["2019"], "volume": ["29"], "fpage": ["1900648"], "pub-id": ["10.1002/adfm.201900648"]}, {"label": ["37."], "surname": ["Dai", "Fu", "Gong", "Song", "Chen"], "given-names": ["J", "K", "Y", "J", "C"], "article-title": ["Flexible solid-state electrolyte with aligned nanostructures derived from wood"], "source": ["ACS Mater. Lett."], "year": ["2019"], "volume": ["1"], "fpage": ["354"], "lpage": ["361"], "pub-id": ["10.1021/acsmaterialslett.9b00189"]}, {"label": ["39."], "surname": ["Zhang", "An", "Yang", "Long", "Nie"], "given-names": ["H", "X", "Y", "Y", "S"], "article-title": ["Vertical aligned solid-state electrolyte templated by nanostructured \u201cupright\u201d cellulose film layers for advanced cell performance"], "source": ["EcoMat"], "year": ["2023"], "volume": ["5"], "fpage": ["e12317"], "pub-id": ["10.1002/eom2.12317"]}, {"label": ["40."], "surname": ["Nie", "Yang", "Luo", "Liu", "Ma"], "given-names": ["Y", "T", "D", "Y", "Q"], "article-title": ["Tailoring vertically aligned inorganic-polymer nanocomposites with abundant lewis acid sites for ultra-stable solid-state lithium metal batteries"], "source": ["Adv. Energy Mater."], "year": ["2023"], "volume": ["13"], "fpage": ["2204218"], "pub-id": ["10.1002/aenm.202204218"]}, {"label": ["41."], "surname": ["Jiang", "Xie", "Wang", "Song", "Yao"], "given-names": ["Z", "H", "S", "X", "X"], "article-title": ["Perovskite membranes with vertically aligned microchannels for all-solid-state lithium batteries"], "source": ["Adv. Energy Mater."], "year": ["2018"], "volume": ["8"], "fpage": ["1801433"], "pub-id": ["10.1002/aenm.201801433"]}, {"label": ["42."], "surname": ["Fang", "Xu", "Grundish", "Xia", "Li"], "given-names": ["R", "B", "NS", "Y", "Y"], "article-title": ["Li"], "sub": ["2", "6"], "source": ["Angew. Chem. Int. Ed."], "year": ["2021"], "volume": ["60"], "fpage": ["17701"], "lpage": ["17706"], "pub-id": ["10.1002/anie.202106039"]}, {"label": ["43."], "surname": ["Wei", "Liu", "Zhou", "Cheng", "Liu"], "given-names": ["Y", "T-H", "W", "H", "X"], "article-title": ["Enabling all-solid-state Li metal batteries operated at 30 \u2103 by molecular regulation of polymer electrolyte"], "source": ["Adv. Energy Mater."], "year": ["2023"], "volume": ["13"], "fpage": ["2203547"], "pub-id": ["10.1002/aenm.202203547"]}, {"label": ["46."], "surname": ["Zhang", "Wang", "Zhang", "Ying", "Zhuang"], "given-names": ["Z", "J", "S", "H", "Z"], "article-title": ["Stable all-solid-state lithium metal batteries with Li"], "sub": ["3"], "source": ["Energy Storage Mater."], "year": ["2021"], "volume": ["43"], "fpage": ["229"], "lpage": ["237"], "pub-id": ["10.1016/j.ensm.2021.09.002"]}, {"label": ["47."], "surname": ["Jabbari", "Yurkiv", "Rasul", "Phakatkar", "Mashayek"], "given-names": ["V", "V", "MG", "AH", "F"], "article-title": ["In situ formation of stable solid electrolyte interphase with high ionic conductivity for long lifespan all-solid-state lithium metal batteries"], "source": ["Energy Storage Mater."], "year": ["2023"], "volume": ["57"], "fpage": ["1"], "lpage": ["13"], "pub-id": ["10.1016/j.ensm.2023.02.009"]}]
{ "acronym": [], "definition": [] }
47
CC BY
no
2024-01-14 23:40:14
Nanomicro Lett. 2024 Jan 12; 16:86
oa_package/e1/6a/PMC10786779.tar.gz
PMC10786780
38216781
[ "<title>Introduction</title>", "<p id=\"Par24\">According to the 2020 Global Cancer Population Survey, liver cancer is the sixth most common cancer type and the third leading cause of cancer death [##REF##33538338##1##]. Primary liver cancer includes hepatocellular carcinoma (HCC) (75–85%), intrahepatic cholangiocarcinoma (10–15%), and other rare types [##REF##28043904##2##]. In recent years, the mortality rate of patients with liver cancer is still increasing at a rate of about 2–3% per year [##REF##32884985##3##]. Usually, patients with liver cancer are diagnosed at an advanced stage and most of them have a poor prognosis. Therefore, it is urgently needed to develop highly sensitive and specific biomarkers and to explore the mechanism of key signaling pathways and factors in the development of liver cancer, which may bring new opportunities for the diagnosis, prognosis, and treatment of liver cancer.</p>", "<p id=\"Par25\">Mitochondrial oxidative phosphorylation system (OXPHOS) deficiency and reactive oxygen species (ROS) production are the main causes of mitochondrial dysfunction [##REF##34440674##4##], which is a research hotspot received extensive attention in recent years. Mitochondrial OXPHOS is the main source of cellular ATP that are generated during electron transfer process. ROS generated in mitochondria interact with cellular and mitochondrial components such as proteins, DNA, lipids, and other molecules, triggering mitochondrial dysfunction [##REF##34929300##5##]. Mitochondrial dysfunction further leads to overproduction of ROS, which in turn induce oxidative stress and aggravate mitochondrial damage. ROS are closely related to various cancers, such as colorectal cancer, breast cancer, liver cancer, and cervical cancer [##REF##31119045##6##–##REF##30356100##9##]. It was found that ROS play dual roles in cancer initiation, progression, inhibition, and therapy. Low levels of ROS intend to stimulate cell proliferation and cancer progression, while excess ROS usually lead to cancer cell apoptosis [##REF##33602787##10##].</p>", "<p id=\"Par26\">Glutamate dehydrogenase 1 (GLUD1) is localized in the mitochondrial matrix, which is one of the key enzymes in glutamine metabolism process and uses NAD or NADP as a cofactor to catalyze the oxidative deamination of glutamate to <italic>α</italic>-ketoglutarate (<italic>α</italic>-KG) [##REF##31610054##11##]. The changes of GLUD1 enzyme activity and its expression level are closely related to the occurrence and development of various diseases. The most reported case is hyperinsulinemic hypoglycemia (HH), which is caused by dominant heterozygous missense mutations in the <italic>GLUD1</italic> gene [##REF##28165182##12##]. Besides, abnormal expression of GLUD1 affects the progression of breast cancer, gastric cancer, and prostate cancer [##REF##33784591##13##–##REF##32801758##15##]. As a metabolism-related enzyme, GLUD1 usually affects tumorigenesis and development by regulating cellular metabolic functions, which have been proved in glioblastoma, lung cancer, and renal clear cell carcinoma [##REF##28720668##16##, ##REF##34269483##17##].</p>", "<p id=\"Par27\">In the previous study, we carried out quantitative proteomic detection of cancer and normal liver tissues of clinical HCC patients, and found that the protein expression level of GLUD1 in cancer tissues was significantly decreased [##REF##34155346##18##]. It suggested that GLUD1 might function as a tumor suppressor during the progression of HCC. Earlier studies have shown that GLUD1 knockdown induces apoptosis of HCC cells in vitro, and GLUD1-mediated glutaminolysis is enhanced in HCC cells under glucose deprivation [##REF##35154470##19##, ##REF##34829892##20##]. However, the effect of GLUD1 on HCC progression and its molecular mechanism is still unclear. In this study, we confirmed down-regulation of GLUD1 in tumor samples from HCC patients. Besides, we found that GLUD1 overexpression enhanced mitochondrial OXPHOS activity and content of cellular ROS. Furthermore, excess ROS lead to activation of p38/JNK signaling pathway and induced mitochondrial apoptosis of HCC cells, which could be counteracted by ROS elimination with N-acetylcysteine (NAC) treatment.</p>" ]
[ "<title>Materials and methods</title>", "<title>Human tissues</title>", "<p id=\"Par28\">Paired (<italic>n</italic> = 24) tumor and adjacent noncancerous liver tissues were acquired from HCC patients in the First Affiliated Hospital of Zhengzhou University. This research obtained approval from the Research Ethics Committee of Zhengzhou University and consent of patients.</p>", "<title>Cell culture and lentivirus transduction</title>", "<p id=\"Par29\">HCC cell lines including HepG2, Huh7, and SMMC-7721 were purchased from GeneChem Co. (Shanghai, China). SNU449 cell line was purchased from Guangzhou Cellcook Biotech Co. (Guangzhou, China). Cells were cultured in RPMI-1640 (HyClone, USA) or DMEM (Solarbio, China) medium (10% FBS) (Gibco, USA) at 37 °C and 5% CO<sub>2</sub>. Lentiviral particles of GLUD1 overexpressing or knockdown were purchased from GeneChem Co. (Shanghai, China) and infected into HCC cells. Stable cell lines were constructed by using puromycin (2 µg/mL). The sequences of GLUD1 shRNA and negative control are as follows: GLUD1 shRNA (sense: 5<sup>,</sup>-GCAGAGTTCCAAGACAGGATA-3<sup>,</sup> ); Negative control (sense: 5<sup>,</sup>-TTCTCCGAACGTGTCACGT-3<sup>,</sup> ).</p>", "<title>Protein extraction and Western blot</title>", "<p id=\"Par30\">Cells were harvested and lysed in radio immunoprecipitation assay (RIPA) buffer (Solarbio, China) supplemented with phenylmethylsulfonyl fluoride (PMSF) (a serine protease inhibitor, Solarbio, China) for 30 min. BCA kit (Solarbio, China) was used to determine the concentration of protein in the supernatant. Proteins were separated on a 10% SDS-PAGE gel and transferred to a PVDF membrane (Merck Millipore, USA), and then incubated overnight with primary antibody (4 °C) after being blocked for 2 h in nonfat milk solution (5%). The membrane was reacted with TBST-diluted HRP-conjugated secondary antibody for 2 h at room temperature. Protein bands were detected by Amersham Imager 600 System (General Electric Company, USA) using ECL Substrate (Beyotime Biotech, China), and quantified with Image J software. The primary antibodies contain anti-GAPDH (BBI, China), anti-GLUD1 (BBI, China), anti-E-cadherin (1:1000, Abcam, USA), anti-Vimentin (1:1000, Boster, China), anti-Cytochrome C (ProteinTech, USA), anti-BCL2 (ProteinTech, USA), anti-BAX (Wanleibio, China), anti-Caspase 3 (Wanleibio, China), anti-JNK (Wanleibio, China), anti-phospho-JNK (Wanleibio, China), anti-p53 (Cell Signaling Technology, USA), anti-p38 (Cell Signaling Technology, USA) and anti-phospho-p38 (Cell Signaling Technology, USA).</p>", "<title>RNA extraction and quantitative reverse transcription PCR (RT-qPCR)</title>", "<p id=\"Par31\">Cell total RNA was extracted using TRIzol reagent (Invitrogen, USA) following the manufacturer’s instructions and cDNA was synthesized by using the PrimeScript RT Reagent Kit (TaKaRa Clontech, China). The RT-qPCR was then performed by using the ChamQ<sup>™</sup> Universal SYBR<sup>®</sup> qPCR Master Mix (Vazyme Biotech, China) and QuantStudio 5 Real-Time PCR System (Thermo Scientific, USA). The mRNA expression levels were normalized to those of GAPDH and quantified by the comparative CT (2<sup>−ΔΔCT</sup>) method. The primers are synthesized by Shenggong (China) and sequences are provided as follows: <italic>GLUD1</italic> forward, 5<sup>,</sup>-GACGACCCCAACTTCTTCAAG-3<sup>,</sup>, reverse, 5<sup>,</sup>-TCCTCCACC AGCTTGTCCT-3<sup>,</sup>; Superoxide dismutase 1 (<italic>SOD1)</italic> forward, 5<sup>,</sup>-GATGACTTGGGCAAAGGTGGAAATG-3<sup>,</sup>, reverse, 5<sup>,</sup>-CCAATTACACCACAAGCCAAACGAC-3<sup>,</sup>; Superoxide dismutase 2 (<italic>SOD2)</italic> forward, 5<sup>,</sup>-CGCCCTGGAACCT CACATCAAC-3<sup>,</sup>, reverse, 5<sup>,</sup>-AACGCCTCCTGGTACTTCTCCTC-3<sup>,</sup>; Catalase (<italic>CAT)</italic> forward, 5<sup>,</sup>-CTCAGGTGCGGGCATTCTATGTG-3<sup>,</sup>, reverse, 5<sup>,</sup>-GGTGGACCTCAGTGAAGT TCTTGAC-3<sup>,</sup>; Glutathione peroxidase 1 (<italic>GPX1)</italic> forward, 5<sup>,</sup>-GCAACCAGTTTGGGCATCA GGAG-3<sup>,</sup>, reverse, 5<sup>,</sup>-CACCGTTCACCTCGCACTTCTC-3<sup>,</sup>; <italic>GAPDH</italic> forward, 5<sup>,</sup>-TCAAGAAGGTGGT GAAGCAGG-3<sup>,</sup>, reverse, 5<sup>,</sup>-TCAAAGGTGGAGGAGT GGGT − 3<sup>,</sup>.</p>", "<title>CCK8 proliferation assay</title>", "<p id=\"Par32\">Cells (3000 cells/100 µL/well) were seeded in the 96-well plate. CCK-8 reagent (10 µL/well) was added to cell culture and then incubated for 2 h at 37 °C in the dark. The absorbance (A) value at 450 nm wavelength was detected with a microplate reader (Thermo, USA) every 24 h from 0 h to 96 h.</p>", "<title>Wound-healing assay</title>", "<p id=\"Par33\">Cells (1 × 10<sup>6</sup> cells/well) were seeded in the 6-well plate. When cell density reached 95%, three parallel lines were scratched onto the confluent cell layer and washed for two times with PBS. Cells were cultured in culture medium with 2% FBS. Images of migrating cells were sequentially taken every 24 h from 0 h to 48 h. The relative wound healing region among different sample groups was evaluated and compared.</p>", "<title>Cell migration and invasion assays</title>", "<p id=\"Par34\">The migration assay was performed as follow: cells (5 × 10<sup>4</sup> cells/well) were plated and cultured in the chambers with serum-free medium in the 24-well transwell plate (Corning, USA), while the culture medium in the well contained 20% FBS. After incubation for 24 h, cells were fixed for 20 min with 10% formalin. Then the chambers were washed with PBS and stained with crystal violet at room temperature for 20 min. Cell numbers in the chambers were analyzed with a microscope (magnification, x200; Olympus BX53, Japan). For invasion assay, Matrigel (BD Biosciences, USA) was diluted in serum-free medium (1:6) and added to the upper chamber before cells were seeded.</p>", "<title>Xenograft mice model</title>", "<p id=\"Par35\">Animal experiments were performed according to the guidelines of the National Act on the Use of Laboratory Animals (P. R. China), and the procedures were approved by the Animal Ethics Committee of Zhengzhou University. 4 weeks old female nude mice were purchased from the Beijing Charles River Laboratory Technology Co. and upraised under SPF condition. Approximately 8 × 10<sup>6</sup> SMMC-7721 or Huh7 cells were suspended in 100 µL PBS and inoculated subcutaneously into nude mice. Mice were sacrificed by cervical dislocation method 20 days after injection. Tumors in the mice were isolated, weighed, and photographed. Tumor volumes were evaluated with the formula: V = (width<sup>2</sup> × length)/2. The tumor size did not exceed the permitted maximal volume of 1000 mm<sup>3</sup>.</p>", "<title>Immunohistochemistry (IHC) staining</title>", "<p id=\"Par36\">Briefly, resected tumor tissue was dehydrated and embedded in paraffin. They were then thermally deparaffinized in EDTA buffer and blocked with 3% BSA. Tissue samples were incubated with anti-GLUD1 antibody overnight at 4 °C followed by secondary antibody at room temperature.</p>", "<title>Untargeted metabolomics</title>", "<p id=\"Par37\">The cell samples were collected and grinded in tubes, then a mixture of methanol: water (4:1, v/v) solution (400 µL) was used to collect the metabolites. The mixture was first grinded for 6 min at −10 °C, 50 Hz, and then sonicated for 30 min 5 °C, 40 kHz. Later samples were centrifuged for 15 min at 4 °C, 13,000 g after incubation for 30 min at −20 °C. The quality control (QC) sample contains a mixture of 20 µL supernatant of each sample. The metabolites were analyzed using the UHPLC-Q Exactive HF-X system (Thermo, USA). It was repeated for 7 times with GLUD1 overexpressing and control SNU449 cells, respectively. The experimental process was carried out by Shanghai Majorbio Bio-pharm Technology Co.</p>", "<title>Detection of ROS content</title>", "<p id=\"Par38\">Cells (1 × 10<sup>5</sup> cells/well) were planted in the 12-well plate. 10 µM H<sub>2</sub>DCFDA or DHE probe was added to cells and cultured for 30 min at 37 °C in the dark. The fluorescence in cells was detected with Eclipse TS100 microscope (Nikon, Japan) and Image J software after being washed with PBS. For the detection of ROS content after NAC treatment, cells were incubated with NAC dilution (10 mM) for 36 h before DHE probe treatment.</p>", "<title>Oxygen consumption rate (OCR) measurement</title>", "<p id=\"Par39\">Cells were seeded into a 96-well plate (8 × 10<sup>4</sup>/100 µL/well) and then cultured at 37 °C with 5% CO<sub>2</sub> for overnight. Next day, the culture medium was discarded and cells were washed with PBS. Then the probe (BBoxiProbe<sup>TM</sup> R01, BestBio, China) diluted with fresh medium and the oxygen barrier solution were sequentially added to the 96-well plate chamber at 37 °C, and the fluorescence intensity at the excitation wavelength of 468 nm was detected by the CLARIOstar Plus (BMG, Germany).</p>", "<title>Cell apoptosis rate detection</title>", "<p id=\"Par40\">Cells were digested, collected and pelleted at 1200 rpm for 4 min, and then washed twice with cold PBS. Cell apoptosis rate was detected by Annexin V-APC/7-AAD apoptosis Detection Kit (KeyGEN; China). Briefly, cells were suspended with 100 µL binding buffer, and then 7-AAD and Annexin V-APC (5 µL) was added and cells were incubated at room temperature for 10 min in darkness. Later cell apoptosis rates were analyzed on ACEA NovoCyte3130 within 1 h.</p>", "<title>Statistical analysis</title>", "<p id=\"Par41\">All statistical analyses were performed with GraphPad Prism 7.0. Data are shown as mean ± standard deviation (SD). Student<sup>,</sup>s t-test was used for the statistical analysis of different groups, and the <italic>p</italic> &lt; 0.05 was considered as statistically significant.</p>" ]
[ "<title>Results</title>", "<title>GLUD1 is down-regulated in tumor tissues of HCC patients</title>", "<p id=\"Par42\">To explore the role of GLUD1 in regulating HCC progression, GLUD1 expression analysis was firstly performed with clinical HCC samples from the (The Cancer Genome Atlas) TCGA and (The Clinical Proteomic Tumor Analysis Consortium) CPTAC databases. As shown in Fig. ##FIG##0##1##A, B, both the mRNA and protein expression levels of GLUD1 were reduced in HCC tumor tissues compared to the normal liver tissues. Additionally, we collected another twenty-four pairs of tissue samples from HCC patients and detected the protein level of GLUD1. Results in Fig. ##FIG##0##1##C, D showed that compared to normal liver tissues, the protein level of GLUD1 was significantly reduced in tumor tissues. Moreover, higher expression level of <italic>GLUD1</italic> was associated with longer overall survivals (OS) and progression-free survivals of HCC patients based on Kaplan meier plotter database (Fig. ##FIG##0##1##E, F). Taken together, these results showed that GLUD1 was down-regulated in tumor tissues, and the high expression level of GLUD1 indicated good prognosis for HCC patients.</p>", "<p id=\"Par43\">\n</p>", "<title>GLUD1 overexpression inhibits tumorigenesis of HCC cells both in vitro and in vivo</title>", "<p id=\"Par44\">Next, we investigated the biological function of GLUD1 on HCC development both in vitro and in vivo. We detected the expression levels of GLUD1 in HCC cell lines including SNU449, SMMC-7721, Huh7, and HepG2. Results showed that the expression levels of GLUD1 in Huh7 and HepG2 cells were higher than those in SNU449 and SMMC-7721 cells (Fig. ##SUPPL##0##S1##A). Thus, GLUD1 was overexpressed in SNU449 and SMMC-7721 cells by lentiviral transfection, which was confirmed with western blot and RT-qPCR analysis (Fig. ##FIG##1##2##A, Fig. ##SUPPL##0##S1##B). CCK8 assay showed that GLUD1 overexpression significantly decreased the proliferation rate of HCC cells (Fig. ##FIG##1##2##B, C). Besides, GLUD1 overexpression inhibited wound closure, migration and invasion of HCC cells (Fig. ##FIG##1##2##D-G). E-cadherin and vimentin are two pivotal factors in regulating tumor cells migration and invasion. Results in Fig. ##FIG##1##2##H showed that E-cadherin was up-regulated while vimentin was down-regulated in GLUD1 overexpressing cells. Collectively, these results demonstrate that GLUD1 overexpression inhibits tumorigenesis of HCC cells in vitro.</p>", "<p id=\"Par45\">\n</p>", "<p id=\"Par46\">Additionally, we investigated the influence of GLUD1 on HCC tumor growth in vivo. The xenograft mice model was generated by subcutaneous injection of SMMC-7721 cells overexpressing GLUD1 or control vectors into the flank of nude mice. About twenty days later, mice were sacrificed and the tumors were collected for analysis (Fig. ##FIG##1##2##I). Both the volume and weight of tumors with GLUD1 overexpression were significantly decreased, compared to those of the control group (Fig. ##FIG##1##2##J and K). Besides, IHC analysis showed that GLUD1 overexpression was maintained in the xenografts (Fig. ##FIG##1##2##L). Moreover, Ki-67 was down-regulated in xenografts with GLUD1 overexpression, which suggested the proliferation ability of HCC cells in vivo was decreased. In summary, these findings demonstrate that GLUD1 acts as an inhibitor in HCC progression.</p>", "<title>GLUD1 knockdown enhances HCC cell proliferation and metastasis abilities</title>", "<p id=\"Par47\">To further confirm the inhibitory function of GLUD1 in HCC progression, we constructed GLUD1 knocking-down and control cell lines with Huh7 and HepG2 cells by using lentiviral targeting GLUD1 (shRNA) and control vector. Knockdown of GLUD1 was confirmed by RT-qPCR and western blot analysis (Fig. ##FIG##2##3##A, Fig. ##SUPPL##0##S1##C). Then we detected the cell viability using CCK8 and found that knockdown of GLUD1 significantly increased proliferation ability of cells (Fig. ##FIG##2##3##B, C). In addition, GLUD1 knockdown enhanced wound healing, migration and invasion abilities of HCC cells (Fig. ##FIG##2##3##D-G), which was consistent with the results that E-cadherin was down-regulated while vimentin was up-regulated in GLUD1 knockdown cells (Fig. ##FIG##2##3##H). These results suggest that knockdown of GLUD1 enhances the proliferation, mobility and invasion capabilities of HCC cells in vitro.</p>", "<p id=\"Par48\">\n</p>", "<p id=\"Par49\">Next, we established the xenograft mice model and Huh7 cells with GLUD1 knockdown or control vector were implanted subcutaneously into nude mice. Twenty days later, mice were sacrificed and the tumors were collected for analysis (Fig. ##FIG##2##3##I). Results in Fig. ##FIG##2##3##J and K showed that the volumes and weights of xenografts from GLUD1 knockdown group were larger and higher than those of control group. Additionally, IHC analysis showed that GLUD1 knockdown was maintained in the xenografts where Ki-67 was overexpressed (Fig. ##FIG##2##3##L). Taken together, these results prove that GLUD1 is a tumor-suppressor and down-regulation of GLUD1 promoted HCC proliferation and metastasis both in vitro and in vivo.</p>", "<title>GLUD1 regulates the metabolism function of HCC cells</title>", "<p id=\"Par50\">GLUD1 is a key mitochondrial enzyme regulating glutamine metabolism. To further investigate the molecular mechanism of GLUD1 affecting HCC development, non-targeted metabolomics study was performed with GLUD1 overexpressing and control SNU449 cells. Notably, the result of Principle component analysis (PCA) showed clear separation between GLUD1 overexpressing and control cells, which indicated marked metabolic differences induced by GLUD1 overexpression (Fig. ##FIG##3##4##A, Fig. ##SUPPL##0##S2##). Accordingly, metabolomics results showed that a total number of 408 metabolites were detected both in GLUD1 overexpression and control HCC cells. About 129 metabolites were identified with significant differences (VIP ≥ 1, <italic>p</italic> &lt; 0.05), among which 49 metabolites were down-regulated and 80 metabolites were up-regulated in GLUD1 overexpressing HCC cells (Fig. ##FIG##3##4##B and C, Table ##SUPPL##1##S1##). Based on the Human Metabolome Database (HMDB) analysis, the differentially expressed metabolites were mainly enriched into four clusters including organic acids and derivatives (31.03%), lipids and lipid-like molecules (27.59%), organoheterocyclic compounds (16.09%), nucleosides, nucleotides, and analogues (10.34%) (Fig. ##FIG##3##4##D). Moreover, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of compounds classification showed that differentially expressed metabolites mainly included amino acids, bases, and phospholipids (Fig. ##SUPPL##0##S3##). To better investigate the metabolic alterations in GLUD1 overexpressing cells, KEGG pathway enrichment analysis was performed. As shown in Fig. ##FIG##3##4##E, the differentially expressed metabolites were highly associated with purine metabolism, pyrimidine metabolism, ABC transporters, and another 17 metabolic pathways.</p>", "<p id=\"Par51\">\n</p>", "<title>GLUD1 enhances the OXPHOS function and aggravates oxidative stress in HCC cells</title>", "<p id=\"Par52\">Specially, we found that a certain content of differentially expressed metabolites were clustered into mitochondrial OXPHOS process. In Fig. ##FIG##4##5##A, the overall analysis of the OXPHOS pathway by KEGG website (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.kegg.jp\">https://www.kegg.jp</ext-link>) showed that the contents of NADH, NAD<sup>+</sup> and PPi in GLUD1 overexpressing cells were significantly changed compared with the control cells. Besides, the differential metabolites involved in OXPHOS pathway were mainly produced by mitochondrial complexes I and V. Mitochondrial OXPHOS is an efficient metabolic process which provides most energy for cell growth [##REF##32397535##21##]. To further verify the effect of GLUD1 on OXPHOS in HCC cells, we determined oxygen consumption by measurement of OCR. Results in Fig. ##FIG##4##5##B-E showed that the OCR was increased in GLUD1 overexpressing cells while decreased in GLUD1 knockdown cells. In summary, our findings demonstrate that GLUD1 has an effect on the metabolism of amino acid, fatty acid, and nucleoside, and enhances OXPHOS function of HCC cells.</p>", "<p id=\"Par53\">\n</p>", "<p id=\"Par54\">Mitochondrial OXPHOS is the main source of ROS production, which induces oxidative stress and participates in cancer progression. To evaluate whether GLUD1 affects the state of oxidative stress, we detected cellular ROS content and found that GLUD1 overexpression increased ROS content while GLUD1 knockdown decreased ROS content in HCC cells (Fig. ##FIG##4##5##F, G). Moreover, the expression levels of antioxidants including <italic>SOD1</italic>, <italic>SOD2</italic>, <italic>CAT</italic>, and <italic>GPX1</italic> were measured by RT-qPCR. Results in Fig. ##FIG##4##5##H, I showed that the transcription levels of these antioxidants in GLUD1 overexpressing cells were decreased, which further confirmed increased oxidative stress with GLUD1 overexpression. Besides, we found that GLUD1 knockdown significantly increased the transcription levels of antioxidants, compared with the control cells (Fig. ##FIG##4##5##J, K). These findings demonstrated that GLUD1 plays an important role in regulation of oxidative stress by affecting ROS generation and antioxidants expression in HCC cells.</p>", "<title>GLUD1 induces mitochondrial apoptosis of HCC cells via ROS</title>", "<p id=\"Par55\"> Studies have shown that oxidative stress caused by excessive ROS production in tumor cells promotes apoptosis through mitochondrial apoptosis pathway [##REF##35213291##22##]. Then we detected the apoptosis ability of GLUD1 overexpressing and control HCC cells. Results in Fig. ##FIG##5##6##A and B showed that GLUD1 overexpression increased the apoptosis percent of HCC cells, compared with control cells. Furthermore, western blot was used to detect the expression levels of mitochondrial apoptosis-related proteins. The results in Fig. ##FIG##5##6##C presented that GLUD1 overexpression increased the expression levels of the pro-apoptotic proteins including p53, Cytochrome C, Bax and Caspase 3, and decreased the expression level of the anti-apoptotic protein Bcl-2. Besides, compared with the control cells, knockdown of GLUD1 in HCC cells significantly inhibited expression of pro-apoptotic proteins such as p53, Cytochrome C, Bax and Caspase 3, and promoted expression of anti-apoptotic protein Bcl-2 (Fig. ##FIG##5##6##D). Collectively, these results suggest that GLUD1 overexpression activates the mitochondrial apoptotic pathway in HCC cells.</p>", "<p id=\"Par56\">\n</p>", "<p id=\"Par57\">To further confirm the function of ROS in inducing mitochondrial apoptosis of HCC cells, we treated GLUD1 overexpressing cells with NAC, which is a ROS scavenger, and examined its effect on mitochondrial apoptosis abilities of HCC cells. As shown in Fig. ##FIG##5##6##E, NAC treatment markedly decreased ROS content in GLUD1 overexpressing cells. In addition, we detected the expression levels of key factors involved in mitochondrial apoptosis process. Results in Fig. ##FIG##5##6##F showed that the expression levels of pro-apoptosis proteins including p53, Cytochrome C, Bax and Caspase 3 were decreased, while the expression level of anti-apoptosis protein Bcl-2 was up-regulated after NAC treatment in GLUD1 overexpressing cells. It indicates that mitochondrial apoptosis of HCC cells induced by GLUD1 overexpression was rescued by ROS elimination.</p>", "<title>ROS activates p38/JNK MAPK signaling pathway in GLUD1 overexpressing HCC cells</title>", "<p id=\"Par58\"> Earlier studies found that ROS-induced apoptosis was related to the activation of p38/JNK MAPK signaling pathway in tumor tissues including HCC [##REF##30466984##23##, ##UREF##0##24##]. Then we detected the expression levels of p38/JNK MAPK signaling pathway-related proteins. Results in Fig. ##FIG##6##7##A and B showed that there were no significant differences in protein expression levels of p38 and JNK whether GLUD1 was overexpressed or knockdown. However, both the phosphorylation levels of p38 and JNK were increased in GLUD1 overexpressing cells, while GLUD1 knockdown inhibited the phosphorylation of p38 and JNK. These results demonstrate that overexpression of GLUD1 can activate the p38/JNK MAPK signaling pathway in HCC cells. Moreover, we detected the phosphorylation levels of p38 and JNK in GLUD1 overexpressing HCC cells after NAC treatment. Results in Fig. ##FIG##6##7##C showed that NAC treatment reduced the expression levels of phosphorylated p38 and JNK in GLUD1 overexpressing HCC cells. In conclusion, our findings demonstrate that GLUD1 overexpression promotes excess ROS generation and oxidative stress, which activates p38/JNK pathway and induces mitochondrial apoptosis of HCC cells.</p>", "<p id=\"Par59\">\n</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par60\">GLUD1 functions in glutamine metabolism progress and provides <italic>α</italic>-KG for tricarboxylic acid (TCA) cycle, which is the central metabolic link which connects glucose, fatty acids, and amino acid metabolism [##REF##28208702##25##]. Reports showed that dysregulation of both the expression level and activity of GLUD1 affected <italic>α</italic>-KG generation, and then regulated tumor cells proliferation and metastasis through affecting cellular metabolism [##REF##25670081##26##]. Here we performed untargeted metabolomics study of GLUD1 overexpressing and control HCC cells and found that GLUD1 overexpression had an influence on cellular metabolism mainly including amino acid, fatty acid, and nucleoside metabolism pathways. These data suggest that GLUD1 participates in HCC progression through regulating cellular metabolism. Moreover, KEGG pathway enrichment showed that mitochondrial OXPHOS was one of the main metabolic pathways where differentially expressed metabolites were enriched in. Enhancement of OXPHOS capacity often leads to increased ROS content, which usually accompanies by decreased expression levels of antioxidant genes and aggravates the oxidative stress state of cancer tissues [##REF##32498250##27##]. Here we found that GLUD1 overexpression not only enhanced mitochondrial OXPHOS function and ROS content, but also decreased the expression levels of antioxidant genes including <italic>SOD1</italic>, <italic>SOD2</italic>, <italic>CAT,</italic> and <italic>GPX1</italic> in HCC cells. These findings suggest that GLUD1 contributes to the cellular redox balance in HCC tissues, and GLUD1 overexpression aggravates oxidative stress state through enhancing OXPHOS activity and ROS content.</p>", "<p id=\"Par61\">Usually, slightly higher levels of ROS act as signaling molecules and promote cancer development [##REF##33922139##28##]. However, when excessive ROS are produced, they promote cell apoptosis and finally inhibit cancer cells proliferation and growth [##REF##31138775##29##]. Here we found that Cytochrome C and Bax were up-regulated while Bcl-2 was down-regulated in GLUD1 overexpressing cells. The release of mitochondrial Cytochrome C is a critical step in mitochondrial apoptosis pathway as it is essential for the aggregation of adaptor molecule Apaf1 [##REF##9219694##30##]. Besides, Bcl-2 family members including Bax form ion channels that allow the excretion of Cytochrome C, and induce sustained activation of caspase family proteins that are necessary for mitochondrial apoptosis [##REF##22824464##31##]. Thus, our findings demonstrate that GLUD1 overexpression promotes mitochondrial apoptosis of HCC cells. It has been demonstrated in many kinds of cancers that inducing ROS production could induce cells apoptosis and prevent cancer cell proliferation and metastasis. Some ROS-promoting drugs showed inhibitory effect on HCC cells proliferation and tumor growth, which are expected to be candidates for clinical treatment of HCC, such as sorafenib, paclitaxel, curcumin, 5-fluorouracil, and so on [##REF##36916054##32##–##REF##35101590##35##]. Therefore, ROS content enhancement of cancer cells is an important and promising strategy for clinical treatment of HCC.</p>", "<p id=\"Par62\">MAPKs signaling pathway consists of a serious of serine-threonine protein kinases, and participates in cell apoptosis and proliferation processes [##REF##27807471##36##]. ERK, p38, and JNK are the main components of MAPKs signaling pathway, and it was reported that activation of MAPKs signaling pathway was closely related to mitochondrial apoptosis of HCC cells [##REF##33488943##37##]. In this study, we found that GLUD1 overexpression promotes HCC cells apoptosis through ROS induced MAPKs signaling pathway activation. In recent years, studies on the activation of p38/JNK MAPK signaling pathway and the induction of tumor cell apoptosis have been confirmed and explored in liver cancer, lung cancer, pancreatic cancer, colorectal cancer, and so on [##REF##33931585##38##–##REF##36978904##40##]. MAPKs signaling pathway are taken as promising targets for cancer therapy, and some compounds that act as activators of MAPKs signaling pathway exhibit inhibitory effects on cancer progression through inducing mitochondrial apoptosis of cancer cells [##REF##28190473##41##, ##REF##30698296##42##]. Our findings verify the activation of MAPKs signaling pathway in inhibiting HCC progression and provide optional strategy for clinical HCC treatment. Besides, researches showed that MAPKs signaling pathway impacts the response of cancer cells to clinical therapy and is associated with drug resistance [##REF##32046099##43##], which not only highlights the importance of MAPKs signaling pathway in cancer progression, but also indicates the influence of MAPKs signaling pathway on HCC treatment.</p>", "<p id=\"Par63\"> In conclusion, our study demonstrates that GLUD1 is down-regulated in tumor tissues of HCC patients and inhibits HCC progression both in vitro and in vivo. GLUD1 overexpression affects cellular metabolism and OXPHOS capacity which induces excess ROS generation and oxidative stress in HCC cells. Furthermore, p38/JNK MAPK signaling pathway is activated by ROS and induces mitochondrial apoptosis in GLUD1 overexpressing cells (Fig. ##FIG##7##8##). These findings provide GLUD1 as a promising biomarker for HCC prognosis, and suggest that ROS generation and MAPKs signaling pathway activation could be taken as candidate targets for HCC treatment.</p>", "<p id=\"Par64\">\n</p>" ]
[]
[ "<p id=\"Par1\">Glutamate dehydrogenase 1 (GLUD1) is an important enzyme in glutamine metabolism. Previously, we found GLUD1 was down-regulated in tumor tissues of hepatocellular carcinoma (HCC) patients by proteomics study. To explore its role in the progression of HCC, the expressional level of GLUD1 was firstly examined and presented as that both the protein and mRNA levels were down-regulated in tumor tissues compared to the normal liver tissues. GLUD1 overexpression significantly inhibited HCC cells proliferation, migration, invasion and tumor growth both in vitro and in vivo, while GLUD1 knocking-down promoted HCC progression. Metabolomics study of GLUD1 overexpressing and control HCC cells showed that 129 differentially expressed metabolites were identified, which mainly included amino acids, bases, and phospholipids. Moreover, metabolites in mitochondrial oxidative phosphorylation system (OXPHOS) were differentially expressed in GLUD1 overexpressing cells. Mechanistic studies showed that GLUD1 overexpression enhanced mitochondrial respiration activity and reactive oxygen species (ROS) production. Excessive ROS lead to mitochondrial apoptosis that was characterized by increased expression levels of p53, Cytochrome C, Bax, Caspase 3 and decreased expression level of Bcl-2. Furthermore, we found that the p38/JNK MAPK pathway was activated in GLUD1 overexpressing cells. N-acetylcysteine (NAC) treatment eliminated cellular ROS and blocked p38/JNK MAPK pathway activation, as well as cell apoptosis induced by GLUD1 overexpression. Taken together, our findings suggest that GLUD1 inhibits HCC progression through regulating cellular metabolism and oxidative stress state, and provide that ROS generation and p38/JNK MAPK pathway activation as promising methods for HCC treatment.</p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s12672-024-00860-1.</p>", "<title>Keywords</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Acknowledgements</title>", "<p>We appreciate the continuous support of Henan Key Laboratory for Pharmacology of Liver Diseases where most of the experiments were performed.</p>", "<title>Author contributions</title>", "<p>JTZ and QWZ designed the study. MDY and JXL performed the experiments. YYG, ZXW, and KFH analyzed data. FX, YXL, and LLL helped in metabolomics detection and data analysis. YZ collected tissue samples. DDW cultured HCC cell lines. QWZ wrote the manuscript. JS revised the manuscript. All authors reviewed the manuscript. All authors have read and approved the final manuscript. QWZ and MDY contributed equally to this work.</p>", "<title>Funding</title>", "<p>This work was supported by the Natural Science Foundation of Henan (No. 222300420306), the Key Scientific and Technological Project of Henan Province (No. 222102310083, No. 212102310124), and the Project of Basic Research Fund of Henan Institute of Medical and Pharmacological Sciences (2023BP0206).</p>", "<title>Data availability</title>", "<p>The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.</p>", "<title>Declarations</title>", "<title>Competing interests</title>", "<p id=\"Par65\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>GLUD1 is down-regulated in HCC tumor tissues. <bold>A</bold> and <bold>B</bold> Analysis of GLUD1 transcription and protein levels based on the TCGA and CPTAC databases. <bold>C</bold> Detection of GLUD1 protein level in tumor and normal liver tissues by western blot. <bold>D</bold> Statistical analysis of GLUD1 relative expression level in paired samples from HCC patients (<italic>n</italic> = 24). <bold>E</bold> and <bold>F</bold> The relationship between GLUD1 expression level and OS or progression-free survival of HCC patients analyzed by the Kaplan-Meier survival curve. <italic>TCGA</italic> The Cancer Genome Atlas, <italic>CPTAC</italic> The Clinical Proteomic Tumor Analysis Consortium, <italic>OS</italic> Overall survivals. T represents tumor tissue, N represents normal liver tissue. <sup>**</sup><italic>p</italic> &lt; 0.01</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>GLUD1 overexpression inhibits HCC cell proliferation, migration and invasion. <bold>A</bold> Western blot analysis of GLUD1 in GLUD1 overexpressing and control HCC cells. <bold>B</bold> and <bold>C</bold> CCK8 assay to detect the proliferation ability of GLUD1 overexpressing and control HCC cells. <bold>D</bold> and <bold>E</bold> wound healing (scale bars, 2 mm), <bold>F</bold> and <bold>G</bold> migration and invasion assays (scale bars, 400 μm) of GLUD1 overexpressing and control HCC cells. <bold>H</bold> Western blot analysis of E-cadherin and vimentin in GLUD1 overexpressing and control HCC cells. <bold>I</bold> Representative image, <bold>J</bold> and <bold>K</bold> Volume and weight of xenografts with GLUD1 overexpression or control HCC cell. <bold>L</bold> IHC staining of GLUD1 and Ki-67 in xenografts (scale bars, 100 μm). GLUD1-OE represents GLUD1 overexpressing HCC cell line, LV-NC represents control HCC cell line. <sup>*</sup><italic>p</italic> &lt; 0.05, <sup>**</sup><italic>p</italic> &lt; 0.01, <sup>***</sup><italic>p</italic> &lt; 0.001</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p>GLUD1 knockdown promotes HCC cell proliferation, migration and invasion. <bold>A</bold> Western blot analysis of GLUD1 in GLUD1 knockdown and control HCC cells. <bold>B</bold> and <bold>C</bold> CCK8 assay to detect the proliferation ability of GLUD1 knockdown and control HCC cells. <bold>D</bold> and <bold>E</bold> Wound healing (scale bars, 2 mm), <bold>F</bold> and <bold>G</bold> migration and invasion assays (scale bars, 400 μm) of GLUD1 knockdown and control HCC cells. <bold>H</bold> Western blot analysis of E-cadherin and vimentin in GLUD1 knockdown and control HCC cells. <bold>I</bold> Representative image, <bold>J</bold> and <bold>K</bold> Volume and weight of xenografts with GLUD1 knockdown or control HCC cells. <bold>L</bold> IHC staining of GLUD1 and Ki-67 in xenografts (scale bars, 100 μm). GLUD1-sh represents GLUD1 knockdown HCC cell line, sh-NC represents control HCC cell line. <sup>**</sup><italic>p</italic> &lt; 0.01, <sup>***</sup><italic>p</italic> &lt; 0.001</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p>GLUD1 regulates cellular metabolism in HCC cells. <bold>A</bold> PCA of peak areas detected in positive-ion modes in QC, GLUD1 overexpressing SNU449 cells, and control SNU449 cells (<italic>n</italic> = 7). <bold>B</bold> Volcano plot of differentially expressed metabolites in GLUD1 overexpressing and control SNU449 cells (VIP ≥ 1, <italic>p</italic> &lt; 0.05). <bold>C</bold> Heatmap of cluster analysis of differentially expressed metabolites. <bold>D</bold> Cluster analysis of differentially expressed metabolites by HMDB. <bold>E</bold> Enriched KEGG pathway (Top 20) of differentially expressed metabolites. <italic>PCA</italic> Principle component analysis, <italic>QC</italic> quality control, <italic>HMDB</italic> Human Metabolome Database, <italic>KEGG</italic> Kyoto Encyclopedia of Genes and Genomes. GLUD1-OE represents GLUD1 overexpressing HCC cell line, LV-NC represents control HCC cell line</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><p>GLUD1 overexpression enhances OXPHOS activity and oxidative stress in HCC cells. <bold>A</bold> Schematic diagram of the OXPHOS process (substances marked in red represent the annotated differentially expressed metabolites). <bold>B</bold>, <bold>C</bold>, <bold>D</bold>, and <bold>E</bold> Detection of OCR in GLUD1 overexpression or knockdown HCC cells. <bold>F</bold> and <bold>G</bold> ROS content detection of HCC cells in GLUD1 overexpression (red fluorophores) or knockdown (green fluorophores) HCC cells. Scale bars, 200 μm. <bold>H</bold>, <bold>I</bold>, <bold>J</bold> and <bold>K</bold> The expression levels of antioxidant genes in GLUD1 overexpression or knockdown HCC cells were detected by RT-qPCR. GLUD1-OE represents GLUD1 overexpressing HCC cell line, LV-NC represents control HCC cell line, GLUD1-sh represents GLUD1 knockdown HCC cell line, sh-NC represents control HCC cell line. <sup>*</sup><italic>p</italic> &lt; 0.05, <sup>**</sup><italic>p</italic> &lt; 0.01, <sup>***</sup><italic>p</italic> &lt; 0.001</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><p>GLUD1 overexpression promotes HCC cells apoptosis via ROS. <bold>A</bold> and <bold>B</bold> Cell apoptosis rates detection of GLUD1 overexpressing and control cells. <bold>C</bold> and <bold>D</bold> Expression levels detection of p53, Cytochrome C, Bax, Caspase 3, and Bcl-2 by western blot in GLUD1 overexpression or knockdown HCC cells. <bold>E</bold> Detection of ROS content in GLUD1 overexpressing HCC cells after treatment with NAC. Scale bars, 200 μm. <bold>F</bold> Expression levels detection of p53, Cytochrome C, Bax, Caspase 3, and Bcl-2 by western blot in GLUD1 overexpressing HCC cells after treatment with NAC. GLUD1-OE represents GLUD1 overexpressing HCC cell line, LV-NC represents control HCC cell line, GLUD1-sh represents GLUD1 knockdown HCC cell line, sh-NC represents control HCC cell line. NAC: N-acetylcysteine. <sup>*</sup><italic>p</italic> &lt; 0.05, <sup>**</sup><italic>p</italic> &lt; 0.01, <sup>***</sup><italic>p</italic> &lt; 0.001</p></caption></fig>", "<fig id=\"Fig7\"><label>Fig. 7</label><caption><p>GLUD1 overexpression activates p38/JNK MAPK signaling pathway which is counteracted by NAC treatment. <bold>A</bold> and <bold>B</bold> Expression levels detection of p38, JNK, p-p38, and p-JNK by western blot in GLUD1 overexpression or knockdown HCC cells. <bold>C</bold> Expression levels detection of p38, JNK, p-p38, and p-JNK by western blot in GLUD1 overexpressing HCC cells after treatment with NAC. GLUD1-OE represents GLUD1 overexpressing HCC cell line, LV-NC represents control HCC cell line, GLUD1-sh represents GLUD1 knockdown HCC cell line, sh-NC represents control HCC cell line. NAC: N-acetylcysteine. <sup>*</sup><italic>p</italic> &lt; 0.05, <sup>***</sup><italic>p</italic> &lt; 0.001</p></caption></fig>", "<fig id=\"Fig8\"><label>Fig. 8</label><caption><p>Schematic model of GLUD1 in promoting the p38/JNK MAPK signaling pathway activation and HCC cell apoptosis via enhanced mitochondrial OXPHOS capacity and ROS generation</p></caption></fig>" ]
[]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"12672_2024_860_Fig1_HTML\" id=\"d32e706\"/>", "<graphic xlink:href=\"12672_2024_860_Fig2_HTML\" id=\"d32e789\"/>", "<graphic xlink:href=\"12672_2024_860_Fig3_HTML\" id=\"d32e875\"/>", "<graphic xlink:href=\"12672_2024_860_Fig4_HTML\" id=\"d32e959\"/>", "<graphic xlink:href=\"12672_2024_860_Fig5_HTML\" id=\"d32e1035\"/>", "<graphic xlink:href=\"12672_2024_860_Fig6_HTML\" id=\"d32e1116\"/>", "<graphic xlink:href=\"12672_2024_860_Fig7_HTML\" id=\"d32e1168\"/>", "<graphic xlink:href=\"12672_2024_860_Fig8_HTML\" id=\"d32e1259\"/>" ]
[ "<media xlink:href=\"12672_2024_860_MOESM1_ESM.docx\"><caption><p>Supplementary material 1 </p></caption></media>", "<media xlink:href=\"12672_2024_860_MOESM2_ESM.csv\"><caption><p>Supplementary material 2 </p></caption></media>" ]
[{"label": ["24."], "mixed-citation": ["Chang WT, Bow YD, Fu PJ, Li CY, Wu CY, Chang YH et al. A marine terpenoid, heteronemin, induces both the apoptosis and ferroptosis of hepatocellular carcinoma cells and involves the ROS and MAPK pathways. Oxid Med Cell Longev. 2021. 10.1155/2021/7689045"]}]
{ "acronym": [ "GLUD1", "HCC", "TCA", "OXPHOS", "ROS", "NAC", "α-KG", "HH", "OS", "TCGA", "CPTAC", "RT-qPCR", "PCA", "HMDB", "IHC", "KEGG", "OCR", "SOD1", "SOD2", "CAT", "GPX1", "QC" ], "definition": [ "Glutamate dehydrogenase 1", "Hepatocellular carcinoma", "Tricarboxylic acid", "Oxidative phosphorylation system", "Reactive oxygen species", "N-acetylcysteine", "α-ketoglutarate", "Hyperinsulinemic hypoglycemia", "Overall survivals", "The Cancer Genome Atlas", "The Clinical Proteomic Tumor Analysis Consortium", "Quantitative reverse transcription PCR", "Principle component analysis", "Human Metabolome database", "Immunohistochemistry", "Kyoto encyclopedia of genes and genomes", "Oxygen consumption rate", "Superoxide dismutase 1", "Superoxide dismutase 2", "Catalase", "Glutathione peroxidase 1", "Quality control" ] }
43
CC BY
no
2024-01-14 23:40:14
Discov Oncol. 2024 Jan 12; 15:8
oa_package/d4/41/PMC10786780.tar.gz
PMC10786789
0
[ "<title>Introduction</title>", "<p id=\"Par2\">One of the widely used thymidylate synthase inhibitors is 5-fluorouracil (5-FU) which is included in different regimens of cancer treatment such as colorectal cancer, squamous cell carcinoma and renal cell carcinoma. Unfortunately, 5-FU is considered as the second most commonly used cardiotoxic drug leading to myocardial ischemia, infarction, arrhythmias, myocarditis and heart failure or even death. Different pathways mediate 5-FU cardiotoxicity such as oxidative stress accompanied with release of reactive-oxygen-species-(ROS) [##REF##35126817##1##, ##REF##33954114##2##]. However, cardiac tissue has a minimal ability to act against their harmful effects because of low level of antioxidant enzymes. Furthermore, 5-FU causes direct cardiac damage and increases the rate of oxygen consumption. This occurs due to mitochondrial uncoupling, injury of the endothelium with depletion of endothelial nitric oxide synthase leading to vasospasm then ischemic injury [##REF##33954114##2##–##REF##32266582##4##].</p>", "<p id=\"Par3\">The early response of the cardiac tissue to oxidative injury is the activation of tumor necrosis factor alpha (TNFα) and nuclear factor-κB (NF-κB) followed by stimulation of toll like receptors (TLR) that induce apoptosis and cell death upon activation of several caspases [##REF##33954114##2##, ##UREF##0##5##]. In addition, TLRs control several pathways in innate immunity and stimulation of these receptors could increase the gene expression of other inflammatory mediators as myeloid differentiation factor 88 (MYD88) signaling cascade [##REF##31707054##6##, ##REF##34800596##7##]. Moreover, NF-κB has an ability to activate macrophages including (M1) and (M2). M1 produces the pro-inflammatory cytokines, such as IL-1 and TNF-α. In contrast, M2 releases the anti-inflammatory ones including IL-10 and IL-13 [##UREF##0##5##]. There is an evidence suggests that MyD88/TLR pathway is a crucial factor for M1 macrophage polarization and enhancing the expression of pro-inflammatory cytokines [##UREF##0##5##, ##REF##32104151##8##]. Release of interleukins and the family-related proteins is a key factor in mediating cardiotoxic injury of anticancer drugs including IL1β, IL6. Thus, controlling the production of these agents represents an essential strategy in treatment of 5-FU-induced heart damage [##REF##34185243##3##]. Furthermore, SGLT are widely distributed in the myocardium and upregulation of them leads to cardiac remodeling, hypertrophy, induce different inflammatory pathways and fibrogenesis so that modulation of these recptors is a critical target to rescue the myocardium [##REF##34343274##9##].</p>", "<p id=\"Par4\">Sodium glucose co-transporter inhibitors (SGLTI) including empagliflozin (EMP) are efficacious oral anti-diabetic drugs. The beneficial role of this drug group is based on decreasing blood glucose level and preventing renal tubular glucose reabsorption in the proximal-convoluted-tubules [##REF##34089496##10##, ##UREF##1##11##]. Furthermore, it diminishes the inflammatory cytokines with an ability to scavenge reactive oxygen and nitrogen species and decrease cardiac inflammation [##REF##33388277##12##–##REF##35934058##14##], control renin angiotensin aldosterone system, ameliorate renal and cardiac complication in diabetic patients and doxorubicin cardiotoxicity. Moreover, EMP enhances NO release, induces vasodiltation and improves endothelial function that could counteract the damaging effect of anticancer drug [##REF##32897742##15##–##REF##33547494##17##].</p>", "<p id=\"Par5\">Depending on EMP pharmacological properties, the pathogenesis of 5-FU cardiotoxic effect and the critical need to discover more guarding agents against 5-FU harmful effects, we aimed to evaluate the ability of EMP to control such toxicity based on modulating SGLT with studying the involved mechanisms focusing on TNFα/TLR/NF-κB/MYD88 pathway.</p>" ]
[ "<title>Materials and methods</title>", "<title>Ethical approval</title>", "<p id=\"Par6\">This study followed the guidelines for the care of experimental animals and it received the approval of the Institutional Ethical Committee, Faculty of Medicine, Minia University, Egypt based on ARRIVE guidelines for taking care and use of laboratory animals, EU Directive 2010/63/EU for animal experiments, the National Research Council’s Guide for the Care and Use of Laboratory. Approval Number: 331-4-2022.</p>", "<title>Chemicals</title>", "<p id=\"Par7\">5-FU was obtained from Hikma Pharmaceutical Co. (6th of October, Egypt). EMP was from Boehringer Ingelheim co. Germany. Elisa kits for measuring cardiac enzymes including creatine kinase-MB (CK-MB) (Catalog # MBS2515061), troponin I (Catalog # MBS722833), lactate dehydrogenase (LDH) (Catalog # MBS043166), SGLT2 (Catalog # MBS1600381), P53 (Catalog # MBS723886), TNFα (Catalog # MBS2507393), TLR4 (Catalog # MBS2024497) and NF-κB (Catalog # MBS453975) were purchased from My BioSource Co., San Diego, CA, USA. Total antioxidant capacity kit (TAC) (Catalog # TA2513) was from Biodiagnostic, Egypt. The polyclonal rabbit/anti-rat MYD88 (Catalog # PA5-19918) and TLR5 (Catalog # PA1-41139) antibodies and the immunostaining detection kits were from Thermo Fisher Scientific Inc. Total Protein-Thiol-Assay Colorimetric-Kit (ab219272, Abcam).</p>", "<title>Study protocol</title>", "<p id=\"Par8\">Forty male rats of Wistar albino species weighed about 200–220 g were purchased from Animal Research Centre, Giza, Egypt. They were kept in a suitable housing condition (3 rats/cage) and left to acclimatize one week with free access to both chow and tap water. Rats were divided randomly into 4 groups (n = 10) and EMP was dissolved in 1% carboxymethylcellulose and 5-FU was dissolved in saline just before administration. Dose of 5-FU was detected according to the previous studies and our pilot study which is relevant to the toxic dose in human. The preliminary part of our study was repeated for 3 times to ensure the success of our model.</p>", "<p id=\"Par9\"><bold>Group Ӏ</bold>: vehicle (1% carboxymethylcellulose) was given orally by gavage for 5 days.</p>", "<p id=\"Par10\"><bold>Group II:</bold> EMP (30 mg/kg/day) [##REF##31033127##18##] was administered orally by gavage for 5 days.</p>", "<p id=\"Par11\"><bold>Group III</bold>: 5-FU (150 mg/kg) single intraperitoneal (i.p.) dose in 1st day [##UREF##2##19##] plus vehicle were given orally by gavage for 5 days.</p>", "<p id=\"Par12\"><bold>Group IV:</bold> 5-FU (150 mg/kg) single i.p. dose in 1st day [##UREF##2##19##] plus EMP (30 mg/kg/d) [##REF##31033127##18##] were given orally by gavage for 5 days.</p>", "<title>Detection of blood pressure</title>", "<p id=\"Par13\">Blood pressure (BP) was detected before animal scarifice using tail-cuff method (LETICA, Panlab S.L., Barcelona, Spain). Each rat was kept calm at 38 ℃ for 15 min for relaxation then we detected the rat tail artery pulsation and the tail–cuff was applied and BP was measured for five successive times in each animal. Results were based on the mean of the several successive measurements [##UREF##3##20##].</p>", "<title>Samples and their storage</title>", "<p id=\"Par14\">On 5th day, each animal was anesthetized by i.p. injection of a general anesthetic agent 20% Urethane hydrochloride (1gm/kg). Arterial blood sample of each rat was obtained from abdominal aorta then centrifuged for 15 min at 5000 rpm to separate the clear sera (JanetzkiT30 centrifuge, Germany). The heart of each rat was excised, washed and weighed. Part of each ventricle was fixed in 10% formalin then embedded in paraffin for histopathological and immunohistochemical evaluation. Another part was stored at − 80 ℃ for further preparation of homogenates in phosphate buffer saline 20%w/v by GLAS-Col homogenizer, USA with centrifugation for 20 min at 3000 rpm then separating the supernatant of each sample and aliquots were kept at − 80 ℃ untill used.</p>", "<title>Measurement of NF-κB, TLR4, TNFα, SGLT-2, P53 and serum cardiac enzymes</title>", "<p id=\"Par15\">We measured cardiac enzymes, NF-κB, TLR4, TNFα, SGLT-2 and P53 by using commercial ELISA kits based on the manufacturers’ instructions depending on sandwich ELISA immunoassay technique. The microtiter plate of each measurement was pre-coated with a monoclonal antibody that is specific for each one then we added the standards or the samples to the microtiter plate wells. The detected protien bound to the antibody pre-coated wells. The reaction was terminated by adding sulphuric acid solution and the change of color was measured spectrophotometrically at the specific wave length of each parameter. The color intensity was detected in proportional to the concentration of the measured protien.</p>", "<title>Evaluation of oxidative stress parameters</title>", "<p id=\"Par16\">Serum TAC was measured at 510 nm by using colorimetric kit which was purchased from Biodiagnostic, Egypt and the result was expressed in mmol/ml. Tissue MDA was evaluated colorimetrically at 535 nm and results were expressed in mmol/g protien using 1, 1, 3, 3-tetramethoxypropane standard curve [##UREF##4##21##]. Tissue GSH evaluation was based on the binding of sulfhydryl group with Ellman’s reagent and formation of a yellow color measured colorimetrically at 405 nm by Beckman DU-64 UV/VIS spectrophotometer, USA in a unit of mmol/g protien [##REF##760819##22##].</p>", "<title>Western blotting measurement of caspase 3, IL1β, IL6, TLR2</title>", "<p id=\"Par17\">Total Protein was measure by Thiol Assay Colorimetric Kit (ab219272, Abcam). Fifty μg of protein was obtained from heart tissue homogenates which were boiled for 5 min in a buffer containing 2-mercaptoethanol followed by loading on 12% sodium dodecyl sulfate–polyacrylamide gel electrophoresis and running for 2 h at 100 V. After electrophoresis, proteins were blotted to polyvinylideneflouride membranes. Blocking step for 1 h in a tris-buffered saline was applied to the samples and a blocking solution contained 5% (w/v) non-fat milk and 0.05% Tween-20. Overnight incubation was at 4 ℃ with primary antibodies (1:1000) for rabbit anti-caspase 3 (ab214430, Abcam, Cambridge, UK), anti-IL1β (ab283818, Abcam, Cambridge, UK), anti-IL6 (ab9324, abcam, Cambridge, UK), anti-TLR2 (ab209217, Abcam, Cambridge, UK) and anti-(Glyceraldehyde-3-phosphate dehydrogenase) β-Actin antibody were allowed overnight at 4 ℃. Goat anti-rabbit polyclonal immunoglobulin conjugated with horseradish peroxidase (Cell Signaling Technology Inc., MA, USA) was used as a secondary antibody (1:5000) in blocking buffer. Bands were visualized by chemiluminescence, using an enhanced chemiluminescence kit (ECL, GE Healthcare, Chicago, IL, USA. Protein bands were evaluated densitometrically relative to β-Actin arbitrary units using Image J Software [##REF##27184601##23##, ##REF##30605226##24##].</p>", "<title>Histopathological evaluation</title>", "<p id=\"Par18\">After sacrifice, part of every heart ventricle was dissected, fixed 10% formalin solution for 24 h then processed to prepare paraffin blocks which were cut into 4 μm sections for hematoxylin and eosin stainning and immunohistochemistry. The pathologist conducted the evaluation process of these slides in a blinded fashion to different groups using light microscopy (Olympus microscope, Japan). Scoring of the histopathological abnormalitiess was performed and the following changes were evaluated; the degree of disruption of cardiac muscles architecture, vascular congestion, inflammatory infiltrate, and necrosis. The slides were graded semi quantitatively: score ( −) = no changes, score ( +) = mild changes, score (+ +) = moderate and score (+ + +) = severe changes [##REF##28130575##25##].</p>", "<title>Immunohistochemical procedure</title>", "<p id=\"Par19\">Briefly, slides were de-paraffinized with xylene, hydrated through gradient ethyl alcohol then treated with 3% hydrogen peroxide for 30 min. Slides were washed in phosphate buffer saline and boiled for 15 min in a citrate buffer (pH 6.0) by microwave then cooled to room temperature. The primary MYD88 (1:100) and TLR5 (1:100) antibodies were applied and incubated overnight in a humidity chamber. Then these slides were washed in phosphate buffer saline before applying the biotinylated secondary antibody for 30 min and streptavidin–biotin complex reagent for another 30 min. Afterwards; the 3, 3-diaminobenzidinetetra hydrochloride was applied and counterstained with hematoxylin and covered.</p>", "<p id=\"Par20\">Regarding immunostaining of both MYD88 and TLR5; intensity was scored as follows: 0 = negative; 1 = weak; 2 = moderate; and 3 = strong staining. The positively stained area was scored as 0–100%. The final immunohistochemical score was got by multiplication of the intensity- score times the percentage of positively stained celluar area, resulting in values ranging from 0 to 300 [##REF##34306609##26##, ##REF##23287987##27##].</p>", "<title>Statistical analysis</title>", "<p id=\"Par21\">Data of our study were analyzed by one way ANOVA followed by the Tukey’s multiple comparison test. Our results were expressed as means ± SEM and for statistical analysis; GraphPad Prism software program (version 5) was used. The differences were considered as significant results when the <italic>p</italic> value less than 0.05.</p>" ]
[ "<title>Results</title>", "<title>Effect of EMP on heart weight, blood pressure and serum cardiac enzymes levels (troponin I, CK-MB, LDH)</title>", "<p id=\"Par22\">5-FU (150 mg/kg) single toxic dose led to significant increase of heart weight, blood pressure and cardiac enzymes in comparison to control group and 5-FU treated group. However, co-administration of EMP diminished them significantly compared to 5-FU given group alone (Table ##TAB##0##1##).</p>", "<title>Effect of EMP on MDA, GSH, and TAC in cardiac tissue</title>", "<p id=\"Par23\">5-FU given group showed significant elevation in the tissue level of MDA but decrease in GSH, and TAC in comparison to control group and 5-FU treated group. On the contrary, EMP plus 5-FU given group showed a significant decrease of MDA level but increase of GSH and TAC in comparison to 5-FU given group (Table ##TAB##1##2##).</p>", "<title>Effect of EMP on NF-κB, TNFα, TLR4, SGLT-2 and P53</title>", "<p id=\"Par24\">NF-κB, TNFα, TLR4, SGLT-2 and P53 increased significantly in 5-FU given group compared to control group and 5-FU treated group. However, EMP plus 5-FU given group significantly decreased all of these parameters in comparison to 5-FU given group (Table ##TAB##2##3##).</p>", "<title>Effect of EMP on cardiac tissue level of caspase 3, IL1β, IL6, TLR2 expression by western blotting</title>", "<p id=\"Par25\">Western blotting evaluation of caspase3, IL1β, TLR2, IL6 showed significant increase of their expressions in 5-FU given group compared to control group and 5-FU treated group. However, EMP co-administered group could significantly decrease caspase3, IL1β, IL6, TLR2 if compared to 5-FU untreated group (Fig. ##FIG##0##1##a–d).</p>", "<title>Histopathological evaluation results (Fig. ##FIG##1##2##)</title>", "<p id=\"Par26\">Sections of both control group and EMP given group revealed preserved integrity of the striated cardiac muscle fibres having acidophilic cytoplasm with central oval nuclei (a &amp; b) respectively. 5-FU cardiotoxic group showed disruption of architecture with loss of cardiac muscle striations, areas of necrotic cardiac tissue, congested dilated blood vessels and inflammatory cellular infiltration (c). Marked amiloration of the histopathological abnormalities was observed in EMP co-administered group with restoration of cardiac muscle integrity (d). These data was supported by scoring of the histopathological findings (Table ##TAB##3##4##).</p>", "<title>Evaluation of MYD88 immunoreactivity (Fig. ##FIG##2##3##)</title>", "<p id=\"Par27\">Control and EMP examined sections showed weak positivity in the cytoplasm of cardiac muscles (<bold>a</bold> &amp; <bold>b</bold>). Meanwhile, 5-FU cardiotoxic group revealed strong immunoexpression in almost all the stained areas (<bold>c</bold>). Weak positivity was detected in the EMP co-administrated group (<bold>d</bold>) (Fig. ##FIG##2##3##).</p>", "<title>Semiquantitative analysis of cardiac tissue sections</title>", "<p id=\"Par28\">Results revealed that MYD88 immunoexpression significantly increased in 5-FU untreated group compared to control group and EMP co-administrated group. However, EMP given group showed significant decrease of its immunoexpression compared to 5-FU given group (Fig. ##FIG##2##3##<bold>e</bold>).</p>", "<title>Evaluation of cardiac tissue TLR5 immunoreactivity (Fig. ##FIG##3##4##)</title>", "<p id=\"Par29\">Negative immunostaining was detected in both control and EMP given groups (<bold>a</bold>, <bold>b</bold>). On the other hand, 5-FU cardiotoxic group showed high positive immunoexpression (<bold>c</bold>). Meanwhile, the EMP co-administrated group exhibited weak immunostaining (<bold>d</bold>).</p>", "<title>Semiquantitative analysis of TLR5 immunoexpression in cardiac tissue sections</title>", "<p id=\"Par30\">Results showed that there was a significant elevation of TLR5 immunoexpression in 5-FU group compared to both control group and 5-FU treated group. However, there was a significant decrease in its immunoexpression in EMP co-administered group compared to 5-FU untreated group (Fig. ##FIG##3##4##<bold>e</bold>).</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par31\">Administration of 5-FU leads to serious cardiovascular toxicities associated with coronary spasm, angina, and myocardial infarction. Although the mechanisms of 5-FU harmful effect and the appropriate methods for preventing or treating its cardiovascular toxicities have not been clarified, it is clinicaly used for many years [##REF##35126817##1##, ##REF##32266582##4##]. This forced us to evaluate the possible protective properties of EMP in 5-FU induced cardiac damage. Our study found significant increases in the measured cardiac enzymes such as troponin I, CK-MB and LDH. Moreover, heart weights, blood pressure, SGLT-2, MDA, TLR2, TLR4, TLR5, MyD88, NF-κB, IL1β, IL6, P53 and caspase3 significantly elevated but GSH and TAC decreased with features of cardiotoxicity in the histopathological results in form of disturbed muscle striation, hemorrhage and inflammation. However, co-administration of EMP could ameliorate 5-FU induced changes with down-regulation of TNFα/TLR/NF-κB pathway, SGLT-2, oxidative stress, apoptosis and inflammation.</p>", "<p id=\"Par32\">Several pathways are involved in mediating 5-FU induced cardiac injury including oxidative stress as the generation of free radicals enhances both intrinsic and extrinsic apoptotic pathways associated with activation of caspase family and p53 [##REF##29764506##28##–##REF##35606482##31##]. Furthermore, different cytokines such as IL1β, IL6 and TNFα can act on certain receptors and stimulate either cell death or survival. In addition, it is well known that the mitochondria-derived ROS could induce Ca<sup>2+</sup> release from the endoplasmic reticulum ryanodine receptors initiating cellular necrosis and death [##REF##31709615##32##, ##REF##32895407##33##].</p>", "<p id=\"Par33\">Antioxidants are considered the most significant defensive system to counteract oxidative stress and the associated mitochondrial dysfunction. There are non-enzymatic and enzymatic agents including glutathione, superoxide dismutase and catalase [##REF##32432806##34##]. Our results are in line with previous studies which showed that 5-FU diminished the antioxidants as GSH and TAC but increased MDA which is considered as an essential indicator of both oxidative stress and membrane lipid peroxidation. Oxidative process damages the cardiac cell membrane and releases the intracellular cardiac enzymes outside the cell followed by elevation of their serum levels [##REF##29548480##35##–##REF##35155943##37##].</p>", "<p id=\"Par34\">Another important signaling cascade in mediating 5-FU cardiotoxicity is TNFα/TLR/MyD88/NF-κB pathway. TLRs are a subfamily of recognizing receptors considered as a major regulator of both innate and adaptive immune response [##REF##31709615##32##, ##REF##21613426##38##]. In addition, TLRs have a great role in mediating different inflammatory and apoptotic disorders associated with releasing pro-inflammatory cytokines. One of TLR family is TLR5 which recognizes several pathogen-associated molecules leading to release of different inflammatory mediators and pro-fibrotic factors causing myocardial infarction. It has been approved that TLR5 deficiency could decrease inflammation, oxidative stress, attenuate cardiac fibrosis and dysfunction [##UREF##5##39##].</p>", "<p id=\"Par35\">5FU upregulates inflammation and releases several pro-inflammatory agents leading to more and more activation of TLRs including TLR2, TLR4 that could initiate NF-κB pathway and form IL-1β, IL-6, TNFα [##REF##28130575##25##, ##REF##29576748##40##, ##REF##34510376##41##]. The latter enhances programmed apoptotic process with an imbalance between both anti-apoptotic and pro-apoptotic factors upon releasing free radicals with elevation of P53 and several caspases including caspase3; a critical indicator of apoptosis [##UREF##5##39##, ##REF##34510376##41##]. Our findings revealed significant increase and activation of TNFα/TLR/MYD88/NF-κB pathway in 5-FU administered group compared to control group and this is supported with previous studies [##UREF##5##39##–##REF##34510376##41##].</p>", "<p id=\"Par36\">Sodium glucose co-transporter 2 inhibitors (SGLTI2) including EMP; is a new class of anti-diabetic drugs used in type 2 diabetic patients and they act on proximal tubule and decrease glucose reabsorption. Despite their great benefit as cardioprotectant, still the mechanism of action is incompletely understood in different models [##REF##33388277##12##, ##REF##33995090##16##]. SGLT are highly expressed in the myocardium and they have a great role in mediating heart damage. EMP could modulate SGLT, ameliorate volume overload, decrease blood pressure and regulate renin angiotensin aldosterone system followed by decreasing cardiac remodeling and hypertrophy, attenuating inflammation and inhibiting the release of different pro-inflammatory cytokines accompanied with downregulation of apoptosis [##REF##34343274##9##, ##REF##31033127##18##, ##REF##35863639##42##, ##REF##32414364##43##].</p>", "<p id=\"Par37\">EMP is able to ameliorate inflammation in different studies and this contributes to give cardiovascular benefits. These models demonstrated significant reductions of a large set of pro-inflammatory cytokines during administration of EMP including monocyte chemoattractant protein, IL6, P-selectin, TNFα, interferon, and intercellular adhesion molecule. Moreover, there are reductions in high sensitivity C-reactive protein and myeloperoxidase with increase in anti-inflammatory IL-10 [##REF##29576748##40##–##REF##35863639##42##].</p>", "<p id=\"Par38\">Recently, it was found that the beneficial effect of SGLTI-2 as a cardioprotective agent may be caused by preventing sodium-hydrogen exchange in both kidneys and myocardium which is responsible for reuptake of sodium after filtration and it markedly increases in cardiac and renal patients [##REF##34089496##10##, ##REF##34607570##44##]. This abnormality may be responsible for the developed resistance to both endogenous natriuretic peptides and diuretics. Concerning EMP, it inhibits sodium-hydrogen exchange leading to reduction in heart injury, cardiac remodeling, hypertrophy, fibrosis, attenuation of myocardial dysfunction and natriuretic peptides resistance [##REF##32897742##15##, ##REF##30987285##45##]. This is confirmed in our results as we found that co-administration of EMP could decrease cardiac injury with marked improvement in both biochemical and histopathological changes. This cardiopreserving role of EMP was already detected in other models as diabetic cardiomyopathy, doxorubicin cardiotoxicity, and heart failure [##REF##34343274##9##, ##REF##34301253##13##, ##REF##30987285##45##–##REF##32396609##49##].</p>", "<p id=\"Par39\">The ability to modify SGLT, regulation of renin angiotensin aldosterone system, anti-oxidant, anti-inflammatory and anti-apoptotic properties of EMP may be the suitable explanation of its protective effect in 5-FU induced cardiac injury [##REF##32897742##15##–##REF##33547494##17##, ##REF##32070346##48##–##REF##30935417##50##]. SGLT-2 is markedly involved in mediating heart damage thereby reducing its activity by EMP could decrease intracellular glucose and sodium, consequently 5’AMP-activated protein kinase that has a great role in cardiomyocyte injury. In addition, it was hypothesized that EMP could reduce interstitial fluid space, control cardiac congestion without reducing the arterial perfusion or filling leading to decrease the hospitalization of heart failure patients [##REF##34301253##13##, ##REF##32897742##15##, ##REF##35863639##42##].</p>", "<p id=\"Par40\">On the other hand, SGLTI-2 promote natriuresis, diuresis, reduce preload, decrease blood pressure, improve subendocardial blood flow without increasing heart rate. Furthermore, potent inhibition of SGLT2 prevents glucose and sodium reabsorption resulting in glycosuria and natriuresis without induction of hypoglycaemia [##REF##32897742##15##, ##REF##32613148##51##, ##REF##30873553##52##]. According to our findings in Table##TAB##2##3##, there is increase in SGLT2 expression in 5-FU cardiotoxic group and decrease of its expression following EMP treatment. This reflects the essential role of SGLT2 in mediating 5-FU cardiotoxicity and EMP cardioprotective effect is dependent on SGLT2 modulation.</p>", "<p id=\"Par41\">EMP has direct cardiac effects through regulating SGLT2 protein and its receptors. It could increase cell viability and preserve ATP levels following hypoxia/re-oxygenation. Moreover, EMP increases complex II respiration, improves mitochondrial function and cell viability. In addition, EMP changes the vascular smooth muscle cell function, induces vasodilation and increases blood follow [##REF##30519189##53##, ##REF##29197997##54##].</p>", "<p id=\"Par42\">These pharmacological actions of EMP interfer with the harmful effect of 5-FU as the latter casuses coronary vasospasm and cardiac ischemia [##UREF##6##55##]. Current research paves the way to consider EMP as a cardioprotector to rescue the patient of 5-FU induced toxicity with myocardial damage.</p>", "<p id=\"Par43\">EMP ameliorated 5-FU cardiotoxicity by different mechanisms including vasodilating effect, modulation of SGLT-2, anti-inflammatory, anti-apoptotic, anti-oxidant properties and inhibition of TNFα/TLR/MyD88/NF-κB pathway. More studies are recommended to evaluate the role of EMP in 5-FU cardiotoxic patients.</p>" ]
[]
[ "<p id=\"Par1\">One of the commoly used chemotherapeutic agents is 5-Fluorouracil (5-FU). Unfortunately, the clinical administration of 5-FU is complicated with serious cardiotoxic effects and the safe use becomes an urgent task in cardio-oncology. Till now, there are no studies discussed the role of empagliflozin (EMP) against 5-FU cardiotoxicity. Thus, we investigated this effect and the involved mechanisms in 5-FU induced heart injury. Forty male rats of Wistar albino species were used and divided randomly into four groups. Group I is the control group, group II is EMP given group, group III is 5-FU cardiotoxic group and group IV is 5-FU plus EMP group. 5-FU (150 mg/kg) was administered as a single intraperitoneal (i.p.) dose on 1st day to induce cardiotoxicity with or without EMP (30 mg/kg/d) orally for 5 days. The dose of 5-FU is relevant to the human toxic dose. Our data showed that 5-FU given group caused cardiotoxicity with significant increase of serum cardiac enzymes, toll like receptors, enhancement of nuclear factor kappa B (NF-κB), interleukin1β (IL1β), IL6, myeloid-differentiation-factor 88 (MYD88), heart weight, malondialdehyde (MDA), tumor-necrosis-factor-alpha (TNFα), sodium glucose co-transporter 2 (SGLT2), P53 and caspase3 expression with clear histopathological features of cardiotoxicity. Moreover, there is a significant decrease in reduced glutathione (GSH) and total antioxidant capacity (TAC). Interestingly, co-administration of EMP could ameliorate 5-FU induced biochemical and histopathological changes. This effect may be due to modulation of SGLT2, decreasing inflammation, oxidative stress and apoptosis with downregulation of an essential inflammatory cascade that mediates 5-FU cardiotoxicity; TNFα/TLR/NF-κB.</p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s43188-023-00204-1.</p>", "<title>Keywords</title>", "<p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p>" ]
[ "<title>Supplementary Information</title>", "<p>Below is the link to the electronic supplementary material.</p>" ]
[ "<title>Author contributions</title>", "<p>Conceptualization: MMMR; methodology: MMMR, SS, ME-H, MAF, NZ, HM, ESMA, AMH, TA; formal analysis: MMMR, ME-H, MAF; writing—original draft preparation: MMMR; writing—review and editing: MMMR, SS, ME-H, MAF, NZ, HM, ESMA, AMH, TA. All authors have read and agreed to the published version of the manuscript.</p>", "<title>Funding</title>", "<p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). This research received no external funding.</p>", "<title>Data availability</title>", "<p>All data is available as supplementary material.</p>", "<title>Code availability</title>", "<p>Not applicable.</p>", "<title>Declarations</title>", "<title>Conflict of interest</title>", "<p id=\"Par44\">The authors declare no competing interests.</p>", "<title>Ethical approval</title>", "<p id=\"Par45\">This study was approved by the Institutional Ethical Committee, Faculty of Medicine, Minia University, Egypt based on ARRIVE guidelines. Approval Number: 331–4-2022.</p>", "<title>Human rights</title>", "<p id=\"Par46\">This research doesn’t contain any human participants or clinical study.</p>", "<title>Informed consent</title>", "<p id=\"Par47\">Not applicable.</p>", "<title>Consent to participate</title>", "<p id=\"Par48\">Not applicable.</p>", "<title>Consent for publication</title>", "<p id=\"Par49\">Not applicable.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p><bold>a</bold>–<bold>d</bold> Western blotting evaluation of caspase3, IL1β, IL6, TLR2 expression. Our data found significant increase of caspase3, IL1β, IL6, TLR2 expression in 5-fluorouracil (5-FU) given group compared to control group. However, empagliflozin (EMP) administration plus 5-fluorouracil (5-FU) revealed significant decrease of these parameters in comparison to 5-fluorouracil (5-FU) given rats. Values represents means ± SEM of 10 animals in each group. It is considered significantly different if <italic>p</italic> value less than 0.05. <sup>a</sup>Significant difference if compared to control, <sup>b</sup>significant difference in comparison to 5-fluorouracil group, <sup>c</sup>significant difference compared to 5-fluorouracil treated group. CON represents control group, EMP is empagliflozin group, 5-FU represents 5-fluorouracil group, 5-FU + EMP is 5-fluorouracil plus empagliflozin group. IL1β is interleukin 1β, IL6 is interleukin 6, TLR2 is toll like receptor 2</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>Histopathological evaluation results. Sections of both control group and empagliflozin (EMP) given group revealed preserved integrity of striated cardiac muscle fibres having acidophilic cytoplasm with central oval nuclei (green arrow) (<bold>a</bold> &amp; <bold>b</bold>). The 5-fluorouracil (5-FU) cardiotoxic group showed disruption of architecture with loss of cardiac muscle striations, areas of necrotic cardiac tissue (black arrow), congested dilated blood vessels (red arrow) and inflammatory cellular infiltration (blue arrow) (<bold>c</bold>). There is significant improvement of the histopathological abnormalities observed in empagliflozin (EMP) co-administered group with restoration of cardiac muscle integrity (<bold>d</bold>). (X200). (Scale bar = 100 µm)</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p>Evaluation of MYD88 immunoreactivity. Sections of both control and empagliflozin (EMP) given group showed weak positivity in the cytoplasm of cardiac muscles (<bold>a</bold>, <bold>b</bold>). Meanwhile, 5-fluorouracil (5-FU) administered group revealed strong immunoexpression in almost all the stained areas (<bold>c</bold>). Weak positivity was observed in the empagliflozin (EMP) co-administered group (<bold>d</bold>). (X200) (Scale bar = 100 µm). Semiquantitative analysis of MYD88 immunoexpression: Data revealed that the immunoexpression significantly increased in the 5-fluorouracil (5-FU) group compared to the control group. However, co-administration of empagliflozin (EMP) could significantly decrease its immunoexpression if compared to fluorouracil (5-FU) group (<bold>e</bold>). Values represents means ± SEM of 10 animals in each group. It is considered significantly different if <italic>p</italic> value less than 0.05. <sup>a</sup>Significant difference if compared to control, <sup>b</sup>significant difference in comparison to 5-fluorouracil group, <sup>c</sup>significant difference compared to 5-fluorouracil treated group. CON represents control group, EMP is empagliflozin group, 5-FU represents 5-fluorouracil group, 5-FU + EMP is 5-fluorouracil plus empagliflozin group. MYD88 is myeloid differentiation factor 88</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p>Evaluation of TLR5 immunoreactivity. Negative immunostaining was detected in both control and empagliflozin (EMP) given groups (<bold>a</bold>, <bold>b</bold>). On the other hand, the 5-fluorouracil (5-FU) given group showed strong positive immunoexpression (<bold>c</bold>). Meanwhile, the empagliflozin (EMP) co-administrated group exhibited weak immunostaining (<bold>d</bold>) (X200) (Scale bar = 100 µm). Semiquantitative analysis of TLR5 immunoexpression: Semiquantitative analysis showed that there is a significant increase of TLR5 immunoexpression in 5-fluorouracil (5-FU) group compared to control group. However, there is a significant decrease in its immunoexpression in empagliflozin (EMP) co-administered group compared to 5-fluorouracil (5-FU) group (<bold>e</bold>). Values represents means ± SEM of 10 animals in each group. It is considered significantly different if <italic>p</italic> value less than 0.05. <sup>a</sup>Significant difference if compared to control, <sup>b</sup>significant difference in comparison to 5-fluorouracil group, <sup>c</sup>significant difference compared to 5-fluorouracil treated group. CON represents control group, EMP is empagliflozin group, 5-FU represents 5-fluorouracil group, 5-FU + EMP is 5-fluorouracil plus empagliflozin group. TLR5 is toll like receptor 5</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Effect of EMP on serum cardiac enzymes, blood pressure, heart weights</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Groups</th><th align=\"left\">CK-MB (U/L)</th><th align=\"left\">LDH (U/L)</th><th align=\"left\">Troponin I (U/L)</th><th align=\"left\">BP(mmHg)</th><th align=\"left\">Heart weight/mg</th></tr></thead><tbody><tr><td align=\"left\">CON</td><td char=\"±\" align=\"char\">203.9 ± 4.9</td><td char=\"±\" align=\"char\">150.6 ± 2.8</td><td align=\"left\">10.2 ± 0.5</td><td char=\"±\" align=\"char\">102.9 ± 2.7</td><td char=\"±\" align=\"char\">299.6 ± 10.6</td></tr><tr><td align=\"left\">EMP</td><td char=\"±\" align=\"char\">204.3 ± 4.9</td><td char=\"±\" align=\"char\">164.5 ± 3.8</td><td align=\"left\">10.6 ± 0.9</td><td char=\"±\" align=\"char\">107.5 ± 2.0</td><td char=\"±\" align=\"char\">334.5 ± 12.9</td></tr><tr><td align=\"left\">5-FU</td><td char=\"±\" align=\"char\">304.5 ± 9.0 <sup>a,c</sup></td><td char=\"±\" align=\"char\">271.1 ± 5.7<sup>a,c</sup></td><td align=\"left\">74.4 ± 4.4<sup>a,c</sup></td><td char=\"±\" align=\"char\">160.5 ± 4.1<sup>a,c</sup></td><td char=\"±\" align=\"char\">440.4 ± 18.2<sup>a,c</sup></td></tr><tr><td align=\"left\">5-FU + EMP</td><td char=\"±\" align=\"char\">250.0 ± 9.2<sup>b</sup></td><td char=\"±\" align=\"char\">189.6 ± 6.1<sup>b</sup></td><td align=\"left\">25.8 + 1.4<sup>b</sup></td><td char=\"±\" align=\"char\">134.4 ± 4.9<sup>ab</sup></td><td char=\"±\" align=\"char\">348.4 ± 22.3<sup>b</sup></td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Effect of EMP on MDA, GSH, TAC</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Groups</th><th align=\"left\">MDA (mmol/g protien)</th><th align=\"left\">GSH (mmol/g protien)</th><th align=\"left\">TAC (mmol/ml)</th></tr></thead><tbody><tr><td align=\"left\">CON</td><td char=\"±\" align=\"char\">4.1 ± 0.3</td><td char=\"±\" align=\"char\">7.4 ± 0.3</td><td char=\"±\" align=\"char\">0.9 ± 0.03</td></tr><tr><td align=\"left\">EMP</td><td char=\"±\" align=\"char\">5.0 ± 0.2</td><td char=\"±\" align=\"char\">7.2 ± 0.3</td><td char=\"±\" align=\"char\">0.7 ± 0.04</td></tr><tr><td align=\"left\">5-FU</td><td char=\"±\" align=\"char\">11.4 ± 0.7<sup>a,c</sup></td><td char=\"±\" align=\"char\">1.8 ± 1.0<sup>a</sup><sup>,c</sup></td><td char=\"±\" align=\"char\">0.5 ± 0.02<sup>a,c</sup></td></tr><tr><td align=\"left\">5-FU + EMP</td><td char=\"±\" align=\"char\">8.0 ± 0.6<sup>b</sup></td><td char=\"±\" align=\"char\">6.2 ± 0.3<sup>b</sup></td><td char=\"±\" align=\"char\">0.7 ± 0.02<sup>ab</sup></td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Effect of EMP on NF-κB, TNFα, TLR4 and SGLT-2</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Groups</th><th align=\"left\">TLR4 (ng/g protien)</th><th align=\"left\">TNFα (ng/g protien)</th><th align=\"left\">SGLT-2 (ng/g protien)</th><th align=\"left\">NF-κB (ng/g protien)</th><th align=\"left\">P53 (ng/g protien)</th></tr></thead><tbody><tr><td align=\"left\">CON</td><td char=\"±\" align=\"char\">101.5 ± 2.0</td><td char=\"±\" align=\"char\">109 ± 3.2</td><td char=\"±\" align=\"char\">233.5 ± 13.4</td><td char=\"±\" align=\"char\">10.0 ± 0.4</td><td char=\"±\" align=\"char\">9.2 ± 8.0</td></tr><tr><td align=\"left\">EMP</td><td char=\"±\" align=\"char\">105.5 ± 1.4</td><td char=\"±\" align=\"char\">121.6 ± 2.1</td><td char=\"±\" align=\"char\">260.5 ± 13.5</td><td char=\"±\" align=\"char\">9.2 ± 0.6</td><td char=\"±\" align=\"char\">13.3 ± 1.3</td></tr><tr><td align=\"left\">5-FU</td><td char=\"±\" align=\"char\">172.1 ± 6.2<sup>ac</sup></td><td char=\"±\" align=\"char\">163.3 ± 5.4<sup>ac</sup></td><td char=\"±\" align=\"char\">630.0 ± 21.0<sup>ac</sup></td><td char=\"±\" align=\"char\">43.9 ± 2.4<sup>ac</sup></td><td char=\"±\" align=\"char\">71.6 ± 4.4<sup>ac</sup></td></tr><tr><td align=\"left\">5-FU + EMP</td><td char=\"±\" align=\"char\">119.8 ± 2.3<sup>ab</sup></td><td char=\"±\" align=\"char\">122.3 ± 1.5<sup>ab</sup></td><td char=\"±\" align=\"char\">491.0 ± 21.1<sup>ab</sup></td><td char=\"±\" align=\"char\">27.40 ± 1.6<sup>ab</sup></td><td char=\"±\" align=\"char\">31.9 ± 2.6<sup>ab</sup></td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab4\"><label>Table 4</label><caption><p>Scoring of the histopathological abnormalitiess</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Histopathological changes</th><th align=\"left\">CON</th><th align=\"left\">EMP</th><th align=\"left\">5-FU</th><th align=\"left\">5-FU + EMP</th></tr></thead><tbody><tr><td align=\"left\">Disruption of cardiac muscles architecture</td><td align=\"left\"> − </td><td align=\"left\"> − </td><td align=\"left\"> +  +  + </td><td align=\"left\"> + </td></tr><tr><td align=\"left\">Vascular congestion</td><td align=\"left\"> − </td><td align=\"left\"> − </td><td align=\"left\"> +  + </td><td align=\"left\"> +  + </td></tr><tr><td align=\"left\">Inflammatory cellular infiltrate</td><td align=\"left\"> − </td><td align=\"left\"> + </td><td align=\"left\"> +  +  + </td><td align=\"left\"> +  + </td></tr><tr><td align=\"left\">Necrosis</td><td align=\"left\"> − </td><td align=\"left\"> − </td><td align=\"left\"> +  +  + </td><td align=\"left\"> + </td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>Values represents means ± SEM of 10 animals in each group</p><p>It is considered significantly different if <italic>p</italic> value less than 0.05</p><p>CON represents control group, EMP is empagliflozin group, 5-FU represents 5-fluorouracil group, 5-FU + EMP is 5-fluorouracil plus empagliflozin group</p><p>CK-MB is creatine kinase MB, LDH is lactate dehydrogenase, BP is blood pressure</p><p><sup>a</sup>Significant difference if compared to control</p><p><sup>b</sup>Significant difference in comparison to 5-fluorouracil group</p><p><sup>c</sup>Significant difference compared to 5-fluorouracil treated group</p></table-wrap-foot>", "<table-wrap-foot><p>Values represents means ± SEM of 10 animals in each group</p><p>It is considered significantly different if <italic>p</italic> value less than 0.05</p><p>CON represents control group, EMP is empagliflozin group, 5-FU represents 5-fluorouracil group, 5-FU + EMP is 5-fluorouracil plus empagliflozin group</p><p>MDA is malondialdehyde, GSH is reduced glutathione, TAC is total antioxidant capacity</p><p><sup>a</sup>Significant difference if compared to control</p><p><sup>b</sup>Significant difference in comparison to 5-fluorouracil group</p><p><sup>c</sup>Significant difference compared to 5-fluorouracil treated group</p></table-wrap-foot>", "<table-wrap-foot><p>Values represents means ± SEM of 10 animals in each group</p><p>It is considered significantly different if <italic>p</italic> value less than 0.05</p><p>CON represents control group, EMP is empagliflozin group, 5-FU represents 5-fluorouracil group, 5-FU + EMP is 5-fluorouracil plus empagliflozin group</p><p>TNFα is tumor necrosis factor alpha, TLR4 is toll like receptor 4, SGLT2 is sodium glucose co-transporter 2, NF-κB is nuclear factor kappa B</p><p><sup>a</sup>Significant difference if compared to control</p><p><sup>b</sup>Significant difference in comparison to 5-fluorouracil group</p><p><sup>c</sup>Significant difference compared to 5-fluorouracil treated group</p></table-wrap-foot>", "<table-wrap-foot><p>Scoring of the histopathological changes in different groups</p><p>The structural changes of tissue were assessed according to the degree of disruption of cardiac muscles architecture; vascular congestion; inflammatory cellular infiltrate and necrosis</p><p>Score ( −) = no changes, score ( +) = mild changes, score (+ +) = moderate and score (+ + +) = severe changes</p><p>CON is control group, EMP is empagliflozin group, 5-FU is 5-fluorouracil group, 5-FU + EMP is 5-fluorouracil plus empagliflozin group</p></table-wrap-foot>" ]
[ "<graphic xlink:href=\"43188_2023_204_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"43188_2023_204_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"43188_2023_204_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"43188_2023_204_Fig4_HTML\" id=\"MO4\"/>" ]
[ "<media xlink:href=\"43188_2023_204_MOESM1_ESM.pdf\"><caption><p>Supplementary file1 (PDF 227 KB)</p></caption></media>" ]
[{"label": ["5."], "surname": ["Liu", "Zhang", "Joo", "Sun"], "given-names": ["T", "L", "D", "C"], "article-title": ["NF-\u03baB signaling in inflammation"], "source": ["Signal Transduct Target Ther"], "year": ["2017"], "volume": ["2"], "fpage": ["e17023"], "pub-id": ["10.1038/sigtrans.2017.23"]}, {"label": ["11."], "surname": ["Connelly", "Zhang", "Desjardins", "Nghiem", "Visram", "Batchu", "Yerra", "Kabir", "Thai", "Advani", "Gilbert"], "given-names": ["KA", "Y", "JF", "L", "A", "SN", "VG", "G", "K", "A", "RE"], "article-title": ["Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction"], "source": ["Cardiovasc Diabetol"], "year": ["2020"], "volume": ["1"], "fpage": ["13"], "pub-id": ["10.1186/s12933-020-0994-y"]}, {"label": ["19."], "surname": ["Mohamed", "Safwat"], "given-names": ["ET", "GM"], "article-title": ["Evaluation of cardioprotective activity of "], "italic": [" Lepidium sativum "], "source": ["Beni-Suef Univ J Basic Appl Sci"], "year": ["2016"], "volume": ["5"], "fpage": ["208"], "lpage": ["215"], "pub-id": ["10.1016/j.bjbas.2016.05.001"]}, {"label": ["20."], "surname": ["Miguel", "Muguerza", "Sanchez", "Delado", "Recio", "Ramos", "Aleixandre"], "given-names": ["M", "B", "E", "MA", "I", "S", "MA"], "article-title": ["Changes in arterial blood pressure caused in hypertensive rats by long-term intake of milk fermented by "], "italic": ["Enterococcus faecalis"], "source": ["Br J Nutr"], "year": ["2005"], "volume": ["93"], "fpage": ["36"], "lpage": ["43"], "pub-id": ["10.1079/bjn20051450"]}, {"label": ["21."], "surname": ["Buege", "Aust"], "given-names": ["JA", "SD"], "article-title": ["Microsomal lipid peroxidation"], "source": ["Meth Enzymol"], "year": ["1978"], "volume": ["52"], "fpage": ["302"], "lpage": ["310"], "pub-id": ["10.1016/s0076-6879(78)52032-6"]}, {"label": ["39."], "surname": ["Ma", "Kong", "Wu", "Song", "Zhang", "Yuan", "Deng", "Tang"], "given-names": ["ZG", "CY", "HM", "P", "X", "YP", "W", "QZ"], "article-title": ["Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice"], "source": ["Theranostics"], "year": ["2022"], "volume": ["10"], "fpage": ["11013"], "lpage": ["11025"], "pub-id": ["10.7150/thno.47516"]}, {"label": ["55."], "surname": ["Sara", "Kaur", "Khodadadi", "Rehman", "Lobo", "Chakrabarti", "Herrmann", "Lerman", "Grothey"], "given-names": ["JD", "J", "R", "M", "R", "S", "J", "A", "A"], "article-title": ["5-Fluorouracil and cardiotoxicity: a review"], "source": ["Ther Adv Med Oncol"], "year": ["2018"], "volume": ["10"], "fpage": ["11"], "lpage": ["18"], "pub-id": ["10.1177/1758835918780140"]}]
{ "acronym": [], "definition": [] }
55
CC BY
no
2024-01-14 23:40:14
Toxicol Res. 2023 Oct 3; 40(1):139-151
oa_package/71/7f/PMC10786789.tar.gz
PMC10786791
38214803
[ "<title>Introduction</title>", "<p id=\"Par3\">The modern landscape is rapidly shifting from wired to wireless connections across a wide range of products. As a result, rechargeable batteries are becoming essential for powering electric vehicles and electronic devices [##UREF##0##1##, ##UREF##1##2##]. Consequently, several types of next-generation rechargeable batteries, such as solid-state lithium metal batteries (SSLMBs) [##UREF##2##3##, ##REF##32292941##4##], lithium-sulfur batteries [##UREF##3##5##, ##UREF##4##6##], sodium-ion batteries [##UREF##5##7##], and potassium-ion batteries [##UREF##0##1##, ##UREF##6##8##–##UREF##8##10##] have been explored. Among them, SSLMBs offer potential as high-energy–density rechargeable batteries due to the low redox potential of –3.04 V <italic>vs.</italic> standard hydrogen electrode and the high theoretical specific capacity of 3860 mAh g<sup>−1</sup> from lithium metal anode [##UREF##2##3##, ##REF##32292941##4##, ##UREF##9##11##, ##UREF##10##12##]. In the context of SSLMBs, the solid electrolyte serves as a crucial component, profoundly influencing the overall performance of the batteries. Therefore, over the past decades, several types of solid electrolytes have been explored in SSLMBs, including inorganic solid electrolytes, solid polymer electrolytes (SPEs), and composite solid electrolytes (CSEs) [##UREF##11##13##, ##UREF##12##14##]. Traditional inorganic solid electrolytes such as garnet [##UREF##13##15##, ##UREF##14##16##], sodium super ionic conductor [##UREF##15##17##], perovskite [##REF##35015520##18##], sulfide [##UREF##14##16##, ##UREF##16##19##, ##UREF##17##20##], and halide [##UREF##18##21##, ##UREF##19##22##] exhibit good ionic conductivity (&gt; 10<sup>–4</sup> S cm<sup>−1</sup>) at room temperature. Their brittle nature and poor contact with electrodes, however, can lead to large interfacial resistance, limiting the overall performance of SSLMBs [##UREF##11##13##, ##UREF##12##14##]. Polymer electrolytes are economical, flexible, and scalable, yet often fall short in ionic conductivity at room temperature [##UREF##11##13##, ##UREF##12##14##, ##UREF##20##23##, ##UREF##21##24##].</p>", "<p id=\"Par4\">To address these limitations, CSEs have gained attention for their ability to merge the benefits of both inorganic and polymer-based SSLMBs [##UREF##22##25##–##UREF##25##28##]. Numerous strategies involving the addition of 0D, 1D, and 2D fillers into a polymer matrix have been proposed over the years [##UREF##11##13##, ##UREF##12##14##]. Unfortunately, these approaches often lead to the random distribution of fillers, resulting in crossing junctions, discontinuous networks, and agglomeration which adversely affect their electrochemical properties [##UREF##12##14##]. Therefore, it is essential to design strategies that create continuous pathways for Li<sup>+</sup> diffusion and prevent filler agglomeration to significantly enhance ionic conductivity.</p>", "<p id=\"Par5\">Additionally, the interface contact between solid electrodes and electrolytes can lead to interfacial incompatibility and increased internal resistance, negatively affecting the electrochemical properties of SSLMBs [##UREF##11##13##, ##UREF##12##14##]. To mitigate this limitation, in-situ polymerization is proposed as a promising approach [##UREF##26##29##–##UREF##28##31##]. This method involves the injection of liquid monomer precursors into batteries to facilitate and establish interfacial contact. Following injection, a polymerization reaction is initiated to convert the monomers into polymer electrolytes. This process integrates the solid electrolyte—solid electrodes interface, significantly reducing interfacial resistance [##UREF##26##29##–##UREF##29##32##].</p>", "<p id=\"Par6\">Motivated by these considerations, this study successfully developed a CSE through the combination of self-supported porous Li<sub>6.4</sub>La<sub>3</sub>Zr<sub>1.4</sub>Ta<sub>0.6</sub>O<sub>12</sub> (LLZT) and in-situ polymerization into the LLZT. The resulting CSE exhibited a unique and integrated structure, comprising continuous inorganic, polymer, and inorganic-polymer interface pathways to promote ion transport. Remarkably, the CSE achieved a high ionic conductivity of 1.117 mS cm<sup>–1</sup> and a high lithium transference number of 0.627, remaining stable up to 5.06 V <italic>vs.</italic> Li/Li<sup>+</sup> at 30 °C. Thanks to the synergistic combination of the well-designed CSE and the formation of LiF and B-rich interphase layers, the solid-state Li|CSE|LiNi<sub>0.8</sub>Co<sub>0.1</sub>Mn<sub>0.1</sub>O<sub>2</sub> cell remained a discharge capacity of 105.1 mAh g<sup>–1</sup> after 400 cycles at 0.5 C and 30 °C, corresponding to a capacity retention of 61%. This strategy suggests a novel approach for designing fast ionic conductor electrolytes for high-energy SSLMBs.</p>" ]
[ "<title>Calculation Method</title>", "<p id=\"Par13\">Density Functional Theory calculations were performed using the generalized gradient approximation in the Heyd–Scuseria–Ernzerhof exchange–correlation functional as implemented in the Quantum Espresso package [##REF##32321275##35##–##UREF##33##37##]. Structure relaxation was executed using the Broyden–Fletcher–Goldfarb–Shanno algorithm, setting the convergence thresholds for energy and force to less than 10<sup>−5</sup> Ry and 10<sup>−5</sup> Ry/Bohr, respectively. Data visualization was accomplished through the utilization of the VESTA and XcrySDen software tools [##UREF##34##38##, ##REF##10736774##39##].</p>" ]
[ "<title>Results and Discussion</title>", "<title>Material Characterization</title>", "<p id=\"Par14\">A CSE with a self-supported porous LLZT structure was prepared as illustrated in Fig. ##FIG##0##1##a. The self-supported porous LLZT structure was prepared via the tape-casting method, as detailed in the Experimental section. Following this, a monomer solution composed of lithium bis(trifluoromethanesulfonyl)imide (LiTFSI) and lithium difluoro(oxalato)borate (LiDFOB) salts, succinonitrile (SN) and fluoroethylene carbonate (FEC) as plasticizers, and polyethylene glycol methyl ether methacrylate (MEMA) monomer at a desired ratio, was injected into this structure. This was subsequently in-situ polymerized to construct the CSE. LiDFOB was chosen for its ability to generate interphase layers on electrodes and its superior solubility compared to its analogues (e.g., lithium bis(oxalato)borate) [##UREF##35##40##]. Additionally, FEC was used to reduce the reactivity of SN towards the Li metal. Meanwhile, the self-supported porous LLZT structure was designed to prevent LLZT particle agglomeration and facilitate Li<sup>+</sup> transport through the ceramic, polymer, and their interface pathways. Concurrently, in-situ polymerization aids in the formation of a beneficial interface between the electrolyte and both electrodes.</p>", "<p id=\"Par15\">The crystallographic structure of the self-supported porous LLZT was analyzed using XRD. As shown in Fig. ##FIG##0##1##b, all diffraction peaks corresponded accurately to the LLZT cubic structure without any trace of impurity phase (COD #96-155-2157) [##UREF##36##41##]. Within the LLZT unit cell, La<sup>3+</sup> occupies the 24c position with eightfold coordination, while Ta<sup>4+</sup> and Zr<sup>4+</sup> are situated at the 16a position in an octahedral arrangement. Both 24d and 94h sites contain Li, while O resides at the 96h sites (Fig. ##SUPPL##0##S1##). These details are exhibited in Fig. ##FIG##0##1##b and Table ##SUPPL##0##S1##. It has been reported that the cubic structure of LLZT enhances lithium conductivity at room temperature [##UREF##14##16##, ##UREF##37##42##]. Additionally, images of the self-supported porous LLZT film and CSE can be found in Fig. S2. The integration of the polymer rendered the originally white LLZT film partially translucent. Furthermore, the XRD pattern of CSE can be found in Fig. S3. The pattern confirms that CSE preserves the inherent cubic structure of the self-supported porous LLZT. A minor peak at 28.5° is attributable to SN. Notably, after a 10-day exposure to ambient conditions, with temperatures varying from 20 to 30 °C and relative humidity levels between 50 and 70%, the structure of CSE exhibited minimal alterations, underscoring its stability in ambient atmospheric conditions.</p>", "<p id=\"Par16\">In the cross-sectional SEM image (Fig. ##FIG##0##1##c), the self-supported porous LLZT presents a thickness of ~ 96 μm, forming a continuous 3D conductive network. Subsequently, the MEMA monomer was permeated and underwent in-situ polymerization within the remaining voids of the structure (Fig. ##FIG##0##1##d). The presence of a continuous interface between the LLZT and the polymer can accelerate Li<sup>+</sup> diffusion. Additionally, the in-situ polymer might also enhance the interface with solid electrodes.</p>", "<p id=\"Par17\">Moreover, the percentage of LLZT in the CSE was determined based on the TGA results, as presented in Fig. ##FIG##1##2##a. The TGA profile for CSE displayed two weight reduction stages. The initial phase, ranging from 30 to 350 °C, corresponds to SN and LiDFOB decomposition, whereas the second phase, from 350 to 490 °C, associates with the decomposition of LiTFSI (Fig. S4). A total weight loss of 45.76 wt% was observed for the CSE. Comparatively, the weight percentage of LLZT slightly decreased by 2.21%. The weight loss difference of 43.55% between LLZT and CSE can be attributed to the organic compounds present in the CSE. The residual 56.45 wt% is attributable to the inorganic component of LLZT. Furthermore, the CSE exhibited thermal stability up to a temperature of 200 °C, registering a weight loss of less than 3 wt%. Additionally, the glass transition temperature (<italic>T</italic><sub><italic>g</italic></sub>) for both SPE and CSE was determined through DSC. Figure S5 reveals that the <italic>T</italic><sub><italic>g</italic></sub> values for SPE and CSE are − 54.49 and − 63.79 °C, respectively. The notably lower <italic>T</italic><sub><italic>g</italic></sub> of CSE can be primarily attributed to the presence of self-supported porous LLZT and the ion–dipole interactions between Li<sup>+</sup> ions and the polar groups within the polymer [##UREF##38##43##]. Such factors promote increased segmental mobility in the polymer, suggesting enhanced ionic conductivity for CSE.</p>", "<p id=\"Par18\">The polymerization mechanism of the MEMA monomer was investigated via FTIR. As observed in Fig. ##FIG##1##2##b, the infrared absorption peak positioned at approximately 1636 cm<sup>−1</sup> is assigned to the C=C in the MEMA monomer. However, following in-situ polymerization, these absorption peaks disappeared, signifying that polymerization of the MEMA occurred. It is also noteworthy that the initial fluid state of the precursor solution transformed into a solid state without any fluidity after polymerization, as displayed in Fig. S6. Moreover, the conversion rate was estimated by comparing the integrals of <sup>1</sup>H signals from hydrogen bonded to C=C with <sup>1</sup>H signals of the polymer from the NMR spectra, as illustrated in Fig. ##FIG##1##2##c [##REF##34593799##44##]. Typically, the proton signals of the precursor were deconvoluted (Fig. ##FIG##1##2##d). Peaks at 5.71 and 6.05 ppm correspond to the signal of hydrogen from =CH<sub>2</sub>, which significantly reduced after a polymerization time of 1 h, corresponding to a conversion rate of 99.92%. As the polymerization period was extended, these peaks disappeared, indicating the full polymerization of MEMA. However, the characteristic peak of the AIBN initiator at 1.70 ppm still existed and was only eliminated when the reaction time reached 12 h. Therefore, to prevent any residual initiator, the polymerization time was maintained at 12 h. Furthermore, based on the FTIR and NMR results, the polymerization reaction is proposed to be a thermal free-radical polymerization (Fig. ##FIG##1##2##e). Upon heating, the AIBN initiator could release free-radicals, which could potentially attack the C=C bond in MEMA, resulting in its polymerization. Subsequently, the resultant polymer is able to capture other components such as salts and plasticizers.</p>", "<title>Electrochemical Characterization</title>", "<p id=\"Par19\">A ternary diagram was employed to optimize the lithium ionic conductivity () of the CSE and to elucidate the influence of its constituent components on the conductivity tendency. The compositions of the electrolytes and their respective ionic conductivities at 30 °C are listed in Table S2. Typically, the maximum ionic conductivity of 1.117 mS cm<sup>−1</sup> can be achieved at a MEMA:SN:lithium salts ratio of 30:50:20, as illustrated in Fig. ##FIG##2##3##a. It is important to note that an increased percentage of SN as a plasticizer might enhance the ionic conductivity, but it can also render the organic component fluid due to its eutectic mixture with FEC [##UREF##30##33##]. Thus, for subsequent investigations, a MEMA:SN:lithium salts ratio of 30:50:20 was employed.</p>", "<p id=\"Par20\">Furthermore, the frontier molecular orbital energies of the salts, plasticizers, and polymer were evaluated to provide additional insight into their reduction and oxidation behaviors. Electrons in the highest occupied molecular orbital (HOMO) are more likely to be donated, which leads to lower oxidation potential stability of the molecule. In contrast, the lowest unoccupied molecular orbital (LUMO) possesses a strong electron affinity and correlates with reductions in higher-potential regions. As displayed in Fig. ##FIG##2##3##b, LiDFOB exhibited the lowest LUMO energy level as well as the highest HOMO energy level. Besides, the average energy gap between LUMO and HOMO, also known as chemical hardness (), can also serve as an indicator of the molecule’s relative reactivity [##UREF##39##45##]. Given that LiDFOB has the lowest value of 2.66, it implies that LiDFOB is most susceptible to decomposition. This suggests that LiDFOB can undergo reduction on the anode side and oxidation on the cathode side, functioning as a dual-role film-forming additive, thereby leading to the formation of LiF and B–rich interphase layers. Further examination of these phenomena will be conducted through XPS and TOF–SIMS techniques. In contrast, SN exhibited a broad LUMO–HOMO gap accompanied by the highest value, indicating its superior thermodynamic stability.</p>", "<p id=\"Par21\">The ionic conductivity of the CSE was measured over a temperature range of 30 to 70 °C. In parallel, the ionic conductivity of the SPE was also investigated for comparative analysis. As indicated in Fig. ##FIG##2##3##c, the ionic conductivity of the CSE was 1.117 mS cm<sup>−1</sup>, superior to that of SPE, which was only 0.464 mS cm<sup>−1</sup> at 30 °C. Moreover, the activation energy () for the CSE was calculated to be 0.161 eV, while the SPE recorded an value of 0.283 eV.</p>", "<p id=\"Par22\">Another key parameter for evaluating solid electrolyte materials is the lithium transference number (). To determine this parameter, the chronoamperometry technique was utilized in lithium symmetric Li|CSE or SPE|Li cells at 30 °C (Figs. ##FIG##2##3##d and S7). Accordingly, the calculated of CSE was 0.627, which is significantly higher than the value of 0.236 observed for SPE. This finding infers that the CSE facilitates more efficient and faster transportation of Li<sup>+</sup> ions. Besides, the enhancement in electrochemical properties can be ascribed to the self-supporting porous LLZT matrix, which facilitates Li<sup>+</sup> ion conduction, consequently shortening their conduction pathway. This can be largely credited to the synergistic interplay between the long-range, continuous conductive porous LLZT framework, the aligned polymer matrices, and the solid-polymer interface, all synergistically contributing to the proficient transport of Li<sup>+</sup> ions. Furthermore, asymmetric Li|SPE or CSE|stainless-steel cells were fabricated to study the electrochemical stability potential of the electrolytes with a scan rate of 1 mV s<sup>−1</sup> at 30 °C. Based on the linear sweep voltammetry (LSV) results shown in Fig. ##FIG##2##3##e, the CSE maintained stability up to 5.06 V <italic>vs.</italic> Li/Li<sup>+</sup>, while the SPE started to exhibit oxidative tendencies above 4.60 V. The remarkable electrochemical stability observed can be attributed to the presence of LLZT ceramic in CSE, which is known for its high oxidative stability [##UREF##25##28##, ##UREF##40##46##, ##UREF##41##47##].</p>", "<p id=\"Par23\">Solid-state NMR is a valuable tool for exploring the chemical environments and mobility of Li<sup>+</sup> within solid electrolytes. Therefore, this method was employed to gain a deeper understanding of the improvement in the transference number and ionic conductivity of CSE. In Fig. ##FIG##2##3##f, the <sup>7</sup>Li solid-state NMR spectra for the LLZT, SPE, and CSE are presented. The <sup>7</sup>Li peak in LLZT and SPE was located at − 0.27 and 1.40 ppm, respectively. However, in CSE, these peaks were downfield shift to − 0.17 and 1.92 ppm, respectively. Moreover, an interface between LLZT and CSE was also formed, as displayed in Fig. ##FIG##2##3##f. This suggests that Li<sup>+</sup> experienced deshielding, resulting in reduced electronic density and weaker interactions with both the polymer and LLZT, thereby facilitating their mobility [##UREF##38##43##]. Furthermore, the <sup>19</sup>F peak of LLZT exhibited an upfield shift and higher intensity compared to that of SPE (Fig. ##FIG##2##3##g). It means the F<sup>–</sup> were shielded and engaged in interactions with the polymer or LLZT, hindering their transport. Consequently, this contributes to the reduction of the anion transference number as well as the enhancement of the Li<sup>+</sup> transference number [##UREF##38##43##].</p>", "<p id=\"Par24\">Besides, the contribution of each component in CSE was identified using <sup>6</sup>Li isotopic-labelled process. On the Earth, two stable isotopes, <sup>6</sup>Li and <sup>7</sup>Li, are found with natural abundances of 7.5% and 92.5%, respectively. Therefore, in any lithium-containing compound (e.g., CSE), <sup>7</sup>Li is predominantly present. Through the application of an external potential to the <sup>6</sup>Li|CSE|<sup>6</sup>Li cell, <sup>6</sup>Li<sup>+</sup> ions pass through and gradually substitute <sup>7</sup>Li<sup>+</sup> ions in the CSE. This process led to the enrichment of the active components of CSE with <sup>6</sup>Li. By analyzing the solid-state NMR of <sup>6</sup>Li before and after testing, we could elucidate the contributions of LLZT, polymer, and their interface [##UREF##27##30##, ##UREF##28##31##, ##UREF##42##48##–##UREF##44##50##]. Typically, the <sup>6</sup>Li peaks for LLZT and SPE were observed at 2.72 and 1.21 ppm, respectively, as depicted in Fig. ##FIG##2##3##h. Subsequently, the <sup>6</sup>Li peak of CSE, both before and after testing, was deconvoluted into three peaks corresponding to the LLZT phase, polymer phase, and their interface. Based on the areas under the fitting curves, the contributions of the LLZT phase, polymer phase, and their interface in CSE before testing were 76.79%, 15.24%, and 7.97%, respectively (Fig. ##FIG##2##3##i and Table S3). After testing, these values changed to 56.79%, 16.47%, and 26.74%, respectively (Fig. ##FIG##2##3##k and Table S3). Furthermore, the increase factor could be calculated based on the area ratio of each phase before and after testing. As illustrated in Fig. ##FIG##2##3##l, the increase factor for LLZT, polymer, and their interface was determined to be 6.87, 10.04, and 31.18, respectively. These results strongly suggest that the LLZT-polymer interface serves as the most favorable route for Li<sup>+</sup> movement.</p>", "<p id=\"Par25\">The stability of the CSE against lithium metal was explored via a galvanostatic lithium stripping/plating test, executed at 30 °C using a symmetric Li|CSE|Li cell. First, the lithium stripping/plating was carried out for 10 cycles at various current densities from 0.1 to 1.0 mA cm<sup>−2</sup>, as represented in Fig. ##FIG##3##4##a, b. Notably, the Li|CSE|Li symmetric cell yielded overpotentials of 6.5, 12.7, 32.2, and 65.1 mV at current densities of 0.1, 0.2, 0.5, and 1.0 mA cm<sup>−2</sup>, respectively. Remarkably, upon reducing the current density back to 0.1 mV cm<sup>−2</sup>, the Li|CSE|Li cell still remained square-wave-like curves with a negligible overpotential of 6.6 mV. On the other hand, the Li|SPE|Li cell displayed sawtooth-wave-like curves with significant polarization. To further emphasize the superior characteristics of CSE, lithium from cycled cells was retrieved for SEM analysis, as shown in Fig. ##FIG##3##4##a, b insets. Cycled lithium metal from Li|CSE|Li cells exhibited a uniform, smooth surface, whereas dendrite-like morphologies were observed on the lithium metal retrieved from Li|SPE|Li cells. These observations suggest that the CSE structure promotes uniform lithium deposition.</p>", "<p id=\"Par26\">Additionally, the long-term interfacial stability of the CSE at 0.1 mA cm<sup>−2</sup> was examined and represented in Fig. ##FIG##3##4##c. The Li|CSE|Li cell exhibited consistent square-wave-like curves with a steady overpotential of approximately 5.0 mV over 2000 h, showing no signs of short-circuiting. In sharp contrast, the Li|SPE|Li cell displayed a significant overpotential of approximately 170 mV, with unstable plating/stripping behavior after 1500 h and an apparent short-circuit after 1900 h. Moreover, at a higher current density of 0.5 mA cm<sup>−2</sup>, the Li|CSE|Li symmetric cell demonstrated outstanding plating and stripping performance, maintaining a negligible overpotential of approximately 29.5 mV over 500 h, as displayed in Fig. ##FIG##3##4##d. These results establish that symmetric Li cells incorporating CSE offer superior long-term cycling stability, even under high current densities. In essence, the CSE demonstrated superior stability in contact with Li metal, suggesting its potential as a solid electrolyte for high energy density SSLMBs.</p>", "<p id=\"Par27\">The practical applicability of CSEs was further demonstrated by testing full cells composed of a LiNi<sub>0.8</sub>Co<sub>0.1</sub>Mn<sub>0.1</sub>O<sub>2</sub> (NCM811) cathode and a lithium metal anode at 30 °C. Figures ##FIG##4##5##a and S8a present the rate capability of the Li|CSE|NCM811 cells, showing discharge capacities of 197.4, 189.4, 171.4, 151.8, 120.6, and 54.7 mAh g<sup>−1</sup> at rates of 0.1, 0.2, 0.5, 1.0, 2.0, and 5.0 C, respectively. Remarkably, even after experiencing a high rate of 5 C, the capacities recovered to 196.3 and 173.9 mAh g<sup>−1</sup> upon returning the C-rate to 0.1 C and 0.5 C. On the other hand, the Li|SPE|NCM811 cells displayed significantly lower discharge capacities under equivalent conditions, further reinforcing the superior capacity reversibility and rate capability of CSE.</p>", "<p id=\"Par28\">In addition, the long-term cyclability of Li|CSE|NCM811 is displayed in Fig. ##FIG##4##5##b. After activation of 5 initial cycles at a low rate of 0.1 C, the cell achieved a discharge-specific capacity of 172.4 mAh g<sup>−1</sup> at 0.5 C. Furthermore, it maintained a specific reversible capacity of 105.1 mAh g<sup>−1</sup> after 400 cycles, corresponding to a capacity retention of 61% and an average Coulombic efficiency of 99.4%. Moreover, the Li|CSE|NCM811 cells with the higher mass loadings of NCM811 cathode material, specifically 5.2 and 10.7 mg cm<sup>−2</sup>, were prepared for cyclability testing. As shown in Fig. S8b, following an activation period of 5 cycles at 0.1 C, the Li|CSE|NCM811 cells displayed specific discharge capacities of 163.1 and 107.6 mAh g<sup>−1</sup> at 0.5 C for mass loadings of 5.2 and 10.7 mg cm<sup>−2</sup>, respectively. After 100 cycles at 0.5 C, these cells still maintained a specific discharge capacity of 116.3 and 65.9 mAh g<sup>−1</sup>, corresponding to capacity retentions of 69.6% and 61.2%, respectively. These observations underscore the impressive long-term cyclability of Li|CSE|NCM811 cells, which is attributed to efficient Li<sup>+</sup> ion diffusion throughout the cell and uniform lithium deposition on the anode, rendering superior full-cell performance. Furthermore, a single-layer Li|CSE|NCM811 pouch cell was assembled, as shown in Fig. ##FIG##4##5##c. This cell sustained a discharge capacity of 144.8 mAh g<sup>−1</sup>, with a capacity retention of 83.3% over 150 cycles at 0.5 C (Fig. ##FIG##4##5##d). These results highlight the promising potential of CSE for scalable applications. Furthermore, the Li|CSE|NCM811 cell displayed a rate capability commensurate with recent data that employed an NCM cathode with solid electrolytes at room temperature, as described in Fig. ##FIG##4##5##e and summarized in Table S4 [##UREF##26##29##, ##UREF##28##31##, ##UREF##40##46##, ##UREF##41##47##, ##UREF##45##51##–##UREF##47##54##].</p>", "<p id=\"Par29\">The cathode − electrolyte interphase (CEI) formed on cycled NCM811 cathodes was investigated using TEM. As presented in Fig. ##FIG##5##6##a, the CEI layer exhibited a thickness of approximately 10.9 nm, indicating its capacity to effectively protect the NMC cathode and inhibit further decomposition during cycling. To determine the chemical composition of the CEI, XPS analysis was conducted, as depicted in Figs. ##FIG##5##6##b–d and S9. The C 1<italic>s</italic> spectrum highlighted a significant enrichment of species such as C–C, C–O, C=O (e.g., ROCO<sub>2</sub>–), and C–F. Concurrently, the F 1<italic>s</italic> spectrum identified the presence of LiF, B–F, and C–F species. The emergence of LiF and B–F suggests that both LiTFSI and LiDFOB undergo decomposition on the NMC surface during cycling. Upon sputtering, the LiF signal was more pronounced, suggesting an enrichment of LiF species within the inner CEI layer. The presence of the C≡N group indicated a thin layer of SN-derived material on the cathode surface, which disappeared post-sputtering [##UREF##46##52##]. The solid electrolyte interphase (SEI) layer on the cycled Li anode was also scrutinized through XPS analysis, as presented in Figs. ##FIG##5##6##e–h and S10. The C 1<italic>s</italic> spectrum identified four peaks, which were attributed to C–C, C–O, C=O, and C–F bonds [##UREF##46##52##, ##UREF##48##55##]. Following etching, the relative intensity of C–C, C–O, and C=O peaks exhibited a significant reduction, suggesting a polymer-dominated outer SEI layer. Such a malleable outer layer would assist in maintaining intimate contact between the Li metal and solid electrolyte during cycling. In the F 1<italic>s</italic> spectrum, there is a decrease in the intensity of the LiF signal accompanied by an increase in the B–F signal, suggesting that LiF is predominant in the outer SEI layer, while B–F is the main component of the intermediate layer. Moreover, the N–SO<sub>2</sub> peaks originate from TFSI<sup>–</sup> in the LiTFSI salt. Additionally, Li–O is detected in the outer layer, while B–O/C–O is dominant in the intermediate layer.</p>", "<p id=\"Par30\">To further decipher the composition and distribution of the CEI and SEI layers, (TOF–SIMS) was executed on the NCM811 and Li metal surfaces after cycling. As demonstrated in Fig. ##FIG##5##6##i, there is a progressive increase in the intensity of the Ni- signal with increased sputtering time, suggesting the formation of the CEI layer on the cycled NCM811. Furthermore, the outer region manifests an accumulation of signals such as BF<sup>2−</sup>, BO<sup>2−</sup>, LiCO<sub>3</sub><sup>−</sup>, and CH<sub>2</sub>O<sup>−</sup>, while the inner region exhibits a build-up of LiF<sup>2−</sup> signals. Similarly, the outer region of the cycled Li anode accumulates signals of BF<sup>2−</sup>, BO<sup>2−</sup>, LiCO<sub>3</sub><sup>−</sup>, C<sub>3</sub>H<sup>−</sup>, and CH<sub>2</sub>O<sup>−</sup>, while LiF<sup>2−</sup> signals are concentrated in the inner region (Fig. ##FIG##5##6##j). The corresponding three-dimensional distribution of LiF<sup>2−</sup>, BO<sup>2−</sup>, LiCO<sub>3</sub><sup>−</sup>, and CH<sub>2</sub>O<sup>−</sup> on the Li anode is depicted in Fig. ##FIG##5##6##k.</p>", "<p id=\"Par31\">Following the XPS and TOF–SIMS analyses, the primary constituents of the CEI and SEI layers are illustrated in Fig. ##FIG##5##6##l, m, respectively. In summary, it is evident that both sides of the electrode are enriched with LiF- and B-rich species. These constituents serve to prevent direct contact between the electrode surface and the electrolyte, thus reducing interfacial side reactions and enhancing the uniformity and efficiency of Li plating/stripping.</p>" ]
[ "<title>Results and Discussion</title>", "<title>Material Characterization</title>", "<p id=\"Par14\">A CSE with a self-supported porous LLZT structure was prepared as illustrated in Fig. ##FIG##0##1##a. The self-supported porous LLZT structure was prepared via the tape-casting method, as detailed in the Experimental section. Following this, a monomer solution composed of lithium bis(trifluoromethanesulfonyl)imide (LiTFSI) and lithium difluoro(oxalato)borate (LiDFOB) salts, succinonitrile (SN) and fluoroethylene carbonate (FEC) as plasticizers, and polyethylene glycol methyl ether methacrylate (MEMA) monomer at a desired ratio, was injected into this structure. This was subsequently in-situ polymerized to construct the CSE. LiDFOB was chosen for its ability to generate interphase layers on electrodes and its superior solubility compared to its analogues (e.g., lithium bis(oxalato)borate) [##UREF##35##40##]. Additionally, FEC was used to reduce the reactivity of SN towards the Li metal. Meanwhile, the self-supported porous LLZT structure was designed to prevent LLZT particle agglomeration and facilitate Li<sup>+</sup> transport through the ceramic, polymer, and their interface pathways. Concurrently, in-situ polymerization aids in the formation of a beneficial interface between the electrolyte and both electrodes.</p>", "<p id=\"Par15\">The crystallographic structure of the self-supported porous LLZT was analyzed using XRD. As shown in Fig. ##FIG##0##1##b, all diffraction peaks corresponded accurately to the LLZT cubic structure without any trace of impurity phase (COD #96-155-2157) [##UREF##36##41##]. Within the LLZT unit cell, La<sup>3+</sup> occupies the 24c position with eightfold coordination, while Ta<sup>4+</sup> and Zr<sup>4+</sup> are situated at the 16a position in an octahedral arrangement. Both 24d and 94h sites contain Li, while O resides at the 96h sites (Fig. ##SUPPL##0##S1##). These details are exhibited in Fig. ##FIG##0##1##b and Table ##SUPPL##0##S1##. It has been reported that the cubic structure of LLZT enhances lithium conductivity at room temperature [##UREF##14##16##, ##UREF##37##42##]. Additionally, images of the self-supported porous LLZT film and CSE can be found in Fig. S2. The integration of the polymer rendered the originally white LLZT film partially translucent. Furthermore, the XRD pattern of CSE can be found in Fig. S3. The pattern confirms that CSE preserves the inherent cubic structure of the self-supported porous LLZT. A minor peak at 28.5° is attributable to SN. Notably, after a 10-day exposure to ambient conditions, with temperatures varying from 20 to 30 °C and relative humidity levels between 50 and 70%, the structure of CSE exhibited minimal alterations, underscoring its stability in ambient atmospheric conditions.</p>", "<p id=\"Par16\">In the cross-sectional SEM image (Fig. ##FIG##0##1##c), the self-supported porous LLZT presents a thickness of ~ 96 μm, forming a continuous 3D conductive network. Subsequently, the MEMA monomer was permeated and underwent in-situ polymerization within the remaining voids of the structure (Fig. ##FIG##0##1##d). The presence of a continuous interface between the LLZT and the polymer can accelerate Li<sup>+</sup> diffusion. Additionally, the in-situ polymer might also enhance the interface with solid electrodes.</p>", "<p id=\"Par17\">Moreover, the percentage of LLZT in the CSE was determined based on the TGA results, as presented in Fig. ##FIG##1##2##a. The TGA profile for CSE displayed two weight reduction stages. The initial phase, ranging from 30 to 350 °C, corresponds to SN and LiDFOB decomposition, whereas the second phase, from 350 to 490 °C, associates with the decomposition of LiTFSI (Fig. S4). A total weight loss of 45.76 wt% was observed for the CSE. Comparatively, the weight percentage of LLZT slightly decreased by 2.21%. The weight loss difference of 43.55% between LLZT and CSE can be attributed to the organic compounds present in the CSE. The residual 56.45 wt% is attributable to the inorganic component of LLZT. Furthermore, the CSE exhibited thermal stability up to a temperature of 200 °C, registering a weight loss of less than 3 wt%. Additionally, the glass transition temperature (<italic>T</italic><sub><italic>g</italic></sub>) for both SPE and CSE was determined through DSC. Figure S5 reveals that the <italic>T</italic><sub><italic>g</italic></sub> values for SPE and CSE are − 54.49 and − 63.79 °C, respectively. The notably lower <italic>T</italic><sub><italic>g</italic></sub> of CSE can be primarily attributed to the presence of self-supported porous LLZT and the ion–dipole interactions between Li<sup>+</sup> ions and the polar groups within the polymer [##UREF##38##43##]. Such factors promote increased segmental mobility in the polymer, suggesting enhanced ionic conductivity for CSE.</p>", "<p id=\"Par18\">The polymerization mechanism of the MEMA monomer was investigated via FTIR. As observed in Fig. ##FIG##1##2##b, the infrared absorption peak positioned at approximately 1636 cm<sup>−1</sup> is assigned to the C=C in the MEMA monomer. However, following in-situ polymerization, these absorption peaks disappeared, signifying that polymerization of the MEMA occurred. It is also noteworthy that the initial fluid state of the precursor solution transformed into a solid state without any fluidity after polymerization, as displayed in Fig. S6. Moreover, the conversion rate was estimated by comparing the integrals of <sup>1</sup>H signals from hydrogen bonded to C=C with <sup>1</sup>H signals of the polymer from the NMR spectra, as illustrated in Fig. ##FIG##1##2##c [##REF##34593799##44##]. Typically, the proton signals of the precursor were deconvoluted (Fig. ##FIG##1##2##d). Peaks at 5.71 and 6.05 ppm correspond to the signal of hydrogen from =CH<sub>2</sub>, which significantly reduced after a polymerization time of 1 h, corresponding to a conversion rate of 99.92%. As the polymerization period was extended, these peaks disappeared, indicating the full polymerization of MEMA. However, the characteristic peak of the AIBN initiator at 1.70 ppm still existed and was only eliminated when the reaction time reached 12 h. Therefore, to prevent any residual initiator, the polymerization time was maintained at 12 h. Furthermore, based on the FTIR and NMR results, the polymerization reaction is proposed to be a thermal free-radical polymerization (Fig. ##FIG##1##2##e). Upon heating, the AIBN initiator could release free-radicals, which could potentially attack the C=C bond in MEMA, resulting in its polymerization. Subsequently, the resultant polymer is able to capture other components such as salts and plasticizers.</p>", "<title>Electrochemical Characterization</title>", "<p id=\"Par19\">A ternary diagram was employed to optimize the lithium ionic conductivity () of the CSE and to elucidate the influence of its constituent components on the conductivity tendency. The compositions of the electrolytes and their respective ionic conductivities at 30 °C are listed in Table S2. Typically, the maximum ionic conductivity of 1.117 mS cm<sup>−1</sup> can be achieved at a MEMA:SN:lithium salts ratio of 30:50:20, as illustrated in Fig. ##FIG##2##3##a. It is important to note that an increased percentage of SN as a plasticizer might enhance the ionic conductivity, but it can also render the organic component fluid due to its eutectic mixture with FEC [##UREF##30##33##]. Thus, for subsequent investigations, a MEMA:SN:lithium salts ratio of 30:50:20 was employed.</p>", "<p id=\"Par20\">Furthermore, the frontier molecular orbital energies of the salts, plasticizers, and polymer were evaluated to provide additional insight into their reduction and oxidation behaviors. Electrons in the highest occupied molecular orbital (HOMO) are more likely to be donated, which leads to lower oxidation potential stability of the molecule. In contrast, the lowest unoccupied molecular orbital (LUMO) possesses a strong electron affinity and correlates with reductions in higher-potential regions. As displayed in Fig. ##FIG##2##3##b, LiDFOB exhibited the lowest LUMO energy level as well as the highest HOMO energy level. Besides, the average energy gap between LUMO and HOMO, also known as chemical hardness (), can also serve as an indicator of the molecule’s relative reactivity [##UREF##39##45##]. Given that LiDFOB has the lowest value of 2.66, it implies that LiDFOB is most susceptible to decomposition. This suggests that LiDFOB can undergo reduction on the anode side and oxidation on the cathode side, functioning as a dual-role film-forming additive, thereby leading to the formation of LiF and B–rich interphase layers. Further examination of these phenomena will be conducted through XPS and TOF–SIMS techniques. In contrast, SN exhibited a broad LUMO–HOMO gap accompanied by the highest value, indicating its superior thermodynamic stability.</p>", "<p id=\"Par21\">The ionic conductivity of the CSE was measured over a temperature range of 30 to 70 °C. In parallel, the ionic conductivity of the SPE was also investigated for comparative analysis. As indicated in Fig. ##FIG##2##3##c, the ionic conductivity of the CSE was 1.117 mS cm<sup>−1</sup>, superior to that of SPE, which was only 0.464 mS cm<sup>−1</sup> at 30 °C. Moreover, the activation energy () for the CSE was calculated to be 0.161 eV, while the SPE recorded an value of 0.283 eV.</p>", "<p id=\"Par22\">Another key parameter for evaluating solid electrolyte materials is the lithium transference number (). To determine this parameter, the chronoamperometry technique was utilized in lithium symmetric Li|CSE or SPE|Li cells at 30 °C (Figs. ##FIG##2##3##d and S7). Accordingly, the calculated of CSE was 0.627, which is significantly higher than the value of 0.236 observed for SPE. This finding infers that the CSE facilitates more efficient and faster transportation of Li<sup>+</sup> ions. Besides, the enhancement in electrochemical properties can be ascribed to the self-supporting porous LLZT matrix, which facilitates Li<sup>+</sup> ion conduction, consequently shortening their conduction pathway. This can be largely credited to the synergistic interplay between the long-range, continuous conductive porous LLZT framework, the aligned polymer matrices, and the solid-polymer interface, all synergistically contributing to the proficient transport of Li<sup>+</sup> ions. Furthermore, asymmetric Li|SPE or CSE|stainless-steel cells were fabricated to study the electrochemical stability potential of the electrolytes with a scan rate of 1 mV s<sup>−1</sup> at 30 °C. Based on the linear sweep voltammetry (LSV) results shown in Fig. ##FIG##2##3##e, the CSE maintained stability up to 5.06 V <italic>vs.</italic> Li/Li<sup>+</sup>, while the SPE started to exhibit oxidative tendencies above 4.60 V. The remarkable electrochemical stability observed can be attributed to the presence of LLZT ceramic in CSE, which is known for its high oxidative stability [##UREF##25##28##, ##UREF##40##46##, ##UREF##41##47##].</p>", "<p id=\"Par23\">Solid-state NMR is a valuable tool for exploring the chemical environments and mobility of Li<sup>+</sup> within solid electrolytes. Therefore, this method was employed to gain a deeper understanding of the improvement in the transference number and ionic conductivity of CSE. In Fig. ##FIG##2##3##f, the <sup>7</sup>Li solid-state NMR spectra for the LLZT, SPE, and CSE are presented. The <sup>7</sup>Li peak in LLZT and SPE was located at − 0.27 and 1.40 ppm, respectively. However, in CSE, these peaks were downfield shift to − 0.17 and 1.92 ppm, respectively. Moreover, an interface between LLZT and CSE was also formed, as displayed in Fig. ##FIG##2##3##f. This suggests that Li<sup>+</sup> experienced deshielding, resulting in reduced electronic density and weaker interactions with both the polymer and LLZT, thereby facilitating their mobility [##UREF##38##43##]. Furthermore, the <sup>19</sup>F peak of LLZT exhibited an upfield shift and higher intensity compared to that of SPE (Fig. ##FIG##2##3##g). It means the F<sup>–</sup> were shielded and engaged in interactions with the polymer or LLZT, hindering their transport. Consequently, this contributes to the reduction of the anion transference number as well as the enhancement of the Li<sup>+</sup> transference number [##UREF##38##43##].</p>", "<p id=\"Par24\">Besides, the contribution of each component in CSE was identified using <sup>6</sup>Li isotopic-labelled process. On the Earth, two stable isotopes, <sup>6</sup>Li and <sup>7</sup>Li, are found with natural abundances of 7.5% and 92.5%, respectively. Therefore, in any lithium-containing compound (e.g., CSE), <sup>7</sup>Li is predominantly present. Through the application of an external potential to the <sup>6</sup>Li|CSE|<sup>6</sup>Li cell, <sup>6</sup>Li<sup>+</sup> ions pass through and gradually substitute <sup>7</sup>Li<sup>+</sup> ions in the CSE. This process led to the enrichment of the active components of CSE with <sup>6</sup>Li. By analyzing the solid-state NMR of <sup>6</sup>Li before and after testing, we could elucidate the contributions of LLZT, polymer, and their interface [##UREF##27##30##, ##UREF##28##31##, ##UREF##42##48##–##UREF##44##50##]. Typically, the <sup>6</sup>Li peaks for LLZT and SPE were observed at 2.72 and 1.21 ppm, respectively, as depicted in Fig. ##FIG##2##3##h. Subsequently, the <sup>6</sup>Li peak of CSE, both before and after testing, was deconvoluted into three peaks corresponding to the LLZT phase, polymer phase, and their interface. Based on the areas under the fitting curves, the contributions of the LLZT phase, polymer phase, and their interface in CSE before testing were 76.79%, 15.24%, and 7.97%, respectively (Fig. ##FIG##2##3##i and Table S3). After testing, these values changed to 56.79%, 16.47%, and 26.74%, respectively (Fig. ##FIG##2##3##k and Table S3). Furthermore, the increase factor could be calculated based on the area ratio of each phase before and after testing. As illustrated in Fig. ##FIG##2##3##l, the increase factor for LLZT, polymer, and their interface was determined to be 6.87, 10.04, and 31.18, respectively. These results strongly suggest that the LLZT-polymer interface serves as the most favorable route for Li<sup>+</sup> movement.</p>", "<p id=\"Par25\">The stability of the CSE against lithium metal was explored via a galvanostatic lithium stripping/plating test, executed at 30 °C using a symmetric Li|CSE|Li cell. First, the lithium stripping/plating was carried out for 10 cycles at various current densities from 0.1 to 1.0 mA cm<sup>−2</sup>, as represented in Fig. ##FIG##3##4##a, b. Notably, the Li|CSE|Li symmetric cell yielded overpotentials of 6.5, 12.7, 32.2, and 65.1 mV at current densities of 0.1, 0.2, 0.5, and 1.0 mA cm<sup>−2</sup>, respectively. Remarkably, upon reducing the current density back to 0.1 mV cm<sup>−2</sup>, the Li|CSE|Li cell still remained square-wave-like curves with a negligible overpotential of 6.6 mV. On the other hand, the Li|SPE|Li cell displayed sawtooth-wave-like curves with significant polarization. To further emphasize the superior characteristics of CSE, lithium from cycled cells was retrieved for SEM analysis, as shown in Fig. ##FIG##3##4##a, b insets. Cycled lithium metal from Li|CSE|Li cells exhibited a uniform, smooth surface, whereas dendrite-like morphologies were observed on the lithium metal retrieved from Li|SPE|Li cells. These observations suggest that the CSE structure promotes uniform lithium deposition.</p>", "<p id=\"Par26\">Additionally, the long-term interfacial stability of the CSE at 0.1 mA cm<sup>−2</sup> was examined and represented in Fig. ##FIG##3##4##c. The Li|CSE|Li cell exhibited consistent square-wave-like curves with a steady overpotential of approximately 5.0 mV over 2000 h, showing no signs of short-circuiting. In sharp contrast, the Li|SPE|Li cell displayed a significant overpotential of approximately 170 mV, with unstable plating/stripping behavior after 1500 h and an apparent short-circuit after 1900 h. Moreover, at a higher current density of 0.5 mA cm<sup>−2</sup>, the Li|CSE|Li symmetric cell demonstrated outstanding plating and stripping performance, maintaining a negligible overpotential of approximately 29.5 mV over 500 h, as displayed in Fig. ##FIG##3##4##d. These results establish that symmetric Li cells incorporating CSE offer superior long-term cycling stability, even under high current densities. In essence, the CSE demonstrated superior stability in contact with Li metal, suggesting its potential as a solid electrolyte for high energy density SSLMBs.</p>", "<p id=\"Par27\">The practical applicability of CSEs was further demonstrated by testing full cells composed of a LiNi<sub>0.8</sub>Co<sub>0.1</sub>Mn<sub>0.1</sub>O<sub>2</sub> (NCM811) cathode and a lithium metal anode at 30 °C. Figures ##FIG##4##5##a and S8a present the rate capability of the Li|CSE|NCM811 cells, showing discharge capacities of 197.4, 189.4, 171.4, 151.8, 120.6, and 54.7 mAh g<sup>−1</sup> at rates of 0.1, 0.2, 0.5, 1.0, 2.0, and 5.0 C, respectively. Remarkably, even after experiencing a high rate of 5 C, the capacities recovered to 196.3 and 173.9 mAh g<sup>−1</sup> upon returning the C-rate to 0.1 C and 0.5 C. On the other hand, the Li|SPE|NCM811 cells displayed significantly lower discharge capacities under equivalent conditions, further reinforcing the superior capacity reversibility and rate capability of CSE.</p>", "<p id=\"Par28\">In addition, the long-term cyclability of Li|CSE|NCM811 is displayed in Fig. ##FIG##4##5##b. After activation of 5 initial cycles at a low rate of 0.1 C, the cell achieved a discharge-specific capacity of 172.4 mAh g<sup>−1</sup> at 0.5 C. Furthermore, it maintained a specific reversible capacity of 105.1 mAh g<sup>−1</sup> after 400 cycles, corresponding to a capacity retention of 61% and an average Coulombic efficiency of 99.4%. Moreover, the Li|CSE|NCM811 cells with the higher mass loadings of NCM811 cathode material, specifically 5.2 and 10.7 mg cm<sup>−2</sup>, were prepared for cyclability testing. As shown in Fig. S8b, following an activation period of 5 cycles at 0.1 C, the Li|CSE|NCM811 cells displayed specific discharge capacities of 163.1 and 107.6 mAh g<sup>−1</sup> at 0.5 C for mass loadings of 5.2 and 10.7 mg cm<sup>−2</sup>, respectively. After 100 cycles at 0.5 C, these cells still maintained a specific discharge capacity of 116.3 and 65.9 mAh g<sup>−1</sup>, corresponding to capacity retentions of 69.6% and 61.2%, respectively. These observations underscore the impressive long-term cyclability of Li|CSE|NCM811 cells, which is attributed to efficient Li<sup>+</sup> ion diffusion throughout the cell and uniform lithium deposition on the anode, rendering superior full-cell performance. Furthermore, a single-layer Li|CSE|NCM811 pouch cell was assembled, as shown in Fig. ##FIG##4##5##c. This cell sustained a discharge capacity of 144.8 mAh g<sup>−1</sup>, with a capacity retention of 83.3% over 150 cycles at 0.5 C (Fig. ##FIG##4##5##d). These results highlight the promising potential of CSE for scalable applications. Furthermore, the Li|CSE|NCM811 cell displayed a rate capability commensurate with recent data that employed an NCM cathode with solid electrolytes at room temperature, as described in Fig. ##FIG##4##5##e and summarized in Table S4 [##UREF##26##29##, ##UREF##28##31##, ##UREF##40##46##, ##UREF##41##47##, ##UREF##45##51##–##UREF##47##54##].</p>", "<p id=\"Par29\">The cathode − electrolyte interphase (CEI) formed on cycled NCM811 cathodes was investigated using TEM. As presented in Fig. ##FIG##5##6##a, the CEI layer exhibited a thickness of approximately 10.9 nm, indicating its capacity to effectively protect the NMC cathode and inhibit further decomposition during cycling. To determine the chemical composition of the CEI, XPS analysis was conducted, as depicted in Figs. ##FIG##5##6##b–d and S9. The C 1<italic>s</italic> spectrum highlighted a significant enrichment of species such as C–C, C–O, C=O (e.g., ROCO<sub>2</sub>–), and C–F. Concurrently, the F 1<italic>s</italic> spectrum identified the presence of LiF, B–F, and C–F species. The emergence of LiF and B–F suggests that both LiTFSI and LiDFOB undergo decomposition on the NMC surface during cycling. Upon sputtering, the LiF signal was more pronounced, suggesting an enrichment of LiF species within the inner CEI layer. The presence of the C≡N group indicated a thin layer of SN-derived material on the cathode surface, which disappeared post-sputtering [##UREF##46##52##]. The solid electrolyte interphase (SEI) layer on the cycled Li anode was also scrutinized through XPS analysis, as presented in Figs. ##FIG##5##6##e–h and S10. The C 1<italic>s</italic> spectrum identified four peaks, which were attributed to C–C, C–O, C=O, and C–F bonds [##UREF##46##52##, ##UREF##48##55##]. Following etching, the relative intensity of C–C, C–O, and C=O peaks exhibited a significant reduction, suggesting a polymer-dominated outer SEI layer. Such a malleable outer layer would assist in maintaining intimate contact between the Li metal and solid electrolyte during cycling. In the F 1<italic>s</italic> spectrum, there is a decrease in the intensity of the LiF signal accompanied by an increase in the B–F signal, suggesting that LiF is predominant in the outer SEI layer, while B–F is the main component of the intermediate layer. Moreover, the N–SO<sub>2</sub> peaks originate from TFSI<sup>–</sup> in the LiTFSI salt. Additionally, Li–O is detected in the outer layer, while B–O/C–O is dominant in the intermediate layer.</p>", "<p id=\"Par30\">To further decipher the composition and distribution of the CEI and SEI layers, (TOF–SIMS) was executed on the NCM811 and Li metal surfaces after cycling. As demonstrated in Fig. ##FIG##5##6##i, there is a progressive increase in the intensity of the Ni- signal with increased sputtering time, suggesting the formation of the CEI layer on the cycled NCM811. Furthermore, the outer region manifests an accumulation of signals such as BF<sup>2−</sup>, BO<sup>2−</sup>, LiCO<sub>3</sub><sup>−</sup>, and CH<sub>2</sub>O<sup>−</sup>, while the inner region exhibits a build-up of LiF<sup>2−</sup> signals. Similarly, the outer region of the cycled Li anode accumulates signals of BF<sup>2−</sup>, BO<sup>2−</sup>, LiCO<sub>3</sub><sup>−</sup>, C<sub>3</sub>H<sup>−</sup>, and CH<sub>2</sub>O<sup>−</sup>, while LiF<sup>2−</sup> signals are concentrated in the inner region (Fig. ##FIG##5##6##j). The corresponding three-dimensional distribution of LiF<sup>2−</sup>, BO<sup>2−</sup>, LiCO<sub>3</sub><sup>−</sup>, and CH<sub>2</sub>O<sup>−</sup> on the Li anode is depicted in Fig. ##FIG##5##6##k.</p>", "<p id=\"Par31\">Following the XPS and TOF–SIMS analyses, the primary constituents of the CEI and SEI layers are illustrated in Fig. ##FIG##5##6##l, m, respectively. In summary, it is evident that both sides of the electrode are enriched with LiF- and B-rich species. These constituents serve to prevent direct contact between the electrode surface and the electrolyte, thus reducing interfacial side reactions and enhancing the uniformity and efficiency of Li plating/stripping.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par32\">The CSE was fabricated via the in-situ polymerization of a MEMA-based electrolyte within a self-supported porous LLZO structure. The resulting CSE demonstrated a high ionic conductivity of 1.117 mS cm<sup>−1</sup> at 30 °C, a substantial lithium transference number of 0.627, and a wide electrochemical window of 5.06 V <italic>vs.</italic> Li/Li<sup>+</sup>. As a result, the Li|CSE|NCM811 cell exhibited remarkable rate capability, facilitating operation at rates of up to 5 C, alongside durable cycling performance, maintaining a discharge-specific capacity of 105.1 mAh g<sup>−1</sup> following 400 cycles at 0.5 C and 30 °C. This exceptional performance can be ascribed to the synergistic influence of continuous conductive paths facilitated by the self-sustaining porous LLZT backbone, contributing to expedited and efficient Li<sup>+</sup> diffusion. Additionally, the formation of LiF and B-rich CEI and SEI layers aids in suppressing interfacial side reactions, thereby enhancing the overall performance of SSLMBs. Furthermore, this approach and structure can also be extended to other ceramic, polymer electrolytes, or battery systems. It offers a feasible approach to address the challenges posed by solid electrolytes in the development of safe, high-energy solid-state lithium metal batteries.</p>" ]
[ "<title>Highlights</title>", "<p id=\"Par1568\">\n<list list-type=\"bullet\"><list-item><p id=\"Par2789\">A scalable tape-casting method produces self-supported porous Li<sub>6.4</sub>La<sub>3</sub>Zr<sub>1.4</sub>Ta<sub>0.6</sub>O<sub>12</sub>.</p></list-item><list-item><p id=\"Par37854\">Combining the in-situ polymerization approach, a composite solid electrolyte with superior electrochemical properties is fabricated.</p></list-item><list-item><p id=\"Par58784\">Solid-state Li|CSE|LiNi<sub>0.8</sub>Co<sub>0.1</sub>Mn<sub>0.1</sub>O<sub>2</sub> cells show remarkable cyclability and rate capability.</p></list-item><list-item><p>LiF-and B-rich interphase layers mitigate interfacial reactions, enhancing solid-state battery performance.</p></list-item></list>\n</p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s40820-023-01294-0.</p>", "<p id=\"Par1\">Composite solid electrolytes (CSEs) have emerged as promising candidates for safe and high-energy–density solid-state lithium metal batteries (SSLMBs). However, concurrently achieving exceptional ionic conductivity and interface compatibility between the electrolyte and electrode presents a significant challenge in the development of high-performance CSEs for SSLMBs. To overcome these challenges, we present a method involving the in-situ polymerization of a monomer within a self-supported porous Li<sub>6.4</sub>La<sub>3</sub>Zr<sub>1.4</sub>Ta<sub>0.6</sub>O<sub>12</sub> (LLZT) to produce the CSE. The synergy of the continuous conductive LLZT network, well-organized polymer, and their interface can enhance the ionic conductivity of the CSE at room temperature. Furthermore, the in-situ polymerization process can also construct the integration and compatibility of the solid electrolyte–solid electrode interface. The synthesized CSE exhibited a high ionic conductivity of 1.117 mS cm<sup>−1</sup>, a significant lithium transference number of 0.627, and exhibited electrochemical stability up to 5.06 V vs. Li/Li<sup>+</sup> at 30 °C. Moreover, the Li|CSE|LiNi<sub>0.8</sub>Co<sub>0.1</sub>Mn<sub>0.1</sub>O<sub>2</sub> cell delivered a discharge capacity of 105.1 mAh g<sup>−1</sup> after 400 cycles at 0.5 C and 30 °C, corresponding to a capacity retention of 61%. This methodology could be extended to a variety of ceramic, polymer electrolytes, or battery systems, thereby offering a viable strategy to improve the electrochemical properties of CSEs for high-energy–density SSLMBs.</p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s40820-023-01294-0.</p>", "<title>Keywords</title>" ]
[ "<title>Experimental Procedure</title>", "<title>Preparation of Composite Solid Electrolyte</title>", "<p id=\"Par7\">The self-supported porous Li<sub>6.4</sub>La<sub>3</sub>Zr<sub>1.4</sub>Ta<sub>0.6</sub>O<sub>12</sub> (LLZT) was prepared using a tape-casting method, as detailed in our previous report [##UREF##28##31##]. Briefly, LLZT, povidone as a surfactant, poly(vinyl butyral) as a binder, benzyl butyl phthalate as a plasticizer, and starch as a porous agent were mixed in a solution containing ethanol and acetone (5:5 in vol%) in the following mass ratios: 100:5:10:20:20, respectively. Furthermore, to counterbalance the Li depletion in LLZT during the subsequent calcination phase, 10 wt% lithium nitrate was incorporated into the aforementioned mixture. Subsequently, the slurry was cast on nylon tape by using a doctor blade and dried at 80 °C. Afterward, the dried tape was cut into a 19 mm circle shape, followed by peeled-off the nylon tape. Then, the self-supported porous LLZT film was obtained by heating the above samples at 1100 °C for 1 h. The thickness of the LLZT film was tried to maintain at 100 ± 5 μm. Solutions containing monomers were meticulously prepared by incorporating a precise ratio of polyethylene glycol methyl ether methacrylate (MEMA) monomer, succinonitrile (SN), fluoroethylene carbonate (FEC) plasticizer, and a mixture of lithium bis(trifluoromethanesulfonyl)imide (LiTFSI) and lithium difluoro(oxalato)borate (LiDFOB) salts. The molar ratio of LiTFSI to LiDFOB was fixed at an optimized ratio of 19:1, according to previous reports [##UREF##30##33##, ##UREF##31##34##]. In addition, FEC was kept at 5 wt%. Subsequently, 1.0 wt% of azobisisobutyronitrile (AIBN) as a thermal initiator was incorporated into the above solution. Thereafter, 20 µL of this solution was injected thrice into the self-supported porous LLZT framework, followed by a heating process at 80 °C for 12 h to initiate polymerization. This sequence resulted in the formation of the CSE. For comparative purposes, the solid polymer electrolyte (SPE) was synthesized using a method analogous to that of the CSE, with the primary distinction being the substitution of Whatman® glass fiber in place of the self-supported porous LLZT.</p>", "<title>Material Characterization</title>", "<p id=\"Par8\">The crystal structures of the materials were determined using an X-ray diffractometer (XRD; Empyrean, Malvern Panalytical) equipped with a PIXcel<sup>3D</sup> detector and a Cu anode (λ = 1.5406 Å). The thermal behavior of the composites was studied using a thermogravimetric analyzer (TGA–50, Shimadzu). The molecular structures of the materials were identified by a Fourier transform infrared spectrometer (FTIR; Spectrum 400, PerkinElmer). A field emission scanning electron microscope (FE–SEM; Gemini 500, Zeiss) and a transmission electron microscope (TEM; JEM-2100F, Jeol) were used to investigate the morphology of the samples. To estimate the conversion ratio of the monomer, the monomer or polymer was dissolved in deuterated dimethyl sulfoxide (DMSO-d6) and analyzed using a nuclear magnetic resonance (NMR) spectrometer (Advance III HD 400, Bruker) operating at 400 MHz. Solid-state NMR analysis was performed using an ECZ400R spectrometer (Jeol) at 9.4 T (400 MHz). The chemical state of materials was examined using an X-ray photoelectron spectrometer (XPS; K–Alpha<sup>+</sup>, Thermo Scientific). The binding energies were calibrated based on the C 1<italic>s</italic> peak (284.8 eV). The surface chemistry of electrodes was characterized utilizing Time-of-Flight Secondary Ion Mass Spectrometry 5 (TOF–SIMS 5; ION-TOF GmbH). Bi<sub>3</sub> primary ions, operating at 30 keV and 0.97 pA, were directed towards a 100 × 100 μm<sup>2</sup> analysis area on the solid surface of the electrodes. Following ion bombardment, the resulting secondary ions were collected and subsequently documented by a detector operating at a resolution of 128 × 128 pixels throughout the data acquisition process. For the depth profile, a 1 keV Cesium ion beam was employed to sputter an area of 300 × 300 μm<sup>2</sup>.</p>", "<title>Electrochemical Characterization</title>", "<p id=\"Par9\">Electrochemical characterization was conducted using CR2032-type coin cells, with stainless steel (SS) serving as a blocking electrode. The electrochemical impedance spectroscopy (EIS) of the electrolytes was analyzed using SS|electrolyte|SS symmetric cells across a frequency range of 100 kHz–1 Hz with an applied voltage amplitude of 10 mV via a potentiostat/impedance analyzer (Zive SP2, WonATech). Ionic conductivity () was measured at different temperatures to compute the activation energy () of the electrolyte using Eq. (##FORMU##2##1##):where <italic>R</italic> represents the gas constant, <italic>A</italic> is the pre-exponential constant, and <italic>T</italic> is the temperature.</p>", "<p id=\"Par10\">Linear sweep voltammetry was performed to assess the electrochemical potential stability of the electrolytes in Li|electrolyte|SS asymmetric cells from open circuit potential to 6 V <italic>vs.</italic> Li/Li<sup>+</sup> at a scan rate of 1 mV s<sup>−1</sup> and temperature of 30 °C. A single-step chronoamperometry technique was applied to calculate the Li-ion transference number () using Li|electrolyte|Li symmetric cells with an overpotential of 10 mV at 30 °C, as per the Bruce and Vincent method [##UREF##12##14##]. The plating/stripping of the electrolyte in Li|electrolyte|Li symmetric cells were analyzed to assess the stability of the electrolyte against Li metal using a battery cycler (WBCS 3000, WonATech).</p>", "<p id=\"Par11\">Electrodes composed of LiNi<sub>0.8</sub>Co<sub>0.1</sub>Mn<sub>0.1</sub>O<sub>2</sub> (NCM811) were prepared via a casting method using a doctor blade. A slurry composed of 70 wt% NCM811 active materials, 20 wt% Super P carbon (Timcal), and 10 wt% polyvinylidene difluoride in N-Methyl-2-pyrrolidone solvent was spread onto an aluminum current collector and dried in a vacuum oven at 80 °C for 12 h. The dried foil was cut into circles with a 14 mm diameter, and the loading mass of the active material was controlled at 1.5 mg cm<sup>−2</sup>. To fabricate a Li|CSE|NCM811 cell, the NCM811 cathode was impregnated with a 5 µL solution of LiTFSI:LiDFOB:SN in a molar ratio of 0.95:0.05:20 at 80 °C. Subsequently, the self-supported porous LLZT framework was inserted, followed by the injection of 20 µL of a monomer-containing solution thrice. Afterward, a 16 mm Li chip was then inserted to construct the Li|CSE|NCM811 cells. The cell was then subjected to heating at 80 °C for 12 h to facilitate in-situ polymerization.</p>", "<p id=\"Par12\">Galvanostatic charge–discharge tests were performed using the battery cycler within a potential range of 2.5 − 4.3 V <italic>vs.</italic> Li/Li<sup>+</sup> at 30 °C. The C-rates were calculated based on the practical specific capacity (200 mAh g<sup>–1</sup>) of the NCM811 cathode.</p>", "<title>Supplementary Information</title>", "<p>Below is the link to the electronic supplementary material.</p>" ]
[ "<title>Acknowledgements</title>", "<p>This work was supported by the National Research Foundation of Korea (NRF) grant funded by the MSIT, Korea (No. 2018R1A5A1025224 and No. 2019R1A2C1084020). In addition, this research received funding support from a grant from the Korea Planning &amp; Evaluation Institute of Industrial Technology (KEIT), funded by the MOTIE of Korea (No. 10077287).</p>", "<title>Declarations</title>", "<title>Conflict of interest</title>", "<p id=\"Par33\">The authors declare no interest confict. They have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p><bold>a</bold> Schematic representation of the CSE fabrication process. <bold>b</bold> Rietveld refinement of the XRD pattern for the self-supported porous LLZT. SEM images of <bold>c</bold> self-supported porous LLZT and <bold>d</bold> CSE</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p><bold>a</bold> TGA curves for LLZT, SPE, and CSE. <bold>b</bold> FTIR spectra for MEMA, SPE, and CSE. <bold>c</bold> Conversion rates of the MEMA-based monomer. <bold>d</bold> Structures and 1H NMR spectra of the precursor at various heat treatment times from 0 to 12 h. <bold>e</bold> Suggested polymerization reaction mechanism</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p><bold>a</bold> Ionic conductivities of CSE depicted on the ternary phase diagram at 30 °C. <bold>b</bold> LUMO and HOMO energy values of LiDFOB, LiTFSI, FEC, SN, and MEMA. <bold>c</bold> Arrhenius plots illustrate the conductivity of CSE and SPE. <bold>d</bold> Current transient profile along with corresponding EIS plots for Li|CSE|Li symmetric cell, both before and after polarization. <bold>e</bold> Linear sweep voltammograms of CSE and SPE. <bold>f</bold>\n<sup>7</sup>Li and <bold>g</bold>\n<sup>19</sup>F solid-state NMR spectra of LLZT, SPE, and CSE. <bold>h</bold>\n<sup>6</sup>Li solid-state NMR spectra of LLZT, SPE, and SE before and after testing. Contribution of LLZT, polymer, and their interface <bold>i</bold> before and <bold>k</bold> after polarization. <bold>l</bold> Increase factor of the intensity of LLZT, polymer, and their interface</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p>Rate capabilities of <bold>a</bold> Li|CSE|Li and <bold>b</bold> Li|SPE|Li symmetric cells. <bold>c</bold> Long-term cycling performance of Li|CSE or SPE|Li symmetric cells at a current density of 0.1 mA cm<sup>−2</sup>. <bold>d</bold> Long-term cycling performance of Li|CSE|Li symmetric cells at a current density of 0.5 mA cm<sup>−2</sup>, conducted at 30 °C</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><p><bold>a</bold> Rate capabilities of the Li|CSE|NCM811 coin cell. <bold>b</bold> Long-term cyclability of the Li|CSE|NCM811 coin cell at 0.5 C and 30 °C. <bold>c</bold> Schematic representation and <bold>d</bold> cyclability of the Li|CSE|NCM811 pouch cell at 0.5 C and 30 °C. <bold>e</bold> Rate capability comparison of recently reported data utilizing an NCM cathode with solid electrolytes at room temperature</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><p><bold>a</bold> TEM image of the cycled NCM811 electrode. High-resolution XPS spectra of <bold>b</bold> C 1<italic>s</italic>, <bold>c</bold> F 1<italic>s</italic>, and <bold>d</bold> N 1<italic>s</italic> derived from the cycled NCM811. High-resolution XPS spectra of <bold>e</bold> C 1<italic>s</italic>, <bold>f</bold> F 1<italic>s</italic>, <bold>g</bold> N 1<italic>s</italic>, and <bold>h</bold> O 1<italic>s</italic> from the cycled Li anode. ToF–SIMS depth profile of <bold>i</bold> NCM811 cathode and <bold>j</bold> Li anode after cycling and <bold>k</bold> its corresponding 3D spatial distribution. Schematic illustration showing the primary chemical compounds formed on the surface of <bold>l</bold> the cycled NCM811 cathode and <bold>m</bold> the cycled Li anode</p></caption></fig>" ]
[]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\sigma$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mi>σ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$E_{a}$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:msub><mml:mi>E</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\sigma = A^{{\\frac{{{-}E_{a} }}{RT}}}$$\\end{document}</tex-math><mml:math id=\"M6\" display=\"block\"><mml:mrow><mml:mi>σ</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mi>A</mml:mi><mml:mfrac><mml:mrow><mml:mo>-</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">RT</mml:mi></mml:mrow></mml:mfrac></mml:msup></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t_{{Li^{ + } }}$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:msup><mml:mi>i</mml:mi><mml:mo>+</mml:mo></mml:msup></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\sigma$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mi>σ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mi>n</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mi>n</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mi>n</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$E_{a}$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:msub><mml:mi>E</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$E_{a}$$\\end{document}</tex-math><mml:math id=\"M20\"><mml:msub><mml:mi>E</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t_{{Li^{ + } }}$$\\end{document}</tex-math><mml:math id=\"M22\"><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:msup><mml:mi>i</mml:mi><mml:mo>+</mml:mo></mml:msup></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t_{{Li^{ + } }}$$\\end{document}</tex-math><mml:math id=\"M24\"><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>L</mml:mi><mml:msup><mml:mi>i</mml:mi><mml:mo>+</mml:mo></mml:msup></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[]
[ "<graphic position=\"anchor\" xlink:href=\"40820_2023_1294_Figa_HTML\" id=\"MO1\"/>", "<inline-graphic xlink:href=\"40820_2023_1294_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"40820_2023_1294_Article_IEq2.gif\"/>", "<graphic xlink:href=\"40820_2023_1294_Article_Equ1.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"40820_2023_1294_Article_IEq3.gif\"/>", "<graphic xlink:href=\"40820_2023_1294_Fig1_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"40820_2023_1294_Fig2_HTML\" id=\"MO3\"/>", "<inline-graphic xlink:href=\"40820_2023_1294_Article_IEq4.gif\"/>", "<graphic xlink:href=\"40820_2023_1294_Fig3_HTML\" id=\"MO4\"/>", "<inline-graphic xlink:href=\"40820_2023_1294_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"40820_2023_1294_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"40820_2023_1294_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"40820_2023_1294_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"40820_2023_1294_Article_IEq9.gif\"/>", "<inline-graphic xlink:href=\"40820_2023_1294_Article_IEq10.gif\"/>", "<inline-graphic xlink:href=\"40820_2023_1294_Article_IEq11.gif\"/>", "<graphic xlink:href=\"40820_2023_1294_Fig4_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"40820_2023_1294_Fig5_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"40820_2023_1294_Fig6_HTML\" id=\"MO7\"/>" ]
[ "<media xlink:href=\"40820_2023_1294_MOESM1_ESM.pdf\"><caption><p>Supplementary file1 (PDF 880 kb)</p></caption></media>" ]
[{"label": ["1."], "surname": ["Gao", "Pan", "Sun", "Liu", "Wang"], "given-names": ["YL", "ZH", "JG", "ZL", "J"], "article-title": ["High-energy batteries: beyond lithium-ion and their long road to commercialisation"], "source": ["Nano-Micro Lett."], "year": ["2022"], "volume": ["14"], "issue": ["1"], "fpage": ["94"], "pub-id": ["10.1007/s40820-022-00844-2"]}, {"label": ["2."], "surname": ["Xu"], "given-names": ["JJ"], "article-title": ["Critical review on cathode-electrolyte interphase toward high-voltage cathodes for Li-ion batteries"], "source": ["Nano-Micro Lett."], "year": ["2022"], "volume": ["14"], "issue": ["1"], "fpage": ["166"], "pub-id": ["10.1007/s40820-022-00917-2"]}, {"label": ["3."], "surname": ["Janek", "Zeier"], "given-names": ["J", "WG"], "article-title": ["Challenges in speeding up solid-state battery development"], "source": ["Nat. Energy"], "year": ["2023"], "volume": ["8"], "fpage": ["230"], "lpage": ["240"], "pub-id": ["10.1038/s41560-023-01208-9"]}, {"label": ["5."], "surname": ["Zhu", "Wang", "Bai", "Lu", "Wu"], "given-names": ["XX", "LG", "ZY", "J", "TP"], "article-title": ["Sulfide-based all-solid-state lithium-sulfur batteries: challenges and perspectives"], "source": ["Nano-Micro Lett."], "year": ["2023"], "volume": ["15"], "issue": ["1"], "fpage": ["75"], "pub-id": ["10.1007/s40820-023-01053-1"]}, {"label": ["6."], "surname": ["Vu", "Kim", "Nguyen", "Park"], "given-names": ["DL", "D", "AG", "CJ"], "article-title": ["Stabilizing interface of novel 3D-hierarchical porous carbon for high-performance lithium-sulfur batteries"], "source": ["Electrochim. Acta"], "year": ["2022"], "volume": ["418"], "fpage": ["140369"], "pub-id": ["10.1016/j.electacta.2022.140369"]}, {"label": ["7."], "surname": ["Nguyen", "Le", "Verma", "Vu", "Park"], "given-names": ["AG", "HTT", "R", "DL", "CJ"], "article-title": ["Boosting sodium-ion battery performance using an antimony nanoparticle self-embedded in a 3D nitrogen-doped carbon framework anode"], "source": ["Chem. Eng. J."], "year": ["2022"], "volume": ["429"], "fpage": ["132359"], "pub-id": ["10.1016/j.cej.2021.132359"]}, {"label": ["8."], "surname": ["Verma", "Nguyen", "Didwal", "Moon", "Kim"], "given-names": ["R", "AG", "PN", "CE", "J"], "article-title": ["In-situ synthesis of antimony nanoparticles encapsulated in nitrogen-doped porous carbon framework as high performance anode material for potassium-ion batteries"], "source": ["Chem. Eng. J."], "year": ["2022"], "volume": ["446"], "fpage": ["137302"], "pub-id": ["10.1016/j.cej.2022.137302"]}, {"label": ["9."], "surname": ["Nazir", "Le", "Nguyen", "Kim", "Park"], "given-names": ["A", "HTT", "AG", "J", "CJ"], "article-title": ["Conductive metal organic framework mediated Sb nanoparticles as high-capacity anodes for rechargeable potassium-ion batteries"], "source": ["Chem. Eng. J."], "year": ["2022"], "volume": ["450"], "fpage": ["138408"], "pub-id": ["10.1016/j.cej.2022.138408"]}, {"label": ["10."], "surname": ["Nguyen", "Verma", "Didwal", "Park"], "given-names": ["AG", "R", "PN", "CJ"], "article-title": ["Challenges and design strategies for alloy-based anode materials toward high-performance future-generation potassium-ion batteries"], "source": ["Energy Mater."], "year": ["2023"], "volume": ["3"], "fpage": ["300030"], "pub-id": ["10.20517/energymater.2023.11"]}, {"label": ["11."], "surname": ["Gu", "Liang", "Shi", "Yang"], "given-names": ["JB", "ZT", "JW", "Y"], "article-title": ["Electrochemo-mechanical stresses and their measurements in sulfide-based all-solid-state batteries: a review"], "source": ["Adv. Energy Mater."], "year": ["2023"], "volume": ["13"], "issue": ["2"], "fpage": ["2203153"], "pub-id": ["10.1002/aenm.202203153"]}, {"label": ["12."], "surname": ["Tan", "Wang", "Tian", "Xin", "Guo"], "given-names": ["SJ", "WP", "YF", "S", "YG"], "article-title": ["Advanced electrolytes enabling safe and stable rechargeable li-metal batteries: progress and prospects"], "source": ["Adv. Funct. Mater."], "year": ["2021"], "volume": ["31"], "issue": ["45"], "fpage": ["2105253"], "pub-id": ["10.1002/adfm.202105253"]}, {"label": ["13."], "surname": ["Liu", "Liu", "Ba", "Zhao", "Ye"], "given-names": ["SL", "WY", "DL", "YZ", "YH"], "article-title": ["Filler-integrated composite polymer electrolyte for solid-state lithium batteries"], "source": ["Adv. Mater."], "year": ["2023"], "volume": ["35"], "issue": ["2"], "fpage": ["2110423"], "pub-id": ["10.1002/adma.202110423"]}, {"label": ["14."], "surname": ["Nguyen", "Park"], "given-names": ["AG", "CJ"], "article-title": ["Insights into tailoring composite solid polymer electrolytes for solid-state lithium batteries"], "source": ["J. Membr. Sci."], "year": ["2023"], "volume": ["675"], "fpage": ["121552"], "pub-id": ["10.1016/j.memsci.2023.121552"]}, {"label": ["15."], "surname": ["Abouali", "Yim", "Merati", "Abu-Lebdeh", "Thangadurai"], "given-names": ["S", "CH", "A", "Y", "V"], "article-title": ["Garnet-based solid-state Li batteries: from materials design to battery architecture"], "source": ["ACS Energy Lett."], "year": ["2021"], "volume": ["6"], "issue": ["5"], "fpage": ["1920"], "lpage": ["1941"], "pub-id": ["10.1021/acsenergylett.1c00401"]}, {"label": ["16."], "surname": ["Liang", "Sun", "Yuan", "Huang", "Hou"], "given-names": ["F", "YL", "YF", "J", "MJ"], "article-title": ["Designing inorganic electrolytes for solid-state Li-ion batteries: a perspectine of LGPS and garnet"], "source": ["Mater. Today"], "year": ["2021"], "volume": ["50"], "fpage": ["418"], "lpage": ["441"], "pub-id": ["10.1016/j.mattod.2021.03.013"]}, {"label": ["17."], "surname": ["Paolella", "Liu", "Daali", "Xu", "Hwang"], "given-names": ["A", "X", "A", "WQ", "I"], "article-title": ["Enabling high-performance NASICON-based solid-state lithium metal batteries towards practical conditions"], "source": ["Adv. Funct. Mater."], "year": ["2021"], "volume": ["31"], "issue": ["30"], "fpage": ["2102765"], "pub-id": ["10.1002/adfm.202102765"]}, {"label": ["19."], "surname": ["Wang", "Adair", "Sun"], "given-names": ["CH", "K", "XL"], "article-title": ["All-solid-state lithium metal batteries with sulfide electrolytes: understanding interfacial ion and electron transport"], "source": ["Acc. Mater. Res."], "year": ["2022"], "volume": ["3"], "issue": ["1"], "fpage": ["21"], "lpage": ["32"], "pub-id": ["10.1021/accountsmr.1c00137"]}, {"label": ["20."], "surname": ["Park", "Jo", "Myung"], "given-names": ["JS", "CH", "ST"], "article-title": ["Comprehensive understanding on lithium argyrodite electrolytes for stable and safe all-solid-state lithium batteries"], "source": ["Energy Storage Mater."], "year": ["2023"], "volume": ["61"], "fpage": ["102869"], "pub-id": ["10.1016/j.ensm.2023.102869"]}, {"label": ["21."], "surname": ["Liang", "van der Maas", "Luo", "Li", "Chen"], "given-names": ["JW", "E", "J", "XN", "N"], "article-title": ["A series of ternary metal chloride superionic conductors for high-performance all-solid-state lithium batteries"], "source": ["Adv. Energy Mater."], "year": ["2022"], "volume": ["12"], "issue": ["21"], "fpage": ["2103921"], "pub-id": ["10.1002/aenm.202103921"]}, {"label": ["22."], "surname": ["Wang", "Xu", "Cui", "Zeng", "Liang"], "given-names": ["SH", "XW", "C", "C", "JN"], "article-title": ["Air sensitivity and degradation evolution of halide solid state electrolytes upon exposure"], "source": ["Adv. Funct. Mater."], "year": ["2022"], "volume": ["32"], "issue": ["7"], "fpage": ["2108805"], "pub-id": ["10.1002/adfm.202108805"]}, {"label": ["23."], "surname": ["Didwal", "Verma", "Nguyen", "Ramasamy", "Lee"], "given-names": ["PN", "R", "AG", "HV", "GH"], "article-title": ["Improving cyclability of all-solid-state batteries via stabilized electrolyte-electrode interface with additive in poly(propylene carbonate) based solid electrolyte"], "source": ["Adv. Sci."], "year": ["2022"], "volume": ["9"], "issue": ["13"], "fpage": ["2105448"], "pub-id": ["10.1002/advs.202105448"]}, {"label": ["24."], "surname": ["Wei", "Huang", "Song", "Wang", "Liu"], "given-names": ["BB", "S", "YH", "X", "M"], "article-title": ["A three-in-one C-60-integrated PEO-based solid polymer electrolyte enables superior all-solid-state lithium-sulfur batteries"], "source": ["J. Mater. Chem. A"], "year": ["2023"], "volume": ["11"], "issue": ["21"], "fpage": ["11426"], "lpage": ["11435"], "pub-id": ["10.1039/d3ta01226c"]}, {"label": ["25."], "surname": ["Yang", "Liu", "Pei", "Chen", "Li"], "given-names": ["XY", "JX", "NB", "ZQ", "RY"], "article-title": ["The critical role of fillers in composite polymer electrolytes for lithium battery"], "source": ["Nano-Micro Lett."], "year": ["2023"], "volume": ["15"], "issue": ["1"], "fpage": ["74"], "pub-id": ["10.1007/s40820-023-01051-3"]}, {"label": ["26."], "surname": ["Liang", "Wang", "Wang", "Song", "Wu"], "given-names": ["HM", "L", "AP", "YZ", "YZ"], "article-title": ["Tailoring practically accessible polymer/inorganic composite electrolytes for all-solid-state lithium metal batteries: a review"], "source": ["Nano-Micro Lett."], "year": ["2023"], "volume": ["15"], "issue": ["1"], "fpage": ["42"], "pub-id": ["10.1007/s40820-022-00996-1"]}, {"label": ["27."], "surname": ["Su", "Xu", "Zhang", "Qiu", "Wang"], "given-names": ["Y", "F", "X", "Y", "H"], "article-title": ["Rational design of high-performance PEO/ceramic composite solid electrolytes for lithium metal batteries"], "source": ["Nano-Micro Lett."], "year": ["2023"], "volume": ["15"], "issue": ["1"], "fpage": ["82"], "pub-id": ["10.1007/s40820-023-01055-z"]}, {"label": ["28."], "surname": ["Xu", "Wang", "Zhang", "Ma", "Peng"], "given-names": ["YA", "K", "XD", "YB", "QF"], "article-title": ["Improved Li-ion conduction and (electro)chemical stability at garnet-polymer interface through metal-nitrogen bonding"], "source": ["Adv. Energy Mater."], "year": ["2023"], "volume": ["13"], "issue": ["14"], "fpage": ["2204377"], "pub-id": ["10.1002/aenm.202204377"]}, {"label": ["29."], "surname": ["Yu", "Lin", "Liu", "Yu", "Robson"], "given-names": ["J", "XD", "JP", "JTT", "MJ"], "article-title": ["In situ fabricated quasi-solid polymer electrolyte for high-energy-density lithium metal battery capable of subzero operation"], "source": ["Adv. Energy Mater."], "year": ["2022"], "volume": ["12"], "issue": ["2"], "fpage": ["2102932"], "pub-id": ["10.1002/aenm.202102932"]}, {"label": ["30."], "surname": ["Wang", "Ju", "Dong", "Yan", "Jiang"], "given-names": ["YT", "JW", "SM", "YY", "F"], "article-title": ["Facile design of sulfide-based all solid-state lithium metal battery: in situ polymerization within self-supported porous argyrodite skeleton"], "source": ["Adv. Funct. Mater."], "year": ["2021"], "volume": ["31"], "issue": ["28"], "fpage": ["2101523"], "pub-id": ["10.1002/adfm.202101523"]}, {"label": ["31."], "surname": ["Nguyen", "Verma", "Song", "Kim", "Park"], "given-names": ["AG", "R", "GC", "J", "CJ"], "article-title": ["In situ polymerization on a 3D ceramic framework of composite solid electrolytes for room-temperature solid-state batteries"], "source": ["Adv. Sci."], "year": ["2023"], "pub-id": ["10.1002/advs.202207744"]}, {"label": ["32."], "surname": ["Chen", "He", "Ding", "Wang", "Wang"], "given-names": ["XZ", "WJ", "LX", "SQ", "HH"], "article-title": ["Enhancing interfacial contact in all solid state batteries with a cathode-supported solid electrolyte membrane framework"], "source": ["Energ. Environ. Sci."], "year": ["2019"], "volume": ["12"], "issue": ["3"], "fpage": ["938"], "lpage": ["944"], "pub-id": ["10.1039/c8ee02617c"]}, {"label": ["33."], "surname": ["Fu", "Ma", "Lou", "Cui", "Xiang"], "given-names": ["CK", "YL", "SF", "C", "LZ"], "article-title": ["A dual-salt coupled fluoroethylene carbonate succinonitrile-based electrolyte enables Li-metal batteries"], "source": ["J. Mater. Chem. A"], "year": ["2020"], "volume": ["8"], "issue": ["4"], "fpage": ["2066"], "lpage": ["2073"], "pub-id": ["10.1039/c9ta11341j"]}, {"label": ["34."], "surname": ["Fu", "Ma", "Zuo", "Zhao", "Tang"], "given-names": ["CK", "YL", "PJ", "W", "WC"], "article-title": ["In-situ thermal polymerization boosts succinonitrile-based composite solid-state electrolyte for high performance Li-metal battery"], "source": ["J. Power. Sources"], "year": ["2021"], "volume": ["496"], "fpage": ["229861"], "pub-id": ["10.1016/j.jpowsour.2021.229861"]}, {"label": ["36."], "surname": ["Giannozzi", "Baroni", "Bonini", "Calandra", "Car"], "given-names": ["P", "S", "N", "M", "R"], "article-title": ["QUANTUM ESPRESSO: a modular and open-source software project for quantum simulations of materials"], "source": ["J. Phys. Condens. Mat."], "year": ["2009"], "volume": ["21"], "issue": ["39"], "fpage": ["395502"], "pub-id": ["10.1088/0953-8984/21/39/395502"]}, {"label": ["37."], "surname": ["Giannozzi", "Andreussi", "Brumme", "Bunau", "Nardelli"], "given-names": ["P", "O", "T", "O", "MB"], "article-title": ["Advanced capabilities for materials modelling with QUANTUM ESPRESSO"], "source": ["J. Phys. Condens. Mat."], "year": ["2017"], "volume": ["29"], "issue": ["46"], "fpage": ["465901"], "pub-id": ["10.1088/1361-648X/aa8f79"]}, {"label": ["38."], "surname": ["Momma", "Izumi"], "given-names": ["K", "F"], "article-title": ["VESTA 3 for three-dimensional visualization of crystal, volumetric and morphology data"], "source": ["J. Appl. Crystallogr."], "year": ["2011"], "volume": ["44"], "fpage": ["1272"], "lpage": ["1276"], "pub-id": ["10.1107/S0021889811038970"]}, {"label": ["40."], "surname": ["Jiao", "Ren", "Cao", "Engelhard", "Liu"], "given-names": ["SH", "XD", "RG", "MH", "YZ"], "article-title": ["Stable cycling of high-voltage lithium metal batteries in ether electrolytes"], "source": ["Nat. Energy"], "year": ["2018"], "volume": ["3"], "issue": ["9"], "fpage": ["739"], "lpage": ["746"], "pub-id": ["10.1038/s41560-018-0199-8"]}, {"label": ["41."], "surname": ["Ishiguro", "Nemori", "Sunahiro", "Nakata", "Sudo"], "given-names": ["K", "H", "S", "Y", "R"], "article-title": ["Ta-doped Li"], "sub": ["7", "3", "2", "12"], "source": ["J. Electrochem. Soc."], "year": ["2014"], "volume": ["161"], "issue": ["5"], "fpage": ["A668"], "lpage": ["A674"], "pub-id": ["10.1149/2.013405jes"]}, {"label": ["42."], "surname": ["Xu", "Li", "Deng", "Shuai", "Li"], "given-names": ["LQ", "JY", "WT", "HL", "S"], "article-title": ["Garnet solid electrolyte for advanced all-solid-state Li batteries"], "source": ["Adv. Energy Mater."], "year": ["2021"], "volume": ["11"], "issue": ["2"], "fpage": ["2000648"], "pub-id": ["10.1002/aenm.202000648"]}, {"label": ["43."], "surname": ["Sung", "Didwal", "Verma", "Nguyen", "Chang"], "given-names": ["BJ", "PN", "R", "AG", "DR"], "article-title": ["Composite solid electrolyte comprising poly(propylene carbonate) and Li"], "sub": ["1.5", "0.5", "1.5", "4"], "source": ["Electrochim. Acta"], "year": ["2021"], "volume": ["392"], "fpage": ["139007"], "pub-id": ["10.1016/j.electacta.2021.139007"]}, {"label": ["45."], "surname": ["Fujimoto", "Satoh"], "given-names": ["H", "S"], "article-title": ["Orbital interactions and chemical hardness"], "source": ["J. Phys. Chem."], "year": ["1994"], "volume": ["98"], "issue": ["5"], "fpage": ["1436"], "lpage": ["1441"], "pub-id": ["10.1021/j100056a011"]}, {"label": ["46."], "surname": ["Jiang", "He", "Wang", "Shen", "Nan"], "given-names": ["TL", "PG", "GX", "Y", "CW"], "article-title": ["Solvent-free synthesis of thin, flexible, nonflammable garnet-based composite solid electrolyte for all-solid-state lithium batteries"], "source": ["Adv. Energy Mater."], "year": ["2020"], "volume": ["10"], "issue": ["12"], "fpage": ["1903376"], "pub-id": ["10.1002/aenm.201903376"]}, {"label": ["47."], "surname": ["Bao", "Zheng", "Wu", "Zhang", "Jin"], "given-names": ["CS", "CJ", "MF", "Y", "J"], "article-title": ["12 mu m-thick sintered garnet ceramic skeleton enabling high-energy-density solid-state lithium metal batteries"], "source": ["Adv. Energy Mater."], "year": ["2023"], "volume": ["13"], "issue": ["13"], "fpage": ["2204028"], "pub-id": ["10.1002/aenm.202204028"]}, {"label": ["48."], "surname": ["Yan", "Ju", "Dong", "Wang", "Huang"], "given-names": ["YY", "JW", "SM", "YT", "L"], "article-title": ["In situ polymerization permeated three-dimensional Li+-percolated porous oxide ceramic framework boosting all solid-state lithium metal battery"], "source": ["Adv. Sci."], "year": ["2021"], "volume": ["8"], "issue": ["9"], "fpage": ["2003887"], "pub-id": ["10.1002/advs.202003887"]}, {"label": ["49."], "surname": ["Jiang", "Wang", "Ju", "Zhou", "Cui"], "given-names": ["F", "YT", "JW", "Q", "LF"], "article-title": ["Percolated sulfide in salt-concentrated polymer matrices extricating high-voltage all-solid-state lithium-metal batteries"], "source": ["Adv. Sci."], "year": ["2022"], "volume": ["9"], "issue": ["25"], "fpage": ["2202474"], "pub-id": ["10.1002/advs.202202474"]}, {"label": ["50."], "surname": ["Li", "Wang", "Xi", "Yu", "Feng"], "given-names": ["XY", "Y", "K", "W", "J"], "article-title": ["Quasi-solid-state ion-conducting arrays composite electrolytes with fast ion transport vertical-aligned interfaces for all-weather practical lithium-metal batteries"], "source": ["Nano-Micro Lett."], "year": ["2022"], "volume": ["14"], "issue": ["1"], "fpage": ["210"], "pub-id": ["10.1007/s40820-022-00952-z"]}, {"label": ["51."], "surname": ["Yao", "Ruan", "Yu", "Zhang", "Zhang"], "given-names": ["M", "QQ", "TH", "HT", "SJ"], "article-title": ["Solid polymer electrolyte with in-situ generated fast Li+ conducting network enable high voltage and dendrite-free lithium metal battery"], "source": ["Energy Storage Mater."], "year": ["2022"], "volume": ["44"], "fpage": ["93"], "lpage": ["103"], "pub-id": ["10.1016/j.ensm.2021.10.009"]}, {"label": ["52."], "surname": ["Lin", "Yu", "Effat", "Zhou", "Robson"], "given-names": ["XD", "J", "MB", "GD", "MJ"], "article-title": ["Ultrathin and non-flammable dual-salt polymer electrolyte for high-energy-density lithium-metal battery"], "source": ["Adv. Funct. Mater."], "year": ["2021"], "volume": ["31"], "issue": ["17"], "fpage": ["2010261"], "pub-id": ["10.1002/adfm.202010261"]}, {"label": ["54."], "surname": ["Yang", "Zhang", "Jing", "Shen", "Wang"], "given-names": ["H", "B", "MX", "XQ", "L"], "article-title": ["In situ catalytic polymerization of a highly homogeneous PDOL composite electrolyte for long-cycle high-voltage solid-state lithium batteries"], "source": ["Adv. Energy Mater."], "year": ["2022"], "volume": ["12"], "issue": ["39"], "fpage": ["2201762"], "pub-id": ["10.1002/aenm.202201762"]}, {"label": ["55."], "surname": ["Yu", "Liu", "Lin", "Law", "Zhou"], "given-names": ["J", "JP", "XD", "HM", "GD"], "article-title": ["A solid-like dual-salt polymer electrolyte for Li-metal batteries capable of stable operation over an extended temperature range"], "source": ["Energy Storage Mater."], "year": ["2021"], "volume": ["37"], "fpage": ["609"], "lpage": ["618"], "pub-id": ["10.1016/j.ensm.2021.02.045"]}]
{ "acronym": [], "definition": [] }
55
CC BY
no
2024-01-14 23:40:14
Nanomicro Lett. 2024 Jan 12; 16:83
oa_package/53/b2/PMC10786791.tar.gz
PMC10786796
38214786
[ "<title>Introduction</title>", "<p id=\"Par3\">As renewable energy sources (e.g., solar and wind) continue to grow, the use of lithium-ion batteries (LIBs) is limited by resources and safety issues. It is urgent to search for inexpensive batteries that are based on earth-abundant elements and can safely store large amounts of energy for intermittent power generation [##REF##18256660##1##–##UREF##1##3##]. Aqueous zinc-ion batteries (AZIBs) with non-flammable aqueous electrolytes have the advantages of environmental friendliness, low cost, and superior safety [##UREF##2##4##–##UREF##3##6##]. Since metallic zinc can be directly used as the anode, it has the potential for large-scale applications considering its high abundance and theoretical capacity (820 mAh g<sup>−1</sup> and 5854 Ah cm<sup>−2</sup>) [##REF##31672899##7##, ##UREF##4##8##].</p>", "<p id=\"Par4\">Despite these unique advantages, AZIBs currently face several issues, especially poor cycling performance due to the instability of zinc metal anodes [##UREF##5##9##–##UREF##8##12##]. Because metallic zinc is not thermodynamically stable against conventional aqueous electrolytes, side reactions such as hydrogen evolution reaction (HER) and zinc corrosion are inevitable at the electrode/electrolyte interface. It lowers the reversibility and long-term stability of the cell [##UREF##7##11##, ##UREF##9##13##]. Meanwhile, Zn<sup>2+</sup> tends to form hydrated zinc ions Zn(H<sub>2</sub>O)<sub>6</sub><sup>2+</sup> in aqueous solutions. It leads to strong interactions between Zn<sup>2+</sup> and water molecules that set a high energy barrier for Zn<sup>2+</sup> dehydration and increase charge transfer resistance. As a result, a large number of water molecules are carried to the zinc metal surface, intensifying water-related side reactions [##UREF##6##10##, ##UREF##10##14##, ##UREF##11##15##]. In addition, morphological changes in the zinc metal anode during cyclic charging/discharging process eventually result in dendrite formation, which disrupts the electrode structure and short-circuits the cell. The enlarged surface area from morphological instability may further promote undesired side reactions [##REF##31851398##16##–##UREF##12##18##].</p>", "<p id=\"Par5\">To solve the above problems in AZIB, researchers have developed modification strategies in recent years, such as artificial coatings on anode [##UREF##13##19##–##UREF##16##22##], design of 3D-structured electrodes [##REF##28450638##23##–##UREF##17##25##], and novel electrolyte systems [##REF##35451192##26##–##REF##29662160##32##]. Among them, the electrolyte modification plays an important role in alleviating the side reactions and promoting uniform deposition of the Zn<sup>2+</sup> on the anode owing to the avoiding of complicated preparation process and excessive invalid weight. For example, the highly concentrated “water-in-salt” strategy of 1 m Zn(TFSI)<sub>2</sub> + 20 m LiTFSI [##REF##29662160##32##] or 30 m ZnCl<sub>2</sub> [##UREF##20##33##], and molecular crowding electrolytes were used to reduce the number of free water molecules in the electrolyte to suppress the activity of water, which also effectively broadens the electrochemical window of the electrolyte. However, the high cost and lowered conductivity make this strategy difficult to be applied to a large scale. On the other hand, the in-situ formation of the solid electrolyte interphases (SEIs) on the anode surface was promoted by the introduction of additives such as Zn(H<sub>2</sub>PO<sub>4</sub>)<sub>2</sub> [##REF##33576130##34##] and Zn(BF<sub>4</sub>)<sub>2</sub> [##UREF##21##35##]. However, since the electrolyte additives are continuously consumed during repeated cycles due to the unstable SEIs, the long-term stability remains an issue. Some researchers have also reported that introducing additives of dimethyl sulfoxide (DMSO) [##REF##33290658##27##], sodium dodecyl benzene sulfonate (SDBS) [##UREF##22##36##], and ethylene glycol [##REF##33148452##37##] can replace H<sub>2</sub>O in the Zn<sup>2+</sup>-solvation sheath, thus inhibiting the side reactions related to H<sub>2</sub>O. In spite of this, a more rational exploration and better understanding of how to optimize the deposition process on anode surface in a long-term cycle is still needed.</p>", "<p id=\"Par6\">From the above, one may conclude that the ideal additive should be able to effectively regulate the Zn<sup>2+</sup>-solvation sheath, inhibit the reaction that occurs when free water comes in contact with the anode surface, and mitigate the dendrite generation on zinc anodes. In this case, we turned our attention to penta-sodium diethylene-triaminepentaacetic acid salt (denoted as DTPA-Na), a widely-used and cheap chelating agent with strong affinity for various metal ions such as Cu<sup>2+</sup> and Ca<sup>2+</sup> [##UREF##23##38##, ##UREF##24##39##]. Meanwhile, analogous to the Sabatier principle about intermediate compound for catalyst design, the chelation strength with Zn<sup>2+</sup> of DTPA-Na is found to be proper, which is able to adjust solvation sheath without causing significant energy barrier for zinc ion dissociation [##UREF##25##40##, ##UREF##26##41##].</p>", "<p id=\"Par7\">We added DTPA-Na to 2 M ZnSO<sub>4</sub> baseline electrolyte and explored the suitable concentration for optimal electrochemical performance. Through the strong interaction between DTPA anion and Zn<sup>2+</sup>, the H<sub>2</sub>O molecules are removed from the solvation sheath of Zn<sup>2+</sup> and improve electrolyte structure. Meanwhile, because the DTPA anions have a higher adsorption capacity than the H<sub>2</sub>O molecules, they are easily adsorbed on the Zn surface to cover the active site of H<sub>2</sub> reduction, thus not only inhibiting the side reactions such as HER but also facilitating the uniform nucleation of Zn by limiting the disordered two-dimensional diffusion [##REF##35765154##42##, ##REF##30420775##43##]. Taking it a step further, we proposed a logical design principle of a reliable electrolyte based on chelation strength for aqueous zinc-ion batteries. With the appropriate amount of the selected DTPA-Na additives, an ultra-long-term stability of Zn electrode with a lifespan of up to 3500 h can be achieved at 1 mA cm<sup>−2</sup>. More importantly, the high Coulomb Efficiency (CE) as well as the long stability achieved in the half-cell studies of both Zn||Cu and Zn||Ti, demonstrating the good reversibility of the Zn plating/stripping process promoted by the introduction of DTPA-Na. Finally, the positive effect of DTPA-Na was further demonstrated in full cells matched with a variety of cathodes. Based on these results, the feasibility of the proposed design principle of electrolyte is verified, which can be further generalized for high-performance aqueous batteries.</p>" ]
[]
[ "<title>Results and Discussions</title>", "<title>Chelation Strength Design</title>", "<p id=\"Par14\">The chemical and electrochemical interactions between the zinc electrode and the electrolyte are schematically shown in Fig. ##FIG##0##1##a. In the control electrolyte, 2 M ZnSO<sub>4</sub> without any electrolyte additives (denoted as blank electrolyte), the uneven deposition on the surface of the zinc anode leads to the formation of dendrites. Such dendrite growth increases the surface area of zinc metal anode, which promotes HER in weakly acidic solution. As a result, HER happens as evidented by continuous bubbling during zinc plating. To solve the problem and inspired by the Sabatier principle for catalyst design [##REF##35524000##50##], we proposed to use a chelating agent DTPA-Na, with intermediate chelation strength to zinc ion, to suppress HER while allowing for stable zinc stripping/plating. The stability constants of zinc ion-coordination compounds are used to reflect the stability of the chelating agent in forming complexes with zinc ions, which can serve as a reference value for the chelation strength (Table ##SUPPL##0##S1##). The stabilization constant of DTPA-Na is 18.2 which is stronger than most chelating agents such as NTA (Nitrilotriacetic acid) and is relatively weaker than chelating agents like DOTA (1,4,7,10-tetraazacyclododecane-<italic>N</italic>,<italic>N</italic>′,<italic>N</italic>,<italic>N</italic>′-tetraacetic acid, another widely known strong chelating agent). The chelation strength of DTPA-Na is strong enough to exclude water molecules from the zinc metal-electrolyte interface (thus suppressing HER and zinc metall corrosion) and not too strong to cause a significant energy barrier for zinc ion dissociation (thus suppressing dendrite formation). The performance of the different additives will be compared later.</p>", "<p id=\"Par15\">Since the structure of the additive plays a key role in this action, FTIR spectra were first obtained for the DTPA-Na solution. As shown in Fig. ##FIG##0##1##b, the peak at 3429 cm<sup>−1</sup> is assigned to symmetric stretching vibrations of O–H. The peaks at 1595 and 1407 cm<sup>−1</sup> correspond to the antisymmetric and symmetric stretching vibrations of C=O in the carboxylate, respectively. The band at 1331 cm<sup>−1</sup> corresponds to the vibration of C–N, whereas the adsorption band at 717 cm<sup>−1</sup> is associated with Na–O bond [##UREF##30##51##, ##REF##26838894##52##]. At the same time, the FTIR characterization results of the 2 M ZnSO<sub>4</sub> blank electrolyte shown in Fig. ##SUPPL##0##S1## revealed little signal besides the O–H alluding to water. The elemental composition of DTPA-Na was investigated by XPS (Fig. ##SUPPL##0##S2##). The de-convoluted peaks of the C 1<italic>s</italic> binding energies are consistent with the C–C, C–N, and O–C=O frequencies at 284.4, 285.2, and 288.1 eV, respectively, and the deconvolution of O 1<italic>s</italic> spectra revealed two peaks, representing C–O (530.8 eV) and C=O (535.2 eV) [##UREF##31##53##, ##UREF##32##54##]. The abundance of oxygen-containing functional groups in the DTPA-Na leads to its strong chelating capabilities and enhances its adhesion on the anode surface [##UREF##33##55##].</p>", "<p id=\"Par16\">To investigate the optimal additive concentration, different amounts of DTPA-Na were dissolved in 2 M ZnSO<sub>4</sub> electrolyte. As shown in Fig. ##FIG##0##1##c, the solutions with 1 and 1.5 wt% DTPA-Na were homogeneous and clear, while those with 2.0 and 2.3 wt% DTPA-Na showed precipitation. The precipitates were characterized by SEM, FTIR, and XPS, attributing to the chelate product of DTPA with Zn (Figs. ##SUPPL##0##S3##–##SUPPL##0##S5##).Then the pH values of the electrolytes with various DTPA-Na concentrations were tested to examine the impact of the additional DTPA-Na on the side reactions occurring at the electrode (Fig. ##FIG##0##1##d). For the blank electrolyte, the pH value of 3.44 indicates an acidic condition that would make hydrogen evolution reactions more likely and lessen the stability of the anode during the battery cycle. After the addition of DTPA-Na, the pH of the electrolyte increased due to the hydrolysis of the DTPA anions. With 1, 1.5, 2.0, and 2.3 wt% DTPA-Na added into the 2 M ZnSO<sub>4</sub> electrolyte, the pH values evolved to, respectively, 5.41, 5.50, 5.54, and 5.56, gradually approaching the neutral environment, which is more unfavorable for HER reactions [##UREF##34##56##]. The current densities of hydrogen and oxygen evolution reactions on the zinc electrode were measured by linear scanning voltammetry (LSV) to demonstrate the intensity of the water splitting in various electrolytes. As shown in Fig. ##FIG##0##1##e, the addition of DTPA-Na reduced the current densities of hydrogen evolution reactions in the voltage range of − 1.0 to − 1.5 V (relative to Ag/AgCl) and oxygen evolution reactions in the range of 1.6–2.0 V, demonstrating that the additive had an impact on preventing the decomposition of water. The best effect was observed for the group with 1.5 wt% additives, whereas the current density controversially increased for the 2.0 and 2.3 wt% groups, since the precipitates produced with too high concentrations instead reduced the salt concentration and the amount of DTPA anion in solution, resulting in a weaker optimization effect. The strong adsorption role of the DTPA anions in competing with H<sub>2</sub>O is responsible for the ability of DTPA-Na to prevent these adverse responses. The Tafel curves were also measured with the Pt wire as the counter electrode (Fig. ##SUPPL##0##S7##). The corrosion current of the electrode in the 1.5 wt% additive-containing electrolyte was calculated to be lower (2.465 mA cm<sup>−2</sup>) than in the blank electrolyte (2.973 mA cm<sup>−2</sup>), indicating the electrode corroded at a lower rate in the modified electrolyte, both due to the weaker acidity of the electrolyte as a result of the additive addition, and the adsorption of the DTPA anion on the electrode surface. Such weaker corrosion was beneficial to the stability of the electrode.</p>", "<title>Electrochemical Performance with Different DTPA-Na Concentrations</title>", "<p id=\"Par17\">Zn||Zn symmetric cells were assembled to evaluate the cycling stability of the cell with or without DTPA-Na additives. At a constant current of 1 mA cm<sup>−2</sup> and an areal capacity of 0.5 mAh cm<sup>−2</sup>, as shown in Fig. ##FIG##1##2##a, the cells containing DTPA-Na exhibited more stable reversible zinc plating/stripping processes, while the cell in the blank electrolyte experienced an abrupt voltage drop at the 240th cycle, indicating the occurrence of short circuit that led to cell failure. To be more specific, the symmetrical cell with 1.0 wt% DTPA-Na in the electrolyte had improved cycling stability and was able to run for 2000 h, but the succeeding cycles encountered large voltage variations. The ultra-long cycling stability of 3500 cycles could be attained with an increase in additive content to 1.5 wt%, but further increases in additive content did not imply better cycle stability. This fact is also consistent with the LSV results, further illustrating the beneficial effect of the proper addition of DTPA-Na on improving cell performance. Figure ##FIG##1##2##b shows the voltage profile amplified during the 20th cycle. With the addition of 1.0, 1.5, 2.0, and 2.3 wt% DTPA-Na, the overpotentials of the Zn symmetric cell were found to increase sequentially from 40.1 mV for the blank electrolyte to 53.7, 47.2, 70.1, and 82.1 mV, respectively (Fig. ##SUPPL##0##S9##). The adsorbed DTPA layer on the electrode surface results in an appropriate level of high overpotential. The solvation sheath creates a high energy barrier to cause unexpected charge transfer resistance. But the sufficient chelating agents can make it easier for the water molecules to leave the solvation sheath, resulting in the lower overpotential in the 1.5 wt% content group than in the 1.0 wt% content group. On the other hand, the larger additive content of 2.0 and 2.3 wt% will produce precipitates, which may led to higher overpotentials. Taking into account the ion conductivity and cycling stability of symmetric cells, the appropriate concentration for further investigation was chosen to be 1.5 wt%.</p>", "<p id=\"Par18\">In order to determine the effect of the DTPA-Na additives on the Zn plating/stripping behavior, coin cells were disassembled for morphological characterizations. The SEM images of the Zn electrode after 100 cycles in the blank electrolyte demonstrated uneven Zn cluster growth, and the surface of the electrode was filled with flaky Zn deposits, corrosion pits, and by-products, which eventually led to cell failure (Fig. ##SUPPL##0##S10##). However, the addition of 1.5 wt% DTPA-Na led to the observation of a smoother surface with grain-fine Zn deposition, which aided in the formation of a dendrite-free electrode surface. The rate performance test was carried out for the electrolytes with or without the addition of 1.5 wt% DTPA-Na. Figure ##FIG##1##2##c shows the voltage profiles of the symmetric cells at current densities ranging from 1 to 5 mA cm<sup>−2</sup> for 20 h of each cycle with the current density subsequently gradually decreasing back to 1 mA cm<sup>−2</sup>. As current densities increased to 2, 3, 4, and 5 mA cm<sup>−2</sup>, the overpotentials of the cell with additives reached 40.9, 45.6, 62.3, and 73.8 mV, respectively (Fig. ##SUPPL##0##S11##). When the current density was returned to 1 mA cm<sup>−2</sup> again, it dropped to approximately 30 mV, indicating good cycling stability. Comparatively, the cell assembled with the blank electrolyte displayed instabilities in overvoltage fluctuations when the current density was changed, which may have been caused by the generation and shedding of “dead zinc” following uneven deposition/exfoliation. The subsequent overpotentials were in turn higher than those of the modified cell, originating from considerable Zn corrosion and passivated by-products. Additionally, the cell then quickly experienced a short circuit. Compared to unmodified cells, which failed after 330 cycles at 2 mA cm<sup>−2</sup> and 1 mAh cm<sup>−2</sup>, cells containing 1.5 wt% DTPA-Na cycled steadily for a longer period of time without experiencing substantial overpotential changes (Fig. ##FIG##1##2##d). The enlarged voltage–time graph for the selected cycles provided additional evidence of the impact of the addition on the stability of the cell (Figs. ##FIG##1##2##e and ##SUPPL##0##S12##). The modified symmetrical cell also outperformed the original one at a current density of 5 mA cm<sup>−2</sup>, which could run for over 450 h (Fig. ##SUPPL##0##S13##). These results are also very competitive with the cutting-edge studies as summarized in Table ##SUPPL##0##S2##.</p>", "<p id=\"Par19\">In order to observe the electrode morphology more clearly and confirm the protective effect of the DTPA-Na additive, symmetrical cells were assembled using the H-shaped mold (Fig. ##SUPPL##0##S14##). Two zinc electrode foils were sandwiched opposite each other in tubes on either side, and the backsides of the foils were covered with insulating tape to maintain a uniform effective surface. The surface morphology of the electrodes was examined by electron microscopy after 100 h of cycling at a current of 2 mA cm<sup>−2</sup> with a capacity of 1 mAh cm<sup>−2</sup>. Due to corrosion side reactions and uneven zinc deposition, many visible protrusions and holes appeared on the surface of the zinc foil tested in the blank electrolyte (Fig. ##FIG##1##2##f). According to previous studies, the presence of the “tip effect” leads to preferential deposition of zinc on the dendrites [##UREF##35##57##, ##REF##35041439##58##]. As a result, tiny protrusions gradually grow until being able to puncture the separator and eventually leading to short-circuiting of the cells. During cycling, bubbles caused by side reactions like HER are constantly present, and the growth of dendrites exposes additional sites for corrosion and side reactions. All of the above will lead to a reduction in coulombic efficiency (CE) as well as cycling performance. In sharp contrast, the zinc foil in the 1.5 wt% DTPA-Na-containing electrolyte showed a flat surface with fine grains and uniform deposition without discernible protrusions (Fig. ##FIG##1##2##g), indicating the added DTPA-Na effectively protected the zinc electrode by suppressing side reactions and uneven deposition, which further inhibits the formation of dendrites.</p>", "<title>Mechanisms of Stabilized Electrode/Electrolyte Interface</title>", "<p id=\"Par20\">To further validate the mechanism of action of DTPA-Na, the plating process of the transparent symmetric cell was observed by in situ optical microscopy at a current density of 10 mA cm<sup>−2</sup>. For the unmodified cell, a hydrogen bubble appeared on the surface of the electrode after 60 min of plating, and the deposited zinc layer started to become uneven. As this bubble continued to grow, more dense bubbles were created one after another. Impressively, after 90 min, multiple distinct Zn dendritic crystals rapidly formed next to the bubbles (Fig. ##FIG##2##3##a). In contrast, no bubbles were detected on the electrode with the addition of 1.5 wt% DTPA-Na, and the surface of the electrode maintained a smooth morphology during the plating process (Fig. ##FIG##2##3##b). Such monitored phenomena suggested H<sub>2</sub> evolution corrosion can be well mitigated by the introduction of the DTPA-Na additive. DTPA was adsorbed on the surface of Zn foil after cycling verified by Raman spectra (Fig. ##SUPPL##0##S15##). Meanwhile, since DTPA could be readily polarized under electrical loading conditions, the concentration gradient of the electrolyte approaching the zinc electrode surface during the deposition process could also be detected in Fig. ##FIG##2##3##b. The polarizable chelate ions reached the surface of the zinc electrode with the presence of an electric field, and the complex layer located on the interface formed a dynamically regulated channel that could modify the original water clusters in the electrolyte solution. With the cooperation of the dynamic layer, the contact between water molecules and the electrode surface is somehow hindered, further improving the passivation and reducing the corrosion as well as by-products. It is worth noting that, unlike the artificial surface coatings in some research methods which are prone to structural damage after long cycles, such dynamic layer will not be affected by zinc plating/stripping but can be self-shaped and adjusted with changes in the electric field, which is more conducive to the long cycle stability of the cell.</p>", "<p id=\"Par21\">Even at rest, the DTPA ions adsorbed on the interface also help mitigate the self-corrosion of the zinc electrode, which was investigated by immersing the Zn foil in the 2 M ZnSO<sub>4</sub> electrolyte solution with/without DTPA-Na. The Zn foil in the blank electrolyte turned gray after 1 month of immersion, which was caused by severe interfacial side reactions between Zn and the electrolyte. SEM images in Fig. ##FIG##2##3##c show a large number of irregular flakes of by-products loosely accumulated on the surface of the foil, which was identified to be Zn<sub>4</sub>SO<sub>4</sub>(OH)<sub>6</sub>·4H<sub>2</sub>O (JCPDS No. 44-0673) via EDS element mapping and XRD patterns with new diffraction peaks at 9.5° (Figs. ##SUPPL##0##S16## and ##FIG##2##3##e). Such corrosion by-products could severely affect the ion diffusion at the interface. In contrast, the Zn foil immersed in the electrolyte containing 1.5 wt% DTPA-Na displayed little visible morphological changes as well as by-products (Fig. ##FIG##2##3##d), indicating its excellent self-corrosion protection. To further explore the dendritic inhibition mechanism of the modified electrolyte, measurements including XPS and Raman were conducted. Note that a significant N 1<italic>s</italic> signal was observed on the surface of the immersed Zn foil with the addition of DTPA-Na compared to that with the blank electrolyte as shown in Fig. ##FIG##2##3##f, suggesting the adsorption of DTPA-Na on the Zn foil during the immersion which is consistent with the previous observations. Also, for the C 1<italic>s</italic> spectrum of the Zn foil placed in the additive-containing electrolyte shown in Fig. ##SUPPL##0##S17##, the two deconvoluted peaks were attributed to O–C=O and C–N, respectively. The abundance of oxygen-containing functional groups in the DTPA anion enhanced its adhesion to the electrode surface. The preliminary DFT computations also indicated that DTPA anion exhibits stronger adsorption energy of − 0.81 eV on the Zn surface compared to that of − 0.29 eV for free water (Fig. ##SUPPL##0##S18##). The addition of DTPA-Na had the function of weakening the dissolution interaction between Zn<sup>2+</sup> and water molecules, which can be confirmed by Raman results (Fig. ##SUPPL##0##S19##). Compared to the original 2 M ZnSO<sub>4</sub> electrolyte, the v-SO<sub>4</sub><sup>2−</sup> band centered at 984–986 cm<sup>−1</sup> in the solution containing the additive showed a clear shoulder shift to higher frequencies [##REF##32797719##59##], implying a tighter association of polymeric ions, which resulted from the DTPA-Na facilitating the stripping of water molecules from the Zn(H<sub>2</sub>O)<sub>6</sub><sup>2+</sup>. Meanwhile, we selected four chelating agents, DOTA, DTPA, EDTA, and NTA, and added the same molar ratio (38.75 mM, which is equivalent to 1 wt% for DTPA) as additives in 2 M ZnSO<sub>4</sub> (Fig. ##SUPPL##0##S20##). The cycling performance of DTPA is optimal, followed by that of EDTA. Such results demonstrate that the chelating agents with stability constants around 18.2 are suitable for use in this application scenario of aqueous zinc-ion batteries.</p>", "<p id=\"Par22\">Combining the above experimental and theoretical exploration, Fig. ##FIG##2##3##g summarized the overall mechanism of Zn dendritic inhibition with the DTPA-Na additive. During the plating/striping of Zn in the original ZnSO<sub>4</sub> electrolyte, the Zn(H<sub>2</sub>O)<sub>6</sub><sup>2+</sup> approaching the interface generates many reactive H<sub>2</sub>O molecules, causing corrosion, hydrogen evolution, and passivation that ultimately lead to severe inhomogeneous deposition and dendritic growth, which has a serious negative impact on the Zn/Zn<sup>2+</sup> reversible conversion process. However, by introducing DTPA-Na into the electrolyte, since the five carboxylated oxygens and the three nitrogens of the amine all have lone pair electrons that can be coordinated to Zn<sup>2+</sup>, the H<sub>2</sub>O molecules in the solvation sheath layer can be replaced by the chelate agents and left in the outer layer. The moderate chelating strength can also avoid a significant energy barrier to the dissociation of zinc ions. Then the DTPA anion adsorbed on the Zn surface further isolates the free water molecules from the Zn foil and thus the water-related side effects are inhibited. Meanwhile, the dynamic channels formed by polarizable DTPA-Na on the interface allow a more uniform flux of Zn<sup>2+</sup> to reach the interface. Together with the electrostatic shielding effect of Na<sup>+</sup>, all of these contribute to the homogeneous deposition of Zn, thus allowing the cell to proceed stably over a long period of time.</p>", "<title>Electrochemical Performance of Half/Full Cells with Optimized DTPA-Na Concentration</title>", "<p id=\"Par23\">Having demonstrated the effective function of the DTPA-Na additive in inhibiting Zn dendrite growth, further reversible plating and stripping measurements were next carried out to further evaluate the sustainability of the addition. Firstly, tests were conducted by assembling Zn||Ti half-cells with various concentrations of additives, from where the obtained coulombic efficiency can reveal the efficiency of the Zn plating/stripping process and is considered a significant parameter for measuring battery performance (Fig. ##SUPPL##0##S21## and Table ##SUPPL##0##S3##). The Zn||Ti half-cell cycled in the 2 M ZnSO<sub>4</sub> blank electrolyte exhibited an initial low CE followed by a slow ascent process. After only 40 cycles, it displayed a sudden reduction in CE, indicating an internal short circuit, whereas the average coulombic efficiency before cell failure was 92.4%. In contrast, the stable operation of the half-cell containing DTPA-Na can be extended to over 250 cycles, and the 1.5 wt% content group exhibited the highest average coulombic efficiency of 97.8%, indicating 1.5 wt% content also remains the better choice. In addition, to verify the role of precipitates, we removed the precipitates in the electrolyte with 2.3 wt% DTPA-Na, and the coulombic efficiency showed that the few precipitates did not have a significant effect on the performance of the cell (Fig. ##SUPPL##0##S22##). Also, we further adjusted the pH of the electrolyte to the same value of 5.5 as that of the DTPA-Na additive with NaOH and compared the performance, and the results of the symmetric cell and the half-cell showed that the performance of the battery was not improved with the addition of NaOH, which also proved that in addition to adjusting the pH, the additive's role is more important in the chelating ability (Figs. ##SUPPL##0##S23## and ##SUPPL##0##S24##).</p>", "<p id=\"Par24\">Then Cu foil was used as a counter electrode with a cut-off voltage of 1.0 V (vs. Zn/Zn<sup>2+</sup>) as shown in Fig. ##FIG##3##4##a. Zn||Cu assembled with the blank electrolyte encountered a sudden drop in CE values after 120 cycles due to dendrite growth or other side reactions. But for Zn||Cu cells using electrolytes containing 1.5 wt% DTPA-Na additive, high and stable CE values were maintained for more than 350 cycles. The voltage curve of the Zn||Cu half-cell in the blank electrolyte zigzagged down at the 120th cycle (Fig. ##FIG##3##4##b), which corresponds to the abnormal short circuit of the cell. In the meantime, the modified cell has a high overlap of the voltage curve for 300 cycles (Fig. ##FIG##3##4##c). Another set of Zn||Cu half-cells was disassembled after 100 cycles to observe the morphology of the deposited Zn on the Cu foils. For the Cu foil cycled in the blank electrolyte, the deposited Zn was in large, disorganized sheets, where the deposited surface was uneven to the naked eye (inset), and the cross-sectional view showed that the deposited Zn was poorly bonded to the base. As shown in Fig. ##FIG##3##4##d, e, the unrestricted and arbitrary plating and stripping process lead to the accumulation of \"dead zinc\" during repeated cycles that dramatically weakened the stability of the cell [##REF##35668132##60##]. For the modified cell, the zinc grains deposited on the Cu foil with 1.5 wt% DTPA-Na in the electrolyte were small and uniform (Fig. ##FIG##3##4##f, g). These results are consistent with the long-lasting and high values of CE, again verifying that cells using DTPA-Na-containing electrolytes could exhibit better cycling stability.</p>", "<p id=\"Par25\">Considering the outstanding electrochemical performance of the additive DTPA-Na in both the symmetric cells and the half-cells, the full zinc-ion cells coupled with the NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> cathodes were assembled and tested further. The cathode active material was prepared according to the previous literature that was verified to match with the NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> phase (JCPDS. No. 24-1155) (Figs. ##SUPPL##0##S18## and ##SUPPL##0##S19##). Figure ##FIG##4##5##a presents the first three CV curves for Zn||NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> with 1.5 wt% DTPA-Na-added electrolyte within the potential window of 0.2–1.6 V (vs. Zn<sup>2+</sup>/Zn) at a scan rate of 0.1 mV s<sup>−1</sup>, where the high overlapping shapes of the cycles showed the reversibility of the reaction. The rate performance of Zn||NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> devices with the additive present effective enhancement compared to that of the original 2 M ZnSO<sub>4</sub> electrolyte. To be specific, the modified full cell exhibited impressive discharge specific capacities of 405.4, 364.1, 332.9, 316.0, 296.3, 279.7, 220.8, and 148.5 mAh g<sup>−1</sup> at 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 2.0, and 4.0, respectively, all of which are higher than that of the blank electrolyte (Figs. ##FIG##4##5##b and S20). It is worth noting that the cell with 1.5 wt% DTPA-Na could reversibly release 103.2 mAh g<sup>−1</sup> even at an ultra-high current density of 6 A g<sup>−1</sup>, while the discharge capacity of the original cell is only 24.0 mAh g<sup>−1</sup> under the same conditions, which proved the superior kinetic properties of the modified electrolytes. After high-rate discharge/charge, the average capacity of the modified cell can still recover rapidly and tend to be around 336 mAh g<sup>−1</sup> when the current density drops to 0.1 A g<sup>−1</sup> again, demonstrating its superior Zn<sup>2+</sup> plating/stripping reversibility. The cycling stability was evaluated at the current density of 1 A g<sup>−1</sup> (0.1 A g<sup>−1</sup> for the first three cycles), as displayed in Fig. ##FIG##4##5##c. The capacity of the full cell assembling with the blank electrolyte decreases rapidly during the cycling, with capacity retention already below 50% (vs. the 4th cycle) after 200 cycles, and only remaining with a negligible discharge capacity of 30 mAh g<sup>−1</sup> after 500 cycles, which is mainly contributed by the capacitance. Simply by adding 1.5 wt% DTPA-Na to the electrolyte, however, the Zn||NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> full cell could still exhibit 249.9 mAh g<sup>−1</sup> capacity after 500 cycles, corresponding to 84.6% capacity retention (Fig. ##FIG##4##5##d). Moreover, the Zn||NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> cell also delivers excellent long-span cycling stability at 3 A g<sup>−1</sup> (Fig. ##FIG##4##5##e). Such long-term cycling stability once again confirms the effectiveness of the additive. Another Na-containing cathode, NaV<sub>6</sub>O<sub>15</sub>, (Figs. ##SUPPL##0##S21## and ##SUPPL##0##S22##) was also introduced as the cathode for comparison, and the full cell performance still demonstrated superior cycling performance over the original 2 M ZnSO<sub>4</sub> electrolyte due to the effectiveness of the DTPA anion and the presence of Na<sup>+</sup> contained in the additive analyzed previously, as shown in Fig. ##SUPPL##0##S23##. These findings demonstrate once more that the DTPA-Na additive can achieve high cycle reversibility by reducing both dendrite-growth and unanticipated side effects.</p>" ]
[ "<title>Results and Discussions</title>", "<title>Chelation Strength Design</title>", "<p id=\"Par14\">The chemical and electrochemical interactions between the zinc electrode and the electrolyte are schematically shown in Fig. ##FIG##0##1##a. In the control electrolyte, 2 M ZnSO<sub>4</sub> without any electrolyte additives (denoted as blank electrolyte), the uneven deposition on the surface of the zinc anode leads to the formation of dendrites. Such dendrite growth increases the surface area of zinc metal anode, which promotes HER in weakly acidic solution. As a result, HER happens as evidented by continuous bubbling during zinc plating. To solve the problem and inspired by the Sabatier principle for catalyst design [##REF##35524000##50##], we proposed to use a chelating agent DTPA-Na, with intermediate chelation strength to zinc ion, to suppress HER while allowing for stable zinc stripping/plating. The stability constants of zinc ion-coordination compounds are used to reflect the stability of the chelating agent in forming complexes with zinc ions, which can serve as a reference value for the chelation strength (Table ##SUPPL##0##S1##). The stabilization constant of DTPA-Na is 18.2 which is stronger than most chelating agents such as NTA (Nitrilotriacetic acid) and is relatively weaker than chelating agents like DOTA (1,4,7,10-tetraazacyclododecane-<italic>N</italic>,<italic>N</italic>′,<italic>N</italic>,<italic>N</italic>′-tetraacetic acid, another widely known strong chelating agent). The chelation strength of DTPA-Na is strong enough to exclude water molecules from the zinc metal-electrolyte interface (thus suppressing HER and zinc metall corrosion) and not too strong to cause a significant energy barrier for zinc ion dissociation (thus suppressing dendrite formation). The performance of the different additives will be compared later.</p>", "<p id=\"Par15\">Since the structure of the additive plays a key role in this action, FTIR spectra were first obtained for the DTPA-Na solution. As shown in Fig. ##FIG##0##1##b, the peak at 3429 cm<sup>−1</sup> is assigned to symmetric stretching vibrations of O–H. The peaks at 1595 and 1407 cm<sup>−1</sup> correspond to the antisymmetric and symmetric stretching vibrations of C=O in the carboxylate, respectively. The band at 1331 cm<sup>−1</sup> corresponds to the vibration of C–N, whereas the adsorption band at 717 cm<sup>−1</sup> is associated with Na–O bond [##UREF##30##51##, ##REF##26838894##52##]. At the same time, the FTIR characterization results of the 2 M ZnSO<sub>4</sub> blank electrolyte shown in Fig. ##SUPPL##0##S1## revealed little signal besides the O–H alluding to water. The elemental composition of DTPA-Na was investigated by XPS (Fig. ##SUPPL##0##S2##). The de-convoluted peaks of the C 1<italic>s</italic> binding energies are consistent with the C–C, C–N, and O–C=O frequencies at 284.4, 285.2, and 288.1 eV, respectively, and the deconvolution of O 1<italic>s</italic> spectra revealed two peaks, representing C–O (530.8 eV) and C=O (535.2 eV) [##UREF##31##53##, ##UREF##32##54##]. The abundance of oxygen-containing functional groups in the DTPA-Na leads to its strong chelating capabilities and enhances its adhesion on the anode surface [##UREF##33##55##].</p>", "<p id=\"Par16\">To investigate the optimal additive concentration, different amounts of DTPA-Na were dissolved in 2 M ZnSO<sub>4</sub> electrolyte. As shown in Fig. ##FIG##0##1##c, the solutions with 1 and 1.5 wt% DTPA-Na were homogeneous and clear, while those with 2.0 and 2.3 wt% DTPA-Na showed precipitation. The precipitates were characterized by SEM, FTIR, and XPS, attributing to the chelate product of DTPA with Zn (Figs. ##SUPPL##0##S3##–##SUPPL##0##S5##).Then the pH values of the electrolytes with various DTPA-Na concentrations were tested to examine the impact of the additional DTPA-Na on the side reactions occurring at the electrode (Fig. ##FIG##0##1##d). For the blank electrolyte, the pH value of 3.44 indicates an acidic condition that would make hydrogen evolution reactions more likely and lessen the stability of the anode during the battery cycle. After the addition of DTPA-Na, the pH of the electrolyte increased due to the hydrolysis of the DTPA anions. With 1, 1.5, 2.0, and 2.3 wt% DTPA-Na added into the 2 M ZnSO<sub>4</sub> electrolyte, the pH values evolved to, respectively, 5.41, 5.50, 5.54, and 5.56, gradually approaching the neutral environment, which is more unfavorable for HER reactions [##UREF##34##56##]. The current densities of hydrogen and oxygen evolution reactions on the zinc electrode were measured by linear scanning voltammetry (LSV) to demonstrate the intensity of the water splitting in various electrolytes. As shown in Fig. ##FIG##0##1##e, the addition of DTPA-Na reduced the current densities of hydrogen evolution reactions in the voltage range of − 1.0 to − 1.5 V (relative to Ag/AgCl) and oxygen evolution reactions in the range of 1.6–2.0 V, demonstrating that the additive had an impact on preventing the decomposition of water. The best effect was observed for the group with 1.5 wt% additives, whereas the current density controversially increased for the 2.0 and 2.3 wt% groups, since the precipitates produced with too high concentrations instead reduced the salt concentration and the amount of DTPA anion in solution, resulting in a weaker optimization effect. The strong adsorption role of the DTPA anions in competing with H<sub>2</sub>O is responsible for the ability of DTPA-Na to prevent these adverse responses. The Tafel curves were also measured with the Pt wire as the counter electrode (Fig. ##SUPPL##0##S7##). The corrosion current of the electrode in the 1.5 wt% additive-containing electrolyte was calculated to be lower (2.465 mA cm<sup>−2</sup>) than in the blank electrolyte (2.973 mA cm<sup>−2</sup>), indicating the electrode corroded at a lower rate in the modified electrolyte, both due to the weaker acidity of the electrolyte as a result of the additive addition, and the adsorption of the DTPA anion on the electrode surface. Such weaker corrosion was beneficial to the stability of the electrode.</p>", "<title>Electrochemical Performance with Different DTPA-Na Concentrations</title>", "<p id=\"Par17\">Zn||Zn symmetric cells were assembled to evaluate the cycling stability of the cell with or without DTPA-Na additives. At a constant current of 1 mA cm<sup>−2</sup> and an areal capacity of 0.5 mAh cm<sup>−2</sup>, as shown in Fig. ##FIG##1##2##a, the cells containing DTPA-Na exhibited more stable reversible zinc plating/stripping processes, while the cell in the blank electrolyte experienced an abrupt voltage drop at the 240th cycle, indicating the occurrence of short circuit that led to cell failure. To be more specific, the symmetrical cell with 1.0 wt% DTPA-Na in the electrolyte had improved cycling stability and was able to run for 2000 h, but the succeeding cycles encountered large voltage variations. The ultra-long cycling stability of 3500 cycles could be attained with an increase in additive content to 1.5 wt%, but further increases in additive content did not imply better cycle stability. This fact is also consistent with the LSV results, further illustrating the beneficial effect of the proper addition of DTPA-Na on improving cell performance. Figure ##FIG##1##2##b shows the voltage profile amplified during the 20th cycle. With the addition of 1.0, 1.5, 2.0, and 2.3 wt% DTPA-Na, the overpotentials of the Zn symmetric cell were found to increase sequentially from 40.1 mV for the blank electrolyte to 53.7, 47.2, 70.1, and 82.1 mV, respectively (Fig. ##SUPPL##0##S9##). The adsorbed DTPA layer on the electrode surface results in an appropriate level of high overpotential. The solvation sheath creates a high energy barrier to cause unexpected charge transfer resistance. But the sufficient chelating agents can make it easier for the water molecules to leave the solvation sheath, resulting in the lower overpotential in the 1.5 wt% content group than in the 1.0 wt% content group. On the other hand, the larger additive content of 2.0 and 2.3 wt% will produce precipitates, which may led to higher overpotentials. Taking into account the ion conductivity and cycling stability of symmetric cells, the appropriate concentration for further investigation was chosen to be 1.5 wt%.</p>", "<p id=\"Par18\">In order to determine the effect of the DTPA-Na additives on the Zn plating/stripping behavior, coin cells were disassembled for morphological characterizations. The SEM images of the Zn electrode after 100 cycles in the blank electrolyte demonstrated uneven Zn cluster growth, and the surface of the electrode was filled with flaky Zn deposits, corrosion pits, and by-products, which eventually led to cell failure (Fig. ##SUPPL##0##S10##). However, the addition of 1.5 wt% DTPA-Na led to the observation of a smoother surface with grain-fine Zn deposition, which aided in the formation of a dendrite-free electrode surface. The rate performance test was carried out for the electrolytes with or without the addition of 1.5 wt% DTPA-Na. Figure ##FIG##1##2##c shows the voltage profiles of the symmetric cells at current densities ranging from 1 to 5 mA cm<sup>−2</sup> for 20 h of each cycle with the current density subsequently gradually decreasing back to 1 mA cm<sup>−2</sup>. As current densities increased to 2, 3, 4, and 5 mA cm<sup>−2</sup>, the overpotentials of the cell with additives reached 40.9, 45.6, 62.3, and 73.8 mV, respectively (Fig. ##SUPPL##0##S11##). When the current density was returned to 1 mA cm<sup>−2</sup> again, it dropped to approximately 30 mV, indicating good cycling stability. Comparatively, the cell assembled with the blank electrolyte displayed instabilities in overvoltage fluctuations when the current density was changed, which may have been caused by the generation and shedding of “dead zinc” following uneven deposition/exfoliation. The subsequent overpotentials were in turn higher than those of the modified cell, originating from considerable Zn corrosion and passivated by-products. Additionally, the cell then quickly experienced a short circuit. Compared to unmodified cells, which failed after 330 cycles at 2 mA cm<sup>−2</sup> and 1 mAh cm<sup>−2</sup>, cells containing 1.5 wt% DTPA-Na cycled steadily for a longer period of time without experiencing substantial overpotential changes (Fig. ##FIG##1##2##d). The enlarged voltage–time graph for the selected cycles provided additional evidence of the impact of the addition on the stability of the cell (Figs. ##FIG##1##2##e and ##SUPPL##0##S12##). The modified symmetrical cell also outperformed the original one at a current density of 5 mA cm<sup>−2</sup>, which could run for over 450 h (Fig. ##SUPPL##0##S13##). These results are also very competitive with the cutting-edge studies as summarized in Table ##SUPPL##0##S2##.</p>", "<p id=\"Par19\">In order to observe the electrode morphology more clearly and confirm the protective effect of the DTPA-Na additive, symmetrical cells were assembled using the H-shaped mold (Fig. ##SUPPL##0##S14##). Two zinc electrode foils were sandwiched opposite each other in tubes on either side, and the backsides of the foils were covered with insulating tape to maintain a uniform effective surface. The surface morphology of the electrodes was examined by electron microscopy after 100 h of cycling at a current of 2 mA cm<sup>−2</sup> with a capacity of 1 mAh cm<sup>−2</sup>. Due to corrosion side reactions and uneven zinc deposition, many visible protrusions and holes appeared on the surface of the zinc foil tested in the blank electrolyte (Fig. ##FIG##1##2##f). According to previous studies, the presence of the “tip effect” leads to preferential deposition of zinc on the dendrites [##UREF##35##57##, ##REF##35041439##58##]. As a result, tiny protrusions gradually grow until being able to puncture the separator and eventually leading to short-circuiting of the cells. During cycling, bubbles caused by side reactions like HER are constantly present, and the growth of dendrites exposes additional sites for corrosion and side reactions. All of the above will lead to a reduction in coulombic efficiency (CE) as well as cycling performance. In sharp contrast, the zinc foil in the 1.5 wt% DTPA-Na-containing electrolyte showed a flat surface with fine grains and uniform deposition without discernible protrusions (Fig. ##FIG##1##2##g), indicating the added DTPA-Na effectively protected the zinc electrode by suppressing side reactions and uneven deposition, which further inhibits the formation of dendrites.</p>", "<title>Mechanisms of Stabilized Electrode/Electrolyte Interface</title>", "<p id=\"Par20\">To further validate the mechanism of action of DTPA-Na, the plating process of the transparent symmetric cell was observed by in situ optical microscopy at a current density of 10 mA cm<sup>−2</sup>. For the unmodified cell, a hydrogen bubble appeared on the surface of the electrode after 60 min of plating, and the deposited zinc layer started to become uneven. As this bubble continued to grow, more dense bubbles were created one after another. Impressively, after 90 min, multiple distinct Zn dendritic crystals rapidly formed next to the bubbles (Fig. ##FIG##2##3##a). In contrast, no bubbles were detected on the electrode with the addition of 1.5 wt% DTPA-Na, and the surface of the electrode maintained a smooth morphology during the plating process (Fig. ##FIG##2##3##b). Such monitored phenomena suggested H<sub>2</sub> evolution corrosion can be well mitigated by the introduction of the DTPA-Na additive. DTPA was adsorbed on the surface of Zn foil after cycling verified by Raman spectra (Fig. ##SUPPL##0##S15##). Meanwhile, since DTPA could be readily polarized under electrical loading conditions, the concentration gradient of the electrolyte approaching the zinc electrode surface during the deposition process could also be detected in Fig. ##FIG##2##3##b. The polarizable chelate ions reached the surface of the zinc electrode with the presence of an electric field, and the complex layer located on the interface formed a dynamically regulated channel that could modify the original water clusters in the electrolyte solution. With the cooperation of the dynamic layer, the contact between water molecules and the electrode surface is somehow hindered, further improving the passivation and reducing the corrosion as well as by-products. It is worth noting that, unlike the artificial surface coatings in some research methods which are prone to structural damage after long cycles, such dynamic layer will not be affected by zinc plating/stripping but can be self-shaped and adjusted with changes in the electric field, which is more conducive to the long cycle stability of the cell.</p>", "<p id=\"Par21\">Even at rest, the DTPA ions adsorbed on the interface also help mitigate the self-corrosion of the zinc electrode, which was investigated by immersing the Zn foil in the 2 M ZnSO<sub>4</sub> electrolyte solution with/without DTPA-Na. The Zn foil in the blank electrolyte turned gray after 1 month of immersion, which was caused by severe interfacial side reactions between Zn and the electrolyte. SEM images in Fig. ##FIG##2##3##c show a large number of irregular flakes of by-products loosely accumulated on the surface of the foil, which was identified to be Zn<sub>4</sub>SO<sub>4</sub>(OH)<sub>6</sub>·4H<sub>2</sub>O (JCPDS No. 44-0673) via EDS element mapping and XRD patterns with new diffraction peaks at 9.5° (Figs. ##SUPPL##0##S16## and ##FIG##2##3##e). Such corrosion by-products could severely affect the ion diffusion at the interface. In contrast, the Zn foil immersed in the electrolyte containing 1.5 wt% DTPA-Na displayed little visible morphological changes as well as by-products (Fig. ##FIG##2##3##d), indicating its excellent self-corrosion protection. To further explore the dendritic inhibition mechanism of the modified electrolyte, measurements including XPS and Raman were conducted. Note that a significant N 1<italic>s</italic> signal was observed on the surface of the immersed Zn foil with the addition of DTPA-Na compared to that with the blank electrolyte as shown in Fig. ##FIG##2##3##f, suggesting the adsorption of DTPA-Na on the Zn foil during the immersion which is consistent with the previous observations. Also, for the C 1<italic>s</italic> spectrum of the Zn foil placed in the additive-containing electrolyte shown in Fig. ##SUPPL##0##S17##, the two deconvoluted peaks were attributed to O–C=O and C–N, respectively. The abundance of oxygen-containing functional groups in the DTPA anion enhanced its adhesion to the electrode surface. The preliminary DFT computations also indicated that DTPA anion exhibits stronger adsorption energy of − 0.81 eV on the Zn surface compared to that of − 0.29 eV for free water (Fig. ##SUPPL##0##S18##). The addition of DTPA-Na had the function of weakening the dissolution interaction between Zn<sup>2+</sup> and water molecules, which can be confirmed by Raman results (Fig. ##SUPPL##0##S19##). Compared to the original 2 M ZnSO<sub>4</sub> electrolyte, the v-SO<sub>4</sub><sup>2−</sup> band centered at 984–986 cm<sup>−1</sup> in the solution containing the additive showed a clear shoulder shift to higher frequencies [##REF##32797719##59##], implying a tighter association of polymeric ions, which resulted from the DTPA-Na facilitating the stripping of water molecules from the Zn(H<sub>2</sub>O)<sub>6</sub><sup>2+</sup>. Meanwhile, we selected four chelating agents, DOTA, DTPA, EDTA, and NTA, and added the same molar ratio (38.75 mM, which is equivalent to 1 wt% for DTPA) as additives in 2 M ZnSO<sub>4</sub> (Fig. ##SUPPL##0##S20##). The cycling performance of DTPA is optimal, followed by that of EDTA. Such results demonstrate that the chelating agents with stability constants around 18.2 are suitable for use in this application scenario of aqueous zinc-ion batteries.</p>", "<p id=\"Par22\">Combining the above experimental and theoretical exploration, Fig. ##FIG##2##3##g summarized the overall mechanism of Zn dendritic inhibition with the DTPA-Na additive. During the plating/striping of Zn in the original ZnSO<sub>4</sub> electrolyte, the Zn(H<sub>2</sub>O)<sub>6</sub><sup>2+</sup> approaching the interface generates many reactive H<sub>2</sub>O molecules, causing corrosion, hydrogen evolution, and passivation that ultimately lead to severe inhomogeneous deposition and dendritic growth, which has a serious negative impact on the Zn/Zn<sup>2+</sup> reversible conversion process. However, by introducing DTPA-Na into the electrolyte, since the five carboxylated oxygens and the three nitrogens of the amine all have lone pair electrons that can be coordinated to Zn<sup>2+</sup>, the H<sub>2</sub>O molecules in the solvation sheath layer can be replaced by the chelate agents and left in the outer layer. The moderate chelating strength can also avoid a significant energy barrier to the dissociation of zinc ions. Then the DTPA anion adsorbed on the Zn surface further isolates the free water molecules from the Zn foil and thus the water-related side effects are inhibited. Meanwhile, the dynamic channels formed by polarizable DTPA-Na on the interface allow a more uniform flux of Zn<sup>2+</sup> to reach the interface. Together with the electrostatic shielding effect of Na<sup>+</sup>, all of these contribute to the homogeneous deposition of Zn, thus allowing the cell to proceed stably over a long period of time.</p>", "<title>Electrochemical Performance of Half/Full Cells with Optimized DTPA-Na Concentration</title>", "<p id=\"Par23\">Having demonstrated the effective function of the DTPA-Na additive in inhibiting Zn dendrite growth, further reversible plating and stripping measurements were next carried out to further evaluate the sustainability of the addition. Firstly, tests were conducted by assembling Zn||Ti half-cells with various concentrations of additives, from where the obtained coulombic efficiency can reveal the efficiency of the Zn plating/stripping process and is considered a significant parameter for measuring battery performance (Fig. ##SUPPL##0##S21## and Table ##SUPPL##0##S3##). The Zn||Ti half-cell cycled in the 2 M ZnSO<sub>4</sub> blank electrolyte exhibited an initial low CE followed by a slow ascent process. After only 40 cycles, it displayed a sudden reduction in CE, indicating an internal short circuit, whereas the average coulombic efficiency before cell failure was 92.4%. In contrast, the stable operation of the half-cell containing DTPA-Na can be extended to over 250 cycles, and the 1.5 wt% content group exhibited the highest average coulombic efficiency of 97.8%, indicating 1.5 wt% content also remains the better choice. In addition, to verify the role of precipitates, we removed the precipitates in the electrolyte with 2.3 wt% DTPA-Na, and the coulombic efficiency showed that the few precipitates did not have a significant effect on the performance of the cell (Fig. ##SUPPL##0##S22##). Also, we further adjusted the pH of the electrolyte to the same value of 5.5 as that of the DTPA-Na additive with NaOH and compared the performance, and the results of the symmetric cell and the half-cell showed that the performance of the battery was not improved with the addition of NaOH, which also proved that in addition to adjusting the pH, the additive's role is more important in the chelating ability (Figs. ##SUPPL##0##S23## and ##SUPPL##0##S24##).</p>", "<p id=\"Par24\">Then Cu foil was used as a counter electrode with a cut-off voltage of 1.0 V (vs. Zn/Zn<sup>2+</sup>) as shown in Fig. ##FIG##3##4##a. Zn||Cu assembled with the blank electrolyte encountered a sudden drop in CE values after 120 cycles due to dendrite growth or other side reactions. But for Zn||Cu cells using electrolytes containing 1.5 wt% DTPA-Na additive, high and stable CE values were maintained for more than 350 cycles. The voltage curve of the Zn||Cu half-cell in the blank electrolyte zigzagged down at the 120th cycle (Fig. ##FIG##3##4##b), which corresponds to the abnormal short circuit of the cell. In the meantime, the modified cell has a high overlap of the voltage curve for 300 cycles (Fig. ##FIG##3##4##c). Another set of Zn||Cu half-cells was disassembled after 100 cycles to observe the morphology of the deposited Zn on the Cu foils. For the Cu foil cycled in the blank electrolyte, the deposited Zn was in large, disorganized sheets, where the deposited surface was uneven to the naked eye (inset), and the cross-sectional view showed that the deposited Zn was poorly bonded to the base. As shown in Fig. ##FIG##3##4##d, e, the unrestricted and arbitrary plating and stripping process lead to the accumulation of \"dead zinc\" during repeated cycles that dramatically weakened the stability of the cell [##REF##35668132##60##]. For the modified cell, the zinc grains deposited on the Cu foil with 1.5 wt% DTPA-Na in the electrolyte were small and uniform (Fig. ##FIG##3##4##f, g). These results are consistent with the long-lasting and high values of CE, again verifying that cells using DTPA-Na-containing electrolytes could exhibit better cycling stability.</p>", "<p id=\"Par25\">Considering the outstanding electrochemical performance of the additive DTPA-Na in both the symmetric cells and the half-cells, the full zinc-ion cells coupled with the NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> cathodes were assembled and tested further. The cathode active material was prepared according to the previous literature that was verified to match with the NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> phase (JCPDS. No. 24-1155) (Figs. ##SUPPL##0##S18## and ##SUPPL##0##S19##). Figure ##FIG##4##5##a presents the first three CV curves for Zn||NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> with 1.5 wt% DTPA-Na-added electrolyte within the potential window of 0.2–1.6 V (vs. Zn<sup>2+</sup>/Zn) at a scan rate of 0.1 mV s<sup>−1</sup>, where the high overlapping shapes of the cycles showed the reversibility of the reaction. The rate performance of Zn||NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> devices with the additive present effective enhancement compared to that of the original 2 M ZnSO<sub>4</sub> electrolyte. To be specific, the modified full cell exhibited impressive discharge specific capacities of 405.4, 364.1, 332.9, 316.0, 296.3, 279.7, 220.8, and 148.5 mAh g<sup>−1</sup> at 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 2.0, and 4.0, respectively, all of which are higher than that of the blank electrolyte (Figs. ##FIG##4##5##b and S20). It is worth noting that the cell with 1.5 wt% DTPA-Na could reversibly release 103.2 mAh g<sup>−1</sup> even at an ultra-high current density of 6 A g<sup>−1</sup>, while the discharge capacity of the original cell is only 24.0 mAh g<sup>−1</sup> under the same conditions, which proved the superior kinetic properties of the modified electrolytes. After high-rate discharge/charge, the average capacity of the modified cell can still recover rapidly and tend to be around 336 mAh g<sup>−1</sup> when the current density drops to 0.1 A g<sup>−1</sup> again, demonstrating its superior Zn<sup>2+</sup> plating/stripping reversibility. The cycling stability was evaluated at the current density of 1 A g<sup>−1</sup> (0.1 A g<sup>−1</sup> for the first three cycles), as displayed in Fig. ##FIG##4##5##c. The capacity of the full cell assembling with the blank electrolyte decreases rapidly during the cycling, with capacity retention already below 50% (vs. the 4th cycle) after 200 cycles, and only remaining with a negligible discharge capacity of 30 mAh g<sup>−1</sup> after 500 cycles, which is mainly contributed by the capacitance. Simply by adding 1.5 wt% DTPA-Na to the electrolyte, however, the Zn||NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> full cell could still exhibit 249.9 mAh g<sup>−1</sup> capacity after 500 cycles, corresponding to 84.6% capacity retention (Fig. ##FIG##4##5##d). Moreover, the Zn||NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> cell also delivers excellent long-span cycling stability at 3 A g<sup>−1</sup> (Fig. ##FIG##4##5##e). Such long-term cycling stability once again confirms the effectiveness of the additive. Another Na-containing cathode, NaV<sub>6</sub>O<sub>15</sub>, (Figs. ##SUPPL##0##S21## and ##SUPPL##0##S22##) was also introduced as the cathode for comparison, and the full cell performance still demonstrated superior cycling performance over the original 2 M ZnSO<sub>4</sub> electrolyte due to the effectiveness of the DTPA anion and the presence of Na<sup>+</sup> contained in the additive analyzed previously, as shown in Fig. ##SUPPL##0##S23##. These findings demonstrate once more that the DTPA-Na additive can achieve high cycle reversibility by reducing both dendrite-growth and unanticipated side effects.</p>" ]
[ "<title>Conclusions</title>", "<p id=\"Par26\">In summary, we proposed to select effetive electrolyte additives for AZIBs using intermediate chelation strength. The selected DTPA-Na additive can effectively modify the electrolyte for dendrite-free and highly reversible AZIBs. By dynamically modulating the anode/electrolyte interface and tuning the solvation sheath of zinc ions, the electrolyte with DTPA-Na suppresses HER and zinc-metal corrosion and regulates Zn<sup>2+</sup> diffusion and deposition, leading to a highly reversible Zn anode. Over 3500 h of steady operation of the Zn||Zn symmetric cells can be achieved with stable overpotential at moderate current densities (1 mA cm<sup>−2</sup> with 0.5 mAh cm<sup>−2)</sup>. Stable Zn plating/stripping processes on Cu foils can be obtained for &gt; 500 cycles with stable CE close to 100%. When applied in Zn||NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> full cells, it enables a high capacity retention of 84.6% after 500 cycles. This work opens a new door for addressing the corrosion and dendrite problems in AZIBs and offers a practical approach to the logical design of reliable aqueous electrolytes.</p>" ]
[ "<title>Highlights</title>", "<p id=\"Par1\">\n<list list-type=\"bullet\"><list-item><p id=\"Par285\">Design principle of a reliable electrolyte based on chelation strength is proposed for high-performance aqueous batteries.</p></list-item><list-item><p id=\"Par3874\">The addition of penta-sodium diethylene-triaminepentaacetic acid salt is effective in dynamically modulating anode/electrolyte interface, inhibiting water-related side reactions, and mitigating dendrite generation on zinc anodes.</p></list-item><list-item><p id=\"Par4856\">Symmetrical, Zn||Cu half and Zn||NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> full cells using the new electrolyte exhibit improved electrochemical performance.</p></list-item></list>\n</p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s40820-023-01305-0.</p>", "<p id=\"Par1742\">Aqueous zinc-ion batteries are promising due to inherent safety, low cost, low toxicity, and high volumetric capacity. However, issues of dendrites and side reactions between zinc metal anode and the electrolyte need to be solved for extended storage and cycle life. Here, we proposed that an electrolyte additive with an intermediate chelation strength of zinc ion—strong enough to exclude water molecules from the zinc metal-electrolyte interface and not too strong to cause a significant energy barrier for zinc ion dissociation—can benefit the electrochemical stability by suppressing hydrogen evolution reaction, overpotential growth, and dendrite formation. Penta-sodium diethylene-triaminepentaacetic acid salt was selected for such a purpose. It has a suitable chelating ability in aqueous solutions to adjust solvation sheath and can be readily polarized under electrical loading conditions to further improve the passivation. Zn||Zn symmetric cells can be stably operated over 3500 h at 1 mA cm<sup>−2</sup>. Zn||NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> full cells with the additive show great cycling stability with 84.6% capacity retention after 500 cycles at 1 A g<sup>−1</sup>. Since the additive not only reduces H<sub>2</sub> evolution and corrosion but also modifies Zn<sup>2+</sup> diffusion and deposition, highlyreversible Zn electrodes can be achieved as verified by the experimental results. Our work offers a practical approach to the logical design of reliable electrolytes for high-performance aqueous batteries.</p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s40820-023-01305-0.</p>", "<title>Keywords</title>" ]
[ "<title>Experiments and Simulations</title>", "<title>Preparation of Electrolytes for Aqueous Zinc-ion Batteries</title>", "<p id=\"Par8\">Zinc sulfate (ZnSO<sub>4</sub>·7H<sub>2</sub>O, Macklin, 99%) was dissolved into the deionized water to obtain the 2 M ZnSO<sub>4</sub> baseline electrolyte. Then various concentrations of penta-sodium diethylenetriaminepentaacetic acid (C<sub>14</sub>H<sub>18</sub>N<sub>3</sub>Na<sub>5</sub>O<sub>10</sub>, DTPA-Na, Macklin) as the additive were added into the baseline electrolyte. The as-prepared baseline electrolyte and the improved electrolytes were used in the coin cells, H-type cells, the transparent-molds cell for in-situ optical microscopy observations, and full cells.</p>", "<title>Synthesis of NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> Cathode</title>", "<p id=\"Par9\">NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> cathode was synthesized by a hydrothermal method [##UREF##27##44##]. Typically, 1.17 g commercial ammonium vanadate (NH<sub>4</sub>VO<sub>3</sub>, Meryer, 99%) powders were dissolved in 70 mL deionized (DI) water at room temperature. Then 1.891 g oxalic acid (H<sub>2</sub>C<sub>2</sub>O<sub>4</sub>·2H<sub>2</sub>O, Meryer, 99%) was added into the solution under vigorous stirring. Later, the mixed solution was transferred into a 100 mL Teflon-lined stainless-steel autoclave. The autoclave was heated at 140 °C for 12 h and then cooled to room temperature naturally. The obtained products were washed with deionized water for 3 times, followed by drying under vacuum at 60 °C overnight to get the final NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> powders.</p>", "<title>Synthesis of NaV<sub>6</sub>O<sub>15</sub> Cathode</title>", "<p id=\"Par10\">NaV<sub>6</sub>O<sub>15</sub> cathode was also synthesized by a hydrothermal method [##REF##29397745##45##]. Typically, 727.5 mg vanadium pentoxide (V<sub>2</sub>O<sub>5</sub>, Macklin, 99%) powders and 160 mg sodium hydroxide (NaOH, Greagent, 96%) were dissolved in 70 mL of DI water. The mixed solution was transferred into a 100 mL Teflon-lined stainless-steel autoclave, which was heated at 180 °C for 24 h. After natural cooling, the products were filtered, washed, and dried.</p>", "<title>Characterizations</title>", "<p id=\"Par11\">Morphology and microstructure of the samples were examined by field emission scanning electron microscopy (FE-SEM, Hitachi, S-4800, Japan) equipped with an energy-dispersive X-ray spectrometer (EDX). Fourier transformed infrared (FTIR) spectra were measured using a spectrophotometer (VERTEX 70 V) by pressed KBr pellets. Raman spectra were measured using a Raman spectrophotometer (Horiba JobinY von, HR800, France) with 633 nm laser radiation in the range of 200–2000 cm<sup>−1</sup>. X-ray diffraction (XRD) data were measured using a Bruker X-ray diffractometer (D8 ADVANCE A25) with Cu Ka (<italic>λ</italic> = 0.154178 nm) radiation. X-ray photoelectron spectroscopy (XPS) data were measured with an ESCALAB 250 Xi electron spectrometer from VG Scientific using 300 W Al Ka radiation.</p>", "<title>Electrochemical Measurements</title>", "<p id=\"Par12\">The composite cathodes were prepared by the following procedure. Typically, the cathode slurry was prepared by mixing 70 wt% active material, 20 wt% carbon black, and 10 wt% polyvinylidene difluoride (PVDF) in N-methylpyrrolidone (NMP), and then coated on stainless-steel foils and dried at 60 °C in vacuum for 12 h. Both the cathode and zinc metal anode foils were punched into disks (Φ = 12 mm for coin cells and Φ = 8 mm for <italic>H</italic>-type cells). CR2032 coin-type cells were assembled using a glass fiber separator with a diameter of 19 mm. A fixed amount of electrolyte (60 μL for symmetric cell and half-cell, and 100 μL for full cell) was added to each coin cell. Charge/discharge tests were conducted using a Land cell test system (Land CT2001A, China). Cyclic voltammetry (CV) measurements were conducted on an electrochemical workstation (CHI614E, China) between 0.2 and 1.6 V at a sweep rate of 0.1 mV s<sup>−1</sup>. The electrochemical impedance (EIS) data of the cells were collected on an electrochemical workstation over a frequency range from 10<sup>5</sup> to 0.1 Hz with an amplitude of 5 mV<sub>rms</sub>. Linear scanning voltammetry (LSV) and Tafel tests were also measured on the electrochemical workstation.</p>", "<title>Atomistic Simulations</title>", "<p id=\"Par13\">Spin-polarized density functional theory (DFT) calculations were performed according to the first principles [##UREF##28##46##] within the generalized gradient approximation (GGA) using the Perdew-Burke-Ernzerhof (PBE) formulation [##REF##10062328##47##]. Projected augmented wave (PAW) potentials [##UREF##29##48##] were used to describe the ionic cores and valence electrons were taken into account using a plane wave basis set with a kinetic energy cutoff of 450 eV. Van der Waals interactions have been considered using the DFT-D3 method of Grimme [##REF##21370243##49##]. A geometry optimization was considered convergent when the energy change was smaller than 0.02 eV Å<sup>−1</sup>. During the relaxation, the Brillouin zone was sampled using a 1 × 1 × 1 Gamma centered grid for geometric optimization and transition state searching. A 15 Å-thick vacuum layer was added to the surface to eliminate the artificial interactions between periodic images.</p>", "<title>Supplementary Information</title>", "<p>Below is the link to the electronic supplementary material.</p>" ]
[ "<title>Acknowledgements</title>", "<p>This work is financially supported by National Natural Science Foundation of China (NSFC-No. 52173257 and 52372064).</p>", "<title>Declarations</title>", "<title>Conflict of interest</title>", "<p id=\"Par27\">The authors declare no interest confict. They have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p><bold>a</bold> Schematics showing the effect of electrolyte additives with various chelation strengths on the stability of Zn/electrolyte interface.<bold> b</bold> FT-IR spectra of DTPA-Na solution. <bold>c</bold> Digital photographs of electrolytes with different DTPA-Na concentrations.<bold> d</bold> pH value and<bold> e</bold> LSV curve of electrolytes with different DTPA-Na concentrations</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p><bold>a</bold> Long cycle performance and <bold>b</bold> the related voltage–time profiles of symmetric cells assembled with different concentrations of DTPA-Na electrolyte at 1 mA cm<sup>−2</sup> and 0.5 mAh cm<sup>−2</sup>. <bold>c</bold>–<bold>d</bold> Plating/stripping cycling stability of symmetric cells in the electrolyte at different current densities. <bold>e</bold> Voltage–time profiles comparison of Zn||Zn symmetric cells at 2 mA cm<sup>−2</sup> and 1 mAh cm<sup>−2</sup> for selected cycles. SEM images of Zn foils after 100 cycles <bold>f</bold> in the baseline electrolyte and <bold>g</bold> the designed electrolyte at 2 mA cm<sup>−2</sup> with an areal capacity of 1 mA h cm.<sup>−2</sup></p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p>In situ optical microscopy images of the cross-sectional Zn deposition morphology <bold>a</bold> in the blank electrolyte and <bold>b</bold> the modified electrolyte in symmetrical cells at a current density of 10 mA cm<sup>−2</sup>. Surface morphology of Zn foils immersed in <bold>c</bold> the blank electrolyte and <bold>d</bold> the modified electrolyte for 1 month. The corresponding (<bold>e</bold>) XRD patterns and <bold>f</bold> the high-resolution XPS spectra for N1s of the immersed Zn foils. <bold>g</bold> Schematic illustration of the effect of DTPA on the desolvation process in the electrolytes</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p><bold>a</bold> Coulombic efficiency of Zn plating/stripping on Cu in the baseline and designed electrolytes. Corresponding voltage profiles of the Zn||Cu cells in <bold>b</bold> the baseline electrolyte and <bold>c</bold> the designed electrolyte at different cycles. Surface and cross-section morphology of Cu foils after 100 cycles in <bold>d</bold>–<bold>e</bold> the blank electrolyte and <bold>f</bold>–<bold>g</bold> the designed electrolyte</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><p><bold>a</bold> CV profiles of Zn||NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> cell in the designed electrolyte at 0.1 mV s<sup>−1</sup>. <bold>b</bold> Rate capability from 0.1 to 6 A g<sup>−1</sup>. <bold>c</bold> Cycling performance at 1 A g<sup>−1</sup> in the voltage range of 0.2–1.6 V (vs Zn/Zn<sup>2+</sup>) and <bold>d</bold> corresponding discharge/charge profiles for selected cycles. <bold>e</bold> Long-span cycling performance of Zn||NH<sub>4</sub>V<sub>4</sub>O<sub>10</sub> cells at 3 A g<sup>−1</sup></p></caption></fig>" ]
[]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[]
[ "<graphic position=\"anchor\" xlink:href=\"40820_2023_1305_Figa_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"40820_2023_1305_Fig1_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"40820_2023_1305_Fig2_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"40820_2023_1305_Fig3_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"40820_2023_1305_Fig4_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"40820_2023_1305_Fig5_HTML\" id=\"MO6\"/>" ]
[ "<media xlink:href=\"40820_2023_1305_MOESM1_ESM.pdf\"><caption><p>Supplementary file1 (PDF 2057 KB)</p></caption></media>" ]
[{"label": ["2."], "surname": ["Olivetti", "Ceder", "Gaustad", "Fu"], "given-names": ["EA", "G", "GG", "X"], "article-title": ["Lithium-ion battery supply chain considerations: analysis of potential bottlenecks in critical metals"], "source": ["Joule"], "year": ["2017"], "volume": ["1"], "fpage": ["229"], "lpage": ["243"], "pub-id": ["10.1016/j.joule.2017.08.019"]}, {"label": ["3."], "surname": ["Blay", "Galian", "Muresan", "Pankratov", "Pinyou"], "given-names": ["V", "RE", "LM", "D", "P"], "article-title": ["Research frontiers in energy-related materials and applications for 2020\u20132030"], "source": ["Adv. Sustain. Syst."], "year": ["2020"], "volume": ["4"], "fpage": ["1900145"], "pub-id": ["10.1002/adsu.201900145"]}, {"label": ["4."], "surname": ["Huang", "Qiu", "Wang", "Wang"], "given-names": ["J", "X", "N", "Y"], "article-title": ["Aqueous rechargeable zinc batteries: challenges and opportunities"], "source": ["Curr. Opin. Electrochem."], "year": ["2021"], "volume": ["30"], "fpage": ["100801"], "pub-id": ["10.1016/j.coelec.2021.100801"]}, {"label": ["6."], "surname": ["Chao", "Zhou", "Ye", "Zhang", "Chen"], "given-names": ["D", "W", "C", "Q", "Y"], "article-title": ["An electrolytic Zn\u2013MnO"], "sub": ["2"], "source": ["Angew. Chem. Int. Ed."], "year": ["2019"], "volume": ["58"], "fpage": ["7823"], "lpage": ["7828"], "pub-id": ["10.1002/anie.201904174"]}, {"label": ["8."], "surname": ["Yan", "Ang", "Yang", "Zhang", "Ye"], "given-names": ["J", "EH", "Y", "Y", "M"], "article-title": ["High-voltage zinc-ion batteries: design strategies and challenges"], "source": ["Adv. Funct. Mater."], "year": ["2021"], "volume": ["31"], "fpage": ["2010213"], "pub-id": ["10.1002/adfm.202010213"]}, {"label": ["9."], "surname": ["Yuan", "Hao", "Kao", "Wu", "Liu"], "given-names": ["L", "J", "C-C", "C", "H-K"], "article-title": ["Regulation methods for the Zn/electrolyte interphase and the effectiveness evaluation in aqueous Zn-ion batteries"], "source": ["Energy Environ. Sci."], "year": ["2021"], "volume": ["14"], "fpage": ["5669"], "lpage": ["5689"], "pub-id": ["10.1039/D1EE02021H"]}, {"label": ["10."], "surname": ["Li", "Guo", "Zhou"], "given-names": ["H", "S", "H"], "article-title": ["Recent advances in manipulating strategy of aqueous electrolytes for Zn anode stabilization"], "source": ["Energy Stor. Mater."], "year": ["2023"], "volume": ["56"], "fpage": ["227"], "lpage": ["257"], "pub-id": ["10.1016/j.ensm.2023.01.027"]}, {"label": ["11."], "surname": ["Zhao", "Zhao", "Hu", "Li", "Li"], "given-names": ["Z", "J", "Z", "J", "J"], "article-title": ["Long-life and deeply rechargeable aqueous Zn anodes enabled by a multifunctional brightener-inspired interphase"], "source": ["Energy Environ. Sci."], "year": ["2019"], "volume": ["12"], "fpage": ["1938"], "lpage": ["1949"], "pub-id": ["10.1039/C9EE00596J"]}, {"label": ["12."], "surname": ["Blanc", "Kundu", "Nazar"], "given-names": ["LE", "D", "LF"], "article-title": ["Scientific challenges for the implementation of Zn-ion batteries"], "source": ["Joule"], "year": ["2020"], "volume": ["4"], "fpage": ["771"], "lpage": ["799"], "pub-id": ["10.1016/j.joule.2020.03.002"]}, {"label": ["13."], "surname": ["Cui", "Zhao", "Wu", "Chen", "Yang"], "given-names": ["Y", "Q", "X", "X", "J"], "article-title": ["An interface-bridged organic-inorganic layer that suppresses dendrite formation and side reactions for ultra-long-life aqueous zinc metal anodes"], "source": ["Angew. Chem. Int. Ed."], "year": ["2020"], "volume": ["59"], "fpage": ["16594"], "lpage": ["16601"], "pub-id": ["10.1002/anie.202005472"]}, {"label": ["14."], "surname": ["Kim", "Liu", "Ardhi", "Park", "Kim"], "given-names": ["JY", "G", "REA", "J", "H"], "article-title": ["Stable Zn metal anodes with limited Zn-doping in MgF"], "sub": ["2"], "source": ["Nano-Micro Lett."], "year": ["2022"], "volume": ["14"], "fpage": ["46"], "pub-id": ["10.1007/s40820-021-00788-z"]}, {"label": ["15."], "surname": ["Xie", "Liang", "Gao", "Guo", "Guo"], "given-names": ["X", "S", "J", "S", "J"], "article-title": ["Manipulating the ion-transfer kinetics and interface stability for high-performance zinc metal anodes"], "source": ["Energy Environ. Sci."], "year": ["2020"], "volume": ["13"], "fpage": ["503"], "lpage": ["510"], "pub-id": ["10.1039/C9EE03545A"]}, {"label": ["18."], "surname": ["Song", "Ruan", "Mao", "Chang", "Wang"], "given-names": ["Y", "P", "C", "Y", "L"], "article-title": ["Metal-organic frameworks functionalized separators for robust aqueous zinc-ion batteries"], "source": ["Nano-Micro Lett."], "year": ["2022"], "volume": ["14"], "fpage": ["218"], "pub-id": ["10.1007/s40820-022-00960-z"]}, {"label": ["19."], "surname": ["Kang", "Cui", "Jiang", "Gao", "Luo"], "given-names": ["L", "M", "F", "Y", "H"], "article-title": ["Nanoporous CaCO"], "sub": ["3"], "source": ["Adv. Energy Mater."], "year": ["2018"], "volume": ["8"], "fpage": ["1801090"], "pub-id": ["10.1002/aenm.201801090"]}, {"label": ["20."], "surname": ["Guo", "Zhou", "Chen", "Zhuang", "Li"], "given-names": ["C", "J", "Y", "H", "Q"], "article-title": ["Synergistic manipulation of hydrogen evolution and zinc ion flux in metal-covalent organic frameworks for dendrite-free Zn-based aqueous batteries"], "source": ["Angew. Chem. Int. Ed."], "year": ["2022"], "volume": ["61"], "fpage": ["e202210871"], "pub-id": ["10.1002/anie.202210871"]}, {"label": ["21."], "surname": ["Xia", "Wang", "Shao", "Wang"], "given-names": ["Y", "H", "G", "C-A"], "article-title": ["Realizing highly reversible and deeply rechargeable Zn anode by porous zeolite layer"], "source": ["J. Power. Sources"], "year": ["2022"], "volume": ["540"], "fpage": ["231659"], "pub-id": ["10.1016/j.jpowsour.2022.231659"]}, {"label": ["22."], "surname": ["Ying", "Huang", "Zhang", "Zhang", "Han"], "given-names": ["H", "P", "Z", "S", "Q"], "article-title": ["Freestanding and flexible interfacial layer enables bottom-up Zn deposition toward dendrite-free aqueous Zn-ion batteries"], "source": ["Nano-Micro Lett."], "year": ["2022"], "volume": ["14"], "fpage": ["180"], "pub-id": ["10.1007/s40820-022-00921-6"]}, {"label": ["25."], "surname": ["Qian", "Zan", "Li", "Lee", "Wang"], "given-names": ["G", "G", "J", "S-J", "Y"], "article-title": ["Structural, dynamic, and chemical complexities in zinc anode of an operating aqueous Zn-ion battery"], "source": ["Adv. Energy Mater."], "year": ["2022"], "volume": ["12"], "fpage": ["2270084"], "pub-id": ["10.1002/aenm.202270084"]}, {"label": ["29."], "surname": ["Hao", "Yuan", "Ye", "Chao", "Davey"], "given-names": ["J", "L", "C", "D", "K"], "article-title": ["Boosting zinc electrode reversibility in aqueous electrolytes by using low-cost antisolvents"], "source": ["Angew. Chem. Int. Ed."], "year": ["2021"], "volume": ["60"], "fpage": ["7366"], "lpage": ["7375"], "pub-id": ["10.1002/anie.202016531"]}, {"label": ["31."], "surname": ["Sun", "Zheng", "Du", "Tao"], "given-names": ["T", "S", "H", "Z"], "article-title": ["Synergistic effect of cation and anion for low-temperature aqueous zinc-ion battery"], "source": ["Nano-Micro Lett."], "year": ["2021"], "volume": ["13"], "fpage": ["204"], "pub-id": ["10.1007/s40820-021-00733-0"]}, {"label": ["33."], "surname": ["Zhang", "Rodr\u00edguez-P\u00e9rez", "Jiang", "Zhang", "Leonard"], "given-names": ["L", "IA", "H", "C", "DP"], "article-title": ["ZnCl"], "sub": ["2"], "source": ["Adv. Funct. Mater."], "year": ["2019"], "volume": ["29"], "fpage": ["1902653"], "pub-id": ["10.1002/adfm.201902653"]}, {"label": ["35."], "surname": ["Santos", "Fern\u00e1ndez Romero"], "given-names": ["F", "AJ"], "article-title": ["Hydration as a solution to zinc batteries"], "source": ["Nat. Sustain."], "year": ["2022"], "volume": ["5"], "fpage": ["179"], "lpage": ["180"], "pub-id": ["10.1038/s41893-021-00834-z"]}, {"label": ["36."], "surname": ["Hou", "Zhang", "Li", "Zhu", "Liang"], "given-names": ["Z", "X", "X", "Y", "J"], "article-title": ["Surfactant widens the electrochemical window of an aqueous electrolyte for better rechargeable aqueous sodium/zinc battery"], "source": ["J. Mater. Chem. A"], "year": ["2017"], "volume": ["5"], "fpage": ["730"], "lpage": ["738"], "pub-id": ["10.1039/C6TA08736A"]}, {"label": ["38."], "surname": ["Liu", "Wang", "Zhu", "Han"], "given-names": ["J", "X", "Y", "Y"], "article-title": ["Flotation separation of scheelite from fluorite by using DTPA as a depressant"], "source": ["Miner. Eng."], "year": ["2022"], "volume": ["175"], "fpage": ["107311"], "pub-id": ["10.1016/j.mineng.2021.107311"]}, {"label": ["39."], "surname": ["Eivazihollagh", "B\u00e4ckstr\u00f6m", "Norgren", "Edlund"], "given-names": ["A", "J", "M", "H"], "article-title": ["Electrochemical recovery of copper complexed by DTPA and C"], "sub": ["12"], "source": ["J. Chem. Technol. Biotechnol."], "year": ["2018"], "volume": ["93"], "fpage": ["1421"], "lpage": ["1431"], "pub-id": ["10.1002/jctb.5510"]}, {"label": ["40."], "surname": ["Watanabe", "Hashimoto", "Ishioka"], "given-names": ["S", "K", "NS"], "article-title": ["Lutetium-177 complexation of DOTA and DTPA in the presence of competing metals"], "source": ["J. Radioanal. Nucl. Chem."], "year": ["2015"], "volume": ["303"], "fpage": ["1519"], "lpage": ["1521"], "pub-id": ["10.1007/s10967-014-3590-3"]}, {"label": ["41."], "surname": ["Maftoun", "Haghighat Nia", "Karimian", "Ronaghi"], "given-names": ["M", "H", "N", "AM"], "article-title": ["Evaluation of chemical extractants for predicting lowland rice response to zinc in highly calcareous soils"], "source": ["Commun. Soil Sci. Plant Anal."], "year": ["2003"], "volume": ["34"], "fpage": ["1269"], "lpage": ["1280"], "pub-id": ["10.1081/css-120020443"]}, {"label": ["44."], "surname": ["Tang", "Zhou", "Fang", "Liu", "Zhu"], "given-names": ["B", "J", "G", "F", "C"], "article-title": ["Engineering the interplanar spacing of ammonium vanadates as a high-performance aqueous zinc-ion battery cathode"], "source": ["J. Mater. Chem. A"], "year": ["2019"], "volume": ["7"], "fpage": ["940"], "lpage": ["945"], "pub-id": ["10.1039/C8TA09338E"]}, {"label": ["46."], "surname": ["Kresse", "Furthm\u00fcller"], "given-names": ["G", "J"], "article-title": ["Efficiency of ab-initio total energy calculations for metals and semiconductors using a plane-wave basis set"], "source": ["Comput. Mater. Sci."], "year": ["1996"], "volume": ["6"], "fpage": ["15"], "lpage": ["50"], "pub-id": ["10.1016/0927-0256(96)00008-0"]}, {"label": ["48."], "surname": ["Kresse", "Joubert"], "given-names": ["G", "D"], "article-title": ["From ultrasoft pseudopotentials to the projector augmented-wave method"], "source": ["Phys. Rev. B"], "year": ["1999"], "volume": ["59"], "fpage": ["1758"], "lpage": ["1775"], "pub-id": ["10.1103/physrevb.59.1758"]}, {"label": ["51."], "surname": ["Yuan", "Zhao", "Zhao", "Wu", "Liu"], "given-names": ["C", "D", "B", "Y", "J"], "article-title": ["2D NMR and FT-raman spectroscopic studies on the interaction of lanthanide ions and ln-DTPA with phospholipid bilayers"], "source": ["Langmuir"], "year": ["1996"], "volume": ["12"], "fpage": ["5375"], "lpage": ["5378"], "pub-id": ["10.1021/la950437y"]}, {"label": ["53."], "surname": ["Erdem", "Hunsicker", "Simmons", "Sudol", "Dimonie"], "given-names": ["B", "RA", "GW", "ED", "VL"], "article-title": ["XPS and FTIR surface characterization of TiO"], "sub": ["2"], "source": ["Langmuir"], "year": ["2001"], "volume": ["17"], "fpage": ["2664"], "lpage": ["2669"], "pub-id": ["10.1021/la0015213"]}, {"label": ["54."], "surname": ["Ravi", "Zhang", "Lee", "Kang", "Kim"], "given-names": ["S", "S", "Y-R", "K-K", "J-M"], "article-title": ["EDTA-functionalized KCC-1 and KIT-6 mesoporous silicas for Nd"], "sup": ["3+"], "source": ["J. Ind. Eng. Chem."], "year": ["2018"], "volume": ["67"], "fpage": ["210"], "lpage": ["218"], "pub-id": ["10.1016/j.jiec.2018.06.031"]}, {"label": ["55."], "surname": ["Sun", "Ma", "Zhou", "Qiu", "Wang"], "given-names": ["P", "L", "W", "M", "Z"], "article-title": ["Simultaneous regulation on solvation shell and electrode interface for dendrite-free Zn ion batteries achieved by a low-cost glucose additive"], "source": ["Angew. Chem. Int. Ed."], "year": ["2021"], "volume": ["60"], "fpage": ["18247"], "lpage": ["18255"], "pub-id": ["10.1002/anie.202105756"]}, {"label": ["56."], "surname": ["Chen", "Zhang", "Huang", "Guan", "Zong"], "given-names": ["R", "W", "Q", "C", "W"], "article-title": ["Trace amounts of triple-functional additives enable reversible aqueous zinc-ion batteries from a comprehensive perspective"], "source": ["Nano-Micro Lett."], "year": ["2023"], "volume": ["15"], "fpage": ["81"], "pub-id": ["10.1007/s40820-023-01050-4"]}, {"label": ["57."], "surname": ["Qian", "Zhou", "Peng", "Qian", "Meng"], "given-names": ["S", "J", "M", "Y", "Y"], "article-title": ["A Lewis acidity adjustable organic ammonium cation derived robust protecting shield for stable aqueous zinc-ion batteries by inhibiting the tip effect"], "source": ["Mater. Chem. Front."], "year": ["2022"], "volume": ["6"], "fpage": ["901"], "lpage": ["907"], "pub-id": ["10.1039/D1QM01604K"]}]
{ "acronym": [], "definition": [] }
60
CC BY
no
2024-01-14 23:40:14
Nanomicro Lett. 2024 Jan 12; 16:82
oa_package/7e/b4/PMC10786796.tar.gz
PMC10786801
38214764
[ "<title>Introduction</title>", "<p id=\"Par7\">In the realm of porous materials, porous organic molecular materials (POMMs) are an emergent class characterized by the formation of extended porous frameworks, mainly held by non-covalent interactions such as hydrogen bonds, ionic interactions, π–π stacking interactions, among others [##UREF##0##1##, ##UREF##1##2##]. From the chemical point of view, POMMs encompass a variety of chemical families, such as hydrogen-bonded organic frameworks (HOFs) [##REF##36589879##3##, ##UREF##2##4##], porous organic salts [##UREF##3##5##], porous organic cages (POCs) [##UREF##4##6##], C–H⋅⋅⋅π microporous crystals [##REF##34859253##7##], supramolecular organic frameworks (SOFs) [##UREF##5##8##], π-organic frameworks [##UREF##6##9##–##REF##32788358##11##], halogen-bonded organic framework (XOF) [##UREF##8##12##], and intrinsically porous molecular materials (IPMs) [##REF##33332097##13##]. Although POMMs are less studied compared to other porous materials, they have already been demonstrated to possess unique properties that are complementary to zeolites [##REF##26477329##14##], covalent organic frameworks (COFs) [##UREF##9##15##] and metal organic frameworks (MOFs) [##UREF##10##16##]. High crystallinity and flexibility, low weight and inherent toxicity, good recyclability, great solution processability and self-healing properties, are a unique combination of properties that makes POMMs excellent candidates for a vast range of applications. Another key advantage of POMMs lies in their tunability and diversity. This chemical versatility can be used to design materials with tailored properties for specific applications, leading to enhanced performance and efficiency [##UREF##11##17##]. Likewise, this also entails the need for a great variety of synthetic strategies and building blocks [##UREF##0##1##]. This variety of building blocks is translated into a variety of chemistries and properties. For example, a wide range of chemical stabilities in POMMs can be found, with enormous progress being achieved in some POMMs such as HOFs and POCs, to the point of being stable in extreme conditions of pH, boiling water, and strong redox conditions. Another fundamental difference among the families of POMMs is how the porosity is constructed during crystallisation. Materials with intrinsic porosity display pores or voids as integral part of the molecule used as building unit. Therefore, the intrinsic porosity is present before crystallisation and introduced during the molecular design as pre-assembled. In contrast, extrinsic porosity is formed during the crystallization, through the inefficient packing of the molecular precursors. Examples of materials with intrinsic porosity are POCs, constructed by distinct (zero-dimensional or 0D) macromolecules, resulting in materials with inherent voids due to their designed cage shape. During crystallisation, POCs can also form extrinsic porosity through inefficient crystal packing of these macromolecules. In contrast, a characteristic example of materials with extrinsic porosity are HOFs, as a new class of crystalline materials composed of organic molecular precursors linked together through hydrogen bonds, and in most cases π-π stacking interactions, yielding 2D and 3D porous frameworks. As the geometry of the molecular precursor is affecting the final assembly, several aspects should be considered during the design of molecular precursors of POMMs. First, common strategies to other porous materials, such reticular chemistry, are not easily applied to POMMs. This is mainly the difficulty of predicting the crystal packing and hence it is not trivial to design POMMs molecular precursors de novo. That difficulty is exacerbated when additional chemical functionalities are introduced during the synthesis of the molecular precursor. Thus, and despite of being a new field with challenges ahead, POMMs have gained significant attention in recent years and have reached early success in fields of gas separation, catalysis, sensing, drug delivery, and environmental remediation [##UREF##1##2##].</p>", "<p id=\"Par8\">Hierarchy is a very fundamental property in many materials [##REF##26477329##14##]. It refers to the presence of multiple levels of organization within a material, ranging from the molecular scale to the micro-, meso- and macroscale. Compared to traditional materials with homogeneous microstructures, where the properties governed by the arrangement of atoms or molecules at a single length scale, hierarchical materials exhibit a complex organization across multiple length scales. Wood and bones are some examples of materials found in nature with hierarchical organization [##UREF##12##18##]. In these materials, each level contributes to the overall structure and properties, forming interactions and synergies between the different length scales, and leading to properties and performances that are out of reach for most of the materials operating at a single scale [##UREF##13##19##, ##UREF##14##20##]. In the field of porous materials, the incorporation of multiscale has been widely adopted in zeolites [##UREF##15##21##], explored in MOFs [##UREF##16##22##] and to some extent in COFs [##REF##32427238##23##], allowing to obtain materials with multifunctionality and optimized properties. In POMMs, particularly, the first degree of hierarchy can be considered the crystalline packing which defines the primary porosity and architecture. The next level of hierarchy is introduced at higher scales, by either incorporating secondary architectures, combining micro-, meso or macroporosity, or integrating different materials at different scales. Recent literature has focused on POMMs. A recent review by Little et al. highlights the relevance of POMMs for a wide range of applications [##UREF##0##1##], where POMMs can be considered as ideal candidates. Similarly, Halliwell et al. focus their review on the synthetic strategies used for the obtention of POMMs with meso- or macroporosity and the combination of multiscale pores [##UREF##1##2##], and how the porosity affects the properties of these materials. Given the fundamental importance of hierarchy in materials, and the relevance that POMMs are reaching in the field of synthetic porous materials, we consider it appropriate to dedicate, for the first time, an integral overview covering both topics. Herein, we will summarize examples found in the literature of hierarchical POMMs (Fig. ##FIG##0##1##), focusing on the main synthetic routes and their applications, while trying to underline the advantages of introducing hierarchy. For the sake of clarity, we will divide the sections following the generally accepted classification of hierarchical materials according to their composition, architecture, and porosity [##UREF##17##24##]. Hierarchical composition refers to the multiscale order of a material having a mixture of 2 or more compositions. Hierarchical architectures have very defined structures at more than one level of organization and hierarchical porosity is present in materials with more than one pore of different scale.</p>" ]
[]
[]
[]
[ "<title>Conclusions</title>", "<p id=\"Par25\">The relevance that hierarchy has achieved in the field of porous materials emphasizes the importance of understanding and utilizing hierarchical structures to devise materials with enhanced properties and optimized performance. Given the growing interest for POMMs in the literature, this review aims to cover the extend of the integration of hierarchy in POMMs and thus contribute to the understanding and future advancement of these materials. From the examples reviewed here, we can conclude that the integration of multiscale in POMMs also offers a fascinating avenue for researchers to explore new frontiers in material design and application.</p>", "<p id=\"Par26\">Next clear steps in the field would be the combination of hierarchies, so multifunctionality could be incorporated, and some early examples have been included here. Also, it is expected that certain combination of hierarchies in one material will be particularly challenging, such as the combination of hierarchical porosity with other hierarchies, and the development of purely organic core–shell crystals combining families of POMMs. Additionally, a clearer understanding of the underlying mechanism governing multiscale growth should be pursued, as it remains elusive in most families, along with more detailed studies for the structure–property relationship at different scales. Future avenues to pursue could be the development of applications using solution processable techniques for the integration of POMMs in electronic devices is in its infancy. For example, despite of their potential, the integration of POMMs in electronic devices is still in its infancy. In this case, additional properties in POMMs such as flexibility and elasticity would be an advantage during their integration in flexible electronic devices. Moreover, with their relatively lower toxicity compared to MOFs, simple synthesis, and solution processability, POMMs also seem more logic candidates for biomedical applications, including biocatalysis, and biosensors. However, and despite of the inherent lower toxicity of POMMs, to the author’s knowledge, no studies on the biodegradability of POMMs in relevant environments have been published, which will be required for biomedical and environmental applications.</p>", "<p id=\"Par27\">For future prospective industrial applications, several considerations should be made. Firstly, the inherent solution processability of POMMs [##UREF##0##1##] represents a key advantage over other porous materials in terms of materials processing and secondly, the study of mechanical properties should be carefully studied if these materials are going to be considered a replacement for current existing materials, or when new applications are targeted. The combination of properties such as flexibility, better biocompatibility, and self-healing nature [##UREF##37##52##] in a single synthetic material are unique and could be the starting point for the development of novel devices based on these properties. However, a long-standing challenge that needs to be addressed in these materials is the incorporation of pore functionalities, since the inclusion of additional chemical functionalities has profound effects on the crystal structure, in most cases altering the packing completely. The integration of hierarchical composition could partially solve this challenge by designing novel composites with materials that can more easily integrate chemical functionalities.</p>", "<p id=\"Par28\">In a personal note, we are convinced that in the future, POMMs can reach a similar level of development to other porous materials with extended networks such as MOFs and COFs. Clearly, the level of integration of multiscale design among the families of POMMs is very heterogeneous, and although a general synthetic strategy for incorporating hierarchy in all POMM families is difficult to foresee, this review aims to stimulate cross-pollination among different families. With this in mind, we believe that chemical strategies could be shared and serve of inspiration for the construction of more complex multiscale structures that would expand the library of POMMs materials [##UREF##46##68##].</p>" ]
[ "<title>Highlights</title>", "<p id=\"Par1\">\n<list list-type=\"bullet\"><list-item><p id=\"Par2\">This review covers the extent of the integration of hierarchy in porous organic molecular materials (POMMs) for the first time.</p></list-item><list-item><p id=\"Par3\">Three main hierarchies are identified in POMMs: composition, architecture, and porosity.</p></list-item><list-item><p id=\"Par4\">The synthesis and applications of hierarchical POMMs, while highlighting the advantages of having hierarchy, are discussed.</p></list-item></list>\n</p>", "<p id=\"Par5\">Porous organic molecular materials (POMMs) are an emergent class of molecular-based materials characterized by the formation of extended porous frameworks, mainly held by non-covalent interactions. POMMs represent a variety of chemical families, such as hydrogen-bonded organic frameworks, porous organic salts, porous organic cages, C − H⋅⋅⋅π microporous crystals, supramolecular organic frameworks, π-organic frameworks, halogen-bonded organic framework, and intrinsically porous molecular materials. In some porous materials such as zeolites and metal organic frameworks, the integration of multiscale has been adopted to build materials with multifunctionality and optimized properties. Therefore, considering the significant role of hierarchy in porous materials and the growing importance of POMMs in the realm of synthetic porous materials, we consider it appropriate to dedicate for the first time a critical review covering both topics. Herein, we will provide a summary of literature examples showcasing hierarchical POMMs, with a focus on their main synthetic approaches, applications, and the advantages brought forth by introducing hierarchy.</p>", "<title>Keywords</title>" ]
[ "<title>Hierarchical Composition</title>", "<p id=\"Par9\">The combination of different materials represents an attractive strategy for the integration of complementary, or even in some cases incompatible, properties in a single material, otherwise impossible or at least very challenging to integrate in a single material. Another fundamental consideration is how these materials are arranged in the mixture, as this arrangement greatly alter the composite properties [##REF##34691494##25##, ##UREF##18##26##]. Hence, a multiscale arrangement represents another variable to consideration during the design of the porous composites. Hierarchical composition refers to a mixture of compositions in a material that are organized at more than one scale. This contrast with hybrid materials, where no order or multiscale order is required. One example of POMMs with multiscale compositional arrangement was reported for the encapsulation of sub-nanometre silver nanoparticles (AgNPs) in multifunctional HOFs (HOF-101 and 102), yielding composites (AgNPs@HOF) with enhanced photoelectrochemical and sensor properties [##UREF##19##27##]. AgNPs@HOF were prepared from HOF precursors mixed with a solution of AgNO<sub>3</sub>, forming a mix of Ag(I) ions and HOF precursors. AgNPs were then assembled and integrated into HOFs via in situ reduction of the encapsulated Ag(I) ions using light irradiation (Fig. ##FIG##1##2##a, b). AgNPs@HOF represents an elegant example of the great potential of integrating hierarchical composition in POMMs as sensors, in a selective, sensitive, and rapid manner for the detection of wide range of highly toxic chemical warfare agents (CWA). The synergistic relationship between size exclusion effect by the HOF and the specific chemical recognition between halogen groups in CWA and the Ag in AgNPs@HOF, renders versatile sensors with high selectivity and very low detection limit that can be easily integrated in a portable sensor device (Fig. ##FIG##1##2##e). This work also represents a clear example of double hierarchy, in composition and architecture, due to dual multiscale structural and compositional organization. In another example, modified porous organic cages (CC3) were used as compartmentalization units for two catalysts, palladium clusters and carbon nitride, to render a hierarchical system (Fig. ##FIG##1##2##f–g, Pd@C-Cage<sup>+</sup>/C<sub>3</sub>N<sub>4</sub><sup>–</sup>) [##UREF##20##28##]. C-Cage<sup>+</sup> was initially prepared from CC3 cage and added into a solution of C<sub>3</sub>N<sub>4</sub><sup>–</sup> during sonication, thus promoting a homogeneous dispersion with strong electrostatic interactions. These two catalysts, although incompatible in homogeneous solution, were both stabilized in presence of CC3, where the palladium clusters were hosted within cationic porous organic cages (Pd@C-Cage<sup>+</sup>) and complexed with anionic carbon nitride (C<sub>3</sub>N<sub>4</sub><sup>–</sup>). Pd@C-Cage<sup>+</sup>/ C<sub>3</sub>N<sub>4</sub><sup>–</sup> can efficiently catalyse complex multistep chemical reactions, including two- and three-steps, as well as convergent catalysis. Mechanistically, it was proposed that the porous organic cages played a prominent multirole in the enhanced catalytic behaviour, mainly stabilization of the palladium clusters that creates substrate channelling effects and compartmentalization of the two catalytic sites. Similarly, porous organic cages following an emulsion-confined strategy can co-assemble with nanoparticles to render a compositional and structural hierarchical material (Fe<sub>3</sub>O<sub>4</sub>-POC) [##REF##35462175##29##]. In particular, this system consists of two-dimensional Fe<sub>3</sub>O<sub>4</sub> nanoparticle superlattices self-assembled on octahedral porous organic cages colloidal crystals (Fig. ##FIG##2##3##a, b). The resulting hierarchical material exhibited strong peroxidase-mimic activity for the conversion of 4-nitrophenyl boronic acid to 4-amino phenol in water, resulting in two-times higher catalytic activity than Fe<sub>3</sub>O<sub>4</sub> nanocrystal alone (Fig. ##FIG##2##3##c). Notably, this enhanced catalytic activity of Fe<sub>3</sub>O<sub>4</sub>-POC is despite of the hydrophobic nature of the hierarchical assembly, which is covered by a bilayer of aliphatic chains and in contrast with the common nature of reported artificial enzymes with hydrophilic surface. Unexpectedly, the authors also observed the enzymatic activity was dependent on the size of the nanoparticles, with larger sized Fe<sub>3</sub>O<sub>4</sub> nanocrystal leading to high catalytic activity.</p>", "<p id=\"Par10\">Core–shell nanostructures composed of distinct racemic or quasiracemic porous organic cages represent a nascent field in materials with hierarchical composition [##UREF##21##30##]. One example of synthesis of such complex systems was obtained by taking advantage of the lower solubility of the racemic or quasiracemic materials, the chiral recognition of enantiomers and the similar lattice parameters for the different porous organic cages, which promoted the epitaxial growth, and consequently, the formation of core–shell structures (Fig. ##FIG##2##3##d, e). This, for example, allowed to obtain the pair CC3-RScore/CC19-RSshell and CC19-RScore/CC3-RSshell by the sequential addition of solutions of the R and S cage enantiomers by exploiting the chiral recognition, demonstrating that its surface chemistry is governed by the functionality decorating the shell layer. It was also observed a synergistic effect between components in the CC3-RScore/CC19-RSshell system that can be used for gas adsorption applications. The combination of the high CO<sub>2</sub> sorption capacity by the CC3-RS core along with the CO<sub>2</sub> selectivity of the CC19-RSshell allowed to achieve high CO<sub>2</sub> selectively from a CO<sub>2</sub>/CH<sub>4</sub> gas mixture, rendering a system with enhanced properties compared to the individual cages components (Fig. ##FIG##2##3##f). The implication of this work is extended beyond porous organic cages, as this strategy could be used to combine porous organic cages with others porous materials such as MOFs or improving the integration of porous organic cages in mixed-matrix membranes. The same core–shell approach to integrate complex hierarchical composition in a material could be extended to components of different nature, rendering materials with synergistic interactions between components and improved functionality. Another great example of this approach is the combination of HOFs and nanoparticles to form core–shell UCNPs@PFC-55 (Fig. ##FIG##2##3##g). Ostwald ripening-mediated grafting was used to assemble the HOF “shell” via ligand-grafting of oleate-stabilized UCNPs “core” particles. Perylenediimide-based HOF (PFC-55) can maintain a free radical state and show photothermal and photodynamic capacities under visible light [##UREF##22##31##]. However, it exhibits a weak absorption in the near-infrared (NIR) region, which limits its bio-applications. Thus, the construction of a core–shell hierarchical nanocomposite UCNPs@PFC-55, with upconversion nanoparticles UCNPs at the core and designed overlapping between core emission and shell excitation, represents a powerful approach for the upconversion of NIR light to visible region, which further excite the HOF shell to render an efficient photothermal and photodynamic antimicrobial activity (Fig. ##FIG##2##3##i).</p>", "<p id=\"Par11\">This core–shell approach has also been extended to the combination of HOFs and MOFs [##UREF##23##32##]. The archetypal NH<sub>2</sub>-UiO-66 MOF, characterized by its high stability, was used as core unit, and functionalized with naphthalenetetracarboxylic dianhydride, precursor of the DAT-HOF, leading to the formation of the nanocomposite NH<sub>2</sub>-UiO-66 MOF@DAT-HOF (Fig. ##FIG##3##4##a–c). The synthesis was possible through the functionalisation of the MOF forming the core, and the posterior interfacial growth HOF (DAT-HOF) shell on NH<sub>2</sub>-UiO-66 MOF. The resulting hierarchical material exhibited an improvement on its structural and photochemical stability—up to eight cyclic runs—, as well as in the photocatalytic degradation of tetracycline, compared to the isolated constituents. This stability was attributed to the hierarchical nature of the material, with a core–shell structure and synergistic interaction between components, which also extended the utilization range of the visible light and improved the charges separation (Fig. ##FIG##3##4##d). This enhanced functionality was also extended to the degradation of other emergent contaminants, such as antimicrobials and pesticides. Ultrathin HOF nanosheets (HOF-25-Ni) were prepared in high yield by post-synthetic metalation of a robust guanine-quadruplex HOF precursor with Ni(ClO<sub>4</sub>)<sub>2</sub>.6H<sub>2</sub>O, followed by solution-supported sonication exfoliation methodology (Fig. ##FIG##3##4##e–g) [##UREF##24##33##]. The high yield obtained during the preparation of HOF-25-Ni was attributed to the intrinsically preferred exfoliation nature of the selected HOF along with the post-synthetic metalation with nickel(II) ions. HOF-25-Ni was then dispersed on graphene oxide (HOF-25-Ni@GO) and tested as catalyst, exhibiting an efficient activity for the visible-light-driven CO<sub>2</sub> reduction reaction –assisted with [Ru(bipyridine)<sub>3</sub>]<sup>2+</sup> and triisopropanolamine–, showing a high conversion rate and 96.3% CO selectivity (Fig. ##FIG##3##4##h).</p>", "<p id=\"Par12\">HOFs can also be valuable candidates to develop hierarchical biocomposites by encapsulating large assemblies. For example, the encapsulation of neural stem cells (NSC) within a HOF doped with porous carbon nanospheres (PCN) provides a robust artificial exoskeleton with hierarchical hydrogen bonds and oxidative stress resistance –with catalase and superoxide dismutase activities–, and NIR-II photodegradable nature, which circumvent some of the major drawbacks found in transplantation of neural stem cells (NSC@PCN/HOF, Fig. ##FIG##4##5##a) [##UREF##25##34##]. The biocomposite was assembled by adding a solution of HOF precursors followed by the sequential addition of PCN and NSC, where the NSC are stabilized by the strong electrostatic interactions with the HOF framework. In this study, it was observed that the multifunctional nature of the final bio-composite resulted from the hierarchical composition and synergistic interactions between components. This approach has been further implemented, taking advantage of the porous nature of carbon nanospheres to charge them with drug molecules –retinol acid– with direct influence on the differentiation of neural stem cells to neurons. The stereotactical transplantation of the prepared hierarchically complex biomaterial into the hippocampus of mice results in an improvement of neural stem cells viability and a significant improvement in memory functions of Alzheimer´s disease mice model, as consequence of promotion of neurogenesis and relieve of cognitive disorders (Fig. ##FIG##4##5##b). Another interesting example of hierarchical porous composite was obtained during the electrostatically induced co-assembly in water of small biomolecules, such as simple dipeptides and porphyrins, leading to the formation of photocatalytically active, multi-chambered microspheres [##UREF##26##35##]. The microspheres were synthesized in a sequential manner, mainly driven by π–π stacking and electrostatic interactions, in very acidic conditions within 1 h of mixing (Fig. ##FIG##4##5##c). These microspheres are porous and possess a water-filled multi-chambered interior, accessible to guest molecules, and constituted by an interconnected network of peptide-porphyrin nanorods, presenting stacks of porphyrins (J-aggregate) with dipeptides interacting electrostatically with light-harvesting abilities. As consequence of the hierarchical structure, this material was used for the sequestration of cationic organic molecules and photocatalysis, promoting the light-induced oxidation of iodide to tri-iodide, as well as the reduction of metal salts and small organic molecules.</p>", "<title>Hierarchical Architectures</title>", "<p id=\"Par13\">The integration of architectures at different scales, by combining two or more structural levels [##UREF##17##24##], one at molecular and a higher up level, could render materials with synergistic or fine-tuned properties by combining the attributes of the individual components. A common challenge during the formation of multiscale architectures is the need of some degree of control during the anisotropic growth, where the orthogonal orientation of the different intermolecular interactions such as hydrogen bonding and π–π stacking present in some POMMs, is proven advantageous during growth. Although obtaining hierarchical architectures in POMMs is a new concept, some initial success was already demonstrated for several families of POMMs. Indeed, examples of superstructures with different dimensionality, scale levels and architectures can be found as thin films, nanosheets, and hollow architectures [##UREF##27##36##, ##UREF##28##37##]. Regarding the synthetic strategies used to obtain multiscale architectures, solution processable approaches are commonly employed while introducing or preserving the porosity. For example, atomically thin 2D nanosheets of a highly crystalline HOF (SEU-1) with uniformly cubic morphology was obtained by exfoliation using ultrasonic force-assisted liquid exfoliation technology [##UREF##29##38##]. SEU-1 consists of TCPP molecules, linked by formate, forming 2D square-like grid skeleton with excellent stability and permanent porosity (Fig. ##FIG##5##6##a, b). The photocatalytic activity of these 2D nanosheets for the removal of contaminants was tested, showing an increased photocatalytic rate in aqueous systems compared to other HOFs, mainly due to an increased surface area (Fig. ##FIG##5##6##c) [##UREF##30##39##–##UREF##32##41##].</p>", "<p id=\"Par14\">Although during the formation of 2D architectures in POMMs, the most common strategy has been the exfoliation, in some cases, different approaches need to be considered. One of these alternative approaches to create 2D assemblies is the interfacial synthesis. For instance, air/liquid interfacial synthetic route was used to assemble a HOF based on triphenylbenzene derivative (LINAS-1) into perfectly oriented highly crystalline non-covalent bonded organic nanosheets [##REF##29061053##42##], while suppressing the favoured assembly of complex interpenetrated structure that is obtained during the synthesis of the bulk crystals (Fig. ##FIG##5##6##d). The high stability of the nanosheets was key to maintain the crystallinity and pore orientation during their transfer to common substrates such as silicon, quartz, gold, graphite (Fig. ##FIG##5##6##e). Gas adsorption measurements indicated low affinity to water vapour, suggesting hydrophobic pore environment, and high affinity towards non-polar molecular such as O<sub>2</sub>, which suggests that LINAS-1 could have potential in industrial relevant environments for gas separations. Thin films were also demonstrated for POMMs by spin-coating, where the first example was reported for porous organic cages for sensing applications [##REF##22941901##43##]. Defect-free microporous thin-film were later obtained by solution processable methods for CC3 and CC13 porous cages and tested as membranes for gas separations of mixtures with selectivities of up to 155 for H<sub>2</sub>/CH<sub>4</sub> and 87 for H<sub>2</sub>/N<sub>2</sub> (Fig. ##FIG##6##7##a–c) [##REF##26800019##44##]. Further studies also confirmed the potential of porous cages as films for molecular separations [##REF##35156832##45##–##REF##32568506##50##]. HOFs can also be deposited on surface as thin films for different methods. One method, electrophoretic deposition (EPD), was used to prepare a HOF film (nano-PFC-1) with a reversible electrochromic [##UREF##36##51##] change from yellow to blue-violet. The film showed high performance with low power consumption, long cycle life, and easy regeneration (Fig. ##FIG##6##7##d, e). Moreover, post-synthetic modification of the HOF films with redox-active species generated multistate electrochromic behaviour with successive colour changes. As example, the modified film was adsorbed with Fe<sup>2+</sup> species showing reversible redox peaks and successive colour changes during the CV process, thus demonstrating its potential as material for electrochromic applications. In another example, films with large areas of a HOF (UPC-HOF-6) also were obtained by casting of a solution of DAT precursor on alumina substrates (Fig. ##FIG##6##7##f). The film assembly was directed by N–H..N and π-π stacking interactions, demonstrating self-healing properties and pressure-responsive performance for gas separation of H<sub>2</sub>/N<sub>2</sub> mixtures with good selectivity [##UREF##37##52##].</p>", "<p id=\"Par15\">Different hierarchical architectures, such as hexagonal mesh networks consisting of nanorods and 2D nanoplates, can be synthesized with fullerene C<sub>60</sub> by a simple co-solvent inclusion strategy. During the mesh network formation, as result of the conversion of 2D fullerene plates to hcp rods, macroporosity was induced during the structural changes as consequence of the loss of solvent mixture (Fig. ##FIG##7##8##a–f). This also resulted in the epitaxial growth of ordered C<sub>60</sub> nanorod arrays, forming out-of-plane vertical rods on the mesh networks [##REF##30742169##53##]. Cubic based micrometric architectures (HFC) of fullerene C<sub>70</sub> decorated with vertical nanorods can be obtained by ultrasound-assisted liquid–liquid interfacial precipitation (ULLIP). During the growth of the superstructures, mesoporosity of average of 8 nm is introduced, which is translated in a much larger BET surface area compared to the original C<sub>70</sub> crystals (Fig. ##FIG##7##8##g–i). These fullerene-based superstructures with high surface are good candidates as materials for the selective detection of aromatic solvent vapours using a quartz crystal microbalance (QCM). Quartz crystal microbalance experiments demonstrated that HFC architecture can act as selective sensor for aromatic guest molecules, mainly due to the high surface area and the hierarchical architecture containing nanorods, that favours the diffusion of aromatic vapours into the mesoporous architectures and the subsequent strong π–π interactions between aromatic groups [##REF##27341124##54##].</p>", "<p id=\"Par16\">Beyond 2D constructions, another type of hierarchical architecture that can be obtained in POMMs are hollow structures that can be attractive as encapsulation vessels among other applications. One example is the hollow single crystals of a HOF (Form II) prepared from a simple building block, trimesic acid, and obtained by crystallization through intermediate steps involving several morphologies and solid morphology (Form I) [##REF##32155330##55##] as starting point (Fig. ##FIG##8##9##a). The resulting hollow hexagonal crystalline tubes of Form II were tested for the adsorption and removal of common pollutants and demonstrated being considerable more effective for the Rhodamine B dye adsorption (82 vs 39%) than the solid form of the crystal Form I, mainly due to additional adsorption into the hollow cavity (Fig. ##FIG##8##9##b–f).</p>", "<p id=\"Par17\">More exotic superstructures such as mesoporous microflowers can be obtained with C<sub>60</sub>-pentacene as building block using liquid–liquid interfacial precipitation (LLIP) [##UREF##38##56##]. The nanofeatured microflower density, introduced (FMFs and FMFs_110) (Fig. ##FIG##8##9##g–i) during the hierarchical formation, was controlled by the temperature used during synthesis and proved to be determinant on the performance of these superstructures as photodetectors. Films made of nanofeatured microflowers showed an increase in the current density as the nanofeature density was also increased in the microflowers (FMFs vs FMFs_110), even in absence of illumination. In contrast, films made of smooth microflowers did not show any photocurrent, indicating the importance of multiscale features and how affect the energy transfer (Fig. ##FIG##8##9##j–k). Both results clearly demonstrated the importance of the presence of structural hierarchy during photo-response, and how it can be tuned by changing the nanofeature density. This tuneability is an attractive feature for these materials and their use on the fabrication of novel optoelectronic devices based on fullerene superstructures.</p>", "<p id=\"Par18\">The combination of multifunctionality and porosity in POMMs can also be achieved with the goal of extending the range of applications of these materials. For example, a HOF with 2D architecture (2D-90) can be obtained by self-assembly of designed 1D strands with woven architecture, exhibiting large-scale elasticity and reversible structural transformations [##UREF##39##57##] (Fig. ##FIG##9##10##a–c). The dynamic molecular woven structure also shows multimode stimuli-responsive luminescence with high-contrast emission colour switching. These properties can be useful in several applications such as sensing, data recording and biomedicine. Additionally, multifunctionality was also demonstrated in atomically thin 1D porous nanoribbons (nr-HOF) prepared by the ultrasonic force-assisted exfoliation [##UREF##40##58##] of 3D HOF crystals based on TCPP building blocks (TCPP-1,3-DPP). The obtained nr-HOF nanoribbons were tested as drug carriers, demonstrating a high load capacity due to their high surface area and better biocompatibility. The doxorubicin loaded nr-HOF showed higher effectiveness than the pure form of the commercial drug, achieving cell viabilities as low as 1.3% during chemotherapy–photodynamic therapy–photothermal therapy (Fig. ##FIG##9##10##d–f).</p>", "<title>Hierarchical Porosity</title>", "<p id=\"Par19\">Multiscale porosity is particularly sought in materials with an inherent tendency to form micropores [##UREF##18##26##]. Certainly, by accommodating different levels of porosity in a harmonized fashion, new functionalities and improved performance can be achieved, principally when an enhanced mass diffusion, by improving interconnectivity between pores, is required [##UREF##41##59##]. Several examples of accommodating micro and mesoporosity can be found in different families of POMMs. Two early examples of micro and mesoporosity in single crystals were obtained during the formation of multiple boronic ester bonds from the reaction of 12 triptycene tetraol and 8 triboronic acid molecules, yielding a crystalline framework (4) with catenated cages (Fig. ##FIG##10##11##a, b). The catenation is held by attractive van der Waals forces and dominated by π–π interactions [##UREF##42##60##]. Despite of the interlocked nature, the micro and mesoporous packing reveals a relatively high BET surface area (1540 m<sup>2</sup> g<sup>−1</sup>). In another example, mesoporosity was introduced in a microporous HOF (BioHOF-1) in presence of a template, the nanoscopic enzyme (BSA), during the framework assembly. BioHOF-1, which is composed of water-soluble tetra-amidinium (1) and tetracarboxylate building blocks (2, Fig. ##FIG##10##11##c), can encapsulate and stabilize relevant enzymes, where the biomolecules also play the role of template during the framework assembly. The biocompatible framework allows the stabilization and protection of enzymes from harsh environments, thus extending their operable pH and temperature range of enzyme activity. Examples of enzymes encapsulated are the fluorescein-tagged catalase (FCAT) and fluorescein-tagged alcohol oxidase (FAOx), resulting in crystalline composites with significantly higher chemical and thermal stability compared to the free enzymes (Fig. ##FIG##10##11##f–g) [##REF##31426638##61##]. This work is a good example of integrating hierarchical porosity and composition in a single material.</p>", "<p id=\"Par20\">Further illustration of the potential of integrating mesoporosity in microporous organic cages for biological applications was exemplified with CC3 cages, yielding micro- and mesoporous MesoCC3. In this case, the mesoporosity was introduced during crystallization via partial accommodation of surfactants within micropores, thus preventing the dense packing during crystal growth due to the size of the surfactant (Fig. ##FIG##11##12##a). The resulting mesoporosity was advantageous for the immobilization of enzymes such as Cyt c by electrostatic interaction yielding Cyt c@MesoCC3-LDAO, while the combination of micro- and mesoporosity in MesoCC3 serves as drug delivery mechanism based on pH-selective electrostatic gating function incorporated by the surfactants with ionic head (Fig. ##FIG##11##12##d) [##UREF##43##62##].</p>", "<p id=\"Par21\">In HOFs, micro- and mesoporosity can also be integrated during framework formation by choosing large and rigid molecular subunits, such as pyrene and benzene core, decorated with COOH groups. For example, the crystallization of the molecular unit formed by a pyrene core and 4 benzoic groups yielded a 3D framework (PFC-2) stabilized by COOH-COOH hydrogen bonds and strong π–π interactions. Gas adsorption applications of industrial relevant mixtures were studied for this HOF, showing a highly selective adsorption of acetylene and ethylene versus methane at room temperature. The high gas uptake, along with the gas selectivity, was rationalized by the highly accessible void space, due to micro- and mesoporosity, and the unpaired hydrogen bond acceptor C=O groups in PFC-2, which significantly increased the affinity between gas molecules and frameworks, resulting in higher selectivity towards acetylene and ethylene hydrocarbons than methane [##REF##31009575##63##].</p>", "<p id=\"Par22\">The solution processability in POMMs is very advantageous for the introduction of macroporosity in inherently microporous materials. This was demonstrated with solution processable porous organic cages (CC3) used for the formation of monolithic scale materials with aligned micro- and macropores and high interconnectivity, obtained by controlled freeze-drying method (Fig. ##FIG##12##13##a–c). Compared to conventional monoliths, highly aligned hierarchical porous monoliths can be used as monolithic catalytic support in continuous flow reactions, giving an increased rate of liquid absorption as result of a reduced pressure drop [##UREF##44##64##]. In another example, the introduction of macroporosity was developed for single component and for racemic mixtures of microporous cages CC3(S,R) coated on inorganic templates (Fig. ##FIG##12##13##d). The resulting hierarchical material was tested for environmental applications, such as the capture and storage of radioactive forms of iodine produced in the nuclear industry. The cage loaded with inorganic beads was 4.5 times more effective than non-porous beads during the removal of iodine that is from solution [##REF##22930483##65##]. This example further demonstrated that the introduction of macroporosity is commonly advantageous to avoid blocking flow during liquid adsorption for the removal of impurities of liquids such as water and organic solvents required in environmental applications.</p>", "<p id=\"Par23\">HOFs are also compatible with the integration of macroporosity. Micro- and macroporosity was introduced in a tripyridine-based HOF (MM-TPY) during crystallization and under conditions that promoted skeletal growth (Fig. ##FIG##13##14##a). The difference in the strength and orientation between intermolecular interactions resulted in a highly anisotropic growth rate during the crystal formation, leading to the formation of gaps or voids, defined as microporosity, in the microporous assembly (Fig. ##FIG##13##14##b, c). Having multilevel porosity could be advantageous in new applications where multiple adsorptions are sought. For example, MM-TPY was tested for the dual adsorption of molecular species in solution and the selective recognition of microparticles. Phenol Red was selectively adsorbed over Methylene Blue within the micropores, while carbon particles were selectively attached within the macropores, mainly due to hydrophobic effects [##UREF##45##66##].</p>", "<p id=\"Par24\">Combining meso- or macroporosity with microporosity can be relatively easier to obtain in POMMs than combining both meso- and macroporosity. This is due to the stability constraints that could arise when a high density of large pores is present in a framework mainly held by weak intermolecular interactions. The only example reported thus far of meso- and macroporosity in POMMs was achieved in C<sub>60</sub> fullerene hexagonal crystals and synthesized by liquid–liquid interfacial precipitation process [##REF##23276230##67##]. By adjusting the solvent ratio, the porosity size and geometry could be controlled during the slow evaporation process leading to the removal of entrapped solvent molecules (Fig. ##FIG##10##11##b–e). The introduction of hierarchical porosity in C<sub>60</sub> crystals influenced the electrochemical properties of these materials, as indicated by the electrochemical active surface area in these C<sub>60</sub> crystals, exhibiting higher current density compared to C<sub>60</sub> crystals with no porosity. The effect of the introducing porosity in porous crystalline material based on C<sub>60</sub> has clear potential for their use as materials for the fabrication of nanodevices such as organic solar cells and miniaturized organic electronic devices [##UREF##46##68##].</p>" ]
[ "<title>Acknowledgements</title>", "<p>J.F.-S. thanks the MICINN (Spain) (Projects PID2019-104778GB-I00, PID2020-115100GB-I00, and Excellence Unit “Maria de Maeztu” CEX2019-000919-M) and the Royal Society of Chemistry. The work has also been funded by Generalitat Valenciana, (PROMETEU/2021/054 and SEJI/2020/034). Thanks are extended to the “Ramón y Cajal” program (RYC2019-027940-I). A.F. thanks to the Royal Society (RGS\\R1\\221390) and Royal Society of Chemistry (R21-5119312833) for the funding.</p>", "<title>Declarations</title>", "<title>Conflict of Interest</title>", "<p id=\"Par29\">The authors declare no interest conflict. They have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p><bold>a</bold> Representation of some of the most common organic building-blocks used for the fabrication of hierarchical POMMs. <bold>b</bold> Schematic illustration of the three main types of hierarchy in porous materials. Creative Commons</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p><bold>a</bold> Illustration of the process followed for the synthesis of AgNPs/HOFs and AgNPs@HOFs nanocomposites. <bold>b</bold> Building blocks of HOF-101 and HOF-102. <bold>c</bold>, <bold>d</bold> Images obtained by TEM of HOF-101 and AgNPs@HOF-101, respectively. <bold>e</bold> Image of a three-electrode detection system for CWA detection, fabricated with AgNPs@HOF-101. <bold>f</bold> Illustration of the three-step sequential reaction for the conversion of 4-nitrophenyl boronic acid to 4-amino phenol with Pd@C-Cage<sup>+</sup>/ C<sub>3</sub>N<sub>4</sub><sup>–</sup> catalyst. <bold>g</bold> Top from left to right: TEM and SEM images of C-Cage<sup>+</sup>/C3N4<sup>–</sup>. bottom, from left to right: HAADF-STEM image and size distribution of Pd@CCage<sup>+</sup>. Modified with permission of [##UREF##19##27##, ##UREF##20##28##].</p><p>Copyright Wiley–VCH 2022 and ACS 2022</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p><bold>a</bold> Schematic illustration of co-assembly of Fe<sub>3</sub>O<sub>4</sub> nanocrystals and POCs molecules. <bold>b</bold> TEM images of hybrid 8.3-nm- Fe<sub>3</sub>O<sub>4</sub>-POC assembly. <bold>c</bold> UV–vis absorption spectra (following the absorption of 3,3′,5,5′-Tetramethylbenzidine (TMB) as chromogenic substrate), showing the catalytic performance of Fe<sub>3</sub>O<sub>4</sub>-POC, in absence or presence of 8.3-nm Fe<sub>3</sub>O<sub>4</sub> nanocrystal assemblies. <bold>d</bold> Molecular representation of the porous cages for CC3 (left), CC19 (center) and general scheme showing the structure of a core–shell multicomponent heterochiral cage cocrystals (right) (core = purple/mauve; shell = yellow/orange). <bold>e</bold> SEM image of a large CC3-RScore/CC19-RS shell crystal. <bold>f</bold> Gas adsorption (closed symbols) and desorption (open symbols) isotherms for CO<sub>2</sub> (black squares) and methane (blue triangles) for CC3-RScore/CC19-RS shell crystal. <bold>g</bold> Fabrication of core–shell UCNPs@PFC-55. <bold>h</bold> Crystal packing of PFC-55 porous frameworks, showing the open channels formed through the stacking layers. <bold>i</bold> Comparison curves for the photothermal conversion for UCNPs, PFC-55, UCNP@PFC-55 powders under NIR irradiation. Modified with permission of [##REF##35462175##29##–##UREF##22##31##].</p><p>Copyright Elsevier, Wiley–VCH 2018, 2021 and 2022</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p><bold>a</bold> Scheme of the synthetic procedure followed for the obtention of NH<sub>2</sub>-UiO-66@DAT-HOF. <bold>b</bold>, <bold>c</bold> SEM images of NH<sub>2</sub>-UiO-66 precursor and NH<sub>2</sub>-UiO-66 MOF@DAT-HOF hybrid, respectively. <bold>d</bold> Comparsion of the photodegradation efficiencies of tetracycline and the apparent reaction rate constants (inset) between NH<sub>2</sub>-UiO-66 MOF@DAT-HOF hybrid and different photocatalysts. <bold>e</bold> Schematic synthesis of HOF-25-Ni nanosheets and HOF-25-Ni@GO for the photocatalytic conversion of CO<sub>2</sub> to CO. C: grey; N: cyan; O: red; H: white; Ni: green; <bold>f</bold> STM images of HOF-25-Ni. <bold>g</bold> Height profile distribution of three measured random HOF-25-Ni nanosheets. <bold>h</bold> Time-dependent CO and H<sub>2</sub> evolution for the photocatalytic reduction of CO<sub>2</sub> under visible light irradiation in presence of HOF-25-Ni@GO-10. Modified with permission of [##UREF##23##32##, ##UREF##24##33##].</p><p>Copyright Wiley–VCH 2022</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><p><bold>a</bold> Illustration representing of the formation of composite NSC@PCN/HOF by the encapsulation of neural stem cells within a HOF. <bold>b</bold> Process for the remodeling of impaired neural networks in mice model. <bold>c</bold> Proposed mechanism for the self-assembly of peptide–porphyrin microspheres, involving dipeptide-mediated charge screening of the porphyrin J-aggregates in combination with local stacking of dipeptide cations specifically around the J-aggregates. <bold>d</bold> SEM (Top) and TEM (bottom) images of a single microsphere showing irregular surface texture and the aggregated nanorods, respectively. <bold>e</bold> UV/Vis spectra of the evolution of the peptide–porphyrin assembly indicated by the variations in the intensities of peaks at 434 and 490 nm Modified with permission of [##UREF##25##34##, ##UREF##26##35##].</p><p>Copyright Wiley–VCH 2014 and 2022</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><p><bold>a-b</bold> Representation of the crystal packing of HOF (SEU-1) showing the TCPP molecules glued by formate yielding 2D square-like grid. Inset: TEM image of SEU-1. Scale bar: 500 nm. <bold>c</bold> Variation of the UV–vis spectra during the photocatalytic degradation of DPA in presence of SEU-1 nanosheets. <bold>d</bold>, <bold>e</bold> Representation of the process for the interfacial synthesis of triphenylbenzene derivative on water, resulting in the creation of crystalline porous nanosheets (LINAS-1) that can be transferred to planar and non-planar substrates. <bold>f</bold> Top: Direct AFM image of LINAS-1 and Bottom: the obtained height profile along the marked red line. Modified with permission of [##UREF##29##38##, ##REF##29061053##42##].</p><p>Copyright 2019 and 2021, RSC and ACS</p></caption></fig>", "<fig id=\"Fig7\"><label>Fig. 7</label><caption><p><bold>a</bold> Representation of the synthesis of porous organic cages CC3 and CC13. <bold>b</bold> Top: Example of the solution-process followed for the formation of thin films using organic cages and bottom: SEM image of CC3 crystals. <bold>c</bold> SEM image of the spin-coated film of CC3 on silica support. <bold>d</bold> Representation of process for the fabrication of the nano-PFC-1 film by EPD method. <bold>e</bold> Left: CV curves for nano-PFC-1 film. Right: images of the formed nano-PFC-1 film showing the change in color when a variation of voltage is applied. <bold>f</bold> Top: Representation of the HOF building block precursor and crystal packing of UPC-HOF-6 (C gray, H white, N blue). Bottom: SEM image for the damaged UPC-HOF-6 membrane and the same membrane after healing. Modified with permission of [##REF##26800019##44##, ##UREF##36##51##, ##UREF##37##52##].</p><p>Copyright Wiley–VCH and ACS 2016 and 2020</p></caption></fig>", "<fig id=\"Fig8\"><label>Fig. 8</label><caption><p><bold>a</bold> Schematic representation for the solvent loss driven conversion of C<sub>60</sub> plate to mesh network. SEM images for <bold>b</bold> initial C<sub>60</sub> plates, <bold>c</bold> synthesized rods and <bold>d</bold> C<sub>60</sub> mesh network. <bold>e</bold>, <bold>f</bold> SEM images of the mesoporous C<sub>60</sub> crystals decorated with vertical nanorods. <bold>g</bold> Schematic illustration of the hierarchical assembly of fullerene C<sub>70</sub> into mesoporous cubes with cube-shaped geometry. <bold>h</bold>, <bold>i</bold> SEM images of mesoporous cubes decorated with nanorods and detailed imaged of the nanocubes. Modified with permission of [##REF##30742169##53##, ##REF##27341124##54##].</p><p>Copyright 2016 and 2019, ACS and RSC</p></caption></fig>", "<fig id=\"Fig9\"><label>Fig. 9</label><caption><p><bold>a</bold> Top: Schematic illustration of the expected mechanism of formation of hollow hexagonal tubes and bottom: FESEM images of evolution during each intermediate step. <bold>b</bold> UV − vis absorption spectra of Rhodamine after adsorption by Form II and Form I. <bold>c</bold>, <bold>d</bold> Optical and confocal laser microscopy images of hollow Form II after RhB dye adsorption and <bold>e</bold>, <bold>f</bold> for Form I. <bold>g</bold> Schematic representation of the synthesis of the FMFs and FMFs_110 by liquid–liquid interfacial precipitation (LLIP) process. <bold>h</bold>, <bold>i</bold> SEM images of FMFs and FMFs_110, respectively. <bold>j</bold>, <bold>k</bold> Time-resolved photoresponse for FMFs and FMFs_110, respectively. Modified with permission of [##REF##32155330##55##, ##UREF##38##56##].</p><p>Copyright 2021 and 2020, Wiley–VCH and ACS</p></caption></fig>", "<fig id=\"Fig10\"><label>Fig. 10</label><caption><p><bold>a</bold> Illustration of the interlocking motif in 2D-90 and the molecular woven structure of 2D-90 obtained by SCXRD. <bold>b</bold> AFM images of exfoliated 2D-90 single crystals. <bold>c</bold> Images of the colour change transformations by dynamic luminescence behaviours under visible light (top) and under 365 nm (bottom). <bold>d</bold> Representation of the crystal packing of the HOF TCPP-1,3-DPP and its exfoliation to obtain 1D Nanoribbons. <bold>e</bold> Left to right: TEM, SAED and AFM image of 1D nanoribbons. <bold>f</bold> Left: In vitro cytotoxicity of Doxo, HOF@ Doxo, nr-HOF@ Doxo, HOF, nr-HOF and for nr-HOF@ Doxo (right) at different concentrations in presence of A549 cells. Modified with permission of [##UREF##39##57##, ##UREF##40##58##].</p><p>Copyright 2019 and 2021, ACS and Elsevier</p></caption></fig>", "<fig id=\"Fig11\"><label>Fig. 11</label><caption><p><bold>a</bold> Schematic representation of the synthesis of [12 + 8] boronic ester cages 3a and 3b and formation of the catenated cage 4 during crystallization. <bold>b</bold> Representation of the crystal packing of 4, resulting for 3b, showing the micro and mesoporosity. <bold>c</bold> Representation of the synthesis enzyme@BioHOF-1. <bold>d</bold>, <bold>e</bold> Confocal laser microscopy and SEM images of the resulting FCAT@BioHOF-1 composite, respectively. <bold>f</bold>, <bold>g</bold> Comparison between the relative activity of free FCAT, FAOx, FCAT@BioHOF-1 and FAOx:BioHOF-1 after: thermal heating, exposure to proteolytic trypsin and unfolding agents such as urea. Modified with permission of [##UREF##42##60##, ##REF##31426638##61##].</p><p>Copyright 2014 and 2019, Wiley–VCH and ACS</p></caption></fig>", "<fig id=\"Fig12\"><label>Fig. 12</label><caption><p><bold>a</bold> Schematic mechanism for the assembly of MesoCC3 from ionic surfactant molecules and microporous CC3 cages. <bold>b</bold> SEM image of MesoCC3 particle. <bold>c</bold> Representation of Cyt c@MesoCC3-LDAO. <bold>d</bold> Electrostatically gated MesoCC3 for the selective release of Rhodamine B and Congo red. <bold>e</bold> Representation of the hydrogen bonding between carboxylic units. <bold>f</bold> Crystal packing of PFC-2 defining the micro and mesopores. g Adsorption isotherms for CH<sub>4</sub>, C<sub>2</sub>H<sub>2</sub>, and C<sub>2</sub>H<sub>4</sub> of PFC-2. Modified with permission of [##UREF##43##62##, ##REF##31009575##63##].</p><p>Copyright 2019 and 2021, Wiley–VCH and ACS</p></caption></fig>", "<fig id=\"Fig13\"><label>Fig. 13</label><caption><p><bold>a</bold> Representation of the preparation of aligned porous monolith from CC13 cages. <bold>b</bold> and <bold>c</bold> SEM images of the monolith at different scale. <bold>d</bold> Left: Images of the macroporous silica beads used as templates and right: SEM image of the internal cross section of the resulting material after the removal of the porous beads. <bold>e</bold> Left: Images of initial iodine solutions with (left to right labels): blank, Al-Si beads equalized by number, Al-Si beads equalized by mass, Cage loaded Al-Si beads. Intervale of time between images is 4 days. Modified with permission [##UREF##44##64##, ##REF##22930483##65##].</p><p>Copyright 2012 and 2015, Wiley–VCH and RSC</p></caption></fig>", "<fig id=\"Fig14\"><label>Fig. 14</label><caption><p><bold>a</bold> Illustration of the chemical structure of the MM-TPY building block and its crystal packing, showing the microporosity. <bold>b</bold> Top: representation of the platelets as hexagonal blue blocks. Bottom: the proposed mechanism of growth during the formation of MM-TPY crystals, rendering a hollow morphology with hierarchical macroporosity. <bold>c</bold> SEM images of MM-TPY crystals in each stage during crystal growth. Scale bars (left to right): 1, 10, 2, 2 μm. <bold>d</bold> Representation of the LLIP method used for the C<sub>60</sub> crystallization of meso and microporous C<sub>60</sub> crystals. <bold>e</bold> SEM image of the resulting C<sub>60</sub> crystals. Modified with permission [##UREF##45##66##, ##REF##23276230##67##].</p><p>Copyright 2013 and 2022, Wiley–VCH and ACS</p></caption></fig>" ]
[]
[]
[]
[]
[]
[]
[]
[]
[ "<graphic position=\"anchor\" xlink:href=\"40820_2023_1237_Figa_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"40820_2023_1237_Fig1_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"40820_2023_1237_Fig2_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"40820_2023_1237_Fig3_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"40820_2023_1237_Fig4_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"40820_2023_1237_Fig5_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"40820_2023_1237_Fig6_HTML\" id=\"MO7\"/>", "<graphic xlink:href=\"40820_2023_1237_Fig7_HTML\" id=\"MO8\"/>", "<graphic xlink:href=\"40820_2023_1237_Fig8_HTML\" id=\"MO9\"/>", "<graphic xlink:href=\"40820_2023_1237_Fig9_HTML\" id=\"MO10\"/>", "<graphic xlink:href=\"40820_2023_1237_Fig10_HTML\" id=\"MO11\"/>", "<graphic xlink:href=\"40820_2023_1237_Fig11_HTML\" id=\"MO12\"/>", "<graphic xlink:href=\"40820_2023_1237_Fig12_HTML\" id=\"MO13\"/>", "<graphic xlink:href=\"40820_2023_1237_Fig13_HTML\" id=\"MO14\"/>", "<graphic xlink:href=\"40820_2023_1237_Fig14_HTML\" id=\"MO15\"/>" ]
[]
[{"label": ["1."], "surname": ["Little", "Cooper"], "given-names": ["MA", "AI"], "article-title": ["The chemistry of porous organic molecular materials"], "source": ["Adv. Funct. Mater."], "year": ["2020"], "volume": ["30"], "fpage": ["1909842"], "pub-id": ["10.1002/adfm.201909842"]}, {"label": ["2."], "surname": ["Halliwell", "Ferrando-Soria", "Fernandez"], "given-names": ["C", "J", "A"], "article-title": ["Beyond microporosity in porous organic molecular materials (POMMs)"], "source": ["Angew. Chem. Int. Ed."], "year": ["2023"], "volume": ["62"], "fpage": ["e202217729"], "pub-id": ["10.1002/anie.202217729"]}, {"label": ["4."], "surname": ["Lin", "Chen"], "given-names": ["R-B", "B"], "article-title": ["Hydrogen-bonded organic frameworks: chemistry and functions"], "source": ["Chem"], "year": ["2022"], "volume": ["8"], "fpage": ["2114"], "lpage": ["2135"], "pub-id": ["10.1016/j.chempr.2022.06.015"]}, {"label": ["5."], "surname": ["Yu", "Xing", "Chen"], "given-names": ["S", "G-L", "L-H"], "article-title": ["Crystalline porous organic salts: from micropore to hierarchical pores"], "source": ["Adv. Mater."], "year": ["2020"], "volume": ["32"], "fpage": ["2003270"], "pub-id": ["10.1002/adma.202003270"]}, {"label": ["6."], "surname": ["Hasell", "Cooper"], "given-names": ["T", "AI"], "article-title": ["Porous organic cages: soluble, modular and molecular pores"], "source": ["Nat. Rev. Mater."], "year": ["2016"], "volume": ["1"], "fpage": ["16053"], "pub-id": ["10.1038/natrevmats.2016.53"]}, {"label": ["8."], "surname": ["Tian", "Wang", "Zhang"], "given-names": ["J", "H", "D-W"], "article-title": ["Supramolecular organic frameworks (SOFs): homogeneous regular 2D and 3D pores in water"], "source": ["Natl. Sci. Rev."], "year": ["2017"], "volume": ["4"], "fpage": ["426"], "lpage": ["436"], "pub-id": ["10.1093/nsr/nwx030"]}, {"label": ["9."], "surname": ["Chen", "Di", "Li"], "given-names": ["C", "Z", "H"], "article-title": ["An ultrastable \u03c0\u2013\u03c0 stacked porous organic molecular framework as a crystalline sponge for rapid molecular structure determination"], "source": ["CCS Chem."], "year": ["2022"], "volume": ["4"], "fpage": ["1315"], "lpage": ["1325"], "pub-id": ["10.31635/ccschem.021.202100910"]}, {"label": ["10."], "surname": ["Chen", "Guan", "Li"], "given-names": ["C", "H", "H"], "article-title": ["A noncovalent \u03c0-stacked porous organic molecular framework for selective separation of aromatics and cyclic aliphatics"], "source": ["Angew. Chem. Int. Ed."], "year": ["2022"], "volume": ["61"], "fpage": ["e202201646"], "pub-id": ["10.1002/anie.202201646"]}, {"label": ["12."], "surname": ["Gong", "Lv", "Han"], "given-names": ["G", "S", "J"], "article-title": ["Halogen-bonded organic framework (XOF) based on iodonium-bridged N\u22c5\u22c5\u22c5I+\u22c5\u22c5\u22c5N interactions: A type of diphase periodic organic network"], "source": ["Angew. Chem. Int. Ed."], "year": ["2021"], "volume": ["60"], "fpage": ["14831"], "lpage": ["14835"], "pub-id": ["10.1002/anie.202102448"]}, {"label": ["15."], "surname": ["Geng", "Liu", "Dalapati"], "given-names": ["K", "R", "S"], "article-title": ["Covalent organic frameworks: design, synthesis, and functions"], "source": ["Chem. Rev."], "year": ["2020"], "volume": ["16"], "fpage": ["8814"], "lpage": ["8933"], "pub-id": ["10.1021/acs.chemrev.9b00550"]}, {"label": ["16."], "surname": ["Wang", "Astruc"], "given-names": ["Q", "D"], "article-title": ["State of the art and prospects in metal-organic framework (MOF)-based and MOF-derived nanocatalysis"], "source": ["Chem. Rev."], "year": ["2020"], "volume": ["2"], "fpage": ["1438"], "lpage": ["1511"], "pub-id": ["10.1021/acs.chemrev.9b00223"]}, {"label": ["17."], "surname": ["Das", "Heasman", "Ben"], "given-names": ["S", "P", "T"], "article-title": ["Porous organic materials: strategic design and structure-function correlation"], "source": ["Chem. Rev."], "year": ["2017"], "volume": ["3"], "fpage": ["1515"], "lpage": ["1563"], "pub-id": ["10.1021/acs.chemrev.6b00439"]}, {"label": ["18."], "surname": ["Chen", "Li", "Su"], "given-names": ["L-H", "Y", "B-L"], "article-title": ["Hierarchy in materials for maximized efficiency"], "source": ["Natl. Sci. Rev."], "year": ["2020"], "volume": ["11"], "fpage": ["1626"], "lpage": ["1630"], "pub-id": ["10.1093/nsr/nwaa251"]}, {"label": ["19."], "surname": ["Lakes"], "given-names": ["R"], "article-title": ["Materials with structural hierarchy"], "source": ["Nature"], "year": ["1993"], "volume": ["361"], "fpage": ["511"], "lpage": ["515"], "pub-id": ["10.1038/361511a0"]}, {"label": ["20."], "surname": ["Levin", "Hakala", "Schnaider"], "given-names": ["A", "TA", "L"], "article-title": ["Biomimetic peptide self-assembly for functional materials"], "source": ["Nat. Rev. Chem."], "year": ["2020"], "volume": ["4"], "fpage": ["615"], "lpage": ["634"], "pub-id": ["10.1038/s41570-020-0215-y"]}, {"label": ["21."], "surname": ["Chen", "Sun", "Wang"], "given-names": ["L-H", "M-H", "Z"], "article-title": ["Hierarchically structured zeolites: from design to application"], "source": ["Chem. Rev."], "year": ["2020"], "volume": ["20"], "fpage": ["11194"], "lpage": ["11294"], "pub-id": ["10.1021/acs.chemrev.0c00016"]}, {"label": ["22."], "surname": ["Feng", "Wang", "Willman"], "given-names": ["L", "K-Y", "J"], "article-title": ["Hierarchy in metal\u2013organic frameworks"], "source": ["ACS Cent. Sci."], "year": ["2020"], "volume": ["3"], "fpage": ["359"], "lpage": ["367"], "pub-id": ["10.1021/acscentsci.0c00158"]}, {"label": ["24."], "surname": ["Luo", "Ahmad", "Schug"], "given-names": ["Y", "M", "A"], "article-title": ["Rising Up: hierarchical metal\u2013organic frameworks in experiments and simulations"], "source": ["Adv. Mater."], "year": ["2019"], "volume": ["31"], "fpage": ["1901744"], "pub-id": ["10.1002/adma.201901744"]}, {"label": ["26."], "surname": ["Doan", "Hamzah", "Prabhakaran"], "given-names": ["HV", "HA", "PK"], "article-title": ["Hierarchical metal\u2013organic frameworks with macroporosity: synthesis, achievements, and challenges"], "source": ["Nano-Micro Lett."], "year": ["2019"], "volume": ["11"], "fpage": ["54"], "pub-id": ["10.1007/s40820-019-0286-9"]}, {"label": ["27."], "surname": ["Wang", "Wang", "Kirlikovali"], "given-names": ["C", "Y", "KO"], "article-title": ["Ultrafine silver nanoparticle encapsulated porous molecular traps for discriminative photoelectrochemical detection of mustard gas simulants by synergistic size-exclusion and site-specific recognition"], "source": ["Adv. Mater."], "year": ["2022"], "volume": ["34"], "fpage": ["2202287"], "pub-id": ["10.1002/adma.202202287"]}, {"label": ["28."], "surname": ["Du", "Zhou", "Tan"], "given-names": ["Y-J", "J-H", "L-X"], "article-title": ["Porous organic cage nanostructures for construction of complex sequential reaction networks"], "source": ["ACS Appl. Nano Mater."], "year": ["2022"], "volume": ["5"], "fpage": ["7974"], "lpage": ["7982"], "pub-id": ["10.1021/acsanm.2c01057"]}, {"label": ["30."], "surname": ["Jiang", "Du", "Marcello"], "given-names": ["S", "Y", "M"], "article-title": ["Core\u2013shell crystals of porous organic cages"], "source": ["Angew. Chem. Int. Ed."], "year": ["2018"], "volume": ["57"], "fpage": ["11228"], "lpage": ["11232"], "pub-id": ["10.1002/anie.201803244"]}, {"label": ["31."], "surname": ["Liu", "Pan", "Zhang"], "given-names": ["B-T", "X-H", "D-Y"], "article-title": ["Construction of function-oriented core\u2013shell nanostructures in hydrogen-bonded organic frameworks for near-infrared-responsive bacterial inhibition"], "source": ["Angew. Chem. Int. Ed."], "year": ["2021"], "volume": ["60"], "fpage": ["25701"], "lpage": ["25707"], "pub-id": ["10.1002/anie.202110028"]}, {"label": ["32."], "surname": ["Wang", "Mao", "Zhang"], "given-names": ["J", "Y", "R"], "article-title": ["In situ assembly of hydrogen-bonded organic framework on metal\u2013organic framework: an effective strategy for constructing core\u2013shell hybrid photocatalyst"], "source": ["Adv. Sci."], "year": ["2022"], "volume": ["9"], "fpage": ["2204036"], "pub-id": ["10.1002/advs.202204036"]}, {"label": ["33."], "surname": ["Yu", "Meng", "Ding"], "given-names": ["B", "T", "X"], "article-title": ["Hydrogen-bonded organic framework ultrathin nanosheets for efficient visible-light photocatalytic CO"], "sub": ["2"], "source": ["Angew. Chem. Int. Ed."], "year": ["2022"], "volume": ["61"], "fpage": ["e202211482"], "pub-id": ["10.1002/anie.202211482"]}, {"label": ["34."], "surname": ["Yu", "Zhang", "Liu"], "given-names": ["D", "H", "Z"], "article-title": ["Hydrogen-bonded organic framework (HOF)-based single-neural stem cell encapsulation and transplantation to remodel impaired neural networks"], "source": ["Angew. Chem. Int. Ed."], "year": ["2022"], "volume": ["134"], "fpage": ["e202201485"], "pub-id": ["10.1002/anie.202201485"]}, {"label": ["35."], "surname": ["Zou", "Zhang", "Yan"], "given-names": ["Q", "L", "X"], "article-title": ["Multifunctional porous microspheres based on peptide\u2013porphyrin hierarchical Co-assembly"], "source": ["Angew. Chem. Int. Ed."], "year": ["2014"], "volume": ["126"], "fpage": ["2398"], "lpage": ["2402"], "pub-id": ["10.1002/ange.201308792"]}, {"label": ["36."], "surname": ["Kaushik", "Marvaniya", "Kulkarni"], "given-names": ["A", "K", "Y"], "article-title": ["Large-area self-standing thin film of porous hydrogen-bonded organic framework for efficient uranium extraction from seawater"], "source": ["Chem"], "year": ["2022"], "volume": ["8"], "fpage": ["2749"], "lpage": ["2765"], "pub-id": ["10.1016/j.chempr.2022.07.009"]}, {"label": ["37."], "surname": ["Wuttke", "Medina", "Rotter"], "given-names": ["S", "DD", "JM"], "article-title": ["Bringing porous organic and carbon-based materials toward thin-film applications"], "source": ["Adv. Funct. Mater."], "year": ["2018"], "volume": ["28"], "fpage": ["1801545"], "pub-id": ["10.1002/adfm.201801545"]}, {"label": ["38."], "surname": ["Luo", "Zhang", "Fang"], "given-names": ["Y-H", "L", "W-X"], "article-title": ["2D hydrogen-bonded organic frameworks: in-site generation and subsequent exfoliation"], "source": ["Chem. Commun."], "year": ["2021"], "volume": ["57"], "fpage": ["5901"], "pub-id": ["10.1039/D1CC01626A"]}, {"label": ["39."], "surname": ["He", "Luo", "Hong"], "given-names": ["X-T", "Y-H", "D-L"], "article-title": ["Atomically thin nanoribbons by exfoliation of hydrogen-bonded organic frameworks for drug delivery"], "source": ["ACS Appl. Nano Mater."], "year": ["2019"], "volume": ["2"], "fpage": ["2437"], "pub-id": ["10.1021/acsanm.9b00303"]}, {"label": ["40."], "surname": ["Luo", "He", "Wang"], "given-names": ["Y-H", "X-T", "C"], "article-title": ["Interconversion between nanoribbons and nanospheres mediated by detachable \u2018invisibility suit\u2019"], "source": ["Mater. Today Nano"], "year": ["2020"], "volume": ["9"], "fpage": ["100068"], "pub-id": ["10.1016/j.mtnano.2019.100068"]}, {"label": ["41."], "surname": ["He", "Luo", "Zheng"], "given-names": ["X-T", "Y-H", "Z-Y"], "article-title": ["Porphyrin-based hydrogen-bonded organic frameworks for the photocatalytic degradation of 9,10-diphenylanthracene"], "source": ["ACS Appl. Nano Mater."], "year": ["2019"], "volume": ["2"], "fpage": ["7719"], "pub-id": ["10.1021/acsanm.9b01787"]}, {"label": ["46."], "surname": ["Xu", "Wu", "Hou"], "given-names": ["T", "B", "L"], "article-title": ["Highly ion-permselective porous organic cage membranes with hierarchical channels"], "source": ["J. Am. Chem. Soc."], "year": ["2022"], "volume": ["23"], "fpage": ["10220"], "lpage": ["10229"], "pub-id": ["10.1021/jacs.2c00318"]}, {"label": ["48."], "surname": ["Jiang", "Song", "Massey"], "given-names": ["S", "Q", "A"], "article-title": ["Oriented two-dimensional porous organic cage crystals"], "source": ["Angew. Chem. Int. Ed."], "year": ["2017"], "volume": ["56"], "fpage": ["9391"], "lpage": ["9395"], "pub-id": ["10.1002/anie.201704579"]}, {"label": ["49."], "surname": ["Jiang", "Wang", "Sheng"], "given-names": ["Z", "Y", "M"], "article-title": ["A highly permeable porous organic cage composite membrane for gas separation"], "source": ["J. Mater. Chem. A"], "year": ["2023"], "volume": ["11"], "fpage": ["6831"], "lpage": ["6841"], "pub-id": ["10.1039/D2TA09632C"]}, {"label": ["51."], "surname": ["Feng", "Liu", "Cao"], "given-names": ["J-F", "T-F", "R"], "article-title": ["An electrochromic hydrogen-bonded organic framework film"], "source": ["Angew. Chem. Int. Ed."], "year": ["2020"], "volume": ["59"], "fpage": ["22392"], "lpage": ["22396"], "pub-id": ["10.1002/anie.202006926"]}, {"label": ["52."], "surname": ["Feng", "Shang", "Wang"], "given-names": ["S", "Y", "Z"], "article-title": ["Fabrication of a hydrogen-bonded organic framework membrane through solution processing for pressure-regulated gas separation"], "source": ["Angew. Chem. Int. Ed."], "year": ["2020"], "volume": ["59"], "fpage": ["3840"], "lpage": ["3845"], "pub-id": ["10.1002/anie.201914548"]}, {"label": ["56."], "surname": ["Tang", "Zhang", "Jiang"], "given-names": ["Q", "G", "B"], "article-title": ["Self-assembled fullerene (C"], "sub": ["60"], "source": ["SmartMat"], "year": ["2021"], "volume": ["2"], "fpage": ["109"], "lpage": ["118"], "pub-id": ["10.1002/smm2.1024"]}, {"label": ["57."], "surname": ["Huang", "Li", "Mao"], "given-names": ["Q", "W", "Z"], "article-title": ["Dynamic molecular weaving in a two-dimensional hydrogen-bonded organic framework"], "source": ["Chem"], "year": ["2021"], "volume": ["7"], "fpage": ["1321"], "lpage": ["1332"], "pub-id": ["10.1016/j.chempr.2021.02.017"]}, {"label": ["58."], "surname": ["He", "He", "Luo"], "given-names": ["X-T", "X-T", "Y-H"], "article-title": ["Atomically Thin nanoribbons by exfoliation of hydrogen-bonded organic frameworks for drug delivery"], "source": ["ACS Appl. Nano Mater."], "year": ["2019"], "volume": ["2"], "fpage": ["2437"], "lpage": ["2445"], "pub-id": ["10.1021/acsanm.9b00303"]}, {"label": ["59."], "surname": ["Lorignon", "Gossard", "Carboni"], "given-names": ["F", "A", "M"], "article-title": ["Hierarchically porous monolithic MOFs: an ongoing challenge for industrial-scale effluent treatment"], "source": ["Chem. Engin. J."], "year": ["2020"], "volume": ["393"], "fpage": ["124765"], "pub-id": ["10.1016/j.cej.2020.124765"]}, {"label": ["60."], "surname": ["Zhang", "Presly", "White"], "given-names": ["G", "O", "F"], "article-title": ["A shape-persistent quadruply interlocked giant cage catenane with two distinct pores in the solid state"], "source": ["Angew. Chem. Int. Ed."], "year": ["2014"], "volume": ["53"], "fpage": ["5126"], "lpage": ["5130"], "pub-id": ["10.1002/anie.201400285"]}, {"label": ["62."], "surname": ["Hua", "Wang", "Gong"], "given-names": ["M", "S", "Y"], "article-title": ["Hierarchically porous organic cages"], "source": ["Angew. Chem. Int. Ed."], "year": ["2021"], "volume": ["60"], "fpage": ["12490"], "lpage": ["12497"], "pub-id": ["10.1002/anie.202100849"]}, {"label": ["64."], "surname": ["Ahmed", "Hasell", "Clowes"], "given-names": ["A", "T", "R"], "article-title": ["Aligned macroporous monoliths with intrinsic microporosity via a frozen-solvent-templating approach"], "source": ["Chem. Commun."], "year": ["2015"], "volume": ["51"], "fpage": ["1717"], "lpage": ["1720"], "pub-id": ["10.1039/C4CC08919G"]}, {"label": ["66."], "surname": ["Halliwell", "Dann", "Ferrando-Soria"], "given-names": ["CA", "SE", "J"], "article-title": ["Hierarchical assembly of a micro- and macroporous hydrogen-bonded organic framework with tailored single-crystal size"], "source": ["Angew. Chem. Int. Ed."], "year": ["2022"], "volume": ["134"], "fpage": ["e202208677"], "pub-id": ["10.1002/anie.202208677"]}, {"label": ["68."], "surname": ["Bao", "Xu", "Guo"], "given-names": ["L", "T", "K"], "article-title": ["Supramolecular engineering of crystalline fullerene micro-/nano-architectures"], "source": ["Adv. Mater."], "year": ["2022"], "volume": ["34"], "fpage": ["2200189"], "pub-id": ["10.1002/adma.202200189"]}]
{ "acronym": [], "definition": [] }
68
CC BY
no
2024-01-14 23:40:14
Nanomicro Lett. 2024 Jan 12; 16:88
oa_package/54/74/PMC10786801.tar.gz
PMC10786802
0
[ "<title>Introduction</title>", "<p id=\"Par2\">Tylosin is known as a safe veterinary macrolide antibiotic drug used to treat pulmonary disease in chicken and swine and liver abscesses in cattle through feeding or intramuscular (IM) injection. Tylosin has broad-spectrum activity against gram-positive and -negative bacteria and mycoplasma [##UREF##0##1##, ##REF##31563955##2##]. This compound is originated from soil microorganisms such as <italic>Streptomyces fradiae</italic> [##UREF##1##3##], and, like other macrolides, it inhibits protein synthesis in bacteria [##REF##3053566##4##].</p>", "<p id=\"Par3\">The drug predominantly consists of tylosin A. The composition of other factors, including desmycosin (factor B), microcin (factor C), and relomycin (factor D), can vary, depending on the manufacturing source. Tylosin A is responsible for most of the microbiological activity, while antibiotic activities of tylosin B, C, and D and dihydrodesmycosin (a metabolite) correspond approximately 50–83%, 70–75%, 30–35%, and 15–31%, respectively, compared to that of tylosin A [##UREF##1##3##, ##UREF##2##5##]. Thus, Tylosin with a marker residue as Tylosin A has been set a tolerance level of 0.1 ppm in edible tissues of livestock (i.e., cattle, swine and poultry) in many countries such as European Union, Japan and Korea.</p>", "<p id=\"Par4\">Tylosin is only used in animal husbandry not in human [##UREF##0##1##]. It was authorized for use in Europe under Regulation (EC) No. 37/2010 in all food-producing species except honeybees. The U. S. Food and Drug Administration (FDA) authorization No. 21 CFR 556.746 permits its use in honey. Similarly, the Japanese Ministry of Food and Drug Safety (MFDS) authorized its use in honey, including royal jelly. </p>", "<p id=\"Par5\">However, according to a document written by a global network called Health Care Without Harm Europe, antibiotics approved for use in animal husbandry are being repurposed in fish due to drug shortage in aquafarming. In line with the OECD-FAO Agricultural Outlook 2022–2031 [##UREF##3##6##], global veterinary drug use in aquafarms is anticipated to grow with the increase in fish consumption over the next decades. Several recent studies suggested that tylosin-based antibiotics could be a good candidate to treat bacterial infections in fishes [##UREF##0##1##, ##REF##34438925##7##]. The pharmaco-kinetics/dynamics profiles of this drug have been explored to determine the optimal treatment regime in fishes [##UREF##0##1##, ##REF##34438925##7##]. Through a variety of studies on safety and efficacy of tylosin in fish, it was revealed that use of tylosin to fish has lots of advantages, including rapid absorption, low acute toxicity, and no critical adverse effects such as mortality or histopathological changes at appropriate therapeutic doses [##UREF##0##1##, ##REF##34438925##7##]. Therefore, establishment of maximum residue limit for tylosin in fish is required because of its potential use in aquaculture to increase production by avoiding disease outbreaks.</p>", "<p id=\"Par6\">In addition to establishment of maximum residue limit for tylosinin fish, Health-based guidance value (HBGV) for tylosin is needed to be reevaluated based on its impact on human intestinal microflora. The guideline discusses the general approach and steps to determine a microbiological ADI (mADI) and exhibits the method to calculate of mADI and its equation. Because a value for volume of colon content has been changed from 220 g to 500 mL in updated guideline, mADI of tylosin should be corrected. The other consideration to evaluate mADI of tylosin is to determine microbiological data. In the past, the microbiological data on tylosin as to disruption of colonization barrier was available from JECFA. Recently, the evaluation report of tylosin announced by food safety commision of Japan (FSCJ) has included the microbiological data of tylosin on Japanese's intestinal microbiome. Thus, the consideration of microbiological data obtained from JECFA and FSCJ would be necessary for reevaluation of mADI of tylosin [##UREF##5##9##].</p>", "<p id=\"Par7\"> Therefore, we will reevaluate the mADI of tylosin following the revised international guidelines [##UREF##4##8##] considering the up-to-date research results under the agreement of committees with relevant expertise.</p>" ]
[ "<title>Materials and methods</title>", "<title>Hazard identification</title>", "<p id=\"Par8\">Tylosin toxicity data were collected from evaluation reports issued by international organizations (i.e. Joint FAO/WHO Expert Committee on Food Additives, and Food Safety Commission of Japan) [##UREF##1##3##, ##UREF##5##9##].</p>", "<title>Point of departure (POD) determination</title>", "<p id=\"Par9\">The most sensitive endpoint was determined by comparing tylosin toxicological and microbiological data. Additionally, the point of departure (i.e., MIC) determination and the final ADI were based on agreement among the expert committees.</p>", "<title>Exposure assessment</title>", "<p id=\"Par10\">The original Global Estimates of Chronic Dietary Exposure (GECDE) model equation (a) recommended by Joint FAO/WHO Expert Committee on Food Additives (JECFA) [##UREF##6##10##], was considered for exposure assessment. However, this study used the mGECDE equation (b) for exposure assessment because median residue-level data were not available.</p>", "<p id=\"Par11\">\n\n</p>", "<p id=\"Par12\">(a) GECDE equation\n</p>", "<p id=\"Par13\">\n\n</p>", "<p id=\"Par14\">(b) mGECDE equation</p>", "<p id=\"Par15\">We estimated the chronic dietary exposure using the 2010–2016 Korea National Health and Nutrition Examination Survey (KNHANES) food consumption data provided by the Korean Disease Control and Prevention Agency (KDCA) and MRL, proposed by the National Fishery Products Quality Management Service (NFQS) and the MFDS. In particular, food consumption data for high consumers were used following the European Food Safety Authority (EFSA) guidance document for exposure assessment [##UREF##7##11##].</p>", "<title>Risk characterization</title>", "<p id=\"Par16\">The hazard index (HI) was determined by dividing the estimated chronic dietary exposure by the ADI, calculated as follows:</p>", "<p id=\"Par17\">*b.w., body weight</p>", "<p id=\"Par18\">HI ≤ 100%: a hazardous effect is not expected.</p>", "<p id=\"Par19\">HI &gt; 100%: a hazardous effect is expected.</p>", "<p id=\"Par20\">The use of a veterinary drug could be considered as causing no public health concern when the exposure to it is below the threshold (i.e., ADI).</p>" ]
[ "<title>Results</title>", "<title>Hazard identification</title>", "<p id=\"Par21\">Various details on tylosin, including its structure, structural identifiers, and physicochemical characteristics, are presented in Fig. ##FIG##0##1## and Table ##TAB##0##1##.</p>", "<title>Absorption, distribution, metabolism, elimination (ADME)</title>", "<p id=\"Par22\">Based on its pharmacokinetic and pharmacodynamic profiles, tylosin bioavailability is likely to differ among exposure routes and species. Tylosin bioavailability following IM injection in chicken was ranged from 22.5 to 34.0%, while it was ranged from 70 to 95% in pigs, cows, and sheep after oral administration [##UREF##8##12##–##REF##4266258##14##]. In contrast, the reported oral bioavailability in mink is poor (41%), while the IM-injected bioavailability in olive flounder is high (approximately 87%) [##REF##34438925##7##, ##REF##33640030##15##].</p>", "<title>Short- and long-term toxicity</title>", "<p id=\"Par23\">Acute toxicity studies performed using various tylosin types, such as base, tartrate, and hydrochloride, routes, and doses indicated that tylosin has low acute toxicity in multiple species [##UREF##0##1##, ##UREF##1##3##]. For instance, studies in rats showed an LD<sub>50</sub> range from 461 to over 6200 mg/kg. Similarly, the LD<sub>50</sub> range in mice was 321 to over 6200 mg/kg and over 800 mg/kg in dogs. Specific information can be referred to in various unpublished studies such as Anderson et al. (1961), Morten (1988), and Quarles (1983). According to the unpublished paper authored by Richards and Berkman (undated), the LD<sub>50</sub> in cockerels following a single dose of tylosin phosphate was 3765 mg/kg after oral exposure and 501 mg/kg when injected subcutaneously. Comparative intravenous studies with tylosin A, B, and C in female rats reported respective LD<sub>50</sub> values of 321, 193, and 189 mg/kg [##UREF##1##3##].</p>", "<p id=\"Par24\">Several repeated dose studies have been conducted in laboratory animals (rats and dogs), poultry (chickens, turkeys, ducks, and quails), pigs, and cattle. The no-observed-adverse-effect level (NOAEL) for kidney toxicity following oral tylosin administration for two years in dogs was 100 mg/kg bw/day [##UREF##1##3##]. A similar study by Anderson et al. (1996) unpublished, in which beagles were exposed to up to 400 mg/kg bw/day oral tylosin through capsules for two years, reported no noticeable adverse effects at all concentrations except occasional diarrhea and vomiting at doses of 10–400 mg/kg bw/day. Since diarrhea and vomiting were common symptoms in untreated animals, the NOAEL was considered to be 100 mg/kg bw/day. In rats, the most critical effect was hematological changes at doses greater than 500 mg/kg bw/day; therefore, the EMA concluded that a NOAEL of 50 mg/kg bw/day was appropriate. A one-year study in Wistar rats reported that the 5000-ppm group had increased urinary pH and blood lymphocyte count, and decreased neutrophil count; therefore, the NOAEL was set at 1000 ppm (equivalent to 39 mg/kg bw/day) [##UREF##5##9##]. Based on the above studies, short- and/or long-term tylosin administration was not considered a cause of critical adverse effects.</p>", "<title>Reproductive and developmental toxicity</title>", "<p id=\"Par25\">Tylosin was investigated for its teratogenicity and multigenerational reproductive toxicity in rats and mice. Drug-related changes between control and treated groups and critical effects on parents or offspring, including mortality, fertility, and malformation rates, were not observed in various unpublished studies (i.e., Anderson et al., 1996; Broddle et al., 1978; EMEA, 1997; Tsubura et al., undated; Tsuchikawa and Akabori, undated). The NOAELs for teratogenicity and reproductive toxicity could not be determined from these studies. Based on these studies, exposure to tylosin was not expected to cause reproductive or developmental health concerns.</p>", "<title>Carcinogenicity and genotoxicity</title>", "<p id=\"Par26\">Tylosin was tested for genotoxicity in four in vitro/in vivo assays. Greis (1990) conducted an in vitro chromosome aberration assay in which Chinese hamster ovarian (CHO) cells were treated with tylosin (purity, 99.3%) at 500–1000 µg/mL in DMSO without metabolic activation. The cells were also exposed to 250–750 µg/mL tylosin in DMSO with metabolic activation. The study found no evidence of chromosomal aberrations. Another study used CHO cells for gene mutation assays and found no change in the HGPRT + locus mutation frequency when the tylosin concentration was 100–1500 µg/mL [##UREF##1##3##]. Greis (1990) also investigated potential gene mutations following treatment with tylosin in mammalian cells. Mouse L5178Y TK + / − cells treated with tylosin (purity, 99.3%) at 10–1000 µg/mL in DMSO showed that tylosin had a weak cytotoxic effect. An in vivo micronucleus assay study performed by Greis (1990) in which ICR mice were administrated up to 5,000 mg/kg bw tylosin (purity, 96%) over 48 h found no evidence of genotoxicity. Therefore, we concluded that tylosin was not a genotoxic compound. Additionally, JECFA reviewed several carcinogenicity studies in rats and found no evidence of carcinogenicity [##UREF##1##3##]. Overall, tylosin was found to have no genotoxic or carcinogenic effect.</p>", "<title>Microbiological data</title>", "<p id=\"Par27\">New antibiotics research has highlighted the link between gut microbiota and host health [##REF##35212478##16##]. Furthermore, as the human microbiota is progressively recognized as a critical therapeutic target when using antibiotics [##REF##33870869##17##], the microbiological effects of tylosin have been investigated in several studies. Tylosin residues are known to disrupt the colonization barrier of the gastrointestinal tract in humans because of their antibiotic activities against bacterial strains in the human colonic flora [##UREF##1##3##]. The most susceptible bacteria were <italic>Bifidobacterium spp.</italic> and <italic>Clostridium spp.,</italic> for which MIC<sub>50</sub> was 0.062 µg/mL. Conversely, tylosin showed little antibacterial activity against various <italic>Escherichia coli</italic> strains [##UREF##1##3##]. JECFA committees evaluated tylosin in compliance with the international cooperation on harmonization of technical requirements for registration of veterinary medicinal products (VICH) and clinical and laboratory standard institute (CLSI) guidelines and recognized the need to establish for it a mADI. Although the VICH guideline recommended assessing genera based on their MIC<sub>50</sub>, JECFA committees decided to use the MIC<sub>90</sub> values for <italic>Bacteroides fragilis</italic>, other <italic>Bacteroides spp., Bifidobacterium spp., Clostridium spp., Enterococcus spp., Eubacterium spp., Fusobacterium spp</italic>., and <italic>Peptostreptococcus spp.</italic> to determine a calculated MIC (MICcalc) as recommended by VICH guideline. The justification for adopting the MIC<sub>90</sub> was derived from the CLSI guideline. Based on a MIC<sub>90</sub> of 5.44 µg/mL, the MICcalc was 1.698 µg/mL [##UREF##1##3##]. A value of 220 g was used for the colon content mass based on the colon content measured in humans. The maximum antibiotic activity available to microorganisms was 64% in human fecal inactivation studies, and the rate its metabolites reach the colon is likely 35% of tylosin in an activity based—pig data as a substitute for human data. Multiplication of these two explained factors yields 0.224, the fraction of an oral dose available to the microorganisms (FA). Therefore, JECFA concluded that an mADI of 0.0–0.03 mg/kg bw/day (rounded-up value as commonly practiced) could be established based on the MIC test and fecal binding data [##UREF##1##3##]. The formula used for the JECFA evaluation is explained below.</p>", "<p id=\"Par28\">In contrast, EMA evaluation of tylosin reported several decades ago established an mADI of 0.006 mg/kg bw/day [##UREF##2##5##]. The committee for medicinal products for veterinary use (CVPM) in European Union recommended using a specific daily fecal bolus value of 150 mL, geometric mean MIC<sub>50</sub> for all sensitive genera, and a correction factor (CF) for microbiological risk assessment. The geometric mean MIC<sub>50</sub> for tylosin was 0.606 µg/mL, calculated from MICs for <italic>Lactobacillus, Bifidobacterium, Clostridium, Bacteroides, Peptostreptococcus, Eubacterium,</italic> and <italic>Enterococcus</italic>. A CF of 2 was used to adjust the inoculum density. An FA of 0.5 was used to account for the nature of the fecal residues because most of the oral dose is excreted through the feces in some species, and data for humans was unavailable. Hence, the formula used by EMA to determine the microbiological risk of tylosin was as follows:</p>", "<p id=\"Par29\">However, a recent study by food safety commission of Japan (FSCJ) established an mADI of 0.005 mg/kg bw/day based on the VICH guidelines, with the only difference from the JECFA evaluation being the MICcalc. The FSCJ used a MICcalc value derived from a domestic investigation of the microbiological effects of veterinary antibiotics in 2006. They obtained a MICcalc of 0.308 µg/mL based on MIC<sub>50</sub> in the same genera following the VICH guidelines [##UREF##4##8##]. The values for other factors (i.e., FA and colon content mass) remained unchanged. Therefore, an mADI of 0.005 mg/kg bw/day was established in Japan. The FSCJ evaluation formula was as follows:</p>", "<title>Point of departure (POD) determination</title>", "<p id=\"Par30\">Given the toxicological and microbiological data, the microbiological effects are likely the most sensitive endpoint. Therefore, we reevaluated the data above for mADI. The toxicological and microbiological ADIs of international organizations (i.e., JECFA, EMA, and FSCJ) are summarized in supplementary Tables 1 and 2 to help better understand our conclusions. This study recalculated an mADI following the VICH guideline [##UREF##4##8##]. The MICcalc data followed the FSCJ approach rather than the JECFA approach, as agreed by the expert committees, for the following reasons. First, in vitro MIC data obtained from Japan could be more reliable than the JECFA data because they are based on enough replicates (preferably ten isolates) and inoculum density (&gt; 10<sup>6</sup>). Second, it is possible that the normal gut microflora in Japanese individuals is comparable to that in Koreans. This opinion could be supported by recent articles on ethnicity-associated differences in gut microflora, although the mechanism remains unclear [##REF##34617511##18##, ##UREF##9##19##]. However, one of the experts expressed concerns about differences in dietary intake patterns between Koreans and Japanese. Unlike the Japanese, most Koreans not only intake kimchi daily, which food fluently contains the beneficial intestinal bacteria, but also prefer salty and spicy food, and such intake habits could result in microbiome differences [##REF##11403148##20##, ##REF##33879965##21##]. Considering all the above, and with a realistic consideration of the Korean gut microbial communities, using the value obtained from the FSCJ seemed reasonable. These rationales are listed in Table ##TAB##1##2##. Hence, using the formula below, the most appropriate mADI would be 0.01 mg/kg bw/day.</p>", "<title>Exposure assessment and risk characterization</title>", "<p id=\"Par31\">Chronic dietary exposure to tylosin residues was estimated using the 2010–2016 KNHANES food consumption data and the proposed MRLs. Multiplication of the two factors (MRL and consumption) yields the exposure amount. A detailed explanation of the exposure assessment model was reported by the World Health Organization [##UREF##10##22##]. A comprehensive explanation of the model was also well-documented as a manual by international organization [##UREF##6##10##]. The estimated dietary exposure was shown up to 0.2251 mg/person/day (as equivalent to 0.00375 mg/kg bw/day). The hazard index was 37.5%, indicating that the tylosin residues from use are unlikely to cause a public health concern. The exposure assessment results are presented in Table ##TAB##2##3##.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par32\">The present study re-evaluated the Korean ADI of tylosin (0.01 mg/kg b.w./day) based on consultations with expert committees and by performing an exposure assessment using a new dietary exposure model for veterinary drugs. This study is significant as it details mADI derivation for veterinary drugs for the first time in Korea, relying on updated international guidelines.</p>", "<p id=\"Par33\">The modified factor applied for the present study is derived from the investigation on measuring the colon volumes of 75 fasting subjects by using three-dimensional abdominal magnetic resonance imaging (MRI) [##REF##24131490##23##]. The main insight of the investigation has been to find out that the mean value of three regional (ascending, transverse, and descending) colon volumes is about 560 mL. Also, the authors figured out the value for 220 g has been estimated to the lower 95th percentile of colon volumes among those subjects [##REF##24131490##23##]. The value for 220 g had been used as mass of colon content for calculating mADI for long time. For these reasons, World Health Organization (WHO) expert working group concluded that the most appropriate value is considered as 500 mL for colon volume given that mean value for 560 mL except for lower sigmodal colon volume [##UREF##11##24##].</p>", "<p id=\"Par34\">The limitation of this study was to use old food consumption data in exposure assessment. Hence, there is a need to consider the up-to-date food consumption data when estimating the exposure amounts of residues for reflecting national food consumption pattern. The diet is recognized as a substantial factor for contributing the change of intestinal microflora composition in several research through comparing with western diet and a plenty of fiber diet [##REF##33736210##25##]. Therefore, further investigation of characteristics of intestinal microflora affected by specific food consumption pattern should be warranted. </p>" ]
[]
[ "<p id=\"Par1\">As veterinary drugs available for fish is very restricted, there is growing trials for repurposing livestock drugs as aquatic animal drugs. Tylosin is one of the most effective antibiotics to treat bacterial infections approved for livestock, and would be used in fish. Hence, we investigated the toxicological and microbiological aspects of tylosin to establish health-based guidance value (HBGV) and maximum residue limit (MRL) in fishes, and reevaluated the microbiological acceptable daily intake (mADI) based on updated relevant data and international guildeline. Lastly, exposure assessment was performed to confirm the appropriateness of MRL. By investigating available microbiologcial studies on tylosin, the microbiological point of departure was determined as 0.308 μg/mL, which was mean 50% minimum inhibitory concentration (MIC<sub>50</sub>), obtained from the Food Safety Committee of Japan (FSCJ) evaluation report. Furthermore, as a factor for the derivation of mADI, the volume of colon content was recently changed to 500 mL in compliance with the International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products (VICH) guidelines. This was previously defined as the mass of colon content (220 g). We applied correction factor 0.224 to the mean MIC<sub>50</sub> for tylosin in the equation of mADI, since the drug is transformed to metabolites with reduced activity prior to entering the colon and bound to fecal materials within the colon of human. The mADI was evaluated as 0.01 mg/kg bw/day. Finally, the hazard index, calculated by dividing the estimated chronic dietary exposure by mADI, did not exceed 100%, suggesting that chronic dietary exposure to tylosin residues from veterinary use was unlikely to be a public health concern. Overall, this study contributes significantly in updating HBGV by application of the concept of mADI for the first time in Korea based on the revised microbiological risk assessment guidelines and in providing scientific rationale for the risk management of veterinary drug residues in food.</p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s43188-023-00179-z.</p>", "<title>Keywords</title>" ]
[ "<title>Supplementary Information</title>", "<p>Below is the link to the electronic supplementary material.</p>" ]
[ "<title>Acknowledgements</title>", "<p>This study was supported by a grant from the Ministry of Food and Drug Safety of Korea for 2021 (No. 21161MFDS361). Special thanks are offered to members of the expert committees for their commitment.</p>", "<title>Funding</title>", "<p>National Institute of Food and Drug Safety Evaluation (21161MFDS361).</p>", "<title>Declarations</title>", "<title>Conflict of interest</title>", "<p id=\"Par35\">The authors declare that there is no personal conflict of interest.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>Structures of tylosin factors <bold>a</bold>, <bold>b</bold> (desmycosin), <bold>c</bold> (microcin) and <bold>d</bold> (relomycin)</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Physico-chemical characteristics</p></caption><table frame=\"hsides\" rules=\"groups\"><tbody><tr><td align=\"left\">Generic name</td><td align=\"left\">Tylosin</td></tr><tr><td align=\"left\">IUPAC Name</td><td align=\"left\">[(2R,3R,4E,6E,9R,11R,12S,13S,14R)-12-{[3,6-Dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranosyl]oxy}-2-ethyl-14-hydroxy-5,9,13-trimethyl-8,16-dioxo-11-(2-oxoethyl)-1-oxacyclohexadeca-4,6-dien-3-yl]methyl 6-deoxy-2,3-di-O-methyl-beta-D-allopyranoside</td></tr><tr><td align=\"left\">Molecular formula</td><td align=\"left\">C46H77NO17</td></tr><tr><td align=\"left\">CAS No</td><td align=\"left\">1401-69-0</td></tr><tr><td align=\"left\">Molecular weight</td><td align=\"left\">916.112 g/mol</td></tr><tr><td align=\"left\">Appearance</td><td align=\"left\">Off-white to yellow powder</td></tr><tr><td align=\"left\">Vapor pressure</td><td align=\"left\">0.00 to 8.72 × 10–10 mmHg</td></tr><tr><td align=\"left\">Melting point</td><td align=\"left\">141℃</td></tr><tr><td align=\"left\">Density</td><td align=\"left\">1.25 g/cm3</td></tr><tr><td align=\"left\">Water solubility</td><td align=\"left\">1.74e−4 to 9.81 mol/L</td></tr><tr><td align=\"left\">logKow</td><td align=\"left\">1.63–3.35</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Korean microbiological ADI and rationales</p></caption><table frame=\"hsides\" rules=\"groups\"><tbody><tr><td align=\"left\">ADI</td><td align=\"left\">0.01 mg/kg bw/day</td></tr><tr><td align=\"left\">Study</td><td align=\"left\">In vitro microbiological study</td></tr><tr><td align=\"left\">Compound</td><td align=\"left\">Tylosin</td></tr><tr><td align=\"left\">Subjects</td><td align=\"left\">Human gut flora from healthy volunteers</td></tr><tr><td align=\"left\">Point of departure (MICcalc)</td><td align=\"left\">0.308 μg/mL (MIC<sub>50</sub>)</td></tr><tr><td align=\"left\">Mass of colon content</td><td align=\"left\">500 mL</td></tr><tr><td align=\"left\">Fraction of oral dose available to microorganisms</td><td align=\"left\">0.224</td></tr><tr><td align=\"left\">Body weight</td><td align=\"left\">60 kg</td></tr><tr><td align=\"left\">Reference</td><td align=\"left\">[##UREF##5##9##]</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Results of estimated chronic dietary exposure and risk (%)</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Food</th><th align=\"left\" rowspan=\"2\">Proposed MRL</th><th align=\"left\" rowspan=\"2\">MR/TRR ratio*</th><th align=\"left\" rowspan=\"2\">Corrected TRR value</th><th align=\"left\" colspan=\"2\">Intake (kg/day)</th><th align=\"left\" colspan=\"2\">Exposure (mg/day)</th></tr><tr><th align=\"left\">Average</th><th align=\"left\">High</th><th align=\"left\">Average</th><th align=\"left\">High</th></tr></thead><tbody><tr><td align=\"left\">Fish</td><td align=\"left\">0.1</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0292</td><td align=\"left\">0.2191</td><td char=\".\" align=\"char\">0.0029</td><td char=\".\" align=\"char\">0.0219</td></tr><tr><td align=\"left\">Cattle muscle</td><td align=\"left\">0.1</td><td align=\"left\">0.7</td><td align=\"left\">0.1</td><td align=\"left\">0.0220</td><td align=\"left\">0.2623</td><td char=\".\" align=\"char\">0.0031</td><td char=\".\" align=\"char\">0.0375</td></tr><tr><td align=\"left\">Cattle liver</td><td align=\"left\">0.1</td><td align=\"left\">0.31</td><td align=\"left\">0.3</td><td align=\"left\">0.0001</td><td align=\"left\">0.1194</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td char=\".\" align=\"char\">0.0385</td></tr><tr><td align=\"left\">Cattle kidney</td><td align=\"left\">0.1</td><td align=\"left\">0.37</td><td align=\"left\">0.3</td><td align=\"left\">0.0000</td><td align=\"left\">0.0004</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td char=\".\" align=\"char\">0.0001</td></tr><tr><td align=\"left\">Cattle fat</td><td align=\"left\">0.1</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0013</td><td align=\"left\">0.0007</td><td char=\".\" align=\"char\">0.0001</td><td char=\".\" align=\"char\">0.0001</td></tr><tr><td align=\"left\">Swine muscle</td><td align=\"left\">0.1</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0471</td><td align=\"left\">0.4319</td><td char=\".\" align=\"char\">0.0047</td><td char=\".\" align=\"char\">0.0432</td></tr><tr><td align=\"left\">Swine liver</td><td align=\"left\">0.1</td><td align=\"left\">0.33</td><td align=\"left\">0.3</td><td align=\"left\">0.0001</td><td align=\"left\">0.0946</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td char=\".\" align=\"char\">0.0287</td></tr><tr><td align=\"left\">Swine kidney</td><td align=\"left\">0.1</td><td align=\"left\">0.43</td><td align=\"left\">0.2</td><td align=\"left\">0.0000</td><td align=\"left\">0.0000</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td char=\".\" align=\"char\"> &lt; 0.0001</td></tr><tr><td align=\"left\">Swine fat</td><td align=\"left\">0.1</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0000</td><td align=\"left\">0.0010</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td char=\".\" align=\"char\">0.0001</td></tr><tr><td align=\"left\">Sheep muscle</td><td align=\"left\">0.1</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0000</td><td align=\"left\">0.0015</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td char=\".\" align=\"char\">0.0001</td></tr><tr><td align=\"left\">Sheep liver</td><td align=\"left\">0.1</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0000</td><td align=\"left\">0.0000</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td char=\".\" align=\"char\"> &lt; 0.0001</td></tr><tr><td align=\"left\">Sheep kidney</td><td align=\"left\">0.1</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0000</td><td align=\"left\">0.0000</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td char=\".\" align=\"char\"> &lt; 0.0001</td></tr><tr><td align=\"left\">Sheep fat</td><td align=\"left\">0.1</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0000</td><td align=\"left\">0.0000</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td char=\".\" align=\"char\"> &lt; 0.0001</td></tr><tr><td align=\"left\">Goat muscle</td><td align=\"left\">0.1</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0000</td><td align=\"left\">0.2184</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td char=\".\" align=\"char\">0.0218</td></tr><tr><td align=\"left\">Goat liver</td><td align=\"left\">0.1</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0000</td><td align=\"left\">0.0000</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td char=\".\" align=\"char\"> &lt; 0.0001</td></tr><tr><td align=\"left\">Goat kidney</td><td align=\"left\">0.1</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0000</td><td align=\"left\">0.0000</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td char=\".\" align=\"char\"> &lt; 0.0001</td></tr><tr><td align=\"left\">Goat fat</td><td align=\"left\">0.1</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0000</td><td align=\"left\">0.0000</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td char=\".\" align=\"char\"> &lt; 0.0001</td></tr><tr><td align=\"left\">Poultry muscle</td><td align=\"left\">0.1</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0270</td><td align=\"left\">0.5179</td><td char=\".\" align=\"char\">0.0027</td><td char=\".\" align=\"char\">0.0518</td></tr><tr><td align=\"left\">Poultry liver</td><td align=\"left\">0.1</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0000</td><td align=\"left\">0.0000</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td char=\".\" align=\"char\"> &lt; 0.0001</td></tr><tr><td align=\"left\">Poultry fat</td><td align=\"left\">0.1</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0000</td><td align=\"left\">0.0044</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td char=\".\" align=\"char\">0.0004</td></tr><tr><td align=\"left\">Poultry kidney</td><td align=\"left\">0.1</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0000</td><td align=\"left\">0.0000</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td char=\".\" align=\"char\"> &lt; 0.0001</td></tr><tr><td align=\"left\">Egg</td><td align=\"left\">0.2</td><td align=\"left\">0.17</td><td align=\"left\">1.2</td><td align=\"left\">0.0330</td><td align=\"left\">0.1757</td><td char=\".\" align=\"char\">0.0388</td><td char=\".\" align=\"char\">0.2067</td></tr><tr><td align=\"left\">Milk</td><td align=\"left\">0.05</td><td align=\"left\">1</td><td align=\"left\">0.1</td><td align=\"left\">0.0963</td><td align=\"left\">0.5533</td><td char=\".\" align=\"char\">0.0048</td><td char=\".\" align=\"char\">0.0277</td></tr><tr><td align=\"left\" colspan=\"6\">Sum of exposure (mg/day)</td><td char=\".\" align=\"char\" colspan=\"2\">0.2251</td></tr><tr><td align=\"left\" colspan=\"6\">ADI = 0.01 mg/kg bw/day × 60 kg</td><td char=\".\" align=\"char\" colspan=\"2\">0.6</td></tr><tr><td align=\"left\" colspan=\"6\">Hazard Index (%)</td><td char=\".\" align=\"char\" colspan=\"2\">37.5</td></tr></tbody></table></table-wrap>" ]
[ "<disp-formula id=\"Equa\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{\\begin{array}{c}high\\, dietary\\, expousre \\,for \\,one\\, food \\,\\left(97.5th \\,percentile \\,by\\, consumers\\, \\times \\,median\\, residue\\, level\\right)\\\\ +\\; mean\\, dietary \\,exposure \\,for\\, all \\,other\\, foods\\; \\left(average\\, consumption\\, by \\,general\\, population\\, \\times \\,median \\,residue\\, levels\\right)\\end{array}}{body\\, weight\\, \\left(kg\\right)}$$\\end{document}</tex-math><mml:math id=\"M2\" display=\"block\"><mml:mfrac><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>h</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>y</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>o</mml:mi><mml:mi>d</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mfenced close=\")\" open=\"(\"><mml:mn>97.5</mml:mn><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>b</mml:mi><mml:mi>y</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>s</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mo>×</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mo>+</mml:mo><mml:mspace width=\"0.277778em\"/><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>y</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>o</mml:mi><mml:mi>d</mml:mi><mml:mi>s</mml:mi><mml:mspace width=\"0.277778em\"/><mml:mfenced close=\")\" open=\"(\"><mml:mi>a</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>p</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>b</mml:mi><mml:mi>y</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mo>×</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>d</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>d</mml:mi><mml:mi>y</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mi>t</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mfenced close=\")\" open=\"(\"><mml:mi>k</mml:mi><mml:mi>g</mml:mi></mml:mfenced></mml:mrow></mml:mfrac></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equb\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{\\begin{array}{c}high\\, dietary \\,exposure\\, for \\,one\\, food \\; \\left(97.5th \\,percentile \\,by \\,consumers \\,\\times \\,proposed \\,MRL\\right)\\\\ + \\, mean \\,dietary \\,exposure\\,for\\, all\\, other\\, foods\\; \\left(average\\, consumption\\, by\\, general \\,population\\,\\times \\,proposed \\,MRL\\right)\\end{array}}{body \\,weight \\; \\left(kg\\right)}$$\\end{document}</tex-math><mml:math id=\"M4\" display=\"block\"><mml:mfrac><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>h</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>y</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>o</mml:mi><mml:mi>d</mml:mi><mml:mspace width=\"0.277778em\"/><mml:mfenced close=\")\" open=\"(\"><mml:mn>97.5</mml:mn><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>b</mml:mi><mml:mi>y</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>s</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mo>×</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>M</mml:mi><mml:mi>R</mml:mi><mml:mi>L</mml:mi></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mo>+</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>y</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>o</mml:mi><mml:mi>d</mml:mi><mml:mi>s</mml:mi><mml:mspace width=\"0.277778em\"/><mml:mfenced close=\")\" open=\"(\"><mml:mi>a</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>p</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>b</mml:mi><mml:mi>y</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mo>×</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>M</mml:mi><mml:mi>R</mml:mi><mml:mi>L</mml:mi></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>d</mml:mi><mml:mi>y</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mi>t</mml:mi><mml:mspace width=\"0.277778em\"/><mml:mfenced close=\")\" open=\"(\"><mml:mi>k</mml:mi><mml:mi>g</mml:mi></mml:mfenced></mml:mrow></mml:mfrac></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equc\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathrm{Hazard \\,Index }\\left(\\mathrm{\\%}\\right)=\\frac{Human \\,daily\\, exposure (mg/kg\\ bw/day)}{ADI(mg/kg\\ bw/day)} \\times 100$$\\end{document}</tex-math><mml:math id=\"M6\" display=\"block\"><mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">Hazard</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi mathvariant=\"normal\">Index</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mo>%</mml:mo></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>H</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>y</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>m</mml:mi><mml:mi>g</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>k</mml:mi><mml:mi>g</mml:mi><mml:mspace width=\"4pt\"/><mml:mi>b</mml:mi><mml:mi>w</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>D</mml:mi><mml:mi>I</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>m</mml:mi><mml:mi>g</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>k</mml:mi><mml:mi>g</mml:mi><mml:mspace width=\"4pt\"/><mml:mi>b</mml:mi><mml:mi>w</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equd\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{mADI }} = \\frac{{{\\text{MICcalc }}\\left( {{1}.{698 }\\mu {\\text{g}}/{\\text{mL}}} \\right) \\, \\times {\\text{ mass of colon content }}\\left( {{22}0{\\text{ g}}} \\right)}}{{{\\text{FA }}\\left( {0.{224}} \\right) \\, \\times {\\text{ body weight }}\\left( {{6}0{\\text{ kg}}} \\right)}}$$\\end{document}</tex-math><mml:math id=\"M8\" display=\"block\"><mml:mrow><mml:mrow><mml:mtext>mADI</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mtext>MICcalc</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1.698</mml:mn><mml:mi>μ</mml:mi><mml:mtext>g</mml:mtext><mml:mo stretchy=\"false\">/</mml:mo><mml:mtext>mL</mml:mtext></mml:mrow></mml:mfenced><mml:mspace width=\"0.166667em\"/><mml:mo>×</mml:mo><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>mass of colon content</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>220</mml:mn><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>g</mml:mtext></mml:mrow></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mrow><mml:mtext>FA</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>0.224</mml:mn></mml:mrow></mml:mfenced><mml:mspace width=\"0.166667em\"/><mml:mo>×</mml:mo><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>body weight</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>60</mml:mn><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>kg</mml:mtext></mml:mrow></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Eque\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{mADI }} = \\frac{{{\\text{geometric mean MIC}}_{{{5}0}} \\left( {0.{6}0{6 }\\mu {\\text{g}}/{\\text{mL}}} \\right) \\, \\times {\\text{ CF }}\\left( {2} \\right) \\, \\times {\\text{ daily fecal bolus }}\\left( {{15}0{\\text{ mL}}} \\right)}}{{{\\text{FA }}\\left( {0.{5}} \\right) \\, \\times {\\text{ body weight }}\\left( {{6}0{\\text{ kg}}} \\right)}}$$\\end{document}</tex-math><mml:math id=\"M10\" display=\"block\"><mml:mrow><mml:mrow><mml:mtext>mADI</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mtext>geometric mean MIC</mml:mtext></mml:mrow><mml:mrow><mml:mn>50</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>0.606</mml:mn><mml:mi>μ</mml:mi><mml:mtext>g</mml:mtext><mml:mo stretchy=\"false\">/</mml:mo><mml:mtext>mL</mml:mtext></mml:mrow></mml:mfenced><mml:mspace width=\"0.166667em\"/><mml:mo>×</mml:mo><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>CF</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced><mml:mspace width=\"0.166667em\"/><mml:mo>×</mml:mo><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>daily fecal bolus</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>150</mml:mn><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>mL</mml:mtext></mml:mrow></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mrow><mml:mtext>FA</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>0.5</mml:mn></mml:mrow></mml:mfenced><mml:mspace width=\"0.166667em\"/><mml:mo>×</mml:mo><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>body weight</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>60</mml:mn><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>kg</mml:mtext></mml:mrow></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equf\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{mADI }} = \\frac{{{\\text{MICcalc }}\\left( {0.{3}0{8 }\\mu {\\text{g}}/{\\text{mL}}} \\right) \\, \\times {\\text{ mass of colon content }}\\left( {{22}0{\\text{ g}}} \\right)}}{{{\\text{FA }}\\left( {0.{224}} \\right) \\, \\times {\\text{ body weight }}\\left( {{6}0{\\text{ kg}}} \\right)}}$$\\end{document}</tex-math><mml:math id=\"M12\" display=\"block\"><mml:mrow><mml:mrow><mml:mtext>mADI</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mtext>MICcalc</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>0.308</mml:mn><mml:mi>μ</mml:mi><mml:mtext>g</mml:mtext><mml:mo stretchy=\"false\">/</mml:mo><mml:mtext>mL</mml:mtext></mml:mrow></mml:mfenced><mml:mspace width=\"0.166667em\"/><mml:mo>×</mml:mo><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>mass of colon content</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>220</mml:mn><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>g</mml:mtext></mml:mrow></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mrow><mml:mtext>FA</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>0.224</mml:mn></mml:mrow></mml:mfenced><mml:mspace width=\"0.166667em\"/><mml:mo>×</mml:mo><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>body weight</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>60</mml:mn><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>kg</mml:mtext></mml:mrow></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equg\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{mADI }} = \\frac{{{\\text{MICcalc }}\\left( {0.{3}0{8 }\\mu {\\text{g}}/{\\text{mL}}} \\right) \\, \\times {\\text{ volume of colon content }}\\left( {{5}00{\\text{ mL}}} \\right)}}{{{\\text{FA }}\\left( {0.{224}} \\right) \\, \\times {\\text{ body weight }}\\left( {{6}0{\\text{ kg}}} \\right)}}$$\\end{document}</tex-math><mml:math id=\"M14\" display=\"block\"><mml:mrow><mml:mrow><mml:mtext>mADI</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mtext>MICcalc</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>0.308</mml:mn><mml:mi>μ</mml:mi><mml:mtext>g</mml:mtext><mml:mo stretchy=\"false\">/</mml:mo><mml:mtext>mL</mml:mtext></mml:mrow></mml:mfenced><mml:mspace width=\"0.166667em\"/><mml:mo>×</mml:mo><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>volume of colon content</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>500</mml:mn><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>mL</mml:mtext></mml:mrow></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mrow><mml:mtext>FA</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>0.224</mml:mn></mml:mrow></mml:mfenced><mml:mspace width=\"0.166667em\"/><mml:mo>×</mml:mo><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>body weight</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>60</mml:mn><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>kg</mml:mtext></mml:mrow></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>*Marker residue (MR) to total radioactivity residue (TRR) ratios were obtained from EMEA report; Ref. [##UREF##2##5##]</p></table-wrap-foot>" ]
[ "<graphic xlink:href=\"43188_2023_179_Article_Equa.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"43188_2023_179_Article_Equb.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"43188_2023_179_Article_Equc.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"43188_2023_179_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"43188_2023_179_Article_Equd.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"43188_2023_179_Article_Eque.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"43188_2023_179_Article_Equf.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"43188_2023_179_Article_Equg.gif\" position=\"anchor\"/>" ]
[ "<media xlink:href=\"43188_2023_179_MOESM1_ESM.docx\"><caption><p>Supplementary file1 (DOCX 39 KB)</p></caption></media>" ]
[{"label": ["1."], "surname": ["Joo", "Hwang", "Choi"], "given-names": ["MS", "SD", "KM"], "article-title": ["Application of tylosin antibiotics to olive flounder ("], "italic": ["Paralichthys olivaceus", "Streptococcus parauberis"], "source": ["Fish Aquatic Sci"], "year": ["2020"], "volume": ["23"], "fpage": ["20"], "pub-id": ["10.1186/s41240-020-00165-8"]}, {"label": ["3."], "mixed-citation": ["International Programme on Chemical Safety & Joint FAO/WHO Expert Committee on Food Additives. Meeting (70th : 2008 : Geneva, Switzerland) (2009) Toxicological evaluation of certain veterinary drug residues in food /prepared by the seventieth meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). World Health Organization. "], "ext-link": ["https://apps.who.int/iris/bitstream/handle/10665/44086/9789241660617_eng.pdf?sequence=1&isAllowed=y"]}, {"label": ["5."], "mixed-citation": ["European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit (1997) Committee for Veterinary Medicinal Products: Tylosin. Summary Report (3). EMEA/MRL/205/97-FINAL. European Medicines Agency. "], "ext-link": ["https://www.ema.europa.eu/en/documents/mrl-report/tylosin-summary-report-3-committee-veterinary-medicinal-products_en.pdf"]}, {"label": ["6."], "mixed-citation": ["OECD and Food and Agriculture Organization of the United Nations (2022) OECD-FAO Agricultural Outlook 2022\u20132031. OECD iLibrary. 10.1787/f1b0b29c-en. Accessed 29 June 2022"]}, {"label": ["8."], "mixed-citation": ["Committee for Medicinal Products for Veterinary Use (2019) VICH GL36: R2: Studies to evaluate the safety of residues of veterinary drugs in human food: general approach to establish a microbiological ADI. European Medicines Agency. "], "ext-link": ["https://www.ema.europa.eu/documents/scientific-guideline/vich-gl36r2-studies-evaluate-safety-residues-veterinary-drugs-human-food-general-approach-establish_en.pdf"]}, {"label": ["9."], "mixed-citation": ["Food Safety Commision of Japan (2019) Tylosin, 3rd edn. Veterinary Drugs and Feed Additives Assessment. Food Safety Commision of Japan [in Japanese]. "], "ext-link": ["http://www.fsc.go.jp/fsciis/attachedFile/download?retrievalId=Kya20190220029&fileId=201"]}, {"label": ["10."], "mixed-citation": ["World Health Organization & Food and Agriculture Organization of the United Nations (2008) Principles and methods for the risk assessment of chemicals in food. Environmental Health Criteria 240, Dietary Exposure Assessment of Chemicals in Food, Chap 6. "], "ext-link": ["https://www.who.int/publications/i/item/9789241572408"]}, {"label": ["11."], "mixed-citation": ["European Food Safety Authority (2011) Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment. EFSA J 9:2097 (34 pp). 10.2903/j.efsa.2011.2097. "], "ext-link": ["https://www.efsa.europa.eu/en/efsajournal/pub/2097#abstract"]}, {"label": ["12."], "surname": ["Baggot"], "given-names": ["JD"], "article-title": ["Some aspects of clinical pharmacokinetics in veterinary medicine: principles of pharmacokinetics I"], "source": ["J Vet Pharmacol Ther"], "year": ["1978"], "volume": ["1"], "issue": ["1"], "fpage": ["5"], "lpage": ["18"], "pub-id": ["10.1111/j.1365-2885.1978.tb00300.x"]}, {"label": ["19."], "surname": ["Mason", "Nagaraja", "Camerlengo", "Joshi", "Kumar"], "given-names": ["MR", "HN", "T", "V", "PS"], "article-title": ["Correction: deep sequencing identifies ethnicity-specific bacterial signatures in the oral microbiome"], "source": ["PLoS ONE"], "year": ["2014"], "volume": ["9"], "issue": ["6"], "fpage": ["e99933"], "pub-id": ["10.1371/journal.pone.0099933"]}, {"label": ["22."], "mixed-citation": ["World Health Organization, Food and Agriculture Organization of the United Nations & Joint FAO/WHO Expert Committee on Food Additives (2014) Evaluation of certain veterinary drug residues in food: seventy-eighth report of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organization. "], "ext-link": ["https://apps.who.int/iris/bitstream/handle/10665/127845/9789241209885_eng.pdf?sequence=1&isAllowed=y"]}, {"label": ["24."], "mixed-citation": ["World Health Organization, Joint FAO/WHO Expert Committee on Food Additives & Food and Agriculture Organization of the United Nations (2018) Evaluation of certain veterinary drug residues in food: eighty-fifth report of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organization. "], "ext-link": ["https://apps.who.int/iris/handle/10665/259895"]}]
{ "acronym": [], "definition": [] }
25
CC BY
no
2024-01-14 23:40:14
Toxicol Res. 2023 Aug 2; 40(1):23-30
oa_package/19/fa/PMC10786802.tar.gz
PMC10786807
38214822
[ "<title>Introduction</title>", "<p id=\"Par6\">The Internet of Things (IoT) system has accelerated the rapid development of wireless communication networks, which relies on millimeter-level electromagnetic waves (EMWs) to achieve the information propagation and interaction of advanced electronics [##UREF##0##1##–##UREF##1##3##]. With the wide-spread popularity of 5G or future 6G wireless communication technology, EMWs have brought great convenience to national innovation and daily life, widely serving in smart sensing, navigational positioning, satellite communication, telemedicine, and other technological fields [##UREF##2##4##–##REF##32227390##7##]. In this regard, the undesirable electromagnetic radiation generated by EMWs has attracted considerable attention because of its probable hazards for electronic security and human health [##REF##36703618##8##–##UREF##6##11##]. The electromagnetic (EM) functional materials play a crucial role in solving EM interference problem [##UREF##7##12##–##UREF##9##14##]. Generally, the traditional approach to achieving electromagnetic compatibility involves the metal-based electromagnetic interference shielding (EMI SE) modules for attenuating EMWs energy [##UREF##10##15##–##UREF##12##17##]. Nevertheless, these SE modules would take up additional three-dimensional space inside electronics, which pose a major obstacle to the integration and miniaturization of electronics, and meanwhile, the existing air gap between elements may cause thermal management issue for the whole framework [##UREF##13##18##, ##UREF##14##19##]. In addition, the intrinsic deficiencies of metals, e.g., high density, difficulty to form, and potential environmental pollution also constrain their practical applications [##UREF##15##20##]. Hence, employing new ingredients and designing appropriate structures are the anticipated requirements for promoting the development of EMI SE materials in multi-scenario electromagnetic environments.</p>", "<p id=\"Par7\">Advanced carbon nanomaterials, typically for carbon nanotube (CNT) [##UREF##12##17##, ##REF##30385571##21##] and graphene (Gr) [##REF##34842337##22##, ##UREF##16##23##], have been regarded as attractive candidates instead of metals owing to their prominent characteristics, e.g., robust electrical conductivity, well-fitting for EMI shielding. Currently, various strategies have been developed to fabricate carbon-based EMI materials by incorporating carbon nanoparticles into different supporting templates, e.g., ceramics, thermoplastic polymers, etc. [##UREF##17##24##, ##UREF##18##25##]. However, the poor interaction between carbon nanoparticles and matrix always limits the assembly and fabrication of multifunctional materials, especially in loading with high-concentration nanoparticles. Cellulose as a biomass polymer, mainly derived from plants, presents a promising potential in promoting the uniform dispersion of Gr and CNT nanoparticles in solution systems, since there exist abundant functional groups in molecular chains, imparting a positive contribution to the interaction between cellulose and carbon nanoparticles, thus realizing a strong interfacial binding in their composites [##UREF##19##26##, ##REF##35902243##27##]. Hence, cellulose and its derivatives as organic templates were employed to develop some novel and versatile EMI shielding materials [##UREF##20##28##, ##UREF##21##29##].</p>", "<p id=\"Par8\">Except for high-performance EMI materials, the optimization of shielding structures may expand their potential advantages in electromagnetic compatibility, better adapting to the miniaturization of integrated electronics [##UREF##15##20##, ##UREF##22##30##, ##UREF##23##31##]. Recently, a novel concept of “conformal-shielding” (c-SE) has been innovatively purposed, which means that the shielding layer is fully integrated with the packaging materials, thereby eliminating the need for additional space to complete SE functions [##UREF##24##32##, ##UREF##25##33##]. Noteworthily, the design principle of c-SE module lies in the arbitrary customization of structures according to electronics [##UREF##26##34##, ##UREF##27##35##]. In this regard, various techniques, including electroplating, spraying, and sputtering methods, are applied to achieve the c-SE module in integrated electronics [##UREF##28##36##–##REF##36549784##38##]. However, these traditional methods are mainly serving for metal-based materials, there is almost no relevant technique for satisfying the manipulation of advanced carbon-based c-SE module to the best of our knowledge. Therefore, the innovation of manufacturing strategy suitable for carbon-based materials, has been attracted considerable attention from scientific vision [##UREF##27##35##, ##UREF##29##39##]. 3D printing technology, owing to the unique layer-by-layer manufacturing manner, illuminates infinite possibilities in designing and fabricating the novel architectures with arbitrarily-customized structures, thereby a serious of 3D printable carbon-based functional materials with free-constructed structures are reported [##UREF##30##40##–##UREF##32##42##]. Our group also concentrates on the development and utilization of 3D printable functional materials [##UREF##33##43##, ##UREF##34##44##]. However, employing 3D printing technology to manufacture carbon-based c-SE modules with ideal SE peculiarity has not been successfully achieved, because of the exiting challenges in accurately manipulating 3D printable carbon-based materials, and programmatically assembling target SE modules suitable for integrated electronics.</p>", "<p id=\"Par9\">In this article, the well-formulated 3D printable functional inks, involving the elaborated manipulation of Gr@CNT nanoparticles with various hybrid proportions, were fabricated with the assistance of cellulose as adherent templates that delivered unique capabilities to resolving the interfacial issue between carbon nanoparticles and matrix, and affording desired rheological behaviors for direct ink writing (DIW) 3D printing. As expected, the 3D-printed patterns with arbitrarily-customized structures and ideal functionalities were manufactured, where the EMI SE efficiency of the optimal one was up to 61.4 dB, accompanied with 802.4 dB cm<sup>3</sup> g<sup>−1</sup>, far beyond the previously reported SE materials [##UREF##35##45##–##UREF##36##47##]. More impressively, as a proof-of-concept, the 3D-printed c-SE modules were successfully designed and integrated with the packaging materials, which performed prominent SE function and thermal management capability for electronics. Overall, the scientific innovation created in this work paves a novel way for manufacturing carbon-based c-SE modules for integrated electronics, and unleashes a promising illumination for the next-generation SE materials with lighter, stronger, and fitter characteristics.</p>" ]
[]
[ "<title>Results and Discussion</title>", "<title>Rheological Performance and 3D Printability of Gr@CNT Functional Inks</title>", "<p id=\"Par14\">A schematic regarding on the Gr@CNT functional inks and their potential application in integrated electronics is depicted in Fig. ##FIG##0##1##a, wherein Gr@CNT nanoparticles as functional mediums were well-formulated to uniformly disperse in CNF matrix for 3D printing. Noteworthily, as a characteristic biopolymer, CNF made a non-negligible contribution to the ink formulation, playing the multiple roles in adherent template, dispersing accelerant, and viscosity management. Due to the promising CH–<italic>π</italic> interaction between CNF and Gr@CNT nanoparticles [##UREF##38##49##], CNF molecules provided sufficient active sites for adsorbing nanoparticles to form the robust intertwined networks (Fig. ##SUPPL##0##S1##). Besides, a negative surface charge owing to the carboxylate functional groups evidenced by the high zeta potential of CNF dispersion, exerted a strong electrostatic repulsion in molecular chains, which in turn improved the dispersion stability of Gr@CNT nanoparticles in CNF dispersion (Fig. S2). Moreover, the thickening effect of CNF molecules endowed the ink with appropriate viscoelastic characteristics for 3D printing. The pseudo-solid ink was strong enough to withstand its loading at a static state (Fig. S3), and meanwhile the smooth extrusion was realized through the narrow printing nozzle upon the suitable pressure (Fig. S4). Followingly, the rheological peculiarity of formulated inks with various Gr@CNT proportions are assessed in Fig. ##FIG##0##1##b–d. Generally, all inks performed ideal viscoelastic characteristics, including shear thinning, thixotropy and appropriate yield moduli. As shown in Fig. ##FIG##0##1##b, a typically shear-thinning behavior was demonstrated, suggesting a non-Newtonian peculiarity for the well-formulated inks, which is essential to uniformly flow out of a convergent nozzle under external pressure [##UREF##39##50##–##REF##35246886##52##]. The power-law property is revealed synchronously in Fig. S5. The result further confirmed the viscoelastic characteristics of inks. Moreover, the thixotropic capability was investigated by examining the change in viscosity upon the alternating loads with a low (0.01 s<sup>−1</sup>) or high (10 s<sup>−1</sup>) shear rate (Fig. ##FIG##0##1##c). Each ink afforded a similar behavior, exhibiting a steady-state viscous contribution as fixed shear rate. Initially, a high viscosity over 10<sup>2</sup> Pa s was detected in an extremely low shear rate (0.01 s<sup>−1</sup>) to simulate the pre-loading process, whereas the viscosity dropped below 10<sup>1</sup> Pa·s when the shear rate increased to 10 s<sup>−1</sup>, indicating that the formed CNF and Gr@CNT intertwined networks were partially destroyed to resist the applied shear rate, thereby exhibiting a shear-thinning behavior. Meanwhile, the viscosity would rapidly recover to its initial state as the shear rate returned to the low one, and a perfect cycle was confirmed in response to the repeated shear rates. This reversible transformation in viscoelastic performance induced by shear rates provides a guarantee for inks with fluid appearance suitable for 3D printing and shape stability of 3D-printed architectures during depositing onto substrate [##UREF##40##51##]. Besides, the storage and loss moduli (<italic>G</italic>′ and <italic>G</italic>′′) of inks were examined by dynamic rheological scanning as a function of wide oscillatory stress (10<sup>–1</sup> ~ 10<sup>3</sup> Pa) in Fig. ##FIG##0##1##d. Generally, the moduli of all inks showed a similar tendency and presented a terminal plateau at the region below the yield point (<italic>G</italic>′ = <italic>G</italic>′′), implying that the networks were strong enough to withstand the loaded stress, performing a quasi-solid peculiarity. When the stress monotonously increased, the pseudo-solid inks were completely yielded and exhibited fluid characteristic, implying the partial broken of networks. Notedly, the appropriate yield moduli would endow the inks with ideal 3D printability and robust supportability, thus laying an essential foundation for the layer-by-layer printing [##REF##35246886##52##]. Thus, these ideal rheological behaviors fully demonstrate that the 3D printability of Gr@CNT functional inks with the assistance of CNF.</p>", "<p id=\"Par15\">Thereafter, the representative ink with Gr@CNT proportion of 2:3 (signed as G<sub>2</sub>C<sub>3</sub>) was employed to experimentally evaluate 3D printability. According to the systematic trajectories, the various 2D patterns were designed and printed in Fig. ##FIG##0##1##e. The well-organized shapes demonstrated that the ink possessed desired printability for manufacturing arbitrarily-customized geometries. Moreover, the 3D architectures including pyramid and lattice structures were programmatically assembled by layer-by-layer stacking (Fig. ##FIG##0##1##f). In addition, due to the extremely low density of Gr@CNT nanoparticles and CNF, the assembled architecture imparted ultralight characteristic (~ 0.076 g cm<sup>−3</sup>), and simultaneously afforded more than 4000 times its own weight without any destruction and collapse. Besides, with the same loading, the good shape-stability of 3D architecture was demonstrated under a relatively high-temperature environment to simulate the effects of the internal heating of electronics on designed structure (Fig. S6). Hence, these physical characteristics provide essential guarantees for the fabrication of high-performance functional frames via 3D printing technique.</p>", "<title>Structural Characterizations of 3D-Printed Frames</title>", "<p id=\"Par16\">Owing to the intrinsic electrical performance of Gr and CNT nanoparticles, the assembled architectures are anticipated to exploit their potentialities in electromagnetic compatibility for integrated electronics. In this context, the representative 3D-printed frames with various stacking modes signed as full-filling (FI) and full-mismatch (FM) architectures are depicted in Fig. ##FIG##1##2##a, b. Accordingly, the surface and cross-section morphologies of as-designed frames are exhibited in Fig. ##FIG##1##2##c, d, and the regular stacks of FI and FM structures manifested the well tailorability of free-constructed shapes via 3D printing, whether in full-filling or full-mismatch modes. Moreover, the artificial porous structures were densely distributed in the interior of frames, exhibiting the lightweight characteristic for frame. In addition, the high-resolution SEM images in the cross-section of FM architecture are performed in Fig. ##FIG##1##2##e, f. As displayed in Fig. ##FIG##1##2##e, the porous structures assembled by CNF were formed and provided sufficient sites for the loading of CNT and Gr nanoparticles. More visualized in Fig. ##FIG##1##2##f, a large number of Gr@CNT nanoparticles were densely entangled on the CNF frameworks, which is mainly attributed to the interaction between CNF and Gr@CNT nanoparticles [##REF##35902243##27##, ##UREF##38##49##].</p>", "<title>EMI SE peculiarity of 3D-Printed Frames</title>", "<p id=\"Par17\">Generally, the intertwined networks of Gr@CNT nanoparticles would endow the materials with robust electrical conductivity, which plays a positive contribution on EMI SE performance [##UREF##20##28##, ##UREF##41##53##, ##UREF##42##54##]. The SE behaviors of 3D-printed frames with various stacking modes assembled by the as-formulated functional inks are evaluated in Fig. ##FIG##2##3##. As displayed in Fig. ##FIG##2##3##a, a similar tendency for shielding properties of 3D-printed frames was revealed, whether in FI or FM modes, i.e., the EMI SE value climbed first and then decreased with the sequential replacement of two-dimensional Gr by one-dimensional CNT nanoparticles. Typically, the optimum one of FI-G<sub>2</sub>C<sub>3</sub> sample was higher than 60 dB in whole X-band region, corresponding to an extremely low transmittance of 0.000001 for EMWs energy, which far exceeds commercial SE standard (20 dB) [##UREF##23##31##, ##REF##32628835##55##]. This outstanding SE behavior was mainly attributed to the excellent electrical performance of intertwined networks assembled by Gr@CNT nanoparticles (Fig. S7). To make a visualized comparison, the average EMI SE and SSE of all FI and FM frames are calculated in Fig. ##FIG##2##3##b, c. Generally, the EMI SE value of FI sample was slightly better than that of FM sample at the same Gr@CNT proportion, which is predominantly attributed to a richer number of pores, imparting longer propagation paths to EMWs, thereby affording a higher internal dissipation of EMWs energy [##UREF##43##56##]. Nevertheless, the ignorable sacrifice for the EMI SE value of FM samples was in exchange for a significant enhancement in SSE performance. For instance, the SSE value of FM-G<sub>2</sub>C<sub>3</sub> frame was up to 802.4 dB cm<sup>3</sup> g<sup>−1</sup>, 88.4% higher than that of FI-G<sub>2</sub>C<sub>3</sub> one, meanwhile the total SE value of FM-G<sub>2</sub>C<sub>3</sub> frame still maintained at 61.4 dB as compared with the FI-G<sub>2</sub>C<sub>3</sub> one (65.7 dB). Particularly, for the conventionally compacted sample with the same Gr@CNT proportion and weight, the EMI SE and SSE values were only 44.2 dB and 63.9 dB cm<sup>3</sup> g<sup>−1</sup>, respectively, implying the significant advantage of designed porous structures than solid structures (Fig. S8). Taken together, the 3D-printed FM frames made an excellent reconciliation in lightweight structure and high-performance SE behavior, thus realizing lighter and stronger shielding characteristics for potential shielding application. Moreover, owing to the free construction via 3D printing, the designed frames also possessed fitting feature for assembling arbitrarily-customized architectures onto integrated electronics.</p>", "<p id=\"Par18\">Followingly, the potential shielding mechanism of 3D-printed frames was investigated by assessing the relevant shielding parameters including SE<sub>total</sub>, SE<sub>A</sub>, and SE<sub>R</sub> (Figs. ##FIG##2##3##d and S9). Whether in FI or FM frames, SE<sub>A</sub> followed the change of SE<sub>total</sub> sequentially, while SE<sub>R</sub> maintained a nearly constant value, below 5 dB, i.e., the characteristic of SE<sub>A</sub> played a dominating role for the total shielding property (SE<sub>total</sub>) of as-designed carbon-based frames. The essence is mainly due to the positive contribution of the porous structures to the electromagnetic interference shielding performance of materials. As EMWs is transmitted into the shielding material, the porous structures allow EMWs to travel a longer distance inside the materials, thus promoting the SE<sub>A</sub> by increasing the reflection and multiple reflections inside the pores, and attenuating the EMWs energy as Joule heat [##UREF##41##53##, ##UREF##43##56##]. More importantly, another parameter of skin depth (δ) representing for the depth where the EMWs energy dissipates to <italic>e</italic><sup>−1</sup> [##UREF##33##43##] is further evaluated in Fig. ##FIG##2##3##e. Obviously, all FM frames existed an extremely low <italic>δ</italic>, and the optimum one was down to ~ 246 μm, implying that the micron-level thickness of FM frame could be responsible for SE requirements, well-fitting for the application in integrated electronics. More importantly, the trinity advantages of 3D-printed frames on “lighter-stronger-fitter” shielding features were demonstrated as compared to other EMI SE materials previously reported in the literature (Fig. ##FIG##2##3##f) (the detailed references inside this plot are listed in Table S3).</p>", "<title>Electrothermal Performance of 3D-Printed Frames</title>", "<p id=\"Par19\">The porous structures of 3D-printed frames as well as the densely intertwined Gr@CNT nanoparticles provided a promising potential in the thermal management of electronics under complicated thermal environments, e.g., high-efficiency heat compensation/dissipation capabilities [##UREF##21##29##, ##UREF##34##44##, ##UREF##44##57##, ##UREF##45##58##]. Hence, a schematic concerning on the evaluation of electrothermal performance of 3D-printed FM frames is depicted in Fig. ##FIG##3##4##a. Initially, the Joule heating performance of FM frames with various Gr@CNT proportions was investigated under a fixed voltage of 3 V (Fig. ##FIG##3##4##b). Apart from FM-G<sub>5</sub>C<sub>0</sub> frame, others presented a similar tendency, that the time-dependent temperature increased first and then reached an equilibrium, and the temperature was down to the initial stage as unloaded voltage. Comparatively, the FM-G<sub>2</sub>C<sub>3</sub> frame possessed the optimal electrothermal behaviors, including high equilibrium temperature and remarkable heating/dissipating efficiencies. Thereafter, the multiple input voltages from 0.5 to 2.5 V were separately conducted on the FM-G<sub>2</sub>C<sub>3</sub> sample in Fig. ##FIG##3##4##c. The superior electrothermal response time of less than 20 s was detected in the loading/unloading voltage process, suggesting the high heating/dissipating efficiencies. In addition, the differential equilibrium temperature was clearly observed, corresponding to 41.4, 56.5, 78.0, 110.6, and 147.4 °C, respectively. This strong voltage dependence was ascribed to the positive correlation between the equilibrium temperature and the square of input voltage (<italic>U</italic><sup>2</sup>) in potential electrothermal energy conversion. Moreover, the linear correlation between <italic>U</italic><sup>2</sup> and temperature is revealed in Fig. ##FIG##3##4##d, which was accompanied by a coefficient of determination (<italic>R</italic><sup>2</sup>) of 0.999, suggesting the stable impedance of frame during electrothermal measurement, thus providing a fundamental guarantee for their long-term thermal management application [##UREF##46##59##]. Thereafter, the generated temperature was detected in real time by loading step-wise voltages from 0.5 to 2.5 V in Fig. ##FIG##3##4##e, and the inset presented the representative infrared images. The step-wise and rapid response of temperature to various voltages laid an essential foundation on the tailorability of the electrothermal capability of 3D-printed frames, thereby using in the thermal management of electronics. The electrothermal reliability and stability are synchronously investigated in Fig. ##FIG##3##4##f, g. As shown in Fig. ##FIG##3##4##f, the multiple cycling measurements were conducted at two fixed voltages of 1.0 and 2.5 V, respectively. The steady step-change of temperature suggested the well repeatability for the thermal management of 3D-printed frame. What’s more, the long-time electrothermal stability of designed frame was confirmed by loading the same voltages over 10 h (Fig. ##FIG##3##4##g). Wherever inputting the voltages of 1.0 or 2.5 V, the equilibrium temperature almost maintained a constant, corresponding to about 56.6 and 146.6 °C, respectively, indicating the good thermal-stability of 3D-printed frame during the electrothermal measurement and excellent reliability for thermal management application. Hence, these ideal electrothermal behaviors posed the promising potentials in efficient heat compensation/dissipation capabilities for better serving electronics in complicated thermal thermal management environments.</p>", "<title>3D-printed Conformal-shielding Module for Integrated Electronics</title>", "<p id=\"Par20\">The 3D-printed frames have been fully demonstrated the prominent functionalities on EMI SE and thermal management capabilities. Toward the potential application of high-efficiency EMI shielding in integrated electronics, a novel alternative strategy regarding on 3D-printed conformal-shielding (c-SE) module was purposed, aiming to replace the traditional metal-based SE module. As a proof-of-concept, a schematic containing 3D-printed c-SE module with FM frame in-situ integrating onto core electronics by the assistance of packaging material is depicted in Fig. ##FIG##4##5##a. Accordingly, the representative models and digital images including traditional metal-based module, disassembled core electronic, and 3D-printed c-SE module are displayed in Fig. ##FIG##4##5##b. Owing to the outstanding capability of 3D printing technology in the customization of structure, the integrated c-SE module could be assembled the arbitrary-designated architecture to satisfy the demanding geometries for electronics. In addition, the good coordination between c-SE module and core electronic didn’t occupy the additional space to realize a positive contribution to the thermal management of the entire framework. Followingly, the principled capabilities of EMI shielding and thermal dissipation of assembled c-SE module are assessed in Fig. ##FIG##4##5##c–h. Notedly, due to operational difficulty in real-time monitoring EMWs shielding and thermal dissipation behaviors, the equivalent confirmatory experiments were designed to evaluate the functionalities of c-SE module. As displayed in Fig. ##FIG##4##5##c, a shielding detection regarding on the blocking of EMWs signal generated by electronics in mobile phone was carried out by a radiation tester. As anticipated, the designed c-SE module possessed the equivalent SE capability to traditional metal-based module disassembled from integrated electronics, exhibiting a completely shielding action to EMWs signal, where the corresponding radiation intensity was down from 1366.26 to 0 μT cm<sup>−2</sup> as loaded c-SE module. Meanwhile, the multiple cycles were conducted to detect the radiation intensity before and after loading module in Fig. ##FIG##4##5##d. The pulse-like fluctuation of signal intensity indicated the well reliability of c-SE module for shielding EMWs inside electronics. Moreover, its SE performance in 2.0 ~ 6.0 GHz covering the commercial EMWs signals is recorded in Fig. ##FIG##4##5##e. The total shielding values were higher than 30 dB, fully satisfying the SE application for the commercial SE standard (20 dB) of electronics [##UREF##34##44##, ##UREF##47##60##]. Thereafter, the thermal dissipation contribution of c-SE module assembling with packaging material was equivalently evaluated on a LED heater, and the representative infrared images is exhibited in Fig. ##FIG##4##5##f (the measured digital image is shown in Fig. S10). As comparison to the pure packaging materials, commonly used in electronics for facilitating thermal dissipation, the packaging materials incorporated with c-SE module posed the better thermal dissipation efficiency than the pure one, and a maximal working-temperature difference could reach ~ 9 °C. Besides, the real-time temperature curves are synchronously provided in Fig. ##FIG##4##5##g. Indeed, the packaging materials with the assistance of c-SE module possessed a well thermal dissipation efficiency in the initial stage and a lower thermal equilibrium after reaching the energy balance, which is mainly attributed to the existing Gr@CNT networks inside packaging materials, leading to a high-efficiency thermal conduction for materials [##UREF##21##29##, ##UREF##34##44##, ##UREF##45##58##]. Moreover, the simulated results concerning on the thermal dissipation behavior in the same pre-set environment are investigated in Fig. ##FIG##4##5##h, and the detailed thermal-conductivity parameters and the geometrical grids are supported in Table S4, Figs. S11 and S12. Obviously, the resultant profiles confirmed the better capability of the packaging materials with c-SE module in facilitating the thermal dissipation of core electronics, which was consistent with the experimental results. Overall, these 3D-printed c-SE modules with high-efficiency EMI SE performance and well thermal management capability illuminate the infinite possibilities for assembling the next-generation multifunctional modules suitable for integrated electronics.</p>" ]
[ "<title>Results and Discussion</title>", "<title>Rheological Performance and 3D Printability of Gr@CNT Functional Inks</title>", "<p id=\"Par14\">A schematic regarding on the Gr@CNT functional inks and their potential application in integrated electronics is depicted in Fig. ##FIG##0##1##a, wherein Gr@CNT nanoparticles as functional mediums were well-formulated to uniformly disperse in CNF matrix for 3D printing. Noteworthily, as a characteristic biopolymer, CNF made a non-negligible contribution to the ink formulation, playing the multiple roles in adherent template, dispersing accelerant, and viscosity management. Due to the promising CH–<italic>π</italic> interaction between CNF and Gr@CNT nanoparticles [##UREF##38##49##], CNF molecules provided sufficient active sites for adsorbing nanoparticles to form the robust intertwined networks (Fig. ##SUPPL##0##S1##). Besides, a negative surface charge owing to the carboxylate functional groups evidenced by the high zeta potential of CNF dispersion, exerted a strong electrostatic repulsion in molecular chains, which in turn improved the dispersion stability of Gr@CNT nanoparticles in CNF dispersion (Fig. S2). Moreover, the thickening effect of CNF molecules endowed the ink with appropriate viscoelastic characteristics for 3D printing. The pseudo-solid ink was strong enough to withstand its loading at a static state (Fig. S3), and meanwhile the smooth extrusion was realized through the narrow printing nozzle upon the suitable pressure (Fig. S4). Followingly, the rheological peculiarity of formulated inks with various Gr@CNT proportions are assessed in Fig. ##FIG##0##1##b–d. Generally, all inks performed ideal viscoelastic characteristics, including shear thinning, thixotropy and appropriate yield moduli. As shown in Fig. ##FIG##0##1##b, a typically shear-thinning behavior was demonstrated, suggesting a non-Newtonian peculiarity for the well-formulated inks, which is essential to uniformly flow out of a convergent nozzle under external pressure [##UREF##39##50##–##REF##35246886##52##]. The power-law property is revealed synchronously in Fig. S5. The result further confirmed the viscoelastic characteristics of inks. Moreover, the thixotropic capability was investigated by examining the change in viscosity upon the alternating loads with a low (0.01 s<sup>−1</sup>) or high (10 s<sup>−1</sup>) shear rate (Fig. ##FIG##0##1##c). Each ink afforded a similar behavior, exhibiting a steady-state viscous contribution as fixed shear rate. Initially, a high viscosity over 10<sup>2</sup> Pa s was detected in an extremely low shear rate (0.01 s<sup>−1</sup>) to simulate the pre-loading process, whereas the viscosity dropped below 10<sup>1</sup> Pa·s when the shear rate increased to 10 s<sup>−1</sup>, indicating that the formed CNF and Gr@CNT intertwined networks were partially destroyed to resist the applied shear rate, thereby exhibiting a shear-thinning behavior. Meanwhile, the viscosity would rapidly recover to its initial state as the shear rate returned to the low one, and a perfect cycle was confirmed in response to the repeated shear rates. This reversible transformation in viscoelastic performance induced by shear rates provides a guarantee for inks with fluid appearance suitable for 3D printing and shape stability of 3D-printed architectures during depositing onto substrate [##UREF##40##51##]. Besides, the storage and loss moduli (<italic>G</italic>′ and <italic>G</italic>′′) of inks were examined by dynamic rheological scanning as a function of wide oscillatory stress (10<sup>–1</sup> ~ 10<sup>3</sup> Pa) in Fig. ##FIG##0##1##d. Generally, the moduli of all inks showed a similar tendency and presented a terminal plateau at the region below the yield point (<italic>G</italic>′ = <italic>G</italic>′′), implying that the networks were strong enough to withstand the loaded stress, performing a quasi-solid peculiarity. When the stress monotonously increased, the pseudo-solid inks were completely yielded and exhibited fluid characteristic, implying the partial broken of networks. Notedly, the appropriate yield moduli would endow the inks with ideal 3D printability and robust supportability, thus laying an essential foundation for the layer-by-layer printing [##REF##35246886##52##]. Thus, these ideal rheological behaviors fully demonstrate that the 3D printability of Gr@CNT functional inks with the assistance of CNF.</p>", "<p id=\"Par15\">Thereafter, the representative ink with Gr@CNT proportion of 2:3 (signed as G<sub>2</sub>C<sub>3</sub>) was employed to experimentally evaluate 3D printability. According to the systematic trajectories, the various 2D patterns were designed and printed in Fig. ##FIG##0##1##e. The well-organized shapes demonstrated that the ink possessed desired printability for manufacturing arbitrarily-customized geometries. Moreover, the 3D architectures including pyramid and lattice structures were programmatically assembled by layer-by-layer stacking (Fig. ##FIG##0##1##f). In addition, due to the extremely low density of Gr@CNT nanoparticles and CNF, the assembled architecture imparted ultralight characteristic (~ 0.076 g cm<sup>−3</sup>), and simultaneously afforded more than 4000 times its own weight without any destruction and collapse. Besides, with the same loading, the good shape-stability of 3D architecture was demonstrated under a relatively high-temperature environment to simulate the effects of the internal heating of electronics on designed structure (Fig. S6). Hence, these physical characteristics provide essential guarantees for the fabrication of high-performance functional frames via 3D printing technique.</p>", "<title>Structural Characterizations of 3D-Printed Frames</title>", "<p id=\"Par16\">Owing to the intrinsic electrical performance of Gr and CNT nanoparticles, the assembled architectures are anticipated to exploit their potentialities in electromagnetic compatibility for integrated electronics. In this context, the representative 3D-printed frames with various stacking modes signed as full-filling (FI) and full-mismatch (FM) architectures are depicted in Fig. ##FIG##1##2##a, b. Accordingly, the surface and cross-section morphologies of as-designed frames are exhibited in Fig. ##FIG##1##2##c, d, and the regular stacks of FI and FM structures manifested the well tailorability of free-constructed shapes via 3D printing, whether in full-filling or full-mismatch modes. Moreover, the artificial porous structures were densely distributed in the interior of frames, exhibiting the lightweight characteristic for frame. In addition, the high-resolution SEM images in the cross-section of FM architecture are performed in Fig. ##FIG##1##2##e, f. As displayed in Fig. ##FIG##1##2##e, the porous structures assembled by CNF were formed and provided sufficient sites for the loading of CNT and Gr nanoparticles. More visualized in Fig. ##FIG##1##2##f, a large number of Gr@CNT nanoparticles were densely entangled on the CNF frameworks, which is mainly attributed to the interaction between CNF and Gr@CNT nanoparticles [##REF##35902243##27##, ##UREF##38##49##].</p>", "<title>EMI SE peculiarity of 3D-Printed Frames</title>", "<p id=\"Par17\">Generally, the intertwined networks of Gr@CNT nanoparticles would endow the materials with robust electrical conductivity, which plays a positive contribution on EMI SE performance [##UREF##20##28##, ##UREF##41##53##, ##UREF##42##54##]. The SE behaviors of 3D-printed frames with various stacking modes assembled by the as-formulated functional inks are evaluated in Fig. ##FIG##2##3##. As displayed in Fig. ##FIG##2##3##a, a similar tendency for shielding properties of 3D-printed frames was revealed, whether in FI or FM modes, i.e., the EMI SE value climbed first and then decreased with the sequential replacement of two-dimensional Gr by one-dimensional CNT nanoparticles. Typically, the optimum one of FI-G<sub>2</sub>C<sub>3</sub> sample was higher than 60 dB in whole X-band region, corresponding to an extremely low transmittance of 0.000001 for EMWs energy, which far exceeds commercial SE standard (20 dB) [##UREF##23##31##, ##REF##32628835##55##]. This outstanding SE behavior was mainly attributed to the excellent electrical performance of intertwined networks assembled by Gr@CNT nanoparticles (Fig. S7). To make a visualized comparison, the average EMI SE and SSE of all FI and FM frames are calculated in Fig. ##FIG##2##3##b, c. Generally, the EMI SE value of FI sample was slightly better than that of FM sample at the same Gr@CNT proportion, which is predominantly attributed to a richer number of pores, imparting longer propagation paths to EMWs, thereby affording a higher internal dissipation of EMWs energy [##UREF##43##56##]. Nevertheless, the ignorable sacrifice for the EMI SE value of FM samples was in exchange for a significant enhancement in SSE performance. For instance, the SSE value of FM-G<sub>2</sub>C<sub>3</sub> frame was up to 802.4 dB cm<sup>3</sup> g<sup>−1</sup>, 88.4% higher than that of FI-G<sub>2</sub>C<sub>3</sub> one, meanwhile the total SE value of FM-G<sub>2</sub>C<sub>3</sub> frame still maintained at 61.4 dB as compared with the FI-G<sub>2</sub>C<sub>3</sub> one (65.7 dB). Particularly, for the conventionally compacted sample with the same Gr@CNT proportion and weight, the EMI SE and SSE values were only 44.2 dB and 63.9 dB cm<sup>3</sup> g<sup>−1</sup>, respectively, implying the significant advantage of designed porous structures than solid structures (Fig. S8). Taken together, the 3D-printed FM frames made an excellent reconciliation in lightweight structure and high-performance SE behavior, thus realizing lighter and stronger shielding characteristics for potential shielding application. Moreover, owing to the free construction via 3D printing, the designed frames also possessed fitting feature for assembling arbitrarily-customized architectures onto integrated electronics.</p>", "<p id=\"Par18\">Followingly, the potential shielding mechanism of 3D-printed frames was investigated by assessing the relevant shielding parameters including SE<sub>total</sub>, SE<sub>A</sub>, and SE<sub>R</sub> (Figs. ##FIG##2##3##d and S9). Whether in FI or FM frames, SE<sub>A</sub> followed the change of SE<sub>total</sub> sequentially, while SE<sub>R</sub> maintained a nearly constant value, below 5 dB, i.e., the characteristic of SE<sub>A</sub> played a dominating role for the total shielding property (SE<sub>total</sub>) of as-designed carbon-based frames. The essence is mainly due to the positive contribution of the porous structures to the electromagnetic interference shielding performance of materials. As EMWs is transmitted into the shielding material, the porous structures allow EMWs to travel a longer distance inside the materials, thus promoting the SE<sub>A</sub> by increasing the reflection and multiple reflections inside the pores, and attenuating the EMWs energy as Joule heat [##UREF##41##53##, ##UREF##43##56##]. More importantly, another parameter of skin depth (δ) representing for the depth where the EMWs energy dissipates to <italic>e</italic><sup>−1</sup> [##UREF##33##43##] is further evaluated in Fig. ##FIG##2##3##e. Obviously, all FM frames existed an extremely low <italic>δ</italic>, and the optimum one was down to ~ 246 μm, implying that the micron-level thickness of FM frame could be responsible for SE requirements, well-fitting for the application in integrated electronics. More importantly, the trinity advantages of 3D-printed frames on “lighter-stronger-fitter” shielding features were demonstrated as compared to other EMI SE materials previously reported in the literature (Fig. ##FIG##2##3##f) (the detailed references inside this plot are listed in Table S3).</p>", "<title>Electrothermal Performance of 3D-Printed Frames</title>", "<p id=\"Par19\">The porous structures of 3D-printed frames as well as the densely intertwined Gr@CNT nanoparticles provided a promising potential in the thermal management of electronics under complicated thermal environments, e.g., high-efficiency heat compensation/dissipation capabilities [##UREF##21##29##, ##UREF##34##44##, ##UREF##44##57##, ##UREF##45##58##]. Hence, a schematic concerning on the evaluation of electrothermal performance of 3D-printed FM frames is depicted in Fig. ##FIG##3##4##a. Initially, the Joule heating performance of FM frames with various Gr@CNT proportions was investigated under a fixed voltage of 3 V (Fig. ##FIG##3##4##b). Apart from FM-G<sub>5</sub>C<sub>0</sub> frame, others presented a similar tendency, that the time-dependent temperature increased first and then reached an equilibrium, and the temperature was down to the initial stage as unloaded voltage. Comparatively, the FM-G<sub>2</sub>C<sub>3</sub> frame possessed the optimal electrothermal behaviors, including high equilibrium temperature and remarkable heating/dissipating efficiencies. Thereafter, the multiple input voltages from 0.5 to 2.5 V were separately conducted on the FM-G<sub>2</sub>C<sub>3</sub> sample in Fig. ##FIG##3##4##c. The superior electrothermal response time of less than 20 s was detected in the loading/unloading voltage process, suggesting the high heating/dissipating efficiencies. In addition, the differential equilibrium temperature was clearly observed, corresponding to 41.4, 56.5, 78.0, 110.6, and 147.4 °C, respectively. This strong voltage dependence was ascribed to the positive correlation between the equilibrium temperature and the square of input voltage (<italic>U</italic><sup>2</sup>) in potential electrothermal energy conversion. Moreover, the linear correlation between <italic>U</italic><sup>2</sup> and temperature is revealed in Fig. ##FIG##3##4##d, which was accompanied by a coefficient of determination (<italic>R</italic><sup>2</sup>) of 0.999, suggesting the stable impedance of frame during electrothermal measurement, thus providing a fundamental guarantee for their long-term thermal management application [##UREF##46##59##]. Thereafter, the generated temperature was detected in real time by loading step-wise voltages from 0.5 to 2.5 V in Fig. ##FIG##3##4##e, and the inset presented the representative infrared images. The step-wise and rapid response of temperature to various voltages laid an essential foundation on the tailorability of the electrothermal capability of 3D-printed frames, thereby using in the thermal management of electronics. The electrothermal reliability and stability are synchronously investigated in Fig. ##FIG##3##4##f, g. As shown in Fig. ##FIG##3##4##f, the multiple cycling measurements were conducted at two fixed voltages of 1.0 and 2.5 V, respectively. The steady step-change of temperature suggested the well repeatability for the thermal management of 3D-printed frame. What’s more, the long-time electrothermal stability of designed frame was confirmed by loading the same voltages over 10 h (Fig. ##FIG##3##4##g). Wherever inputting the voltages of 1.0 or 2.5 V, the equilibrium temperature almost maintained a constant, corresponding to about 56.6 and 146.6 °C, respectively, indicating the good thermal-stability of 3D-printed frame during the electrothermal measurement and excellent reliability for thermal management application. Hence, these ideal electrothermal behaviors posed the promising potentials in efficient heat compensation/dissipation capabilities for better serving electronics in complicated thermal thermal management environments.</p>", "<title>3D-printed Conformal-shielding Module for Integrated Electronics</title>", "<p id=\"Par20\">The 3D-printed frames have been fully demonstrated the prominent functionalities on EMI SE and thermal management capabilities. Toward the potential application of high-efficiency EMI shielding in integrated electronics, a novel alternative strategy regarding on 3D-printed conformal-shielding (c-SE) module was purposed, aiming to replace the traditional metal-based SE module. As a proof-of-concept, a schematic containing 3D-printed c-SE module with FM frame in-situ integrating onto core electronics by the assistance of packaging material is depicted in Fig. ##FIG##4##5##a. Accordingly, the representative models and digital images including traditional metal-based module, disassembled core electronic, and 3D-printed c-SE module are displayed in Fig. ##FIG##4##5##b. Owing to the outstanding capability of 3D printing technology in the customization of structure, the integrated c-SE module could be assembled the arbitrary-designated architecture to satisfy the demanding geometries for electronics. In addition, the good coordination between c-SE module and core electronic didn’t occupy the additional space to realize a positive contribution to the thermal management of the entire framework. Followingly, the principled capabilities of EMI shielding and thermal dissipation of assembled c-SE module are assessed in Fig. ##FIG##4##5##c–h. Notedly, due to operational difficulty in real-time monitoring EMWs shielding and thermal dissipation behaviors, the equivalent confirmatory experiments were designed to evaluate the functionalities of c-SE module. As displayed in Fig. ##FIG##4##5##c, a shielding detection regarding on the blocking of EMWs signal generated by electronics in mobile phone was carried out by a radiation tester. As anticipated, the designed c-SE module possessed the equivalent SE capability to traditional metal-based module disassembled from integrated electronics, exhibiting a completely shielding action to EMWs signal, where the corresponding radiation intensity was down from 1366.26 to 0 μT cm<sup>−2</sup> as loaded c-SE module. Meanwhile, the multiple cycles were conducted to detect the radiation intensity before and after loading module in Fig. ##FIG##4##5##d. The pulse-like fluctuation of signal intensity indicated the well reliability of c-SE module for shielding EMWs inside electronics. Moreover, its SE performance in 2.0 ~ 6.0 GHz covering the commercial EMWs signals is recorded in Fig. ##FIG##4##5##e. The total shielding values were higher than 30 dB, fully satisfying the SE application for the commercial SE standard (20 dB) of electronics [##UREF##34##44##, ##UREF##47##60##]. Thereafter, the thermal dissipation contribution of c-SE module assembling with packaging material was equivalently evaluated on a LED heater, and the representative infrared images is exhibited in Fig. ##FIG##4##5##f (the measured digital image is shown in Fig. S10). As comparison to the pure packaging materials, commonly used in electronics for facilitating thermal dissipation, the packaging materials incorporated with c-SE module posed the better thermal dissipation efficiency than the pure one, and a maximal working-temperature difference could reach ~ 9 °C. Besides, the real-time temperature curves are synchronously provided in Fig. ##FIG##4##5##g. Indeed, the packaging materials with the assistance of c-SE module possessed a well thermal dissipation efficiency in the initial stage and a lower thermal equilibrium after reaching the energy balance, which is mainly attributed to the existing Gr@CNT networks inside packaging materials, leading to a high-efficiency thermal conduction for materials [##UREF##21##29##, ##UREF##34##44##, ##UREF##45##58##]. Moreover, the simulated results concerning on the thermal dissipation behavior in the same pre-set environment are investigated in Fig. ##FIG##4##5##h, and the detailed thermal-conductivity parameters and the geometrical grids are supported in Table S4, Figs. S11 and S12. Obviously, the resultant profiles confirmed the better capability of the packaging materials with c-SE module in facilitating the thermal dissipation of core electronics, which was consistent with the experimental results. Overall, these 3D-printed c-SE modules with high-efficiency EMI SE performance and well thermal management capability illuminate the infinite possibilities for assembling the next-generation multifunctional modules suitable for integrated electronics.</p>" ]
[ "<title>Conclusions</title>", "<p id=\"Par21\">In this study, to better serve the electromagnetic compatibility of integrated electronics, a novel Gr@CNT conformal-shielding (c-SE) module with arbitrarily-customized architectures and prominent functionalities was assembled by taking full advantages of 3D printing. Initially, the systematic experiments involving that the well-formulated inks featuring appropriate rheological capabilities were elaborately manipulated by incorporating various proportions of Gr and CNT nanoparticles into cellulose matrix. The as-prepared functional inks possessed ideal viscoelastic characteristics, taking charge of 3D printability. Thus, a series of 2D patterns and 3D architectures were free-constructed based on the pre-programmed printing trajectories. Meanwhile, the as-fabricated 3D-printed frames afforded expected functionalities, showing outstanding EMI SE performance and superior thermal management capability. As a representative, the optimum frame assembled by G<sub>2</sub>C<sub>3</sub> ink exhibited an ultralight architecture (0.076 g cm<sup>−3</sup>) and remarkable SE capability (61.4 dB), as well as superhigh SSE peculiarity (802.4 dB cm<sup>3</sup> g<sup>−1</sup>), far exceeding the reported carbon-based SE materials. Besides, the well tailorability for equilibrium temperature of designed frames was confirmed, imparting efficiency heat compensation/dissipation capabilities to electronics. What’s more, in order to expand the promising application of these high-performance architectures, an innovative concept concerning on 3D-printed c-SE module was purposed to replace traditional metal-based module to afford multiple functions for advanced electronics. The resultant behaviors of c-SE module on EMI SE performance and thermal dissipation full demonstrated their potentials on integrated electronics. Thus, the outstanding features of 3D-printed c-SE modules illuminate the infinite possibilities for assembling the next generation of high-performance carbon-based SE materials for integrated electronic.</p>" ]
[ "<title>Highlights</title>", "<p id=\"Par1\">\n<list list-type=\"bullet\"><list-item><p id=\"Par2\">3D printable functional inks incorporated with graphene and carbon nanotube nanoparticles were well-formulated by manipulating their rheological performance</p></list-item><list-item><p id=\"Par3\">The frame with ultralight structure (0.076 g cm<sup>−3</sup>) and high-efficiency electromagnetic interference shielding (61.4 dB) was assembled</p></list-item><list-item><p id=\"Par4\">3D-printed c-SE module was in situ integrated onto the electronics, affording multiple functions of electromagnetic compatibility and thermal dissipation.</p></list-item></list>\n</p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s40820-023-01317-w.</p>", "<p id=\"Par5\">Electromagnetic interference shielding (EMI SE) modules are the core component of modern electronics. However, the traditional metal-based SE modules always take up indispensable three-dimensional space inside electronics, posing a major obstacle to the integration of electronics. The innovation of integrating 3D-printed conformal shielding (c-SE) modules with packaging materials onto core electronics offers infinite possibilities to satisfy ideal SE function without occupying additional space. Herein, the 3D printable carbon-based inks with various proportions of graphene and carbon nanotube nanoparticles are well-formulated by manipulating their rheological peculiarity. Accordingly, the free-constructed architectures with arbitrarily-customized structure and multifunctionality are created via 3D printing. In particular, the SE performance of 3D-printed frame is up to 61.4 dB, simultaneously accompanied with an ultralight architecture of 0.076 g cm<sup>−3</sup> and a superhigh specific shielding of 802.4 dB cm<sup>3</sup> g<sup>−1</sup>. Moreover, as a proof-of-concept, the 3D-printed c-SE module is <italic>in situ</italic> integrated into core electronics, successfully replacing the traditional metal-based module to afford multiple functions for electromagnetic compatibility and thermal dissipation. Thus, this scientific innovation completely makes up the blank for assembling carbon-based c-SE modules and sheds a brilliant light on developing the next generation of high-performance shielding materials with arbitrarily-customized structure for integrated electronics.</p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1007/s40820-023-01317-w.</p>", "<title>Keywords</title>" ]
[ "<title>Experimental Section</title>", "<title>Materials</title>", "<p id=\"Par10\">Multi-walled carbon nanotubes (CNT, average length: ~ 1.5 μm, average diameter: ~ 9.5 nm) were provided by Nanocyl S.A., Belgium. Graphene (Gr, thickness range: 3.4 ~ 8.0 nm, flake size: 5 ~ 20 μm) was supplied by Suzhou Tanfeng Graphene Technology Co., Ltd., China. Carboxylated cellulose nanofibers (CNF, carboxyl content: 1.2 mmol g<sup>−1</sup>, chain length range: 1 ~ 3 μm, average diameter: ~ 7 nm) were purchased from Guilin Qihong Tech. Co., Ltd., China. Polyvinylpyrrolidone (PVP, average molecular weight: 101,200 ~ 110,000) was provided by Macklin Co. Ltd, China. Deionized water was supplied by Kelong Chemical Reagent Factory, China. All chemicals were used directly without purification treatment.</p>", "<title>Preparation of 3D Printable Gr@CNT Inks</title>", "<p id=\"Par11\">1.0 g of Gr@CNT nanoparticles with a mass ratio of <italic>x:y</italic> (5:0, 4:1, 3:2, 2:3, 1:4, and 0:5), 0.3 g of CNF, and 0.15 g of PVP as a surfactant were dispersed in 300 mL deionized water under the ultrasonic treatment at 2 °C for 0.5 h by an ultrasonic cell disruptor (Ymnl-1800Y, Nanjing YMNL Instrument and Equipment, China). Noticeably, the detailed compositions of carbon-based functional inks are provided in Table ##SUPPL##0##S1##. After uniform dispersion, the solution was mechanically stirred and concentrated at 80 °C to obtain the pseudo-solid inks (14.5 g). Then, the inks were centrifuged to remove the internal bubbles. After treatment, the prepared inks were stored at 4 °C for 3D printing. It is worth noting that the proportion of carbon-based inks were well-formulated by the principles of 3D printability and functionality. Particularly, the lacking of CNF would deteriorate the 3D printability of carbon-based ink, whereas the excessive CNF would sacrifice the electrical conductivity of as-fabricated frames, resulting in a weak EMI SE performance for materials. Moreover, for the sake of convenience, the Gr@CNT functional inks were signed as G<sub><italic>x</italic></sub>C<sub><italic>y</italic></sub> to represent the relative ratio of Gr and CNT, where “<italic>x</italic>” and “<italic>y</italic>” represent the relative ratio of Gr and CNT in Gr@CNT nanoparticles, e.g., G<sub>5</sub>C<sub>0</sub>, G<sub>4</sub>C<sub>1</sub>, G<sub>3</sub>C<sub>2</sub>, G<sub>2</sub>C<sub>3</sub>, G<sub>1</sub>C<sub>4</sub>, and G<sub>0</sub>C<sub>5</sub>.</p>", "<title>Direct Ink Writing (DIW) 3D Printing of Gr@CNT Frames</title>", "<p id=\"Par12\">According to the pre-programmed 3D printing program, the as-prepared Gr@CNT functional ink was loaded into the syringe and extruded by a desktop dispenser (TS-200BN, Shenzhen Tensun Precision Equipment, China) with a nozzle diameter of 800 μm, a step resolution of 20 μm, an appropriate pressure of 30 psi, and a writing speed of 5 mm s<sup>−1</sup> (more detailed printing information is supported in Table S2). After printing, the assembled samples were placed into an ultra-low temperature freezer (MDF-382, Panasonic Appliances Cold Chain, Co. Ltd, China) and freeze for 2 h, and then moved to a freeze dryer (Ymnl-10N, Nanjing YMNL Instrument and Equipment Co. Ltd., China) for freeze-drying 10 h to obtain 3D-printed Gr@CNT frames.</p>", "<title>Characterization</title>", "<p id=\"Par13\">The Zeta potentials of CNF, Gr@CNT and Gr@CNT/CNF dispersions with a dilutional concentration of ~ 5.0 mg mL<sup>−1</sup> were measured by a Malvern Zetasizer NANO-ZS (Malvern Instruments, Worcestershire, UK). The rheological properties of Gr@CNT functional inks with a diameter of 25 mm and a gap of 1 mm were evaluated at 25 °C by a rotational rheometer (AR2000ex, TA Instruments, USA), the oscillatory angular frequency sweep was assessed in the range of 0.01–100 rad s<sup>−1</sup> at a fixed strain of 5%, and the time sweep was tested at a step change of shear rates in 0.01 and 10 s<sup>−1</sup>. The oscillatory stress sweep was conducted on a shear rate range of 0.1–1000 Pa at a fixed angular frequency of 1 rad s<sup>−1</sup>. The thermal conductivity (<italic>λ</italic>) of packaging material and Gr@CNT frames with a size of 10 × 10 × 2.5 mm<sup>3</sup> was tested by a laser flash analyzer (LFA467, NEXTZSCH, Germany), and the representative infrared images were obtained using an infrared camera (FLIRONE Pro, FLIR, USA). The surface and cross-sectional morphologies of 3D-printed frames were characterized by a field-emission scanning electron microscopy (SEM) (SU8020, Hitachi, Japan). The electrical conductivity of 3D-printed frames was evaluated by a multifunctional digital four-probe tester (ST2258C, Suzhou Crystal Electronic Co., Ltd., China). The radiation intensity generated by electronics of mobile phone was recorded by a radiation test instrument (620A, Ningbo Kemai Instrument and Equipment, China). The scattering parameters (S<sub>11</sub>, S<sub>22</sub>, S<sub>12</sub> and S<sub>21</sub>) of 3D-printed frames with a diameter of 13.0 mm and a thickness of ~ 2.50 mm and compacted sample with a diameter of 13.0 mm and a thickness of ~ 0.40 mm in the 2.0–6.0 GHz and 8.2–12.4 GHz frequency range were measured by a vector network analyzer (N5230, Agilent Technologies, USA). The relevant electromagnetic characteristics of EMI shielding materials, e.g., absorption shielding (SE<sub>A</sub>), reflection shielding (SE<sub>R</sub>), total SE (SE<sub>total</sub>), specific SE value (SSE) and skin depth (<italic>δ</italic>) were calculated by the scattering parameters according to Eqs. (##FORMU##0##1##–##FORMU##6##7##) [##UREF##23##31##, ##UREF##33##43##, ##UREF##37##48##].where <italic>R</italic>, <italic>T</italic>, and <italic>A</italic>, represent reflection coefficient, transmission coefficient, and absorption coefficient, respectively; SE<sub>A</sub>, SE<sub>R</sub>, and SE<sub>m</sub> represent absorption attenuation, reflection attenuation and multiple-internal reflection attenuation; SE<sub>total</sub> and SSE represents the total EMI SE value and specific SE value; <italic>ρ'</italic> represents apparent density, according to the equation: <italic>ρ'</italic> = <italic>m/V</italic>, where <italic>m</italic> and <italic>V</italic> are the weight and the apparent volume of 3D printing models, respectively; besides, the <italic>ρ'</italic> of compacted sample is 0.692 g cm<sup>−3</sup>; <italic>f</italic> represents frequency; <italic>σ</italic> and <italic>μ</italic> represents electrical conductivity and permeability. Noticeably, when SE<sub>total</sub> &gt; 10 dB, SE<sub>m</sub> could be neglected [##UREF##33##43##].</p>", "<title>Supplementary Information</title>", "<p>Below is the link to the electronic supplementary material.</p>" ]
[ "<title>Acknowledgements</title>", "<p>This work is financially supported by the National Natural Science Foundation of China (52303036), the Natural Science Foundation of Guangxi Province (2020GXNSFAA297028), the Guangxi Science and Technology Base and Talent Special Project (GUIKE AD23026179), the International Science &amp; Technology Cooperation Project of Chengdu (2021-GH03-00009-HZ), the Program of Innovative Research Team for Young Scientists of Sichuan Province (22CXTD0019), the Natural Science Foundation of Sichuan Province (2023NSFSC0986), and the Opening Project of State Key Laboratory of Polymer Materials Engineering (Sichuan University) (Sklpme2023-3-18).</p>", "<title>Declarations</title>", "<title>Conflict of interest</title>", "<p id=\"Par22\">The authors declare no conflict of interest. They have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>Rheological performance of Gr@CNT functional inks with various proportions. <bold>a</bold> Schematic of 3D printable Gr@CNT functional inks and their potential application in integrated electronics. <bold>b</bold> Complex viscosity (<italic>η</italic>*) as a function of oscillatory shear rate (<italic>ω</italic>). <bold>c</bold>\n<italic>η</italic>* upon the loads of two alternating shear rates of 0.01 and 10 s<sup>−1</sup>, respectively. <bold>d</bold> Moduli (<italic>G</italic>′ and <italic>G</italic>′′) as a function of oscillatory shear stress. <bold>e, f</bold> Digital images of 2D patterns and 3D architectures featuring ultralight and strong characteristics</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>Morphologies of 3D-printed full-filling (FI) and full-mismatch (FM) frames with G<sub>2</sub>C<sub>3</sub> ink. <bold>a, b</bold> Schematic of 3D printing FI and FM models. <bold>c, d</bold> SEM images of the surface (left) and cross-section (right) structures. <bold>e, f</bold> The high-resolution SEM images of FM sample</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p>EMI SE peculiarity of 3D-printed FI and FM frames with various Gr@CNT proportions. <bold>a</bold> EMI SE properties in the X-band frequency range. <bold>b, c</bold> The average EMI SE and SSE values. <bold>d, e</bold> The electromagnetic parameters (SE<sub>total</sub>, SE<sub>A</sub>, and SE<sub>R</sub>) and skin depth (<italic>δ</italic>) of FM frames. <bold>f</bold> A radar plot benchmarking the key parameters (lighter, stronger, and fitter features) of 3D-printed FM frame in this work and other SE materials previously reported in the literatures (the references inside this plot listed in Table S3, ANF: aramid nanofiber, PU: Polyurethane, Cs: Carbon-matrix nanocomposites, CF: carbon foam, NR: Natural rubber, PLA: Polylactic acid, PYC: Pyrolytic carbon, GN: Graphene nanosheets, EP: Epoxy). (The inset in <bold>e</bold> shows schematic of energy dissipation of EMWs to <italic>e</italic><sup>−1</sup>)</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p>Electrothermal performance of 3D-printed FM frames with various Gr@CNT proportions. <bold>a</bold> Schematic of electrothermal energy conversion. <bold>b</bold> Joule heating performance at a fixed voltage of 3 V. <bold>c, d</bold> Joule heating performance of FM-G<sub>2</sub>C<sub>3</sub> frame upon multiple input voltages from 0.5 to 2.5 V, and the corresponding linear fit of equilibrium temperature vs. square of input voltage (<italic>U</italic><sup>2</sup>). <bold>e</bold> The real-time temperature of FM-G<sub>2</sub>C<sub>3</sub> frame by loading the step-wise voltages from 0.5 to 2.5 V. <bold>f</bold> The temperature of FM-G<sub>2</sub>C<sub>3</sub> frame upon the multiple cycling tests at two fixed voltages of 1.0 and 2.5 V. <bold>g</bold> The long-time electrothermal stability of FM-G<sub>2</sub>C<sub>3</sub> frame at two fixed voltages of 1.0 and 2.5 V over 10 h. (the insets in <bold>e</bold> &amp; <bold>g</bold> shows the representative infrared images)</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><p>3D-printed c-SE module for integrated electronics. <bold>a</bold> Schematic of 3D-printed c-SE module onto core electronics. <bold>b</bold> The representative models and digital images including traditional metal-based module, disassembled core electronic, and 3D-printed c-SE module. <bold>c</bold> Digital images of the radiation intensity of EMWs signals before and after loading metal-based module or c-SE module. <bold>d</bold> Multiple cycles of the radiation intensity before and after loading c-SE module. <bold>e</bold> EMI SE performance of c-SE module in the 2.0–6.0 GHz frequency range. <bold>f, g</bold> The representative infrared thermal images of pure packaging material and the packaging material with c-SE module for assisting the thermal dissipation of electronics, and the corresponding real-time temperature curves. <bold>h</bold> COMSOL simulation of the thermal dissipation behaviors of pure packaging material and the packaging material with c-SE module</p></caption></fig>" ]
[]
[ "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R = \\left| {S_{11} } \\right|^{2} = \\left| {S_{22} } \\right|^{2} ;\\;T = \\left| {S_{12} } \\right|^{2} = \\left| {S_{21} } \\right|^{2}$$\\end{document}</tex-math><mml:math id=\"M2\" display=\"block\"><mml:mrow><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mfenced close=\"|\" open=\"|\"><mml:msub><mml:mi>S</mml:mi><mml:mn>11</mml:mn></mml:msub></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:msup><mml:mfenced close=\"|\" open=\"|\"><mml:msub><mml:mi>S</mml:mi><mml:mn>22</mml:mn></mml:msub></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:mo>;</mml:mo><mml:mspace width=\"0.277778em\"/><mml:mi>T</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mfenced close=\"|\" open=\"|\"><mml:msub><mml:mi>S</mml:mi><mml:mn>12</mml:mn></mml:msub></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:msup><mml:mfenced close=\"|\" open=\"|\"><mml:msub><mml:mi>S</mml:mi><mml:mn>21</mml:mn></mml:msub></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$A = 1 - R - T$$\\end{document}</tex-math><mml:math id=\"M4\" display=\"block\"><mml:mrow><mml:mi>A</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>R</mml:mi><mml:mo>-</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{SE}}_{{\\text{A}}} = - 10\\log \\left( {T/\\left( {1 - R} \\right)} \\right)$$\\end{document}</tex-math><mml:math id=\"M6\" display=\"block\"><mml:mrow><mml:msub><mml:mtext>SE</mml:mtext><mml:mtext>A</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>10</mml:mn><mml:mo>log</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>T</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>R</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ4\"><label>4</label><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{SE}}_{R} = - 10\\log \\left( {1 - R} \\right)$$\\end{document}</tex-math><mml:math id=\"M8\" display=\"block\"><mml:mrow><mml:msub><mml:mtext>SE</mml:mtext><mml:mi>R</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>10</mml:mn><mml:mo>log</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>R</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ5\"><label>5</label><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{SE}}_{{{\\text{total}}}} = {\\text{SE}}_{{\\text{R}}} + {\\text{SE}}_{{\\text{A}}} + {\\text{SE}}_{{\\text{m}}}$$\\end{document}</tex-math><mml:math id=\"M10\" display=\"block\"><mml:mrow><mml:msub><mml:mtext>SE</mml:mtext><mml:mtext>total</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mtext>SE</mml:mtext><mml:mtext>R</mml:mtext></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>SE</mml:mtext><mml:mtext>A</mml:mtext></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>SE</mml:mtext><mml:mtext>m</mml:mtext></mml:msub></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ6\"><label>6</label><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{SSE}} = {\\text{SE}}_{{{\\text{total}}}} /\\rho^{\\prime}$$\\end{document}</tex-math><mml:math id=\"M12\" display=\"block\"><mml:mrow><mml:mtext>SSE</mml:mtext><mml:mo>=</mml:mo><mml:msub><mml:mtext>SE</mml:mtext><mml:mtext>total</mml:mtext></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:msup><mml:mi>ρ</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ7\"><label>7</label><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\delta= \\sqrt {1/\\pi f\\sigma \\mu }$$\\end{document}</tex-math><mml:math id=\"M14\" display=\"block\"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:msqrt><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>π</mml:mi><mml:mi>f</mml:mi><mml:mi>σ</mml:mi><mml:mi>μ</mml:mi></mml:mrow></mml:msqrt></mml:mrow></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[]
[ "<graphic position=\"anchor\" xlink:href=\"40820_2023_1317_Figa_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"40820_2023_1317_Article_Equ1.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"40820_2023_1317_Article_Equ2.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"40820_2023_1317_Article_Equ3.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"40820_2023_1317_Article_Equ4.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"40820_2023_1317_Article_Equ5.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"40820_2023_1317_Article_Equ6.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"40820_2023_1317_Article_Equ7.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"40820_2023_1317_Fig1_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"40820_2023_1317_Fig2_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"40820_2023_1317_Fig3_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"40820_2023_1317_Fig4_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"40820_2023_1317_Fig5_HTML\" id=\"MO6\"/>" ]
[ "<media xlink:href=\"40820_2023_1317_MOESM1_ESM.pdf\"><caption><p>Supplementary file1 (PDF 651 KB)</p></caption></media>" ]
[{"label": ["1."], "mixed-citation": ["Y. Xie, S. Liu, K. Huang, B. Chen, P. Shi et al., Ultra-broadband strong electromagnetic interference shielding with ferromagnetic graphene quartz fabric. Adv. Mater."], "bold": [" 34"]}, {"label": ["3."], "surname": ["Jiang", "Lian", "Xu", "Sun", "Xu"], "given-names": ["D", "M", "M", "Q", "BB"], "article-title": ["Advances in triboelectric nanogenerator technology\u2014applications in self-powered sensors, Internet of Things, biomedicine, and blue energy"], "source": ["Adv. Compos. Hybrid Mater."], "year": ["2023"], "volume": ["6"], "fpage": ["57"], "pub-id": ["10.1007/s42114-023-00632-5"]}, {"label": ["4."], "surname": ["Dang", "Amin", "Shihada", "Alouini"], "given-names": ["S", "O", "B", "M-S"], "article-title": ["What should 6G be?"], "source": ["Nat. Electron."], "year": ["2020"], "volume": ["3"], "fpage": ["20"], "lpage": ["29"], "pub-id": ["10.1038/s41928-019-0355-6"]}, {"label": ["5."], "surname": ["Zhang", "Zheng", "Aouraghe", "Xu"], "given-names": ["K", "L", "MA", "F"], "article-title": ["Ultra-light-weight kevlar/polyimide 3D woven spacer multifunctional composites for high-gain microstrip antenna"], "source": ["Adv. Compos. Hybrid Mater."], "year": ["2022"], "volume": ["5"], "fpage": ["872"], "lpage": ["883"], "pub-id": ["10.1007/s42114-021-00382-2"]}, {"label": ["6."], "mixed-citation": ["J. Singh, Z. Din, Energy efficient data aggregation and density-based spatial clustering of applications with noise for activity monitoring in wireless sensor networks. Eng. Sci."], "bold": [" 19"]}, {"label": ["10."], "surname": ["Hao", "Leng", "Yu", "Xie", "Meng"], "given-names": ["Y", "Z", "C", "P", "S"], "article-title": ["Ultra-lightweight hollow bowl-like carbon as microwave absorber owning broad band and low filler loading"], "source": ["Carbon"], "year": ["2023"], "volume": ["212"], "fpage": ["118156"], "pub-id": ["10.1016/j.carbon.2023.118156"]}, {"label": ["11."], "surname": ["Xie", "Liu", "Feng", "Niu", "Liu"], "given-names": ["P", "Y", "M", "M", "C"], "article-title": ["Hierarchically porous Co/C nanocomposites for ultralight high-performance microwave absorption"], "source": ["Adv. Compos. Hybrid Mater."], "year": ["2021"], "volume": ["4"], "fpage": ["173"], "lpage": ["185"], "pub-id": ["10.1007/s42114-020-00202-z"]}, {"label": ["12."], "surname": ["Li", "Wu", "Kimura", "Wang", "Xu"], "given-names": ["F", "N", "H", "Y", "BB"], "article-title": ["Initiating binary metal oxides microcubes electrsomagnetic wave absorber toward ultrabroad absorption bandwidth through interfacial and defects modulation"], "source": ["Nano-Micro Lett."], "year": ["2023"], "volume": ["15"], "fpage": ["220"], "pub-id": ["10.1007/s40820-023-01197-0"]}, {"label": ["13."], "mixed-citation": ["Y. Cheng, X. Li, Y. Qin, Y. Fang, G. Liu et al., Hierarchically porous polyimide/Ti3C2Tx film with stable electromagnetic interference shielding after resisting harsh conditions. Sci. Adv."], "bold": [" 7"]}, {"label": ["14."], "surname": ["Ruan", "Chang", "Rong", "Alomar", "Zhu"], "given-names": ["J", "Z", "H", "TS", "D"], "article-title": ["High-conductivity nickel shells encapsulated wood-derived porous carbon for improved electromagnetic interference shielding"], "source": ["Carbon"], "year": ["2023"], "volume": ["213"], "fpage": ["118208"], "pub-id": ["10.1016/j.carbon.2023.118208"]}, {"label": ["15."], "surname": ["Zhu", "Li", "Deng", "Yu", "Shui"], "given-names": ["R", "Z", "G", "Y", "J"], "article-title": ["Anisotropic magnetic liquid metal film for wearable wireless electromagnetic sensing and smart electromagnetic interference shielding"], "source": ["Nano Energy"], "year": ["2022"], "volume": ["92"], "fpage": ["106700"], "pub-id": ["10.1016/j.nanoen.2021.106700"]}, {"label": ["16."], "surname": ["Zhang", "Gu"], "given-names": ["Y", "J"], "article-title": ["A perspective for developing polymer-based electromagnetic interference shielding composites"], "source": ["Nano-Micro Lett."], "year": ["2022"], "volume": ["14"], "fpage": ["89"], "pub-id": ["10.1007/s40820-022-00843-3"]}, {"label": ["17."], "surname": ["He", "Tao", "Yang", "Yang", "Zhang"], "given-names": ["Q-M", "J-R", "Y", "D", "K"], "article-title": ["Effect surface micro-wrinkles and micro-cracks on microwave shielding performance of copper-coated carbon nanotubes/polydimethylsiloxane composites"], "source": ["Carbon"], "year": ["2023"], "volume": ["213"], "fpage": ["118216"], "pub-id": ["10.1016/j.carbon.2023.118216"]}, {"label": ["18."], "surname": ["Shen", "Kim"], "given-names": ["X", "J-K"], "article-title": ["Building 3D architecture in 2D thin film for effective EMI shielding"], "source": ["Matter"], "year": ["2019"], "volume": ["1"], "fpage": ["796"], "lpage": ["798"], "pub-id": ["10.1016/j.matt.2019.09.007"]}, {"label": ["19."], "surname": ["Chen", "Shi", "Zou", "Chen"], "given-names": ["W-Y", "X-L", "J", "Z-G"], "article-title": ["Thermoelectric coolers for on-chip thermal management: materials, design, and optimization"], "source": ["Mater. Sci. Eng. R. Rep."], "year": ["2022"], "volume": ["151"], "fpage": ["100700"], "pub-id": ["10.1016/j.mser.2022.100700"]}, {"label": ["20."], "surname": ["Liu", "Yu", "Yu", "Nicolosi"], "given-names": ["J", "M-Y", "Z-Z", "V"], "article-title": ["Design and advanced manufacturing of electromagnetic interference shielding materials"], "source": ["Mater. Today"], "year": ["2023"], "volume": ["66"], "fpage": ["245"], "lpage": ["272"], "pub-id": ["10.1016/j.mattod.2023.03.022"]}, {"label": ["23."], "surname": ["Song", "Ma", "Qiu", "Ru", "Gu"], "given-names": ["P", "Z", "H", "Y", "J"], "article-title": ["High-efficiency electromagnetic interference shielding of rGO@FeNi/epoxy composites with regular honeycomb structures"], "source": ["Nano-Micro Lett."], "year": ["2022"], "volume": ["14"], "fpage": ["51"], "pub-id": ["10.1007/s40820-022-00798-5"]}, {"label": ["24."], "surname": ["Chen", "Yang", "Xiong", "Zhang", "Xu"], "given-names": ["Y", "Y", "Y", "L", "W"], "article-title": ["Porous aerogel and sponge composites: assisted by novel nanomaterials for electromagnetic interference shielding"], "source": ["Nano Today"], "year": ["2021"], "volume": ["38"], "fpage": ["101204"], "pub-id": ["10.1016/j.nantod.2021.101204"]}, {"label": ["25."], "surname": ["Wang", "Kong", "Yu", "Gao", "Dai"], "given-names": ["T", "W-W", "W-C", "J-F", "K"], "article-title": ["A healable and mechanically enhanced composite with segregated conductive network structure for high-efficient electromagnetic interference shielding"], "source": ["Nano-Micro Lett."], "year": ["2021"], "volume": ["13"], "fpage": ["162"], "pub-id": ["10.1007/s40820-021-00693-5"]}, {"label": ["26."], "surname": ["Kang", "Zeng", "Ling", "Zhang"], "given-names": ["W", "L", "S", "C"], "article-title": ["3D printed supercapacitors toward trinity excellence in kinetics, energy density, and flexibility"], "source": ["Adv. Energy Mater."], "year": ["2021"], "volume": ["11"], "fpage": ["2100020"], "pub-id": ["10.1002/aenm.202100020"]}, {"label": ["28."], "surname": ["Erfanian", "Moaref", "Ajdary", "Tam", "Rojas"], "given-names": ["E", "R", "R", "KC", "OJ"], "article-title": ["Electrochemically synthesized graphene/TEMPO-oxidized cellulose nanofibrils hydrogels: highly conductive green inks for 3D printing of robust structured EMI shielding aerogels"], "source": ["Carbon"], "year": ["2023"], "volume": ["210"], "fpage": ["118037"], "pub-id": ["10.1016/j.carbon.2023.118037"]}, {"label": ["29."], "surname": ["Song", "Liu", "Liang", "Ruan", "Qiu"], "given-names": ["P", "B", "C", "K", "H"], "article-title": ["Lightweight, flexible cellulose-derived carbon Aerogel@Reduced graphene oxide/PDMS composites with outstanding EMI shielding performances and excellent thermal conductivities"], "source": ["Nano-Micro Lett."], "year": ["2021"], "volume": ["13"], "fpage": ["91"], "pub-id": ["10.1007/s40820-021-00624-4"]}, {"label": ["30."], "surname": ["Wang", "Gao", "Liang", "Liu", "Zhang"], "given-names": ["C", "H", "D", "S", "H"], "article-title": ["Effective fabrication of flexible nickel chains/acrylate composite pressure-sensitive adhesives with layered structure for tunable electromagnetic interference shielding"], "source": ["Adv. Compos. Hybrid Mater."], "year": ["2022"], "volume": ["5"], "fpage": ["2906"], "lpage": ["2920"], "pub-id": ["10.1007/s42114-022-00482-7"]}, {"label": ["31."], "surname": ["Liang", "Gu", "Zhang", "Ma", "Qiu"], "given-names": ["C", "Z", "Y", "Z", "H"], "article-title": ["Structural design strategies of polymer matrix composites for electromagnetic interference shielding: a review"], "source": ["Nano-Micro Lett."], "year": ["2021"], "volume": ["13"], "fpage": ["181"], "pub-id": ["10.1007/s40820-021-00707-2"]}, {"label": ["32."], "surname": ["Liu", "Chen", "Zhang", "Wang", "Guan"], "given-names": ["L-X", "W", "H-B", "Q-W", "F"], "article-title": ["Flexible and multifunctional silk textiles with biomimetic leaf-like MXene/silver nanowire nanostructures for electromagnetic interference shielding, humidity monitoring, and self-derived hydrophobicity"], "source": ["Adv. Funct. Mater."], "year": ["2019"], "volume": ["29"], "fpage": ["1905197"], "pub-id": ["10.1002/adfm.201905197"]}, {"label": ["33."], "surname": ["Xu", "Chang", "Zhao", "Li", "Cui"], "given-names": ["J", "H", "B", "R", "T"], "article-title": ["Highly stretchable and conformal electromagnetic interference shielding armor with strain sensing ability"], "source": ["Chem. Eng. J."], "year": ["2022"], "volume": ["431"], "fpage": ["133908"], "pub-id": ["10.1016/j.cej.2021.133908"]}, {"label": ["34."], "surname": ["Kuo", "Kuo", "Wang"], "given-names": ["H-C", "C-W", "C-C"], "article-title": ["Effective low-frequency EMI conformal shielding for system-in-package (SiP) modules"], "source": ["Micro Opt. Tech. Lett."], "year": ["2023"], "volume": ["65"], "fpage": ["1892"], "lpage": ["1897"], "pub-id": ["10.1002/mop.33658"]}, {"label": ["35."], "surname": ["Liu", "McKeon", "Garcia", "Pinilla", "Barwich"], "given-names": ["J", "L", "J", "S", "S"], "article-title": ["Additive manufacturing of Ti3C2-MXene-functionalized conductive polymer hydrogels for electromagnetic-interference shielding"], "source": ["Adv. Mater."], "year": ["2022"], "volume": ["34"], "fpage": ["2106253"], "pub-id": ["10.1002/adma.202106253"]}, {"label": ["36."], "surname": ["Li", "Fu", "Zou", "Zheng", "Luo"], "given-names": ["R", "Q", "X", "Z", "W"], "article-title": ["Mn-Co-Ni-O thin films prepared by sputtering with alloy target"], "source": ["J. Adv. Ceram."], "year": ["2020"], "volume": ["9"], "fpage": ["64"], "lpage": ["71"], "pub-id": ["10.1007/s40145-019-0348-y"]}, {"label": ["39."], "surname": ["Abbasi", "Antunes", "Velasco"], "given-names": ["H", "M", "JI"], "article-title": ["Recent advances in carbon-based polymer nanocomposites for electromagnetic interference shielding"], "source": ["Prog. Mater. Sci."], "year": ["2019"], "volume": ["103"], "fpage": ["319"], "lpage": ["373"], "pub-id": ["10.1016/j.pmatsci.2019.02.003"]}, {"label": ["40."], "surname": ["Liu", "Gao", "Wang", "Wang", "Wang"], "given-names": ["F", "Y", "G", "D", "Y"], "article-title": ["Laser-induced graphene enabled additive manufacturing of multifunctional 3D architectures with freeform structures"], "source": ["Adv. Sci."], "year": ["2023"], "volume": ["10"], "fpage": ["e2204990"], "pub-id": ["10.1002/advs.202204990"]}, {"label": ["41."], "surname": ["Liu", "Garcia", "Leahy", "Song", "Mullarkey"], "given-names": ["J", "J", "LM", "R", "D"], "article-title": ["3D printing of multifunctional conductive polymer composite hydrogels"], "source": ["Adv. Funct. Mater."], "year": ["2023"], "volume": ["33"], "fpage": ["2214196"], "pub-id": ["10.1002/adfm.202214196"]}, {"label": ["42."], "surname": ["Lee", "Baum", "Shanks", "Daver"], "given-names": ["KPM", "T", "R", "F"], "article-title": ["Electromagnetic interference shielding of 3D-printed graphene\u2013polyamide-6 composites with 3D-printed morphology"], "source": ["Addit. Manuf."], "year": ["2021"], "volume": ["43"], "fpage": ["102020"], "pub-id": ["10.1016/j.addma.2021.102020"]}, {"label": ["43."], "surname": ["Lv", "Tao", "Shi", "Li", "Chen"], "given-names": ["Q", "X", "S", "Y", "N"], "article-title": ["From materials to components: 3D-printed architected honeycombs toward high-performance and tunable electromagnetic interference shielding"], "source": ["Compos. Part B Eng."], "year": ["2022"], "volume": ["230"], "fpage": ["109500"], "pub-id": ["10.1016/j.compositesb.2021.109500"]}, {"label": ["44."], "surname": ["Shi", "Dai", "Tao", "Wu", "Sun"], "given-names": ["S", "M", "X", "F", "J"], "article-title": ["3D printed polylactic acid/graphene nanocomposites with tailored multifunctionality towards superior thermal management and high-efficient electromagnetic interference shielding"], "source": ["Chem. Eng. J."], "year": ["2022"], "volume": ["450"], "fpage": ["138248"], "pub-id": ["10.1016/j.cej.2022.138248"]}, {"label": ["45."], "surname": ["Agrawal", "Kumar", "Teotia", "Kumari", "Mondal"], "given-names": ["PR", "R", "S", "S", "DP"], "article-title": ["Lightweight, high electrical and thermal conducting carbon-rGO composites foam for superior electromagnetic interference shielding"], "source": ["Compos. Part B Eng."], "year": ["2019"], "volume": ["160"], "fpage": ["131"], "lpage": ["139"], "pub-id": ["10.1016/j.compositesb.2018.10.033"]}, {"label": ["47."], "surname": ["Liu", "Li", "Sun", "Tang", "Deng"], "given-names": ["X", "Y", "X", "W", "G"], "article-title": ["Off/on switchable smart electromagnetic interference shielding aerogel"], "source": ["Matter"], "year": ["2021"], "volume": ["4"], "fpage": ["1735"], "lpage": ["1747"], "pub-id": ["10.1016/j.matt.2021.02.022"]}, {"label": ["48."], "surname": ["Gao", "Wang", "Yue", "Zhao", "Che"], "given-names": ["Y-N", "Y", "T-N", "B", "R"], "article-title": ["Superstructure silver micro-tube composites for ultrahigh electromagnetic wave shielding"], "source": ["Chem. Eng. J."], "year": ["2022"], "volume": ["430"], "fpage": ["132949"], "pub-id": ["10.1016/j.cej.2021.132949"]}, {"label": ["49."], "surname": ["Wu", "Yuan", "Yuan", "Cheng"], "given-names": ["H", "W", "X", "L"], "article-title": ["Atmosphere-free activation methodology for holey graphene/cellulose nanofiber-based film electrode with highly efficient capacitance performance"], "source": ["Carbon Energy"], "year": ["2023"], "volume": ["5"], "fpage": ["e229"], "pub-id": ["10.1002/cey2.229"]}, {"label": ["50."], "surname": ["Gevorkian", "Morozova", "Kheiri", "Khuu", "Chen"], "given-names": ["A", "SM", "S", "N", "H"], "article-title": ["Actuation of three-dimensional-printed nanocolloidal hydrogel with structural anisotropy"], "source": ["Adv. Funct. Mater."], "year": ["2021"], "volume": ["31"], "fpage": ["2010743"], "pub-id": ["10.1002/adfm.202010743"]}, {"label": ["51."], "surname": ["Zhou", "Li", "Liu", "Wu", "Mei"], "given-names": ["G", "M-C", "C", "Q", "C"], "article-title": ["3D printed Ti3C2Tx MXene/cellulose nanofiber architectures for solid-state supercapacitors: ink rheology, 3D printability, and electrochemical performance"], "source": ["Adv. Funct. Mater."], "year": ["2022"], "volume": ["32"], "fpage": ["2109593"], "pub-id": ["10.1002/adfm.202109593"]}, {"label": ["53."], "surname": ["Li", "Sun", "Yi", "Zou", "Zhang"], "given-names": ["J", "H", "S-Q", "K-K", "D"], "article-title": ["Flexible polydimethylsiloxane composite with multi-scale conductive network for ultra-strong electromagnetic interference protection"], "source": ["Nano-Micro Lett."], "year": ["2022"], "volume": ["15"], "fpage": ["15"], "pub-id": ["10.1007/s40820-022-00990-7"]}, {"label": ["54."], "surname": ["Cao", "Cai", "Zhang", "Tian"], "given-names": ["G", "S", "H", "Y"], "article-title": ["High-performance conductive adhesives based on water-soluble resins for printed circuits, flexible conductive films, and electromagnetic interference shielding devices"], "source": ["Adv. Compos. Hybrid Mater."], "year": ["2022"], "volume": ["5"], "fpage": ["1730"], "lpage": ["1742"], "pub-id": ["10.1007/s42114-021-00402-1"]}, {"label": ["56."], "surname": ["Liu", "Gu", "Zhang", "Miyamoto", "Chen"], "given-names": ["Q", "J", "W", "Y", "Z"], "article-title": ["Biomorphic porous graphitic carbon for electromagnetic interference shielding"], "source": ["J. Mater. Chem."], "year": ["2012"], "volume": ["22"], "fpage": ["21183"], "lpage": ["21188"], "pub-id": ["10.1039/C2JM34590K"]}, {"label": ["57."], "surname": ["She", "Zhao", "Yuan", "Chen", "Fan"], "given-names": ["L", "B", "M", "J", "B"], "article-title": ["Joule-heated flexible carbon composite towards the boosted electromagnetic wave shielding properties"], "source": ["Adv. Compos. Hybrid Mater."], "year": ["2022"], "volume": ["5"], "fpage": ["3012"], "lpage": ["3022"], "pub-id": ["10.1007/s42114-022-00530-2"]}, {"label": ["58."], "surname": ["Zhou", "Tan", "Wang", "Wu", "Liang"], "given-names": ["M", "S", "J", "Y", "L"], "article-title": ["\u201cthree-in-one\u201d multi-scale structural design of carbon fiber-based composites for personal electromagnetic protection and thermal management"], "source": ["Nano-Micro Lett."], "year": ["2023"], "volume": ["15"], "fpage": ["176"], "pub-id": ["10.1007/s40820-023-01144-z"]}, {"label": ["59."], "surname": ["He", "Zheng", "Dong", "Jiang", "Lou"], "given-names": ["W", "J", "W", "S", "G"], "article-title": ["Efficient electromagnetic wave absorption and Joule heating via ultra-light carbon composite aerogels derived from bimetal-organic frameworks"], "source": ["Chem. Eng. J."], "year": ["2023"], "volume": ["459"], "fpage": ["141677"], "pub-id": ["10.1016/j.cej.2023.141677"]}, {"label": ["60."], "surname": ["Wang", "Ma", "Zhang", "Chen", "Cao"], "given-names": ["L", "Z", "Y", "L", "D"], "article-title": ["Polymer-based EMI shielding composites with 3D conductive networks: a mini-review"], "source": ["SusMat"], "year": ["2021"], "volume": ["1"], "fpage": ["413"], "lpage": ["431"], "pub-id": ["10.1002/sus2.21"]}]
{ "acronym": [], "definition": [] }
60
CC BY
no
2024-01-14 23:40:14
Nanomicro Lett. 2024 Jan 12; 16:85
oa_package/01/92/PMC10786807.tar.gz
PMC10786812
38214823
[ "<title>Introduction</title>", "<p id=\"Par12\">The majority of patients initiating hemodialysis in the United States do so with a tunneled central venous catheter while awaiting placement and/or maturation of a working arteriovenous (AV) access. Although tunneled dialysis catheters remain an important bridge to surgical AV access, the complications of these devices can lead to eventual central venous stenosis and occlusion.</p>", "<p id=\"Par13\">Chronic CVO remains a significant source of morbidity among hemodialysis patients occurring in approximately 25–30%, and can manifest with debilitating arm swelling, inability to utilize the existing AV access, and neck and facial swelling [##REF##9464608##1##–##UREF##0##3##]. While conventional catheter-based techniques are often successful in crossing these occlusions to enable angioplasty with or without stenting, these techniques fail in a significant subset of these patients, 11–24% [##REF##2969991##4##, ##REF##7865390##5##]. Previously this subset of patients was left with few remaining treatment options, and additional endovascular technologies are needed to increase the spectrum of patients who can continue to use their access without the morbidity and pain of limb and facial swelling.</p>", "<p id=\"Par14\">The RF-wire technology (PowerWire, Baylis Medical, Toronto, Ontario, Canada) has been described as a means of crossing a chronic central thoracic venous occlusion under fluoroscopic and angiographic guidance, followed by conventional angioplasty and stent placement for successful recanalization. This study reports experience with the PowerWire device from a large academic medical center which serves as a regional referral center for hemodialysis patients with complex vascular access.</p>" ]
[ "<title>Patients and methods</title>", "<p id=\"Par15\">This study was approved by the local institutional review board and was in accordance with the Health Insurance Portability and Accountability Act; informed consent was not required for this type of retrospective study. Between January 2017 and August 2022, a consecutive cohort of 21 procedures in 20 patients was identified from a prospectively maintained quality assurance database; this cohort underwent elective RF-wire facilitated thoracic central venous recanalization. All patients had undergone one or more unsuccessful attempts at central venous recanalization using conventional catheter-based techniques at the authors’ or an outside institution.</p>", "<p id=\"Par16\">A similar clinical protocol was utilized in all patients. Patients were seen in the IR clinic prior to the RF-wire procedure. During that encounter, a detailed review of arteriovenous access history and relevant imaging was performed, and patients and family members counseled on the potential risks of the procedure, including hemothorax, pneumothorax, cardiac tamponade and death. Since all patients had failed prior attempts at central venous recanalization, the venographic images from the prior procedure(s) were sufficient for procedural planning so that CT venography was not obtained.</p>", "<p id=\"Par17\">All procedures were performed with general or monitored anesthesia care, at the discretion of the anesthesiologist. Pre-procedural type and screening was performed in anticipation of potential initiation of a rapid transfusion protocol. Two large-bore sites of IV access were established and a radial artery monitoring line placed with ultrasound guidance.</p>", "<p id=\"Par18\">The RF-wire recanalization technique was performed as follows. Femoral access was established with placement of a 70 cm 7-French sheath in the right atrium (Cook Medical, Bloomington, IN). A directional catheter was advanced through the sheath to the leading edge of the central venous occlusion (superior vena cava, brachiocephalic vein or subclavian vein). The arteriovenous access was punctured and a 6 French angled sheath (Ansel sheath, Cook Medical, Bloomington, IN or Destination sheath, Terumo, Somerset, NJ) placed near the peripheral edge of the central venous occlusion. Through the peripheral sheath and the central venous directional catheter, simultaneous injections of contrast were performed with digital subtraction angiography (DSA) to delineate the length and anatomy of the central venous occlusion. At the discretion of the operator, an ‘outside-in’ or ‘inside-out’ strategy was then selected depending on the geometry of the occlusion. In general, the side of the occlusion with a venographically tapered edge or ‘beak’ was selected as the site of RF-wire recanalization.</p>", "<p id=\"Par19\">An Amplatz-type snare (One-Snare, Merit Medical, South Jordan, UT) or tri-petal snare (En-Snare, Merit) was positioned on the opposite side of the occlusion. A 4-French or 5-French angled-tip catheter was advanced over a wire to the leading edge of the occlusion. Through this, an 0.035-in, 110-g tip Baylis RF guidewire (Powerwire) was advanced through the angled-tip catheter to the edge of the occlusion. Straight-tip or 40-degree angled tip PowerWire selection was at the discretion of the operator.</p>", "<p id=\"Par20\">Using 1 or 2-s pulses of RF energy, the RF-wire was advanced in 2-mm increments across the occlusion with fluoroscopic guidance. Triangulation techniques were utilized after each second or third pass of the RF-wire to ensure intended traversal of the occlusion was occurring; these consisted of 30 to 50 degree oblique and contralateral oblique static and dynamic fluoroscopic views after each 5 mm excursion of the RF-wire. Although all procedures were performed in a biplane angiography suite equipped with cone-beam CT (Artis, Siemens, Erlangen, Germany) it was seldom possible to perform cone-beam CT due to positioning of the patient and ventilatory equipment.</p>", "<p id=\"Par21\">Contrast injections through the directional catheter were used when position of the RF-wire in relation to the snare on the opposite side of the occlusion could not be ascertained with orthogonal, steep oblique fluoroscopic views. When necessary, the RF wire was withdrawn and advanced across the occlusion using a different tract. Successful crossing of the occlusion was confirmed by visualization of the RF wire within or beyond the snare, at which point the RF wire was retrieved with the snare and withdrawn through the sheath to establish though-and-through guidewire access spanning from the site of femoral access to the site of upper extremity and/or internal jugular access. A 4 French, 100 cm long Berenstein catheter was then advanced over the RF-wire through both sheaths, and the RF-wire exchanged for a 260 cm 0.035-in Amplatz wire.</p>", "<p id=\"Par22\">Sequential dilation of the occlusion was performed in 2-mm increments beginning with a 6-mm diameter balloon. Venograms were performed after each balloon angioplasty until a diameter of 12 mm had been obtained. After upsizing the upper extremity sheath to 11-French (Terumo), an polytetrafluoroethylene (PTFE)-covered stent graft (typically 13 mm in diameter, Viabahn, Gore, Flagstaff, Arizona) was deployed across the occlusion and post-dilated with a 12-mm or 14-mm balloon; a single patient underwent placement of a 8 mm × 29 mm Gore VBX stent graft post-dilated to 14 mm. Completion venograms were performed and if venography showed that a portion of the recanalized central venous segment remained unstented, an additional overlapping stent graft was placed, balloon dilated and additional completion venograms performed. Figures ##FIG##0##1## and ##FIG##1##2## show representative examples of right and left sided central venous occlusions from the present series.</p>", "<p id=\"Par23\">Access sheaths were removed and hemostasis achieved with manual compression. Patients remained in hospital overnight. Dual antiplatelet therapy with clopidogrel and acetylsalicylic acid (ASA) was started immediately after the procedure. A chest radiograph and follow-up hemoglobin level were obtained within 6 h of the completion of the procedure, or sooner if the patient developed a change in vital signs or symptoms. Patients were dialyzed the following morning and typically discharged from hospital later that day, and then re-evaluated in the IR clinic within 30 days to confirm resolution of facial, neck and/or arm swelling. Thereafter, patients were seen at 3-, 6- and 12-months following stent graft placement with duplex ultrasound evaluation of the stent construct. Thereafter, patients were seen every 6 months. Patients would continue to receive periodic endovascular interventions on their remaining hemodialysis access circuit at outside facilities as clinically indicated, so it was not possible to determine duration of patency of the remaining dialysis access circuit.</p>", "<p id=\"Par24\">Technical success was defined as successful RF-wire advancement across the thoracic venous occlusion enabling snaring of a through-and-through guidewire to enable endovascular recanalization. Complications were defined in accordance with the Society of Interventional Radiology consensus guidelines [##REF##28757285##6##]. Kaplan Meier estimates of central venous stent construct patency were performed including primary unassisted, primary assisted and secondary patency. Intergroup comparisons of central venous stent patency were performed with the log-rank test.</p>" ]
[ "<title>Results</title>", "<p id=\"Par25\">Demographics and lesion characteristics of the patient cohort are shown in Table ##TAB##0##1##. A total of 21 procedures were performed on 20 patients. Technical success was achieved in 17 lesions (81%). There was 1 acute stent thrombosis that required thrombectomy and re-stenting on post procedure day 2. At the 30-day interventional radiology clinic visit, all patients had resolution of arm ± facial swelling. The location of the occlusions and stent placement are shown in Table ##TAB##1##2##. Two bifurcated stent constructs were required, one which involved right subclavian and bilateral brachiocephalic veins, and the other which recanalized and stented the base of the right internal jugular vein and the right subclavian and brachiocephalic veins. All cases were crossed with an “outside-in” approach except for one. The straight tip RF-wire was used in 12 cases (57%) and the 40° angle RF-wire was used in 8 cases (38%). One lesion required the use of both the straight and angled tip PowerWires. Fourteen cases (67%) were performed under general anesthesia and 7 cases (33%) performed under monitored anesthesia care (MAC). Mean duration of hospital stay was 2 days ± 3 days. Mean procedure time was 158 ± 46 min with a mean fluoroscopy time of 31.7 ± 16.3 min. Mean contrast volume used during the procedure was 70 mL.\n</p>", "<p id=\"Par26\">The mean length of occlusion was 3.6 cm ± 1.6 and with occlusion length ranging from 0.5 cm to 7.2 cm. The median PTFE-covered stent graft diameter was 13 mm (range 9–14 mm). The mean follow-up was 827 days with primary unassisted patency of 94 ± 6% and 85 ± 10% at 6 and 12 months, respectively. Additional interventions including angioplasty (8 procedures in 4 patients), restenting (<italic>n</italic> = 2) and thrombectomy (<italic>n</italic> = 1) resulted in significantly increased primary assisted and secondary stent graft patency (<italic>P</italic> = 0.006); secondary patency was 100% at 36 months (Fig. ##FIG##2##3##).</p>", "<p id=\"Par27\">There were 3 major complications (14%) in the current study. Two patients developed a hemothorax ipsilateral to the side of the CVO managed with image-guided chest tube placement and blood transfusion (Fig. ##FIG##3##4##). One patient had hemopericardium that was managed by percutaneous pericardial drain placement on post operative day 1, and the patient was discharged the following day. One of the hemothorax patients had had a failed attempt initially and deferred returning for a repeat attempt until 15 months later, with successful crossing of the occlusion using the PowerWire device during the second procedure.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par28\">Endovascular techniques for recanalization of chronic central venous occlusions among hemodialysis patients continue to evolve. Sharp recanalization utilizes the stiff end of a guidewire or a small-caliber (e.g. Chiba) needle to cross a occlusion [##REF##10082101##7##–##UREF##1##9##] enabling subsequent angioplasty and stenting. Extension of this needle-based technique to an integrated crossing needle within the tip of a delivery catheter was reported by Anil and Tenaja using the Outback device [##REF##20598479##10##]. Subsequent technology employed by the Surfacer device (Bluegrass Vascular Technologies, San Antonio, Texas) utilizes a longer needle and a cutaneous radio-opaque targeting marker for crossing right-sided thoracic venous occlusions, enabling tunneled hemodialysis catheter insertion [##REF##32951972##11##, ##REF##32597356##12##]. However, the Surfacer device cannot be used for left-side central venous occlusions nor as a means of venous recanalization and stenting as it does not establish continuity of the subclavian and brachiocephalic veins. Radiofrequency wire recanalization may provide a more versatile technology to treat both left- and right-sided occlusions, as well as occlusions that are longer than the excursion length of needle-based devices such as the Surfacer or Outback devices. In the present series, radiofrequency wire recanalization of refractory thoracic central venous occlusions was a relatively safe and effective option. Technical success rate was 81% compared to several prior reports ranging from 50–100%. The current study had a mean occlusion length of 3.6 cm. Kundu et al. reported successful PowerWire crossing of 50% of central venous occlusions with a mean length of 7.3 cm [##REF##22865527##13##]. Sivananthan et al. reported a 69% success in RF-wire crossing of central occlusions in 12 patients; successfully crossed occlusions were shorter (mean length 3 cm) compared to uncrossable occlusions (mean length 9 cm) [##REF##25656250##14##]. In a larger cohort of 42 patients with occlusion lengths ranging from 1.5 cm to 10 cm, Guimaraes et al. reported 100% success in PowerWire crossing with most occlusions (67%) involving the brachiocephalic vein [##REF##22739648##15##]. More recently, Keller et al. reported 80% success in PowerWire crossing of thoracic and infradiaphragmatic central venous occlusions including a cohort of 11 patients with brachiocephalic/SVC occlusions; mean lesion length was 4.9 cm [##REF##30293732##16##].</p>", "<p id=\"Par29\">A major concern of this technology is that the RF wire can pass through virtually any surrounding soft tissue. Another limitation is that the electrical current within the monopolar system is deactivated when the tip of the PowerWire contacts a metal structure such as a prior stent; while this can be advantageous when crossing a native venous occlusion (as the deactivation produces an audible signal, thereby confirming that the RF-wire has established contact with the snare positioned on the distal end of the occlusion), this can make crossing occluded venous stent constructs more challenging. All of the patients in the present series had native venous occlusions with the exception of one patient who had a cephalic arch stent ‘jailing’ the axillosubclavian junction (Fig. ##FIG##1##2##); in this patient numerous oblique views were necessary to ensure the RF wire did not pass through the interstices of the prior stent.</p>", "<p id=\"Par30\">We experienced 3 major complications during RF-wire enabled recanalization which included two hemothoraces and one hemopericardium. Hemopericardium has been recognized as a known complication on prior studies in which the RF wire inadvertently enters the pericardial space [##REF##26676109##8##, ##UREF##1##9##]. This event was identified during the procedure using post-traversal venography and treated with pericardial drain placement and close monitoring. Lesion location was at the border of the right brachiocephalic and subclavian veins with a 4.2 cm length of occlusion. The two patients with hemothoraces were managed by chest tube placement and prolonged admission. One of the patients had a hemothorax diagnosed post procedure during recovery after successful crossing and stent placement. Notably, this is the same patient who had an acute in-stent occlusive thrombus (post procedure day 2) that was treated with thrombectomy and extension of the stent construct more peripherally into the axillary vein. This in-stent thrombus may have been attributable to a low flow state given the large hemothorax requiring blood transfusion and intensive care unit admission. In the second patient, hemothorax occurred after a failed RF-wire crossing attempt. A chest CT performed for shortness of breath revealed a moderate-size hemothorax requiring chest tube placement; this patient returned for successful PowerWire crossing after 15 months. Both patients had right sided lesions with lengths of occlusion of 3.6 and 4.2 cm, respectively. Sivananthan et al. [##REF##25656250##14##] had a 69% success rate with 1 fatal complication secondary to tracheal perforation. We did not observe any tracheal perforation in the present series but when long, left-sided brachiocephalic occlusions are being crossed (thereby creating potential for tracheal puncture) frequent triangulation and interval venography are mandatory.</p>", "<p id=\"Par31\">In addition to the initial failure of the patient with the right brachiocephalic occlusion in whom a hemothorax developed after the first procedure, the three additional failures occurred from inability to transverse the central occlusion to establish true lumen re-entry and snaring of the RF-wire. Following each of these three remaining failures, patients were offered a repeat attempt at RF-wire recanalization however each of the patients declined.</p>", "<p id=\"Par32\">All patients with successful recanalization had resolution of arm/facial swelling with preservation of dialysis access in the involved extremity. This is in line with the previously reported literature [##REF##22865527##13##–##REF##30293732##16##].</p>", "<p id=\"Par33\">The primary unassisted patency in the current study was 94 ± 6% and 85 ± 10% at 6 and 12 months respectively. Similarly, Guimaraes et al. demonstrated a 95% patency at 6 and 9 months. However, the reported patency did not specify whether it was primary unassisted, primary assisted or secondary patency [##REF##22739648##15##]. Keller et al. reported primary unassisted patency of 56% at median follow up of 14.1 months [##REF##30293732##16##]. However, restenosis/occlusion was noted in that series to occur less often in patients with ESRD and central venous catheter usage.</p>", "<p id=\"Par34\">This study has a number of limitations, including its retrospective design, small cohort size, absence of long-term follow up and single center experience.</p>" ]
[ "<title>Conclusions</title>", "<p id=\"Par35\">RF-wire facilitated recanalization demonstrated a high rate of technical success and resolution of arm and facial swelling. This technology enabled resumed use of the ipsilateral dialysis access which is essential for ESRD patients with limited venous reserve. Although a superior safety profile was seen than with needle-based techniques such as sharp recanalization, major complications were not infrequent indicating that this RF-wire procedure should be performed in centers equipped to manage central venous perforations.</p>" ]
[ "<title>Purpose</title>", "<p id=\"Par1\">To assess the outcome and safety of radiofrequency (RF) wire recanalization in patients with end-stage renal disease (ESRD) and chronic central venous occlusions (CVO).</p>", "<title>Materials and Methods</title>", "<p id=\"Par2\">A retrospective review of ESRD patients who underwent RF-wire recanalization of symptomatic chronic thoracic CVO from January 2017 to August 2022 yielded 20 patients who underwent 21 procedures. All patients had undergone at least one prior unsuccessful attempt at central venous recanalization using conventional catheter-based techniques. Technical success was defined by the ability to cross the CVO using RF-wire recanalization enabling endovascular treatment. Access circuit patency was evaluated based on follow-up imaging and symptomatic improvement.</p>", "<title>Results</title>", "<p id=\"Par3\">Radiofrequency wire recanalization was successful in 17/21 procedures (81%) with all patients (100%) reporting resolution of arm ± facial swelling. Three major complications occurred (14%): two hemothoraces and one hemopericardium. Medial stent diameter was 13 mm (range, 9–14 mm). Mean duration of hospital stay was 2 days ± 3 days. Mean procedure time was 158 ± 46 min with a mean fluoroscopy time of 31.7 ± 16.3 min. Primary unassisted patency at 6 and 12 months was 94 ± 6% and 85 ± 10%, respectively. Additional interventions resulted in significantly increased stent graft patency (<italic>P</italic> = 0.006).</p>", "<title>Conclusion</title>", "<p id=\"Par4\">Radiofrequency wire-enabled recanalization of CVO in symptomatic dialysis patients has a high rate of technical success with resolution of arm and facial swelling and resumed use of the ipsilateral dialysis access. Although a superior safety profile was seen than with needle-based techniques such as sharp recanalization, major complications were not infrequent indicating that this RF-wire procedure should be performed in centers equipped to manage central venous perforations.</p>" ]
[]
[ "<title>Acknowledgements</title>", "<p>Not applicable.</p>", "<title>Authors’ contributions</title>", "<p>SM, AZ, RC and TC analyzed and interpreted the data and wrote the manuscript. All authors read, revised and approved the final manuscript.</p>", "<title>Funding</title>", "<p>None.</p>", "<title>Availability of data and materials</title>", "<p>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p>", "<title>Declarations</title>", "<title>Ethics approval and consent to participate</title>", "<p id=\"Par36\">This retrospective study was approved by the local institutional review board and was in accordance with the Health Insurance Portability and Accountability Act; informed consent was not required for this type of study.</p>", "<title>Consent for publication</title>", "<p id=\"Par37\">Not applicable.</p>", "<title>Competing interests</title>", "<p id=\"Par38\">TC is a consultant to Baylis Medical.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>66-year old male on hemodialysis with multiple failed prior access sites and massive arm swelling. He had a poorly functioning right transposed brachiocephalic fistula with high venous pressures and prolonged bleeding after needle decannulation secondary to chronic brachiocephalic occlusion. <bold>A</bold> Initial IR clinic visit showing right arm swelling. <bold>B</bold> Initial venograms performed through the right brachiocephalic fistula and the superior vena cava showing chronic occlusion of the brachiocephalic vein (arrow). <bold>C</bold> Left anterior oblique vein during triangulation of PowerWire (tip shown with arrow) across the occlusion toward the snare in the superior vena cava. <bold>D</bold> Capture of the PowerWire with the snare. <bold>E</bold> Balloon dilation of the brachiocephalic occlusion to 14 mm (performed following serial dilation from 6/10/12 diameter balloons, with interval venograms). <bold>F</bold> Venography during positioning of a 13 mm × 50 mm PTFE-lined stent graft (Viabahn, Flagstaff, AZ) across the site of elastic recoil following 14 mm venoplasty. <bold>G</bold> Completion venogram following stent deployment and post dilation with a 14 mm balloon. <bold>H</bold> IR clinic visit at 4 weeks following interval resolution of both arm swelling and access site dysfunction</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>67-year old male on hemodialysis with multiple failed prior access sites and a poorly functioning left transposed brachiobasilic fistula with high venous pressures. He has a chronic left axillosubclavian vein occlusion, secondary to a bare nitinol stent placed within the cephalic arch at an outside facility at the time of a previously functioning brachiocephalic fistula which has since been abandoned. <bold>A</bold> Initial IR clinic visit showing left arm swelling and hyperpigmentation from chronic venous hypertension. <bold>B</bold> Initial venogram performed through the left brachiobasilic fistula showing chronic occlusion of the axillary vein at the site of the prior cephalic arch stent (arrow) with mediastinal collaterals reconstituting the left brachiocephalic vein (arrowheads). <bold>C</bold> Fluoroscopic view after traversal of PowerWire (tip shown with arrow) across the occlusion into the snare in the left subclavian vein. <bold>D</bold> Capture of the PowerWire with the snare. <bold>E</bold> Initial balloon dilation of the axillosubclavian occlusion with an 8 mm ultrahigh pressure balloon (Conquest, Becton Dickinson, Franklin Lakes, NJ). <bold>F</bold> Completion venogram following serial balloon dilation to 10 mm, deployment of a 10 mm × 100 mm PTFE-lined stent graft (Viabahn) and 10 mm venoplasty. <bold>G</bold> IR clinic visit at 4 weeks showing complete resolution of arm swelling</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p>Kaplan Meier curve showing access circuit primary unassisted, primary assisted and secondary patency in the study cohort following RF-wire enabled recanalization</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p>Complication following successful RF-wire enabled recanalization and stenting of a right brachiocephalic occlusion. <bold>A</bold> Portable chest radiograph obtained immediately following procedure showing stent graft in good position (arrow) but the presence of a large right hemothorax (arrowheads). <bold>B</bold> Locking loop 14 French chest tube was placed in the IR suite, yielding 800 mL of blood. <bold>C</bold> Chest radiograph obtained 48 h later showing resolution of hemothorax. The chest tube was subsequently capped and then removed</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Patient demographics and lesion characteristics, N, (%)</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Characteristic</th><th align=\"left\">Value</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"2\"><bold>Sex</bold></td></tr><tr><td align=\"left\"> Male</td><td align=\"left\">11 (55)</td></tr><tr><td align=\"left\"> Female</td><td align=\"left\">9 (45)</td></tr><tr><td align=\"left\" colspan=\"2\"><bold>Age</bold></td></tr><tr><td align=\"left\"> Mean</td><td align=\"left\">64.0 (SD 8.6)</td></tr><tr><td align=\"left\"> Range</td><td align=\"left\">50–78</td></tr><tr><td align=\"left\" colspan=\"2\"><bold>AV Access type</bold></td></tr><tr><td align=\"left\"> Fistula</td><td align=\"left\">14 (74%)</td></tr><tr><td align=\"left\"> Graft</td><td align=\"left\">5 (26%)</td></tr><tr><td align=\"left\" colspan=\"2\"><bold>Laterality</bold></td></tr><tr><td align=\"left\"> Right</td><td align=\"left\">14 (70%)</td></tr><tr><td align=\"left\"> Left</td><td align=\"left\">5 (25%)</td></tr><tr><td align=\"left\"> Central</td><td align=\"left\">1 (5%)</td></tr><tr><td align=\"left\" colspan=\"2\"><bold>Main indication for intervention</bold></td></tr><tr><td align=\"left\"> Arm Swelling</td><td align=\"left\">18 (90%)</td></tr><tr><td align=\"left\"> Face/neck swelling</td><td align=\"left\">2 (10%)</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Stent placement location in 17 successful recanalization procedures</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Stent location</th><th align=\"left\">N</th></tr></thead><tbody><tr><td align=\"left\">BCV only</td><td align=\"left\">6</td></tr><tr><td align=\"left\">Border of BCV and SCV</td><td align=\"left\">7</td></tr><tr><td align=\"left\">Border of SCV and AV</td><td align=\"left\">1</td></tr><tr><td align=\"left\">Bifurcated stent construct – IJ and BCV</td><td align=\"left\">1</td></tr><tr><td align=\"left\">Bifurcated stent construct – R and L BCV</td><td align=\"left\">1</td></tr><tr><td align=\"left\">SVC</td><td align=\"left\">1</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[]
[ "<table-wrap-foot><p><italic>BCV</italic> Brachiocephalic vein, <italic>SCV</italic> Subclavian vein, <italic>AV</italic> Axillary vein, <italic>SVC</italic> Superior vena cava</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher’s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"42155_2023_422_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"42155_2023_422_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"42155_2023_422_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"42155_2023_422_Fig4_HTML\" id=\"MO4\"/>" ]
[]
[{"label": ["3."], "surname": ["Agarwal", "Patel", "Farhan"], "given-names": ["AK", "BM", "NJ"], "article-title": ["Central venous stenosis in hemodialysis patients is a common complication of ipsilateral central vein catheterization"], "source": ["J Am Soc Nephrol"], "year": ["2004"], "volume": ["15"], "fpage": ["368A"], "lpage": ["369A"]}, {"label": ["9."], "mixed-citation": ["Nasser MM, Ghoneim BM, Elmahdy H, Younis S. The outcome of sharp recanalization of chronic central venous occlusions in patients undergoing hemodialysis. J Vasc Surg Venous Lymphat Disord. 2023:101692. 10.1016/j.jvsv.2023.09.006."]}]
{ "acronym": [ "CVO", "AV", "RF", "ESRD", "PTFE", "CT", "ASA" ], "definition": [ "Central venous occlusion", "Arteriovenous", "Radiofrequency", "End stage renal disease", "Polytetrafluoroethylene", "Computed tomography", "Acetylsalicylic acid" ] }
16
CC BY
no
2024-01-14 23:40:15
CVIR Endovasc. 2024 Jan 12; 7:10
oa_package/76/56/PMC10786812.tar.gz
PMC10786813
0
[ "<title>Introduction</title>", "<p id=\"Par2\">Currently, more and more attention is devoted to almost all areas of life of nanoparticles (NPs) and nanostructures sized 1‒100 nm. The use of metallic NPs is wide. Molybdenum disulphide IV (MoS<sub>2</sub>) is exerting an increasing impact on industrial applications. It is a transition metal dichalcogenide, an inorganic chemical compound in the IV oxidation state. The crystalline structure of MoS<sub>2</sub> is a hexagonal layer of Mo atoms and 2 external hexagonal layers of chalcogen sulphur (S) atoms. The unique tribological properties of MoS<sub>2</sub>, resulting from its hexagonal crystal structure, make it widely used as a high-temperature lubricant, in dry, solid and liquid forms [##UREF##0##1##–##UREF##1##3##]. In a form of powder, MoS<sub>2</sub> improves the parameters and durability of motorcycle and car engines. It is also used as a semiconductor and catalyst in the fuel and petrochemical industries. Physicochemical properties of Mo make it a useful alloy metal, both in the production of special steels as well as non-ferrous alloys and pigments. It is also used in the aerospace and defense industries, and in the production of Mo wires and rods for electric bulbs and furnaces [##UREF##2##4##, ##REF##35806680##5##]. In accordance with Regulation (EC) No. 1272/2008, MoS<sub>2</sub> is classified as a hazardous substance; H332—Harmful if inhaled [##UREF##3##6##, ##UREF##4##7##].</p>", "<p id=\"Par3\">It is commonly known that the toxic properties of chemical substances and their adverse health effects in both occupationally and environmentally exposed populations may differ depending on the dose, time or route of exposure. The state of aggregation and the chemical form of a given metal are other factors affecting its toxic properties. Numerous animal studies have confirmed that NPs relatively quickly and easily overcome all the protective barriers of the body [##REF##21944826##8##–##REF##31004840##11##]. Works by Tjälve et al. [##REF##9000264##12##], Oberdörster et al. [##REF##15204759##13##], as well as Engin and Engin [##REF##30961871##14##] have indicated that nanometer size particles reach the brain via the olfactory nerve. Therefore, they may come into contact with olfactory neurons in the olfactory epithelium, and be transported through olfactory cell axons to the olfactory bulb, where they directly affect the central nervous system [##REF##15204759##13##]. However, little data is available on the distribution of MoS<sub>2</sub>-nanoparticles (MoS<sub>2</sub>-NPs) after inhalation or intratracheal exposure [##REF##32629262##15##–##UREF##6##17##]. Uncertainty related to the safety and assessment of exposure to MoS<sub>2</sub>-NPs and/or MoS<sub>2</sub>-microparticles (MoS<sub>2</sub>-MPs) during their industrial production as well as during work in exposure to MoS<sub>2</sub> results from insufficient knowledge on the mechanism of their toxicity.</p>", "<p id=\"Par4\">The main objective of the study was the combination of advanced and specialized analytical methodologies [inductively coupled plasma mass spectrometry (ICP-MS), inductively coupled plasma optical emission spectrometry (ICP-OES), and laser ablation technique combined with inductively coupled plasma mass spectrometry with ionization of the sample (LA-ICP-MS)] allowing for the determination of MoS<sub>2</sub>-NPs and MoS<sub>2</sub>-MPs concentration in the blood, and mineralized tissue samples, as well as their spatial distribution and accumulation content in selected tissue sections (brain, lung, liver, spleen) obtained from the rats exposed to nano- and micrometer Mo particles, either once or 7 times at a dose of 1.5 mg Mo kg<sup>−1</sup> b.w. and 5 mg Mo kg<sup>−1</sup> b.w. (at 2-week intervals), or to polyvinylpyrrolidone (PVP) as a control substance, respectively, for each form into the trachea.</p>", "<p id=\"Par5\">Moreover, MoS<sub>2</sub>-NPs as well as MoS<sub>2</sub>-MPs were used in an intratracheal instillation study in rats, in a single and repeated exposure model at doses of 1.5 and 5 mg MoS<sub>2</sub> per kg b.w., to obtain data on the absorption and kinetics of MoS<sub>2</sub> particles, including their possible accumulation in the body. It was hypothesized that biodistribution is dependent on the primary particle size, assessed distribution, and tissue accumulation at various time points, both during and after exposure. The possible implementation of this type of analysis in toxicological research was also assessed.</p>" ]
[ "<title>Materials and methods</title>", "<title>Study design</title>", "<p id=\"Par6\">Having been approved by the Ethics Committee for Animal Experiments (Resolution No. 6/ŁB 86/2018), the experimental study was performed using albino Wistar rats. The animals were at 6‒8 weeks of age and weighed 80‒120 g. The rats were acclimated for a week under 12-h day/12-h night cycles with unlimited access to water, at standard air humidity conditions as well as in temperature of 22 ± 3 °C. The general study design, including exposure time, the doses of Mo and the number of animals, was adopted in line with the guidelines reported by Warheit et al. [##REF##16495353##18##, ##REF##17030555##19##] and Ma-Hock et al. [##REF##18800274##20##]. For further assay, at least 4 animals were selected, according to the OECD TG 417 Toxicokinetics guidelines (Adopted: 22 July 2010). Finally, a decision was made to follow the experimental scheme summarized in Table ##TAB##0##1##, assuming the exposure of animals to a single dose (1.5 or 5 mg MoS<sub>2</sub> kg<sup>−1</sup> b.w.) with the analysis performed after 24 h and 7 days, and a multiple dose (7 administrations at 2-week intervals).</p>", "<title>Reagents and standards</title>", "<p id=\"Par7\">Multi-element CRM Comprehensive Mix B Standard 10.00 ± 0.05 mg per l (LGC, USA), ultra-pure deionized water from a Milli-Q water purification system (Millipore, Milli-Q Ellix 3, resistivity of 18.2 MΩ cm<sup>−1</sup>) and 65% nitric acid (HNO<sub>3</sub>, ULTREX II Ultrapure Reagent, J.T.Baker™), Triton-X (Sigma Aldrich) were used for the preparation of calibration standard solutions. Laboratory solid standards of agarose powder matrix (Sigma Aldrich, Darmstadt, Germany) were prepared as agarose gel tablets in the range of 0.5‒50 μg g<sup>−1</sup> for the calibration by LA-ICP-MS.</p>", "<p id=\"Par8\">Additionally, the ICP-MS method and the analytical procedure were verified by applying the available reference material Seronorm™ Trace Elements Whole Blood (Sero, Norway), as well as certified reference materials of the dogfish liver (DOLT-5, NRC-CNRC, Canada). Tablets of lyophilized reference material DOLT-5 using manual hydraulic press (Specac Atlas<italic>™</italic> Manual 15 T) were used to check the accuracy of LA-ICP-MS.</p>", "<title><bold><italic>Preparation of a colloid and a suspension of MoS</italic></bold><sub><bold><italic>2</italic></bold></sub></title>", "<p id=\"Par9\">A stable aqueous dispersion, a colloid of MoS<sub>2</sub>-NPs as well as a suspension of MoS<sub>2</sub>-MPs stabilized by PVP, with the weight ratio of MoS<sub>2</sub>:PVP 1:1; K 90, Mw = 360 000 (Fluka) were prepared. The size of the NPs ranged 50‒100 nm, and that of MPs 0.5‒5 μm. The procedure of MoS<sub>2</sub> particles preparation was described by Sobańska et al. [##REF##32629262##15##]. In this paper, the authors also presented the 3-dimensional morphology of particles analysis (Fig. ##FIG##0##1##), including the size, shape and possible agglomerations of MoS<sub>2</sub> particles using high resolution scanning electron microscopy (FEI-Nova NanoSEM 450). In the same paper, a size distribution histogram was presented using the dynamic light scattering (DLS) technique with zeta potential measurements (Fig. ##FIG##1##2##). DLS measurements revealed that the hydrodynamic diameter of the MoS<sub>2</sub> particles was: dH MoS<sub>2</sub>-NPs = 251 ± 94 nm for nanoparticles and dH MoS<sub>2</sub>-MPs = 0.7 ± 0.3 μm for microparticles. As described earlier MoS<sub>2</sub>-NPs in solution were dispersed and stabilized by PVP, so the high molecular weight polymer strongly increased the hydrodynamic diameter of the MoS<sub>2</sub>-NPs nanoparticles compared to the diameter measured by the HR-SEM technique. In the end, the internalization of MoS<sub>2</sub>-NPs as well as MoS<sub>2</sub>-MPs was performed by scanning transmission electron microscopy (STEM) with energy-dispersive X-ray spectroscopy (EDS) [##REF##32629262##15##]. The volumes of the PVP solution, as well as of the solutions of the tested nano- and micro-MoS<sub>2</sub>, administered each time to the trachea of the rats, were calculated individually for each animal, maintaining the proportions depending on their body weight. More specifically, 100 µL of the substance was administered per 250 g of the rat’s body weight. The physico-chemical analysis of the prepared MoS<sub>2</sub> suspensions indicates that they were nano- and micrometric forms with satisfactory stability to perform biological tests.</p>", "<title>Tissue sample preparation</title>", "<p id=\"Par10\">The blood samples from the rats’ tail veins were collected twice into EDTA tubes (SARSTEDT), before and after intratracheal instillation. All blood samples were collected from the right ventricle of the heart into Monovette 7.5 mL containing lithium heparin (SARSTEDT) during the dissection. All blood samples were stored at −20 °C until analysis.</p>", "<p id=\"Par11\">The soft tissue samples collected during autopsy were weighed (approx. 100 mg each) using the analytical balance Sartorius (BA 210S), and then they were mineralized under the appropriate conditions using an UltraWave mineralizer (Milestone, SpectroLab). The mineralization process was carried out according to the program using concentrated HNO<sub>3</sub>.</p>", "<p id=\"Par12\">For determination and tissue distribution of Mo in the tissue samples using LA-ICP-MS analysis, the brain, spleen, lung and liver samples were first formalin-fixed and then paraffin-embedded (automated Belair RVG/1 Vacuum Tissue Processor; TES 99 Tissue Embedding System). Then, the paraffin blocks were cut into 20 µm thick sections (HM 325 Rotary Microtome). In order to check the analyte contamination, all solutions (formalin, paraffin, agarose and the PVP solution) were determined using the inductively coupled plasma excitation mass spectrometry (ICP-MS) technique.</p>", "<p id=\"Par13\">The bronchoalveolar lavage cells and lung tissues were processed using routine histopathological protocols (light microscopy using Giemsa and hematoxylin-eosin staining; electron scanning microscopy with lead and osmium contrasting) to evaluate tissue changes and MoS<sub>2</sub> particles distribution in the cells in different organ compartments.</p>", "<title>Instrumentation and experimental parameters</title>", "<p id=\"Par14\">Molybdenum determination in blood samples was performed by ICP-MS (ELAN DRC-e, PerkinElmer, SCIEX, USA) using a dynamic reaction cell (DRC) with methane (CH<sub>4</sub>) reaction gas, eliminating spectral and matrix-derived interferences. The linear calibration curve for Mo determination in blood ranged 0.5‒50 μg L<sup>−1</sup> with the correlation coefficient <italic>r</italic> = 0.9999. The analytical precision of the method amounted to 5.4%. The repeatability of measurements using the Seronorm™ Trace Elements Whole Blood as an internal quality control amounted to 8.8%. The limit of detection (LOD) based on 3*standard deviation (SD)/slope, by the 5 repetitive analysis of the response of the curve amounted to 0.026 µg L<sup>−1</sup> and the limit of quantitation (LOQ: 6*SD/slope) amounted to 0.052 µg L<sup>−1</sup>.</p>", "<p id=\"Par15\">The mineralized tissue samples were diluted appropriately before the analysis using deionized water. Molybdenum determination in the mineralized tissue samples was performed using the ICP-OES technique (Agilent 5100 SVDV, MS Spectrum). The ranges of the calibration method for Mo determination in the mineralized tissue samples ranged 2‒500 μg L<sup>−1</sup> with the correlation coefficient <italic>r</italic> = 0.9999. The analytical precision of the method amounted to 1.6%. The repeatability of measurements using a solution of Mo with a concentration of 100 µg L<sup>−1</sup> amounted to 2.7%. The LOD and LOQ estimated using 10 blank samples amounted to 0.16 µg L<sup>−1</sup> and 0.32 µg L<sup>−1</sup>, respectively.</p>", "<p id=\"Par16\">The bioimaging of tissue slices was performed by the LA system (J200 Tandem LA/LIBS Applied Spectra Inc., USA) with LA-ICP-MS used as a complementary analysis. The ranges of the calibration method for Mo determination in gel standards ranged 0.5‒50 μg L<sup>–1</sup>. An intra- and inter-assay coefficient of variability as well as the recovery of Mo per DOLT-5 pellet (8 replicate ablation lines) amounted to 12.9%, 16.5% and 90%, respectively. The LOD and LOQ estimated using 10 blank agarose samples amounted to 0.017 µg g<sup>−1</sup> and 0.034 µg g<sup>−1</sup>, respectively.</p>", "<title>Statistical analysis</title>", "<p id=\"Par17\">Quantitative data were presented as mean ± standard deviations (SDs). The mean and SD values were calculated using the GraphPad Prism Software v.6.01 for Windows (GraphPad Prism Software, Inc., USA). Due to a small number of observations per group, the data were assumed to lack normal distribution. Therefore, the Kruskal–Wallis test with Dunn’s post hoc test were used for determining statistical significance. The statistical significance was set at <italic>p</italic> &lt; 0.05.</p>" ]
[ "<title>Results</title>", "<title>Tissue content</title>", "<title>Analysis of Mo in blood samples by ICP-MS</title>", "<p id=\"Par18\">In the tail venous blood obtained from the animals before exposure, Mo concentrations ranged 10.2‒38.4 μg L<sup>−1</sup> (mean: 22.4 ± 8.0 μg L<sup>−1</sup>, median: 22.2 μg L<sup>−1</sup>). Blood was collected from the same animal before and after exposure, i.e., changes in Mo concentrations were monitored in each animal individually. After 24 h of exposure, a slight increase in Mo concentration was observed; however, this increase was not dependent either on the form of MoS<sub>2</sub> or its dose (Fig. ##FIG##2##3##a). In addition, there were no statistically significant differences between the groups. Similarly, there were no differences in Mo concentrations between the groups after 7 days of exposure (Fig. ##FIG##2##3##b).</p>", "<p id=\"Par19\">In the venous blood collected from the tail of animals after exposure for 7 times at 2-week intervals and with the analysis performed within 90 days, Mo concentrations were comparable to each other and they were not dependent either on the form of MoS<sub>2</sub> or its dose (Fig. ##FIG##3##4##).</p>", "<p id=\"Par20\">For MoS<sub>2</sub>-NPs (at both doses), a slight decrease in Mo concentration was observed from the first administration, which then slowly increased from the fourth administration. For MoS<sub>2</sub>-MPs (also at both doses), a slight increase in Mo concentration was observed from the first administration, which then slowly increased again from the fourth administration.</p>", "<p id=\"Par21\">After the determination of Mo concentration in the venous blood taken from the right ventricle of the animals’ hearts during autopsy performed after 90 days of exposure to MoS<sub>2</sub> at a higher dose (5 mg kg<sup>−1</sup>), an approximately twofold increase in Mo concentration for both forms was shown (a slightly higher concentration for MoS<sub>2</sub>-MPs: 15.3 ± 3.9 vs. 21.3 ± 7.3 μg L<sup>−1</sup>, respectively, for MoS<sub>2</sub>-NPs and MoS<sub>2</sub>-MPs. A similar relationship was observed in venous blood, in which the Mo concentration before autopsy after 90 days was slightly higher for MoS<sub>2</sub>-MPs (17.8 ± 2.6 μg L<sup>−1</sup>) than for MoS<sub>2</sub>-NPs (13.1 ± 4.3 μg L<sup>−1</sup>) at a dose of 1.5 mg MoS<sub>2</sub> kg<sup>−1</sup> b.w.</p>", "<title>Kinetic profiles for MoS<sub><italic>2</italic></sub>-MPs and MoS<sub><italic>2</italic></sub>-NPs</title>", "<p id=\"Par22\">The multiple-dose toxicokinetics in the experiment performed reflects how the body responds to substances introduced intratracheally. The concentration curves of various forms of Mo in the blood over time, after repeated administration of 2 different fixed doses (1.5 and 5 mg kg<sup>−1</sup>), are presented in Fig. ##FIG##4##5##.</p>", "<p id=\"Par23\">The trend indicating the presence of 2 phases is visible. During the first phase, the Mo concentration in the blood decreases until day 14 (the Mo concentration before the second administration), below the pre-exposure concentration. The second phase is linear, less abrupt and practically flat, but with an increasing trend towards the end of the experiment. The multi-compartment model assumes an exponential curve of Mo concentration over time with different half-lives for the distribution and elimination phases of MoS<sub>2</sub>-MPs and MoS<sub>2</sub>-NPs. Following the intratracheal instillation, the distribution half-life was the fastest for the lower MoS<sub>2</sub>-NPs dose (1.5 mg kg<sup>−1</sup>) at <italic>T</italic><sub>1/2</sub> 8.8 days. At the same dose, the calculated <italic>T</italic><sub>1/2</sub> was 2 days longer for the MoS<sub>2</sub>-MPs. MoS<sub>2</sub>-NPs and MoS<sub>2</sub>-MPs at the higher dose (5 mg kg<sup>−1</sup>) showed similar values of <italic>T</italic><sub>1/2</sub> 11.5 vs. 11.8 days, respectively. The multiple-dose elimination trend is increasing for both formulations in the blood Mo concentration.</p>", "<p id=\"Par24\">Although the multiple-dose elimination trend is increasing for both formulations in the blood Mo concentration, compared to the control group at day 90, all concentrations (except MoS<sub>2</sub>-MPs at a dose of 5 mg kg<sup>−1</sup>) were lower (Fig. ##FIG##5##6##). MoS<sub>2</sub>-MPs were absorbed in higher amounts and was more slowly removed from the bloodstream. For MoS<sub>2</sub>-MPs it could be seen that after 90 days the concentrations were higher than at the beginning of the experiment, so it was excreted more slowly. After 90 days of the experiment, MoS<sub>2</sub>-NPs concentration returned to their baseline thus, excretion even after a repeated doses was fast.</p>", "<p id=\"Par25\">Statistically, for MoS2-NPs and MoS2-MPs at the lower dose of (1.5 mg kg<sup>−1</sup>) the differences are statistically significant <italic>p</italic> = 0.046, and despite apparent differences there is no statistical significance for MoS<sub>2</sub>-NPs and MoS<sub>2</sub>-MPs at a higher dose (5 mg kg<sup>−1</sup>).</p>", "<title>Analysis of Mo soft tissue samples by ICP-OES</title>", "<title>Analysis of Mo concentration in the rat’s lung</title>", "<p id=\"Par26\">In accordance with macroscopic observations indicating an uneven distribution of Mo in the sampled tissues, the lung tissue collected during the autopsy was completely mineralized. Measurements of the Mo content in the lung tissue performed 7 days after exposure to MoS<sub>2</sub> showed a large scatter of individual values (Fig. ##FIG##6##7##a). A greater accumulation of MoS<sub>2</sub>-MPs in the lung tissue was observed. The concentration of Mo in the lungs of animals repeatedly exposed to MoS<sub>2</sub>, both MoS<sub>2</sub>-NPs and MoS<sub>2</sub>-MPs, was significantly higher compared to a single administration of MoS<sub>2</sub>, proving the material accumulation of the tested preparations in the lungs of the exposed rats. The determination of Mo content in the lung tissue after exposure to MoS<sub>2</sub> in 90 days showed and confirmed a several times higher accumulation for MoS<sub>2</sub>-MPs compared to MoS<sub>2</sub>-NPs (Fig. ##FIG##6##7##b). Differences between the results of Mo concentrations in individual rats may be due to the actual differences in the baseline Mo status, the animals’ natural adaptive abilities disorder and the Mo absorbed after administration.</p>", "<title>Analysis of Mo concentration in the rat’s liver</title>", "<p id=\"Par27\">The measurements of Mo content in the liver tissue performed 7 days after exposure to MoS<sub>2</sub> showed no differences between the groups of exposed animals (there was no dependence on the administered dose) or in relation to the control group which was administered PVP (Table ##TAB##1##2##). The analysis of Mo content performed after 90 days showed a slightly higher concentration for MoS<sub>2</sub>-NPs compared to MoS<sub>2</sub>-MPs. However, these values did not differ significantly between each other or in relation to the control group which was administered PVP.</p>", "<title>Analysis of Mo concentration in the rat spleen</title>", "<p id=\"Par28\">The measurements of Mo content in the spleen tissue performed 7 days after exposure to MoS<sub>2</sub> showed no differences between the groups of exposed animals (there was no dependence on the administered dose) or in relation to the control group which was administered PVP (Table ##TAB##1##2##). Similar to the liver tissue, the analysis of Mo content performed after 90 days showed a higher concentration for MoS<sub>2</sub>-NPs compared to MoS<sub>2</sub>-MPs. However, these values did not differ significantly between each other or in relation to the control group which was administered PVP.</p>", "<title>Analysis of Mo concentration in the rat’s brain</title>", "<p id=\"Par29\">The results for the brain were below the calculated detection limit, indicating that Mo concentrations were at trace levels.</p>", "<title>Tissue distribution</title>", "<title>Analysis of Mo in soft tissue samples by LA-ICP-MS</title>", "<p id=\"Par30\">There are few studies using laser bioimaging techniques that can be very helpful in assessing the distribution and concentration of NPs in tissues as an important tool in assessing toxicity. Taking into consideration the complexity and multidirectional nature of factors determining the toxicity of NPs, biological studies should be carried out in many directions. Direct micro-sampling of solids allows for determining distribution, i.e., for obtaining detailed images of specific tissue regions of the selected elements on the surface of a solid sample (mapping). In this paper, the tissue sections from soft tissues (brain, lung, liver, spleen) were used for the confirmation of tissue distribution of both Mo forms using the LA-ICP-MS technique as a complementary tool in the experiment. Figure ##FIG##7##8## shows an example of tissue distribution for Mo. The higher signal intensity for the MoS<sub>2</sub>-MPs in the lung tissue analyzed after 90 days at a dose of 5 mg MoS<sub>2</sub> per kg b.w. confirms the results obtained by ICP-OES. Moreover, an analysis of Mo distribution in the liver and spleen samples revealed a higher concentration of MoS<sub>2</sub>-NPs in the same dose of 5 mg MoS<sub>2</sub> per kg b.w. after 7 administrations, which was in accordance with the results obtained by ICP-OES. The bioimaging analysis confirmed the different tissue distribution of Mo and its non-heterogeneity. The concentration of Mo in the brain tissue was the lowest compared to other tissues and was below the calculated value of LOD (0.017 µg g<sup>−1</sup>) for LA-ICP-MS, which was also in good agreement with ICP-OES data.</p>", "<title>Analysis of MoS<sub>2</sub> particle distribution in BAL cells and lung tissue</title>", "<p id=\"Par31\">Exemplary images of the alveolar macrophages isolated from bronchoalveolar lavage (BAL) and the lung tissues of the rats exposed to 5 mg kg<sup>−1</sup> b.w. and analysed after 7 days are shown in Fig. ##FIG##8##9##. Based on the images an efficient internalization of MoS<sub>2</sub> particles by the alveolar macrophages can be proven, without induction of visible morphological changes of the macrophages as well as the cells in the interstitial tissue. The similar changes indicating an efficient clearance of the particles without induction of profibrotic reaction could be observed in the animals at the end of the experiment, i.e., after 90 days of exposure.</p>" ]
[ "<title>Discussion</title>", "<title>Toxicokinetics parameters of MoS<sub><bold><italic>2</italic></bold></sub> in both forms in the rats</title>", "<title>Inhalatory route</title>", "<p id=\"Par32\">The rate of absorption of Mo depends, inter alia, on its solubility. In contrast to MoO<sub>3</sub>, MoS<sub>2</sub> particles are practically insoluble in water, hence their absorption from the lung tissue is expected to proceed at a very slow rate [##REF##18192668##21##, ##UREF##7##22##]. Quantitative estimates of absorption following inhalation exposure to molybdenum in humans or animals were not identified [##UREF##8##23##]. Some evidence for absorption of molybdenum trioxide from the airways mucosa is available from inhalation studies on molybdenum trioxide conducted in rodents, i.e. in guinea pigs [##UREF##9##24##] well as rats and mice [##REF##12587014##25##]. To our knowledge, our study is the only one available in the published literature which evaluated kinetics parameters in rats exposed via inhalatory route to MoS<sub>2</sub> particles, hence any reliable comparisons to the published data cannot be made.</p>", "<title>Oral and intravenous routes</title>", "<p id=\"Par33\">Available data on Mo kinetic parameters after exposure via other routes indicate its rather fast absorption, distribution and elimination, depending to a great extent on the chemical form of Mo. In the study conducted by Werner et al. [##REF##11077927##26##] on volunteers, the elimination of Mo from the blood after a single intravenous injection of a trace quantity of Mo (ranging 300‒450 μg) occurred in the <italic>T</italic><sub>1/2</sub> range of 4‒70 min (half the time of the fast component of clearance) and in the <italic>T</italic><sub>1/2</sub> range of 3‒30 h (half the time of the slow component of clearance) in a two-compartment model. In the presented biokinetic model, the authors claimed that the clearance of plasma was much faster than the literature data. In addition, the authors showed that the volumes of distribution were significantly higher than the plasma volumes, but smaller than the calculated extracellular spaces. The authors further claimed that the faster Mo clearance from plasma might be explained by a quick uptake of Mo into tissues. This may indicate a very fast distribution of Mo in body fluids. The slight differences in results observed in our paper may be explained by both physiological inter-individual differences and also by the sampling schedule. Moreover, we also assume it may be related to the changing physiology of animals with maturation leading to lower demand for Mo in a growing organisms and eventually lower Mo plasma concentration. Unfortunately, we were not able to identify studies which could provide any support for such hypothesis (and as mentioned above no studies were found on relevant Mo blood kinetic parameters after inhalation exposure to particulate forms of Mo). It can be assumed that an unknown fraction of each dose administered after various time intervals was absorbed from the lungs (not known if in the form of particles or ions released after dissolution of the particles), causing comparable spikes in Mo concentration, but it was afterwards efficiently eliminated from the blood before the next dose. It is probable that within 2 weeks between administrations an equilibrium of the Mo distribution between the tissues and the blood has been established, which did not lead to increased Mo blood concentrations. As we calculated, the expected elimination half-life was <italic>T</italic><sub>1/2</sub> 354 vs. 195 days for the higher dose (5 mg kg<sup>−1</sup>) of MoS<sub>2</sub>-MPs vs. MoS<sub>2</sub>-NPs, respectively, compared with an elimination half-life of <italic>T</italic><sub>1/2</sub> 221 vs. 212 days for the lower dose (1.5 mg kg<sup>−1</sup>) of MoS<sub>2</sub>-MPs vs. MoS<sub>2</sub>-NPs, respectively. Based on these data, we hypothesize that, after repeated dosing, there is quite a rapid absorption of a certain amount (most probably very small) of the particles fraction administered (including ions after dissolution), while the remaining part of the particle fraction accumulates in the lungs. Moreover, For MoS<sub>2</sub>-MPs it could be seen that after 90 days the concentrations were higher than at the beginning of the experiment, so it was excreted more slowly. This is consistent with the observations of Kuraś et al. [##UREF##10##27##], as a lot of MoS2-MPs are observed in the lungs, the same MoS2-MPs absorption into the blood is faster, greater and excretion longer, as confirmed in Fig. ##FIG##5##6##.</p>", "<p id=\"Par34\">Turnlund and Keyes [##REF##14972348##28##] conducted a study on the clearance of Mo from the blood in men after administration of Mo, first intravenously (33 μg of <sup>97</sup>Mo) and then orally (22 μg day<sup>−1</sup> Mo). The administration of Mo increased both the natural intrinsic Mo in plasma and the total Mo in plasma during the first minutes (6.9 vs. 6.9 nmol L<sup>−1</sup>, respectively) up to 1 h (13.0 nmol L<sup>−1</sup> vs. 17.1 nmol L<sup>−1</sup>, respectively), then it again decreased to near baseline after 24 h of uptake (5.7 nmol L<sup>−1</sup> vs. 6.0 nmol L<sup>−1</sup>, respectively). Eventually, 48 h after infusion Mo concentration remained at a similar but only slightly lower level (5.1 mmol L<sup>−1</sup> vs. 5.3 mmol L<sup>−1</sup>, respectively). After 72 days, Mo concentration remained unchanged (5.8 ± 2.5 nmol L<sup>−1</sup>). These findings on urinary excretion are in agreement with the data obtained by Werner et al. (2000). The authors of the study suggest that the introduced Mo disturbed the overall Mo metabolism at the beginning of the experiment. It resulted in an increased level of Mo after exposure, combined with the physiological level of natural Mo. More specifically, Mo could have been absorbed by the tissues that released the pool of bioavailable intrinsic Mo in the body increasing its concentration in the blood. Further exposure to low dietary Mo may have resulted in physiological adaptation [##REF##14972348##28##]. Another study concerning compartmental modeling to explain the alteration in Mo distribution and excretion with the urine showed a positive correlation in the studied men, where increased Mo intake was associated with both increased Mo absorption and urinary excretion. The fraction deposited in tissues was inversely correlated [##REF##17182798##29##]. It is known that Mo is mainly excreted in the urine and it is a key pathway for modulating exposure to Mo in the body. Molybdenum from feces is eliminated in lower amounts. In humans, it is up to 17‒80% of the total absorbed Mo dose [##REF##6029070##30##, ##REF##26309918##31##], but Giussani et al. [##REF##18640703##32##] and Novotny and Turnlund [##REF##17182798##29##] reported that this excretion was on the level of 75–90% of the absorbed Mo dose. Urinary Mo excretion, according to the results obtained by Bell et al. [##REF##14242354##33##] after oral administration to rats, showed that 90% of the dose was eliminated by the kidneys. The lack of multiple urine collection from the freely moving rats may be considered a limitation of this article. This was not included in the study implementation schedule because attention was focused on the intratracheal instillation exposure and on following the Mo metabolism and key pathways of its regulation connected with blood kinetics and tissue distribution.</p>", "<title>Induction of pro-inflammatory reactions in the lung</title>", "<p id=\"Par35\">The latest research has revealed that MoS<sub>2</sub> has the ability to cause inflammatory reactions [##REF##26309918##31##, ##REF##33429540##34##]. It was shown that MoS<sub>2</sub>-MPs as well as MoS<sub>2</sub>-NPs deposited in the lung tissue of the rats after intratracheal instillation may cause inflammatory reactions, although a stronger response was observed for MoS<sub>2</sub>-MPs. The authors observed inflammation in the respiratory system in the rats after a single administration. The difference in the inflammatory response was statistically significant for both doses (1.5 and 5 mg MoS<sub>2</sub> kg<sup>−1</sup> b.w.) 7 days after the autopsy for MoS<sub>2</sub>-MPs compared to control (PVP) rats [##REF##32629262##15##]. Moreover, the authors showed interstitial inflammation at a higher dose, both 24 h after the autopsy (for both forms) and 7 days after the autopsy for MoS<sub>2</sub>-MPs. This data is confirmed by the results presented in our paper. STEM with EDS unambiguously revealed multiple alveolar macrophages loaded with plate-shaped Mo-MPs as well as agglomerates of Mo-NPs. The characteristically expanded lysosomes in these macrophages containing similar clusters of particles were observed in the cytoplasm of macrophages. The authors also showed the presence of NPs in epithelial cells, which may suggest that the process of internalization indicates the possibility of NPs penetration through the epithelium and systemic circulation extended clearance [##REF##32629262##15##]. Chng et al. [##REF##25341082##35##] noticed that disk-shaped particles were conducive to proinflammatory reactions in the respiratory system. Moreover, the histopathological assessment after chronic inhalation of 6.6 mg MoO<sub>3</sub> mg/m<sup>3</sup> in mice revealed significantly greater instances of adenoma or carcinoma of alveolar/bronchiolar in the exposed groups in comparison to control ones [##REF##9848111##36##]. Furthermore, in the same study the authors pointed to marginally greater incidents of lung tumor in male rats. The initial histopathological lung damages were observed already at 10 mg/m<sup>3</sup>. In another study, Huber and Cerreta [##UREF##11##37##] reported an increase in the neutrophils and multinucleated macrophages in BAL fluid in hamsters after one day of inhalation of 5 mg Mo/m<sup>3</sup>, and lymphocytes after 7 days of exposure. The increase in neutrophils in BAL fluid was also observed in mice after inhalation of 90 mg Mo/m<sup>3</sup> [##UREF##5##16##]. What is more, the tidal volume was already decreased after the lowest exposure level (8 mg MoS<sub>2</sub>/m<sup>3</sup>). Another study conducted by Peña et al. [##UREF##6##17##] also confirmed a lung inflammation caused by MoS<sub>2</sub> nanosheets after a single inhalation in mice. Inflammatory cytokines and extracellular vesicles as well as immune cells detected in BAL fluid effected on inflammatory status.</p>", "<p id=\"Par36\">Another study assessed the toxicity of Mo-NPs on rat BRL3A, i.e., rat liver cells, after 24-h exposure [##REF##16125895##38##]. The authors of this study observed a significant increase in the lactate dehydrogenase enzyme release at the Mo-NPs concentration of 250 μg m L<sup>−1</sup>—much higher than in the study conducted by Braydich-Stolle et al. [##REF##16014736##39##]. Also, an increase in mitochondrial activity reduction occurred at a much higher concentration—250 μg m L<sup>−1</sup> [##REF##16125895##38##]. Mo supplementation significantly increased the activity of xanthine dehydrogenase/xanthine oxidase, sulfite oxidase and superoxide dismutase in the liver [##REF##1552358##40##]. This is also confirmed by a study conducted by Yang and Yang [##REF##2918395##41##]. The authors investigated an effect of Mo supplementation (0.1 mg Mo L<sup>−1</sup>) of rats on the concentration of hepatic Mo, which was increased significantly compared to controls. Thus, it is very likely that the increased concentration of Mo in this study, observed after 7 administrations, caused disturbances in the metabolism of liver enzymes due to tissue retention.</p>", "<p id=\"Par37\">Moreover, Mo is an essential trace element, which, as an enzyme component, supports iron metabolism and thus contributes to hematopoesis. Accumulation of Mo in tissues can cause the risk of anemia [##REF##13097245##42##, ##REF##12046721##43##]. In our study, we observed deviations in basic hematological parameters in exposed animals. Similar to Sobańska et al. [##REF##32629262##15##] study. Therefore, lower Mo concentrations in blood after exposure are associated with hematological changes and damage to the vascular system during material collection, that directly affects hematological parameters (decrease in red blood cells, lower Mo concentrations). Kusum et al. [##REF##21170251##44##] obtained similar results. According to authors, oral exposure to Mo in goats may altered haematological profile, because it causes a state of secondary copper deficiency. As a consequence, the study revealed significant reduce in mean hemoglobin, packed cell volume, total leukocyte as well as erythrocyte count. The mean of corpuscular hemoglobin concentration was also significantly decreased. Lyubimov et al. [##REF##15501388##45##] confirmed a decrease in erythrocyte count as well as hematocrit in rats after gavage administered by 4.4 mg Mo/kg/day. Moreover, in the study Asadi et al. [##REF##27260534##46##] the number of white blood cells increased with increasing levels in Mo NP dosage, after intraperitoneal injections in rats. NPs cause inflammation due to disorders in the lymphatic system.</p>", "<p id=\"Par38\">In the described study, rats were exposed by intratracheal administration to nano- and micro-metric forms of Mo. It can be concluded that, after such exposure, MoS<sub>2</sub>-NPs as well as MoS<sub>2</sub>-MPs were mostly retained in the lung tissues. Distribution of the administered molybdenum disulfide particles was also observed in extrapulmonary tissues. Repeated exposure resulted in a significant accumulation of particles in both lungs and other tissues, with the following order of concentration: liver &gt; spleen &gt; brain. The distribution exponent was the fastest for the lower nanoparticle dose at <italic>T</italic><sub>1/2</sub> 8.8 days. The calculated elimination half-life was also faster for the nano-forms of Mo in comparison to the micro-forms, regardless of the dose.</p>", "<p id=\"Par39\">The present results provide a solid basis for further research on the fate of nanoparticles in the body. Additional studies, such as information on the extent of oral exposure after inhalation exposure, are necessary to clarify the routes of exposure. In addition, this is the first study in which 3 techniques were used to complement each other for the evaluation of the effects of intratracheal instillation of MoS<sub>2</sub>-MPs and MoS<sub>2</sub>-NPs on tissue distribution in rats. The LA-ICP-MS technique was proposed as a complementary tool for ICP-OES and ICP-MS, for the identification as well as bioimaging of different sizes of Mo particles in rat tissue. The impact of the particle size and form was investigated, which may be an important tool in further internal biokinetics studies. Intratracheal exposure to Mo particles showed their retention and deposition, mainly in the lung tissue, in the form of MoS<sub>2</sub>-MPs, and to a lower extent in the liver and spleen, but mainly in the form of MoS<sub>2</sub>-NPs. Taking into consideration the complex nature of factors determining the toxicity of NPs and MPs, biological as well as toxicological studies should be carried out multidirectionally.</p>" ]
[]
[ "<p id=\"Par1\">There is still little literature data on the toxicity and safety of the commonly used molybdenum (Mo) disulfide which is present in the working as well as living environments. Thus, an experiment was carried out involving rats, with single and repeated intratracheal exposure (in the latter case, 7 administrations at 2-week intervals with the analysis performed after 90 days) to lower (1.5 mg Mo kg<sup>−1</sup> b.w.) and higher (5 mg Mo kg<sup>−1</sup> b.w.) doses of molybdenum(IV) sulfide nanoparticles (MoS<sub>2</sub>-NPs) and microparticles (MoS<sub>2</sub>-MPs). The analysis of Mo concentrations in the tail and heart blood as well as in soft tissues (lung, liver, spleen, brain), after mineralization and bioimaging, was meant to facilitate an assessment of its accumulation and potential effects on the body following short- and long-term exposure. The multi-compartment model with an exponential curve of Mo concentration over time with different half-lives for the distribution and elimination phases of MoS<sub>2</sub>-MPs and MoS<sub>2</sub>-NPs was observed. After 24 h of exposure, a slight increase in Mo concentration in blood was observed. Next, Mo concentration indicated a decrease in blood concentration from 24 h to day 14 (the Mo concentration before the second administration), below the pre-exposure concentration. The next phase was linear, less abrupt and practically flat, but with an increasing trend towards the end of the experiment. Significantly higher Mo concentrations in MoS<sub>2</sub>-NPs and MoS<sub>2</sub>-MPs was found in the lungs of repeatedly exposed rats compared to those exposed to a single dose. The analysis of Mo content in the liver and the spleen tissue showed a slightly higher concentration for MoS<sub>2</sub>-NPs compared to MoS<sub>2</sub>-MPs. The results for the brain were below the calculated detection limit. Results were consistent with results obtained by bioimaging technique.</p>", "<title>Keywords</title>" ]
[]
[ "<title>Acknowledgements</title>", "<p>The authors would like to thank K. Ranoszek-Soliwoda, G. Celichowski from the University of Łódź, (Department of Materials Technology and Chemistry, Faculty of Chemistry, Łódź, Poland) for the chemical synthesis of MoS<sub>2</sub>, as well as K. Sitarek, R. Świercz, Z. Pisarek, B. Pawlak and K. Mader for their assistance during the animal experiments, and T. Podsiadły and W. Kuszka for the determination of Mo concentration in blood. Moreover, the authors would like to thank C. Derrick Quarles Jr. (Elemental Scientific, Inc.) and Charles Sisson (Applied Spectra, Inc.) for their valuable suggestions and excellent technical assistance during the training and optimization of the J200 Tandem LA/LIBS.</p>", "<title>Funding</title>", "<p>This study was funded by the National Science Centre (Grant no. 2019/33/N/NZ7/02215) and was supported by the Central Institute for Labour Protection—National Research Institute (the fourth stage of the national program entitled “Improvement of safety and working conditions,” supported in 2017–2019, coordinated by the Central Institute for Labour Protection—National Research Institute).</p>", "<title>Data availability</title>", "<p>Data generated and/or analyzed during the current study are available from the corresponding authors upon reasonable request.</p>", "<title>Declarations</title>", "<title>Conflict of interest</title>", "<p id=\"Par40\">The authors declared no conflict of interest.</p>", "<title>Ethical approval and consent to participate</title>", "<p id=\"Par41\">Research involving rats. Ethics Committee for Animal Experiments (Resolution No. 6/ŁB 86/2018).</p>", "<title>Consent for publication</title>", "<p id=\"Par42\">All authors agree to be published.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>High-resolution scanning electron microscopy (FEI-Nova NanoSEM 450) images of MoS<sub>2</sub>-NPs (<bold>a</bold>) and MoS<sub>2</sub>-MPs (<bold>b</bold>).The scale bar is 200 nm and 2 µm, respectively</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>DLS histograms determining the hydrodynamic diameter of the MoS<sub>2</sub> particles</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p>Mo concentration (mean ± SD) in the venous blood collected from the tail vein of male rats exposed to MoS<sub>2</sub>-NPs and MoS<sub>2</sub>-MPs after a single administration, and the analysis performed after 24 h (<bold>a</bold>) and 7 days (<bold>b</bold>), at a dose of 1.5 and 5 mg MoS<sub>2</sub> per kg b.w. In individual groups, the same rat was bled before exposure, and after 24 h or 7 days. The study groups were composed of 3 animals</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p>Mo concentration (mean ± SD) in the venous blood collected from the tail vein from male rats exposed to MoS<sub>2</sub>-NPs (<bold>a</bold>) and MoS<sub>2</sub>-MPs (<bold>b</bold>) after 7 administrations at 2-week intervals, and with the analysis performed over 90 days, at a dose of 1.5 and 5 mg MoS<sub>2</sub> per kg b.w. within each group, the same rat was bled after exposure at specific time intervals. The study groups were composed of 3 animals</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><p>The mean blood concentration–time relationship for MoS<sub>2</sub>-MPs and MoS<sub>2</sub>-NPs after intratracheal instillation to rats. The logarithm linear regression curve equation. Each data point represents the mean and SD of Mo concentrations measured (<italic>n</italic> = 6)</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><p>Median blood concentration for MoS<sub>2</sub>-MPs and MoS<sub>2</sub>-NPs for both doses (5 mg kg<sup>−1</sup> and 1.5 mg kg<sup>−1</sup>) before autopsy (90 days)</p></caption></fig>", "<fig id=\"Fig7\"><label>Fig. 7</label><caption><p>Molybdenum concentration (mean values ± SD) in the lungs of male rats exposed to MoS<sub>2</sub>-NPs and MoS<sub>2</sub>-MPs after: <bold>a</bold> single administration, and the analysis performed after 7 days, at a dose of 1.5 and 5 mg MoS<sub>2</sub> per kg b.w., vs. CON (<italic>N</italic> = 3‒4); <bold>b</bold> 7 administrations (at 2-week intervals), and the analysis performed after 90 days, at a dose of 5 mg MoS<sub>2</sub> per kg b.w., vs. CON (<italic>N</italic> = 4); The PVP was administered in a volume of 400 µL of PVP per kg b.w. (<italic>N</italic> = 4) (CON)</p></caption></fig>", "<fig id=\"Fig8\"><label>Fig. 8</label><caption><p>LA-ICP-MS Mo bioimaging Mo (the <sup>97/95</sup>Mo ratio) in the lung sections of the rats exposed to MoS<sub>2</sub>-NPs and MoS<sub>2</sub>-MPs vs. CON, normalized to the size of the sample</p></caption></fig>", "<fig id=\"Fig9\"><label>Fig. 9</label><caption><p>Exemplary images of the lung tissue of the rats exposed to 5 mg kg<sup>−1</sup> bw and analysed after 7 days. <bold>a</bold> Alveolar macrophages isolated from BAL heavily loaded with MoS<sub>2</sub> particles (Giemsa staining). The cells attached to the macrophages are probably monocytes. <bold>b</bold> Light microscopy images of the lung tissue showing MoS<sub>2</sub> particles (dark brown or black agglomerates) present in alveolar macrophages and interstitial tissue (routing HE staining 200×). <bold>c</bold> SEM pictures of macrophages loaded with MoS<sub>2</sub> particles. The particles are engulfed in clusters in vesicular organelles (endosomes)</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Study design including Mo doses, day of analysis, sampling and data collection</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\"/><th align=\"left\" rowspan=\"2\">Type of exposure/dose</th><th align=\"left\" rowspan=\"2\">Analysis</th><th align=\"left\" colspan=\"5\">Tissue</th></tr><tr><th align=\"left\">Blood</th><th align=\"left\">Lung</th><th align=\"left\">Liver</th><th align=\"left\">Spleen</th><th align=\"left\">Brain</th></tr></thead><tbody><tr><td align=\"left\">1</td><td align=\"left\">CON</td><td align=\"left\">7 days</td><td align=\"left\">–</td><td align=\"left\"> + </td><td align=\"left\"> + </td><td align=\"left\"> + </td><td align=\"left\"> + </td></tr><tr><td align=\"left\" rowspan=\"2\">2</td><td align=\"left\" rowspan=\"2\"><p>1 administration</p><p>1.5 mg MoS<sub>2</sub>-NPs kg<sup>−1</sup> b.w</p></td><td align=\"left\">24 h</td><td align=\"left\" rowspan=\"2\">Tail vein*</td><td align=\"left\">−</td><td align=\"left\">−</td><td align=\"left\">−</td><td align=\"left\">−</td></tr><tr><td align=\"left\">7 days</td><td align=\"left\"> + </td><td align=\"left\"> + </td><td align=\"left\"> + </td><td align=\"left\"> + </td></tr><tr><td align=\"left\" rowspan=\"2\">3</td><td align=\"left\" rowspan=\"2\"><p>1 administration</p><p>1.5 mg MoS<sub>2</sub>-MPs kg<sup>−1</sup> b.w</p></td><td align=\"left\">24 h</td><td align=\"left\" rowspan=\"2\">Tail vein*</td><td align=\"left\">−</td><td align=\"left\">−</td><td align=\"left\">−</td><td align=\"left\">−</td></tr><tr><td align=\"left\">7 days</td><td align=\"left\"> + </td><td align=\"left\"> + </td><td align=\"left\"> + </td><td align=\"left\"> + </td></tr><tr><td align=\"left\" rowspan=\"2\">4</td><td align=\"left\" rowspan=\"2\"><p>1 administration</p><p>5 mg MoS<sub>2</sub>-NPs kg<sup>−1</sup> b.w</p></td><td align=\"left\">24 h</td><td align=\"left\" rowspan=\"2\">Tail vein*</td><td align=\"left\">−</td><td align=\"left\">−</td><td align=\"left\">−</td><td align=\"left\">−</td></tr><tr><td align=\"left\">7 days</td><td align=\"left\"> + </td><td align=\"left\"> + </td><td align=\"left\"> + </td><td align=\"left\"> + </td></tr><tr><td align=\"left\" rowspan=\"2\">5</td><td align=\"left\" rowspan=\"2\"><p>1 administration</p><p>5 mg MoS<sub>2</sub>-MPs kg<sup>−1</sup> b.w</p></td><td align=\"left\">24 h</td><td align=\"left\" rowspan=\"2\">Tail vein*</td><td align=\"left\">−</td><td align=\"left\">−</td><td align=\"left\">−</td><td align=\"left\">−</td></tr><tr><td align=\"left\">7 days</td><td align=\"left\"> + </td><td align=\"left\"> + </td><td align=\"left\"> + </td><td align=\"left\"> + </td></tr><tr><td align=\"left\">6</td><td align=\"left\">CON</td><td align=\"left\">After 90 days</td><td align=\"left\">Venous blood from the heart during autopsy</td><td align=\"left\"> + </td><td align=\"left\"> + </td><td align=\"left\"> + </td><td align=\"left\"> + </td></tr><tr><td align=\"left\">7</td><td align=\"left\"><p>7 administrations</p><p>1.5 mg MoS<sub>2</sub>-NPs kg<sup>−1</sup> b.w</p></td><td align=\"left\">After 90 days</td><td align=\"left\">Tail vein*</td><td align=\"left\">−</td><td align=\"left\">−</td><td align=\"left\">−</td><td align=\"left\">−</td></tr><tr><td align=\"left\">8</td><td align=\"left\"><p>7 administrations</p><p>1.5 mg MoS<sub>2</sub>-MPs kg<sup>−1</sup> b.w</p></td><td align=\"left\">After 90 days</td><td align=\"left\">Tail vein*</td><td align=\"left\">−</td><td align=\"left\">−</td><td align=\"left\">−</td><td align=\"left\">−</td></tr><tr><td align=\"left\">9</td><td align=\"left\"><p>7 administrations</p><p>5 mg MoS<sub>2</sub>-NPs kg<sup>−1</sup> b.w</p></td><td align=\"left\">After 90 days</td><td align=\"left\"><p>Tail vein*</p><p>Venous blood from the heart during autopsy</p></td><td align=\"left\"> + </td><td align=\"left\"> + </td><td align=\"left\"> + </td><td align=\"left\"> + </td></tr><tr><td align=\"left\">10</td><td align=\"left\"><p>7 administrations</p><p>5 mg MoS<sub>2</sub>sMPs kg<sup>−1</sup> b.w</p></td><td align=\"left\">After 90 days</td><td align=\"left\"><p>Tail vein*</p><p>Venous blood from the heart during autopsy</p></td><td align=\"left\"> + </td><td align=\"left\"> + </td><td align=\"left\"> + </td><td align=\"left\"> + </td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Molybdenum concentration (mean values ± SD) in the liver and the spleen of male rats exposed to MoS<sub>2</sub>-NPs and MoS<sub>2</sub>-MPs after: single administration, and the analysis performed after 7 days, at a dose of 1.5 and 5 mg MoS<sub>2</sub> per kg b.w., vs. CON (<italic>N</italic> = 4); 7 administrations (at 2-week intervals), and the analysis performed after 90 days, at a dose of 5 mg MoS<sub>2</sub> per kg b.w., vs. CON (<italic>N</italic> = 4); PVP was administered in a volume of 400 µL PVP per kg b.w. (<italic>N</italic> = 4) (CON)</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Organ</th><th align=\"left\" rowspan=\"2\">Parameter</th><th align=\"left\" colspan=\"2\">Interval</th></tr><tr><th align=\"left\">7 days</th><th align=\"left\">90 days</th></tr></thead><tbody><tr><td align=\"left\">Liver</td><td align=\"left\">CON</td><td char=\"±\" align=\"char\">1.19 ± 0.49</td><td align=\"left\">1.09 ± 0.34</td></tr><tr><td align=\"left\"/><td align=\"left\">MoS<sub>2</sub>-NPs 1.5 mg kg<sup>−1</sup></td><td char=\"±\" align=\"char\">1.10 ± 0.49</td><td align=\"left\">–</td></tr><tr><td align=\"left\"/><td align=\"left\">MoS<sub>2</sub>-NPs 5 mg kg<sup>−1</sup></td><td char=\"±\" align=\"char\">1.24 ± 0.61</td><td align=\"left\">1.67 ± 0.38</td></tr><tr><td align=\"left\"/><td align=\"left\">MoS<sub>2</sub>-MPs 1.5 mg kg<sup>−1</sup></td><td char=\"±\" align=\"char\">1.28 ± 0.51</td><td align=\"left\">–</td></tr><tr><td align=\"left\"/><td align=\"left\">MoS<sub>2</sub>-MPs 5 mg kg<sup>−1</sup></td><td char=\"±\" align=\"char\">1.09 ± 0.45</td><td align=\"left\">1.38 ± 0.23</td></tr><tr><td align=\"left\">Spleen</td><td align=\"left\">CON</td><td char=\"±\" align=\"char\">0.15 ± 0.02</td><td align=\"left\">0.16 ± 0.06</td></tr><tr><td align=\"left\"/><td align=\"left\">MoS<sub>2</sub>-NPs 1.5 mg kg<sup>−1</sup></td><td char=\"±\" align=\"char\">0.27 ± 0.15</td><td align=\"left\">–</td></tr><tr><td align=\"left\"/><td align=\"left\">MoS<sub>2</sub>-NPs 5 mg kg<sup>−1</sup></td><td char=\"±\" align=\"char\">0.16 ± 0.05</td><td align=\"left\">0.87 ± 0.09</td></tr><tr><td align=\"left\"/><td align=\"left\">MoS<sub>2</sub>-MPs 1.5 mg kg<sup>−1</sup></td><td char=\"±\" align=\"char\">0.14 ± 0.10</td><td align=\"left\">–</td></tr><tr><td align=\"left\"/><td align=\"left\">MoS<sub>2</sub>-MPs 5 mg kg<sup>−1</sup></td><td char=\"±\" align=\"char\">0.16 ± 0.05</td><td align=\"left\">0.32 ± 0.08</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[]
[ "<table-wrap-foot><p>*The blood was collected from the same animal before and after exposure (the animal was self-controlled)</p></table-wrap-foot>" ]
[ "<graphic xlink:href=\"43188_2023_213_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"43188_2023_213_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"43188_2023_213_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"43188_2023_213_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"43188_2023_213_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"43188_2023_213_Fig6_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"43188_2023_213_Fig7_HTML\" id=\"MO7\"/>", "<graphic xlink:href=\"43188_2023_213_Fig8_HTML\" id=\"MO8\"/>", "<graphic xlink:href=\"43188_2023_213_Fig9_HTML\" id=\"MO9\"/>" ]
[]
[{"label": ["1."], "surname": ["Meng", "Cui", "Cheng", "Han"], "given-names": ["FM", "ZT", "ZT", "HL"], "article-title": ["Experimental study on tribological properties of graphite-MoS"], "sub": ["2"], "source": ["J Tribol"], "year": ["2018"], "volume": ["140"], "fpage": ["051303"], "pub-id": ["10.1115/1.4039796"]}, {"label": ["3."], "surname": ["Zhang", "Li", "Li Ji", "Liu", "Wan", "Chen", "Li", "Jin"], "given-names": ["Y", "P", "L", "X", "H", "L", "H", "Z"], "article-title": ["Tribological properties of MoS"], "sub": ["2"], "source": ["Friction"], "year": ["2021"], "volume": ["9"], "fpage": ["789"], "lpage": ["801"], "pub-id": ["10.1007/s40544-020-0374-3"]}, {"label": ["4."], "surname": ["Zan", "Geng", "Liu", "Yao"], "given-names": ["W", "W", "H", "X"], "article-title": ["Electronic properties of MoS2 on monolayer, bilayer and bulk SiC: a density functional theory study"], "source": ["J Alloys Compd"], "year": ["2016"], "volume": ["666"], "fpage": ["204"], "lpage": ["208"], "pub-id": ["10.1016/j.jallcom.2016.01.108"]}, {"label": ["6."], "mixed-citation": ["European Commission, Directorate-General for Environment (1999) Guidelines for setting specific concentration limits for carcinogens in Annex I of Directive 67/548/EEC: inclusion of potency considerations. Publications Office. "], "ext-link": ["https://op.europa.eu/en/publication-detail/-/publication/33b0ae1e-bba6-4fcc-8005-d137fdd76113"]}, {"label": ["7."], "mixed-citation": ["Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance). "], "ext-link": ["https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32008R1272"]}, {"label": ["16."], "surname": ["S\u00f8rli", "Jensen", "Mortensen", "Szarek", "Gutierrez", "Givelet", "Loeschner", "Loizides", "Hafez", "Biskos", "Vogel", "Hadrup"], "given-names": ["JB", "AC\u00d8", "A", "J", "CAT", "L", "K", "C", "I", "G", "U", "N"], "article-title": ["Pulmonary toxicity of molybdenum disulphide after inhalation in mice"], "source": ["Toxicol"], "year": ["2023"], "volume": ["485"], "fpage": ["153428"], "pub-id": ["10.1016/j.tox.2023.153428"]}, {"label": ["17."], "surname": ["Pe\u00f1a", "Cherukula", "Even", "Ji", "Razafindrakoto", "Peng", "Silva", "Moyon", "Hillaireau", "Bianco", "Fattal", "Alloyeau", "Gazeau"], "given-names": ["NO", "K", "B", "DK", "S", "S", "AKA", "CM", "H", "A", "E", "D", "F"], "article-title": ["Resolution of MoS"], "sub": ["2"], "source": ["Adv Mater"], "year": ["2023"], "volume": ["35"], "fpage": ["2209615"], "pub-id": ["10.1002/adma.202209615"]}, {"label": ["22."], "mixed-citation": ["ICRP (2012) Annals of the ICRP: Compendium of dose coefficients based on ICRP publication 60. International Commission on Radiological Protection. ICRP Publication 119. "], "ext-link": ["http://www.icrp.org/publication.asp?id=ICRP%20Publication%20119"]}, {"label": ["23."], "mixed-citation": ["Agency for Toxic Substances and Disease Registry (ATSDR) (2020) Toxicological profile for Molybdenum. U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA"]}, {"label": ["24."], "surname": ["Fairhall", "Dunn", "Sharpless", "Pritchard"], "given-names": ["LT", "RC", "NE", "EA"], "article-title": ["The toxicity of molybdenum"], "source": ["Public Health Bull"], "year": ["1945"], "volume": ["293"], "issue": ["36"], "fpage": ["52"]}, {"label": ["27."], "mixed-citation": ["Kura\u015b R, St\u0119pnik M, Domeradzka-Gajda K, Janasik B (2024) The use of LA-ICP-MS as an auxiliary tool to assess the pulmonary toxicity of molybdenum(IV) sulfide (MoS"], "sub": ["2"]}, {"label": ["37."], "surname": ["Huber", "Cerreta"], "given-names": ["EA", "JM"], "article-title": ["Mechanisms of cell injury induced by inhaled molybdenum trioxide nanoparticles in Golden Syrian Hamsters"], "source": ["Exp Biol Med"], "year": ["2022"], "volume": ["247"], "fpage": ["2067"], "lpage": ["2080"], "pub-id": ["10.1177/15353702221104033"]}]
{ "acronym": [], "definition": [] }
46
CC BY
no
2024-01-14 23:40:15
Toxicol Res. 2023 Nov 14; 40(1):163-177
oa_package/4b/08/PMC10786813.tar.gz
PMC10786816
38216801
[ "<title>Introduction</title>", "<p id=\"Par39\">Since the discovery of the first MTs, aflatoxins (AFs), in 1965, there has been an upward trend in the publication of scholarly articles on MTs, with 16,821 papers being listed in Scopus. Data unmistakably demonstrated the importance of MTs research, nevertheless, in many low-income nations where MTs have an impact on staple foods, the MTs-related global health problem is still commonly disregarded (Wild &amp; Gong ##REF##19875698##2009##). Unfortunately, these locations represent the least controlled regarding farming methods and exposure to humans, resulting in long-term and frequently high amounts of exposure. Only the wealthier countries in the world have focused on adhering to strict import laws regarding MTs contamination (Battilani et al. ##UREF##4##2016##). The population in developing nations, particularly in rural regions, depends on locally produced foods and frequently faces issues with food security and MTs contamination, which is seen as a significant problem with food quality (Singh and Mehta ##REF##32405376##2020##).</p>", "<p id=\"Par40\">MTs are secondary metabolites of filamentous fungi, belonging to the <italic>Ascomycota phylum</italic>, with a low molecular mass (MW 700 Da) that endanger the health of both people and animals (Liew &amp; Mohd-Redzwan ##REF##29535978##2018##) (Alshannaq and Yu ##REF##28608841##2017##). The incidence of the AF-caused Turkey X sickness, which claimed the lives of over 100,000 turkeys in 1960, sparked research in MTs. After that, it was discovered that Hepatocellular carcinoma (HCC) can develop because of AFs, which are carcinogenic in both people and animals (Liew &amp; Mohd-Redzwan ##REF##29535978##2018##). Since then, we discovered more than 400 distinct MTs with varied chemical compositions and characteristics that are produced by numerous different fungi species (Palumbo et al. ##REF##31947721##2020##). <italic>Penicillium, Alternaria, Claviceps, Aspergillus, Fusarium,</italic> and <italic>Stachybotrys</italic> are the primary genera of mycotoxigenic fungus (Zain ##UREF##36##2011##). The most dangerous MTs are deoxynivalenol (DON), fumonisins (FBs), ergot alkaloids (EAs), T-2 and HT-2 toxins (T-2, HT-2) as well as aflatoxins (AFs), ochratoxin A (OTA), zearalenone (ZEN), enniatins (ENs), patulin (PAT), and <italic>Alternaria</italic> toxins (ATs) (Wokorach et al. ##UREF##34##2021##; Abrunhosa et al. ##REF##11298933##2001##). MTs have been discovered to be present in a variety of agricultural goods, including wheat, barley, maize, oats, rice (Palumbo et al. ##REF##31947721##2020##), vegetables, and fruits (Sanzani et al. ##UREF##29##2016##). Additionally, MTs can infect herbs (Sedova et al. ##REF##30380767##2018##; Ałtyn et al. ##REF##32183391##2020##), spices (Potortì et al. ##REF##30957566##2020##), drinks such as wine, fruit juices, and beer (Quintela ##UREF##24##2020##), milk (Becker-Algeri et al. ##REF##26799355##2016##), nuts (Kluczkovski ##UREF##12##2019##), coffee and cocoa (Bessaire et al. ##UREF##5##2019##; Huertas-Pérez et al. ##REF##26744990##2017##). Various fungal species' development and MT generation processes can be influenced by a variety of variables. These include the surrounding environment, including its humidity, temperature, pH, water activity, substrate type, nutrients, physiological condition, level of inoculation, and microbial interactions (Brzonkalik et al. ##REF##22608165##2012##; Agriopoulou et al. ##REF##32012820##2020##). MTs production can take place during the preparation, packaging, distribution, and storage of agricultural products, or during the preparation of food (Karlovsky et al. ##REF##27554261##2016##). Due to the environment, inadequate production methods, and poor storage conditions in developing nations, MTs contamination occurs more frequently in food and feed (Al-Jaal et al. ##REF##31586556##2019##). Additionally, because many MTs are resistant to heat, chemical, and physical treatments, they are challenging to remove from food during processing (Marin et al. ##REF##23907020##2013##). Numerous approaches have been put out to reduce the MTs contamination of various food products, but no definitive answers have been found.</p>", "<p id=\"Par41\">MTs harm people’s and animals’ health, impede international trade, waste food and feed, and take money away from initiatives to address MTs’ problems through legislation, research, and enforcement (Stoev ##REF##23768181##2013##). Unfortunately, every year, MTs infect over 25% of the world’s harvested crops, resulting in billion-dollar losses for business and agriculture (Marin et al. ##REF##23907020##2013##). A recent study revealed that MTs are present in 60–80% of crops globally (Eskola et al. ##REF##31478403##2020##). Both OTA and AFB1 were categorized by the International Agency for Research on Cancer (IARC) as being potentially carcinogenic to humans in Group 2B and Group 1, respectively while Trichothecenes and ZEN (Group 3) were not acknowledged as Human Carcinogens (Accessed on 12 November 2023). The World Health Organisation (WHO), the European Commission (EC) (<ext-link ext-link-type=\"uri\" xlink:href=\"https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:02006R1881-20140701&amp;from=EN\">https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:02006R1881-20140701&amp;from=EN</ext-link><underline>)</underline> (Accessed on 12 November 2023), the Food and Agriculture Organisation of the United Nations (FAO), and other national and international institutions and organizations have identified potential health risks to humans and animals associated with food- or feedborne MTs intoxication. They have addressed this issue by developing regulatory limits for major MTs classes and selected individual MTs types (Krska et al. ##UREF##13##2008##). Based on the health consequences of MTs, there is an urgent need for rapid, easy, and accurate methods of MTs detection in food as a quality control and to ensure food safety and lower health dangers. Accordingly, we highlighted and discussed the up-to-date innovative approaches that have been employed for MT detection pointing out current challenges and future directions. The limitations<bold>,</bold> current challenges, and future directions of conventional detection methods versus innovative methods have also been highlighted and discussed.</p>", "<title>Occurrence of mycotoxicosis</title>", "<p id=\"Par42\">When exposure to mold toxins/substances results in poisoning, this condition is known as Mycotoxicosis. Mycotoxicosis can affect the health of people and animals in a variety of ways, including ingestion, inhalation, skin contact, lymphatic system entry, and bloodstream entry. While chronic impacts can take months, years, or even decades to appear, acute effects show up within 72 h of exposure. The type of MT determines the symptoms and effects of mycotoxicosis, although two or more MTs may have comparable effects (Bulgaru et al. ##REF##33807171##2021##). When MTs are present in toxic doses, they typically have the following impacts on humans and animals: recognizable diseases, weakened immunity, mortality, and acting as irritants or allergens. Numerous MTs are toxic to other living things, including fungi and bacteria (Keller et al. ##REF##16322742##2005##). The uncommon phenotypical sex changes in chickens, whereby they appear and behave as though they are male, have been attributed to MTs in stored animal feed (Melina ##UREF##20##2020##). By means of inhalation and absorption into the blood and lymphatic pathways, MTs infect humans (Bennett and Klich ##REF##12857779##2003##). Mycotoxicosis symptoms depend on mycotoxin type, sex, age, and general health of the victims, as well as the amount of MT present and the duration of exposure (Claeys et al. ##REF##33337079##2020##). Insufficient research has been done on the interactions between several elements, including food, genetics, and relationships with various toxins. As a result, there is a chance that mycotoxicosis will be made worse by vitamin deficiencies, alcoholism, calorie restriction, and viral infections (Bennett and Klich ##REF##12857779##2003##). In the 1990s, MTs contributed to public health worries over the increasing number of mold settlements, which might have cost millions of dollars. This was a direct outcome of research conducted in Cleveland, Ohio, which gave proof of the association between MTs in infants’ pulmonary hemorrhage and the spores of <italic>Stachybotrys</italic> (Agriopoulou et al. ##REF##32012820##2020##). The maximal concentration of MTs in research on dietary (nutritional) supplements derived from plants in 2015 was estimated to be around 37 mg per kg for the supplement based on milk thistle (Veprikova et al. ##REF##26168136##2015##).</p>", "<title>Types of mycotoxins</title>", "<title>Aflatoxins (AFs)</title>", "<p id=\"Par43\">Many <italic>Aspergillus</italic> species, particularly <italic>Aspergillus parasiticus</italic> and <italic>Aspergillus flavus,</italic> are responsible for the production of AFs (Martins et al. ##REF##11339266##2001##). The four main forms of AFs are AFs B1, B2, G1, and G2 (Fig. ##FIG##0##1##). Total AFs is the name for all AFs taken collectively. AFs are well-known MTs that are produced by molds that thrive in hay, cereals, decomposing plants, and soil. Cereals (such as acha, millet, guinea corn, rice, wheat, sorghum, and corn), tree nuts (such as walnut, coconut, pistachio, and almond), oilseeds (such as sesame, cotton, sunflower, peanut, and soybean seeds), and spices (such as ginger, turmeric, coriander, black pepper, garlic, and chili peppers) are among the crops that are frequently impacted by such moulds. The strongest carcinogen and most harmful toxin known as AFB1 has been directly connected to numerous health issues in various animals, including liver cancer (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.who.int/news-room/fact-sheets/detail/mycotoxins\">https://www.who.int/news-room/fact-sheets/detail/mycotoxins</ext-link><underline>)</underline> (Accessed on 14 November 2023); Agriopoulou et al. ##REF##32012820##2020##; Martins et al. ##REF##11339266##2001##). Animal dairy and milk products can also include these MTs, especially if the animals were fed contaminated feed (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.who.int/news-room/fact-sheets/detail/mycotoxins\">https://www.who.int/news-room/fact-sheets/detail/mycotoxins</ext-link><underline>)</underline> (Accessed on 14 November 2023). It is usual to find AFM1, a byproduct of AFB1 detoxication, in dairy products. The primary sources of AFs in feeds are maize, cottonseed, and peanut meal. According to the World Health Organisation (WHO), AFs can cause Acute aflatoxicosis poisoning which can be fatal frequently due to liver damage. It has also been claimed that AFs are genotoxic, meaning they could harm DNA and result in animal cancer. There is enough proof to conclude that AFs cause liver cancer in both humans and animals (Wild &amp; Turner ##REF##12435844##2002##).</p>", "<title>Mechanisms of action of AFs</title>", "<p id=\"Par44\">Numerous studies have been conducted on AFB1, with a spot on the mutagenicity and carcinogenicity of AFs. Due to the double bond at positions 8, and 9, AFB1 is typically metabolized to AFB1-8,9-epoxide, which can attach to biological macromolecules like deoxyribonucleic acid (DNA) in its reactive form (Wild &amp; Turner ##REF##12435844##2002##; Urusov et al. ##REF##25633750##2015##; Anfossi et al. ##UREF##1##2016##). The primary DNA adduct, a pro-mutagenic lesion called AFB-N7-guanine, frequently results in G-T transversions.</p>", "<p id=\"Par45\">Urine tests show the presence of AFB-N7-guanine, which is utilized as an exposure biomarker in epidemiological research. Because they lack the 8,9 double bond, AFG2 and AFB2 are less physiologically active. AFB1-8,9-epoxide promptly inserts into the DNA in comparison to AFG1, resulting in the development of greater quantities of DNA adduct at any given dose. AFG1 is capable of biological activation to 8,9- epoxide, yet it is not as mutagenic as AFB1 (Agriopoulou et al. ##REF##32012820##2020##; Qiu et al. ##REF##26867679##2016##). Years ago, reports of AFs poisoning in humans were made, yet prior research on the causes seemed to be unclear (Awuchi et al. ##UREF##3##2020##). The affected individuals initially displayed anorexia, fever, and jaundice after vomiting, which developed into lower extremity edema and ascites. There is proof that people with AFs poisoning exhibit low-grade fever, general malaise, anorexia, stomach discomfort, and tachycardia. Kenya, an East African nation, was the site of an aflatoxicosis incident in 2004 (Lewis et al. ##REF##16330360##2005##; Azziz-Baumgartner et al. ##REF##16330363##2005##). As a result of these outbreaks, hundreds of people died after eating maize infected with AFs. Aflatoxicosis is characterized by severe jaundice of unclear source. Case–control studies on the disease showed that foods from exposed families have much more AFs in them than foods from unexposed families. Examining blood levels of AFs biomarkers revealed significant differences between patients and controls. (Azziz-Baumgartner et al. ##REF##16330363##2005##; McCoy et al. ##UREF##19##2008##).</p>", "<p id=\"Par46\">Aflatoxin-contaminated maize has been linked to aflatoxicosis and acute hepatitis, and the evidence for this association is strong enough. Most cases of aflatoxicosis are recorded in areas where maize is a common staple grain. It has been investigated how much AFs people consume to get aflatoxicosis and the reasons why (Wild and Gong ##REF##19875698##2009##). Natural AFs are categorized by the International Agency for Research on Cancer (IARC) as Group 1 human carcinogens (<ext-link ext-link-type=\"uri\" xlink:href=\"https://monographs.iarc.who.int/wp-content/uploads/2018/06/mono82.pdf\">https://monographs.iarc.who.int/wp-content/uploads/2018/06/mono82.pdf</ext-link>) (Accessed on 14 November 2023). Moreover, children who live in areas where food contamination is common are exposed to high levels of AFs regularly. Exposure begins during pregnancy and continues during the first few years of life; however, nursing provides some relief from high daily intake. Numerous animal studies have demonstrated that being exposed to AFs has negative impacts on growth (Lombard ##REF##25341872##2014##). Early investigations looked at the connection between AFs exposure and kwashiorkor (Hendrickse et al. ##REF##6811035##1982##). Research also connected the presence of AFs in mothers' blood to considerably lower birth weights in female infants (De Vries et al. ##REF##2741679##1989##).</p>", "<title>Ochratoxin A (OTA)</title>", "<p id=\"Par47\">Ochratoxin A (OTA), ochratoxin B (OTB), and ochratoxin C (OTC) are three different MTs known as OTs (Fig. ##FIG##1##2##). The fungal species <italic>A. niger, A. ochraceus, Aspergillus melleus, Aspergillus sclerotiorum, Aspergillus sulphureus, Penicillium verrucosum, and A. carbonarius</italic> create OTA, which is poisonous. Species of <italic>Aspergillus</italic> and <italic>Penicillium</italic> release all OTs. OTC is OTA’s ethyl ester, whereas OTB is its non-chlorinated version (Bayman and Baker ##REF##16944288##2006##). OTA was initially discovered in the Balkan area (Vrabcheva et al. ##REF##10888572##2000##). Numerous products, including cereals, seeds, coffee, nuts, fruits, dried meat, and alcoholic beverages like wine and beer, are thought to be contaminated by OTA. The primary <italic>Aspergillus</italic> found in vine fruit is <italic>A</italic>. <italic>carbonarius</italic>, which produces harmful byproducts during the production of beverages (Mateo et al. ##REF##17716764##2007##).</p>", "<title>OTA toxicity</title>", "<p id=\"Par48\">Although there has been little research on people due to confounding variables (Bayman and Baker ##REF##16944288##2006##; Mateo et al. ##REF##17716764##2007##) it showed that OTA is a carcinogen and nephrotoxin, directly connected to tumors in the human urinary tract. In poultry and pigs, OTA has been connected to nephropathy. OTA has been linked to the etiology of a number of kidney diseases (Fuchs and Peraica ##REF##16332622##2005##; Marin-Kuan et al. ##REF##18649906##2008##; Pfohl-Leszkowicz and Manderville ##REF##17195275##2007##). Balkan endemic nephropathy (BEN) is a Chronic tubulointerstitial disease that causes irreversible renal failure. Indeed, 15-year research found that BEN is linked to cancer of the upper urothelial tract (Rouprêt et al. ##REF##26188393##2015##). The OTA's toxic action modes are the inhibition of protein synthesis and energy production, the formation of DNA adducts, apoptosis, and oxidative stress induction (Kőszegi and Poór, ##REF##27092524##2016##). Evidence for OTA carcinogenicity primarily comes from research done on experimental an←imals. OTA is carcinogenic to rats and mice according to studies of laboratory, causing kidney cancer in mice and rats and HCC in mice (Bayman and Baker ##REF##16944288##2006##; Mateo et al. ##REF##17716764##2007##).</p>", "<p id=\"Par49\">OTA carcinogenicity's exact mechanism of action is still being investigated. Consuming OTAs has been linked with an increased risk of cancer according to descriptive studies. As stated by the International Agency for Research on Cancer, there is enough data to classify OTA as dangerous for lab animals’ cancer, but not enough to say that it raises the risk of cancer in humans. As a result, OTA is classified by the IARC as Group 2B, potentially carcinogenic to humans (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.who.int/news-room/fact-sheets/detail/mycotoxins\">https://www.who.int/news-room/fact-sheets/detail/mycotoxins</ext-link><underline>)</underline> (Accessed on 14 November 2023;) (Accessed on 12 November 2023). Other OTA toxicities include kidney lesions in poultry, bone marrow toxicities in mice, GI tract and lymphoid tissue lesions in hamsters, as well as liver and heart lesions in rats and chickens (Pfohl-Leszkowicz &amp; Manderville ##REF##17195275##2007##). Furthermore, recent research has shown that OTA causes autism through an epigenetic mechanism (Mezzelani et al. ##REF##25597866##2016##). Previous research has revealed that OTA causes gut changes in addition to its negative effects on the kidney. Nutrition absorption in the intestine was altered by OTA. In vitro studies revealed that OTA reduced glucose absorption via the SGLT1 transporter (Liew &amp; Mohd-Redzwan ##REF##29535978##2018##).</p>", "<title>Zearalenone (ZEN)</title>", "<p id=\"Par50\">Some <italic>Fusarium</italic> and <italic>Gibberella</italic> species produce ZEN, also named as F-2 mycotoxin (Fig. ##FIG##2##3##a), which is an estrogenic nonsteroidal metabolite (Bulgaru et al. ##REF##33807171##2021##; Malir et al. ##REF##27384585##2016##). ZEN has been found in oats, almonds, soybeans, and sesame, along with corn, sorghum, wheat, rice, barley, and other grains (Gadzała-Kopciuch et al. ##REF##21750881##2011##).</p>", "<title>ZEN toxicity</title>", "<p id=\"Par51\">Because ZEN resembles naturally occurring estrogens, it has been observed in multiple in vivo experiments to alter the hormonal balance (Abia et al. ##UREF##0##2013##). Since this MT has a strong affinity for estrogen receptors, it causes fertility and reproductive problems in mammals (El-Sayed et al. ##UREF##8##2022##). Based on the hormonal mechanism of ZEN and its carcinogenic effect, it can increase the occurrence of pituitary various tumors in mice (Rai et al. ##REF##31446772##2020##<bold>;</bold>\n<ext-link ext-link-type=\"uri\" xlink:href=\"https://publications.iarc.fr/74\">https://publications.iarc.fr/74</ext-link>) (Accessed on 15 November 2023). The IARC categorized ZEN as being in Group 3, or not classifiable as human carcinogenic. Additionally, current research indicates that ZEN is metabolized in the liver and has been shown in animal research to have nephrotoxic, immunotoxic, carcinogenic, and hepatotoxic effects (Chatopadhyay et al. ##REF##22481690##2012##). Since this MT is so dangerous to consumer health, the European Union (EU) has set ZEN limits for a diversity of uncooked and processed cereals (20–350 g/kg) (El-Sayed et al. ##UREF##8##2022##).</p>", "<p id=\"Par52\">Even though its major target is the reproductive organ, adverse effects on the gastrointestinal tract have been documented. When compared to other MTs, the impacts of ZEN ingestion on the GI tract are not as severe. ZEN caused cell death in intestinal epithelial cells without affecting cell integrity. As ZEN can cause hyperkeratotic papillomas in the rat esophageal squamous epithelium stomach, ZEN may contribute to the development of tumors in the gastrointestinal tract. Regions with high MTs contamination are thought to have a higher incidence of esophageal cancer (Richard ##REF##17719115##2007##). In summary, ZEN harms gut health, although no visible histological changes have been observed.</p>", "<title>Deoxynivalenol (DON)</title>", "<p id=\"Par53\">DON (Fig. ##FIG##2##3##b) is a trichothecene MT that is generated in a variety of cereals like wheat by fungi like <italic>Fusarium graminearum.</italic> Various toxins are released by <italic>fusarium fungus</italic>, which are frequently found in soil. Fumonisins, DON, fumonisol (NIV), T-2, HT-2 toxins, and ZEN are few examples of trichothecenes. (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.who.int/news-room/fact-sheets/detail/mycotoxins\">https://www.who.int/news-room/fact-sheets/detail/mycotoxins</ext-link><underline>)</underline> (accessed on 14 November 2023).</p>", "<title>DON toxicity</title>", "<p id=\"Par54\">In humans, trichothecenes can be acutely hazardous, causing cutaneous or intestinal mucosal irritation quickly and diarrhea as a result (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.who.int/news-room/fact-sheets/detail/mycotoxins\">https://www.who.int/news-room/fact-sheets/detail/mycotoxins</ext-link><underline>)</underline> (Accessed on 14 November 2023). DON causes vomiting (hence the name “vomitoxin”), reproductive toxicity, oxidative damage, and digestive problems, but it is not carcinogenic to humans (Ji et al. ##UREF##11##2019##). DON is categorized as Group 3 by the International Agency for Research on Cancer (IARC) (non-carcinogenic substances) (Ji et al. ##UREF##11##2019##). DON has been shown to have numerous poisonous effects, such as diarrhea, reduced weight gain, immunotoxicity, teratogenicity, cardiotoxicity, and feed refusal (Chidozie and Pestka ##REF##19805407##2010##; Gray and Pestka ##REF##17636245##2007##). A recent study conducted in 2023 showed that, glycyrrhinic acid and probiotics relieved deoxynivalenol-induced cytotoxicity in intestinal tissues (Xu et al. ##REF##37249811##2023##).</p>", "<title>Fumonisins</title>", "<p id=\"Par55\">MTs called fumonisins are created by the section <italic>Liseola</italic> of the genus <italic>Fusarium</italic>. They structurally resemble sphinganine, the precursor of the sphingolipid backbone (Fig. ##FIG##2##3##c). The most prevalent fumonisins are types B1, B2, B3, and B4 (FB1, FB2, FB3, and FB4, respectively) (Marasas ##UREF##18##2000##). There are currently over 28 fumonisins that have been identified and categorized into four classes (A, B, C, and P). (Marasas ##UREF##18##2000##). Grapes with <italic>Aspergillus welwitschiae</italic> infections were found to have an uncommon class of non-aminated fumonisins in 2015, although their toxicity has not yet been fully determined (Renaud et al. ##REF##26467225##2015##)<bold>.</bold> The majority of fumonisins are found in maize, with smaller amounts in other grains. (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.who.int/news-room/fact-sheets/detail/mycotoxins)(accessed\">https://www.who.int/news-room/fact-sheets/detail/mycotoxins)(accessed</ext-link> on 14 November 2023); <ext-link ext-link-type=\"uri\" xlink:href=\"https://iris.who.int/bitstream/handle/10665/42448/WHO_TRS_906.pdf;sequence=1)(accessed\">https://iris.who.int/bitstream/handle/10665/42448/WHO_TRS_906.pdf;sequence=1)(accessed</ext-link> on 14 November 2023); <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.who.int/publications/i/item/9789240060760)(accessed\">https://www.who.int/publications/i/item/9789240060760)(accessed</ext-link> on 14 November 2023). Fumonisin has been connected to esophageal cancer in people (Shephard ##UREF##30##2012##). It also has diverse effects on animals. It has been linked to several disorders, including leukoencephalomalacia in horses and rabbits (Giannitti et al. ##UREF##9##2011##).</p>", "<title>Patulin</title>", "<p id=\"Par56\">Patulin (Fig. ##FIG##2##3##d) is released by species of <italic>Aspergillus</italic>, <italic>Penicillium</italic>, and <italic>Paecilomyces</italic>. <italic>Penicillium expansum</italic> is typically found in a wide variety of vegetables, rotting fruits, grains, including rotting maize, apple, peanuts, fig and acha (Awuchi et al. ##UREF##2##2019##; Moss ##REF##18217939##2008##). Since patulin is known to be destroyed by fermentation, it is not present in apple beverages that are fermented, such as cider. Although patulin has not been proven to cause cancer, it has been shown to impair animal immune systems (Moss ##REF##18217939##2008##). Apples and their juices from diseased fruits are the primary dietary sources of patulin in humans, however, it is also found in numerous grains, fruits, and other foods (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.who.int/news-room/fact-sheets/detail/mycotoxins\">https://www.who.int/news-room/fact-sheets/detail/mycotoxins</ext-link><underline>)</underline> (Accessed on 14 November 2023).</p>", "<title>Patulin toxicity</title>", "<p id=\"Par57\">Immunological toxicity, spleen damage and toxicity, and toxicity to the liver and kidneys are some of the acute signs of patulin. Gastrointestinal problems, nausea and vomiting are frequently documented in humans. 6-Methylsalicylic Acid is the precursor to patulin; combined, they are acetyl-CoA derivatives, making them polyketides and potential carcinogens (Ahmed Adam et al. ##REF##28184933##2017##). When administered to pregnant mice, patulin has also shown toxicity; both female and male mice died. In addition to damaging the intestine, patulin is carcinogenic, mutagenic, and teratogenic. It also damages cellular DNA in both bacteria and human, which can result in cancer and tumour development (Ahmed Adam et al. ##REF##28184933##2017##; Mahfoud et al. ##UREF##16##2002##). Even though the IARC has voiced serious concerns about the potential carcinogenicity of patulin, it has assigned the substance to Carcinogenicity Group 3 (Baert et al. ##REF##17900726##2007##). Prior to its discovery as being harmful, patulin was used as an antimicrobial against both Gram-negative and Gram-positive bacteria. As a result, its use as an Antibiotic has been discouraged due to its toxicity (Puel et al. ##REF##22069602##2010##).</p>", "<title>Citrinin</title>", "<p id=\"Par58\">A MT called citrinin (Fig. ##FIG##2##3##e) was initially discovered in the mould <italic>Penicillium citrinum.</italic> More than 12 <italic>Penicillium</italic> species and multiple <italic>Aspergillus</italic> species have documented cases of it (Bennett and Klich ##REF##12857779##2003##). Additionally, citrinin is produced by several <italic>Monascus species</italic> (Singh and Mehta ##REF##32405376##2020##). MT citrinin is a polyketide. Its natural fluorescence is caused by its conjugated, planar structure; the maximum fluorescence is produced by a nonionized citrinin molecule at pH 2.5 (Singh and Mehta ##REF##32405376##2020##). Citrinin is linked to the yellowed rice illness that has been documented in Japan, according to a study in 2003 by Bennett and Klich. Additionally, it is a nephrotoxin in all studied animal species. Citrinin has been linked to several agricultural grains, including oats, barley, maize, rye, rice, and wheat, as well as foods coloured with the Monascus pigment, although its full effects on humans are still unknown. Citrinin and OTA are said to work together to inhibit RNA synthesis in murine kidneys (Bennett and Klich ##REF##12857779##2003##). Citrinin was identified quantitatively in samples of red fermented rice using high-performance liquid chromatography with fluorescence detection (HPLC-FLD) and LC–MS/MS, and it was found that LC–MS/MS performed better than HPLC-FLD concerning quantification and limit of detection (LOD) (Ji et al. ##REF##25943499##2015##).</p>", "<title>Ergot alkaloids</title>", "<p id=\"Par59\">Ergot alkaloids are poisonous alkaloid combinations that <italic>Claviceps</italic> species, which are popular pathogenic microorganisms of many types of grasses, emit in their sclerotia. Ergotism, often named as St. Anthony’s Fire, is a human disease caused by ingesting ergot sclerotia from infected cereals, typically in the shape of baked bread from polluted flour (Bennett and Klich ##REF##12857779##2003##). Convulsive ergotism, which affects the central nervous system (CNS), and gangrenous ergotism, which is known to damage the blood supply to the extremities, are the two types of ergotism. Ergot alkaloids cause low nerve fever and ergotism and have significant impacts on human fertility (Bhat et al. ##REF##33467806##2010##). Ergotism incidence has been greatly reduced as a human disease, according to Bennett and Klich, but it is still a significant veterinary issue (Bennett and Klich ##REF##12857779##2003##). Additional file ##SUPPL##0##1##: Table S1 is a summary of the different types of MT, Predominant Food Sources, Toxicity Levels, IARC Carcinogenicity Classification, and Regulatory Limits in the US and EU. The different factors affecting MT production are summarized in Additional file ##SUPPL##0##1##: Table S2.</p>", "<title>Analysis of MTs</title>", "<p id=\"Par60\">More reliable analytical techniques for MTs determination are desperately needed, as the EU and other developed countries have reduced the restriction limits of MTs in foods and feeds (EC466 2001; EC472 2002). Currently, the most often used analytical techniques are confirmatory quantification and fast screening approaches. Trichothecenes in food and several other MTs in feed are being studied, and standardized procedures for AFs (EN12955 1999; EN14123 2001), OTA (EN14132 2003), fumonisins (EN13585 2001; EN14352 2004), and patulin (EN14177 2003) in diverse foods are available. A comprehensive set of official MTs analysis methods has been published in previous studies (Rahmani et al. ##REF##33467794##2009##). The International Official Procedures of Analysis of the AOAC 991.31(Association of Agriculture and Culture) includes approved analytical techniques for determining the presence of MTs in food and feed (Rai et al. ##REF##31446772##2020##)<bold>.</bold> MTs levels in food samples are often determined using procedures that involve the sampling, homogenization, extraction, cleanup, and ultimately detection and quantification, which are carried out using a variety of instrumental and non-instrumental approaches (Pereira et al. ##UREF##21##2014##; Shephard ##REF##27455927##2016##; Whitaker ##REF##12611270##2003##).. Biological degradation as a method of analysis proved to be more effective, specialized, and environmentally friendly (Xia et al. ##REF##35181837##2022##).</p>", "<title>Sampling</title>", "<p id=\"Par61\">Among environmental factors, humidity and temperature have the greatest effect on mycotoxigenic fungi to produce MTs. In terms of Optimal storage procedures, temperature, humidity, and moisture content in the warehouse are critical factors for mould growth and MTs production (Agriopoulou et al. ##REF##32012820##2020##). MTs are generated in isolated areas and are not uniformly distributed in commodities that are stored. Furthermore, because of its heterogeneity, it is difficult to collect representative samples. By making the sample size larger, degree of crushing, and number of aliquots quantified, the inconsistency associated with MTs analyses is reduced (Whitaker ##REF##12611270##2003##). EC has defined sample collection requirements as well as performance criteria for analytical techniques (Elkenany and Awad ##UREF##7##2020##). The method used to sample grains and grains products for lots under 50 tonnes, for instance, calls for the employment of a sampling plan and incremental samples of 10 to 100, depending on the weight, for an aggregate sample of 1 to 10 kg (<ext-link ext-link-type=\"uri\" xlink:href=\"https://food.ec.europa.eu/system/files/2016-10/cs_contaminants_sampling_guidance-sampling-final_en.pdf#:~:text=Commission%20Regulation%20%28EC%29%20No%20401%2F2006%20of%2023%20February,for%20the%20control%20of%20mycotoxins%20in%20various%20foodstuffs\">https://food.ec.europa.eu/system/files/2016-10/cs_contaminants_sampling_guidance-sampling-final_en.pdf#:~:text=Commission%20Regulation%20%28EC%29%20No%20401%2F2006%20of%2023%20February,for%20the%20control%20of%20mycotoxins%20in%20various%20foodstuffs</ext-link><underline>)</underline>. (Accessed on 25 september 2023).</p>", "<title>Sample preparation (grinding and mixing)</title>", "<p id=\"Par62\">The sample should be homogenised and milled to a final particle size of around 500 µm opening size to speed up the chemical reaction process of extraction and improve the likelihood that the MTs will be detected (Nakhjavan et al. ##REF##32707728##2020##). The sample should be blended once homogeneity has been achieved. slurry mixing yields lowest variation ratio. (Spanjer et al. ##REF##16393817##2006##).</p>", "<title>Extraction and purification (clean up)</title>", "<title>Extraction</title>", "<p id=\"Par63\">The initial step in sample preparation is MTs extraction from the sample, which is succeeded by cleanup techniques to improve the specificity and sensitivity of a particular detection method (krska ##REF##9718706##1998##). Three main considerations often determine the choice of extraction and cleanup procedures for MTs from food samples: the chemical makeup of the MTs, the makeup of the food matrix, and the intended technique of detection (Ridgway et al. ##UREF##27##2012##). The QuEChERS (Quick, Easy, Cheap, Effective, Rugged, and Safe) procedure is an extraction using acetonitrile–water, followed by the induction of liquid–liquid partitioning with adding inorganic salts followed by dispersive solid phase extraction to remove additional matrix components from the organic phase (González-Jartín et al. ##REF##30724252##2019##). Another extraction technique, called liquid–liquid extraction (LLE), depends on the differing solubilities of toxins in aqueous and immiscible organic layers (Turner et al. ##REF##19110091##2009##). The extraction of MTs from solid matrices of varied consistencies can be accomplished easily using the liquid–solid extraction (SLE) technique (Xie et al. ##REF##25840003##2016##). Pressurised liquid extraction (PLE), commonly referred to as accelerated solvent extraction (ASE), is the similar process to solvent-free extraction (SLE), but it is carried out at higher temperature and pressure in a pressure-resistant vessel (Rico-Yuste et al. ##UREF##26##2018##). These techniques use ordinary solvents at high pressures (1500–2000 psi) and temperatures (100–180 °C) to enhance the extraction of analytes from the matrix <bold>(</bold>Razzazi-Fazeli and Reiter ##UREF##25##2011##). Supercritical Fluid Extraction (SFE) is another technique. By using supercritical CO2, SFE can reduce or eliminate the need of organic solvents. The SFE process is primarily used to extract non-polar chemical compounds (Xie et al. ##REF##25840003##2016##).</p>", "<title>Clean-up</title>", "<p id=\"Par64\">After extraction, it's critical to further clean up the extract to lessen matrix impacts and get rid of everything that might get in the way of the next MT detection. The extract's purification improves the extract's specificity and sensitivity, which raises the accuracy and precision of measurement. Immunoaffinity columns (IAC) and solid phase extraction (SPE), which are quick, effective, repeatable, and have a broad spectrum of selectivity, are the two techniques most frequently employed for MTs cleanup (Alshannaq &amp; Yu ##REF##28608841##2017##; Razzazi-Fazeli &amp; Reiter ##UREF##25##2011##)<bold>.</bold> The SPE method involves the solid absorbents and capture the MTs (Huertas-Pérez et al. ##REF##26744990##2017##). SPE is a quick, effective, and repeatable technology, but it has significant drawbacks, such as the difficulty to identify all mycotoxins with a single cartridge. Additionally, several factors, including the solvent type used or the ionic strength and pH of the sample, might have an impact on efficiency (Pereira et al. ##UREF##21##2014##).</p>", "<p id=\"Par65\">Monoclonal antibodies are employed in the case of IAC to identify specific MTs. Particular antibodies on the column bind the target MT in the extract as the sample flows through the column. Pure methanol or acetonitrile is used to elute the MTs from the IAC for further detection while water-soluble contaminants are also eliminated during column washing. IACs are a highly sensitive and selective purification method that can be used to identify MTs. Because of the specificity of the antibodies, it is also a solvent-saving and easy-to-use technique (Liu et al. ##REF##30413078##2018##). However, this strategy has significant drawbacks. MTs can only be absorbed by columns to a certain extent; if the sample's MTs content exceeds this limit, the MTs cannot be efficiently captured and bound, leading to incorrect results. Furthermore, the matrix's many components may conflict with the antibodies (Castegnaro et al. ##REF##16671060##2006##). Moreover, the organic solvents have another disadvantage as they might denature the antibodies, and has very high operational costs (Liu et al. ##REF##30413078##2018##).</p>", "<title>Conventional techniques used in detection and analysis of MTs</title>", "<p id=\"Par66\">Numerous techniques have been tried and tested to determine the presence of MTs in food and feed since the first MTs were discovered (Le et al. ##REF##33340616##2021##). The employment of several distinct chromatography types, including High-performance liquid chromatography (HPLC) and thin-layer chromatography (TLC) in combination with diverse detectors including UV, fluorescence, and diode array, is what primarily accounts for the supremacy of chromatographic techniques. MTs detection has also made extensive use of Liquid chromatography-tandem mass spectrometry (LC–MS/MS) and gas chromatography-tandem mass spectrometry (GC–MS/MS) (Turner et al. ##REF##26614054##2015##). Immunoassay techniques, such as (ELISA) enzyme-linked immunosorbent assay, (Hendrickson et al. ##UREF##10##2018##) and (LFIA) lateral flow immunoassay also (Lattanzio et al. ##REF##30791649##2019##) are used when a quick mycotoxin detection is necessary. A recent study conducted by Boshra et al. (##REF##37922052##2023##) revealed no significant differences were determined between ELISA and immunoaffinity fluorometric analysis. They can substitute for each other whenever necessary. However, significant differences were detected upon analyzing different food categories, highlighting the urgent need for more specific, rapid and accurate detection methods that can cover all food categories whenever possible (Boshra et al. ##REF##37922052##2023##).</p>", "<title>Chromatography techniques</title>", "<title>Thin layer chromotography (TLC)</title>", "<p id=\"Par67\">TLC is a well-known method of MT detection that allows for the cost-effective screening of several samples (Yang et al. ##REF##24188233##2014##). TLC consists of a stationary phase consisting of cellulose, silica, or immobilized alumina on an inert matrix made of glass or plastic. Methanol, acetonitrile, and water mixes make up the mobile phase, which transports the sample in the solid stationary phase (Wacoo et al. ##UREF##33##2014##). It is crucial in the investigation of several MTs due to its simplicity, low costs and luminous spots under UV light. This method was created for MTs qualitative (Abrunhosa et al. ##REF##11298933##2001##) and quantitative analysis (Andrade et al. ##REF##23871563##2013##)<bold>.</bold> However, due to TL’s weak accuracy and sensitivity, quantification is quite difficult (Singh &amp; Mehta ##REF##32405376##2020##). Additionally, one of the primary criteria is sample preparation and the kind of cleanup method, that heavily relies on the characteristics and MT type (Yang et al. ##REF##24188233##2014##).</p>", "<title>Liquid chromatography (LC)</title>", "<p id=\"Par68\">The LC methods have been created to get over some of the TLC technique's drawbacks, such as the limited plate height or effects of temperature and humidity (Singh and Mehta ##REF##32405376##2020##). A mobile phase and an analytical column are utilized to separate the analytes from the matrix components, and for high polarity, non-volatile, and thermally labile MTs, LC is also utilized as a separation and determination method. This is true regardless of their biological activity and chemistry (Yang et al. ##UREF##35##2020##). According to the physical and chemical makeup of the MTs, the analysis of MTs mainly depends on HPLC with various adsorbents. Most of the detection procedures for MTs are relatively similar. The most popular HPLC detectors are fluorescent (FLD) or UV–visible (UV) ones, which depend on the molecules having a chromophore but also on MS (single mass spectrometry, and tandem MS (MS/MS) (Turner et al. ##REF##19110091##2009##). Some MTs such AFs and OTA already have a natural fluorescence and can be found in HPLC-FLD without further testing. For the detection of OTA in diverse matrices, like rice, HPLC-FLD is most frequently utilized (Zinedine et al. ##REF##17364931##2007##). Derivatization is required for other varieties of MTs, like fumonisin B1 (FB1), which have no chromophores in their composition (Zhang et al. ##REF##29393905##2018a##, ##UREF##37##b##). The portability, practical concerns depending on the matrix impact, sample preparation and type, as well as the calibration, are the primary drawbacks of the HPLC technique (Singh &amp; Mehta ##REF##32405376##2020##). Over the past two decades, there has been a substantial growth in the usage of LC–MS/MS for the detection of low molecular weight pollutants and residues. Better reliability and sensitivity are offered by MS/MS when combined with LC. Because of this, LC–MS/MS is an excellent standard instrument for addressing the analytical issues in food and feed safety chemical analysis, both in research and in a commercial study (Malachová et al. ##REF##29273904##2018##). Compared to conventional procedures employing conventional detectors, LC–MS/MS offers excellent selectivity and sensitivity, greater assurance of analyte identification, and a larger choice of matrices (Pascale et al. ##REF##31113530##2019##).</p>", "<title>Gas chromatography (GC)</title>", "<p id=\"Par69\">The differential analytes partitioning between the two GC column phases is essential for GC. Between the stationary and mobile phases, the sample's numerous chemical components are distributed. Utilizing a flame ionization detector (FID), a mass spectrometer, or an electron capture detector (ECD), volatile compounds are found following the separation procedure (Singh and Mehta ##REF##32405376##2020##). Due to the minimal volatility and strong polarity of the analytes, GC is not frequently utilized in the analysis of MTs. Additionally, the derivatization process is necessary for their transformation into volatile derivatives (Alshannaq and Yu ##REF##28608841##2017##). However, volatile MTs like trichothecenes (TCTC) and patulin have been identified and quantified using gas chromatography (GC) in conjunction with flame ionization (FID), electron capture (ECD), or MS detectors (Pereira et al. ##UREF##21##2014##). The method can be derivatized to a chemical that is volatile enough to be applied to gas chromatography and is very sensitive and specific to MTs. Column obstruction, swaying consequences, cross-contamination from previous samples, and nonlinearity of calibration curves in specific detector types are the main issues in MTs GC analysis (Singh &amp; Mehta ##REF##32405376##2020##).</p>", "<title>Enzyme-linked immunosorbent assay (ELISA)</title>", "<p id=\"Par70\">Immunochemical approaches, like ELISA, are quick and easy screening procedures for the on-site MTs analysis together with the sensitive but difficult and expensive techniques of chromatography (Al-Jaal et al. ##REF##31586556##2019##). ELISA is easy to use, allows for simultaneous examination of numerous samples, and has accurate detection (Urusov et al. ##UREF##31##2010##). In comparison to chromatographic techniques like HPLC or TLC, it requires less sample volume, fewer clean-up steps and is a high-throughput test (Singh &amp; Mehta ##REF##32405376##2020##). The antigen–antibody complex's interaction with chromogenic substrates serves as the basis for the test. By using spectrophotometric analysis, the quantitative outcome is obtained (Li et al. ##UREF##14##2009##). This method does, however, have evident disadvantages. The antibodies can react with elements that share similar chemical moieties (Thway &amp; Salimi-Moosavi ##REF##24830892##2014##). Furthermore, inadequate ELISA validation limits the method to the media for which they have accepted validation (Omar et al. ##REF##32443841##2020##).</p>", "<title>Lateral flow immunoassay (LFIA)</title>", "<p id=\"Par71\">As a signal reagent, a labeled antibody is utilized in the membrane-based immunoassay known as LFIA, also known as the immunochromatographic strip test (Song et al. ##REF##24745689##2014##). Capillary beds, which resemble porous pieces of paper, drive the analyte during the test, and particular elements of recognition bind moieties adsorbed on the surface of the membrane (Anfossi et al. ##REF##22543716##2013##). Signal labels have a major impact on LFIA accuracy. Gold nanoparticles (GNPs) have historically been the most popular label for producing visual signals (Li et al. ##UREF##15##2019##). Commercially available LFDs are accessible for the identification of OTA, ZEN, DON, T-2 toxin, and AFs (Krska &amp; Molinelli ##REF##18936919##2009##). However, because of several issues with the sensitivity and dependability of various matrices, their use in the field is limited (Goryacheva et al. ##REF##17886190##2007##).</p>", "<title>Limitations and current challenges of the conventional detection methods</title>", "<p id=\"Par72\">Although numerous conventional techniques including different chromatographic methods, ELISA, and immunoaffinity methods, have been extensively employed for the detection of various MTs in food. However, they still have many drawbacks and limitations such as the need for accurate and very long procedures for sample preparation (including, grinding, mixing, and ensuring homogenization), extraction, and clean up which are considered very tedious processes in addition to the extensive use of solvents, need of well-trained personnel as well as high cost of analysis. Because of heterogeneity of the tested samples, it is difficult to collect representative samples. Therefore, by making the sample size larger, degree of crushing, and number of aliquots quantified, the inconsistency associated with MTs analyses in food is reduced (Whitaker ##REF##12611270##2003##). Moreover, organic solvents have another disadvantage as they might denature the antibodies in the case of ELISA and Immunoaffinity analysis, and besides the very high operational costs (Liu et al. ##REF##30413078##2018##). All such factors encourage researchers worldwide to find and examine novel approaches to circumvent the respective drawbacks of the conventional methods of analysis.</p>", "<title>Novel technologies of mycotoxins analysis and detection</title>", "<title>Biosensors</title>", "<p id=\"Par73\">Typically, biosensors include a transducer that transforms biological signals into electrical signals, along with a biological or sensory element with a biological basis to identify bio-analytes (Perumal and Hashim ##UREF##22##2014##). MTs detection can be carried out using a variety of transducers, including optical (fluorescence and surface plasmon resonance-SPR), electrochemical (potentiometric, amperometric, and impedimetric), and piezoelectric (quartz crystal microbalance-QCM) ones (Santana et al. ##UREF##28##2019##). Cells, peptides, enzymes, antibodies, and nucleic acids are well-known materials, but other bioinspired components can also be used, such as molecules imprinted polymers (MIPs), aptamers, and recombinant antibodies (Malekzad et al. ##REF##29335674##2017##). Additionally, a wide range of QDs, metal nanoparticles, nanofibers, and carbon nanotubes (CNTs) are used in the biosensors to increase their sensitivity because of their physicochemical properties, biocompatibility, and a high surface volume ratio (Doria et al. ##REF##22438731##2012##). One significant privilege of biosensors over other rapid screening strip tests is their possibility for recycling use. Surface plasmon biosensor chips with DON immobilized can be reused more than 500 folds without experiencing significant activity reduction (Tüdös et al. ##REF##13129282##2003##). Most biosensor processes still require sample cleanup, even though several formats for biosensors could be helpful in MTs analysis. Additionally, the equipment is unable to do numerous analyte studies simultaneously (Logrieco et al. ##REF##16019803##2005##).</p>", "<title>Electronic nose</title>", "<p id=\"Par74\">An electronic nose, often known as a “e-nose,” is made up of a variety of general-purpose chemical detectors that can pick up a variety of volatile organic compounds (VOCs) and identify the toxic fungi’s qualitative volatile fingerprints. Finding a fingerprint comes after odor identification provides a pattern recognition system’s early classification of the generated metabolites (Camardo et al. ##UREF##6##2021##). E-nose technology depends on recognizing particular VOCs connected to the fungi growth on grains to detect fungal infections. A relationship between VOCs and the amount of MTs in food can be seen, and this relationship is influenced by the proliferation and metabolic pattern of mycotoxigenic fungal species (Ottoboni et al. ##REF##30332757##2018##). The e-nose has been utilised well to find OTA in the dry-cured pork (Lippolis et al. ##REF##26619315##2016##), AFs and fumonisins in maize (Ottoboni et al. ##REF##30332757##2018##), and DON in wheat bran (Lippolis et al. ##REF##29577312##2018##). The measurement of low quantities of MTs in food samples must be optimized to accomplish widespread use of e-nose for the identification of MTs. A further issue with e-nose detection is that the bulk of MTs are non-volatile chemical substances (Alshannaq &amp; Yu ##REF##28608841##2017##).</p>", "<title>Fluorescent polarization</title>", "<p id=\"Par75\">The principle behind fluorescent polarization (FP) immunoassay is that the tracer and the analyte (fluorophore-labeled analyte) compete for antibody-binding sites. The fluorescence polarization value is raised by the tracer's rotation due to the tracer's binding to the antibody. The value of polarization has an inverse relationship to the analyte concentration because the amount of bound tracer has an inverse relationship to the concentration of free analyte in the sample (Valenzano et al. ##UREF##32##2014##). Some immunoassay procedures, such as ELISA, demand that the analyte be separated from antibody-bound analyte or washed several times. The pre-analytical processes that consume time are not required with the FP approach (Huang et al. ##REF##33138019##2020##). FP immunoassay has been used to identify a variety of MTs in food products, including ZEN in corn (Zhang et al. ##REF##28231710##2017##), DON in wheat-based products (Lippolis et al. ##REF##17133816##2006##), AFB1 in maize (Zhang et al. ##REF##29393905##2018a##, ##UREF##37##b##), and OTA in rice (Huang et al. ##REF##33138019##2020##). Compared to HPLC, the FP method has lower accuracy and sensitivity. This is most likely caused by antibodies' cross-reactivity with food matrix components and other fungal metabolites (Alshannaq and Yu ##REF##28608841##2017##).</p>", "<title>Capillary electrophoresis</title>", "<p id=\"Par76\">Using fluorescence or UV absorbance, capillary electrophoresis (CE) separates various components according to electrochemical potential. Small volumes of solvents and buffers are needed for this approach, which has the particular advantage of producing only small amounts of waste (Shephard ##REF##18949120##2008##). Numerous MTs have been distinguished by CE, including AFs, DON, fumonisins, OTA, and ZEN (Maragos &amp;Appell 2007). However, as only small sample quantities can be evaluated, this approach lacks sensitivity (Maragos ##UREF##17##1998##). ZEN in maize has recently been analyzed using CE combined with cyclodextrin-enhanced fluorescence, which has a 5 ng/g detection limit (Maragos &amp;Appell 2007).</p>", "<title>Infrared spectroscopy</title>", "<p id=\"Par77\">Optical non-destructive and Fast methods for MTs detection in grains include principal component analysis (PCA) and infrared (IR) analyzers for identification and quantitative determination of MTs without preparation of sample<bold>.</bold> These procedures have the advantages of being simple to use, not needing the use of chemicals, extraction or sample preparation and having quick results (Pettersson and Aberg ##UREF##23##2003##). Although the two methods face difficulties, including the non-homogeneous distribution of MTs within the food matrix, the particle size distribution of ground grains, and the detection limits of the method, more research is required to fully realize IR spectroscopy's potential for detecting various MTs (Shepherd, 2008).</p>", "<title>The aggregation-induced emission</title>", "<p id=\"Par78\">A collection of fluorescent dyes shines dimly in the condition of diluted solution, but their fluorescence is noticeably amplified in the state of aggregation due to a photophysical phenomenon known as aggregation-induced emission (AIE) (Zhu et al. ##UREF##38##2019##). One possible explanation for the high fluorescence of dyes in the aggregate state could be limited intramolecular rotations (Li et al. ##REF##29155547##2018##). AIE dyes such as 9,10-distyryllanthracene (DSA), silacyclopentadiene (silole), tetraphenylethene (TPE), and its derivatives exhibit high emission of fluorescence in the aggregate states (Wang and Liu ##REF##32255148##2018##). Aptasensor (biosensor) based on AIE dye, has been created effectively for OTA detection in wine and coffee (Zhu et al. ##UREF##38##2019##). Table ##TAB##0##1## summarizes different types of technologies and which technologies can be applied best in different circumstances in terms of sample material, sample condition cost-effectiveness and comparison of sensitivity for these methods.</p>", "<title>Current challengs and future directions</title>", "<p id=\"Par79\">Several novel techniques that have been created and may be helpful in MTs detection have been developed in addition to the traditional techniques mentioned above. However, outside of the study fields, these techniques have not been extensively used and have limited utility. Additionally, they need additional validation and verification from reputable organizations like the European Standardization Committee (EN), International Organization for Standardization (ISO), or Association of Official Analytical Chemists (AOAC) (Alshannaq &amp; Yu ##REF##28608841##2017##).</p>", "<p id=\"Par80\">In conclusion, in food and feed all over the world, MTs are unpredictable pollutants. These low molecular weight substances constitute a significant risk to human and animal health, raise questions about food safety, and cause the agriculture sector to suffer enormous financial losses. Although Numerous conventional techniques including different chromatographic methods, ELISA and immunoaffinity methods, have been extensively employed for the detection of various MTs in food. However, they still have many drawbacks and some limitations such as tedious sampling, extensive use of solvents, need of well-trained personnel as well as high cost of analysis. Various innovative approaches have been recently studied to bypass the disadvantages of conventional methods; however, they are still not widely used and have limited utility. Additionally, they need additional validation and verification from reputable and standard organizations and committees.</p>" ]
[ "<title>Limitations and current challenges of the conventional detection methods</title>", "<p id=\"Par72\">Although numerous conventional techniques including different chromatographic methods, ELISA, and immunoaffinity methods, have been extensively employed for the detection of various MTs in food. However, they still have many drawbacks and limitations such as the need for accurate and very long procedures for sample preparation (including, grinding, mixing, and ensuring homogenization), extraction, and clean up which are considered very tedious processes in addition to the extensive use of solvents, need of well-trained personnel as well as high cost of analysis. Because of heterogeneity of the tested samples, it is difficult to collect representative samples. Therefore, by making the sample size larger, degree of crushing, and number of aliquots quantified, the inconsistency associated with MTs analyses in food is reduced (Whitaker ##REF##12611270##2003##). Moreover, organic solvents have another disadvantage as they might denature the antibodies in the case of ELISA and Immunoaffinity analysis, and besides the very high operational costs (Liu et al. ##REF##30413078##2018##). All such factors encourage researchers worldwide to find and examine novel approaches to circumvent the respective drawbacks of the conventional methods of analysis.</p>" ]
[]
[]
[]
[ "<p id=\"Par1\">Mycotoxins (MTs), produced by filamentous fungi, represent a severe hazard to the health of humans and food safety, affecting the quality of various agricultural products. They can contaminate a wide range of foods, during any processing phase before or after harvest. Animals and humans who consume MTs-contaminated food or feed may experience acute or chronic poisoning, which may result in serious pathological consequences. Accordingly, developing rapid, easy, and accurate methods of MTs detection in food becomes highly urgent and critical as a quality control and to guarantee food safety and lower health hazards. In this review, we highlighted and discussed innovative approaches like biosensors, fluorescent polarization, capillary electrophoresis, infrared spectroscopy, and electronic noses for MT identification pointing out current challenges and future directions. The limitations<bold>,</bold> current challenges, and future directions of conventional detection methods versus innovative methods have also been highlighted and discussed.</p>", "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1186/s13568-024-01662-y.</p>", "<title>Keywords</title>", "<p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Acknowledgements</title>", "<p>The authors extend their gratefulness to the Department of MTs, Central Public Health Laboratories (CPHL), Ministry of Health, Cairo, Egypt for providing the required information as well as the facilities needed for the analysis. The author also acknowledges the Microbiology and Immunology Department, Faculty of Pharmacy, Ain Shams University, for the great help, and support in the current study.</p>", "<title>Author contributions</title>", "<p>Conceptualization, MHB, GSE, MMSF, and KMA; methodology, MHB, GSE, MMSF, and KMA; validation, GSE, MMSF, and KMA; formal analysis, MHB, GSE; investigation, GSE, MMSF, and KMA; resources, MHB, and KMA; data curation, MHB, GSE, and KMA; writing—original draft preparation, MHB; writing—review and editing, GSE, MMSF, and KMA; supervision, GSE, MMSF, and KMA. All authors have read and agreed to the published version of the manuscript.”</p>", "<title>Funding</title>", "<p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p>", "<title>Availability of data and materials</title>", "<p>All data generated or analyzed during this study are included in this published article and supplementary file.</p>", "<title>Declarations</title>", "<title>Ethics approval and consent to participate</title>", "<p id=\"Par81\">Not applicable.</p>", "<title>Consent for publication</title>", "<p id=\"Par82\">Not applicable.</p>", "<title>Competing interests</title>", "<p id=\"Par83\">The authors declare that there is no conflict of interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>Chemical Structures of Various AFs Forms (structure were created using the ChemSpider|Search and share chemistry)( <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.chemspider.com/FullSearch.aspx\">https://www.chemspider.com/FullSearch.aspx</ext-link> (Accesed on 21 November 2023)</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>Chemical Structures of Various ochratoxins Forms (structure obtained from ChemSpider|Search and share chemistry) (Accesed on 21 November 2023)</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p>Structural Representation of <bold>a</bold> ZEN <bold>b</bold> DON <bold>c</bold> Fumonisin <bold>d</bold> patulin <bold>e</bold> citrinin (structure obtained from ChemSpider|Search and share chemistry(Accesed on 21 November 2023)</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Comparative analysis of mycotoxin detection technologies: Suitability across aample materials, conditions, cost considerations and sensitivity of each method</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Technology type</th><th align=\"left\">Suitability across sample materials, conditions, and cost considerations</th><th align=\"left\">Sensitivity of each method</th><th align=\"left\">References</th></tr></thead><tbody><tr><td align=\"left\">TLC</td><td align=\"left\">Cost-effective and can be used for the screening of several samples. needs sample preparation</td><td align=\"left\">Low sensitivity and poor accuracy</td><td align=\"left\">(Yang et al. ##REF##24188233##2014##; Singh and Mehta ##REF##32405376##2020##)</td></tr><tr><td align=\"left\">LC</td><td align=\"left\">For high polarity, non-volatile, and thermally labile MTs</td><td align=\"left\">LC–MS/MS offers excellent selectivity and sensitivity, greater assurance of analyte identification, and can be used for the detection of multi-mycotoxins</td><td align=\"left\">(Yang et al. ##UREF##35##2020##; Pascale et al. ##REF##31113530##2019##)</td></tr><tr><td align=\"left\">GC</td><td align=\"left\">Due to the minimal volatility and strong polarity of the analytes, GC is not frequently utilized in the analysis of MTs. Additionally, the derivatization Process is necessary for their transformation into volatile derivatives. volatile MTs like TCTC and patulin have been identified and quantified using gas chromatography (GC) in conjunction with flame ionization (FID), electron capture (ECD), or MS detector</td><td align=\"left\">The method can be derivatized to a chemical that is volatile enough to be applied to gas chromatography and is very Sensitive and specific to MTs</td><td align=\"left\">(Alshannaq and Yu ##REF##28608841##2017##; Pereira et al. ##UREF##21##2014##; Singh and Mehta ##REF##32405376##2020##)</td></tr><tr><td align=\"left\">ELISA</td><td align=\"left\">Quick and easy screening procedures for the on-site MTs analysis, accurate detection, Effective for routine monitoring, especially in resource-limited settings. In comparison to chromatographic techniques like HPLC or TLC, it requires less sample volume, fewer clean-up steps and is a high-throughput test</td><td align=\"left\">Cross reactivity (less specificity and sensitivity)</td><td align=\"left\">(Al-Jaal et al. ##REF##31586556##2019##; Urusov et al. ##UREF##31##2010##; Singh and Mehta ##REF##32405376##2020##; Thway a Salimi-Moosavi ##REF##24830892##2014##)</td></tr><tr><td align=\"left\">LFIA</td><td align=\"left\">Quick results, economic and is suitable for large-scale on-site screening. sample clean-up can be neglected. It is used for the identification of OTA, ZEN, DON, T-2 toxin, and AFs</td><td align=\"left\">Less sensitive</td><td align=\"left\">(Krska and Molinelli ##REF##18936919##2009##; Goryacheva et al. ##REF##17886190##2007##; Liu et al. ##REF##32275211##2020##)</td></tr><tr><td align=\"left\">Biosensors</td><td align=\"left\">Rapid screening strip tests, easy and inexpensive sample analysis, reproducibility, stability, and on-site testing of samples, possible for recycling use. Require sample clean up</td><td align=\"left\">High sensitivity and real-time analysis are the main advantages of optical biosensors</td><td align=\"left\">(Tüdös et al. ##REF##13129282##2003##; Pirinçci et al. ##REF##29641432##2018##; Logrieco et al. ##REF##16019803##2005##; Chen and Wang ##REF##31970360##2020##)</td></tr><tr><td align=\"left\">Electronic nose</td><td align=\"left\"><p>It can pick up a variety of volatile organic compounds (VOCs). It can be used to detect OTA in dry-cured pork, AFs, and fumonisins in maize, and DON in wheat bran</p><p>Apples, oranges, strawberries, and peaches are some fruits in which the application of this technique has been successfully implemented for the detection of fungi that produce mycotoxins</p></td><td align=\"left\">Unique fingerprint for each food, characteristic of its taste and aroma. Less sensitive to low quantities of MTs</td><td align=\"left\">(Camardo et al. ##UREF##6##2021##; Lippolis et al. ##REF##26619315##2016##, ##REF##29577312##2018##; Ottoboni et al. ##REF##30332757##2018##; Jia et al. ##REF##30934812##2019##)</td></tr><tr><td align=\"left\">Infrared spectroscopy</td><td align=\"left\">No need for preparation of samples</td><td align=\"left\">Less sensitive compared to other techniques</td><td align=\"left\">(Pettersson and Aberg ##UREF##23##2003##)</td></tr><tr><td align=\"left\">Fluorescent polarization</td><td align=\"left\"><p>Used to identify ZEN in corn, DON in wheat-based products, AFB1 in maize), and OTA in rice</p><p>Does not require preanalytical steps like washing many times as done in ELISA</p></td><td align=\"left\">Comparatively to HPLC, the FP method has lower accuracy and sensitivity (antibodies' cross-reactivity with food matrix components)</td><td align=\"left\">(Zhang et al. ##REF##28231710##2017##; Lippolis et al. ##REF##17133816##2006##; Zhang et al. ##REF##29393905##2018a##, ##UREF##37##b##; Huang et al. ##REF##33138019##2020##; Alshannaq and Yu ##REF##28608841##2017##)</td></tr><tr><td align=\"left\">Capillary electrophoresis</td><td align=\"left\">Only small sample quantities can be evaluated</td><td align=\"left\">Lacks sensitivity</td><td align=\"left\">(Maragos ##UREF##17##1998##)</td></tr><tr><td align=\"left\">Aggregation induced emission</td><td align=\"left\">The on-site detection of food contaminations and the simple operation make the application of AIE dyes very effective</td><td align=\"left\">Highly sensitive AIE dyes showed high affinity to aptamers and fluoresce through the process of dye aggregation</td><td align=\"left\">(Zhu et al. ##UREF##38##2019##)</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"13568_2024_1662_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"13568_2024_1662_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"13568_2024_1662_Fig3_HTML\" id=\"MO3\"/>" ]
[ "<media xlink:href=\"13568_2024_1662_MOESM1_ESM.docx\"><caption><p><bold>Additional file 1:</bold>\n<bold>Table S1</bold>. Comprehensive Overview of Mycotoxins: Their Varied types and forms Predominant Food Sources, Toxicity Levels, IARC Carcinogenicity Classification, and Regulatory Limits in the US and EU. <bold>Table S2</bold>. Contributing Factors to MTs Production: Effects and Required Conditions.</p></caption></media>" ]
[{"surname": ["Abia", "Warth", "Sulyok", "Krska", "Tchana", "Njobeh", "Dutton", "Moundipa"], "given-names": ["WA", "B", "M", "R", "AN", "PB", "MF", "PF"], "article-title": ["Determination of multi-mycotoxin occurrence in cereals, nuts and their products in Cameroon by liquid chromatography tandem mass spectrometry (LC-MS/MS)"], "source": ["Food Control"], "year": ["2013"], "volume": ["31"], "issue": ["2"], "fpage": ["438"], "lpage": ["453"], "pub-id": ["10.1016/j.foodcont.2012.10.006"]}, {"surname": ["Anfossi", "Giovannoli", "Baggiani"], "given-names": ["L", "C", "C"], "article-title": ["Mycotoxin detection"], "source": ["Curr Opin Biotechno"], "year": ["2016"], "volume": ["37"], "fpage": ["120"], "lpage": ["126"], "pub-id": ["10.1016/j.copbio.2015.11.005"]}, {"surname": ["Awuchi", "Clifford", "Chika", "Victory"], "given-names": ["CG", "OI", "OC", "Igwe S"], "article-title": ["Evaluation of patulin levels and impacts on the physical characteristics of grains"], "source": ["Int J Adv Acad Res Sci Eng Technol"], "year": ["2019"], "volume": ["5"], "issue": ["4"], "fpage": ["2488"]}, {"surname": ["Awuchi", "Owuamanam", "Ogueke", "Hannington"], "given-names": ["CG", "IC", "CC", "T"], "article-title": ["The impacts of mycotoxins on the proximate composition and functional properties of grains"], "source": ["Eur Acad Res"], "year": ["2020"], "volume": ["8"], "fpage": ["1024"], "lpage": ["1071"]}, {"surname": ["Battilani", "Stroka", "Magan"], "given-names": ["P", "J", "N"], "article-title": ["Foreword: mycotoxins in a changing world"], "source": ["World Mycotoxin J"], "year": ["2016"], "volume": ["9"], "issue": ["5"], "fpage": ["647"], "lpage": ["651"], "pub-id": ["10.3920/WMJ2016.x004"]}, {"surname": ["Bessaire", "Perrin", "Tarres", "Bebius", "Reding", "Theurillat"], "given-names": ["T", "I", "A", "A", "F", "V"], "article-title": ["Mycotoxins in green coffee: occurrence and risk assessment"], "source": ["Food Control"], "year": ["2019"], "volume": ["96"], "fpage": ["59"], "lpage": ["67"], "pub-id": ["10.1016/j.foodcont.2018.08.033"]}, {"surname": ["Camardo Leggieri", "Mazzoni", "Fodil", "Moschini", "Bertuzzi", "Prandini", "Battilani"], "given-names": ["M", "M", "S", "M", "T", "A", "P"], "article-title": ["An electronic nose supported by an artificial neural network for the rapid detection of aflatoxin B1 and fumonisins in maize"], "source": ["Food Control"], "year": ["2021"], "volume": ["123"], "fpage": ["107722"], "pub-id": ["10.1016/j.foodcont.2020.107722"]}, {"surname": ["Elkenany", "Awad"], "given-names": ["RM", "A"], "article-title": ["Types of Mycotoxins and different approaches used for their detection in foodstuffs"], "source": ["Mansoura Vet Med J"], "year": ["2020"], "volume": ["21"], "issue": ["4"], "fpage": ["25"], "lpage": ["32"], "pub-id": ["10.35943/mvmj.2021.161191"]}, {"surname": ["El-Sayed", "Jebur", "Kang", "El-Demerdash"], "given-names": ["RA", "AB", "W", "FM"], "article-title": ["An overview of the major mycotoxins in food products: characteristics, toxicity, and analysis"], "source": ["J Futur Foods"], "year": ["2022"], "volume": ["2"], "issue": ["2"], "fpage": ["91"], "lpage": ["102"], "pub-id": ["10.1016/j.jfutfo.2022.03.002"]}, {"surname": ["Giannitti", "Diab", "Pacin", "Barrandeguy", "Larrere", "Ortega", "Uzal"], "given-names": ["F", "SS", "AM", "M", "C", "J", "FA"], "article-title": ["Equine leukoencephalomalacia (ELEM) due to fumonisins B1 and B2 in Argentina"], "source": ["Pesqui Vet Bras"], "year": ["2011"], "volume": ["31"], "issue": ["5"], "fpage": ["407"], "lpage": ["412"], "pub-id": ["10.1590/S0100-736X2011000500007"]}, {"surname": ["Hendrickson", "Chertovich", "Zherdev", "Sveshnikov", "Dzantiev"], "given-names": ["OD", "JO", "AV", "PG", "BB"], "article-title": ["Ultrasensitive magnetic ELISA of zearalenone with pre-concentration and chemiluminescent detection"], "source": ["Food Control"], "year": ["2018"], "volume": ["84"], "fpage": ["330"], "lpage": ["338"], "pub-id": ["10.1016/j.foodcont.2017.08.008"]}, {"surname": ["Ji", "He", "Olaniran", "Mokoena", "Xu", "Shi"], "given-names": ["F", "D", "AO", "MP", "J", "J"], "article-title": ["Occurrence, toxicity, production and detection of "], "italic": ["Fusarium"], "source": ["Food Prod Process and Nutr."], "year": ["2019"], "volume": ["1"], "issue": ["1"], "fpage": ["6"], "pub-id": ["10.1186/s43014-019-0007-2"]}, {"surname": ["Kluczkovski"], "given-names": ["AM"], "article-title": ["Fungal and mycotoxin problems in the nut industry"], "source": ["Curr Opin Food Sci"], "year": ["2019"], "volume": ["29"], "fpage": ["56"], "lpage": ["63"], "pub-id": ["10.1016/j.cofs.2019.07.009"]}, {"surname": ["Krska", "Schubert-Ullrich", "Molinelli", "Sulyok", "MacDonald", "Crews"], "given-names": ["R", "P", "A", "M", "S", "C"], "article-title": ["Mycotoxin analysis: an update"], "source": ["Food Addit Contam Part A"], "year": ["2008"], "volume": ["25"], "issue": ["2"], "fpage": ["152"], "lpage": ["163"], "pub-id": ["10.1080/02652030701765723"]}, {"surname": ["Li", "Zhang", "Zhang"], "given-names": ["P", "Q", "W"], "article-title": ["Immunoassays for aflatoxins"], "source": ["TrAC Trends Anal Chem"], "year": ["2009"], "volume": ["28"], "issue": ["9"], "fpage": ["1115"], "lpage": ["1126"], "pub-id": ["10.1016/j.trac.2009.07.003"]}, {"surname": ["Li", "Meng", "Wen", "Fu", "He"], "given-names": ["R", "C", "Y", "W", "P"], "article-title": ["Fluorometric lateral flow immunoassay for simultaneous determination of three mycotoxins (aflatoxin B1, zearalenone, and deoxynivalenol) using quantum dot microbeads"], "source": ["Microchim Acta"], "year": ["2019"], "volume": ["186"], "fpage": ["748"], "pub-id": ["10.1007/s00604-019-3879-6"]}, {"surname": ["Mahfoud", "Maresca", "Garmy", "Fantini"], "given-names": ["R", "M", "N", "J"], "article-title": ["The mycotoxin patulin alters the barrier function of the intestinal epithelium: mechanism of action of the toxin and protective effects of glutathione"], "source": ["Toxicol Appl Pharm"], "year": ["2002"], "volume": ["181"], "issue": ["3"], "fpage": ["209"], "lpage": ["218"], "pub-id": ["10.1006/taap.2002.9417"]}, {"surname": ["Maragos"], "given-names": ["CM"], "article-title": ["Analysis of mycotoxins with capillary electrophoresis"], "source": ["Sem Food Anal"], "year": ["1998"], "volume": ["3"], "fpage": ["353"], "lpage": ["373"]}, {"mixed-citation": ["Marasas WFO (2000) Fumonisin B"], "sub": ["1"], "ext-link": ["https://books.google.com.eg/books?hl=de&lr=&id=I-KopkvOkqoC&oi=fnd&pg=PA239&dq=Marasas+WFO+(2000)+Fumonisin+B%E2%82%81.+World+Health+Organization.&ots=eQ8yJpXBGV&sig=0Rb-utgsGrm9XhsALZuYjA7FGlU&redir_esc=y#v=onepage&q&f=false"]}, {"surname": ["McCoy", "Scholl", "Sutcliffe", "Kieszak", "Powers", "Rogers", "Gong", "Groopman", "Wild", "Schleicher"], "given-names": ["LF", "PF", "AE", "SM", "CD", "HS", "YY", "JD", "CP", "RL"], "article-title": ["Human aflatoxin albumin adducts quantitatively compared by ELISA, HPLC with fluorescence detection, and HPLC with isotope dilution mass spectrometry cancer"], "source": ["Epidemiol Biomarkers Prev"], "year": ["2008"], "volume": ["17"], "issue": ["7"], "fpage": ["1653"], "lpage": ["1657"], "pub-id": ["10.1158/1055-9965.EPI-07-2780"]}, {"mixed-citation": ["Melina R (2020) Sex-Change Chicken: Gertie d Hen Becomes Bertie d Cockerel; Live Science: New York, NY, USA. "], "ext-link": ["https://www.livescience.com/13514-sex-change-chicken-gertie-hen-bertie-cockerel.html"]}, {"surname": ["Pereira", "Fernandes", "Cunha"], "given-names": ["VL", "JO", "SC"], "article-title": ["Mycotoxins in cereals and related foodstuffs: a review on occurrence and recent methods of analysis"], "source": ["Trends Food Sci Technol"], "year": ["2014"], "volume": ["36"], "issue": ["2"], "fpage": ["96"], "lpage": ["136"], "pub-id": ["10.1016/j.tifs.2014.01.005"]}, {"surname": ["Perumal", "Hashim"], "given-names": ["V", "U"], "article-title": ["Advances in biosensors: principle, architecture and applications"], "source": ["J Appl Biomed"], "year": ["2014"], "volume": ["12"], "fpage": ["1"], "lpage": ["15"], "pub-id": ["10.1016/j.jab.2013.02.001"]}, {"surname": ["Pettersson", "Aberg"], "given-names": ["H", "L"], "article-title": ["Near infrared spectroscopy for determination of mycotoxins in cereals"], "source": ["Food Control"], "year": ["2003"], "volume": ["14"], "issue": ["4"], "fpage": ["229"], "lpage": ["232"], "pub-id": ["10.1016/S0956-7135(03)00011-2"]}, {"surname": ["Quintela", "Grumezescu"], "given-names": ["S", "AM"], "article-title": ["Mycotoxins in beverages occurrence, regulation, economic impact and cost-effectiveness of preventive and removal methods"], "source": ["Safety issues in beverage production"], "year": ["2020"], "publisher-loc": ["London"], "publisher-name": ["Academic Press"], "fpage": ["147"], "lpage": ["186"]}, {"surname": ["Razzazi-Fazeli", "Reiter"], "given-names": ["E", "E"], "article-title": ["Sample preparation and clean up in mycotoxin analysis: principles, applications and recent developments determ"], "source": ["Mycotoxins Mycotoxigenic Fungi Food Feed"], "year": ["2011"], "pub-id": ["10.1533/9780857090973.1.37"]}, {"surname": ["Rico-Yuste", "G\u00f3mez-Arribas", "P\u00e9rez-Conde", "Urraca", "Moreno-Bondi"], "given-names": ["A", "LN", "MC", "JL", "MC"], "article-title": ["Rapid determination of Alternaria mycotoxins in tomato samples by pressurised liquid extraction coupled to liquid chromatography with fluorescence detection"], "source": ["Food Addit Contam Part A"], "year": ["2018"], "volume": ["35"], "issue": ["11"], "fpage": ["2175"], "lpage": ["2182"], "pub-id": ["10.1080/19440049.2018.1512759"]}, {"surname": ["Ridgway", "Smith", "Lalljie"], "given-names": ["K", "RM", "SP"], "article-title": ["Sample preparation for food contaminant analysis"], "source": ["LC GC Eur"], "year": ["2012"], "volume": ["25"], "fpage": ["1"], "lpage": ["8"], "pub-id": ["10.1016/B978-0-12-381373-2.00115-0"]}, {"surname": ["Santana Oliveira", "da Silva Junior", "de Andrade", "Lima Oliveira"], "given-names": ["I", "AG", "CAS", "MD"], "article-title": ["Biosensors for early detection of fungi spoilage and toxigenic and mycotoxins in food"], "source": ["Curr Opin Food Sci"], "year": ["2019"], "volume": ["29"], "fpage": ["64"], "lpage": ["79"], "pub-id": ["10.1016/j.cofs.2019.08.004"]}, {"surname": ["Sanzani", "Reverberi", "Geisen"], "given-names": ["SM", "M", "R"], "article-title": ["Mycotoxins in harvested fruits and vegetables: Insights in producing fungi, biological role, conducive conditions, and tools to manage postharvest contamination"], "source": ["Postharvest Biol Technol"], "year": ["2016"], "volume": ["122"], "fpage": ["95"], "lpage": ["105"], "pub-id": ["10.1016/j.postharvbio.2016.07.003"]}, {"surname": ["Shephard"], "given-names": ["GS"], "italic": ["Fusarium"], "source": ["J Plant Breed Seed Sci"], "year": ["2012"], "volume": ["64"], "issue": ["1"], "fpage": ["113"], "lpage": ["121"], "pub-id": ["10.2478/v10129-011-0034-x"]}, {"surname": ["Urusov", "Zherdev", "Dzantiev"], "given-names": ["AE", "AV", "BB"], "article-title": ["Immunochemical methods of mycotoxin analysis (review)"], "source": ["Appl Biochem Microbiol"], "year": ["2010"], "volume": ["46"], "fpage": ["253"], "lpage": ["266"], "pub-id": ["10.1134/S0003683810030038"]}, {"surname": ["Valenzano", "Lippolis", "Pascale", "De Marco", "Maragos", "Suman", "Visconti"], "given-names": ["S", "V", "M", "A", "CM", "M", "A"], "article-title": ["Determination of deoxynivalenol in wheat bran and whole-wheat flour by fluorescence polarization immunoassay"], "source": ["Food Anal Methods"], "year": ["2014"], "volume": ["7"], "fpage": ["806"], "lpage": ["813"], "pub-id": ["10.1007/s12161-013-9684-7"]}, {"surname": ["Wacoo", "Wendiro", "Vuzi", "Hawumba"], "given-names": ["AP", "D", "PC", "JF"], "article-title": ["Methods for detection of aflatoxins in agricultural food crops"], "source": ["J Appl Chem"], "year": ["2014"], "volume": ["2014"], "fpage": ["706291"], "pub-id": ["10.1155/2014/706291"]}, {"surname": ["Wokorach", "Landschoot", "Anena", "Audenaert", "Echodu", "Haesaert"], "given-names": ["G", "S", "J", "K", "R", "G"], "article-title": ["Mycotoxin profile of staple grains in northern Uganda: understanding the level of human exposure and potential risks"], "source": ["Food Control"], "year": ["2021"], "volume": ["122"], "fpage": ["107813"], "pub-id": ["10.1016/j.foodcont.2020.107813"]}, {"surname": ["Yang", "Li", "Wu", "Liu", "Li", "Luo", "Hu", "Wang", "Wu"], "given-names": ["Y", "G", "D", "J", "X", "P", "N", "H", "Y"], "article-title": ["Recent advances on toxicity and determination methods of mycotoxins in foodstuffs Trends"], "source": ["Food Sci Technol"], "year": ["2020"], "volume": ["96"], "fpage": ["233"], "lpage": ["252"], "pub-id": ["10.1016/j.tifs.2019.12.021"]}, {"surname": ["Zain"], "given-names": ["ME"], "article-title": ["Impact of mycotoxins on humans and animals"], "source": ["J Saudi Chem Soc"], "year": ["2011"], "volume": ["15"], "issue": ["2"], "fpage": ["129"], "lpage": ["144"], "pub-id": ["10.1016/j.jscs.2010.06.006"]}, {"surname": ["Zhang", "Tang", "Mi", "Zhao", "Wen", "Guo", "Mi", "Zhang", "Shi", "Shen", "Ke", "Wang"], "given-names": ["X", "Q", "T", "S", "K", "L", "J", "S", "W", "J", "Y", "Z"], "article-title": ["Dual-wavelength fluorescence polarization immunoassay to increase information content per screen: applications for simultaneous detection of total aflatoxins and family zearalenones in maize"], "source": ["Food Control"], "year": ["2018"], "volume": ["87"], "fpage": ["100"], "lpage": ["108"], "pub-id": ["10.1016/j.foodcont.2017.12.002"]}, {"surname": ["Zhu", "Xia", "Deng", "Yan", "Dong", "Zhang", "Deng", "He"], "given-names": ["Y", "X", "S", "B", "Y", "K", "R", "Q"], "article-title": ["Label-free fluorescent aptasensing of mycotoxins via aggregation-induced emission dye"], "source": ["Dyes Pigm"], "year": ["2019"], "volume": ["170"], "fpage": ["107572"], "pub-id": ["10.1016/j.dyepig.2019.107572"]}]
{ "acronym": [ "ASE", "Afs", "ATs", "AOAC", "CNTs", "CNS", "DON", "ECD", "Ens", "ELISA", "Eas", "EC", "FID", "FAO", "FBs", "GC", "GC–MS/MS", "HCC", "HPLC", "IAC", "IARC", "ISO", "LFIA", "LOD", "SLE", "LC–MS/MS", "MIPs", "MTs", "OTA", "PAT", "PLE", "TLC", "TCTC", "VOCs", "WHO", "ZEN" ], "definition": [ "Accelerated solvent extraction", "Aflatoxins", "Alternaria toxins", "Association of Official Analytical Chemists", "Carbon nanotubes", "Central nervous system", "Deoxynivalenol", "Electron capture detector", "Enniatins", "Enzyme-linked immunosorbent assay", "Ergot alkaloids", "European Commission", "Flame ionization detector", "Food and Agriculture Organisation of the United Nations", "Fumonisins", "Gas Chromatography", "Gas chromatography-tandem mass spectrometry", "Hepatocellular carcinoma", "High-performance liquid chromatography", "Immunoaffinity column", "International Agency for Research on Cancer", "International Organization for Standardization", "Lateral flow immunoassay", "Limit of detection", "Solvent-free extraction", "Liquid chromatography-tandem mass spectrometry", "Molecules imprinted polymers", "Mycotoxins", "Ochratoxin A", "Patulin", "Pressurised liquid extraction", "Thin-layer chromatography", "Trichothecenes", "Volatile organic compounds", "World Health Organisation", "Zearalenone" ] }
140
CC BY
no
2024-01-14 23:40:15
AMB Express. 2024 Jan 12; 14:7
oa_package/1c/49/PMC10786816.tar.gz
PMC10786818
38216613
[ "<title>Introduction</title>", "<p id=\"Par2\">Koala populations across the eastern Australian states of New South Wales (NSW), Queensland (Qld) and the Australian Capital Territory (ACT) have been recently declared endangered<sup>##UREF##0##1##</sup> with infertility, blindness and urinary tract disease due to <italic>Chlamydia pecorum</italic> infection being a major contributor to population declines<sup>##REF##30589897##2##,##UREF##1##3##</sup>. Another important pathogen, koala retrovirus (KoRV), exists in both endogenous and exogenous forms, and with subtypes of varying prevalence detected across koala populations<sup>##REF##33219558##4##</sup>. KoRV appears likely to cause neoplasia<sup>##REF##23798387##5##,##REF##33397941##6##</sup> and is associated with greater severity or prevalence of chlamydia<sup>##REF##28127051##7##,##REF##31243137##8##</sup>, though causation is not proven. The impact of two recently identified gammaherpesviruses, phascolartid gammaherpesvirus 1 (PhaHV-1)<sup>##REF##21719855##9##</sup>, and phascolartid gammaherpesvirus 2 (PhaHV-2)<sup>##REF##22247398##10##</sup>, are less well understood, though significant associations have been identified between the PhaHVs and detection of <italic>C. pecorum</italic><sup>##REF##30626662##11##,##REF##26222660##12##</sup>, and between PhaHV-1 infection and presence of KoRV<sup>##REF##30626662##11##</sup>. Co-infections between these four koala pathogens may have compounding impacts on koala health, with further research required to determine these impacts and inform appropriate management actions.</p>", "<p id=\"Par3\">Herpesviruses are double-stranded DNA viruses that are well known for establishing latency, with the site of latent infections being one of the distinguishing features of the three subfamilies, <italic>Alpha</italic>-, <italic>Beta- and Gammaherpesvirinae</italic><sup>##UREF##2##13##</sup>. Gammaherpesviruses establish latent infections in B and T lymphocytes with active infections occurring in epithelial cells<sup>##REF##8645091##14##,##REF##12438427##15##</sup>. Detection of PhaHVs in koala liver and spleen<sup>##UREF##3##16##,##REF##32867109##17##</sup> suggests lymphocytes are also a likely site of latent PhaHV infection in koalas. In human and mouse studies, gammaherpesvirus infections have resulted in lymphoproliferative disorders in immunocompromised individuals<sup>##REF##32059472##18##</sup>. Given the high prevalence of chlamydial infection in koala populations<sup>##REF##32556174##19##</sup>, along with the potential immunosuppressive role of KoRV<sup>##REF##27706211##20##,##REF##30626917##21##</sup>, and its associations with neoplasia<sup>##REF##23798387##5##,##REF##15722540##22##</sup>, the impacts of co-infections with PhaHVs may play a significant role in koala health outcomes.</p>", "<p id=\"Par4\">Research on the distribution and impacts of PhaHVs is currently limited to southern koala populations<sup>##REF##30626662##11##,##REF##26222660##12##,##REF##32867109##17##</sup>. Of 80 wild-caught koalas from the Mount Lofty Ranges in South Australia, active shedding of PhaHVs were detected in 72.5%<sup>##REF##32867109##17##</sup>. PhaHV-1 prevalence across Victorian populations ranges from 7.4% to 45.5%, with PhaHV-2 prevalence ranging from 0.9% to 54.6% (N ranges from 28 to 109 samples per population)<sup>##REF##30626662##11##</sup>. Importantly, in Victorian populations, significant associations have been found between herpesvirus infection and infection with both <italic>C. pecorum</italic> and KoRV<sup>##REF##30626662##11##,##REF##26222660##12##</sup>. Comparisons between oropharyngeal swabs and spleen samples in euthanised koalas demonstrated that while 72.4% of koalas were systemically infected with PhaHVs, only 54% were actively shedding the virus, with PhaHV-1 actively shed in 48.9% of koalas and PhaHV-2 shed in 14.9%<sup>##REF##32867109##17##</sup>. Active shedding of gammaherpesviruses can be stimulated by stress or co-infections<sup>##REF##32059472##18##,##REF##16332416##23##</sup>.</p>", "<p id=\"Par5\">Although gammaherpesvirus infection has been identified as a negligible to moderate risk to koala populations, certainty on this evaluation is low, with the recent National Koala Disease Risk Analysis recommending increased research effort into the distribution of PhaHVs in northern koala populations<sup>##UREF##4##24##</sup>. To further identify the distribution and impacts of PhaHVs in koalas, we recently developed new diagnostic assays for PhaHV-1 infections<sup>##REF##37262062##25##</sup>. Additional molecular assays for assessing PhaHV-2 are currently in development but are limited by lack of genomic sequence information for suitable target design. To date, only PhaHV-1 has been associated with increasing koala age and KoRV infections<sup>##REF##30626662##11##,##REF##32867109##17##</sup> in Victorian and South Australian koalas. We here apply our new quantitative polymerase chain reaction (qPCR) assay to the detection of PhaHV-1 in the previously untested endangered populations of koalas across Qld and NSW. We provide valuable insights into the distribution of this important koala pathogen along with an assessment of factors that may be associated with PhaHV-1 detection, including chlamydial infection.</p>" ]
[ "<title>Methods</title>", "<title>Samples</title>", "<p id=\"Par15\">We examined a total of 298 koala samples including 247 clinical samples from the Koala Health Hub sample archive (University of Sydney), consisting of previously extracted DNA from UGT swabs submitted for clinical chlamydial diagnostics. These samples were obtained opportunistically and collected as part of routine clinical examination from rescued koalas in care at veterinary hospitals and wildlife care clinics and are subsequently referred to as the “rescued cohort”. The majority of clinical samples were collected between 2017 and 2022, with seven samples from Victoria collected between 2010 and 2015. The remaining archived samples (<italic>n</italic> = 51) were collected during previous field surveys (prior to the current study) in the Southern Highlands and Campbelltown region of NSW (collected between 2021 and 2022) and three wild populations across Qld located at St Bees Island and Clarke Connors range in Central Qld and Oakey in Southern Qld (collected between 2016 and 2017) and are subsequently referred to as the “free-living cohort” (Fig. ##FIG##0##1##). All methods are reported in accordance with ARRIVE guidelines <sup>##REF##32663221##31##</sup> and were carried out in accordance with relevant guidelines and regulations. All experimental protocols were approved by the relevant institutions (University of Sydney Ethics approval 2019–1547, University of Queensland Ethics approval CMLR/304/13/QLD GOVT and CMLR/091/12/ARC/RIO TINTO, Central Queensland University Animal Ethics Approval A72/04–282, and Scientific Purposes permits WISP16162915 and WISP15517315). We selected urogenital swabs because evidence is equivocal as to whether urogenital or oropharyngeal swabs are more sensitive for PhaHV-1 detection<sup>##REF##30626662##11##,##REF##32867109##17##,##REF##37262062##25##</sup>, and one of our aims was to investigate correlations with chlamydial infection as determined from UGT swabs. Archived samples were selected to represent a wide geographic area of the koalas’ range, especially from previously untested regions in Qld and NSW, as well as 27 samples from southern populations for comparison (Table ##TAB##0##1##). As sampling was opportunistic, and largely biased to clinical samples from koalas admitted to care, we note that our assessment of PhaHV-1 prevalence is not reflective of a random sample of free-ranging koalas.</p>", "<p id=\"Par16\">Quantitative PCR assays were applied as previously described<sup>##REF##37262062##25##</sup> using a koala β-actin gene qPCR<sup>##REF##29629645##32##</sup> as a sample quality control to ensure sample integrity and sufficient DNA present in the sample for amplification. All clinical samples had been tested for <italic>C. pecorum</italic> infection status using previous diagnostic assays<sup>##REF##29629645##32##–##UREF##6##35##</sup>. Data on age, sex and clinical signs were available for the majority of samples (Table ##TAB##0##1##). Koala age was grouped into age classes based on reported tooth wear as follows: I (1–2 yrs), II (2–3 yrs), III (4 yrs), IV (5–6 yrs), V (10–12 yrs), VI (12 + yrs), VII (15 + yrs)<sup>##UREF##7##36##,##UREF##8##37##</sup>. Data on clinical signs were very general only and consisted of indications of either clinical signs consistent with chlamydial disease being urogenital signs, ocular signs or both, or no clinical signs present. Only broad age categorisations were available for wild caught koalas from the three Qld populations, but the majority (32/36, 89%) were classified as adults.</p>", "<title>Statistical analyses</title>", "<p id=\"Par17\">We used generalised linear models (GLMs) to investigate the relationships between detection of PhaHV1 and infection with <italic>C. pecorum</italic> (Cpec), age, sex and region. PhaHV-1 detection was the binary response variable using the binomial family in R (v 4.2.0)<sup>##UREF##9##38##</sup>. As our sampling strategy did not allow population-level assessment of PhaHV-1 prevalence, koala (N = 298) sampling locations were grouped into five broad regions based on previously identified biogeographic barriers on the east coast and historical translocations impacting phylogenetics of southern populations<sup>##REF##29967444##39##,##REF##27588685##40##</sup>. Data on age and sex were available for 197 koalas so these variables were included as potential predictors of PhaHV-1 detection for these samples. As we were interested in whether co-infection would increase the likelihood of presenting clinical signs, we studied a further subset of koalas that had tested positive for <italic>C. pecorum</italic> and had data on clinical signs consistent with chlamydiosis (N = 73). Clinical signs consisted of observational recording of urogenital and/or ocular signs of potential disease and as the level of detail varied across records this was reduced to a binary term. We conducted GLMs using clinical data (binary; yes, no) as the response variable and PhaHV-1 detection (HV1) and sex as potential explanatory variables. Age was included as a factor for a subset of 59 <italic>C. pecorum</italic> positive koalas. GLMs were conducted in R<sup>##UREF##9##38##</sup>, using the ‘LMe4’ package<sup>##UREF##10##41##</sup>. We employed an information theoretic approach to identify the best models using model averaging following Grueber et al.<sup>##REF##21272107##42##</sup>. This approach first standardises models using the ‘arm’ package<sup>##REF##17960576##43##,##UREF##11##44##</sup>, then uses the top two AIC<sub>C</sub> (small sample-size corrected Akaike information criterion) of models using the ‘MuMIn’ package<sup>##UREF##12##45##</sup> to generate final models. The relative importance (RI) of each explanatory variable was calculated by summing the Akaike weight of each of the final models that the predictor appeared in, with RI of 1 being indicative of a strong predictor. We also conducted univariate analyses to obtain p values and 95% confidence intervals via odds ratios and <italic>X</italic><sup>2</sup> using 2 × 2 tables for significant predictors identified using GLM.</p>" ]
[ "<title>Results</title>", "<p id=\"Par6\">We surveyed 298 koala urogenital (UGT) swab samples from archived clinical and field-collected samples using qPCR<sup>##REF##37262062##25##</sup> and assessed relationships between detection of PhaHV-1, <italic>C. pecorum</italic>, age, sex and geographic region . We note that this sample type is likely to be detecting active shedding rather than latent infection which would require samples from a full necropsy. Samples comprised 247 clinical and 51 field-collected swabs from 137 males, 132 females and 29 of unknown sex. Age classes ranged from 1–7 and numbers of samples per population ranged from 5–26 (Table ##TAB##0##1##). The percentage of <italic>C. pecorum</italic> detected in samples across broad regions ranged from 8–59%.</p>", "<p id=\"Par7\">PhaHV-1 was detected in all populations sampled except the population of Clarke Connor’s Range in Central Qld (Table ##TAB##0##1##). From 298 samples surveyed using the PhaHV-1 qPCR assay, 69 (23%) were positive. As our sampling strategy was not appropriate for accurate assessment of PhaHV-1 prevalence across regions, we grouped samples into five broad biogeographic regions (see Methods) and found a similar prevalence among them with the exception of Central Qld (Fig. ##FIG##0##1##). Detection of PhaHV-1 was nearly four times more likely among <italic>C. pecorum</italic>-positive koalas than <italic>C. pecorum</italic>-negative (38/92, 41%; vs 31/206, 15%; <italic>X</italic><sup>2</sup> = 23.19, df = 1, p &lt; 0.001; Odds ratio = 3.97, 95% CI = 2.26—6.98). Generalised linear model (GLM) results indicate PhaHV-1 is associated with increasing age and <italic>C. pecorum</italic> infection but not sex or bioregion (Tables ##TAB##1##2## and ##TAB##2##3##a). PhaHV-1 detection was more likely in older animals than younger animals (Table ##TAB##1##2##, Fig. ##FIG##1##2##).</p>", "<p id=\"Par8\">Detection of PhaHV-1 was 4.2 times more likely in the rescued cohort of koalas relative to the free-living cohort (65/247, 26% vs 4/51, 8%;<italic> X</italic><sup>2</sup> = 7.102, df = 1, p-value = 0.008; Odds ratio = 4.20, 95% CI = 1.45—12.11). Age class ranges were similar across the rescued and free-living cohorts (Table ##TAB##0##1##) suggesting that age differences between the two cohorts is not driving the difference in PhaHV-1 detection (see Methods for cohort distinctions). Data on age were not available for all samples and were missing for a greater proportion of free-living samples (Table ##TAB##0##1##), so we cannot make an accurate comparison of age differences between the two cohorts. For 73 <italic>C. pecorum</italic> known-positive koalas, clinical signs (consistent with chlamydial disease) were not associated with detection of PhaHV-1 or age, but were associated with sex (Table ##TAB##2##3##b). Of these 73 koalas, females were more likely than males to present clinical signs (Males 12/37, 32%; Females 25/36, 69%; <italic>X</italic><sup>2</sup> = 8.57, df = 1, p = 0.003; Odds ratio = 4.73, 95% CI = 1.76, 12.72). Of 230 koalas with data recorded on clinical signs, 81 were observed to display clinical signs. Sex differences were evident in the site of clinical signs with 24 males and 14 females showing ocular signs, and 13 males and 30 females showing urogenital signs.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par9\">We have identified PhaHV-1 in all regions sampled in this study extending the known range of this potential pathogen into the endangered koala populations of NSW and Qld. Although the opportunistic nature of sampling meant that sample numbers were small and biased towards rescued koalas in many populations, low detection of PhaHV-1 in some populations warrants further investigation. We have corroborated previous work that found an association between PhaHV-1 detection and increasing age in koalas from Victoria and South Australia<sup>##REF##30626662##11##,##REF##32867109##17##</sup>. Likewise, our study confirms previous work identifying an association between PhaHV-1 and chlamydia in southern populations<sup>##REF##30626662##11##,##REF##26222660##12##</sup>. Detection of PhaHV-1 was not associated with presentation of clinical signs in koalas also testing positive for <italic>C. pecorum</italic> but this analysis was limited by incomplete metadata in clinical and field-collected records.</p>", "<p id=\"Par10\">Due to the opportunistic and the largely rescue-sourced nature of sampling in our study, we are unable to determine precise prevalence of PhaHV-1 across free-living koala populations. The similarity in percentage of PhaHV-1 detection (22 – 30%) found among rescued koalas across the broad biogeographic regions does not necessarily indicate homogeneity within those regions and further targeted sampling effort is required to determine if differences exist in prevalence between free-living vs rescued koalas. For example, two populations from the Mackay region of Central Qld (St Bees Island and Connors range to the west of Mackay) had low PhaHV-1 detection frequency, as did the Campbelltown population in the Sydney region, which was assessed separately to other Sydney region populations as it is currently considered to be <italic>Chlamydia</italic>-free<sup>##UREF##5##26##</sup> and potentially isolated. All three populations were sampled during field research rather than by clinical sampling following rescue. Previous work has also found regional differences in PhaHV-1 prevalence, with lower (8.4%) than average (17.4%) prevalence in the closed French Island population<sup>##REF##30626662##11##</sup> which also has a very low prevalence of chlamydia<sup>##REF##26981690##27##</sup>.</p>", "<p id=\"Par11\">The higher proportion of PhaHV-1 detection in koala samples from rescued koalas in comparison to free-living koalas may also indicate higher shedding of the virus from sick or injured koalas, and/or increased stress due to being held in captivity for treatment. The qPCR assay and sample types used in the current study are not suited to detection of latent infection, and previous studies have shown only 48.9% of koalas infected with PhaHV-1 to be actively shedding the virus<sup>##REF##32867109##17##</sup>. In human studies <italic>Chlamydia trachomatis</italic> infection can induce replication of latent Human herpesvirus-6 infections<sup>##REF##23620749##28##</sup>. More research is needed to understand the mechanistic relationship between <italic>C. pecorum</italic> and PhaHV infections. Likewise, while the current study supports previous work identifying an association between PhaHV-1 and <italic>C. pecorum</italic> infection<sup>##REF##30626662##11##,##REF##26222660##12##</sup>, this association may indicate activation and shedding of PhaHV-1 as a result of chlamydial infection, detection of latent virus in cells exuded as a result of chlamydial inflammation, or greater shedding of both due to an unidentified underlying mechanism or co-infection. A targeted study of the impact to koalas health of coinfections by <italic>C. pecorum</italic>, PhaHV-1 and KoRV is needed, but was beyond the scope of the current study as data on clinical signs and coinfections were not available for all samples limiting the power of analyses.</p>", "<p id=\"Par12\">Our findings support previous work demonstrating an increasing prevalence of PhaHV-1 and increasing age in koalas<sup>##REF##30626662##11##,##REF##32867109##17##</sup>. The low prevalence in younger age classes may indicate that acquiring PhaHV-1 infection occurs as koalas mature and engage in sexual or aggressive contact<sup>##REF##30626662##11##,##REF##32867109##17##</sup>. We did not find an association between sex and PhaHV-1 detection, and past research has been equivocal on this<sup>##REF##30626662##11##,##REF##26222660##12##,##REF##32867109##17##</sup>. Stalder et al.<sup>##REF##26222660##12##</sup> found PhaHV-1 more likely to be detected in male koalas, while Vaz et al.<sup>##REF##30626662##11##</sup> and Kasimov et al.<sup>##REF##32867109##17##</sup> found no association with sex. Vaz et al.<sup>##REF##30626662##11##</sup> found females without young to be 1.7 times more likely to be infected with PhaHV-1 than females with young. Further research should use a targeted sampling approach across age classes, balanced sex ratios and over time and breeding seasons to fully understand transmission dynamics of PhaHVs.</p>", "<p id=\"Par13\">PhaHV-1 infection has been associated with clinical signs<sup>##REF##30626662##11##</sup>, but we did not find an increased likelihood of clinical signs in koalas with both <italic>C. pecorum</italic> and PhaHV-1 detected. The available metadata was not consistent across samples and had limited detail, so we were not able to assess any association between coinfections and severity of clinical signs. Clinical signs were more commonly recorded in female koalas though this was likely influenced by the higher proportion of urogenital clinical signs recorded in our dataset. Male koalas are more likely to present ocular signs and female koalas are more likely to present urogenital signs<sup>##REF##23523170##29##,##REF##23307368##30##</sup>. As our samples and metadata were obtained from a wide variety of sources, we cannot confirm that procedures were the same across facilities but have controlled for sample quality by testing for the koala β-actin gene. The associations between PhaHV-1, chlamydia and KoRV<sup>##REF##30626662##11##,##REF##26222660##12##</sup> necessitates careful sampling and standardised recording of metadata to enable future studies to resolve uncertainties relating to factors influencing co-infections, causal associations and clinical outcomes for koalas.</p>", "<p id=\"Par14\">Our study has confirmed the widespread presence of PhaHV-1 in koala populations across NSW and Qld, and across biogeographic barriers, contributing to our understanding of exposure risk in disease risk analyses and laying the basis for future work investigating prevalence of PhaHV-1 infection in these regions. The wide distribution, potential differences in prevalence of PhaHV-1 among populations and free-living versus rescued cohorts, and the limited understanding of the impact of PhaHV-1 and other co-infections on koala health and clinical presentations highlights the need for further research and precautionary routine surveillance of PhaHV-1 prior to management interventions in wild, rehabilitation and captive koala populations.</p>" ]
[]
[ "<p id=\"Par1\">Koala populations across the east coast of Australia are under threat of extinction with little known about the presence or distribution of a potential pathogen, phascolartid gammaherpesvirus 1 (PhaHV-1) across these threatened populations. Co-infections with PhaHV-1 and <italic>Chlamydia pecorum</italic> may be common and there is currently a limited understanding of the impact of these co-infections on koala health. To address these knowledge gaps, archived clinical and field-collected koala samples were examined by quantitative polymerase chain reaction to determine the distribution of PhaHV-1 in previously untested populations across New South Wales and Queensland. We detected PhaHV-1 in all regions surveyed with differences in detection rate between clinical samples from rescued koalas (26%) and field-collected samples from free-living koalas (8%). This may reflect increased viral shedding in koalas that have been admitted into care. We have corroborated previous work indicating greater detection of PhaHV-1 with increasing age in koalas and an association between PhaHV-1 and <italic>C. pecorum</italic> detection. Our work highlights the need for continued surveillance of PhaHV-1 in koala populations to inform management interventions, and targeted research to understand the pathogenesis of PhaHV-1 and determine the impact of infection and co-infection with <italic>C. pecorum.</italic></p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-023-50496-4.</p>", "<title>Acknowledgements</title>", "<p>This study was funded by the Australian Department of Agriculture, Water and the Environment Bushfire Recovery Multiregional Species Program. BRW is supported by the NSW Wildlife Information Rescue and Education Service (WIRES). The authors would like to thank Port Macquarie Koala Hospital, Friends of the Koala, Port Stephens Koala Hospital, WIRES, UQ Koala Ecology Group and the many wildlife carers and veterinary clinics that submitted samples for diagnostics used in this study.</p>", "<title>Author contributions</title>", "<p>B.R.W wrote the manuscript, conducted laboratory work and analysed the data; A.C conducted laboratory work and assisted with interpretation of findings; Y.S.S.M, L.H, and S.J.S collected samples, contributed to laboratory work and interpretation of findings; A.R.L, P.K.V and J.M.D assisted with conceptualisation and interpretation of findings; M.B.K and D.P.H conceived and oversaw the project and contributed to interpretation of findings; all co-authors contributed to the final manuscript.</p>", "<title>Data availability</title>", "<p>Complete dataset is available in Supplementary Table ##SUPPL##0##1##.</p>", "<title>Competing interests</title>", "<p id=\"Par18\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Sampling locations and numbers of koalas used in this study. Locations are approximate only as GPS co-ordinates were not available for most samples so location is based on submitting clinic. The five broad biogeographic areas are indicated by coloured circles: orange = Central QLD, pink = SE QLD/Northern NSW, blue = Mid-north NSW, green = Central/Southern NSW, red = Southern Australia.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>PhaHV-1 infection is more likely with increasing age class in koalas. Numbers of koalas in each age class: I (N = 37), II (N = 28), III (N = 37), IV (N = 65), V (N = 26), VI–VII (N = 4). Older age classes of VI and VII combined due to low numbers (2 in each). Error bars indicate 95% confidence intervals.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Samples surveyed from koala swabs across a range of regions with number of detections (+ve) for PhaHV-1 and <italic>C. pecorum</italic> (Cpec) using qPCR.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Region</th><th align=\"left\">No. of koalas</th><th align=\"left\">M</th><th align=\"left\">F</th><th align=\"left\">Unk</th><th align=\"left\">Age classes</th><th align=\"left\">PhaHV-1 + ve (%)</th><th align=\"left\">Cpec + ve (%)</th></tr></thead><tbody><tr><td align=\"left\">St Bees Island Qld*</td><td char=\".\" align=\"char\">9</td><td char=\".\" align=\"char\">5</td><td char=\".\" align=\"char\">4</td><td char=\".\" align=\"char\">0</td><td align=\"left\">NA</td><td char=\"(\" align=\"char\">1 (11)</td><td char=\"(\" align=\"char\">0 (0)</td></tr><tr><td align=\"left\">Connors Range Qld*</td><td char=\".\" align=\"char\">16</td><td char=\".\" align=\"char\">4</td><td char=\".\" align=\"char\">12</td><td char=\".\" align=\"char\">0</td><td align=\"left\">NA</td><td char=\"(\" align=\"char\">0 (0)</td><td char=\"(\" align=\"char\">2 (13)</td></tr><tr><td align=\"left\"><italic>Total</italic></td><td char=\".\" align=\"char\"><italic>25</italic></td><td char=\".\" align=\"char\"><italic>9</italic></td><td char=\".\" align=\"char\"><italic>16</italic></td><td char=\".\" align=\"char\"><italic>0</italic></td><td align=\"left\"/><td char=\"(\" align=\"char\"><italic>1 (4)</italic></td><td char=\"(\" align=\"char\"><italic>2 (8)</italic></td></tr><tr><td align=\"left\">South East Qld</td><td char=\".\" align=\"char\">23</td><td char=\".\" align=\"char\">7</td><td char=\".\" align=\"char\">16</td><td char=\".\" align=\"char\">0</td><td align=\"left\">I–V</td><td char=\"(\" align=\"char\">7 (30)</td><td char=\"(\" align=\"char\">9 (39)</td></tr><tr><td align=\"left\">Southern Qld†</td><td char=\".\" align=\"char\">16</td><td char=\".\" align=\"char\">12</td><td char=\".\" align=\"char\">3</td><td char=\".\" align=\"char\">1</td><td align=\"left\">II–V</td><td char=\"(\" align=\"char\">4 (25)</td><td char=\"(\" align=\"char\">9 (56)</td></tr><tr><td align=\"left\">North coast NSW</td><td char=\".\" align=\"char\">7</td><td char=\".\" align=\"char\">5</td><td char=\".\" align=\"char\">2</td><td char=\".\" align=\"char\">0</td><td align=\"left\">III–V</td><td char=\"(\" align=\"char\">2 (29)</td><td char=\"(\" align=\"char\">0 (0)</td></tr><tr><td align=\"left\">Northern Rivers NSW</td><td char=\".\" align=\"char\">20</td><td char=\".\" align=\"char\">12</td><td char=\".\" align=\"char\">7</td><td char=\".\" align=\"char\">1</td><td align=\"left\">I–VII</td><td char=\"(\" align=\"char\">3 (15)</td><td char=\"(\" align=\"char\">0 (0)</td></tr><tr><td align=\"left\">Northern NSW</td><td char=\".\" align=\"char\">13</td><td char=\".\" align=\"char\">4</td><td char=\".\" align=\"char\">8</td><td char=\".\" align=\"char\">1</td><td align=\"left\">II–V</td><td char=\"(\" align=\"char\">5 (38)</td><td char=\"(\" align=\"char\">5 (38)</td></tr><tr><td align=\"left\"><italic>Total</italic></td><td char=\".\" align=\"char\"><italic>79</italic></td><td char=\".\" align=\"char\"><italic>40</italic></td><td char=\".\" align=\"char\"><italic>36</italic></td><td char=\".\" align=\"char\"><italic>3</italic></td><td align=\"left\"/><td char=\"(\" align=\"char\"><italic>21 (27)</italic></td><td char=\"(\" align=\"char\"><italic>23 (29)</italic></td></tr><tr><td align=\"left\">Northern Tablelands NSW</td><td char=\".\" align=\"char\">9</td><td char=\".\" align=\"char\">5</td><td char=\".\" align=\"char\">4</td><td char=\".\" align=\"char\">0</td><td align=\"left\">IV–V</td><td char=\"(\" align=\"char\">2 (22)</td><td char=\"(\" align=\"char\">6 (67)</td></tr><tr><td align=\"left\">Liverpool Plains</td><td char=\".\" align=\"char\">15</td><td char=\".\" align=\"char\">5</td><td char=\".\" align=\"char\">1</td><td char=\".\" align=\"char\">9</td><td align=\"left\">I–IV</td><td char=\"(\" align=\"char\">7 (47)</td><td char=\"(\" align=\"char\">0 (0)</td></tr><tr><td align=\"left\">Mid-north coast NSW</td><td char=\".\" align=\"char\">26</td><td char=\".\" align=\"char\">7</td><td char=\".\" align=\"char\">11</td><td char=\".\" align=\"char\">8</td><td align=\"left\">I–IV</td><td char=\"(\" align=\"char\">6 (23)</td><td char=\"(\" align=\"char\">8 (31)</td></tr><tr><td align=\"left\"><italic>Total</italic></td><td char=\".\" align=\"char\"><italic>50</italic></td><td char=\".\" align=\"char\"><italic>17</italic></td><td char=\".\" align=\"char\"><italic>16</italic></td><td char=\".\" align=\"char\"><italic>17</italic></td><td align=\"left\"/><td char=\"(\" align=\"char\"><italic>15 (30)</italic></td><td char=\"(\" align=\"char\"><italic>14 (28)</italic></td></tr><tr><td align=\"left\">Central West NSW</td><td char=\".\" align=\"char\">24</td><td char=\".\" align=\"char\">17</td><td char=\".\" align=\"char\">7</td><td char=\".\" align=\"char\">0</td><td align=\"left\">I–V</td><td char=\"(\" align=\"char\">4 (17)</td><td char=\"(\" align=\"char\">7 (29)</td></tr><tr><td align=\"left\">Port Stephens</td><td char=\".\" align=\"char\">17</td><td char=\".\" align=\"char\">6</td><td char=\".\" align=\"char\">11</td><td char=\".\" align=\"char\">0</td><td align=\"left\">II–VI</td><td char=\"(\" align=\"char\">6 (35)</td><td char=\"(\" align=\"char\">7 (41)</td></tr><tr><td align=\"left\">Central Coast NSW/Hunter</td><td char=\".\" align=\"char\">5</td><td char=\".\" align=\"char\">4</td><td char=\".\" align=\"char\">1</td><td char=\".\" align=\"char\">0</td><td align=\"left\">II–V</td><td char=\"(\" align=\"char\">4 (80)</td><td char=\"(\" align=\"char\">3 (60)</td></tr><tr><td align=\"left\">Sydney region</td><td char=\".\" align=\"char\">26</td><td char=\".\" align=\"char\">14</td><td char=\".\" align=\"char\">12</td><td char=\".\" align=\"char\">0</td><td align=\"left\">I–V</td><td char=\"(\" align=\"char\">5 (19)</td><td char=\"(\" align=\"char\">8 (31)</td></tr><tr><td align=\"left\">Campbelltown*</td><td char=\".\" align=\"char\">10</td><td char=\".\" align=\"char\">6</td><td char=\".\" align=\"char\">4</td><td char=\".\" align=\"char\">0</td><td align=\"left\">I–IV</td><td char=\"(\" align=\"char\">1 (10)</td><td char=\"(\" align=\"char\">0 (0)</td></tr><tr><td align=\"left\">Southern Highlands†</td><td char=\".\" align=\"char\">15</td><td char=\".\" align=\"char\">8</td><td char=\".\" align=\"char\">7</td><td char=\".\" align=\"char\">0</td><td align=\"left\">I–III</td><td char=\"(\" align=\"char\">2 (13)</td><td char=\"(\" align=\"char\">2 (13)</td></tr><tr><td align=\"left\">Southern Tablelands NSW</td><td char=\".\" align=\"char\">20</td><td char=\".\" align=\"char\">8</td><td char=\".\" align=\"char\">10</td><td char=\".\" align=\"char\">2</td><td align=\"left\">I–VI</td><td char=\"(\" align=\"char\">4 (20)</td><td char=\"(\" align=\"char\">10 (50)</td></tr><tr><td align=\"left\"><italic>Total</italic></td><td char=\".\" align=\"char\"><italic>117</italic></td><td char=\".\" align=\"char\"><italic>63</italic></td><td char=\".\" align=\"char\"><italic>52</italic></td><td char=\".\" align=\"char\"><italic>2</italic></td><td align=\"left\"/><td char=\"(\" align=\"char\"><italic>26 (22)</italic></td><td char=\"(\" align=\"char\"><italic>37 (32)</italic></td></tr><tr><td align=\"left\">South Australia</td><td char=\".\" align=\"char\">20</td><td char=\".\" align=\"char\">8</td><td char=\".\" align=\"char\">12</td><td char=\".\" align=\"char\">0</td><td align=\"left\">I–V</td><td char=\"(\" align=\"char\">4 (20)</td><td char=\"(\" align=\"char\">9 (45)</td></tr><tr><td align=\"left\">Victoria</td><td char=\".\" align=\"char\">7</td><td char=\".\" align=\"char\">0</td><td char=\".\" align=\"char\">0</td><td char=\".\" align=\"char\">7</td><td align=\"left\">NA</td><td char=\"(\" align=\"char\">2 (29)</td><td char=\"(\" align=\"char\">7 (100)</td></tr><tr><td align=\"left\"><italic>Total</italic></td><td char=\".\" align=\"char\">27</td><td char=\".\" align=\"char\">8</td><td char=\".\" align=\"char\">12</td><td char=\".\" align=\"char\">7</td><td align=\"left\"/><td char=\"(\" align=\"char\">6 (22)</td><td char=\"(\" align=\"char\">16 (59)</td></tr><tr><td align=\"left\"><italic>Grand total</italic></td><td char=\".\" align=\"char\"><italic>298</italic></td><td char=\".\" align=\"char\"><italic>137</italic></td><td char=\".\" align=\"char\"><italic>132</italic></td><td char=\".\" align=\"char\"><italic>29</italic></td><td align=\"left\"><italic>I</italic>–<italic>VII</italic></td><td char=\"(\" align=\"char\"><italic>69 (23)</italic></td><td char=\"(\" align=\"char\"><italic>92 (31)</italic></td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Results of GLMs investigating factors predicting PhaHV-1 infection using <italic>C. pecorum</italic>, age and sex as predictors (N = 197).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Predictor</th><th align=\"left\">Estimate (95% CI)</th><th align=\"left\">Std. Error</th><th align=\"left\">P value</th></tr></thead><tbody><tr><td align=\"left\"><italic>(Intercept)</italic></td><td char=\"(\" align=\"char\"><italic>− 2.8670 (− 4.02 to 1.84)</italic></td><td char=\".\" align=\"char\"><italic>0.5526</italic></td><td align=\"left\"> &lt; <italic>0.0001</italic></td></tr><tr><td align=\"left\"><italic>C. pecorum</italic></td><td char=\"(\" align=\"char\">1.3578 (0.67 to 2.07)</td><td char=\".\" align=\"char\">0.3571</td><td align=\"left\"><bold>0.0001</bold></td></tr><tr><td align=\"left\">Age</td><td char=\"(\" align=\"char\">0.3622 (0.10 to 0.64)</td><td char=\".\" align=\"char\">0.1357</td><td align=\"left\"><bold>0.0076</bold></td></tr><tr><td align=\"left\">Sex</td><td char=\"(\" align=\"char\"><italic>− </italic>0.0865 (<italic>− </italic>0.80 to 0.61)</td><td char=\".\" align=\"char\">0.3589</td><td align=\"left\">0.8095</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p><bold>a.</bold> Results of GLMs investigating factors predicting PhaHV-1 infection using <italic>C. pecorum</italic> and broad geographic bioregion as predictors (N = 298). Top two AIC<sub>C</sub> used in final models: 311.6, 313.43. Coefficient estimate and adjusted standard error are presented. Significant p values are in bold. <bold>b.</bold> Modelling results for 73 <italic>C. pecorum</italic> positive koalas with data available on clinical signs, using PhaHV-1 infection and sex as predictor variables. Age was included for a subset of 59 koalas but did not appear in final models so is not presented. Top two AIC<sub>C</sub> used in final models: 94.32, 95.11.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Predictor</th><th align=\"left\">Estimate (95% CI)</th><th align=\"left\">Adjusted SE</th><th align=\"left\">RI</th><th align=\"left\">N. models</th><th align=\"left\">P value</th></tr></thead><tbody><tr><td align=\"left\"><bold>a.</bold><italic> (Intercept)</italic></td><td char=\"(\" align=\"char\"><italic>0.2075 (0.09–0.33)</italic></td><td align=\"left\"><italic>0.0604</italic></td><td align=\"left\"/><td align=\"left\"/><td char=\".\" align=\"char\"><italic>0.0006</italic></td></tr><tr><td align=\"left\"><italic>C. pecorum</italic></td><td char=\"(\" align=\"char\">0.2629 (0.16<italic>–</italic>0.36)</td><td align=\"left\">0.0514</td><td align=\"left\">1</td><td align=\"left\">2</td><td char=\".\" align=\"char\"><bold> &lt; 0.0001</bold></td></tr><tr><td align=\"left\" colspan=\"6\"><italic>Bioregion *</italic></td></tr><tr><td align=\"left\"> Central Qld</td><td char=\"(\" align=\"char\">− 0.0135 (− 0.27 to 0.18)</td><td align=\"left\">0.0654</td><td align=\"left\">0.29</td><td align=\"left\">1</td><td char=\".\" align=\"char\">0.8369</td></tr><tr><td align=\"left\"> SE Qld</td><td char=\"(\" align=\"char\">0.0352 (− 0.06 to 0.30)</td><td align=\"left\">0.0742</td><td align=\"left\">0.29</td><td align=\"left\">1</td><td char=\".\" align=\"char\">0.6351</td></tr><tr><td align=\"left\"> Mid NSW</td><td char=\"(\" align=\"char\">0.0458 (− 0.03 to 0.35)</td><td align=\"left\">0.0894</td><td align=\"left\">0.29</td><td align=\"left\">1</td><td char=\".\" align=\"char\">0.6085</td></tr><tr><td align=\"left\"> Southern NSW</td><td char=\"(\" align=\"char\">0.0208 (− 0.10 to 0.24)</td><td align=\"left\">0.0573</td><td align=\"left\">0.29</td><td align=\"left\">1</td><td char=\".\" align=\"char\">0.7163</td></tr><tr><td align=\"left\"><bold>b.</bold>\n<italic>(Intercept)</italic></td><td char=\"(\" align=\"char\"><italic>0.0351 (</italic>− <italic>0.48 to 0.55)</italic></td><td align=\"left\"><italic>0.2597</italic></td><td align=\"left\"/><td align=\"left\"/><td char=\".\" align=\"char\"><italic>0.8925</italic></td></tr><tr><td align=\"left\">PhaHV-1</td><td char=\"(\" align=\"char\">0.5356 (− 0.16 to 1.95)</td><td align=\"left\">0.6040</td><td align=\"left\">0.6</td><td align=\"left\">1</td><td char=\".\" align=\"char\">0.3752</td></tr><tr><td align=\"left\">Sex</td><td char=\"(\" align=\"char\">1.5619 (0.54<italic>–</italic>2.59)</td><td align=\"left\">0.5209</td><td align=\"left\">1</td><td align=\"left\">2</td><td char=\".\" align=\"char\"><bold>0.0027</bold></td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>Sub-totals are based on broad biogeographic regions. See Supplementary Table ##SUPPL##0##1## for detailed data across all 298 samples.</p><p>*Samples were wild caught.</p><p><sup>†</sup>Samples mixture of wild caught and rescue. All other samples were from archived clinical samples from rescued koalas. <italic>M</italic> male, <italic>F</italic> female, <italic>Unk</italic> unknown sex. PhaHV-1 results are from current study, Cpec (<italic>C. pecorum</italic>) are from previous clinical data.</p></table-wrap-foot>", "<table-wrap-foot><p>Coefficient estimate and standard error are presented. Significant p values are in bold.</p><p>Nb. Model averaging was not possible for this model as there was only one top model. Confidence intervals (CI) do not include 0 for significant predictors.</p></table-wrap-foot>", "<table-wrap-foot><p>*Southern Australia used as the reference level for broad bioregion. Each region was assessed as the reference level for comparison and no significant effects of Bioregion were found (data not shown). Relative importance (RI) and number of top models (N. models) is for Bioregion as a single factor. Confidence intervals (CI) do not include 0 for significant predictors.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2023_50496_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2023_50496_Fig2_HTML\" id=\"MO2\"/>" ]
[ "<media xlink:href=\"41598_2023_50496_MOESM1_ESM.xlsx\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["1."], "mixed-citation": ["Australian Government Department of Climate Change Energy the Environment and Water. "], "ext-link": ["https://www.environment.gov.au/cgi-bin/sprat/public/publicthreatenedlist.pl?wanted=fauna"]}, {"label": ["3."], "surname": ["Grogan"], "given-names": ["LF"], "article-title": ["Is disease a major causal factor in declines? An evidence framework and case study on koala chlamydiosis"], "source": ["Biol. Cons."], "year": ["2018"], "volume": ["221"], "fpage": ["334"], "lpage": ["344"], "pub-id": ["10.1016/j.biocon.2018.03.030"]}, {"label": ["13."], "surname": ["Matthews"], "given-names": ["R"], "article-title": ["Classification and nomenclature of viruses"], "source": ["Intervirology"], "year": ["1982"], "volume": ["17"], "fpage": ["199"]}, {"label": ["16."], "surname": ["Vaz"], "given-names": ["PK"], "article-title": ["Koala and wombat gammaherpesviruses encode the first known viral NTPDase homologs and are phylogenetically divergent from all known gammaherpesviruses"], "source": ["J. Virol."], "year": ["2018"], "volume": ["93"], "fpage": ["e01404"], "lpage": ["01418"]}, {"label": ["24."], "surname": ["Vitali", "Reiss", "Jakob-Hoff", "Stephenson", "Holz", "Higgins"], "given-names": ["SD", "A", "RM", "TL", "PH", "DP"], "source": ["National Koala Disease Risk Analysis Report"], "year": ["2022"], "publisher-name": ["University of Sydney"]}, {"label": ["26."], "collab": ["Koala Independent Expert Panel"], "source": ["Advice on the protection of the Campbelltown Koala population"], "year": ["2020"], "publisher-name": ["NSW Chief Scientist & Engineer"]}, {"label": ["35."], "mixed-citation": ["Griffith, J. E. "], "italic": ["Studies into the diagnosis, treatment and management of chlamydiosis in koalas"]}, {"label": ["36."], "surname": ["Martin"], "given-names": ["R"], "article-title": ["Age-specific fertility in three populations of the koala, "], "italic": ["Phascolarctos cinereus"], "source": ["Wildl. Res."], "year": ["1981"], "volume": ["8"], "fpage": ["275"], "lpage": ["283"], "pub-id": ["10.1071/WR9810275"]}, {"label": ["37."], "surname": ["Gordon"], "given-names": ["G"], "article-title": ["Estimation of the age of the Koala, "], "italic": ["Phascolarctos cinereus"], "source": ["Aust. Mammal."], "year": ["1991"], "volume": ["14"], "fpage": ["5"], "lpage": ["12"], "pub-id": ["10.1071/AM91001"]}, {"label": ["38."], "mixed-citation": ["R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2017. ISBN3-900051-07-0. "], "ext-link": ["https://www.R-project.org"]}, {"label": ["41."], "mixed-citation": ["Bates, D., M\u00e4chler, M., Bolker, B. & Walker, S. Fitting linear mixed-effects models using lme4. arXiv preprint "], "ext-link": ["arXiv:1406.5823"]}, {"label": ["44."], "mixed-citation": ["arm: Data analysis using regression and multilevel/hierarchical models (2011)."]}, {"label": ["45."], "mixed-citation": ["MuMIn: Multi-model inference. R package version 1. 0. 0 (2009)."]}]
{ "acronym": [], "definition": [] }
45
CC BY
no
2024-01-14 23:40:15
Sci Rep. 2024 Jan 12; 14:1223
oa_package/62/30/PMC10786818.tar.gz
PMC10786819
38216597
[ "<title>Introduction</title>", "<p id=\"Par2\">Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), is a chronic and relapsing inflammatory disorder of the gastrointestinal tract<sup>##REF##33382932##1##,##REF##35152240##2##</sup>. The global incidence of inflammatory bowel disease (IBD) increased by 47.45%, from an estimated 3.32 million cases to 4.90 million cases between 1990 and 2019, which poses significant impacts in patients' quality of life and challenges in terms of diagnosis, treatment, and management<sup>##REF##35508952##3##–##REF##36977543##7##</sup>. One of the key complications of IBD is the development of fibrosis, a pathological process characterized by excessive accumulation of extracellular matrix components in the affected intestinal wall<sup>##REF##34876680##8##</sup>. Fibrosis can lead to structural alterations, strictures, and functional impairments, ultimately contributing to disease progression and complications<sup>##REF##37064539##9##</sup>.</p>", "<p id=\"Par3\">Accurate assessment and stratification of fibrosis in IBD patients are crucial for determining appropriate treatment strategies and optimizing patient outcomes. While conventional imaging modalities, such as magnetic resonance imaging (MRI) and computed tomography (CT), have been used to evaluate fibrosis in IBD, their limitations in providing quantitative and objective measurements have prompted the exploration of alternative approaches<sup>##REF##35812031##10##</sup>. Radiomics, a rapidly evolving field in medical imaging, has gained significant attention in various clinical domains, where it has shown great potential for predicting treatment response, prognosis, and even guiding personalized therapies<sup>##REF##34188576##11##</sup>. Radiomics refers to the extraction of a large number of quantitative imaging features from medical images, followed by the application of advanced data analysis techniques<sup>##REF##37443616##12##,##REF##36474598##13##</sup>. These features capture the heterogeneity and spatial patterns of tissues, enabling a more comprehensive and objective characterization of disease processes<sup>##REF##34309893##14##</sup>. It has been used in the identification of pre-therapeutic predictive markers for response and prognosis in individualized patient treatment for gastric cancer<sup>##REF##31348029##15##</sup>, colorectal cancer<sup>##REF##35109864##16##</sup>, liver cancer<sup>##UREF##2##17##</sup>, and other digestive disorders<sup>##REF##33609503##18##</sup>. In the context of IBD, radiomics-based approaches have emerged as a valuable tool for assessing disease activity<sup>##REF##37149448##19##</sup>, distinguishing between active inflammation and fibrosis<sup>##UREF##3##20##</sup>, and predicting treatment response<sup>##REF##36250776##21##</sup>.</p>", "<p id=\"Par4\">Especially, a study demonstrated that semi-automated measurements of structural bowel damage, including bowel wall thickness, dilation, and lumen diameter, are highly comparable to those taken by experienced radiologists, with similar accuracy in detecting intestinal strictures<sup>##REF##31504540##22##</sup>. Another multicenter, retrospective study used a machine learning-based radiomic model and demonstrated superior performance to radiologists in accurately predicting intestinal fibrosis<sup>##REF##33609503##18##</sup>. Moreover, research also revealed that apparent diffusional kurtosis could effectively differentiate between no or mild fibrosis and moderate to severe fibrosis in CD patients, achieving a high sensitivity of 95.9% and a specificity of 78.1%. This indicates the potential of apparent diffusional kurtosis as a valuable MRI imaging tool for evaluating bowel fibrosis. However, most of these current studies employing radiomics have been limited to traditional CT and MRI scans, with patient cohorts typically smaller than 200. Considering the superior advantages of Multi-Slice Computed Tomography (MSCT) over traditional CT, such as faster imaging of larger body areas and higher spatial resolution for detecting fine details, MSCT could potentially reveal more intricate imaging features in IBD fibrosis. Therefore, it's essential to establish a comprehensive and reliable radiomics model based on MSCT, specifically designed for stratifying fibrosis in IBD patients, in a larger population. This remains an active area of research, with MSCT's advanced capabilities offering promising avenues for improved diagnostic accuracy.</p>", "<p id=\"Par5\">This study aims to address this research gap by proposing a radiomics nomogram based on MSCT and clinical factors for 218 IBD patients. By combining quantitative imaging features extracted from MSCT scans with relevant clinical parameters, we aim to develop a robust and user-friendly tool that can accurately stratify fibrosis in IBD patients. The nomogram will enable clinicians to make informed decisions regarding treatment selection, surgical planning, and disease monitoring, ultimately leading to enhance precision and effectiveness of fibrosis assessment in IBD patients.</p>" ]
[ "<title>Methods</title>", "<title>Participants</title>", "<p id=\"Par6\">This study was conducted in accordance with the Declaration of Helsinki guidelines and approved by The Second Affiliated Hospital of Harbin Medical University. Informed consent was obtained from all participants in this study. Clinical data from IBD patients treated at The Second Affiliated Hospital of Harbin Medical University, between June 2015 and October 2022 were collected. In terms of original images, the quality control was conducted following the guidelines for imaging examination and reporting of IBD in China. Inclusion criteria consisted of patients who have been diagnosed as CD or UC<sup>##UREF##4##23##</sup>, and have the qualification of MSCT images. Exclusion criteria included pregnant or nursing women, hyperthyroidism or iodine allergy, severe diseases affecting vital signs, mental illness or low cognitive ability, liver diseases, kidney diseases, digestive tract cancer, unqualified images, and images outside the colon and rectum. A total of 218 IBD patients (113 CD, 105 UC) who underwent both MSCT enhancement scans and endoscopy were included in the study. The dataset was divided into training data (n = 145) and test data (n = 73) using a random split method (2:1 ratio) (Fig. ##FIG##0##1##).</p>", "<title>Image data</title>", "<p id=\"Par7\">Prior to the CT examination, patients followed a diet without solid food. They abstained from eating for 8 h prior to the examinations and the laxatives were taken beforehand. Additionally, they consumed 2000–3000 mL of 2.5% isotonic mannitol in intervals of 400–500 mL every 15 min.</p>", "<p id=\"Par8\">For the enhanced scanning procedure, a SOMATOM definition flash CT machine was used. From the diaphragmatic crest to the pubic symphysis, a 5 mm thick scan was performed along with a 0.75 mm thick thin layer reconstruction. A contrast medium was administered through a high-pressure syringe inserted into the anterior cubital vein. A dosage of 60–80 mL of the contrast medium containing 300 mg/mL of iodine was injected at a rate of 3.0–3.5 ml/s. After contrast injection, an arterial phase scan (25–35 s after) and an intravenous phase scan (65–90 s after) were performed.</p>" ]
[ "<title>Results</title>", "<title>Clinicoradiological characteristics</title>", "<p id=\"Par22\">Table ##TAB##0##1## presents a comprehensive comparison of clinical and radiological features between the UC and CD groups. Gender distribution demonstrated no significant difference (<italic>P</italic> = 0.584), with comparable percentages of females and males in both groups. The assessment of histologic fibrosis revealed that the majority of patients in both groups exhibited none to mild fibrosis, and there was no significant disparity in fibrosis severity between the UC and CD groups (<italic>P</italic> &gt; 0.05). Perienteric edema or inflammation, engorged vasa recta, and lymphadenopathy showed no significant differences between the UC and CD groups (all <italic>P</italic> &gt; 0.05). Lesion location analysis indicated no significant variation between the groups (<italic>P</italic> = 0.101), with the colon and cecum being the most common locations in both. Additionally, there were no significant differences in age and thickness of the intestinal wall (all <italic>P</italic> &gt; 0.05). However, a significant difference was observed in AP-CT value between the UC and CD groups (<italic>P</italic> &lt; 0.05).</p>", "<title>Radiomics score building</title>", "<p id=\"Par23\">Table ##TAB##1##2## summarizes the performance of different models on the training set (n = 145) and test set (n = 73). The models include LDA, LR, RF, SGD, SVM, clinical model, and the nomogram. On the test set, the nomogram demonstrated the highest AUC of 0.865 (95% CI 0.738–0.992), indicating excellent discriminative ability. It also exhibited a high accuracy of 0.791, sensitivity of 0.852, and specificity of 0.913. The LR model achieved the second-highest AUC of 0.821 (95% CI 0.647–0.995) with a high accuracy of 0.656 and sensitivity of 0.812. The SVM model had the lowest AUC of 0.711 (95% CI 0.559–0.863) and moderate performance metrics. On the training set, the nomogram maintained a high AUC of 0.971 (95% CI 0.950–0.992) and achieved exceptional accuracy, sensitivity, and specificity. The RF and SVM models exhibited perfect AUCs of 1.000, indicating excellent performance. The other models, including LDA, LR, and SGD, demonstrated good discriminative ability with AUC values ranging from 0.922 to 0.988. Overall, The LR model demonstrated superior performance on the test set, while all models exhibited excellent performance on the training set.</p>", "<p id=\"Par24\">In the LR model, the top 10 features with the highest weights were carefully selected. A probability score, called a Rscore, is generated by calculating correlation coefficients between selected features and outcomes. It served as a representative measure for assessing the risk of fibrosis for IBD. The formula was as follows:</p>", "<title>Clinical-radiomics nomogram building and validation</title>", "<p id=\"Par25\">In the construction of the nomogram by combining the radiomics features and clinical factors, the radiomics score, engorged vasa recta, AP-CT value, and lesion location were integrated as predictive factors (Fig. ##FIG##1##2##A). Each factor was assigned a specific point value based on its relative contribution to the overall risk assessment. By summing the points associated with each factor, a total point score was calculated, which was then translated into a predicted probability of the fibrosis of IBD using a calibration curve (Fig. ##FIG##1##2##B). The model performance on the training set and test set was shown in Fig. ##FIG##1##2##C by a decision curve. In the validation sets, the AUC of the ROC curve, a widely used metric for evaluating diagnostic accuracy, was determined to be 0.865 (Fig. ##FIG##1##2##D). This indicates a favorable discriminative ability of the nomogram in distinguishing the fibrosis of IBD. We also compared the performance of different models in both the training set and the test set (Fig. ##FIG##2##3##). In the test set, the LR model exhibited an AUC of 0.821, indicating good predictive performance. On the other hand, the clinical model achieved an AUC of 0.602, suggesting lower discriminatory ability. Notably, the nomogram demonstrated the highest AUC of 0.865, indicating superior predictive accuracy compared to both LR and the clinical model. In the train set, the LR model achieved a high AUC of 0.975, surpassing the clinical model with an AUC of 0.735. Similarly, the nomogram showcased excellent performance with an AUC of 0.971, further highlighting its predictive superiority over the other models.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par26\">Accurate measurement of fibrosis in IBD is essential for the effective management and prognosis of patients. However, conventional approaches suffer from limitations, particularly subjective interpretation by radiologists, leading to variability and potential diagnostic errors. Therefore, there is a pressing need to improve fibrosis assessment in IBD. To address these limitations, this study focuses on leveraging the emerging field of radiomics, which combines advanced imaging techniques and computational algorithms to extract quantitative features from medical images. By utilizing radiomics, the study aims to develop a novel radiomics nomogram that integrates MSCT images and clinical factors. This nomogram holds great promise in providing more objective and accurate fibrosis assessment in IBD patients. The ultimate goal is to enhance clinical decision-making and improve patient care by overcoming the subjectivity and variability associated with conventional approaches.</p>", "<p id=\"Par27\">The development of fibrosis in IBD involves a complex interplay of various factors, including chronic inflammation, extracellular matrix remodeling, and profibrotic signaling pathways<sup>##REF##32092217##30##,##REF##31254502##31##</sup>. Persistent inflammation triggers the activation of fibroblasts, which then produce excessive collagen and other extracellular matrix components, leading to the formation of fibrotic tissue<sup>##REF##33993489##32##</sup>. MSCT imaging provides high-resolution images and allows for multi-planar reconstruction, enabling the visualization of morphological features, bowel wall thickness, and lesion distribution. MSCT can also evaluate vascular supply and vasodilation of the intestines, which are important factors in the development of fibrosis. In MSCT examinations, findings such as increased bowel wall thickness, luminal stenosis, and mural stratification are indicative of fibrosis<sup>##REF##32855670##33##,##REF##33987270##34##</sup>. Moreover, the presence of engorged vasa recta and pericentric fat stranding may suggest the severity of fibrosis<sup>##UREF##5##35##</sup>. MSCT not only aids in the detection and localization of fibrotic lesions but also assists in assessing the extent and complications associated with fibrosis, such as strictures and fistulas<sup>##REF##36279627##36##</sup>. The use of MSCT in fibrosis evaluation in IBD offers several advantages, including its non-invasive nature, widespread availability, and ability to provide detailed anatomical information<sup>##REF##37443616##12##</sup>. In this study, a nomogram was developed to predict fibrosis in IBD by integrating radiomics score, engorged vasa recta, AP-CT value, and lesion location. The nomogram demonstrated superior predictive accuracy with an AUC of 0.865 in the validation sets, outperforming logistic regression and clinical models. This result can primarily be attributed to the nomogram's integrated approach, which synergistically combines clinical data with radiomic features. This comprehensive framework harnesses the strengths of both data types, offering a more nuanced and holistic assessment than models relying on singular data sources. The integration of diverse data types potentially captures a broader spectrum of disease markers, resulting in improved predictive accuracy. These findings highlight the potential of the nomogram as a valuable tool for accurately stratifying fibrosis in IBD patients.</p>", "<p id=\"Par28\">In contrast, the LR model, which achieved the second-highest AUC of 0.821 (95% CI 0.647–0.995), may have been limited by its focus on a singular type of data (only radiomic). This limitation could account for its slightly lower performance compared to the nomogram. The SVM model displayed the lowest AUC of 0.711 (95% CI 0.559–0.863). The underperformance of the SVM model might be attributed to its inherent characteristics, such as sensitivity to the scale and distribution of the data, which may not have been ideally suited for the heterogeneous nature of our dataset<sup>##REF##31388413##37##</sup>. The SVM model's moderate performance emphasizes the necessity of choosing appropriate machine learning algorithms that align with the specific attributes of the data being analyzed. The similar results can also be found in previous studies<sup>##REF##33987270##34##</sup>.</p>", "<p id=\"Par29\">Additionally, the number of features selected in a model crucially impacts its accuracy, risk of overfitting or underfitting, computational cost, interpretability, and the potential inter-correlations among features, thereby influencing the overall effectiveness and efficiency of the model<sup>##UREF##6##38##</sup>. In our study, the meticulous selection of the top 10 features, characterized by their significantly higher weights, was informed by their proven relevance to IBD fibrosis. These features were not only chosen for their superior predictive power but also for their substantial contribution to the model's overall accuracy. This selection process reflects a comprehensive and intentional effort to identify the most informative and relevant radiomic characteristics. Consistent with existing literature, this approach employs image-based radiomics signatures to proficiently differentiate between disease and control groups, underscoring the method's effectiveness in disease characterization<sup>##REF##31850216##39##,##REF##35116742##40##</sup>.</p>", "<p id=\"Par30\">Most interestingly, engorged vasa recta, AP-CT value, and lesion location are important factors in the assessment of fibrosis in IBD due to their significant contributions and clinical value. Engorged vasa recta reflect the degree of vascular supply and vasodilation in the intestines, which are closely associated with the development of fibrosis<sup>##UREF##7##41##</sup>. This feature provides valuable information about the extent and severity of fibrotic changes in the bowel wall. The AP-CT value, obtained through MSCT, is a quantitative measure that reflects the density of tissues. In the context of fibrosis, a higher AP-CT value indicates increased collagen deposition and fibrotic tissue, allowing for the identification and characterization of fibrotic lesions<sup>##REF##22744764##42##</sup>. This parameter offers an objective and quantitative assessment of fibrosis severity, aiding in treatment planning and monitoring disease progression. Lesion location is another crucial factor in evaluating fibrosis in IBD. The specific site and distribution of fibrotic lesions provide insights into the spatial pattern and involvement of different segments of the gastrointestinal tract. This information helps in determining the extent and complications associated with fibrosis, such as strictures and fistulas<sup>##REF##32592777##43##</sup>. Incorporating lesion location into the nomogram enables a more comprehensive assessment of fibrosis and assists in personalized treatment decisions.</p>", "<p id=\"Par31\">Despite its significant findings, this study has a few limitations. Firstly, the sample size in the study was relatively small, which may limit the generalizability of the findings. A larger sample size would provide more robust results and enhance the reliability of the nomogram. Secondly, the study mainly focused on MSCT and clinical factors, potentially overlooking other relevant variables that could influence fibrosis in IBD. Including a broader range of factors, such as genetic markers or histopathological characteristics, would provide a more comprehensive understanding of fibrosis in this context. Thirdly, although the performance of the radiomics nomogram was promising, external validation in independent cohorts is necessary to confirm its accuracy and generalizability. Lastly, the study did not explore the impact of treatment interventions or longitudinal changes in fibrosis over time, which could provide valuable insights into disease progression and therapeutic response. Future research should address these limitations to further strengthen the clinical applicability and utility of the radiomics nomogram in stratifying fibrosis in IBD. In considering the implementation of the radiomics nomogram in clinical settings, the integration of this tool holds great promise for enhancing patient care, yet several potential barriers and considerations must be addressed to ensure its widespread adoption. Standardizing imaging protocols and ensuring data consistency are crucial for reliable results, while addressing data privacy and security concerns is essential to maintain patient confidentiality. Additionally, fostering interdisciplinary collaboration and ensuring the medical staff’s proficiency with the tool are vital steps towards seamlessly incorporating the radiomics nomogram into routine clinical practice.</p>", "<p id=\"Par32\">In conclusion, the radiomics nomogram based on MSCT and clinical factors shows promise in stratifying fibrosis in inflammatory bowel disease. It outperforms traditional clinical models and provides a personalized risk assessment. Further validation and addressing identified limitations are needed to enhance its applicability. Implementing this nomogram can improve patient care by enabling accurate fibrosis stratification and guiding tailored treatment strategies in IBD.</p>" ]
[]
[ "<p id=\"Par1\">Intestinal fibrosis is one of the major complications of inflammatory bowel disease (IBD) and a pathological process that significantly impacts patient prognosis and treatment selection. Although current imaging assessment and clinical markers are widely used for the diagnosis and stratification of fibrosis, these methods suffer from subjectivity and limitations. In this study, we aim to develop a radiomics diagnostic model based on multi-slice computed tomography (MSCT) and clinical factors. MSCT images and relevant clinical data were collected from 218 IBD patients, and a large number of quantitative image features were extracted. Using these features, we constructed a radiomics model and transformed it into a user-friendly diagnostic nomogram. A nomogram was developed to predict fibrosis in IBD by integrating multiple factors. The nomogram exhibited favorable discriminative ability, with an AUC of 0.865 in the validation sets, surpassing both the logistic regression (LR) model (AUC = 0.821) and the clinical model (AUC = 0.602) in the test set. In the train set, the LR model achieved an AUC of 0.975, while the clinical model had an AUC of 0.735. The nomogram demonstrated superior performance with an AUC of 0.971, suggesting its potential as a valuable tool for predicting fibrosis in IBD and improving clinical decision-making. The radiomics nomogram, incorporating MSCT and clinical factors, demonstrates promise in stratifying fibrosis in IBD. The nomogram outperforms traditional clinical models and offers personalized risk assessment. However, further validation and addressing identified limitations are necessary to enhance its applicability.</p>", "<title>Subject terms</title>" ]
[ "<title>Reference standard for intestinal fibrosis</title>", "<p id=\"Par9\">We obtained histological tissue samples through endoscopic biopsies or surgical resections performed at our hospitals. Histological sections obtained from our hospitals were subjected to evaluation by a skilled pathologist who specialized in bowel pathology for 15 years. The pathologist, blinded to the clinical and radiological data, applied consistent criteria to assess the degree of bowel fibrosis using Masson's trichrome staining and bowel inflammation using H&amp;E staining. A semi-quantitative scoring system was employed to assign scores ranging from 0 to 4, representing the severity of fibrosis and inflammation, with 0 indicating no fibrosis/inflammation and 4 indicating severe fibrosis/inflammation<sup>##REF##33609503##18##</sup>. These scores facilitated the categorization of fibrosis and inflammation into two groups: none-mild (scores 0–2) and moderate-severe (scores 3–4).</p>", "<title>Image segmentation and feature extraction</title>", "<p id=\"Par10\">An original DICOM image was analyzed for radiomics features based on a two-dimensional region of interest (ROI), which was meticulously delineated by an experienced abdominal radiologist using manual segmentation on the axial slices of the MSCT images. The radiologist conducted this process while blinded to the clinical and pathological data. Care was taken to include the entire thickness of the bowel wall in the ROI, while excluding adjacent fat and vascular structures. This delineation was performed using ITK-SNAP software (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.itksnap.org\">www.itksnap.org</ext-link>), ensuring precision and consistency across all cases.</p>", "<p id=\"Par11\">For the image resampling process, we employed the B-spline interpolation method, setting the target resolution to 1mm x 1mm x 1mm. The order of interpolation was set at 3, providing a balance between smoothness and accuracy in the resampling results. Various image preprocessing methods were applied, such as gray level co-occurrence matrix (GLCM), gray level run length matrix (GLRLM), gray level size zone matrix (GLSZM), and gray level dependence matrix (GLDM). To be specific, we quantized the image grayscale values into 64 discrete levels. For the application of various image preprocessing methods, a window size of 5mm x 5mm was utilized. Specifically, for the extraction of Gray Level Co-occurrence Matrix (GLCM) features, a pixel pair distance of 1 was set, and features were calculated in all four principal directions (0°, 45°, 90°, and 135°). At last, a total of 1,450 standardized radiomic features were extracted.</p>", "<p id=\"Par12\">The features were named by the categorization structured in three distinct levels: the initial level detailed the image preprocessing method and associated parameters, for instance, log-sigma-1-0-mm. Subsequently, the second level denoted the type of feature, encompassing options such as first-order, sphericity, and GLDM. Finally, the third level pinpointed the precise feature extraction method, like run length non-uniformity, ensuring a comprehensive and systematic representation of the process.</p>", "<p id=\"Par13\">The extraction process utilized PyRadiomics, an open-source platform implemented in Python for processing and extracting radiomic features from medical images<sup>##REF##29092951##24##–##REF##34535728##26##</sup>.</p>", "<title>Feature selection and radiomics score construction</title>", "<p id=\"Par14\">To ensure proper model evaluation, the dataset was divided into training (n = 279) and testing (n = 139) sets. Feature selection was performed using various machine learning algorithms, including Logistic Regression (LR), Support Vector Machine (SVM), Random Forest (RF), Stochastic Gradient Descent (SGD), and Linear Discriminative Analysis (LDA). Specifically, we employed LR with an L1 regularization parameter finely set at 0.01. Simultaneously, a SVM with a linear kernel was utilized, and its regularization parameter (C) was calibrated at 1. The RF algorithm played a crucial role as well, configured with 100 trees and a maximum depth of 10. Additionally, SGD was applied, operating under a logistic loss function and a learning rate set at 0.01. Lastly, LDA was implemented, primarily focusing on finding the most discriminating linear combination of features, and operated with its default parameter settings.</p>", "<p id=\"Par15\">To identify the most relevant and informative features from these algorithms for constructing the radiomics score (Rscore), we first gathered all the features selected by different machine learning algorithms into one pool. We then assigned weights to these features based on how often they were selected across the algorithms, giving more importance to those chosen frequently. After normalizing the weights to ensure they added up to one, we calculated the radiomics score for each data instance by multiplying each feature’s value by its weight and summing these products. Finally, we checked the accuracy of these scores using our testing dataset, making adjustments to the weights as needed to optimize performance.</p>", "<title>Development of the clinical-radiomics nomogram</title>", "<p id=\"Par16\">To incorporate relevant clinical information, the clinical factors were selected based on their relevance and significance to the outcome of interest, as established through a comprehensive review of existing literature<sup>##REF##31596960##27##–##REF##32007542##29##</sup>. We identified eight clinical factors that were potentially associated with the outcome of interest.</p>", "<p id=\"Par17\">To determine their significance, single-factor analysis was performed, comparing the fibrosis or non-fibrosis in IBD. Factors showing significant differences were considered for further analysis and inclusion in the nomogram. The clinical and radiomic features were combined in a multivariate LR analysis to construct the nomogram.</p>", "<p id=\"Par18\">The regression coefficients derived from the analysis were used to assign weights to each feature in the nomogram. Features with higher absolute values of coefficients were assigned higher weights, reflecting their stronger influence on the outcome. By summing the weighted scores of the selected features, the nomogram provided a personalized risk estimation for each patient. In detail, each patient’s values for the selected predictors were input into the nomogram, and the corresponding weighted scores were summed up to obtain a total score. This total score was then translated into a probability of the outcome, using the logistic function. This process allows for individualized risk estimation, taking into account the unique combination of characteristics for each patient.</p>", "<p id=\"Par19\">The performance of the clinical-radiomics nomogram was evaluated using various statistical measures. Calibration curves were constructed to assess the agreement between the predicted probabilities from the nomogram and the actual probabilities observed in the data, aiming for a close match to the 45° line indicating perfect calibration. The nomogram's discriminative ability was evaluated using AUC, with values closer to 1.0 denoting superior discriminatory ability. Additionally, decision curve analysis was performed to evaluate the clinical usefulness of the nomogram by assessing the net benefits at different threshold probabilities, helping to visualize the potential benefit of using the nomogram for decision-making across various risk thresholds.</p>", "<title>Statistical analysis</title>", "<p id=\"Par20\">The statistical analysis was conducted utilizing the Deepwise DxAI platform (version 1.0.3, <ext-link ext-link-type=\"uri\" xlink:href=\"http://dxonline.deepwise.com\">http://dxonline.deepwise.com</ext-link>). Descriptive statistics, including mean, variance, frequency, and percentage, were employed for comprehensive data characterization. Prior to hypothesis testing, an assessment of normality was performed on numerical variables. Subsequently, normally distributed variables were tested using independent sample t-tests, while non-normally distributed variables were tested using Wilcoxon tests. Using unordered categorical variables, the chi-square test was applied. Significance levels were determined using a two-tailed t-test, with a predetermined threshold of <italic>P</italic> &lt; 0.05, denoting statistical significance.</p>", "<title>Ethical approval and consent</title>", "<p id=\"Par21\">Ethical approval to access the patients data was granted by The Second Affiliated Hospital of Harbin Medical University (No. HSA2014-075).</p>" ]
[ "<title>Author contributions</title>", "<p>All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.</p>", "<title>Funding</title>", "<p>This work was supported by the National Natural Science Foundation of China (No. 62171167).</p>", "<title>Data availability</title>", "<p>The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.</p>", "<title>Competing interests</title>", "<p id=\"Par33\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>The process in the development of the clinical-radiomics nomogram for predicting the risk of fibrosis in inflammatory bowel disease.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>The construction of a personalized comprehensive nomogram and the assessment of its performance in predicting the risk of fibrosis in inflammatory bowel disease. (<bold>A</bold>) Nomogram; (<bold>B</bold>) calibration curve; (<bold>C</bold>) decision curve; (<bold>D</bold>) ROC curve on the test set. ROC, receiver operating characteristic.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>ROC curves illustrate the performance of the LR model, clinical model, and clinical-radiomics model on the training set and the validation set.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>The characteristics of patients with inflammatory bowel disease.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Features</th><th align=\"left\" colspan=\"2\">UC (n = 105)</th><th align=\"left\" colspan=\"2\">CD (n = 113)</th><th align=\"left\" rowspan=\"2\"><italic>P</italic> value</th></tr><tr><th align=\"left\">n</th><th align=\"left\">%</th><th align=\"left\">n</th><th align=\"left\">%</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"5\">Gender</td><td align=\"left\">0.584</td></tr><tr><td align=\"left\"> Female</td><td align=\"left\">50</td><td align=\"left\">47.62%</td><td align=\"left\">58</td><td char=\".\" align=\"char\">51.33%</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Male</td><td align=\"left\">55</td><td align=\"left\">52.38%</td><td align=\"left\">55</td><td char=\".\" align=\"char\">48.67%</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\" colspan=\"5\">Histologic fibrosis</td><td align=\"left\">0.880</td></tr><tr><td align=\"left\"> None–mild</td><td align=\"left\">64</td><td align=\"left\">60.95%</td><td align=\"left\">70</td><td char=\".\" align=\"char\">61.95%</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Moderate–severe</td><td align=\"left\">41</td><td align=\"left\">39.05%</td><td align=\"left\">43</td><td char=\".\" align=\"char\">38.05%</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\">Perienteric edema or inflammation</td><td align=\"left\">63</td><td align=\"left\">60.00%</td><td align=\"left\">65</td><td char=\".\" align=\"char\">57.52%</td><td char=\".\" align=\"char\">0.710</td></tr><tr><td align=\"left\">Engorged vasa recta</td><td align=\"left\">46</td><td align=\"left\">43.81%</td><td align=\"left\">53</td><td char=\".\" align=\"char\">46.90%</td><td char=\".\" align=\"char\">0.647</td></tr><tr><td align=\"left\">Lymphadenopathy</td><td align=\"left\">58</td><td align=\"left\">55.24%</td><td align=\"left\">64</td><td char=\".\" align=\"char\">56.64%</td><td char=\".\" align=\"char\">0.835</td></tr><tr><td align=\"left\" colspan=\"5\">Lesion location</td><td align=\"left\">0.101</td></tr><tr><td align=\"left\"> Terminal ileum</td><td align=\"left\">28</td><td align=\"left\">26.67%</td><td align=\"left\">21</td><td char=\".\" align=\"char\">18.58%</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Cecum</td><td align=\"left\">29</td><td align=\"left\">27.65%</td><td align=\"left\">31</td><td char=\".\" align=\"char\">27.43%</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Colon</td><td align=\"left\">37</td><td align=\"left\">35.24%</td><td align=\"left\">36</td><td char=\".\" align=\"char\">31.86%</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Rectum</td><td align=\"left\">11</td><td align=\"left\">10.48%</td><td align=\"left\">25</td><td char=\".\" align=\"char\">22.12%</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\">Age (years)</td><td align=\"left\" colspan=\"2\">46.55 ± 13.28</td><td align=\"left\" colspan=\"2\">47.05 ± 16.33</td><td align=\"left\">0.864</td></tr><tr><td align=\"left\">Thickness of intestinal wall (mm)</td><td align=\"left\" colspan=\"2\">9.55 ± 2.71</td><td align=\"left\" colspan=\"2\">11.00 ± 3.28</td><td align=\"left\">0.382</td></tr><tr><td align=\"left\">AP-CT value (Hu)</td><td align=\"left\" colspan=\"2\">53.94 ± 17.58</td><td align=\"left\" colspan=\"2\">65.57 ± 14.25</td><td align=\"left\">0.034*</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Performance of different models on the training set and test set.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Model</th><th align=\"left\" colspan=\"4\">Test set (n = 145)</th><th align=\"left\" colspan=\"4\">Training set (n = 73)</th></tr><tr><th align=\"left\">AUC (95% CI)</th><th align=\"left\">Accuracy</th><th align=\"left\">Sensitivity</th><th align=\"left\">Specificity</th><th align=\"left\">AUC (95% CI)</th><th align=\"left\">Accuracy</th><th align=\"left\">Sensitivity</th><th align=\"left\">Specificity</th></tr></thead><tbody><tr><td align=\"left\">LDA</td><td align=\"left\">0.738 (0.589–0.907)</td><td align=\"left\">0.691</td><td align=\"left\">0.834</td><td align=\"left\">0.528</td><td align=\"left\">0.922 (0.909–0.935)</td><td align=\"left\">0.828</td><td align=\"left\">0.879</td><td align=\"left\">0.728</td></tr><tr><td align=\"left\">LR</td><td align=\"left\">0.821 (0.647–0.995)</td><td align=\"left\">0.656</td><td align=\"left\">0.812</td><td align=\"left\">0.517</td><td align=\"left\">0.975 (0.963–0.987)</td><td align=\"left\">0.972</td><td align=\"left\">0.962</td><td align=\"left\">0.958</td></tr><tr><td align=\"left\">RF</td><td align=\"left\">0.718 (0.535–0.901)</td><td align=\"left\">0.635</td><td align=\"left\">0.800</td><td align=\"left\">0.319</td><td align=\"left\">1.000 (0.998–1.000)</td><td align=\"left\">1.000</td><td align=\"left\">1.000</td><td align=\"left\">1.000</td></tr><tr><td align=\"left\">SGD</td><td align=\"left\">0.817 (0.646–0.987)</td><td align=\"left\">0.608</td><td align=\"left\">0.729</td><td align=\"left\">0.525</td><td align=\"left\">0.988 (0.977–0.999)</td><td align=\"left\">0.945</td><td align=\"left\">0.962</td><td align=\"left\">0.913</td></tr><tr><td align=\"left\">SVM</td><td align=\"left\">0.711 (0.559–0.863)</td><td align=\"left\">0.619</td><td align=\"left\">0.631</td><td align=\"left\">0.628</td><td align=\"left\">0.997 (0.992–1.000)</td><td align=\"left\">0.986</td><td align=\"left\">0.974</td><td align=\"left\">1.000</td></tr><tr><td align=\"left\">Clinical model</td><td align=\"left\">0.602 (0.447–0.757)</td><td align=\"left\">0.563</td><td align=\"left\">0.693</td><td align=\"left\">0.517</td><td align=\"left\">0.735 (0.716–0.754)</td><td align=\"left\">0.689</td><td align=\"left\">0.619</td><td align=\"left\">0.732</td></tr><tr><td align=\"left\">Nomogram</td><td align=\"left\">0.865 (0.738–0.992)</td><td align=\"left\">0.791</td><td align=\"left\">0.852</td><td align=\"left\">0.913</td><td align=\"left\">0.971 (0.950–0.992)</td><td align=\"left\">0.996</td><td align=\"left\">0.824</td><td align=\"left\">0.965</td></tr></tbody></table></table-wrap>" ]
[ "<disp-formula id=\"Equa\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{gathered} {\\text{Radiomic score}} \\hfill \\\\ \\quad \\quad = 0.36732{\\text{*wavelet}} - {\\text{HHL}}\\_{\\text{glszm}}\\_{\\text{GrayLevelVariance}} + 0.4281 \\hfill \\\\ \\quad \\quad {\\text{*wavelet}} - {\\text{LLL}}\\_{\\text{glcm}}\\_{\\text{Imc}}2 + 0.2896 \\hfill \\\\ \\quad \\quad {\\text{*exponential}}\\_{\\text{glrlm}}\\_{\\text{ShortRunEmphasis}} + 0.1778 \\hfill \\\\ \\quad \\quad {\\text{*logarithm}}\\_{\\text{gldm}}\\_{\\text{LargeDependenceLowGrayLevelEmphasis}} + 0.3584 \\hfill \\\\ \\quad \\quad {\\text{*squareroot}}\\_{\\text{glszm}}\\_{\\text{LargeAreaEmphasis}} - 0.2987{\\text{*wavelet}} \\hfill \\\\ \\quad \\quad - {\\text{HHH}}\\_{\\text{firstorder}}\\_{\\text{Median }} - 0.3012 \\hfill \\\\ \\quad \\quad {\\text{*original}}\\_{\\text{shape}}\\_{\\text{Maximum}}2{\\text{DDiameterSlice}} - 0.2883 \\hfill \\\\ \\quad \\quad {\\text{*gradient}}\\_{\\text{firstorder}}\\_{\\text{Minimum}} - 0.3841{\\text{*original}}\\_{\\text{shape}}\\_{\\text{Sphericity}} \\hfill \\\\ \\quad \\quad - 0.3356{\\text{*gradient}}\\_{\\text{glrlm}}\\_{\\text{RunLengthNonUniformity}} \\hfill \\\\ \\end{gathered}$$\\end{document}</tex-math><mml:math id=\"M2\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mtext>Radiomic score</mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mspace width=\"1em\"/><mml:mspace width=\"1em\"/><mml:mo>=</mml:mo><mml:mn>0.36732</mml:mn><mml:mtext>*wavelet</mml:mtext><mml:mo>-</mml:mo><mml:mtext>HHL</mml:mtext><mml:mi>_</mml:mi><mml:mtext>glszm</mml:mtext><mml:mi>_</mml:mi><mml:mtext>GrayLevelVariance</mml:mtext><mml:mo>+</mml:mo><mml:mn>0.4281</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mspace width=\"1em\"/><mml:mspace width=\"1em\"/><mml:mtext>*wavelet</mml:mtext><mml:mo>-</mml:mo><mml:mtext>LLL</mml:mtext><mml:mi>_</mml:mi><mml:mtext>glcm</mml:mtext><mml:mi>_</mml:mi><mml:mtext>Imc</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo><mml:mn>0.2896</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mspace width=\"1em\"/><mml:mspace width=\"1em\"/><mml:mtext>*exponential</mml:mtext><mml:mi>_</mml:mi><mml:mtext>glrlm</mml:mtext><mml:mi>_</mml:mi><mml:mtext>ShortRunEmphasis</mml:mtext><mml:mo>+</mml:mo><mml:mn>0.1778</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mspace width=\"1em\"/><mml:mspace width=\"1em\"/><mml:mtext>*logarithm</mml:mtext><mml:mi>_</mml:mi><mml:mtext>gldm</mml:mtext><mml:mi>_</mml:mi><mml:mtext>LargeDependenceLowGrayLevelEmphasis</mml:mtext><mml:mo>+</mml:mo><mml:mn>0.3584</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mspace width=\"1em\"/><mml:mspace width=\"1em\"/><mml:mtext>*squareroot</mml:mtext><mml:mi>_</mml:mi><mml:mtext>glszm</mml:mtext><mml:mi>_</mml:mi><mml:mtext>LargeAreaEmphasis</mml:mtext><mml:mo>-</mml:mo><mml:mn>0.2987</mml:mn><mml:mtext>*wavelet</mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mspace width=\"1em\"/><mml:mspace width=\"1em\"/><mml:mo>-</mml:mo><mml:mtext>HHH</mml:mtext><mml:mi>_</mml:mi><mml:mtext>firstorder</mml:mtext><mml:mi>_</mml:mi><mml:mrow><mml:mtext>Median</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mo>-</mml:mo><mml:mn>0.3012</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mspace width=\"1em\"/><mml:mspace width=\"1em\"/><mml:mtext>*original</mml:mtext><mml:mi>_</mml:mi><mml:mtext>shape</mml:mtext><mml:mi>_</mml:mi><mml:mtext>Maximum</mml:mtext><mml:mn>2</mml:mn><mml:mtext>DDiameterSlice</mml:mtext><mml:mo>-</mml:mo><mml:mn>0.2883</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mspace width=\"1em\"/><mml:mspace width=\"1em\"/><mml:mtext>*gradient</mml:mtext><mml:mi>_</mml:mi><mml:mtext>firstorder</mml:mtext><mml:mi>_</mml:mi><mml:mtext>Minimum</mml:mtext><mml:mo>-</mml:mo><mml:mn>0.3841</mml:mn><mml:mtext>*original</mml:mtext><mml:mi>_</mml:mi><mml:mtext>shape</mml:mtext><mml:mi>_</mml:mi><mml:mtext>Sphericity</mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mspace width=\"1em\"/><mml:mspace width=\"1em\"/><mml:mo>-</mml:mo><mml:mn>0.3356</mml:mn><mml:mtext>*gradient</mml:mtext><mml:mi>_</mml:mi><mml:mtext>glrlm</mml:mtext><mml:mi>_</mml:mi><mml:mtext>RunLengthNonUniformity</mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[]
[ "<table-wrap-foot><p>*<italic>P</italic> &lt; 0.05.</p><p><italic>CD</italic> Crohn’s disease, <italic>UC</italic> ulcerative colitis, <italic>AP-CT value</italic> CT value of arterial phase-enhancement.</p></table-wrap-foot>", "<table-wrap-foot><p><italic>LDA</italic> linear discriminative analysis, <italic>LR</italic> logistic regression, <italic>RF</italic> random forest, <italic>SGD</italic> stochastic gradient descent, <italic>SVM</italic> support vector machine.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2023_51036_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2023_51036_Article_Equa.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_51036_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2023_51036_Fig3_HTML\" id=\"MO3\"/>" ]
[]
[{"label": ["4."], "surname": ["Greywoode", "Cunningham", "Hollins", "Aroniadis"], "given-names": ["R", "C", "M", "O"], "article-title": ["Medical cannabis use patterns and adverse effects in inflammatory bowel disease"], "source": ["J. Clin. Gastroenterol."], "year": ["2022"], "pub-id": ["10.1097/MCG.0000000000001782"]}, {"label": ["6."], "surname": ["Akiyama", "Hamdeh", "Sakamoto"], "given-names": ["S", "S", "T"], "article-title": ["The feasibility, safety, and long-term outcomes of endoscopic submucosal dissection for colorectal neoplasia in patients with inflammatory bowel disease: A systematic review and meta-analysis"], "source": ["J. Clin. Gastroenterol."], "year": ["2022"], "volume": ["57"], "fpage": ["721"], "lpage": ["730"], "pub-id": ["10.1097/MCG.0000000000001740"]}, {"label": ["17."], "surname": ["Fu", "Cao", "Song"], "given-names": ["J", "S-J", "L"], "article-title": ["Radiomics/Radiogenomics in hepatocellular carcinoma: Applications and challenges in interventional management"], "source": ["iLiver"], "year": ["2022"], "volume": ["1"], "fpage": ["96"], "lpage": ["100"], "pub-id": ["10.1016/j.iliver.2022.07.001"]}, {"label": ["20."], "surname": ["Sleiman", "Chirra", "Gandhi", "Gordon", "Viswanath", "Rieder"], "given-names": ["J", "P", "N", "IO", "S", "F"], "collab": ["Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium"], "article-title": ["DOP12 Validation of radiomics features on MR enterography characterizing inflammation and fibrosis in stricturing Crohn\u2019s disease"], "source": ["J. Crohns Colitis"], "year": ["2023"], "pub-id": ["10.1093/ecco-jcc/jjac190.0052"]}, {"label": ["23."], "surname": ["Flynn", "Eisenstein"], "given-names": ["S", "S"], "article-title": ["Inflammatory bowel disease presentation and diagnosis"], "source": ["Surg. Clin."], "year": ["2019"], "volume": ["99"], "fpage": ["1051"], "lpage": ["1062"]}, {"label": ["35."], "surname": ["Vanslembrouck", "Rimola"], "given-names": ["R", "J"], "article-title": ["MR enterography and CT enterography for detecting activity and complications"], "source": ["Cross-Sectional Imaging in Crohn\u2019s Disease"], "year": ["2019"], "publisher-name": ["Springer International Publishing"], "fpage": ["77"], "lpage": ["91"]}, {"label": ["38."], "surname": ["Zhang", "Wen"], "given-names": ["L", "J"], "article-title": ["A systematic feature selection procedure for short-term data-driven building energy forecasting model development"], "source": ["Energy Build."], "year": ["2019"], "volume": ["183"], "fpage": ["428"], "lpage": ["442"], "pub-id": ["10.1016/j.enbuild.2018.11.010"]}, {"label": ["41."], "surname": ["Mohamed", "Amin", "El-Shinnawy"], "given-names": ["AM", "SK", "MA"], "article-title": ["Role of CT enterography in assessment of Crohn\u2019s disease activity: Correlation with histopathologic diagnosis"], "source": ["Egypt. J. Radiol. Nucl. Med."], "year": ["2012"], "volume": ["43"], "fpage": ["353"], "lpage": ["359"], "pub-id": ["10.1016/j.ejrnm.2012.05.005"]}]
{ "acronym": [], "definition": [] }
43
CC BY
no
2024-01-14 23:40:15
Sci Rep. 2024 Jan 12; 14:1176
oa_package/77/8b/PMC10786819.tar.gz
PMC10786820
38216676
[ "<title>Introduction</title>", "<p id=\"Par3\">Fatty acid synthase (FAS) is responsible for de novo synthesis of palmitate (Fig. ##FIG##0##1A##), a 16-carbon chain hydrocarbon molecule involved in lipid synthesis, energy storage, and intra-cellular signaling<sup>##REF##36151372##1##–##REF##24457260##4##</sup> Type I Fungal FAS is a well-structured and highly stable complex with approximately 95% of the assembly being static with elastic motion<sup>##REF##24457260##4##,##REF##25456814##5##</sup>. In yeast model organism, <italic>Saccharomyces cerevisiae</italic>, it was found that six copies of each <italic>FAS1</italic> and <italic>FAS2</italic> gene products, termed beta and alpha chains, respectively, form a 2.6 MDa barrel-shaped complex intersected at the equator with a central disk, creating two reaction chambers (Fig. ##FIG##0##1B##)<sup>##REF##17448991##6##–##REF##18725634##9##</sup>. Recently, Tma17p has been identified as a weakly interacting protein in <italic>S. cerevisiae</italic> FAS as an integral part of the complex and is termed γ-subunit<sup>##REF##32160528##10##</sup>. Fatty acid synthesis including priming, elongation, and termination occurs inside the barrel by shuttling of the substrates and intermediates between catalytic domains<sup>##REF##36151372##1##,##REF##20731893##11##</sup>.</p>", "<p id=\"Par4\"><italic>S. cerevisiae</italic> Acyl Carrier Protein (ACP), an 18 kDa, eight alpha-helical protein domains, is doubly tethered to the wall and central disk of the reaction chamber by a N-terminal 45 amino acid and a C-terminal 25 amino acid flexible linkers. ACP is post-translationally modified on its catalytic serine residue by attachment of a coenzyme-A derived phosphopantetheine (Ppant) moiety<sup>##REF##19679086##12##</sup>. During fatty acid synthesis, substrate and reaction intermediates are covalently bound to the terminal thiol of Ppant enabling ACP-mediated substrate shuttling. The pivot points of the linkers are located opposite to the site of the phosphopantetheine prosthetic group, allowing the ACP to sample the entire space of the reaction chamber, as well as preventing the linkers from interfering with ACP docking to catalytic domains<sup>##REF##20704262##13##</sup>.</p>", "<p id=\"Par5\">ACP has been observed bound to the keto synthase (KS) domain in majority of high-resolution structures of <italic>S. cerevisiae</italic> FAS<sup>##REF##17448991##6##,##UREF##0##14##</sup>. Using cryo-EM it was shown that the highest ACP occupancy is at the KS domain<sup>##REF##20231485##15##,##REF##31506493##16##</sup>, however ACP interaction landscape is prone to modulation by acyl chains<sup>##REF##31506493##16##,##REF##31925316##17##</sup>, regulatory proteins, and global conformations of the FAS scaffold<sup>##REF##32160528##10##,##REF##37949058##18##</sup>. ACP exhibits surface electrostatic complementarity to FAS catalytic domains, and it has been speculated that the ACP evolved in step with the canonical lobe to optimally interact with catalytic clefts in the reaction chamber<sup>##REF##17448991##6##,##UREF##1##19##</sup>. Using coarse grain simulation, Anselmi et al. shown that distribution of the ACP among FAS reaction compartments is asymmetric despite the flexibility and proper length of its associated linkers<sup>##REF##20704262##13##</sup>. The asymmetry was attributed to the molecular crowding that would interfere with the freedom of ACP achieving the electrostatic surface interactions in each of the catalytic sites equally.</p>", "<p id=\"Par6\">The three-fold symmetry of a FAS reaction chamber and the long, flexible linkers grant one ACP domain access to three of “each” catalytic centers. For example, one ACP domain may be able to access each of the three KS catalytic sites within one reaction chamber. However, the ACP linkers are invisible in X-ray crystallography and cryoEM reconstructions because of their heterogenous conformation. In fact, ACP linkers are amongst the most divergent regions of FAS, in terms of sequence composition when compared across fungal species<sup>##REF##17431175##7##</sup>. Since ACP linkers are structurally unresolved, it is not possible to identify the position of an ACP domain relative to its FAS2 polypeptide. Therefore, localization pattern of a single ACP domain remains elusive in fungal FAS.</p>", "<p id=\"Par7\">Hence, an overarching question about fatty acid biosynthesis is how an ACP domain shuttles substrates and reaction intermediates among catalytic sites to undergo the iterative fatty acid biosynthesis. Lack of experimental evidence for the ACP distribution due to constraints of FAS symmetricity brought up the idea of developing a method for creating an asymmetric FAS protein that enables study of this question. Here, focusing on <italic>S. cerevisiae</italic> as a model system, we engineered an asymmetric fungal FAS to experimentally probe the distribution of a single ACP domain within the FAS reaction chamber.</p>" ]
[ "<title>Methods</title>", "<title>Cloning</title>", "<p id=\"Par20\">Plasmid constructs used in this study are listed in Supplementary Table ##SUPPL##0##3##. The plasmid containing the chimeric <italic>FAS1-FAS2</italic> fusion (fusFAS plasmid), was constructed as described<sup>##UREF##2##20##</sup>. Series of overlap extension PCR2 performed for substitution of HIS and URA auxotrophic markers along with the insertion of the 10× Histidine affinity tag at the C-terminus of the fused <italic>FAS1-FAS2</italic> gene.</p>", "<p id=\"Par21\">For the insertion of Maltose Binding Protein (MBP) to the N-terminus of the beta chain in the fused <italic>FAS1-FAS2</italic> construct, the MBP was amplified from pET15b -MBP plasmid with primers that contained 50 base pair homology with the <italic>FAS1</italic> linked by a single Glycine to the 18 base pair homology with the C-terminus of <italic>malE</italic> gene. This PCR fragment was then elongated to contain restriction digest sites and subsequently cloned to the NheI-PacI double-digested fused <italic>FAS1-FAS2</italic> using T4-ligation.</p>", "<p id=\"Par22\">For insertion of MBP to the conserved break of Rhodosporidium toruloids (Rtor) fatty acid synthase into the fused <italic>FAS1-FAS2</italic>, MBP elongation was performed out of pET15b-MPB plasmid using primers that contained a homologous region of the MBP linked by 8 repeats of Glycine-Serine to the homologous region of <italic>FAS1</italic> or <italic>FAS2</italic>. This fragment was then elongated from both sides in a way to contain restriction digestion sites and then cloned to the NheI-PacI doubled digested fused <italic>FAS1-FAS2</italic> using NEBuilder (Gibson assembly).</p>", "<p id=\"Par23\">For deletion of the ACP from the FAS2 and <sup>fus</sup>FAS<sup>Rtor-MBP</sup>, a primer was designed containing a sequence immediately before and after the ACP linker’s sequence. This primer was used along with a second primer to amplify a fragment from the centromeric plasmid, which contained restriction digested sites of NheI and PacI. The resulting PCR fragment was double-digested with NheI-PacI and then cloned into the digested plasmid using T4-ligation. Sequences were verified using full plasmid sequencing.</p>", "<title>Yeast strain</title>", "<p id=\"Par24\">Two yeast strains used in this study are listed in Supplementary Table ##SUPPL##0##2##. The haploid <italic>S. cerevisiae</italic> strain W303-FAS1-3×FLAG was prepared as previously reported<sup>##REF##31506493##16##</sup>. The <italic>FAS1 FAS2</italic> double knockout <italic>S. cerevisiae</italic> strain with BY background (BY.PK1238_FAS1-FAS2-dKO) was created by replacing each open reading frame for <italic>FAS1</italic> and <italic>FAS2</italic> with the KanMX cassette<sup>##UREF##4##31##</sup>, and is selected for by growth in presence of 200–500 μg/mL G418 antibiotic.</p>", "<title>Transformation and expression</title>", "<p id=\"Par25\">The fused <italic>FAS1-FAS2</italic> expression vector was transformed into W303-FAS1-3xFLAG yeast strain and selected using HIS3 nutritional marker. Each of the MBP fusion expression vectors were either transfected alone or co-transformed with MF639K1_PRS315_FAS1 (C-terminus twin strepII tag) and MF319d_PRS313_FAS2 to the BY.PK1238_FAS1-FAS2-dKO strain. The transformation was performed firstly by growing each strain on the nutrient-rich plates (Yeast Extract Peptone Dextrose) with G418 (200 μg /mL) and subsequent growth in the same media at 30 degrees to the OD<sub>660</sub> = 0.6–1. Transformation into yeast cells were via the standard lithium acetate method followed by selection on SD plates made up of synthetic dropout media (selective for each expression plasmid’s auxotrophic marker) and D-Glucose. Transfected colonies were then re-streaked on new selective plates and grown for additional two days at 30 degrees.</p>", "<title>Protein purification</title>", "<p id=\"Par26\">To purify fused MBP-tagged FAS constructs from <italic>S. cerevisiae</italic> (i.e., prep <bold>2</bold> and <bold>3</bold>), transfected cells were grown in selective media followed by scale-up in 1 Litter YPD to OD<sub>660</sub> = 2.5-3. Cells were harvested via centrifugation at 4000 g, 4 °C, 15 min and resuspended in lysis buffer (pH 7.5, 33.5 mM KH<sub>2</sub>PO<sub>4</sub>, 66 mM K<sub>2</sub>HPO<sub>4</sub>, 300 mM KCl, 10 mM Imidazole) with protease inhibitors (0.5 mM PMSF, 1 mM benzamidine, 5 mM aminocaproic acid, 10 mM NaF, 50 mM β-glycerophosphate). Cell lysis was performed by bead-beating in the Stainless-Steel Chamber Jar (Biospec Products) with 0.5 mm glass beads for 10 cycles of 30 s bead beating followed by 1 min rest to cool the sample. The resultant lysate was spun twice, first at 4000 g at 4 °C for 15 min to eliminate crude cell debris and then at 110,000 g at 4 °C for 1 h to remove fine debris. The lysate was filtered through a 0.22 μm syringe filter. For prep <bold>1</bold>, the lysate passed through the Poly-Prep Chromatography Column (Bio-Rad, United States) with 0.5 ml bed volume of Anti-FLAG M2 affinity gel (Sigma-Aldrich, United States). Following protein binding, the column was washed with 5 bed volumes of lysis buffer, followed by 5 bed volumes of Tris Buffered Saline (TBS) (pH 7.4, 50 mM Tris, 150 mM NaCl). Protein was eluted with 3 bed volumes of 150 μg/mL 3 × FLAG peptide in TBS buffer. For preps <bold>2</bold> and <bold>3</bold>, Ni- NTA affinity chromatography (20 mM imidazole wash, 300 mM imidazole elution) followed by size-exclusion (Superose 6 Increase 10/300 GL column in TBS buffer) was used to purify the fused FAS1-FAS2, MBP-tagged fatty acid constructs.</p>", "<p id=\"Par27\">For the tandem purification of Rtor-MBP tagged <sup>fus</sup>FAS and the endogenous FAS (i.e., preps <bold>4</bold> and <bold>5</bold>), first Ni-NTA affinity beads were used to purify the Rtor-MBP tagged FAS which had a 10× Histidine, followed by passing through Streptactin column connected to ÄKTA pure to capture endogenous FAS with the twin strep-II tag on C-terminus of FAS1 and eluting with 2.5 millimolar desthiobiotin.</p>", "<title>Negative stain electron microscopy</title>", "<p id=\"Par28\">For preparing negative stain grids, Cu/Rh grids coated with an amorphous carbon support layer were glow discharged for 25 sec using 15 mA current, in air at a pressure of 0.39 bar. Proteins (0.01–0.05 mg/ml) were dispersed on the grid and incubated for 2 min at room temperature. Excess proteins were washed three time in 50 μl water drops followed by staining with a 50 μl of 0.02% w/v Uranyl Acetate. Grids were screened on the Talos L120C equipped with an LaB<sub>6</sub> filament and a Ceta-M camera at 57,000 × (2.48 Å/px) and 73,000 × (1.94 Å/px) with ~50 e<sup>−</sup>/Å<sup>2</sup> dose. Image analysis for the N-terminus MBP-fused FAS1-FAS2 was performed by <italic>cryoSPARC v3.2</italic> on a small dataset of 25 micrographs. CTF estimation was performed with CTFFIND4. Particles were picked manually to generate templates for automatic particle picking using template matching, followed by iterations of 2D classification to isolate the best particles.</p>", "<title>Cryo-EM specimen preparation</title>", "<p id=\"Par29\">Purified FAS complexes concentrated to 2 mg/ml followed by applying 3 μl onto in-house nanofabricated holy sputtered gold girds with a hole size of ~2 μm and a 4 μm period. Grid freezing was done in Vitrobot Mark IV (FEI) with 3-second blotting at 4 °C, 90% humidity and using liquid ethane kept at liquid nitrogen temperature.</p>", "<title>Cryo-EM data collection and analysis</title>", "<p id=\"Par30\">Image processing statistics can be found in Table ##TAB##0##1##. Cryo screening was done using a ThermoFisher Scientific (TFS) Talos L120C G2 transmission electron microscope (TEM) equipped with a LaB<sub>6</sub> crystal and a Ceta camera, operating at 120 kV Cryo-EM. Movies for high-resolution analysis were collected with a Titan Krios G3 microscope operated at 300 kV and equipped with Falcon 4i camera (TFS). Automated data collection was performed by EPU.</p>", "<p id=\"Par31\">Patch motion correction and patch CTF estimation were used to align and averaged movie frames and correct for CTF in <italic>cryoSPARCv4</italic> with last movie frame ignored. Automatic particle picking was done using template matching with template generated via manual particle image picking and 2D classification. For all constructs discussed in this study, the initial auto-picked particle image stacks were subjected to 2D classifications and heterogenous refinements to remove images corresponding to contaminants and broken particles. The final particle image stacks were subjected to local and global CTF refinements followed by a homogenous refinement with either no symmetry or D3 symmetry enforced. Default parameters were used unless stated otherwise. For reconstruction of asymmetric FAS cryoEM density maps, D3 refined particle images stacks were symmetry expanded and were 3D classified without orientation search using a focused mask as described in the manuscript. 3D classifications without orientation search were done in <italic>cryoSPARC v4.1.0</italic> using default parameters. Particle images belonging to the MBP-containing 3D classes were selected followed by the removal of duplicate images. These images were used to reconstruct the final 3D volume of the asymmetric FAS constructs as described in the manuscript. More specifically, default parameters were used in the final local refinement except for (1) rotation and shift search extends were limited to 1 degree and 1 Å, respectively, (2) maximum alignment resolution was set to 0.1 degrees, (3) force-redo GS split was set to on, and 4) non-uniform refine enable was set to off.</p>", "<p id=\"Par32\">cryoEM densities corresponding to ACP domains (residues 141-302 of FAS2) docked at the KS binding sites were quantified in UCSF Chimera v1.16 for each 3D reconstruction of asymmetric FAS from preps <bold>4</bold> and <bold>5</bold>. Specifically, atomic model of FAS (PDB 6TA1) was rigid body docked into the respective cryoEM maps of the asymmetric FAS aligned based on MBP domain as described above. Densities around each amino acid of each ACP domain was then measured at an identical threshold value within each map. These densities were normalized to the average cryoEM density of KS heterodimer composed of two sets of residues 1120-1179 contributed from two FAS2 chains (Supplementary Fig. ##SUPPL##0##4##) for each respective cryoEM map. This region of the KS heterodimer faces both reaction chambers of FAS and forms two docking sites on each side of the FAS central disks for ACP binding in each respective reaction chamber. Data were plotted as box plots in excel indicating median line, first and third quartiles, whiskers, and outliers (Fig. ##FIG##4##5##).</p>", "<title>Statistics and reproducibility</title>", "<p id=\"Par33\">CryoEM datasets contain hundreds of thousands to millions of particle images, creating an inherent replication in the method. However, the extensive cryoEM dataset could not be duplicated due to the expenses associated with electron microscope data collection and the constraints of available disk space. The size of the cryoEM data was chosen based on its capacity to achieve a final 3D reconstruction with a global resolution of 3.5 Angstroms or better. Statistical analysis for the differences in cryoEM densities of amino acids corresponding to the ACP domains of FAS in Fig. ##FIG##4##5## was done using homoscedastic, one-tailed <italic>T</italic> tests.</p>", "<title>Reporting summary</title>", "<p id=\"Par34\">Further information on research design is available in the ##SUPPL##4##Nature Portfolio Reporting Summary## linked to this article.</p>" ]
[ "<title>Results</title>", "<title>Protein engineering and expression setup</title>", "<p id=\"Par8\">As a proof of concept, we set out to test if expression of a FAS1-FAS2 fusion (i.e., <sup>fus</sup>FAS) polypeptide in a yeast strain expressing native <italic>FAS1</italic> and <italic>FAS2</italic> genes results in the integration of fusion polypeptide into endogenous FAS protein complex (Supplementary Table ##SUPPL##0##1##). A centromeric plasmid with the <sup><italic>fus</italic></sup><italic>FAS</italic> gene under control of FAS1 promoter and FAS2 terminator was previously designed and shown to be functional in yeast cells<sup>##UREF##2##20##</sup>. Gene fusion was done using <italic>Ustilago maydis FAS</italic> sequence that naturally expresses a fusion gene. The fusion construct lacked any affinity tag, while a 3 × FLAG was inserted at the c-terminus of the <italic>FAS1</italic> gene on yeast genomic DNA (W303 strain, Supplementary Table ##SUPPL##0##2##). A single step affinity purification against 3 × FLAG showed co-purification of a ~400 kDa polypeptide by the SDS-PAGE that approximately corresponded to the combined molecular weights of FAS1 (~220 kDa) and FAS2 (~200 kDa) polypeptides (Fig. ##FIG##1##2##). We name this protein preparation ‘prep <bold>1</bold>’ and assign increasing numbers for subsequent protein preparations described below. This observation indicated integration of the fusion polypeptide into the native FAS architecture. Band intensity analysis estimated an approximate 15:1 ratio of the native polypeptides (i.e., endogenous FAS1 and FAS2) to that of the <sup>fus</sup>FAS polypeptide. If one fusion polypeptide is integrated per FAS assembly, one would expect a ratio of 5:1 native:fusion chain. 15:1 ratio implies that the fusion polypeptide was purified at lower stoichiometry that its native counterparts with some FAS complexes composed solely by native FAS1 and FAS2 chains.</p>", "<p id=\"Par9\">Presence of <sup>fus</sup>FAS chain at a limiting stoichiometry is beneficial for in silico alignment of the cryoEM particle images based on the position of the fusion polypeptide within the assembly as described later. However, the 15:1 ratio indicated that at least half of the purified proteins were devoid of <sup>fus</sup>FAS chain. Therefore, we asked if this ratio can be modulated by a tandem affinity purification scheme with the capture of the <sup>fus</sup>FAS chain followed by the capture of the native FAS1 chain. Accordingly, we modified the purification method to enable a tandem affinity capture procedure as described below.</p>", "<title><italic>Image alignment based on</italic><sup>fus</sup>FAS polypeptide</title>", "<p id=\"Par10\">To facilitate FAS particle image alignment based on the position of the <sup>fus</sup>FAS chain; a unique structural feature is needed that distinguishes the engineered polypeptide from its native counterparts. We chose maltose-binding protein (MBP), which is a 6 nm wide soluble tag and considered insertion at two distinct sites on the <sup>fus</sup>FAS chain. These sites included single tethering to the N-terminus of <sup>fus</sup>FAS chain (i.e., <sup>fus</sup>FAS<sup>N-MBP</sup> chain) and double tethering to a loop in the FAS1 segment of the <sup>fus</sup>FAS chain that is naturally disconnected in FAS from <italic>Rhodosporidium toruloides</italic> yeast<sup>##REF##25761671##21##</sup> (i.e., <sup>fus</sup>FAS<sup>Rtor-MBP</sup> chain). Ideally, insertion of the MBP tag should have minimal impact on FAS structural assembly. Therefore, we decided not to insert the MBP domain at the natural breaking point in <italic>S. cerevisiae</italic> FAS since MPT domain is the site of co-translational assembly of FAS1 and FAS2 polypeptides<sup>##REF##30158700##22##</sup>. MBP domain was linked to the N-terminus of the <sup>fus</sup>FAS chain with a two amino acid linker sequence (i.e., GS) to minimize domain flexibility that can degrade the accuracy of image classification based on MBP occupancy. Similarly, to minimize MBP domain flexibility, an eight amino acid linker (i.e., GSGSGSGS) was used for MBP double tethering (Fig. ##FIG##2##3A##) based on the distance between the N- and C-terminal ends of the MBP domain (i.e., 36 Å based on PDB 3MBP<sup>##REF##9309217##23##</sup>).</p>", "<p id=\"Par11\">For the two MBP insertion sites discussed above, impact of structural modification on FAS assembly was assessed in a yeast strain with <italic>FAS1</italic> and <italic>FAS2</italic> genes deleted (strain BY.PK1238, Supplementary Table ##SUPPL##0##2##). We hypothesized that expression of the fusion polypeptide in the absence of native chains will result in FAS assemblies composed completely of engineered chains (i.e., preps <bold>2</bold> and <bold>3</bold>). All constructs were expressed by transformation of the yeast cells with a centromeric plasmid containing the target MBP-tagged FAS fusion gene with a C-terminal 10×HIS affinity tag. Prep <bold>2</bold> (i.e., 6 × <sup>fus</sup>FAS<sup>N-MBP</sup> chains) was expressed and purified but was unstable as judged by lack of image alignment for the apical region of the FAS dome (Supplementary Fig. ##SUPPL##0##1A, B##). The observed structural instability is likely due to the proximity of the N-termini of <sup>fus</sup>FAS chains (&lt;10 Å) at the 3-fold axis of the barrel-shaped structure that results in steric clashes between the MBP tags. Surprisingly, however, the <italic>FAS1</italic> and <italic>FAS2</italic> KO yeast cells were able to grow in the absence of exogenous fatty acids by transformation with centromeric plasmid expressing <sup>fus</sup>FAS<sup>N-MBP</sup> chain, indicating that the complex maintained minimal catalytic activity necessary for the fungal growth. Prep <bold>3</bold> (i.e., 6 × <sup>fus</sup>FAS<sup>Rtor-MBP</sup> chain) was not dependent on exogenous fatty acids as well and resulted in 2D classes and a 3D cryoEM map representative for the native FAS assemblies (Supplementary Fig. ##SUPPL##0##2##). The position of the MBP density was clearly observed at the site of insertion in the cryoEM density map. Rigid body fitting of FAS1 and FAS2 chains from native FAS atomic model (PDB 6TA1)<sup>##REF##32148850##24##</sup> into the cryoEM density demonstrated minimal structural impact from the inserted MBP domain (Supplementary Fig. ##SUPPL##0##2C##). <sup>fus</sup>FAS<sup>Rtor-MBP</sup> chain was therefore chosen to be co-expressed with native FAS1 and FAS2 polypeptides to generate asymmetric FAS assemblies containing MBP domains as discussed below.</p>", "<p id=\"Par12\">The centromeric plasmid expressing <sup>fus</sup>FAS<sup>Rtor-MBP</sup> chain was co-transformed in a <italic>FAS1</italic> and <italic>FAS2</italic> KO yeast strain with centromeric plasmids containing native <italic>FAS1</italic> and <sup>Δ</sup><italic>FAS2</italic> genes, with <sup>Δ</sup> representing ACP deletion (prep <bold>4</bold>). To delete ACP domain, the N- and C-terminal linkers of the shuttling domain were fused at their junction with the shuttling domain (Fig. ##FIG##2##3B##). <italic>FAS1</italic> gene was tagged with a C-terminal twin strep-II tag. Tandem purification of FAS from this strain estimated a chain intensity ratio of approximately 5:2 of native:fusion polypeptide (Fig. ##FIG##2##3C##). Mixed chain FAS was also purified even when ACP domain was deleted on the fusion chain, while maintained on the FAS2 chain (i.e., prep <bold>5</bold>) (Fig. ##FIG##2##3D##). Applying 2D classification and 3D reconstruction, we obtained cryoEM maps that closely resembled the structure of the wild type FAS, except for weak densities corresponding to the MBP domains that protruded out of the barrel (Fig. ##FIG##2##3C, D##). MBP densities are considerably weaker than the corresponding densities for the FAS barrel since most FAS complexes have only one MBP tagged fusion chain and image alignment is primarily influenced by the FAS barrel protein that compose ~95% of the signal (i.e., protein mass) in the particle images.</p>", "<p id=\"Par13\">We then set out to align FAS particle images based on the position of the MBP fusion chain from prep <bold>4</bold> and <bold>5</bold> (Fig. ##FIG##3##4A, B##, respectively). 2D and 3D classifications were used to select intact particle projections and discard partially unfolded particle images that are the result of FAS interaction with air-water interface as shown previously via electron tomography studies on fungal FAS<sup>##REF##30932812##25##</sup>. Intact particle images were symmetry expanded based on alignment information from a consensus 3D refinement with D3 symmetry imposed. A focused mask composed of segments of ER and DH domains (i.e., FAS1 residues 561-812, 1056-1109, 1123-1256), plus the expected position of the MBP domain in prep <bold>4</bold> and <bold>5</bold> was made. The expected position of MBP domain was determined from the cryoEM map of prep <bold>3</bold> (Supplementary Fig. ##SUPPL##0##2##). Symmetry expanded particles were 3D classified using orientation information from the consensus D3 refinement. We previously used a similar strategy to classify FAS particles based on ACP domain occupancy at the dehydratase catalytic site in fungal FAS<sup>##REF##31925316##17##</sup>. Approximately 10% and 22% of the total symmetry expanded particle images classified in 3D classes with a strong signal corresponding to the MBP domain, for prep <bold>4</bold> and <bold>5</bold>, respectively. We then removed duplicate particles to revert to original non symmetry expanded particle images. Duplicate particles indicate that the symmetry rotated and translated version of the same particle image was classified as containing MBP domain, which is indicative of FAS assemblies that have more than one <sup>fus</sup>FAS<sup>Rtor-MBP</sup> chain. Therefore, by removing duplicates, assemblies with only one <sup>fus</sup>FAS<sup>Rtor-MBP</sup> chain were selected. 34% and 38% of the intact (i.e., not disassembled by air-water interface) FAS particle projections from prep <bold>4</bold> and <bold>5</bold>, respectively, contained a single fusion chain with the remainder containing more than one. Intact FAS projections containing a single MBP domain were used to reconstruct a 3D density map with no symmetry imposed starting from the alignment information from their respective focused 3D classification (Supplementary Fig. ##SUPPL##0##3##). Reference volume for the final 3D reconstruction did not contain any signal for MBP or ACP domains and orientation search was restricted to 1 degree rotational and 1 Å translational searches. This was to ensure that MBP and ACP density reconstruction in the final map were not affected by priori bias and no major deviation from the orientation assignment from the 3D classification occurs during C1 refinement since 95% of signal is contributed by FAS barrel.</p>", "<p id=\"Par14\">MBP domain is localized strongly to only one asymmetric unit of FAS in the final cryoEM reconstruction from prep <bold>4</bold> (Fig. ##FIG##3##4A##) and ACP densities are almost non-existent in the reaction chamber opposite to the one containing the MBP domain (Fig. ##FIG##4##5A##). Densities corresponding to the ACP domain within the MBP-containing reaction chamber are non-uniformly distributed in each asymmetric unit with a small but statistically significant increase in density for the ACP domain closest to the MBP-fusion chain (Fig. ##FIG##4##5A##). Therefore, one ACP domain can reach all three ketoacyl synthase sites within a reaction chamber with a small preference for localization closer to its N-terminal tethering point attached to the MPT domain of own protomer (Fig. ##FIG##4##5A##, black dot on cryoEM slice).</p>", "<p id=\"Par15\">Steric occlusions by other ACP domains may influence the localization of the substrate shuttling domain<sup>##REF##20704262##13##,##REF##31925316##17##</sup>. Therefore, to further test our observations in FAS from prep <bold>4</bold> in a scenario where there are two ACP domains within a reaction chamber containing MBP domain, we analyzed the FAS complex where ACP was present in the native FAS2 chain but absent in the MBP-fusion chain (i.e., prep <bold>5</bold>). Co-expression of FAS1 and FAS2 chains with <sup>Δfus</sup>FAS<sup>Rtor-MBP</sup> enabled purification of assembly <bold>5</bold> as discussed above. Analysis of cryoEM densities corresponding to the shuttling domains, demonstrated ACP density for all three ketoacyl synthase sites in the MBP-containing reaction chamber but this time with weaker ACP density in proximity of the MBP-fusion chain (Fig. ##FIG##4##5B##), corroborating the observations for assembly <bold>4</bold>. Overall, our studies on asymmetric FAS support the notion of an ACP domain ability to interact with all three KS catalytic sites within one reaction chamber with partial preference to interact with a KS domain that is closer to the MPT tether of ACP’s own protomer.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par16\">One of the key questions in the FAS biosynthesis mechanism relates to the ACP domain interaction landscape within a reaction chamber. This is a multifaceted question since a multitude of factors can impact ACP localization<sup>##UREF##3##26##</sup>, including the nature of the acyl-moiety bound to the terminal thiol of Ppant arm and relative position of catalytic domains to the tethering points of ACP linkers on the reaction chamber. In the conformationally dynamic mammalian FAS<sup>##REF##18772430##27##–##REF##29023094##29##</sup>, the ACP may in addition be restricted in its trajectory by the positional variability of domain, but such constraints do not apply for the rigid fungal FAS. When FAS is purified from yeast, the multienzyme complex loses access to substrates and NADPH and therefore ACP domain will be in a heterogenous chemical state with different acyl intermediates conjugated to its Ppant arms. Considering the above and the time scale of protein domain dynamics that ranges from nano- to micro-seconds, our observation here is a time and chemical average of ACP distribution in FAS when it is isolated from yeast. It is intriguing to observe that one ACP domain can interact with all three available ketoacyl synthase sites in the reaction chamber and populate those sites. This observation is consistent with the perception that an ACP domain cannot just reach the closest set of active sites but also serve more distant catalytic sites.</p>", "<p id=\"Par17\">Although ACP domains show a stochastic interaction pattern at the KS domains, our study indicates that FAS2 chains tend to keep their respective shuttling domain in close proximity to their anchoring points within the <italic>S. cerevisiae</italic> multienzyme complex. Our study indicates that the strongest ACP density belongs to a KS site where both the N- and C-terminus of the ACP are closest to the tethering points of its own FAS2 chain. Tethering point of the N-terminus of an ACP to the MPT domain is 3.8 (own FAS2 chain), 7.1, and 7.3 nm away and the distance of the C-terminal tethering point of the ACP to the FAS2 tethering point is 2.3 nm (own FAS2), 3.2 nm and 3.2 nm. These observations suggest that proximity of the ACP domain tethering point impacts localization of the substrate shuttling domain in fungal FAS. In addition, the length of the linkers as well as their persistence length<sup>##REF##29168376##30##</sup>, the latter defined by the amino acid composition, will define the distribution of ACPs, and the knowledge of these properties allow predicting ACP localization in these enzymes. As an example, the ACP domains of type I FAS from <italic>Mycobacterium tuberculosis</italic> are shorter<sup>##REF##17431175##7##</sup> compared to those from <italic>S. cerevisiae</italic>, which could imply a more proximal shuttling pathway of the ACP domains relative to its tethering points in <italic>M. tuberculosis</italic>.</p>", "<p id=\"Par18\">A caveat in our study is the deletion of one or two ACP domains. Simulation studies have shown that ACP linkers play a major role in the distribution of the shuttling domain through steric collisions and therefore were present in our deletion constructs. However, ACP domain themselves were also shown through simulation to provide some steric guidance in determining the interaction landscape of the shuttling domain<sup>##REF##20704262##13##</sup>. Therefore, it is possible that our observations here are impacted by more space available for ACP movements in both assemblies <bold>4</bold> and <bold>5</bold>.</p>", "<p id=\"Par19\">To experimentally study translocation of a single ACP domain in a chemically controlled manner and in the presence of all three ACP domains within a reaction chamber, one can envision a similar protein production platform with following modification. Instead of domain deletion, ACP domain can be inactivated via a point mutation of S180 (<italic>S. cerevisiae</italic> numbering) to alanine in the FAS2 polypeptide while maintain wild type ACP on the MBP fusion polypeptide. We have shown previously that ACP can be translocated to and away from KS domain in <italic>S. cerevisiae</italic> FAS by stalling the FAS reaction cycle using inactivating point mutation on a target catalytic site (e.g., DH or ER domains)<sup>##REF##31925316##17##</sup>. Similar ACP translocation strategy on FAS complexes with holo ACP domain on the MBP-fusion chain will enable tracking of the shuttling domain to the stalled catalytic sites via cryoEM. Therefore, our work presented here provide an experimental foundation to probe a single ACP domain localization in fungal FAS.</p>" ]
[]
[ "<p id=\"Par1\">Acyl carrier protein (ACP) is the work horse of polyketide (PKS) and fatty acid synthases (FAS) and acts as a substrate shuttling domain in these mega enzymes. In fungi, FAS forms a 2.6 MDa symmetric assembly with six identical copies of FAS1 and FAS2 polypeptides. However, ACP spatial distribution is not restricted by symmetry owing to the long and flexible loops that tether the shuttling domain to its corresponding FAS2 polypeptide. This symmetry breaking has hampered experimental investigation of substrate shuttling route in fungal FAS. Here, we develop a protein engineering and expression method to isolate asymmetric fungal FAS proteins containing odd numbers of ACP domains. Electron cryomicroscopy (cryoEM) observation of the engineered complex reveals a non-uniform distribution of the substrate shuttling domain relative to its corresponding FAS2 polypeptide at 2.9 Å resolution. This work lays the methodological foundation for experimental study of ACP shuttling route in fungi.</p>", "<p id=\"Par2\">A protein engineering strategy has revealed that an acyl carrier protein domain is asymmetrically distributed within the reaction chamber of a fatty acid synthase from the yeast <italic>Saccharomyces cerevisiae</italic>.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n\n\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s42003-024-05777-7.</p>", "<title>Acknowledgements</title>", "<p>This study was supported by Canadian Institutes of Health Research (CIHR) project grant number: 419240, a discovery grant from the Natural Sciences and Engineering Research Council of Canada (NSERC, RGPIN-2018-06070), and Princess Margaret Cancer Foundation (PMCF). EKS and AFAK were supported by PMCF. JWL and DLD were supported by PMCF and NSERC CGS-D awards. MTMJ was supported by PMCF. We thank the Toronto High Resolution High Throughput cryo-EM facility, supported by the Canada Foundation for Innovation and Ontario Research Fund, for cryo-EM data collection. Talos L120C was funded by Canada Foundation for Innovation (CFI) and Ontario Research Fund-Research Innovation (ORF-RI).</p>", "<title>Author contributions</title>", "<p>E.K.S. performed DNA cloning, protein purification, cryoEM and negative stain sample preparation, data collection, image analysis, and wrote the manuscript; A.C.C. performed protein purification, EM sample preparation, and data collection and analysis; J.W.L. performed DNA cloning; D.L.D. and A.F.A.K. performed cryoEM screening and data collection; G.T. performed DNA cloning; C.B. and M.T.M.J. supervised the experiments; M.G. provided resources and aid experimental design. MTMJ conceived the study, provided funding, wrote the manuscript, and all authors reviewed and edited the final manuscript.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par35\"><italic>Communications Biology</italic> thanks the anonymous reviewers for their contribution to the peer review of this work. Primary Handling Editors: Tuan Anh Nguyen and David Favero.</p>", "<title>Data availability</title>", "<p>cryoEM density maps are deposited into EMDB with accession codes EMD-40783, EMD-40784, EMD-40785. Source data for Fig. ##FIG##4##5## can be found in supplementary data ##SUPPL##2##1## and supplementary data ##SUPPL##3##2##. Uncropped and unedited images of gel shown in Figs. ##FIG##1##2## and ##FIG##2##3## are provided in supplementary Fig. ##SUPPL##0##5##. All materials are available upon reasonable request.</p>", "<title>Competing interests</title>", "<p id=\"Par36\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Fungal fatty acid synthesis.</title><p><bold>A</bold> FAS catalyzed anabolism of saturated fatty acids from acetyl- and malonyl-CoA using NADPH and FMN as cofactors. <bold>B</bold> Structure (PDB 6TA1) and domain organization of <italic>S. cerevisiae</italic> FAS. One α- and β-chain that are integrated within the MPT domain are colored in the 3D model and highlighted in the schematic architecture of FAS to the right. The N- and C-terminus of α- and β-chains, respectively, within the MPT domain are shown as an inset.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>Production of asymmetric fungal FAS.</title><p><bold>A</bold> schematic representation for biosynthesis of asymmetric FAS proteins (i.e., prep <bold>1</bold>). The schematics of a yeast cells expressing asymmetric FAS protein is shown. The promoters and terminators of each gene are shown as a color-coded line flanking the respective gene. <bold>B</bold> SDS-PAGE analysis of purified FAS from <italic>S. cerevisiae</italic> yeast alone or transformed with vector expressing the β-α fusion polypeptide. A representative negative stain micrograph of FAS proteins purified from yeast transformed with the fusion FAS vector.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Preparation of MBP-tagged fatty acid synthase.</title><p><bold>A</bold> MBP insertion site in <sup>fus</sup>FAS chain is shown. Two eight-residue linkers were used to doubly tether the MBP domain (PDB: 3MBP) to FAS1. <bold>B</bold> ACP domain deletion strategy is shown. ACP model from PDB 6TA1. Purification of asymmetric FAS with deletion of the ACP domain in (<bold>C</bold>) FAS2 (i.e., prep <bold>4</bold>) and <bold>D</bold>) <sup>fus</sup>FAS chain (i.e., prep <bold>5</bold>). From left to right: schematic of cell expressing the MBP tagged constructs, SDS-PAGE of tandem affinity purification (Ni-NTA pull down followed by twin strep-II tag affinity purification) of the engineered FAS, and 3D cryoEM density maps of the purified complex. One MBP domain is highlighted with red circle in each cryoEM map.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>In silico purification and alignment of FAS complexes containing one MBP tag.</title><p>Polypeptides composing each sample in panels (<bold>A</bold>) from prep <bold>4</bold> and (<bold>B</bold>) prep <bold>5</bold> are shown on the top. Transparent cryoEM map in the middle, shows the region of the complex used in focused 3D classification. 2D projections of selected 3D cryoEM density maps are shown. All 3D maps and 2D projections are shown from the same viewing direction.</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><title>ACP domain distribution in asymmetric <italic>S. cerevisiae</italic> FAS.</title><p>Schematic illustration and slices of the cryoEM density maps of FAS complexes containing (<bold>A</bold>) one (i.e., prep <bold>4</bold>) and (<bold>B</bold>) five ACP domains (i.e., prep <bold>5</bold>). The tethering point of ACP to the MPT domain of <sup>fus</sup>FAS chain is highlighted with a black dot in the cryoEM slices. cryoEM density (denoted as (i)) around each amino acid of each ACP domain is normalized against the cryoEM density of KS domain (Supplementary Fig. ##SUPPL##0##4##) and is plotted as box plots. Mean voxel density is set to zero for each 3D reconstruction. See material and method for details of density quantification. Final cryoEM density reconstruction (Table ##TAB##0##1##, EMD-40784 and EMD-40785) was used for density quantification of FAS2 amino acids 141 to 166 corresponding to the ACP domain (<italic>n</italic> = 161). Differences are statistically assess using a homoscedastic, one-tailed <italic>T</italic> test.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>cryoEM Data collection and refinement statistics.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th/><th><sup>fus</sup>FAS<sup>Rtor-MBP</sup> (EMD-40783)</th><th><sup>fus</sup>FAS<sup>Rtor-MBP</sup> + FAS1 + FAS2<sup>ΔACP</sup> (EMD-40784)</th><th><sup>ΔACP-fus</sup>FAS<sup>Rtor-MBP</sup> + FAS1 + FAS2 (EMD-40785)</th></tr></thead><tbody><tr><td colspan=\"4\"><bold>Data collection and processing</bold></td></tr><tr><td>Magnification</td><td>75,000</td><td>75,000</td><td>75,000</td></tr><tr><td>Voltage (kV)</td><td>300</td><td>300</td><td>300</td></tr><tr><td>Electron exposure (e–/Å<sup>##REF##34156235##2##</sup>)</td><td>54.76</td><td>40.36</td><td>36.00</td></tr><tr><td>Defocus range (μm)</td><td>0.6–2.5</td><td>0.6–2.5</td><td>0.6–2.5</td></tr><tr><td>Pixel size (Å)</td><td>1.03</td><td>1.03</td><td>1.03</td></tr><tr><td>Symmetry imposed</td><td>C1</td><td>C1</td><td>C1</td></tr><tr><td>Initial particle images (no.)</td><td>102,657</td><td>623,888</td><td>640,558</td></tr><tr><td>Final particle images (no.)</td><td>71,932</td><td>49,548</td><td>167,630</td></tr><tr><td>Map resolution (Å) (FSC 0.143)</td><td>3.21</td><td>3.19</td><td>2.87</td></tr><tr><td>Map resolution range (Å)</td><td>10–2.5</td><td>10–2.5</td><td>10–2.5</td></tr><tr><td colspan=\"4\"><bold>Refinement</bold></td></tr><tr><td>Initial model used (PDB code)</td><td>N/A</td><td>N/A</td><td>N/A</td></tr><tr><td>Model resolution (Å)</td><td>N/A</td><td>N/A</td><td>N/A</td></tr><tr><td>   FSC threshold</td><td/><td/><td/></tr><tr><td>Model resolution range (Å)</td><td>N/A</td><td>N/A</td><td>N/A</td></tr><tr><td>Map sharpening <italic>B</italic> factor (Å<sup>2</sup>)</td><td>N/A</td><td>N/A</td><td>N/A</td></tr><tr><td><italic>Model composition</italic></td><td>N/A</td><td>N/A</td><td>N/A</td></tr><tr><td>  Non-hydrogen atoms</td><td/><td/><td/></tr><tr><td>  Protein residues</td><td/><td/><td/></tr><tr><td>  Ligands</td><td/><td/><td/></tr><tr><td><italic>B factors (Å</italic><sup><italic>2</italic></sup><italic>)</italic></td><td>N/A</td><td>N/A</td><td>N/A</td></tr><tr><td>  Protein</td><td/><td/><td/></tr><tr><td>  Ligand</td><td/><td/><td/></tr><tr><td><italic>R.m.s. deviations</italic></td><td>N/A</td><td>N/A</td><td>N/A</td></tr><tr><td>  Bond lengths (Å)</td><td/><td/><td/></tr><tr><td>  Bond angles (°)</td><td/><td/><td/></tr><tr><td><italic>Validation</italic></td><td>N/A</td><td>N/A</td><td>N/A</td></tr><tr><td>  MolProbity score</td><td/><td/><td/></tr><tr><td>  Clashscore</td><td/><td/><td/></tr><tr><td>  Poor rotamers (%)</td><td/><td/><td/></tr><tr><td><italic>Ramachandran plot</italic></td><td>N/A</td><td>N/A</td><td>N/A</td></tr><tr><td>  Favored (%)</td><td/><td/><td/></tr><tr><td>  Allowed (%)</td><td/><td/><td/></tr><tr><td>  Disallowed (%)</td><td/><td/><td/></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM5\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"42003_2024_5777_Fig1_HTML\" id=\"d32e321\"/>", "<graphic xlink:href=\"42003_2024_5777_Fig2_HTML\" id=\"d32e455\"/>", "<graphic xlink:href=\"42003_2024_5777_Fig3_HTML\" id=\"d32e543\"/>", "<graphic xlink:href=\"42003_2024_5777_Fig4_HTML\" id=\"d32e728\"/>", "<graphic xlink:href=\"42003_2024_5777_Fig5_HTML\" id=\"d32e786\"/>" ]
[ "<media xlink:href=\"42003_2024_5777_MOESM1_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>", "<media xlink:href=\"42003_2024_5777_MOESM2_ESM.pdf\"><caption><p>Description of Additional Supplementary Files</p></caption></media>", "<media xlink:href=\"42003_2024_5777_MOESM3_ESM.xlsx\"><caption><p>Supplementary Data 1</p></caption></media>", "<media xlink:href=\"42003_2024_5777_MOESM4_ESM.xlsx\"><caption><p>Supplementary Data 2</p></caption></media>", "<media xlink:href=\"42003_2024_5777_MOESM5_ESM.pdf\"><caption><p>Reporting Summary</p></caption></media>" ]
[{"label": ["14."], "mixed-citation": ["Leibundgut, M., Maier, T., Jenni, S. & Ban, N. The multienzyme architecture of eukaryotic fatty acid synthases. "], "italic": ["Curr. Opin. Struct. Biol."]}, {"label": ["19."], "surname": ["Rossini", "Gajewski", "Klaus", "Hummer", "Grininger"], "given-names": ["E", "J", "M", "G", "M"], "article-title": ["Analysis and engineering of substrate shuttling by the acyl carrier protein (ACP) in fatty acid synthases (FASs)"], "source": ["Chem. Commun."], "year": ["2018"], "volume": ["54"], "fpage": ["11606"], "lpage": ["11609"], "pub-id": ["10.1039/C8CC06838K"]}, {"label": ["20."], "mixed-citation": ["Wernig, F., Born, S., Boles, E., Grininger, M. & Oreb, M. Fusing \u03b1 and \u03b2 subunits of the fungal fatty acid synthase leads to improved production of fatty acids. "], "italic": ["Sci. Rep."], "bold": ["10"]}, {"label": ["26."], "mixed-citation": ["Buyachuihan, L. et al. How acyl carrier proteins (ACPs) direct fatty acid and polyketide biosynthesis. "], "italic": ["Angew. Chem. International Ed."]}, {"label": ["31."], "mixed-citation": ["Gajewski, J., Pavlovic, R., Fischer, M., Boles, E. & Grininger, M. ARTICLE Engineering fungal de novo fatty acid synthesis for short chain fatty acid production. 10.1038/ncomms14650 (2017)."]}]
{ "acronym": [], "definition": [] }
31
CC BY
no
2024-01-14 23:40:15
Commun Biol. 2024 Jan 12; 7:92
oa_package/60/9d/PMC10786820.tar.gz
PMC10786821
38216614
[ "<title>Introduction</title>", "<p id=\"Par2\">The urgency for new and effective drugs is becoming increasingly pressing in modern medicine across various classes of drugs, such as antibiotics, owing to the emergence of drug-resistant bacteria, cancer treatments, tumor heterogeneity, and neurodegenerative conditions, hindered by complexities in drug delivery and understanding disease mechanisms, autoimmune disorders, reflecting complex immune system targeting, and antiviral treatments, complicated by rapid mutation rates and latent viral reservoirs<sup>##REF##26791724##1##–##REF##27156434##4##</sup>. This evolving landscape emphasizes the urgent requirement for new therapeutic agents, calling for a renewed focus and investment in research and development to stay ahead of this critical healthcare need.</p>", "<p id=\"Par3\">Drug discovery is a complex and time-consuming process that requires exploration of a vast chemical space. In living systems, proteins and small molecules constitute a very small portion of all possible small carbon-based compounds. The exploration of this chemical space could lead to the discovery of novel and potentially transformative drugs<sup>##REF##15602547##5##</sup>.</p>", "<p id=\"Par4\">Estimates suggest that the number of chemically feasible molecules ranges from 10<sup>60</sup> to 10<sup>100</sup>. Despite this vast landscape, computational methods for drug design guide the process towards an intended optimal goal, bypassing the necessity for exhaustive, individual compound evaluation<sup>##REF##16056391##6##</sup>.</p>", "<p id=\"Par5\">In recent years, deep learning has emerged as a promising approach by upscaling the potential of large virtual screening libraries, uncovering new patterns and interconnections to discover new potential bioactive molecules among large databases of molecules through docking, screening, or de novo design. Generative AI can offer rapid access to exhaustive chemical libraries, learning and predicting new binding poses or molecule combinations based on learning patterns, becoming more efficient and accurate over time in developing drug candidates<sup>##REF##37220305##7##</sup>.</p>", "<p id=\"Par6\">Several applications have already been pursued, such as drug repurposing of existing molecules to discover new antibiotics<sup>##REF##32084340##8##</sup>, or drug optimization and design by applying recursive neural networks, autoencoders, generative adversarial networks, and reinforcement learning to generate new molecules while optimizing resources<sup>##UREF##0##9##–##UREF##1##11##</sup>.</p>", "<p id=\"Par7\">This study aims to design and implement MedGAN, an optimized and fine-tuned generative architecture using an optimized Generative Adversarial Network (GAN), where two models are trained simultaneously: a generative model (G) that captures the data distribution and a discriminative model (D) that estimates the probability of a sample coming from the training data, with the generative model mapping random noise through multilayer perceptrons and leveraging the backpropagation and dropout algorithms<sup>##UREF##2##12##</sup>. Molecules are represented as graphs by employing a Graph Convolutional Network (GCN) that handles graph-structured data with various types of relations, such as bonds (edges) between atoms (nodes) and their characteristics, including atom types, chirality, and atom charge (features)<sup>##UREF##3##13##</sup>. The optimization of the GAN model was performed by employing a Wasserstein GAN (WGAN) with a GCN<sup>##UREF##4##14##,##UREF##5##15##</sup>. This approach offers stable training dynamics, effectively overcoming issues such as mode collapse by utilizing the Wasserstein distance as the loss function, a gradient penalty that stabilizes training by ensuring that the critic’s output changes smoothly and not suddenly when the input varies, and the refining of node and edge representations through GCN layers. Studies using WGAN with GCN for molecule generation have already been conducted, achieving small molecular graphs<sup>##UREF##1##11##,##UREF##6##16##</sup>. Their size, complexity, and performance are limited by the complexity of the drug-like molecules.</p>", "<p id=\"Par8\">Building on the complex landscape of drug discovery and the emerging role of generative models, a specialized approach can further enhance the efficiency of this process by selecting a single scaffold with known biological interest for drug discovery, therefore addressing a common pattern and reducing the latent space required for learning, achieving a more efficient and accurate generative model<sup>##REF##29392184##17##</sup>.</p>", "<p id=\"Par9\">Quinoline scaffold molecules are ideal candidates because of their distinctive chemical properties and broad biological activities. Their polycyclic aromatic rings and pyridine-like nitrogen are crucial components of a variety of biologically active compounds that allow various electrophilic substitutions, creating a multitude of diverse molecules with distinct stereochemistry that have proven efficacy as therapeutic agents. Recognized for their potential anticancer, anti-inflammatory, antibacterial, and antiviral activities, quinoline and its derivatives offer a rich path for the development of novel drugs (Fig. ##SUPPL##0##S1##). Numerous mechanisms of action facilitate the inhibition of cell proliferation through cell cycle arrest and apoptosis to disrupt angiogenesis and modulate cell migration, making it an interesting and promising structure for further exploration in drug design<sup>##REF##33618829##18##,##UREF##7##19##</sup>.</p>" ]
[ "<title>Methods</title>", "<p id=\"Par31\">In this section, we describe the deep learning methodologies and data management strategies employed to generate novel quinoline-like molecules. The central challenge of this study is the enhancement and optimization of Wasserstein Generative Adversarial Network (WGAN) architecture. The goal was to construct a new GAN model capable of generating valid, unique, and complex scaffold-specific molecules without resorting to attention or reinforcement mechanisms. This approach aims to refine the model's performance to its utmost potential, focusing on the learning of specific core patterns, such as the molecular scaffold inherent to the quinoline structure, and laying the processes for further generalization of other scaffold-specific structures or oriented biological activities.</p>", "<title>MedGAN generative model</title>", "<p id=\"Par32\">GANs can be difficult to train because of issues such as mode collapse, in which the GAN generates a limited diversity of samples, and unstable training dynamics, in which the Generator and Discriminator oscillate without improvement. To overcome these difficulties, Wasserstein GANs have been developed, and together with a Graph Convolutional Network, are the basis of small molecular graph generation (Fig. ##FIG##3##4##)<sup>##UREF##2##12##,##UREF##4##14##,##UREF##5##15##</sup>. WGAN uses a different type of loss function—the Wasserstein distance (Earth Moving Distance)–accompanied by a gradient penalty function, which provides a smoother gradient for the generator to learn from, reducing the likelihood of training getting stuck, and therefore can lead to more stable and reliable training<sup>##UREF##4##14##,##UREF##5##15##</sup>. The WGAN framework is utilized for training both the generator and discriminator in a min–max game, with the Wasserstein distance as the minimized objective. Consequently, the generator learns to progressively create realistic graphs, whereas the discriminator improves its proficiency in distinguishing between genuine and fabricated graphs. The generator network first processes random noise through dense layers to form initial node and edge representations, which are further refined by several Graph Convolutional Network (GCN) layers considering both features and graph connectivity.</p>", "<p id=\"Par33\">After several iterations, these refined representations are processed through another set of dense layers to yield the final node and edge features of the synthetically generated graph with nonhomogeneous relations. The discriminator network employs a GCN to process the input graph. It starts by extracting node and edge features and then feeds them through GCN layers to generate a graph-level representation considering both local features and the overall graph structure. This representation was subsequently passed through a dense layer to produce a scalar value, signifying the authenticity of the input graph.</p>", "<p id=\"Par34\">The base model (Table ##SUPPL##0##S2##) serves as the foundational architecture for our deep learning approach as a solid starting point for further customization and experimentation, inspired by previous studies in which small molecular graphs were generated<sup>##UREF##1##11##</sup>. In this study, we did not use reinforcement learning strategies, so that we could focus on the capacity of the model to generate diverse molecular structures, reducing potential overfitting, decreasing the risk of mode collapse, and ensuring simplicity and computational efficiency. Without conditioning for specific chemical properties, the final models may serve a broader set of problems.</p>", "<title>Data pre-processing</title>", "<p id=\"Par35\">Two datasets were collected: PubMed and ZINC15<sup>##REF##36305812##27##,##REF##26479676##28##</sup>. The PubChem dataset was used as a first small subset for model optimization, obtained from a search for “quinoline” keyword and 357,422 valid molecules obtained. The dataset was filtered for true quinoline scaffold molecules and reduced in dimension until it worked with the base model without gradient vanishing, which led to a dimensionality reduction to a maximum of 50 atoms, limited to atom types of carbon, hydrogen, oxygen, and nitrogen (68,881 quinoline molecules). In parallel, the ZINC15 dataset, a collection of 981 million molecules with molecular weight between 250 and 500 Daltons and LogP between -1 and 5, was collected over several days for model fine-tuning after optimization. A filter for the quinoline scaffold in the ZINC15 dataset identified 4,607,029 molecules. The characterization of both datasets is available in Fig. ##SUPPL##0##S2## and Table ##SUPPL##0##S1##.</p>", "<p id=\"Par36\">The atom-type frequency shows that carbon, hydrogen, and nitrogen are present in all molecules, as expected, whereas oxygen is present in almost all molecules. Atoms such as fluorine, sulfur, and chlorine are present in almost 20% of quinoline molecules and can significantly influence the properties of a molecule and its biological activity. Fluorine, owing to its high electronegativity, can alter the polarity, shape, reactivity, and metabolic stability of molecule<sup>##REF##18197347##29##</sup>. Sulfur can participate in different types of bonding, influencing reactivity, and potentially forming metabolites with varying activities<sup>##UREF##13##30##</sup>. Chlorine enhances lipophilicity and improves drug absorption<sup>##UREF##14##31##</sup>. Overall, these atoms play key roles in structure–activity relationship studies, significantly affecting the optimization process in medicinal chemistry.</p>", "<p id=\"Par37\">To discern whether the size of molecules or the complexity of their constitution has a greater influence on the optimized parameters of these models and to aid in generating molecules with superior chemical properties that could become lead compounds of interest, the ZINC15 dataset was divided into three distinct subsets according to complexity with 1 million random molecules and C, H, N, O, Cl, S, and F atom types for each: ZINC15-I included quinoline molecules up to 100 atoms; ZINC15-II included molecules up to 50 atoms; ZINC15-III included quinoline molecules up to 50 atoms, atom’s chiral centers, and charge. The subsets are planned to be used sequentially for fine-tuning training in this order.</p>", "<title>Optimization and fine-tuning</title>", "<p id=\"Par38\">A hyperparameter search was conducted on the WGAN base model (Table ##SUPPL##0##S2##) to ascertain the most effective parameters for optimal model performance. A variety of configurations were tested by varying one parameter at a time while holding the others constant over a span of 100 iterations for each configuration using the PubChem dataset (quinoline scaffold, up to 50 atoms, and C, H, N, and O atom types). The parameters included neuron units, latent space, activation functions, optimizers with various learning rates, regularizers, dropouts, number of generator and discriminator neuron units, and batch sizes. When the upper or lower limits showed no improvement, no further investigation was conducted on this parameter.</p>", "<p id=\"Par39\">The model attempted to generate 100 graphs for each parameter and convert them into molecules. The training progress for the validity metrics and the plausible generated molecules obtained for the parameters that revealed major improvements compared to the base model are available in Fig. ##SUPPL##0##S3##.</p>", "<p id=\"Par40\">To facilitate a comprehensive comparison, we configured different models alongside our baseline WGAN-GCN model to fine-tune these parameter combinations and determine the optimal configuration of the hyperparameters for high-quality graph output generation (Table ##TAB##1##2##). The endpoint for the additional models was when a model achieved the generation of valid quinoline molecules, leading to Models 1, 2, and 3.</p>", "<p id=\"Par41\">Model 1 maintained the structure of the base model in several features, which consequently implied an equal number of trainable parameters, namely 6,713,687 for the generator and 578,177 for the discriminator. Variations were observed in the activation function, where Leaky ReLU replaced Tanh + ReLU, and the optimizer was changed to RMSprop with a learning rate of 0.00001. Additionally, the regularizer employs a lower dropout rate of 0.01, which is a shift from the base model rate of 0.2. Model 2, similar to Model 1, retains the structure of the base model, including the trainable parameters. However, it resulted in a more aggressive RMSprop learning rate of 0.0001, accompanied by an increased dropout rate of 0.5. This promotes a more robust defense against overfitting while also offering greater potential for explorative learning. Model 3 has a significantly different form. By increasing the latent dimension to 256, the capacity of the model to represent various features significantly expands. Moreover, the generator and discriminator units increase to 4096, which results in an increase in trainable parameters to 63,451,470 for the generator and 22,831,617 for the discriminator. Despite these changes, the RMSprop optimizer, learning rate of 0.0001, and dropout rate of 0.5 are retained to ensure consistency across models. These models were evaluated for up to 1000 epochs using a hardware configuration consisting of a 24 GB GPU with 32 CPUs and 32 GB of memory. Each model presents a unique blend of hyperparameters, giving us a broad range of configurations to assess their impact on graph output quality (Fig. ##FIG##4##5##).</p>", "<title>Drug-likeness</title>", "<p id=\"Par42\">Following the capacity of Model 3 to generate quinoline molecules, an assessment was conducted to evaluate their adherence to Lipinski's rule of 5, synthetic accessibility (SA), and predicted toxicity. This multifaceted evaluation allowed us to identify promising candidates that are theoretically viable for further development.</p>", "<p id=\"Par43\">Lipinski's Rule of Five offers a robust method to gauge the bioavailability of the generated molecules, encompassing factors such as molecular weight (less than 500 Da), hydrogen bond donors (not more than 5), hydrogen bond acceptors (not more than 10), and the partition coefficient (logP not greater than 5)<sup>##UREF##12##25##</sup>.</p>", "<p id=\"Par44\">Synthetic Accessibility (SA) evaluation quantifies the ease with which a molecule can be synthesized in a laboratory setting. It considers the complexity of the molecular structure, the nature of the fragments, how they combine, penalties related to the size and cycles within the molecule, and additional challenges such as synthesizing specific chiral centers. The SA of the generated quinoline molecules was calculated using the Ertl algorithm, providing a nuanced and comprehensive understanding of the synthetic challenges and potential barriers to laboratory production<sup>##REF##20142984##26##</sup>.</p>", "<p id=\"Par45\">To ensure the safety profile of the generated molecules, toxicity was predicted using DeepChem's pretrained model on Toxicology in the 21st Century (Tox21) dataset, which comprises 12,060 training samples and 647 test samples with 801 features that represent chemical descriptors (molecular weight, solubility, or surface area) and 272,776 features that represent chemical substructures for machine learning applications<sup>##REF##23732176##32##</sup>. For each sample, 12 binary labels represented the outcome (active/inactive) of 12 different toxicological experiments. This tool facilitates the assessment of potential toxicity risks based on molecular structure, offering key insights into the suitability of each molecule for pharmaceutical development. The program systematically evaluated the activity of compounds across 12 specific biological targets. Among these targets are five nuclear receptors: Androgen Receptor (AR), which is involved in male sexual development; Estrogen Receptor (ER), which is key to female reproductive health; Peroxisome Proliferator-Activated Receptor Gamma (PPARγ), a regulator of metabolism; Aryl Hydrocarbon Receptor (AhR), a sensor of environmental toxins; and Thyroid Receptor Beta (TRβ), which is essential for thyroid hormone balance. Additionally, five stress response pathways were identified: ATPase family, AAA domain-containing 5 (ATAD5), an indicator of DNA damage; p53, a tumor suppressor; Heat Shock Element (HSE), a sensor for protein damage; Antioxidant Response Element (ARE), key in oxidative stress response; and Estrogen Response Element (ERE), involved in estrogen signaling. Two other essential targets, the Mitochondrial Membrane Potential, indicating mitochondrial health, and the estrogen receptor (ER), already covered by nuclear receptors, provide further insights into cell health and endocrine function, respectively. Through analysis of the generated quinoline molecules using DeepChem's Tox21 model, this comprehensive evaluation forecasts potential toxic effects across these carefully selected targets, allowing for the elimination of compounds that could present significant risks in later stages of drug development<sup>##REF##23732176##32##</sup>.</p>", "<p id=\"Par46\">The Tox21 model was trained using a convolutional graph method with data constraints tailored to molecules with a maximum of 50 atoms, including C, H, N, O, Cl, S, or F atom types (5.509 training samples, 714 validation samples, and 704 test samples). This constraint is harmonized with the generative model specifications. Over the course of 100 epochs, the training process exhibited a consistent decline in loss and enhancement in the area under the curve (AUC) for both the training and validation sets. The model stabilized at a final loss of 0.135, a training AUC of 0.987, and a validation AUC of 0.741 (Fig. ##SUPPL##0##S4##). This trend underscores the ability of the model to learn the underlying pattern in the data, culminating in a reliable predictive model, with performance being monitored and optimized for both training and validation.</p>" ]
[ "<title>Results</title>", "<p id=\"Par10\">In our endeavor to develop an effective model for generating novel quinoline scaffolds, we optimized several configurations of the WGAN with the GCN architecture by employing different training parameters in three different models to compare them with a base model and different dataset properties. Input data were structured as graphs with adjacency and feature tensors built from chemical information collected from the training dataset of quinoline molecules. GCN layers analyze the relationships between atoms (nodes) and bonds (edges), learning the intricate patterns that define the molecular structure, while the generator and discriminator compete to produce increasingly realistic molecular structures retaining the quinoline scaffold. The training results led to optimal hyperparameters such as the latent space (256 inputs), optimizer (RMSprop), learning rate (0.0001), and neurons for the Generator and Discriminator (4.092 units) with 63,451,470 and 22,831,617 trainable parameters, respectively. The fine-tuned model with the best performance (Model 3) obtained a 0.25 and 0.62 validity and connectivity scores, respectively, and achieved a 92% success rate in generating quinoline molecules of up to 50 atoms and 7 atom types (C, H, N, O, Cl, S, F), with 93% being novel and 95% unique, preserving properties such as chirality, atom charge, and favorable drug-like properties. Model 3 generated up to 4831 fully connected, novel, and unique quinoline molecules that were absent from the original training dataset. The summarized outcomes are presented in Table ##TAB##0##1##, providing insights into their respective performances, and samples of the generated molecules are shown in Fig. ##FIG##1##2## and Fig. ##SUPPL##0##S5##.</p>", "<title>Optimizer and learning rates</title>", "<p id=\"Par11\">The improved performance of the Root Mean Squared Propagation (RMSProp) over Adaptive Moment Estimation (Adam) algorithms in the task of generating graphs was crucial in our optimization stage. RMSProp employs a moving average of squared gradients to normalize the gradient, which assists in overcoming the issues of aggressiveness and diminishing learning rates. This normalization is particularly beneficial in complex graph generation tasks, where the loss landscape may contain many local minima, making it challenging to find the global minimum. In the case of quinoline generation, this helped RMSProp navigate through these complexities more efficiently. Adam, while also using an adaptive learning approach, may have underperformed because of its momentum component. This component helps accelerate convergence by considering previous gradients, but in the complex task of generating graphs of quinoline molecules, it could lead to overshooting the global minimum or getting stuck in local minima, contributing to RMSProp's superior performance in this specific task<sup>##UREF##8##20##,##UREF##9##21##</sup>.</p>", "<title>Activation function</title>", "<p id=\"Par12\">During the optimization stage of quinoline molecule generation, the Leaky Rectified Linear Unit (LeakyReLU) slightly outperformed both the Hyperbolic Tangent (tanh) and Rectified Linear Unit (ReLU) activation functions. The ability of LeakyReLU to allow small negative activations for inputs less than zero potentially mitigates the “dying ReLU” problem, where negative inputs may cause neurons to become inactive. Despite this advantage, the improvement was not significant because the inputs were all binary and positive; therefore, the choice of activation function seemed less critical in this context. During the fine-tuning stage, Model 3, which utilized a combination of tanh and ReLU, achieved the best results among all the model combinations. This outcome suggests that the choice of activation function may have a nuanced impact, depending on the specific stage of training and the characteristics of the task, highlighting the importance of empirical evaluation in selecting the most suitable activation functions for quinoline molecule generation<sup>##UREF##10##22##,##UREF##11##23##</sup>.</p>", "<title>Latent dimensions, generator and discriminator units</title>", "<p id=\"Par13\">Increasing the latent dimensions enabled Model 3 to capture more complex variations within the quinoline molecules, enhancing the quality of the generated graphs. Similarly, expanding the number of neurons in the generator and discriminator units allows the model to learn intricate features and improve overall representations. While these enhancements were not pronounced in the optimization stage, they became more significant with a larger dataset in the fine-tuning stage. This indicated a relationship between the volume of data fed into the model and its ability to learn and discern patterns, demonstrating that our baseline model was under parameterized for the task. Nevertheless, it is crucial to recognize the potential risk of overfitting with such complexity, which requires careful balancing using appropriate regularization techniques. Our findings reveal that the increase in these parameters was beneficial up to a certain threshold, reinforcing the importance of finding the optimal balance for the given task<sup>##UREF##2##12##,##REF##16873662##24##</sup>.</p>", "<title>Data complexity</title>", "<p id=\"Par14\">Because the optimization step laid the groundwork for a minimum dataset structure to work with this model, composed of quinolines with up to 50 atoms and four atom types, the first step of the fine-tuning stage was to determine the capacity of the model to handle increasingly complex training datasets by testing larger molecules, additional atom types, or additional atom properties. Therefore, the original ZINC15 dataset, composed of 4.6 million quinoline molecules with molecular weight between 250 and 500 Daltons and LogP between − 1 and 5, was divided into three subsets of 1 million random quinolines, according to Fig. ##SUPPL##0##S2## and Table ##SUPPL##0##S1##. In subset ZINC15-I, the purpose was to explore an increase in atom length and include halogens, while in subset ZINC15-II, the purpose was to keep the same atom length but include halogens. In subset ZINC15-III, the objective was to enlarge the tensor size to incorporate atom charges, chiral centers, and stereochemistry. Each subset was used to train all the models.</p>", "<p id=\"Par15\">Training collapsed for ZINC15-I, but the remaining subsets allowed training to be performed, which led us to conclude that hyperparameters from model optimization, designed for molecules up to 50 atoms with four atom types, were insufficient for a molecular length of up to 100 atoms. However, they remained effective for molecules with increased complexity, including halogens, charge, chiral centers, and stereochemistry, indicating that model parameters are more sensitive to molecular size than to slight additional complexity in molecule constitution. ZINC-15 subsets II and III were used to proceed with the fine-tuning stage, allowing for an augmentation in the diversity of chemical composition.</p>", "<title>Validity and connected validity</title>", "<p id=\"Par16\">In the optimization stage, where the PubChem dataset of quinoline molecules was used, models 1, 2, and 3 showed a marked improvement over the base model in terms of generating valid chemical structures (Table ##TAB##0##1## and Fig. ##FIG##4##5##). Validity results (percentage of chemically valid molecules among all the generated graphs) for models 2 and 3 achieved scores of 0.14 and 0.16, respectively, leading to their selection for further fine-tuning, where a larger ZINC15 dataset of quinoline molecules was used (subsets ZINC15-II and ZINC15-III, detailed in Methods section). Model 1 was excluded due to its failure to achieve connected validity (a score of 0.00) with ZINC15-II subset, a crucial factor for representing meaningful chemical structures. During the fine-tuning training stage (Table ##TAB##0##1## and Fig. ##FIG##4##5##), Model 2 reached a validity score of 0.19 and a maximum connected validity of 0.47 with the ZINC15-II subset at iteration 64, but lost its ability to generate fully connected molecules during the remaining training, leading to an early termination of its training at iteration 350, despite reaching a validity of 0.46. Conversely, Model 3 demonstrated strong performance with a validity score of 0.26 and maintained a connected validity score of 0.65 until epoch 500 with the ZINC15-II subset, when the training was halted owing to stabilization in performance. For the ZINC15-III subset, Model 2 was unable to generate any molecule (validity 0.00), while Model 3 reached a validity of 0.25 and connected validity of 0.62 at epoch 300, when training was halted due to comparable metric performance with the ZINC15-II subset.</p>", "<title>Novelty and uniqueness</title>", "<p id=\"Par17\">In the generation of quinoline scaffolds during the optimization stage, models 2 and 3 achieved remarkable quinoline rates of 0.96 and 0.98, respectively. During the fine-tuning stage, Model 3 outperformed Model 2 for the same training subset ZINC15-II by achieving 0.96 in quinoline scaffolds, 0.90 in novel molecules (valid molecules not included in training data among the generated molecules), and 0.96 in unique structures (non-repeated valid molecules generated). For the ZINC15-III subset, Model 3 achieves similar metrics in a shorter time. This novelty metric particularly underscores the capacity of these models to invent new molecular structures, which is an essential aspect in drug discovery and design. To evaluate the capacity of the model to generate new quinoline molecules, 100 graphs were generated in each run until the model was unable to deliver additional graphs that successfully represented fully connected quinoline molecules after 100 consecutive runs. This led to 4831 and 3020 novel and unique quinoline molecules, respectively, achieved by Model 3 with the training subsets ZINC15-II and ZINC15-III (Fig. ##FIG##0##1##).</p>", "<title>Drug-likeness compliance</title>", "<p id=\"Par18\">Adherence to pharmaceutical guidelines was particularly prominent in Model 3, which generated compounds closely aligned with the Lipinski Rule of 5<sup>##UREF##12##25##</sup> in 96.1–99.2% of instances. This model also demonstrated a synthetic accessibility score<sup>##REF##20142984##26##</sup> below 6 for 96.0–100.0% of the compounds. Furthermore, a significant 22.0–31.0% of the molecules generated by Model 3 showed no toxicity across the 12 predefined targets in a Tox21 pre-trained model (Table ##SUPPL##0##S3##). The range of inactivity was the lowest for the nuclear androgen receptor-ligand-binding domain (NR-AR-LBD), with values of approximately 50%, and the highest for the nuclear androgen receptor (NR-AR), a crucial transcriptional regulator and therapeutic target in prostate cancer, with values of approximately 100%. The upper and lower limits were achieved for the nuclear androgen receptor (NR-AR), a crucial transcriptional regulator and therapeutic target in prostate cancer (Table ##SUPPL##0##S3##). In terms of drug discovery, these quinoline molecules might be interesting scaffolds for regulating androgen nuclear receptor activity indirectly through the ligand-binding domain owing to their affinity for interaction, but this should be monitored in terms of toxicity analysis if quinolines are intended for other biological activities. These outcomes adhere to early stage safety assessment practices and highlight the robust and effective approaches applied in our study.</p>", "<p id=\"Par19\">The scaled models learned faster and more effectively. When the ZINC15 larger dataset was used (fine-tune stage), Model 2 started generating quinolines at a very early stage, while Model 3 started generating quinolines at epoch 30 (Fig. ##FIG##4##5##). Nevertheless, Model 2 lost the capacity to generate fully connected molecules with a larger training dataset. Model 3 revealed a large capacity to produce diverse and unique fully connected quinoline molecules while preserving the atom charge and stereochemistry.</p>", "<title>Molecules generation</title>", "<p id=\"Par20\">MedGAN was able to generate thousands of valid, unique, and novel quinoline molecules, most of which have a high probability of being tolerable, non-toxic to humans, and easily synthetized. The following examples show the top 10 quinoline molecules with the lowest average toxicity scores (Tox) for Model 3, trained with the ZINC15-III subset (Fig. ##FIG##1##2##).</p>", "<p id=\"Par21\">We also conducted a comparative analysis using the t-distributed Stochastic Neighbor Embedding (t-SNE) technique, which reduces high-dimensional data into two interpretable dimensions, to understand the model’s capacity for generalization (Fig. ##FIG##2##3##). The analysis indicated distinct clustering patterns, with Model 3 representing a more diverse spread of data points for both subsets when compared to Model 2, and a balanced coverage of the training data chemical space, suggesting its superior ability to explore novel chemical spaces effectively.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par22\">Tasks were performed to optimize time and computational resources, ensuring an effective balance between computational complexity and accuracy. This efficiency of task performance sets the stage for our findings.</p>", "<p id=\"Par23\">The sensitivity of the parameters of the generative models to the molecule size and constitution has significant implications. Scaling to larger molecules requires major reoptimization, while scaling to molecules with additional attributes, such as stereochemistry and atom charge, requires less modification, pointing to the complexity of the relationship between molecular structure and the models’ response. MedGAN offers a methodology to search for optimal parameters associated with molecule size and constitution, while using graphs to represent molecules.</p>", "<p id=\"Par24\">The base model and Model 1 were unable to generate quinoline molecules. Models 2 and 3, which were able to generate structurally similar and fully connected molecules, were influenced by factors such as training data size and type, activation function, optimizer, learning rate, latent space, and neuron units of the Generator and Discriminator. Model 2 focused on speed and validity, achieved using the RMSProp optimizer and lower latent space and neuron units in the generator and discriminator. In contrast to Model 3, the superior capacity for generating diverse and fully connected molecules based on the RMSProp optimizer, larger latent space, and higher neuron units highlights the trade-offs inherent in these models. Additionally, testing the generative capacity at different iterations in Model 3 allowed a better understanding of the link between performance metrics and model output, providing new insights into generation effectiveness.</p>", "<p id=\"Par25\">The drug-likeness evaluation for the generated molecules combines efficiency with theoretical feasibility in the selection and development of quinoline-based therapeutics. The comprehensive nature of this analysis reinforces the strategic direction for identifying promising candidates for future novel drugs.</p>", "<p id=\"Par26\">The absence of attention mechanisms and reinforcement learning in this study provides important insights into the optimization and adaptability of generative models for molecular design. Without the focus provided by the attention mechanisms, the model was still able to preserve the quinoline scaffold, indicating a robust learning capacity that did not rely on conditional localized information. The absence of reinforcement learning, typically used for fine-grained optimization through a reward-based paradigm, did not hold back the model's ability to continuously improve validity, novelty, and uniqueness in Model 3. This suggests that a more exploratory and less constrained approach may offer greater flexibility in generating diverse structures, corroborated by previous studies using WGAN and GCN for molecular generation, where a twofold increase in connectivity (reward) also lead to a 6 × decrease in uniqueness<sup>##UREF##6##16##</sup>. These aspects highlight a potentially more streamlined and adaptable modeling process.</p>", "<p id=\"Par27\">Although there is no direct comparison of MedGAN in the existing literature, an indirect comparison between MolGAN and L-MolGAN without a reinforcement learning strategy (RL) was performed (Table ##SUPPL##0##S4##). These models with published results were built on a similar architecture of a WGAN with GCN for molecular generation, where the major difference relies on the training data diversity; this study focused on a single scaffold, the optimizer function, where Adam was the choice for both comparators, and different neurons or latent space dimensions due to different molecular lengths. The base model from our work used parameters similar to those of the published models. Compared to the results for L-MolGAN without reinforcement learning, MedGAN improved connectivity (0.620 vs. 0.598) and uniqueness (0.950 vs. 0.197). MedGAN also outperformed it in terms of synthesizability (1.000 vs. 0.950 for MolGAN and 0.290 for L-MolGAN). While indirect comparison has limitations owing to differences in training data, code implementation, and methods used for metrics assessment, it is clear that our model reached the main goal of generating new and diverse molecules<sup>##UREF##1##11##,##UREF##6##16##</sup>.</p>", "<p id=\"Par28\">The capacity of MedGAN to generate valid, unique, and large quinoline-scaffold molecules provides a strong foundation for enhancing drug discovery in various therapeutic areas. The specific achievement of optimizing parameters for quinoline-scaffold molecules with up to 50 atoms with seven atom types and preserving the atom’s chirality and charge from graphs provides a concrete path for generating more complex structures in the future and targeting certain biological activities. This specialization not only serves the current scaffold but also provides a framework for other molecular structures, potentially expanding its utility in the broader field of medicinal chemistry.</p>", "<p id=\"Par29\">Using graphs to generate new molecules of therapeutic interest is just a starting point in drug development and has some limitations that can be addressed, as generative models progressively show proven efficacy in generating valid molecules. The interpretability of Generative Adversarial Networks is not straightforward, and training a generative model requires intensive computational power, leading to training constraints that can lead to information loss.</p>", "<p id=\"Par30\">In conclusion, the discoveries made in this study synthesized the complexities of generative modeling with the specific needs of drug discovery. The insights gained extend beyond the immediate findings and offer a nuanced understanding of model behaviors, optimization strategies, and the complexities of molecular design. This study lays the groundwork for future research and development, contributing to a more robust and tailored approach to drug discovery.</p>" ]
[]
[ "<p id=\"Par1\">Generative Artificial Intelligence can be an important asset in the drug discovery process to meet the demand for novel medicines. This work outlines the optimization and fine-tuning steps of MedGAN, a deep learning model based on Wasserstein Generative Adversarial Networks and Graph Convolutional Networks, developed to generate new quinoline-scaffold molecules from complex molecular graphs, including hyperparameter adjustments and evaluations of drug-likeness attributes such as pharmacokinetics, toxicity, and synthetic accessibility. The best model was capable of generating 25% valid molecules, 62% fully connected, from which 92% were quinolines, 93% were novel, and 95% unique, preserving chirality, atom charge, and favorable drug-like properties while generating 4831 novel quinolines. These results provide valuable insights into how activation functions, optimizers, learning rates, neuron units, molecule size and constitution, and scaffold structure affect the performance of generative models and their potential to create new molecular structures, enhancing deep learning applications in computational drug design.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-023-50834-6.</p>", "<title>Author contributions</title>", "<p>The author B.M. confirms his main responsibility for the study conception and design, data collection, implementation code, analysis, methods, results interpretation and manuscript preparation. T.T.G. collaborated in the review of code design and implementation, I.R.V. collaborated in the methods defined for drug-likeness analysis. I.R.V. and T.T.G. collaborated in the analysis and interpretation of results, and review the manuscript writing.</p>", "<title>Data availability</title>", "<p>The datasets and code used for training in this study are available from the MedGAN GitHub repository (<ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/bmacedo111/MedGAN/\">https://github.com/bmacedo111/MedGAN/</ext-link>).</p>", "<title>Competing interests</title>", "<p id=\"Par47\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Model generation performance. Molecule generation stopped after 100 consecutive attempts, without producing novel, valid, and unique quinoline molecules. In the optimization stage, Model 3 generated 253 molecules, whereas Model 2 produced 115. During the fine-tuning stage, Model 3 generated 4831 and 3020 unique quinoline molecules when trained with ZINC15-II and ZINC15-III, respectively. In contrast, Model 2 generated 54 molecules before losing its capacity to form fully connected molecules. Model 3, at iterations 235 and 281, had similar validity (0.19), a slightly different result for connected validity (0.64 and 0.68, respectively), and a substantial difference in model performance (22% increase in molecule generation at iteration 281) which indicates a non-linear relation between training performance metrics and molecule diversity.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Newly generated quinoline molecules. Ten novel molecules were generated using Model 3, trained with the ZINC15-III subset that passed the Lipinsky rule of five, with SA lower than 6 and not being active for any of the 12 targets on the Tox-21 pre-trained model (top 10 lowest average scores on the classifier model, where Tox values lower than 0.5 means non predicted toxicity for a target).</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Molecules for t-SNE visualization. 10,000 random samples from the training data (grey) compared with the generated molecules from Model 3 (subsets ZINC15-ii, blue, and ZINC15-iii, green) and Model 2 (subset ZINC15-ii, red).</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>MedGAN Generative Model Architecture. Illustration of the MedGAN model using Wasserstein GANs and Graph Convolutional Networks for molecular graph generation and a sample of a molecule converted to a graph. Beginning with data from PubChem or ZINC15, the process flows through SMILES conversion to Mol, serialization, learning, and deserialization, utilizing specific configurations for optimization, leading to the generation of quinoline-scaffold molecules. Additional details are available in Supplementary Data 3.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Optimization and fine-tuning performance. The validity and percentage of quinoline molecules were assessed for each model (base, 1, 2, and 3) in the optimization stage (PubChem dataset). Models 2 and 3 revealed the best performance and where further assessed in the fine-tune stage (ZINC15 subsets II and III) for their validity, percentage of quinoline molecules generated, non-fragmented molecules generation (connected validity), and different molecules from the ZINC15 dataset (novelty). For more suitable visualization, a smoothing factor was applied (moving average of five data points).</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>MedGAN results. Model performance on molecule generation for the optimization and fine-tuning stages with 95% confidence intervals obtained from 1,000 iterations for each model.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\"/><th align=\"left\">Base Model</th><th align=\"left\">Model 1</th><th align=\"left\" colspan=\"3\">Model 2</th><th align=\"left\" colspan=\"3\">Model 3</th></tr></thead><tbody><tr><td align=\"left\">Latent space</td><td align=\"left\">64</td><td align=\"left\">64</td><td align=\"left\" colspan=\"3\">64</td><td align=\"left\" colspan=\"3\">256</td></tr><tr><td align=\"left\">Activation</td><td align=\"left\">Tanh/ReLU</td><td align=\"left\">Leaky ReLU</td><td align=\"left\" colspan=\"3\">Leaky ReLU</td><td align=\"left\" colspan=\"3\">Tanh/ReLU</td></tr><tr><td align=\"left\">Optimizer</td><td align=\"left\">Adam (1e−5)</td><td align=\"left\">RMSprop (1e−5)</td><td align=\"left\" colspan=\"3\">RMSprop (1e−4)</td><td align=\"left\" colspan=\"3\">RMSprop (1e−4)</td></tr><tr><td align=\"left\">G and D units</td><td align=\"left\">512</td><td align=\"left\">512</td><td align=\"left\" colspan=\"3\">512</td><td align=\"left\" colspan=\"3\">4092</td></tr><tr><td align=\"left\">Training iterations*</td><td align=\"left\">1000</td><td align=\"left\">1000</td><td align=\"left\">1000</td><td align=\"left\">64</td><td align=\"left\">350*</td><td align=\"left\">1000</td><td align=\"left\">500*</td><td align=\"left\">300</td></tr><tr><td align=\"left\">Training stage</td><td align=\"left\">Optimize (PubChem)</td><td align=\"left\">Optimize (PubChem)</td><td align=\"left\">Optimize (PubChem)</td><td align=\"left\">Fine-tune (ZINC15-II)</td><td align=\"left\">Fine-tune (ZINC15-II)</td><td align=\"left\">Optimize (PubChem)</td><td align=\"left\">Fine-tune (ZINC15-II)</td><td align=\"left\">Fine-tune (ZINC15-III)</td></tr><tr><td align=\"left\">Validity</td><td align=\"left\">0.00 (0.00:0.00)</td><td align=\"left\">0.02 (0.02:0.02)</td><td align=\"left\">0.14 (0.13:0.14)</td><td align=\"left\">0.19 (0.19:0.20)</td><td align=\"left\">0.46 (0.46:0.47)</td><td align=\"left\">0.16 (0.15:0.16)</td><td align=\"left\">0.26 (0.26:0.26)</td><td align=\"left\">0.25 (0.24:0.25)</td></tr><tr><td align=\"left\">Connected validity</td><td align=\"left\">–</td><td align=\"left\">0.00 (0.00:0.00)</td><td align=\"left\">0.60 (0.59:0.61)</td><td align=\"left\">0.47 (0.46:0.47)</td><td align=\"left\">0.00 (0.00:0.00)</td><td align=\"left\">0.56 (0.56:0.56)</td><td align=\"left\">0.65 (0.65:0.65)</td><td align=\"left\">0.62 (0.62:0.63)</td></tr><tr><td align=\"left\">Quinoline scaffold</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">0.96 (0.96:0.97)</td><td align=\"left\">0.96 (0.96:0.97)</td><td align=\"left\">–</td><td align=\"left\">0.98 (0.98:0.98)</td><td align=\"left\">0.96 (0.96:0.96)</td><td align=\"left\">0.92 (0.91:0.92)</td></tr><tr><td align=\"left\">Novelty</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">0.65 (0.64:0.66)</td><td align=\"left\">0.99 (0.99:1.00)</td><td align=\"left\">–</td><td align=\"left\">0.61 (0.60:0.62)</td><td align=\"left\">0.90 (0.89:0.90)</td><td align=\"left\">0.93 (0.92:0.93)</td></tr><tr><td align=\"left\">Diversity</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">0.84 (0.83:0.84)</td><td align=\"left\">0.75 (0.74:0.76))</td><td align=\"left\">–</td><td align=\"left\">0.91 (0.90:0.91)</td><td align=\"left\">0.96 (0.95:0.96)</td><td align=\"left\">0.95 (0.94:0.95)</td></tr><tr><td align=\"left\">Novel and unique quinolines **</td><td align=\"left\">0</td><td align=\"left\">0</td><td align=\"left\">115</td><td align=\"left\">54</td><td align=\"left\">0</td><td align=\"left\">294</td><td align=\"left\">4,831</td><td align=\"left\">3,020</td></tr><tr><td align=\"left\">PK (Lipinsky)</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">54 (100.0%)</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">4644 (96.1%)</td><td align=\"left\">2996 (99.2%)</td></tr><tr><td align=\"left\">Toxicity (inactive)</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">20 (37.0%)</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">1009 (22.0%)</td><td align=\"left\">935 (31.0%)</td></tr><tr><td align=\"left\">SA (Erl)</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">54 (100.0%)</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">4640 (96.0%)</td><td align=\"left\">3020 (100,0%)</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Fine-tuned model parameters.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\"/><th align=\"left\">Base model</th><th align=\"left\">Model 1</th><th align=\"left\">Model 2</th><th align=\"left\">Model 3</th></tr></thead><tbody><tr><td align=\"left\">Neuron units</td><td align=\"left\">128</td><td align=\"left\">128</td><td align=\"left\">128</td><td align=\"left\">128</td></tr><tr><td align=\"left\">Latent dimension</td><td align=\"left\">64</td><td align=\"left\">64</td><td align=\"left\">64</td><td align=\"left\">256</td></tr><tr><td align=\"left\">Activation function</td><td align=\"left\">Tanh/ReLU</td><td align=\"left\">Leaky ReLU</td><td align=\"left\">Leaky ReLU</td><td align=\"left\">Tanh/ReLU</td></tr><tr><td align=\"left\">Optimizer and learning rate</td><td align=\"left\">Adam (1e−5)</td><td align=\"left\">RMSprop (1e−5)</td><td align=\"left\">RMSprop (1e−4)</td><td align=\"left\">RMSprop (1e−4)</td></tr><tr><td align=\"left\">Regularizer</td><td align=\"left\">Dropout (0.2)</td><td align=\"left\">Dropout (0.01)</td><td align=\"left\">Dropout (0.5)</td><td align=\"left\">Dropout (0.5)</td></tr><tr><td align=\"left\">Generator units</td><td align=\"left\">512</td><td align=\"left\">512</td><td align=\"left\">512</td><td align=\"left\">4092</td></tr><tr><td align=\"left\">Discriminator units</td><td align=\"left\">512</td><td align=\"left\">512</td><td align=\"left\">512</td><td align=\"left\">4092</td></tr><tr><td align=\"left\">Batch size</td><td align=\"left\">32</td><td align=\"left\">32</td><td align=\"left\">128</td><td align=\"left\">32 (512)</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>*Model 2 training stopped at epoch 350 owing to the loss of ability to generate fully connected molecules. Model 3 training stopped at epoch 500 owing to a lack of improvement in both validity and connected validity at this point.</p><p>**Each model was evaluated with consecutive runs to generate novel and unique fully connected quinolines not present in the ZINC15 dataset per run until stopped generating additional molecules for 100 consecutive iterations. Pharmacokinetics (PK) were assessed using the Lipinsky rule of 5 (no more than 5 hydrogen bond donors and 10 hydrogen bond acceptors, molecular mass &lt; 500 Da, and logP &lt; 5), and toxicity was assessed as inactive for all 12 targets from the Tox21 pre-trained model; Synthetic Accessibility (SA) score below 6, which indicates that compounds are easily synthesized.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2023_50834_Fig1_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2023_50834_Fig2_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2023_50834_Fig3_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2023_50834_Fig4_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2023_50834_Fig5_HTML\" id=\"MO2\"/>" ]
[ "<media xlink:href=\"41598_2023_50834_MOESM1_ESM.docx\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["9."], "surname": ["Elton", "Boukouvalas", "Fuge", "Chung"], "given-names": ["DC", "Z", "MD", "PW"], "article-title": ["Deep learning for molecular design\u2014A review of the state of the art"], "source": ["Mol. Syst. Des. Eng."], "year": ["2019"], "volume": ["4"], "fpage": ["828"], "lpage": ["849"], "pub-id": ["10.1039/C9ME00039A"]}, {"label": ["11."], "mixed-citation": ["De Cao, N. & Kipf, T. MolGAN: An implicit generative model for small molecular graphs (2018)."]}, {"label": ["12."], "mixed-citation": ["Goodfellow, I. "], "italic": ["et al.", "NIPS\u201914 Proc. 27th Int. Conf. Neural Inf. Process. Syst. - Vol. 2"], "bold": ["63"]}, {"label": ["13."], "surname": ["Duvenaud"], "given-names": ["D"], "article-title": ["Convolutional networks on graphs for learning molecular fingerprints"], "source": ["Adv. Neural Inf. Process. Syst."], "year": ["2015"], "volume": ["2015"], "fpage": ["2224"], "lpage": ["2232"]}, {"label": ["14."], "mixed-citation": ["Arjovsky, M., Chintala, S. & Bottou, L. Wasserstein GAN (2017)."]}, {"label": ["15."], "surname": ["Gulrajani", "Ahmed", "Arjovsky", "Dumoulin", "Courville"], "given-names": ["I", "F", "M", "V", "A"], "article-title": ["Improved training of wasserstein GANs"], "source": ["Adv. Neural Inf. Process. Syst."], "year": ["2017"], "volume": ["2017"], "fpage": ["5768"], "lpage": ["5778"]}, {"label": ["16."], "surname": ["Tsujimoto", "Hiwa", "Nakamura", "Oe", "Hiroyasu"], "given-names": ["Y", "S", "Y", "Y", "T"], "article-title": ["L-MolGAN: an improved implicit generative model for generation of large molecular graphs"], "source": ["Chemxriv"], "year": ["2021"], "pub-id": ["10.26434/chemrxiv.14569545.v3"]}, {"label": ["19."], "surname": ["McMurry"], "given-names": ["J"], "source": ["Organic Chemistry"], "year": ["2016"], "publisher-name": ["Cengage Learning"]}, {"label": ["20."], "surname": ["Tieleman", "Hinton"], "given-names": ["T", "G"], "article-title": ["Lecture 6.5-rmsprop: Divide the gradient by a running average of its recent magnitude"], "source": ["COURSERA Neural Netw. Mach. Learn."], "year": ["2012"], "volume": ["4"], "fpage": ["26"], "lpage": ["31"]}, {"label": ["21."], "mixed-citation": ["Kingma, D. P. & Ba, J. L. Adam: A method for stochastic optimization. In "], "italic": ["3rd International Conference for Learning Representations ICLR 2015"]}, {"label": ["22."], "mixed-citation": ["Nair, V. & Hinton, G. E. Rectified linear units improve restricted Boltzmann machines. In "], "italic": ["Proceedings of the 27th International Conference on International Conference on Machine Learning"]}, {"label": ["23."], "surname": ["Maas", "Hannun", "Ng"], "given-names": ["AL", "AY", "AY"], "article-title": ["Rectifier nonlinearities improve neural network acoustic models"], "source": ["ICML Work. Deep Learn. Audio Speech Lang. Process."], "year": ["2013"], "volume": ["28"], "fpage": ["1"], "lpage": ["6"]}, {"label": ["25."], "surname": ["Lipinski", "Lombardo", "Dominy", "Feeney"], "given-names": ["CA", "F", "BW", "PJ"], "article-title": ["Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings"], "source": ["Adv. Drug Deliv. Rev."], "year": ["1997"], "volume": ["23"], "fpage": ["3"], "lpage": ["25"], "pub-id": ["10.1016/S0169-409X(96)00423-1"]}, {"label": ["30."], "surname": ["Malhotra", "Hocking"], "given-names": ["SS", "D"], "article-title": ["Biochemical and cytological effects of sulphur dioxide on plant metabolism"], "source": ["New Phytol."], "year": ["1976"], "volume": ["76"], "fpage": ["227"], "lpage": ["237"], "pub-id": ["10.1111/j.1469-8137.1976.tb01456.x"]}, {"label": ["31."], "mixed-citation": ["Naumann, K. How chlorine in molecules affects biological activity. "], "italic": ["Euro Chlor"]}]
{ "acronym": [], "definition": [] }
32
CC BY
no
2024-01-14 23:40:15
Sci Rep. 2024 Jan 12; 14:1212
oa_package/70/41/PMC10786821.tar.gz
PMC10786822
38216651
[ "<title>Introduction</title>", "<p id=\"Par2\">Water is a fundamental concern for human life and ecosystem as well. Recently, notably, fast-paced industrialization and growing population have attracted more attention due to the discharge of toxic effluents onto water surfaces<sup>##UREF##0##1##,##REF##31078029##2##</sup>. Synthetic organic dyes are considered one of the most significant pollutants that are utilized in several industrial areas, for instance, textiles, printing, etc. They cause a large amount of contamination in our environment. Cationic dyes are non-biodegradable, the primary source of contaminated water, and not easily eliminated using conventional removal approaches<sup>##UREF##1##3##–##UREF##4##7##</sup>. For example, triphenylmethane dyes are shining, deeply colored, and based on the hydrocarbon triphenylmethane in their molecular structure, such as Malachite green (MG) dye. MG is a cationic organic dye and is widely applied in several industries, including food, paper, textiles, leather, printing, and cosmetics<sup>##REF##16844368##8##</sup>. However, it has outstanding disadvantages. For example, it produces stable, non-biodegradable, and carcinogenic byproducts that cause a variety of human health problems, including carcinogenicity, eye irritation, mutagenesis, headache, and malformation<sup>##REF##15978990##9##,##UREF##5##10##</sup>.</p>", "<p id=\"Par3\">To solve this environmental problem, various conventional techniques can be applied for the purification of dye-based contaminated water, including electrochemical<sup>##REF##35977587##11##</sup>, catalytic degradation<sup>##REF##18164810##12##</sup>, membrane separation<sup>##UREF##6##13##</sup>, photo-degradation<sup>##REF##31071399##14##</sup>, and coagulation-flocculation<sup>##REF##31071399##14##</sup>. However, there are various essential disadvantages, including high-cost techniques, long-time and high-energy consumptions, and low-separation capabilities. In the past decades, adsorption approach has played a crucial role in water purification applications to remove toxic dyes thanks to its remarkable advantages, for instance being a cost-effective method, as well as its high removal efficiency, low operating costs, and high performance<sup>##REF##32422256##15##,##UREF##7##16##</sup>.</p>", "<p id=\"Par4\">So, designing adsorbents with excellent separation efficiency is an attractive strategy. As a result, over the past few years, biodegradable polymer nanocomposite had great attention in the adsorption approach to purify polluted water from pathogenic effluents. Biodegradable polymeric materials, including gelatin, chitosan, etc. are being widely applied to eliminate wastewater pollutants. Abu Elella et al<italic>.</italic> is very interested in developing high-efficient adsorbents based on low-cost biodegradable and biocompatible materials for the removal of different pollutants from an aqueous solution. For the removal of cationic dyes, our research group had published several researches in literature<sup>##REF##31279059##17##–##UREF##10##22##</sup> based on modified natural polymers.</p>", "<p id=\"Par5\">Gelatin is considered an attractive natural biodegradable polymeric material. It is a hydrolysis product extracted form collagen with a structural formula (NH<sub>2</sub>COOH–CH–R), where R is an amino acid derived from glycine, proline, or hydroxyproline<sup>##UREF##11##23##</sup>. Gelatin has several outstanding advantages, including biocompatibility, non-toxicity, low-cost material, biodegradability, and availability. It has several attractive functional moieties: amino, carboxyl, and hydroxyl moieties, which make it an effective adsorbent<sup>##UREF##12##24##,##REF##35019494##25##</sup>.</p>", "<p id=\"Par6\">Although Gelatin has some drawbacks: weak thermal stability, low removal separation, and fast degradability in water, which made it lose its capability to be applied as a suitable adsorbent for wastewater treatment without any modification<sup>##REF##18164810##12##,##UREF##6##13##</sup>.</p>", "<p id=\"Par7\">Natural polymer nanocomposites are intensively used for removing various dyes from contaminated water due to their unique properties like; fast kinetics, recyclability, good adsorption performance, and low cost<sup>##UREF##13##26##</sup>. Among them, gelatin-based nanocomposites exhibit better physicochemical characteristics than unmodified gelatin, such as good thermal stability, excellent separation efficiency, and good recyclability<sup>##UREF##14##27##</sup>. In the designing of gelatin nanocomposites, numerous different nano-fillers have been employed, among them, multilayer nanoclays. These materials, which have clearly defined and manageable morphologies with appropriate sizes and porosities, are potential adsorbents for treating wastewater due to their outstanding features including high surface area, significant chemical reactivity, mechanical properties, cost-effectiveness, specific selectivity, sustainability, recyclability, low power consumption, and the ease of chemical or physical modification<sup>##UREF##15##28##–##UREF##17##30##</sup>. Natural polymer nanocomposites based on Montmorillonite (MMT) nanoclay, have been widely used for adsorbing different pigments and dyes from contaminated water<sup>##UREF##18##31##–##UREF##19##33##</sup>. MMT is a smectite-family phyllosilicate mineral composed of two silica tetrahedral sheets jammed together with one edge-shared octahedral sheet of aluminum hydroxide. Its chemical formula is hydrated sodium calcium aluminum magnesium silicate hydroxide, (Na, Ca) × (Al Mg)<sub>2</sub>(Si<sub>4</sub>O<sub>10</sub>)(OH)<sub>2</sub>⋅nH<sub>2</sub>O<sup>##REF##20869169##34##</sup>. Its high surface area is due to its layered structure, which has an excellent cation exchange capacity, making it suitable for organic pigments and dyes removal from water<italic>.</italic> The nano-structured montmorillonite clay enables it to be applied in three-dimensional cross-linked composites, which are used for dye adsorption due to their high adsorption capacity, stability, and good thermal stability<sup>##REF##33197479##21##,##UREF##20##35##</sup>.</p>", "<p id=\"Par8\">The current study intends to synthesize a highly efficient modified gelatin nanocomposite as an adsorbent for the capture of toxic cationic organic dye (malachite green) from an aqueous solution via an adsorption batch approach. The gelatin-grafted-poly (acrylamide (AAM)-<italic>co</italic>-itaconic acid (IA))/MMT nanocomposite is prepared via free radical polymerization technique using crosslinking agent <italic>N, N</italic>-methylene bisacrylamide. Furthermore, the prepared gelatin nanocomposites’ structure was elucidated using various physicochemical analysis techniques such as FE-SEM, FTIR, EDX, XRD, and TEM while the thermal stability was investigated via TGA. The adsorption study of the synthesized nanocomposites was studied in aqueous solution nanocomposites under the effect of various factors. The findings confirm that the fabricated nanocomposite adsorbent showed remarkable separation for MG dye with excellent adsorption capacity, which will promise a low-cost and effective adsorbent for the wastewater treatment field.</p>" ]
[ "<title>Experimental methods</title>", "<title>Synthesis of grafted gelatin/MMT nanoclay nanocomposites</title>", "<p id=\"Par10\">The gelatin-<italic>cl</italic>-poly (AAM-<italic>co</italic>-IA)/MMT nanoclay nanocomposites were synthesized by in-situ homogenous dispersion of different MMT nanoclay concentrations (1–5%) (w/w) via free radical grafting polymerization technique using crosslinking agent <italic>N, N</italic>-methylene bisacrylamide. Initially, 1.0 g of gelatin was dissolved in 25 mL of distilled water for 20 min under constant stirring. After that, different concentrations of MMT nanoclay suspension (1, 2, 3, 4, and 5% of the total gelatin weight) were dispersed homogenously in the abovementioned solution for 30 min under constant stirring without disturbance. Subsequently, 25 mM APS was dissolved in 5 mL distilled water and then added to gelatin solution at 60 °C under 15 min stirring by purging N<sub>2</sub> gas. Following both acrylamide (0.3 M) and itaconic acid (0.3 M) were added to the gelatin/MMT mixture. Next 5 wt.% of MBA solution was partially poured under stirring at 60 °C. After 2.5 h, the obtained nanocomposites were purified using ethanol/ distilled water solution under stirring at 50 °C, and then washed with distilled water several times to remove any unreacted materials. Finally, the purified nanocomposites were dried at 50 °C for 48 h. The controlled grafted gelatin hydrogel using 5 wt.% of MBA was synthesized according to the above pathway in the absence of MMT nanoclay as a control sample.</p>", "<title>Adsorption batch studies</title>", "<p id=\"Par11\">The adsorption of MG dye was performed using gelatin-<italic>cl</italic>-poly (AAM-<italic>co</italic>-IA)/MMT nanocomposites under the effect of various parameters like; MMT nanoclay concentration, MG initial concentration, pH of MG solution, weight of adsorbent, and contact adsorption time. 10 mg of polymer was immersed into MG (10 mL) at room temperature (30 °C) for 60 min in the range of pH (2–9). The dyed samples were decanted, and then the residual MG concentration was determined using a UV–Vis spectrophotometer at a wavelength of 670 nm.</p>", "<p id=\"Par12\">Equation (##FORMU##0##1##) was used to calculate the adsorption capacity of MG at equilibrium.where C<sub>o</sub> and C<sub>e</sub> are the initial and equilibrium MG concentrations (mg/L), respectively. V is the soaked volume of MG solution (L), and W is the gelatin montmorillonite nanocomposites weight (g).</p>", "<title>Regeneration study</title>", "<p id=\"Par13\">The regeneration (adsorption–desorption) ability of the modified gelatin/MMT nanocomposite was carried out within 4 consecutive cycles. The reusability test occurred via soaking MG-dyed nanocomposite sample in 100 mM HCl (desorbing agent). After 24 h, the non-dyed nanocomposites were extracted with decantation and then washed and neutralized by 100 mM NaOH, and subsequently dried in a vacuum oven at 50 °C. Desorption of MG % was determined using the following Eq. (##FORMU##1##2##)<sup>##UREF##21##36##</sup>.</p>" ]
[ "<title>Results &amp; discussion</title>", "<title>Preparation of modified gelatin/ MMT nanocomposites</title>", "<p id=\"Par21\">Gelatin-<italic>cl</italic>-poly(AAM-<italic>co</italic>-IA)/MMT nanocomposites were synthesized via free-radical polymerization method using APS and MBA as an initiator, and crosslinking agent, respectively, and MMT as a nano-filler (Fig. ##FIG##0##1##). According to Fig. ##FIG##0##1##, APS produces sulfate anion radicals by heating which attract hydrogen atoms from –NH<sub>2</sub> groups on gelatin backbone, then acrylamide and itaconic acid were grafted onto gelatin side chains. MBA acts as a cross-linker by coupling the end vinyl groups in MBA molecules with the free NH radical of gelatin. MMT nanoparticles were in situ dispersed within copolymer chains to form the 3D structure of the hydrogel nanocomposite.</p>", "<title>Characterization of modified gelatin/ montmorillonite nanocomposite</title>", "<p id=\"Par22\">Various analysis techniques were performed to characterize the structure of the prepared gelatin-<italic>cl</italic>-poly (AAM-<italic>co</italic>-IA)/MMT nanocomposites compared to native gelatin, MMT, and gelatin hydrogel in absence of MMT. Figure ##FIG##1##2##a depicts the FTIR spectra of MMT, non-modified gelatin, gelatin-<italic>cl</italic>-poly (AAM-<italic>co</italic>-IA)/hydrogel and modified gelatin/MMT nanocomposites containing (1, 3, and 5 w/w%) of MMT.</p>", "<p id=\"Par23\">The FTIR spectrum of non-modified gelatin shows the characteristic signals of the polypeptide. In the region of 3584 cm<sup>−1</sup> to 3407 cm<sup>−1</sup>, a broad band is observed, which is associated with the narrowing of the –OH and –N–H bonds for the secondary amides<sup>##UREF##22##37##</sup>. The presence of the amide A band at a higher wave number is associated with less degradation of the gelatin chains and a high molecular weight structure predominates<sup>##UREF##23##38##,##UREF##24##39##</sup>. The asymmetric stretching vibration band of =C–H and ammonium correspond to the peak of type B amide. The low intensity band at 2941 cm<sup>−1</sup> is attributed to the symmetric and asymmetric vibrations of the –CH<sub>2</sub> group<sup>##REF##31847323##40##</sup>. It has been reported, the tendency of the stretching vibrations of amide A, amide B and –CH<sub>2</sub> to overlap due to possible dimeric intermolecular associations of carboxyl groups<sup>##UREF##25##41##</sup>. Additionally, peaks at 1625, 1370, and 1278 cm<sup>−1</sup> correspond to stretching of –C=O bonds<sup>##UREF##24##39##</sup>, stretching of –C–N bonds, and bending vibration of –N–H bonds<sup>##REF##30261678##42##</sup>.</p>", "<p id=\"Par24\">The spectrum of the hydrogel presents very notable changes in the position and intensity of the typical bands of the non-modified gelatin, in addition to the observation of new signals. Typical bands of hydrogel formation were observed at 1520–1646 cm<sup>−1</sup> for the NH amino bond and the -OH band (3200–3500 cm<sup>−1</sup>)<sup>##REF##33801249##43##</sup>. At 1543 cm<sup>−1</sup> an intense band is observed due to the formation of C–N bond for the union of the MBA, carbonyl group of IA, and amide of acrylamide<sup>##UREF##26##44##</sup>. The stretching vibration was observed at 1207 cm<sup>−1</sup> corresponding to –C–N-bond. The presence of these two peaks is indicative of copolymerization and crosslinking with MBA<sup>##REF##30023901##45##,##UREF##27##46##</sup>.</p>", "<p id=\"Par25\">Furthermore, peaks at 3648–3428 cm<sup>−1</sup> refer to stretching of –OH bonds belonging to octahedral structure of the clay and adsorbed water molecules. The characteristic signals of MMT are observed at 1010 cm<sup>−1</sup> and 640 cm<sup>−1</sup> (stretching –Si–O–Si) and with two strain vibration bands 536 cm<sup>−1</sup> (Si–O–Al) and 467 cm<sup>−1</sup> (Al–OH)<sup>##UREF##28##47##</sup>. The spectra for the nanocomposites containing 1–5% MMT show very similar patterns. Notably some displacements and changes in intensity occur in the characteristic bands of the hydrogel and the MMT. The signals at 1750–1612 cm<sup>−1</sup> demonstrate the electrostatic interaction between the carboxyl groups of the hydrogel and the cationic sites existed in MMT. In the region of 3439–3740 cm<sup>–1</sup>, different signals are observed that can be attributed to the interaction of amides with the surface of silane groups in MMT.</p>", "<p id=\"Par26\">On the other hand, the XRD patterns of MMT, non-modified gelatin, grafted gelatin hydrogel, and grafted gelatin/MMT nanocomposites (1, 3, and 5% MMT) are shown in Fig. ##FIG##1##2##b. To understand the structural effects of the nanocomposites formed with the hydrogel and MMT, XRD analyzes were performed. As expected, the XRD pattern of gelatin presents a very broad peak at 2θ = 20°, representing its amorphous structure<sup>##UREF##28##47##</sup>. The synthesis of the gelatin-based hydrogel leads to a reduction in intensity and a broadening of the peak observed in pure gelatin, demonstrating the formation of a highly amorphous structure. The MMT diffractogram shows greater crystallinity presenting some peaks at 2θ = 19° (corresponding to plane 110), 26, and 35°. However, the incorporation of MMT into the hydrogel matrix causes these peaks to disappear and the amorphous structure conferred by the hydrogel to predominate<sup>##UREF##29##48##</sup>.</p>", "<p id=\"Par27\">Moreover, the surface morphology of non-modified gelatin, modified gelatin hydrogel, MMT, and nanocomposites with MMT (1, 3, and 5%) was examined using FE-SEM technique as shown in Fig. ##FIG##2##3##, with magnification 10 μ and 20 kV.</p>", "<p id=\"Par28\">To complement the structural and morphological behavior of the hydrogel and its nanocomposites with MMT, SEM analyses were performed. The SEM image of pure gelatin shows a rough surface with irregular arrangements. On the other hand, in the micrograph of the hydrogel, it is observed that it acquires a more porous surface that allows a greater permeability to the structure<sup>##UREF##29##48##</sup>. The SEM image of MMT highlights its structure composed of a mixture of randomly distributed particle aggregates and flakes. The incorporation of MMT into the polymeric matrix of the gelatin-based hydrogel results in the formation of a more compact and less porous structure at a dose of 1% MMT<sup>##UREF##30##49##</sup>. In a 3% dose of MMT, the nanocomposite can be seen to favor a less smooth surface, areas with a greater number of pores, and a kind of arrangement such as scaffolding that could contribute to the MG transport process and interact with a greater number of substances are identified. anionic sites along the entire internal and external surface of the nanocomposite. The surface composition of the nanocomposite was approximated by the EDX analysis, confirming the presence of the characteristic elements of Al, Si, Mg, and O. The morphology of the nanocomposite with a dose of 5% MMT is not favored in these desirable aspects for the process of adsorption of aqueous contaminants, consider that the image shows a very smooth and compact surface.</p>", "<p id=\"Par29\">The exfoliation of MMT nanoclay between modified gelatin hydrogels to form in situ synthesized polymer nanocomposites was confirmed by TEM technique (Fig. ##FIG##3##4##). Accordingly, MMT nanoclay (Fig. ##FIG##3##4##a) exhibited leaves-like nanosheet layers, which exfoliated homogenously between hydrogel chains. Therefore, the TEM image of polymer nanocomposite in the presence of 5% (wt/wt) (Fig. ##FIG##3##4##b) shows a good distribution of MMT nanosheets between gelatin hydrogels.</p>", "<p id=\"Par30\">Additionally, the thermal stability of the examined samples; gelatin, gelatin hydrogel, MMT, and gelatin/MMT nanocomposites (1, 3, and 5%) was evaluated through TGA technique, and the data is shown in Fig. ##FIG##4##5##. The gelatin thermogram shows two main and characteristic trends of thermal decomposition for biopolymers. In the first, a weight loss of 13% is obtained in a range from 25 to 174 °C followed by the most pronounced loss between 250 and 500 °C attributed to a weight loss of 82%<sup>##UREF##31##50##</sup>.</p>", "<p id=\"Par31\">Gelatin modification and hydrogel formation are also confirmed by the increase in thermal stability compared to pure gelatin. The hydrogel has a very similar tendency of weight loss to gelatin in the range of 25 °C to 142 °C, while the degradation of the hydrogel begins at a higher temperature (357 °C) in response to the formation of new bonds that give the hydrogel higher thermal stability. In this temperature range, a weight loss of 65% is achieved. On the other hand, MMT undergoes two stages of thermal decomposition, the first 10% weight loss is attributed to water molecules adsorbed between the pores and interlayers<sup>##UREF##31##50##</sup>. The weight loss between 200 °C and 400 °C can be attributed to molecules found between the interlayers of the nanoclay. Above 400°C the MTT undergoes another phase of less pronounced weight loss corresponding to the thermal degradation of the phyllosilicate of the amorphous phase<sup>##UREF##31##50##</sup>. The incorporation of the different doses of MMT in the hydrogel leads to a thermal behavior very similar to the trend observed for the hydrogel, where the percentages of remaining weights were 48%, 22.8% and 10.4%, for 1% MMT, 3% MMT, and 5% MMT, respectively. It is noteworthy that the 1% MMT nanocomposite exhibits the lowest weight loss.</p>", "<title>Adsorption process</title>", "<p id=\"Par32\">The current study pursued to optimize the parameters of maximum adsorption capacity by preparing a high-efficient MG adsorbent based on modified gelatin /MMT nanocomposites underneath the influence of various variables, including different MMT nanoclay concentrations, initial MG dye concentration, pH of dye solution, nanocomposite dose, and adsorption contact time. The adsorption results are shown in Fig. ##FIG##4##5##.</p>", "<title>Effect of MMT content</title>", "<p id=\"Par33\">Modified gelatin /MMT nanocomposites (1–5%) (w/w%) were compared to cross-linked gelatin hydrogel in the absence of MMT, which was used to clarify the effect of MMT concentration on MG adsorption. The effect of MMT contents (0–5%) was studied at 10 mL of initial concentrations of 50 and 150 mg/L, pH 7, and sample weight 10 mg at 30 °C for 60 min, and the data is exhibited in Fig. ##FIG##5##6##a. The results demonstrated a significant increase in dye adsorption capacity by increasing MMT ratio from 0 to 3%, with the highest value of 38.9 (mg/g) and 69.3 (mg/g) for 50 mg/L and 100 mg/L, respectively, which could be attributed to the increased surface area, and hence an increase in the number of active adsorption sites. Followed by a decline in the rejection capacity by growing up the MMT concentrations, as a result of the agglomeration of the MMT particles on the nanocomposite surface. Thus, 3% of the MMT ratio was chosen in the next experiments.</p>", "<title>Effect of initial concentration of MG dye</title>", "<p id=\"Par34\">The dye concentration effect on MG removal using gelatin-<italic>cl</italic>-poly (AAm-<italic>co</italic>-IA) (3% MMT) nanocomposites was examined at a temperature of 30 °C, different MG concentrations: 25–550 mg/L, pH 7, 10 mg adsorbent, 10 mL dye solution, and immersion time of 60 min as shown in Fig. ##FIG##5##6##b. It was found that the polymer nanocomposite adsorbent had a sufficient number of active sites, which, due to an increase in MG concentration, enhanced its adsorption capacity. Moreover, the rise in MG concentration facilitated the transfer and interaction of adsorbate and adsorbents, resulting in increased adsorption capabilities. For example, the adsorption capacity increased from 22.5 mg/g at 25 mg/L to 331.1 mg/g at 350 mg/L because of forming MG monolayer on nanocomposites<sup>’</sup> surface, which is caused by the adsorption of large amounts of dye over the active sites. Subsequently, the adsorption of MG dye decreased with increasing MG concentration (above 350 mg/L), reaching 53.6 mg/g at 550 mg/L due to complete saturation for all the active sites on the 3% MMT surface. So, the MG concentration of 350 mg/L was chosen for the next study.</p>", "<title>Effect of solution pH</title>", "<p id=\"Par35\">The pH of the adsorption solution is the most essential parameter for adsorbing contaminants from water, as it has the greatest impact on the process. To identify the ideal pH value for this process, the pH influence on elimination of MG dye was investigated using 10 mg of gelatin nanocomposite in 10 mL of dye (350 mg/L) over a pH range of 3 to 9 at a temperature of 30°C within 60 min. Figure ##FIG##5##6##c shows that the rejection efficiency improved from 65.9 mg/g at pH 3 to its highest value of 345 mg/g at pH 9. Adsorption capacity increased as a result of an increase in the negatively charged groups and a decrease in H<sup>+</sup> in the aqueous solution. This causes electrostatic attraction between the adsorbent surface and MG dye. At pH ˂ 5, the adsorption efficiency decreased, which may be because H<sup>+</sup> was competing for surface adsorption with MG dye molecules, as well as the fact that most carboxylic groups are protonated at lower pH values; this causes repulsion among the protonated adsorbent’s surface and the positive charges on MG dye molecules. Hence, pH 9 was chosen for the next study.</p>", "<title>Effect of polymer dose</title>", "<p id=\"Par36\">Adsorption behaviour is also affected by the adsorbent dose (Fig. ##FIG##5##6##d). The dosage of gelatin nanocomposite was adjusted between 2 and 20 mg at pH 9 in 350 mg/L (10 mL) of MG solution for 60 min. The adsorption capability of adsorbent declined with increasing dosage, and maximal adsorption capacity (733 mg/g) was attained at a lower (2 mg) polymer concentration. In general, increasing the adsorbent dose reduces adsorption ability because more active sites are inaccessible to the adsorbate. This is because greater doses may promote adsorbent agglomeration and a reduction in the active adsorption sites.</p>", "<title>Effect of adsorption time</title>", "<p id=\"Par37\">The effect of the adsorption contact time of gelatin nanocomposite was studied using 2 mg of adsorbent in 10 mL of 350 mg/L MG dye, and the solution pH was adjusted to 9 during the time (5–60 min) as illustrated in Fig. ##FIG##5##6##e. The data exhibited two stages for the removal process, such as quick adsorption and gradual equilibrium.</p>", "<p id=\"Par38\">In the first rapid adsorption stage, the adsorption capacity increased quickly with the increase in the contact time from 5 min (151.5 mg/g) to reach a maximum adsorption value of 733 (mg/g) at 45 min thanks to the intensive interaction among MG and the adsorption surface sites, which are progressively occupied.</p>", "<p id=\"Par39\">After that, the adsorption capacity remains constant with time increase, therefore, the adsorption equilibrium was established after 45 min.</p>", "<title>Adsorption isotherm</title>", "<p id=\"Par40\">The adsorption isotherm demonstrates the relationship among the examined adsorbent and adsorbate surface at equilibrium. In this study, the adsorption isotherm study was investigated for the prepared gelatin nanocomposite at optimum conditions: pH 9, 350 mg/L of MG dye (10 mL), and 2 mg of polymer within 45 min using Langmuir, Freundlich, and Temkin isotherm models.</p>", "<p id=\"Par41\">The Langmuir model is the most widely used form of isotherm in the study of organic dye adsorption. The assumption of uniform adsorption on the adsorbent surface supports this model. As a result, the Langmuir isotherm is applied to explain the monolayer adsorption process that occurs at identified active sites. The linear Langmuir form can be expressed as the following Eq. (##FORMU##2##3##)<sup>##UREF##32##51##</sup>.where Q<sub>e</sub> and Q<sub>max</sub> refer to an equilibrium and maximum adsorption capacity (mg/g), respectively. While b (L/mg) is the Langmuir constant.</p>", "<p id=\"Par42\">While the Freundlich isotherm model is used to describe heterogeneous surfaces. This model is used to describe multisite intermolecular interactions between ions that are adsorbed to active site neighbors, resulting in multilayer adsorption. The Freundlich isotherm model's linear form is described by the following Eq. (##FORMU##3##4##)<sup>##UREF##33##52##,##UREF##34##53##</sup>.:where K<sub>F</sub> (mg/g) and n are Freundlich constants for adsorption capacity and adsorption intensity, respectively.</p>", "<p id=\"Par43\">Moreover, the multi-layer chemisorption process is the basis of the Temkin model. The Temkin isotherm model accounts for the adsorbent-adsorbate interaction through the declined adsorption heat against a heterogeneous coverage surface (Eq. (##FORMU##4##5##))<sup>##REF##33197479##21##,##UREF##35##54##,##UREF##36##55##</sup>.where β is the constant of heat removal (= <italic>RT/b</italic>), b is the heat of adsorption constant (J/mol), R is the universal gas constant (8.314 J/mol/K), and T is the equilibrium temperature (273.15 K), and K<sub>t</sub> is the equilibrium binding constant of the Temkin isotherm (L/g). Figure ##FIG##6##7## and Table ##TAB##0##1## exhibited the obtained findings, which illustrated MG removal from an aqueous solution with the synthesized nanocomposite, they were compatible with Langmuir model because it has a higher R<sup>2</sup> (0.9827), which referred to the creation of homogenous MG monolayer. Additionally, Q<sub>max</sub> was determined as 950.5 mg/g, while 1/n was calculated as 0.964, which confirmed a favorable adsorption process of dye molecules onto the prepared modified gelatin/MMT nanocomposite surface.</p>", "<p id=\"Par44\">In the literature, several nanocomposite-based adsorbents were previously reported for MG dye removal from an aqueous solution; however, the prepared modified gelatin nanocomposite in this study showed significant removal than others previously reported. For example, in Table ##TAB##1##2##, there is a comparison between Q<sub>max</sub> of the modified gelatin nanocomposite (950.5 mg/g) and other reported nanocomposite adsorbents for the elimination of MG dye molecules from their aqueous solutions.</p>", "<title>Adsorption kinetic studies</title>", "<p id=\"Par45\">The time of MG adsorption could affect its removal performance using the prepared modified gelatin nanocomposite. The kinetic adsorption study of capturing MG dye investigated within the adsorption relation among removal time and adsorbed MG dye molecules onto nanocomposite surface. Indeed, the removal process includes MG movement from solution to adsorbent’s interface, and then MG diffusion to reach the inner active sites<sup>##UREF##46##68##,##REF##27106587##69##</sup>. The kinetic performance of MG adsorption using gelatin-<italic>cl</italic>-p(AAM-<italic>co</italic>-IA)/MMT nanocomposite was investigated using pseudo-first order, pseudo-second order, second order, and Weber-Morris intraparticle diffusion models.</p>", "<p id=\"Par46\">Their linear equation forms can be expressed by the following Eqs. (##FORMU##5##6##–##FORMU##8##9##), respectively<sup>##UREF##47##70##–##REF##22749139##73##</sup>, and their findings are illustrated in Fig. ##FIG##7##8## and Table ##TAB##2##3##.where Q<sub>t</sub> (mg/g) is the adsorption capacity of adsorbents at different contact time (t); K<sub>1</sub> (1/min), K<sub>2</sub> (g/mg. min), K<sub>3</sub> (g/mg. min), K<sub>4</sub> (mg/g. min<sup>0.5</sup>) represent the rate constant of pseudo-first order, pseudo-second order, second order, and Weber-Morris models, respectively. While C refers to the thickness of nanocomposite surface’s boundary layer. The data shown illustrated that pseudo-first order has higher R<sup>2</sup> (0.9744), and Q<sub>e</sub>, which was calculated from the same model, was very close to Q<sub>max</sub> that was recorded from Langmuir isotherm model (Table ##TAB##0##1##). Therefore, pseudo-first order is the most promising model for the removal of MG dye using the prepared gelatin nanocomposite.</p>", "<p id=\"Par47\">Moreover, Fig. ##FIG##7##8## exhibited that Weber-Morris intraparticle diffusion model includes two straight sections, corresponding to multi-steps adsorption process. The first linear section resulted from the immigration of MG from bulk solution to boundary external layer of adsorbent to be adsorbed on its surface via strong electrostatic and hydrogen bonding interactions. Meanwhile second straight-line exhibits intraparticle diffusion process of MG molecules through the inner nanocomposite surface pores.</p>", "<p id=\"Par48\">On the other hand, C = 133, which refers to boundary layer thickness. As a result, data confirmed that Weber-Morris model is a rate-limiting step for the rejection of dye molecules. According to the findings, the pseudo-first order and Weber–Morris intraparticle diffusion models participated together for the adsorption mechanism of MG dye on the surface of modified gelatin/MMT nanocomposite.</p>", "<title>Chemical elucidation of MG loaded- gelatin/MMT nanocomposites</title>", "<p id=\"Par49\">The elucidation of the chemical structure of the adsorbent before and after MG adsorption may be used to suggest a reasonable mechanism for MG adsorption by gelatin-<italic>cl</italic>-p(AAM-<italic>co</italic>-IA)/MMT nanocomposite (Fig. ##FIG##8##9##). The structure of MG adsorbed nanocomposite was studied compared with unloaded nanocomposite using different techniques: FTIR, XRD, FE-SEM, and EDX.</p>", "<p id=\"Par50\">The elucidated MG adsorption mechanism is supported by the characterization and study of the nanocomposite before and after loading the cationic dye. In the FTIR spectrum for 3% MMT/hydrogel and MG loaded- 3% MMT/hydrogel, we can observe that the suppression of some characteristic signals of the nanocomposite, discussed above, occurred which indicates the adsorption effect of MG at different active sites, and different types of chemical interactions that promote their effective removal. SEM images highlighted the formation of MG clusters or crystals adsorbed on the surface of the nanocomposite. EDX analysis confirms the chemical composition of these zones and shows the content of chlorine atoms coming from MG dye molecules. Additionally, XRD pattern indicates that the adsorption of MG confers a more amorphous structure to the nanocomposite, a peak at 2θ = 5.2° characteristic for MG dye is also observed.</p>", "<title>Adsorption MG dye mechanism</title>", "<p id=\"Par51\">A possible adsorption mechanism between MG dye molecules and the adsorbent nanocomposite is shown in Fig. ##FIG##9##10##. Accordingly, the interaction mechanism here consists mainly of: electrostatic forces, coordination bonding, and hydrogen bonding interactions. The electrostatic interactions formed between cationic quaternized amino groups on MG dye surface and the negative groups onto the nanocomposite surface. While the coordination interactions were created among metal ions of MMT nanoclay and the lone pairs on tertiary amino groups onto the dye surface as well as H-bonding interaction bonds.</p>", "<title>Regeneration study</title>", "<p id=\"Par52\">Adsorbent regeneration is one of the most important methods for determining the most efficient adsorbent for wastewater treatment applications. Real-world applications account for the management of pollutant-loaded adsorbents. Indeed, the reusability of pollutant-loaded adsorbent materials is crucial for both the economic and environmental sectors<sup>##REF##31954790##66##,##UREF##46##68##,##REF##24579659##74##</sup>. The regeneration of the MG-loaded nanocomposite was done through four reusable cycles and the findings exhibited that adsorption capacity was determined as 733 mg/g (1st cycle), 719.9 mg/g (2nd cycle), 680.1 mg/g (3rd cycle), and 641.8 mg/g after 4th cycle (Fig. ##FIG##10##11##). This test confirmed the good recyclability of the prepared modified nanocomposite for MG dye rejection.</p>" ]
[ "<title>Results &amp; discussion</title>", "<title>Preparation of modified gelatin/ MMT nanocomposites</title>", "<p id=\"Par21\">Gelatin-<italic>cl</italic>-poly(AAM-<italic>co</italic>-IA)/MMT nanocomposites were synthesized via free-radical polymerization method using APS and MBA as an initiator, and crosslinking agent, respectively, and MMT as a nano-filler (Fig. ##FIG##0##1##). According to Fig. ##FIG##0##1##, APS produces sulfate anion radicals by heating which attract hydrogen atoms from –NH<sub>2</sub> groups on gelatin backbone, then acrylamide and itaconic acid were grafted onto gelatin side chains. MBA acts as a cross-linker by coupling the end vinyl groups in MBA molecules with the free NH radical of gelatin. MMT nanoparticles were in situ dispersed within copolymer chains to form the 3D structure of the hydrogel nanocomposite.</p>", "<title>Characterization of modified gelatin/ montmorillonite nanocomposite</title>", "<p id=\"Par22\">Various analysis techniques were performed to characterize the structure of the prepared gelatin-<italic>cl</italic>-poly (AAM-<italic>co</italic>-IA)/MMT nanocomposites compared to native gelatin, MMT, and gelatin hydrogel in absence of MMT. Figure ##FIG##1##2##a depicts the FTIR spectra of MMT, non-modified gelatin, gelatin-<italic>cl</italic>-poly (AAM-<italic>co</italic>-IA)/hydrogel and modified gelatin/MMT nanocomposites containing (1, 3, and 5 w/w%) of MMT.</p>", "<p id=\"Par23\">The FTIR spectrum of non-modified gelatin shows the characteristic signals of the polypeptide. In the region of 3584 cm<sup>−1</sup> to 3407 cm<sup>−1</sup>, a broad band is observed, which is associated with the narrowing of the –OH and –N–H bonds for the secondary amides<sup>##UREF##22##37##</sup>. The presence of the amide A band at a higher wave number is associated with less degradation of the gelatin chains and a high molecular weight structure predominates<sup>##UREF##23##38##,##UREF##24##39##</sup>. The asymmetric stretching vibration band of =C–H and ammonium correspond to the peak of type B amide. The low intensity band at 2941 cm<sup>−1</sup> is attributed to the symmetric and asymmetric vibrations of the –CH<sub>2</sub> group<sup>##REF##31847323##40##</sup>. It has been reported, the tendency of the stretching vibrations of amide A, amide B and –CH<sub>2</sub> to overlap due to possible dimeric intermolecular associations of carboxyl groups<sup>##UREF##25##41##</sup>. Additionally, peaks at 1625, 1370, and 1278 cm<sup>−1</sup> correspond to stretching of –C=O bonds<sup>##UREF##24##39##</sup>, stretching of –C–N bonds, and bending vibration of –N–H bonds<sup>##REF##30261678##42##</sup>.</p>", "<p id=\"Par24\">The spectrum of the hydrogel presents very notable changes in the position and intensity of the typical bands of the non-modified gelatin, in addition to the observation of new signals. Typical bands of hydrogel formation were observed at 1520–1646 cm<sup>−1</sup> for the NH amino bond and the -OH band (3200–3500 cm<sup>−1</sup>)<sup>##REF##33801249##43##</sup>. At 1543 cm<sup>−1</sup> an intense band is observed due to the formation of C–N bond for the union of the MBA, carbonyl group of IA, and amide of acrylamide<sup>##UREF##26##44##</sup>. The stretching vibration was observed at 1207 cm<sup>−1</sup> corresponding to –C–N-bond. The presence of these two peaks is indicative of copolymerization and crosslinking with MBA<sup>##REF##30023901##45##,##UREF##27##46##</sup>.</p>", "<p id=\"Par25\">Furthermore, peaks at 3648–3428 cm<sup>−1</sup> refer to stretching of –OH bonds belonging to octahedral structure of the clay and adsorbed water molecules. The characteristic signals of MMT are observed at 1010 cm<sup>−1</sup> and 640 cm<sup>−1</sup> (stretching –Si–O–Si) and with two strain vibration bands 536 cm<sup>−1</sup> (Si–O–Al) and 467 cm<sup>−1</sup> (Al–OH)<sup>##UREF##28##47##</sup>. The spectra for the nanocomposites containing 1–5% MMT show very similar patterns. Notably some displacements and changes in intensity occur in the characteristic bands of the hydrogel and the MMT. The signals at 1750–1612 cm<sup>−1</sup> demonstrate the electrostatic interaction between the carboxyl groups of the hydrogel and the cationic sites existed in MMT. In the region of 3439–3740 cm<sup>–1</sup>, different signals are observed that can be attributed to the interaction of amides with the surface of silane groups in MMT.</p>", "<p id=\"Par26\">On the other hand, the XRD patterns of MMT, non-modified gelatin, grafted gelatin hydrogel, and grafted gelatin/MMT nanocomposites (1, 3, and 5% MMT) are shown in Fig. ##FIG##1##2##b. To understand the structural effects of the nanocomposites formed with the hydrogel and MMT, XRD analyzes were performed. As expected, the XRD pattern of gelatin presents a very broad peak at 2θ = 20°, representing its amorphous structure<sup>##UREF##28##47##</sup>. The synthesis of the gelatin-based hydrogel leads to a reduction in intensity and a broadening of the peak observed in pure gelatin, demonstrating the formation of a highly amorphous structure. The MMT diffractogram shows greater crystallinity presenting some peaks at 2θ = 19° (corresponding to plane 110), 26, and 35°. However, the incorporation of MMT into the hydrogel matrix causes these peaks to disappear and the amorphous structure conferred by the hydrogel to predominate<sup>##UREF##29##48##</sup>.</p>", "<p id=\"Par27\">Moreover, the surface morphology of non-modified gelatin, modified gelatin hydrogel, MMT, and nanocomposites with MMT (1, 3, and 5%) was examined using FE-SEM technique as shown in Fig. ##FIG##2##3##, with magnification 10 μ and 20 kV.</p>", "<p id=\"Par28\">To complement the structural and morphological behavior of the hydrogel and its nanocomposites with MMT, SEM analyses were performed. The SEM image of pure gelatin shows a rough surface with irregular arrangements. On the other hand, in the micrograph of the hydrogel, it is observed that it acquires a more porous surface that allows a greater permeability to the structure<sup>##UREF##29##48##</sup>. The SEM image of MMT highlights its structure composed of a mixture of randomly distributed particle aggregates and flakes. The incorporation of MMT into the polymeric matrix of the gelatin-based hydrogel results in the formation of a more compact and less porous structure at a dose of 1% MMT<sup>##UREF##30##49##</sup>. In a 3% dose of MMT, the nanocomposite can be seen to favor a less smooth surface, areas with a greater number of pores, and a kind of arrangement such as scaffolding that could contribute to the MG transport process and interact with a greater number of substances are identified. anionic sites along the entire internal and external surface of the nanocomposite. The surface composition of the nanocomposite was approximated by the EDX analysis, confirming the presence of the characteristic elements of Al, Si, Mg, and O. The morphology of the nanocomposite with a dose of 5% MMT is not favored in these desirable aspects for the process of adsorption of aqueous contaminants, consider that the image shows a very smooth and compact surface.</p>", "<p id=\"Par29\">The exfoliation of MMT nanoclay between modified gelatin hydrogels to form in situ synthesized polymer nanocomposites was confirmed by TEM technique (Fig. ##FIG##3##4##). Accordingly, MMT nanoclay (Fig. ##FIG##3##4##a) exhibited leaves-like nanosheet layers, which exfoliated homogenously between hydrogel chains. Therefore, the TEM image of polymer nanocomposite in the presence of 5% (wt/wt) (Fig. ##FIG##3##4##b) shows a good distribution of MMT nanosheets between gelatin hydrogels.</p>", "<p id=\"Par30\">Additionally, the thermal stability of the examined samples; gelatin, gelatin hydrogel, MMT, and gelatin/MMT nanocomposites (1, 3, and 5%) was evaluated through TGA technique, and the data is shown in Fig. ##FIG##4##5##. The gelatin thermogram shows two main and characteristic trends of thermal decomposition for biopolymers. In the first, a weight loss of 13% is obtained in a range from 25 to 174 °C followed by the most pronounced loss between 250 and 500 °C attributed to a weight loss of 82%<sup>##UREF##31##50##</sup>.</p>", "<p id=\"Par31\">Gelatin modification and hydrogel formation are also confirmed by the increase in thermal stability compared to pure gelatin. The hydrogel has a very similar tendency of weight loss to gelatin in the range of 25 °C to 142 °C, while the degradation of the hydrogel begins at a higher temperature (357 °C) in response to the formation of new bonds that give the hydrogel higher thermal stability. In this temperature range, a weight loss of 65% is achieved. On the other hand, MMT undergoes two stages of thermal decomposition, the first 10% weight loss is attributed to water molecules adsorbed between the pores and interlayers<sup>##UREF##31##50##</sup>. The weight loss between 200 °C and 400 °C can be attributed to molecules found between the interlayers of the nanoclay. Above 400°C the MTT undergoes another phase of less pronounced weight loss corresponding to the thermal degradation of the phyllosilicate of the amorphous phase<sup>##UREF##31##50##</sup>. The incorporation of the different doses of MMT in the hydrogel leads to a thermal behavior very similar to the trend observed for the hydrogel, where the percentages of remaining weights were 48%, 22.8% and 10.4%, for 1% MMT, 3% MMT, and 5% MMT, respectively. It is noteworthy that the 1% MMT nanocomposite exhibits the lowest weight loss.</p>", "<title>Adsorption process</title>", "<p id=\"Par32\">The current study pursued to optimize the parameters of maximum adsorption capacity by preparing a high-efficient MG adsorbent based on modified gelatin /MMT nanocomposites underneath the influence of various variables, including different MMT nanoclay concentrations, initial MG dye concentration, pH of dye solution, nanocomposite dose, and adsorption contact time. The adsorption results are shown in Fig. ##FIG##4##5##.</p>", "<title>Effect of MMT content</title>", "<p id=\"Par33\">Modified gelatin /MMT nanocomposites (1–5%) (w/w%) were compared to cross-linked gelatin hydrogel in the absence of MMT, which was used to clarify the effect of MMT concentration on MG adsorption. The effect of MMT contents (0–5%) was studied at 10 mL of initial concentrations of 50 and 150 mg/L, pH 7, and sample weight 10 mg at 30 °C for 60 min, and the data is exhibited in Fig. ##FIG##5##6##a. The results demonstrated a significant increase in dye adsorption capacity by increasing MMT ratio from 0 to 3%, with the highest value of 38.9 (mg/g) and 69.3 (mg/g) for 50 mg/L and 100 mg/L, respectively, which could be attributed to the increased surface area, and hence an increase in the number of active adsorption sites. Followed by a decline in the rejection capacity by growing up the MMT concentrations, as a result of the agglomeration of the MMT particles on the nanocomposite surface. Thus, 3% of the MMT ratio was chosen in the next experiments.</p>", "<title>Effect of initial concentration of MG dye</title>", "<p id=\"Par34\">The dye concentration effect on MG removal using gelatin-<italic>cl</italic>-poly (AAm-<italic>co</italic>-IA) (3% MMT) nanocomposites was examined at a temperature of 30 °C, different MG concentrations: 25–550 mg/L, pH 7, 10 mg adsorbent, 10 mL dye solution, and immersion time of 60 min as shown in Fig. ##FIG##5##6##b. It was found that the polymer nanocomposite adsorbent had a sufficient number of active sites, which, due to an increase in MG concentration, enhanced its adsorption capacity. Moreover, the rise in MG concentration facilitated the transfer and interaction of adsorbate and adsorbents, resulting in increased adsorption capabilities. For example, the adsorption capacity increased from 22.5 mg/g at 25 mg/L to 331.1 mg/g at 350 mg/L because of forming MG monolayer on nanocomposites<sup>’</sup> surface, which is caused by the adsorption of large amounts of dye over the active sites. Subsequently, the adsorption of MG dye decreased with increasing MG concentration (above 350 mg/L), reaching 53.6 mg/g at 550 mg/L due to complete saturation for all the active sites on the 3% MMT surface. So, the MG concentration of 350 mg/L was chosen for the next study.</p>", "<title>Effect of solution pH</title>", "<p id=\"Par35\">The pH of the adsorption solution is the most essential parameter for adsorbing contaminants from water, as it has the greatest impact on the process. To identify the ideal pH value for this process, the pH influence on elimination of MG dye was investigated using 10 mg of gelatin nanocomposite in 10 mL of dye (350 mg/L) over a pH range of 3 to 9 at a temperature of 30°C within 60 min. Figure ##FIG##5##6##c shows that the rejection efficiency improved from 65.9 mg/g at pH 3 to its highest value of 345 mg/g at pH 9. Adsorption capacity increased as a result of an increase in the negatively charged groups and a decrease in H<sup>+</sup> in the aqueous solution. This causes electrostatic attraction between the adsorbent surface and MG dye. At pH ˂ 5, the adsorption efficiency decreased, which may be because H<sup>+</sup> was competing for surface adsorption with MG dye molecules, as well as the fact that most carboxylic groups are protonated at lower pH values; this causes repulsion among the protonated adsorbent’s surface and the positive charges on MG dye molecules. Hence, pH 9 was chosen for the next study.</p>", "<title>Effect of polymer dose</title>", "<p id=\"Par36\">Adsorption behaviour is also affected by the adsorbent dose (Fig. ##FIG##5##6##d). The dosage of gelatin nanocomposite was adjusted between 2 and 20 mg at pH 9 in 350 mg/L (10 mL) of MG solution for 60 min. The adsorption capability of adsorbent declined with increasing dosage, and maximal adsorption capacity (733 mg/g) was attained at a lower (2 mg) polymer concentration. In general, increasing the adsorbent dose reduces adsorption ability because more active sites are inaccessible to the adsorbate. This is because greater doses may promote adsorbent agglomeration and a reduction in the active adsorption sites.</p>", "<title>Effect of adsorption time</title>", "<p id=\"Par37\">The effect of the adsorption contact time of gelatin nanocomposite was studied using 2 mg of adsorbent in 10 mL of 350 mg/L MG dye, and the solution pH was adjusted to 9 during the time (5–60 min) as illustrated in Fig. ##FIG##5##6##e. The data exhibited two stages for the removal process, such as quick adsorption and gradual equilibrium.</p>", "<p id=\"Par38\">In the first rapid adsorption stage, the adsorption capacity increased quickly with the increase in the contact time from 5 min (151.5 mg/g) to reach a maximum adsorption value of 733 (mg/g) at 45 min thanks to the intensive interaction among MG and the adsorption surface sites, which are progressively occupied.</p>", "<p id=\"Par39\">After that, the adsorption capacity remains constant with time increase, therefore, the adsorption equilibrium was established after 45 min.</p>", "<title>Adsorption isotherm</title>", "<p id=\"Par40\">The adsorption isotherm demonstrates the relationship among the examined adsorbent and adsorbate surface at equilibrium. In this study, the adsorption isotherm study was investigated for the prepared gelatin nanocomposite at optimum conditions: pH 9, 350 mg/L of MG dye (10 mL), and 2 mg of polymer within 45 min using Langmuir, Freundlich, and Temkin isotherm models.</p>", "<p id=\"Par41\">The Langmuir model is the most widely used form of isotherm in the study of organic dye adsorption. The assumption of uniform adsorption on the adsorbent surface supports this model. As a result, the Langmuir isotherm is applied to explain the monolayer adsorption process that occurs at identified active sites. The linear Langmuir form can be expressed as the following Eq. (##FORMU##2##3##)<sup>##UREF##32##51##</sup>.where Q<sub>e</sub> and Q<sub>max</sub> refer to an equilibrium and maximum adsorption capacity (mg/g), respectively. While b (L/mg) is the Langmuir constant.</p>", "<p id=\"Par42\">While the Freundlich isotherm model is used to describe heterogeneous surfaces. This model is used to describe multisite intermolecular interactions between ions that are adsorbed to active site neighbors, resulting in multilayer adsorption. The Freundlich isotherm model's linear form is described by the following Eq. (##FORMU##3##4##)<sup>##UREF##33##52##,##UREF##34##53##</sup>.:where K<sub>F</sub> (mg/g) and n are Freundlich constants for adsorption capacity and adsorption intensity, respectively.</p>", "<p id=\"Par43\">Moreover, the multi-layer chemisorption process is the basis of the Temkin model. The Temkin isotherm model accounts for the adsorbent-adsorbate interaction through the declined adsorption heat against a heterogeneous coverage surface (Eq. (##FORMU##4##5##))<sup>##REF##33197479##21##,##UREF##35##54##,##UREF##36##55##</sup>.where β is the constant of heat removal (= <italic>RT/b</italic>), b is the heat of adsorption constant (J/mol), R is the universal gas constant (8.314 J/mol/K), and T is the equilibrium temperature (273.15 K), and K<sub>t</sub> is the equilibrium binding constant of the Temkin isotherm (L/g). Figure ##FIG##6##7## and Table ##TAB##0##1## exhibited the obtained findings, which illustrated MG removal from an aqueous solution with the synthesized nanocomposite, they were compatible with Langmuir model because it has a higher R<sup>2</sup> (0.9827), which referred to the creation of homogenous MG monolayer. Additionally, Q<sub>max</sub> was determined as 950.5 mg/g, while 1/n was calculated as 0.964, which confirmed a favorable adsorption process of dye molecules onto the prepared modified gelatin/MMT nanocomposite surface.</p>", "<p id=\"Par44\">In the literature, several nanocomposite-based adsorbents were previously reported for MG dye removal from an aqueous solution; however, the prepared modified gelatin nanocomposite in this study showed significant removal than others previously reported. For example, in Table ##TAB##1##2##, there is a comparison between Q<sub>max</sub> of the modified gelatin nanocomposite (950.5 mg/g) and other reported nanocomposite adsorbents for the elimination of MG dye molecules from their aqueous solutions.</p>", "<title>Adsorption kinetic studies</title>", "<p id=\"Par45\">The time of MG adsorption could affect its removal performance using the prepared modified gelatin nanocomposite. The kinetic adsorption study of capturing MG dye investigated within the adsorption relation among removal time and adsorbed MG dye molecules onto nanocomposite surface. Indeed, the removal process includes MG movement from solution to adsorbent’s interface, and then MG diffusion to reach the inner active sites<sup>##UREF##46##68##,##REF##27106587##69##</sup>. The kinetic performance of MG adsorption using gelatin-<italic>cl</italic>-p(AAM-<italic>co</italic>-IA)/MMT nanocomposite was investigated using pseudo-first order, pseudo-second order, second order, and Weber-Morris intraparticle diffusion models.</p>", "<p id=\"Par46\">Their linear equation forms can be expressed by the following Eqs. (##FORMU##5##6##–##FORMU##8##9##), respectively<sup>##UREF##47##70##–##REF##22749139##73##</sup>, and their findings are illustrated in Fig. ##FIG##7##8## and Table ##TAB##2##3##.where Q<sub>t</sub> (mg/g) is the adsorption capacity of adsorbents at different contact time (t); K<sub>1</sub> (1/min), K<sub>2</sub> (g/mg. min), K<sub>3</sub> (g/mg. min), K<sub>4</sub> (mg/g. min<sup>0.5</sup>) represent the rate constant of pseudo-first order, pseudo-second order, second order, and Weber-Morris models, respectively. While C refers to the thickness of nanocomposite surface’s boundary layer. The data shown illustrated that pseudo-first order has higher R<sup>2</sup> (0.9744), and Q<sub>e</sub>, which was calculated from the same model, was very close to Q<sub>max</sub> that was recorded from Langmuir isotherm model (Table ##TAB##0##1##). Therefore, pseudo-first order is the most promising model for the removal of MG dye using the prepared gelatin nanocomposite.</p>", "<p id=\"Par47\">Moreover, Fig. ##FIG##7##8## exhibited that Weber-Morris intraparticle diffusion model includes two straight sections, corresponding to multi-steps adsorption process. The first linear section resulted from the immigration of MG from bulk solution to boundary external layer of adsorbent to be adsorbed on its surface via strong electrostatic and hydrogen bonding interactions. Meanwhile second straight-line exhibits intraparticle diffusion process of MG molecules through the inner nanocomposite surface pores.</p>", "<p id=\"Par48\">On the other hand, C = 133, which refers to boundary layer thickness. As a result, data confirmed that Weber-Morris model is a rate-limiting step for the rejection of dye molecules. According to the findings, the pseudo-first order and Weber–Morris intraparticle diffusion models participated together for the adsorption mechanism of MG dye on the surface of modified gelatin/MMT nanocomposite.</p>", "<title>Chemical elucidation of MG loaded- gelatin/MMT nanocomposites</title>", "<p id=\"Par49\">The elucidation of the chemical structure of the adsorbent before and after MG adsorption may be used to suggest a reasonable mechanism for MG adsorption by gelatin-<italic>cl</italic>-p(AAM-<italic>co</italic>-IA)/MMT nanocomposite (Fig. ##FIG##8##9##). The structure of MG adsorbed nanocomposite was studied compared with unloaded nanocomposite using different techniques: FTIR, XRD, FE-SEM, and EDX.</p>", "<p id=\"Par50\">The elucidated MG adsorption mechanism is supported by the characterization and study of the nanocomposite before and after loading the cationic dye. In the FTIR spectrum for 3% MMT/hydrogel and MG loaded- 3% MMT/hydrogel, we can observe that the suppression of some characteristic signals of the nanocomposite, discussed above, occurred which indicates the adsorption effect of MG at different active sites, and different types of chemical interactions that promote their effective removal. SEM images highlighted the formation of MG clusters or crystals adsorbed on the surface of the nanocomposite. EDX analysis confirms the chemical composition of these zones and shows the content of chlorine atoms coming from MG dye molecules. Additionally, XRD pattern indicates that the adsorption of MG confers a more amorphous structure to the nanocomposite, a peak at 2θ = 5.2° characteristic for MG dye is also observed.</p>", "<title>Adsorption MG dye mechanism</title>", "<p id=\"Par51\">A possible adsorption mechanism between MG dye molecules and the adsorbent nanocomposite is shown in Fig. ##FIG##9##10##. Accordingly, the interaction mechanism here consists mainly of: electrostatic forces, coordination bonding, and hydrogen bonding interactions. The electrostatic interactions formed between cationic quaternized amino groups on MG dye surface and the negative groups onto the nanocomposite surface. While the coordination interactions were created among metal ions of MMT nanoclay and the lone pairs on tertiary amino groups onto the dye surface as well as H-bonding interaction bonds.</p>", "<title>Regeneration study</title>", "<p id=\"Par52\">Adsorbent regeneration is one of the most important methods for determining the most efficient adsorbent for wastewater treatment applications. Real-world applications account for the management of pollutant-loaded adsorbents. Indeed, the reusability of pollutant-loaded adsorbent materials is crucial for both the economic and environmental sectors<sup>##REF##31954790##66##,##UREF##46##68##,##REF##24579659##74##</sup>. The regeneration of the MG-loaded nanocomposite was done through four reusable cycles and the findings exhibited that adsorption capacity was determined as 733 mg/g (1st cycle), 719.9 mg/g (2nd cycle), 680.1 mg/g (3rd cycle), and 641.8 mg/g after 4th cycle (Fig. ##FIG##10##11##). This test confirmed the good recyclability of the prepared modified nanocomposite for MG dye rejection.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par53\">In the present work, gelatin-<italic>cl</italic>-p(AAM-<italic>co</italic>-IA)/MMT nanocomposite was successfully synthesized with free-radical polymerization approach as a potential adsorbent for rejecting MG dye from an aqueous solution. The developed adsorbent was elucidated using various analytical instrumentation: FTIR, XRD, TGA, TEM, FE-SEM, and EDX techniques. The data confirmed that MMT nanoclays were mixed homogenously among grafted gelatin chains, thereby reinforcing the adsorption and thermal properties of the polymeric nanocomposites, comparing with non-modified gelatin and modified gelatin hydrogel. The adsorption MG dye process was influenced by various parameters. According to the adsorption process, the nanocomposite adsorbent was well fitted with Langmuir isotherm model (R<sup>2</sup> value of 0.9827), with maximum adsorption efficiency of 950.5 mg/g. Meanwhile, the adsorption kinetics results were compatible with pseudo-first order and intraparticle diffusion kinetic models.</p>", "<p id=\"Par54\">The adsorbents were successfully regenerated in four adsorption/desorption cycles, and the findings indicated good recyclability for the prepared modified gelatin nanocomposite. The adsorption process between MG dye molecules and adsorbent nanocomposite was dominated by electrostatic force, coordination bonding, and hydrogen bonding interactions. Overall, the fabricated nanocomposite is one of the most promising low-cost and highly efficient adsorbent for water purification.</p>" ]
[ "<p id=\"Par1\">Shortage of drinking water has gained potential interest over the last few decades. Discharged industrial effluent, including various toxic pollutants, to water surfaces is one of the most serious environmental issues. The adsorption technique has become a widely studied method for the removal of toxic pollutants, specifically synthetic dyes, from wastewater due to its cost-effectiveness, high selectivity, and ease of operation. In this study, a novel gelatin-crosslinked-poly(acrylamide-<italic>co</italic>-itaconic acid)/montmorillonite (MMT) nanoclay nanocomposites-based adsorbent has been prepared for removing malachite green (MG) dye from an aqueous solution. Modified gelatin nanocomposites were synthesized using a free-radical polymerization technique in the presence and absence of MMT. Various analytical instrumentation: including FTIR, FESEM, XRD, and TEM techniques were used to elucidate the chemical structure and surface morphology of the prepared samples. Using a batch adsorption experiment, Langmuir isotherm model showed that the prepared modified gelatin nanocomposite had a maximum adsorption capacity of 950.5 mg/g using 350 mg/L of MG dye at pH 9 within 45 min. Furthermore, the regeneration study showed good recyclability for the obtained nanocomposite through four consecutive reusable cycles. Therefore, the fabricated gelatin nanocomposite is an attractive adsorbent for MG dye elimination from aqueous solutions.</p>", "<title>Subject terms</title>", "<p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p>" ]
[ "<title>Experiments</title>", "<title>Materials</title>", "<p id=\"Par9\">Gelatin was obtained from S.D. Fine Chemical, India, and Ammonium persulfate (APS) was bought from Maharashtra, India, and IA and MBA were purchased from Sigma-Aldrich, Germany. AAM and MG were purchased from Loba-Chemi Pvt. Ltd., India. Also, Hydrochloric acid and sodium hydroxide were purchased by Merck-Germany. Nanoclay, Nanomer 1.31PS, montmorillonite nanoclay was provided from Aldrich, Germany.</p>", "<title>Characterization</title>", "<p id=\"Par14\">The chemical structure of the prepared gelatin-<italic>cl</italic>-poly(AAM-<italic>co</italic>-IA)/MMT nanocomposites was elucidated, comparing with non-modified gelatin, MMT, and gelatin hydrogel, via various analytical instrumentation such as:<list list-type=\"bullet\"><list-item><p id=\"Par15\"> FTIR (Jasco 4100, Japan) was used to determine the chemical structure within the wavenumber 4000–400 cm<sup>−1</sup> at 25 °C.</p></list-item><list-item><p id=\"Par16\">XRD, a Philips Xpert MPD Pro, is used at 50 kV, 40 mA, 3°/s as a speed scan rate to demonstrate the crystallinity of the prepared nanocomposites.</p></list-item><list-item><p id=\"Par17\">Shimadzu Thermogravimetric Analyzer was used to determine the thermal stability of the prepared nanocomposites (TGA-50H). The temperature range was 25 to 800 °C with a heating rate of 10 °C/min in a nitrogen atmosphere.</p></list-item><list-item><p id=\"Par18\">Surface morphology for tested samples was investigated with FE-SEM (Quanta 250) at various magnifications and 30 kV. The FE-SEM technique is equipped with an EDX unit to investigate all incorporated elements for gelatin nanocomposite.</p></list-item><list-item><p id=\"Par19\">TEM images of polymer nanocomposites compared with MMT nanoclay were taken using a JEM-100S Transmission Electron Microscope (TEM, Japan).</p></list-item><list-item><p id=\"Par20\"> MG adsorption studies were performed with a Unico 1200 UV–Vis spectrophotometer set to max wavelength = 670 nm.</p></list-item></list></p>" ]
[ "<title>Acknowledgements</title>", "<p>The authors acknowledge STDF (Egypt) for their valuable support through research project fund (project ID 27777).</p>", "<title>Author contributions</title>", "<p>M.H.A.E.: Conceptualization, Methodology, Validation; Visualization; Writing—original draft; Review &amp; editing, Supervision. N.A.: Methodology, Data Curation, Software, Writing—original draft. H.M.A.: Methodology. E.A.L.-M.: Data Curation, Software, Writing—original draft; Review, and editing. Y.M.A.M.: Resources and characterization. H.A.E.N.: Resources and characterization. R.R.M.: Review &amp; editing, Supervision.</p>", "<title>Funding</title>", "<p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). STDF (Egypt) support the research project within project fund ID 27777.</p>", "<title>Data availability</title>", "<p>The data will be available from the corresponding author upon request.</p>", "<title>Competing interests</title>", "<p id=\"Par55\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Schematic illustration of the preparation of gelatin-cl-poly (AAM-co-IA)/MMT nanocomposites via free radical polymerization technique.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>(<bold>a</bold>) FTIR spectrums and (<bold>b</bold>) XDR patterns for unmodified gelatin, hydrogel, MMT, and 1% to 5% MMT/hydrogel nanocomposites.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>FESEM images of gelatin, modified gelatin hydrogel, MMT, and 1–5%MMT/hydrogel nanocomposites.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>TEM images of (<bold>a</bold>) MMT nanoclay, and (<bold>b</bold>) gelatin/MMT (5%) nanocomposites.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>TGA thermogram of gelatin, modified gelatin hydrogel, MMT, and 1–5%MMT/hydrogel nanocomposites.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>The influence of (<bold>a</bold>) MMT and (<bold>b</bold>) MG concentrations, (<bold>c</bold>) pH, and (<bold>d</bold>) polymer dose, as well as (<bold>e</bold>) adsorption time on MG removal by gelatin-cl-p(AAM-co-IA) /MMT nanocomposite (the standard deviation SD for three measurements for all factors is between ± 1 and ± 2).</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>Fitting curves of linear adsorption isotherms with Langmuir model, Freundlich model, and Temkin model for removal of MG dye using modified gelatin nanocomposite.</p></caption></fig>", "<fig id=\"Fig8\"><label>Figure 8</label><caption><p>Fitting curves of linear pseudo-first-order, pseudo-second-order, second-order, and Weber–Morris models for MG rejection using modified gelatin nanocomposite.</p></caption></fig>", "<fig id=\"Fig9\"><label>Figure 9</label><caption><p>Physicochemical characterization of 3% MMT nanocomposite and MG loaded-3% MMT nanocomposite: FTIR spectrum (<bold>a</bold>), SEM images-EDX (<bold>b</bold>) and XRD pattern (<bold>c</bold>).</p></caption></fig>", "<fig id=\"Fig10\"><label>Figure 10</label><caption><p>Schematic illustration of the proposed adsorption mechanism of MG dye with modified gelatin nanocomposite.</p></caption></fig>", "<fig id=\"Fig11\"><label>Figure 11</label><caption><p>Schematic diagram of regeneration study within four consecutive reusable cycles.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Linear isotherm parameters for MG dye adsorption onto modified gelatin nanocomposites.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Langmuir model</th><th align=\"left\">Freundlich model</th><th align=\"left\">Temkin model</th></tr></thead><tbody><tr><td align=\"left\"><p>Q<sub>max</sub> = 950.5 mg/g</p><p>b = 0.0022 L/mg</p><p>R<sup>2</sup> (0.9827)</p></td><td align=\"left\"><p>K<sub>F</sub> = 2.26 mg/g</p><p>1/n = 0.964</p><p>R<sup>2</sup> (0.9647)</p></td><td align=\"left\"><p>β = 375.16</p><p>K<sub>t</sub> = 1.3 L/g</p><p>R<sup>2</sup> (0.8575)</p></td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>A comparison of Q<sub>max</sub> of the prepared nanocomposite with other previously reported adsorbents for MG dye molecules.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Reported adsorbents</th><th align=\"left\">Q<sub>max</sub> (mg/g)</th><th align=\"left\">References</th></tr></thead><tbody><tr><td align=\"left\">Unsaturated polyester Ce(IV) phosphate</td><td char=\".\" align=\"char\">1.01</td><td align=\"left\"><sup>##UREF##37##56##</sup></td></tr><tr><td align=\"left\">XG/psyllium</td><td char=\".\" align=\"char\">3.2</td><td align=\"left\"><sup>##UREF##38##57##</sup></td></tr><tr><td align=\"left\">Poly(MMA)/GO/Fe<sub>3</sub>O<sub>4</sub></td><td char=\".\" align=\"char\">3.5</td><td align=\"left\"><sup>##UREF##39##58##</sup></td></tr><tr><td align=\"left\">Water nut modified carbon</td><td char=\".\" align=\"char\">47.7</td><td align=\"left\"><sup>##UREF##40##59##</sup></td></tr><tr><td align=\"left\">Poly(AAM)-<italic>g</italic>-Ch/Fe<sub>2</sub>O<sub>3</sub></td><td char=\".\" align=\"char\">86.9</td><td align=\"left\"><sup>##UREF##41##60##</sup></td></tr><tr><td align=\"left\">CMC-<italic>g</italic>-poly(AAM)/MMT</td><td char=\".\" align=\"char\">172.4</td><td align=\"left\"><sup>##REF##32422256##15##</sup></td></tr><tr><td align=\"left\">Treated ginger waste</td><td char=\".\" align=\"char\">188.6</td><td align=\"left\"><sup>##UREF##42##61##</sup></td></tr><tr><td align=\"left\">St-<italic>g</italic>-poly(AAM)/GO/hydroxyapatite</td><td char=\".\" align=\"char\">297.0</td><td align=\"left\"><sup>##REF##28778526##62##</sup></td></tr><tr><td align=\"left\">Ch/MMT</td><td char=\".\" align=\"char\">322.6</td><td align=\"left\"><sup>##UREF##43##63##</sup></td></tr><tr><td align=\"left\">Ch/poly(AA)/bentonite</td><td char=\".\" align=\"char\">454.6</td><td align=\"left\"><sup>##UREF##44##64##</sup></td></tr><tr><td align=\"left\">XG-<italic>g</italic>-poly(AA-co-AAM)/Fe<sub>3</sub>O<sub>4</sub></td><td char=\".\" align=\"char\">497.2</td><td align=\"left\"><sup>##UREF##45##65##</sup></td></tr><tr><td align=\"left\">XG-<italic>g</italic>-poly(VI)/SiO<sub>2</sub></td><td char=\".\" align=\"char\">588.2</td><td align=\"left\"><sup>##REF##34537301##20##</sup></td></tr><tr><td align=\"left\">Alg/poly (AA)/graphite</td><td char=\".\" align=\"char\">628.9</td><td align=\"left\"><sup>##REF##31954790##66##</sup></td></tr><tr><td align=\"left\">Modified GG/SiO<sub>2</sub></td><td char=\".\" align=\"char\">781.3</td><td align=\"left\"><sup>##REF##27956333##67##</sup></td></tr><tr><td align=\"left\">XG-<italic>g</italic>-poly(VI)/MMT</td><td char=\".\" align=\"char\">909.1</td><td align=\"left\"><sup>##REF##33197479##21##</sup></td></tr><tr><td align=\"left\">Gelatin-<italic>cl</italic>-poly(AAm-co-IA)/MMT</td><td char=\".\" align=\"char\">950.5</td><td align=\"left\">Present work</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>The parameters of kinetic adsorption models for the rejection of MG dye using gelatin nanocomposite.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Pseudo-first order</th><th align=\"left\">Pseudo-second order</th><th align=\"left\">Second order</th><th align=\"left\">Intraparticle diffusion</th></tr></thead><tbody><tr><td align=\"left\"><p>K<sub>1</sub> = 0.0741 min<sup>−1</sup></p><p>Q<sub>e</sub> = 960.45 mg/g</p><p>R<sup>2</sup> (0.9744)</p></td><td align=\"left\"><p>K<sub>2</sub> = 9.3 × 10<sup>–8</sup> g/mg min</p><p>Q<sub>e</sub> = 1250 mg/g</p><p>R<sup>2</sup> (0.9742)</p></td><td align=\"left\"><p>K<sub>3</sub> = 0.001 g/mg.min</p><p>Q<sub>e</sub> = 212.7 mg/g</p><p>R<sup>2</sup> (0.7574)</p></td><td align=\"left\"><p>K<sub>4</sub> = 108.14 mg/g min<sup>0.5</sup></p><p>C = 133</p></td></tr></tbody></table></table-wrap>" ]
[ "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathrm{Adsorption \\,\\,capacity }({\\text{Q}}) =\\frac{(C0-Ce)}{W}\\times V$$\\end{document}</tex-math><mml:math id=\"M2\" display=\"block\"><mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">Adsorption</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mi mathvariant=\"normal\">capacity</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mtext>Q</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>C</mml:mi><mml:mn>0</mml:mn><mml:mo>-</mml:mo><mml:mi>C</mml:mi><mml:mi>e</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>W</mml:mi></mml:mfrac><mml:mo>×</mml:mo><mml:mi>V</mml:mi></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\% \\, \\mathrm{MG \\,\\, desorption }=\\frac{\\mathrm{Desorbed \\,\\,conc}.({\\text{mg}}/{\\text{L}})}{\\mathrm{Adsorbed \\,\\, conc}. ({\\text{mg}}/{\\text{L}})}\\times 100$$\\end{document}</tex-math><mml:math id=\"M4\" display=\"block\"><mml:mrow><mml:mo>%</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mrow><mml:mi mathvariant=\"normal\">MG</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mi mathvariant=\"normal\">desorption</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">Desorbed</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mi mathvariant=\"normal\">conc</mml:mi></mml:mrow><mml:mo>.</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:mtext>mg</mml:mtext><mml:mo stretchy=\"false\">/</mml:mo><mml:mtext>L</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">Adsorbed</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mi mathvariant=\"normal\">conc</mml:mi></mml:mrow><mml:mo>.</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:mtext>mg</mml:mtext><mml:mo stretchy=\"false\">/</mml:mo><mml:mtext>L</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\frac{1}{{{\\text{Q}}_{{\\text{e}}} }} = \\frac{1}{{{\\text{Q}}_{\\max } }} + \\frac{1}{{{\\text{Q}}_{\\max } {\\text{bC}}_{{\\text{e}}} }} $$\\end{document}</tex-math><mml:math id=\"M6\" display=\"block\"><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:msub><mml:mtext>Q</mml:mtext><mml:mtext>e</mml:mtext></mml:msub></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msub><mml:mtext>Q</mml:mtext><mml:mo movablelimits=\"true\">max</mml:mo></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mtext>Q</mml:mtext><mml:mo movablelimits=\"true\">max</mml:mo></mml:msub><mml:msub><mml:mtext>bC</mml:mtext><mml:mtext>e</mml:mtext></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ4\"><label>4</label><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ {\\text{In Q}}_{{\\text{e}}} = {\\text{ In K}}_{{\\text{F}}} + \\frac{1}{{\\text{n}}}{\\text{ ln C}}_{{\\text{e}}} $$\\end{document}</tex-math><mml:math id=\"M8\" display=\"block\"><mml:mrow><mml:msub><mml:mrow><mml:mtext>In Q</mml:mtext></mml:mrow><mml:mtext>e</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>In K</mml:mtext></mml:mrow><mml:mtext>F</mml:mtext></mml:msub><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mtext>n</mml:mtext></mml:mfrac><mml:msub><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>ln C</mml:mtext></mml:mrow><mml:mtext>e</mml:mtext></mml:msub></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ5\"><label>5</label><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ {\\text{Q}}_{{\\text{e}}} = \\upbeta\\,\\, {\\text{ln K}}_{{\\text{t}}} + \\upbeta\\,\\, {\\text{ln C}}_{{\\text{e}}} $$\\end{document}</tex-math><mml:math id=\"M10\" display=\"block\"><mml:mrow><mml:msub><mml:mtext>Q</mml:mtext><mml:mtext>e</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant=\"normal\">β</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:msub><mml:mrow><mml:mtext>ln K</mml:mtext></mml:mrow><mml:mtext>t</mml:mtext></mml:msub><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">β</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:msub><mml:mrow><mml:mtext>ln C</mml:mtext></mml:mrow><mml:mtext>e</mml:mtext></mml:msub></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ6\"><label>6</label><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ {\\text{ln }}({\\text{Q}}_{{\\text{e}}} - {\\text{Q}}_{{\\text{t}}} ) \\, = {\\text{ ln Q}}_{{\\text{e}}} - {\\text{K}}_{{1}} {\\text{t}} $$\\end{document}</tex-math><mml:math id=\"M12\" display=\"block\"><mml:mrow><mml:mrow><mml:mtext>ln</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>Q</mml:mtext><mml:mtext>e</mml:mtext></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mtext>Q</mml:mtext><mml:mtext>t</mml:mtext></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mspace width=\"0.166667em\"/><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>ln Q</mml:mtext></mml:mrow><mml:mtext>e</mml:mtext></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mtext>K</mml:mtext><mml:mn>1</mml:mn></mml:msub><mml:mtext>t</mml:mtext></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ7\"><label>7</label><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\frac{{\\text{t}}}{{{\\text{Q}}_{{\\text{t}}} }} = \\frac{1}{{{\\text{K}}_{{2}} {\\text{Q}}_{{\\text{e}}}^{2} }} + \\frac{{\\text{t}}}{{{\\text{Q}}_{{\\text{e}}} }} $$\\end{document}</tex-math><mml:math id=\"M14\" display=\"block\"><mml:mrow><mml:mfrac><mml:mtext>t</mml:mtext><mml:msub><mml:mtext>Q</mml:mtext><mml:mtext>t</mml:mtext></mml:msub></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mtext>K</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:msubsup><mml:mtext>Q</mml:mtext><mml:mrow><mml:mtext>e</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mtext>t</mml:mtext><mml:msub><mml:mtext>Q</mml:mtext><mml:mtext>e</mml:mtext></mml:msub></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ8\"><label>8</label><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\frac{1}{{{\\text{Q}}_{{\\text{e}}} - {\\text{Q}}_{{\\text{t}}} }} = \\frac{1}{{{\\text{Q}}_{{\\text{e}}} }} + {\\text{K}}_{3} {\\text{t}} $$\\end{document}</tex-math><mml:math id=\"M16\" display=\"block\"><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mtext>Q</mml:mtext><mml:mtext>e</mml:mtext></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mtext>Q</mml:mtext><mml:mtext>t</mml:mtext></mml:msub></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msub><mml:mtext>Q</mml:mtext><mml:mtext>e</mml:mtext></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mtext>K</mml:mtext><mml:mn>3</mml:mn></mml:msub><mml:mtext>t</mml:mtext></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ9\"><label>9</label><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ {\\text{Q}}_{{\\text{t}}} = {\\text{ K}}_{{4}} {\\text{t}}^{{0.{5}}} + {\\text{ C}} $$\\end{document}</tex-math><mml:math id=\"M18\" display=\"block\"><mml:mrow><mml:msub><mml:mtext>Q</mml:mtext><mml:mtext>t</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>K</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub><mml:msup><mml:mrow><mml:mtext>t</mml:mtext></mml:mrow><mml:mrow><mml:mn>0.5</mml:mn></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>C</mml:mtext></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51321_Article_Equ1.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51321_Article_Equ2.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51321_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51321_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51321_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51321_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51321_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2024_51321_Fig6_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"41598_2024_51321_Article_Equ3.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51321_Article_Equ4.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51321_Article_Equ5.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51321_Fig7_HTML\" id=\"MO7\"/>", "<graphic xlink:href=\"41598_2024_51321_Article_Equ6.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51321_Article_Equ7.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51321_Article_Equ8.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51321_Article_Equ9.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51321_Fig8_HTML\" id=\"MO8\"/>", "<graphic xlink:href=\"41598_2024_51321_Fig9_HTML\" id=\"MO9\"/>", "<graphic xlink:href=\"41598_2024_51321_Fig10_HTML\" id=\"MO10\"/>", "<graphic xlink:href=\"41598_2024_51321_Fig11_HTML\" id=\"MO11\"/>" ]
[]
[{"label": ["1."], "surname": ["Perumal", "Atchudan", "Yoon", "Joo", "Cheong"], "given-names": ["S", "R", "DH", "J", "IWJI"], "collab": ["E.C. Research"], "article-title": ["Spherical chitosan/gelatin hydrogel particles for removal of multiple heavy metal ions from wastewater"], "source": ["Indus. Eng. Chem. Res."], "year": ["2019"], "volume": ["58"], "issue": ["23"], "fpage": ["9900"], "lpage": ["9907"], "pub-id": ["10.1021/acs.iecr.9b01298"]}, {"label": ["3."], "surname": ["Pandey", "Makhado", "Kim", "Kang"], "given-names": ["S", "E", "S", "MJER"], "article-title": ["Recent developments of polysaccharide based superabsorbent nanocomposite for organic dye contamination removal from wastewater\u2014A review"], "source": ["Environ. Res."], "year": ["2022"], "volume": ["3"], "fpage": ["114909"]}, {"label": ["4."], "surname": ["Sharma", "Kaith", "Chandel", "Singh"], "given-names": ["AK", "BS", "K", "AJMC"], "article-title": ["Physics, Bifunctional gelatin/dextrin hybrid backbone based fluorescent chemo-sensor for the detection of tannic acid and removal of eosin yellow dye"], "source": ["Mater. Chem. Phys."], "year": ["2020"], "volume": ["254"], "fpage": ["123304"], "pub-id": ["10.1016/j.matchemphys.2020.123304"]}, {"label": ["6."], "surname": ["Mensah", "Samy", "Ezz", "Elkady", "Shokry"], "given-names": ["K", "M", "H", "M", "H"], "article-title": ["Utilization of iron waste from steel industries in persulfate activation for effective degradation of dye solutions"], "source": ["J. Environ. Manag."], "year": ["2022"], "volume": ["314"], "fpage": ["115108"], "pub-id": ["10.1016/j.jenvman.2022.115108"]}, {"label": ["7."], "surname": ["Rubangakene", "Elkady", "Elwardany", "Fujii", "Sekiguchi", "Shokry"], "given-names": ["NO", "M", "A", "M", "H", "H"], "article-title": ["Novel nano-biosorbent materials from thermal catalytic degradation of green pea waste for cationic and anionic dye decolorization"], "source": ["Biomass Convers. Biorefinery"], "year": ["2023"], "volume": ["13"], "issue": ["16"], "fpage": ["14873"], "lpage": ["14888"], "pub-id": ["10.1007/s13399-022-03299-y"]}, {"label": ["10."], "surname": ["Lu", "Xiang", "Huang", "Li", "Zhao", "Zhang", "Zhao"], "given-names": ["T", "T", "X-L", "C", "W-F", "Q", "C-SJCP"], "article-title": ["Post-crosslinking towards stimuli-responsive sodium alginate beads for the removal of dye and heavy metals"], "source": ["Carbohydr. Polymers"], "year": ["2015"], "volume": ["133"], "issue": ["2015"], "fpage": ["587"], "lpage": ["595"], "pub-id": ["10.1016/j.carbpol.2015.07.048"]}, {"label": ["13."], "surname": ["Ao", "Zhao", "Li", "Zhang", "Huang", "Wang", "Gai", "Chen", "Zhang", "Lu"], "given-names": ["C", "J", "Q", "J", "B", "Q", "J", "Z", "W", "CJ"], "article-title": ["Biodegradable all-cellulose composite membranes for simultaneous oil/water separation and dye removal from water"], "source": ["Carbohydr. Polymers"], "year": ["2020"], "volume": ["250"], "fpage": ["116872"], "pub-id": ["10.1016/j.carbpol.2020.116872"]}, {"label": ["16."], "surname": ["Fakhry", "El-Sonbati", "Omar", "El-Henawy", "Zhang", "Marwa"], "given-names": ["H", "M", "B", "R", "Y", "E-K"], "article-title": ["Novel fabricated low-cost hybrid polyacrylonitrile/polyvinylpyrrolidone coated polyurethane foam (PAN/PVP@ PUF) membrane for the decolorization of cationic and anionic dyes"], "source": ["J. Environ. Manag."], "year": ["2022"], "volume": ["315"], "fpage": ["115128"], "pub-id": ["10.1016/j.jenvman.2022.115128"]}, {"label": ["18."], "surname": ["Mohamed", "Abu Elella", "Sabaa", "Saad"], "given-names": ["RR", "MH", "MW", "GRJC"], "article-title": ["Synthesis of an efficient adsorbent hydrogel based on biodegradable polymers for removing crystal violet dye from aqueous solution"], "source": ["Cellulose"], "year": ["2018"], "volume": ["25"], "fpage": ["6513"], "lpage": ["6529"], "pub-id": ["10.1007/s10570-018-2014-x"]}, {"label": ["19."], "surname": ["Abu Elella", "El Hafeez", "Goda", "Lee", "Yoon"], "given-names": ["MH", "EA", "ES", "S", "KRJC"], "article-title": ["Smart bactericidal filter containing biodegradable polymers for crystal violet dye adsorption"], "source": ["Cellulose"], "year": ["2019"], "volume": ["26"], "fpage": ["9179"], "lpage": ["9206"], "pub-id": ["10.1007/s10570-019-02698-1"]}, {"label": ["22."], "surname": ["Elella", "Aamer", "Mohamed", "El Nazer", "Mohamed"], "given-names": ["MHA", "N", "YM", "HA", "RR"], "article-title": ["Innovation of high-performance adsorbent based on modified gelatin for wastewater treatment"], "source": ["Polym. Bull."], "year": ["2022"], "volume": ["23"], "fpage": ["1"], "lpage": ["17"]}, {"label": ["23."], "surname": ["Olad", "Azhar"], "given-names": ["A", "FF"], "article-title": ["The synergetic effect of bioactive ceramic and nanoclay on the properties of chitosan\u2013gelatin/nanohydroxyapatite\u2013montmorillonite scaffold for bone tissue engineering"], "source": ["Ceram. Int."], "year": ["2014"], "volume": ["40"], "issue": ["7"], "fpage": ["10061"], "lpage": ["10072"], "pub-id": ["10.1016/j.ceramint.2014.04.010"]}, {"label": ["24."], "surname": ["Rigueto", "Nazari", "Massuda", "Ostwald", "Piccin", "Dettmer"], "given-names": ["CVT", "MT", "L\u00c1", "BEP", "JS", "A"], "article-title": ["Production and environmental applications of gelatin-based composite adsorbents for contaminants removal: A review"], "source": ["Environ. Chem. Lett."], "year": ["2021"], "volume": ["19"], "issue": ["3"], "fpage": ["2465"], "lpage": ["2486"], "pub-id": ["10.1007/s10311-021-01184-0"]}, {"label": ["26."], "surname": ["Dhiman", "Bhatia", "Singh"], "given-names": ["A", "RK", "A"], "article-title": ["Development of bionanocomposite from natural polymer and its application in wastewater treatment and as an antimicrobial agent"], "source": ["Polymer Sci."], "year": ["2023"], "volume": ["2"], "fpage": ["1"], "lpage": ["14"]}, {"label": ["27."], "surname": ["Thakur", "Govender", "Mamo", "Tamulevicius", "Thakur"], "given-names": ["S", "PP", "MA", "S", "V"], "article-title": ["Recent progress in gelatin hydrogel nanocomposites for water purification and beyond"], "source": ["Vacuum"], "year": ["2017"], "volume": ["146"], "fpage": ["396"], "lpage": ["408"], "pub-id": ["10.1016/j.vacuum.2017.05.032"]}, {"label": ["28."], "surname": ["Dadfar", "Alemzadeh", "Dadfar", "Vosoughi"], "given-names": ["SA", "I", "SR", "M"], "article-title": ["Studies on the oxygen barrier and mechanical properties of low density polyethylene/organoclay nanocomposite films in the presence of ethylene vinyl acetate copolymer as a new type of compatibilizer"], "source": ["Mater. Des."], "year": ["2011"], "volume": ["32"], "issue": ["4"], "fpage": ["1806"], "lpage": ["1813"], "pub-id": ["10.1016/j.matdes.2010.12.028"]}, {"label": ["29."], "surname": ["Dadfar", "Ramazani", "Dadfar"], "given-names": ["SR", "SA", "SA"], "article-title": ["Investigation of oxygen barrier properties of organoclay/HDPE/EVA nanocomposite films prepared using a two-step solution method"], "source": ["Polymer Compos."], "year": ["2009"], "volume": ["30"], "issue": ["6"], "fpage": ["812"], "lpage": ["819"], "pub-id": ["10.1002/pc.20711"]}, {"label": ["30."], "surname": ["Rao"], "given-names": ["Y"], "article-title": ["Gelatin\u2013clay nanocomposites of improved properties"], "source": ["Polymer"], "year": ["2007"], "volume": ["48"], "issue": ["18"], "fpage": ["5369"], "lpage": ["5375"], "pub-id": ["10.1016/j.polymer.2007.06.068"]}, {"label": ["31."], "surname": ["Xin", "Wei", "Yang", "Yan", "Feng", "Chen", "Li"], "given-names": ["X", "Q", "J", "L", "R", "G", "B"], "article-title": ["Highly efficient removal of heavy metal ions by amine-functionalized mesoporous Fe"], "sub": ["3", "4"], "source": ["Chem. Eng. J."], "year": ["2012"], "volume": ["184"], "fpage": ["132"], "lpage": ["140"], "pub-id": ["10.1016/j.cej.2012.01.016"]}, {"label": ["33."], "surname": ["Rahmani", "DadvandKoohi"], "given-names": ["M", "A"], "article-title": ["Adsorption of malachite green on the modified montmorillonite/xanthan gum-sodium alginate hybrid nanocomposite"], "source": ["Polymer Bull."], "year": ["2021"], "volume": ["79"], "fpage": ["1"], "lpage": ["27"]}, {"label": ["35."], "surname": ["Bhagath", "Vivek", "Krishna", "Mittal", "Balachandran"], "given-names": ["S", "A", "VV", "SS", "M"], "article-title": ["Synthesis and characteristics of MMT reinforced chitosan nanocomposite"], "source": ["Mater. Today Proc."], "year": ["2021"], "volume": ["46"], "fpage": ["4487"], "lpage": ["4492"], "pub-id": ["10.1016/j.matpr.2020.09.685"]}, {"label": ["36."], "surname": ["Abu Elella", "El Hafeez", "Goda", "Lee", "Yoon"], "given-names": ["MH", "EA", "ES", "S", "KR"], "article-title": ["Smart bactericidal filter containing biodegradable polymers for crystal violet dye adsorption"], "source": ["Cellulose"], "year": ["2019"], "volume": ["26"], "issue": ["17"], "fpage": ["9179"], "lpage": ["9206"], "pub-id": ["10.1007/s10570-019-02698-1"]}, {"label": ["37."], "surname": ["Muyonga", "Cole", "Duodu"], "given-names": ["J", "C", "KJ"], "article-title": ["Characterisation of acid soluble collagen from skins of young and adult Nile perch ("], "italic": ["Lates ", "niloticus"], "source": ["Food Chem."], "year": ["2004"], "volume": ["85"], "issue": ["1"], "fpage": ["81"], "lpage": ["89"], "pub-id": ["10.1016/j.foodchem.2003.06.006"]}, {"label": ["38."], "surname": ["Silva", "Bandeira", "Pinto"], "given-names": ["RDSGD", "SF", "LAA"], "article-title": ["[EMBARGAR] Characteristics and chemical composition of skins gelatin from cobia ("], "italic": ["Rachycentron canadum"], "source": ["LWT-Food Sci. Technol."], "year": ["2014"], "volume": ["57"], "fpage": ["580"], "lpage": ["585"], "pub-id": ["10.1016/j.lwt.2014.02.026"]}, {"label": ["39."], "surname": ["Martins", "Sousa", "Claudino", "Lino", "Vale", "Silva", "Morais", "De Souza Filho", "De Souza"], "given-names": ["MEO", "JR", "RL", "SCO", "DAD", "ALC", "JPS", "MDSM", "BWJ"], "article-title": ["Thermal and chemical properties of gelatin from tilapia ("], "italic": ["Oreochromis ", "niloticus"], "source": ["J. Aquat. Food Prod. Technol."], "year": ["2018"], "volume": ["27"], "issue": ["10"], "fpage": ["1120"], "lpage": ["1133"], "pub-id": ["10.1080/10498850.2018.1535530"]}, {"label": ["41."], "surname": ["Das", "Suguna", "Prasad", "Vijaylakshmi", "Renuka"], "given-names": ["MP", "P", "K", "J", "MJ"], "article-title": ["Extraction and characterization of gelatin: A functional biopolymer"], "source": ["Int. J. Pharm. Pharmaceut. Sci."], "year": ["2017"], "volume": ["9"], "issue": ["9"], "fpage": ["239"]}, {"label": ["44."], "surname": ["Dan", "Banivaheb", "Hashemipour", "Kalantari"], "given-names": ["S", "S", "H", "M"], "article-title": ["Synthesis, characterization and absorption study of chitosan-"], "italic": ["g", "co"], "source": ["Polymer Bull."], "year": ["2021"], "volume": ["78"], "fpage": ["1887"], "lpage": ["1907"], "pub-id": ["10.1007/s00289-020-03190-8"]}, {"label": ["46."], "surname": ["Bukhari", "Khan", "Rehanullah", "Ranjha"], "given-names": ["SMH", "S", "M", "NM"], "article-title": ["Synthesis and characterization of chemically cross-linked acrylic acid/gelatin hydrogels: Effect of pH and composition on swelling and drug release"], "source": ["Int. J. Polymer Sci."], "year": ["2015"], "volume": ["4"], "fpage": ["1"], "lpage": ["15"], "pub-id": ["10.1155/2015/187961"]}, {"label": ["47."], "surname": ["Tireli", "Guimar\u00e3es", "Terra", "da Silva", "Guerreiro"], "given-names": ["AA", "IDR", "JCDS", "RR", "MC"], "collab": ["P. Research"], "article-title": ["Fenton-like processes and adsorption using iron oxide-pillared clay with magnetic properties for organic compound mitigation"], "source": ["Environ Sci. Pollut. Res."], "year": ["2015"], "volume": ["22"], "fpage": ["870"], "lpage": ["881"], "pub-id": ["10.1007/s11356-014-2973-x"]}, {"label": ["48."], "surname": ["Siddiqua", "Ranjha", "Rehman", "Shoukat", "Ramzan", "Sultana"], "given-names": ["A", "NM", "S", "H", "N", "HJPB"], "article-title": ["Preparation and characterization of methylene bisacrylamide crosslinked pectin/acrylamide hydrogels"], "source": ["Polymer Bull."], "year": ["2022"], "volume": ["79"], "issue": ["9"], "fpage": ["7655"], "lpage": ["7677"], "pub-id": ["10.1007/s00289-021-03870-z"]}, {"label": ["49."], "surname": ["Salles", "Lombello", "d'\u00c1vila"], "given-names": ["THC", "CB", "MA"], "article-title": ["Electrospinning of gelatin/poly (vinyl pyrrolidone) blends from water/acetic acid solutions"], "source": ["Mater. Res."], "year": ["2015"], "volume": ["18"], "fpage": ["509"], "lpage": ["518"], "pub-id": ["10.1590/1516-1439.310114"]}, {"label": ["50."], "surname": ["Martins", "Martins", "de Carvalho", "Mercante", "Soriano", "Andruh", "Vieira", "Vaz"], "given-names": ["MG", "DO", "BL", "LA", "S", "M", "MD", "MGJ"], "article-title": ["Synthesis and characterization of montmorillonite clay intercalated with molecular magnetic compounds"], "source": ["J. Solid State Chem."], "year": ["2015"], "volume": ["228"], "fpage": ["99"], "lpage": ["104"], "pub-id": ["10.1016/j.jssc.2015.04.024"]}, {"label": ["51."], "surname": ["Makhado", "Pandey", "Nomngongo", "Ramontja"], "given-names": ["E", "S", "PN", "JJCP"], "article-title": ["Fast microwave-assisted green synthesis of xanthan gum grafted acrylic acid for enhanced methylene blue dye removal from aqueous solution"], "source": ["Carbohydr. Polymers"], "year": ["2017"], "volume": ["176"], "fpage": ["315"], "lpage": ["326"], "pub-id": ["10.1016/j.carbpol.2017.08.093"]}, {"label": ["52."], "surname": ["Tang", "Huang", "Wang", "Wu", "Tang", "Li"], "given-names": ["H", "H", "X", "K", "G", "C"], "article-title": ["Hydrothermal synthesis of 3D hierarchical flower-like MoSe2 microspheres and their adsorption performances for methyl orange"], "source": ["Appl. Surf. Sci."], "year": ["2016"], "volume": ["379"], "fpage": ["296"], "lpage": ["303"], "pub-id": ["10.1016/j.apsusc.2016.04.086"]}, {"label": ["53."], "surname": ["Freundlich"], "given-names": ["H"], "article-title": ["\u00dcber die adsorption in l\u00f6sungen"], "source": ["Z. Phys. Chem."], "year": ["1907"], "volume": ["57"], "issue": ["1"], "fpage": ["385"], "lpage": ["470"], "pub-id": ["10.1515/zpch-1907-5723"]}, {"label": ["54."], "surname": ["Temkin"], "given-names": ["M"], "article-title": ["Kinetics of ammonia synthesis on promoted iron catalysts"], "source": ["Acta Physiochim. URSS"], "year": ["1940"], "volume": ["12"], "fpage": ["327"], "lpage": ["356"]}, {"label": ["55."], "surname": ["Khan", "Dahiya", "Ali"], "given-names": ["TA", "S", "I"], "article-title": ["Use of kaolinite as adsorbent: Equilibrium, dynamics and thermodynamic studies on the adsorption of Rhodamine B from aqueous solution"], "source": ["Appl. Clay Sci."], "year": ["2012"], "volume": ["69"], "fpage": ["58"], "lpage": ["66"], "pub-id": ["10.1016/j.clay.2012.09.001"]}, {"label": ["56."], "surname": ["Khan", "Ahmad", "Khan", "Mondal"], "given-names": ["AA", "R", "A", "PK"], "article-title": ["Preparation of unsaturated polyester Ce (IV) phosphate by plastic waste bottles and its application for removal of Malachite green dye from water samples"], "source": ["Arabian J. Chem."], "year": ["2013"], "volume": ["6"], "issue": ["4"], "fpage": ["361"], "lpage": ["368"], "pub-id": ["10.1016/j.arabjc.2010.10.012"]}, {"label": ["57."], "surname": ["Kaith", "Sukriti", "Sharma", "Kaur", "Sethi", "Shanker", "Jassal"], "given-names": ["B", "J", "T", "S", "U", "VJ"], "article-title": ["Microwave-assisted green synthesis of hybrid nanocomposite: Removal of Malachite green from waste water"], "source": ["Iran. Polymer J."], "year": ["2016"], "volume": ["25"], "fpage": ["787"], "lpage": ["797"], "pub-id": ["10.1007/s13726-016-0467-z"]}, {"label": ["58."], "surname": ["Rajabi", "Mahanpoor", "Moradi"], "given-names": ["M", "K", "O"], "article-title": ["Preparation of PMMA/GO and PMMA/GO-Fe"], "sub": ["3", "4"], "source": ["Compos. Part B Eng."], "year": ["2019"], "volume": ["167"], "fpage": ["544"], "lpage": ["555"], "pub-id": ["10.1016/j.compositesb.2019.03.030"]}, {"label": ["59."], "surname": ["Ahmad", "Mondal"], "given-names": ["R", "PK"], "article-title": ["Application of modified water nut carbon as a sorbent in congo red and malachite green dye contaminated wastewater remediation"], "source": ["Sep. Sci. Technol."], "year": ["2010"], "volume": ["45"], "issue": ["3"], "fpage": ["394"], "lpage": ["403"], "pub-id": ["10.1080/01496390903484875"]}, {"label": ["60."], "surname": ["Hasan", "Bhatia", "Walia", "Singh"], "given-names": ["I", "D", "S", "P"], "article-title": ["Removal of malachite green by polyacrylamide-"], "italic": ["g"], "sub": ["2", "3"], "source": ["Groundw. Sustain. Dev."], "year": ["2020"], "volume": ["11"], "fpage": ["100378"], "pub-id": ["10.1016/j.gsd.2020.100378"]}, {"label": ["61."], "surname": ["Ahmad", "Kumar"], "given-names": ["R", "R"], "article-title": ["Adsorption studies of hazardous malachite green onto treated ginger waste"], "source": ["J. Environ. Manag."], "year": ["2010"], "volume": ["91"], "issue": ["4"], "fpage": ["1032"], "lpage": ["1038"], "pub-id": ["10.1016/j.jenvman.2009.12.016"]}, {"label": ["63."], "mixed-citation": ["Umpuch, C. & Sopasin, S.J.I.K. Adsorption of malachite green by chitosan modified montmorillonite. In "], "italic": ["International Science and Technology Conference"]}, {"label": ["64."], "surname": ["Yildirim", "Bulut"], "given-names": ["A", "Y"], "article-title": ["Innovation, adsorption behaviors of malachite green by using crosslinked chitosan/polyacrylic acid/bentonite composites with different ratios"], "source": ["Environ. Technol. Innov."], "year": ["2020"], "volume": ["17"], "fpage": ["100560"], "pub-id": ["10.1016/j.eti.2019.100560"]}, {"label": ["65."], "surname": ["Mittal", "Parashar", "Mishra", "Mishra"], "given-names": ["H", "V", "S", "A"], "article-title": ["Fe3O4 MNPs and gum xanthan based hydrogels nanocomposites for the efficient capture of malachite green from aqueous solution"], "source": ["Chem. Eng. J."], "year": ["2014"], "volume": ["255"], "fpage": ["471"], "lpage": ["482"], "pub-id": ["10.1016/j.cej.2014.04.098"]}, {"label": ["68."], "surname": ["Pal", "Ghorai", "Das", "Samrat", "Ghosh", "Panda"], "given-names": ["S", "S", "C", "S", "A", "AB"], "article-title": ["Carboxymethyl tamarind-"], "italic": ["g"], "source": ["Ind. Eng. Chem. Res."], "year": ["2012"], "volume": ["51"], "issue": ["48"], "fpage": ["15546"], "lpage": ["15556"], "pub-id": ["10.1021/ie301134a"]}, {"label": ["70."], "surname": ["Thakur", "Arotiba"], "given-names": ["S", "O"], "article-title": ["Synthesis, characterization and adsorption studies of an acrylic acid-grafted sodium alginate-based TiO"], "sub": ["2"], "source": ["Adsorp. Sci. Technol."], "year": ["2018"], "volume": ["36"], "issue": ["1\u20132"], "fpage": ["458"], "lpage": ["477"], "pub-id": ["10.1177/0263617417700636"]}, {"label": ["71."], "surname": ["Mohamed", "Elella", "Sabaa", "Saad"], "given-names": ["RR", "MHA", "MW", "GR"], "article-title": ["Synthesis of an efficient adsorbent hydrogel based on biodegradable polymers for removing crystal violet dye from aqueous solution"], "source": ["Cellulose"], "year": ["2018"], "volume": ["25"], "issue": ["11"], "fpage": ["6513"], "lpage": ["6529"], "pub-id": ["10.1007/s10570-018-2014-x"]}]
{ "acronym": [], "definition": [] }
74
CC BY
no
2024-01-14 23:40:15
Sci Rep. 2024 Jan 12; 14:1228
oa_package/06/88/PMC10786822.tar.gz
PMC10786823
38216628
[ "<title>Introduction</title>", "<p id=\"Par3\">Y chromosomes are unique in the genome of many organisms, including mammals and Drosophila, in being haploid, male-limited, repeat-rich, highly heterochromatic, and, in particular, having reduced or no recombination<sup>##REF##23329112##1##</sup>. The resulting selective pressures on Y chromosomes cause rapid degeneration of most protein-coding genes, yet a few genes are maintained on Y chromosomes with remarkable evolutionary persistence. Such genes are maintained for extended periods under strong purifying or sometimes positive selection, repeatedly and independently acquired in different lineages, or undergo massive copy-number amplification on the Y chromosome<sup>##REF##24974375##2##–##REF##31329593##5##</sup>. These patterns of variation indicate that selection favors placing such genes into this seemingly inhospitable genomic environment. In support of this concept, there is striking similarity in both the expression patterns and functions of many Y-linked genes<sup>##REF##28978907##6##–##REF##9381176##8##</sup>.</p>", "<p id=\"Par4\">The 40 MB <italic>Drosophila melanogaster</italic> Y chromosome contains only 14 known protein-coding genes<sup>##REF##35457001##9##–##REF##30420487##11##</sup>. X0 flies are male yet sterile—therefore, the Y chromosome is required for male fertility but not for sex determination or viability<sup>##REF##17245853##12##</sup>. Six genetic loci on the Y, known as the fertility factors, contribute to this fertility function. The fertility factors were defined by a series of X-ray-induced X-Y translocations<sup>##REF##17247923##13##,##REF##17249098##14##</sup> and, remarkably, half of them were discovered to be axonemal dyneins<sup>##REF##11069293##15##,##REF##8248219##16##</sup>, suggesting that the <italic>Drosophila melanogaster</italic> Y chromosome plays a pivotal role in sperm motility. All of the Y-linked fertility factors encode sperm proteins; three of these, kl-2, 3, and 5, are among the most abundant proteins detected in sperm proteomic analyses<sup>##UREF##0##17##</sup>. This is consistent with their presumed role in sperm function and more specifically as major axoneme structural components<sup>##REF##11069293##15##,##REF##11687639##18##,##REF##6818544##19##</sup>.</p>", "<p id=\"Par5\"><italic>kl-1</italic> mutant males, in contrast to all other Y-linked fertility factor mutations, produce mature and motile sperm despite being completely sterile<sup>##REF##5802558##20##</sup>. <italic>kl-1</italic> sperm are transferred to the female reproductive tract (RT) following mating but cannot be recovered from the female sperm storage organs. The specific defect that prevents <italic>kl-1</italic> mutant sperm from entering storage or fertilizing eggs is unknown. The molecular identity of <italic>kl-1</italic> remained unknown until, recently, the gene <italic>WDY</italic> was found to be contained within the <italic>kl-1</italic> region<sup>##REF##18660539##21##</sup> and required for male fertility based on RNA interference (RNAi)<sup>##REF##32098759##22##</sup>. Other protein-coding genes or functional repetitive elements may still reside in the <italic>kl-1</italic> genetic region, which is estimated cytologically to span ~3% of the length of the Y chromosome<sup>##UREF##1##23##</sup>, and it is unclear whether <italic>WDY</italic> mutants produce mature sperm or show a sperm storage defect. More generally, the importance of motility for sperm storage and the mechanisms that regulate sperm motility remain poorly understood in Drosophila.</p>", "<p id=\"Par6\">Here we generated CRISPR mutants to investigate the function of <italic>WDY</italic>. We demonstrate that <italic>WDY</italic> mutant sperm display the storage defect suggested for <italic>kl-1</italic>. Furthermore, mutant sperm have reduced beat frequency and are unable to swim beyond the seminal vesicle. We show that mutants that we generated in another Y-linked gene, <italic>PRY</italic>, also have impaired sperm storage. <italic>WDY</italic> shows significant changes in key amino acid residues in a conserved calcium-binding domain, suggesting the functional evolution of this gene.</p>", "<p id=\"Par7\">A high incidence of genes with predicted sperm motility functions is seen on Y chromosomes across many species, from Drosophila to great apes<sup>##REF##33020265##7##,##REF##20824190##24##</sup>. Carvalho et al.<sup>##REF##11069293##15##</sup> hypothesized that, in species where there is a high level of sperm competition (such as <italic>Drosophila melanogaster</italic>), motor proteins are specifically recruited to the Y chromosome where they can evolve without constraint from male-female antagonistic selective forces. Our study provides an in-road to studying the evolutionary logic of this association.</p>" ]
[ "<title>Methods</title>", "<title>Drosophila stocks and husbandry</title>", "<p id=\"Par26\">Flies were reared on a cornmeal-agar-sucrose medium (recipe available at <ext-link ext-link-type=\"uri\" xlink:href=\"https://cornellfly.wordpress.com/s-food/\">https://cornellfly.wordpress.com/s-food/</ext-link>) at 25°, with a 12 hr light–dark cycle. The stocks used in this study are described in Supplementary Table ##SUPPL##1##1##.</p>", "<title>Generation of a <italic>WDY</italic> Mutant with CRISPR</title>", "<p id=\"Par27\">Three 20-base pair guide RNAs were designed to target exon 2 of <italic>WDY</italic>, a region of the gene with no known duplications (Supplementary Fig. ##SUPPL##1##1##)<sup>##REF##30420487##11##</sup>. We also targeted <italic>ebony</italic>, a visible Co-CRISPR marker<sup>##UREF##6##50##</sup>. Guide sequences were incorporated into pAC-U63-tgRNA-Rev (Addgene, Plasmid #112811), which is analogous to the “tgFE” construct from<sup>##REF##30504366##51##</sup>. This was done by appending guide RNA sequences to tracrRNA core and tRNA sequences from pMGC (Addgene, Plasmid #112812) through tailed primers (Supplementary Table ##SUPPL##1##3##) to create inserts that were then inserted by Gibson Assembly into a <italic>SapI</italic>-digested pAC-U63-tgRNA-Rev (Addgene, Plasmid #112811). The plasmid backbone contained attB, and we used PhiC31 to integrate it into an attP-9A site on chromosome 3 R. The construct was injected into <italic>yw nanos-phiC31; PBac{y</italic> + <italic>-attP-9A}VK00027</italic> by Rainbow Transgenic Flies Inc. Transformants were identified by eye colour from a <italic>mini-white</italic>+ marker. Transformants express the four guides ubiquitously under the U6:3 promoter as a single polycistronic transcript that is processed by the endogenous cellular tRNA processing machinery (RNase P and Z) to release the individual mature gRNAs and interspersed tRNAs. The transformants were balanced, and inserts were confirmed by PCR and sequencing. A few of the transformants had light-red eyes, but we only used those with dark-red eyes.</p>", "<p id=\"Par28\">The combination of transformants and germline Cas9 drivers was optimized for efficiency. Males containing <italic>vasa-Cas9</italic> and our guide RNAs were sterile, while females showed a 6.2% CRISPR efficiency based on the generation of <italic>ebony</italic> mutants. In contrast, F1 males from crosses with <italic>nanos-Cas9</italic> drivers on chromosomes 2 and 3 produced progeny. F2 progeny (from male and female crosses combined) showed that these two lines had editing efficiencies of 2.2% and 2.6%, respectively. Our observation of higher efficiency and sterility from <italic>vasa-Cas9</italic> is consistent with the earlier<sup>##REF##28073824##52##</sup> and higher somatic<sup>##REF##29735716##53##,##REF##23213382##54##</sup> protein expression of Vasa versus Nanos, as well as the RNAi phenotype of <italic>WDY</italic><sup>##REF##32098759##22##</sup>. We proceeded to make stable mutants by crossing transformant #1 to <italic>nanos-Cas9</italic> in a compound chromosome background.</p>", "<p id=\"Par29\">Our crossing scheme for creating <italic>WDY</italic> alleles is shown in Supplementary Fig. ##SUPPL##1##3##. We combined the <italic>nanos-Cas9</italic> driver on chromosome 3 with a Y chromosome marked with <italic>3xP3-tdTomato</italic><sup>##REF##30079589##55##</sup>. We also combined the guide-expressing insert on 3 R with a compound X (; <italic>C(1)M4, y[1]</italic>). CRISPR editing occurred in F1 females (<italic>/Y</italic><sup>3XP3-tdTomato</sup>) that carried the marked Y chromosome. By crossing to a compound X-Y (<italic>, C(1;Y)1, y[1]</italic>) we were able to establish balanced lines from 55 <italic>ebony</italic> and 5 non-<italic>ebony</italic> F2 flies. Males were of genotype / <italic>Y</italic><sup><italic>3XP3-tdTomato</italic></sup> and were fertile regardless of CRISPR-mediated edits of the free Y chromosome. We screened these lines for visible deletions in the <italic>WDY</italic> target site—first by gel, then by sequencing. Alleles derived from our crossing scheme are listed in Supplementary Table ##SUPPL##1##4## and described in Supplementary Fig. ##SUPPL##1##4##. They are maintained as stable lines with females and males; the free Y chromosome is edited.</p>", "<p id=\"Par30\">In several of our lines, we saw varying, intermediate degrees of position effect variegation (PEV) (Supplementary Fig. ##SUPPL##1##2##). This corresponded with either failed amplification at the target site in <italic>WDY</italic> or the presence of several bands of unexpected size. Based on our previous results when editing <italic>FDY</italic> with CRISPR<sup>##REF##32098759##22##</sup>, we hypothesized that these mutations were large deletions in the Y chromosome Thus, we did not phenotype these mutants for sperm or fertility characteristics. C(1)M4 contains <italic>white</italic><sup><italic>mottled-4</italic></sup>, a PEV marker that is highly sensitive to Y chromosome dosage. females with C(1)M4 have mostly white eyes, while females have an almost entirely red eye. We previously showed that lines with visibly altered PEV lacked large sections of the Y chromosome<sup>##REF##32098759##22##</sup>. Such deletions may be caused by the presence of uncharacterized copies of the target region present in unassembled regions of the Y chromosome.</p>", "<title>Sterility, mating, and sperm storage</title>", "<p id=\"Par31\">Crosses and experiments were done with flies 2–5 days after eclosion (dAE). To test for sterility, we crossed individual XY males to 4 Canton S virgin females in a food-containing vial with wet yeast. Adults were transferred to a new vial after one week. Crosses were scored for the presence of progeny. 15–20 crosses were tested per line. For experiments that required timing from the start of mating, one Canton S virgin female was mated to three males of a given genotype, and flies were observed. Once mating began the time was noted. Females were analyzed or flash frozen in liquid nitrogen 30 minutes, 2 hours, or 24 hours after the start of mating (30 mASM, 2 hASM, 24 hASM). Reproductive tracts were dissected from frozen females in PBS, fixed in 4% paraformaldehyde, and mounted in Vectashield with DAPI. Samples were imaged on an Echo Revolve microscope or a Leica DMRE confocal microscope. The distribution of sperm in the female reproductive tract was assessed from the images. Each region was scored as containing 0, 10 or fewer, or &gt;10 sperm.</p>", "<title>Sperm counting with Imaris software</title>", "<p id=\"Par32\">To quantify sperm transferred, female reproductive tracts 30 mASM were imaged on a Leica DMRE confocal using standardized settings. Two μm Z-stacks through each sample were collected. Using Imaris 9.8.0 software (RRID:SCR_007370), first the female reproductive tract was extracted in each image by manually drawing a contour surface. The mating plug and cuticle were specifically excluded due to their high autofluorescence<sup>##REF##11267893##56##</sup>. Second, protamine-labeled sperm heads were automatically detected using the “Surfaces” function (smoothing and background elimination enabled, 2.0 µm surface grain size, 1 µm diameter of largest sphere, 2.747–13.048 manual threshold, &gt;15 quality, &lt;0.8 sphericity).</p>", "<title>Sperm tail-beat frequency analysis</title>", "<p id=\"Par33\">Tail-beat frequency was measured for sperm dissected from the reproductive tracts of females 2–5 dAE and 30 mASM or males 2–5 dAE into PBS. Sperm were released into a 15 µl drop of PBS on a glass slide by tearing the male seminal vesicle or female uterus. Sperm were observed under brightfield optics with an Olympus BX51WDI microscope and a ×50 LMPLFLN objective. Eight-second raw movie clips at 1280 × 720 resolution and 60 frames per second were captured from 4–6 different regions around the sperm mass using a Canon EOS Rebel T6 camera. Dissected sperm masses all contain sperm tails beating at a range of frequencies. We specifically quantified the beat frequency of the 1–2 fastest-beating sperm tails from each clip.</p>", "<p id=\"Par34\">To measure sperm tail-beat frequency, video clips were imported to FIJI (RRID:SCR_002285) using the ffmpeg plugin. From each clip, we measured beat frequencies of the 1-2 fastest-beating sperm and limited to tails that were not overlapping or entangled with other sperm tails. A selection line was drawn across an isolated section of sperm tail. A 1-pixel “Multi Kymograph” was generated, which shows pixel intensities across the selection line on the <italic>X</italic> axis for each frame along the Y-axis. The beating of the sperm tail appears as a traveling wave form. The number of beats and the number of frames were counted for the region where the sperm tail remained in focus and isolated from other tails. Beat frequency was then calculated as: Hz = (no. of beats × 60 fps)/no. of frames.</p>", "<title>Sperm swimming analysis</title>", "<p id=\"Par35\">Videos of sperm swimming were acquired from either male reproductive tracts or female reproductive tracts 1 hASM. Tracts were dissected and mounted in 15 µL PBS. Spacers (2 layers of double-stick tape) were used to avoid compression of the tissue by the coverslip. Fluorescent sperm heads were recorded through screen recording of the preview window on an Echo Revolve. We used ffmpeg (RRID:SCR_016075) to convert videos to constant frame rate of 60 fps and. mov format. Videos were then imported into FIJI (RRID:SCR_002285) using the ffmpeg plugin. We manually tracked sperm heads across 60 frames using the “Manual Tracking” plugin in FIJI. The tracking shown in Fig. ##FIG##2##3## represents movement across 30 frames.</p>", "<title>Annotation of <italic>D. melanogaster</italic> WDY</title>", "<p id=\"Par36\">EF hand motifs were identified by searching (using Geneious software, RRID:SCR_010519) for the canonical and pseudo PROSITE motif consensus sequences defined in Zhou et al.<sup>##UREF##5##44##</sup> and allowing for a maximum 1 base pair mismatch. Because the pseudo EF hand motif contains a variable size region, there were two potential start locations in the sequence—residue 44 or 47. However, Alphafold prediction showed residues that should form the loop region would instead form part of the alpha helix in the motif beginning at residue 44. We, therefore, favored the motif beginning at residue 47. Locations of the calcium-binding residues were determined based on the consensus sequence logograms<sup>##UREF##5##44##</sup>.</p>", "<p id=\"Par37\">Three WD40 domains<sup>##REF##18660539##21##</sup> were originally identified in the protein sequence based on homology. Flybase reported a handful of WD40 repeats (2 for Pfam and 8 for SMART) were identified. 4–16 of these repeat domains may together form a circular beta-propeller structure called a WD40 domain<sup>##REF##11814058##57##–##REF##10322433##59##</sup>; however, insufficient WD40 repeats were identified in WDY to predict the presence of a WD40 domain. We used the structural prediction of <italic>D. melanogaster</italic> WDY by Alphafold (PDB B4F7L9)<sup>##REF##34265844##60##</sup> to identify the locations of the characteristic β-propeller, consisting of four antiparallel sheets<sup>##REF##30069656##58##</sup>. WDY is predicted to form two WD40 domains–one with 6 WD40 repeats and one with 7 WD40 repeats.</p>", "<title>Identification of WDY ortholog sequences</title>", "<p id=\"Par38\">WDY ortholog sequences were obtained from GenBank, Chang et al.<sup>##UREF##7##61##</sup>, or extracted from publicly available genomes using Exonerate version 2.2.0<sup>##REF##15713233##62##</sup>, as noted in Supplementary Supplementary Table ##SUPPL##1##7##. Newly extracted sequences were obtained by aligning the <italic>D. melanogaster</italic> WDY protein sequence (NM_001316659.1) to the genomic scaffolds containing WDY in other species via the Protein2Genome command. The top-scoring prediction from Exonerate was used to define the sequence.</p>", "<p id=\"Par39\">For the comparisons in Fig. ##FIG##3##4##, protein sequences were aligned in Geneious software (RRID:SCR_010519) using a BLOSUM cost matrix with a gap open cost of 10 and a gap extend cost of 0.1.</p>", "<title>Selection analysis</title>", "<p id=\"Par40\">To create sequence alignments for selection analysis, we translated the WDY coding sequences and then aligned the protein sequences with MAFFT<sup>##REF##23329690##63##</sup>. Protein alignments were converted to nucleotide alignments by PAL2NAL<sup>##REF##16845082##64##</sup>. Sites, where &gt;50% of the species had a gap in the alignment were removed from the final alignment used in the analysis. We pruned the phylogeny published in Kim et al.<sup>##UREF##8##65##</sup> to include only relevant species as input phylogenies for codeml analysis.</p>", "<p id=\"Par41\">We used the codeml program of PAML 4.8<sup>##REF##17483113##66##</sup> to determine if there was evidence of positive selection in WDY and to potentially identify specific codons subject to positive selection. We compared neutral models to models including positive selection (M1a v. M2a, M7 v. M8, and M8a v. M8) via a likelihood ratio test (LRT). The LRT statistic was calculated from the model likelihoods as 2*[log(<italic>L</italic><sub><italic>a</italic></sub>) −log(<italic>L</italic><sub><italic>0</italic></sub>)], where <italic>L</italic><sub><italic>a</italic></sub> and <italic>L</italic><sub><italic>0</italic></sub> are the likelihoods under the alternate and null hypotheses, respectively. For M1a v M2a and M7 v M8 comparisons, the LRT statistic was compared to the Chi-squared distribution with 2 degrees of freedom<sup>##REF##17483113##66##</sup>. For the M8a v M8 comparison, 1 degree of freedom was used<sup>##REF##12519901##67##</sup>. Specific codons evolving under positive selection were identified via M8 in codeml with Bayes Empirical Bayes probabilities &gt;0.9<sup>##REF##12519901##67##</sup>. We also used model 0 in codeml to obtain <italic>d</italic><sub><italic>N</italic></sub>/<italic>d</italic><sub><italic>S</italic></sub> values on a pairwise comparison between <italic>D. melanogaster</italic> and <italic>D. obscura</italic> and performed a branch-site model test (M0 v. M2) using all available WDY sequences.</p>", "<title>Statistics and reproducibility</title>", "<p id=\"Par42\">Statistical analysis was done using R and R-Studio (RRID:SCR_001905).</p>", "<p id=\"Par43\">Distributions of sperm in the female reproductive tract were examined for 20–30 samples for each genotype. Differences in the distribution of sperm between different genotypes were compared using an Asymptotic Linear-by-Linear Association Test for an ordered categorical variable by genotype, stratified by reproductive tract region.</p>", "<p id=\"Par44\">Counts of transferred sperm from control and <italic>WDY</italic> males showed homogeneity of variance and were approximately normal. They were therefore statistically compared using a Student’s <italic>t</italic>-test.</p>", "<p id=\"Par45\">Sperm tail-beat frequencies were measured from a minimum of three individuals for each allele and ten measurements per individual. Using the lme4 package in R, linear mixed models were fitted to the data, incorporating the individual as a random effect and the experimental batch and the experimenter who measured beat frequency as fixed effects. We then ran a Likelihood Ratio test to compare the model with and without “Genotype” as a fixed effect. Approximately one-third of samples were scored blind, and statistical analysis indicated consistent results whether or not samples were scored blind.</p>", "<title>Reporting summary</title>", "<p id=\"Par46\">Further information on research design is available in the ##SUPPL##16##Nature Portfolio Reporting Summary## linked to this article.</p>" ]
[ "<title>Results and discussion</title>", "<title><italic>WDY</italic> mutants are sterile but produce mature, motile sperm</title>", "<p id=\"Par8\">We used CRISPR to precisely target <italic>WDY</italic> (Supplementary Figs. ##SUPPL##1##1## and ##SUPPL##1##2##, Supplementary Tables ##SUPPL##1##1##–##SUPPL##1##4##). One of the major challenges of studying the Y chromosome is in propagating sterile mutations on a haploid, sex-limited chromosome. We used a crossing strategy involving compound sex chromosomes to make and stably propagate heritable mutations in <italic>WDY</italic> (mutant stocks consist of /<italic>Y,WDY</italic> females and /<italic>Y,WDY</italic> males, see Methods, Supplementary Fig. ##SUPPL##1##3##<sup>##REF##32098759##22##</sup>). Our crossing scheme also enabled us to identify and eliminate large chromosomal truncations that are common during genetic editing of the Y chromosome, likely due to its highly repetitive nature<sup>##REF##32098759##22##</sup>. To evaluate the phenotype of our mutants, we then removed the compound chromosomes by selective breeding to generate X/Y,<italic>WDY</italic> mutant males. We confirmed each phenotype with three different <italic>WDY</italic> alleles, <italic>F8</italic>, <italic>C104</italic>, and <italic>C3</italic>, containing deletions of 547 bp, 545 bp, and 443 bp, respectively (Supplementary Fig. ##SUPPL##1##4##, Supplementary Table ##SUPPL##1##4##). All are large deletions close to the N-terminus that disrupt the reading frame and are therefore expected to be null; all three gave the same phenotype. We compared mutants to controls that account for the genetic background (Y<sup>Tomato</sup>) or crossing scheme (Y<sup>C7</sup> and Y<sup>G107</sup>). In individual crosses to females from a wild-type strain (Canton S), control males produced progeny, while <italic>WDY</italic> males were sterile (Supplementary Table ##SUPPL##1##5##).</p>", "<p id=\"Par9\">To investigate the cause of this sterility, we first examined the distribution of sperm in the testes using Protamine-GFP<sup>##REF##20299550##25##</sup>, which labels sperm heads. Sperm of mutants in Y-linked fertility factors <italic>kl-2</italic>, <italic>kl-3</italic>, <italic>kl-5</italic>, <italic>ks-1</italic>, and <italic>ks-2</italic> are eliminated before this time, during the individualization stage<sup>##REF##32098759##22##,##REF##32404399##26##,##REF##6794995##27##</sup>. In contrast, we observed an accumulation of <italic>WDY</italic> mutant sperm in the posterior-most section of the testes, where individualized sperm accumulate while sperm coiling occurs, causing that region to bulge in the mutant (Fig. ##FIG##0##1a–f##). Sperm coiling is thought to function as a quality control step during which sperm with abnormal tails are eliminated by ingestion by the terminal epithelium<sup>##UREF##2##28##</sup>. The accumulation of <italic>WDY</italic> sperm in the posterior testes may be due to their progression being stalled by this quality control mechanism or may indicate insufficient motility to exit the testes.</p>", "<p id=\"Par10\">In the seminal vesicles, there were fewer sperm in <italic>WDY</italic> mutants than in the controls (Fig. ##FIG##0##1c, d##). Yet tails of sperm from both <italic>WDY</italic> and control males were observed to beat after we tore open the seminal vesicles (Supplementary Movie ##SUPPL##3##1## and ##SUPPL##4##2##). Visual inspection showed no obvious differences in the movement of <italic>WDY</italic> versus control sperm. These observations match Kiefer’s conclusion that <italic>kl-1</italic> mutants were sterile but produced seemingly motile sperm<sup>##REF##5802558##20##</sup>. Our results—that <italic>WDY</italic> mutations are sufficient to result in sterility, yet produce sperm that are motile—make it highly likely that <italic>WDY</italic> is the fertility factor known in the literature as <italic>kl-1</italic>.</p>", "<title><italic>WDY</italic> mutant sperm are transferred to females, but do not enter the storage organs</title>", "<p id=\"Par11\">We next tracked the movement of Protamine-labeled sperm in the RT of wild-type (Canton S) females 30 min after the start of mating (mASM). Sperm from both control and <italic>WDY</italic> mutant males were found in the female’s uterus (bursa) (Supplementary Fig. ##SUPPL##1##5##), and their tails were observed to beat when dissected out of the uterus (Supplementary Movie ##SUPPL##5##3##, ##SUPPL##6##4##). In both <italic>WDY</italic> and control genotypes, an open or folded conformation of the uterus correlated with the presence or absence of sperm, respectively, as expected<sup>##REF##17276455##29##,##REF##19805225##30##</sup>. We conclude that motile <italic>WDY</italic> sperm are transferred to females and that <italic>WDY</italic> seminal fluid induces conformational changes in the uterus normally.</p>", "<p id=\"Par12\">We did, however, observe defects in the number of sperm transferred to, and the distribution of the sperm within, the female RT. <italic>WDY</italic> males transferred fewer than half as many sperm as control males as quantified at 30 mASM (Fig. ##FIG##1##2a##, <italic>p</italic> value = 8e-6, Student’s <italic>t</italic> test). After mating, Drosophila sperm move rapidly from the uterus into either the primary storage organ, the seminal receptacle, or one of the two long-term storage organs, the spermathecae<sup>##REF##12679097##31##</sup> (Fig. ##FIG##1##2b##). At 30 mASM most control samples contained some stored sperm, but no <italic>WDY</italic> sperm were found in the storage organs. At 2 hASM maximal numbers of sperm are stored in most control samples<sup>##UREF##3##32##</sup>. Yet, again, no sperm from <italic>WDY</italic> mutants were seen in storage (Fig. ##FIG##1##2c–e##). We also examined sperm in RTs of females left to mate overnight to see if a longer time or multiple mating could enable <italic>WDY</italic> mutant sperm to enter storage (Supplementary Fig. ##SUPPL##1##5##). Control samples all had stored sperm. <italic>WDY</italic> sperm were regularly observed in the uterus but never in any of the storage organs (Fig. ##FIG##1##2c##). We conclude that <italic>WDY</italic> mutant sperm are unable to enter the storage organs. In many animals, storage is required for sperm to become competent for fertilization<sup>##REF##12071887##33##,##REF##18077584##34##</sup>. Thus the lack of sperm storage might explain why <italic>WDY</italic> males are sterile.</p>", "<title><italic>WDY</italic> mutant sperm in the male seminal vesicle and female uterus have decreased tail-beat frequency</title>", "<p id=\"Par13\">Although <italic>WDY</italic> mutant sperm beat visibly in vitro (Supplementary Movie ##SUPPL##3##1##–##SUPPL##6##4##), we wished to test whether subtle motility defects prevent them from being able to enter storage. We measured the beat frequency of sperm tails, by recording videos of control and <italic>WDY</italic> mutant sperm dissected directly from the male’s seminal vesicle or from the female’s uterus at 30 mASM (Methods, Supplementary Movie ##SUPPL##3##1##–##SUPPL##6##4##, Fig. ##FIG##2##3a, b##). In the seminal vesicle, the fastest <italic>WDY</italic> mutant sperm tails beat at an average of 6.0 Hz, whereas the fastest control sperm tails beat at an average of 12.3 Hz (p-value = 3.5e-10, Likelihood Ratio Test). In the uterus, the fastest <italic>WDY</italic> mutant sperm tails beat at an average of 7.0 Hz, whereas the fastest control sperm tails beat at an average of 13.1 Hz (<italic>p</italic> value = 7.3e-6, Likelihood Ratio Test). We conclude that <italic>WDY</italic> mutant sperm have a lower tail-beat frequency than wild-type sperm in both the male and female RTs.</p>", "<title><italic>WDY</italic> mutant sperm are unable to swim in the male ejaculatory duct and female uterus</title>", "<p id=\"Par14\">We hypothesized that the lower tail-beat frequency affects the ability of <italic>WDY</italic> mutant sperm to propel themselves. To test for defects in sperm swimming, sperm movement was assessed in videos by tracking the protamine-labeled heads of control and <italic>WDY</italic> mutant sperm. In all regions the swimming speed of individual sperm varied, but there was an overriding regional pattern to the motility (Fig. ##FIG##2##3c–j##). In mammals, sperm leaving the testes are immotile and must go undergo epididymal maturation in order to gain the ability to move progressively<sup>##REF##28297559##35##</sup>. It was previously suggested, and has often been repeated, that, similarly, Drosophila sperm do not gain motility until they reach the seminal vesicle<sup>##REF##13929245##36##</sup>. We were thus surprised to see some individualized sperm heads slowly swimming within the posterior testes of most control samples (Fig. ##FIG##2##3c, ci##, Supplementary Movie ##SUPPL##7##5##). This suggests that, in Drosophila, sperm motility is normally initiated within the testes. <italic>WDY</italic> mutant sperm heads in this region also often moved around, suggesting that at least some mutant sperm develop motility (Fig. ##FIG##2##3d, di##, Supplementary Movie ##SUPPL##8##6##).</p>", "<p id=\"Par15\">Individual sperm heads generally ceased to move in the seminal vesicles of both control and <italic>WDY</italic> mutant flies, while flagella remained beating. However, mass movements occurred from contractions of the whole organ. It was unclear whether dense packing of sperm or some physical or chemical property of the seminal vesicle caused the immobilization of sperm heads while sperm tails continued to beat vigorously (Fig. ##FIG##2##3e, ei##, Supplementary Movie ##SUPPL##9##7##). This highlights that flagellar beating does not necessarily correlate with sperm swimming (i.e., moving through space). There were far fewer sperm in <italic>WDY</italic> mutant seminal vesicles, but the mutant sperm heads were predominantly immobilized, as in controls (Fig. ##FIG##2##3f, fi##, Supplementary Movie ##SUPPL##10##8##). We conclude that at least some <italic>WDY</italic> sperm develop the ability to swim in the testes and become immobilized in the seminal vesicle, as normal.</p>", "<p id=\"Par16\">In contrast, a striking difference was seen in the ability of <italic>WDY</italic> sperm to swim beyond the seminal vesicle. In samples where sperm were found in the ejaculatory duct, control sperm heads were observed to move swiftly while <italic>WDY</italic> sperm heads appeared motionless (Fig. ##FIG##2##3g, h, gi–hi##, Supplementary Movie ##SUPPL##11##9##, ##SUPPL##12##10##), and the same pattern was observed for sperm heads in the uterus 1 hASM (Fig. ##FIG##2##3I, j, ii, ji##, Supplementary Movie ##SUPPL##13##11##, ##SUPPL##14##12##). These sperm appear to be alive, as their tails continue to beat in place (Fig. ##FIG##2##3a, b##). The inability of <italic>WDY</italic> sperm to enter the sperm storage organs likely reflects their diminished swimming in the uterus, though other defects may also exist and contribute<sup>##REF##33649997##37##</sup>. That <italic>WDY</italic> sperm in the posterior testes can swim suggests either (1) there is a subclass of <italic>WDY</italic> sperm that are capable of swimming but degenerate, or (2) <italic>WDY</italic> mutant sperm are unable to navigate between different regions of the RT.</p>", "<title>Significant hydrophobicity differences in putative calcium-binding residues coincide with <italic>WDY</italic>’s transition to Y-linkage in the <italic>melanogaster</italic> lineage</title>", "<p id=\"Par17\">Calcium regulates sperm motility in many organisms, including humans<sup>##UREF##4##38##</sup> and Drosophila<sup>##REF##14680634##39##–##REF##21625494##41##</sup>. WDY’s amino acid sequence contains a calcium-binding domain signature: an EF Hand (Interpro<sup>##REF##36350672##42##</sup>). Functional EF Hand domains contain a pair of motifs, each consisting of a loop flanked by alpha helices, that can bind Ca<sup>2+</sup> ions. The specific characteristics of the loop affect calcium-binding affinity<sup>##REF##11827810##43##</sup>. We identified a putative pseudo EF hand motif followed by a canonical EF hand motif in WDY (Methods, Fig. ##FIG##3##4a–c##, Supplementary Table ##SUPPL##1##6##). Known calcium-binding proteins (e.g. Calbindin D9K<sup>##UREF##5##44##</sup>) also display this configuration. We also improved the annotation of two WD40 domains (Methods, Fig. ##FIG##3##4a##, Supplementary Table ##SUPPL##1##6##), which typically mediate protein-protein interactions in protein complex assembly and/or signal transduction. Based on these findings, we speculate that <italic>WDY</italic> is necessary for sperm to adjust their motility based on differences in calcium levels in different regions of the RT.</p>", "<p id=\"Par18\">We also compared sequences of the EF Hand domain between WDY orthologs in Drosophila species from three groups encompassing: (1) the initial transition of WDY to the Y chromosome from its ancestral autosomal site during the <italic>melanogaster-obscura</italic> group split, (2) a whole-chromosome Y-incorporation event in the montium subgroup, in which the Y chromosome is thought to have become duplicated elsewhere in the genome, and (3) the subsequent reestablishment of Y-linkage in the <italic>kikkawai</italic> clade (Fig. ##FIG##3##4b, c##,<sup>##REF##19011613##3##,##REF##30388103##4##</sup>). We note a higher rate of sequence divergence of the Odd EF Hand Motif (55.9% Identity, Fig. ##FIG##3##4b##) relative to that of the Even EF Hand motif (92.7% Identity, Fig. ##FIG##3##4c##) in Drosophila sequences. Similarly, we observed a 12-fold difference in <italic>d</italic><sub><italic>N</italic></sub>/<italic>d</italic><sub><italic>S</italic></sub> between the Odd EF hand (omega = 0.00239) and the Even EF hand (omega = 0.00020) in a pairwise comparison between <italic>D. melanogaster</italic> and <italic>D. obscura</italic> WDY using Model 0 of codeml. This supports the idea that the Odd EF hand sequence is diverging more rapidly or has more relaxed purifying selection than the Even EF hand sequence.</p>", "<p id=\"Par19\">The amino acid transition in the Odd EF Hand Motif at position “X” is particularly compelling, since it involves a profound biochemical change in a conserved residue thought to directly bind calcium<sup>##UREF##5##44##</sup> (Fig. ##FIG##3##4d, e##). The shift away from canonical residues in the <italic>melanogaster</italic> group could indicate a modulation of calcium binding, and, thus significant functional evolution in the EF Hand domain, coinciding with WDY’s initial Y-linkage. Corresponding shifts in hydrophobicity are not observed to be correlated with the genomic movements of WDY in the <italic>montium</italic> subgroup, but we would not necessarily expect a change that occurred when a gene moved to the Y chromosome to reverse if the gene moves off the Y chromosome. Moreover, selective pressures that drove a chromosome-wide Y-incorporation event are likely to have been significantly different from those driving movement of a single gene onto the Y chromosome. Future functional studies will be required to formally test the significance of the change in hydrophobicity at position “X”.</p>", "<p id=\"Par20\">A previous publication from our lab identified signatures of positive selection in WDY. We hypothesized that positively selected sites may be present within the EF-hand domain<sup>##REF##24974375##2##</sup>. We thus updated the analysis of variation in WDY by including sequences from thirteen addition species (Supplementary Table ##SUPPL##1##7##), a more stringent model comparison and statistical analysis to account for neutral evolution, and running the analysis on individual Drosophila clades, to avoid synonymous saturation. Our updated analysis (Supplementary Tables ##SUPPL##1##8## and ##SUPPL##1##9##) indicates that there is no evidence of positive selection that could not be better explained by neutral evolution. Furthermore, posterior probabilities for site classes, determined by Bayes Empirical Bayes (<italic>p</italic> &gt; 0.9), identified no specific sites under positive selection. Similar results were obtained with a branch-site test on full-length WDY (Supplementary Table ##SUPPL##1##10##). Therefore, although there seems to be an amino acid change in the EF hand domain as WDY became Y-linked, these sites cannot be shown to be undergoing positive selection. The initial movement of a gene to the Y chromosome may be more significant for its functional evolution than subsequent movements onto/off of the Y chromosome. This is consistent with the observation of high incidence of gene re-appearance on the Y chromosome after Y-incorporation events<sup>##REF##30388103##4##</sup>.</p>", "<title><italic>PRY</italic> is also required for efficient sperm storage</title>", "<p id=\"Par21\">We previously generated and characterized mutants in another Y-linked gene, <italic>PRY</italic>, whose phenotype was consistent with abnormal sperm storage in females: mutants had low levels of fertility on the first day after mating but no fertility on subsequent days<sup>##REF##32098759##22##</sup>. Our finding that <italic>WDY</italic> affects sperm entry to the storage organs led us to wonder whether <italic>PRY</italic> affects a similar step. Indeed, the number of <italic>PRY</italic> sperm stored was significantly reduced compared to controls at 2 hASM (Fig. ##FIG##1##2f–h##, <italic>p</italic> value = 5.6e-15, Asymptotic Linear-by-Linear Association Test for difference in sperm distribution). <italic>PRY</italic> mutant sperm were frequently absent or reduced in the seminal receptacle, and rarely observed in the spermathecae. The number of stored <italic>PRY</italic> sperm remained low at 24 hASM (Supplementary Fig. 5, <italic>p</italic> value &lt; 2.2e-16, Asymptotic Linear-by-Linear Association Test for difference in sperm distribution), however, significantly more sperm entered storage organs if males and females were housed together overnight (Supplementary Fig. 5, <italic>p</italic> value = 1.9e-5 for comparison of <italic>PRY</italic> versus control after overnight mating, 5.1e-6 for comparison of <italic>PRY</italic> 24 hASM versus after overnight mating, and 0.9462 for comparison of control 24 hASM versus after overnight mating, Asymptotic Linear-by-Linear Association Tests for difference in sperm distributions). Seminal fluid proteins responsible for long-term physiological effects of mating on females, including the inhibition of remating, can bind to sperm tails<sup>##REF##24974375##2##,##REF##15694303##45##–##REF##36514080##47##</sup>. Thus, lack of stored <italic>PRY</italic> sperm may lead to increased remating in these females.</p>", "<p id=\"Par22\">In contrast to <italic>WDY</italic>, <italic>PRY</italic> mutant sperm did swim in the female RT (Supplementary Movie ##SUPPL##15##13##) and the beat frequency of the fastest-beating <italic>PRY</italic> mutant sperm tails (12.2 Hz) was not significantly different from the corresponding control’s (11.5 Hz, Supplementary Fig. 6, <italic>p</italic> value = 0.5316, Likelihood Ratio Test). Defects in other aspects of motility or navigation<sup>##REF##21293028##48##</sup> may prevent the majority of <italic>PRY</italic> mutant sperm from entering sperm storage.</p>" ]
[ "<title>Results and discussion</title>", "<title><italic>WDY</italic> mutants are sterile but produce mature, motile sperm</title>", "<p id=\"Par8\">We used CRISPR to precisely target <italic>WDY</italic> (Supplementary Figs. ##SUPPL##1##1## and ##SUPPL##1##2##, Supplementary Tables ##SUPPL##1##1##–##SUPPL##1##4##). One of the major challenges of studying the Y chromosome is in propagating sterile mutations on a haploid, sex-limited chromosome. We used a crossing strategy involving compound sex chromosomes to make and stably propagate heritable mutations in <italic>WDY</italic> (mutant stocks consist of /<italic>Y,WDY</italic> females and /<italic>Y,WDY</italic> males, see Methods, Supplementary Fig. ##SUPPL##1##3##<sup>##REF##32098759##22##</sup>). Our crossing scheme also enabled us to identify and eliminate large chromosomal truncations that are common during genetic editing of the Y chromosome, likely due to its highly repetitive nature<sup>##REF##32098759##22##</sup>. To evaluate the phenotype of our mutants, we then removed the compound chromosomes by selective breeding to generate X/Y,<italic>WDY</italic> mutant males. We confirmed each phenotype with three different <italic>WDY</italic> alleles, <italic>F8</italic>, <italic>C104</italic>, and <italic>C3</italic>, containing deletions of 547 bp, 545 bp, and 443 bp, respectively (Supplementary Fig. ##SUPPL##1##4##, Supplementary Table ##SUPPL##1##4##). All are large deletions close to the N-terminus that disrupt the reading frame and are therefore expected to be null; all three gave the same phenotype. We compared mutants to controls that account for the genetic background (Y<sup>Tomato</sup>) or crossing scheme (Y<sup>C7</sup> and Y<sup>G107</sup>). In individual crosses to females from a wild-type strain (Canton S), control males produced progeny, while <italic>WDY</italic> males were sterile (Supplementary Table ##SUPPL##1##5##).</p>", "<p id=\"Par9\">To investigate the cause of this sterility, we first examined the distribution of sperm in the testes using Protamine-GFP<sup>##REF##20299550##25##</sup>, which labels sperm heads. Sperm of mutants in Y-linked fertility factors <italic>kl-2</italic>, <italic>kl-3</italic>, <italic>kl-5</italic>, <italic>ks-1</italic>, and <italic>ks-2</italic> are eliminated before this time, during the individualization stage<sup>##REF##32098759##22##,##REF##32404399##26##,##REF##6794995##27##</sup>. In contrast, we observed an accumulation of <italic>WDY</italic> mutant sperm in the posterior-most section of the testes, where individualized sperm accumulate while sperm coiling occurs, causing that region to bulge in the mutant (Fig. ##FIG##0##1a–f##). Sperm coiling is thought to function as a quality control step during which sperm with abnormal tails are eliminated by ingestion by the terminal epithelium<sup>##UREF##2##28##</sup>. The accumulation of <italic>WDY</italic> sperm in the posterior testes may be due to their progression being stalled by this quality control mechanism or may indicate insufficient motility to exit the testes.</p>", "<p id=\"Par10\">In the seminal vesicles, there were fewer sperm in <italic>WDY</italic> mutants than in the controls (Fig. ##FIG##0##1c, d##). Yet tails of sperm from both <italic>WDY</italic> and control males were observed to beat after we tore open the seminal vesicles (Supplementary Movie ##SUPPL##3##1## and ##SUPPL##4##2##). Visual inspection showed no obvious differences in the movement of <italic>WDY</italic> versus control sperm. These observations match Kiefer’s conclusion that <italic>kl-1</italic> mutants were sterile but produced seemingly motile sperm<sup>##REF##5802558##20##</sup>. Our results—that <italic>WDY</italic> mutations are sufficient to result in sterility, yet produce sperm that are motile—make it highly likely that <italic>WDY</italic> is the fertility factor known in the literature as <italic>kl-1</italic>.</p>", "<title><italic>WDY</italic> mutant sperm are transferred to females, but do not enter the storage organs</title>", "<p id=\"Par11\">We next tracked the movement of Protamine-labeled sperm in the RT of wild-type (Canton S) females 30 min after the start of mating (mASM). Sperm from both control and <italic>WDY</italic> mutant males were found in the female’s uterus (bursa) (Supplementary Fig. ##SUPPL##1##5##), and their tails were observed to beat when dissected out of the uterus (Supplementary Movie ##SUPPL##5##3##, ##SUPPL##6##4##). In both <italic>WDY</italic> and control genotypes, an open or folded conformation of the uterus correlated with the presence or absence of sperm, respectively, as expected<sup>##REF##17276455##29##,##REF##19805225##30##</sup>. We conclude that motile <italic>WDY</italic> sperm are transferred to females and that <italic>WDY</italic> seminal fluid induces conformational changes in the uterus normally.</p>", "<p id=\"Par12\">We did, however, observe defects in the number of sperm transferred to, and the distribution of the sperm within, the female RT. <italic>WDY</italic> males transferred fewer than half as many sperm as control males as quantified at 30 mASM (Fig. ##FIG##1##2a##, <italic>p</italic> value = 8e-6, Student’s <italic>t</italic> test). After mating, Drosophila sperm move rapidly from the uterus into either the primary storage organ, the seminal receptacle, or one of the two long-term storage organs, the spermathecae<sup>##REF##12679097##31##</sup> (Fig. ##FIG##1##2b##). At 30 mASM most control samples contained some stored sperm, but no <italic>WDY</italic> sperm were found in the storage organs. At 2 hASM maximal numbers of sperm are stored in most control samples<sup>##UREF##3##32##</sup>. Yet, again, no sperm from <italic>WDY</italic> mutants were seen in storage (Fig. ##FIG##1##2c–e##). We also examined sperm in RTs of females left to mate overnight to see if a longer time or multiple mating could enable <italic>WDY</italic> mutant sperm to enter storage (Supplementary Fig. ##SUPPL##1##5##). Control samples all had stored sperm. <italic>WDY</italic> sperm were regularly observed in the uterus but never in any of the storage organs (Fig. ##FIG##1##2c##). We conclude that <italic>WDY</italic> mutant sperm are unable to enter the storage organs. In many animals, storage is required for sperm to become competent for fertilization<sup>##REF##12071887##33##,##REF##18077584##34##</sup>. Thus the lack of sperm storage might explain why <italic>WDY</italic> males are sterile.</p>", "<title><italic>WDY</italic> mutant sperm in the male seminal vesicle and female uterus have decreased tail-beat frequency</title>", "<p id=\"Par13\">Although <italic>WDY</italic> mutant sperm beat visibly in vitro (Supplementary Movie ##SUPPL##3##1##–##SUPPL##6##4##), we wished to test whether subtle motility defects prevent them from being able to enter storage. We measured the beat frequency of sperm tails, by recording videos of control and <italic>WDY</italic> mutant sperm dissected directly from the male’s seminal vesicle or from the female’s uterus at 30 mASM (Methods, Supplementary Movie ##SUPPL##3##1##–##SUPPL##6##4##, Fig. ##FIG##2##3a, b##). In the seminal vesicle, the fastest <italic>WDY</italic> mutant sperm tails beat at an average of 6.0 Hz, whereas the fastest control sperm tails beat at an average of 12.3 Hz (p-value = 3.5e-10, Likelihood Ratio Test). In the uterus, the fastest <italic>WDY</italic> mutant sperm tails beat at an average of 7.0 Hz, whereas the fastest control sperm tails beat at an average of 13.1 Hz (<italic>p</italic> value = 7.3e-6, Likelihood Ratio Test). We conclude that <italic>WDY</italic> mutant sperm have a lower tail-beat frequency than wild-type sperm in both the male and female RTs.</p>", "<title><italic>WDY</italic> mutant sperm are unable to swim in the male ejaculatory duct and female uterus</title>", "<p id=\"Par14\">We hypothesized that the lower tail-beat frequency affects the ability of <italic>WDY</italic> mutant sperm to propel themselves. To test for defects in sperm swimming, sperm movement was assessed in videos by tracking the protamine-labeled heads of control and <italic>WDY</italic> mutant sperm. In all regions the swimming speed of individual sperm varied, but there was an overriding regional pattern to the motility (Fig. ##FIG##2##3c–j##). In mammals, sperm leaving the testes are immotile and must go undergo epididymal maturation in order to gain the ability to move progressively<sup>##REF##28297559##35##</sup>. It was previously suggested, and has often been repeated, that, similarly, Drosophila sperm do not gain motility until they reach the seminal vesicle<sup>##REF##13929245##36##</sup>. We were thus surprised to see some individualized sperm heads slowly swimming within the posterior testes of most control samples (Fig. ##FIG##2##3c, ci##, Supplementary Movie ##SUPPL##7##5##). This suggests that, in Drosophila, sperm motility is normally initiated within the testes. <italic>WDY</italic> mutant sperm heads in this region also often moved around, suggesting that at least some mutant sperm develop motility (Fig. ##FIG##2##3d, di##, Supplementary Movie ##SUPPL##8##6##).</p>", "<p id=\"Par15\">Individual sperm heads generally ceased to move in the seminal vesicles of both control and <italic>WDY</italic> mutant flies, while flagella remained beating. However, mass movements occurred from contractions of the whole organ. It was unclear whether dense packing of sperm or some physical or chemical property of the seminal vesicle caused the immobilization of sperm heads while sperm tails continued to beat vigorously (Fig. ##FIG##2##3e, ei##, Supplementary Movie ##SUPPL##9##7##). This highlights that flagellar beating does not necessarily correlate with sperm swimming (i.e., moving through space). There were far fewer sperm in <italic>WDY</italic> mutant seminal vesicles, but the mutant sperm heads were predominantly immobilized, as in controls (Fig. ##FIG##2##3f, fi##, Supplementary Movie ##SUPPL##10##8##). We conclude that at least some <italic>WDY</italic> sperm develop the ability to swim in the testes and become immobilized in the seminal vesicle, as normal.</p>", "<p id=\"Par16\">In contrast, a striking difference was seen in the ability of <italic>WDY</italic> sperm to swim beyond the seminal vesicle. In samples where sperm were found in the ejaculatory duct, control sperm heads were observed to move swiftly while <italic>WDY</italic> sperm heads appeared motionless (Fig. ##FIG##2##3g, h, gi–hi##, Supplementary Movie ##SUPPL##11##9##, ##SUPPL##12##10##), and the same pattern was observed for sperm heads in the uterus 1 hASM (Fig. ##FIG##2##3I, j, ii, ji##, Supplementary Movie ##SUPPL##13##11##, ##SUPPL##14##12##). These sperm appear to be alive, as their tails continue to beat in place (Fig. ##FIG##2##3a, b##). The inability of <italic>WDY</italic> sperm to enter the sperm storage organs likely reflects their diminished swimming in the uterus, though other defects may also exist and contribute<sup>##REF##33649997##37##</sup>. That <italic>WDY</italic> sperm in the posterior testes can swim suggests either (1) there is a subclass of <italic>WDY</italic> sperm that are capable of swimming but degenerate, or (2) <italic>WDY</italic> mutant sperm are unable to navigate between different regions of the RT.</p>", "<title>Significant hydrophobicity differences in putative calcium-binding residues coincide with <italic>WDY</italic>’s transition to Y-linkage in the <italic>melanogaster</italic> lineage</title>", "<p id=\"Par17\">Calcium regulates sperm motility in many organisms, including humans<sup>##UREF##4##38##</sup> and Drosophila<sup>##REF##14680634##39##–##REF##21625494##41##</sup>. WDY’s amino acid sequence contains a calcium-binding domain signature: an EF Hand (Interpro<sup>##REF##36350672##42##</sup>). Functional EF Hand domains contain a pair of motifs, each consisting of a loop flanked by alpha helices, that can bind Ca<sup>2+</sup> ions. The specific characteristics of the loop affect calcium-binding affinity<sup>##REF##11827810##43##</sup>. We identified a putative pseudo EF hand motif followed by a canonical EF hand motif in WDY (Methods, Fig. ##FIG##3##4a–c##, Supplementary Table ##SUPPL##1##6##). Known calcium-binding proteins (e.g. Calbindin D9K<sup>##UREF##5##44##</sup>) also display this configuration. We also improved the annotation of two WD40 domains (Methods, Fig. ##FIG##3##4a##, Supplementary Table ##SUPPL##1##6##), which typically mediate protein-protein interactions in protein complex assembly and/or signal transduction. Based on these findings, we speculate that <italic>WDY</italic> is necessary for sperm to adjust their motility based on differences in calcium levels in different regions of the RT.</p>", "<p id=\"Par18\">We also compared sequences of the EF Hand domain between WDY orthologs in Drosophila species from three groups encompassing: (1) the initial transition of WDY to the Y chromosome from its ancestral autosomal site during the <italic>melanogaster-obscura</italic> group split, (2) a whole-chromosome Y-incorporation event in the montium subgroup, in which the Y chromosome is thought to have become duplicated elsewhere in the genome, and (3) the subsequent reestablishment of Y-linkage in the <italic>kikkawai</italic> clade (Fig. ##FIG##3##4b, c##,<sup>##REF##19011613##3##,##REF##30388103##4##</sup>). We note a higher rate of sequence divergence of the Odd EF Hand Motif (55.9% Identity, Fig. ##FIG##3##4b##) relative to that of the Even EF Hand motif (92.7% Identity, Fig. ##FIG##3##4c##) in Drosophila sequences. Similarly, we observed a 12-fold difference in <italic>d</italic><sub><italic>N</italic></sub>/<italic>d</italic><sub><italic>S</italic></sub> between the Odd EF hand (omega = 0.00239) and the Even EF hand (omega = 0.00020) in a pairwise comparison between <italic>D. melanogaster</italic> and <italic>D. obscura</italic> WDY using Model 0 of codeml. This supports the idea that the Odd EF hand sequence is diverging more rapidly or has more relaxed purifying selection than the Even EF hand sequence.</p>", "<p id=\"Par19\">The amino acid transition in the Odd EF Hand Motif at position “X” is particularly compelling, since it involves a profound biochemical change in a conserved residue thought to directly bind calcium<sup>##UREF##5##44##</sup> (Fig. ##FIG##3##4d, e##). The shift away from canonical residues in the <italic>melanogaster</italic> group could indicate a modulation of calcium binding, and, thus significant functional evolution in the EF Hand domain, coinciding with WDY’s initial Y-linkage. Corresponding shifts in hydrophobicity are not observed to be correlated with the genomic movements of WDY in the <italic>montium</italic> subgroup, but we would not necessarily expect a change that occurred when a gene moved to the Y chromosome to reverse if the gene moves off the Y chromosome. Moreover, selective pressures that drove a chromosome-wide Y-incorporation event are likely to have been significantly different from those driving movement of a single gene onto the Y chromosome. Future functional studies will be required to formally test the significance of the change in hydrophobicity at position “X”.</p>", "<p id=\"Par20\">A previous publication from our lab identified signatures of positive selection in WDY. We hypothesized that positively selected sites may be present within the EF-hand domain<sup>##REF##24974375##2##</sup>. We thus updated the analysis of variation in WDY by including sequences from thirteen addition species (Supplementary Table ##SUPPL##1##7##), a more stringent model comparison and statistical analysis to account for neutral evolution, and running the analysis on individual Drosophila clades, to avoid synonymous saturation. Our updated analysis (Supplementary Tables ##SUPPL##1##8## and ##SUPPL##1##9##) indicates that there is no evidence of positive selection that could not be better explained by neutral evolution. Furthermore, posterior probabilities for site classes, determined by Bayes Empirical Bayes (<italic>p</italic> &gt; 0.9), identified no specific sites under positive selection. Similar results were obtained with a branch-site test on full-length WDY (Supplementary Table ##SUPPL##1##10##). Therefore, although there seems to be an amino acid change in the EF hand domain as WDY became Y-linked, these sites cannot be shown to be undergoing positive selection. The initial movement of a gene to the Y chromosome may be more significant for its functional evolution than subsequent movements onto/off of the Y chromosome. This is consistent with the observation of high incidence of gene re-appearance on the Y chromosome after Y-incorporation events<sup>##REF##30388103##4##</sup>.</p>", "<title><italic>PRY</italic> is also required for efficient sperm storage</title>", "<p id=\"Par21\">We previously generated and characterized mutants in another Y-linked gene, <italic>PRY</italic>, whose phenotype was consistent with abnormal sperm storage in females: mutants had low levels of fertility on the first day after mating but no fertility on subsequent days<sup>##REF##32098759##22##</sup>. Our finding that <italic>WDY</italic> affects sperm entry to the storage organs led us to wonder whether <italic>PRY</italic> affects a similar step. Indeed, the number of <italic>PRY</italic> sperm stored was significantly reduced compared to controls at 2 hASM (Fig. ##FIG##1##2f–h##, <italic>p</italic> value = 5.6e-15, Asymptotic Linear-by-Linear Association Test for difference in sperm distribution). <italic>PRY</italic> mutant sperm were frequently absent or reduced in the seminal receptacle, and rarely observed in the spermathecae. The number of stored <italic>PRY</italic> sperm remained low at 24 hASM (Supplementary Fig. 5, <italic>p</italic> value &lt; 2.2e-16, Asymptotic Linear-by-Linear Association Test for difference in sperm distribution), however, significantly more sperm entered storage organs if males and females were housed together overnight (Supplementary Fig. 5, <italic>p</italic> value = 1.9e-5 for comparison of <italic>PRY</italic> versus control after overnight mating, 5.1e-6 for comparison of <italic>PRY</italic> 24 hASM versus after overnight mating, and 0.9462 for comparison of control 24 hASM versus after overnight mating, Asymptotic Linear-by-Linear Association Tests for difference in sperm distributions). Seminal fluid proteins responsible for long-term physiological effects of mating on females, including the inhibition of remating, can bind to sperm tails<sup>##REF##24974375##2##,##REF##15694303##45##–##REF##36514080##47##</sup>. Thus, lack of stored <italic>PRY</italic> sperm may lead to increased remating in these females.</p>", "<p id=\"Par22\">In contrast to <italic>WDY</italic>, <italic>PRY</italic> mutant sperm did swim in the female RT (Supplementary Movie ##SUPPL##15##13##) and the beat frequency of the fastest-beating <italic>PRY</italic> mutant sperm tails (12.2 Hz) was not significantly different from the corresponding control’s (11.5 Hz, Supplementary Fig. 6, <italic>p</italic> value = 0.5316, Likelihood Ratio Test). Defects in other aspects of motility or navigation<sup>##REF##21293028##48##</sup> may prevent the majority of <italic>PRY</italic> mutant sperm from entering sperm storage.</p>" ]
[ "<title>Conclusions</title>", "<p id=\"Par23\">Overall, we present functional evidence for a role for two Y-linked genes in sperm storage and demonstrate that <italic>WDY</italic> mutants have specific defects in sperm motility. Our work extends Kiefer’s intriguing observation that <italic>kl-1</italic> mutants produce beating sperm despite being sterile. <italic>WDY</italic> mutants recapitulate this unusual phenotype. In the absence of the ability to test complementation, this strongly suggests that <italic>kl-1</italic> and <italic>WDY</italic> mutants perturb the same gene.</p>", "<p id=\"Par24\">Two broad themes emerge from this work. First, sperm may be unable to enter storage for different reasons—insufficient swimming speeds or an inability to navigate or gain entry into the storage organs. We demonstrate that sperm motility defects do manifest in an inability to enter storage. Female secretions are necessary to promote sperm storage<sup>##REF##22087073##49##</sup>, so entry to sperm storage may be a hurdle imposed by females to ensure that only sperm with a certain level of motility/fitness are able to fertilize eggs.</p>", "<p id=\"Par25\">Second, across species, Y-linked genes appear to show ‘functional coherence’<sup>##REF##28978907##6##,##REF##32404399##26##</sup>. Even within the realm of male fertility, a disproportionate number of Y-linked genes seem to be singularly focused on aspects of sperm motility<sup>##REF##11069293##15##,##REF##8248219##16##</sup>. Three axonemal dyneins were previously discovered on the Drosophila Y chromosome<sup>##REF##11069293##15##,##REF##8248219##16##</sup>. However, since no sperm are produced upon genetic ablation of five out of the six fertility factor genes, the role of these genes in sperm motility was never previously tested<sup>##REF##17247923##13##,##REF##17249098##14##,##REF##32098759##22##,##REF##32404399##26##</sup>. We now add strength and stringency to the picture of functional coherence on the Drosophila Y chromosome. On the one hand, being Y-linked allows sperm motility genes to escape the problems of countervailing selection in females (sexual conflict). However, being Y-linked bears the cost of not being able to recombine, which reduces the efficacy of natural selection (the Hill-Robertson effect<sup>##REF##23329112##1##</sup>). The fact that so many sperm motility genes are retained on the Y chromosome indicates a dynamic balance between these two opposing selective forces in different regions of the genome.</p>" ]
[ "<p id=\"Par1\">Unique patterns of inheritance and selection on Y chromosomes have led to the evolution of specialized gene functions. We report CRISPR mutants in Drosophila of the Y-linked gene, <italic>WDY</italic>, which is required for male fertility. We demonstrate that the sperm tails of <italic>WDY</italic> mutants beat approximately half as fast as those of wild-type and that mutant sperm do not propel themselves within the male ejaculatory duct or female reproductive tract. Therefore, although mature sperm are produced by <italic>WDY</italic> mutant males, and are transferred to females, those sperm fail to enter the female sperm storage organs. We report genotype-dependent and regional differences in sperm motility that appear to break the correlation between sperm tail beating and propulsion. Furthermore, we identify a significant change in hydrophobicity at a residue at a putative calcium-binding site in WDY orthologs at the split between the <italic>melanogaster</italic> and <italic>obscura</italic> species groups, when <italic>WDY</italic> first became Y-linked. This suggests that a major functional change in <italic>WDY</italic> coincided with its appearance on the Y chromosome. Finally, we show that mutants for another Y-linked gene, <italic>PRY</italic>, also show a sperm storage defect that may explain their subfertility. Overall, we provide direct evidence for the long-held presumption that protein-coding genes on the Drosophila Y regulate sperm motility.</p>", "<p id=\"Par2\">Analysis of CRISPR mutants of two Y-linked genes, <italic>WDY</italic> and <italic>PRY</italic>, suggest they play roles in different aspects of sperm motility, culminating in an inability of sperm to be stored in female <italic>Drosophila melanogaster</italic>.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s42003-023-05717-x.</p>", "<title>Acknowledgements</title>", "<p>We thank Yaoyi Xing, Emeka Okorie, Julia Kelso, Elissa Cosgrove, Nora Brown, Sarah Allen, the Imaging Facility at the Cornell Institute of Biotechnology (RRID:SCR_021741), the Cornell Statistical Consulting Unit and members of the Clark and Wolfner laboratories for advice and assistance with experiments or analysis. We thank Susan Suarez and the reviewers for their feedback and advice on the experiments and manuscript. Stocks obtained from the Bloomington Drosophila Stock Center (National Institutes of Health grant P40OD018537) were used in this study. This work was supported by funds from the National Institutes of Health (R01-HD059060 to A. Clark and M. Wolfner and R01-GM119125 to A. Clark and D. Barbash) and a seed grant from the Cornell Center for Vertebrate Genomics.</p>", "<title>Author contributions</title>", "<p>Y.H. and A.G.C. conceived the study. Y.H., J.A.C., M.F.W., and A.G.C. designed the experiments. Y.H. and A.O. made the <italic>WDY</italic> CRISPR mutants. Y.H. performed the phenotypic experiments in Figs. ##FIG##0##1##–##FIG##2##3##. I.V.C assisted with the image analysis in Fig. ##FIG##2##3##. Y.H. and J.A.C. performed the orthologue comparisons in Fig. ##FIG##3##4##. J.A.C. performed the selection analysis and annotation of WDY. Y.H., J.A.C., M.F.W., and A.G.C. wrote the manuscript.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par47\"><italic>Communications Biology</italic> thanks Maria Vibranovski, Alberto Civetta and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editor: George Inglis. A peer review file is available.</p>", "<title>Data availability</title>", "<p>Data from this study, including the raw images, data tables, and videos from the phenotypic analysis, <italic>D. melanogaster</italic> WDY protein annotation file, and selection analysis files (alignments, phylogenies, control files, and output files), are publicly available through Cornell eCommons: 10.7298/vtr8-ab60.</p>", "<title>Competing interests</title>", "<p id=\"Par48\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Spermatogenesis is backed up in <italic>WDY</italic> testes, but some mature sperm are found in the seminal vesicle.</title><p>Whole testes from control (<bold>a</bold>) and <italic>WDY</italic> mutant (<bold>b</bold>) males whose sperm were labeled with Protamine-GFP (green), Phalloidin (red) and DAPI (blue) overlaid on brightfield images. <bold>c</bold>–<bold>f</bold> Higher magnification view of posterior testes and seminal vesicle. Inset (di) shows Protamine-labeled sperm in the seminal vesicle of mutant. Testes (T) and seminal vesicle (SV) are marked. Images are representative of 6–10 samples each. Bar denotes 100 µm for <bold>a</bold>, <bold>b</bold>, 50 µm for <bold>c</bold>–<bold>f</bold>, and 20 µm for di.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title><italic>WDY</italic> and <italic>PRY</italic> mutant sperm fail to enter the storage organs in the female RT.</title><p><bold>a</bold> Quantification of the number of sperm transferred to the female uterus 30 mASM by control (<italic>n</italic> = 16 reproductive tracts) or <italic>WDY</italic> mutant males (<italic>n</italic> = 18 reproductive tracts). Bars indicate standard error; <italic>p</italic> value = 8e-6 by Student’s <italic>t</italic> test. <bold>b</bold> Cartoon of the female RT indicating the mating plug (MP, brown), uterus (yellow), and the storage organs—the seminal receptacle (SR, green) and two spermathecae (STH, blue). <bold>c</bold>–<bold>h</bold> Quantification of the distribution of Protamine-labeled sperm within the female RT 2hASM. <bold>c</bold> Distributions of sperm from control males (<italic>n</italic> = 28 female RTs) and <italic>WDY</italic> mutant males (<italic>n</italic> = 25 female RTs) were compared (<italic>p</italic> value &lt; 2.2e-16, Asymptotic Linear-by-Linear Association Test). Representative images shown in <bold>d</bold>, <bold>e</bold>. <bold>f</bold> Distributions of sperm from control males (<italic>n</italic> = 25 female RTs) and <italic>PRY</italic> mutant males (<italic>n</italic> = 20 female RTs) were compared (<italic>p</italic> value = 5.6e-15, Asymptotic Linear-by-Linear Association Test). Representative images shown in <bold>g</bold>, <bold>h</bold>. Bars denote 100 µm.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title><italic>WDY</italic> mutant sperm have reduced tail-beat frequency and do not swim in the female RT.</title><p><bold>a</bold>, <bold>b</bold> Quantification of tail-beat frequency of sperm. Boxplots show median, first and third quartiles, and values within 1.5× the interquartile range for each genotype. Numbers quantified are indicated next to the legend (n = sperm tails per genotype). <bold>a</bold>\n<italic>WDY</italic> and control sperm dissected from seminal vesicles (<italic>p</italic> value = 3.5e-10, Likelihood Ratio Test) and <bold>b</bold>\n<italic>WDY</italic> and control sperm dissected from the female RT 30 mASM (<italic>p</italic> value = 7.3e-6, Likelihood Ratio Test). <bold>c</bold>–<bold>ji</bold> Manual tracking of sperm heads. Protamine-GFP-labeled control (<bold>c</bold>, <bold>e</bold>, <bold>g</bold>, <bold>i</bold>) and <italic>WDY</italic> mutant (<bold>d</bold>, <bold>f</bold>, <bold>h</bold>, <bold>j</bold>) sperm heads over a 0.5 sec interval for representative videos of the posterior testes (<bold>c</bold>, <bold>d</bold>), seminal vesicle (<bold>e</bold>, <bold>f</bold>), ejaculatory duct (<bold>g</bold>, <bold>h</bold>), and uterus 1 h ASM (<bold>I</bold>, <bold>j</bold>). (<bold>ci</bold>–<bold>ji</bold>) Corresponding quantification of the number of sperm heads and degree of movement observed from videos of each region of the RTs. The number of each type of organ that was scored is indicated on each plot. Bar denotes 25 µm for <bold>c</bold>–<bold>j</bold>.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>Difference in hydrophobicity in the Odd EF hand domain motif coincide with the initial movement of <italic>WDY</italic> to the Y chromosome at the <italic>melanogaster</italic><italic>-obscura</italic> species group split.</title><p><bold>a</bold> Domain structure of WDY. <bold>b</bold>, <bold>c</bold> Protein alignment of melanogaster and obscura group species for the region with the Odd (Pseudo) (<bold>b</bold>) and Even (Canonical) (<bold>c</bold>) EF Hand motif. Green bar indicates the motif, M indicates the position of any mismatch between the <italic>melanogaster</italic> sequence and the consensus, and black boxes indicate putative calcium-binding residues (X, Y, Z,-X,-Y,-Z). Blue-red scale indicates hydrophobicity (Red is hydrophobic, Blue is hydrophilic). <bold>d</bold>, <bold>e</bold> Predicted AlphaFold structure of Odd EF Hand domain with putative calcium-binding residues labeled, generated in PyMOL for <italic>Drosophila melanogaster</italic> (<bold>d</bold>) and<italic> Drosophila obscura</italic> (<bold>e</bold>).</p></caption></fig>" ]
[]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\widehat{{XX}}$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mover accent=\"true\"><mml:mrow><mml:mi>X</mml:mi><mml:mi>X</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\widehat{{XY}}$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mover accent=\"true\"><mml:mrow><mml:mi>X</mml:mi><mml:mi>Y</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\widehat{{XX}}$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mover accent=\"true\"><mml:mrow><mml:mi>X</mml:mi><mml:mi>X</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\widehat{{XX}}$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:mover accent=\"true\"><mml:mrow><mml:mi>X</mml:mi><mml:mi>X</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\widehat{{XY}}$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mover accent=\"true\"><mml:mrow><mml:mi>X</mml:mi><mml:mi>Y</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\widehat{{XY}}$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mover accent=\"true\"><mml:mrow><mml:mi>X</mml:mi><mml:mi>Y</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\widehat{{XX}}/Y$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mover accent=\"true\"><mml:mrow><mml:mi>X</mml:mi><mml:mi>X</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>/</mml:mo><mml:mi>Y</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\widehat{{XY}}/Y$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mover accent=\"true\"><mml:mrow><mml:mi>X</mml:mi><mml:mi>Y</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>/</mml:mo><mml:mi>Y</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\widehat{{XX}}$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:mover accent=\"true\"><mml:mrow><mml:mi>X</mml:mi><mml:mi>X</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\widehat{{XX}}$$\\end{document}</tex-math><mml:math id=\"M20\"><mml:mover accent=\"true\"><mml:mrow><mml:mi>X</mml:mi><mml:mi>X</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM5\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM6\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM7\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM8\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM9\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM10\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM11\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM12\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM13\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM14\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM15\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM16\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM17\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<inline-graphic xlink:href=\"42003_2023_5717_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"42003_2023_5717_Article_IEq2.gif\"/>", "<graphic xlink:href=\"42003_2023_5717_Fig1_HTML\" id=\"d32e572\"/>", "<graphic xlink:href=\"42003_2023_5717_Fig2_HTML\" id=\"d32e793\"/>", "<graphic xlink:href=\"42003_2023_5717_Fig3_HTML\" id=\"d32e944\"/>", "<graphic xlink:href=\"42003_2023_5717_Fig4_HTML\" id=\"d32e1162\"/>", "<inline-graphic xlink:href=\"42003_2023_5717_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"42003_2023_5717_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"42003_2023_5717_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"42003_2023_5717_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"42003_2023_5717_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"42003_2023_5717_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"42003_2023_5717_Article_IEq9.gif\"/>", "<inline-graphic xlink:href=\"42003_2023_5717_Article_IEq10.gif\"/>" ]
[ "<media xlink:href=\"42003_2023_5717_MOESM1_ESM.pdf\"><caption><p>Peer Review File</p></caption></media>", "<media xlink:href=\"42003_2023_5717_MOESM2_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>", "<media xlink:href=\"42003_2023_5717_MOESM3_ESM.pdf\"><caption><p>Description of Additional Supplementary Files</p></caption></media>", "<media xlink:href=\"42003_2023_5717_MOESM4_ESM.mp4\"><caption><p>Supplementary Movie 1</p></caption></media>", "<media xlink:href=\"42003_2023_5717_MOESM5_ESM.mp4\"><caption><p>Supplementary Movie 2</p></caption></media>", "<media xlink:href=\"42003_2023_5717_MOESM6_ESM.mp4\"><caption><p>Supplementary Movie 3</p></caption></media>", "<media xlink:href=\"42003_2023_5717_MOESM7_ESM.mp4\"><caption><p>Supplementary Movie 4</p></caption></media>", "<media xlink:href=\"42003_2023_5717_MOESM8_ESM.mp4\"><caption><p>Supplementary Movie 5</p></caption></media>", "<media xlink:href=\"42003_2023_5717_MOESM9_ESM.mp4\"><caption><p>Supplementary Movie 6</p></caption></media>", "<media xlink:href=\"42003_2023_5717_MOESM10_ESM.mp4\"><caption><p>Supplementary Movie 7</p></caption></media>", "<media xlink:href=\"42003_2023_5717_MOESM11_ESM.mp4\"><caption><p>Supplementary Movie 8</p></caption></media>", "<media xlink:href=\"42003_2023_5717_MOESM12_ESM.mp4\"><caption><p>Supplementary Movie 9</p></caption></media>", "<media xlink:href=\"42003_2023_5717_MOESM13_ESM.mp4\"><caption><p>Supplementary Movie 10</p></caption></media>", "<media xlink:href=\"42003_2023_5717_MOESM14_ESM.mp4\"><caption><p>Supplementary Movie 11</p></caption></media>", "<media xlink:href=\"42003_2023_5717_MOESM15_ESM.mp4\"><caption><p>Supplementary Movie 12</p></caption></media>", "<media xlink:href=\"42003_2023_5717_MOESM16_ESM.mp4\"><caption><p>Supplementary Movie 13</p></caption></media>", "<media xlink:href=\"42003_2023_5717_MOESM17_ESM.pdf\"><caption><p>Reporting Summary</p></caption></media>" ]
[{"label": ["17."], "surname": ["Garlovsky", "Sandler", "Karr"], "given-names": ["MD", "JA", "TL"], "article-title": ["Functional diversity and evolution of the drosophila sperm proteome"], "source": ["Mol. Cell. Proteom."], "year": ["2022"], "volume": ["21"], "fpage": ["100281"], "pub-id": ["10.1016/j.mcpro.2022.100281"]}, {"label": ["23."], "surname": ["Gatti", "Pimpinelli"], "given-names": ["M", "S"], "article-title": ["Cytological and genetic analysis of the Y chromosome of Drosophila melanogaster"], "source": ["Chromosoma"], "year": ["1983"], "volume": ["88"], "fpage": ["349"], "lpage": ["373"], "pub-id": ["10.1007/BF00285858"]}, {"label": ["28."], "surname": ["Tokuyasu", "Peacock", "Hardy"], "given-names": ["KT", "WJ", "RW"], "article-title": ["Dynamics of spermiogenesis in Drosophila melanogaster. II. Coiling process"], "source": ["Z. F.\u00fcr. Zellforsch. Mikrosk. Anat."], "year": ["1972"], "volume": ["127"], "fpage": ["492"], "lpage": ["525"], "pub-id": ["10.1007/BF00306868"]}, {"label": ["32."], "surname": ["Gilbert"], "given-names": ["DG"], "article-title": ["Ejaculate esterase 6 and initial sperm use by female Drosophila melanogaster"], "source": ["J. Insect Physiol."], "year": ["1981"], "volume": ["27"], "fpage": ["641"], "lpage": ["650"], "pub-id": ["10.1016/0022-1910(81)90112-8"]}, {"label": ["38."], "surname": ["Hong", "Chiang", "Turner"], "given-names": ["CY", "BN", "P"], "article-title": ["Calcium ion is the key regulator of human sperm function"], "source": ["Lancet Lond. Engl."], "year": ["1984"], "volume": ["2"], "fpage": ["1449"], "lpage": ["1451"], "pub-id": ["10.1016/S0140-6736(84)91634-9"]}, {"label": ["44."], "surname": ["Zhou"], "given-names": ["Y"], "article-title": ["Prediction of EF-hand calcium-binding proteins and analysis of bacterial EF-hand proteins"], "source": ["Proteins Struct. Funct. Bioinformatics"], "year": ["2006"], "volume": ["65"], "fpage": ["643"], "lpage": ["655"], "pub-id": ["10.1002/prot.21139"]}, {"label": ["50."], "surname": ["Kane", "Vora", "Varre", "Padgett"], "given-names": ["NS", "M", "KJ", "RW"], "article-title": ["Efficient screening of CRISPR/Cas9-induced events in drosophila using a co-CRISPR strategy"], "source": ["G3"], "year": ["2016"], "volume": ["7"], "fpage": ["87"], "lpage": ["93"], "pub-id": ["10.1534/g3.116.036723"]}, {"label": ["61."], "mixed-citation": ["Chang, C. H., Gregory, L. E., Gordon, K. E., Meiklejohn, C. D. & Larracuente, A. M. Unique structure and positive selection promote the rapid divergence of Drosophila Y chromosomes. "], "italic": ["Elife"], "bold": ["11"]}, {"label": ["65."], "mixed-citation": ["Kim, B. Y. et al. Highly contiguous assemblies of 101 drosophilid genomes. "], "italic": ["Elife"], "bold": ["10"]}]
{ "acronym": [], "definition": [] }
67
CC BY
no
2024-01-14 23:40:15
Commun Biol. 2024 Jan 12; 7:90
oa_package/f8/09/PMC10786823.tar.gz
PMC10786824
38216602
[ "<title>Introduction</title>", "<p id=\"Par2\">The continued emergence and spread of combined gonococcal resistance to ceftriaxone and azithromycin has reinvigorated the search for alternative therapies<sup>##REF##30403954##1##</sup>. One of the most promising new treatments currently in phase 3 clinical trials is zoliflodacin (NCT03959527)<sup>##REF##30403954##1##</sup>. Zoliflodacin (ETX0914) belongs to a new class of antibiotics that inhibit bacterial DNA replication via interactions with DNA gyrase subunit B<sup>##REF##32329999##2##</sup>. Studies have found very little resistance to zoliflodacin in currently circulating strains of <italic>Neisseria gonorrhoeae</italic><sup>##REF##34324655##3##</sup>. In addition, a number of in-vitro experiments have found that it is difficult to induce zoliflodacin resistance in <italic>N. gonorrhoeae</italic> using currently recommended treatment regimens<sup>##REF##31730160##4##–##REF##25534723##6##</sup>. Based on these findings, several authors have concluded that there is a low probability of zoliflodacin resistance emerging in <italic>N. gonorrhoeae</italic> following its introduction as a treatment for gonorrhoea<sup>##REF##34324655##3##,##REF##31730160##4##,##REF##25534723##6##</sup>.</p>", "<p id=\"Par3\">We and others have hypothesized that zoliflodacin resistance may emerge in commensal <italic>Neisseria</italic> spp. which could then be transferred to <italic>N. gonorrhoeae</italic> via transformation<sup>##REF##34062856##7##</sup>. This hypothesis was based on the fact that transformation of resistance from commensal <italic>Neisseria</italic> spp. into <italic>N. gonorrhoeae</italic> has been instrumental in the emergence of cephalosporin, sulfonamide and macrolide resistance<sup>##UREF##0##8##–##UREF##2##11##</sup>. Transformation of <italic>gyrA</italic> has also played an important role in the genesis of fluoroquinolone resistance in <italic>N. meningitidis</italic>. A study in Shanghai, found that 99.3% of commensal <italic>Neisseria</italic> and 67.7% of <italic>N. meningitidis</italic> isolates were resistant to fluoroquinolones and that horizontal gene transfer (HGT) from commensals was responsible for fluoroquinolone resistance in over half the <italic>N. meningitidis</italic> isolates<sup>##UREF##3##12##</sup>. An in silico analysis of 20,047 <italic>Neisseria</italic> isolates from around the world found evidence that a number of strains of <italic>N. gonorrhoeae</italic> have previously taken up sections of <italic>gyrB</italic> from commensal <italic>Neisseria</italic>, including the quinolone resistance-determining region (QRDR; 1255–1488 bp) of <italic>gyrB</italic>, which is also the zoliflodacin resistance-conferring region<sup>##UREF##4##13##</sup>.</p>", "<p id=\"Par4\">In vitro studies have demonstrated that gonococcal zoliflodacin resistance typically emerges via three substitutions in GyrB—Asp429Asn, Lys450Thr or Ser467Asn<sup>##REF##32329999##2##,##REF##25534723##6##</sup>. These findings provided the justification for the current paper where we investigated the commensal-resistance-pathway hypothesis as follows: Firstly, we sought to assess the zoliflodacin MICs of circulating commensal <italic>Neisseria</italic> species. Secondly, we assessed if we could induce zoliflodacin resistance in <italic>N. cinerea, N. lactamica, N. macacae</italic>, <italic>N. mucosa</italic> and <italic>N. subflava</italic><sup>##REF##34992227##14##</sup>. Thirdly, we evaluated which <italic>gyrB</italic> mutations were associated with evolved decreased susceptibility to zoliflodacin in these species. Finally, we attempted to transform zoliflodacin resistance-conferring DNA within and between <italic>Neisseria</italic> species including from <italic>N. subflava</italic>/<italic>N. mucosa</italic> into <italic>N. gonorrhoeae</italic>.</p>" ]
[ "<title>Methods</title>", "<title>Sampling, ethical approval and bacterial isolates used in the study</title>", "<p id=\"Par5\">Details of the isolates used for this experiment are provided in Tables ##TAB##0##1##, ##TAB##1##2## and Suppl Table ##SUPPL##0##1##. The commensal <italic>Neisseria</italic> isolates were cultured from oropharyngeal swabs from asymptomatic men and women participating in three recently performed clinical studies at our centre in Belgium—the Resistogenicity, ComCom, PReGo and ResistAZM (NCT05027516) studies<sup>##REF##34992227##14##–##REF##33676596##16##</sup>. The samples were obtained between 2019 and 2022. Written informed consent was obtained from all participating patients and the studies were approved by the Institute of Tropical Medicine’s Institutional Review Board (1276/18 and 1351/20) and from the Ethics Committee of the University of Antwerp (19/06/058 and AB/ac/003). Our selection of isolates from these studies was biased towards <italic>N. mucosa</italic> and <italic>N. macacae,</italic> as in a previous phylogenetic study of 20, 047 <italic>Neisseria</italic> isolates, we found that these were the only two commensal <italic>Neisseria</italic> species which were donors of <italic>gyrB</italic> DNA into <italic>N. gonorrhoeae</italic><sup>##UREF##4##13##</sup>. We also included a number of <italic>Neisseria</italic> isolates from reference collections (Suppl Table ##SUPPL##0##1##).</p>", "<p id=\"Par6\">All methods were performed in accordance with the relevant guidelines and regulations. Briefly, suspensions from tenfold dilutions of the oropharyngeal swabs in PBS were inoculated on <italic>Neisseria</italic> commensal selective agar plates (LBVT.SNR). Species identity was confirmed via MALDI-TOF and whole genome sequencing (WGS) was carried out as detailed elsewhere<sup>##REF##34992227##17##</sup>.</p>", "<title>In vitro assays</title>", "<title>Determination of the MIC</title>", "<p id=\"Par7\">All the frozen isolates stored in skimmed milk at − 80 °C were revived on gonococcal base (GCB) agar (Gonococcal Medium Base, BD Difco™) supplemented with 1% IsoVitaleX (BD BBL™) and subcultured twice before starting the experiments.</p>", "<p id=\"Par8\">Minimal inhibitory concentrations (MIC ≤ 0.015 to 16 µg/mL) for zoliflodacin (obtained from MedChemExpress) were determined on GCB agar in accordance with the CLSI methodology<sup>##UREF##5##18##</sup>. The WHO gonococcal reference strains F, P, X, Z and the ATCC strain 49,226 were included as the control isolates. The bacterial inoculum size was 10<sup>4</sup> colony-forming units. The inoculated plates were incubated at 36 °C in 5% CO<sub>2</sub> with high humidity. MICs were read after 24 h of incubation.</p>", "<title>Serial passage experiments</title>", "<p id=\"Par9\">Briefly, the strains were inoculated on a GCB agar plate containing 0.015 mg/L zoliflodacin and incubated at 36 °C in an atmosphere of 5% CO<sub>2</sub>. After visible growth was attained, colonies from the GCB agar plate with 0.015 mg/L zoliflodacin were inoculated onto a GCB agar plate with a twofold higher zoliflodacin concentration compared to the previous plate (0.03 mg/L). This process was repeated for each strain until no visible growth was seen on cultured plates or growth was obtained on the plate with the final concentration of 16 µg/mL. The cultures from each time point were stored in skimmed milk (Skim Milk, BD Difco™) supplemented with 20% of glycerol and stored at − 80 °C.</p>", "<title>Genomic DNA extraction and fragmentation</title>", "<p id=\"Par10\">Suspensions of bacteria from overnight cultures on GC agar plates were prepared in 2 mL of phosphate buffered saline (PBS; pH 7.6). Genomic DNA extraction was carried out using the QIAamp DNA Mini kit (Qiagen, Hilden, Germany) following the manufacturer’s protocol for isolation of genomic DNA from bacterial cultures. DNA was eluted in a total volume of 300 µL Aqua SteropFlexo (Sterop group, Belgium) and stored at 4 °C for further use. The DNA concentration and purity was determined using the Nanodrop® ND-1000 spectrophotometer (Thermo Scientific, Waltham, MA, USA). A concentration of 100 ng/µL was used in subsequent experiments.</p>", "<p id=\"Par11\">Samples of purified genomic DNA (gDNA) were sheared into short fragments using ultrasonication shearing to be used in transformation experiments<sup>##REF##2693020##19##</sup>. After sonication, all samples were stored at 4 °C. The size of the gDNA fragments were assessed with the Agilent Tape station (Agilent Technologies, Waldbronn, Germany) and visualized on 1% agarose gel<sup>##UREF##6##20##</sup>.</p>", "<title>PCR amplification of <italic>gyrB</italic></title>", "<p id=\"Par12\">PCR amplification of a 253 bp <italic>gyrB</italic> that included the resistance mutation at position D249 were amplified using the primer pairs gyrB-F1-1118-1353_Zoli (5ʹ-TCATCACCARCAAAATCGTC-3ʹ) and gyrB-R1-1118-1353_Zoli (5ʹ-ACCTTTGAGCGGCAAAATC-3ʹ). The primers were synthesized by Eurogentec (Seraing, Belgium). The PCR mixture consisted of 1× PE Buffer (Perkin–Elmer, Cetus, Norwalk, CT, USA), 2 mM MgCl<sub>2</sub>, 0.28 mM deoxyribonucleoside triphosphate (dNTP) (Pharmacia Biotech, St Albans, UK), 0.15 μM of primers, and 2 U of Taq polymerase (Perkin–Elmer, Cetus, Norwalk, CT, USA). 20 ng of DNA extract was added to the reaction mixture.</p>", "<p id=\"Par13\">A one-step thermocycling protocol was carried out in a thermocycler (Perkin–Elmer, Cetus, Norwalk, CT, USA) as follows: Initial denaturation at 94 °C for 10 min, followed by 35 cycles of denaturation at 94 <bold>°</bold>C for 45 s (s), annealing at 54 °C for 45 s, and extension at 72 °C for 1 min (min). The final extension step was carried out at 72 °C for 5 min. The PCR amplicon (15 μL) was visualized via electrophoresis in a 1% agarose gel in 1× Tris–acetate-EDTA buffer (pH 8.5). The gel was stained with Gelred (0.5 mg/L; Sigma, Bornem, Belgium) and was photographed under short-UV light. The size of the amplified products was assessed by comparing with a 100 bp Smartladder marker (Eurogentec).</p>", "<title>Intra- and inter-species transformation</title>", "<title>Transformation of reduced zoliflodacin susceptibility isolates with fragmented genomic DNA</title>", "<p id=\"Par14\">For intra-species transformation, the genomic DNA from the resistant strains that were generated via serial passage experiments were transformed into the susceptible wild-type strains from which the resistant strains were evolved (Table ##TAB##1##2##). For intra-species transformation, the WHO P <italic>N. gonorrhoeae</italic> recipient strain was transformed with genomic DNA from pools of two commensal strains each (Table ##TAB##2##3##). Transformations were conducted as described in Ref.<sup>##UREF##0##8##</sup>. Briefly, the strains were suspended in GCB broth (15 g/L protease peptone 3, 1 g/L soluble starch, 4 g/L dibasic K2HPO4, 1 g/L monobasic KH<sub>2</sub>PO<sub>4</sub>, 5 g/L NaCl) supplemented with 1% isovitalex, 10 µM MgSO<sub>4</sub> and 2.5 µg of fragmented gDNA. The suspensions were incubated at 37 °C for 1h and plated on non-selective GCB agar plates overnight. The recovered transformants were then placed on selective GCB plates with 0.125, 1, 2 and 4 µg/mL of zoliflodacin for 18–24 h.</p>", "<title>Transformation of PCR amplicon with zoliflodacin mutation</title>", "<p id=\"Par15\">For intra- and inter-species transformation, the recipient strains were transformed with ~ 2.5 µg of PCR-purified products and the transformation was carried out as described above. The experiment was carried out for limited isolates (Table ##TAB##2##3##, Suppl Table ##SUPPL##0##2##).</p>", "<title>Whole genome sequencing and analysis</title>", "<p id=\"Par16\">The whole genome data available from the Resistogenicity, ComCom and PReGo studies were included in this study (Suppl Table ##SUPPL##0##1##). In addition, eight isolates, including isolates with zoliflodacin resistance determining mutations with confirmed phenotypic resistance from the serial passage (highest obtained MIC) and transformation experiments, as well as their wild-type baselines, were subjected to WGS (Table ##TAB##1##2##). WGS was outsourced to Eurofins (Konstanz, Germany). The Dneasy® Blood &amp; Tissue Kit (Qiagen, Hilden, Germany) was used to extract genomic DNA, which was then suspended in nuclease-free water (Sigma-Aldrich, Seelze, Germany). Library preparation was carried out using Nextera XT DNA library prep kit followed by Illumina sequencing using paired-end 150-bp read sequencing chemistry (Illumina, San Diego, CA, USA). Raw reads that were generated were quality-controlled using FastQC (v0.11.9) and trimmed using Trimmomatic (v0.39)<sup>##UREF##7##21##,##REF##24695404##22##</sup>. Shovill (v1.0.4, <ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/tseemann/shovill\">https://github.com/tseemann/shovill</ext-link>) was used to de novo assemble the wild-type baseline isolates, which were subsequently annotated with Prokka (v1.14.6)<sup>##REF##24642063##23##</sup>. The consensus <italic>gyrB</italic> gene, encoding the DNA gyrase subunit B, was extracted, and reads of the isolates exhibiting zoliflodacin decreased susceptibility were mapped to their baseline using the Burrows-Wheeler Alignment Tool (v0.7.17-r1188) and Samtools (v1.9)<sup>##REF##19451168##24##</sup>. Reference mappings were visualized using the Integrative Genomics Viewer (IGV, v2.5.3) to discover single-nucleotide polymorphisms (SNPs) compared to the baseline and to estimate the proportion of reads mutated<sup>##REF##21221095##25##</sup>. Multiple sequence alignments of the <italic>gyrB</italic> were generated using MEGA software<sup>##REF##31904846##26##</sup>. The raw reads are deposited at <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/sra/PRJNA926517\">https://www.ncbi.nlm.nih.gov/sra/PRJNA926517</ext-link>.</p>", "<p id=\"Par17\">The overview of the study is illustrated in Fig. ##FIG##0##1##.</p>", "<title>Statistics</title>", "<p id=\"Par18\">Differences in MICs between groups were assessed using the Mann–Whitney test. Statistical analyses were performed using GraphPad Prism v9.</p>" ]
[ "<title>Results</title>", "<title>Baseline MICs of <italic>Neisseria</italic> species isolates</title>", "<p id=\"Par19\">In the absence of a breakpoint for zoliflodacin resistance, we classified a MIC of ≥ 4 µg/mL as resistantThe zoliflodacin MICs of <italic>N. cinerea</italic> (median 1 µg/mL, IQR 0.5–2 µg/Ml, n = 4; P &lt; 0.0005), <italic>N. macacae</italic> (median 1 µg/mL, IQR 1–2 µg/mL, n = 15; P &lt; 0.005), and <italic>N. mucosa</italic> (median 2 µg/mL, IQR 0.5–2 µg/mL, n = 30; P &lt; 0.0005), were higher than those of <italic>N. gonorrhoeae</italic> (median 0.125 µg/mL, IQR 0.06–0.19 µg/mL, n = 5; Fig. ##FIG##1##2##; Suppl Table ##SUPPL##0##1##). The MICs of <italic>N. lactamica</italic> (median 0.25 µg/mL, IQR 0.125–0.5 µg/mL, n = 5) were similar to those of <italic>N. gonorrhoeae</italic>. The sample size for <italic>N. subflava</italic> was too small (n = 2) to warrant statistical testing.</p>", "<title>Induction of zoliflodacin resistance</title>", "<p id=\"Par20\">To induce zoliflodacin resistance, ten susceptible <italic>Neisseria</italic> isolates [<italic>N. lactamica</italic> (n = 1), <italic>N. cinerea</italic> (n = 1), <italic>N. macacae</italic> (n = 1), <italic>N. subflava</italic> (n = 2), <italic>N. mucosa</italic> (n = 3)<italic>,</italic> and <italic>N. gonorrhoeae</italic> (n = 2)] were serially passaged on agar plates containing increasing zoliflodacin concentrations (Fig. ##FIG##2##3##). Within 7 to 10 days, all strains, except the <italic>N. lactamica</italic> strain, attained MICs of 4 µg/mL or higher, resulting in MIC increases ranging from 8- to 64-fold (Supplemental Table ##SUPPL##0##1##). There was only a two-fold increase in MIC for the <italic>N. lactamica</italic> strain (Fig. ##FIG##2##3##). The increase in MIC was most rapid in <italic>N. subflava</italic> 45/1, with the MIC increasing from 2 to ≥ 16 µg/mL in 3 days. The minimum time required for the emergence of zoliflodacin resistance was thus 3 days. The last passaged strains from the passage experiment and their baselines were subjected to WGS. In all strains, in vitro<italic>-</italic>induced zoliflodacin resistance was associated with mutations in the <italic>gyrB</italic> gene (Table ##TAB##1##2##). In <italic>N. subflava</italic> and <italic>N. gonorrhoeae,</italic> we detected mutations previously reported to cause zoliflodacin resistance, i.e. D429N and S467N. At position 467, we also identified a serine to glycine amino acid substitution in a <italic>N. cinerea</italic> strain, rather than the 467-asparagine resistance mutant described in the literature. Although we did not find the well-known K450N/T mutation, the consensus sequence reported an Isoleucine at position 450 in a <italic>N. cinerea</italic> strain. However, reference mapping revealed heteroresistance at this position, with 75% of the reads corresponding to K450I and 25% leading to K450N substitutions. Novel mutations, M464R and T472P, were discovered in the quinolone resistance-determining region (QRDR) of <italic>N. mucosa</italic>. Interestingly, we also observed novel mutations at amino acid positions 28 and 29 outside the QRDR in <italic>N. subflava</italic> and <italic>N. gonorrhoeae,</italic> respectively, that were the only genetic variants detected in <italic>gyrB</italic> in the resistant strains compared to their wild-type baseline. We found no evidence of multiple or multi-step mutations in <italic>gyrB</italic>.</p>", "<title>Intra-species transformation of zoliflodacin resistance determinants</title>", "<p id=\"Par21\">The genomic DNA of the resistant strains was transformed into their own susceptible baseline strain. This procedure resulted in zoliflodacin MICs of 8 µg/mL or higher (Table ##TAB##1##2##). WGS of transformants with decreased zoliflodacin susceptibility revealed the presence of the same zoliflodacin resistance determinants as observed in the donor (Table ##TAB##1##2##). The WHO-P <italic>N. gonorrhoeae</italic> reference strain was exposed to a pool of genomic DNA of zoliflodacin-resistant <italic>N. gonorrhoeae</italic> WHO-P and ATCC strain 49226. Only the mutation found in the ATCC strain (S467N) was detected in the transformant’s sequence analysis (Table ##TAB##1##2##). Attempts to transform the PCR product of <italic>gyrB</italic> from zoliflodacin resistant <italic>N. gonorrhoeae</italic> ATCC 49226_8 and WHO-P_8 into <italic>N. gonorrhoeae</italic> WHO-P failed (Table ##SUPPL##0##S2##).</p>", "<title>Inter-species transformation of zoliflodacin resistance determinants</title>", "<p id=\"Par22\">Three inter-species transformation experiments were conducted to investigate whether zoliflodacin resistance determinants of commensal <italic>Neisseria</italic> could be acquired by <italic>N. gonorrhoeae</italic>. <italic>N. gonorrhoeae</italic> reference strain WHO-P was exposed to pooled genomic DNA from the three resistant <italic>N. mucosa</italic> strains, resulting in a MIC of ≥ 16 µg/mL and uptake of the previously reported K450N mutation present in a proportion of the reads of the heteroresistant donor strain 801/1_8 (Table ##TAB##2##3##). No evidence of transformation was detected in equivalent experiments with the same donor strains but with <italic>N. gonorrhoeae</italic>, Res 18 as the recipient (Table ##TAB##2##3##).</p>", "<p id=\"Par23\">In the third experiment, the <italic>gyrB</italic> amplicon (253 bp) (Fig. ##FIG##3##4##) of the zoliflodacin resistant <italic>N. subflava</italic> strain 45/1_8 was used as the donor, and <italic>N. gonorrhoeae</italic> WHO-P as the recipient. The zoliflodacin MIC of <italic>N. gonorrhoeae</italic> WHO-P showed an increase from 0.125 to 216 µg/mL, and sequence alignment revealed that it had taken up a part of the gyrB amplicon of the resistant <italic>N. subflava</italic> strain 45/1_8 (Table ##TAB##2##3##, Fig. ##SUPPL##0##S1##).</p>", "<title><italic>gyrB</italic> mutations in circulating commensal <italic>Neisseria</italic> species</title>", "<p id=\"Par24\">We found 7 mutations in <italic>gyrB</italic> that emerged in response to zoliflodacin selection pressure. We assessed if any of these mutations were present in the zoliflodacin MIC panel of commensal <italic>Neisseria</italic> species. None of these strains had any of these mutations. We did however find a different single amino acid substitution at position 472. T472P mutation that was followed by a 32-fold increase in zoliflodacin MIC, emerged in <italic>N. mucosa</italic> DSM4631. We found two strains of <italic>N. lactamica</italic> (CO000761/1, CO000771/1) and three strains of <italic>N. cinerea</italic> (CO000776/4, CO000782/1) that had T472A substitution. This single amino acid change was not associated with zoliflodacin MICs (Mann–Whitney test, P &gt; 0.05 for both species).</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par25\">We found that the zoliflodacin MICs of <italic>N. cinerea</italic>, <italic>N. macacae</italic> and <italic>N. mucosae</italic> were higher than those of <italic>N. gonorrhoeae.</italic> Our passage experiments revealed that zoliflodacin resistance could be induced in all species assessed—an 8- to 64-fold increase within 7 to 10 days. Finally, we were able to transform zoliflodacin resistance both within and between <italic>Neisseria</italic> species. Of particular concern, transformation experiments revealed that <italic>N. gonorrhoeae</italic> could obtain zoliflodacin resistance from <italic>N. subflava</italic>—the most prevalent commensal <italic>Neisseria</italic> species.</p>", "<p id=\"Par26\">As noted above, transformation of resistance from commensal <italic>Neisseria</italic> spp. into <italic>N. gonorrhoeae</italic> has been instrumental in the emergence of cephalosporin, sulfonamide and macrolide resistance<sup>##UREF##0##8##–##UREF##2##11##</sup>. Transformation from commensal <italic>Neisseria</italic> has also been found to be responsible for fluoroquinolone resistance in over half the <italic>N. meningitidis</italic> isolates in one study from China<sup>##UREF##3##12##</sup>. Our findings support the possibility that gonococcal resistance to zoliflodacin could emerge via resistance in commensal <italic>Neisseria</italic>. Because commensal <italic>Neisseria</italic> such as <italic>N. subflava</italic> are a key component of a healthy oropharyngeal microbiome they are present in almost all individuals<sup>##REF##34992227##14##,##REF##32423437##27##</sup>. This high prevalence means they are at considerably greater risk for bystander selection—the emergence of AMR in response to antimicrobials taken for other indications<sup>##REF##30559213##28##</sup>. The broader the range of infections that zoliflodacin is used to treat, the higher the risk of this bystander selection. Even if the use of zoliflodacin is restricted to STIs such as <italic>N. gonorrhoeae</italic> and <italic>M. genitalium</italic>, the high prevalence of these infections in high risk groups such as HIV PrEP cohorts (around 10–15% for both infections<sup>##REF##34982008##29##,##REF##29485537##30##</sup>), will translate into high zoliflodacin exposure within these groups. The higher prevalence of commensal than pathogenic <italic>Neisseria</italic> in these groups will mean that the commensals are under a greater selection pressure to acquire resistance to zoliflodacin. This effect may be particularly prominent for zoliflodacin on commensal <italic>Neisseria</italic> as the penetration of zoliflodacin in the oropharynx appears to be particularly poor. Poor oropharyngeal penetration of zoliflodacin is the most plausible explanation for the lower cure rates for gonorrhoea in the pharynx (50%) than urogenital sites (96%)<sup>##REF##30403954##1##</sup>.</p>", "<p id=\"Par27\">In this study we found that the zoliflodacin MICs of <italic>N. mucosa</italic>, <italic>N. macacae</italic> and <italic>N. cinerea</italic> were higher than those in <italic>N. gonorrhoeae</italic>. These higher MICs could not be explained by established <italic>gyrB</italic> resistance associated mutations. It should also be noted that other studies have found that the known zoliflodacin resistance associated mutations are not able to fully explain differences in zoliflodacin MICs. For example, a study of 986 gonococcal isolates collected in China between 2014 and 2018 found a doubling in MIC<sub>50</sub> and MIC<sub>90</sub> over the time period, but no known zoliflodacin RAMs were detected<sup>##REF##33318010##31##</sup>. We found that zoliflodacin resistance can emerge fairly rapidly within commensal <italic>Neisseria</italic> species and be transformed into <italic>N. gonorrhoeae</italic>. These results suggest it may be prudent to include surveillance of zoliflodacin susceptibility in commensal <italic>Neisseria</italic> in clinical trials and programmes using this agent. This suggestion would fit into calls to include surveillance of antimicrobial susceptibility of commensal Neisseria within gonococcal surveillance programmes such as Euro-GASP<sup>##REF##34062856##7##,##REF##36154280##32##</sup>.</p>", "<p id=\"Par28\">There are a number of limitations to this study. Our study only used a limited number of strains from a small number of commensal species. We did not include <italic>N. meningitidis</italic>. The main <italic>gyrB</italic> mutations we found to be implicated in zoliflodacin resistance are well-established in previous studies. We did however find two additional <italic>gyrB</italic> mutations which may increase zoliflodacin MICs. However, we were unable to prove this effect experimentally. Additionally, we would like to acknowledge that several aspects were not assessed in our study. We did not determine the mutation frequency and the stability of the induced zoliflodacin resistance, assess the transformation efficacy, explore potential fitness effects associated with induced zoliflodacin resistance, or investigate cross-resistance to other antimicrobials. These are important considerations that should be addressed in future studies to gain a more comprehensive understanding of zoliflodacin resistance. Furthermore, it is crucial to acknowledge that in vitro induced mutations may not fully represent the mutations that develop in vivo. While our study provides insights into the potential mechanisms of zoliflodacin resistance, the translation of these findings to clinical settings requires further investigation.</p>", "<p id=\"Par29\">Transformation efficacy between <italic>Neisseria</italic> spp. is heavily influenced by the similarity of the direct uptake sequences (DUS) of the recipient and donor<sup>##REF##23637627##33##</sup>. Analyses have revealed the existence of eight families of DUS sequence with the <italic>Neisseriaceae</italic> family<sup>##REF##23637627##33##</sup>. <italic>N. gonorrhoeae</italic> is from the same DUS family (AT-DUS) as <italic>N. meningitidis, N. lactamica, N. polysaccharea</italic> and <italic>N. cinerea</italic><sup>##REF##23637627##33##</sup>. The <italic>N. mucosa</italic> and <italic>N. subflava</italic> used in the transformation experiments are from the closely related to AG-DUS family<sup>##REF##23637627##33##</sup>. Thus the fact that the donor species used in the transformation experiments were from a different DUS family to <italic>N. gonorrhoeae</italic> may be considered as further study limitation.</p>", "<p id=\"Par30\">Notwithstanding these limitations, this is the first study to report that zoliflodacin resistance can be induced in commensal <italic>Neisseria</italic> and subsequently acquired by <italic>N. gonorrhoeae</italic> via transformation. This finding has important implications for how we introduce this novel antimicrobial and how we monitor for the emergence of zoliflodacin resistance.</p>" ]
[]
[ "<p id=\"Par1\">One of the most promising new treatments for gonorrhoea currently in phase 3 clinical trials is zoliflodacin. Studies have found very little resistance to zoliflodacin in currently circulating <italic>N. gonorrhoeae</italic> strains, and in-vitro experiments demonstrated that it is difficult to induce resistance. However, zoliflodacin resistance may emerge in commensal <italic>Neisseria</italic> spp., which could then be transferred to <italic>N. gonorrhoeae</italic> via transformation. In this study, we investigated this commensal-resistance-pathway hypothesis for zoliflodacin. To induce zoliflodacin resistance, ten wild-type susceptible isolates belonging to 5 <italic>Neisseria</italic> species were serially passaged for up to 48 h on gonococcal agar plates containing increasing zoliflodacin concentrations. Within 7 to 10 days, all strains except <italic>N. lactamica</italic>, exhibited MICs of ≥ 4 µg/mL, resulting in MIC increase ranging from 8- to 64-fold. The last passaged strains and their baseline were sequenced. We detected mutations previously reported to cause zoliflodacin resistance in GyrB (D429N and S467N), novel mutations in the quinolone resistance determining region (QRDR) (M464R and T472P) and mutations outside the QRDR at amino acid positions 28 and 29 associated with low level resistance (MIC 2 µg/mL). Genomic DNA from the laboratory evolved zoliflodacin-resistant strains was transformed into the respective baseline wild-type strain, resulting in MICs of ≥ 8 µg/mL in most cases. WGS of transformants with decreased zoliflodacin susceptibility revealed presence of the same zoliflodacin resistance determinants as observed in the donor strains. Two inter-species transformation experiments were conducted to investigate whether zoliflodacin resistance determinants of commensal <italic>Neisseria</italic> spp. could be acquired by <italic>N. gonorrhoeae</italic>. <italic>N. gonorrhoeae</italic> strain WHO P was exposed to (i) pooled genomic DNA from the two resistant <italic>N. mucosa</italic> strains and (ii) a <italic>gyrB</italic> amplicon of the resistant <italic>N. subflava</italic> strain 45/1_8. Transformants of both experiments exhibited an MIC of 2 µg/mL and whole genome analysis revealed uptake of the mutations detected in the donor strains. This is the first in-vitro study to report that zoliflodacin resistance can be induced in commensal <italic>Neisseria</italic> spp. and subsequently transformed into <italic>N. gonorrhoeae.</italic></p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-023-49943-z.</p>", "<title>Author contributions</title>", "<p>S.A., J.L., S.M.B. and C.K. conceptualized the study. J.L. and S.A. conducted the experiments. J.L., S.A., S.M.B. and C.K. were responsible for the acquisition, analysis and interpretation of the analyses. C.K., J.L., S.A. and S.M.B. wrote the first draft, and all authors (C.K., J.L., S.A., T.D.B., C.V.D., I.D.B., D.V.D.B. and S.M.B.) read and approved the final draft.</p>", "<title>Data availability</title>", "<p>All data generated or analysed during this study are included in this published article and its Supplementary Information files. Please see: <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/sra/PRJNA926517\">https://www.ncbi.nlm.nih.gov/sra/PRJNA926517</ext-link>.</p>", "<title>Competing interests</title>", "<p id=\"Par31\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Overview of the study. The figure was created using BioRender.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Zoliflidacin MICs of 62 strains from 5 <italic>Neisseria</italic> species (**P &lt; 0.001; ***P &lt; 0.0001; <italic>ns</italic> non-significant).</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Increase of zoliflodacin MICs during passage experiments using increasing concentrations of zoliflodacin for 10 strains from 5 <italic>Neisseria</italic> species. Zoliflodacin MICs were truncated at 16 µg/mL.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>An image showing the PCR amplified <italic>gyrB</italic> (235 bp) in 1% agarose gel electrophoresis. <italic>GyrB</italic> was amplified from DNA of Ng (<italic>Neisseria gonorrhoeae</italic>; n = 2) and Ns (<italic>Neisseria subflava</italic>; n = 2). Milli Q. H<sub>2</sub>O was was used as a negative control.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Characteristics of strains used for transformation and induction of resistance experiments.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Isolate</th><th align=\"left\">Species</th><th align=\"left\">Zoliflodacin MIC (mg/L)*</th><th align=\"left\">Azithromycin MIC (mg/L)</th><th align=\"left\">Ceftriaxone MIC (mg/L)</th><th align=\"left\">Ciprofloxacin MIC (mg/L)</th><th align=\"left\">Source of isolate</th></tr></thead><tbody><tr><td align=\"left\">9/1</td><td align=\"left\"><italic>N. subflava</italic></td><td align=\"left\">0.5</td><td align=\"left\">3</td><td align=\"left\">0.023</td><td align=\"left\">ND</td><td align=\"left\">Resistogenicity study<sup>##REF##33806962##15##</sup></td></tr><tr><td align=\"left\">45/1</td><td align=\"left\"><italic>N. subflava</italic></td><td align=\"left\">2</td><td align=\"left\">6</td><td align=\"left\">0.047</td><td align=\"left\">ND</td><td align=\"left\">Resistogenicity study</td></tr><tr><td align=\"left\">773/3</td><td align=\"left\"><italic>N. mucosa</italic></td><td align=\"left\">0.125</td><td align=\"left\">2</td><td align=\"left\">0.032</td><td align=\"left\">0.006</td><td align=\"left\">PREGO/ComCom study<sup>##REF##33676596##16##</sup></td></tr><tr><td align=\"left\">801/1</td><td align=\"left\"><italic>N. mucosa</italic></td><td align=\"left\">1</td><td align=\"left\">ND</td><td align=\"left\">ND</td><td align=\"left\">ND</td><td align=\"left\">PREGO/ComCom study<sup>##REF##33676596##16##</sup></td></tr><tr><td align=\"left\">DSM4631</td><td align=\"left\"><italic>N. mucosa</italic></td><td align=\"left\">0.5</td><td align=\"left\">ND</td><td align=\"left\">ND</td><td align=\"left\">ND</td><td align=\"left\">Reference strain</td></tr><tr><td align=\"left\">793/3</td><td align=\"left\"><italic>N. macacae</italic></td><td align=\"left\">0.5</td><td align=\"left\">ND</td><td align=\"left\">ND</td><td align=\"left\">ND</td><td align=\"left\">PREGO/ComCom study<sup>##REF##33676596##16##</sup></td></tr><tr><td align=\"left\">782/1</td><td align=\"left\"><italic>N. cinerea</italic></td><td align=\"left\">0.125</td><td align=\"left\">2</td><td align=\"left\"> &lt; 0.016</td><td align=\"left\">0.012</td><td align=\"left\">PREGO/ComCom study<sup>##REF##33676596##16##</sup></td></tr><tr><td align=\"left\">761/1</td><td align=\"left\"><italic>N. lactamica</italic></td><td align=\"left\">0.125</td><td align=\"left\">2</td><td align=\"left\"> &lt; 0.016</td><td align=\"left\">0.19</td><td align=\"left\">PREGO/ComCom study<sup>##REF##33676596##16##</sup></td></tr><tr><td align=\"left\">ATCC49226</td><td align=\"left\"><italic>N. gonorrhoeae</italic></td><td align=\"left\">0.125</td><td align=\"left\">0.25</td><td align=\"left\"> &lt; 0.016</td><td align=\"left\">0.003</td><td align=\"left\">Reference strain</td></tr><tr><td align=\"left\">WHO F</td><td align=\"left\"><italic>N. gonorrhoeae</italic></td><td align=\"left\">0.032</td><td align=\"left\">0.125</td><td align=\"left\"> &lt; 0.016</td><td align=\"left\">0.004</td><td align=\"left\">WHO reference strain<sup>##REF##27432602##34##</sup></td></tr><tr><td align=\"left\">WHO P</td><td align=\"left\"><italic>N. gonorrhoeae</italic></td><td align=\"left\">0.125</td><td align=\"left\">4</td><td align=\"left\">0.004</td><td align=\"left\">0.004</td><td align=\"left\">WHO reference strain<sup>##REF##27432602##34##</sup></td></tr><tr><td align=\"left\">WHO X</td><td align=\"left\"><italic>N. gonorrhoeae</italic></td><td align=\"left\">0.125</td><td align=\"left\">0.25</td><td align=\"left\">1.5</td><td align=\"left\"> &gt; 32</td><td align=\"left\">WHO reference strain<sup>##REF##27432602##34##</sup></td></tr><tr><td align=\"left\">WHO Z</td><td align=\"left\"><italic>N. gonorrhoeae</italic></td><td align=\"left\">0.125</td><td align=\"left\">0.75</td><td align=\"left\">0.5</td><td align=\"left\"> &gt; 32</td><td align=\"left\">WHO reference strain<sup>##REF##27432602##34##</sup></td></tr><tr><td align=\"left\">38/1</td><td align=\"left\"><italic>N. gonorrhoeae</italic></td><td align=\"left\">0.125</td><td align=\"left\">0.25</td><td align=\"left\">0.016</td><td align=\"left\">ND</td><td align=\"left\">Resistogenicity study<sup>##REF##33806962##15##</sup></td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Intraspecies transformation of DNA conferring reduced susceptibility to zoliflodacin.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" colspan=\"3\">Initial strain</th><th align=\"left\" rowspan=\"2\">Sample_ID</th><th align=\"left\" rowspan=\"2\">SRA run no</th><th align=\"left\">Resistant strain</th><th align=\"left\" rowspan=\"2\">GyrB substitution (AA)</th><th align=\"left\" rowspan=\"2\">Nucleotide [nr of reads (%)]</th><th align=\"left\" colspan=\"2\">Transformant</th></tr><tr><th align=\"left\">Species</th><th align=\"left\">Sample_ID</th><th align=\"left\">Initial MIC (µg/mL)</th><th align=\"left\">Final MIC (µg/mL)</th><th align=\"left\">gyrB mutation transformant [nr of reads (%)]</th><th align=\"left\">MIC (µg/mL)</th></tr></thead><tbody><tr><td align=\"left\"><italic>Neisseria subflava</italic></td><td align=\"left\">9/1</td><td align=\"left\">0.5</td><td align=\"left\">9/1_8<sup>#</sup></td><td align=\"left\">SRR23198175</td><td char=\".\" align=\"char\">8</td><td align=\"left\">G28C</td><td align=\"left\">G82T (581/584 (99%))</td><td align=\"left\">NS</td><td align=\"left\">2</td></tr><tr><td align=\"left\"><italic>Neisseria subflava</italic></td><td align=\"left\">45/1</td><td align=\"left\">2</td><td align=\"left\">45/1_8<sup>#</sup></td><td align=\"left\"><bold>SRR23198182</bold></td><td char=\".\" align=\"char\"> ≥ 16</td><td align=\"left\">D429N</td><td align=\"left\">G1285A (977/983 (99%))</td><td align=\"left\">D429N (696/697 (100%))</td><td align=\"left\">8</td></tr><tr><td align=\"left\"><italic>Neisseria mucosa</italic></td><td align=\"left\">773/3</td><td align=\"left\">0.25</td><td align=\"left\">773/3_8<sup>#</sup></td><td align=\"left\"><bold>SRR23198181</bold></td><td char=\".\" align=\"char\"> ≥ 16</td><td align=\"left\">M464R</td><td align=\"left\">T1391G (898/901 (100%))</td><td align=\"left\">M464R (523/524 (100%))</td><td align=\"left\"> ≥ 16</td></tr><tr><td align=\"left\"><italic>Neisseria mucosa</italic></td><td align=\"left\">801/1</td><td align=\"left\">2</td><td align=\"left\">801/1_8<sup>#</sup></td><td align=\"left\"><bold>SRR23198179</bold></td><td char=\".\" align=\"char\"> ≥ 16</td><td align=\"left\">K450I</td><td align=\"left\">Heteroresistance</td><td align=\"left\">K450I–A1349T (703/706 (100%))</td><td align=\"left\"> ≥ 16</td></tr><tr><td align=\"left\"><italic>Neisseria mucosa</italic></td><td align=\"left\">DSM4631</td><td align=\"left\">0.5</td><td align=\"left\">DSM4631_8<sup>#</sup></td><td align=\"left\"><bold>SRR23198178</bold></td><td char=\".\" align=\"char\"> ≥ 16</td><td align=\"left\">T472P</td><td align=\"left\">A1414C (782/1195 (65%))</td><td align=\"left\">No mutations in gyrB</td><td align=\"left\"> ≥ 16</td></tr><tr><td align=\"left\"><italic>Neisseria macacae</italic></td><td align=\"left\">793/1</td><td align=\"left\">0.5</td><td align=\"left\">793/1</td><td align=\"left\"/><td char=\".\" align=\"char\">4</td><td align=\"left\">NS</td><td align=\"left\">NS</td><td align=\"left\">NS</td><td align=\"left\">NS</td></tr><tr><td align=\"left\"><italic>Neisseria cinerea</italic></td><td align=\"left\">782/1</td><td align=\"left\">0.25</td><td align=\"left\">782/1_8<sup>#</sup></td><td align=\"left\"><bold>SRR23198180</bold></td><td char=\".\" align=\"char\">8</td><td align=\"left\">S467G</td><td align=\"left\">A1399G (956/958 (100%))</td><td align=\"left\">S467G (645/646 (100%))</td><td align=\"left\">8</td></tr><tr><td align=\"left\"><italic>Neisseria gonorrhoeae</italic></td><td align=\"left\">ATCC49226</td><td align=\"left\">0.25</td><td align=\"left\">ATCC49226_8<sup>#</sup></td><td align=\"left\">SRR23198175</td><td char=\".\" align=\"char\">8</td><td align=\"left\">S467N</td><td align=\"left\">G1400A (1107/1109 (100%)</td><td align=\"left\">NA**</td><td align=\"left\">NA</td></tr><tr><td align=\"left\"><italic>Neisseria gonorrhoeae</italic></td><td align=\"left\">WHO P</td><td align=\"left\">0.125</td><td align=\"left\">WHO P_8<sup>#</sup></td><td align=\"left\"><bold>SRR23198175</bold></td><td char=\".\" align=\"char\">8</td><td align=\"left\">M29I</td><td align=\"left\">G87A (1481/1484 100%)</td><td align=\"left\">S467N (945/947 (100%)**</td><td align=\"left\">2</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Interspecies transformation of DNA conferring reduced susceptibility to zoliflodacin.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" colspan=\"3\">Recipient</th><th align=\"left\" colspan=\"3\">Donor</th><th align=\"left\" colspan=\"2\">Transformant</th></tr><tr><th align=\"left\">Species</th><th align=\"left\">Sample_ID</th><th align=\"left\">MIC</th><th align=\"left\">Species</th><th align=\"left\">Sample_ID</th><th align=\"left\">MIC</th><th align=\"left\">GyrB substitution</th><th align=\"left\">MIC</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"8\">A. Transformation with genomic DNA</td></tr><tr><td align=\"left\" rowspan=\"7\">Neisseria gonorrhoeae </td><td align=\"left\" rowspan=\"7\">WHO P</td><td align=\"left\" rowspan=\"7\">0.125</td><td align=\"left\" rowspan=\"2\">Neisseria mucosa</td><td align=\"left\">801/1_8</td><td char=\".\" align=\"char\">8</td><td align=\"left\" rowspan=\"2\">K450N</td><td align=\"left\" rowspan=\"2\">2</td></tr><tr><td align=\"left\">DSM4631_8</td><td char=\".\" align=\"char\">8</td></tr><tr><td align=\"left\" rowspan=\"2\">Neisseria subflava</td><td align=\"left\">45/1_16</td><td char=\".\" align=\"char\"> ≥ 16</td><td align=\"left\">No growth</td><td align=\"left\">NA</td></tr><tr><td align=\"left\">9/1_8</td><td char=\".\" align=\"char\">8</td><td align=\"left\">No growth</td><td align=\"left\">NA</td></tr><tr><td align=\"left\" rowspan=\"2\">Neisseria mucosa/macacae</td><td align=\"left\">773/2_ ≥ 16</td><td char=\".\" align=\"char\"> ≥ 16</td><td align=\"left\">No growth</td><td align=\"left\">NA</td></tr><tr><td align=\"left\">793/1_4</td><td char=\".\" align=\"char\">4</td><td align=\"left\">No growth</td><td align=\"left\">NA</td></tr><tr><td align=\"left\">Neisseria cinerea</td><td align=\"left\">782/1_8</td><td char=\".\" align=\"char\">8</td><td align=\"left\">No growth</td><td align=\"left\">NA</td></tr><tr><td align=\"left\" rowspan=\"7\">Neisseria gonorrhoeae </td><td align=\"left\" rowspan=\"7\">Res18</td><td align=\"left\" rowspan=\"7\">0.125</td><td align=\"left\" rowspan=\"2\">Neisseria mucosa</td><td align=\"left\">801/1_8</td><td char=\".\" align=\"char\">8</td><td align=\"left\">No growth</td><td align=\"left\">NA</td></tr><tr><td align=\"left\">DSM4631_8</td><td char=\".\" align=\"char\">8</td><td align=\"left\">No growth</td><td align=\"left\">NA</td></tr><tr><td align=\"left\" rowspan=\"2\">Neisseria subflava</td><td align=\"left\">45/1_16</td><td char=\".\" align=\"char\"> ≥ 16</td><td align=\"left\">No growth</td><td align=\"left\">NA</td></tr><tr><td align=\"left\">9/1_8</td><td char=\".\" align=\"char\">8</td><td align=\"left\">No growth</td><td align=\"left\">NA</td></tr><tr><td align=\"left\" rowspan=\"2\">Neisseria mucosa/macacae</td><td align=\"left\">773/2_ ≥  16</td><td char=\".\" align=\"char\"> ≥ 16</td><td align=\"left\">No growth</td><td align=\"left\">NA</td></tr><tr><td align=\"left\">793/1_4</td><td char=\".\" align=\"char\">4</td><td align=\"left\">No growth</td><td align=\"left\">NA</td></tr><tr><td align=\"left\">Neisseria cinerea</td><td align=\"left\">782/1_8</td><td char=\".\" align=\"char\">8</td><td align=\"left\">No growth</td><td align=\"left\">NA</td></tr><tr><td align=\"left\" colspan=\"8\">B. Transformation with amplicon DNA</td></tr><tr><td align=\"left\">Neisseria gonorrhoeae </td><td align=\"left\">WHO P</td><td align=\"left\">0.125</td><td align=\"left\">Neisseria subflava</td><td align=\"left\">45/1_8</td><td char=\".\" align=\"char\"> ≥ 16</td><td align=\"left\">D429N</td><td align=\"left\">2</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p><italic>ND</italic> not determined.</p><p>*MIC’s determined in the present study.</p></table-wrap-foot>", "<table-wrap-foot><p><italic>NS</italic> not sequenced, <italic>NA</italic> not applicable.</p><p><sup>#</sup>Isolates that were whole genome sequenced.</p><p>**Pool: ATCC49226_8 and WHO-P_8 as donor and WHO-P as recipient.</p><p>Significant values are in bold.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Saïd Abdellati, Jolein Gyonne Elise Laumen, Sheeba Santhini Manoharan-Basil and Chris Kenyon.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2023_49943_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2023_49943_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2023_49943_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2023_49943_Fig4_HTML\" id=\"MO4\"/>" ]
[ "<media xlink:href=\"41598_2023_49943_MOESM1_ESM.docx\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["8."], "surname": ["Wadsworth", "Arnold", "Sater", "Grad"], "given-names": ["CB", "BJ", "MRA", "YH"], "article-title": ["Azithromycin resistance through interspecific acquisition of an epistasis-dependent efflux pump component and transcriptional regulator in "], "italic": ["Neisseria gonorrhoeae"], "source": ["Mbio"], "year": ["2018"], "volume": ["9"], "issue": ["4"], "fpage": ["18"], "pub-id": ["10.1128/mBio.01419-18"]}, {"label": ["9."], "surname": ["Kanesaka", "Ohno", "Katsuse", "Takahashi", "Kobayashi"], "given-names": ["I", "A", "AK", "H", "I"], "article-title": ["The emergence of the ceftriaxone-resistant "], "italic": ["Neisseria gonorrhoeae", "Neisseria subflava"], "source": ["J. Antimicrob. Chemother."], "year": ["2021"], "volume": ["77"], "fpage": ["364"], "pub-id": ["10.1093/jac/dkab390"]}, {"label": ["11."], "surname": ["Manoharan-Basil", "Laumen", "Van Dijck", "De Block", "De Baetselier", "Kenyon"], "given-names": ["SS", "JGE", "C", "T", "I", "C"], "article-title": ["Evidence of horizontal gene transfer of 50S ribosomal genes rplB, rplD, and rplY in "], "italic": ["Neisseria gonorrhoeae"], "source": ["Front. Microbiol."], "year": ["2021"], "volume": ["12"], "fpage": ["1263"], "pub-id": ["10.3389/fmicb.2021.683901"]}, {"label": ["12."], "surname": ["Chen", "Zhang", "Zhang", "Chen"], "given-names": ["M", "C", "X", "M"], "article-title": ["Meningococcal quinolone resistance originated from several commensal Neisseria species"], "source": ["Antimicrob. Agents Chemother."], "year": ["2019"], "volume": ["64"], "fpage": ["10"]}, {"label": ["13."], "surname": ["Manoharan-Basil", "Gonzalez", "Laumen", "Kenyon"], "given-names": ["SS", "N", "J", "C"], "article-title": ["Horizontal gene transfer of fluoroquinolone resistance-conferring genes from commensal Neisseria to "], "italic": ["Neisseria gonorrhoeae"], "source": ["Front. Microbiol."], "year": ["2022"], "volume": ["13"], "fpage": ["225"], "pub-id": ["10.3389/fmicb.2022.793612"]}, {"label": ["18."], "collab": ["CLSI"], "source": ["Performance Standards for Antimicrobial Susceptibility Testing CLSI Supplement M100"], "year": ["2020"], "edition": ["30"], "publisher-name": ["Clinical and Laboratory Standards Institute"]}, {"label": ["20."], "surname": ["Sambrook", "Russell"], "given-names": ["J", "DW"], "article-title": ["Agarose gel electrophoresis"], "source": ["Cold Spring Harbor Protoc."], "year": ["2006"], "volume": ["2006"], "issue": ["1"], "fpage": ["4020"], "pub-id": ["10.1101/pdb.prot4020"]}, {"label": ["21."], "surname": ["Andrews"], "given-names": ["S"], "source": ["FastQC: A Quality Control Tool for High Throughput Sequence Data"], "year": ["2010"], "publisher-name": ["Babraham Bioinformatics, Babraham Institute"]}]
{ "acronym": [], "definition": [] }
34
CC BY
no
2024-01-14 23:40:15
Sci Rep. 2024 Jan 12; 14:1179
oa_package/cc/e8/PMC10786824.tar.gz
PMC10786825
38216562
[ "<title>Background &amp; Summary</title>", "<p id=\"Par2\">Biological traits are increasingly used to characterize predator-prey interactions within changing ecosystems<sup>##REF##16701083##1##</sup>. When combined, a suite of traits can be used to describe diet selection<sup>##REF##24861366##2##</sup> or identify prey guilds based on functional role##UREF##0##3##. Ultimately trait approaches seek to help scientists better predict interactions within ecological communities, especially in the scope of global change. In particular, habitat, behavior, morphology, and nutritional quality are important traits that can affect prey vulnerability across different aspects of the predation process (encounter, attack, capture)<sup>##UREF##1##4##</sup>. Habitat use (e.g., water column position) and migration behaviors impact encounter rates through spatiotemporal overlap, and schooling behavior can deter or facilitate predator attack. Morphological traits such as body shape and physical defenses influence the costs of prey capture, while body size affects consumption for gape-limited predators, and relative eye, fin or appendage size can influence predator detection and evasion<sup>##UREF##2##5##</sup>. Nutritional quality traits also mediate prey selection; predators select prey items in a manner that maximizes energy gain while minimizing energy expenditure<sup>##UREF##1##4##</sup>. Nutritional quality varies not only among species but also within species, reflecting geographic, seasonal, interannual, and longer-scale changes in environmental conditions<sup>##REF##35255319##6##</sup>.</p>", "<p id=\"Par3\">Understanding how species will interact with one another is important for predicting how ecological systems and services will be altered by forces such as climate change and biological invasions<sup>##UREF##3##7##,##REF##30742106##8##</sup>. Trait-based approaches focus on the mechanistic drivers of ecological interactions and are emerging as a useful method for predicting variability in species distributions, community structures, and population dynamics under global change<sup>##UREF##4##9##–##UREF##5##11##</sup>. Further, identifying traits that recur across unrelated prey taxa offers a means to better anticipate predator resource use by simplifying complex foraging dynamics<sup>##UREF##0##3##</sup>. Assembling comprehensive databases of traits for biological communities facilitates ecological modeling of future species abundances, distributions, and food web structures<sup>##UREF##5##11##,##REF##32066887##12##</sup>.</p>", "<p id=\"Par4\">This dataset<sup>##UREF##6##13##</sup> contains traits for adults, juveniles, and larvae of 529 pelagic fish and invertebrate species found worldwide. Traits included describe 1) habitat use and behavior, 2) morphology and morphometrics, 3) nutritional quality (lipid, protein, energy density), and 4) population status information. The dataset was specifically created for its application in multi-facetted ecological modeling occurring in the California Current System (CCS) located within the NE Pacific Ocean. Therefore, species in the dataset are primarily from the CCS and broader NE Pacific Ocean to encompass both known and potential prey for pelagic predators<sup>##UREF##0##3##</sup> (given anticipated future shifts in species distributions; Fig. ##FIG##0##1##). Globally important pelagic species known to be consumed by top ocean predators that are found in both the NE Pacific and other ocean basins (NW Pacific, Atlantic, Indian, Mediterranean) are also included to promote the use of trait-based approaches in marine ecosystems and predator populations worldwide. Detailed protocols are provided for trait data collection to serve as a framework for the expansion of this dataset in the future for other systems and predators.</p>", "<p id=\"Par5\">With the publication of this trait dataset for pelagic species, we aim to encourage and facilitate the use of trait information in analysis of open-ocean ecosystem status and change, as well as enable pelagic systems to be a candidate for testing emerging trait-based analytical methods. In particular, the dataset as a whole serves as an opportunity to train and test statistical methods for trait imputation<sup>##UREF##7##14##</sup>. Knowledge gaps within the current dataset also emphasize directions for future work that further resolves trait classification analytically (Figs. ##FIG##1##2##–##FIG##4##5##). Of the species included in the dataset, 25% had complete records for all traits queried, while only 5% had less than half of the traits. Interestingly, species that are the focus of either commercial or recreational fisheries had information available for 95% of traits, while on average we were able to identify trait values for 87% of traits for non-fishery species. Nutritional traits are especially data poor, likely because values are generated from laboratory analyses that are time and resource intensive, requiring freshly collected specimens. Nutritional quality traits had the lowest data coverage (Fig. ##FIG##3##4##), with only 34% of species searched having protein content information, 41% for energy content, and 47% for lipid content. For this reason, this dataset augments literature searches with nutritional values for 55 CCS taxa from laboratory analyses (included in summary statistics), that fills prior data gaps in the region and globally.</p>" ]
[ "<title>Methods</title>", "<title>Species list</title>", "<p id=\"Par6\">The Pelagic Species Trait Database<sup>##UREF##6##13##</sup> includes species representing pelagic communities of the CCS, as well as cosmopolitan species known to be important prey for pelagic predators in other ocean basins (n = 529; Fig. ##FIG##0##1##). For the NE Pacific, we included species observed in 15 years (2005–2019) of annual NOAA midwater trawls conducted in the CCS by the Southwest Fisheries Science Center Fisheries Ecology Division (SWFSC-FED) Rockfish Recruitment and Ecosystem Assessment Survey<sup>##UREF##8##15##,##UREF##9##16##</sup>, SWFSC Fisheries Resources Division (SWFSC-FRD) California Current Ecosystem Survey<sup>##UREF##10##17##</sup>, Northwest Fisheries Science Center Fish Ecology Division (NWFSC-FED) Stock Assessment Improvement Program (2005–2011)<sup>##UREF##11##18##</sup>, and NWFSC Coastwide Cooperative Pre-Recruit Survey (2011–2019)<sup>##UREF##12##19##</sup>. To encompass other communities in the NE Pacific we included species sampled by Fisheries and Oceans Canada (DFO; 2017–2019) and the North Pacific Anadromous Fish Commission’s International Year of the Salmon (2020). Beyond the NE Pacific, we included many known prey of a highly-migratory generalist predator, albacore tuna (<italic>Thunnus alalunga</italic>), compiled from a recent global meta-analysis of its diet<sup>##UREF##0##3##</sup> (1880–2020). We note the dataset includes all species reported in the diets of <italic>T. alalunga</italic> collected in the CCS from 2005–2019<sup>##UREF##13##20##–##UREF##15##23##</sup>. Overall, species in this dataset represent 118 families of fish, 27 families of cephalopods, and 66 families of other invertebrates (e.g., crustaceans, jellies). Species names and phylogenetic information were verified using the Open Tree of Life<sup>##UREF##16##24##</sup> and the World Register of Marine Species (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.marinespecies.org\">www.marinespecies.org</ext-link>).</p>", "<title>Trait data collection</title>", "<p id=\"Par7\">For each species we collected information on four trait categories: (1) habitat/behavior, (2) morphology (including morphometric ratios), (3) nutritional quality, and (4) population status. We searched online repositories (FishBase [<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.fishbase.org\">www.fishbase.org</ext-link>] and SeaLifeBase [<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.sealifebase.ca\">www.sealifebase.ca</ext-link>], Google Images [<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.images.google.com\">www.images.google.com</ext-link>]) and primary literature though bibliographic databases (Google Scholar [<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.scholar.google.com\">www.scholar.google.com</ext-link>], Web of Science [<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.webofscience.com\">www.webofscience.com</ext-link>], Aquatic Sciences and Fisheries Abstracts [<ext-link ext-link-type=\"uri\" xlink:href=\"https://proquest.libguides.com/asfa\">https://proquest.libguides.com/asfa</ext-link>], Federal Science Library Canada [<ext-link ext-link-type=\"uri\" xlink:href=\"https://science-libraries.canada.ca\">https://science-libraries.canada.ca</ext-link>]) for species-level information and images. Search terms included scientific name or common name, lifestage (e.g. adult, juvenile, larva), and the trait of interest. When possible, trait data collection protocols followed standards outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses<sup>##REF##33960637##25##</sup>, including consistent search terms, eligibility criteria for including data sources, data collection, source metadata, review, and bias reporting. We note that known trait information may change after data collection, especially for cryptic species and/or lifestages. All data manipulations, calculations, and summaries are described below and detailed in the R code included with the dataset<sup>##UREF##6##13##</sup> (Fig. ##FIG##5##6##). Specific source information and notes on data collection are given in the sections below and reported for each trait per species and lifestage<sup>##UREF##6##13##</sup> (Fig. ##FIG##5##6##, Table ##SUPPL##0##S1##).</p>", "<title>Habitat/behavioral traits</title>", "<p id=\"Par8\">Habitat/behavioral traits include vertical and horizontal habitat (categorical), depth and temperature range (numeric), aggregation, diel vertical migration, seasonal migration, and refuge use behaviors (binary; Fig. ##FIG##1##2##, Table ##TAB##0##1##). These traits were collected separately for adult, juvenile, and larval lifestages, and qualitative trait confidence level was noted based on the amount of available sources. If limited information was available for the species, adult traits were applied to the juveniles (but not larvae), unless specific information was found indicating a different value and it was reasonable that both lifestages likely occupy the same habitats<sup>##UREF##0##3##</sup>. Vertical and horizontal habitat use traits were directly recorded from online repositories and corroborated with species distribution maps and reported depth ranges from the primary literature when possible<sup>##UREF##0##3##</sup>. Where published literature expanded on, or differed from a general value reported by repositories, we used values from the published literature and data. For some traits, ordinal and binary versions were also included to facilitate future analyses.</p>", "<title>Morphological traits and morphometric ratios</title>", "<p id=\"Par9\">Morphological traits include lifestage-specific length range, body shape, and the presence and nature of defensive spines, exoskeleton, transparency, disruptive coloration patterns, silvering, countershading, and photophores (Fig. ##FIG##2##3##, Table ##TAB##0##1##). Morphometric ratios (relationships between body dimensions) are also included with the morphological traits to describe different aspects of body shape using continuous, numerical data, and were part of a separate data collection effort, which is detailed below. Morphometric ratios were only collected for adults and juveniles. Ratios were also used to convert different length types to total length, thus larvae lengths were unable to be converted to total length in some cases.</p>", "<p id=\"Par10\">For each species and lifestage we quantified the relative total length (TL), standard length (SL), total height (TH), body height (BH), eye diameter, and dorsal fin height (Table ##TAB##1##2##). Measurements were taken from ~6 replicate images (range: 1–10) that were selected from the image search results based on a set of criteria to ensure accurate relative measurements. The criteria includes that images show the following: i) the correct species and lifestage, ii) the organism perpendicular to the frame of reference and not angled toward/away from the camera, iii) all dimensions measurable from the same image (lateral view for most organisms, dorsal view for flatfish, rays, crabs), and iv) soft-bodied organisms (e.g., cephalopods) with arms extended. When photographs or drawings from literature sources were not found we used the best available images. For some rare species and juvenile lifestages, the selection of images to choose from was limited and we were not able to adhere to all the criteria. Measurements based on any images that do not meet all the measurement criteria are noted. While morphometric ratios were lifestage-specific, we acknowledge that there is likely some variation within a lifestage that we are not capturing based on sample sizes and images available.</p>", "<p id=\"Par11\">Relative measurements for each image were collected in pixels, using ImageJ<sup>##REF##22930834##26##</sup> and measurements for each dimension were based on definitions from the literature (Table ##TAB##1##2##). SL is also used to describe the standardized length measurements for non-fish taxa (e.g. mantle length, shell length, carapace width). Morphometric ratios were calculated for each image as TL:SL, TL:TH, SL:TH, TL:BH, SL:BH, and eye diameter:TL. Fins can be folded or destroyed when individuals are removed from the water and/or preserved, thus fins were not always visible. In these instances, TH (includes dorsal and anal fins) or TL (includes caudal fin) could not be measured. Similarly, TL could not be measured if the arms (for cephalopod) or urosome (for crustaceans) were folded or not visible. Mean ratios were then calculated for each species and lifestage (n = 2–10), except in instances where only a single image was available. If species-specific morphometric ratios were not available, a proxy for the next available level of taxonomic identification (e.g genus, family) was used for the lifestage. Trait source information and notes on data collection are reported<sup>##UREF##6##13##</sup> (Fig. ##FIG##5##6##, Table ##SUPPL##0##S1##).</p>", "<title>Nutritional quality traits</title>", "<p id=\"Par12\">For each species, we quantified lipid content (% wet weight, ww), protein content (% ww), and energy density (kJ/g ww) through a meta-analysis of published literature (Fig. ##FIG##3##4##). Keyword search terms include the scientific name, each nutritional quality metric (or synonym), and optional location keywords. To expand the search, we excluded quotations on some search terms to allow the search engine to also return results with synonyms (e.g., <italic>percent</italic> includes results for <italic>proportion</italic>). We also include data from laboratory analyses of energy density by bomb calorimetry and lipid and protein percentages by proximate composition for specimens collected in the CCS (see ‘Nutrional quality laboratory analyses’). Search results were evaluated for relevance using the title, abstract, keyword searches within the publication, and/or by visually scanning the paper. Lipid, protein, and energy density information were recorded to the highest level of detail reported in the publication, using individual values instead of mean values when possible. We recorded lipid and protein content in percent weight, and energy density in kJ/g, converting units as necessary. Research articles predominantly reported nutritional quality content as a proportion of ww, however dry weight (dw) and ash-free dry weight (afdw) data are also included in the literature. We standardized nutritional quality metrics as ww, converting dw and afdw as follows:</p>", "<p id=\"Par13\">Conversions use water (or moisture) content (%) and/or ash content (% dw) associated with the nutritional quality data reported in the paper. If these values were not reported with the dw or afdw values, the nutritional quality data was reported, but percentage ww could not be calculated. However, a water content proxy from the same species in the same region was used in a few invertebrates with consistently high water content (e.g., pyrosomes) or if a proxy has been used in the literature (e.g., krill).</p>", "<p id=\"Par14\">In addition to nutritional quality information, we also reported covariates associated with each data point, when available. Covariates included sample size, moisture content, ash content, lifestage, age, sex, weight (ww mean, minimum, maximum), length (mean, minimum, maximum), temporal variables (sampling start/end year, month, day), and geographic location (latitude, longitude, ocean basin, descriptive location). Mean weight and length were estimated from the minimum and maximum values if not directly reported. Additionally, some location covariates were estimated if not reported (e.g., coordinates estimated from descriptive location), and details were noted. We standardized location information using Longhurst provinces, assigned by intersecting coordinates with Longhurst province polygons in R software<sup>##UREF##17##27##</sup> (Version 3.6.0), or manually if only a general location was reported.</p>", "<p id=\"Par15\">Mean nutritional quality metrics were calculated for each species using data (standardized to % ww) from 1) all global regions and 2) only values from the Pacific Ocean<sup>##UREF##6##13##</sup> (Fig. ##FIG##5##6##, Table ##SUPPL##0##S1##). We also include disaggregated, individual nutritional quality data in the dataset. Due to limited information about lifestage or age included in the literature, nutritional quality values from adults and juveniles are combined in mean values<sup>##UREF##6##13##</sup> (Figs. ##FIG##3##4##, ##FIG##5##6##). Nutritional quality data was not collected for larvae, thus mean nutritional quality values were only applied to adults and juveniles.</p>", "<title>Nutritional quality laboratory analyses</title>", "<title>Sample collection</title>", "<p id=\"Par16\">Specimens were primarily collected during annual surveys performed by NOAA in the CCS. This includes the SWFSC-FRD California Current Ecosystem Survey from July - October 2021<sup>##UREF##10##17##</sup>, NWFSC Juvenile Salmon Ocean and Ecosystem Survey (JSOES) in May and June of 2016–2022<sup>##UREF##18##28##,##UREF##19##29##</sup>, NWFSC-FED Coastwide Cooperative Pre-Recruit Survey in May of 2016–2022<sup>##UREF##12##19##</sup>, NWFSC Newport Hydrographic Line (NHL) biweekly sampling from 2021–2022<sup>##UREF##20##30##</sup>, NWFSC Salmon Ocean Behavior and Distribution (SoBad) purse seine sampling effort in April of 2021<sup>##UREF##21##31##</sup>, NWFSC Fisheries Resource Analysis and Monitoring division (FRAM) sampling in June of 2022<sup>##UREF##22##32##</sup>, and NWFSC Cooperative research program quarterly survey collections from 2019–2022<sup>##UREF##23##33##</sup>. Additional specimens were collected during educational cruises associated with the Scripps Institution of Oceanography’s graduate courses (SIO295L Marine Biodiversity and Conservation, SIO277 Deep Sea Biology) in the summer of 2021 and 2022, and winter of 2022. Specimens were frozen and stored at −20 °C or colder until analysis.</p>", "<title>Sample processing</title>", "<p id=\"Par17\">Specimens were thawed, measured (standard, fork, or total length for fishes, mantle length for cephalopods, total length for crustaceans and other invertebrates; to the nearest mm), and weighted (nearest 0.01 or 0.00001 g for small samples). Sex and maturity were assigned based on visual inspection of the reproductive organs. To prepare samples for nutritional analysis, the whole individuals were either oven or freeze dried. In some instances, individuals were grouped across similar sizes, locations, and dates, and treated as a single sample to have sufficient dry material for analyses (n = 2–100’s for mesozooplankton and juvenile stages of crustaceans, 2–8 for juvenile fishes and cephalopods). For oven drying, samples were placed into a desiccating oven at approximately 60 °C for 2–3 days, until a consistent dry weight was achieved. For freeze drying, weighed samples were refrozen at −80 °C and placed in a benchtop freeze-dryer (FreeZone 2.5 L, Labconco, USA) for 3–7 days, until a consistent dry weight was achieved. Dry weights were recorded and moisture content was calculated for each sample.</p>", "<p id=\"Par18\">Whole, dried samples were homogenized using either a mortar and pestle, coffee grinder, or tube mill (Tube mill 100 control, IKA, Germany; 25000 rpm for 30 second intervals), until a homogenous powder with consistent particle size was achieved. Dried tissues were stored in air-tight containers inside a desiccator for up to three weeks before being further processed or moved to long-term storage at −80 °C.</p>", "<title>Energy density analysis using bomb calorimetry</title>", "<p id=\"Par19\">Dried, homogenized samples were pressed into pellets (10–772 mg) using a Parr pellet press with a 3.75–10 mm die. The pressure applied to form each pellet was adjusted to prevent expressing oils out of the sample. The die and press were examined for expressed oil and cleaned with 95% ethanol between each sample. For some species with very high oil content (e.g., myctophids), pellets were hand-rolled to minimize oil loss. Specimens that when dried and pulverized formed a pellet of less than 0.02 g, were combined with benzoic powder and then pelletized for combustion with the energy of the added benzoic powder removed during the final calculation<sup>##UREF##24##34##</sup>.</p>", "<p id=\"Par20\">Energy density was calculated by combusting pellets in a semi-micro calorimeter (6725, Parr Instruments, United States) with a water trap or an isoperibol calorimeter (C6000, IKA, Germany) without a water trap at either 22 °C or 25 °C. Both types of calorimeters used two decomposition vessels that were calibrated separately for each reaction temperature. Calibrations were checked at the beginning of each day by running 2–4 combustions of benzoic acid standard. Two replicates of each specimen were run then averaged together. When replicates differed by &gt;8%, we ran a third replicate. To optimize consistency and accuracy of energy density measurements, benzoic acid standards tests were performed every 10–15 runs using a 200–1000 mg of benzoic acid.</p>", "<title>Lipid and protein analysis using proximate composition</title>", "<p id=\"Par21\">Total lipid and protein content was analyzed on a subset of specimens examined for energy density using the remaining dried, homogenized sample. Percent protein, lipid, dry matter and ash were determined in accordance with the standard methods of the Association of Official Analytical Chemists<sup>##UREF##25##35##</sup>. Carbohydrate percentage was not calculated, as it is negligible in these species. Total lipid content was determined by gravimetric analysis on 0.5 g of dry material using the Folch method with extraction using hexane (1 mL per sample). Nitrogen content was measured on a Leco C/N Analyzer using samples of 5–7 mg dry material and EDTA (Ethylenediaminetetraacetic acid) standards. A conversion factor of 6.25 was used to calculate crude protein from nitrogen content. Residual moisture content was measured following lipid extraction by heating lipid free tissue in an oven at 40 °C overnight. Ash content was determined by placing the dry tissue in a 120 °C furnace overnight. Replicate samples run for energy density (above) indicated adequate homogenization of all samples, thus replicates were unnecessary for lipid and protein analysis.</p>", "<title>Population status</title>", "<p id=\"Par22\">Population status traits include trophic level, fisheries and conservation status (Fig. ##FIG##4##5##, Table ##TAB##0##1##). The trophic level is an estimate collected from FishBase and SealifeBase calculated by Ecopath software using the trophic levels of a predator’s known prey<sup>##UREF##26##36##,##REF##9452385##37##</sup>. Trophic level is only available for adult lifestages of all fish species and some marine invertebrates. The fishery status was primarily collected from FishBase/SealifeBase, as well as online keyword searches for the species scientific or common name and the term “‘commercial”, “recreational” or “fishery”. The conservation status is collected from the IUCN Red List of Threatened Species (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.iucnredlist.org\">www.iucnredlist.org</ext-link>) for adults only.</p>" ]
[]
[]
[]
[ "<p id=\"Par1\">Trait-based frameworks are increasingly used for predicting how ecological communities respond to ongoing global change. As species range shifts result in novel encounters between predators and prey, identifying prey ‘guilds’, based on a suite of shared traits, can distill complex species interactions, and aid in predicting food web dynamics. To support advances in trait-based research in open-ocean systems, we present the Pelagic Species Trait Database, an extensive resource documenting functional traits of 529 pelagic fish and invertebrate species in a single, open-source repository. We synthesized literature sources and online resources, conducted morphometric analysis of species images, as well as laboratory analyses of trawl-captured specimens to collate traits describing 1) habitat use and behavior, 2) morphology, 3) nutritional quality, and 4) population status information. Species in the dataset primarily inhabit the California Current system and broader NE Pacific Ocean, but also includes pelagic species known to be consumed by top ocean predators from other ocean basins. The aim of this dataset is to enhance the use of trait-based approaches in marine ecosystems and for predator populations worldwide.</p>", "<title>Subject terms</title>" ]
[ "<title>Data Records</title>", "<p id=\"Par23\">The Pelagic Species Trait Database<sup>##UREF##6##13##</sup> is publicly available on <italic>Borealis</italic>, an open-source repository in the Dataverse consortium maintained by a network of Canadian research universities, accessible by 10.5683/SP3/0YFJED. The dataset has three main components: 1) overview, 2) trait data, and 3) data collection files (Fig. ##FIG##5##6##, Table ##SUPPL##0##S1##). The overview files include a README pdf, R code, BibTeX reference file, and summary tables with key trait variables (Table ##TAB##0##1##) for quick user access, and a species list with known geographic source information. Trait data modules include subfolders for each category of trait variables (habitat/behavior, morphology, nutritional quality, population status) with detailed references, expanded versions of variables (e.g., categorical, binary, ordinal), and data collection notes. Additionally, the trait categories ‘morphological’ and ‘nutritional quality’ each include a table with disaggregated data used to calculate mean morphometric ratios and nutritional quality values. The mean values calculated from these individual observations are reported in the summary trait table for each category (Table ##SUPPL##0##S1##), and overview table (Table ##TAB##0##1##). Finally, the data collection information includes pdf files of protocols and raw data collection tables to support future collaborations to expand this dataset to other species and study systems.</p>", "<p id=\"Par24\">Dataset files can be downloaded individually, or all together in a.zip folder with the structure described above (Fig. ##FIG##5##6##). Table ##SUPPL##0##S1## further details folders, filenames, and file descriptions. Tables are available for download in .csv or .tab format, and metadata tables are included with each detailing column descriptions, data types, and values. Tables have species, associated taxonomic classifications (e.g., Class, Order, Family, Genus) and lifestages as rows and their corresponding traits as columns. Missing information was labeled with ‘NA’, to identify gaps in the dataset. Some species were not included in data collection for all trait categories, these instances of traits not searched were labeled with ‘−9999’.</p>", "<title>Technical Validation</title>", "<p id=\"Par25\">We used tiered steps during the data collection, processing, and sharing phases of dataset creation to validate data and ensure accuracy. First, all individuals performing data collection were trained through mentorship with a data collection supervisor. In total only 4–6 individuals performed data collection for traits, supervised by S.J.G, N.H., then M.R.G. over the creation of the dataset. This data collection team manually curated trait variables to ensure record accuracy performed through cross-checks between data collectors and often multiple data sources, with all references provided in the dataset. This collaborative process also included comparing interpretations of values found and assessing evidence in distilling ecological information to categorical and binary data types. If discrepancies were found, additional research was done or if information was indecisive an NA was assigned, with notes detailing the conflicting sources. This effort was version controlled through collaborative Google Sheets. The dataset files, including training materials such as protocols and tables for trait data collection, were compiled and reviewed by all data collectors and supervisors. These materials enable streamlined training of individuals to augment the dataset or fill in data gaps in the future.</p>", "<p id=\"Par26\">Second, data processing involved outlier detection, cleaning of values, and comparisons of related traits. All numerical trait variables (e.g., nutritional values, morphometric ratios, depth, temp, etc.) were checked for outliers with frequency histograms. Values greater than two standard deviations from the mean were flagged and manually checked for validity against the original source to confirm they were correctly entered, and either retained, corrected or purged, as necessary. Morphometric ratio outlier values were re-measured on the original image, and values corrected, unless image issues were detected and data flagged as unusable. Categorical variables were cleaned during data processing to detect erroneous values and some variables checked by comparing relationships between related traits (e.g., body shape and morphometric ratios, vertical habitat and depth). All data processing steps were done in R software<sup>##UREF##17##27##</sup> (Version 3.6.0), and version controlled through GitHub.</p>", "<p id=\"Par27\">Finally, we provide an opportunity for dataset users to provide feedback through a guestbook feature. Our aim is to encourage engagement from users on maintaining the quality of this open-source dataset, thus we welcome any reporting of data errors, or suggestions on the dataset structure. We will incorporate these edits in updated versions of the dataset.</p>", "<title>Usage Notes</title>", "<p id=\"Par28\">The Pelagic Species Trait Database is open source<sup>##UREF##6##13##</sup> and publicly available on <italic>Borealis</italic>. The dataset is released under a CC-BY license permitting reuse with citation of this data descriptor, the dataset and any original sources, when possible. Users are requested to provide contact information prior to downloading to ensure updated versions are distributed to the user community, as well as enable solicitation of feedback from the community on the dataset design for user accessibility.</p>", "<p id=\"Par29\">The dataset uses species names and phylogenetic information based on the World Register of Marine Species (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.marinespecies.org\">www.marinespecies.org</ext-link>), thus users should confirm species names before querying the dataset for an accurate name match. Many traits were obtained from resources or literature indicating generalized characteristics of species and/or lifestages. We acknowledge that many traits are variable with environmental conditions, however this is not represented by the static trait variables. Users should reference the metadata files associated with data and data collection tables for descriptions of variables and collection information.</p>", "<p id=\"Par30\">The R-script file provided with the dataset on <italic>Borealis</italic> details data manipulation, standardization, and calculations from initial data collections for the output files. This dataset is a static release, however as an evolving data product, successive versions may be released containing updates and corrections. Version 2 is used in this descriptor<sup>##UREF##6##13##</sup>; updated versions will be available on <italic>Borealis</italic>, accessed by 10.5683/SP3/0YFJED. Contact M.R.G. or S.J.G. for the status of dataset versions.</p>", "<title>Supplementary information</title>", "<p>\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s41597-023-02689-9.</p>", "<title>Acknowledgements</title>", "<p>We are grateful to the Lenfest Ocean Program of the Pew Charitable Trust (Grant #00032174), for funding and regular support. We especially thank James Doiran and John Huck from the University of Alberta Library for their technical assistance in publishing the dataset on <italic>Borealis</italic>. We thank Catherine Nickels for initial feedback on the dataset. Additional funding from a Marine Environmental Observation Prediction and Response Network Postdoctoral Fellowship supported NAH, a Sloan Research Fellowship in Ocean Sciences, Canada Research Chair, and NSERC Discovery Grant supported SJG. Nutritional quality data collection performed by EAD was funded by the Bonneville Power Administration (#1998-014-00), with samples also collected onboard cruises funded by NOAA Fisheries and the Cooperative Research Program. Traits data collection performed and supervised by CAC and EJP was made possible by samples collected aboard cruises funded by the UC Ship Funds Program, awarded to CAC, and to the Master of Advanced Studies program in Marine Biodiversity and Conservation at the University of California San Diego, as well as US National Science Foundation awards to CAC (Award #1829812) and EJP (Postdoctoral Research Fellowship in Biology Award #2011031).</p>", "<title>Author contributions</title>", "<p>M.R.G., N.H., Z.R., C.J.M., A.K.M., Z.T., I.G., E.J.P. and C.M. collected the trait data. E.A.D., E.J.P. and A.K.M. conducted laboratory analyses for nutritional quality. M.R.G., N.H., E.J.P., C.A.C. and S.J.G. managed the data collection. M.R.G. cleaned and processed the trait data. M.R.G., N.H., Z.R., C.J.M., I.G., C.B., E.J.P., C.A.C. and S.J.G. developed data collection protocols. M.R.G. developed the R code. M.R.G. wrote and compiled the dataset for <italic>Borealis</italic>. M.R.G. prepared the manuscript with contributions from N.H., E.A.D., E.J.P., C.A.C. and S.J.G. All authors approved the final version for submission. S.J.G. and L.B.C. acquired funding, designed and supervised the project.</p>", "<title>Code availability</title>", "<p>The R code used to process trait data is included with the Pelagic Species Trait Database files on <italic>Borealis</italic><sup>##UREF##6##13##</sup>. Raw data inputs for the code are the data collection tables, with all other tables containing the processed, output data. Users are recommended to download the entire dataset, as the file structure is integrated into the code for data inputs.</p>", "<title>Competing interests</title>", "<p id=\"Par31\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>Venn diagram showing overlap in species among the datasets used to identify taxa for inclusion in the Pelagic Species Trait Database. NE Pacific trawl surveys = species observed in 15 years of annual National Oceanic and Atmospheric Administration (NOAA) midwater trawl summer surveys throughout the California Current System (CCS; 2005–2019), recent survey efforts by Fisheries and Oceans Canada (2017–2019) and the North Pacific Anadromous Fish Commission (2020). Global albacore diet analyses = species consumed globally by albacore tuna (<italic>Thunnus alalunga</italic>)<sup>##UREF##0##3##</sup>, including species consumed by albacore tuna in the CCS (2005–2019)<sup>##UREF##14##21##–##UREF##15##23##</sup>. Sample size for each species source is listed in parentheses.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>Phylogenetic distribution of habitat and behavioral trait data in the Pelagic Species Trait Database. Individual trait values are shown for adults of each species, although juvenile and limited larval information are also available in the dataset. White = species searched and no data found (NA), grey = species not searched in this dataset version (−9999). Traits are static for the species and lifestage.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p>Phylogenetic distribution of morphological trait data in the Pelagic Species Trait Database. Individual trait values are shown for adults of each species, although juvenile information is also available in the dataset. White = species searched and no data found (NA), grey = species not searched in this dataset version (−9999). Length:Height ratios are mean values from multiple observations in the dataset, all other traits are static for the species and lifestage.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p>Phylogenetic distribution of nutritional quality trait data in the Pelagic Species Trait Database. Energy density, protein and lipid content are mean values from multiple observations in the dataset, integrating both adults and juvenile information. White = species searched and no data found (NA), grey = species not searched in this dataset version (−9999). %ww = percent wet weight.</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><p>Phylogenetic distribution of population status trait data in the Pelagic Species Trait Database. Individual trait values are shown for adults of each species. White = species searched and no data found (NA), grey = species not searched in this dataset version (−9999).</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><p>Overview of the design of the Pelagic Species Trait Database. Tables in .csv or .tab format are numbered according to the dataset file structure. Italics indicate .pdf file format, the R code is a .Rmd file, and references are included as a BibTeX file. Open rectangles indicate folders and shaded rectangles are subfolders in the file structure. Each Table (1–11) has an associated metadata table.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Overview of key traits included in the Pelagic Species Trait Database. Binary values are 1 = yes/present, 0 = no/absent; categorical values are listed in the description. Method lists the data collection search method used for each trait (L = primary literature, D = existing database, O = other online resource, I = image &amp; measurements).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Trait category</th><th>Variable name</th><th>Variable description</th><th>Unit</th><th>Method</th></tr></thead><tbody><tr><td rowspan=\"6\">Habitat</td><td>depth_min</td><td>Minimum depth limit recorded for this species.</td><td>meters</td><td>L,D,O</td></tr><tr><td>depth_max</td><td>Maximum depth limit recorded for this species.</td><td>meters</td><td>L,D,O</td></tr><tr><td>temp_min</td><td>Minimum temperature limit recorded for this species</td><td>degrees celsius</td><td>L,D,O</td></tr><tr><td>temp_max</td><td>Maximum temperature limit recorded for this species</td><td>degrees celsius</td><td>L,D,O</td></tr><tr><td>vert_habitat</td><td>Primary vertical habitat association (benthic, demersal, epipelagic, mesopelagic, bathypelagic)</td><td>categorical</td><td>L,D,O</td></tr><tr><td>horz_habitat</td><td>Primary horizontal habitat association (intertidal, reef-associated, coastal, continental shelf, continental slope, oceanic, freshwater)</td><td>categorical</td><td>L,D,O</td></tr><tr><td rowspan=\"4\">Behavior</td><td>diel_migrant</td><td>Diel/diurnal vertical migration behavior.</td><td>binary</td><td>L,D,O</td></tr><tr><td>refuge</td><td>Use of physical refuge</td><td>binary</td><td>L,D,O</td></tr><tr><td>season_migrant</td><td>Seasonal migration behavior</td><td>binary</td><td>L,D,O</td></tr><tr><td>gregarious</td><td>Primary aggregation trait (solitary, shoaling, schooling)</td><td>categorical</td><td>L,D,O</td></tr><tr><td rowspan=\"16\">Morphology</td><td>body_shape</td><td>Body shape (eel-like, elongated, fusiform, globiform, compressiform, depressiform)</td><td>categorical</td><td>I</td></tr><tr><td>l_min</td><td>Minimum length for the specific lifestage</td><td>centimeters</td><td>L,D,O</td></tr><tr><td>l_max</td><td>Maximum length for the specific lifestage</td><td>centimeters</td><td>L,D,O</td></tr><tr><td>defense_spines</td><td>Defensive spines present</td><td>binary</td><td>L,D,O,I</td></tr><tr><td>exoskeleton</td><td>Presence of exoskeleton, carapace or armouring</td><td>binary</td><td>L,D,O,I</td></tr><tr><td>transparent</td><td>Transparency present</td><td>binary</td><td>L,D,O,I</td></tr><tr><td>col_disrupt</td><td>Disruptive colouration present</td><td>binary</td><td>L,D,O,I</td></tr><tr><td>silver</td><td>Silvering present</td><td>binary</td><td>L,D,O,I</td></tr><tr><td>countershade</td><td>Countershading present</td><td>binary</td><td>L,D,O,I</td></tr><tr><td>photophore</td><td>Photophores present</td><td>binary</td><td>L,D,O,I</td></tr><tr><td>TL_BH</td><td>Total length:body height morphometric ratio</td><td>ratio</td><td>I</td></tr><tr><td>SL_BH</td><td>Standard length:body height morphometric ratio</td><td>ratio</td><td>I</td></tr><tr><td>TL_TH</td><td>Total length:total height morphometric ratio</td><td>ratio</td><td>I</td></tr><tr><td>SL_TH</td><td>Standard length:total height morphometric ratio</td><td>ratio</td><td>I</td></tr><tr><td>SL_TL</td><td>Standard length:total length morphometric ratio</td><td>ratio</td><td>I</td></tr><tr><td>eye_TL</td><td>Eye diameter:total length morphometric ratio</td><td>ratio</td><td>I</td></tr><tr><td rowspan=\"3\">Nutritional quality</td><td>lipid</td><td>Lipid content in wet weight</td><td>percent</td><td>L</td></tr><tr><td>protein</td><td>Protein content in wet weight</td><td>percent</td><td>L</td></tr><tr><td>energy</td><td>Energy density in wet weight</td><td>kJ/g</td><td>L</td></tr><tr><td rowspan=\"4\">Population status</td><td>trophic_level</td><td>Trophic Level (0–5); rfishbase covariate.</td><td>trophic level</td><td>D</td></tr><tr><td>IUCN_status</td><td>IUCN Redlist status.</td><td>categorical</td><td>D</td></tr><tr><td>commercial</td><td>Does the species have commercial value?</td><td>binary</td><td>D,O</td></tr><tr><td>recreational</td><td>Does the species have recreational value?</td><td>binary</td><td>D,O</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Descriptions of length type measurements collected for different taxa in the dataset. The measurement guide included with the ‘data collection’ materials in the dataset further details these measurements.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Dataset measurement</th><th>Taxa</th><th>Measurement</th><th>Definition</th></tr></thead><tbody><tr><td rowspan=\"6\">Total length (TL)</td><td>fish</td><td>total length</td><td>Tip of the snout (or end of the longest jaw) to the end of the longest caudal lobe<sup>##UREF##27##38##</sup></td></tr><tr><td>cephalopod</td><td>total length</td><td>Tip of the tail (posterior end of mantle) to the end of longest arm; excludes the feeding tentacles which can retract<sup>##UREF##28##39##</sup></td></tr><tr><td>crabs</td><td>total length</td><td>Tip of longest pereopod on one side of body to tip of pereopod on other side of body</td></tr><tr><td>other crustaceans</td><td>total length</td><td>Rostral margin (e.g., base of the antennae/setae) to the posterior margin of the telson excluding setae<sup>##UREF##29##40##,##UREF##30##41##</sup></td></tr><tr><td>gastropod</td><td>total length</td><td>Tip of the shell to the end of the body extended out of the shell</td></tr><tr><td>other invertebrates</td><td>total length</td><td>Longest dimension (TL = SL)</td></tr><tr><td rowspan=\"7\">Standard length (SL)</td><td>fish</td><td>standard length</td><td>Tip of the snout (or end of the longest jaw) along the lateral line to the base of the caudal fin (posterior limit of the hypural plate)<sup>##UREF##27##38##,##UREF##31##42##</sup>, where a groove forms</td></tr><tr><td>cephalopod</td><td>mantle length</td><td>Tip of the tail (posterior end of mantle) to anterior most point of mantle<sup>##UREF##28##39##</sup></td></tr><tr><td>octopus</td><td>mantle length</td><td>Posterior tip of the mantle to the midpoint between eyes<sup>##UREF##28##39##</sup></td></tr><tr><td>crabs</td><td>carapace width</td><td>Distance between lateral spines of the carapace, at the widest point</td></tr><tr><td>other crustaceans</td><td>standard length</td><td>Rostral margin to the base of the telson (posterior edge of 6th abdominal segment)<sup>##UREF##29##40##,##UREF##32##43##</sup></td></tr><tr><td>gastropod</td><td>shell length</td><td>Lateral distance from anterior to posterior on the shell (e.g., longest dimension)<sup>##UREF##33##44##</sup></td></tr><tr><td>other invertebrates</td><td>standard length</td><td>Longest dimension (TL = SL)</td></tr><tr><td rowspan=\"6\">Total height (TH)</td><td>fish</td><td>total height</td><td>Tip of dorsal fin to tip of pelvic fin (or widest dimension to tips of fins), with fins fully extended (body height + fin lengths)</td></tr><tr><td>cephalopod</td><td>total width</td><td>With fins (e.g., squid): diameter of mantle and fins combined, at the widest point; tip to tip of stabilizing fins. No fins (e.g., octopus): TH = BH</td></tr><tr><td>crabs</td><td>total width</td><td>In dorsal view, anterior side of the folded claws to the posterior end of the carapace (carapace length plus folded claws)</td></tr><tr><td>other crustaceans</td><td>total height</td><td>In lateral view, distance from dorsal-most margin to ventral-most margin at the widest point, including limbs</td></tr><tr><td>gastropod</td><td>shell width</td><td>Shell width at widest point, including body out of shell (shell + appendages)</td></tr><tr><td>other invertebrates</td><td>total height</td><td>Second longest dimension (TH = BH)</td></tr><tr><td rowspan=\"6\">Body height (BH)</td><td>fish</td><td>body height</td><td>Base of the dorsal fin to base of pelvic fin; deepest part of the fish</td></tr><tr><td>cephalopod</td><td>mantle width</td><td>Diameter of the mantle at the widest point (not including fins)</td></tr><tr><td>crabs</td><td>carapace length</td><td>In dorsal view, distance from anterior to posterior ends of the carapace</td></tr><tr><td>other crustaceans</td><td>carapace width</td><td>In lateral view, distance from dorsal side of the carapace to the base of the limbs</td></tr><tr><td>gastropod</td><td>shell width</td><td>Shell width at widest point</td></tr><tr><td>other invertebrates</td><td>body height</td><td>Second longest dimension (TH = BH)</td></tr><tr><td rowspan=\"2\">Fin height (FH)</td><td>fish</td><td>fin height</td><td>Dorsal fin, from base to tip</td></tr><tr><td>cephalopod</td><td>fin height</td><td>Stabilizing fin, from base to tip on one side</td></tr><tr><td>Eye diameter</td><td>all</td><td>eye diameter</td><td>Diameter of the eye, excluding tissue that contains the eye</td></tr></tbody></table></table-wrap>" ]
[ "<disp-formula id=\"Equa\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{array}{c}{\\rm{ \\% }}\\,{\\rm{w}}{\\rm{w}}=({\\rm{ \\% }}\\,{\\rm{d}}{\\rm{w}}\\,/\\,100)\\ast (100-{\\rm{ \\% }}\\,{\\rm{w}}{\\rm{a}}{\\rm{t}}{\\rm{e}}{\\rm{r}})\\\\ {\\rm{ \\% }}\\,{\\rm{w}}{\\rm{w}}=((({\\rm{ \\% }}\\,{\\rm{a}}{\\rm{f}}{\\rm{d}}{\\rm{w}}\\,/\\,100)\\ast (100-{\\rm{ \\% }}\\,{\\rm{a}}{\\rm{s}}{\\rm{h}}\\,{\\rm{d}}{\\rm{w}}))\\,/\\,100)\\ast (100-{\\rm{ \\% }}\\,{\\rm{w}}{\\rm{a}}{\\rm{t}}{\\rm{e}}{\\rm{r}})\\end{array}$$\\end{document}</tex-math><mml:math id=\"M2\" display=\"block\"><mml:mtable columnalign=\"left\" columnspacing=\"1em\" rowspacing=\"4pt\"><mml:mtr><mml:mtd><mml:mi mathvariant=\"normal\">%</mml:mi><mml:mspace width=\"thinmathspace\"/><mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">w</mml:mi><mml:mi mathvariant=\"normal\">w</mml:mi></mml:mrow></mml:mrow><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mi mathvariant=\"normal\">%</mml:mi><mml:mspace width=\"thinmathspace\"/><mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">d</mml:mi><mml:mi mathvariant=\"normal\">w</mml:mi></mml:mrow></mml:mrow><mml:mspace width=\"thinmathspace\"/><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mspace width=\"thinmathspace\"/><mml:mrow><mml:mrow><mml:mn>100</mml:mn></mml:mrow></mml:mrow><mml:mo>)</mml:mo><mml:mo>∗</mml:mo><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mn>100</mml:mn></mml:mrow></mml:mrow><mml:mo>−</mml:mo><mml:mi mathvariant=\"normal\">%</mml:mi><mml:mspace width=\"thinmathspace\"/><mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">w</mml:mi><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mi mathvariant=\"normal\">t</mml:mi><mml:mi mathvariant=\"normal\">e</mml:mi><mml:mi mathvariant=\"normal\">r</mml:mi></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mi mathvariant=\"normal\">%</mml:mi><mml:mspace width=\"thinmathspace\"/><mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">w</mml:mi><mml:mi mathvariant=\"normal\">w</mml:mi></mml:mrow></mml:mrow><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mo>(</mml:mo><mml:mo>(</mml:mo><mml:mi mathvariant=\"normal\">%</mml:mi><mml:mspace width=\"thinmathspace\"/><mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mi mathvariant=\"normal\">f</mml:mi><mml:mi mathvariant=\"normal\">d</mml:mi><mml:mi mathvariant=\"normal\">w</mml:mi></mml:mrow></mml:mrow><mml:mspace width=\"thinmathspace\"/><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mspace width=\"thinmathspace\"/><mml:mrow><mml:mrow><mml:mn>100</mml:mn></mml:mrow></mml:mrow><mml:mo>)</mml:mo><mml:mo>∗</mml:mo><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mn>100</mml:mn></mml:mrow></mml:mrow><mml:mo>−</mml:mo><mml:mi mathvariant=\"normal\">%</mml:mi><mml:mspace width=\"thinmathspace\"/><mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mi mathvariant=\"normal\">s</mml:mi><mml:mi mathvariant=\"normal\">h</mml:mi></mml:mrow></mml:mrow><mml:mspace width=\"thickmathspace\"/><mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">d</mml:mi><mml:mi mathvariant=\"normal\">w</mml:mi></mml:mrow></mml:mrow><mml:mo>)</mml:mo><mml:mo>)</mml:mo><mml:mspace width=\"thinmathspace\"/><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mspace width=\"thinmathspace\"/><mml:mrow><mml:mrow><mml:mn>100</mml:mn></mml:mrow></mml:mrow><mml:mo>)</mml:mo><mml:mo>∗</mml:mo><mml:mo>(</mml:mo><mml:mn>100</mml:mn><mml:mo>−</mml:mo><mml:mi mathvariant=\"normal\">%</mml:mi><mml:mspace width=\"thinmathspace\"/><mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">w</mml:mi><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mi mathvariant=\"normal\">t</mml:mi><mml:mi mathvariant=\"normal\">e</mml:mi><mml:mi mathvariant=\"normal\">r</mml:mi></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41597_2023_2689_Fig1_HTML\" id=\"d32e413\"/>", "<graphic xlink:href=\"41597_2023_2689_Fig2_HTML\" id=\"d32e435\"/>", "<graphic xlink:href=\"41597_2023_2689_Fig3_HTML\" id=\"d32e442\"/>", "<graphic xlink:href=\"41597_2023_2689_Fig4_HTML\" id=\"d32e450\"/>", "<graphic xlink:href=\"41597_2023_2689_Fig5_HTML\" id=\"d32e457\"/>", "<graphic xlink:href=\"41597_2023_2689_Fig6_HTML\" id=\"d32e578\"/>", "<graphic xlink:href=\"41597_2023_2689_Article_Equa.gif\" position=\"anchor\"/>" ]
[ "<media xlink:href=\"41597_2023_2689_MOESM1_ESM.docx\"><caption><p>Table S1</p></caption></media>" ]
[{"label": ["3."], "mixed-citation": ["Hardy, N. A. "], "italic": ["et al", "Fish and Fisheries"]}, {"label": ["4."], "surname": ["Pyke", "Pulliam", "Charnov"], "given-names": ["GH", "HR", "EL"], "article-title": ["Optimal foraging: a selective review of theory and tests"], "source": ["Q. Rev. Biol."], "year": ["1977"], "volume": ["52"], "fpage": ["137"], "lpage": ["154"], "pub-id": ["10.1086/409852"]}, {"label": ["5."], "surname": ["Green"], "given-names": ["SJ"], "article-title": ["Trait-mediated foraging drives patterns of selective predation by native and invasive coral-reef fishes"], "source": ["Ecosphere"], "year": ["2019"], "volume": ["10"], "fpage": ["1"], "lpage": ["15"], "pub-id": ["10.1002/ecs2.2752"]}, {"label": ["7."], "surname": ["Poloczanska"], "given-names": ["ES"], "article-title": ["Responses of marine organisms to climate change across oceans"], "source": ["Front. Mar. Sci."], "year": ["2016"], "volume": ["3"], "fpage": ["1"], "lpage": ["21"], "pub-id": ["10.3389/fmars.2016.00062"]}, {"label": ["9."], "surname": ["Laigle"], "given-names": ["I"], "article-title": ["Species traits as drivers of food web structure"], "source": ["Oikos"], "year": ["2018"], "volume": ["127"], "fpage": ["316"], "lpage": ["326"], "pub-id": ["10.1111/oik.04712"]}, {"label": ["11."], "surname": ["Green", "Brookson", "Hardy", "Crowder"], "given-names": ["SJ", "CB", "NA", "LB"], "article-title": ["Trait-based approaches to global change ecology: moving from description to prediction"], "source": ["Proc. R. Soc. B Biol. Sci."], "year": ["2022"], "volume": ["289"], "fpage": ["20220071"], "pub-id": ["10.1098/rspb.2022.0071"]}, {"label": ["13."], "surname": ["Gleiber"], "given-names": ["MR"], "year": ["2022"], "data-title": ["Pelagic Species Trait Database"], "source": ["Borealis"], "pub-id": ["10.5683/SP3/0YFJED"]}, {"label": ["14."], "surname": ["Thorson"], "given-names": ["JT"], "article-title": ["Identifying direct and indirect associations among traits by merging phylogenetic comparative methods and structural equation models"], "source": ["Methods Ecol. Evol."], "year": ["2023"], "volume": ["14"], "fpage": ["1259"], "lpage": ["1275"], "pub-id": ["10.1111/2041-210X.14076"]}, {"label": ["15."], "surname": ["Sakuma"], "given-names": ["KM"], "article-title": ["Anomalous epipelagic micronekton assemblage patterns in the neritic water of the California Current spring 2015 during a period of extreme ocean conditions"], "source": ["CalCOFI Rep."], "year": ["2016"], "volume": ["57"], "fpage": ["163"], "lpage": ["183"]}, {"label": ["16."], "surname": ["Santora"], "given-names": ["JA"], "article-title": ["Pelagic biodiversity, ecosystem function, and services: an integrated observing and modeling approach"], "source": ["Oceanography"], "year": ["2021"], "volume": ["34"], "fpage": ["16"], "lpage": ["37"], "pub-id": ["10.5670/oceanog.2021.212"]}, {"label": ["17."], "surname": ["Zwolinski", "Stierhoff", "Demer"], "given-names": ["JP", "KL", "DA"], "article-title": ["Distribution, biomass, and demography of coastal pelagic fishes in the California current ecosystem during summer 2017 based on acoustic-trawl sampling"], "source": ["NOAA Tech. Memo. NMFS"], "year": ["2019"], "volume": ["610"], "fpage": ["1"], "lpage": ["74"]}, {"label": ["18."], "surname": ["Phillips", "Brodeur", "Suntsov"], "given-names": ["JA", "RD", "AV"], "article-title": ["Micronekton community structure in the epipelagic zone of the northern California Current upwelling system"], "source": ["Prog. Oceanogr."], "year": ["2009"], "volume": ["80"], "fpage": ["74"], "lpage": ["92"], "pub-id": ["10.1016/j.pocean.2008.12.001"]}, {"label": ["19."], "surname": ["Brodeur", "Auth", "Phillips"], "given-names": ["RD", "TD", "AJ"], "article-title": ["Major shifts in pelagic micronekton and macrozooplankton community structure in an upwelling ecosystem related to an unprecedented marine heatwave"], "source": ["Front. Mar. Sci."], "year": ["2019"], "volume": ["6"], "fpage": ["212"], "pub-id": ["10.3389/fmars.2019.00212"]}, {"label": ["20."], "surname": ["Glaser"], "given-names": ["SM"], "article-title": ["Interdecadal variability in predator-prey interactions of juvenile North Pacific albacore in the California Current System"], "source": ["Mar. Ecol. Prog. Ser."], "year": ["2010"], "volume": ["414"], "fpage": ["209"], "lpage": ["221"], "pub-id": ["10.3354/meps08723"]}, {"label": ["21."], "surname": ["Glaser", "Waechter", "Bransome"], "given-names": ["SM", "KE", "NC"], "article-title": ["Through the stomach of a predator: regional patterns of forage in the diet of albacore tuna in the California Current System and metrics needed for ecosystem-based management"], "source": ["J. Mar. Syst."], "year": ["2015"], "volume": ["146"], "fpage": ["38"], "lpage": ["49"], "pub-id": ["10.1016/j.jmarsys.2014.07.019"]}, {"label": ["23."], "mixed-citation": ["Nickels, C. F., Portner, E. J., Snodgrass, O. E., Muhling, B. A. & Dewar, H. Juvenile Albacore Tuna ("], "italic": ["Thunnus alalunga", "Fish. Oceanogr."], "bold": ["32"]}, {"label": ["24."], "surname": ["OpenTreeofLife"], "year": ["2019"], "data-title": ["Open Tree of Life Taxonomy"], "source": ["Zenodo"], "pub-id": ["10.5281/zenodo.3937751"]}, {"label": ["27."], "mixed-citation": ["R Core Team. R: A language and environment for statistical computing. (2022)."]}, {"label": ["28."], "mixed-citation": ["Daly, E. A., Brodeur, R. D., Morgan, C. A., Burke, B. J. & Huff, D. D. Prey Selectivity and Diet Partitioning of Juvenile Salmon in Coastal Waters in Relation to Prey Biomass and Implications for Salmon Early Marine Survival. "], "italic": ["North Pac. Anadromous Fish Comm. Tech. Rep"]}, {"label": ["29."], "surname": ["Daly", "Brodeur", "Auth"], "given-names": ["EA", "RD", "TD"], "article-title": ["Anomalous ocean conditions in 2015: impacts on spring Chinook salmon and their prey field"], "source": ["Mar. Ecol. Prog. Ser."], "year": ["2017"], "volume": ["566"], "fpage": ["169"], "lpage": ["182"], "pub-id": ["10.3354/meps12021"]}, {"label": ["30."], "surname": ["Dumelle"], "given-names": ["M"], "article-title": ["Capturing copepod dynamics in the Northern California Current using sentinel stations"], "source": ["Prog. Oceanogr."], "year": ["2021"], "volume": ["193"], "fpage": ["102550"], "pub-id": ["10.1016/j.pocean.2021.102550"]}, {"label": ["31."], "mixed-citation": ["Weitkamp, L. A., Bentley, P. J. & Litz, M. N. Seasonal and interannual variation in juvenile salmonids and associated fish assemblage in open waters of the lower Columbia River estuary. "], "italic": ["Fish Bulletin"], "bold": ["110"]}, {"label": ["32."], "mixed-citation": ["Keller, A. A., Wallace, J. R. & Methot, R. D. The Northwest Fisheries Science Center\u2019s West Coast Groundfish Bottom Trawl Survey: history, design, and description. "], "italic": ["NOAA Technical Memorandum NMFS"]}, {"label": ["33."], "surname": ["Auth", "Daly", "Brodeur", "Fisher"], "given-names": ["TD", "EA", "RD", "JL"], "article-title": ["Phenological and distributional shifts in ichthyoplankton associated with recent warming in the northeast Pacific Ocean"], "source": ["Glob. Change Biol."], "year": ["2018"], "volume": ["24"], "fpage": ["259"], "lpage": ["272"], "pub-id": ["10.1111/gcb.13872"]}, {"label": ["34."], "surname": ["Churney", "Armstrong"], "given-names": ["KL", "GT"], "article-title": ["Studies in Bomb Calorimetry. A New Determination of the Energy of Combustion of Benzoic Acid in Terms of Electrical Units"], "source": ["J. Res. Natl. Bur. Stand. Sect. Phys. Chem."], "year": ["1968"], "volume": ["72A"], "fpage": ["453"], "lpage": ["465"], "pub-id": ["10.6028/jres.072A.036"]}, {"label": ["35."], "mixed-citation": ["AOAC. "], "italic": ["Official Methods of Analysis of AOAC International"]}, {"label": ["36."], "surname": ["Pauly", "Christensen"], "given-names": ["D", "V"], "article-title": ["Primary production required to sustain global fisheries"], "source": ["Nature"], "year": ["1995"], "volume": ["374"], "fpage": ["255"], "lpage": ["257"], "pub-id": ["10.1038/374255a0"]}, {"label": ["38."], "surname": ["Kahn", "Pearson", "Dick"], "given-names": ["RG", "DE", "EJ"], "article-title": ["Comparison of standard length, fork length, and total length for measuring west coast marine fishes"], "source": ["Mar. Fish. Rev."], "year": ["2004"], "volume": ["66"], "fpage": ["31"], "lpage": ["33"]}, {"label": ["39."], "surname": ["Roper", "Voss"], "given-names": ["CF", "GL"], "article-title": ["Guidelines for taxonomic descriptions of cephalopod species"], "source": ["Biol. Resour. Potential Cephalop. Mem. Natl. Mus. Vic."], "year": ["1983"], "volume": ["44"], "fpage": ["48"], "lpage": ["63"], "pub-id": ["10.24199/j.mmv.1983.44.03"]}, {"label": ["40."], "surname": ["Morris", "Watkins", "Ricketts", "Buchholz", "Priddle"], "given-names": ["DJ", "JL", "CF", "F", "J"], "article-title": ["An assessment of the merits of length and weight measurements of Antarctic krill "], "italic": ["Euphausia superba"], "source": ["Br. Antarct. Surv. Bull."], "year": ["1988"], "volume": ["79"], "fpage": ["27"], "lpage": ["50"]}, {"label": ["41."], "surname": ["Guerao", "D\u00edaz", "Abell\u00f3"], "given-names": ["G", "D", "P"], "article-title": ["Morphology of Puerulus and Early Juvenile Stages of the Spiny Lobster Palinurus Mauritanicus (Decapoda: Palinuridae)"], "source": ["J. Crustac. Biol."], "year": ["2006"], "volume": ["26"], "fpage": ["480"], "lpage": ["494"], "pub-id": ["10.1651/C-2615.1"]}, {"label": ["42."], "surname": ["Howe"], "given-names": ["JC"], "article-title": ["Standard length: not quite so standard"], "source": ["Fish. Res."], "year": ["2002"], "volume": ["56"], "fpage": ["1"], "lpage": ["7"], "pub-id": ["10.1016/S0165-7836(01)00312-5"]}, {"label": ["43."], "mixed-citation": ["Isaacs, J. D., Fleminger, A. & Miller, J. K. "], "italic": ["Distributional atlas of zooplankton biomass in the California Current region: spring and fall 1955\u20131959"]}, {"label": ["44."], "surname": ["Obaza", "Ruehl"], "given-names": ["A", "CB"], "article-title": ["Regressions for estimating gastropod biomass with multiple shell metrics"], "source": ["Malacologia"], "year": ["2013"], "volume": ["56"], "fpage": ["343"], "lpage": ["349"], "pub-id": ["10.4002/040.056.0224"]}]
{ "acronym": [], "definition": [] }
44
CC BY
no
2024-01-14 23:40:15
Sci Data. 2024 Jan 12; 11:2
oa_package/e7/17/PMC10786825.tar.gz
PMC10786826
38216722
[ "<title>Introduction</title>", "<p id=\"Par2\">Urban parks serve as integral elements of urban green infrastructure<sup>##UREF##0##1##,##UREF##1##2##</sup>, playing a crucial role in sustaining urban ecosystems<sup>##UREF##2##3##,##UREF##3##4##</sup>. Not only do they provide valuable ecological services, they also offer urban residents greater opportunities to connect with nature,<sup>##UREF##4##5##–##UREF##6##8##</sup>, alleviating psychological stress, promoting increased social interaction, and supporting fitness and leisure activities<sup>##UREF##7##9##</sup>, further ensuring the physical and mental well-being of urban communities<sup>##UREF##8##10##–##REF##37614701##13##</sup>. However, as China’s urbanisation process accelerates, the population of Beijing has reached a staggering 21.843 million people. As a representative of the core city cluster in terms of economic development, Beijing faces a range of challenges relating to high-density development, such as uncontrolled land expansion and excessive population concentration<sup>##UREF##10##14##</sup>. In densely populated urban environments, the condensed spatial configuration, combined with high population density and limited land resources<sup>##UREF##11##15##</sup>, has led to a reduction in the quantity and a deterioration in the quality and functionality of urban parks<sup>##UREF##12##16##–##UREF##14##18##</sup>. These factors have had a detrimental impact on the provision of urban green spaces, with many residents unable to enjoy equal access to green resources. To alleviate this pressure regarding resource distribution disparity in high-density urban parks, it is necessary to evaluate the supply capacity of urban park resources, considering both spatial distribution and park quality, while adhering to stock development planning policy<sup>##UREF##15##19##</sup>. Merely evaluating urban parks supply capacity through an analysis of spatial distribution patterns is inadequate to address the contemporary needs of densely populated cities<sup>##UREF##16##20##</sup>. Stock development primarily focuses on enhancing the quality of limited available space. Therefore, it is crucial to integrate park quality evaluations to comprehensively assess the supply–demand relationship between urban parks and users.</p>", "<p id=\"Par3\">Recent studies concerning the equity of urban parks have increasingly considered the impact of inherent differences in park quality on resource distribution equity. For instance, some studies have incorporated quantitative indicators of the cooling impact of green park areas to adjust the parameters used in accessibility calculations and have combined these indicators with demand factors to evaluate the equity of cooling services provided by parks within a given region<sup>##UREF##17##21##,##UREF##18##22##</sup>. Some researchers have focused on improving accessibility analysis methods by incorporating multiple dimensions of park quality evaluation, including availability, attractiveness, and aesthetics when assessing the equity of urban parks<sup>##UREF##19##23##,##UREF##20##24##</sup>. Several research endeavors have also investigated the influence of various modes of transportation, as well as the uneven quality of urban green spaces when determining equity considerations<sup>##UREF##21##25##</sup>.</p>", "<p id=\"Par4\">Traditional analytical methods regarding the spatial equity of urban park distribution typically use the park accessibility index as the supply measure and population size as the demand measure. Assessments are conducted by analysing the ratio between the two<sup>##UREF##22##26##–##UREF##24##28##</sup>. Accessibility pertains to the residents’ capability to overcome challenges such as distance and time when reaching their intended destination. It is an effective method for evaluating whether the distribution of urban public resources meets the relevant demand needs<sup>##UREF##25##29##,##UREF##26##30##</sup>. Common methods for measuring accessibility include buffer zone analysis<sup>##UREF##27##31##</sup>, gravity models<sup>##UREF##28##32##</sup>, minimum distance<sup>##REF##26188808##33##</sup>, network analysis<sup>##UREF##29##34##</sup>, cost-weighted distance<sup>##UREF##30##35##</sup>, and the Gaussian two-step floating catchment area (G2SFCA) method<sup>##UREF##31##36##</sup>. Among these approaches, the G2SFCA method, in particular, comprehensively considers supply and demand and calculates the accessibility of public service facilities using two steps<sup>##UREF##23##27##,##UREF##32##37##</sup>. This method can be optimised and expanded by adjusting the distance decay functions, search radius, and other parameters<sup>##UREF##33##38##,##UREF##34##39##</sup>, and is widely applied in accessibility evaluations owing to its intuitive expression, simple computation, and strong operability.</p>", "<p id=\"Par5\">Considering the impact of inherent differences in urban park quality on equity, combining equity research with quality analysis can further enhance the reliability of the research methods and results. As visitors are both users and evaluators of parks, analysing visitor evaluations can offer a more holistic insight into the extent of public contentment with park recreational quality<sup>##UREF##35##40##</sup>, thus playing a crucial role in assessing inherent differences in park quality<sup>##UREF##36##41##,##UREF##37##42##</sup>. Compared to traditional questionnaire surveys, evaluation data from social media are more easily accessible and offer larger sample sizes. With the development of network technology, combining software programs to analyze big data has become a popular trend and is being applied in various research fields<sup>##UREF##38##43##,##UREF##39##44##</sup>. Previous studies have utilised big data from online media platforms to conduct semantic analysis for evaluating park recreational quality<sup>##UREF##40##45##–##UREF##42##47##</sup>. However, there is limited research that incorporates the quantified data from semantic analysis into the calculation of park accessibility.</p>", "<p id=\"Par6\">The population density in Chaoyang District, Beijing is approximately 7564 people per square kilometer, with a higher concentration of population on the western side of the urban area. To alleviate the loading pressure in the district and improve the quality of residents’ living spaces, the district’s zoning plan proposes suggestions such as optimising park layouts, enhancing park service efficiency, and emphasising the characteristic development of parks<sup>##UREF##43##48##</sup>. This study first analyzes 96,220 evaluations of parks in Chaoyang District with 43 blocks, obtaining sentiment scores for 83 parks. These sentiment scores are then incorporated into an accessibility calculation formula, using an improved accessibility (IA) index and approximately 55,797 community population data to provide a more accurate assessment of the social equity of parks in Beijing’s Chaoyang District accurately. By doing so, it will provide valuable insights for other high-density urban areas facing similar situations, offering guidance on optimising park layouts, enhancing service efficiency, and emphasising characteristic park development.</p>", "<p id=\"Par7\">The article consists of an introduction, methodology, result, discussion, and conclusions. The introduction presents the research hotspots, analysis methods, and study framework. The “<xref rid=\"Sec2\" ref-type=\"sec\">Methodology</xref>” section describes the research subjects and analysis methods. The “<xref rid=\"Sec10\" ref-type=\"sec\">Result</xref>” section includes street-level maps and data summaries. The “<xref rid=\"Sec20\" ref-type=\"sec\">Discussion</xref>” section provides suggestions based on the results. The “<xref rid=\"Sec26\" ref-type=\"sec\">Conclusions</xref>” summarizes the experiment, results, innovation, challenges, and future research possibilities.</p>" ]
[ "<title>Methodology</title>", "<title>Study area</title>", "<p id=\"Par8\">The primary emphasis of this investigation was placed on 83 urban parks in the Chaoyang District of Beijing, as listed in the “Beijing Park Directory (First Batch)”<sup>##UREF##44##49##</sup>. Administrative blocks within the district were selected as the spatial units for comparative analysis. Located in the southern segment of Beijing’s primary urban zone (39°49′–40°5′ N, 116°21′–116°38′ E), Chaoyang District covers an area of 470.8 km<sup>2</sup>. It consists of 43 blocks and has a permanent population of 3.449 million people<sup>##UREF##45##50##</sup>. As of 2022, its GDP reached 791.12 billion yuan<sup>##UREF##46##51##</sup>, making it the largest and most densely populated district in Beijing. The per capita park area in the district is currently 18.54 m<sup>2</sup>, and the coverage rate of park coverage within a 500-m service radius is 88.91%<sup>##UREF##47##52##</sup>. These figures indicate that the management of green spaces in Chaoyang District has achieved a certain degree of success (Fig. ##FIG##0##1##).</p>", "<title>Research method</title>", "<p id=\"Par9\">This study used Chaoyang District in Beijing as the research sample area and utilised the SnowNLP package in Python for the semantic sentiment analysis of online media reviews. The perceived emotional scores of visitors towards the parks were used as the evaluation criteria for park recreational quality. Subsequently, by incorporating park sentiment scores into G2SFCA accessibility calculations, the integrated accessibility index, which considers the quality of park recreation, was used to measure the supply capacity of park resources in Chaoyang District. Furthermore, park distribution equity was analysed by combining different user data at the block level. Finally, by integrating the results for park accessibility, spatial equity, and recreational quality analyses, optimisation, appropriate policy suggestions were provided (Fig. ##FIG##1##2##).</p>", "<title>Park recreational quality evaluation</title>", "<p id=\"Par10\">User reviews were gathered from China's most popular tourist review websites, including Dianping, Ctrip, and Mafengwo, to obtain detailed feedback on the urban parks in Chaoyang District. The collected data included user IPs, review timestamps, and content. After filtering out irrelevant reviews, such as advertisements and web links, a total of 96,220 textual reviews were obtained.</p>", "<p id=\"Par11\">A sentiment analysis was conducted of the obtained review texts using the SnowNLP library in Python. SnowNLP is a toolset founded on a Bayesian model tailored for the purpose of conducting natural language processing and sentiment analysis in the Chinese language<sup>##UREF##48##53##</sup>. The formula for the sentiment analysis was as follows:where and represent the positive and negative sentiment of the sample, respectively. represents the probability of a specific sentiment feature word appearing in the test sample, and represents the probability of a sentence with the feature belonging to sentiment class .</p>", "<p id=\"Par12\">The programming technique used references from the English natural language processing library TextBlob but did not cite the Natural Language Toolkit (NLTK) library. To improve the accuracy of sentiment analysis in SnowNLP, 4336 comment texts were randomly extracted from the source data and classified into positive and negative sentiments. The classification results were used to train SnowNLP for sentiment analysis. Additionally, stop words were incorporated to avoid unnecessary interference from certain vocabulary items in the analysis results. The segmentation of the evaluation texts was also optimised by combining them with the Jieba word segmenter. The sentiment analysis output values range was between 0 and 1. A value closer to 1 indicated a more positive sentiment in the comment, whereas a value closer to 0 suggested a more negative sentiment<sup>##UREF##49##54##</sup>.</p>", "<p id=\"Par13\">To explore the key elements of the park that influence visitors' recreational experiences, in this study, texts were categorized as expressing positive emotions if their sentiment scores were greater than or equal to 0.5, while those with scores less than 0.5 were deemed to convey negative emotions. The Jieba Chinese word segmenter was used to analyse the word frequency in both positive and negative sentiment texts. The key elements affecting visitors' emotions were identified through this analysis. These findings serve as a reference point for proposing strategies to enhance the overall experience of park leisure and set the foundation for suggesting optimisation strategies for park equity in Chaoyang District.</p>", "<title>Improved accessibility analysis</title>", "<p id=\"Par14\">The G2SFCA approach employs a Gaussian function as the distance decay model, with low decay rates for short and long distances, and a notable decay rate in the intermediate distance range. This method comprehensively considers the interactions between supply and demand. It sequentially sets the supply and demand points as centres and draws service radii, conducting two rounds of searching to determine the accessibility of public facilities<sup>##UREF##31##36##</sup>.</p>", "<p id=\"Par15\">In the first step, entrance/exit point of the park was considered the supply point. A threshold was set based on the size and type of the park to establish a search domain. Within this search domain, the community demand points were identified, and the total population within the search domain was aggregated. The supply–demand ratio of the park was calculated as follows:where represents the spatial separation from supply point to demand point . represents the service radius of the park. represents the park area. represents the population at demand point . represents the Gaussian distance attenuation function.</p>", "<p id=\"Par16\">In the second step, a search domain was established around each community demand point . The supply demand ratios of supply point within the search domain were summed using a Gaussian decay function. This yielded park accessibility for demand point , where a higher value signified increased accessibility. The formula was as follows:where represents the distance from demand point to supply point . represents the travel capacity of residents to the urban park. represents the park area. represents the population at demand point . represents the Gaussian distance decay function.</p>", "<p id=\"Par17\">To ensure the validity of the experiment, data regarding community locations and household numbers were collected for Chaoyang District. The data were then cross-referenced with the 7th National Census data at the block level to adjust the population count for each community. When delineating the search domains, we took into account the maximum network distance that residents would travel to reach the park, as opposed to a straightforward linear distance. The search domains for the same park entrances/exits were also merged. The residents' travel capacity was based on the 15-min living circle planning recommendations, with walking, cycling, and driving travel distances set at 1.25 km, 3.75 km, and 7.5 km, respectively. The park service radius was determined based on the results from the relevant literature<sup>##UREF##16##20##,##UREF##50##55##–##UREF##52##57##</sup> and the “Urban Green Space Classification Standards”. The specific radius was set according to the type and level of park (Table ##TAB##0##1##). In the traditional approach, represents the park area. However, in the improved method, the indicators for evaluating the quality of park recreation are incorporated. is a measure of the park's supply capacity, reflecting its recreational quality.</p>", "<p id=\"Par18\">In the above equation, represents the visitor’s sentiment scores for their overall park experience, whereas is considered an indicator that reflects the park’s supply capacity in terms of recreational quality.</p>", "<title>Equity evaluation</title>", "<title>Lorenz curve and Gini coefficient</title>", "<p id=\"Par19\">Equity in the distribution of urban park resources across diverse demographic groups in Chaoyang District was evaluated through the utilization of the Lorenz curve and the Gini coefficient. The horizontal axis represented the cumulative percentage of the resident population, while the vertical axis depicted the cumulative percentage of accessibility to urban parks. The ratio of the coordinates on the horizontal and vertical axes equals 1 and represents the absolute equality line, indicating a state of absolute equity in terms of park resource distribution. The proximity of the Lorenz curve to the line of absolute equality indicates the level of fairness in the distribution of park resources. The Gini coefficient, which ranges between 0 and 1, is a statistical indicator of equity based on the Lorenz curve. A higher value indicates a greater degree of inequality and curvature in the Lorenz curve (Table ##TAB##1##2##)<sup>##UREF##53##58##–##UREF##55##60##</sup>. The formula for the Gini coefficient is:where represents the cumulative percentage of demand (total population, older population, and child population) for each block, represents the cumulative percentage of park accessibility for each block, and represents the number of blocks.</p>", "<title>Bivariate local Moran’s I</title>", "<p id=\"Par20\">Performing a Bivariate local Moran’s I analysis on park accessibility and population density at the block level in Chaoyang District using GeoDa software<sup>##UREF##56##61##</sup>, the formula is as follows:where represents the local Moran's I (LISA) for block , represents the spatial weight value, and represents the standardised values of accessibility and population density in a particular block.</p>", "<p id=\"Par21\">By assessing the level of matching between supply and demand, the assessment outcomes reveal four clustering types for park resource supply capacity: H–H (high–high), H–L (high–low), L–H (low–high), and L–L (low–low) (Table ##TAB##2##3##).</p>" ]
[ "<title>Result</title>", "<title>Evaluation of park recreational quality</title>", "<title>Sentiment score for review texts</title>", "<p id=\"Par22\">The sentiment scores of the evaluation texts ranged from 0 to 1 (Table ##TAB##3##4##). By averaging these scores, the sentiment score was obtained for each park (Fig. ##FIG##2##3##). Among the 75 parks for which evaluation texts were collected, the sentiment scores ranged from 0.992,127,375 to 0.417,140,671. Sunhe Suburban Park received the highest score, whereas Green Shadow Park received the lowest.</p>", "<p id=\"Par23\">To further investigate the factors influencing visitor perceptions and evaluations, a correlation analysis was conducted between the sentiment scores and other characteristic park attributes (Table ##TAB##4##5##). The results indicated a significant correlation between the number of park reviews and the park type, level, and size, suggesting that larger-scale and higher-level parks attract more visitors. However, there was no correlation between the number of park reviews and , indicating that the popularity of a park does not entirely reflect visitors’ recreational experience or the quality of a park's recreational activities. There was also no correlation between and park size, suggesting that park size was not significantly associated with visitors’ recreational experiences. Moreover, a significant correlation was found between and park type, indicating that comprehensive parks generally received higher sentiment scores in visitor evaluations, whereas recreational gardens received lower scores. Furthermore, was significantly negatively correlated with park level, indicating that lower-level parks received lower sentiment scores in the evaluation texts.</p>", "<title>Frequent words in the comments text</title>", "<p id=\"Par24\">Word frequency analysis was conducted on the review text and categorised into positive and negative sentiments. The analysis sorted the vocabulary based on the frequency of occurrence, and repetitive and irrelevant words were eliminated multiple times to obtain the 100 most frequently occurring words in each category. The results (Table ##TAB##5##6##) indicate that positive reviews consisted primarily of adjectives and verbs. Frequently used adjectives included cost considerations (免费free), visitor experience (舒服comfortable), and park characteristics (干净clean, 安静quiet). Frequently used verbs addressed leisure activities (拍照photography, 跑步run, 散步walk, 健身exercise, 野餐picnic) and pre-made appointments (预约pre-book). Nouns mainly referred to the natural environment (环境environment, 向日葵sunflower, 树木tree, 草坪lawn, 湿地wetland), transportation facilities (停车场parking lot, 交通transportation), artificial landscapes (广场square, 建筑building, 喷泉fountain), and historical cultural elements (heritage site).</p>", "<p id=\"Par25\">In contrast, negative comments were primarily defined by the use of nouns, including references to personnel (孩子children, 保安security guard, 工作人员staff, 游客visitor), ticketing (门票entrance ticket, 套票package ticket, 押金deposit, 停车费parking fee), transportation facilities (停车场parking lot, 自行车bicycle, 电瓶车electric scooter, 公交public transportation), cultural events (庙会temple fair), entertainment facilities (游乐场playground, 冰场skating rink), and service facilities (厕所restroom). The adjectives used in negative comments primarily revolved around cost considerations (免费free, 收费charged, 便宜inexpensive) and park characteristics (太大too large, 人多crowded, 没人empty). The verbs used primarily addressed leisure and recreational activities (划船boating, 搭帐篷set up a tent, 拍照photograph), and the subject of making reservations for specific activities was also mentioned (排队queue up, 预约pre-book). The terms “pandemic”(疫情) and “internet celebrity”(网红) were also frequently referenced.</p>", "<title>Improved accessibility</title>", "<title>Improved accessibility of the community</title>", "<p id=\"Par26\">The level of park accessibility represents how easily they can be reached from community units. A higher accessibility index indicates that urban parks are more easily accessible to a community. By adopting the improved G2SFCA method and analysing the different travel patterns of community residents, the accessibility index of 55,797 community locations in Chaoyang District was calculated (Fig. ##FIG##3##4##). The results showed that the improved community walking accessibility (IA-W(c)) index range is from 0 to 8,546.390, and there were 21,392 communities with an IA-W(c) index of 0, and that the community with the highest index was located in the Heizhuanghu Subdistrict. Communities with high park accessibility exhibited a chequerboard-like spatial pattern, mainly located around park areas such as the Conference Center Leisure Park, Dawangjing Park, Jiangfu Suburban Park, Dongba Suburban Park, Jintian Suburban Park, Majiawan Wetland Park, and Xiaohongmen Fanglin Park, indicating higher accessibility indices. The reason could be that, owing to travel mode restrictions, residents can only reach parks near their residential areas within a 15-min travel time. Highly accessible communities have a lower population, but greater park supply in their vicinity, which produces this result.</p>", "<p id=\"Par27\">The improved community cycling accessibility (IA-C(c)) index range is from 0 to 42,540.369, and there were 603 communities with an IA-C(c) index of 0, which was significantly lower than that of IA-W(c), indicating a reduced number of communities that could not access any parks. The community with the highest accessibility index was located in the Laiguangying Subdistrict. Communities with high park accessibility exhibited belt-like spatial patterns, with communities in the northwest and southeast exhibiting higher accessibility indices. This could be because residents can reach more parks within the same travel time when using cycling as the travel mode, leading to a more pronounced regional distribution pattern of accessibility indices.</p>", "<p id=\"Par28\">The improved community driving accessibility (IA-D(c)) index range is from 0 to 61,890.425, and there were 51 communities with an IA-D(c) index of 0, and the community with the highest index was located in the Cuigezhuang Subdistrict. High-accessibility areas accounted for a larger proportion, exhibiting a more coherent belt-like spatial pattern, with lower accessibility in the southwest and northeast and higher accessibility in the northwest and southeast. This could be because driving allows access to the majority of the parks in Chaoyang District, resulting in a greater increase in accessibility. This leads to a more pronounced belt-like spatial distribution pattern of highly accessible communities, with sparser residential locations in the northwest and southeast. The parks in these areas are larger and have higher sentiment scores, contributing to higher accessibility indices.</p>", "<title>Improved accessibility of the block</title>", "<p id=\"Par29\">To facilitate comparative analysis, the average park accessibility values for each street were calculated, and a geometric interval method was used to classify them into five categories: high, relatively high, medium, relatively low, and low (Fig. ##FIG##4##5##). The results indicated that 4 blocks were classified as high in the improved block walking accessibility (IA-W(b)), including the Dougezhuang Subdistrict (187.786) and Wangsiying Subdistrict (139.120). 11 blocks were classified as relatively high, including the Laiguangying Subdistrict (65.265) and Gaobeidian Subdistrict (52.325). 8 blocks fell into the medium category, including the Changying Subdistrict (27.590) and Guanzhuang Subdistrict (26.971). 8 blocks were classified as relatively low, including Jinsong Street (9.571) and Xiaoguan Street (8.082). 12 blocks fell under the low category, with the lowest IA-W(b) observed in Capital Airport Street (0.000). The results of the analysis suggest that in areas such as the Dougezhuang and Wangsiying Subdistricts, although the population is relatively small, there are a greater number of parks distributed there. Due to travel mode restrictions, residents tend to visit parks closer to their homes, resulting in a relatively higher distribution of parks per capita and higher walking accessibility. Conversely, Capital Airport Street has a smaller population, but is furthest from the urban park locations, with fewer access routes, leading to the lowest park accessibility in that area.</p>", "<p id=\"Par30\">In terms of the improved block cycling accessibility (IA-C(b)) classification, there are 2 blocks classified as high: Heizhuanghu Subdistrict (4,266.356) and Dougezhuang Subdistrict (3,548.887). 7 blocks were classified as relatively high, 14 as medium, 10 as relatively low, and 10 as low. The lowest IA-C(b) value was observed in Capital Airport Street (0.000), followed by Jinzhan Subdistrict (11.620) and Hujialou Street (14.209). Compared with walking, fewer blocks were categorised as having low accessibility using cycling as the mode of transportation. The reason for this could be that blocks with a higher population, such as the Shibalidian and Sanjianfang Subdistricts, have a lower per capita distribution of park resources for walking. However, these blocks also have a higher number of surrounding parks, meaning the 15-min cycling distance allows access to a greater number of parks than walking.</p>", "<p id=\"Par31\">In terms of the improved block driving accessibility (IA-D(b)) classification, there are 4 blocks classified as high, including the Laiguangying Subdistrict (24,156.163) and Cuigezhuang Subdistrict (14,972.491). 5 blocks were classified as relatively high, 12 as medium, 13 as relatively low, and 9 as low. The lowest IA-D(b) value was observed in Capital Airport Street (41.641). The reason for this could be that areas with higher populations, such as the Laiguangying and Cuigezhuang Subdistricts, have relatively fewer parks. As a result, residents in these areas can reach most of the urban parks in Chaoyang District within a 15-min drive, thus increasing their accessibility level. However, areas located in the central part of Chaoyang District, such as the Dongba Sub-district, showed a decreased accessibility level compared to walking and cycling modes. This could be as the number of parks accessible by car in each community is similar, but the central region exhibits a greater concentration of population, resulting in a slightly lower per capita distribution of park resources compared with other regions.</p>", "<title>Park equity analysis</title>", "<title>Measurement of park equity</title>", "<p id=\"Par32\">Drawing on the cumulative percentage of IA under different modes of travel, a Lorenz curve was plotted, and the Gini coefficient was calculated to explore the corresponding distribution of park resources (Fig. ##FIG##5##6##). The results indicate that the equity of park distribution in the examined region is generally limited, with greater curve distortion in the cycling transport mode specifically. The Gini coefficients for all modes were above 0.600, indicating a notable discrepancy in the allocation of park resources in Chaoyang District. Among the three transportation modes covered, the Lorenz curves for children were closest to the line of absolute equality, with Gini coefficients of 0.561,585,794 for walking, 0.624,461,074 for cycling, and 0.590,679,821 for driving, respectively. The next closest were the curves for the total population, with Gini coefficients of 0.591,972,493 for walking, 0.624,852,273 for cycling, and 0.592,396,953 for driving. The Lorenz curves for older residents showed the greatest distortion, with Gini coefficients of 0.701,143,459 for walking, 0.725,670,406 for cycling, and 0.696,781,465 for driving. This result indicates that the supply–demand match of park resources is more balanced among children, while the distribution of parks is extremely unequal for older residents.</p>", "<title>Analysis of park supply and demand match</title>", "<p id=\"Par33\">The results indicate that in certain blocks within Chaoyang District, the correlation between park accessibility and the total population is not particularly noteworthy. Under different modes of travel, the Dougezhuang Subdistrict showed a positive spatial match, indicating that the supply of parks and population demand are relatively high. In contrast, blocks such as Capital Airport Street, Heping Street, Tuanjiehu Street, and Chaowai Street exhibited a negative spatial match, indicating that both supply and demand are limited in terms of quantity. However, with the convenience of different travel modes, blocks such as Wangjing Street and Jiangtai Subdistrict have shifted from positive to negative mismatches (Fig. ##FIG##6##7##).</p>", "<p id=\"Par34\">There a clear spatial mismatch was found between accessibility and the older population. Blocks with positive mismatches were predominantly found to reside within the southeastern section of Chaoyang District, where the older population is relatively low but park resources are excessive. Blocks with negative mismatches were mainly distributed on the western side of Chaoyang District, near the core area of Beijing, where there is a greater number of older residents and insufficient park resources. Blocks with positive matches were distributed in the northwest, where the supply of parks more closely matches the number of older residents. Blocks with negative matches were located in the eastern part of Chaoyang District, where both parks and older residents are scarce.</p>", "<p id=\"Par35\">Numerous blocks were detected with negative matches between accessibility and child population; these were predominantly located in the southwest near the core area of Beijing. In this area, there is a lower supply of parks and smaller demand from the child population. Blocks such as the Olympic Village and Jinzhan Subdistricts exhibited negative spatial mismatches, indicating a lower supply of parks despite a higher level of demand from the child population. The Cuigezhuang Subdistrict showed a positive match under the walking and driving modes but a negative match under the cycling mode of transportation.</p>" ]
[ "<title>Discussion</title>", "<title>Exploring factors affecting the recreational quality of urban parks in Chaoyang District</title>", "<p id=\"Par36\">The results indicated that visitors exhibited heightened concern regarding park ticket pricing and recreational activities. Free admission and a diverse range of activities were more likely to provide visitors with positive experiences. Positive evaluations were predominantly related to the parks’ natural environment including the flora and artificial architectural landscape. Abundant greenery and fresh air contributed to a comfortable experience, whereas well-maintained facilities and architecture played a pivotal role in enhancing visitor relaxation. The historical and cultural aspects of parks also attract visitors, as they endow the landscape with a sense of uniqueness and cultural value<sup>##UREF##57##62##</sup>. Negative evaluations were primarily related to park management issues, encompassing concerns such as discourteous staff attitudes, complicated ticket reservation procedures, high fees, and inadequately maintained public amenities such as restrooms. These problems can create feelings of embarrassment and frustration among visitors, negatively affecting their recreational experience. This study also found that the “pandemic”(疫情) was a key concern for visitors. This may be because the pandemic has significantly affected park operations and management, making parks with free-entry and those that are well-managed more popular among visitors. The recurring mention of the term “Internet celebrity” (网红) implies that the proliferation of social media and online content wields a considerable influence on the allure of parks. However, evaluations of popular parks vary, indicating that a park’s intrinsic recreational quality exerts a more pronounced impact on visitors’ experiences<sup>##UREF##58##63##</sup>. In addition to overall park quality, the proximity and available modes of transportation also affected visitors’ evaluations, highlighting the importance of park accessibility as a key concern for visitors.</p>", "<title>Advantages of improved accessibility</title>", "<p id=\"Par37\">Previous studies have incorporated park quality into their assessment of urban park accessibility<sup>##UREF##20##24##</sup>. This study considers recreational quality scores and integrates them into the accessibility calculation using the improved accessibility index to represent the park resources available to residents. The research findings suggest that park sentiment scores exhibit no discernible correlation with popularity and size. However, the number of reviews had a robust positive correlation with park size. This indicates that traditional accessibility calculations relying only on park size can, to a certain extent, represent the allure of a park but are insufficient to represent the supply of park resources. This improved approach quantifies the recreational quality of parks using sentiment scores from textual evaluations of park review networks. The recreational quality index was then utilised to adjust the parameters of park resource supplies. By integrating real evaluations of park recreational quality by visitors, this approach more authentically captures the true supply capacity of park resources, surpassing the limitations associated with sole reliance on park size. This improvement in the calculation method enhances the accuracy of the results.</p>", "<title>Spatial differentiation of park accessibility levels in Chaoyang District</title>", "<p id=\"Par38\">The spatial differentiation of park accessibility levels in Chaoyang District is quite pronounced, and both the Lorenz curves and Gini coefficients for different travel modes indicate an imbalance in resource distribution. The issue of unfairness was particularly pronounced with regard to the cycling mode. The reasons for reduced accessibility in some areas can be summarised as follows: (1) Park resources are inadequate to meet the population demand. Communities near the core area of Beijing have reduced accessibility, possibly owing to their proximity to the area, which is characterised by high-density development. Despite parks being closer to these communities, the excessive population density, coupled with limited park resources, contributes to lower overall accessibility<sup>##UREF##59##64##</sup>. (2) Difficulty accessing park resources. Capital Airport Street has the lowest level of park accessibility. This is likely because even though the density of residents in this region is relatively small, the distance from parks is greater, and there are fewer transportation routes available, which hinders residents from enjoying park resources<sup>##UREF##60##65##,##UREF##61##66##</sup>. (3) Poor park resources. Communities near small parks that lacked sentiment scores had lower accessibility. Insufficient and low-quality greenspace resources fail to meet population demands.</p>", "<p id=\"Par39\">Communities with better park accessibility were primarily located in blocks with high park recreational quality, larger park areas, and a greater number of parks. Observations have revealed that areas with high accessibility are mostly concentrated near Beijing’s first greenbelt<sup>##UREF##62##67##</sup>. This greenbelt, which forms an urban park ring, has the largest proportion in Chaoyang District. Serving as an ecological barrier for the city, it plays a key role in controlling urban development and provides high ecological service value<sup>##UREF##63##68##</sup>. The construction of the urban park ring offers residents increased chances to connect with natural surroundings.</p>", "<title>The distribution of urban park resources is inequitable</title>", "<p id=\"Par40\">Urban parks play a significant role as spaces for recreation and amusement, catering to both older citizens and children. However, owing to the respective limitations of both of these population demographics, they are both relatively disadvantaged in this regard. From the perspective of providing adequate care, older residents and children should be key populations of concern when addressing the issue of equity distribution in urban parks<sup>##UREF##64##69##,##UREF##65##70##</sup>. Existing research has shown that urban parks not only improve the health of older residents, reducing the incidence and mortality rates of certain diseases, they also provide many broader physiological and psychological benefits<sup>##UREF##54##59##,##UREF##66##71##</sup>. Unfortunately, the distribution of park resources among the older residents in Chaoyang District shows the most severe polarisation, with the majority of older people having access to only a few urban parks. Limited content was found in the park evaluation texts analysed in this study relating to the older population, despite many countries facing the challenge of an aging population. Therefore, park planning and design should prioritise placing a greater focus on the older population. Compared to the total population, the distribution of urban park resources among children is more balanced. Children are a significant beneficiary group of parks, as urban parks play a vital role in maintaining children’s physical and mental health and promoting cognitive development<sup>##UREF##67##72##</sup>. A higher level of attention was paid in the park reviews covered in this study to children and the availability of children's playground facilities, indicating that children's needs should be a key consideration in park planning and design. Similarly, the allocation of urban park resources among the entire population lacks fairness, with a small percentage of people occupying the majority of greenspace resources. Thus, it can be clearly stated that the supply and utilisation rate of park resources in Chaoyang District needs improvement.</p>", "<title>Optimisation suggestions for urban parks in Chaoyang District</title>", "<p id=\"Par41\">Enhancing the quality of urban park recreation. One of the important reasons for this inequitable distribution is the difference in park resources. To some extent, improving park quality can alleviate the problem of insufficient park supply. Based on this analysis of park reviews, measures such as optimising green space quality, improving park management models, enriching activities within parks, and maintaining public service facilities can enhance park recreational quality. Additionally, it is important to consider the greenspace needs of vulnerable groups, such as older residents and children, by providing accessible facilities and creating older adult and child-friendly parks.</p>", "<p id=\"Par42\">Optimizing the horizontal spatial arrangement of urban parks is crucial. There exists a significant disparity in the horizontal spatial accessibility of urban parks in Chaoyang District, which has created an uneven distribution of park resources. Rational planning of the horizontal spatial layout of urban parks can help mitigate inequities in resource distribution. However, Chaoyang District is a densely developed urban area with limited land resources, making it difficult to expand urban parks extensively. One potential approach is to conduct research and identify unused or abandoned areas to create pocket parks and micro-green spaces that can provide additional green resources for residents and improve the accessibility and equitable distribution of urban parks. This can also serve to enhance the connectivity of green spaces, significantly optimising the urban ecological environment.</p>", "<p id=\"Par43\">Industrial development in residential areas. In Chaoyang District, an imbalance between the supply and demand of urban park resources and the population is mainly observed in the blocks located near the core area of Beijing and near the outer ring road. This disparity could be attributed to the large population near the core area of Beijing, which has a scarcity of parks. By comparison, the south-eastern part of Chaoyang has a smaller population, but a higher concentration of parks with better recreational quality. Engaging in industrial development in the residential areas on the outskirts of Beijing can effectively increase the utilisation rate of parks, more widely disperse the population near the core area, and alleviate the supply pressure on urban parks within the inner ring (##SUPPL##0##Supplementary Information##).</p>" ]
[ "<title>Conclusions</title>", "<p id=\"Par44\">Urban park accessibility is a crucial aspect of environmental equity. This study, using Chaoyang District in Beijing as a case study, incorporates web-based sentiment scores and travel patterns into the traditional G2SFCA accessibility calculation for urban parks. This method provides a more comprehensive and accurate reflection of urban park supply capacity while examining the impact of park recreational quality and travel patterns on accessibility. Furthermore, by analysing park review texts, valuable insights from both residents and visitors were obtained, enabling a holistic understanding of the key factors influencing park recreational quality. This, in turn, enables more tailored recommendations for optimising future park spatial layouts and quality improvements. The study yields several key findings: (1) users prioritise park management and expect high standards of convenience and cleanliness of public facilities; (2) recreational quality impacts park distribution equity, with improved accessibility near Beijing’s first greenbelt; (3) park resources in Chaoyang District are distributed unequally among various social groups, with significant spatial disparities in the northwest and southeast; (4) enhancing park layout equity can be achieved through repurposing idle spaces, establishing pocket parks, and other small-scale green areas, and improving recreational quality; and (5) urban park planning and construction should consider the specific needs of vulnerable groups such as older residents and children. In conclusion, by incorporating the improved accessibility analysis method based on tourist reviews, this study considers the impact of park recreational quality on park attractiveness, enabling a more accurate and objective analysis of park accessibility. This approach demonstrates a certain level of innovation and universality in its application. However, the analysis method employed in this study faces several challenges in real-time applications. This paper relied solely on sentiment scores from online media as a quantifiable indicator of recreational quality, posing limitations. Additionally, the simulation of different travel patterns only considered time costs and did not explore the influence of different types of roads on travel. The SnowNLP model requires a large amount of training text, and sentiment analysis is greatly influenced by the selection and judgment of training text. Further discussions are needed to determine which computer models can more accurately and reasonably analyze the emotional states of tourist reviews, how to collect more authentic online evaluation data, and how to ensure the real-time nature of the geographical data required for accessibility analysis.</p>" ]
[ "<p id=\"Par1\">Urban parks are essential components of urban ecosystems, providing vital ecological resources for city residents. However, the rapid expansion of high-density urban areas has led to an unequal distribution of park resources, raising growing concerns about spatial equity. To address these challenges, we employed an improved Gaussian two-step floating catchment area (2SFCA) method, considering park quality variations and integrating sentiment scores from park reviews to calculate a comprehensive park accessibility index, accounting for both supply and demand dynamics among park users. The results demonstrate the significance of park management, as users prioritise convenience and cleanliness of public facilities. Recreational quality significantly influences park distribution equity, with areas near Beijing’s initial greenbelt zone showing improved accessibility (IA). Nonetheless, our analysis exposes disparities in urban park resource allocation within the Chaoyang District, indicating relative inequity. Spatial supply and demand mismatches, especially in the northwest and southeast, are evident. To enhance park layout equity, we recommend strategies like identifying and repurposing underused spaces, establishing pocket parks and micro-green areas, and improving recreational facilities. It is crucial to address the needs of vulnerable groups such as older residents and children. These insights stress the importance of ensuring fair urban park access to enhance the well-being of all city residents.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51239-9.</p>", "<title>Acknowledgements</title>", "<p>Thanks to the fundings by National Natural Science Foundation of China, grant number 52008022; National Natural Science Foundation of China, grant number 32271948; Beijing Key Research and Development Program of China, grant number D171100007117003; Operation Fund Project of the National Forestry Grassland Landscape Engineering Technology Research Center (2023), grant number PTYX202333; Special Fund for Beijing Common Construction Project, grant number 2019GJ-03.</p>", "<title>Author contributions</title>", "<p>N.Z. conducted the conceptualization, N.H. and N.Z. conceived the methodology, N.Z., X.M. and Y.X.conducted the formal analysis, N.H. and Y.L. provided the resources and funds. All authors reviewed the manuscript.</p>", "<title>Data availability</title>", "<p>The data presented in this study are available on request from the corresponding author.</p>", "<title>Competing interests</title>", "<p id=\"Par45\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Study area.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Research method flow.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Sentiment score chart of visitors in urban parks of Chaoyang District.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Graded map of improved accessibility of the community.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Graded map of improved accessibility of the block.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Lorenz curves of park improved accessibility for different population groups.</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>Bivariate local Moran’s I clustering maps.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Service radius of urban parks in Chaoyang District.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Park type</th><th align=\"left\">Park level</th><th align=\"left\">Service radius/m<sup>2</sup></th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"2\">Comprehensive Park</td><td align=\"left\">First level</td><td align=\"left\">5000</td></tr><tr><td align=\"left\">Second level</td><td align=\"left\">3000</td></tr><tr><td align=\"left\">Historical Park</td><td align=\"left\">First level</td><td align=\"left\">5000</td></tr><tr><td align=\"left\" rowspan=\"3\">Specialised Park</td><td align=\"left\">First level</td><td align=\"left\">5000</td></tr><tr><td align=\"left\">Second level</td><td align=\"left\">3000</td></tr><tr><td align=\"left\">Third level</td><td align=\"left\">1000</td></tr><tr><td align=\"left\" rowspan=\"2\">Community Park</td><td align=\"left\">Second level</td><td align=\"left\">1000</td></tr><tr><td align=\"left\">Third level</td><td align=\"left\">500</td></tr><tr><td align=\"left\" rowspan=\"2\">Ecological Park</td><td align=\"left\">Second level</td><td align=\"left\">1000</td></tr><tr><td align=\"left\">Third level</td><td align=\"left\">500</td></tr><tr><td align=\"left\" rowspan=\"2\">Recreational Garden</td><td align=\"left\">Third level</td><td align=\"left\">500</td></tr><tr><td align=\"left\">Fourth level</td><td align=\"left\">300</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Gini coefficient fairness indicators.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Range of Gini coefficient</th><th align=\"left\">Distribution of park resources</th><th align=\"left\">Equity status</th></tr></thead><tbody><tr><td align=\"left\">0 ≤ Gini &lt; 0.200</td><td align=\"left\">Highly equitable</td><td align=\"left\">Extremely equity</td></tr><tr><td align=\"left\">0.200 ≤ Gini &lt; 0.300</td><td align=\"left\">Relatively equitable</td><td align=\"left\">Fairly equity</td></tr><tr><td align=\"left\">0.300 ≤ Gini &lt; 0.400</td><td align=\"left\">Reasonably balanced</td><td align=\"left\">Relatively equity</td></tr><tr><td align=\"left\">0.400 ≤ Gini &lt; 0.600</td><td align=\"left\">Significant disparities</td><td align=\"left\">Fairly inequity</td></tr><tr><td align=\"left\">0.600 ≤ Gini &lt; 1.000</td><td align=\"left\">Vast disparities</td><td align=\"left\">Extremely inequity</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Supply–demand matching relationship.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Autocorrelation level clustering type</th><th align=\"left\" colspan=\"4\">Variable description</th></tr><tr><th align=\"left\">Park accessibility</th><th align=\"left\">Population density</th><th align=\"left\">Matching relationship</th><th align=\"left\">Park supply capacity</th></tr></thead><tbody><tr><td align=\"left\">H–H</td><td align=\"left\">High supply</td><td align=\"left\">High demand</td><td align=\"left\">Spatial positive matching</td><td align=\"left\">Supply and demand matching</td></tr><tr><td align=\"left\">H–L</td><td align=\"left\">High supply</td><td align=\"left\">Low demand</td><td align=\"left\">Spatial positive mismatch</td><td align=\"left\">Oversupply</td></tr><tr><td align=\"left\">L–H</td><td align=\"left\">Low supply</td><td align=\"left\">High demand</td><td align=\"left\">Spatial negative mismatch</td><td align=\"left\">Insufficient supply</td></tr><tr><td align=\"left\">L–L</td><td align=\"left\">Low supply</td><td align=\"left\">Low demand</td><td align=\"left\">Spatial negative matching</td><td align=\"left\">Supply and demand matching</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab4\"><label>Table 4</label><caption><p>Examples of sentiment analysis in evaluation texts.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Evaluation text</th><th align=\"left\">Sentiment score</th></tr></thead><tbody><tr><td align=\"left\">“朝阳公园”应该是北京四环以内最大的城市公园, 住在附近的人们, 很是幸福啊!园内有丰富的林木和绿地, 可以户外野餐, 放放风筝, 娱乐嬉戏, 好是惬意的!(“Chaoyang Park” is probably the largest urban park within the Fourth Ring Road in Beijing. People who live nearby are truly fortunate! The park is abundant with trees and greenery, providing opportunities for outdoor picnics, kite flying, and recreational activities)</td><td char=\".\" align=\"char\">0.999,998,590</td></tr><tr><td align=\"left\">12月11日去仰山公园, 发现厕所不能正常使用, 全部是用铁丝把门拧死的, 唯一一个开门的是被人破门的, 里面的水龙头都是坏的。门口的停车位也很少, 只开了大门外面那一片。(During my visit to Yangshan Park on December 11th, I found the toilets to be unusable. All the doors were secured with twisted wire, except for one that had been forcefully broken. The taps inside were also damaged. Moreover, there were limited parking spaces near the entrance, with only the area outside the main gate available)</td><td char=\".\" align=\"char\">0.000,000,005</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab5\"><label>Table 5</label><caption><p>Correlation between sentiment scores and other park attributes.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\"/><th align=\"left\"/><th align=\"left\">Park type</th><th align=\"left\">Park level</th><th align=\"left\">Park size</th><th align=\"left\">Number of reviews</th><th align=\"left\"></th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"3\"></td><td align=\"left\">Pearson correlation</td><td align=\"left\">− 0.221*</td><td align=\"left\">− 0.281*</td><td align=\"left\">0.089</td><td align=\"left\">0.122</td><td align=\"left\"/></tr><tr><td align=\"left\">Sig. (two-tailed)</td><td align=\"left\">0.045</td><td align=\"left\">0.01</td><td align=\"left\">0.426</td><td align=\"left\">0.272</td><td align=\"left\"/></tr><tr><td align=\"left\">Number of cases</td><td align=\"left\">83</td><td align=\"left\">83</td><td align=\"left\">83</td><td align=\"left\">83</td><td align=\"left\"/></tr><tr><td align=\"left\" rowspan=\"3\">Number of reviews</td><td align=\"left\">Pearson correlation</td><td align=\"left\">− 0.357**</td><td align=\"left\">− 0.418**</td><td align=\"left\">0.798**</td><td align=\"left\"/><td align=\"left\">0.122</td></tr><tr><td align=\"left\">Sig. (two-tailed)</td><td align=\"left\">0.001</td><td align=\"left\">0</td><td align=\"left\">0</td><td align=\"left\"/><td align=\"left\">0.272</td></tr><tr><td align=\"left\">Number of cases</td><td align=\"left\">83</td><td align=\"left\">83</td><td align=\"left\">83</td><td align=\"left\"/><td align=\"left\">83</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab6\"><label>Table 6</label><caption><p>Partial high-frequency vocabulary.</p></caption><table frame=\"hsides\" rules=\"groups\"><tbody><tr><td align=\"left\">Frequent vocabulary in positive sentiment reviews</td><td align=\"left\">免费(free), 拍照(photography), 跑步(running), 环境(environment), 设施(facilities), 停车场(parking lot), 门票(tickets), 交通(transportation), 疫情(epidemic), 面积(area), 散步(walking), 溜达(strolling), 健身(fitness), 门口(entrance), 秋天(autumn), 小朋友(children), 休闲(leisure), 野餐(picnic), 开放(open), 划船(boating), 锻炼(exercise), 风景(scenery), 银杏(ginkgo), 向日葵(sunflower), 广场(square), 游乐(amusement), 运动(sports)……</td></tr><tr><td align=\"left\">Frequent vocabulary in negative sentiment reviews</td><td align=\"left\">孩子(children), 停车场(parking lot), 门票(tickets), 停车(parking), 庙会(temple fair), 设施(facilities), 门口(entrance), 免费(free), 自行车(bicycles), 游乐(amusement), 不让(not allowed), 收费(fees), 疫情(epidemic), 帐篷(tent), 划船(boating), 排队(queuing), 环境(environment), 电瓶车(electric scooters), 游乐场(playground), 搭帐篷(setting up tents), 沙滩(beach), 野餐(picnic), 保安(security), 进门(entering), 向日葵(sunflower)……</td></tr></tbody></table></table-wrap>" ]
[ "<disp-formula id=\"Equa\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P(c_{i} |w_{1} ,...,w_{n} ) = \\frac{{[P(w_{1} ,...,w_{n} |c_{i} ) \\times P\\left( {c_{i} } \\right)]}}{{[P(w_{1} ,...,w_{n} |c_{1} ) \\times P\\left( {c_{1} } \\right) + P(w_{1} ,...,w_{n} |c_{2} ) \\times P\\left( {c_{2} } \\right)]}},i = 1,2$$\\end{document}</tex-math><mml:math id=\"M2\" display=\"block\"><mml:mrow><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy=\"false\">|</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy=\"false\">|</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>c</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy=\"false\">|</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy=\"false\">|</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mfenced><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c_{1}$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:msub><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c_{2}$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:msub><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$w_{n}$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:msub><mml:mi>w</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$w$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mi>w</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P\\left( {c_{i} } \\right)$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mrow><mml:mi>P</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>c</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$w_{n}$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:msub><mml:mi>w</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c_{i}$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:msub><mml:mi>c</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$j$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:mi>j</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d_{0}$$\\end{document}</tex-math><mml:math id=\"M20\"><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k$$\\end{document}</tex-math><mml:math id=\"M22\"><mml:mi>k</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{j}$$\\end{document}</tex-math><mml:math id=\"M24\"><mml:msub><mml:mi>R</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equb\"><alternatives><tex-math id=\"M25\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{j} = \\frac{{S_{j} }}{{\\mathop \\sum \\nolimits_{{k \\in \\left\\{ {d_{kj} \\le } \\right.\\left. {d_{0} } \\right\\}}} G\\left( {d_{kj} ,d_{0} } \\right)P_{k} }}$$\\end{document}</tex-math><mml:math id=\"M26\" display=\"block\"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>S</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mrow><mml:msub><mml:mo>∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>∈</mml:mo><mml:mfenced open=\"{\"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">kj</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo></mml:mrow></mml:mfenced><mml:mfenced close=\"}\"><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced></mml:mrow></mml:msub><mml:mi>G</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">kj</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:msub><mml:mi>P</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equc\"><alternatives><tex-math id=\"M27\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$G\\left( {d_{kj} ,d_{0} } \\right) = \\left\\{ {\\begin{array}{ll} {\\frac{{e^{{ - \\left( \\frac{1}{2} \\right) \\times \\left( {\\frac{{d_{kj} }}{{d_{0} }}} \\right)^{2} }} - e^{{ - \\left( \\frac{1}{2} \\right)}} }}{{1 - e^{{ - \\left( \\frac{1}{2} \\right)}} }}, \\quad d_{kj} \\le d_{0} } \\\\ 0, \\qquad \\qquad\\qquad \\qquad d_{kj} &gt; d_{0} \\end{array} } \\right.$$\\end{document}</tex-math><mml:math id=\"M28\" display=\"block\"><mml:mrow><mml:mi>G</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">kj</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced open=\"{\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"left\"><mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:mfrac></mml:mfenced><mml:mo>×</mml:mo><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">kj</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfrac></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:mfrac></mml:mfenced></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:mfrac></mml:mfenced></mml:mrow></mml:msup></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width=\"1em\"/><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">kj</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width=\"2em\"/><mml:mspace width=\"2em\"/><mml:mspace width=\"2em\"/><mml:mspace width=\"2em\"/><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">kj</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq12\"><alternatives><tex-math id=\"M29\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d_{kj}$$\\end{document}</tex-math><mml:math id=\"M30\"><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">kj</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq13\"><alternatives><tex-math id=\"M31\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$j$$\\end{document}</tex-math><mml:math id=\"M32\"><mml:mi>j</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq14\"><alternatives><tex-math id=\"M33\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k$$\\end{document}</tex-math><mml:math id=\"M34\"><mml:mi>k</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq15\"><alternatives><tex-math id=\"M35\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d_{0}$$\\end{document}</tex-math><mml:math id=\"M36\"><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq16\"><alternatives><tex-math id=\"M37\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$S_{j}$$\\end{document}</tex-math><mml:math id=\"M38\"><mml:msub><mml:mi>S</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq17\"><alternatives><tex-math id=\"M39\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P_{k}$$\\end{document}</tex-math><mml:math id=\"M40\"><mml:msub><mml:mi>P</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq18\"><alternatives><tex-math id=\"M41\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k$$\\end{document}</tex-math><mml:math id=\"M42\"><mml:mi>k</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq19\"><alternatives><tex-math id=\"M43\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$G\\left( {d_{kj} ,d_{0} } \\right)$$\\end{document}</tex-math><mml:math id=\"M44\"><mml:mrow><mml:mi>G</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">kj</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq20\"><alternatives><tex-math id=\"M45\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k$$\\end{document}</tex-math><mml:math id=\"M46\"><mml:mi>k</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq21\"><alternatives><tex-math id=\"M47\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{j}$$\\end{document}</tex-math><mml:math id=\"M48\"><mml:msub><mml:mi>R</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq22\"><alternatives><tex-math id=\"M49\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$j$$\\end{document}</tex-math><mml:math id=\"M50\"><mml:mi>j</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq23\"><alternatives><tex-math id=\"M51\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$A_{k}^{F}$$\\end{document}</tex-math><mml:math id=\"M52\"><mml:msubsup><mml:mi>A</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mi>F</mml:mi></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq24\"><alternatives><tex-math id=\"M53\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k$$\\end{document}</tex-math><mml:math id=\"M54\"><mml:mi>k</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equd\"><alternatives><tex-math id=\"M55\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$A_{k}^{F} = \\mathop \\sum \\limits_{{j \\in \\left\\{ {d_{kj} \\le d_{0} } \\right\\}}} G\\left( {d_{kj} ,d_{0} } \\right)R_{j}$$\\end{document}</tex-math><mml:math id=\"M56\" display=\"block\"><mml:mrow><mml:msubsup><mml:mi>A</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mi>F</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:munder><mml:mo movablelimits=\"false\">∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>∈</mml:mo><mml:mfenced close=\"}\" open=\"{\"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">kj</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:munder><mml:mi>G</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">kj</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:msub><mml:mi>R</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq25\"><alternatives><tex-math id=\"M57\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d_{jk}$$\\end{document}</tex-math><mml:math id=\"M58\"><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">jk</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq26\"><alternatives><tex-math id=\"M59\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k$$\\end{document}</tex-math><mml:math id=\"M60\"><mml:mi>k</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq27\"><alternatives><tex-math id=\"M61\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$j$$\\end{document}</tex-math><mml:math id=\"M62\"><mml:mi>j</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq28\"><alternatives><tex-math id=\"M63\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d_{0}$$\\end{document}</tex-math><mml:math id=\"M64\"><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq29\"><alternatives><tex-math id=\"M65\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$S_{j}$$\\end{document}</tex-math><mml:math id=\"M66\"><mml:msub><mml:mi>S</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq30\"><alternatives><tex-math id=\"M67\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P_{k}$$\\end{document}</tex-math><mml:math id=\"M68\"><mml:msub><mml:mi>P</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq31\"><alternatives><tex-math id=\"M69\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k$$\\end{document}</tex-math><mml:math id=\"M70\"><mml:mi>k</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq32\"><alternatives><tex-math id=\"M71\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$G\\left( {d_{kj} ,d_{0} } \\right)$$\\end{document}</tex-math><mml:math id=\"M72\"><mml:mrow><mml:mi>G</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">kj</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq33\"><alternatives><tex-math id=\"M73\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${d}_{0}$$\\end{document}</tex-math><mml:math id=\"M74\"><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq34\"><alternatives><tex-math id=\"M75\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$S_{j}$$\\end{document}</tex-math><mml:math id=\"M76\"><mml:msub><mml:mi>S</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq35\"><alternatives><tex-math id=\"M77\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$S_{j}$$\\end{document}</tex-math><mml:math id=\"M78\"><mml:msub><mml:mi>S</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Eque\"><alternatives><tex-math id=\"M79\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$S_{{j\\left( {RQ} \\right)}} = S_{j} \\left( {1 + x_{EM} } \\right)$$\\end{document}</tex-math><mml:math id=\"M80\" display=\"block\"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"italic\">RQ</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">EM</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq36\"><alternatives><tex-math id=\"M81\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x_{EM}$$\\end{document}</tex-math><mml:math id=\"M82\"><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">EM</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq37\"><alternatives><tex-math id=\"M83\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$S_{{j\\left( {RQ} \\right)}}$$\\end{document}</tex-math><mml:math id=\"M84\"><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"italic\">RQ</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equf\"><alternatives><tex-math id=\"M85\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$Gini = 1 - \\mathop \\sum \\limits_{k = 1}^{n} \\left( {P_{k} - P_{k - 1} } \\right)\\left( {R_{k} + R_{k - 1} } \\right)$$\\end{document}</tex-math><mml:math id=\"M86\" display=\"block\"><mml:mrow><mml:mi>G</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:munderover><mml:mo movablelimits=\"false\">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:munderover><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq38\"><alternatives><tex-math id=\"M87\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P_{k}$$\\end{document}</tex-math><mml:math id=\"M88\"><mml:msub><mml:mi>P</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq39\"><alternatives><tex-math id=\"M89\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{k}$$\\end{document}</tex-math><mml:math id=\"M90\"><mml:msub><mml:mi>R</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq40\"><alternatives><tex-math id=\"M91\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n$$\\end{document}</tex-math><mml:math id=\"M92\"><mml:mi>n</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equg\"><alternatives><tex-math id=\"M93\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$I_{i} = Z_{xi} \\mathop \\sum \\limits_{{j = 1,{ }j \\ne i}}^{n} W_{ij} Z_{yj}$$\\end{document}</tex-math><mml:math id=\"M94\" display=\"block\"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">xi</mml:mi></mml:mrow></mml:msub><mml:munderover><mml:mo movablelimits=\"false\">∑</mml:mo><mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mrow/><mml:mi>j</mml:mi><mml:mo>≠</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:mrow><mml:mi>n</mml:mi></mml:munderover><mml:msub><mml:mi>W</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">ij</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">yj</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq41\"><alternatives><tex-math id=\"M95\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$I_{i}$$\\end{document}</tex-math><mml:math id=\"M96\"><mml:msub><mml:mi>I</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq42\"><alternatives><tex-math id=\"M97\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$i$$\\end{document}</tex-math><mml:math id=\"M98\"><mml:mi>i</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq43\"><alternatives><tex-math id=\"M99\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$W_{ij}$$\\end{document}</tex-math><mml:math id=\"M100\"><mml:msub><mml:mi>W</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">ij</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq44\"><alternatives><tex-math id=\"M101\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$Z_{xi}$$\\end{document}</tex-math><mml:math id=\"M102\"><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">xi</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq45\"><alternatives><tex-math id=\"M103\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$Z_{yj}$$\\end{document}</tex-math><mml:math id=\"M104\"><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">yj</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq46\"><alternatives><tex-math id=\"M105\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x_{EM}$$\\end{document}</tex-math><mml:math id=\"M106\"><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">EM</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq47\"><alternatives><tex-math id=\"M107\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x_{EM}$$\\end{document}</tex-math><mml:math id=\"M108\"><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">EM</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq48\"><alternatives><tex-math id=\"M109\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x_{EM}$$\\end{document}</tex-math><mml:math id=\"M110\"><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">EM</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq49\"><alternatives><tex-math id=\"M111\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x_{EM}$$\\end{document}</tex-math><mml:math id=\"M112\"><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">EM</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq50\"><alternatives><tex-math id=\"M113\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x_{EM}$$\\end{document}</tex-math><mml:math id=\"M114\"><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">EM</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq51\"><alternatives><tex-math id=\"M115\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x_{EM}$$\\end{document}</tex-math><mml:math id=\"M116\"><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">EM</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq52\"><alternatives><tex-math id=\"M117\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x_{EM}$$\\end{document}</tex-math><mml:math id=\"M118\"><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">EM</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>Note: * indicates significance at the 0.05 level (two-tailed), ** indicates significance at the 0.01 level (two-tailed), indicating significant correlation.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51239_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51239_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51239_Article_Equa.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq9.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq10.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq11.gif\"/>", "<graphic xlink:href=\"41598_2024_51239_Article_Equb.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51239_Article_Equc.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq12.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq13.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq14.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq15.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq16.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq17.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq18.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq19.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq20.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq21.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq22.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq23.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq24.gif\"/>", "<graphic xlink:href=\"41598_2024_51239_Article_Equd.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq25.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq26.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq27.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq28.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq29.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq30.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq31.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq32.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq33.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq34.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq35.gif\"/>", "<graphic xlink:href=\"41598_2024_51239_Article_Eque.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq36.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq37.gif\"/>", "<graphic xlink:href=\"41598_2024_51239_Article_Equf.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq38.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq39.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq40.gif\"/>", "<graphic xlink:href=\"41598_2024_51239_Article_Equg.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq41.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq42.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq43.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq44.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq45.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq46.gif\"/>", "<graphic xlink:href=\"41598_2024_51239_Fig3_HTML\" id=\"MO3\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq47.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq48.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq49.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq50.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq51.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51239_Article_IEq52.gif\"/>", "<graphic xlink:href=\"41598_2024_51239_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51239_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2024_51239_Fig6_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"41598_2024_51239_Fig7_HTML\" id=\"MO7\"/>" ]
[ "<media xlink:href=\"41598_2024_51239_MOESM1_ESM.docx\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["1."], "surname": ["Ye", "Hu", "Li"], "given-names": ["CD", "LQ", "M"], "article-title": ["Urban green space accessibility changes in a high-density city: A case study of Macau from 2010 to 2015"], "source": ["J. Transp. Geogr."], "year": ["2018"], "volume": ["66"], "fpage": ["106"], "lpage": ["115"], "pub-id": ["10.1016/j.jtrangeo.2017.11.009"]}, {"label": ["2."], "surname": ["Kicic", "Haase", "Marin", "Vuletic", "Ostoic"], "given-names": ["M", "D", "AM", "D", "SK"], "article-title": ["Perceptions of cultural ecosystem services of tree-based green infrastructure: A focus group participatory mapping in Zagreb, Croatia"], "source": ["Urban For. Urban Green."], "year": ["2022"], "volume": ["78"], "fpage": ["114"], "pub-id": ["10.1016/j.ufug.2022.127767"]}, {"label": ["3."], "surname": ["Chiesura"], "given-names": ["A"], "article-title": ["The role of urban parks for the sustainable city"], "source": ["Landsc. Urban Plan."], "year": ["2004"], "volume": ["68"], "fpage": ["129"], "lpage": ["138"], "pub-id": ["10.1016/j.landurbplan.2003.08.003"]}, {"label": ["4."], "surname": ["Rigolon"], "given-names": ["A"], "article-title": ["A complex landscape of inequity in access to urban parks: A literature review"], "source": ["Landsc. Urban Plan."], "year": ["2016"], "volume": ["153"], "fpage": ["160"], "lpage": ["169"], "pub-id": ["10.1016/j.landurbplan.2016.05.017"]}, {"label": ["5."], "surname": ["Yu"], "given-names": ["ZW"], "article-title": ["Critical review on the cooling effect of urban blue-green space: A threshold-size perspective"], "source": ["Urban For. Urban Green."], "year": ["2020"], "volume": ["49"], "fpage": ["126630"], "pub-id": ["10.1016/j.ufug.2020.126630"]}, {"label": ["7."], "surname": ["Fan", "Duan", "Lu", "Zou", "Lan"], "given-names": ["ZX", "J", "Y", "WT", "WL"], "article-title": ["A geographical detector study on factors influencing urban park use in Nanjing China"], "source": ["Urban For. Urban Green."], "year": ["2021"], "volume": ["59"], "fpage": ["126996"], "pub-id": ["10.1016/j.ufug.2021.126996"]}, {"label": ["8."], "surname": ["Chiang", "Li"], "given-names": ["YC", "DY"], "article-title": ["Metric or topological proximity? The associations among proximity to parks, the frequency of residents\u2019 visits to parks, and perceived stress"], "source": ["Urban For. Urban Green."], "year": ["2019"], "volume": ["38"], "fpage": ["205"], "lpage": ["214"], "pub-id": ["10.1016/j.ufug.2018.12.011"]}, {"label": ["9."], "surname": ["Yan", "Zhu", "Wang", "Tang"], "given-names": ["JS", "W", "BS", "LN"], "article-title": ["Social equity of park green space in transitional industrial cities: A case study of Dongcheng Street in Dongguan City"], "source": ["Acta Ecol. Sin."], "year": ["2021"], "volume": ["41"], "fpage": ["8921"], "lpage": ["8930"]}, {"label": ["10."], "surname": ["Yigitcanlar", "Kamruzzaman", "Teimouri", "Degirmenci", "Alanjagh"], "given-names": ["T", "M", "R", "K", "FA"], "article-title": ["Association between park visits and mental health in a developing country context: The case of Tabriz, Iran"], "source": ["Landsc. Urban Plan."], "year": ["2020"], "volume": ["199"], "fpage": ["125"], "pub-id": ["10.1016/j.landurbplan.2020.103805"]}, {"label": ["12."], "surname": ["Coppel", "Wustemann"], "given-names": ["G", "H"], "article-title": ["The impact of urban green space on health in Berlin, Germany: Empirical findings and implications for urban planning"], "source": ["Landsc. Urban Plan."], "year": ["2017"], "volume": ["167"], "fpage": ["410"], "lpage": ["418"], "pub-id": ["10.1016/j.landurbplan.2017.06.015"]}, {"label": ["14."], "surname": ["Li", "Ye"], "given-names": ["M", "CD"], "article-title": ["Threshold standard and global distribution of high-desity cities"], "source": ["World Reg. Stud."], "year": ["2015"], "volume": ["24"], "fpage": ["38"], "lpage": ["45"]}, {"label": ["15."], "surname": ["Yao", "Yao", "Cenci", "Liao", "Zhang"], "given-names": ["MX", "B", "J", "CY", "JZ"], "article-title": ["Visualisation of high-density city research evolution, trends, and outlook in the 21st century"], "source": ["Land"], "year": ["2023"], "volume": ["12"], "fpage": ["145"], "pub-id": ["10.3390/land12020485"]}, {"label": ["16."], "surname": ["Zhou", "Shen", "Woodfin", "Chen", "Song"], "given-names": ["L", "GQ", "T", "T", "K"], "article-title": ["Ecological and economic impacts of green roofs and permeable pavements at the city level: The case of Corvallis, Oregon"], "source": ["J. Environ. Plan. Manag."], "year": ["2018"], "volume": ["61"], "fpage": ["430"], "lpage": ["450"], "pub-id": ["10.1080/09640568.2017.1314859"]}, {"label": ["17."], "surname": ["Wustemann", "Kalisch", "Kolbe"], "given-names": ["H", "D", "J"], "article-title": ["Access to urban green space and environmental inequalities in Germany"], "source": ["Landsc. Urban Plan."], "year": ["2017"], "volume": ["164"], "fpage": ["124"], "lpage": ["131"], "pub-id": ["10.1016/j.landurbplan.2017.04.002"]}, {"label": ["18."], "surname": ["Zhou", "Zhang"], "given-names": ["CH", "Y"], "article-title": ["Mini-Park layout formation method in high-density cities"], "source": ["Chin. Landsc. Archit."], "year": ["2021"], "volume": ["37"], "fpage": ["60"], "lpage": ["65"]}, {"label": ["19."], "mixed-citation": ["National New Urbanization Plan (2014\u20132020). "], "italic": ["The State Council and The People\u2019s Republic of China."], "ext-link": ["https://www.gov.cn/zhengce/2014-03/16/content_2640075.htm"]}, {"label": ["20."], "surname": ["Wang", "Huang", "Deng", "Wei"], "given-names": ["CX", "SY", "MT", "W"], "article-title": ["Research on equity of park green spaces in high-density cities from the perspective of supply-demand coupling coordination: A case study of Longhua District, Shenzhen"], "source": ["Chin. Landsc. Archit."], "year": ["2023"], "volume": ["39"], "fpage": ["79"], "lpage": ["84"]}, {"label": ["21."], "surname": ["Shi", "Chen", "Jia", "Du", "Wang"], "given-names": ["MQ", "M", "WX", "CL", "YT"], "article-title": ["Cooling effect and cooling accessibility of urban parks during hot summers in China?s largest sustainability experiment"], "source": ["Sustain. Cities Soc."], "year": ["2023"], "volume": ["93"], "fpage": ["104519"], "pub-id": ["10.1016/j.scs.2023.104519"]}, {"label": ["22."], "surname": ["Lan", "Liu", "Huang", "Corcoran", "Peng"], "given-names": ["TH", "YX", "GL", "J", "J"], "article-title": ["Urban green space and cooling services: Opposing changes of integrated accessibility and social equity along with urbanization"], "source": ["Sustain. Cities Soc."], "year": ["2022"], "volume": ["84"], "fpage": ["104500"], "pub-id": ["10.1016/j.scs.2022.104005"]}, {"label": ["23."], "surname": ["Wang", "Cao", "Yao", "Wu"], "given-names": ["RY", "MQ", "Y", "WJ"], "article-title": ["The inequalities of different dimensions of visible street urban green space provision: A machine learning approach"], "source": ["Land Use Policy"], "year": ["2022"], "volume": ["123"], "fpage": ["106410"], "pub-id": ["10.1016/j.landusepol.2022.106410"]}, {"label": ["24."], "surname": ["Zhang", "Peng", "Sun", "Deng", "Che"], "given-names": ["R", "SJ", "FY", "LZ", "Y"], "article-title": ["Assessing the social equity of urban parks: An improved index integrating multiple quality dimensions and service accessibility"], "source": ["Cities"], "year": ["2022"], "volume": ["129"], "fpage": ["108329"], "pub-id": ["10.1016/j.cities.2022.103839"]}, {"label": ["25."], "surname": ["Li", "Huang", "Ma"], "given-names": ["X", "Y", "XD"], "article-title": ["Evaluation of the accessible urban public green space at the community-scale with the consideration of temporal accessibility and quality"], "source": ["Ecol. Indic."], "year": ["2021"], "volume": ["131"], "fpage": ["108231"], "pub-id": ["10.1016/j.ecolind.2021.108231"]}, {"label": ["26."], "surname": ["Talen", "Anselin"], "given-names": ["E", "L"], "article-title": ["Assessing spatial equity: An evaluation of measures of accessibility to public playgrounds"], "source": ["Environ. Plan. A"], "year": ["1998"], "volume": ["30"], "fpage": ["595"], "lpage": ["613"], "pub-id": ["10.1068/a300595"]}, {"label": ["27."], "surname": ["Hu", "Song", "Li", "Lu"], "given-names": ["SJ", "W", "CG", "J"], "article-title": ["A multi-mode Gaussian-based two-step floating catchment area method for measuring accessibility of urban parks"], "source": ["Cities"], "year": ["2020"], "volume": ["105"], "fpage": ["10215"], "pub-id": ["10.1016/j.cities.2020.102815"]}, {"label": ["28."], "surname": ["Taleai", "Sliuzas", "Flacke"], "given-names": ["M", "R", "J"], "article-title": ["An integrated framework to evaluate the equity of urban public facilities using spatial multi-criteria analysis"], "source": ["Cities"], "year": ["2014"], "volume": ["40"], "fpage": ["56"], "lpage": ["69"], "pub-id": ["10.1016/j.cities.2014.04.006"]}, {"label": ["29."], "surname": ["Van Herzele", "Wiedemann"], "given-names": ["A", "T"], "article-title": ["A monitoring tool for the provision of accessible and attractive urban green spaces"], "source": ["Landsc. Urban Plan."], "year": ["2003"], "volume": ["63"], "fpage": ["109"], "lpage": ["126"], "pub-id": ["10.1016/S0169-2046(02)00192-5"]}, {"label": ["30."], "surname": ["Comber", "Brunsdon", "Green"], "given-names": ["A", "C", "E"], "article-title": ["Using a GIS-based network analysis to determine urban greenspace accessibility for different ethnic and religious groups"], "source": ["Landsc. Urban Plan."], "year": ["2008"], "volume": ["86"], "fpage": ["103"], "lpage": ["114"], "pub-id": ["10.1016/j.landurbplan.2008.01.002"]}, {"label": ["31."], "mixed-citation": ["Zhao, F., Chow, L. F., Li, M. T., Ubaka, I. & Gan, A. Forecasting transit walk accessibility\u2014Regression model alternative to buffer method. In "], "italic": ["Transit: Planning and Development, Management and Performance, Marketing and Fare Policy, And Intermodal Transfer Facilities: Public Transit"]}, {"label": ["32."], "surname": ["Chang", "Chen", "Li", "Li"], "given-names": ["Z", "JY", "WF", "X"], "article-title": ["Public transportation and the spatial inequality of urban park accessibility: New evidence from Hong Kong"], "source": ["Transp. Res. PART Transp. Environ."], "year": ["2019"], "volume": ["76"], "fpage": ["111"], "lpage": ["122"], "pub-id": ["10.1016/j.trd.2019.09.012"]}, {"label": ["34."], "surname": ["Oh", "Jeong"], "given-names": ["K", "S"], "article-title": ["Assessing the spatial distribution of urban parks using GIS"], "source": ["Landsc. Urban Plan."], "year": ["2007"], "volume": ["82"], "fpage": ["25"], "lpage": ["32"], "pub-id": ["10.1016/j.landurbplan.2007.01.014"]}, {"label": ["35."], "surname": ["Dou"], "given-names": ["Y"], "article-title": ["An empirical study on transit-oriented low-carbon urban land use planning: Exploratory Spatial Data Analysis (ESDA) on Shanghai, China"], "source": ["Habitat Int."], "year": ["2016"], "volume": ["53"], "fpage": ["379"], "lpage": ["389"], "pub-id": ["10.1016/j.habitatint.2015.12.005"]}, {"label": ["36."], "surname": ["Dai"], "given-names": ["D"], "article-title": ["Racial/ethnic and socioeconomic disparities in urban green space accessibility: Where to intervene?"], "source": ["Landsc. Urban Plan."], "year": ["2011"], "volume": ["102"], "fpage": ["234"], "lpage": ["244"], "pub-id": ["10.1016/j.landurbplan.2011.05.002"]}, {"label": ["37."], "surname": ["Xing", "Liu", "Liu", "Wei", "Mao"], "given-names": ["LJ", "YF", "XJ", "XJ", "Y"], "article-title": ["Spatio-temporal disparity between demand and supply of park green space service in urban area of Wuhan from 2000 to 2014"], "source": ["Habitat Int."], "year": ["2018"], "volume": ["71"], "fpage": ["49"], "lpage": ["59"], "pub-id": ["10.1016/j.habitatint.2017.11.002"]}, {"label": ["38."], "surname": ["Li", "Xie", "Sun", "Hu"], "given-names": ["YM", "YL", "SQ", "LF"], "article-title": ["Evaluation of park accessibility based on improved gaussian two-step floating catchment area method: A case study of Xi\u2019an city"], "source": ["Buildings"], "year": ["2022"], "volume": ["12"], "fpage": ["145"]}, {"label": ["39."], "surname": ["Wu", "Chen", "Wang", "He", "Zhou"], "given-names": ["JY", "HT", "HY", "QS", "K"], "article-title": ["Will the opening community policy improve the equity of green accessibility and in what ways? - Response based on a 2-step floating catchment area method and genetic algorithm"], "source": ["J. Clean. Prod."], "year": ["2020"], "volume": ["263"], "fpage": ["145"], "pub-id": ["10.1016/j.jclepro.2020.121454"]}, {"label": ["40."], "surname": ["Feng", "Li", "Lyv", "Li"], "given-names": ["JM", "Y", "S", "C"], "article-title": ["Route selection planning for urban pedestrian and bicycle transport corridor based on internet word-of-mouth big data: A case study of Haidian District in Beijing"], "source": ["Landsc. Archit."], "year": ["2022"], "volume": ["29"], "fpage": ["120"], "lpage": ["126"]}, {"label": ["41."], "surname": ["Zhang", "Wu"], "given-names": ["JB", "E"], "article-title": ["Recreation function in national parks based on tourists\u2019 perceived value: Two case studies of Yellowstone National Park and Wuyishan National Park"], "source": ["World Reg. Stud."], "year": ["2023"], "volume": ["32"], "fpage": ["146"], "lpage": ["157"]}, {"label": ["42."], "surname": ["Zhang", "Yan", "Liu", "Xu"], "given-names": ["YX", "SR", "J", "PQ"], "article-title": ["Popularity influence mechanism of creative industry parks: A semantic analysis based on social media data"], "source": ["Sustain. Cities Soc."], "year": ["2023"], "volume": ["90"], "fpage": ["104384"], "pub-id": ["10.1016/j.scs.2022.104384"]}, {"label": ["43."], "surname": ["Kumar"], "given-names": ["R"], "article-title": ["A hybrid fuzzy rule-based multi-criteria framework for sustainable-security assessment of web application"], "source": ["Ain Shams Eng. J."], "year": ["2021"], "volume": ["12"], "fpage": ["2227"], "lpage": ["2240"], "pub-id": ["10.1016/j.asej.2021.01.003"]}, {"label": ["44."], "surname": ["Kumar", "Alenezi", "Ansari", "Gupta", "Khan"], "given-names": ["R", "M", "MTJ", "BK", "RA"], "article-title": ["Evaluating the impact of malware analysis techniques for securing web applications through a decision-making framework under fuzzy environment"], "source": ["Int. J. Intell. Eng. Syst."], "year": ["2020"], "volume": ["13"], "fpage": ["94"], "lpage": ["109"]}, {"label": ["45."], "surname": ["Mou"], "given-names": ["NX"], "article-title": ["Flowers as attractions in urban parks: Evidence from social media data"], "source": ["Urban For. Urban Green."], "year": ["2023"], "volume": ["82"], "fpage": ["128774"], "pub-id": ["10.1016/j.ufug.2023.127874"]}, {"label": ["46."], "surname": ["Zhu", "Gao", "Zhang", "Zhang"], "given-names": ["X", "M", "R", "B"], "article-title": ["Quantifying emotional differences in urban green spaces extracted from photos on social networking sites: A study of 34 parks in three cities in northern China"], "source": ["Urban For. Urban Green."], "year": ["2021"], "volume": ["62"], "fpage": ["127133"], "pub-id": ["10.1016/j.ufug.2021.127133"]}, {"label": ["47."], "surname": ["Wang"], "given-names": ["ZF"], "article-title": ["Revealing the differences of urban parks\u2019 services to human wellbeing based upon social media data"], "source": ["Urban For. Urban Green."], "year": ["2021"], "volume": ["63"], "fpage": ["127233"], "pub-id": ["10.1016/j.ufug.2021.127233"]}, {"label": ["48."], "mixed-citation": ["Chaoyang District People\u2018s Government of Beijing Municipality. Chaoyang District District Planning (Land and Space Planning) (2017\u20132035). "], "ext-link": ["http://www.bjchy.gov.cn/affair/announcement/8a24fe836e8810aa016ef2c051994efb.html"]}, {"label": ["49."], "mixed-citation": ["List of Parks in Beijing (First Batch). "], "ext-link": ["http://yllhj.beijing.gov.cn/ggfw/bjsggml/bjsgymlzb/202304/P020230428531509735432.pdf"]}, {"label": ["50."], "mixed-citation": ["Nation Bureau of Statistics. "], "italic": ["Nation Bureau of Statistics."], "ext-link": ["http://www.stats.gov.cn/sj/tjbz/tjyqhdmhcxhfdm/2022/11/01/110105.html"]}, {"label": ["51."], "mixed-citation": ["Statistical Bulletin on National Economic and Social Development in Chaoyang District in 2022. "], "italic": ["Chaoyang District People\u2019s Government of Beijing Municipality"], "ext-link": ["http://www.bjchy.gov.cn/affair/tjgb/4028805a8797c86401879891fa960123.html"]}, {"label": ["52."], "mixed-citation": ["Creating an Ecological Business Card of \u2018National Forest City\u2019 in Chaoyang District, Beijing. "], "italic": ["Beijing Municipal Forestry and Park Bureau (Office of Beijing Greening Commission)"], "ext-link": ["http://yllhj.beijing.gov.cn/zwgk/zwxx/202301/t20230118_2903460.shtml"]}, {"label": ["53."], "surname": ["Yu", "Eisenman", "Han"], "given-names": ["SB", "D", "ZQ"], "article-title": ["Temporal dynamics of public emotions during the COVID-19 pandemic at the epicenter of the outbreak: Sentiment analysis of Weibo posts From Wuhan"], "source": ["J. Med. Internet Res."], "year": ["2021"], "volume": ["23"], "fpage": ["149"], "pub-id": ["10.2196/27078"]}, {"label": ["54."], "surname": ["Wang", "Xia", "Wu"], "given-names": ["JB", "Y", "YT"], "article-title": ["Sensing tourist distributions and their sentiment variations using social media: Evidence from 5A scenic areas in China"], "source": ["ISPRS Int. J. GEO-Inf."], "year": ["2022"], "volume": ["11"], "fpage": ["492"], "pub-id": ["10.3390/ijgi11090492"]}, {"label": ["55."], "surname": ["Zhai", "Zhou"], "given-names": ["YJ", "CH"], "article-title": ["Comparison among Urban park accessibility evaluation models based on empirical cases"], "source": ["Chin. Landsc. Archit."], "year": ["2019"], "volume": ["35"], "fpage": ["78"], "lpage": ["83"]}, {"label": ["56."], "surname": ["Wang", "Chen", "Zhou"], "given-names": ["M", "ZJ", "C"], "article-title": ["Accessibility of urban green open space based on weighted two-step floating catchment area method: A case study of the central district of Nanjing City"], "source": ["Acta Ecol. Sin."], "year": ["2023"], "volume": ["43"], "fpage": ["5347"], "lpage": ["5356"]}, {"label": ["57."], "surname": ["Wu", "Zheng"], "given-names": ["W", "TH"], "article-title": ["Establishing a \u2018dynamic two-step floating catchment area method\u2019 to assess the accessibility of urban green space in Shenyang based on dynamic population data and multiple modes of transportation"], "source": ["Urban For. Urban Green."], "year": ["2023"], "volume": ["82"], "fpage": ["127893"], "pub-id": ["10.1016/j.ufug.2023.127893"]}, {"label": ["58."], "surname": ["Ricciardi", "Xia", "Currie"], "given-names": ["AM", "JH", "G"], "article-title": ["Exploring public transport equity between separate disadvantaged cohorts: A case study in Perth, Australia"], "source": ["J. Transp. Geogr."], "year": ["2015"], "volume": ["43"], "fpage": ["111"], "lpage": ["122"], "pub-id": ["10.1016/j.jtrangeo.2015.01.011"]}, {"label": ["59."], "surname": ["Guo"], "given-names": ["SH"], "article-title": ["Accessibility to urban parks for elderly residents: Perspectives from mobile phone data"], "source": ["Landsc. Urban Plan."], "year": ["2019"], "volume": ["191"], "fpage": ["10369"], "pub-id": ["10.1016/j.landurbplan.2019.103642"]}, {"label": ["60."], "surname": ["Xiao", "Wang", "Fang"], "given-names": ["Y", "D", "J"], "article-title": ["Exploring the disparities in park access through mobile phone data: Evidence from Shanghai, China"], "source": ["Landsc. Urban Plan."], "year": ["2019"], "volume": ["181"], "fpage": ["80"], "lpage": ["91"], "pub-id": ["10.1016/j.landurbplan.2018.09.013"]}, {"label": ["61."], "surname": ["Shiode", "Morita", "Shiode", "Okunuki"], "given-names": ["N", "M", "S", "K"], "article-title": ["Urban and rural geographies of aging: A local spatial correlation analysis of aging population measures"], "source": ["Urban Geogr."], "year": ["2014"], "volume": ["35"], "fpage": ["608"], "lpage": ["628"], "pub-id": ["10.1080/02723638.2014.905256"]}, {"label": ["62."], "surname": ["Jelen", "Santruckova", "Komarek"], "given-names": ["J", "M", "M"], "article-title": ["Typology of historical cultural landscapes based on their cultural elements"], "source": ["Geografie"], "year": ["2021"], "volume": ["126"], "fpage": ["243"], "lpage": ["261"], "pub-id": ["10.37040/geografie2021126030243"]}, {"label": ["63."], "surname": ["Jin", "Lee", "Lee"], "given-names": ["N", "S", "H"], "article-title": ["The effect of experience quality on perceived value, satisfaction, image and behavioral intention of water park patrons: New versus repeat visitors"], "source": ["Int. J. Tour. Res."], "year": ["2015"], "volume": ["17"], "fpage": ["82"], "lpage": ["95"], "pub-id": ["10.1002/jtr.1968"]}, {"label": ["64."], "surname": ["Zlender", "Thompson"], "given-names": ["V", "CW"], "article-title": ["Accessibility and use of peri-urban green space for inner-city dwellers: A comparative study"], "source": ["Landsc. Urban Plan."], "year": ["2017"], "volume": ["165"], "fpage": ["193"], "lpage": ["205"], "pub-id": ["10.1016/j.landurbplan.2016.06.011"]}, {"label": ["65."], "surname": ["Zhou", "Chen", "Xu"], "given-names": ["S", "F", "Z"], "article-title": ["Evaluating the accessibility of urban parks and waterfronts through online map services: A case study of Shaoxing, China"], "source": ["Urban For. Urban Green."], "year": ["2022"], "volume": ["77"], "fpage": ["156"], "pub-id": ["10.1016/j.ufug.2022.127731"]}, {"label": ["66."], "surname": ["Tu", "Huang", "Wu", "Guo"], "given-names": ["XY", "GL", "JG", "X"], "article-title": ["How do travel distance and park size influence urban park visits?"], "source": ["Urban For. Urban Green."], "year": ["2020"], "volume": ["52"], "fpage": ["12289"], "pub-id": ["10.1016/j.ufug.2020.126689"]}, {"label": ["67."], "mixed-citation": ["Parks in the first green belt area of Beijing. "], "italic": ["Beijing Municipal Forestry and Park Bureau (Office of Beijing Greening Commission)"], "ext-link": ["https://yllhj.beijing.gov.cn/zwgk/sjfb/mlxx/202204/t20220419_2681195.shtml"]}, {"label": ["68."], "surname": ["Sun"], "given-names": ["Z"], "article-title": ["Thermal environment characteristic and cooling effect of greenery in Beijing First Green Belt area"], "source": ["Chin. J. Ecol."], "year": ["2019"], "volume": ["38"], "fpage": ["3496"], "lpage": ["3505"]}, {"label": ["69."], "surname": ["La Rosa", "Takatori", "Shimizu", "Privitera"], "given-names": ["D", "C", "H", "R"], "article-title": ["A planning framework to evaluate demands and preferences by different social groups for accessibility to urban greenspaces"], "source": ["Sustain. Cities Soc."], "year": ["2018"], "volume": ["36"], "fpage": ["346"], "lpage": ["362"], "pub-id": ["10.1016/j.scs.2017.10.026"]}, {"label": ["70."], "surname": ["Reyes", "Paez", "Morency"], "given-names": ["M", "A", "C"], "article-title": ["Walking accessibility to urban parks by children: A case study of Montreal"], "source": ["Landsc. Urban Plan."], "year": ["2014"], "volume": ["125"], "fpage": ["38"], "lpage": ["47"], "pub-id": ["10.1016/j.landurbplan.2014.02.002"]}, {"label": ["71."], "surname": ["Grilli", "Mohan", "Curtis"], "given-names": ["G", "G", "J"], "article-title": ["Public park attributes, park visits, and associated health status"], "source": ["Landsc. Urban Plan."], "year": ["2020"], "volume": ["199"], "fpage": ["1038"], "pub-id": ["10.1016/j.landurbplan.2020.103814"]}, {"label": ["72."], "surname": ["Maas"], "given-names": ["J"], "article-title": ["Morbidity is related to a green living environment"], "source": ["J. Epidemiol. Commun. Health"], "year": ["2009"], "volume": ["63"], "fpage": ["967"], "lpage": ["973"], "pub-id": ["10.1136/jech.2008.079038"]}]
{ "acronym": [], "definition": [] }
72
CC BY
no
2024-01-14 23:40:15
Sci Rep. 2024 Jan 12; 14:1160
oa_package/31/99/PMC10786826.tar.gz
PMC10786827
38216641
[ "<title>Introduction</title>", "<p id=\"Par2\">Coaching and training help athletes improve performance and win competitions. Skill-based training, strength and conditioning, and competition drive performance. To improve, the coaching team must understand and determine the type, amount, and training frequency<sup>##UREF##0##1##,##UREF##1##2##</sup>. Forecasting performance using Artificial Intelligence (AI)<sup>##REF##31270636##3##,##REF##33855647##4##</sup> allows for optimized strategies and benefits stakeholders. These methods using large datasets can provide the coaches with robust feedback and help make informed decisions. Also, combining AI techniques with coaches’ expertise can improve prediction<sup>##REF##28488907##5##</sup>.</p>", "<p id=\"Par3\">Driven by big data and machine learning (ML), sports data analytics (SDA) has started to support evidence-based knowledge. In basketball, ML techniques are focused on players and the team, with performance prediction and injury risk as key challenges to be handled<sup>##UREF##2##6##</sup>. The ML approaches use supervised learning that builds models using input–output data pairs or unsupervised learning that identifies patterns using only input data<sup>##UREF##2##6##</sup>. The performance prediction is made using Artificial Neural Network (ANN), Decision Trees (DT) based Ensemble methods, and Support Vector Machine (SVM)<sup>##REF##31270636##3##,##REF##33855647##4##</sup>.</p>", "<p id=\"Par4\">Performance prediction is made using technical and tactical analysis, and factors shown in Fig. ##FIG##0##1## are covered by ML techniques<sup>##REF##31270636##3##,##UREF##2##6##–##UREF##5##11##</sup> for performance prediction. The objective evaluation of the ML technique and coaches’ expertise significantly impacts player-level performance. Team-level performance can be used to evaluate individual games and team performance across the season or conference. A player’s importance is determined by measuring the average marginal contribution to winning a basketball game<sup>##UREF##4##10##</sup>. The method predicts winning probabilities associated with a selected lineup, and by averaging over many lineups, the player’s importance is estimated using Shapley values<sup>##UREF##4##10##</sup>. Players can also be ranked according to their contribution to the team’s performance using the Bayesian framework<sup>##UREF##6##12##,##UREF##7##13##</sup>. It is also necessary to build a predictive model that generalizes for individual athletes or the whole group<sup>##REF##35091649##8##</sup> with improved performance. Also, new features provide interesting insights into athletic performance by considering high sampling rate tracking systems<sup>##REF##36075956##9##</sup>.</p>", "<p id=\"Par5\">The coaches must know and adjust key factors, training variables, practice schedules, and overall stress to improve performance. Therefore, this paper uses a multi-level approach with supervised ML to analyze a competitive basketball season and predict individual, team, and whole-season performance.</p>" ]
[ "<title>Methods</title>", "<p id=\"Par6\">We define key performance indicators (KPIs) at each level to address the three-tiered question. At the tier 1—athlete level, we study their weekly readiness using countermovement jumps. The readiness was defined using KPI <italic>reactive strength index modified</italic> (RSImod), which is defined as follows (<sup>##REF##32132844##14##</sup>):where <italic>JH</italic> is the Jump Height and <italic>CT</italic> is the Contact Time. At the team level (tier 2), we calculate the <italic>game score</italic><sup>##UREF##8##15##</sup> for each game of the season. The game score KPI is computed using key game metrics and reflects the player’s in-game contribution. The KPI used at the conference level (tier 3) is <italic>player efficiency rating</italic> (PER); it shows a player’s efficiency in comparison to the average across the player’s conference<sup>##UREF##8##15##</sup>. The PER is computed after each game to account for scheduling difficulty during the season.</p>", "<p id=\"Par7\">RSImod examined the effects of weekly training and stress on the athlete. We tied it with team-level KPI to examine if better readiness leads to better game scores. Finally, we tied level 2 and level 3 by checking if a greater game score across the season raised the PER.</p>", "<p id=\"Par8\">The three levels and each measured feature can be found in Fig. ##FIG##1##2##. Division-1 teams are categorized into conferences based on the region for collegiate athletics. Sacred Heart University’s Division-1 women’s basketball team is in the Northeast Conference (NEC) with eight other schools; therefore, PER is calculated based on NEC data. All conferences are under the National Collegiate Athletic Association (NCAA), considered the league.</p>", "<title>Participants and ethics</title>", "<p id=\"Par9\">Sixteen Division -1 female basketball players (Age: 21 ± 3 yrs; Height: 174.21 ± 19.27 cm; Body Mass: 73.98 ± 11.52 kg) were tested and monitored between October 2021 and March 2022. A season’s analysis incorporated training and game workload measures, vertical jumps, subjective athlete questionnaires, sleep data, game score, and player efficiency rating parameters. This information was cleaned, organized, and analyzed with machine learning methods to find the critical features that predict performance. This project was submitted and approved by the University’s Institutional Review Board (IRB#170720A). The methods and procedures of the study were explained to the participants, and signed informed consent was obtained. All procedures followed the Declaration of Helsinki.</p>", "<title>Data collection</title>", "<p id=\"Par10\">A sample of unidentified data used for the analysis (along with the Jupyter Notebook code file) is provided as additional Supplementary Data files.</p>", "<title>Workload data</title>", "<p id=\"Par11\">Training load was calculated as a weekly score by summing the total work completed in sports practice, metabolic conditioning, strength training, and gameplay. Following each training session, a session rating of perceived exertion (sRPE) was calculated based on a 1–10 Likert scale. The sRPE was completed by taking the total training time and the athletes' subjective rating. Total Weekly Load (TWLoad) and standard deviation were calculated using all sRPE values for the week. The weekly resistance training load was calculated by summing the total weight lifted during each session (sets x repetitions x load). Practice and game metrics (distance, heart rate, velocities, and accelerations) were calculated through the Polar Team Pro system (Polar Team Pro, Polar Electro, Kempele, FI) sampling at 10 Hz. All metrics were calculated using Polar’s proprietary collection and analysis software. Training monotony was calculated by taking the mean daily load and normalizing it by the weekly standard deviation of the training load. Training strain was calculated by taking TWLoad and multiplying it by the monotony score.</p>", "<title>Vertical jump data</title>", "<p id=\"Par12\">Countermovement Vertical jumps were collected once per week on the first practice day of each week (typically Monday or Tuesday). Subjects completed a standardized general warm-up in concert with practice. Then, they completed two vertical jumps of 50 and 75% of the athlete's perceived maximum with 30 s of passive rest between repetitions. Next, subjects would complete two maximal vertical jumps with a near-weightless polyvinyl chloride pipe placed below the C7 spinous process in the back-squat position to limit arm swing. The average of the two jumps was considered for analysis. All jumps occurred on dual force plates (FD Lites, Force decks, Newstead, QLS, AUS) sampling at 1000 Hz. All data were collected and analyzed in the proprietary Force Decks software. The metric of interest for this study was the RSImod, the KPI at the player level. Additional metrics collected were jump height via flight time and peak power, which were reported to the training staff as part of normal monitoring and testing of the athletes.</p>", "<title>Subjective questionnaire data</title>", "<p id=\"Par13\">Athletes were instructed to complete a bi-weekly recovery and stress questionnaire upon waking<sup>##UREF##9##16##,##UREF##10##17##</sup>. Each athlete individually completed eight questions (4 stress and 4 recovery questions). A 0–6 Likert scale was used for questions related to Negative Emotional State (NES), Overall Recovery (OR), Overall Stress (OS), Mental Performance Capability (MPC), Muscular Stress (MS), Physical Performance Capability (PPC), Emotional Balance (EB) and Lack of Activation (LA). This survey is valid and reliable for athletic populations<sup>##UREF##10##17##</sup>.</p>", "<title>Sleep data collection</title>", "<p id=\"Par14\">Whoop straps were distributed to all athletes and worn during the entire collection period. Athletes were instructed to wear them during sleep and daily activity, and data was collected through Whoop’s proprietary collection software. They were removed during games and practice. The metrics analyzed through the study were resting heart rate, heart rate variability, sleep parameters, and recovery parameters. In total, 22 features were collected and monitored daily for each athlete. The Whoop has been determined to be both reliable and valid compared to polysomnography in third-party testing for sleep and heart rate<sup>##REF##32043961##18##,##REF##32713257##19##</sup>.</p>", "<title>Game score calculation</title>", "<p id=\"Par15\">John Hollinger developed a metric, game score<sup>##UREF##8##15##</sup>, for calculating the athlete’s value per game. This being a compact measure of the productivity of the athlete as it quantifies the athlete's impact in a particular game, the game performance was quantified as <italic>game score</italic>. Please refer to Appendix I in the supplementary material.</p>", "<title>Player efficiency rating calculation</title>", "<p id=\"Par16\">PER is calculated using various factors, including points, rebounds, attempts, assists, steals, blocks, and turnovers<sup>##UREF##8##15##,##UREF##11##20##</sup>. Individual players’ names, the date, points scored, minutes played, 3-pointers attempted and made, 2-pointers attempted and made, free throws attempted and made, offensive rebounds, defensive rebounds, blocks, steals, turnovers, and personal fouls were exported from the university’s affiliated open-access athletic website into an Excel sheet<sup>##UREF##12##21##</sup>. The possession was then calculated for each team, allowing the League Pace to be found. The League pace was averaged by the game date and then averaged together to create the overall conference pace. Please refer to Appendix II in the supplementary material.</p>", "<title>Ethics approval</title>", "<p id=\"Par17\">This project was submitted and approved by the University’s Institutional Review Board (IRB#170720A). The methods and procedures of the study were explained to the participants, and signed informed consent was obtained. All procedures were by the Declaration of Helsinki.</p>" ]
[]
[ "<title>Discussion</title>", "<p id=\"Par29\">This study predicts performance at three tiers—player, team, and conference using ML. The KPIs at each level and their interactions across levels provide coaches insight into how to prepare for training and manage workloads during the competitive season. We use partial dependence plots (PDPs) to interpret the impact of a feature on the performance<sup>##REF##32134965##30##</sup>. PDP captures the instantaneous change in a feature over the target while holding all other features constant.</p>", "<title>Athlete level (RSImod prediction)</title>", "<p id=\"Par30\">RSImod positively correlated with training metrics, physiological measurement by WHOOP, and subjective stress. Adequate stimulus across modalities allows athletes to show better readiness for the following week. The appropriate amount of strain with proper training strategies increased the RSImod, as shown by the PDP of the strain in Appendix VIII (Fig. S5). However, when strain increases beyond the point of positive adaptation, it can result in fatigue, impaired recovery, and reduced readiness associated with overtraining. Therefore, when overtraining is present, it can lead to stagnation in the RSImod. We found a decreased RSI due to an increased RT volume load due to overtraining. The increased RT volume load also results in a plateauing effect due to a longer recovery time. The PDP for TWLoad signifies that we must avoid too little or too much training as it negatively impacts RSImod. Evidence from sports science suggests the negative impact of excessive training load on RSImod<sup>##UREF##21##31##</sup>. The heart rate variability indicates physiological readiness, and its greater value signifies better adaptability<sup>##REF##32132844##14##</sup>. Providing feedback on HRV improves athlete performance<sup>##UREF##22##32##</sup>, and the intensity and RT volume load negatively impacts HRV<sup>##REF##28573597##33##,##REF##25657120##34##</sup>. MPC’s fifth most important feature is the subjective stress category, which provides insights into how an athlete copes with demands. Thus, all five factors contribute to the athlete’s readiness for the coming week.</p>", "<p id=\"Par31\">We performed a time series analysis and predicted the N + 1 week’s RSI score using the past N weeks' data. The best accuracy (70%) and F1 (0.71) were observed for week 17. However, we could not observe consistency as some players contracted COVID-19 and missed the practice season. For the upcoming season, we will improve methodology with robust data collection and refine time series analysis.</p>", "<title>Team level (game score prediction)</title>", "<p id=\"Par32\">The motor abilities of athletes during the game, like jumping, sprinting, accelerating, changing directions, and decelerating, reflect their strength, endurance, and speed<sup>##UREF##20##29##</sup>. From a technical and tactical viewpoint, these factors impact the athlete’s game performance. Four of the five most important features (average speed and distance, recovery time, speed and total acceleration zones, and high-intensity acceleration zones) are in-game motor abilities. Usually, high-scoring athletes cover lesser distances but achieve top speeds during the games<sup>##UREF##20##29##</sup>. The most important factor—Average speed and distance (F1) includes the maximum speed achieved by an athlete during a game, as shown in the PDP of Appendix VIII (Fig. S6). An athlete in high speed indicates high-intensity moments like shooting or scoring<sup>##UREF##21##31##</sup>, which suggests the athlete is recording more time in high-intensity acceleration zones<sup>##REF##25756657##35##</sup>. It increases the probability of an athlete achieving a greater game score. Acceleration profiles may vary among players and throughout a game<sup>##REF##35173368##36##</sup>. Higher accelerations were found in the game and during key moments when the match was tightly contested<sup>##REF##35173368##36##,##REF##31284445##37##</sup>.</p>", "<p id=\"Par33\">Recovery time depicts physical preparedness and is related to overall fitness. More time spent in recovery prevents acute spikes in workload, resulting in less fatigue, improved game performance (as shown in PDP), and injury prevention<sup>##REF##31479464##38##</sup>. The daily average is representative of the total workload, encompassing physical training, metabolic stress, sports practice, and competition. When extrapolating from the player level, the daily load is related to the amount of training. Consistent exposure to the correct amount of training provides better individual readiness and impacts game scores (as shown in PDP). This implies that coaches and training staff should examine the global workload incurred by each athlete during preparation and competition.</p>", "<title>Conference level (player efficiency rating prediction)</title>", "<p id=\"Par34\">Interestingly, peak power emerged as the main predictor of the PER (Appendix VIII, Fig. S7). However, previous research has demonstrated that power output is a discriminator of players within a team and between competitive levels<sup>##REF##17138630##39##</sup>. In this context, peak power was derived from a countermovement jump used for weekly monitoring. This may provide insights into which athletes are better prepared each week and the need for fatigue management. Next, maximum speed depicts high-intensity moments in competitions. Maximal intensity moments in a match (shooting or scoring) lead athletes to higher speed zones. Hence, the maximum speed of athletes recorded during competitions positively correlates with their conference performance<sup>##UREF##23##40##</sup>. The following two predictors come from the Whoop strap data set. Deep sleep hours are when athletes recover from the stress they undergo during training and competition. Sleep consistency is the rating of how regular the sleep patterns of the athlete are over the days of the week. Previous studies have shown that sleep extension improved basketball performance<sup>##REF##21731144##41##,##UREF##24##42##</sup>. Greater sleep hours and more time spent in deep sleep may provide recovery as this is the time the body repairs itself and provides the most restorative sleep<sup>##UREF##25##43##,##REF##28754605##44##</sup>. Finally, emotional balance is a subjective feature reflecting the recovery/stress of the athlete from the overlapping demands of training, competitions, and academic pressure imposed upon them. Across the season, emotional balance is likely to reflect the recovery and stress an athlete is experiencing and be viewed as a cumulative aspect of the athletic preparation process.</p>", "<title>Most important modality at each level</title>", "<p id=\"Par35\">This paper uses data from five modalities—reactive strength, in-game statistics, sleep and recovery, subjective stress, and training to predict metrics at three levels. We added each modality's ten most important features to find the most important modality (MIM) for RSImod, Game score, and PER. It can be observed from Fig. ##FIG##3##4## that training, sleep, recovery, and subjective stress impact RSImod and MIM's training data. The game score is impacted by in-game statistics, training, and sleep and recovery data, and MIM is in-game statistics. PER is impacted by in-game statistics, sleep and recovery, subjective stress, and reactive strength, with MIM as in-game statistics.</p>", "<title>Strengths and limitations</title>", "<p id=\"Par36\">Detailed analysis is possible as data for the whole team is available during preparation and competitive periods. These differences in training can be observed for off, pre, and competitive seasons. The quantification of internal and external metrics allowed for analyzing athletes’ responses to training and competitive stresses. ML techniques revealed the most important modalities that help optimally prepare athletes for competition. The combination of three perspectives—player, team, and conference spanned from micro to medium to macro exploration. The most important features are selected at each level for analysis and prediction. Sports scientists can use the feature importance to make an informed decision.</p>", "<p id=\"Par37\">The paper studies a homogeneous group of female basketball players, and the model may not generalize across sports or genders. This project only encompassed one year of data, and more is needed for the model to work across seasons with changing rosters and changes in the competitive schedule. The analysis on each level was based on a single metric (RSI, Game Score, or PER), which may limit understanding of the impact on performance. Although the data imbalance was handled, data biases due to using a particular data imputation technique or bias in measurements due to gender would need to be addressed.</p>", "<title>Recommendations for practice and research</title>", "<p id=\"Par38\">Coaches and practitioners should attempt to collect multiple data streams to make informed decisions about training, sports practice, and competition. By identifying KPIs at various levels of performance, practitioners can monitor athletes in the long term and make key changes when necessary to help the athletes better prepare for competing (and sometimes conflicting) demands. Real-time dashboard applications can provide timely feedback to coaches to make informed decisions (see Appendix IX for an example)<sup>##UREF##26##45##</sup>. The current research focused on identifying the key performance indicators to hypothesize how they can help to improve performance. Our future work will test these hypotheses and see how well they help improve athletic performance. No metrics should be considered in isolation, but part of a well-rounded monitoring program that provides actionable information for sports coaches, strength coaches, and sports scientists. Future research should attempt to quantify key metrics in other sports of various levels to create prediction and modeling that fits that sport's requirements.</p>", "<p id=\"Par39\">There are emerging metrics that monitor cumulative workload’s influence over time for better imputation and analysis<sup>##REF##31798948##46##</sup>. Adjusting the decreasing parameter allows the coach consistent monitoring even with many observations missing in the dataset<sup>##REF##31798948##46##</sup>, which could be implemented for future work. The data and algorithm debiasing techniques may be used to improve the fairness of the approach. The XAI approach may have coach and player centricity with explanations in the sports science vocabulary. Time-series approaches can also be incorporated to predict performance for the following week using the previous weeks’ data, which will also be the future work for this research group (current progress on the time-series explorations is summarized in Appendix X). Similarly, game performance for the following game could be predicted using the previous games’ data.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par40\">Athletes' performance was predicted at the individual, team, and conference levels for a fine-grained assessment of the impact of different modalities at different levels. Quantification and explanation of these predictions would provide actionable insights to coaches for continuously monitoring athlete readiness and guided training (based on individual level performance), deciding team composition for the coming matches (based on team level performance), and identifying the most valuable player of the conference—strategizing for the coming season (based on conference level performance).</p>" ]
[ "<p id=\"Par1\">Predictive sports data analytics can be revolutionary for sports performance. Existing literature discusses players' or teams' performance, independently or in tandem. Using Machine Learning (ML), this paper aims to holistically evaluate player-, team-, and conference (season)-level performances in Division-1 Women's basketball. The players were monitored and tested through a full competitive year. The performance was quantified at the player level using the reactive strength index modified (RSImod), at the team level by the game score (GS) metric, and finally at the conference level through Player Efficiency Rating (PER). The data includes parameters from training, subjective stress, sleep, and recovery (WHOOP straps), in-game statistics (Polar monitors), and countermovement jumps. We used data balancing techniques and an Extreme Gradient Boosting (XGB) classifier to predict RSI and GS with greater than 90% accuracy and a 0.9 F1 score. The XGB regressor predicted PER with an MSE of 0.026 and an R<sup>2</sup> of 0.680. Ensemble of Random Forest, XGB, and correlation finds feature importance at all levels. We used Partial Dependence Plots to understand the impact of each feature on the target variable. Quantifying and predicting performance at all levels will allow coaches to monitor athlete readiness and help improve training.</p>", "<title>Subject terms</title>" ]
[ "<title>Data analysis and prediction</title>", "<p id=\"Par18\">There were missing data entries in the sleep, recovery, and questionnaire data. The missing data appeared to follow a Missing at Random (MAR) pattern, with a missingness rate of 13%. Therefore, we used the Multiple Imputation by Chained Equation (MICE) technique for imputing missing data, as it relies on conditional modeling of the missing feature with respect to available features<sup>##UREF##13##22##</sup>.</p>", "<p id=\"Par19\">Multicollinearity analysis (correlation among parameters) revealed linear dependencies among features, causing bias in the ML model’s prediction. Simply dropping features would affect their impact on the game score. Using factor analysis (FA), we combined features having similar variance to obtain compact, lossless, and alternative representation. The features were modeled as a function of latent variables and combined in smaller groups known as factors<sup>##UREF##14##23##,##UREF##15##24##</sup>. ML techniques are then applied to factors that generate player, team, and conference-level predictions. Like any domain in which ML is applied, sports science also requires fairness, accountability, and transparency in decisions made by ML models. Feature importance explains ML decisions by assigning scores to factors impacting the game score<sup>##UREF##16##25##</sup>. It ranks them based on their influence on the game score and provides interpretability on the model’s predictions.</p>", "<title>Factor analysis</title>", "<p id=\"Par20\">We observed linear dependency in some features, introducing redundancy and bias in the dataset. We performed factor analysis to discover latent factors for obtaining a lossless and compact feature representation. The in-game data from the Polar Band had 40 features on heart rate, distance, speed zones, recovery time, and accelerations, and FA resulted in 8 compact factors, as shown in Table ##TAB##0##1##.</p>", "<title>Prediction</title>", "<title>Player level</title>", "<p id=\"Par21\">RSImod measures an athlete’s fatigue due to training and competition. Their readiness is measured using a countermovement jump test conducted at the beginning of the week. Athletes’ sleep and recovery patterns, training workload, and cognitive state in week N predict RSI for week N + 1. Using the quartile range of RSI, athletes were categorized into four groups or classes: Upper-performance group (U): RSI of 0.41 to 0.67, Upper-Middle performance group (UM): RSI of 0.36 to 0.41, Lower-Middle performance group (LM): RSI of 0.32 to 0.36, Lower performance group (L): RSI of 0.2 to 0.32.</p>", "<p id=\"Par22\">Fewer observations, 110 in U + UM compared to 181 in the LM + L group, resulted in data imbalance. Therefore, the synthetic minority oversampling technique (SMOTE) is used for oversampling the minority (U + UM) classes and balancing the dataset<sup>##UREF##17##26##</sup>. The eXtreme Gradient Boosting (XGB) classifier was used as it is efficient, flexible, portable, robust to outliers, and has superior regularization capabilities<sup>##UREF##18##27##</sup>. The training and test sets are divided into 70 (1106 records): 30 (374 records) splits. The training set fits the model, while the test set evaluates the model's performance. The XGB classifier, while predicting RSImod, had an accuracy of 98.67% and an F1 score of 0.986. Figure ##FIG##2##3##a represents the confusion matrix for predictions. Diagonal (highlighted in green) refers to the correct predictions, and off-diagonal shows an incorrect prediction. Please refer to Appendix III in the supplementary material for formulas. We have assessed the uncertainty of XGB by fixing the seed to ensure reproducibility and consistency, using the K fold cross-validation technique<sup>##UREF##19##28##</sup>, which observes prediction variability across data splits and measures standard deviation in feature importance scores. Detailed analysis of the uncertainty experimentation is provided in Appendix IV.</p>", "<title>Team level</title>", "<p id=\"Par23\">Athlete’s game performance was quantified at the team level by the game score<sup>##UREF##8##15##</sup>. It is an in-game statistic and reflects an athlete's contribution to the team. We have predicted game scores using previous weeks’ sleep, training, questionnaire<sup>##UREF##10##17##</sup>, jump, and in-game statistics (measured using the polar unit). Using k-means clustering over a game score dataset, it is divided into three clusters—bad, average, and good. We observed that generating synthetic samples from the minority class does not always work well as it does not account for the complete data variability. Therefore, we used a combination of over (SMOTE) and undersampling (ENN) techniques in the season for data balancing. Appendix V discusses the various under and over-sampling techniques and their performance. Using train-to-test splits of 70 (87 records): 30 (37 records), and stratified K-fold cross-validation, the XGB classifier for predicting the class of the game score provided an accuracy of 94.20% and an F1 score of 0.94. Figure ##FIG##2##3##b depicts the confusion matrix for game score prediction.</p>", "<title>Conference-level</title>", "<p id=\"Par24\">Player efficiency rating evaluates an individual's efficiency compared to the average across the conference<sup>##UREF##8##15##</sup>. It was predicted using sleep and recovery input features, training, subjective stress, reactive strength, and in-game statistics. We used the XGB regressor to predict PER as a continuous variable. The 70:30 train test splits resulted in 84 records for training and 35 for testing. With K fold cross-validation, the XGB regressor provided a Mean Squared Error (MSE) of 0.026 (ideal ⁓ 0) and R<sup>2</sup> of 0.68 (ideal ⁓ 1). Please refer to Appendix III in the supplementary material.</p>", "<title>Feature importance</title>", "<p id=\"Par25\">We devise an ensemble-based feature importance approach using scores from Random Forest (RF), XGB classifier/regressor, and correlation (CORR) to yield robust results<sup>##UREF##18##27##</sup>. In RF and XGB, feature importance Gini index (GI), which measures node impurity, is used to compute feature importance. The important feature causes a decrease in the value of GI and allows their selection. The RF and XGB determine the feature's contribution to prediction and their feature importance. The CORR also determines feature importance by finding their contribution to target prediction, but it generates a value between − 1 and 1. We utilized a nonlinear weighted average technique to aggregate the XGB, RF, and CORR feature importance scores. This allowed us to customize weighing, leverage the advantages of different methods, and provide a balanced assessment of feature importance (see Appendix VI).</p>", "<title>Player</title>", "<p id=\"Par26\">Appendix VII (Fig. S2) in supplementary material represents the importance of the explanatory features for the target feature Reactive Strength Index, a player-level KPI. It was predicted using three modalities—sleep and recovery, training, in-game, and subjective stress. The top five features contributing to RSI prediction are Training Strain, RT Volume Load, TWLoad—all three from the training modality, HRV from the sleep and recovery modality, and MPC subjective stress modality. It is important to note that the top three features of RSI are from the training data.</p>", "<title>Team</title>", "<p id=\"Par27\">Appendix VII (Fig. S4) in supplementary represents the feature importance for the target feature Game Score, a team-level KPI. The input data for game score prediction comes from modalities—reactive strength, in-game statistics, sleep and recovery, subjective stress, and training<sup>##UREF##20##29##</sup>. The top five features for game score prediction are Average Speed and Distance (Factor F1), Recovery Time—in-game statistics modality, Daily Average—training modality, Speed and Total Acceleration Zones (F0), and High-Intensity Acceleration Zone (F7) again from in-game statistics modality. One can observe that the most important features of game scores are derived from in-game statistics.</p>", "<title>Conference</title>", "<p id=\"Par28\">Player efficiency rating is a conference-level KPI used in the present work. Appendix VII (Fig. S5) in the supplementary document represents its feature importance. Again, they are derived from five modalities—reactive strength, in-game statistics, sleep and recovery, subjective stress, and training. The top five features significantly contribute to PER prediction: Peak Power—reactive strength modality, Maximum Speed—in-game statistics, Sleep consistency, Deep Sleep Hours—sleep and recovery modality, and Emotional Balance (EB)—subjective stress modality. It can be observed that unlike player level and team level, no category dominates in feature importance.</p>", "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51658-8.</p>", "<title>Acknowledgements</title>", "<p>Authors thank Welch College of Business and Technology and the College of Health Professionals for their support in obtaining WHOOP straps and Polar heart rate monitors. Julia Piascik helped regenerate Fig. ##FIG##1##2##.</p>", "<title>Author contributions</title>", "<p>C.B.T. led the data collection and wrote the introduction and discussion. S.S. and M.S.R. ran machine learning algorithms and wrote methods and data analysis sections. S.S. analyzed the data and contributed to machine learning coding. A.K., J.S., and E.P. assisted with data collection and overall paper editing. J.N. and N.S.A. supervised the research team. T.K. led the research team, prepared the paper outline, and assisted with the writing of each section.</p>", "<title>Funding</title>", "<p>Sacred Heart University funded this research, specifically the Welch College of Business and Technology and the College of Health Professionals, in obtaining WHOOP straps and Polar heart rate monitors. No external funds were utilized.</p>", "<title>Data availability</title>", "<p>Data cannot be made available publicly because participants can be identified by cross-referencing the university’s athletic website (the game score parameter was obtained from publicly available data). However, a sub-portion of the data that is de-identified was made available. Contact the corresponding author, Dr. Tolga Kaya, for further inquiries about the data.</p>", "<title>Code availability</title>", "<p>Jupyter Notebook was included as a Supplementary file.</p>", "<title>Competing interests</title>", "<p id=\"Par41\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Graphical representation of how machine learning and statistical approaches help technical and tactical performance analysis of the player and team level. The factors highlighted in yellow are the methods used in this study.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Experimental approach to the basketball performance prediction. At the player level, readiness is measured with all the data modalities in this study. The game score parameter measures team-level performance, whereas the Player Efficiency Rating evaluates conference-level performance. <italic>SRSS</italic> Short Recovery Short Stress, <italic>TWLoad</italic> Total Weekly Load, <italic>RT</italic> Resistance Training.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>(<bold>a</bold>) (Left) Confusion matrix for the RSI prediction and the player-level performance KPI. Only 5 out of 291 predictions were incorrect (highlighted in Red). (<bold>b</bold>) (Right) Confusion matrix for the game score prediction; the KPI for the team-level performance. Green cells indicate correct predictions and red cells show misclassification. <italic>U</italic> Upper-performance group, <italic>UM</italic> Upper-Middle performance group, <italic>LM</italic> Lower-Middle performance group, <italic>L</italic> Lower performance group.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Most important modality analysis on which parameter groups contributed to the prediction the most in each category.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Categorization of polar data features using factor analysis that reduced the number of features from 40 to 8 (as factors).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Factors</th><th align=\"left\">Feature</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"9\"><italic>Speed and Total Acceleration Zones (F0)</italic></td><td align=\"left\">Number of accelerations: 2.99–2.00 (m/s<sup>2</sup>)</td></tr><tr><td align=\"left\">Number of accelerations: 1.99–1.00 (m/s<sup>2</sup>)</td></tr><tr><td align=\"left\">Number of accelerations: 0.99–0.50 (m/s<sup>2</sup>)</td></tr><tr><td align=\"left\">Number of accelerations: 0.50–0.99 (m/s<sup>2</sup>)</td></tr><tr><td align=\"left\">Number of accelerations: 1.00–1.99 (m/s<sup>2</sup>)</td></tr><tr><td align=\"left\">Distance in Speed zone 1: 1.00–4.99 (km/h)</td></tr><tr><td align=\"left\">Distance in Speed zone 2: 5.00–6.99 (km/h)</td></tr><tr><td align=\"left\">Distance in Speed zone 3: 7.00–10.99 (km/h)</td></tr><tr><td align=\"left\">Total distance (m)</td></tr><tr><td align=\"left\"><italic>Average Speed and Distance (F1)</italic></td><td align=\"left\">Average speed (km/h), Distance (m/min), HR avg (bpm)</td></tr><tr><td align=\"left\" rowspan=\"5\"><italic>Average Speed and Acceleration Zone (F2)</italic></td><td align=\"left\">Number of accelerations: 2.00–2.99 (m/s<sup>2</sup>)</td></tr><tr><td align=\"left\">Distance in Speed zone 4: 11.00–14.99 (km/h)</td></tr><tr><td align=\"left\">Distance in Speed zone 5: 15.00 (km/h)</td></tr><tr><td align=\"left\">Number of accelerations: 50.00–3.00 (m/s<sup>2</sup>)</td></tr><tr><td align=\"left\">Sprints</td></tr><tr><td align=\"left\"><italic>Minimum Heart Rate (F3)</italic></td><td align=\"left\">HR min (bpm)</td></tr><tr><td align=\"left\"><italic>Maximum Heart Rate (F4)</italic></td><td align=\"left\">HR max (bpm)</td></tr><tr><td align=\"left\"><italic>Recovery Time (F5)</italic></td><td align=\"left\">Recovery time (h)</td></tr><tr><td align=\"left\"><italic>Maximum Speed (F6)</italic></td><td align=\"left\">Maximum speed (km/h)</td></tr><tr><td align=\"left\"><italic>High Intensity Acceleration Zone (F7)</italic></td><td align=\"left\">Number of accelerations: 3.00–50.00 (m/s<sup>2</sup>)</td></tr></tbody></table></table-wrap>" ]
[ "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{RSImod }} = JH/CT$$\\end{document}</tex-math><mml:math id=\"M2\" display=\"block\"><mml:mrow><mml:mrow><mml:mtext>RSImod</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mo>=</mml:mo><mml:mi>J</mml:mi><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>C</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>" ]
[ "<table-wrap-foot><p>The factors are named based on the features they combined.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Christopher B. Taber and Srishti Sharma.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51658_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51658_Article_Equ1.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51658_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51658_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51658_Fig4_HTML\" id=\"MO4\"/>" ]
[ "<media xlink:href=\"41598_2024_51658_MOESM1_ESM.docx\"><caption><p>Supplementary Information 1.</p></caption></media>", "<media xlink:href=\"41598_2024_51658_MOESM2_ESM.csv\"><caption><p>Supplementary Information 2.</p></caption></media>", "<media xlink:href=\"41598_2024_51658_MOESM3_ESM.zip\"><caption><p>Supplementary Information 3.</p></caption></media>" ]
[{"label": ["1."], "surname": ["Joyner"], "given-names": ["MJ"], "article-title": ["Modeling: Optimal marathon performance on the basis of physiological factors"], "source": ["J. Appl. Physiol."], "year": ["1991"], "volume": ["1985"], "issue": ["70"], "fpage": ["683"], "lpage": ["687"], "pub-id": ["10.1152/jappl.1991.70.2.683"]}, {"label": ["2."], "surname": ["Morton", "Fitz-Clarke", "Banister"], "given-names": ["RH", "JR", "EW"], "article-title": ["Modeling human performance in running"], "source": ["J. Appl. Physiol."], "year": ["1990"], "volume": ["1985"], "issue": ["69"], "fpage": ["1171"], "lpage": ["1177"], "pub-id": ["10.1152/jappl.1990.69.3.1171"]}, {"label": ["6."], "surname": ["Li", "Xu"], "given-names": ["B", "X"], "article-title": ["Application of artificial intelligence in basketball sport"], "source": ["J. Educ. Health Sport"], "year": ["2021"], "volume": ["11"], "fpage": ["54"], "lpage": ["67"], "pub-id": ["10.12775/JEHS.2021.11.07.005"]}, {"label": ["7."], "mixed-citation": ["Cao, C. Sports data mining technology used in basketball outcome prediction. Masters Dissertation. Technological University Dublin (2012)."]}, {"label": ["10."], "surname": ["Schumaker", "Solieman", "Chen"], "given-names": ["RP", "OK", "H"], "article-title": ["Sports knowledge management and data mining"], "source": ["Annu. Rev. Inf. Sci. Technol."], "year": ["2010"], "volume": ["44"], "issue": ["1"], "fpage": ["115"], "lpage": ["157"], "pub-id": ["10.1002/aris.2010.1440440110"]}, {"label": ["11."], "mixed-citation": ["Talukder, H. V. T., Foster, G., Hu, C., Huerta, J. & Kumar, A. Preventing in-game injuries for NBA players. In "], "italic": ["Proceedings of the MIT Sloan Sports Analytics Conference"]}, {"label": ["12."], "surname": ["Barrientos", "Deborsherr Sen", "Dunson"], "given-names": ["AF", "GL", "DB"], "article-title": ["Bayesian inferences on uncertain ranks and orderings: Application to ranking players and lineups"], "source": ["Bayesian Anal."], "year": ["2022"], "volume": ["1"], "fpage": ["1"], "lpage": ["3"]}, {"label": ["13."], "surname": ["Metulini", "Gnecco"], "given-names": ["R", "G"], "article-title": ["Measuring players\u2019 importance in basketball using the generalized Shapley value"], "source": ["Ann. Oper. Res."], "year": ["2022"], "pub-id": ["10.1007/s10479-022-04653-z"]}, {"label": ["15."], "surname": ["Hollinger"], "given-names": ["J"], "source": ["Pro Basketball Forecast: 2005\u20132006"], "year": ["2005"], "publisher-name": ["Potomac Books"]}, {"label": ["16."], "surname": ["Kellmann", "Kolling"], "given-names": ["M", "S"], "source": ["Recovery and Stress in Sport: A Manual for Testing and Assessment"], "year": ["2019"], "publisher-name": ["Routledge"]}, {"label": ["17."], "surname": ["Kellmann", "Wolfgang Kallus"], "given-names": ["M", "K"], "source": ["Recovery-Stress Questionnaire for Athletes: User Manual, Part 2"], "year": ["2001"], "publisher-name": ["Human Kinetics"]}, {"label": ["20."], "mixed-citation": ["Nagarajan, R. & Li, L. Optimizing NBA player selection strategies based on salary and statistics analysis. In "], "italic": ["IEEE 15th International Conference on Dependable, Autonomic and Secure Computing"]}, {"label": ["21."], "mixed-citation": ["2021\u201322 Women\u2019s Basketball Cumulative Statistics. Available from: "], "ext-link": ["https://sacredheartpioneers.com/sports/womens-basketball/stats"]}, {"label": ["22."], "mixed-citation": ["Guguloth, S., Telu, A., Sairam, U. & Voruganti, S. (2022). Activity recognition in missing data scenario using MICE algorithm. In "], "italic": ["International Conference on Soft Computing and Pattern Recognition"]}, {"label": ["23."], "mixed-citation": ["Bandalos, D and Finney, S. Factor analysis: Exploratory and confirmatory. In "], "italic": ["The reviewer\u2019s guide to quantitative methods in the social sciences"]}, {"label": ["24."], "surname": ["Chen", "Liao", "Zhang", "Du"], "given-names": ["J", "L", "W", "L"], "article-title": ["Mixture factor analysis with distance metric constraint for dimensionality reduction"], "source": ["Pattern Recognit."], "year": ["2022"], "volume": ["121"], "fpage": ["108156"], "pub-id": ["10.1016/j.patcog.2021.108156"]}, {"label": ["25."], "surname": ["Mehrabi", "Morstatter", "Saxena", "Lerman", "Galstyan"], "given-names": ["N", "F", "N", "K", "A"], "article-title": ["A survey on bias and fairness in machine learning"], "source": ["ACM Comput. Surv."], "year": ["2021"], "volume": ["54"], "fpage": ["115:1"], "lpage": ["115:35"]}, {"label": ["26."], "surname": ["Chawla", "Bowyer", "Hall", "Kegelmeyer"], "given-names": ["NV", "KW", "LO", "WP"], "article-title": ["SMOTE: Synthetic minority over-sampling technique"], "source": ["J. Artif. Intell. Res."], "year": ["2002"], "volume": ["16"], "fpage": ["321"], "lpage": ["357"], "pub-id": ["10.1613/jair.953"]}, {"label": ["27."], "mixed-citation": ["Rajliwall, N. S., Davey, R. & Chetty, G. Cardiovascular risk prediction based on XGBoost. In "], "italic": ["Proceedings of the 5th Asia-Pacific World Congress on Computer Science and Engineering,"]}, {"label": ["28."], "surname": ["Senbel", "Sharma", "Raval", "Taber", "Nolan", "Artan", "Ezzeddine", "Kaya"], "given-names": ["S", "S", "MS", "C", "J", "NS", "D", "T"], "article-title": ["Impact of sleep and training on game performance and injury in division-1 women\u2019s Basketball Amidst the Pandemic"], "source": ["IEEE Access"], "year": ["2022"], "volume": ["10"], "fpage": ["15516"], "lpage": ["15527"], "pub-id": ["10.1109/ACCESS.2022.3145368"]}, {"label": ["29."], "surname": ["Saeys", "Abeel", "Van de Peer"], "given-names": ["Y", "T", "Y"], "article-title": ["Robust feature selection using ensemble feature selection techniques"], "source": ["Mach. Learn. Knowl. Discov. Databases"], "year": ["2008"], "volume": ["5212"], "fpage": ["313"], "lpage": ["325"], "pub-id": ["10.1007/978-3-540-87481-2_21"]}, {"label": ["31."], "mixed-citation": ["Molnar, C. Interpretable Machine Learning. Available from: "], "ext-link": ["https://christophm.github.io/interpretable-ml-book/"]}, {"label": ["32."], "surname": ["Makivic", "Nikic", "Willis"], "given-names": ["B", "M", "M"], "article-title": ["Heart rate variability (HRV) as a tool for diagnostic and monitoring performance in sport and physical activities"], "source": ["J. Exerc. Physiol. Online"], "year": ["2013"], "volume": ["16"], "fpage": ["103"], "lpage": ["131"]}, {"label": ["40."], "surname": ["Haff", "Nimphius"], "given-names": ["GG", "S"], "article-title": ["Training principles for power"], "source": ["Strength Cond. J."], "year": ["2012"], "volume": ["34"], "fpage": ["2"], "lpage": ["12"], "pub-id": ["10.1519/SSC.0b013e31826db467"]}, {"label": ["42."], "surname": ["Sosa", "Lorenzo", "Trapero", "Ribas", "Alonso", "Jimenez"], "given-names": ["C", "A", "J", "C", "E", "SL"], "article-title": ["Specific absolute velocity thresholds during male basketball games using local positional system: Differences between age categories"], "source": ["Appl. Sci."], "year": ["2021"], "volume": ["11"], "fpage": ["4390"], "pub-id": ["10.3390/app11104390"]}, {"label": ["43."], "surname": ["Bonnar", "Bartel", "Kakoschke", "Lang"], "given-names": ["D", "K", "N", "C"], "article-title": ["Sleep interventions designed to improve athletic performance and recovery: A systematic review of current approaches"], "source": ["Sports Med. Auckl. NZ"], "year": ["2018"], "volume": ["48"], "fpage": ["683"], "lpage": ["703"], "pub-id": ["10.1007/s40279-017-0832-x"]}, {"label": ["45."], "mixed-citation": ["Juliano, E., Thakkar, C., Taber, C., Raval, M., Kaya, T. & Senbel, S. A dynamic online dashboard for tracking the performance of division 1 basketball athletic performance. "], "italic": ["The International Sports Analytics Conference and Exhibition (ISACE) Series"]}]
{ "acronym": [], "definition": [] }
46
CC BY
no
2024-01-14 23:40:15
Sci Rep. 2024 Jan 12; 14:1162
oa_package/af/a9/PMC10786827.tar.gz
PMC10786828
38216634
[ "<title>Introduction</title>", "<p id=\"Par2\">Anaerobic digestion (AD) is a successful and robust waste treatment biotechnology converting organic waste into clean energy in the form of biogas<sup>##REF##27523710##1##</sup> and recovering nutrients as fertilizers and soil conditioners<sup>##UREF##0##2##</sup>. AD plays a crucial role in achieving the ambitious goal of the European Climate Law, aiming for climate neutrality by 2050<sup>##UREF##0##2##</sup>. An estimated increase from 0.3 EJ to 8.3 EJ by 2050 from biogas upgraded to biomethane (90% methane) makes it the non-fossil source with the greatest potential to be carbon neutral<sup>##UREF##0##2##</sup>. AD systems mitigate the emission of greenhouse gases (GHG), by recovering methane (CH<sub>4</sub>) from organic wastes, and, when used as a combustion fuel, release carbon–neutral carbon dioxide (CO<sub>2</sub>)<sup>##REF##21530224##3##</sup>. About 60 to 80% of GHG emissions from transportation can be reduced by replacing gasoline with biomethane produced from AD<sup>##UREF##1##4##</sup>. Currently, the global potential for energy generation from biogas is estimated to be 10,000 to 14,000 TWh, with the potential to replace up to 10% of the world's primary energy consumption<sup>##UREF##2##5##</sup> of electric power, heat and automotive fuel. Unlike other sources of non-fossil energy, organic residues are the raw primary source for biogas production, which is relatively less sensitive to seasonality or scarcity.</p>", "<p id=\"Par3\">Due to integrated socioenvironmental benefits<sup>##REF##27523710##1##</sup> e.g., the replacement of energy resources such as firewood by biogas can improve quality of life, and promote gender equality, and higher educational levels<sup>##UREF##3##6##</sup>. AD surpasses several other renewable energy sources<sup>##UREF##4##7##</sup> representing the major technological pathway for the implementation of the United Nations Sustainable Development Goals (SDGs)<sup>##UREF##1##4##</sup>. Besides expanding local employment opportunities<sup>##UREF##3##6##</sup>, AD promotes energy decentralization, with electricity supply to remote areas, e.g., rural communities by the implementation of small-scale biogas plants or by direct injection into the existing natural gas grid<sup>##UREF##1##4##,##UREF##5##8##,##UREF##6##9##</sup>.</p>", "<p id=\"Par4\">AD follows 4 steps: hydrolysis, acidogenesis, acetogenesis and methanogenesis<sup>##UREF##6##9##</sup>. Hydrolysis by microbial extracellular enzymes converts complex biopolymers (i.e., protein, lipid, polysaccharides) into smaller compounds (i.e., sugar, amino acids, fatty acids)<sup>##UREF##7##10##</sup>, which in turn are converted into volatile fatty acids (VFA), CO<sub>2</sub> and H<sub>2</sub> in the acidogenesis step<sup>##UREF##8##11##</sup>. Subsequently, acetate is produced in the acetogenesis step, providing the product for the generation of mainly CH<sub>4</sub> and CO<sub>2</sub> in the methanogenesis step<sup>##UREF##7##10##,##UREF##8##11##</sup>. Studies have exhaustively identified hydrolysis as the bottleneck for biogas production from recalcitrant biomass<sup>##REF##27908585##12##,##REF##33249324##13##</sup> usually leading to low AD efficiency upon application in, for example, agricultural sectors<sup>##REF##21868219##14##</sup>.</p>", "<p id=\"Par5\">Substrates are often subjected to pretreatment prior to AD, and the potential of pretreatments to improve hydrolysis has been extensively reported in the literature. Several chemical, physical and biological pretreatments (Fig. ##SUPPL##0##S1##) are applied to organic wastes to modify their physical–chemical structures and improve their biodegradability<sup>##UREF##9##15##–##UREF##11##17##</sup>. The resulting reduction in particle size and increase in surface area, porosity, and solubility of particulate organic matter<sup>##UREF##12##18##</sup> enhances the accessibility by microorganisms, improving hydrolysis and biogas production<sup>##REF##31911817##19##</sup>. However, all of those pretreatments also increase the cost of the AD process, as they lead to increased energy consumption, require the purchase of additives, and usually depend on operational investments to adapt equipment to suit the pretreatment<sup>##REF##33249324##13##,##REF##27714444##20##</sup>. In addition, pretreatments may even have adverse effects on AD and result in lower CH<sub>4</sub> yields<sup>##REF##27523710##1##,##REF##26670779##21##</sup> if the selected pretreatment is not suitable for a given substrate. The proper choice of pretreatment is crucial to achieving viable and cost-effective conversion of recalcitrant feedstocks and to increasing biogas production<sup>##REF##27714444##20##</sup>; therefore, the effects of pretreatment on organic wastes must be evaluated with respect to the chemical composition of the biomass.</p>", "<p id=\"Par6\">Grouping substrates by origin (e.g., agricultural, municipal, industrial wastes, and aquatic biomass) is a widespread and common strategy applied in the industry to lower logistics costs and to promote the digestion of the greatest amount of waste available in a given geographic area. This has led to the application of pretreatments disregarding the heterogeneity of the biomass chemical composition or even to the implementation of co-digestion. Co-digestion is a strategy applied for simultaneous management of different waste streams by AD where two or more types of feedstock are combined<sup>##REF##30743981##22##</sup>. Since in co-digestion the substrate is mixed as a strategy to optimize the AD process<sup>##UREF##6##9##,##REF##30743981##22##</sup> (e.g. balancing macro and micronutrients supply, and the moisture content or diluting inhibitory compounds), interventions such as pretreatment may lead to adverse process performance due to organic matter overload. For instance, co-digestion of (30% primary sludge and 70% sewage sludge) and glycerol (1% v/v) decreased CH<sub>4</sub> yields from 500 to 70 mL/gVS<sub>added</sub> after alkaline pretreatment application<sup>##UREF##6##9##</sup>. Several studies (e.g.<sup>##UREF##9##15##,##UREF##11##17##,##UREF##13##23##–##REF##18599291##25##</sup>) have tested the application of specific pretreatments to specific substrates, but to the best of our knowledge, not a single study has yet consistently quantified the efficiencies of different pretreatments with varying types of substrates sorted by predominant chemical composition. Identifying proper pretreatments by substrate chemical predominance may open an opportunity for the management of new organic streams (individual or in combination) via AD. Also, it prevents unnecessary costs as the pretreatment implementation comprises a substantial proportion (up to ca 20%) of the total biomethane production cost<sup>##REF##28050842##26##</sup>.</p>", "<p id=\"Par7\">Here we conducted a systematic review and a comprehensive meta-analysis to quantify the performance of different pretreatments according to the predominant chemical composition of the organic waste. Despite inherent limitations of performing a meta-analysis in AD systems, e.g., encompassing variations in operating conditions and feedstock characteristics across studies, the application of meta-analysis in AD systems offers substantial advantages. The outcomes derived from meta-analysis play a pivotal role in steering research efforts, shaping best practices, and advancing the knowledge base in AD systems. A comprehensive synthesis of the existing research allows for the identification of trends and overarching insights that may not be apparent in individual studies. Here, we evaluated 192 studies from which 1374 individual effect sizes were calculated from peer-reviewed scientific articles over the past 45 years (Table ##SUPPL##1##S1##) and provide a comprehensive decision-making guideline for the choice of appropriate pretreatment based on the predominant organic chemical composition of the substrates.</p>" ]
[ "<title>Methods</title>", "<title>Search strategy and study selection</title>", "<p id=\"Par35\">We performed a systematic review and meta-analysis of studies published in the Web of Science database between 1975 and July 2020 based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA, <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.prisma-statement.org/\">http://www.prisma-statement.org/</ext-link>) checklist. The search was performed using the following keywords: “hydrolysis”, “anaerobic digestion”, “methane yield” and “pretreatment”<italic>.</italic> The search was restricted to only articles (document type) and only publications in English (language) (Fig. ##SUPPL##0##S9##).</p>", "<p id=\"Par36\">The eligibility criteria for inclusion of articles in the meta-analysis were as follows: (i) description of the average value, standard deviation (SD) and number of replicates for methane yield with and without pretreatment (control); (ii) description of the pretreatment applied; and (iii) methane yield provided separately from the total biogas production rate. We included studies with replicates ranging from 2 to 5, recognizing that, despite the general recommendation of a minimum of 3 replicates for Biochemical Methane Potential (BMP) tests, particularly for treatment bottles, the number of replicates of larger lab-scale reactors are seldom above 2.</p>", "<title>Data collection</title>", "<p id=\"Par37\">Articles eligible after screening by the inclusion criteria had their data collected in an Excel spreadsheet. The data extracted from each article includes general information (e.g., first author's name, article title and year of publication), substrate type, substrate chemical composition, inoculum description, operational configuration (e.g., temperature condition, hydraulic retention time (HRT), stirring (i.e., RPM), reactor type, operational scale, total volume and working volume), pretreatment method, specific pretreatment conditions and methane yield data (mean, standard deviation (SD) and number of replicates).</p>", "<p id=\"Par38\">Pretreatment techniques (e.g., autoclave, mechanical, alkaline, acid and enzyme) were grouped into methods (e.g., physical, chemical, biological and combined) since the transformations achieved in organic matter are rather similar within techniques belonging to the same group<sup>##REF##28050842##26##</sup>. Once the effect of each pretreatment method is significant in the quantitative synthesis, all the techniques that compose it are individually evaluated. Also, the different feedstocks were grouped by the predominance of the chemical composition.</p>", "<title>Substrate classification by predominant chemical composition</title>", "<p id=\"Par39\">The substrates tested in the studies included in the meta-analysis were grouped into categories according to their predominant chemical composition in dry weight (DW). Based on the chemical characterization reported in the articles from the systematic review, the substrates were divided into 4 main categories: protein-rich, lipid-rich, lignocellulosic-rich and mixed.</p>", "<p id=\"Par40\">As the AD literature does not present a range of protein content for protein-rich substrates<sup>##REF##27908585##12##,##UREF##17##30##,##REF##23660521##32##</sup>, data from the articles included in the systematic review were screened in order to assess their chemical composition. Protein-rich substrates were then considered those with an average protein content of ≥ 40% DW.</p>", "<p id=\"Par41\">Due to operational limitations mono-digestion of lipid-rich substrates is rare<sup>##REF##23660521##32##,##REF##30060402##33##</sup>, and so is the chemical characterization. Based on the classification of lipid-rich substrates from previous studies in the literature, the average lipid content of lipid-rich substrates was ≥ 40% DW.</p>", "<p id=\"Par42\">Lignocellulosic substrates have at least &gt; 50% lignocellulose content per DW. The chemical composition of lignocellulosic biomass is composed of three main biopolymers: cellulose, hemicellulose and lignin<sup>##UREF##20##39##</sup>. Lignin was selected as the independent variable due to its widespread description in the literature as one of the main barriers to the degradation of lignocellulosic content<sup>##UREF##8##11##</sup>. Lignocellulosic substrates were here divided into three lignin concentration ranges. The choice of lignin content range was based on the difficulty in converting crop residues into biogas in the range of 10–25% DW of lignin applied as mono-digestion, either due to the complexity of the structure of the material or the generation of phenolic compounds that inhibit AD<sup>##UREF##18##36##</sup>. In addition, most crop residues applied to energy generation are in this range of lignin content, which requires high attention to optimize the digestion<sup>##UREF##18##36##</sup>. Lignocellulosic substrates were then classified into 0–10%, 10–25% and &gt; 25% DW lignin relative to the total lignocellulosic content. The lignin content (%DW) in lignocellulosic biomass (LB) was calculated with the equation used by Thomsen et al. (2014), where LB is composed of cellulose (), hemicellulose () and lignin () (Eqs. ##FORMU##3##1## and ##FORMU##4##2##).</p>", "<p id=\"Par43\">Mixed substrates consisted of highly variable biomass sources that did not show any pattern of chemical predominance. For instance, the chemical compositions of food waste and sewage are often affected by culture, season, social class and holidays<sup>##REF##29208531##46##</sup>, making it impossible to precisely determine their chemical composition over time.</p>", "<title>Data analysis</title>", "<p id=\"Par44\">We applied the standardized mean difference (SMD) estimated by Hedge’s g as the effect size with which to quantify methane yield data. Following the formula<sup>##UREF##15##27##</sup>:where the is the treated group and is the control group, and are the sample size while and are the estimated population variance for the treated and control group, respectively<sup>##UREF##15##27##</sup>. This effect size is considered less biased than other calculation approaches and is recommended for small sample sizes<sup>##UREF##25##48##</sup>.</p>", "<p id=\"Par45\">Mean effect sizes (Hedges’ g), 95% confidence interval (CI) with bias correction and p-value were calculated in R software (R Core Team, 2021) using the “metafor” package (version 3.0-2) for each pretreatment as well as for the specific techniques of significant pretreatment methods<sup>##UREF##15##27##,##UREF##26##49##</sup>. Pretreatments were considered significant (p &lt; 0.05) when their mean value and CI did not overlap the zero line. Mean and CI values below the zero line indicated a negative response (pretreatment &lt; control), while mean and CI values above the zero line indicated a positive response (pretreatment &gt; control).</p>", "<p id=\"Par46\">A multilevel meta-analysis was performed followed by a subgroup analysis as the data were grouped into pretreatment categories for analysis<sup>##UREF##26##49##</sup>. Also, the dependence of effect sizes was considered since a given study can compare several treatments to a single control group, which means that the data are not independent. Furthermore, we assumed the random effect model considering the difference in methodology of experiments performed in each study included in the analysis<sup>##UREF##15##27##,##UREF##26##49##</sup>.</p>" ]
[]
[]
[ "<title>Conclusions</title>", "<p id=\"Par34\">Lack of cost-effective pretreatment options or the application of suboptimum pretreatments to specific substrates are among the factors that currently limit the global potential for biogas production. Our meta-analysis showed that the choice of pretreatment should be defined by the predominant chemical composition of the targeted organic waste. For example, major global crop residues including corncob, rice husk, rice straw, sugarcane bagasse, and wheat straw with a combined annual generation of ca 1.3 billion tones by the key producing countries are all grouped as lignocellulosic substances with intermediate lignin content based on our categorization (&lt; 25% lignin). Most of the studies (87%) utilize laboratory batch conditions using a Biochemical Methane Potential (BMP) assay for pretreatment evaluation. Despite concerns of upscaling results to the industry, BMP assays are the first step applied by researchers and industrial biomethane producers for the evaluation of the feasibility of biomass as a feedstock for AD. Thus, the outcomes reported based on BMP quantifications can aid the selection of suitable pretreatments for laboratory- or pilot-scale simulations of AD processes for the industry. Our outcomes suggest that the current methane potential of these substrates could be enhanced by up to 170% if appropriate pretreatment methods are applied. This would add up to 1800 TWh of the global renewable energy potential assuming roughly 90% dry matter content and a conservative methane potential of 220 m<sup>3</sup> CH<sub>4</sub> per dry weight of the untreated feedstock. The guideline provided in this study assists selection of proper pretreatment methods based on the knowledge generated in past 45 years to boost economic gains and promote the contribution of AD to societal sustainability and decarbonization.</p>" ]
[ "<p id=\"Par1\">Proper pretreatment of organic residues prior to anaerobic digestion (AD) can maximize global biogas production from varying sources without increasing the amount of digestate, contributing to global decarbonization goals. However, the efficiency of pretreatments applied on varying organic streams is poorly assessed. Thus, we performed a meta-analysis on AD studies to evaluate the efficiencies of pretreatments with respect to biogas production measured as methane yield. Based on 1374 observations our analysis shows that pretreatment efficiency is dependent on substrate chemical dominance. Grouping substrates by chemical composition e.g., lignocellulosic-, protein- and lipid-rich dominance helps to highlight the appropriate choice of pretreatment that supports maximum substrate degradation and more efficient conversion to biogas. Methane yield can undergo an impactful increase compared to untreated controls if proper pretreatment of substrates of a given chemical dominance is applied. Non-significant or even adverse effects on AD are, however, observed when the substrate chemical dominance is disregarded.</p>", "<title>Subject terms</title>", "<p>Open access funding provided by Linköping University.</p>" ]
[ "<title>Substrate chemical composition affects pretreatment efficiency</title>", "<p id=\"Par8\">The effect and magnitude of the different pretreatments were assessed by calculating the standardized mean difference (SMD), which is the CH<sub>4</sub> yield difference between the treated and untreated (control) substrate groups. SMD Hedges’ g ≤ 0.2 represents a small effect, 0.3–0.5 a medium effect, and ≥ 0.6 a large effect<sup>##UREF##15##27##</sup>. CH<sub>4</sub> yield is significantly improved by a given pretreatment if SMD is higher than zero and the lower limit of the confidence interval (CI) does not cross zero, while significantly depressed by a given pretreatment if SMD is lower than zero and the upper limit of the CI does not cross zero. Our findings indicate that to reach higher efficiencies for biogas production, classification based on chemical predominance rather than on the origin of the waste, prior to the choice of proper pretreatment is fundamental (Fig. ##FIG##0##1##).</p>", "<title>Protein-rich substrates</title>", "<p id=\"Par9\">About 1 million tons of protein-rich waste is produced globally every year<sup>##REF##27908585##12##</sup>. Although protein-rich substrates have high theoretical methane potential, ca 0.5 Nm<sup>3</sup>/kg volatile solid (VS), AD can be severely affected by ammonia accumulation from protein breakdown<sup>##REF##27908585##12##,##REF##26384658##28##</sup>. High concentrations of ammonia can particularly inhibit acetoclastic methanogenesis<sup>##UREF##12##18##</sup>, leading to VFA accumulation, a lower biomethane yield, and process disturbances<sup>##REF##21530224##3##</sup>.</p>", "<p id=\"Par10\">Our literature search demonstrated that microalgae, meat processing waste, slaughterhouse waste, and swine and chicken manure are those substrates that have been reported as protein-rich feedstock of AD<sup>##UREF##16##29##</sup>. Microalgae were the most common feedstock studied among protein-rich substrates (Fig. ##SUPPL##0##S6##), which can be explained by their rapid growth rates and cultivation viability without requiring arable lands<sup>##UREF##10##16##</sup>.</p>", "<p id=\"Par11\">The outcomes of the meta-analysis resulted in 213 effect sizes from pretreatment of protein-rich substrates (Fig. ##FIG##0##1##B). Biological (SMD = 5.061, 95% CI 2.839–7.282) and physical (SMD = 4.301, 95% CI 2.405–6.197) pretreatments applied alone or in combination led to the highest CH<sub>4</sub> yields from protein-rich substrates (Fig. ##FIG##0##1##B), while chemical pretreatments (SMD = − 0.573, 95% CI − 2.520 to 1.374) had no significant effect. Biological pretreatments (e.g., enzymatic pretreatment), which increase protein hydrolysis and solubilization<sup>##UREF##10##16##</sup>. Some biological pretreatments such as bacteria flocculation (flocs) increase methanogens tolerance to NH<sub>3</sub> concentration and toxic compounds (i.e., furfural)<sup>##REF##27908585##12##</sup>. At full-scale, biological pretreatments have proven to further reduce substrate viscosity and the energy demand for mixing<sup>##UREF##17##30##</sup>. In particular, the application of protease as enzymatic pretreatment led to a significant increase in CH<sub>4</sub> yield (SMD = 5.132, 95% CI 1.178–9.085, Fig. ##FIG##1##2##), which can be attributed to the specificity of protease in hydrolyzing proteins. The application of protease is associated with low pollution risk to the environment and low energy demand, making it more suitable than energy-intensive options such as thermal pretreatments at the laboratory or full-scale<sup>##UREF##17##30##</sup>. The overall advantages of biological pretreatments are their reaction specificity (in case of enzymatic pretreatment), low operating and energy costs, and a lack of toxic end products<sup>##UREF##9##15##</sup>.</p>", "<p id=\"Par12\">Pretreatments that involve heat application, including thermal (SMD = 3.655, 95% CI 0.748–6.561), steam explosion (SMD = 7.386, 95% CI 4.851–9.922), and hydrothermal (SMD = 13.144, 95% CI 6.693–19.595) were those exhibiting the best performance for protein-rich substrates (Fig. ##FIG##1##2##). These pretreatments are effective in breaking down organic matter and increasing its exposure to enzymatic degradation during the hydrolysis step<sup>##REF##31911817##19##</sup>. Heat pretreatments are one of the most applied in full-scale biogas plants<sup>##UREF##6##9##</sup>, which may be a result of the mandatory pasteurization requirement for some substrates. However, the relatively high cost:effectiveness ratio of these pretreatments discourages their use, especially when compared with biological pretreatments, which are relatively inexpensive to implement.</p>", "<p id=\"Par13\">Homogenization is a promising physical pretreatment at the industrial scale, as it disrupts substrate structure and decreases particle sizes, consequently improving the substrate accessibility for microbial degradation<sup>##UREF##13##23##</sup>. Homogenization significantly increased the CH<sub>4</sub> yield (SMD = 8.339, 95% CI 3.798–13.001) of protein-rich substrates. Similarly, ultrasonication (SMD = 5.421, 95% CI 3.434–7.407, Fig. ##FIG##1##2##) promotes organic waste degradation via hydromechanical stress, reducing hydrolysis time and increasing the production of biogas<sup>##UREF##11##17##</sup>. Although homogenization requires high pressure (&gt; 800 bar) to increase up to 15% of the protein solubilization, the energy balance of the pretreatment is positive<sup>##UREF##6##9##</sup>, as energy costs are covered by biomethane production, and has been successfully applied on a full-scale<sup>##UREF##13##23##</sup>. Ultrasonication is equally successful at practical levels, producing 3–10 kW in CH<sub>4</sub> yield for every kilowatt of ultrasonic energy applied<sup>##UREF##11##17##</sup>.</p>", "<p id=\"Par14\">Chemical pretreatments applied to protein-rich substrates led to an overall reduction, though non-significant, in CH<sub>4</sub> yield (Fig. ##FIG##0##1##B). This can be attributed to the generation of secondary degradation products from complex molecular bonds of proteins in addition to the formation of inhibitory compounds such as ammonia<sup>##REF##27908585##12##</sup>.</p>", "<title>Lipid-rich substrates</title>", "<p id=\"Par15\">Milk and meat processing waste, oilseeds, and kitchen waste are examples of lipid-rich substrates (Fig. ##SUPPL##0##S7##)<sup>##REF##27699172##31##</sup>. Lipid-rich substrates can exhibit greater biogas production than protein- and carbohydrate-rich substrates<sup>##REF##23660521##32##</sup>, with the theoretical methane potential of ca 1.0 Nm<sup>3</sup>/kg VS<sup>##UREF##7##10##</sup>. Lipids consist of long-chain fatty acids (LCFAs) linked to glycerol, alcohols or other groups by ester or ether linkages<sup>##REF##27699172##31##</sup>. However, high concentrations of LCFAs are harmful to AD and cause severe inhibition to microorganisms, especially in the acetogenesis and methanogen stages<sup>##REF##27699172##31##</sup>.</p>", "<p id=\"Par16\">As shown in Fig. ##FIG##0##1##C, 16 effect sizes were calculated for lipid-rich substrates. Pretreatments had marginal positive effects, and none of the tested categories yielded a higher efficiency than those of the non-pretreated controls (Fig. ##FIG##2##3##C). However, this result should be interpreted with caution, as the number of observations was considerably lower than the number reported for other substrates.</p>", "<p id=\"Par17\">The use of lipid sources as a sole substrate is not a common practice for biogas production due to the need for nutrient balance (C:N:P:S ratio) to achieve optimal microbial activity. Thus, substrates with high lipid content (&gt; 60% of wet weight) achieve the highest production of biogas in co-digestion<sup>##REF##30060402##33##</sup>. Nevertheless, biogas production can be hampered by excessive loads of lipids due to the hydrophobic nature of lipid-rich materials<sup>##REF##23660521##32##</sup> and by disturbances such as foaming that inhibit microbial activity<sup>##REF##27699172##31##</sup>.</p>", "<p id=\"Par18\">Appropriate pretreatment can mitigate the AD instability associated with high loads of waste lipids by improving the dispersion and solubilization of lipids in the sludge matrix<sup>##REF##31911817##19##</sup>. Nevertheless, our results suggest that optimizing the balance of substrates and nutrient ratios via co-digestion could be more promising than investments in pretreatments. LCFAs from the lipid-rich substrate are usually stabilized when co-digested with low biodegradability co-substrates<sup>##UREF##7##10##</sup>, improving overall biogas production. Alternative operational approaches such as effluent solid recirculation or pulse feeding has also shown promising results on increasing the capacity of AD for handling high loads of lipids<sup>##REF##33402195##34##,##REF##28402870##35##</sup>.</p>", "<title>Lignocellulosic-rich substrates</title>", "<p id=\"Par19\">Lignocellulosic biomass is one of the most abundant sources globally for biofuel production<sup>##REF##27714444##20##</sup>. Approximately 181.5 billion tons of lignocellulosic biomass are generated worldwide every year<sup>##UREF##18##36##</sup>. It is classified by its molecular organization consisting of crystalline cellulose, organized into macrofibrils firmly attached by intermolecular hydrogen bonds, combined with amorphous chains of hemicelluloses, all immersed in a lignin matrix<sup>##REF##32113832##37##</sup>. However, the broad chemical heterogeneity of this organic source prevents the application of a single operational condition that meets all requirements of this feedstock<sup>##UREF##19##38##</sup>. The biogas production of its widely heterogeneous composition decreases dramatically if treated under equal operating conditions<sup>##UREF##19##38##</sup>. Although feedstocks e.g., hardwoods, soybeans, sugar beets, manure, and sugarcane bagasse have been treated under the same classification, their distinct content of biopolymers sorts them apart.</p>", "<p id=\"Par20\">A total of 742 effect sizes were calculated for lignocellulosic substrate, more than the sum of all other substrates (Fig. ##FIG##0##1##D). With a few exceptions, pretreatments applied to lignocellulosic-rich biomasses had positive effects on CH<sub>4</sub> yields, despite an unclear response towards specific pretreatments (Fig. ##FIG##0##1##D). This was probably a result of a large number of different biomass sources that were merged into this group implying large variations in the substrate chemical composition. Lignocellulosic biomass e.g., wood, energy crop, and plant residues are primarily comprised of cellulose, hemicellulose, and lignin, and the composition of these components determines the recalcitrance nature and biodegradability of their chemical structure<sup>##REF##18599291##25##,##REF##32113832##37##</sup>.</p>", "<p id=\"Par21\">Lignin in plants mainly provides structural support, impermeability, and resistance against microbial attack and oxidative stress<sup>##REF##18599291##25##</sup>. Despite the difficulty in degrading lignin, the application of appropriate pretreatment resulted in a CH<sub>4</sub> yield increase of almost 40%<sup>##UREF##20##39##</sup>. Lignin content has been identified as one of the main barriers to the AD of lignocellulosic biomass<sup>##UREF##8##11##</sup> and can be used as an independent variable to assess the effects of pretreatments on lignocellulosic-rich substrates<sup>##REF##21868219##14##</sup>. Therefore, lignocellulosic-rich substrates were divided into three categories according to their lignin content (&lt; 10%, 10–25%, and &gt; 25% lignin dry weight (DW), Fig. ##FIG##2##3##).</p>", "<p id=\"Par22\">Chemical pretreatments degrade lignin very efficiently and are commonly applied to overcome the recalcitrance of lignocellulosic-rich organic residues<sup>##REF##28050842##26##</sup>. Chemical additives (such as sulfuric acid, hydrochloric acid, sodium hydroxide, potassium hydroxide, lime, and hydrogen peroxide) remove the protective barrier created by lignocellulosic fibers, increasing cellulose exposure and facilitating its degradation during AD<sup>##REF##28050842##26##</sup>. However, chemical addition implies an increase in operational costs when applied at full-scale<sup>##REF##21687609##40##</sup> related to chemical reagents and construction of corrosion-resistant reactors<sup>##UREF##21##41##</sup>. Generation of toxic compounds<sup>##UREF##1##4##</sup> that can disturb biogas production is also identified as a drawback of using chemical pretreatments<sup>##UREF##1##4##</sup>. Nevertheless, the overall effect of various chemical pretreatment applied on lignocellulosic-rich substrates resulted in an increase in CH<sub>4</sub> yield based on the outcomes of our meta-analysis (Fig. ##FIG##2##3##A–C).</p>", "<p id=\"Par23\">Interestingly, at low and medium lignin content (&lt; 25% lignin DW), combined physical and biological pretreatments were more efficient than the addition of chemicals and should be used preferentially if the main reason for pretreatment is to increase CH<sub>4</sub> yield. As an exception, biogas production from the lignocellulosic substrate at medium lignin content (Fig. ##FIG##2##3##B), dropped dramatically when subjected to a combination of temperature, pressure and enzymatic pretreatment, in contrast to the high performance of the physical + biological combination<sup>##UREF##6##9##</sup>. The adverse effect possibly occurred in response to multiple interventions generating a highly bioavailable organic matter, overloading the AD system negatively affecting biogas production<sup>##UREF##6##9##</sup>.</p>", "<p id=\"Par24\">Lignocellulosic substrates with low lignin contents (≤ 10% DW) have less of a protective barrier and are therefore more susceptible to biodegradation; hence, pretreatment may have no effect or even an inhibitory effect on CH<sub>4</sub> yield due to the accumulation of toxic compounds such as phenolic substances, 5-hydroxymethylfurfural (HMF) furfurals and aldehydes<sup>##REF##27523710##1##,##REF##28133592##42##</sup>. Our results suggest that substrates with low lignin content require only milder interventions, including the application of biological pretreatments, e.g., enzymes. Enzymatic pretreatment alone (SMD = 11.390, 95% CI 1.169–21.610) or combined with autoclavation (SMD = 25.941, 95% CI 10.998–40.884) or rumen fluid addition (SMD = 8.525, 95% CI 4.368–12.682) led to the highest CH<sub>4</sub> yields from substrates at low lignin content (Fig. ##FIG##3##4##). Up to 83% increase in CH<sub>4</sub> yields of low-lignin substrates was achieved after biological pretreatment (Table ##SUPPL##0##S3##).</p>", "<p id=\"Par25\">Sugar beet pulp and Napier grass are examples of lignocellulosic sources with low lignin content that were subjected to biological pretreatment (Table ##SUPPL##0##S2##; Fig. ##FIG##3##4##). The addition of microbial consortia (bacteria and fungi) and enzymes for pretreatment, not only preserved the weight of cellulose for the hydrolysis step but also increased ca 84% of the total sugar yield which serves as methanogenic substrate in AD systems<sup>##REF##25459810##43##</sup>. Also, enzymes from fungi have been reported as a strategy for the optimization of AD on full-scale, where its addition increased CH<sub>4</sub> yield by 8% and reduced the AD operational costs by 10%<sup>##UREF##17##30##</sup>. Thus, indicating that, the use of biological pretreatments of lignocellulosic substrates with lignin content &lt; 10% should be prioritized over the use of chemicals.</p>", "<p id=\"Par26\">Most agricultural residues have intermediate levels of lignin content (10–25% DW)<sup>##UREF##20##39##</sup> and comprised the majority of the lignocellulosic substrates used for biogas production (Fig. ##FIG##2##3##) with 295 individual effect sizes. The overall effect of all pretreatments applied to lignocellulosic substrates with intermediate lignin contents was positive and significant (SMD = 3.331, 95% CI 2.055–4.607, Fig. ##FIG##4##5##).</p>", "<p id=\"Par27\">A common strategy used in the agricultural sector to deal with intermediate lignin content is to apply physical pretreatment to reduce particle sizes; this process alone has a small positive effect. However, combining particle size reduction with fungal (SMD = 12.734, 95% CI 7.520–17.948) or alkaline (SMD = 2.426, 95% CI 0.082–4.771) addition significantly enhanced CH<sub>4</sub> yields (Fig. ##FIG##4##5##) and led to increases of up to 170% compared to the untreated substrate (Table ##SUPPL##0##S4##). Particle size reduction increases surface area and facilitates microbial access to biodegradable cellular compounds<sup>##REF##33249324##13##</sup>; furthermore, when this approach was combined with the application of ligninolytic enzymes excreted by fungi, a highly delignified biomass was obtained, and the benefits of this combined approach surpassed the positive effect of fungal addition alone (SMD = 4.377, 95% CI 1.050–7.703, Fig. ##FIG##4##5##).</p>", "<p id=\"Par28\">Alkaline addition decreases the recalcitrance of lignocellulosic materials by enhancing lignin and hemicellulose solubilization, thus reducing the crystallinity of the cellulose<sup>##REF##32113832##37##</sup>. It also promotes the removal of acetyl groups and uronic acid substitutions in hemicelluloses, increasing access to carbohydrates during hydrolysis, being more favorable for biomass with low/medium lignin content<sup>##UREF##22##44##</sup>. Alkaline pretreatments alone had positive effects (SMD = 3.936, 95% CI 0.594–7.277) on CH<sub>4</sub> yield and can be considered for application as the only pretreatment since this approach is cost-effective even at full-scale<sup>##REF##33249324##13##</sup>.</p>", "<p id=\"Par29\">Thermal (SMD = 4.675, 95% CI 0.498–8.852) and autoclave (SMD = 4.920, 95% CI 1.468–8.372) are physical pretreatments that resulted in significant increases in CH<sub>4</sub> yields when applied to substrates with moderate lignin contents. The increase in temperature promotes cell lysis making intracellular material available for microbiological degradation<sup>##UREF##21##41##</sup>. Autoclaving is a combined pretreatment method involving high temperatures and pressures and leads to a steam explosion when applied to organic matter.</p>", "<p id=\"Par30\">The lignin content in lignocellulosic-rich substrates is proportional to the ability of the substrate to withstand microbial hydrolysis<sup>##REF##33249324##13##</sup>. Accordingly, lignocellulose substrates with lignin contents above 25% e.g., woods, stalks, processed bagasse, and silage (Fig. ##SUPPL##0##S8##) are less effectively biodegraded and exhibit limited potential for methane production. Substrates with this high lignin content have been more rarely tested leading to only 122 individual effect sizes (Fig. ##FIG##5##6##), for which chemical pretreatments applied alone or in combination are the only viable strategy for increasing the CH<sub>4</sub> yield.</p>", "<p id=\"Par31\">Acid pretreatments are the most commonly applied to such substrates with a CH<sub>4</sub> yield increase in up to 500% (Table ##SUPPL##0##S5##). The addition of acid can accelerate the sugar conversion rate over 90%, by promoting the breakdown of glycosidic bonds of long chains of cellulose and hemicellulose into sugar monomers<sup>##UREF##22##44##</sup>. However, the use of acids requires extra care, as high concentrations of reagents can cause serious damage and corrosion of the operational system in addition to causing imbalances in the AD process<sup>##UREF##19##38##</sup>. At a practical level, chemical addition handled with accuracy and caution is supported techno-economically<sup>##REF##33249324##13##</sup> despite the requirement of high investments for operation and final safe environmental disposal via the digestate<sup>##UREF##8##11##</sup>.</p>", "<title>Mixed substrates</title>", "<p id=\"Par32\">As mentioned earlier, substrate mixing is a very common practice, either to treat all organic waste from a given location in a single operation or to perform co-digestion. However, except for co-digestion, chemical predominance and nutrient balance are not often considered for mixed substrates. Here, mixed substrates are those in which carbohydrates, lipids, and proteins are roughly equal without major disproportions between their contents. Although food waste, sewage, and co-digestion comprise a mixture of several organic sources, food waste seems to be the most suitable to be used as a model, since co-digestion prioritizes geographical location and stabilization of organic matter without the addition of pretreatment<sup>##UREF##23##45##</sup> while the sewage is often pointed out as lipid-rich<sup>##REF##31911817##19##</sup>.</p>", "<p id=\"Par33\">Food waste constitutes a complex organic matrix where the final composition depends on eating habits and varies between countries, regions and periods of the year<sup>##REF##29208531##46##</sup>, preventing a unified characterization of food wastes. From the 72 individual estimated effect sizes, there were no significant differences among pretreatments applied to food waste with an overall effect of SMD = 0.693, 95% CI − 1.132 to 2.518 (Fig. ##FIG##0##1##E). The outcomes highlight that the application of pretreatments might even have a negative marginal effect on CH<sub>4</sub> yield of food waste. Therefore, the appropriate pretreatment should be identified on a case-by-case basis depending on the chemical predominance of the analyzed substrate<sup>##UREF##24##47##</sup>. If no chemical component predominates, targeted pretreatment cannot be advised, and therefore, positive effects on substrate degradation might be drastically reduced. Therefore, the selection of pretreatments applied to mixed substrates with undefined chemical compositions should consider other factors, such as decreased costs or the need to meet legal requirements (i.e., pasteurization).</p>", "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51603-9.</p>", "<title>Acknowledgements</title>", "<p>This study was financed in part by the Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro—FAPERJ and the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)—Finance Code 001, through PhD scholarships for TMA. AE-P gratefully acknowledges financial support from Vinnova (project number 2019-05382), the Swedish Energy Agency (project number P2023-00827) and the funding agency Formas [Grant number: 2021-02429]. AE-P, SSY and AB received funds from the Swedish Energy Agency [Grant number: 35624-2] at the Biogas Research Solution Center hosted by Linköping University, Sweden.</p>", "<title>Author contributions</title>", "<p>T.M.A: Conceptualization, Methodology, Software, Writing—Original draft preparation. Investigation. B.K.-S: Conceptualization, Methodology, Writing—Original draft preparation. A.B.: Methodology, Writing—Reviewing and Editing. S.S.Y.: Methodology, Writing- Reviewing and Editing. L.S.M.M.: Conceptualization, Writing—Reviewing and Editing. V.P.O.: Methodology, Writing—Reviewing and Editing. A.E.-P.: Supervision, Writing—Reviewing and Editing.</p>", "<title>Funding</title>", "<p>Open access funding provided by Linköping University.</p>", "<title>Data availability</title>", "<p>The data supporting the findings of this study are publicly available in the Zenodo with the following 10.5281/zenodo.6619882.</p>", "<title>Code availability</title>", "<p>The software used for analysis is available from <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.r-project.org/\">https://www.r-project.org/</ext-link>. The source code is accessible in the tutorial by Assink and Wibbelink<sup>##UREF##26##49##</sup>.</p>", "<title>Competing interests</title>", "<p id=\"Par47\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Mean effect size (Hedges’ g) and 95% confidence intervals for CH<sub>4</sub> yield from protein-, lipid- and lignocellulosic-rich substrates subjected to different pretreatments. <italic>Phys</italic> physical, <italic>Chem</italic> chemical, <italic>Bio</italic> biological (Figs. ##SUPPL##0##S3##–##SUPPL##0##S5##); these abbreviations denote the treatments and combinations applied to different substrates. (<bold>A</bold>) All substrates were sorted by pretreatment regardless of their chemical composition. (<bold>B</bold>) Protein-rich substrates were predominantly composed of animal waste, microalgae, or high protein content (≥ 40% dry matter). (<bold>C</bold>) Lipid-rich substrates were predominantly composed of agricultural oil residues, swine slaughterhouse wastewater, or any source with high lipid content (≥ 40% dry matter). (<bold>D</bold>) Lignocellulosic-rich substrates were predominantly composed of crop residues, cattle manure, or high lignocellulose content (≥ 50% dry matter). (<bold>E</bold>) Mixed substrates included only food waste. Detailed information on the substrate categories can be found in the ##SUPPL##0##Supplementary material## (Figs. ##SUPPL##0##S6##–##SUPPL##0##S8##). Significance level: p ≤ 0.001 (***); p ≤ 0.01 (**); p ≤ 0.05 (*). n = number of effect sizes per treatment type.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Mean effect size (Hedges’ g) and 95% confidence intervals for CH<sub>4</sub> yield for the most efficient pretreatment methods (biological = squares, physical = triangles and combinations thereof = circles) applied to protein-rich substrates; the plot depicts 95% confidence intervals of the Hedges’ g effect size for CH<sub>4</sub> yield. Significance level: p ≤ 0.001 (***); p ≤ 0.01 (**); p ≤ 0.05 (*). n = number of effect sizes per treatment type.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Mean effect size (Hedges’ g) and 95% confidence intervals of CH<sub>4</sub> yield for lignocellulosic-rich substrates subjected to different pretreatments. <italic>Phys</italic> physical, <italic>Chem</italic> chemical and <italic>Bio</italic> biological; these abbreviations denote the treatments and their combinations applied to substrates with different lignin contents. (<bold>A</bold>) lignin &lt; 10%, (<bold>B</bold>) lignin 10–25% and (<bold>C</bold>) lignin &gt; 25% DW. Significance level: p ≤ 0.001 (***); p ≤ 0.01 (**); p ≤ 0.05 (*). n = number of effect sizes per treatment type.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Methane yields for the most efficient pretreatment methods (biological = squares, combinations = circles) applied to lignocellulosic-rich substrates (lignin &lt; 10% DW). The plots depict 95% confidence intervals of Hedges’ g effect size for CH<sub>4</sub> yield. Significance level: p ≤ 0.001 (***); p ≤ 0.01 (**); p ≤ 0.05 (*). n = number of effect sizes per treatment type.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Methane yield effects for the most efficient pretreatment methods (chemical = squares, biological = triangles and combined methods = circles) applied to lignocellulosic-rich substrates (lignin 10–25% DW). The plots depict 95% confidence intervals of Hedges’ g effect size for CH<sub>4</sub> yield. Significance level: p ≤ 0.001 (***); p ≤ 0.01 (**); p ≤ 0.05 (*). n = number of effect sizes per treatment type.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Methane yield effects for the most efficient pretreatment methods (chemical = squares and combinations = circles) applied to lignocellulosic-rich substrates (lignin &gt; 25% DW). The plot depicts 95% confidence intervals of Hedges’ g effect size for CH<sub>4</sub> yield. Significance level: p ≤ 0.001 (***); p ≤ 0.01 (**); p ≤ 0.05 (*). n = number of effect sizes per treatment type.</p></caption></fig>" ]
[]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${X}_{C}$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:msub><mml:mi>X</mml:mi><mml:mi>C</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${X}_{H}$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:msub><mml:mi>X</mml:mi><mml:mi>H</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${X}_{L}$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:msub><mml:mi>X</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$LB=\\left({X}_{C}+{X}_{H}+{X}_{L}\\right)$$\\end{document}</tex-math><mml:math id=\"M8\" display=\"block\"><mml:mrow><mml:mi>L</mml:mi><mml:mi>B</mml:mi><mml:mo>=</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>X</mml:mi><mml:mi>C</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>H</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$Lignincontent\\left(\\%DW\\right)=\\frac{{X}_{L}\\text{*100}}{\\text{LB}}$$\\end{document}</tex-math><mml:math id=\"M10\" display=\"block\"><mml:mrow><mml:mi>L</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>n</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mo>%</mml:mo><mml:mi>D</mml:mi><mml:mi>W</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mi>L</mml:mi></mml:msub><mml:mtext>*100</mml:mtext></mml:mrow><mml:mtext>LB</mml:mtext></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$g=\\frac{{Mean}_{T}-{Mean}_{C}}{\\sqrt{({n}_{1}-{1)s}_{1}^{2}+({n}_{2}-1){s}_{2}^{2}}}* 1- \\frac{4}{4({n}_{1}+{n}_{2})-9}$$\\end{document}</tex-math><mml:math id=\"M12\" display=\"block\"><mml:mrow><mml:mi>g</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"italic\">Mean</mml:mi></mml:mrow><mml:mi>T</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"italic\">Mean</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msub></mml:mrow><mml:msqrt><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msubsup><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msubsup><mml:mi>s</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:msqrt></mml:mfrac><mml:mrow/><mml:mo>∗</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mfrac><mml:mn>4</mml:mn><mml:mrow><mml:mn>4</mml:mn><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>-</mml:mo><mml:mn>9</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${Mean}_{T}$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:msub><mml:mrow><mml:mi mathvariant=\"italic\">Mean</mml:mi></mml:mrow><mml:mi>T</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${Mean}_{C}$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:msub><mml:mrow><mml:mi mathvariant=\"italic\">Mean</mml:mi></mml:mrow><mml:mi>C</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${n}_{1}$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:msub><mml:mi>n</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${n}_{2}$$\\end{document}</tex-math><mml:math id=\"M20\"><mml:msub><mml:mi>n</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${s}_{1}^{2}$$\\end{document}</tex-math><mml:math id=\"M22\"><mml:msubsup><mml:mi>s</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${s}_{2}^{2}$$\\end{document}</tex-math><mml:math id=\"M24\"><mml:msubsup><mml:mi>s</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51603_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51603_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51603_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51603_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51603_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2024_51603_Fig6_HTML\" id=\"MO6\"/>", "<inline-graphic xlink:href=\"41598_2024_51603_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51603_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51603_Article_IEq3.gif\"/>", "<graphic xlink:href=\"41598_2024_51603_Article_Equ1.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51603_Article_Equ2.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51603_Article_Equ3.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51603_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51603_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51603_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51603_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51603_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51603_Article_IEq9.gif\"/>" ]
[ "<media xlink:href=\"41598_2024_51603_MOESM1_ESM.pdf\"><caption><p>Supplementary Information.</p></caption></media>", "<media xlink:href=\"41598_2024_51603_MOESM2_ESM.xlsx\"><caption><p>Supplementary Table S1.</p></caption></media>" ]
[{"label": ["2."], "surname": ["Nagarajan", "Ranade"], "given-names": ["S", "VV"], "article-title": ["Valorizing waste biomass via hydrodynamic cavitation and anaerobic digestion"], "source": ["Ind. Eng. Chem. Res."], "year": ["2021"], "volume": ["60"], "fpage": ["16577"], "lpage": ["16598"], "pub-id": ["10.1021/acs.iecr.1c03177"]}, {"label": ["4."], "surname": ["Sahota"], "given-names": ["S"], "article-title": ["Review of trends in biogas upgradation technologies and future perspectives"], "source": ["Bioresour. Technol. Rep."], "year": ["2018"], "volume": ["1"], "fpage": ["79"], "lpage": ["88"], "pub-id": ["10.1016/j.biteb.2018.01.002"]}, {"label": ["5."], "collab": ["WBA"], "source": ["Global Potential of Biogas"], "year": ["2019"], "publisher-name": ["World Biogas Association"], "fpage": ["1"], "lpage": ["56"]}, {"label": ["6."], "surname": ["Surendra", "Takara", "Hashimoto", "Khanal"], "given-names": ["KC", "D", "AG", "SK"], "article-title": ["Biogas as a sustainable energy source for developing countries: Opportunities and challenges"], "source": ["Renew. Sustain. Energy Rev."], "year": ["2014"], "volume": ["31"], "fpage": ["846"], "lpage": ["859"], "pub-id": ["10.1016/j.rser.2013.12.015"]}, {"label": ["7."], "surname": ["Khalil", "Berawi", "Heryanto", "Rizalie"], "given-names": ["M", "MA", "R", "A"], "article-title": ["Waste to energy technology: The potential of sustainable biogas production from animal waste in Indonesia"], "source": ["Renew. Sustain. Energy Rev."], "year": ["2019"], "volume": ["105"], "fpage": ["323"], "lpage": ["331"], "pub-id": ["10.1016/j.rser.2019.02.011"]}, {"label": ["8."], "surname": ["Giwa", "Alabi", "Yusuf", "Olukan"], "given-names": ["A", "A", "A", "T"], "article-title": ["A comprehensive review on biomass and solar energy for sustainable energy generation in Nigeria"], "source": ["Renew. Sustain. Energy Rev."], "year": ["2017"], "volume": ["69"], "fpage": ["620"], "lpage": ["641"], "pub-id": ["10.1016/j.rser.2016.11.160"]}, {"label": ["9."], "surname": ["Elalami"], "given-names": ["D"], "article-title": ["Pretreatment and co-digestion of wastewater sludge for biogas production: Recent research advances and trends"], "source": ["Renew. Sustain. Energy Rev."], "year": ["2019"], "volume": ["114"], "fpage": ["109287"], "pub-id": ["10.1016/j.rser.2019.109287"]}, {"label": ["10."], "surname": ["Rasit", "Idris", "Harun", "Wan Ab Karim Ghani"], "given-names": ["N", "A", "R", "WA"], "article-title": ["Effects of lipid inhibition on biogas production of anaerobic digestion from oily effluents and sludges: An overview"], "source": ["Renew. Sustain. Energy Rev."], "year": ["2015"], "volume": ["45"], "fpage": ["351"], "lpage": ["358"], "pub-id": ["10.1016/j.rser.2015.01.066"]}, {"label": ["11."], "surname": ["Hashemi", "Sarker", "Lamb", "Lien"], "given-names": ["B", "S", "JJ", "KM"], "article-title": ["Yield improvements in anaerobic digestion of lignocellulosic feedstocks"], "source": ["J. Clean. Prod."], "year": ["2021"], "volume": ["288"], "fpage": ["125447"], "pub-id": ["10.1016/j.jclepro.2020.125447"]}, {"label": ["15."], "surname": ["Sharma", "Xu", "Qin"], "given-names": ["HK", "C", "W"], "article-title": ["Biological pretreatment of lignocellulosic biomass for biofuels and bioproducts: An overview"], "source": ["Waste Biomass Valoriz."], "year": ["2019"], "volume": ["10"], "fpage": ["235"], "lpage": ["251"], "pub-id": ["10.1007/s12649-017-0059-y"]}, {"label": ["16."], "surname": ["Zabed"], "given-names": ["HM"], "article-title": ["Recent advances in biological pretreatment of microalgae and lignocellulosic biomass for biofuel production"], "source": ["Renew. Sustain. Energy Rev."], "year": ["2019"], "volume": ["105"], "fpage": ["105"], "lpage": ["128"], "pub-id": ["10.1016/j.rser.2019.01.048"]}, {"label": ["17."], "surname": ["Roebuck", "Kennedy", "Delatolla"], "given-names": ["P", "K", "R"], "article-title": ["Ultrasonic pretreatment for anaerobic digestion of suspended and attached growth sludges"], "source": ["Water Qual. Res. J. Can."], "year": ["2019"], "volume": ["54"], "fpage": ["265"], "lpage": ["277"], "pub-id": ["10.2166/wqrj.2019.039"]}, {"label": ["18."], "surname": ["Atelge"], "given-names": ["MR"], "article-title": ["Biogas production from organic waste: Recent progress and perspectives"], "source": ["Waste Biomass Valoriz."], "year": ["2020"], "volume": ["11"], "fpage": ["1019"], "lpage": ["1040"], "pub-id": ["10.1007/s12649-018-00546-0"]}, {"label": ["23."], "surname": ["Nabi"], "given-names": ["M"], "article-title": ["Enhancement of high pressure homogenization pretreatment on biogas production from sewage sludge: A review"], "source": ["Desalination Water Treat."], "year": ["2020"], "volume": ["175"], "fpage": ["341"], "lpage": ["351"], "pub-id": ["10.5004/dwt.2020.24670"]}, {"label": ["24."], "surname": ["Shah", "Ullah"], "given-names": ["TA", "R"], "article-title": ["Pretreatment of wheat straw with ligninolytic fungi for increased biogas productivity"], "source": ["Int. J. Environ. Sci. Technol."], "year": ["2019"], "volume": ["16"], "fpage": ["7497"], "lpage": ["7508"], "pub-id": ["10.1007/s13762-019-02277-8"]}, {"label": ["27."], "surname": ["Guo"], "given-names": ["J"], "article-title": ["Application of meta-analysis towards understanding the effect of adding a methionine hydroxy analogue in the diet on growth performance and feed utilization of fish and shrimp"], "source": ["Rev. Aquac."], "year": ["2020"], "volume": ["12"], "fpage": ["2316"], "lpage": ["2332"], "pub-id": ["10.1111/raq.12436"]}, {"label": ["29."], "surname": ["Rasapoor"], "given-names": ["M"], "article-title": ["Recognizing the challenges of anaerobic digestion: Critical steps toward improving biogas generation"], "source": ["Fuel"], "year": ["2020"], "volume": ["261"], "fpage": ["116497"], "pub-id": ["10.1016/j.fuel.2019.116497"]}, {"label": ["30."], "surname": ["Br\u00e9mond", "de Buyer", "Steyer", "Bernet", "Carrere"], "given-names": ["U", "R", "JP", "N", "H"], "article-title": ["Biological pretreatments of biomass for improving biogas production: An overview from lab scale to full-scale"], "source": ["Renew. Sustain. Energy Rev."], "year": ["2018"], "volume": ["90"], "fpage": ["583"], "lpage": ["604"], "pub-id": ["10.1016/j.rser.2018.03.103"]}, {"label": ["36."], "surname": ["Paul", "Dutta"], "given-names": ["S", "A"], "article-title": ["Challenges and opportunities of lignocellulosic biomass for anaerobic digestion"], "source": ["Resour. Conserv. Recycl."], "year": ["2018"], "volume": ["130"], "fpage": ["164"], "lpage": ["174"], "pub-id": ["10.1016/j.resconrec.2017.12.005"]}, {"label": ["38."], "surname": ["Hern\u00e1ndez-Beltr\u00e1n"], "given-names": ["JU"], "article-title": ["Insight into pretreatment methods of lignocellulosic biomass to increase biogas yield: Current state, challenges, and opportunities"], "source": ["Appl. Sci."], "year": ["2019"], "volume": ["9"], "fpage": ["3721"], "pub-id": ["10.3390/app9183721"]}, {"label": ["39."], "surname": ["Kumar", "Kumar", "Bhaskar"], "given-names": ["A", "J", "T"], "article-title": ["Utilization of lignin: A sustainable and eco-friendly approach"], "source": ["J. Energy Inst."], "year": ["2020"], "volume": ["93"], "fpage": ["235"], "lpage": ["271"], "pub-id": ["10.1016/j.joei.2019.03.005"]}, {"label": ["41."], "surname": ["Thompson", "Young", "Baroutian"], "given-names": ["TM", "BR", "S"], "article-title": ["Advances in the pretreatment of brown macroalgae for biogas production"], "source": ["Fuel Process. Technol."], "year": ["2019"], "volume": ["195"], "fpage": ["106151"], "pub-id": ["10.1016/j.fuproc.2019.106151"]}, {"label": ["44."], "surname": ["Baruah"], "given-names": ["J"], "article-title": ["Recent trends in the pretreatment of lignocellulosic biomass for value-added products"], "source": ["Front. Energy Res."], "year": ["2018"], "volume": ["6"], "fpage": ["141"], "pub-id": ["10.3389/fenrg.2018.00141"]}, {"label": ["45."], "surname": ["Edstr\u00f6m", "Nordberg", "Thyselius"], "given-names": ["M", "\u00c5", "L"], "article-title": ["Anaerobic treatment of animal byproducts from slaughterhouses at laboratory and pilot scale"], "source": ["Appl. Biochem. Biotechnol. Part A Enzym. Eng. Biotechnol."], "year": ["2003"], "volume": ["109"], "fpage": ["127"], "lpage": ["138"], "pub-id": ["10.1385/ABAB:109:1-3:127"]}, {"label": ["47."], "surname": ["Pagliaccia"], "given-names": ["P"], "article-title": ["Variability of food waste chemical composition: Impact of thermal pre-treatment on lignocellulosic matrix and anaerobic biodegradability"], "source": ["J. Environ. Manag."], "year": ["2019"], "volume": ["236"], "fpage": ["100"], "lpage": ["107"], "pub-id": ["10.1016/j.jenvman.2019.01.084"]}, {"label": ["48."], "surname": ["Lin"], "given-names": ["L"], "article-title": ["Bias caused by sampling error in meta-analysis with small sample sizes"], "source": ["PLoS\u00a0One"], "year": ["2018"], "volume": ["13"], "fpage": ["1"], "lpage": ["19"]}, {"label": ["49."], "surname": ["Assink", "Wibbelink"], "given-names": ["M", "C"], "article-title": ["Fitting three-level meta-analytic models in R: A step-by-step tutorial mark Assink and Carlijn J. M. Wibbelink"], "source": ["Quant. Methods Psychol."], "year": ["2016"], "volume": ["12"], "fpage": ["154"], "lpage": ["174"], "pub-id": ["10.20982/tqmp.12.3.p154"]}]
{ "acronym": [], "definition": [] }
49
CC BY
no
2024-01-14 23:40:15
Sci Rep. 2024 Jan 12; 14:1240
oa_package/1c/eb/PMC10786828.tar.gz
PMC10786829
38216584
[ "<title>Introduction</title>", "<p id=\"Par2\">The physiological responses of humans exposed to microgravity have been of particular interest since the beginning of human spaceflight. The conditions in space cause severe adaptations in sensorimotor, cardiovascular and neuromuscular systems of astronauts<sup>##REF##28173929##1##</sup>. To safeguard astronauts’ health, it is essential to identify functionally relevant declines in fitness levels upon their return to Earth in order to facilitate a fast and full recovery.</p>", "<p id=\"Par3\">Generally, gait speed has been recognized as an informative functional test to assess a person’s health<sup>##REF##3177082##2##–##REF##16320148##5##</sup>. Slow gait speed, for instance, is an indicator of decreased functionality, and even of mortality in older adults<sup>##REF##12147005##6##,##REF##17916121##7##</sup>. Many factors are likely involved in decreases in gait speed. To name a few; muscular factors including loss of motor units, decrease in muscular contraction speed and velocity, disrupted muscular activation, and neurological factors including decrease in nerve conduction velocity, decrease in the reaction time and other diseases related with the central and peripheral nervous systems<sup>##REF##16085338##8##–##REF##10998639##11##</sup>. A systematic review stated that “gait speed at usual pace was a strong and consistent predictor of adverse health outcomes, and gait speed as a single-item tool was at least as sensible as the composite tools in predicting these outcomes over time” in older adults<sup>##REF##19924348##12##</sup>.</p>", "<p id=\"Par4\">Bed-rest is a well-accepted model to simulate the impact of spaceflight on human physiology,<sup>##REF##28173929##1##</sup>. Immobilization by bed-rest leads to a rapid de-conditioning process in most bodily organs<sup>##REF##17661073##13##</sup>. Eight weeks of strict bed-rest lead to a reduction in calf muscle size by ~20%<sup>##REF##19732856##14##</sup>, to a similar reduction in plantar flexor muscle strength and a decline in peak jumping power of ~30%<sup>##REF##21527664##15##</sup>. It can only be assumed that such musculoskeletal de-conditioning would affect a person’s ability to locomote rapidly. Previous work involving gait course analyses after 60 days of bed-rest showed that preferred walking speed is impaired up to 7 days after re-ambulation<sup>##REF##30559676##16##</sup>.</p>", "<p id=\"Par5\">In previous bed-rest studies, individual fitness levels were mainly assessed by using maximal effort tests<sup>##REF##21626041##17##</sup>. However, measurements were only taken at discrete points in time and only until 2 weeks after the end of bed-rest. It is known that discrete measurements as gait tests have a high day-to-day variability<sup>##REF##11424630##18##,##REF##21969239##19##</sup>, thus a continuous and long-term measurement of RWS can provide additional insight in the recovery process after bed-rest. Moreover, it is well known now that gait speed of subjects who are observed under artificial conditions significantly differs from their self-selected gait speed<sup>##REF##30092204##20##–##REF##30837520##24##</sup>. In a previous study<sup>##REF##20801257##21##</sup>, where walking behavior was investigated during the recovery after total hip replacement surgery, patients exaggerated their walking speed while under observation compared to their natural behavior at home. This seems to suggest that longer monitoring periods in an unobserved environment would add valuable information on functional fitness.</p>", "<p id=\"Par6\">The main aim of this study was to investigate if and how RWS is affected by 60 days of bed-rest, and whether RWS can be used as an indicator of fitness status. The main hypothesis was that a decrease in walking speed would occur after the bed-rest period, with a subsequent fast recovery towards RWS values observed before the bed-rest period. Moreover, effects of training interventions on RWS across the different study groups were also analyzed.</p>", "<p id=\"Par7\">Lastly, an exploratory analysis was done to explore whether changes in RWS are associated to other more commonly used maximal physical assessments (VO<sub>2max</sub> measurements and maximal vertical jump tests), to understand whether there is agreement in the outcomes between RWS and the other tests, or if there is a generally poor agreement, suggesting that they measure something complementary to each other.</p>" ]
[ "<title>Methods</title>", "<title>Study design</title>", "<p id=\"Par24\">This bed-rest study was performed at the <italic>:envihab</italic> facility of the German Aerospace Center (Deutsches Zentrum fur Luft- und Raumfahrt, DLR). The study was conducted in two separate campaigns with twelve participants in each campaign. For each subject, each campaign lasted 89 days, which consisted of a 15-day baseline data collection (<italic>BDC</italic>), 60-day 6° head down tilt (<italic>HDT</italic>), and a 14-day recovery (<italic>R</italic> + ) phase. During the ambulatory stationary phases of the study, the subjects stayed in the controlled environment of the DLR facility. Artificial gravity (AG) exposure was presented as a potential countermeasure and was provided by means of horizontal centrifugation during the <italic>HDT</italic> phase with a 3.8 meters radius short-arm human centrifuge. Daily, the participants were exposed to 30 min of centrifugation at 1 G at the center of mass and ~2 G at the feet. The 30-min AG intervention was completed either in one continuous 30-min run (cAG), or intermittently with 3-min breaks in between six 5-min bouts of centrifugation (iAG) (see Fig. ##FIG##3##4a## for illustration of training sessions). Participants were positioned on one arm of the human-centrifuge, with their feet pointing outwards. All sessions were supervised by a medical doctor. During the ambulatory phases (<italic>BDC</italic> and <italic>R</italic>+), physical activity was restricted to free movement within the ward and to standardized reconditioning sessions. Additionally, half of the participants underwent 30 min of Functional Re-adaptive Exercise Device (FRED) training every day during the <italic>R</italic> + (recovery) phase. Prior to the study, subjects were assigned to the FRED group in a stratified manner to ensure that experimental group allocation and FRED Training were balanced. Subjects who underwent FRED Training were selected from both campaigns (six subjects from campaign 1, and six subjects from campaign 2).</p>", "<title>Subjects</title>", "<p id=\"Par25\">In total, 24 healthy participants were recruited from the general public to participate in the study. The recruitment of the subjects included methods, such as use of test subject archives, announcements in electronic media and the internet. A participant was deemed to be healthy after undergoing thorough physical and psychological examinations. Physical examinations included resting and stress electrocardiogram, orthostatic testing, lung function and eye examinations as well as a medical anamnesis, followed by blood test for HIV, hepatitis, tuberculosis, and thrombophilia. The psychological screening consisted of an initial preliminary psychological evaluation, the Freiburger Persönlichkeitsinventar (FPI) personality checklist. Candidates then underwent detailed psychological screening that involved additional questionnaires; the Temperament Structure Scale and the 60-item NEO-FFI personality inventory, along with the subject’s self-reported biography and a concluding in-person interview.</p>", "<p id=\"Par26\">On the first day of the <italic>HDT</italic> intervention, the recruited subjects were randomly assigned to either the continuous centrifugation group (cAG, <italic>n</italic> = 8, age 32 ± 10 years, height 173 ± 8 cm, body mass 72 ± 10 kg, 3 female), intermittent centrifugation group (iAG, <italic>n</italic> = 8, age 34 ± 11 years, height 174 ± 11 cm, body mass 71 ± 5 kg, 3 female) or the control group (CTRL, <italic>n</italic> = 8, age 34 ± 8 years, height 177 ± 7 cm, body mass 79 ± 13 kg, 2 female), please see Table ##TAB##4##5## for summary statistics of participants’ anthropometric and demographic data, and significance levels of differences between groups. Prior to commencing the study, all participants gave written informed consent to the experimental procedures, which were authorized by the ethics committee of the Northern Rhine Medical Association (Ärztekammer Nordrhein) in Duesseldorf, Germany. The subjects received financial compensation for their participation. The study is registered at the German Clinical Trials Register (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.drks.de\">www.drks.de</ext-link>) under the number DRKS00015677.</p>", "<title>3D-accelerometry</title>", "<p id=\"Par27\">During the entire <italic>BDC</italic> and <italic>R+</italic> periods in the facility, subjects were equipped with a tri-axial accelerometer (actibelt®, Trium Analysis Online GmbH, Munich, Germany) positioned on the frontal region, below the umbilicus. The device is rechargeable, portable in size and records the accelerations in the three dimensions with a sample frequency of 100 Hz. The participants kept the actibelt® on for the duration of the <italic>BDC</italic> phases (from <italic>BDC-28</italic> to <italic>BDC-21</italic>, and from <italic>BDC-15</italic> to <italic>BDC-1</italic>), and again during three distinct recovery phases (from <italic>R</italic> + <italic>0</italic> to <italic>R</italic> + <italic>12</italic>, from <italic>R</italic> + <italic>21</italic> to <italic>R</italic> + <italic>28</italic> and from <italic>R</italic> + <italic>83</italic> to <italic>R</italic> + <italic>90</italic>). The participants were instructed to remove the belts only for all MRI experiments, and when taking a shower or when sleeping. Thus, actibelt® was used during five distinct periods throughout the study (see Fig. ##FIG##3##4b## for overview and phases abbreviation names and schematic of study phases in which actibelt® measurements were acquired). For each period, actibelt® wearing time was assessed via an electronic switch of the device that senses physical closure of the buckle.</p>", "<title>VO<sub>2max</sub> measurements</title>", "<p id=\"Par28\">Maximum oxygen uptake capacity (VO<sub>2max</sub>) was assessed by means of a maximal cycle ergometry (Lode Excalibur, Groningen, The Netherlands) once before (BDC-3) and once immediately following bed-rest (R + 0) in an environmentally (temperature/humidity) controlled laboratory. Ambient temperature and humidity were controlled by AC units, while ambient pressure was used to calibrate the cycle ergometry together with the ambient temperature at the time of the measurements. The measurement protocol consisted of 5 min of seated rest on the cycle ergometer followed by 3 min of pedaling at a cadence of 75 rpm at 50 Watts. Subsequently, the power was increased by 25 Watts every minute, starting from 3 min at 50 W, until voluntary exhaustion under strong verbal encouragement. Following voluntary exhaustion, subjects continued to pedal for 5 min at a low work rate to allow for an active recovery. Subjects were asked to rate their perceived exertion on a 6-20 point Borg scale and continuous (breath-by-breath) systemic oxygen uptake (VO<sub>2</sub>) and carbon dioxide (CO<sub>2</sub>) emission were obtained using the Innocor system (Innovision, Odense, Dänemark). Moreover, a 12-lead ECG (Padsy, Medset Medizintechnik, Germany) was used to continuously monitor and record the heart rate. Lastly, spiroergometric data were filtered by calculating the median of 5 breaths and the moving average over 30 s and the peak values for the VO<sub>2max</sub> values were calculated. For statistical analyses, Delta values were calculated, and given in percent of the BDC-value.</p>", "<title>Vertical jump measurements</title>", "<p id=\"Par29\">Before (BDC-8) and after (R + 0) the bed-rest period, subjects performed maximal countermovement jumps. Peak vertical jump power (Pmax) was calculated from the time course of ground reaction forces (Novotec Medical GmbH, Pforzheim, Germany). Subjects were familiarized with the test in a separate session before the baseline measurements. Before the maximal vertical jump attempt, subjects warmed-up by means of three warm-up squats and then were instructed to practice three countermovement jumps at roughly half of maximum effort to ensure that the test instruction was correctly understood. Thereafter, subjects performed three maximal countermovement jumps with short breaks in between. Pmax (in kW) was chosen as the highest value of the three trials. For statistical analyses, Delta values were calculated, and given in percent of the BDC-value.</p>", "<title>Data processing</title>", "<p id=\"Par30\">Accelerometry data were uploaded to the actibelt® data warehouse and checked for completeness. For each subject, a total of 48 days with at least 10 h/day of recording time each were expected (making up for a total of 1152 expected measurements). Data were subsequently analyzed, and gait speed, daily number of steps and wearing time calculated with the <italic>stepwave</italic> algorithm<sup>##REF##31469864##42##</sup> along with other gait parameters were retrieved. The <italic>stepwave</italic> algorithm calculates mean speed per walking step, thus, RWS is calculated as the average of the mean speed per walking step in a given day. To address the main hypothesis, a decrease in RWS after the bed-rest period with a subsequent recovery to the initial RWS values measured before the bed-rest, walking speed was selected as the principal parameter for the analysis. As a first step we manually investigated the completeness of the retrieved data with respect to the phases and neglected data which were recorded outside the scheduled phases. Adherence is a parameter which represents the number of hours the actibelt® was worn by the individual subjects. Data with adherence below 1 h/day were omitted. Measurements with &lt; 10 h/day of recording time for a given day were marked as incomplete. For the <italic>pre.home</italic> period a visual inspection of the walking speed data was performed in order to ensure that the notable difference between the group cAG and the other two groups, iAG and Ctrl, did not originate from recording issues.</p>", "<p id=\"Par31\">VO<sub>2max</sub> data and maximal vertical jump power data were loaded into R Studio and distinctly merged with the walking speed data using as a merging key the subject id and the date. This implies that the daily RWS used as baseline to calculate the relative difference is the daily RWS calculated at the day of the VO<sub>2max</sub> test for the comparison RWS vs. VO<sub>2max</sub>, and the daily RWS calculated at the day of the maximal vertical jump power test. Out of the three maximal countermovement jumps, we selected the jump that showed the highest power output. Once the three datasets were merged, the relative changes after bed-rest were calculated with the formula , where A denotes the baseline value of <italic>x</italic>, B denotes the values of <italic>x</italic> after bed-rest and <italic>x</italic> denotes the type of data used, either RWS data, VO<sub>2max</sub> data or maximal vertical jump power data. Thus, negative values will denote a decrease in performance after bed-rest from baseline values, and vice versa, positive values will denote an improvement in performance after bed-rest from the baseline values.</p>", "<title>Statistical analysis</title>", "<p id=\"Par32\">Statistical analysis was performed using R Studio v. 4.0.3 (RStudio: Integrated Development Environment for R, RStudio, Inc., Boston, MA). It included: an assessment of whether the incomplete measurements were missing data at random, fitting of a linear mixed effect (lme) model and pruning of variables with low statistical significance.</p>", "<p id=\"Par33\">A common approach to dealing with incomplete observations is to remove them from the analysis. However, this process may introduce bias, and it wastes valuable partial data. Instead, it was assessed if the incomplete measurements are missing data at random by randomly removing segments of measurement from the complete observations (measurements with ten or more hours of recording per day) and compare the two distributions to determine whether the data are missing at random or not (please see ##SUPPL##0##Supplementary Methods## and ##SUPPL##0##Supplementary Figures## for more details on the procedure). Compelling evidence was not found to conclude that the data were not missing at random, and thus, they were included in further analysis.</p>", "<p id=\"Par34\">Denote the indication function with:Where either: <italic>t</italic> is time in days and <italic>p</italic> is a period or <italic>t</italic> is a patient index and <italic>p</italic> is a patient group. The lme model for subject <italic>i</italic> and day <italic>t</italic> took the following form:Where:</p>", "<p id=\"Par35\">\n<italic>a</italic>nd <italic>t*</italic> is the first day of the <italic>post.dlr</italic> period,</p>", "<p id=\"Par36\"> and all <italic>β</italic> coefficients above are reals.</p>", "<p id=\"Par37\">The term <italic>post.dlr.days</italic> is a vector containing numbers representing the elapsed days in the <italic>post.dlr</italic> period since <italic>R</italic> + <italic>0</italic>. The terms <italic>offset.int.cAG.post.dlr</italic> and <italic>offset.int.iAG.post.dlr</italic> are the terms to offset the group intercepts in the <italic>post.dlr</italic> phase. Those two terms have been introduced to account for group differences in RWS that might occur randomly, and not related to the study interventions, and thus interfere with the interpretation of the group RWS recovery. Thus, the intercept in the <italic>post.dlr</italic> phase was set to 0.</p>", "<p id=\"Par38\">The model formula was implemented using the command <italic>lmer</italic> from the R package <italic>lmerTest</italic>, using Satterthwaite’s method for computing the <italic>t</italic>-tests<sup>##REF##20287815##50##</sup>.</p>", "<p id=\"Par39\">This model formula was chosen using a simplification strategy, removing model terms whenever showing not significant importance in the model. Significance of model terms was determined using Satterthwaite approximation<sup>##REF##20287815##50##</sup>. The initial model additionally contained one linear term to account for those subjects that underwent FRED training every day during the recovery phase within the DLR ward (from R + 0 to R + 12); an interaction term between <italic>group</italic> and <italic>post.dlr.days</italic>; and additional interaction term between <italic>group</italic> and <italic>period</italic>. However, the linear term and both interaction terms did not show any significance in the model formula and were thus pruned away.</p>", "<p id=\"Par40\">Lastly, Bland-Altman plots<sup>##UREF##6##51##</sup> and correlation analysis using Pearson’s product moment correlation coefficient was done aimed at finding out the level of agreement and correlation between changes in daily RWS between pre/post-bed-rest and (i) changes in VO<sub>2max</sub> pre/post-bed-rest and (ii) the maximal power exerted during vertical jump between pre/post-bed-rest<sup>##REF##19022418##52##,##REF##17406887##53##</sup>.</p>", "<title>Reporting summary</title>", "<p id=\"Par41\">Further information on research design is available in the ##SUPPL##1##Nature Research Reporting Summary## linked to this article.</p>" ]
[ "<title>Results</title>", "<title>Data completeness</title>", "<p id=\"Par8\">Out of the 120 expected periods (5 periods × 24 subjects), 112 periods were captured. For two subjects, measurements were not collected for either the <italic>pre.home</italic> or the <italic>pre.dlr</italic> periods, making it impossible to establish a baseline measurement for RWS. Thus, it was decided to remove those two subjects from the dataset since no before/after bed-rest comparison was possible. For three other subjects, measurements from the <italic>pre.home</italic> period were not collected, and for one subject measurements for the <italic>post.home(R</italic> + <italic>90)</italic> period were not collected. Those four subjects were not excluded from the dataset since the <italic>pre.dlr</italic> period was available, and thus the before/after comparison was still possible.</p>", "<title>Randomness of incomplete observations</title>", "<p id=\"Par9\">Out of the 944 recording days, 182 (17%) had a wearing time smaller than 10 h per day (mean ± sd: 5.76 ± 2.52). From visual inspection of the Q-Q plot (see ##SUPPL##0##Supplementary Methods## for further details on the method employed to establish validity of measurements with &lt;10 h of recording per day) it was seen that most of the cumulative distribution function of the average walking speed are closely distributed according to a uniform distribution on [0,1], suggesting that the data were missing at random.</p>", "<title>Wearing time</title>", "<p id=\"Par10\">Wearing time, or adherence, was generally very high throughout all the study phases (h/day; mean ± sd): <italic>pre.home</italic>: 14.2 ± 4.1; <italic>pre.dlr</italic>: 13.5 ± 3.5; <italic>post.dlr</italic>: 12.9 ± 3.5; <italic>post.home(R</italic> + <italic>28)</italic>: 11.3 ± 5.1; <italic>post.home(R</italic> + <italic>90)</italic>: 12.7 ± 5.1. Data about wearing time by group and period are summarized in Table ##TAB##0##1##.</p>", "<title>Linear mixed effect model</title>", "<p id=\"Par11\">After it was concluded that it was acceptable to include all measurements with wearing time &gt; 1 h per day without introducing a systematic bias in the data, the final dataset resulted in 944 days of measurement with a mean wearing time (mean ± sd) of 13 ± 4.17 h per day (please see Table ##TAB##0##1## for details about wearing time per group and study phase). In the lme model significant effects were found in RWS in <italic>post.dlr</italic> (RWS <italic>pre.dlr</italic>: 0.96 ± 0.09 m/s; RWS <italic>post.dlr</italic>: 0.84 ± 0.08 m/s; changes in RWS: 0.12 m/s; t<sub>915.9</sub> = -7.33, <italic>p</italic> &lt; 0.001), <italic>post.home(R</italic> + <italic>28)</italic> period (RWS <italic>pre.dlr</italic>: 0.96 ± 0.09 m/s; RWS <italic>post.home(R</italic> + <italic>28)</italic>: 0.99 ± 0.21 m/s; changes in RWS: 0.03 m/s; t<sub>916.9</sub> = 2.02, <italic>p</italic> = 0.044), <italic>post.home(R</italic> + <italic>90)</italic> period (RWS <italic>pre.dlr</italic>: 0.96 ± 0.09 m/s; RWS <italic>post.home(R</italic> + <italic>90)</italic>: 1.00 ± 0.19 m/s; changes in RWS: 0.04 m/s; t<sub>917.6</sub> = 2.6, <italic>p</italic> = 0.01), in the group cAG (t<sub>21.2</sub> = 2.31, <italic>P</italic> = 0.031), in <italic>post.dlr.days</italic> (t<sub>916.1</sub> = 4.02, <italic>p</italic> &lt; 0.001) and in the intercept offset in the <italic>post.dlr</italic> phase for the group cAG (t<sub>915.5</sub> = -2.53, <italic>p</italic> = 0.012). Please see Fig. ##FIG##0##1## and Table ##TAB##0##1## for an overview of the RWS values per group and period, and Table ##TAB##1##2## for summary statistics of the lme model.</p>", "<title>Exploratory analysis</title>", "<p id=\"Par12\">For each of the three parameters (VO<sub>2max</sub>, maximal vertical jumping power and RWS) the relative change was computed and the level of agreement and correlation between (i) VO<sub>2max</sub> vs. RWS and (ii) maximal vertical jumping power vs. RWS was calculated. The comparison between VO<sub>2max</sub> vs. RWS showed no agreement (mean bias = -10.01%, upper and lower limit of agreement = 19.82%, -39.84%) and no correlation (t<sub>20</sub> = 0.24, <italic>p</italic> = 0.81, r: 0.05). Similarly, the comparison of maximal vertical jumping power against RWS showed little agreement (mean bias = -8.01%, upper and lower limit of agreement = 33.15%, -49.16%) and no correlation (t<sub>19</sub> = 1.41, p = 0.173, r: 0.31) (please see Table ##TAB##2##3## for Bland-Altman plot and correlation statistics). Moreover, the Bland-Altman plot in Fig. ##FIG##1##2a## showed a negative correlation (r: -0.71) between the mean of the two measures (VO<sub>2max</sub> and RWS) and the difference of the two, suggesting an unequal variance between the measurements (variance VO<sub>2max</sub> = 35.0, variance RWS = 205.8). After checking normality of distribution of the two measures, a <italic>F</italic>-Test for equality of variances<sup>##UREF##0##25##</sup> was performed showing a significant difference (F<sub>21</sub> = 0.17, <italic>p</italic> &lt; 0.001).</p>", "<p id=\"Par13\">Lastly, all the three groups showed a significant decrease of VO<sub>2max</sub> after bed-rest with no significant differences between groups observed in the loss of VO<sub>2max</sub> (mean ± sd of differences in percentage pre/post bed-rest per group: Ctrl: -23.8 ± 7.3; iAG; -20.3 ± 4.8, cAG; -21.8 ± 5.7). Similarly, also in maximal vertical jumping power all the three groups had a significant decrease after the bed-rest, although the decrease was more accentuated in the Ctrl group (mean ± sd of differences in percentage pre/post bed-rest per group: Ctrl: -24.5 ± 27.1; iAG; -20.2 ± 10.5, cAG; -12.7 ± 22) (please see Table ##TAB##3##4## for absolute and relative values of VO<sub>2max</sub> and JUMP before and after bed-rest). Results about VO<sub>2max</sub> and maximal vertical jumping power are originally described elsewhere<sup>##REF##33811556##26##</sup> to a greater extent than what was reported in this section.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par14\">The objective of this bed-rest study was to simulate conditions similar to microgravity in space in order to investigate the effects of artificial gravity exposure as countermeasure to bed-rest. By separating the subjects into three groups, which were exposed to intermittent, continuous, or no artificial gravity at all, it was intended to gain insight into possible benefit of artificial gravity as a countermeasure to human physical decondition in space. Results have shown that a decrease occurred in all three groups in each of the parameters studied in this work (RWS, VO<sub>2max</sub> and vertical jump power), with very little difference between the two intervention groups and the control group. Even though the number of participants was relatively low and gender distribution among subjects was not completely even, the data obtained provided valuable information to address our research questions.</p>", "<p id=\"Par15\">The continuous measurement of RWS opens up possibilities in addition to conventionally used, discrete measurements such as vertical jump power or VO<sub>2max</sub> measurements<sup>##REF##21205966##27##,##UREF##1##28##</sup>. First, continuous measurements of RWS, in both controlled and “at-home” environment, offers continuous insight into a patient’s functionality and its recovery process over a longer period of time. In this study, it was shown a high level of compliance, measured as wearing time, not only during the two phases in the DLR ward but also in the “at-home” phases. Although it is difficult to state an absolute threshold, wearing times &gt; 10 h/day are often considered as representative of habitual exposure<sup>##REF##19564665##29##</sup>, and wearing times in the order of 12 or 14 h/day are close to the time that people are awake. This, in combination with laboratory gait tests, would allow to not only gain insight into the <italic>can-do</italic> walking speed, but also into the <italic>do-do</italic> walking speed, which adds a measure of real-word exposure, and thus of greater ecological validity to the laboratory-assessed walking speed<sup>##REF##25879750##30##</sup>.</p>", "<p id=\"Par16\">The main findings from the lme model are that RWS decreased after bed-rest, with an average decrease of 13.2% for Ctrl, 10.6% for iAG and 15.2% for cAG compared to the average RWS values observed in the <italic>pre.dlr</italic> phase. Interestingly, the lme showed a significant difference in RWS between <italic>pre.dlr</italic> phase and the two <italic>post.home</italic> phases, suggesting a full recovery and a subsequent improvement in RWS in the periods at home. However, it has to be noted that in the <italic>pre.dlr</italic> phase subjects were confined in the DLR ward, where they had a fixed daily schedule and more days of recordings compared to the two <italic>post.home</italic> phases (13 days of recording in the <italic>pre.dlr</italic> phase vs. 7 days of recording in the <italic>post.home</italic> phases). Moreover, as this improvement is seen in all the three groups, it cannot be attributed to the different training interventions. Interestingly, the cAG group showed on average greater RWS compared to the Ctrl group regardless of the study phase, as faster RWS is observed in all the study phases except for the <italic>post.dlr</italic> phase. These differences are likely explained by the random assignment of participants in the groups, rather than training interventions as faster RWS is also observed in the <italic>pre.home</italic> phase, where no treatment was administered to the intervention groups. During the recovery period (<italic>post.dlr</italic> phase), all the three groups showed a consistent recovery of RWS over time, with an average RWS of 0.82 ± 0.09 m/s for Ctrl, 0.86 ± 0.08 m/s for iAG and 0.83 ± 0.09 m/s for cAG group. However, the group cAG showed a slower recovery of RWS in the <italic>post.dlr</italic> phase compared to the Ctrl group, with an average daily rate of change of RWS of 0.007 m/s for the cAG group compared to 0.008 m/s for the Ctrl group. This is an interesting observation as in all the other study phases, the cAG group showed a greater RWS compared to the Ctrl group; however, the observed slower recovery of RWS of the cAG group in the <italic>post.dlr</italic> phase can be seen as further confirmation that the training interventions used in this study did not help to prevent the reduction nor subsequent recovery of RWS in the recovery phase. Lastly, subjects who underwent FRED training during the <italic>post.dlr</italic> phase did not show any significance difference compared to subjects that did not underwent FRED training, suggesting little impact of the training on the recovery course of RWS (see Fig. ##FIG##2##3## to daily RWS values by FRED training group).</p>", "<p id=\"Par17\">Changes in RWS observed after the bed-rest should be considered with caution. On one hand, they could be considered clinically meaningful according to works done by Perera and Kwon<sup>##REF##16696738##31##,##REF##19536422##32##</sup>, where the authors demonstrated that changes in RWS of 0.05 m/s are to be considered clinically meaningful in older adults. In our study, the participants showed on average a RWS decrease from <italic>pre.dlr</italic> to <italic>post.dlr</italic> of 0.13 m/s, a 13% decrease from the initial value (Ctrl: 0.12 m/s, 13.2% decrease; iAG: 0.10 m/s, 10.6% decrease; cAG: 0.15 m/s, 15.2% decrease), values well above the threshold suggested by Perera in his work from 2006<sup>##REF##16696738##31##</sup> to start considering those changes clinically meaningful. However, on the other hand, it is not totally clear in this type of setting (immobilization by bed-rest and young participants) what these changes represent. Do they reflect a real deconditioning or are they observed mainly because the participants have been more cautious in walking after bed-rest to e.g., reduce the risk of stumbling? It is safe to think that it can be attributed to a combination of all those elements, although reduction in gait speed was also observed in shorter bed-rest studies<sup>##REF##25122628##33##</sup> to a very similar extent than what observed in this study. This observation is of interest as it is well known that muscle deconditioning in shorter bed-rest studies is less severe than in longer bed-rest studies<sup>##REF##8526835##34##–##REF##15338217##36##</sup>, suggesting that decreases in walking speed in these settings can be partially attributed to factors that goes beyond the mere muscle deconditioning. However, as bed-rest studies that included measurement of walking speed (either under laboratory conditions and/or in real-world settings) are scarce, to further answer these questions, additional bed-rest studies would be needed where RWS is measured together with laboratory gait tests to also understand the correlation and agreement between those two variables and see whether the functional ability to walk at either chosen speed or maximal speed is impaired at the same magnitude at which the RWS is impaired.</p>", "<p id=\"Par18\">Kuspinar<sup>##REF##20801260##37##</sup> previously investigated the predictability of VO<sub>2max</sub> data with submaximal tests including the vertical jump test as well as mean walking speed in patients suffering from multiple sclerosis. In that study, the 6-min walking test (6MWT) as a submaximal effort test had the highest, though still weak, correlation with absolute values of VO<sub>2max</sub>. The exploratory analysis in the present study pertaining the level of agreement between changes in VO<sub>2max</sub> and RWS before and after bed-rest, and maximum vertical jump power and RWS before and after bed-rest, showed that changes in VO<sub>2max</sub> and JUMP values also have very little to no agreement and correlation with RWS. Although both walking and cycling (and thus the VO<sub>2max</sub> test on the cycle ergometer) involve regular distinct phases that alternate bilaterally, the VO<sub>2max</sub> test on the cycle ergometer involved bursts of incremental effort until exhaustion with much greater muscle activation that cannot be sustained for a prolonged time, and therefore it is used to assess only the cardiorespiratory fitness. On the other hand, walking at self-selected speed is a low-effort movement that can be sustained for a prolonged period, which results in a combination of multiple factors, such as metabolic and coordination factors and muscles power, thus it should be expected that the two will assess different types of fitness. This is supported by Abellan van Kan<sup>##REF##19924348##12##</sup> who also postulated that individual’s self-selected or usual walking speed is indicative of current functional status and numerous health outcomes in older adults. However, in this study, it was preferred to assess the VO<sub>2max</sub> with a cycle ergometer rather than a treadmill, although it is known that VO<sub>2max</sub> assess via treadmill is generally higher than the VO<sub>2max</sub> assessed via a cycle ergometer<sup>##UREF##2##38##–##REF##5762873##40##</sup>. Assessing the VO<sub>2max</sub> via cycle ergometer was chosen mainly due to safety reasons as it is safer to use following bed-rest and it allows better standardization and data robustness due to fewer artifacts coming from the upper body motion. Similarly, this applies also to the comparison of walking speed and JUMP. The latter is a test of maximal neuromuscular power with most of the movement exerted in the vertical direction, while during walking most of the movement acts predominantly on the horizontal direction, so it is not surprising that the two assess different types of fitness.</p>", "<p id=\"Par19\">Importantly, the findings of these studies indicate that measurements from one submaximal test such as the daily average walking speed are insufficient for reliably predicting a maximal test such as the VO<sub>2max</sub> measurements, but also vice-versa. Furthermore, walking speed, not walking distance, was shown to be a robust outcome variable, as shown by a study involving patients suffering from multiple sclerosis<sup>##REF##11424630##18##</sup>. In light of the above, continuous monitoring of RWS can provide additional insight into a person’s recovery process, in combination with others, more established functional tests (e.g., VO<sub>2max</sub>) to monitor the recovery state of individuals after bed-rest or after a prolonged space flight, where the multifactorial syndrome with disturbance in gait patterns is experienced by many astronauts upon return to Earth<sup>##REF##19509005##41##</sup>. Lastly, if it can be fully demonstrated that the loss and the subsequent recovery of RWS does reflect in part the health status of individuals in populations with characteristics similar to those observed in astronauts, it opens up possibilities in the monitoring of the recovery process of astronauts upon return from mid to long space flights, as daily RWS values are easy to obtain, very unintrusive as it was shown by the high level of acceptance and they offer a robust outcome hardly influenced by potential outliers (as opposed to other functional tests performed on single test days—e.g., VO<sub>2max</sub> of maximal vertical jump test, where the influence of one outlier has a greater impact on the final outcome and its interpretation).</p>", "<p id=\"Par20\">As it is typically the case for bed-rest studies, in the present study, sample size was rather small, limited to 24 participants with 8 participants per group. There were also limitations that were specific to the present bed-rest study. Following the bed-rest, subjects were instructed to use a wheelchair on R + 0 and R + 1. Nonetheless, many physically challenging tests were performed on the first day of re-ambulation and subjects would likely have had muscle soreness from the acute reloading. It also seems reasonable to assume that RWS during the early recovery phase could have been influenced by the leg muscle biopsy that was obtained at the end of bed-rest. Additionally, during the <italic>post.dlr</italic> period, subjects walked to and from experiments, together with the facility personnel. There is a possibility that the subjects’ chosen RWS was conditioned by the accompanying person, although this seems unlikely as the DLR staff adjusted their walking speed to match the subject’s walking speed.</p>", "<p id=\"Par21\">Another limitation of this study is the <italic>stepwave</italic> algorithm used to estimate RWS. Keppler<sup>##REF##31469864##42##</sup> originally proposed and validated the <italic>stepwave</italic> algorithm on an average older population than what was presented in this study. Even though walking parameters are naturally affected by age, the <italic>stepwave</italic> algorithm did proof to be relatively robust against aging as shown by Wiedmann in her study<sup>##REF##33585360##43##</sup>, where it was shown that the algorithm was able to reliably detect the presence of gait in a pediatric population with or without cerebral palsy. Moreover, actibelt® was chosen as it has a track record of scientific literature supporting that the platform used to gather accelerometry data and convert them to actimetry data is reliable and used in clinical settings and space research (refs. <sup>##REF##21945386##44##–##UREF##4##46##</sup><sup>,</sup><sup>##REF##25879750##30##</sup><sup>,</sup><sup>##UREF##5##47##–##REF##21850254##49##</sup>).</p>", "<p id=\"Par22\">Finally, it would have been interesting to compare RWS with a standard lab-based walking test, which, however, was not implemented as part of this bed-rest study.</p>", "<p id=\"Par23\">It was shown that RWS decreases with bed-rest to an extent that in different populations (e.g., elderly population or frail populations) is clinically meaningful. Even though the decreases in RWS observed here do not necessarily have immediate health implication, it is a remarkable finding in itself that RWS is sensitive enough to reflect a deconditioned physique in healthy young/middle-aged individuals. For future studies, it would be of interest to investigate how the deconditioning and recovery process of RWS compare against laboratory gait speed tests. It is concluded that, given the fact that RWS can be obtained unobtrusively, at a low operational cost and at a low risk, it can be considered as a functional relevant tool to continuously monitor the recovery process of individuals after bed-rest and other deconditioning processes.</p>" ]
[]
[ "<p id=\"Par1\">The aim of this work was to explore whether real-world walking speed (RWS) would change as a consequence of 60-day bed-rest. The main hypothesis was that daily RWS would decrease after the bed-rest, with a subsequent recovery during the first days of re-ambulation. Moreover, an exploratory analysis was done in order to understand whether there is an agreement between the loss in RWS after bed-rest and the loss in the maximum oxygen uptake capacity (VO<sub>2max</sub>), or the loss in maximal vertical jump power (JUMP) respectively. Twenty-four subjects were randomly assigned to one of three groups: a continuous artificial gravity group, an intermittent artificial gravity group, or a control group. The fitted linear mixed effects model showed a significant decrease (<italic>p</italic> &lt; 0.001) of RWS after the 60-day bed-rest and a subsequent increase (<italic>p</italic> &lt; 0.001) of RWS during the 14-day recovery period in the study facility. No or little agreement was found between the loss in RWS and the loss in VO<sub>2max</sub> capacity or the loss in maximal vertical jumping power (RWS vs. VO<sub>2max</sub>: <italic>p</italic> = 0.81, RWS vs. JUMP: <italic>p</italic> = 0.173). Decreased RWS after bed-rest, with a follow-up recovery was observed for all three groups, regardless of the training intervention. This suggests that RWS, also in these settings, was able to reflect a de-conditioning and follow-up recovery process.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s41526-023-00342-8.</p>", "<title>Acknowledgements</title>", "<p>The authors want to thank all participants and personnel from DLR involved in the study that made it possible.</p>", "<title>Author contributions</title>", "<p>M.G., C.P. and F.V.D.S. analyzed the data and drafted the manuscript. M.G. implemented the statistical analysis. J.L. acquired data and revised the manuscript. U.M. contributed to study preparation and data management and revised the manuscript. W.S. has performed the VO<sub>2max</sub> tests and revised the manuscript. E.M. has supervised the study and revised the manuscript. J.R. participated in study design, study implementation, study preparation, supervised the data analysis and revised the manuscript. M.M. supervised the data analysis and revised the manuscript. M.D. participated in the study design, supervised the data analysis, and revised the manuscript.</p>", "<title>Funding</title>", "<p>Open Access funding enabled and organized by Projekt DEAL.</p>", "<title>Data availability</title>", "<p>The datasets used for producing the current work are available in the Open Science Framework repositories agbresa2019_rws/data_frames and agbresa2019_rws/input under the following link <ext-link ext-link-type=\"uri\" xlink:href=\"https://osf.io/3rqex/?view_only=fa4b5b086d8e41eb9cf8a3c473b81ad4\">https://osf.io/3rqex/?view_only=fa4b5b086d8e41eb9cf8a3c473b81ad4</ext-link>.</p>", "<title>Code availability</title>", "<p>The code used for producing the current work is available in the Open Science Framework repository agbresa2019_rws/Rscripts under the following link <ext-link ext-link-type=\"uri\" xlink:href=\"https://osf.io/3rqex/?view_only=fa4b5b086d8e41eb9cf8a3c473b81ad4\">https://osf.io/3rqex/?view_only=fa4b5b086d8e41eb9cf8a3c473b81ad4</ext-link>.</p>", "<title>Competing interests</title>", "<p id=\"Par42\">The authors declare the following competing interests: M.M. and M.D. are employed by Trium Analysis Online GmbH. M.D. serves as Scientific Director for Sylvia Lawry Centre for Multiple Sclerosis Research e.V. and, together with Trium Analysis Online GmbH have ownership of trademarks/design/patent applications linked to actibelt® technology. M.G. has a competing non/financial interest as Sylvia Lawry Center for Multiple Sclerosis Research e.V. is providing access to the actibelt® data and related algorithms to pursue a doctoral title. The remaining authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Average real-world walking speed.</title><p><bold>a</bold> average RWS values per period per group. Error bars represent ±1 standard deviation. Speed values are expressed in m/s. <bold>b</bold> average RWS values per day per group. Speed values are expressed in m/s. Group name <italic>Ctrl</italic> refers to the control group, which did not receive any type of intervention to counteract the effects of bed-rest. The group name <italic>iAG</italic> refers to the group that received intermitted artificial gravity training sessions as intervention to counteract the effects of bed-rest. The group name <italic>cAG</italic> refers to the group that received continuous artificial gravity training sessions as intervention to counteract the effects of bed-rest. The phase names refer to the different phases of the study: <italic>pre.home</italic> refers to a 1-week measurement from the 28th to the 21st day at home prior the bed-rest study; <italic>pre.dlr</italic> refers to a 2-week measurement in the DLR ward in the 14 days prior the bed-rest study; <italic>post.dlr</italic> refers to a 2-week measurement in the 13 days after the bed-rest study; <italic>post.home(R</italic> + <italic>28)</italic> refers to a 1-week measurement from the 21st to the 28th day after the bed-rest; <italic>post.home(R</italic> + <italic>90)</italic> refers to a 1-week measurement from the 83rd to the 90th day after the bed-rest.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>Bland-Altman and correlation plot of the relative differences between post/pre bed-rest.</title><p><bold>a</bold> Bland-Altman plot for level of agreement between relative pre/post bed-rest changes of VO<sub>2max</sub> and RWS. On the <italic>x</italic>-axis are shown the mean of the values and on the <italic>y</italic>-axis are shown the differences between the relative values. <bold>b</bold> Scatterplot showing the correlation between relative pre/post bed-rest changes of VO<sub>2max</sub> and RWS. On the <italic>x</italic>-axis are shown the VO<sub>2max</sub> relative changes and on the <italic>y</italic>-axis are shown the RWS relative changes. <bold>c</bold> Bland-Altman plot for level of agreement between relative pre/post bed-rest changes of maximal jump power vs. RWS. On the <italic>x</italic>-axis are shown the mean values and on the <italic>y</italic>-axis are shown the differences between the relative values. <bold>d</bold> Scatterplot showing the correlation between relative pre/post bed-rest changes of maximal jump power and RWS. On the <italic>x</italic>-axis are shown the maximal jump power relative changes and on the <italic>y</italic>-axis are shown the RWS relative changes.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>FRED intervention effect on average Real-world Walking Speed (RWS).</title><p>Average Real-world Walking Speed (RWS) values per FRED training group and day during the <italic>post.dlr</italic> period. Speed values are expressed in m/s. Error bars represent ±1 standard deviation. Group name <italic>TRUE</italic> refers to the group of participants who underwent the FRED training. The group name <italic>FALSE</italic> refers to the group of participants who did not undergo the FRED training. The plot facet name refers to the phase name in which FRED training occurred, the <italic>post.dlr</italic> period which refers to a 2-week measurement in the 13 days after the bed-rest study.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>Visual representations of the training sessions and the study phases.</title><p><bold>a</bold> Schematic of the training sessions used as countermeasure to bed-rest for the two training groups. On the <italic>x</italic>-axis is represented the elapsed time in minutes, on the <italic>y</italic>-axis is shown the acceleration of gravity (G) perceived at the body center of mass. In the top plot is shown the schematic representing the training sessions of the continuous artificial gravity (cAG) group. On the bottom plot is shown the schematic representing the training session of the intermittent artificial gravity (iAG) group. Both groups had daily training sessions. The cAG was exposed to artificial gravity for 30 consecutive minutes, while the iAG group was exposed to artificial gravity for six 5-min bouts, with a 3-min break in between the bouts. <bold>b</bold> Schematic of the study phases in which continuous tri-axial accelerometer measurements were acquired. <italic>X</italic>-axis represents time in days, and vertical dashed lines represent start and end of each of the study phases. Text in colored bars denotes the duration of the phase. Study phase abbreviations are shown in squared brackets after the name period in the top of the diagram.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>mean ± sd of daily RWS, walking distance and wearing time per period and per group.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th/><th><italic>pre.home</italic></th><th><italic>pre.dlr</italic></th><th><italic>post.dlr</italic></th><th><italic>post.home(R</italic> + <italic>28)</italic></th><th><italic>post.home(R</italic> + <italic>90)</italic></th></tr></thead><tbody><tr><td>group</td><td colspan=\"5\">Walking speed (m/s)</td></tr><tr><td><bold>Ctrl</bold></td><td><p>0.93 ± 019</p><p>(−0.01)</p></td><td><p>0.94 ± 0.07</p><p>(–)</p></td><td><p>0.82 ± 0.09</p><p>(−0.12)</p></td><td><p>0.95 ± 0.22</p><p>(0.01)</p></td><td><p>0.95 ± 0.16</p><p>(0.02)</p></td></tr><tr><td><bold>iAG</bold></td><td><p>0.94 ± 0.18</p><p>(−0.03)</p></td><td><p>0.96 ± 0.07</p><p>(–)</p></td><td><p>0.86 ± 0.08</p><p>(−0.11)</p></td><td><p>0.98 ± 0.18</p><p>(0.01)</p></td><td><p>0.96 ± 0.17</p><p>(−0.01)</p></td></tr><tr><td><bold>cAG</bold></td><td><p>1.00 ± 0.3</p><p>(0.02)</p></td><td><p>0.98 ± 0.12</p><p>(–)</p></td><td><p>0.83 ± 0.09</p><p>(−0.15)</p></td><td><p>1.04 ± 0.23</p><p>(0.06)</p></td><td><p>1.08 ± 0.21</p><p>(0.11)</p></td></tr><tr><td/><td colspan=\"5\">Walking distance (m)</td></tr><tr><td><bold>Ctrl</bold></td><td><p>4862.9 ± 2438.6</p><p>(2711.5)</p></td><td><p>2151.4 ± 1148.3</p><p>(–)</p></td><td><p>2525.6 ± 1928.6</p><p>(374.2)</p></td><td><p>3219.8 ± 3309.2</p><p>(1068.4)</p></td><td><p>3841.9 ± 3050.1</p><p>(1690.5)</p></td></tr><tr><td><bold>iAG</bold></td><td><p>4375 ± 3735.4</p><p>(2323.4)</p></td><td><p>2051.6 ± 975.2</p><p>(–)</p></td><td><p>2306.2 ± 1135.2</p><p>(254.6)</p></td><td><p>4317.1 ± 5637.6</p><p>(2265.5)</p></td><td><p>3707.8 ± 2450.4</p><p>(1656.2)</p></td></tr><tr><td><bold>cAG</bold></td><td><p>4312.6 ± 2774.2</p><p>(2281.4)</p></td><td><p>2031.2 ± 1010.1</p><p>(–)</p></td><td><p>1997.6 ± 964.5</p><p>(−33.6)</p></td><td><p>3973.2 ± 3623</p><p>(1942)</p></td><td><p>5333.4 ± 4294.5</p><p>(3302.2)</p></td></tr><tr><td/><td colspan=\"5\">Wearing time (hours/day)</td></tr><tr><td><bold>Ctrl</bold></td><td><p>14.1 ± 3.2</p><p>(−0.1)</p></td><td><p>14.2 ± 3.2</p><p>(–)</p></td><td><p>13.2 ± 3.4</p><p>(−1)</p></td><td><p>11.5 ± 4.5</p><p>(−2.7)</p></td><td><p>13.2 ± 6.3</p><p>(−1)</p></td></tr><tr><td><bold>iAG</bold></td><td><p>14.6 ± 3</p><p>(1.6)</p></td><td><p>13 ± 3.1</p><p>(–)</p></td><td><p>13 ± 2.9</p><p>(0)</p></td><td><p>11.2 ± 5.8</p><p>(−1.8)</p></td><td><p>12.4 ± 4.5</p><p>(−0.6)</p></td></tr><tr><td><bold>cAG</bold></td><td><p>14 ± 5.5</p><p>(0.6)</p></td><td><p>13.4 ± 4.1</p><p>(–)</p></td><td><p>12.6 ± 4</p><p>(−0.8)</p></td><td><p>11.3 ± 5.1</p><p>(−2.1)</p></td><td><p>12.5 ± 4.4</p><p>(−0.9)</p></td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Summary of the lme model fitted to the real-world walking speed data.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Variables</th><th>Estimate</th><th>DoF</th><th><italic>t</italic>-value</th><th><italic>p</italic>-value</th></tr></thead><tbody><tr><td>Intercept</td><td>0.932</td><td>23.97</td><td>38.77</td><td> <bold>&lt;</bold> <bold>0.001</bold></td></tr><tr><td>period_<italic>pre.home</italic></td><td>0.000</td><td>917.61</td><td>−0.01</td><td>0.994</td></tr><tr><td>period_<italic>post.dlr</italic></td><td>−0.175</td><td>915.89</td><td>−7.33</td><td> <bold>&lt;</bold> <bold>0.001</bold></td></tr><tr><td>period_<italic>post.home(R</italic> + <italic>28)</italic></td><td>0.029</td><td>916.86</td><td>2.02</td><td><bold>0.044</bold></td></tr><tr><td>period_<italic>post.home(R</italic> + <italic>90)</italic></td><td>0.037</td><td>917.62</td><td>2.6</td><td><bold>0.01</bold></td></tr><tr><td>group_<italic>iAG</italic></td><td>0.016</td><td>21.21</td><td>0.48</td><td>0.638</td></tr><tr><td>group_<italic>cAG</italic></td><td>0.074</td><td>21.23</td><td>2.31</td><td><bold>0.031</bold></td></tr><tr><td>post.dlr.days</td><td>0.009</td><td>916.15</td><td>4.02</td><td> <bold>&lt;</bold> <bold>0.001</bold></td></tr><tr><td>offset.int.cAG.post.dlr</td><td>−0.060</td><td>915.53</td><td>−2.53</td><td><bold>0.012</bold></td></tr><tr><td>offset.int.iAG.post.dlr</td><td>0.029</td><td>916.13</td><td>1.18</td><td>0.236</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Bland-Altman plot and correlation analysis statistics for the comparisons of the relative changes post bed-rest in RWS vs. VO<sub>2max</sub> and RWS vs. JUMP.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Parameter</th><th>VO<sub>2max</sub></th><th>JUMP</th></tr></thead><tbody><tr><td>Mean Bias</td><td>−10.01%</td><td>−8.01%</td></tr><tr><td>Upper limit of agreement</td><td>19.82%</td><td>33.15%</td></tr><tr><td>Lower limit of agreement</td><td>−39.84%</td><td>−49.16%</td></tr><tr><td>Pearson’s r correlation coefficient (95% CI)</td><td>0.05 (−0.38:0.46)</td><td>0.31 (−0.14:0.65)</td></tr><tr><td>Degree of freedom</td><td>20</td><td>19</td></tr><tr><td><italic>t</italic>-value</td><td>0.24</td><td>1.42</td></tr><tr><td><italic>p</italic>-value</td><td>0.81</td><td>0.17</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab4\"><label>Table 4</label><caption><p>Mean ± standard deviation of the absolute and relative values before and after bed-rest for the parameters VO<sub>2max</sub> and maximal jump power (JUMP).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>VO<sub>2max</sub></th><th/><th/><th/></tr><tr><th/><th>Absolute (L/min)</th><th>Relative (%)</th><th><italic>p</italic>-value</th></tr></thead><tbody><tr><td colspan=\"4\"><bold>iAG</bold></td></tr><tr><td> pre bed-rest</td><td>3.2 ± 0.6</td><td>−</td><td> <bold>&lt;</bold> <bold>0.001</bold></td></tr><tr><td> post bed-rest</td><td>2.4 ± 0.3</td><td>−23.8 ± 7.3</td><td/></tr><tr><td colspan=\"4\"><bold>cAG</bold></td></tr><tr><td> pre bed-rest</td><td>2.6 ± 0.7</td><td>−</td><td> <bold>&lt;</bold> <bold>0.001</bold></td></tr><tr><td> post bed-rest</td><td>2 ± 0.5</td><td>−20.3 ± 4.8</td><td/></tr><tr><td colspan=\"4\"><bold>Ctrl</bold></td></tr><tr><td> pre bed-rest</td><td>2.8 ± 0.8</td><td>−</td><td> <bold>&lt;</bold> <bold>0.001</bold></td></tr><tr><td> post bed-rest</td><td>2.1 ± 0.6</td><td>−21.8 ± 5.7</td><td/></tr><tr><td><bold>JUMP</bold></td><td/><td/><td/></tr><tr><td/><td>Absolute (kW)</td><td>Relative (%)</td><td><italic>p</italic>-value</td></tr><tr><td colspan=\"4\"><bold>iAG</bold></td></tr><tr><td> pre bed-rest</td><td>3.9 ± 0.7</td><td>−</td><td><bold>0.02</bold></td></tr><tr><td> post bed-rest</td><td>2.9 ± 1.2</td><td>−24.5 ± 27.1</td><td/></tr><tr><td><bold>cAG</bold></td><td/><td/><td/></tr><tr><td> pre bed-rest</td><td>2.9 ± 0.8</td><td>−</td><td> <bold>&lt;</bold> <bold>0.001</bold></td></tr><tr><td> post bed-rest</td><td>2.4 ± 0.8</td><td>−20.2 ± 10.5</td><td/></tr><tr><td colspan=\"4\"><bold>Ctrl</bold></td></tr><tr><td> pre bed-rest</td><td>3.4 ± 1.1</td><td>−</td><td><bold>0.02</bold></td></tr><tr><td> post bed-rest</td><td>3.1 ± 1.6</td><td>−12.7 ± 22</td><td/></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab5\"><label>Table 5</label><caption><p>Summary statistics of participants’ anthropometric and demographic data.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Characteristics</th><th>N</th><th>Ctrl, <italic>N</italic> = 8</th><th>cAG, <italic>N</italic> = 8</th><th>iAG, <italic>N</italic> = 8</th><th><italic>p</italic>-value<sup>a</sup></th><th><italic>q</italic>-value<sup>b</sup></th></tr></thead><tbody><tr><td>Gender, n / N (%)</td><td>24</td><td/><td/><td/><td> &gt; 0.9</td><td> &gt; 0.9</td></tr><tr><td> Females</td><td/><td>2 / 8 (25%)</td><td>3 / 8 (38%)</td><td>3 / 8 (38%)</td><td/><td/></tr><tr><td> Males</td><td/><td>6 / 8 (75%)</td><td>5 / 8 (62%)</td><td>5 / 8 (62%)</td><td/><td/></tr><tr><td>Age, Mean ± SD</td><td>24</td><td>34.2 ± 7.9</td><td>31.9 ± 9.7</td><td>33.8 ± 10.8</td><td>0.7</td><td>0.9</td></tr><tr><td>Height (cm), Mean ± SD</td><td>24</td><td>177.0 ± 7.3</td><td>172.5 ± 8.0</td><td>174.1 ± 10.5</td><td>0.4</td><td>0.8</td></tr><tr><td>Weight (kg), Mean ± SD</td><td>24</td><td>79.4 ± 12.7</td><td>71.8 ± 10.2</td><td>71.4 ± 4.5</td><td>0.087</td><td>0.3</td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$100* \\frac{{B}_{x}-{A}_{x}}{{A}_{x}}$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mrow><mml:mn>100</mml:mn><mml:mo>*</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>B</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\chi }_{p}(t):=\\left\\{\\begin{array}{l}1,when\\,t\\in p,\\\\ 0,else,\\end{array}\\right.$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mrow><mml:msub><mml:mrow><mml:mi>χ</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>:</mml:mo><mml:mo>=</mml:mo><mml:mfenced open=\"{\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"left\"><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>w</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi>t</mml:mi><mml:mo>∈</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"left\"><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{array}{c}RW{S}_{i}(t)={\\beta }_{0}+({\\beta }_{1,1}{\\chi }_{pre.home}(t)+{\\beta }_{1,2}{\\chi }_{post.dlr}(t)+{\\beta }_{1,3}{\\chi }_{post.home(R+28)}(t)\\,\\\\ \\,+{\\beta }_{1,4}{\\chi }_{post.home(R+90)}(t))+({\\beta }_{2,1}{\\chi }_{cAG}(i)+{\\beta }_{2,2}{\\chi }_{iAG}(i))+{\\beta }_{3}post.dlr.days(t)\\\\ \\,+{\\beta }_{4}offset.int.cAG.post.dl{r}_{i}(t)+{\\beta }_{5}offset.int.iAG.post.dl{r}_{i}(t)+{{\\epsilon }}_{i}(t)\\end{array}$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mtable><mml:mtr columnalign=\"left\"><mml:mtd columnalign=\"left\"><mml:mi>R</mml:mi><mml:mi>W</mml:mi><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"true\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"true\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"true\">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>χ</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mo>.</mml:mo><mml:mi>h</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"true\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"true\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>χ</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>d</mml:mi><mml:mi>l</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"true\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"true\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>χ</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>h</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mrow><mml:mo stretchy=\"true\">(</mml:mo><mml:mrow><mml:mi>R</mml:mi><mml:mo>+</mml:mo><mml:mn>28</mml:mn></mml:mrow><mml:mo stretchy=\"true\">)</mml:mo></mml:mrow></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"true\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"true\">)</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mspace width=\".25em\"/></mml:mtd></mml:mtr><mml:mtr columnalign=\"left\"><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow><mml:mspace width=\".25em\"/><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>χ</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>h</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mrow><mml:mo stretchy=\"true\">(</mml:mo><mml:mrow><mml:mi>R</mml:mi><mml:mo>+</mml:mo><mml:mn>90</mml:mn></mml:mrow><mml:mo stretchy=\"true\">)</mml:mo></mml:mrow></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"true\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"true\">)</mml:mo></mml:mrow></mml:mrow><mml:mo stretchy=\"true\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"true\">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>χ</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>A</mml:mi><mml:mi>G</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"true\">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy=\"true\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>χ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>A</mml:mi><mml:mi>G</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"true\">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy=\"true\">)</mml:mo></mml:mrow></mml:mrow><mml:mo stretchy=\"true\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>d</mml:mi><mml:mi>l</mml:mi><mml:mi>r</mml:mi><mml:mo>.</mml:mo><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi><mml:mi>s</mml:mi><mml:mrow><mml:mo stretchy=\"true\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"true\">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign=\"left\"><mml:mtd columnalign=\"left\"><mml:mspace width=\".25em\"/><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>c</mml:mi><mml:mi>A</mml:mi><mml:mi>G</mml:mi><mml:mo>.</mml:mo><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>d</mml:mi><mml:mi>l</mml:mi><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"true\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"true\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:msub><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>i</mml:mi><mml:mi>A</mml:mi><mml:mi>G</mml:mi><mml:mo>.</mml:mo><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>d</mml:mi><mml:mi>l</mml:mi><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"true\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"true\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"italic\">ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"true\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"true\">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${post}.{dlr}.{days}(t):=[t-{t}^{* }+1]{\\chi }_{{post}.{dlr}}(t),$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:mrow><mml:mi mathvariant=\"italic\">post</mml:mi><mml:mo>.</mml:mo><mml:mi mathvariant=\"italic\">dlr</mml:mi><mml:mo>.</mml:mo><mml:mi mathvariant=\"italic\">days</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mrow><mml:mo>∶</mml:mo><mml:mo>=</mml:mo></mml:mrow><mml:mo>[</mml:mo><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mo>*</mml:mo></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo>]</mml:mo><mml:msub><mml:mrow><mml:mi>χ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">post</mml:mi><mml:mo>.</mml:mo><mml:mi mathvariant=\"italic\">dlr</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equa\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{offset}.{int}.{cAG}.{post}.{dlr}}_{i}(t):={\\chi }_{{post}.{dlr}}(t){\\chi }_{{cAG}}(i),$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mrow><mml:msub><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>c</mml:mi><mml:mi>A</mml:mi><mml:mi>G</mml:mi><mml:mo>.</mml:mo><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>d</mml:mi><mml:mi>l</mml:mi><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>:</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>χ</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>d</mml:mi><mml:mi>l</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>χ</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>A</mml:mi><mml:mi>G</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equb\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{offset}.{int}.{iAG}.{post}.{dlr}}_{i}(t):={\\chi }_{{post}.{dlr}}(t){\\chi }_{{iAG}}(i),$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mrow><mml:msub><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>i</mml:mi><mml:mi>A</mml:mi><mml:mi>G</mml:mi><mml:mo>.</mml:mo><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>d</mml:mi><mml:mi>l</mml:mi><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>:</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>χ</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mi>d</mml:mi><mml:mi>l</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>χ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>A</mml:mi><mml:mi>G</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\epsilon }_{i}(t) \\sim {\\rm{{\\rm N}}}(0,{\\rm{\\sigma }})$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mrow><mml:msub><mml:mrow><mml:mi>ϵ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>~</mml:mo><mml:mi mathvariant=\"normal\">Ν</mml:mi><mml:mo>(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">σ</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>" ]
[ "<table-wrap-foot><p>In brackets are reported the effect sizes of the differences compared to the <italic>pre.dlr</italic> phase (reference). Bold font is used to represent groups name. Italic font is used to represent names of the study phases.</p><p>Group name <italic>Ctrl</italic> refers to the control group, which did not receive any type of intervention to counteract the effects of bed-rest. The group name <italic>iAG</italic> refers to the group that received intermitted artificial gravity training sessions as intervention to counteract the effects of bed-rest. The group name <italic>cAG</italic> refers to the group that received continuous artificial gravity training sessions as intervention to counteract the effects of bed-rest. The phase names refer to the different phases of the study: <italic>pre.home</italic> refers to a 1-week measurement from the 28th to the 21st day at home prior the bed-rest study; <italic>pre.dlr</italic> refers to a 2-week measurement in the DLR ward in the 14 days prior the bed-rest study; <italic>post.dlr</italic> refers to a 2-week measurement in the 13 days after the bed-rest study; <italic>post.home(R</italic> + <italic>28)</italic> refers to a 1-week measurement from the 21st to the 28th day after the bed-rest; <italic>post.home(R</italic> + <italic>90)</italic> refers to a 1-week measurement from the 83rd to the 90th day after the bed-rest.</p><p>Summary statistics of real-world walking speed, wearing time and walking distance.</p></table-wrap-foot>", "<table-wrap-foot><p><italic>T</italic>-tests use Satterthwaite’s method. Bold font is used to highlight variables with <italic>p</italic>-value &lt; 0.05. <italic>DoF</italic> Degrees of freedom. Base levels of the model terms are <italic>pre.dlr</italic> for the period variable and <italic>Ctrl</italic> group for the variable group (Group name <italic>Ctrl</italic> refers to the control group, which did not receive any type of intervention to counteract the effects of bed-rest).</p><p>The group name <italic>iAG</italic> refers to the group that received intermitted artificial gravity training sessions as intervention to counteract the effects of bed-rest. The group name <italic>cAG</italic> refers to the group that received continuous artificial gravity training sessions as intervention to counteract the effects of bed-rest. The phase names refer to the different phases of the study: <italic>pre.home</italic> refers to a 1-week measurement from the 28th to the 21st day at home prior the bed-rest study; <italic>pre.dlr</italic> refers to a 2-week measurement in the DLR ward in the 14 days prior the bed-rest study; <italic>post.dlr</italic> refers to a 2-week measurement in the 13 days after the bed-rest study; <italic>post.home(R</italic> + <italic>28)</italic> refers to a 1-week measurement from the 21st to the 28th day after the bed-rest; <italic>post.home(R</italic> + <italic>90)</italic> refers to a 1-week measurement from the 83rd to the 90th day after the bed-rest.</p><p>Model summary of lme model fitted to RWS data.</p></table-wrap-foot>", "<table-wrap-foot><p>Upper and Lower limits of agreement are calculated as mean bias ± 1.96 St. Dev. of the differences between measurements.</p><p>Bland-Altmann and correlation analysis statistics.</p></table-wrap-foot>", "<table-wrap-foot><p>Significance levels are also calculated for each before/after bed-rest comparison and reported. Bold font is used to highlight variables with <italic>p</italic>-value &lt; 0.05 and to highlight the groups name.</p><p>Absolute and relative values of VO<sub>2max</sub> and maximal jump power (JUMP).</p></table-wrap-foot>", "<table-wrap-foot><p><sup>a</sup> Fisher’s exact test for categorical variables and Kruskal–Wallis rank sum test for continuous variables.</p><p><sup>b</sup> Benjamini &amp; Hochberg correction for multiple testing.</p><p>Summary statistics of participants.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41526_2023_342_Fig1_HTML\" id=\"d32e803\"/>", "<graphic xlink:href=\"41526_2023_342_Fig2_HTML\" id=\"d32e1218\"/>", "<graphic xlink:href=\"41526_2023_342_Fig3_HTML\" id=\"d32e1562\"/>", "<graphic xlink:href=\"41526_2023_342_Fig4_HTML\" id=\"d32e1752\"/>", "<inline-graphic xlink:href=\"41526_2023_342_Article_IEq1.gif\"/>", "<graphic xlink:href=\"41526_2023_342_Article_Equ1.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41526_2023_342_Article_Equ2.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41526_2023_342_Article_IEq2.gif\"/>", "<graphic xlink:href=\"41526_2023_342_Article_Equa.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41526_2023_342_Article_Equb.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41526_2023_342_Article_IEq3.gif\"/>" ]
[ "<media xlink:href=\"41526_2023_342_MOESM1_ESM.pdf\"><caption><p>Supplementary material</p></caption></media>", "<media xlink:href=\"41526_2023_342_MOESM2_ESM.pdf\"><caption><p>Reporting Summary</p></caption></media>" ]
[{"label": ["25."], "mixed-citation": ["Snedecor, G. W. & Cochran, W. G. "], "italic": ["Statistical Methods"]}, {"label": ["28."], "surname": ["Herssens"], "given-names": ["N"], "article-title": ["Do spatiotemporal parameters and gait variability differ across the lifespan of healthy adults? A systematic review"], "source": ["Gait Post."], "year": ["2018"], "volume": ["64"], "fpage": ["191"], "lpage": ["190"], "pub-id": ["10.1016/j.gaitpost.2018.06.012"]}, {"label": ["38."], "surname": ["Keren", "Magazanik", "Epstein"], "given-names": ["G", "A", "Y"], "article-title": ["A comparison of various methods for the determination of VO2max"], "source": ["Eur. J. Appl. Physiol."], "year": ["1980"], "volume": ["45"], "fpage": ["117"], "lpage": ["124"], "pub-id": ["10.1007/BF00421319"]}, {"label": ["39."], "surname": ["McKay", "Banister"], "given-names": ["GA", "EW"], "article-title": ["A comparison of maximum oxygen uptake determination by bicycle ergometry at various pedaling frequencies and by treadmill running at various speeds"], "source": ["Eur. J. Appl. Physiol."], "year": ["1976"], "volume": ["35"], "fpage": ["191"], "lpage": ["200"], "pub-id": ["10.1007/BF02336193"]}, {"label": ["46."], "mixed-citation": ["NASA/TM. "], "italic": ["C-9 and Other Microgravity Simulations Summary Report"], "ext-link": ["https://ntrs.nasa.gov/api/citations/20100017577/downloads/20100017577.pdf"]}, {"label": ["47."], "surname": ["Aigner", "Grimm", "Lederer", "Daumer"], "given-names": ["G", "B", "C", "M"], "article-title": ["Method to collect ground truth data for walking speed in real-world environments: description and validation"], "source": ["PeerJ Prepr."], "year": ["2019"], "volume": ["7"], "fpage": ["e27558v1"]}, {"label": ["51."], "surname": ["Altman", "Bland"], "given-names": ["DG", "JM"], "article-title": ["Measurement in medicine: the analysis of method comparison studies"], "source": ["J. R. Stat. Soc. Ser. D. Stat."], "year": ["1983"], "volume": ["32"], "fpage": ["307"], "lpage": ["317"]}]
{ "acronym": [], "definition": [] }
53
CC BY
no
2024-01-14 23:40:15
NPJ Microgravity. 2024 Jan 13; 10:6
oa_package/6f/9a/PMC10786829.tar.gz
PMC10786830
38216640
[ "<title>Introduction</title>", "<p id=\"Par2\">Distressing topics regarding current problems or future uncertainties are increasingly pervasive and salient. Young people in particular are constantly confronted with worrisome issues through digital media and social networks. Current examples include the Covid-19 pandemic, economic slowdown, and climate change. Recent studies have highlighted the difficulty of resisting the impulse to consume negative news, especially during periods of crisis, with negative health consequences<sup>##REF##31001584##1##,##UREF##0##2##</sup>. At the same time, the rate of anxiety in the population has been increasing, reaching very high levels in many contexts, including France, and affecting particularly young adults<sup>##UREF##1##3##–##UREF##3##5##</sup>.</p>", "<p id=\"Par3\">This paper studies the impact of exposure to such worrisome topics on cognitive performance. Worries can be distracting and make it hard to concentrate on the task at hand. The behavioral economics literature has shown that stressful events and economic hardships may impair cognitive performance and economic decisions<sup>##UREF##4##6##–##REF##30910964##8##</sup>. The psychology of poverty and scarcity theory suggests that anxiety, linked to financial vulnerability or uncertainty regarding future resources, can increase ‘cognitive load’, thus imposing a tax on ‘mental bandwidth’<sup>##REF##23118192##9##–##REF##29547249##13##</sup>. For instance, making financially-constrained people think about a worrisome financial decision has been found to decrease cognitive performance<sup>##REF##23990553##14##</sup>. Financially-constraint workers can be more productive after receiving their cash payments, which alleviates their financial worries<sup>##UREF##8##15##,##UREF##9##16##</sup>. Students from a lower socio-economic background were found to score worse on mathematical exam questions that make large sums of money salient, suggesting that financial salience can capture the attention of those financially vulnerable<sup>##UREF##10##17##</sup>. In a lab experiment, asset losses have been found to decrease cognitive performance by decreasing accuracy and increasing response times<sup>##UREF##11##18##</sup>. Closer to this paper, a recent study found that people affected by negative Covid-19 shocks performed worse in a cognitive reflection task. Yet, reminding participants of negative emotions did not affect their cognitive performance<sup>##REF##33414495##19##</sup>.</p>", "<p id=\"Par4\">However, the psychological literature has highlighted the possibility of an opposite effect, called ‘tunneling’<sup>##REF##13658305##20##,##UREF##12##21##</sup>. Given the high cost of bad decisions when resources are limited, a scarcity mindset can cause an attentional focus on the problem at hand. Studies have shown that this effect can increase the efficiency of resource use, memory-encoding, and rationality<sup>##REF##23118192##9##,##REF##25676256##22##,##UREF##13##23##</sup>. Yet, other studies find no effect of financial scarcity on cognitive function and decision-making<sup>##UREF##14##24##–##REF##28003681##26##</sup>. These mixed results led some researchers to argue recently that economic rationality might be unaffected by temporary impairments in cognitive resources<sup>##UREF##16##27##,##UREF##17##28##</sup>. A recent review of scarcity theory finds some support for both tunneling and cognitive load mechanisms in the literature, though it concludes that important methodological issues prevent firm conclusions<sup>##UREF##12##21##</sup>.</p>", "<p id=\"Par5\">A similar story can hold when considering the effect of stress on cognitive outcomes. Exposure to worries can increase stress levels, which have been shown to increase cognitive performance until a certain point and decrease performance thereafter (the so-called ‘Yerkes-Dodson law’)<sup>##REF##13481281##29##</sup>. Yet, later studies failed to find empirical support for such an inverted-U relationship between stress and performance<sup>##REF##1454896##30##–##UREF##20##33##</sup>. Moreover, how stressful a topic is perceived can depend on its contents but also on the profile of the person being exposed.</p>", "<p id=\"Par6\">As a result, different effects can be expected based on the type and the consequences of the worries being considered. While certain worries might alter cognitive functions and decrease performance, others might be motivating, in particular when they relate to future hardships that can still be mitigated through effort. People with the time and means to cope with the consequences might even see those issues as a challenge<sup>##REF##6571423##34##–##UREF##21##36##</sup>. Yet, such capacity might be available only to individuals with certain favorable characteristics, such as good mental health or financial stability.</p>", "<p id=\"Par7\">Furthermore, the overall response to worries and the relative strength of these opposite effects are also likely to depend on what is at stake. For instance, if there is a clear performance goal to strive for, worries may push individuals to focus on the goal and exert greater effort in scarcity-related tasks. Various laboratory studies have shown that the financial incentive structure can affect effort and task performance<sup>##UREF##22##37##</sup>. Yet, the literature on the effect of stake size and the amount of bonus payments on performance is also mixed<sup>##UREF##23##38##–##UREF##24##40##</sup>.</p>", "<p id=\"Par8\">Despite the potentially important implications of the different effects discussed, there is limited causal evidence regarding their existence, relative strength, and underlying mechanisms – especially in settings that involve real-life worries and stakes<sup>##UREF##12##21##</sup>. This paper aims to fill the gap by generating meaningful exogenous variations in both the type of worry and emphasis on a performance goal.</p>" ]
[ "<title>Methods</title>", "<title>Recruitment</title>", "<p id=\"Par39\">Participants were recruited from the Aix-Marseille University (AMU), a large public French university. Interested students were invited by email to sign up for a paid online survey, approved by the AMU ethics committee. Students signed up with their unique official university email addresses. Between February and April 2021, for six weeks, 500 students who had signed up were randomly selected and sent an individual survey link on a Tuesday that was valid until the Friday of the same week. Participants had 90 minutes to finish the survey once started. Participants received payment for completing the survey of 7€ paid in the form of a voucher. The final amount received depended on the outcome of the different tasks and could vary between 3 and 28€, with an average payment of 16€. Out of the 500 students invited each week, on average, 52% started it. For the last week of invites, all those previously not selected received the survey link, as well as those who had been invited but had not started the survey.</p>", "<title>Ethics</title>", "<p id=\"Par40\">All methods were carried out in accordance with relevant guidelines and regulations. The experimental procedure (recruitment process, consent form, treatments, and questionnaire) received approval from the ethics committee of AMU, reference number 2020-12-03-00. Informed consent was obtained from all participants at the beginning of the experiment.</p>", "<p id=\"Par41\">In the experiment, students were purposely faced with reflection topics that can be expected to trigger negative emotions. To minimize the risk of an effect that extends beyond the duration of the experiment, the following steps were undertaken. First, students were informed that the survey would deal with the pandemic when they signed up and when they started the survey. Students could end the anonymous survey at any moment. Second, the informational material in the reflection topics (article, graphics), though negatively framed, were taken from standard newspapers and official organisations and judged “non-sensational”. They thus reflect information in a format that young people are constantly confronted with, presumably multiple times a day. The reflection questions were questions that young people are generally faced with as well. Third, at the end of the survey, participants were provided with additional information about the university’s support system and other relevant Covid information if they were interested. Participants who did not complete the survey after reaching the topic treatment stage were sent an email to inform them about the university’s support system.</p>", "<title>Survey structure</title>", "<p id=\"Par42\">The survey, illustrated in SI Figure ##SUPPL##0##2##, started with an information and consent page which described the survey structure and the topics covered. The students were told that the survey would cover topics related to the pandemic. Following, respondents were asked some basic socio-demographic questions in the pre-questionnaire (age, scholarship recipient, field of study, gender). All participants then faced the first round of the cognitive performance task, incentivized by a linear payment scheme. Before the treatment articles, half of the sample randomly selected were asked questions about their current mood. The other half were asked the same questions after the treatment section. Participants were then moved on to the treatment topics.</p>", "<p id=\"Par43\">After the treatment topics and the questions about their current mood, participants were faced with the second round of the cognitive performance task with the different payment structures. This was followed by incentivized measures for cognitive reasoning, risk-taking, and the willingness to pay for an individual online coaching program (see below).</p>", "<p id=\"Par44\">Respondents were then asked questions about their studies, their career expectations and pressures, their Covid and lockdown experience, their current social habits, and their financial situation. This part also included questions for eliciting mental health, anxiety, and locus of control. The survey ended with a questionnaire on the socio-demographics of the student and their family. After the survey, participants were informed of their payment and could choose the method of payment (Amazon or Cultura voucher). Finally, they were provided information and links to the university’s and general support programs.</p>", "<title>Treatments</title>", "<p id=\"Par45\">In the experiment, we cross-randomize the reflection topic and the payment scheme (see SI Figure ##SUPPL##0##1##). A translation of the treatment topics can be found in the SI section ##SUPPL##0##3##. The original French questionnaire can be found in section ##SUPPL##0##5##. </p>", "<title>Topic treatments</title>", "<p id=\"Par46\">Participants were randomly shown one of four topics. Each topic contained an article of around 600 words including two graphical illustrations followed by non-incentivized comprehension questions. The topics also included several reflective questions to motivate the students to think about the topic and their situation. The format, length and number of questions were the same for all topics.</p>", "<p id=\"Par47\">Both the Labor Market (LM) and Mental Health (MH) topic included information on the negative consequences of the Covid pandemic and the lockdowns. For the control groups, we chose two different topics: one article about the progressive elimination of cage rearing in France (Animal Welfare) and one article on the future of the Artemis program to land humans on the moon again (Space Program). The two control topics differed in some dimensions (potential emotional response, forward-looking perspective) but were both chosen to not make respondents anxious or worried about their own situation (see discussion in SI section ##SUPPL##0##2.2##).</p>", "<p id=\"Par48\">All articles were taken from online platforms of actual newspapers and reflect information that students are confronted with daily. While addressing negative topics, we purposely chose articles that were factual and not sensational. The treatments were designed to make the labor market or mental health consequences of the Covid pandemic salient and to have participants reflect on their situation.</p>", "<p id=\"Par49\"><bold>Labor market (LM) topic</bold>: The LM topic started with an article about the difficulty of young graduates entering the labor market. It mentioned a decreasing number of job offers due to the pandemic and described expected increases in unemployment. It included two graphs, one illustrating the expected increase in unemployment, and one highlighting the pessimistic view that many young people have about their labor market prospects. The reflective questions asked about the participant’s views on their labor market perspectives and their economic situation.</p>", "<p id=\"Par50\"><bold>Mental health (MH) topic</bold>: The MH topic included an article about the psychological effects of the pandemic, focusing on the isolation of young people due to national lockdowns. It included a graph that illustrated the depression rate for different age groups and a graph displaying how prevalent mental health problems, stress and anxiety are. The reflective questions asked about the participants’ stress, and feelings of isolation and regret about their social life. Although France was not in lockdown at the time of the survey, there were still heavy restrictions in place, especially affecting students (e.g. remote or hybrid classes, a curfew, closed bars and cultural institutions).</p>", "<title>Payment schemes</title>", "<p id=\"Par51\">For the second round of cognitive performance, participants were randomly allocated to one of two payment structures, cross-randomized with the topic treatments. In the <bold>piece-rate treatment</bold>, participants received 1€ per correctly solved matrix. In the <bold>threshold treatment</bold>, participants received 1€ per correctly solved matrix only if they correctly solved at least 5 matrices. If they solved less than 5 matrices, their payout was 0€. If they solved 5 or more, their payout was the same as in the piece-rate treatment. The payoff structure was illustrated in a table.</p>", "<title>Main outcomes</title>", "<p id=\"Par52\"><bold>Cognitive performance:</bold> To measure cognitive performance we use matrices from a collection of open-access abstract reasoning items (the matrix reasoning item bank<sup>##REF##31824684##54##</sup>), similar to the Raven’s Matrices<sup>##UREF##35##69##</sup>. Participants were shown an incomplete matrix containing colorful, abstract forms with one missing field and were asked to select the missing item among six options.</p>", "<p id=\"Par53\">In the first round - the training task -, participants were shown one example and then asked to correctly solve 4 matrices. They had a time limit of 3 minutes (45 seconds per matrix). For each correctly solved matrix, they received 0.5€. We use the number of correctly solved matrices of this first round as “baseline cognitive performance score”. In the second round, which took place after the treatment, participants were asked to correctly solve 10 items with a time limit of 6 minutes and 40 seconds (40 seconds per matrix). The payment scheme for the second round varied by treatment. The number of correctly solved matrices in the second round is our main outcome of cognitive performance.</p>", "<p id=\"Par54\"><bold>Emotional state:</bold> Participants were asked a short translated version of the multidimensional mood questionnaire<sup>##REF##22271232##53##</sup>, MDMQ to measure their current emotional state. This version of the MDMQ consists of 12 questions along three dimensions: feeling good versus bad, feeling awake versus tired, and feeling calm versus nervous. For each mood dimension, four questions are asked, two phrased positively and two negatively. Importantly, the MDMQ explicitly asks how the respondent feels at this current moment. Half of the participants were asked about their emotional state before the treatment and half after the treatment but before the incentivized tasks. This was cross-randomized with the topic treatments and the payment schemes to verify if administering the questionnaire in itself after the treatment topics had an effect.</p>", "<title>Other tasks and measures</title>", "<p id=\"Par55\">We measure cognitive reasoning with three questions in the style of Frederick (2005)<sup>##UREF##36##70##</sup>. Participants had 4 minutes and 30 seconds to answer the questions and could earn 1€ per question.</p>", "<p id=\"Par56\">To measure risk-taking, we used a lottery choice in the style of Gneezy and Potters (1997)<sup>##UREF##37##71##</sup>. Participants could invest up to 3€ from their baseline payment. They had a 50% chance to triple their investment, and a 50% chance to lose their investment.</p>", "<p id=\"Par57\">Participants were offered to participate in a lottery to win an individual online coaching program of a market value of 385€. The coaching program included an orientation test and three individual sessions with a coach. Participants could choose between different modules: interview simulation, work methodology, self-confidence and stress management, and psychological support.</p>", "<p id=\"Par58\">We compute a Depression score through the Patient Health Questionnaire-9<sup>##UREF##38##72##</sup>, PHQ-9. We changed the last question from the PHQ-9, which explicitly asked for the presence of suicidal thoughts, to one related to depression from HADS. We also compute an Anxiety score through a short version of the Hospital Anxiety and Depression Score<sup>##REF##6880820##73##</sup>, HADS.</p>", "<p id=\"Par59\">Finally, we use a short version of The Internal Locus of Control Index<sup>##UREF##39##74##</sup>, ICI. This index measures to what extent subjects feel they have control over their lives. Highly internal subjects feel responsible for the things that happen in their lives, while low internal subjects believe that factors beyond their control determine their lives.</p>", "<title>Descriptive statistics</title>", "<p id=\"Par60\">Of the 1562 students that started the questionnaire, 1503 students finished it. As specified in the pre-analysis plan, we excluded respondents who took less than 8 minutes (20% of the median time) or more than 100 minutes to respond to the survey, as well as participants younger than 18 years and older than 30 years. The overall rate of attrition is 3.8%, with no differential attrition between the treatment groups. 779 participants played under the piece rate and 724 under the threshold payment scheme. 352 participants saw the labor market, 359 the mental health, 386 the animal welfare, and 406 the space topic. 66% of the respondents are female, the average age is 21.6 years. 70% are in their undergraduate studies, 27% in their masters or equivalent, and 3% are doing a PhD. 37% are from Science and Technology, 25% of the students are within the field of Law, Economics and Management, followed by Humanities and Social Sciences (17%), Art and Languages (14%) and Health Science (11%). Around 45% receive the means-tested state scholarship that depends on their parent’s income. The distribution of the covariates is balanced across the treatments on all pre-registered covariates (see SI Table ##SUPPL##0##15##). The joint orthogonality test is insignificant when comparing the topic treatments and the payment structures. As pre-registered, we include these variables as baseline controls in all our specifications.</p>", "<title>Statistical analysis</title>", "<p id=\"Par61\">The main analysis was done by OLS in Stata 15. The displayed results are based on regression including the specified pre-registered controls with robust standard errors (see SI Section ##SUPPL##0##2.1##). The Causal Forest was run in R version 4.2.1 using the randomForest version 4.7-1.1 package. The regression tables are reproduced in SI Section ##SUPPL##0##1##. The Causal Forest method, as well as the related test, are described in SI Section ##SUPPL##0##2.4##. The experiment was pre-registered at <ext-link ext-link-type=\"uri\" xlink:href=\"https://aspredicted.org/h69ht.pdf\">https://aspredicted.org/h69ht.pdf</ext-link>. A discussion of the pre-registration plan can be found in SI Section ##SUPPL##0##4.1##, and the original pre-registration plan in SI Section ##SUPPL##0##4.2##.</p>" ]
[ "<title>Results</title>", "<title>Treatement effect on emotions</title>", "<p id=\"Par13\">We first assess the effectiveness of the treatment by measuring participants’ emotional responses. We administer a multidimensional mood questionnaire<sup>##REF##22271232##53##</sup>, randomly directly before or after the treatment topics. Figure ##FIG##0##1## illustrates the responses for the three mood dimensions measured with the questionnaire. The regression results are displayed in SI Table ##SUPPL##0##1##. We control for baseline characteristics in every specification (see SI section ##SUPPL##0##2.1##. for specification details). We focus on the results that pool both control topics, as the emotional states of participants after either of the control topics are nearly identical. SI section ##SUPPL##0##2.2## discusses the differences between the two control topics.</p>", "<p id=\"Par14\">We find that the two control topics do not affect the participants’ emotional state significantly in any dimension compared to those asked before, except for weakly making respondents more tired (0.115 Standard Deviation (SD), p=0.062) and feeling better (0.098 SD, p=0.098). By contrast, we find that participants state feeling significantly worse after facing either of the two treatment topics compared to the control topics (LM: -0.308 SD, p=0.001, MH: -0.403 SD, p=0.000). Participants are also weakly more tired after reading the mental health article (-0.165 SD, p=0.065). Importantly, they are significantly less calm after reading the two treatment articles compared to those reading the control articles (LM: -0.226 SD, p=0.007; MH: -0.358 SD, p=0.000). The effects of the two treatments are not significantly different from each other on any of the three mood dimensions. Overall, the treatments had a negative effect on the emotional state of the participants. Yet, we cannot exclude an experimenter demand effect as participants could feel that after the treatment topics they are expected to feel worse.</p>", "<title>Treatment effect on cognitive performance</title>", "<p id=\"Par15\">We measure cognitive performance through a Raven-matrices-like task, in which participants have to find the missing element in an incomplete series of colorful and abstract forms<sup>##REF##31824684##54##</sup>. Students were either faced with a standard payment for each correct answer (piece-rate payment) or received this same payment only upon reaching an achievable minimum level (threshold payment).</p>", "<p id=\"Par16\">Figure ##FIG##1##2## illustrates the treatment effects on cognitive performance, measured through the number of correct matrices (out of 10) for each payment scheme. Under the piece-rate payment, the coefficients for both treatments are negative but not significantly different from zero. The coefficients (LM =-0.238 matrices, MH = -0.227 matrices, see SI Table ##SUPPL##0##2##) are smaller in absolute terms than 0.73 matrices – the minimal detectable effect pre-registered based on pilot data – which we consider a ‘medium-size effect’. However, based on a “two one-sided tests” procedure<sup>##REF##3450848##55##,##REF##28736600##56##</sup>, we cannot reject the presence of a ‘small negative effect’ defined as -0.37 matrices – i.e. half of the minimal detectable effect (see SI Section ##SUPPL##0##2.3## for discussion). Furthermore, while the treatment effects are not significant when compared to the pooled control groups, they are negative and significant when compared to the space exploration control only (LM = -0.317 matrices, p=0.039; MH =-0.306 matrices, p=0.049; SI Table ##SUPPL##0##19##).</p>", "<p id=\"Par17\">However, under the threshold payment, the LM treatment positively and significantly affects students’ cognitive performance (+0.459 matrices, p=0.036). Treated students improved their performance by 7% relative to the control group mean. In contrast, the MH treatment does not lead to any significant effect. Interestingly, the payment scheme alone does not have a significant effect on cognitive performance (SI Table ##SUPPL##0##4##). It is the combination of the threshold payment and LM treatment that enhances the cognitive performance of students.</p>", "<p id=\"Par18\">Moreover, we find that the effect is larger (+0.584 matrices, an increase of 9%, p=0.009, SI Table ##SUPPL##0##5##) when we include only individuals who answered correctly at least three of the four comprehension questions (88% of the participants). This suggests that the effect is indeed driven by those who were attentive to the articles and questions. Yet, students might have given wrong answers for different reasons in the different treatment groups limiting the interpretation of these results.</p>", "<p id=\"Par19\">The positive effect of the LM treatment under the threshold payment scheme holds when compared to each control group separately (see SI section ##SUPPL##0##2.2##). The coefficient is still significant at 10% when controlling for the testing of two hypotheses (p=0.062, SI Table ##SUPPL##0##3##), corresponding to within-payment scheme multiple hypothesis testing (MHT). The p-value drops to 0.133 when controlling for the testing of four hypotheses (between-and-within-payment scheme MHT).</p>", "<title>Investigating heterogeneity in the treatment effects</title>", "<p id=\"Par20\">We pre-registered heterogeneity for gender, receiving a state-funded scholarship as a measure of parental income, the field of study, the level of study, being close to finishing their studies, depression and anxiety score, and whether the mood questionnaire was asked before or after the treatment topics. Figure ##FIG##2##3## Panel A illustrates the treatment effect for the different subgroups for the piece-rate treatment and Panel B for the threshold payment (see SI Tables ##SUPPL##0##6## and ##SUPPL##0##7## for the regression results).</p>", "<p id=\"Par21\">Under piece-rate payment, we find no significant treatment effect of the LM topic in any pre-registered dimension. For the MH topic, we find that it decreases cognitive performance among those without a scholarship (-0.634 matrices, a decrease of 9%, p=0.028), those with a depression score above the median (-0.600 matrices, a decrease of 9%, p=0.036), and among students in “health science” (-1.244 matrices, a decrease of 17%, p=0.016) - though the sample of health students is too small to draw clear conclusions.</p>", "<p id=\"Par22\">We find that the MH topic negatively affects the depression score though the questions were asked about the previous weeks (see SI Table ##SUPPL##0##13## column (1)). We verify if assignment to treatment changes the group composition into those below and above the median. If treatment changed the composition, the subgroups would not be comparable between treatments. However, we find that the median for each treatment cell is the same, such that using the overall median to divide the participants into two groups and the group-specific median leads to the same results. Results are also the same if we correct the mental health score by the treatment effect (see SI Table ##SUPPL##0##8##). We also find in a quantile regression that the MH topic negatively affects those with an already high score (see SI Table ##SUPPL##0##9##).</p>", "<p id=\"Par23\">We expected those with a scholarship to be more vulnerable as they come from a poorer background. Yet, receiving a state scholarship might also give students a stable income and thus improve their financial stability compared to those who do not receive it but have a similar financial background. The effect on those with poor mental health is in line with expectations: those who are especially vulnerable perform worse. The coefficient for the anxiety score goes in the same direction, though is not significant (-0.496 matrices, p=0.146).</p>", "<p id=\"Par24\">Under the threshold payment, the treatment effect of the LM topic is consistently positive for all subgroups. The treatment effect appears to be especially strong for women (+0.601 matrices, an increase of 9%, p=0.021), those not in the first year of their studies (+0.540, an increase of 8%, p=0.042), and those not close to graduation and labor market entry (+0.521, an increase of 8%, p=0.030) - though none of the coefficients is significantly different from each other. The MH topic does not have a significant effect on cognitive performance for any pre-registered subgroup.</p>", "<title>Causal machine learning</title>", "<p id=\"Par25\"> We use a “Causal Forest” to uncover subgroups that react differently to our treatments in a data-driven approach<sup>##UREF##32##57##</sup>. This heterogeneity analysis allows us to go beyond the pre-defined subgroup analysis by accounting for high dimensional combinations of covariates. We estimate the Conditional Average Treatment Effect (CATE) on a vector of observable characteristics, including baseline controls and a large number of covariates that provide information on participants’ financial situation, expectations, family background, mental health measures, Covid-19 experience, and some self-perception questions. We then use the predicted CATE to rank the observations from those with the lowest CATE to the highest CATE and group them into quartiles.</p>", "<p id=\"Par26\">We apply the causal forest to each of our treatments. However, after assessing the quality of the forest’s estimates, we only detect heterogeneity in the LM treatment and the threshold payment — the only treatment where we find an average treatment effect (see SI Section ##SUPPL##0##2.4## for further explanation). Therefore, we limit our analysis to this treatment arm. To compare the two most contrasting groups, we analyze the difference between those in the first and the fourth quartiles (see SI Tables ##SUPPL##0##24## and ##SUPPL##0##25##). For the first quartile, the average treatment effect is close to zero and not significant (-0.35 matrices, p=0.508) while for the fourth quartile, the average treatment effect is strongly positive and significant (+1.19 matrices, an increase of 18%, p=0.02). We compare the characteristics of those within these groups to uncover what predicts whether or not respondents benefit from the treatment (focusing on those with a difference significant at 1%). Table ##TAB##0##1## displays the results.</p>", "<p id=\"Par27\">Similar to the pre-registered heterogeneity analysis, we find that students without a scholarship and students not close to graduation and labor market entry are more likely to be in the first quartile than in the last, thus benefiting from being treated with the LM topic and the threshold payment (Table ##TAB##0##1##, Panel A). Furthermore, we can pin down other characteristics that seem relevant to generating a positive effect. First, the financial situation and family background plays an important role: on average, participants in the highest quartile are less likely to struggle financially, more likely to be able to cover additional expenses, and less likely to work beside their studies (Panel C). They are more likely to be non-migrants, have highly educated parents, and have both their parents working (Panel E). Second, participants who were more socially active during the lockdown are more likely to respond positively to the treatment: students in the highest quartile state not having passed the lockdown alone and claim seeing friends and going to the university more often than those in the lowest quartile (Panel H). Finally, being able to switch from task to task easily (lower cognitive rigidity) and having a lower locus of control seem related to performing better (Panel I).</p>", "<title>Effect on other outcomes</title>", "<p id=\"Par28\">For the other outcomes (see Methods section), we do not have variation in the payment scheme. Hence, we only study the effect of being exposed to the different topics. We do not find any significant effect on cognitive reasoning or risk-taking (SI Table ##SUPPL##0##10## columns 1-4). We also verify if the treatment topics affect the willingness to pay for a lottery ticket to win a real individual online coaching session by a leading student counselling firm (SI Table ##SUPPL##0##10## columns 5-6). We do not find any significant effect (though the coefficients are positive as expected) when controlling for baseline characteristics. With extended controls, we find a weak positive effect of the LM treatment (significant at 10%). Investigating further, the LM treatment significantly increases the likelihood of respondents choosing the module “interview simulation” as one of their two module choices by almost 20%. We find no other significant effect for either of the two treatments (SI Table ##SUPPL##0##11##).</p>" ]
[ "<title>Discussion</title>", "<title>Different effects of the two topics and interaction with the goal-based payment scheme</title>", "<p id=\"Par29\">The LM topic is a reminder for students that finding a job at the end of their studies might not be easy. Yet, it is not an immediate problem and it is partly endogenous, as students can take action to face up to the adverse situation, in particular through academic effort. Hence, the topic can be motivating – at least for those who believe that they have the possibility to cope with the consequences. This interpretation is underlined by the observation that the positive result is driven by those not too close to labor market entry. We also find that the LM treatment significantly increases the perceived importance of finding a well-paid job after university (see SI Table ##SUPPL##0##12## column 2), as well as the willingness to pay for a real career coaching session. The LM treatment thus increased the salience of job-finding challenges at the end of the studies. Psychological studies have shown that a higher stress level can increase performance when the stressor is seen as a challenge rather than a threat<sup>##REF##19843261##35##,##REF##19455173##58##</sup>. For this, the stressor might need to be ‘controllable’<sup>##UREF##21##36##</sup>. This can explain why we see a positive effect for the LM topic that leaves ‘scope for action’.</p>", "<p id=\"Par30\">This motivation effect seems to have been picked up by the more challenging or motivating threshold-payment scheme. Payment schemes that provide explicit and achievable goals can enhance motivation and performance more than schemes where payment is linked to the individual unit of output<sup>##UREF##33##59##</sup>. Indeed, the threshold in our experiment is achievable: 76% of the participants reach the minimum level of 5 correct answers. The threshold payment should be especially motivating for those who believe they are just below the threshold. We indeed find that the treatment effect is the strongest among students with a lower “baseline cognitive performance score” (see SI Figure ##SUPPL##0##3##). The score measures how many matrices they got right in the incentivized training task before the treatment. This result suggests that the threshold-payment scheme successfully motivated those students to increase effort.</p>", "<p id=\"Par31\">We also find that the threshold payment increases the perceived importance of having good grades as well as a well-paying career (see SI Table ##SUPPL##0##12## columns 1 and 2). The threshold condition seemed to make academic performance more salient and connect it with the cognitive performance task. The results are thus consistent with a ‘tunneling effect’ where the attention of the respondent focuses on a task that is related to the source of scarcity or worry<sup>##REF##23118192##9##,##UREF##12##21##</sup>. It is likely that the combination of the specific topic and the goal-based payment created the conditions to improve students’ cognitive performance.</p>", "<p id=\"Par32\">Contrary to the LM topic, the MH topic exposed students to a current and certain ‘state of affairs’, with very limited scope for action, and not linked with academic performance. This decreases to likelihood of observing a ‘tunneling effect’ since the cognitive performance task is unrelated to the topic. The topic thus is only expected to increase stress levels and to tax ‘mental bandwidth’. We indeed find that the MH topic worsens participants’ depression score (SI Table ##SUPPL##0##13## column 1) as well as locus of control – their belief that their outcomes are mainly driven by their actions rather than chance and circumstances (SI Table ##SUPPL##0##13## column 2). In the piece-rate treatment, we find a negative effect among different subgroups, including those with a high depression score. Thus, there is a potential detrimental effect of this topic on the most vulnerable. The negative effect, albeit weak, is in line with the ‘mental bandwidth’ effect or a negative stress effect, caused by the different content (mental health vs. job uncertainty) or the deterministic nature of the issue.</p>", "<p id=\"Par33\">Under the threshold payment, we see an average null effect of the MH topic, and no sub-group with a positive or negative effect. The threshold payment is only expected to be motivating if people believe that they will reach the goal and effort is useful. The MH topic might just do the opposite. Moreover, if the treatment topic taxes the ‘mental bandwidth’ and thus increases the cost of effort, people who are not sure to pass the threshold might decrease their effort because the expected benefits are lower. This could counteract the otherwise motivating effect of the threshold payment.</p>", "<title>Inequality-widening mechanism</title>", "<p id=\"Par34\">We find that the increase in performance, after the exposure to a worrisome topic with scope for action and given a goal-based payment scheme, is driven by participants from a better-off background. Students with larger socioeconomic resources seem to be able to draw motivation from future uncertainty, provided the right incentives are in place. This is not the case for those with a more vulnerable profile. Hence, during periods when students are faced with worrisome news, we expect those who face financial, social, or psychological vulnerabilities to perform worse than better-off students. We hypothesize that they are less able to perceive the opportunities in the situation. Therefore, they are more often blocked by worries about negative consequences. Such a mechanism implies that students with unequal preexisting socioeconomic characteristics will perform differently. The consequence is a deepening of preexisting inequalities. That is, our study highlights a new inequality-widening or poverty-preserving mechanism.</p>", "<p id=\"Par35\">In the case of the Covid pandemic, this adds to the ample evidence that the negative consequences of lockdowns on student learning were especially severe among students from less-educated and poorer families<sup>##UREF##34##60##–##REF##34629567##64##</sup>. More generally, our finding is in line with previous studies showing that financially vulnerable people experience a worse cognitive performance when faced with financially worrying tasks or situations<sup>##REF##23990553##14##,##UREF##10##17##</sup>. It also echoes the so-called ‘broaden-and-build’ theory in psychology about the role of emotions<sup>##REF##11315248##65##</sup>. Some experiments showed that positive emotions are linked to a broader scope of action or psychological resilience<sup>##REF##14769087##66##,##REF##21852891##67##</sup>. While our experiment induced negative emotions, it is likely that better-off participants benefited from having a more positive baseline emotional level. Indeed, we observe that facing financial struggles is associated with lower emotional scores along the three dimensions, among those who answered the emotions questionnaire before the treatment (see SI Table ##SUPPL##0##14##).</p>", "<title>Effect sizes and external validity</title>", "<p id=\"Par36\">When students were invited to sign up and when they started the survey, they were informed about it including pandemic-related questions. While the invitation was sent to all students and, based on limited administrative data available, our sample looks similar to the general French student population, those who participated might differ in unobserved characteristics. Specifically, those who were the most vulnerable might have not taken part in the survey. Furthermore, we selected topics that were negative but correct and not sensationalist. On social media, people are often confronted with much more negative framing. Also, we only test the effect of one reminder of a topic that they probably have already heard a lot about and contemplated on several occasions. Therefore, we most likely find a lower bound of the potential negative effect.</p>", "<p id=\"Par37\">In this online experiment, respondents were faced with worrisome topics in an online format – which mirrors how young adults generally consume news and are confronted with such topics. However, their cognitive performance response could have been different if the task was in person rather than online. Within a lab or face-to-face setting, participants might have already been under more stress. Again, this points towards us finding a lower bound of the potential negative effect. Yet, many professional tasks are nowadays done in a setting similar to the one in our experiment (online and distant clients). We thus argue that the online setting might be more relevant than a lab setting for this type of question. It also allowed us the run the experiment at a larger scale and recruit students who would not have participated in a lab experiment, which was important for the study of heterogeneity.</p>", "<p id=\"Par38\">The question arises if these results hold beyond a sample of university students. First, students might be more responsive to our goal-based payment scheme, which resembles an academic exam situation. Yet, other papers have shown that similar payment schemes can affect the performance of adults<sup>##UREF##22##37##,##REF##12237980##68##</sup>. Second, for students, the LM topic implies future difficulties, for which they can prepare individually through effort. Arguably, those already at work might see the topic more often as a threat and less often as a challenge. Yet, the key distinction between worries about topics with and without scope for action is general. For instance, a topic such as climate change can be seen as a challenge by some - who then get motivated to become active - and as a distracting worry by others.</p>" ]
[]
[ "<p id=\"Par1\">Worrisome topics, such as climate change, economic crises, or pandemics including Covid-19, are increasingly present and pervasive due to digital media and social networks. Do worries triggered by such topics affect the cognitive capacities of young adults? In an online experiment during the Covid-19 pandemic (N=1503), we test how the cognitive performance of university students responds when exposed to topics discussing (i) current adverse mental health consequences of social restrictions or (ii) future labor market hardships linked to the economic contraction. Moreover, we study how such a response is affected by a performance goal. We find that the labor market topic increases cognitive performance when it is motivated by a goal, consistent with a ‘tunneling effect’ of scarcity or a positive stress effect. However, we show that the positive reaction is mainly concentrated among students with larger financial and social resources, pointing to an inequality-widening mechanism. Conversely, we find limited support for a negative stress effect or a ‘cognitive load effect’ of scarcity, as the mental health topic has a negative but insignificant average effect on cognitive performance. Yet, there is a negative response among psychologically vulnerable individuals when the payout is not conditioned on reaching a goal.</p>", "<title>Subject terms</title>" ]
[ "<title>Study setting</title>", "<p id=\"Par9\">In an online experiment conducted during the Covid-19 pandemic, we investigate the impact of different types of worries on the cognitive performance of university students. We leverage real-life sources of anxiety made salient by the pandemic: mental health issues related to social restrictions and future labor market uncertainties linked to the economic contraction. The treatments are motivated by the evidence that, during the pandemic, young people worried mostly about uncertain employment opportunities and that social restrictions burden their psychological well-being<sup>##UREF##25##41##–##UREF##28##46##</sup>. Moreover, the different topics of the two treatments allow us to discuss different mechanisms.</p>", "<p id=\"Par10\">In addition, we cross-randomized the way performance is rewarded. Participants were either compensated for each correct answer or received payment upon reaching a specified threshold, set as correctly solving half of the tasks. This goal was chosen to be achievable for most participants (based on pilot data) and mirrored exam conditions where half of the points are needed to pass. This reflects many real-life situations, such as passing an academic, qualifying, or entrance exam or reaching a performance threshold to qualify for a bonus, job, or promotion. We thus have a between-subject design where individuals were randomly exposed to one topic - either a treatment topic or a control/placebo topic - and do the performance task under one payment scheme. Supplementary Information (SI) Figure ##SUPPL##0##1## illustrates the experimental design and SI Figure ##SUPPL##0##2## the survey design.</p>", "<p id=\"Par11\">Our main outcome is cognitive performance – the ability to solve challenging problems, by processing information quickly and going beyond memorization or imitation (also sometimes referred to as cognitive ability, abstract reasoning, or fluid intelligence)<sup>##REF##23020641##47##,##UREF##29##48##</sup>. It is a strong predictor of key real outcomes, such as educational and professional success or good health<sup>##UREF##30##49##–##REF##19005537##52##</sup>. Beyond average treatment effects, we study carefully the heterogeneity of such effects, focusing particularly on characteristics linked to financial or mental health vulnerability that can decrease the ability to cope with negative facts.</p>", "<p id=\"Par12\">In practice, we ran the experiment on a sample of 1503 students at a French public university with a mixed student body, between February and April 2021. The treatment and control topics included a newspaper article and two graphics, followed by comprehension and reflection questions. The mental health (MH) topic discussed the situation of students during a lockdown. At the time, France was just out of its second national lockdown, partial lockdowns were progressively put in place at the regional level, and vaccines were not yet available for the general population. The topic thus increased the salience of a current stressful issue which participants had been unwillingly confronted with. The labor market (LM) topic discussed the projected difficult labor market situation of young adults. With students not being in the labor market yet, the topic could stimulate anxiety about an uncertain future. Yet, by nature, the topic leaves room for action, as students are potentially able to influence their personal outcomes through increased effort over the coming months and years. The articles were included to give context and substance to the treatment but generally did not provide novel information: only 16% and 9% of participants stated that they “learned a lot” from the LM and the MH topics, respectively. Participants in the control group were presented with topics that were intentionally selected to be non-distressing. These topics included animal welfare and NASA’s space program, and they were designed to occupy participants for an equal amount of time and to induce a similar “reflective state” without causing any worry or stress.</p>", "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-023-50036-0.</p>", "<title>Acknowledgements</title>", "<p>We are grateful to Laurence Bouvard for administering the survey and to the admin team that made the project possible. We thank Michele Belot, Nicolas Berman, Björn Brey, Yannick Dupraz, Romain Ferrali, Mathieu Lefebvre, Golvine de Rochambeau, Avner Seror, Roberta Ziparo, and seminar and conference participants at Aix-Marseille School of Economics, University College Dublin, LMU Munich, FETS online seminar, EEA annual conference in Milan, and ASFEE conference in Lyon for their helpful comments.</p>", "<title>Author contributions</title>", "<p>T.D., D.H.S. and E.R. conceived and conducted the experiment, D.H.S. took the lead in data analysis, and T.D., D.H.S. and E.R. wrote the manuscript.</p>", "<title>Funding</title>", "<p>This project has received funding from the French National Research Agency Grant RA-Covid-19 LearninCov, the French government under the “France 2030” investment plan managed by the French National Research Agency (reference: ANR-17-EURE-0020), and from Excellence Initiative of Aix-Marseille University - A*MIDEX.</p>", "<title>Data availibility</title>", "<p>The dataset generated and analysed during the current study is available at Harvard Dataverse DOI <ext-link ext-link-type=\"uri\" xlink:href=\"https://doi.org/10.7910/DVN/VLQXJG\">https://doi.org/10.7910/DVN/VLQXJG</ext-link>. It includes the replication codes. The questionnaire is available in the Supplementary Information.</p>", "<title>Competing interests</title>", "<p id=\"Par62\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Emotional states before and after the topic treatments. Note: Linear prediction of emotional state before and after the topic treatment, with 95% confidence intervals. The standardized scores are based on four questions for each mood (two positively phrased, two negatively). Includes pre-registered baseline controls: gender, field of study, undergraduate, scholarship recipient, as well as age and number of correct matrices in the first round. See SI Table ##SUPPL##0##1##.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Treatment effect on cognitive performance. Note: Treatment effects on cognitive performance according to the payment scheme, with 90% and 95% confidence intervals. The dependent variable is the number of correct matrices (Minimum possible: 0, maximum possible: 10). Includes pre-registered baseline controls: gender, the field of study, undergraduate, scholarship recipient, as well as age and number of correct matrices in the first round. See SI Table ##SUPPL##0##2##.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Treatment effect on cognitive performance: pre-registered heterogeneity. Note: Differential treatment effects on cognitive performance for the piece-rate payment (panel a) and the threshold payment (panel b) for the pre-registered groups, with 90% and 95% confidence intervals. The dependent variable is the number of correct matrices (Minimum possible: 0, maximum possible: 10). Includes pre-registered baseline controls: gender, the field of study, undergraduate, scholarship recipient, as well as age and number of correct matrices in the first round. “Emotion questionnaire” refers to the emotions questionnaire being asked before or after the topic treatment. See SI Tables ##SUPPL##0##6## and ##SUPPL##0##7##.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Causal Forest: cognitive performance - labor market and threshold treatment.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Variable</th><th align=\"left\">Highest quartile</th><th align=\"left\">Lowest quartile</th><th align=\"left\">Diff.</th><th align=\"left\">P-values</th></tr></thead><tbody><tr><td align=\"left\"/><td align=\"left\" colspan=\"4\"><italic>Panel A. Baseline controls</italic></td></tr><tr><td align=\"left\">Age</td><td align=\"left\">20.346</td><td align=\"left\">22.928</td><td align=\"left\">2.582</td><td align=\"left\">0.00***</td></tr><tr><td align=\"left\">Woman</td><td align=\"left\">0.713</td><td align=\"left\">0.703</td><td align=\"left\">0.010</td><td align=\"left\">0.85</td></tr><tr><td align=\"left\">Scholarship</td><td align=\"left\">0.346</td><td align=\"left\">0.543</td><td align=\"left\">0.198</td><td align=\"left\">0.00***</td></tr><tr><td align=\"left\">1st year student</td><td align=\"left\">0.404</td><td align=\"left\">0.261</td><td align=\"left\">0.144</td><td align=\"left\">0.01**</td></tr><tr><td align=\"left\">Close to labor market</td><td align=\"left\">0.066</td><td align=\"left\">0.196</td><td align=\"left\">0.129</td><td align=\"left\">0.00***</td></tr><tr><td align=\"left\">Fatigued</td><td align=\"left\">0.779</td><td align=\"left\">0.804</td><td align=\"left\">0.025</td><td align=\"left\">0.61</td></tr><tr><td align=\"left\">First round matrices</td><td align=\"left\">1.875</td><td align=\"left\">1.993</td><td align=\"left\">0.118</td><td align=\"left\">0.45</td></tr><tr><td align=\"left\"/><td align=\"left\" colspan=\"4\">\n<italic>Panel B. Field of study</italic></td></tr><tr><td align=\"left\">Health Sciences</td><td align=\"left\">0.088</td><td align=\"left\">0.101</td><td align=\"left\">0.013</td><td align=\"left\">0.71</td></tr><tr><td align=\"left\">Arts and Languages</td><td align=\"left\">0.162</td><td align=\"left\">0.094</td><td align=\"left\">0.068</td><td align=\"left\">0.10*</td></tr><tr><td align=\"left\">Law, Economics, Management</td><td align=\"left\">0.250</td><td align=\"left\">0.254</td><td align=\"left\">0.004</td><td align=\"left\">0.95</td></tr><tr><td align=\"left\">Science and Technology</td><td align=\"left\">0.257</td><td align=\"left\">0.370</td><td align=\"left\">0.112</td><td align=\"left\">0.05**</td></tr><tr><td align=\"left\">Humanities and Social Science</td><td align=\"left\">0.235</td><td align=\"left\">0.181</td><td align=\"left\">0.054</td><td align=\"left\">0.27</td></tr><tr><td align=\"left\"/><td align=\"left\" colspan=\"4\">\n<italic>Panel C. Financial Situation</italic></td></tr><tr><td align=\"left\">Having financial struggles</td><td align=\"left\">0.118</td><td align=\"left\">0.341</td><td align=\"left\">0.223</td><td align=\"left\">0.00***</td></tr><tr><td align=\"left\">Can afford extra expenses</td><td align=\"left\">0.875</td><td align=\"left\">0.717</td><td align=\"left\">0.158</td><td align=\"left\">0.00***</td></tr><tr><td align=\"left\">Having own salary</td><td align=\"left\">0.118</td><td align=\"left\">0.203</td><td align=\"left\">0.085</td><td align=\"left\">0.05*</td></tr><tr><td align=\"left\"/><td align=\"left\" colspan=\"4\">\n<italic>Panel D. Expectations</italic></td></tr><tr><td align=\"left\">Low prob. success career</td><td align=\"left\">0.140</td><td align=\"left\">0.210</td><td align=\"left\">0.070</td><td align=\"left\">0.13</td></tr><tr><td align=\"left\">Low prob. success studies</td><td align=\"left\">0.449</td><td align=\"left\">0.420</td><td align=\"left\">0.028</td><td align=\"left\">0.64</td></tr><tr><td align=\"left\">Pessimistic about the next 5 years</td><td align=\"left\">0.324</td><td align=\"left\">0.377</td><td align=\"left\">0.053</td><td align=\"left\">0.36</td></tr><tr><td align=\"left\">Pressure to have diploma</td><td align=\"left\">0.434</td><td align=\"left\">0.297</td><td align=\"left\">0.137</td><td align=\"left\">0.02**</td></tr><tr><td align=\"left\">Pressure to have good grades</td><td align=\"left\">0.250</td><td align=\"left\">0.217</td><td align=\"left\">0.033</td><td align=\"left\">0.53</td></tr><tr><td align=\"left\"/><td align=\"left\" colspan=\"4\">\n<italic>Panel E. Family Background</italic></td></tr><tr><td align=\"left\">Migrant</td><td align=\"left\">0.029</td><td align=\"left\">0.304</td><td align=\"left\">0.275</td><td align=\"left\">0.00***</td></tr><tr><td align=\"left\">Living alone</td><td align=\"left\">0.250</td><td align=\"left\">0.290</td><td align=\"left\">0.040</td><td align=\"left\">0.46</td></tr><tr><td align=\"left\">Father university degree</td><td align=\"left\">0.551</td><td align=\"left\">0.174</td><td align=\"left\">0.378</td><td align=\"left\">0.00***</td></tr><tr><td align=\"left\">Mother university degree</td><td align=\"left\">0.816</td><td align=\"left\">0.094</td><td align=\"left\">0.722</td><td align=\"left\">0.00***</td></tr><tr><td align=\"left\">Both parents work</td><td align=\"left\">0.787</td><td align=\"left\">0.406</td><td align=\"left\">0.381</td><td align=\"left\">0.00***</td></tr><tr><td align=\"left\"/><td align=\"left\" colspan=\"4\">\n<italic>Panel F. Mental Health</italic></td></tr><tr><td align=\"left\">Depression</td><td align=\"left\">0.441</td><td align=\"left\">0.543</td><td align=\"left\">0.102</td><td align=\"left\">0.09*</td></tr><tr><td align=\"left\">Anxiety</td><td align=\"left\">0.397</td><td align=\"left\">0.471</td><td align=\"left\">0.074</td><td align=\"left\">0.22</td></tr><tr><td align=\"left\"/><td align=\"left\" colspan=\"4\">\n<italic>Panel G. Covid-19 Experience</italic></td></tr><tr><td align=\"left\">Had Covid-19</td><td align=\"left\">0.103</td><td align=\"left\">0.036</td><td align=\"left\">0.067</td><td align=\"left\">0.03**</td></tr><tr><td align=\"left\">Family member had Covid-19</td><td align=\"left\">0.272</td><td align=\"left\">0.304</td><td align=\"left\">0.032</td><td align=\"left\">0.56</td></tr><tr><td align=\"left\">Personal traumatic Covid experience</td><td align=\"left\">0.184</td><td align=\"left\">0.268</td><td align=\"left\">0.084</td><td align=\"left\">0.10*</td></tr><tr><td align=\"left\">Family member lost job</td><td align=\"left\">0.176</td><td align=\"left\">0.225</td><td align=\"left\">0.048</td><td align=\"left\">0.32</td></tr><tr><td align=\"left\">Positive attitude tw vaccination</td><td align=\"left\">0.449</td><td align=\"left\">0.348</td><td align=\"left\">0.101</td><td align=\"left\">0.09*</td></tr><tr><td align=\"left\">Lock-down alone</td><td align=\"left\">0.029</td><td align=\"left\">0.109</td><td align=\"left\">0.079</td><td align=\"left\">0.01***</td></tr><tr><td align=\"left\">Seeing friends</td><td align=\"left\">2.985</td><td align=\"left\">0.949</td><td align=\"left\">2.036</td><td align=\"left\">0.00***</td></tr><tr><td align=\"left\">Going to the university</td><td align=\"left\">1.463</td><td align=\"left\">0.935</td><td align=\"left\">0.528</td><td align=\"left\">0.01***</td></tr><tr><td align=\"left\"/><td align=\"left\" colspan=\"4\">\n<italic>Panel I. Self- perception</italic></td></tr><tr><td align=\"left\">Cognitive rigidity</td><td align=\"left\">3.110</td><td align=\"left\">3.761</td><td align=\"left\">0.651</td><td align=\"left\">0.00***</td></tr><tr><td align=\"left\">Cognitive control</td><td align=\"left\">2.867</td><td align=\"left\">2.993</td><td align=\"left\">0.126</td><td align=\"left\">0.27</td></tr><tr><td align=\"left\">Locus of control</td><td align=\"left\">17.945</td><td align=\"left\">20.007</td><td align=\"left\">2.062</td><td align=\"left\">0.00***</td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M20\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M22\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq12\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M24\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq13\"><alternatives><tex-math id=\"M25\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M26\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq14\"><alternatives><tex-math id=\"M27\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M28\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq15\"><alternatives><tex-math id=\"M29\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M30\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq16\"><alternatives><tex-math id=\"M31\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M32\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq17\"><alternatives><tex-math id=\"M33\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M34\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq18\"><alternatives><tex-math id=\"M35\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M36\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq19\"><alternatives><tex-math id=\"M37\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M38\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq20\"><alternatives><tex-math id=\"M39\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M40\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq21\"><alternatives><tex-math id=\"M41\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M42\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq22\"><alternatives><tex-math id=\"M43\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M44\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq23\"><alternatives><tex-math id=\"M45\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M46\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq24\"><alternatives><tex-math id=\"M47\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p&lt; 0.1$$\\end{document}</tex-math><mml:math id=\"M48\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq25\"><alternatives><tex-math id=\"M49\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p &lt; 0.05$$\\end{document}</tex-math><mml:math id=\"M50\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.05</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq26\"><alternatives><tex-math id=\"M51\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p &lt; 0.01$$\\end{document}</tex-math><mml:math id=\"M52\"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>Note: * , ** , *** . Compares the characteristics of students who belong to the highest and lowest quartiles of the CATE distribution. Those in the highest quartile are predicted to have a positive treatment effect while those in the lowest quartile are predicted to have no treatment effect.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Timothée Demont, Daniela Horta Sáenz and Eva Raiber.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2023_50036_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2023_50036_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2023_50036_Fig3_HTML\" id=\"MO3\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq9.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq10.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq11.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq12.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq13.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq14.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq15.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq16.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq17.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq18.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq19.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq20.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq21.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq22.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq23.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq24.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq25.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50036_Article_IEq26.gif\"/>" ]
[ "<media xlink:href=\"41598_2023_50036_MOESM1_ESM.pdf\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["2."], "surname": ["McLaughlin", "Gotlieb", "Mills"], "given-names": ["B", "MR", "DJ"], "article-title": ["Caught in a dangerous world: Problematic news consumption and its relationship to mental and physical ill-being"], "source": ["Health Commun."], "year": ["2022"], "volume": ["0"], "fpage": ["1"], "lpage": ["11"], "pub-id": ["10.1080/10410236.2022.2106086"]}, {"label": ["3."], "surname": ["Organization"], "given-names": ["WH"], "source": ["World mental health report: transforming mental health for all"], "year": ["2022"], "publisher-loc": ["Rep"], "publisher-name": ["Tech"]}, {"label": ["4."], "mixed-citation": ["publique France, S. Synth\u00e8se des r\u00e9sultats des \u00e9tudes de l\u2019impact de l\u2019\u00e9pid\u00e9mie de covid-19 sur la sant\u00e9 mentale, les addictions et les troubles du sommeil parmi les actifs occup\u00e9s. Tech. Rep. (2023)."]}, {"label": ["5."], "mixed-citation": ["IPSOS. Les adolescents face au monde: le mal-\u00eatre et la d\u00e9tresse s\u2019amplifient. deuxi\u00e8me vague du barom\u00e8tre des adolescents de notre avenir \u00e0 tous. Tech. Rep. (2022)."]}, {"label": ["6."], "surname": ["Deck", "Jahedi"], "given-names": ["C", "S"], "article-title": ["The effect of cognitive load on economic decision making: A survey and new experiments"], "source": ["Eur. Econ. Rev."], "year": ["2015"], "volume": ["78"], "fpage": ["97"], "lpage": ["119"], "pub-id": ["10.1016/j.euroecorev.2015.05.004"]}, {"label": ["7."], "surname": ["Shah", "Zhao", "Mullainathan", "Shafir"], "given-names": ["AK", "J", "S", "E"], "article-title": ["Money in the mental lives of the poor"], "source": ["Soc. Cogn."], "year": ["2018"], "volume": ["36"], "fpage": ["4"], "lpage": ["19"], "pub-id": ["10.1521/soco.2018.36.1.4"]}, {"label": ["10."], "mixed-citation": ["Mullainathan, S. & Shafir, E. "], "italic": ["Scarcity: Why having too little means so much"]}, {"label": ["11."], "mixed-citation": ["Mullainathan, S. & Shafir, E. Decision making and policy in contexts of poverty. In "], "italic": ["The Behavioral Foundations of Public Policy"]}, {"label": ["15."], "surname": ["Kaur", "Mullainathan", "Oh", "Schilbach"], "given-names": ["S", "S", "S", "F"], "source": ["Do financial concerns make workers less productive?"], "year": ["2021"], "publisher-loc": ["National Bureau of Economic Research"], "publisher-name": ["Tech. Rep"]}, {"label": ["16."], "surname": ["Mani", "Mullainathan", "Shafir", "Zhao"], "given-names": ["A", "S", "E", "J"], "article-title": ["Scarcity and cognitive function around payday: A conceptual and empirical analysis"], "source": ["J. Assoc. Consum. Res."], "year": ["2020"], "volume": ["5"], "fpage": ["365"], "lpage": ["376"]}, {"label": ["17."], "surname": ["Duquennois"], "given-names": ["C"], "article-title": ["Fictional money, real costs: Impacts of financial salience on disadvantaged students"], "source": ["Am. Econ. Rev."], "year": ["2022"], "volume": ["112"], "fpage": ["798"], "lpage": ["826"], "pub-id": ["10.1257/aer.20201661"]}, {"label": ["18."], "surname": ["Bogliacino", "Montealegre"], "given-names": ["F", "F"], "article-title": ["Do negative economic shocks affect cognitive function, adherence to social norms and loss aversion?"], "source": ["J. Econ. Sci. Assoc."], "year": ["2020"], "volume": ["6"], "fpage": ["57"], "lpage": ["67"], "pub-id": ["10.1007/s40881-020-00091-4"]}, {"label": ["21."], "surname": ["de Bruijn", "Antonides"], "given-names": ["E", "G"], "article-title": ["Poverty and economic decision making: a review of scarcity theory"], "source": ["Theor. Decis."], "year": ["2022"], "volume": ["92"], "fpage": ["5"], "lpage": ["37"], "pub-id": ["10.1007/s11238-021-09802-"]}, {"label": ["23."], "surname": ["Fehr", "Fink", "Jack"], "given-names": ["D", "G", "BK"], "article-title": ["Poor and rational: Decision-making under scarcity"], "source": ["J. Polit. Econ."], "year": ["2022"], "volume": ["130"], "fpage": ["2862"], "lpage": ["2897"], "pub-id": ["10.1086/720466"]}, {"label": ["24."], "mixed-citation": ["Gonz\u00e1lez-Arango, F. "], "italic": ["et\u00a0al.", "Theory and Decision"]}, {"label": ["25."], "surname": ["Dalton", "Nhung", "R\u00fcschenp\u00f6hler"], "given-names": ["PS", "N", "J"], "article-title": ["Worries of the poor: The impact of financial burden on the risk attitudes of micro-entrepreneurs"], "source": ["J. Econ. Psychol."], "year": ["2020"], "volume": ["79"], "fpage": ["102198"], "pub-id": ["10.1016/j.joep.2019.102198"]}, {"label": ["27."], "surname": ["Canavari", "Drichoutis", "Lusk", "Nayga"], "given-names": ["M", "AC", "JL", "RM"], "suffix": ["Jr"], "article-title": ["How to run an experimental auction: A review of recent advances"], "source": ["Eur. Rev. Agric. Econ."], "year": ["2019"], "volume": ["46"], "fpage": ["862"], "lpage": ["922"], "pub-id": ["10.1093/erae/jbz038"]}, {"label": ["28."], "mixed-citation": ["Achtziger, A., Al\u00f3s-Ferrer, C. & Ritschel, A. Cognitive load in economic decisions. "], "italic": ["University of Zurich, Department of Economics, Working Paper"]}, {"label": ["31."], "surname": ["Teigen"], "given-names": ["KH"], "article-title": ["Yerkes-dodson: A law for all seasons"], "source": ["Theory Psychol."], "year": ["1994"], "volume": ["4"], "fpage": ["525"], "lpage": ["547"], "pub-id": ["10.1177/0959354394044004"]}, {"label": ["32."], "surname": ["Westman", "Eden"], "given-names": ["M", "D"], "article-title": ["The inverted-u relationship between stress and performance: A field study"], "source": ["Work Stress"], "year": ["1996"], "volume": ["10"], "fpage": ["165"], "lpage": ["173"], "pub-id": ["10.1080/02678379608256795"]}, {"label": ["33."], "mixed-citation": ["Stokes, A.\u00a0F. & Kite, K. "], "italic": ["Flight stress: Stress, fatigue and performance in aviation"]}, {"label": ["36."], "surname": ["Robertson"], "given-names": ["I"], "article-title": ["The stress test: Can stress ever be beneficial"], "source": ["J. Br. Acad."], "year": ["2017"], "volume": ["5"], "fpage": ["163"], "lpage": ["176"], "pub-id": ["10.5871/jba/005.163"]}, {"label": ["37."], "surname": ["Bonner", "Sprinkle"], "given-names": ["SE", "GB"], "article-title": ["The effects of monetary incentives on effort and task performance: theories, evidence, and a framework for research"], "source": ["Acc. Organ. Soc."], "year": ["2002"], "volume": ["27"], "fpage": ["303"], "lpage": ["345"], "pub-id": ["10.1016/S0361-3682(01)00052-6"]}, {"label": ["38."], "surname": ["Ariely", "Gneezy", "Loewenstein", "Mazar"], "given-names": ["D", "U", "G", "N"], "article-title": ["Large stakes and big mistakes"], "source": ["Rev. Econ. Stud."], "year": ["2009"], "volume": ["76"], "fpage": ["451"], "lpage": ["469"], "pub-id": ["10.1111/j.1467-937X.2009.00534.x"]}, {"label": ["40."], "surname": ["Elbaek", "Lystb\u00e6k", "Mitkidis"], "given-names": ["CT", "MN", "P"], "article-title": ["On the psychology of bonuses: The effects of loss aversion and yerkes-dodson law on performance in cognitively and mechanically demanding tasks"], "source": ["J. Behav. Exp. Econ."], "year": ["2022"], "volume": ["98"], "fpage": ["101870"], "pub-id": ["10.1016/j.socec.2022.101870"]}, {"label": ["41."], "mixed-citation": ["OECD. Youth and covid-19: Response, recovery and resilience. Tech. Rep. (2020)."]}, {"label": ["42."], "mixed-citation": ["Fetzer, T., Hensel, L., Hermle, J. & Roth, C. Coronavirus perceptions and economic anxiety. "], "italic": ["Rev. Econ. Stat."]}, {"label": ["45."], "mixed-citation": ["Sant\u00e9 publique France. "], "italic": ["Coviprev: une enqu\u00eate pour suivre l\u2019\u00e9volution des comportements et de la sant\u00e9 mentale pendant l\u2019\u00e9pid\u00e9mie"]}, {"label": ["46."], "mixed-citation": ["Wathelet, M. "], "italic": ["et\u00a0al.", "JAMA Network Open"], "bold": ["5"], "ext-link": ["https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2799963/wathelet_2022_oi_221394_1671211075.77605.pdf"]}, {"label": ["48."], "surname": ["Varriale", "van der Molen", "De Pascalis"], "given-names": ["V", "MW", "V"], "article-title": ["Mental rotation and fluid intelligence: A brain potential analysis"], "source": ["Intelligence"], "year": ["2018"], "volume": ["69"], "fpage": ["146"], "lpage": ["157"], "pub-id": ["10.1016/j.intell.2018.05.007"]}, {"label": ["49."], "surname": ["Ree", "Earles", "Teachout"], "given-names": ["MJ", "JA", "MS"], "article-title": ["Predicting job performance: Not much more than g"], "source": ["J. Appl. Psychol."], "year": ["1994"], "volume": ["79"], "fpage": ["518"], "pub-id": ["10.1037/0021-9010.79.4.518"]}, {"label": ["50."], "surname": ["Rohde", "Thompson"], "given-names": ["TE", "LA"], "article-title": ["Predicting academic achievement with cognitive ability"], "source": ["Intelligence"], "year": ["2007"], "volume": ["35"], "fpage": ["83"], "lpage": ["92"], "pub-id": ["10.1016/j.intell.2006.05.004"]}, {"label": ["57."], "surname": ["Wager", "Athey"], "given-names": ["S", "S"], "article-title": ["Estimation and inference of heterogeneous treatment effects using random forests"], "source": ["J. Am. Stat. Assoc."], "year": ["2018"], "volume": ["113"], "fpage": ["1228"], "lpage": ["1242"], "pub-id": ["10.1080/01621459.2017.1319839"]}, {"label": ["59."], "surname": ["Bonner", "Hastie", "Sprinkle", "Young"], "given-names": ["SE", "R", "GB", "SM"], "article-title": ["A review of the effects of financial incentives on performance in laboratory tasks: Implications for management accounting"], "source": ["J. Manag. Account. Res."], "year": ["2000"], "volume": ["12"], "fpage": ["19"], "lpage": ["64"], "pub-id": ["10.2308/jmar.2000.12.1.19"]}, {"label": ["60."], "mixed-citation": ["Betth\u00e4user, B.\u00a0A., Bach-Mortensen, A.\u00a0M. & Engzell, P. A systematic review and meta-analysis of the evidence on learning during the covid-19 pandemic. "], "italic": ["Nat. Human Behav."]}, {"label": ["69."], "mixed-citation": ["Raven, J. "], "italic": ["et\u00a0al.", "Handbook of Nonverbal Assessment"]}, {"label": ["70."], "surname": ["Frederick"], "given-names": ["S"], "article-title": ["Cognitive reflection and decision making"], "source": ["J. Econ. Perspect."], "year": ["2005"], "volume": ["19"], "fpage": ["25"], "lpage": ["42"], "pub-id": ["10.1257/089533005775196732"]}, {"label": ["71."], "surname": ["Gneezy", "Potters"], "given-names": ["U", "J"], "article-title": ["An experiment on risk taking and evaluation periods"], "source": ["Q. J. Econ."], "year": ["1997"], "volume": ["112"], "fpage": ["631"], "lpage": ["645"], "pub-id": ["10.1162/003355397555217"]}, {"label": ["72."], "mixed-citation": ["Kroenke, K. & Spitzer, R.\u00a0L. The phq-9: a new depression diagnostic and severity measure (2002)."]}, {"label": ["74."], "surname": ["Duttweiler"], "given-names": ["PC"], "article-title": ["The internal control index: A newly developed measure of locus of control"], "source": ["Educ. Psychol. Measur."], "year": ["1984"], "volume": ["44"], "fpage": ["209"], "lpage": ["221"], "pub-id": ["10.1177/0013164484442004"]}]
{ "acronym": [], "definition": [] }
74
CC BY
no
2024-01-14 23:40:15
Sci Rep. 2024 Jan 12; 14:1204
oa_package/b2/d3/PMC10786830.tar.gz
PMC10786831
38216556
[ "<title>Introduction</title>", "<p id=\"Par3\">Periodontal disease is the most prevalent oral disease. WHO’s latest reports indicate that around 19% of the global adult population is suffering from its severe form, characterised by irreversible destruction of the periodontium, causing tooth loss<sup>##UREF##0##1##</sup>. The periodontium is a complex structure supporting the tooth, composed of the gingiva (soft tissue) protecting and sealing the cervical part of the tooth within the oral cavity; the periodontal ligament (soft tissue) that anchors the tooth through the cementum (mineralised tissue) to the alveolar bone (mineralised tissue). Regenerating such complex arrangement of mineralised and soft tissues, and their interfaces, is a longstanding challenge for tissue engineering, making the periodontium a good model to benchmark regenerative strategies<sup>##REF##31692298##2##,##REF##33227711##3##</sup>. While periodontal regenerative approaches are becoming available in the clinic and provide some degree of alveolar bone restoration, they have limited effect on the other tissues involved<sup>##UREF##1##4##</sup>.</p>", "<p id=\"Par4\">Silicon-based materials are osteoinductive and play an important role in mineralised tissue regeneration, including for the treatment of periodontitis<sup>##REF##29386798##5##</sup>. Incorporating lithium within silicon-based biomaterials is particularly appealing to strengthen their regenerative capacity. Lithium is a potent GSK3 inhibitor, stimulating Wnt/β-catenin signalling<sup>##REF##15173837##6##,##REF##22732362##7##</sup>. The Wnt/β-catenin pathway is a master regulator of osteogenesis, cell differentiation, and proliferation, providing established regenerative stimuli for mineralised<sup>##REF##28067250##8##</sup> and soft tissues<sup>##UREF##2##9##,##REF##30701455##10##</sup>. Lithium can stimulate bone formation in mice<sup>##REF##16293698##11##</sup> and decrease bone fracture risk in humans<sup>##REF##16007481##12##</sup>. Wnt/β-catenin signalling promotes proliferation and differentiation of human periodontal ligament cells (hPDLCs)<sup>##REF##26369531##13##</sup>, and lithium ions promote their cementogenic differentiation, inducing regeneration of cementum and periodontal ligament fibres<sup>##REF##22732362##7##,##REF##25556853##14##</sup>.</p>", "<p id=\"Par5\">Bioactive glasses have established the crucial role of silicic acid and lithium ions in bone regeneration, encountering widespread clinical success<sup>##REF##22732362##15##</sup>. Aluminosilicate clays containing lithium, such as laponite, can also provide sustained release of lithium and silicon ions and induce osteogenesis<sup>##REF##29331807##16##</sup>. Yet, constraints in material formulation and control over release kinetics limit the contribution that lithium can bring to the regenerative efficacy of these approaches<sup>##UREF##3##17##–##REF##33730142##19##</sup>.</p>", "<p id=\"Par6\">Porous silicon is a compelling alternative to improve ion release kinetics for tissue regeneration. Porous silicon has an established osteogenic potential<sup>##UREF##5##20##</sup>, high biocompatibility<sup>##UREF##6##21##,##REF##24398914##22##</sup>, tuneable particle size<sup>##UREF##7##23##–##REF##29185771##25##</sup> and tailorable bioresorption<sup>##UREF##8##26##</sup>. The dissolution of porous silicon regulates ion release kinetic, which can be tailored from a few hours to days simply by controlling its porous structure during formation<sup>##REF##23911070##27##</sup>. Further surface derivatisation can extend release over several months<sup>##REF##24450851##28##</sup>. Strategies for doping silicon with high precision using several elements across the periodic table are highly established in the semiconductor industry. These strategies are directly applicable to porous silicon<sup>##UREF##9##29##</sup>, highlighting a path to exploit the dissolution of porous silicon for the controlled release of its dopants. In particular, porous silicon can theoretically host up to 52 wt% of lithium (Li<sub>22</sub>Si<sub>5</sub>)<sup>##REF##24038172##30##</sup>, while providing a platform for controlled ion release, through its tailorable dissolution kinetics. Several prelithiation strategies have been developed in lithium battery technology to incorporate large amounts of lithium within the crystal structure of silicon<sup>##REF##32261896##31##–##REF##21711012##33##</sup>. Particularly, the prelithiation of porous silicon nanowires has been extensively investigated, since the porous structure assists maintaining anode integrity through the volumetric expansions and contractions arising from lithium-ion exchange during battery cycling<sup>##UREF##9##29##,##REF##22486769##34##,##REF##28801555##35##</sup>. While pre-lithiation allows incorporating large and controllable amounts of lithium within porous silicon, it typically yields pyrophoric and highly reactive materials<sup>##REF##27313206##36##</sup>. It would be appealing to develop similarly effective lithiation approaches suitable for biological applications.</p>" ]
[ "<title>Methods</title>", "<title>Metal assisted chemical etching (MACE)</title>", "<p id=\"Par24\">Porous silicon nanowires were etched via metal assisted chemical etching (MACE) as described in our previous publications<sup>##UREF##0##1##</sup>. A schematic representation of the MACE process can be found in Fig. ##FIG##0##1a##. Briefly, prime grade 100 mm silicon wafers, with boron doping, 0.01-0.02 Ωcm resistivity, and (100) orientation, were purchased from University Wafers Inc (USA). Wafers were first cleaned from native surface oxide by dipping them into 1:4 mixture of hydrofluoric acid 50% (Honeywell 40213H) and deionised (DI) water (10% HF). Cleaned wafers were rinsed with DI water and isopropanol and dried in N<sub>2</sub> flow. After cleaning, wafers were immersed into solution of 20 mM silver nitrate (AgNO<sub>3</sub>, Sigma-Aldrich 99.9999%) in 10 % HF for 2 min under constant gentle stirring. Wafers were rinsed and dried as before. Etching of porous silicon nanowires was done by immersing silver deposited wafers for 20 min in an etching solution containing 0.6 wt% (or 1.2 wt%) of H<sub>2</sub>O<sub>2</sub> (Honeywell, 95299) in 10% HF. Etched wafers were rinsed and dried as before. As a last step, deposited silver particles were removed by 10 min treatment with standard gold etchant (Aldrich, 651818). Etched wafers were rinsed and dried as before. Prior the use, nanowires were collected by scraping with razor blade.</p>", "<title>Lithiation</title>", "<p id=\"Par25\">Schematic representation of the lithiation process can be found in Fig. ##FIG##0##1b##. Porous silicon nanowire powder was mixed with lithium containing agents: LiCl (Fluorochem, 091451), LiOH*H<sub>2</sub>O (Fluorochem, 009861) or Li<sub>2</sub>CO<sub>3</sub> (Acros Organics, 197785000). Two different mixing processes were used, grinding for LiOH and Li<sub>2</sub>CO<sub>3</sub> or liquid evaporation for LiCl. In the grinding method, a pre-weighted pSi nanowire powder (brown) and solid lithium source (white) were combined in a mortar (Supplementary Fig. ##SUPPL##0##2##). The particle size of the lithium source and agglomerate size of pSi nanowires was reduced by gently grinding with a pestle. Mixing/grinding was done until the powder appeared homogenous in structure and colour. The powder was then poured on top of a silicon wafer, covered with a steel vial, and moved on a hotplate preheated to 450 °C. In the solvent evaporation method, LiCl was dissolved into methanol at 40 mg/ml concentration. pSi nanowire powder and LiCl solution were combined in mortar, mixed briefly with the pestle, and moved to a hotplate preheated to 100 °C. After the methanol had evaporated, the temperature was increased to 150 °C for 10 min to enable evaporation of any remaining solvent or moisture. The solid mixture of pSi and LiCl was moved onto a Si wafer preheated to 150 °C and made into a fine powder. The Si wafer was moved onto a hotplate preheated to 450 °C and covered immediately with a bell jar. If treatment was performed in ambient atmosphere, the top cap was left open, if the treatment was performed in N<sub>2</sub> atmosphere, N<sub>2</sub> flow was directed into bell jar through the top valve.</p>", "<p id=\"Par26\">After lithiation, the excess lithium precursor was washed by dispersing the nanowires into dilute 1 mM HCl (in case of the LiOH precursor 1 M HCl was used), mixed with a sonicator bath, centrifuged for 8 min at 18,000 × <italic>g</italic>, and the supernatant was then discarded. The washing cycle was repeated 4 times with different media (HCl, H<sub>2</sub>O, isopropanol, isopropanol). After the final wash, nanowires were dispersed into isopropanol with a sonicator bath and stored at RT.</p>", "<p id=\"Par27\">The concentration of the LipSi suspension was determined by weighting the solid content. 0.5 ml of LipSi suspension was pipetted into a pre-weighted 1.5 ml microcentrifuge tubes, nanowires were spun down, isopropanol was discarded and the tubes were dried at 60 °C for at least 30 min. The caps were closed and the tubes were allowed to reach the original temperature and moisture level by keeping them at RT for at least 15 min prior weighing again. At least two microcentrifuge tubes were use per one sample and the weighing was performed at least 3 times.</p>", "<title>Reporting summary</title>", "<p id=\"Par28\">Further information on research design is available in the ##SUPPL##2##Nature Portfolio Reporting Summary## linked to this article.</p>" ]
[ "<title>Results</title>", "<title>Porous silicon lithiation</title>", "<p id=\"Par7\">The potential of lithiated porous silicon as a competitive regenerative material for combined lithium and silicon release led us to develop a lithiation approach to generate biocompatible, bioresorbable LipSiNs. The parameters used to optimise the lithiation process are summarised in Supplementary Fig. ##SUPPL##0##1##. This prelithiation strategy uses porous silicon nanowires (pSiNs) generated via metal assisted chemical etching<sup>##REF##21057669##37##</sup> (MACE, Fig. ##FIG##0##1a##) with controllable porosity ranging between 51 % and 63 % (Supplementary Fig. ##SUPPL##0##2##). The pSiNs are mixed with a lithium precursor such as LiOH and LiCl. Mixing can occur in the solid state by grinding pSiNs with the lithium precursor in a mortar, or in the liquid phase by adding pSiNs to aqueous or methanolic lithium solutions (Fig. ##FIG##0##1b##, Supplementary Fig. ##SUPPL##0##3##). Heating this mixture induces lithiation, producing LipSiNs (Fig. ##FIG##1##2a, b##). The lithiation process occurs in the presence of oxygen and/or nitrogen as well as humidity. The exposure of the particles to oxidising and/or nitriding agents yields LipSiNs which are inert when exposed to air and biological fluids. The lithium precursor, the ratio of Li:Si precursors, atmosphere, temperature, and time are key parameters determining the amount of lithium incorporation (Fig. ##FIG##0##1c##, Supplementary Fig. ##SUPPL##0##4##). The Li/Si mass ratio ranges from 1 % for LiOH at 450 °C, up to 40 % for LiCl at 800 °C (Fig. ##FIG##0##1c##), providing a broad range of accessible lithium content.</p>", "<title>Physicochemical characterisation</title>", "<p id=\"Par8\">Lithiation preserves the shape of nanowires (Fig. ##FIG##1##2a, b##) which retain their length and diameter (Supplementary Fig. ##SUPPL##0##6##). LipSiNs remain mesoporous, although with reduced specific surface areas (Fig. ##FIG##1##2c##, Supplementary Figs. ##SUPPL##0##2## and ##SUPPL##0##5##) as expected from the volumetric expansion induced by lithium insertion<sup>##REF##24067244##38##</sup>. Centrifugal field-flow fractionation (CF3) combined with in-line dynamic light scattering (DLS), multiangle light scattering (MALS), and inductively coupled plasma mass spectrometry (ICPMS), abbreviated as CF3-MALS-ICPMS, was used to determine the size distribution and elemental composition of LipSiNs in comparison to the precursor pSiNs. LipSiN containing 5% lithium (LipSiN-5%) and pSiNs show similar nanowire concentrations across all size fractions (ICPMS, Fig. ##FIG##1##2d##) and similar distributions for radius of gyration (MALS) and hydrodynamic radius (DLS) (Fig. ##FIG##1##2e##).</p>", "<p id=\"Par9\">High resolution transmission electron microscopy (HRTEM) of LipSi-5% show the nanowires extending along the &lt;100&gt; direction with an inner core single-crystal structure surrounded by an amorphous shell (Fig. ##FIG##2##3a##). LipSi 1.2% show a similar structure, with a thinner shell. LipSi-4% instead remains crystalline throughout, analogously to pSiNs. The processing temperature of 650 °C, above the melting point of lithium chloride likely improves the doping and annealing process, contributing to the fully crystalline structure of LipSi 4%, unlike the 450 °C temperature, below LiCl melting point, used for LipSi-5% and LipSi-1.2%. Electron energy loss spectroscopy (EELS) of LipSi-5% show the presence of silicon and lithium thorough both the amorphous and crystalline phases. Furthermore, the amorphous shell displays a higher Li/Si ratio with respect to the core (Fig. ##FIG##2##3b##, Supplementary Fig. ##SUPPL##0##7##). The relative intensity of peaks within the fine structure of the silicon absorption edge varies between the shell and the core, suggesting a different coordination across the two regions. The elemental analysis of the size-fractionated nanowire population (CF3-MALS-ICPMS) confirms the simultaneous presence of lithium and silicon throughout all fractions (Fig. ##FIG##1##2d##).</p>", "<p id=\"Par10\">X-ray photoelectron spectroscopy (XPS) analysis of the core level spectra of Si 2p and Li 1s before and after thermal treatment at 450 °C confirms the incorporation of lithium within the silicon nanowires (Supplementary Fig. ##SUPPL##0##8##). The Si 2p spectra show increasing oxidation between the lithium and silicon mixture and the treated LipSiNs, as the peak at ∼103.8 eV assigned to SiO<sub>2</sub> becomes more prominent after heat treatment, especially in air. Suboxides are also present at lower binding energies between the bulk oxide and the Si<sub>0</sub> doublet, which may contain contribution from the lithium silicate structures present in LipSiNs. Similarly, the binding energy of the Li 1s peak is reduced from the initial ∼57.2 eV of LiCl to ∼55.8–56.2 eV, which can be attributed to lithium oxides forming following heat treatment.</p>", "<p id=\"Par11\">Further XPS analysis before and after surface etching by argon clusters show increasing silicon content towards the core and approximately constant lithium content, resulting in higher surface Li/Si mass ratio compared to the core (Fig. ##FIG##3##4a##, Supplementary Fig. ##SUPPL##0##9##). XPS analysis also shows a trend for reduction in the binding energy of the Li 1s peak (Supplementary Fig. ##SUPPL##0##10##) and reduced amounts of oxygen towards the core (Supplementary Fig. ##SUPPL##0##9##). These findings suggest an decrease of oxidised lithium species towards LipSiNs core and confirm that the oxidation and lithiation processes occur from the surface. Across all samples, the XPS and ICPMS measurements agree on the relative lithium and silicon content of the nanowires, (Figs. ##FIG##1##2##e and ##FIG##3##4a##) confirming the broad range of lithium content achievable with porous silicon lithiation. Chlorine is absent from the XPS survey scans, suggesting that the contribution to lithium content from residual LiCl within the mesoporous structure is minimal (Supplementary Fig. ##SUPPL##0##11##). The reduced Li binding energy in LipSi compared to that of the physical mixture of pSi and LiCl further support that the lithium on the surface of LipSiNs preferentially coordinates with the silicon in the nanowire forming lithium silicate structures with varying degrees of oxidation (Supplementary Fig. ##SUPPL##0##8##).</p>", "<p id=\"Par12\">The combined EELS, CF3-MALS-ICPMS and XPS data indicate that across all size ranges individual LipSi nanowires are composed of both lithium and silicon. The crystallinity of the nanowires depends on the details and factors of their lithiation process, with LipSi-5% and LipSi 1.2% displaying an amorphous shell with increased lithium content around a crystalline core containing both lithium and silicon, while LipSi-4% are fully crystalline and more homogenous in lithium content throughout.</p>", "<p id=\"Par13\">Raman microspectroscopy of LipSiNs shows a significant blue shift of the Si peak dependent on lithiation conditions, compared to pSiNs undergoing analogous thermal treatments (Fig. ##FIG##3##4b##, Supplementary Fig. ##SUPPL##0##12##). The peak for LipSi-1.3% shifts to 519 cm<sup>−1</sup> compared to the 515 cm<sup>−1</sup> for oxidation in air at 450 °C for 30 min, the peak for LipSi-5% shifts to 515 cm<sup>−1</sup> compared to 512 cm<sup>−1</sup>, and the peak for LipSi-1.2% shifts to 516 cm<sup>−1</sup> compared to 514 cm<sup>−1</sup>. Non-lithiated, non-thermally treated porous silicon instead shows an expected red shift compared to crystalline silicon (c-Si)<sup>##UREF##11##39##</sup>. The Raman analysis suggests an underlying strain in the crystal structure due to lithium coordination. X-ray diffraction highlights the presence of crystalline lithium silicates, Li<sub>2</sub>SiO<sub>3</sub> and Li<sub>2</sub>Si<sub>2</sub>O<sub>5</sub>, which likely contribute to the passivation of LipSiNs via oxidation, and can impact the solubility of LipSiN (Fig. ##FIG##3##4c##). Several LipSiNs treated at 450 °C also display a broad band between 17° and 27° (LipSi-1.2% and LipSi-1.3%), which is absent in pSiNs treated in comparable conditions, and a broadening of the lithium silicate peaks (LipSi-5%) attributed to the presence of amorphous lithium structures (Supplementary Fig. ##SUPPL##0##13##). This amorphous phase likely includes a contribution from the shell observed by HRTEM and could be a consequence of incomplete annealing due to the lower processing temperatures for these materials (Fig. ##FIG##2##3a##). NMR-MAS of <sup>29</sup>Si confirms the presence of silicon oxides (Q<sup>1</sup>-Q<sup>4</sup> Fig. ##FIG##3##4d##) alongside lithium metasilicate (Li<sub>2</sub>SiO<sub>3</sub>), while <sup>7</sup>Li NMR-MAS confirms the presence of multiple species of dielectric Li within LipSiNs.</p>", "<p id=\"Par14\">Silicon L-edge XANES shows a double peak at 102–104 eV associated with crystalline elemental silicon present in the Si wafer reference and in all lithiated substrates. This peak is absent from the amorphous Li<sub>x</sub>Si<sub>y</sub> and silicate glass references. Features above 104.2 eV are attributable to surface oxides, consistent with a spectral fine structure similar to SiO<sub>2</sub><sup>##REF##30626917##40##</sup> with a shift in the white-line of the lithiated substrates attributable to reduced bond lengths. Lithium L-edge XANES suggests lithiation yields amorphous and crystalline arrangements of Li, Si, and O dependent on degree of lithiation. Experimental spectra are a fit of multiple phases, further supporting the presence of lithium silicate structures (Supplementary Fig. ##SUPPL##0##14##).</p>", "<title>Controlled ion release</title>", "<p id=\"Par15\">When exposed to phosphate buffer, LipSiNs do not exhibit visible reactions and dissolve over time analogously to pSiNs, releasing Li and silicate ions including orthosilicic acid<sup>##REF##29185771##25##</sup> (Fig. ##FIG##4##5##). The modality of lithiation determines the dissolution kinetics of LipSiNs. Overall, lithiation reduces the solubility of LipSiNs with respect to the precursor pSiNs. Lithiated nanowires release 75% of their silicon content (Fig. ##FIG##4##5a,b## T-75%) within 2 to 4 days depending on the lithiation process, while porous silicon nanowires have a T-75% of 3 hours. The lithiation process controls the degree of burst release for LipSiNs (Fig. ##FIG##4##5c##). While LipSi-4% shows minimal burst release, LipSi-1.2% releases 45% lithium immediately, and LipSi-1.3% and LipSi-5% reach 74% burst release. Independently of the degree of initial burst release, the subsequent release can last between a few hours for LipSi-5% for up to 4 days for LipSi-1.2%. Comparing the ion release kinetics for LipSi-5% and LipSi-1.2% against LipSi-4%, highlights that the thickness of the amorphous lithium-rich shell correlates with an increase in burst lithium release. The chemical characterisation indicates the concurrent presence of several lithium species within LipSiNs. These species include crystalline lithium silicates which contribute to the stabilisation of the surface of the nanowires and are expected to slow the release kinetics<sup>##REF##27701809##41##,##REF##32009741##42##</sup>. Alongside the more stable silicate species, LipSiNs contain amorphous lithium which contributes soluble material for rapid release. The processing temperature influences LipSiNs crystallinity and in turn regulates the release profile. Indeed, in the high-temperature LipSi-4% (650 °C) the crystalline phase with low-solubility extends all the way to the surface preventing the initial rapid lithium release and slowing silicate ions release compared to pSi. The Li-rich amorphous shell of the low-temperature LipSi-5% (450 °C) and LipSi-1.2% (450 °C) instead contain species that dissolve rapidly contributing to a burst Li release; once the crystalline core is exposed a sustained release occurs analogous to LipSi-4%. The XRD data and the low processing temperature suggest that LipSi-1.3% (450 °C) also possess an amorphous shell and a crystalline core, contributing to its observed dual-release analogous to LipSi-5% and LipSi-1.2%. When LipSi-1.2% and LipSi-5% are exposed to simulated salivary fluid to mimic the oral environment, LipSiNs retain their tuneable dissolution, displaying a burst early Li release from the amorphous layer, followed by a sustained release from the crystalline structure (Supplementary Fig. ##SUPPL##0##15##). Silicon release rate is slowed with respect to phosphate buffer, due to the reduced hydrolytic process in the lower pH environment<sup>##UREF##8##26##</sup>. Overall, the ion release data indicates that our process can regulate the introduction of lithium within porous silicon to achieve a tuneable, controlled release of lithium and silicon in simulated biological fluids. Since the temporal modulation of the Wnt/β-catenin stimulus is important to determine its regenerative effect, the tunability of lithium release provided by LipSiNs can contribute to optimise the activation profile of Wnt/β-catenin.</p>", "<title>In-vitro bioactivity</title>", "<p id=\"Par16\">Investigating the effect of LipSiNs-conditioned medium (LipSiN-CM) on human periodontal ligament stem cells (hPDLSCs) enables rapid screening in a simple, patient-relevant model, to identify the lithiation conditions with the most promising osteogenic and Wnt/β-catenin activation capacity for periodontal regeneration. Incubating LipSiNs with cell culture medium to prepare LipSiN-CM does not affect the pH of the medium (Supplementary Fig. ##SUPPL##0##16##) in solubility limit conditions (Supplementary Fig. ##SUPPL##0##17##). Lithiation improves the cytocompatibility of the nanowires, since hPDLSCs retain viability after 24 h in LipSiN-CM up to 1.6 mg/ml, while pSiN-CM shows cytotoxic effects starting from around 0.8 mg/ml (Fig. ##FIG##5##6a, b##). The ability of LipSiN-CM to stimulate <italic>AXIN2</italic> gene expression and activate the Wnt/β-catenin pathway depends on LipSi nanowires formulation. LipSi-1.2% shows dose-dependent <italic>AXIN2</italic> activation after 24 h, which matches the stimulus provided by 5 mM LiCl at 1.6 mg/ml (Fig. ##FIG##5##6c##). Conversely, LipSi-5% does not exhibit <italic>AXIN2</italic> activation, similarly to pSiNs. As expected from the osteogenic activity of pSi, both pSiN-CM and LipSiN-CM upregulate key osteogenic markers (OCN, BMP, RUNX2) in hPDLSCs over 14 days, at levels comparable to osteogenic medium (Fig. ##FIG##5##6d##). Interestingly for periodontal regeneration, LipSiN-CM and pSiN-CM also upregulate the cementogenic marker (CAP) over the same timeframe.</p>", "<p id=\"Par17\">LipSiN in direct contact with cells also stimulate Wnt/βcat and osteogenesis (Supplementary Fig. ##SUPPL##0##18##). Incubation with LipSiNs induces toxicity at concentrations above 50 μg/ml, while upregulating <italic>AXIN2</italic> expression and stimulating osteogenesis at concentrations above 10 μg/ml. In this setup, cells are directly exposed to LipSiN dissolving for up to 14 days, indicating that the ion release profile has a stimulatory effect towards the Wnt/βcat pathway and osteogenesis over the desired timeframe. These data indicate that lithiation improves the biocompatibility of pSiNs, while the details of the concentration and release profile of lithium play an important role in determining GSK3 inhibitory activity for LipSiNs in cell models relevant for human periodontal regeneration. Overall, LipSi-1.2%, a slow lithium-releasing formulation (Fig. ##FIG##4##5##), displays the combination of Wnt/β-catenin and osteogenic stimuli desired for in vivo regeneration of periodontal defects.</p>", "<title>Periodontal regeneration</title>", "<p id=\"Par18\">Preliminary testing of LipSiNs in mouse models enabled determining the efficacy of their controlled release for Wnt/β-catenin stimulation in vivo (Fig. ##FIG##6##7##). LipSiNs injected from solution within the periodontal pocket of mice remain in situ for up to 24 h (Fig. ##FIG##6##7a##). The injection and retention of the LipSiNs does not affect the structure or the morphology of the tissue. When injected in the periodontal ligament of an Axin2<sup>LacZ/LacZ</sup> murine reporter, LipSiNs show periodontal <italic>AXIN2</italic> activation within 24 h, demonstrating in vivo Wnt/β-catenin stimulation (Fig. ##FIG##6##7b##).</p>", "<p id=\"Par19\">A rat model of periodontal fenestration defect involving alveolar bone, periodontal ligament, and tooth was used to determine the efficacy of LipSiN treatment for periodontal regeneration (Fig. ##FIG##7##8a##). The animals were treated using nanowires incorporated within a pluronic F-127 hydrogel carrier, necessary to fill the defect void (supplementary information §1.20.1). Based on the efficacy and biocompatibility data gathered from periodontal cells in vitro, LipSi-1.2% at 1.6 mg/ml concentration were selected as the treatment group. The control groups included no treatment (Fig. ##FIG##7##8b##), as well as the use of the hydrogel carrier in combination with: pSiNs at 1.6 mg/ml concentration to evaluate the effect of lithium over silicon, lithium chloride at 25 mM concentration to evaluate the effect of combining lithium with silicon and the effect of sustained lithium release, and a commercial guided tissue regeneration membrane (GTR, BioGide®) used for periodontal regeneration in the clinic as a gold standard. At two weeks post-treatment μCT shows that only LipSiN treatment improves bone mineral density (BMD), by 119% compared to untreated control, while both LipSiN and LiCl improve bone volume over total volume (BV/TV) by 78% and 64%, respectively, over control (Fig. ##FIG##7##8b–d##). Furthermore, at two weeks, LipSiNs improve BMD over GTR by 32%. The six-week analysis analogously shows that LipSiNs increase BMD by 34% over control and 33% over GTR, while BV/TV trends 21% higher than control and 12–18% higher than other groups (Fig. ##FIG##7##8b–d##). The μCT data indicate that LipSiN treatment accelerates bone regeneration in periodontal defects.</p>", "<p id=\"Par20\">Histological analysis of H&amp;E tissue sections collected at two and six weeks following treatment confirms the bone regeneration observed by μCT (Fig. ##FIG##8##9a, b##). Furthermore, histology highlights LipSiN’s effective cementum regeneration, shown by the appearance of new cementum in the vicinity of the regeneration site (Fig. ##FIG##8##9a, b##, black arrowheads at new cementum interface in LipSi-1.2% group). Masson staining indicates that LipSiN induce significant formation of cell-laden, collagen-rich, non-mineralised tissue in the interstitium between the newly formed bone and new cementum, where the periodontal ligament compartmentalizes. The newly formed fibres in the LipSiN group have regular orientation and are embedded within the new cementum and new bone, unlike the untreated group. The presence of both CD31+ vascular endothelial cells and Osterix+ osteoblasts within newly-formed bone only for LipSiNs stimulation, indicates their ability to establish vascularised bone (Fig. ##FIG##9##10a##, Supplementary Fig. ##SUPPL##0##19##). Perivascular α-SMA-expressing progenitors are hypothesised to differentiate into osteoblasts, cementoblasts and fibroblasts during periodontal regeneration<sup>##UREF##12##43##</sup>. The newly formed bone in the LipSiN group includes α-SMA expressing cells, suggesting a possible link to α-SMA+ mediated regeneration. Elemental mapping of histological samples by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) does not evidence additional silicon or lithium within the newly-formed tissue, indicating that released ions stimulate regeneration but are not incorporated within the resulting tissues (Fig. ##FIG##9##10b##). The histological presentation of the liver and kidney of LipSi-treated animals was comparable to the control group, confirming the lack of toxicity to organs beyond the oral cavity (Supplementary Fig. ##SUPPL##0##20##).</p>", "<p id=\"Par21\">We also compared the regenerative capability of LipSiN to that of bioglass where the sodium content was fully substituted with lithium (Li-BG), as a model of lithium and silicate ion release with an established stimulatory capacity<sup>##UREF##13##44##–##REF##29056759##46##</sup> (Supplementary Figs. ##SUPPL##0##21##–##SUPPL##0##23##). MicroCT analysis showed that both Li-BG and LipSiN stimulated the regeneration of the bone defect, with LipSiN outperforming Li-BG for both bone volume and bone mineral density at 2 weeks and 6 weeks (Supplementary Fig. ##SUPPL##0##21##). Histological analysis revealed that LipSi and Li-BG stimulated the regeneration of new cementum and soft tissue (Supplementary Fig. ##SUPPL##0##22##) and immunohistochemistry showed the formation of comparably vascularised tissue for LipSi and Li-BG (Supplementary Fig. ##SUPPL##0##23##). Overall LipSiN demonstrated a comparable effectiveness to Li-BG with a capability for bone regeneration.</p>", "<p id=\"Par22\">These data indicate that LipSiNs stimulate Wnt/β-catenin in vivo and display a regenerative activity towards bone, cementum and periodontal ligament in our model of periodontal defect. This regenerative potential is significantly higher than that of lithium chloride, porous silicon nanowires, lithium-substituted bioglass, and a commercial GTR membrane used for the treatment of periodontitis.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par23\">Overall, lithiated porous silicon has broadly tuneable physicochemical properties, enabling tight control over ion release kinetics, and in turn determining their bioactivity, which can be tailored to provide effective regenerative stimuli. Porous silicon nanowires produced by metal assisted chemical etching are a compelling material for biomedical applications. Conventional silicon nanowire manufacturing processes, such as vapour-liquid-solid growth, require high-temperature processes, highly controlled environments and high purity starting materials, leading to limited scalability and high costs. Metal assisted chemical etching instead is a room-temperature, solution-based process that can use low grade and bio-sourced silicon to yield large quantities of porous silicon at competitive costs<sup>##REF##21057669##37##,##UREF##14##47##,##UREF##15##48##</sup>. Surface passivation through lithium and silicon species provides a surprising combination of non-reactivity, improved biocompatibility and retained degradability. This tailorability and bioactivity of lithiated porous silicon promise to extend the range of application for porous silicon-based materials. This work demonstrated the suitability of lithiated porous silicon for the regeneration for complex structures comprising mineralised and soft tissue, and tissue interfaces. Beyond tissue regeneration, the controlled activation of Wnt/β-catenin provided by the sustained lithium release can find applications in chronic wound healing, and the treatment of neuropsychiatric disorders and neurodegenerative diseases. Moving forward, in order to broaden the use of lithiated porous silicon across biomedical applications that can benefit from sustained lithium release, it is crucial to gain a systematic understanding of the effect that lithiation parameters have on its physicochemical properties, and to further investigate its biocompatibility for a broader range of cells and tissues. Specifically for periodontal regeneration, tailoring LipSiNs formulation towards the broad range of clinical presentations of periodontal defects is essential to bring the technology to the clinic.</p>" ]
[]
[ "<p id=\"Par1\">Periodontal disease is a significant burden for oral health, causing progressive and irreversible damage to the support structure of the tooth. This complex structure, the periodontium, is composed of interconnected soft and mineralised tissues, posing a challenge for regenerative approaches. Materials combining silicon and lithium are widely studied in periodontal regeneration, as they stimulate bone repair via silicic acid release while providing regenerative stimuli through lithium activation of the Wnt/β-catenin pathway. Yet, existing materials for combined lithium and silicon release have limited control over ion release amounts and kinetics. Porous silicon can provide controlled silicic acid release, inducing osteogenesis to support bone regeneration. Prelithiation, a strategy developed for battery technology, can introduce large, controllable amounts of lithium within porous silicon, but yields a highly reactive material, unsuitable for biomedicine. This work debuts a strategy to lithiate porous silicon nanowires (LipSiNs) which generates a biocompatible and bioresorbable material. LipSiNs incorporate lithium to between 1% and 40% of silicon content, releasing lithium and silicic acid in a tailorable fashion from days to weeks. LipSiNs combine osteogenic, cementogenic and Wnt/β-catenin stimuli to regenerate bone, cementum and periodontal ligament fibres in a murine periodontal defect.</p>", "<p id=\"Par2\">Prelithiation can introduce controllable amounts of lithium within porous silicon, however it yields a highly reactive material unsuitable for biomedicine. In this study, the authors present a strategy to lithiate porous silicon nanowires, resulting in a biocompatible and bioresorbable material.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s41467-023-44581-5.</p>", "<title>Acknowledgements</title>", "<p>C.C. acknowledges funding from the European Research Council Starting Grant award ‘ENBION’ (759577), from the Medical Research Council Confidence in Concept award (MC_PC_18052). We acknowledge funds from the EPSRC (EP/R02863X/1) for access to the Leeds EPSRC Nanoscience and Nanotechnology (LENNF) Facility for electron microscopy, and from the King’s College London – Peking University Health Science Center joint initiative for Medical Research. R.Z. acknowledges funding from The National Natural Science Foundation of China(82270945). The X-ray photoelectron (XPS) data collection was performed at the EPSRC National Facility for XPS (“HarwellXPS”), operated by Cardiff University and UCL, under Contract No. PR16195. P.S. acknowledges support from the Czech Science Foundation, project GACR 21-21409S. We acknowledge beamline VLS-PGM at the Canadian Light Source (proposal number 10662) for access to their instruments resulting in data presented within this study. We acknowledge the Materials Research Infrastructure (MARI) at Department of Physics and Astronomy, University of Turku for access and support with the SEM, XPS and XRD facilities.</p>", "<title>Author contributions</title>", "<p>Author contributions based on CRediT taxonomy. M.K.: Conceptualisation, methodology, investigation, formal analysis, Writing – original draft, Visualisation, funding acquisition. R.Z.: methodology, formal analysis, Writing – Review &amp; editing, Visualisation, funding acquisition. P.V.: methodology, investigation, formal analysis, Writing-review and editing. A.A.B.: investigation, formal analysis, writing – Review &amp; editing. Ma.S’A.: investigation, formal analysis, writing – Review &amp; editing. D.M.: investigation, formal analysis. M.I.: methodology, investigation, formal analysis, visualisation, writing – Review &amp; editing, funding acquisition. E.M.: investigation, formal analysis. C.W.: investigation. E.M.: methodology, investigation, formal analysis. P.C.: resources, writing – review &amp; editing. A.P.: investigation, formal analysis. V.C.: investigation. X.Z.: investigation. S.A.M.: investigation. A.P.M.: methodology, investigation, formal analysis. E.G.: resources, review and editing. D.S.B.: resources, review and editing. O.A.: methodology, formal analysis, review &amp; editing. X.Z.: methodology, investigation. A.A.: resources, writing – review &amp; editing. M.B.: methodology, resources, formal analysis, writing – review &amp; editing. K.A.-J.: resources, writing – review &amp; editing. J.S.: resources, formal analysis, writing – review &amp; editing. N.H.: resources, formal analysis, writing – review &amp; editing, funding acquisition. P.S.: conceptualisation, methodology, resources, funding acquisition, writing – review &amp; editing. C.C.: conceptualisation, methodology, formal analysis, resources, Writing – original draft, supervision, project administration, funding acquisition.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par29\"><italic>Nature Communications</italic> thanks Hélder A. Santos, Nicolas Voelcker and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.</p>", "<title>Data availability</title>", "<p>All data presented in the manuscript is available from the authors upon request.</p>", "<title>Competing interests</title>", "<p id=\"Par30\">M.K., P.S. and C.C. declare a financial competing interest as inventors of patent application EP4192788A1 currently at PCT stage and assigned to King’s College London. The patent application covers the method to obtain lithiated porous silicon nanomaterials presented in this manuscript. No other authors have competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Lithiation of porous silicon nanowires.</title><p><bold>a</bold> Schematic of the metal assisted electrochemical etching (MACE) process used to generate porous silicon nanowires. (1) A dense network of silver dendrites is deposited by electroless deposition over the surface of a silicon wafer. (2) MACE generates vertically-aligned porous silicon nanowires by etching the silicon substrate in an aqueous solution of hydrofluoric acid and hydrogen peroxide. The resulting porosity depends on the composition of the solution and the resistivity of the silicon wafer. (3) The silver nanoparticles are dissolved and the nanowires collected by mechanical scraping of the silicon wafer. The 45° tilted scanning electron micrograph shows pSiNs being detached from the wafer. <bold>b</bold> Schematic of the lithiation process for porous silicon nanowires. (1) The nanowires are mixed with a lithium precursor either (1a) in a mortar or (1b) in a solution which is then evaporated. (2) The mixed precursors are heated to the desired temperature in a controlled atmosphere which includes the presence of oxygen. (3) Once cooled, the nanowires are washed four times to remove unreacted lithium precursor. The resulting lithiated porous silicon nanowires are ready for use. <bold>c</bold> Quantification of Li/Si ratio of LipSiNs by ICPMS of fully dissolved nanowires as a function lithium precursor, lithiation temperature, time and atmosphere. <bold>a</bold>, <bold>b</bold> Created with biorender.com.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>Physicochemical characterisation of lithiated porous silicon nanowires.</title><p><bold>a</bold> Overview scanning electron micrographs show comparable size distribution of the prepared LipSiNs and precursor pSiNs. Analysis was performed on at least three independent samples for each group. <bold>b</bold> Scanning electron micrographs of LipSiNs and pSiNs showing the morphology and mesoporous structure of the nanowires. Analysis was performed on at least three independent samples for each group. <bold>c</bold> Specific surface area of LipSiNs from Brunauer–Emmett–Teller (BET) analysis. <bold>d</bold> Lithium and silicon content of LipSiNs (top) and pSiNs measured in-flow by ICPMS following CF3 separation. Lithium trace in teal blue, silicon trace in red. <bold>e</bold> Radius of gyration, hydrodynamic radius and concentration of LipSiNs and pSiNs measured respectively with in-flow MALS, DLS and UV detectors following CF3 separation.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Influence of lithiation on nanowire ultrastructure.</title><p><bold>a</bold> High resolution transmission electron microscopy of pSiNs and LipSi-4% reveals the crystalline structure of the nanowires extending along the &lt;100&gt; direction, verified with selected area electron diffraction (SAED). LipSi-5% and LipSi-1.2% display a core-shell structure, the FFT pattern of LipSi-5% verifies the single-crystal structure of the core and amorphous phase of the shell. Analysis was performed on five independent nanowires per group. <bold>b</bold> Electron energy-loss spectroscopy spectrum images of Li and Si distribution within pSiNs and LipSi-5% reflecting relative intensity of the Li-K and Si-L<sub>2.3</sub> edge, respectively. Representative EELS spectra are extracted from the boxed regions. Line profile of Li and Si content alongside relative thickness as quantified from EELS spectra for pSiNs and LipSiNs. The shell to core transition is indicated with a dotted line on the LipSiN graph. Analysis was performed on two independent nanowires per group.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>Influence of lithiation on chemical composition of nanowires.</title><p><bold>a</bold> Quantification of Li/Si content from x-ray photoelectron spectroscopy analysis of the elemental composition of pSiNs and LipSiNs before and after surface sputtering by argon cluster beam. <bold>b</bold> Blue shift in Si Raman peak position for pSiNs and LipSiNs, upon lithiation with respect to comparable thermal treatments for pSiNs. LipSi-1.3% compared to air 0.5 h, LipSi-1.2% compared to N<sub>2</sub> 5-6 h and LipSi-5% compared to air 5-6 h. Data are presented as mean values ± S.D. Statistical significance was tested with one-way ANOVA followed by Bonferroni’s multiple comparison test. Data was collected from crystalline silicon (c-Si) <italic>n</italic> = 7, pSi <italic>n</italic> = 8, Ox 0.5 h <italic>n</italic> = 8, Ox 6.7 h <italic>n</italic> = 9, OxN2 5.5 h <italic>n</italic> = 11, LipSi 1.2% <italic>n</italic> = 8, LipSi 1.3% <italic>n</italic> = 10, LipSi 4% <italic>n</italic> = 10, LipSi 5% <italic>n</italic> = 10, LipSi 40% <italic>n</italic> = 10 independent measurements. <bold>c</bold> X-ray diffractograms for pSiNs and LipSiNs showing peaks associated with crystalline Si, lithium silicates and amorphous phases within LipSiNs. <bold>d</bold>\n<sup>7</sup>Li and <sup>29</sup>Si NMR-MAS spectra of LipSi-1.2% alongside <sup>7</sup>Li spectra from LiOH and LiCl.</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><title>Lithiation modulates ion release.</title><p><bold>a</bold> Si release profile quantified by longitudinal inductively copuple plasma mass spectrometry (ICP-MS) from nanowires dissolving in phosphate buffer solution; <bold>b</bold> estimated time to achieve 75% of total ion release as calculated from profiles (<bold>a</bold>, <bold>c</bold>); <bold>c</bold> Li release profiles for LipSiNs quantified by longitudinal ICPMS from nanowires dissolving in phosphate buffer solution. <bold>a</bold>, <bold>c</bold> Data are presented as mean values ± S.D. Data was collected from <italic>n</italic> = 3 independent measurements.</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><title>Lithiated porous silicon nanowires are biocompatible and bioactive.</title><p><bold>a</bold> Metabolic activity for hPDLCs cultured using pSiNs and LipSiNs conditioned medium as determined by ATP activity assay. Med group represents control medium which was thermally treated without nanowires, Neg group represents cells treated with Triton X-100. Data are presented as mean values ± S.D. Statistical significance was tested with one-way ANOVA followed by Dunnett’s multiple comparisons post-hoc test. <italic>n</italic> = 3 biologically independent samples were examined in all cases except: <italic>n</italic> = 4 in LipSi-1.2% (0.2 mg/ml), LipSi-5% (0.8 mg/ml) and Med; <italic>n</italic> = 5 in pSi (0.4 mg/ml and 0.8 mg/ml); <italic>n</italic> = 6 in LipSi-1.2% (0.8 mg/ml). <italic>p</italic>-values are reported with respect to control medium. <bold>b</bold> Bright field images of hPDLCs cultured in conditioned media for 24 h. <bold>c</bold> Relative expression of <italic>AXIN2</italic> as quantified by qPCR for hPDLSCs cultured in media conditioned with different types of LipSiNs. Medium with the addition of 5 mM LiCl serves as positive control for <italic>AXIN2</italic> expression while non-conditioned medium is used as reference. Data are presented as mean values ± S.D. Statistical significance was tested with one-way ANOVA followed by Tukey’s multiple comparison post-hoc test. <italic>N</italic> = 3 independent biological samples. <bold>d</bold> qPCR analysis of relative expression of osteogenic (<italic>BMP2</italic>, <italic>RUNX2</italic>, <italic>OCN</italic>) and cementogenic (<italic>CAP</italic>) genes for hPDLSCs cultured in media conditioned with pSiN or LipSiN-1.2%. Basal medium serves as reference for non-stimulated cells, while osteogenic medium serves as positive control. Data are presented as mean values ± S.D. Statistical significance was tested with one-way ANOVA followed by followed by Tukey’s multiple comparison post-hoc test. <italic>N</italic> = 3 independent biological samples. <italic>p</italic>-values are reported with respect to basal medium gene expression for the same timepoint.</p></caption></fig>", "<fig id=\"Fig7\"><label>Fig. 7</label><caption><title>LipSiNs stimulate Wnt/β-catenin signalling in vivo.</title><p><bold>a</bold> Immunofluorescence analysis of histological slides of the mandible of a mouse 24 h post-injection of LipSi−1.2% in the periodontal space. LipSi−1.2% labelled with Alexa Fluor 568 in orange, DAPI in blue. Analysis was performed on 4 animals. <bold>b</bold> Immunohistochemical analysis of Axin2 expression in histological slides of the mandible of an <italic>Axin2</italic><sup><italic>LacZ/LacZ</italic></sup> mouse 24 h following post-treatment with LipSi−1.2% compared to untreated control. The punctate blue signal (shown by black arrows) indicates Axin2-expressing cells. Analysis was performed on 4 animals.</p></caption></fig>", "<fig id=\"Fig8\"><label>Fig. 8</label><caption><title>LipSiNs promote bone regeneration in periodontal defects.</title><p><bold>a</bold> The model of periodontal fenestration defect (standardised with 3 mm in length, 3 mm in height and &lt;1 mm in deep) used in this study. <bold>b</bold> μCT scans of rat mandibles at day 0. Scale bar 3 mm. Analysis was performed on 5 animals. <bold>c</bold> μCT scans of rat mandibles showing regeneration of periodontal defects 2-weeks and 6-weeks post-operative with lithium chloride, BioGide® GTR membrane, pSi, and LipSi−1.2%; serves as baseline comparison. The dotted yellow line outlines the newly formed bone. Scale bar 3 mm. Analysis was performed on 5 animals per group. <bold>d</bold> μCT analysis for the quantification of BV/TV and BMD. Data are presented as mean values ± S.D. Statistical significance was tested by Kruskal–Wallis non-parametric multivariate analysis followed by Dunn’s multiple comparison post-hoc test. <italic>N</italic> = 5 independent biological samples.</p></caption></fig>", "<fig id=\"Fig9\"><label>Fig. 9</label><caption><title>LipSiNs stimulates regeneration of mineralised and soft tissue in the periodontium.</title><p><bold>a</bold> Histological analysis of alveolar bone, cementum and periodontal ligament regeneration at 2 weeks and (<bold>b</bold>) 6-week post-operative. Three left panels H&amp;E staining, rightmost panel Masson’s Trichrome staining. Leftside panel shows an overview of the periodontal defect and its regeneration. Within the leftside panel yellow dotted line indicates newly formed bone; black dotted line box locates the magnification panel used to visualise bone regeneration; black solid line box locates the magnification panel used to visualise cementum regeneration. Rightmost panel indicates periodontal ligament regeneration and its integration with bone and cementum. NB new bone, NC new cementum, NPDL new periodontal ligament. Black arrow heads indicate the interface of the newly formed cementum on the root dentin. Scale bars 200 µm. <bold>a</bold>, <bold>b</bold> Analysis was performed on 5 animals per group.</p></caption></fig>", "<fig id=\"Fig10\"><label>Fig. 10</label><caption><title>Molecular and chemical characterisation of LipSiN-regenerated periodontium.</title><p><bold>a</bold> Co-immunofluorescence staining of histological slides with Osterix (green), α-SMA (white) and CD31 (red) in the area of the regenerated periodontium. Scale bars 50 µm. Analysis was performed on 5 animals per group. <bold>b</bold> Elemental mapping of histology slides with LA-ICP-MS, TIC represents the total ion count for all elements imaged including <sup>7</sup>Li, <sup>29</sup>Si, <sup>31</sup>P, <sup>55</sup>Mn, <sup>57</sup>Fe and <sup>88</sup>Sr. The figure axis indicate distance in mm.</p></caption></fig>" ]
[]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Martti Kaasalainen, Ran Zhang</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41467_2023_44581_Fig1_HTML\" id=\"d32e730\"/>", "<graphic xlink:href=\"41467_2023_44581_Fig2_HTML\" id=\"d32e754\"/>", "<graphic xlink:href=\"41467_2023_44581_Fig3_HTML\" id=\"d32e814\"/>", "<graphic xlink:href=\"41467_2023_44581_Fig4_HTML\" id=\"d32e910\"/>", "<graphic xlink:href=\"41467_2023_44581_Fig5_HTML\" id=\"d32e1053\"/>", "<graphic xlink:href=\"41467_2023_44581_Fig6_HTML\" id=\"d32e1146\"/>", "<graphic xlink:href=\"41467_2023_44581_Fig7_HTML\" id=\"d32e1196\"/>", "<graphic xlink:href=\"41467_2023_44581_Fig8_HTML\" id=\"d32e1233\"/>", "<graphic xlink:href=\"41467_2023_44581_Fig9_HTML\" id=\"d32e1278\"/>", "<graphic xlink:href=\"41467_2023_44581_Fig10_HTML\" id=\"d32e1305\"/>" ]
[ "<media xlink:href=\"41467_2023_44581_MOESM1_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>", "<media xlink:href=\"41467_2023_44581_MOESM2_ESM.pdf\"><caption><p>Peer Review File</p></caption></media>", "<media xlink:href=\"41467_2023_44581_MOESM3_ESM.pdf\"><caption><p>Reporting Summary</p></caption></media>" ]
[{"label": ["1."], "mixed-citation": ["Lindhe, J., Lang, N. P., Karring, T. "], "italic": ["Clinical periodontology and implant dentistry"]}, {"label": ["4."], "surname": ["Nibali"], "given-names": ["L"], "article-title": ["Periodontal infrabony defects: systematic review of healing by defect morphology following regenerative surgery"], "source": ["J. Clin. Periodontol."], "year": ["2021"], "volume": ["48"], "fpage": ["101"], "lpage": ["114"], "pub-id": ["10.1111/jcpe.13381"]}, {"label": ["9."], "surname": ["Uhl"], "given-names": ["FE"], "article-title": ["Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures"], "source": ["Eur. Respiratory J."], "year": ["2015"], "volume": ["46"], "fpage": ["1150"], "lpage": ["1166"], "pub-id": ["10.1183/09031936.00183214"]}, {"label": ["17."], "surname": ["Liu"], "given-names": ["Z"], "article-title": ["Close-loop dynamic nanohybrids on collagen-ark with: In situ gelling transformation capability for biomimetic stage-specific diabetic wound healing"], "source": ["Mater. Horiz."], "year": ["2019"], "volume": ["6"], "fpage": ["385"], "lpage": ["393"], "pub-id": ["10.1039/C8MH01145A"]}, {"label": ["18."], "surname": ["Miguez-Pacheco"], "given-names": ["V"], "article-title": ["Development and characterization of lithium-releasing silicate bioactive glasses and their scaffolds for bone repair"], "source": ["J. Non Cryst. Solids"], "year": ["2016"], "volume": ["432"], "fpage": ["65"], "lpage": ["72"], "pub-id": ["10.1016/j.jnoncrysol.2015.03.027"]}, {"label": ["20."], "surname": ["Wang"], "given-names": ["PY"], "article-title": ["Screening mesenchymal stem cell attachment and differentiation on porous silicon gradients"], "source": ["Adv. Funct. Mater."], "year": ["2012"], "volume": ["22"], "fpage": ["3414"], "lpage": ["3423"], "pub-id": ["10.1002/adfm.201200447"]}, {"label": ["21."], "surname": ["Canham"], "given-names": ["LT"], "article-title": ["Bioactive silicon structure fabrication through nanoetching techniques"], "source": ["Adv. Mater."], "year": ["1995"], "volume": ["7"], "fpage": ["1033"], "lpage": ["1037"], "pub-id": ["10.1002/adma.19950071215"]}, {"label": ["23."], "mixed-citation": ["Kaasalainen et al. Size, stability, and porosity of mesoporous nanoparticles characterized with light scattering. "], "italic": ["Nanoscale Res. Lett"], "bold": ["12"]}, {"label": ["26."], "surname": ["Anderson", "Elliott", "Wallis", "Canham", "Powell"], "given-names": ["SHC", "H", "DJ", "LT", "JJ"], "article-title": ["Dissolution of different forms of partially porous silicon wafers under simulated physiological conditions"], "source": ["Phys. Status Solidi A."], "year": ["2003"], "volume": ["197"], "fpage": ["331"], "lpage": ["335"], "pub-id": ["10.1002/pssa.200306519"]}, {"label": ["29."], "surname": ["McSweeney", "Geaney", "O\u2019Dwyer"], "given-names": ["W", "H", "C"], "article-title": ["Metal-assisted chemical etching of silicon and the behavior of nanoscale silicon materials as Li-ion battery anodes"], "source": ["Nano Res."], "year": ["2015"], "volume": ["8"], "fpage": ["1395"], "lpage": ["1442"], "pub-id": ["10.1007/s12274-014-0659-9"]}, {"label": ["32."], "surname": ["Holtstiege", "B\u00e4rmann", "N\u00f6lle", "Winter", "Placke"], "given-names": ["F", "P", "R", "M", "T"], "article-title": ["Pre-lithiation strategies for rechargeable energy storage technologies: concepts, promises and challenges"], "source": ["Batteries"], "year": ["2018"], "volume": ["4"], "fpage": ["4"], "pub-id": ["10.3390/batteries4010004"]}, {"label": ["39."], "surname": ["Kadle\u010d\u00edkov\u00e1"], "given-names": ["M"], "article-title": ["Raman spectroscopy of porous silicon substrates"], "source": ["Opttik"], "year": ["2018"], "volume": ["174"], "fpage": ["347"], "lpage": ["353"], "pub-id": ["10.1016/j.ijleo.2018.08.084"]}, {"label": ["43."], "mixed-citation": ["Roguljic, H. et al. In vivo identification of periodontal progenitor cells. Published online 10.1177/002203451349343 (2013)."]}, {"label": ["44."], "surname": ["Tylkowski", "Brauer"], "given-names": ["M", "DS"], "article-title": ["Mixed alkali effects in Bioglass\u00ae 45S5"], "source": ["J. Non Cryst. Solids"], "year": ["2013"], "volume": ["376"], "fpage": ["175"], "lpage": ["181"], "pub-id": ["10.1016/j.jnoncrysol.2013.05.039"]}, {"label": ["47."], "surname": ["Loni"], "given-names": ["A"], "article-title": ["Extremely high surface area metallurgical-grade porous silicon powder prepared by metal-assisted etching"], "source": ["Electrochem. Solid-State Lett."], "year": ["2011"], "volume": ["14"], "fpage": ["K25"], "lpage": ["K27"], "pub-id": ["10.1149/1.3548513"]}, {"label": ["48."], "surname": ["Batchelor", "Loni", "Canham", "Hasan", "Coffer"], "given-names": ["L", "A", "LT", "M", "JL"], "article-title": ["Manufacture of mesoporous silicon from living plants and agricultural waste: an environmentally friendly and scalable process"], "source": ["Silicon"], "year": ["2012"], "volume": ["4"], "fpage": ["259"], "lpage": ["266"], "pub-id": ["10.1007/s12633-012-9129-8"]}]
{ "acronym": [], "definition": [] }
48
CC BY
no
2024-01-14 23:40:15
Nat Commun. 2024 Jan 12; 15:487
oa_package/5e/be/PMC10786831.tar.gz
PMC10786832
38216626
[]
[]
[]
[]
[]
[ "<title>Subject terms</title>" ]
[ "<p id=\"Par1\">Correction to: <italic>npj Digital Medicine</italic> 10.1038/s41746-023-00956-y, published online 25 November 2023</p>", "<p id=\"Par2\">In this article Ashkan Dehghani Zahedani and Tracey McLaughlin should have been denoted as equally contributing authors. The author order was also incorrect as Tracey McLaughlin should have appeared after Ashkan Dehghani Zahedani but before Arvind Veluvali in the list of authors. Additionally, Tracey McLaughlin should have been listed as co-corresponding the author. The original article has been corrected.</p>" ]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
{ "acronym": [], "definition": [] }
0
CC BY
no
2024-01-14 23:40:15
NPJ Digit Med. 2024 Jan 12; 7:9
oa_package/db/91/PMC10786832.tar.gz
PMC10786833
38216745
[ "<title>Introduction</title>", "<p id=\"Par3\">To mitigate against unpredictable climate and food shortages humans moved from hunter gathering to an agrarian existence<sup>##REF##12167878##1##</sup>. In consequence, animals, plants and unwittingly, some microorganisms were domesticated<sup>##REF##31112692##2##</sup> including the ethanol-forming and CO<sub>2</sub>-generating yeast <italic>S. cerevisiae</italic>. The latter event occurred in multiple geographical locations resulting in the almost universal exploitation of the abilities of <italic>Saccharomyces</italic> yeasts to leaven bread and produce a multitude of alcoholic beverages<sup>##REF##29643504##3##,##REF##27610566##4##</sup>.</p>", "<p id=\"Par4\">Largely based on its ease of cultivation and <italic>GRAS</italic> designation <italic>S. cerevisiae</italic> has become the model for eukaryotic cell biology<sup>##REF##22084421##5##,##REF##8805271##6##</sup>. Principal component analysis of single nucleotide polymorphisms (SNPs) have established a Chinese origin<sup>##REF##29643504##3##</sup> of <italic>S. cerevisiae</italic> with the <italic>Saccharomyces</italic> genus believed to be of Asian origin<sup>##REF##36755033##7##</sup>. Publications using industrial strains have provided further understanding of the phylogenetic origins of <italic>S. cerevisiae</italic> used in wine and beer production<sup>##REF##27610566##4##,##REF##27720622##8##</sup>. Recent publications have established the effects of European and Asian wine admixture on today’s industrial brewing yeast<sup>##REF##30835725##9##</sup> with those yeast more readily associated with commercial brewing activities dominated by Asian admixture<sup>##REF##35180385##10##</sup>. Admixture within domesticated <italic>S. cerevisiae</italic> is incongruous with other <italic>Saccharomyces</italic> yeast, where admixture and heterozygosity levels are low<sup>##REF##36755033##7##</sup>. Many of these industrial <italic>S. cerevisiae</italic> strains have genomes which feature polyploidy, aneuploidy and loss of fitness, all characteristic of domestication<sup>##REF##29643504##3##</sup>. These domesticated yeasts carry mutations conferring properties that make them suitable for beer fermentations. These include the formation of a spectrum of beer flavour yeast metabolites, the ability to utilise sugars such as maltotriose and maltose; ethanol tolerance and an ability to separate from beer at the end of fermentation via the process of flocculation<sup>##REF##27720622##8##</sup>.</p>", "<p id=\"Par5\">Historically, distinct beer styles were associated with specific geographical regions based on the availability of raw materials and the mineral composition of the water supply<sup>##UREF##0##11##</sup>. In addition, specific yeast strains were selected to enhance and meet the desired beer style qualities. Initially this was unwitting since the role of yeast was only proven in the early 19th century independently in France by Cagniard-Latour and Germany by Schwann and Kutzing<sup>##UREF##0##11##</sup>. Nevertheless, brewers had actively been selecting yeast for their phenotypes in Europe from at least the 1600s<sup>##REF##27610566##4##</sup>. This led to selection of specific industrial brewing yeast strains from geographical locations containing specific SNPs. Confirmation of geographical specific SNPs have been observed in yeasts isolated from beers brewed in Germany, Belgium, Britain, the USA and Norway<sup>##REF##27610566##4##,##REF##30258422##12##</sup>.</p>", "<p id=\"Par6\">Founded in 1759 by Arthur Guinness, the St James’s Gate Dublin brewery was by 1886 the world’s largest by volume<sup>##UREF##1##13##</sup> (1.8 MHl per annum) becoming synonymous with stout beer brewed in the Irish dry stout style. The brewery archives provide comprehensive details of the yeast studies performed by scientists employed by Guinness; however, no information is held regarding the origins of the yeast first used to brew beer at St James’s Gate. The first mention of a starting culture (yeast) is detailed in the 1809 Guinness Brewing Book on the 10th and 11th of May. At the time of writing, the two principal Guinness stouts; Guinness Irish Draught Stout (IDS) and Guinness Foreign Extra Stout (FES) are brewed using yeast isolated from the 1959 Guinness pitching yeast. The Guinness archives confirm that the 1959 isolates were selected from the 1903 Watling Laboratory Guinness yeast.</p>", "<p id=\"Par7\">In this study, 13 Guinness yeast strains, the two current production yeasts and six other historical Guinness strains were assessed to establish the origins and nature of the Guinness yeast. Our analyses have established that the Guinness yeast form a subgrouping within the previously described Beer 1 clade<sup>##REF##27610566##4##</sup>. Furthermore, the Guinness strains are mosaic sharing ancestral lineage that is different to other historical Irish brewing yeast. Genomic assessment of the Guinness yeasts confirmed that the Guinness yeast are genetically similar with different phenotypes, demonstrating the importance of phenotypic validation of yeast for brewing. The assessment of the Guinness yeast chromosome and copy number variation (CNVs) supports previous conclusions regarding the role of gene copy number and phenotype. Consequently, the principal findings of this paper are that the Guinness yeast strains are intimately related and are derived from a common ancestor.</p>" ]
[ "<title>Methods</title>", "<title>Yeast strain selection and maintenance</title>", "<p id=\"Par50\">A total of 19 Irish brewing yeast strains including 13 from the Guinness collection were selected for assessment (Table ##TAB##0##1##). The Guinness strains included two current production strains and 11 other historical strains selected as they were the principal brewing strains used to produce Guinness at that time. Cultures were stored in cryo vials (Fisher) in liquid nitrogen at −196 °C using 50% glycerol (Sigma–Aldrich) as a cryo-preservative. Cultures were recovered and inoculated into 25 ml tubes containing 10 ml of YPD (10 g l<sup>−1</sup> yeast extract, 20 g l<sup>−1</sup> peptone, 20 g l<sup>−1</sup> glucose) (Oxoid) and incubated at 25 °C in an orbital shaker (Stuart Scientific) at 120 rpm for 24 h. Serial dilutions of 100 µl of cultures were spread plated onto Wallerstein Nutrient Agar (Oxoid) and incubated at 25 °C for 12 days in accordance with the EBC Yeast Giant Colony method 3.2.1.1<sup>##UREF##31##78##</sup>. At the end of the incubation, single yeast colonies were selected.</p>", "<title>DNA extraction and interdelta yeast typing</title>", "<p id=\"Par51\">Three giant colonies of each culture were selected and transferred to microfuge tubes containing 700 µl of molecular grade water (Fisher). Yeast cells were recovered by centrifugation and DNA was extracted in accordance with the manufacture’s guidelines using a PureLink Microbiome DNA Purification Kit (Invitrogen). Individual strains were identified using the interdelta (ITS) Polymerase chain reaction PCR method<sup>##REF##12725935##14##,##UREF##32##79##</sup>; primers δ2 (5′-GTGGATTTTTATTCCAAC-3′) and δ12 (5′-TCAACAATGGAATCCCAAC-3′), using a BioRad T100 Thermocycler and Invitrogen’s Platinum Hot start PCR Master Mix. PCR products were analysed on an Agilent 2100 Bioanalyzer using the Agilent DNA 7500 chip. The resulting bands were analysed using Minitab 19 Statistical software (2019) hierarchical clustering function with dendrograms produced using Euclidean distance function.</p>", "<title>Illumina whole-genome sequencing and de novo assembly</title>", "<p id=\"Par52\">The ITS results were used to select strains for whole-genome sequencing with typical ITS banding used as the selection criterion for the historical Guinness and Irish brewing yeast. In the case of the FES and IDS production yeast all yeasts that were determined to be unique were selected. In total, 16 Guinness strains and 6 other historical Irish brewing yeast were subjected to whole-genome sequencing performed by Elda Biotech (Kildare, Ireland). Yeast samples were sub-cultured onto Wallerstein Nutrient Agar (Oxoid) and single colonies were picked for DNA extraction using the Thermo Scientific Yeast DNA extraction kit (Thermo Scientific). Extracted DNA was analysed using a Qubit (Thermo Fisher Scientific) to determine dsDNA content. Aliquots of 1 ng of DNA was used as input for library preparation using the Illumina Nextera XT DNA library prep protocol with no deviations. Stock libraries of 1–4 nM were generated and samples were pooled for sequencing and denatured according to the manufacturer’s instructions for loading on the Illumina MiSeq(12 pM) sequencer. Samples were sequenced using the Illumina MiSeq machine reading with a minimum depth of 30× coverage using 2 × 250 bp paired reads. All samples were quality checked for low-quality sequence bases and the presence of adaptor contamination using Trimgalore (Version 0.6.1). All identified adaptors were cleaved from both the forward and reverse sequencing reads and those with runs of low-quality bases were trimmed using a Phred scale cutoff of 10. All samples were aligned to the reference genome <italic>S. cerevisiae</italic> S288C (<ext-link ext-link-type=\"uri\" xlink:href=\"http://downloads.yeastgenome.org/sequence/S288C_reference/genome_releases/S288C_reference_genome_R64-1-1_20110203.tgz\">http://downloads.yeastgenome.org/sequence/S288C_reference/genome_releases/S288C_reference_genome_R64-1-1_20110203.tgz</ext-link>) using BWA (Version 0.7.17)<sup>##REF##19451168##80##</sup>. Alignments were sorted and duplicate reads were identified and marked for exclusion from downstream analysis using Samtools (Version 1.10)<sup>##REF##33590861##81##</sup>. Alignment metrics for each sample were collated using Qualimap (Version 2.2.1)<sup>##REF##26428292##82##</sup>. All samples were de novo assembled using Spades (Version 3.14). For each sample all contigs shorter than 500 base pairs in length were discarded. A reference guided scaffold of each assembled sample genome against the <italic>Saccharomyces cerevisiae</italic> S288C genome sequence was generated using Ragtag (v. 1.0.2)<sup>##REF##30606230##83##</sup> Artificial padding of “N” characters was placed between the reference scaffolded contigs. All bioinformatic software used in this study is specified in Supplementary Table ##SUPPL##1##1##.</p>", "<title>Nanopore MINION sequencing</title>", "<p id=\"Par53\">Two nanopore Minion runs of Irish Draught Stout yeast number 1 (IDS1) were carried out by ELDA Biotech (Kildare, Ireland). DNA from an IDS1 colony grown on Wallerstein Nutrient Agar (Oxoid) was extract using the Thermo Scientific Yeast DNA extraction kit (Thermo Scientific). Extracted DNA was processed using the 1D Genomic DNA by ligation (SQK-LSK108) protocol from Oxford Nanopore Technologies. DNA was fragmented using a Covaris g-TUBE (Covaris) with DNA repair performed using End Prep (New England Biolabs). Library clean up and adaptor ligation were performed with AMPure XP beads (Beckman Coulter), and extracted DNA measured using a Qubit (Thermo Fisher Scientific). 3.6fmol of DNA library was loaded onto the flongle for sequencing (Oxford Nanopore Technologies). Sequencing was conducted according to the Nanopore Minion manufacturer’s instructions (Oxford Nanopore Technologies). All Minion run Fast5 files were converted to FASTQ format using Guppy (3.6). NanoFilt was used to remove low-quality reads (Q10) and reads shorter than 1000 bases, with Porechop v6<sup>##REF##33347571##84##</sup> used to find and remove adaptors located at the start, end or internal reads. Contaminant (non-fungal) reads were identified using both Kraken2 and BLAST searches against the NCBI non-redundant database. Identified contaminant reads were removed using Seqtk (v1.3). The first Nanopore Minion run resulted in 421,040 usable reads and 64,105 in the second. Reads from both runs were combined for a unified assembly using Flye (v. 2.8)<sup>##REF##33020656##21##</sup>. A corrected consensus sequence for the Flye assembly was generated using Medaka (v 1.0.3). Racon was used as a polishing tool for the Medaka consensus sequence using the previously generated IDS1 Illumina data and an assembly evaluation using Quast 5.10.0 was carried out using this nanopore assembled genome and the previously assembled Illumina only IDS1 genome. Gene content completeness of the assembled genome was estimated using Busco (v3)<sup>##REF##29220515##85##</sup> with the assembled nanopore genome scaffolded against the <italic>S. cerevisiae</italic> S288C reference genome using Ragtag (v. 1.0.2)<sup>##REF##30606230##83##</sup>. Finally, the scaffolded assembly was annotated using Funannotate (v 1.74)<sup>##UREF##33##86##</sup>.</p>", "<title>Determination of the Guinness yeast phylogeny</title>", "<p id=\"Par54\">Sequencing data for 154 <italic>S. cerevisiae</italic> samples<sup>##REF##27610566##4##</sup> were retrieved from NCBI (BioProject PRJNA323691) and combined with the 22 <italic>S. cerevisiae</italic> sequenced for this investigation. All retrieved samples were quality checked for low-quality sequence bases and the presence of adaptor contamination using Trimgalore (Version 0.6.1). All identified adaptors were cleaved from both the forward and reverse sequencing reads and reads with runs of low-quality bases trimmed using a Phred scale cutoff of 10. All samples were aligned to <italic>S. cerevisiae</italic> S288C reference genome using BWA mem (version 0.7.17)<sup>##REF##19451168##80##</sup>. Alignments were sorted and duplicate reads were identified and marked for exclusion from downstream analysis using Picard (Version 2.18.23). Alignment metrics for each sample were collated using Qualimap (Version 2.2.1)<sup>##REF##26428292##82##</sup>. Misalignment of reads in original BWA alignments were corrected using GATK (Version 4.1.4-1)<sup>##UREF##34##87##</sup> with the base score recalibration carried out on the corrected alignments. SNP and Indel discovery and genotyping was performed across all 176 samples simultaneously with GATK used to filter sites based on the following metrics: quality score &gt;30, mapping scores &gt;40, read position rank sum &lt;8. All individual genotypes with less than 10× coverage were set to uncalled. Annotation and effect prediction for each variant was estimated using SnpEff (Version 4.3)<sup>##REF##22728672##88##</sup>.</p>", "<p id=\"Par55\">Orthologous genes across all assembled genomes were inferred using Orthofinder (Version 2.3.3)<sup>##REF##30606230##89##</sup>. Sequences from orthologous genes were concatenated and aligned using MUSCLE (Version 3.8.31). A phylogenetic analysis of the concatenated alignment of data from all orthologous genes was carried out using the maximum-likelihood approach implemented in RAxML (Version 8.2.4)<sup>##REF##24451623##15##</sup> based on the GTRGAMMA model of sequence evolution and a rapid bootstrap analysis for 1000 bootstrap replicates. The tree which was rooted using the outgroup species <italic>S. paradoxus</italic> was visualised and annotated using the ggtree<sup>##REF##30351396##16##</sup> package in R.</p>", "<p id=\"Par56\">FastSTRUCTURE (Version 1.0)<sup>##REF##24700103##17##</sup> was used to quantify the number of populations and the degree of admixture in the genomes examined in this study. Owing to the high degree of sequence similarity between the Guinness samples a single representative sample (IDS1) was used in this analysis consequently 161 genomes admixture were assessed. The full set of biallelic segregating sites identified across all samples was filtered based on a minor allele frequency (MAF) &lt; 0.05 and SNPs in linkage-disequilibrium, using PLINK (v1.09)<sup>##REF##17701901##90##</sup>. FastSTRUCTURE<sup>##REF##24700103##17##</sup> was run on a filtered set of SNPs, varying the number of ancestral populations (K) between 1 and 10 using the simple prior implemented in fastSTRUCTURE<sup>##REF##24700103##17##</sup> with <italic>K</italic> = 8 found to be optimal. The admixture of IDS1 was determined from the sequence data of the 154 <italic>S. cerevisiae</italic> samples<sup>##REF##27610566##4##</sup> using Alpaca (v1)<sup>##UREF##2##18##</sup> and a kmer length of 21 over 5000 base pair sliding windows.</p>", "<title>Copy number variation</title>", "<p id=\"Par57\">Analysis of the heterozygous biallelic SNPs for each Guinness yeast established variable copy number across the chromosomes and subsequently CNVs was normalised against an appropriate background copy number for each strain. In addition, CNVs was estimated in 250 base pair non-overlapping windows across the entire ~12 million bases of the <italic>S. cerevisiae</italic> genome using Control-FREEC (Version 5.7)<sup>##REF##22155870##91##</sup>. Plots depicting CNVs for the Guinness yeasts were generated in R using publicly available code<sup>##UREF##35##92##</sup>.</p>", "<title>Sporulation</title>", "<p id=\"Par58\">The sporulation potential of the different Guinness yeast strains was assessed using the ASBC Yeast 7 sporulation method<sup>##UREF##36##93##</sup>. A total of 1000 cells per sample were examined using a Nikon Eclipse C<italic>i</italic> microscope 100× magnification. Ascospores stained green to blue green while vegetative yeast cells-stained pink to red. independent triplicate analyses were performed for each strain. The incidence of sporulation was expressed as a percentage.</p>", "<title>Assessment of fermentation properties</title>", "<p id=\"Par59\">Fermentation ability was assessed using 180 ml mini fermenters (Fisher) containing 120 ml of 12<sup>o</sup>P wort. Cultures were recovered from liquid nitrogen and sufficient yeast for the experiments generated by successive serial aerobic incubations in 10 ml YPD, 90 ml 12<sup>o</sup>P wort and 900 ml 12<sup>o</sup>P wort. A single batch of all-malt hopped wort was used for all experiments to eliminate batch to batch variation. Wort was produced in the Guinness Pilot plant and stored at −20 °C in 5 l aliquots. Prior to use it was thawed and sterilised by autoclaving.</p>", "<p id=\"Par60\">Yeast cells were recovered by centrifugation and washed three times by successive suspension in distilled water and re-centrifugation. Viability and yeast cell concentration of each culture was determined using the EBC methods, EBC 3.1.1.1 Haemocytometer<sup>##UREF##37##94##</sup> and EBC 3.2.1.1 Methylene Blue<sup>##UREF##38##95##</sup>. Triplicate fermentations were inoculated with 1 × 10<sup>7</sup> viable yeast cells per ml into 180 ml mini fermenters containing 120 ml of air-saturated 12<sup>o</sup>P wort. Fermentations were incubated at 25 °C and stirred continuously using a stirrer plate (mix 15 eco plate Camlab) set at 250 rpm. Mini fermenters were sealed with a butyl rubber plug secured with an aluminium cap (Fisher) and fitted with a Bunsen valve to allow CO<sub>2</sub> to be released. Fermentation progression was measured by periodically monitoring weight loss. The endpoint was established when three successive identical readings were recorded.</p>", "<title>Analysis of fermentation metabolites</title>", "<p id=\"Par61\">Concentrations of selected yeast-derived flavour compounds were measured using a gas chromatographic procedure using a modified version of the EBC Vicinal Diketone method Analytica-EBC Method 9.24.2<sup>##UREF##39##96##</sup>. End-fermentation samples (30 ml) previously clarified by centrifugation were transferred to McCartney bottles which after sealing were heated at 65 °C for 30 min to convert precursor α-acetolactate into free diacetyl. Diacetyl (2,3 butanedione) concentration was determined using an ECD detector; with esters and higher alcohol concentrations determined using an FID detector. Peak areas for the metabolites were normalised using appropriate internal standards.</p>", "<title>Analysis for phenolic off-flavour (4-vinyl guaiacol, 4-VG)</title>", "<p id=\"Par62\">The ability of yeast to produce 4-vinyl guaiacol was determined according to Analytica-EBC Method 2.3.9.5<sup>##UREF##40##97##</sup> phenolic off-flavour method using gas chromatography mass spectrometry. Washed yeast samples were inoculated at a concentration of 1 × 10<sup>6</sup> viable cells ml<sup>−1</sup> into 25 ml tubes containing 10 mls of YPD medium supplemented with 0.1 ml of ferulic acid (hydroxycinnamic acid) solution. Triplicate incubations were performed for each yeast strain. After incubation at 25 °C for 48 h. 5 ml was transferred to an autosampler vial (Fisher) containing 2 µl of the internal standard containing: 4-vinyl guaiacol (Sigma–Aldrich). Analyses were carried out using an Agilent 6890/7890 GC systems fitted with a Zebron ZB-Wax 60.0 m × 250.00 μm × 0.25μm column. The initial oven temperature was 60 °C. After 10 min this was increased to 220 °C at a rate of 10 °C min<sup>−1</sup> then held for 2 min. 4-vinyl guaiacol concentration was determined using an ECB detector; temperature 150 °C, make-up flow rate of 60 ml min<sup>−1</sup> (Helium gas). Peak area for 4-vinyl guaiacol were normalised against the internal 4-vinyl guaiacol standard.</p>", "<title>Alcohol concentration</title>", "<p id=\"Par63\">Ethanol concentration was determined using near infrared spectroscopy using an Anton Paar Alcolyser in accordance with the manufacture’s guidelines.</p>", "<title>Sugar concentration</title>", "<p id=\"Par64\">Samples were analysed tested using an Agilent 1260 Infinity II system with a refractive index detector (Infinity II 1260 WR RID) and a Zorbax Carbohydrate column (4.6 × 250 mm, 5 µm, P/N: 840300-908). The other acquisition conditions were as follows: mobile phase was a 70/30 mix of acetonitrile and water; sample injection volume was 50 µL; flow rate was isocratic and set at 1.5 ml min<sup>−1</sup>. The column oven was kept at a constant 35 °C. No internal standard was used. However, samples were bracketed either side with freshly made known standard.</p>", "<title>Flocculation</title>", "<p id=\"Par65\">Flocculation was assessed using EBC Gilliland method EBC 3.5.31<sup>##UREF##16##48##</sup>. The EBC method uses visual inspection of flocculation behaviour categorising the yeast using prescribed classifications: Class 1 non-flocculant, Class 2 slightly flocculant, Class 3 moderately flocculant and Class 4 highly flocculant. An addendum to the EBC method was the addition of four control yeasts representing the different classifications.</p>", "<title>1HL fermentations</title>", "<p id=\"Par66\">In order to prepare sufficient beer for taste testing 1 hL fermentations using selected yeast strains were carried out using the Guinness pilot scale plant. Standard Guinness wort was taken from the St James’ Gate Brewery and diluted to 12<sup>o</sup>P with deaerated water and autoclaved prior to use. Yeast strains were retrieved from long-term liquid nitrogen and propagated by successive serial aerobic incubations in 10 ml YPD, 90 ml 12<sup>o</sup>P wort and 900 ml 12<sup>o</sup>P wort. To ensure that sufficient yeast was available the terminal cultures were prepared in a Carlsberg flask (GEA) containing 15 litres of sterile 12<sup>o</sup>P Guinness wort and incubated at 25 °C for 48 h with continuous oxygenation. This generated sufficient yeast to inoculate 80 L of wort at an initial count of 1 × 10<sup>7</sup> viable yeast cells ml<sup>−1</sup>. Fermentations were attemperated at 22 °C. After the desired final gravity was achieved the beer was held at 25 °C for 24 h to allow removal of diacetyl. A 20 L sample of beer was then removed and transferred to a sterile keg. After storage at 4 °C for 48 h the beer was clarified by passage through a sheet filter then bottled and pasteurised (25 PU). Triplicate samples of the beers were analysed for alcohol, fermentation metabolites, and POF production using an Anton Paar Alcolyser, gas chromatographic procedure using a modified version of the EBC Vicinal Diketone method Analytica-EBC Method 9.24.2<sup>##UREF##39##96##</sup> and Analytica-EBC Method 2.3.9.5<sup>##UREF##40##97##</sup>, phenolic off-flavour method using gas chromatography mass spectrometry. Organoleptic properties were assessed by a trained beer sensory panel consisting of 18 members. Using Quantitative Descriptive methodology<sup>##UREF##41##98##</sup> and a list of predefined Guinness Stout sensory attributes all three samples were tested in duplicate by the panel in a single tasting session. Individual sensory attributes were rated on a linear scale (0–10)<sup>##UREF##42##99##</sup>, with a subset of these attributes identified to explain differences and similarities across samples. The samples were randomised and presented to the taste panel labelled with a three-digit code. Sensory scores were analysed using a 2-way ANOVA including sensory assessor’s as a random factor<sup>##UREF##42##99##</sup>.</p>", "<title>Statistics and reproducibility</title>", "<p id=\"Par67\">Statistical analyses were preformed using Minitab 19 Statistical software (2019) and Xlstat 20 Excel statistical package (2020). Mini-fermentations were performed using three independent biological replicates and statistical significance of ethanol production, fermentation metabolites and POF determined using one way ANOVAs. The organoleptic properties of the 1Hl fermentation Guinness brews were determined by Quantitative Descriptive methodology<sup>##UREF##41##98##</sup> using a trained taste panel of 18 independent members, and the resulting data analysed using 2-way ANOVA. <italic>T-</italic>test were performed on isobutanol production of IDS1 and IDS2. The effects of CNV on POF production was established using <italic>f</italic> and <italic>t-tests</italic>.</p>", "<title>Reporting summary</title>", "<p id=\"Par68\">Further information on research design is available in the ##SUPPL##8##Nature Portfolio Reporting Summary## linked to this article.</p>" ]
[ "<title>Results</title>", "<title>Determining the origins of the Guinness yeast</title>", "<p id=\"Par8\">The two current Guinness production and eleven historical Guinness yeast were chosen to understand the origins and phylogeny of Guinness yeast. Selection was based on a review of historical records held in the Guinness archives (Table ##TAB##0##1##). The purity of the 13 Guinness yeast strains was determined using the interdelta PCR method of the TY retrotransposon elements<sup>##REF##12725935##14##</sup>. The method generated a ‘fingerprint’ for each of the yeast strains (Supplementary Fig. ##SUPPL##1##1##). Dendrograms of the PCR fragment lengths were assessed using hierarchical clustering (Euclidean distance) with yeast confirmed as being identical given a 100% similarity score. For the two Guinness production yeast, FES and IDS, the interdelta PCR method established that all three FES strains were &lt;100% similar, two of IDS strains were 100% similar and the third 98%. Interdelta PCR assessment of the other eleven historical Guinness yeast established the principal fingerprint of the strains; subsequently representative samples of each of the eleven historical Guinness yeast were determined. The fingerprinting evaluation of the 13 Guinness yeast, two production yeast encompassing the five isolated individual yeast strains, and the eleven historical yeasts, resulted in a selection of 16 Guinness yeast for whole-genome sequencing.</p>", "<p id=\"Par9\">In addition to the 16 selected Guinness yeast a further 6 historical Irish brewing yeast (Table ##TAB##0##1##) were sequenced using an Illumina MiSeq machine reading with a minimum depth of 30× coverage using 2 × 250 bp paired reads. The Sequences were assembled de novo using the <italic>S. cerevisiae</italic> S288C reference genome (R64 1-1). Origins of the Guinness strains were probed by comparing their genomes with those of the 6 other Irish Brewing yeasts and 154 previously published <italic>S. cerevisiae</italic> strains<sup>##REF##27610566##4##</sup>. A total of 466,327 filtered variant sites were identified: 434,890 SNPs and 31,427 indels. For the Guinness yeast, 96,821 filtered variant sites were identified with: 88,271 SNPs and 8550 indels (Table ##TAB##1##2##). Some 5407 filtered variant sites were exclusive to the Guinness yeasts, a total of 4907 SNPs and 500 indels.</p>", "<p id=\"Par10\">A maximum-likelihood (ML) phylogenetic tree of the 176 yeast was constructed using RAxML v8.2.12<sup>##REF##24451623##15##</sup> based on the concatenated alignment of orthologues protein coding genes and visualised using ggtree (v 3.6.2)<sup>##REF##30351396##16##</sup> (Fig. ##FIG##0##1##). Previous work has placed the 154 <italic>S. cerevisiae</italic> strains into 8 separate lineages<sup>##REF##27610566##4##</sup>. Brewing strains were located in either the Beer 1 or Beer 2 lineage. Our analysis confirmed these observations with the Guinness and other historical Irish brewing yeast placed within the Beer 1 clade (Fig. ##FIG##0##1##).</p>", "<p id=\"Par11\">The Beer 1 clade contains three separate subpopulations; a consequence of allopatric activity. These three distinct geographical groupings are Belgium/Germany, Britain and the USA. The non-Guinness Irish brewing strains were located in the ‘Britain’ subpopulations, whereas the Guinness yeast occupy their own subgroup outside the USA and ‘Britain’ subpopulations. This was an unexpected observation as the Guinness archives contain multiple records of the company requesting and supplying yeast to other Irish brewers, examples of a practice common until the mid-20th Century.</p>", "<p id=\"Par12\">To understand the origins of the Guinness yeast populations, structure and degree of admixture were determined for the 176 genomes used in this study using FastSTRUCTURE (Version 1.0)<sup>##REF##24700103##17##</sup>. Owing to the high degree of sequence similarity between the Guinness samples a single representative, IDS1, was selected for analysis. Varying the number of ancestral populations (K) between 1 and 10, <italic>K</italic> = 8 was found to be optimal (Fig. ##FIG##0##1##); an observation in accordance with previous ancestral population investigations<sup>##REF##27610566##4##</sup>. The non-Guinness Irish brewing strains were all placed within the ‘Britain’ subpopulation, based on &gt;80% common ancestry. The brewing strains of companies Perry, Cherry and Smithwicks aligned completely to the Britain subpopulation, whereas the Great Northern, Macardles 1966, and Macardles 1993 yeast aligned with the ‘Britain’ group (&gt;88%) but also the US and Belgium/Germany subpopulations.</p>", "<p id=\"Par13\">Mosaicism within the phylogenetic tree is defined as a yeast possessing an ancestry of &lt;80% from a single population<sup>##REF##27610566##4##</sup>. Within the Beer 1 subpopulation, 10 yeasts were designated as being mosaic; these yeasts that are marked in highlighted orange in Fig. ##FIG##0##1##. Analysis of the representative Guinness yeast, IDS1, established the ancestry of IDS1 being &lt;80% from one grouping. The Guinness yeast are therefore Mosaic. Further analysis of the admixture (Supplementary Fig. ##SUPPL##1##2##) using the Alpaca<sup>##UREF##2##18##</sup> software confirmed the observations of the FastSTRUCTURE<sup>##REF##24700103##17##</sup> analysis, with the genome hereditary of the Guinness yeast belonging to multiple ancestry origins. The admixture and Alpaca<sup>##UREF##2##18##</sup> analysis establish a non-linear monophyletic origin of the Guinness strains. The non-overlapping segments across the 16 chromosomes display a high degree of similarity with segments from yeasts derived from very distinct phylogenetic subclades and geographical locations. Consequently, analysis present in Supplementary Fig. ##SUPPL##1##2## confirmed the highly non-linear genetic content of the Guinness yeast relative to other members of the Beer 1 clade. Furthermore, the phylogenetic tree presented in Fig. ##FIG##0##1## placed the yeast Beer042 as the closest relative to the Guinness yeast. The Alpaca<sup>##UREF##2##18##</sup> analysis confirms this observation with all of the chromosomes sharing SNPs observed in Beer042. Omission of the Beer042 from the analysis confirmed that SNPs from the ‘not specified’ ancestry were the most significant (38.8%) (Supplementary Fig. ##SUPPL##1##2##).</p>", "<title>Phylogeny assessment of the Guinness yeast using long read sequencing technology</title>", "<p id=\"Par14\">Short read sequencing de novo assembly against a reference genome introduces potential scaffolding bias<sup>##UREF##3##19##</sup>. It has been observed that using <italic>S. cerevisiae</italic> S288C as the reference genome results in large sequencing gaps in sub-telomeric regions and in consequence poor yeast genome assembly<sup>##UREF##4##20##</sup>. Long read sequencing provides a more comprehensive genome assessment from which a reference genome can be assembled and annotated<sup>##UREF##4##20##</sup>. Using a Guinness yeast as the reference genome is suitable since <italic>S. cerevisiae</italic> S288C is a distant relation and this could result in potential phylogeny misrepresentation. The Guinness yeast IDS1 was selected for long read sequencing using the Minion system (Oxford Nanopore Technology, Oxford, UK). 421,040 reads were generated and the genome assembled using Flye<sup>##REF##33020656##21##</sup> (v 2.9) programme. The other 15 Guinness yeast were then assembled against IDS1. Following removal of intergenic variants, a total of 20,039 SNPs present in protein coding genes were identified in the 16 Guinness strains. Hierarchical clustering of the 16 Guinness strains was established using standard dissimilarity matrix analysis. The analysis of all SNPs identified in protein coding genes resulted in assessment of 20,000 protein coding biallelic SNPs<sup>##REF##29643504##3##</sup> (Fig. ##FIG##1##2##). With the exception of the 1955 Brewing Pitching yeast the Guinness yeast divide into two groupings, pre and post-1959. The observed hierarchical clustering generated using IDS1 as the reference genome was different from the observed clustering derived using <italic>S. cerevisiae</italic> S288C. Analysis using the former indicated that there was a deliberate selection of the Guinness yeast in 1959 confirming the archival account of Robert Gilliland’s 1959 Guinness yeast reselection programme.</p>", "<title>Copy number variation and chromosomal arrangement of the Guinness yeast</title>", "<p id=\"Par15\">To determine the CNV for the different Guinness strains a full normalised read depth analysis was performed in 250 bp windows across each chromosome. The result was normalised against an estimated copy number of 4 as this was the average chromosome copy number estimated for the Guinness strains. The likely accuracy of Guinness ploidy estimates was confirmed by reassessing the ploidy of previously published yeast samples<sup>##REF##27610566##4##</sup>. The 250 bp window assessment of the Guinness strains (Fig. ##FIG##2##3##) showed the presence of multiple copies of chromosomes and CNVs within individual chromosomes. Whilst there are chromosomal CNVs across all 16 chromosomes only chromosomes II, XIII and XV have 5 chromosomal copies in 6 or more Guinness strains; even yeast that are closely related, IDS1 and IDS2, exhibit difference in CNV in chromosome II, VI, X and XVI. Consequently all 16 Guinness yeast are aneuploid.</p>", "<p id=\"Par16\">Aneuploidy is common for ale brewing strains and has been previously reported in multiple studies<sup>##REF##27610566##4##,##UREF##0##11##,##REF##30809248##22##</sup>. Unlike natural isolates, domesticated yeast have been influenced by human activity. This selection pressures result in polyploidy for genes conferring sought-after phenotypic qualities. In concert with this, decreased global cellular fitness occurs<sup>##REF##29643504##3##</sup>. Consequently, wild type <italic>S. cerevisiae</italic> are more likely to be diploid with a functioning sexual phenotype<sup>##REF##30809248##22##</sup>. In contrast and presumably a consequence of the effects of aneuploidy, all 16 of the Guinness strains exhibited poor sporulation (Table ##TAB##1##2##); 7 strains did not sporulate at all and of the other 9 the 1959 pitching yeast had the highest sporulation percentage of just 2.8%. This observation is concurrent with Bilinski and Casey<sup>##UREF##5##23##</sup> who also reported poor sporulation in aneuploid yeast.</p>", "<title>Phenotype analysis of the Guinness yeast</title>", "<p id=\"Par17\">In order to determine whether the genetic similarity defined a ‘Guinness yeast phenotype’, the 16 strains were assessed for phenotypic traits using mini-fermentations as described in the methods section. Some differences in both patterns and extent of attenuation, as well as ethanol production were observed (Fig. ##FIG##3##4##). A one way ANOVA with Tukey’s post-hoc test of the 16 Guinness yeast determined that ethanol production was significantly different (<italic>P</italic> = 3.09 × 10<sup>−9</sup>). Assessment of all of the Guinness yeast using a single representative IDS, FES and Park Royal yeast confirms that ethanol production is significantly different (one way ANOVA <italic>P</italic> = 0.00036), but separate one way ANOVA analysis of the ethanol production of the two yeast identified within the IDS yeast were not statistically significant (<italic>P</italic> = 0.64) likewise analysis of the Park Royal yeast showed that there was no statistical difference between the Park Royal yeast (<italic>P</italic> = 0.13). Only the FES yeast demonstrated significant difference in ethanol production (One way ANOVA <italic>P</italic> = 0.00011) but when FES 2 and FES 3 were assessed without the inclusion of FES 1 ethanol production was determined not to be statistically significant (<italic>P</italic> = 0.08). Likewise, time to attenuation varied between strains with the Park Royal 1979 yeast achieving attenuation in 22 h compared with 72 h for the 1959 Guinness pitching yeast (Fig. ##FIG##3##4##).</p>", "<p id=\"Par18\">The progress of brewing fermentations is typically assessed by recording the decrease in wort density. Measuring loss of weight, in the mini-fermentations described here is an indirect method which also relies on a fall in density. This decrease is a consequence of the utilisation of wort sugars by yeast and the formation of ethanol. Brewing yeast strains can assimilate simple wort sugars which include glucose, fructose, sucrose, maltose and maltotriose; dextrins are not fermented<sup>##UREF##6##24##</sup>.</p>", "<p id=\"Par19\">Maltotriose utilisation correlates with the maltose multigene loci, five of which (<italic>MAL1, 2, 3, 4</italic> and 6) have been identified in <italic>S. cerevisiae</italic><sup>##REF##2548922##25##</sup>. Only the <italic>MAL1</italic> and <italic>MAL3</italic> multigene are present within the reference yeast <italic>S. cerevisiae</italic> S288C. The <italic>MAL</italic> locus comprises three genes, a maltose permease (gene 1), maltase (gene 2) and a <italic>Trans</italic> acting <italic>MAL</italic>-activator (gene 3). Illumina sequencing of the 16 Guinness strains confirmed the presence of <italic>MAL1</italic> and <italic>MAL3</italic>. A homozygous premature stop codon was identified in the <italic>MAL1</italic> maltose permease gene (<italic>MAL11</italic>) for all 16 Guinness yeast (Supplementary data ##SUPPL##3##1##). This stop codon mutation potentially prevents the loss of gene function, although the occurrence of this stop codon is present within 145 of the 176 yeast assessed in this study and maltotriose is utilised by all of the Guinness yeast (Fig. ##FIG##3##4##). Within the phylogenetic tree disruption to <italic>MAL11</italic>, whilst present in a small number of Beer 1 yeast, is more readily associated with brewing yeast present in the Beer 2 brewing yeast grouping<sup>##REF##27610566##4##</sup>.</p>", "<p id=\"Par20\">Illumina analysis of <italic>MAL3</italic> of S288C, established the presence of 16 heterozygous frameshift mutations in the maltose permease, <italic>MAL31</italic>. Similar mutations were present in all the different Guinness yeast strains (Supplementary Data ##SUPPL##3##1##). The frameshift mutations in <italic>MAL31</italic> did not result in loss of maltose and maltotriose utilisation as assessment of maltose and maltotriose at the end of the fermentation confirmed the consumption of these wort sugars (Fig. ##FIG##3##4##).</p>", "<p id=\"Par21\">Further analysis of the Guinness strains using the longer nanopore sequencing reads determined that the <italic>MAL6</italic> locus was present. When detected in other <italic>S. cerevisiae</italic> strains the <italic>MAL6</italic> multigene locus is located on Chromosome VIII and is arranged from the centromere as <italic>MAL63</italic>, <italic>MAL61</italic> and <italic>MAL62</italic><sup>##REF##8005435##26##</sup>. In contrast, assessment of the Guinness strains showed that <italic>MAL61</italic> and <italic>MAL62</italic> were arranged on Chromosome VIII, as expected; however, <italic>MAL63</italic> mapped to the sub-telomeric region of chromosome XVI. In the reference strain <italic>S. cerevisiae</italic> S288C this Open Reading Frame (ORF) on chromosome XVI is designated as gene YPR196W and is described as a “Putative maltose-responsive transcription factor”. The unusual arrangement of the <italic>MAL6</italic> locus appears to be specific to the Guinness yeast and should be considered provisional until confirmed through additional experimental data.</p>", "<title>Production of flavour metabolites by Guinness yeast</title>", "<p id=\"Par22\">Beer recovered from the completed mini-fermentations were analysed for the flavour active esters: isoamyl acetate, ethyl butyrate, ethyl hexanoate and ethyl acetate (Fig. ##FIG##3##4##). All were detected in the Guinness yeast fermentations apart from ethyl butyrate. Ethyl hexanoate was produced by 7 of the 16 Guinness strains, but at concentrations lower than the flavour threshold of 0.2 ppm<sup>##UREF##7##27##</sup>. The concentrations of ethyl esters varied with strain. In the case of ethyl hexanoate, isoamyl acetate and ethyl acetate the differences were statistically significant; more so in the case of the latter two esters, one way ANOVA <italic>p</italic> = 0.011, <italic>p</italic> = 9.32 × 10<sup>−20</sup> and <italic>p</italic> = 6.91 × 10<sup>−20</sup>, respectively. The 1947, 1950 and Park Royal 1960 yeasts produce isoamyl acetate at concentrations above the flavour threshold (1.1 ppm<sup>##UREF##7##27##</sup>) whereas ethyl acetate is the most widely produced ethyl ester. Eight of the 16 Guinness yeast strains produce ethyl acetate above the flavour threshold of 10 ppm<sup>##UREF##7##27##</sup>. A one way ANOVA of these 8 yeast confirms that ethyl acetate production in the Guinness yeast is strain-specific (<italic>p</italic> = 8.06 × 10<sup>−5</sup>); however, further analysis of ethyl acetate production of the four Guinness yeast collected in 1959 and 1960 show no statistical significance (One way ANOVA <italic>p</italic> = 0.86), likewise there is no statistical significance between the 1947 and 1950 pitching yeast (One way ANOVA <italic>p</italic> = 0.51).</p>", "<p id=\"Par23\">Higher alcohols (fusel alcohols) are the most abundant yeast-derived organoleptic compounds present in beer apart from ethanol<sup>##REF##24384752##28##</sup>. Isobutanol and propanol impart solvent and alcohol/sweet aromas to the beer. As in the case of ethanol production, the concentrations of higher alcohols arising in the beers varied with strain (Fig. ##FIG##3##4##); one way ANOVA isobutanol <italic>p</italic> = 4.79 × 10<sup>−21</sup> and propanol <italic>p</italic> = 4.42 × 10<sup>−32</sup>.</p>", "<p id=\"Par24\">Higher alcohols are formed by transamination, decarboxylation and reduction via the Ehrlich pathway<sup>##UREF##6##24##</sup>. Transamination is rate-determining and over-expression of <italic>BAT2</italic> results in increased higher alcohol production<sup>##REF##16879424##29##,##REF##23111598##30##</sup>. CNV of the genes responsible for the Ehrlich pathway (Supplementary data ##SUPPL##4##2##) established that CNV of <italic>BAT2</italic> differed between the Guinness strains with a median value of 4. The Park Royal 1960 produced the highest concentration of isobutanol and was shown to have 6 copies of the <italic>BAT2</italic> gene. The Guinness production yeast IDS2 produce similar amounts of isobutanol compared to the Park Royal 1960 strain (<italic>t</italic>-test <italic>P</italic> = 0.61) and has 4 copies of <italic>BAT2</italic>. Both IDS1 and IDS2, have the same CNV of <italic>BAT2</italic>, but IDS1 produced significantly less isobutanol (<italic>t</italic>-test <italic>P</italic> = 0.00048) indicating the involvement of other factors. In fact, a frameshift mutation was identified in the <italic>THI3</italic> decarboxylase gene and the dehydrogenase <italic>AAD6</italic> gene was not detected in the Guinness yeasts; deletions of <italic>THI3</italic> and <italic>AAD6</italic> have been observed to negatively affect isobutanol production<sup>##REF##23111598##30##</sup>.</p>", "<p id=\"Par25\">The vicinal diketone, diacetyl (2,3 butanedione) arises in beer during fermentation where it imparts a buttery or butterscotch like flavour<sup>##REF##30306366##31##</sup>. Diacetyl is formed indirectly by brewing yeast during fermentation from α-acetolactate. The latter is an intermediate in the isoleucine valine (ILV) synthetic pathway and part of the pool is exported from yeast cells where it undergoes spontaneous oxidative decarboxylation in fermenting wort to form diacetyl. Diacetyl was present at the end of fermentation for all of the Guinness yeast (Fig. ##FIG##3##4##); however, only 7 of the 16 strains at a concentration greater than the flavour threshold of 100–400 ppb<sup>##UREF##8##32##</sup>. Differences in diacetyl concentrations for individual strains were highly statistically significant (one way ANOVA <italic>p</italic> = 7.09 × 10<sup>−13</sup>).</p>", "<p id=\"Par26\">The diacetyl precursor α-acetolactate is produced by the enzyme acetolactate synthase<sup>##UREF##8##32##</sup>. The responsible genes <italic>ILV2</italic> and <italic>ILV6</italic><sup>##REF##8972574##33##,##REF##2989783##34##</sup> were found in all Guinness yeasts, with a total of 11 SNPs present in <italic>ILV2</italic> compared to the reference yeast <italic>S. cerevisiae</italic> S288C. A total of 5 SNPs, and two non-synonymous mutations, for <italic>ILV6</italic> were found in all of the Guinness strains (Supplementary data ##SUPPL##5##3##). 4 of the 5 Guinness yeasts which produced the highest residual diacetyl concentration had 5 copies of the <italic>ILV2</italic> gene compared to a median value of 4 CNV. The apparent correlation between copy number of <italic>ILV2</italic> and residual diacetyl concentration could be causative; for many traditional beers’ diacetyl removal occurs via lengthy periods of storage, post-fermentation, at cool temperatures in the presence of yeast. For the Guinness yeast it was observed that the strains with the most rapid fermentations and corresponding longer post-fermentation time had the lowest diacetyl concentration (Fig. ##FIG##3##4##). This is not surprising since diacetyl is reduced principally in late fermentation through passive uptake by yeast and subsequently enzymatic conversion of diacetyl first to acetoin and thence to 2,3-butanediol<sup>##REF##2180695##35##,##UREF##9##36##</sup>. Consequently for FES production, where the presence of diacetyl is part of the beer’s flavour profile, reducing yeast contact time post attenuation ensures that the diacetyl flavour remains within the beer.</p>", "<p id=\"Par27\">Fermentations were repeated at a scale of 1hl as fermentations at this increased scale are more representative of commercial-scale brewing. Additionally, the increased volume allowed for the resultant beers to be subjected to standard sensory profiling. Fermentations were carried out in a pilot brewery using 12-degree Plato (<sup>o</sup>P) wort. Degree Plato is a measurement, related to density, and used by brewers to determine the concentration of dissolved solids including fermentable and non-fermentable sugars in brewers’ wort. Guinness stout wort was sourced from St James’s Gate Brewery, Dublin. Two Guinness strains, Park Royal 1979 and IDS2 were chosen for the trial as the Park Royal 1979 time to attenuation was the shortest of the 16 Guinness strains and the IDS2 yeast was chosen as it was the atypical IDS production yeast. The chosen yeasts were compared with a control, a third-generation production Irish Draught yeast culture taken from the St James’s Gate brewery. Third generation refers to a culture that had already been used for 3 previous cycles of serial fermentations with intermediate cropping and storage. Yeast cultures of this “age” is considered to produce standard fermentation performance and generate typical beer. When the fermentations were completed, the resultant beers were processed using the standard Irish Guinness stout procedure. Beers were assessed chemically via analysis and organoleptically via the Guinness external taste panel using quantitative descriptive methodology.</p>", "<p id=\"Par28\">The results were largely in accord with those obtained from the mini-fermentation study (Fig. ##FIG##4##5##). The flavour panel detected isoamyl acetate and phenolic off-flavour in the beer made with Park Royal 1979, and diacetyl in Guinness made using IDS2; these observations were confirmed by GC-MS analysis (Supplementary Fig. ##SUPPL##1##3##). Times to attenuation and final ethanol concentrations for both small and larger scale fermentations were also similar.</p>", "<title>Phenolic off-flavour (POF) phenotype of the Guinness yeast</title>", "<p id=\"Par29\">The formation of 4-vinyl guaiacol, also known as <italic>Phenolic off-flavour</italic> (POF), imbues beers with a medicinal, clove-like aroma and flavour. It is produced from a precursor, ferulic acid, derived from cereal grains, via expression of yeast genes<sup>##UREF##10##37##</sup>. All the Guinness yeast strains used in this study were POF<sup>+</sup> (Fig. ##FIG##5##6##). The degree of POF character which developed varied with yeast strain (one way ANOVA <italic>P</italic> value = 4.7 × 10<sup>−21</sup>). The flavour threshold of 4-vinyl guaiacol in beer is reportedly 200–400 ppb<sup>##UREF##11##38##</sup>. Here, the Guinness yeasts: 1950, 1959BY, Ikeja and 1981 yeast all produced 4-vinyl guaiacol at concentrations below the flavour threshold limit, whereas, the 1947, 1960 and Park Royal 1960 yeast all produced 4-vinyl guaiacol at a mean concentrations &gt;1000 ppb.</p>", "<p id=\"Par30\">The POF phenotype performs an important environmental fitness function for wild <italic>S. cerevisiae</italic> as it enables the yeast cell to detoxify the phenylacrylic acids present in plant cell walls<sup>##UREF##12##39##,##REF##24507903##40##</sup>. The genes <italic>PAD1</italic> and <italic>FDC1</italic>, encoding a phenylacrylic acid decarboxylase and a ferulic acid decarboxylase respectively decarboxylate the phenylacrylic acid, ferulic acid, to 4-vinyl guaiacol<sup>##REF##24507903##40##</sup>. Illumina sequence analysis of the Guinness yeasts identified two SNPs in <italic>FDC1</italic> gene, and 9 SNPs in <italic>PAD1</italic> (8 homozygous and 1 heterozygous). Of the 11 identified SNPs, 9 SNPs have been previously identified in other strains of <italic>S. cerevisiae</italic><sup>##REF##24507903##40##</sup>. The two SNPs identified only in the Guinness yeast are the heterozygous SNP at position 425 in <italic>PAD1</italic> gene and the homozygous SNP at position 790 in <italic>FDC1</italic>. The identified non-synonymous changes do not result in a loss of POF production function.</p>", "<p id=\"Par31\">The median average of the CNV of <italic>PAD1</italic> and <italic>FDC1</italic> within the Guinness yeast was 4. Examination of the data showed that CNV and 4-vinyl guaiacol occurrence in beers were not related for the production for the Guinness yeast studied here (<italic>f</italic>-test <italic>P</italic> = 0.86; <italic>t</italic>-test <italic>P</italic> = 0.17) POF; yeasts with identical SNPs and CNV within <italic>PAD1</italic> and <italic>FDC1</italic> genes produced different concentrations of 4-vinyl guaiacol under identical experimental conditions.</p>", "<title>Flocculation phenotype of the Guinness yeast</title>", "<p id=\"Par32\">Yeast flocculation is a reversible, non-sexual aggregation of cells which is of benefit to brewers since it improves the efficiency of sedimentation or separation from beer at the end of fermentation<sup>##UREF##13##41##</sup>. The timing of flocculation in <italic>S. cerevisiae</italic> is dependent upon expression of the flocculation genes <italic>FLO1, FLO5, FLO8, FLO9, FLO10</italic> and <italic>FLO11</italic> and environmental factors such as calcium, pH, temperature, fermentable sugars and other nutrients<sup>##REF##18001350##42##–##REF##20640875##47##</sup>. For the Guinness yeasts, the degree of flocculation observed was strain-specific (Fig. ##FIG##5##6##).</p>", "<p id=\"Par33\">Gilliland<sup>##UREF##16##48##</sup> developed a method for describing the flocculence characteristics of brewing yeast. Four classification types were defined: Class I non-flocculant, Class II slight flocculant, Class III moderately flocculant and Class IV highly flocculant. The production yeast IDS and FES were shown to be Class II and Class I respectively, confirming that the flocculation phenotype of the current Guinness production yeast is the same as those selected in 1959 and 1960 (Fig. ##FIG##5##6c##).</p>", "<p id=\"Par34\">Nanopore assessment of the IDS1 Guinness production yeast established that three complete <italic>FLO</italic> genes, <italic>FLO9, FLO11</italic> and <italic>FLO8</italic> were present. Scaffolding of the other Guinness yeast using IDS1 as the reference genome confirmed the presence of the three <italic>FLO</italic> genes indicating that <italic>FLO9, FLO11</italic> and <italic>FLO8</italic> are common to the Guinness yeasts. Of the incomplete <italic>FLO</italic> genes, <italic>FLO1, FLO5</italic> and <italic>FLO10</italic>, a truncated version of <italic>FLO1</italic> was identified. A partial read of <italic>FLO5</italic> was identified in the sub-telomeric region of chromosome VIII. The presence of <italic>FLO10</italic> could not be confirmed as the sub-telomeric region of chromosome XI was absent in the nanopore sequencing data resulting in the loss of <italic>FLO10</italic> and the adjacent genes <italic>VBA5, NFT1</italic> and <italic>GEX2</italic>.</p>", "<p id=\"Par35\">The <italic>FLO</italic> genes identified in the Guinness yeast encode flocculins, <italic>FLO9</italic> and <italic>FLO11</italic>, and the flocculation transcription factor <italic>FLO8</italic>. Flocculation phenotype is affected by the length of the flocculin molecules which projects from the cell wall surface. The longer the flocculin the stronger flocculation competence<sup>##REF##16086015##49##</sup>. The size of the <italic>FLO</italic> encoded flocculins is a consequence of the number of tandem repeats within the ORF<sup>##REF##16086015##49##,##UREF##17##50##</sup> (Supplementary data ##SUPPL##6##4##). The <italic>FLO11</italic> ORF in the Guinness yeasts transcribes a 744 amino acid protein, in comparison that of the reference <italic>S. cerevisiae</italic> S288C genome comprises 1367 amino acid residues<sup>##REF##8955395##51##</sup>. Furthermore, <italic>FLO9</italic> contains two ORF encoding two fragments of the flocculin gene. For the Guinness yeasts FES 3, Ikeja, 1960 pitching yeast, and the 1979 and 1986 Park Royal yeasts a heterozygous SNP mutation at position 12,114 induces a premature stop codon, all the other Guinness yeast retain the consensus SNP resulting in a functioning ORF. The five Guinness yeast that carry the heterozygous SNP in <italic>FLO9</italic> have a flocculation phenotype of &lt;1.5 with three of the yeast observed to be Class I and therefore described as being non-flocculant. The <italic>FLO8</italic> transcription factor is functional in all of the Guinness yeasts examined here.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par36\">Our analysis established that the Guinness yeast form their own subgroup within the previously described Beer 1 brewing clade and that the grouping of the Guinness yeast is separate from other historical Irish Brewing yeast strains. The Beer 1 clade SNPs are of European and Asian origin<sup>##REF##30835725##9##,##REF##35180385##10##</sup> and unlike the other historical Irish Brewing yeast that group within the ‘Britain’ subpopulations, the data presented in this study indicates the contribution of several lineages to the genetic make-up of the Guinness strains. These different lineages presented in this study establishes that the Guinness yeast are mosaic with an ancestry &lt;80% from a single geographical population.</p>", "<p id=\"Par37\">The analysis presented in Fig. ##FIG##0##1## and Supplementary Fig. ##SUPPL##1##2## establishes that the yeast Beer042 shares a recent common ancestor with the Guinness yeast. The Beer042 was deposited in 1979 and at that time was used to brew a lager-style beer in Belgium (personal communication with the owners of Beer042). Beer042 was deposited using the then accepted nomenclature for lager strains <italic>Saccharomyces carlsbergensis</italic> Hansen. Subsequent whole-genome sequencing has confirmed that it was mislabelled and that it is a <italic>S. cerevisiae</italic> yeast. Within the Guinness archive, the last mention of yeast being brought into the brewery is on the 2nd of January 1854. The performance of this yeast was described as poor, consequently it was disposed of, and brewing continued using the then house yeast. There are no subsequent entries of additional yeast in the Guinness archives, other than the Guinness yeast, being used to brew Guinness. As Beer042 was labelled as <italic>Saccharomyces carlsbergensis</italic> Hansen it is likely that it originated from Emil Hansen’s Carlsberg group yeast collection. At the end of the 19th century Emil Hansen pioneered the selection and propagation of pure yeast strains for use in brewing<sup>##UREF##0##11##</sup>. At that time this was a novel concept, and it prompted much interaction between various European brewers<sup>##UREF##18##52##</sup>. In the case of Guinness, company scientists visited numerous breweries in the UK on multiple occasions<sup>##UREF##19##53##</sup>. Consequently, a plausible reason for the relationship demonstrated here with Beer042 and the Guinness yeast is that a common ancestor was shared from Dublin to other European brewers. Originally, this common ancestor would have been deposited in Emil Hansen’s collection. The resulting observed differences in SNPs between Beer042 and the Guinness yeast are likely due to the consequences of yeast evolution driven by differences in handling practices.</p>", "<p id=\"Par38\">The phylogeny assessment of the Guinness yeast confirmed the expected genealogical relationship between the historical and current production strains, with a division being observed at a pre- and post- ‘1959’ timeline. The 1960 pitching yeast and Park Royal 1960, were collected in 1960 but are yeasts derived from pre-1959 stock. The selection that was undertaken in 1959 used single-cell isolates obtained from the then Guinness Pitching yeast (Guinness Archives). These isolates were tested in the Guinness Research Laboratory with the flocculation phenotype used as the principal differentiating selection criterion. Subsequently the Class II IDS yeast was chosen to brew Guinness Irish Stout, with a second selection from the single-cell isolates undertaken in 1960. This produced a Class I flocculant yeast which was chosen to produce FES on the basis that it was advantageous for yeast to remain suspended in bottle conditioned stout intended for the export market.</p>", "<p id=\"Par39\">The flocculation assessment of the Guinness yeast reported in this study confirmed that the phenotype of the production yeasts FES and IDS have been preserved when compared with their 1959 and 1960 phenotypes. Whilst the flocculation phenotype of the production yeast has been maintained the present production yeast have diverged from the 1959 Guinness pitching yeast with regard to other characteristics. The reason for this may be related to changes in the methods used for preserving cultures. Prior to 1986 all yeast cultures were maintained on wort agar slopes stored at 4 °C and sub-cultured every 6 months. This method was standard industry practice up until the 1970s and 1980s. Following the work by Labatt’s Brewing Company<sup>##UREF##20##54##</sup> yeast culture storage in liquid nitrogen was introduced and widely adopted.</p>", "<p id=\"Par40\">The production yeast IDS and FES were subjected to an additional reselection procedure which started with individual non-petite yeast colonies from which phenotypes were chosen that were ‘prone to spontaneous changes’<sup>##UREF##21##55##</sup>. The phenotypic characters of interest were flocculation, maltotriose utilisation and head formation (cropping behaviour at the end of fermentation). Some 50 colonies were selected, pooled, and cultured on fresh agar slopes. The rationale was that this should minimise the risk of selection of a potential defect or mutation from a single source which would adversely affect the Guinness yeast. This strategy was adopted since it was concluded that it would mitigate the potential adverse effects of long-term maintenance of yeast cultures on slopes<sup>##UREF##22##56##</sup>. This process of selecting positive phenotypic traits could over time increase dissimilarities resulting in potential divergence from the original 1959 Guinness yeast. This process is similar to adaptive evolution, the process of positive selection of an advantageous phenotype. Adaptive evolution has been used successfully by others to enhance yeast phenotypes<sup>##REF##30306366##31##,##REF##23414064##57##,##REF##31951488##58##</sup>. The ‘adaptive evolution’ hypothesis is further supported by the observable differences in the 1981 IDS Guinness yeast compared to the IDS1 and IDS2 production yeast. The last reselection of the Guinness production yeast took place in 1989, 8 years after the 1981 Guinness pitching yeast was deposited in the yeast library. The 1981 IDS yeast is chronologically the closest yeast to the current IDS production yeast, unlike the IDS yeast, the 1981 IDS yeast was not reselected therefore the 1981 yeast is a record of IDS yeast at that time. The observable hierarchal clustering of the Nanopore phylogeny assessment places the 1981 IDS yeast closest to the IDS yeasts, accordingly the observable differences between the IDS yeasts and the 1981 IDS yeast are likely to be a consequence of the Guinness yeast ‘adaptive evolution’ reselection process.</p>", "<p id=\"Par41\">The loss of meiotic cell division and observed aneuploidy of the Guinness yeast are congruent with yeast domestication<sup>##UREF##23##59##</sup>. Aneuploidy can confer phenotypic advantages such as enhanced tolerance to ethanol, temperature and oxidative stresses<sup>##REF##26202939##60##–##REF##33734361##63##</sup>. Although assessment of stress resistance was not in the scope of this study the observed variable ploidy together with the phenotypic assessments made via studies of fermentation performance suggest that the Guinness strains have evolved to manage environmental stresses associated with commercial brewing. For example, acquisition of additional copies of chromosome III which correlated with improved ethanol tolerance has been reported<sup>##REF##30809248##22##</sup>. Others, studying industrial processes employing <italic>S. cerevisiae</italic>, including baking and sake brewing, have suggested there is no evidence of amplification of specific chromosomes carrying traits which can be directly attributable to industrial practices<sup>##REF##33734361##63##</sup>. The studies reported here support the latter contention. For the strains examined, no specific chromosome was identified as being responsible for the Guinness yeast phenotype.</p>", "<p id=\"Par42\">In addition to ploidy, gene copy number correlates with gene expression. Aneuploid yeast with multiple gene copy numbers will have increased expression levels compared to a haploid yeast with a single copy gene<sup>##REF##30809248##22##,##REF##23197825##61##</sup>. Increased gene copy numbers does not always result in an increase in the concentrations of the resultant proteins, even though the genes are translated since turnover via proteolysis also occurs<sup>##REF##17702937##64##</sup>. Data presented in this study established that there are gene CNVs between the different Guinness yeast strains but with reference to the concentrations of important beer flavour yeast-derived metabolites: higher alcohols, diacetyl and phenolic off-flavour (POF), the CNV did not significantly influence the phenotypic outcome.</p>", "<p id=\"Par43\">The observed difference in phenotype between the Guinness yeasts are of interest to brewers as the data presented in this study establishes that yeast that are genotypically similar can be phenotypically diverse. The phenotypic data presented in this study does not correlate with the group of yeast. For example, there are differences between the Park Royal Guinness yeast, present production yeast, pre-1959 and post-1959 Guinness yeast. The difference in POF, esters, higher alcohols and ethanol production is yeast strain-specific. Predicting phenotype based upon genotype is challenging<sup>##REF##26566239##65##–##REF##23133362##68##</sup>, even with the use of machine learning predicting phenotype based upon genotype<sup>##REF##32174648##69##</sup> has a poor correlation for <italic>S. cerevisiae</italic> (&lt;22%). The data presented in this study provides further valuable awareness of the relationship of genotype and phenotype and confirms previous studies’ conclusions on the difficulty of predicting phenotype from genotype.</p>", "<p id=\"Par44\">Good brewing practice is to replace pitching yeast; the yeast added to wort, after 8–15 re-pitching procedures<sup>##REF##1797013##70##,##UREF##25##71##</sup>. A major reason for this practice is to avoid genetic drift so that the fermentation outputs remain consistent<sup>##UREF##26##72##</sup>. The data presented in this study offers another potential explanation; especially for pitching yeast that are not pooled from a pure culture. The differences in fermentation behaviour maybe a consequence of the difference in phenotype. The Guinness production yeast, IDS and FES contain yeast that are phenotypically diverse although they are genotypically similar, consequently, as the yeast is re-pitched there is potential for the concentration of the different yeast to change resulting in a different fermentation/phenotype response. The observations of phenotype and genotype in this study raises important questions for brewers and other groups that use <italic>S. cerevisiae</italic> yeast for industrial processes and highlights the importance of brewers maintaining their production yeast. Further consideration should be given to understanding the role of genotype on phenotype as this will improve <italic>S. cerevisiae</italic> industrial comprehension.</p>", "<p id=\"Par45\">All Guinness yeast strains examined had a POF<sup>+</sup> phenotype. This phenotype is widely found within the wild <italic>S. cerevisiae</italic> population but much less common in industrial strains<sup>##REF##27610566##4##</sup>. The same authors and others have reported that none of the examples of the Britain, Ireland and USA brewing yeasts assessed were POF<sup>+</sup>\n<sup>##REF##27610566##4##,##REF##27720622##8##</sup>. This suggested that the loss of POF production is a consequence of deliberate selection by the brewer. In contrast, where the POF flavour is an important characteristic; as with German Hefeweizen beers (wheat beers), the POF phenotype has been retained<sup>##REF##27610566##4##,##REF##27720622##8##</sup>. In the case of the Guinness yeast retention of the POF genotype is unusual for domesticated brewing yeast<sup>##REF##27610566##4##,##REF##27720622##8##</sup>.</p>", "<p id=\"Par46\">Retention of the POF phenotype in the Guinness yeasts was unlikely to have been a deliberate act; rather at the concentrations found in the beers the effect was benign as it did not create flavour issues. The precursor of 4-vinyl guaiacol, the causative agent of POF, is ferulic acid a component of cell wall polysaccharides of barley, wheat, rice and maize<sup>##UREF##11##38##</sup>. Free ferulic acid is released during the mashing stage, a process used by brewers to convert grain starches into fermentable sugars during wort production. The free ferulic acid is then converted to 4-vinyl guaiacol by POF<sup>+</sup> yeast during fermentation. The extent of ferulic acid release is influenced by the conditions employed during mashing<sup>##UREF##27##73##</sup>. A mash temperature stand of 45–50 °C is optimal for releasing ferulic acid<sup>##UREF##6##24##</sup>. This is a typical starting temperature for Continental European brewers and consequently this suits those beers that have a pronounced POF character, otherwise POF<sup>−</sup> yeast strains must be used<sup>##UREF##28##74##</sup>. Irish and British brewers prefer isothermal or infusion mashing using a temperature of 67 °C<sup>##UREF##28##74##</sup>. This regime does not favour extensive release of ferulic acid<sup>##UREF##28##74##</sup> and therefore the potential for development of POF in Guinness stouts would not be great. The importance of the presence of POF in Guinness beers is further reduced since an internal expert sensory panel has determined that the flavour threshold concentration for 4-vinyl guaiacol in Guinness stouts is higher than in other beer styles. These factors in concert would reduce pressures to eliminate POF genes in Guinness production yeast.</p>", "<p id=\"Par47\">All Guinness yeasts are POF<sup>+</sup> but the concentration of 4-vinyl guaiacol formed varies with individual yeast strains. The Guinness yeast all share the same SNP mutations and the CNV number does not affect POF production. The presence of stop codon in <italic>FDC1</italic> and <italic>PAD1</italic> result in the loss of POF in negative yeast strains<sup>##REF##27610566##4##,##REF##27720622##8##</sup>. However, Gonçalves et al.<sup>##REF##27720622##8##</sup> observed that in the yeast TUM 507 stop codons present in <italic>PAD1</italic> and <italic>FDC1</italic> did not result in loss of POF phenotype, moreover, in the TUM 380 yeast where there were functioning <italic>PAD1</italic> and <italic>FDC1</italic> genes present, there was a loss of POF production phenotype<sup>##REF##27720622##8##</sup>. Gonçalves<sup>##REF##27720622##8##</sup> concluded that as yet unidentified compounds or enzymes were affecting POF production in TUM 380 and 507 yeasts. Observations made in this study may corroborate Gonçalves’s<sup>##REF##27720622##8##</sup> conclusions since individual Guinness strains produce significantly different concentrations of 4-vinyl guaiacol even though all yeast share the same gene content. These observations warrant further investigation.</p>", "<p id=\"Par48\">This study provides evidence of beer style influencing yeast selection. With the exception of Hefeweizen specific yeast, previous studies have demonstrated that yeast subdivide along geographical locations and not beer style<sup>##REF##27610566##4##</sup>; our findings run contradictory to this observation. The data presented in this study establishes that yeast from a similar geographical location, Ireland, are genealogically dissimilar despite documented evidence of the wide sharing of yeast between brewers. All of the non-Guinness Irish brewing yeast were used to brew ales, whilst the Guinness yeast were used to make stout. The phylogeny assessment of the Irish yeast divide on the stout/ale brewing axis. Perhaps the reason for the difference is that yeast used to brew ales are generalist, brewing different types of beers, consequently yeast with universally preferable characteristics such as good flocculation and POF<sup>−</sup> would be selected for by the brewer. For yeast that brew a specific beer style these universal characteristics are not essential subsequently brewers can select a yeast that enhances the features of a particular beer style even if these characteristics are unsuitable for generalist yeast. This hypothesis is supported by the findings of both Gallone et al.<sup>##REF##27610566##4##</sup> and Gonçalves et al.<sup>##REF##27720622##8##</sup> who observed that yeast used to brew beers in the Hefeweizen style are distinct, forming their own subgrouping; interestingly like the Guinness yeast Hefeweizen yeast are also mosaic<sup>##REF##27610566##4##,##REF##27720622##8##</sup>. The effects of raw material, especially the mineral content of water are well known<sup>##UREF##6##24##</sup>. This has led to the association of geographical locations with certain beer types such as Burton on Trent in the United Kingdom with ales, and delicate lagers associated with Pilsen in the Czech Republic<sup>##UREF##6##24##</sup>. Unlike brewers vintners use the microflora of the raw material grapes to ferment. Studies have demonstrated that the microflora of geographical regions are associated with certain types of wine<sup>##UREF##29##75##</sup> this has resulted in the concept of terroir. For wine terroir is well-established but the concept of terroir in beer is still in its infancy despite the recent studies on the terroir of hops<sup>##REF##32247886##76##,##UREF##30##77##</sup>. Our findings provide another possible avenue for brewers to further explore the concept of beer associated terroir.</p>", "<p id=\"Par49\">In conclusion the analysis presented in this study establishes that the Guinness yeast are not only significantly different from other historical Irish Brewing yeast but they form a sub- group within the brewing yeast clade. The genealogy of the different Guinness yeast is confirmed by our analysis and supports the Guinness archive historical records that the Guinness yeast used today is related to the first deposited Guinness yeast; the 1903 Watling Laboratory Guinness yeast.</p>" ]
[]
[ "<p id=\"Par1\">Beer is made via the fermentation of an aqueous extract predominantly composed of malted barley flavoured with hops. The transforming microorganism is typically a single strain of <italic>Saccharomyces cerevisiae</italic>, and for the majority of major beer brands the yeast strain is a unique component. The present yeast used to make Guinness stout brewed in Dublin, Ireland, can be traced back to 1903, but its origins are unknown. To that end, we used Illumina and Nanopore sequencing to generate whole-genome sequencing data for a total of 22 <italic>S. cerevisiae</italic> yeast strains: 16 from the Guinness collection and 6 other historical Irish brewing. The origins of the Guinness yeast were determined with a SNP-based analysis, demonstrating that the Guinness strains occupy a distinct group separate from other historical Irish brewing yeasts. Assessment of chromosome number, copy number variation and phenotypic evaluation of key brewing attributes established Guinness yeast-specific SNPs but no specific chromosomal amplifications. Our analysis also demonstrated the effects of yeast storage on phylogeny. Altogether, our results suggest that the Guinness yeast used today is related to the first deposited Guinness yeast; the 1903 Watling Laboratory Guinness yeast.</p>", "<p id=\"Par2\">A genomic analysis of 22 <italic>S. cereviseae</italic> yeast strains used in beer brewing suggest that yeast used to brew Guinness form a distinct evolutionary sub-clade, and that the modern-day Guinness yeast is closely related to the 1903 Watling Laboratory Guinness yeast.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n\n\n\n\n\n\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s42003-023-05587-3.</p>", "<title>Acknowledgements</title>", "<p>The authors would like to thank the Guinness Brand Team for sponsoring the work. The historic records presented in this study were curated with the help of former Guinness Group Microbiologists Dr Edward Bourke. The authors would like to thank Dr Kieran Joyce and his team for their analytical support and Marcus Bengelstorff and Patrick Kerr for their brewing expertise. D.K. and P.C. would like to thank Dr Brigida Gallone, Dr Jan Steensels, Prof Kevin Verstrepen et al. for their 2016 investigation. The St James’s Gate Yeast Library has been maintained since 1903 by numerous Guinness’ Microbiologists however the authors would like to give special thanks to June Hurley, Dr Barbara Cantwell, Dr Daniel Donnelly, Angela Larkin, Dr Vidya Dixit and Noel Early.</p>", "<title>Author contributions</title>", "<p>Illumina and Nanopore sequencing were performed by E.K. with bioinformatic analysis done by P.C. Phenotypic analysis was conducted by D.K. and J.K. Historical archive analysis was provided by E.C. D.K designed the study with bioinformatic experimental design made with P.C. and E.K. D.K. wrote the manuscript with editorial input from E.K., P.C., C.B. and S.S.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par69\"><italic>Communications Biology</italic> thanks Isheng Tsai and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editor: George Inglis. A peer review file is available.</p>", "<title>Data availability</title>", "<p>Illumina and Nanopore (basecalled, demultiplexed) reads for all sequenced samples in this manuscript are deposited in the European Nucleotide Archive (ENA) under the project accession PRJEB62101. All experimental data underlying figures are presented in Supplementary Data ##SUPPL##7##5##.</p>", "<title>Competing interests</title>", "<p id=\"Par70\">Daniel Kerrruish, Jessica Kearns, Eibhlin Colgan, and Sandra Stelma are employees of Diageo Ireland, the owners of Guinness. Chris Boulton is employed as a consultant by Diageo Ireland. All other authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Phylogeny and population structure of the Guinness yeast and other industrial <italic>S. cerevisiae</italic> strains.</title><p><bold>a</bold> Guinness and other Irish brewing yeast within the maximum-likelihood phylogenetic tree of <italic>S. cerevisiae</italic>. Guinness and other Irish brewing yeast were sequenced using an Illumina MiSeq platform and combined with 154 previously sequenced <italic>S. cerevisiae</italic><sup>##REF##27610566##4##</sup>. Branch length reflects the number of substitutions per site, with colour denoting the yeast lineage. A maximum-likelihood (ML) phylogenetic tree was reconstructed in RAxML v8.2.4<sup>##REF##24451623##15##</sup>, performing 100 iterations to search for the best tree, using a discrete GTRGAMMA model of rate heterogeneity. Bootstrap branch support was assessed by performing 1000 pseudoreplicates. Trees were visualised using ggtree (v 3.6.2)<sup>##REF##30351396##16##</sup>. Yeasts that are marked in highlighted orange are described as being Mosaic<sup>##REF##27610566##4##</sup>. Yeast marked with three asterisk are used to brew beers in the Hefeweizen style. <bold>b</bold> Principal component analysis of 434,890 SNPs sites from the assessed 176 <italic>S. cerevisiae</italic> strains. Population differences indicated by colour; NS not specified. <bold>c</bold> Population structure of the 434,890 SNPs sites of the <italic>S. cerevisiae</italic> strains used in this study. IDS1 was used as a representative Guinness yeast sample for all Guinness yeast due to the high degree of sequence similarity analysis consequently 161 genomes admixture were assessed. Resolved population fractions are represented by the vertical axis; colours denote estimated ancestral membership. Varying the number of ancestral populations (K) between 1 and 10 using the simple prior implemented in fastSTRUCTURE<sup>##REF##24700103##17##</sup>, <italic>K</italic> = 8 found to be optimal.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>Hierarchical clustering of the 16 Guinness yeast using standard dissimilarity matrix of 20,000 protein coding biallelic SNPs as determined by de novo assembly of the Guinness yeast to the MinION sequenced reference genome IDS1.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Estimated CNV in 250 base pair non-overlapping windows across the entire genome of the 16 Guinness yeast.</title><p>A black dot on a plot represents a window where the estimate copy number is 4. A blue dot represents a region with an estimated loss of copy number (&lt;4) and an orange dot represents a region of estimated increased copy number (&gt;4).</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>Phenotypic assessment of the Guinness yeast.</title><p><bold>a</bold> Percentage weight loss, <bold>b</bold> ethanol production, <bold>c</bold> sugar concentration <bold>d</bold> assessment of esters, <bold>e</bold> higher alcohols and <bold>f</bold> 2, 3 butanedione (diacetyl) production at the cessation of fermentation using the different Guinness yeast. Fermentations were performed using 100 ml of 12<sup>o</sup>P all-malt wort, with an inoculation rate of 1 × 10<sup>7</sup> ml<sup>−1</sup> cells. Samples were incubated at 25 °C and stirred at 250 rpm. Observations presented are <italic>n</italic> = 3 biologically independent experiments. In <bold>a</bold> each time point represents the mean of 3 independent replicates and standard errors are shown as SD ± error bars.</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><title>1HL fermentation and flavour assessment of the Guinness Park Royal 1979 and IDS2 yeast strains compared to present Guinness production yeast.</title><p><bold>a</bold> Rate of fermentation and <bold>b</bold> flavour of Guinness Irish Draught Stout brewed using a control Guinness yeast from Dublin St James’s Gate and the Guinness yeasts: Park Royal 1979 and IDS2. All fermentations were conducted in 100 L fermentation vessels with Guinness wort collected from St James’s Gate Brewery. The tasting samples were assessed, in duplicate using the Guinness Draught attribute list by an expert panel using Quantitative Descriptive methodology. A minimum of <italic>n</italic> = 18 assessors were used to determine flavour attributes.</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><title>Phenolic off-flavour and flocculation phenotype of the Guinness yeast.</title><p><bold>a</bold> Phenolic Off Flavours (POF) production as determined by the Analytica-EBC Method 2.3.9.5<sup>##UREF##40##97##</sup> and Gas chromatography mass spectrometry, and <bold>b</bold> Illumina sequencing data of the single nucleotide polymorphism mutations of the POF genes <italic>FDC1</italic> and <italic>PAD1</italic> of the different Guinness yeast. The effects of the SNP mutations result in amino acid substitutions that are non-synonymous (NS) or synonymous (S). Each POF observations presented are <italic>n</italic> = 3 biologically independent experiments. <bold>c</bold> Flocculence characteristics of the different Guinness yeast as determined by the Analytica-EBC Gilliland Method EBC 3.5.3.1<sup>##UREF##16##48##</sup>. The method class yeast flocculence in terms of non-flocculant (Class 1), slightly flocculant (Class 2), moderately flocculant (Class 3) and highly flocculant (Class 4). Observations presented are <italic>n</italic> = 10 biologically independent experiments.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Name and description of yeast strains used in this study and selected following a literature review of the Guinness archives.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Yeast</th><th>Name</th><th>Source</th><th>Brewing group</th></tr></thead><tbody><tr><td>Irish Draught Stout 1*</td><td>IDS1</td><td>1959 St James’s Gate Pitching Yeast</td><td>Guinness</td></tr><tr><td>Irish Draught Stout 2*</td><td>IDS2</td><td>1959 St James’s Gate Pitching Yeast</td><td>Guinness</td></tr><tr><td>Foreign Extra Stout 1*</td><td>FES 1</td><td>Class I mutant from IDS</td><td>Guinness</td></tr><tr><td>Foreign Extra Stout 2*</td><td>FES 2</td><td>Class I mutant from IDS</td><td>Guinness</td></tr><tr><td>Foreign Extra Stout 3*</td><td>FES 3</td><td>Class I mutant from IDS</td><td>Guinness</td></tr><tr><td>1947</td><td>1947</td><td>1947 St James’s Gate Pitching Yeast</td><td>Guinness</td></tr><tr><td>1950</td><td>1950</td><td>1950 St James’s Gate Pitching Yeast</td><td>Guinness</td></tr><tr><td>1955</td><td>1955</td><td>1955 St James’s Gate Pitching Yeast Pitching yeast</td><td>Guinness</td></tr><tr><td>1959 brewing yeast</td><td>59 BY</td><td>Co-flocculant yeast used with IDS between 1959 and 1963 to aid beer processing</td><td>Guinness</td></tr><tr><td>1959</td><td>1959</td><td>1959 St James’s Gate Pitching Yeast</td><td>Guinness</td></tr><tr><td>Ikeja</td><td>Ikeja</td><td>Yeast selected from the 1959 St James’s Gate Pitching Yeast. Used in the first Guinness African Brewery, Ikeja, Lagos, Nigeria</td><td>Guinness</td></tr><tr><td>1960</td><td>1960</td><td>Yeast reselected from 1947 St James’s Gate Pitching Yeast</td><td>Guinness</td></tr><tr><td>1981</td><td>1981</td><td>Yeast reselected from IDS</td><td>Guinness</td></tr><tr><td>Park Royal 1960</td><td>PR1960</td><td>1960 Guinness Park Royal Brewery Pitching Yeast</td><td>Guinness</td></tr><tr><td>Park Royal 1979</td><td>PR1979</td><td>1979 Guinness Park Royal Brewery Pitching Yeast</td><td>Guinness</td></tr><tr><td>Park Royal 1986</td><td>PR1986</td><td>1986 Guinness Park Royal Brewery Pitching Yeast</td><td>Guinness</td></tr><tr><td>Cherry</td><td>Cherry 1960</td><td>Cherry’s Pitching Yeast</td><td>Cherry</td></tr><tr><td>Great Northern Brewery 1958</td><td>GNB 1958</td><td>Great Northern Brewery Stout Pitching Yeast</td><td>GNB</td></tr><tr><td>Macardle 1965</td><td>Macardle 1965</td><td>1965 Macardle Pitching Yeast</td><td>Macardle Moore</td></tr><tr><td>Macardle 1993</td><td>Macardle 1993</td><td>1970 Smithwick’s Pitching latterly used as Macardles Pitching Yeast</td><td>Macardle Moore</td></tr><tr><td>Perry</td><td>Perry 1967</td><td>1967 Perry Pitching Yeast</td><td>Perry</td></tr><tr><td>Smithwicks*</td><td>Smithwicks 1986</td><td>1986 Smithwicks Production Yeast</td><td>Smithwick’s</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Sporulation percentage; mean sequencing coverage along <italic>S. cerevisiae</italic> S288C genome, transition, transversion and singleton SNPs, and total indels of the 16 sequenced Guinness yeast.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Guinness yeast</th><th>Sporulation (%)</th><th>Average sequencing coverage (x)</th><th>Total transition SNPs</th><th>Total transversion SNPs</th><th>Number of singletons</th><th>Total indels</th></tr></thead><tbody><tr><td>IDS1</td><td>0</td><td>417.6</td><td>59787</td><td>20606</td><td>142</td><td>7033</td></tr><tr><td>IDS2</td><td>0.03</td><td>1230.1</td><td>59226</td><td>20494</td><td>56</td><td>7111</td></tr><tr><td>FES 1</td><td>1.09</td><td>391.8</td><td>59740</td><td>20579</td><td>168</td><td>7075</td></tr><tr><td>FES 2</td><td>0.13</td><td>713.4</td><td>59841</td><td>20659</td><td>30</td><td>7099</td></tr><tr><td>FES 3</td><td>0</td><td>968.1</td><td>60000</td><td>20715</td><td>29</td><td>7166</td></tr><tr><td>1947</td><td>0.2</td><td>835.8</td><td>58899</td><td>20322</td><td>59</td><td>7073</td></tr><tr><td>1950</td><td>0</td><td>770.5</td><td>58795</td><td>20238</td><td>39</td><td>7017</td></tr><tr><td>1955</td><td>0</td><td>767.8</td><td>60012</td><td>20731</td><td>1676</td><td>7198</td></tr><tr><td>59 brewing yeast</td><td>0</td><td>879.2</td><td>58392</td><td>20082</td><td>84</td><td>6855</td></tr><tr><td>1959</td><td>2.77</td><td>996.3</td><td>58525</td><td>20163</td><td>93</td><td>6999</td></tr><tr><td>Ikeja</td><td>0.79</td><td>1010.1</td><td>59703</td><td>20618</td><td>334</td><td>7079</td></tr><tr><td>1960</td><td>0.1</td><td>849.9</td><td>57754</td><td>19935</td><td>303</td><td>6897</td></tr><tr><td>1981</td><td>0.2</td><td>531.2</td><td>60227</td><td>20815</td><td>117</td><td>7181</td></tr><tr><td>Park Royal 1960</td><td>0.03</td><td>888.1</td><td>57735</td><td>19978</td><td>342</td><td>6885</td></tr><tr><td>Park Royal 1979</td><td>0</td><td>718.7</td><td>59815</td><td>20637</td><td>84</td><td>7138</td></tr><tr><td>Park Royal 1986</td><td>0</td><td>304.6</td><td>59898</td><td>20694</td><td>132</td><td>7057</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM5\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM6\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM7\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM8\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM9\"></supplementary-material>" ]
[ "<table-wrap-foot><p>*Denotes yeast presently used in beer production.</p></table-wrap-foot>", "<table-wrap-foot><p>Sporulation percentage was determined using the ASBC sporulation method<sup>##UREF##36##93##</sup>. Sequencing analysis of the Guinness yeast were performed using an Illumina MiSeq machine reading with a minimum depth of 30× coverage using 2 × 250 bp paired reads. SNPs and indels were determined through de novo assembly of the Guinness yeast compared to the reference yeast <italic>S. cerevisiae</italic> S288C.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"42003_2023_5587_Fig1_HTML\" id=\"d32e937\"/>", "<graphic xlink:href=\"42003_2023_5587_Fig2_HTML\" id=\"d32e1037\"/>", "<graphic xlink:href=\"42003_2023_5587_Fig3_HTML\" id=\"d32e1056\"/>", "<graphic xlink:href=\"42003_2023_5587_Fig4_HTML\" id=\"d32e1157\"/>", "<graphic xlink:href=\"42003_2023_5587_Fig5_HTML\" id=\"d32e1496\"/>", "<graphic xlink:href=\"42003_2023_5587_Fig6_HTML\" id=\"d32e1560\"/>" ]
[ "<media xlink:href=\"42003_2023_5587_MOESM1_ESM.pdf\"><caption><p>Peer Review File</p></caption></media>", "<media xlink:href=\"42003_2023_5587_MOESM2_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>", "<media xlink:href=\"42003_2023_5587_MOESM3_ESM.docx\"><caption><p>Description of Additional Supplementary Files</p></caption></media>", "<media xlink:href=\"42003_2023_5587_MOESM4_ESM.xlsx\"><caption><p>Supplementary Data 1</p></caption></media>", "<media xlink:href=\"42003_2023_5587_MOESM5_ESM.xlsx\"><caption><p>Supplementary Data 2</p></caption></media>", "<media xlink:href=\"42003_2023_5587_MOESM6_ESM.xlsx\"><caption><p>Supplementary Data 3</p></caption></media>", "<media xlink:href=\"42003_2023_5587_MOESM7_ESM.xlsx\"><caption><p>Supplementary Data 4</p></caption></media>", "<media xlink:href=\"42003_2023_5587_MOESM8_ESM.xlsx\"><caption><p>Supplementary Data 5</p></caption></media>", "<media xlink:href=\"42003_2023_5587_MOESM9_ESM.pdf\"><caption><p>Reporting Summary</p></caption></media>" ]
[{"label": ["11."], "mixed-citation": ["Boulton, C. & Quain, D. "], "italic": ["Brewing Yeast and Fermentation"]}, {"label": ["13."], "mixed-citation": ["GDB/FN05/0002 Articles of Association. Two copies of the Memorandum and Articles of Association of Arthur Guinness Son and Company, "], "italic": ["Guinness Archives."]}, {"label": ["18."], "mixed-citation": ["Salazar, A. N. & Abeel, T., Alpaca: a kmer-based approach for investigating mosaic structures in microbial genomes. Preprint at "], "italic": ["bioRxiv"]}, {"label": ["19."], "mixed-citation": ["Salazar, A. N. et al. Nanopore sequencing enables near-complete de novo assembly of Saccharomyces cerevisiae reference strain CEN. PK113-7D. "], "italic": ["FEMS Yeast Res."], "bold": ["17"]}, {"label": ["20."], "surname": ["Nijkamp"], "given-names": ["JF"], "article-title": ["De novo sequencing, assembly and analysis of the genome of the laboratory strain Saccharomyces cerevisiae CEN. PK113-7D, a model for modern industrial biotechnology"], "source": ["Microb. Cell Factories"], "year": ["2012"], "volume": ["11"], "fpage": ["1"], "lpage": ["17"], "pub-id": ["10.1186/1475-2859-11-36"]}, {"label": ["23."], "surname": ["Bilinski", "Casey"], "given-names": ["CA", "GP"], "article-title": ["Developments in sporulation and breeding of brewer\u2019s yeast"], "source": ["Yeast"], "year": ["1989"], "volume": ["5"], "fpage": ["429"], "lpage": ["438"], "pub-id": ["10.1002/yea.320050603"]}, {"label": ["24."], "mixed-citation": ["Briggs, D. E., Brookes, P. A., Boulton, C. A. & Stevens, R. "], "italic": ["Brewing: Science and Practice"]}, {"label": ["27."], "surname": ["Meilgaard", "Reid", "Wyborski"], "given-names": ["MC", "DS", "KA"], "article-title": ["Reference standards for beer flavor terminology system"], "source": ["J. Am. Soc. Brew. Chem."], "year": ["1982"], "volume": ["40"], "fpage": ["119"], "lpage": ["128"]}, {"label": ["32."], "surname": ["Krogerus", "Gibson"], "given-names": ["K", "BR"], "article-title": ["125th anniversary review: diacetyl and its control during brewery fermentation"], "source": ["J. Inst. Brew."], "year": ["2013"], "volume": ["119"], "fpage": ["86"], "lpage": ["97"]}, {"label": ["36."], "surname": ["Katz", "Hahn-H\u00e4gerdal", "Gorwa-Grauslund"], "given-names": ["M", "B", "MF"], "article-title": ["Screening of two complementary collections of Saccharomyces cerevisiae to identify enzymes involved in stereo-selective reductions of specific carbonyl compounds: an alternative to protein purification"], "source": ["Enzym. Microb. Technol."], "year": ["2003"], "volume": ["33"], "fpage": ["163"], "lpage": ["172"], "pub-id": ["10.1016/S0141-0229(03)00086-3"]}, {"label": ["37."], "mixed-citation": ["Brumsted, D., Lauterbach, A. F. & West, D. B. Phenolic characteristics in brewing 111. The role of yeast. In "], "italic": ["Proc. American Society of Brewing Chemists Annual Meeting, St Louis"]}, {"label": ["38."], "surname": ["Madigan", "McMurrough", "Smyth"], "given-names": ["D", "I", "MR"], "article-title": ["Rapid determination of 4-vinyl guaiacol and ferulic acid in beers and worts by high-performance liquid chromatography"], "source": ["J. Am. Soc. Brew. Chem."], "year": ["1994"], "volume": ["52"], "fpage": ["152"], "lpage": ["155"]}, {"label": ["39."], "surname": ["Maillard", "Berset"], "given-names": ["MN", "C"], "article-title": ["Evolution of antioxidant activity during kilning: role of insoluble bound phenolic acids of barley and malt"], "source": ["J. Agric. Food Chem."], "year": ["1995"], "volume": ["43"], "fpage": ["1789"], "lpage": ["1793"], "pub-id": ["10.1021/jf00055a008"]}, {"label": ["41."], "surname": ["Vidgren", "Londesborough"], "given-names": ["V", "J"], "article-title": ["125th anniversary review: yeast flocculation and sedimentation in brewing"], "source": ["J. Inst. Brew."], "year": ["2011"], "volume": ["117"], "fpage": ["475"], "lpage": ["487"], "pub-id": ["10.1002/j.2050-0416.2011.tb00495.x"]}, {"label": ["43."], "surname": ["Stratford"], "given-names": ["M"], "article-title": ["Yeast flocculation: calcium specificity"], "source": ["Yeast"], "year": ["1989"], "volume": ["5"], "fpage": ["487"], "lpage": ["496"], "pub-id": ["10.1002/yea.320050608"]}, {"label": ["44."], "surname": ["Stratford"], "given-names": ["M"], "article-title": ["Yeast flocculation: a new perspective"], "source": ["Adv. Microb. Physiol."], "year": ["1992"], "volume": ["33"], "fpage": ["1"], "lpage": ["71"], "pub-id": ["10.1016/S0065-2911(08)60215-5"]}, {"label": ["48."], "mixed-citation": ["Gilliland, R. B. "], "italic": ["Proc. European Brewery Convention, Brighton"]}, {"label": ["50."], "surname": ["Watari", "Nomura", "Sahara", "Koshino", "Ker\u00e4nen"], "given-names": ["J", "M", "H", "S", "S"], "article-title": ["Construction of flocculent brewer\u2019s yeast by chromosomal integration of the yeast flocculation gene FLO1"], "source": ["J. Inst. Brew."], "year": ["1994"], "volume": ["100"], "fpage": ["73"], "lpage": ["77"], "pub-id": ["10.1002/j.2050-0416.1994.tb00809.x"]}, {"label": ["52."], "surname": ["Anderson"], "given-names": ["R"], "article-title": ["One yeast or two? Pure yeast and top fermentation"], "source": ["Brew. Hist."], "year": ["2012"], "volume": ["149"], "fpage": ["30"], "lpage": ["38"]}, {"label": ["53."], "mixed-citation": ["GDB/RD02/0365. File No 521A - Visits in Great Britain and Ireland 1902-11-21-1978-12-07. In "], "italic": ["Guinness Archives."]}, {"label": ["54."], "surname": ["Russell", "Stewart"], "given-names": ["I", "GG"], "article-title": ["Liquid nitrogen storage of yeast cultures compared to more traditional storage methods"], "source": ["J. Am. Soc. Brew. Chem."], "year": ["1981"], "volume": ["39"], "fpage": ["19"], "lpage": ["24"]}, {"label": ["55."], "surname": ["Donnelly", "Hurley"], "given-names": ["D", "J"], "article-title": ["Yeast monitoring: the Guinness experience"], "source": ["Ferment"], "year": ["1996"], "volume": ["9"], "fpage": ["283"], "lpage": ["286"]}, {"label": ["56."], "mixed-citation": ["Berry, D. R. & Slaughter, J. C., Alcoholic beverage fermentations. In "], "italic": ["Fermented beverage production"]}, {"label": ["59."], "surname": ["Albertin"], "given-names": ["W"], "article-title": ["Evidence for autotetraploidy associated with reproductive isolation in Saccharomyces cerevisiae: towards a new domesticated species"], "source": ["J. Evolut. Biol."], "year": ["2009"], "volume": ["22"], "fpage": ["2157"], "lpage": ["2170"], "pub-id": ["10.1111/j.1420-9101.2009.01828.x"]}, {"label": ["62."], "surname": ["Linder", "Greco", "Seidl", "Matsui", "Ehrenreich"], "given-names": ["RA", "JP", "F", "T", "IM"], "article-title": ["The stress-inducible peroxidase TSA2 underlies a conditionally beneficial chromosomal duplication in Saccharomyces cerevisiae"], "source": ["G3 Genes Genomes Genet."], "year": ["2017"], "volume": ["7"], "fpage": ["3177"], "lpage": ["3184"], "pub-id": ["10.1534/g3.117.300069"]}, {"label": ["71."], "surname": ["Smart", "Whisker"], "given-names": ["KA", "S"], "article-title": ["Effect of serial repitching on the fermentation properties and condition of brewing yeast"], "source": ["J. Am. Soc. Brew. Chem."], "year": ["1996"], "volume": ["54"], "fpage": ["41"], "lpage": ["44"]}, {"label": ["72."], "surname": ["Powell", "Diacetis"], "given-names": ["CD", "AN"], "article-title": ["Long term serial repitching and the genetic and phenotypic stability of brewer\u2019s yeast"], "source": ["J. Inst. Brew."], "year": ["2007"], "volume": ["113"], "fpage": ["67"], "lpage": ["74"], "pub-id": ["10.1002/j.2050-0416.2007.tb00258.x"]}, {"label": ["73."], "surname": ["McMurrough"], "given-names": ["I"], "article-title": ["Control of ferulic acid and 4\u2010vinyl guaiacol in brewing"], "source": ["J. Inst. Brew."], "year": ["1996"], "volume": ["102"], "fpage": ["327"], "lpage": ["332"], "pub-id": ["10.1002/j.2050-0416.1996.tb00918.x"]}, {"label": ["74."], "mixed-citation": ["Stewart, G. G., Russell, I. & Anstruther, A. eds. "], "italic": ["Handbook of Brewing"]}, {"label": ["75."], "surname": ["Knight", "Klaere", "Fedrizzi", "Goddard"], "given-names": ["S", "S", "B", "MR"], "article-title": ["Regional microbial signatures positively correlate with differential wine phenotypes: evidence for a microbial aspect to terroir"], "source": ["Sci. Rep."], "year": ["2015"], "volume": ["5"], "fpage": ["1"], "lpage": ["10"], "pub-id": ["10.1038/srep14233"]}, {"label": ["77."], "surname": ["Van Holle"], "given-names": ["A"], "article-title": ["Relevance of hop terroir for beer flavour"], "source": ["J. Inst. Brew."], "year": ["2021"], "volume": ["127"], "fpage": ["238"], "lpage": ["247"], "pub-id": ["10.1002/jib.648"]}, {"label": ["78."], "surname": ["Richards"], "given-names": ["M"], "article-title": ["The use of giant\u2010colony morphology for the differentiation of brewing yeasts"], "source": ["J. Inst. Brew."], "year": ["1967"], "volume": ["73"], "fpage": ["162"], "lpage": ["166"], "pub-id": ["10.1002/j.2050-0416.1967.tb03028.x"]}, {"label": ["79."], "collab": ["ASBC method yeast 13. American Society of Brewing Chemists."], "article-title": ["Report of subcommittee on differentiation of brewing yeast strains by PCR fingerprinting"], "source": ["J. Am. Soc. Brew. Chem."], "year": ["2008"], "volume": ["66"], "fpage": ["256"], "lpage": ["260"]}, {"label": ["86."], "surname": ["Palmer", "Stajich"], "given-names": ["J", "J"], "article-title": ["nextgenusfs/funannotate: funannotate v1.5.3 (Version 1.5.3)"], "source": ["Zenodo"], "year": ["2019"], "pub-id": ["10.5281/zenodo.2604804"]}, {"label": ["87."], "mixed-citation": ["Van der Auwera, G. A. & O\u2019Connor, B. D. "], "italic": ["Genomics in the Cloud: Using Docker, GATK, and WDL in Terra"]}, {"label": ["92."], "surname": ["Fijarczyk"], "given-names": ["A"], "article-title": ["The genome sequence of the Jean-Talon strain, an archeological beer yeast from Qu\u00e9bec, reveals traces of adaptation to specific brewing conditions"], "source": ["G3 Genes Genomes Genet."], "year": ["2020"], "volume": ["10"], "fpage": ["3087"], "lpage": ["3097"], "pub-id": ["10.1534/g3.120.401149"]}, {"label": ["93."], "collab": ["ASBC method yeast 7. American Society of Brewing Chemists."], "article-title": ["Report of Subcommittee on Microbiology"], "source": ["J. Am. Soc. Brew. Chem."], "year": ["1985"], "volume": ["43"], "fpage": ["16"]}, {"label": ["94."], "mixed-citation": ["Jorgensen A. & Hansen A. "], "italic": ["Mikroorganismen der G\u00e4rungsindustrie"]}, {"label": ["95."], "surname": ["Smart", "Chambers", "Lambert", "Jenkins"], "given-names": ["KA", "KM", "I", "C"], "source": ["J. Am. Soc. Brew. Chem."], "year": ["1999"], "volume": ["57"], "fpage": ["18"]}, {"label": ["96."], "surname": ["Buckee", "Mundy"], "given-names": ["GK", "AP"], "article-title": ["Determination of vicinal diketones in beer by gas chromatography (headspace technique) \u2013 collaborative trial"], "source": ["J. Inst. Brew."], "year": ["1994"], "volume": ["100"], "fpage": ["247"], "lpage": ["253"], "pub-id": ["10.1002/j.2050-0416.1994.tb00820.x"]}, {"label": ["97."], "mixed-citation": ["Brewers of Europe. Phenolic off Flavour Method. "], "italic": ["Analytica-EBC"]}, {"label": ["98."], "surname": ["dos Santos Navarro"], "given-names": ["RDC"], "article-title": ["Optimized Descriptive Profile: a rapid methodology for sensory description"], "source": ["Food Qual. Preference"], "year": ["2012"], "volume": ["24"], "fpage": ["190"], "lpage": ["200"], "pub-id": ["10.1016/j.foodqual.2011.10.014"]}, {"label": ["99."], "mixed-citation": ["Lawless, H. T. & Heymann, H. "], "italic": ["Sensory Evaluation of Food: Principles and Practices"]}]
{ "acronym": [], "definition": [] }
99
CC BY
no
2024-01-14 23:40:15
Commun Biol. 2024 Jan 12; 7:68
oa_package/57/65/PMC10786833.tar.gz
PMC10786834
38216629
[ "<title>Introduction</title>", "<p id=\"Par2\">Owing it almost entirely to classical philosophy, morality and moral decision-making have been traditionally presumed to be solely the fruits of rational thought and deliberation<sup>##REF##11699120##1##</sup>. Nevertheless, recent research has observed that emotion and negative emotionality<sup>##REF##26177954##2##</sup>, both of which can be rooted in interoception and the bodily sense of self<sup>##UREF##0##3##</sup>, play fundamental roles in moral reasoning.</p>", "<p id=\"Par3\">Regarding negative emotionality, studies have shown that it is able to prompt reluctance towards engaging in anti-social behaviors<sup>##REF##23484345##4##</sup>. Individuals who tend to act and adhere to societal norms and social pressure, are more prone to have increased levels of negative affect as a function of their aversion towards risk and uncertainty<sup>##REF##23484345##4##–##REF##22854791##7##</sup>. Furthermore, the “gut” feeling commonly described when conflicting with others or incurred in by the expectation of harming another person<sup>##REF##15473975##8##</sup>, has been observed to be a common trigger for negative emotionality, as well as anxiety<sup>##REF##23783199##9##,##REF##22033741##10##</sup>. What’s more, research using the moral dilemma task, has also observed that psychopaths possessing low-anxiety are more likely than either high-anxiety psychopaths and non-psychopathic participants to endorse directly harmful behaviors in moral-personal dilemmas. Both clinical observations and criterion group studies of psychopaths therefore suggest that anxiety may play a key role in modulating preferences for direct harmful acts in moral-personal dilemmas. Nonetheless, the latter conclusions must be taken with caution, as they have been determined by using correlational data, which cannot test for a causal role of anxiety in moral decision-making<sup>##REF##23025561##11##</sup>.</p>", "<p id=\"Par4\">Interestingly, studies using false feedback paradigms –where subjects listened to a fake-fast or a fake-normal heartbeat posing to be that of themselves– have shown that an increased heart rate (even when fake) predisposed participants to volunteer more towards charitable causes, and curbed down lying for selfish purposes<sup>##REF##22889162##12##</sup>. Moreover, research has also observed that both physical and moral disgust equally provoke facial expressions of disgust<sup>##REF##19251631##13##,##REF##8014832##14##</sup>, owing to the fact that brain regions that deal with physical and moral disgust overlap with one another<sup>##REF##11923438##15##,##REF##18345982##16##</sup>. But how is it that morality and moral decision-making, both of which have been intimately linked to neural and cognitive processes (being them through rationalist, intuitionist, dual or dynamic models)<sup>##UREF##3##17##,##REF##28343626##18##</sup>, interact with interoception and biological regulation –i.e. bodily functions? One prominent hypothesis explaining such findings posits that emotional experiences guide morality and moral decision-making by making use of bodily signals or ‘somatic states’, which exert influence over conscious responses and decisions. Such hypothesis has come to be known as the somatic marker hypothesis<sup>##REF##8941953##19##,##REF##27126289##20##</sup>. In line with this hypothesis, studies using the noradrenergic beta-adrenoceptor antagonist propranolol –originally developed to treat heart and circulatory-related conditions<sup>##REF##23085134##21##,##REF##36077489##22##</sup>– have observed the drug’s ability to influence moral decision-making; as its administration reduced participants’ utilitarian responses in a moral dilemma task. This is due to propranolol being able to suppress noradrenergic receptors, reduce heart rate, and lower overall emotional arousal, which leads to an increase in aversion towards harming others<sup>##REF##27126289##20##,##REF##23085134##21##</sup>, as well as a decrease in aggression<sup>##REF##27126289##20##,##REF##10440008##23##</sup>. Furthermore, research using the selective serotonin reuptake inhibitor (SSRI) citalopram, showed that increasing serotonin via SSRI administration promotes prosocial behaviors by amplifying harm aversion<sup>##REF##20876101##24##</sup>, owing to the fact that serotonin seems to be essential for translating aversive stimuli and distress cues into behavioral inhibition and withdrawal responses<sup>##REF##7587017##25##,##REF##22643930##26##</sup>. Moreover, envisioning harmful behaviors directed towards others engages neural areas such as the ventromedial prefrontal cortex, anterior cingulate cortex, the striatum and the amygdala, all of which possess dense serotonergic projections<sup>##REF##25627116##27##</sup>. Conversely, it has been observed that pharmacological enhancements of dopamine function increase harm aversion towards oneself, but decrease harm aversion towards others; thus, reducing altruism and prosocial behaviors<sup>##REF##26144968##28##</sup>.</p>", "<p id=\"Par5\">The anxiolytic drug lorazepam is a high-potency 3-hydroxy benzodiazepine prescribed for the relief of anxious symptomatology<sup>##UREF##4##29##</sup>, as it enhances GABA release in the brain by binding to the GABA receptors. Past research has also demonstrated that there is a dose-dependent decrease in insula and amygdala activation during emotional processing following lorazepam administration<sup>##REF##15753241##30##</sup>. This is in line with the current neuroscientific consensus which posits the amygdala as a key neural region implicated in fear conditioning, and the insula as a key brain region involved in the modulation of affective and aversive interoceptive processing<sup>##REF##15753241##30##,##REF##16780813##31##</sup>. Furthermore, insular interoceptive processing has been observed to be correlated with GABA concentrations in this same brain region, to such degree that both GABA and interoceptive signal changes in the insula predict the intensity of depressed affect in individuals<sup>##REF##23618604##32##</sup>. Interestingly, when it comes to morality, psychopharmacological research in human subjects has demonstrated that lorazepam incurs in a dose-dependent increase in the participants' willingness to endorse responses that directly harm others in moral-personal dilemmas, regardless of whether the motivation for those harmful acts is deontological or utilitarian, this due to the drug’s ability to reduce threat intensity during the moral dilemma task<sup>##REF##23025561##11##</sup>. Therefore, it is strongly suggested that anxiolytic drugs cause their effects by altering GABAergic modulation and activity in neural regions involved in emotional negativity and anxious symptomatology, as well as, presumably, interoceptive processing<sup>##REF##16780813##31##,##UREF##5##33##</sup>.</p>", "<p id=\"Par6\">The general objective of the present double-blind, crossover design, placebo-controlled study is that of evaluating lorazepam’s GABAergic modulation on moral decision-making. In order to reach this objective, this study aims to tackle the limitations of previous studies delving into the GABAergic modulation of neural regions involved in moral reasoning and moral decision-making. More specifically, Perkins, et al.<sup>##REF##23025561##11##</sup>’s study, which was able to observe that lorazepam administration prompted participants to endorse direct harmful acts more readily when engaging in moral-personal dilemmas; consequently, arriving at the conclusion that lorazepam’s GABAergic modulation within emotional centers in the brain decreases inhibitions when partaking in the moral dilemma task, thus, effectively increasing the participants’ ruthlessness. Nevertheless, said study would have highly benefitted from introducing perspective taking (1st vs. 3rd person perspective) among the variables in its experimental design, in order to observe lorazepam’s interaction on the moral dilemma task depending on personal perspective-taking. In the same manner, we think that said study might also benefit from analizing the differential effects of lorazepam in evitable and inevitable harm in the moral dilemma task, since, and despite their shared theoretical relevance to emotional processes, no study has examined said associations between inevitability of bringing about harm and fear conditioning, as well as aversive interoceptive processes. As such, we have included these new variables in the experimental design of the present study, as to complement Perkins et al.’s findings. We hypothesize, as Perkins et al. did before us, that lorazepam will be able to modulate the participants’ willingness to commit (or not) certain kinds of moral acts. Specifically, our primary hypothesis (H1) is that our study will be able to replicate Perkins et al.’s results concerning the interaction between lorazepam and the degree of physical involvement of the participant in the moral dilemma task –e.g. non-moral dilemma vs. personal dilemma vs. impersonal dilemma–, with lorazepam exerting a larger effect on personal dilemmas versus non-moral and impersonal dilemmas (study 1). For our second hypothesis (H2), we anticipate a larger lorazepam effect for the outcome of evitable harm. Personal moral dilemmas which include evitable harm tend to elicit a greater and more pronounced conflict between deontological and utilitarian styles of moral decision-making (Study 1). Third, we hypothesize (H3) that the effects of lorazepam will interact with choice-of-action endorsement and moral judgment during the moral dilemma task evaluation, with choice-of-action endorsement being operationalized as the emotional processing of moral dilemmas dependent of 1st person perspective-taking (e.g. “is it morally permissible for <italic>you</italic> to press the switch?”), and moral judgement being operationalized as the emotional processing of moral dilemmas dependent of 3rd person perspective-taking (e.g. “is it morally permissible for [X individual] to press the switch?”) (study 2). Specifically, we anticipate a larger lorazepam effect for choice-of-action endorsements than for moral judgements.</p>" ]
[ "<title>Methods</title>", "<title>Participants</title>", "<p id=\"Par7\">Forty-one healthy volunteers (23 males), aged between 21 and 31 (mean ± SD: 23.63 ± 2.44) years, were recruited from the community via online posts and paper flyers. All participants were Han Chinese and right-handed.</p>", "<p id=\"Par8\">Participants were screened for major psychiatric illnesses (e.g. general anxiety disorder) by the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and excluded if there was evidence of comorbid neurological disorders (e.g. dementia, seizures), history of head injury, and alcohol or substance abuse or dependence within the past 5 years. The sample size was estimated using G*Power<sup>##REF##17695343##34##</sup> prior to the data collection. To detect a medium effect size<sup>##REF##23025561##11##</sup> for main effects in the ANOVA with 95% power (f = 0.3, with alpha = 0.05, number of groups = 2, number of measurements = 3), a sample size of 32 participants was required. All participants had normal vision or corrected normal vision. They participated in the study after providing written informed consent. This study was approved by the Ethics Committee of the National Yang-Ming Chiao-Tung University (YM104041E), and conducted in accordance with the Declaration of Helsinki. This study was not preregistered.</p>", "<title>Procedure</title>", "<p id=\"Par9\">In this double-blind, placebo-controlled, crossover design study, participants received a single 0.5-mg dose of lorazepam (ATIVAN) on one day, and a single dose of placebo (i.e. vitamin E) on another day. A crossover study is a longitudinal study in which subjects receive a sequence of different treatments. Every participant received 0.5 mg lorazepam one day and placebo on another day. The two sessions were scheduled at least 2 days apart. Both lorazepam and placebo were administered orally. The experimental sequence of lorazepam and placebo administration was counter-balanced between participants through a Latin square design, which randomizes through having equal number of AB (lorazepam-placebo) and BA (placebo-lorazepam) sequences. Thus, half of the participants went first through the lorazepam session, and half of them went first through the placebo session. To coincide with the pharmacokinetics of lorazepam<sup>##REF##30762##35##</sup>, participants filled out the moral dilemma to access the moral permissibility of harm approximately 2-h after treatment administration (Fig. ##FIG##0##1##).</p>" ]
[ "<title>Results</title>", "<p id=\"Par12\">Table ##TAB##0##1## presents descriptive statistics for the outcomes of endorsement rate by dilemma type and drug condition for the whole sample (n = 41). Given that the endorsement rates across participants are not normally distributed, we utilized non-parametric analysis for related samples in a within-subject design. This involved applying the Wilcoxon signed ranks test for two-sample comparisons and the Friedman Test for comparisons involving more than two groups (please see supplementary results, Tables ##SUPPL##0##S1## and ##SUPPL##0##S2## for the results of sensitivity tests using parametric analysis of repeated ANOVA).</p>", "<title>H1: Associations between source of bringing about harm and the effect of lorazepam</title>", "<p id=\"Par13\">An interaction between the source of bringing about harm (personal vs. impersonal) and the lorazepam effect was found. Lorazepam administration increased the endorsement of harming for the personal dilemmas (Lorazepam: 40.33 ± 2.32, Placebo: 33.59 ± 2.51, Z = 2.705, <italic>P</italic> = 0.007) but not for impersonal dilemmas (Lorazepam: 48.29 ± 4.47, Placebo: 63.9 ± 4.95, Z = 1.802, <italic>P</italic> = 0.069). This study replicated these findings from previous literature<sup>##REF##23025561##11##</sup>. Hypotheses 1 was supported (Table ##TAB##0##1##).</p>", "<title>H2: Associations between inevitability of bringing about harm and the effect of lorazepam</title>", "<p id=\"Par14\">In order to further examine whether the outcomes regarding harm in personal dilemmas interact with lorazepam administration, we compared the rates of harm endorsement under placebo and lorazepam conditions, specifically focusing on 'personal evitable harm' and 'personal inevitable harm' scenarios. Lorazepam administration had stronger endorsement for personal harming in both inevitable harm (Lorazepam: 58.8 ± 3.84, Placebo: 48.9 ± 4.831, Z = 2.092, <italic>P</italic> = 0.036) and evitable harm (Lorazepam: 28.17 ± 1.94, Placebo: 22.59 ± 2.23, Z = 2.018, <italic>P</italic> = 0.044), with similar Z value. The effect size of lorazepam administration did not change across the inevitability of bringing about harm (Table ##TAB##0##1##, Fig. ##FIG##1##2##). Hypotheses 2 was not supported.</p>" ]
[ "<title>General discussion</title>", "<p id=\"Par22\">The objective of the present double-blind, crossover design, placebo-controlled study, was that of assessing the potential modulation of fear conditioning and aversive interoceptive processing on moral decision-making. For this purpose, pharmacological interventions using the GABAergic agonist lorazepam where employed in order to evaluate whether the drug’s anxiolytic effect exerted any influence over moral-decision making in general, or if this modulation was dependent on the inevitability of harm, or on perspective-taking. Our initial results showed that acute lorazepam administration increased the endorsement of harming actions for personal moral dilemmas, but not for impersonal moral dilemmas; thus, confirming our first hypothesis (H1), and replicating Perkins, et al.<sup>##REF##23025561##11##</sup>’s findings. Nevertheless, our second hypothesis (2) was rejected, as we found that lorazepam administration had no significant effect on the endorsement of harm dependent of inevitability of harm. Last but not least, our results do corroborate our third hypothesis (H3), which states that when the moral dilemma task is modified to include perspective-taking (1st versus 3rd person perspective), lorazepam administration significantly increased the endorsement of harm in the 1st person choice-of-action probe, but not in the 3rd person moral judgement condition.</p>", "<p id=\"Par23\">In line with Perkins, et al.<sup>##REF##23025561##11##</sup>’s research, our findings demonstrate that lorazepam administration increases the endorsement of harming behaviors in personal moral dilemmas. In general, personal moral dilemmas tend to elicit a greater emotional arousal compared to impersonal moral dilemmas, as they highlight the individual’s direct bodily involvement when causing harm (e.g. having to physically push the man into the tracks in the footbridge dilemma, rather than just activating a switch in the trolley dilemma). Subsequently, this makes it more likely for the majority of participants to reject the endorsement of harmful behaviors proposed in the personal moral dilemmas<sup>##REF##15473975##8##,##REF##23025561##11##,##REF##11557895##37##,##REF##17377536##39##,##REF##23845564##42##–##REF##25071621##44##</sup>. However, we cannot conclude, as Perkins et al., that this is due to lorazepam administration incurring in an increment in ruthlessness. The moral dilemma task Perkins et al. utilized, and which was also used in the present research, is based on a particular type of dilemma, were participants are asked to decide whether they would sacrifice the life of a stranger in order to save the lives of numerous others; namely, ‘sacrificial dilemmas’. As such, and as other research has already argued<sup>##REF##32770106##45##</sup>, sacrificial dilemmas tend to disregard the prosocial and altruistic aspects–e.g. impartial concern and fairness in regards to the welfare of everyone<sup>##REF##31911126##46##</sup>– at the center of the utilitarian choices in these type of dilemmas. It is important to note though, that Perkins et al. do point out that ruthless decision-making is context-dependent: sometimes decisions that are considered ruthless benefit the greater good even when they are seen as objectively wrong (utilitarian perspective); and vice versa, sometimes ruthless decisions can be considered as objectively good when they’re in fact acting against the well-being of many (Kantian/deontological perspective) –e.g. telling the truth regarding the location of innocent victims of persecution, as lying is considered to be objectively wrong.</p>", "<p id=\"Par24\">The sole fact that the anxiolytic drug lorazepam was capable of increasing the endorsement of harming behaviors in personal moral dilemmas, adds to the mounting evidence observing that anxiogenic states –or at least negative emotionality– have an important part to play in moral decision-making. Furthermore, and although past studies concerning emotion regulation have already shown that the downregulation or suppression of negative affects (such as fear) have the ability to foster risky and utilitarian moral preferences, and that, conversely, the upregulation of negative emotionality inhibits utilitarian moral choices and incurs in important risk-avoidance biases<sup>##REF##26177954##2##,##UREF##8##47##</sup>; other research has observed that said risk-avoidant behaviors may be overly specific to anxiety, and not to negative affect as a whole<sup>##REF##22854791##7##</sup>.</p>", "<p id=\"Par25\">Moreover, the same mechanisms leading towards uncertainty and risky behaviors (i.e. actions made with no knowledge of their final consequences<sup>##UREF##9##48##</sup>) seem to underlie utilitarian moral choices. There is an important distinction to be made between anticipatory and anticipated emotions during the decision-making process<sup>##REF##11316014##49##</sup>. Anticipatory emotions are those with immediate emotional, deep-rooted visceral reactions (e.g. anxiety, fear, dread) towards risk and uncertainty. Anticipated emotions are those expected to be experienced in the future as a consequence of an action; notwithstanding, these are shaped and informed by those experienced in the anticipatory state. While both deontological and utilitarian options arouse negative anticipatory emotions, when it comes to deontological choices, individuals know what to expect and what will happen exactly due to their actions (e.g. the trolley will kill the five workmen because they didn’t push the stranger to the tracks in the footbridge dilemma). On the contrary, for the utilitarian choice, the anticipated emotions and psychological burden are not clearly delineated (e.g. will they feel guilty? Will they regret their choice? How intense will these feelings be? For how long will they feel them?), hence, the utilitarian option is equated to a risky and anxiety-inducing choice<sup>##UREF##10##50##</sup>. If this is the case, there’s no surprise in lorazepam promoting utilitarian decision-making, not only in general, but also during personal and first-person perspective, as it would mediate both anticipatory and anticipated emotions. This is not only in line with the somatic marker hypothesis, but also with the risk-as-feelings hypothesis, with the caveat that contrary to the somatic marker hypothesis –which assumes that affect typically informs and complements the decision-making process–, the risk-as-feelings hypothesis posits that emotions may also dominate the decision-making process and generate behaviors which may deviate from what could be objectively seen as the “best course of action”<sup>##REF##11316014##49##</sup>. In this sense, lorazepam would hamper this negative side of emotion and anxiety, correcting their course towards its informational aspect, and echoing the words of Luu, Tucker, and Derryberry<sup>##UREF##11##51##</sup> who stated that “appropriate levels of anxiety reflect the highest level of normal motivational control of working memory, through which the operations of memory in planning and behavioral sequencing are continually linked with adaptive significance”<sup>##REF##11316014##49##</sup>.</p>", "<p id=\"Par26\">When it comes to the role of genetics and neurophysiology, a study using genetic data<sup>##REF##32754089##52##</sup> found that people with the short allele relative to those with the long allele of the 5-HTTLPR serotonin transporter polymorphism, tend to endorse more deontological moral choices than utilitarian ones. The short-allele of the 5-HTTLPR polymorphism transports less serotonin from the synaptic cleft back to the pre-synaptic neuron, thus, leaving more of said serotonin to interact with the serotonergic receptors; as such, the population of individuals with the short allele of this polymorphism tend to be more vulnerable towards developing neuroticism, negative emotionality, and finally, anxiety<sup>##REF##17726476##53##</sup>. This is in line with studies showing that SSRIs are capable of increasing harm aversion and promoting prosocial behaviors<sup>##REF##20876101##24##</sup>, as serotonin is a key component in processes transducing aversive cues into behavioral inhibition<sup>##REF##7587017##25##,##REF##22643930##26##</sup>. Moreover, envisioning harmful behaviors directed towards others engages neural areas such as the ventromedial prefrontal cortex, anterior cingulate cortex, the striatum and the amygdala, all of which possess dense serotonergic projections<sup>##REF##25627116##27##</sup>. Although, and as its name states, the 5-HTTLPR is involved in the serotonergic system, whereas lorazepam is a GABAergic agonist, previous studies have found that both the serotonin transporter, as well as the GABAergic receptor Pro385Ser, are associated with neuroticism<sup>##REF##14744464##54##</sup>. The short and long variants of the 5-HTTLPR predominantly affect the activity of the amygdala<sup>##REF##17726476##53##,##REF##32157156##55##</sup>, a region heavy in serotonergic activity where lorazepam has been observed to produce a significant inhibitory response<sup>##REF##25627116##27##,##REF##15753241##30##,##REF##28364943##56##–##REF##19460871##58##</sup>. Nonetheless, the interactions between the GABAergic and serotonergic systems are complex, and no conclusive results, to our knowledge, have elucidated any clear or exact relationship between these systems and their definitive implication in the negative emotionality related to anxiety<sup>##REF##23781201##59##,##REF##33980291##60##</sup>.</p>", "<p id=\"Par27\">Interestingly, previous neuroscientific research using mice models<sup>##REF##12547473##61##</sup> has shown that noradrenergic reuptake inhibitors reduce behavioral reactivity to stress and modify central GABAergic neurotransmission in the hippocampus, the lateral septum and the amygdala, which indicate that central GABAergic pathways may modulate the effects of noradrenergic reuptake inhibitors on stress reduction. Nevertheless, these results seem at odds with the mechanisms proposed in some human studies, by which the noradrenergic beta-adrenoceptor antagonist propranolol would have an influence in moral decision-making through a physiological pathway leading to a reduction in emotional arousal<sup>##REF##27126289##20##,##REF##23085134##21##</sup>. Consequently, it is no surprise that other studies have contested such findings, casting doubt on the anxiolytic and stress-reducing effects of the beta-noradrenergic antagonist<sup>##REF##36077489##22##,##REF##26487439##62##</sup>. Notwithstanding, it is important to note that this can be due to a lack of inclusion of somatic marker data, as well as endophenotypes<sup>##REF##17726476##53##</sup>, in the experimental design. It has been suggested that the anterior insula and the amygdala are implicated in anxiety due to their crucial role in interoception. Moreover, individuals with a higher susceptibility towards anxiety are more prone to perceive a heightened interoceptive prediction signal, which might originate as a consequence of a heightened signaling of salience elicited by the amygdala<sup>##REF##16780813##31##</sup>.</p>", "<p id=\"Par28\">A competing explanation to all the mentioned above, might be that benzodiazepines seem to decrease empathic responses and promote antisocial behavior<sup>##REF##28405353##63##</sup>. This is in accordance with previous research showing that SSRI anxiolytics and antidepressants tend to inhibit empathy and induce emotional blunting<sup>##REF##34970173##64##–##REF##12135539##66##</sup>. A longitudinal fMRI study found that antidepressant interventions decreased neural responses in the bilateral anterior insular cortex and the anterior midcingulate cortex (two brain regions involved in the empathic response to pain), to the extent that previous findings attributing changes in empathy and emotional regulation to major depressive disorders might be actually associated with antidepressant treatment<sup>##REF##31175273##67##</sup>. Furthermore, Benzodiazepines in general have been observed to increase aggressive behaviors in rats<sup>##REF##15316711##68##,##REF##18080114##69##</sup>. Flunitrazepam in particular, has been previously implicated in criminal and violent behaviors in male juvenile offenders, as it appears to suppress fear, enhance feelings of security and power, and increase aggression<sup>##REF##28405353##63##,##REF##15704634##70##–##REF##12108561##72##</sup>. Nonetheless, all of the aforementioned studies with juvenile offenders assessed their outcomes in populations with a history of benzodiazepine addiction and abuse, while the present study was conducted using neurotypical and healthy volunteers. Additionally, said studies on juvenile offenders are observational in nature, as such a causal relationship between benzodiazepines, aggression and criminal behavior cannot be clearly established<sup>##REF##28405353##63##</sup>.</p>", "<p id=\"Par29\">The finding that endorsement of harm towards others diminishes with 1st person perspective-taking, and that lorazepam is capable of reverting such phenomenon, just shows that the old quarrel between Kantian/deontological and utilitarian moral reasoning might not be viable when the individual is physically involved in the predicament (being it in the real, actual space or the virtual, mental space) during moral decision-making. This is more evident with the finding that lorazepam does not have any significant effect on the endorsement of evitable or inevitable harm. Similar with the first hypothesis, a probable reason for this finding is that first person perspective, as well as moral personal dilemmas, increase negative emotionality, with the personal dilemmas enhancing it in an even greater manner than what was previously thought. Consequently, it doesn’t matter whether the harm is inevitable or evitable, lorazepam by itself might not be strong enough to override the excessive emotional arousal. Personal-inevitable moral dilemmas refer to moral dilemmas were an action involving direct physical contact, and which ends in harm or death for another person, is required in order to solve the predicament. As the name suggests, said harm or death is inevitable, independently of the responder’s negative or positive answer. One example is that of the “Rescue 911 dilemma”, where the leading character (being it the participants themselves in the 1st person perspective condition, or another person in the 3rd person perspective condition) is aboard a helicopter alongside other people (among them a patient), and which suddenly experiences a technical error. The only way of saving the crew on board is by lightening the load and throwing off the patient. If the main character decides not to throw off the patient, all people in the helicopter die. Conversely, if the main character throws the patient out, all the other people will be saved. Therefore, independently on whether the main character decides to throw out the patient or not, the patient still dies; hence, being the death or harm inevitable<sup>##REF##25071621##44##</sup>. Nevertheless, it is important to note, that although not statistically significant, participants did show a stronger endorsement towards inevitable harm when compared to evitable harm, which is the most common outcome due to the principle of lesser evil<sup>##UREF##7##40##,##REF##17329147##41##</sup>.</p>", "<p id=\"Par30\">In line with the first hypothesis, an alternate explanation to the finding that the endorsement of harm decreased in the 1st person perspective-taking condition, but that lorazepam was capable of reverting said occurrence, might also be due to the aforementioned effects of benzodiazepines as empathic function inhibitors and emotional blunting agents<sup>##REF##28405353##63##</sup>.</p>", "<p id=\"Par31\">Some limitations of this study should be acknowledged. First, self-reported measures such as the moral dilemma task are very much able to be affected by individual differences regarding the willingness to please the experimenter, or to avoid the negative social reputation incurred by endorsing harming or unjust behaviors, as well as may also be affected by cognitive load and/or the participant’s ability to successfully imagine actions with various moral consequences<sup>##REF##29178984##73##</sup>. As such, post-session questionnaires to assess the perceived interpersonal behavior of the experimenter might be helpful to evaluate the effects of response expectancy to the intervention in drug-placebo studies<sup>##REF##30723231##74##</sup>. Second, this study makes no use of endophenotypes (e.g. EEG, fMRI, etc.); thus, this study is unable to elucidate the exact neural mechanisms by which lorazepam has its effect on the moral dilemma task and its different conditions. Nevertheless, this study makes use of pharmacological interventions with the GABA agonist lorazepam, whose anxiolytic effects and neuromodulation on brain regions such as the insula and the amygdala have already been well studied and documented<sup>##REF##15753241##30##,##REF##32157156##55##,##REF##36478922##75##</sup>. Third, the study used solely sacrificial dilemmas to examine the effects of lorazepam on moral decision-making. Previous research has observed that sacrificial dilemmas are incapable of evaluating equality-based morality, as well as simultaneously assessing minimization of harm and maximization of benefits. Therefore, further research using different types of paradigms (e.g. minimal group, resource allocation, etc.) is highly warranted. Additionally, the latter types of paradigms are better suited to reflect real-life scenarios regarding moral decision-making<sup>##REF##32770106##45##</sup>.</p>", "<p id=\"Par32\">All in all, our findings were not only able to support those of Perkins et al.<sup>##REF##23025561##11##</sup>, but also to complement and expand them. Our results suggest that the anxiolytic GABA agonist lorazepam is capable of downregulating key brain centers involved in fear conditioning and aversive interoceptive processing –i.e. the insula and amygdala. Consequently, modulating anticipatory and anticipated emotions, and reverting the negative emotionality generated by the physical involvement promoted during personal moral dilemmas, and moral dilemma tasks utilizing first-person perspective-taking.</p>", "<p id=\"Par33\">In conclusion, this study highlights the role of GABAergic neuromodulation and negative affect, as well as the involvement of the amygdala and the insula, in moral decision-making processes. These findings are in agreement with research demonstrating that reason and emotion are not the only two components weighing in during moral decision-making, but rather there is a dynamic interplay between emotional salient information and first-hand physical, bodily and interoceptive inputs, all of which give rise to moral reasoning<sup>##UREF##0##3##</sup>. Furthermore, it is possible to see how applications of the dual-process model of moral decision-making –which regards moral reasoning as the product of two opposed subsystems competing against each other: one automatic and emotion-based against a rational and conscious-controlled<sup>##REF##15473975##8##,##REF##11557895##37##</sup>– would be dependent on the degree of physical, bodily involvement of the agent in different kinds of moral dilemma scenarios.</p>" ]
[]
[ "<p id=\"Par1\">Previous neuroscientific research has expounded on the fundamental role played by emotion during moral decision-making. Negative emotionality has been observed to exert a general inhibitory effect towards harmful behaviors against others. Nevertheless, the downregulation of negative affects at different levels of moral processing (e.g. impersonal versus personal moral dilemmas) alongside its possible interactions with other factors (e.g. perspective taking) hasn’t been directly assessed; both of which can assist in predicting future moral decision-making. In the present research, we empirically test (Study 1, N = 41) whether downregulating negative emotionality through pharmacological interventions using lorazepam (a GABA receptor agonist), modulate the permissibility of harm to others –i.e. if participants find it more morally permissible to harm others when harm is unavoidable (inevitable harm moral dilemmas), than when it may be avoided (evitable harm moral dilemmas). Furthermore, using another sample (Study 2, N = 31), we assess whether lorazepam’s effect is modulated by different perspective-taking conditions during a moral dilemma task –e.g. “is it morally permissible for <italic>you</italic> to […]?” (1st person perspective), relative to “is it morally permissible for [x individual] to […]?” (3rd person perspective)–, where the outcome of the different scenarios is controlled. The results of both studies converge, revealing an emotion-dependent, rather than an outcome-dependent, pharmacological modulation. Lorazepam only influenced interpersonal moral judgments when not modulated by the evitable/inevitable condition. Furthermore, there was a significant interaction between perspective-taking and drug administration, as lorazepam exerted a larger effect in modulating moral choices rather than moral judgements.</p>", "<title>Subject terms</title>" ]
[ "<title>Study 1</title>", "<title>Materials</title>", "<title>Moral dilemma task</title>", "<p id=\"Par10\">Based on previous work<sup>##REF##15473975##8##,##REF##19375075##36##–##UREF##6##38##</sup> [<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.cell.com/cms/\">https://www.cell.com/cms/</ext-link>10.1016/j.neuron.2004.09.027/attachment/86c8c813-bafc-49fe-8393-be1f9226358d/mmc1.pdf], forty-eight moral dilemmas were selected in order to make two versions (Version A and Version B) of the moral judgment task balanced on emotional intensity<sup>##REF##15473975##8##,##REF##17377536##39##</sup>. Each version consists of twenty-four dilemmas, which include nine non-moral dilemmas and fifteen moral dilemmas – these fifteen subdivide into five impersonal dilemmas, and ten personal dilemmas. Furthermore, each of the fifteen moral dilemmas consist of a predicament were the responder needs to decide on whether they would induce (being it directly or indirectly) harm or death to another person in order to save a larger number of people. Impersonal dilemmas involve indirect harm (e.g. flipping a switch), whereas personal dilemmas include harm through direct physical contact (pushing a stranger), such as in the Trolley dilemma. Personal dilemmas are further divided into dilemmas in which the death or harm to the victim is inevitable or evitable. Moral permissibility judgments are higher for transgressions that lead to inevitable harm, due to the principle of lesser evil<sup>##UREF##7##40##,##REF##17329147##41##</sup>. In each dilemma, participants were asked to definitively choose between 'yes' and 'no' in response to the moral permissibility of the behaviors described in the scenario. The sequence of dilemma version used for lorazepam and placebo sessions was counter-balanced between participants through a Latin square design, which randomizes through having equal number of AB (Version A-Version B) and BA (Version B-Version A) sequences in both lorazepam and placebo sessions. Since one of the objectives of Study 1 was to replicate the findings of Perkins et al.<sup>##REF##23025561##11##</sup>, the moral dilemmas presented to participants were framed in the first-person perspective, consistent with the approach used in Perkins et al.'s research, without explicitly priming this perspective.</p>", "<p id=\"Par11\">The dilemmas were translated from English to Chinese, and then translated back from Chinese to English and checked for consistency by a native English speaker. Participants read the moral dilemmas in a paper booklet provided to them by the experimenters, and responded to the dilemmas with a decision of yes (endorsement of action) or no (disapproval of the action) in a separate answer sheet. All participants completed the moral dilemma task at their own pace. Moral permissibility is assessed by the percentage of harm endorsements in each dilemma type, calculated by dividing the number of trials with harm endorsements by the total number of trials. The endorsement rate (%) for each dilemma type is then used as the dependent variable for further analyses.</p>", "<title>Study 2</title>", "<title>Methods</title>", "<title>Participants</title>", "<p id=\"Par15\">An independent sample of participants (N = 31, 15 males), aged between 21 and 28 (23.26 ± 1.65) years, participated in study 2 after providing written informed consent. All participants had normal vision or corrected for normal vision, were Han Chinese, right-handed, screened for major psychiatric illnesses (e.g. general anxiety disorder) by the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), and excluded if there was evidence of comorbid neurological disorders (e.g. dementia, seizures), history of head injury, and alcohol or substance abuse or dependence within the past five years. This study was approved by the Ethics Committee of the National Yang-Ming Chiao-Tung University (YM104041E), and conducted in accordance with the Declaration of Helsinki. This study was not preregistered.</p>", "<title>Procedure</title>", "<p id=\"Par16\">In study 2, the same double-blind, placebo-controlled, crossover design was applied. Participants received a single 0.5-mg dose of lorazepam (ATIVAN) on one day, and a single dose of placebo (i.e. vitamin E) on another day. As in study 1, The experimental sequence of lorazepam and placebo administration was counter-balanced between participants through a Latin square design, which randomizes through having equal number of AB (lorazepam-placebo) and BA (placebo-lorazepam) sequences. After treatment administration and a 2-h interval to coincide with the pharmacokinetics of lorazepam, participants filled out the moral dilemma task in order to assess their moral permissibility.</p>", "<title>Materials</title>", "<title>Moral dilemma task</title>", "<p id=\"Par17\">In study 2, we employed the same moral dilemma task as in study 1: two versions of the moral dilemma task (Version A and Version B), balanced in terms of emotional intensity<sup>##REF##17377536##39##</sup>, were used to counterbalance the administration of lorazepam and placebo. Each version included five impersonal dilemmas, five personal-inevitable dilemmas, and five personal-evitable dilemmas. Notwithstanding, for study 2, we included two variations in the moral dilemma task. First, the moral dilemmas were re-written and reframed from a neutral perspective (contrary to study 1, where the moral dilemmas retained the first person perspective from Perkins et al.’s research). Second, following each moral dilemma scenario, and in order to foster third-person versus first-person perspective-taking, participants were asked two questions: 'Is it morally permissible for other people to perform the behaviors depicted in this dilemma?' (3rd person-perspective condition), and 'is ti morally permissible for you perform the behaviors depicted in this dilemma?' (1st person-perspective condition). The order of third-person and first-person perspective conditions was counterbalanced among participants using a Latin square design. This ensured an equal number of third-person-first-person and first-person-third-person sequences in both the lorazepam and placebo sessions. All participants completed the moral dilemma task at their own pace.</p>", "<title>Results</title>", "<p id=\"Par18\">Table ##TAB##1##2## presents descriptive statistics for the outcomes of endorsement of harm rate by dilemma type, drug condition, and moral perspective-taking (n = 31). Given that the endorsement rates across participants are not normally distributed, we utilized non-parametric analysis for related samples in a within-subject design. This involved applying the Wilcoxon Signed Ranks Test for two-sample comparisons and the Friedman Test for comparisons involving more than two groups (please see supplementary results, Tables ##SUPPL##0##S1## and ##SUPPL##0##S2## for the results of sensitivity tests using parametric analysis of repeated ANOVA).</p>", "<title>H3: Associations between moral perspective-taking and the effect of lorazepam for moral dilemmas</title>", "<p id=\"Par19\">In this analysis we controlled for harming outcomes across different moral perspective-taking conditions. In order to examine whether the lorazepam administration interact with different moral perspective-takings regardless of harming outcomes, we compared harm endorsement rates across various dilemma scenarios under both placebo and lorazepam conditions. This comparison specifically focused on scenarios viewed from the '1st person' and '3rd person' perspectives. Lorazepam administration significantly increased the 1st-person choice for the endorsement of harm (Lorazepam: 48.08 ± 3.05, Placebo: 39.86 ± 2.71, Z = 2.156, <italic>P</italic> = 0.031) but did not change the 3rd-person judgement (Lorazepam: 52.47 ± 3.45, Placebo: 51.02 ± 3.25, Z = 0.47, <italic>P</italic> = 0.638) (Table ##TAB##1##2##, Fig. ##FIG##2##3##). The Hypotheses 3 was supported.</p>", "<title>Summary</title>", "<p id=\"Par20\">The analyses showed that the effect of lorazepam administration on moral endorsement of harm was modulated by the source of bringing about harm (personal vs. impersonal), as well as the moral perspective-taking (1st-person choice vs. 3rd-person judgement), but not by the inevitability of bringing about harm (evitable harm vs. inevitable harm).</p>", "<title>Informed consent</title>", "<p id=\"Par21\">A written informed consent was obtained from all the participants, as well as were given a monetary compensation at the end of the study.</p>", "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51345-8.</p>", "<title>Author contributions</title>", "<p>R.M.M., S.H.C. and C.C. conceived and conceptualized the study. Y.T.F., Y.C.C. and K.K.G. collected and analyzed the data. R.M.M., S.H.C. and C.C. conducted the necessary literature reviews and drafted the first manuscript. All authors contributed towards the writing and revision of the final draft.</p>", "<title>Funding</title>", "<p>The study was funded by the Ministry of Science and Technology (MOST 112-2636-H-038-005; 112-2410-H-038-029; 111-2410-H-155-023-), Taipei Medical University Hospital (111TMU-TMUH-15), and Taipei Medical University – Wan Fang Hospital (112TMU-WFH-15).</p>", "<title>Data availability</title>", "<p>All data generated or analyzed during this study are included in this published article and its supplementary information files. Further enquiries can be directed to the corresponding author.</p>", "<title>Competing interests</title>", "<p id=\"Par34\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Diagrammatic representation of the study design and data collection process.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Dilemma judgements (i.e. % utilitarian responses) by treatment administration for the evitable harm and inevitable harm (<italic>F</italic><sub>1, 40</sub> = 0.6, <italic>P</italic> = 0.444).</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Dilemma judgements (i.e. % utilitarian responses) by treatment administration for the first-person choice and third-person judgement (<italic>F</italic><sub>1, 30</sub> = 4.98, <italic>P</italic> = 0.033).</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Descriptive statistics for moral permissibility [Study 1, N = 41 (23 males), between 21 and 31 (mean ± SD: 23.63 ± 2.44) years of age] by dilemma type and drug condition.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Moral permissibility</th><th align=\"left\">Placebo</th><th align=\"left\">Lorazepam</th><th align=\"left\" rowspan=\"2\">Z value</th><th align=\"left\" rowspan=\"2\">P value</th></tr><tr><th align=\"left\">Measurements (%)</th><th align=\"left\">Mean ± SE</th><th align=\"left\">Mean ± SE</th></tr></thead><tbody><tr><td align=\"left\">Nonmoral</td><td char=\".\" align=\"char\">63.69 ± 5.47</td><td char=\".\" align=\"char\">55.28 ± 5.37</td><td align=\"left\">0.293</td><td align=\"left\">0.769</td></tr><tr><td align=\"left\">Moral-impersonal</td><td char=\".\" align=\"char\">63.9 ± 4.95</td><td char=\".\" align=\"char\">48.29 ± 4.47</td><td align=\"left\">1.802</td><td align=\"left\">0.069</td></tr><tr><td align=\"left\">Moral-personal (all)</td><td char=\".\" align=\"char\">33.59 ± 2.51</td><td char=\".\" align=\"char\">40.33 ± 2.32</td><td align=\"left\">2.705</td><td align=\"left\">0.007</td></tr><tr><td align=\"left\">Moral-personal-evitable</td><td char=\".\" align=\"char\">22.59 ± 2.23</td><td char=\".\" align=\"char\">28.17 ± 1.94</td><td align=\"left\">2.018</td><td align=\"left\">0.044</td></tr><tr><td align=\"left\">Moral-personal-inevitable</td><td char=\".\" align=\"char\">48.9 ± 4.83</td><td char=\".\" align=\"char\">58.8 ± 3.84</td><td align=\"left\">2.092</td><td align=\"left\">0.036</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Descriptive statistics for moral judgement and choice [Study 2, N = 31 (15 males), between 21 and 28 (mean ± SD:23.26 ± 1.65) years of age] by dilemma type and drug condition.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Moral permissibility</th><th align=\"left\">Placebo</th><th align=\"left\">Lorazepam</th><th align=\"left\" rowspan=\"2\">Z value</th><th align=\"left\" rowspan=\"2\">P value</th></tr><tr><th align=\"left\">Measurements (%)</th><th align=\"left\">Mean ± SE</th><th align=\"left\">Mean ± SE</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"5\">Moral judgement (3rd person-perspective)</td></tr><tr><td align=\"left\"> Moral judgement (all)</td><td char=\".\" align=\"char\">51.02 ± 3.25</td><td char=\".\" align=\"char\">52.47 ± 3.45</td><td align=\"left\">0.47</td><td align=\"left\">0.638</td></tr><tr><td align=\"left\"> Moral-impersonal</td><td char=\".\" align=\"char\">55.48 ± 6.06</td><td char=\".\" align=\"char\">63.87 ± 6.04</td><td align=\"left\">0.788</td><td align=\"left\">0.431</td></tr><tr><td align=\"left\"> Moral-personal-evitable</td><td char=\".\" align=\"char\">33.87 ± 3.41</td><td char=\".\" align=\"char\">30.65 ± 3.2</td><td align=\"left\">1.388</td><td align=\"left\">0.165</td></tr><tr><td align=\"left\"> Moral-personal-inevitable</td><td char=\".\" align=\"char\">63.71 ± 5.54</td><td char=\".\" align=\"char\">62.9 ± 5.54</td><td align=\"left\">0.047</td><td align=\"left\">0.963</td></tr><tr><td align=\"left\" colspan=\"5\">Moral choice (1st person-perspective)</td></tr><tr><td align=\"left\"> Moral choice (all)</td><td char=\".\" align=\"char\">39.86 ± 2.71</td><td char=\".\" align=\"char\">48.08 ± 3.05</td><td align=\"left\">2.156</td><td align=\"left\">0.031</td></tr><tr><td align=\"left\"> Moral-impersonal</td><td char=\".\" align=\"char\">44.03 ± 5.73</td><td char=\".\" align=\"char\">60.65 ± 6.12</td><td align=\"left\">1.48</td><td align=\"left\">0.139</td></tr><tr><td align=\"left\"> Moral-personal-evitable</td><td char=\".\" align=\"char\">23.12 ± 2.96</td><td char=\".\" align=\"char\">27.96 ± 2.83</td><td align=\"left\">1.442</td><td align=\"left\">0.149</td></tr><tr><td align=\"left\"> Moral-personal-inevitable</td><td char=\".\" align=\"char\">52.42 ± 5.72</td><td char=\".\" align=\"char\">55.65 ± 5.65</td><td align=\"left\">0.587</td><td align=\"left\">0.557</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>Moral permissibility is assessed by the percentage of harm endorsements in each dilemma type, calculated by dividing the number of trials with harm endorsements by the total number of trials. The Z value represents the results from non-parametric analyses conducted using the Wilcoxon Signed Ranks Test. This test compares two related samples in a within-subject design, specifically evaluating moral permissibility in placebo and lorazepam conditions.</p></table-wrap-foot>", "<table-wrap-foot><p>Moral permissibility is assessed by the percentage of harm endorsements in each dilemma type, calculated by dividing the number of trials with harm endorsements by the total number of trials. The Z value represents the results from non-parametric analyses conducted using the Wilcoxon signed ranks test. This test compares two related samples in a within-subject design, specifically evaluating moral permissibility in placebo and lorazepam conditions.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Roger Marcelo Martinez and Shih-Han Chou.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51345_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51345_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51345_Fig3_HTML\" id=\"MO3\"/>" ]
[ "<media xlink:href=\"41598_2024_51345_MOESM1_ESM.docx\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["3."], "surname": ["Strejcek", "Zhong"], "given-names": ["B", "C-B"], "source": ["The Routledge Handbook of Embodied Cognition. Routledge Handbooks in Philosophy"], "year": ["2014"], "publisher-name": ["Routledge/Taylor & Francis Group"], "fpage": ["220"], "lpage": ["230"]}, {"label": ["5."], "surname": ["Allik", "McCrae"], "given-names": ["J", "RR"], "article-title": ["Toward a geography of personality traits: Patterns of profiles across 36 cultures"], "source": ["J. Cross-Cult. Psychol."], "year": ["2004"], "volume": ["35"], "fpage": ["13"], "lpage": ["28"], "pub-id": ["10.1177/0022022103260382"]}, {"label": ["6."], "surname": ["Drake"], "given-names": ["KE"], "article-title": ["Interrogative suggestibility: Life adversity, neuroticism, and compliance"], "source": ["Personal. Individ. Differ."], "year": ["2010"], "volume": ["48"], "fpage": ["493"], "lpage": ["498"], "pub-id": ["10.1016/j.paid.2009.11.030"]}, {"label": ["17."], "surname": ["Van Bavel", "FeldmanHall", "Mende-Siedlecki"], "given-names": ["JJ", "O", "P"], "article-title": ["The neuroscience of moral cognition: From dual processes to dynamic systems"], "source": ["Curr. Opin. Psychol."], "year": ["2015"], "volume": ["6"], "fpage": ["167"], "lpage": ["172"], "pub-id": ["10.1016/j.copsyc.2015.08.009"]}, {"label": ["29."], "surname": ["Gould", "Otto", "Pollack", "Yap"], "given-names": ["RA", "MW", "MH", "L"], "article-title": ["Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: A preliminary meta-analysis"], "source": ["Behav. Ther."], "year": ["1997"], "volume": ["28"], "fpage": ["285"], "lpage": ["305"], "pub-id": ["10.1016/S0005-7894(97)80048-2"]}, {"label": ["33."], "surname": ["Richter", "Grimm", "Northoff"], "given-names": ["A", "S", "G"], "article-title": ["Lorazepam modulates orbitofrontal signal changes during emotional processing in catatonia"], "source": ["Hum. Psychopharmacol. Clin. Exp."], "year": ["2010"], "volume": ["25"], "fpage": ["55"], "lpage": ["62"], "pub-id": ["10.1002/hup.1084"]}, {"label": ["38."], "surname": ["Huebner", "Hauser", "Pettit"], "given-names": ["B", "MD", "P"], "article-title": ["How the source, inevitability and means of bringing about harm interact in folk-moral judgments"], "source": ["Mind Lang."], "year": ["2011"], "volume": ["26"], "fpage": ["210"], "lpage": ["233"], "pub-id": ["10.1111/j.1468-0017.2011.01416.x"]}, {"label": ["40."], "surname": ["Hauser"], "given-names": ["M"], "source": ["Moral Minds: How Nature Designed Our Universal Sense of Right and Wrong"], "year": ["2006"], "publisher-name": ["Harper Collins"]}, {"label": ["47."], "surname": ["Lee", "Gino"], "given-names": ["JJ", "F"], "article-title": ["Poker-faced morality: Concealing emotions leads to utilitarian decision making"], "source": ["Org. Behav. Hum. Decis. Process."], "year": ["2015"], "volume": ["126"], "fpage": ["49"], "lpage": ["64"], "pub-id": ["10.1016/j.obhdp.2014.10.006"]}, {"label": ["48."], "surname": ["Kahneman", "Tversky"], "given-names": ["D", "A"], "article-title": ["Choices, values, and frames"], "source": ["Am. Psychol."], "year": ["1984"], "volume": ["39"], "fpage": ["341"], "lpage": ["350"], "pub-id": ["10.1037/0003-066X.39.4.341"]}, {"label": ["50."], "surname": ["Zhao", "Harris", "Vigo"], "given-names": ["J", "M", "R"], "article-title": ["Anxiety and moral judgment: The shared deontological tendency of the behavioral inhibition system and the unique utilitarian tendency of trait anxiety"], "source": ["Personal. Individ. Differ."], "year": ["2016"], "volume": ["95"], "fpage": ["29"], "lpage": ["33"], "pub-id": ["10.1016/j.paid.2016.02.024"]}, {"label": ["51."], "surname": ["Luu", "Tucker", "Derryberry"], "given-names": ["P", "DM", "D"], "article-title": ["Anxiety and the motivational basis of working memory"], "source": ["Cogn. Ther. Res."], "year": ["1998"], "volume": ["22"], "fpage": ["577"], "lpage": ["594"], "pub-id": ["10.1023/A:1018742120255"]}]
{ "acronym": [], "definition": [] }
75
CC BY
no
2024-01-14 23:40:15
Sci Rep. 2024 Jan 12; 14:1200
oa_package/3c/34/PMC10786834.tar.gz
PMC10786835
38216598
[ "<title>Introduction</title>", "<p id=\"Par2\">Mastitis is one of the main reasons for the use of antimicrobials on dairy farms, representing around 80% of the total use of antimicrobials in dairy production<sup>##REF##17183093##1##</sup>. However, antimicrobial treatment of all clinical mastitis (CM) cases is not always justified, because around 40% of CM cases have no isolation of mastitis-causing pathogens. Moreover, among culture-positive results, some pathogens respond poorly to antimicrobial therapy, and/or have a high rate of spontaneous cure (e.g., <italic>Escherichia coli</italic><sup>##REF##23679229##2##</sup>). The rapid and accurate diagnosis of mastitis pathogens is an important element of an effective protocol for selective therapy of clinical mastitis<sup>##REF##37080782##3##</sup>. Different on-farm microbiological culture (OFC) methods have been used for rapid on-farm identification of mastitis pathogens, including the use of chromogenic culture media<sup>##REF##33934869##4##</sup>. The adoption of OFC enables selective treatment for CM, which can reduce antimicrobial use by 50%<sup>##UREF##0##5##,##UREF##1##6##</sup>, without reduction on bacteriological cure risk<sup>##REF##36543640##7##</sup>.</p>", "<p id=\"Par3\">Interpreting OFC results requires adequate training and experienced farm personnel, which can be a limitation to the adoption of OFC systems in dairy herds. Substantial differences in accuracy are observed between specialists and untrained users, showing that specific training is critical to appropriate mastitis treatment decisions based on OFC results<sup>##UREF##1##6##</sup>. Furthermore, in chromogenic media-based OFC, because of the subjectivity of color interpretation of colonies, variation in diagnostic performance is observed between specialists and farm personnel users (FPU)<sup>##REF##33612204##8##</sup>, which can compromise the diagnostic performance of the method.</p>", "<p id=\"Par4\">Automation in the culture media evaluation can be an alternative to minimize subjectivity in the OFC results interpretation. It has been reported that automatic evaluation systems can present similar accuracy as the evaluation of a trained specialist when using urine samples<sup>##REF##28840987##9##</sup>. Automating procedures and diagnoses using computational techniques is not a recent subject in research. Solutions using machine learning for automatic image diagnosis have been explored with several applications, such as: analysis using X-ray images<sup>##REF##27816861##10##</sup>, photo-anthropometric analysis of facial images<sup>##UREF##2##11##,##REF##32820357##12##</sup>, identification of cancer cells<sup>##UREF##3##13##</sup>, dental sexual dimorphism classification using radiography images<sup>##REF##34992227##14##</sup>, classification of bacteria and nematodes on microscope images<sup>##UREF##4##15##,##UREF##5##16##</sup>. The automation of the chromogenic culture results interpretation comprises the use of artificial intelligence (AI) to analyze images of culture media plates and, in real time, categorize them as positive or negative for specific pathogens based on interpreting the color and colony characteristics of specific microorganisms<sup>##UREF##6##17##</sup>.</p>", "<p id=\"Par5\">AI-based application has been tested in human medicine and have achieved satisfactory accuracy (&gt; 80% sensitivity) in interpreting microbiological culture results in urinary tract isolates<sup>##REF##28840987##9##,##UREF##7##18##</sup>; screening for methicillin-resistant/sensible <italic>Staphylococcus aureus</italic> infection in patients in intensive care units<sup>##UREF##6##17##</sup>; detection of group B <italic>Streptococcus</italic> in women<sup>##UREF##8##19##</sup> and <italic>Streptococcus pyogenes</italic> isolates in pharyngitis cases<sup>##UREF##9##20##</sup>. However, there are no studies evaluating AI-based application method for chromogenic culture media used for mastitis-causing pathogens identification.</p>", "<p id=\"Par6\">We hypothesize that employing an AI-driven automated mobile application for plate reading, designed to interpret images of prevalent mastitis-causing bacteria in chromogenic culture media, can achieve diagnostic accuracy comparable to that of a trained specialist. Such a technological advancement holds the potential to streamline milk culturing on farms, mitigating the risk of diagnostic errors that may arise when untrained personnel are responsible for plate reading. Therefore, the aim of the present study was to evaluate the diagnostic accuracy of an AI-based application (Rumi; OnFarm, Piracicaba, São Paulo, Brazil) for interpreting images of mastitis-causing microorganism colonies grown in chromogenic culture media. The study was organized into two trials with the following objectives: 1) Assess the diagnostic accuracy of Rumi in contrast to a trained specialist, using MALDI-TOF-MS as the gold standard; 2) compare the accuracy of Rumi and FPU to read plates on farms, which will serve as a proxy to estimate the improvements in diagnostic accuracy attributed to the implementation of Rumi (Table ##TAB##4##5##).\n</p>" ]
[ "<title>Methods</title>", "<title>On-farm microbiological culture system</title>", "<p id=\"Par21\">The OFC system provided by OnFarm (Piracicaba, São Paulo, Brazil) is currently used by approximately 2,000 dairy farms located in 20 different states of Brazil. The OFC system is composed of the following items: (1) triplate chromogenic culture media plates (SmartColor 2), (2) incubators equipped with a Petri dish reader support, a dark background (for photography of SmartColor 2 plate) and luminosity with 6000 K LED light (SmartLab; Fig. ##FIG##0##1##) and (3) a mobile application for herd and cow mastitis data recording (OnFarmApp). When implementing OnFarm’s system, the farms receive an online training by OnFarm’s team about how to operate the OnFarmApp and how to perform OFC.</p>", "<p id=\"Par22\">OFC procedures are generally carried out by trained employees, chosen from the farm existing staff, following the farm's own criteria, but with no specific qualification required at first (only the initial training by OnFarm). All CM cases are identified by farm personnel, based on the identification of abnormalities in milk secretion or in the udder of cows. The OnFarm training program emphasizes protocols for obtaining milk samples aseptically, inoculating, and incubating culture plates, and utilizing the OnFarmApp for storing information and reading culture plates. After the microbiological identification, FPU are oriented to record pictures of the SmartColor 2 triplates on the reader support of the SmartLab and upload it in the OnFarmApp along with the CM case data. The images are recorded by individuals with no advanced technical knowledge of photography using a variety of phone devices, and stored at a resolution of 2500 × 2500 pixels, 24 bits of color. When FPU have doubts regarding the identification of specific pathogens, a remote inspection of uploaded images can be requested.</p>", "<title>Chromogenic culture media interpretation</title>", "<p id=\"Par23\">The Smartcolor 2 triplate, whose images were used in the study, comprises of a triplate Petri dish composed of three different selective chromogenic culture media: Section 1: <italic>Streptococcus</italic> spp.; Section 2: <italic>Staphylococcus aureus</italic> and <italic>Staphylococcus</italic> spp. and Section 3: gram-negative bacteria. Interpretation of the growth in each section of the plate was done according to the following colony colors:<list list-type=\"bullet\"><list-item><p id=\"Par24\">Section 1—(a) dark blue = <italic>Streptococcus uberis</italic>; (b) turquoise blue = <italic>Streptococcus agalactiae</italic> or <italic>Streptococcus dysgalactiae</italic>; (c) purple = <italic>Enterococcus</italic> spp.; (d) lilac = <italic>Lactococcus</italic> spp., and (e) other colors = Gram-positive microorganism other than <italic>Streptococcus uberis</italic>; <italic>Streptococcus agalactiae</italic>; <italic>Streptococcus dysgalactiae</italic>; <italic>Enterococcus</italic> spp. or <italic>Lactococcus</italic> spp. (other Gram-positive microorganism).</p></list-item><list-item><p id=\"Par25\">Section 2—Gram-negative: (a) purple = <italic>E. coli</italic>; (b) metallic blue = <italic>Klebsiella</italic> spp., <italic>Enterobacter</italic> spp., or <italic>Serratia</italic> spp.; (c) yellow = <italic>Pseudomonas</italic> spp.; (d) white and dry = yeast and <italic>Prototheca</italic> spp., and (e) other colors = Gram-negative microorganism other than <italic>E. coli; Klebsiella</italic> spp.; <italic>Enterobacter</italic> spp.; <italic>Serratia</italic> spp. or <italic>Pseudomonas</italic> spp. (other Gram-negative microorganism).</p></list-item><list-item><p id=\"Par26\">Section 3—(a) pink = <italic>Staphylococcus aureus</italic>; (b) other colors = other bacteria from <italic>Staphylococcus</italic> spp genus other than <italic>Staphylococcus aureus</italic> (non-aureus staphylococci).</p></list-item></list></p>" ]
[ "<title>Results</title>", "<title>Trial 1</title>", "<p id=\"Par7\">Nearly half of the CM samples (267/476) were considered negative, while 43.9% (209/476) were considered positive. From all samples, 20.4% (97/476) contained isolates with two distinct morphologies (mixed culture). In total, 306 isolates from 46 different species were identified in MALDI-TOF MS. Among the groups of pathogens that can be identified by Smartcolor2, <italic>Lactococcus</italic> spp., <italic>Pseudomonas</italic> spp., yeast, <italic>Prototheca</italic> spp., other Gram-negative and other Gram-positive microorganism had a low frequency of isolation (n &lt; 10) and were, therefore, grouped as “other pathogens”. The most frequently isolated pathogen group was non-<italic>aureus</italic> staphylococci (10.9%) followed by <italic>E. coli</italic> (7.6%) and <italic>Staphylococcus aureus</italic> (7.3%; Table ##TAB##0##1##).</p>", "<p id=\"Par8\">Both the specialist and Rumi had Sp results &gt; 0.96 for all the groups of pathogens evaluated (Table ##TAB##0##1##). The specialist Se ranged from 0.60 (<italic>Enterococcus</italic> spp.) to 0.97 (<italic>E. coli</italic>), while Rumi’s Se ranged from 0.20 (<italic>Enterococcus</italic> spp.) to 0.97 (<italic>Klebsiella</italic> spp./<italic>Enterobacter</italic> spp./<italic>Serratia</italic> spp.). There were no significant differences in the Se and Sp of Rumi and the specialist to identify most group of pathogens evaluated (Table ##TAB##1##2##). For non-aureus staphylococci, Rumi had lower Se (0.94) than the specialist (0.73).A list of cross tabulated results according to the MALDI-TOF MS status is available as supplemental material (Tables ##SUPPL##0##S1##).</p>", "<title>Trial 2</title>", "<p id=\"Par9\">According to our case definition, 28.8% (60/208) of the samples were considered negative, while 71.1% (148/208) were positive. A total of 31.2% (65/208) of samples had mixed cultures. <italic>Lactococcus</italic> spp., <italic>Serratia</italic> spp., <italic>Pseudomonas</italic> spp., yeast, <italic>Prototheca</italic> spp., other Gram-negative and other Gram-positive microorganism had a low frequency of isolation (n &lt; 10) and were not considered for Bayesian Latent Class models. Non-aureus staphylococci was the most frequently isolated group (35.1%) followed by <italic>Streptococcus agalactiae/dysgalactiae</italic> (13.0%) and <italic>Streptococcus uberis</italic> (11.5%; Table ##TAB##2##3##).</p>", "<p id=\"Par10\">In total, 35 models (5 models per pathogen group) were run. In general, Rumi performed as well as the FPU for all groups of pathogens evaluated (Table ##TAB##1##2##). No statistically significant differences in Se and Sp were observed between Rumi and FPUs for identifying isolates, irrespective of bacterial species (Table ##TAB##3##4##). These comparisons were not affected by our choice of prevalence or diagnostic prior information, as demonstrated by sensitivity analysis (Tables ##SUPPL##0##S3##, ##SUPPL##0##S4##). A list of cross tabulated results for the two diagnostic procedures is available as supplemental material (Tables ##SUPPL##0##S2##).\n</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par11\">The diagnostic accuracy of the OFC depends on various factors, which includes the pathogen and culture media diagnostic accuracy, the level of training and experience of the operator in interpreting the results<sup>##REF##33612204##8##</sup>. AI-based application that automatically interprets OFC results can be an alternative to enhance the diagnostic accuracy of OFC systems. The present study was divided in two trials which aimed to: (a) evaluated the performance of an AI-based application for microbiological diagnosis of mastitis-causing pathogens using chromogenic culture media images (b) evaluate if this AI-based application can improve the accuracy OFC diagnosis of CM in comparison to a farm personal user.</p>", "<title>Trial 1</title>", "<p id=\"Par12\">Rumi demonstrated high Se for the most prevalent environmental pathogens evaluated (<italic>Streptococcus uberis; Klebsiella</italic> spp./<italic>Enterobacter</italic> spp<italic>.</italic>/<italic>Serratia</italic> spp. and <italic>Escherichia coli</italic>), indicating that, for this group of pathogens, the AI-based application can perform comparably to a specialist in interpretating chromogenic culture media results. Considering the majority of the herds using the OFC system were compost-barn farms, and that environmental streptococci and <italic>Escherichia coli</italic> were the most prevalent causes of CM in compost-barn Brazilian herds<sup>##UREF##10##21##</sup>, achieving a high diagnostic accuracy for these pathogens is crucial for implementing adequate CM treatments. Additionally, for the Gram-negative pathogens evaluated (<italic>Klebsiella</italic> spp./<italic>Enterobacter</italic> spp<italic>.</italic>/<italic>Serratia</italic> spp. and <italic>Escherichia coli</italic>) both the specialist and Rumi had all high diagnostic accuracy results, indicating the identification capacity of the chromogenic culture media for those groups, as observed by Granja et al.<sup>##REF##33934869##4##</sup> and Ferreira et al.<sup>##UREF##11##22##</sup>. Moreover, the results indicate that Rumi was able to differentiate between the two groups, <italic>Klebsiella</italic> spp./<italic>Enterobacter</italic> spp./<italic>Serratia</italic> spp. and <italic>Escherichia coli</italic>. This ability is critical for decision-making on mastitis treatment using OFC results, since <italic>Escherichia coli</italic> usually does not require antibiotic treatment because of its high spontaneous cure rate<sup>##REF##23679229##2##</sup>, while <italic>Klebsiella</italic> spp. would benefit of antimicrobial therapy in the treatment of non-severe and clinical mastitis<sup>##REF##30981475##23##</sup>.</p>", "<p id=\"Par13\">Regarding the predominantly contagious pathogens evaluated, although Rumi’s Sp results were all &gt; 0.95, the Se results were &lt; 0.80. As contagious pathogens control is predominantly related to prevention of transmission and identification of the positive cows<sup>##UREF##12##24##</sup>, Se results are the most important accuracy predictors. Rumi’s Se results for <italic>Staphylococcus aureus</italic> was 0.73, which can be related to the misidentification between <italic>Staphylococcus aureus</italic> and non-aureus staphylococci, since 5 out of 9 FN results were classified as non-aureus staphylococci. However, despite of been numerically greater, the specialist Se results for <italic>Staphylococcus aureus</italic> and the <italic>Streptococcus agalactiae/Streptococcus dysgalactiae</italic> group weren’t statistically different at a 5% significance level, which denotes that the low Se is probably related to the accuracy of the chromogenic culture media itself for those species. Similar results were reported by Garcia et al.<sup>##UREF##13##25##</sup> using the same chromogenic culture media, but with post-partum subclinical mastitis samples (Se = 0.67), and those results were attributed to inconsistencies in the colony color pattern of this pathogen, in the chromogenic culture media. <italic>Staphylococcus aureus</italic> identification is particularly important because of its high transmission capacity, low cure rates and high resistance to antimicrobial treatment<sup>##UREF##12##24##,##REF##29063353##26##</sup>. However, <italic>Staphylococcus aureus</italic> is mostly associated with subclinical mastitis, and the primarily focus of Rumi’s microbiological identification is related to CM cases for selective treatment decisions.</p>", "<p id=\"Par14\">The group non-<italic>aureus</italic> staphylococci was the only one in which a statistical difference in accuracy parameter results was observed between the specialist and Rumi. A lower Se was observed for Rumi compared to the specialist, potentially resulting in fewer treatment of positive cows for non-<italic>aureus</italic> staphylococci, since FN results correspond to positive samples classified as negative within this group. This difference can possibly be atributed to the chromogenic culture media not having a specific color definition for non-<italic>aureus</italic> staphylococci as a group, and classifying it as any color other than pink. Rumi’s supervised machine-learning model was developed based on digital images of SmartColor 2 plates labeled with the presumptive microbiological identification result. Considering that the non-aureus staphylococci group presents about 11 different species causing mastitis<sup>##REF##24622096##27##</sup>, Rumi was exposed to a broad variation in colony color and morphology in the training process, which may have decreased the accuracy of the identification for the group.</p>", "<p id=\"Par15\">Although a difference was observed in the Se results of one of the pathogen groups evaluated, Rumi performed similarly as the specialist in Sp results. Both the specialist and Rumi presented satisfactory results regarding Sp, for all groups of pathogens evaluated. Considering that the selective treatment of CM presupposes that only cases which will benefit from treatment are treated<sup>##REF##37080782##3##</sup>, a high Sp is essential for adopting OFC results as a criterion for therapy. For most of the evaluated groups of pathogens (with the only exception of <italic>Escherichia coli</italic>), an FP result could lead to unnecessary treatment, and so a high Sp is crucial for the reduction of antimicrobial therapy on mastitis control, which is one of the primary reasons for the OFC implementation on dairy herds.</p>", "<p id=\"Par16\">The only group of pathogens witch Rumi presented diagnostic accuracy results &lt;0.60 was <italic>Enterococcus</italic> spp. (Se = 0.20). Although, Rumi’s low accuracy for this group can be probably attributed to the chromogenic culture media performance itself, since both the specialist and Rumi evaluation presented low Se. The specialist interpretation had 4 FN results, while Rumi had 8 FN results for <italic>Enterococcus</italic> spp. identification. Half of Rumi’s FN results (4 out of 8) were in the same samples that were classified as FN for the specialist’s evaluation, indicating that this incorrect identification is associated with the chromogenic culture media performance. Those results agree with the diagnostic accuracy obtained by Granja et al. (2021), evaluating the same chromogenic culture media for clinical mastitis samples (Se = 0.43) and subclinical mastitis (Se = 0.25). Additionally, <italic>Enterococcus</italic> spp. and <italic>Streptococcus</italic> spp. genus has narrow phenotypic similarity which leads to a difficult morphological differentiation<sup>##UREF##14##28##</sup>, even in chromogenic media, in which the identification is made by the color patterns. Ferreira et al.<sup>##UREF##11##22##</sup> found, in Accumast chromogenic culture media, the group <italic>Lactococcus</italic>/<italic>Enterococcus</italic> as the most common cause of FP results, leading to a low PPV (0,538±0.26), as it was observed in our study. Probably, the low isolation frequency of <italic>Enterococcus</italic> spp. (n = 13) has compromised the results of Se, both for the specialist and Rumi evaluation. Considering that the criteria for separately calculating the diagnostic accuracy predictors (out of the “other pathogens” group) were, at least 10 isolations, <italic>Enterococcus</italic> spp. had only 3 isolates above the breakpoint.</p>", "<p id=\"Par17\">It is necessary to consider that, our gold standard method used blood agar as the primary isolation medium incubated by 48-hour period (with inspections at 24 and 48 hours), while the SmartColor 2 plates had a period incubation of only 24 hours. This difference of incubation period between the methods can be considered a limitation of the study because some pathogens have fastidious growth and demand a longer period of incubation (e.g., 2 to 3 days for growth of <italic>Corynebacterium</italic> spp.<sup>##UREF##15##29##</sup>). Although, 24 hours is the maximum safe awaiting period recommended for decision-making on CM treatment without affecting cure rates<sup>##REF##37080782##3##,##REF##33663824##30##</sup>. In this sense, prolonging the incubation period of SmartColor 2 plates to match the gold standard methodology would bias our results, once this procedure is not replicable on the field. Another potential limitation is the use of swabs instead of platinum loops for the inoculation procedures of both methodologies, which, due to the lack of a standardized volume, could increase the risk of FP results. However, as the OFC procedure is based on the swab inoculation, using a platinum loop only on blood agar would lead to additional bias, as low colony-forming unit samples could be erroneously considered FP on SmartColor 2 due to the inoculation volume difference between methods. To mitigate bias, we chose to apply the same procedure for both, SmartColor2 and blood agar.</p>", "<title>Trial 2</title>", "<p id=\"Par18\">The results of the Bayesian Latent Class Model indicate no differences in accuracy parameters between FPU and Rumi. Although no accuracy improvement was found, the use of Rumi can help in simplifying the OFC identification process, reducing the need for an additional operation. Considering that, currently, all FPU need to be trained by OnFarm employees to perform microbiological identification, the use of Rumi can make the process simpler and faster for new FPU that are implementing the selective treatment of CM based on OFC. This simpler implementation process can also be important for farms to decide on implementing the OFC system, as changes in management can present challenges. Additionally, as Rumi automatically provides the microbiological identification, there is no need for manually registering the results on the CM management recordings, which improve the record-keeping efficiency.</p>", "<p id=\"Par19\">Despite the lower Se results of Rumi in comparison to the specialist in Trial 1, no difference was observed in the diagnostic accuracy parameters of the non-<italic>aureus</italic> staphylococci identification between Rumi and FPU. This denotes that there is no disadvantage in using Rumi for microbiological identification of this group. Although, concurrently, it indicates that the OFC method itself does not have a good diagnostic performance for this group of pathogens, since the use of Rumi did not affect the accuracy, even though it was lower than the specialists Se in Trial 1.</p>", "<p id=\"Par20\">It should be pointed out that the Rumi and FPU evaluations were not performed under the same conditions. The FPU had the advantage of holding and moving the chromogenic culture media Petri dishes for the interpretation of the microbiological colonies, while Rumi only had access to the digital image of each plate. Nevertheless, similar accuracy parameter results were observed for all groups of pathogens evaluated. Even though, none of Rumi’s evaluations presented lower diagnostic accuracy results than an FPU, the use of Rumi did not improve the diagnostic accuracy of the OFC method as it was hypothesized. Our results indicated that there is still room for improvement in the development of the AI-based application for chromogenic culture media plate reading. Using a greater number of images for the training could be an alternative, especially for some groups of pathogens with low frequencies of isolation (e.g. <italic>Enterococcus</italic> spp.) or a broad difference in colony morphology among the species within a specific group (e.g. non-<italic>aureus</italic> staphylococci). Additionally, it is necessary to highlight that the frequency of isolation found for some groups of pathogens in Trial 2 limited the power of the test, which can address the sample size as a limitation of the trial.</p>" ]
[]
[ "<p id=\"Par1\">Using on-farm microbiological culture (OFC), based on chromogenic culture media, enables the identification of mastitis causing pathogens in about 24 h, allows rapid decision making on selective treatment and control management measures of cows with clinical mastitis (CM). However, accurate interpretation of OFC results requires trained and experienced operators, which could be a limitation for the use of OFC in dairy farms. Our hypothesis was that AI-based automated plate reading mobile application can analyze images of microorganisms’ colonies in chromogenic culture media with similar diagnostic performance as a trained specialist evaluator. Therefore, the aim of the present study was to evaluate the diagnostic accuracy of an AI-based application (Rumi; OnFarm, Piracicaba, São Paulo, Brazil) for interpreting images of mastitis causing microorganism colonies grown in chromogenic culture media. For this study two trials were organized to compare the results obtained using an AI-based application Rumi with the interpretation of: (1) a trained specialist, using MALDI-TOF MS as the gold standard; (2) farm personnel users (FPU). In trial 1, a total of 476 CM milk samples, from 11 farms located in São Paulo (n = 7) and Minas Gerais (n = 4), southeast Brazil, were inoculated in chromogenic culture media plates (Smartcolor 2, OnFarm, Piracicaba, São Paulo, Brazil) by specialists under lab conditions, and digital images were recorded 24 h after incubation at 37 °C. After that, all the 476 digital images were analyzed by the Rumi and by another specialist (who only had access to the digital images) and the diagnostic accuracy indicators sensitivity (Se) and specificity (Sp) were calculated using MALDI-TOF MS microbiological identification of the isolates as the reference. In Trial 2, a total of 208 CM milk samples, from 150 farms from Brazil, were inoculated in chromogenic culture media plates by FPU, and the results of microbiological growth were visually interpreted by FPU under on-farm conditions. After visual interpretation, results were recorded using an OnFarmApp application (herd manage application for mastitis by OnFarm, Piracicaba, São Paulo, Brazil), and the images of the chromogenic culture plates were captured by the OnFarmApp to be evaluated by Rumi and Bayesian Latent Class Models were performed to compare Rumi and the FPU. In Trial 1, Rumi presented high and intermediate accuracy results, with the only exception of the low <italic>Enterococcus</italic> spp.’s Se. In comparison with the specialist, Rumi performed similarly in Se and Sp for most groups of pathogens, with the only exception of non-aureus staphylococci where Se results were lower. Both Rumi and the specialist achieved Sp results &gt; 0.96. In Trial 2, Rumi had similar results as the FPU in the Bayesian Latent Class Model analysis. In conclusion, the use of the AI-based automated plate reading mobile application can be an alternative for visual interpretation of OFC results, simplifying the procedures for selective treatment decisions for CM based on OFC.</p>", "<title>Subject terms</title>" ]
[ "<title>Development of the AI-based mobile application</title>", "<title>Convolutional neural networks model: inputs, training and the validation procedure</title>", "<p id=\"Par27\">Machine learning methods based on supervised learning were used to create an automatic classifier based on a convolutional neural networks model to make an automated diagnosis of mastitis-causing pathogens growth in chromogenic culture media (Smartcolor 2). The image database contained images of Petri dishes that presented growth of at least one microorganism colony isolated from milk samples from mastitic cows. All images were captured at the farms using OnFarm OFC system and were registered using the OnFarmApp.</p>", "<p id=\"Par28\">Before the training procedure, all the images were labeled by a specialist (PhD veterinarian specializing in microbiology, with six years of experience in microbiological identification by the chromogenic culture media triplate used in the study) with bounding boxes indicating on images the object's region (microorganism’s colonies) with their respective object classes (positive diagnosis)<sup>##UREF##16##31##</sup>. The labeled database with target information (classes for positive diagnosis) is the procedure in a supervised learning approach that indicates what the model should learn using the data from the dataset in the training process<sup>##UREF##17##32##</sup>.</p>", "<title>Experimental set-up and evaluation metrics</title>", "<p id=\"Par29\">An experimental set using the Petri dishes images was adopted to create the classifier of the automatic mastitis-causing pathogen diagnosis. For this, we used an open-source model for object detection in images named YoloV5 version “M”<sup>##UREF##18##33##</sup>. The main model’s features used in this study were: model size = 42.2 megabytes; trainable parameters = 20,875,359; image size = 640 X 640 and depth = 169. The main hyperparameters used in the training procedure were: optimization algorithm = stochastic gradient descent; batch size = 32; momentum = 0.937; weight decay = 0.0005 and learning rate = 0.01.</p>", "<p id=\"Par30\">To the training process we adopted the weights and a trained model using the “transfer learning” approach in our application. In this procedure, the model (YoloV5m) was trained using the Common Objects in Context dataset (COCO) composed of over 330 thousand images, around 1.5 million instances of objects to detect 80 different types of objects in images<sup>##UREF##19##34##</sup>. The transfer learning technique uses a trained model as a starting point (mode = l’s weights) to train a new model for a new context using new images, for new objects, new classes and especially, using a smaller training dataset<sup>##UREF##20##35##</sup>. Our application was implemented using the programming language Python 3.8<sup>##UREF##21##36##</sup> combined with PyTorch 1.8<sup>##UREF##22##37##</sup> as back-end. To evaluate the classifier model, the Diagnostic Accuracy Measures was adopted<sup>##REF##24135733##38##</sup>, which was composed by four parameters: True Positives (TP), True Negatives (TN), False Positives (FP) and False Negatives (FN), that enabled the analyses of the Accuracy (Acc), Sensitivity (Se), Specificity (Sp), Positive Predictive Value (PPV) and Negative Predictive Value (NPV).</p>", "<p id=\"Par31\">To develop the classifier, we utilized 1,550 images randomly selected from the OnFarmApp database, which contained around 450,000 mastitis case images recorded by FPU during standard OFC procedures. All images underwent encryption of farm and cow information prior to selection to safeguard the privacy of the farms involved. The dataset was divided randomly into two subsets, representing 80% and 20% from the dataset. In the first subset, the total of 1,240 images were selected for the training process and in the second, 310 images were selected for the validation process. To evaluate entire database in the training process, we adopted the k-fold cross-validation method<sup>##UREF##23##39##,##UREF##24##40##</sup>. In our experiment a fivefold cross-validation procedure was used, randomly separating the dataset five times with 80% of images for training the classifiers and 20% of images for testing ensuring the best model at the end of the training process. After the training procedure, the machine learning model has been deployed a Rest service with a HTTP protocol developed in Flask Python in an EC2 service hosted in an Amazon Web Service (AWS). Then, a mobile and web application was built (Rumi, OnFarm, Piracicaba, Brazil), which was integrated with the machine learning algorithms services using an Application Program Interface (API). The service worked uploading the digital image in the service and getting back the result from the Rumi AI-based application service.</p>", "<title>Evaluation of the reliability of the AI-based application</title>", "<p id=\"Par32\">The database for training and validation, composed of 1,550 images, was used to ensure the best model at the end of the training process. Meanwhile, the test data set, which was not used in the training procedure, was a sample of unknown data for the trained model. The test dataset contained 684 images, including 476 from plates with bacteria previously identified by Matrix-Assisted Laser Desorption Ionization—Time-of-Flight Mass Spectrometry (MALDI-TOF MS), as described by Granja et al. (2021). The remaining 208 images were randomly selected from the OnFarmApp image database, and identified by the trained specialist.</p>", "<title>Trial 1 Diagnostic accuracy of Rumi and a trained specialist for the identification of CM causing pathogens in chromogenic culture media images, using MALDI-TOF MS as the reference (Fig. ##FIG##1##2##)</title>", "<title>Objective</title>", "<p id=\"Par33\">Evaluate the diagnostic accuracy of Rumi using MALDI-TOF MS as the gold standard, and compare its results with the accuracy of a specialist with six years of experience in microbiological identification using the chromogenic culture media triplate Smartcolor 2.</p>", "<title>Images, data collection and diagnostic accuracy under laboratory conditions</title>", "<p id=\"Par34\">A total of 476 images of SmartColor 2 triplate with colony growth from CM milk samples, originating from a previous study<sup>##REF##33934869##4##</sup> were used in Trial 1. These images were generated from 476 CM cases, from 441 cows of 25 farms located in two states of Brazil (São Paulo and Minas Gerais), selected as a non-probabilistic convenience sampling. The number of samples was chosen in accordance with the comparable literature<sup>##UREF##25##41##,##REF##21854917##42##</sup>. Briefly, all CM milk samples were sent from the farm to the laboratory frozen at −20°C and then, in laboratory conditions, milk samples were inoculated, with a sterile swab, simultaneously in SmartColor 2 and in blood agar. After 24 h (for SmartColor 2) and 24 to 48 hours (for blood agar) of incubation at 37°C, the plates were inspected and all microbiological colonies grown in SmartColor 2 and in blood agar were submitted to species identification using MALDI-TOF MS. Concurrently, the SmartColor 2 plates were photographed for further evaluation.</p>", "<p id=\"Par35\">All images were classified by the following two methods: (a) a trained specialist (not involved in the previous study) and (b) Rumi. The specialist had access to the digital images and recorded a presumptive diagnosis based on colonies color patterns and growth on selective media, following manufacturer’s recommendations. Rumi’s readings were carried out by uploading and processing digital images using the Web OnFarmApp.</p>", "<title>Diagnostic performance indicators</title>", "<p id=\"Par36\">The diagnostic accuracy (Se, Sp and accuracy), for the microbiological identification of the specialist and Rumi, were estimated using the MALDI-TOF MS microbiological identification results as gold standard. The recorded number of colonies of each isolate was considered to classify a sample as positive. In our criteria, all samples with the isolation of less than three colonies (with the exception of <italic>Staphylococcus aureus</italic>), were classified as negative for that particular species. Images of plates displaying the isolation of two different morphologies of colonies were classified as mixed culture, and considered positive for the two species in the analysis. Contaminated samples (defined as the presence of three or more morphologically-distinct colonies in the same sample) were not included in the analysis. Pathogens with a frequency of isolation lower than 10 were grouped as “other pathogens”.</p>", "<p id=\"Par37\">For each pathogen group evaluated, samples were considered TP when microbiological growth was observed, and the visual presumptive identification of chromogenic media coincided with the identification in MALDI-TOF MS for isolates in blood-agar. A sample was considered TN when no microbiological growth with color pattern associated with this specie was observed in chromogenic media and no identification of the species was done by MALDI-TOF MS in blood-agar isolates of the same sample. A sample was considered FP when there was an isolation of microorganism with different identification result between the chromogenic culture media and MALDI-TOF MS identification of blood-agar isolates of the same sample. Finally, a sample was considered FN when no bacterial growth with color pattern associated with this specie was observed in chromogenic media, but a microbiological identification of the pathogen was made in MALDI-TOF MS for blood-agar isolates of the same sample.</p>", "<p id=\"Par38\">The diagnostic performance indicators were calculated using the software R Studio (version 4.1.3). Using the recorded results of TP, TN, FP and TN. A confusion matrix was created using bdpv package<sup>##UREF##26##43##</sup>, and the results were used to generate the Se and Sp, as well as the Wald confidence intervals (0.95 confidence limits). McNemar’s Exact tests were used for comparing sensitivities and specificities between the specialist and Rumi for each pathogen group.</p>", "<title>Trial 2 Diagnostic accuracy of Rumi and farm personnel users for the identification of mastitis-causing pathogens in chromogenic culture media plates (Fig. ##FIG##2##3##)</title>", "<title>Objective</title>", "<p id=\"Par39\">Compare the diagnostic accuracy of Rumi and FPU to estimate potential gains of using Rumi for the interpretation of OFC results.</p>", "<title>Images and Data Selection</title>", "<p id=\"Par40\">For this trial, we selected 208 images, originating from 150 Brazilian dairy farms located in three Brazilian states (Minas Gerais, São Paulo and Paraná). Images were randomly selected from a pool of eligible images meeting the following criteria: (1) Image captured using the Onfarm’s reader support located at the top of the SmartLab incubator; (2) Image of a plate placed in the correct position at the reader support and (3) Image without environmental interferences (e.g., camera flashes, objects in front of the plate). No minimum specification was required for the devices or image quality. The images, as well as the FPU’s presumptive microbiological identification, were previously recorded in OnFarmApp. Additionally, images were also identified using the Rumi.</p>", "<p id=\"Par41\">Milk samples were considered culture-positive if 3 or more colonies with the color patterns defined for the species were present. The only exception was <italic>Staphylococcus aureus,</italic> in which the growth of a single colony was considered positive. Mixed samples were defined as the presence of 2 distinct species in sufficient numbers on the same sample. Plates were considered contaminated when &gt; 2 different morphology of colonies were present. Mixed culture plates were considered positive for both groups of pathogens whereas contaminated samples were not included in the analyses.</p>", "<title>Bayesian Latent Class Model</title>", "<p id=\"Par42\">Since two distinct tests (Rumi and FPU reading) were used, and none of the two could be regarded as a gold standard for bacterial identification, we opted for a Bayesian approach to estimate the differences in sensitivity and specificity between Rumi and FPU. This difference served as a proxy for assessing the potential on-farm gains in diagnostic accuracy through automated plate reading. Trial 2 contained no missing data or indeterminate results.</p>", "<p id=\"Par43\">To accomplish this, we developed a set of Bayesian latent class models following the STARD-BLCM guidelines (Table ##SUPPL##0##S1##). These models were tailored for each group of pathogens, taking into account the utilization of the two tests within a particular population<sup>##REF##15820113##44##</sup>. The latent variable in this instance was a positive culture result on blood agar for a species or group of species, as identified by MALDI-TOF. The two tests were considered independent from one another. A multinomial distribution was used to represent all possible 4 outcome combinations, as follows:where y<sub>observed</sub> is a vector that denotes the number of observed results after n trials that fall in each possible combination according to the diagnostic test results, assumed to follow a multinomial distribution with cell probability P<sub>observed</sub>. P<sub>population</sub> represents the true prevalence of each group of pathogens. P<sub>observed</sub> [1] to [4] represent the different probabilities of samples being classified as test positive or negative in each diagnostic test according to the true pathogen prevalence. Se<sub>FPU</sub>, Se<sub>Rumi</sub>, Sp<sub>FPU</sub> and Sp<sub>Rumi</sub>, represent the sensitivities and specificities of the FPU and Rumi, respectively. A sample code is available as supplementary material (Supplementary Text ##SUPPL##0##1##).</p>", "<p id=\"Par44\">Prior information on the Se and Sp of Rumi as well as true prevalence priors were incorporated into the Bayesian latent class models (Table ##TAB##4##5##). These were chosen according to the Trial 1 results. Non-informative priors were used for the Se and Sp of FPU. Priors were determined using the <italic>betaExpert</italic> function in R<sup>##UREF##27##45##</sup>. Distributions were not truncated and could attain any value in the parameter space. We carried a set of sensitivity analysis considering alternative prevalence priors, as well as weaker diagnostic priors for Rumi with identical modes.</p>", "<p id=\"Par45\">A Markov chain Monte Carlo approach using Gibbs sampling was performed with 4 chains in parallel with a total of 400,000 iterations using the <italic>runjags</italic> package in R<sup>##UREF##28##46##</sup>. Visual inspection of the chains, effective sample sizes, and autocorrelation plots were used as measures of efficacy. An effective sample size of at least 10,000 was required for all parameters. The <italic>step()</italic> function was used to estimate the probability of the Se and Sp of Rumi being greater than those of the FPU for the identification of each group of pathogens. Statistical significance was considered at the 5% level. These analyses were carried out in R.</p>", "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-023-50296-w.</p>", "<title>Acknowledgements</title>", "<p>The authors acknowledge OnFarm-Rumina (Piracicaba, Sao Paulo, Brazil), Qualileite Laboratory (Qualileite Milk Quality Laboratory, School of Veterinary Medicine and Animal Science, University of Sao Paulo, Pirassununga, Brazil) for all contributions on this study. The study was partially sponsored by Rúmina. However, the authors were solely responsible for study conceptualization, writing and design, and the decision to publish.</p>", "<title>Author contributions</title>", "<p>B.L.N.G.: drafted the manuscript, ran the experiments, interpretated the data, approved the submitted version, and agrees to be accountable for all aspects of the work. C.M.M.R.M.: drafted the work, worked on the data acquisition and image processing, agrees to be accountable for all aspects of the work, and approved the submitted version. L.P.: designed the work, processed images, developed the deep learning model, drafted the work, approved the submitted version, and agrees to be accountable for all aspects of the work. D.B.N.: carried out the data analysis for Trials 1 and 2, interpreted findings, revised the text, approved the submitted version, and agrees to be accountable for all aspects of the work. M.V.S.: responsible for study conceptualization and design, drafted the manuscript, approved the submitted version, and agrees to be accountable for all aspects of the work.</p>", "<title>Data availability</title>", "<p>The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.</p>", "<title>Competing interests</title>", "<p id=\"Par46\">The authors B.L.N.G., D. B. N. and M.V.S. declare no competing interests. The authors C.M.M.R.M and L.P are employees of Rumina, company that owns OnFarm, which the mobile application (OnFarmApp) was used in the study for accessing the data. However, in the present study they had no role in the analysis and interpretation of the results.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Reader Support (<bold>A</bold>) located at the SmartLab Incubator (<bold>B</bold>; OnFarm, Piracicaba, São Paulo, Brazil) used to take pictures for model training and performance evaluation.</p><p><italic>Source</italic>: OnFarm (Piracicaba, São Paulo, Brazil).</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Trial 1 Flowchart—Estimation of the Sensitivity (Se) and Specificity (Sp) of the artificial intelligence-based application (Rumi; OnFarm, Piracicaba, São Paulo, Brazil) and the trained specialist to identify pathogens growing on chromogenic culture media on farms. MALDI-TOF MS was considered as the gold standard.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Trial 2 Flowchart—A comparison of Sensitivity (Se) and Specificity (Sp) between the artificial intelligence-based application (Rumi; OnFarm, Piracicaba, São Paulo, Brazil) and farm personnel users for the identification of clinical mastitis pathogens in images from chromogenic culture media plates.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Frequency isolation of mastitis-causing pathogens from 476 clinical mastitis samples cultured in blood agar and identified by MALDI-TOF MS.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Variable</th><th align=\"left\">Frequency (n)</th><th align=\"left\">%</th></tr></thead><tbody><tr><td align=\"left\">Total</td><td char=\".\" align=\"char\">476</td><td char=\".\" align=\"char\">100.0</td></tr><tr><td align=\"left\">Negative</td><td char=\".\" align=\"char\">267</td><td char=\".\" align=\"char\">56.1</td></tr><tr><td align=\"left\">Mixed culture</td><td char=\".\" align=\"char\">97</td><td char=\".\" align=\"char\">20.4</td></tr><tr><td align=\"left\">Gram-positive</td><td char=\".\" align=\"char\">214</td><td char=\".\" align=\"char\">45.0</td></tr><tr><td align=\"left\"> <italic>Streptococcus agalactiae</italic></td><td char=\".\" align=\"char\">9</td><td char=\".\" align=\"char\">1.9</td></tr><tr><td align=\"left\"> <italic>Streptococcus dysgalactiae</italic></td><td char=\".\" align=\"char\">13</td><td char=\".\" align=\"char\">2.7</td></tr><tr><td align=\"left\"> <italic>Streptococcus uberis</italic></td><td char=\".\" align=\"char\">19</td><td char=\".\" align=\"char\">4.0</td></tr><tr><td align=\"left\"> <italic>Enterococcus</italic> spp.</td><td char=\".\" align=\"char\">10</td><td char=\".\" align=\"char\">2.1</td></tr><tr><td align=\"left\"> <italic>Lactococcus</italic> spp.</td><td char=\".\" align=\"char\">6</td><td char=\".\" align=\"char\">1.3</td></tr><tr><td align=\"left\"> <italic>Staphylococcus aureus</italic></td><td char=\".\" align=\"char\">35</td><td char=\".\" align=\"char\">7.3</td></tr><tr><td align=\"left\"> Non-<italic>aureus</italic> staphylococci</td><td char=\".\" align=\"char\">52</td><td char=\".\" align=\"char\">10.9</td></tr><tr><td align=\"left\"> Other Gram-positive pathogens</td><td char=\".\" align=\"char\">70</td><td char=\".\" align=\"char\">14.7</td></tr><tr><td align=\"left\">Gram-negative</td><td char=\".\" align=\"char\">92</td><td char=\".\" align=\"char\">19.3</td></tr><tr><td align=\"left\"> <italic>Escherichia coli</italic></td><td char=\".\" align=\"char\">36</td><td char=\".\" align=\"char\">7.6</td></tr><tr><td align=\"left\"> <italic>Klebsiella</italic> spp.</td><td char=\".\" align=\"char\">20</td><td char=\".\" align=\"char\">4.2</td></tr><tr><td align=\"left\"> <italic>Enterobacter</italic> spp.</td><td char=\".\" align=\"char\">5</td><td char=\".\" align=\"char\">1.0</td></tr><tr><td align=\"left\"> <italic>Serratia</italic> spp.</td><td char=\".\" align=\"char\">5</td><td char=\".\" align=\"char\">1.0</td></tr><tr><td align=\"left\"> <italic>Pseudomonas</italic> spp.</td><td char=\".\" align=\"char\">8</td><td char=\".\" align=\"char\">1.7</td></tr><tr><td align=\"left\"> Yeast and <italic>Prototheca</italic> spp.</td><td char=\".\" align=\"char\">10</td><td char=\".\" align=\"char\">2.1</td></tr><tr><td align=\"left\"> Other Gram-negative pathogens</td><td char=\".\" align=\"char\">8</td><td char=\".\" align=\"char\">1.7</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Diagnostic sensitivity (Se) and specificity (Sp) of the visual identification of mastitis-causing pathogens from clinical mastitis samples (n = 476) in chromogenic culture media triplates (SmartColor 2—OnFarm. Brazil) made by a trained specialist and by an artificial intelligence-based application (Rumi; OnFarm. Piracicaba. São Paulo. Brazil).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\"/><th align=\"left\">Frequency (n)</th><th align=\"left\" colspan=\"2\">Se (CI)</th><th align=\"left\" colspan=\"2\">Sp (CI)</th></tr></thead><tbody><tr><td align=\"left\"><italic>Streptococcus agalactiae/Streptococcus dysgalactiae</italic></td><td align=\"left\">25</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\">Specialist</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\">0.86</td><td char=\"–\" align=\"char\">(0.65–0.97)</td><td char=\".\" align=\"char\">0.97</td><td align=\"left\">(0.95 -0.98)</td></tr><tr><td align=\"left\">Rumi</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\">0.68</td><td char=\"–\" align=\"char\">(0.45–0.86)</td><td char=\".\" align=\"char\">0.98</td><td align=\"left\">(0.96–0.99)</td></tr><tr><td align=\"left\"><italic>Streptococcus uberis</italic></td><td char=\".\" align=\"char\">24</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td align=\"left\"/></tr><tr><td align=\"left\">Specialist</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\">0.89</td><td char=\"–\" align=\"char\">(0.67–0.99)</td><td char=\".\" align=\"char\">0.98</td><td align=\"left\">(0.96–0.99)</td></tr><tr><td align=\"left\">Rumi</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\">0.84</td><td char=\"–\" align=\"char\">(0.60–0.97)</td><td char=\".\" align=\"char\">0.96</td><td align=\"left\">(0.94–0.97)</td></tr><tr><td align=\"left\"><italic>Enterococcus</italic> spp.</td><td char=\".\" align=\"char\">13</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td align=\"left\"/></tr><tr><td align=\"left\">Specialist</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\">0.60</td><td char=\"–\" align=\"char\">(0.26–0.88)</td><td char=\".\" align=\"char\">0.97</td><td align=\"left\">(0.95–0.98)</td></tr><tr><td align=\"left\">Rumi</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\">0.20</td><td char=\"–\" align=\"char\">(0.02–0.56)</td><td char=\".\" align=\"char\">0.97</td><td align=\"left\">(0.95–0.99)</td></tr><tr><td align=\"left\">Other Pathogens</td><td char=\".\" align=\"char\">7</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td align=\"left\"/></tr><tr><td align=\"left\">Specialist</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\">0.61</td><td char=\"–\" align=\"char\">(0.49–0.71)</td><td char=\".\" align=\"char\">0.98</td><td align=\"left\">(0.96–0.99)</td></tr><tr><td align=\"left\">Rumi</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\">0.38</td><td char=\"–\" align=\"char\">(0.29–0.49)</td><td char=\".\" align=\"char\">0.98</td><td align=\"left\">(0.97–0.99)</td></tr><tr><td align=\"left\"><italic>Klebsiella</italic> spp./<italic>Enterobacter</italic> spp./<italic>Serratia</italic> spp.</td><td char=\".\" align=\"char\">31</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td align=\"left\"/></tr><tr><td align=\"left\">Specialist</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\">0.93</td><td char=\"–\" align=\"char\">(0.78–0.99)</td><td char=\".\" align=\"char\">1.00</td><td align=\"left\">(0.98–1.00)</td></tr><tr><td align=\"left\">Rumi</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\">0.97</td><td char=\"–\" align=\"char\">(0.83–1.00)</td><td char=\".\" align=\"char\">0.99</td><td align=\"left\">(0.98–1.00)</td></tr><tr><td align=\"left\"><italic>Escherichia coli</italic></td><td char=\".\" align=\"char\">47</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td align=\"left\"/></tr><tr><td align=\"left\">Specialist</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\">0.97</td><td char=\"–\" align=\"char\">(0.88–1.00)</td><td char=\".\" align=\"char\">0.99</td><td align=\"left\">(0.98–1.00)</td></tr><tr><td align=\"left\">Rumi</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\">0.89</td><td char=\"–\" align=\"char\">(0.74–0.97)</td><td char=\".\" align=\"char\">0.99</td><td align=\"left\">(0.98–1.00)</td></tr><tr><td align=\"left\"><italic>Staphylococcus aureus</italic></td><td char=\".\" align=\"char\">35</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td align=\"left\"/></tr><tr><td align=\"left\">Specialist</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\">0.83</td><td char=\"–\" align=\"char\">(0.66–0.93)</td><td char=\".\" align=\"char\">0.99</td><td align=\"left\">(0.98–1.00)</td></tr><tr><td align=\"left\">Rumi</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\">0.74</td><td char=\"–\" align=\"char\">(0.57–0.87)</td><td char=\".\" align=\"char\">0.98</td><td align=\"left\">(0.97–0.99)</td></tr><tr><td align=\"left\">Non-<italic>aureus</italic> staphylococci</td><td char=\".\" align=\"char\">70</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td align=\"left\"/></tr><tr><td align=\"left\">Specialist</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\">0.94<sup>a</sup></td><td char=\"–\" align=\"char\">(0.84–0.99)</td><td char=\".\" align=\"char\">0.99</td><td align=\"left\">(0.98–1.00)</td></tr><tr><td align=\"left\">Rumi</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\">0.73<sup>b</sup></td><td char=\"–\" align=\"char\">(0.61–0.84)</td><td char=\".\" align=\"char\">0.98</td><td align=\"left\">(0.97–1.00)</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Distribution of mastitis-causing pathogens of 208 clinical mastitis samples cultured on chromogenic culture media triplate (Smartcolor 2. OnFarm. Piracicaba. São Paulo. Brazil).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Variable</th><th align=\"left\">Frequency (n)</th><th align=\"left\">%</th></tr></thead><tbody><tr><td align=\"left\">Total</td><td char=\".\" align=\"char\">208</td><td char=\".\" align=\"char\">100.0</td></tr><tr><td align=\"left\">Negative</td><td char=\".\" align=\"char\">60</td><td char=\".\" align=\"char\">28.8</td></tr><tr><td align=\"left\">Mixed culture</td><td char=\".\" align=\"char\">65</td><td char=\".\" align=\"char\">31.2</td></tr><tr><td align=\"left\"><italic>Streptococcus agalactiae</italic>/<italic>Streptococcus dysgalactiae</italic></td><td char=\".\" align=\"char\">27</td><td char=\".\" align=\"char\">13.0</td></tr><tr><td align=\"left\"><italic>Streptococcus uberis</italic></td><td char=\".\" align=\"char\">24</td><td char=\".\" align=\"char\">11.5</td></tr><tr><td align=\"left\"><italic>Enterococcus</italic> spp.</td><td char=\".\" align=\"char\">16</td><td char=\".\" align=\"char\">7.7</td></tr><tr><td align=\"left\"><italic>Staphylococcus aureus</italic></td><td char=\".\" align=\"char\">16</td><td char=\".\" align=\"char\">7.7</td></tr><tr><td align=\"left\">Non-<italic>aureus</italic> staphylococci</td><td char=\".\" align=\"char\">73</td><td char=\".\" align=\"char\">35.1</td></tr><tr><td align=\"left\"><italic>Escherichia coli</italic></td><td char=\".\" align=\"char\">18</td><td char=\".\" align=\"char\">8.6</td></tr><tr><td align=\"left\"><italic>Klebsiella</italic> spp./<italic>Enterobacter</italic> spp./<italic>Serratia</italic> spp.</td><td char=\".\" align=\"char\">10</td><td char=\".\" align=\"char\">4.8</td></tr><tr><td align=\"left\">Other pathogens</td><td char=\".\" align=\"char\">55</td><td char=\".\" align=\"char\">26.4</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab4\"><label>Table 4</label><caption><p>Mode Sensitivity (Se) and Specificity (Sp) of the visual identification of mastitis-causing pathogens from clinical mastitis milk samples (n = 208) in chromogenic culture media triplates (SmartColor 2—OnFarm. Brazil) made by farm personnel users (FPU) and by an artificial intelligence-based application (Rumi; OnFarm. Piracicaba. São Paulo. Brazil).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\"/><th align=\"left\">Comparison</th><th align=\"left\">Mode</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"2\"><italic>Streptococcus agalactiae/Streptococcus dysgalactiae</italic></td><td align=\"left\">Se Rumi &gt; Se FPU</td><td char=\".\" align=\"char\">0.06</td></tr><tr><td align=\"left\">Sp Rumi &gt; Sp FPU</td><td char=\".\" align=\"char\">0.67</td></tr><tr><td align=\"left\" rowspan=\"2\"><italic>Sreptococcus uberis</italic></td><td align=\"left\">Se Rumi &gt; Se FPU</td><td char=\".\" align=\"char\">0.37</td></tr><tr><td align=\"left\">Sp Rumi &gt; Sp FPU</td><td char=\".\" align=\"char\">0.72</td></tr><tr><td align=\"left\" rowspan=\"2\"><italic>Enterococcus</italic> spp.</td><td align=\"left\">Se Rumi &gt; Se FPU</td><td char=\".\" align=\"char\">0.33</td></tr><tr><td align=\"left\">Sp Rumi &gt; Sp FPU</td><td char=\".\" align=\"char\">0.33</td></tr><tr><td align=\"left\" rowspan=\"2\"><italic>Klebsiella</italic> spp./<italic>Enterobacter</italic> spp./<italic>Serratia</italic> spp.</td><td align=\"left\">Se Rumi &gt; Se FPU</td><td char=\".\" align=\"char\">0.5</td></tr><tr><td align=\"left\">Sp Rumi &gt; Sp FPU</td><td char=\".\" align=\"char\">0.65</td></tr><tr><td align=\"left\" rowspan=\"2\"><italic>Escherichia coli</italic></td><td align=\"left\">Se Rumi &gt; Se FPU</td><td char=\".\" align=\"char\">0.41</td></tr><tr><td align=\"left\">Sp Rumi &gt; Sp FPU</td><td char=\".\" align=\"char\">0.59</td></tr><tr><td align=\"left\" rowspan=\"2\"><italic>Staphylococcus aureus</italic></td><td align=\"left\">Se Rumi &gt; Se FPU</td><td char=\".\" align=\"char\">0.18</td></tr><tr><td align=\"left\">Sp Rumi &gt; Sp FPU</td><td char=\".\" align=\"char\">0.92</td></tr><tr><td align=\"left\" rowspan=\"2\">Non-aureus staphylococci</td><td align=\"left\">Se Rumi &gt; Se FPU</td><td char=\".\" align=\"char\">0.22</td></tr><tr><td align=\"left\">Sp Rumi &gt; Sp FPU</td><td char=\".\" align=\"char\">0.69</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab5\"><label>Table 5</label><caption><p>Prior distributions used in final Bayesian Latent Class models and their interpretation.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Pathogen</th><th align=\"left\">Parameter</th><th align=\"left\">Distribution</th><th align=\"left\">Mode</th><th align=\"left\">95% certainty that true value</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"3\"><italic>Streptococcus agalactiae/Streptococcus dysgalactiae</italic></td><td align=\"left\">Prevalence</td><td align=\"left\">(1.93, 20.30)</td><td char=\".\" align=\"char\">0.05</td><td char=\".\" align=\"char\"> &lt; 20%</td></tr><tr><td align=\"left\">Sensitivity</td><td align=\"left\">(15.43, 7.73)</td><td char=\".\" align=\"char\">0.68</td><td char=\".\" align=\"char\"> &gt; 50%</td></tr><tr><td align=\"left\">Specificity</td><td align=\"left\">(9.20, 1.17)</td><td char=\".\" align=\"char\">0.98</td><td char=\".\" align=\"char\"> &gt; 70%</td></tr><tr><td align=\"left\" rowspan=\"3\"><italic>Streptococcus uberis</italic></td><td align=\"left\">Prevalence</td><td align=\"left\">(1.75, 19.06)</td><td char=\".\" align=\"char\">0.04</td><td char=\".\" align=\"char\"> &lt; 20%</td></tr><tr><td align=\"left\">Sensitivity</td><td align=\"left\">(26.18, 5.72)</td><td char=\".\" align=\"char\">0.84</td><td char=\".\" align=\"char\"> &gt; 70%</td></tr><tr><td align=\"left\">Specificity</td><td align=\"left\">(10.29, 1.40)</td><td char=\".\" align=\"char\">0.96</td><td char=\".\" align=\"char\"> &gt; 70%</td></tr><tr><td align=\"left\" rowspan=\"3\"><italic>Enterococcus</italic> spp.</td><td align=\"left\">Prevalence</td><td align=\"left\">(1.49, 23.66)</td><td char=\".\" align=\"char\">0.02</td><td char=\".\" align=\"char\"> &lt; 20%</td></tr><tr><td align=\"left\">Sensitivity</td><td align=\"left\">(1.34, 2.36)</td><td char=\".\" align=\"char\">0.20</td><td char=\".\" align=\"char\"> &gt; 5%</td></tr><tr><td align=\"left\">Specificity</td><td align=\"left\">(9.47, 1.22)</td><td char=\".\" align=\"char\">0.97</td><td char=\".\" align=\"char\"> &gt; 70%</td></tr><tr><td align=\"left\" rowspan=\"3\"><italic>Klebsiella</italic> spp<italic>./Enterobacter</italic> spp<italic>./Serratia</italic> spp<italic>.</italic></td><td align=\"left\">Prevalence</td><td align=\"left\">(2.59, 24.66)</td><td char=\".\" align=\"char\">0.06</td><td char=\".\" align=\"char\"> &lt; 20%</td></tr><tr><td align=\"left\">Sensitivity</td><td align=\"left\">(9.84, 1.30)</td><td char=\".\" align=\"char\">0.97</td><td char=\".\" align=\"char\"> &gt; 70%</td></tr><tr><td align=\"left\">Specificity</td><td align=\"left\">(8.65, 1.05)</td><td char=\".\" align=\"char\">0.99</td><td char=\".\" align=\"char\"> &gt; 70%</td></tr><tr><td align=\"left\" rowspan=\"3\"><italic>Escherichia coli</italic></td><td align=\"left\">Prevalence</td><td align=\"left\">(3.30, 29.06)</td><td char=\".\" align=\"char\">0.08</td><td char=\".\" align=\"char\"> &lt; 20%</td></tr><tr><td align=\"left\">Sensitivity</td><td align=\"left\">(16.44, 2.93)</td><td char=\".\" align=\"char\">0.89</td><td char=\".\" align=\"char\"> &gt; 70%</td></tr><tr><td align=\"left\">Specificity</td><td align=\"left\">(8.57, 1.03)</td><td char=\".\" align=\"char\">1.00</td><td char=\".\" align=\"char\"> &gt; 70%</td></tr><tr><td align=\"left\" rowspan=\"3\"><italic>Staphylococcus aureus</italic></td><td align=\"left\">Prevalence</td><td align=\"left\">(3.16, 28.24)</td><td char=\".\" align=\"char\">0.07</td><td char=\".\" align=\"char\"> &lt; 20%</td></tr><tr><td align=\"left\">Sensitivity</td><td align=\"left\">(10.02, 4.12)</td><td char=\".\" align=\"char\">0.74</td><td char=\".\" align=\"char\"> &gt; 50%</td></tr><tr><td align=\"left\">Specificity</td><td align=\"left\">(9.03, 1.13)</td><td char=\".\" align=\"char\">0.98</td><td char=\".\" align=\"char\"> &gt; 70%</td></tr><tr><td align=\"left\" rowspan=\"3\"><italic>Non-aureus</italic> staphylococci</td><td align=\"left\">Prevalence</td><td align=\"left\">(2.86, 16.18)</td><td char=\".\" align=\"char\">0.11</td><td char=\".\" align=\"char\"> &lt; 30%</td></tr><tr><td align=\"left\">Sensitivity</td><td align=\"left\">(10.78, 4.60)</td><td char=\".\" align=\"char\">0.73</td><td char=\".\" align=\"char\"> &gt; 50%</td></tr><tr><td align=\"left\">Specificity</td><td align=\"left\">(9.16, 1.16)</td><td char=\".\" align=\"char\">0.98</td><td char=\".\" align=\"char\"> &gt; 70%</td></tr></tbody></table></table-wrap>" ]
[ "<disp-formula id=\"Equa\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$y_{observed} = multinomial\\left( {P_{{observed\\left[ {1:4} \\right]}} , n} \\right)$$\\end{document}</tex-math><mml:math id=\"M2\" display=\"block\"><mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">observed</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mfenced close=\"]\" open=\"[\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>:</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equb\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P_{observed\\left[ 1 \\right]} = P_{population} \\times \\left( {Se_{Rumi} \\times Se_{FPU} } \\right) + \\left( {1 - P_{population} } \\right) \\times \\left( {\\left( {1 - Sp_{Rumi} } \\right) \\times \\left( {1 - Sp_{FPU} } \\right)} \\right)$$\\end{document}</tex-math><mml:math id=\"M4\" display=\"block\"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mfenced close=\"]\" open=\"[\"><mml:mn>1</mml:mn></mml:mfenced></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">population</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>S</mml:mi><mml:msub><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">Rumi</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">FPU</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">population</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>×</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">Rumi</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>×</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">FPU</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equc\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P_{observed\\left[ 2 \\right]} = P_{population} \\times \\left( {Se_{Rumi} \\times (1 - Se_{FPU} )} \\right) + \\left( {1 - P_{population} } \\right) \\times \\left( {\\left( {1 - Sp_{Rumi} } \\right) \\times Sp_{FPU} } \\right)$$\\end{document}</tex-math><mml:math id=\"M6\" display=\"block\"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mfenced close=\"]\" open=\"[\"><mml:mn>2</mml:mn></mml:mfenced></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">population</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>S</mml:mi><mml:msub><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">Rumi</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">FPU</mml:mi></mml:mrow></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">population</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>×</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">Rumi</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>×</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">FPU</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equd\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P_{observed\\left[ 3 \\right]} = P_{population} \\times \\left( {\\left( {1 - Se_{Rumi} } \\right) \\times Se_{FPU} } \\right) + \\left( {1 - P_{population} } \\right) \\times \\left( {Sp_{Rumi} \\times \\left( {1 - Sp_{FPU} } \\right)} \\right)$$\\end{document}</tex-math><mml:math id=\"M8\" display=\"block\"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mfenced close=\"]\" open=\"[\"><mml:mn>3</mml:mn></mml:mfenced></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">population</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">Rumi</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>×</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">FPU</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">population</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>×</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>S</mml:mi><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">Rumi</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">FPU</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Eque\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P_{observed\\left[ 4 \\right]} = P_{population} \\times \\left( {\\left( {1 - Se_{Rumi} } \\right) \\times (1 - Se_{FPU} )} \\right) + \\left( {1 - P_{population} } \\right) \\times \\left( {Sp_{Rumi} \\times Sp_{FPU} } \\right)$$\\end{document}</tex-math><mml:math id=\"M10\" display=\"block\"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mfenced close=\"]\" open=\"[\"><mml:mn>4</mml:mn></mml:mfenced></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">population</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">Rumi</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>×</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">FPU</mml:mi></mml:mrow></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">population</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>×</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>S</mml:mi><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">Rumi</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">FPU</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>The microbiological identification using MALDI-TOF MS was considered the gold standard. CI = 95% confidence intervals.</p><p><sup>a,b</sup>Accuracy parameters followed by different superscripts for the same pathogen category denote statistically significant differences at 5% significance level.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2023_50296_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2023_50296_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2023_50296_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2023_50296_Article_Equa.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50296_Article_Equb.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50296_Article_Equc.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50296_Article_Equd.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50296_Article_Eque.gif\" position=\"anchor\"/>" ]
[ "<media xlink:href=\"41598_2023_50296_MOESM1_ESM.docx\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["5."], "surname": ["Roberson"], "given-names": ["JR"], "article-title": ["Establishing treatment protocols for clinical mastitis"], "source": ["Vet. Clin. N. Am. Food Anim. Pract."], "year": ["2003"], "volume": ["19"], "fpage": ["223"], "lpage": ["234"], "pub-id": ["10.1016/S0749-0720(02)00071-3"]}, {"label": ["6."], "surname": ["Lago", "Godden"], "given-names": ["A", "SM"], "article-title": ["Use of rapid culture systems to guide clinical mastitis treatment decisions"], "source": ["Vet. Clin. N. Am. Food Anim. Pract."], "year": ["2018"], "volume": ["34"], "fpage": ["389"], "lpage": ["412"], "pub-id": ["10.1016/j.cvfa.2018.06.001"]}, {"label": ["11."], "surname": ["Porto"], "given-names": ["LF"], "article-title": ["Automatic cephalometric landmarks detection on frontal faces: An approach based on supervised learning techniques"], "source": ["Digit. Investig."], "year": ["2019"], "volume": ["30"], "fpage": ["108"], "lpage": ["116"], "pub-id": ["10.1016/j.diin.2019.07.008"]}, {"label": ["13."], "surname": ["Khan", "Islam", "Jan", "Ud Din", "Rodrigues"], "given-names": ["SU", "N", "Z", "I", "JJPC"], "article-title": ["A novel deep learning based framework for the detection and classification of breast cancer using transfer learning"], "source": ["Pattern Recognit. Lett."], "year": ["2019"], "volume": ["125"], "fpage": ["1"], "lpage": ["6"], "pub-id": ["10.1016/j.patrec.2019.03.022"]}, {"label": ["15."], "mixed-citation": ["Shaily, T. & Kala, S. Bacterial image classification using convolutional neural networks. In "], "italic": ["Bacterial Image Classification Using Convolutional Neural Networks"]}, {"label": ["16."], "surname": ["Abade", "Porto", "Ferreira", "Vidal"], "given-names": ["A", "LF", "PA", "FDB"], "article-title": ["NemaNet: A convolutional neural network model for identification of nematodes soybean crop in Brazil"], "source": ["Biosyst. Eng."], "year": ["2021"], "volume": ["213"], "fpage": ["39"], "lpage": ["62"], "pub-id": ["10.1016/j.biosystemseng.2021.11.016"]}, {"label": ["17."], "surname": ["Gammel"], "given-names": ["N"], "article-title": ["Comparison of an automated plate assessment system (APAS independence) and artificial intelligence (AI) to manual plate "], "italic": ["Staphylococcus aureus"], "source": ["J. Clin. Microbiol."], "year": ["2021"], "volume": ["59"], "fpage": ["1"], "lpage": ["6"], "pub-id": ["10.1128/JCM.00971-21"]}, {"label": ["18."], "surname": ["Faron", "Buchan", "Samra", "Ledeboera"], "given-names": ["ML", "BW", "H", "NA"], "article-title": ["Evaluation of WASPLab software to automatically read chromid CPS elite agar for reporting of urine cultures"], "source": ["J. Clin. Microbiol."], "year": ["2020"], "volume": ["58"], "fpage": ["1"], "lpage": ["9"], "pub-id": ["10.1128/JCM.01683-19"]}, {"label": ["19."], "surname": ["Baker", "Timm", "Faron", "Ledeboer", "Culbreath"], "given-names": ["J", "K", "M", "N", "K"], "article-title": ["Digital image analysis for the detection of group B "], "italic": ["Streptococcus"], "source": ["J. Clin. Microbiol."], "year": ["2021"], "volume": ["59"], "fpage": ["1"], "lpage": ["7"]}, {"label": ["20."], "surname": ["Van", "Mata", "Bard"], "given-names": ["TT", "K", "JD"], "article-title": ["Automated detection of streptococcus pyogenes pharyngitis by use of colorex strep a CHROMagar and WASPLab artificial intelligence chromogenic detection module software"], "source": ["J. Clin. Microbiol."], "year": ["2019"], "volume": ["57"], "fpage": ["1"], "lpage": ["7"], "pub-id": ["10.1128/JCM.00811-19"]}, {"label": ["21."], "surname": ["Freu"], "given-names": ["G"], "article-title": ["Association between mastitis occurrence in dairy cows and bedding characteristics of compost-bedded pack barns"], "source": ["Pathogens"], "year": ["2023"], "volume": ["12"], "fpage": ["1"], "lpage": ["13"], "pub-id": ["10.3390/pathogens12040583"]}, {"label": ["22."], "surname": ["Ferreira"], "given-names": ["JC"], "article-title": ["Comparative analysis of four commercial on-farm culture methods to identify bacteria associated with clinical mastitis in dairy cattle"], "source": ["PLoS One"], "year": ["2018"], "volume": ["13"], "fpage": ["1"], "lpage": ["15"], "pub-id": ["10.1371/journal.pone.0194211"]}, {"label": ["24."], "surname": ["Keefe"], "given-names": ["G"], "article-title": ["Update on control of "], "italic": ["Staphylococcus aureus", "Streptococcus agalactiae"], "source": ["VFP"], "year": ["2012"], "volume": ["28"], "fpage": ["203"], "lpage": ["216"]}, {"label": ["25."], "surname": ["Garcia", "Fidelis", "Freu", "Granja", "dos Santos"], "given-names": ["BLN", "CE", "G", "BDM", "MV"], "article-title": ["Evaluation of chromogenic culture media for rapid identification of gram-positive bacteria causing mastitis"], "source": ["Front. Vet. Sci."], "year": ["2021"], "volume": ["8"], "fpage": ["1"], "lpage": ["11"], "pub-id": ["10.3389/fvets.2021.662201"]}, {"label": ["28."], "surname": ["Braga"], "given-names": ["PAC"], "article-title": ["Rapid identification of bovine mastitis pathogens by MALDI-TOF Mass Spectrometry"], "source": ["Pesquisa Veterinaria Brasileira"], "year": ["2018"], "volume": ["38"], "fpage": ["586"], "lpage": ["594"], "pub-id": ["10.1590/1678-5150-pvb-4821"]}, {"label": ["29."], "collab": ["NMC"], "source": ["Laboratory Handbook on Bovine Mastitis"], "year": ["2017"], "edition": ["3"], "publisher-name": ["National Mastitis Council, Inc"]}, {"label": ["31."], "surname": ["Liu"], "given-names": ["L"], "article-title": ["Deep Learning for generic object detection: A survey"], "source": ["Int. J. Comput. Vis."], "year": ["2020"], "volume": ["128"], "fpage": ["261"], "lpage": ["318"], "pub-id": ["10.1007/s11263-019-01247-4"]}, {"label": ["32."], "surname": ["Sathya", "Abraham"], "given-names": ["R", "A"], "article-title": ["Comparison of supervised and unsupervised learning algorithms for pattern classification"], "source": ["Int. J. Adv. Res. Artif. Intell."], "year": ["2013"], "volume": ["2"], "fpage": ["34"], "lpage": ["38"]}, {"label": ["33."], "mixed-citation": ["Jocher, G. "], "italic": ["et al."]}, {"label": ["34."], "mixed-citation": ["Lin, T. "], "italic": ["et al.", "European Conference on Computer Vision"]}, {"label": ["35."], "mixed-citation": ["Torrey, L. & Shavlik, J. Transfer Learning. In "], "italic": ["Handbook of Research on Machine Learning Applications and Trends"]}, {"label": ["36."], "mixed-citation": ["Van Rossum, G. & Drake, F. L. "], "italic": ["Python 3 Reference Manual. Scotts: CreateSpace."]}, {"label": ["37."], "mixed-citation": ["Paszke, A. "], "italic": ["et al.", "33rd Conference on Neural Information Processing Systems"]}, {"label": ["39."], "mixed-citation": ["Kohavi, R. A study of cross-validation and bootstrap for accuracy estimation and model selection. In "], "italic": ["International Joint Conference on Artificial Intelligence"]}, {"label": ["40."], "mixed-citation": ["Hastie, T., Tibshirani, R. & Friedman, J. "], "italic": ["The Elements of Statistical Learning Data Mining, Inference, and Prediction"]}, {"label": ["41."], "surname": ["Ganda", "Bisinotto", "Decter", "Bicalho"], "given-names": ["EK", "RS", "DH", "RC"], "article-title": ["Evaluation of an on-farm culture system (Accumast) for fast identification of milk pathogens associated with clinical mastitis in dairy cows"], "source": ["PLoS One"], "year": ["2016"], "volume": ["11"], "fpage": ["1"], "lpage": ["16"], "pub-id": ["10.1371/journal.pone.0155314"]}, {"label": ["43."], "mixed-citation": ["Package, T. & Inference, T. Package \u2018bdpv\u2019. Preprint at (2022)."]}, {"label": ["45."], "mixed-citation": ["Devleesschauwer, B., Torgerson, P. R., Charlier, J. & Levecke, B. Package \u2018prevalence\u2019. Preprint at 10.5167/uzh-89061 (2013)."]}, {"label": ["46."], "surname": ["Denwood"], "given-names": ["MJ"], "article-title": ["runjags: An R package providing interface utilities, model templates, parallel computing methods and additional distributions for MCMC models in JAGS"], "source": ["J. Stat. Softw."], "year": ["2016"], "volume": ["71"], "fpage": ["1"], "lpage": ["25"], "pub-id": ["10.18637/jss.v071.i09"]}]
{ "acronym": [], "definition": [] }
46
CC BY
no
2024-01-14 23:40:15
Sci Rep. 2024 Jan 12; 14:1208
oa_package/6d/c3/PMC10786835.tar.gz
PMC10786836
38216668
[]
[]
[]
[]
[ "<title>Conclusions</title>", "<p id=\"Par10\">This Advancing Cancer Immunotherapy Collection in <italic>Scientific Reports</italic> embodies diverse studies pushing the boundaries of cancer immunology and treatment. These papers deepen our understanding of immunotherapeutic mechanisms and present novel strategies and perspectives to advance cancer treatment outcomes. The research findings within this Collection include innovations and highlight the power of collaborations across disciplines, paving the way to expanding the application of cancer immunotherapy so more cancer patients will benefit.</p>" ]
[ "<p id=\"Par1\">The rapid expansion of cancer immunology and immunotherapy builds upon the success of early immune checkpoint inhibitors (ICI) and chimeric antigen receptor T cells for some cancer types. Many gaps still exist, however, in the scientific knowledge of immune dysfunction in the tumour microenvironment and predicting clinical immunotherapy response to allow more cancer patients to benefit from immunotherapy. The Cancer Immunotherapy Collection within <italic>Scientific Reports</italic> describes pioneering preclinical and clinical studies addressing these concepts, representing significant insights and breakthroughs in the field.</p>", "<title>Subject terms</title>" ]
[ "<p id=\"Par2\">The studies featured in this Collection showcase the innovative endeavours in cancer immunotherapy using preclinical models and clinical data. The diverse works explored novel avenues and challenges in therapies such as cytokines, cellular therapies and small molecules. In metastatic castration-resistant prostate cancer, Korentzelos and collaborators investigated the ability of interferon-γ (IFNγ) to increase major histocompatibility class-I (MHC-I) and PD-L1 expression, facilitating antigen presentation and immune checkpoint blockade therapy. Combining IFNγ with paclitaxel mitigated metastatic disease in a murine tumour model, suggesting promise for combinatory regimens<sup>##REF##35459800##1##</sup>. The functional limitations of natural killer (NK) cells in glioblastoma patients were unravelled by Sönmez and collaborators, who showed that the blockade of the inhibitory KIR receptors and IL-2 stimulation bolsters NK responses<sup>##REF##35474089##2##</sup>. This study sheds light on new approaches for cancer immunotherapy to glioblastoma. Diverging from this approach, yet converging in the quest for innovative therapies, Panyam and collaborators demonstrated that novel small molecule TLR7/8 agonists induce robust pro-inflammatory cytokine and enhance NK cell-mediated antibody-dependent cellular cytotoxicity in their models<sup>##REF##33558639##3##</sup>. These agonists show promise in augmenting the anti-cancer efficacy of monoclonal antibodies, offering new dimensions to combinatory immunotherapy.</p>", "<p id=\"Par3\">A novel approach to targeted immunotherapy for triple-negative breast cancer (TNBC) was introduced by Lin and collaborators, who identified tropomyosin receptor kinase B (TrkB) as a selective TNBC cell marker for refined antibody–drug conjugates to enhance treatment precision<sup>##REF##34290315##4##</sup>. This study both opens avenue to explore applications of refined antibody–drug conjugates and addresses the challenge associated with the lack of targets for TNBC. In a parallel exploration, the expression of PD-1 on murine melanoma cells was validated by Martins and collaborators who, in doing so, provide a foundation for further investigations into PD-1 biology and implications in immune checkpoint therapy<sup>##REF##35864188##5##</sup>. Takahashi and collaborators also pursued a preclinical angle, introducing a novel humanized mouse model to evaluate ICI targeting PD-1 by merging an immunocompromised mouse strain with two IgG receptor knockouts<sup>##REF##34702924##6##</sup>. The authors showed improved tumour growth restriction by Nivolumab, prompting future studies testing other immunotherapies in this model.</p>", "<p id=\"Par4\">The pathways leading to the recruitment of Tissue-resident memory (Trm) CD8 T cells in mouse pancreatic cancer models were evaluated by Gough and collaborators, who found that the activation of CD8 Trm is dependent on CD40L signalling in tumour-draining lymph nodes<sup>##REF##37072485##7##</sup>. These findings inform new strategies for harnessing Trm cells' potential in cancer treatment. In another study, Trinklein and collaborators reported novel bispecific antibodies that act as an agonist of IL-2 signalling in cytotoxic T cells and NK cells without activating regulatory T cells. One of these bispecific antibodies activates STAT5 signalling and expanded CD8 T cells in a monkey model, with no overt toxicities observed<sup>##REF##34011961##8##</sup>. This new approach to harness the desired effects of the IL-2 pathway is primed for further testing in various cancers.</p>", "<p id=\"Par5\">In exploration at the intersection of veterinary and human oncology, Dias and collaborators showed the potential of canine lymphoma (cNHL) as a preclinical model for testing anti-CD20 immunotherapies in B-cell malignancies. A novel single-domain antibody that binds to both human and canine CD20 and can be used in therapeutic and diagnostic approaches thus advancing both veterinary and human oncology<sup>##REF##35177658##9##</sup>.</p>", "<p id=\"Par6\">Amengual-Rigo and Guallar presented NetCleave tool, an open-source and retrainable algorithm predicting C-terminal antigen processing for both MHC-I and MHC-II pathways<sup>##REF##34162981##10##</sup>. This enhances our ability to understand and potentially manipulate antigen processing, thereby influencing immune responses<sup>##REF##37258917##11##</sup>. A different tool was presented by Mehdizadeh and colleagues for simulating myeloid-derived suppressor cells (MDSC) depletion in a mouse model of aggressive tumours. The computational simulations suggest that vaccination with a small number of tumour cells in combination with MDSC depletion elicits an effective anti-tumour immune response and tumour dormancy<sup>##REF##37041172##12##</sup>.</p>", "<p id=\"Par7\">The studies using clinical data featured in this Collection exemplify efforts to eventually translate research on biomarkers and mechanisms of immunotherapy responders or non-responders in clinical trials or clinical care, thus offering insights into improving cancer treatment strategies. Kauffmann-Guerrero and collaborators investigated the potential of inflammation and cytokine profiles as biomarkers for non-small-cell lung cancer patients receiving ICI and revealed inflammation markers that dictate response to ICI treatment<sup>##REF##34035415##13##</sup>. This study highlights the limitations of relying solely on PD-L1 expression and emphasizes the importance of inflammatory biomarkers for predicting treatment response. The analysis of immune changes in multiple myeloma patients receiving ICI and the immunomodulator pomalidomide in Phase 1b trial (NCT02616640) reported by Newhall and collaborators emphasized transcriptome changes consistent with favourable immunomodulation<sup>##REF##34385543##14##</sup>, but also the risk of increasing autoimmune response and adverse events, as evidenced by other ongoing trials. In a parallel exploration, Mendoza and co-workers detailed patients’ symptom burden in early-phase trials for rare solid tumours treated with immunotherapy. This prospective longitudinal study showed the distribution of high immunotherapy-specific symptom burden<sup>##REF##35999229##15##</sup>, and the results may help inform the planning of future symptom interventional clinical trials for patients receiving ICI.</p>", "<p id=\"Par8\">Continuing the quest for the efficacy of combination therapies, the real-world outcomes for metastatic non-small cell lung cancer patients treated with first-line Pembrolizumab plus chemotherapy were compared by Velcheti and collaborators to the clinical trial that led to the approval of this combined immunotherapy. This study provided substantial evidence of outcomes from combination therapy in a more heterogeneous patient cohort and clinical care setting<sup>##REF##33911121##16##</sup>. In a departure from traditional biomarkers, Naing and collaborators brought us the associations between microbiome composition and fatigue in advanced cancer patients. The authors revealed microbiome-associated bacteria negatively and positively associated with fatigue severity<sup>##REF##33712647##17##</sup>, uncovering potential insights into patient well-being and treatment outcomes.</p>", "<p id=\"Par9\">In searching for novel immune molecular classification, Yu and colleagues applied a non-negative matrix factorization algorithm and subdivided colorectal cancer into immune classes based on the immunocyte infiltration and enrichment of immune response-associated signatures. The immune-suppressed subclass had the worst overall prognosis, while patients within the immune-activated subclass showed better prognosis and response to anti-PD-1 therapy<sup>##REF##34593914##18##</sup>. Finally, from a different perspective, Krishnan and colleagues proposed the GaWRDenMap framework utilizing geographically weighted regression and a density function-based classification model that discriminates between chronic pancreatitis, pancreatic ductal adenocarcinoma (PDAC) and intraductal papillary mucinous neoplasm at both the subject- and image-levels<sup>##REF##35260589##19##</sup>. It could also reasonably discriminate between PDAC. These results indicate a potential difference in the spatial arrangement of epithelial and immune cells in the pancreas can have diagnostic significance.</p>" ]
[ "<title>Competing interests</title>", "<p id=\"Par11\">The authors declare no competing interests.</p>" ]
[]
[]
[]
[]
[]
[]
[]
[]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[]
[]
[]
{ "acronym": [], "definition": [] }
19
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1205
oa_package/bf/b7/PMC10786836.tar.gz
PMC10786837
38216675
[ "<title>Introduction</title>", "<p id=\"Par2\">Mycotoxins are secondary metabolites produced by different species of fungi that can cause agricultural damage worldwide by contaminating feed<sup>##REF##21417259##1##</sup>. Among others, the most prominent mycotoxins are the trichothecenes produced by various <italic>Fusarium</italic>, <italic>Myrothecium</italic> and <italic>Stachybotrys</italic> species. One important member of the trichothecenes is the T-2 toxin originated from different <italic>Fusarium</italic> species, including <italic>F. soprotrichioides</italic>, <italic>F. poae</italic>, and <italic>F. acuinatum</italic>, that contaminate a wide range of cereals and are most prevalent in cold climates or under wet storage conditions<sup>##REF##21417259##1##</sup>. The most commonly affected cereals are maize, wheat and oat, which are highly involved in both human nutrition and livestock feeding<sup>##UREF##0##2##</sup>. The uptake of T-2 toxin happens by food or water intake, by inhalation of air or aerosols and by transdermal absorption. Most of the T-2 toxin is absorbed from the gastrointestinal tract and subsequently transported to the liver via the <italic>v. portae</italic>, which is thereby directly exposed to toxic compounds of enteric origin<sup>##REF##21417259##1##,##REF##3571401##3##,##REF##18220574##4##</sup>.</p>", "<p id=\"Par3\">Poultry species as mainly grain consumers may come into regular contact with mycotoxins, including T-2 toxin which can be accumulated in their feed due to inadequate plant production, harvesting or storage conditions<sup>##REF##33430378##5##</sup>. They are generally more tolerant to trichothecenes than mammalian species<sup>##REF##31941063##6##</sup>. The lower susceptibility is probably due to the moderate absorption as well as the rapid metabolism and elimination of these mycotoxins. On the other hand, exposure to these mycotoxins has serious negative effects in these animals too, and is a major problem for the poultry industry worldwide<sup>##REF##31941063##6##,##UREF##1##7##</sup>. The major detrimental effects of T-2 toxin in poultry include reduced growth and appetite, modified immune response, gastrointestinal impairment, neurological and reproductive disorders, mostly mediated by the inhibition of protein synthesis on the cellular level<sup>##REF##22334729##8##,##REF##23313610##9##</sup>. Furthermore, T-2 toxin is known to induce apoptosis, and it may also elevate free radical production causing oxidative stress, which is associated with DNA damage and increased lipid peroxidation<sup>##REF##21417259##1##,##REF##31941063##6##</sup>. Certain signalling pathways that are strongly linked to reactive oxygen species (ROS) responses, such as the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase 1 (Nrf2/HO-1) pathway, the endoplasmic reticulum (ER) stress pathway, and the mammalian target of rapamycin/protein kinase (mTOR/Akt) system, appear to be involved in the toxicity caused by T-2 toxin<sup>##REF##31570981##10##</sup>. In addition, T-2 toxin stimulated the gene expression of specific proinflammatory cytokines, such as interleukin- (IL-)1α, IL-1β, IL-6, IL-11 and tumor necrosis factor-α (TNF-α) both in vitro and in vivo<sup>##REF##31279042##11##</sup>.</p>", "<p id=\"Par4\">The possible oxidative stress caused by the toxin is often associated with the development of ER stress<sup>##REF##25773464##12##,##REF##29191461##13##</sup>. In physiological conditions, newly synthesized proteins are folded and modified in the ER. These processes are controlled by various chaperones and folding enzymes such as glucose-regulated protein 78 (GRP78), a member of the heat shock protein 70 (HSP70) family, located in the membrane of the ER. If the folding of the produced proteins is not sufficient due to various stress factors, the ER triggers the unfolded-protein response (UPR) mechanism to restore the cell homeostasis or, in severe cases, to induce apoptosis<sup>##REF##25120434##14##</sup>.</p>", "<p id=\"Par5\">Oxidative and ER stress also affect the production of certain small heat shock proteins (sHSPs). These proteins have a molecular mass of about 15–30 kDa and are often involved in response to various stress factors. Among them, early reversible phosphorylation of heat shock protein 27 (HSP27) upon oxidative and ER stress has been reported in several cell types<sup>##REF##29191461##13##,##REF##15864808##15##</sup>. If the protein homeostasis is not restored after oxidative or ER stress, cell and tissue damage occurs. In response, inflammatory processes are triggered, which limit the extent of tissue damage and promote tissue regeneration. Several studies have already reported the complex interactions between oxidative stress, ER stress and inflammation, although the exact interplay of these processes are not yet known<sup>##REF##29191461##13##,##REF##25120434##14##</sup>.</p>", "<p id=\"Par6\">The majority of in vitro and in vivo studies on T-2 toxin have focused mainly on a single metabolic pathway or organ in one experiment, using conventional biochemical and molecular biology methods<sup>##REF##31279042##11##,##REF##29870751##16##,##UREF##2##17##</sup>. To further understand the toxic effects of this molecule, a comprehensive study of the systemic metabolic effects of T-2 toxin was required<sup>##REF##25588579##18##</sup>. Metabolomics as a novel and increasingly widely used approach in life sciences can provide a coherent overview of the metabolic subsystems of the organism, rather than studying a few components at a time<sup>##UREF##3##19##</sup>.</p>", "<p id=\"Par7\">Hepatic cell cultures can serve as proper models for studying the cellular effects of T-2 toxin on the liver as a major site of mycotoxin exposure. In recent years, three-dimensional (3D) cell cultures have become widely used due to their numerous advantages over traditional two-dimensional (2D) cell cultures. In monolayer cultures, hepatic cells are prone to dedifferentiation and loss of morphology, probably due to the limited contact between cells and between cells and the extracellular matrix (ECM)<sup>##UREF##4##20##</sup>. In contrast, 3D cell cultures are able to develop a microenvironment and function similar to the physiological conditions<sup>##REF##21160950##21##</sup>. In these cultures, cells keep their phenotype and characteristic functions as well as their ability to grow and interact with their surroundings, allowing the formation of diverse cell–cell and cell–ECM interactions<sup>##REF##29623827##22##</sup>. In this study, magnetic 3D bioprinting was used to create 3D hepatic cell cultures. By this method, isolated cells are incubated with magnetic nanoparticles consisting of iron oxide, gold, and poly-<sc>l</sc>-lysine. These nanoparticles electrostatically bind to the cell membranes via the poly-<sc>l</sc>-lysine at a concentration of approximately 50 pg/cell. At this rate, the nanoparticles coat the cells in a scattered manner rather than the entire membrane, giving them a pepped-like appearance<sup>##UREF##5##23##,##UREF##6##24##</sup>. However, this amount is enough to magnetize the cells, therefore they are able to aggregate into spheroids when placed in magnetic field<sup>##UREF##4##20##</sup>. The nanoparticles are biocompatible and have no effect on the cellular viability and proliferation<sup>##REF##23017116##25##–##REF##24036238##27##</sup>. Additionally, Tseng et al. also observed that their effect on inflammatory processes was minimal and negligible in 3D multitype bronchiole co-cultures<sup>##REF##23301612##26##</sup>. Furthermore, it was also demonstrated in aortic valve 3D co-cultures that they had no significant effect on the cellular oxidative processes<sup>##REF##24036238##27##</sup>.</p>", "<p id=\"Par8\">The aim of this study was to investigate the cellular effects of T-2 toxin on oxidative and ER stress as well as inflammatory response in the chicken liver, carried out on a newly characterized chicken derived primary 3D hepatic cell culture gained by magnetic bioprinting. As 3D cell cultures may reflect in vivo conditions more accurately than traditional monolayer cultures, the applied 3D cell culture can serve as a good model to monitor the effects of mycotoxins on the avian liver. The present study can also provide an insight into the complex interplay of the ER and oxidative stress with the inflammatory pathways. Moreover, to investigate the cellular effects of T-2 toxin, a wide range of metabolites related to amino acid, glucose and lipid metabolism as well as to inflammatory processes were assessed by a targeted metabolomics approach.</p>" ]
[ "<title>Materials and methods</title>", "<p id=\"Par51\">All reagents used in the present study were purchased from Merck KGaA (Darmstadt, Germany) except when otherwise specified. Animal procedures were performed according to the international and national law as well as the institutional guidelines and were confirmed by the Government Office of Zala County, Food Chain Safety, Plant Protection and Soil Conservation Directorate, Budapest, Hungary (permission number: ZAI/040/00522-7/2020). The study was conducted following the ARRIVE guidelines 2.0 (<ext-link ext-link-type=\"uri\" xlink:href=\"https://arriveguidelines.org/\">https://arriveguidelines.org/</ext-link>). The animals were fed and reared in accordance with the requirements of the Ross Technology<sup>##UREF##19##92##</sup>.</p>", "<title>Cell isolation and culturing conditions</title>", "<p id=\"Par52\">The cells were isolated from a 3-week-old Ross 308 male broiler chicken (obtained from Gallus Poultry Farming and Hatching Ltd, Devecser, Hungary) as described by Mackei et al.<sup>##UREF##7##28##</sup>. Under CO<sub>2</sub> narcosis, the animal was decapitated, and the liver was perfused through the gastropancreaticoduodenal vein by three-step perfusion. During the procedure, all buffers were heated to 40 °C and freshly oxygenated with Carbogen (95% O<sub>2</sub>, 5% CO<sub>2</sub>), the velocity of the perfusion was set to 30 ml/min.</p>", "<p id=\"Par53\">In the first step, the liver was washed with 150 ml of 0.5 nM ethylene glycol tetraacetic acid (EGTA) containing Hanks' Balanced Salt Solution (HBSS), followed by 150 ml of EGTA-free HBSS. As a final step, 130 ml of MgCl<sub>2</sub> and CaCl<sub>2</sub> (both 7 mM) containing HBSS supplemented with 1 mg/ml type IV collagenase (Nordmark, Uetersen, Germany) was rinsed to ensure that the extracellular matrix was degraded and the organ was disrupted.</p>", "<p id=\"Par54\">After excision of the liver, the Glisson's capsule was opened and the freshly gained cells were suspended in 50 ml of ice-cold bovine serum albumin (BSA, 2.5%) containing HBSS. The suspension was filtered through 3 layers of sterile gauze to remove any cell aggregate leftovers and undigested interstitial tissue. The resulting cell suspension was incubated on ice for 50 min.</p>", "<p id=\"Par55\">Afterward, the fractions containing hepatocytes and NP cells were separated by multistep differential centrifugation. The suspension was centrifuged three times for 3 min at 100×<italic>g</italic>. Between the steps, the NP cell containing supernatant was collected separately and the hepatocyte enriched sediment was resuspended in Williams' Medium E supplemented with 0.22% NaHCO<sub>3</sub>, 50 mg/ml gentamycin, 2 mM glutamine, 4 µg/l dexamethasone, 20 IU/l insulin and 5% foetal bovine serum (FBS). At the end of centrifugation, a purified hepatocyte fraction free of NP cells was obtained.</p>", "<p id=\"Par56\">To separate the NP cell containing fraction, the previously collected supernatants were centrifuged first at 350×<italic>g</italic> for 10 min in order to remove residual hepatocytes and red blood cells, and then the supernatant was centrifuged at 800×<italic>g</italic> for 10 min, gaining the final sediment containing the NP cells.</p>", "<p id=\"Par57\">Cell viability and total cell number were determined in Bürker chambers by trypan blue exclusion test. The number of viable cells exceeded 90% for both cell types. The appropriate cell concentrations were adjusted to 5 × 10<sup>5</sup> cells/ml and the hepatocyte:NP cell ratio was set to 6:1.</p>", "<p id=\"Par58\">All the needed equipment and chemicals for the preparation of magnetic 3D cell cultures were purchased from Greiner Bio-One Hungary Ltd (Mosonmagyaróvár, Hungary). In order to magnetize the cells, 800 µl of magnetic nanoparticles (NanoShuttle™-PL) were added to 8 ml of hepatocyte—NP cell co-culture suspension. These nanoparticles are biocompatible and have no effect on the viability and proliferation of the cells<sup>##REF##23017116##25##–##REF##24036238##27##</sup>. The cells were then seeded onto a 96-well cell repellent plate and were incubated at 37 °C for 1 h. During this time, the magnetic nanoparticles bound to the cell membrane. Afterwards, the plate was placed on top of a magnetic drive with small magnets under each well of the plate (Spheroid Drive) and was incubated for 48 h at 37 °C in 100% relative humidity with 5% CO<sub>2</sub>. The culture medium was changed to serum-free medium after 24 h with the use of a Holding Drive.</p>", "<title>Treatment of the cell cultures</title>", "<p id=\"Par59\">After 48 h incubation, the 3D cell cultures were exposed to culture media supplemented with 0 (control), 100, 500 or 1000 nM T-2 toxin for 24 h. Samples were collected at the end of the incubation from the cell culture media, and the cells were lysed by intermittent sonication (1/s) in 40 µl of M-PER buffer for 5 s using a Bandelin Sonopuls HD 2200 homogenizer (Bandelin Electronic GmbH &amp; Co. KG, Berlin, Germany). The samples were stored at − 80 °C until further analysis. The control, untreated spheroids have been fixed in 10% buffered formalin solution and after embedding and sectioning the slides they were stained with haematoxylin and eosin to examine the spheroid morphology.</p>", "<title>Measurements</title>", "<title>Metabolic activity of the cells</title>", "<p id=\"Par60\">The metabolic activity of the cells was evaluated by CCK-8 assay (Dojindo Molecular Technologies, Rockville, MD, USA) according to the manufacturer’s protocol, detecting the amount of NADH + H<sup>+</sup> produced in the catabolic processes of the cells. 10 µl CCK-8 reagent and 100 µl of the cell culture media were added to each well of a 96-well plate, and after 4 h of incubation, the absorbance was measured at 450 nm with a Multiskan GO 3.2 reader (Thermo Fisher Scientific, Waltham, MA, USA).</p>", "<title>Lactate dehydrogenase activity of the cells</title>", "<p id=\"Par61\">To investigate the damage of the cell membranes, the extracellular activity of LDH was determined by LDH Activity Assay Kit. Measurements were performed following the manufacturer's instructions on 96-well plates. First, 50 µl of Master Reaction Mix (48 µl LDH Assay Buffer, 2 µl LDH Substrate Mix) was added to 50 µl of sample and absorbances were measured at 450 nm using a Multiskan GO 3.2 reader (Thermo Fisher Scientific, Waltham, MA, USA). To determine the LDH activity, absorbances were read at 5 min intervals until the most active sample exceeded the highest standard concentration. LDH activity was then calculated according to the manufacturer's protocol.</p>", "<title>Cellular inflammation and oxidative stress</title>", "<p id=\"Par62\">All measurements concerning stress and inflammatory markers were performed using chicken specific ELISA kits (MyBioSource, San Diego, CA, USA) according to the manufacturer’s instructions. To investigate the oxidative stress, the concentration of a lipid peroxidation marker, MDA was measured from the cell culture media. The protein damage caused by oxidative stress was detected by the determination of PC content from the cell lysates. In order to determine the effects of T-2 toxin on cellular inflammation, the concentrations of two pro-inflammatory cytokines, IL-6 and IL-8 were assayed from cell-free supernatants. ER stress was evaluated by measuring the concentration of GRP78 and HSP27 from the media.</p>", "<title>Metabolome analysis</title>", "<p id=\"Par63\">Metabolome analysis of the media samples was carried out using the AbsoluteIDQ p180 Kit (Biocrates Life Sciences AG, Innsbruck, Austria) in accordance with the manufacturer's instructions. This kit detects and quantifies up to 188 metabolites belonging to 5 separate compound classes: acylcarnitines (40), proteinogenic and modified amino acids (19), glycerophospho- and sphingolipids (76 phosphatidylcholines, 14 lysophosphatidylcholines, 15 sphingomyelins), biogenic amines (19) and hexoses (1) (Supplementary Table ##SUPPL##3##3##). The amino acids and biogenic amines were analyzed by liquid chromatography–mass spectrometry (LC–MS/MS) and the acylcarnitines, phosphatidylcholines (including lysophosphatidylcholines), sphingomyelines and hexoses were assesed by flow injection analysis–mass spectrometry (FIA–MS/MS) at the Core Facility of the University of Hohenheim (Stuttgart, Germany)<sup>##REF##34140596##93##</sup>. 10 µl of culture medium with internal standard, PBS and calibration standards in a multititer plate and dried under nitrogen (nitrogen evaporator 96 well plate, VLM GmbH, Bielefeld, Germany) for 30 min. Afterwards, the metabolites were derivatized with 5% phenylisothiocyanate (PITC) for 25 min at room temperature and dried under nitrogen flow for 60 min. For extraction, first 300 µl of extraction solvent (5 mM ammonium acetate in methanol) was added and then incubated with shaking at 450 rpm (Thermomixer comfort Eppendorf, Hamburg, Germany) for 30 min at room temperature. The extraction solvent was then eluted using a nitrogen pressure unit. Thereafter, 50 µl of filtrate was removed and transferred to a fresh multititer deepwell plate where it was diluted with 450 µl of 40% HPLC grade methanol for LC–MS analysis. For FIA-MS/MS analysis, 10 µl of filtrate and 490 µl of mobile phase solvent were added to a new 96-well microplate. Both measurements were performed with a QTRAP mass spectrometer applying electrospray ionization (ESI) (AB Sciex API 5500Q-TRAP). MS was coupled to an ultra-performance liquid chromatography (UPLC) (Agilent 1290, Agilent Technologies Deutschland GmbH, Waldbronn, Germany). For LC–MS, the metabolites were separated by a hyphenated reverse phase column (Waters, ACQUITY BEH C18, 2.1 × 75 mm, 1.7 µm; Waters, Milford, United States) preceded with a precolumn (Security Guard, Phenomenex, C18, 4 × 3 mm; Phenomenex, Aschaffenburg, Germany) applying a gradient of solvent A (formic acid 0. 2% in water) and solvent B (formic acid 0.2% in acetonitrile) over 7.3 min (0.45 min 0% B, 3.3 min 15% B, 5.9 min 70% B, 0.15 min 70% B, 0.5 min 0% B) at a flow rate of 800 µl/min. Oven temperature was 50 °C. For LC–MS analysis 5 µl, for FIA analysis 2 × 20 µl were subjected for measurements in both positive and negative mode. Identification and quantification were achieved by multiple reaction monitoring (MRM), which was standardized by applying spiked-in isotopically labelled standards in positive and negative mode, respectively. A calibrator mix consisting of seven different concentrations was used for calibration. Quality controls were derived from lyophilized human plasma samples at 3 different concentrations. For FIA, an isocratic method was used (100/% organic running solvent) with varying flow conditions (0 min, 30 µl/min; 1.6 min, 30 µl/min; 2.4 min, 200 µl/min; 2.8 min, 200 µl/min; 3 min, 30 µl/min) and the MS settings were as follows: scan time 0.5 s, IS voltage for positive mode 5500 V, for negative mode − 4500 V, source temperature 200 °C, nitrogen as collision gas medium. During LC–MS the corresponding parameters were: scan time 0.5 s, source temperature 500 °C, nitrogen as collision gas medium.</p>", "<p id=\"Par64\">All reagents used for processing and analysis were LC–MS grade unless otherwise specified. Milli-Q Water ultrapure was used fresh after preparation with a high-purity water system (Merck KGaA, Darmstadt, Germany). LC–MS grade acetonitrile, methanol, pyridine and formic acid were purchased from Merck KGaA, and PITC as well as ammonium acetate from Sigma Aldrich Chemie GmbH (Steinheim, Germany).</p>", "<p id=\"Par65\">Raw data obtained with Analyst software (AB Sciex, Framingham, MA, USA) were processed with MetIDQ software, an integrated member of the AbsoluteIDQ p180 Kit. This streamlines data analysis by automated calculation of metabolite concentrations providing quality measures and quantification. For fully quantitative measurements, the lower limit of quantification (LLOQ) was determined in plasma experimentally by Biocrates Life Sciences AG.</p>", "<title>Statistical analysis</title>", "<p id=\"Par66\">The statistical analysis was performed using the R Statistical Software (v4.1.1; R Core Team 2021). Each treatment group contained 15 replicates (n = 15/group). During the analysis, treatment groups were compared to the control group. Shapiro–Wilk test and Levene’s test were used to verify normal distribution and homogeneity of variance, respectively. Differences between various groups were assessed using one-way analysis of variance (ANOVA) and Dunett’s post hoc tests for pairwise comparisons. Results were expressed as mean ± standard error of the mean (SEM). Differences were considered significant at<italic> p</italic> &lt; 0.05. Results were visualized using Graphad Prism version 9.1.2 for Windows (GraphPad Software, San Diego, CA, USA). Results were visualised with relative values and Supplementary Table ##SUPPL##1##1## shows the corresponding group means.</p>", "<p id=\"Par67\">The data from the metabolome analysis were processed with MetaboAnalyst 5.0 after log transformation and Pareto scaling normalization. Metabolites with significantly altered abundance in different treatment groups (toxin-exposed cells compared to the control group) were determined using the ANOVA function with Tukey’s HSD (honestly significant difference) for pairwise comparisons. Further, the metabolome of the control group was also compared to that of cell-free culture media to monitor the spheroid-associated metabolic changes independently from the toxin exposure. In order to determine the significantly changed metabolites between the cell-free medium and control group, unpaired t-test was used. The correlation between the parameters measured by chicken specific ELISA tests (MDA, PC, IL-6, IL-8, GRP78, HSP27) and metabolites derived from the metabolomics approach was also investigated using the Pattern Hunter function of the program. The correlation coefficients (R<sup>2</sup>) were interpreted according to a guide for medical research<sup>##REF##23638278##94##</sup>.</p>" ]
[ "<title>Results</title>", "<title>Haematoxylin and eosin (H&amp;E) staining</title>", "<p id=\"Par9\">Figure ##FIG##0##1## shows a formalin fixed paraffin embedded (FFPE) slice after haematoxylin and eosin (H&amp;E) staining. Morphologically intact hepatocytes are observable in high abundance in loose connection with each other as well as other non-parenchymal (NP) cells with smaller nucleus. Severe degenerative changes are not visible.</p>", "<title>Metabolic activity</title>", "<p id=\"Par10\">Metabolic activity of the cultured cells was measured by Cell Counting Kit-8 (CCK-8) test from the cell culture media after treatment with 100, 500 and 1000 nM T-2 toxin for 24 h. T-2 toxin significantly decreased (<italic>p</italic> &lt; 0.001) the metabolic activity in every treatment group compared to the control (Fig. ##FIG##1##2##). The mean ± SEM values obtained from the CCK-8 measurement are shown in Supplementary Table ##SUPPL##1##1##.</p>", "<title>Lactate dehydrogenase (LDH) activity</title>", "<p id=\"Par11\">The extracellular LDH activity of the cell cultures was measured after 24 h of T-2 toxin treatment. The 500 nM T-2 toxin concentration significantly increased (<italic>p</italic> = 0.038) the LDH activity of the cells in comparison with the control group (Fig. ##FIG##2##3##). The mean ± SEM values obtained from the LDH activity measurement are shown in Supplementary Table ##SUPPL##1##1##.</p>", "<title>Malondialdehyde (MDA) and protein carbonyl (PC) concentrations</title>", "<p id=\"Par12\">The MDA concentration was measured from the cell culture media and the PC content was determined from the cell lysates by chicken specific ELISA test after 24 h of T-2 toxin treatment. The MDA level was significantly decreased (<italic>p</italic> = 0.030) in the 1000 nM treatment group after 24 h (Fig. ##FIG##3##4##a). The higher levels of T-2 toxin (500 nM and 1000 nM) significantly decreased (<italic>p</italic> = 0.007, <italic>p</italic> = 0.001, respectively) the intracellular PC concentration of the cultured cells compared to the control group (Fig. ##FIG##3##4##b). The mean ± SEM values obtained from the MDA and PC measurements are shown in Supplementary Table ##SUPPL##1##1##.</p>", "<title>Interleukin (IL) concentrations</title>", "<p id=\"Par13\">After 24 h of T-2 toxin treatment, the concentrations of IL-6 and IL-8 were assessed from the cell culture media using chicken-specific ELISA tests. The extracellular concentration of IL-6 was significantly lowered (<italic>p</italic> = 0.026) after 24 h by the 100 nM T-2 toxin treatment when compared to that of the control cells (Fig. ##FIG##4##5##a). The IL-8 concentration was significantly increased (<italic>p</italic> = 0.025) after 24 h in the 100 nM T-2 toxin treatment group (Fig. ##FIG##4##5##b). The mean ± SEM values obtained from the IL-6 and IL-8 measurements are shown in Supplementary Table ##SUPPL##1##1##.</p>", "<title>Glucose-regulated protein 78 (GRP78) and heat shock protein 27 (HSP27) concentrations</title>", "<p id=\"Par14\">The GRP78 and HSP27 contents were assessed after 24 h of T-2 toxin treatment by chicken specific ELISA tests. The applied toxin exposures did not influence significantly the concentrations of these two parameters (Fig. ##FIG##5##6##a,b). The mean ± SEM values obtained from the GRP78 and HSP27 measurements are shown in Supplementary Table ##SUPPL##1##1##.</p>", "<title>Metabolome analysis</title>", "<p id=\"Par15\">Figure ##FIG##6##7## and Table ##TAB##0##1## show overviews of the 41 metabolites being significantly influenced by T-2 toxin exposure, visualised on a heatmap. As reflected by the colour scheme of the heatmap, most of the significantly changed metabolites showed T-2 toxin triggered increased abundance (alpha-aminoadipic acid [alpha-AAA], citrulline [Cit], proline [Pro], carnosine, spermidine, alanine [Ala], methionine [Met], decanoylcarnitine [C10], free carnitine [C0], hydroxyisovalerylcarnitine [C5-OH], phosphatidylcholine with acyl-alkyl residue sum [PC ae] C42:4, C38:1 and 42:0, phosphatidylcholine with diacyl residue sum [PC aa] C26:1 and C28:1, lysophosphatidylcholine with acyl residue [lysoPC a] C24:0 and 26:1, hexose [H1]), while the concentrations of other metabolites (glutamine [Gln], lysine [Lys], serine [Ser], threonine [Thr], aspartate [Asp], glutamate [Glug, putrescine, sarcosine, glutaconylcarnitine [C5:1-DC], decadienoylcarnitine [C10:2], glutarylcarnitine [C5-DC], hydroxybutyrylcarnitine [C3-DC], dodecanoylcarnitine [C12-DC], C12, nonanoylcarnitine [C9], hexenoylcarnitine [C6:1], butyrylcarnitine [C4], PC aa C34:1, PC aa C38:4, PC aa C36:4, PC aa C32:1, PC aa C34:2, lysoPC a C14:0) were found to be decreased after the T-2 toxin treatment compared to the control group.</p>", "<p id=\"Par16\">Further, the metabolic profile of the control group was also compared to that of the cell-free culture medium. The list of metabolites significantly changed between the cell-free medium and the control group and the corresponding p-values are given in Supplementary Table ##SUPPL##2##2##. Overall, 72 metabolites changed significantly, of which 40 decreased and 32 increased in the control samples compared to the cell-free medium.</p>", "<p id=\"Par17\">Moderate (0.50 &gt; R<sup>2</sup> &gt; 0.70) and high (0.70 &gt; R<sup>2</sup> &gt; 0.90) positive as well as moderate (− 0.50 &gt; R<sup>2</sup> &gt; − 0.70) and high (− 0.70 &gt; R<sup>2</sup> &gt; − 0.90) negative correlations were found between the concentrations of many metabolites and the parameters (MDA, PC, IL-6, IL-8, GRP78 and HSP27) determined by chicken-specific ELISA tests. These correlations are depicted in Fig. ##FIG##7##8##a–f.</p>", "<p id=\"Par18\">Three amino acids (ornithine [Orn], Ser, Asp), two biogenic amines (putrescine, symmetric dimethylarginine [SDMA]) and a phosphatidylcholine (PC aa C36:1) were correlated positively (R<sup>2</sup> = 0.628, R<sup>2</sup> = 0.682, R<sup>2</sup> = 0.560, R<sup>2</sup> = 0.643, R<sup>2</sup> = 0.501, R<sup>2</sup> = 0.545 respectively) with the MDA concentration of the culture media. An amino acid (Ala) and an acylcarnitine (tetradecadienoylcarnitine [C14:2]) had a negative correlation (R<sup>2</sup> = − 0.565, R<sup>2</sup> = − 0.603 respectively) with the MDA concentration (Fig. ##FIG##7##8##a).</p>", "<p id=\"Par19\">An amino acid (Ala), an acylcarnitine (C3-DC) and two phosphatidylcholines (PC aa C42:6, PC ae C44:4) had a positive correlation (R<sup>2</sup> = 0.763, R<sup>2</sup> = 0.524, R<sup>2</sup> = 0.534, R<sup>2</sup> = 0.508 respectively) with the intracellular PC concentration. A biogenic amine (spermidine), an acylcarnitine (C4), a sphingomyelin (SM-OH C22:2) and a phosphatidylcholine (PC aa C32:3) were negatively correlated (R<sup>2</sup> = − 0.857, R<sup>2</sup> = − 0.610, R<sup>2</sup> = − 0.530, R<sup>2</sup> = − 0.501 respectively) with the PC concentration (Fig. ##FIG##7##8##b).</p>", "<p id=\"Par20\">Only one metabolite, a lysophospatidylcholine (lysoPC a C24:0) was correlated positively (R<sup>2</sup> = 0.502) with the IL-6 concentration (Fig. ##FIG##7##8##c). Also, only a phoshatidylcholine (PC ae C32:1) had a negative correlation (R<sup>2</sup> = − 0.546) with the IL-8 content (Fig. ##FIG##7##8##d).</p>", "<p id=\"Par21\">Three phosphatidylcholines (PC ae C38:5, PC aa C32:0, PC aa C42:1) had a positive correlation (R<sup>2</sup> = − 0.622, R<sup>2</sup> = − 0.571, R<sup>2</sup> = − 0.521 respectively) with the GRP78 concentration (Fig. ##FIG##7##8##e).</p>", "<p id=\"Par22\">Several metabolites showed positive correlation with the HSP27, including three amino acids (Orn, Asp, Ser) (R<sup>2</sup> = 0.779, R<sup>2</sup> = 0.731, R<sup>2</sup> = 0.622 respectively), five biogenic amines (histamine, taurine, putrescine, spermidine, carnosine) (R<sup>2</sup> = 0.752, R<sup>2</sup> = 0.738, R<sup>2</sup> = 0.607, R<sup>2</sup> = 0.566, R<sup>2</sup> = 0.561 respectively), an acylcarnitine (C3-DC) (R<sup>2</sup> = 0.521) and four phosphatidylcholines (PC aa C36:1, PC aa C36:3, PC aa C40:6, PC ae C38:5) (R<sup>2</sup> = 0.701, R<sup>2</sup> = 0.578, R<sup>2</sup> = 0.531, R<sup>2</sup> = 0.522 respectively). Only two metabolites, an amino acid (asparagine [Asn]) and a phosphatidylcholine (PC ae C40:5) had a negative correlation (R<sup>2</sup> = − 0.763, R<sup>2</sup> = − 0.520 respectively) with the HSP27 level (Fig. ##FIG##7##8##f).</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par23\">In the present study, chicken derived 3D hepatic cell cultures were used to demonstrate the effects of T-2 toxin to understand the molecular pathways which are affected by T-2 toxin. 3D cell cultures can provide a more proper model of the microenvironment and cellular function under in vivo conditions; in these cultures, cells keep their in vivo phenotype and characteristics as well as their ability to grow and interact with other cells and the ECM. In addition, 3D hepatic cell cultures can be maintained for longer than traditional 2D cell cultures<sup>##REF##21160950##21##,##REF##29623827##22##</sup>. In this study, we used hepatocyte—NP cell co-culture to mimic a near-physiological state. These models allow a better understanding of how cells respond to stress and inflammation, including cytokine production and the regulation of redox homeostasis<sup>##UREF##7##28##</sup>.</p>", "<p id=\"Par24\">In order to investigate the adverse effects of T-2 toxin, 3D hepatocyte—NP cell co-cultures were treated with different concentrations of the toxin for 24 h. Metabolic activity of the cells was measured since T-2 toxin binds to various proteins and inhibits the function of several key enzymes involved in cellular catabolic processes, such as succinate dehydrogenase and mitochondrial NADH dehydrogenase, thereby causing cellular energy deficiency<sup>##REF##31941063##6##,##REF##25588579##18##,##REF##28430618##29##</sup>. The metabolic activity of all treatment groups showed a steady yet significant decrease, which was inversely correlated with the increasing T-2 toxin concentration in the cell culture media. Our results indicate a mild decline (on average 19%) of hepatocellular metabolic activity triggered by T-2 toxin, which is in line with previous findings, such as the decreased viability of the liver cells in vitro both in the previous study of our research group on chicken 2D hepatocyte mono-cultures and hepatocyte—NP cell co-cultures as well as in porcine brain capillary endothelial cells (PBCEC) after T-2 toxin treatment described by Weidner et al.<sup>##REF##31941063##6##,##REF##23544145##30##</sup>.</p>", "<p id=\"Par25\">To evaluate the toxin-associated necrosis of the cells, LDH activity was measured. LDH is rapidly released into the medium in case of membrane damage which could indicate necrosis. The LDH leakage of the hepatic cells was significantly increased by the 500 nM T-2 toxin treatment, suggesting impaired membrane integrity following the toxin exposure<sup>##UREF##7##28##,##REF##26683309##31##</sup>. Measuring the metabolic activity of viable cells and the LDH activity of damaged cells can give a comprehensive picture about the cell viability and the toxicity of the toxin in both untreated and treated cell cultures.</p>", "<p id=\"Par26\">Since T-2 toxin might induce oxidative stress, the amount of MDA, a lipid peroxidation product, and PC, a protein damage marker were measured in the cell culture media or in the cell lysates, respectively. Significant toxin-evoked decline was observed for both tested markers in certain groups. The highest T-2 toxin treatment effectively reduced the MDA level, whereas the PC concentration was significantly decreased after both the 500 nM and 1000 nM toxin exposure. These findings suggest that T-2 toxin induced protective mechanisms in the cells, resulting in the alleviation of oxidative stress as reflected by the assayed markers<sup>##REF##31941063##6##</sup>. T-2 toxin has multiplex effects on the regulation of the stress response, it can either up- or downregulate the Nrf2 transcription factor in a dose- and time-dependent manner. If Nrf2 expression is elevated, it promotes the expression and production of antioxidant enzymes in response to oxidative stress, which could lead to the decrease of oxidative stress markers, such as MDA and PC<sup>##REF##29870751##16##,##REF##33554281##32##</sup>.</p>", "<p id=\"Par27\">The immunomodulatory effects of T-2 toxin were investigated by measuring the IL-6 and IL-8 concentrations. The 100 nM T-2 toxin concentration significantly decreased the level of IL-6 in the culture media. The detected decrease in the IL-6 concentration triggered by low toxin concentration might be explained by the activation of autophagy. Autophagy has a major role in cytoprotection as it is a key regulator of the removal of irregular, non-functioning cellular components<sup>##REF##34440679##33##</sup>. Previous studies indicate the activation of autophagy by T-2 toxin through autophagy-related gene 5 (ATG5) and mTOR regulation<sup>##REF##29413859##34##</sup>. Furthermore, autophagy has been shown to prevent the release of inflammatory cytokines from macrophages during fibrogenesis in the liver, which may result in decreased levels of IL-6 in the cell culture media<sup>##REF##30609663##35##</sup>. In addition, it is likely that IL-6 expression is regulated at the translational and post-translational level, given that IL-6 expression was unaffected at the mRNA level in a previous study in mice<sup>##REF##21781762##36##</sup>.</p>", "<p id=\"Par28\">The IL-8 release of the spheroids was significantly increased by the lowest toxin concentration. Previous studies have already shown that trichothecene mycotoxins, including T-2 toxin are able to activate the mitogen-activated protein kinase (MAPK) signaling pathway, through which they can stimulate the production of various pro-inflammatory cytokines that trigger functional disorders and apoptosis in order to protect the cells from harmful external stimuli<sup>##REF##31941063##6##,##UREF##2##17##,##REF##22069639##37##</sup>.</p>", "<p id=\"Par29\">In order to investigate the effect of T-2 toxin and the potential oxidative stress on the ER stress, the levels of HSP27 and GRP78 were measured. In response to cytotoxic conditions, several changes happen in the ER leading to unfolded protein accumulation and aggregation. These changes are collectively called ER stress. Upon ER stress, certain signaling pathways are activated, such as the UPR and the ER overloaded response (EOR) pathways. Furthermore, some studies indicate that the ER cooperates with other organelles and plays a role in autophagy<sup>##REF##16977377##38##</sup>. GRP78 is member of the HSP70 family, located in the membrane of the ER. It has a crucial role in the protein quality control of the ER and the regulation of the UPR<sup>##REF##25120434##14##,##REF##29893033##39##</sup>. The proteins responsible for the UPR are negatively regulated by the GRP78 in unstressed or healthy cells, but the elevated levels of unfolded proteins cause the dissociation of GRP78 from the URP transducer proteins, thereby releasing them from the inhibition<sup>##REF##25120434##14##</sup>.</p>", "<p id=\"Par30\">HSP27 is a molecular chaperone that belongs to the sHSPs and has a role in the early response upon oxidative and ER stress<sup>##REF##29191461##13##,##REF##15864808##15##</sup>. No significant changes were observed related to these parameters, indicating that the used T-2 toxin concentrations and incubation time did not induce ER stress in the cells. Hence, it can be suggested that ER stress is not primarily involved in the cellular effects of T-2 toxin on the avian liver.</p>", "<p id=\"Par31\">Concerning the metabolome analysis, the abundance of 41 metabolites was significantly influenced by the toxin exposure. Among them, several significantly varied metabolites were phosphatidylcholines or their derivatives. This is consistent with the fact that T-2 toxin also affects lipid metabolism. On the one hand, due to its lipophilicity, T-2 toxin can damage the integrity and function of cell membranes, allowing it to rapidly reach various cellular components, leading to cytotoxicity<sup>##REF##25588579##18##,##REF##26714875##40##</sup>. Furthermore, T-2 toxin also stimulates ROS production, which induces the peroxidation of membrane lipids<sup>##REF##17127370##41##</sup>. This may explain the decrease in the levels of certain phosphatidylcholines, as they are the main membrane-forming glycerophospholipid<sup>##REF##17623088##42##</sup>. However, our results suggest that the rate of lipid peroxidation is reduced, probably due to the activation of the cytoprotective mechanisms described above in response to the highest toxin concentration.</p>", "<p id=\"Par32\">One lysophosphatidylcholine—a phosphatidylcholine derivate—had a moderate positive correlation with the IL-6 content. Increased abundance of lysophosphatidylcholines has a lytic effect on the membrane and is often associated with inflammatory processes<sup>##REF##17623088##42##</sup>. In addition, changes in their levels may also be indicative of processes caused by oxidative stress in cells as mentioned above<sup>##REF##17127370##41##,##REF##10884297##43##</sup>.</p>", "<p id=\"Par33\">T-2 toxin also affects amino acid metabolism. In our experiments, the concentrations of four amino acids (proline, methionine, alanine, citrulline) and two biogenic amines (carnosine, spermidine) were significantly increased in the media by the treatments. A significant decrease in the levels of proline and methionine was observed in the control group compared to the cell-free medium. This suggests that the cells have taken up these two amino acids from their environment. For methionine, the increase in response to treatment did not surpass that measured in the cell-free medium, which may indicate that the uptake of the amino acid decreased after the treatment. However, in the case of proline, the increase in response to the highest toxin treatment exceeded the amount measured in the cell-free medium, suggesting an elevated secretion as a result of the treatment. Proline, alanine and citrulline play an important role in maintaining oxidative homeostasis. Several experiments have demonstrated that alanine was cytoprotective against oxidative stress<sup>##REF##23220409##44##</sup>. It stimulated the expression of certain proteins involved in the antioxidant defense system in human endothelial cells and reduced LDH leakage in rat hepatocytes<sup>##REF##14733911##45##,##REF##11866426##46##</sup>. The hydroxyl radical scavenger property of citrulline and its DNA protective role during oxidative stress have also been described<sup>##REF##11728468##47##,##UREF##8##48##</sup>. Proline can also effectively protect against oxidative stress in a variety of cell types<sup>##REF##23220409##44##</sup>. Proline synthesis is enhanced during H<sub>2</sub>O<sub>2</sub>-induced oxidative stress and plays a role in the maintenance and protection of the intracellular glutathione redox system, possibly through its direct ROS scavenging property. In addition, elevated proline levels may activate glutathione synthesis, stabilize antioxidant enzymes or trigger signalling pathways that up-regulate certain cellular antioxidant processes<sup>##REF##18036351##49##</sup>.</p>", "<p id=\"Par34\">The levels of carnosine and spermidine were already increased in the control group compared to the cell-free medium, and this increase was further enhanced by the toxin treatments. Carnosine is a dipeptide composed of β-alanine and <sc>l</sc>-histidine<sup>##UREF##9##50##</sup>. It acts as a natural cellular antioxidant, neutralizing free radicals, cooperating with other antioxidants, regulating the function of antioxidant enzymes, and inhibiting lipid peroxidation and protein oxidation<sup>##REF##23872881##51##,##REF##19430956##52##</sup>. In addition, an in vivo study revealed that it was able to alleviate epithelial damage caused by another trichothecene mycotoxin, deoxynivalenol (DON), by reducing oxidative stress<sup>##UREF##9##50##</sup>.</p>", "<p id=\"Par35\">Spermidine is an evolutionarily conserved polyamine with protective and lifespan-extending effects in mammals due to its anti-inflammatory and antioxidant properties. In addition, it improves mitochondrial metabolic function, proteostasis and chaperone activity<sup>##REF##34835956##53##,##REF##28386016##54##</sup>. In mice liver, spermidine improved the defense against oxidative stress both in vivo and in vitro<sup>##REF##34835956##53##</sup>. Moreover, it reduced the production of pro-inflammatory cytokines through inhibition of nuclear translocation of nuclear factor κ-light-chain-enhancer of activated B cells (NFκB)<sup>##REF##33810101##55##</sup>.</p>", "<p id=\"Par36\">All these suggest that the elevated amino acid and biogenic amine levels are likely to be associated with oxidative stress caused by T-2 toxin, possibly mediating the activation of cellular protective mechanisms leading to maintained or even decreased MDA and PC levels.</p>", "<p id=\"Par37\">Six amino acids (glutamine, glutamate, aspartate, lysine, serine, threonine) and two biogenic amines (putrescine, sarcosine) were significantly decreased in the media by the treatments. The levels of glutamine, glutamate and aspartate increased in the medium of control cells compared to the cell-free medium, indicating that the cells secrete these amino acids. The treatment-induced decrease did not exceed the amount of these amino acids in the cell-free medium, suggesting that the treatment caused a decrease in the release of these amino acids. In case of the glutamine, one possible reason for this decrease can be that glutamine is one of the precursors for the biosynthesis of proline in the mitochondria<sup>##UREF##10##56##</sup>. Accordingly, proline levels increased significantly during our experiment. Glutamine also plays a role in maintaining the oxidative homeostasis in the cells because of its ROS scavenging properties<sup>##REF##23922725##57##</sup>. Glutamine concentration has also been shown to decrease during catabolic stress. This may be due to a decrease in the activity of the enzyme glutamine synthetase in response to ROS<sup>##REF##11906817##58##</sup>. Glutamine may also serve as a precursor for the synthesis of glutathione<sup>##REF##15795900##59##</sup>. This suggests that its abundance may be substantially reduced due to the activation of the glutathione system against the oxidative stress caused by T-2 toxin treatment.</p>", "<p id=\"Par38\">Levels of glutamate, an intermediate of the glutamine metabolism, and aspartate were also reduced by the toxin treatment. Both glutamate and aspartate are key substrates for other biologically active molecules such as glutamine, glutathione, proline, ornithine and arginine, which may also explain why their release into the medium was reduced in the samples<sup>##REF##22286833##60##–##REF##26255283##62##</sup>.</p>", "<p id=\"Par39\">Interestingly, the level of another amino acid, lysine, was also significantly decreased by the T-2 toxin treatments, but the amount of α-aminoadipic acid, the end product of the lysine oxidation, was significantly increased<sup>##UREF##11##63##</sup>. α-aminoadipic acid is an appropriate indicator of in vivo protein oxidation during oxidative stress, which has long been recognized and used in the study of various human diseases and aging<sup>##REF##32738373##64##</sup>. Therefore, the increase in α-aminoadipic acid level may confirm the development of oxidative stress in the hepatic cells.</p>", "<p id=\"Par40\">Serine concentration was also decreased by the T-2 toxin treatment. Serine plays an important role in glycolysis as well as purine synthesis, the one-carbon metabolic cycle and glutathione synthesis. It is a non-essential amino acid, as it can be produced in sufficient quantities by the organism under physiological conditions. However, several studies have described that a serine deficiency can occur under oxidative stress<sup>##UREF##12##65##</sup>. The consequence of this is a stronger response to oxidative stress and higher ROS concentrations<sup>##UREF##12##65##,##REF##25875335##66##</sup>. During oxidative stress, the one-carbon cycle switches from methylation to transsulfuration in order to synthesize more glutathione, where serine may also serve as a precursor<sup>##UREF##12##65##</sup>.</p>", "<p id=\"Par41\">In addition to a decrease in serine, a decrease in threonine content has also been described under oxidative stress<sup>##REF##25875335##66##,##UREF##13##67##</sup>. Threonine is an essential amino acid for chickens<sup>##UREF##13##67##</sup>. Adequate levels of threonine are important for proper growth and threonine also plays an important role as a precursor in the synthesis of several amino acids<sup>##UREF##13##67##</sup>. Furthermore, serine/threonine kinases are often associated with the response during oxidative stress. These serine/threonine kinases can phosphorylate either serine or threonine and play a key role in the induction of cell growth, proliferation and apoptosis<sup>##REF##30373220##68##</sup>. Such serine/threonine kinase is the Akt, which phosphorylates mTOR<sup>##REF##32013230##69##</sup>. This pathway can be inhibited by several mycotoxins, including T-2 toxin, thereby regulating autophagy<sup>##REF##30373220##68##,##REF##32013230##69##</sup>.</p>", "<p id=\"Par42\">The amount of putrescine and sarcosine increased in the medium of control cells compared to the cell-free medium, indicating their release by the cells. This secretion was reduced by T-2 toxin treatment. Putrescine (1,4-diaminobutane) is a naturally occurring polyamine, along with spermidine and spermine<sup>##REF##169440##70##</sup>. Putrescine plays an important role in proliferation and cell growth as well as in the regulation of transcription and translation<sup>##REF##36800189##71##,##REF##19714672##72##</sup>. Furthermore, it serves as a precursor for the synthesis of other polyamines such as spermidine<sup>##REF##19714672##72##</sup>. Accordingly, the level of putrescine in media samples decreased, while the concentration of spermidine increased significantly, which may indicate a putrescine-spermidine conversion.</p>", "<p id=\"Par43\">The concentration of sarcosine was significantly decreased by the toxin treatment. The methylation of sarcosine (<italic>N</italic>-methylglycine) leads to the formation of trimethylglycine, a metabolite that typically accumulates during oxidative stress and has a protective role against it<sup>##REF##28542385##73##</sup>. Moreover, sarcosine typically forms complexes with metals, which can also prevent nucleic acid oxidation<sup>##REF##28542385##73##,##UREF##14##74##</sup>. Both of these processes could lead to a decline in the sarcosine content.</p>", "<p id=\"Par44\">It was found that the concentration of eight acylcarnitines decreased, while three increased significantly after the T-2 toxin treatment. Different acylcarnitines also showed both moderate positive correlations with PC and HSP27, while another had a moderate negative correlation with MDA. L-carnitine is found in free form or as acylcarnitine, an esterified form in the cytoplasm of cells<sup>##REF##24983359##75##</sup>. <sc>l</sc>-Carnitine and acylcarnitines play a key role in lipid metabolism, as the carnitine shuttle system transports fatty acids into the mitochondria where β-oxidation occurs. In this process, acylcarnitine crosses the mitochondrial membrane, where the fatty acids are detached, and the free carnitine is returned to the cytoplasm<sup>##REF##22020112##76##</sup>. <sc>l</sc>-Carnitine also has a role in stimulating the production of antioxidant enzymes and reducing oxidative stress and inflammatory cytokine release<sup>##REF##30795537##77##</sup>. In addition, acylcarnitines are known to have antioxidant activity, but the underlying mechanism is not yet fully understood<sup>##UREF##15##78##</sup>.</p>", "<p id=\"Par45\">Histamine and taurine had a strong positive correlation with the HSP27 levels. Histamine is a key mediator of inflammation and has an important role in a number of other cellular processes, including the regulation of the stress response<sup>##REF##19653065##79##</sup>. Previous studies have already described its role in the phosphorylation and activation of HSP27, which may support why their levels were so closely correlated in the examined samples after the toxin treatment<sup>##REF##19653065##79##,##REF##34516752##80##</sup>.</p>", "<p id=\"Par46\">Taurine is a biogenic amine with a long-established cytoprotective effect. It has been shown to play a role in ER stress defence through downregulation of UPR-related proteins such as GRP78<sup>##UREF##16##81##,##REF##20804591##82##</sup>. Moreover, in chickens exposed to taurine, it was observed that the expression of certain heat shock proteins was reduced in vivo<sup>##UREF##17##83##</sup>. In addition, it can reduce inflammation by decreasing the levels of several pro-inflammatory cytokines, and has an antioxidant effect by stimulating the expression of the transcription factor Nrf2 as well as reducing lipid peroxidation<sup>##UREF##16##81##,##UREF##18##84##</sup>.</p>", "<p id=\"Par47\">Asparagine concentration was negatively correlated with that of HSP27. This could be explained by the fact that transcription of the asparagine synthetase enzyme is enhanced by ER stress via the UPR<sup>##REF##29084849##85##,##REF##12881527##86##</sup>. Asparagine synthetase catalyses the synthesis of asparagine and glutamate, and therefore enhances asparagine formation in the presence of ER stress<sup>##REF##29084849##85##</sup>.</p>", "<p id=\"Par48\">Ornithine level was positively correlated with the concentration of MDA and HSP27. Ornithine decarboxylase is an important enzyme in polyamine biosynthesis, converting ornithine to putrescine, which, as mentioned above, then serves as a precursor for the synthesis of spermidine<sup>##REF##19714672##72##,##REF##22579641##87##</sup>. The function of the enzymes catalysing polyamine synthesis is usually affected by various stress situations, such as exposure to T-2 toxin<sup>##REF##22579641##87##,##REF##8539264##88##</sup>. Among them, the transcription of the ornithine decarboxylase gene was significantly upregulated by chemically induced oxidative stress in vitro<sup>##REF##22579641##87##</sup>.</p>", "<p id=\"Par49\">Symmetric dimethylarginine (SDMA) and asymmetric dimethylarginine (ADMA) are methylated derivatives of <sc>l</sc>-Arginine<sup>##REF##31234586##89##</sup>. Both are toxic, non-proteinogenic amino acids capable of inhibiting nitric oxide (NO) production<sup>##REF##28272322##90##,##REF##15482350##91##</sup>. In addition, SDMA has a possible proinflammatory effect and may also induce ROS formation<sup>##REF##28272322##90##</sup>. This may be related to our finding that the amount of SDMA was positively correlated with the concentration of an oxidative stress marker, MDA.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par50\">T-2 toxin decreased the metabolic activity of cells and increased the extent of cell membrane damage, therefore had a negative effect on the viability of liver cells. Our results suggest that T-2 toxin may also alter the cellular oxidative homeostasis through the promotion of ROS production as well as the regulation of the Nrf2 transcription factor and may influence immune function including the release of pro-inflammatory cytokines such as IL-6 and IL-8. According to our results, lipid and amino acid metabolism were also affected by the toxin leading to remarkable alterations in the metabolome of cell cultures. In conclusion, several cellular processes, such as the inflammatory and oxidative stress response or the metabolic profile of hepatic spheroids were modulated by T-2 toxin exposure, and investigating the complex interactions of these processes is a good basis for future studies on the mechanism of action of T-2 toxin. Furthermore, our applied cell culture model can serve as a promising tool for the investigation of various further mycotoxins as well as other toxic agents in the future.</p>" ]
[ "<p id=\"Par1\">Despite being one of the most common contaminants of poultry feed, the molecular effects of T-2 toxin on the liver of the exposed animals are still not fully elucidated. To gain more accurate understanding, the effects of T-2 toxin were investigated in the present study in chicken-derived three-dimensional (3D) primary hepatic cell cultures. 3D spheroids were treated with three concentrations (100, 500, 1000 nM) of T-2 toxin for 24 h. Cellular metabolic activity declined in all treated groups as reflected by the Cell Counting Kit-8 assay, while extracellular lactate dehydrogenase activity was increased after 500 nM T-2 toxin exposure. The levels of oxidative stress markers malondialdehyde and protein carbonyl were reduced by the toxin, suggesting effective antioxidant compensatory mechanisms of the liver. Concerning the pro-inflammatory cytokines, IL-6 concentration was decreased, while IL-8 concentration was increased by 100 nM T-2 toxin exposure, indicating the multifaceted immunomodulatory action of the toxin. Further, the metabolic profile of hepatic spheroids was also modulated, confirming the altered lipid and amino acid metabolism of toxin-exposed liver cells. Based on these results, T-2 toxin affected cell viability, hepatocellular metabolism and inflammatory response, likely carried out its toxic effects by affecting the oxidative homeostasis of the cells.</p>", "<title>Subject terms</title>", "<p>Open access funding provided by University of Veterinary Medicine.</p>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51689-1.</p>", "<title>Acknowledgements</title>", "<p>The author would like to thank Márton Papp for his help during the statistical analysis, and Szilvia Pálinkás for her professional assistance during laboratory work. We acknowledge Iris Klaiber and Ute Bertsche from the Core Facility Hohenheim (University of Hohenheim, Stuttgart, Germany) for their support on mass spectrometry analysis.</p>", "<title>Author contributions</title>", "<p>Conception and design: J.V., M.M., C.S., P.T., R.A.M., K.H., Z.N., G.M., original draft preparation: J.V., M.M., Z.N., G.M., methodology: J.V., M.M., C.S., P.T., R.A.M., D.G.H., K.H., Z.N., G.M., analysis of data: J.V., M.M., G.M., visualization: J.V., supervision: K.H., Z.N., G.M., funding acquisition: M.M., R.A.M., G.M. All authors have reviewed the manuscript.</p>", "<title>Funding</title>", "<p>Open access funding provided by University of Veterinary Medicine. The work was supported by the Hungarian National Research, Development and Innovation Office (Grant number OTKA FK 134940), by the strategic research fund of the University of Veterinary Medicine Budapest (Grant no. SRF-001.). Project no. RRF-2.3.1-21-2022-00001 has been implemented with the support provided by the Recovery and Resilience Facility (RRF), financed under the National Recovery Fund budget estimate, RRF-2.3.1-21 funding scheme. The QTRAP 5500 mass spectrometer was co-funded by the German Research Foundation (DFG-INST 36/152-1 FUGG) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>", "<title>Data availability</title>", "<p>All data generated or analyzed during this study are included in this published article (and its Supplementary Information files).</p>", "<title>Competing interests</title>", "<p id=\"Par68\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Primary 3D hepatic spheroids from chicken origin. The black arrow shows an NP cell, while red arrows show hepatocytes. H&amp;E staining, bar: 20 µm.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Effects of 24 h T-2 toxin treatment on the metabolic activity of primary hepatic 3D cell co-cultures of chicken origin assessed by CCK-8 test. Control: cells without T-2 toxin exposure; T100: 100 nM, T500: 500 nM, T1000: 1000 nM T-2 toxin treatment. Relative absorbances were calculated by considering the mean value of the Control group as 1. Results are expressed as mean ± SEM. ***p &lt; 0.001.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Effects of 24 h T-2 toxin treatment on the LDH activity of primary hepatic 3D cell co-cultures of chicken origin. Control: cells without T-2 toxin exposure; T100: 100 nM, T500: 500 nM, T1000: 1000 nM T-2 toxin treatment. Relative activity was calculated by considering the mean value of the Control group as 1. Results are expressed as mean ± SEM. *p &lt; 0.05.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Effects of 24 h T-2 toxin treatment on the (<bold>a</bold>) MDA and (<bold>b</bold>) PC concentrations of primary hepatic 3D cell co-cultures of chicken origin assessed by chicken specific ELISA test. Control: cells without T-2 toxin exposure; T100: 100 nM, T500: 500 nM, T1000: 1000 nM T-2 toxin treatment. Relative concentrations were calculated by considering the mean value of the Control group as 1. Results are expressed as mean ± SEM. *p &lt; 0.05, **p &lt; 0.01.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Effects of 24 h T-2 toxin treatment on the (<bold>a</bold>) IL-6 and (<bold>b</bold>) IL-8 concentrations of primary hepatic 3D cell co-cultures of chicken origin assessed by chicken specific ELISA test. Control: cells without T-2 toxin exposure; T100: 100 nM, T500: 500 nM, T1000: 1000 nM T-2 toxin treatment. Relative concentrations were calculated by considering the mean value of the Control group as 1. Results are expressed as mean ± SEM. *p &lt; 0.05.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Effects of 24 h T-2 toxin treatment on the (<bold>a</bold>) GRP78 and (<bold>b</bold>) HSP27 concentrations of primary hepatic 3D cell co-cultures of chicken origin assessed by chicken specific ELISA test. Control: cells without T-2 toxin exposure; T100: 100 nM, T500: 500 nM, T1000: 1000 nM T-2 toxin treatment. Relative concentrations were calculated by considering the mean value of the Control group as 1. Results are expressed as mean ± SEM.</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>Heatmap visualising the concentrations of 41 metabolites in spheroid media with significantly changed abundance in response to 24 h T-2 toxin treatment. Control: cells without T-2 toxin exposure; T100: 100 nM, T500: 500 nM, T1000: 1000 nM T-2 toxin treatment.</p></caption></fig>", "<fig id=\"Fig8\"><label>Figure 8</label><caption><p>Correlation between the parameters measured by chicken-specific ELISA tests and metabolites measured by the AbsoluteIDQ p180 kit. Correlation between (<bold>a</bold>) MDA and metabolites, (<bold>b</bold>) PC and metabolites, (<bold>c</bold>) IL-6 and metabolites, (<bold>d</bold>) IL-8 and metabolites, (<bold>e</bold>) GRP78 and metabolites, (<bold>f</bold>) HSP27 and metabolites. Correlation was assessed using the Pattern Hunter function of the MetaboAnalyst 5.0 program.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Metabolites significantly different from the control group. Statistics were calculated by ANOVA, pairwise comparisons by Tukey's HSD.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Metabolite</th><th align=\"left\">Control mean ± SEM</th><th align=\"left\">T100 mean ± SEM</th><th align=\"left\">T500 mean ± SEM</th><th align=\"left\">T1000 mean ± SEM</th><th align=\"left\">Significance</th></tr></thead><tbody><tr><td align=\"left\">Alpha-AAA</td><td align=\"left\">ND</td><td align=\"left\">ND</td><td align=\"left\">0.323 ± 0.083</td><td align=\"left\">0.593 ± 0.022</td><td align=\"left\">***</td></tr><tr><td align=\"left\">Cit</td><td align=\"left\">ND</td><td align=\"left\">0.002 ± 0.002</td><td align=\"left\">0.664 ± 0.393</td><td align=\"left\">0.972 ± 0.140</td><td align=\"left\">***</td></tr><tr><td align=\"left\">Pro</td><td align=\"left\">281.750 ± 6.075</td><td align=\"left\">289.917 ± 5.032</td><td align=\"left\">302.750 ± 8.567</td><td align=\"left\">340.750 ± 8.816</td><td align=\"left\">***</td></tr><tr><td align=\"left\">Carnosine</td><td align=\"left\">0.196 ± 0.019</td><td align=\"left\">0.193 ± 0.012</td><td align=\"left\">0.321 ± 0.039</td><td align=\"left\">0.432 ± 0.008</td><td align=\"left\">***</td></tr><tr><td align=\"left\">Spermidine</td><td align=\"left\">0.094 ± 0.014</td><td align=\"left\">0.122 ± 0.009</td><td align=\"left\">0.199 ± 0.011</td><td align=\"left\">0.200 ± 0.009</td><td align=\"left\">***</td></tr><tr><td align=\"left\">Ala</td><td align=\"left\">937.583 ± 18.555</td><td align=\"left\">1034.750 ± 13.268</td><td align=\"left\">993.667 ± 16.078</td><td align=\"left\">1024.500 ± 9.882</td><td align=\"left\">***</td></tr><tr><td align=\"left\">Met</td><td align=\"left\">95.842 ± 2.056</td><td align=\"left\">101.833 ± 1.872</td><td align=\"left\">104.000 ± 2.086</td><td align=\"left\">111.117 ± 2.564</td><td align=\"left\">***</td></tr><tr><td align=\"left\">C10</td><td align=\"left\">0.634 ± 0.014</td><td align=\"left\">0.666 ± 0.014</td><td align=\"left\">0.726 ± 0.025</td><td align=\"left\">0.764 ± 0.025</td><td align=\"left\">***</td></tr><tr><td align=\"left\">PC ae C42:4</td><td align=\"left\">ND</td><td align=\"left\">ND</td><td align=\"left\">0.003 ± 0.002</td><td align=\"left\">0.007 ± 0.003</td><td align=\"left\">***</td></tr><tr><td align=\"left\">C0</td><td align=\"left\">1.095 ± 0.021</td><td align=\"left\">1.047 ± 0.041</td><td align=\"left\">1.173 ± 0.033</td><td align=\"left\">1.265 ± 0.052</td><td align=\"left\">***</td></tr><tr><td align=\"left\">PC ae C38:1</td><td align=\"left\">ND</td><td align=\"left\">0.004 ± 0.002</td><td align=\"left\">0.007 ± 0.002</td><td align=\"left\">0.018 ± 0.009</td><td align=\"left\">**</td></tr><tr><td align=\"left\">lysoPC a C24:0</td><td align=\"left\">0.040 ± 0.011</td><td align=\"left\">0.043 ± 0.009</td><td align=\"left\">0.079 ± 0.012</td><td align=\"left\">0.111 ± 0.006</td><td align=\"left\">**</td></tr><tr><td align=\"left\">PC ae C42:0</td><td align=\"left\">0.170 ± 0.003</td><td align=\"left\">0.176 ± 0.003</td><td align=\"left\">0.183 ± 0.005</td><td align=\"left\">0.191 ± 0.003</td><td align=\"left\">**</td></tr><tr><td align=\"left\">lysoPC a C26:1</td><td align=\"left\">0.013 ± 0.006</td><td align=\"left\">0.008 ± 0.005</td><td align=\"left\">0.023 ± 0.009</td><td align=\"left\">0.046 ± 0.007</td><td align=\"left\">**</td></tr><tr><td align=\"left\">H1</td><td align=\"left\">12,322.083 ± 240.933</td><td align=\"left\">13,085 ± 252.481</td><td align=\"left\">12,549.420 ± 323.376</td><td align=\"left\">12,753.250 ± 289.951</td><td align=\"left\">**</td></tr><tr><td align=\"left\">PC aa C26:0</td><td align=\"left\">0.288 ± 0.006</td><td align=\"left\">0.286 ± 0.005</td><td align=\"left\">0.313 ± 0.007</td><td align=\"left\">0.305 ± 0.006</td><td align=\"left\">**</td></tr><tr><td align=\"left\">C5-OH</td><td align=\"left\">0.073 ± 0.002</td><td align=\"left\">0.066 ± 0.003</td><td align=\"left\">0.086 ± 0.006</td><td align=\"left\">0.068 ± 0.003</td><td align=\"left\">**</td></tr><tr><td align=\"left\">PC aa C28:1</td><td align=\"left\">0.001 ± 0.001</td><td align=\"left\">ND</td><td align=\"left\">0.002 ± 0.002</td><td align=\"left\">0.010 ± 0.004</td><td align=\"left\">**</td></tr><tr><td align=\"left\">C5:1-DC</td><td align=\"left\">0.211 ± 0.006</td><td align=\"left\">0.142 ± 0.010</td><td align=\"left\">0.148 ± 0.011</td><td align=\"left\">0.101 ± 0.005</td><td align=\"left\">***</td></tr><tr><td align=\"left\">Putrescine</td><td align=\"left\">0.144 ± 0.012</td><td align=\"left\">0.128 ± 0.005</td><td align=\"left\">0.082 ± 0.005</td><td align=\"left\">0.076 ± 0.005</td><td align=\"left\">***</td></tr><tr><td align=\"left\">C10:2</td><td align=\"left\">0.200 ± 0.006</td><td align=\"left\">0.219 ± 0.006</td><td align=\"left\">0.166 ± 0.013</td><td align=\"left\">0.155 ± 0.006</td><td align=\"left\">***</td></tr><tr><td align=\"left\">C5-DC</td><td align=\"left\">0.133 ± 0.005</td><td align=\"left\">0.099 ± 0.005</td><td align=\"left\">0.115 ± 0.009</td><td align=\"left\">0.088 ± 0.004</td><td align=\"left\">***</td></tr><tr><td align=\"left\">PC aa C38:4</td><td align=\"left\">0.068 ± 0.006</td><td align=\"left\">0.028 ± 0.004</td><td align=\"left\">0.021 ± 0.008</td><td align=\"left\">0.074 ± 0.032</td><td align=\"left\">***</td></tr><tr><td align=\"left\">PC aa C34:1</td><td align=\"left\">0.219 ± 0.020</td><td align=\"left\">0.083 ± 0.008</td><td align=\"left\">0.089 ± 0.018</td><td align=\"left\">0.148 ± 0.043</td><td align=\"left\">***</td></tr><tr><td align=\"left\">Sarcosine</td><td align=\"left\">0.781 ± 0.069</td><td align=\"left\">0.316 ± 0.015</td><td align=\"left\">0.373 ± 0.069</td><td align=\"left\">0.685 ± 0.035</td><td align=\"left\">***</td></tr><tr><td align=\"left\">PC aa C36:4</td><td align=\"left\">0.068 ± 0.007</td><td align=\"left\">0.023 ± 0.004</td><td align=\"left\">0.017 ± 0.005</td><td align=\"left\">0.091 ± 0.052</td><td align=\"left\">***</td></tr><tr><td align=\"left\">Lys</td><td align=\"left\">535.250 ± 15.572</td><td align=\"left\">466.833 ± 9.482</td><td align=\"left\">473.833 ± 12.696</td><td align=\"left\">469.000 ± 10.462</td><td align=\"left\">***</td></tr><tr><td align=\"left\">C3-DC</td><td align=\"left\">0.152 ± 0.011</td><td align=\"left\">0.189 ± 0.008</td><td align=\"left\">0.122 ± 0.005</td><td align=\"left\">0.125 ± 0.019</td><td align=\"left\">**</td></tr><tr><td align=\"left\">Ser</td><td align=\"left\">136.633 ± 4.786</td><td align=\"left\">122.833 ± 2.522</td><td align=\"left\">115.333 ± 2.986</td><td align=\"left\">118.833 ± 3.353</td><td align=\"left\">**</td></tr><tr><td align=\"left\">Gln</td><td align=\"left\">2324.167 ± 35.918</td><td align=\"left\">2397.500 ± 33.803</td><td align=\"left\">2206.667 ± 62.284</td><td align=\"left\">2147.5000 ± 43.920</td><td align=\"left\">**</td></tr><tr><td align=\"left\">PC aa C32:1</td><td align=\"left\">0.035 ± 0.004</td><td align=\"left\">0.010 ± 0.003</td><td align=\"left\">0.013 ± 0.003</td><td align=\"left\">0.020 ± 0.003</td><td align=\"left\">**</td></tr><tr><td align=\"left\">C12-DC</td><td align=\"left\">0.465 ± 0.010</td><td align=\"left\">0.442 ± 0.009</td><td align=\"left\">0.430 ± 0.008</td><td align=\"left\">0.412 ± 0.010</td><td align=\"left\">**</td></tr><tr><td align=\"left\">C9</td><td align=\"left\">0.085 ± 0.003</td><td align=\"left\">0.074 ± 0.002</td><td align=\"left\">0.072 ± 0.003</td><td align=\"left\">0.069 ± 0.003</td><td align=\"left\">**</td></tr><tr><td align=\"left\">C12</td><td align=\"left\">0.075 ± 0.002</td><td align=\"left\">0.051 ± 0.005</td><td align=\"left\">0.058 ± 0.004</td><td align=\"left\">0.047 ± 0.003</td><td align=\"left\">**</td></tr><tr><td align=\"left\">PC aa C34:2</td><td align=\"left\">0.073 ± 0.006</td><td align=\"left\">0.040 ± 0.013</td><td align=\"left\">0.036 ± 0.005</td><td align=\"left\">0.177 ± 0.108</td><td align=\"left\">**</td></tr><tr><td align=\"left\">lysoPC a C14:0</td><td align=\"left\">0.253 ± 0.009</td><td align=\"left\">0.226 ± 0.006</td><td align=\"left\">0.255 ± 0.007</td><td align=\"left\">0.261 ± 0.008</td><td align=\"left\">**</td></tr><tr><td align=\"left\">C6:1</td><td align=\"left\">0.108 ± 0.006</td><td align=\"left\">0.087 ± 0.003</td><td align=\"left\">0.093 ± 0.004</td><td align=\"left\">0.094 ± 0.003</td><td align=\"left\">**</td></tr><tr><td align=\"left\">Thr</td><td align=\"left\">375.750 ± 5.015</td><td align=\"left\">372.917 ± 4.864</td><td align=\"left\">344.667 ± 11.981</td><td align=\"left\">377.250 ± 5.021</td><td align=\"left\">**</td></tr><tr><td align=\"left\">Asp</td><td align=\"left\">497.833 ± 28.112</td><td align=\"left\">489.333 ± 15.234</td><td align=\"left\">434.500 ± 17.047</td><td align=\"left\">409.083 ± 5.864</td><td align=\"left\">**</td></tr><tr><td align=\"left\">C4</td><td align=\"left\">0.068 ± 0.003</td><td align=\"left\">0.053 ± 0.004</td><td align=\"left\">0.053 ± 0.003</td><td align=\"left\">0.044 ± 0.005</td><td align=\"left\">**</td></tr><tr><td align=\"left\">Glu</td><td align=\"left\">360.750 ± 4.910</td><td align=\"left\">366.250 ± 6.426</td><td align=\"left\">341.500 ± 6.161</td><td align=\"left\">348.333 ± 4.552</td><td align=\"left\">**</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>" ]
[ "<table-wrap-foot><p>ND: not detected under detection level.</p><p>Control: cells without T-2 toxin exposure; T100: 100 nM, T500: 500 nM, T1000: 1000 nM T-2 toxin treatment.</p><p>*p &lt; 0.05, **p &lt; 0.01, ***&lt; 0.001.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51689_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51689_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51689_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51689_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51689_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2024_51689_Fig6_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"41598_2024_51689_Fig7_HTML\" id=\"MO7\"/>", "<graphic xlink:href=\"41598_2024_51689_Fig8_HTML\" id=\"MO8\"/>" ]
[ "<media xlink:href=\"41598_2024_51689_MOESM1_ESM.docx\"><caption><p>Supplementary Legends.</p></caption></media>", "<media xlink:href=\"41598_2024_51689_MOESM2_ESM.xlsx\"><caption><p>Supplementary Table 1.</p></caption></media>", "<media xlink:href=\"41598_2024_51689_MOESM3_ESM.xlsx\"><caption><p>Supplementary Table 2.</p></caption></media>", "<media xlink:href=\"41598_2024_51689_MOESM4_ESM.xlsx\"><caption><p>Supplementary Table 3.</p></caption></media>" ]
[{"label": ["2."], "surname": ["Galbenu-Morvay", "Trif", "Damiescu", "Simion"], "given-names": ["PL", "A", "L", "G"], "article-title": ["T-2 toxin occurrence in cereals and cereal-based foods"], "source": ["Bull. Univ. Agric. Sci. Vet. Med. Cluj-Napoca. Agric."], "year": ["2011"], "volume": ["68"], "fpage": ["274"], "lpage": ["280"]}, {"label": ["7."], "surname": ["Awad"], "given-names": ["WA"], "article-title": ["The impact of the fusarium toxin deoxynivalenol (DON) on poultry"], "source": ["Int. J. Poultry Sci."], "year": ["2008"], "volume": ["7"], "fpage": ["827"], "lpage": ["842"], "pub-id": ["10.3923/ijps.2008.827.842"]}, {"label": ["17."], "surname": ["Pomothy"], "given-names": ["JM"], "article-title": ["Beneficial effects of rosmarinic acid on IPEC-J2 cells exposed to the combination of deoxynivalenol and T-2 toxin"], "source": ["Mediators Inflamm."], "year": ["2020"], "volume": ["2020"], "fpage": ["e8880651"], "pub-id": ["10.1155/2020/8880651"]}, {"label": ["19."], "surname": ["Ken\u00e9z", "D\u00e4nicke", "Rolle-Kampczyk", "von Bergen", "Huber"], "given-names": ["\u00c1", "S", "U", "M", "K"], "article-title": ["A metabolomics approach to characterize phenotypes of metabolic transition from late pregnancy to early lactation in dairy cows"], "source": ["Metabolomics"], "year": ["2016"], "volume": ["12"], "fpage": ["165"], "pub-id": ["10.1007/s11306-016-1112-8"]}, {"label": ["20."], "surname": ["Desai", "Tseng", "Souza"], "given-names": ["PK", "H", "GR"], "article-title": ["Assembly of hepatocyte spheroids using magnetic 3D cell culture for CYP450 inhibition/induction"], "source": ["Int. J. Mol. Sci."], "year": ["2017"], "volume": ["18"], "fpage": ["E1085"], "pub-id": ["10.3390/ijms18051085"]}, {"label": ["23."], "mixed-citation": ["Tseng, H. & Souza, G. R. M3D cell culture: Bicompatibility of nanoshuttle-PL and the magnetic field. "], "ext-link": ["https://www.gbo.com/fileadmin/media/GBO-International/01_Downloads_BioScience/SALES_White_Papers/F075068_m3D_White_Paper_Biocompatibility_Nanoshuttle_EN.pdf"]}, {"label": ["24."], "surname": ["V\u00e9kony", "Matta", "P\u00e1l", "Szab\u00f3"], "given-names": ["V", "C", "P", "IA"], "article-title": ["Structural and magnetic characterisation of a biocompatible magnetic nanoparticle assembly"], "source": ["J. Magnet. Magnet. Mater."], "year": ["2022"], "volume": ["545"], "fpage": ["168772"], "pub-id": ["10.1016/j.jmmm.2021.168772"]}, {"label": ["28."], "surname": ["Mackei"], "given-names": ["M"], "article-title": ["Effects of acute heat stress on a newly established chicken hepatocyte-nonparenchymal cell co-culture model"], "source": ["Animals (Basel)"], "year": ["2020"], "volume": ["10"], "fpage": ["E409"], "pub-id": ["10.3390/ani10030409"]}, {"label": ["48."], "surname": ["Kaore", "Amane", "Kaore"], "given-names": ["SN", "HS", "NM"], "article-title": ["Citrulline: Pharmacological perspectives and its role as an emerging biomarker in future"], "source": ["Fundamental Clin. Pharmacol."], "year": ["2013"], "volume": ["27"], "fpage": ["35"], "lpage": ["50"], "pub-id": ["10.1111/j.1472-8206.2012.01059.x"]}, {"label": ["50."], "surname": ["Zhou"], "given-names": ["J"], "article-title": ["l-Carnosine protects against deoxynivalenol-induced oxidative stress in intestinal stem cells by regulating the Keap1/Nrf2 signaling pathway"], "source": ["Mol. Nutr. Food Res."], "year": ["2021"], "volume": ["65"], "fpage": ["2100406"], "pub-id": ["10.1002/mnfr.202100406"]}, {"label": ["56."], "surname": ["Burke"], "given-names": ["L"], "article-title": ["The Janus-like role of proline metabolism in cancer"], "source": ["Cell Death Discov."], "year": ["2020"], "volume": ["6"], "fpage": ["1"], "lpage": ["17"], "pub-id": ["10.1038/s41420-020-00341-8"]}, {"label": ["63."], "surname": ["D\u00edaz-Velasco", "Delgado", "Pe\u00f1a", "Est\u00e9vez"], "given-names": ["S", "J", "FJ", "M"], "article-title": ["Protein oxidation marker, \u03b1-amino adipic acid, impairs proteome of differentiated human enterocytes: Underlying toxicological mechanisms"], "source": ["Biochimica et Biophysica Acta BBA Proteins Proteom."], "year": ["2022"], "volume": ["1870"], "fpage": ["140797"], "pub-id": ["10.1016/j.bbapap.2022.140797"]}, {"label": ["65."], "surname": ["Zhou"], "given-names": ["X"], "article-title": ["Serine alleviates oxidative stress via supporting glutathione synthesis and methionine cycle in mice"], "source": ["Mol. Nutr. Food Res."], "year": ["2017"], "volume": ["61"], "fpage": ["1700262"], "pub-id": ["10.1002/mnfr.201700262"]}, {"label": ["67."], "surname": ["Shirisha", "Bu", "Prashanth"], "given-names": ["DR", "DU", "DK"], "article-title": ["Effect of L-threonine supplementation on broiler chicken: A review"], "source": ["Pharma Innovation"], "year": ["2018"], "volume": ["7"], "fpage": ["490"], "lpage": ["493"]}, {"label": ["74."], "surname": ["Tanas"], "given-names": ["A"], "article-title": ["In vitro and in vivo neuroprotective effects of sarcosine"], "source": ["BioMed. Res. Int."], "year": ["2022"], "volume": ["2022"], "fpage": ["e5467498"], "pub-id": ["10.1155/2022/5467498"]}, {"label": ["78."], "surname": ["Jones", "McDonald", "Borum"], "given-names": ["LL", "DA", "PR"], "article-title": ["Acylcarnitines: Role in brain"], "source": ["Progress Lipid Res."], "year": ["2010"], "volume": ["49"], "fpage": ["61"], "lpage": ["75"], "pub-id": ["10.1016/j.plipres.2009.08.004"]}, {"label": ["81."], "surname": ["Baliou"], "given-names": ["S"], "article-title": ["Protective role of taurine against oxidative stress (Review)"], "source": ["Mol. Med. Rep."], "year": ["2021"], "volume": ["24"], "fpage": ["1"], "lpage": ["19"], "pub-id": ["10.3892/mmr.2021.12242"]}, {"label": ["83."], "surname": ["Belal", "Kang", "Cho", "Park", "Shim"], "given-names": ["SA", "DR", "ESR", "GH", "KS"], "article-title": ["Taurine reduces heat stress by regulating the expression of heat shock proteins in broilers exposed to chronic heat"], "source": ["Braz. J. Poult. Sci."], "year": ["2018"], "volume": ["20"], "fpage": ["479"], "lpage": ["486"], "pub-id": ["10.1590/1806-9061-2017-0712"]}, {"label": ["84."], "surname": ["Surai", "Kochish", "Kidd"], "given-names": ["PF", "II", "MT"], "article-title": ["Taurine in poultry nutrition"], "source": ["Animal Feed Sci. Technol."], "year": ["2020"], "volume": ["260"], "fpage": ["114339"], "pub-id": ["10.1016/j.anifeedsci.2019.114339"]}, {"label": ["92."], "mixed-citation": ["Aviagen. Ross Broiler Management Handbook. "], "ext-link": ["https://aviagen.com/assets/Tech_Center/Ross_Broiler/Ross-BroilerHandbook2018-EN.pdf"]}]
{ "acronym": [], "definition": [] }
94
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1195
oa_package/a9/c0/PMC10786837.tar.gz
PMC10786838
38216688
[ "<title>Introduction</title>", "<p id=\"Par7\">Gestational diabetes mellitus (GDM), a state of hyperglycemia due to insufficient insulin secretion and/or insulin resistance that occurs during pregnancy, is the most common metabolic disorder of pregnancy, affecting 6–12% of pregnancies globally<sup>##UREF##0##1##,##REF##34883186##2##</sup>. A diagnosis of GDM is not only associated with risk of acute pregnancy and delivery complications, but also carries implications for the long-term risk of type 2 diabetes (T2D)<sup>##REF##31048434##3##,##REF##29519626##4##</sup> and cardiovascular disease (CVD)<sup>##REF##30843102##5##</sup>. Additionally, offspring exposed to GDM in utero have higher adiposity and a worse metabolic profile across the life course than their unexposed counterparts<sup>##REF##31451868##6##,##UREF##1##7##</sup>. The wide-ranging and intergenerational sequelae of GDM-affected pregnancies emphasize the importance of characterizing not only the short- and long-term consequences of this common pregnancy complication. Further, identification of bellwethers of such consequences will facilitate preventive intervention of such comorbidities and complications, also known as disease prognosis.</p>", "<p id=\"Par8\">Recent technological advancements have improved the capacity to comprehensively assess physiology. In turn, these developments facilitated the ability to harness metabolic heterogeneity – the phenomenon of interest to precision medicine by which similar exposures and risk factors yield differential health sequelae across individuals. In the context of GDM prognosis, this effort requires the identification of prognostic factors and biomarkers among women with a history of GDM and/or their offspring who were exposed to GDM in utero that may serve as both causal and non-causal indicators of future health risks.</p>", "<p id=\"Par9\">Recognizing the relevance of metabolic heterogeneity in accurate and precise assessment of disease prediction, diagnosis, treatment, and prognosis, the Precision Medicine in Diabetes Initiative (PMDI) was established in 2018 by the American Diabetes Association (ADA) in partnership with the European Association for the Study of Diabetes (EASD). The ADA/EASD PMDI includes global thought leaders in precision diabetes medicine who are working to address the burgeoning need for better diabetes prevention and care through precision medicine<sup>##REF##35050364##8##</sup>. This Systematic Review is written on behalf of the ADA/EASD PMDI as part of a comprehensive evidence evaluation in support of the 2nd International Consensus Report on Precision Diabetes Medicine<sup>##REF##37794253##9##</sup>.</p>", "<p id=\"Par10\">Thus, in an effort to evaluate prognostic factors to better understand health risks related to postpartum and long-term cardiometabolic health outcomes among mothers with GDM and her offspring, we conducted a systematic review that synthesizes evidence from empirical research papers published through September 1st, 2021, to evaluate and identify prognostic conditions, risk factors, and biomarkers among women and offspring affected by GDM pregnancies, focusing on clinical endpoints of CVD and T2D among women with a history of GDM; and adiposity and cardiometabolic risk profile among offspring exposed to GDM in utero. Overall, we find that GDM severity, maternal obesity, self-identified race/ethnicity, poor diet, and low physical activity levels predict postpartum T2D and CVD in the women, and unfavorable long-term cardiometabolic health in offspring with GDM exposure.</p>" ]
[ "<title>Methods</title>", "<title>Systematic review protocol development</title>", "<p id=\"Par11\">We registered our search strategy and systematic review protocol to PROSPERO CRD42021276094<sup>##UREF##2##10##</sup>. We developed a systematic review protocol to comprehensively include and evaluate individual research studies reporting on risk factors for long-term clinical outcomes in women with GDM and a range of cardiometabolic health and anthropometric outcomes in GDM-exposed offspring. Nota bene, ADA/EASD PDMI is committed to using inclusive language, especially in relation to gender. We choose to use gendered terminology throughout the article following the rationale for using gendered language in studies of maternal and child health, including but not limited to reducing risk of exposure misclassification and avoidance of dehumanizing terms<sup>##REF##35224545##11##</sup>. Further, most of the original studies reviewed used ‘women’ as their terminology to describe their population, as GDM per definition occurs in pregnancy which can only occurs in individuals that are female at birth. In this review, we use the term ‘women’ throughout, but acknowledge that not all individuals who experienced a pregnancy may self-identify as a woman.</p>", "<p id=\"Par12\">Our strategy aimed to identify two broad categories of empirical studies: (1) populations of women with a history of prior GDM that investigated additional exposures or risk factors for incident postpartum T2D or CVD; (2) populations comprising offspring exposed to GDM in utero that investigated additional exposures or risk factors for an adverse cardiometabolic profile. Studies including pregnancies unaffected by GDM were eligible only if results were included for GDM subgroups.</p>", "<p id=\"Par13\">Prognostic factors of interest, hereafter also referred to as exposures, included sociodemographic factors, lifestyle and behavioral characteristics, traditional clinical traits, and ‘omics biomarkers. We considered these prognostic factors during the perinatal/postpartum periods and across the lifecourse for both the mothers and offspring. Maternal outcomes of interest were incident T2D or CVD, including study-specific composites of clinical cardiovascular events, non-fatal and fatal myocardial infarction or stroke, and chronic kidney disease (CKD). For offspring, we were interested in outcomes reported 12 weeks of age and older, and limited to anthropometrics, glycemic and cardiometabolic traits or biomarkers, and incident metabolic syndrome (MetS), T2D, or CVD.</p>", "<title>Data sources, search strategy, and screening criteria</title>", "<p id=\"Par14\">We developed search terms for Medline EMBASE, and Cochrane CENTRAL (Supplementary Data ##SUPPL##3##1##) for eligible citations published in English language from January 1st, 1990, through September 30<sup>th</sup>, 2021. References of accepted manuscripts and relevant systematic reviews published within the past 2 years were screened to identify additional citations. We included prospective and retrospective observational studies identifying factors with incident outcomes of interest in women or offspring exposed to GDM. We excluded cross-sectional analyses among populations with prevalent disease outcomes or traits. While studies could include non-GDM exposed pregnancies, those without subgroup findings exclusively among GDM pregnancies were excluded. We also included interventions prospectively comparing effects of a treatment assignment on the outcome. Exclusion criteria comprised studies with outcomes &lt;6 weeks postpartum, maternal studies reporting only intermediate phenotypes, glycemic traits, or cardiometabolic biomarkers, and studies in offspring that only assessed endpoints outside of the cardiometabolic outcomes of interest (e.g., neurodevelopment, allergic disease). Using these, two independent reviewers conducted screening at the title abstract level. For accepted citations, two independent reviewers implemented screening of the full manuscripts. Conflicts at all screening stages were resolved by a third reviewer. All screening was conducted in the Covidence online systematic review tracking platform.</p>", "<title>Data extraction and synthesis of results</title>", "<p id=\"Par15\">We developed and piloted a data extraction template for eligible manuscripts. Data included manuscript information, study level details and design, population enrollment and characteristics, exposure and outcome ascertainment and diagnosis criteria, follow-up time of outcome assessment since index GDM pregnancy and other pertinent details. We indicated the population in which outcomes were assessed (e.g., maternal, offspring, or both), and recorded the exposures that were investigated in four broad categories: (i) social/genetics factors across the life course; (ii) all factors in perinatal/postpartum window; (iii) long-term maternal exposures; and (iv) long-term offspring exposures.</p>", "<title>Quality assessment (risk of bias) and synthesis</title>", "<p id=\"Par16\">We assessed the quality of each study using the Joanna Briggs Institute’s (JBI) critical appraisal tools for cohort studies and randomized controlled trials (RCTs)<sup>##REF##37794253##9##</sup>. For cohort studies, we assessed quality based on 11 items which evaluated population recruitment, exposure and outcome ascertainment, confounding, statistical methodology, and follow-up. For the RCTs, the JBI criteria evaluated 13 items which assessed selection and allocation, intervention, administration, outcome ascertainment, follow-up, and statistical analysis. Each JBI item was categorized as, ‘Yes,’ ‘No,’ ‘Unclear,’ or ‘Not applicable’ following the guidelines. Any uncertainty in assessment was further discussed by the full research team.</p>", "<title>Overall evidence certainty assessment and synthesis</title>", "<p id=\"Par17\">The certainty of evidence was determined using the Diabetes Canada 2018 Clinical Practice Guidelines for studies<sup>##REF##29650079##12##</sup>. Levels were based on study design and criteria focused on inception cohort of patients presenting GDM but without outcomes of interest, inclusion/exclusion reproducibility, follow-up of at least 80% of participants and assessment of loss to follow-up, adjustment for confounding factors, and reproducible outcome measures. Scoring ranged from level 1 to 4, with Level 1 indicating the highest certainty of evidence and Level 4 indicating the lowest certainty of evidence. Details on the criteria and guidelines are in Supplementary Table ##SUPPL##1##1##.</p>", "<title>Reporting summary</title>", "<p id=\"Par18\">Further information on research design is available in the ##SUPPL##13##Nature Portfolio Reporting Summary## linked to this article.</p>" ]
[ "<title>Results</title>", "<p id=\"Par19\">Of the 8141 studies identified, five were excluded due to duplication (Fig. ##FIG##0##1##). Another 7770 were excluded following title and abstract review. The remaining 366 studies were reviewed in full, of which 106 studies met the inclusion criteria through the database search. An additional three studies were identified through manual search. A total of 109 studies were included in this review.</p>", "<p id=\"Par20\">Of the 109 included, 98 were observational studies and 11 were RCTs (Supplementary Data ##SUPPL##4##2## and ##SUPPL##5##3##). Of the studies, 51 focused on maternal outcomes and 38 focused on offspring outcomes. Of the RCTs, three evaluated maternal outcomes and eight assessed offspring outcomes. Studies included data from primarily from white populations from North America and Europe. Sample sizes of the eligible studies ranged from 26 to 23,302.</p>", "<title>Maternal outcomes</title>", "<title>Maternal type 2 diabetes</title>", "<p id=\"Par21\">Forty-nine observational studies (Supplementary Data ##SUPPL##6##4##) and two RCTs (Supplementary Data ##SUPPL##7##5##) assessed sociodemographic, lifestyle, clinical, and pregnancy characteristics associated with the risk of T2D among GDM women. The most frequently studied characteristics were maternal BMI and GDM severity. All observational studies that assessed maternal BMI as a prognostic factor showed that higher maternal BMI prior to and/or during pregnancy, and later in the lifecourse predicted higher risk of T2D. One observational study<sup>##UREF##3##13##</sup> further demonstrated that a greater pre-pregnancy weight increased the risk of T2D, though this study did not observe a significant association of gestational weight gain with T2D (Supplementary Data ##SUPPL##6##4##). Seventeen observational studies, including one that derived a composite risk score for future T2D risk<sup>##REF##19641163##14##</sup>, assessed GDM severity in relation to risk of T2D. Findings indicate that more severe GDM, measured by either clinical markers assessing degree of hyperglycemia or need for insulin treatment, predicts risk of developing T2D (Supplementary Data ##SUPPL##6##4##<bold>)</bold>. Fewer studies examined the role of lifestyle behaviors and prenatal clinical characteristics. Four observational studies<sup>##UREF##4##15##–##REF##26818892##18##</sup> investigated the role of self-identified race/ethnicity – which we view as social constructs as opposed to biological forms of determinism – for the risk of T2D, two of which showed no significant associations<sup>##UREF##4##15##,##REF##15111544##17##</sup> and two suggested that the risk was higher among women with non-white European ancestry<sup>##REF##17392549##16##,##REF##26818892##18##</sup> (Supplementary Data ##SUPPL##6##4##).</p>", "<p id=\"Par22\">Four<sup>##REF##25312813##19##–##REF##26686048##22##</sup> of seven<sup>##REF##15111544##17##,##REF##25312813##19##–##REF##10388966##24##</sup> observational studies that focused on prognostic value of pregnancy or delivery complications reported that additional pregnancy complications beyond GDM conferred higher risk of T2D. The pregnancy complications assessed varied across reports including stillbirth, gestational hypertension, and cesarian section. Seven studies explored the role of parity<sup>##REF##10388966##24##–##REF##16505245##30##</sup>, of which five<sup>##UREF##7##25##–##REF##31969529##28##,##REF##16505245##30##</sup> found that higher parity predicted risk of T2D. Four observational studies<sup>##REF##29340577##31##–##REF##30548991##34##</sup> showed that breastfeeding was associated with a reduced risk of developing T2D in later life. Two observational studies<sup>##REF##22987062##35##,##REF##26577416##36##</sup> and one RCT<sup>##REF##18826999##37##</sup> assessed associations of healthy dietary patterns during mid-life with risk of incident T2D among women with a history of GDM but showed inconsistent results. Ten studies assessed biomarkers of T2D risk<sup>##REF##19641163##14##,##REF##16505245##30##,##REF##29945965##38##–##UREF##8##45##</sup>, including metabolomics, lipidomics, sICAM and sE-selectin, and proinsulin-to-insulin ratio.</p>", "<title>Maternal cardiovascular diseases</title>", "<p id=\"Par23\">Six observational studies<sup>##REF##25312813##19##,##REF##29128412##46##–##REF##29149255##50##</sup> explored the role of sociodemographic, lifestyle, and pregnancy characteristics in future risk of CVD among women with GDM (Supplementary Data ##SUPPL##8##6##). Two studies identified maternal BMI before<sup>##REF##29128412##46##</sup> and during<sup>##REF##24762194##48##</sup> pregnancy as risk factors for future CVD, in which women with overweight or obesity, in addition to GDM, have a higher risk of CVD as compared to normal weight women with GDM. One study<sup>##REF##29049820##47##</sup> further showed that a healthy lifestyle – i.e., healthy diet, physical activity, and being a non-smoker – was associated with a lower risk of CVD. Two studies showed that pregnancy complications—namely, gestational hypertension<sup>##REF##29149255##50##</sup> and stillbirth<sup>##REF##25312813##19##</sup>—predicted risk of CVD. No effect modification was identified with respect to family history of CVD<sup>##REF##29049820##47##</sup> or chronic hypertension<sup>##REF##24762194##48##</sup>.</p>", "<title>Quality of studies conducted and certainty of evidence in women with a history of GDM</title>", "<p id=\"Par24\">The quality of studies for prognostic factors indicative of future T2D or CVD risk is low and the overall certainty of evidence ranked between Levels 3 and 4 according to the Diabetes Canada 2018 Clinical Practice Guidelines<sup>##REF##29650079##12##</sup>. (Fig. ##FIG##1##2## for observational studies; Fig. ##FIG##2##3## for RCTs). Most current literature were based on retrospective studies leveraging registry data and observational cohort studies, both of which are vulnerable to bias due to residual confounding, reverse causation bias by pre-existing conditions, and other characteristics around the time of pregnancy and GDM diagnoses.</p>", "<title>Offspring outcomes</title>", "<title>Anthropometry and body composition</title>", "<p id=\"Par25\">In comparison to the large maternal literature, relatively few studies focused on prognostic factors associated with suboptimal offspring body composition among those exposed to GDM <italic>in utero</italic>. Forty observational studies (Supplementary Data ##SUPPL##9##7##) and five RCTs (Supplementary Data ##SUPPL##10##8##) examined associations of sociodemographic, lifestyle, clinical and pregnancy characteristics associated with anthropometric outcomes in offspring of GDM women. The RCTs, by nature, also enabled assessment of the effect of GDM treatment type (e.g., Metformin vs. insulin; dietary advice, glucose monitoring, and insulin therapy vs. routine care) on offspring outcomes.</p>", "<p id=\"Par26\">The most studied associations included maternal BMI, GDM severity, breastfeeding status, and offspring birthweight, in relation to offspring anthropometric outcomes (e.g., BMI and risk of overweight/obesity). Seven observational studies<sup>##REF##20435793##51##–##UREF##9##57##</sup> found that higher maternal pre-pregnancy BMI was associated with higher adiposity in the offspring, as reflected by a higher BMI, waist circumference or directly-assessed fat mass, and greater risk of overweight or obesity. Nine studies<sup>##REF##9203438##55##,##REF##10480772##56##,##REF##20536487##58##–##REF##26817507##64##</sup> assessed the associations of maternal GDM severity, measured by either clinical markers of hyperglycemia or need for insulin treatment, with offspring body composition, of which four observational studies<sup>##REF##9203438##55##,##REF##10480772##56##,##REF##25802854##63##,##REF##26817507##64##</sup> indicated that more severe maternal GDM is associated with a higher offspring BMI and overweight risk. RCTs that evaluated GDM severity and showed no significant association with offspring anthropometry or body composition.</p>", "<p id=\"Par27\">Six<sup>##REF##9203438##55##–##UREF##9##57##,##REF##15983329##60##,##REF##32005877##65##,##REF##27788515##66##</sup> of 10 observational studies<sup>##REF##20435793##51##,##REF##9203438##55##–##UREF##9##57##,##REF##15983329##60##,##REF##32005877##65##–##REF##30421138##69##</sup> showed that a larger size and/or higher adiposity at birth predicts higher future BMI and risk of overweight among GDM-exposed offspring.</p>", "<p id=\"Par28\">With regards to breastfeeding status, one study<sup>##REF##30421138##69##</sup> reported that breastfed offspring with larger size at birth had lower future BMI and lower risk of overweight or obesity. Multiple observational studies showed that exclusive breastfeeding and longer vs. shorter duration of breastfeeding are associated with lower offspring BMI and risk of overweight or obesity (Supplementary Data ##SUPPL##9##7##). Additionally, a study in the SWIFT cohort showed that inadequate duration and/or exclusivity of breastfeeding, alone and in combination with consumption of fruit juice or sugar sweetened beverages during the first year of life, predicts higher offspring BMI at ages 2–5 years<sup>##REF##33495846##70##</sup>. Three studies using data from the Danish National Birth Cohort indicated that maternal prenatal diet consisting of fatty fish<sup>##REF##30336645##71##</sup>, refined grain<sup>##REF##28592607##72##</sup>, and sugar-sweetened beverage intake<sup>##REF##28586472##73##</sup> were associated with higher offspring BMI, whereas protein intake<sup>##REF##28679553##74##</sup> and glycemic index/load<sup>##REF##30250133##75##</sup> did not show significant impact on offspring abdominal fat. Finally, one study identified a genetic risk score that predicted higher BMI among offspring exposed to GDM in utero<sup>##REF##32861332##76##</sup>.</p>", "<p id=\"Par29\">Of the five RCTs testing an effect of GDM treatment on offspring anthropometry and body composition, three<sup>##REF##20150300##77##–##REF##16681566##79##</sup> yielded null findings and two found that treatment with Metformin, as compared to insulin, was associated with higher offspring adiposity according to skinfold thicknesses<sup>##REF##21949222##80##</sup> and weight<sup>##REF##25039582##81##</sup> within the first 18 months of life (Supplementary Data ##SUPPL##10##8##).</p>", "<title>Cardiometabolic profile</title>", "<p id=\"Par30\">We identified fourteen observational studies (Supplementary Data ##SUPPL##11##9##) and five RCTs (Supplementary Data ##SUPPL##12##10##) that evaluated prognostic risk factors for adverse cardiometabolic outcomes among GDM-exposed offspring. These studies focused on blood pressure, lipids, and glycemic markers in the offspring separately or via a score comprising multiple biomarkers.</p>", "<p id=\"Par31\">Birthweight was the most studied predictor of the offspring prognostic factors, but only two observational studies<sup>##REF##15741354##82##,##REF##26707052##83##</sup> showed that a higher birthweight predicted MetS components in offspring later in life. Four observational studies assessed associations of specific maternal dietary components (glycemic index/load<sup>##REF##30250133##75##</sup>, fish<sup>##REF##30336645##71##</sup>, magnesium<sup>##REF##22728448##84##</sup>, and protein<sup>##REF##28679553##74##</sup>), though no consistent associations were observed in relation to offspring cardiometabolic outcomes. Although one observational study showed that breastfeeding was associated with a lower risk of a MetS phenotype in the offspring<sup>##REF##30734524##85##</sup>, but this finding was not recapitulated in other observational studies.</p>", "<p id=\"Par32\">Several RCTs compared diet vs. insulin treatment of GDM and showed no significant associations with the development of a MetS phenotype in the offspring (Supplementary Data ##SUPPL##12##10##). One RCT<sup>##REF##31175958##86##</sup> assessed the effect of a lifestyle intervention comprising exercise and diet counselling for treatment of GDM vs. usual clinical care and found higher risk of unfavorable metabolic outcomes among offspring in the intervention group.</p>", "<title>Quality of studies and certainty of evidence conducted in offspring exposed to GDM in utero</title>", "<p id=\"Par33\">We identified low quality of evidence for prognostic factors indicative of future adiposity and cardiometabolic risk among offspring exposed to GDM <italic>in utero</italic> (Fig. ##FIG##2##3## for RCTs; Fig. ##FIG##3##4## for observational studies). As with the maternal literature, most studies focusing on offspring outcomes were based on retrospective study designs leveraging registry data and observational cohort studies, both of which can be fraught with residual confounding and reverse causation bias, as well as structural biases like selection and attrition bias. Moreover, the literature of offspring outcomes remains scant and with potentially inadequate durations of follow-up for manifestation of clinically relevant cardiometabolic outcomes, though additional research is warranted. Furthermore, the certainty of evidence for maternal and offspring exposures with cardiometabolic outcomes were scored at Level 4<sup>##REF##29650079##12##</sup>, based on several factors including limited studies, small sample sizes, heterogeneity of study designs, and inadequate statistical methods.</p>" ]
[ "<title>Discussion</title>", "<title>Summary</title>", "<p id=\"Par34\">This systematic review sought to identify prognostic risk factors during the perinatal period and across the lifecourse for maternal and offspring cardiovascular and metabolic outcomes among women and offspring affected by GDM pregnancies. We hypothesized that worse glycemic control at the time of GDM diagnosis (i.e., severity of GDM), older maternal age, belonging to a racial/ethnic minority group as proxy of upstream social experiences that trickle down to affect physiology<sup>##REF##34402850##87##</sup>, unhealthy lifestyle behaviors during the prenatal period (i.e., poor diet quality and low physical activity levels) predict risk of incident type 2 diabetes (T2D) and cardiovascular disease (CVD) among women with a history of GDM, and an unfavorable cardiometabolic profile among offspring exposed to GDM in utero.</p>", "<p id=\"Par35\">The studies identified herein were primarily long-term retrospective and prospective studies. The level of evidence for prognostic risk factors of maternal T2D and CVD and for offspring cardiometabolic risk is low due to unmeasured confounding by lifestyle behaviors, the possibility of reverse causation bias due to pre-existing chronic conditions prior to or at the time of GDM diagnosis. Additionally, for offspring outcomes, the small body of literature on prognostic factors indicative of future adiposity and cardiometabolic risk and major loss to follow-up in both observational and intervention studies.</p>", "<title>Maternal outcomes</title>", "<p id=\"Par36\">Among women with GDM, higher BMI at any time in relation to the index pregnancy – i.e., pre-pregnancy, during the index pregnancy including gestational weight gain, and lifecourse measures of weight – predicted higher risk of T2D later in life. GDM severity, typically estimated by use of insulin or higher blood glucose values during the index pregnancy, was consistently associated with higher risk of developing T2D. While few studies assessed race and/or ethnicity as a prognostic risk factor, women of Asian or non-white European descent with a history of GDM had higher risk of future T2D than white women<sup>##REF##17392549##16##,##REF##26818892##18##,##REF##29128412##46##</sup>. Breastfeeding duration and/or exclusivity was consistently associated with lower risk T2D risk following a GDM diagnosis during pregnancy, though follow-up often ended &lt;2 years postpartum—a period within which occult T2D incidence is relatively low (Supplementary Data ##SUPPL##6##4##). Longer duration follow-up is necessary to better evaluate the benefits of breastfeeding on T2D risk. Some observational studies indicated a protective effect of lifestyle factors such as physical activity level during the perinatal and postpartum periods, and compliance with a healthy diet (e.g., adherence to a Mediterranean or DASH-like dietary pattern; the Healthy Eating Index score). However, RCTs investigating the effects of dietary interventions yielded mixed results (Supplementary Data ##SUPPL##7##5##). Several observational studies also examined biomarkers of T2D risk following GDM pregnancies, including degree of hyperglycemia at the time of GDM diagnosis, lipids, inflammation, and metabolomics biomarkers<sup>##REF##29945965##38##–##REF##25281032##40##</sup>. However, low certainty of evidence from the studies and lack of replication/validation of findings prevent us from drawing firm conclusions regarding which factors may be the best predictors of future diabetes.</p>", "<p id=\"Par37\">In line with a large literature demonstrating that women with a history of GDM are at higher risk CVD than their non-diabetic counterparts<sup>##REF##30843102##5##</sup>, studies among women with a history of GDM indicated dose-response associations of maternal BMI – primarily, pre-pregnancy BMI—and GDM severity with these endpoints. However, the extent to which these physiological factors are modifiable remains yet to be determined. Given the paucity of available research on CVD risk in women with a history of GDM, and the low certainty of evidence assessment, this is a research area ripe for investigation.</p>", "<title>Quality of maternal studies</title>", "<p id=\"Par38\">We ranked the quality of evidence for prognostic factors indicative of risk of T2D or CVD in women as Level 4 (low)<sup>##REF##29650079##12##</sup>. Most empirical literature comes predominantly from large health care registries that boast large sample sizes and decades of follow-up. However, they carry high risk of bias in terms of identifying and interpretation specific prognostic characteristics as causal risk factors due to residual confounding due to maternal lifestyle, pre-existing chronic conditions, and other characteristics around time of pregnancy and GDM diagnoses. For example, although maternal hypertension during pregnancy may be a risk factor for T2D or CVD, the association may be explained by maternal BMI, diet quality, physical activity, smoking status, socioeconomic factors, and more. In contrast, there are notable large prospective cohorts, including CARDIA (e.g. refs. <sup>##REF##29340577##31##,##REF##29128412##46##</sup>) and the Nurses’ Health Study II (e.g. refs. <sup>##REF##29049820##47##,##REF##12612275##67##</sup>), that collected detailed prospective information on the above-mentioned variables, thereby mitigating risk of bias in these studies.</p>", "<title>Offspring outcomes</title>", "<p id=\"Par39\">The most common measure of offspring anthropometry was BMI between 2 and 10 years after birth. As with maternal outcomes, observational evidence for offspring indicates that greater GDM severity and higher maternal pre-pregnancy BMI predicts higher offspring adiposity. Yet, interpretation of these findings should be tempered with results of intervention studies showing that GDM treatment did not affect offspring anthropometrics<sup>##REF##20150300##77##–##REF##16681566##79##</sup>. Other frequently studied perinatal predictors of offspring adiposity included birth size and breastfeeding duration/exclusivity. Generally, higher birthweight tended to be associated with higher future BMI<sup>##REF##9203438##55##–##UREF##9##57##,##REF##32005877##65##,##REF##27788515##66##</sup>. Some observational studies showed a protective effect of breastfeeding against offspring obesity risk during childhood, though this finding was not consistently observed. A few observational studies reported a modifying effect of offspring biological sex on future body composition among children exposed to GDM (e.g.<sup>##UREF##9##57##,##UREF##10##88##</sup>), but the direction of association was not consistent. Of the five RCTs that investigated the effect of GDM treatment on offspring anthropometry and body composition, two found that treatment with Metformin, as compared to insulin, predicted higher offspring adiposity according to skinfold thicknesses<sup>##REF##21949222##80##</sup> and weight<sup>##REF##25039582##81##</sup> within the first 18 months of life. These results call for additional research to assess long-term offspring outcomes related to pharmaceutical treatments for GDM, especially given findings indicating comparable neonatal outcomes among women treated with Metformin and insulin<sup>##REF##23724063##89##</sup>.</p>", "<p id=\"Par40\">Most studies that assessed offspring cardiometabolic profile were observational and focused on prognostic factors that occurred during the perinatal/postpartum period, though a few RCTs targeting maternal glycemic control during pregnancy via pharmaceutical treatments and/or lifestyle alterations. Among observational studies (Supplementary Data ##SUPPL##11##9##), common prognostic factors included maternal BMI and diet, for which both prognostic factors yielded inconsistent associations with offspring cardiometabolic profile. As with the studies assessing offspring anthropometry and body composition as outcomes, RCTs to prevent GDM among high-risk women generally found minimal effects of the pharmaceutical and/or lifestyle interventions on offspring cardiometabolic profile (Supplementary Data ##SUPPL##12##10##). This, again, suggests that additional research is needed to better understand the pathophysiology of maternal GDM, to characterize relevant in utero programming pathways<sup>##REF##37014638##90##–##REF##34061777##92##</sup>, and identify accurate and valid prognostic biomarkers—including those in cord blood—as well as outcomes in offspring that are more relevant to future disease risk<sup>##REF##31451868##6##</sup> such as directly-assessed neonatal adiposity<sup>##REF##34061777##92##</sup>.</p>", "<title>Quality of offspring studies</title>", "<p id=\"Par41\">As with the maternal studies, we categorized the literature on prognostic factors for offspring outcomes as being of low quality (Level 4)<sup>##REF##29650079##12##</sup>. The inconsistent observational findings in conjunction with null results of RCTs targeting prevention of GDM among high-risk women indicate the existence of residual confounding for observational studies, and in the cases of the trials, the possibility that the interventions were developed with a suboptimal endpoint (e.g., a focus on preventing macrosomia based on birth size rather than directly assessed neonatal adiposity). Future work is needed to gain a better understanding of in utero programming mechanisms that may link maternal GDM to offspring adiposity, as well as interventions specifically formulated to prevent neonatal adiposity assessed via gold standard methods such as computed tomography or dual X-ray absorptiometry<sup>##REF##27398414##93##,##UREF##11##94##</sup>.</p>", "<title>Strengths and limitations of studies included in the systematic review</title>", "<p id=\"Par42\">A key strength of many studies included in this systematic review is the prospective study design, which enhances temporal and causal inference regarding prognostic capacity of the maternal and offspring characteristics and behaviors assessed in studies herein. Additional strengths of some, but not all studies, include multi-ethnic study populations, which enhance generalizability of findings; large sample sizes, which improves capacity to detect biologically relevant associations; and use of gold standard assessments of the maternal and offspring outcomes of interest.</p>", "<p id=\"Par43\">Limitations include the low-grade quality of studies included in this review (residual confounding, reverse causation bias, attrition and selection bias, inadequate duration of follow-up). Additionally, most studies were not designed to explore the long-term prognosis of GDM. Accordingly, many studies comprise post hoc analyses that were likely underpowered to detect smaller but biologically relevant effects of prognostic risk factors solely among mothers and/or offspring exposed to GDM. When screening studies, we also noted that a general limitation of the literature on GDM prognostics in relation to offspring outcomes is assessment of the prognostic variable(s) of interest contemporaneously with outcome assessment, which limits our ability to make causal inference on the effect of the prognostic variable on outcomes of interest. These shortcomings resulted in high risk of bias and low quality of studies.</p>", "<title>Strengths and limitations of systematic review approach and methodology</title>", "<p id=\"Par44\">Strengths of the methodology for this systematic review include implementation of at least two independent reviews across all phases of the extraction and assessment process, with an additional review by a third independent reviewer to resolve conflicts; and adherence to well-established assessments of research quality and assessments of bias. Limitations include the exclusively qualitative synthesis of results—a necessity given the relatively small number of studies identified; and as with all systematic reviews, the potential for our conclusions to be impacted by publication bias.</p>", "<title>Future directions</title>", "<p id=\"Par45\">Given the low quality of evidence identified in this systematic review, there is need for prospective cohort studies in diverse populations with granular data collection on prognostic risk factors as well as clinical and subclinical outcomes. Additionally, high fidelity of follow-up across the lifecourse, particularly during sensitive windows of development during which there is greater developmental plasticity to respond to external cues<sup>##UREF##12##95##</sup>, will shed light on avenues for primordial and/or primary prevention. Finally, consideration of appropriate adjustment covariates depending on the specific prognostic risk factor of interest (e.g., there is discourse regarding whether maternal pre-pregnancy BMI should be included as a covariate in models where GDM severity is the prognostic factor of interest given that these variables share overlapping in utero programming pathways<sup>##REF##31451868##6##,##REF##35323708##91##</sup>); and appropriate causal inference and analytical approaches to address structural biases that afflict observational study designs<sup>##UREF##12##95##,##REF##33499782##96##</sup>.</p>", "<p id=\"Par46\">As interest in the application of precision prognostics to improve health for women and offspring affected by GDM pregnancies grows, there remains a crucial need to establish foundational knowledge regarding traditional prognostic factors which, in turn, will enhance our ability to identify new prognostic biomarkers that improve risk stratification for unfavorable health outcomes among both women and children affected by GDM.</p>" ]
[]
[ "<title>Background</title>", "<p id=\"Par1\">The objective of this systematic review is to identify prognostic factors among women and their offspring affected by gestational diabetes mellitus (GDM), focusing on endpoints of cardiovascular disease (CVD) and type 2 diabetes (T2D) for women, and cardiometabolic profile for offspring.</p>", "<title>Methods</title>", "<p id=\"Par2\">This review included studies published in English language from January 1st, 1990, through September 30th, 2021, that focused on the above outcomes of interest with respect to sociodemographic factors, lifestyle and behavioral characteristics, traditional clinical traits, and ‘omics biomarkers in the mothers and offspring during the perinatal/postpartum periods and across the lifecourse. Studies that did not report associations of prognostic factors with outcomes of interest among GDM-exposed women or children were excluded.</p>", "<title>Results</title>", "<p id=\"Par3\">Here, we identified 109 publications comprising 98 observational studies and 11 randomized-controlled trials. Findings indicate that GDM severity, maternal obesity, race/ethnicity, and unhealthy diet and physical activity levels predict T2D and CVD in women, and greater cardiometabolic risk in offspring. However, using the Diabetes Canada 2018 Clinical Practice Guidelines for studies, the level of evidence was low due to potential for confounding, reverse causation, and selection biases.</p>", "<title>Conclusions</title>", "<p id=\"Par4\">GDM pregnancies with greater severity, as well as those accompanied by maternal obesity, unhealthy diet, and low physical activity, as well as cases that occur among women who identify as racial/ethnic minorities are associated with worse cardiometabolic prognosis in mothers and offspring. However, given the low quality of evidence, prospective studies with detailed covariate data collection and high fidelity of follow-up are warranted.</p>", "<title>Plain language summary</title>", "<p id=\"Par5\">Gestational diabetes mellitus (GDM) occurs when levels of sugar in the blood are high during pregnancy. We sought to identify factors associated with short- and long-term cardiometabolic disease risk, health conditions that involve heart-related issues and complications in bodily function, among women with GDM and their offspring. We reviewed publications on factors related to type 2 diabetes (T2D) and cardiovascular disease (CVD) risk among women with GDM, and additionally assessed body composition in offspring of women with GDM. We found that GDM severity, maternal obesity, self-identified race/ethnicity, poor diet, and low physical activity levels predict postpartum T2D and CVD in the women, and unfavorable long-term cardiometabolic disease risk in offspring. The quality of evidence was poor, emphasizing a need for high-quality research capturing detailed short- and long-term outcome data to facilitate preventative interventions to improve health of women and children.</p>", "<p id=\"Par6\">Semnani-Azad et al. review the evidence on prognostic factors that predict cardiovascular disease and type 2 diabetes for women, and cardiometabolic profile in offspring subsequent to gestational diabetes. The evidence was of low quality, but some maternal characteristics were predictive of unfavourable outcomes in women and their offspring.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s43856-023-00427-1.</p>", "<title>Acknowledgements</title>", "<p>The ADA/EASD Precision Diabetes Medicine Initiative, within which this work was conducted, has received the following support: The Covidence license was funded by Lund University (Sweden) for which technical support was provided by Maria Björklund and Krister Aronsson (Faculty of Medicine Library, Lund University, Sweden). Administrative support was provided by Lund University (Malmö, Sweden), University of Chicago (IL, USA), and the American Diabetes Association (Washington D.C., USA). The Novo Nordisk Foundation (Hellerup, Denmark) provided grant support for in-person writing group meetings (PI: L Phillipson, University of Chicago, IL). We also thank Marie-France Hivert for her valuable insights and feedback on this work. In addition, the following individuals were funded by the following sources:</p>", "<p>• <italic>Zhila Semnani-Azad</italic> is funded by Canadian Institutes of Health Research (CIHR) Fellowship.</p>", "<p>• <italic>Romy Gaillard</italic> is funded by the Dutch Diabetes Foundation (grant number 2017.81.002), the Netherlands Organization for Health Research and Development (NWO, ZonMw, grant number 543003109; NWO, ZonMw VIDI 09150172110034) and from the European Union’s Horizon 2020 research and innovation programme under the ERA-NET Cofund action (no 727565), EndObesity, ZonMW the Netherlands (no. 529051026).</p>", "<p>• <italic>Alice Hughes</italic> is funded by a Wellcome Trust GW4-Clinical Academic PhD Fellowship [WT203918].</p>", "<p>• <italic>Kristen Boyle</italic> is funded by R01DK117168.</p>", "<p>• <italic>Deirdre K. Tobias</italic> is funded by ADA-1-19-JDF-115.</p>", "<p>• <italic>Wei Perng</italic> is funded by American Diabetes Association (ADA)−7-22-ICTSPM-08 and National Institutes of Health (NIH) U01 DK134981.</p>", "<p>Funders did not play any role in the design of this study or the interpretation of the findings.</p>", "<title>Author contributions</title>", "<p>Z.S.A., R.G., A.E.H., K.E.B., D.K.T. and W.P. completed the review, extraction, and quality assessment of papers. Z.S.A., R.G. and W.P. drafted the initial version of the manuscript. A.E.H., K.E.B. and D.K.T. provided critical intellectual feedback. All authors approved the final version for publication.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par47\"><italic>Communications Medicine</italic> thanks Delphine Mitanchez, Erica Gunderson, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.</p>", "<title>Data availability</title>", "<p>The data that support the findings of this study are derived from published, peer-reviewed manuscripts. The search terms used to retrieve studies are found in the Supplementary Data ##SUPPL##3##1## and the list of included studies is described in Supplementary Data ##SUPPL##4##2## and ##SUPPL##5##3##. The source data underlying Figs. ##FIG##1##2##–##FIG##3##4## is provided in Supplementary Data ##SUPPL##6##4## to 10. All other relevant data are available from the authors upon request.</p>", "<title>Competing interests</title>", "<p id=\"Par48\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagrams for study identification, screening, and retention of studies included in this systematic review.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>Heat map of study quality according to the Diabetes Canada Clinical Practice Guidelines for observational studies assess maternal type 2 diabetes (T2D) and cardiovascular disease (CVD) as outcomes.</title><p>Green cells indicate high quality; red cells indicate low quality. Yellow cells indicate unclear/unable to assess quality based on information provided.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Heat map of study quality according to the Diabetes Canada Clinical Practice Guidelines for randomized controlled trials (RCTs) assessing GDM intervention on maternal and offspring outcomes.</title><p>Green cells indicate high quality; red cells indicate low quality. Yellow cells indicate unclear/unable to assess quality based on information provided.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>Heat map of study quality according to the Diabetes Canada Clinical Practice Guidelines for observational studies assessing offspring anthropometric and cardiometabolic outcomes.</title><p>Green cells indicate high quality; red cells indicate low quality. Yellow cells indicate unclear/unable to assess quality based on information provided.</p></caption></fig>" ]
[]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM5\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM6\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM7\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM8\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM9\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM10\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM11\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM12\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM13\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM14\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>A list of authors and their affiliations appears at the end of the paper.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"43856_2023_427_Fig1_HTML\" id=\"d32e3705\"/>", "<graphic xlink:href=\"43856_2023_427_Fig2_HTML\" id=\"d32e3902\"/>", "<graphic xlink:href=\"43856_2023_427_Fig3_HTML\" id=\"d32e3910\"/>", "<graphic xlink:href=\"43856_2023_427_Fig4_HTML\" id=\"d32e4129\"/>" ]
[ "<media xlink:href=\"43856_2023_427_MOESM1_ESM.pdf\"><caption><p>Peer Review File</p></caption></media>", "<media xlink:href=\"43856_2023_427_MOESM2_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>", "<media xlink:href=\"43856_2023_427_MOESM3_ESM.pdf\"><caption><p>Description of Additional Supplementary Files</p></caption></media>", "<media xlink:href=\"43856_2023_427_MOESM4_ESM.xlsx\"><caption><p>Supplementary Data 1</p></caption></media>", "<media xlink:href=\"43856_2023_427_MOESM5_ESM.xlsx\"><caption><p>Supplementary Data 2</p></caption></media>", "<media xlink:href=\"43856_2023_427_MOESM6_ESM.xlsx\"><caption><p>Supplementary Data 3</p></caption></media>", "<media xlink:href=\"43856_2023_427_MOESM7_ESM.xlsx\"><caption><p>Supplementary Data 4</p></caption></media>", "<media xlink:href=\"43856_2023_427_MOESM8_ESM.xlsx\"><caption><p>Supplementary Data 5</p></caption></media>", "<media xlink:href=\"43856_2023_427_MOESM9_ESM.xlsx\"><caption><p>Supplementary Data 6</p></caption></media>", "<media xlink:href=\"43856_2023_427_MOESM10_ESM.xlsx\"><caption><p>Supplementary Data 7</p></caption></media>", "<media xlink:href=\"43856_2023_427_MOESM11_ESM.xlsx\"><caption><p>Supplementary Data 8</p></caption></media>", "<media xlink:href=\"43856_2023_427_MOESM12_ESM.xlsx\"><caption><p>Supplementary Data 9</p></caption></media>", "<media xlink:href=\"43856_2023_427_MOESM13_ESM.xlsx\"><caption><p>Supplementary Data 10</p></caption></media>", "<media xlink:href=\"43856_2023_427_MOESM14_ESM.pdf\"><caption><p>Reporting Summary</p></caption></media>" ]
[{"label": ["1."], "surname": ["Zhu", "Zhang"], "given-names": ["Y", "C"], "article-title": ["Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective"], "source": ["Curr. Diabetes Rep."], "year": ["2016"], "volume": ["16"], "fpage": ["7"], "pub-id": ["10.1007/s11892-015-0699-x"]}, {"label": ["7."], "surname": ["Leybovitz-Haleluya", "Wainstock", "Landau", "Sheiner"], "given-names": ["N", "T", "D", "E"], "article-title": ["Maternal gestational diabetes mellitus and the risk of subsequent pediatric cardiovascular diseases of the offspring: a population-based cohort study with up to 18 years of follow up"], "source": ["Acta Diabetolog."], "year": ["2018"], "volume": ["55"], "fpage": ["1037"], "lpage": ["1042"], "pub-id": ["10.1007/s00592-018-1176-1"]}, {"label": ["10."], "mixed-citation": ["Tobias D. K., et al. Predictors and risk factors of short-term and long-term outcomes in women with GDM and their offspring. "], "italic": ["PROSPERO: International prospective register of systematic reviews"], "ext-link": ["https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021276094"]}, {"label": ["13."], "surname": ["Eades", "Styles", "Leese", "Cheyne", "Evans"], "given-names": ["CE", "M", "GP", "H", "JM"], "article-title": ["Progression from gestational diabetes to type 2 diabetes in one region of Scotland: an observational follow-up study"], "source": ["BMC Preg. Childbirth"], "year": ["2015"], "volume": ["15"], "fpage": ["11"], "pub-id": ["10.1186/s12884-015-0457-8"]}, {"label": ["15."], "surname": ["Wang"], "given-names": ["Y"], "article-title": ["Racial differences in the association between gestational diabetes mellitus and risk of type 2 diabetes"], "source": ["J Women\u2019s Health (2002)"], "year": ["2012"], "volume": ["21"], "fpage": ["628"], "lpage": ["633"], "pub-id": ["10.1089/jwh.2011.3318"]}, {"label": ["20."], "surname": ["Yuan"], "given-names": ["X"], "article-title": ["Gestational hypertension and chronic hypertension on the risk of diabetes among gestational diabetes women"], "source": ["J. Diabetes Complic."], "year": ["2016"], "volume": ["30"], "fpage": ["1269"], "lpage": ["1274"], "pub-id": ["10.1016/j.jdiacomp.2016.04.025"]}, {"label": ["21."], "surname": ["Li"], "given-names": ["W"], "article-title": ["Nomograms for incident risk of post-partum type 2 diabetes in Chinese women with prior gestational diabetes mellitus"], "source": ["Clin. Endocrinol."], "year": ["2019"], "volume": ["90"], "fpage": ["417"], "lpage": ["424"], "pub-id": ["10.1111/cen.13863"]}, {"label": ["25."], "surname": ["Varner"], "given-names": ["MW"], "article-title": ["Pregnancies after the diagnosis of mild gestational diabetes mellitus and risk of cardiometabolic disorders"], "source": ["Obstetr. Gynecol."], "year": ["2017"], "volume": ["129"], "fpage": ["273"], "lpage": ["280"], "pub-id": ["10.1097/AOG.0000000000001863"]}, {"label": ["45."], "surname": ["Weerasiri", "Riley", "Sheedy", "Walstab", "Wein"], "given-names": ["T", "SF", "MT", "JE", "P"], "article-title": ["Amniotic fluid insulin values in women with gestational diabetes as a predictor of emerging diabetes mellitus"], "source": ["Aust. N.Z. J. Obstetr. Gynaecol."], "year": ["1993"], "volume": ["33"], "fpage": ["358"], "lpage": ["361"], "pub-id": ["10.1111/j.1479-828X.1993.tb02108.x"]}, {"label": ["57."], "surname": ["Zhao"], "given-names": ["YL"], "article-title": ["Maternal gestational diabetes mellitus and overweight and obesity in offspring: a study in Chinese children"], "source": ["J. Dev Origins Health Dis."], "year": ["2015"], "volume": ["6"], "fpage": ["479"], "lpage": ["484"], "pub-id": ["10.1017/S2040174415007205"]}, {"label": ["88."], "surname": ["Nouhjah", "Shahbazian", "Latifi", "Malamiri", "Ghodrati"], "given-names": ["S", "H", "SM", "RA", "N"], "article-title": ["Body mass index growth trajectories from birth through 24 months in Iranian infants of mothers with gestational diabetes mellitus"], "source": ["Diabetes Metab. Syndrome"], "year": ["2019"], "volume": ["13"], "fpage": ["408"], "lpage": ["412"], "pub-id": ["10.1016/j.dsx.2018.10.002"]}, {"label": ["94."], "mixed-citation": ["Willett W. Anthropometric measures and body composition. In: "], "italic": ["Nutritional Epidemiology"]}, {"label": ["95."], "surname": ["Laubach", "Holekamp", "Aris", "Slopen", "Perng"], "given-names": ["ZM", "KE", "IM", "N", "W"], "article-title": ["Applications of conceptual models from lifecourse epidemiology in ecology and evolutionary biology"], "source": ["Biology Lett."], "year": ["2022"], "volume": ["18"], "fpage": ["20220194"], "pub-id": ["10.1098/rsbl.2022.0194"]}]
{ "acronym": [], "definition": [] }
96
CC BY
no
2024-01-14 23:40:16
Commun Med (Lond). 2024 Jan 12; 4:9
oa_package/61/2f/PMC10786838.tar.gz
PMC10786839
38216642
[ "<title>Introduction</title>", "<p id=\"Par2\">Depending on the working principle, spectrometers can be arranged in different types and subtypes. Recently, their possible miniaturization capability has entered as a merit parameter in the choice process<sup>##REF##33509998##1##,##REF##27572631##2##</sup>. Among all the techniques, in the last decades the spectroscopic methodology sometimes referred to as Spatial Heterodyne Spectroscopy (SHS), or Static Fourier Transform Spectroscopy (S-FTS)<sup>##UREF##0##3##–##REF##26832561##8##</sup>, has gathered increasing visibility and interest. The methodology is nowadays well documented<sup>##UREF##3##9##</sup> and we redirect the interested reader to the suggested references for a proper description of the technique. Here is an overview, sufficient to summarize the working principle of this technique: indicating with λ the wavelength of a generic monochromatic component of the analysed light, an interferometer produces a periodic pattern, called interferogram, in which the spatial frequency depends on λ. The central aspect of the SHS technique is the presence in the optical path of dispersive elements that produce a great change in the spatial frequency of the interferogram when λ differs from a particular λ<sub>L</sub> called Littrow wavelength. This variation depends on the difference , and for no interference fringes are produced. This effect explains the use of the term “heterodyne”.</p>", "<p id=\"Par3\">This technique has been used in a wide range of applications<sup>##UREF##4##10##–##UREF##5##15##</sup>.</p>", "<p id=\"Par4\">Traditionally, the most common dispersive elements are reflective diffractive gratings but, in general, every generic retro-dispersive element can be used. In a previous work we have analysed the use of Littrow prisms just to increase the signal to noise ratio<sup>##REF##34154166##16##</sup>. The use of prisms paves the way to a second interesting possibility that is analysed in this work: gluing the prisms to the beam splitter without any spacer or supporting structure, thus realizing in this way a compact and extremely robust assembly without any air gap in the interferometric assembly. Here we report on the optical concept, the realization procedure and laboratory tests made on a demonstrative prototype. The absence of air gaps in the interferometric assembly, hereafter IA, prevents possible contaminations of the internal surfaces of the IA itself and makes it more robust with respect to framed configurations. Moreover, due to the frame-free assembly this device can be easily miniaturized.</p>", "<p id=\"Par5\">The spectral dispersion produced by prisms cannot be as high as the one typical of gratings, nevertheless, the use of compound prisms<sup>##REF##22423145##17##–##REF##22423147##19##</sup> can be a possible way to increase the spectral resolution of this kind of instruments.</p>", "<p id=\"Par6\">To our knowledge, this optical configuration is new and never tested; we consider it of possible great interest in applications where low to medium resolution is required over an extended spectral interval together with the necessity to have a good light throughput. Some examples of similar applications, for astronomical or Raman spectroscopy, are reported in<sup>##UREF##6##20##–##UREF##9##23##</sup>. The mechanical solidity of the IA, the scalability and the simplicity of the optical layout make this optical concept interesting in a wide range of experimental cases. Possible applications benefiting from this technique include the ones related to the space environment, in particular the spectroscopy of planetary atmospheres or the realization of portable instrumentation, but also the realization of instruments for harsh environments.</p>" ]
[]
[]
[ "<title>Conclusions and discussion</title>", "<p id=\"Par25\">In this paper, a monolithic and static Fourier transform spectrometer has been realized and tested. The instrument uses two Littrow’s prisms as retro-dispersive elements, no diffraction gratings are used. The interferometric part is realized gluing the two prisms to the beam splitter. As a result, the interferometer has no hollow volumes inside and all the surfaces between the splitting and recombination of the wavefront in the interferometer are protected. The dispersion of glasses makes the resolution extremely variable across the spectral working range (from 300 to 3000); we show how the degrees of freedom in the optical design can be used to tune the instrument operation and performance. Thanks to the robustness of the IA the realization of the instrument on a fully 3D printed plastic structure has been possible. The absence of hollow parts gives to the IA assembly the same rigidity of a typical cube beam-splitter, making it suitable for harsh environment: as an example those in which vibrations or a high level of dust contamination can be an issue. Moreover, gratings can act as a source of diffuse light, unless expensive gratings are used, while the surfaces of the Littrow’s prisms can be more easily realized with a low roughness.</p>", "<p id=\"Par26\">We consider this optical implementation of interest for specific applications both in the research and industrial fields, especially when medium resolution is required on the VIS–NIR spectral region. Moreover, we think that this work can drive further investigations on open questions such as the field widening techniques and the focusing depth of the fringe localization plane.</p>" ]
[ "<title>Conclusions and discussion</title>", "<p id=\"Par25\">In this paper, a monolithic and static Fourier transform spectrometer has been realized and tested. The instrument uses two Littrow’s prisms as retro-dispersive elements, no diffraction gratings are used. The interferometric part is realized gluing the two prisms to the beam splitter. As a result, the interferometer has no hollow volumes inside and all the surfaces between the splitting and recombination of the wavefront in the interferometer are protected. The dispersion of glasses makes the resolution extremely variable across the spectral working range (from 300 to 3000); we show how the degrees of freedom in the optical design can be used to tune the instrument operation and performance. Thanks to the robustness of the IA the realization of the instrument on a fully 3D printed plastic structure has been possible. The absence of hollow parts gives to the IA assembly the same rigidity of a typical cube beam-splitter, making it suitable for harsh environment: as an example those in which vibrations or a high level of dust contamination can be an issue. Moreover, gratings can act as a source of diffuse light, unless expensive gratings are used, while the surfaces of the Littrow’s prisms can be more easily realized with a low roughness.</p>", "<p id=\"Par26\">We consider this optical implementation of interest for specific applications both in the research and industrial fields, especially when medium resolution is required on the VIS–NIR spectral region. Moreover, we think that this work can drive further investigations on open questions such as the field widening techniques and the focusing depth of the fringe localization plane.</p>" ]
[ "<p id=\"Par1\">Static Fourier transform spectrometers are devices that can be realized as monolithic and compact assemblies. In the “grating-based” monolithic version, they are usually realized gluing together a beam-splitter with two reflective diffraction gratings using spacers as connecting elements. In this work we present the development and test of an alternative form of this kind of instrument in which the dispersive elements are Littrow’s prisms and are glued to the splitting element, forming in this way a robust and filled structure with no air gaps. The device can work in the visible/near infrared spectral region with a resolution power that varies across the spectral range due to the dispersion of the used glasses. The absence of hollow regions inside the monolithic block makes the device extremely robust and protects the optical surfaces inside the interferometer from possible contaminations. The device can be easily miniaturized, as it does not require spacers or structural elements other than just the optical parts. The tested instrument works in the 470–850 nm wavelength range with a variable resolution between 3000 and 300.</p>", "<title>Subject terms</title>" ]
[ "<title>Optical design</title>", "<p id=\"Par7\">This section illustrates the analytical model used to evaluate the angular dispersion of a generic monochromatic component exiting the interferometric assembly. In Fig. ##FIG##0##1##a the coloured region representing the IA is composed of four physical elements named A, B, C and D. A and B constitute the beam splitter and are realized of an appropriate glass GL1. C and D are identical, and realized with a different glass, GL2. The radiation enters the beam-splitter orthogonally to the entering surface and no angular dispersion is introduced at this surface. The beam is separated at the beam splitter surface by a 50–50 non polarizing coating: a half is transmitted into path 1 and the other half reflected into path 2. On the two paths, two Littrow prisms, C and D, are glued to the beam splitter. The mirror coated surface on the two Littrow prisms introduces a mirror symmetry that permits to analyse each path as the equivalent fully transmissive optical system, as the one schematised in Fig. ##FIG##0##1##b. The choice of GL2 is an important degree of freedom that, joined with the choice of the apex angle of the two prisms and the inclination of the exit surfaces of the beam splitter, permits to tune the optical characteristic of the spectrometer.</p>", "<p id=\"Par8\">Indicating with the incidence angle of the radiation at the interface between the elements A–C or equivalently B–D, the apex angle of the Littrow prisms C and D and with the refractive index of the two glasses used for the elements A and B and C and D respectively, the refracted angle can be evaluated as:</p>", "<p id=\"Par9\">As previously mentioned, there is a particular wavelength, called Littrow wavelength and indicated as , for which . For the angle that the radiation, still propagating in the elements A or B, forms with the optical axis is . Exiting the IA, the radiation undergoes another refraction and the propagation angle, measured with respect the optical axis, changes from to following the Snell’s law, Eq. (##FORMU##27##2##).</p>", "<p id=\"Par10\">For a generic wavelength \n is considered positive, and the opposite for a generic wavelength .</p>", "<p id=\"Par11\">Considering a generic wavelength exiting the IA with an angle , the two beams propagating along Path 1 and Path 2 produce at the fringe localization plane, hereafter FLP, spatial fringes with separation between the maxima given by the Eq. (##FORMU##32##3##).</p>", "<p id=\"Par12\">The FLP can be visualized backpropagating two rays exiting the IA and produced by the same incoming ray and looking at the plane where they recombine.</p>", "<p id=\"Par13\">Using as freedom degrees the values of , and , spectrometers working in different spectral regions and with different resolutions can be designed. As an example, in Fig. ##FIG##1##2## the values of and are evaluated using Eqs. (##FORMU##20##1##–##FORMU##32##3##) for five different cases: cases 1 to 4 show the effect of the change in the values of and ; case 5 gives an indication on how the change in the glass used for the prisms C and D changes the dispersion capability of the IA.</p>", "<title>The prototype instrument</title>", "<p id=\"Par14\">With the purpose of realizing and testing a demonstrative instrument we choose to work close to the centre of the visible band by imposing = 550 nm; this permits to easily explore the behaviour of the spectrometer both at higher and lower wavelengths with respect to . Moreover, we planned to test the instrument over the 625–792 nm band (a region where we could evaluate several atmospheric absorption features as references). In order to keep the longest wavelength in the spectrum far from the Nyquist limit (where instrument performance may be affected by aberrations of the imaging system) we have chosen = 31.21° and = 25.11°.</p>", "<p id=\"Par15\">The instrument layout is shown in Fig. ##FIG##2##3##. The light entering the instrument is spectrally limited by the band pass filter, F. L1 is a condenser lens and focalizes the radiation in a circular aperture, I, used to limit the angular acceptance of the spectrometer. L2 is a commercial optical system used to collimate the light before the IA. At the exit port of the IA a second commercial optical system, L3, conjugates the FLP with the detector plane.</p>", "<p id=\"Par16\">The physical realization of the instrument is presented in Fig. ##FIG##3##4##. Figure ##FIG##3##4##a shows the whole instrument and a detail of the IA clamping system. Figure ##FIG##3##4##b illustrates the geometrical dimensions of IA. Surface 1 is the splitting surface and realized on the element A. Surfaces 2 and 3 are aluminum coated. All the optical elements are installed on a 3D printed structure made of sintered PA12. Figure ##FIG##3##4##c is a picture of the bare IA with a ruler as scale element. The main parameters of the instrument are listed in Table ##TAB##0##1##. The mass of the IA is 87 g and the envelope of a rectangular cuboid containing IA is 43 mm × 43 mm × 25 mm.</p>", "<title>Assembling of the interferometer</title>", "<p id=\"Par17\">The gluing procedure of the IA has been carefully evaluated. Several tests intended to verify the most effective gluing sequence have been performed using an index matching liquid (Cargille Immersion Liquid, Code 81520 BK-7 Matching Liquid, Product code: 19586) instead of the glue. Each sequence has been done selectively locking two elements and using the remaining two as compensators for the equalization of the optical path length along the two optical paths and to provide degrees of freedom to align the interference pattern orthogonally to the dispersion plane. Figure ##FIG##4##5##a shows the scheme of the IA with the indication of the alignment points and the movements used in the alignment procedure, Fig. ##FIG##4##5##b the IA on the alignment platform.</p>", "<p id=\"Par18\">An almost optimal alignment is reachable, as illustrated in Fig. ##FIG##5##6## where an example of a nearly optimally aligned interferogram, acquired during these tests with the matching liquid, is presented.</p>", "<p id=\"Par19\">The adopted procedure is finally described here. The two BK7 elements, A and B in Fig. ##FIG##4##5##a, are initially glued aligning the edges E1 with E2 and E3 with E4. This alignment is purely visual, no optical references are monitored in this phase. Subsequently, the two prisms C and D are joined to the assembly. These two optical elements can be translated along the directions indicated with a red arrow in Fig. ##FIG##4##5##a. These translations are used to equalize the optical path along Path 1 and Path 2. Having two translations to act on, this equalization can be tuned to centre the interferogram of a broad band test source in the middle of the field of view. The edge originated in E3–E4, when part A and B are glued together, only permits movements in one direction. Rotations around the axes c and d in Fig. ##FIG##3##4##a are realized using shims, see Fig. ##FIG##3##4##b, and are used to align the interference fringes pattern orthogonally to the dispersion plane.</p>", "<p id=\"Par20\">The index matching liquid used for tests was then carefully removed with acetone before the final gluing, which was then done in a permanent way.</p>", "<p id=\"Par21\">The used glue is the Optical Adhesive 61, NOA61, from Norland Products Inc., and is cured by using a UV diode lamp (365 nm) after a final interferometric check of the alignment.</p>", "<p id=\"Par22\">The final alignment is not optimal as the one shown in Fig. ##FIG##5##6## but is acceptable and has produced the results presented in the next paragraph.</p>", "<title>Spectral calibration</title>", "<p id=\"Par23\">The instrument has been calibrated using a monochromator as an illumination system. While varying the wavelength across (and beyond) the working spectral region, various interferograms have been acquired and the corresponding spectra have been reconstructed. Figure ##FIG##6##7##a illustrates the variation of the fringe separation at the FLP (calculated considering the magnification factor of L3) for a generic monochromatic component. The black dots and the empty red circles represent the values calculated from the analytical model and those calculated from experimental acquisitions respectively. The horizontal blue line, set at 12 µm, is used to identify the Nyquist limit corresponding to two sample intervals. The vertical green lines show the spectral region investigated later in the article. It is interesting to observe that at 930 nm there is a minimum in the variation law of Δ: for wavelength larger than 930 nm the term dominating in the fraction of Eq. ##FORMU##32##3## is the numerator, and the curve becomes increasing. Figure ##FIG##6##7##b presents the calibration fit of the instrument in the range 600–850 nm.</p>", "<title>Experimental verification</title>", "<p id=\"Par24\">In order to test the instrument with a diffuse, extended and broad band source, we have acquired the diffuse skylight during a mostly sunny day and compared the results with a spectrum obtained soon after using a commercial spectrometer (Admesy Hera), while pointing at the same sky region. This comparison is only qualitative due to the source variability originated both from the clouds movements and from the pointing error between the two instruments. Moreover, we expect a change in the instrumental response associated with a variation in the FLP distance (as a function of wavelength) that L3 focuses on the detector plane. As we focus the imaging optics on a particular FLP distance, we obtain a spectral response peaking at that corresponding wavelength. The circular aperture was set to 3 mm as this setting showed no noticeable degradation of the spectral resolution. These phenomena are not discussed in this work and need further investigations. To avoid the aliasing effect, we have installed an interferential bandpass filter in front of both the spectrometers. This filter (Semrock 709 167) limits the spectral band of the analysed radiation to the interval 625–792 nm: this is the spectral region illustrated in Fig. ##FIG##6##7##a with the two vertical green lines. Compared to the best obtained result of Fig. ##FIG##5##6##, in Fig. ##FIG##7##8## the fringes of the interferogram are slightly tilted. This effect does not cause an appreciable degradation in the performance of the instrument.</p>" ]
[ "<title>Acknowledgements</title>", "<p>This work has been supported by the Italian Space Agency ASI—Agenzia Spaziale Italiana-Agreement No. 2019-33-HH.0 and subsequent addendum No. 2019-33-HH.1-2021.</p>", "<title>Author contributions</title>", "<p>F.F., L.C.: conceptualization, optical design and realization, laboratory tests, data analysis and interpretation, writing and review of the original draft. P.Z., V.D.D.: major intellectual discussion, review of the original draft. L.P.: major intellectual discussion, data analysis and interpretation, review of the original draft.</p>", "<title>Data availability</title>", "<p>The datasets used and analysed during the current study are available from the corresponding author upon reasonable request.</p>", "<title>Competing interests</title>", "<p id=\"Par27\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>(<bold>a</bold>) Geometrical model of the interferometric assembly with the indications of its main characteristics. The green arrow represents the exiting direction for the Littrow wavelength, that is parallel to the optical axis. The arrows indicate the emerging directions of a generic wavelength . (<bold>b</bold>) Equivalent fully transmissive model of each of the two paths of the interferometric assembly.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Effect of the variation of , and on the working spectral range and dispersion. (1) is the configuration realized and analysed in this work. In (2) and (3) one of the two parameters , is varied. In (4) , are varied with the purpose of keeping constant. (5) shows the effect of changing the glass GL2, SF57, with SF19 while , are tuned in order to maintain unaltered . (<bold>a</bold>) in the five considered cases in the 450–550 nm spectral region. (<bold>b</bold>) evaluated at the FLP for the five different considered cases in the 450–850 nm spectral region.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Layout of the realized instrument. F, band pass filter; L1, condensing lens; I, circular aperture; L2, collimator; L3, imaging system. Apparent FLP indicated location is the position as seen by the imaging system in an average focusing condition.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>The instrument as realized for the tests. (<bold>a</bold>) Image of the spectrometer. All the optical elements are installed on the 3D printed frame. The name convention is the same as in Fig. ##FIG##2##3##. The insight shows a different view of the IA and its clamping system. (<bold>b</bold>) Geometrical dimensions of the IA. (<bold>c</bold>) Detail of the interferometric assembly.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>IA alignment tests. (<bold>a</bold>) Alignment points (green circles) and movements used as freedom degrees for the remaining parts C and D. (<bold>b</bold>) The IA on the alignment mount: the black lines are used to highlight the glass structure. In blue the metallic structure used to link two parts, in this particular case the parts A and B. The red arrow indicates the shim. The screws on top are used to maintain in place the optical group.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Interferogram corresponding to an almost optimal alignment. (<bold>a</bold>) The full interferogram, the bubbles are due to air inclusions in the oil. (<bold>b</bold>) Zoom in the region 800–1000 pixels.</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>Spectral calibration of the spectrometer. (<bold>a</bold>) Fringe separation at the FLP for a monochromatic component. Empty red circles are from measured data, black dots represent values obtained from the analytical model. The discrepancy between measured and simulated values that appears at wavelengths smaller than 470 nm is due to aliasing. The horizontal blue line, positioned at 12 µm, indicates the two pixels limit. The secondary plot shows a zoom into the region 800–1100 nm, where a minimum for the curve appears at about 930 nm. The spectral interval delimited with two vertical green lines is the working spectral region used in the final part of the paper. (<bold>b</bold>) Calibration plot: in abscissa the pixel coordinate in the Fourier domain, in ordinate the corresponding wavelength. The equation on top is a polynomial fit having the indicated coefficient of determination.</p></caption></fig>", "<fig id=\"Fig8\"><label>Figure 8</label><caption><p>Spectrum of the diffuse skylight. (<bold>a</bold>) The acquired interferogram. For clarity of representation, the image is 1200 pixels high and 400 pixels wide. (<bold>b</bold>) Comparison between measurements: the red curve is the spectrum acquired with the reference spectrometer, the blue one is the spectrum originated with the spectrometer under test and originated from the interferogram on the (<bold>a</bold>) panel. All the spectra have been acquired using an interferential filter in front of the spectrometers limiting the wavelength range to the 625–792 nm interval.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>List of the main characteristics of the spectrometer.</p></caption><table frame=\"hsides\" rules=\"groups\"><tbody><tr><td align=\"left\">L1</td><td align=\"left\">Diameter 25 mm, focal length 75 mm</td></tr><tr><td align=\"left\">L2</td><td align=\"left\">Navitar F2.8/50 mm</td></tr><tr><td align=\"left\">L3</td><td align=\"left\">Navitar F2/35 mm</td></tr><tr><td align=\"left\">I</td><td align=\"left\">Variable diameter 0.5–3 mm</td></tr><tr><td align=\"left\">Detector</td><td align=\"left\">Basler aca 1920–40 um, 1920 px × 1200 px, 5.86 µm × 5.86 µm, mono, CMOS</td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda -{\\lambda }_{L}$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mrow><mml:mi>λ</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda ={\\lambda }_{L}$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mrow><mml:mi>λ</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq28\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda \\ne \\lambda }_{L}$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:msub><mml:mrow><mml:mi>λ</mml:mi><mml:mo>≠</mml:mo><mml:mi>λ</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq29\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\vartheta }^{I}$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:msup><mml:mrow><mml:mi>ϑ</mml:mi></mml:mrow><mml:mi>I</mml:mi></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq30\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mi>α</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq31\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${n}_{\\mathrm{1,2}}\\left(\\lambda \\right)$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq32\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\vartheta }^{I}$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:msup><mml:mrow><mml:mi>ϑ</mml:mi></mml:mrow><mml:mi>I</mml:mi></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq33\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mi>α</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq34\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\vartheta }^{I}$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:msup><mml:mrow><mml:mi>ϑ</mml:mi></mml:mrow><mml:mi>I</mml:mi></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq35\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha$$\\end{document}</tex-math><mml:math id=\"M20\"><mml:mi>α</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq36\"><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{L}$$\\end{document}</tex-math><mml:math id=\"M22\"><mml:msub><mml:mi>λ</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq37\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\vartheta }^{I}$$\\end{document}</tex-math><mml:math id=\"M24\"><mml:msup><mml:mrow><mml:mi>ϑ</mml:mi></mml:mrow><mml:mi>I</mml:mi></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq38\"><alternatives><tex-math id=\"M25\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha$$\\end{document}</tex-math><mml:math id=\"M26\"><mml:mi>α</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq39\"><alternatives><tex-math id=\"M27\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{L}$$\\end{document}</tex-math><mml:math id=\"M28\"><mml:msub><mml:mi>λ</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq40\"><alternatives><tex-math id=\"M29\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\delta \\left(\\lambda \\right)$$\\end{document}</tex-math><mml:math id=\"M30\"><mml:mrow><mml:mi>δ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq41\"><alternatives><tex-math id=\"M31\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta \\left(\\lambda \\right)$$\\end{document}</tex-math><mml:math id=\"M32\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M33\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\vartheta }^{I}$$\\end{document}</tex-math><mml:math id=\"M34\"><mml:msup><mml:mrow><mml:mi>ϑ</mml:mi></mml:mrow><mml:mi>I</mml:mi></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M35\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha$$\\end{document}</tex-math><mml:math id=\"M36\"><mml:mi>α</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M37\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${n}_{\\mathrm{1,2}}\\left(\\lambda \\right)$$\\end{document}</tex-math><mml:math id=\"M38\"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M39\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\vartheta }^{O}\\left(\\lambda \\right)$$\\end{document}</tex-math><mml:math id=\"M40\"><mml:mrow><mml:msup><mml:mrow><mml:mi>ϑ</mml:mi></mml:mrow><mml:mi>O</mml:mi></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M41\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\vartheta }^{O}\\left(\\lambda \\right)={{\\text{sin}}}^{-1}\\left(\\frac{{n}_{2}\\left(\\lambda \\right)}{{n}_{1}\\left(\\lambda \\right)}{\\text{sin}}\\left(2\\alpha -{{\\text{sin}}}^{-1}\\left(\\frac{{n}_{1}\\left(\\lambda \\right)}{{n}_{2}\\left(\\lambda \\right)}{\\text{sin}}\\left({\\vartheta }^{I}\\right)\\right)\\right)\\right).$$\\end{document}</tex-math><mml:math id=\"M42\" display=\"block\"><mml:mrow><mml:msup><mml:mrow><mml:mi>ϑ</mml:mi></mml:mrow><mml:mi>O</mml:mi></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mtext>sin</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow></mml:mfrac><mml:mtext>sin</mml:mtext><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn><mml:mi>α</mml:mi><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mtext>sin</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow></mml:mfrac><mml:mtext>sin</mml:mtext><mml:mfenced close=\")\" open=\"(\"><mml:msup><mml:mrow><mml:mi>ϑ</mml:mi></mml:mrow><mml:mi>I</mml:mi></mml:msup></mml:mfenced></mml:mfenced></mml:mfenced></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M43\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{L}$$\\end{document}</tex-math><mml:math id=\"M44\"><mml:msub><mml:mi>λ</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M45\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\vartheta }^{I}={\\vartheta }^{O}\\left(\\lambda \\right)$$\\end{document}</tex-math><mml:math id=\"M46\"><mml:mrow><mml:msup><mml:mrow><mml:mi>ϑ</mml:mi></mml:mrow><mml:mi>I</mml:mi></mml:msup><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>ϑ</mml:mi></mml:mrow><mml:mi>O</mml:mi></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M47\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda \\ne \\lambda }_{L}$$\\end{document}</tex-math><mml:math id=\"M48\"><mml:msub><mml:mrow><mml:mi>λ</mml:mi><mml:mo>≠</mml:mo><mml:mi>λ</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M49\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma \\left(\\lambda \\right)={\\vartheta }^{I}-{\\vartheta }^{O}\\left(\\lambda \\right)$$\\end{document}</tex-math><mml:math id=\"M50\"><mml:mrow><mml:mi>γ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>ϑ</mml:mi></mml:mrow><mml:mi>I</mml:mi></mml:msup><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mi>ϑ</mml:mi></mml:mrow><mml:mi>O</mml:mi></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M51\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma \\left(\\lambda \\right)$$\\end{document}</tex-math><mml:math id=\"M52\"><mml:mrow><mml:mi>γ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq12\"><alternatives><tex-math id=\"M53\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\delta \\left(\\lambda \\right)$$\\end{document}</tex-math><mml:math id=\"M54\"><mml:mrow><mml:mi>δ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M55\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\delta \\left(\\lambda \\right)={{\\text{sin}}}^{-1}\\left({n}_{1}\\left(\\lambda \\right){\\text{sin}}\\left(\\gamma \\left(\\lambda \\right)\\right)\\right)$$\\end{document}</tex-math><mml:math id=\"M56\" display=\"block\"><mml:mrow><mml:mi>δ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mtext>sin</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>n</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced><mml:mtext>sin</mml:mtext><mml:mfenced close=\")\" open=\"(\"><mml:mi>γ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mfenced></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq13\"><alternatives><tex-math id=\"M57\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\lambda }_{R}&gt;\\lambda }_{L}$$\\end{document}</tex-math><mml:math id=\"M58\"><mml:msub><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mi>R</mml:mi></mml:msub><mml:mo>&gt;</mml:mo><mml:mi>λ</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq14\"><alternatives><tex-math id=\"M59\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\delta \\left({\\lambda }_{R}\\right)$$\\end{document}</tex-math><mml:math id=\"M60\"><mml:mrow><mml:mi>δ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>λ</mml:mi><mml:mi>R</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq15\"><alternatives><tex-math id=\"M61\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\lambda }_{B}&lt;\\lambda }_{L}$$\\end{document}</tex-math><mml:math id=\"M62\"><mml:msub><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mi>B</mml:mi></mml:msub><mml:mo>&lt;</mml:mo><mml:mi>λ</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq16\"><alternatives><tex-math id=\"M63\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\delta \\left(\\lambda \\right)$$\\end{document}</tex-math><mml:math id=\"M64\"><mml:mrow><mml:mi>δ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M65\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta \\left(\\lambda \\right)=\\frac{\\lambda }{2{\\text{sin}}\\left(\\delta \\left(\\lambda \\right)\\right)}$$\\end{document}</tex-math><mml:math id=\"M66\" display=\"block\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mi>λ</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mtext>sin</mml:mtext><mml:mfenced close=\")\" open=\"(\"><mml:mi>δ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq17\"><alternatives><tex-math id=\"M67\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\vartheta }^{I}$$\\end{document}</tex-math><mml:math id=\"M68\"><mml:msup><mml:mrow><mml:mi>ϑ</mml:mi></mml:mrow><mml:mi>I</mml:mi></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq18\"><alternatives><tex-math id=\"M69\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha$$\\end{document}</tex-math><mml:math id=\"M70\"><mml:mi>α</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq19\"><alternatives><tex-math id=\"M71\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${n}_{\\mathrm{1,2}}\\left(\\lambda \\right)$$\\end{document}</tex-math><mml:math id=\"M72\"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq20\"><alternatives><tex-math id=\"M73\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\delta \\left(\\lambda \\right)$$\\end{document}</tex-math><mml:math id=\"M74\"><mml:mrow><mml:mi>δ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq21\"><alternatives><tex-math id=\"M75\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta \\left(\\lambda \\right)$$\\end{document}</tex-math><mml:math id=\"M76\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>λ</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq22\"><alternatives><tex-math id=\"M77\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\vartheta }^{I}$$\\end{document}</tex-math><mml:math id=\"M78\"><mml:msup><mml:mrow><mml:mi>ϑ</mml:mi></mml:mrow><mml:mi>I</mml:mi></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq23\"><alternatives><tex-math id=\"M79\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha$$\\end{document}</tex-math><mml:math id=\"M80\"><mml:mi>α</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq24\"><alternatives><tex-math id=\"M81\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{L}$$\\end{document}</tex-math><mml:math id=\"M82\"><mml:msub><mml:mi>λ</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq25\"><alternatives><tex-math id=\"M83\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{L}$$\\end{document}</tex-math><mml:math id=\"M84\"><mml:msub><mml:mi>λ</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq26\"><alternatives><tex-math id=\"M85\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\vartheta }^{I}$$\\end{document}</tex-math><mml:math id=\"M86\"><mml:msup><mml:mrow><mml:mi>ϑ</mml:mi></mml:mrow><mml:mi>I</mml:mi></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq27\"><alternatives><tex-math id=\"M87\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha$$\\end{document}</tex-math><mml:math id=\"M88\"><mml:mi>α</mml:mi></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Fabio Frassetto and Lorenzo Cocola.</p></fn></fn-group>" ]
[ "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq28.gif\"/>", "<graphic xlink:href=\"41598_2023_51008_Fig1_HTML\" id=\"MO1\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq29.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq30.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq31.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq32.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq33.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq34.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq35.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq36.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq37.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq38.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq39.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq40.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq41.gif\"/>", "<graphic xlink:href=\"41598_2023_51008_Fig2_HTML\" id=\"MO8\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq6.gif\"/>", "<graphic xlink:href=\"41598_2023_51008_Article_Equ1.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq9.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq10.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq11.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq12.gif\"/>", "<graphic xlink:href=\"41598_2023_51008_Article_Equ2.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq13.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq14.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq15.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq16.gif\"/>", "<graphic xlink:href=\"41598_2023_51008_Article_Equ3.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq17.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq18.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq19.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq20.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq21.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq22.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq23.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq24.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq25.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq26.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51008_Article_IEq27.gif\"/>", "<graphic xlink:href=\"41598_2023_51008_Fig3_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2023_51008_Fig4_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2023_51008_Fig5_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2023_51008_Fig6_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2023_51008_Fig7_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"41598_2023_51008_Fig8_HTML\" id=\"MO7\"/>" ]
[]
[{"label": ["3."], "mixed-citation": ["Harlander, J. M. Spatial heterodyne spectroscopy: Interferometric performance at any wavelength without scanning. Thesis (Ph.D.) University of Wisconsin, Madison, "], "ext-link": ["https://ui.adsabs.harvard.edu/abs/1991PhDT........62H"]}, {"label": ["6."], "mixed-citation": ["Englert, C. R., Harlander, J. M., Harding, B. J. & Marr, K. D. Low-signal phase shift: Characterizing an unexpected detector deterioration of the ICON/MIGHTI instrument. In "], "italic": ["Optica Sensing Congress 2023 (AIS, FTS, HISE, Sensors, ES), Technical Digest Series"]}, {"label": ["7."], "surname": ["Kaufmann"], "given-names": ["M"], "article-title": ["A highly miniaturized satellite payload based on a spatial heterodyne spectrometer for atmospheric temperature measurements in the mesosphere and lower thermosphere"], "source": ["Atmos. Meas. Tech."], "year": ["2018"], "volume": ["11"], "fpage": ["3861"], "lpage": ["3870"], "pub-id": ["10.5194/amt-11-3861-2018"]}, {"label": ["9."], "surname": ["Zhang"], "given-names": ["W-L"], "article-title": ["Research status of spatial Heterodyne spectroscopy - A review"], "source": ["Microchem. J."], "year": ["2021"], "volume": ["166"], "fpage": ["106228"], "pub-id": ["10.1016/j.microc.2021.106228"]}, {"label": ["10."], "surname": ["Yi", "Zhang", "Liu", "Zhang", "Yi"], "given-names": ["Y", "S", "F", "Y", "F"], "article-title": ["Laboratory fabrication of monolithic interferometers for one and two-dimensional spatial heterodyne spectrometers"], "source": ["Opt. Express"], "year": ["2017"], "volume": ["25"], "fpage": ["29121"], "lpage": ["29134"], "pub-id": ["10.1364/OE.25.029121"]}, {"label": ["15."], "surname": ["Kaufmann"], "given-names": ["M"], "article-title": ["On the assembly and calibration of a spatial heterodyne interferometer for limb sounding of the middle atmosphere"], "source": ["CEAS Space J."], "year": ["2019"], "volume": ["11"], "fpage": ["525"], "lpage": ["531"], "pub-id": ["10.1007/s12567-019-00262-y"]}, {"label": ["20."], "surname": ["Ammler-von Eiff", "Sebastian", "Guenther", "Stecklum", "Cabrera"], "given-names": ["M", "D", "EW", "B", "J"], "article-title": ["The power of low-resolution spectroscopy: On the spectral classification of planet candidates in the ground-based CoRoT follow-up"], "source": ["Astron. Nachr."], "year": ["2015"], "volume": ["336"], "fpage": ["134"], "lpage": ["144"], "pub-id": ["10.1002/asna.201412153"]}, {"label": ["21."], "surname": ["Boonsit", "Kalasuwan", "van Dommelen", "Daengngam"], "given-names": ["S", "P", "P", "C"], "article-title": ["Rapid material identification via low-resolution Raman spectroscopy and deep convolutional neural network"], "source": ["J. Phys: Conf. Ser."], "year": ["2021"], "volume": ["1719"], "fpage": ["012081"], "pub-id": ["10.1088/1742-6596/1719/1/012081"]}, {"label": ["22."], "surname": ["Oke"], "given-names": ["JB"], "article-title": ["The keck low-resolution imaging spectrometer"], "source": ["PASP"], "year": ["1995"], "volume": ["107"], "issue": ["710"], "fpage": ["375"], "pub-id": ["10.1086/133562"]}, {"label": ["23."], "surname": ["Zemcov"], "given-names": ["M"], "article-title": ["The cosmic infrared background experiment (CIBER): A sounding rocket payload to study the near infrared extragalactic background light"], "source": ["ApJS"], "year": ["2013"], "volume": ["207"], "issue": ["2"], "fpage": ["31"], "pub-id": ["10.1088/0067-0049/207/2/31"]}]
{ "acronym": [], "definition": [] }
23
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1164
oa_package/b9/9a/PMC10786839.tar.gz
PMC10786840
38216637
[ "<title>Introduction</title>", "<p id=\"Par17\">Long-term unloading of the cardiovascular system in microgravity environments causes cardiovascular deconditioning. Orthostatic intolerance (OI) due to impaired blood pressure (BP) regulation is a known health risk when returning from spaceflight, having been first described in the early 1960s when the pilot of the Mercury-Atlas 9 could not complete a head-up tilt test after only 34-h of flight<sup>##UREF##0##1##</sup>. Meck and colleagues provided the first data on greater incidence of OI after long-duration spaceflights<sup>##REF##11719623##2##</sup>, and Lee et al. summarized data from 85 Shuttle and ISS astronauts who completed lower body negative pressure (LBNP), tilt or stand tests at different times after return to Earth<sup>##REF##26630196##3##</sup>. They reported that on the day of landing the majority (52 of 56) of Shuttle astronauts could complete the orthostatic test, compared to only 2 of 6 astronauts following missions on the ISS (data not differentiated by sex). Additional data from the same study also suggested slower postflight recovery after long-duration flights. Two of 8 male astronauts developed orthostatic hypotension during a 3-min stand test completed 18–36-h after 6-month missions on the ISS<sup>##REF##31633009##4##</sup>. NASA now considers postflight OI an acceptable risk of spaceflight<sup>##UREF##1##5##</sup>, as research-led development of techniques including on-orbit exercises, return-associated oral and intravenous saline, and compression garments, assist in BP regulation<sup>##REF##4062772##6##,##REF##33664672##7##</sup>.</p>", "<p id=\"Par18\">Certain astronauts appear be at greater risk of OI, possibly due to individualized physiological adaptations to microgravity and subsequent return to upright posture on Earth. Altered baroreflex control following spaceflight could contribute to reduced orthostatic tolerance immediately following landing. Following short-duration Shuttle flights, astronauts with poor orthostatic tolerance had impaired vagally-mediated cardiac baroreflexes<sup>##REF##1399995##8##</sup>, lower levels of sympathetic activation and peripheral vasoconstriction<sup>##REF##8828642##9##,##REF##11796668##10##</sup> and, in women, greater reduction in blood volume<sup>##REF##11796668##10##</sup>. Analyzing responses to postflight tilt across short-duration and long-duration missions, an index derived from diastolic BP and stroke volume predicted OI<sup>##REF##26630196##3##</sup>. Factors during spaceflight that might contribute to OI are complex and interactive. In addition to gravitational unloading, overall levels of physical activity are reduced despite exercise countermeasures<sup>##REF##22764612##11##–##REF##19150852##13##</sup>.</p>", "<p id=\"Par19\">Changes to central vein compliance in returning astronauts may also exacerbate orthostatic intolerance<sup>##REF##2007392##14##</sup>. In the absence of head-to-foot gravity vector, fluid shifts increase cross-sectional area of the jugular and femoral vein by 40% compared to preflight supine posture<sup>##REF##11822475##15##</sup>. Persistent venous dilation in a rat model may ‘reset’ venous wall tone<sup>##UREF##2##16##</sup> with increased tangential wall stress and sympathetic innervation, leading to decreased distensibility at lower intraluminal pressures with dampened myocyte contractility, potentially affecting cardiopulmonary baroreflex sensitivity via alteration of venous return to the heart. These relationships have never been assessed following spaceflight.</p>", "<p id=\"Par20\">Rapid cardiovascular deconditioning increases the incidence of orthostatic intolerance with only hours of exposure to head-down bed rest<sup>##REF##2007392##14##</sup> and recovery quickly follows return to upright posture<sup>##REF##15501923##17##</sup>. Astronauts who had impaired baroreflex responses during 9–10-day space missions did not exhibit baroreflex impairment when tested on landing day following Shuttle missions<sup>##REF##20156846##18##</sup> but were upright and walking for several hours before testing. There was no indication if these astronauts exhibited any symptoms of OI following flight. To better understand potential changes to cardiovascular control to orthostatic challenge we took advantage of long-duration astronauts landing in a supine position on the Shuttle then being transported to the laboratory in a supine position with minimal exposure to head-to-foot gravity vector as they transitioned to the crew transport vehicle. For Soyuz landed astronauts, they were upright during transport back to crew quarters but then spent the night in bed and were collected from their bed and carried to the laboratory in supine position before testing. We hypothesized that baroreflex control following spaceflight would be altered, with enhancement of cardiopulmonary and attenuation of arterial baroreflex responses during LBNP in the hours following landing. We limited post-flight stimuli to normal head-up position that might provoke blood volume and vascular regulatory adaptations in order to better test this hypothesis. Following on previous findings of attenuated flow reduction in the splanchnic and femoral veins during LBNP post bed rest that were associated with OI<sup>##REF##18757480##19##</sup>, we hypothesized that reductions to portal vein diameters during LBNP would be attenuated post-flight.</p>" ]
[ "<title>Methods</title>", "<title>Participants</title>", "<p id=\"Par21\">Seven ISS astronauts (1 female, 47 ± 4 years of age, mean mission length: 146 ± 43 days) were recruited following informed consent procedures approved by the University of Waterloo Office of Research Ethics (ORE#11763), European Space Agency Medical Review Board, Japanese Space Agency Medical Review Board, NASA Human Research Medical Review Board and Johnson Space Center Institutional Review Board (previously known as Committee for the Protection of Human Subjects) (NASA7116301606HR), in accordance with the Declaration of Helsinki. All participants signed an informed consent form before participating and were made aware that they could withdraw from the study at any time.</p>", "<p id=\"Par22\">Testing was performed at either the Johnson Space Center (Houston, TX), Kennedy Space Center (Cape Canaveral, FL), Dryden Flight Research Center (Edwards, CA), or Gagarin Cosmonaut Training Center (Star City, Russia) depending on mission parameters. Preflight data were collected approximately 30-days before launch. Four of the astronauts launched aboard the space Shuttle, and three launched on the Soyuz. All astronauts fluid-loaded immediately prior to landing, some wore lower body compression garments during return to Earth<sup>##REF##25946732##20##,##UREF##3##21##</sup> that were removed prior to testing. Shuttle-landed astronauts returned to Earth in a supine position with only very brief periods of head-up posture during transition to a gurney on the crew transport vehicle. They were delivered to the research laboratory and moved to the experiment bed whilst remaining supine. Astronauts who returned to Earth on Soyuz were transported to Star City with upright posture and walking; testing for one astronaut was delayed by 24 h due to weather. After their first overnight sleep, the experiment team transported the astronauts to the laboratory in a supine position to avoid upright posture on the day of experimentation. The time between landing and testing in Shuttle participants was 3 h and 30 min ± 22 min. The time between landing and testing in Soyuz participants was 25 h and 25 min and 28 h 25 min for two Soyuz astronauts while the other was 49 h and 33 min (Table ##TAB##0##1##).</p>", "<title>Experimental protocol</title>", "<p id=\"Par23\">Physiological data were collected during Constant and Random LBNP protocols. The Constant Protocol was always performed first, following supine instrumentation and 5-min of baseline data collection. The Constant Protocol consisted of four periods each nominally lasting 2-min including time for ultrasound imaging: Baseline, − 10 mmHg LBNP, − 20 mmHg LBNP, and Recovery. Following this, another rest period preceded the Random Protocol, which itself consisted of a sequence of LBNP steps as shown in Fig. ##FIG##0##1##, reaching a maximum negative pressure of − 30 mmHg. At these levels of LBNP, estimated redistribution of blood volume to the extremities would be approximately 400–500 ml<sup>##REF##15016789##22##</sup>. The Random Protocol was required for analysis with our chosen Auto Regressive Moving Average investigative technique.</p>", "<title>Equipment</title>", "<p id=\"Par24\">Physiological variables were recorded at 1000 Hz through a PowerLab system (ADInstruments, Australia). For those astronauts landing in Russia, finger pressure was recorded with a Finapres device (Finapres Medical, Netherlands), with subsequent modelling of continual cardiac output () values via Beatscope software (Finapres Medical, Netherlands). When calculated, stroke volume (SV) was obtained by dividing (l/min) by heart rate (HR). For all other astronauts, finger pressure was recorded alongside modelled cardiac output (Finometer, Finapres Medical, Netherlands). HR was calculated from the electrocardiogram (Model 7830A, Hewlett-Packard, USA). Central venous pressure (CVP) was estimated from the dependent arm technique via a pressure transducer (TransStar 60″ Single Monitoring Kit, Smith Medical ASD, Inc., USA) attached to a saline-flushed 21G cannula placed in the right antecubital fossa<sup>##REF##13277113##23##</sup>. Astronauts were positioned with a custom foam wedge into a right tilt to maintain a continuous column of blood from the catheter to the right atrium, and the position of the pressure transducer was established by a laser level at the right atrium referenced to the anterior axillary line. LBNP was achieved using a custom-built LBNP box that allowed foot support, with pressure monitored via a pressure transducer (ADInstruments, Australia). We calculated total peripheral resistance (TPR) from mean arterial pressure (MAP), CVP and from the equation:</p>", "<p id=\"Par25\">Measurements of the diameters of the Inferior Vena Cava (IVC ø) and Portal Vein (PV ø) were performed on images obtained via standard ultrasound techniques using either a Sonosite (Sonosite, USA) or Logiq Book (GE Healthcare, USA) ultrasound device. Images of both the IVC and PV were obtained at 0 mmHg, − 10 mmHg and − 20 mmHg LBNP during the first three LBNP step-changes of the Constant Protocol. Ultrasound landmarks in the proximity of the IVC and PV were confirmed during the preflight collections and were visualized at postflight collections to ensure the measurement of vein diameters at the same location. Astronauts were instructed to calmly hold their breath at normal inspiration without performing a Valsalva during acquisitions to reduce the impact of respiratory cycle on venous dimensions. No ultrasound measurements were taken during the Random Protocol.</p>", "<title>Data analysis</title>", "<p id=\"Par26\">We obtained beat-by-beat values for RR interval, SBP, DBP, MAP, and respiration rate. CVP was recorded as the mean of values obtained between each heartbeat. For datasets without Finometer-recorded , Finapres finger waveforms were calibrated to simultaneous manual sphygmomanometer measurements performed by a trained researcher, down sampled to 100 Hz and processed with Beatscope software (Finapres Medical Systems, Netherlands) to produce modelled brachial blood pressures and cardiac output, then time-synced to data obtained for all other variables. Beat-by-beat data were interpolated to achieve equally spaced 1-s sampling for all variables prior to further analyses. Venous diameters were taken from a mean of 3 cross-sectional acquisitions perpendicular to each vessel, acquired during a relaxed breath hold with the interpreter blinded to participant and/or the timing of the acquired images.</p>", "<p id=\"Par27\">Baseline data are reported as mean values of the last 30 s of an initial baseline data collection period prior to commencing LBNP (Table ##TAB##1##2##). For steady-state analyses, we averaged measurements of all variables over the last 30 s of each LBNP step, allowing for identification of cardiovascular responses to differing LBNP intensities. Vein diameter/CVP relationships were derived from vein diameter (mm) and CVP (cmH<sub>2</sub>O) measurements recorded simultaneously during the baseline, − 10 mmHg and − 20 mmHg LBNP steps of the Constant Protocol.</p>", "<p id=\"Par28\">Spectral analyses were performed on interpolated Random LBNP protocol data. We saw consistent patterns of power identified with discrete Fourier transform, with the greatest power at the sixth harmonic of both input signals (LBNP and CVP). Subsequent reconstitution of transformed signals, with differing numbers of harmonic frequencies, were then compared to original signals following calculation of mean square errors. After consideration of mean square error, absolute gains and spectral patterns, it was concluded that the first 9 harmonics would allow accurate analyses of changes in the LBNP, CVP and TPR signals, a methodology for signal analysis validation previously described by Hughson et al.<sup>##REF##2318786##24##</sup>. In addition to spectral analyses, autoregressive moving average (ARMA) investigations were also performed on Random protocol data. ARMA represents a linear time-invariant system, allowing for analysis of multiple input variables for a single output signal<sup>##REF##8567000##25##,##UREF##4##26##</sup>. For these experiments, two sets of input and output signals were analysed to further quantify the cardiovascular responses to LBNP (Input: CVP and DBP, Output: TPR; or Input CVP and SBP, Output HR). Computation was performed using custom written ARMA Matlab software<sup>##UREF##4##26##</sup>. From the resulting step-changes (the modelled change in output signal for a sustained change of 1 unit Input signal), values for the plateau, and time taken to reach 95% of the plateau, were calculated and compared. All signal interpolation, spectral, and ARMA analyses were performed using Matlab software (MathWorks, USA). Due to poor CVP signal quality during the random LBNP protocol for two participants, we were only able to use data from five of the seven participants for spectral and ARMA analyses.</p>", "<title>Statistics</title>", "<p id=\"Par29\">Differences in baseline preflight and postflight CVP, TPR, HR and were investigated with paired t-tests. Two-way matched repeated measures ANOVAs (Flight Status x LBNP) were used to test for significant differences at differing LBNP intensities between preflight and postflight for HR, SBP, DBP, , SV, TPR, CVP, IVC ø, PV ø and PV velocity. If deemed necessary, Bonferroni multiple comparisons were used when required. Repeated measures correlations were performed (CVP vs TPR, CVP vs SV, CVP vs IVC ø, and CVP vs PV ø) using the package ‘rmcorr’ from RStudio, and provided us with the ability to investigate responses within the group without violating assumptions of interdependence<sup>##REF##28439244##27##</sup>. Subsequently, ARMA results were analysed with Wilcoxon matched pairs, testing significant differences in the plateau and time to 95% of plateau values. Statistical analyses were performed with Prism software (GraphPad, USA) and R-(RStudio, USA), with statistical significance reported when p &lt; 0.05. All data are presented as mean ± SD unless otherwise stated.</p>" ]
[ "<title>Results</title>", "<title>Resting pre-test postflight variables</title>", "<p id=\"Par30\">We identified elevations to resting TPR immediately following spaceflight and prior to LBNP, accompanied by close-to-significant increases in SBP and DBP, and reductions to , with marked reduction in SV (Table ##TAB##1##2##). There were no differences to resting HR or CVP.</p>", "<title>Responses to LBNP</title>", "<p id=\"Par31\">Progressive LBNP intensity resulted in reductions to SBP (p = 0.0008, Fig. ##FIG##1##2##B), (p &lt; 0.0001), CVP (p &lt; 0.0001, Fig. ##FIG##1##2##F), IVC ø (p = 0.0016) and PV ø (p = 0.0007), with reciprocal increases in HR (p = 0.0012, Fig. ##FIG##1##2##A) and TPR (p = 0.0091, Fig. ##FIG##1##2##E). SV also decreased with LBNP (P &lt; 0.0001, Fig. ##FIG##1##2##D) with an additional effect of spaceflight (p &lt; 0.01). DBP was not altered by LBNP before or after spaceflight during our testing (Fig. ##FIG##1##2##C).</p>", "<p id=\"Par32\">Cardiovascular responses expressed as a function of changes in CVP while manipulating LBNP are shown for individual astronauts preflight and postflight with repeated measures correlation in Fig. ##FIG##2##3##. With reductions in CVP, stimulating the vasoconstrictor arm of the cardiopulmonary baroreflex, TPR increased preflight (Fig. ##FIG##2##3##A, r = − 0.70, slope coefficient = − 0.49, p &lt; 0.0001) and postflight (Fig. ##FIG##2##3##B, r = − 0.49, slope coefficient = − 0.29, p &lt; 0.0001). SV positively correlated with CVP, an index of cardiac filling pressure, during both the preflight and postflight sessions (Fig. ##FIG##2##3##C, r = 0.75, slope coefficient = 2.03, p &lt; 0.0001, and Fig. ##FIG##2##3##D r = 0.59, slope coefficient = 1.53, p &lt; 0.0001, respectively).</p>", "<p id=\"Par33\">We note positive relationships between CVP and venous volume indicated by IVC diameter (ø) preflight (Fig. ##FIG##2##3##E, r = 0.73, slope coefficient = 0.43, p = 0.002) and postflight (Fig. ##FIG##2##3##F, r = 0.69, slope coefficient = 0.50, p = 0.004). Similarly, CVP had a positive relationship with PV diameter preflight (Fig. ##FIG##2##3##G, r = 0.71, slope coefficient = 0.25, p = 0.003) and postflight (Fig. ##FIG##2##3##H, r = 0.72, slope coefficient = 0.33, p = 0.003). Assessment of differences in vein diameter/CVP relationships during LBNP were identified from pre- to postflight (Fig. ##FIG##3##4## and Table ##TAB##2##3##). Two-way RM ANOVAs confirmed significant interaction effects (p = 0.0268 for IVCø/CVP Fig. ##FIG##3##4##C and p = 0.005 for PVø/CVP Fig. ##FIG##3##4##D), with post-hoc comparisons identifying no differences at LBNP 0 mmHg, but significant differences at − 10 mmHg and − 20 mmHg for postflight compared to preflight measurements for IVCø/CVP and PVø/CVP. Noted elevations to PV velocities between preflight and postflight sessions at all levels of LBNP were close to achieving statistical significance (p = 0.058, Table ##TAB##2##3##), with no independent effect of LBNP nor interactive effect of LBNP*Spaceflight.</p>", "<title>Dynamic cardiovascular interactions</title>", "<p id=\"Par34\">Cardiopulmonary and arterial baroreflex response characteristics were explored during the Random LBNP Protocol. In the frequency domain, the gain of the cardiopulmonary baroreflex obtained from the relationship of TPR to CVP was no different preflight to postflight (data not shown). These findings were corroborated by ARMA modeling (Fig. ##FIG##4##5##) that found no differences in absolute changes in TPR to a 1 cmH<sub>2</sub>O increase in CVP (− 0.49 ± 0.29 TPR units/cmH<sub>2</sub>O preflight, − 0.90 ± 1.43 TPR units/cmH<sub>2</sub>O postflight) and time to 95% plateau (15.4 ± 6.8 s preflight, 22.2 ± 10.4 s postflight). Visually, the postflight change in TPR appeared greater than preflight but was driven entirely by one astronaut with small changes in CVP (see cluster of points in upper left quadrant of Fig. ##FIG##2##3##B). Arterial vascular baroreflex relationship of DBP to TPR showed little change following spaceflight (Fig. ##FIG##4##5##B), with no difference in plateau values for step response to a 1 mmHg increase in DBP changes (0.41 ± 0.16 TPR units/mmHg preflight, 0.40 ± 0.15 TPR units/mmHg postflight) or time to 95% plateau values (8.6 ± 9.3 s preflight, 4.6 ± 3.1 s postflight).</p>", "<p id=\"Par35\">HR responses to changes in SBP revealed no difference in the plateau values for SBP → HR (− 0.08 ± 0.18 vs − 0.01 ± 0.16 bpm/mmHg), nor the time to 95% of plateau (25.4 ± 16.1s vs 13.2 ± 8.8s bpm/mmHg), preflight and postflight respectively (Fig. ##FIG##4##5##C). Plateau CVP → HR step responses (Fig. ##FIG##4##5##D) did not identify significant changes in either plateau (0.18 ± 0.51 bpm/cmH<sub>2</sub>O preflight, − 0.69 ± 0.70 bpm/cmH<sub>2</sub>O postflight, p = 0.3) or the time to 95% of plateau values. Three of the five tested astronauts had greater postflight HR responses to changes in CVP leading to visual differences, but these were not statistically significant.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par36\">The incidence of orthostatic intolerance on return from long-duration spaceflight is greater than that after shorter duration flights<sup>##REF##11719623##2##,##REF##26630196##3##</sup>. In this investigation of long-duration spaceflight, we applied submaximal orthostatic-like stresses with mild LBNP to investigate potential changes in cardiac, vascular and reflex control mechanisms. Uniquely, the astronauts were exposed to no, or minimal, upright posture between landing and test sessions by transporting in supine position from Shuttle landings or carrying supine from bed to the laboratory after overnight supine posture for Soyuz landings. This approach limited physiological readaptation to orthostatic stresses following spaceflight, minimizing stimulation of neurohumoral mechanisms promoting the expansion of blood volume and the concomitant priming of cardiovascular responses to such challenges. Contrary to our hypothesis, and to previous bed rest findings<sup>##REF##22984250##28##,##REF##17872408##29##</sup>, the estimate of CVP was unchanged rather than lower following spaceflight. Instead, we unexpectedly observed smaller IVC and PV diameters relative to the changes in CVP during exposure to mild LBNP after spaceflight. We also found that SV was reduced postflight despite no change in estimated CVP. Additionally, and unlike observations of cardiovascular deconditioning after bed rest<sup>##REF##17872408##29##,##REF##1002644##30##</sup> or other investigations of spaceflight<sup>##UREF##5##31##,##REF##22134699##32##</sup>, there were no significant changes in HR, SBP, DBP or baroreflex responses in supine rest or during mild LBNP from preflight to postflight.</p>", "<title>Venous responses to LBNP after spaceflight</title>", "<p id=\"Par37\">This is the first study to explore adaptations of the Inferior Vena Cava and Portal Vein and their impact on an astronaut’s cardiovascular responses postflight. With spaceflight, directly measured CVP is elevated on assuming a launch position and during the high g period of launch but decreases rapidly on entry to microgravity<sup>##REF##8828643##33##</sup> as has also been observed with parabolic flight<sup>##REF##28092926##34##</sup>. In bed rest studies, CVP is elevated on initial movement to head-down position but decreases within the first few hours<sup>##REF##2317179##35##,##REF##4050700##36##</sup>. This decline probably reflects “creep” of venous smooth muscle<sup>##REF##6361810##37##</sup> since it occurs before plasma volume is significantly reduced, and was speculated to underlie impaired orthostatic tolerance after only 4-h in the head-down position<sup>##REF##2007392##14##</sup>. Further, it was observed after 4- or 28-h head down bed rest that estimated CVP was lower on return to supine position and remained lower throughout an LBNP challenge<sup>##REF##22984250##28##,##REF##17872408##29##</sup> unless fluid loading was introduced<sup>##REF##30298552##38##</sup>. However, in the current study, where estimated CVP was not different at rest or during LBNP following spaceflight, a non-quantified pre- and post-return fluid loading and other factors, including hormonal responses, could have impacted total blood volume affecting our measurements. Nevertheless, alternative adaptations of the venous system should also be considered.</p>", "<p id=\"Par38\">Central veins including the portal vein are enlarged during spaceflight<sup>##REF##25991027##39##</sup> as a consequence of enhanced transmural pressure, despite no elevation to CVP<sup>##REF##8828643##33##</sup>. Chronic in-flight dilation of the IVC and PV might underlie the changes we observed to the relationship between vein diameter and estimated CVP at each LBNP step (Fig. ##FIG##3##4##). We found a marked reduction in IVC diameter/CVP and PV diameter/CVP at both − 10 mmHg and − 20 mmHg, but not at 0 mmHg. Central veins are often regarded as relatively passive, adjusting their diameter to the current distending pressure. In each of pre-flight and post-flight testing, this characteristic that defines venous compliance is observed during LBNP (Fig. ##FIG##3##4##A and B) but we observed a shift identified by the significant reduction in diameter/CVP ratio (Fig. ##FIG##3##4##C and D). Alterations in venous properties and innervation have been identified under conditions that chronically manipulate venous distending pressure. Chronic distension of rat saphenous vein caused multiple adaptations including increased diameter with maintained wall thickness, increased tangential wall stress, reduced distensibility, smooth muscle cell hyperpolarization that could dampen myocyte contraction, and evidence of increased sympathetic neural input following selective blockade with tetrodotoxin<sup>##UREF##2##16##</sup>. Therefore, the attenuated post-flight venous responses to LBNP-induced changes in CVP we identify in our participants here may relate to a relative vessel hypertrophy, altered sympathetic activation, or reduced vasomotor responses of the PV similar to those observed in the femoral artery during head-down bed rest<sup>##REF##18757480##19##</sup>.</p>", "<title>Cardiac and vascular responses following spaceflight with LBNP</title>", "<p id=\"Par39\">Responses of the primary cardiovascular variables in the current study contrast somewhat with the responses at rest and to LBNP measured 1–2 days after returning from 8 to 20 days in space by Baisch et al.<sup>##REF##11122320##40##</sup>. Most notably, while we found an elevation in TPR during pre-LBNP supine rest, Baisch et al. reported a significant reduction. They also noted a lower SBP while we observed a trend to elevated SBP and DBP corresponding to the higher TPR. Baisch et al. studied cardiovascular responses to LBNP at − 15, − 30 and − 45 mmHg. They did not report statistical comparisons at the two lower levels of LBNP that would have corresponded to LBNP used in the current study but did find significant elevation in HR and reduction in SV and Q postflight at − 45 mmHg LBNP. In postflight testing, we observed no change in HR despite lower SV at rest and during LBNP. It is not known if the differences between studies resulted from the longer duration of spaceflight in the current study that allowed for adaptations and enhanced countermeasures, patterns of physical activity or other countermeasures during flight, or if greater exposure to upright posture prior to testing in their study might have contributed to the contrary findings. Baisch et al. observed clear evidence, through body impedance measurements, that reduced intravascular volume played a critical role in the postflight cardiovascular response to LBNP, while autonomic regulation of cardiovascular responses was not changed<sup>##REF##11122320##40##</sup>. Reduced intravascular volume appears consistent with our observation of smaller IVC and PV diameter relative to CVP during postflight LBNP testing, but we do not have blood volume measurements and no data on fluid loading regimes. Our findings of reductions to SV postflight despite little change in estimated CVP, with small and statistically insignificant differences to TPR and blood pressure, might suggest cardiac-specific mechanisms, such as reduced cardiac mass observed in short-duration spaceflights<sup>##UREF##5##31##</sup> or impaired diastolic untwisting observed after 18-days head-down bed rest<sup>##REF##18239079##41##</sup>. However, changes in cardiac function with longer duration spaceflight are not clear, with some astronauts showing improved cardiac function during maximal exercise<sup>##UREF##6##42##</sup>.</p>", "<p id=\"Par40\">Following the 16-day Neurolab mission, Levine et al. described the cardiovascular and autonomic responses while supine and during a 10-min 60-deg head-up tilt test<sup>##REF##11773340##43##</sup>. During supine rest, SV was smaller post flight as we found, but the elevation in TPR was not significant which contrasts to our observations. The non-significant elevation of TPR while supine and in head-up tilt in the Neurolab study occurred with significant elevations in muscle sympathetic nerve activity<sup>##REF##11773340##43##</sup>. Elevated resting TPR in the current study was probably accompanied by increased sympathetic vasoconstriction. The greater orthostatic challenge of head-up tilt in Neurolab compared to that of LBNP in the current study was associated with significant postflight elevation in HR which we did not observe. Their findings of little change to postflight blood pressures during tilt matched our findings during LBNP.</p>", "<title>Dynamic and reflex responses</title>", "<p id=\"Par41\">The ARMA modeling approach to investigate cardiovascular control considered the potential simultaneous effects of different inputs on the output variable of interest. For the dynamic regulation of TPR, the model included the cardiopulmonary baroreflex effects of changes in CVP on TPR together with the arterial baroreflex effects of changes in DBP on TPR. There was no difference in the gain of either of these reflex loops on comparing preflight to postflight models for the cohort as a whole. The cardiopulmonary baroreflex was also assessed in the frequency domain with similar observations of no effect of spaceflight. These results were not expected, as previous ground-based studies identified augmented cardiopulmonary baroreflexes using similar ARMA methodology following 4-h head-down bed rest<sup>##REF##17872408##29##</sup>. Enhanced cardiopulmonary baroreflex was also found from the relationship between CVP and forearm vascular resistance after 7-days head-down bed rest<sup>##REF##8024053##44##</sup>. Enhanced cardiopulmonary baroreflex probably also contributed to observations after the 16-day Neurolab mission of increased muscle sympathetic nerve activity in direct proportion to the reduction in cardiac stroke volume during 60-degree upright tilt<sup>##REF##11773340##43##</sup>, and increased norepinephrine spillover at baseline and during LBNP<sup>##REF##11773339##45##</sup>. Our contradictory results may relate to a resetting of cardiopulmonary baroreflexes after longer-duration spaceflight following changes in pressure–volume relationships and/or elevated central blood volume. Additionally, CVP was not measured during the Neurolab mission, and CVP-SV relationships may have been altered<sup>##REF##18239079##41##</sup>.</p>", "<p id=\"Par42\">Our identification of one astronaut with considerably different CVP → HR and CVP → TPR responses postflight is in keeping with heterogeneous individual orthostatic responses postflight<sup>##REF##8828642##9##</sup>. This one astronaut accounts for a large proportion of the wide variability in the postflight responses seen in Fig. ##FIG##4##5##A and D. Additionally, these responses were accompanied by small central venous diameters and minimal changes to vessel size during LBNP. Therefore, the enhancement of cardiopulmonary baroreflexes in this individual was potentially accompanied by maximal stimulation of central veins throughout testing; the diameter of both the IVC and PV in this astronaut were smaller postflight. The lack of any reduction in vein diameter may suggest an almost maximal stimulation of these vessels even at baseline. Subsequently, it may be that this individual would have had a low tolerability to tilt-table or formal orthostatic intolerance testing at the time of testing, but the minimal LBNP intensities used during this study were too low to elicit pre-syncopal symptomatology. SBP → HR responses were not affected by flight in this individual.</p>", "<p id=\"Par43\">Dynamic regulation of HR was modeled by ARMA with the input of the arterial baroreflex from changes in SBP to HR, and with the potential effects of changes in CVP to HR. Previously, in the male astronauts of the current study, we reported reduced spontaneous arterial baroreflex responses that related changes in R-R interval to changes systolic BP only when the astronauts were seated upright during paced-breathing<sup>##REF##22134699##32##</sup>. Here, while testing under the challenge of mild to moderate LBNP in our population of 6 men and 1 woman, there were no changes in the SBP to HR relationship following spaceflight, even though SV was lower postflight. Previously after short-duration spaceflights arterial baroreflex gain was reduced even in supine rest<sup>##REF##1399995##8##,##REF##20156846##18##</sup>. These results could relate to the very stressful short missions with limited time for countermeasures, disrupted sleep and no indication of fluid-loading prior to return to Earth. With longer ISS missions, cardiovascular control appears to stabilize near Earth supine values while in space<sup>##UREF##7##46##</sup>, but some astronauts have greater increases in resting HR reflecting lower vagal activity<sup>##REF##22134699##32##</sup>.</p>", "<title>Consideration of protocol and limitations</title>", "<p id=\"Par44\">Investigations in astronauts are limited by the number of available participants for physiological research. Nevertheless, conducting such research is important and provides the scientific community with precious insight into physiological changes occurring during spaceflight. We acknowledge that the small sample size in this investigation may have been inadequate to achieve statistical significance for some outcomes. Other limitations of this study include the maximal LBNP of − 30 mmHg, resulting in relatively mild fluid shifts that challenge the cardiovascular system less than that incurred during a lying-to-standing postural change. The decision to limit LBNP to this low level was made for safety reasons in place at the time of the study and we were unable to expose our participants to greater magnitudes of LBNP. However, we did see changes to estimated CVP, and were subsequently able to identify differences in venous properties, investigate autonomic baroreflexes, and identify variability within individuals. Differences in post-landing test session timing between astronauts flown in the Shuttle vs Soyuz required differences in posture with periods upright after a Soyuz landing, that may have masked spaceflight-induced changes. The additional time delay occurred for three of our participants, during which time a degree of blood volume recouperation could have occurred. However, it is known that autonomic changes associated with spaceflight persist for a number of days following short missions<sup>##REF##7836199##47##</sup>, and therefore any impact of this brief delay to our results was likely to be minimal especially when the astronauts were carried horizontal from their bed to the laboratory.</p>", "<p id=\"Par45\">Methodological considerations included our inability to directly measure CVP during these experiments due to astronaut safety considerations and the invasiveness of placing central catheters immediately following spaceflight. The dependent arm technique relies on establishing a continuous column of blood from the transducer, through the catheter to the central vein<sup>##REF##13277113##23##</sup>. The presence of characteristic pulsatility in the pressure signal in combination with careful positioning of the transducer at right heart level by a laser level minimized the risk of aberrant values. Changes in the tissue properties of the vessel wall, skin and sub-cutaneous tissues surrounding the venous catheter, nor their potential influence on absolute CVP pressures were not assessed. However, there was no obstruction from the central column of blood to the pressure transducer recording these values, and we believe any tissue changes would therefore not influence absolute CVP values measured in our study. Measuring absolute CVP with this technique is not perfect and must be taken into consideration when interpreting our findings; however, changes in CVP should be reflected by our method. Additionally, determination of cardiac output and SV using Modelflow algorithms could have been influenced by increases in arterial stiffness following 6-months of spaceflight<sup>##REF##26747504##12##</sup>. Estimated SV is smaller at older ages for a given arterial pulse wave<sup>##REF##21292839##48##</sup>; however, Modelflow has never been compared to a standard method before and after spaceflight, and comparisons of pre-flight with inflight<sup>##REF##26747504##12##</sup> focused on very different physiological conditions. Finally, the constant LBNP protocol preceded the random LBNP protocol for each participant at both timepoints. A test order effect might have occurred but it was not evident in data pooled across the test types as in Fig. ##FIG##2##3##.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par46\">The ability to study astronauts within hours of returning to Earth, especially prior to resuming upright posture, provided us with a unique opportunity to test cardiovascular responses before the re-establishment of compensatory physiological responses to 1G. We identified changes to resting supine cardiovascular variables that corroborate previously identified elevations to global sympathetic tone following spaceflight. Our investigations of dynamic cardiovascular responses to incremental and random LBNP challenge did not support our initial hypotheses of enhanced cardiopulmonary and diminished arterial baroreflexes in our participants. However, we did identify one astronaut with enhancement of both CVP → HR and CVP → TPR responses postflight, reinforcing the heterogeneity with some astronauts more susceptible to stresses of upright posture after spaceflight. Finally, we found important alterations to IVC/CVP and PV/CVP relationships during LBNP, which could suggest central vein hypertrophy or enhanced sympathetic innervation in these vessels. It may be that changes in venous pressure/volume relationships influence maintenance or elevation of CVP in central venous capacitance vessels during postflight orthostatic challenges.</p>" ]
[ "<p id=\"Par1\">Cardiovascular deconditioning and altered baroreflexes predispose returning astronauts to Orthostatic Intolerance. We assessed 7 astronauts (1 female) before and following long-duration spaceflight (146 ± 43 days) with minimal upright posture prior to testing. We applied lower body negative pressure (LBNP) of up to − 30 mmHg to supine astronauts instrumented for continual synchronous measurements of cardiovascular variables, and intermittent imaging the Portal Vein (PV) and Inferior Vena Cava (IVC). During supine rest without LBNP, postflight elevations to total peripheral resistance (TPR; 15.8 ± 4.6 vs. 20.8 ± 7.1 mmHg min/l, p &lt; 0.05) and reductions in stroke volume (SV; 104.4 ± 16.7 vs. 87.4 ± 11.5 ml, p &lt; 0.05) were unaccompanied by changes to heart rate (HR) or estimated central venous pressure (CVP). Small increases to systolic blood pressure (SBP) and diastolic blood pressure (DBP) were not statistically significant. Autoregressive moving average modelling (ARMA) during LBNP did not identify differences to either arterial (DBP → TPR and SBP → HR) or cardiopulmonary (CVP → TPR) baroreflexes consistent with intact cardiovascular control. On the other hand, IVC and PV diameter-CVP relationships during LBNP revealed smaller diameter for a given CVP postflight consistent with altered postflight venous wall dynamics.</p>", "<title>Subject terms</title>" ]
[]
[ "<title>Acknowledgements</title>", "<p>We thank the astronauts for their enthusiasm and dedication to the success of the project (Cardiovascular and Cerebrovascular Control on Return from ISS, CCISS). The assistance and support of personnel at the Canadian Space Agency (CSA) and National Aeronautics and Space Administration were essential. In particular, we thank the support teams at CSA, the experiment support team and the cardiovascular laboratory at the Johnson Space Center, Kennedy Space Center, Dryden Flight Research Center, and the Gagarin Cosmonaut Training Centre.</p>", "<title>Author contributions</title>", "<p>R.H., D.G., J.S., A.B. and P.A. conceived and designed the study. R.H., D.G., J.S., A.B. and P.A. performed the data collection. C.M. analyzed the data. C.M. drafted the manuscript. All authors contributed to critical review and revisions of the manuscript. The authors declare no conflicts of interest.</p>", "<title>Funding</title>", "<p>This research was supported by CSA Grant 9F007-02-0213, CNES Grant DAR 480000462, and Natural Sciences and Engineering Research Council RGPIN-2018-04729.</p>", "<title>Data availability</title>", "<p>The datasets used and/or analyzed during the current study are available from Dr. Richard Hughson ([email protected]) on reasonable request.</p>", "<title>Competing interests</title>", "<p id=\"Par47\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Example preflight data acquisitions from Constant (Left) and Random (Right) LBNP Protocols in one subject showing SBP (mmHg), DBP (mmHg), HR (bpm), TPR (mmHg.min/l), CVP (cmH<sub>2</sub>O), and LBNP pressure (mmHg). Data collection periods in Constant LBNP were nominally 5-min for instrumentation and baseline then 2-min at each LBNP including ultrasound scan times.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Group changes in cardiovascular variables with increasing negative pressure, displayed here as mean group values during the last 30 s of each period without LBNP and each LBNP intensity. Therefore, the LBNP ‘0’ includes data from all periods without LBNP during the constant and random LBNP protocol. Preflight (black circles with solid line) and postflight (grey triangles with dashed line). Data shown as mean ± SD in 7 participants for: HR (<bold>A</bold>), SBP (<bold>B</bold>), DBP (<bold>C</bold>), SV (<bold>D</bold>) and in 5 participants for TPR (<bold>E</bold>), and CVP (<bold>F</bold>). <sup>†</sup>Significant effect of LBNP, <sup>†</sup>p &lt; 0.05, <sup>††</sup>p &lt; 0.01, <sup>†††</sup>p &lt; 0.001, <sup>††††</sup>p &lt; 0.0001. <sup>#</sup>Significant effect of spaceflight, <sup>##</sup>p &lt; 0.01. The slight horizontal offset exists to aid visualisation.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Repeated Measures Correlations for CVP vs TPR (<bold>A</bold> and <bold>B</bold>), CVP vs SV (<bold>C</bold> and <bold>D</bold>), CVP vs IVC ø (<bold>E</bold> and <bold>F</bold>), and CVP vs PV ø (<bold>G</bold> and <bold>H</bold>). Preflight data with solid lines (<bold>A</bold>,<bold>C</bold>,<bold>E</bold>,<bold>G</bold>) left, and Postflight data with dashed lines (<bold>B</bold>,<bold>D</bold>,<bold>F</bold>,<bold>H</bold>) right, are shown as circles representing Shuttle astronauts (black circles with solid line) and triangles representing Soyuz astronauts (black triangles with dashed line). Colour represents individual participants. For 2 of the 7 participants, only data taken from the Constant Protocol is plotted for CVP vs TPR and CVP vs SV, due to poor CVP quality during the Random LBNP Protocol.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Vein ø shown as a function of CVP for the inferior vena cava (IVC) (<bold>A</bold>) and portal vein (PV) (<bold>B</bold>), and the ratio for IVCø/CVP (<bold>C</bold>) and PVø/CVP (<bold>D</bold>) (mean ± SD) at different LBNP intensities in preflight (black circles) and postflight (open circles). Two-way ANOVA identified significant interaction effects for both veins (p = 0.0268 for IVCø/CVP and p = 0.005 for PVø/CVP). Post-hoc Bonferroni testing identified significant differences between preflight and postflight groups at − 10 mmHg and − 20 mmHg LBNP. **p &lt; 0.01, ***p &lt; 0.001. The slight horizontal offset exists to aid visualisation.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Calculated Step Responses (ARMA analyses) of CVP → TPR (<bold>A</bold>), DBP → TPR (<bold>B</bold>), SBP → HR (<bold>C</bold>) and CVP → HR (<bold>D</bold>). Preflight (solid line and dark shading) and postflight (dashed line and pale shading). No differences in plateau values or time to 95% plateau values were noted.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Exact delays between landing and the start of data collection for each astronaut investigated in this study.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Landing vehicle</th><th align=\"left\">Landing to testing (hours and minutes)</th></tr></thead><tbody><tr><td align=\"left\">Shuttle</td><td align=\"left\">3 h and 59 min</td></tr><tr><td align=\"left\">Shuttle</td><td align=\"left\">3 h and 8 min</td></tr><tr><td align=\"left\">Soyuz</td><td align=\"left\">25 h and 25 min</td></tr><tr><td align=\"left\">Shuttle</td><td align=\"left\">3 h and 6 min</td></tr><tr><td align=\"left\">Soyuz</td><td align=\"left\">28 h and 28 min</td></tr><tr><td align=\"left\">Soyuz</td><td align=\"left\">49 h and 33 min</td></tr><tr><td align=\"left\">Shuttle</td><td align=\"left\">3 h and 37 min</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Group resting cardiovascular variables in the supine position prior to the commencement of LBNP (n = 7).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Resting variable</th><th align=\"left\">Measurement technique</th><th align=\"left\">Preflight</th><th align=\"left\">Postflight</th><th align=\"left\">p-value</th></tr></thead><tbody><tr><td align=\"left\">Heart rate (bpm)</td><td align=\"left\">ECG R-R intervals</td><td char=\"±\" align=\"char\">51.8 ± 7.2</td><td char=\"±\" align=\"char\">51.9 ± 6.0</td><td char=\".\" align=\"char\">0.9528</td></tr><tr><td align=\"left\">Systolic blood pressure (mmHg)</td><td align=\"left\">Modelled from finger waveform</td><td char=\"±\" align=\"char\">120.6 ± 13.9</td><td char=\"±\" align=\"char\">129.1 ± 15.6</td><td char=\".\" align=\"char\">0.0629</td></tr><tr><td align=\"left\">Diastolic blood pressure (mmHg)</td><td align=\"left\">Modelled from finger waveform</td><td char=\"±\" align=\"char\">74.3 ± 8.6</td><td char=\"±\" align=\"char\">83.6 ± 11.8</td><td char=\".\" align=\"char\">0.0511</td></tr><tr><td align=\"left\">Cardiac output (l/min)</td><td align=\"left\">Modelled from finger waveform</td><td char=\"±\" align=\"char\">5.5 ± 1.6</td><td char=\"±\" align=\"char\">4.6 ± 1.1</td><td char=\".\" align=\"char\">0.0800</td></tr><tr><td align=\"left\">Stroke volume (ml)</td><td align=\"left\">Modelled from finger waveform</td><td char=\"±\" align=\"char\">104.4 ± 16.7</td><td char=\"±\" align=\"char\">87.4 ± 11.5*</td><td char=\".\" align=\"char\">0.0109</td></tr><tr><td align=\"left\">TPR (mmHg min/l)</td><td align=\"left\">Calculated from MAP, CVP &amp; </td><td char=\"±\" align=\"char\">15.8 ± 4.6</td><td char=\"±\" align=\"char\">20.8 ± 7.1*</td><td char=\".\" align=\"char\">0.0158</td></tr><tr><td align=\"left\">CVP (cmH<sub>2</sub>O)</td><td align=\"left\">Pressure transducer waveform</td><td char=\"±\" align=\"char\">11.6 ± 1.1</td><td char=\"±\" align=\"char\">13.0 ± 3.8</td><td char=\".\" align=\"char\">0.3966</td></tr><tr><td align=\"left\">IVC diameter (cm)</td><td align=\"left\">Ultrasound imaging</td><td char=\"±\" align=\"char\">1.5 ± 0.3</td><td char=\"±\" align=\"char\">1.4 ± 0.4</td><td char=\".\" align=\"char\">0.0969</td></tr><tr><td align=\"left\">PV diameter (cm)</td><td align=\"left\">Ultrasound imaging</td><td char=\"±\" align=\"char\">0.7 ± 0.3</td><td char=\"±\" align=\"char\">0.7 ± 0.1</td><td char=\".\" align=\"char\">0.4245</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>CVP (mmHg), Vein Diameters (ø<bold>,</bold> cm) and velocities (cm/s) measured at each step LBNP intensity during the Constant LBNP Protocol.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\"/><th align=\"left\">LBNP = 0mmHg</th><th align=\"left\">LBNP = − 10mmHg</th><th align=\"left\">LBNP = − 20mmHg</th></tr></thead><tbody><tr><td align=\"left\">CVP PRE</td><td char=\"±\" align=\"char\">9.03 ± 0.80</td><td char=\"±\" align=\"char\">6.03 ± 1.16</td><td char=\"±\" align=\"char\">4.89 ± 1.26</td></tr><tr><td align=\"left\">CVP POST</td><td char=\"±\" align=\"char\">10.09 ± 2.73</td><td char=\"±\" align=\"char\">7.73 ± 2.39</td><td char=\"±\" align=\"char\">6.23 ± 1.95</td></tr><tr><td align=\"left\">IVC ø PRE</td><td char=\"±\" align=\"char\">1.54 ± 0.27</td><td char=\"±\" align=\"char\">1.35 ± 0.41</td><td char=\"±\" align=\"char\">1.29 ± 0.38</td></tr><tr><td align=\"left\">IVC ø POST</td><td char=\"±\" align=\"char\">1.38 ± 0.37</td><td char=\"±\" align=\"char\">1.23 ± 0.56</td><td char=\"±\" align=\"char\">1.11 ± 0.46</td></tr><tr><td align=\"left\">PV ø PRE</td><td char=\"±\" align=\"char\">0.73 ± 0.25</td><td char=\"±\" align=\"char\">0.66 ± 0.24</td><td char=\"±\" align=\"char\">0.60 ± 0.17</td></tr><tr><td align=\"left\">PV ø POST</td><td char=\"±\" align=\"char\">0.65 ± 0.09</td><td char=\"±\" align=\"char\">0.48 ± 0.08</td><td char=\"±\" align=\"char\">0.47 ± 0.08</td></tr><tr><td align=\"left\">PV velocity PRE</td><td char=\"±\" align=\"char\">19.1 ± 3.34</td><td char=\"±\" align=\"char\">17.7 ± 5.31</td><td char=\"±\" align=\"char\">17.9 ± 4.72</td></tr><tr><td align=\"left\">PV velocity POST</td><td char=\"±\" align=\"char\">20.0 ± 4.56</td><td char=\"±\" align=\"char\">22.7 ± 3.71</td><td char=\"±\" align=\"char\">22.1 ± 3.70</td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\dot{\\text{Q}}}$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mover accent=\"true\"><mml:mtext>Q</mml:mtext><mml:mo>˙</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\dot{\\text{Q}}}$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mover accent=\"true\"><mml:mtext>Q</mml:mtext><mml:mo>˙</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\dot{\\text{Q}}}$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mover accent=\"true\"><mml:mtext>Q</mml:mtext><mml:mo>˙</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equa\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$TPR\\left( {{\\text{mmHg}}\\;\\min /{\\text{l}}} \\right) = \\frac{{MAP\\left( {{\\text{mmHg}}} \\right) - CVP\\left( {{\\text{mmHg}}} \\right)}}{{\\dot{Q}\\left( {{\\text{l}}/\\min } \\right)}}$$\\end{document}</tex-math><mml:math id=\"M8\" display=\"block\"><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mi>R</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtext>mmHg</mml:mtext><mml:mspace width=\"0.277778em\"/><mml:mo movablelimits=\"true\">min</mml:mo><mml:mo stretchy=\"false\">/</mml:mo><mml:mtext>l</mml:mtext></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>M</mml:mi><mml:mi>A</mml:mi><mml:mi>P</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mtext>mmHg</mml:mtext></mml:mfenced><mml:mo>-</mml:mo><mml:mi>C</mml:mi><mml:mi>V</mml:mi><mml:mi>P</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mtext>mmHg</mml:mtext></mml:mfenced></mml:mrow><mml:mrow><mml:mover accent=\"true\"><mml:mi>Q</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtext>l</mml:mtext><mml:mo stretchy=\"false\">/</mml:mo><mml:mo movablelimits=\"true\">min</mml:mo></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\dot{\\text{Q}}}$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mover accent=\"true\"><mml:mtext>Q</mml:mtext><mml:mo>˙</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\dot{\\text{Q}}}$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mover accent=\"true\"><mml:mtext>Q</mml:mtext><mml:mo>˙</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\dot{\\text{Q}}}$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mover accent=\"true\"><mml:mtext>Q</mml:mtext><mml:mo>˙</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\dot{\\text{Q}}}$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mover accent=\"true\"><mml:mtext>Q</mml:mtext><mml:mo>˙</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\dot{\\text{Q}}}$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:mover accent=\"true\"><mml:mtext>Q</mml:mtext><mml:mo>˙</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\dot{\\text{Q}}}$$\\end{document}</tex-math><mml:math id=\"M20\"><mml:mover accent=\"true\"><mml:mtext>Q</mml:mtext><mml:mo>˙</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\dot{\\text{Q}}}$$\\end{document}</tex-math><mml:math id=\"M22\"><mml:mover accent=\"true\"><mml:mtext>Q</mml:mtext><mml:mo>˙</mml:mo></mml:mover></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[]
[ "<table-wrap-foot><p>Data provided as mean ± standard deviation. p-value provided for comparisons between preflight and postflight values.</p><p>*p &lt; 0.05.</p></table-wrap-foot>", "<table-wrap-foot><p>Note that the resting CVP values in Table ##TAB##1##2## represent those prior to commencement of the experiment, whilst those in Table ##TAB##2##3## are pressures recorded simultaneously with the ultrasound collections and are therefore slightly different and incorporate experimental stimuli.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51643_Fig1_HTML\" id=\"MO1\"/>", "<inline-graphic xlink:href=\"41598_2024_51643_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51643_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51643_Article_IEq3.gif\"/>", "<graphic xlink:href=\"41598_2024_51643_Article_Equa.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51643_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51643_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51643_Article_IEq9.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51643_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51643_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51643_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51643_Article_IEq10.gif\"/>", "<graphic xlink:href=\"41598_2024_51643_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51643_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51643_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51643_Fig5_HTML\" id=\"MO5\"/>" ]
[]
[{"label": ["1."], "mixed-citation": ["Stenger, M. B. "], "italic": ["et al. Risk of Orthostatic Intolerance During Re-exposure to Gravity"]}, {"label": ["5."], "mixed-citation": ["NASA. HRR-Risk-Risk of Orthostatic Intolerance During Re-Exposure to Gravity. "], "ext-link": ["https://humanresearchroadmap.nasa.gov/Risks/risk.aspx?i=86"]}, {"label": ["16."], "surname": ["Monos", "Contney", "Cowley", "Stekiel"], "given-names": ["E", "SJ", "AW", "WJ"], "article-title": ["Effect of long-term tilt on mechanical and electrical properties of rat saphenous vein"], "source": ["Am. J. Physiol.-Heart Circ. Physiol."], "year": ["1989"], "volume": ["256"], "fpage": ["H1185"], "lpage": ["H1191"], "pub-id": ["10.1152/ajpheart.1989.256.4.H1185"]}, {"label": ["21."], "mixed-citation": ["NASA. Space Shuttle Operational Flight Rules. Vol A. All flights. Houston (TX): Mission Operations Directorate. NASA Johnson Space Centerl June 2002. NSTS 12820. Flight Rule A13-202. "], "ext-link": ["http://archive.org/details/flight_rules_generic"]}, {"label": ["26."], "surname": ["Hughson"], "given-names": ["RL"], "article-title": ["Searching for the vascular component of the arterial baroreflex"], "source": ["Cardiovasc. Eng."], "year": ["2004"], "volume": ["4"], "fpage": ["155"], "lpage": ["162"], "pub-id": ["10.1023/B:CARE.0000031544.75716.9d"]}, {"label": ["31."], "surname": ["Perhonen"], "given-names": ["MA"], "article-title": ["Cardiac atrophy after bed rest and spaceflight"], "source": ["J. Appl. Physiol."], "year": ["2001"], "volume": ["1985"], "issue": ["91"], "fpage": ["645"], "lpage": ["653"], "pub-id": ["10.1152/jappl.2001.91.2.645"]}, {"label": ["42."], "surname": ["Moore"], "given-names": ["AD"], "article-title": ["Peak exercise oxygen uptake during and following long-duration spaceflight"], "source": ["J. Appl. Physiol."], "year": ["2014"], "volume": ["1985"], "issue": ["117"], "fpage": ["231"], "lpage": ["238"], "pub-id": ["10.1152/japplphysiol.01251.2013"]}, {"label": ["46."], "surname": ["Verheyden", "Liu", "Beckers", "Aubert"], "given-names": ["B", "J", "F", "AE"], "article-title": ["Operational point of neural cardiovascular regulation in humans up to 6 months in space"], "source": ["J. Appl. Physiol."], "year": ["2010"], "volume": ["1985"], "issue": ["108"], "fpage": ["646"], "lpage": ["654"], "pub-id": ["10.1152/japplphysiol.00883.2009"]}]
{ "acronym": [ "ARMA", "BP", "CVP", "DBP", "HR", "IVC", "ISS", "LBNP", "MAP", "OI", "PV", "Q̇", "SV", "SBP", "TPR" ], "definition": [ "Autoregressive moving average", "Blood pressure", "Central venous pressure", "Diastolic blood pressure", "Heart rate", "Inferior vena cava", "International space station", "Lower body negative pressure", "Mean arterial pressure", "Orthostatic intolerance", "Portal vein", "Cardiac output", "Stroke volume", "Systolic blood pressure", "Total peripheral resistance" ] }
48
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1215
oa_package/8d/32/PMC10786840.tar.gz
PMC10786841
38216656
[ "<title>Introduction</title>", "<p id=\"Par2\">Lung cancer remains the most commonly diagnosed cancer type and leading cause of tumor-related death worldwide<sup>##REF##26667336##1##,##UREF##0##2##</sup>. Although great advances in treatment strategies including the surgical techniques and anti-tumor drugs have been achieved in the past decade, the overall survival of lung cancer patients remains unsatisfied<sup>##REF##36935643##3##</sup>. Besides, it is still difficult to predict the prognosis of lung cancer patients accurately and formulate the most appropriate therapy strategy now. Therefore, identifying more useful and reliable indicators contributing to the survival prediction of lung cancer patients is one of the urgent problems to be solved.</p>", "<p id=\"Par3\">Albumin, as the most abundant protein in the blood, can reflect the body’s systemic inflammatory response and basic nutritional status. The serum albumin content in cancer patients usually decreases gradually with the progression of the disease, and studies have confirmed that the decrease of serum albumin indicates poor clinical prognosis<sup>##REF##26864349##4##,##REF##33833991##5##</sup>. Serum alkaline phosphatase is a hydrolytic enzyme concentrated in the liver, bile ducts, and kidneys, and serum levels can be significantly elevated when cancer affects the bone or liver. Studies of patients with hepatocellular carcinoma have demonstrated that the ratio of serum albumin to serum alkaline phosphatase as a prognostic factor can provide additional guidance compared with a single marker<sup>##REF##30417313##6##,##REF##31768692##7##</sup>. Therefore, the novel index, albumin-to-alkaline phosphatase ratio (AAPR), is believed to serve as a valuable prognostic indicator in cancer patients.</p>", "<p id=\"Par4\">Xie et al. included 16 eligible studies with 5716 patients and manifested that low pretreatment AAPR was related to poor prognosis in patients with cancer<sup>##REF##33376729##8##</sup>. However, only five studies focused on lung cancer cases in their meta-analysis. Thus, whether pretreatment AAPR is a reliable prognostic indicator in lung cancer is unclear.</p>", "<p id=\"Par5\">This meta-analysis aimed to further identify the clinical role of pretreatment AAPR based on current evidence, contributing to the accurate prediction of survival and also formulation of treatment strategy of lung cancer patients.</p>" ]
[ "<title>Materials and methods</title>", "<p id=\"Par6\">This meta-analysis was performed according to the Preferred Reporting Items for Systematic Review and Meta-Analyses 2020<sup>##UREF##1##9##</sup>.</p>", "<title>Literature retrieval</title>", "<p id=\"Par7\">The PubMed, EMBASE, Web of Science and CNKI electronic databases were searched from inception to October 14, 2022. During the literature search, the following terms were used: albumin-to-alkaline phosphatase ratio, AAPR, lung, pulmonary, tumor, cancer, carcinoma, neoplasm, survival, prognosis and prognostic. In detail, the specific search strategy was as follows: (albumin-to-alkaline phosphatase ratio OR AAPR) AND (lung OR pulmonary) AND (tumor OR cancer OR carcinoma OR neoplasm) AND (survival OR prognosis OR prognostic). Meanwhile, the free texts and MeSH terms were used during the search. References cited in included studies were also reviewed for availability.</p>", "<title>Inclusion criteria and exclusion criteria</title>", "<p id=\"Par8\">The inclusion criteria were as follows: (1) patients were diagnosed with primary lung cancer; (2) the serum albumin and alkaline phosphatase levels were detected before any anti-tumor treatment; (3) patients were divided into two groups according to the pretreatment AAPR and the primary outcomes including the overall survival (OS) and progression-free survival (PFS), were compared between the two groups; (4) the hazard ratios (HRs) and 95% confidence intervals (CIs) were directly provided in the articles; 5) high-quality studies with the Newcastle–Ottawa Scale (NOS) score &gt; 5<sup>##UREF##2##10##</sup>.</p>", "<p id=\"Par9\">Exclusion criteria: (1) duplicated or overlapped data; (2) letters, editorials, case reports, animal trials or reviews.</p>", "<title>Data collection</title>", "<p id=\"Par10\">The following data were extracted from each included studies: the name of first author, year, country, sample size, pathologic type, treatment, tumor stage, cutoff value of AAPR, endpoint, age, gender, smoking history, differentiation degree, T stage, N stage, TNM stage, HR and 95% CI.</p>", "<title>Study quality assessment</title>", "<p id=\"Par11\">The quality of all included studies was assessed according to the NOS score tool and only high-quality studies with the NOS of 6 or higher were included as above mentioned<sup>##UREF##2##10##</sup>.</p>", "<p id=\"Par12\">In our meta-analysis, the literature search, selection, data extraction and quality assessment were all performed by two independent authors.</p>", "<title>Statistical analysis</title>", "<p id=\"Par13\">In this meta-analysis, all statistical analyses were performed using STATA 15.0 software. Heterogeneity among studies was evaluated using I<sup>2</sup> statistics and the Q-test. When obvious heterogeneity was detected, representing I<sup>2</sup> &gt; 50% and/or <italic>P</italic> &lt; 0.1, the random effects model was used; otherwise, the fixed effects model was used. The HRs, relative risks (RRs) and 95% CIs were combined. Sensitivity analysis was performed to detect sources of heterogeneity and assess the stability of the pooled results. Besides, the Begg’s funnel plot and Egger’s test were performed to detect publication bias, and significant publication bias was defined as <italic>P</italic> &lt; 0.05<sup>##REF##7786990##11##,##UREF##3##12##</sup>. If we detected significant publication bias, then the nonparametric trim-and-fill method was used to re-estimate a corrective effect size after publication bias was adjusted<sup>##REF##31319409##13##</sup>.</p>", "<title>Ethical statement</title>", "<p id=\"Par14\">The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All procedures performed in studies that involved human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.</p>" ]
[ "<title>Results</title>", "<title>Literature search and selection</title>", "<p id=\"Par15\">Sixty-seven records were searched from the four databases initially and 23 duplicated records were removed. Then the titles and abstracts of remaining 44 records were reviewed and full texts of 16 studies were further reviewed. Finally, 11 relevant studies were included our meta-analysis<sup>##REF##31303770##14##–##UREF##4##24##</sup>. The detailed process was displayed in the Fig. ##FIG##0##1##.</p>", "<title>Basic characteristics of included studies</title>", "<p id=\"Par16\">A total of 10,589 patients were enrolled in the analysis with the sample size ranged from 116 to 7078. Except the study by Birgitte et al.<sup>##REF##34885242##21##</sup>, all included studies were from China. Eight and four studies focused on the NSCLC and SCLC patients, respectively. The cutoff values of AAPR ranged from 0.238 to 0.64. Other detailed information was presented in Table ##TAB##0##1##.</p>", "<title>The association between pretreatment AAPR and OS</title>", "<p id=\"Par17\">All 11 included studies explored the predictive role of pretreatment AAPR for OS of lung cancer<sup>##REF##31303770##14##–##UREF##4##24##</sup>. The pooled results demonstrated that a lower pretreatment AAPR was significantly associated with poorer OS (HR = 0.65, 95% CI 0.59–0.71, <italic>P</italic> &lt; 0.001; I<sup>2</sup> = 52.0%, <italic>P</italic> = 0.018) (Fig. ##FIG##1##2##). Then, subgroup analysis based on the pathological type (NSCLC vs SCLC) and treatment (non-surgery vs. surgery vs. mixed) also showed that a lower pretreatment AAPR was related to worse OS (NSCLC: HR = 0.65, 95% CI 0.58–0.73, <italic>P</italic> &lt; 0.001; SCLC: HR = 0.62, 95% CI 0.54–0.71, <italic>P</italic> &lt; 0.001; non-surgery: HR = 0.60, 95% CI 0.53–0.68, <italic>P</italic> &lt; 0.001; surgery: HR = 0.46, 95% CI 0.33–0.65, <italic>P</italic> &lt; 0.001; mixed: HR = 0.65, 95% CI 0.59–0.71, <italic>P</italic> &lt; 0.001) (Table ##TAB##1##2##).</p>", "<title>The association between pretreatment AAPR and PFS</title>", "<p id=\"Par18\">Six studies explored the association between pretreatment AAPR and PFS of lung cancer patients<sup>##REF##31319230##15##–##REF##32982294##18##,##REF##33565707##22##,##REF##35378914##23##</sup>. The pooled results indicated that pretreatment AAPR was obviously related to poor PFS (HR = 0.68, 95% CI 0.59–0.78, <italic>P</italic> &lt; 0.001; I<sup>2</sup> = 32.5%, <italic>P</italic> = 0.192) (Fig. ##FIG##2##3##). Subgroup analysis stratified by the pathological type and treatment manifested similar results (NSCLC: HR = 0.70, 95% CI 0.60–0.80, <italic>P</italic> &lt; 0.001; SCLC: HR = 0.59, 95% CI 0.40–0.86, <italic>P</italic> = 0.007; non-surgery: HR = 0.72, 95% CI 0.62–0.84, <italic>P</italic> &lt; 0.001; surgery: HR = 0.55, 95% CI 0.40–0.74, <italic>P</italic> &lt; 0.001) (Table ##TAB##1##2##).</p>", "<title>The association between pretreatment AAPR and clinicopathological parameters</title>", "<p id=\"Par19\">Based on available data, we identified the relationship between pretreatment AAPR and age, gender, smoking history, differentiation degree, T stage, N stage and TNM stage. Pooled results indicated that lower pretreatment AAPR was significantly associated with male (RR = 1.08, 95% CI 1.03–1.13, <italic>P</italic> &lt; 0.001; I<sup>2</sup> = 34.3%, <italic>P</italic> = 0.124), poor differentiation (RR = 1.33, 95% CI 1.03–1.73, <italic>P</italic> = 0.029; I<sup>2</sup> = 0.0%, <italic>P</italic> = 0.380), advanced T stage (RR = 1.25, 95% CI 1.03–1.52, <italic>P</italic> = 0.026; I<sup>2</sup> = 59.6%, <italic>P</italic> = 0.060), N stage (RR = 1.34, 95% CI 1.15–1.55, <italic>P</italic> &lt; 0.001; I<sup>2</sup> = 0.0%, <italic>P</italic> = 0.610) and TNM stage (RR = 1.14, 95% CI 1.06–1.223, <italic>P</italic> &lt; 0.001; I<sup>2</sup> = 87.9%, <italic>P</italic> &lt; 0.001) (Table ##TAB##2##3##).</p>", "<title>Sensitivity analysis and publication bias</title>", "<p id=\"Par20\">The sensitivity analysis for the OS showed that our results were stable and reliable (Fig. ##FIG##3##4##). Due to the asymmetrical Begg’s funnel plot (Fig. ##FIG##4##5##) and <italic>P</italic> &lt; 0.001 of Egger’s test, obvious publication bias was detected. Therefore, the nonparametric trim-and-fill method was used to identify potentially unpublished studies. However, no potentially unpublished studies were detected (Fig. ##FIG##5##6##). Thus, more high-quality studies are still needed to verify our findings.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par21\">The current meta-analysis demonstrated that pretreatment AAPR was significantly associated with prognosis and tumor stage and lung cancer patients with a lower pretreatment AAPR experienced poorer survival and advanced tumor stage. According to our findings, the pretreatment AAPR is a novel and reliable prognostic factor in lung cancer. However, more prospective high-quality studies are still needed to verify our findings due to limitations existed in this meta-analysis.</p>", "<p id=\"Par22\">AAPR, as a novel parameter which has been reported in the past few years, is defined as the ratio of the serum albumin and serum alkaline phosphatase. It has been well manifested that the albumin level is related to the development, progression and prognosis among cancer patients<sup>##REF##37668558##25##–##REF##38160157##27##</sup>. Albumin concentration could reflect the nutritional status, liver function and human defense capabilities<sup>##REF##35378914##23##</sup>. Decreased albumin concentration indicates the sign of malnutrition and decrease in immunity and the production of albumin is suppressed by the activation of inflammatory cytokines<sup>##REF##11759282##28##</sup>. Besides, it has been also reported that the alteration in protein binding shows an impact on the drug half-life, which means hypoalbuminemia could cause a poor response to anti-tumor therapeutics<sup>##REF##30439428##29##</sup>. Therefore, albumin is closely related to the disease progression and prognosis of cancers<sup>##REF##36741261##30##–##REF##37213304##32##</sup>. On the other hand, alkaline phosphatase is a novel factor predicting the survival of cancer patients. It is a hydrolase enzyme that widely exists in the kidney, liver and bone. Thus, alkaline phosphatase is usually applied as a biomarker reflecting the liver and bone health. In recent years, alkaline phosphatase has been demonstrated to play an important role in the anti-inflammation and immune response<sup>##REF##28824625##33##</sup>. Meanwhile, numerous studies indicate that alkaline phosphatase concentration is also significantly related to the development and disease progression in cancers<sup>##REF##35900644##34##,##REF##34692474##35##</sup>. Besides, alkaline phosphatase has also been reported to associated with the survival in several types of cancers including the lung cancer<sup>##REF##36936017##36##</sup>.</p>", "<p id=\"Par23\">Although the association of serum and alkaline phosphatase concentration with prognosis in tumor patients have been reported<sup>##REF##30439428##29##–##REF##37213304##32##,##REF##36936017##36##</sup>. Some studies suggest that AAPR is more effective in predicting the survival and prognosis of lung cancer patients compared to individual biomarkers<sup>##REF##31319230##15##–##REF##32982294##18##,##REF##33565707##22##,##REF##35378914##23##</sup>. It demonstrates greater sensitivity in capturing the patient’s physical condition and disease progression, thus holding stronger predictive value<sup>##REF##31319230##15##–##REF##32982294##18##,##REF##33565707##22##,##REF##35378914##23##</sup>. Moreover, monitoring changes in AAPR during the course of treatment allows for a more comprehensive understanding of the patient’s response to therapy. The effectiveness of treatment may manifest in various aspects, including cellular activity, inflammation levels, and protein metabolism, and AAPR, as a composite indicator, is better positioned to reflect these complex biological changes. Therefore, AAPR is considered to show greater clinical value than the individual levels of albumin and alkaline phosphatase.</p>", "<p id=\"Par24\">Actually, the prognosis role of pretreatment AAPR has been verified in some cancers<sup>##REF##36720974##37##,##REF##33685425##38##</sup>. An et al. conducted a meta-analysis by including 18 studies involving 25 cohorts with 7019 cancer patients and revealed that decreased AAPR was significantly related to poor OS (HR = 2.14, 95% CI 1.83–2.51), disease-free survival (DFS) (HR = 1.81, 95% CI 1.60–2.04), PFS (HR = 1.71, 95% CI 1.31–2.22) and cancer-specific survival (CSS) (HR = 2.22, 95% CI 1.67–2.95)<sup>##REF##36720974##37##</sup>. Notably, in their meta-analysis only five included studies focused on lung cancer<sup>##REF##36720974##37##</sup>. Besides, Zhang et al. included 12 cohorts and demonstrated that lower AAPR predicted significantly poorer OS (HR = 2.02, 95% CI 1.78–2.30) and RFS (HR = 1.88, 95% CI 1.37–2.57) in hepatocellular carcinoma patients<sup>##REF##36720974##37##</sup>. This was the first meta-analysis to identify the prognosis role of AAPR in lung cancer and our results strongly indicated the association of lower pretreatment AAPR with worse survival of lung cancer patients.</p>", "<p id=\"Par25\">According to current evidence, we speculate some application of AAPR in clinics. AAPR is used as a prognostic indicator in assessing lung cancer patients. A lower AAPR is typically associated with an unfavorable prognosis, indicating a poorer physical condition in patients and a higher susceptibility to malignant tumor-related complications. Physicians can monitor changes in AAPR before and after treatment to assess the effectiveness of therapy and the overall condition of the patient. AAPR can serve as an auxiliary metric, aiding doctors in devising more personalized treatment plans. For patients with a lower AAPR, more proactive supportive therapies, such as nutritional support or adjustments to the treatment plan, may be necessary to enhance treatment tolerance. Changes in AAPR can also be utilized to monitor disease recurrence in lung cancer patients. Following treatment, a rapid decline in AAPR may suggest tumor recurrence or progression, prompting physicians to undertake further examinations or adjust the treatment plan. However, AAPR should be considered as part of a comprehensive evaluation alongside other clinical and laboratory indicators, rather than being used in isolation. Other factors influencing AAPR, such as infections, inflammation, and other chronic diseases, should also be taken into account. Additionally, caution is advised when interpreting AAPR results, as they may be influenced by various factors. Clinical practitioners should integrate AAPR with the overall patient profile and other relevant indicators for a more accurate assessment of the patient’s disease status and the formulation of individualized treatment plans.</p>", "<p id=\"Par26\">Several limitations existed in our meta-analysis. First, all included studies are retrospective with relatively small sample sizes. Second, most included studies are from China, limiting the generalizability of our results. Third, it was unable to conduct more subgroup analysis based on other important parameters such as the tumor stage and age. Four, it is not feasible to determine the optimal threshold of AAPR due to the lack of original data.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par27\">Pretreatment AAPR is significantly related to prognosis and tumor stage in lung cancer and patients with a lower pretreatment AAPR are more likely to experience poor survival and advanced tumor stage. Therefore, the pretreatment AAPR could serve as a novel and valuable prognostic factor in lung cancer patients.</p>" ]
[ "<p id=\"Par1\">The association between pretreatment albumin-to-alkaline phosphatase ratio (AAPR) and clinicopathological parameters and prognosis in lung cancer is unclear. The study aimed to identify the clinical role of pretreatment AAPR among lung cancer patients. Several databases were searched for relevant studies. The primary outcome and secondary outcome were long-term survival including the overall survival (OS) and progression-free survival (PFS) and clinicopathological characteristics, respectively. The hazard ratios (HRs) and relative risks (RRs) with 95% confidence intervals (CIs) were combined. A total of 11 publications involving 10,589 participants were included in this meta-analysis. The pooled results manifested that a lower pretreatment AAPR predicted poorer OS (HR = 0.65, 95% CI 0.59–0.71, <italic>P</italic> &lt; 0.001) and PFS (HR = 0.68, 95% CI 0.59–0.78, <italic>P</italic> &lt; 0.001). Furthermore, subgroup analysis for the OS and PFS based on the pathological type and treatment showed similar results and pretreatment AAPR was significantly associated with worse prognosis. Besides, pretreatment AAPR was significantly associated with male (RR = 1.08, 95% CI 1.03–1.13, <italic>P</italic> &lt; 0.001), poor differentiation (RR = 1.33, 95% CI 1.03–1.73, <italic>P</italic> = 0.029), advanced T stage (RR = 1.25, 95% CI 1.03–1.52, <italic>P</italic> = 0.026), N stage (RR = 1.34, 95% CI 1.15–1.55, <italic>P</italic> &lt; 0.001) and TNM stage (RR = 1.14, 95% CI 1.06–1.223, <italic>P</italic> &lt; 0.001). Therefore, pretreatment AAPR is significantly related to prognosis and tumor stage in lung cancer and patients with a lower pretreatment AAPR are more likely to experience poor survival and advanced tumor stage.</p>", "<title>Subject terms</title>" ]
[]
[ "<title>Acknowledgements</title>", "<p>None.</p>", "<title>Author contributions</title>", "<p>X.X. designed the study. Y.Y. and Y.W. established the process of literature selection and screened the abstracts and articles. Y.W. and X.L. analyzed data. Y.Y. and X.X. wrote the main manuscript. All authors reviewed and approved the final manuscript.</p>", "<title>Funding</title>", "<p>This work is supported by Sichuan Provincial Health Committee Research Project Grand (20PJ289) and Natural Science Foundation of Sichuan Province (2023NSFSC1893).</p>", "<title>Data availability</title>", "<p>All data generated or analyzed during this study are included in this published article.</p>", "<title>Competing interests</title>", "<p id=\"Par28\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Prisma flow diagram.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>The association between pretreatment albumin-to-alkaline phosphatase ratio and overall survival of lung cancer patients.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>The association between pretreatment albumin-to-alkaline phosphatase ratio and progression-free survival of lung cancer patients.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Sensitivity analysis about the association between pretreatment albumin-to-alkaline phosphatase ratio and overall survival of lung cancer patients.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Begg’s funnel plot for the association between pretreatment albumin-to-alkaline phosphatase ratio and overall survival of lung cancer patients.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Filled Begg’s funnel plot for the association between pretreatment albumin-to-alkaline phosphatase ratio and overall survival of lung cancer patients.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Basic characteristics of included studies.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Author</th><th align=\"left\">Year</th><th align=\"left\">Country</th><th align=\"left\">Sample size</th><th align=\"left\">Pathological type</th><th align=\"left\">Treatment</th><th align=\"left\">Tumor stage</th><th align=\"left\">Cutoff value of AAPR</th><th align=\"left\">Survival endpoint</th><th align=\"left\">NOS</th></tr></thead><tbody><tr><td align=\"left\">Li<sup>##REF##31303770##14##</sup></td><td align=\"left\">2019</td><td align=\"left\">China</td><td char=\".\" align=\"char\">290</td><td align=\"left\">NSCLC</td><td align=\"left\">Non-surgery</td><td align=\"left\">TNM IV</td><td char=\".\" align=\"char\">0.36</td><td align=\"left\">OS</td><td align=\"left\">8</td></tr><tr><td align=\"left\">Li<sup>##REF##31319230##15##</sup></td><td align=\"left\">2019</td><td align=\"left\">China</td><td char=\".\" align=\"char\">390</td><td align=\"left\">NSCLC</td><td align=\"left\">Surgery</td><td align=\"left\">TNM I-IIIA</td><td char=\".\" align=\"char\">0.57</td><td align=\"left\">OS, PFS</td><td align=\"left\">8</td></tr><tr><td align=\"left\">Li<sup>##REF##30644319##16##</sup></td><td align=\"left\">2019</td><td align=\"left\">China</td><td char=\".\" align=\"char\">122</td><td align=\"left\">SCLC</td><td align=\"left\">Non-surgery</td><td align=\"left\">Limited stage</td><td char=\".\" align=\"char\">0.61</td><td align=\"left\">OS, PFS</td><td align=\"left\">7</td></tr><tr><td align=\"left\">Zhang<sup>##REF##31161711##17##</sup></td><td align=\"left\">2019</td><td align=\"left\">China</td><td char=\".\" align=\"char\">496</td><td align=\"left\">NSCLC</td><td align=\"left\">Surgery</td><td align=\"left\">TNM I-III</td><td char=\".\" align=\"char\">0.64</td><td align=\"left\">OS, PFS</td><td align=\"left\">8</td></tr><tr><td align=\"left\">Li<sup>##REF##32982294##18##</sup></td><td align=\"left\">2020</td><td align=\"left\">China</td><td char=\".\" align=\"char\">300</td><td align=\"left\">SCLC</td><td align=\"left\">Non-surgery</td><td align=\"left\">Extensive stage</td><td char=\".\" align=\"char\">0.52</td><td align=\"left\">OS, PFS</td><td align=\"left\">7</td></tr><tr><td align=\"left\">Zhou<sup>##REF##32691996##19##</sup></td><td align=\"left\">2020</td><td align=\"left\">China</td><td char=\".\" align=\"char\">808</td><td align=\"left\">NSCLC</td><td align=\"left\">Non-surgery</td><td align=\"left\">TNM III-IV</td><td char=\".\" align=\"char\">0.34</td><td align=\"left\">OS</td><td align=\"left\">7</td></tr><tr><td align=\"left\">Zhou<sup>##REF##32256109##20##</sup></td><td align=\"left\">2020</td><td align=\"left\">China</td><td char=\".\" align=\"char\">224</td><td align=\"left\">SCLC</td><td align=\"left\">Non-surgery</td><td align=\"left\">Extensive stage</td><td char=\".\" align=\"char\">0.35</td><td align=\"left\">OS</td><td align=\"left\">8</td></tr><tr><td align=\"left\">Birgitte<sup>##REF##34885242##21##</sup></td><td align=\"left\">2021</td><td align=\"left\">Denmark</td><td char=\".\" align=\"char\">5979</td><td align=\"left\">NSCLC</td><td align=\"left\">Mixed</td><td align=\"left\">TNM I-IV</td><td char=\".\" align=\"char\">0.35</td><td align=\"left\">OS</td><td align=\"left\">7</td></tr><tr><td align=\"left\">Birgitte<sup>##REF##34885242##21##</sup></td><td align=\"left\">2021</td><td align=\"left\">Denmark</td><td char=\".\" align=\"char\">1099</td><td align=\"left\">SCLC</td><td align=\"left\">Mixed</td><td align=\"left\">TNM I-IV</td><td char=\".\" align=\"char\">0.35</td><td align=\"left\">OS</td><td align=\"left\">7</td></tr><tr><td align=\"left\">Liu<sup>##REF##33565707##22##</sup></td><td align=\"left\">2021</td><td align=\"left\">China</td><td char=\".\" align=\"char\">167</td><td align=\"left\">NSCLC</td><td align=\"left\">Non-surgery</td><td align=\"left\">Advanced</td><td char=\".\" align=\"char\">0.238</td><td align=\"left\">OS, PFS</td><td align=\"left\">8</td></tr><tr><td align=\"left\">Gan<sup>##REF##35378914##23##</sup></td><td align=\"left\">2022</td><td align=\"left\">China</td><td char=\".\" align=\"char\">598</td><td align=\"left\">NSCLC</td><td align=\"left\">Non-surgery</td><td align=\"left\">TNM IIIB-IV</td><td char=\".\" align=\"char\">0.47</td><td align=\"left\">OS, PFS</td><td align=\"left\">7</td></tr><tr><td align=\"left\">Hu<sup>##UREF##4##24##</sup></td><td align=\"left\">2022</td><td align=\"left\">China</td><td char=\".\" align=\"char\">116</td><td align=\"left\">NSCLC</td><td align=\"left\">Mixed</td><td align=\"left\">TNM I-IV</td><td char=\".\" align=\"char\">0.35</td><td align=\"left\">OS</td><td align=\"left\">6</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>The association between albumin-to-alkaline phosphatase ratio and prognosis in lung cancer.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\"/><th align=\"left\">No. of studies</th><th align=\"left\">Hazard ratio</th><th align=\"left\">95% confidence interval</th><th align=\"left\">P value</th><th align=\"left\">I<sup>2</sup> (%)</th><th align=\"left\">P value</th></tr></thead><tbody><tr><td align=\"left\">Overall survival</td><td align=\"left\">11<sup>##REF##31303770##14##–##UREF##4##24##</sup></td><td char=\".\" align=\"char\">0.65</td><td align=\"left\">0.59–0.71</td><td char=\".\" align=\"char\">&lt; 0.001</td><td char=\".\" align=\"char\">52.0</td><td char=\".\" align=\"char\">0.018</td></tr><tr><td align=\"left\" colspan=\"7\">Pathological type</td></tr><tr><td align=\"left\"> NSCLC</td><td align=\"left\">8<sup>##REF##31303770##14##,##REF##31319230##15##,##REF##31161711##17##,##REF##32691996##19##,##REF##34885242##21##–##UREF##4##24##</sup></td><td char=\".\" align=\"char\">0.65</td><td align=\"left\">0.58–0.73</td><td char=\".\" align=\"char\">&lt; 0.001</td><td char=\".\" align=\"char\">63.0</td><td char=\".\" align=\"char\">0.008</td></tr><tr><td align=\"left\"> SCLC</td><td align=\"left\">4<sup>##REF##30644319##16##,##REF##32982294##18##,##REF##32256109##20##,##REF##34885242##21##</sup></td><td char=\".\" align=\"char\">0.62</td><td align=\"left\">0.54–0.71</td><td char=\".\" align=\"char\">&lt; 0.001</td><td char=\".\" align=\"char\">0.0</td><td char=\".\" align=\"char\">0.994</td></tr><tr><td align=\"left\" colspan=\"7\">Treatment</td></tr><tr><td align=\"left\"> Non-surgery</td><td align=\"left\">7<sup>##REF##31303770##14##,##REF##30644319##16##,##REF##32982294##18##–##REF##32256109##20##,##REF##33565707##22##,##REF##35378914##23##</sup></td><td char=\".\" align=\"char\">0.60</td><td align=\"left\">0.53–0.68</td><td char=\".\" align=\"char\">&lt; 0.001</td><td char=\".\" align=\"char\">0.0</td><td char=\".\" align=\"char\">0.804</td></tr><tr><td align=\"left\"> Surgery</td><td align=\"left\">2<sup>##REF##31319230##15##,##REF##31161711##17##</sup></td><td char=\".\" align=\"char\">0.46</td><td align=\"left\">0.33–0.65</td><td char=\".\" align=\"char\">&lt; 0.001</td><td char=\".\" align=\"char\">47.8</td><td char=\".\" align=\"char\">0.166</td></tr><tr><td align=\"left\"> Mixed</td><td align=\"left\">2<sup>##REF##34885242##21##,##UREF##4##24##</sup></td><td char=\".\" align=\"char\">0.73</td><td align=\"left\">0.70–0.77</td><td char=\".\" align=\"char\">&lt; 0.001</td><td char=\".\" align=\"char\">48.7</td><td char=\".\" align=\"char\">0.142</td></tr><tr><td align=\"left\">Progression-free survival</td><td align=\"left\">6<sup>##REF##31319230##15##–##REF##32982294##18##,##REF##33565707##22##,##REF##35378914##23##</sup></td><td char=\".\" align=\"char\">0.68</td><td align=\"left\">0.59–0.78</td><td char=\".\" align=\"char\">&lt; 0.001</td><td char=\".\" align=\"char\">32.5</td><td char=\".\" align=\"char\">0.192</td></tr><tr><td align=\"left\" colspan=\"7\">Pathological type</td></tr><tr><td align=\"left\"> NSCLC</td><td align=\"left\">4<sup>##REF##31319230##15##,##REF##31161711##17##,##REF##33565707##22##,##REF##35378914##23##</sup></td><td char=\".\" align=\"char\">0.70</td><td align=\"left\">0.60–0.80</td><td char=\".\" align=\"char\">&lt; 0.001</td><td char=\".\" align=\"char\">54.0</td><td char=\".\" align=\"char\">0.089</td></tr><tr><td align=\"left\"> SCLC</td><td align=\"left\">2<sup>##REF##30644319##16##,##REF##32982294##18##</sup></td><td char=\".\" align=\"char\">0.59</td><td align=\"left\">0.40–0.86</td><td char=\".\" align=\"char\">0.007</td><td char=\".\" align=\"char\">0.0</td><td char=\".\" align=\"char\">0.632</td></tr><tr><td align=\"left\" colspan=\"7\">Treatment</td></tr><tr><td align=\"left\"> Non-surgery</td><td align=\"left\">4<sup>##REF##30644319##16##,##REF##32982294##18##,##REF##33565707##22##,##REF##35378914##23##</sup></td><td char=\".\" align=\"char\">0.72</td><td align=\"left\">0.62–0.84</td><td char=\".\" align=\"char\">&lt; 0.001</td><td char=\".\" align=\"char\">36.7</td><td char=\".\" align=\"char\">0.192</td></tr><tr><td align=\"left\"> Surgery</td><td align=\"left\">2<sup>##REF##31319230##15##,##REF##31161711##17##</sup></td><td char=\".\" align=\"char\">0.55</td><td align=\"left\">0.40–0.74</td><td char=\".\" align=\"char\">&lt; 0.001</td><td char=\".\" align=\"char\">0.0</td><td char=\".\" align=\"char\">0.603</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>The association between albumin-to-alkaline phosphatase ratio and clinicopathological parameters in lung cancer.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Author</th><th align=\"left\">Age (older)</th><th align=\"left\">Gender (male)</th><th align=\"left\">Smoking history</th><th align=\"left\">Differentiation degree (low)</th><th align=\"left\">T stage (advanced)</th><th align=\"left\">N stage (advanced)</th><th align=\"left\">TNM stage (advanced)</th></tr></thead><tbody><tr><td align=\"left\">Li<sup>##REF##31303770##14##</sup></td><td align=\"left\">1.027 (0.777–1.356)</td><td align=\"left\">1.054 (0.867–1.282)</td><td align=\"left\">1.012 (0.781–1.311)</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td></tr><tr><td align=\"left\">Li<sup>##REF##31319230##15##</sup></td><td align=\"left\">1.096 (0.868–1.384)</td><td align=\"left\">1.050 (0.898–1.227)</td><td align=\"left\">1.206 (0.978–1.486)</td><td align=\"left\">1.175 (0.800–1.728)</td><td align=\"left\">1.225 (1.012–1.483)</td><td align=\"left\">1.746 (1.132–2.694)</td><td align=\"left\">2.029 (1.454–2.832)</td></tr><tr><td align=\"left\">Li<sup>##REF##30644319##16##</sup></td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td></tr><tr><td align=\"left\">Zhang<sup>##REF##31161711##17##</sup></td><td align=\"left\">1.145 (0.941–1.394)</td><td align=\"left\">1.013 (0.893–1.148)</td><td align=\"left\">1.115 (0.979–1.270)</td><td align=\"left\">–</td><td align=\"left\">1.864 (1.298–2.676)</td><td align=\"left\">1.330 (1.063–1.665)</td><td align=\"left\">1.450 (1.135–1.852)</td></tr><tr><td align=\"left\">Li<sup>##REF##32982294##18##</sup></td><td align=\"left\">1.000 (0.750–1.332)</td><td align=\"left\">1.089 (0.930–1.276)</td><td align=\"left\">1.028 (0.835–1.266)</td><td align=\"left\">–</td><td align=\"left\">1.190 (0.922–1.534)</td><td align=\"left\">1.250 (0.912–1.715)</td><td align=\"left\">–</td></tr><tr><td align=\"left\">Zhou<sup>##REF##32691996##19##</sup></td><td align=\"left\">0.755 (0.587–0.971)</td><td align=\"left\">1.083 (0.986–1.191)</td><td align=\"left\">1.085 (0.945–1.246)</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">1.134 (1.076–1.195)</td></tr><tr><td align=\"left\">Zhou<sup>##REF##32256109##20##</sup></td><td align=\"left\">1.075 (0.825–1.402)</td><td align=\"left\">1.127 (1.039–1.223)</td><td align=\"left\">1.042 (0.906–1.197)</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td></tr><tr><td align=\"left\">Birgitte<sup>##REF##34885242##21##</sup></td><td align=\"left\">–</td><td align=\"left\">1.064 (1.012–1.119)</td><td align=\"left\">1.001 (0.986–1.017)</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">1.177 (1.139–1.216)</td></tr><tr><td align=\"left\">Birgitte<sup>##REF##34885242##21##</sup></td><td align=\"left\">–</td><td align=\"left\">1.276 (1.134–1.437)</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">1.058 (1.023–1.093)</td></tr><tr><td align=\"left\">Liu<sup>##REF##33565707##22##</sup></td><td align=\"left\">0.982 (0.780–1.236)</td><td align=\"left\">0.821 (0.630–1.069)</td><td align=\"left\">–</td><td align=\"left\">1.484 (1.045–2.109)</td><td align=\"left\">1.031 (0.822–1.294)</td><td align=\"left\">1.243 (0.896–1.725)</td><td align=\"left\">0.957 (0.762–1.201)</td></tr><tr><td align=\"left\">Gan<sup>##REF##35378914##23##</sup></td><td align=\"left\">1.094 (0.921–1.298)</td><td align=\"left\">1.115 (0.925–1.344)</td><td align=\"left\">1.315 (0.991–1.745)</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">1.024 (0.987–1.062)</td></tr><tr><td align=\"left\">Hu<sup>##UREF##4##24##</sup></td><td align=\"left\">–</td><td align=\"left\">0.854 (0.514–1.419)</td><td align=\"left\">0.980 (0.781–1.230)</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">1.207 (0.969–1.504)</td></tr><tr><td align=\"left\">Poole RR with 95% CI</td><td align=\"left\">1.03 (0.95–1.12), <italic> P</italic> = 0.448</td><td align=\"left\">1.08 (1.03–1.13), <italic> P</italic> &lt; 0.001</td><td align=\"left\">1.00 (0.99–1.02), <italic> P</italic> = 0.537</td><td align=\"left\">1.33 (1.03–1.73), <italic> P</italic> = 0.029</td><td align=\"left\">1.25 (1.03–1.52), <italic> P</italic> = 0.026</td><td align=\"left\">1.34 (1.15–1.55), <italic> P</italic> &lt; 0.001</td><td align=\"left\">1.14 (1.06–1.22), <italic> P</italic> &lt; 0.001</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[]
[ "<table-wrap-foot><p>NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer; TNM, tumor-node-metastasis; AAPR, albumin-to-alkaline phosphatase ratio; OS, overall survival; PFS, progression-free survival; NOS, NOS: Newcastle–Ottawa Scale.</p></table-wrap-foot>", "<table-wrap-foot><p>NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer.</p></table-wrap-foot>", "<table-wrap-foot><p>RR, relative risk; CI, confidence interval.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51844_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51844_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51844_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51844_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51844_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2024_51844_Fig6_HTML\" id=\"MO6\"/>" ]
[]
[{"label": ["2."], "mixed-citation": ["Release Notice - Canadian Cancer Statistics: A 2020 special report on lung cancer. (2020). Health Promot Chronic Dis Prev Can "], "italic": ["40"]}, {"label": ["9."], "surname": ["Page", "McKenzie", "Bossuyt", "Boutron", "Hoffmann", "Mulrow", "Shamseer", "Tetzlaff", "Akl", "Brennan"], "given-names": ["MJ", "JE", "PM", "I", "TC", "CD", "L", "JM", "EA", "SE"], "article-title": ["The PRISMA 2020 statement: An updated guideline for reporting systematic reviews"], "source": ["BMJ (Clin. Res. Ed.)"], "year": ["2021"], "volume": ["372"], "fpage": ["n71"], "pub-id": ["10.1136/bmj.n71"]}, {"label": ["10."], "surname": ["Wang", "Li", "Chang", "Dong", "Che"], "given-names": ["Y", "J", "S", "Y", "G"], "article-title": ["Risk and influencing factors for subsequent primary lung cancer after treatment of breast cancer: A systematic review and two meta-analyses based on four million cases"], "source": ["J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"], "year": ["2021"], "volume": ["16"], "fpage": ["1893"], "lpage": ["1908"], "pub-id": ["10.1016/j.jtho.2021.07.001"]}, {"label": ["12."], "surname": ["Egger", "Davey Smith", "Schneider", "Minder"], "given-names": ["M", "G", "M", "C"], "article-title": ["Bias in meta-analysis detected by a simple, graphical test"], "source": ["BMJ (Clin. Res. Ed.)"], "year": ["1997"], "volume": ["315"], "fpage": ["629"], "lpage": ["634"], "pub-id": ["10.1136/bmj.315.7109.629"]}, {"label": ["24."], "surname": ["Hu", "Li", "Xiang", "Zhang"], "given-names": ["S", "X", "M", "X"], "article-title": ["Value of albumin to alkaline phosphatase ratio in predicting clinical outcome of patients with non-small cell lung cancer"], "source": ["J. Med. Forum"], "year": ["2022"], "volume": ["43"], "fpage": ["1"], "lpage": ["4+9"]}]
{ "acronym": [], "definition": [] }
38
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1166
oa_package/12/05/PMC10786841.tar.gz
PMC10786842
38216575
[ "<title>Introduction</title>", "<p id=\"Par2\">Several horse breeds were developed and adapted to different Brazilian regions over the centuries, meeting local needs. Among these breeds, the <italic>Nordestino</italic> horse stands out: a small to medium-sized trotting gait, light in general appearance, well-proportioned, small and robust hooves, sound resistance, and adapted to the semiarid region<sup>##UREF##0##1##</sup>. The semiarid region is characterized by a negative water balance resulting from an average annual precipitation of lower than 800 mm, insolation of 2800 h per year, an average annual temperature ranging from 23 to 28 °C, evaporation of 2000 mm per year, and a relative humidity around 60%<sup>##UREF##1##2##</sup>.</p>", "<p id=\"Par3\">Most horses in the Northeastern semiarid region are animals without a defined breed pattern, remnants of breeds resulting from crossings with other breeds, which managed to adapt to the bioclimatic conditions of the region<sup>##UREF##0##1##</sup>. Today, the crosses mentioned above are with the Quarto de Milha, Mangalarga, and English Thoroughbred horse breeds. Indiscriminate crossbreeding, the castration of males, and using females in stud farms as recipients keep the breed under constant threat, so a genetic conservation plan is necessary.</p>", "<p id=\"Par4\">Phenotypic characterization is one of the first steps in conserving animal genetic resources programs since the results obtained from zoometric measurements allow for characterizing or classifying individuals within a population or breed. Body size and body conformation are essential traits to characterize horse breeds. Breeders' associations typically select horses based on functional criteria and encourage breeding animals with the best available body structure, with correct skeletal conformation being a key determinant of body type<sup>##REF##21070291##3##</sup>. According to Parés-Casanova<sup>##UREF##2##4##</sup> and Pimentel et al.<sup>##UREF##3##5##</sup>, linear measurements have been used for selection, breed differentiation, and identification of specific abilities of each breed, as they can contribute to verifying the qualities and defects of each body region. Zootechnical selection should instead be carried out within the breed to correct defects that could harm and prevent its use<sup>##UREF##4##6##</sup>.</p>", "<p id=\"Par5\">Due to the lack of information, the present study aimed to describe the breeding systems and characterize the phenotypical profile of the Nordestino horse in Paraiba state, seeking to contribute to breed conservation.</p>" ]
[ "<title>Materials and methods</title>", "<title>Animals and locals of data collection</title>", "<p id=\"Par6\">This study was carried out following the ethical principles of animal experimentation and under the approval of the Animal Ethics Committee of the <italic>Instituto Nacional do Semiárido</italic> (National Institute of Semi-Arid) (protocol n° 0002/2022), Brazil. Data from males (entire and castrated) and females from 50 municipalities in Paraíba state were used (Fig. ##FIG##0##1##).</p>", "<p id=\"Par7\">The initial data file was composed of information referring to 310 animals. However, after preliminary data analysis, it was decided to use animals whose height was within the breed standard described by the <italic>Associação Brasileira de Criadores do Cavalo Nordestino</italic> (Brazilian Association of Breeders of the <italic>Nordestino</italic> horse) (ABCCN) (Fig. ##FIG##1##2##). Therefore, data from 269 animals (111 females, 121 castrated males, and 37 entire males) were analyzed. The animals were evaluated by dental chronometry; all were in their first molt and entire mouth. Table ##TAB##0##1## shows the number of animals and the wither height (WH) of animals excluded from the study, considering the minimum and maximum WH.</p>", "<title>Data collection of the breeding system</title>", "<p id=\"Par8\">Interviews were carried out with 128 breeders using a questionnaire composed of direct questions adapted from Arandas et al.<sup>##UREF##5##7##,##UREF##6##8##</sup>. To guarantee uniformity of the data collected, all questions, answer options, and the sequence of questions were identical for all interviewees. To ensure that the differences in the results obtained were due to each breeder's vision, the interviewers were trained adequately through in-person and virtual workshops.</p>", "<p id=\"Par9\">The questionnaire was subdivided into sections, whose questions addressed the profile of the breeders, the general traits of the farms, quantitative characteristics of farm infrastructure, qualitative aspects of the herds—food management, health and reproductive, technological traits of the farms; zootechnical management and control.</p>", "<title>Morphometric traits measurements</title>", "<p id=\"Par10\">It was used a tape measure and a hypometer to measure the variables according to Melo et al.<sup>##UREF##0##1##</sup>:</p>", "<p id=\"Par11\">The measurements performed were:</p>", "<p id=\"Par12\">Wither height (WH) corresponding to the highest point of the interscapular region to the ground;</p>", "<p id=\"Par13\">Croup height (CH) from the highest point of the sacral tuberosity of the ileum to the ground;</p>", "<p id=\"Par14\">Body length (BL) traced between the greater tubercle of the humerus and the ischial tuberosity;</p>", "<p id=\"Par15\">Neck length (NL) distance between the nape of the neck and the superior junction with the withers;</p>", "<p id=\"Par16\">Substernal void height (SVH) distance between the ground and the sternum;</p>", "<p id=\"Par17\">Thoracic depth (TD) vertical distance between the highest point of the interscapular region and the xiphoid cartilage perpendicularly to the ground;</p>", "<p id=\"Par18\">Croup length (CL) vertical distance between the highest point of the croup and the flank crease perpendicular to the ground;</p>", "<p id=\"Par19\">Cannon girth (CaG) was measured by the circumference of the left metacarpal bone in its middle third;</p>", "<p id=\"Par20\">Thoracic perimeter (TP) circumference of the chest traced along the line of the spinous apophysis of the 7th-8th thoracic vertebra to the corresponding lower sternal region at the level of the olecranon tuberosity;</p>", "<p id=\"Par21\">Head length (HL) corresponds to the distance from the occipital protuberance to the most rostral point of the upper lip;</p>", "<p id=\"Par22\">Head width (HW) was the distance between the free part of the right supraorbital border and the left border.</p>", "<title>Zoometric indices</title>", "<p id=\"Par23\">The following zoometric indices were calculated:</p>", "<p id=\"Par24\">Dactyl-thoracic index (DTI = CaG/TP): the relationship between the cannon girth (CaG) and the thoracic perimeter (TP). It should not be less than 0.105 for light horses, 0.108 for intermediate horses, 0.110 for light traction horses, and 0.115 for heavy traction horses<sup>##UREF##7##9##</sup>;</p>", "<p id=\"Par25\">Body index (BI = BL/TP × 100): the relationship between body length and thoracic perimeter multiplied by 100. Allows classifying animals, considering the Baronian system, into brevilines when less than or equal to 85, mediolines if between 86 and 88, and long when greater than or equal to 90<sup>##UREF##2##4##</sup>;</p>", "<p id=\"Par26\">Conformation index (CFI = TP<sup>2</sup>/WH): the ratio between the thoracic perimeter squared and divided by the height at the withers. The value of 2.1125 is ideal for the saddle horse, while higher values indicate animals suitable for traction<sup>##UREF##7##9##</sup>;</p>", "<p id=\"Par27\">Compactness index (COI = (W/WH/100): the relationship between weight (kg) and height at the withers, in cm. For a heavy draft horse, the value must be at least equal to 3.15; for a horse with light traction, 2.75; and, for the saddle horse, 2.60<sup>##UREF##7##9##</sup>;</p>", "<p id=\"Par28\">The ratio between height at withers and croup (WCR = WH/CH): the ratio between height at withers divided by height at the croup. The value obtained must be equal to 1.00, which expresses a balance factor<sup>##UREF##7##9##</sup>;</p>", "<p id=\"Par29\">Load index 1 (LOI1 = (TP<sup>2</sup> × 56)/WH): thoracic perimeter squared and multiplied by the constant 56, divided by the wither height. It expresses the weight, in kilograms, that the animal can support without excessive effort on its back, working at a trot or gallop<sup>##UREF##7##9##</sup>;</p>", "<p id=\"Par30\">Load index 2 (LOI2 = (TP<sup>2</sup> × 95)/WH): thoracic perimeter squared and multiplied by the constant 95, divided by the wither height. It expresses the weight, in kilograms, that the animal can support without excessive effort on its back, working at a pace<sup>##UREF##7##9##</sup>;</p>", "<p id=\"Par31\">Observed body weight (OBW): body weight obtained with a measuring tape when measuring thoracic perimeter;</p>", "<p id=\"Par32\">Estimated body weight (EBW) (W3 = TP<sup>3</sup> × 80) corresponds to the thoracic perimeter cubed and multiplied by the constant 80<sup>##UREF##7##9##</sup>.</p>", "<title>Statistical analysis</title>", "<p id=\"Par33\">Data relating to the characterization of the production system were subjected to a frequency analysis. A simple descriptive analysis was conducted for morphometric data, calculating means and standard deviations. The t-test with a significance level of 5%<sup>##UREF##8##10##</sup> was applied.</p>", "<p id=\"Par34\">The morphometric traits were submitted to discriminant analysis using the <italic>stepwise</italic> method. The animals were categorized into three groups: Female, Castrated Male, and Whole Male. Multivariate discriminant analysis was chosen as the main statistical approach to identify significant morphometric variables in group differentiation. The stepwise method, an iterative approach that incorporates or removes variables sequentially based on statistical criteria, was chosen. The final discriminant model, composed of the most relevant variables, was developed through this process.</p>", "<p id=\"Par35\">The general form of the discriminant model is expressed as:where <italic>Y</italic> was the discriminant trait; coefficients to be estimated; independent traits (morphometrical traits).</p>", "<title>Arrive</title>", "<p id=\"Par36\">The study is reported by ARRIVE guidelines (<ext-link ext-link-type=\"uri\" xlink:href=\"https://arriveguidelines.org\">https://arriveguidelines.org</ext-link>).</p>" ]
[ "<title>Results</title>", "<title>Characterization of the hearing system</title>", "<p id=\"Par37\">Most breeders adopt the extensive breeding system (85%), where most animals (80%) consume only native pasture (Table ##TAB##1##2##), which is characteristic of the local production system.</p>", "<p id=\"Par38\">The predominance of the extensive breeding system reflects the adaptation of the Nordestino horse to the local conditions. This result is consistent with the traditional characteristics of the breed, known for its rusticity and resistance. The lower frequency use of cultivated pastures may be related to issues of economic viability since the maintenance of cultivated pastures may require additional investments compared to the use of natural pastures.</p>", "<p id=\"Par39\">Most breeders (88.27%) have between one and three animals (Table ##TAB##2##3##) used in carts, cultivation, or cattle management; this requires specific management for these animals, as they require different sanitary and reproductive food management strategies than those applied to cattle. The small number of animals per breeder is typical in systems where the horse was used only for handling and managing livestock, unlike horse breeding for other purposes.</p>", "<p id=\"Par40\">Regarding nutritional aspects, horses were kept together with cattle in large areas of native pastures comprising the food base. Twenty-three percent of the interviewed reported the use of mineral or food supplies. Twenty-five percent use concentrate, hay, silage, or corn in supply. A breeder said using a mix of palm Mexican Elephant Ear (<italic>Opuntia stricta</italic>) and corn bran (in the morning shift) (Fig. ##FIG##2##3##) and bran made from Maniçoba hay (<italic>Manihot pseudoglaziovii</italic>) (in the afternoon shift).</p>", "<p id=\"Par41\">Many breeders (48%) stated that they provide mineral supplementation for their animals (Fig. ##FIG##3##4##). Considering zootechnical records, only 10% of breeders use birth notes and genealogical information (Fig. ##FIG##4##5##).</p>", "<p id=\"Par42\">Most breeders adopt controlled breeding as they have few animals, which helps prevent inbreeding. A minority of breeders split animals by sex to avoid endogamic mating and exchanging stallions (58%). This practice was observed on-farm, as seen in Fig. ##FIG##5##6##. Only 10% of breeders carry out selection. Those who adopt this practice do so based on conformation criteria, such as animal size (from small to medium), suitable aplomb, transmission of the main characteristics to the offspring, age, and number of offspring per breeder.</p>", "<p id=\"Par43\">Rational taming was adopted by only 10% of breeders, whether sending their animals to specialized tamers or a skilled cowboy to carry out the process. On the other hand, it was found that 90% of breeders face difficulties in finding a tamer, resulting in the option for traditional taming or castration.</p>", "<p id=\"Par44\">Regarding sanitary management, it was found that 65% of breeders adopt strategic deworming at the end of the drought and at the beginning of the rainy season when the animals are dewormed. However, only 10% of the breeders said they carried out ectoparasite control and periodic examinations to detect Equine Infectious Anemia (EIA).</p>", "<title>Phenotypic profile of animals</title>", "<p id=\"Par45\">It was observed that neck length (<italic>P</italic> = 0.0044), body length (<italic>P</italic> = 0.0449), thoracic perimeter (<italic>P</italic> = 0.0496), cannon girth (<italic>P</italic> = 0.0029), thoracic depth (<italic>P</italic> &lt; 0.0001), and croup height (<italic>P</italic> = 0.0003) showed significant differences depending on sex (Table ##TAB##3##4##).</p>", "<p id=\"Par46\">Females and castrated males had greater neck length than all males (<italic>P</italic> = 0.0044). Females had greater body length and were castrated, and all males had statistically equal body length values (<italic>P</italic> = 0.0449). Castrated males had a larger thoracic perimeter than females and all males. Cannon girth (<italic>P</italic> = 0.0024) and height at substernal void (<italic>P</italic> &lt; 0.001) were more significant in castrated males. On the other hand, female and castrated males presented higher values of thoracic depth (<italic>P</italic> = 0.0003) than all males. This results in good lung development and greater digestive capacity, which is of great importance for the performance of the animals. In the case of entire males, the values may be associated with the lower body weight observed in these animals.</p>", "<p id=\"Par47\">In this study, one of the criteria was to evaluate entire males with a minimum withers height (WH) of 130 cm, a value that is within that established by the <italic>Associação Brasileira de Criadores do Cavalo Nordestino</italic> (Brazilian Association of Breeders of the Nordestino Horse)<sup>##UREF##9##11##</sup>, which is 130–138 cm, with 146 cm being the maximum height allowed by the current regulations of the association as mentioned earlier. Animals with WH below 130 cm are considered minor. However, they are the most commonly found in the different municipalities studied. Genetic factors and management seem responsible for the difficulty in the Nordestino horse growth since most have had a history of poor nutritional management. Together with their mothers, the foal stage has feeding based only on native forage and without food supplementation.</p>", "<p id=\"Par48\">The studied animals are characteristic of the northeastern semi-arid landscape and well-suited to open-field breeding conditions. Our findings revealed that those animals born between 2019 and 2022 exhibited greater height and superior body weights. During this period, they experienced more regular rainfall, increasing forage availability in pastures.</p>", "<p id=\"Par49\">In the present study, it was observed that adult females (full mouth) kept on native pasture were small (short stature) and had WH ranging from 123 to 126 cm, which was to the above statements about the importance of the availability of forages.</p>", "<p id=\"Par50\">The relationship between height at withers and body length (Table ##TAB##3##4##) varies from 0.99 (females) to 1.01 (castrated and entirely males) and indicates that, in general, they are well-proportioned animals.</p>", "<p id=\"Par51\">The average croup height of the females was equal to the height at the withers (Table ##TAB##3##4##), which is desirable for the animal's balance and, as established by ABCCN. Castrated and all males had WH greater than CH, 137 and 135 cm; 135 and 134 cm, respectively. Preferably, the horse should have equal CH and WH. When the height at the withers is higher than at the croup, the horse is called tall in front, and if the opposite is true, it is called short in front. Both cases constitute defects resulting from the abnormal opening of the anterior and posterior joint angles, more or less affecting the animal's gaits and resistance<sup>##UREF##10##12##</sup>.</p>", "<title>Morphometric indices</title>", "<p id=\"Par52\">The DTI (<italic>P</italic> = 0.0347), CFI (<italic>P</italic> = 0.0066), COI (<italic>P</italic> = 0.0167), WCR (<italic>P</italic> = 0.0124), LOI2 (<italic>P</italic> = 0.0116), and WH/NL (<italic>P</italic> = 0.0082) showed a significant difference depending on sex (Table ##TAB##4##5##).</p>", "<p id=\"Par53\">The DTI presented a higher value for all males and was statistically similar to castrated males. The animals gave DTI above 0.115, classifying them as heavy traction horses. The females and castrated males showed higher CFI (1.78 and 1.82, respectively), below the ideal value for saddle horses, which is 2.1125. Even so, the animals are better suited to saddle than traction.</p>", "<p id=\"Par54\">All animals in this study were classified as hypometric because they had a body weight (observed and estimated) (Table ##TAB##4##5##) below 350 kg, according to the classification of Torres &amp; Jardim<sup>##UREF##7##9##</sup>, therefore suitable for services that require speed.</p>", "<title>Multivariate analysis of morphometric traits</title>", "<p id=\"Par55\">Among the 11 morphometric measurements, only five were considered discriminating by the stepwise analysis. They were the OBW obtained by the tape, the height of the substernal void, cannon girth, body length, and withers height.</p>", "<p id=\"Par56\">Observed body weight is a fundamental measurement of the animal's condition and general health. It is an essential indicator of body size and mass and can influence several morphological characteristics. Body length is a measurement that contributes to assessing the animal's overall size. It is relevant to understand the proportions and conformation of the horse, which can affect its suitability for different purposes, such as work or sport. Wither height is a measurement traditionally used to determine a horse's stature. Classifying the animal according to its breed and breed pattern is a vital characteristic.</p>", "<p id=\"Par57\">Table ##TAB##5##6## lists the animals' classifications in the different groups (sex) based on the morphometric variables evaluated. Among the 110 females considered, only 56.36% (62) were allocated to their group. The others were given to the group of castrated animals and all males. In other words, 43.36% of females have a phenotypic profile similar to males, which explains the high classification error of females. Castrated males differed from the different sexual categories since 79.33% of the animals in this group were correctly classified.</p>", "<p id=\"Par58\">In the linear discriminant classification (Table ##TAB##6##7##), it is observed that the variable withers height presented greater weight, followed by thoracic perimeter and Cannon girth.</p>", "<p id=\"Par59\">Thoracic perimeter and Cannon girth are necessary morphometric measurements in evaluating horses, as they provide valuable information about the animal's physical conformation and ability to perform different activities.</p>", "<p id=\"Par60\">Almost the majority of the remaining were classified in the female group, and only two animals were classified as entire males (Table ##TAB##6##7##). The highest proportion of animals classified incorrectly, that is, in a group different from their group of origin, were castrated males (75.68%), followed by females (43.64%) and entire males (24.67%).</p>" ]
[ "<title>Discussion</title>", "<title>Characterization of the hearing system</title>", "<p id=\"Par61\">Unfortunately, many of the interviewees reported that animals return with physical and psychological problems. According to Hering<sup>##UREF##11##13##</sup>, in the traditional taming model, the peculiarities of the animal's natural behavior are not considered, and little care is given to mental and, in some cases, physical health. In this process, the horse is often driven to exhaustion instead of establishing a trusting connection with the animal.</p>", "<title>Phenotypic profile of animals</title>", "<p id=\"Par62\">In terms of proportionality, when dividing the height at the withers of all classes of animals by 2.5, as described by Camargo &amp; Chieffi<sup>##UREF##12##14##</sup>, the animals had a harmonic head, that is, a shorter head, which is desirable, according to the ABCCN<sup>##UREF##9##11##</sup> breed standard. The width of the head must be equivalent to a third of its length, according to the Eclectic System of Linear Proportions by Lesbre, cited by Torres &amp; Jardim<sup>##UREF##7##9##</sup>, demonstrating that the animals presented this proportionality, especially entire males.</p>", "<p id=\"Par63\">In the substernal void height, castrated males presented a higher value, which allowed classifying all animals as “long-legged,” with an elevation at the substernal void greater than that of the thoracic depth. The males had bodies further from the ground than the others and were more suitable for speed tests<sup>##UREF##10##12##</sup>.</p>", "<p id=\"Par64\">According to ABCCN<sup>##UREF##9##11##</sup>, the ideal WH for females is 135 cm, with a minimum of 127 cm and a maximum of 143 cm. The differences observed in many studies for the same breed are due to the other climate conditions and food availability in the Caatinga ecosystem.</p>", "<p id=\"Par65\">Melo et al.<sup>##UREF##0##1##</sup> verified adult males from the Nordestino horse in Pernambuco with an average WH of 132.31 cm, ranging from 122 to 147 cm. Travassos<sup>##UREF##13##15##</sup> verified WH for males over three years at 136 cm and females older than three years at 131 cm. Dias<sup>##UREF##14##16##</sup>, on the other hand, observed an average WH for males of 128.60 cm, females of 125.86 cm, and castrated males of 127.64 cm. For females, the average WH was 135 cm, varying from 123 to 143 cm.</p>", "<p id=\"Par66\">The relationship between withers, height, and body length must be equal<sup>##UREF##12##14##</sup>. Melo et al.<sup>##UREF##0##1##</sup> observed that this relationship was 0.97 for females and 1.01 for males.</p>", "<p id=\"Par67\">Both males and females are classified as small animals, which, according to Torres &amp; Jardim<sup>##UREF##7##9##</sup>, must have a withers height below 1.50 m. The differences found for the same breed by different authors must be related to the sampling effect and ecological conditions. They are samples of different sizes obtained from animals of varying ages under other management systems and collected by several evaluators in different locations<sup>##UREF##0##1##</sup>.</p>", "<p id=\"Par68\">At birth, the foal already presents appreciable linear growth with around 60–70% of the withers height of an adult animal, reaching 88% at 12 months, 95% of its maximum growth at 24 months, and 100% at 60 months, in average, in its WH<sup>##UREF##15##17##</sup>.</p>", "<p id=\"Par69\">In the prenatal phase, the development of the skeleton and organs occurs. After birth, there is an acceleration of growth and an increase in tissue deposition until puberty. From puberty onwards, around two and a half to 3 years of age, muscle deposition ceases, and fat deposition occurs; there is a slowdown in growth, and the animals reach mature weight and size<sup>##UREF##16##18##</sup>.</p>", "<p id=\"Par70\">Many factors can interfere with animals' pre- and post-natal growth, such as nutrition and feeding, stressful environmental conditions, mother's age, breed, sex, climate, birth year, geographic location, and training. Among these, nutrition plays the most crucial role in the success of all stages of animal life, as it influences placental development and, consequently, fetal and postnatal growth, particularly maternal nutrition<sup>##UREF##3##5##</sup>. Deficient management conditions lead to growth retardation, and the nutritional impact on the foal's development manifests itself in several ways, from slowed global growth to changes in metabolic and structural characteristics usually displayed at an older age<sup>##UREF##17##19##</sup>. Inadequate feeding of the Nordestino horse can contribute to an unfair comparison of this breed against others<sup>##UREF##18##20##</sup>. Animals have a genetically predetermined growth pattern, but the actual growth of animals involves, in addition to genetic factors, environmental factors. In this way, animals grow to a maximum size according to their breed<sup>##UREF##19##21##</sup>.</p>", "<p id=\"Par71\">Travassos<sup>##UREF##13##15##</sup> recorded an average croup height of 136.20 cm in male animals and 131.70 cm in females in Pernambuco. On the other hand, Dias<sup>##UREF##14##16##</sup> observed smaller values in animals from Piauí, noting 128.42 cm for females, 127.48 cm for castrated males, and 127.65 cm for entire males, all of which were smaller than the measurements observed in our study.</p>", "<p id=\"Par72\">The cannon girth in this study was more significant in males than in females. It allowed the characterization of males (entire or castrated) as having thicker shins, indicating a more robust and sturdy build, providing a solid foundation crucial for their activity performance. These results corroborate with Melo et al.<sup>##UREF##0##1##</sup>, who found sexual dimorphism for cannon girth in Nordestino horses in Pernambuco state, with the cannon girth value of males (castrated or entire) being more significant than that of females.</p>", "<title>Morphometric indices</title>", "<p id=\"Par73\">Our results differ from those observed by Travassos<sup>##UREF##13##15##</sup>, which were lower for the DTI, 0.110 and 0.113 for females and males, respectively. Melo et al.<sup>##UREF##0##1##</sup> observed DTI in animals from Piauí state of 0.115 and 0.116 for females and males (castrated and entire), respectively.</p>", "<p id=\"Par74\">The characterization of most animals as being suitable for heavy traction does not reflect the biotype of the Nordestino horse, which is light in build and weighs, on average, less than 350 kg. Thus, although the indices indicate the animal's fitness, they should not be unique evaluation and characterization parameters for that genotype.</p>", "<p id=\"Par75\">Based on the BI value, the animals were classified as mediolines<sup>##UREF##2##4##</sup> and, according to Torres &amp; Jardim<sup>##UREF##7##9##</sup>, with an intermediate aptitude for activities that require speed and strength. Medioline horses have balanced body proportions, are ideal for riding, and can be used for saddle activities<sup>##UREF##20##22##</sup>. Medioline horses were also observed by Dias<sup>##UREF##14##16##</sup> and Melo et al.<sup>##UREF##0##1##</sup>, who studied animals from Pernambuco and Piauí states.</p>", "<p id=\"Par76\">The Eclectic System of Linear Proportions, proposed by Lesbre<sup>##UREF##21##23##</sup> and cited by Souza et al.<sup>##UREF##22##24##</sup>, has been used for several decades to study the proportions of saddle horses.</p>", "<p id=\"Par77\">This study is based on the relationships between the different regions of the body and the assemblage formed by them. This relationship is presented as follows: the WH and croup, and the length of the body are equivalent to two and a half times the length of the head, and the length of the neck and shoulders have the same value as the length of the head. The animals in this research are recommended for saddle riding using the eclectic system.</p>", "<p id=\"Par78\">Melo et al.<sup>##UREF##0##1##</sup> found average values of 1.7081 and 1.7558 for the conformation index, for males and females, respectively, of the Nordestino horse in Juazeiro, in Bahia. Serra<sup>##UREF##23##25##</sup>, evaluating animals from the Baixadeiro horse, found a value of 1.65, close to those obtained in this study for animals from the state of Piauí, and characterized the Baixadeiro horse as suitable for saddle riding.</p>", "<p id=\"Par79\">The compactness index presented a higher value for females and castrated males. However, the value was below what Torres &amp; Jardim<sup>##UREF##7##9##</sup> determined to classify as a saddle animal, below 2.60. The values found in this research were similar to those of Melo et al.<sup>##UREF##0##1##</sup>.</p>", "<p id=\"Par80\">With LOI1, it was observed that the animals have greater load capacity on their backs without excessive effort when working at a trot or gallop, with an overall average support load of 98.67 kg. According to LOI2, the support load on the back is 167.80 kg, which allows the animals to work at a pace without excessive effort. A similar value was found by Melo et al.<sup>##UREF##0##1##</sup> in animals from the state of Pernambuco (168.26 kg).</p>", "<p id=\"Par81\">The differences found for the same breed by different authors must be associated with the sampling effect and ecological conditions. They are samples of various sizes, obtained from animals of different ages, under other management systems, and collected by different measurers in different locations.</p>", "<p id=\"Par82\">However, it is emphasized that the hypermetric size of Nordestino horses seems to be advantageous due to their speed, agility, and resistance during cattle management activities in pastures, mainly in the caatinga, and, perhaps, it is one of the preferred sizes by breeders and cowboys for work or to practice “Pega de Boi no Mato”– Cattle Capture in the Brush, in free translation—a sporting activity traditionally practiced in the Northeast region.</p>", "<p id=\"Par83\">On the other hand, there is an expectation on the part of breeders and technicians, demonstrated during this study, for the emergence of horses of this breed with larger sizes and specific gaits (walk, trot, gallop) or ambling (walk, rack, or tolt) so that they can participate in other equestrian activities, such as “<italic>free de ouro</italic>,” “<italic>vaquejadas</italic>” [Bull-catching] and hiding tours.</p>", "<p id=\"Par84\">However, the emergence of animals with some of these characteristics will be, at least, in the medium term, as animals of this breed have not received the attention they deserve for more than 200 years. Therefore, there is now an urgent need for a strong effort on the part of the actors involved (breeders, breeders' association, technicians, researchers, development, teaching, and S&amp;T institutions, among others) to develop actions aimed at improving the conditions of management (nutritional, reproductive and sanitary) that result in herds with animals subject to animal selection and genetic improvement.</p>" ]
[ "<title>Conclusions</title>", "<p id=\"Par85\">The remaining Nordestino horses have morphological characteristics within the breed standard. One problem identified is that the larger males are being castrated, leaving the smaller ones as entire males.</p>", "<p id=\"Par86\">The predominant breeding system in the region is extensive, with animals consuming native forage and deficient breeding management.</p>", "<p id=\"Par87\">It was observed that a high percentage of the females and all males were classified into different groups because the animals had very similar phenotypes in terms of withers height. The variables that best discriminate animals are live weight, substernal void height, Cannon girth, body length, and withers height.</p>", "<p id=\"Par88\">Most of the animals evaluated met the standards established for the breed. Larger males are often being castrated, while smaller ones remain as whole males. The extensive breeding system is the predominant one. The variables that best discriminate animals are live weight, substernal void height, Cannon girth, body length, and withers height.</p>", "<p id=\"Par89\">Identifying discriminant variables helps us understand the morphology of the Northeast horse, provides practical tools for future studies with the breed, and provides tangible parameters for the careful selection of sires.</p>", "<p id=\"Par90\">Practical interventions and sustainable management strategies can be developed based on the results of this research. This includes guidance for breeders on reproductive practices to conserve the breed's genetic diversity and distinctive morphological characteristics.</p>", "<p id=\"Par91\">This research contributes to understanding the morphological characteristics of the Nordestino horse breed and highlights the importance of responsible and sustainable management practices to ensure the permanence of the breed.</p>" ]
[ "<p id=\"Par1\">Zootechnical data is a big challenge in the extensive rearing system of Brazilian locally adapted breeds once smallholdings with limited resources and funds rear them. So, information on Brazil's breeding system of locally adapted breeds is still scarce; this situation is more challenging for equine breeds<bold>.</bold> The present study aimed to describe the local rearing systems and the phenotypic profile of the Nordestino horse breed in Paraíba state and contribute to breed conservation. Data from males (entire and castrated) and females from 50 municipalities in Paraíba state were used. Two hundred sixty-nine animals (111 females, 121 castrated males, and 37 entire males) from 129 breeders were analyzed. A questionnaire consisting of direct and objective questions was applied to understand the breeding system adopted. There was a predominance of the extensive breeding system (85%), which reflects the adaptation of the Nordestino Horse to the region's natural conditions. The lower frequency of use of cultivated pastures may be related to issues of economic viability since the maintenance of cultivated pastures may require additional investments compared to the use of natural pastures. Entire males had a minimum withers height (WH) of 135 cm. Of the 11 morphometric measurements, only five were considered discriminating by the stepwise analysis. The remaining Nordestino horses have morphological characteristics within the breed standard.</p>", "<title>Subject terms</title>" ]
[]
[ "<title>Author contributions</title>", "<p>All authors contributed to the study’s conception and design. Sample collection and analysis and writing of the first draft of the manuscript were performed by N.L.R., M.N.R., G.R.M., K.O.S., J.K.G.M., G.V.N., and N.M.V.S., contributed to the work design and follow-up stages of application, statistical analysis, and revision of the manuscript. N.L.R. collected and statistical analysis.</p>", "<title>Funding</title>", "<p>Scholarship funding for the research was provided by CAPES.</p>", "<title>Data availability</title>", "<p>The datasets analyzed during the current study are available from the corresponding author on reasonable request.</p>", "<title>Competing interests</title>", "<p id=\"Par92\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Mapa state of Paraiba/Brazil.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Selection protocol for animals used in the research considering whether height.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Nordestino horse receiving cactus spear (<italic>Opuntia stricta</italic>) in trough.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Female receiving mineral supplementation in block form.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Zootechnical and pedigree control form adopted by one of the breeders interviewed.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Female <italic>Dalila</italic> is the daughter of <italic>Lobo Mal</italic> stallion with <italic>Cigana</italic> female.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Withers height (WH) values of animals excluded from the study.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Sex</th><th align=\"left\">Number of animals</th><th align=\"left\">Minimum and maximum value WH</th><th align=\"left\">Average WH</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"2\">Female</td><td align=\"left\">16</td><td char=\"–\" align=\"char\">1.20–1.26</td><td char=\".\" align=\"char\">1.24</td></tr><tr><td align=\"left\">6</td><td char=\"–\" align=\"char\">1.44–1.50</td><td char=\".\" align=\"char\">1.46</td></tr><tr><td align=\"left\" rowspan=\"2\">Castrated male</td><td align=\"left\">5</td><td char=\"–\" align=\"char\">1.23–1.29</td><td char=\".\" align=\"char\">1.25</td></tr><tr><td align=\"left\">3</td><td char=\"–\" align=\"char\">1.47–1.50</td><td char=\".\" align=\"char\">1.48</td></tr><tr><td align=\"left\">Entire male</td><td align=\"left\">11</td><td char=\"–\" align=\"char\">1.26–1.29</td><td char=\".\" align=\"char\">1.28</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Frequency of breeders adopting or not adopting feed, health, and reproductive management practices for the <italic>Nordestino</italic> horse in Paraíba State.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" colspan=\"2\">Management practice</th><th align=\"left\">Yes (%)</th><th align=\"left\">No (%)</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"4\"><italic>Feeding management</italic></td></tr><tr><td align=\"left\">Cultivated pasture</td><td align=\"left\"/><td align=\"left\">20</td><td align=\"left\">80</td></tr><tr><td align=\"left\">Strategic feeding</td><td align=\"left\"/><td align=\"left\">23</td><td align=\"left\">77</td></tr><tr><td align=\"left\">Feed supplementation</td><td align=\"left\"/><td align=\"left\">25</td><td align=\"left\">75</td></tr><tr><td align=\"left\">Mineral supplementation</td><td align=\"left\"/><td align=\"left\">48</td><td align=\"left\">52</td></tr><tr><td align=\"left\" colspan=\"4\"><italic>Reproductive management</italic></td></tr><tr><td align=\"left\">Zootechnical Bookkeeping</td><td align=\"left\"/><td align=\"left\">10</td><td align=\"left\">90</td></tr><tr><td align=\"left\">Controlled mating</td><td align=\"left\"/><td align=\"left\">100</td><td align=\"left\">0</td></tr><tr><td align=\"left\">Stallion replace</td><td align=\"left\"/><td align=\"left\">58</td><td align=\"left\">42</td></tr><tr><td align=\"left\">Selection</td><td align=\"left\"/><td align=\"left\">10</td><td align=\"left\">90</td></tr><tr><td align=\"left\">Castrated</td><td align=\"left\"/><td align=\"left\">87</td><td align=\"left\">13</td></tr><tr><td align=\"left\">Taming</td><td align=\"left\"/><td align=\"left\">10</td><td align=\"left\">90</td></tr><tr><td align=\"left\" colspan=\"4\"><italic>Sanitary management</italic></td></tr><tr><td align=\"left\">Strategic deworming</td><td align=\"left\"/><td align=\"left\">65</td><td align=\"left\">35</td></tr><tr><td align=\"left\">Periodic tests and EIA control</td><td align=\"left\"/><td align=\"left\">10</td><td align=\"left\">90</td></tr><tr><td align=\"left\">Ectoparasite control</td><td align=\"left\"/><td align=\"left\">10</td><td align=\"left\">90</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Number of animals (NA), number of breeders (NB) and percentage of breeders (%B).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">NA</th><th align=\"left\">NB</th><th align=\"left\">%B</th></tr></thead><tbody><tr><td align=\"left\">1</td><td align=\"left\">55</td><td align=\"left\">42.96</td></tr><tr><td align=\"left\">2</td><td align=\"left\">43</td><td align=\"left\">33.59</td></tr><tr><td align=\"left\">3</td><td align=\"left\">15</td><td align=\"left\">11.72</td></tr><tr><td align=\"left\">4</td><td align=\"left\">6</td><td align=\"left\">4.69</td></tr><tr><td align=\"left\">5</td><td align=\"left\">3</td><td align=\"left\">2.34</td></tr><tr><td align=\"left\">6</td><td align=\"left\">2</td><td align=\"left\">1.56</td></tr><tr><td align=\"left\">7</td><td align=\"left\">2</td><td align=\"left\">1.56</td></tr><tr><td align=\"left\">8</td><td align=\"left\">1</td><td align=\"left\">0.79</td></tr><tr><td align=\"left\">9</td><td align=\"left\">1</td><td align=\"left\">0.79</td></tr><tr><td align=\"left\">269</td><td align=\"left\">128</td><td align=\"left\">100</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab4\"><label>Table 4</label><caption><p>Mean ± standard deviation of morphometric measurements of the <italic>Nordestino</italic> horse in Paraíba state, according to the animal's sex.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Variables</th><th align=\"left\">Female (110)</th><th align=\"left\">Castrated male (121)</th><th align=\"left\">Entire male (37)</th><th align=\"left\"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align=\"left\">Head length</td><td char=\".\" align=\"char\">49.19 ± 3.99</td><td char=\".\" align=\"char\">50.03 ± 3.57</td><td char=\".\" align=\"char\">49.59 ± 4.43</td><td align=\"left\">0.3116</td></tr><tr><td align=\"left\">Head width</td><td char=\".\" align=\"char\">17.05 ± 1.54</td><td char=\".\" align=\"char\">17.16 ± 1.44</td><td char=\".\" align=\"char\">16.97 ± 1.74</td><td align=\"left\">0.7408</td></tr><tr><td align=\"left\">Neck length</td><td char=\".\" align=\"char\">60.21 ± 5.08ª</td><td char=\".\" align=\"char\">61.22 ± 3.83ª</td><td char=\".\" align=\"char\">58.21 ± 6.63b</td><td align=\"left\">0.0044</td></tr><tr><td align=\"left\">Wither height</td><td char=\".\" align=\"char\">1.35 ± 0.04</td><td char=\".\" align=\"char\">1.37 ± 0.04</td><td char=\".\" align=\"char\">1.35 ± 0.04</td><td align=\"left\">0.4360</td></tr><tr><td align=\"left\">Croup height</td><td char=\".\" align=\"char\">1.35 ± 0.05</td><td char=\".\" align=\"char\">1.35 ± 0.05</td><td char=\".\" align=\"char\">1.34 ± 0.05</td><td align=\"left\">0.4540</td></tr><tr><td align=\"left\">Body length</td><td char=\".\" align=\"char\">1.36 ± 0.07ª</td><td char=\".\" align=\"char\">1.35 ± 0.06ab</td><td char=\".\" align=\"char\">1.33 ± 0.06b</td><td align=\"left\">0.0449</td></tr><tr><td align=\"left\">Thoracic perimeter</td><td char=\".\" align=\"char\">1.54 ± 0.10ab</td><td char=\".\" align=\"char\">1.57 ± 0.09ª</td><td char=\".\" align=\"char\">1.53 ± 0.11b</td><td align=\"left\">0.0496</td></tr><tr><td align=\"left\">Cannon girth</td><td char=\".\" align=\"char\">0.177 ± 0.01b</td><td char=\".\" align=\"char\">0.184 ± 0.01ª</td><td char=\".\" align=\"char\">0.181 ± 0.01a</td><td align=\"left\">0.0029</td></tr><tr><td align=\"left\">Substernal void height</td><td char=\".\" align=\"char\">65.19 ± 3.54b</td><td char=\".\" align=\"char\">69.60 ± 4.80ª</td><td char=\".\" align=\"char\">67.70 ± 4.63a</td><td align=\"left\"> &lt; .0001</td></tr><tr><td align=\"left\">Thoracic depth</td><td char=\".\" align=\"char\">59.84 ± 8.12ª</td><td char=\".\" align=\"char\">61.47 ± 6.76ª</td><td char=\".\" align=\"char\">55.78 ± 6.60b</td><td align=\"left\">0.0003</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab5\"><label>Table 5</label><caption><p>Mean ± standard deviation and maximum and minimum values of the morphometric indices of the <italic>Nordestino</italic> horse in Paraiba state according to the animal´s sex.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Variables</th><th align=\"left\">Females (110)</th><th align=\"left\">Castrated males (121)</th><th align=\"left\">Entire males (37)</th><th align=\"left\"><italic>P</italic> value</th></tr></thead><tbody><tr><td align=\"left\">Dactyl-thoracic index</td><td align=\"left\">0.115 ± 0.01b</td><td char=\".\" align=\"char\">0.117 ± 0.01ab</td><td char=\".\" align=\"char\">0.119 ± 0.01a</td><td char=\".\" align=\"char\">0.0347</td></tr><tr><td align=\"left\">Body index</td><td align=\"left\">88.26 ± 6.07</td><td char=\".\" align=\"char\">86.64 ± 5.90</td><td char=\".\" align=\"char\">87.65 ± 5.09</td><td char=\".\" align=\"char\">0.1107</td></tr><tr><td align=\"left\">Conformation index</td><td align=\"left\">2.30–1.24</td><td char=\".\" align=\"char\">1.82 ± 0.20a</td><td char=\".\" align=\"char\">1.74 ± 0.22b</td><td char=\".\" align=\"char\">0.0066</td></tr><tr><td align=\"left\">Compactness index</td><td align=\"left\">2.24 ± 0.39ª</td><td char=\".\" align=\"char\">2.25 ± 0.36a</td><td char=\".\" align=\"char\">2.08 ± 0.48b</td><td char=\".\" align=\"char\">0.0167</td></tr><tr><td align=\"left\">WCR</td><td align=\"left\">1.00 ± 0.02b</td><td char=\".\" align=\"char\">1.01 ± 0.02a</td><td char=\".\" align=\"char\">1.01 ± 0.01a</td><td char=\".\" align=\"char\">0.0124</td></tr><tr><td align=\"left\">Load index 1</td><td align=\"left\">99.44 ± 12.24</td><td char=\".\" align=\"char\">100.11 ± 14.79</td><td char=\".\" align=\"char\">96.46 ± 12.36</td><td char=\".\" align=\"char\">0.3693</td></tr><tr><td align=\"left\">Load index 2</td><td align=\"left\">168.71 ± 20.76ab</td><td char=\".\" align=\"char\">171.05 ± 19.82a</td><td char=\".\" align=\"char\">163.64 ± 20.96b</td><td char=\".\" align=\"char\">0.0116</td></tr><tr><td align=\"left\">Estimated body weight</td><td align=\"left\">300.99 ± 60.03ab</td><td char=\".\" align=\"char\">311.72 ± 57.31a</td><td char=\".\" align=\"char\">288.48 ± 65.01b</td><td char=\".\" align=\"char\">0.0912</td></tr><tr><td align=\"left\">Observed body weight</td><td align=\"left\">303.24 ± 57.88ab</td><td char=\".\" align=\"char\">309.05 ± 52.52a</td><td char=\".\" align=\"char\">281.78 ± 70.17b</td><td char=\".\" align=\"char\">0.0809</td></tr><tr><td align=\"left\">WH/TD</td><td align=\"left\">1.15 ± 0.15</td><td char=\".\" align=\"char\">1.14 ± 0.13</td><td char=\".\" align=\"char\">1.18 ± 0.14</td><td char=\".\" align=\"char\">0.4000</td></tr><tr><td align=\"left\">HL/NL</td><td align=\"left\">0.82 ± 0.06b</td><td char=\".\" align=\"char\">0.82 ± 0.06b</td><td char=\".\" align=\"char\">0.86 ± 1.04a</td><td char=\".\" align=\"char\">0.0082</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab6\"><label>Table 6</label><caption><p>Matrix classification of the animals into their groups (percentage of correct classifications on the principal diagonal).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Sex</th><th align=\"left\">Percentage</th><th align=\"left\">Female</th><th align=\"left\">Castrated male</th><th align=\"left\">Entire male</th></tr></thead><tbody><tr><td align=\"left\">Female</td><td char=\".\" align=\"char\">56.36</td><td align=\"left\">62</td><td align=\"left\">38</td><td align=\"left\">10</td></tr><tr><td align=\"left\">Castrated male</td><td char=\".\" align=\"char\">79.33</td><td align=\"left\">23</td><td align=\"left\">96</td><td align=\"left\">2</td></tr><tr><td align=\"left\">Entire male</td><td char=\".\" align=\"char\">24.32</td><td align=\"left\">13</td><td align=\"left\">15</td><td align=\"left\">9</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab7\"><label>Table 7</label><caption><p>Linear discriminant analysis of the variables selected by the stepwise method to classify animals into the three categories (females, castrated males, and entire males).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Variables</th><th align=\"left\">Female</th><th align=\"left\">Castrated male</th><th align=\"left\">Entire male</th></tr></thead><tbody><tr><td align=\"left\">Head length</td><td char=\".\" align=\"char\">1.85</td><td char=\".\" align=\"char\">1.84</td><td char=\".\" align=\"char\">1.94</td></tr><tr><td align=\"left\">Head width</td><td char=\".\" align=\"char\">1.21</td><td char=\".\" align=\"char\">1.06</td><td char=\".\" align=\"char\">1.07</td></tr><tr><td align=\"left\">Neck length</td><td char=\".\" align=\"char\"> − 0.17</td><td char=\".\" align=\"char\"> − 0.19</td><td char=\".\" align=\"char\"> − 0.24</td></tr><tr><td align=\"left\">Withers height</td><td char=\".\" align=\"char\">528.49</td><td char=\".\" align=\"char\">551.13</td><td char=\".\" align=\"char\">549.21</td></tr><tr><td align=\"left\">Croup height</td><td char=\".\" align=\"char\">44.70</td><td char=\".\" align=\"char\">32.10</td><td char=\".\" align=\"char\">36.53</td></tr><tr><td align=\"left\">Body length</td><td char=\".\" align=\"char\">6.28</td><td char=\".\" align=\"char\"> − 2.53</td><td char=\".\" align=\"char\"> − 2.56</td></tr><tr><td align=\"left\">Thoracic perimeter</td><td char=\".\" align=\"char\">82.18</td><td char=\".\" align=\"char\">79.69</td><td char=\".\" align=\"char\">82.49</td></tr><tr><td align=\"left\">Cannon girth</td><td char=\".\" align=\"char\">81.17</td><td char=\".\" align=\"char\">115.36</td><td char=\".\" align=\"char\">107.59</td></tr><tr><td align=\"left\">Substernal void height</td><td char=\".\" align=\"char\"> − 0.51</td><td char=\".\" align=\"char\"> − 0.44</td><td char=\".\" align=\"char\"> − 0.57</td></tr><tr><td align=\"left\">Thoracic depth</td><td char=\".\" align=\"char\">0.97</td><td char=\".\" align=\"char\">0.99</td><td char=\".\" align=\"char\">0.95</td></tr><tr><td align=\"left\">Live weight</td><td char=\".\" align=\"char\"> − 0.12</td><td char=\".\" align=\"char\"> − 0.12</td><td char=\".\" align=\"char\"> − 0.13</td></tr><tr><td align=\"left\">Constant</td><td char=\".\" align=\"char\"> − 509.49</td><td char=\".\" align=\"char\"> − 516.96</td><td char=\".\" align=\"char\"> − 512.42</td></tr></tbody></table></table-wrap>" ]
[ "<disp-formula id=\"Equa\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$Y = a_{0} + a_{1} X_{1} + a_{2} X_{2} + \\ldots + a_{p} X_{p}$$\\end{document}</tex-math><mml:math id=\"M2\" display=\"block\"><mml:mrow><mml:mi>Y</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>X</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>X</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mo>…</mml:mo><mml:mo>+</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:msub><mml:mi>X</mml:mi><mml:mi>p</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$a_{0} ,a_{1} ,a_{2} , \\ldots ,a_{p}$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mi>p</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq100\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$X_{1} ,X_{2} , \\ldots ,X_{p}$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>p</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[]
[ "<table-wrap-foot><p>Distinct letters in the row differ from each other by the <italic>t</italic>-test at a 5% significant level.</p></table-wrap-foot>", "<table-wrap-foot><p>Distinct letters in the row differ from each other by the <italic>t</italic>-test at a 5% significant level; WCR = relationship between height at withers and croup; WH/TD = ratio between withers height (WH) and thoracic depth (TD); HL/NL = ratio between head length/neck length.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2023_51018_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2023_51018_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2023_51018_Article_Equa.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_51018_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51018_Article_IEq100.gif\"/>", "<graphic xlink:href=\"41598_2023_51018_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2023_51018_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2023_51018_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2023_51018_Fig6_HTML\" id=\"MO6\"/>" ]
[]
[{"label": ["1."], "surname": ["Melo", "Pires", "Ribeiro", "Santos", "Silva"], "given-names": ["JB", "DA", "MN", "DO", "HG"], "article-title": ["Estudo zoom\u00e9trico de remanescentes da ra\u00e7a equina nordestina no munic\u00edpio de Floresta"], "source": ["Pernamb. Bras. Actas Iberoam. de Conserv. Animal."], "year": ["2011"], "volume": ["1"], "fpage": ["71"], "lpage": ["74"]}, {"label": ["2."], "surname": ["Gois", "Campos", "Carneiro", "Silva", "Matias"], "given-names": ["GC", "FS", "GG", "TS", "AGS"], "article-title": ["Estrat\u00b4egias de alimenta\u00e7\u00e3o para caprinos e ovinos no semi\u00b4arido brasileiro"], "source": ["Nutri. Time"], "year": ["2017"], "volume": ["14"], "fpage": ["7001"], "lpage": ["7007"]}, {"label": ["4."], "mixed-citation": ["Par\u00e9s-Casanova, P.M. 2009. Zoometr\u00eda. In: ASTIZ, C.S. (Ed.). "], "italic": ["Valoraci\u00f3n morfol\u00f3gica de los animales dom\u00e9sticos"]}, {"label": ["5."], "surname": ["Pimentel", "Rodrigues", "Martins", "Montanez", "Boligon", "Souza"], "given-names": ["AMH", "VB", "CF", "NR", "AA", "JRM"], "article-title": ["Gender on the growth of Criollo foals from birth to three years of age"], "source": ["Ci\u00eanc. Rural"], "year": ["2017"], "volume": ["47"], "fpage": ["1"], "lpage": ["7"], "pub-id": ["10.1590/0103-8478cr20150989"]}, {"label": ["6."], "surname": ["Santos", "Souza", "Oliveira", "Sereno"], "given-names": ["SA", "GS", "MR", "JR"], "article-title": ["Using nonlinear models to describe height growth curves in Pantaneiro horses"], "source": ["Pesq. Agrop. Bras."], "year": ["1999"], "volume": ["34"], "fpage": ["1133"], "lpage": ["1138"], "pub-id": ["10.1590/S0100-204X1999000700003"]}, {"label": ["7."], "mixed-citation": ["Arandas, J.K.G. Etnozootecnia da ra\u00e7a ovina Morada Nova em seu centro de origem: hist\u00f3ia, crit\u00e9rios de sele\u00e7\u00e3o e Sistema de produ\u00e7\u00e3o. Tese (Doutorado) Universidade Federal Rural de Pernambuco 140f (2017)."]}, {"label": ["8."], "surname": ["Arandas", "Alves", "Fac\u00f3", "Belchior", "Shiotsuki", "Ribeiro"], "given-names": ["JKG", "AGC", "O", "EB", "L", "MN"], "article-title": ["Characterization of the sheep farming system in the Brazilian semiarid from the multivariate perspective"], "source": ["Am. J. Anim. Vet. Sci."], "year": ["2020"], "volume": ["15"], "fpage": ["185"], "lpage": ["197"], "pub-id": ["10.3844/ajavsp.2020.185.197"]}, {"label": ["9."], "mixed-citation": ["Torres, A.P., Jardim, W.R. Cria\u00e7\u00e3o do cavalo e de outros eq\u00fcinos"], "italic": ["."]}, {"label": ["10."], "mixed-citation": ["Statistical Analysis Systems Institute (SAS). User's guide: statistics, version 9.2, SAS Institute Inc., Cary, NC, USA (2001)."]}, {"label": ["11."], "mixed-citation": ["Associa\u00e7\u00e3o Brasileira dos Criadores do Cavalo Nordestino\u2014ABCCN. Regulamento do Registro Geneal\u00f3gico do Cavalo Nordestino. Recife. p. 33\u201334. (1987)"]}, {"label": ["12."], "surname": ["Ribeiro"], "given-names": ["DBO"], "source": ["Cavalo: ra\u00e7as, qualidades e defeitos"], "year": ["1998"], "publisher-name": ["Globo Rural"], "fpage": ["290p"]}, {"label": ["13."], "surname": ["Hering"], "given-names": ["C"], "article-title": ["Da domina\u00e7\u00e3o \u00e0 tentativa de comunica\u00e7\u00e3o: uma an\u00e1lise dos m\u00e9todos de doma para equita\u00e7\u00e3o"], "source": ["Rev. Latinoam. de Estudios Cr\u00edt. Anim."], "year": ["2020"], "volume": ["1"], "fpage": ["275"], "lpage": ["314"]}, {"label": ["14."], "mixed-citation": ["Camargo, M.X., Chieffi, A. Ezoogn\u00f3sia. S\u00e3o Paulo: Instituto de Zootecnia (1971)."]}, {"label": ["15."], "mixed-citation": ["Travassos, A.E.V. Caracteriza\u00e7\u00e3o fenot\u00edpica do Cavalo Nordestino no Estado de 410 Pernambuco. Disserta\u00e7\u00e3o (Mestrado em Zootecnia). Universidade Federal Rural de 411 Pernambuco. Recife. 59 pp. (2004)"]}, {"label": ["16."], "mixed-citation": ["Dias, S.M.D.N. Caracteriza\u00e7\u00e3o populacional e morfol\u00f3gica de equinos da ra\u00e7a Nordestina criados na microrregi\u00e3o de Campo Maior\u2014PI. 2010. 28f. Monografia (Gradua\u00e7\u00e3o em Zootecnia)\u2014Centro de Ci\u00eancias Agr\u00e1rias, Universidade Federal da Para\u00edba, Areia (2010)"]}, {"label": ["17."], "surname": ["Cabral", "Almeida", "Quirino", "Azevedo", "Pinto", "Santos"], "given-names": ["GC", "FQ", "CR", "PCN", "LFB", "EM"], "article-title": ["Avalia\u00e7\u00e3o morfom\u00e9trica de equinos da ra\u00e7a Mangalarga Marchador: conforma\u00e7\u00e3o e propor\u00e7\u00f5es corporais"], "source": ["Revis. Bras. de Zootec."], "year": ["2004"], "volume": ["33"], "fpage": ["1798"], "lpage": ["1805"], "pub-id": ["10.1590/S1516-35982004000700018"]}, {"label": ["18."], "surname": ["Freitas"], "given-names": ["AR"], "article-title": ["Curvas de crescimento na produ\u00e7\u00e3o animal"], "source": ["Revis. Bras. de Zootec."], "year": ["2005"], "volume": ["34"], "fpage": ["786"], "lpage": ["795"], "pub-id": ["10.1590/S1516-35982005000300010"]}, {"label": ["19."], "surname": ["Becvarova", "Buechner-Maxwell"], "given-names": ["I", "V"], "article-title": ["Feeding the foal for immediate and long-term health"], "source": ["Equine Vet. J."], "year": ["2012"], "volume": ["44"], "fpage": ["s41"], "pub-id": ["10.1111/j.2042-3306.2011.00522.x"]}, {"label": ["20."], "mixed-citation": ["Santos Junior, E.C., Velozo Junior, V.A. Cavalo Nordestino: Uma Hist\u00f3ria de Resist\u00eancia. Ed. KDP: Columbia, SC, 129 p. ISBN-13: 979\u20138824822892. ASIN: B0B4D8FHK4 (2022)."]}, {"label": ["21."], "surname": ["Ribeiro", "Souza", "Muniz", "Fernandes", "Moura"], "given-names": ["RA", "FAC", "JA", "TJ", "RS"], "article-title": ["Curva de crescimento em altura na cernelha de equinos da ra\u00e7a Mangalarga Marchador considerando-se heterocedasticidade"], "source": ["Arquivo Bras. de Med. Vet. Zootec."], "year": ["2018"], "volume": ["70"], "fpage": ["272"], "lpage": ["278"], "pub-id": ["10.1590/1678-4162-9322"]}, {"label": ["22."], "surname": ["McManus", "Falc\u00e3o", "Spritze", "Costa", "Louvandini", "Dias", "Teixeira", "Rezende", "Garcia"], "given-names": ["C", "RA", "A", "D", "H", "LT", "RA", "MJM", "JAS"], "article-title": ["Caracteriza\u00e7\u00e3o Morfol\u00f3gica de Equinos da Ra\u00e7a Campeiro"], "source": ["Revis. Bras. de Zootec."], "year": ["2005"], "volume": ["34"], "fpage": ["1553"], "lpage": ["1562"], "pub-id": ["10.1590/S1516-35982005000500015"]}, {"label": ["23."], "mixed-citation": ["Lesbre, F.X. Precis d\u2019Exterieur du Cheval. Paris: Freres Ed (1920)."]}, {"label": ["24."], "surname": ["Souza", "Fernandes", "Moura", "Meirelles", "Ribeiro", "Cunha", "Muniz"], "given-names": ["FAC", "TJ", "RS", "SLC", "RA", "FO", "JA"], "article-title": ["Nonlinear modeling growth body weight of Mangalarga Marchador horses"], "source": ["Ci\u00eanc. Rural"], "year": ["2017"], "volume": ["47"], "fpage": ["e20160636"], "pub-id": ["10.1590/0103-8478cr20160636"]}, {"label": ["25."], "mixed-citation": ["Serra, O.R. Condi\u00e7\u00f5es de manejo, preserva\u00e7\u00e3o e caracteriza\u00e7\u00e3o fenot\u00edpica do grupamento gen\u00e9tico equino baixadeiro. Disserta\u00e7\u00e3o (Mestrado em Agroecologia)\u2014Universidade Estadual do Maranh\u00e3o. 84 p. (2004)"]}]
{ "acronym": [], "definition": [] }
25
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1173
oa_package/3c/c8/PMC10786842.tar.gz
PMC10786843
38216623
[ "<title>Introduction</title>", "<p id=\"Par2\">Supervised machine learning methods rely on tagged training data<sup>##UREF##0##1##</sup>. The more tagged training data that is available, the more accurately the model can learn to recognize patterns and generalize to unseen data.</p>", "<p id=\"Par3\">Crowdsourcing and Human-Based Computation (HBC) has become an increasingly popular approach for acquiring training labels in machine learning classification tasks, as it can be a cost-effective way to share the labeling effort among a large number of annotators. This approach can be particularly useful in cases where expert labeling is expensive or not feasible, or where a large amount of labeled data is needed to train a machine learning model<sup>##UREF##1##2##</sup>. There exist various tactics for human users to contribute their problem-solving skills<sup>##UREF##2##3##</sup>:<list list-type=\"bullet\"><list-item><p id=\"Par4\"><italic>Altruistic contribution</italic> This strategy involves appealing to the altruistic nature of individuals willing to contribute their time and skills to solve problems for the common good<sup>##UREF##3##4##–##UREF##5##6##</sup>.</p></list-item><list-item><p id=\"Par5\"><italic>Gamification</italic> This strategy involves creating engaging and fun video games incorporating problem-solving tasks<sup>##UREF##6##7##–##UREF##8##9##</sup>.</p></list-item><list-item><p id=\"Par6\"><italic>Forced labor</italic> This strategy involves forcing website users to perform a task if they want to use its services<sup>##UREF##9##10##,##UREF##10##11##</sup>.</p></list-item><list-item><p id=\"Par7\"><italic>Microtask markets</italic> This strategy involves breaking down complex tasks into smaller, simpler tasks and then outsourcing them to a large group of people<sup>##REF##22274839##12##,##UREF##11##13##</sup>.</p></list-item></list></p>", "<p id=\"Par8\">Sickle Cell Disease (SCD) is a serious inherited blood disorder that affects millions of people worldwide. The disease is caused by a mutation in the HBB gene, which codes for one of the components of the hemoglobin protein, which produces abnormal hemoglobin molecules that can cause the Red Blood Cells (RBCs) to have the shape of a sickle or half-moon instead of the smooth, circular shape as normal RBCs have<sup>##REF##33075715##14##</sup>. According to data from the World Health Organization (WHO)<sup>##UREF##12##15##</sup>, it is estimated that approximately 5% of the global population possesses the genetic traits associated with haemoglobin disorders, primarily SCD and thalassaemia. Furthermore, more than 300,000 infants born annually are afflicted with severe haemoglobin disorders. Globally, SCD resulted in 112,900 fatalities in 1990, 176,200 fatalities in 2013, and 55,3000 fatalities in 2016, as reported in previous studies<sup>##REF##25530442##16##,##REF##28919116##17##</sup>.</p>", "<p id=\"Par9\">Morphological analysis of Peripheral Blood Smear (PBS) is a vital diagnostic aid for SCD. PBS cannot be used for diagnosing newborns (due to sickling of cells not occurring until the baby is a bit older and switches from producing hemoglobin F to hemoglobin A), which is actually the optimal time of diagnosing SCD. It is thus only suitable for diagnosing older babies/children and adults, but also useful for monitoring treatment outcomes of already diagnosed patients. However, it is a labor-intensive and time-consuming process, which can lead to delays in diagnosis and treatment. To address this issue, automated methods for analyzing blood samples are developed, which use image analysis and machine learning algorithms to detect and count sickle cells<sup>##UREF##13##18##–##UREF##15##20##</sup>. Due to this demanding and prolonged process, there is limited public availability of tagged PBS datasets from patients with SCD<sup>##REF##33075715##14##,##UREF##13##18##,##REF##32222951##21##–##REF##28815426##23##</sup>.</p>", "<p id=\"Par10\">We performed a systematic literature review<sup>##UREF##16##24##</sup> about the use of crowdsourcing HBC systems for the analysis of medical images. From the findings of this systematic literature review, we derived guidelines for practitioners and scientists to help them improve their research on the topic. Non-expert HBC for RBC analysis showed promising results to detect malaria parasites in digitized blood sample images<sup>##UREF##7##8##,##UREF##8##9##</sup> and a first attempt for SCD<sup>##UREF##17##25##</sup>. In the literature, we also found non-expert HBC approaches used for labeling various types of medical images<sup>##UREF##16##24##</sup>, including tomographs, MRIs, retinal images, breast cancer images, endoscopic images, microscopy images, polyps, and biomarkers. Mitry et al.<sup>##UREF##18##26##</sup> showed encouriging results of crowdsourcing in retinal image analysis. They achieved sensitivity of 96% in normal versus severely abnormal detections, even without any restriction on eligible participants. Lung nodule detection with sensitivity of over 90% for 20 patient CT datasets <sup>##UREF##19##27##</sup> showed that crowdsourcing can provide highly accurate training data for computer-aided algorithms. Analysing biomedical images in Gurari et al. <sup>##UREF##20##28##</sup>, Gurari et al. found that after experts, non-experts performed better than algorithms and that fusing those results together yielded improved final results.</p>", "<p id=\"Par11\">In this paper, we present an approach for the analysis of PBS images in patients affected by SCD through crowdsourcing HBC with non-expert individuals using the Mechanical Turk (MTurk) that is an online crowdsourcing platform that allows individuals and businesses to outsource small tasks or “Human Intelligence Tasks” to a global network of workers. The design and experimental framework of our approach strictly adhered to the guidelines recommended by Petrovic et al.<sup>##UREF##16##24##</sup> in the context of crowdsourcing methodologies. Additionally, we leveraged the expert-tagged erythrocytesIDB dataset, provided by Gonzalez et al.<sup>##UREF##13##18##</sup>, to establish the accuracy and reliability of our analysis. We utilized the predefined categories by the dataset: circular, elongated, and other cell classifications to facilitate SCD diagnosis, as meticulously curated and labeled by medical experts, to maintain consistency with the dataset’s structure, crucial for accurate analysis and cross-study comparisons.</p>", "<p id=\"Par12\">The aim of our research was not to substitute automated procedures utilized for diagnostic assistance in the context of patients afflicted with SCD. Instead, the main objective was to investigate the feasibility of using HBC to help label large datasets to facilitate the training of automated methods, particularly in situations where expert assistance is not possible. In such instances, we were chiefly interested in determining the circumstances under which we can place almost complete confidence in the labels provided by non-expert users via HBC.</p>" ]
[ "<title>Methods and experiments</title>", "<p id=\"Par13\">In this section, we propose the utilization of MTurk as a valuable tool for the analysis of PBS images obtained from patients with SCD. The dataset employed for this research comprised a comprehensive collection of PBS images derived from individuals diagnosed with SCD, obtained from a reputable medical institution. Prior to conducting the analysis, a preprocessing stage was executed to segment individual cells from full images. Subsequently, the preprocessed images were uploaded to the MTurk platform<sup>##UREF##21##29##</sup>, where a group of trained workers, who perform a wide range of tasks in exchange for payment, known as MTurkers, were assigned the task of examining and annotating various properties of the PBS within the images. The responses collected from the MTurkers were then subjected to a quantitative measure.</p>", "<title>Dataset</title>", "<p id=\"Par14\">We used erythrocytesIDB<sup>##UREF##13##18##</sup>, available at <ext-link ext-link-type=\"uri\" xlink:href=\"http://erythrocytesidb.uib.es/\">http://erythrocytesidb.uib.es/</ext-link>, which is a database of prepared blood samples from patients with SCD. The samples were obtained from voluntary donors by pricking their thumbs and collecting a drop of blood on a sheet. The blood was spread and fixed with a May-Grünwald methanol solution, and the images were acquired using a Leica microscope and a Kodak EasyShare V803 camera. Each image was labeled by a medical expert from “Dr. Juan Bruno Zayas” Hospital General in Santiago de Cuba, and the images were classified based on the specialist’s criteria for circular, elongated, and other cells. Examination of PBS by experienced individuals looking for features of SCD can be a sensitive test<sup>##UREF##22##30##</sup>.</p>", "<title>Image preprocessing</title>", "<p id=\"Par15\">Individual cells were extracted from full images of erythrocytesIDB. The Chan-Vese active contour model<sup>##REF##18249617##31##</sup> was employed for image segmentation. This model was chosen due to its exceptional performance in achieving a broader range of convergence and effectively handling topological changes.</p>", "<p id=\"Par16\">The Chan-Vese method was employed without prior preprocessing steps. The application of this method resulted in the generation of a binarized image, after eliminating small objects that could potentially disrupt the subsequent classification process. We used a regularization parameter () value of 0.2 and a maximum iteration limit of 1000. However, it is noteworthy that the specified maximum iteration value was nominal, as convergence was achieved much earlier for the images under investigation.</p>", "<title>MTurk task design for PBS image analysis of patients with SCD</title>", "<p id=\"Par17\">The proposed approach’s design and experimental framework closely followed the guidelines proposed by Petrovic et al.<sup>##UREF##16##24##</sup> regarding crowdsourcing methodologies. We defined a task on MTurk titled: “Sicklemia: Classify Red Blood Cells”, with a description that prompts MTurkers to determine the type of RBC: Circular, Elongated, or Other. This task was clearly visible to MTurkers, ensuring their comprehension. It was appropriately labeled as “image, classify, red blood cells” to facilitate search and filtering based on MTurker interests.</p>", "<p id=\"Par18\">In order to ensure a comprehensive understanding of the tasks that needed to be performed by the MTurker, a set of detailed crafted instructions was meticulously prepared. These instructions were thoughtfully designed to not only provide clear guidance but also incorporate illustrative examples for each specific task type (see Fig. ##FIG##0##1##).</p>", "<p id=\"Par19\">Each MTurker was tasked with reviewing images in pairs (Fig. ##FIG##1##2##). For each image pair, MTurkers were required to indicate the type of cell (Circular, Elongated, or Other). They received a reward of 0.01$ for every classified image pair. It is important to note that not all registered MTurkers were eligible to perform these tasks, as two conditions were imposed:<list list-type=\"bullet\"><list-item><p id=\"Par20\">Additional Requirement: Require that MTurkers be Masters to do their tasks. Master Workers on MTurk have a high success rate, holding the Masters Qualification for quality, experience, and a variety of tasks, determined through statistical analysis.</p></list-item><list-item><p id=\"Par21\">HIT Approval Rate (%) for all Requesters’ HITs greater than 90%.</p></list-item></list></p>", "<p id=\"Par22\">These conditions were imposed as a means of selectively filtering external MTurkers, thereby incurring a nominal cost of $ per processed image. Consequently, the overall cost amounts to $ per classified image, accounting for the multiple layers of scrutiny and assessment involved in the classification process. The requirement for each image to undergo processing by a total of five distinct MTurkers ensured a robust and reliable outcome through a collective endeavor. This multi-worker approach not only aimed to promote the reliability and accuracy of the classification results but also sought to mitigate potential biases or errors that may arise from relying solely on the judgment of a single worker. By harnessing the collective efforts of multiple MTurkers, the aim was to leverage diverse perspectives and expertise, thereby enhancing the overall quality and credibility of the classification process. This inclusive and collaborative approach aligns with the principles of scientific rigor and objectivity, providing a comprehensive and dependable foundation for the research findings presented in this study.</p>", "<title>MTurk parameters</title>", "<p id=\"Par23\">The parameters of the task were configured in order to obtain the quality of the responses needed to ensure a valid analysis and minimize the economic spending:<list list-type=\"bullet\"><list-item><p id=\"Par24\">Reward per assignment: $.</p></list-item><list-item><p id=\"Par25\">Number of assignments per task: 5.</p></list-item><list-item><p id=\"Par26\">Time allotted per assignment: 1 h.</p></list-item><list-item><p id=\"Par27\">Task expiration period: 3 days.</p></list-item><list-item><p id=\"Par28\">Auto-approval and payment of MTurkers: 7 days.</p></list-item></list>MTurkers requirements:<list list-type=\"bullet\"><list-item><p id=\"Par29\">Require MTurkers to be Masters to perform tasks: Yes.</p></list-item><list-item><p id=\"Par30\">Additional qualifications for MTurkers: HIT Approval Rate (%) for all Requester’s HIT greater than 90%.</p></list-item><list-item><p id=\"Par31\">Task Visibility: Hidden (Only MTurkers who meet my qualification requirements can see and preview my tasks).</p></list-item></list></p>", "<title>Measurements</title>", "<p id=\"Par32\">Given a MTurker, their accuracy can be determined by comparing their responses to the Ground Truth (GT) for each image, where GT is the correct and known label or category of the image. To assess the classification performance, we generated the confusion matrix, which is a summary of the model’s predictions versus the actual GT values, and is typically a square table with rows and columns representing the actual classes or categories and the predicted classes, respectively. We also provided raw data and calculated the Accuracy Rate and F-measure<sup>##UREF##23##32##,##UREF##24##33##</sup>. We also utilized the Sickle Cell Disease Diagnosis Support score (SDS-score) as a measure proposed in Delgado-Font et al.<sup>##REF##32222951##21##</sup> to assess the classification of three classes of RBCs investigated in this study: circular, elongated cell, and other deformations. The SDS-score was designed to aid in the evaluation of SCD analysis. It was determined by calculating the ratio of the sum of true positives for all three classes to the number of sickle cells classified as other deformations and vice versa, divided by the sum of the aforementioned numerator and the sum of incorrect classifications associated with circular cells. The SDS-score indicates the usefulness of the method’s results in supporting the analysis of the studied disease.</p>", "<p id=\"Par33\">Moreover, the classification task involves imbalanced classes due to the larger quantity of circular cells compared to elongated or deformed cells. To address this issue and evaluate the overall process, we employed two measures: Class Balance Accuracy (CBA)<sup>##REF##32222951##21##,##UREF##25##34##</sup> and Matthews Correlation Coefficient (MCC)<sup>##REF##32222951##21##,##REF##15556477##35##</sup>. These measures provide valuable insights into the performance and effectiveness of our approach.</p>", "<p id=\"Par34\">Regarding Accuracy Rate, for each image there were responses from MTurkers. If three or more responses coincided, there was a consensus and the response determined by the MTurkers was considered. The response configurations that yielded a valid response were: 5 (complete consensus), 4-1 (four out of the five MTurkers agreed on one class, while the remaining MTurker selected a different one, 3-1-1 (three out of the five MTurkers agreed on one category, while each of the remaining two MTurkers selected a different one from the remaining categories), and 3-2 (three out of the five MTurkers agreed on one class, while the remaining two MTurkers selected a different one). Otherwise, N/A (not answer) response was considered. The response configuration that did not yield a valid response was 2-2-1 (two out of the five MTurkers agreed on one class, another two MTurkers agreed on a different class, and the remaining MTurker selected yet another class). MTurkers were deemed correct if their response matched the ground truth classification.</p>", "<p id=\"Par35\">Finally, in this study, we elucidated the methodology for computing the Accuracy Rate under the assumption of independence. Specifically, we considered the classification proficiency of a particular cell type among the MTurkers, denoting the average accuracy for this type as . Subsequently, we estimated accuracy (<italic>X</italic>) through the following procedure:where first term is the case 5 MTurkers classify correctly, second term 4 classify correctly and the other one mistakes, and last term 3 MTurkers classify correctly and 2 misclassify.</p>" ]
[ "<title>Results and discussion</title>", "<p id=\"Par36\">The accuracies for each cell type and each MTurker are detailed in Table ##TAB##0##1##. The circular cell type demonstrated an accuracy of , while the elongated and other cell types exhibited an accuracy of and respectively. Notably, when the elongated and other classes were combined into a unified category, an overall accuracy of was attained. These results highlighted the distinct accuracies associated with different cell types and underscored the enhanced performance achieved by consolidating specific categories.</p>", "<p id=\"Par37\">The adoption of a consensus-based cell type selection method, wherein a consensus was reached when 3 or more MTurkers selected the same class, produced a improved accuracy as shown in Table ##TAB##1##2##. In 20 cases there was not consensus, so the responses were considered as N/A. Notably, this approach demonstrated an overall improvement in accuracy. The results highlighted the effectiveness of leveraging consensus among multiple MTurkers to enhance the accuracy of cell type classification.</p>", "<p id=\"Par38\">Assuming independence among the classifications, the following levels of accuracy should be obtained using the individual accuracy of 5 MTurkers, see Table ##TAB##2##3##. The estimated outcomes exhibited superior performance compared to the observed results. This disparity challenges the assumption of independence, indicating a propensity for MTurkers to commit similar errors. These findings substantiated the inadequacy of assuming independence within the realm of MTurker behavior, underscoring the presence of correlated errors among MTurkers. The implications of these results highlighted the need for a deeper understanding of the underlying factors influencing MTurker judgments and the importance of considering inter-rater agreement in future studies.</p>", "<p id=\"Par39\">In Fig. ##FIG##2##3##, we present a collection of images showcasing instances where the MTurkers exhibit errors. The classification process employed a voting-based system, where the first row pertains to circular cell types, the second row corresponds to elongated cells, and the last row represents other cell types. The visual analysis clearly indicates the presence of challenging cases that pose difficulties for accurate classification. These observations shed light on the intricacies involved in effectively categorizing certain cell types and emphasize the importance of addressing classification uncertainties in MTurker-based studies.</p>", "<p id=\"Par40\">Unlike computational methods, the results obtained by MTurkers provided additional information on the reliability of the decision made. This reliability was determined by the number of consensus in determining the cell’s class. We separately analyzed three cases: when all 5 MTurkers agreed (463 cases), when 4 MTurkers agreed (226 cases), and when 3 MTurkers agreed (135 cases). In Tables ##TAB##3##4## and ##TAB##4##5## we show the metrics we obtained in these cases and compared them with the state-of-art of automated methods for analyzing blood samples<sup>##REF##33075715##14##,##UREF##13##18##,##REF##32222951##21##–##REF##28815426##23##</sup>. Elongated and other cells can be consolidated because the misclassification of the normal cells as the elongated or other cells will cause the alert to the medical specialist that the patient’s condition has worsened and that the therapy should be changed<sup>##REF##32222951##21##</sup>. Then, it is up to the specialist to review the diagnosis and to decide whether the more drastic treatment should be prescribed. This type of error is not so serious because the treatment usually has no side effects. More dangerous scenario would be to classify deformed cells (elongated or other) as normal. In this case, the specialist could decide that the patient is not at risk of a vaso-occlusive crisis, and the necessary treatment would not be applied. To support the diagnosis in a good way, classifiers need to minimize the misclassification rate of elongated cells and cells with other deformations as normal cells, and the misclassification of normal cells as elongated and cells with other deformations. On the one hand, we can observe that if there was absolute consensus (55% of the cases) or if 4 out of 5 MTurkers agreed (26% of the cases), the probability of error was very low. On the other hand, we can observe that there were only 24 cases without a consensus and 135 cases where there was consensus among 3 MTurkers, meaning these cases should be reviewed by a specialist, out of a total of 848 (19% of the cases).</p>", "<p id=\"Par41\">The objective of our research is not to replace automated procedures utilized for diagnostic assistance in the context of patients afflicted with SCD. Instead, our focus is on investigating the feasibility of employing HBC to tag large datasets, thereby facilitating the training of automated methods, especially in situations where expert assistance is not feasible. The results demonstrate that in cases where there is a strong consensus among the MTurkers, the outcomes are comparable to the state-of-the-art automated methods. As a result, our proposed approach proves to be effective in annotating large datasets. The more tagged training data that is available, the more accurately the model can learn to recognize patterns and generalize to unseen data.</p>", "<p id=\"Par42\">In our investigation of individual MTurkers, a notable observation emerged: an increase in the number of classifications did not yield an improvement in accuracy. This finding is visually represented in Fig. ##FIG##3##4##. The results challenge the prevailing assumption that increased participation levels invariably lead to enhanced performance. These findings prompt a reevaluation of the role of quantity versus quality in the context of MTurker contributions, raising important considerations for optimizing crowd-based classification tasks.</p>" ]
[ "<title>Results and discussion</title>", "<p id=\"Par36\">The accuracies for each cell type and each MTurker are detailed in Table ##TAB##0##1##. The circular cell type demonstrated an accuracy of , while the elongated and other cell types exhibited an accuracy of and respectively. Notably, when the elongated and other classes were combined into a unified category, an overall accuracy of was attained. These results highlighted the distinct accuracies associated with different cell types and underscored the enhanced performance achieved by consolidating specific categories.</p>", "<p id=\"Par37\">The adoption of a consensus-based cell type selection method, wherein a consensus was reached when 3 or more MTurkers selected the same class, produced a improved accuracy as shown in Table ##TAB##1##2##. In 20 cases there was not consensus, so the responses were considered as N/A. Notably, this approach demonstrated an overall improvement in accuracy. The results highlighted the effectiveness of leveraging consensus among multiple MTurkers to enhance the accuracy of cell type classification.</p>", "<p id=\"Par38\">Assuming independence among the classifications, the following levels of accuracy should be obtained using the individual accuracy of 5 MTurkers, see Table ##TAB##2##3##. The estimated outcomes exhibited superior performance compared to the observed results. This disparity challenges the assumption of independence, indicating a propensity for MTurkers to commit similar errors. These findings substantiated the inadequacy of assuming independence within the realm of MTurker behavior, underscoring the presence of correlated errors among MTurkers. The implications of these results highlighted the need for a deeper understanding of the underlying factors influencing MTurker judgments and the importance of considering inter-rater agreement in future studies.</p>", "<p id=\"Par39\">In Fig. ##FIG##2##3##, we present a collection of images showcasing instances where the MTurkers exhibit errors. The classification process employed a voting-based system, where the first row pertains to circular cell types, the second row corresponds to elongated cells, and the last row represents other cell types. The visual analysis clearly indicates the presence of challenging cases that pose difficulties for accurate classification. These observations shed light on the intricacies involved in effectively categorizing certain cell types and emphasize the importance of addressing classification uncertainties in MTurker-based studies.</p>", "<p id=\"Par40\">Unlike computational methods, the results obtained by MTurkers provided additional information on the reliability of the decision made. This reliability was determined by the number of consensus in determining the cell’s class. We separately analyzed three cases: when all 5 MTurkers agreed (463 cases), when 4 MTurkers agreed (226 cases), and when 3 MTurkers agreed (135 cases). In Tables ##TAB##3##4## and ##TAB##4##5## we show the metrics we obtained in these cases and compared them with the state-of-art of automated methods for analyzing blood samples<sup>##REF##33075715##14##,##UREF##13##18##,##REF##32222951##21##–##REF##28815426##23##</sup>. Elongated and other cells can be consolidated because the misclassification of the normal cells as the elongated or other cells will cause the alert to the medical specialist that the patient’s condition has worsened and that the therapy should be changed<sup>##REF##32222951##21##</sup>. Then, it is up to the specialist to review the diagnosis and to decide whether the more drastic treatment should be prescribed. This type of error is not so serious because the treatment usually has no side effects. More dangerous scenario would be to classify deformed cells (elongated or other) as normal. In this case, the specialist could decide that the patient is not at risk of a vaso-occlusive crisis, and the necessary treatment would not be applied. To support the diagnosis in a good way, classifiers need to minimize the misclassification rate of elongated cells and cells with other deformations as normal cells, and the misclassification of normal cells as elongated and cells with other deformations. On the one hand, we can observe that if there was absolute consensus (55% of the cases) or if 4 out of 5 MTurkers agreed (26% of the cases), the probability of error was very low. On the other hand, we can observe that there were only 24 cases without a consensus and 135 cases where there was consensus among 3 MTurkers, meaning these cases should be reviewed by a specialist, out of a total of 848 (19% of the cases).</p>", "<p id=\"Par41\">The objective of our research is not to replace automated procedures utilized for diagnostic assistance in the context of patients afflicted with SCD. Instead, our focus is on investigating the feasibility of employing HBC to tag large datasets, thereby facilitating the training of automated methods, especially in situations where expert assistance is not feasible. The results demonstrate that in cases where there is a strong consensus among the MTurkers, the outcomes are comparable to the state-of-the-art automated methods. As a result, our proposed approach proves to be effective in annotating large datasets. The more tagged training data that is available, the more accurately the model can learn to recognize patterns and generalize to unseen data.</p>", "<p id=\"Par42\">In our investigation of individual MTurkers, a notable observation emerged: an increase in the number of classifications did not yield an improvement in accuracy. This finding is visually represented in Fig. ##FIG##3##4##. The results challenge the prevailing assumption that increased participation levels invariably lead to enhanced performance. These findings prompt a reevaluation of the role of quantity versus quality in the context of MTurker contributions, raising important considerations for optimizing crowd-based classification tasks.</p>" ]
[ "<title>Conclusions</title>", "<p id=\"Par43\">This research paper introduced an approach for the analysis of Red Blood Cell images in patients afflicted by Sickle Cell Disease. The proposed method leverages crowdsourcing Human-based Computation by engaging non-expert individuals through the Mechanical Turk microtask market, especially in situations where expert assistance is not feasible.</p>", "<p id=\"Par44\">The findings of this study indicate that when a robust consensus is achieved among the Mechanical Turk micro-task market workers, the results exhibit that probability of error is very low, based on comparison with expert analysis. Consequently, our proposed approach could be employed for dataset annotation.</p>", "<p id=\"Par45\">The present study incorporates the confusion matrices, along with the raw data, within the results to facilitate researchers in computing additional metrics. The dataset utilized in this research can be accessed at <ext-link ext-link-type=\"uri\" xlink:href=\"http://erythrocytesidb.uib.es/\">http://erythrocytesidb.uib.es/</ext-link>. In the interest of advancing scientific knowledge, it is advantageous for authors to share their raw data and image datasets used in their investigations.</p>", "<p id=\"Par46\">The morphological analysis of PBS as a diagnostic tool for SCD are still used by some health systems and hospitals, even so we acknowledge recent developments in SCD point-of care diagnostics<sup>##UREF##26##36##</sup>. In this work we verified that non-expert users had good results in labeling tasks for circular, elongated and other, with the aim that as further work we can tag large PBS datasets from patients with SCD with non-expert users to feed automated methods. Moreover, we consider that our method could be transferable to new cells morphologies<sup>##UREF##27##37##</sup> for other hemoglobinopathies that can be detected/analyzed/diagnosed by visual inspection methods. For this reason, as a further work we are interested in validating our proposal with other hemoglobinopathies.</p>", "<p id=\"Par47\">Moreover, this research endeavors to establish the fundamental principles for the effective labeling of extensive datasets, particularly in scenarios where expert involvement is unfeasible. As part of future work, it foresees explorations aimed at investigating the potential integration of these findings with outcomes obtained through automated methodologies. Within the context of extensive dataset labeling, the incorporation of human-decided, reliable labels in conjunction with those obtained through automated methods holds notable significance. This dual-input approach has the potential to mitigate the risk of preserving errors and biases inherent in automated methods during the final labeling process. Consequently, this methodology could lead to a reduction in the transfer of such biases during the training of subsequent models, ultimately enhancing the quality of derived insights and predictive outcomes.</p>" ]
[ "<p id=\"Par1\">In this paper, we present a human-based computation approach for the analysis of peripheral blood smear (PBS) images images in patients with Sickle Cell Disease (SCD). We used the Mechanical Turk microtask market to crowdsource the labeling of PBS images. We then use the expert-tagged erythrocytesIDB dataset to assess the accuracy and reliability of our proposal. Our results showed that when a robust consensus is achieved among the Mechanical Turk workers, probability of error is very low, based on comparison with expert analysis. This suggests that our proposed approach can be used to annotate datasets of PBS images, which can then be used to train automated methods for the diagnosis of SCD. In future work, we plan to explore the potential integration of our findings with outcomes obtained through automated methodologies. This could lead to the development of more accurate and reliable methods for the diagnosis of SCD.</p>", "<title>Subject terms</title>" ]
[]
[ "<title>Author contributions</title>", "<p>J.B., G.M., and A.J. wrote the main manuscript text. A.J. and N.P. wrote the state of the art. J.B. prepared the data and executed the experiments. All authors designed the experimentation and reviewed the manuscript.</p>", "<title>Funding</title>", "<p>Project PID2019-104829RA-I00 “EXPLainable Artificial INtelligence systems for health and well-beING (EXPLAINING)” funded by MCIN/AEI/10.13039/501100011033.</p>", "<title>Data availability</title>", "<p>erythrocytesIDB <ext-link ext-link-type=\"uri\" xlink:href=\"http://erythrocytesidb.uib.es/\">http://erythrocytesidb.uib.es/</ext-link>.</p>", "<title>Competing interests</title>", "<p id=\"Par48\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Instructions for cell classification.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Cell classification task.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>MTurk miss-classifications. The top row shows circular cells, the middle row shows elongated cells, and the bottom row shows other cell types. Each label shows the class that the MTurkers have classified them, the numbers in parenthesis show the votes: circular, elongated and other. These miss-classifications are indicative of the difficulty of accurately classifying cells.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Ratio of cells correctly classified regarding to the number of cells classified. We can observe that this calculation can be approximated through a linear regression. The classification ratio is maintained independently of the number of classified cells.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Results of classification of each cell by each MTurker. GT stands for Ground Truth.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">GT</th><th align=\"left\" colspan=\"5\">Prediction</th></tr><tr><th align=\"left\">Circular</th><th align=\"left\">Elongated</th><th align=\"left\">Other</th><th align=\"left\">Total</th><th align=\"left\">Accuracy (%)</th></tr></thead><tbody><tr><td align=\"left\">Circular</td><td align=\"left\">2676</td><td align=\"left\">58</td><td align=\"left\">351</td><td align=\"left\">3058</td><td align=\"left\">86.74</td></tr><tr><td align=\"left\">Elongated</td><td align=\"left\">48</td><td align=\"left\">614</td><td align=\"left\">243</td><td align=\"left\">905</td><td align=\"left\">67.58</td></tr><tr><td align=\"left\">Other</td><td align=\"left\">69</td><td align=\"left\">28</td><td align=\"left\">153</td><td align=\"left\">250</td><td align=\"left\">61.20</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Results of consensus-based cell type selection method. Consensus was reached when 3 or more MTurkers classify a cell with the same label.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Consensus</th><th align=\"left\">Correct</th><th align=\"left\">Total</th><th align=\"left\">Accuracy (%)</th></tr></thead><tbody><tr><td align=\"left\">Circular</td><td align=\"left\">566</td><td align=\"left\">617</td><td align=\"left\">91.73</td></tr><tr><td align=\"left\">Elongated</td><td align=\"left\">128</td><td align=\"left\">181</td><td align=\"left\">70.72</td></tr><tr><td align=\"left\">Other</td><td align=\"left\">32</td><td align=\"left\">50</td><td align=\"left\">64.00</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Comparison between the estimated accuracy, using Eq. (##FORMU##6##1##), and the obtained accuracy using a consensus-based cell type selection method.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Total</th><th align=\"left\"> (%)</th><th align=\"left\">Accuracy (%)</th></tr></thead><tbody><tr><td align=\"left\">Circular</td><td align=\"left\">98.11</td><td align=\"left\">91.73</td></tr><tr><td align=\"left\">Elongated</td><td align=\"left\">80.73</td><td align=\"left\">70.72</td></tr><tr><td align=\"left\">Other</td><td align=\"left\">70.31</td><td align=\"left\">64.00</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab4\"><label>Table 4</label><caption><p>Metrics obtained in the classification with 3 classes and comparison with the state-of-art. Individual, refers to results obtained from individual MTurkers. 5 MTurkers aggregated means that we consider the votes of 5 MTurkers even if the response is N/A. Consensus means that three or more MTurkers agreed on the classification. <italic>5 agree</italic> means that all MTurkers agreed. <italic>4 agree</italic> means that four MTurkers agreed and one disagreed. <italic>3 agree</italic> means that three MTurkers agreed and the other two classified differently.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Method</th><th align=\"left\" colspan=\"4\">Measure</th></tr><tr><th align=\"left\">SDS-Score</th><th align=\"left\">F-Measure</th><th align=\"left\">CBA</th><th align=\"left\">MCC</th></tr></thead><tbody><tr><td align=\"left\">Delgado et al.<sup>##REF##32222951##21##</sup></td><td align=\"left\">0.95</td><td align=\"left\">0.9483</td><td align=\"left\">0.80</td><td align=\"left\">0.82</td></tr><tr><td align=\"left\">Petrovic et al.<sup>##REF##33075715##14##</sup> GB</td><td align=\"left\">0.9518</td><td align=\"left\">0.9350</td><td align=\"left\">0.8839</td><td align=\"left\">0.8843</td></tr><tr><td align=\"left\">Petrovic et al.<sup>##REF##33075715##14##</sup> RF</td><td align=\"left\">0.9505</td><td align=\"left\">0.9336</td><td align=\"left\">0.8806</td><td align=\"left\">0.8820</td></tr><tr><td align=\"left\">Asakura et al.<sup>##REF##9075581##22##</sup></td><td align=\"left\">0.6180</td><td align=\"left\">0.4533</td><td align=\"left\">0.3748</td><td align=\"left\">0.3543</td></tr><tr><td align=\"left\">Our proposal Individual</td><td align=\"left\">0.8759</td><td align=\"left\">0.7802</td><td align=\"left\">0.7193</td><td align=\"left\">0.6748</td></tr><tr><td align=\"left\">Our proposal 5 MTurkers aggregated</td><td align=\"left\">0.9009</td><td align=\"left\">0.8838</td><td align=\"left\">0.7435</td><td align=\"left\">0.7485</td></tr><tr><td align=\"left\">Consensus</td><td align=\"left\">0.9272</td><td align=\"left\">0.8982</td><td align=\"left\">0.7435</td><td align=\"left\">0.7492</td></tr><tr><td align=\"left\">Our proposal 5 agree</td><td align=\"left\">0.9957</td><td align=\"left\">0.9887</td><td align=\"left\">0.8571</td><td align=\"left\">0.9537</td></tr><tr><td align=\"left\">Our proposal 4 agree</td><td align=\"left\">0.9204</td><td align=\"left\">0.8715</td><td align=\"left\">0.7529</td><td align=\"left\">0.7338</td></tr><tr><td align=\"left\">Our proposal 3 agree</td><td align=\"left\">0.7037</td><td align=\"left\">0.6115</td><td align=\"left\">0.6108</td><td align=\"left\">0.4699</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab5\"><label>Table 5</label><caption><p>Metrics obtained in the classification with 2 classes (mixing elongated and others in one class) and comparison with the state-of-art. Individual, refers to results obtained from individual MTurkers. 5 MTurkers aggregated means that we considered the votes of 5 MTurkers even if the response is N/A. Consensus means that three or more MTurkers agreed on the classification. <italic>5 agree</italic> means that all MTurkers agreed. <italic>4 agree</italic> means that four MTurkers agreed and one disagreed. <italic>3 agree</italic> means that three MTurkers agreed and the other two classified differently.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Method</th><th align=\"left\" colspan=\"4\">Measure</th></tr><tr><th align=\"left\">SDS-Score</th><th align=\"left\">F-Measure</th><th align=\"left\">CBA</th><th align=\"left\">MCC</th></tr></thead><tbody><tr><td align=\"left\">Delgado et al.<sup>##REF##32222951##21##</sup></td><td align=\"left\">0.95</td><td align=\"left\">0.9506</td><td align=\"left\">0.89</td><td align=\"left\">0.84</td></tr><tr><td align=\"left\">Petrovic et al.<sup>##REF##33075715##14##</sup> GB</td><td align=\"left\">0.9468</td><td align=\"left\">0.9467</td><td align=\"left\">0.9398</td><td align=\"left\">0.8872</td></tr><tr><td align=\"left\">Petrovic et al.<sup>##REF##33075715##14##</sup> RF</td><td align=\"left\">0.9444</td><td align=\"left\">0.9442</td><td align=\"left\">0.9366</td><td align=\"left\">0.8819</td></tr><tr><td align=\"left\">Acharya et al.<sup>##REF##28815426##23##</sup></td><td align=\"left\">0.7849</td><td align=\"left\">0.7876</td><td align=\"left\">0.8116</td><td align=\"left\">0.6080</td></tr><tr><td align=\"left\">González et al.<sup>##UREF##13##18##</sup></td><td align=\"left\">0.4932</td><td align=\"left\">0.4897</td><td align=\"left\">0.5281</td><td align=\"left\">0.0570</td></tr><tr><td align=\"left\">Our proposal Individual</td><td align=\"left\">0.8759</td><td align=\"left\">0.8721</td><td align=\"left\">0.8831</td><td align=\"left\">0.7194</td></tr><tr><td align=\"left\">Our proposal 5 MTurkers aggregated</td><td align=\"left\">0.9009</td><td align=\"left\">0.9083</td><td align=\"left\">0.8700</td><td align=\"left\">0.7571</td></tr><tr><td align=\"left\">Our proposal Consensus</td><td align=\"left\">0.9272</td><td align=\"left\">0.9202</td><td align=\"left\">0.8971</td><td align=\"left\">0.8204</td></tr><tr><td align=\"left\">Our proposal 5 agree</td><td align=\"left\">0.9957</td><td align=\"left\">0.9957</td><td align=\"left\">0.9868</td><td align=\"left\">0.9842</td></tr><tr><td align=\"left\">Our proposal 4 agree</td><td align=\"left\">0.9204</td><td align=\"left\">0.9213</td><td align=\"left\">0.9050</td><td align=\"left\">0.8286</td></tr><tr><td align=\"left\">Our proposal 3 agree</td><td align=\"left\">0.7037</td><td align=\"left\">0.7012</td><td align=\"left\">0.7131</td><td align=\"left\">0.4189</td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mi>μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$0.01\\$ $$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mrow><mml:mn>0.01</mml:mn><mml:mspace width=\"4pt\"/></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$0.02\\$ $$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mrow><mml:mn>0.02</mml:mn><mml:mspace width=\"4pt\"/></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$0.01\\$ $$\\end{document}</tex-math><mml:math id=\"M8\"><mml:mrow><mml:mn>0.01</mml:mn><mml:mspace width=\"4pt\"/></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k=5$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mi>α</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} P_X\\{success\\} = Acc_{estimated} = \\left( {\\begin{array}{c}5\\\\ 1\\end{array}}\\right) \\alpha ^5 + \\left( {\\begin{array}{c}5\\\\ 2\\end{array}}\\right) \\alpha ^4 (1-\\alpha ) + \\left( {\\begin{array}{c}5\\\\ 3\\end{array}}\\right) \\alpha ^3 (1-\\alpha )^2, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M14\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mi>X</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">{</mml:mo><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>c</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>s</mml:mi><mml:mo stretchy=\"false\">}</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>A</mml:mi><mml:mi>c</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">estimated</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mn>5</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mn>1</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:msup><mml:mi>α</mml:mi><mml:mn>5</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mn>5</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mn>2</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:msup><mml:mi>α</mml:mi><mml:mn>4</mml:mn></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>α</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mn>5</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mn>3</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:msup><mml:mi>α</mml:mi><mml:mn>3</mml:mn></mml:msup><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>α</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$86.74\\%$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mrow><mml:mn>86.74</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$67.58\\%$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:mrow><mml:mn>67.58</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$61.20\\%$$\\end{document}</tex-math><mml:math id=\"M20\"><mml:mrow><mml:mn>61.20</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$92.99\\%$$\\end{document}</tex-math><mml:math id=\"M22\"><mml:mrow><mml:mn>92.99</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$Acc_{estimated}$$\\end{document}</tex-math><mml:math id=\"M24\"><mml:mrow><mml:mi>A</mml:mi><mml:mi>c</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">estimated</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<inline-graphic xlink:href=\"41598_2024_51591_Article_IEq1.gif\"/>", "<graphic xlink:href=\"41598_2024_51591_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51591_Fig2_HTML\" id=\"MO2\"/>", "<inline-graphic xlink:href=\"41598_2024_51591_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51591_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51591_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51591_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51591_Article_IEq6.gif\"/>", "<graphic xlink:href=\"41598_2024_51591_Article_Equ1.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51591_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51591_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51591_Article_IEq9.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51591_Article_IEq10.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51591_Article_IEq11.gif\"/>", "<graphic xlink:href=\"41598_2024_51591_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51591_Fig4_HTML\" id=\"MO4\"/>" ]
[]
[{"label": ["1."], "mixed-citation": ["\u00d8rting, S., Doyle, A., Hilten, A., Hirth, M., Inel, O., Madan, C.R., Mavridis, P., Spiers, H. & Cheplygina, V. A survey of crowdsourcing in medical image analysis. "], "ext-link": ["arXiv:1902.09159"]}, {"label": ["2."], "surname": ["Ruiz", "Morales-\u00c1lvarez", "Coughlin", "Molina", "Katsaggelos"], "given-names": ["P", "P", "S", "R", "AK"], "article-title": ["Probabilistic fusion of crowds and experts for the search of gravitational waves"], "source": ["Knowl.-Based Syst."], "year": ["2023"], "volume": ["261"], "fpage": ["110183"], "pub-id": ["10.1016/j.knosys.2022.110183"]}, {"label": ["3."], "mixed-citation": ["Quinn, A.J. & Bederson, B.B. Human computation: A survey and taxonomy of a growing field. in "], "italic": ["Proceedings of the SIGCHI Conference on Human Factors in Computing Systems"]}, {"label": ["4."], "surname": ["Raddick", "Bracey", "Gay", "Lintott", "Murray", "Schawinski", "Szalay", "Vandenberg"], "given-names": ["MJ", "G", "PL", "CJ", "P", "K", "AS", "J"], "article-title": ["Galaxy zoo: Exploring the motivations of citizen science volunteers"], "source": ["Astron. Educ. Rev."], "year": ["2010"], "volume": ["9"], "issue": ["1"], "fpage": ["010103"], "pub-id": ["10.3847/AER2009036"]}, {"label": ["5."], "surname": ["Kawrykow", "Roumanis", "Kam", "Kwak", "Leung", "Wu", "Zarour", "players", "Sarmenta", "Blanchette"], "given-names": ["A", "G", "A", "D", "C", "C", "E", "P", "L", "M"], "article-title": ["Phylo: A citizen science approach for improving multiple sequence alignment"], "source": ["PloS One"], "year": ["2012"], "volume": ["7"], "issue": ["3"], "fpage": ["31362"], "pub-id": ["10.1371/journal.pone.0031362"]}, {"label": ["6."], "surname": ["Pharoah"], "given-names": ["PD"], "article-title": ["Cell slider: Using crowd sourcing for the scoring of molecular pathology"], "source": ["Cancer Res."], "year": ["2014"], "volume": ["74"], "issue": ["19\u2013Supplement"], "fpage": ["303"], "lpage": ["303"], "pub-id": ["10.1158/1538-7445.AM2014-303"]}, {"label": ["7."], "surname": ["Schwamb", "Orosz", "Carter", "Welsh", "Fischer", "Torres", "Howard", "Crepp", "Keel", "Lintott"], "given-names": ["ME", "JA", "JA", "WF", "DA", "G", "AW", "JR", "WC", "CJ"], "article-title": ["Planet hunters: A transiting circumbinary planet in a quadruple star system"], "source": ["Astrophys. J."], "year": ["2013"], "volume": ["768"], "issue": ["2"], "fpage": ["127"], "pub-id": ["10.1088/0004-637X/768/2/127"]}, {"label": ["8."], "surname": ["Luengo-Oroz", "Arranz", "Frean"], "given-names": ["MA", "A", "J"], "article-title": ["Crowdsourcing malaria parasite quantification: An online game for analyzing images of infected thick blood smears"], "source": ["J. Med. Internet Res."], "year": ["2012"], "volume": ["14"], "issue": ["6"], "fpage": ["167"], "pub-id": ["10.2196/jmir.2338"]}, {"label": ["9."], "surname": ["Mavandadi", "Dimitrov", "Feng", "Yu", "Sikora", "Yaglidere", "Padmanabhan", "Nielsen", "Ozcan"], "given-names": ["S", "S", "S", "F", "U", "O", "S", "K", "A"], "article-title": ["Distributed medical image analysis and diagnosis through crowd-sourced games: A malaria case study"], "source": ["PloS One"], "year": ["2012"], "volume": ["7"], "issue": ["5"], "fpage": ["37245"], "pub-id": ["10.1371/journal.pone.0037245"]}, {"label": ["10."], "mixed-citation": ["Von Ahn, L., Blum, M., Hopper, N.J. & Langford, J. Captcha: Using hard ai problems for security. in "], "italic": ["Eurocrypt"], "bold": ["2656"]}, {"label": ["11."], "surname": ["McCoy", "Wright", "Laxmisan", "Ottosen", "McCoy", "Butten", "Sittig"], "given-names": ["AB", "A", "A", "MJ", "JA", "D", "DF"], "article-title": ["Development and evaluation of a crowdsourcing methodology for knowledge base construction: Identifying relationships between clinical problems and medications"], "source": ["J. Am. Med. Informatics Assoc."], "year": ["2012"], "volume": ["19"], "issue": ["5"], "fpage": ["713"], "lpage": ["718"], "pub-id": ["10.1136/amiajnl-2012-000852"]}, {"label": ["13."], "mixed-citation": ["Wang, S., Anugu, V., Nguyen, T., Rose, N., Burns, J., McKenna, M., Petrick, N. & Summers, R.M. Fusion of machine intelligence and human intelligence for colonic polyp detection in ct colonography. in "], "italic": ["2011 IEEE International Symposium on Biomedical Imaging: From Nano to Macro"]}, {"label": ["15."], "mixed-citation": ["World Health Organization: Sickle Cell Disease. "], "ext-link": ["https://www.afro.who.int/health-topics/sickle-cell-disease"]}, {"label": ["18."], "surname": ["Gonz\u00e1lez-Hidalgo", "Guerrero-Pena", "Herold-Garc\u00eda", "Jaume-i-Cap\u00f3", "Marrero-Fern\u00e1ndez"], "given-names": ["M", "F", "S", "A", "PD"], "article-title": ["Red blood cell cluster separation from digital images for use in sickle cell disease"], "source": ["IEEE J. Biomed. Health Informatics"], "year": ["2015"], "volume": ["19"], "issue": ["4"], "fpage": ["1514"], "lpage": ["1525"], "pub-id": ["10.1109/JBHI.2014.2356402"]}, {"label": ["19."], "surname": ["Alzubaidi", "Fadhel", "Al-Shamma", "Zhang", "Duan"], "given-names": ["L", "MA", "O", "J", "Y"], "article-title": ["Deep learning models for classification of red blood cells in microscopy images to aid in sickle cell anemia diagnosis"], "source": ["Electronics"], "year": ["2020"], "volume": ["9"], "issue": ["3"], "fpage": ["427"], "pub-id": ["10.3390/electronics9030427"]}, {"label": ["20."], "mixed-citation": ["Bushra, S.N. & Shobana, G. Paediatric sickle cell detection using deep learning\u2014A review. in "], "italic": ["2021 International Conference on Artificial Intelligence and Smart Systems (ICAIS)"]}, {"label": ["24."], "surname": ["Petrovi\u0107", "Moy\u00e0-Alcover", "Varona", "Jaume-i-Cap\u00f3"], "given-names": ["N", "G", "J", "A"], "article-title": ["Crowdsourcing human-based computation for medical image analysis: A systematic literature review"], "source": ["Health Inform. J."], "year": ["2020"], "volume": ["26"], "issue": ["4"], "fpage": ["2446"], "lpage": ["2469"], "pub-id": ["10.1177/1460458220907435"]}, {"label": ["25."], "mixed-citation": ["Jaume-i-Cap\u00f3, A., Mena-Barco, C. & Moy\u00e0-Alcover, B. Analysis of blood cell morphology in touch-based devices using a captcha. in "], "italic": ["Proceedings of the XVII International Conference on Human Computer Interaction"]}, {"label": ["26."], "surname": ["Mitry", "Peto", "Hayat", "Morgan", "Khaw", "Foster"], "given-names": ["D", "T", "S", "JE", "K-T", "PJ"], "article-title": ["Crowdsourcing as a novel technique for retinal fundus photography classification: Analysis of images in the epic norfolk cohort on behalf of the ukbiobank eye and vision consortium"], "source": ["PloS One"], "year": ["2013"], "volume": ["8"], "issue": ["8"], "fpage": ["71154"], "pub-id": ["10.1371/journal.pone.0071154"]}, {"label": ["27."], "mixed-citation": ["Boorboor, S., Nadeem, S., Park, J.H., Baker, K. & Kaufman, A. Crowdsourcing lung nodules detection and annotation. in: "], "italic": ["Medical Imaging 2018: Imaging Informatics for Healthcare, Research, and Applications"], "bold": ["10579"]}, {"label": ["28."], "mixed-citation": ["Gurari, D., Theriault, D., Sameki, M., Isenberg, B., Pham, T.A., Purwada, A., Solski, P., Walker, M., Zhang, C., Wong, J.Y., et al.: How to collect segmentations for biomedical images? A benchmark evaluating the performance of experts, crowdsourced non-experts, and algorithms. in "], "italic": ["2015 IEEE Winter Conference on Applications of Computer Vision"]}, {"label": ["29."], "mixed-citation": ["Amazon Mechanical Turk: Introduction to Amazon Mechanical Turk. "], "ext-link": ["https://docs.aws.amazon.com/AWSMechTurk/latest/AWSMechanicalTurkGettingStartedGuide/SvcIntro.html"]}, {"label": ["30."], "surname": ["Bakulumpagi", "Raghunandan", "George", "Wegmann", "Bengo", "Kasirye", "Wasswa"], "given-names": ["D", "S", "P", "N", "D", "P", "P"], "article-title": ["Peripheral blood smear as a diagnostic tool for sickle cell disease in a resource limited setting"], "source": ["Pediatrics"], "year": ["2020"], "volume": ["146"], "issue": ["1-MeetingAbstract"], "fpage": ["297"], "lpage": ["298"], "pub-id": ["10.1542/peds.146.1MA4.297"]}, {"label": ["32."], "mixed-citation": ["St\u0105por, K. Evaluating and comparing classifiers: Review, some recommendations and limitations. in (Kurzynski, M., Wozniak, M. & Burduk, R., eds.) "], "italic": ["Proceedings of the 10th International Conference on Computer Recognition Systems CORES 2017"]}, {"label": ["33."], "mixed-citation": ["Labatut, V. & Cherifi, H.: Accuracy measures for the comparison of classifiers. in (Ali, A.-D., ed.) "], "italic": ["The 5th International Conference on Information Technology"], "ext-link": ["https://hal.archives-ouvertes.fr/hal-00611319"]}, {"label": ["34."], "mixed-citation": ["Mosley, L. A balanced approach to the multi-class imbalance problem. PhD thesis, Iowa State University, Industrial and Manufacturing Systems Engineering Department (2013)"]}, {"label": ["36."], "surname": ["Ilyas", "Sher", "Du", "Asghar"], "given-names": ["S", "M", "E", "W"], "article-title": ["Smartphone-based sickle cell disease detection and monitoring for point-of-care settings"], "source": ["Biosensors Bioelectron."], "year": ["2020"], "volume": ["165"], "fpage": ["112417"], "pub-id": ["10.1016/j.bios.2020.112417"]}, {"label": ["37."], "mixed-citation": ["Lynch, E.C. Peripheral blood smear. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd Edn. (1990)"]}]
{ "acronym": [], "definition": [] }
37
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1201
oa_package/89/77/PMC10786843.tar.gz
PMC10786844
38216632
[ "<title>Introduction</title>", "<p id=\"Par2\">NMO is an autoimmune inflammatory disease that mostly affect optic nerve and spinal cord, and can lead to severe disability of patients through frequent relapse. The pathogenesis of NMO is driven by disease-specific autoantibodies against aquaporin 4 (NMO-IgG)<sup>##REF##15589308##1##,##REF##16087714##2##</sup>. During the acute phase, NMO-IgG infiltrates the CNS perivascular space and binds to AQP4 located on astrocytic endfeet. The destruction of astrocytes (astrocytopathy) through complement-dependent cytotoxicity or antibody-dependent cell-mediated cytotoxicity (CDC/ADCC) triggers an inflammatory response mediated by damage-associated molecular patterns (DAMPs), inflammatory cytokines (such as IL-1β, IL-6, IFN-I), and complement activation (C1q, C3a, C5a)<sup>##REF##31033014##3##–##REF##32503977##5##</sup>. Animal models have been developed to induce inflammatory responses by astrocytopathy, using the passive transfer of patient-derived NMO-IgG and human complement into the brain such as the striatum or ventricles. Additionally, various T cell-based active transfer NMO pathology models have been investigated, including the administration of NMO-IgG alongside experimental autoimmune encephalomyelitis (EAE) or the transfer of encephalogenic AQP4-specific T cells<sup>##REF##31587392##6##,##REF##33781948##7##</sup>. These mechanistic-based models have significantly contributed to understanding the disease pathogenesis, aiding in the development of treatments like complement inhibitors and IL-6 inhibitors<sup>##REF##33513036##8##</sup>. In these animal models, the infiltration of innate immune cells such as monocytes/macrophages and microglia has been identified as a pivotal mechanism contributing to demyelination through myelin debris phagocytosis<sup>##REF##22725961##9##</sup>, becoming a promising therapeutic target.</p>", "<p id=\"Par3\">Monocyte/macrophages and microglia play a crucial role in the acute phase of inflammatory disease of the central nervous system as multiple sclerosis (MS), actively phagocytosing myelin and uniformly distributed throughout the active inflammatory lesion<sup>##REF##28541408##10##,##REF##35882229##11##</sup>. In NMO, activated-demyelinating monocyte/macrophages and microglia characterized by the presence of myelin-laden macrophages are observed along with loss of AQP4 and GFAP<sup>##REF##24345222##12##</sup>. Moreover, activated monocyte/macrophages and microglia secrete chemokines such as MCP-1, MCP-2, and MCP-4, which promote the infiltration of peripheral T cells and leukocytes (monocytes, neutrophils, eosinophils) into the brain<sup>##REF##33930716##13##–##REF##30083159##16##</sup>. They also increase neurotoxicity through the secretion of inflammatory cytokines like IL-1β, TNF-α, IL-6, and the production of C1q via interactions with astrocytes<sup>##REF##32488063##17##,##REF##32568214##18##</sup>. Therefore, it is highly plausible that monocyte/macrophages and microglia play an important role in the early response to injury, contributing to neuroinflammatory demyelination.</p>", "<p id=\"Par4\">Monocytes/macrophages originate from the bone marrow, while microglia derive from yolk sac precursors during CNS development. Despite their distinct origins, classical markers such as Iba1, CD68, F4/80, CD11b, CD45, and Cx3cr1 are commonly shared between monocyte/macrophage and microglia populations, making it challenging to distinguish and analyze their distribution and functions in basic research. Recent advancements in transcriptome analysis and sequencing have facilitated extensive genomic research, leading to the identification of microglia-specific markers such as P2ry12, Tmem119, Siglec H, Olfm3, Fcrls, and Sall1<sup>##REF##23850290##19##,##REF##24316888##20##</sup>. Among these, P2ry12, Tmem119, and Fcrls, which are cell surface markers, have enabled functional analysis of mouse and human microglia using various techniques and methodologies<sup>##REF##26884166##21##</sup>. These markers have been utilized in recent studies to investigate the distribution and functions of monocyte/macrophages and microglia in various neurological disorders, including multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), ischemia, and Alzheimer's disease<sup>##REF##28541408##10##,##REF##26250788##22##–##REF##31829283##24##</sup>. However, there is a significant lack of research on the distribution and functions of monocyte/macrophages and microglia specific to NMO using these markers. Therefore, in this study, we aim to analyze the distribution and functions of monocyte/macrophages and microglia using the microglia-specific markers P2ry12 and Tmem119 in an NMO-like mouse model.</p>" ]
[ "<title>Methods</title>", "<title>Mice</title>", "<p id=\"Par19\">All experiments were performed using female mice. We established an NMO-like animal model using female wild-type C57BL/6N mice (purchased from Orient Bio, Seongnam, Korea) at 12 weeks of age.The presence or absence of astrocyte damage was confirmed using Aldh1l1–EGFP–Rpl10a transgenic mice [B6; FVB-Tg (Aldh1l1/EGFP/Rpl10a) JD130Htz/J] (#030247, the Jackson Laboratory). All animal experiments were performed in compliance with the standards operating guidelines and approved by the Institutional Animal Care and Use Committee at Seoul National University (SNU-220215-1). All the animal experiments in this study are conducted in accordance with ARRIVE (Animal Research: Reporting of in vivo) guidelines.</p>", "<title>Patient-derived NMO-IgG preparations</title>", "<p id=\"Par20\">Purified NMO-IgG and Control-IgG were prepared following the methods described in a previous study<sup>##REF##27462020##40##</sup>. Briefly, IgG purification was performed using a commercially available kit (Amicon® Pro Affinity Concentration Kit–IgG, Billerica, MA) in accordance with the manufacturer's protocols. Plasma protein was added to a protein A resin-embedded exchange device and incubated at room temperature for 60 min with gentle agitation. Following the protein-binding step, the resin was centrifuged at 1000×<italic>g</italic> for 1 min. For the wash step, 1.5 ml of Bind/Wash Buffer was added, and the mixture was centrifuged again at 1000×<italic>g</italic> for 1 min. Elution buffer was added to the samples, and the mixture was centrifuged at 1000×<italic>g</italic> for 2 min. The pH was adjusted by adding neutralization buffer. The concentration of NMO-IgG was measured using the NanoDrop One, and aliquots of 100 mg/ml NMO-IgG were prepared in 35 μl volumes and stored until use. The present study was approved by the SNUH Institutional Review Board (approval number: H-1902-083-1010). All patients provided written informed consent before participating. All methods were performed in accordance with the relevant guidelines and regulations.</p>", "<title>NMO-like mouse model</title>", "<p id=\"Par21\">A NMO-like mouse model was created by unilateral intrastriatal injection of NMO-IgG and human complement (S1764, Sigma). The mice were anaesthetized using Zoletil (20 mg/kg, Zolazepam + Tiletamine) and Xylazine (10 mg/kg) and mounted onto a stereotaxic Instrument (#900, Kopf). A Midline incision was made to expose bregma, and a burr hole was created on the right side at the 0.5 mm of anterior, 2 mm of lateral from bregma. 10 μl gas-tight glass Hamilton syringe with a 33 g needle (#80008, Hamilton) was inserted 2.5 mm deep to infuse NMO-IgG and complement mixture. To determine optimal concentration of mixture, we tested 0, 10, 30 and 50 mg/ml NMO-IgG along with 0, 1, 5 and 10% complement. The optimal mixture, consisting of 3ul of 50 mg/ml of NMO-IgG with 5% complement, was injected at a rate of 1ul/min. Following the injection, a resting period of 2 min was provided to ensure sufficient diffusion of the injected material. The scalp was then closed with 6-0 silk suture. We established experimental groups comprising non-treated normal mice, as well as groups receiving injections of Control − IgG + hC and NMO − IgG + hC mixtures at equivalent concentrations into the unilateral striatum. These groups were sacrificed at 1, 3, and 7 days post-injection for immunofluorescence, qPCR, and flow cytometry analyses. For the monocyte/macrophages depletion experiment, groups were categorized as Normal, NMO, and NMO + CL. These groups were sacrificed at 1 day post-injection for flow cytometry, qPCR, immunofluorescence, and western blotting analyses. Additionally, at 1 week post-injection, LFB (luxol fast blue) staining and western blotting were conducted to assess the extent of demyelination. For the RNAseq of monocyte experiment, blood monocytes from Normal and NMO mice, as well as brain monocytes from NMO mice, were sorted from the immune cells and their transcriptomes were compared at 1 day post-injection. The RNAseq study of microglia included Normal, NMO, and NMO + CL groups, where brain immune cells were isolated for comparative transcriptome analysis. Detailed experiments and sample number in each group are provided in Supplementary Table ##SUPPL##0##S1##.</p>", "<title>Tissue preparation and immunofluoresence</title>", "<p id=\"Par22\">At 1 day, 3 days and 7 days after injury, mice were anesthetized using Zoletil + Xylazine and perfused fixed through the left cardiac injection of PBS followed by 4% paraformaldehyde (PFA, PC2031-100, Biosesang, Korea). Brain tissue was harvested and post-fixed in 4% PFA. The tissues were then dehydrated using a progressive treatment with 10–30% sucrose, embedded in frozen section compound (3801480, Leica, Richmond, IL, USA), and frozen at − 80 ℃. Serial floating sections, with a thickness of 30 μm, were preserved in a storage solution (30% Glycerol in PBS) in 24-well plates at − 20 ℃ until use.</p>", "<p id=\"Par23\">Sections were immunostained with the following primary antibodies: goat anti-AQP4 (1:500, sc-9888, Santa Cruz), rabbit anti-AQP4 (1:500, AQP-014, Alomone), rabbit anti-GFAP (1:500, ab7260, Abcam), rat anti-MBP (1:500, ab7349, Abcam), goat anti-Iba1 (1:200, NB100-1028, Novus), rat anti-P2ry12 (1:200, 848002, Biolegend), and rabbit anti-Tmem119 (1:100, ab209064, Abcam). The sections were then incubated with the appropriate secondary antibodies for each species: FITC-conjugated donkey anti-goat IgG (H + L) (1:200, 705-056-147, Jackson ImmunoResearch), Alexa Fluor® 594-conjugated donkey anti-rat IgG (H + L) (1:200, 712-585-153, Jackson ImmunoResearch), and Alexa Fluor® 594-conjugated donkey anti-rabbit IgG (H + L) (1:200, 711-586-152, Jackson ImmunoResearch) The sections were coverslipped with VECTASHIELD® Antifade Mounting Medium (H-1200, Vector Laboratories) and immunofluorescence was visualized using a Nikon ECLPSE N<italic>i</italic>-E microscope. The loss volumes of AQP4 and GFAP were measured through serial sections at 290 μm intervals. The fluorescence intensity of Iba1 immunoreactivity was measured using ImageJ. The extent of axonal bundle damage in the MBP-stained sections was analyzed using the Analyze Particles plug-in in ImageJ (Supplementary Fig. ##SUPPL##0##S1##F).</p>", "<title>Quantitative PCR</title>", "<p id=\"Par24\">Fresh tissue samples were collected from the Normal group (n = 3), Control − IgG + hC group (n = 3), and NMO − IgG + hC group (n = 3) at 1 day, 3 days, and 7 days post-injury, respectively. The samples were obtained from the 2 mm thickness of the ipsilateral hemisphere around bregma using a 2 mm biopsy punch to isolate the striatum tissue. Subsequently, these collected samples were stored at − 80 °C until further processing. Total RNA was isolated using the RNeasy Mini Kit (74104, Qiagen), and cDNA synthesis was performed using the AccuPower® CycleScript™ RT PreMix &amp; Master Mix (74004, Bioneer). The following primers were used: forward 5ʹ-CTTCCCAGGATGAGGACATGAGCAC-3ʹ and reverse 5ʹ-TCATCATCCCATGAGTCACAGAGG-3ʹ for <italic>IL1B</italic>; forward 5ʹ-AGCCGATGGGTTGTACCTTG-3ʹ and reverse 5ʹ-GTGGGTGAGGAGCACGTAGTC-3ʹ for <italic>TNF</italic>; forward 5ʹ-CCCTTCAATGGTTGGTACATGG-3ʹ and reverse 5ʹ-ACATTGATCTCCGTGACAGCC-3ʹ for <italic>NOS2</italic>; forward 5ʹ-ATGAACGCTACACACTGCATC-3ʹ and reverse 5ʹ-CCATCCTTTTGCCAGTTCCTC-3ʹ for <italic>IFNG</italic>. Quantitative real time PCR analyses were performed using Real-Time PCR instrument system (ABI7500, apppliedBiosystems) with PowerUP™ SYBR™ Green master mix (A25741, apppliedBiosystems) The expression of genes were normalized to that of housekeeping gene GAPDH and quantified using the 2<sup>−∆∆Ct</sup> method.</p>", "<title>Flow cytometry analysis of CNS immune cells</title>", "<p id=\"Par25\">The mice were anesthetized and then transcardially perfused with cold PBS. The brains were isolated and placed in 2 ml of ice-cold Hank's Balanced Salt Solution (HBSS). To facilitate dissociation, 123 μl of Liberase TL (05401020001, Roche) and 5 μl of 100 mg/ml DNase I (DN25, Sigma) were added to the brain tissues and incubated for 30 min at 37 ℃. After enzymatic dissociation, the cells were resuspended in 30% Percoll (17089101, Citiva, Sweden) and centrifuged for 25 min at 2850 rpm without a brake. Myelin was removed, and the pelleted cells were washed with HBSS. Red blood cells (RBC) were lysed using RBC lysis buffer (420301, BioLegend), and the cells were then counted using AO/PI (CS2-0106, Nexelom Bioscience, MA, USA) staining and a Fluorescent cell counter (Cellometer K2, Nexelom Bioscience, MA, USA).</p>", "<p id=\"Par26\">CNS immune cells were stained with the LIVE/DEAD™ Fixable Blue Dead Cell Stain Kit (L34962, Invitrogen) and incubated with Fc-Receptors blocker (101302, BioLegend). The cells were then labeled with the following antibodies: PECy7 anti-CD45 (561868, BD), FITC anti-CD11b (101206, BioLegend), PE anti-P2ry12 (848004, BioLegend).</p>", "<title>Monocyte/macrophage depletion</title>", "<p id=\"Par27\">Mice underwent monocyte depletion through intraperitonial injection of 200ul Clophosome<sup>®</sup>-A-Clodronate Liposomes (F70101C-A, 7 mg/ml, FormuMax) 6 h prior to NMO − IgG + complement injection. Mice were divided into three groups: Normal, NMO (NMO − IgG + complement), and NMO + CL (NMO − IgG + complement + clodronate liposome). After inducing NMO damage, the mice were sacrificed at 1 day post-injury to collect brain tissues. The obtained brain tissues were subjected to FACS analysis using FITC anti-CD11b (101206, BioLegend), PE anti-P2ry12 (848004, BioLegend), APC anti-Ly6G (127614, BioLegend), BV711 anti-Ly6C (128037, BioLegend) antibodies and Zombie Violet™ (423113, BioLegend) for Live/Dead cells. Additionally, the gene expression of <italic>IL1B</italic>, <italic>TNF</italic>, and <italic>IFN</italic> were analyzed using quantitative PCR.</p>", "<p id=\"Par28\">LFB staining was performed using the VitroView™ Luxol Fast Blue Stain Kit (VB-3006, VitroVivo Biotech, USA) according to the manufacturer's instructions. Briefly, the sections were immersed in a defat solution overnight. Then, the sections were hydrated in 95% ethanol. Subsequently, the sections were stained with a Luxol Fast Blue solution and differentiated in a lithium carbonate solution. Finally, the sections were washed with distilled water to remove any remaining stains.</p>", "<p id=\"Par29\">The samples, obtained using a 2 mm biopsy punch from the 2 mm thickness of the ipsilateral hemisphere around bregma to isolate striatum tissue, were stored at − 80 °C until further processing. For MBP expression analysis at 1 day and 7 days, brain tissues were homogenized and extracted in RIPA buffer (RC2002-050-00, Biosesang) containing a protease inhibitor (11836170001, Roche).The protein concentration was quantified using the Pierce™ BCA Protein Assay Kit (23227, Thermo Inc.). Subsequently, protein denaturation was achieved with 4 × Laemmli sample buffer (#1610747, Bio-Rad), and 5 μg of protein was loaded per well. The proteins were separated using a 12% polyacrylamide gel and transferred to a PVDF membrane using the iBlot2 system (Invitogen). After blocking with 5% skim milk, the membrane was probed with rat anti-MBP antibody (1:1000, ab7349, Abcam) and mouse anti-actin antibody (643802, BioLegend). MBP was detected using HRP-conjugated goat anti-mouse IgG antibody (1:10,000, 405306, BioLegend) and HRP-conjugated goat anti-rat IgG antibody (1:10,000, ab205720, Abcam), followed by visualization using a chemi image system (Amersham 680, GE Lifesciences).</p>", "<title>RNA-seq analysis of sorted monocyte and microglia</title>", "<p id=\"Par30\">The immune cells from the brain tissue of the Normal and NMO groups on day 1 were isolated using the method described above. Each experimental group consisted of three independent biological replicates derived from a pool of five samples. Mouse peripheral blood mononuclear cells (PBMC) were isolated using density gradient medium Lymphoprep™ (#07861, stemcell technologies, Germany). For purification of monocytes, CD45 + P2ry12 − CD11b + Ly6G − Ly6C<sup>high</sup> Cells were sorted using BD FACsymphony™ S6 cell sorter. For microglia sorting, Normal, NMO, NMO + CL groups consisted of three independent biological replicates from a pool of three samples. CD45 + P2ry12 + CD11b + cells were sorted, and the obtained monocytes and microglia were subjected to RNA-seq analysis.</p>", "<p id=\"Par31\">Total RNA was isolated using Trizol reagent (15596026, Invitrogen). RNA quality was assessed by Agilent TapeStation 4000 system (Agilent Technologies, Amstelveen, The Netherlands), and RNA quantification was performed using ND-2000 Spectrophotometer (Thermo Inc., DE, USA). The construction of library was performed using QuantSeq 3ʹ mRNA-Seq Library Prep Kit (Lexogen, Inc., Austria) according to the manufacturer’s instructions. In brief, each total RNA were prepared and an oligo-dT primer containing an Illumina-compatible sequence at its 5ʹ end was hybridized to the RNA and reverse transcription was performed. After degradation of the RNA template, second strand synthesis was initiated by a random primer containing an Illumina-compatible linker sequence at its 5ʹ end. The double-stranded library was purified by using magnetic beads to remove all reaction components. The library was amplified to add the complete adapter sequences required for cluster generation. The finished library is purified from PCR components. High-throughput sequencing was performed as single-end 75 sequencing using NextSeq 550 (Illumina, Inc., USA). QuantSeq 3ʹ mRNA-Seq reads were aligned using Bowtie2<sup>##REF##22388286##41##</sup>. Bowtie2 indices were either generated from genome assembly sequence or the representative transcript sequences for aligning to the genome and transcriptome. The alignment file was used for assembling transcripts, estimating their abundances and detecting differential expression of genes. Differentially expressed gene were determined based on counts from unique and multiple alignments using coverage in Bedtools<sup>##REF##20110278##42##</sup>. The RC (Read Count) data were processed based on TMM + CPM normalization method using EdgeR within R (R development Core Team, 2020) using Bioconductor<sup>##REF##15461798##43##</sup>. Gene classification was based on searches done by DAVID (<ext-link ext-link-type=\"uri\" xlink:href=\"http://david.abcc.ncifcrf.gov/\">http://david.abcc.ncifcrf.gov/</ext-link>) and Medline databases (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ncbi.nlm.nih.gov/\">http://www.ncbi.nlm.nih.gov/</ext-link>). Data mining and graphic visualization were performed using ExDEGA (Ebiogen Inc., Korea).</p>", "<title>Statistical analysis</title>", "<p id=\"Par32\">Statistical significance was tested using GraphPad Prism by performing a two-tailed student-t test, ANOVA with Bonferroni’s correction, or a Kruskal–Wallis test with Bonferroni’s correction (*p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001; n.s., non-significant). N represents the number of animals used in the experiment.</p>" ]
[ "<title>Results</title>", "<title>Temporal evolution of immune cell profiles in an NMO-like lesion</title>", "<p id=\"Par5\">A pilot experiment was conducted to determine the optimal concentrations of NMO-IgG and human complement. NMO-like mouse model was established using a mixture of 3 μl of 50 mg/ml NMO-IgG and 5% human complement (Supplementary Fig. ##SUPPL##0##S1##A,B). On 1 day after NMO-IgG + hC injection, staining for AQP4 and GFAP revealed damage to astrocytes (Fig. ##FIG##0##1##A,B), which was further confirmed by testing astrocyte death using aldh1L1 TG mice (Supplementary Fig. ##SUPPL##0##S1##C). Activated Iba-1 + monocytes/microglia exhibiting amoeboid morphology were detected at the lesion center 1 day after NMO-IgG injection (Supplementary Fig. ##SUPPL##0##S1##D). These cells were densely concentrated and proliferating within the axon bundles of the striatum at 1 week (Fig. ##FIG##0##1##A,C, and supplementary Fig. ##SUPPL##0##S1##E), coinciding with the gradual collapse of myelin structures (Fig. ##FIG##0##1##A,D). Upregulation of proinflammatory cytokines were also observed at day 1 (TNFα and IL1β) and also 1 week (IFNγ and IL1β) after injection (Fig. ##FIG##0##1##E). These results indicated that loss of aquaporin-4 and damage to astrocyte were followed by consecutive activation and/or recruit of innate immune cells with upregulation of proinflammatory cytokines at the lesion center of NMO-like model.</p>", "<title>Monocyte and lymphocyte, rather than microglia, can be actively involved in acute NMO lesion</title>", "<p id=\"Par6\">We performed immunofluorescence staining of the microglia-specific markers Tmem119 and P2ry12 to differentiate monocytes and microglia and analyze their dynamics (Fig. ##FIG##1##2##A). Tmem119 expression was not observed at lesion center at 1 day, 3 days, and 1 week after injury. In contrast, P2ry12 staining was observed at 1 day after NMO-IgG injection but disappeared at lesion center after 3 days and 7 days (Fig. ##FIG##1##2##A). These results indicated that P2ry12 can be more stably expressed at acute inflammatory/activation stage than Tmem119 in NMO pathology, which implies that it can be used as a marker to distinguish monocytes and microglia at 1 day of our NMO-like model.</p>", "<p id=\"Par7\">Next, we attempted to analyze the infiltration/activation of monocytes and microglia into the NMO-like brain lesion using FACS and the microglia-specific marker P2ry12 (Fig. ##FIG##1##2##B,C) at 1 day after NMO-IgG injection. Only a very small number of CD11b + P2ry12− monocytes/macrophages and CD45<sup>high</sup>CD11b-P2ry12- lymphocytes were observed in the normal brain. The number of CD11b + P2ry12 + microglia remained unchanged, while the infiltration of CD11b + P2ry12− monocytes/macrophages and CD45<sup>high</sup>CD11b − P2ry12− lymphocytes into the inflamed brain was observed (Fig. ##FIG##1##2##B,C) 1 day after NMO-IgG injection. These results demonstrated that at acute stage of NMO attack, monocyte/macrophage and lymphocyte, rather than microglia, can play as an early player that is involved in inflammation.</p>", "<title>Systemic depletion of monocyte inhibit the expression of the proinflammatory cytokines and loss of myelin in NMO lesion</title>", "<p id=\"Par8\">To evaluate the function of infiltrated monocytes in NMO pathogenesis, we systemically depleted monocyte by clodronate treatment in NMO-like mouse model (Fig. ##FIG##2##3##A). While clodronate treatment did not alter microglia (CD11b + P2ry12+) and neutrophil (CD11b + Ly6c + Ly6G+), it selectively depleted monocyte (CD11b + Ly6C + Ly6G−) population in the CNS of NMO-like model (Fig. ##FIG##2##3##B,C). Depletion of monocyte in NMO-like model significantly reduced the expression of IL1b and iNOS (Fig. ##FIG##2##3##D) and also loss of myelin in NMO lesion, whoever it did not affect the loss of AQP4, it significantly inhibit the loss of myelin. (Fig. ##FIG##2##3##E and Supplementary Fig. ##SUPPL##0##S2##). These results implied that recruitment of monocyte can be a sequential process that occurs after AQP4 loss by NMO-IgG (or astrocytopathy) and can contribute to the activation of proinflammatory cytokine and demyelination in NMO.</p>", "<title>Monocyte transcriptomic profiles in NMO-like model: infiltrated monocytes express proinflammatory genes in NMO lesion</title>", "<p id=\"Par9\">To investigate the functionality of monocytes in NMO pathogenesis, we performed the QuantSeq 3ʹ RNA-sequencing analysis (Fig. ##FIG##3##4##A and supplementary Fig. ##SUPPL##0##S3##) and investigated the differentially expressed genes (DEGs) between blood monocytes (Bl_mono) and brain-infiltrated monocytes (Br_mono) in NMO-like model. To obtain monocytes, cells were labeled with CD45, CD11b, P2ry12, Ly6C and Ly6G, and sorted CD45 + CD11b + P2ry12 − Ly6C + Ly6G− cells for monocytes (Fig. ##FIG##3##4##A). While Nor_Bl_mono and NMO_Bl_mono displayed similar expression patterns, a comparison of DEGs in NMO_Br_mono with NMO_Bl_mono revealed that 279 genes were significantly upregulated in NMO_Br_mono, and 290 genes exhibited significant downregulation (fold change of 1.2, p-value &lt; 0.05; Fig. ##FIG##3##4##B). The gene ontology (GO) of NMO_Br_mono show upregulate DEG were specifically associated with inflammation (red square outline) and receptor-mediated endocytosis (blue square outline) (Fig. ##FIG##3##4##C). These results indicate that monocytes infiltrating in NMO-like model are involved in inflammation and acute myelin phagocytosis. Furthermore, various inflammation-related genes showed a significant increase in expression, including <italic>Il1b, Il18, Il6st, Ccl2, Ccl7, Ccr5, Spp1, Osm, Tnfsf11a, CFP, C1qa</italic> and <italic>C1qc</italic> in NMO_Br_mono (Fig. ##FIG##3##4##D). Similarly, among the 27 scavenger receptors associated with receptor-mediated endocytosis, the expression of <italic>Cd68</italic>, <italic>Cd14</italic>, <italic>Fcrls</italic>, <italic>Lrp1</italic>, <italic>Clec7a</italic>, and <italic>Mrc1</italic> significantly increased in infiltrated monocytes (Fig. ##FIG##3##4##E). These findings suggest that infiltrating monocytes are associated with the early occurrence of inflammation and demyelination in the NMO-like model.</p>", "<title>Transcriptomic profiles of microglia in NMO-like model and effect of monocytes depletion on it</title>", "<p id=\"Par10\">To analyze microglial function in the NMO-like model, CD45 + CD11b + P2ry12 + cells were sorted, and RNA-seq analysis was performed (Fig. ##FIG##4##5##A and supplementary Fig. ##SUPPL##0##S3##A). A total of 885 DEGs were detected, with 480 upregulated and 405 downregulated genes after NMO induction (1.5-fold change, p-value &lt; 0.05; Fig. ##FIG##4##5##B). Among the downregulated DEGs, functional categorization using DAVID analysis revealed enrichment in \"Wnt signaling pathway\" annotations (Fig. ##SUPPL##0##S4##A). Furthermore, microglial homeostasis genes showed decreased expression after the NMO-like model (Fig. ##FIG##4##5##C). The expression of Wnt-related genes and microglia homeostatic genes decreased in NMO groups compared to the normal group, showing a potential relationship of microglial polarization and activation The GO in the upregulated DEGs were associated with terms related to protein synthesis, DNA replication, and inflammation (Fig. ##FIG##4##5##D). Genes involved in inflammation, cytokine/chemokine response, complement/receptor, and TNF signaling pathways were upregulated in microglia after NMO-IgG injection, indicating early-stage activation and induction of inflammation through the secretion of various inflammatory cytokines and chemokines (Fig. ##FIG##4##5##E). An increase in scavenger receptor genes such as <italic>Scarf2</italic>, <italic>Msr1</italic>, and <italic>Marco</italic> was observed (Fig. ##FIG##4##5##F). To assess the interaction between monocytes and microglia, clodronate was used to deplete monocytes. Clodronate treatment again showed monocyte-specific depletion in our model (Supplementary Fig. ##SUPPL##0##S3##B). This led to further activation of microglia, as indicated by decreased expression of Wnt genes (Supplemenraty Fig. ##SUPPL##0##S4##A) and microglial homeostatic markers (Fig. ##FIG##4##5##C). GO analysis on 217 genes that commonly increased between NMO + CL/NMO and NMO + CL/Normal (1.5-fold change, p-value &lt; 0.05; Fig. ##FIG##4##5##G,H) showed increased enriched genes associated with inflammatory response, innate immunity, and the complement pathway after clodronate treatment. Additionaly, statistically significant increases in inflammatory genes related to chemokine/cytokine, complement, oxidative stress, and inflammation were observed after clodronate treatment (Fig. ##FIG##4##5##I). These results indicate that microglia are rapidly activated immediately after astrocytopathy, and they secrete various inflammatory cytokines/chemokines, inducing inflammation. An interesting observation is that microglia become even more activated when monocytes are depleted, which is possibly the result of a regulatory interaction by monocytes. The activation of infiltrated monocytes during the first week of injury seems to be associated with the inhibition of microglial activation and may play a significant role in demyelination.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par11\">In this study, we aimed to elucidate the role of blood-derived monocytes in the pathogenesis of NMO. We used NMO-IgG to create NMO-like pathology and observed marker changes in monocytes/macrophages and microglia at different time points. During the acute phase, we confirmed that P2ry12 acted as a specific marker for microglia. Furthermore, we found that monocytes contributed to the exacerbation of NMO pathology through the secretion of inflammatory cytokines, particularly IL1b. In addition, microglia exhibited an inflammatory function regardless of monocyte infiltration, indicating their activation as inflammatory microglia. In this manner, we observed the interplay between monocytes and microglia influencing the disease pathology in the NMO-like animal model. Specifically, we confirmed through transcriptome analysis that monocytes play a role in early inflammation and demyelination.</p>", "<p id=\"Par12\">Monocytes can contribute to the exacerbation of NMO as a secondary damage following astrocytopathy induced by NMO-IgG. Astrocytes release chemokines, and HMGB1 acting as damage-associated molecular patterns (DAMPs), which directly enhance monocyte recruitment<sup>##REF##32764561##25##</sup> and blood–brain barrier (BBB) leakage<sup>##REF##33321691##26##</sup>. Once infiltrated, activated monocytes promote the production of inflammatory chemokines/cytokines and complement factors, such as Ccl2, Ccl7, Il1b, Il18, C1qa, and C1qc in our study (Fig. ##FIG##3##4##D). Furthermore, it was also involved in early demyelination through an increase in the expression of scavenger receptors and an increase in receptor-mediated endocytosis (Fig. ##FIG##3##4##E). This demyelination was reduced after the depletion of pro-inflammatory monocytes by clodronate (Fig. ##FIG##2##3##E and supplementary Fig. ##SUPPL##0##S2##). Similar findings were observed in previous studies using chimeric symbiotic mice and a dual reporter system in an EAE mouse model<sup>##REF##21804537##27##</sup>. Ajami et al. reported a positive correlation between infiltrated monocytes and EAE severity, while Ccr2−/− mice showed suppressed EAE progression. Yamasaki et al. demonstrated that monocyte-derived macrophages induced demyelination at EAE onset, and depletion studies showed a moderate delay in disease onset<sup>##REF##25002752##28##</sup>. Taken together, it was evident that monocytes infiltrating in the early pathology of NMO are a key cell type that exacerbates the lesion.</p>", "<p id=\"Par13\">IL-1β plays a role in the expansion of GM-CSF-producing Th17 cells<sup>##REF##21516111##29##</sup>, breakdown of the blood–brain barrier (BBB)<sup>##REF##24252536##30##</sup>, activation of microglia<sup>##UREF##0##31##</sup>, and promotion of IL-1β production/secretion to amplify inflammation. In our results, <italic>Il1b</italic> showed decreased expression after monocyte depletion (Fig. ##FIG##2##3##D), whereas microglia showed no change in <italic>Il1b</italic> expression after clodronate treatment (Supplementary Fig. ##SUPPL##0##S4##B). This implies that monocytes are the primary secretory cells for <italic>Il1b</italic>. IL-1β is known as characteristic biomarkers in the serum and cerebrospinal fluid (CSF) of NMO patients<sup>##REF##36451827##32##,##REF##35401423##33##</sup>. Additionally, IL-1β increased in the serum of patients with acute stages of NMO<sup>##REF##32919144##34##</sup>. These findings support our study's assertion that monocytes induced IL-1β play an important role in the early stages of NMO. The current treatment for NMO primarily focuses on long-term management and prevention of relapses. However, targeting monocytes for acute management in patients with relapses is predicted to offer therapeutic potential that could reduce the severity. Additionally, IL-1β is known not only as a major cytokine amplifying inflammation but also as a regulator of proliferation and differentiation in Oligodendrocyte Progenitor Cells (OPCs)<sup>##REF##11549714##35##,##REF##12139924##36##</sup>. In this study, delayed expression of <italic>Il1b</italic> was observed at 1 week, but unfortunately, the cellular source of this expression remained unidentified. In-depth research into this delayed expression could significantly contribute to understanding the regulation of demyelination and remyelination in demyelinating diseases.</p>", "<p id=\"Par14\">This study confirmed the substantial involvement of monocytes in inflammation and demyelination in NMO early lesions. Simultaneously, a regulatory function decreasing microglial activation was also observed after clodronate treatment (Fig. ##FIG##4##5##G,H). The analysis of selected signature genes related to pro-inflammatory (<italic>Il6</italic>, <italic>Tnf</italic>) or anti-inflammatory (<italic>Arg1</italic>, <italic>Tgfb1</italic>)<sup>##REF##32030468##37##</sup> responses revealed increased expression of <italic>Arg1</italic> and <italic>Tgfb1</italic> after infiltration, while <italic>Il6</italic> and <italic>Tnf</italic> decreased in the brain following infiltration (Supplementary Fig. ##SUPPL##0##S4##C). Further detailed research is needed to determine whether monocytes perform both of these functions or if there is a distinct population contributing to these effects. One hypothesis is that the P2ry12 − CD11b + Ly6G − Ly6C + cell population sorted for this study might encompass myeloid-derived suppressor cells, which could potentially explain the observed phenomenon. Despite enhanced microglial activation after clodronate treatment, the importance of monocytes in contributing to acute lesion development remains unchanged, as evidenced by the reduction in myelin damage. Additionally, the significance of the increase in <italic>Il1b</italic>, irrespective of the decrease in <italic>Il6</italic> and <italic>Tnf</italic>, remains unchanged.</p>", "<p id=\"Par15\">Microglia, like monocytes, are known to play a crucial role in the pathogenesis of NMO<sup>##REF##33679755##38##</sup>. The exact mechanisms and stimuli leading to microglia activation are not fully understood, but our study showing that monocyte depletion does not reduce microglia activation, suggests that microglia, similar to monocytes, may act as the first responders to astrocytic chemokines/cytokines and DAMPs. Moreover, recent research has reported that C3a, produced by astrocytes in precytotic tissue injury in NMO, can activate microglia<sup>##REF##32568214##18##</sup>. Our microglia transcriptome analysis supports this microglia-astrocyte interaction, as it showed an increase in C3aR expression (Fig. ##FIG##4##5##E). Additionally, the immediate reduction in Wnt signaling and homeostatic microglia markers after NMO-IgG injection well indicates acute microglia activation (Fig. ##FIG##4##5##C, Supplementary Fig. ##SUPPL##0##S4##A). Microglia are known to be involved in various functions in NMO, including inducing neuronal damage, clearing debris, and promoting inflammation. In our study, microglia exhibited an increased enrichment of cell proliferation, protein synthesis, and inflammation-related genes after NMO-IgG injection (Fig. ##FIG##4##5##D). Moreover, the upregulation of inflammatory chemokines/cytokines and complement expression well strongly indicates their role as inflammation-associated microglia (Fig. ##FIG##4##5##E). However, due to the results showing the disappearing pattern of the P2ry12 marker, we were unable to determine microglia's roles in the chronic phase.</p>", "<p id=\"Par16\">Among homeostatic microglia markers, P2ry12 and Tmem119, as cell membrane proteins, have the advantage of enabling analysis through immune reactivity techniques such as FACS, immunostaining, and Western blotting. Tmem119 has recently been identified as a microglia-specific marker capable of distinguishing macrophages from microglia in both human and murine tissues<sup>##REF##26884166##21##,##REF##26250788##22##</sup>. However, the discrepancies between <italic>Tmem119</italic> mRNA and protein expression, as well as its disappearance in CNS disease animal models with tissue damage, raise concerns about its reliability as a marker<sup>##REF##35221925##39##</sup>. On the other hand, P2ry12 exhibited a different expression pattern, maintaining immunoreactivity on day 1 after injection and disappearing on days 3 and 7 (Fig. ##FIG##1##2##A). This pattern is consistent with observations in post-mortem brain tissue of MS patients, where P2ry12 remains in chronic-active lesions while both P2ry12 and Tmem119 are lost in active lesions<sup>##REF##31829283##24##</sup>. These differing expression patterns suggest that P2ry12 is less affected by lesion activity and may serve as a more reliable marker for microglia during the acute phase.</p>", "<p id=\"Par17\">In most studies that utilized P2ry12 and Tmem119 to distinguish and analyze monocytes/macrophages from microglia, immunoreactivity in active lesions disappeared, similar to our study. However, by considering the expression characteristics based on lesion activity, as demonstrated in our research, it is possible to effectively distinguish between monocytes/macrophages and microglia. Therefore, a primary focus should be on understanding the lesion activity of the disease under investigation, and the timing of analysis also becomes a critical factor. Additionally, a comprehensive understanding of P2ry12 and Tmem119 in microglia should be accompanied by in-depth research, and the exploration of new markers that can distinguish monocytes/macrophages from inflammatory microglia is also crucial.</p>", "<p id=\"Par18\">Finally, this study demonstrated that monocytes infiltrating during the acute stage can play a critical role in initiating early inflammation. Additionally, we showed an increase in the secretion of Il1b from infiltrated monocytes. The upregulation of Il1b during the acute attack is a common feature in most demyelinating diseases. Further additional research is needed to determine whether therapies targeting monocyte/macrophage and Il1b in NMO patients can effectively prevent relapses and reduce disability in the clinical field.</p>" ]
[]
[ "<p id=\"Par1\">Neuromyelitis optica (NMO) is an autoimmune inflammatory disease that primarily affects the optic nerve and spinal cord within the central nervous system (CNS). Acute astrocyte injury caused by autoantibodies against aquaporin 4 (NMO-IgG) is a well-established key factor in the pathogenesis, ultimately leading to neuronal damage and patient disability. In addition to these humoral immune processes, numerous innate immune cells were found in the acute lesions of NMO patients. However, the origin and function of these innate immune cells remain unclear in NMO pathogenesis. Therefore, this study aims to analyze the origin and functions of these innate immune cells in an NMO-like mouse model and evaluate their role in the pathophysiology of NMO. The expression of Tmem119 on Iba1 + cells in brain tissue disappeared immediately after the injection of NMO-IgG + human complement mixture, while the expression of P2ry12 remained well-maintained at 1 day after injection. Based on these observations, it was demonstrated that monocytes infiltrate the brain during the early stages of the pathological process and are closely associated with the inflammatory response through the expression of the proinflammatory cytokine IL-1β. Understanding the variations in the expression patterns of P2ry12, Tmem119, and other markers could be helpful in distinguishing between these cell types and further analyzing their functions. Therefore, this research may contribute to a better understanding of the mechanisms and potential treatments for NMO.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51759-4.</p>", "<title>Acknowledgements</title>", "<p>This work was supported by the National Research Foundation of Korea (NRF-2021R1C1C2012932) Grant funded by the Ministry of Science and ICT (MSIT), Republic of Korea</p>", "<title>Author contributions</title>", "<p>M.K. and S.M.K. conceived and designed the experiments; M.K., W.S.K., H.C., B.K. and Y.N.K. performed the experiments; M.K. developed the data and analyzed the data; M.K. and S.M.K. wrote the manuscript. All authors reviewed the manuscript.</p>", "<title>Data availability</title>", "<p>All high throughput sequencing data have been deposited with the Gene Expression Ombudsman (GEO) and are available under the accession number GSE235278.</p>", "<title>Competing interests</title>", "<p id=\"Par33\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Temporal evolution of astrocytopathy, innate immune cell activation, and myein damage in an NMO-like mouse model. (<bold>A</bold>) Immunostain of injury extent (AQP4 and GFAP), inflammation (Iba1), and MBP loss (MBP) in NMO − IgG + hC and Control − IgG + hC groups at 1, 3, and 7 days. (Scale bar = 500 μm and 100 μm). (<bold>B</bold>) The loss volume of AQP4 and GFAP. (<bold>C</bold>) Quantification of Iba1 + cell activation. (<bold>D</bold>) Measurement of axon buldle size. (<bold>E</bold>) Expression of proinflammatory genes in fresh tissue using qPCR at 1 day, 3 days, and 7 days. (Two-way ANOVA with Tukey's post-hoc test, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001, N = 3).</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>P2ry12 maintains immunoreactivity in early lesion, while Tmem119 does not. (<bold>A</bold>) Immunostaining of Tmem119 (red) and P2ry12 (red) microglia, along with Iba1 (green), at 1, 3, and 7 days post-injury to distinguish infiltrating monocytes/macrophages from microglia and assess their dynamics. Colocalization of each marker was evaluated in the lesion center (Scale bar = 1000 μm and 100 μm). Large images indicate contralateral and ipsilateral expression of Tmem119 and P2ry12 at 1 day after injury. (<bold>B</bold>) Flow cytometry analysis using P2ry12 to differentiate monocytes/macrophages from microglia. CD45 + CD11b + cells were gated, and lymphocytes, monocytes/macrophages and microglia were identified as CD45<sup>high</sup>CD11b−, CD11b + P2ry12− and CD11b + P2ry12 + populations, respectively. (<bold>C</bold>) Each bar graph represents relative number of identified CD11b + P2ry12− monocytes/macrophages, CD11b + P2ry12 + microglia, and CD45<sup>high</sup>CD11b− lymphocytes populations. (Kruskal–Walli's test with Dunn's post-hoc, **p &lt; 0.01 and n.s. = non-significant, n = 6).</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Clodronate depletes monocytes, reduces IL-1β expression and myelin loss. (<bold>A</bold>) Schematic design for monocyte-depleted NMO model. (<bold>B</bold>) Immune cells were isolated from the brains of normal, NMO, and NMO + CL (Clodronate) groups. The dot plot was gated on Live/CD45+, and Ly6C/Ly6G populations were further gated from CD11b + cells. The transparent red squares represent populations of CD11b + P2ry12 + microglia, CD11b + P2ry12− myeloid cells, Ly6C + Ly6G + neutrophils, and Ly6C + Ly6G− monocytes. (<bold>C</bold>) A bar graph displaying differences in cell numbers for each cell type. (Kruskal–Wallis test with Dunn's post-hoc, **p &lt; 0.01, *p &lt; 0.05, and n.s. = non-significant, n = 5–6). (<bold>D</bold>) Relative expression differences of iNOS, IL1β, and TNFα in fresh tissue from each group at day 1 post-injury evaluated by qPCR. (Kruskal–Wallis test with Dunn's post-hoc, **p &lt; 0.01, ****p &lt; 0.0001, and n.s. = non-significant, N = 3). (<bold>E</bold>) Evaluation of demyelination at the injury site through AQP4 immunostaining and Luxol fast blue (LFB) staining, comparing NMO and NMO + CL groups. The dotted line indicates disappeared myelin on LFB staining.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Inflammatory gene and scavenger receptor expression in monocytes infiltrating early NMO lesions increased. (<bold>A</bold>) Schematic design for monocyte sorting and RNA-seq analysis. (<bold>B</bold>) A heat map of RNA-seq data from normal blood monocytes (Nor_Bl_Mono), NMO blood monocytes (NMO_Bl_Mono), and NMO brain monocytes (NMO_Br_Mono) was created using selected genes that showed significant changes (fold change = 1.2, p &lt; 0.05) between NMO_Bl_Mono and NMO_Br_Mono. (<bold>C</bold>) Through the GO analysis of 279 up-regulated genes, the top 10 ontologies were inferred. The red and blue square outlines indicate gene ontologies associated with inflammation and receptor-mediated endocytosis, respectively. (<bold>D</bold>) A heatmap and (<bold>E</bold>) volcano plot represent the expression of inflammation-related genes and scavenger receptors, respectively.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Microglia are activated in early NMO lesions, and monocyte depletion further amplifies this activation. (<bold>A</bold>) Schematic design for microglia sorting and RNA-seq analysis. (<bold>B</bold>–<bold>E</bold>) Depict microglial transcriptome analysis in NMO, while (<bold>F</bold>–<bold>H</bold>) illustrate changes in microglial transcriptome following clodronate treatment. (<bold>B</bold>) A heat map shows DEGs between Normal and NMO (fold change = 1.2, p &lt; 0.05). (<bold>C</bold>) A heat map and a volcano plot related to various microglia-specific marker of DEGs for NMO vs. Normal, NMO + CL vs. Normal and NMO + CL vs. NMO (fold change = 1.2, p &lt; 0.05). Significantly expressed microglial homeostatic markers are highlighted. (<bold>D</bold>) Gene ontology analysis of the upregulated 480 DEGs were inferred. (<bold>E</bold>) The heat map represent the expression of chemokine/cytokine, complement and TNF singling pathway-related genes using average normalized data (log2). (<bold>F</bold>) Volcano plot represent the expression of scarvenger receptors. (<bold>G</bold>) A Venn diagram shows the overlap of upregulated genes in NMO + CL vs. NMO and NMO + CL vs. Normal. (<bold>H</bold>) GO analysis of the 217 overlapping upregulated genes between NMO + CL vs. NMO and NMO + CL vs. Normal. (<bold>I</bold>) A heat map is used to represent the expression of chemokine/cytokine, complement, oxidative stress, and inflammation-related genes within the 217 overlapping upregulated genes.</p></caption></fig>" ]
[]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51759_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51759_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51759_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51759_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51759_Fig5_HTML\" id=\"MO5\"/>" ]
[ "<media xlink:href=\"41598_2024_51759_MOESM1_ESM.pdf\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["31."], "surname": ["Monif"], "given-names": ["M"], "article-title": ["Interleukin-1beta has trophic effects in microglia and its release is mediated by P2X7R pore"], "source": ["J. Neuroinflam."], "year": ["2016"], "volume": ["13"], "fpage": ["173"], "pub-id": ["10.1186/s12974-016-0621-8"]}]
{ "acronym": [], "definition": [] }
43
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1177
oa_package/00/d2/PMC10786844.tar.gz
PMC10786845
38216681
[ "<title>Introduction</title>", "<p id=\"Par2\">Vascular inflammatory responses include complex interactions involving ExtraCellular Matrices (ECMs) with various inflammatory cells, such as monocytes, macrophages, neutrophils, lymphocytes, Vascular Smooth Muscle Cells (VSMCs), and platelets. When ECMs undergo inflammatory activation in response to external stimuli, an increase in the expression of adhesion molecules such as selectins, Vascular Cell Adhesion Molecule-1 (VCAM-1), and InterCellular Adhesion Molecule-1 (ICAM-1) promotes adherence to the inflammatory cells. These monocytes, neutrophils, lymphocytes, and macrophages also recruit additional cytokines, growth factors, and Matrix Metalloproteinases (MMPs). When the injurious stimulus is removed, inflammation is generally terminated, and all the mediators disappear or are inhibited. The released cytokines include TNFα (Tumor Necrosis Factor α), chemokines, interleukins, interferons, colony-stimulating factors, and growth factors. If vascular inflammation progresses unresolved, it can lead to various vascular diseases<sup>##REF##19413999##1##</sup>.</p>", "<p id=\"Par3\">Percutaneous Coronary Intervention (PCI) is a landmark advance in the therapeutic history of Acute Myocardial Infarction (AMI) which reduces inpatient mortality and incidence of complications<sup>##REF##12566381##2##</sup>. In PCI patients stent implantation induces over-inflammation leading to cytokine release<sup>##REF##12551878##3##</sup>. Recent documentation about the release of various cytokines after stent implantation in various heart conditions has been reported. It is observed that STEMI-diagnosed diabetes patients have more inflammatory cells with severe atherosclerotic plaques than nondiabetes patients. Incretin therapy reduces inflammatory cells and MACE (Major Adverse Cardiac Events) in STEMI-diabetic Mv-NOCS (Multivessel Non-Obstructive Coronary Stenosis) patients with lower mortality<sup>##REF##29308090##4##</sup>. Similarly, incretin users of NSTEMI-NOCs patients with diabetes showed a lower incidence of mortality and cardiac death compared to nondiabetic patients. The Incretin-based therapy exerts its effect by reducing inflammatory burden in diabetic NSTEMI-NOC patients<sup>##REF##28950045##5##</sup>. PCI patients with diabetes also have an increased incidence of restenosis and stent thrombosis than non-diabetic patients. SGLT2 (Sodium/glucose cotransporter 2) inhibitor therapy reduced MACE in Type II diabetes (T2DM) and acute coronary syndrome patients. This reduction is attributed to the anti-inflammatory effect of SGLT2<sup>##UREF##0##6##</sup>. Due to higher oxidative stress hyperglycemic AMI patients have lower circulating EPC (Endothelial Progenitor Cells) and SIRT1 levels that differentiate EPCs<sup>##REF##15862417##7##,##REF##23342163##8##</sup>. Notably, it is demonstrated that SGLT2 therapy in PCI with hyperglycemic patients having similar stents induces an anti-inflammatory effect and increases SIRT1 level with EPCs that leads to myocardial regeneration and neovascularization leading to better clinical outcome<sup>s</sup><sup>##REF##23876463##9##</sup>.</p>", "<p id=\"Par4\">The principle cytokines are mainly IL8 and TNFα with Hs-CRP (Hypersensitive C-Reactive Protein) for AMI<sup>##REF##16455670##10##,##REF##19568720##11##</sup>, TNFα, Hs-CRP, IL6 with STEMI patients <sup>##REF##30315494##12##</sup>, IL-1ß for coronary endothelial dysfunction in CAD (Coronary Artery Disease) patients<sup>##REF##28116487##13##</sup>, IL6, IL8, and TNFα for patients with severe stenosis in a saphenous vein<sup>##REF##23649933##14##</sup>, TNFα for restenosis patients after coronary angiography<sup>##REF##17208993##15##</sup>, IL-1ß, IL6 and TNFα for AMI patients with significant stenosis of the ramus interventricularis anterior<sup>##REF##20229266##16##</sup>. T2DM Mv-NOCS patients with SGLT2 inhibitor users showed reduced BMI, and inflammation than non-users with lower levels of NLRP3 inflammasome formation and IL-1ß<sup>##UREF##1##17##</sup>. Adiponectin that is exclusively secreted from adipose tissue and inflammatory cytokines including TNFα, PAI-1 (Plasminogen Activator Inhibitor type 1), IL-6, leptin, and resistin favorably modulate the endothelial inflammatory responses to vascular injury<sup>##REF##15082700##18##</sup> and linked to restenosis and Acute Coronary symptoms after PCI<sup>##UREF##2##19##</sup>. It is observed that lower levels of adiponectin and TNFα in preprocedural serum are significantly associated with the development of restenosis due to endothelium function impairment. Increased levels of resistin and adiponectin are significantly associated with better clinical outcomes in restenosis patients after PCI with angioplasty and DES<sup>##UREF##2##19##</sup>. Most importantly, a majority of these reports only studied a single cytokine release after stent implantation, without any correlation to several cytokines released together.</p>", "<p id=\"Par5\">The outcome of stent implantation depends on several factors such as age, various clinical conditions, the number of stents, or the length/volume of stents being implanted. Six types of either plastic or metallic stent are generally used to maintain normal blood flow. Recently DES (Drug Eluting Stent) showed major advances in reducing morbidities and other health complications<sup>##UREF##3##20##,##REF##27856669##21##</sup>. Since cytokine release is an inevitable outcome of stent implantation, a correlation of the extent of cytokine releases with the number of stent implantation or total stent length or volume may strengthen the hypothesis of cytokine-mediated complications.</p>", "<p id=\"Par6\">Here we assessed the levels of TNFα, IL-1ß, IL2 receptor, IL6, IL8, IL10, and Hs-CRP and correlated their levels with various conditions in 311 AMI patients with PCI after metallic DES stent implantation. We studied the correlation of two or more cytokines release to understand whether they are occurring in a maximum number of patients significantly. Most of the studies earlier focused on single cytokine release after stent implantation, thus we enquired if the expression of two or more cytokines is correlated with the increased number or length, or volume of stent implantation. We observed that after stent implantation co-release of TNFα with IL-1ß or IL8 are the major cytokines that are correlated with various conditions, such as in diabetes and NSTEMI patients with AMI after PCI. These results could be confirmed with more recurrent studies with a larger cohort and would pave the way for better diagnostics and treatment options in PCI patients after stent implantation.</p>" ]
[ "<title>Materials and methods</title>", "<title>A Ethical statement</title>", "<p id=\"Par34\">The Ethics Review Committee of the Chongming Branch of Shanghai Tenth Peoples Hospital approved this study (Ethics Number: EC20221104-1001, Dated: 2013–09-10). <bold>All methods were performed following the relevant guidelines and regulations</bold>. All subjects provided written informed consent before participating in this study. During CAD evaluation both the angiography and coronary stent implantation were completed voluntarily and were selected by the patients and their family members. The patient’s family members signed the informed consent forms in all cases.</p>", "<title>Recruitment of patients</title>", "<p id=\"Par35\">Inpatients were admitted to the Department of Cardiology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine from 2014 to 2015. All blood biochemistry, electrocardiogram, echocardiography, etc. were examined in the hospital. All patient records and test results were collected after discharge. The patient diagnosis, measurements, and treatment outcomes are in Supplementary Tables 1, 2, and 3.</p>", "<title>Inclusion and exclusion of patients</title>", "<p id=\"Par36\">During the study period (01/2014–05/2015, 17 months), approximately ~ 40 patients were recruited every month (a total of 672 patients). Most patients who refused to have a stent implanted (n = 32) or required surgical bypass (n = 221) or could not be followed up (n = 31), so they were excluded from this study. All patients with STEMI, NSTEMI, UA, and CAD are diagnosed based on international guidelines. Some patients did not give consent for a research study (n = 14). Other patients (n = 63) have different types of stents except for DES of various shapes and unique manufacturers that are excluded from the study analysis. 311 patients are included in the study with similar types of stents (mostly balloons).</p>", "<title>Detailed procedures</title>", "<title>STEMI (ST-Elevation Myocardial Infarction) patients:</title>", "<p id=\"Par37\">STEMI patients have a significant elevation of ST segment in ECG associated with myocardial ischemia with persistent chest discomfort or other associated symptoms suggestive of ischemia as shortness of breath, nausea, fatigue, and palpitations. STEMI was diagnosed based on international guidelines as at least two anatomically contiguous leads (for men &lt; 40 years, &gt; 2.5 mm; &lt; 40 years, &gt; 2 mm; for women, &gt; 1.5 mm, for men and women, V4R, V3R, V7-V9 &gt; 0.5 mm). Elevated cardiac troponin values were at least one value above the 99<sup>th</sup> percentile.</p>", "<title>NSTEMI (Non-ST Segment Elevation (NSTEMI) Myocardial Infarction) patients</title>", "<p id=\"Par38\">NSTEMI patients have elevated cardiac troponin levels but no ST-segment elevation in ECG. According to the Grace score, very high-risk patients received coronary angiography within 2 h with PCI; moderate-risk patients received coronary angiography within 24 h with PCI; low-risk patients received coronary angiography within 72 h with PCI treatment.</p>", "<title>UA (Unstable Angina)</title>", "<p id=\"Par39\">UA has the same timing as NSTEMI that are collectively referred to as NST-ACS (non-ST-segment elevation-Acute Coronary Syndrome) those have neither ST-segment elevation nor passed the elevated troponin level criteria. According to the Grace score, very high-risk patients underwent coronary angiography within 2 h after PCI; intermediate-risk patients underwent coronary angiography within 24 h after PCI; and low-risk patients underwent coronary angiography within 72 h after PCI.</p>", "<title>CAD (Coronary Artery Disease)</title>", "<p id=\"Par40\">For CAD patients having symptoms of chest pain and discomfort, non-invasive examinations, such as electrocardiogram, exercise treadmill test, etc., are generally performed first. If myocardial ischemia is observed, coronary angiography is performed. If the vascular stenosis is &gt; 75%, PCI treatment is performed.</p>", "<title>PCI</title>", "<p id=\"Par41\">After an initial assessment, primary PCI was performed within 3 h of hospital admission as a standard procedure by inserting a catheter into the artery that released a \"radio-opaque dye (iodine-based) to locate the lesions clearly by a real-time x-ray imaging. The catheter left the DES spanning the lesions in the artery.</p>", "<p id=\"Par42\">For STEMI patients, when the STEMI onset was less than 12 h, they underwent emergency PCI; When the onset was more than 12 h, they first received conservative treatment with drugs; If the patient's condition was relieved and the vital signs were stable, then PCI was performed after one week; if the patients were not well remitted or if there was progressive aggravation, they were given emergency PCI.</p>", "<title>LAD-PCI, RCA-PCI and LCX-PCI</title>", "<p id=\"Par43\">Percutaneous Coronary Intervention (PCI) of lesions in the proximal Left Anterior Descending coronary artery (LAD) is worse in conditions than proximal Right Coronary Artery (RCA) and Left Circumflex coronary artery (LCX).</p>", "<title>Stent implantation</title>", "<p id=\"Par44\">The severity of the patient's disease and the damage to the blood vessels combined with the consent of their families were considered for selecting stents, which vary based on length, number, and manufacturer. In some patients, a single blood vessel has a long course. In some patients with multivessel disease, multiple stents of the same type were implanted. All stents are drug-eluting metal stents (DES) that are imported (Lepu, Medtronic, Resolute) or domestically obtained (JWMS). Most of them used in this study are balloon stents of Firebird, Excel, NANO, and TIVOLI. We limited our study analysis to the level of cytokine and chemokines from similar types of stents to minimize the errors. As diverse types of stents of various lengths, types, or volumes may affect the release of different levels of cytokines and complicate the analysis,</p>", "<title>Medications</title>", "<p id=\"Par45\">Patients admitted to the hospital with a diagnosis of ACS (including STEMI, NSTEMI, UA, and CAD) are treated with antibodies, anticoagulants, enhanced statins, beta receptor antagonists, ACEI, or ARB. Medications are started approximately within 2–3 h after stent implantation. The drugs used were Brilinta (AstraZeneca Pharmaceuticals, China), Metoprolol (AstraZeneca Pharmaceuticals, China), Clopidogrel (Shenzhen Xinitai Pharmaceuticals, China), Simvastatin (Hangzhou Merck), Rosuvastatin (AstraZeneca Pharmaceuticals, China), Valsartan, Olmesartan, Benazepril (Changzhou Siyao Pharmaceuticals, China).</p>", "<title>Cytokines (IL-6/IL-8/IL-10/TNF-a/IL-1B/Hs-CRP) and cholesterol measurement</title>", "<p id=\"Par46\">For emergency PCI patients after stent implantation, blood was drawn after 12 h. Cytokines (cytokine kit, LS BIO, WA, USA) and Hs-CRP (Hs-CRP kit, Abnova, USA ) were measured immediately by a two-site chemiluminescent enzyme immunometric assay in an IMMULITE analyzer (SIEMENS Healthineers, Germany). Cholesterols were measured (HDL and LDL assay kit, LS BIO, WA, USA) using standard laboratory equipment, Hitachi 7104 Analyzer (Hitachi, Tokyo, Japan).</p>", "<title>SYNTAX score</title>", "<p id=\"Par47\">The SYNTAX score, an angiographic score, was applied to assess the severity and complexity of cardiovascular disease and the severity of coronary lesions <sup>##REF##23539552##44##</sup>. The total SYNTAX score for each participant was calculated by taking the sum of the total points assigned to each lesion with &gt; 50% stenosis and &gt; 1.5 mm diameter in coronary arteries. Two observers independently calculated the SYNTAX score based on Coronary Angiography. The participants were divided into three subsets according to SYNTAX score: Group 1: score ≤ 22, Group 2: score = 23–32, Group 3: score &gt; 33 <sup>##REF##26296238##45##</sup>.</p>", "<title>Total length/volume of stent</title>", "<p id=\"Par48\">The total length/volume of the stent was calculated by multiplying the dimension of each stent (cubic mm). This value is again multiplied by the number of stents for a single type or multiple types of cubic mm value of each stent are added as specified for each patient.</p>", "<title>Statistical analysis</title>", "<p id=\"Par49\">Statistical analysis was done using various software such as SPSS 16.0 and MEDCALC etc. To calculate the simple arithmetic means with the significance of occurrence for the normalized distribution, a D’Augustino Pearson Test or Chi-square test was done.</p>", "<p id=\"Par50\">For all statistical analysis, a single data table was prepared to consist of all parameters provided in supplementary Tables 1, 2, and 3 and used as data in the MEDCALC software.</p>", "<title>Summary statistics</title>", "<p id=\"Par51\">For determining the arithmetic mean and normal distribution, parameters were selected manually with various combinations, such as age vs number of stents, number of stents vs IL8 level, and so on. In each case, D'Augustino Pearson Test is selected for normal distribution, and software output of arithmetic mean, normal distribution, 95% Confidence Intervals (CI), and acceptability of normal distribution are mentioned.</p>", "<title>Correlation</title>", "<p id=\"Par52\">R<sup>2</sup> (correlation coefficient) was calculated by using the correlation coefficient test using the same data table. In each case, variable X and variable Y are selected, such as X = TNFα and Y = IL8 with a filter, such as Hypertension = \"Yes\". Similarly, to assess the effect of stent implantation, the number of stents &gt; 1 is set for filter and other covariates such as EF% in Y-axis, and other cytokines, such as IL8, IL-1B, etc. in the X-axis. For results, r<sup>2</sup>, p-value, and 95% CI are noted from the software output. Depending upon the r<sup>2</sup> value as &gt; 0.80-high, 0.4–0.8-moderate and 0.0–0.4-poor were designated as the extent of correlation with a p-value below &lt; 0.05 as significant.</p>", "<title>Regression analysis</title>", "<p id=\"Par53\">Regression (designated here as R<sup>2</sup>) and logistic regression were done by calculating intercept and slope by plotting x and y with the use of each criterion in the data. Both independent and paired t-tests were used to test the hypothesis of the release of cytokines together.</p>", "<p id=\"Par54\">Baseline characteristics of PCI patients for statistical analysis with various criteria are listed in Supplementary Table 4 (Baseline characteristics). A Kolmogorov–Smirnov test was used to assess the normality of the distribution for all variables. The distribution of biochemical markers among the participants, excluding the blood glucose, TG, TC, LDL, and HDL values, was skewed in this study. The skewed variables were expressed in the median, and the interquartile range was analyzed after a logarithmic transformation. The correlation between the inflammatory cytokines was analyzed with a Spearman coefficient. We compared the inflammatory cytokines of participants using one-way ANOVA. Generalized linear regression analysis was performed to determine the association between inflammatory cytokines and various conditions. All tests were two-sided and p &lt; 0.05 was considered statistically significant.</p>" ]
[ "<title>Results</title>", "<title>TNFα is correlated with IL-1ß and IL8 in PCI patients after stent implantation</title>", "<p id=\"Par7\">\n<italic>STEMI (ST-Elevation Myocardial Infarction), NSTEMI (Non ST-Elevation Myocardial Infarction), CAD (Coronary Artery Disease), and UA (Unstable Angina).</italic>\n</p>", "<p id=\"Par8\">When PCI patients are diagnostically divided into STEMI, NSTEMI, CAD, and UA respectively, TNFα and IL8 levels are significantly correlated in NSTEMI (r2 = 0.82, p = 0.001) (Table ##TAB##0##1##, Fig. ##FIG##0##1##a) but moderately correlated in STEMI (r2 = 0.52, p = 0.014), and UA (r2 = 0.53, p = 0.001). In NSTEMI, TNFα and IL-1ß are also significantly and highly correlated (r2 = 0.97, p = 0.001) (Fig. ##FIG##0##1##a) but moderately with UA (r2 = 0.57, p = 0.001) and not with STEMI (r2 = 0.15, p = 0.6124). In CAD patients, TNFα is significantly correlated with IL8 secretion (r2 = 0.84, p = 0.0001) but not with IL-1ß secretion (r2 = 0.27, p = 0.101) (Table ##TAB##0##1##, Fig. ##FIG##0##1##a).</p>", "<title>Patients with LAD-PCI, RCA-PCI, and LCX-PCI</title>", "<p id=\"Par9\">TNFα secretion also varies significantly with diagnosis in LAD-PCI (Mean = 44.7401, p &lt; 0.0001) better than RCA-PCI (Mean = 42.77, p &lt; 0.0001) as the mean patient number is more in LAD-PCI. TNFα is moderately correlated with IL8 in both LAD-PCI (r2 = 0.56, p &lt; 0.0001) and, RCA-PCI (r2 = 0.79, p &lt; 0.0001) (Fig. ##FIG##0##1##b, Table ##TAB##0##1##). However, TNFα is less correlated with IL-1ß in RCA-PCI (r2 = 0.43, p = 0.0021) and very poorly with LAD-PCI (r2 = 0.31, p = 0.0086). In LCX-PCI, TNFα and IL8 are moderately (r2 = 0.65, p &lt; 0.0001) correlated but poorly (0.43, p = 0.032) with TNFα and IL-1ß.</p>", "<title>TNFα, IL-1ß, and IL8 release increases with the increased number of stents with various clinical conditions of PCI Patients</title>", "<title>Age</title>", "<p id=\"Par10\">We observed that PCI patient age is not correlated with diabetes (diabetes: r2 = -0.04, p = 0.39; no diabetes; r2 = 0.05, p = 0.39) or hypertension (hypertension: r2 = 0.12, p = 0.03; no hypertension; r2 =—0.12, p = 0.29). Similarly, age is neither correlated with TNFα secretion (r2 = -0.07, p = 0.39), IL8 secretion (r2 = -0.11, p = 0.15) nor with IL-1ß ((r2 = -0.11, p = 0.26)) in PCI patients.</p>", "<title>Diabetes</title>", "<p id=\"Par11\">In diabetes, TNFα and 1L-1ß are moderately correlated (r2 = 0.59, p = 0.001) (Table ##TAB##1##2##) but their association is less correlated (r2 = 0.32, p = 0.0103) with PCI patients without diabetic complications (Fig. ##FIG##0##1##c). PCI Diabetes patients exhibit less correlation with TNFα and IL8 secretion (r2 = 0.46, p = 0.0001) than PCI without diabetes (r2 = 0.63, p = 0.0001) (Table ##TAB##1##2##). For other cytokines, such as IL6 significantly but poorly correlated (r2 = 0.23, p = 0.045, 95% CI 0.0053–0.4413), but IL2 receptor (r2 = 0.088, p = 0.40, 95% CI -0.1195–0.2893) or IL10 (r2 = -0.04, p = 0.78, 95% CI -0.3249–0.2465) are not highly and significantly correlated.</p>", "<title>Hypertension</title>", "<p id=\"Par12\">TNFα and IL8 levels are significantly but moderately correlated (r2 = 0.64, p &lt; 0.0001) (Table ##TAB##1##2##, Fig. ##FIG##0##1##c) with AMI patients without hypertension than AMI patients with hypertension (r2 = 0.53, p &lt; 0.001). But TNFα and IL-1ß are neither correlated with patients with hypertension (r2 = 0.30, p = 0.005) nor with patients without hypertension (r2 = 0.35, p &lt; 0.0068). We observed that the number of stents is normally distributed with hypertension. An increased number of patients with hypertension is associated with a higher number of stent implantation (Mean = 1.8103. p &lt; 0.001, 95% CI 1.6669–1.9537) than the AMI group without hypertension (Mean = 1.6869, p &lt; 0.001, CI 1.4881–1.8861) as the later has less Mean for stent Number. However, increased stent numbers are not correlated with TNFα either in AMI patients with (r2 = 0.20, p = 0.006, CI 95% 0.0570–0.3227) or without hypertension (r2 = 0.038, p = 0.70, 95% CI -0.1603–0.2340).</p>", "<p id=\"Par13\">As expected, we observed that there is very little correlation between stent implantation directly with LDL_C (r2 = -0.22, p = 0.0064, 95#%CI -0.3723–0.0624) or HDL_C (r2 = 0.19, p = 0.0068, 95%CI -0.3435–0.0325).</p>", "<title>Stent implantation is associated with Hs-CRP release with IL8 in PCI patients</title>", "<p id=\"Par14\">We observed that the number of the stent (Mean) increases the level of Hs-CRP from &lt; 5 mg/L (Mean = 1.7447, p &lt; 0.0001, 95% CI 1.5952–1.8941) to above &gt; 5 mg/L (Mean = 1.8730, p &lt; 0.0001, 95% CI 1.6316–2.115) suggesting a higher number of stents is associated with higher Hs-CRP release. However, the Hs-CRP level does not correlate with age when the stent number is increased (r2 = 0.15, p = 0.1044) nor with blood glucose level (r2 = 0.16, p = 0.06) (Table ##TAB##2##3##). With increased stent number, an insignificantly poor correlation was observed in the Hs-CRP level with IL8 (r2 = 0.059, p = 0.5066) suggesting that their associated release does not occur as the stent number increases. Similarly, significantly but very little or almost no correlation was observed for IL6 release (r2 = 0.22, p = 0.02), for IL2 receptor (r2 = 0.20, p = 0.019), for IL10 (r2 = 0.28, p = 0.009) and IL-1ß (r2 = 0.01, p = 0.93) (Fig. ##FIG##0##1##d). As we did not observe any correlation with Hs-CRP and IL8 with an increased number of the stent, we sub-grouped IL8 level into two concentrations, &gt; 20 pg/L and &lt; 20 mg/L, and performed a t-test. The t-test shows that when Hs-CRP levels are &gt; 5 mg/L and IL8 levels are &gt; 20 pg/L (t = 4.5, p &lt; 0.0001, 95% CI 35.2924–88.4235), their association is significant, but it is not associated with &lt; 20 pg/L) (t statistic =—4.7, p &lt; 0.0001, 95% CI -21.3233- -8.723) as t-statistic is negative (Fig. ##FIG##1##2##). An increased number of stents (&gt; 1) is associated with Hs-CRP &gt; 5 mg/L (t statistic = 8.9, p &lt; 0.0001, CI 19.38–30.52) whereas no correlation is observed with increased stent number and a lower Hs-CRP level at &lt; 5 mg/L (t statistic = -7.73, p &lt; 0.0001, CI -1.09- -0.65).</p>", "<title>An increased number of stents is correlated with the release of TNFα and other major cytokines</title>", "<p id=\"Par15\">We observed that an increased number of stents (Mean value) significantly varied with TNFα when the level is &lt; 20 pg/L (Mean = 1.57, p &lt; 0.0001, CI 95% 3.00–4.00)<bold>.</bold> Above this level at &gt; 20 pg/L, the number of stents has no effect (Mean = 0.6, p = 0.039, 95% CI 0.5207–0.6793) as it implies that only 0.6 (0.5207–0.6793) number of stent implantation corresponds to &gt; 20 pg/L TNFα whereas &lt; 20 pg/L TNFα is associated with 1.57 (3.00–4.00 the number of the stent. Similarly, IL-1ß release also varies with an increased number of stents when &lt; 5 pg/L (Mean = 1.69, p &lt; 0.0001, 95% CI 3.00–4.000) than &gt; 5 pg/L (Mean = 0.04, p &lt; 0.0001, 95% CI 0.000–0.084). Other cytokines also vary significantly with an increase in the number of stents, such as IL2 receptor when it is both &lt; 500 pg/L (Mean = 1.71, p &lt; 0.0001, 97.5% CI 4.00–5.00) and &gt; 500 pg/L (Mean = 1.86, p &lt; 0.0001, 95% CI 4.00–5.00). An IL6 level &gt; 3 pg/L also varies significantly with an increased number of stents (Mean = 1.86, p &lt; 0.0001, 97.5 CI 4.00–5.000) than &lt; 3 pg/L (Mean = 0.4, p = 0.06, 95% CI 0.3179–0.4917). The release IL8 is also dependent on the number of stents in both &lt; 20 pg/L (Mean = 1.63, p &lt; 0.0001, 95% CI 3.000–4.000) and &gt; 20 pg/L (Mean = 1.86, p &lt; 0.0001, 97.5% CI 4.000–5.00) whereas IL10 with &lt; 5 pg/L (Mean = 1.7, p &lt; 0.0001, 95% CI 3.00–4.00) than &gt; 10 pg/L (Mean = 0.10, p =  &lt; 0.0001, 95% CI 0.041–0.1630) are significantly dependent. When the number of the stent is greater than 1 and TNFα levels are either &gt; 25 pg/L, (t statistic 19.515, p &lt; 0.001, 95% CI 60.4148–74.007) or &lt; 25 pg/L (t statistic 26.587, p &lt; 0.001, 95% CI 11.26–13.06), they appear to be significantly associated (Fig. ##FIG##2##3##a, b). Similarly, TNFα and IL8 are significantly correlated with IL2 receptor at lower (&lt; 500 pg/L) concentrations (r2 = 0.73, p = 0.0001, 95% CI 0.6644–0.7932) but moderately at higher concentrations (&gt; 500 pg/L) (r2 = 0.46, p = 0.0001, 95% CI 0.2940–0.5954).</p>", "<p id=\"Par16\">However, regression analysis shows that an increased number of stent implantation is slightly associated with TNFα and IL-1ß together (R<sup>##REF##12566381##2##</sup> = 0.38, p &lt; 0.0001) when the IL8 level is &gt; 20 pg/L. This association is not at all significant at &lt; 20 pg/L (R<sup>##REF##12566381##2##</sup> = 0.30, p = 0.10). At the same level as IL8, TNFα is neither associated with the Hs-CRP level (R<sup>##REF##12566381##2##</sup> = 0.01440, p &lt; 0.305) nor with any other cytokines like IL-1B (R2 = 0.07, p = 0.72), IL2 receptor (R2 = 0.008, p = 0.14), IL6 (R2 = 0.10, p = 0.12), and IL10 (R2 = 0.00, p = 0.998). With increasing stent number, Hs-CRP level is significantly associated when an IL8 level above 20 pg/L (R<sup>2</sup> = 0.3712, p &lt; 0.0001) (Fig. ##FIG##2##3##c) but not when IL8 is below 20 pg/L (R<sup>2</sup> = 0.14, p = 0.3052). Again, with an increased number of stents, TNFα release is poorly associated with IL-1ß secretion (R<sup>2</sup> = 0.38, p &lt; 0.0001) (Fig. ##FIG##2##3##d).</p>", "<title>Left ventricular ejection fraction (LVEF) is negatively correlated with IL2 receptor</title>", "<p id=\"Par17\">We studied whether ejection fraction (LVEF%) is correlated with any of these cytokine release with the increased number of stents (Supplementary Table 5). We did not observe any significant correlation except Hs-CRP and IL2 receptor. Hs-CRP is nearly significant but poorly co-related with a total length of the stent (r2 = 0.14, p = 0.055) but not (negatively) with a total number of the stent (r2 = -0.07, p = 0.5). EF is negatively and poorly but significantly correlated with IL2 receptor in both stent number (r2 = -0.27, p = 0.004) and total length of the stent (r2 = 0.23, p = 0.006) suggesting that the increase of LVEF% could be assessed with a larger cohort of patients to lower IL2 receptor release.</p>", "<title>Medications after PCI alters TNFα and IL8 or IL-1ß release</title>", "<p id=\"Par18\">During prognosis and diagnosis, stent number varies significantly better with simvastatin-20 (Mean = 1.648, p = 0.0042, 95% 1.000–4.000) than with Rosuvastatin-10 (Mean = 1.69, p = 0.0001, 95% CO 4.00–5.59). Both Simvastatin-20 (r2 = 0.77, p = 0.0001) and Rosuvastatin-10 (r2 = 0.63, p = 0.0001) (Table ##TAB##3##4##) are highly correlated with both release levels of TNFα and IL8. However, with Simvastatin-20, TNFα and IL-1ß are not significantly correlated (r2 = 0.16, p = 0.7014) but moderately associated with Rosuvastatin 10 (r2 = 0.47, p = 0.0001). Thus, Simvastatin-20 would be a better inflammatory suppressor for TNFα and IL8 release than Rosuvastatin-10. ACI/ARB treatment with Benazepril-5.0 (r2 = 0.93, p = 0.000) (Fig. ##FIG##3##4##a) or Olmesartan 20 (r2 = 0.90, p = 0.0001) is strongly associated with the release of TNFα and IL8 (Table ##TAB##3##4##) but not with other drugs, such as Valsartan 80 (r2 = 0.43, p = 0.0011).</p>", "<p id=\"Par19\">TNFα level also significantly but moderately varies with the antiplatelet drug Clopidogrel (Mean = 46.64, p &lt; 0.0001, 95% CI 60.2343–270.4321) and Brilinta (Mean = 48.34, p &lt; 0.0001, 95% CI 89.4843–122.4321). and TNFα is significantly but moderately correlated with IL8 with the antiplatelet drug Brilinta (r2 = 0.58, p &lt; 0.0001) or Clopidogrel (r2 = 0.46, p = 0.0008). Similarly, TNFα is significantly and highly correlated with IL-1ß secretion for Clopidogrel (r2 = 0.87, p &lt; 0.0001) (Fig. ##FIG##3##4##b, Table ##TAB##3##4##) but not for Brilinta (r2 = 0.30, p &lt; 0.0001).</p>", "<p id=\"Par20\">After stent implantation, when beta-adrenergic receptor Metoprolol-23.75 is used, TNFα levels are moderately correlated with IL8 (r2 = 0.58 p &lt; 0.0001) (Table ##TAB##3##4##, Fig. ##FIG##3##4##c, d) but not significantly in lower dose with Metoprolol 11.87 (r2 = 0.80, p = 0.5306). Similarly, the TNFα level is significantly but moderately correlated with IL-1ß (r2 = 0.43, p &lt; 0.0001) but not significant with Metoprolol 11.87 (r2 = -0.55, p = 0.62). Thus IL-1ß and IL8 are both moderately suppressed by Metoprolol 23.75 but not by Metoprolol 11.87.</p>", "<title>The extent of cytokine secretion does not differ with stent number or the total stent length</title>", "<p id=\"Par21\">It could be hypothesized that “the total length of stent” may be more critical than the \"number of stents\" for the extent of cytokine secretion after stent implantation. The number of stents is highly correlated with the total stent length/volume as expected (Table ##TAB##4##5##). However, none of the criteria as Age, Diabetes or hypertension, and cytokine release is highly correlated with the total length of stent nor with the total number of stents (Table ##TAB##4##5##). In some of the cases like in coronary angioplasty results with RCA-PCI, LAD-PCI, and LCX-PCI, both numbers of the stent and the total length of the stent are significant but poorly correlated.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par22\">The inflammatory biomarkers are potential non-invasive, diagnostic, predictive, prognostic, and therapeutic molecular biomarkers after implantations of stents<sup>##REF##32044669##22##,##REF##32022379##23##</sup>. Cytokine release is an obvious outcome after stent implantation. Although major cytokines like TNFα, Hs-CRP, IL-1ß, IL6, and IL8 are reported after stent implantation in several related disease conditions, such as AMI with PCI, stenosis, coronary angiography, coronary endothelial dysfunction, etc.<sup>##REF##30315494##12##–##REF##20229266##16##</sup>, their correlation of co-release in blood has not been extensively established with special emphasis on age, sex, gender, clinical conditions (diabetes, hypertension), various diagnosis criteria (e.g. STEMI, NSTEMI, UA, CAD) and for treatments with antiplatelet drugs, statins, and beta-blockers, etc.</p>", "<p id=\"Par23\">TNFα is the most common cytokine release after stent implantation in PCI <sup>##REF##19413999##1##,##REF##30315494##12##,##REF##32022379##23##</sup>. Hs-CRP <sup>##REF##19568720##11##,##REF##30315494##12##,##REF##32044669##22##</sup>, IL-1ß<sup>##REF##28116487##13##,##REF##20229266##16##</sup>, IL6<sup>##REF##23649933##14##,##REF##20229266##16##,##REF##14597930##24##</sup>, and IL8<sup>##REF##16455670##10##</sup> release have already been assessed independently. In diabetic patients after stent implantation, IL-1ß and IL8 release are significantly but moderately correlated with TNFα but less significant in nondiabetic patients. Although each of these cytokines’ release with TNFα has been observed previously in diabetic patients with PCI, their correlation of composed secretion was not established<sup>##REF##16455670##10##,##REF##28116487##13##</sup>. Our results suggest that in diabetic patients, IL-1ß and IL8 secretion with TNFα could be developed as targets for drug treatment after stent implantation to suppress inflammatory complications.</p>", "<p id=\"Par24\">An increased number of stents is significantly correlated with TNFα and IL-1ß or IL8 release in PCI patients when diagnosed with NSTEMI but not with STEMI or UA. Kozel et al<sup>##REF##30315494##12##</sup> observed no difference in TNFα, IL6, or HS-CRP levels until after one year of metallic stent implantation in 46 STEMI patients which supports our results as our STEMI patients with DES did not show any significant correlation with any of these cytokine releases. In CAD we also observed the correlated expression of TNFα with IL8 but not with IL-1ß. No information or study was conducted earlier in NSTEMI, UA, or CAD patients for the release of these cytokines together. Nevertheless, a large cohort of patients can be recruited to validate the correlations of TNFα and IL-1ß or IL8 in NSTEMI or CAD patients. An increase in IL6 level is correlated with an increased number of stents, while the levels of IL-1ß, IL2 receptor, IL8, and IL10 are unchanged, indicating that these cytokines do not change with the increased number of stents in PCI patients.</p>", "<p id=\"Par25\">Hs-CRP is a new independent index for CHD (Coronary Heart Disease) with a strong utility for forecasting cardiovascular disease. Hs-CRP level varies extensively after stent implantation in STEMI-diagnosed patients<sup>##REF##30315494##12##,##REF##32044669##22##,##REF##32022379##23##</sup>. We observed an increased number of stent varies slightly with Hs-CRP levels at &gt; 5 mg/L, but remains unchanged at basal levels (&lt; 5 mg/L) but does not correlate with age or blood glucose level. With an increased number of stents, a poor correlation is observed between Hs-CRP and IL2 receptor, IL-1ß, IL6, or IL10 implying that their secretions are not coordinated. But a higher Hs-CRP (&gt; 5 mg/L) level is significantly associated with both &gt; 20 pg/L and &lt; 20 pg/L concentrations of IL8. Although the release of these two cytokines is not studied earlier together, our observation suggests that IL8 release is coupled with Hs-CRP level and that could be potent diagnostics criteria after stent implantation in PCI patients.</p>", "<p id=\"Par26\">The use of certain medications is obvious as a precaution to suppress inflammatory cardiovascular complications after stent implantation <sup>##REF##19413999##1##,##UREF##0##6##</sup>. In this study, all medications related to the suppression of inflammation were used within 2–3 h after stent implantation. The suppressive effect of medication on inflammatory cytokine would represent a negative or poor correlation. To develop a prognostic approach after stent complications, it is extremely important to correlate their secretion in blood in a cumulative way for understanding their full function.</p>", "<p id=\"Par27\">Beta-blockers are shown to effectively suppress inflammatory molecules, such as TNFα and IL10 in cardiomyopathy patients<sup>##REF##11216955##25##</sup>. During AMI, the leukocytes especially neutrophils and monocytes readily migrate to the injury site to clear the dead cells and debris as delayed response leads to maladaptive tissue remodeling or scar formation with a negative impact on heart function. VCAM1 and CCL2 positively and CCR2 negatively regulate the migration of these leukocytes. Chronic beta-blocker treatment increases VCAM1 and decreases CCR2 expression to augment the recruitment of leukocytes and reduce the severity of innate immune responses leading to increased wound healing capacity at the injury site<sup>##UREF##4##26##</sup>. In addition, ß1-AR (beta-adrenergic receptor) antagonist Metoprolol treatment also increases VCAM1 expression and leukocyte accumulation while reducing CCR2 expression and alters the leukocyte function for responsiveness to acute injury. We observed that a lower dose of beta-blocker Metoprolol-11.87 is highly correlated with the increased level of TNFα and IL8 but moderately with a higher dose of Metoprolol-23.25. Thus, the effect of a higher dose of this beta blocker could have a better suppressive effect after stent implantation which could be further evaluated with other supporting studies.</p>", "<p id=\"Par28\">Rosuvastatin-10 users have higher TNFα and IL8 or IL-1ß levels than the patients using Simvastatin-20 or Simvastatin-10. This implies that having similar blood vessel damage Simvastatin better suppresses cytokine releases than Rosuvastatin-10. Thus, after stent implantation before choosing any of these drugs, it could be helpful to determine the correlated release of TNFα and IL-1ß or IL8 levels.</p>", "<p id=\"Par29\">Antiplatelet drug Clopidogrel, but not Brilinta, is more effective for suppressing the effect of TNFα and IL8. TNFα varies significantly with the antiplatelet drug Clopidogrel and it conjugately varies with IL8 when both Clopidogrel and Brilinta are used. Several combinations, such as Dual Antiplatelet Therapy (DAPT) are helpful to reduce morbidities but increase DAPT-related bleeding complications and stent thrombosis <sup>##UREF##5##27##</sup>,<sup>##REF##18294566##28##</sup>. After discontinuing DAPT Bioabsorbable polymer Everolimus-Eluting Synergy Stents in high-risk patients reduces these symptoms<sup>##REF##27974669##29##</sup>.</p>", "<p id=\"Par30\">TNFα and IL8 levels are significantly correlated with ACI/ARB drug Benazepril 5.0 or Olmesartan 20 but not with Valsartan 80 or Perindopril 4. However, further research and supporting evidence are needed to evaluate whether Perindopril 4 or Valsartan 80 should be preferable to Benazepril 5.0 or Olmesartan 20 after PCI intervention with stent implantation. It also appears that the differences in the number/length/volume of the stent may not have a profound effect on cytokine release or other factors such as Age or hypertension or medications used.</p>", "<p id=\"Par31\">Several approaches could be manifested to neutralize these cytokines to reduce inflammation after stent implantation. TNFα antibody eluting stents are shown to reduce restenosis in saphenous vein organ culture in vivo and may have potential clinical benefit in PCI <sup>##REF##12231212##30##</sup>. Further, these TNFα antibodies eluting stents may be conjugated with IL-1ß or IL8 based on their correlation with stent implantation in PCI patients. Apart from this strategy, intravenous anti-TNFα (etanercept, Adalimumab, Infliximab)<sup>##UREF##6##31##,##REF##17204912##32##</sup>, anti-IL8<sup>##REF##19617600##33##,##REF##9671905##34##</sup> or anti-IL-1ß (canakinumab, gevokizumab)<sup>##REF##21282498##35##–##REF##28845751##37##</sup> gene disruption or treatment are shown to reduce myocardial infarction (MI) in animal models, human patients or human cells<sup>##UREF##7##38##–##REF##34707513##41##</sup>. However, the Clinical trial with anti-TNFα alone did not reduce heart failure possibilities in heart failure patients<sup>##UREF##8##42##,##REF##32902739##43##</sup> and has been attributed to the counterplay of TNF receptor, TNFR1, and TNFR2 mediated inflammasome activation<sup>##REF##21282498##35##</sup>. Nevertheless, IL-1ß or IL8 treatment with TNFα could have the potential clinical benefit after stent implantation. The advantages of using these antibodies are already used for various heart ailments, and their safety issues are well documented.</p>" ]
[ "<title>Conclusions</title>", "<p id=\"Par33\">Stent implantation causes cardiovascular injury that leads to multiple cytokine releases but their co-release has not been extensively established. We showed here that in diabetic PCI patients, IL8 and IL-1ß release is correlated with TNFα release, thus together they could be a predictor of complications and should be suppressed. Similarly, in NSTEMI patients, TNFα, IL-1ß, or IL8 release is significantly correlated with an increased number of stents and thus needs further attention to treat these patients. In CAD patients, TNFα secretion is correlated with IL8 but not with IL-1ß. Our data also suggest that the release of TNFα and IL8 is better suppressed by beta-adrenergic receptor Metoprolol 23.75 but not with its lower dose and also better suppressed by Clopidogrel than Brilinta. TNFα and IL-1ß release is poorly correlated with Simvastatin-20 but not with Rosuvastatin-10, thus former should be evaluated for better clinical outcomes in further studies. We also observed that after stent implantation, Valsartan 80, or perindopril 4, should have higher efficacy than Benazepril 5.0 or Olmesartan 20. Our results suggest that after DES implantation, measurements of TNFα, IL8, and IL-1ß and their correlation analyses could be evaluated further in a large cohort to select drugs to reduce over-inflammation-mediated cardiovascular complications to prevent morbidities.</p>" ]
[ "<p id=\"Par1\">Acute Myocardial Infarction (AMI) after Percutaneous Coronary Intervention (PCI) often requires stent implantation leading to cardiovascular injury and cytokine release. Stent implantation induces cytokines production including TNFα, Hs-CRP, IL-1ß, IL2 receptor, IL6, IL8, and IL10, but their co-release is not extensively established. In 311 PCI patients with Drug-Eluting Stent (DES) implantation, we statistically evaluate the correlation of these cytokines release in various clinical conditions, stent numbers, and medications. We observed that TNFα is moderately correlated with IL-1ß (r<sup>2</sup> = 0.59, <italic>p</italic> = 0.001) in diabetic PCI patients. Similarly, in NSTEMI (Non-ST Segment Elevation) patients, TNFα is strongly correlated with both IL-1ß (r<sup>2</sup> = 0.97, <italic>p</italic> = 0.001) and IL8 (r<sup>2</sup> = 0.82, <italic>p</italic> = 0.001). In CAD (Coronary Artery Disease)-diagnosed patients TNFα is highly correlated (r<sup>2</sup> = 0.84, <italic>p</italic> = 0.0001) with IL8 release but not with IL-1ß. In patients with an increased number of stents, Hs-CRP is significantly coupled with IL8 &gt; 5 pg/ml (t-statistic = 4.5, <italic>p</italic> &lt; 0.0001). Inflammatory suppressor drugs are correlated as TNFα and IL8 are better suppressed by Metoprolol 23.75 (r<sup>2</sup> = 0.58, <italic>p</italic> &lt; 0.0001) than by Metoprolol 11.87 (r<sup>2</sup> = 0.80, <italic>p</italic> = 0.5306). Increased TNFα and IL-1ß are better suppressed by the antiplatelet drug Brilinta (r<sup>2</sup> = 0.30, <italic>p</italic> &lt; 0.0001) but not with Clopidogrel (r<sup>2</sup> = 0.87, <italic>p</italic> &lt; 0.0001). ACI/ARB Valsartan 80 (r<sup>2</sup> = 0.43, <italic>p</italic> = 0.0011) should be preferred over Benazepril 5.0 (r<sup>2</sup> = 0.9291, <italic>p</italic> &lt; 0.0001) or Olmesartan (r<sup>2</sup> = 0.90, <italic>p</italic> = 0.0001). Thus, the co-release of IL-1ß, IL8 with TNFα, or only IL8 with TNFα could be a better predictor for the outcome of stent implantation in NSTEMI and CAD-diagnosed AMI patients respectively. Cytokine suppressive medications should be chosen carefully to inhibit further cardiovascular damage.</p>", "<title>Subject terms</title>" ]
[ "<title>Limitations</title>", "<p id=\"Par32\">This is a single-center study that includes evaluations of cytokine release after stent implantation. Although we considered the total length or volume of stents by the addition of several small stents, a longer single stent could affect cytokine secretion differently which has not been addressed. Stent length/volume may be extensively assessed in future studies with more subtle criteria to evaluate the extent of cytokine secretion. ACS (Acute Coronary Syndrome) is an acute occlusion of a coronary artery segment or an at least relevant stenosis leading to schema and hypoxia of the myocardium, respectively. So, the measured cytokines here could also represent the cumulative effect of both processes rather than from the damage of the vascular wall alone after stent implantation. Whatever the reason for cytokine secretion, we raised the possibility that instead of studying single cytokine, correlating two or multiple cytokine releases may be better predictors of various conditions in PCI patients after stent implantations.</p>", "<title>Informed consent</title>", "<p id=\"Par55\">All participants consented to the study.</p>", "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51496-8.</p>", "<title>Acknowledgements</title>", "<p>We sincerely thank Vikram Norton for critically reading our manuscript and checking the English grammar. We also thank the anonymous reviewer for valuable suggestions to improve the manuscript. This work was supported by grants from the Shanghai Municipal Health Bureau (SMHB, Grant No. 202340117) and Natural Science Foundation of colleges and universities Anhui Province, China (NSFAPC, Grant No. 2023AH053425) to M.W. <bold>Institutional Review Board Statement:</bold> All measurements are done with the approved IRB of the institution</p>", "<title>Author contributions</title>", "<p>M.W. and C.W. performed the cytokine analysis. Y.H.L. and Q.Y. helped to obtain samples. M.W., K.H., Y.L., C.W., B.M., A.K.M., Z.Z., Y.H.L., H.W. performed the analysis. M.W., K.H., Y.L., C.W., B.M., Z.Z. and Y.H.L. conceived the work and arranged all patient information, and made available their samples. M.W, A.K.M., K.H., Y.L., B.M., Z.Z., H.W., and Y.H. L. wrote the manuscript.</p>", "<title>Funding</title>", "<p>This work was supported by a grant from the Science and Technology Development Foundation of Chongming District Shanghai (CKY2020-29). This work was also supported by Shanghai Municipal Health Bureau (SMHB, Grant No. 202340117) and National Science Foundation of Colleges and Universities Anhui provinces, China (NSFAPC, Grant No. 2023AH053425).</p>", "<title>Data availability</title>", "<p>All data will be available to the researcher upon request to Dr. Minying Wan, Dr. Yihong Luo, or Dr. Amit K Maiti.</p>", "<title>Competing interests</title>", "<p id=\"Par56\">The authors declare no competing interests</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Correlation coefficient (r<sup>2</sup>) in various PCI patients with TNFα or Hs-CRP release. (<bold>a</bold>) r<sup>2</sup> of TNFα and IL-1ß or IL8 in STEMI, NSTEMI, UA and CAD patients. (<bold>b</bold>) r<sup>2</sup> of TNFα and IL8 or IL-1ß in patients with LAD-PCI, RCA-PCI and LCX-PCI. (<bold>c</bold>) r<sup>2</sup> of TNFα release and IL8 or IL-1ß in various symptomatic conditions. (<bold>d</bold>) r<sup>2</sup> of HS-CRP release and various cytokines in diabetes patients with PCI.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Student’s t-test statistic of Hs-CRP release and number of stents with TNFα and IL8 secretion. In t-test, error bar represents the 95% CI (<bold>a</bold>) Hs-CRP release at below &lt; 5 mg/L, IL8 &gt; 20 pg/L is significant (t-statistic = 4.6, p &lt; 0.0001: 95% CI for Hs-CRP = 19.77–35.41 and for IL8 &gt; 20 mg/L = 74.03–104.81) but (<bold>b</bold>) their co-release is not supported (negative t value) for IL8 &lt; 20 pg/L (t-statistic = -4.74, p &lt; 0.0001; 95% CI for HS-CRP = 19.41–35.41 and for IL8 &lt; 20 mg/L = 11.75–13.31. (<bold>c</bold>) At the higher number of stent implantation, increased Hs-CRP level (&gt; 5 mg/L) is also significantly released (t-statistic = 8.9, p &lt; 0.0001, 95% CI for number of stent = 2.44–2.73 and for HS-CRP &gt; 5 mg/L = 19.41–35.77) (<bold>d</bold>) but their co-release is not supported (negative t value) with below &lt; 5 mg/L Hs-CRP level (t-statistic = -7.73, p &lt; 0.0001, 95% CI for HS-CRP &lt; 0.5 mg/L = 2.44–35.77 and for number of stent = 1.55–1.87).</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Increased number of stent implantation is significantly associated with TNFα, IL-1ß, and IL8. (<bold>a</bold>) t-test shows that the increased number of stent implantation is significant with TNFα release in both with positive t-statistic and p-value &lt; 0.001 a) &gt; 25 pg/L), error bar represents the 95% CI for stent number (2.44–2.73) and for TNFα (63.00–76.59) and (<bold>b</bold>) below &lt; 25 pg/L of TNFα release. Error bar represents the 95% CI for stent number (2.44–2.73) and for TNFα (13.78–15.71). (<bold>c</bold>) Regression analysis shows that in patients with IL8 &gt; 20 pg/L, number of stent and HS-CRP increase are not significantly associated with IL-1ß release (p = 0.3052) as IL-1ß is decreasing. In the left panel, the regression parameters and calculations are shown. (<bold>d</bold>) Regression analysis shows that the increased number of stent implantation with higher TNFα release is also associated with higher IL-1ß secretion. Orange rounds are patients, and the line represents the IL-1ß release increases as the TNFα and number of stents increases that starts from little more than 1(1.026 + 0.0138). Regression parameters and calculations are shown in the left panel.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Selective ACE-ARB and antiplatelet drugs also suppress TNFα release in PCI Patients. (<bold>a</bold>) ACE-ARB drug Benazepril 5 is effective as it shows correlated with TNFα and IL8 release but no other ACE-ARB-drug. Left panel shows the distribution and right panel shows the heatmap of patients (maximum number of patients belong in the orange area) releasing these cytokines. (<bold>b</bold>) Similarly, antiplatelet Clopidogrel is correlated with TNFα and IL-1ß release but no other antiplatelet drug, such as Brilinta. Left graph shows the distribution and right graph shows the heatmap of patients with both TNFα and IL-1ß release. (<bold>c</bold>) TNFα is significantly correlated with IL8 in various medications used after stent implantation. (<bold>d</bold>) Significant correlation of TNFα with IL-1ß in various medications used after stent implantation.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>TNFα level is correlated in various diagnosed PCI patients after stent implantation.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Diagnosis</th><th align=\"left\">Cytokines/Chemokines</th><th align=\"left\">Sample No</th><th align=\"left\">Correlation</th><th align=\"left\">r<sup>2</sup> (Correlation coefficient) and p- value</th></tr></thead><tbody><tr><td align=\"left\">NSTEMI</td><td align=\"left\">TNFα and IL8</td><td align=\"left\">20</td><td align=\"left\">High</td><td align=\"left\">r2 = 0.82, p = 0.001, 95% CI 0.5975–0.9275</td></tr><tr><td align=\"left\">STEMI</td><td align=\"left\">TNFα and IL8</td><td align=\"left\">23</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.52, p = 0.014, 95% CI 0.1412–0.7613</td></tr><tr><td align=\"left\">UA</td><td align=\"left\">TNFα and IL8</td><td align=\"left\">123</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.53, p = 0.001, 95% CI 0.3899–0.6464</td></tr><tr><td align=\"left\">NSTEMI</td><td align=\"left\">TNFα and IL-1ß</td><td align=\"left\">12</td><td align=\"left\">High</td><td align=\"left\">r2 = 0.97, p = 0.001, 95% CI 0.9018–0.9926</td></tr><tr><td align=\"left\">STEMI</td><td align=\"left\">TNFα and IL-1ß</td><td align=\"left\">13</td><td align=\"left\">Not Corelated</td><td align=\"left\">r2 = 0.15, p = 0.6124, 95% CI -0.4346–6496</td></tr><tr><td align=\"left\">UA</td><td align=\"left\">TNFα and IL-1ß</td><td align=\"left\">60</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.57, p = 0.001, 95% CI 0.3752–0.7229</td></tr><tr><td align=\"left\">CAD</td><td align=\"left\">TNFα and IL8</td><td align=\"left\">48</td><td align=\"left\">High</td><td align=\"left\">r2 = 0.84, p &lt; 0.0001, 95% CI 0.7298–0.9074</td></tr><tr><td align=\"left\">CAD</td><td align=\"left\">TNFα and IL-1ß</td><td align=\"left\">36</td><td align=\"left\">Not significant</td><td align=\"left\">r2 = 0.27, p &lt; 0.101, 95% CI 0.0554–0.8865)</td></tr><tr><td align=\"left\">LAD-PCI</td><td align=\"left\">TNFα and IL8</td><td align=\"left\">118</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.56, p &lt; 0.0001, 95% CI 0.4232–0.6342</td></tr><tr><td align=\"left\">LAD-PCI</td><td align=\"left\">TNFα and IL-1ß</td><td align=\"left\">67</td><td align=\"left\">Poorly correlated</td><td align=\"left\">r2 = 0.31, p = 0.0086, 95% CI 0.08475–0.9015</td></tr><tr><td align=\"left\">RCA-PCI</td><td align=\"left\">TNFα and IL8</td><td align=\"left\">82</td><td align=\"left\">High</td><td align=\"left\">r2 = 0.79, p &lt; 0.0001, 95% CI 0.7004–0.8640</td></tr><tr><td align=\"left\">RCA-PCI</td><td align=\"left\">TNFα and IL-1ß</td><td align=\"left\">49</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.43, p = 0.0021, 95% CI 0.1684–0.6389</td></tr><tr><td align=\"left\">LCX-PCI</td><td align=\"left\">TNFα and IL8</td><td align=\"left\">46</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.65, p &lt; 0.0001, 95% CI 0.4432–0.7910</td></tr><tr><td align=\"left\">LCX-PCI</td><td align=\"left\">TNFα and IL-1ß</td><td align=\"left\">25</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.43, p = 0.032, 95% CI 0.04189–0.7052</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>TNFα, IL-1ß, and IL8 release increases with an increased number of stents with various clinical conditions of PCI Patients.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Diagnosis</th><th align=\"left\">Cytokine/<break/>Chemokine</th><th align=\"left\">Sample<break/>No</th><th align=\"left\">Correlation</th><th align=\"left\">r<sup>2</sup> (Correlation coefficient) and <italic>p</italic>-value</th></tr></thead><tbody><tr><td align=\"left\">PCI with Diabetes</td><td align=\"left\">TNFα and IL-1ß</td><td align=\"left\">49</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.59, p = 0.001, 95% CI 0.3741–0.7492</td></tr><tr><td align=\"left\">PCI without Diabetes</td><td align=\"left\">TNFα and IL-1ß</td><td align=\"left\">49</td><td align=\"left\">Poor</td><td align=\"left\">r2 = 0.32, p = 0.0103, 95% CI 0.0535–0.3766</td></tr><tr><td align=\"left\">PCI with Diabetes</td><td align=\"left\">TNFα and IL8</td><td align=\"left\">90</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.46, p = 0.0001, 95% CI 0.2848–0.6137</td></tr><tr><td align=\"left\">PCI without Diabetes</td><td align=\"left\">TNFα and IL8</td><td align=\"left\">218</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.63, p = 0.0001, 95% CI 0.5526—0.7111</td></tr><tr><td align=\"left\">PCI with Hypertension</td><td align=\"left\">TNFα and IL8</td><td align=\"left\">206</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.53, p = 0.001, 95% CI 0.4296–0.6258</td></tr><tr><td align=\"left\">PCI without hypertension</td><td align=\"left\">TNFα and IL8</td><td align=\"left\">102</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.64, p &lt; 0.0001, 95% CI 0.5027–0.7427</td></tr><tr><td align=\"left\">PCI with Hypertension</td><td align=\"left\">TNFα and IL-1ß</td><td align=\"left\">125</td><td align=\"left\">Poor</td><td align=\"left\">r2 = 0.30, p = 0.005, 95% CI 0.1365–0.4560</td></tr><tr><td align=\"left\">PCI without hypertension</td><td align=\"left\">TNFα and IL-1ß</td><td align=\"left\">58</td><td align=\"left\">Poor</td><td align=\"left\">r2 = 0.35, p &lt; 0.0068, 95% CI 0.1088–0.5592</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Stent implantation induces Hs-CRP release with IL8 in PCI patients.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Diagnosis</th><th align=\"left\">Stent</th><th align=\"left\">Cytokine/Chemokine</th><th align=\"left\">Sample<break/>No</th><th align=\"left\">Correlation</th><th align=\"left\">r<sup>2</sup> (Correlation coefficient) and <italic>p</italic>-Value</th></tr></thead><tbody><tr><td align=\"left\">Age</td><td align=\"left\">Increased</td><td align=\"left\">Hs-CRP</td><td align=\"left\">251</td><td align=\"left\">Poor</td><td align=\"left\">r2 = 0.15, p = 0.1044, 95% CI -0.02931–0.3088</td></tr><tr><td align=\"left\">Diabetes</td><td align=\"left\">Increased</td><td align=\"left\">Hs-CRP</td><td align=\"left\">73</td><td align=\"left\">Poor</td><td align=\"left\">r2 =—0.080, p = 0.5, 95% CI -0.3046—0.1527</td></tr><tr><td align=\"left\">PCI</td><td align=\"left\">Increased</td><td align=\"left\">Hs-CRP and IL8</td><td align=\"left\">128</td><td align=\"left\">Poor</td><td align=\"left\">r2 = 0.059, p = 0.51, 95% CI -0.1155—0.2304</td></tr><tr><td align=\"left\">PCI</td><td align=\"left\">Increased</td><td align=\"left\">Hs-CRP and IL-1ß</td><td align=\"left\">78</td><td align=\"left\">Poor</td><td align=\"left\">r2 = 0.01, p = 0.93, 95% CI -0.2139—0.2311</td></tr><tr><td align=\"left\">PCI</td><td align=\"left\">Increased</td><td align=\"left\">Hs-CRP and IL6</td><td align=\"left\">107</td><td align=\"left\">Poor</td><td align=\"left\">r2 = 0.22, p = 0.02, 95% CI 0.02714—0.3898</td></tr><tr><td align=\"left\">PCI</td><td align=\"left\">Increased</td><td align=\"left\">Hs-CRP and IL2 receptor</td><td align=\"left\">129</td><td align=\"left\">Poor</td><td align=\"left\">r2 = 0.20, p = 0.019, 95% CI 0.03458—0.3660</td></tr><tr><td align=\"left\">PCI</td><td align=\"left\">Increased</td><td align=\"left\">Hs-CRP and IL10</td><td align=\"left\">82</td><td align=\"left\">Poor</td><td align=\"left\">r2 = 0.28, p = 0.009, 95% CI 0.07419 -0.4741</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab4\"><label>Table 4</label><caption><p>Medications are correlated with TNFα.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Medications</th><th align=\"left\">Cytokine</th><th align=\"left\">Cytokine</th><th align=\"left\">Sample No</th><th align=\"left\">Correlation</th><th align=\"left\">r<sup>2</sup> (Correlation coefficient) and <italic>p</italic>-Value</th></tr></thead><tbody><tr><td align=\"left\">Metoprolol-23.75</td><td align=\"left\">TNFα</td><td align=\"left\">IL8</td><td align=\"left\">204</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.58 p &lt; 0.0001, 95%CI 0.4831–0.6660</td></tr><tr><td align=\"left\">Metoprolol 11.87</td><td align=\"left\">TNFα</td><td align=\"left\">IL8</td><td align=\"left\">6</td><td align=\"left\">Not significant</td><td align=\"left\">r2 = 0.80, p = 0.5306, 95%CI -0.0206–0.9666</td></tr><tr><td align=\"left\">Metoprolol-23.75</td><td align=\"left\">TNFα</td><td align=\"left\">IL-1ß</td><td align=\"left\">128</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.44 p &lt; 0.0001, 95%CI 0.2872–0.5691</td></tr><tr><td align=\"left\">Metoprolol-11.87</td><td align=\"left\">TNFα</td><td align=\"left\">IL-1ß</td><td align=\"left\">3</td><td align=\"left\">Poor</td><td align=\"left\">r2 = 0.44 p &lt; 0.0001, 95%CI 0.0–0.00</td></tr><tr><td align=\"left\">Simvastatin-20</td><td align=\"left\">TNFα</td><td align=\"left\">IL8</td><td align=\"left\">19</td><td align=\"left\">High</td><td align=\"left\">r2 = -0.55, p = 0.62, 95% CI 0.4842–0.9067</td></tr><tr><td align=\"left\">Rosuvastatin-10</td><td align=\"left\">TNFα</td><td align=\"left\">IL8</td><td align=\"left\">185</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.63, p = 0.0001, 95% CI 0.5325–0.7085</td></tr><tr><td align=\"left\">Simvastatin-20</td><td align=\"left\">TNFα</td><td align=\"left\">IL-1ß</td><td align=\"left\">8</td><td align=\"left\">Poor</td><td align=\"left\">r2 = 0.16, p = 0.7014, 95% CI -0.6124–0.7064</td></tr><tr><td align=\"left\">Rosuvastatin-10</td><td align=\"left\">TNFα</td><td align=\"left\">IL-1ß</td><td align=\"left\">113</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.47, p = 0.0001, 95% CI 0.3203–0.6079</td></tr><tr><td align=\"left\">Benazepril-5.0</td><td align=\"left\">TNFα</td><td align=\"left\">IL8</td><td align=\"left\">13</td><td align=\"left\">High</td><td align=\"left\">r2 = 0.93, p = 0.0001, 95% CI 0.7764–0.9791</td></tr><tr><td align=\"left\">Benazepril-5.0</td><td align=\"left\">TNFα</td><td align=\"left\">IL-1ß</td><td align=\"left\">5</td><td align=\"left\">Not significant</td><td align=\"left\">r2 = 0.51, p = 0.3735, 95% CI -0.6724–0.9608</td></tr><tr><td align=\"left\">Valsartan 80</td><td align=\"left\">TNFα</td><td align=\"left\">IL8</td><td align=\"left\">53</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.43, p = 0.011, 95% CI 0.1881–0.6320</td></tr><tr><td align=\"left\">Olmesartan 20</td><td align=\"left\">TNFα</td><td align=\"left\">IL8</td><td align=\"left\">13</td><td align=\"left\">High</td><td align=\"left\">r2 = 0.90, p = 0.0001, 95% CI 0.7114–0.9721</td></tr><tr><td align=\"left\">Brilinta</td><td align=\"left\">TNFα</td><td align=\"left\">IL8</td><td align=\"left\">259</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.58, p &lt; 0.0001, 95%CI 0.4986–0.6598</td></tr><tr><td align=\"left\">Brilinta</td><td align=\"left\">TNFα</td><td align=\"left\">IL-1ß</td><td align=\"left\">154</td><td align=\"left\">Poor</td><td align=\"left\">r2 = 0.30, p &lt; 0.0001 95%CI 0.1586–0.3344</td></tr><tr><td align=\"left\">Clopidogrel</td><td align=\"left\">TNFα</td><td align=\"left\">IL8</td><td align=\"left\">48</td><td align=\"left\">Moderate</td><td align=\"left\">r2 = 0.46, p = 0.0008, 95% CI 0.2128–0.6643</td></tr><tr><td align=\"left\">Clopidogrel</td><td align=\"left\">TNFα</td><td align=\"left\">IL-1ß</td><td align=\"left\">29</td><td align=\"left\">High</td><td align=\"left\">r2 = 0.87, p &lt; 0.0001 95% CI 0.7425–0.9478</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab5\"><label>Table 5</label><caption><p>Correlation of cytokine expression with stent number and total stent length.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Criteria</th><th align=\"left\">Sample No</th><th align=\"left\">No of Stent<break/>Correlation coefficient (r<sup>2</sup>)</th><th align=\"left\"><italic>p</italic>-Value</th><th align=\"left\">Sample No</th><th align=\"left\">The total length of the stent<break/>Correlation coefficient (r2)</th><th align=\"left\"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align=\"left\">No of Stent</td><td align=\"left\">––</td><td align=\"left\">–––</td><td char=\".\" align=\"char\"/><td align=\"left\">285</td><td char=\".\" align=\"char\">r2 = 0.69, 95% CI 0.6254–0.74</td><td char=\".\" align=\"char\">p = 0.001</td></tr><tr><td align=\"left\">Age</td><td align=\"left\">294</td><td align=\"left\">r2 = 0.09, 95% CI 0.-.029–0.19</td><td char=\".\" align=\"char\">p = 0.48</td><td align=\"left\">298</td><td char=\".\" align=\"char\">r2 = 0.04, 95% CI 0.-.073–0.15</td><td char=\".\" align=\"char\">p = 0.48</td></tr><tr><td align=\"left\">Hypertension</td><td align=\"left\">294</td><td align=\"left\">r2 = -0.057, 95% CI -0.056–0.17</td><td char=\".\" align=\"char\">p = 0.32</td><td align=\"left\">298</td><td char=\".\" align=\"char\">r2 = -0.18, 95% CI -0.13–0.95</td><td char=\".\" align=\"char\">p = 0.75</td></tr><tr><td align=\"left\">Diabetes</td><td align=\"left\">294</td><td align=\"left\">R2 = -0.14, 95% CI -0.033–0.25</td><td char=\".\" align=\"char\">p = 0.01</td><td align=\"left\">298</td><td char=\".\" align=\"char\">r2 = -0.04, 95% CI -0.066–0.67</td><td char=\".\" align=\"char\">p = 0.41</td></tr><tr><td align=\"left\">Blood glucose</td><td align=\"left\">299</td><td align=\"left\">r2 = -0.022, 95% CI -0.09–0.13</td><td char=\".\" align=\"char\">p = 0.69</td><td align=\"left\">297</td><td char=\".\" align=\"char\">r2 = -0.055, 95% CI -0.058–0.16</td><td char=\".\" align=\"char\">p = 0.34</td></tr><tr><td align=\"left\">HS-CRP</td><td align=\"left\">251</td><td align=\"left\">r2 = -0.030, 95% CI -0.15–0.09</td><td char=\".\" align=\"char\">p = 0.62</td><td align=\"left\">254</td><td char=\".\" align=\"char\">r2 = -0.029, 95% CI -0.15–0.09</td><td char=\".\" align=\"char\">p = 0.63</td></tr><tr><td align=\"left\">IL-1ß</td><td align=\"left\">176</td><td align=\"left\">r2 = -0.14, 95% CI -0.007–0.28</td><td char=\".\" align=\"char\">p = 0.06</td><td align=\"left\">177</td><td char=\".\" align=\"char\">R2 = -0.15, 95% CI -0.005–0.29</td><td char=\".\" align=\"char\">p = 0.04</td></tr><tr><td align=\"left\">IL8</td><td align=\"left\">292</td><td align=\"left\">r2 = -0.09, 95% CI -0.020–0.20</td><td char=\".\" align=\"char\">p = 0.1</td><td align=\"left\">296</td><td char=\".\" align=\"char\">r2 = -0.07, 95% CI -0.044–0.18</td><td char=\".\" align=\"char\">p = 0.22</td></tr><tr><td align=\"left\">IL_10</td><td align=\"left\">178</td><td align=\"left\">R2 = -0.012, 95% CI -0.13–0.15</td><td char=\".\" align=\"char\">p = 0.12</td><td align=\"left\">179</td><td char=\".\" align=\"char\">r2 = -0.03, 95% CI -0.18–0.10</td><td char=\".\" align=\"char\">p = 0.6</td></tr><tr><td align=\"left\">IL_2 receptor</td><td align=\"left\">294</td><td align=\"left\">r2 = -0.035, 95% CI -0.17–0.11</td><td char=\".\" align=\"char\">p = 0.95</td><td align=\"left\">298</td><td char=\".\" align=\"char\">r2 = -0.015, 95% CI -0.099–0.12</td><td char=\".\" align=\"char\">p = 0.79</td></tr><tr><td align=\"left\">IL6</td><td align=\"left\">294</td><td align=\"left\">r2 = -0.0035, 95% CI -0.11–0.11</td><td char=\".\" align=\"char\">p = 0.95</td><td align=\"left\">261</td><td char=\".\" align=\"char\">r2 = -0.05, 95% CI -0.17–0.11</td><td char=\".\" align=\"char\">p = 0.37</td></tr><tr><td align=\"left\">TNF</td><td align=\"left\">294</td><td align=\"left\">r2 = -0.14, 95% CI -0.031–0.25</td><td char=\".\" align=\"char\">p = 0.01</td><td align=\"left\">298</td><td char=\".\" align=\"char\">r2 = -0.021, 95% CI -0.091–0.13</td><td char=\".\" align=\"char\">p = 0.71</td></tr><tr><td align=\"left\">LAD-PCI</td><td align=\"left\">294</td><td align=\"left\">r2 = -0.18, 95% CI -0.29–0.07</td><td char=\".\" align=\"char\">p = 0.03</td><td align=\"left\">298</td><td char=\".\" align=\"char\">r2 = -0.10, 95% CI -0.21–0.013</td><td char=\".\" align=\"char\">p = 0.08</td></tr><tr><td align=\"left\">RCA-PCI</td><td align=\"left\">294</td><td align=\"left\">r2 = -0.16, 95% CI -0.048–0.27</td><td char=\".\" align=\"char\">p = 0.05</td><td align=\"left\">298</td><td char=\".\" align=\"char\">R2 = -0.14, 95% CI -0.033–0.25</td><td char=\".\" align=\"char\">p = 0.01</td></tr><tr><td align=\"left\">LCX-PCI</td><td align=\"left\">294</td><td align=\"left\">r2 = -0.17, 95% CI -0.28–0.06</td><td char=\".\" align=\"char\">p = 0.02</td><td align=\"left\">298</td><td char=\".\" align=\"char\">r2 = -0.16, 95% CI -0.048–0.27</td><td char=\".\" align=\"char\">p = 0.006</td></tr><tr><td align=\"left\">Metoprolol 23.75</td><td align=\"left\">259</td><td align=\"left\">r2 = -0.00</td><td char=\".\" align=\"char\">p = 1.0</td><td align=\"left\">261</td><td char=\".\" align=\"char\">r2 = -0.00</td><td char=\".\" align=\"char\">p = 1.0</td></tr><tr><td align=\"left\">Metoprolol 11.87</td><td align=\"left\">259</td><td align=\"left\">r2 = -0.00</td><td char=\".\" align=\"char\">p = 1.0</td><td align=\"left\">261</td><td char=\".\" align=\"char\">r2 = -0.00</td><td char=\".\" align=\"char\">p = 1.0</td></tr><tr><td align=\"left\">Valsartan 80</td><td align=\"left\">155</td><td align=\"left\">r2 = -0.00</td><td char=\".\" align=\"char\">p = 1.0</td><td align=\"left\">157</td><td char=\".\" align=\"char\">r2 = -0.00</td><td char=\".\" align=\"char\">p = 1.0</td></tr><tr><td align=\"left\">Benazepril 2.5</td><td align=\"left\">155</td><td align=\"left\">R2 = -0.090, 95% CI -0.24–0.06</td><td char=\".\" align=\"char\">p = 0.26</td><td align=\"left\">157</td><td char=\".\" align=\"char\">r2 = -0.064, 95% CI -0.21–0.93</td><td char=\".\" align=\"char\">p = 0.42</td></tr><tr><td align=\"left\">Rosuvastatin 10</td><td align=\"left\">286</td><td align=\"left\">r2 = -0.09, 95% CI -0.22–0.09</td><td char=\".\" align=\"char\">p = 0.10</td><td align=\"left\">289</td><td char=\".\" align=\"char\">r2 = -0.095, 95% CI -0.20–0.02</td><td char=\".\" align=\"char\">p = 0.10</td></tr><tr><td align=\"left\">Simvastatin 20</td><td align=\"left\">286</td><td align=\"left\">r2 = -0.0</td><td char=\".\" align=\"char\">p = 0.12</td><td align=\"left\">289</td><td char=\".\" align=\"char\">r2 = -0.0</td><td char=\".\" align=\"char\">p = 0.11</td></tr><tr><td align=\"left\">Olmesartan 20</td><td align=\"left\">155</td><td align=\"left\">r2 = -0.085, 95% CI -0.24–0.07</td><td char=\".\" align=\"char\">p = 0.29</td><td align=\"left\">157</td><td char=\".\" align=\"char\">r2 = -0.035, 95% CI -0.19–0.12</td><td char=\".\" align=\"char\">p = 0.6</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Minying Wan, Kun Hu and Yi Lu.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51496_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51496_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51496_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51496_Fig4_HTML\" id=\"MO4\"/>" ]
[ "<media xlink:href=\"41598_2024_51496_MOESM1_ESM.zip\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["6."], "mixed-citation": ["Marfella R, Sardu C, D'Onofrio N, et al. SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes. "], "italic": ["BMC Med"]}, {"label": ["17."], "mixed-citation": ["Sardu C, Trotta MC, Sasso FC, et al. SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosis. "], "italic": ["Cardiovasc Diabetol"]}, {"label": ["19."], "mixed-citation": ["Sasso FC, Pafundi PC, Marfella R, et al. Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study. "], "italic": ["Cardiovasc Diabetol"]}, {"label": ["20."], "mixed-citation": ["Chichareon P, Modolo R, Collet C, et al. Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction. "], "italic": ["J Am Coll Cardiol"]}, {"label": ["26."], "mixed-citation": ["Grisanti LA, de Lucia C, Thomas TP, et al. Prior \u03b2-blocker treatment decreases leukocyte responsiveness to injury. "], "italic": ["JCI Insight"]}, {"label": ["27."], "mixed-citation": ["Woods EA, Ackman ML, Graham MM, Koshman SL, Boswell RM, Barry AR. Anticoagulant and Antiplatelet Prescribing Patterns for Patients with Atrial Fibrillation after Percutaneous Coronary Intervention. "], "italic": ["Can J Hosp Pharm"]}, {"label": ["31."], "mixed-citation": ["Di Minno MN, Iervolino S, Peluso R, Scarpa R, Di Minno G, group Cs. Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-\u03b1 blockers and traditional disease-modifying antirheumatic drugs. "], "italic": ["Arterioscler Thromb Vasc Biol"]}, {"label": ["38."], "mixed-citation": ["Liberale L, Ministrini S, Carbone F, Camici GG, Montecucco F. Cytokines as therapeutic targets for cardio- and cerebrovascular diseases. "], "italic": ["Basic Res Cardiol"]}, {"label": ["42."], "mixed-citation": ["Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT, Investigators A-TTACHF. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. "], "italic": ["Circulation"]}]
{ "acronym": [], "definition": [] }
45
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1236
oa_package/af/98/PMC10786845.tar.gz
PMC10786846
38216616
[ "<title>Introduction</title>", "<p id=\"Par2\">Recently in Korea, the problem of youth employment, especially the deterioration of employment for college graduates, has become a social issue. However, companies are also complaining of a shortage of human resources, and one of the causes is the frequent turnover of new employees with college graduates<sup>##UREF##0##1##</sup>. According to the Ministry of Trade Industry and Energy, the early retirement rate of experienced people is 13%, while the early retirement rate of new employees is 66%<sup>##UREF##1##2##</sup>. According to a survey of economic activities by Statistics Korea, if young people aged 15–29 quit their first job, the average service period is 1.9 months. While most young people are eager to secure employment, a paradox emerges as many of those who successfully obtain jobs soon contemplate either changing their positions or resigning altogether<sup>##UREF##2##3##</sup>. We can look at the attrition of new hires and college graduates from two opposing perspectives. There is a view that new employee turnover is a job search process in the initial labor market entry process. There is a view that finding better working conditions is economical and rational<sup>##UREF##3##4##</sup>. However, failure to settle in the early stages of a career and the accumulation of unstable labor market experience can negatively affect an individual's career development, future wages and working conditions<sup>##UREF##4##5##,##UREF##5##6##</sup>. The turnover of these new employees can cause many difficulties for companies. This is because it is difficult to recover the costs spent on employee selection and training<sup>##UREF##6##7##</sup>. Also, turnover is contagious. New employees know much about the external labor market in the job search process, so they view the organization more objectively. Therefore, employees who see them change jobs also recognize a problem with the organization and tend to change jobs when they have the opportunity<sup>##UREF##7##8##,##UREF##8##9##</sup>. Therefore, quickly selecting and managing new employees with turnover intention can reduce the cost of hiring new employees and managing personnel.</p>", "<p id=\"Par3\">However, it is not easy for companies to measure the turnover intention of new employees. Turnover intention is a sensitive issue for individuals, often concealed due to concerns about potential repercussions if disclosed externally<sup>##UREF##9##10##</sup>. Also, even if it disclosed, it is not easy to determine whether the content is true. Companies are facing difficulties in selecting and managing new employees with turnover intentions. Therefore, it is time to research ways to classify new employees with turnover intention quickly. Furthermore, prior studies<sup>##UREF##10##11##–##UREF##12##13##</sup> have analyzed the causal relationship between dependent and independent variables using traditional econometric models but have limitations in that they have been unable to suggest whether new employees with actual turnover intentions can be predicted with these independent variables. In the case of rapid turnover among early career workers, predicting the dependent variable itself can be a significant problem<sup>##REF##24635003##14##,##UREF##13##15##</sup>.</p>", "<p id=\"Par4\">The turnover intention is being studied a lot in organizational psychology. Turnover intention refers to the degree of perception that people want to leave their current job<sup>##UREF##14##16##</sup>. Although they did not act, it indicates a tendency toward turnover. It can be said to be the degree to which an alternative to leaving the current organization and working in another organization is explored and considered. Previous studies on turnover intention identified various factors affecting turnover intention<sup>##UREF##0##1##,##UREF##15##17##–##UREF##18##20##</sup>. These research results helped improve the understanding of the turnover phenomenon. Turnover intention is the variable that has the most direct and robust influence on turnover<sup>##REF##701211##21##</sup>. According to Brown and Peterson, although an employee's turnover intention does not necessarily lead to turnover, turnover intention plays a role in effectively predicting the actual behavior of turnover<sup>##UREF##19##22##</sup>. This result supports the research result of Alderfer theory of reasoned action, which shows that the correlation between behavioral intention and actual behavior is very high<sup>##UREF##20##23##</sup>. Previous Studies confirmed that turnover intention and actual turnover had a high correlation<sup>##UREF##21##24##–##UREF##24##27##</sup>. As the such, turnover intention is highly correlated with turnover and is used as a dependent variable in place of turnover<sup>##UREF##21##24##</sup>. Therefore, the turnover intention is one of the important variables in the field of organizational psychology. The turnover intention in this study is, 'Are you engaged in activities to find another job?'. Looking at the turnover intention that contains actions from a practical point of view, it will be possible to understand the turnover phenomenon of new college graduates and a plan to manage them. Previous studies that identified the factors affecting this turnover intention are as follows.</p>", "<p id=\"Par5\">A meta-analysis of previous studies on turnover intention revealed that factors influencing this phenomenon have been extensively studied<sup>##UREF##25##28##</sup>. These factors include personal characteristics such as age, years of service, gender, and educational status; job-related factors like salary, job performance, and overall job satisfaction; as well as external factors such as unemployment, new employment rate, and perception of employment.</p>", "<p id=\"Par6\">It was found that reduced emotional and normative commitment were associated with increased turnover intention among new nurses<sup>##REF##35623235##29##</sup>. Another study argued that perceptions of distributive justice, procedural justice, and interactional justice can reduce turnover intention in the context of organizational citizenship behavior<sup>##UREF##26##30##</sup>. Research identified job stress and sleep disorder as significant factors impacting turnover intention among new nurses during the 8th week of employment<sup>##REF##35742172##31##</sup>. A study found that poor workplace behavior, high levels of work-related stress, and poor work-life balance were factors influencing turnover intention among new project management professionals in the construction field<sup>##UREF##27##32##</sup>. It was confirmed that citizenship behavior can mediate the relationship between organizational learning culture and turnover intention<sup>##UREF##28##33##</sup>. Another study identified subjective norms and training as major factors impacting turnover intention among new employees in the Hong Kong hotel industry<sup>##UREF##29##34##</sup>. Research found that the effectiveness of the onboarding program was an important factor influencing turnover intention for new employees with less than 2 years of experience in the ICT industry<sup>##UREF##30##35##</sup>. This study focuses on individual psychological changes as a factor influencing turnover intention. Specifically, it examines job selection motivation, satisfaction of needs, and suitability with the job as potential influences. It was found that job dissatisfaction under poor working conditions was related to job search, which was also related to actual turnover, using national representative data obtained from national registers<sup>##UREF##31##36##</sup>.</p>", "<p id=\"Par7\">Motivation Plays a very important role in humanistic psychology, which presents human free will as a core concept<sup>##UREF##32##37##,##UREF##33##38##</sup>. Motivation was also defined motivation as a determinant that makes individuals put their efforts into and maintain specific tasks<sup>##UREF##34##39##</sup>. Motivation was defined as a belief that induces or sustains behavior so people can achieve their desired goals and achievements<sup>##REF##11392867##40##</sup>. Another study defined motivation as a force that not only causes an action to occur but also suggests its direction, energizes it, and sustains it over time<sup>##UREF##35##41##</sup>. According to Self-Determination Theory (SDT), human behavior is caused by multiple motivations, and the outcome of the behavior depends on whether the motivation is intrinsic or extrinsic<sup>##UREF##32##37##</sup>. From this point of view, various studies have been conducted to determine what motivates people to choose a job. In general, the intrinsic motivation for choosing a job is an individual expectation, fulfillment, and satisfaction, and the extrinsic motivation for choosing a job is a material environment, human relationships, and rewards<sup>##UREF##36##42##,##UREF##37##43##</sup>. Therefore, the motivation for job selection is the degree to which the intrinsic and external motivation for the job work when an individual chooses a job.</p>", "<p id=\"Par8\">The previous studies that suggested the factors of job choice motive are as follows. A study showed that working environment, opportunities to learn new things, future career prospects, challenging work, recognition from others, matching of aptitudes, job security, welfare benefits, working environment, ease of employment, working hours, promotion opportunity, time leeway, salary, bonus, ease of job transfer, self-actualization, and potential for self-development were suggested as motivating factors<sup>##UREF##38##44##</sup>. Another study suggested salary, employment stability, mental and physical relaxation, recognition from others, influence on others, voluntarily setting and achieving goals, work autonomy, and the possibility of acquiring new knowledge as motivation factors<sup>##UREF##39##45##</sup>. It was also suggested that motivation factors are motivation factors of income, employment stability, benefits, working hours, workload, working environment, company size, work distance, major suitability, aptitude and interest, job content, prospects, and social reputation<sup>##UREF##13##15##</sup>. This study conceptualizes human needs based on ERG theory, which categorizes and presents human needs from a general point of view in explaining job selection motivation<sup>##UREF##20##23##</sup>.</p>", "<p id=\"Par9\">According to ERG theory, humans require existence (E), a need for relationship (R), and a need for growth (G), and the level of satisfaction of these needs affects motivation<sup>##UREF##20##23##</sup>. Individuals expect to satisfy their needs through their career choice<sup>##UREF##40##46##</sup> and leave the organization if their needs are not satisfied through that career<sup>##UREF##41##47##,##UREF##42##48##</sup>. Therefore, the level at which the desire is satisfied can determine turnover intention. The three desires suggested by Alderfer (1972) are as follows.</p>", "<p id=\"Par10\"><bold>Existence needs (E)</bold>: It is the need for humans to maintain survival. Organizations include salary, benefits, job security, and working environment.</p>", "<p id=\"Par11\"><bold>Relatedness needs (R)</bold>: It is a desire to form and maintain relationships with groups (family, friends, and peer relationships, etc.) related to individuals. In organizations, include human relationships and desire for promotion.</p>", "<p id=\"Par12\"><bold>Growth needs (G)</bold>: It is a desire to develop an individual and realize oneself. In the organization, including individual development potential, sense of achievement, aptitude and interest, and social recognition.</p>", "<p id=\"Par13\">Previous studies to identify the factors of existence, relationship, and growth desire are as follows. A study presented his desire for existence: promotion, promotion evaluation fairness, salary satisfaction, relationship needs: recognition of peer work ability, job satisfaction, work environment, growth needs: personal development, confidence, and acquisition of new knowledge and skills<sup>##UREF##43##49##</sup>. Another study presented the desire for existence: financial compensation, employment stability, mental and physical relaxation, relationship needs: recognition from others, possibility of exerting influence on others, growth needs: goal setting and achievement, work autonomy, and new knowledge acquisition<sup>##UREF##39##45##</sup>. It also describes existence needs: security and stability for the future, financial compensation, promotion opportunities, welfare benefits, working hours, relationship needs: family atmosphere and support of the organization, smooth human relationships with colleagues, positive evaluation of superiors, Customers' positive evaluation, growth needs: suitability for job and individual, sense of achievement through work, acquisition of new knowledge and experience, opportunities for growth through work, social contribution of work, and sense of achievement through work are presented<sup>##UREF##44##50##</sup>. A study measured the ERG needs of knowledge-based employees using three variables: salary satisfaction, work relationship, and career growth<sup>##UREF##45##51##</sup>.</p>", "<p id=\"Par14\">Personal-job fit can be seen as the level of agreement between the capabilities of individuals and the demands of their jobs<sup>##UREF##46##52##</sup>. This means the relationship between the characteristics of an individual and the characteristics of the job given to him<sup>##UREF##0##1##</sup>. Personal-job fit was related to job satisfaction, positive work attitude, quality of work performance, improved adaptability in new organizations, and reduced turnover intention<sup>##UREF##18##20##,##REF##12395812##53##,##UREF##47##54##</sup>. Therefore, studies have investigated the relationship between various work-related attitudes and behaviors. A study presented a research model explaining individual-job suitability, defining it as two concepts: the degree to which the individual's ability and the ability required in the job match and the harmony between the individual's needs and the rewards provided in the job<sup>##UREF##48##55##</sup>. Looking at this, individual characteristics and job characteristics directly affect an individual's work-related attitude, the relationship between job characteristics and attitudes depends on the individual's ability and demand level, and the relationship between individual characteristics and attitudes depends on the job demand or supply level. A meta-analysis on 836 studies related to five individual-environmental suitability including individual-job suitability. Among them, 62 studies related to this analyzed in the case of individual-job suitability<sup>##UREF##49##56##</sup>. As a result, it was found to have a high correlation with job satisfaction, organizational commitment, and turnover intention. In addition, it found to be related to peer and boss satisfaction, organizational commitment, job performance, burden, tenure, turnover, organizational attraction, and recruitment intention. In this study, the subcategories of personal-job fit include level of work matching your level of education, skill level of job-matching your level of skill, and contents of work-matching your major.</p>", "<p id=\"Par15\">As such, research to measure the turnover intention of college graduates is being conducted steadily. According to previous study, job-related factors, such as supervisor support, personnel systems, and job prospects, can increase turnover intention<sup>##UREF##50##57##</sup>. It was posited that the acquisition of competencies and understanding of organizational rules can reduce turnover intention<sup>##REF##24635003##14##</sup>. It was also identified that workplace bullying, peer bullying, and supervisor bullying as factors that increase turnover intention<sup>##REF##32336223##58##</sup>. Previous studies have primarily examined factors affecting turnover intention from the perspective of external factors, such as the job and organization. These findings aid in understanding the turnover phenomenon. However, considering that turnover intention is a tendency that represents individual psychological factors<sup>##UREF##14##16##</sup>, it is essential to focus on psychological changes such as motivation and the satisfaction of needs as the root cause of the problem. This is because motivation and desire are key research topics in explaining individual psychology, behavior, or organizational behavior<sup>##REF##15709944##59##</sup>. From this perspective, this study differentiates itself from previous studies by focusing on the individual's psychological state and change by considering the motivation for job selection and satisfaction of needs of new employees and their suitability with the job.</p>", "<p id=\"Par16\">Based on the above discussion, the following hypothesis was derived in this study.</p>", "<title>H1</title>", "<p id=\"Par17\">As job preference are satisfied, turnover intention will decrease.<list list-type=\"alpha-lower\"><list-item><p id=\"Par18\">As recognizing workload importance is satisfied, turnover intention will decrease.</p></list-item><list-item><p id=\"Par19\">As recognizing the importance of the major field is satisfied, turnover intention will decrease.</p></list-item><list-item><p id=\"Par20\">As recognizing work’s social reputation is satisfied, turnover intention will decrease.</p></list-item></list></p>", "<title>H2</title>", "<p id=\"Par21\">As existence needs are satisfied, turnover intention will decrease.<list list-type=\"alpha-lower\"><list-item><p id=\"Par22\">As satisfaction with wage or income is satisfied, turnover intention will decrease.</p></list-item><list-item><p id=\"Par23\">As satisfaction with job security is satisfied, turnover intention will decrease.</p></list-item></list></p>", "<title>H3</title>", "<p id=\"Par24\">As relatedness needs are satisfied, turnover intention will decrease.<list list-type=\"alpha-lower\"><list-item><p id=\"Par25\">As satisfaction with organization is satisfied, turnover intention will decrease.</p></list-item><list-item><p id=\"Par26\">As satisfaction with group membership is satisfied, turnover intention will decrease.</p></list-item></list></p>", "<title>H4</title>", "<p id=\"Par27\">As growth needs are satisfied, turnover intention will decrease.<list list-type=\"alpha-lower\"><list-item><p id=\"Par28\">As satisfaction with personnel system (promotion system) is satisfied, turnover intention will decrease.</p></list-item><list-item><p id=\"Par29\">As satisfaction with individual development potential is satisfied, turnover intention will decrease.</p></list-item><list-item><p id=\"Par30\">As satisfaction with work’s social reputation is satisfied, turnover intention will decrease.</p></list-item></list></p>", "<p>And, the subcategories of personal-job fit include Level of work matching level of education, skill level of job matching level of skill, contents of work matching major. Based on the discussion above, it was judged that job choice motivation would affect turnover intention, and the following hypotheses were derived.</p>", "<title>H5</title>", "<p id=\"Par32\">As personal-job fit increases, turnover intention will decrease.<list list-type=\"alpha-lower\"><list-item><p id=\"Par33\">As the level of work matching the individual's level of education is met, turnover intention will decrease.</p></list-item><list-item><p id=\"Par34\">As the skill level of the job aligns with the individual's skill level, turnover intention will decrease.</p></list-item><list-item><p id=\"Par35\">As the content of work aligns with the individual's major, turnover intention will decrease.</p></list-item></list></p>", "<p>Based on the above theoretical basis and hypothesis, this study aims to identify factors that influence turnover intention, and to establish and verify a predictive model. If a predictive model is built using public data and machine learning algorithms that measure the turnover intention of new college graduates, and the independent variables used in model construction are measured on new employees and put into the model, their turnover intention can be predicted. This approach not only provides practical implications for promptly identifying new employees with turnover intentions in situations where it is challenging to easily obtain sensitive information such as turnover intention, but also supplements the limitations of traditional econometric models that solely focus on causal analysis.</p>", "<p>The structure of this study is as follows. First, through OLS regression analysis, the influence of job choice motivation and sub-variables of personal-job fit category on turnover intention was analyzed. After that, a prediction model of turnover intention was developed and analyzed through logistic regression (LR), k-nearest neighbor (KNN), and extreme gradient boosting (XGB) machine learning techniques. Through this, the factors affecting turnover intention were examined, and a plan to predict the turnover intention of new college graduates was presented.</p>" ]
[ "<title>Methods</title>", "<title>Research model</title>", "<p id=\"Par38\">This study aims to analyze the factors affecting the turnover intention of new college graduates and to suggest a plan to predict the turnover intention of new employees through these factors. Many studies have overlooked the risk of omitted variable bias by focusing on specific factors that influence turnover intention and not including important explanatory variables. While the selection of explanatory variables should be based on theory, it is virtually impossible to consider all potential explanatory variables that may affect turnover intention with current theories and existing research results. Furthermore, many existing studies have used methods such as factor analysis to reduce the number of explanatory variables in order to preserve degrees of freedom due to relatively small sample sizes, which can obscure the interpretation of specific aspects of the influencing factors. In other words, even one factor influencing turnover intention may have multiple facets, but this is not sufficiently considered in previous studies.</p>", "<p id=\"Par39\">Therefore, in this study, each specific questionnaire item was separated as one variable. Job choice motivation is divided into three questions related to job preference. And based on the ERG theory, it is assumed that it is divided into 2 questions for existence needs, 2 questions for related needs, and 3 questions for growth needs, and will reduce turnover intention. In addition, personal-job fit is divided into three items, and it is assumed that it will reduce turnover intention. Job preference includes recognizing workload importance, recognizing the importance of the major field, recognizing work’s social reputation. Existence needs include satisfaction with wage or income, satisfaction with job security. Relatedness needs include satisfaction with organization, satisfaction with group membership). Growth needs include satisfaction with personnel system (promotion system), satisfaction with individual development potential, satisfaction with work’s social reputation).</p>", "<p id=\"Par40\">In addition, to anticipate the anxiety of some researchers about the possibility of common method bias (CMB) problems in studies using one source, as in this study, procedural and statistical efforts were carried out<sup>##UREF##51##60##–##REF##35893275##64##</sup>. Therefore, this study conducted a principal component analysis using scikit-learn's PCA class to perform Harman's single factor test. This analysis calculated the proportion of the first principal component in the total data variance. It was found that the first principal component accounted for 31% of the data variance. This percentage does not exceed the commonly used threshold of 50% for detecting significant common method bias in Harman's single factor test. Consequently, no significant common method bias was detected in this dataset. Figure ##FIG##0##1## below is the model of our study, and Table ##TAB##0##1## defines detailed variables. The satisfaction of group membership of a 7-point Likert scale, and all other variables were composed of a 5-point Likert scale.</p>", "<title>Data</title>", "<p id=\"Par41\">This study utilized data from the 2019 Graduates Occupation Mobility Survey (GOMS) conducted by the Korea employment information service, comprising 18,163 samples. The survey targets individuals who have graduated within the past two years and is recognized as government-approved statistics, officially accredited by the national statistical office (Statistics office approval number: 327004). Informed consent was obtained from all participants and their legal guardians, adhering to the relevant guidelines and regulations. Each year, GOMS establishes a panel of 18,000–20,000 people, or about 4% of them, with the population of graduates who completed a 2- to 3-year university or higher curriculum in the previous year. Therefore, it does not represent the Republic of Korea. However, the existence value of data is very high as it is used in the manpower supply and demand outlook in Korea. For the purpose of predicting turnover intention among currently employed respondents, 12,202 samples were selected, representing those who reported working in the past four weeks. The data consists of 6947 (56.9%) male and 5255 (43.1%) female. The study's dependent variable was turnover intention, assessed through the question, 'Are you ready to change your current job?' This was measured as a discrete variable with responses categorized as 'no (0)' or 'yes (1)'. The distribution of turnover intention was 9340 respondents (76.54%) indicating 'no' and 2862 (23.46%) indicating 'yes' (Fig. ##FIG##1##2##).</p>", "<p id=\"Par42\">The Cronbach's Alpha value for the variables used in this study was 0.807 or higher. Discriminant validity was assessed by determining whether the smallest AVE squared value exceeded the largest correlation coefficient among the constituent concepts. As a result of the analysis, it was found that the criteria requirements<sup>##UREF##55##65##</sup> for reliability and validity were met. Therefore, the reliability and validity of the measurement tools employed in this study were confirmed to be without any abnormalities.</p>", "<title>Influencing factors of turnover intention</title>", "<p id=\"Par43\">This study analyzed path coefficient values and significance levels using ‘Ordinary Least Squares (OLS)’ regression analysis included in python's stats models package to examine the effects of 13 independent variables presented in Table ##TAB##0##1## on turnover intention. OLS is a method to obtain a weight vector that minimizes the Residual Sum of Squares (RSS). This study presents average values, path coefficient values, t values, p values, and R<sup>2</sup> values by referring to the indicators of previous studies using OLS regression analysis<sup>##UREF##56##66##–##UREF##58##68##</sup>.</p>", "<title>Machine learning techniques</title>", "<p id=\"Par44\">Contrary to multiple linear regression, machine learning methods in artificial intelligence (AI) are increasingly used for prediction-related studies<sup>##UREF##59##69##–##UREF##63##76##</sup>. Machine learning is a way of implementing artificial intelligence, where computers discover new rules and patterns or make predictions about new data through data learning using algorithms<sup>##UREF##64##77##</sup>. Such machine learning can be divided mainly into supervised learning and unsupervised learning. Supervised learning involves labeling data and using it to predict future outcomes. It can be divided into regression and classification according to the characteristics of the results. Unsupervised learning is finding hidden patterns or structures in data by giving data to a computer but without a label. There is clustering and principal components analysis. In this study, classification techniques were used during supervised learning to classify given data based on discrete expectations for the digital divide. The classification technique is to build a model to distinguish different data dimensions according to specific criteria and predict discrete results for new data<sup>##UREF##65##78##</sup>.</p>", "<p id=\"Par45\">The advantage of machine learning is the ability to use both categorical and numerical predictors to generate models by assessing linear and non-linear relationships between variables and the importance of each predictor. In regression analysis, a traditional statistical method, when many variables are used simultaneously, the basic assumptions about independent variables, such as exogeneity and homoscedasticity, are difficult to maintain, and the high correlation between variables can cause multicollinearity<sup>##UREF##8##9##</sup>. In contrast, the analysis of the accuracy of the machine learning-based prediction model assumes that dependent and independent variables are associated with each other. In addition, the roles that dependent variables play in predicting independent variables are analyzed, so the predictive power is unaffected even when multicollinearity is caused<sup>##UREF##66##79##</sup>. Therefore, an analysis can be performed even in the presence of many variables. These machine learning classification algorithms include LR, KNN, XGB.</p>", "<p id=\"Par46\">LR is an analysis technique to prove the causal relationship between the independent and dependent variables. Here, the form of the dependent variable is categorical data, and when there are two categories, it's a binary logistic regression, and when there are more than two, it's a multinomial logistic regression.</p>", "<p id=\"Par47\">KNN is a non-parametric method that, given some data, looks at the surrounding (neighbor) data and classifies it into a category that contains more data<sup>##UREF##67##80##</sup>. It is used in a state where the type of class to be classified is known, but the probability density function for each sample is not known. Since it is a labor-intensive method when large amounts of training data are given, it did not gain a reputation until the 1960s, but has been widely used in pattern recognition since computer performance improved. KNN generally calculates the distance between data and data through Euclidean distance. The formula is as follows.</p>", "<p id=\"Par48\">XGB, a model developed by improving the boosting method of the decision tree, has an internal function of regularizing overfitting and carries out internal cross-validation at each trial<sup>##UREF##68##81##</sup>. Due to its excellent classification performance, XGB is often used in competitions, such as kaggle. Above all, the greatest advantage of XGB is its high practical usefulness. XGB allows for the derivation of important indices, which indicate relatively more important variables among various independent variables, so that the relative predictive power of various independent variables can be reviewed. Therefore, XGB was used in this study.</p>", "<p id=\"Par49\">Various studies have used these machine learning techniques, such as credit card fraud detection, student satisfaction prediction, cyberbullying detection model construction, and youth suicide risk prediction. A study developed a predictive model for credit card fraud detection using public data on credit card transaction records and machine learning algorithms (LR, Naïve Bayes, KNN)<sup>##UREF##69##82##</sup>. The analysis results prove that KNN has the highest prediction accuracy. Another study developed a youth suicide risk prediction model using public data from the Korean adolescent risk behavior survey and machine learning algorithms (LR, RF, SVM, ANN, XGB)<sup>##REF##31170212##83##</sup>. XGB showed the highest prediction accuracy. In previous study, a cyberbullying detection model was developed using twitter data and machine learning algorithms (Naïve bayes, KNN, DT, RF, SVM), and SVM showed the highest prediction accuracy<sup>##REF##33108392##84##</sup>. Another study developed a student satisfaction prediction model using traditional regression analysis and machine learning algorithms (KNN, SVM, Light GBM, RF, ENet), and ENet showed the highest prediction accuracy<sup>##REF##33798204##85##</sup>. Recently a study have highlighted the frequent use of machine learning techniques for data mining, including LR, SVM, DT, and ANN. Therefore, using machine learning algorithms to solve the digital divide can be a future exploratory direction<sup>##UREF##70##86##</sup>.</p>", "<title>Prediction model training</title>", "<p id=\"Par50\">In this study, to predict turnover intention, using a supervised learning method during machine learning, data were trained on a prediction model, and then the accuracy was analyzed. The specific method is as follows. First, a turnover intention prediction model was constructed in which all the variables presented in Table ##TAB##0##1## were set as independent variables, and turnover intention was set as the dependent variable. Second, the data was divided into 70% training set and 30% test set, and the model was trained with the training set, and then the prediction accuracy of the model analyzed with the test set. Third, the prediction accuracy of the prediction model was analyzed using LR, KNN, and XGB.</p>", "<title>Accuracy analysis</title>", "<p id=\"Par51\">Meanwhile, cross-validation was performed four times to prevent the model from overfitting only a specific data set and to generalize the analysis results. On the other hand, the widely used accuracy, precision, recall, and f1-score are used as the performance evaluation indicators of the predictive model. The meaning and formula of each indicator are as follows.</p>", "<p id=\"Par52\"><italic>Accuracy</italic> Accuracy is the most intuitive performance measure and is simply a ratio of correctly predicted observations to the total observations.</p>", "<p id=\"Par53\"><italic>Precision</italic>: Precision is the ratio of correctly predicted positive observations to the total predicted positive observations.</p>", "<p id=\"Par54\"><italic>Recall</italic>: Recall is the ratio of correctly predicted positive observations to all observations in the actual “yes” class.</p>", "<p id=\"Par55\"><italic>F1-score</italic>: F1-score is the weighted average of precision and recall.</p>", "<p id=\"Par56\">In order to obtain the above performance measures, a confusion matrix is required. Confusion matrix is also expressed as a 'mixed matrix', 'contemporaneous table', and 'error matrix'. Excluding the title of each row and column, it is an array composed of 2 × 2, and is expressed as follows. TP stands for True positive, which is actually True, when the prediction is judged to be True in the classification model. TN stands for True negative, which is actual False, when the prediction is judged to be False in the classification model. FP stands for False positive, which is actually False, which is when the prediction is judged to be true in the classification model. FN stands for False negative, which is actually True, when the prediction is judged to be False in the classification model.</p>" ]
[ "<title>Results</title>", "<title>Analysis of influencing factors of turnover intention</title>", "<p id=\"Par57\">As a result of analyzing the effect of the independent variables in this study on turnover intention through regression analysis, the three variables of job preference (recognizing workload importance, recognizing the importance of the major field, and recognizing work's social reputation) and one of growth needs All variables except for the variable of satisfaction with work's social reputation were found to have an effect (p &lt; 0.001). To summarize this, Table ##TAB##1##2## is as follows.</p>", "<title>Analysis result of prediction accuracy of turnover intention</title>", "<p id=\"Par58\">As a result of the turnover intention prediction model analysis, looking at the average values of the four sets of cross validation, accuracy showed the highest accuracy of XGB (0.785), followed by LR (0.783), and KNN (0.761). Precision showed that XGB showed the highest accuracy (0.806), followed by LR (0.798) and KNN (0.798). Recall showed that LR showed the highest accuracy (0.956), followed by XGB (0.942), and KNN (0.915). The f1-score showed that LR showed the highest accuracy (0.870), followed by XGB (0.869), and KNN (0.853). This is summarized as shown in Table ##TAB##2##3##.</p>", "<title>Feature importance</title>", "<p id=\"Par59\">One of the advantages of XGB used in this study is that it can calculate the importance of independent variables input to the prediction model. This importance does not indicate the direction of turnover intention, but provides insight into the ranking of important variables in predicting turnover intention. In this study, the importance ranking of independent variables was analyzed through XGB's 'plot_importance' library (Fig. ##FIG##2##3##). The f1-score is an indicator of how often the corresponding feature was used when splitting a tree, and the higher the F score, the more often it is used for splitting a tree<sup>##UREF##71##87##</sup>. As a result of the analysis, the most important variable in predicting turnover intention was satisfaction with job security. After that, satisfaction with organization, and contents of work-matching your major appeared in order.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par60\">This study tried to analyze the factors affecting the turnover intention of new employees with college graduates while the turnover of new employees is intensifying and to suggest a way to predict new employees with turnover intention through these factors. In this study, 13 variables that affect turnover intention were verified. The result is existence needs (satisfaction with wage or income, satisfaction with job security), relatedness needs (satisfaction with organization, satisfaction with group membership), growth needs (satisfaction with personnel system (promotion system), satisfaction with individual development potential, satisfaction with Work's social reputation) and personal-job fit (level of work matching level of education, skill level of job matching level of skill, contents of work matching major) were found to have an effect on turnover intention.</p>", "<p id=\"Par61\">Next, the results of the accuracy analysis of turnover intention prediction through 13 variables were examined based on the average value of each performance evaluation index. Accuracy showed the highest, with XGB showing 78.5%, but it did not show a significant difference with 78.3% of LR that followed, and KNN showed the lowest accuracy with 76.1%. Precision was highest with XGB at 80.6%, while LR and KNN showed 79.8% accuracy. On the other hand, in recall, LR showed the highest accuracy with 95.6%, followed by XGB with 94.2% and KNN with 91.5% accuracy. In f1-score, LR showed the highest at 87%, but there was no significant difference from 86.9% of XGB that followed, and KNN showed the lowest accuracy with 85.3%.</p>", "<p id=\"Par62\">Upon analyzing the importance of variables, it was found that satisfaction with job security of existence needs was the most significant predictor of turnover intention. Additionally, it was found that satisfaction with the organization of relatedness needs, the alignment of work with one's major in terms of personal-job fit, and satisfaction with potential for individual development of growth needs were also of high importance.</p>", "<p id=\"Par63\">The findings of this study are consistent with the results of previous research<sup>##UREF##72##88##,##UREF##73##89##</sup>, which have found that factors such as wage or income can reduce turnover intention. Specifically, job security, which is defined as the psychological state of feeling that one's job and employment status are secure<sup>##UREF##74##90##</sup>, has been identified as a factor that reduces job search behavior among new employees<sup>##UREF##75##91##</sup>, increases organizational commitment<sup>##UREF##76##92##,##UREF##77##93##</sup>. Thus, from the perspective of satisfying existence needs, it can be inferred that the satisfaction of wage or income and job security are factors that reduce turnover intention, which aligns with the results of previous studies.</p>", "<p id=\"Par64\">Meanwhile, newcomers to society often face the challenge of adapting to new environments and forming human relationships<sup>##UREF##78##94##</sup>. If adaptation is not successful and satisfaction with relationships is low, individuals may experience continuous psychological stress and an increase in turnover intention<sup>##UREF##79##95##,##UREF##80##96##</sup>. Conflicts in relationships appear in terms of interpersonal relationships outside of work<sup>##UREF##81##97##</sup>, and it has been reported that when such conflicts occur in new employees who have not yet adapted to the organization, their intention to turnover increases<sup>##UREF##82##98##–##UREF##84##100##</sup>. This is believed to be related to psychological stress, as individuals may seek to leave the organization as a means of relieving negative emotions<sup>##UREF##85##101##</sup>. Additionally, organizational satisfaction and turnover intention have been identified as indicators of successful adaptation of new employees to the organization, and a high correlation has been reported between the two<sup>##UREF##86##102##–##UREF##88##104##</sup>. Furthermore, satisfaction with a team, a smaller concept than an organization, has also been found to influence turnover intention<sup>##UREF##49##56##,##UREF##89##105##,##UREF##90##106##</sup>. Therefore, from the perspective of satisfying relatedness needs, it can be inferred that an increase in satisfaction with the organization and group membership leads to a decrease in turnover intention. For individuals who are new to society, such as recent college graduates, personal growth is of paramount importance. Those in the early stages of the life-career development cycle should focus on exploring their career options and developing the skills necessary to excel in their chosen field. New employees, in particular, have a strong desire for self-realization through their work and tend to continually evaluate whether the organization they are working for can support their growth<sup>##UREF##0##1##,##UREF##91##107##</sup>. Additionally, they tend to view the organization's personnel system more objectively as they have not been in the workforce for very long<sup>##UREF##8##9##</sup>. As a result, it can be inferred that satisfaction with personnel system, satisfaction with individual development potential from the perspective of satisfying individual growth needs, can lead to a decrease in turnover intention, which is consistent with the findings of previous studies.</p>", "<p id=\"Par65\">Alignment between an individual and their environment is known to lead to higher levels of performance, satisfaction, and reduced stress<sup>##UREF##92##108##</sup>. This means that when an individual's competencies align with the competencies required by the job, their job performance will be more positive<sup>##REF##12395812##53##,##UREF##93##109##</sup>. As a result, personal-job fit has been identified as a factor that can increase organizational members' commitment and satisfaction and decrease turnover<sup>##UREF##42##48##,##UREF##46##52##,##UREF##94##110##–##UREF##96##112##</sup>. This can be explained by the attraction-selection-attrition theory advocated<sup>##UREF##41##47##</sup>. This is a series of processes in which people who are attracted to a specific organization or job apply, the organization selects more suitable people among them, and after the selection, those who fail to adapt to the organization and job and are not suitable are kicked out. Therefore, the subjects for whom the concept of suitability is important are mainly early entrants such as new employees<sup>##UREF##97##113##</sup>. Specifically, it has been reported that when there is a low alignment between an individual's education and their actual job, turnover intention increases<sup>##UREF##48##55##</sup>. Therefore, it can be inferred that the higher the person-job fit, the lower the turnover intention, which is consistent with the findings of previous studies.</p>", "<p id=\"Par66\">However, our study found that job preference, specifically recognizing workload importance, recognizing the importance of the major field, and recognizing work’s social reputation of the work, is no longer a factor influencing turnover intention. These results differ from previous studies<sup>##UREF##98##114##–##UREF##100##116##</sup>, suggesting an information asymmetry between job suppliers and consumers. For example, previous research has found that workload is a significant factor influencing turnover intention among new employees<sup>##UREF##101##117##</sup>. However, our study found that recognizing the importance of workload before employment did not affect turnover intention. This may be due to the structural limitations of the Korean recruitment process, which only provides fragmentary information about jobs, making it difficult for prospective employees to accurately determine the workload. This could be estimated by looking at job postings on social media or internet sites. As a result, it is interpreted that the recognizing workload importance before employment did not affect turnover intention.</p>", "<p id=\"Par67\">In addition, previous research has found a relationship between an individual's major and job prior to employment as a factor that reduces turnover intention<sup>##UREF##100##116##</sup>. However, this study found that the recognizing the importance of the major field did not have an impact on turnover intention. This is likely due to changes in the labor market and educational environment in Korea. Currently, due to the deterioration of the job market in Korea, there is a trend towards seeking employment regardless of one's major<sup>##UREF##102##118##</sup>. Furthermore, Korea has implemented a blind system in which personal information, such as name, age, school, and major, cannot be disclosed during recruitment. As a result, companies are unable to determine an applicant's major. In this context, companies are increasingly seeking versatile candidates, regardless of their majors, while universities are responding by offering convergence departments and majors. Therefore, it is believed that the results of this study, which showed that the relationship between the job prior to employment and the individual's major did not affect turnover intention are reflection of these changes. However, the study also found that contents of work-matching your major reduces turnover intention. In other words, even if the relevance to the major prior to employment does not affect turnover intention, if the compatibility with the major after employment is low, turnover will be considered. These findings highlight the importance of how majors in college can impact turnover intentions.</p>", "<p id=\"Par68\">In addition, it has been reported that new employees value the reputation of their job or the organization in which they work<sup>##UREF##103##119##,##UREF##104##120##</sup>. A positive reputation for a job is known to increase satisfaction with the organization<sup>##UREF##105##121##</sup> and reduce turnover intention<sup>##UREF##98##114##,##UREF##99##115##</sup>. However, according to this study, recognizing work's social reputation for pre-employment jobs does not affect turnover intention. However, a more important finding is that the greater the satisfaction with the social reputation of one's job after employment, the more likely they are to consider turnover. According to Social Identity Theory, individuals derive pride from their work through the social evaluation of others<sup>##UREF##106##122##</sup>. In particular, comparison between the current organization and other organizations strengthens self-esteem, allowing individuals to vicariously experience the organization's status and reputation, and to remain or become immersed in the organization<sup>##UREF##17##19##</sup>. In other words, it can be seen that a positive social reputation for work increases individual self-esteem and induces movement to a better place through organizational comparison.</p>", "<p id=\"Par69\">Next, according to the results of this study, the highest accuracy was obtained when XGB was used. Recently, XGB claimed to perform relatively better than other classifiers in various competitions, such as kaggle<sup>##UREF##67##80##</sup>. Although the ensemble technique is superior in classification problem-solving, the results of this study did not show much difference from LR. As with public data, there are various variables, such as continuous and categorical variables. When the data size is different, it is not easy to guarantee which classification algorithm is the best for creating and analyzing a predictive model. The best method is to use various algorithms. It is a desirable method to apply and select the algorithm with the best performance among them. But, the XGB model is praised for its ability to rank the importance of features, but it is crucial to note that this does not indicate the (causal) direction of the relationship. Identifying that a variable is essential for predicting turnover is useful, but without understanding how it influences turnover (positively or negatively), the empirical estimates have limited practical applications.</p>", "<p id=\"Par70\">Meanwhile, from the perspective of important variables in predicting turnover intention, this study results can be interpreted as having the needs strength effect, as proposed by ERG theory. According to this theory, individuals experience needs in the order of existence, relatedness, and growth, and as lower-level needs are met, the intensity of higher-level needs increases. Therefore, it is crucial to consider satisfaction with job security of existence needs, satisfaction with the organization of relatedness needs, and satisfaction with potential for individual development of growth needs when predicting turnover intention. However, the theory also suggests that the need strength effect can occur in the reverse direction, where even if higher-level needs are met, the intensity of lower-level needs may increase at any time. This should be taken into consideration, especially for early career individuals such as new college graduates, as their needs may change frequently.</p>", "<p id=\"Par71\">This study advances the field of turnover intention research by integrating machine learning techniques with traditional econometric analysis. Key findings include the diminished or even inverse impact of certain variables previously thought to affect turnover intention, and the establishment of a hierarchy of variables critical in predicting turnover intention. A notable discovery is that low pre-employment recognition of a job's major field and social reputation can lead to increased turnover intention if post-employment desires remain unfulfilled. Additionally, this study highlights job security satisfaction as the most vital predictor of turnover intention among new college graduates, offering a more nuanced understanding of their turnover motivations. Practical applications of this study involve the development of a predictive model for turnover intention, using the methodology and variables outlined. It can help organizations identify and manage new employees at higher risk of turnover, potentially reducing related costs. The study’s comprehensive analysis of factors influencing turnover intention, such as existence, relatedness, and growth needs, along with personal-job fit, provides organizations with actionable insights. For instance, enhancing compensation, job security, positive organizational culture, career development opportunities, and aligning job roles with individual skills and education can effectively reduce turnover intention. Overall, this study not only expands the methodology for predicting turnover intention by applying machine learning but also underscores the importance of examining job choice motivation, individual need satisfaction, and job suitability to mitigate turnover intention in new employees. This offers valuable guidance for organizations in managing and retaining new talent.</p>", "<p id=\"Par72\">The study has limitations, including its reliance on cross-sectional public data, making causality inference cautious. The findings, specific to university graduate newcomers, require further validation across diverse populations. Additionally, the data imbalance in turnover intention and the limited use of classification algorithms in the study suggest areas for future research enhancement. In addition, in future studies, it is believed that more diverse implications can be obtained by reflecting the characteristics of Generation Z, which refers to the younger generation born between the mid-1990s and the early 2000s, in the model. In particular, job security, organizational satisfaction, and work matching one’s major field were the most important variables in classifying employees with intention to turnover through XGB. In future studies, it is expected that more diverse practical implications can be derived if research focuses on these variables.</p>" ]
[]
[ "<p id=\"Par1\">In recent years, the turnover phenomenon of new college graduates has been intensifying. The turnover of new employees creates many difficulties for businesses as it is difficult to recover the costs spent on their hiring and training. Therefore, it is necessary to promptly identify and effectively manage new employees who are inclined to change jobs. So far previous studies related to turnover intention have contributed to understanding the turnover phenomenon of new employees by identifying factors influencing turnover intention. However, with these factors, there is a limitation that it has not been able to present how much it is possible to predict employees who are actually willing to change jobs. Therefore, this study proposes a method of developing a machine learning-based turnover intention prediction model to overcome the limitations of previous studies. In this study, data from the Korea Employment Information Service's Job Movement Path Survey for college graduates were used, and OLS regression analysis was performed to confirm the influence of predictors. And model learning and classification were performed using a logistic regression (LR), k-nearest neighbor (KNN), and extreme gradient boosting (XGB) classifier. A novel finding of this research is the diminished or reversed influence of certain traditional factors, such as workload importance and the relevance of one's major field, on turnover intention. Instead, job security emerged as the most significant predictor. The model's accuracy rates, highest with XGB at 78.5%, demonstrate the efficacy of applying machine learning in turnover intention prediction, marking a significant advancement over traditional econometric models. This study breaks new ground by integrating advanced predictive analytics into turnover intention research, offering a more nuanced understanding of the factors influencing the turnover intentions of new college graduates. The insights gained could guide organizations in effectively managing and retaining new talent, highlighting the need for a focus on job security and organizational satisfaction, and the shifting relevance of traditional factors like job preference.</p>", "<title>Subject terms</title>" ]
[]
[ "<title>Author contributions</title>", "<p>J.R. proposed the paper's subject, performed data analysis, and wrote the paper. Y.T. analyzed data and confirmed the structure and contents of the paper. S.P. analyzed the data and reviewed the sentences in the paper. All authors reviewed the manuscript.</p>", "<title>Data availability</title>", "<p>The datasets analysed during the current study are available in the [Github] repository, [<ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/jrpark16/GOMS.git\">https://github.com/jrpark16/GOMS.git</ext-link>].</p>", "<title>Competing interests</title>", "<p id=\"Par73\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Research model.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Turnover intention rate.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Feature importance results.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Influencing factors of turnover intention.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" colspan=\"3\">Constructs</th><th align=\"left\">Variables</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"10\">Job choice motivation</td><td align=\"left\" rowspan=\"7\"> Extrinsic motivation</td><td align=\"left\" rowspan=\"3\">  Job preference</td><td align=\"left\">Recognizing workload importance</td></tr><tr><td align=\"left\">Recognizing the importance of the major field</td></tr><tr><td align=\"left\">Recognizing work's social reputation</td></tr><tr><td align=\"left\" rowspan=\"2\">  Existence needs</td><td align=\"left\">Satisfaction with wage or income</td></tr><tr><td align=\"left\">Satisfaction with job security</td></tr><tr><td align=\"left\" rowspan=\"2\">  Relatedness needs</td><td align=\"left\">Satisfaction with organization</td></tr><tr><td align=\"left\">Satisfaction with group membership</td></tr><tr><td align=\"left\" rowspan=\"3\"> Intrinsic motivation</td><td align=\"left\" rowspan=\"3\">  Growth needs</td><td align=\"left\">Satisfaction with personnel system (promotion system)</td></tr><tr><td align=\"left\">Satisfaction with individual development potential</td></tr><tr><td align=\"left\">Satisfaction with work’s social reputation</td></tr><tr><td align=\"left\" rowspan=\"3\" colspan=\"3\">Personal-job fit</td><td align=\"left\">Level of work matching level of education</td></tr><tr><td align=\"left\">Skill level of job matching level of skill</td></tr><tr><td align=\"left\">contents of work matching major</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Analysis result of influencing factors of turnover intention.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">No</th><th align=\"left\">Variables</th><th align=\"left\">Mean</th><th align=\"left\">Coefficient</th><th align=\"left\">t-value</th><th align=\"left\">p &gt;|t|</th><th align=\"left\">Hypothesis</th></tr></thead><tbody><tr><td align=\"left\">Q1</td><td align=\"left\">Recognizing workload importance</td><td char=\".\" align=\"char\">3.955</td><td char=\".\" align=\"char\">0.056</td><td char=\".\" align=\"char\">1.319</td><td char=\".\" align=\"char\">0.187</td><td align=\"left\">Not supported</td></tr><tr><td align=\"left\">Q2</td><td align=\"left\">Recognizing the importance of the major field</td><td char=\".\" align=\"char\">3.708</td><td char=\".\" align=\"char\">0.050</td><td char=\".\" align=\"char\">1.412</td><td char=\".\" align=\"char\">0.158</td><td align=\"left\">Not supported</td></tr><tr><td align=\"left\">Q3</td><td align=\"left\">Recognizing work's social reputation</td><td char=\".\" align=\"char\">3.636</td><td char=\".\" align=\"char\">0.025</td><td char=\".\" align=\"char\">0.644</td><td char=\".\" align=\"char\">0.520</td><td align=\"left\">Not supported</td></tr><tr><td align=\"left\">Q4</td><td align=\"left\">Satisfaction with wage or income</td><td char=\".\" align=\"char\">3.291</td><td char=\".\" align=\"char\">− 0.113</td><td char=\".\" align=\"char\">2.521</td><td char=\".\" align=\"char\">0.012</td><td align=\"left\">Supported</td></tr><tr><td align=\"left\">Q5</td><td align=\"left\">Satisfaction with job security</td><td char=\".\" align=\"char\">3.786</td><td char=\".\" align=\"char\">− 0.252</td><td char=\".\" align=\"char\">5.675</td><td char=\".\" align=\"char\">0.000</td><td align=\"left\">Supported</td></tr><tr><td align=\"left\">Q6</td><td align=\"left\">Satisfaction with organization</td><td char=\".\" align=\"char\">3.612</td><td char=\".\" align=\"char\">− 0.928</td><td char=\".\" align=\"char\">15.389</td><td char=\".\" align=\"char\">0.000</td><td align=\"left\">Supported</td></tr><tr><td align=\"left\">Q7</td><td align=\"left\">Satisfaction with group membership</td><td char=\".\" align=\"char\">5.220</td><td char=\".\" align=\"char\">− 0.065</td><td char=\".\" align=\"char\">2.030</td><td char=\".\" align=\"char\">0.042</td><td align=\"left\">Supported</td></tr><tr><td align=\"left\">Q8</td><td align=\"left\">Satisfaction with personnel system (promotion system)</td><td char=\".\" align=\"char\">3.293</td><td char=\".\" align=\"char\">− 0.277</td><td char=\".\" align=\"char\">5.667</td><td char=\".\" align=\"char\">0.000</td><td align=\"left\">Supported</td></tr><tr><td align=\"left\">Q9</td><td align=\"left\">Satisfaction with individual development potential</td><td char=\".\" align=\"char\">3.616</td><td char=\".\" align=\"char\">− 0.377</td><td char=\".\" align=\"char\">7.840</td><td char=\".\" align=\"char\">0.000</td><td align=\"left\">Supported</td></tr><tr><td align=\"left\">Q10</td><td align=\"left\">Satisfaction with work’s social reputation</td><td char=\".\" align=\"char\">3.693</td><td char=\".\" align=\"char\">0.298</td><td char=\".\" align=\"char\">5.765</td><td char=\".\" align=\"char\">0.000</td><td align=\"left\">Not supported</td></tr><tr><td align=\"left\">Q11</td><td align=\"left\">Level of work matching level of education</td><td char=\".\" align=\"char\">2.984</td><td char=\".\" align=\"char\">− 0.255</td><td char=\".\" align=\"char\">3.251</td><td char=\".\" align=\"char\">0.001</td><td align=\"left\">Supported</td></tr><tr><td align=\"left\">Q12</td><td align=\"left\">Skill level of job matching level of skill</td><td char=\".\" align=\"char\">3.010</td><td char=\".\" align=\"char\">− 0.225</td><td char=\".\" align=\"char\">2.879</td><td char=\".\" align=\"char\">0.004</td><td align=\"left\">Supported</td></tr><tr><td align=\"left\">Q13</td><td align=\"left\">contents of work matching major</td><td char=\".\" align=\"char\">3.245</td><td char=\".\" align=\"char\">− 0.168</td><td char=\".\" align=\"char\">5.402</td><td char=\".\" align=\"char\">0.000</td><td align=\"left\">Supported</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Analysis result of prediction models.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Set</th><th align=\"left\">Classifications</th><th align=\"left\">Accuracy</th><th align=\"left\">Precision</th><th align=\"left\">Recall</th><th align=\"left\">F1-score</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"3\">Set 1</td><td align=\"left\">LR</td><td char=\".\" align=\"char\">0.788</td><td char=\".\" align=\"char\">0.806</td><td char=\".\" align=\"char\">0.951</td><td char=\".\" align=\"char\">0.873</td></tr><tr><td align=\"left\">KNN</td><td char=\".\" align=\"char\">0.769</td><td char=\".\" align=\"char\">0.808</td><td char=\".\" align=\"char\">0.915</td><td char=\".\" align=\"char\">0.858</td></tr><tr><td align=\"left\">XGB</td><td char=\".\" align=\"char\">0.785</td><td char=\".\" align=\"char\">0.811</td><td char=\".\" align=\"char\">0.936</td><td char=\".\" align=\"char\">0.869</td></tr><tr><td align=\"left\" rowspan=\"3\">Set 2</td><td align=\"left\">LR</td><td char=\".\" align=\"char\">0.770</td><td char=\".\" align=\"char\">0.782</td><td char=\".\" align=\"char\">0.958</td><td char=\".\" align=\"char\">0.861</td></tr><tr><td align=\"left\">KNN</td><td char=\".\" align=\"char\">0.748</td><td char=\".\" align=\"char\">0.779</td><td char=\".\" align=\"char\">0.921</td><td char=\".\" align=\"char\">0.844</td></tr><tr><td align=\"left\">XGB</td><td char=\".\" align=\"char\">0.772</td><td char=\".\" align=\"char\">0.789</td><td char=\".\" align=\"char\">0.945</td><td char=\".\" align=\"char\">0.860</td></tr><tr><td align=\"left\" rowspan=\"3\">Set 3</td><td align=\"left\">LR</td><td char=\".\" align=\"char\">0.800</td><td char=\".\" align=\"char\">0.817</td><td char=\".\" align=\"char\">0.957</td><td char=\".\" align=\"char\">0.881</td></tr><tr><td align=\"left\">KNN</td><td char=\".\" align=\"char\">0.778</td><td char=\".\" align=\"char\">0.819</td><td char=\".\" align=\"char\">0.917</td><td char=\".\" align=\"char\">0.865</td></tr><tr><td align=\"left\">XGB</td><td char=\".\" align=\"char\">0.802</td><td char=\".\" align=\"char\">0.828</td><td char=\".\" align=\"char\">0.940</td><td char=\".\" align=\"char\">0.880</td></tr><tr><td align=\"left\" rowspan=\"3\">Set 4</td><td align=\"left\">LR</td><td char=\".\" align=\"char\">0.776</td><td char=\".\" align=\"char\">0.787</td><td char=\".\" align=\"char\">0.958</td><td char=\".\" align=\"char\">0.864</td></tr><tr><td align=\"left\">KNN</td><td char=\".\" align=\"char\">0.752</td><td char=\".\" align=\"char\">0.789</td><td char=\".\" align=\"char\">0.916</td><td char=\".\" align=\"char\">0.848</td></tr><tr><td align=\"left\">XGB</td><td char=\".\" align=\"char\">0.781</td><td char=\".\" align=\"char\">0.796</td><td char=\".\" align=\"char\">0.946</td><td char=\".\" align=\"char\">0.865</td></tr><tr><td align=\"left\" rowspan=\"3\">Cross validation average</td><td align=\"left\">LR</td><td char=\".\" align=\"char\">0.783</td><td char=\".\" align=\"char\">0.798</td><td char=\".\" align=\"char\">0.956</td><td char=\".\" align=\"char\">0.870</td></tr><tr><td align=\"left\">KNN</td><td char=\".\" align=\"char\">0.761</td><td char=\".\" align=\"char\">0.798</td><td char=\".\" align=\"char\">0.915</td><td char=\".\" align=\"char\">0.853</td></tr><tr><td align=\"left\">XGB</td><td char=\".\" align=\"char\">0.785</td><td char=\".\" align=\"char\">0.806</td><td char=\".\" align=\"char\">0.942</td><td char=\".\" align=\"char\">0.869</td></tr></tbody></table></table-wrap>" ]
[ "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$In\\left(\\frac{\\pi }{1-\\pi }\\right)=\\upbeta 0+\\upbeta 1{\\text{X}}1+\\upbeta 2{\\text{X}}2+\\cdot \\cdot \\cdot +\\mathrm{\\beta pXp}$$\\end{document}</tex-math><mml:math id=\"M2\" display=\"block\"><mml:mrow><mml:mi>I</mml:mi><mml:mi>n</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mi>π</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>π</mml:mi></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>=</mml:mo><mml:mi mathvariant=\"normal\">β</mml:mi><mml:mn>0</mml:mn><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">β</mml:mi><mml:mn>1</mml:mn><mml:mtext>X</mml:mtext><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">β</mml:mi><mml:mn>2</mml:mn><mml:mtext>X</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo><mml:mo>·</mml:mo><mml:mo>·</mml:mo><mml:mo>·</mml:mo><mml:mo>+</mml:mo><mml:mrow><mml:mi>β</mml:mi><mml:mi mathvariant=\"normal\">pXp</mml:mi></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f\\left( {{\\text{A}},{\\text{B}}} \\right) = \\,\\,\\left| {{\\text{x}}1 - {\\text{x}}2} \\right| + \\left| {{\\text{y}}1 - {\\text{y}}2} \\right|$$\\end{document}</tex-math><mml:math id=\"M4\" display=\"block\"><mml:mrow><mml:mi>f</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtext>A</mml:mtext><mml:mo>,</mml:mo><mml:mtext>B</mml:mtext></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mfenced close=\"|\" open=\"|\"><mml:mrow><mml:mtext>x</mml:mtext><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mtext>x</mml:mtext><mml:mn>2</mml:mn></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=\"|\" open=\"|\"><mml:mrow><mml:mtext>y</mml:mtext><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mtext>y</mml:mtext><mml:mn>2</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\mathcal{L}}^{\\left(t\\right)}={\\sum }_{i=1}^{n} {l} (\\mathcal{Y}_{i},{\\widehat{\\mathcal{Y}}_{i}}^{\\left(t-1\\right)}+{f}_{t}({x}_{{i}}))+\\Omega ({f}_{t})$$\\end{document}</tex-math><mml:math id=\"M6\" display=\"block\"><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant=\"script\">L</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:msup><mml:mo>=</mml:mo><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msubsup><mml:mi>l</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi mathvariant=\"script\">Y</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msup><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi mathvariant=\"script\">Y</mml:mi><mml:mo stretchy=\"true\">^</mml:mo></mml:mover><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ4\"><label>4</label><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left({\\text{Accuracy}}\\right)= \\frac{TP+TN}{TP+FN+FP+TN}$$\\end{document}</tex-math><mml:math id=\"M8\" display=\"block\"><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mtext>Accuracy</mml:mtext></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ5\"><label>5</label><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left({\\text{Precision}}\\right)= \\frac{TP}{TP+FP}$$\\end{document}</tex-math><mml:math id=\"M10\" display=\"block\"><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mtext>Precision</mml:mtext></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant=\"italic\">TP</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ6\"><label>6</label><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left({\\text{Recall}}\\right)=\\frac{TP}{TP+FN}$$\\end{document}</tex-math><mml:math id=\"M12\" display=\"block\"><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mtext>Recall</mml:mtext></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant=\"italic\">TP</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ7\"><label>7</label><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left({\\text{F}}1-{\\text{score}}\\right)=2 \\times \\frac{1}{\\frac{1}{Precision} + \\frac{1}{Recall}} =2 \\times \\frac{Precision \\times Recall }{Precision+Recall}$$\\end{document}</tex-math><mml:math id=\"M14\" display=\"block\"><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mtext>F</mml:mtext><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mtext>score</mml:mtext></mml:mfenced><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant=\"italic\">Precision</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant=\"italic\">Recall</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mfrac><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mo>×</mml:mo><mml:mi>R</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mi>R</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[]
[ "<table-wrap-foot><p>R<sup>2</sup> 0.800.</p></table-wrap-foot>", "<table-wrap-foot><p><italic>LR</italic> logistic regression, <italic>KNN</italic> K-nearest neighbor classifier, <italic>XGB</italic> eXtreme gradient boosting.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2023_50593_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2023_50593_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2023_50593_Article_Equ1.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50593_Article_Equ2.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50593_Article_Equ3.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50593_Article_Equ4.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50593_Article_Equ5.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50593_Article_Equ6.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50593_Article_Equ7.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50593_Fig3_HTML\" id=\"MO3\"/>" ]
[]
[{"label": ["1."], "mixed-citation": ["Chung, D. B. Major factors affecting turnover intention of college graduates: Comparison and analysis according to regular workers. "], "italic": ["Q. J. Labor Policy"]}, {"label": ["2."], "mixed-citation": ["Ministry of Trade, Industry and Energy. A survey on the supply and demand trend of industrial technology personnel in industrial technology (2017)."]}, {"label": ["3."], "mixed-citation": ["Statistics Korea. The results of an additional survey of young people in the May 2018 economically active population survey (2018)."]}, {"label": ["4."], "surname": ["Lee", "Cho", "Song"], "given-names": ["EJ", "HS", "YS"], "article-title": ["An exploratory study on determinants predicting university graduate newcomers\u2019 early turn over"], "source": ["J. Corp. Educ. Talent Res."], "year": ["2020"], "volume": ["22"], "issue": ["1"], "fpage": ["163"], "lpage": ["193"], "pub-id": ["10.46260/KSLP.22.1.7"]}, {"label": ["5."], "surname": ["Light", "McGarry"], "given-names": ["A", "K"], "article-title": ["Job change patterns and the wages of young men"], "source": ["Rev. Econ. Stat."], "year": ["1998"], "volume": ["80"], "issue": ["2"], "fpage": ["276"], "lpage": ["286"], "pub-id": ["10.1162/003465398557519"]}, {"label": ["6."], "surname": ["Munasinghe", "Sigman"], "given-names": ["L", "K"], "article-title": ["A hobo syndrome? Mobility, wages, and job turnover"], "source": ["Labour Econ."], "year": ["2004"], "volume": ["11"], "issue": ["2"], "fpage": ["191"], "lpage": ["218"], "pub-id": ["10.1016/j.labeco.2003.05.001"]}, {"label": ["7."], "surname": ["Drory", "Shamir"], "given-names": ["A", "B"], "article-title": ["Effects of organizational and life variables on job satisfaction and burnout"], "source": ["Group Organ. Stud."], "year": ["1988"], "volume": ["13"], "issue": ["4"], "fpage": ["441"], "lpage": ["455"], "pub-id": ["10.1177/105960118801300403"]}, {"label": ["8."], "surname": ["Sousa-Poza", "Henneberger"], "given-names": ["A", "F"], "article-title": ["Analyzing job mobility with job turnover intentions: An international comparative study"], "source": ["J. Econ. Issues"], "year": ["2004"], "volume": ["38"], "issue": ["1"], "fpage": ["113"], "lpage": ["137"], "pub-id": ["10.1080/00213624.2004.11506667"]}, {"label": ["9."], "surname": ["Oh", "Lee", "Park"], "given-names": ["SS", "JW", "OW"], "article-title": ["Contagion effect of newcomer turnover on firm performance: Moderating effect of the strategic orientation of the HR function"], "source": ["J. Organ. Manag."], "year": ["2021"], "volume": ["45"], "issue": ["3"], "fpage": ["1"], "lpage": ["19"]}, {"label": ["10."], "surname": ["Mobley"], "given-names": ["WH"], "article-title": ["Some unanswered questions in turnover and withdrawal research"], "source": ["Acad. Manag. Rev."], "year": ["1982"], "volume": ["7"], "issue": ["1"], "fpage": ["111"], "lpage": ["116"], "pub-id": ["10.2307/257255"]}, {"label": ["11."], "surname": ["Lee", "Zheng", "Yeh", "Yu"], "given-names": ["CC", "YR", "WC", "Z"], "article-title": ["The influence of communication climate, organizational identification, and burnout on real estate agents\u2019 turnover intention"], "source": ["Hum. Soc. Sci. Commun."], "year": ["2023"], "volume": ["10"], "issue": ["1"], "fpage": ["1"], "lpage": ["14"]}, {"label": ["12."], "surname": ["Le", "Hancer", "Chaulagain", "Pham"], "given-names": ["LH", "M", "S", "P"], "article-title": ["Reducing hotel employee turnover intention by promoting pride in job and meaning of work: A cross-cultural perspective"], "source": ["Int. J. Hosp. Manag."], "year": ["2023"], "volume": ["109"], "fpage": ["103409"], "pub-id": ["10.1016/j.ijhm.2022.103409"]}, {"label": ["13."], "surname": ["Lu", "Guo", "Qu", "Lin", "Lev"], "given-names": ["J", "S", "J", "W", "B"], "article-title": ["\u201cStay\u201d or \u201cLeave\u201d: Influence of employee-oriented social responsibility on the turnover intention of new-generation employees"], "source": ["J. Bus. Res."], "year": ["2023"], "volume": ["161"], "fpage": ["113814"], "pub-id": ["10.1016/j.jbusres.2023.113814"]}, {"label": ["15."], "surname": ["Lee", "Kang"], "given-names": ["HY", "SH"], "article-title": ["Effect of motives for choosing small and medium business on occupational adaptation of college graduates: Focusing on the mediating effects of need fulfillment"], "source": ["J. Employ. Career (JEC)"], "year": ["2020"], "volume": ["10"], "issue": ["4"], "fpage": ["147"], "lpage": ["170"]}, {"label": ["16."], "surname": ["Meyer", "Allen"], "given-names": ["JP", "NJ"], "article-title": ["Testing the \"side-bet theory\" of organizational commitment: Some methodological considerations"], "source": ["J. Appl. Psychol."], "year": ["1984"], "volume": ["69"], "issue": ["3"], "fpage": ["372"], "pub-id": ["10.1037/0021-9010.69.3.372"]}, {"label": ["17."], "mixed-citation": ["Mehrabian, A. Silent messages (Vol. 8, No. 152, p. 30). Belmont, CA: Wadsworth (1971)."]}, {"label": ["18."], "surname": ["Mor Barak", "Nissly", "Levin"], "given-names": ["ME", "JA", "A"], "article-title": ["Antecedents to retention and turnover among child welfare, social work, and other human service employees: What can we learn from past research? A review and metanalysis"], "source": ["Soc. Serv. Rev."], "year": ["2001"], "volume": ["75"], "issue": ["4"], "fpage": ["625"], "lpage": ["661"], "pub-id": ["10.1086/323166"]}, {"label": ["19."], "surname": ["Smidts", "Pruyn", "Van Riel"], "given-names": ["A", "ATH", "CB"], "article-title": ["The impact of employee communication and perceived external prestige on organizational identification"], "source": ["Acad. Manag. J."], "year": ["2001"], "volume": ["44"], "issue": ["5"], "fpage": ["1051"], "lpage": ["1062"], "pub-id": ["10.2307/3069448"]}, {"label": ["20."], "surname": ["Memon", "Salleh", "Baharom"], "given-names": ["MA", "R", "MNR"], "article-title": ["Linking person-job fit, person-organization fit, employee engagement and turnover intention: A three-step conceptual model"], "source": ["Asian Soc. Sci."], "year": ["2015"], "volume": ["11"], "issue": ["2"], "fpage": ["313"]}, {"label": ["22."], "surname": ["Brown", "Peterson"], "given-names": ["SP", "RA"], "article-title": ["Antecedents and consequences of salespersonjob satisfaction: Meta-analysis and assessment of causal effects"], "source": ["J. Mark. Res."], "year": ["1993"], "volume": ["30"], "issue": ["1"], "fpage": ["63"], "lpage": ["77"], "pub-id": ["10.1177/002224379303000106"]}, {"label": ["23."], "mixed-citation": ["Alderfer, C. P. Existence, relatedness, and growth: Human needs in organizational settings (1972)."]}, {"label": ["24."], "surname": ["Rousseau"], "given-names": ["DM"], "article-title": ["Characteristics of departments, positions, and individuals: Contexts for attitudes and behavior"], "source": ["Admin. Sci. Q."], "year": ["1978"], "volume": ["1"], "fpage": ["521"], "lpage": ["540"], "pub-id": ["10.2307/2392578"]}, {"label": ["25."], "surname": ["Steel", "Ovalle"], "given-names": ["RP", "NK"], "article-title": ["A review and meta-analysis of research on the relationship between behavioral intentions and employee turnover"], "source": ["J. Appl. Psychol."], "year": ["1984"], "volume": ["69"], "issue": ["4"], "fpage": ["673"], "pub-id": ["10.1037/0021-9010.69.4.673"]}, {"label": ["26."], "surname": ["Thatcher", "Stepina", "Boyle"], "given-names": ["JB", "LP", "RJ"], "article-title": ["Turnover of information technology workers: Examining empirically the influence of attitudes, job characteristics, and external markets"], "source": ["J. Manag. Inf. Syst."], "year": ["2002"], "volume": ["19"], "issue": ["3"], "fpage": ["231"], "lpage": ["261"], "pub-id": ["10.1080/07421222.2002.11045736"]}, {"label": ["27."], "mixed-citation": ["Bigliardi, B., Petroni, A., & Dormio, A. I. Organizational socialization, career aspirations and turnover intentions among design engineers. "], "italic": ["Leadership Organ. Dev. J."]}, {"label": ["28."], "surname": ["Cotton", "Tuttle"], "given-names": ["JL", "JM"], "article-title": ["Employee turnover: A meta-analysis and review with implications for research"], "source": ["Acad. Manag. Rev."], "year": ["1986"], "volume": ["11"], "issue": ["1"], "fpage": ["55"], "lpage": ["70"], "pub-id": ["10.2307/258331"]}, {"label": ["30."], "surname": ["Saoula", "Fareed", "Ismail", "Husin", "Hamid"], "given-names": ["O", "M", "SA", "NS", "RA"], "article-title": ["A conceptualization of the effect of organisational justice on turnover intention: The mediating role of organisational citizenship behaviour"], "source": ["Int. J. Financ. Res."], "year": ["2019"], "volume": ["10"], "issue": ["5"], "fpage": ["327"], "lpage": ["337"], "pub-id": ["10.5430/ijfr.v10n5p327"]}, {"label": ["32."], "surname": ["Borg", "Scott-Young"], "given-names": ["J", "CM"], "article-title": ["Contributing factors to turnover intentions of early career project management professionals in construction"], "source": ["Constr. Manag. Econ."], "year": ["2022"], "volume": ["40"], "issue": ["10"], "fpage": ["835"], "lpage": ["853"], "pub-id": ["10.1080/01446193.2022.2110602"]}, {"label": ["33."], "surname": ["Saoula", "Johari", "Fareed"], "given-names": ["O", "H", "M"], "article-title": ["A conceptualization of the role of organisational learning culture and organisational citizenship behaviour in reducing turnover intention"], "source": ["J. Bus. Retail Manag. Res."], "year": ["2018"], "volume": ["12"], "issue": ["4"], "fpage": ["1"], "pub-id": ["10.24052/JBRMR/V12IS04/ART-13"]}, {"label": ["34."], "surname": ["Lam", "Lo", "Chan"], "given-names": ["T", "A", "J"], "article-title": ["New employees' turnover intentions and organizational commitment in the Hong Kong hotel industry"], "source": ["J. Hosp. Tour. Res."], "year": ["2002"], "volume": ["26"], "issue": ["3"], "fpage": ["217"], "lpage": ["234"], "pub-id": ["10.1177/1096348002026003002"]}, {"label": ["35."], "surname": ["Narayansany", "Isa"], "given-names": ["K", "RM"], "article-title": ["The relationships between onboarding program and newcomers' turnover intention: The role of organizational identification as mediator"], "source": ["J. Pengurusan"], "year": ["2021"], "volume": ["63"], "fpage": ["1"], "lpage": ["15"]}, {"label": ["36."], "surname": ["B\u00f6ckerman", "Ilmakunnas"], "given-names": ["P", "P"], "article-title": ["Job disamenities, job satisfaction, quit intentions, and actual separations: Putting the pieces together"], "source": ["Ind. Relat. J. Econ. Soc."], "year": ["2009"], "volume": ["48"], "issue": ["1"], "fpage": ["73"], "lpage": ["96"]}, {"label": ["37."], "mixed-citation": ["Deci, E. L., & Ryan, R. M. Intrinsic motivation and self-determination in human behaviour (Springer, 2013)."]}, {"label": ["38."], "surname": ["Reeve"], "given-names": ["J"], "source": ["Understanding motivation and emotion"], "year": ["2018"], "publisher-name": ["John Wiley & Sons"]}, {"label": ["39."], "surname": ["Campbell", "Pritchard"], "given-names": ["JP", "RD"], "article-title": ["Motivation theory in industrial and organizational psychology"], "source": ["Handb. Ind. Organ. Psychol."], "year": ["1976"], "volume": ["1"], "issue": ["63"], "fpage": ["V130"]}, {"label": ["41."], "surname": ["Kim"], "given-names": ["AY"], "article-title": ["Educational application of motivation theories and issues for future research: Focused on self-efficacy theory"], "source": ["Kor. J. Educ. Psychol."], "year": ["1998"], "volume": ["12"], "fpage": ["105"], "lpage": ["128"]}, {"label": ["42."], "surname": ["Kalleberg"], "given-names": ["AL"], "article-title": ["Work values and job rewards: A theory of job satisfaction"], "source": ["Am. Sociol. Rev."], "year": ["1977"], "volume": ["1"], "fpage": ["124"], "lpage": ["143"], "pub-id": ["10.2307/2117735"]}, {"label": ["43."], "surname": ["Guay", "Vallerand", "Blanchard"], "given-names": ["F", "RJ", "C"], "article-title": ["On the assessment of situational intrinsic and extrinsic motivation: The Situational Motivation Scale (SIMS)"], "source": ["Motiv. Emotion"], "year": ["2000"], "volume": ["24"], "issue": ["3"], "fpage": ["175"], "lpage": ["213"], "pub-id": ["10.1023/A:1005614228250"]}, {"label": ["44."], "surname": ["Kim", "Ko"], "given-names": ["KC", "JS"], "article-title": ["A study on the influence of hotel employees occupational choice motivation through the application of IPA on hotel recommend intentions"], "source": ["Korea Tour. Manag."], "year": ["2012"], "volume": ["16"], "issue": ["1"], "fpage": ["1"], "lpage": ["20"]}, {"label": ["45."], "surname": ["Kim", "Min", "Lee", "Park"], "given-names": ["SA", "KR", "S", "SM"], "article-title": ["Unveiling the relationship among job choice motivation, job satisfaction and turnover intention in the public and private sector: With a focus on a moderating role of person-job fit"], "source": ["Korea Public Admin. J."], "year": ["2013"], "volume": ["22"], "issue": ["3"], "fpage": ["271"], "lpage": ["314"]}, {"label": ["46."], "mixed-citation": ["Hoppock, R. Job satisfaction (1935)."]}, {"label": ["47."], "surname": ["Schneider"], "given-names": ["B"], "article-title": ["The people make the place"], "source": ["Person. Psychol."], "year": ["1987"], "volume": ["40"], "issue": ["3"], "fpage": ["437"], "lpage": ["453"], "pub-id": ["10.1111/j.1744-6570.1987.tb00609.x"]}, {"label": ["48."], "surname": ["Lauver", "Kristof-Brown"], "given-names": ["KJ", "A"], "article-title": ["Distinguishing between employees' perceptions of person\u2013job and person\u2013organization fit"], "source": ["J. Vocation. Behav."], "year": ["2001"], "volume": ["59"], "issue": ["3"], "fpage": ["454"], "lpage": ["470"], "pub-id": ["10.1006/jvbe.2001.1807"]}, {"label": ["49."], "mixed-citation": ["Hong. S. Y. A study on the determinants affecting event PD's Job Satisfaction\u2014Focused on Alderfer's ERG theory. Masters Thesis, Yensei University (2006)."]}, {"label": ["50."], "mixed-citation": ["Ji, S. H. The study of the flight attendants' ERG motivation, job crafting, core self-evaluation, turnover intention-based on the mediating effects of the positive psychological capital. Ph.D. Thesis, Dong-A University (2020)."]}, {"label": ["51."], "surname": ["Che", "Zhu", "Huang"], "given-names": ["Y", "J", "H"], "article-title": ["How does employee\u2013organization relationship affect work engagement and work well-being of knowledge-based employees?"], "source": ["Front. Psychol."], "year": ["2022"], "volume": ["13"], "fpage": ["1"], "pub-id": ["10.3389/fpsyg.2022.814324"]}, {"label": ["52."], "surname": ["O'Reilly", "Chatman", "Caldwell"], "given-names": ["CA", "J", "DF"], "suffix": ["III"], "article-title": ["People and organizational culture: A profile comparison approach to assessing person-organization fit"], "source": ["Acad. Manag. J."], "year": ["1991"], "volume": ["34"], "issue": ["3"], "fpage": ["487"], "lpage": ["516"], "pub-id": ["10.2307/256404"]}, {"label": ["54."], "surname": ["Guan", "Deng", "Bond", "Chen", "Chan"], "given-names": ["Y", "H", "MH", "SX", "CCH"], "article-title": ["Person\u2013job fit and work-related attitudes among Chinese employees: Need for cognitive closure as moderator"], "source": ["Basic Appl. Soc. Psychol."], "year": ["2010"], "volume": ["32"], "issue": ["3"], "fpage": ["250"], "lpage": ["260"], "pub-id": ["10.1080/01973533.2010.495664"]}, {"label": ["55."], "surname": ["Edwards"], "given-names": ["JR"], "source": ["Person-job fit: A conceptual integration, literature review, and methodological critique"], "year": ["1991"], "publisher-name": ["John Wiley & Sons"]}, {"label": ["56."], "surname": ["Kristof-Brown", "Zimmerman", "Johnson"], "given-names": ["AL", "RD", "EC"], "article-title": ["Consequences of individuals' fit at work: A meta-analysis of person\u2013job, person\u2013organization, person\u2013group, and person\u2013supervisor fit"], "source": ["Person. Psychol."], "year": ["2005"], "volume": ["58"], "issue": ["2"], "fpage": ["281"], "lpage": ["342"], "pub-id": ["10.1111/j.1744-6570.2005.00672.x"]}, {"label": ["57."], "surname": ["Kim"], "given-names": ["N"], "article-title": ["Employee turnover intention among newcomers in travel industry"], "source": ["Int. J. Tour. Res."], "year": ["2014"], "volume": ["16"], "issue": ["1"], "fpage": ["56"], "lpage": ["64"], "pub-id": ["10.1002/jtr.1898"]}, {"label": ["60."], "surname": ["Fuller"], "article-title": ["Common methods variance detection in business research"], "source": ["J. Bus. Res."], "year": ["2016"], "volume": ["69"], "fpage": ["3192"], "lpage": ["3198"], "pub-id": ["10.1016/j.jbusres.2015.12.008"]}, {"label": ["61."], "surname": ["Malhotra"], "article-title": ["Common method variance in advertising research: When to be concerned and how to control for it"], "source": ["J. Advert."], "year": ["2017"], "volume": ["46"], "fpage": ["193"], "lpage": ["212"], "pub-id": ["10.1080/00913367.2016.1252287"]}, {"label": ["62."], "surname": ["Tehseen"], "article-title": ["Testing and controlling for common method variance: A review of available methods"], "source": ["J. Manag. Sci."], "year": ["2017"], "volume": ["4"], "fpage": ["142"], "lpage": ["168"]}, {"label": ["63."], "surname": ["Spector"], "article-title": ["A new perspective on method variance: A measure-centric approach"], "source": ["J. Manag."], "year": ["2019"], "volume": ["45"], "fpage": ["855"], "lpage": ["880"]}, {"label": ["65."], "surname": ["Fornell", "Larcker"], "given-names": ["C", "DF"], "article-title": ["Evaluating structural equation models with unobservable variables and measurement error"], "source": ["J. Mark. Res."], "year": ["1981"], "volume": ["18"], "issue": ["1"], "fpage": ["39"], "lpage": ["50"], "pub-id": ["10.1177/002224378101800104"]}, {"label": ["66."], "mixed-citation": ["Seabold, S., & Perktold, J. Statsmodels: Econometric and statistical modeling with python. In "], "italic": ["Proceedings of the 9th Python in Science Conference"]}, {"label": ["67."], "mixed-citation": ["Leung, A. Factor analysis on determinants of stock price & returns with python OLS linear regression (2019)."]}, {"label": ["68."], "mixed-citation": ["Sargent, T. J., & Stachurski, J. Linear regression in python (2020)."]}, {"label": ["69."], "surname": ["Maity", "Bhagwat", "Bhatnagar"], "given-names": ["R", "PP", "A"], "article-title": ["Potential of support vector regression for prediction of monthly streamflow using endogenous property"], "source": ["Hydrol. Process. Int. J."], "year": ["2010"], "volume": ["24"], "issue": ["7"], "fpage": ["917"], "lpage": ["923"], "pub-id": ["10.1002/hyp.7535"]}, {"label": ["70."], "mixed-citation": ["Cutler, A., Cutler, D. R., & Stevens, J. R. Random forests. In "], "italic": ["Ensemble machine learning"]}, {"label": ["72."], "surname": ["Choubin", "Khalighi-Sigaroodi", "Malekian", "Ki\u015fi"], "given-names": ["B", "S", "A", "\u00d6"], "article-title": ["Multiple linear regression, multi-layer perceptron network and adaptive neuro-fuzzy inference system for forecasting precipitation based on large-scale climate signals"], "source": ["Hydrol. Sci. J."], "year": ["2016"], "volume": ["61"], "issue": ["6"], "fpage": ["1001"], "lpage": ["1009"], "pub-id": ["10.1080/02626667.2014.966721"]}, {"label": ["75."], "surname": ["Ahmed", "Li", "Qalati"], "given-names": ["N", "C", "SA"], "article-title": ["Impact of business incubators on sustainable entrepreneurship growth with mediation effect"], "source": ["Entrepreneurship Res. J."], "year": ["2020"], "volume": ["1"], "fpage": ["1"]}, {"label": ["76."], "surname": ["Wang", "Wang"], "given-names": ["Y", "T"], "article-title": ["Application of improved LightGBM model in blood glucose prediction"], "source": ["Appl. Sci."], "year": ["2020"], "volume": ["10"], "issue": ["9"], "fpage": ["3227"], "pub-id": ["10.3390/app10093227"]}, {"label": ["77."], "surname": ["Murphy"], "given-names": ["K"], "article-title": ["The social pillar of sustainable development: A literature review and framework for policy analysis"], "source": ["Sustain. Sci. Pract. Policy"], "year": ["2012"], "volume": ["8"], "issue": ["1"], "fpage": ["15"], "lpage": ["29"]}, {"label": ["78."], "surname": ["Ngai", "Hu", "Wong", "Chen", "Sun"], "given-names": ["EW", "Y", "YH", "Y", "X"], "article-title": ["The application of data mining techniques in financial fraud detection: A classification framework and an academic review of literature"], "source": ["Decis. Support Syst."], "year": ["2011"], "volume": ["50"], "issue": ["3"], "fpage": ["559"], "lpage": ["569"], "pub-id": ["10.1016/j.dss.2010.08.006"]}, {"label": ["79."], "surname": ["Varian"], "given-names": ["HR"], "article-title": ["Big data: New tricks for econometrics"], "source": ["J. Econ. Perspect."], "year": ["2014"], "volume": ["28"], "issue": ["2"], "fpage": ["3"], "lpage": ["28"], "pub-id": ["10.1257/jep.28.2.3"]}, {"label": ["80."], "surname": ["Altman"], "given-names": ["NS"], "article-title": ["An introduction to kernel and nearest-neighbor nonparametric regression"], "source": ["Am. Stat."], "year": ["1992"], "volume": ["46"], "issue": ["3"], "fpage": ["175"], "lpage": ["185"]}, {"label": ["81."], "mixed-citation": ["Chen, T., & Guestrin, C. Xgboost: A scalable tree boosting system. In "], "italic": ["Proceedings of the 22nd acm sigkdd international conference on knowledge discovery and data mining"]}, {"label": ["82."], "mixed-citation": ["Awoyemi, J. O., Adetunmbi, A. O., & Oluwadare, S. A. Credit card fraud detection using machine learning techniques: A comparative analysis. In "], "italic": ["2017 international conference on computing networking and informatics (ICCNI)"]}, {"label": ["86."], "surname": ["Abu Saa", "Al-Emran", "Shaalan"], "given-names": ["A", "M", "K"], "article-title": ["Factors affecting students\u2019 performance in higher education: A systematic review of predictive data mining techniques"], "source": ["Technol. Knowl. Learn."], "year": ["2019"], "volume": ["24"], "issue": ["4"], "fpage": ["567"], "lpage": ["598"], "pub-id": ["10.1007/s10758-019-09408-7"]}, {"label": ["87."], "surname": ["Wu", "Zhang", "Hu", "Sun-Woo", "Zhang", "Zhu", "Li"], "given-names": ["Y", "Q", "Y", "K", "X", "H", "S"], "article-title": ["Novel binary logistic regression model based on feature transformation of XGBoost for type 2 Diabetes Mellitus prediction in healthcare systems"], "source": ["Future Gen. Comput. Syst."], "year": ["2022"], "volume": ["129"], "fpage": ["1"], "lpage": ["12"], "pub-id": ["10.1016/j.future.2021.11.003"]}, {"label": ["88."], "surname": ["Price", "Mueller"], "given-names": ["JL", "CW"], "article-title": ["A causal model of turnover for nurses"], "source": ["Acad. Manag. J."], "year": ["1981"], "volume": ["24"], "issue": ["3"], "fpage": ["543"], "lpage": ["565"], "pub-id": ["10.2307/255574"]}, {"label": ["89."], "surname": ["Kang", "Lee"], "given-names": ["CH", "JH"], "article-title": ["A study of social workers\u2019 turnover intention: Analysis on organizational mobility and occupational mobility"], "source": ["Kor. J. Soc. Welf. Stud."], "year": ["2019"], "volume": ["50"], "issue": ["3"], "fpage": ["93"], "lpage": ["129"]}, {"label": ["90."], "surname": ["Pearce"], "given-names": ["D"], "article-title": ["Cost benefit analysis and environmental policy"], "source": ["Oxford Rev. Econ. Policy"], "year": ["1998"], "volume": ["14"], "issue": ["4"], "fpage": ["84"], "lpage": ["100"], "pub-id": ["10.1093/oxrep/14.4.84"]}, {"label": ["91."], "surname": ["Greenhalgh", "Rosenblatt"], "given-names": ["L", "Z"], "article-title": ["Job insecurity, toward conceptional clarity"], "source": ["Acad. Manag. Rev."], "year": ["1984"], "volume": ["9"], "issue": ["3"], "fpage": ["438"], "lpage": ["448"], "pub-id": ["10.2307/258284"]}, {"label": ["92."], "surname": ["Pfeffer"], "given-names": ["J"], "source": ["The human equation: Building profits by putting people first"], "year": ["1998"], "publisher-name": ["Harvard Business School Pr"]}, {"label": ["93."], "surname": ["King"], "given-names": ["J"], "article-title": ["White-collar reactions to job insecurity and the role of the psychological contract: Implications for human resource management"], "source": ["Hum. Resour. Manag."], "year": ["2000"], "volume": ["39"], "issue": ["1"], "fpage": ["79"], "lpage": ["92"], "pub-id": ["10.1002/(SICI)1099-050X(200021)39:1<79::AID-HRM7>3.0.CO;2-A"]}, {"label": ["94."], "mixed-citation": ["Joo. H. S. The relationship among work adjustment, pre-entry knowledge, post-employment expectation, proactivity, organizational socialization strategies, and social support at work of university graduate newcomers in large corporations. PhD thesis, Seoul National University (2014)."]}, {"label": ["95."], "surname": ["Shin", "Kim"], "given-names": ["SI", "SI"], "article-title": ["Effects of career identity and career barriers on career decision level: Focused on moderated mediation effect of outcome expectation"], "source": ["Korea J. Counseling"], "year": ["2013"], "volume": ["14"], "issue": ["5"], "fpage": ["2681"], "lpage": ["2697"], "pub-id": ["10.15703/kjc.14.5.201310.2681"]}, {"label": ["96."], "surname": ["Ryu", "Kim"], "given-names": ["KH", "JN"], "article-title": ["The effects of evaluative concerns perfectionism of the new employee on trait anxiety: The double mediating effects of maladaptive cognitive emotion regulation strategy and entrapment"], "source": ["Korean J. Health Psychol."], "year": ["2019"], "volume": ["24"], "issue": ["4"], "fpage": ["871"], "lpage": ["889"], "pub-id": ["10.17315/kjhp.2019.24.4.005"]}, {"label": ["97."], "surname": ["Porter", "Steers"], "given-names": ["LW", "RM"], "article-title": ["Organizational, work, and personal factors in employee turnover and absenteeism"], "source": ["Psychol. Bull."], "year": ["1973"], "volume": ["80"], "issue": ["2"], "fpage": ["151"], "pub-id": ["10.1037/h0034829"]}, {"label": ["98."], "surname": ["Jehn"], "given-names": ["KA"], "article-title": ["A multimethod examination of the benefits and detriments of intragroup conflict"], "source": ["Admin. Sci. Q."], "year": ["1995"], "volume": ["1"], "fpage": ["256"], "lpage": ["282"], "pub-id": ["10.2307/2393638"]}, {"label": ["99."], "surname": ["Pelled"], "given-names": ["LH"], "article-title": ["Demographic diversity, conflict, and work group outcomes: An intervening process theory"], "source": ["Organ. Sci."], "year": ["1996"], "volume": ["7"], "issue": ["6"], "fpage": ["615"], "lpage": ["631"], "pub-id": ["10.1287/orsc.7.6.615"]}, {"label": ["100."], "surname": ["De Dreu", "Beersma"], "given-names": ["CKW", "B"], "article-title": ["Conflict in organizations: Beyond effectiveness and performance"], "source": ["Eur. J. Work Organ. Psychol."], "year": ["2005"], "volume": ["14"], "issue": ["2"], "fpage": ["105"], "lpage": ["117"], "pub-id": ["10.1080/13594320444000227"]}, {"label": ["101."], "surname": ["Walton", "Dutton"], "given-names": ["RE", "J"], "article-title": ["The management of interdepartment conflict: A model and review"], "source": ["Admin. Sci. Q."], "year": ["1969"], "volume": ["14"], "fpage": ["73"], "lpage": ["84"], "pub-id": ["10.2307/2391364"]}, {"label": ["102."], "surname": ["Kopelman", "Greenhaus", "Connolly"], "given-names": ["RE", "JH", "TF"], "article-title": ["A model of work, family, and interrole conflict: A construct validation study"], "source": ["Organ. Behav. Hum. Perform."], "year": ["1983"], "volume": ["32"], "issue": ["2"], "fpage": ["198"], "lpage": ["215"], "pub-id": ["10.1016/0030-5073(83)90147-2"]}, {"label": ["103."], "surname": ["Yogev", "Brett"], "given-names": ["S", "J"], "article-title": ["Patterns of work and family involvement among single-and dual-earner couples"], "source": ["J. Appl. Psychol."], "year": ["1985"], "volume": ["70"], "issue": ["4"], "fpage": ["754"], "pub-id": ["10.1037/0021-9010.70.4.754"]}, {"label": ["104."], "surname": ["Wanous"], "given-names": ["JP"], "source": ["Organizational entry: Recruitment, selection and socialization of newcomers"], "year": ["1992"], "publisher-name": ["Addison Wesley"]}, {"label": ["105."], "surname": ["Becker"], "given-names": ["TE"], "article-title": ["Foci and bases of commitment: Are they distinctions worth making?"], "source": ["Acad. Manag. J."], "year": ["1992"], "volume": ["35"], "issue": ["1"], "fpage": ["232"], "lpage": ["244"], "pub-id": ["10.2307/256481"]}, {"label": ["106."], "surname": ["Kristof"], "given-names": ["AL"], "article-title": ["Person-organization fit: An integrative review of its conceptualizations, measurement, and implications"], "source": ["Person. Psychol."], "year": ["1996"], "volume": ["49"], "issue": ["1"], "fpage": ["1"], "lpage": ["49"], "pub-id": ["10.1111/j.1744-6570.1996.tb01790.x"]}, {"label": ["107."], "surname": ["Casado"], "given-names": ["MA"], "article-title": ["Students expectations of hospitality jobs"], "source": ["Cornell Hotel Restaur. Admin. Q."], "year": ["1992"], "volume": ["33"], "issue": ["4"], "fpage": ["80"], "lpage": ["82"], "pub-id": ["10.1177/001088049203300413"]}, {"label": ["108."], "surname": ["Pervin"], "given-names": ["LA"], "article-title": ["Performance and satisfaction as a function of individual-environment fit"], "source": ["Psychol. Bull."], "year": ["1968"], "volume": ["69"], "issue": ["1"], "fpage": ["56"], "pub-id": ["10.1037/h0025271"]}, {"label": ["109."], "surname": ["Moreland"], "given-names": ["J"], "article-title": ["Improving job fit can improve employee engagement and productivity"], "source": ["Employ. Relat. Today"], "year": ["2013"], "volume": ["40"], "issue": ["1"], "fpage": ["57"], "lpage": ["62"], "pub-id": ["10.1002/ert.21400"]}, {"label": ["110."], "surname": ["Vancouver", "Schmitt"], "given-names": ["JB", "NW"], "article-title": ["An exploratory examination of person-organization fit: Organizational goal congruence"], "source": ["Person. Psychol."], "year": ["1991"], "volume": ["44"], "issue": ["2"], "fpage": ["333"], "lpage": ["352"], "pub-id": ["10.1111/j.1744-6570.1991.tb00962.x"]}, {"label": ["111."], "mixed-citation": ["Lutrick, E. C., & Moriaty, K. O. Measuring perceived fit directly and indirectly: Does method matter? In "], "italic": ["Presented at the 17th Annual Conference of the Society for Industrial and Organizational Psychology, Toronto, Canada"]}, {"label": ["112."], "surname": ["Verquer", "Beehr", "Wagner"], "given-names": ["ML", "TA", "SH"], "article-title": ["A meta-analysis of relations between person\u2013organization fit and work attitudes"], "source": ["J. Vocation. Behav."], "year": ["2003"], "volume": ["63"], "issue": ["3"], "fpage": ["473"], "lpage": ["489"], "pub-id": ["10.1016/S0001-8791(02)00036-2"]}, {"label": ["113."], "mixed-citation": ["Holland, J. L. Making vocational choices (2nd.). Englewood Cliffs, NJ: Prentice-Hall (1985)."]}, {"label": ["114."], "mixed-citation": ["Miller, D. G. Effect of value-based training on job-esteem and hospitality value of front-line hotel employees unpublished. PhD dissertation of The University of Utah (1999)."]}, {"label": ["115."], "surname": ["Yoon", "Ko", "Chun", "Hong", "James"], "given-names": ["YS", "DW", "BG", "KW", "M"], "article-title": ["International comparison of perceived job-esteems for the tourism industry: Focus on comparison from Korean' and American' perspectives"], "source": ["J. Hosp. Tour. Stud."], "year": ["2008"], "volume": ["10"], "issue": ["2"], "fpage": ["317"], "lpage": ["331"]}, {"label": ["116."], "surname": ["Park", "Choi", "Yu", "Bae", "Ko", "Min"], "given-names": ["JK", "SJ", "HJ", "SH", "GY", "JS"], "article-title": ["A study on the types and Characteristics of youth employment based on their comparative job preferences"], "source": ["J. Career Educ. Res."], "year": ["2020"], "volume": ["33"], "issue": ["4"], "fpage": ["153"], "lpage": ["173"], "pub-id": ["10.32341/JCER.2020.12.33.4.153"]}, {"label": ["117."], "surname": ["Kim", "Lee"], "given-names": ["JH", "MH"], "article-title": ["Factors affecting the turnover intention of the new graduated nurses"], "source": ["J. Korea Acad. Ind. Cooper. Soc."], "year": ["2020"], "volume": ["21"], "issue": ["5"], "fpage": ["312"], "lpage": ["319"]}, {"label": ["118."], "mixed-citation": ["Yang, J. S. (2017). The change in the labor market for university graduates over the last decade. KRIVET Issue Brief 126."]}, {"label": ["119."], "surname": ["Jenkins"], "given-names": ["AK"], "article-title": ["Making a career of it? Hospitality students\u2019 future perspectives: An anglo-dutch study"], "source": ["Int. J. Contemp. Hosp. Manag."], "year": ["2001"], "volume": ["13"], "issue": ["1"], "fpage": ["13"], "lpage": ["20"], "pub-id": ["10.1108/09596110110365599"]}, {"label": ["120."], "surname": ["Omahony", "McWilliams", "Whitelaw"], "given-names": ["GB", "AM", "PA"], "article-title": ["Why students choose a hospitality-degree program"], "source": ["Cornell Hotel Rest. Admin. Q."], "year": ["2001"], "volume": ["42"], "issue": ["1"], "fpage": ["92"], "lpage": ["96"], "pub-id": ["10.1177/0010880401421011"]}, {"label": ["121."], "surname": ["Dunham", "Grube", "Castaneda"], "given-names": ["RB", "JA", "MB"], "article-title": ["Organizational commitment: Utility of an integrative definition"], "source": ["J. Appl. Psychol."], "year": ["1994"], "volume": ["79"], "issue": ["3"], "fpage": ["370"], "lpage": ["380"], "pub-id": ["10.1037/0021-9010.79.3.370"]}, {"label": ["122."], "surname": ["Stets", "Burke"], "given-names": ["JE", "PJ"], "article-title": ["Identity theory and social identity theory"], "source": ["Soc. Psychol. Q."], "year": ["2000"], "volume": ["63"], "issue": ["3"], "fpage": ["224"], "lpage": ["237"], "pub-id": ["10.2307/2695870"]}]
{ "acronym": [], "definition": [] }
122
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1221
oa_package/5c/bb/PMC10786846.tar.gz
PMC10786847
38216567
[ "<title>Introduction</title>", "<p id=\"Par2\">Humans use their hands daily to interact with the environment and control several arm muscle movements<sup>##REF##31296554##1##</sup>. The control of human muscle movements is achieved through the cooperation of the nervous system, such as the spinal cord, cerebellum, and primary motor cortex<sup>##REF##12612022##2##</sup>. The interaction between motor mechanisms created by the cooperation of these neural systems and sensory mechanisms related to the explorative function of the fingers enables the performance of refined motor behaviors, such as grasping an object<sup>##REF##6705863##3##</sup>. Humans use power grip motions, which is a form of grasping ball or cylindrical shaped objects, and pinch grip motions, which is a form of gripping with only the thumb and index finger, to hold objects and perform tasks according to their size, shape, and progress through the object<sup>##REF##17694874##4##,##UREF##0##5##</sup>. Among these, the power grip force, which is the force produced by a person’s power grip, is a dominant parameter representing the ability of the human neuromuscular system<sup>##REF##8350134##6##–##REF##31913322##9##</sup>. So, power grip force is widely used in bioengineering research and rehabilitation fields. Previous studies have shown that the ability of the neuromuscular system to generate maximum power grip force declines with age. These studies have compared the differences in ability between the general population and stroke patients<sup>##REF##8350134##6##,##REF##15753069##8##,##UREF##1##10##,##REF##22781814##11##</sup>. In addition, in the isometric contraction position, where the joint angle and muscle length do not change during muscle contraction, the task of maintaining power grip force is performed by the activity of the primary motor cortex<sup>##REF##12612022##2##,##REF##9212286##12##,##REF##10497133##13##</sup>. However, according to previous studies, even if the same power grip task is performed, the primary motor cortex area and degree of activation within the brain differ depending on the visual feedback showing the current state or magnitude of the force, and external force<sup>##REF##11395017##14##–##REF##18378494##17##</sup>. The findings of these studies imply that each condition’s primarily used motor sensory function differs<sup>##REF##8670662##18##,##UREF##2##19##</sup>. In other words, even if the same power grip task is given, each goal is accomplished using a different control strategy depending on the given conditions.</p>", "<p id=\"Par3\">The goal of the current study was therefore to find the parameters that affect the power grip task more dominantly. To this end, we assumed that even if participant proceeds with the same power maintenance task, setting the visual feedback, target power grip force and external disturbance would lead to different results. For this purpose, data normalization was performed, and the target power grip force was expressed as the Maximal Voluntary Contraction (MVC), which is the maximal force-generating capacity of a muscle or a group of muscles in humans<sup>##REF##33414495##20##</sup>.</p>", "<p id=\"Par4\">This study investigated a force maintenance control strategy to maintain power grip force under various conditions in an isometric contraction posture. Experiments were conducted on 25 participants under conditions for providing visual feedback (VFB), the magnitude of the Maximal Voluntary Contraction (target MVC) to be maintained, and external disturbance conditions (Disturbance Level) to study human power maintenance control ability. The MVC error was calculated for each condition. Statistically, significant differences were observed when analyzing the sensory feedback and control strategies used by humans to maintain a constant power grip force.</p>", "<p id=\"Par5\">Before experiment, we predicted that the MVC error would be large when no visual feedback was provided, when the target MVC was large, and when external disturbances were present. The first reason for making that prediction was because people perform many activities through visual feedback throughout their lives, so we thought that it would be difficult to maintain MVC if visual feedback disappeared. Second, when a person produces a relatively large force, more energy is needed than when a person produces a relatively small force, so more energy is needed to maintain and control it. Therefore, we thought that it would be difficult to maintain MVC. Also, when the environment changes, people spend a lot of time and energy adapting to it, but when a disturbance occurs, more energy is spent adapting to the variable, so we thought that it would be difficult to maintain MVC as a result. Based on these predictions, we developed seven two-tailed null hypotheses: (1) The visual feedback significantly did not affect MVC error, (2) the target MVC significantly did not affect MVC error, (3) the disturbance level significantly did not affect MVC error, (4) the interaction between the visual feedback and the target MVC significantly did not affect MVC error, (5) the interaction between the visual feedback and the disturbance level significantly did not affect MVC error, (6) the interaction between the target MVC and the disturbance level significantly did not affect MVC error, and (7) the interaction between the visual feedback, the target MVC and the disturbance level significantly did not affect MVC error. An evaluation experiment for the participants is shown in Fig. ##FIG##0##1##.</p>" ]
[ "<title>Materials and methods</title>", "<title>Participant</title>", "<p id=\"Par25\">An experiment was conducted on 25 right-handed university students aged years who did not have disabilities in the upper limb movement. We explained the experimental plan and purpose to all participants in advance. Informed consent is obtained from all participants, and we conducted the experiment in compliance with appropriate regulations and guidelines. The experiment was conducted with approval from the Handong Global University Institutional Review Board (protocol code: 2022-HGUA009; date of approval: 08 June 2022).</p>", "<title>Experimental system</title>", "<p id=\"Par26\">The participants were instructed to make a power grip by making a fist with their left hand and to perform an isometric contraction task while maintaining the power grip force at a constant magnitude. Based on the fact that the muscles that move the fingers are inside the forearm muscles, the surface electromyogram (sEMG) of the forearm muscles was measured, and the sEMG signal was then converted into the MVC percentage of the power grip force<sup>##REF##31913322##9##,##REF##12775491##27##–##REF##20719654##29##</sup>. An armband (Myo, Thalmic Labs) that measures sEMG signals was worn on the forearm muscle area located 2 cm from the left elbow to the wrist, and an air-pocket glove (HiiiiiFive, HiiiiiFive®) that provided external disturbance to the fingers was worn on the left hand<sup>##UREF##7##30##–##UREF##9##32##</sup>. During the experiment, the magnitude of the participant’s MVC was provided as a bar graph on the monitor to be checked in real-time<sup>##REF##14724214##33##</sup>.</p>", "<title>Experimental design</title>", "<p id=\"Par27\">As mentioned in previous studies, people achieve their goals with different control strategies depending on visual feedback, target MVC, and external disturbances; therefore, the experiment was conducted under three conditions<sup>##REF##18316207##15##–##REF##18378494##17##</sup>. Under these three conditions, the core goal of the experiment was to give participants a task to maintain MVC and to determine the control strategies they use to reduce MVC errors that occur during the task.</p>", "<p id=\"Par28\">First, the task cases were divided according to the presence or absence of visual feedback and the target MVC (Table ##TAB##0##1##). When visual feedback was provided, the participant was allowed to maintain the feedback while viewing it in real-time. When visual feedback was not provided, the participant maintained the target MVC. If the participants maintained the target MVC well through visual feedback, they were instructed to continue maintaining it with the visual feedback removed.</p>", "<p id=\"Par29\">Additionally, each case was classified according to when the external disturbance was applied. In other words, each case was divided into Disturbance Level A when the disturbance was not applied, Disturbance Level B when the internal pressure of the air-pocket glove was linearly increased by 0.085 bar per second, and Disturbance Level C when the internal pressure of the air-pocket glove was maximized (Fig. ##FIG##3##4##). The disturbance conditions were always fixed in the order of disturbances A, B, and C, and disturbance levels A, B, and C lasted 5, 10, and 3 s, respectively. The participants experimented three times for each case, and a 2-min break was provided for each experimental trial. In addition, prior practice time was provided to maintain the MVC sufficiently before the experiment so that the participants could familiarize themselves with the system.</p>", "<title>Data processing</title>", "<p id=\"Par30\">We measured the sEMG in all directions of the forearm muscle using armbands and added it to express it as MVC for data normalization. Before that, the noise of the sEMG signal was signal-dependent and increased linearly with the absolute value of the signal<sup>##REF##9723616##34##</sup>. A quasi-tension filter, a type of 2nd low-pass filter, was used to remove high-frequency noise from the sEMG signals of the participant<sup>##REF##9723616##34##,##REF##16243341##35##</sup>. The transfer function of the quasi-tension filter used in the experiment is expressed by Eq. (##FORMU##18##1##).</p>", "<p id=\"Par31\">The mean absolute error (MAE) was used to convert the sEMG signal into the MVC percentage during filtering<sup>##UREF##10##36##,##REF##24048337##37##</sup>. After setting the sEMG values when the participant applied maximum force in the isometric contraction posture and when the participant did not apply any force at all to reference values of 100% and 0%, respectively, the participant’s sEMG signal was represented by the MVC of the participant in real-time using the MAE (Eq. ##FORMU##19##2## and Fig. ##FIG##3##4##A).</p>", "<p id=\"Par32\">Figure ##FIG##3##4##A shows that armband sensor noise and muscle noise were mixed in the participant’s MVC signal. The MVC signal’s power spectral density (PSD) was calculated using Welch’s method with a positive FFT to determine the appropriate cut-off frequency of the low-pass filter<sup>##UREF##11##38##</sup>. Welch’s method divides data in a long-time area into sections and averages the PSDs obtained by the Fourier Transformation (FT) of the data in each section. PSD bias occurs because the length of the FT signal is shortened, and the frequency resolution decreases. However, the averaging operation removes randomness to reduce the PSD deviation<sup>##UREF##12##39##,##UREF##13##40##</sup>. Welch’s method was used to remove sensor and muscle noise from the PSD and to emphasize the components containing the participant’s movement intention. The window size used in Welch’s method was approximately 10 s, half the signal length. The FT was performed by moving a 10-s window at 1-s intervals, and the resulting PSD was averaged.</p>", "<p id=\"Par33\">Considering all the participant data, 95% of the power was concentrated below 2.6996 Hz on average. This finding proves that the effective cut-off frequency of the muscle is approximately 2–3 Hz and can be said to be a very physiologically valid value<sup>##UREF##0##5##</sup>. A third-order Butterworth filter was selected with a cut-off frequency of 6 Hz, which is more than twice that of the filter that was implemented using the filtfilt function of the MATLAB R2021b (The MathWorks, Inc.) library to preserve the original signal by the Nyquist theorem, (Fig. ##FIG##3##4##B). The MVC signal of the participant was filtered using the corresponding filter, and the MVC error was calculated based on the difference from the target MVC. In addition, the average and variance of the participants’ MVC errors were calculated for each condition (Fig. ##FIG##4##5##).</p>", "<p id=\"Par34\">We studied the parameters predominantly involved in MVC maintenance in humans. We calculated the participants’ MVC errors quantitatively for each condition and analyzed the errors using a three-way repeated-measures ANOVA test for visual feedback (with two levels: i.e., providing visual feedback, VFB On; not providing visual feedback, VFB Off), target MVC (with two levels: 20% and 50%), and external disturbance (with three levels: external disturbance = 0, Disturbance Level A increasing external disturbance, Disturbance Level B; maximum external disturbance, Disturbance Level C) factors. Statistical analyses were performed using the IBM SPSS Statistics version 26 (IBM Corp.).</p>" ]
[ "<title>Results</title>", "<p id=\"Par6\">As a result of statistical analysis, it was confirmed that the target MVC ( partial , item A in Table ##SUPPL##0##S1##), the Disturbance Level ( partial , item A in Table ##SUPPL##0##S1##), the interaction between the visual feedback and the target MVC ( partial , item A in Table ##SUPPL##0##S1##), the interaction between the visual feedback, the target MVC, and the Disturbance Level ( partial , item A in Table ##SUPPL##0##S1##) significantly affected the MVC error. Through the results, we confirmed that among the seven null hypotheses, only the first, fifth, and sixth null hypotheses satisfy the hypothesis.</p>", "<p id=\"Par7\">Figure ##FIG##1##2## shows the statistical results of comparing MVC errors according to visual feedback, target MVC, and Disturbance Level. We can see from Fig. ##FIG##1##2##A that there is no statistically significant difference in MVC error between the case that provided visual feedback to the participant and the case that did not provide visual feedback (item B in Table ##SUPPL##0##S1##). In other words, visual feedback did not significantly help the participant maintain the target MVC.</p>", "<p id=\"Par8\">Figure ##FIG##1##2##B shows that the MVC error differs significantly depending on the target MVC (item C in Table ##SUPPL##0##S1##). When the target MVC is 20% , the error is smaller compared to when it is 50% , indicating that it is easy for the participant to maintain the MVC if the target MVC is small. This finding aligns with previous studies proving that when the target MVC is increased, the magnitude of the MVC that the participant’s muscles must produce increases, and the noise of the muscles increases, resulting in a greater error<sup>##REF##15014922##21##</sup>.</p>", "<p id=\"Par9\">In addition, Fig. ##FIG##1##2##C shows that the MVC errors in Disturbance Level A and Disturbance Level C , in which the muscle lengths are stationary, do not differ significantly. Also, in Disturbance Level B , where the muscle length changes because of external disturbances, the MVC error differs significantly from other Disturbance Levels (item D in Table ##SUPPL##0##S1##). In other words, when the participant’s muscle length increased and the joint moved because of external disturbances, there was a difference in the ability to maintain the MVC.</p>", "<p id=\"Par10\">Figure ##FIG##2##3##A presents the statistical results of comparing the MVC errors for the conditions in which the visual feedback and the target MVC interacted. First, through Fig. ##FIG##1##2##A, we confirmed that visual feedback does not help significantly in maintaining the MVC. Figure ##FIG##2##3##B confirms that the MVC error increases when the target MVC increases. However, Fig. ##FIG##2##3##A shows that when visual feedback was not provided, the magnitude of the MVC error, which increased with increasing target MVC, was much larger than when visual feedback was provided.</p>", "<p id=\"Par11\">Figure ##FIG##2##3##B–D presents the statistical results of comparing MVC errors for the conditions in which the visual feedback, target MVC, and external disturbances interacted. Thus, it can be confirmed that the results illustrated in Fig. ##FIG##2##3##A are not similarly applied to all Disturbance Levels but only to Disturbance Levels B and C, where an external disturbance exists. In contrast, at Disturbance Level A, external disturbance exists. The magnitude of the increasing error is similar when the target MVC increases from 20 to 50%, regardless of the visual feedback.</p>", "<p id=\"Par12\">Additionally, although the subjects looked at the actual value of MVC error and controlled to reduce it, we conducted a three-way repeated measures ANOVA test on the absolute MVC error for each condition (S2 Table). What is noteworthy in that results is that the visual feedback ( partial , item A in S2 Table) significantly affected the absolute MVC error.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par13\">In this study, we analyzed MVC maintenance control strategies in humans using MVC maintenance experiments. Evaluation experiments were conducted under visual feedback, target MVC, and external disturbance conditions. Based on the experimental results, the following sections will be discovered: (1) Human MVC maintenance ability and the offset effect of visual feedback that complements the limitations of that ability, (2) analyzing human MVC maintenance control strategies, and (3) applications and future work.</p>", "<title>Human MVC maintenance ability and the offset effect of visual feedback complement the limitations of that ability</title>", "<p id=\"Par14\">This experiment confirmed that visual feedback does not significantly help participants maintain their MVC bias (Fig. ##FIG##1##2##A). However, as a result of the experimental data for each condition, the overall error did not deviate significantly, and most errors were close to zero. In other words, there is a dominant parameter that helps participants maintain their MVC. There were two types of feedback available to the participants in this experiment: visual feedback provided by the evaluation system and proprioception feedback the participants provided by themselves. However, because visual feedback does not significantly help maintain MVC, the participants’ MVC maintenance control ability-based proprioception helps them maintain MVC bias properly<sup>##REF##31296554##1##,##REF##19352402##22##</sup>. In other words, sufficient maintenance effects can be achieved using human MVC maintenance capabilities without additional visual feedback. These findings confirm the results of previous studies that the human body does not use the senses more than necessary to control them efficiently without consuming energy<sup>##REF##19403815##23##</sup>.</p>", "<p id=\"Par15\">However, as the target MVC increases, the MVC error increases, confirming that the human MVC maintenance ability is limited according to the target MVC (Fig. ##FIG##1##2##B)<sup>##REF##31296554##1##</sup>. We found that this helps to reduce the MVC error under conditions in which visual feedback and target MVC interact to compensate for this limitation (Fig. ##FIG##2##3##A). Although visual feedback does not help maintain the MVC, we find the ‘offset effect’ that compensates for the limitations of the MVC maintenance ability, increasing the MVC error as the target MVC increases. However, only Disturbance Levels B and C with external disturbances showed an offset effect (Fig. ##FIG##2##3##C–D). In contrast, Disturbance Level A without external disturbances did not show an offset effect (Fig. ##FIG##2##3##B). In other words, visual feedback can obtain an offset effect that reduces the increase in error if an external disturbance and interaction are applied with a large force.</p>", "<p id=\"Par16\">On the other hand, we performed statistical analysis on the absolute value of MVC error in the same way. The results of statistical analysis showed that visual feedback does not reduce the bias of MVC error but has an effect on reducing variation. In this study, only the signed MVC error was shown to the subjects and the experiment was conducted using this as a factor. However, if we design and analyze an experiment with absolute MVC error as a factor, it is believed that we will be able to find out more about people’s MVC maintenance strategies.</p>", "<title>Analyzing human MVC maintenance control strategies</title>", "<p id=\"Par17\">From the results of this experiment, we confirmed that there is a difference in MVC maintenance when an external disturbance moves the finger joint and that the length of the muscle that moves the finger joint changes. The MVC errors were not statistically significant at disturbance levels A and C, where the muscle length was stationary. At Disturbance Level B, where the muscle length changed, the MVC errors differed significantly from the other Disturbance Levels (Fig. ##FIG##1##2##C).</p>", "<p id=\"Par18\">An external disturbance was generated from disturbances A to B, and as the magnitude increased, the muscle length increased. As a result, the MVC error increases, and the offset effect provided by the visual feedback acts. However, the statistical difference in MVC errors between Disturbance Levels A and B indicated that the participants did not fully obtain the offset effect through visual feedback at Disturbance Level B. In other words, the offset effect was not applied simultaneously with the external disturbance. However, the offset effect compensates for the increase in MVC error when it reaches a certain threshold level. Although the visual feedback provides an offset effect, the effect is not expressed from the beginning of Disturbance Level B. Therefore, it is reasonable that the MVC errors at Disturbance Levels A and B are statistically significant.</p>", "<p id=\"Par19\">The muscle length was maximized and maintained from Disturbance Levels B to C. Because Disturbance Level C has different muscle lengths from Disturbance Levels A and B, the MVC error should also differ significantly from the errors in Disturbance Levels A and B. However, it can be interpreted that the offset effect was sufficiently expressed, and the error changed, as shown in Disturbance Level A. That is, although the error in Disturbance Level B is closer to zero than those in Disturbance Levels A and C, the offset effect changes the error in Disturbance Level C to one similar to that in Disturbance Level A, indicating that maintaining a constant MVC difference of bias is a much smoother maintenance strategy used by humans than trying to accurately zero when an external disturbance is applied.</p>", "<p id=\"Par20\">Through this study, it was revealed that there are a total of three strategies for controlling humans to maintain MVC according to external disturbance. First, human controls generally maintain MVC using their inherent MVC maintenance ability. Secondly, as the magnitude of the target MVC to be maintained increases, it becomes relatively difficult to maintain the MVC, and the MVC error increases. Third, if the MVC error increases and reaches a certain level, the offset effect is expressed through visual feedback, which helps to reduce the MVC error and maintain it smoothly.</p>", "<title>Applications and future work</title>", "<p id=\"Par21\">This study investigated strategies for controlling humans to maintain the MVC according to external disturbances. The results of this study can be applied to tasks that maintain MVC. They can be used effectively in the fields of rehabilitation and robot collaboration.</p>", "<p id=\"Par22\">In previous studies, the power grip force during an isometric contraction task was used as an indicator of the neuromuscular ability of stroke patients. As a result of this study, the interaction between visual feedback and target MVC was found to affect the maintenance of the MVC<sup>##REF##8350134##6##,##REF##15753069##8##,##UREF##1##10##,##REF##22781814##11##</sup>. Therefore, when rehabilitation is performed with isometric contractions, it will have a greater effect if performed while visually showing the magnitude of a patient’s strength.</p>", "<p id=\"Par23\">In addition, they can be applied to collaborative fields, such as humans and robots, by applying force to each other and lifting and transporting objects together. In most existing environments where humans and robots collaborate, collaborations are carried out by providing the location and speed of robots working together with people. However, it can be much more helpful if it provides a human with a robot’s position and a speed indicator and visually provides the magnitude of its force as a new indicator.</p>", "<p id=\"Par24\">In this study, an external disturbance was applied to the participant by placing air in an air-pocket glove, and the person’s control strategies to maintain the MVC according to the external disturbance were studied. In previous studies applying external forces to humans, the quantitative external force value was measured, and the studies were conducted<sup>##UREF##3##24##,##UREF##4##25##</sup>. However, in this study, the magnitude of the external disturbance caused by the air-pocket glove was not calculated quantitatively. Additionally, the magnitude of the participant’s force was expressed as an MVC percentage and not as an absolute value. In future work, other quantitative results will be obtained if the experiment is conducted by measuring the magnitude of the external force and the participant’s force, which can be obtained to support Hill’s muscle model, which represents the length and force of the muscles as spring and contractile components<sup>##UREF##5##26##</sup>.</p>" ]
[]
[ "<p id=\"Par1\">Power grip force is used as a representative indicator of the ability of the human neuromuscular system. However, people maintain the power grip force via different control strategies depending on the visual feedback that shows the magnitude of the force, the magnitude of the target grip force, and external disturbance. In this study, we investigated the control strategy of maintaining the power grip force in an isometric contraction depending on these conditions by expressing the power grip force as a person’s Maximal Voluntary Contraction (MVC). The participants were asked to maintain the MVC for each condition. Experimental results showed that humans typically control their MVC constant abilities based on proprioception, and maintaining the target MVC becomes relatively difficult as the magnitude of the target MVC increases. In addition, through interactions between the external disturbance and the target MVC, the MVC error increases when the target MVC increases and an external disturbance is applied. When the MVC error reaches a certain level, the offset effect is expressed through visual feedback, helping to reduce the MVC error and maintain it smoothly, revealing a person’s MVC maintenance control strategy for each condition.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-023-51096-y.</p>", "<title>Acknowledgements</title>", "<p>This study was supported by the Translational R&amp;D Program on Smart Rehabilitation</p>", "<p>Exercises (#TRSRE-MD02), National Rehabilitation Center, Ministry of Health and Welfare, Korea, and the National Research Foundation, Korea, under project BK21 FOUR (No.5199990314060).</p>", "<title>Author contributions</title>", "<p>J.Y. conceived, designed the experiments, performed the experiments, analyzed the data, and wrote the manuscript. W.C. conceived, designed the experiments, and supervised the work. J.K. conceived, designed the experiments, funded, and supervised the work.</p>", "<title>Data availability</title>", "<p>Data are fully available through the corresponding author upon reasonable request.</p>", "<title>Competing interests</title>", "<p id=\"Par35\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Experimental overview<italic>.</italic> (<bold>A</bold>) Participants are made to wear an armband and an air-pocket glove. As shown in Table ##TAB##0##1##, we divided the experimental task cases into four cases according to the conditions given to the participants. In the case of C1 and C3, which provide visual feedback, participants can check their MVC in real-time through the monitor. In addition, by putting air into the air-pocket glove worn by the participant to open the hand, we provided an external disturbance that hinders the isometric contraction task maintained in the power grip posture. (<bold>B</bold>) A block diagram showing the MVC maintenance mechanism. Participants use a proprioception model to main the target MVC. At this time, an external disturbance is applied to the participant, and the participant uses visual feedback to match the Participant’s MVC as much as possible with the target MVC.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Comparison of the average MVC error for each condition. (<bold>A</bold>) Comparison graph of average MVC error according to presence or absence of visual feedback (<italic>p</italic> value = 0.666). (<bold>B</bold>) Comparison graph of average MVC error according to the target MVC (<italic>p</italic> value = 0.000). (<bold>C</bold>) Comparison graph of average MVC error according to External Disturbances (<italic>p</italic> value between Disturbance Level A and B = 0.000, <italic>p</italic> value between Disturbance Level A and C = 0.796, <italic>p</italic> value between Disturbance Level B and C = 0.000).</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Average MVC error graph according to the interaction of each condition. (<bold>A</bold>) MVC error graph according to the interaction between visual feedback and the target MVC (<italic>p</italic> value = 0.001). (<bold>B</bold>) MVC error graph according to the interaction between visual feedback, the target MVC, and the External Disturbance in Disturbance Level A (<italic>p </italic>value = 0.001). (<bold>C</bold>) MVC error graph according to the interaction between visual feedback, the target MVC, and the External Disturbance in Disturbance Level B (<italic>p</italic> value = 0.001). (<bold>D</bold>) MVC error graph according to the interaction between visual feedback, the target MVC, and the External Disturbance in Disturbance Level C (<italic>p</italic> value = 0.001).</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>MVC error graph at the C1 task of representative participants. It is divided into Disturbance Level A sections where no external disturbance is applied, Disturbance Level B sections where a gradually increasing external disturbance is applied, and Disturbance Level C sections where the external disturbance is maximum. (<bold>A</bold>) MVC raw data before filtering. (<bold>B</bold>) MVC filtered data after filtering. It can be confirmed that the sensor and muscle noise are greatly improved using the 3rd Butterworth filter.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>The bar and error bar graphs show the average MVC error and variance of the representative participants for each condition. The bar graph shows the average of each MVC error, and the error bar graph shows the variance of each MVC error.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Task cases of participants according to conditions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Case</th><th align=\"left\">Visual feedback</th><th align=\"left\">Target MVC (%)</th></tr></thead><tbody><tr><td align=\"left\">C1</td><td align=\"left\"><italic>On</italic></td><td align=\"left\">20</td></tr><tr><td align=\"left\">C2</td><td align=\"left\"><italic>Off</italic></td><td align=\"left\">20</td></tr><tr><td align=\"left\">C3</td><td align=\"left\"><italic>On</italic></td><td align=\"left\">50</td></tr><tr><td align=\"left\">C4</td><td align=\"left\"><italic>Off</italic></td><td align=\"left\">50</td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F \\left(1, 24\\right)=51.492, p=0.000,$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mrow><mml:mi>F</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>24</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mn>51.492</mml:mn><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.000</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\eta }^{2}=0.682$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mrow><mml:msup><mml:mrow><mml:mi>η</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:mn>0.682</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F \\left(1.582, 37.958\\right)=25.203, p=0.000,$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mrow><mml:mi>F</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1.582</mml:mn><mml:mo>,</mml:mo><mml:mn>37.958</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mn>25.203</mml:mn><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.000</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\eta }^{2}=0.512$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:mrow><mml:msup><mml:mrow><mml:mi>η</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:mn>0.512</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F \\left(1, 24\\right)=15.685, p=0.001,$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mrow><mml:mi>F</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>24</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mn>15.685</mml:mn><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\eta }^{2}=0.395$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mrow><mml:msup><mml:mrow><mml:mi>η</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:mn>0.395</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F \\left(1.536, 36.866\\right)=9.981, p=0.001,$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mrow><mml:mi>F</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1.536</mml:mn><mml:mo>,</mml:mo><mml:mn>36.866</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mn>9.981</mml:mn><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\eta }^{2}=0.294$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mrow><mml:msup><mml:mrow><mml:mi>η</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:mn>0.294</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(-1.360 \\pm 4.082)$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mo>-</mml:mo><mml:mn>1.360</mml:mn><mml:mo>±</mml:mo><mml:mn>4.082</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(-1.587 \\pm 4.387)$$\\end{document}</tex-math><mml:math id=\"M20\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mo>-</mml:mo><mml:mn>1.587</mml:mn><mml:mo>±</mml:mo><mml:mn>4.387</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(0.292 \\pm 2.847)$$\\end{document}</tex-math><mml:math id=\"M22\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0.292</mml:mn><mml:mo>±</mml:mo><mml:mn>2.847</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq12\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(-3.239 \\pm 5.623)$$\\end{document}</tex-math><mml:math id=\"M24\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mo>-</mml:mo><mml:mn>3.239</mml:mn><mml:mo>±</mml:mo><mml:mn>5.623</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq13\"><alternatives><tex-math id=\"M25\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(-2.639 \\pm 3.711)$$\\end{document}</tex-math><mml:math id=\"M26\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mo>-</mml:mo><mml:mn>2.639</mml:mn><mml:mo>±</mml:mo><mml:mn>3.711</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq14\"><alternatives><tex-math id=\"M27\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(-2.040 \\pm 3.652)$$\\end{document}</tex-math><mml:math id=\"M28\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mo>-</mml:mo><mml:mn>2.040</mml:mn><mml:mo>±</mml:mo><mml:mn>3.652</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq15\"><alternatives><tex-math id=\"M29\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(0.259 \\pm 5.341)$$\\end{document}</tex-math><mml:math id=\"M30\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0.259</mml:mn><mml:mo>±</mml:mo><mml:mn>5.341</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq16\"><alternatives><tex-math id=\"M31\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F \\left(1, 24\\right)=62.443, p=0.000,$$\\end{document}</tex-math><mml:math id=\"M32\"><mml:mrow><mml:mi>F</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>24</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mn>62.443</mml:mn><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.000</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq17\"><alternatives><tex-math id=\"M33\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\eta }^{2}=0.722$$\\end{document}</tex-math><mml:math id=\"M34\"><mml:mrow><mml:msup><mml:mrow><mml:mi>η</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:mn>0.722</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq18\"><alternatives><tex-math id=\"M35\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$22.96 \\pm 2.07$$\\end{document}</tex-math><mml:math id=\"M36\"><mml:mrow><mml:mn>22.96</mml:mn><mml:mo>±</mml:mo><mml:mn>2.07</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M37\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$Quasi \\;tension \\;filter=\\frac{36.84}{{s}^{2}+27.32s+178.4}$$\\end{document}</tex-math><mml:math id=\"M38\" display=\"block\"><mml:mrow><mml:mi>Q</mml:mi><mml:mi>u</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mspace width=\"0.277778em\"/><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mspace width=\"0.277778em\"/><mml:mi>f</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>36.84</mml:mn></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mn>27.32</mml:mn><mml:mi>s</mml:mi><mml:mo>+</mml:mo><mml:mn>178.4</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M39\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$Total \\;Contraction \\;Level[\\%]=\\frac{100}{Standar{d}_{100\\%}-Standar{d}_{0\\%}}(sEMG-Standar{d}_{0\\%})$$\\end{document}</tex-math><mml:math id=\"M40\" display=\"block\"><mml:mrow><mml:mi>T</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mspace width=\"0.277778em\"/><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mspace width=\"0.277778em\"/><mml:mi>L</mml:mi><mml:mi>e</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mo>%</mml:mo><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mn>100</mml:mn><mml:mrow><mml:mi>S</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mn>100</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mi>S</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>s</mml:mi><mml:mi>E</mml:mi><mml:mi>M</mml:mi><mml:mi>G</mml:mi><mml:mo>-</mml:mo><mml:mi>S</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2023_51096_Fig1_HTML\" id=\"MO1\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq9.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq10.gif\"/>", "<graphic xlink:href=\"41598_2023_51096_Fig2_HTML\" id=\"MO2\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq11.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq12.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq13.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq14.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq15.gif\"/>", "<graphic xlink:href=\"41598_2023_51096_Fig3_HTML\" id=\"MO3\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq16.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq17.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51096_Article_IEq18.gif\"/>", "<graphic xlink:href=\"41598_2023_51096_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2023_51096_Article_Equ1.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_51096_Article_Equ2.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_51096_Fig5_HTML\" id=\"MO5\"/>" ]
[ "<media xlink:href=\"41598_2023_51096_MOESM1_ESM.docx\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["5."], "surname": ["Burdet", "Franklin", "Milner"], "given-names": ["E", "DW", "TE"], "source": ["Human Robotics: Neuromechanics and motor control"], "year": ["2013"], "publisher-name": ["MIT Press"]}, {"label": ["10."], "surname": ["Allen"], "given-names": ["MD"], "article-title": ["Neuroprotective effects of exercise on the aging human neuromuscular system"], "source": ["Exp. Gerontol."], "year": ["2021"], "volume": ["152"], "fpage": ["1"], "lpage": ["12"], "pub-id": ["10.1016/j.exger.2021.111465"]}, {"label": ["19."], "surname": ["Preuss", "Stepniewska", "Jain", "Kaas"], "given-names": ["TM", "I", "N", "JH"], "article-title": ["Multiple divisions of macaque precentral motor cortex identified with neurofilament antibody SMI-32"], "source": ["Brain Res."], "year": ["1997"], "volume": ["67"], "fpage": ["148"], "lpage": ["153"], "pub-id": ["10.1016/S0006-8993(97)00704-X"]}, {"label": ["24."], "surname": ["Kim"], "given-names": ["J"], "article-title": ["Human postural control against external force perturbation applied to the high-back"], "source": ["Int. J. Precis. Eng. Manuf."], "year": ["2009"], "volume": ["10"], "fpage": ["147"], "lpage": ["151"]}, {"label": ["25."], "mixed-citation": ["Ding, M. "], "italic": ["et al.", "2010 IEEE International Conference on Robotics and Biomimetics"]}, {"label": ["26."], "mixed-citation": ["Hill, A. V. The heat of shortening and the dynamic constants of muscle. In "], "italic": ["Proceedings of the Royal Society of London. Series B-Biological Sciences."], "bold": ["126"]}, {"label": ["28."], "surname": ["Noh", "Cho", "Kim"], "given-names": ["J", "W", "J"], "article-title": ["Design of a regression model for four grasping patterns and three grip force intensities of a myoelectric prosthetic hand"], "source": ["J. Korean Soc. Precis. Eng."], "year": ["2017"], "volume": ["34"], "fpage": ["1"], "lpage": ["3"]}, {"label": ["30."], "surname": ["Yoon", "Kim", "Kim", "Kim"], "given-names": ["J", "Y", "M", "J"], "article-title": ["An air pocket glove for finger rehabilitation and quantitative assessment of hemiplegic patients"], "source": ["J. Korean Soc. Precis. Eng."], "year": ["2018"], "volume": ["5"], "fpage": ["817"], "lpage": ["823"], "pub-id": ["10.7736/KSPE.2018.35.8.817"]}, {"label": ["31."], "mixed-citation": ["Rawat, S, Vats, S. & Kumar, P. Evaluating and exploring the MYO ARMBAND. In "], "italic": ["2016 International Conference System Modeling & Advancement in Research Trends (SMART)"]}, {"label": ["32."], "mixed-citation": ["Mendez, I. "], "italic": ["et al.", "2017 International Conference on Rehabilitation Robotics (ICORR)"]}, {"label": ["36."], "surname": ["Willmott", "Matsuura"], "given-names": ["CJ", "K"], "article-title": ["Advantages of the mean absolute error (MAE) over the root mean square error (RMSE) in assessing average model performance"], "source": ["Cent. Clim. Res."], "year": ["2005"], "volume": ["30"], "fpage": ["79"], "lpage": ["82"], "pub-id": ["10.3354/cr030079"]}, {"label": ["38."], "surname": ["Peebles"], "given-names": ["PZ"], "suffix": ["Jr"], "source": ["Probability, Random Variables, and Random Signal Principles"], "year": ["2001"], "publisher-name": ["McGraw-Hill"]}, {"label": ["39."], "surname": ["Welch"], "given-names": ["PD"], "article-title": ["The use of fast Fourier transform for the estimation of power spectra: A method based on time averaging over short, modified periodograms"], "source": ["IEEE Trans. Audio Electroacoust."], "year": ["1967"], "volume": ["15"], "fpage": ["70"], "lpage": ["73"], "pub-id": ["10.1109/TAU.1967.1161901"]}, {"label": ["40."], "surname": ["Smith"], "given-names": ["JO"], "source": ["Spectral Audio Signal Processing"], "year": ["2011"], "publisher-name": ["Springer"]}]
{ "acronym": [], "definition": [] }
40
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1174
oa_package/67/9c/PMC10786847.tar.gz
PMC10786848
38216711
[ "<title>Introduction</title>", "<p id=\"Par3\">Over the years, the trajectory of natural science has been conventionally steered by the intuition of individual researchers, guiding the formulation of hypotheses and their subsequent validation through experimentation. However, with the advent of a data-driven approach, this paradigm is now shifting, challenging established norms and registering significant success across diverse fields, including catalysis<sup>##UREF##0##1##–##UREF##2##4##</sup>. Within the realm of data-driven catalysis research, particularly in the context of experimental catalyst discoveries, the limited availability of data characterized by both sufficient quantity and quality for effective machine learning (ML) presents a major hurdle<sup>##REF##35258973##5##–##UREF##5##8##</sup>. In this context, data typically assume the form of tabular datasets comprising observations (e.g., catalyst samples) and parameters describing these observations (properties of catalysts), commonly referred to as features or descriptors when employed to predict a specific target variable (performance of catalysts) within the framework of supervised ML. In the field of catalysis, data are predominantly categorized into small data, seldom surpassing a thousand observations. This characteristic renders the data unsuitable for the deployment of elaborate ML models with a multitude of adjustable parameters necessary to capture intricate trends. Thus, the design of descriptors that encapsulate the essence of catalysis is imperative for the efficient and accurate capturing of data trends using simple ML models. However, except in limited cases of crystal structures<sup>##REF##29874459##9##</sup> and organic reactions<sup>##REF##30746086##10##</sup>, the data limitation has rendered the application of deep learning impractical, prompting researchers to address the fundamental issue of descriptor design in ML<sup>##UREF##0##1##,##REF##36468086##11##</sup>. Indeed, descriptor design based on individual researchers’ insights into structure–activity relationships, such as the <italic>d</italic>-band center in metal nanoalloys<sup>##UREF##6##12##</sup> and the buried volume in organometallic asymmetric catalysis<sup>##UREF##7##13##</sup>, constitutes a key aspect of the progress in catalyst informatics<sup>##UREF##3##6##,##REF##37147278##14##–##UREF##8##16##</sup>. However, such descriptor design is generally challenging and performed ad hoc, as it requires profound domain knowledge to identify all pertinent factors for the target catalysis<sup>##UREF##0##1##,##UREF##8##16##,##UREF##9##17##</sup>. In particular, practical solid catalysts constitute multiple components that are structured in an ill-defined manner, and the complex interplay of these components over multiple spatiotemporal scales results in the overall catalytic performance<sup>##UREF##10##18##,##UREF##11##19##</sup>. This intricacy, coupled with data scarcity, elevates the difficulty of crafting descriptors in catalysis, when compared to other fields.</p>", "<p id=\"Par4\">To surmount these challenges, in this study, we developed an automatic feature engineering (AFE) technique that works on small data for complex materials, such as solid catalysts, without requiring any prior knowledge of the target system. The AFE is a structured pipeline of (i) assigning a series of features to materials of arbitrary compositions, (ii) synthesizing numerous higher-order features considering nonlinear and combinatorial effects, and (iii) selecting a feature subset in the context of supervised ML. This study explores the applicability of AFE across various heterogeneous catalysis scenarios, each characterized by distinct catalyst designs. Furthermore, an extension of AFE to active learning, coupled with high-throughput experimentation (HTE), is implemented to comprehend catalyst design rules and streamline catalyst discoveries.</p>" ]
[ "<title>Methods</title>", "<title>Automatic feature engineering</title>", "<p id=\"Par11\">Feature engineering is an essential part of catalyst informatics, as constructing predictive ML models necessitates features that capture the essence of catalysts. Although deep learning can automate feature engineering, the accompanying training requires big data and is often not suitable in the catalysis field where small data are prevalent. Consequently, current feature engineering heavily relies on researchers’ intuition, but this empirical approach is insufficient for exploring diverse designs of catalysts. To address this challenge, we developed an AFE technique capable of handling small data on a variety of materials, including catalysts, without prior knowledge. This technique involves assigning features, synthesizing higher-order features, and selecting important features in the context of supervised ML (Fig. ##FIG##0##1##). Each step is detailed below, using multi-element solid catalysts as a representative example.</p>", "<title>Feature assignment</title>", "<p id=\"Par12\">A feature library is created by collecting all possible properties of elements from public databases. It can be appropriately normalized and shifted to prevent the divergence of first-order features. Commutative operations are applied to this feature library to assign primary features (denoted as <bold>X</bold><sub><bold>0</bold></sub>) that consider the notational order invariance and elemental composition of individual catalysts<sup>##UREF##12##20##</sup>. We adopted 58 features of elements stored in XenonPy<sup>##UREF##21##33##</sup> and applied eight types of commutative operations (maximum, minimum, weighted sum, weighted average, weighted sum of squared distance, weighted average squared distance, weighted product, and weighted geometric mean), resulting in 464 primary features.</p>", "<title>Feature synthesis</title>", "<p id=\"Par13\">Expressive ML models generally require larger training datasets. Simpler models are suitable for small data, but the reduced expressiveness must be compensated through feature engineering. Therefore, first-order features (f(<bold>X</bold><sub><bold>0</bold></sub>)) that consider nonlinearity and second- or higher-order features (f(<bold>X</bold><sub><bold>0</bold></sub>)·g(<bold>X</bold><sub><bold>0</bold></sub>), etc.) that combines two or more first-order features are synthesized<sup>##REF##25815947##21##–##REF##26783247##23##</sup>. We adopted 12 types of functions (<italic>x</italic>, <italic>x</italic><sup>1/2</sup>, <italic>x</italic><sup>2</sup>, <italic>x</italic><sup>3</sup>, exp(<italic>x</italic>), ln(<italic>x</italic>), and their reciprocals), resulting in 5568 first-order features.</p>", "<title>Feature selection</title>", "<p id=\"Par14\">Identifying a feature subset is crucial for constructing predictive models, as it is not feasible to use all synthesized higher-order features for model fitting. Despite the availability of several feature selection techniques, an exhaustive approach is typically recommended. We employed a genetic algorithm mainly to minimize the MAE value in LOOCV with a specified number of selected features. Huber regression<sup>##UREF##22##34##</sup> was adopted owing to its superior performance in handling experimental noise and singular catalysts compared to that of its non-robust counterpart.</p>", "<p id=\"Par15\">AFE was implemented using Python 3.8 and common libraries such as Pandas, NumPy, and scikit-learn, executed in parallel on a PC cluster. The significance of each step is outlined in Table ##SUPPL##0##S7##, wherein AFE was applied to the OCM dataset, with certain steps intentionally omitted. The analysis revealed that both feature assignment and feature selection were critical for producing a meaningful model, emphasizing the importance of selecting appropriate physicochemical descriptions of catalysts. Higher-order features resulted in a systematic improvement in the score by providing more direct features to the target variable. For small datasets like the OCM dataset, controlling the overfitting in complex models such as random forest regression was difficult. A genetic algorithm (an exhaustive approach) yielded better feature sets than sequential feature selection (a greedy approach)<sup>##UREF##33##46##</sup>.</p>", "<title>Dataset</title>", "<p id=\"Par16\">We used three HTE datasets for different heterogeneous catalytic systems to demonstrate AFE (Tables ##SUPPL##0##S2##‒##SUPPL##0##S4##). These datasets were obtained using a single protocol, rendering them process-consistent, a crucial feature for reliable ML<sup>##UREF##34##47##</sup>. A brief overview of the datasets is provided below, with additional details available in published papers<sup>##UREF##17##27##–##UREF##20##32##</sup>.</p>", "<title>Dataset for oxidative coupling of methane</title>", "<p id=\"Par17\">The C<sub>2</sub> yields of 95 M1‒M2‒M3/BaO catalysts during OCM were collected<sup>##UREF##17##27##–##REF##34327995##30##</sup>. M1‒M3 were selected from Li, Na, Mg, K, Ca, Ti, V, Mn, Fe, Co, Ni, Cu, Zn, Sr, Y, Zr, Mo, Pd, Cs, Ba, La, Ce, Nd, Eu, Tb, Hf, W, and none (blank), with repetitive selection allowed. The amount of each element was fixed at 0.371 mmol per gram support. Although most catalysts were obtained through random selection of elements, certain catalysts were recommended by different ML methods. The experimental protocol used to obtain this dataset is identical to that of the high-throughput experiment described later in this section.</p>", "<title>Dataset for conversion of ethanol to butadiene</title>", "<p id=\"Par18\">The butadiene (C<sub>4</sub>H<sub>6</sub>) yields in ethanol conversion were collected for 177 catalysts<sup>##UREF##19##31##</sup>. The catalysts were prepared by co-supporting up to 14 elements (Mg, Zn, Cu, Ag, Ni, Al, La, Y, Hf, Zr, Cr, Ga, Nb, and Mo) on SBA-15 through wet impregnation. The loadings of individual elements were optimized within a total loading of 3.00 mmol per gram support to maximize the C<sub>4</sub>H<sub>6</sub> yield using a genetic algorithm. The C<sub>4</sub>H<sub>6</sub> yield was measured using a catalyst bed packed in a fused quartz reactor (bed height: 2.0 cm; inner diameter: 4 mm on the influent side and 2 mm on the effluent side) at 400 °C and 21.8 mL min<sup>−1</sup> of 8.4% ethanol diluted in Ar.</p>", "<title>Dataset for three-way catalysis</title>", "<p id=\"Par19\">The light-off temperatures of 51 nanoparticle-supported catalysts for NO reduction in three-way catalysis were collected<sup>##UREF##20##32##</sup>. The light-off temperature is defined as the temperature at 50% NO conversion. Bimetallic to pentametallic nanoparticles with equimolar compositions and containing at least one Pt-group element were prepared using a hot-injection method and deposited onto a γ-Al<sub>2</sub>O<sub>3</sub> support at 0.3 wt%. Temperature ramping experiments were performed using a catalyst bed packed in a fused quartz reactor (bed weight: 60 mg; inner diameter: 4 mm on the influent side and 2 mm on the effluent side) with a 10 mL min<sup>−1</sup> gas flow of a stoichiometric mixture of CO (13000 ppm), C<sub>3</sub>H<sub>6</sub> (2000 ppm), NO (3000 ppm), CO<sub>2</sub> (100000 ppm), O<sub>2</sub> (14000 ppm), and He (balance).</p>", "<title>High-throughput experiment</title>", "<p id=\"Par20\">To demonstrate active learning, selected catalysts were actually prepared and evaluated using the same experimental method that was used to obtain the training data<sup>##UREF##17##27##–##REF##34327995##30##</sup>. The catalysts were sampled from a pool of 4060 candidates, generally expressed as M1‒M2‒M3/BaO. M1‒M3 were chosen from Li, Na, Mg, K, Ca, Ti, V, Mn, Fe, Co, Ni, Cu, Zn, Sr, Y, Zr, Mo, Pd, Cs, Ba, La, Ce, Nd, Eu, Tb, Hf, W, or none, with repetitive selection allowed. They were prepared using a parallelized impregnation method using LiNO<sub>3</sub>, NaNO<sub>3</sub>, Mg(NO<sub>3</sub>)<sub>2</sub>, KNO<sub>3</sub>, Ca(NO<sub>3</sub>)<sub>2</sub>·4H<sub>2</sub>O, Ti(O<italic>i</italic>Pr)<sub>4</sub>, VOSO<sub>4</sub>·<italic>x</italic>H<sub>2</sub>O (<italic>x</italic> = 4), Mn(NO<sub>3</sub>)<sub>2</sub>·6H<sub>2</sub>O, Fe(NO<sub>3</sub>)<sub>3</sub>·9H<sub>2</sub>O, Co(NO<sub>3</sub>)<sub>2</sub>·6H<sub>2</sub>O, Ni(NO<sub>3</sub>)<sub>2</sub>·6H<sub>2</sub>O, Cu(NO<sub>3</sub>)<sub>2</sub>·3H<sub>2</sub>O, Zn(NO<sub>3</sub>)<sub>2</sub>·6H<sub>2</sub>O, Sr(NO<sub>3</sub>)<sub>2</sub>, Y(NO<sub>3</sub>)<sub>3</sub>·6H<sub>2</sub>O, ZrO(NO<sub>3</sub>)<sub>2</sub>·2H<sub>2</sub>O, (NH<sub>4</sub>)<sub>6</sub>Mo<sub>7</sub>O<sub>24</sub>·4H<sub>2</sub>O, Pd(OAc)<sub>2</sub>, CsNO<sub>3</sub>, Ba(NO<sub>3</sub>)<sub>2</sub>, La(NO<sub>3</sub>)<sub>3</sub>·6H<sub>2</sub>O, Ce(NO<sub>3</sub>)<sub>3</sub>·6H<sub>2</sub>O, Nd(NO<sub>3</sub>)<sub>3</sub>·6H<sub>2</sub>O, Eu(OAc)<sub>3</sub>·4H<sub>2</sub>O, Tb(NO<sub>3</sub>)<sub>3</sub>·5H<sub>2</sub>O, Hf(OEt)<sub>4</sub>, and (NH<sub>4</sub>)<sub>10</sub>H<sub>2</sub>(W<sub>2</sub>O<sub>7</sub>)<sub>6</sub> as precursors. These precursors were obtained from Sigma-Aldrich, Kanto Chemical, Wako Pure Chemical Industries, and Alfa Aesar. Ba(OH)<sub>2</sub>·8H<sub>2</sub>O purchased from Wako Pure Chemical Industries was used as the precursor for the BaO support. The support powder (1.0 g) was suspended in 4‒5 mL of a precursor solution under stirring at 50 °C for 6 h. The concentration of the solution was adjusted to 0.371 mmol per gram support for each of the selected elements. After drying, the catalyst was calcined in air at 1000 °C for 3 h and thoroughly ground using a mortar and pestle before use. When using metal alkoxides, impregnation was performed in two steps, starting with an aqueous solution and followed by an ethanol solution of the metal alkoxides.</p>", "<p id=\"Par21\">The performance of the catalysts in OCM was evaluated using an in-house high-throughput screening instrument<sup>##UREF##34##47##</sup>. The instrument comprises a gas mixer for generating the reaction gas mixture (MU-3504, HORIBA STEC), a gas distributor for splitting the reaction gas equally into 20 reactor tubes (fused quartz tubes with an inner diameter of 4 mm on the influent side and 2 mm on the effluent side) loaded with catalyst powder and symmetrically placed in a hollow electric furnace, and an auto-sampler for supplying the effluent gas from individual tubes to a quadruple mass spectrometer (Transpector CPM 3, INFICON). Mass signals were converted into the relative pressures of individual gases based on external calibration. Cooperative action among the programmed gas generation, temperature, and auto-sampling enabled an automatic evaluation of the performance of 20 catalysts under a predetermined set of reaction conditions.</p>", "<p id=\"Par22\">The catalyst powder was packed at a height of 10 mm in the neck of the reactor tube using quartz wool and was in-line calcined at 1000 °C under an O<sub>2</sub> atmosphere for 3 h. A reaction gas mixture of CH<sub>4</sub> and O<sub>2</sub> balanced with Ar was flowed through the 20 tubes, and the temperature was decreased stepwise from 900 to 700 °C in 50 °C increments. The total gas flow volume (10, 15, and 20 mL min<sup>−1</sup>), CH<sub>4</sub>/O<sub>2</sub> ratio (2, 4, and 6 mol mol<sup>−1</sup>), and Ar concentration (P<sub>Ar</sub> = 0.15, 0.40, and 0.70 atm) were respectively varied at each temperature, resulting in a total of 135 reaction conditions. The C<sub>2</sub> yield, defined as the percentage of the doubled sum of the partial pressures of C<sub>2</sub>H<sub>6</sub> and C<sub>2</sub>H<sub>4</sub> relative to that of CH<sub>4</sub> in the influent, was obtained at each of the 135 conditions, and the maximum C<sub>2</sub> yield was recorded for further analysis.</p>" ]
[ "<title>Results and discussion</title>", "<title>Automatic feature engineering</title>", "<p id=\"Par5\">Figure ##FIG##0##1a## illustrates the workflow of AFE. Here, we consider supported multi-element catalysts as typical examples, wherein the dataset comprises elemental composition and performance data for individual catalysts. While the straightforward and commonly employed approach involves directly using elemental compositions as descriptors in constructing an ML model, this neglects the physical properties of elements, leading to drawbacks such as insufficient prediction accuracy and an inability to handle elements absent in the training data. However, crafting physically meaningful features of catalysts remains challenging, as proposing these features is equivalent to hypothesizing their relevance in the target catalysis. The proposed AFE technique is based on the premise of our scarce knowledge of a system, a common characteristic in today’s research and development landscape with continually emerging demands over a short period. The first step in AFE involves assigning primary features to catalysts by computing commutative operations of a feature library, such as a maximum and weighted average. This accounts for notational order invariance (e.g., features of Li‒W must be equal to those of W‒Li) and the elemental compositions of catalysts (e.g., the features of Li‒Li‒W must be differentiated from those of Li‒W‒W)<sup>##UREF##12##20##</sup>. The feature library collects all possible features of the catalyst constituents (such as the properties of elements and molecules) from all available sources, assuming that all features are equally probable. In the next step, higher-order features, also called compound features<sup>##REF##25815947##21##–##REF##26783247##23##</sup>, are synthesized. These features are arbitrary functions of primary features (first order) and products of two or more of these functions (second or higher order), addressing the nonlinear and combinatorial aspects of the problem. This compensates for the limited expressive power of simple ML models suitable for small data. A detailed classification of different feature types is presented in Table ##SUPPL##0##S1##. In the final step, the optimum feature combination that maximizes the performance of supervised ML is selected from a large pool of features (typically 10<sup>3</sup>‒10<sup>6</sup>). Hence, AFE generates a vast number of features (hypotheses) and recommends the most plausible combination within the context of supervised ML. While previous studies have employed preselected physical properties of elements to describe multi-element catalysts<sup>##UREF##14##24##–##UREF##16##26##</sup>, these properties have been hardly utilized to systematize feature engineering through the synthesis and screening of a large number of features. Herein, AFE was demonstrated using three HTE datasets of supported multi-element catalysts for different catalysis<sup>##UREF##17##27##–##UREF##20##32##</sup> (Fig. ##FIG##0##1b‒d##; the datasets are given in Tables ##SUPPL##0##S2##‒##SUPPL##0##4##). In particular, 5568 first-order features were constructed by applying eight types of commutative operations and 12 types of functions to 58 features of elements stored in XenonPy<sup>##UREF##21##33##</sup>. Then, eight features were selected to minimize the mean absolute error (MAE) in leave-one-out cross-validation (LOOCV) using Huber regression. Note that Huber regression is a linear regression method that employs the Huber loss instead of ordinary least squares to enhance robustness against outliers<sup>##UREF##22##34##</sup>. This approach not only mitigates the risk of overfitting on small data owing to its simplicity but also provides resilience against experimental errors and singular catalysts. Note that many of the generated features are inherently ineffective in describing the desired catalysis. However, given the limited knowledge and the fact that algorithm-based filtrations necessarily deteriorate the regression scores, filtering these features prior to feature selection is discouraged. Further details on this aspect are presented in the Methods section. In all cases, reasonable regression results evidenced the versatility of the method in tailoring the features for individual catalysis without prior knowledge (Fig. ##FIG##0##1b‒d##). The MAE values of the obtained models during training and CV were 1.69% and 1.73% in C<sub>2</sub> yields, 3.77% and 3.93% in butadiene yields, and 11.2 °C and 11.9 °C in T<sub>50</sub> of NO conversion, respectively. Notably, these MAE values are significantly smaller than the span of each target variable and comparable to the respective experimental errors. The remarkable accuracy of the AFE-generated models in CV was unattainable when using catalyst elemental compositions as descriptors, regardless of the ML methods and hyperparameter sets (Fig. ##SUPPL##0##S1##). In particular, relatively complex methods such as support vector regression and random forest regression exhibited a tendency of overfitting with MAE in training significantly lower than that in CV. By contrast, AFE led to consistently low MAE values in both training and CV, offering a minimal set of engineered features suitable for capturing complex trends with limited data.</p>", "<title>Integration with active learning</title>", "<p id=\"Par6\">In scenarios where the available data are limited, researchers cannot disregard alternative hypotheses. Similarly, when the training data are either limited in size or constrained in the diversity of elemental compositions in catalysts, AFE proposes multiple models exhibiting similar scores, even though different feature sets are selected. Although these models demonstrate similar performance in explaining the training data, their predictive behaviors for unknown catalysts can vary significantly. In other words, many of these models are only locally fit, lacking the global characteristics necessary to explain the entire composition. An active learning strategy enables AFE to exclude locally fit models and identify a globally fit model, i.e., the true hypothesis set. Here, this was practised using the oxidative coupling of methane (OCM) dataset (Table ##SUPPL##0##S2##). The dataset includes the C<sub>2</sub> yield of catalysts with up to three elements selected from an element library and supported on BaO, each at a fixed amount<sup>##UREF##17##27##</sup>. Initially, eight first-order features were selected based on LOOCV-MAE in Huber regression on a given training dataset. Subsequently, 20 catalysts were prepared and evaluated through HTE, among which 18 catalysts were selected via farthest point sampling (FPS) in the selected feature space, and two were chosen based on their highest absolute errors in the regression. Note that FPS adds catalysts that are least similar to those in the training data within the selected feature space, which aids in efficiently excluding models lacking global characteristics. The obtained data were fed back to AFE to update the feature space (Fig. ##FIG##1##2a##). This process was repeated over four iterations, resulting in the addition of 80 new catalysts (Table ##SUPPL##0##S5##). A more detailed procedure is presented in Figure ##SUPPL##0##S2##. Figure ##FIG##1##2b, c## provides a summary of the relevant scores and individual test results, respectively. In the first cycle, the largest diversification of catalyst composition driven by FPS moderately increased the MAE<sub>train,CV</sub> values, but subsequent cycles did not largely change these values. The final MAE<sub>trainv,CV</sub> values (2.2‒2.3%) were higher than the typical experimental error (1.0‒2.0%), partly because the linear model failed to capture various 0% C<sub>2</sub> yield data (any observed inactivity may be attributed to several reasons). Excluding these data points reduced the MAE<sub>CV</sub> to ~1.9%. The changes in the test score were larger than those in the training and CV scores. Several extrapolations occurred during the first cycle, where the predicted yield was &gt;30% or &lt;0%, resulting in an extremely large MAE<sub>test</sub>. These extrapolations correspond to the model attempting to explain catalysts entirely beyond its original consideration. As the cycle progressed and the catalysts in the training dataset diversified sufficiently, these extrapolations disappeared, and the difference between the observations and predictions decreased monotonically. Pearson’s correlation coefficient between the regression models increased from 0.6 in Cycles 0 and 1 to 0.9 in Cycles 3 and 4, indicating the convergence of feature engineering toward a global model.</p>", "<title>Decoding machine’s perception</title>", "<p id=\"Par7\">Figure ##FIG##1##2d## visualizes the progress of feature engineering using t-distributed stochastic neighbor embedding (t-SNE)<sup>##UREF##23##35##</sup>, where the eight features selected during each active learning cycle were reduced in two dimensions, maintaining the pairwise similarities of the catalysts. This approach allowed us to monitor the evolution of the machine’s ability to perceive individual catalysts. The plot shows all 4060 catalysts in the library (including both tested and untested ones), with the color indicating the predicted C<sub>2</sub> yield and circled data points representing the test results. Leveraging the advancements in active learning, the data were divided into a larger number of clusters, representing the machine’s process of refining a feature space to distinguish the catalysts better through distinct composition–performance relationships. Then, the question is how does the machine perceive the composition-performance relationships? This was addressed in two steps. First, the dataset was subjected to manual statistical analysis, as shown in Fig. ##SUPPL##0##S3##. Early transition metals such as Mo and Zr and heavy alkali metals such as K and Cs are attributed high performance (Fig. ##SUPPL##0##S3a, b##). This is because early transition metals can form oxometalate anions active for OCM when they are combined with Ba in the support or other supported elements with low electron affinity<sup>##UREF##18##28##,##UREF##24##36##,##UREF##25##37##</sup>. Alkali metals can enhance the C<sub>2</sub> selectivity by strengthening the basicity of alkali earth metal oxides<sup>##UREF##26##38##–##UREF##28##40##</sup>. By contrast, late transition metals (excluding Zn with completely filled 3d orbitals) tend to decrease the C<sub>2</sub> yield with increasing group number (Fig. ##SUPPL##0##S3a, c##), as they act as combustion catalysts<sup>##UREF##29##41##</sup>. Next, keeping the abovementioned researcher’s observations in mind, the machine’s perception was interpreted by analyzing the distribution of individual elements in the feature space (Fig. ##SUPPL##0##S4##). Figure ##FIG##2##3## summarizes the regions where individual elements are concentrated after active learning, which decodes the machine perception. Late transition metals form separate clusters, whereas Mo and W are concentrated in narrow regions, indicating that the machine recognizes these elements as having differently significant impacts on the performance. By contrast, elements with a wide spatial distribution either have limited data points (e.g., La) or exhibit significantly different performance depending on their combination (e.g., Mg and Mn). Elements with overlapping distributions are not only similar in their physicochemical properties but also in their impact on the catalytic performance. For example, high-performing K and Cs have overlapping distributions, whereas the less-effective Li and Na are separated. These observations align with the researchers’ understanding acquired from Fig. ##SUPPL##0##S3##. An application of the same analysis to the unselected feature set and the feature set selected before active learning (Fig. ##SUPPL##0##S5##) revealed the essentiality of both feature engineering and active learning in achieving such level of discrimination. Eventually, AFE transformed general physicochemical knowledge of elements into an OCM-specific one, while active learning enhanced the machine’s accuracy in discriminating elements. The visualization of the feature space is also valuable for uncovering combinatorial rules (Fig. ##SUPPL##0##S6##). For example, catalysts containing both high-performing Mo and low-performing Pd are found within the cluster of Pd-based catalysts, suggesting that Pd has a more dominant influence than Mo in OCM. Strongly interacting combinations, such as those of Cs with Ti, Zr, and Mo, that are frequently observed in high-performing catalysts, are distributed in small clusters separated from the main cluster for Cs-based catalysts. Additionally, Fe-Zn, while not prominently featured in the training data, is isolated in a very narrow region with relatively high predicted C<sub>2</sub> yields, an aspect to be explored further.</p>", "<title>Validation, limitations, and future prospects</title>", "<p id=\"Par8\">The primary advantage of AFE, particularly when combined with active learning, lies in its high predictive accuracy and applicability across a wide range of catalysts. To showcase this, we applied FPS to a subset of catalysts with predicted C<sub>2</sub> yields ≥ 15% using the model obtained after active learning; this resulted in the recommendation of 36 catalysts. Subsequent experimental evaluation revealed that 30 out of the 36 catalysts actually exhibited C<sub>2</sub> yields ≥ 15%, with 16 of them surpassing a yield of 18% (Fig. ##FIG##3##4##, Table ##SUPPL##0##S6##). This is compared to only 37 cases exceeding a yield of 18% among 175 catalysts in the training data. These catalysts predominantly comprise elements whose oxides possess high basicity, such as alkaline, alkaline earth, and rare earth metal elements, along with early transition metal elements from groups 4 to 6. By contrast, many of the high-performing catalysts identified in Fig. ##FIG##3##4## do not conform to this pattern, with a notable presence of elements like Fe and Zn. These elements are largely underexplored in the history of OCM research<sup>##UREF##30##42##</sup>. A unique advantage of our methodology lies in utilizing the integration of AFE and HTE to systematize the model’s education, rather than solely focusing on catalyst discoveries. As a result, the model, enhanced through active learning, significantly streamlined the discovery of high-performing catalysts.</p>", "<p id=\"Par9\">The preceding discussions have elucidated the usefulness of the model involving the engineered features in understanding catalyst design rules and identifying various high-performing catalysts. Conversely, directly extracting physical insights from the engineered features themselves is currently not practical. The engineered features, either individually or in combination, exhibit statistical correlations with catalytic performance. However, statistical correlations do not guarantee causality in catalysis. Moreover, the physical properties of single elements used to generate catalyst features are logically too distant from causal relationships. For instance, the model obtained after active learning is presented as a combination of features: 22.0 (first_ion_en_max)<sup>3</sup> + 3.32 ln(gs_mag_moment_min)<sup>−1</sup> − 8.63 (Polarizability_min)<sup>−0.5</sup> + 4.59 (dipole_polarizability_min)<sup>−0.5</sup> − 4.22 lattice_constant_min − 6.44 exp(electron_affinity_pro)<sup>−1</sup> + 10.0 (gs_mag_moment_std)<sup>2</sup> + 3.26 hhi_r_max + 27.8, among which Polarizability_min, dipole_polarizability_min, and first_ion_en_max are identified to be particularly impactful. These features serve to discriminate between elements whose oxides exhibit strong basicity, those that are useful for O<sub>2</sub> activation, and other elements, particularly late transition metal elements that catalyze unselective combustion. However, such interpretations are not insights gained directly from the features themselves but rather post hoc explanations assigned to their roles with reference to existing knowledge. Indeed, attempts to extract physical insights based on elemental features have been hardly successful in literature<sup>##UREF##14##24##,##UREF##16##26##</sup>. To extract physical insights from the engineered features without relying on prior knowledge, a diverse and comprehensive collection of catalytically relevant properties of elements, so-called a catalysis feature library, is essential (e.g., formation energies of oxides, redox properties, acidity/basicity, and interaction with various molecules). Such a library, albeit currently unavailable, would leverage the advantage of AFE’s compatibility with simple and interpretable ML models. This catalysis feature library, in addition to transparent ML models<sup>##UREF##31##43##</sup>, is another indispensable piece for achieving fully interpretable catalyst informatics, where density functional theory calculations are expected to play a significant role<sup>##REF##31138814##44##</sup>.</p>" ]
[ "<title>Results and discussion</title>", "<title>Automatic feature engineering</title>", "<p id=\"Par5\">Figure ##FIG##0##1a## illustrates the workflow of AFE. Here, we consider supported multi-element catalysts as typical examples, wherein the dataset comprises elemental composition and performance data for individual catalysts. While the straightforward and commonly employed approach involves directly using elemental compositions as descriptors in constructing an ML model, this neglects the physical properties of elements, leading to drawbacks such as insufficient prediction accuracy and an inability to handle elements absent in the training data. However, crafting physically meaningful features of catalysts remains challenging, as proposing these features is equivalent to hypothesizing their relevance in the target catalysis. The proposed AFE technique is based on the premise of our scarce knowledge of a system, a common characteristic in today’s research and development landscape with continually emerging demands over a short period. The first step in AFE involves assigning primary features to catalysts by computing commutative operations of a feature library, such as a maximum and weighted average. This accounts for notational order invariance (e.g., features of Li‒W must be equal to those of W‒Li) and the elemental compositions of catalysts (e.g., the features of Li‒Li‒W must be differentiated from those of Li‒W‒W)<sup>##UREF##12##20##</sup>. The feature library collects all possible features of the catalyst constituents (such as the properties of elements and molecules) from all available sources, assuming that all features are equally probable. In the next step, higher-order features, also called compound features<sup>##REF##25815947##21##–##REF##26783247##23##</sup>, are synthesized. These features are arbitrary functions of primary features (first order) and products of two or more of these functions (second or higher order), addressing the nonlinear and combinatorial aspects of the problem. This compensates for the limited expressive power of simple ML models suitable for small data. A detailed classification of different feature types is presented in Table ##SUPPL##0##S1##. In the final step, the optimum feature combination that maximizes the performance of supervised ML is selected from a large pool of features (typically 10<sup>3</sup>‒10<sup>6</sup>). Hence, AFE generates a vast number of features (hypotheses) and recommends the most plausible combination within the context of supervised ML. While previous studies have employed preselected physical properties of elements to describe multi-element catalysts<sup>##UREF##14##24##–##UREF##16##26##</sup>, these properties have been hardly utilized to systematize feature engineering through the synthesis and screening of a large number of features. Herein, AFE was demonstrated using three HTE datasets of supported multi-element catalysts for different catalysis<sup>##UREF##17##27##–##UREF##20##32##</sup> (Fig. ##FIG##0##1b‒d##; the datasets are given in Tables ##SUPPL##0##S2##‒##SUPPL##0##4##). In particular, 5568 first-order features were constructed by applying eight types of commutative operations and 12 types of functions to 58 features of elements stored in XenonPy<sup>##UREF##21##33##</sup>. Then, eight features were selected to minimize the mean absolute error (MAE) in leave-one-out cross-validation (LOOCV) using Huber regression. Note that Huber regression is a linear regression method that employs the Huber loss instead of ordinary least squares to enhance robustness against outliers<sup>##UREF##22##34##</sup>. This approach not only mitigates the risk of overfitting on small data owing to its simplicity but also provides resilience against experimental errors and singular catalysts. Note that many of the generated features are inherently ineffective in describing the desired catalysis. However, given the limited knowledge and the fact that algorithm-based filtrations necessarily deteriorate the regression scores, filtering these features prior to feature selection is discouraged. Further details on this aspect are presented in the Methods section. In all cases, reasonable regression results evidenced the versatility of the method in tailoring the features for individual catalysis without prior knowledge (Fig. ##FIG##0##1b‒d##). The MAE values of the obtained models during training and CV were 1.69% and 1.73% in C<sub>2</sub> yields, 3.77% and 3.93% in butadiene yields, and 11.2 °C and 11.9 °C in T<sub>50</sub> of NO conversion, respectively. Notably, these MAE values are significantly smaller than the span of each target variable and comparable to the respective experimental errors. The remarkable accuracy of the AFE-generated models in CV was unattainable when using catalyst elemental compositions as descriptors, regardless of the ML methods and hyperparameter sets (Fig. ##SUPPL##0##S1##). In particular, relatively complex methods such as support vector regression and random forest regression exhibited a tendency of overfitting with MAE in training significantly lower than that in CV. By contrast, AFE led to consistently low MAE values in both training and CV, offering a minimal set of engineered features suitable for capturing complex trends with limited data.</p>", "<title>Integration with active learning</title>", "<p id=\"Par6\">In scenarios where the available data are limited, researchers cannot disregard alternative hypotheses. Similarly, when the training data are either limited in size or constrained in the diversity of elemental compositions in catalysts, AFE proposes multiple models exhibiting similar scores, even though different feature sets are selected. Although these models demonstrate similar performance in explaining the training data, their predictive behaviors for unknown catalysts can vary significantly. In other words, many of these models are only locally fit, lacking the global characteristics necessary to explain the entire composition. An active learning strategy enables AFE to exclude locally fit models and identify a globally fit model, i.e., the true hypothesis set. Here, this was practised using the oxidative coupling of methane (OCM) dataset (Table ##SUPPL##0##S2##). The dataset includes the C<sub>2</sub> yield of catalysts with up to three elements selected from an element library and supported on BaO, each at a fixed amount<sup>##UREF##17##27##</sup>. Initially, eight first-order features were selected based on LOOCV-MAE in Huber regression on a given training dataset. Subsequently, 20 catalysts were prepared and evaluated through HTE, among which 18 catalysts were selected via farthest point sampling (FPS) in the selected feature space, and two were chosen based on their highest absolute errors in the regression. Note that FPS adds catalysts that are least similar to those in the training data within the selected feature space, which aids in efficiently excluding models lacking global characteristics. The obtained data were fed back to AFE to update the feature space (Fig. ##FIG##1##2a##). This process was repeated over four iterations, resulting in the addition of 80 new catalysts (Table ##SUPPL##0##S5##). A more detailed procedure is presented in Figure ##SUPPL##0##S2##. Figure ##FIG##1##2b, c## provides a summary of the relevant scores and individual test results, respectively. In the first cycle, the largest diversification of catalyst composition driven by FPS moderately increased the MAE<sub>train,CV</sub> values, but subsequent cycles did not largely change these values. The final MAE<sub>trainv,CV</sub> values (2.2‒2.3%) were higher than the typical experimental error (1.0‒2.0%), partly because the linear model failed to capture various 0% C<sub>2</sub> yield data (any observed inactivity may be attributed to several reasons). Excluding these data points reduced the MAE<sub>CV</sub> to ~1.9%. The changes in the test score were larger than those in the training and CV scores. Several extrapolations occurred during the first cycle, where the predicted yield was &gt;30% or &lt;0%, resulting in an extremely large MAE<sub>test</sub>. These extrapolations correspond to the model attempting to explain catalysts entirely beyond its original consideration. As the cycle progressed and the catalysts in the training dataset diversified sufficiently, these extrapolations disappeared, and the difference between the observations and predictions decreased monotonically. Pearson’s correlation coefficient between the regression models increased from 0.6 in Cycles 0 and 1 to 0.9 in Cycles 3 and 4, indicating the convergence of feature engineering toward a global model.</p>", "<title>Decoding machine’s perception</title>", "<p id=\"Par7\">Figure ##FIG##1##2d## visualizes the progress of feature engineering using t-distributed stochastic neighbor embedding (t-SNE)<sup>##UREF##23##35##</sup>, where the eight features selected during each active learning cycle were reduced in two dimensions, maintaining the pairwise similarities of the catalysts. This approach allowed us to monitor the evolution of the machine’s ability to perceive individual catalysts. The plot shows all 4060 catalysts in the library (including both tested and untested ones), with the color indicating the predicted C<sub>2</sub> yield and circled data points representing the test results. Leveraging the advancements in active learning, the data were divided into a larger number of clusters, representing the machine’s process of refining a feature space to distinguish the catalysts better through distinct composition–performance relationships. Then, the question is how does the machine perceive the composition-performance relationships? This was addressed in two steps. First, the dataset was subjected to manual statistical analysis, as shown in Fig. ##SUPPL##0##S3##. Early transition metals such as Mo and Zr and heavy alkali metals such as K and Cs are attributed high performance (Fig. ##SUPPL##0##S3a, b##). This is because early transition metals can form oxometalate anions active for OCM when they are combined with Ba in the support or other supported elements with low electron affinity<sup>##UREF##18##28##,##UREF##24##36##,##UREF##25##37##</sup>. Alkali metals can enhance the C<sub>2</sub> selectivity by strengthening the basicity of alkali earth metal oxides<sup>##UREF##26##38##–##UREF##28##40##</sup>. By contrast, late transition metals (excluding Zn with completely filled 3d orbitals) tend to decrease the C<sub>2</sub> yield with increasing group number (Fig. ##SUPPL##0##S3a, c##), as they act as combustion catalysts<sup>##UREF##29##41##</sup>. Next, keeping the abovementioned researcher’s observations in mind, the machine’s perception was interpreted by analyzing the distribution of individual elements in the feature space (Fig. ##SUPPL##0##S4##). Figure ##FIG##2##3## summarizes the regions where individual elements are concentrated after active learning, which decodes the machine perception. Late transition metals form separate clusters, whereas Mo and W are concentrated in narrow regions, indicating that the machine recognizes these elements as having differently significant impacts on the performance. By contrast, elements with a wide spatial distribution either have limited data points (e.g., La) or exhibit significantly different performance depending on their combination (e.g., Mg and Mn). Elements with overlapping distributions are not only similar in their physicochemical properties but also in their impact on the catalytic performance. For example, high-performing K and Cs have overlapping distributions, whereas the less-effective Li and Na are separated. These observations align with the researchers’ understanding acquired from Fig. ##SUPPL##0##S3##. An application of the same analysis to the unselected feature set and the feature set selected before active learning (Fig. ##SUPPL##0##S5##) revealed the essentiality of both feature engineering and active learning in achieving such level of discrimination. Eventually, AFE transformed general physicochemical knowledge of elements into an OCM-specific one, while active learning enhanced the machine’s accuracy in discriminating elements. The visualization of the feature space is also valuable for uncovering combinatorial rules (Fig. ##SUPPL##0##S6##). For example, catalysts containing both high-performing Mo and low-performing Pd are found within the cluster of Pd-based catalysts, suggesting that Pd has a more dominant influence than Mo in OCM. Strongly interacting combinations, such as those of Cs with Ti, Zr, and Mo, that are frequently observed in high-performing catalysts, are distributed in small clusters separated from the main cluster for Cs-based catalysts. Additionally, Fe-Zn, while not prominently featured in the training data, is isolated in a very narrow region with relatively high predicted C<sub>2</sub> yields, an aspect to be explored further.</p>", "<title>Validation, limitations, and future prospects</title>", "<p id=\"Par8\">The primary advantage of AFE, particularly when combined with active learning, lies in its high predictive accuracy and applicability across a wide range of catalysts. To showcase this, we applied FPS to a subset of catalysts with predicted C<sub>2</sub> yields ≥ 15% using the model obtained after active learning; this resulted in the recommendation of 36 catalysts. Subsequent experimental evaluation revealed that 30 out of the 36 catalysts actually exhibited C<sub>2</sub> yields ≥ 15%, with 16 of them surpassing a yield of 18% (Fig. ##FIG##3##4##, Table ##SUPPL##0##S6##). This is compared to only 37 cases exceeding a yield of 18% among 175 catalysts in the training data. These catalysts predominantly comprise elements whose oxides possess high basicity, such as alkaline, alkaline earth, and rare earth metal elements, along with early transition metal elements from groups 4 to 6. By contrast, many of the high-performing catalysts identified in Fig. ##FIG##3##4## do not conform to this pattern, with a notable presence of elements like Fe and Zn. These elements are largely underexplored in the history of OCM research<sup>##UREF##30##42##</sup>. A unique advantage of our methodology lies in utilizing the integration of AFE and HTE to systematize the model’s education, rather than solely focusing on catalyst discoveries. As a result, the model, enhanced through active learning, significantly streamlined the discovery of high-performing catalysts.</p>", "<p id=\"Par9\">The preceding discussions have elucidated the usefulness of the model involving the engineered features in understanding catalyst design rules and identifying various high-performing catalysts. Conversely, directly extracting physical insights from the engineered features themselves is currently not practical. The engineered features, either individually or in combination, exhibit statistical correlations with catalytic performance. However, statistical correlations do not guarantee causality in catalysis. Moreover, the physical properties of single elements used to generate catalyst features are logically too distant from causal relationships. For instance, the model obtained after active learning is presented as a combination of features: 22.0 (first_ion_en_max)<sup>3</sup> + 3.32 ln(gs_mag_moment_min)<sup>−1</sup> − 8.63 (Polarizability_min)<sup>−0.5</sup> + 4.59 (dipole_polarizability_min)<sup>−0.5</sup> − 4.22 lattice_constant_min − 6.44 exp(electron_affinity_pro)<sup>−1</sup> + 10.0 (gs_mag_moment_std)<sup>2</sup> + 3.26 hhi_r_max + 27.8, among which Polarizability_min, dipole_polarizability_min, and first_ion_en_max are identified to be particularly impactful. These features serve to discriminate between elements whose oxides exhibit strong basicity, those that are useful for O<sub>2</sub> activation, and other elements, particularly late transition metal elements that catalyze unselective combustion. However, such interpretations are not insights gained directly from the features themselves but rather post hoc explanations assigned to their roles with reference to existing knowledge. Indeed, attempts to extract physical insights based on elemental features have been hardly successful in literature<sup>##UREF##14##24##,##UREF##16##26##</sup>. To extract physical insights from the engineered features without relying on prior knowledge, a diverse and comprehensive collection of catalytically relevant properties of elements, so-called a catalysis feature library, is essential (e.g., formation energies of oxides, redox properties, acidity/basicity, and interaction with various molecules). Such a library, albeit currently unavailable, would leverage the advantage of AFE’s compatibility with simple and interpretable ML models. This catalysis feature library, in addition to transparent ML models<sup>##UREF##31##43##</sup>, is another indispensable piece for achieving fully interpretable catalyst informatics, where density functional theory calculations are expected to play a significant role<sup>##REF##31138814##44##</sup>.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par10\">In summary, we developed and demonstrated AFE as a versatile technique, facilitating effective ML for small datasets of solid catalysts characterized by diverse compositions. AFE exceled in designing highly expressive features tailored to a specific catalyst system without requiring prior knowledge of the system. The availability of process-consistent datasets obtained through HTE was crucial in the development of AFE. The integration of AFE, FPS, and HTE in an iterative loop through active learning systematized the process to educate the machine, promoting the elimination of alternative hypotheses and the identification of a true hypothesis set that applies to a wide array of catalysts. This success can be attributed to the ability of the machine to develop a feature or knowledge space for recognizing the composition–performance relationships of catalysts. Our systematic approach led the enhanced machine to equip remarkable efficiency in pinpointing various high-performing catalysts. However, the extraction of direct insights from engineered features remains a future challenge, necessitating a comprehensive collection of catalytically relevant properties. The integration of AFE into automated experiments<sup>##UREF##32##45##</sup> would enable highly efficient autonomous catalyst designs. Furthermore, the knowledge acquired for a specific system is not only beneficial for predicting the performance of unknown compositions within the same system but also for facilitating knowledge acquisition for different systems through transfer learning. As the machine accumulates knowledge across diverse catalytic systems, it is poised to develop comprehensive catalytic knowledge. This advancement promises a future in catalyst development that transcends reliance on researchers’ experiences and knowledge.</p>" ]
[ "<p id=\"Par1\">The empirical aspect of descriptor design in catalyst informatics, particularly when confronted with limited data, necessitates adequate prior knowledge for delving into unknown territories, thus presenting a logical contradiction. This study introduces a technique for automatic feature engineering (AFE) that works on small catalyst datasets, without reliance on specific assumptions or pre-existing knowledge about the target catalysis when designing descriptors and building machine-learning models. This technique generates numerous features through mathematical operations on general physicochemical features of catalytic components and extracts relevant features for the desired catalysis, essentially screening numerous hypotheses on a machine. AFE yields reasonable regression results for three types of heterogeneous catalysis: oxidative coupling of methane (OCM), conversion of ethanol to butadiene, and three-way catalysis, where only the training set is swapped. Moreover, through the application of active learning that combines AFE and high-throughput experimentation for OCM, we successfully visualize the machine’s process of acquiring precise recognition of the catalyst design. Thus, AFE is a versatile technique for data-driven catalysis research and a key step towards fully automated catalyst discoveries.</p>", "<p id=\"Par2\">Descriptor design in catalyst informatics necessitates adequate prior knowledge for delving into unknown territories, particularly when confronted with limited data, thus presenting a logical contradiction. Here, the authors report a technique for automatic feature engineering that works on small catalyst datasets without reliance on pre-existing knowledge about the target catalysis.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s42004-023-01086-y.</p>", "<title>Acknowledgements</title>", "<p>The authors acknowledge funding from the Japan Science and Technology Agency (JST) CREST (Grant number JPMJCR17P2) and JST Mirai Program (Grant Number JPMJMI22G4).</p>", "<title>Author contributions</title>", "<p>T.T. designed the study and wrote the paper. T.T. and A.F. performed the research. T.T., S.N., F.G.E., and K.T. analyzed the data. All authors approved the final paper.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par23\"><italic>Communications Chemistry</italic> thanks the anonymous reviewers for their contribution to the peer review of this work.</p>", "<title>Data availability</title>", "<p>The three datasets used to demonstrate automatic feature engineering in Fig. ##FIG##0##1## are curated from published papers and listed in the Supplementary Information. The authors declare that all data supporting the findings and those used for reproducing the figures in this paper are available within the paper and its Supplementary Information. Source data are provided with this paper.</p>", "<title>Code availability</title>", "<p>Codes are available at <ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/TaniikeLaboratory/Automatic-feature-engineering-for-catalyst-small-data\">https://github.com/TaniikeLaboratory/Automatic-feature-engineering-for-catalyst-small-data</ext-link>.</p>", "<title>Competing interests</title>", "<p id=\"Par24\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Automatic feature engineering (AFE) and its demonstration.</title><p><bold>a</bold> Schematic of the AFE pipeline. Prediction of (<bold>b</bold>) C<sub>2</sub> yields in the oxidative coupling of methane (OCM), (<bold>c</bold>) butadiene yields in ethanol conversion, and (<bold>d</bold>) light-off temperatures for NO conversion in three-way catalysis. Eight features that minimized the mean absolute error (MAE) in leave-one-out cross-validation (LOOCV) with Huber regression were selected from 5568 first-order features.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>Active learning implemented for the OCM catalyst design.</title><p><bold>a</bold> Schematic of the active learning loop. The feature engineering was repeated five times with the data of 20 catalysts added per update. The model scores and the testing results are shown in (<bold>b</bold>) and (<bold>c</bold>), respectively. The deviation between predicted and observed C<sub>2</sub> yields decreased monotonically throughout the active learning cycle. (<bold>d</bold>) Eight features were selected from 5568 first-order features to minimize the MAE in LOOCV with Huber regression. The development of the feature engineering and prediction is visualized based on t-distributed stochastic neighbor embedding (t-SNE). The circled data points are the test results except for the last cycle, which used the training data instead. The color reflects the predicted or observed C<sub>2</sub> yield. Each t-SNE image delineates how the machine perceives the composition and performance of individual catalysts in each active learning cycle. The increase in the number of clusters during active learning signifies the evolution of the machine’s ability to discern diverse catalysts based on their distinct composition-performance relationships.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Machine perception of the OCM catalyst design.</title><p>The feature space of the latest model is visualized by t-SNE, along with the Gaussian kernel density estimation for the C<sub>2</sub> yield above 18%. The dotted lines indicate the regions where catalysts containing individual elements are concentrated. This visualization illustrates the machine’s perception in identifying the composition and performance of catalysts based on specific elements. It showcases common elements found in high and low-performing catalysts, similarities among elements within the feature space, and other pertinent insights.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>Discovery of high-performing OCM catalysts using the developed ML model.</title><p>Herein, 36 catalysts were selected from a subset of catalysts with predicted C<sub>2</sub> yields ≥ 15% using FPS. The bars represent experimentally obtained C<sub>2</sub> yields, with colors indicating the yield levels.</p></caption></fig>" ]
[]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"42004_2023_1086_Fig1_HTML\" id=\"d32e354\"/>", "<graphic xlink:href=\"42004_2023_1086_Fig2_HTML\" id=\"d32e415\"/>", "<graphic xlink:href=\"42004_2023_1086_Fig3_HTML\" id=\"d32e493\"/>", "<graphic xlink:href=\"42004_2023_1086_Fig4_HTML\" id=\"d32e528\"/>" ]
[ "<media xlink:href=\"42004_2023_1086_MOESM1_ESM.pdf\"><caption><p>Summplementary Information</p></caption></media>" ]
[{"label": ["1."], "surname": ["Ramprasad", "Batra", "Pilania", "Mannodi-Kanakkithodi", "Kim"], "given-names": ["R", "R", "G", "A", "C"], "article-title": ["Machine learning in materials informatics: recent applications and prospects"], "source": ["npj Comput. Mater."], "year": ["2017"], "volume": ["3"], "fpage": ["54"], "pub-id": ["10.1038/s41524-017-0056-5"]}, {"label": ["3."], "surname": ["Toyao"], "given-names": ["T"], "article-title": ["Machine learning for catalysis informatics: recent applications and prospects"], "source": ["ACS Catal."], "year": ["2020"], "volume": ["10"], "fpage": ["2260"], "lpage": ["2297"], "pub-id": ["10.1021/acscatal.9b04186"]}, {"label": ["4."], "surname": ["Takahashi"], "given-names": ["K"], "article-title": ["Catalysts informatics: paradigm shift towards data-driven catalyst design"], "source": ["Chem. Commun."], "year": ["2023"], "volume": ["59"], "fpage": ["2222"], "lpage": ["2238"], "pub-id": ["10.1039/D2CC05938J"]}, {"label": ["6."], "surname": ["Schmidt", "Marques", "Botti", "Marques"], "given-names": ["J", "MRG", "S", "MAL"], "article-title": ["Recent advances and applications of machine learning in solid-state materials science"], "source": ["npj Comput. Mater."], "year": ["2019"], "volume": ["5"], "fpage": ["83"], "pub-id": ["10.1038/s41524-019-0221-0"]}, {"label": ["7."], "surname": ["Strieth-Kalthoff"], "given-names": ["F"], "article-title": ["Machine learning for chemical reactivity: the importance of failed experiments"], "source": ["Angew. Chem. Int. Ed."], "year": ["2022"], "volume": ["61"], "fpage": ["e202204647"], "pub-id": ["10.1002/anie.202204647"]}, {"label": ["8."], "surname": ["Taniike", "Takahashi"], "given-names": ["T", "K"], "article-title": ["The value of negative results in data-driven catalysis research"], "source": ["Nat. Catal."], "year": ["2023"], "volume": ["6"], "fpage": ["108"], "lpage": ["111"], "pub-id": ["10.1038/s41929-023-00920-9"]}, {"label": ["12."], "surname": ["Hammer", "N\u00f8rskov"], "given-names": ["B", "JK"], "article-title": ["Theoretical surface science and catalysis\u2014calculations and concepts"], "source": ["Adv. Catal."], "year": ["2000"], "volume": ["45"], "fpage": ["71"], "lpage": ["129"]}, {"label": ["13."], "surname": ["Clavier", "Nolan"], "given-names": ["H", "SP"], "article-title": ["Percent buried volume for phosphine and N-eterocyclic carbeneligands: steric properties in organometallic chemistry"], "source": ["Chem. Commun."], "year": ["2010"], "volume": ["46"], "fpage": ["841"], "lpage": ["861"], "pub-id": ["10.1039/b922984a"]}, {"label": ["16."], "surname": ["Liu"], "given-names": ["J"], "article-title": ["Toward excellence of electrocatalyst design by emerging descriptor-oriented machine learning"], "source": ["Adv. Funct. Mater."], "year": ["2022"], "volume": ["32"], "fpage": ["2110748"], "pub-id": ["10.1002/adfm.202110748"]}, {"label": ["17."], "surname": ["Zhang"], "given-names": ["Y"], "article-title": ["Descriptor-free design of multicomponent catalysts"], "source": ["ACS Catal."], "year": ["2022"], "volume": ["12"], "fpage": ["10562"], "lpage": ["10571"], "pub-id": ["10.1021/acscatal.2c02807"]}, {"label": ["18."], "surname": ["Urakawa", "Baiker"], "given-names": ["A", "A"], "article-title": ["Space-resolved profiling relevant in heterogeneous catalysis"], "source": ["Top. Catal."], "year": ["2009"], "volume": ["52"], "fpage": ["1312"], "lpage": ["1322"], "pub-id": ["10.1007/s11244-009-9312-3"]}, {"label": ["19."], "surname": ["Wada"], "given-names": ["T"], "article-title": ["Structure-performance relationship of Mg(OEt)"], "sub": ["2"], "source": ["J. Catal."], "year": ["2020"], "volume": ["389"], "fpage": ["525"], "lpage": ["532"], "pub-id": ["10.1016/j.jcat.2020.06.030"]}, {"label": ["20."], "surname": ["Liu"], "given-names": ["C"], "article-title": ["Machine learning to predict quasicrystals from chemical compositions"], "source": ["Adv. Mater."], "year": ["2021"], "volume": ["33"], "fpage": ["2102507"], "pub-id": ["10.1002/adma.202102507"]}, {"label": ["22."], "surname": ["Kim", "Pilania", "Ramprasad"], "given-names": ["C", "G", "R"], "article-title": ["From organized high-throughput data to phenomenological theory using machine learning: the example of dielectric breakdown"], "source": ["Chem. Mater."], "year": ["2016"], "volume": ["28"], "fpage": ["1304"], "lpage": ["1311"], "pub-id": ["10.1021/acs.chemmater.5b04109"]}, {"label": ["24."], "surname": ["Suzuki"], "given-names": ["K"], "article-title": ["Statistical analysis and discovery of heterogeneous catalysts based on machine learning from diverse published data"], "source": ["ChemCatChem."], "year": ["2019"], "volume": ["11"], "fpage": ["4537"], "lpage": ["4547"], "pub-id": ["10.1002/cctc.201900971"]}, {"label": ["25."], "surname": ["Williams", "McCullough", "Lauterbach"], "given-names": ["T", "K", "JA"], "article-title": ["Enabling catalyst discovery through machine learning and high-throughput experimentation"], "source": ["Chem. Mater."], "year": ["2020"], "volume": ["32"], "fpage": ["157"], "lpage": ["165"], "pub-id": ["10.1021/acs.chemmater.9b03043"]}, {"label": ["26."], "surname": ["Ishioka"], "given-names": ["S"], "article-title": ["Designing catalyst descriptors for machine learning in oxidative coupling of methane"], "source": ["ACS Catal."], "year": ["2022"], "volume": ["12"], "fpage": ["11541"], "lpage": ["11546"], "pub-id": ["10.1021/acscatal.2c03142"]}, {"label": ["27."], "surname": ["Nguyen"], "given-names": ["TN"], "article-title": ["Learning catalyst design based on bias-free data set for oxidative coupling of methane"], "source": ["ACS Catal."], "year": ["2021"], "volume": ["11"], "fpage": ["1797"], "lpage": ["1809"], "pub-id": ["10.1021/acscatal.0c04629"]}, {"label": ["28."], "surname": ["Nakanowatari"], "given-names": ["S"], "article-title": ["Extraction of catalyst design heuristics from random catalyst dataset and their utilization in catalyst development for oxidative coupling of methane"], "source": ["ChemCatChem."], "year": ["2021"], "volume": ["13"], "fpage": ["3262"], "lpage": ["3269"], "pub-id": ["10.1002/cctc.202100460"]}, {"label": ["31."], "surname": ["Jayakumar"], "given-names": ["TP"], "article-title": ["Exploration of ethanol-to-butadiene catalysts by high-throughput experimentation and machine learning"], "source": ["Appl. Catal. A Gen."], "year": ["2023"], "volume": ["666"], "fpage": ["119427"], "pub-id": ["10.1016/j.apcata.2023.119427"]}, {"label": ["32."], "mixed-citation": ["Son, S. D. et al. High-throughput screening of multimetallic catalysts for three-way catalysis. "], "italic": ["Sci. Technol. Adv. Mater. Methods"]}, {"label": ["33."], "mixed-citation": ["Yoshida, R. XenonPy is a Python software for materials informatics. "], "ext-link": ["https://github.com/yoshida-lab/XenonPy"]}, {"label": ["34."], "surname": ["Huber"], "given-names": ["PJ"], "article-title": ["Robust estimation of a location parameter"], "source": ["Ann. Math. Stat."], "year": ["1964"], "volume": ["35"], "fpage": ["73"], "lpage": ["101"], "pub-id": ["10.1214/aoms/1177703732"]}, {"label": ["35."], "surname": ["Maaten", "Hinton"], "given-names": ["LVD", "G"], "article-title": ["Visualizing data using t-SNE"], "source": ["J. Mach. Learn. Res."], "year": ["2008"], "volume": ["9"], "fpage": ["2579"], "lpage": ["2605"]}, {"label": ["36."], "surname": ["Wu", "Li"], "given-names": ["J", "S"], "article-title": ["The role of distorted WO"], "sub": ["4"], "source": ["J. Phys. Chem."], "year": ["1995"], "volume": ["99"], "fpage": ["4566"], "lpage": ["4568"], "pub-id": ["10.1021/j100013a030"]}, {"label": ["37."], "surname": ["Ji"], "given-names": ["S"], "article-title": ["Surface WO"], "sub": ["4", "2"], "source": ["J. Catal."], "year": ["2003"], "volume": ["220"], "fpage": ["47"], "lpage": ["56"], "pub-id": ["10.1016/S0021-9517(03)00248-3"]}, {"label": ["38."], "surname": ["Ito", "Wang", "Lin", "Lunsford"], "given-names": ["T", "J", "CH", "JH"], "article-title": ["Oxidative dimerization of methane over a lithium-promoted magnesium oxide catalyst"], "source": ["J. Am. Chem. Soc."], "year": ["1985"], "volume": ["107"], "fpage": ["5062"], "lpage": ["5068"], "pub-id": ["10.1021/ja00304a008"]}, {"label": ["39."], "surname": ["Xu", "Yu", "Cai", "Huang", "Guo"], "given-names": ["Y", "L", "C", "J", "X"], "article-title": ["A study of the oxidative coupling of methane over SrO-La"], "sub": ["2", "3", "2"], "source": ["Catal. Lett."], "year": ["1995"], "volume": ["35"], "fpage": ["215"], "lpage": ["231"], "pub-id": ["10.1007/BF00807178"]}, {"label": ["40."], "surname": ["Ortiz-Bravo", "Chagas", "Toniolo"], "given-names": ["CA", "CA", "FS"], "article-title": ["Oxidative coupling of methane (OCM): An overview of the challenges and opportunities for developing new technologies"], "source": ["J. Nat. Gas. Sci. Eng."], "year": ["2021"], "volume": ["96"], "fpage": ["104254"], "pub-id": ["10.1016/j.jngse.2021.104254"]}, {"label": ["41."], "surname": ["Choudhary", "Banerjee", "Choudhary"], "given-names": ["TV", "S", "VR"], "article-title": ["Catalysts for combustion of methane and lower alkanes"], "source": ["Appl. Catal. A Gen."], "year": ["2002"], "volume": ["234"], "fpage": ["1"], "lpage": ["23"], "pub-id": ["10.1016/S0926-860X(02)00231-4"]}, {"label": ["42."], "surname": ["Mine"], "given-names": ["S"], "article-title": ["Analysis of updated literature data up to 2019 on the oxidative coupling of methane using an extrapolative machine-learning method to identify novel catalysts"], "source": ["ChemCatChem."], "year": ["2021"], "volume": ["13"], "fpage": ["3636"], "lpage": ["3655"], "pub-id": ["10.1002/cctc.202100495"]}, {"label": ["43."], "surname": ["Esterhuizen", "Goldsmith", "Linic"], "given-names": ["JA", "BR", "S"], "article-title": ["Interpretable machine learning for knowledge generation in heterogeneous catalysis"], "source": ["Nat. Catal."], "year": ["2022"], "volume": ["5"], "fpage": ["175"], "lpage": ["184"], "pub-id": ["10.1038/s41929-022-00744-z"]}, {"label": ["45."], "surname": ["Trunschke"], "given-names": ["A"], "article-title": ["Prospects and challenges for autonomous catalyst discovery viewed from an experimental perspective"], "source": ["Catal. Sci. Technol."], "year": ["2022"], "volume": ["12"], "fpage": ["3650"], "lpage": ["3669"], "pub-id": ["10.1039/D2CY00275B"]}, {"label": ["46."], "mixed-citation": ["Ferri, F. J., Pudil, P., Hatef, M. & Kittler, J. Comparative study of techniques for large-scale feature selection. In: "], "italic": ["Pattern Recognition in Practice Iv: Multiple Paradigms, Comparative Studies, and Hybrid Systems: Proceedings of an International Workshop held on Vlieland, The Netherlands, 1\u20133 June 1994"]}, {"label": ["47."], "surname": ["Nguyen"], "given-names": ["TN"], "article-title": ["High-throughput experimentation and catalyst informatics for oxidative coupling of methane"], "source": ["ACS Catal."], "year": ["2020"], "volume": ["10"], "fpage": ["921"], "lpage": ["932"], "pub-id": ["10.1021/acscatal.9b04293"]}]
{ "acronym": [], "definition": [] }
47
CC BY
no
2024-01-14 23:40:16
Commun Chem. 2024 Jan 12; 7:11
oa_package/d7/e6/PMC10786848.tar.gz
PMC10786849
38216585
[ "<title>Introduction</title>", "<p id=\"Par3\">Antimicrobial resistance (AMR) has become one of the most serious public health problems of the 21st century, threatening the effective prevention and treatment of infections in humans and animals alike<sup>##UREF##0##1##,##UREF##1##2##</sup>. A bacterial strain is considered multidrug-resistant (MDR) if it is resistant to at least one agent in three or more antimicrobial classes<sup>##REF##21793988##3##</sup>. Carbapenems are a group of last-line antibiotics for treating infections caused by MDR Gram-negative bacteria<sup>##REF##21859938##4##</sup>. However, carbapenem resistance has been observed in many pathogens, including members of the Enterobacteriaceae family such as <italic>Escherichia coli</italic><sup>##REF##21859938##4##,##REF##26862399##5##</sup>. The most frequently observed carbapenem resistance mechanism in Enterobacteriaceae is the production of carbapenemases that hydrolyse carbapenems<sup>##REF##21859938##4##,##REF##31481937##6##</sup>. <italic>Klebsiella pneumoniae</italic> carbapenemase, New Delhi metallo-β-lactamase (NDM), imipenemase, Verona integron-encoded metallo-β-lactamase, and oxacillinase-48 (OXA-48) are the most commonly encountered carbapenemases in Enterobacteriaceae<sup>##REF##22000347##7##–##REF##34535075##9##</sup>. Among these, NDM has been reported to be highly prevalent in many parts of the world<sup>##REF##34535075##9##–##REF##30700432##11##</sup>.</p>", "<p id=\"Par4\">In the past two decades, carbapenem-resistant <italic>E. coli</italic> (CREC) has emerged rapidly and become increasingly prevalent around the globe, causing various hard-to-treat clinical infections<sup>##REF##34535075##9##,##REF##27866944##10##,##REF##27033631##12##</sup>. The global CREC population is made up of diverse multilocus sequence types (STs) with varied geographic distributions. A previous study reported two major (&gt;10%) STs (ST410 and ST131) and three minor (5–10%) STs (ST1248, ST167, and ST405) in a global collection of 229 CREC collected by two global surveillance programs during 2015–2017<sup>##UREF##2##13##</sup>. No CREC from China was reported in that study<sup>##UREF##2##13##</sup>, although CREC isolates are frequently isolated in Chinese healthcare settings. Two Chinese national surveillance studies carried out over a similar period (2014–2017) revealed that most CREC isolates in China belonged to ST167 or ST131, with ST410 the third most prevalent<sup>##REF##34535075##9##,##REF##28479289##14##</sup>.</p>", "<p id=\"Par5\"><italic>E. coli</italic> ST410 is an extraintestinal pathogen associated with multidrug resistance, and has been recognised as a high-risk international clone<sup>##UREF##3##15##,##REF##31482141##16##</sup>. Whole-genome sequence analysis and evolutionary reconstruction of <italic>E. coli</italic> ST410 revealed that ST410 is comprised of two lineages, namely lineage A with <italic>fimH</italic>53 (A/H53) and lineage B with <italic>fimH</italic>24 (B/H24)<sup>##UREF##3##15##</sup>. The B/H24 lineage is further divided into four sub-lineages: B1/H24, B2/H24R, B3/H24Rx and B4/H24RxC. Sub-lineage B2/H24R is characterised by fluoroquinolone resistance associated with mutations in <italic>gyrA</italic> and <italic>parC</italic>, B3/H24Rx is defined by the introduction of the extended-spectrum β-lactamase-encoding gene <italic>bla</italic><sub>CTX-M-15</sub>, and B4/H24RxC is defined by a further introduction of the carbapenem resistance gene <italic>bla</italic><sub>OXA-181</sub> carried on an IncX3 plasmid<sup>##UREF##3##15##</sup>. A more recent study has proposed a modification to this classification, where ST410-B1 is identical to B1/H24, ST410-B2 includes both B2/H24R and B3/H24Rx, and ST410-B3 is identical to B4/H24RxC<sup>##UREF##4##17##</sup>. That study characterised ST410-B2 by the introduction of fluoroquinolone resistance mutations and ST410-B3 by the acquisition of a four-amino-acid (YRIN N337N) insertion in the <italic>ftsI</italic>-encoded penicillin-binding protein 3 (PBP3, also called FtsI)<sup>##UREF##4##17##</sup>. The YRIN insertion in PBP3, together with YRIK and TIPY insertions, were reported to confer reduced susceptibility to a broad range of β-lactams such as ceftazidime, cefepime and aztreonam<sup>##REF##25634992##18##,##UREF##5##19##</sup>. Chen et al. reported that nearly all (292/293) ST410-B3 isolates analysed contain the <italic>ftsI</italic> YRIN insetion<sup>##UREF##4##17##</sup>. Over the past decade, there have been increasing reports of serious infections and possible hospital outbreaks involving the carbapenem-resistant ST410 sub-lineage B4/H24RxC in both developed and low- and middle-income countries<sup>##UREF##3##15##,##REF##31482141##16##,##REF##31576153##20##–##REF##31176748##23##</sup>.</p>", "<p id=\"Par6\">In this work, we investigate the population of clinical CREC isolates from Chinese hospital patients between 2017 and 2021. The most commonly isolated CREC lineage, ST410, is analysed further. We examine the global ST410 population structure by comparing 847 publicly available ST410 genomes to the 109 ST410 genomes generated in this study. A hypervirulent MDR ST410 clone is identified and designated B5/H24RxC. Comparative genomic analyses and phenotypic assays are performed to characterise B5/H24RxC and provide insights into its emergence and evolution.</p>" ]
[ "<title>Methods</title>", "<title>Ethics and consent</title>", "<p id=\"Par30\">This study was approved by the medical ethics committee of the First Affiliated Hospital of Guangzhou Medical University (GMU) on 21 May 2018. For the work involving the CREC isolates from the children’s hospital, ethics was approved by the medical ethics committee of the Children’s Hospital of Soochow University on 5 January, 2021. Individual consent was obtained from the patients’ guardians by hospital staff.</p>", "<title>Bacterial isolates and antimicrobial susceptibility testing</title>", "<p id=\"Par31\">An initial collection of 168 CREC isolates (GMU collection) were isolated from patients admitted to municipal hospitals in Guangzhou, Jiangsu and Beijing during 2018–2021. All isolates were identified as <italic>E. coli</italic> by a VITEK 2 Compact system (BioMérieux, Marcy l’Etoile, France) and confirmed to be carbapenem resistant by antimicrobial susceptibility testing. Minimum inhibitory concentrations (MICs) of meropenem, imipenem and ertapenem were determined by broth microdilution method according to the Clinical Laboratory and Standards Institute (CLSI) M100 (31st edition). The MICs of other antibiotics, including polymyxin B and tigecycline, were also determined by broth microdilution method according to European Committee on Antimicrobial Susceptibility Testing (EUCAST). For polymyxin B and tigecycline, the breakpoints defined by the EUCAST were used. All antibiotics were purchased from Macklin, Shanghai, China. <italic>E. coli</italic> ATCC 25922 and <italic>P. aeruginosa</italic> ATCC 27853 were used for standardisation.</p>", "<p id=\"Par32\">A further 220 CREC collected by the China Antimicrobial Surveillance Network (CHINET) from Chinese hospitals in 26 provinces during 2017–2021 were also included in this study. Whole-genome sequencing data and relevant metadata of the isolates, including MICs for meropenem, imipenem, polymyxin B and tigecycline, were provided by CHINET. Metadata for isolates from both collections are presented in Supplementary Data ##SUPPL##3##1##.</p>", "<title>Whole-genome sequencing and publicly available sequences</title>", "<p id=\"Par33\">Whole-genome sequencing was performed for all CREC isolates (<italic>n</italic> = 168) for the initial collection. Briefly, single colonies from an overnight agar plate were cultured in 4 ml of LB broth at 37 °C for 16 h, and genomic DNA was extracted using a Bacterial DNA Kit D3350 (Omega BioTek, USA). Sequencing was conducted by Novogene (Beijing, China) using an Illumina Novaseq 6000 platform (Illumina, San Diego, CA, USA). Five isolates were also subjected to whole-genome sequencing using the long-read MinION Sequencer (Nanopore; Oxford, UK) by Novogene (Beijing, China). These five isolates (E22, 18-4, 20-16, 19-7, and 20-20; Table ##SUPPL##0##S1##) belong to the B5/H24RxC clone and they were selected based on their genomic differences, representing the range of diversity as suggested by their positions in the phylogeny.</p>", "<p id=\"Par34\">For the analysis of a resistant clone of <italic>E. coli</italic> ST410 identified in this study, EnteroBase (<ext-link ext-link-type=\"uri\" xlink:href=\"http://enterobase.warwick.ac.uk/\">http://enterobase.warwick.ac.uk/</ext-link>) was searched for <italic>E. coli</italic> ST410 genomes (accessed on 13 Jan 2022) and only genomes with relevant metadata (year of collection, country and source type) and availability of raw reads were included (<italic>n</italic> = 790). <italic>E. coli</italic> ST410 genomes used by a previous study<sup>##UREF##3##15##</sup> that were not present in the EnteroBase data set (<italic>n</italic> = 84) were also included. SRA and ENA accession numbers were extracted and raw reads for the genomes were downloaded from the European Nucleotide Archive. Metadata for the genomes are presented in Supplementary Data ##SUPPL##4##2##.</p>", "<title>Genome assembly, annotation, and characterisation</title>", "<p id=\"Par35\">Illumina sequence reads were trimmed and assembled with Shovill v1.1.0 with default settings (<ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/tseemann/shovill\">https://github.com/tseemann/shovill</ext-link>) and assemblies were assessed for contamination and completeness using QUAST v5.0.2, CheckM v1.1.3 and Centrifuge v1.0.4<sup>##REF##27852649##42##–##REF##29949969##44##</sup>. Assemblies with a genome size greater than six million base pairs, an N50 smaller than 15,000 or a genome contamination greater than 2% were excluded from further analysis. A de novo hybrid of assembly of both Illumina reads and Nanopore reads was carried out using Unicycler v0.4.8 with default settings<sup>##REF##28594827##45##</sup>. Prokka v1.14.0 was used to annotate the genome sequences<sup>##REF##24642063##46##</sup>. Acquired ARGs and mutations that confer resistance were identified using abritAMR v1.0.13, an ISO-certified bioinformatics platform for genomics-based bacterial AMR detection<sup>##REF##36599823##47##</sup>. Plasmid replicons, virulence factors and serotypes were identified with ABRicate v1.0.1 (<ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/tseemann/abricate\">https://github.com/tseemann/abricate</ext-link>), using the Resfinder<sup>##REF##22782487##48##</sup>, Plasmidfinder<sup>##REF##24777092##49##</sup>, Ecoli-vf and EcOH<sup>##UREF##6##27##</sup> databases (updated on 15 September 2022) with default parameters. Multilocus sequence types (MLSTs) were determined using MLST v2.19.0 (<ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/tseemann/mlst\">https://github.com/tseemann/mlst</ext-link>) with the “ecoli” scheme. <italic>fimH</italic> types were identified with FimTyper v1.0<sup>##REF##28592545##50##</sup>.</p>", "<p id=\"Par36\">Protein sequences of GyrA, GyrB, ParC, ParE, FtsI (PBP3), and FyuA were obtained from all genomes by performing a TBLASTN query of a representative protein sequence for each of the six proteins. Amino acid substitutions in the quinolone resistance-determining regions (QRDRs; in GyrA, GyrB, ParC and ParE) and insertion in FstI were identified by comparing their protein sequences with the corresponding protein sequences from quinolone- and fluoroquinolone-susceptible <italic>E. coli</italic> K-12 MG1655 GenBank: <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/nuccore/NC_000913.3/\">NC_000913.3</ext-link>).</p>", "<title>Phylogenetic analysis of <italic>E. coli</italic> ST410</title>", "<p id=\"Par37\">To construct a global phylogeny for ST410 <italic>E. coli</italic>, 956 genomes (109 from this study and 847 publicly available genomes that passed quality control) were used to generate a full-length whole-genome alignment using Snippy v4.6.0 (<ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/tseemann/snippy\">https://github.com/tseemann/snippy</ext-link>) with ST410 isolate YD786 (GenBank accession <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/datasets/genome/GCF_001442495.1/\">CP013112.1</ext-link>) as the reference. The full-length whole-genome alignment was cleaned with the snippy-clean function and then used as an input to Gubbins v2.4.1<sup>##REF##25414349##51##</sup> for identifying and filtering regions of homologous recombination. Variant sites in the alignment were extracted using SNP-sites v2.5.1<sup>##REF##28348851##52##</sup> and a maximum-likelihood (ML) phylogenetic tree was reconstructed using IQ-tree<sup>##REF##25371430##53##</sup> accounting for constant sites in the alignment and run for 1000 bootstraps using the extended model selection function. The resulting tree was annotated in iTOL<sup>##REF##33885785##54##</sup>. The phylogeny of the ST410 CREC isolated from a Chinese children’s hospital with potential outbreaks was also constructed with the complete genome of isolate 19-7 as the reference using the methods described above.</p>", "<p id=\"Par38\">Analysis of population structure within the ML phylogeny was conducted using Fastbaps v1.0 to identify major clusters under default parameters<sup>##REF##31076776##32##</sup>. Pairwise SNP distances between isolate genomes were calculated using snp-dists v0.8.2 (<ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/tseemann/snp-dists\">https://github.com/tseemann/snp-dists</ext-link>) using the recombination removed alignment from Gubbins as input.</p>", "<title>Comparative genomic analysis of B4/H24RxC and B5/H24RxC clones</title>", "<p id=\"Par39\">Prokka-annotated sequences of both B4/H24RxC (<italic>n</italic> = 214) and B5/H24RxC (<italic>n</italic> = 174) were analysed with Panaroo v1.2.7<sup>##REF##32698896##55##</sup> under default settings to infer core and pangenomes. Clone association analysis of the genes in the pangenome matrix was performed with Scoary v1.6.16<sup>##REF##27887642##56##</sup> with a maximum Benjamini–Hochberg adjusted <italic>P</italic> value of 1E-30.</p>", "<p id=\"Par40\">Using the method described above, a smaller scale core-genome SNP phylogeny was reconstructed only for the genomes in these two clones with the complete genome of a previously reported isolate 020026 (B4/H24RxC; Genbank: <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/datasets/genome/GCF_002164975.2/\">CP034954 to CP034958</ext-link>) used as the reference<sup>##REF##31482141##16##</sup> and isolate A8 (B3/H24Rx) from this study as outgroup. SNPs specific to the B5/H24RxC MDR clone were identified by feeding the entire SNP matrix of all genomes of both clones into Scoary v1.6.16<sup>##REF##27887642##56##</sup> using the same settings as described above. Gubbins v2.4.1<sup>##REF##25414349##51##</sup> was used to determine whether the clone-specific genes and SNPs were due to recombination. The exact sequence locations for phage regions in the complete genomes of reference strains 19-7 and 020026 were identified using the PHASTER server<sup>##REF##27141966##57##</sup>.</p>", "<p id=\"Par41\">Plasmid sequences were examined and manually annotated in Gene Construction Kit v4.5.1 (Textco Biosoftware, Raleigh, USA). Plasmid replicons were initially identified with the PlasmidFinder database as described above, and PubMLST was used to sub-type F-type replicons (<ext-link ext-link-type=\"uri\" xlink:href=\"https://pubmlst.org/organisms/plasmid-mlst\">https://pubmlst.org/organisms/plasmid-mlst</ext-link>). Insertion sequences were identified using the ISFinder database (<ext-link ext-link-type=\"uri\" xlink:href=\"https://isfinder.biotoul.fr/\">https://isfinder.biotoul.fr/</ext-link>).</p>", "<p id=\"Par42\">The sequence of the O-antigen Onovel1 identified in the majority of B5/H24RxC isolates was used to perform a web nucleotide BLAST. The top match was a previously reported O-antigen OgN5<sup>##UREF##6##27##</sup>. Pairwise alignment and visualisation of the two sequences were carried out using clinker v0.0.28<sup>##REF##33459763##58##</sup>.</p>", "<title>Coalescent analysis of <italic>E. coli</italic> ST410</title>", "<p id=\"Par43\">Treemmer v0.3<sup>##REF##29716518##59##</sup> was used to reduce the ST410 global phylogeny to 500 genomes, maintaining ~95% of the original genetic diversity. The subsampled genomes had also maintained the diversity in year of isolation and country of origin (Fig. S##SUPPL##0##4##). A time-calibrated phylogeny for ST410 was reconstructed using the SNP alignment data generated from the raw sequence data of the selected 500 genomes as described above. Each sequence in the alignment was annotated with the year of isolation. The presence of a temporal signal in the data was investigated by inferring linear relationship between root-to-tip distances of the phylogenetic branches and the year of sample isolation using TempEst v1.5.3<sup>##UREF##10##60##</sup>, which revealed a correlation coefficient of <italic>R</italic><sup>2</sup> = 0.32. Coalescence-based analysis was performed with BEAST v2.6.6<sup>##REF##30958812##61##</sup>. In order to identify the most suitable model, analyses were performed using different substitution models (GTR and HKY), strict and relaxed molecular clock, and different demographic models including Bayesian Skyline, constant population and exponential population. Model selection was performed using Nested Sampling<sup>##REF##29961836##62##</sup> v1.1.0 within the BEAST2 package with a particle count of 1, sub chain length of 5000, and Epsilon of 1.0 × 10<sup>−12</sup>. The best fit model was estimated to be a GTR model and a relaxed molecular clock with a Bayesian Skyline population model (Table ##SUPPL##0##S4##). Three replicates for this model were run for 700 million Markov chain Monte Carlo (MCMC) iterations, sampling every 50,000 states. Log files were combined with a 10% burn-in using LogCombiner v2.6.6 and assessed for convergence by checking the effective sample size (ESS, &gt;200 for each parameter) using Tracer v1.7.2. A maximum clade creditability tree summarising the posterior sample of trees in the combined MCMC runs was generated with TreeAnnotator v2.6.6. The resulting tree was annotated and visualised with iTOL<sup>##REF##33885785##54##</sup> and ggtree v3.2.1<sup>##UREF##11##63##</sup>.</p>", "<title>Growth curves and qPCR-based competition assays</title>", "<p id=\"Par44\">An optical growth analyser (BioTek Epoch2, USA) was used to monitor the growth rate of ST410 strains of B4/H24RxC and B5/H24RxC clones. Based on their availability and their genetic characteristics, B4/H24RxC isolates (005828 and 045869) and B5/H24RxC isolates (18-13, 19-3, 19-17, 20-11, 20-25, and 20-30) were selected for the assay. Briefly, overnight cultures in LB were adjusted to a turbidity equivalent to that of a 0.5 McFarland standard and then inoculated 1:1000 in fresh LB, half strength LB or 1/10 strength LB. For each strain, 300 μl of inoculated medium was added into wells of the microplate in triplicate. Fresh medium was also added to three wells acting as blank controls. Cultures were incubated at 37 °C with continuous shaking for 24 h and OD<sub>600</sub> was measured every 30 min. Growth curves for each strain during the exponential phase were analysed with the GraphPad Prism 9 software. The doubling time was calculated from growth curve using fitted curve of sigmoid function with a Python script available at <ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/huoww07/calulate_bacteria_doubling_time\">https://github.com/huoww07/calulate_bacteria_doubling_time</ext-link>. Strain ATCC 25922 was included as a growth control in the assay. Two-tailed unpaired Student’s <italic>t</italic> test was employed to measure the difference between the doubling time of the two clones.</p>", "<p id=\"Par45\">The growth dynamics of both clones were further investigated using a qPCR-based head to head competition assay in LB. In each competition group, a <italic>yodB</italic> positive isolate of the B4/H24RxC clone was in competition with a <italic>fyuA</italic> positive isolate of the B5/H24RxC clone. For instance, overnight cultures of isolate 005828 (B4/H24RxC) and 18-13 (B5/H24RxC) in LB were adjusted to a turbidity equivalent to that of a 0.5 McFarland standard and equal amount of the adjusted cultures were inoculated 1:200 into the same tube of fresh LB. Culture was incubated at 37 °C with continuous shaking for 24 h and samples were taken at hour 0, 4, 8, 12, and 24 for DNA extraction using the Bacterial DNA kit D3350 (Omega BioTek, USA). qPCR was performed using the HiScript III RT SuperMix for qPCR kit (Vazyme, China) on a Roche LightCycler PCR instrument (Roche, Sweden) using <italic>yodB</italic> and <italic>fyuA</italic> primers. Relative amount of the genes was calculated using 16S rRNA as the reference. The 2<sup>-ΔΔCt</sup> method was used to determine the ratio of <italic>fyuA</italic> to <italic>yodB</italic><sub>.</sub> The primers used were 16srRNA-F: GGAAGAAGCTTGCTTCTTTGCTGAC and 16srRNA-R: AGCCCGGGGATTTCACATCTGACTTA; <italic>yodB</italic>-F: GGTGGCACAATAGAAGGAT and <italic>yodB</italic>-R: TTATCTGCTGATGCGAGAA; <italic>fyuA</italic>-F: CAGTAGGCACGATGTTGTA and <italic>fyuA</italic>-R: GCTATCCGCAGGCTATATG.</p>", "<title>Virulence assay</title>", "<p id=\"Par46\">The wax moth (<italic>Galleria mellonella</italic>) larvae assay was based on a previously described method<sup>##REF##31482141##16##,##REF##27824518##64##</sup>. The larvae (~35 days after hatching and of 300 ± 50 mg) were purchased from Huiyude Biotechnology (Tianjin, China). B4/H24RxC isolates (005828 and 045869) and B5/H24RxC isolates (18-13, 19-3, 19-17, 20-11, 20-25 and 20-30) were assessed for their virulence. Hypervirulent <italic>Klebsiella pneumoniae</italic> strain K1088<sup>##REF##28864030##65##</sup> and hypervirulent <italic>Acinetobacter baumannii</italic> strain AB5075<sup>##REF##24865555##66##</sup> were used as positive controls while <italic>Acinetobacter baumannii</italic> ATCC 19606 and PBS were used as negative controls. Single bacterial colonies were used to inoculate 5 ml of LB and incubated at 37 °C with 200 rpm shaking for about 6 to 8 h to reach the exponential phase. Cultures then were adjusted to a turbidity equivalent to 10<sup>8</sup> CFU/ml in PBS as predetermined by plate count and further diluted 1:10 to obtain cultures of 10<sup>7</sup> CFU/ml. For each strain, three groups of larvae (<italic>n</italic> = 10 in each group) were injected with 20 μl of aliquots of diluted culture via the last left proleg using a Disposable Sterile Insulin Syringe U-100 (B.Braun, Germany). The infected larvae were kept at 37 °C during the course of the assay and survival of the larvae was recorded at hour 6, 12, 18, 24, 36, 48 and 72. Survival curves were generated and analysed using GraphPad Prism 9 software.</p>", "<title>Iron source growth assay</title>", "<p id=\"Par47\">The growth of B5/H24RxC isolates (18-13, 19-3, 19-17, 20-11, 20-25, and 20-30) were evaluated under different iron sources on LB agar plates using B4/H24RxC isolates (005828 and 045869) as controls as described previously with modifications<sup>##REF##31482141##16##,##REF##22554901##67##</sup>. Briefly, the MIC of 2′2-dipyridyl (DIP; Macklin, China) was determined using a previously described method<sup>##REF##31482141##16##</sup> and all the isolates had an MIC of 300 μM. For each isolate, a single colony from an overnight LB agar plate was cultured in LB broth containing 200 μM DIP for 6 h to limit the growth of the isolate. Bacterial cells were then collected by centrifugation at 4000 × <italic>g</italic>, washed and resuspended in PBS to a turbidity equivalent to that of a 0.5 McFarland standard. About 10<sup>5</sup> CFU of each isolate were then spread onto LB agar plates containing DIP at the MIC (300 μM for all isolates). Iron sources (10 μl) of different concentrations including bovine serum albumin (10 mg/ml, 25 mg/ml, 50 mg/ml), FeCl<sub>2</sub> (1 mM, 5 mM, 10 mM), hemin (0.01 mM, 0.1 mM, 1 mM), haemoglobin (1 mg/ml, 10 mg/ml, 50 mg/ml), holo-transferrin (10 mg/ml, 25 mg/ml, 50 mg/ml), and lactoferrin (10 mg/ml, 25 mg/ml, 50 mg/ml) were spotted directly onto the plates and were incubated 48 to 72 h at 37 °C. Plates without iron sources added were used as negative control. The growth of bacteria was detected by visual inspection. All iron sources were purchased from Macklin, China.</p>", "<title>Biofilm formation assays</title>", "<p id=\"Par48\">Biofilm formation assays were performed on the strains above following a previously described method<sup>##REF##21860999##31##</sup>. For each strain, bacterial cells harvested from overnight culture were resuspended in PBS to a turbidity equivalent to that of a 0.5 McFarland standard and further inoculated 1:100 into fresh LB medium. Aliquots (200 μl, <italic>n</italic> = 12) of the inoculated LB were added into a 96-well polystyrene microplate and were incubated at 37 °C for 24 h. The microplate was then washed three times with PBS and air-dried for 30 mins. Biofilms in the wells were stained with 250 μl 1% (w/v) crystal violet for 20 mins at room temperature. The stained wells were again washed with distilled water to remove unbound stain and allowed to dry for 30 mins. The stained biofilms were treated with 200 μl 33% acetic acid and OD<sub>570</sub> was recorded using a fluorometer plate reader (BioTek Epoch2, USA). <italic>Acinetobacter baumannii</italic> ATCC 27853 and fresh LB were used as positive and negative controls. Optical density cutoff (ODc) was calculated as the average OD of the negative control plus three times the standard deviation of the negative control as proposed previously<sup>##REF##17696944##30##,##REF##21860999##31##</sup>. An average OD value ≤ ODc, &gt;ODc and ≤2x ODc, &gt;2x ODc and ≤ 4x ODc, and &gt;4x ODc indicates non-, weak, moderate and strong biofilm production, respectively.</p>", "<title>Statistics and reproducibility</title>", "<p id=\"Par49\">Statistical analyses were performed using GraphPad Prism (version 9.3.1). Level of significance between two groups was assessed with two-tailed unpaired Student’s <italic>t</italic> test. Survival analysis for wax moth larvae infected with different bacterial strains was performed using Log-rank (Mantel–Cox) test with GraphPad Prism (version 9.3.1). All information on sample sizes and statistics can be found in the figure legends and the reporting summary. No statistical method was used to predetermine sample size. No data were excluded from the analyses. Wax moth larvae were randomly allocated into different groups. Other experiments were not randomised. The investigators were not blinded to allocation during experiments and outcome assessment.</p>", "<title>Data visualisation</title>", "<p id=\"Par50\">Bar charts, violin plots and line charts were generated using GraphPad Prism (version 9.3.1). Maps were generated using ggplot2<sup>##UREF##12##68##</sup> and sf <sup>##UREF##13##69##</sup> packages. Phylogenetic trees were annotated and visualised with iTOL<sup>##REF##33885785##54##</sup>, ggtree v3.2.1<sup>##UREF##11##63##</sup> or Phandango<sup>##REF##29028899##70##</sup>. Pairwise alignment and visualisation of the genomic sequences were carried out using clinker v0.0.28<sup>##REF##33459763##58##</sup>.</p>", "<title>Reporting summary</title>", "<p id=\"Par51\">Further information on research design is available in the ##SUPPL##11##Nature Portfolio Reporting Summary## linked to this article.</p>" ]
[ "<title>Results</title>", "<title>Characteristics of CREC isolates from Chinese hospitals</title>", "<p id=\"Par7\">A total of 388 CREC isolates were collected from hospitals across 26 Chinese provinces between 2017 and 2021 (Fig. ##FIG##0##1##a, ##FIG##0##c##; Supplementary Data ##SUPPL##3##1##). The isolates were recovered from various clinical samples, including ascites, bile, blood, bronchoalveolar fluid, pus, wound secretion, sputum and urine. The most common clinical sample types were urine (<italic>n</italic> = 111), sputum (<italic>n</italic> = 64) and blood (<italic>n</italic> = 47) (Fig. ##FIG##0##1b##), indicating possible associations between CREC and urinary tract infections (UTIs), pneumonia and bloodstream infections. All CREC isolates were resistant to at least one of the carbapenem antibiotics tested. The isolates had a median MIC for imipenem of 8 mg/L (range 0.125 to &gt;128 mg/L), a median MIC for meropenem of 32 mg/L (&lt;0.03 to &gt;128 mg/L) and a median MIC for ertapenem of 32 mg/L (&lt;0.03 to &gt;128 mg/L) (Fig. ##FIG##0##1f##; Supplementary Data ##SUPPL##3##1##). It is to be noted here that analysis for ertapenem MIC was based only on the 168 isolates collected by Guangzhou Medical University, excluding isolates collected by China Antimicrobial Surveillance Network (CHINET) as ertapenem MIC was not routinely determined by CHINET. Amongst the isolates tested for tigecycline and polymyxin resistance, 40 were resistant to tigecycline (MIC, 1–4 mg/L) and 12 were resistant to polymyxin B (MIC, 4–64 mg/L) (Supplementary Data ##SUPPL##3##1##).</p>", "<p id=\"Par8\">Genomic analysis revealed that the most prevalent carbapenem resistance gene in this CREC collection was <italic>bla</italic><sub>NDM-5</sub> (<italic>n</italic> = 282), followed by <italic>bla</italic><sub>NDM-1</sub> (<italic>n</italic> = 42) (Fig. ##FIG##0##1e##; Supplementary Data ##SUPPL##3##1##). Interestingly, only 87.1% (338/388) of the CREC isolates possessed at least one carbapenem resistance gene, suggesting alternative carbapenem resistance mechanisms in the rest of the isolates. Eleven isolates carried the colistin resistance gene <italic>mcr-1</italic> (Supplementary Data ##SUPPL##3##1##). The CREC isolates belonged to 71 STs with 16 of them not assigned an ST. The most commonly isolated STs were ST410 (<italic>n</italic> = 109), ST167 (<italic>n</italic> = 41), ST131 (<italic>n</italic> = 12) and ST617 (<italic>n</italic> = 12) (Fig. ##FIG##0##1d##). This indicated a change in CREC population in China relative to studies conducted between 2015 and 2017<sup>##REF##34535075##9##,##REF##28479289##14##</sup>, where ST410 was reported to be the third most commonly isolated CREC ST behind ST131 and ST167.</p>", "<title>Outbreaks of a CREC ST410 clone in a children’s hospital</title>", "<p id=\"Par9\">Of the 109 ST410 CREC, 49 were isolated from 47 inpatients admitted to a children’s hospital in eastern China between 2018 and 2020. Most of the patients (<italic>n</italic> = 33, 70.2%) were under 60 days of age and 72.3% (<italic>n</italic> = 34) of them were female (Fig. ##FIG##1##2b##). The patients were admitted to different hospital departments and suffered from various infections, including UTI (<italic>n</italic> = 31, 66.0%), pneumonia, septicaemia and bacteraemia (Supplementary Data ##SUPPL##5##3##). Patients were grouped into two cohorts according to their time of admission and the length of hospital stay (Fig. ##FIG##1##2a##). One cohort stayed in the hospital from March 2018 to August 2019 and the other from January 2020 to September 2020.</p>", "<p id=\"Par10\">Four groups of <italic>E. coli</italic> ST410 were identified in this children’s hospital, characterised by SNP analysis relative to the complete genome of isolate 19-7 (Genbank: <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/datasets/genome/GCF_029854495.1/\">CP123017 to CP123023</ext-link>) which was from a patient with UTI in the same hospital (Fig. ##FIG##1##2c##). A pairwise comparison of the SNP differences across all isolates showed that isolates within the two groups differed by no more than 23 SNPs, suggesting possible outbreaks in the hospital based on a previously recommended threshold of ≤25 SNPs<sup>##REF##35544081##24##</sup>. The outbreaks happened within multiple hospital departments as well as inter-departmentally as indicated by where and when the patients stayed during their treatment (Fig. ##FIG##1##2a##). Group-1 included 20 isolates mainly from between March 2018 and August 2019, with the exception of isolate 20-20 from June 2020, while group-2 only included 27 isolates from 2020 (Fig. ##FIG##1##2##a, ##FIG##1##c##). The pairwise comparison also revealed that there were just 29–69 SNPs between isolates in these two groups. Singletons 18-4 and 18-10 did not belong to either group and each formed a group of their own, but 18-4 was closely related with the isolates in the two main groups as indicated by a pairwise SNP distance of 29 to 48. However, isolate 18-10 was distant from all other isolates with a pairwise SNP distance of 215–240. The dividing of the groups was further supported by a Fastbaps analysis of the phylogeny of the isolates, although 18-4 was separated from Group-1 at the second Fastbaps level (Fig. S##SUPPL##0##3c##, S##SUPPL##0##3d##). Apart from isolate 18-10, the CREC ST410 in this children’s hospital were found to be distinct from previously reported ST410 clones and therefore were analysed further to define their genomic characteristics and determine their origins.</p>", "<title>Global population structure of <italic>E. coli</italic> ST410 reveals an MDR clone, B5/H24RxC</title>", "<p id=\"Par11\">In order to analyse the CREC ST410 isolated from the children’s hospital in a global context, we constructed a phylogeny of 956 <italic>E. coli</italic> ST410 isolates based on a core-genome SNP alignment (Fig. ##FIG##2##3a##). Fastbaps clustered this global collection into 11 BAP groups based on the SNP alignment and phylogeny. Most of the isolates were assigned to two of the main groups, BAP1 (<italic>n</italic> = 429) and BAP2 (<italic>n</italic> = 434), which made up 90.3% of the collection. The previously reported MDR clone B4/H24RxC, which carries the <italic>bla</italic><sub>OXA-181</sub> carbapenemase gene in an X3 plasmid, was found to belong to BAP1. All of the CREC ST410 isolates from the children’s hospital outbreaks, apart from isolate 18-10, also belonged to group BAP1. However, the children’s hospital isolates clustered into a subclade that was distinct from the B4/H24RxC clone. This subclade, here designated B5/H24RxC (<italic>n</italic> = 174), rarely contained the X3 plasmid-associated <italic>bla</italic><sub>OXA-181</sub> of B4/H24RxC. Instead, 97.7% (170/174) of the B5/H24RxC genomes contained a F-type plasmid (Fig. ##FIG##2##3a##, S##SUPPL##0##2##), carrying the <italic>bla</italic><sub>NDM-5</sub> carbapenemase gene. Another obvious difference between the two clones was that most B5/H24RxC genomes lacked a small plasmid with a pColKP3-like replicon, which was present in the majority of B4/H24RxC genomes (Fig. ##FIG##2##3a##, S##SUPPL##0##2##).</p>", "<p id=\"Par12\">Further comparative analyses of the two clones showed that B5/H24RxC contained a larger (two-tailed unpaired <italic>t</italic> test, <italic>p</italic> = 0.047) number of acquired antimicrobial resistance genes (ARGs) and mutations that confer resistance (Fig. ##FIG##2##3b##; Supplementary Data ##SUPPL##6##4##). B5/H24RxC isolates were found to have more (two-tailed unpaired <italic>t</italic> test, <italic>p</italic> &lt; 0.0001) putative virulence genes than B4/H24RxC isolates (Fig. ##FIG##2##3c##). B5/H24RxC isolates had a median of 176 putative virulence genes (range 159–190) while the B4/H24RxC clone had a median of 166 (143–181). The difference was mainly caused by the presence of the high pathogenicity island (HPI) that was originally identified in <italic>Yersinia enterocolitica</italic><sup>##REF##15493818##25##,##REF##11418330##26##</sup>, in 77.6% (135/174) of the B5/H24RxC clone but in none of the isolates of the B4/H24RxC clone (Fig. S##SUPPL##0##2##). The HPI in these isolates contained all 11 virulence-associated genes (<italic>fyuA, irp1, irp2, ybtA, ybtE, ybtP, ybtQ, ybtS, ybtT, ybtU,</italic> and <italic>ybtX</italic>). In silico serotyping revealed that, 99.0% (384/388) of all isolates of both clones produced a H9 flagellar antigen, but the majority (95.3%, 204/214) of the B4/H24RxC isolates had an O8 lipopolysaccharide while the majority (74.7%, 130/174) of B5/H24RxC isolates had an Onovel1 (as labelled in the EcOH database by Ingle et al.<sup>##UREF##6##27##</sup>) lipopolysaccharide (Fig. ##FIG##2##3d##). BLAST analysis revealed that Onovel1 matched (96.3% coverage and 98.66% identity) a previously reported O-antigen OgN5 (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/nuccore/LC177549.1/\">LC177549.1</ext-link>) identified in enterotoxigenic <italic>E. coli</italic> of various STs<sup>##UREF##7##28##</sup> (Fig. ##FIG##2##3e##).</p>", "<p id=\"Par13\">The isolates of the B5/H24RxC clone in this international collection were isolated between 2015 and 2021 from humans, food and companion animals across 11 countries on 5 continents (Fig. S##SUPPL##0##1##; Supplementary Data ##SUPPL##4##2##). The majority of the isolates (89.1%, 155/174) were from countries in eastern and south-eastern Asia, such as China (<italic>n</italic> = 78) and Thailand (<italic>n</italic> = 71).</p>", "<title>Emergence of the B5/H24RxC MDR clone driven by recombination and horizontal gene transfer</title>", "<p id=\"Par14\">A smaller scale phylogeny reconstruction was performed only on the B4/H24RxC and the B5/H24RxC MDR clones using the complete genome of a previously reported isolate 020026 (B4/H24RxC; Genbank: <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/datasets/genome/GCF_002164975.2/\">CP034954 to CP034958</ext-link>) as the reference. Gubbins identified several recombination regions associated with the B5/H24RxC MDR clone, including a 5.7-kb region that contained genes of unknown function in all 174 isolates of the clone (Fig. S##SUPPL##0##5##). By excluding SNPs within the recombination regions, the average pairwise distance among the 174 isolates of B5/H24RxC MDR clone was 41, ranging from 0 to 136 (Supplementary Data ##SUPPL##7##5##), suggesting likely ongoing global dissemination of this recently emerged clone. A total of 204 SNPs were identified on the branch separating the B5/H24RxC MDR clone from its most closely related isolate (Fig. S##SUPPL##0##5##), of which 171 were within the recombination regions, giving a per site r/m ratio (the probabilities that a given site was altered through recombination and mutation) of 5.18. This suggests that homologous recombination contributed to the evolutionary events resulting the emergence of the B5/H24RxC MDR clone. Further comparative analysis of the recombination regions in both clones also revealed the O-antigen gene cluster (O-AGC) switch from O8 in B4/H24RxC to Onovel1 in B5/H24RxC, and the HPI gene cluster in B5/H24RxC clone (Fig. ##FIG##2##3e##).</p>", "<p id=\"Par15\">Both clones possessed a F-type plasmid containing FII-1, FIA-1, and FIB-49 replicons. The plasmid consisted of a backbone and an antibiotic resistance region. The resistance region was bounded at one end by a copy of IS<italic>1</italic> and at the other end by a partial copy of Tn<italic>5403</italic> (Fig. ##FIG##3##4a##). Most differences between variants of this F-type plasmid were within the resistance region, while their backbones were almost identical (Fig. ##FIG##3##4a##). The conserved backbone contained three replicons and genes associated with stability (restriction-modification and toxin-antitoxin systems). Although it contained <italic>finO</italic> and <italic>traX</italic> genes, these were the only remnants of a F-like transfer region and this plasmid was not expected to be conjugative. Outside the resistance region, the backbone was only interrupted by two insertion sequences, IS<italic>Ec12</italic> and IS<italic>1</italic> (Fig. ##FIG##3##4a##). IS<italic>Ec12</italic> was flanked by a target site duplication but IS<italic>1</italic> was not, suggesting that it had mediated a deletion event post-insertion. Importantly, 695 bp immediately adjacent to the left end of the resistance region were absent from plasmid variants found in B5/H24RxC (Fig. ##FIG##3##4a##), and appeared to have been lost in a deletion event mediated by the IS<italic>1</italic> at the boundary of the resistance region. This deletion was clear evidence that the backbone variant present in B4/H24RxC was ancestral to that in B5/H24RxC. The resistance region was comprised of a series of ARG-containing translocatable element sequences interspersed with copies of IS<italic>26</italic> (Fig. ##FIG##3##4b##). Resistance region variants present in the B5/H24RxC clone included an IS<italic>26-</italic>flanked segment that contained <italic>bla</italic><sub>NDM-5</sub>, <italic>bla</italic><sub>TEM-1</sub>, and <italic>sul1</italic>, <italic>aadA2</italic> and <italic>dfrA12</italic> in a class 1 integron. Although the <italic>bla</italic><sub>NDM-5</sub> gene was also present in some B4/H24RxC isolates, in those it was found in variants of the <italic>bla</italic><sub>OXA-181</sub> carrying X3 plasmid (Fig. S##SUPPL##0##6##) as previously reported<sup>##REF##31482141##16##,##UREF##4##17##</sup>.</p>", "<title>Core-genome genes and SNPs associated with B5/H24RxC MDR clone</title>", "<p id=\"Par16\">Pangenome-wide association study (pan-GWAS) using Scoary for the two clones identified 199 genes that were positively or negatively associated with B5/H24RxC (Fig. ##FIG##4##5##; Supplementary Data ##SUPPL##8##6##). Amongst these genes, 84 were annotated as non-hypothetical, of which 44 were over-represented in B5/H24RxC and 40 under-represented. In addition to the expected identification of accessory genes carried by different plasmids in these two clones, chromosomal accessory genes were also found to be associated with B5/H24RxC. A number of these chromosomal genes, including all 11 genes located in the HPI, were found in the majority of B5/H24RxC isolates (75.3–77.6%, 131–135/174), but in none of the B4/H24RxC isolates. A prophage integrase gene (<italic>intA</italic>), a histone-like protein gene (<italic>hns</italic>) and two 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase genes (<italic>dapH</italic>) were also found in B5/H24RxC (75.3–77.6%, 131–135/174) but not in B4/H24RxC. Consistent with the serotyping result, O-antigen genes <italic>wzm</italic>/<italic>wzt</italic> O8 were associated with B4/H24RxC (204/214, 95.3%) and <italic>wzx</italic>/<italic>wzy</italic> Onovel1 were associated with B5/H24RxC (130/174, 74.7%) (Fig. ##FIG##4##5##).</p>", "<p id=\"Par17\">Similarly, association analysis using Scoary revealed that 423 chromosomal SNPs were positively associated with B5/H24RxC (Supplementary Data ##SUPPL##9##7##). Amongst the 423 SNPs, 403 were in coding sequences and 20 were in intergenic regions. Only 63 of the 403 substitutions in coding sequences were non-synonymous, present in 32 genes (Fig. S##SUPPL##0##7##; Supplementary Data ##SUPPL##9##7##), most of which were found in the recombination regions, such as genes in the histidine operon (<italic>hisB, hisD</italic> etc.), the colanic acid biosynthesis genes cluster (<italic>wcaL and wcaM</italic>) and the nitrogen assimilation transcriptional regulator gene <italic>nac</italic>. Premature stop codons were found in three genes which encode a PstS family phosphate ABC transporter substrate-binding protein, the inverse autotransporter adhesin-like protein YeeJ and the cardiolipin synthase ClsB. 145 SNPs were exclusively found in B5/H24RxC, with only 12 present in all 174 isolates investigated. Gubbins revealed that amongst the B5/H24RxC specific SNPs, 129 were found to be introduced via recombination events (Fig. S##SUPPL##0##7##; Supplementary Data ##SUPPL##9##7##).</p>", "<title>Time of origin of the B5/H24RxC MDR clone</title>", "<p id=\"Par18\">The estimated time of the most recent common ancestor (TMRCA) of different phylogenetic groups was investigated with BEAST2 on the 500 Treemmer selected ST410 genomes from the 956 global collection. A mutation rate of 6.42E-7 SNPs per site per year [95% highest posterior density (HPD) intervals 5.69E-7, 7.19E-7] was estimated. The analysis estimated the age of the ST410 lineage to be approximately 205 years, with a TMRCA of around 1816 (95% HPD, 1739–1879) (Fig. ##FIG##5##6a##), close to a previous estimate of 1803<sup>##UREF##3##15##</sup>. The B4/H24RxC ancestor was estimated to have originated in 2003 (95% HPD, 2000–2005), which is identical to the estimate of 2003 from the same previous study<sup>##UREF##3##15##</sup>. The TMRCA of B5/H24RxC was estimated at around May 2006 (95% HPD, 2004–2008) (Fig. ##FIG##5##6c##).</p>", "<title>B5/H24RxC shows a fitness advantage and enhanced virulence</title>", "<p id=\"Par19\">In two different assays, isolates of the B5/H24RxC clone exhibited a fitness advantage compared with isolates of the B4/H24RxC clone in LB medium. Growth curve analysis showed that the isolates of B5/H24RxC grew considerably better, with a reduced doubling time of 68.5 mins in half strength LB (average of 6 isolates) compared with isolates of B4/H24RxC (83.5 mins, average of 2 isolates) (Fig. ##FIG##6##7##a, ##FIG##6##b##; Table ##SUPPL##0##S2##). In full strength LB and 1/10 strength LB, B5/H24RxC isolates also showed significantly better growth (Fig. S##SUPPL##0##8##; Table ##SUPPL##0##S2##). Genomic analysis revealed that these isolates of the B5/H24RxC clone possessed gene <italic>fyuA</italic> but not <italic>yodB</italic>, while isolates of the B4/H24RxC clone contained gene <italic>yodB</italic> but not <italic>fyuA</italic>. A qPCR-based (targeting <italic>yodB</italic> and <italic>fyuA</italic>) growth competition experiment between isolates of the two clones also confirmed that isolates of B5/H24RxC grew faster than isolates of B4/H24RxC, as demonstrated by the increasing ratio of <italic>fyuA</italic> to <italic>yodB</italic> levels in the same culture (Fig. ##FIG##6##7##c, ##FIG##6##d##).</p>", "<p id=\"Par20\">In a wax moth larvae infection model, larvae infected with isolates of B5/H24RxC had a significantly lower survival rate (<italic>P</italic> &lt; 0.002 or <italic>P</italic> &lt; 0.001, Log-rank [Mantel–Cox] test) than those infected with isolates of B4/H24RxC (Fig. ##FIG##6##7e##; Table ##SUPPL##0##S3##) after 72 h. The result also showed that larvae infected with isolates of B5/H24RxC had a lower survival rate than those infected with hypervirulent <italic>Klebsiella</italic>\n<italic>pneumoniae</italic> strain K1088 (<italic>P</italic> = 0.0053 to <italic>P</italic> = 0.0263, Log-rank [Mantel–Cox] test) and a similar survival rate to those infected with hypervirulent <italic>Acinetobacter baumannii</italic> strain AB5075 (<italic>P</italic> &gt; 0.1, Log-rank [Mantel–Cox] test). Based on this data relative to these two hypervirulent bacterial strains, we consider that B5/H24RxC is a hypervirulent <italic>E. coli</italic> clone. This result was expected as these B5/H24RxC isolates possessed the characterised pathogenicity island HPI, which was not present in  the B4/H24RxC isolates. The HPI also contributes to iron acquisition by <italic>E. coli</italic> through the production of yersiniabactin<sup>##REF##12183596##29##</sup>. Our iron source growth assay confirmed the enhanced ability of B5/H24RxC to utilise iron in comparison to B4/H24RxC (Fig. ##FIG##6##7f##). The growth of all tested isolates was completely inhibited in the presence of 300 μM DIP, suggesting that they were equally resistant to iron-deprived conditions. The addition of FeCl<sub>2</sub> restored growth of all isolates, while the addition of holo-transferrin only restored the growth of B5/H24RxC isolates. The result also showed that a higher concentration of haemoglobin and hemin was required to restore growth of the B4/H24RxC isolates than the B5/H24RxC isolates. Interestingly, growth was restored in none of the isolates with the addition of lactoferrin, which was different from a previous study where B4/H24RxC isolates tested were shown to be able to utilise iron from lactoferrin<sup>##REF##31482141##16##</sup>. It suggests that not all B4/H24RxC isolates could utilise iron from lactoferrin as we had used two different isolates in this study.</p>", "<p id=\"Par21\">Biofilm formation assays revealed that isolates of B4/H24RxC clone were poor biofilm formers as suggested previously<sup>##REF##31482141##16##</sup>. The biofilm formation abilities of isolates of the B5/H24RxC clone were also categorised as weak or non-production (Fig. S##SUPPL##0##9##) following previously proposed interpretation criteria<sup>##REF##17696944##30##,##REF##21860999##31##</sup>.</p>", "<title>B5/H24RxC is globally disseminated</title>", "<p id=\"Par22\">The isolates of the B5/H24RxC clone (<italic>n</italic> = 174) in this international collection (<italic>n</italic> = 956) were collected between 2015 and 2021 from humans, food and companion animals across 11 countries on 5 continents (Fig. S##SUPPL##0##1##; Supplementary Data ##SUPPL##4##2##). The majority of the isolates (89.1%, 155/174) were from countries in eastern and south-eastern Asia, such as China (<italic>n</italic> = 78) and Thailand (<italic>n</italic> = 71).</p>", "<p id=\"Par23\">To capture a more up-to-date picture of the spread of the B5/H24RxC clone worldwide since our analysis, we screened a new collection of <italic>E. coli</italic> ST410 genomes (<italic>n</italic> = 714, Supplementary Data ##SUPPL##10##8##) available from 14 Jan 2022 to 27 Sept 2023 on EnteroBase. A further 84 B5/H24RxC genomes were identified from the collection (Fig. S##SUPPL##0##10##; Supplementary Data ##SUPPL##10##8##). The isolates providing these genomes were collected between 2016 and 2023 across 13 countries on 5 continents (Fig. S##SUPPL##0##10##), mainly from humans, with two isolates from dogs and two from environmental samples. The countries with the most isolates were Thailand (<italic>n</italic> = 26), United States (<italic>n</italic> = 17), Germany (<italic>n</italic> = 7), China (<italic>n</italic> = 6), Cambodia (<italic>n</italic> = 6), Australia (<italic>n</italic> = 5) and Norway (<italic>n</italic> = 4), suggesting the ongoing spread of this clone globally.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par24\">In this study, we report the emergence of a hypervirulent MDR clone of <italic>E. coli</italic> ST410. <italic>E. coli</italic> ST410 has emerged recently as a successful MDR extraintestinal pathogenic <italic>E. coli</italic> lineage responsible for increasing numbers of infections worldwide<sup>##UREF##3##15##,##REF##31482141##16##</sup>. Our genomic surveillance of CREC in Chinese hospitals between 2017 and 2021 revealed that ST410 was the most commonly isolated CREC ST, overtaking ST167, ST131 and ST617 which were reported to be most common during surveillance carried out in 2015–2017<sup>##REF##34535075##9##,##REF##28479289##14##</sup>. Previous studies have identified significant clades in the ST410 lineages based on their genomic characteristics, and reported a globally widespread MDR clone, B4/H24RxC<sup>##UREF##3##15##,##REF##31482141##16##</sup>. The clone identified here, B5/H24RxC, possessed distinctive features that distinguish it from B4/H24RxC. It was similarly globally disseminated and was found to have caused two separate outbreaks in a children’s hospital in eastern China.</p>", "<p id=\"Par25\">Genomic analysis revealed that the B5/H24RxC clone was closely related to and likely emerged from B4/H24RxC. Both clones were grouped into BAP1 by Fastbaps<sup>##REF##31076776##32##</sup> based on a SNP alignment and a phylogeny of an international collection of ST410 genomes (<italic>n</italic> = 956). However, the B5/H24RxC clone lacked the X3 plasmid-borne <italic>bla</italic><sub>OXA-181</sub>, which is a defining feature of B4/H24RxC<sup>##UREF##3##15##</sup>. Instead, B5/H24RxC carried <italic>bla</italic><sub>NDM-5</sub> in a F-type plasmid derived from an ancestral variant found in B4/H24RxC, which lacks <italic>bla</italic><sub>NDM-5</sub>. However, <italic>bla</italic><sub>NDM-5</sub>-bearing plasmids of the same F-type lineage, F1:A1:B49, have been described in some B4/H24RxC isolates<sup>##UREF##4##17##</sup>, suggesting either that this plasmid lineage acquired <italic>bla</italic><sub>NDM-5</sub> in a B4/H24RxC host that was the progenitor to B5/H24RxC, or that the IS<italic>26</italic>-associated <italic>bla</italic><sub>NDM-5</sub> was acquired on at least two occasions. Importantly, the majority of B5/H24RxC isolates investigated in this study carried the high pathogenicity island HPI and a novel O-antigen (Onovel1) which were likely introduced via recombination (Fig. S##SUPPL##0##2##). Based on these findings, we argue that adding a new sub-lineage (B5/H24RxC) to the Roer et al. <sup>##UREF##3##15##</sup> classification scheme provides better resolution for distinguishing ST410 <italic>E. coli</italic> with distinctive genotypic and phenotypic features than the modified classification scheme proposed by Chen et al. <sup>##UREF##4##17##</sup>.</p>", "<p id=\"Par26\">Our wax larvae infection assay demonstrated that the HPI-containing B5/H24RxC was more virulent than B4/H24RxC, adding further evidence that HPI contributes to enhanced virulence in <italic>E. coli</italic> as previously described<sup>##REF##12183596##29##,##REF##16270391##33##</sup>. The HPI element is frequently found in the genomes of extraintestinal pathogenic <italic>E.coli</italic> (ExPEC) associated with UTIs<sup>##REF##10531259##34##</sup>, especially in uropathogenic <italic>E.coli</italic> (UPEC) strains<sup>##REF##22431806##35##,##REF##26883590##36##</sup>. The HPI allows <italic>E. coli</italic> to obtain iron from the urinary tract, which is normally a low-iron environment. This enhances the ability of the bacteria to colonise and persist within the urinary tract and causing infections<sup>##UREF##8##37##,##REF##25853778##38##</sup>. Our data from the children’s hospital in eastern China also showed that a large proportion of HPI-carrying B5/H24RxC isolates were from paitients with UTI, suggesting that HPI may have played a role in the emergence of this highly virulent clone. However, it should be noted that we did not explore other genetic factors, apart from the HPI, that could contribute to the enhanced virulence in the B5/H24RxC clone. Another important genomic difference that may also have contributed to the emergence and dissemination of B5/H24RxC is the O-antigen switching from O8 in B4/H24RxC to Onovel1 in B5/H24RxC. It is not clear why <italic>E. coli</italic> changes its O-antigen, but it is known that the ability to vary the O-antigen structure is important for bacterial adaptation to changing environments, including evasion of host immune responses<sup>##REF##16594963##39##,##REF##29897467##40##</sup>. Our data also indicated that B5/H24RxC had a fitness advantage over B4/H24RxC, exhibiting a higher growth rate in vitro. These traits could explain the successful global dissemination of B5/H24RxC over the last 15 years.</p>", "<p id=\"Par27\">Additionally, non-synonymous SNPs associated with B5/H24RxC clone were identified in 32 genes, which are mostly involved in metabolism and cell wall biosynthesis, such as the genes in the histidine operon and the colanic acid biosynthesis genes cluster. It is unclear whether these substitutions in these genes contributed to the emergence of B5/H24RxC from B4/H24RxC, but they may have played a role in its increased fitness. Interestingly, the inverse autotransporter adhesin-like protein YeeJ, which was reported to promote biofilm formation<sup>##UREF##9##41##</sup>, was disrupted by a premature stop codon caused by an SNP. This may have contributed to the poor ability of B5/H24RxC to form biofilm (Fig. S##SUPPL##0##9##), although B4/H24RxC with an intact YeeJ is also a poor biofilm former<sup>##REF##31482141##16##</sup>. It should also be noted that, in this study, non-synonymous SNPs associated with B5/H24RxC were not further investigated to validate their possible links to some phenotypic changes. Therefore, it remains unclear if YeeJ plays a role in biofilm formation in these CREC clones.</p>", "<p id=\"Par28\">Coalescence analysis on a global selection of 500 ST410 isolates indicated a most recent comment ancestor existed ~205 years ago (1816; 95% HPD, 1739–1879), similar to a previous estimate of 1803<sup>##UREF##3##15##</sup>. The B4/H24RxC clone was estimated to have originated in 2003, which also agrees with the same previous study<sup>##UREF##3##15##</sup>. The TMRCA of the B5/H24RxC clone was estimated at around May 2008 (95% HPD, 2004–2008).</p>", "<p id=\"Par29\">In this study, we have identified a CREC ST410 clone, B5/H24RxC, that may have greater clinical impact relative to its precursors due to the acquisition of resistance elements and the high pathogenicity island, HPI. Although the majority of B5/H24RxC were of human origin because of sampling bias, a few isolates (<italic>n</italic> = 3) were collected from companion animals and food samples, implying that various routes of transmission may be contributing to its dissemination. It is important to note that at the time of this study, most B5/H24RxC isolates were collected from low- and middle-income countries. The multidrug-resistant and hypervirulent nature of this clone, coupled with various socioeconomic factors in these countries, makes it a challenging problem for healthcare systems already stretched to their limits. The emergence of both B4/H24RxC and B5/H24RxC MDR clones over the last two decades highlights the rapidly evolving landscape of pathogenic <italic>E. coli</italic>, which is being driven by continued evolution towards enhanced resistance and virulence, which in turn is being driven by recombination of key loci involved in mammalian pathogenesis and colonisation. To mitigate the impact of newly emerged and future clones, additional research is required to understand the evolutionary mechanisms involved in the emergence of the new <italic>E. coli</italic> clones that are of human and veterinary clinical importance.</p>" ]
[]
[ "<p id=\"Par1\">Carbapenem-resistant <italic>Escherichia coli</italic> (CREC) ST410 has recently emerged as a major global health problem. Here, we report a shift in CREC prevalence in Chinese hospitals between 2017 and 2021 with ST410 becoming the most commonly isolated sequence type. Genomic analysis identifies a hypervirulent CREC ST410 clone, B5/H24RxC, which caused two separate outbreaks in a children’s hospital. It may have emerged from the previously characterised B4/H24RxC in 2006 and has been isolated in ten other countries from 2015 to 2021. Compared with B4/H24RxC, B5/H24RxC lacks the <italic>bla</italic><sub>OXA-181</sub>-bearing X3 plasmid, but carries a F-type plasmid containing <italic>bla</italic><sub>NDM-5</sub>. Most of B5/H24RxC also carry a high pathogenicity island and a novel O-antigen gene cluster. We find that B5/H24RxC grew faster in vitro and is more virulent in vivo. The identification of this newly emerged but already globally disseminated hypervirulent CREC clone, highlights the ongoing evolution of ST410 towards increased resistance and virulence.</p>", "<p id=\"Par2\">In this work, the authors identified a hypervirulent carbapenem-resistant <italic>Escherichia coli</italic> ST410 clone which carries a high pathogenicity island and an O-antigen gene cluster. The findings highlight the ongoing evolution of ST410 towards increased resistance and virulence.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n\n\n\n\n\n\n\n\n\n\n</p>", "<title>Source data</title>", "<p>\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s41467-023-43854-3.</p>", "<title>Acknowledgements</title>", "<p>This work was undertaken as part of the DETECTIVE research project funded by the National Natural Science Foundation of China (8181101332) and the Medical Research Council (MR/S013660/1). W.v.S. was also supported by a Wolfson Research Merit Award (WM160092). We thank Dr. Andries J. van Tonder for guidance on the bioinformatics analysis.</p>", "<title>Author contributions</title>", "<p>C.Z., M.A.H., A.M., W.v.S., and X.B. initiated and designed the study. X.B., Y.G., R.A.M., and E.L.D. performed the experiments and analyses. B.L. and L.Y. performed experiments. Y.G., B.L., J.L., N.H., S.S., and Y.L. collected and provided the bacterial isolates. X.B. worte the manuscript with input from C.Z., M.A.H, A.M., W.v.S., Y.G., and R.A.M. All the authors reviewed the manuscript.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par52\"><italic>Nature Communications</italic> thanks the anonymous, reviewers for their contribution to the peer review of this work. A peer review file is available.</p>", "<title>Data availability</title>", "<p>Sequence data and genome assemblies generated in this study have been submitted to GenBank under the BioProject <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA931432\">PRJNA931432</ext-link> and <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA951454\">PRJNA951454</ext-link>. The individual Illumina sequence read accession numbers of ST410 isolates are listed in Supplementary Data ##SUPPL##4##2##. The accession numbers for the nanopore sequenced isolates in this study can be found in Table ##SUPPL##0##S1##. <xref ref-type=\"sec\" rid=\"Sec28\">Source data</xref> are provided with this paper.</p>", "<title>Competing interests</title>", "<p id=\"Par53\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Characteristics of CREC isolates (<italic>n</italic> = 388) from Chinese hospitals.</title><p><bold>a</bold> The geographical distribution of the CREC isolates collected in this study shown on the map of P. R. China. <bold>b</bold> Bar chart showing the various types of clinical samples used in this study for the isolation of CREC. <bold>c</bold> Bar chart showing the distribution of isolation years. <bold>d</bold> Bar chart showing the 10 most identified STs in this CREC collection. <bold>e</bold> Bar chart showing identified carbapenem-resistant genes in this CREC collection. <bold>f</bold> Violin plot showing the distribution of MICs of imipenem, meropenem and ertapenem for the CREC isolates, the median MIC for each carbapenem antibiotics is represented with a black line. The plot for ertapenem MIC was generated based on data for isolates (<italic>n</italic> = 168) in the Guangzhou Medical University (GMU) collection. Source data are provided as a Source Data file.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>Outbreaks of a ST410 lineage in a children’s hospital.</title><p><bold>a</bold> Gantt plot showing the length of hospital stay of the patients in the children’s hospital in eastern China. Patient ID are presented on the <italic>y</italic> axis and the length of stay of each patient is represented with coloured bars. A black dot within the coloured bars indicates the time of the isolation of the isolates. <bold>b</bold> Bar chart showing the age distribution of the patients. <bold>c</bold> Maximum-likelihood core-genome SNP phylogeny of the 49 ST410 CREC isolates in the children’s hospital. Colours indicates the SNP distance to the reference genome 19-7. Bootstrap values are represented by gradient colours. Source data are provided as a Source Data file.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Phylogeny of a global ST410 collection.</title><p><bold>a</bold> Midpoint rooted maximum-likelihood phylogeny of 956 global ST410 was constructed using a core-genome SNP alignment generated by Snippy v4.6.0 with ST410 isolate YD786 (GenBank accession <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/datasets/genome/GCF_001442495.1/\">CP013112.1</ext-link>) as the reference. Branch support was performed with 1000 bootstrap replicates. Bootstrap values are represented with gradient colours. Isolates from this study are indicated with a red star. <bold>b</bold> Violin plot showing the distribution of total number of ARGs and mutations that confer resistance in B4/H24RxC and B5/H24RxC clones. Statistical difference between the two clones was assessed with two-tailed unpaired Student’s <italic>t</italic> test. <bold>c</bold> Violin plot showing distribution of total number of virulence factors in B4/H24RxC and B5/H24RxC clones. Statistical difference was assessed with two-tailed unpaired Student’s <italic>t</italic> test. <bold>d</bold> Bar plot showing the presence of the lipopolysaccharide (O) and flagellar (H) surface antigens in B4/H24RxC and B5/H24RxC clones. <bold>e</bold> Comparison of the recombination regions in strain 020026 and 19-7 identified the O-antigen switch from O8 in B4/H24RxC to Onovel1 (OgN5) in B5/H24RxC and the HPI gene cluster in B5/H24RxC clone. Source data are provided as a Source Data file.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>FII-1:FIA-1:FIB-49 plasmids analysis.</title><p><bold>a</bold> Comparison of the backbone of the F-type plasmids in the B4/H24RxC and B5/H24RxC clones. <bold>b</bold> Comparison of resistance regions found in F-type plasmids. Genbank accessions for plasmids: pCTXM15_020026 (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/nuccore/CP034956.1/\">CP034956</ext-link>), pE22P1 (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/nuccore/CP123037\">CP123037</ext-link>), p18-4P1 (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/nuccore/CP123014\">CP123014</ext-link>), p19-7P2 (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/nuccore/CP123019\">CP123019</ext-link>), p20-20P2 (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/nuccore/CP123031\">CP123031</ext-link>).</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><title>Core-genome genes associated with the B5/H24RxC MDR clone.</title><p><bold>a</bold> Presence and absence of the genes positively and negatively associated with the B5/H24RxC clone mapped to the phylogeny. Genes are aligned and ordered against the complete genomes of the reference strains 020026 (Genbank: <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/datasets/genome/GCF_002164975.2/\">CP034954 to CP034958</ext-link>) and 19-7 (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/datasets/genome/GCF_029854495.1/\">CP123017 to CP123023</ext-link>). Genes located in phage regions are shaded in orange, genes found in the high pathogenicity island (HPI) are in green and O-group genes are in red. <bold>b</bold> Schematic representation of the chromosome and plasmids in the reference strains 020026 and 19-7. Colour bars and arrows indicate the location of the genes in the genomes of the reference strains. <italic>bla</italic><sub>CMY-2</sub> was chromosomally integrated in B4/H24RxC as reported previously<sup>##UREF##4##17##</sup> and in B5/H24RxC. Source data are provided as a Source Data file.</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><title>Coalescence-based analysis of <italic>E. coli</italic> ST410.</title><p><bold>a</bold> A time-calibrated phylogeny was reconstructed using BEAST2.0 based on the nonrecombinant SNPs for the 500 selected <italic>E. coli</italic> ST410. The MDR clone B4/H24RxC and B5/H24RxC are coloured in orange and blue, respectively. <bold>b</bold> The Bayesian skyline plot illustrates the predicted demographic changes of the ST410 clades. The thick solid line represents the median estimate of the effective population size, with 95% confidence interval shown in lighter blue area. <bold>c</bold> An enlarged phylogenetic tree showing the B4/H24RxC and B5/H24/RxC clones.</p></caption></fig>", "<fig id=\"Fig7\"><label>Fig. 7</label><caption><title>Phenotypic comparison of B4/H24RxC and B5/H24RxC clones.</title><p><bold>a</bold> Growth curves in half strength LB for strains of both clones. Strain ATCC 25922 was included as a growth control. Data are shown as mean ± SD from <italic>n</italic> = 3 biological replicates. <bold>b</bold> Doubling time in half strength LB for isolates of both clones. Strain ATCC 25922 was included as a growth control. Data are shown as mean ± SD from <italic>n</italic> = 3 biological replicates. Statistical difference was assessed with two-tailed unpaired Student’s <italic>t</italic> test. <bold>c</bold>, <bold>d</bold> qPCR-based competition assay for strains of both clones. The figures show the relative quantity ratio of gene <italic>fyuA</italic> in B5/H24RxC strains to gene <italic>yodB</italic> in B4/H24RxC strains 005828 and 045869. Data are shown as mean ± SD from <italic>n</italic> = 3 biological replicates. Statistical difference was assessed with two-tailed unpaired Student’s <italic>t</italic> test. <bold>e</bold> Survival curves for wax moth larvae (<italic>G. mellonella</italic>) infected with ~2 × 10<sup>6</sup> CFU of different isolates in the B4/H24RxC and B5/H24RxC clones. Hypervirulent <italic>Klebsiella pneumoniae</italic> strain K1088<sup>##REF##28864030##65##</sup> and hypervirulent <italic>Acinetobacter baumannii</italic> strain AB5075<sup>##REF##24865555##66##</sup> were used as positive controls while <italic>Acinetobacter baumannii</italic> ATCC 19606 and PBS were used as negative controls. The curves represent the mean of three biological repeats. <bold>f</bold> The ability to utilise different iron sources by B4/H24RxC and B5/H24RxC clones. Green circles indicate growth and the numbers inside show the lowest tested concentration of the iron sources needed for the isolates to grow. Grey circles indicate no growth was observed at any concentration of the iron sources used. <italic>n</italic> = 2 biological independent experiments with the same result. Source data are provided as a Source Data file.</p></caption></fig>" ]
[]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM5\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM6\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM7\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM8\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM9\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM10\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM11\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM12\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM13\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Xiaoliang Ba, Yingyi Guo.</p></fn><fn><p>These authors jointly supervised this work: Mark A. Holmes, Chao Zhuo.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41467_2023_43854_Fig1_HTML\" id=\"d32e545\"/>", "<graphic xlink:href=\"41467_2023_43854_Fig2_HTML\" id=\"d32e640\"/>", "<graphic xlink:href=\"41467_2023_43854_Fig3_HTML\" id=\"d32e755\"/>", "<graphic xlink:href=\"41467_2023_43854_Fig4_HTML\" id=\"d32e978\"/>", "<graphic xlink:href=\"41467_2023_43854_Fig5_HTML\" id=\"d32e1044\"/>", "<graphic xlink:href=\"41467_2023_43854_Fig6_HTML\" id=\"d32e1113\"/>", "<graphic xlink:href=\"41467_2023_43854_Fig7_HTML\" id=\"d32e1239\"/>" ]
[ "<media xlink:href=\"41467_2023_43854_MOESM1_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>", "<media xlink:href=\"41467_2023_43854_MOESM2_ESM.pdf\"><caption><p>Peer Review File</p></caption></media>", "<media xlink:href=\"41467_2023_43854_MOESM3_ESM.pdf\"><caption><p>Description of Additional Supplementary Files</p></caption></media>", "<media xlink:href=\"41467_2023_43854_MOESM4_ESM.xlsx\"><caption><p>Supplementary Data 1</p></caption></media>", "<media xlink:href=\"41467_2023_43854_MOESM5_ESM.xlsx\"><caption><p>Supplementary Data 2</p></caption></media>", "<media xlink:href=\"41467_2023_43854_MOESM6_ESM.xlsx\"><caption><p>Supplementary Data 3</p></caption></media>", "<media xlink:href=\"41467_2023_43854_MOESM7_ESM.xlsx\"><caption><p>Supplementary Data 4</p></caption></media>", "<media xlink:href=\"41467_2023_43854_MOESM8_ESM.xlsx\"><caption><p>Supplementary Data 5</p></caption></media>", "<media xlink:href=\"41467_2023_43854_MOESM9_ESM.xlsx\"><caption><p>Supplementary Data 6</p></caption></media>", "<media xlink:href=\"41467_2023_43854_MOESM10_ESM.xlsx\"><caption><p>Supplementary Data 7</p></caption></media>", "<media xlink:href=\"41467_2023_43854_MOESM11_ESM.xlsx\"><caption><p>Supplementary Data 8</p></caption></media>", "<media xlink:href=\"41467_2023_43854_MOESM12_ESM.pdf\"><caption><p>Reporting Summary</p></caption></media>", "<media xlink:href=\"41467_2023_43854_MOESM13_ESM.xlsx\"><caption><p>Source Data</p></caption></media>" ]
[{"label": ["1."], "mixed-citation": ["Murray C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. "], "italic": ["Lancet"], "bold": ["399"]}, {"label": ["2."], "mixed-citation": ["Hickman R. A. et al. Exploring the antibiotic resistance burden in livestock, livestock handlers and their non-livestock handling contacts: a one health perspective. "], "italic": ["Front. Microbiol."], "bold": ["12"]}, {"label": ["13."], "mixed-citation": ["Peirano G. et al. Genomic epidemiology of global carbapenemase-producing "], "italic": ["Escherichia coli", "Emerg. Infect. Dis"], "bold": ["28"]}, {"label": ["15."], "mixed-citation": ["Roer L. et al. "], "italic": ["Escherichia coli", "Msphere"], "bold": ["3"]}, {"label": ["17."], "mixed-citation": ["Chen L., Peirano G., Kreiswirth B. N., Devinney R., Pitout J. D. D. Acquisition of genomic elements were pivotal for the success of "], "italic": ["Escherichia coli", "J. Antimicrob. Chemother."], "bold": ["77"]}, {"label": ["19."], "mixed-citation": ["Zhang Y., Kashikar A., Brown C. A., Denys G., Bush K. Unusual "], "italic": ["Escherichia coli", "Antimicrob. Agents Chemother"], "bold": ["61"]}, {"label": ["27."], "mixed-citation": ["Ingle D. J. et al. In silico serotyping of "], "italic": ["E. coli", "Microb. Genom."], "bold": ["2"]}, {"label": ["28."], "mixed-citation": ["Iguchi A., von Mentzer A., Kikuchi T., Thomson N. R. An untypeable enterotoxigenic "], "italic": ["Escherichia coli", "Microb. Genom."], "bold": ["3"]}, {"label": ["37."], "surname": ["Robinson", "Heffernan", "Henderson"], "given-names": ["AE", "JR", "JP"], "article-title": ["The iron hand of uropathogenic "], "italic": ["Escherichia coli"], "source": ["Future Microbiol."], "year": ["2018"], "volume": ["13"], "fpage": ["813"], "lpage": ["829"], "pub-id": ["10.2217/fmb-2017-0295"]}, {"label": ["41."], "mixed-citation": ["Martinez-Gil M. et al. YeeJ is an inverse autotransporter from "], "italic": ["Escherichia coli", "Sci. Rep."], "bold": ["7"]}, {"label": ["60."], "mixed-citation": ["Rambaut A., Lam T. T., Carvalho L. M., Pybus O. G. Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen). "], "italic": ["Virus Evol."], "bold": ["2"]}, {"label": ["63."], "surname": ["Yu", "Smith", "Zhu", "Guan", "Lam"], "given-names": ["GC", "DK", "HC", "Y", "TTY"], "article-title": ["GGTREE: an R package for visualization and annotation of phylogenetic trees with their covariates and other associated data"], "source": ["Methods Ecol. Evol."], "year": ["2017"], "volume": ["8"], "fpage": ["28"], "lpage": ["36"], "pub-id": ["10.1111/2041-210X.12628"]}, {"label": ["68."], "mixed-citation": ["Wickham H. ggplot2: elegant graphics for data analysis. "], "italic": ["Use R"]}, {"label": ["69."], "surname": ["Pebesma"], "given-names": ["E"], "article-title": ["Simple features for R: standardized support for spatial vector data"], "source": ["R. J."], "year": ["2018"], "volume": ["10"], "fpage": ["439"], "lpage": ["446"], "pub-id": ["10.32614/RJ-2018-009"]}]
{ "acronym": [], "definition": [] }
70
CC BY
no
2024-01-14 23:40:16
Nat Commun. 2024 Jan 12; 15:494
oa_package/1f/8a/PMC10786849.tar.gz
PMC10786850
38216700
[ "<title>Introduction</title>", "<p id=\"Par2\">The flow regime and its components influence downstream deltaic systems worldwide<sup>##UREF##0##1##</sup>. The duration and intensity of flow discharge are fundamentally dependent on climatic variables and the operation of basin-wide infrastructures such as hydropower dams and water diversion structures<sup>##UREF##1##2##</sup>. Sediment transport is critical for morphological changes and impacts river hydrology cycles<sup>##UREF##2##3##,##UREF##3##4##</sup>. River sediment is much more connected to the activities of humanity and other species. Therefore, managing river sediment is one of the most important considerations for ensuring the maximum benefits of rivers. The evidence from many rivers worldwide indicates that sediment load has been substantially disturbed due to dam construction, sand mining, land use-land cover (LULC) change, and climate variability<sup>##UREF##4##5##–##UREF##7##8##</sup>. Recent studies also show that these anthropogenic and climate-induced changes can significantly alter hydrology, ecological health, and water resources at very large scales<sup>##UREF##8##9##–##REF##37865681##11##</sup>. Understanding the morphological changes and sediment budget is crucial for determining the flow capacity to reduce flood risks, sediment erosion, and deposition from mountainous areas to the sea. Therefore, assessing the impact of human activities on sediment loads can provide scientific insight into the sediment budget and complex basin hydrology and aid in the development of strategies for river basin management and sustainability. Until now, there has been significant progress in river sediment research from experiments to actual, specific methods to integrated approaches; from local problems to global issues, and from academic perspectives to policy implications<sup>##UREF##9##12##</sup>.</p>", "<p id=\"Par3\">A boom in reservoir construction has occurred mainly in regions with emerging economies for irrigation, drinking water, hydropower generation, and hydrological hazard control. It is undeniable that reservoirs are necessary for flood control and securing water supplies for agriculture and the environment in tropical river basins with complex climate characteristics<sup>##UREF##10##13##</sup>. However, despite their benefits, reservoirs remain controversial owing to their potentially negative impacts on discharge, sediment, and morphology<sup>##UREF##11##14##</sup>. Dams trap substantial amounts of sediment, reducing the sediment supply downstream<sup>##UREF##6##7##,##UREF##12##15##–##UREF##14##17##</sup>. A sediment deficit may occur below a dam, depending on the relative sediment supply and transport capacity change. Nevertheless, most commonly, the reach downstream of a dam is characterized by sediment starvation, which can erode the bed and banks to regain some of its former sediment load. These erosive flows commonly induce incisions, undermine other infrastructure, and coarsen the bed<sup>##REF##9175542##18##</sup>. In addition, sand mining has severe negative impacts on rivers, deltas, and coastal and marine ecosystems through, for example, the loss of land through rivers or coastal erosion, the lowering of water levels, and decreases in sediment supply, and it also affects socioeconomic development<sup>##REF##29288998##19##</sup>. The scope of these adverse effects extends from the local area to more significant regions far from the sites where sand is taken. The natural sediment supplied from upstream regions cannot compensate for the extracted amount of sand, leading to a substantial annual deficit. The consequent sediment starvation within the water acts as a trigger for erosion processes. The downcutting of riverbanks can propagate upstream and downstream from extraction sites, affecting river bathymetry and ecosystems over a large area. As a result of the incision of river channels, bank erosion is strikingly exposed, resulting in coastline recession and increasing salinity intrusion.</p>", "<p id=\"Par4\">The VGTB is a basin that has advantages in hydropower development and ranks 4th in terms of hydropower potential in Vietnam<sup>##UREF##17##22##</sup> (Fig. ##FIG##0##1##a). The VGTB River basin is facing difficulties in maintaining its water supply and controlling saltwater intrusion, primarily due to the rapid development of artificial hydrostructures that alter the region’s hydrological dynamics<sup>##UREF##18##23##,##UREF##19##24##</sup>. Young dams, constructed since 2008 in the VGTB River basin downstream part region would take time for their impacts on the hydrological system to become visible. These dams modify the underlying hydrological regime, resulting in a concurrent shortage of sediment for the downstream region. The primary cause of changes in water resources for the Vu Gia and Thu Bon Rivers can be attributed to the transfer of water through the Dak Mi 4 hydropower plant and the Quang Hue channel<sup>##UREF##18##23##</sup> (Fig. ##FIG##0##1##a). The Vu Gia River serves as the primary water supply source for Da Nang city and supports agricultural activities in the region. Water diversion has resulted in deficits in agricultural and drinking water supplies and increased salinity intrusion in Da Nang city<sup>##UREF##20##25##,##UREF##21##26##</sup>. Water shortages induced by saltwater intrusion, particularly during drought, significantly challenge the local population's domestic water supply and livelihood<sup>##UREF##22##27##,##UREF##23##28##</sup>. Thus, a controversial discussion between Da Nang city and Quang Nam Province has emerged, centering on the impact of hydropower development and water diversion and highlighting the complexities of water resource management in the region<sup>##UREF##18##23##</sup>. In contrast, the entire VGTB basin has only two stations measuring discharge, both of which are located upstream (Fig. ##FIG##0##1##a, c, d). The downstream tributaries, which are home to numerous hydropower plants, lack discharge observations, which poses a significant challenge in addressing this question. It is difficult to comprehensively investigate discharge, sediment, and reservoir impacts. Therefore, extending the estimated of discharge records for recent decades in this region is necessary to strengthen the scientific foundation for addressing this situation more effectively.</p>", "<p id=\"Par5\">A full investigation of changes in the basin will help better manage planning. However, previous studies in the VGTB River basin have focused mainly on hydrology<sup>##UREF##21##26##,##UREF##24##29##–##UREF##26##31##</sup>, and geomorphological studies have been concentrated in the Cua Dai estuary<sup>##UREF##27##32##,##UREF##28##33##</sup>. These studies did not assess discharge, sediment, or river morphological changes from upstream to downstream<sup>##UREF##29##34##,##UREF##30##35##</sup>. Analysis and simulation use data from only two stations, so they cannot reveal dam impacts on streamflow and sediment<sup>##UREF##26##31##,##UREF##31##36##</sup>. Obviously, most past studies that analysed the sediment budget and morphological changes in the VGTB basin have not comprehensively analysed the sediment budget and morphological change due to a lack of data. In addition, the relationship between the headwater area and downstream area has not been determined, so the potential impacts from upstream to downstream areas may be quite large and serious. Therefore, this study aimed to collect data from many different approaches to comprehensively investigate the effects of anthropogenic activities on discharge, sediment budget, and morphological changes. The contents of this study are organized as follows: (1) investigate the discharge and sediment magnitude of the entire VGTB River basin using a semidistributed hydrological model (SWAT), (2) provide a complete understanding of the impacts of upstream anthropogenic developments on long-term discharge and sediment, (3) link reductions in sediment upstream and increase sand mining to spatiotemporal morphological changes, and (4) clarify the responses of water levels to streamflow alterations, sediment budgets, and morphological changes. The results of this study provide evidence and a reference for water resource and sediment management, hydropower development, and sand mining to quickly adapt to climate change and ensure sustainable development in the VGTB River basin.</p>", "<title>Study area</title>", "<p id=\"Par6\">The VGTB basin has a tropical monsoon climate (approximately 10,350 km<sup>2</sup>). The rainfall is distributed unevenly across the basin, descending from the mountains to the plain coast. The average annual rainfall varies significantly from 2184 mm in the central and downstream regions to more than 4188 mm in the southern mountainous areas<sup>##UREF##19##24##</sup> (Fig. ##FIG##0##1##b). Its upper part is short and steep, with a narrow riverbed, steep banks, and many cascades. The riverbed is relatively wide and shallow in the middle and downstream regions, respectively. The altitude, rugged terrain, and significant precipitation provided great potential for hydropower energy in the upper parts of the basin (Fig. ##FIG##0##1##a).</p>", "<p id=\"Par7\">The basin is formed by two primary subbasins: the Vu Gia and Thu Bon subbasins. The river network is dense, and water is exchanged between Vu Gia and Thu Bon through the Quang Hue Channel and Dak Mi 4 hydropower plant (Fig. ##FIG##0##1##a). The VGTB basin interacts with the east sea directly through the Cua Han and Cua Dai mouths. Therefore, tidal features strongly affect the hydrological regime of estuaries.</p>", "<p id=\"Par8\">According to the Department of Natural Resources and Environment and the Japan International Cooperation Agency (JICA), the total sand-mining volume during this period was 443 Mm<sup>3</sup> from 1990 to 2007. The total annual sand-mining volume ranged from 0.3 to 3.2 Mm<sup>3</sup>/yr from 2008 to 2017. The amount of sand mined from the river from 2011 to 2017 was approximately 7.9 Mm<sup>3</sup>, with an annual average of 1.12 Mm<sup>3</sup>/yr.</p>", "<p id=\"Par9\">The experimental results of the grain size distribution showed that there was a significant difference in the grain size from upstream to downstream and for each cross-section in the VGTB River system (Fig. ##FIG##1##2##). In the upstream region of the Vu Gia River, the grain size was characterized by medium to coarse sand with d50 values of 0.31–0.99 mm, while the middle and downstream regions were mainly composed of medium sand with d50 values ranging between 0.21 mm and 0.57 mm (Fig. ##FIG##1##2##b). From upstream to downstream in the Thu Bon River, the grain size was characterized by fine to medium sand with a d50 of 0.15–0.71 mm. The grain size of the Quang Hue Channel changed little, and there was medium sand. In the cross-section, the grain size increased from the riverbed to the side bank (Fig. ##FIG##1##2##c, d). In the estuaries of the Vu Gia River (Cua Han) and Thu Bon River (Cua Dai), the grain size increases gradually from the outlet to the side-beach (Fig. ##FIG##1##2##b).</p>" ]
[ "<title>Data and methodology</title>", "<title>Data collection</title>", "<p id=\"Par10\">In this study, hydrometeorological, hydrological, hydraulic, topographic, bathymetric, landuse, soil type, infrastructure structure, and sand mining data were collected. The discharge and sediment data were collected from observations and from the SWAT model simulation results. Specifically, we collected discharge and sediment at Thanh My, Nong Son (upstream region), and data from the Ai Nghia and Giao Thuy locations in the middle of the basin were obtained from the SWAT model (Fig. ##FIG##0##1##a).</p>", "<p id=\"Par11\">We selected two stations (Ai Nghia and Giao Thuy) in typical locations to analyse and clarify spatiotemporal water level changes. The Ai Nghia and Giao Thuy stations are located in the middle of the subbasins and downstream of the Quang Hue Channel. Therefore, we can assess the impact of upstream infrastructure and water diversion (Fig. ##FIG##0##1##a).</p>", "<p id=\"Par12\">The field surveys were conducted in March 2021 along the two main rivers and the Quang Hue Channel, totaling approximately 240 km. The Thanh My station was measured from the Cua Han estuary (Vu Gia River), and the Nong Son station was measured from the Cua Dai estuary (Thu Bon River) (Fig. ##FIG##0##1##a). Bathymetric surveys were conducted using an acoustic Doppler current profiler (ADCP) and single-beam echosounder (Odom Hydrotrac II) accompanied by the Trimble R5 and R8 GPS system. Seventy-one cross-sections were intentionally measured at each site in 2010, 2015, 2018, and 2021.</p>", "<p id=\"Par13\">We collected 98 samples of sediment from the riverbank along the VGTB River system and the Cua Han and Cua Dai estuaries to study the mechanism of the suspended sediment (Fig. ##FIG##1##2##a). The samples were collected on riverbeds, floodplains, roads, fields, near estuaries, and along the beach. Materials were collected from the cross-sections of the left bank, riverbed, and right bank of the riverbed. Approximately 1–2 kg of each sample was collected, stored in a plastic bag and labelled. Then the sediment samples were brought to the laboratory for futher experiments.</p>", "<title>Data processing and analysis</title>", "<p id=\"Par14\">Changes in daily flow, sediment, and water level were investigated. First, we identified the trend and change point of discharge and sediment by Pettitt and used the nonparametric slope methods of Mann–Kendall and Sen (p = 0.05) to estimate the change rates<sup>##UREF##32##37##–##UREF##36##41##</sup> (Fig. ##FIG##2##3##). Based on the change years, we divided the time series into two analysis predam (1996–2010) and postdam (2011–2020) periods. Hydrologic alteration (IHA) indicators were applied to quantify the difference between periods<sup>##UREF##37##42##–##UREF##39##44##</sup>. The IHA method used daily data and included thirty-two hydrologic indicators, which were categorized into groups according to magnitude, timing, duration, and frequency.</p>", "<p id=\"Par15\">The Analyst module in ArcGIS®10.4.1, which includes deterministic and geostatistical methods with different parameters, was selected for analysing the 2021 bathymetric data. Universal kriging was identified as the best method, in addition to the exponential method with the kernel function. The selected method was applied to interpolate the 2010, 2015, and 2018 bathymetric data. To minimize distortions in the resulting values due to outliers and gaps in the bathymetry difference raster, the focal statistic tool at a 5-pixel window was chosen to fill and average the values via interpolation. The dataset was resampled via bilinear interpolation at a 10-m resolution before being clipped to match the study area.</p>", "<p id=\"Par16\">The Geomorphic Change Detection (GCD) tool integrated with ArcGIS was used to quantify the geomorphic processes of erosion and deposition and estimate the sediment budget during the study period. GCD provides a suite of tools for measuring such uncertainties independently in each DEM and propagating to provide a DEM of differences. The program also provides ways to segregate the best spatial change estimates using different types of masks. The volumetric storage change was calculated from the surface elevation differences discerned from digital elevation models (DEMs)<sup>##UREF##40##45##</sup>.</p>", "<title>Semidistributed hydrological model SWAT</title>", "<p id=\"Par17\">The entire VGTB basin has only two stations measuring discharge; both are located upstream. The downstream tributaries, which are home to numerous hydropower plants, lack discharge observations, which poses a significant challenge in addressing this question (Fig. ##FIG##0##1##a). Therefore, it is difficult to investigate discharge and reservoir impacts comprehensively. A semi-distributed hydrological model SWAT was selected to set up for the VGTB basin from 1990 to 2020<sup>##UREF##19##24##,##UREF##22##27##</sup> (“##SUPPL##0##Supplementary Information##”). The calibration and validation periods in the warning model from 1990 to 1995 are 1996–2010 and 2011–2020, respectively.</p>", "<p id=\"Par18\">The Soil and Water Assessment Tool (SWAT) is a time-based, semidistributed hydrological model developed and supported by the U.S. Department of Agriculture (USDA) and Agriculture Research Service (ARS)<sup>##UREF##41##46##</sup>. The SWAT model stores basin characteristics (DEM, land use, soils) and estimated runoff in minor spatial units known as hydrologic response units (HRUs). Runoff was calculated separately and stored in each HRU, after which subbasin and total basin runoff were calculated by summing them<sup>##UREF##41##46##,##UREF##42##47##</sup>. SWAT has been applied in many different watersheds to assess the impact of LULC, climate change, and other human activities on streamflow, sediment load, ecology, and the environment<sup>##REF##37012264##10##,##UREF##43##48##–##UREF##45##50##</sup>. The SWAT model calculates daily surface runoff using the Soil Conservation Service (SCS) curve number (CN), a function of soil permeability, land use, and 5-day antecedent soil moisture content. For streamflow routing, the Muskingum method is used. Potential evapotranspiration (PET) was calculated by using the Penman–Monteith method. The hydrological cycle simulated by SWAT is based on the water balance equation<sup>##UREF##46##51##</sup>. The modified universal soil loss equation (MUSLE), a function of runoff factors, was used to predict sediment yield on a given day<sup>##UREF##47##52##</sup>. The MUSLE model was implemented in the SWAT model by assuming a simple hydrograph shape to estimate the daily runoff volume with a peak flow rate within the subwatershed area; this model was further used to predict the variation in runoff erosive energy. However, studies stress the need for further investigations of runoff curve numbers and the use of the Green-Ampt method for hydrologic data<sup>##REF##25602536##53##–##REF##25602556##55##</sup>. In addition, there is a need to continue testing and developing erosion estimation and sediment routing algorithms to suit different landscapes<sup>##REF##25602538##56##–##REF##25602535##58##</sup>.</p>", "<p id=\"Par19\">The basin was divided into 153 subbasins and 2580 HRUs. The subbasins were categorized based on their slope classes, land classes, soil classes, hydrological stations, dam locations, water transfer and receiving sites, and uniform size distributions. The water was transferred from the Vu Gia subbasins to the Thu Bon subbasins via the Dak Mi 4 hydropower plant, and the Quang Hue channel was also established in the model<sup>##UREF##19##24##</sup>.</p>", "<p id=\"Par20\">The calibration process for daily streamflow simulation was conducted using the Sequential Uncertainty Fitting algorithm version 2 (SUFI-2)<sup>##UREF##48##59##,##UREF##49##60##</sup> within the SWAT-CUP program (version 5.2.1)<sup>##UREF##50##61##</sup>. For this study, nineteen primary parameters known for their high sensitivity within the SWAT model were selected<sup>##UREF##51##62##</sup>. The calibration process was conducted to select the most accurate fitted values for each scenario, the calibration process was conducted with a total of 500 simulations, and the validation process also involved 500 simulations. The Nash–Sutcliffe efficiency (NSE) was employed as the objective function to evaluate the model performance, ensuring a robust and accurate calibration and validation process for the SWAT model.</p>", "<p id=\"Par21\">The simulated flow of the model shows good agreement with the observed data in both the calibration and validation periods. The four performance evaluation criteria show the quality of the simulation model for the VGTB. The R<sup>2</sup>, NSE, RMSE, and PBIAS coefficients at the Thanh My and Nong Son stations during the validation period were 0.83, 0.67, 105.3 m<sup>3</sup>/s, and − 32.9; 0.91, 0.80, 246.8 m<sup>3</sup>/s, and − 6.3, respectively (Fig. ##FIG##3##4##a). For sediment simulation, the efficiency is lower than that for streamflow. There was also good agreement between the simulation and observation results during the calibration and validation periods at both stations (Fig. ##FIG##3##4##b). Therefore, the model is suitable for investigating the variation in discharge and sediment under the effect of anthropogenic activities.</p>" ]
[ "<title>Results</title>", "<title>River discharge characterization</title>", "<p id=\"Par22\">Figure ##FIG##4##5## shows that the VGTB River discharge changes significantly during the postdam period compared to the predam period. The general trend is a decreased annual discharge in the Vu Gia River and increased discharge in the Thu Bon River. The annual discharge at the Thanh My, Ai Nghia, Nong Son, and Giao Thuy stations in the predam and postdam periods is 154 m<sup>3</sup>/s, 245 m<sup>3</sup>/s, 283 m<sup>3</sup>/s, and 469.5 m<sup>3</sup>/s, respectively, and at 82 m<sup>3</sup>/s, 160.9 m<sup>3</sup>/s, 330.8 m<sup>3</sup>/s, and 481.7 m<sup>3</sup>/s, respectively (Table ##TAB##0##1##, Fig. ##FIG##5##6##).</p>", "<p id=\"Par23\">We found that the annual discharges at Nong Son and Giao Thuy increased, while the sediment decreased sharply, especially at Nong Son, according to the Mann–Kendall test (Fig. ##FIG##4##5##). On the other hand, discharge and sediment decreased at Thanh My and Ai Nghia, especially at Ai Nghia. The change point occurred in 2011, as detected by the Pettitt test. The sediment concentration decreased significantly at the same time that the Dak Mi 4 Song Tranh 2 reservoirs were completed in the Vu Gia and Thu Bon Rivers (Figs. ##FIG##0##1##a, ##FIG##4##5##).</p>", "<p id=\"Par24\">Due to anthropogenic intervention in the postdam period, the annual discharge of Thanh My decreased by 68%, and that of Nong Son increased by 11% (Table ##TAB##0##1##). During the postdam period, the annual impact variation in the dry season (January–August) increased slightly in Nong Son but decreased considerably in Thanh My (Table ##TAB##0##1##). At Thanh My, the percentage of rates decreased by 59–81%, and at Nong Son, the percentage increased by 13–64%. The diversion of Dak Mi 4 alternately decreased the mean daily streamflow in individual years in Vu Gia. As a result, the dam regulation increases the expected flow variability and the frequency of low flow. The general trend decreased at four stations in the flood season (September–December) (Table ##TAB##0##1##, Fig. ##FIG##5##6##).</p>", "<title>Long-term spatiotemporal alterations in sediment load</title>", "<p id=\"Par25\">Box plots of the daily suspended sediment concentration (SSC) showed that the mean daily SSC decreased significantly from the predam period to the postdam period at Nong Son, Ai Nghia, and Giao Thuy (Fig. ##FIG##6##7##a). The SSC decreased by 12.2 g/m<sup>3</sup>, 15.3 g/m<sup>3</sup>, and 5 g/m<sup>3</sup>, respectively. However, Thanh My station increased from 135 to 153 g/m<sup>3</sup>. The data spread is more significant in the predam period than in the postdam period. In addition, the higher probabilities of the four stations are concentrated in the median value during the postdam period.</p>", "<p id=\"Par26\">We found that the annual sediment amount decreased at four stations during the postdam period compared with that during the predam period (Fig. ##FIG##6##7##b). When Ai Nghia decreased the most, the mean annual sediment decreased by 57.3%, from 5.5 to 2.35 million tons. Although sediment was received from the Vu Gia River at two locations, the mean annual sediment at Giao Thuy still decreased by 1.58 million tons (23.8%), from 6.63 to 5.05 million tons. The mean annual sediment also decreased at Thanh My and Nong Son by 0.34 and 1.41 million tons, respectively. This result was in agreement with the values reported by JICA in 2018. After dam construction, the sediment volume was reduced by 1.4 million tons, compared to that before dam construction<sup>##UREF##53##64##</sup>. In addition, the sediment decreased at the Thanh My and Ai Nghia stations on the Vu Gia River because of the flow discharge and sediment diversion from the Dak Mi 4 hydropower plant and Quang Hue channel<sup>##UREF##18##23##,##UREF##19##24##,##UREF##22##27##,##UREF##23##28##</sup> (Fig. ##FIG##0##1##a).</p>", "<title>Effects of reducing sediment and sand mining on bathymetry</title>", "<p id=\"Par27\">Figure ##FIG##7##8## plots the thalweg elevation in 2010, 2015, 2018, and 2021 along the Vu Gia, Thu Bon Rivers, and Quang Hue channels. We found that the period with widespread human activity was 2018–2021, which was different from the 2010–2015, and 2015–2018 periods. The effects of dams on morphological changes extend and shift progressively downstream. The riverbed elevation changes from 68 and 74 km from downstream dams on the Vu Gia and Thu Bon Rivers, respectively (Fig. ##FIG##7##8##a, b). The effective distances to the delta were 98 km and 94 km, respectively.</p>", "<p id=\"Par28\">Sand mining sites are concentrated in the middle of the basin and close to the delta. Sand mining removes large quantities of riverbed sediments and creates numerous pits and pools. By analysing cross-sectional and longitudinal profiles obtained during our 2021 survey distinct sand mining pockmarks, were found of reach depths of up to 7.1 m (~ 36 km Vu Gia River), 4.2 m (~ 27 km Thu Bon River), and 5.5 m (~ 5.0 km Quang Hue channel) compared with those in 2010 (Fig. ##FIG##7##8##a–c). Reducing sediment from upstream and large sand mining downstream leads to a decrease in riverbed bathymetry in the downstream Vu Gia and Thu Bon Rivers. Generally, the riverbed elevation of the VGTB River system decreases over time. The average thalweg elevation decreased from 2010 to 2021 along the Vu Gia, Thu Bon, and Quang Hue channels by 0.98 m, 1.45 m, and 4.62 m, respectively (Fig. ##FIG##7##8##a–c). This also occurs in cross-sections, for example, CS-VG on the Vu Gia River and CS-TB on the Thu Bon River (Fig. ##FIG##7##8##d, e).</p>", "<p id=\"Par29\">A comparison of the cross-sectional and longitudinal profiles from 2010 and 2021 reveals distinct signs of sand mining (Fig. ##FIG##7##8##e). There were notable irregularities in the riverbed in 2021. The observed disparities in these cross-sectional and longitudinal profiles provide substantial evidence of ongoing and intensifying sand mining operations in the basin, especially during the period from 2018–2021. This has had a significant impact on the riverbed elevation.</p>", "<title>Effects of hydropower dams and sand mining on morphological changes and sediment budgets</title>", "<p id=\"Par30\">The sediment budget exhibited a balance between erosion and deposition during the period 2015–2010 (Figs. ##FIG##8##9##e, ##FIG##9##10##a). However, the riverbed elevation and sediment budget significantly changed between 2018 and 2015 and between 2021 and 2018. The riverbed is mostly eroded. The net annual volume is 9.1 Mm<sup>3</sup> and 7.1 Mm<sup>3</sup>, respectively (Figs. ##FIG##8##9##f, 9g, ##FIG##9##10##b, c).</p>", "<p id=\"Par31\">A Comparison of riverbed elevation over 12 years between 2010 and 2021 revealed that the VGTB River system exhibited severe net riverbed incision. Figures ##FIG##8##9##a, d, h and ##FIG##9##10##d indicate that the recent sediment budget of the VGTB has a net deficit. We estimated the total incision volume during the period from 2010–2021 in our river sector (63.3 Mm<sup>3</sup>), in which the Vu Gia and Thu Bon Rivers accounted for 12.2 Mm<sup>3</sup> and 33.0 Mm<sup>3</sup>, respectively.</p>", "<p id=\"Par32\">For Vu Gia, riverbed incisions occurred in the middle and head downstream areas, and the erosion points were located on straight river sections. For Thu Bon, the erosion points developed strongly downstream, and erosion occurred in the bend areas (Figs. ##FIG##7##8##, ##FIG##8##9##). Significant incisions were recorded along the Vu Gia, Thu Bon River, and Quang Hue channels, which varied widely between periods. There seems to be a clear indication of accelerated incisions in recent years. The results presented in this study provide compelling evidence that sand mining is a major contributing factor instead of an upstream dam (Figs. ##FIG##6##7##, ##FIG##7##8##, ##FIG##8##9##, ##FIG##9##10##). This process drives riverbed changes and sediment budgets in the VGTB River. This finding is also consistent with the research of JICA (2018). Through detailed comparisons of riverbed elevation in three periods, incisions by sand mining were clearly distinguished in the VGTB River.</p>", "<title>Long-term spatiotemporal alterations in water level</title>", "<p id=\"Par33\">During the dry and flood seasons, the water level decreased at Ai Nghia and Giao Thuy (Table ##TAB##1##2##). The water level decreased by 21.1% at Ai Nghia and 44.3% at Giao Thuy. The annual water level decreased by 0.557 m (15.1%) and 0.832 m (38.2%). The annual daily minimum decreased from the predam to the postdam at these stations. Especially at Giao Thuy, the annual daily minimum water level sharply decreased by 93.3%, from 1.051 to 0.07 m.</p>" ]
[ "<title>Discussion</title>", "<title>The role of sand mining and cascade dams in riverbed incisions</title>", "<p id=\"Par34\">The annual discharges at Nong Son and Giao Thuy increased, while the sediment decreased sharply, especially at Nong Son (Figs. ##FIG##4##5##, ##FIG##5##6##, ##FIG##6##7##; Table ##TAB##0##1##). We also note that these two locations in the Thu Bon River receive streamflow and sediment from the Vu Gia River. On the other hand, discharge and sediment decreased at Thanh My and Ai Nghia (Figs. ##FIG##4##5##, ##FIG##5##6##, ##FIG##6##7##; Table ##TAB##0##1##). The sediment content sharply decreased at Ai Nghia because the Quang Hue Channel transferred most of the sediment to the Thu Bon River. In addition, sediment significantly decreased when reservoirs were built in the upstream basin (for example, A Vuong, Song Bung 4, Dak Mi 4, and Song Tranh 2) (Figs. ##FIG##4##5##, ##FIG##6##7##).</p>", "<p id=\"Par35\">Da Nang city and Quang Nam Province are experiencing rapid economic development<sup>##UREF##54##65##</sup>. The amount of sand material available for infrastructure is enormous and is mainly mined from the VGTB River system. Discharge and sediment reduction combined with sand mining activities, diversion drive riverbed incisions, morphological changes, and water level changes downstream (Table ##TAB##1##2##). The riverbed incision in the Vu Gia and Thu Bon Rivers started in 2011 when reservoirs began operating and sand mining increased (Figs. ##FIG##7##8##, ##FIG##8##9##). The thalweg elevation decreased at Ai Nghia and Giao Thuy between 2010 and 2021 by 1.8 m and 3.9 m, respectively (Fig. ##FIG##7##8##a, b). Morphological changes can damage structures along riverbanks, affect essential water availability for public water supplies and irrigation, and increase flood risk. Field surveys show that sixty-eight hot spots are distributed from upstream to downstream. Erosion sites were mainly found in the sand mining area and at the intersection of river tributaries according to the 2021 field survey.</p>", "<title>Linking change in bathymetry to the water level</title>", "<p id=\"Par36\">The monthly and annual minimum water levels at Giao Thuy decreased, although the corresponding discharges increased (Tables ##TAB##0##1##, ##TAB##1##2##, Figs. ##FIG##4##5##, ##FIG##5##6##). Dam operations cannot explain these decreases in the water level due to the increased dry season water level through increased discharge. Irrigation expansion is likely not the cause because it did not reduce the dry season discharge of the Thu Bon subbasin. Moreover, the Thu Bon River also receives water from the Vu Gia River via Dak Mi 4 and Quang Hue. Giao Thuy is located in the middle of the basin and is not affected by tides (Fig. ##FIG##0##1##a). Therefore, we argue that these decreases in the water level are mainly driven by riverbed incision caused by the decreased sediment load and accelerated sand mining (Figs. ##FIG##7##8##, ##FIG##8##9##, ##FIG##9##10##). Sand mining occurs in large quantities in the middle and downstream areas (from the Giao Thuy station to the outlet). Thalweg elevation in this river section has greatly decreased (Figs. ##FIG##7##8##b, ##FIG##8##9##). This approach is suitable for decreasing in the annual mean water levels at Giao Thuy starting in 2011 (Table ##TAB##1##2##, Fig. ##FIG##10##11##).</p>", "<p id=\"Par37\">The annual daily minimum and monthly water levels decreased at the Ai Nghia station (Table ##TAB##1##2##, Fig. ##FIG##10##11##). Riverbed incision also occurs downstream of Vu Gia due to the decreased sediment load and accelerated sand mining (Figs. ##FIG##7##8##a, ##FIG##8##9##). In addition, part of the streamflow and sediment diverted to the Thu Bon River also affects the bathymetry and water level downstream.</p>", "<title>Linking changes in discharge and water level reduction on saline intrusion, water supply, and agricultural production</title>", "<p id=\"Par38\">Changes in discharge patterns resulting from anthropogenic activities such as hydropower development and water diversion can lead to severe consequences. In addition, river deepening can also trigger and increase salinity intrusions and subsequently affect the water supply and agricultural production<sup>##UREF##7##8##,##UREF##12##15##</sup>. Saltwater intrusion-induced water shortages during drought are the main constraints hindering the domestic water supply and agricultural production. Additionally, the outlet of the VGTB basin experiences a semidiurnal tidal regime, with the water level rising and falling twice daily. Therefore, downstream flow is frequently affected by saline intrusion during the dry season. In recent years, saltwater intrusion has become a significant problem in Da Nang city, particularly at the outlet of the Vu Gia basin. Monitoring data from the Da Nang Water Supply Joint Stock Company (DAWACO) indicate that there has been an increase in the maximum salt intrusion and the number of days with salinities above the threshold since the operation of reservoirs in 2012. In addition, saltwater intrusion is expected to be exacerbated by climate change and rising sea levels. The data observed from 1983 to 2020 at the Son Tra oceanographic station (Fig. ##FIG##0##1##a), which is located at the outlet of the Vu Gia Basin show that sea level has increased 3.3 mm/year. Considering the impacts of climate change, sea level rise, riverbed incision, and the operation of upstream dams, saltwater intrusion in the downstream VGTB basin is predicted to worsen both in frequency and magnitude during the dry season<sup>##UREF##21##26##,##UREF##55##66##</sup>.</p>", "<p id=\"Par39\">Economic development and rising populations increase energy demand and natural resources, including water resources. With the rapid increase in urbanization in the study area, the demand for water supplies for living and production will continue to increase. Water resources have become more vulnerable due to hydraulic infrastructure, water transfer, and climate change. Typically, salinization at the Cau Do water plant has caused stress in the domestic water supply to Da Nang city (Fig. ##FIG##0##1##a). Salinity in the Vinh Dien Channel affects pumping stations serving agricultural irrigation in part of Quang Nam Province. A similar situation has also been found in the Mekong and Red River deltas<sup>##UREF##56##67##–##UREF##58##70##</sup>.</p>", "<p id=\"Par40\">Agriculture is an important economic sector of the basin, with 70% of irrigated agriculture being paddy rice<sup>##UREF##21##26##</sup>. Therefore, agricultural production in the VGTB basin may become increasingly vulnerable due to interrupted irrigation. Analysis of land use data from 2010 to 2020 showed that rice areas gradually decreased by 11.8%. These findings provide a scientific basis for future management plans of stakeholders and decision-makers regarding water resource management in the VGTB basin, especially for sustainable agricultural development.</p>", "<title>Proposing mitigation measures for the integrated management of the VGTB River basin mountain-to-sea</title>", "<p id=\"Par41\">There is an inseparable biological link between the general ecosystem and the water sources of the river basin, the coastal zone, and the sea<sup>##UREF##59##71##–##UREF##62##74##</sup>. The interaction scale, however, depends on the scale and morphologic characteristics of the river basin.</p>", "<p id=\"Par42\">The results showed that anthropogenic and climate variability severely impact the VGTB River basin. Therefore, an approach for integrated water resource management in river basins and coastal zones in needed to ensure sustainable development in the VGTB River basin. This will then enable the integration of policies, development plans, and adaptive solutions for river basins and coastal zones (Fig. ##FIG##11##12##). Strengthened coordination is needed across sectors, incentives, and institutionalizations of the participation of related stakeholders as well as the community in the field of river basins and coastal zones. Selecting and developing regional (interregional) linkages are the basis for tackling and mitigating the impacts of river basins on coastal areas, as well as the impacts of coastal areas on the sea<sup>##UREF##63##75##</sup>.</p>" ]
[ "<title>Conclusion and recommendations</title>", "<p id=\"Par43\">We applied different statistical methods and numerical models (SWAT) to assess long-term spatiotemporal changes in sediment load from 1996 to 2020. River bathymetric data (from 2010, 2015, 2018, and 2021) were also investigated further to clarify the impact of upstream dams and sand mining. We found that dam development, sand mining, and land use changes are the main drivers for flow discharge and sediment alterations. Morphological changes have increased the water transfer rate from the Vu Gia River to the Thu Bon River through the Quang Hue Channel. This has not only affected the water supply but also increased the risk of saltwater intrusion. As a result, water shortages induced by saltwater intrusion during drought periods have emerged as a significant constraint in hindering the domestic water supply and agricultural production. These results can thus provide a scientific basis for policymakers and decision-makers to design and implement effective and sustainable water management plans for the VGTB basin. Our findings are summarized as follows:<list list-type=\"order\"><list-item><p id=\"Par44\">The annual discharge at Nong Son and Giao Thuy increased, while the sediment decreased sharply. On the other hand, discharge and sediment decreased at Thanh My and Ai Nghia. Similarly, compared with those in the predam period, the annual sediment in the Vu Gia and Thu Bon Rivers decreased by 57.3% and 23.8%, respectively, in the postdam period. Reducing sediment from upstream areas and large sand mines downstream led a decrease in riverbed bathymetry in the VGTB River system from 2010 to 2021. The thalweg elevation decreased at Ai Nghia and Giao Thuy between 2010 and 2021 by 1.8 m and 3.9 m, respectively.</p></list-item><list-item><p id=\"Par45\">We also found that riverbed incisions occur downstream of the Vu Gia and Thu Bon Rivers by reducing the sediment load and accelerating sand mining. The total incision volume during the period of 2010–2021 in our concerned river sector was 63.3 Mm<sup>3</sup>, in which the Vu Gia and Thu Bon Rivers accounted for 12.2 Mm<sup>3</sup> and 33.0 Mm<sup>3</sup>, respectively.</p></list-item><list-item><p id=\"Par46\">Discharge and sediment reduction drivers of morphological changes and water level changes downstream. The water level decreased by 21.1% at Ai Nghia and 44.3% at Giao Thuy. The annual water level decreased by 0.557 m (15.1%) and 0.832 m (38.2%).</p></list-item></list></p>", "<p id=\"Par47\">A complex river network connects the VGTB River basin. Therefore, to investigate the basin in detail, especially under the impact of climate change and anthropogenic activities, it is necessary to collect data and establish a full hydro-sediment-morphodynamics model. From there, we can fully understand the effects of cascade dams, sand mining, and diversion on flow discharge, sediment budget, and morphological change.</p>" ]
[ "<p id=\"Par1\">Human interventions at the river basin scale, such as sand mining and hydropower dam construction, have profoundly affected hydrological and hydraulic alteration regimes, sediment budgets, and morphological changes worldwide. Quantifying the consequences of unsustainable ongoing sand mining and hydropower is crucial for obtaining sediment load data and managing hydrogeomorphology. In this study, comprehensive long-term consecutive four-field monitoring, statistical methods, and hydrological models (SWAT) were applied to quantify the spatiotemporal changes in long-term discharge and sediment load from 1996 to 2020 for the tropical river of the Vu Gia Thu Bon (VGTB) in the central region of Vietnam. The SWAT model was calibrated from 1996 to 2010, validated from 2011 to 2020 and showed good performance for daily discharge and monthly sediment. The evolution of river bathymetric data (2010, 2015, 2018, and 2021) was analysed to clarify the upstream sediment supply trapped in the riverbed and how the sand mining volume was removed. The results showed that the mean annual sediment in the Vu Gia and Thu Bon Rivers decreased by 57.3% and 23.8%, respectively, in the postdam period compared with the predam period. The thalweg elevation decreased at the Ai Nghia and Giao Thuy stations from 2010 to 2021 by 1.8 m and 3.9 m, respectively. The water level decreased by 21.1% at Ai Nghia and 44.3% at Giao Thuy. Dam development, sand mining, and changes in land use are the main factors responsible for flow discharge and sediment morphodynamic alterations. Morphological change have increased the water transfer rate from the Vu Gia River to the Thu Bon River through the Quang Hue channel. Downstream of the Vu Gia River, water transfer and riverbed incision have decreased flow discharge and water level and increased saltwater intrusion in recent years. As a result, water shortages induced by saltwater intrusion during drought periods have emerged as a significant constraint in hindering the domestic water supply and agricultural production.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51405-z.</p>", "<title>Acknowledgements</title>", "<p>This work was funded by APN “Asia-Pacific Network for Global Change Research” under project reference number CRRP2020-09MYKantoush (Funder ID: 10.13039/100005536), Japan-ASEAN Science, Technology and Innovation Platform (JASTIP), Research Unit for Realization of Sustainable Society (RURSS) at Kyoto University, JSPS Core-to-Core Program (Grant Number: JPJSCCB20220004), and JSPS Postdoctoral Fellowships Program (Fellowship ID: P24064).</p>", "<title>Author contributions</title>", "<p>B.Q.N.: conceptualization, methodology, software, formal analysis, investigation, resources, data curation, writing—original draft, writing—review &amp; editing, visualization. S.A. K.: conceptualization, methodology, investigation, resources, data curation, supervision, writing—review &amp; editing. T.S.: supervision, writing—review &amp; editing.</p>", "<title>Data availability</title>", "<p>The DEM, land use, and soil maps were obtained from the website of the “Land Use and Climate Change Interaction in Central Vietnam”—(LUCCi) project (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.lucci-vietnam.info\">www.lucci-vietnam.info</ext-link>). The datasets used and analysed during the current study are available from the corresponding author upon reasonable request.</p>", "<title>Competing interests</title>", "<p id=\"Par48\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>(<bold>a</bold>) Map of the VGTB River basin, (<bold>b</bold>) rainfall and temperature, (<bold>c</bold>) and (<bold>d</bold>) flow discharge at the Thanh My and Nong Son stations. Maps created in the QGIS version 3.28.4 (<ext-link ext-link-type=\"uri\" xlink:href=\"http://qgis.org/\">http://qgis.org/</ext-link>) and OriginPro 2023 (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.originlab.com/\">https://www.originlab.com/</ext-link>) softwares<sup>##UREF##15##20##,##UREF##16##21##</sup>.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>(<bold>a</bold>) General map of the Vu Gia Thu Bon River basin showing samples collected in the main river, estuaries, and along the beach (the red, navy blue, blue, yellow, and green circles represent sediment samples collected in the Vu Gia River, Thu Bon River, Quang Hue channel, Cua Han estuary, and Cua Dai estuary, respectively). (<bold>b</bold>) Mean grain size (d50) of the Vu Gia River, Thu Bon River, Quang Hue Channel, Cua Han in estuary, and Cua Dai estuary. (<bold>c</bold>–<bold>d</bold>) Grain size from the left bank to the riverbed and right bank at a cross-section in the Quang Hue channel (QH7) and the Thu Bon River (TB13). Maps created in the QGIS version 3.28.4 (<ext-link ext-link-type=\"uri\" xlink:href=\"http://qgis.org/\">http://qgis.org/</ext-link>) and OriginPro 2023 (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.originlab.com/\">https://www.originlab.com/</ext-link>) softwares<sup>##UREF##15##20##,##UREF##16##21##</sup>.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Schematic methodology framework of the research.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Calibrated and validated hydrographs of the discharge and sediment at (<bold>a</bold>) the Thanh My station and (<bold>b</bold>) the Nong Son station; calibrated (1996–2010) and validated (2011–2020).</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>The long-term annual discharge and sediment load at the Thanh My, Nong Son, Ai Nghia, and Giao Thuy stations from 1996 to 2020 (DM4: Dak Mi 4 reservoir; ST2: Song Tranh 2 reservoir; SB4: Song Bung 4 reservoir).</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Monthly discharge in the predam (1996–2010) and postdam (2011–2020) periods at the Thanh My, Ai Nghia, Nong Son, and Giao Thuy stations. The highlights show the months with significant changes in the two periods. Yellow, green, and violet indicate significant changes in the dry season, flood season, and annually, respectively.</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>The violins represent kernel density plots of the daily suspended sediment concentration (<bold>a</bold>) and annual sediment concentration (<bold>b</bold>) at the Thanh My, Nong Son, Ai Nghia, and Giao Thuy stations in the predam and postdam periods. The black lines represent box-whisker plots, the white points represent the means, and the white lines represent the medians.</p></caption></fig>", "<fig id=\"Fig8\"><label>Figure 8</label><caption><p>(<bold>a</bold>) Thalweg elevation of the Vu Gia River from Thanh My station to the Cua Han estuary, (<bold>b</bold>) Thalweg elevation of the Thu Bon River from the Nong Son station to the Cua Dai estuary, (<bold>c</bold>) Thalweg elevation of the Quang Hue channel, (<bold>d</bold>) Elevation of cross-section CS-VG on the Vu Gia River, (<bold>e</bold>) Elevation of cross-section CS-TB on the Thu Bon River.</p></caption></fig>", "<fig id=\"Fig9\"><label>Figure 9</label><caption><p>(<bold>a</bold>–<bold>d</bold>) The riverbed elevation in 2010, 2015, 2018, and 2021. (<bold>e</bold>–<bold>h</bold>) The riverbed elevation differences in the 2015–2010, 2018–2015, 2021–2018, and 2021–2010 periods. The units of riverbed elevation and riverbed elevation differences are meter. Maps created in the QGIS version 3.28.4 (<ext-link ext-link-type=\"uri\" xlink:href=\"http://qgis.org/\">http://qgis.org/</ext-link>) softwares<sup>##UREF##16##21##</sup>.</p></caption></fig>", "<fig id=\"Fig10\"><label>Figure 10</label><caption><p>Diagram of the sediment budget by elevation change in the (<bold>a</bold>) 2015–2010, (<bold>b</bold>) 2018–2015, (<bold>c</bold>) 2021–2018, and (<bold>d</bold>) 2021–2010 periods.</p></caption></fig>", "<fig id=\"Fig11\"><label>Figure 11</label><caption><p>Daily water level and the maximum, mean, and minimum water level trends at the Ai Nghia and Giao Thuy stations.</p></caption></fig>", "<fig id=\"Fig12\"><label>Figure 12</label><caption><p>Mitigation measures should be proposed for the integrated management of the VGTB River basin.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>The results of the IHA analysis determined discharge alterations at the Thanh My and Nong Son stations.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Indicator</th><th align=\"left\" rowspan=\"2\">Units</th><th align=\"left\" colspan=\"3\">Thanh My station</th><th align=\"left\" colspan=\"3\">Nong Son station</th></tr><tr><th align=\"left\">Predam</th><th align=\"left\">Postdam</th><th align=\"left\">Deviation magnitude (%)</th><th align=\"left\">Predam</th><th align=\"left\">Postdam</th><th align=\"left\">Deviation magnitude (%)</th></tr></thead><tbody><tr><td align=\"left\">January</td><td align=\"left\">m<sup>3</sup>/s</td><td align=\"left\">120</td><td align=\"left\">49</td><td align=\"left\">− 71(− 59)</td><td align=\"left\">227</td><td align=\"left\">297</td><td align=\"left\">70(31)</td></tr><tr><td align=\"left\">February</td><td align=\"left\">m<sup>3</sup>/s</td><td align=\"left\">81</td><td align=\"left\">23</td><td align=\"left\">− 58(− 72)</td><td align=\"left\">148</td><td align=\"left\">167</td><td align=\"left\">19(13)</td></tr><tr><td align=\"left\">March</td><td align=\"left\">m<sup>3</sup>/s</td><td align=\"left\">57</td><td align=\"left\">13</td><td align=\"left\">− 44(− 77)</td><td align=\"left\">99</td><td align=\"left\">148</td><td align=\"left\">48(49)</td></tr><tr><td align=\"left\">April</td><td align=\"left\">m<sup>3</sup>/s</td><td align=\"left\">47</td><td align=\"left\">16</td><td align=\"left\">− 31(− 66)</td><td align=\"left\">72</td><td align=\"left\">112</td><td align=\"left\">40(55)</td></tr><tr><td align=\"left\">May</td><td align=\"left\">m<sup>3</sup>/s</td><td align=\"left\">57</td><td align=\"left\">19</td><td align=\"left\">− 38(− 67)</td><td align=\"left\">93</td><td align=\"left\">154</td><td align=\"left\">60(64)</td></tr><tr><td align=\"left\">June</td><td align=\"left\">m<sup>3</sup>/s</td><td align=\"left\">48</td><td align=\"left\">11</td><td align=\"left\">− 37(− 77)</td><td align=\"left\">87</td><td align=\"left\">135</td><td align=\"left\">48(56)</td></tr><tr><td align=\"left\">July</td><td align=\"left\">m<sup>3</sup>/s</td><td align=\"left\">44</td><td align=\"left\">10</td><td align=\"left\">− 34(− 77)</td><td align=\"left\">64</td><td align=\"left\">104</td><td align=\"left\">40(63)</td></tr><tr><td align=\"left\">August</td><td align=\"left\">m<sup>3</sup>/s</td><td align=\"left\">59</td><td align=\"left\">11</td><td align=\"left\">− 48(− 81)</td><td align=\"left\">69</td><td align=\"left\">101</td><td align=\"left\">32(47)</td></tr><tr><td align=\"left\">September</td><td align=\"left\">m<sup>3</sup>/s</td><td align=\"left\">89</td><td align=\"left\">24</td><td align=\"left\">− 65(− 73)</td><td align=\"left\">113</td><td align=\"left\">132</td><td align=\"left\">19(17)</td></tr><tr><td align=\"left\">October</td><td align=\"left\">m<sup>3</sup>/s</td><td align=\"left\">193</td><td align=\"left\">50</td><td align=\"left\">− 143(− 74)</td><td align=\"left\">381</td><td align=\"left\">294</td><td align=\"left\">− 87(− 23)</td></tr><tr><td align=\"left\">November</td><td align=\"left\">m<sup>3</sup>/s</td><td align=\"left\">262</td><td align=\"left\">90</td><td align=\"left\">− 172(− 66)</td><td align=\"left\">696</td><td align=\"left\">573</td><td align=\"left\">− 124(− 18)</td></tr><tr><td align=\"left\">December</td><td align=\"left\">m<sup>3</sup>/s</td><td align=\"left\">209</td><td align=\"left\">83</td><td align=\"left\">− 126(− 60)</td><td align=\"left\">483</td><td align=\"left\">587</td><td align=\"left\">104(22)</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Changes in the water level between the predam and postdam periods at the Ai Nghia and Giao Thuy stations.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Indicators</th><th align=\"left\" colspan=\"3\">Ai Nghia station</th><th align=\"left\" colspan=\"3\">Giao Thuy station</th></tr><tr><th align=\"left\">Predam<break/>(m)</th><th align=\"left\">Postdam<break/>(m)</th><th align=\"left\">Deviation<break/>magnitude (%)</th><th align=\"left\">Predam<break/>(m)</th><th align=\"left\">Postdam<break/>(m)</th><th align=\"left\">Deviation<break/>magnitude (%)</th></tr></thead><tbody><tr><td align=\"left\">January</td><td char=\".\" align=\"char\">3.712</td><td char=\".\" align=\"char\">3.079</td><td char=\"(\" align=\"char\">− 0.633(− 17)</td><td char=\".\" align=\"char\">2.418</td><td char=\".\" align=\"char\">1.511</td><td char=\"(\" align=\"char\">− 0.907(− 37.5)</td></tr><tr><td align=\"left\">February</td><td char=\".\" align=\"char\">3.232</td><td char=\".\" align=\"char\">2.715</td><td char=\"(\" align=\"char\">− 0.517(− 16)</td><td char=\".\" align=\"char\">1.858</td><td char=\".\" align=\"char\">1.101</td><td char=\"(\" align=\"char\">− 0.757(− 40.8)</td></tr><tr><td align=\"left\">March</td><td char=\".\" align=\"char\">3.001</td><td char=\".\" align=\"char\">2.677</td><td char=\"(\" align=\"char\">− 0.324(− 10.8)</td><td char=\".\" align=\"char\">1.534</td><td char=\".\" align=\"char\">0.966</td><td char=\"(\" align=\"char\">− 0.568(− 37.1)</td></tr><tr><td align=\"left\">April</td><td char=\".\" align=\"char\">2.958</td><td char=\".\" align=\"char\">2.646</td><td char=\"(\" align=\"char\">− 0.312(− 10.5)</td><td char=\".\" align=\"char\">1.421</td><td char=\".\" align=\"char\">0.857</td><td char=\"(\" align=\"char\">− 0.564(− 39.7)</td></tr><tr><td align=\"left\">May</td><td char=\".\" align=\"char\">3.236</td><td char=\".\" align=\"char\">2.867</td><td char=\"(\" align=\"char\">− 0.369(− 11.4)</td><td char=\".\" align=\"char\">1.633</td><td char=\".\" align=\"char\">0.964</td><td char=\"(\" align=\"char\">− 0.669(− 41)</td></tr><tr><td align=\"left\">June</td><td char=\".\" align=\"char\">3.111</td><td char=\".\" align=\"char\">2.860</td><td char=\"(\" align=\"char\">− 0.251(− 8.1)</td><td char=\".\" align=\"char\">1.519</td><td char=\".\" align=\"char\">0.931</td><td char=\"(\" align=\"char\">− 0.588(− 38.7)</td></tr><tr><td align=\"left\">July</td><td char=\".\" align=\"char\">3.012</td><td char=\".\" align=\"char\">2.785</td><td char=\"(\" align=\"char\">− 0.228(− 7.6)</td><td char=\".\" align=\"char\">1.344</td><td char=\".\" align=\"char\">0.824</td><td char=\"(\" align=\"char\">− 0.52(− 38.7)</td></tr><tr><td align=\"left\">August</td><td char=\".\" align=\"char\">3.329</td><td char=\".\" align=\"char\">2.742</td><td char=\"(\" align=\"char\">− 0.587(− 17.6)</td><td char=\".\" align=\"char\">1.497</td><td char=\".\" align=\"char\">0.834</td><td char=\"(\" align=\"char\">− 0.663(− 44.3)</td></tr><tr><td align=\"left\">September</td><td char=\".\" align=\"char\">3.971</td><td char=\".\" align=\"char\">3.135</td><td char=\"(\" align=\"char\">− 0.836(− 21.1)</td><td char=\".\" align=\"char\">2.073</td><td char=\".\" align=\"char\">1.154</td><td char=\"(\" align=\"char\">− 0.919(− 44.3)</td></tr><tr><td align=\"left\">October</td><td char=\".\" align=\"char\">4.799</td><td char=\".\" align=\"char\">3.878</td><td char=\"(\" align=\"char\">− 0.92(− 19.2)</td><td char=\".\" align=\"char\">3.330</td><td char=\".\" align=\"char\">1.958</td><td char=\"(\" align=\"char\">− 1.372(− 41.2)</td></tr><tr><td align=\"left\">November</td><td char=\".\" align=\"char\">5.191</td><td char=\".\" align=\"char\">4.351</td><td char=\"(\" align=\"char\">− 0.839(− 16.2)</td><td char=\".\" align=\"char\">4.107</td><td char=\".\" align=\"char\">2.752</td><td char=\"(\" align=\"char\">− 1.355(− 33)</td></tr><tr><td align=\"left\">December</td><td char=\".\" align=\"char\">4.586</td><td char=\".\" align=\"char\">3.728</td><td char=\"(\" align=\"char\">− 0.858(− 18.7)</td><td char=\".\" align=\"char\">3.402</td><td char=\".\" align=\"char\">2.308</td><td char=\"(\" align=\"char\">− 1.094(− 32.2)</td></tr><tr><td align=\"left\">Annual</td><td char=\".\" align=\"char\">3.680</td><td char=\".\" align=\"char\">3.123</td><td char=\"(\" align=\"char\">− 0.557(− 15.1)</td><td char=\".\" align=\"char\">2.179</td><td char=\".\" align=\"char\">1.347</td><td char=\"(\" align=\"char\">− 0.832(− 38.2)</td></tr><tr><td align=\"left\">1-day minimum</td><td char=\".\" align=\"char\">2.564</td><td char=\".\" align=\"char\">1.550</td><td char=\"(\" align=\"char\">− 1.014(− 39.5)</td><td char=\".\" align=\"char\">1.051</td><td char=\".\" align=\"char\">0.070</td><td char=\"(\" align=\"char\">− 0.981(− 93.3)</td></tr><tr><td align=\"left\">1-day maximum</td><td char=\".\" align=\"char\">8.862</td><td char=\".\" align=\"char\">9.670</td><td char=\"(\" align=\"char\">0.808(9.1)</td><td char=\".\" align=\"char\">8.153</td><td char=\".\" align=\"char\">9.030</td><td char=\"(\" align=\"char\">0.877(10.8)</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51405_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51405_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51405_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51405_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51405_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2024_51405_Fig6_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"41598_2024_51405_Fig7_HTML\" id=\"MO7\"/>", "<graphic xlink:href=\"41598_2024_51405_Fig8_HTML\" id=\"MO8\"/>", "<graphic xlink:href=\"41598_2024_51405_Fig9_HTML\" id=\"MO9\"/>", "<graphic xlink:href=\"41598_2024_51405_Fig10_HTML\" id=\"MO10\"/>", "<graphic xlink:href=\"41598_2024_51405_Fig11_HTML\" id=\"MO11\"/>", "<graphic xlink:href=\"41598_2024_51405_Fig12_HTML\" id=\"MO12\"/>" ]
[ "<media xlink:href=\"41598_2024_51405_MOESM1_ESM.docx\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["1."], "surname": ["De-Girolamo", "Barca", "Pappagallo", "Porto"], "given-names": ["AM", "E", "G", "AL"], "article-title": ["Simulating ecologically relevant hydrological indicators in a temporary river system"], "source": ["Agric. Water Manag."], "year": ["2017"], "volume": ["180"], "fpage": ["194"], "lpage": ["204"], "pub-id": ["10.1016/j.agwat.2016.05.034"]}, {"label": ["2."], "surname": ["Ahn", "Merwade"], "given-names": ["K-H", "V"], "article-title": ["Quantifying the relative impact of climate and human activities on streamflow"], "source": ["J. Hydrol."], "year": ["2014"], "volume": ["515"], "fpage": ["257"], "lpage": ["266"], "pub-id": ["10.1016/j.jhydrol.2014.04.062"]}, {"label": ["3."], "surname": ["Keesstra", "Kondrlova", "Czajka", "Seeger", "Maroulis"], "given-names": ["SD", "E", "A", "M", "J"], "article-title": ["Assessing riparian zone impacts on water and sediment movement: A new approach"], "source": ["Netherl. J. Geosci."], "year": ["2012"], "volume": ["91"], "fpage": ["245"], "lpage": ["255"], "pub-id": ["10.1017/S0016774600001633"]}, {"label": ["4."], "surname": ["Syvitski"], "given-names": ["JPM"], "article-title": ["Sinking deltas due to human activities"], "source": ["Nat. Geosci."], "year": ["2009"], "volume": ["2"], "fpage": ["681"], "lpage": ["686"], "pub-id": ["10.1038/ngeo629"]}, {"label": ["5."], "surname": ["Boix-Fayos", "Barber\u00e1", "L\u00f3pez-Berm\u00fadez", "Castillo"], "given-names": ["C", "GG", "F", "VM"], "article-title": ["Effects of check dams, reforestation and land-use changes on river channel morphology: Case study of the Rogativa catchment (Murcia, Spain)"], "source": ["Geomorphology"], "year": ["2007"], "volume": ["91"], "fpage": ["103"], "lpage": ["123"], "pub-id": ["10.1016/j.geomorph.2007.02.003"]}, {"label": ["6."], "surname": ["Gomez", "Cui", "Kettner", "Peacock", "Syvitski"], "given-names": ["B", "Y", "AJ", "DH", "JPM"], "article-title": ["Simulating changes to the sediment transport regime of the Waipaoa River, New Zealand, driven by climate change in the twenty-first century"], "source": ["Glob. Planet. Change"], "year": ["2009"], "volume": ["67"], "fpage": ["153"], "lpage": ["166"], "pub-id": ["10.1016/j.gloplacha.2009.02.002"]}, {"label": ["7."], "surname": ["Best"], "given-names": ["J"], "article-title": ["Anthropogenic stresses on the world\u2019s big rivers"], "source": ["Nat. Geosci."], "year": ["2019"], "volume": ["12"], "fpage": ["7"], "lpage": ["21"], "pub-id": ["10.1038/s41561-018-0262-x"]}, {"label": ["8."], "surname": ["Binh"], "given-names": ["DV"], "article-title": ["Effects of riverbed incision on the hydrology of the Vietnamese Mekong Delta"], "source": ["Hydrol. Process."], "year": ["2021"], "volume": ["35"], "fpage": ["e14030"], "pub-id": ["10.1002/hyp.14030"]}, {"label": ["9."], "surname": ["Malekmohammadi", "Uvo", "Moghadam", "Noori", "Abolfathi"], "given-names": ["B", "CB", "NT", "R", "S"], "article-title": ["Environmental risk assessment of wetland ecosystems using Bayesian belief networks"], "source": ["Hydrology"], "year": ["2023"], "volume": ["10"], "fpage": ["16"], "pub-id": ["10.3390/hydrology10010016"]}, {"label": ["12."], "surname": ["Fukuoka", "Nakagawa", "Sumi", "Zhang"], "given-names": ["S", "H", "T", "H"], "source": ["Advances in River Sediment Research"], "year": ["2013"], "publisher-name": ["CRC Press"]}, {"label": ["13."], "surname": ["Zarfl", "Lumsdon", "Berlekamp", "Tydecks", "Tockner"], "given-names": ["C", "AE", "J", "L", "K"], "article-title": ["A global boom in hydropower dam construction"], "source": ["Aquat. Sci."], "year": ["2015"], "volume": ["77"], "fpage": ["161"], "lpage": ["170"], "pub-id": ["10.1007/s00027-014-0377-0"]}, {"label": ["14."], "surname": ["Van Binh"], "given-names": ["D"], "article-title": ["Long-term alterations of flow regimes of the Mekong River and adaptation strategies for the Vietnamese Mekong Delta"], "source": ["J. Hydrol. Reg. Stud."], "year": ["2020"], "volume": ["32"], "fpage": ["100742"], "pub-id": ["10.1016/j.ejrh.2020.100742"]}, {"label": ["15."], "surname": ["Yuen"], "given-names": ["KW"], "article-title": ["Interacting effects of land-use change and natural hazards on rice agriculture in the Mekong and Red River deltas in Vietnam"], "source": ["Nat. Hazards Earth Syst. Sci."], "year": ["2021"], "volume": ["21"], "fpage": ["1473"], "lpage": ["1493"], "pub-id": ["10.5194/nhess-21-1473-2021"]}, {"label": ["16."], "surname": ["Besset", "Anthony", "Bouchette"], "given-names": ["M", "EJ", "F"], "article-title": ["Multi-decadal variations in delta shorelines and their relationship to river sediment supply: An assessment and review"], "source": ["Earth-Sci. Rev."], "year": ["2019"], "volume": ["193"], "fpage": ["199"], "lpage": ["219"], "pub-id": ["10.1016/j.earscirev.2019.04.018"]}, {"label": ["17."], "surname": ["Van Binh", "Kantoush", "Sumi"], "given-names": ["D", "S", "T"], "article-title": ["Changes to long-term discharge and sediment loads in the Vietnamese Mekong Delta caused by upstream dams"], "source": ["Geomorphology"], "year": ["2020"], "volume": ["353"], "fpage": ["107011"], "pub-id": ["10.1016/j.geomorph.2019.107011"]}, {"label": ["20."], "mixed-citation": ["OriginLab Corporation. OriginPro 2023 (64-bit). "], "ext-link": ["https://www.originlab.com/"]}, {"label": ["21."], "mixed-citation": ["QGIS Development Team. QGIS Geographic Information System (version 3.28.4). Open Source Geospatial Foundation. "], "ext-link": ["http://qgis.org/"]}, {"label": ["22."], "mixed-citation": ["ICEM. "], "italic": ["Strategic Environmental Assessment of the Quang Nam Province Hydropower Plan for the Vu Gia-Thu Bon River Basin, Prepared for the ADB, MONRE, MOITT & EVN, Hanoi, Vietnam"]}, {"label": ["23."], "surname": ["Nguyen"], "given-names": ["BQ"], "article-title": ["Understanding the anthropogenic development impacts on long-term flow regimes in a tropical river basin, Central Vietnam"], "source": ["Hydrol. Sci. J."], "year": ["2023"], "volume": ["2013"], "fpage": ["1"], "lpage": ["14"]}, {"label": ["24."], "surname": ["Nguyen"], "given-names": ["BQ"], "article-title": ["Quantifying the impacts of hydraulic infrastructure on tropical streamflows"], "source": ["Hydrol. Process."], "year": ["2023"], "volume": ["37"], "fpage": ["3"], "pub-id": ["10.1002/hyp.14834"]}, {"label": ["25."], "mixed-citation": ["Nguyen, T. N. U. Harmonizing multi-sectorial water management with minimum flow requirements in an anthropogenically impacted river basin. In "], "italic": ["The case of Vu Gia\u2013Thu Bon, Central Viet Nam"]}, {"label": ["26."], "mixed-citation": ["Viet, T. Q. Estimating the impact of climate change induced saltwater intrusion on agriculture in estuaries-the case of Vu Gia Thu Bon. In "], "italic": ["Ruhr-Universit\u00e4t Bochum, Vietnam"]}, {"label": ["27."], "mixed-citation": ["Nguyen, B. Q. "], "italic": ["et al.", "Proceedings of the 40th IAHR World Congress"]}, {"label": ["28."], "mixed-citation": ["Kantoush, S. "], "italic": ["et al.", "Proceedings of the 40th IAHR World Congress"]}, {"label": ["29."], "surname": ["Vo", "Gourbesville", "Vu", "Raghavan", "Liong"], "given-names": ["ND", "P", "MT", "SV", "S-Y"], "article-title": ["A deterministic hydrological approach to estimate climate change impact on river flow: Vu Gia-Thu Bon catchment, Vietnam"], "source": ["J. Hydro-env. Res."], "year": ["2016"], "volume": ["11"], "fpage": ["59"], "lpage": ["74"], "pub-id": ["10.1016/j.jher.2015.11.001"]}, {"label": ["30."], "surname": ["Vo", "Gourbesville"], "given-names": ["ND", "P"], "article-title": ["Application of deterministic distributed hydrological model for large catchment\u2014a case study at Vu Gia-Thu Bon catchment\u2014Viet Nam"], "source": ["J. Hydroinform."], "year": ["2016"], "volume": ["18"], "fpage": ["885"], "pub-id": ["10.2166/hydro.2016.138"]}, {"label": ["31."], "surname": ["Vu", "Vo", "Gourbesville", "Raghavan", "Liong"], "given-names": ["MT", "ND", "P", "SV", "S-Y"], "article-title": ["Hydro-meteorological drought assessment under climate change impact over the Vu Gia-Thu Bon river basin Vietnam"], "source": ["Hydrol. Sci. J."], "year": ["2017"], "volume": ["62"], "fpage": ["1654"], "lpage": ["1668"], "pub-id": ["10.1080/02626667.2017.1346374"]}, {"label": ["32."], "surname": ["Hoang", "Viet", "Tanaka"], "given-names": ["VC", "NT", "H"], "article-title": ["Morphological change on Cua Dai Beach, Vietnam: Part II theoretical analysis"], "source": ["Tohoku J. Nat. Disaster Sci."], "year": ["2015"], "volume": ["51"], "fpage": ["87"], "lpage": ["92"]}, {"label": ["33."], "mixed-citation": ["Viet, N. T. "], "italic": ["et al.", "Proceedings of Fifth International Conference on Estuaries and Coasts (ICEC2015)"]}, {"label": ["34."], "surname": ["Hung", "Vinh", "Nam", "Lee"], "given-names": ["NT", "BT", "SY", "JL"], "article-title": ["Cause analysis of erosion-induced resort washout on Cua Dai Beach"], "source": ["Vietnam. J. Coast. Res."], "year": ["2017"], "volume": ["2017"], "fpage": ["214"], "lpage": ["218"], "pub-id": ["10.2112/SI79-044.1"]}, {"label": ["35."], "mixed-citation": ["Cham, D. D., Minh, N. Q., Lam, N. T., Son, N. T. & Thanh, N. T. Identification of Erosion-Accretion Causes and Regimes along the Quang Nam Coast, Vietnam. In "], "italic": ["International Conference on Asian and Pacific Coasts"]}, {"label": ["36."], "surname": ["Loi"], "given-names": ["NK"], "article-title": ["Automated procedure of real-time flood forecasting in Vu Gia-Thu Bon river basin, Vietnam by integrating SWAT and HEC-RAS models"], "source": ["J. Water Clim. Chang."], "year": ["2019"], "volume": ["10"], "fpage": ["535"], "lpage": ["545"], "pub-id": ["10.2166/wcc.2018.015"]}, {"label": ["37."], "surname": ["Vogel", "Fennessey"], "given-names": ["RM", "NM"], "article-title": ["Flow-duration curves. I: New interpretation and confidence intervals"], "source": ["J. Water Resour. Plan. Manag."], "year": ["1994"], "volume": ["120"], "fpage": ["485"], "lpage": ["504"], "pub-id": ["10.1061/(ASCE)0733-9496(1994)120:4(485)"]}, {"label": ["38."], "surname": ["Sen"], "given-names": ["PK"], "article-title": ["Estimates of the regression coefficient based on Kendall\u2019s tau"], "source": ["J. Am. Stat. Assoc."], "year": ["1968"], "volume": ["63"], "fpage": ["1379"], "lpage": ["1389"], "pub-id": ["10.1080/01621459.1968.10480934"]}, {"label": ["39."], "surname": ["Kendall"], "given-names": ["MG"], "article-title": ["A new measure of rank correlation"], "source": ["Biometrika"], "year": ["1938"], "volume": ["30"], "fpage": ["81"], "lpage": ["93"], "pub-id": ["10.1093/biomet/30.1-2.81"]}, {"label": ["40."], "surname": ["Mann"], "given-names": ["HB"], "article-title": ["Nonparametric tests against trend"], "source": ["Econom. J. Econom. Soc."], "year": ["1945"], "volume": ["1945"], "fpage": ["245"], "lpage": ["259"]}, {"label": ["41."], "surname": ["Pettitt"], "given-names": ["AN"], "article-title": ["A non-parametric approach to the change-point problem"], "source": ["J. R. Stat. Soc. Ser. C Appl. Stat."], "year": ["1979"], "volume": ["28"], "fpage": ["126"], "lpage": ["135"]}, {"label": ["42."], "surname": ["Richter", "Baumgartner", "Braun", "Powell"], "given-names": ["BD", "JV", "DP", "J"], "article-title": ["A spatial assessment of hydrologic alteration within a river network"], "source": ["Regul. Rivers Res. Manag. An Int. J. Devoted to River Res. Manag."], "year": ["1998"], "volume": ["14"], "fpage": ["329"], "lpage": ["340"], "pub-id": ["10.1002/(SICI)1099-1646(199807/08)14:4<329::AID-RRR505>3.0.CO;2-E"]}, {"label": ["43."], "surname": ["Richter", "Baumgartner", "Powell", "Braun"], "given-names": ["BD", "JV", "J", "DP"], "article-title": ["A method for assessing hydrologic alteration within ecosystems"], "source": ["Conserv. Biol."], "year": ["1996"], "volume": ["10"], "fpage": ["1163"], "lpage": ["1174"], "pub-id": ["10.1046/j.1523-1739.1996.10041163.x"]}, {"label": ["44."], "surname": ["Richter", "Mathews", "Harrison", "Wigington"], "given-names": ["BD", "R", "DL", "R"], "article-title": ["Ecologically sustainable water management: Managing river flows for ecological integrity"], "source": ["Ecol. Appl."], "year": ["2003"], "volume": ["13"], "fpage": ["206"], "lpage": ["224"], "pub-id": ["10.1890/1051-0761(2003)013[0206:ESWMMR]2.0.CO;2"]}, {"label": ["45."], "mixed-citation": ["Wheaton, J. M. "], "italic": ["Uncertainity in Morphological Sediment Budgeting of Rivers. PhD Thesis. University of Southampton"]}, {"label": ["46."], "surname": ["Arnold"], "given-names": ["JG"], "article-title": ["SWAT: Model use, calibration, and validation"], "source": ["Trans. ASABE"], "year": ["2012"], "volume": ["55"], "fpage": ["1491"], "lpage": ["1508"], "pub-id": ["10.13031/2013.42256"]}, {"label": ["47."], "surname": ["Neitsch", "Arnold", "Kiniry", "Williams"], "given-names": ["S", "J", "J", "J"], "article-title": ["Soil & Water Assessment Tool Theoretical Documentation Version 2009"], "source": ["Texas Water Resour. Inst."], "year": ["2011"], "volume": ["2011"], "fpage": ["1"], "lpage": ["647"], "pub-id": ["10.1016/j.scitotenv.2015.11.063"]}, {"label": ["48."], "surname": ["Tran", "Le", "Zhang", "Nguyen", "Bolten", "Lakshmi"], "given-names": ["T-N-D", "M-H", "R", "BQ", "JD", "V"], "article-title": ["Robustness of gridded precipitation products for Vietnam basins using the comprehensive assessment framework of rainfall"], "source": ["Atmos. Res."], "year": ["2023"], "volume": ["293"], "fpage": ["106923"], "pub-id": ["10.1016/j.atmosres.2023.106923"]}, {"label": ["49."], "surname": ["Nguyen"], "given-names": ["BQ"], "article-title": ["Quantification of global Digital Elevation Model (DEM)\u2013A case study of the newly released NASADEM for a river basin in Central Vietnam"], "source": ["J. Hydrol. Reg. Stud."], "year": ["2023"], "volume": ["45"], "fpage": ["101282"], "pub-id": ["10.1016/j.ejrh.2022.101282"]}, {"label": ["50."], "surname": ["Tran", "Nguyen", "Grodzka-\u0141ukaszewska", "Sinicyn", "Lakshmi"], "given-names": ["T-N-D", "BQ", "M", "G", "V"], "article-title": ["The role of reservoirs under the impacts of climate change on the Srepok River Basin Central Highlands Vietnam"], "source": ["Front. Environ. Sci."], "year": ["2023"], "volume": ["11"], "fpage": ["1304845"], "pub-id": ["10.3389/fenvs.2023.1304845"]}, {"label": ["51."], "surname": ["Setegn", "Srinivasan", "Dargahi", "Melesse"], "given-names": ["SG", "R", "B", "AM"], "article-title": ["Spatial delineation of soil erosion vulnerability in the Lake Tana Basin, Ethiopia"], "source": ["Hydrol. Process. An Int. J."], "year": ["2009"], "volume": ["23"], "fpage": ["3738"], "lpage": ["3750"], "pub-id": ["10.1002/hyp.7476"]}, {"label": ["52."], "mixed-citation": ["Wischmeier, W. H. & Smith, D. D. "], "italic": ["Predicting Rainfall-Erosion Losses from Cropland East of the Rocky Mountains: Guide for Selection of Practices For Soil and Water Conservation"]}, {"label": ["59."], "surname": ["Abbaspour"], "given-names": ["KC"], "article-title": ["Modelling hydrology and water quality in the pre-alpine/alpine Thur watershed using SWAT"], "source": ["J. Hydrol."], "year": ["2007"], "volume": ["333"], "fpage": ["413"], "lpage": ["430"], "pub-id": ["10.1016/j.jhydrol.2006.09.014"]}, {"label": ["60."], "surname": ["Sao"], "given-names": ["D"], "article-title": ["Evaluation of different objective functions used in the SUFI-2 calibration process of SWAT-CUP on water balance analysis: A case study of the pursat river basin, cambodia"], "source": ["Water"], "year": ["2020"], "volume": ["12"], "fpage": ["2901"], "pub-id": ["10.3390/w12102901"]}, {"label": ["61."], "surname": ["Abbaspour"], "given-names": ["KC"], "article-title": ["A continental-scale hydrology and water quality model for Europe: Calibration and uncertainty of a high-resolution large-scale SWAT model"], "source": ["J. Hydrol."], "year": ["2015"], "volume": ["524"], "fpage": ["733"], "lpage": ["752"], "pub-id": ["10.1016/j.jhydrol.2015.03.027"]}, {"label": ["62."], "surname": ["Kumar", "Singh", "Srivastava", "Narsimlu"], "given-names": ["N", "SK", "PK", "B"], "article-title": ["SWAT Model calibration and uncertainty analysis for streamflow prediction of the Tons River Basin, India, using Sequential Uncertainty Fitting (SUFI-2) algorithm"], "source": ["Model. Earth Syst. Environ."], "year": ["2017"], "volume": ["3"], "fpage": ["30"], "pub-id": ["10.1007/s40808-017-0306-z"]}, {"label": ["63."], "mixed-citation": ["RETA, 6470. "], "italic": ["Investment, Managing Water in Asia\u2019s River Basins: Charting Progress and Facilitating\u2014The Vu Gia-Thu Bon Basin. Quang Nam Province, Vietnam: Department of Natural Resources and Environment"]}, {"label": ["64."], "mixed-citation": ["JICA. "], "italic": ["Data Collection Survey on Basin-based Comprehensive Sediment Management in River Systems of the Central Region in Vietnam. Final Report"]}, {"label": ["65."], "mixed-citation": ["Nguyen, B. Q., Tran, T., \u0141ukaszewska, M. G.- & Sinicyn, G. "], "italic": ["Assessment of Urbanization-Induced Land-Use Change and Its Impact on Temperature, Evaporation, and Humidity in Central Vietnam. Water,"], "bold": ["14"]}, {"label": ["66."], "mixed-citation": ["Nga, T. T., Cong, V. H. & Hung, L. Assessing the impacts of climate change and reservoir operation on saltwater intrusion in the Vu Gia-Thu bon river basin. In "], "italic": ["International Conference on Asian and Pacific Coasts"]}, {"label": ["67."], "surname": ["Pandey", "Kumar", "Pandey", "Thongbam"], "given-names": ["A", "A", "DS", "PD"], "article-title": ["Rice quality under water stress"], "source": ["Indian J. Adv. Plant Res"], "year": ["2014"], "volume": ["1"], "fpage": ["23"], "lpage": ["26"]}, {"label": ["69."], "mixed-citation": ["Church, J. A. "], "italic": ["et al. Sea Level Change. PM Cambridge University Press"]}, {"label": ["70."], "surname": ["Hens"], "given-names": ["L"], "article-title": ["Sea-level rise and resilience in Vietnam and the Asia-Pacific: A synthesis"], "source": ["Vietnam J. Earth Sci."], "year": ["2018"], "volume": ["40"], "fpage": ["126"], "lpage": ["152"]}, {"label": ["71."], "surname": ["Milliman", "Mei-e"], "given-names": ["JD", "R"], "source": ["River Flux to the Sea: Impact of Human Intervention on River Systems and Adjacent Coastal Areas Climate Change"], "year": ["2021"], "publisher-name": ["CRC Press"], "fpage": ["57"], "lpage": ["83"]}, {"label": ["72."], "surname": ["Billen", "Garnier"], "given-names": ["G", "J"], "article-title": ["River basin nutrient delivery to the coastal sea: Assessing its potential to sustain new production of non-siliceous algae"], "source": ["Mar. Chem."], "year": ["2007"], "volume": ["106"], "fpage": ["148"], "lpage": ["160"], "pub-id": ["10.1016/j.marchem.2006.12.017"]}, {"label": ["73."], "surname": ["Santana", "Barroso"], "given-names": ["SE", "GF"], "article-title": ["Integrated ecosystem management of river basins and the coastal zone in Brazil"], "source": ["Water Resour. Manag."], "year": ["2014"], "volume": ["28"], "fpage": ["4927"], "lpage": ["4942"], "pub-id": ["10.1007/s11269-014-0754-4"]}, {"label": ["74."], "surname": ["Massoud", "Scrimshaw", "Lester"], "given-names": ["MA", "MD", "JN"], "article-title": ["Integrated coastal zone and river basin management: A review of the literature, concepts and trends for decision makers"], "source": ["Water Policy"], "year": ["2004"], "volume": ["6"], "fpage": ["519"], "lpage": ["548"], "pub-id": ["10.2166/wp.2004.0034"]}, {"label": ["75."], "mixed-citation": ["Dao, T. T., Hien, B. T. T. & Nguyen, C. H. "], "italic": ["Integrated River Basin Management of Vu Gia-Thu Bon and Coastal Quang Nam-Da Nang, Viet Nam. IUCN: International Union for Conservation of Nature. Hanns Seidle Stiftung, DE, Mangroves for the Future"]}]
{ "acronym": [], "definition": [] }
75
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1178
oa_package/a0/de/PMC10786850.tar.gz
PMC10786851
38216648
[]
[ "<title>Methods</title>", "<title>High <italic>P</italic>–<italic>T</italic> experiments</title>", "<p id=\"Par14\">Experiments were performed in a laser-heated diamond-anvil cell (DAC) with flat 300 μm culet anvils. Fe + 3wt%P foil (3N, Rare Metallic, 5–7 μm thick) was loaded into a ~ 130 µm hole at the centre of a pre-indented rhenium gasket, being sandwiched between the MORB glass powder. We used two MORB glass samples; both are similar in composition to that employed in previous experimental studies<sup>##REF##33976113##26##,##UREF##25##27##</sup> except titanium and calcium in SM1 (Table ##TAB##1##2##). Basaltic materials were employed because the solidus temperature is lower than that of pyrolite in the present experimental pressure range, which is helpful to secure a larger volume of silicate melt surrounding metallic liquid, and the chemical composition is closer to those of the standard silicates for the SIMS analyses. After loading the sample, the entire DAC was dried in a vacuum oven at 400 K for at least 24 h to eliminate moisture on the sample. Then, the sample was flushed with argon gas and subsequently compressed to a high pressure of interest in an argon atmosphere.</p>", "<p id=\"Par15\">The sample was heated from both sides using a couple of 100 W single-mode Yb fibre lasers (IPG Photonics). The laser beam was converted to a flat-top distribution using beam shaping optics (New Focus). The laser spot size was around 40 μm. Heating duration was 10 s, which should be long enough to reach chemical equilibrium between liquid Fe and coexisting silicate melt when considering their sizes (~ 30 µm) (Fig. ##FIG##0##1## and Supplementary Figs. ##SUPPL##0##S1## to ##SUPPL##0##S6##). It has been discussed that such heating time scale (~ 10 s) is sufficient for chemical equilibrium in metal–silicate partitioning in a multi-anvil press in which the sample size is much larger<sup>##UREF##26##28##,##UREF##27##29##</sup>. Note that the diffusivity of phosphorus should be similar to those of Si and S in molten Fe (Ref.<sup>##UREF##28##30##</sup>) and is slightly smaller than that of silicon at ~ 1300 K and 1 bar but larger at &gt; 3000 K in silicate melt<sup>##UREF##29##31##</sup>. Indeed, both liquid metal and molten silicate were found to be homogeneous in composition (Table ##TAB##1##2##), ensuring chemical equilibrium between them. Temperature was measured using a spectro-radiometric method. Experimental temperature was the one at the boundary between liquid metal and molten silicate. Sample pressure was determined from the Raman shift of the diamond anvil at ambient temperature after heating<sup>##UREF##30##32##</sup>. We considered the additional contribution of thermal pressure that has been estimated to be + 2.5 GPa per 1000 K. The overall errors in temperature and pressure may be ± 5% and ± 10%, respectively, according to Mori et al.<sup>##UREF##31##33##</sup> in which such uncertainties were required for all of their experimental data to be consistent with each other.</p>", "<title>Chemical analyses with SIMS and EPMA</title>", "<p id=\"Par16\">After recovering a sample from DAC at ambient condition, we prepared its cross-section at the centre of the laser-heated portion parallel to the compression/laser-heating axis by using a focused ion beam (FIB, FEI Versa 3D™). Textural and preliminary compositional characterizations were made on the sample cross section based on the X-ray elemental maps obtained by a field-emission-type scanning electron microscope (FE-SEM) and an energy-dispersive X-ray spectrometer (EDS) in the dual-beam FIB system (Fig. ##FIG##0##1## and Supplementary Figs. ##SUPPL##0##S2## to ##SUPPL##0##S7##). We then performed quantitative chemical analyses of quenched molten Fe and neighbouring silicate melt with FE-type electron probe microanalyzer (FE-EPMA, JXA-8530F, JEOL), except for phosphorus in silicate melt (Table ##TAB##1##2##). An acceleration voltage was 12 keV, a beam current was 15 nA and an electron beam diameter was 3 μm. We used Fe, Si, SiO<sub>2</sub>, Al<sub>2</sub>O<sub>3</sub>, MgO, CaSiO<sub>3</sub>, NaAlSi<sub>3</sub>O<sub>8</sub>, KAlSi<sub>3</sub>O<sub>8</sub>, KTiOPO<sub>4</sub>, Fe–0.84wt%C and Fe<sub>3</sub>C as standards, and LIF (Fe), LDE1 (O), PETJ (Si, Ca, P), TAP (Al, Na), TAPH (Mg), PETH (K) and LDE2H (C) as analysing crystals. The EPMA analytical totals for quenched silicate melt and liquid metal are low in some experiments because of the presence of small metal and oxide particles in silicate and metal, respectively, that were formed upon quenching temperature.</p>", "<p id=\"Par17\">The phosphorus contents in silicate melts were determined with an isotope microscope system consisting of a stigmatic secondary ion mass spectrometry instrument (SIMS, CAMECA ims-1270e7) and a stacked CMOS-type active pixel sensor (SCAPS) at Hokkaido University<sup>##UREF##32##34##</sup>. This system provides projection images of secondary ions emitted from the sample surface. The images are converted to concentration maps by calibration curve methods<sup>##REF##33976113##26##,##REF##17569827##35##</sup>. <sup>133</sup>Cs<sup>+</sup> primary beam (15 keV, 30 nA) was irradiated over an approximately 100 μm × 100 μm area of the sample surface. A normal incidence electron gun was utilized for charge compensation of the analysis area. The contrast aperture was set 100 μm in diameter for projecting secondary ion imaging onto the SCAPS. Secondary ion images of <sup>31</sup>P<sup>−</sup> and <sup>28</sup>Si<sup>−</sup> were obtained by peak jumping of a sector magnet with accumulation times of 100 and 25 s, respectively (Fig. ##FIG##0##1## and Supplementary Figs. ##SUPPL##0##S1## to ##SUPPL##0##S6##). Differences in <sup>31</sup>P<sup>−</sup> intensities between metal and silicate melt are more than two orders of magnitude (Supplementary Figs. ##SUPPL##0##S1## to ##SUPPL##0##S6##). The high intensity from the metals leaks into the surrounding silicate melts due to lens-flare or aberration effects of the ion optics of the isotope microscope. We carefully avoided the affected region to set regions of interest (ROIs) in the silicate melts which are free from the <sup>31</sup>P<sup>−</sup> intensity flare from the metals. The interference of <sup>30</sup>Si<sup>1</sup>H<sup>−</sup> on <sup>31</sup>P<sup>−</sup> was cut by the exit slit. Phosphorus concentrations in quenched silicate melts were quantified from the <sup>31</sup>P<sup>−</sup>/<sup>28</sup>Si<sup>−</sup> intensity ratio in ROIs (see areas surrounded by red lines in Fig. ##FIG##0##1## and Supplementary Figs. ##SUPPL##0##S1## to ##SUPPL##0##S6##), using a calibration curve established by standard glasses of Suprasil®, IND-G1, IND-G2 and FJ-G2<sup>##UREF##33##36##</sup> (Supplementary Fig. ##SUPPL##0##S10##) and the silicon content determined with an FE-EPMA. Errors in the phosphorus contents in silicate melts were calculated from the standard deviations of the <sup>31</sup>P<sup>−</sup>/<sup>28</sup>Si<sup>−</sup> intensity ratio in the ROI pixels (Table ##TAB##0##1##).</p>", "<p id=\"Par18\">For runs #2 and #4, the sample cross sections were first analysed by an FE-EPMA. They were then further milled by an FIB until quenched liquid metal was lost, which provided a wide silicate melt area for subsequent SIMS analyses. The SIMS measurements were performed first on the sample cross sections from runs #1, 3, 5 and 6. The FE-EPMA analyses were made after re-polishing the sample surface with the FIB.</p>" ]
[ "<title>Results</title>", "<p id=\"Par5\">Six separate metal–silicate partitioning experiments were conducted at 27–61 GPa and 3820–4760 K in a diamond-anvil cell (DAC) (Table ##TAB##0##1##) (see “<xref rid=\"Sec6\" ref-type=\"sec\">Methods</xref>” section). The chemical compositions of coexisting molten silicate and liquid metal are given in Table ##TAB##1##2##. We found 19,600 to 37,500 ppm P in liquid metal and only 39 to 266 ppm P in surrounding silicate melt (both by weight) (Fig. ##FIG##0##1## and Supplementary Figs. ##SUPPL##0##S1## to ##SUPPL##0##S6##), providing (mole based) = 73 to 918 (see Supplementary Fig. ##SUPPL##0##S7## for relations between mole-based and weight-based <italic>D</italic><sub>P</sub>). The metal–silicate partitioning of phosphorus can be expressed as a chemical reaction;</p>", "<p id=\"Par6\">The exchange coefficient <italic>K</italic><sub>D</sub> for this reaction is parameterized as a function of <italic>P</italic>, <italic>T</italic> and <italic>nbo</italic>/<italic>t</italic> (Ref.<sup>##UREF##5##6##</sup>) with regression constants <italic>a</italic>, <italic>b</italic>, <italic>c</italic> and <italic>d</italic>;where <italic>x</italic> and <italic>x</italic>′ represent molar fractions in silicate and metal, respectively (see “##SUPPL##0##Supplementary text##”), and <italic>nbo</italic>/<italic>t</italic> is an empirical parameter, the molar ratio of non-bridging oxygens per cations that are tetrahedrally coordinated at low pressures. Oxygen fugacity relative to the iron-wüstite (IW) buffer is approximated as .</p>", "<p id=\"Par7\">The values we obtained at 27–61 GPa are comparable to the majority of data previously reported at 10–20 GPa (Fig. ##FIG##1##2##a). These data cannot be fitted by a single equation (Eq. ##FORMU##2##2##), since the positive pressure dependence that has been observed in a previous dataset to 8 GPa<sup>##UREF##10##11##</sup> and to 18 GPa<sup>##UREF##5##6##</sup> is not consistent with the present data obtained at higher pressures (Fig. ##FIG##1##2##b). We therefore performed fitting separately for data collected below and above 15 GPa. Indeed, when we employ a lower pressure for the fitting boundary, the <italic>c</italic> parameter (giving the pressure dependence in Eq. ##FORMU##2##2##) for data in a higher pressure range remarkably changes from large negative to nearly zero because of the positive pressure dependence at low pressures (Supplementary Fig. ##SUPPL##0##S8##). The fitting of Eq. ##FORMU##2##2## to earlier data below 15 GPa listed in Supplementary Table ##SUPPL##0##S1## yields <italic>a</italic> = − 3.12(171),<italic> b</italic> = 3835(2860), <italic>c</italic> = 594(112) and <italic>d</italic> = − 0.650(103); the large scatter of previous data reported below 1.5 GPa results in R<sup>2</sup> = 0.55. On the other hand, the fitting to data for the higher pressure range above 15 GPa including the present ones provides <italic>a</italic> = 4.27(72),<italic> b</italic> = − 1464(883), <italic>c</italic> = − 212(49) and <italic>d</italic> = − 1.19(15) with R<sup>2</sup> = 0.95, showing that the pressure dependence of <italic>D</italic><sub>P</sub> changes from positive to negative at 15 GPa (Fig. ##FIG##1##2##b). The <italic>d</italic> value, the <italic>nbo</italic>/<italic>t</italic> dependence, is found to be large negative even above 15 GPa, comparable to − 0.71(5) previously obtained from data collected up to 18 GPa<sup>##UREF##5##6##</sup>. Indeed, the definition of <italic>nbo</italic>/<italic>t</italic> assumes fourfold Si and is not applied to melts above ~ 10 GPa where Si is no longer tetrahedrally coordinated<sup>##UREF##19##20##</sup>. Nevertheless, the use of <italic>nbo</italic>/<italic>t</italic> is practical in this study since the effect of silicate melt composition is important at relatively low pressures<sup>##UREF##5##6##</sup> and we realized that existing <italic>D</italic><sub>P</sub> data above 15 GPa from earlier studies<sup>##UREF##2##3##,##UREF##5##6##</sup> and the present experiments are not well fitted without the effect of <italic>nbo</italic>/<italic>t</italic>. The present data give the mole-based <italic>D</italic><sub>P</sub> values ranging from 4 to 177 after adjusting to <italic>f</italic>O<sub>2</sub> = IW-2.3 and <italic>nbo</italic>/<italic>t</italic> = 2.57 for a pyrolite composition, indicating that phosphorus is only modestly siderophile at typical conditions of Earth’s core metal segregation from silicate.</p>" ]
[ "<title>Discussion</title>", "<title>Change in pressure dependence of <bold><italic>D</italic></bold><sub>P</sub></title>", "<p id=\"Par8\">Changes in the pressure evolution of metal–silicate partitioning have been suggested for a variety of elements. Cottrell et al<italic>.</italic><sup>##UREF##15##16##</sup> argued that the pressure dependence of the metal/silicate partition coefficient of tungsten alters from positive to negative around 3 GPa. Not only for W but also for Ni, Co, Mo, V and Cr, Rai and van Westrenen<sup>##UREF##16##17##</sup> demonstrated that the pressure dependence found in data collected below 5 GPa is different from those observed in data obtained in a wider pressure range including &gt; 5 GPa. For tungsten, recent XAFS measurements<sup>##UREF##20##21##</sup> revealed an increase in the coordination number of W<sup>6+</sup> from four to six, which can change the pressure dependence of its metal–silicate partitioning.</p>", "<p id=\"Par9\">Since P<sup>5+</sup> is a high-field strength element with relatively small ionic radius and high valence similar to W<sup>6+</sup>, the local structure of P<sup>5+</sup> is close to that of W<sup>6+</sup> in silicate melts and glasses. Ozawa et al.<sup>##UREF##20##21##</sup> therefore supposed, based on the bond valence theory, that P<sup>5+</sup> also increases its coordination number in a similar pressure range, leading to a remarkable volume reduction of PO<sub>2.5</sub> in silicate melt. It can cause the volume of the left-hand side of Eq. ##FORMU##1##1## (PO<sub>2.5</sub> + 2.5Fe) to be smaller than that of the right-hand side (P + 2.5FeO) (the pressure dependence of <italic>D</italic><sub>P</sub> therefore changes from positive to negative) above 15 GPa as we found in this study (Fig. ##FIG##1##2##b). Other high-field strength elements such as Mo and As may also undergo the coordination number increase in a comparable pressure range, which changes the pressure evolution of their metal–silicate partitioning. Furthermore, the observed changes in pressure dependence of the metal–silicate partitioning of W, Mo, V, and P and those of Ni and Co (Refs.<sup>##UREF##15##16##,##UREF##16##17##</sup> and this study) might be explained by the onset and termination of the steep coordination number increase<sup>##UREF##20##21##,##UREF##21##22##</sup>, respectively.</p>", "<title>Core–mantle partitioning of phosphorus</title>", "<p id=\"Par10\">Present experiments demonstrate that phosphorus is a modestly siderophile element under typical <italic>P</italic>–<italic>T</italic> conditions of the Earth’s core formation as a result of the change in pressure dependence of its metal–silicate partitioning around 15 GPa (Fig. ##FIG##1##2##b). Phosphorus concentrations have been estimated for the mantle (80–90 ppm) and for the bulk Earth (700–1200 ppm) with and without considering its volatility<sup>##UREF##12##13##,##UREF##13##14##,##UREF##17##18##,##UREF##18##19##</sup>. They give the P abundance in the core to be 2000–3700 ppm by weight from mass-balance calculations. These mantle and core concentrations show the apparent core/mantle distribution <italic>D</italic><sub>P</sub> (core/mantle) = 20 to 50 (mole based)<sup>##UREF##22##23##</sup>. Siebert et al.<sup>##UREF##5##6##</sup> argued that the extrapolation of low-pressure data does not match such apparent <italic>D</italic><sub>P</sub> (core/mantle) under typical conditions of the Earth’s core formation, 30–60 GPa and 2500–4000 K (Fig. ##FIG##2##3##).</p>", "<p id=\"Par11\">With the present new at ΔIW = − 2.3 and <italic>nbo</italic>/<italic>t</italic> = 2.57 (Fig. ##FIG##1##2##b), we first consider conceptually simple, single-stage core formation scenarios that assume entire core–mantle chemical equilibration at a single <italic>P</italic>, <italic>T</italic> and <italic>f</italic>O<sub>2</sub> condition. Figure ##FIG##2##3## illustrates the range of <italic>P–T</italic> conditions under which the <italic>D</italic><sub>P</sub> (core/mantle) = 20–50 is obtained from the present high-pressure partitioning data (yellow area), along with that from earlier low-pressure data (orange area)<sup>##UREF##5##6##</sup>. The new data in this study overlaps with the range of 31–42 GPa and 2700–3800 K previously estimated on the basis of the core/mantle distributions of Ni, Co, Cr, Mn, W, Mo and Zn (Ref.<sup>##UREF##5##6##</sup>). It also overlaps with conditions for other pervious single-stage core formation models<sup>##UREF##23##24##,##UREF##24##25##</sup>.</p>", "<p id=\"Par12\">Next we calculate how much phosphorus is incorporated into the core when employing the multi-stage core formation models previously reported by Tagawa et al.<sup>##REF##33976113##26##</sup>, which account for core mass, the mantle FeO, Ni and Co abundances, and ~ 700 ppm H<sub>2</sub>O in the bulk silicate Earth including oceans (see Supplementary Fig. 6 in Ref.<sup>##REF##33976113##26##</sup> for parameter space searched). In their models, metal–silicate partitioning took place by 1000 steps upon accretion of identical impactors, and the metal from each impactor equilibrated only with a limited fraction of silicate melt at the base of an existing magma ocean. We found that three out of nine models by Tagawa et al.<sup>##REF##33976113##26##</sup> explain P concentration observed in the mantle (Fig. ##FIG##3##4##, Supplementary Table ##SUPPL##0##S2##). These three models show ~ 2000 ppm P in the core, consistent with the value calculated from the bulk Earth abundance that was estimated by considering the effect of its volatility<sup>##UREF##17##18##,##UREF##18##19##</sup>. Other six models result in the mantle P contents more than twice higher than observations as a consequence of relatively low in the latter half of the Earth’s accretion, which derive from comparatively high final pressures at the bottom of a magma ocean, low temperatures or high <italic>nbo</italic>/<italic>t</italic> (Supplementary Fig. ##SUPPL##0##S9##).</p>", "<p id=\"Par13\">This study suggests that the core/mantle distribution of phosphorus, similar to those of other siderophile elements, is a natural consequence of core metal segregation in a deep magma ocean, where phosphorus is a modestly siderophile element. The Si effects proposed by Righter et al.<sup>##UREF##8##9##</sup> may not have been serious for core–mantle partitioning in the Earth and the Mars.</p>" ]
[]
[ "<p id=\"Par1\">Previous experiments performed below 20 GPa suggested that the metal/silicate partition coefficient of phosphorus (P), <italic>D</italic><sub>P</sub>, extrapolated to typical high-pressure and -temperature conditions of the Earth’s core formation gives too high P concentration in the core unless a large amount of silicon was included in metals. Here we examined <italic>D</italic><sub>P</sub> between liquid metal and coexisting molten silicate at 27–61 GPa and 3820–4760 K, corresponding to conditions of core-forming metal segregation from silicate, by measuring recovered samples using a high-resolution imaging technique coupled with secondary ion mass spectrometry. The results demonstrate that the pressure dependence of <italic>D</italic><sub>P</sub> changes from positive to negative above 15 GPa, likely because of an increase in the coordination number of P<sup>5+</sup> in silicate melt. With the present new partitioning data, the observed mantle P abundance may indicate ~ 0.2 wt% P in the core, consistent with the cosmo-/geochemical estimates, based on both single-stage and multi-stage core formation models without involving high amounts of silicon in metals.</p>", "<title>Subject terms</title>" ]
[ "<p id=\"Par2\">Phosphorus is moderately siderophile and could be one of important light elements in planetary cores<sup>##UREF##0##1##</sup>. The metal/silicate partition coefficients of phosphorus <italic>D</italic><sub>P</sub> have been extensively studied below 3 GPa and previously reported up to 20 GPa and 2873 K using multi-anvil apparatuses<sup>##UREF##1##2##–##UREF##11##12##</sup> (Supplementary Table ##SUPPL##0##S1##). These earlier experiments demonstrated that the relatively high P abundance in the Martian mantle is explained by metal–silicate partitioning at the base of a magma ocean under relatively low pressure–temperature (<italic>P</italic>–<italic>T</italic>) and high oxygen fugacity (<italic>f</italic>O<sub>2</sub>) conditions (6–10 GPa, 1900–2200 K and ΔIW–1.5 to − 1)<sup>##UREF##10##11##</sup>. On the other hand, extrapolation of these low <italic>P</italic>–<italic>T</italic> data to typical high <italic>P</italic>–<italic>T</italic> conditions of the Earth’s core formation (30–60 GPa, 2500–4000 K, ΔIW = − 2.3) shows <italic>D</italic><sub>P</sub> &gt; 1300 (mole based)<sup>##UREF##5##6##</sup>. With such high <italic>D</italic><sub>P</sub> value, P concentration in the mantle (80–90 ppm)<sup>##UREF##12##13##,##UREF##13##14##</sup> suggests &gt; 11 wt% P in the core, which almost explains the core density deficit without any additional light elements<sup>##UREF##0##1##</sup> and is thus unlikely. Alternatively Righter et al.<sup>##UREF##8##9##</sup> demonstrated that when metals are enriched in silicon (&gt; 10 wt%), <italic>D</italic><sub>P</sub> is sufficiently low and gives little P abundance in the core. The &gt; 10 wt% Si is, however, more than required to explain the core density deficit and velocity excess<sup>##UREF##14##15##</sup>.</p>", "<p id=\"Par3\">Indeed, extrapolation of existing metal–silicate partitioning data to higher pressures may not be straightforward. Cottrell et al<italic>.</italic><sup>##UREF##15##16##</sup> demonstrated that the pressure evolution of the metal–silicate partitioning of tungsten, a high-field strength element similar to phosphorus, changes from positive to negative above ~ 3 GPa. Rai and van Westrenen<sup>##UREF##16##17##</sup> also showed that the pressure dependence of the metal–silicate partitioning of Ni, Co, Mo, V and Cr also changes above 5 GPa. A clear change has not been found for P, but it could be because high-pressure data (&gt; 5 GPa) were limited (Supplementary Table ##SUPPL##0##S1##).</p>", "<p id=\"Par4\">In this study, we explore the metal–silicate partitioning of phosphorus to <italic>P</italic>–<italic>T</italic> conditions much higher than in earlier experiments (Table ##TAB##0##1##). Low P concentrations in quenched silicate melts were determined with high-resolution SIMS analyses. Combining with previous low <italic>P</italic>–<italic>T</italic> experimental data, we found that the pressure dependence changes from positive to negative above 15 GPa. 80–90 ppm P observed in the Earth’s mantle may suggest ~ 0.2 wt% P in the core when considering metal–silicate partitioning in a deep magma ocean in both single-stage and multi-stage core formation scenarios, consistent with cosmo-/geochemical estimates of the bulk Earth P abundance<sup>##UREF##17##18##,##UREF##18##19##</sup>.</p>", "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51662-y.</p>", "<title>Acknowledgements</title>", "<p>We thank K. Yonemitsu for her help in FIB/SEM/EDS and EPMA analyses. Y. Fei and two anonymous reviewers provided valuable comments on the manuscript.</p>", "<title>Author contributions</title>", "<p>The project was designed by S.T. and K.H. and led by N.I. SIMS analyses were performed by N.S., N.I., Y.T. and H.Y. Core formation modelling was carried out by S.Y. and S.T. The manuscript was written by K.H. and N.I. and commented by all authors.</p>", "<title>Data availability</title>", "<p>The datasets obtained and analyzed during the current study are available from the corresponding author on reasonable request.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Secondary ion images for (<bold>a</bold>) <sup>31</sup>P<sup>−</sup> and (<bold>b</bold>) <sup>28</sup>Si<sup>−</sup>, EDS X-ray maps for (<bold>c</bold>) Si and (<bold>d</bold>) Fe/Ca/Mg, and (<bold>e</bold>) back-scattered electron image of a sample cross section obtained in run #3. Quenched liquid metal was surrounded by silicate melt. Ca-rich silicate (labelled as Ca-pv) with a composition similar to that of CaSiO<sub>3</sub> perovskite was present outside the silicate melt. Note that the images in (<bold>c–e</bold>) were obtained after imaging by SIMS (<bold>a</bold>, <bold>b</bold>) and repolishing by FIB technique. As a result, the area of liquid metal was enlarged. The liquid metal area of (<bold>a</bold>) is apparently larger than that of (<bold>b</bold>) because of lens-flare effects of the secondary ion optics due to extremely high <sup>31</sup>P intensities from liquid metal (&gt; 0.6 ion/pixel/s). Portions surrounded by red lines (ROI) in the silicate melt shown in (<bold>a</bold>, <bold>b</bold>) is free from the lens-flare effects (Supplementary Fig. ##SUPPL##0##S1##). The reason why the secondary ion intensities of P and Si are apparently high along the crack is unknown, but probably due to some artifact effects of secondary ion emissions. Small liquid metal particles are scattered, especially in the right-hand side portion, in the silicate melt as shown in (<bold>e</bold>). Indeed, secondary ion intensities of P from the particles are high (<bold>a</bold>). From these petrographic analyses, the ROIs shown in (<bold>a</bold>, <bold>b</bold>) are assumed to be the silicate melt equilibrated with the liquid metal, to calculate the P content. P concentration in the ROI varies from 24 to 170 ppm, and the concentration in the silicate melt is determined to be 87 ± 36 ppm.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p><italic>D</italic><sub>P</sub> (metal/silicate) (mole based) from this study and earlier experiments (only data with <italic>f</italic>O<sub>2</sub> greater than ΔIW = -3, <italic>nbo</italic>/<italic>t</italic> &lt; 3.7 and &lt; 4 wt% C in metal, Supplementary Table ##SUPPL##0##S1##). (<bold>a</bold>) Raw experimental data and (<bold>b</bold>) those adjusted to conditions for the Earth’s core formation (ΔIW = -2.3 and <italic>nbo</italic>/<italic>t</italic> = 2.57) using Eq. ##FORMU##2##2##. The fitting of Eq. ##FORMU##2##2## was performed separately to data below 15 GPa and above, demonstrating changes in pressure and temperature effects on <italic>D</italic><sub>P</sub>. The grey band in (<bold>b</bold>) indicates the geo-/cosmochemically estimated core/mantle distribution of phosphorus<sup>##UREF##22##23##</sup>.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>The range of <italic>P</italic>–<italic>T</italic> conditions at which metal/silicate partition coefficient that explains the Earth’s core/mantle distribution is obtained for each element. The yellow (this study) and orange areas<sup>##UREF##5##6##</sup> for P; the blue area for Ni, Co, Cr, Mn, W, Mo and Zn (Ref.<sup>##UREF##5##6##</sup>); the green area for Ni, Co, Mn, Cr, V and Nb (Ref.<sup>##UREF##23##24##</sup>); the purple area for Ni and Co (Ref.<sup>##UREF##24##25##</sup>). The <italic>P</italic>–<italic>T</italic> range for P obtained in this study (yellow) overlaps with those for other siderophile elements, while the previous estimate based on low-pressure partitioning data (orange) does not.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Evolutions of (<bold>a</bold>) pressure, (<bold>b</bold>) temperature, and phosphorus concentration in the (<bold>c</bold>) mantle and (<bold>d</bold>) core as a function of mass fraction of Earth accreted, based on the multi-stage core formation models S1 (red), R2 (green) and R3 (blue) reported by Tagawa et al.<sup>##REF##33976113##26##</sup> (Supplementary Table ##SUPPL##0##S2##). Grey bands in (<bold>c</bold>) and (<bold>d</bold>) show geo-/cosmochemical estimates considering ± 15% uncertainty<sup>##UREF##18##19##</sup>. See Supplementary Fig. ##SUPPL##0##S9## for results using other models.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Summary of the present experiments.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Run #</th><th align=\"left\">1</th><th align=\"left\">2</th><th align=\"left\">3</th><th align=\"left\">4</th><th align=\"left\">5</th><th align=\"left\">6</th></tr></thead><tbody><tr><td align=\"left\"><italic>P</italic> (GPa)</td><td align=\"left\">45 (5)</td><td align=\"left\">56 (6)</td><td align=\"left\">60 (6)</td><td align=\"left\">34 (3)</td><td align=\"left\">61 (6)</td><td align=\"left\">27 (3)</td></tr><tr><td align=\"left\"><italic>T</italic> (K)</td><td align=\"left\">4410 (220)</td><td align=\"left\">4260 (210)</td><td align=\"left\">4760 (240)</td><td align=\"left\">3820 (190)</td><td align=\"left\">4560 (230)</td><td align=\"left\">4060 (200)</td></tr><tr><td align=\"left\">P in metal by EPMA (wt %)</td><td align=\"left\">2.25 (28)</td><td align=\"left\">3.75 (7)</td><td align=\"left\">1.96 (10)</td><td align=\"left\">2.61 (26)</td><td align=\"left\">1.96 (10)</td><td align=\"left\">2.16 (40)</td></tr><tr><td align=\"left\">P in silicate by SIMS (ppm wt)</td><td align=\"left\">133 (45)</td><td align=\"left\">39 (17)</td><td align=\"left\">87 (36)</td><td align=\"left\">42 (27)</td><td align=\"left\">206 (106)</td><td align=\"left\">266 (38)</td></tr><tr><td align=\"left\"><italic>D</italic><sub>P</sub> (weight based)</td><td align=\"left\">169 (61)</td><td align=\"left\">960 (407)</td><td align=\"left\">226 (93)</td><td align=\"left\">615 (390)</td><td align=\"left\">95 (49)</td><td align=\"left\">81 (19)</td></tr><tr><td align=\"left\"><italic>D</italic><sub>P</sub> (mole based)</td><td align=\"left\">164 (60)</td><td align=\"left\">918 (389)</td><td align=\"left\">234 (97)</td><td align=\"left\">564 (358)</td><td align=\"left\">94 (49)</td><td align=\"left\">73 (19)</td></tr><tr><td align=\"left\"><italic>f</italic>O<sub>2</sub> (ΔIW)</td><td align=\"left\">− 1.29</td><td align=\"left\">− 1.92</td><td align=\"left\">− 1.69</td><td align=\"left\">− 1.37</td><td align=\"left\">− 1.62</td><td align=\"left\">− 0.99</td></tr><tr><td align=\"left\"><italic>nbo</italic>/<italic>t</italic></td><td align=\"left\">1.15</td><td align=\"left\">0.65</td><td align=\"left\">0.75</td><td align=\"left\">1.18</td><td align=\"left\">0.69</td><td align=\"left\">1.49</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Chemical compositions (wt%) of the silicate starting material, silicate melts and quenched liquid metals formed by melting experiments.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Run #</th><th align=\"left\"/><th align=\"left\">SM1</th><th align=\"left\">SM2</th><th align=\"left\">1</th><th align=\"left\">2</th><th align=\"left\">3</th><th align=\"left\">4</th><th align=\"left\">5</th><th align=\"left\">6</th></tr></thead><tbody><tr><td align=\"left\">SM</td><td align=\"left\"/><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">1</td><td align=\"left\">1</td><td align=\"left\">1</td><td align=\"left\">1</td><td align=\"left\">1</td><td align=\"left\">2</td></tr><tr><td align=\"left\" rowspan=\"10\">Silicate</td><td align=\"left\">Num.<sup>a</sup></td><td align=\"left\">6</td><td align=\"left\">6</td><td align=\"left\">6</td><td align=\"left\">6</td><td align=\"left\">6</td><td align=\"left\">6</td><td align=\"left\">6</td><td align=\"left\">8</td></tr><tr><td align=\"left\">SiO<sub>2</sub></td><td align=\"left\">51.19 (44)</td><td align=\"left\">48.59 (57)</td><td align=\"left\">41.32 (56)</td><td align=\"left\">40.24 (104)</td><td align=\"left\">44.10 (99)</td><td align=\"left\">43.51 (80)</td><td align=\"left\">43.23 (86)</td><td align=\"left\">37.98 (118)</td></tr><tr><td align=\"left\">Al<sub>2</sub>O<sub>3</sub></td><td align=\"left\">16.49 (24)</td><td align=\"left\">15.20 (11)</td><td align=\"left\">14.64 (62)</td><td align=\"left\">24.82 (55)</td><td align=\"left\">21.75 (26)</td><td align=\"left\">12.75 (109)</td><td align=\"left\">22.84 (86)</td><td align=\"left\">10.47 (56)</td></tr><tr><td align=\"left\">FeO</td><td align=\"left\">9.46 (8)</td><td align=\"left\">9.40 (35)</td><td align=\"left\">25.78 (114)</td><td align=\"left\">11.99 (116)</td><td align=\"left\">16.45 (65)</td><td align=\"left\">22.72 (233)</td><td align=\"left\">17.05 (85)</td><td align=\"left\">28.36 (251)</td></tr><tr><td align=\"left\">MgO</td><td align=\"left\">8.59 (6)</td><td align=\"left\">8.57 (7)</td><td align=\"left\">8.74 (29)</td><td align=\"left\">11.43 (17)</td><td align=\"left\">9.87 (19)</td><td align=\"left\">9.20 (66)</td><td align=\"left\">9.02 (35)</td><td align=\"left\">8.38 (48)</td></tr><tr><td align=\"left\">CaO</td><td align=\"left\">4.94 (23)</td><td align=\"left\">9.36 (14)</td><td align=\"left\">3.45 (15)</td><td align=\"left\">4.41 (7)</td><td align=\"left\">4.83 (12)</td><td align=\"left\">4.71 (41)</td><td align=\"left\">4.02 (21)</td><td align=\"left\">5.29 (23)</td></tr><tr><td align=\"left\">Na<sub>2</sub>O</td><td align=\"left\">4.20 (10)</td><td align=\"left\">3.40 (11)</td><td align=\"left\">3.96 (14)</td><td align=\"left\">4.98 (116)</td><td align=\"left\">5.37 (30)</td><td align=\"left\">4.18 (27)</td><td align=\"left\">5.53 (35)</td><td align=\"left\">2.40 (14)</td></tr><tr><td align=\"left\">K<sub>2</sub>O</td><td align=\"left\">0.10 (1)</td><td align=\"left\">0.14 (2)</td><td align=\"left\">0.24 (2)</td><td align=\"left\">0.69 (5)</td><td align=\"left\">0.31 (1)</td><td align=\"left\">0.23 (1)</td><td align=\"left\">0.29 (6)</td><td align=\"left\">0.13 (3)</td></tr><tr><td align=\"left\">TiO<sub>2</sub></td><td align=\"left\">–</td><td align=\"left\">1.00 (6)</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">1.28 (9)</td></tr><tr><td align=\"left\">Total</td><td align=\"left\">94.96 (64)</td><td align=\"left\">95.66 (65)</td><td align=\"left\">98.13 (55)</td><td align=\"left\">98.58 (82)</td><td align=\"left\">102.69 (61)</td><td align=\"left\">97.30 (83)</td><td align=\"left\">101.98 (48)</td><td align=\"left\">96.61 (62)</td></tr><tr><td align=\"left\" rowspan=\"10\">Metal</td><td align=\"left\">Num.<sup>a</sup></td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">6</td><td align=\"left\">6</td><td align=\"left\">6</td><td align=\"left\">12</td><td align=\"left\">6</td><td align=\"left\">20</td></tr><tr><td align=\"left\">Fe</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">91.75 (90)</td><td align=\"left\">88.75 (29)</td><td align=\"left\">86.49 (34)</td><td align=\"left\">92.79 (117)</td><td align=\"left\">86.70 (206)</td><td align=\"left\">76.75 (238)</td></tr><tr><td align=\"left\">Si</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">0.09 (4)</td><td align=\"left\">3.14 (16)</td><td align=\"left\">3.72 (21)</td><td align=\"left\">0.96 (31)</td><td align=\"left\">2.55 (24)</td><td align=\"left\">3.36 (101)</td></tr><tr><td align=\"left\">O</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">1.85 (67)</td><td align=\"left\">2.40 (16)</td><td align=\"left\">2.15 (23)</td><td align=\"left\">2.28 (53)</td><td align=\"left\">3.67 (33)</td><td align=\"left\">5.18 (134)</td></tr><tr><td align=\"left\">Al</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">ND</td><td align=\"left\">0.03 (2)</td><td align=\"left\">0.03 (0)</td><td align=\"left\">0.01 (1)</td><td align=\"left\">0.06 (1)</td><td align=\"left\">–</td></tr><tr><td align=\"left\">Mg</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">ND</td><td align=\"left\">0.02 (1)</td><td align=\"left\">0.01 (1)</td><td align=\"left\">ND</td><td align=\"left\">0.02 (1)</td><td align=\"left\">–</td></tr><tr><td align=\"left\">Ti</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">0.12 (5)</td></tr><tr><td align=\"left\">C</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">1.58 (24)</td><td align=\"left\">1.42 (15)</td><td align=\"left\">1.61 (11)</td><td align=\"left\">0.82 (7)</td><td align=\"left\">1.15 (12)</td><td align=\"left\">2.31 (26)</td></tr><tr><td align=\"left\">P</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">2.25 (28)</td><td align=\"left\">3.75 (7)</td><td align=\"left\">1.96 (10)</td><td align=\"left\">2.61 (26)</td><td align=\"left\">1.96 (10)</td><td align=\"left\">2.16 (41)</td></tr><tr><td align=\"left\">Total</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">97.54 (61)</td><td align=\"left\">99.52 (17)</td><td align=\"left\">95.98 (34)</td><td align=\"left\">99.48 (65)</td><td align=\"left\">96.10 (153)</td><td align=\"left\">89.88 (77)</td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}_{{\\text{P}}}^{metal/silicate}$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:msubsup><mml:mi>D</mml:mi><mml:mrow><mml:mtext>P</mml:mtext></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\text{PO}}}_{2.5}^{silicate\\ melt}+\\frac{5}{2}{{\\text{Fe}}}^{metal}={{\\text{P}}}^{metal}+\\frac{5}{2}{{\\text{FeO}}}^{silicate\\ melt}$$\\end{document}</tex-math><mml:math id=\"M4\" display=\"block\"><mml:mrow><mml:msubsup><mml:mtext>PO</mml:mtext><mml:mrow><mml:mn>2.5</mml:mn></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mspace width=\"4pt\"/><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:mfrac><mml:mn>5</mml:mn><mml:mn>2</mml:mn></mml:mfrac><mml:msup><mml:mrow><mml:mtext>Fe</mml:mtext></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">metal</mml:mi></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mtext>P</mml:mtext></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">metal</mml:mi></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mfrac><mml:mn>5</mml:mn><mml:mn>2</mml:mn></mml:mfrac><mml:msup><mml:mrow><mml:mtext>FeO</mml:mtext></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mspace width=\"4pt\"/><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\log_{10} K_{{\\text{D}}} &amp; = \\log_{10} \\frac{{{x^{\\prime}}_{{\\text{P}}}^{metal} }}{{x_{{\\text{PO}_{2.5} }}^{silicate} }} \\cdot \\left( {\\frac{{x_{{{\\text{FeO}}}}^{silicate} }}{{{x^{\\prime}}_{\\text{Fe}}^{metal} }}} \\right)^{\\frac{5}{2}} = \\log_{10} \\frac{{{x^{\\prime}}_{{\\text{P}}}^{metal} }}{{x_{{\\text{PO}_{2.5} }}^{silicate} }} + \\frac{5}{4}\\Delta {\\text{IW}} \\\\ &amp; = \\log_{10} D_{{\\text{P}}}^{metal/silicate} + \\frac{5}{4}\\Delta {\\text{IW}} = a + \\frac{b}{T} + c \\cdot \\frac{P}{T} + d \\cdot \\frac{nbo}{t} \\\\ \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M6\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msub><mml:mo>log</mml:mo><mml:mn>10</mml:mn></mml:msub><mml:msub><mml:mi>K</mml:mi><mml:mtext>D</mml:mtext></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mo>log</mml:mo><mml:mn>10</mml:mn></mml:msub><mml:mfrac><mml:msubsup><mml:mrow><mml:msup><mml:mi>x</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mrow><mml:mtext>P</mml:mtext></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">metal</mml:mi></mml:mrow></mml:msubsup><mml:msubsup><mml:mi>x</mml:mi><mml:mrow><mml:msub><mml:mtext>PO</mml:mtext><mml:mrow><mml:mn>2.5</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">silicate</mml:mi></mml:mrow></mml:msubsup></mml:mfrac><mml:mo>·</mml:mo><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:msubsup><mml:mi>x</mml:mi><mml:mrow><mml:mtext>FeO</mml:mtext></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">silicate</mml:mi></mml:mrow></mml:msubsup><mml:msubsup><mml:mrow><mml:msup><mml:mi>x</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mrow><mml:mtext>Fe</mml:mtext></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">metal</mml:mi></mml:mrow></mml:msubsup></mml:mfrac></mml:mfenced><mml:mfrac><mml:mn>5</mml:mn><mml:mn>2</mml:mn></mml:mfrac></mml:msup><mml:mo>=</mml:mo><mml:msub><mml:mo>log</mml:mo><mml:mn>10</mml:mn></mml:msub><mml:mfrac><mml:msubsup><mml:mrow><mml:msup><mml:mi>x</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mrow><mml:mtext>P</mml:mtext></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">metal</mml:mi></mml:mrow></mml:msubsup><mml:msubsup><mml:mi>x</mml:mi><mml:mrow><mml:msub><mml:mtext>PO</mml:mtext><mml:mrow><mml:mn>2.5</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">silicate</mml:mi></mml:mrow></mml:msubsup></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>5</mml:mn><mml:mn>4</mml:mn></mml:mfrac><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mtext>IW</mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow/></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mo>log</mml:mo><mml:mn>10</mml:mn></mml:msub><mml:msubsup><mml:mi>D</mml:mi><mml:mrow><mml:mtext>P</mml:mtext></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:mfrac><mml:mn>5</mml:mn><mml:mn>4</mml:mn></mml:mfrac><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mtext>IW</mml:mtext><mml:mo>=</mml:mo><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:mi>b</mml:mi><mml:mi>T</mml:mi></mml:mfrac><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mo>·</mml:mo><mml:mfrac><mml:mi>P</mml:mi><mml:mi>T</mml:mi></mml:mfrac><mml:mo>+</mml:mo><mml:mi>d</mml:mi><mml:mo>·</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant=\"italic\">nbo</mml:mi></mml:mrow><mml:mi>t</mml:mi></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathrm{\\Delta IW}\\approx 2 \\ {{\\text{log}}}_{10}\\left(\\frac{{x}_{{\\text{FeO}}}^{silicate}}{{{x^{\\prime}}}_{{\\text{Fe}}}^{metal}}\\right)$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi mathvariant=\"normal\">IW</mml:mi></mml:mrow><mml:mo>≈</mml:mo><mml:mn>2</mml:mn><mml:mspace width=\"4pt\"/><mml:msub><mml:mtext>log</mml:mtext><mml:mn>10</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:msubsup><mml:mi>x</mml:mi><mml:mrow><mml:mtext>FeO</mml:mtext></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">silicate</mml:mi></mml:mrow></mml:msubsup><mml:msubsup><mml:mrow><mml:msup><mml:mi>x</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mrow><mml:mtext>Fe</mml:mtext></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">metal</mml:mi></mml:mrow></mml:msubsup></mml:mfrac></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}_{{\\text{P}}}^{metal/silicate}$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:msubsup><mml:mi>D</mml:mi><mml:mrow><mml:mtext>P</mml:mtext></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}_{{\\text{P}}}^{metal/silicate}$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:msubsup><mml:mi>D</mml:mi><mml:mrow><mml:mtext>P</mml:mtext></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}_{{\\text{P}}}^{metal/silicate}$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:msubsup><mml:mi>D</mml:mi><mml:mrow><mml:mtext>P</mml:mtext></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>Numbers in parentheses indicate one standard deviation in the last digits.</p></table-wrap-foot>", "<table-wrap-foot><p>Numbers in parenthesis indicate one standard deviation in the last digits. <sup>a</sup>Number of analyses.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<inline-graphic xlink:href=\"41598_2024_51662_Article_IEq1.gif\"/>", "<graphic xlink:href=\"41598_2024_51662_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51662_Article_Equ1.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51662_Article_Equ2.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51662_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51662_Article_IEq3.gif\"/>", "<graphic xlink:href=\"41598_2024_51662_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51662_Fig3_HTML\" id=\"MO3\"/>", "<inline-graphic xlink:href=\"41598_2024_51662_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51662_Article_IEq5.gif\"/>", "<graphic xlink:href=\"41598_2024_51662_Fig4_HTML\" id=\"MO4\"/>" ]
[ "<media xlink:href=\"41598_2024_51662_MOESM1_ESM.pdf\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["1."], "surname": ["Kinoshita"], "given-names": ["D"], "article-title": ["Sound velocity of liquid Fe-P at high pressure"], "source": ["Phys. Status Solidi B"], "year": ["2020"], "volume": ["257"], "fpage": ["2000171"], "pub-id": ["10.1002/pssb.202000171"]}, {"label": ["2."], "surname": ["Hillgren", "Drake", "Rubie"], "given-names": ["VJ", "MJ", "DC"], "article-title": ["High pressure and high temperature metal\u2013silicate partitioning of siderophile elements: The importance of silicate liquid composition"], "source": ["Geochim. Cosmochim. Acta"], "year": ["1996"], "volume": ["60"], "fpage": ["2257"], "lpage": ["2263"], "pub-id": ["10.1016/0016-7037(96)00079-8"]}, {"label": ["3."], "surname": ["Ohtani", "Yurimoto", "Seto"], "given-names": ["E", "H", "S"], "article-title": ["Element partitioning between metallic liquid, silicate liquid, and lower-mantle minerals: Implications for core formation of the Earth"], "source": ["Phys. Earth Planet. Inter."], "year": ["1997"], "volume": ["100"], "fpage": ["97"], "lpage": ["114"], "pub-id": ["10.1016/S0031-9201(96)03234-7"]}, {"label": ["4."], "surname": ["Righter", "Drake", "Yaxley"], "given-names": ["K", "MJ", "G"], "article-title": ["Prediction of siderophile element metal\u2013silicate partition coefficients to 20\u00a0GPa and 2800\u00a0\u00b0C: The effects of pressure, temperature, oxygen fugacity, and silicate and metallic melt compositions"], "source": ["Phys. Earth Planet. Inter."], "year": ["1997"], "volume": ["100"], "fpage": ["115"], "lpage": ["134"], "pub-id": ["10.1016/S0031-9201(96)03235-9"]}, {"label": ["5."], "surname": ["Righter", "Pando", "Danielson", "Lee"], "given-names": ["K", "KM", "L", "CT"], "article-title": ["Partitioning of Mo, P and other siderophile elements (Cu, Ga, Sn, Ni Co, Cr, Mn, V, and W) between metal and silicate melt as a function of temperature and silicate melt composition"], "source": ["Earth Planet. Sci. Lett."], "year": ["2010"], "volume": ["291"], "fpage": ["1"], "lpage": ["9"], "pub-id": ["10.1016/j.epsl.2009.12.018"]}, {"label": ["6."], "surname": ["Siebert", "Corgne", "Ryerson"], "given-names": ["J", "A", "FJ"], "article-title": ["Systematics of metal\u2013silicate partitioning for many siderophile elements applied to Earth\u2019s core formation"], "source": ["Geochim. Cosmochim. Acta"], "year": ["2011"], "volume": ["75"], "fpage": ["1451"], "lpage": ["1489"], "pub-id": ["10.1016/j.gca.2010.12.013"]}, {"label": ["7."], "surname": ["Ballhaus"], "given-names": ["C"], "article-title": ["The U/Pb ratio of the Earth\u2019s mantle\u2014A signature of late volatile addition"], "source": ["Earth Planet. Sci. Lett."], "year": ["2013"], "volume": ["362"], "fpage": ["237"], "lpage": ["245"], "pub-id": ["10.1016/j.epsl.2012.11.049"]}, {"label": ["8."], "surname": ["Steenstra"], "given-names": ["ES"], "article-title": ["The effect of melt composition on metal\u2013silicate partitioning of siderophile elements and constraints on core formation in the angrite parent body"], "source": ["Geochim. Cosmochim. Acta"], "year": ["2017"], "volume": ["212"], "fpage": ["62"], "lpage": ["83"], "pub-id": ["10.1016/j.gca.2017.05.034"]}, {"label": ["9."], "surname": ["Righter"], "given-names": ["K"], "article-title": ["Effect of silicon on activity coefficients of siderophile elements (Au, Pd, Pt, P, Ga, Cu, Zn, and Pb) in liquid Fe: Roles of core formation, late sulfide matte, and late veneer in shaping terrestrial mantle geochemistry"], "source": ["Geochim. Cosmochim. Acta"], "year": ["2018"], "volume": ["232"], "fpage": ["101"], "lpage": ["123"], "pub-id": ["10.1016/j.gca.2018.04.011"]}, {"label": ["10."], "surname": ["Vogel", "Jennings", "Laurenz", "Rubie", "Frost"], "given-names": ["AK", "ES", "V", "DC", "DJ"], "article-title": ["The dependence of metal\u2013silicate partitioning of moderately volatile elements on oxygen fugacity and Si contents of Fe metal: Implications for their valence states in silicate liquids"], "source": ["Geochim. Cosmochim. Acta"], "year": ["2018"], "volume": ["237"], "fpage": ["275"], "lpage": ["293"], "pub-id": ["10.1016/j.gca.2018.06.022"]}, {"label": ["11."], "surname": ["Gu", "Stagno", "Fei"], "given-names": ["T", "V", "Y"], "article-title": ["Partition coefficient of phosphorus between liquid metal and silicate melt with implications for the Martian magma ocean"], "source": ["Phys. Earth Planet. Inter."], "year": ["2019"], "volume": ["295"], "fpage": ["106298"], "pub-id": ["10.1016/j.pepi.2019.106298"]}, {"label": ["12."], "surname": ["Steenstra"], "given-names": ["ES"], "article-title": ["Metal\u2013silicate partitioning systematics of siderophile elements at reducing conditions: A new experimental database"], "source": ["Icarus"], "year": ["2020"], "volume": ["335"], "fpage": ["113391"], "pub-id": ["10.1016/j.icarus.2019.113391"]}, {"label": ["13."], "surname": ["All\u00e8gre", "Poirier", "Humler", "Hofmann"], "given-names": ["CJ", "J-P", "E", "AW"], "article-title": ["The chemical composition of the Earth"], "source": ["Earth Planet. Sci. Lett."], "year": ["1995"], "volume": ["134"], "fpage": ["515"], "lpage": ["526"], "pub-id": ["10.1016/0012-821X(95)00123-T"]}, {"label": ["14."], "surname": ["McDonough", "Sun"], "given-names": ["WF", "S"], "article-title": ["The composition of the Earth"], "source": ["Chem. Geol."], "year": ["1995"], "volume": ["120"], "fpage": ["223"], "lpage": ["253"], "pub-id": ["10.1016/0009-2541(94)00140-4"]}, {"label": ["15."], "surname": ["Umemoto", "Hirose"], "given-names": ["K", "K"], "article-title": ["Chemical compositions of the outer core examined by the first principles calculations"], "source": ["Earth Planet. Sci. Lett."], "year": ["2020"], "volume": ["531"], "fpage": ["116009"], "pub-id": ["10.1016/j.epsl.2019.116009"]}, {"label": ["16."], "surname": ["Cottrell", "Walter", "Walker"], "given-names": ["E", "MJ", "D"], "article-title": ["Metal\u2013silicate partitioning of tungsten at high pressure and temperature: Implications for equilibrium core formation in Earth"], "source": ["Earth Planet. Sci. Lett."], "year": ["2009"], "volume": ["281"], "fpage": ["275"], "lpage": ["287"], "pub-id": ["10.1016/j.epsl.2009.02.024"]}, {"label": ["17."], "surname": ["Rai", "van Westrenen"], "given-names": ["N", "W"], "article-title": ["Lunar core formation: New constraints from metal\u2013silicate partitioning of siderophile elements"], "source": ["Earth Planet. Sci. Lett."], "year": ["2014"], "volume": ["388"], "fpage": ["343"], "lpage": ["352"], "pub-id": ["10.1016/j.epsl.2013.12.001"]}, {"label": ["18."], "surname": ["All\u00e8gre", "Manh\u00e8s", "Lewin"], "given-names": ["CJ", "G", "E"], "article-title": ["Chemical composition of the Earth and the volatility control on planetary genetics"], "source": ["Earth Planet. Sci. Lett."], "year": ["2001"], "volume": ["185"], "fpage": ["49"], "lpage": ["69"], "pub-id": ["10.1016/S0012-821X(00)00359-9"]}, {"label": ["19."], "surname": ["McDonough", "Holland", "Turekian"], "given-names": ["WF", "HD", "KK"], "article-title": ["Compositional model for the Earth\u2019s core"], "source": ["Treatise on Geochemistry"], "year": ["2014"], "edition": ["2"], "publisher-name": ["Elsevier"], "fpage": ["559"], "lpage": ["576"]}, {"label": ["20."], "surname": ["Sanloup"], "given-names": ["C"], "article-title": ["Density of magmas at depth"], "source": ["Chem. Geol."], "year": ["2016"], "volume": ["429"], "fpage": ["51"], "lpage": ["59"], "pub-id": ["10.1016/j.chemgeo.2016.03.002"]}, {"label": ["21."], "surname": ["Ozawa", "Hirose", "Kuwayama", "Takahashi"], "given-names": ["K", "K", "Y", "Y"], "article-title": ["The pressure-induced local structural change around tungsten in silicate glass"], "source": ["Geochem. Perspect. Lett."], "year": ["2021"], "volume": ["18"], "fpage": ["6"], "lpage": ["10"], "pub-id": ["10.7185/geochemlet.2116"]}, {"label": ["22."], "surname": ["Ozawa", "Hirose", "Takahashi"], "given-names": ["K", "K", "Y"], "article-title": ["High-pressure XAFS measurements of the coordination environments of Fe"], "sup": ["2+", "3+"], "source": ["J. Geophys. Res. Solid Earth"], "year": ["2022"], "volume": ["127"], "fpage": ["e2021JB023902"], "pub-id": ["10.1029/2021JB023902"]}, {"label": ["23."], "surname": ["Wade", "Wood"], "given-names": ["J", "BJ"], "article-title": ["Core formation and the oxidation state of the Earth"], "source": ["Earth Planet. Sci. Lett."], "year": ["2005"], "volume": ["236"], "fpage": ["78"], "lpage": ["95"], "pub-id": ["10.1016/j.epsl.2005.05.017"]}, {"label": ["24."], "surname": ["Corgne", "Siebert", "Badro"], "given-names": ["A", "J", "J"], "article-title": ["Oxygen as a light element: A solution to single-stage core formation"], "source": ["Earth Planet. Sci. Lett."], "year": ["2009"], "volume": ["288"], "fpage": ["108"], "lpage": ["114"], "pub-id": ["10.1016/j.epsl.2009.09.012"]}, {"label": ["25."], "surname": ["Fischer"], "given-names": ["RA"], "article-title": ["High pressure metal\u2013silicate partitioning of Ni Co, V, Cr, Si, and O"], "source": ["Geochim. Cosmochim. Acta"], "year": ["2015"], "volume": ["167"], "fpage": ["177"], "lpage": ["194"], "pub-id": ["10.1016/j.gca.2015.06.026"]}, {"label": ["27."], "surname": ["Hirose", "Fei", "Ma", "Mao"], "given-names": ["K", "Y", "Y", "H"], "article-title": ["The fate of subducted basaltic crust in the Earth\u2019s lower mantle"], "source": ["Nature"], "year": ["1999"], "volume": ["397"], "fpage": ["53"], "lpage": ["56"], "pub-id": ["10.1038/16225"]}, {"label": ["28."], "surname": ["Thibault", "Walter"], "given-names": ["Y", "MJ"], "article-title": ["The influence of pressure and temperature on the metal\u2013silicate partition coefficients of nickel and cobalt in a model C1 chondrite and implications for metal segregation in a deep magma ocean"], "source": ["Geochim. Cosmochim. Acta"], "year": ["1995"], "volume": ["59"], "fpage": ["991"], "lpage": ["1002"], "pub-id": ["10.1016/0016-7037(95)00017-8"]}, {"label": ["29."], "surname": ["Corgne", "Keshav", "Wood", "McDonough", "Fei"], "given-names": ["A", "S", "BJ", "WF", "Y"], "article-title": ["Metal\u2013silicate partitioning and constraints on core composition and oxygen fugacity during Earth accretion"], "source": ["Geochim. Cosmochim. Acta"], "year": ["2008"], "volume": ["72"], "fpage": ["574"], "lpage": ["589"], "pub-id": ["10.1016/j.gca.2007.10.006"]}, {"label": ["30."], "surname": ["Helffrich"], "given-names": ["G"], "article-title": ["Outer core compositional layering and constraints on core liquid transport properties"], "source": ["Earth Planet. Sci. Lett."], "year": ["2014"], "volume": ["391"], "fpage": ["256"], "lpage": ["262"], "pub-id": ["10.1016/j.epsl.2014.01.039"]}, {"label": ["31."], "surname": ["Harrison", "Watson"], "given-names": ["TM", "EB"], "article-title": ["Kinetics of zircon dissolution and zirconium diffusion in granitic melts of variable water content"], "source": ["Contrib. Mineral. Petrol."], "year": ["1983"], "volume": ["84"], "fpage": ["66"], "lpage": ["72"], "pub-id": ["10.1007/BF01132331"]}, {"label": ["32."], "surname": ["Akahama", "Kawamura"], "given-names": ["Y", "H"], "article-title": ["High-pressure Raman spectroscopy of diamond anvils to 250 GPa: Method for pressure determination in the multimegabar pressure range"], "source": ["J. Appl. Phys."], "year": ["2004"], "volume": ["96"], "fpage": ["3748"], "lpage": ["3751"], "pub-id": ["10.1063/1.1778482"]}, {"label": ["33."], "surname": ["Mori"], "given-names": ["Y"], "article-title": ["Melting experiments on Fe\u2013Fe"], "sub": ["3"], "source": ["Earth Planet. Sci. Lett."], "year": ["2017"], "volume": ["464"], "fpage": ["135"], "lpage": ["141"], "pub-id": ["10.1016/j.epsl.2017.02.021"]}, {"label": ["34."], "surname": ["Yurimoto", "Nagashima", "Kunihiro"], "given-names": ["H", "K", "T"], "article-title": ["High precision isotope micro-imaging of materials"], "source": ["Appl. Surf. Sci."], "year": ["2003"], "volume": ["203\u2013204"], "fpage": ["793"], "lpage": ["797"], "pub-id": ["10.1016/S0169-4332(02)00825-5"]}, {"label": ["36."], "surname": ["Shimizu"], "given-names": ["S"], "article-title": ["H"], "sub": ["2", "2", "2", "5"], "source": ["Geochem. J."], "year": ["2017"], "volume": ["51"], "fpage": ["299"], "lpage": ["313"], "pub-id": ["10.2343/geochemj.2.0470"]}]
{ "acronym": [], "definition": [] }
36
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1194
oa_package/54/20/PMC10786851.tar.gz
PMC10786852
0
[]
[]
[]
[]
[]
[ "<title>Subject terms</title>" ]
[ "<p id=\"Par1\">Correction to: <italic>Communications Medicine</italic> 10.1038/s43856-022-00176-7, published online 16 September 2022</p>", "<p id=\"Par2\">In the Background section of the Abstract, we would like to clarify that the 41% of recorded new cases mentioned is a proportion of recorded new symptomatic infections, not total new infections. The text read ‘…with about 41% of recorded new cases aged twelve or above being symptomatic breakthrough infections…’. It now reads ‘…with about 41% of recorded new symptomatic cases aged twelve or above being symptomatic breakthrough infections…’.</p>", "<p id=\"Par3\">In the Introduction, we omitted a reference to SurvStat at the end of the following sentence: ‘In the four weeks between Oct 11, 2021, and Nov 7, 2021, Germany’s central public health institute, the Robert Koch Institute (RKI) reported 250,552 new symptomatic infections in individuals with known vaccination status, 90,471 of which were attributed to vaccinated individuals, i.e. 36% were symptomatic breakthrough cases (41% in age groups eligible for vaccination)<sup>11</sup>’. This reference (which was previously reference 26 but is now reference 12) has now been added to explain how the figure of 250,552 was derived.</p>", "<p id=\"Par4\">These corrections have been made in the PDF and HTML versions of the article.</p>" ]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
{ "acronym": [], "definition": [] }
0
CC BY
no
2024-01-14 23:40:16
Commun Med (Lond). 2024 Jan 12; 4:8
oa_package/57/0a/PMC10786852.tar.gz
PMC10786853
38216638
[ "<title>Introduction</title>", "<p id=\"Par24\">The endothelium functions as gate-keeper between the blood vessels and the underlying tissue, thereby controlling the transport of nutrients, cells and proteins circulating in the blood<sup>##REF##35741064##1##,##REF##25610592##2##</sup>. This process involves the opening and closure of cell–cell contacts<sup>##REF##20148685##3##</sup>, where several molecules such as the second messenger, cyclic adenosine monophosphate (cAMP), Ras homologous small guanosine-triphosphatases (Rho-GTPases) and endothelial junctional molecules are involved<sup>##REF##28057793##4##,##UREF##0##5##</sup>. Endothelial junctions, formed by transmembrane adhesive proteins consist of adherens junctions (AJs), formed by homophilic interaction between vascular endothelial cadherin (VE-cadherin); and tight junctions (TJ), predominantly comprised of claudins, like the endothelial-specific Claudin-5. These proteins, not only mediate the interactions between neighboring cells, but are also linked through their cytoplasmic domains to the actin cytoskeleton via adaptor proteins like the catenin family members (α-catenin, β-catenin and γ –catenin, also known as plakoglobin) and Zonula Occludens-1 (ZO-1)<sup>##REF##31586306##6##,##REF##31140373##7##</sup>. Actin is the main component of the cytoskeleton, actin dynamics have been demonstrated to be critical for endothelial barrier function in vivo and for cadherin-mediated binding and AJ stability in vitro<sup>##REF##15528228##8##</sup>. Polymerization and interlinking of actin filaments provide critical functions to the cell including mobility, cell adhesion and mechanical support to preserve the cell shape<sup>##REF##31003495##9##,##REF##33343823##10##</sup>. The ever-changing dynamics of this network are governed not only by different signaling molecules but also by actin-binding proteins (ABPs) such as Cortactin and Adducin<sup>##REF##31003495##9##,##UREF##1##11##–##REF##36056066##13##</sup>. Under pathophysiological conditions such as the exacerbated inflammatory response seen in sepsis, enhanced actomyosin contractility associates with increased vascular permeability and death<sup>##REF##26696899##14##–##REF##35625756##17##</sup>. Therefore, besides intercellular junctional integrity, dynamics of the actin cytoskeleton and ABPs are critical for endothelial barrier stability.</p>", "<p id=\"Par25\">Cttn is a multifunctional protein; it participates in lamellipodia, invadopodia, cell–cell adhesion and cell migration. The structure of this protein consists of different domains such as a N-terminal, a 6.5 tandem repeat known as the cortactin repeat, an α-Helix, Prolin-rich and Src-homology 3 (SH3)<sup>##REF##35562995##18##,##REF##29162307##19##</sup> This molecule acts as a platform where different structural and signaling proteins interact. For instance, its N-terminal domain is responsible for actin filament branching by supporting the activation of the Arp2/3 complex<sup>##REF##15186216##20##–##REF##22566665##22##</sup>. Cttn directly binds to F-actin via the tandem repeat, thereby participating in several cellular processes requiring actin. Furthermore, its SH3 domain can interact with E-cadherin in epithelial cells and ZO-1 in mouse tissues<sup>##REF##27179075##23##,##REF##9792678##24##</sup>. These features highlight Cttn as a relevant player in endothelial barrier homeostasis. Previously, it was reported that one of the mechanisms Cttn employs to preserve the endothelial barrier homeostasis involves preventing actin stress fibers polymerization and actomyosin contractility<sup>##UREF##2##25##,##REF##27357373##26##</sup>. In addition, Cttn supports the efficient secretion of the peptide hormone adrenomedullin (ADM) in the circulation, known to stimulate cAMP production<sup>##REF##27357373##26##–##REF##11149956##30##</sup>. cAMP is another important player in barrier regulation and its enhanced intracellular level has been extensively associated with improved barrier stability<sup>##REF##24322391##31##–##REF##15601837##34##</sup>. This enhancement results in the activation of the small GTPase Rac1, facilitating the translocation of Cttn to the cell periphery, on the one hand, and reducing stress fibers formation on the other<sup>##REF##9683637##35##,##UREF##4##36##</sup>. Therefore, cAMP has emerged as a master regulator of cadherin-mediated adhesion both in endothelial AJ as well as in desmosomal contacts of the myocardium and of keratinocytes<sup>##UREF##5##37##</sup>. Moreover, a report from Schnoor et al. associated the lack of Cttn with impaired cAMP-mediated signaling demonstrated by reduced active levels of Rap1<sup>##REF##21788407##38##</sup>. However, the activation state of Rac1 or RhoA and the composition of the intercellular contacts were not investigated in detail in the aforementioned studies.</p>", "<p id=\"Par26\">In the current study, we aimed to further understand the molecular machinery by which Cttn promotes endothelial barrier function and its contribution towards cAMP-mediated signaling. We demonstrated that Cttn facilitates the proper membrane localization of junctional proteins and efficient endothelial barrier recovery, partly involving the regulation of Rap1 and Rac1 via cAMP.</p>" ]
[ "<title>Material and methods</title>", "<title>Endothelial cells isolation and ethical approval</title>", "<p id=\"Par38\">The transgenic C57BL/6J Cttn-mice were provided by Prof. Klemens Rottner (Department of Molecular Cell Biology, TU Braunschweig). Cttn-deficient animals do not show any visible phenotype, are healthy and have a normal life expectancy<sup>##REF##21788407##38##,##REF##31024527##52##</sup>. The animals were hosted in our local animal facility. The handling and use of the mice were approved by the Ethics committee of the Regierung von Oberbayern, Germany (Gz. 55.2-1-54-2532-139-2014). This study is in accordance with ARRIVE guidelines (<ext-link ext-link-type=\"uri\" xlink:href=\"https://arriveguidelines.org\">https://arriveguidelines.org</ext-link>). All methods were performed in accordance with the relevant guidelines and regulations. The litters were generated by crossing Cttn-Heterozygous adult mice. Dr. Mariya Y. Radeva was aware about the mice allocation and handling; she performed the isolation of the cells. A total number of 9 neonatal mice (2–4 days old) derived from 1 litter were used for Myocardial Endothelial cells (MyEnds) isolation. The WT and Cttn-KO cell lines analyzed in the current project are derived from a single animal. The pups were transferred to the animal trials room inside a thermo-isolated dark box filled with soft padding to reduce exposure to light, noise and sudden temperature alterations. Once in the room, the pups were left to acclimate for at least 30 min inside the box. One by one, the mice were transferred to a sterile S2-laminal flow hood and were sacrificed by decapitation without anesthesia. Next, the tip of the tail was dissected and processed for DNA extraction and genotyping. Subsequently, the heart was extracted and MyEnds were isolated as described previously<sup>##REF##36056066##13##,##REF##32992982##43##</sup>. Briefly, the isolation procedure was performed at room temperature under the laminar flow hood. Here, the mouse myocardial tissues were chopped into small fragments, which subsequently were digested with Trypsin (0.05%)-Collagenase A (0.02%) solution for at least 2 h at 37 °C, receiving vigorous shaking every 15 min. The digestion was terminated by adding an equal volume of ice-cold buffer (153 mM NaCl, 5.6 mM KCl, 2.3 mM CaCl<sub>2</sub> × 2H<sub>2</sub>O, 2.6 mM MgCl<sub>2</sub> × 6H<sub>2</sub>O, 15 mM HEPES, 1% BSA) to the tissue debris and cell suspension. After short centrifugation, the supernatant was gently removed and the resulting pellet was resuspended into the Dulbecco’s Modified Eagle’s medium (DMEM, Gibco-Thermo Fisher, #41966-029), supplemented with 50 U/ml Penicillin G/Streptomycin (Sigma Aldrich Chemie GmbH, Taufkirchen, Germany), and 10% Fetal calf serum (FCS, Biochrom, #S0115/0247X). Cell suspensions were cultivated on gelatin-coated dishes and grown in humidified incubator at 37 °C with 5% CO<sub>2</sub>. One day after plating, adherent cells were transfected with Polyoma virus middle T antigen secreted by GP+E-86 Neo (GPENeo) fibroblast. This treatment causes growth advantage of endothelial over nonendothelial cells, resulting to a homogeneous monolayer of endothelial cells after 4–6 weeks of culturing. The endothelial markers von Wilebrand Factor (vWF), PECAM-1 and VE-cadherin were used to confirm the cells´ phenotype. In addition to PCR genotyping, Western Blot and immunostaining were conducted to confirm the presence or lack of Cttn in the cells (Supplementary Fig. ##SUPPL##0##1##). All experiments were performed in vitro.</p>", "<title>Test reagents and antibodies</title>", "<p id=\"Par39\">To elevate intracellular cAMP concentration, 5 μM Forskolin (Sigma Aldrich Chemie, #F6886), and 10 μM Rolipram (Sigma Aldrich Chemie, #R6520) were applied for 1 h. To stimulate the activation of Rho family small GTPases cells were treated with 0.25 μg/ml Rho/Rac/Cdc42 Activator I (Cytoskeleton Inc, #CN04-A) for 2 h. Triggering of RhoA was achieved with the Rho activator I, Calpeptin at 1 U/ml (#CN01-A, Cytoskeleton Inc.). Inhibition of PKA was achieved using 10 µM Dihydrochloride (H89, Santa Cruz, sc-3537).</p>", "<p id=\"Par40\">The following antibodies were used in this study.</p>", "<title>Western blot</title>", "<p id=\"Par41\">Cells were washed with ice-cold PBS and lysed with SDS-lysis buffer (25 mM HEPES, 2 mM EDTA, 25 mM NaF and 1% SDS, pH 7.6), in combination with cOmplete™ protease inhibitor cocktail (Roche Diagnostics, #11697498001) and PhosStop EASYpack (Roche Diagnostics, #4906845001). The resulting whole cell lysates were sonicated, centrifuged at 4 °C and 14,000 rpm for 1 min, right after the supernatants were collected and transferred to fresh tubes. Protein concentration was estimated by BCA standard colorimetric assay (Thermo Fischer Scientific, #23225). Next, samples were mixed 1:1 with 3 × Laemmli buffer and denatured by boiling for 5 min at 95 °C. Samples were separated by SDS-PAGE and transferred onto nitrocellulose membrane (Thermo Fischer Scientific, #LC2006), with 0.45 µm pore size. Membranes were blocked with 5% bovine serum albumin (BSA) in Tris-Buffered Saline with 0,1% Tween (TBS-T) for 1 h at room temperature and subsequently incubated with the primary antibodies of interest overnight at 4 °C on a rocker. The day after, the membranes were washed with TBS-T and incubated with horse-radish-peroxidase-(HRP)-species-specific secondary antibodies at room temperature for 1 h. After three rounds of washing with TBS-T, proteins were visualized using the Amersham Imager 600 (GE Healthcare, AI600). Pixel intensity quantifications from SDS-PAGE were performed using ImageJ (NIH, Windows version 64-bit).</p>", "<title>Immunoprecipitation</title>", "<p id=\"Par42\">To conduct the experiment, cells were cultured in T75 flask and lysed with NP-40 lysis buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl<sub>2</sub> × 6H<sub>2</sub>O, 10 mM KCl, 5 mM EDTA, 2 mM EGTA and 1% NP-40) containing cOmplete™ and PhosStop EASYpack. Samples were kept on ice for 30 min and passed through a 20G needle 10–12 times. Next, supernatants were collected after separation from the pellet by centrifugation at 10,000 rpm for 3 min at 4 °C. Once the protein concentration was estimated, 1000 µg of protein were mixed with lysis buffer to obtain a total volume of 1 ml. Next, samples were placed on rotator and incubated with pre-washed protein A/G agarose beads (Santa Cruz, #SC-2003) for 1.5 h at 4 °C in order to prevent non-specific binding. After centrifugation (15,000 rpm, 10 min, 4 °C), supernatants were mixed with either 1 µg of VE-cadherin Rabbit antibody or respective IgG control antibody (Cell Signaling Tech, #2729S) overnight on an overhead rotator at 4 °C. Next day, samples were transferred to pre-washed agarose beads and mixed on rotator for 2 h as explained above. Subsequently, beads were collected after centrifugation (15,000 rpm at 4 °C for 8 min), washed and mixed with 22 μl 1 × Laemmli and boiled for 10 min at 95 °C. Following a final centrifugation step at 15,000 rpm for 5 min at room temperature, 20 μl of each supernatant was loaded on SDS-PAGE and analyzed by Western blot as described before.</p>", "<title>Evaluation of the mRNA levels by PCR analysis</title>", "<p id=\"Par43\">To analyze the mRNA level of junctional proteins, total RNA was extracted using RNeasy Plus Mini Kit (QIAGEN, #74134). cDNA was prepared using the SuperScript™ II Reverse Transcriptase (Thermo Fisher, #18064014) according to the manufacture’s instruction. PCR analyses were performed using following primers with the same conditions, initial denaturation for 3 min at 95 °C, 35 cycles of 30 s at 95 °C (denaturation), 30 s at 55°/60 °C (annealing) followed by 45 s at 72 °C (extension). The housekeeping gene ß2-microglobulin (B2M) was employed as a loading control. Pixel intensity quantifications from agarose gels were performed using ImageJ.</p>", "<title>Transendothelial electrical resistance (TEER) measurements</title>", "<p id=\"Par44\">To monitor barrier integrity over time, TEER measurements were performed using the ECIS Z Theta system (Applied Biophysics). The 8W10E gold arrays (Ibidi, #72010) were stabilized and coated with gelatin, cells were seeded, electrodes were mounted on the ECIS station and the measurements were started. Every 5 min, electrical resistance was measured using the multi-frequency mode but the frequency of 4000 Hz was used for data presentation.</p>", "<title>Immunostaining</title>", "<p id=\"Par45\">Immunofluorescence stainings were performed to analyze the localization of junctional proteins. For this purpose, MyEnd cells were seeded on 12 mm glass coverslip coated with 5% gelatin. Confluent monolayers were fixed with 4% paraformaldehyde for 10 min at room temperature. Membrane permeabilization was achieved using 0.1% Triton-X-100 diluted in PBS for 5 min. Unspecific antibody binding was blocked by incubating the cells with a mix of 1% bovine serum albumin (VWR, #422351S) and 10% normal goat serum (Thermo Fisher Scientific, # 31872) for 20 min. To detect the proteins of interest, cells were incubated with primary antibodies for 1 h at room temperature. After several washes with 1 × PBS, the monolayers were incubated with a mix solution containing species-specific Cy3-labelled secondary antibodies, Alexa Fluor® 488 Phalloidin (Molecular Probes\\Life technologies, #A12379) and Dapi (Roche, #10236276001) which were diluted to 1:400 and 1:200 respectively. After washing with 1 × PBS and ddH2O, the coverslips were mounted on microscope glass slides with mounting media. The images were taken with a laser scanning confocal microscope (Leica SP5) equipped with a HCX PL APO Lambda blue 63 × 1.4 oil immersion objective (Leica).</p>", "<title>Quantification of junctional and intracellular pixel intensity</title>", "<p id=\"Par46\">Confocal immunofluorescence full projections were analyzed with the ImageJ software<sup>##REF##22930834##95##</sup>. To quantify the intensity and signal distribution of cell contact proteins, Z-stack full projections were prepared, the straight-line tool was used to draw a line that crosses the junctional signal perpendicularly. An equal number of points before and after the highest value was recorded to generate a bell-shape diagram. To quantify the intracellular pixel intensity the built-in “rectangle” tool was used. Rectangles were drawn on 5 random intracellular areas from at least 10 different cells per experiment and condition. To discard differences caused by the size of the line or square, the “integrated density” was recorded.</p>", "<title>Quantification of junctional fragmentation</title>", "<p id=\"Par47\">Junctional fragmentation was quantified as previously described<sup>##REF##36056066##13##</sup>. Briefly, after preparation of the images, the threshold value should be set to eliminate the unspecific staining, background. Next, using skeletonized 2D/3D tools, the junctional signal linearized and appeared with 1 pixel thickness. To quantify the fragmentation which has value 0, freehand tool was employed to manually draw a line along the junction. The total number of “0” values counted are divided by the total number of pixel values multiplied by 100 determines the percentage of fragmentation.</p>", "<title>Calcium switch assay</title>", "<p id=\"Par48\">Endothelial barrier recovery was investigated using confluent cell monolayers as described before<sup>##REF##36056066##13##</sup>. In short, cells seeded on 8WE10 gold arrays or on gelatin-coated glass coverslips were treated with 2.5 mM EGTA for 30 min. Afterwards, CaCl<sub>2</sub> was added to the medium to a final concentration of 5 mM. The TEER was measured during the whole experiment.</p>", "<title>Determination of cyclic-AMP concentration</title>", "<p id=\"Par49\">The intracellular concentration of cAMP was determined using a commercially available ELISA kit (Sigma Aldrich Chemie, #CA200-1KT). The experiment was performed according to manufacturer’s protocol. The absorbance measurements were done using a wavelength of 450 nm using the TECAN Infinite 200 PRO microplate reader (Tecan Deutschland GmbH).</p>", "<title>Rap1 Activity measurement</title>", "<p id=\"Par50\">Rap1 activation was assessed using the non-radioactive Rap1 activation kit (Sigma-Aldrich, #17,321) following the manufacturer’s instructions. Briefly, Rap1-GTP was pulled down using Ral GDS-RBD agarose beads. Subsequently, equal amount of protein (100 µg) from control and treated cells was used for Western Blot analysis. The pixel intensity of the resulting bands was quantified and the ratio between total and active Rap1 was calculated.</p>", "<title>Colorimetric G-LISA for Rac1 and RhoA activity measurements</title>", "<p id=\"Par51\">The activation state of small GTPases was estimated using the Rac1 and RhoA G-LISA kits (Cytoskeleton, #BK128 and #BK124, respectively). The experiments were conducted based on the manufacturer’s protocol and the absorbance measured at 490 nm using a TECAN Infinite 200 PRO device.</p>", "<title>Statistical analysis</title>", "<p id=\"Par52\">To perform statistical analysis, Prism Software version 8 (Graph pad) was used. Data are presented as mean ± SEM. To statistically compare the difference between two groups, unpaired two-tailed Student T-test was applied and for three or more conditions, Two-way analysis of variance (ANOVA) followed by Sidak ´s multiple comparison test. Values equal or below 0.05 (*); 0.01 (**); 0.001 (***) and 0.0001 (****) were considered statistically significant.</p>" ]
[ "<title>Results</title>", "<title>The absence of Cttn leads to fragmented intercellular junctions, altered F-actin distribution and impaired barrier function</title>", "<p id=\"Par27\">Although a link between Cttn and endothelial barrier regulation has been previously established<sup>##REF##27357373##26##,##REF##21788407##38##</sup>, it is unclear if Cttn participates in the junctional distribution of endothelial cell contact components. For this reason, we analyzed by immunostainings the membrane distribution of critical TJ and AJ proteins in confluent WT and Cttn-KO Myocardial Endothelial (MyEnd) monolayers (for confirmation of the endothelial phenotype and Cttn protein and gene ablation please refer to Supplementary Fig. ##SUPPL##0##1##a, b). In contrast to the previous studies where changes in cell contacts were not determined<sup>##REF##27357373##26##,##REF##21788407##38##</sup>, we noticed that VE-cadherin, β-catenin and ZO-1 showed fragmented membrane distribution in cells lacking Cttn (Fig. ##FIG##0##1##a, arrows, squares for zoomed areas). No important differences were observed for plakoglobin (Pg) between WT and Cttn-KO cells. Besides, while WT cells had a well-defined and thick cortical actin belt, cells missing Cttn rather exhibited a thin cortical actin and a marked presence of intracellular actin fibers (Fig. ##FIG##0##1##a, yellow arrows and arrowheads, respectively and zoomed area; information for antibodies is found on Tables ##TAB##0##1## and ##TAB##1##2##). Furthermore, the radically disturbed junctional proteins distribution observed in Cttn-KO cells was verified by calculating the ratio between continuous and fragmented junctions (Fig. ##FIG##0##1##b). Despite the increased presence of fragments in cells without Cttn, the fluorescence signal intensity and thickness of these molecules were comparable between both cell lines (Fig. ##FIG##0##1##c). Moreover, the increased junctional fragmentation observed in cells without Cttn appeared to be associated with compromised barrier stability demonstrated by lower electrical resistance (Fig. ##FIG##0##1##d). These results were further confirmed by calculating the Rb and alpha (α) values from confluent monolayers. Rb is a measure for the electrical resistancein the intercellular clefts directly affected by the tightness of cell–cell contacts. α is a measure for the constraint of current flow within the subcellular cleft<sup>##REF##25537398##39##</sup>. Cttn-KO cells exhibited significantly lower Rb (Supplementary Fig. ##SUPPL##0##2##b). On the other hand, α was comparable between both cell lines (Supplementary Fig. ##SUPPL##0##2##b). On the other hand, no critical changes in the protein levels of VE-cadherin, Pg and ZO-1 were detected. Interestingly, only the expression of β-catenin was considerably elevated due to the absence of Cttn, probably as part of a compensatory response aiming to preserve endothelial barrier function (Fig. ##FIG##1##2##a; information for antibodies is found on Tables ##TAB##0##1## and ##TAB##1##2##). The mRNA expression analysis of AJ components was comparable between both cell types, but only Cttn-KO cells displayed important increased levels for ZO-1 and claudin-5 (Fig. ##FIG##1##2##b; information for primers is found on Table ##TAB##2##3##).</p>", "<title>Cttn is found within the VE-cadherin-based complex and is required for efficient barrier recovery after calcium switch</title>", "<p id=\"Par28\">Considering that Cttn is known to interact with ZO-1<sup>##REF##9792678##24##</sup> and E-cadherin<sup>##REF##27179075##23##</sup> via the SH3 domain in other cell types, we speculated that it might interact with junctional molecules and be required for the establishment of endothelial cell contacts. To investigate this idea, we performed VE-cadherin immunoprecipitation using confluent cell monolayers. Surprisingly, we found that Cttn and VE-cadherin can be found within the same molecular complex along with β-catenin and Pg (Fig. ##FIG##2##3##a). To further analyze if Cttn is associated with the stability of the Ca<sup>2+</sup>-dependent VE-cadherin homophilic interaction and endothelial barrier recovery, calcium switch assay combined with TEER was performed. EGTA was used as chelator to remove the extracellular Ca<sup>2+</sup>, thus disrupting pre-stablished AJs. Subsequent addition of Ca<sup>2+</sup> facilitates junctional re-assembly. Both cell lines reacted to EGTA with a drop in resistance (Fig. ##FIG##2##3##b, green line for WT; gray line for KO). However, only WT cells were able to quickly recover back to baseline after Ca<sup>2+</sup> addition (Fig. ##FIG##2##3##b, purple line). Cttn-KO cells also showed a slight but insignificant recovery after Ca<sup>2+</sup> (Fig. ##FIG##2##3##b, orange line). In addition, VE-cadherin dynamics were analyzed after calcium switch. As expected, in vehicle-treated Cttn-KO, a clear fragmented VE-cadherin membrane staining was recognized (Fig. ##FIG##2##3##c, arrowheads). In both cell lines, treatment with EGTA resulted in diffused intracellular staining of VE-cadherin (Fig. ##FIG##2##3##c, asterisks “*”) and decreased signal intensity along the junctions. The effect was associated with prominent segmented junctions (Fig. ##FIG##2##3##c, arrowheads). Following Ca<sup>2+</sup> repletion, WT cells showed better VE-cadherin membrane distribution and considerably less intracellular signal (Fig. ##FIG##2##3##c, arrows and bar chart). Cells without Cttn also reacted favorably to repletion of Ca<sup>2+</sup> by improving VE-cadherin membrane staining, although the intracellular signal was still visible (Fig. ##FIG##2##3##c, asterisks “*”). Altogether, the data show that the proper membrane translocation of VE-cadherin is partly dependent on its interaction with Cttn.</p>", "<title>Cells lacking Cttn are unable to improve barrier function upon intracellular cAMP increase</title>", "<p id=\"Par29\">It is widely accepted that augmented intracellular cAMP concentration benefits the endothelial barrier<sup>##REF##9609742##40##–##REF##32992982##43##</sup>. Although Cttn has been linked to cAMP-mediated signaling<sup>##REF##27357373##26##,##REF##21788407##38##</sup> its role in the cAMP-dependent barrier stabilization or cAMP production is unclear. For this reason, we performed TEER measurements in confluent endothelial monolayers subjected to either vehicle (DMSO) or Forskolin and Rolipram (F/R), which act as an adenylyl cyclase activator/protein kinase A agonist and as a selective phosphodiesterase 4 inhibitor respectively. As expected, WT endothelial cells responded with increased TEER shortly after F/R treatment (Fig. ##FIG##3##4##a, green line). On the other hand, Cttn-KO cells did not respond to this stimulus (Fig. ##FIG##3##4##a, red line). Vehicle-treated cells displayed insignificant change during the experiment (Fig. ##FIG##3##4##a, blue line for WT; black line for KO). Additionally, we investigated the contribution of protein kinase A (PKA) by treating the cells with dihydrochloride (H89), a specific PKA inhibitor. Both WT and Cttn-KO cells displayed significantly lower TEER shortly after PKA inhibition. Interestingly, the minimum resistance registered was still significantly lower in cells lacking Cttn (Supplementary Fig. ##SUPPL##0##3##a).We hypothesized that the lack of response seen in Cttn-KO cells following F/R application could be due to their inability to produce enough cAMP. To corroborate this idea, cAMP Enzyme-Linked Immunosorbent Assay (ELISA) was done. To our surprise, under control conditions, the cAMP concentration between WT and KO cells was comparable (Fig. ##FIG##3##4##b). Moreover, in both cell lines, a meaningful increase of intracellular cAMP after F/R application was observed (Fig. ##FIG##3##4##b). The value was however, much higher in cells without Cttn. These findings suggest that Cttn is involved in cAMP-mediated barrier enhancement and may regulate cAMP production once adenylyl cyclase is activated or phosphodiesterase-4 inhibited. Next, we studied the protein dynamics of different junctional proteins after cAMP elevation by Western blot and immunostaining. We observed that WT cells responded to F/R with a reproducible modest but notable increase in the protein level expression of the AJ components, VE-cadherin, β-catenin and Pg. Meanwhile, Cttn-KO cells displayed no substantial rise after the treatment (Fig. ##FIG##3##4##c). However, these changes in protein expression did not translate to differential membrane distribution of the same molecules, except β-catenin, where the elevation of cAMP resulted in stronger junctional signal (Fig. ##FIG##4##5##a, arrows and 5b bell-shape graph; data for the other proteins not shown). Nevertheless, in Cttn-KO cells all molecules tested remained unchanged despite the increase of cAMP (Fig. ##FIG##4##5##a). As next, we explored the effects of cAMP on cytoskeleton dynamics. These experiments revealed that treatment of WT cells with F/R induced thickening of the cortical actin belt (Fig. ##FIG##4##5##a, yellow arrows). In Cttn-depleted cells, F-actin distribution was also affected by F/R application. Here, in contrast to the vehicle treated cells, the cortical actin was broader and easily observable upon treatment (Fig. ##FIG##4##5##a, yellow arrows). Nonetheless, the presence of intracellular actin fibers was detected in both control and treated Cttn-KO cells (Fig. ##FIG##4##5##a, yellow arrowheads). Likewise, the influence of PKA towards junctional structural stability was examined. WT and Cttn-KO monolayers treated with H89 showed disrupted VE-cadherin signal at the membrane, although the effect was more visible in the latter (Supplementary Fig. ##SUPPL##0##3##b, arrows). For β-catenin and ZO-1, however, the effect was less obvious, suggesting that PKA inhibition acts mainly on VE-cadherin. In addition, WT cells shifted from a well-defined cortical F-actin distribution to stress fibers along the cells (Supplementary Fig. ##SUPPL##0##3##b, yellow arrows and arrowheads, respectively). Whereas cells lacking Cttn, which already had abundant stress fibers, exhibited a less organized F-actin network after the treatment (Supplementary Fig. ##SUPPL##0##3##b, arrowheads). Our findings suggest that Cttn is required to strengthen barrier function following cAMP-mediated signaling; on the one hand, by allowing AJ proteins level build up and on the other, by promoting β-catenin membrane accumulation. This process appears to require an important actin cytoskeleton rearrangement.</p>", "<title>cAMP-mediated activation of Rap1 and Rac1 small GTPases require Cttn</title>", "<p id=\"Par30\">Since Cttn affected the cAMP-mediated barrier enhancement and previous studies have shown that it regulates small Rho GTPases<sup>##REF##19458196##44##,##REF##24665381##45##</sup>, we explored the contributions of Cttn towards cAMP modulation of Rap1, Rac1 and RhoA, well-known critical players in endothelial barrier homeostasis<sup>##REF##12747959##46##–##REF##20299335##48##</sup>. First, we investigated whether lack of Cttn affects the raw protein levels of the small GTPases Rac1 and RhoA. We found that the total amount of Rac1 was similar between WT and Cttn-KO cells in all experimental conditions tested. However, the expression of RhoA was substantially higher in vehicle-treated Cttn-KO compared to WT cells (Fig. ##FIG##5##6##a). Subsequently, we measured the activity of both GTPases by G-LISA. Our data showed that vehicle treated WT and Cttn-KO cells had equivalent Rac1 activation (Fig. ##FIG##5##6##b). More importantly, stimulation of cAMP was able to increase Rac1 activation in WT but not in cells lacking Cttn (Fig. ##FIG##5##6##b). In addition, despite the increased RhoA protein expression in Cttn-KO cells, the activity level was similar in both cell types with and without F/R (Fig. ##FIG##5##6##b). Finally, we evaluated the activation state of Rap1, known to function upstream of Rac1 and RhoA<sup>##UREF##0##5##,##REF##23798437##49##–##REF##28178039##51##</sup>. Notably, once cAMP increase was induced, only the WT endothelial cells reacted with considerably higher activation of Rap1 (Fig. ##FIG##5##6##c). These findings indicate that Cttn plays a role downstream of cAMP but upstream of Rap1.</p>", "<title>Synchronous activation of Rac1 and RhoA by CN04 lead to enhanced barrier function despite the absence of Cttn</title>", "<p id=\"Par31\">As lack of Cttn affected both Rap1 and Rac1-mediated cAMP activation, we questioned whether Cttn may act downstream from small Rho GTPases independently of cAMP. To answer this, we treated the cells with CN04 which triggers direct simultaneous activation of Rac1 and RhoA. TEER measurements of confluent cell monolayers revealed that CN04 meaningfully enhanced the resistance in both cell lines (Fig. ##FIG##6##7##a, green line for WT; red line for KO). However, 2 h after the application, the increase was considerably higher in WT compared to Cttn-KO cells (Fig. ##FIG##6##7##A, “#”). Additionally, the activation of both GTPases was assessed by G-LISA. In line with the TEER data, the activity of Rac1 and RhoA was importantly increased following CN04 treatment and the effect was similar between WT and Cttn-KO cells (Fig. ##FIG##6##7##b). The total protein levels of Rac1 were also similar in both cell types, but as observed before, RhoA was upregulated in KO cells under control conditions. Interestingly, CN04 treatment attenuated RhoA expression in Cttn-KO cells (Fig. ##FIG##6##7##c). The data shows that Cttn is not required for cAMP-independent activation of Rac1 and RhoA. To understand further, how CN04 is able to augment endothelial barrier function, we analyzed the expression and localization of junctional molecules as well as the actin cytoskeleton. We observed that despite the strong increase in TEER caused by the treatment, there were no important changes in the total protein amount of VE-cadherin, β-catenin, Pg or ZO-1 neither in WT nor in Cttn-KO cells (Fig. ##FIG##6##7##d). Immunostainings for the same proteins revealed that CN04 application drives membrane mobilization of all proteins in both cell types, which was made evident by areas with slightly thicker and finger-like signal (Fig. ##FIG##7##8##a, arrows and arrowheads, respectively). However, quantification of the mean fluorescence intensity from all proteins along the membrane revealed no prominent change after CN04 (data not shown), except for β-catenin and ZO-1 where it was considerably higher in WT cells (Fig. ##FIG##7##8##b). On the other hand, while vehicle-treated WT cells displayed well-defined cortical F-actin distribution in both conditions (Fig. ##FIG##7##8##a); Cttn-KO endothelium had more actin fibers crossing the cell bodies (Fig. ##FIG##7##8##a, yellow arrowheads). Importantly, CN04 induced a more defined cortical actin pattern and increased amount of aligned intracellular actin fibers in WT cells (Fig. ##FIG##7##8##a, yellow arrow and arrowheads, respectively). In Cttn-KO cells, the cytoskeleton shifted to a better-defined cortical actin, similar to the control cells but not as strongly demarcated (Fig. ##FIG##7##8##a, yellow arrows and arrowheads, respectively). To differentiate the role of Rac1 and RhoA, we treated the cells with calpeptin (CN01), a specific RhoA activator. To no surprise, the treatment led to diminished barrier function of both WT and Cttn-KO cells. Nevertheless, the maximum resistance drop observed, was significantly lower in cells without Cttn (Supplementary Fig. ##SUPPL##0##4##a). Activation of RhoA after CN01 showed comparable behavior between both cell lines (Supplementary Fig. ##SUPPL##0##4##b). This effect was associated in part, with junctional fragmentation and formation of zipper-like VE-cadherin junctions (Supplementary Fig. ##SUPPL##0##4##c, white arrows and arrowheads, respectively), as well as with prominent presence of stress fibers (Supplementary Fig. ##SUPPL##0##4##c, yellow arrowheads). Thus, stimulation of RhoA alone, is detrimental for MyEnds’ barrier function. In summary, the data indicate that Cttn does not affect the cAMP-independent direct activation of Rac1 and RhoA. This activation is sufficient to augment barrier resistance even without the presence of Cttn, indicating that other proteins may compensate for the loss of this protein.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par32\">As a widely expressed multifunctional protein, Cttn was associated with diverse cellular functions ranging from synapse remodeling to cell migration and disease, such as pemphigus<sup>##REF##31024527##52##</sup> or cancer progression<sup>##UREF##7##53##–##REF##36944183##58##</sup>, as well as cell junctions regulation<sup>##REF##27179075##23##,##REF##19437513##59##</sup>. However, the current information regarding the relationship between Cttn and endothelial cell–cell contacts is limited. It was documented that Cttn is important to preserve barrier function in different endothelial cells e.g., Cttn-deficient human dermal microvascular and human umbilical vein endothelial cells, as well as, in Cttn-KO murine lung endothelial cells (MLEC)<sup>##REF##27357373##26##</sup>. In line with those findings, we show that Cttn is also critical for maintaining barrier function in myocardial endothelial cells. In our experiments, we found that the absence of Cttn resulted in a critical disruption of VE-cadherin, β-catenin and ZO-1 at cell junctions (Fig. ##FIG##0##1##). This is in contrast to the previous discovery where lack of Cttn did not affect VE-cadherin membrane distribution<sup>##REF##27357373##26##</sup> and to the report by Schnoor et al., showing no meaningful VE-cadherin protein regulation in mouse lung lysates or staining in cremaster venules after Cttn gene disruption<sup>##REF##21788407##38##</sup>. On the other hand, our results matched those from the study by Citalán-Madrid, in which the absence of Cttn disrupted the cell contact localization of ZO-1 in mouse colonic tissue. An explanation for the discrepancy above is that the endothelial cells used across these studies have a different organ or tissue origin, which leads to endothelial heterogeneity<sup>##REF##14759250##60##</sup>. Despite the differences, our findings that Cttn absence leads to lower TEER and altered actin cytoskeleton distribution (Fig. ##FIG##0##1##) are consistent with the literature<sup>##REF##27357373##26##,##REF##21788407##38##,##REF##18495841##61##–##REF##28120846##63##</sup>. A direct interaction between Cttn and any of the endothelial junctional components could explain the effects observed in this study. In fact, we were able to demonstrate that VE-cadherin, β-catenin and Cttn form a molecular complex in our endothelial model (Fig. ##FIG##2##3##), which to the best of our knowledge was not confirmed before. In regards of protein levels, we could only detect an increased amount of β-catenin in cells devoid from Cttn (Fig. ##FIG##1##2##). However, the mechanism behind the upregulation of β-catenin remains to be explored, but it may occur as a result from de novo protein synthesis or increased protein half-life involving the canonical Wnt signaling pathway<sup>##REF##35320710##64##,##REF##34980884##65##</sup>. We investigated if the Cttn/VE-cadherin interaction accounts for any important functional role in endothelial barrier regulation by combining TEER measurements with calcium switch assays. These experiments showed that in contrast to WT cells, disruption of Cttn gene expression led to slower barrier recovery after Ca<sup>2+</sup> switch and the resistance value did not recover back to that of the vehicle-treated Cttn-KO cells (Fig. ##FIG##2##3##). However, the VE-cadherin intracellular fluorescent signal between WT and Cttn-KO cells was similar. The data suggest that the efficient recovery of the endothelial barrier requires the presence of Cttn. On the other hand, the interaction between Cttn and VE-cadherin, which appears to participate in this process may not be the only player governing VE-cadherin´s cellular distribution. Thus, it is possible to reason that Cttn partially mediates VE-cadherin expression or localization. The process may involve the degradation or accumulation of VE-cadherin shortly after its translocation to the cytosol, mediated by different pathways e.g., VE-cadherin tyrosine phosphorylation and activation of the Rho/ROCK/MLC pathway, endosome/lysosome or the proteasome<sup>##REF##12626512##66##,##REF##31970155##67##</sup>. In fact, Cttn has not only been linked to endosome/lysosome regulation<sup>##REF##26323691##68##,##REF##29515177##69##</sup> but also to the Rho/ROCK/MLC signalosome in endothelial cells<sup>##REF##27357373##26##,##REF##10362724##70##</sup>. Given the connection between Cttn and this pathway, it is also tempting to speculate that the calcium/calmodulin-dependent serine/threonine phosphatase “calcineurin” (also known as PP2B), could be important in this context, because of its very well-known activity on the myosin phosphatase target subunit 1 (MYPT1), which prevents myosin contractility<sup>##REF##22869619##71##,##UREF##8##72##</sup>. However, whether Cttn is somehow connected or not to PP2B in endothelial cells remains to be elucidated. This possibility is supported by the study from Passaro et al.<sup>##REF##26058076##73##</sup>, where PP2B was shown to affect the expression of Cttn in leukemic T cells. Although the differences observed here cannot be solely attributed to VE-cadherin modulation, it is broadly accepted that it is the most important adhesion molecule for the stability of endothelial junctions<sup>##REF##31970155##67##,##REF##32670077##74##,##REF##24044891##75##</sup>. Hence, our data indicates that the interaction between Cttn and VE-cadherin is of physiological importance and could occur directly or indirectly, given the broad possibilities allowed by the many functional domains comprising Cttn’s protein structure.</p>", "<p id=\"Par33\">In the current study, we also explored the contribution of Cttn to cAMP-mediated barrier enhancement and could induce a notable increase of cAMP concentration with F/R treatment in both cell lines, however, MyEnds lacking Cttn were not able to improve barrier resistance as the WT controls did (Fig. ##FIG##3##4##), clearly indicating that Cttn is necessary for the cAMP-mediated barrier enhancement. Why are Cttn-KO cells unable to enhance barrier resistance after cAMP stimulation? This could be explained in part, by compartmentalization of the signaling molecule to different subcellular locations. Once translocated, it may require the contribution of additional signaling molecules which may include for example, the group of A-kinase anchor proteins (AKAPs) or IQ Motif Containing GTPase Activating Proteins (IQGAPs)<sup>##REF##24281338##76##,##UREF##9##77##</sup>. With the current data, we can only speculate that such process requires the participation of Cttn. Our findings are in contrast to the study by Schnoor et al., where treatment of HUVECs or MLECs with the cAMP analogue 8-pCPT-2Me-cAMP (8-(4-Chlorophenylthio)-2’-O-methyl-cAMP; or 007) counteracted the increased permeability caused by Cttn knockdown<sup>##REF##21788407##38##</sup>. This highlights that although different endothelial cell types share similar structure and molecular composition, the same signaling pathway may have an alternate modus operandi. In addition, cAMP induction led to a mild but noteworthy increase in the total protein level of junctional proteins but accumulation at the membrane was only visible for β-catenin (Fig. ##FIG##3##4##–##FIG##4##5##). An explanation for these effects could be that F/R triggers a rapid increase in barrier resistance starting with β-catenin mobilization. Indeed, different studies performed in models of blood–brain barrier and human dermal microvascular endothelial cells have demonstrated a critical role for β-catenin in vascular permeability and barrier-related genes regulation<sup>##UREF##10##78##–##REF##12176738##80##</sup>. Although Cttn-KO cells had less defined cortical actin and more intracellular actin fibers (Fig. ##FIG##0##1##), we observed a considerable reorganization of the actin cytoskeleton following the increase of cAMP in both cell lines (Fig. ##FIG##4##5##). Therefore, our data suggest that this rearrangement supports junctional molecules redistribution to the membrane, but it is not entirely dependent on Cttn. In summary, our findings hint that β-catenin accumulation at the membrane may require the contribution of Cttn and its capabilities to serve as a molecular scaffold that enhances junctional proteins mobilization. This process could involve the actin cytoskeleton and related signaling proteins.</p>", "<p id=\"Par34\">We analyzed the impact of PKA by treating the cells with H89. Our data showed that inhibition of PKA significantly decreases the barrier resistance of both WT and Cttn-KO cells. However, the values from WT cells were higher than those from cells lacking Cttn (Supplementary Fig. ##SUPPL##0##3##), implying a link between Cttn and PKA regulation. To the best of our knowledge, a direct interaction relating these molecules has not been reported. Nevertheless, different studies point towards this possibility. For example, Rezaee et al.<sup>##REF##28759570##81##</sup>, demonstrated that application of forskolin to confluent airway epithelial cells activates PKA and prevents the accumulation of apical actin bundles and the translocation of Cttn to them, phenomena normally induced by the respiratory syncytial virus infection. Moreover, PKA was shown to co-distribute to invadopodia with the tumor-associated carbonic anhydrase IX (CAIX) and Cttn. In this context, however, activation of CAIX by PKA favors invadopodia and metastasis through a signaling pathway involving Cttn-cofilin, Arp2/3 complex and actin polymerization<sup>##REF##31167468##82##</sup>. Thus, it is not clear whether the potential connection between PKA and Cttn is biologically positive or negative in regards to Cttn function, especially in endothelial cells.</p>", "<p id=\"Par35\">We explored the role of the small GTPases Rac1 and RhoA, which have well characterized functions on cytoskeletal and cell contact dynamics<sup>##REF##12747959##46##,##REF##20299335##48##</sup>. We found that the activation state of both signaling molecules under resting conditions was comparable between the cell lines analyzed, suggesting that Cttn does not play a role in controlling Rac1 or RhoA activity and probably acts downstream of these molecules. On the other side, increased cAMP concentration by F/R triggered Rac1 activation only in WT endothelium and had no effect on RhoA activity in either WT or KO cells. Furthermore, Rap1 activation was hindered in cells lacking Cttn (Fig. ##FIG##5##6##). Combined, our data demonstrate a clear contribution of Cttn towards the cAMP-mediated activation of the Rap1/Rac1 axis to engage endothelial barrier strengthening, an idea which has been suggested by previous reports<sup>##REF##27357373##26##,##REF##21788407##38##</sup> but not proven yet. In this regard, we have reported that Epac1 has a more prominent role than PKA in MyEnds<sup>##UREF##11##83##</sup>. This idea is supported by our finding that WT cells could elevate barrier resistance after F/R or 007 treatment, but not after specific activation of PKA by 6-Bnz-cAMP. Thus, it is tempting to hypothesize that Cttn collaborates with Epac1 or different GTPase-activating proteins (GAPs) or guanine nucleotide exchange factors (GEFs) to drive cAMP signaling and improve endothelial barrier function. For instance, it was shown that Cttn through its SH3 domain, is able to interact with the RhoGAP known as BPGAP1 to target Cttn towards the cell periphery and support cell migration<sup>##REF##15064355##84##</sup>. Additionally, the RhoAGAP p190RhoGAP binds to Cttn via the protrusion localization sequence (PLS) and regulates the activity of RhoA<sup>##REF##27646271##85##</sup>. Nevertheless, no evidence has been provided approaching the intricate nature of such regulations in regards to endothelial barrier homeostasis and the cAMP-mediated signaling pathway.</p>", "<p id=\"Par36\">Simultaneous activation of small Rho GTPases by CN04 resulted in a substantial increase in TEER of both cell lines, bypassing the absence of Cttn (Fig. ##FIG##6##7##). This effect was accompanied by slightly improved membrane localization of junctional proteins in both WT and Cttn-KO cells. The cytoskeleton was also altered by CN04, where a more defined cortical actin belt in both cell lines was visible. Although, these effects were not as prominent in cells lacking Cttn, they seemed to be enough to develop a stronger endothelial barrier. These results show that other proteins can compensate for the lack of Cttn and support cytoskeletal and junctional reorganization following small GTPases activation. In contrast, activation of RhoA alone weakened barrier function regardless of the presence or absence of Cttn, but the absolute resistance values were significantly lower in the KO cells. This was a consequence of altered VE-cadherin junctional distribution and enhanced presence of actin stress fibers (Supplementary Fig. ##SUPPL##0##4##). These results are not surprising, since it is widely accepted that RhoA induces endothelial barrier disruption<sup>##REF##28949796##86##–##UREF##12##88##</sup>. Thus, our data highlights two possibilities: (a) the barrier-fortifying effects caused by CN04 treatment require a coordinated and well-tuned spatial and temporal regulation of Rac1 and RhoA; or (b) the effects seen are predominantly mediated by Rac1 activation, as reported by others<sup>##REF##25344477##89##–##REF##23383114##91##</sup>. A cooperation between Rac1 and RhoA in corneal endothelial cells was exposed by Ortega M. C. et al.<sup>##REF##27849309##92##</sup>. This demonstrates that we still do not fully understand the complex molecular machinery involved in the regulation of these GTPases and that it requires further investigation.</p>", "<p id=\"Par37\">In summary, our data set a precedent to place Cttn as a molecular hub able to interact with different junctional proteins like VE-cadherin and β-catenin to preserve basal endothelial junction stability and on the other hand, support cAMP-mediated barrier fortification by enabling the activation of Rap1 and Rac1. Finally, it is important to note that the functions of Cttn in modulation of cAMP-mediated regulation of small GTPases is in line with previous findings on vasodilator-stimulated phosphoprotein (VASP)<sup>##REF##17989211##93##,##REF##19118163##94##</sup> and adducin<sup>##REF##36056066##13##</sup>. From this, we conclude that a central function of actin binding proteins associated with endothelial AJ is to fine-tune small GTPases such as Rap1, Rac1 and RhoA in response to changes in cAMP levels during inflammation and potentially also to extracellular mechanical cues.</p>" ]
[]
[ "<p id=\"Par1\">Vascular permeability is mediated by Cortactin (Cttn) and regulated by several molecules including cyclic-adenosine-monophosphate, small Rho family GTPases and the actin cytoskeleton. However, it is unclear whether Cttn directly interacts with any of the junctional components or if Cttn intervenes with signaling pathways affecting the intercellular contacts and the cytoskeleton. To address these questions, we employed immortalized microvascular myocardial endothelial cells derived from wild-type and Cttn-knock-out mice. We found that lack of Cttn compromised barrier integrity due to fragmented membrane distribution of different junctional proteins. Moreover, immunoprecipitations revealed that Cttn is within the VE-cadherin-based adherens junction complex. In addition, lack of Cttn slowed-down barrier recovery after Ca<sup>2+</sup> repletion. The role of Cttn for cAMP-mediated endothelial barrier regulation was analyzed using Forskolin/Rolipram. In contrast to Cttn-KO, WT cells reacted with increased transendothelial electrical resistance. Absence of Cttn disturbed Rap1 and Rac1 activation in Cttn-depleted cells. Surprisingly, despite the absence of Cttn, direct activation of Rac1/Cdc42/RhoA by CN04 increased barrier resistance and induced well-defined cortical actin and intracellular actin bundles. In summary, our data show that Cttn is required for basal barrier integrity by allowing proper membrane distribution of junctional proteins and for cAMP–mediated activation of the Rap1/Rac1 signaling pathway.</p>", "<title>Subject terms</title>", "<p>Open Access funding enabled and organized by Projekt DEAL.</p>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51269-3.</p>", "<title>Acknowledgements</title>", "<p>This work was supported by an internal institutional funding and the grant number 2019_A176 by the Else Kröner-Fresenius-Stiftung (EKFS). We thank Dr. Sunil Yeruva for supporting us with the rendering of the graphical abstract created for this publication.</p>", "<title>Author contributions</title>", "<p>A.G.P. and M.Y.R. designed research and analyzed data; A.G.P. and S.M. wrote the paper; S.M. performed research and analyzed data; I.H. and S.S. performed research; A.G.P., M.Y. R. and J.W. participated in funding acquisition; A.G.P. administrated the project, revised and discussed the paper; J.W. and M.Y.R. revised and discussed the paper.</p>", "<title>Funding</title>", "<p>Open Access funding enabled and organized by Projekt DEAL.</p>", "<title>Data availability</title>", "<p>The datasets generated and/or analyzed during the current study are available upon reasonable request to the corresponding author. We do not have the means to provide a permanent link to a storage database.</p>", "<title>Competing interests</title>", "<p id=\"Par53\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Cttn loss led to junctional fragmentation and compromised barrier integrity. (<bold>a</bold>) Staining of VE-cadherin, β-catenin, Pg, ZO-1 and F-actin. White arrows indicate spots of junctional fragmentation. Yellow arrows show formed cortical actin and arrowheads illustrate intracellular actin fibers. White frames indicate zoomed areas within the Cttn-KO monolayer, N = 4–5. (<bold>b</bold>) Bar graphs depict the quantification of junctional fragmentation for each protein shown in A, N = 4–5. (<bold>c</bold>) Bell-shaped curves depict the pixel intensity of each corresponding junctional protein presented in (<bold>a</bold>), N = 4–5. (<bold>d</bold>) TEER measurements of confluent WT and Cttn-KO cells. The bar diagram represents the values recorded under basal conditions, N = 3. Data are represented as mean ± SEM; **p &lt; 0.01; ***p &lt; 0.001.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Effect of Cttn deficiency on junctional protein and mRNA levels. (<bold>a</bold>) Western blot analysis of AJ and TJ components. α-tubulin was used as loading control, N = 5–7. (<bold>b</bold>) mRNA levels for Cttn and junctional molecules were analyzed by PCR. β2M house-keeping gene was used as loading control. Bars represent the quantification of the band pixel density normalized to the respective WT control, N = 4. Data are represented as mean ± SEM; *p &lt; 0.05; **p &lt; 0.01.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>VE-cadherin immunoprecipitation and Ca<sup>+2</sup> depletion and repletion effect on WT and Cttn-KO cells barrier recovery. (<bold>a</bold>) Representative Western Blots from VE-cadherin immunoprecipitation assays, N = 6. (<bold>b</bold>) TEER analysis, the diagrams represent the data normalized to the corresponding starting point. The segmented lines indicate treatment application, (***) depicts a substantial difference between EGTA and EGTA + Ca <sup>2+</sup> in WT cells, N = 4. (<bold>c</bold>) VE-cadherin distribution after depletion and repletion of Ca <sup>2+</sup> analyzed by immunofluorescence. Arrowheads highlight spots where the membrane is fragmented, (*) shows intracellular VE-cadherin staining and the diagram represents intracellular intensity quantification. The data are normalized to the respective control, N = 3. Data are represented as mean ± SEM; *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Barrier dynamics and protein expression upon cAMP elevation. (<bold>a</bold>) TEER measurements from confluent WT and Cttn-KO monolayers treated with either vehicle or F/R. The segmented red line indicates treatment application. (***) indicates the meaningful difference in TEER between WT and Cttn-KO cells after F/R application, N = 3 per group. (<bold>b</bold>) Bar diagram represents the intracellular cAMP concentration assessed by ELISA, N = 7 per group. (<bold>c</bold>) Western blot from confluent monolayers of WT and Cttn-KO cells treated with vehicle or F/R. Equal loading was verified by α-tubulin expression. The bar diagram represents relative expression of each protein of interest. Here, the densitometric measurements for each band of target protein was normalized to the corresponding control, N = 4–6. Data are represented as mean ± SEM; *p &lt; 0.05; ***p &lt; 0.001.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Localization of junctional molecules after F/R application. (<bold>a</bold>) Representative immunostaining for VE- cadherin, β- catenin, Pg, ZO-1 and F-actin in WT and Cttn-KO cells subjected to vehicle or mediator. White arrows show thicker areas of immunofluorescence signal. Yellow arrows illustrate cortical actin. Yellow arrowheads show the presence of intracellular actin fibers, N = 3–7. (<bold>b</bold>) Bell shaped curve represents the pixel intensity of β-catenin after Vehicle or F/R treatment in WT and Cttn-KO cells, N = 7. Data are represented as mean ± SEM; *p &lt; 0.05.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Analysis of small GTPases expression and activation after cAMP. (<bold>a</bold>) Protein level of small GTPases was analyzed after treatment with vehicle or F/R. Diagrams represent the densitometric band analysis normalized to WT vehicle, N = 3. (<bold>b</bold>) Rac1 and RhoA G-LISAs. The diagrams depict the level of small GTPases activity, before and after cAMP level elevation, N = 3–4. (<bold>c</bold>) Rap1 Activity analysis, the diagram represents the band intensity quantification, normalized to respective control, N = 3. Data are represented as mean ± SEM; *p &lt; 0.05.</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>WT and Cttn-KO cells response to CN04 treatment. (<bold>a</bold>) TEER measurement of confluent monolayer treated with either vehicle or CN04. The diagram illustrates the recorded data normalized to the initial point. The segmented red line determines the start point of the treatment. (*) shows that CN04 treatment considerably improved barrier resistance in both cell lines. (#) Illustrates a substantial change between WT and Cttn-KO cells after CN04 treatment at the experimental end-point, N = 3. (<bold>b</bold>) G-LISA analysis for Rac1 and RhoA depicted in bar diagrams respectively, N = 4–5. (<bold>c</bold>) Representative Western blot for Rac1 and RhoA from WT and Cttn-KO cell monolayers treated with vehicle or mediator and the respective bar diagrams where the band intensity quantification was normalized to WT control, N = 4–5. (<bold>d</bold>) Western blot analysis of junctional proteins before and after CN04 treatment. The diagrams illustrate the densitometric analysis, normalized to the respective control, N = 4–7. Data are represented as mean ± SEM; *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001.</p></caption></fig>", "<fig id=\"Fig8\"><label>Figure 8</label><caption><p>Junctional proteins localization and F-actin dynamics after simultaneous Rac1 and RhoA activation by CN04. (<bold>a</bold>) Immunostaining of junctional proteins distribution after treatment with vehicle or mediator. White arrows determine an increase in intensity and thickness, white arrowheads illustrate finger-like signals. Yellow arrows show cortical actin and yellow arrowheads display the presence of intracellular F-actin, N = 4–5. (<bold>b</bold>) The bell shape diagrams represent the densitometric measurement of the fluorescence signal for each protein of interest, N = 4–5. Data are represented as mean ± SEM; *p &lt; 0.05.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>List of primary antibodies.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Antibody</th><th align=\"left\">Species</th><th align=\"left\">Cat. number</th><th align=\"left\">Dilution rate/purpose</th><th align=\"left\">Company</th></tr></thead><tbody><tr><td align=\"left\">VE-cadherin</td><td align=\"left\">Rabbit</td><td align=\"left\">33168</td><td align=\"left\"><p>1:1000-WB</p><p>1:100-IF</p></td><td align=\"left\">Abcam</td></tr><tr><td align=\"left\">α-Tubulin</td><td align=\"left\">Mouse</td><td align=\"left\">7291</td><td align=\"left\">1:1000-WB</td><td align=\"left\">Abcam</td></tr><tr><td align=\"left\">ZO-1</td><td align=\"left\">Rabbit</td><td align=\"left\">617300</td><td align=\"left\"><p>1:1000-WB</p><p>1:100- IF</p></td><td align=\"left\">Thermo Fisher Scientific</td></tr><tr><td align=\"left\">β-catenin</td><td align=\"left\">Mouse</td><td align=\"left\">61054</td><td align=\"left\"><p>1:1000-WB</p><p>1:100- IF</p></td><td align=\"left\">BD Transduction Laboratories</td></tr><tr><td align=\"left\">Plakoglobin</td><td align=\"left\">Mouse</td><td align=\"left\">61005</td><td align=\"left\"><p>1:1000-WB</p><p>1:50- IF</p></td><td align=\"left\">Progen</td></tr><tr><td align=\"left\">vWF</td><td align=\"left\">Rabbit</td><td align=\"left\">A0082</td><td align=\"left\">1:100- IF</td><td align=\"left\">Dako</td></tr><tr><td align=\"left\">PECAM-1</td><td align=\"left\">Mouse</td><td align=\"left\">37676</td><td align=\"left\">1:100- IF</td><td align=\"left\">Santa Cruz</td></tr><tr><td align=\"left\">Rac1</td><td align=\"left\">Mouse</td><td align=\"left\">BK128</td><td align=\"left\">1:1000-WB</td><td align=\"left\">Cytoskeleton</td></tr><tr><td align=\"left\">RhoA</td><td align=\"left\">Rabbit</td><td align=\"left\">10749-1-AP</td><td align=\"left\">1:1000-WB</td><td align=\"left\">Proteintech</td></tr><tr><td align=\"left\">Rap1</td><td align=\"left\">Rabbit</td><td align=\"left\">07916</td><td align=\"left\">1:1000-WB</td><td align=\"left\">Millipore</td></tr><tr><td align=\"left\">Cortactin</td><td align=\"left\">Mouse</td><td align=\"left\">868102</td><td align=\"left\"><p>1:1000-WB</p><p>1:100-IF</p></td><td align=\"left\">BIOZOL</td></tr><tr><td align=\"left\">IgG control antibody</td><td align=\"left\">Rabbit</td><td align=\"left\">2729S</td><td align=\"left\">1:1000 IP</td><td align=\"left\">Cell Signaling Tech</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>List of secondary antibodies.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Antibody</th><th align=\"left\">Species</th><th align=\"left\">Cat number</th><th align=\"left\">Dilution Rate/Purpose</th><th align=\"left\">Company</th></tr></thead><tbody><tr><td align=\"left\">Cy3-AffiniPure</td><td align=\"left\">Goat Anti-Rabbit IgG (H + L)</td><td align=\"left\">111-165-003</td><td align=\"left\">1:100-IF</td><td align=\"left\">Dianova</td></tr><tr><td align=\"left\">Cy3-AffiniPure</td><td align=\"left\">Goat Anti-Mouse IgG</td><td align=\"left\">115-165-164</td><td align=\"left\">1:100-IF</td><td align=\"left\">Dianova</td></tr><tr><td align=\"left\">Peroxidase-AffiniPure</td><td align=\"left\">Goat Anti-Rabbit IgG (H + L)</td><td align=\"left\">11-035-003</td><td align=\"left\">1:10000-WB</td><td align=\"left\">Dianova</td></tr><tr><td align=\"left\">Peroxidase-AffiniPure</td><td align=\"left\">Goat Anti-Mouse IgG + IgM (H + L)</td><td align=\"left\">115-035-068</td><td align=\"left\">1:10000-WB</td><td align=\"left\">Dianova</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Primers used for RT-PCR.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Target analyzed</th><th align=\"left\">5′- &gt; 3′</th><th align=\"left\">Amplicon size (bp)</th></tr></thead><tbody><tr><td align=\"left\">Cttn</td><td align=\"left\"><p>FW: GGAAGACTGAGAAGCATGCCT</p><p>REV: CTGGGATTCGTGCTTCTCTGTC</p></td><td align=\"left\">248</td></tr><tr><td align=\"left\">VE-cadherin</td><td align=\"left\"><p>FW: GAGTTCACCTTC TGTGAGGAGATG</p><p>REV: CTTCTGCACCTGCGTGTACAC</p></td><td align=\"left\">329</td></tr><tr><td align=\"left\">β-catenin</td><td align=\"left\"><p>FW: GAGGACCTACACTTATGAGAAGC</p><p>REV: GGCAGTCCATAATGAAGGCG</p></td><td align=\"left\">492</td></tr><tr><td align=\"left\">Pg</td><td align=\"left\"><p>FW: GTTCGGTTACTGAGTTGCTGCCTTGG</p><p>REV: GGTATTCCAGGTCACCTTGGTTCTG</p></td><td align=\"left\">369</td></tr><tr><td align=\"left\">ZO-1</td><td align=\"left\"><p>FW: CCACCTCTGTCC AGC TCTTC</p><p>REV: CACCGG AGTGATGGTTTTCT</p></td><td align=\"left\">248</td></tr><tr><td align=\"left\">Claudin-5</td><td align=\"left\"><p>FW: GATGTCGTGCGTGGTGCAGAG TAC</p><p>REV: CTTGTCGTAATCGCCATTGGCCGTG</p></td><td align=\"left\">489</td></tr><tr><td align=\"left\">B2M</td><td align=\"left\"><p>FW: CAAGTATACTCACGCCACCCAC</p><p>REV: CATCATGATGCTTGATCACATGTCTC</p></td><td align=\"left\">292</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51269_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51269_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51269_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51269_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51269_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2024_51269_Fig6_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"41598_2024_51269_Fig7_HTML\" id=\"MO7\"/>", "<graphic xlink:href=\"41598_2024_51269_Fig8_HTML\" id=\"MO8\"/>" ]
[ "<media xlink:href=\"41598_2024_51269_MOESM1_ESM.pdf\"><caption><p>Supplementary Figures.</p></caption></media>" ]
[{"label": ["5."], "surname": ["Radeva", "Waschke"], "given-names": ["M", "J"], "article-title": ["Mind the gap: Mechanisms regulating the endothelial barrier"], "source": ["Acta Physiol."], "year": ["2018"], "volume": ["222"], "issue": ["1"], "fpage": ["e12860"], "pub-id": ["10.1111/apha.12860"]}, {"label": ["11."], "surname": ["Ponce", "Radeva", "Waschke"], "given-names": ["AG", "MY", "J"], "article-title": ["\u03b1-Adducin is crucial for endothelial Tight Junction Integrity"], "source": ["FASEB J."], "year": ["2019"], "volume": ["33"], "issue": ["S1"], "fpage": ["686"], "pub-id": ["10.1096/fasebj.2019.33.1_supplement.686.3"]}, {"label": ["25."], "surname": ["Citalan-Madrid"], "given-names": ["A"], "article-title": ["Cortactin deficiency causes increased RhoA/ROCK1-dependent actomyosin contractility, intestinal epithelial barrier dysfunction, and disproportionately severe DSS-induced colitis"], "source": ["Mucos. Immunol."], "year": ["2017"], "volume": ["10"], "issue": ["5"], "fpage": ["1237"], "lpage": ["1247"], "pub-id": ["10.1038/mi.2016.136"]}, {"label": ["33."], "surname": ["Garc\u00eda-Ponce", "Cital\u00e1n-Madrid", "Vel\u00e1zquez-Avila", "Vargas-Robles", "Schnoor"], "given-names": ["A", "AF", "M", "H", "M"], "article-title": ["The role of actin-binding proteins in the control of endothelial barrier integrity"], "source": ["Thromb. Haemostas."], "year": ["2015"], "volume": ["113"], "issue": ["01"], "fpage": ["20"], "lpage": ["36"], "pub-id": ["10.1160/TH14-04-0298"]}, {"label": ["36."], "surname": ["Curry", "Adamson"], "given-names": ["FR", "RH"], "article-title": ["Tonic regulation of vascular permeability"], "source": ["Acta Physiol."], "year": ["2013"], "volume": ["207"], "issue": ["4"], "fpage": ["628"], "lpage": ["649"], "pub-id": ["10.1111/apha.12076"]}, {"label": ["37."], "surname": ["Vielmuth", "Radeva", "Yeruva", "Sigmund", "Waschke"], "given-names": ["F", "MY", "S", "AM", "J"], "article-title": ["cAMP: A master regulator of cadherin-mediated binding in endothelium, epithelium and myocardium"], "source": ["Acta Physiol. Oxf."], "year": ["2023"], "volume": ["2023"], "fpage": ["e14006"], "pub-id": ["10.1111/apha.14006"]}, {"label": ["42."], "surname": ["Aslam", "Tanislav", "Troidl", "Schulz", "Hamm", "Gunduz"], "given-names": ["M", "C", "C", "R", "C", "D"], "article-title": ["cAMP controls the restoration of endothelial barrier function after thrombin-induced hyperpermeability via Rac1 activation"], "source": ["Physiol. Rep."], "year": ["2014"], "volume": ["2"], "fpage": ["10"], "pub-id": ["10.14814/phy2.12175"]}, {"label": ["53."], "surname": ["Cosen-Binker", "Kapus"], "given-names": ["LI", "A"], "article-title": ["Cortactin: The gray eminence of the cytoskeleton"], "source": ["Physiol. (Bethesda)"], "year": ["2006"], "volume": ["21"], "fpage": ["352"], "lpage": ["361"], "pub-id": ["10.1152/physiol.00012.2006"]}, {"label": ["72."], "surname": ["Kolozsv\u00e1ri"], "given-names": ["B"], "article-title": ["Role of calcineurin in thrombin-mediated endothelial cell contraction"], "source": ["Cytometry Part A J. Int. Soc. Adv. Cytometry"], "year": ["2009"], "volume": ["75"], "issue": ["5"], "fpage": ["405"], "lpage": ["411"], "pub-id": ["10.1002/cyto.a.20707"]}, {"label": ["77."], "surname": ["Cameron", "Kapiloff"], "given-names": ["EG", "MS"], "article-title": ["Intracellular compartmentation of cAMP promotes neuroprotection and regeneration of CNS neurons"], "source": ["Neural Regener. Res."], "year": ["2017"], "volume": ["12"], "issue": ["2"], "fpage": ["201"], "lpage": ["202"], "pub-id": ["10.4103/1673-5374.200797"]}, {"label": ["78."], "surname": ["Wang", "Sabbagh", "Gu", "Rattner", "Williams", "Nathans"], "given-names": ["Y", "MF", "X", "A", "J", "J"], "article-title": ["Beta-catenin signaling regulates barrier-specific gene expression in circumventricular organ and ocular vasculatures"], "source": ["Elife"], "year": ["2019"], "volume": ["8"], "fpage": ["1"], "pub-id": ["10.7554/eLife.43257"]}, {"label": ["83."], "surname": ["Garcia-Ponce"], "given-names": ["A"], "article-title": ["Epac1 Is crucial for maintenance of endothelial barrier function through A mechanism partly independent of Rac1"], "source": ["Cells"], "year": ["2020"], "volume": ["9"], "fpage": ["10"], "pub-id": ["10.3390/cells9102170"]}, {"label": ["88."], "surname": ["Carbajal", "Schaeffer"], "given-names": ["JM", "RC"], "suffix": ["Jr"], "article-title": ["RhoA inactivation enhances endothelial barrier function"], "source": ["Am. J. Physiol.-Cell Physiol."], "year": ["1999"], "volume": ["277"], "issue": ["5"], "fpage": ["C955"], "lpage": ["C964"], "pub-id": ["10.1152/ajpcell.1999.277.5.C955"]}]
{ "acronym": [ "MyEnd", "ADM", "Epac1", "PKA", "Cttn", "TJ", "AJ", "Pg", "TEER", "cAMP", "IP", "CN04", "CN01", "H89", "F/R", "GTPase", "ELISA", "WT", "KO", "BSA", "TBS-T", "SDS-PAGE" ], "definition": [ "Myocardial Endothelial cells", "Adrenomedullin", "Exchange Protein Directly Activated By CAMP 1", "Protein Kinase A", "Cortactin", "Tight junction", "Adherens junction", "Plakoglobin, Y-catenin", "Transendothelial electrical resistance", "Cyclic adenosine monophosphate", "Immunoprecipitations", "Rho/Rac/Cdc42 Activator I", "Calpeptin", "Dihydrochloride", "Forskolin/Rolipram", "Guanosine-Triphosphatase", "Enzyme-Linked Immunosorbent Assay", "Wild-type", "Knock-out", "Bovin serum albumin", "Tris-Buffered Saline with 0.1% Tween", "Sodium dodecyl-sulfate polyacrylamide gel electrophoresis" ] }
95
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1218
oa_package/aa/32/PMC10786853.tar.gz
PMC10786854
38216717
[ "<title>Introduction</title>", "<p id=\"Par2\">The flow of blood is constrained across damaged arteries with stenosis. This stenosis is caused by plaque accumulation on the arterial walls triggered by oil and fat deposits. This plaque accumulation can potentially cause multiple stenoses in severe cases. Because of multiple stenoses, the flow through these arteries is limited in several regions under certain conditions. Ponalagusamy<sup>##UREF##0##1##</sup> investigated the flow through such narrowed tubes for the very first time in his Doctoral thesis. Mandal<sup>##UREF##1##2##</sup> used the power law stream model to describe the unsteady blood flow via such tapering tubes. A numerical inquiry was conducted by Waqas et al.<sup>##UREF##2##3##</sup> to examine the flow of nanofluid containing silver and gold nanoparticles introduced into a stenotic artery. Ponalagusamy’s<sup>##UREF##3##4##</sup> analysis incorporates the different geometries of stenosis. Vonruden et al.<sup>##REF##14160158##5##</sup> reported a tentative examination of the flow of blood across a damaged artery with various stenosis. Javed et al.<sup>##UREF##4##6##</sup> performed a comprehensive meta-analysis to investigate the impact of heterogeneous–homogeneous reactions within a sinusoidal wavy curved channel. Nadeem et al.<sup>##UREF##5##7##</sup> used varying viscosity to theoretically describe the movement of nanotubes over an artery containing multiple stenoses. Misra et al.<sup>##UREF##6##8##</sup> hypothesized blood flow as Casson fluid inside of an artery with multiple stenosis. Tang et al.<sup>##REF##36014225##9##</sup> investigated the flow characteristics of Au-nanofluid within a stenotic artery with porous walls, incorporating the Sisko model and accounting for the influence of viscous dissipation. Sreenadh et al.<sup>##UREF##7##10##</sup> explored the blood flow through the artery with multiple stenoses, taking into account a mild example of multiple stenoses all along the artery’s length. There are three phases of stenosis development. It is modest at first (clogs approximately 5–15% of the artery area), then the obstruction rises to around 20 to 35% in the following stage and the stream retains laminar, although dissociation of flow and reverse stream occurs near the stenosis. Turbulence characterizes the last stage, with congestion exceeding 40% of the artery’s area<sup>##REF##1306368##11##</sup>.</p>", "<p id=\"Par3\">Another common kind of cardiovascular illness that can emerge as a consequence of stenosis worsening is thrombosis, which results from the establishment of a clot, which also barricades blood flow in the veins. Its progression can result in a variety of illnesses and ailments, including infarction, strokes, malignancy, and infections<sup>##UREF##8##12##</sup>. An arterial thrombus is a blood clot in the artery that can be deadly because it prevents blood from reaching vital organs. Several academics have recently focused on studying of bloodstream through arteries with thrombus in the center. Such blood clots (Thrombus) grow more commonly in sick arteries with tapering walls. As a result, the artery with severe stenosis seems to be more likely to develop a thrombus. This is a life-threatening case that almost limits the flow of blood and it has catastrophic implications. In this case, catheter insertion improves flow once again. This thin, empty pipe can be inserted into such problematic arteries to improve the flow. Doffin et al.<sup>##REF##7240275##13##</sup> inspected the flow issue with both scenarios (stenosis and thrombus) both analytically and experimentally. In this context, research into hybrid nanoparticles may lead to novel ways of avoiding thrombus development within stenosed arteries, thereby lowering the risk of life-threatening consequences such as embolism or stroke.</p>", "<p id=\"Par4\">Catheters are frequent therapeutic and diagnostic instruments in modern healthcare. It is thin pipe put into the blood vessel to dispense medicine or to eliminate blood vessel blockages. The insertion of catheters helps to enhance blood flow to vital organs, and gasses () in the transmission are frequently examined. A thin needle is located in the major artery at the arm, neck, or leg for clot removal, and a pliable wire is prolonged out in the artery through the lump. The catheter is directed along this line to the area of the thrombus to dissolve, split apart, and discharge it<sup>##REF##27789351##14##</sup>. In the event of a congested or restricted artery, an inflatable balloon can be added from the catheter to unblock the conduit and improve blood flow. Catheters are also employed in disease diagnosis (e.g. X-ray angiography, intravascular ultrasound). Furthermore, in individuals who have a breathing problem or drastic acid/base disruption, a catheter is suitable for regular arterial blood gas analysis. When patients have a serious lung disease, the levels of carbon dioxide or oxygen in the blood must be checked more than three to four times each day. In this scenario, an artery catheter is utilized to take blood rather than repeatedly inserting a needle into the patient’s body<sup>##REF##5515002##15##</sup>. Srivastava et al.<sup>##UREF##9##16##</sup> numerically analyzed the macroscopic dual-phase hydrological model for blood circulation over a thin tube using a catheter. Nadeem et al.<sup>##UREF##10##17##</sup> inspected blood flow through the catheterized artery with moderate stenosis numerically.</p>", "<p id=\"Par5\">Choi<sup>##UREF##11##18##</sup> was the first who invented nano-fluids. These are manipulated colloids constituted of nanoparticles and the base fluid. The nanoparticles are composed of metals, oxides and carbon nanotubes. These nanoparticles contain thermal conductivity and have a magnitude greater than the base fluid. Also, the sizes of nanoparticles are less than 100 nm. The preface of nanoparticles meliorates the performance of base fluids in heat transfer. These base fluids can be organic liquids, water, lubricants and oils, polymeric solutions, bio-fluids and a lot of other liquids. The nanoparticles have broad applications in medical like as bio-medicines, because of how nanoparticles collaborate with matter<sup>##UREF##12##19##</sup>. The dimensions and tailored shapes of hybrid nano-objects have diverted large-scale research due to their enormous concern in various exercises, including their optical characteristics and the capability for imaging. Nanoparticles may be utilized in the investigation, like mediators in optical, photoacoustic, in the delivery of drugs, as shippers capable of enhancing cancer disclosure to a therapeutic assistant, developing treatment fallout by continuance circulation times, preserving transported drugs from deterioration and increasing tumor assimilation. The blood-mediated nanoparticles consignment is the expanded and latest area in the progression of therapeutics and diagnostics. The characteristics of nanoparticles like surface chemistry, shape, and size can be handled to increase their objectives in human circulatory systems. This article offers a moving through a perfused area to determine how hybridized could assist in improving blood flow.</p>", "<p id=\"Par6\">Mekheimer et al.<sup>##UREF##13##20##</sup> used the combined action of a magnetic field and metallic nanoparticles on the micro-polar fluid flowing over an overlapped thrombosed artery like a blood circulation model. Atashafrooz et al.<sup>##UREF##14##21##</sup> studied the simulation to analyze the coupled convective-radiative heat transfer phenomena in the flow of a hybrid nanofluid within an open trapezoidal enclosure, with a particular focus on assessing the influence of magnetic forces. Lubna et al.<sup>##UREF##15##22##</sup> investigated the influence of nanofluids on an artery afflicted by stenosis and structural damage. A. Hussain et al.<sup>##UREF##16##23##</sup> conducted a study to analyze the influence of heat transfer on time-dependent laminar fluid flow through a series of elliptic tubes. This investigation aimed to ascertain the extremes in velocity, pressure, and temperature results within the system. Waqas et al.<sup>##UREF##17##24##</sup> explored heat transport characteristics in the context of nanofluid flow through a porous channel, while considering the impact of thermal radiation effects. Hybrid nano-fluids are relatively novel forms of nanofluid that may be created by suspending distinct types (two or more) of nanoparticles in the base fluid, and hybrid (compound) nanoparticles in the base fluid. A hybrid constituent is a substance that blends the physical and biochemical properties of many substances at the same time and delivers the properties in a uniform phase. Waqas et al.<sup>##UREF##18##25##</sup> explored heat transfer phenomena in the context of hybrid nanofluid flow, taking into account the influence of thermal radiation, within the framework of a stretching sheet. The utilization of hybrid nanoparticles enables the exact delivery of therapeutic medicines to particular areas inside the arteries, optimizing medication concentrations precisely where they are required. Waqas et al.<sup>##UREF##19##26##</sup> discovered a Proportional study of hybrid nanofluids with the Cattaneo-Christov convective heat flux model. Hybrid nanoparticles can help with minimally invasive therapies, which reduces the need for invasive surgeries, increasing patient outcomes and shortening recovery periods. Increased accuracy in medication administration can result in lower drug doses while retaining therapeutic efficacy, potentially lowering the likelihood of side effects. Waqas et al.<sup>##UREF##20##27##</sup> explored a numerical and computational simulation to investigate blood flow with heat transfer in a stenotic artery, incorporating the use of hybrid nanofluids. The physicochemical characteristics of synthesized hybrid nanostructures are exceptional since they are not present in the separate components. A substantial chunk of investigation has been conducted on the characteristics of these composite materials<sup>##REF##22914969##28##</sup>, and hybrid substances carbon nanotubes (CNTs) are being utilized in chemical devices, spectroscopy, nanofibers, and other applications<sup>##REF##11069736##29##</sup>, however, the application of these composite nanomaterials in nanofluids has not established. Research on hybrid nanofluids is still in its early stages, with more scientific and theoretical studies yet to be conducted. Nazir et al.<sup>##REF##34599255##30##</sup> examined finite element simulations to analyze the behavior of a hybrid nano-Carreau Yasuda fluid under the influence of Hall and ion slip forces over a rotating heated porous cone. Ahmed and Nadeem<sup>##UREF##21##31##</sup> studied the presence of minor stenosis plaques in the presence of several types of nanoparticles composed with copper (Cu), aluminum (Al2O3), and titanium dioxide (TiO2).</p>", "<p id=\"Par7\">Bio-magnetic hydrodynamics is a novel field of fluid mechanics that studies the fluid dynamics of bio-fluids in the existence of magnetic fields. Several scientists are eager to learn more about the impact of magnetic flux on the blood flow. Nevertheless, Haik et al.<sup>##UREF##22##32##</sup> discovered bio-magnetic fluid dynamics. Akbar et al.<sup>##UREF##23##33##</sup> discovered 3-D magnetohydrodynamic (MHD) viscous flow, considering the effects of thermal radiation and viscous dissipation. Biological fluids are Ferro-fluids, which are magnetic fluids that do not carry electricity. Ferro-fluids are used in a variety of applications, including pharmaceuticals, and anti-tumor drug haulers. Researchers are interested in investigating basic bio-magnetic hydrodynamics flow problems because of the innumerable major applications in biomedical engineering and biological sciences, like the advancement of magnetic materials for cell parting, targeted therapies transfer employing magnetic nanoparticles as medication delivery transporters, magnetic help combat and cancer therapy instigating magnetic hypoglycemia, minimizing blood loss during surgical treatment, and incitement of occlusive disease. Another notable implementation of these liquids is in chemotherapy. Tang et al.<sup>##UREF##24##34##</sup> numerically studied the magnetized flow of Powell–Eyring hybrid nanomaterial, incorporating variable heat transfer phenomena in the presence of artificial bacteria and explored potential applications in tumor removal and the destruction of cancer cells. Magnetic field effects can improve the targeting of drug-loaded nanoparticles to stenosed areas, resulting in more efficient drug administration and fewer systemic adverse effects. Understanding how hybrid nanoparticles behave in multi-stenosed catheterized arteries in the presence of a magnetic field might help to create personalized medication delivery systems customized to particular patients’ vascular problems. The medicine is coated with magnetized nanoparticles and administered adjacent to the malignance in the treatment. The drug is immersed by the malignant tumor using an extravagant magnetic field focused around the tumor’s midpoint. This method diminishes the adverse effects of anticancer drugs. This approach has primarily been tested on tiny animals. Recently, several studies reported the use of such a technology for human therapy in cases when the tumor is close to the skin<sup>##REF##11118047##35##</sup>.</p>", "<p id=\"Par8\">The previously collected research work is extensively examined and it is found that the consequence of hybrid nanoparticles and uniform magnetic field on the bloodstream in defective arteries with several stenoses on the exterior walls and a thrombus (clot) in the middle has not yet been studied using a catheter through three-dimensional computational simulation. This type of investigation is carried out to cover this void in the literature by getting the prevailing nonlinear Navier Stokes equations. These findings will help future research in analyzing the use of magnetic resonance imaging (MRI) and catheterization for circulation, which are both important radiological tests for atherosclerosis<sup>##UREF##25##36##</sup>. This technique improves fluid dynamics and convection inside restricted arteries, optimizing heat transfer, allowing for effective heat removal from stenotic sites, and enhancing heat dispersion into neighboring tissues. The findings of this study might aid in the development of new medical devices that use magnetic fields to optimize medicine delivery within stenosed arteries. Finally, this discovery might pave the way for the creation of new treatment modalities that use the potential of hybrid nanoparticles and magnetic fields to address difficult vascular diseases.</p>" ]
[ "<title>Materials and methods</title>", "<p id=\"Par9\">Let us look into the computational simulation for the unsteady, incompressible, two-dimensional, and laminar blood flow across a circular artery of finite Length L 2.7 m, that is made up of two co-axial cylinders: the outer cylinder with a radius of 0.3 m, which is an axisymmetric having multiple stenoses, and an inner pipe (catheter) with radius 0.03 m containing hybrid nanoparticles (silver and gold) which are injected in the artery as a drug, passing through a thrombus (blood clot) developed at the center of the stenosed artery. We seek to emulate blood artery flow and electrical characteristics. Thus a uniform magnetic field is given to the catheter to examine its effect on blood flow. Blood is diamagnetic because it mostly comprises water (plasma) and red blood cells. The relative permeability of diamagnetic materials is extremely near to, or slightly lower than, 1. In the majority of applications, the magnetic properties of blood are thought to be insignificant. So we inject hybrid nanoparticles to enhance the magnetic characteristics which can determine relative permeability. The electrical conductivity of the blood is taken as 0.70 and its relative permittivity is . The tube’s wall has a relative permittivity and conductivity of and 0.31 respectively<sup>##UREF##26##37##</sup>. As illustrated in Fig. ##FIG##0##1##, it is preferable to work with the cylindrical coordinates (r, θ, z), where the z-axis is considered along the direction of the horizontal artery and θ and r the circumferential and radial directions, correspondingly. The flow is taken along the axial direction z and r is perpendicular to the flow.</p>", "<p id=\"Par10\">Correspondingly, the equations of an unsteady, viscous, and incompressible, hybrid nano-fluid along a catheterized stenotic artery having thrombosis and applying a magnetic field to the catheter and thrombus are given as<sup>##UREF##27##38##</sup>:where .</p>", "<p id=\"Par11\">The underlying relationships comprise the Eq. (##FORMU##21##6##).where and </p>", "<p id=\"Par12\">The equations of the functional magnetic field are given as:</p>", "<p id=\"Par13\"> is Ampère’s law for magneto-statics. It states that the curl of the magnetic field intensity (H) is equal to the current density (J). relates the magnetic field (B) to the curl of the vector potential (A). describes the current density (J) in terms of two components: conduction current density and any additional current density . The first term represents the conduction of electric current due to the electric field (E) and the electrical conductivity (σ) of the material. The second term accounts for any other sources of current density that might be present. represents Faraday’s law of electromagnetic induction. It states that the electric field E is equal to the negative rate of change of the vector potential A concerning time t. This law indicates that a changing magnetic field induces an electric field, which is a foundational principle in electromagnetic theory.</p>" ]
[ "<title>Results and outcomes</title>", "<p id=\"Par33\">The effect of uniform magnetic field and hybrid nanoparticles (silver and gold) on blood flow in defective arteries with several stenosis on the exterior walls and a thrombus (clot) in the middle of the artery using a catheter through three-dimensional computational simulation is deliberate in this research. The findings indicate that the shape of stenosis and thrombus in the middle of an artery is the key cause of elevated blood pressure at arterial walls. The outcomes proffered here validate the bloodstream features of the arteries with stenosis and thrombosis. The inclusion of hybridized nanoparticles altered the physical possessions of blood, like density, heat capacity, thermal conductivity, and dynamic viscosity, which influenced the simulation results.</p>", "<title>Surface and contour velocity preeminence</title>", "<p id=\"Par34\">Figures ##FIG##2##3##, ##FIG##3##4##, ##FIG##4##5##, ##FIG##5##6## and ##FIG##6##7##, delineate the magnitude of the velocity profile at various periods of 0.5 s, 1.5 s, 2.5 s, 8.5 s, and 9.5 s. Figure ##FIG##2##3## depicts the surface velocity through three shapes of impedances at the walls, magnetized catheter, and thrombus at the center of the artery for 0.5 s. The maximum velocity at this time is 0.08 ms<sup>−1</sup> along the artery’s length in the region of elliptical impedance where there is a thrombus and velocity is minimum at the boundary walls as shown by legend. The area where the velocity abruptly upsurges to 0.08 ms<sup>−1</sup> is due to the blockage at walls and thrombus due to which blood has less space to flow and its speed increases and pressure increases at the boundary which can cause the rupture of the artery. Figure ##FIG##3##4## shows the maximum velocity is 0.07 ms<sup>−1</sup> at 1.5 s. Beyond the stenosis region of the artery, the study identified a transition to a more scattered flow regime. Extensive variations in surface magnitude were observed at both the upper and lower boundaries of the stenosed artery. This observation underscores the significant impact of stenosis on flow patterns and pressures within the artery. The Figure demarcates that velocity is maximum for elliptic shape followed by trapezium and minimum for triangular form. A novel aspect of the study involved the application of an external magnetic field to manipulate the motion of magnetized hybrid nanoparticles, inducing what is commonly referred to as magneto-hydrodynamics (MHD). This process generated micro-scale vortices and secondary flows within the surrounding blood, consequently enhancing blood circulation. These induced flows exhibited the potential to improve blood component mixing, alleviate stagnant zones, and potentially mitigate the adverse effects of stenosis by enhancing blood perfusion. The blood flow improves due to the addition of magnetized hybrid nanoparticles which are injected through a catheter as compared to when we did not deliver nanoparticles in the artery. The magnetic hybrid nanoparticles control the pressure at the boundary walls which reduces the risk of rupture of the artery wall. Figure ##FIG##4##5##, ##FIG##5##6## and ##FIG##6##7## delineates the velocity at 2.5 s, 8.5 s, and 9.5 s. The maximum velocity for all these times is 0.07 0.07 ms<sup>−1</sup> at the center of the artery. An external magnetic field applied to magnetized hybrid nanoparticles can cause fluid movement in the surrounding blood or plasma. This result supports the notion that when blood flows through the tiny segment, blood velocity increases rapidly the pressure imposed on the arterial walls increases. A noteworthy finding was the symmetrical nature of surface velocity and contour velocity patterns observed both above and below the catheter along the entire length of the artery. This symmetry suggests that the presence of the catheter did not disrupt the overall flow symmetry within the artery. In conclusion, these graphs provide valuable insights into the intricate flow dynamics present within arterial segments, particularly in the presence of thrombus and the application of magnetized hybrid nanoparticles. The nanoparticles hold promise as a means to enhance blood flow regulation and reduce the risk of arterial wall rupture. Additionally, the utilization of an external magnetic field to manipulate nanoparticle motion highlights the potential of magneto-hydrodynamics to augment blood circulation and ameliorate complications associated with stenosis. These findings contribute significantly to our understanding of vascular physiology and offer potential avenues for therapeutic interventions in the management of arterial obstructions.</p>", "<title>Surface and contour pressure preeminence</title>", "<p id=\"Par35\">Figures ##FIG##7##8##, ##FIG##8##9##, ##FIG##9##10##, ##FIG##10##11## and ##FIG##11##12##, depict the magnitude of pressure exerted by blood at various periods of 0.5 s, 1.5 s, 2.5 s, 8.5 s, and 9.5 s in 3-D. The pressure endeavor at the walls of a constricted artery owing to fluid activity is depicted for 0.5 s in Fig. ##FIG##7##8##. It is noted that the pressure gradient is a maximum of pa and a minimum of pa. As can be seen from Fig. ##FIG##7##8## the surface pressure and contour pressure are approximately normal all along the artery and it is due to the delivery of magnetized hybrid nanoparticles which is much higher when we did not deliver the nanoparticles. The combination of hybrid nanoparticles, especially those with magnetic properties, along with the application of a magnetic field, shows promise in enhancing the wall shear rate. Fluid flow interactions with the nanoparticles contribute to the rise in wall shear rate. Elevated wall shear rates can lead to improved fluid mixing, increased oxygen and nutrient transfer, and potentially mitigate the formation of blood clots or thrombi. Figure ##FIG##8##9## delineates the pressure of hybrid nano-fluid at time 1.5 s. The maximum value of pressure at this period is pa and the minimum is pa throughout the artery which is approximately the normal value of blood pressure in humans. Figures ##FIG##9##10##, ##FIG##10##11## and ##FIG##11##12##, depict the blood pressure for 2.5, 8.5, and 9.5 s respectively. All these figures suggest that due to the addition of hybrid nanoparticles and magnetic field, pressure decreases at the walls and improves blood flow. The maximum and minimum values for all other times can be seen from legends and also the nature of pressure graphs can be observed in all cases. All the graphs are symmetrical. Pressure values vary concerning position as well as concerning time. The results reveal that this approach has the potential to enhance wall shear rates and promote more uniform pressure distribution along the artery. This could, in turn, facilitate improved fluid mixing, nutrient transport, and potentially mitigate thrombus formation. Importantly, the observed symmetrical pressure profiles and their variation over time highlight the robustness of this approach. These findings hold promise for furthering our understanding of vascular dynamics and the potential development of therapeutic strategies for managing arterial constriction and related complications.</p>", "<title>Surface temperature preeminence</title>", "<p id=\"Par36\">When subjected to an alternating magnetic field, hybrid nanoparticles such as magnetite-gold or magnetite-silver nanoparticles can exhibit outstanding heat-generating capabilities. Magnetic hyperthermia or magnetic nanoparticle hyperthermia is the name given to this phenomenon. When nanoparticles are targeted to stenosed areas and subjected to an external alternating magnetic field, they can create localized heat, perhaps leading to thermal ablation of the stenotic plaque and better blood flow.</p>", "<p id=\"Par37\">Figures ##FIG##12##13##, ##FIG##13##14##, ##FIG##14##15##, ##FIG##15##16## and ##FIG##16##17##, depict the magnitude of temperature employed by nano-fluid at various periods of 0.5 s, 1.5 s, 2.5 s, 8.5 s, and 9.5 s. Since hybrid nanoparticles are used to control the temperature, we can see in Figs. ##FIG##12##13##, ##FIG##13##14##, ##FIG##14##15##, ##FIG##15##16## and ##FIG##16##17## that the maximum value of temperature is 316 K and the minimum value is 315 K. There is a very negligible change in the temperature found with respect to time. This is due to the employed magnetic field and delivery of hybrid nanoparticles into the bloodstream. As time increases from 0.5 to 9.5 s the color of the graph gets a bit dark after every step which means temperature is slightly decreasing with time. The maximum temperature is at the inlet otherwise the temperature remains almost constant throughout the stenotic artery. In summary, magnetic hyperthermia utilizing hybrid nanoparticles represents a promising approach to precisely control temperature within stenosed arteries. The study demonstrates stable and controlled temperature profiles, with minimal temporal temperature variation. The application of a magnetic field enhances heat transport and convection, contributing to effective cooling and mitigating the risk of excessive temperature rise within stenotic zones. These findings hold significant potential for the development of therapeutic strategies aimed at improving blood flow and addressing stenotic conditions.</p>" ]
[]
[]
[ "<p id=\"Par1\">This groundbreaking study pioneers the exploration of the therapeutic implications of a constant magnetic field simultaneously with hybrid nanoparticles on blood flow within a tapered artery, characterized by multiple stenosis along its exterior walls and a central thrombus, employing three-dimensional bio-fluid simulations. In addition, a magnetized catheter is inserted into the thrombus to increase the therapeutic potential of this novel method. The flow condition under consideration has applications in targeted medication distribution, improved medical device design, and improved diagnostics, as well as in advancing healthcare and biomedical engineering. Our investigation primarily aims to optimize blood flow efficiency, encompassing key parameters like pressure, velocity, and heat fluctuations influenced by diverse geometric constraints within the stenotic artery. Precise solutions are obtained through the finite element method (FEM) coupled with advanced bio-fluid dynamics (BFD) software. Hybrid nanoparticles and magnetic fields impacted pressure and velocity, notably reducing pressure within the stenosis. Convective heat flux remained uniform, while temperature profiles showed consistent inlet rise and gradual decline with transient variations. This approach promotes fluid flow, and convection within stenosed arteries, enhances heat transport, evacuates heat from stenotic regions, and improves heat dispersion to surrounding tissues. These findings hold promise for targeted therapies, benefiting patients with vascular disorders, and advancing our understanding of complex bio-fluid dynamics.</p>", "<title>Subject terms</title>" ]
[ "<title>Boundary conditions</title>", "<p id=\"Par14\">Boundary conditions at arteries wall can be prescribed as<sup>##UREF##20##27##</sup>.</p>", "<title>Inlet boundary condition</title>", "<p id=\"Par15\">At the inlet of the artery, blood velocity is zero. The regulation of arterial pressure can be influenced by the velocity at the intake and the inflow rate.</p>", "<p id=\"Par16\">The boundary condition equation at the inlet is expressed as follows:</p>", "<title>Outlet boundary condition</title>", "<p id=\"Par17\">To enhance the realism of the simulations, we included the blood supply model’s pressure at the outflow, which is located on the other side of the inlet border. The outlet equation is as follows:</p>", "<title>Wall boundary condition</title>", "<p id=\"Par18\">Due to the viscous characteristics of blood, it exhibits adherence to the walls without penetrating them, and a no-slip condition is assumed. Consequently, the equation at the wall is expressed as follows:</p>", "<title>Thermal insulation condition</title>", "<p id=\"Par19\">All boundaries surrounding the geometry are thermally insulated, and the equation governing thermal insulation is presented as follows:</p>", "<title>Heat flux condition</title>", "<p id=\"Par20\">A general inward heat flux of is supplied to the inlet of the cylinder. The main equation of heat flux is specified as:</p>", "<p id=\"Par21\">Boundary conditions at the catheter wall are given as follows.</p>", "<title>Magnetic insulation condition</title>", "<p id=\"Par22\">The equation of magnetic insulation is given by</p>", "<title>Mathematical modeling</title>", "<p id=\"Par23\">The equations for momentum, mass, and energy for the specified velocity field is as follows<sup>##UREF##28##39##</sup>.</p>", "<p id=\"Par24\">\n<bold>Continuity equation</bold>\n\n</p>", "<p id=\"Par25\"><bold>Momentum equations</bold>where .</p>", "<p id=\"Par26\">\n<bold>Energy equation</bold>\n\n</p>", "<p id=\"Par27\">In the context of compressible flow, the dissipation function within cylindrical coordinates is represented as follows:</p>", "<p id=\"Par28\">After relating the velocity vector U = [, and uniform magnetic field the above equation reduces to the following equations</p>", "<p id=\"Par29\">In this formulation, represents the density, denotes the kinematic viscosity of the hybrid nano-fluid, and T signifies the absolute temperature. Additionally, the specific heat capacity and thermal conductivity of nanoparticles are represented as and , respectively.</p>", "<p id=\"Par30\">The following are the thermo-physical characteristics of hybrid nanoparticles<sup>##UREF##29##40##</sup> (Table ##TAB##0##1##):</p>", "<title>Computational mesh and numerical methodology</title>", "<p id=\"Par31\">We used a numerical technique based on finite element discretization because no other solutions were available. After linearization, we used an iterative direct-type solver in COMSOL Multi-physics software to solve the nonlinear algebraic problem. Grid refinement was accomplished by employing normal grid with comparable degrees of freedom, as seen in Fig. ##FIG##1##2##. To achieve a better degree of accuracy in our results, the simulation procedure, statistical data, and all graphs were only constructed using the normal element mesh. We chose this particular mesh arrangement to acquire the most dependable and exact results for our investigation. The finite element discretization of the geometry follows the same principles as the discretization of the system’s mathematical model, the result is approximated as continuous across each couple of points in the mesh. It is noted that the mesh is extra rectified in the stenotic section, as can be observed by the stenotic area, and less rectified while far distant from the stenosis, as seen in Fig. ##FIG##1##2##. The elucidation of the size of the mesh and other information about the mesh stats is given in Tables ##TAB##1##2## and ##TAB##2##3## respectively.</p>", "<p id=\"Par32\">The mesh enables the numerical solution of the governing equations by separating the computational domain into smaller elements or cells. The equations are solved on this discrete mesh to approximate the behavior of the physical system under study. The mesh plays a substantial role in achieving convergence of the numerical solution. The mesh is designed with a normal element size, and considerations are made to maintain mesh quality by evaluating the skewness measure. The partial mesh consists of mesh vertices, comprising various types of vertex elements, edge elements, quadrilateral elements, triangular elements, prism elements, tetrahedron elements and many other aspects. The description of all the mesh these mesh dimensions is specified in Table ##TAB##2##3##.</p>", "<title>Description of line graphs</title>", "<p id=\"Par38\">Line graph depicts the performance of blood flow and temperature all along the artery.</p>", "<p id=\"Par39\">Figure ##FIG##17##18## presents a comprehensive visualization of the velocity profile as a function of both position along the x-axis and time within the arterial system. Initially, within the non-stenotic region, blood flow maintains a consistent, physiologically normal velocity. However, as the bloodstream encounters the triangular stenosis, there is a discernible increment in velocity, reaching an approximate value of 0.045 ms<sup>−1</sup>. Upon entering into the domain of the elliptical stenosis and thrombus, the velocity undergoes a significant surge, culminating in its zenith at approximately 0.06 ms<sup>−1</sup>. Within the confines of the trapezoidal stenosis, velocity displays notable variations, ascending to a maximum of 0.06 ms<sup>−1</sup> during specific time intervals, such as 0.5, 1.5, and 2.5 s. Remarkably, the velocity records slightly elevated levels during time intervals of 8.5 and 9.5 s. In summation, the velocity profile distinctly portrays a direct temporal correlation with velocity along the x-axis. As time unfolds, there is a corresponding augmentation in velocity. The highest velocities manifest within the elliptical stenosis segment, while the lowest velocities are evident in the presence of triangular-shaped stenosis. The legend embedded in the graph impeccably elucidates the temporal evolution of velocity.</p>", "<p id=\"Par40\">Figure ##FIG##18##19## presents the pressure profile within the artery, highlighting the influence of introducing gold and silver hybrid nanoparticles along with a uniform magnetic field. Notably, this combination results in a substantial reduction in pressure, dropping from 14,500 to 13,500 Pa compared to the scenario with the base fluid alone. Throughout the examined time intervals, the inlet of the artery consistently exhibits the highest pressure, with the peak occurring at 1.5 s and the lowest at 0.5 s. As the blood traverses the artery, including regions with thrombus and various stenotic structures, it gradually converges to a nearly uniform pressure level of approximately 14,000 Pa, as depicted in Fig. ##FIG##18##19##. This graph succinctly illustrates the significant impact of hybrid nanoparticles and magnetic fields on pressure dynamics.</p>", "<p id=\"Par41\">Figure ##FIG##19##20## provides a comprehensive depiction of the temperature profile within the artery. Notably, the temperature reaches its maximum value at the inlet for all examined time intervals, as indicated by the color legend. Subsequently, as blood traverses a specific segment of the artery, a noticeable temperature reduction occurs. Beyond this point, the temperature stabilizes and maintains a relatively constant level throughout the entire arterial passage. Furthermore, temporal variations in temperature are evident, as highlighted by the accompanying legend. The most significant temperature fluctuations occur at 9.5 s, followed by 8.5, 2.5, and 1.5 s, with the least variation observed at 0.5 s. In summary, Fig. ##FIG##19##20## effectively portrays the temperature dynamics within the artery, with the highest temperatures at the inlet and subsequent stabilization along the arterial length. These temperature changes are also influenced by the passage of time, as indicated by the legend.</p>", "<p id=\"Par42\">Figure ##FIG##20##21## displays the convective heat flux profile within the artery, offering insights into the heat transfer between a surface and the surrounding fluid or gas at various locations or along a defined pathway. Remarkably, Fig. ##FIG##20##21## demonstrates that the convective heat flux remains consistently uniform throughout the entire length of the artery concerning both position and time. This uniformity signifies that there is no significant variation in convective heat flux within the arterial system.</p>", "<title>Concluding remarks</title>", "<p id=\"Par43\">In this study, a mathematical and computational model has been constructed to explore the features of blood flow inoculating silver and gold hybrid nanoparticles and uniform magnetic field in multiple stenosed catheterized arteries with thrombosis. Newtonian properties of blood and the result was determined numerically using the finite element approach (FEM). The catheter is used to regulate the limited flow over the affected artery. It is imperative to remember that in certain situations, magnetic fields can be employed for magnetic medication aiming. The following are some of the key verdicts of the contemporary investigation as revealed by the graphical analysis:<list list-type=\"bullet\"><list-item><p id=\"Par44\">The introduction of hybrid nanoparticles and the magnetic field had a notable impact on pressure and velocity profiles. A significant reduction in pressure was observed, particularly within stenotic regions. Velocity profiles exhibited complex variations, with the highest velocities occurring in the presence of elliptical stenosis.</p></list-item><list-item><p id=\"Par45\">Magnetized hybrid nanoparticles assist in thrombus clearance when blood clots or thrombi are creating blockage or hindering blood flow. These nanoparticles are programmed to adhere to the clot or thrombus, and an external magnetic field is utilized to attract and concentrate them at the location. This localized concentration helps with clot breakdown or dissolution, resulting in increased blood flow.</p></list-item><list-item><p id=\"Par46\">The convective heat flux remained remarkably uniform throughout the artery, suggesting consistent heat transfer characteristics along its length.</p></list-item><list-item><p id=\"Par47\">Fluid flow and the interaction between the nanoparticles and the blood flow are responsible for the rise in the wall shear rate. Higher wall shear rates can enhance fluid mixing, oxygen, and nutrition transfer, and perhaps reduce the development of blood clots or thrombi.</p></list-item><list-item><p id=\"Par48\">Temperature profiles revealed a consistent rise at the artery’s inlet, followed by a gradual decrease along the arterial length. Temperature changes were most pronounced at specific time intervals, indicating transient behavior.</p></list-item><list-item><p id=\"Par49\">Magnetic hyperthermia, enabled by hybrid nanoparticles, offers a precise method for temperature control within stenosed regions. This controlled temperature rise can potentially facilitate the thermal ablation of stenotic plaque, ultimately improving blood flow dynamics.</p></list-item><list-item><p id=\"Par50\">Exposure to the uniform magnetic field raises arterial pressure drop, which is most noticeable at the optimal flow rate.</p></list-item></list></p>", "<p id=\"Par51\">It is crucial to emphasize that the efficacy and consequences of utilizing magnetized hybrid nanoparticles to improve blood flow continue to be investigated, and more study is needed to fully understand their potential and limits. The nanoparticles’ exact design, characteristics, and placement, as well as the external magnetic field strength and arrangement, all play key roles in obtaining the necessary blood flow increases.</p>" ]
[ "<title>Acknowledgements</title>", "<p>This work was financially supported by the Natural Science Foundation of China (81600370), the Natural Science Foundation of Liaoning Province (2023-MS-096), and Fundamental Research Funds for the Central Universities (DUT22YG107).</p>", "<title>Author contributions</title>", "<p>A.H. Conceptualized and supervised the current research. W.K.C. modeled and solved the problem. W.K.C. and M.N.R.D. has contributed for plotting the graphical results. Y.H. has made revision and improved the language structure of revised manuscript. He will also help to Pay APC. R.K. reviewed the revised manuscript and technically correction was made. All authors are agreed on the final draft of the submission file.</p>", "<title>Competing interests</title>", "<p id=\"Par52\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>3-D visualization of catheterized arteries with intricate stenosis and thrombotic clots.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Exploring the intricacies of complex geometry through its elaborate finite element mesh.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Velocity profile for .</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Velocity profile for .</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Velocity profile for .</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Velocity profile for .</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>Velocity profile for .</p></caption></fig>", "<fig id=\"Fig8\"><label>Figure 8</label><caption><p>Surface and contour pressure profile for .</p></caption></fig>", "<fig id=\"Fig9\"><label>Figure 9</label><caption><p>Surface and contour pressure profile for .</p></caption></fig>", "<fig id=\"Fig10\"><label>Figure 10</label><caption><p>Surface and contour pressure profile for .</p></caption></fig>", "<fig id=\"Fig11\"><label>Figure 11</label><caption><p>Surface and contour pressure profile for .</p></caption></fig>", "<fig id=\"Fig12\"><label>Figure 12</label><caption><p>Surface and contour pressure profile for .</p></caption></fig>", "<fig id=\"Fig13\"><label>Figure 13</label><caption><p>Surface temperature profile for .</p></caption></fig>", "<fig id=\"Fig14\"><label>Figure 14</label><caption><p>Surface temperature profile for .</p></caption></fig>", "<fig id=\"Fig15\"><label>Figure 15</label><caption><p>Surface temperature profile for .</p></caption></fig>", "<fig id=\"Fig16\"><label>Figure 16</label><caption><p>Surface temperature profile for .</p></caption></fig>", "<fig id=\"Fig17\"><label>Figure 17</label><caption><p>Surface temperature profile for .</p></caption></fig>", "<fig id=\"Fig18\"><label>Figure 18</label><caption><p>Line graph of blood velocity.</p></caption></fig>", "<fig id=\"Fig19\"><label>Figure 19</label><caption><p>Line graph of blood pressure.</p></caption></fig>", "<fig id=\"Fig20\"><label>Figure 20</label><caption><p>Line graph of blood temperature.</p></caption></fig>", "<fig id=\"Fig21\"><label>Figure 21</label><caption><p>Line graph of convective heat flux.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Numerical data of blood, gold, and silver nanoparticles<sup>##UREF##30##41##</sup>.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Property</th><th align=\"left\">Heat capacity </th><th align=\"left\">Thermal conductivity </th><th align=\"left\">Dynamic viscosity </th><th align=\"left\">Density </th></tr></thead><tbody><tr><td align=\"left\">Blood</td><td char=\".\" align=\"char\">3746</td><td align=\"left\">0.52</td><td char=\".\" align=\"char\">0.003</td><td char=\".\" align=\"char\">1063</td></tr><tr><td align=\"left\">Gold (Au)</td><td char=\".\" align=\"char\">129</td><td align=\"left\">310</td><td char=\".\" align=\"char\">0.00464</td><td char=\".\" align=\"char\">19,300</td></tr><tr><td align=\"left\">Silver (Ag)</td><td char=\".\" align=\"char\">235</td><td align=\"left\">429</td><td char=\".\" align=\"char\">0.005</td><td char=\".\" align=\"char\">10,500</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Description of mesh dimensions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Geometric constituents units</th><th align=\"left\">Bounds</th><th align=\"left\">Geometric constituents units</th><th align=\"left\">Bounds</th></tr></thead><tbody><tr><td align=\"left\">Illustrate for</td><td align=\"left\">Fluid dynamics</td><td align=\"left\">Least element size</td><td align=\"left\">0.031</td></tr><tr><td align=\"left\">Perseverance of contracted section</td><td align=\"left\">0.7</td><td align=\"left\">Determination of confined zone</td><td align=\"left\">0.7</td></tr><tr><td align=\"left\">Extreme constituent growth rate</td><td align=\"left\">1.15</td><td align=\"left\">Curvature factor</td><td align=\"left\">0.6</td></tr><tr><td align=\"left\">Maximum component size</td><td align=\"left\">0.104</td><td align=\"left\">Predefined size</td><td align=\"left\">Normal</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Description of mesh dimensions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Characteristics</th><th align=\"left\">Values</th></tr></thead><tbody><tr><td align=\"left\">Number of elements</td><td align=\"left\">279,109</td></tr><tr><td align=\"left\">Tetrahedrons</td><td align=\"left\">250,001</td></tr><tr><td align=\"left\">Prisms</td><td align=\"left\">28,016</td></tr><tr><td align=\"left\">Triangles</td><td align=\"left\">16,424</td></tr><tr><td align=\"left\">Quads</td><td align=\"left\">172</td></tr><tr><td align=\"left\">Pyramids</td><td align=\"left\">1092</td></tr><tr><td align=\"left\">Vertex elements</td><td align=\"left\">70</td></tr><tr><td align=\"left\">Edge elements</td><td align=\"left\">1620</td></tr><tr><td align=\"left\">Normal element quality</td><td align=\"left\">0.6633</td></tr><tr><td align=\"left\">Least element quality</td><td align=\"left\">0.07794</td></tr><tr><td align=\"left\">Mesh vertices</td><td align=\"left\">58,620</td></tr><tr><td align=\"left\">Element volume ratio</td><td align=\"left\">6.445E−4</td></tr><tr><td align=\"left\">Mesh volume</td><td align=\"left\"></td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{O}}_{2}\\text{ and C}{\\text{O}}_{2}$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mrow><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mspace width=\"0.333333em\"/><mml:mtext>and C</mml:mtext><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{S}}/{\\text{m}}$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mrow><mml:mtext>S</mml:mtext><mml:mo stretchy=\"false\">/</mml:mo><mml:mtext>m</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$5\\times {10}^{3}$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mrow><mml:mn>5</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>3</mml:mn></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$1.63\\times {10}^{3}$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:mrow><mml:mn>1.63</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>3</mml:mn></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{S}}/{\\text{m}}$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mrow><mml:mtext>S</mml:mtext><mml:mo stretchy=\"false\">/</mml:mo><mml:mtext>m</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho \\frac{\\partial \\mathbf{u}}{\\partial t}+\\rho \\left(\\mathbf{u}\\cdot \\nabla \\right)\\mathbf{u}=\\nabla \\cdot \\left[-p\\mathbf{I}]+\\nabla [{\\varvec{K}}\\right]+{\\varvec{F}},$$\\end{document}</tex-math><mml:math id=\"M12\" display=\"block\"><mml:mrow><mml:mi>ρ</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi mathvariant=\"bold\">u</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mi>ρ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi mathvariant=\"bold\">u</mml:mi><mml:mo>·</mml:mo><mml:mi mathvariant=\"normal\">∇</mml:mi></mml:mfenced><mml:mi mathvariant=\"bold\">u</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mo>·</mml:mo><mml:mfenced close=\"]\" open=\"[\"><mml:mo>-</mml:mo><mml:mi>p</mml:mi><mml:mi mathvariant=\"bold\">I</mml:mi><mml:mo stretchy=\"false\">]</mml:mo><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mo stretchy=\"false\">[</mml:mo><mml:mrow><mml:mi mathvariant=\"bold-italic\">K</mml:mi></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mrow><mml:mi mathvariant=\"bold-italic\">F</mml:mi></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathbf{K}={\\upmu (\\nabla \\mathbf{u}+(\\nabla (\\mathbf{u}))}^{{\\text{T}}})$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mrow><mml:mi mathvariant=\"bold\">K</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mi mathvariant=\"bold\">u</mml:mi><mml:mo>+</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi mathvariant=\"bold\">u</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mtext>T</mml:mtext></mml:msup><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho \\nabla \\cdot \\left(\\mathbf{u}\\right)=0, \\left(\\mathrm{Incompressible\\, flow}\\right),$$\\end{document}</tex-math><mml:math id=\"M16\" display=\"block\"><mml:mrow><mml:mi>ρ</mml:mi><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mo>·</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mi mathvariant=\"bold\">u</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"normal\">Incompressible</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi mathvariant=\"normal\">flow</mml:mi></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho {{\\text{C}}}_{{\\text{p}}}\\frac{\\partial {\\text{T}}}{\\partial t}+\\rho {C}_{p}\\mathbf{u}\\cdot \\nabla {\\text{T}}+\\nabla \\cdot {\\varvec{q}}={Q}_{p}+{Q}_{vd}+Q.$$\\end{document}</tex-math><mml:math id=\"M18\" display=\"block\"><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mtext>C</mml:mtext><mml:mtext>p</mml:mtext></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>T</mml:mtext></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mi>ρ</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mi mathvariant=\"bold\">u</mml:mi><mml:mo>·</mml:mo><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mtext>T</mml:mtext><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mo>·</mml:mo><mml:mrow><mml:mi mathvariant=\"bold-italic\">q</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">vd</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>Q</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ4\"><label>4</label><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\varvec{q}}=-k\\nabla T, Q=0, { Q}_{vd}=\\tau .\\nabla u, { Q}_{p}={\\alpha }_{p}T\\left(\\frac{\\partial p}{\\partial t}+u\\nabla p\\right), {\\alpha }_{p}=-\\frac{1}{p}\\frac{\\partial p}{\\partial t},$$\\end{document}</tex-math><mml:math id=\"M20\" display=\"block\"><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">q</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mi>k</mml:mi><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mi>T</mml:mi><mml:mo>,</mml:mo><mml:mi>Q</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">vd</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>τ</mml:mi><mml:mo>.</mml:mo><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mi>u</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mi>T</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mi>u</mml:mi><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mi>p</mml:mi></mml:mfenced><mml:mo>,</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>p</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau =-pI+\\mu {A}_{1}$$\\end{document}</tex-math><mml:math id=\"M22\"><mml:mrow><mml:mi>τ</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mi>p</mml:mi><mml:mi>I</mml:mi><mml:mo>+</mml:mo><mml:mi>μ</mml:mi><mml:msub><mml:mi>A</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$trace\\left(\\tau \\cdot \\nabla {\\text{u}}\\right)=\\tau .$$\\end{document}</tex-math><mml:math id=\"M24\"><mml:mrow><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>τ</mml:mi><mml:mo>·</mml:mo><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mtext>u</mml:mtext></mml:mfenced><mml:mo>=</mml:mo><mml:mi>τ</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ5\"><label>5</label><alternatives><tex-math id=\"M25\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\nabla \\times H=J, B=\\nabla \\times A, J=\\sigma E+{J}_{e}, E=-\\frac{\\partial A}{\\partial t}.$$\\end{document}</tex-math><mml:math id=\"M26\" display=\"block\"><mml:mrow><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mo>×</mml:mo><mml:mi>H</mml:mi><mml:mo>=</mml:mo><mml:mi>J</mml:mi><mml:mo>,</mml:mo><mml:mi>B</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mo>×</mml:mo><mml:mi>A</mml:mi><mml:mo>,</mml:mo><mml:mi>J</mml:mi><mml:mo>=</mml:mo><mml:mi>σ</mml:mi><mml:mi>E</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>J</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M27\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\nabla \\times H=J$$\\end{document}</tex-math><mml:math id=\"M28\"><mml:mrow><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mo>×</mml:mo><mml:mi>H</mml:mi><mml:mo>=</mml:mo><mml:mi>J</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M29\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$B=\\nabla \\times A$$\\end{document}</tex-math><mml:math id=\"M30\"><mml:mrow><mml:mi>B</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mo>×</mml:mo><mml:mi>A</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M31\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$J=\\sigma E+{J}_{e}$$\\end{document}</tex-math><mml:math id=\"M32\"><mml:mrow><mml:mi>J</mml:mi><mml:mo>=</mml:mo><mml:mi>σ</mml:mi><mml:mi>E</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>J</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq12\"><alternatives><tex-math id=\"M33\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\sigma E$$\\end{document}</tex-math><mml:math id=\"M34\"><mml:mrow><mml:mi>σ</mml:mi><mml:mi>E</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq13\"><alternatives><tex-math id=\"M35\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${J}_{e}$$\\end{document}</tex-math><mml:math id=\"M36\"><mml:msub><mml:mi>J</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq14\"><alternatives><tex-math id=\"M37\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\sigma E$$\\end{document}</tex-math><mml:math id=\"M38\"><mml:mrow><mml:mi>σ</mml:mi><mml:mi>E</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq15\"><alternatives><tex-math id=\"M39\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${J}_{e}$$\\end{document}</tex-math><mml:math id=\"M40\"><mml:msub><mml:mi>J</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq16\"><alternatives><tex-math id=\"M41\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$E=-\\frac{\\partial A}{\\partial t}$$\\end{document}</tex-math><mml:math id=\"M42\"><mml:mrow><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ6\"><label>6</label><alternatives><tex-math id=\"M43\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${u}_{r }\\left({\\text{r}},\\mathrm{ z},\\mathrm{ t}\\right)= -{U}_{0}\\mathbf{n}.$$\\end{document}</tex-math><mml:math id=\"M44\" display=\"block\"><mml:mrow><mml:msub><mml:mi>u</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mtext>r</mml:mtext><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">z</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mi mathvariant=\"bold\">n</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ7\"><label>7</label><alternatives><tex-math id=\"M45\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left[-{\\text{P}}\\mathbf{I}+\\mathbf{K}\\right]\\mathsf{n} = -\\widehat{{{\\text{P}}}_{0}}\\mathsf{n},$$\\end{document}</tex-math><mml:math id=\"M46\" display=\"block\"><mml:mrow><mml:mfenced close=\"]\" open=\"[\"><mml:mo>-</mml:mo><mml:mtext>P</mml:mtext><mml:mi mathvariant=\"bold\">I</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant=\"bold\">K</mml:mi></mml:mfenced><mml:mi mathvariant=\"sans-serif\">n</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mover accent=\"true\"><mml:msub><mml:mtext>P</mml:mtext><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy=\"true\">^</mml:mo></mml:mover><mml:mi mathvariant=\"sans-serif\">n</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equa\"><alternatives><tex-math id=\"M47\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\widehat{{{\\text{P}}}_{0}} \\le {{\\text{P}}}_{0}.$$\\end{document}</tex-math><mml:math id=\"M48\" display=\"block\"><mml:mrow><mml:mover accent=\"true\"><mml:msub><mml:mtext>P</mml:mtext><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy=\"true\">^</mml:mo></mml:mover><mml:mo>≤</mml:mo><mml:msub><mml:mtext>P</mml:mtext><mml:mn>0</mml:mn></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ8\"><label>8</label><alternatives><tex-math id=\"M49\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${u}_{r }=0, {u}_{z}=0.$$\\end{document}</tex-math><mml:math id=\"M50\" display=\"block\"><mml:mrow><mml:msub><mml:mi>u</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>u</mml:mi><mml:mi>z</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ9\"><label>9</label><alternatives><tex-math id=\"M51\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-\\mathbf{n}.\\mathbf{q}= 0.$$\\end{document}</tex-math><mml:math id=\"M52\" display=\"block\"><mml:mrow><mml:mo>-</mml:mo><mml:mi mathvariant=\"bold\">n</mml:mi><mml:mo>.</mml:mo><mml:mi mathvariant=\"bold\">q</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq17\"><alternatives><tex-math id=\"M53\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$1200\\text{ Wm}^{2}$$\\end{document}</tex-math><mml:math id=\"M54\"><mml:mrow><mml:mn>1200</mml:mn><mml:mspace width=\"0.333333em\"/><mml:msup><mml:mtext>Wm</mml:mtext><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ10\"><label>10</label><alternatives><tex-math id=\"M55\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-\\mathbf{n} \\cdot \\mathbf{q}= {\\mathbf{q}}_{0}.$$\\end{document}</tex-math><mml:math id=\"M56\" display=\"block\"><mml:mrow><mml:mo>-</mml:mo><mml:mi mathvariant=\"bold\">n</mml:mi><mml:mo>·</mml:mo><mml:mi mathvariant=\"bold\">q</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant=\"bold\">q</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ11\"><label>11</label><alternatives><tex-math id=\"M57\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathsf{n}\\times \\mathsf{A}=0.$$\\end{document}</tex-math><mml:math id=\"M58\" display=\"block\"><mml:mrow><mml:mi mathvariant=\"sans-serif\">n</mml:mi><mml:mo>×</mml:mo><mml:mi mathvariant=\"sans-serif\">A</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq18\"><alternatives><tex-math id=\"M59\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$V=\\left({v}_{r }\\left(r, \\theta , z, t\\right),{v}_{\\theta }\\left(r, \\theta , z, t\\right),{v}_{z}\\left({\\text{r}},\\uptheta ,\\mathrm{ z},\\mathrm{ t}\\right)\\right)$$\\end{document}</tex-math><mml:math id=\"M60\"><mml:mrow><mml:mi>V</mml:mi><mml:mo>=</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>θ</mml:mi><mml:mo>,</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced><mml:mo>,</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>θ</mml:mi></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>θ</mml:mi><mml:mo>,</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced><mml:mo>,</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mtext>r</mml:mtext><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">θ</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">z</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">t</mml:mi></mml:mfenced></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ12\"><label>12</label><alternatives><tex-math id=\"M61\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{\\partial {v}_{r }}{\\partial r}+\\frac{1}{r}{v}_{r }+\\frac{1}{r}\\frac{\\partial {v}_{\\theta }}{\\partial \\theta }+\\frac{\\partial {v}_{z }}{\\partial z}=0.$$\\end{document}</tex-math><mml:math id=\"M62\" display=\"block\"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>r</mml:mi></mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>r</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>θ</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>θ</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ13\"><label>13</label><alternatives><tex-math id=\"M63\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\rho }_{hnf}\\left( \\frac{\\partial {{\\text{v}}}_{\\mathrm{r }}}{\\partial {\\text{t}}}+ {{\\text{v}}}_{\\mathrm{r }} \\frac{\\partial {{\\text{v}}}_{\\mathrm{r }}}{\\partial {\\text{r}}}+\\frac{{{\\text{v}}}_{\\uptheta }}{{\\text{r}}} \\frac{\\partial {{\\text{v}}}_{\\mathrm{r }}}{\\partial\\uptheta }-\\frac{{{{\\text{v}}}_{\\uptheta }}^{2}}{{\\text{r}}}+ {{\\text{v}}}_{\\mathrm{z }} \\frac{\\partial {{\\text{v}}}_{\\mathrm{r }}}{\\partial {\\text{z}}}\\right)=-\\frac{\\partial p}{\\partial r}+\\frac{1}{r}\\frac{\\partial \\left(r{\\mathcal{T}}_{rr}\\right)}{\\partial r}+\\frac{1}{r}\\frac{\\partial \\left({\\mathcal{T}}_{r\\theta }\\right)}{\\partial \\theta }-\\frac{{\\mathcal{T}}_{\\theta \\theta }}{r}+\\frac{\\partial \\left({\\mathcal{T}}_{rz}\\right)}{\\partial z},$$\\end{document}</tex-math><mml:math id=\"M64\" display=\"block\"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">r</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>t</mml:mtext></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">r</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">r</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>r</mml:mtext></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">θ</mml:mi></mml:msub><mml:mtext>r</mml:mtext></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">r</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi mathvariant=\"normal\">θ</mml:mi></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:msup><mml:mrow><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">θ</mml:mi></mml:msub></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mtext>r</mml:mtext></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">z</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">r</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>z</mml:mtext></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>r</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>r</mml:mi><mml:msub><mml:mi mathvariant=\"script\">T</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">rr</mml:mi></mml:mrow></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>r</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi mathvariant=\"script\">T</mml:mi><mml:mrow><mml:mi>r</mml:mi><mml:mi>θ</mml:mi></mml:mrow></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>θ</mml:mi></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:msub><mml:mi mathvariant=\"script\">T</mml:mi><mml:mrow><mml:mi>θ</mml:mi><mml:mi>θ</mml:mi></mml:mrow></mml:msub><mml:mi>r</mml:mi></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi mathvariant=\"script\">T</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">rz</mml:mi></mml:mrow></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ14\"><label>14</label><alternatives><tex-math id=\"M65\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\rho }_{hnf}\\left( \\frac{\\partial {{\\text{v}}}_{\\uptheta }}{\\partial {\\text{t}}}+ {{\\text{v}}}_{\\mathrm{r }} \\frac{\\partial {{\\text{v}}}_{\\uptheta }}{\\partial {\\text{r}}}+\\frac{{{\\text{v}}}_{\\uptheta }}{{\\text{r}}} \\frac{\\partial {{\\text{v}}}_{\\uptheta }}{\\partial\\uptheta }-\\frac{{{\\text{v}}}_{{\\text{r}}}{{\\text{v}}}_{\\uptheta }}{{\\text{r}}}+ {{\\text{v}}}_{\\mathrm{z }} \\frac{\\partial {{\\text{v}}}_{\\uptheta }}{\\partial {\\text{z}}}\\right)=-\\frac{1}{{\\text{r}}}\\frac{\\partial {\\text{p}}}{\\partial\\uptheta }+\\frac{1}{{{\\text{r}}}^{2}}\\frac{\\partial \\left({{\\text{r}}}^{2}{\\mathcal{T}}_{\\mathrm{\\theta r}}\\right)}{\\partial {\\text{r}}}+\\frac{1}{{\\text{r}}}\\frac{\\partial {\\mathcal{T}}_{\\mathrm{\\theta \\theta }}}{\\partial\\uptheta }+\\frac{\\partial {\\mathcal{T}}_{\\mathrm{\\theta z}}}{\\partial {\\text{z}}},$$\\end{document}</tex-math><mml:math id=\"M66\" display=\"block\"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">θ</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>t</mml:mtext></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">r</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">θ</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>r</mml:mtext></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">θ</mml:mi></mml:msub><mml:mtext>r</mml:mtext></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">θ</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi mathvariant=\"normal\">θ</mml:mi></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mtext>v</mml:mtext><mml:mtext>r</mml:mtext></mml:msub><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">θ</mml:mi></mml:msub></mml:mrow><mml:mtext>r</mml:mtext></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">z</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">θ</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>z</mml:mtext></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mtext>r</mml:mtext></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>p</mml:mtext></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi mathvariant=\"normal\">θ</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msup><mml:mrow><mml:mtext>r</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msup><mml:mrow><mml:mtext>r</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"script\">T</mml:mi><mml:mrow><mml:mi>θ</mml:mi><mml:mi mathvariant=\"normal\">r</mml:mi></mml:mrow></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>r</mml:mtext></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mtext>r</mml:mtext></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi mathvariant=\"script\">T</mml:mi><mml:mrow><mml:mi>θ</mml:mi><mml:mi>θ</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi mathvariant=\"normal\">θ</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi mathvariant=\"script\">T</mml:mi><mml:mrow><mml:mi>θ</mml:mi><mml:mi mathvariant=\"normal\">z</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>z</mml:mtext></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ15\"><label>15</label><alternatives><tex-math id=\"M67\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\rho }_{hnf}\\left( \\frac{\\partial {{\\text{v}}}_{\\mathrm{z }}}{\\partial {\\text{t}}}+ {{\\text{v}}}_{\\mathrm{r }} \\frac{\\partial {{\\text{v}}}_{\\mathrm{z }}}{\\partial {\\text{r}}}+\\frac{{{\\text{v}}}_{\\uptheta }}{{\\text{r}}} \\frac{\\partial {{\\text{v}}}_{\\mathrm{z }}}{\\partial\\uptheta }+ {{\\text{v}}}_{\\mathrm{z }} \\frac{\\partial {{\\text{v}}}_{\\uptheta }}{\\partial {\\text{z}}}\\right)=-\\frac{\\partial {\\text{p}}}{\\partial {\\text{z}}}+\\frac{1}{{\\text{r}}}\\frac{\\partial \\left({\\text{r}}{\\mathcal{T}}_{{\\text{rz}}}\\right)}{\\partial {\\text{r}}}+\\frac{1}{{\\text{r}}}\\frac{\\partial \\left({\\mathcal{T}}_{\\mathrm{\\theta z}}\\right)}{\\partial\\uptheta }+\\frac{\\partial \\left({\\mathcal{T}}_{{\\text{zz}}}\\right)}{\\partial {\\text{z}}},$$\\end{document}</tex-math><mml:math id=\"M68\" display=\"block\"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">z</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>t</mml:mtext></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">r</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">z</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>r</mml:mtext></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">θ</mml:mi></mml:msub><mml:mtext>r</mml:mtext></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">z</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi mathvariant=\"normal\">θ</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">z</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mtext>v</mml:mtext><mml:mi mathvariant=\"normal\">θ</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>z</mml:mtext></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>p</mml:mtext></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>z</mml:mtext></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mtext>r</mml:mtext></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mtext>r</mml:mtext><mml:msub><mml:mi mathvariant=\"script\">T</mml:mi><mml:mtext>rz</mml:mtext></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>r</mml:mtext></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mtext>r</mml:mtext></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi mathvariant=\"script\">T</mml:mi><mml:mrow><mml:mi>θ</mml:mi><mml:mi mathvariant=\"normal\">z</mml:mi></mml:mrow></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi mathvariant=\"normal\">θ</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi mathvariant=\"script\">T</mml:mi><mml:mtext>zz</mml:mtext></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mtext>z</mml:mtext></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq19\"><alternatives><tex-math id=\"M69\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathcal{T}=\\left({\\left(\\nabla \\left(U\\right)\\right)}^{T}+\\nabla \\left(U\\right)\\right)$$\\end{document}</tex-math><mml:math id=\"M70\"><mml:mrow><mml:mi mathvariant=\"script\">T</mml:mi><mml:mo>=</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>U</mml:mi></mml:mfenced></mml:mfenced></mml:mrow><mml:mi>T</mml:mi></mml:msup><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>U</mml:mi></mml:mfenced></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ16\"><label>16</label><alternatives><tex-math id=\"M71\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${(\\rho {C}_{p})}_{hnf}\\left(\\frac{\\partial T}{\\partial t}+{v}_{r }\\frac{\\partial T}{\\partial r}+\\frac{{v}_{\\theta }}{r}\\frac{\\partial T}{\\partial \\theta }+{v}_{z }\\frac{\\partial T}{\\partial z}\\right)={{\\text{k}}}_{hnf}\\left[\\frac{1}{r}\\frac{\\partial }{\\partial r}\\left(r\\frac{\\partial T}{\\partial r}\\right)+\\frac{1}{{r}^{2}}\\frac{{\\partial }^{2}T}{\\partial {\\theta }^{2}}+\\frac{{\\partial }^{2}T}{\\partial {z}^{2}}\\right]+{\\mu }_{hnf}\\varphi .$$\\end{document}</tex-math><mml:math id=\"M72\" display=\"block\"><mml:mrow><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ρ</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mi>θ</mml:mi></mml:msub><mml:mi>r</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>θ</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mtext>k</mml:mtext><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub><mml:mfenced close=\"]\" open=\"[\"><mml:mfrac><mml:mn>1</mml:mn><mml:mi>r</mml:mi></mml:mfrac><mml:mfrac><mml:mi>∂</mml:mi><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mi>r</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mfrac><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>θ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub><mml:mi>φ</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equb\"><alternatives><tex-math id=\"M73\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varphi =2{\\left( \\frac{\\partial {v}_{r }}{\\partial r}\\right)}^{2}+2{\\left(\\frac{1}{r}\\frac{\\partial {v}_{\\theta }}{\\partial \\theta }+\\frac{{v}_{r }}{r}\\right)}^{2}+2{\\left( \\frac{\\partial {v}_{z}}{\\partial z}\\right)}^{2}+{\\left( \\frac{\\partial {v}_{\\theta }}{\\partial r}-\\frac{{v}_{\\theta }}{r}+\\frac{1}{r} \\frac{\\partial {v}_{r }}{\\partial \\theta }\\right)}^{2}+{\\left(\\frac{1}{r}\\frac{\\partial {v}_{z }}{\\partial \\theta }+\\frac{\\partial {v}_{\\theta }}{\\partial z}\\right)}^{2}+{\\left( \\frac{\\partial {v}_{r }}{\\partial z}+\\frac{\\partial {v}_{z }}{\\partial r}\\right)}^{2}.$$\\end{document}</tex-math><mml:math id=\"M74\" display=\"block\"><mml:mrow><mml:mi>φ</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mn>1</mml:mn><mml:mi>r</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>θ</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>θ</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mi>r</mml:mi></mml:mfrac></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow></mml:mfrac></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>θ</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mi>θ</mml:mi></mml:msub><mml:mi>r</mml:mi></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>r</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>θ</mml:mi></mml:mrow></mml:mfrac></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mn>1</mml:mn><mml:mi>r</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>θ</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>θ</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow></mml:mfrac></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq20\"><alternatives><tex-math id=\"M75\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${v}_{r}(r, z, t),0, {v}_{z }(z, r, t)]$$\\end{document}</tex-math><mml:math id=\"M76\"><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ17\"><label>17</label><alternatives><tex-math id=\"M77\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{\\partial {v}_{r}}{\\partial r}+\\frac{{v}_{r}}{r}+\\frac{\\partial {v}_{z }}{\\partial z}=0,$$\\end{document}</tex-math><mml:math id=\"M78\" display=\"block\"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mi>r</mml:mi></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ18\"><label>18</label><alternatives><tex-math id=\"M79\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left(\\frac{\\partial {v}_{r }}{\\partial t}+ {v}_{r }\\frac{\\partial {v}_{r }}{\\partial r}+ {v}_{z }\\frac{\\partial {v}_{r }}{\\partial z}\\right)=-\\frac{1}{\\rho }\\frac{\\partial p}{\\partial r}+{\\nu }_{hnf}\\left(\\frac{{\\partial }^{2}{v}_{r}}{\\partial {r}^{2}}+\\frac{1}{r}\\right. \\frac{\\partial {v}_{r }}{\\partial r}+\\frac{{\\partial }^{2}{v}_{r}}{\\partial {z}^{2}}\\left.-\\frac{{v}_{r}}{{r}^{2}}\\right)+g({\\rho \\gamma )}_{hnf}\\alpha \\left(T-{T}_{0}\\right)-\\sigma {{B}_{0}}^{2}{v}_{r },$$\\end{document}</tex-math><mml:math id=\"M80\" display=\"block\"><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>ρ</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>ν</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub><mml:mfenced open=\"(\"><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>r</mml:mi></mml:mfrac></mml:mfenced><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mfenced close=\")\"><mml:mo>-</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:msup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mfrac></mml:mfenced><mml:mrow><mml:mo>+</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy=\"false\">(</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub><mml:mi>α</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>T</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mo>-</mml:mo><mml:mi>σ</mml:mi><mml:msup><mml:mrow><mml:msub><mml:mi>B</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ19\"><label>19</label><alternatives><tex-math id=\"M81\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{\\partial p}{\\partial \\theta }=0,$$\\end{document}</tex-math><mml:math id=\"M82\" display=\"block\"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>θ</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ20\"><label>20</label><alternatives><tex-math id=\"M83\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left(\\frac{\\partial {v}_{z }}{\\partial t}+ {v}_{r }\\frac{\\partial {v}_{z }}{\\partial r}+ {v}_{z }\\frac{\\partial {v}_{z}}{\\partial z}\\right)=-\\frac{1}{\\rho }\\frac{\\partial p}{\\partial z}+{\\nu }_{hnf}\\left(\\frac{{\\partial }^{2}{v}_{z}}{\\partial {r}^{2}}+\\frac{{\\partial }^{2}{v}_{z}}{\\partial {z}^{2}}+\\frac{1}{r}\\frac{\\partial {v}_{z}}{\\partial r}\\right)+g({\\rho \\gamma )}_{hnf}\\alpha \\left(T-{T}_{0}\\right)-\\sigma {{B}_{0}}^{2}{v}_{z },$$\\end{document}</tex-math><mml:math id=\"M84\" display=\"block\"><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>ρ</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>ν</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>r</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac></mml:mfenced><mml:mrow><mml:mo>+</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy=\"false\">(</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub><mml:mi>α</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>T</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mo>-</mml:mo><mml:mi>σ</mml:mi><mml:msup><mml:mrow><mml:msub><mml:mi>B</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ21\"><label>21</label><alternatives><tex-math id=\"M85\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${(\\rho {C}_{p})}_{hnf}\\left(\\frac{\\partial T}{\\partial t}+{v}_{r }\\frac{\\partial T}{\\partial r}+{v}_{z}\\frac{\\partial T}{\\partial z}\\right)={K}_{hnf}\\left(\\frac{1}{r}\\frac{\\partial T}{\\partial r}+\\frac{{\\partial }^{2}T}{\\partial {r}^{2}}+\\frac{{\\partial }^{2}T}{\\partial {z}^{2}}\\right)+{Q}_{0}.$$\\end{document}</tex-math><mml:math id=\"M86\" display=\"block\"><mml:mrow><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ρ</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mi>z</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mn>1</mml:mn><mml:mi>r</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq21\"><alternatives><tex-math id=\"M87\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\rho }_{hnf}$$\\end{document}</tex-math><mml:math id=\"M88\"><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq22\"><alternatives><tex-math id=\"M89\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\nu }_{hnf}$$\\end{document}</tex-math><mml:math id=\"M90\"><mml:msub><mml:mi>ν</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq23\"><alternatives><tex-math id=\"M91\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\left(\\rho {C}_{p}\\right)}_{hnf}$$\\end{document}</tex-math><mml:math id=\"M92\"><mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>ρ</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mi>p</mml:mi></mml:msub></mml:mfenced><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq24\"><alternatives><tex-math id=\"M93\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{hnf}$$\\end{document}</tex-math><mml:math id=\"M94\"><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq25\"><alternatives><tex-math id=\"M95\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left({\\text{J}}{\\text{ K}}^{-1} {\\text{kg}}^{-1}\\right)$$\\end{document}</tex-math><mml:math id=\"M96\"><mml:mfenced close=\")\" open=\"(\"><mml:mtext>J</mml:mtext><mml:msup><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>K</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mtext>kg</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mfenced></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq26\"><alternatives><tex-math id=\"M97\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left({\\text{W m}}^{-1} {k}^{-1}\\right)$$\\end{document}</tex-math><mml:math id=\"M98\"><mml:mfenced close=\")\" open=\"(\"><mml:msup><mml:mrow><mml:mtext>W m</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mfenced></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq27\"><alternatives><tex-math id=\"M99\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left({\\text{Nm}}^{-2}\\text{ s}\\right)$$\\end{document}</tex-math><mml:math id=\"M100\"><mml:mfenced close=\")\" open=\"(\"><mml:msup><mml:mrow><mml:mtext>Nm</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mspace width=\"0.333333em\"/><mml:mtext>s</mml:mtext></mml:mfenced></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq28\"><alternatives><tex-math id=\"M101\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left({\\text{kg m}}^{-3}\\right)$$\\end{document}</tex-math><mml:math id=\"M102\"><mml:mfenced close=\")\" open=\"(\"><mml:msup><mml:mrow><mml:mtext>kg m</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mfenced></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ22\"><label>22</label><alternatives><tex-math id=\"M103\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left.\\begin{array}{c}{\\rho }_{hnf}= \\left(1-{\\phi }_{2}\\right)\\left( \\left(1-{\\phi }_{1}\\right)\\right.{\\rho }_{f}+{\\phi }_{1} {\\rho }_{{s}_{1}})+{\\phi }_{2}{\\rho }_{{s}_{2}}\\\\ {(\\rho {C}_{p})}_{hnf}=\\left(1-{\\phi }_{2}\\right){(\\left(1-{\\phi }_{1}\\right)\\rho {C}_{p})}_{f}+{\\phi }_{1}{(\\rho {C}_{p})}_{{s}_{1}})+{\\phi }_{2}{(\\rho {C}_{p})}_{{s}_{2}}\\\\ {\\mu }_{hnf}= \\frac{{\\mu }_{f}}{{\\left(1-{\\phi }_{1}\\right)}^{2.5}{\\left(1-{\\phi }_{2}\\right)}^{2.5}}\\\\ \\frac{{K}_{hnf}}{{K}_{f}}= \\left\\{\\frac{{k}_{{s}_{1}+}2{k}_{f}-2{\\phi }_{1}\\left({k}_{f}-{k}_{{s}_{1}}\\right)}{{k}_{{s}_{1}+}2{k}_{f}+{\\phi }_{1}\\left({k}_{f}-{k}_{{s}_{1}}\\right)}\\times \\frac{{k}_{{s}_{2}+}2{k}_{nf}-2{\\phi }_{2}\\left({k}_{nf}-{k}_{{s}_{2}}\\right)}{{k}_{{s}_{2}+}2{k}_{nf}+{\\phi }_{2}\\left({k}_{nf}-{k}_{{s}_{2}}\\right)}\\right\\}\\end{array}\\right\\}.$$\\end{document}</tex-math><mml:math id=\"M104\" display=\"block\"><mml:mrow><mml:mfenced close=\"}\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mfenced><mml:mfenced open=\"(\"><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mfenced><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:msub><mml:mi>s</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>+</mml:mo></mml:mrow><mml:msub><mml:mi>ϕ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:msub><mml:mi>s</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ρ</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mfenced><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mi>ρ</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>f</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ρ</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>+</mml:mo></mml:mrow><mml:msub><mml:mi>ϕ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ρ</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>μ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mrow><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2.5</mml:mn></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2.5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mfrac><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">hnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>K</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>=</mml:mo><mml:mfenced close=\"}\" open=\"{\"><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo></mml:mrow></mml:msub><mml:mn>2</mml:mn><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi>ϕ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:msub><mml:mi>s</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo></mml:mrow></mml:msub><mml:mn>2</mml:mn><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:msub><mml:mi>s</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:msub></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>×</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo></mml:mrow></mml:msub><mml:mn>2</mml:mn><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">nf</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi>ϕ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">nf</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:msub><mml:mi>s</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo></mml:mrow></mml:msub><mml:mn>2</mml:mn><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">nf</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">nf</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:msub><mml:mi>s</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq29\"><alternatives><tex-math id=\"M105\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${0.6429\\text{ m}}^{3}$$\\end{document}</tex-math><mml:math id=\"M106\"><mml:msup><mml:mrow><mml:mn>0.6429</mml:mn><mml:mspace width=\"0.333333em\"/><mml:mtext>m</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq30\"><alternatives><tex-math id=\"M107\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=0.5\\text{ s}$$\\end{document}</tex-math><mml:math id=\"M108\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn><mml:mspace width=\"0.333333em\"/><mml:mtext>s</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq31\"><alternatives><tex-math id=\"M109\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=1.5\\text{ s}$$\\end{document}</tex-math><mml:math id=\"M110\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>1.5</mml:mn><mml:mspace width=\"0.333333em\"/><mml:mtext>s</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq32\"><alternatives><tex-math id=\"M111\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=2.5\\text{ s}$$\\end{document}</tex-math><mml:math id=\"M112\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>2.5</mml:mn><mml:mspace width=\"0.333333em\"/><mml:mtext>s</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq33\"><alternatives><tex-math id=\"M113\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=8.5\\text{ s}$$\\end{document}</tex-math><mml:math id=\"M114\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>8.5</mml:mn><mml:mspace width=\"0.333333em\"/><mml:mtext>s</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq34\"><alternatives><tex-math id=\"M115\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=9.5\\text{ s}$$\\end{document}</tex-math><mml:math id=\"M116\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>9.5</mml:mn><mml:mspace width=\"0.333333em\"/><mml:mtext>s</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq35\"><alternatives><tex-math id=\"M117\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$1.4\\times {10}^{4}$$\\end{document}</tex-math><mml:math id=\"M118\"><mml:mrow><mml:mn>1.4</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq36\"><alternatives><tex-math id=\"M119\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$1.35\\times {10}^{4}$$\\end{document}</tex-math><mml:math id=\"M120\"><mml:mrow><mml:mn>1.35</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq37\"><alternatives><tex-math id=\"M121\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$1.45\\times {10}^{4}$$\\end{document}</tex-math><mml:math id=\"M122\"><mml:mrow><mml:mn>1.45</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq38\"><alternatives><tex-math id=\"M123\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$1.39\\times {10}^{4}$$\\end{document}</tex-math><mml:math id=\"M124\"><mml:mrow><mml:mn>1.39</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq39\"><alternatives><tex-math id=\"M125\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=0.5\\text{ s}$$\\end{document}</tex-math><mml:math id=\"M126\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn><mml:mspace width=\"0.333333em\"/><mml:mtext>s</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq40\"><alternatives><tex-math id=\"M127\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=1.5\\text{ s}$$\\end{document}</tex-math><mml:math id=\"M128\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>1.5</mml:mn><mml:mspace width=\"0.333333em\"/><mml:mtext>s</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq41\"><alternatives><tex-math id=\"M129\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=2.5\\text{ s}$$\\end{document}</tex-math><mml:math id=\"M130\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>2.5</mml:mn><mml:mspace width=\"0.333333em\"/><mml:mtext>s</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq42\"><alternatives><tex-math id=\"M131\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=8.5\\text{ s}$$\\end{document}</tex-math><mml:math id=\"M132\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>8.5</mml:mn><mml:mspace width=\"0.333333em\"/><mml:mtext>s</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq43\"><alternatives><tex-math id=\"M133\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=9.5\\text{ s}$$\\end{document}</tex-math><mml:math id=\"M134\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>9.5</mml:mn><mml:mspace width=\"0.333333em\"/><mml:mtext>s</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq44\"><alternatives><tex-math id=\"M135\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=0.5\\text{ s}$$\\end{document}</tex-math><mml:math id=\"M136\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn><mml:mspace width=\"0.333333em\"/><mml:mtext>s</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq45\"><alternatives><tex-math id=\"M137\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=1.5\\text{ s}$$\\end{document}</tex-math><mml:math id=\"M138\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>1.5</mml:mn><mml:mspace width=\"0.333333em\"/><mml:mtext>s</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq46\"><alternatives><tex-math id=\"M139\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=2.5\\text{ s}$$\\end{document}</tex-math><mml:math id=\"M140\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>2.5</mml:mn><mml:mspace width=\"0.333333em\"/><mml:mtext>s</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq47\"><alternatives><tex-math id=\"M141\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=8.5\\text{ s}$$\\end{document}</tex-math><mml:math id=\"M142\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>8.5</mml:mn><mml:mspace width=\"0.333333em\"/><mml:mtext>s</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq48\"><alternatives><tex-math id=\"M143\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=9.5\\text{ s}$$\\end{document}</tex-math><mml:math id=\"M144\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>9.5</mml:mn><mml:mspace width=\"0.333333em\"/><mml:mtext>s</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq5.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ1.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq6.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ2.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ3.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ4.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq8.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ5.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq9.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq10.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq11.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq12.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq13.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq14.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq15.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq16.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ6.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ7.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equa.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ8.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ9.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq17.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ10.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ11.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq18.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ12.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ13.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ14.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ15.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq19.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ16.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equb.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq20.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ17.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ18.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ19.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ20.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ21.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq21.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq22.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq23.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq24.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq25.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq26.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq27.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq28.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Article_Equ22.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig2_HTML\" id=\"MO2\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq29.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq30.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig3_HTML\" id=\"MO3\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq31.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig4_HTML\" id=\"MO4\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq32.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig5_HTML\" id=\"MO5\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq33.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig6_HTML\" id=\"MO6\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq34.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig7_HTML\" id=\"MO7\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq35.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq36.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq37.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq38.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq39.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig8_HTML\" id=\"MO8\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq40.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig9_HTML\" id=\"MO9\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq41.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig10_HTML\" id=\"MO10\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq42.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig11_HTML\" id=\"MO11\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq43.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig12_HTML\" id=\"MO12\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq44.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig13_HTML\" id=\"MO13\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq45.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig14_HTML\" id=\"MO14\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq46.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig15_HTML\" id=\"MO15\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq47.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig16_HTML\" id=\"MO16\"/>", "<inline-graphic xlink:href=\"41598_2024_51607_Article_IEq48.gif\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig17_HTML\" id=\"MO17\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig18_HTML\" id=\"MO18\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig19_HTML\" id=\"MO19\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig20_HTML\" id=\"MO20\"/>", "<graphic xlink:href=\"41598_2024_51607_Fig21_HTML\" id=\"MO21\"/>" ]
[]
[{"label": ["1."], "mixed-citation": ["Ponalagusamy, R. "], "italic": ["Blood flow through Stenosed Tube"]}, {"label": ["2."], "surname": ["Mandal"], "given-names": ["PK"], "article-title": ["An unsteady analysis of non-Newtonian blood flow through tapered arteries with stenosis"], "source": ["Int. J. Non-Linear Mech."], "year": ["2005"], "volume": ["40"], "issue": ["1"], "fpage": ["151"], "lpage": ["164"], "pub-id": ["10.1016/j.ijnonlinmec.2004.07.007"]}, {"label": ["3."], "surname": ["Waqas", "Farooq", "Liu", "Alghamdi", "Noreen", "Muhammad"], "given-names": ["H", "U", "D", "M", "S", "T"], "article-title": ["Numerical investigation of nanofluid flow with gold and silver nanoparticles injected inside a stenotic artery"], "source": ["Mater. Des."], "year": ["2022"], "volume": ["223"], "fpage": ["111130"], "pub-id": ["10.1016/j.matdes.2022.111130"]}, {"label": ["4."], "surname": ["Ponalagusamy"], "given-names": ["R"], "article-title": ["Blood flow through an artery with mild stenosis: A two-layered model, different shapes of stenoses and slip velocity at the wall"], "source": ["J. Appl. Sci."], "year": ["2007"], "volume": ["7"], "issue": ["7"], "fpage": ["1071"], "lpage": ["1077"], "pub-id": ["10.3923/jas.2007.1071.1077"]}, {"label": ["6."], "surname": ["Javed", "Imran", "Arooj", "Sohail"], "given-names": ["M", "N", "A", "M"], "article-title": ["Meta-analysis on homogeneous\u2013heterogeneous reaction effects in a sinusoidal wavy curved channel"], "source": ["Chem. Phys. Lett."], "year": ["2021"], "volume": ["763"], "fpage": ["138200"], "pub-id": ["10.1016/j.cplett.2020.138200"]}, {"label": ["7."], "surname": ["Nadeem", "Ijaz"], "given-names": ["S", "S"], "article-title": ["Single wall carbon nanotube (SWCNT) examination on blood flow through a multiple stenosed artery with variable nanofluid viscosity"], "source": ["AIP Adv."], "year": ["2015"], "volume": ["5"], "issue": ["10"], "fpage": ["583"], "pub-id": ["10.1063/1.4934583"]}, {"label": ["8."], "surname": ["Misra", "Sinha", "Shit"], "given-names": ["JC", "A", "GC"], "article-title": ["Theoretical analysis of blood flow through an arterial segment having multiple stenosis"], "source": ["J. Mech. Med. Biol."], "year": ["2008"], "volume": ["8"], "issue": ["02"], "fpage": ["265"], "lpage": ["279"], "pub-id": ["10.1142/S0219519408002620"]}, {"label": ["10."], "surname": ["Sreenadh", "Pallavi", "Satyanarayana"], "given-names": ["S", "AR", "BH"], "article-title": ["Flow of a Casson fluid through an inclined tube of the non-uniform cross-section with multiple stenosis"], "source": ["Adv. Appl. Sci. Res."], "year": ["2011"], "volume": ["2"], "issue": ["5"], "fpage": ["340"], "lpage": ["349"]}, {"label": ["12."], "surname": ["Al-Saad", "Suarez", "Obeidat", "Bordas", "Kulasegaram"], "given-names": ["M", "C", "A", "S", "S"], "article-title": ["Application of smooth particle hydrodynamics method for modeling blood flow with thrombus formation"], "source": ["Comput. Model. Eng. Sci."], "year": ["2020"], "volume": ["122"], "issue": ["3"], "fpage": ["831"], "lpage": ["862"]}, {"label": ["16."], "surname": ["Srivastava", "Rastogi"], "given-names": ["VP", "R"], "article-title": ["Blood flow through a stenosed catheterized artery: Effects of hematocrit and stenosis shape"], "source": ["Comput. Math. Appl."], "year": ["2010"], "volume": ["59"], "issue": ["4"], "fpage": ["1377"], "lpage": ["1385"], "pub-id": ["10.1016/j.camwa.2009.12.007"]}, {"label": ["17."], "surname": ["Nadeem", "Ijaz"], "given-names": ["S", "S"], "article-title": ["Nanoparticles analysis on the blood flow through a tapered catheterized elastic artery with overlapping stenosis"], "source": ["Eur. Phys. J. Plus"], "year": ["2014"], "volume": ["129"], "issue": ["11"], "fpage": ["249"], "pub-id": ["10.1140/epjp/i2014-14249-1"]}, {"label": ["18."], "surname": ["Choi", "Eastman"], "given-names": ["SUS", "JA"], "article-title": ["Enhancing thermal conductivity of fluids with nanofluids"], "source": ["ASME Fluids Eng. Div."], "year": ["1995"], "volume": ["231"], "fpage": ["99"], "lpage": ["105"]}, {"label": ["19."], "surname": ["Wagner", "Dullaart", "Bock", "Zweck"], "given-names": ["V", "A", "AK", "A"], "article-title": ["The emerging nanomedicine landscape"], "source": ["Nat. Biotechnol."], "year": ["2006"], "volume": ["24"], "fpage": ["10"], "pub-id": ["10.1038/nbt1006-1211"]}, {"label": ["20."], "surname": ["Mekheimer", "Elnaqeeb", "ElKot", "Alghamdi"], "given-names": ["KhS", "T", "MA", "F"], "article-title": ["Simultaneous effect of magnetic field and metallic nanoparticles on a micropolar fluid through an overlapping stenotic artery: Blood flow model"], "source": ["Phys. Essays"], "year": ["2016"], "volume": ["29"], "issue": ["2"], "fpage": ["272"], "lpage": ["283"], "pub-id": ["10.4006/0836-1398-29.2.272"]}, {"label": ["21."], "surname": ["Atashafrooz", "Sajjadi", "Delouei"], "given-names": ["M", "H", "AA"], "article-title": ["Simulation of combined convective\u2013radiative heat transfer of hybrid nanofluid flow inside an open trapezoidal enclosure considering the magnetic force impacts"], "source": ["J. Magn. Magn. Mater."], "year": ["2023"], "volume": ["567"], "fpage": ["170354"], "pub-id": ["10.1016/j.jmmm.2023.170354"]}, {"label": ["22."], "surname": ["Sarwar", "Hussain"], "given-names": ["L", "A"], "article-title": ["Flow characteristics of Au\u2013blood nanofluid in the stenotic artery"], "source": ["Int. Commun. Heat Mass Transf."], "year": ["2021"], "volume": ["127"], "fpage": ["105486"], "pub-id": ["10.1016/j.icheatmasstransfer.2021.105486"]}, {"label": ["23."], "surname": ["Hussain", "Hassan", "Al Mdallal", "Ahmad", "Rehman", "Altanji", "Arshad"], "given-names": ["A", "A", "Q", "H", "A", "M", "M"], "article-title": ["Heat transportation enrichment and elliptic cylindrical solution of time-dependent flow"], "source": ["Case Stud. Therm. Eng."], "year": ["2021"], "volume": ["27"], "fpage": ["101248"], "pub-id": ["10.1016/j.csite.2021.101248"]}, {"label": ["24."], "surname": ["Waqas", "Fida", "Liu", "Manzoor", "Alghamdi", "Muhammad"], "given-names": ["H", "M", "D", "U", "M", "T"], "article-title": ["Heat transport of nanofluid flow through a porous channel with thermal radiation effects"], "source": ["Int. Commun. Heat Mass Transf."], "year": ["2022"], "volume": ["138"], "fpage": ["106376"], "pub-id": ["10.1016/j.icheatmasstransfer.2022.106376"]}, {"label": ["25."], "surname": ["Waqas", "Farooq", "Liu", "Abid", "Imran", "Muhammad"], "given-names": ["H", "U", "D", "M", "M", "T"], "article-title": ["Heat transfer analysis of hybrid nanofluid flow with thermal radiation through a stretching sheet: A comparative study"], "source": ["Int. Commun. Heat Mass Transf."], "year": ["2022"], "volume": ["138"], "fpage": ["106303"], "pub-id": ["10.1016/j.icheatmasstransfer.2022.106303"]}, {"label": ["26."], "surname": ["Waqas", "Farooq", "Liu", "Imran", "Muhammad", "Alshomrani", "Umar"], "given-names": ["H", "U", "D", "M", "T", "AS", "M"], "article-title": ["Comparative analysis of hybrid nanofluids with Cattaneo\u2013Christov heat flux model: A thermal case study"], "source": ["Case Stud. Therm. Eng."], "year": ["2022"], "volume": ["36"], "fpage": ["102212"], "pub-id": ["10.1016/j.csite.2022.102212"]}, {"label": ["27."], "surname": ["Waqas", "Farooq", "Hassan", "Liu", "Noreen", "Makki"], "given-names": ["H", "U", "A", "D", "S", "R"], "article-title": ["Numerical and computational simulation of blood flow on hybrid nanofluid with heat transfer through a stenotic artery: Silver and gold nanoparticles"], "source": ["Results Phys."], "year": ["2023"], "volume": ["44"], "fpage": ["106152"], "pub-id": ["10.1016/j.rinp.2022.106152"]}, {"label": ["31."], "surname": ["Ahmed", "Nadeem"], "given-names": ["A", "S"], "article-title": ["The study of (Cu, TiO2, Al2O3) nanoparticles as antimicrobials of blood flow through diseased arteries"], "source": ["J. Mol. Liq."], "year": ["2016"], "volume": ["216"], "fpage": ["615"], "lpage": ["623"], "pub-id": ["10.1016/j.molliq.2016.01.059"]}, {"label": ["32."], "surname": ["Haik", "Pai", "Chen", "Shyy", "Narayanan"], "given-names": ["Y", "V", "CJ", "W", "R"], "article-title": ["Biomagnetic fluid dynamics"], "source": ["Fluid Dynamics at Interfaces"], "year": ["1999"], "publisher-name": ["Cambridge University Press"], "fpage": ["439"], "lpage": ["452"]}, {"label": ["33."], "surname": ["Akbar", "Sohail"], "given-names": ["S", "M"], "article-title": ["Three dimensional MHD viscous flow under the influence of thermal radiation and viscous dissipation"], "source": ["Int. J. Emerg. Multidiscip. Math."], "year": ["2022"], "volume": ["1"], "issue": ["3"], "fpage": ["106"], "lpage": ["117"]}, {"label": ["34."], "surname": ["Tang", "Rooman", "Shah", "Khan", "Vrinceanu", "Alshehri", "Racheriu"], "given-names": ["TQ", "M", "Z", "S", "N", "A", "M"], "article-title": ["Numerical study of magnetized Powell\u2013Eyring hybrid nanomaterial flow with variable heat transfer in the presence of artificial bacteria: Applications for tumor removal and cancer cell destruction"], "source": ["Front. Mater."], "year": ["2023"], "volume": ["10"], "fpage": ["1144854"], "pub-id": ["10.3389/fmats.2023.1144854"]}, {"label": ["36."], "surname": ["Szymanski", "Fraczek", "Markowicz", "Mikiciuk-Olasik"], "given-names": ["P", "T", "M", "E"], "article-title": ["Development of copper-based drugs"], "source": ["Radiopharm. Med. Mater."], "year": ["2012"], "volume": ["25"], "issue": ["6"], "fpage": ["1089"], "lpage": ["1112"]}, {"label": ["37."], "surname": ["Abdessalem", "Salah"], "given-names": ["KB", "RB"], "article-title": ["Diagnosis of arterial thrombosis and stenosis in blood vessels using bioimpedance analysis"], "source": ["Int. Res. J. Eng. Technol."], "year": ["2015"], "volume": ["2"], "fpage": ["316"], "lpage": ["321"]}, {"label": ["38."], "mixed-citation": ["Dar, M. N. R. & Hussain, A. Computational analysis of an incompressible blood flow in bifurcated arteries. In "], "italic": ["Waves in Random and Complex Media"]}, {"label": ["39."], "surname": ["Hussain", "Dar", "Cheema", "Tag-eldin", "Kanwal"], "given-names": ["A", "MNR", "WK", "EM", "R"], "article-title": ["Numerical simulation of unsteady generic Newtonian blood flow and heat transfer through discrepant shaped dilatable arterial stenosis"], "source": ["Results Eng."], "year": ["2023"], "volume": ["18"], "fpage": ["101189"], "pub-id": ["10.1016/j.rineng.2023.101189"]}, {"label": ["40."], "surname": ["Hussain", "Sarwar", "Rehman", "Akbar", "Gamaoun", "Coban"], "given-names": ["A", "L", "A", "S", "F", "HH"], "article-title": ["Heat transfer analysis and effects of (silver and gold) nanoparticles on blood flow inside arterial stenosis"], "source": ["Appl. Sci."], "year": ["2022"], "volume": ["12"], "issue": ["3"], "fpage": ["1601"], "pub-id": ["10.3390/app12031601"]}, {"label": ["41."], "surname": ["Nasrin", "Hossain", "Zahan"], "given-names": ["R", "A", "I"], "article-title": ["Blood flow analysis inside a stenotic artery using Power-Law fluid model"], "source": ["RDMS"], "year": ["2020"], "volume": ["13"], "fpage": ["1"], "lpage": ["10"], "pub-id": ["10.31031/RDMS.2020.13.000803"]}]
{ "acronym": [], "definition": [] }
41
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1170
oa_package/ea/4e/PMC10786854.tar.gz
PMC10786855
38216698
[ "<title>Introduction</title>", "<p id=\"Par2\">Facilitating healthy aging has become a major goal in medical research, as both life expectancy and incidence of age-related disease increases<sup>##REF##26331998##1##</sup>. Although it has been pointed out that there exists an ongoing nonconcensus on defining what “biological aging” is<sup>##REF##32693105##2##</sup>, the concept of biological age can be found in literature dating back several decades<sup>##REF##26331998##1##</sup>. Considerable effort has been made in order to define and quantify biological age and a huge number of biomarkers that correlate with age have been elucidated and combined into various quantitative measures of biological age or so-called “aging clocks”<sup>##UREF##0##3##,##REF##28396265##4##</sup> and the related “frailty indexes”<sup>##REF##28847723##5##–##REF##28255823##7##</sup>. However the concept of biological age lacks a precise and generally accepted definition<sup>##REF##26331998##1##,##REF##16318865##8##,##REF##32949595##9##</sup>.</p>", "<p id=\"Par3\">Several authors have pointed out the need for understanding the system as a whole rather than focusing on individual molecular or cellular factors<sup>##REF##26331998##1##,##REF##37117782##10##</sup>. More general features and underlying mechanisms of aging may be discovered by adopting a complex systems approach and shifting the perspective to studying the joint influence of several interacting subsystems. Elucidating hierarchical structures and patterns of interactions between subsystems may reveal how underlying mechanisms of aging emerge on larger scales. Here we focus on one of the most well-known emergent demographic mortality patterns, namely the Gompertz Law<sup>##UREF##2##11##–##REF##9074828##13##</sup>, stating that adult mortality rates increase exponentially with age:</p>", "<p id=\"Par4\">Here is the mortality rate, also known as the “force of mortality”, “failure rate” or “hazard rate”<sup>##UREF##3##12##,##UREF##4##14##,##UREF##5##15##</sup> and <italic>t</italic> equals chronological age, i.e., time since birth. The Gompertz Law has two parameters: is the hypothetical mortality rate at birth, and <italic>b</italic> is the “Gompertz coefficient”<sup>##REF##13835176##16##</sup> that determines the rate of increase of the exponential term. Apart from its application to mortality rate, the Gompertz Law is also able to describe patterns in disease incidence rates, as the risk of many diseases have been observed to increase exponentially with age with the same doubling time as risk of death<sup>##REF##30458244##17##–##REF##7639811##21##</sup>. The Gompertz Law is also observed in failure rates of computer code<sup>##UREF##6##22##</sup> and in more abstract measures such as termination rates of self-avoiding random walks in a random network<sup>##UREF##7##23##</sup>. A key facet of Gompertzian mortality is that it is universal and is used to describe the main temporal mortality-pattern observed in many different species, with only few exceptions<sup>##UREF##3##12##,##REF##24317695##24##–##REF##9599158##26##</sup>. This universality indicates that all such species may share a common age-related dynamical trait, accounting for the pace of increasing mortality rate with age. Identifying a mechanism that drives the emergence of Gompertzian mortality would be of great value in order to understand the driving forces behind mortality, shared by all species displaying Gompertzian mortality patterns, and in order to understand the aging process itself<sup>##REF##37117782##10##,##REF##11742523##25##,##UREF##8##27##</sup>. Understanding why the mortality rate increases with age may also give insight into the field of biological age research and the possibility of inter-individual heterogeneity in the pace of aging.</p>", "<p id=\"Par5\">Previous research has focused on mechanistic (kinetic) models that result in the emergence of Gompertzian mortality patterns, either by mimicking concrete biological processes, or through more abstract models related to reliability theory (general theory of system failure). Some of these models incorporate an explicit exponential parametric shape but do not show how this time-dependence emerges<sup>##UREF##5##15##,##REF##13835176##16##,##REF##21262255##28##</sup>. Other models have been shown to produce Gompertzian mortality, without assuming an explicit exponential parametric shape—i.e., the exponential increase in mortality rates emerges naturally from the model structure and the architecture of dynamic interactions between model variables<sup>##REF##28847723##5##,##UREF##4##14##,##REF##33559235##19##,##UREF##7##23##,##REF##11742523##25##,##REF##31792199##29##,##UREF##9##30##</sup>. A commonality in these models is an underlying stochastic process describing either the accumulation or depletion of a physical entity. The model introduced by Alon et. al. focuses on a specific biological component, namely senescent cells<sup>##REF##33559235##19##,##REF##31792199##29##</sup>, and describes how the amount of senescent cells may increase with age due to saturation of repair mechanisms. In this model death occurs, when the density of senescent cells reaches a predefined fatal threshold. Other models describe abstract entities such as “frailty” or “vitality”, and the stochastic process may therefore be interpreted as, e.g., accumulation of damage or depletion of capacity (also termed <italic>resilience</italic> or <italic>redundancy</italic>). An early approach introduced by Beard<sup>##UREF##4##14##</sup>, named these models “forward” and “backward” models respectively, and wrote: “<italic>In the forward model hits are assumed to accumulate and death to occur when the total reaches a certain figure. In the backward model the individual is assumed to start with a quota of units which are progressively lost in time, death occurring when the total remaining falls below a certain figure</italic>”<sup>##UREF##4##14##</sup>. It is difficult to assert whether these models mimic a sufficiently generalizable system, because the modeled entity tends to be very abstract and without biological justification or a link to biological mechanisms and processes. Furthermore, both the abstract models and the more specific model by Alon et. al. assume that death occurs once the stochastic process reaches a predefined fatal threshold (or “figure” in the parlance of Beard<sup>##UREF##4##14##</sup>). The need for such a threshold seems undesirable as it is somewhat arbitrary and additionally conflicts with the notion that death may occur due to many different reasons. One related model to what we propose was introduced by Gavrilov and Gavrilova in 2001<sup>##REF##11742523##25##</sup> where mortality rates are modelled via <italic>redundancy exhaustion</italic> in a system exposed to random initial flaws. In this model the organisms are represented by a number of irreplaceable “blocks” and each block comprises a certain number of redundant elements. The elements fail individually through a stochastic process, but since the elements in the same block represent redundancy, the entire organism only dies when an entire block is failed. The authors show that this model system produces Gompertzian mortality patterns, if the blocks are subject to random initial failures, which is equivalent to assuming a certain distribution of block sizes. This model successfully describes death as the outcome of one of many different fatal states (each “block” represents one cause of death), and shows how Gompertzian mortality may emerge from a model consisting of non-aging elements, as the failure rate of individual elements is constant. However, recent advances within the field now referred to as “Network Medicine” has underlined the notion that both pathology and mortality is rarely the consequence of a single exposure, but instead the result of biological processes that interact in a complex network of inter-dependencies (see, e.g. Barabási et. al. 2011 and references therein<sup>##REF##21164525##31##</sup>). The strictly block compartmentalised structure of the model by Gavrilov and Gavrilova can be argued to disagree with the complex interconnected architecture of biological systems<sup>##UREF##10##32##</sup>, as the blocks are completely independent with no inter-connections and no overlap. Another relevant model that does use a network approach is proposed by Rutenberg et. al.<sup>##REF##28847723##5##–##REF##28255823##7##</sup>. Here, each node in a scale-free network represents a “health attribute”, which is subject to damage. Random damage initialising in peripheral nodes with low connectivity can therefore spread through nodes of higher connectivity, resulting in a situation where damage promotes more damage<sup>##UREF##1##6##</sup>. This model is also able to produce Gompertzian mortality patterns, when death is modelled as the event where the two top most connected nodes are damaged<sup>##REF##28847723##5##</sup>. While the structure and implications of this model are relevant, the representation of death (top two nodes in combination) seems somewhat abstract.</p>", "<p id=\"Par6\">Here, we adopt a complex systems approach and show how the Gompertz law emerges naturally from an extremely simple stochastic system. The proposed model is highly related to several of the above mentioned models, but our model is distinguished by its parsimony and incorporation of both inter-dependencies and broad range of causes of death. Our goal is to provide a general theoretical explanation for the emergence of Gompertzian mortality using a minimal set of highly plausible assumptions. We represent an individual as a collection of <italic>subsystems</italic>, which can fail and can trigger subsequent failures (Fig. ##FIG##0##1##). Our model describes the probability that an organism (or system) will enter one of many fatal states, agreeing with the notion that organisms may die due to many different causes. Each fatal state is described as a combination of subsystem failures and the living organism is modelled as an ensemble of <italic>many</italic> subsystems. We do not specify exactly what these individual subsystems are, and it is likely they could be defined on multiple levels. At any time there is an instantaneous probability (risk) that any subsystem will cease to function correctly and thereby fail. For simplicity we focus first on the special case where subsystem function/failure is modeled as a binary irreversible state, but we also show that the model can easily be expanded to include a repair mechanism.</p>", "<p id=\"Par7\">While our model is constructed using typical methodology from systems biology and statistical physics, it can very easily be related to the widely used epidemiological <italic>Sufficient-Component Cause Model</italic> by Rothman<sup>##UREF##11##33##</sup>. Failure of an individual subsystem is equal to one <italic>component cause</italic>. Each fatal state—i.e., fatal combination of subsystem failures—corresponds to a <italic>sufficient cause</italic>. Our model describes how the number of subsystem failures within an organism increases with time and how this in turn leads to an increased probability (risk) for the organism to die. The mortality rate for a population is then given by the average risk of death at any point in time. We show that our simple conceptual model is able to describe Gompertzian mortality patterns emerging from the following five assumptions:</p>", "<p id=\"Par8\">Taken together we term this model a “<italic>Multiple and Inter-dependent Component Cause model</italic>” (MICC). As the model is intended to minimize the number of assumptions, while still producing an explanation for the Gompertz Law, the five points in the above list presents a somewhat simplified representation of real biological organisms. The model is equivalent to a fully connected network in which each node is one subsystem and all edges (links) have equal strength. This is a simplification of real biological organisms, which contain detailed and highly organised but also interconnected structures—examples of larger structures could be, e.g., the cardiovascular system, the immune system, the different organs etc. The model can easily be expanded to include an explicit network structure such as scale-free or modular—both of which have been observed in real biological systems<sup>##UREF##10##32##</sup>—but here we choose to model the organism as a fully connected network with equal edge strengths in order to show that the explicit network structure is not required for the emergence of Gompertzian mortality. As we do not define the individual subsystems explicitly, the assumption that subsystems are inter-dependent (point 2 in the above list) also becomes a simplified representation of the true detailed structure found in real biological organisms. The assumption that failure of subsystems increase the failure-risk of other subsystems is supported by the fact that many diseases (i.e., certain combinations subsystem failures) are also risk factors for other diseases (i.e., further subsystem failures), leading to increased comorbidity<sup>##UREF##12##34##</sup>, and also supported by the studies of “Frailty Indexes”<sup>##UREF##1##6##,##REF##28255823##7##</sup>, showing that an increased number of health deficits (i.e., certain subsystem failures) is generally associated with higher risk of disease outcomes (i.e., further subsystem failures). The assumption that certain combinations of subsystem failures lead to death (point 3 in the above list) is in line with the conceptual model of causation put forward by Rothman in 1976<sup>##REF##998606##35##</sup>, arguing that a <italic>sufficient cause</italic> for an outcome (e.g., death) consists of a combination of <italic>component causes</italic> (here equal to subsystem failures) and that several different combinations may constitute different sufficient causes for the same outcome. While the combinations of subsystem failures that lead to death relate to the “blocks” described in the model by Gavrilov and Gavrilova<sup>##REF##11742523##25##</sup>, the model presented here includes possible overlap between different causes of death as well as correlations and inter-dependencies between the individual subsystems. Additionally, this model describes the entire set of subsystems in an organism and not only the ones that enter in possible fatal combinations. The model therefore also describes the gradual accumulation of failure that happen before death occurs. In our model, not only death, but also diseases may be described as combinations of subsystem failure.</p>", "<p id=\"Par9\">The MICC model results in a logistical growth of the fraction of failed subsystems. This logistical growth exhibits an exponentially increasing mortality rate in the limit where the fraction of failed sub-systems is relatively small. If death of biological organisms occurs at relatively small fractions of subsystem failures (point 5 in the above list), the model thus succeeds in explaining Gompertzian mortality. Dependent on parameters, the model is also able to explain the possible “late life mortality deceleration”<sup>##REF##9599158##26##,##REF##10511720##36##–##REF##8137895##38##</sup>, i.e., deviation from Gompertzian mortality at advanced ages, as the logistic growth of the mortality rate approaches the inflection point and starts to saturate. The model is also able to explain why the incidence of many diseases also increase exponentially with age<sup>##REF##30458244##17##,##REF##30729179##18##</sup>.</p>", "<p id=\"Par10\">The inter-dependency between subsystems is a key assumption in order to gain exponential increase, as this is what drives a self-amplifying process, leading to the accelerated increase in mortality rate. In the terminology of the “<italic>Sufficient-Component Cause Model</italic>”<sup>##UREF##11##33##</sup>, this is equal to stating that every component cause on average will increase the risk of other component causes to occur. The addition of this simple form of interaction between subsystems is sufficient to expand the original “<italic>Sufficient-Component Cause Model</italic>” to explain the emergence of Gompertizian mortality patterns.</p>", "<p id=\"Par11\">The MICC model is very simple, yet comprehensive. Its strength is the complex systems view, describing not a specific biological pathway but the overall system and the interactions between subsystems. The complexity of living organisms is captured by the large number of subsystems in the model and the notion that many (different) combinations of subsystem failure can lead to death.</p>" ]
[]
[ "<title>Results</title>", "<title>Multiple and inter-dependent component cause model in a <italic>mean field</italic> version</title>", "<p id=\"Par12\">We consider an organism consisting of <italic>N</italic> subsystems. Ideally all <italic>N</italic> subsystems are functioning correctly, but at any time there is a risk for each individual subsystem to fail. This risk is given by the probability <italic>p</italic>. At time <italic>t</italic> the number of failed subsystems is given by <italic>F</italic>(<italic>t</italic>), and the number of subsystems that are still functioning correctly is given by <italic>M</italic>(<italic>t</italic>), such that total number of subsystems is conserved, i.e., .</p>", "<p id=\"Par13\">Within a small time-step, , the number of failed subsystems will increase by . The probability (risk) of failure for <italic>each</italic> individual subsystem is given by <italic>p</italic>(<italic>t</italic>) and the number of subsystems that are at risk of failing is given by <italic>M</italic>(<italic>t</italic>).</p>", "<p id=\"Par14\">A constant risk of subsystem failure, , corresponds to the case where all subsystems fail independently at a constant rate <italic>C</italic>. Such a situation will <italic>not</italic> result in Gompertzian mortality (see Supplemental Appendix ##SUPPL##0##A##). Instead we describe a situation where the risk of failure depends on the amount of subsystems that have already failed, i.e., the subsystems are <italic>inter-dependent</italic>: failure in one subsystem increases the risk of failure in other subsystems. On <italic>average</italic> we have , making the individual risk of subsystem failure proportional to <italic>F</italic>(<italic>t</italic>), the number of already failed subsystems. From the above we obtain a differential equation for the average change in <italic>F</italic>(<italic>t</italic>), in the limit of :</p>", "<p id=\"Par15\">The solution to Eq. (##FORMU##10##3##) is a standard logistic growth curve:<italic>F</italic>(<italic>t</italic>) has a sigmoidal shape: starting from the value at time zero, <italic>F</italic>(<italic>t</italic>) increases exponentially at early times. The exponential increase levels off and an inflection point is reached at time, , after which the increase of <italic>F</italic>(<italic>t</italic>) decelerates and finally saturates at a level . See Fig.  ##FIG##1##2##A.</p>", "<title>Mortality rate in a <italic>Mean field</italic> model</title>", "<p id=\"Par16\">According to third assumption defined in the introduction, we assume that certain combinations of failed subsystems lead to the death of the organism, but we do not specify a weighting or the explicit sets of combinations that lead to death. Instead, and according to the fourth assumption, we model the probability of obtaining any such fatal combination as being proportional to the fraction of failed subsystems; <italic>F</italic>(<italic>t</italic>)/<italic>N</italic>. The mortality rate in a population of such organisms will therefore also be proportional to <italic>F</italic>(<italic>t</italic>)/<italic>N</italic>:</p>", "<p id=\"Par17\">For living organisms we find it a plausible assumption that death occurs at relatively small fractions of failed subsystems—as stated in the fifth assumption. In this limit <italic>F</italic>(<italic>t</italic>) grows exponentially with time and times are small compared to the time of inflection ().</p>", "<p id=\"Par18\">In this limit we therefore obtain the Gompertzian mortality ratewhere . See Fig. ##FIG##1##2##B.</p>", "<p id=\"Par19\">An additional requirement for the model to fit empirical data is that the exponential range () is a good approximation for the entire age range that displays Gompertzian mortality, i.e., the inflection point of the logistic growth curve, , must be larger than the typical age range (for humans, years, but possibly much larger). Since we have, , the requirement of large is equivalent to requiring very small , i.e., the fraction of failed subsystems at time zero must be very small. The model was fitted to empirical data from the Danish population, using three different choices of (Fig.  ##FIG##1##2##A,B). The corresponding survival function and distribution of total life-span (using one specific choice of model parameters) is plotted in Fig. ##FIG##1##2##C,D, together with statistical data for all deaths occurring in Denmark in the period 1990–2019 (pooled data).</p>", "<p id=\"Par20\">The five assumptions set up in the Introduction therefore leads to a Gompertzian mortality pattern, i.e., exponential increase of the mortality rate with age. The model also has the potential of explaining why the mortality rate deviates from the exponential increase at later times (deceleration at very old age), as the logistic growth curve starts to deviate from the exponential at ages approaching —see Fig.  ##FIG##1##2##A,B.</p>", "<title>Multiple and inter-dependent component cause model in a <italic>stochastic</italic> version</title>", "<p id=\"Par21\">While the “Mean Field model” above describes the <italic>average</italic> dynamics of <italic>F</italic>(<italic>t</italic>), a more realistic model would be to model as a stochastic variable, allowing individual organisms to undergo individual trajectories of failure accumulation. For the individual trajectory we denote the number of failed subsystems . The number of non-failed subsystems at time <italic>t</italic> is given by , and the probability, , for <italic>each</italic> of the subsystems to fail within the next small time-step, , is proportional to the number of already failed subsystems; . We performed a Monte Carlo simulation of stochastic subsystem failure and subsequent death, resulting in individual trajectories of , see Fig. ##FIG##2##3##A (displaying 12 individual trajectories) and Fig. ##FIG##2##3##B (displaying 220 individual trajectories).</p>", "<title>Mortality rate in the stochastic model</title>", "<p id=\"Par22\">For the i’th individual organism, we model the probability of obtaining a fatal combination of subsystems failures as proportional to the fraction of failed subsystems, . The risk of death for the i’th individual organism (“individual mortality-risk”) is therefore given by:</p>", "<p id=\"Par23\">Two individuals having equal trajectories will, due to chance, not necessarily die at the exact same time, but they will share the same risk of dying at time <italic>t</italic>. The individual times of death are also computed by Monte Carlo simulation (death events are marked by black dots in Fig.  ##FIG##2##3##A,B). Parameters for the simulation have been chosen to fit empirical mortality data from the Danish population, and initial conditions have been chosen to be equal for all individuals. A histogram of the total life-spans of the 220 individual trajectories shown in Fig. ##FIG##2##3##B is shown in Fig.  ##FIG##1##2##D, and is seen to agree well with the analytical distribution fitted to empirical data.</p>", "<p id=\"Par24\">The individual times of death are subject to a relatively large stochastic element, resulting from the fact that overall mortality rates are small (as determined by the empirical data). As a result, individuals of very similar mortality-risk trajectories may die at very different ages.</p>", "<p id=\"Par25\">The individual mortality-risk trajectories display increasing variance with time, showing that some individuals have faster increasing mortality-risk than others. Below we develop a full stochastic model, describing all possible trajectories and their probability distribution as a function of time.</p>", "<title>Average and variance of individual trajectories</title>", "<p id=\"Par26\">In order to obtain expressions for the average and variance of many individual trajectories, we must consider the full set of all possible trajectories. An organism consisting of <italic>N</italic> subsystems can be described by different states, corresponding to failed subsystems and non-failed subsystems. Note that we only describe the <italic>number</italic> of failed subsystems, but do not discriminate between different combinations of failures, nor do we discriminate between different orders of obtaining the subsystems failures.</p>", "<p id=\"Par27\">We define <italic>P</italic>(<italic>f</italic>, <italic>t</italic>) as the probability of having exactly <italic>f</italic> failed subsystems at time <italic>t</italic>, and derive an expression for the time evolution of <italic>P</italic>(<italic>f</italic>, <italic>t</italic>). The <italic>master equation</italic> for may be expressed in two terms: one term describing the risk of <italic>transitioning</italic> from to <italic>f</italic> failed subsystems, and one term describing the risk of <italic>transitioning</italic> from <italic>f</italic> to failed subsystems. Following the same logic as for the mean field model, the risk of experiencing another subsystem failure within an infinitesimal time-step—and hence make a transition from one state to the next—is proportional to . We therefore have the following expression for the master equation:</p>", "<p id=\"Par28\">An approximate analytical solution to Eq. (##FORMU##70##9##) may be obtained by performing Van Kampen’s system size expansion<sup>##UREF##13##39##</sup> (i.e., the limit of very large <italic>N</italic>) and using Linear Noise Approximation (LNA) to obtain expressions for the average, , and variance, , as functions of time. See Supplemental Appendix ##SUPPL##0##B## for details of the derivation. The approximate solution to Eq. (##FORMU##70##9##) confirms that the average behaves as the mean field model described above; a logistic growth curve, which displays exponential growth for times .</p>", "<p id=\"Par29\">The solution to is therefore equal to the mean field solutions shown in Fig.  ##FIG##1##2##A,B.</p>", "<p id=\"Par30\">The approximate solution to Eq. (##FORMU##70##9##) also provides an analytical expression for the variance . A general solution for is given in Supplemental Appendix ##SUPPL##0##B##. Here we provide the solution for the special case where (zero variance at time ) in the limit :</p>", "<p id=\"Par31\">In Fig.  ##FIG##2##3##C, the analytical solution given by Eq. (##FORMU##81##11##) is plotted together with the variance of 220 individual mortality-risk trajectories computed by Monte Carlo simulation. The results reveal that the variance of individual trajectories increases almost exponentially with age (exponential growth is plotted for comparison), but that the variance grows slower than exponential for more advanced ages. We note that the variance computed from the Monte Carlo simulations corresponds to the variance of 220 trajectories in the case where death events are ignored, such that right censoring of data is avoided.</p>", "<p id=\"Par32\">The individual trajectories shown in Fig.  ##FIG##2##3##A,B indicate that the “fate” of an individual trajectory is largely determined by stochastic events in early life. At more advanced ages trajectories rarely cross. Another way to represent this dependence on events in early age is to display the individual trajectories in terms of a measure of “Biological age”. We relate the individual trajectories of subsystem failure () to a measure of “Biological Age” by projecting the individual values of onto the mean field average, see Fig.  ##FIG##2##3##D. The construction of such a “Biological Age” provides an alternative but equally valid representation of the individual trajectories of mortality risk. The individual trajectories of “Biological Age” are largely determined by stochastic events in early life—at more advanced ages the trajectories become close to linear.</p>", "<title>Full numerical solution reveals stochastic effects</title>", "<p id=\"Par33\">In order to compute the full distribution of <italic>P</italic>(<italic>f</italic>, <italic>t</italic>) for a finite value of the parameter <italic>N</italic>, we derive an expression that may be solved numerically for discrete time. The derivation is given in Supplemental Appendix ##SUPPL##0##C##. Calculation of the full distribution of <italic>P</italic>(<italic>f</italic>, <italic>t</italic>) reveals that the distribution is asymmetric and right-skewed at early times such that the average is slightly higher than the median. The asymmetry becomes more pronounced for smaller values of the parameter <italic>N</italic> (see Supplementary Fig.  ##SUPPL##0##1##A in Supplemental Appendix ##SUPPL##0##C##). As we need to choose a relatively large value for <italic>N</italic> in order to fit the empirical data for human mortality, the asymmetry is not very pronounced in the plots shown in Fig.  ##FIG##2##3##A,B.</p>", "<p id=\"Par34\">The calculations also reveal that the average and median of the stochastic model displays a small time-lag compared to the mean-field model (see Supplementary Fig.  ##SUPPL##0##1##B in Supplemental Appendix ##SUPPL##0##C##). This stochastic effect means that the individual trajectories grow slightly slower than expected from the mean-field model and that the parameter <italic>r</italic> used in the stochastic model should therefore be slightly adjusted in order to fit the empirical data. Exact values for all simulations is given in the figure captions.</p>", "<title>Model alterations: spontaneous failure and repair mechanism</title>", "<p id=\"Par35\">It is possible to alter the model to incorporate a small risk of spontaneous subsystem failure in addition to the inter-dependent subsystem failure. In this case we have , where is small. If is of same order as , then the term proportional to will very quickly start to dominate and the model is still able to produce Gompertzian mortality. However, if is much larger than then the term proportional to will dominate and the increase in will not display Gompertzian mortality, but instead resemble the situation with constant subsystem failure-rate as described in Supplemental Appendix ##SUPPL##0##A##.</p>", "<p id=\"Par36\">Another possible alteration of the model is to incorporate a repair mechanism, making it possible for failed subsystems to reverse back to the non-failed state. If the repair mechanism is spontaneous, and given by the rate parameter , then the rate equation for the corresponding mean-field model isThus the resulting model is still able to produce Gompertizan mortality, but the parameter <italic>N</italic>, should be substituted by .</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par37\">Within the broad field of aging research there exists an ongoing nonconsensus regarding the definition of the aging process itself<sup>##REF##32693105##2##</sup>. Many researchers have attempted to set up defining paradigms, uncover molecular biomarkers and pathways, and construct mathematical models, all aiming to capture the essential aging process and possibly to quantify it<sup>##REF##26331998##1##,##REF##28396265##4##,##REF##28847723##5##,##REF##23746838##40##–##REF##27138087##42##</sup>. It has recently been argued that we may enrich our general understanding of aging by shifting focus towards interactions occurring on multiple hierarchical scales ranging from molecular to clinical<sup>##REF##26331998##1##,##REF##32949595##9##,##REF##37117782##10##</sup>, as opposed to focusing solely on cellular and molecular scales. Although all biology is ultimately dependent on interacting molecules, many functionalities only emerge on larger scales, where several molecules, cells, tissues and organs interact in self-organising synergy. Functionalities that emerge on larger scales are not easily understood through a focus on individual molecular interactions but necessitate a shift in perspective towards a more coarse grained understanding of phenomenological mechanisms. Here we define simple laws (assumptions) that explain the overall mortality pattern termed Gompertzian mortality. As an analogy consider the planetary movements, which were described by Kepler’s Laws of planetary motion in the early 1600s, and later even better understood by Newton’s Laws of motion. Both Kepler’s and Newton’s Laws ignores many details—e.g., detailed appearance and material composition of the different planets—and aims to set up simple laws that explain the overall movement in sufficient detail.</p>", "<p id=\"Par38\">Building on modern epidemiological theory<sup>##UREF##11##33##</sup>, viewing mortality as a “<italic>sufficient cause</italic>” comprised of its variable “<italic>component causes</italic>”, we propose that the process of aging can be described as the accumulation of inter-dependent subsystem failures. We show the model is able to explain the emergence of Gompertzian mortality with only five simple assumptions, which seems both reasonable and sufficiently general to be applicable to many different species. These assumptions have the advantage that they do not relate to specific cellular or molecular pathways. A key assumption driving the accelerated increase in mortality risk is the inter-dependency between subsystems and the second assumption of the model stating that—on average—failure of one subsystem leads to an increased risk of failure within other subsystems. Inter-dependencies between subsystems agree extremely well with empirical data, wherein significant increases in hazard rates are observed for outcomes related to numerous relevant exposures.</p>", "<p id=\"Par39\">The MICC model serves to explain overall driving mechanisms of aging, and allows for different aging trajectories to be contained within this framework. While Rothman’s <italic>Sufficient-Component Cause Model</italic><sup>##UREF##11##33##</sup> is deterministic in its set-up, the MICC model adds stochasticity in terms of the individual trajectories of subsystem failures.</p>", "<p id=\"Par40\">The model is extendable to outcomes other than death. Age-related diseases may also be described as endpoints that are attained by different combinations of subsystem failures. Hence the model also explains why complex, non-communicable diseases display incidence rates that increase exponentially with age<sup>##REF##30458244##17##,##REF##30729179##18##</sup>. The detailed structure of different aging trajectories, possibly involving disease manifestation, are structures that share similar overall kinetics of aging, but relate to different combinations of subsystem failures all of which contribute to mortality risk. A possible extension of our proposed model is to assume that not all subsystems are equally dependent and that there may exist clusters of highly inter-dependent subsystems with a correlation structure. The model introduced in this paper represents the basic case of a fully connected and uniformly weighted network. The network structure of our model could easily be extended to include a modular structure or a scale-free structure as proposed by Rutenberg et al.<sup>##REF##28847723##5##</sup>. Both network models would be highly relevant: scale-free networks are found in many natural systems<sup>##UREF##10##32##</sup> and modular networks are also found in many biological systems<sup>##REF##16174729##43##</sup>—organs are simple examples of a highly modular structure. In Fig. ##FIG##3##4##, we visually show a simple example of how one could incorporate a highly modular structure by compartmentalising the many subsystems into <italic>clusters</italic> of highly connected subsystems. In this example, one cluster represents the cardiovascular system, another cluster represents the respiratory system and so forth. It would then be straightforward to assume that subsystems <italic>within</italic> the same cluster would be highly inter-dependent (failure of one subsystem would considerably increase the risk of failure for fellow subsystems), while subsystems from <italic>different</italic> clusters might not be very inter-dependent or not inter-dependent at all (failure of a subsystem in one cluster would not increase the risk of subsystems in other clusters). However, we would then expect that certain subsystems would serve as connections between different clusters and therefore—on average—any subsystem failure could eventually increase the risk for other subsystem failures. We hypothesize that the subsystems (network-nodes) that act as connectors between clusters (network modules) would be prime targets for intervention in order to reduce the pace of damage accumulation.</p>", "<p id=\"Par41\">The detailed network structure of inter-dependencies described above and represented by Fig. ##FIG##3##4## would lead to clusters in individual failure trajectories. Such clusters of failure trajectories could represent different diseases and individual trajectories that fall within these clusters would represent persons that have the same disease although slightly different manifestations of it. Recent studies confirm the presence of a multiorgan aging network, in which the biological age of organs selectively influences the aging of other organ systems<sup>##REF##37468667##44##</sup>. The uncovering of this network structure is of the essence in order to understand how living systems function. Future work could extend the MICC framework to explore how interventions designed to prevent failure will affect the overall aging of the organism and possibly modulate aging trajectories. Deeper understanding of such structures would be valuable for understanding the progression of specific aging phenotypes as well as for elucidating possible targets for intervention in order to prolong health-span through counteracting disease progression.</p>", "<p id=\"Par42\">As we have shown here, a detailed network structure is not necessary for explaining the emergence of Gompertzian mortality. The MICC model is able to robustly produce Gompertzian mortality patterns as long as the number of subsystems is large enough to allow for the exponential range to span an appropriate age range—for the case of human mortality the age range is of the order of 100 years. By fitting the model to empirical data for human mortality we arrive at values of <italic>N</italic> (system size) of order (see Fig.  ##FIG##1##2##A and caption). The robust emergence of Gompertzian mortality patterns agrees well with the empirical observations across many species. The MICC model implies that Gompertzian mortality patterns will emerge in large systems consisting of inter-dependent subsystems—this would include many (if not all) biological species, and is also able to explain why the Gompertz Law also holds for complex computer code.</p>", "<title>Ethical approval</title>", "<p id=\"Par43\">Human participants are only passively involved through national register data, which does not require approval from ethics committee. Approval to use register data was granted by Statistics Denmark and the Danish Health Data Authority.</p>", "<title>Patient and public involvement</title>", "<p id=\"Par44\">Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.</p>" ]
[]
[ "<p id=\"Par1\">Understanding and facilitating healthy aging has become a major goal in medical research and it is becoming increasingly acknowledged that there is a need for understanding the aging phenotype as a whole rather than focusing on individual factors. Here, we provide a universal explanation for the emergence of Gompertzian mortality patterns using a systems approach to describe aging in complex organisms that consist of many inter-dependent subsystems. Our model relates to the Sufficient-Component Cause Model, widely used within the field of epidemiology, and we show that including inter-dependencies between subsystems and modeling the temporal evolution of subsystem failure results in Gompertizan mortality on the population level. Our model also provides temporal trajectories of mortality-risk for the individual. These results may give insight into understanding how biological age evolves stochastically within the individual, and how this in turn leads to a natural heterogeneity of biological age in a population.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51669-5.</p>", "<title>Acknowledgements</title>", "<p>We wish to thank professor Rudi J. Westendorp for interesting discussions and perspectives, and for supporting the development of the model at early stages. We also thank Héléne Toinét Cronjé and Rebecca Bolt Ettlinger for critically revising the manuscript and giving valuable feedback.</p>", "<title>Author contributions</title>", "<p>P.Y.N. developed the model, performed all simulations, and wrote the original draft. N.M. performed the mathematical analysis providing the approximate analytical solution to the stochastic system. P.Y.N., M.K.J., N.M. and S.B. contributed to the writing of the manuscript. All authors have critically revised and approved the final version.</p>", "<title>Funding</title>", "<p>The study was funded by the Novo Nordisk Challenge Programme [NNF17OC0027812]. S.B. acknowledges funding from the MRC Centre for Global Infectious Disease Analysis (reference MR/X020258/1), funded by the UK Medical Research Council (MRC). This UK funded award is carried out in the frame of the Global Health EDCTP3 Joint Undertaking. S.B. acknowledges support from the National Institute for Health and Care Research (NIHR) via the Health Protection Research Unit in Modelling and Health Economics, which is a partnership between the UK Health Security Agency (UKHSA), Imperial College London, and the London School of Hygiene &amp;; Tropical Medicine (grant code NIHR200908). (The views expressed are those of the authors and not necessarily those of the UK Department of Health and Social Care, NIHR, or UKHSA.). S.B. acknowledges support from the Novo Nordisk Foundation via The Novo Nordisk Young Investigator Award (NNF20OC0059309). S.B. acknowledges the Danish National Research Foundation (DNRF160) through the chair grant. S.B. acknowledges support from The Eric and Wendy Schmidt Fund For Strategic Innovation via the Schmidt Polymath Award (G-22-63345).</p>", "<title>Data availibility</title>", "<p>The life-span data for the Danish population 1990–2019 (see Fig. ##FIG##1##2##C,D) is available in a supplementary file included in this publication. The simulated data for trajectories of mortality-risk (see Fig.  ##FIG##2##3##) are available from the corresponding author on reasonable request.</p>", "<title>Competing interests</title>", "<p id=\"Par45\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Accumulation of subsystem failures increase with time. An organism is schematically displayed as a system with many subsystems (individual squares). Individual subsystems may “fail” (indicated by black squares) and therefore the overall system will accumulate failed subsystems over time (number of black subsystems increases with age). Certain combinations of failed subsystems will cause death. Other combinations of failed subsystems may result in certain disease.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Gompertzian mortality emerges from logistic growth of subsystem failures. (<bold>A</bold>) Risk of death—equal to mortality rate on population scale—as a function of age. The blue line shows classical Gompertzian mortality (exponential increase of mortality rate with age). The three black lines show the mortality rate as predicted by the MICC model for three different choices of (full line: , dashed-dotted line: , dashed line: ). The inset marked with a red boarder corresponds to the age range which is relevant for human life-span. Within this age range the mortality rate increases approximately exponentially with age. The age range for which the exponential approximation is valid increases with decreasing values of . Parameters used for the mean field model are: per year, per year, , and . (<bold>B</bold>) Zoom of the relevant age-range, shown in both linear and logarithmic scale. (<bold>C</bold>,<bold>D</bold>) The survival function (<bold>C</bold>) and life-span distribution (<bold>D</bold>) corresponding to an approximately exponential mortality rate is displayed overlayed with empirical data from the Danish population—the data consists of all deaths occurring in the Danish population in the time period 1990–2019. The theoretical survival function and life-span distribution correspond to the parameter choice of .</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Individual trajectories of mortality-risk and biological age. (<bold>A</bold>) 12 individual trajectories of mortality risk as computed by Monte Carlo simulation. The insert displays trajectories at early ages, for which the stochastic nature of the trajectories is more clear. Black dots indicate death-events. Parameters used for the model are: , , per year, per year, and is used in order to correct for the fact that the stochastic model lags slightly compared to the mean field model (see main text and Supplemental Appendix ##SUPPL##0##C##). (<bold>B</bold>) 220 individual trajectories of mortality risk are displayed together with the median (black line). Black dots indicate death-events. The corresponding distribution of total life-span (age at death) in shown in Fig. ##FIG##1##2##D. (<bold>C</bold>) Standard deviation (shown in grey dots) of the 220 individual trajectories shown in panel B. The black line corresponds to the approximate solution for standard deviation given by the square root of equation (##FORMU##81##11##). We see that the approximate solution agrees extremely well with the simulated data. The standard deviation increases almost exponentially (an exponential curve is displayed by the blue dashed line for comparison). (<bold>D</bold>) Individual trajectories of “Biological age” corresponding to the 220 individual trajectories shown in panel (<bold>B</bold>). The colored trajectories correspond to the trajectories shown in panel (<bold>A</bold>). Black dots indicate death-events. Here “Biological Age” is defined as the age obtained by projection of individual values of onto the average . From this plot it is clear that the timing of stochastic events at early age have large impact on the individual trajectory.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Clustering of subsystems within the complex organism. A possible extension of the model would be to attribute each subsystem to certain compartments or <italic>clusters</italic> (indicated by different colors) of highly connected subsystems that relate to higher order of organizational functionalities, e.g. one cluster represents the cardiovascular system, another cluster represents the respiratory system and so forth.</p></caption></fig>" ]
[ "<table-wrap id=\"Taba\"><table frame=\"hsides\" rules=\"groups\"><tbody><tr><td align=\"left\" colspan=\"2\">1. Organisms consist of multiple subsystems, and all subsystems are at risk of failure</td></tr><tr><td align=\"left\" colspan=\"2\">2. Subsystems are <italic>inter-dependent</italic> and failure of one subsystem will <italic>on average</italic> increase the failure-risk of other subsystems</td></tr><tr><td align=\"left\" colspan=\"2\">3. Certain combinations of subsystem failures cause death of the entire organism. There may be <italic>many</italic> different combinations of subsystem failures that lead to death—reflecting different causes of death</td></tr><tr><td align=\"left\" colspan=\"2\">4. The probability of obtaining a fatal combination of subsystem failures is proportional to the fraction of failed subsystems within the organism</td></tr><tr><td align=\"left\" colspan=\"2\">5. Death occurs at fractions of failed subsystems which are relatively small</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tabb\"><table frame=\"hsides\" rules=\"groups\"><tbody><tr><td align=\"left\"><italic>N</italic>:</td><td align=\"left\">Total number of subsystems in one organism</td></tr><tr><td align=\"left\"><italic>F</italic>(<italic>t</italic>):</td><td align=\"left\">The number of failed subsystems at time t, </td></tr><tr><td align=\"left\"><italic>M</italic>(<italic>t</italic>):</td><td align=\"left\">The number of subsystems which are functioning correctly at time t, </td></tr><tr><td align=\"left\">:</td><td align=\"left\">inflection point , such that </td></tr><tr><td align=\"left\">:</td><td align=\"left\"><p>mortality rate, </p><p>In the limit of small fractions of failed subsystems (small <italic>F</italic>(<italic>t</italic>)/<italic>N</italic>): </p><p>where </p></td></tr></tbody></table></table-wrap>" ]
[ "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\begin{aligned} \\mu (t)&amp;= R_0 e^{b t} \\end{aligned} \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M2\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">bt</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu (t)$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mrow><mml:mi>μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_0$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F(t) + M(t) = N$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>+</mml:mo><mml:mi>M</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>=</mml:mo><mml:mi>N</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta t$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta F = F(t+\\Delta t) - F(t)$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>F</mml:mi><mml:mo>=</mml:mo><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>-</mml:mo><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\Delta F&amp;= p(t) \\cdot M(t) = p(t) \\cdot \\left( N - F(t) \\right) \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M14\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mo>=</mml:mo><mml:mi>p</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>·</mml:mo><mml:mi>M</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>p</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>·</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p(t) = C \\cdot \\Delta t$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mrow><mml:mi>p</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>=</mml:mo><mml:mi>C</mml:mi><mml:mo>·</mml:mo><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p(t) = r \\cdot F(t) \\cdot \\Delta t$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:mrow><mml:mi>p</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>=</mml:mo><mml:mi>r</mml:mi><mml:mo>·</mml:mo><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>·</mml:mo><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta t \\rightarrow 0$$\\end{document}</tex-math><mml:math id=\"M20\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\frac{d F(t)}{d t} = \\lim _{\\Delta t \\rightarrow 0} \\frac{\\Delta F}{\\Delta t}&amp;= r \\cdot F(t) \\left( N - F(t) \\right) \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M22\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:munder><mml:mo movablelimits=\"true\">lim</mml:mo><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:munder><mml:mfrac><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mo>=</mml:mo><mml:mi>r</mml:mi><mml:mo>·</mml:mo><mml:mi>F</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ4\"><label>4</label><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} F(t)&amp;= \\frac{N \\cdot F_0}{F_0 + (N-F_0) e^{- r N t}} \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M24\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>N</mml:mi><mml:mo>·</mml:mo><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>r</mml:mi><mml:mi>N</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M25\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F_0$$\\end{document}</tex-math><mml:math id=\"M26\"><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M27\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t = \\tau$$\\end{document}</tex-math><mml:math id=\"M28\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M29\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F(t) = N$$\\end{document}</tex-math><mml:math id=\"M30\"><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>=</mml:mo><mml:mi>N</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq12\"><alternatives><tex-math id=\"M31\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F_0/N$$\\end{document}</tex-math><mml:math id=\"M32\"><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>N</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq13\"><alternatives><tex-math id=\"M33\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F_0/N = 1 \\times 10^{-6}$$\\end{document}</tex-math><mml:math id=\"M34\"><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq14\"><alternatives><tex-math id=\"M35\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F_0/N = 1 \\times 10^{-5}$$\\end{document}</tex-math><mml:math id=\"M36\"><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq15\"><alternatives><tex-math id=\"M37\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F_0/N = 2 \\times 10^{-5}$$\\end{document}</tex-math><mml:math id=\"M38\"><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq16\"><alternatives><tex-math id=\"M39\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F_0/N$$\\end{document}</tex-math><mml:math id=\"M40\"><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>N</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq17\"><alternatives><tex-math id=\"M41\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$b = 9.24 \\times 10^{-3}$$\\end{document}</tex-math><mml:math id=\"M42\"><mml:mrow><mml:mi>b</mml:mi><mml:mo>=</mml:mo><mml:mn>9.24</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq18\"><alternatives><tex-math id=\"M43\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_0 = 4.2 \\times 10^{-5}$$\\end{document}</tex-math><mml:math id=\"M44\"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>4.2</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq19\"><alternatives><tex-math id=\"M45\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$N = 10^{6}$$\\end{document}</tex-math><mml:math id=\"M46\"><mml:mrow><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mn>6</mml:mn></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq20\"><alternatives><tex-math id=\"M47\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$rN = b$$\\end{document}</tex-math><mml:math id=\"M48\"><mml:mrow><mml:mi>r</mml:mi><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:mi>b</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq21\"><alternatives><tex-math id=\"M49\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F_0/N = 1 \\times 10^{-5}$$\\end{document}</tex-math><mml:math id=\"M50\"><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ5\"><label>5</label><alternatives><tex-math id=\"M51\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\mu (t)&amp;\\propto \\frac{F(t)}{N} = \\frac{F_0}{F_0 + (N-F_0) e^{- r N t}} \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M52\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mo>∝</mml:mo><mml:mfrac><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>N</mml:mi></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>r</mml:mi><mml:mi>N</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq22\"><alternatives><tex-math id=\"M53\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t&lt;&lt;\\tau$$\\end{document}</tex-math><mml:math id=\"M54\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>&lt;</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ6\"><label>6</label><alternatives><tex-math id=\"M55\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} F(t)&amp;\\approx F_0 e^{rNt} \\hspace{1cm }\\text {for} \\hspace{.5cm } t&lt;&lt; \\tau \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M56\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mo>≈</mml:mo><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">rNt</mml:mi></mml:mrow></mml:msup><mml:mspace width=\"28.45274pt\"/><mml:mtext>for</mml:mtext><mml:mspace width=\"14.22636pt\"/><mml:mi>t</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>&lt;</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ7\"><label>7</label><alternatives><tex-math id=\"M57\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\begin{aligned} \\mu (t)&amp;\\approx R_0 e^{b t} \\end{aligned} \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M58\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mo>≈</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">bt</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq23\"><alternatives><tex-math id=\"M59\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$b = r N$$\\end{document}</tex-math><mml:math id=\"M60\"><mml:mrow><mml:mi>b</mml:mi><mml:mo>=</mml:mo><mml:mi>r</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq24\"><alternatives><tex-math id=\"M61\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t&lt;&lt;\\tau$$\\end{document}</tex-math><mml:math id=\"M62\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>&lt;</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq25\"><alternatives><tex-math id=\"M63\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau$$\\end{document}</tex-math><mml:math id=\"M64\"><mml:mi>τ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq26\"><alternatives><tex-math id=\"M65\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau &gt; \\sim 100$$\\end{document}</tex-math><mml:math id=\"M66\"><mml:mrow><mml:mi>τ</mml:mi><mml:mo>&gt;</mml:mo><mml:mo>∼</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq27\"><alternatives><tex-math id=\"M67\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau = 1/b \\cdot \\ln (N/F_0 - 1)$$\\end{document}</tex-math><mml:math id=\"M68\"><mml:mrow><mml:mi>τ</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>b</mml:mi><mml:mo>·</mml:mo><mml:mo>ln</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq28\"><alternatives><tex-math id=\"M69\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau$$\\end{document}</tex-math><mml:math id=\"M70\"><mml:mi>τ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq29\"><alternatives><tex-math id=\"M71\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F_0/N$$\\end{document}</tex-math><mml:math id=\"M72\"><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>N</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq30\"><alternatives><tex-math id=\"M73\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau$$\\end{document}</tex-math><mml:math id=\"M74\"><mml:mi>τ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq31\"><alternatives><tex-math id=\"M75\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau$$\\end{document}</tex-math><mml:math id=\"M76\"><mml:mi>τ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq32\"><alternatives><tex-math id=\"M77\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F(t) = \\frac{N \\cdot F_0}{F_0 + (N-F_0) e^{- r N t}}$$\\end{document}</tex-math><mml:math id=\"M78\"><mml:mrow><mml:mi>F</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>N</mml:mi><mml:mo>·</mml:mo><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>r</mml:mi><mml:mi>N</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq33\"><alternatives><tex-math id=\"M79\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$M(t) = N - F(t)$$\\end{document}</tex-math><mml:math id=\"M80\"><mml:mrow><mml:mi>M</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>=</mml:mo><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq34\"><alternatives><tex-math id=\"M81\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau$$\\end{document}</tex-math><mml:math id=\"M82\"><mml:mi>τ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq35\"><alternatives><tex-math id=\"M83\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau = 1/(rN) \\cdot \\ln (N/F_0 - 1)$$\\end{document}</tex-math><mml:math id=\"M84\"><mml:mrow><mml:mi>τ</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>r</mml:mi><mml:mi>N</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>·</mml:mo><mml:mo>ln</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq36\"><alternatives><tex-math id=\"M85\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F(\\tau ) = N/2$$\\end{document}</tex-math><mml:math id=\"M86\"><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>τ</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>=</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq37\"><alternatives><tex-math id=\"M87\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu (t)$$\\end{document}</tex-math><mml:math id=\"M88\"><mml:mrow><mml:mi>μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq38\"><alternatives><tex-math id=\"M89\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu (t) \\propto \\frac{F_0}{F_0 + (N-F_0) e^{- r N t}}$$\\end{document}</tex-math><mml:math id=\"M90\"><mml:mrow><mml:mi>μ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>∝</mml:mo><mml:mfrac><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>r</mml:mi><mml:mi>N</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq39\"><alternatives><tex-math id=\"M91\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu (t) \\approx R_0 e^{b t}$$\\end{document}</tex-math><mml:math id=\"M92\"><mml:mrow><mml:mi>μ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>≈</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">bt</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq40\"><alternatives><tex-math id=\"M93\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$b = r N$$\\end{document}</tex-math><mml:math id=\"M94\"><mml:mrow><mml:mi>b</mml:mi><mml:mo>=</mml:mo><mml:mi>r</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq41\"><alternatives><tex-math id=\"M95\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta F$$\\end{document}</tex-math><mml:math id=\"M96\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>F</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq42\"><alternatives><tex-math id=\"M97\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f_i(t)$$\\end{document}</tex-math><mml:math id=\"M98\"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq43\"><alternatives><tex-math id=\"M99\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(N-f_i(t))$$\\end{document}</tex-math><mml:math id=\"M100\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq44\"><alternatives><tex-math id=\"M101\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p_i(t)$$\\end{document}</tex-math><mml:math id=\"M102\"><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq45\"><alternatives><tex-math id=\"M103\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta t$$\\end{document}</tex-math><mml:math id=\"M104\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq46\"><alternatives><tex-math id=\"M105\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p_i(t) = r \\cdot f_i(t) \\cdot \\Delta t$$\\end{document}</tex-math><mml:math id=\"M106\"><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>r</mml:mi><mml:mo>·</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>·</mml:mo><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq47\"><alternatives><tex-math id=\"M107\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f_i(t)$$\\end{document}</tex-math><mml:math id=\"M108\"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq48\"><alternatives><tex-math id=\"M109\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$N = 10^{6}$$\\end{document}</tex-math><mml:math id=\"M110\"><mml:mrow><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mn>6</mml:mn></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq49\"><alternatives><tex-math id=\"M111\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F_0/N = 1 \\times 10^{-5}$$\\end{document}</tex-math><mml:math id=\"M112\"><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq50\"><alternatives><tex-math id=\"M113\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$b = 9.24 \\times 10^{-3}$$\\end{document}</tex-math><mml:math id=\"M114\"><mml:mrow><mml:mi>b</mml:mi><mml:mo>=</mml:mo><mml:mn>9.24</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq51\"><alternatives><tex-math id=\"M115\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_0 = 4.2 \\times 10^{-5}$$\\end{document}</tex-math><mml:math id=\"M116\"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>4.2</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq52\"><alternatives><tex-math id=\"M117\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$r N = b / 0.977$$\\end{document}</tex-math><mml:math id=\"M118\"><mml:mrow><mml:mi>r</mml:mi><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:mi>b</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>0.977</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq53\"><alternatives><tex-math id=\"M119\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f_i(t)$$\\end{document}</tex-math><mml:math id=\"M120\"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq54\"><alternatives><tex-math id=\"M121\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\langle f \\rangle$$\\end{document}</tex-math><mml:math id=\"M122\"><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>f</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq55\"><alternatives><tex-math id=\"M123\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f_i(t)/N$$\\end{document}</tex-math><mml:math id=\"M124\"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>N</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ8\"><label>8</label><alternatives><tex-math id=\"M125\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\mu _i(t)&amp;\\propto \\frac{f_i(t)}{N} \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M126\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msub><mml:mi>μ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mo>∝</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mi>N</mml:mi></mml:mfrac></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq56\"><alternatives><tex-math id=\"M127\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(N+1)$$\\end{document}</tex-math><mml:math id=\"M128\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq57\"><alternatives><tex-math id=\"M129\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f_i = \\{0, 1, 2, \\ldots , N\\}$$\\end{document}</tex-math><mml:math id=\"M130\"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy=\"false\">{</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy=\"false\">}</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq58\"><alternatives><tex-math id=\"M131\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(N-f_i)$$\\end{document}</tex-math><mml:math id=\"M132\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq59\"><alternatives><tex-math id=\"M133\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{d}{dt}P(f,t)$$\\end{document}</tex-math><mml:math id=\"M134\"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>f</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq60\"><alternatives><tex-math id=\"M135\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(f-1)$$\\end{document}</tex-math><mml:math id=\"M136\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>f</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq61\"><alternatives><tex-math id=\"M137\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(f+1)$$\\end{document}</tex-math><mml:math id=\"M138\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>f</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq62\"><alternatives><tex-math id=\"M139\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$r \\cdot (N-f_i) \\cdot f_i$$\\end{document}</tex-math><mml:math id=\"M140\"><mml:mrow><mml:mi>r</mml:mi><mml:mo>·</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>·</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ9\"><label>9</label><alternatives><tex-math id=\"M141\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\frac{d}{dt}P(f,t)= r(N-f+1) (f-1) P(f-1,t) - r (N-f) f P(f,t). \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M142\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>f</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>r</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:mi>f</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>f</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>f</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mi>r</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:mi>f</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>f</mml:mi><mml:mi>P</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>f</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq63\"><alternatives><tex-math id=\"M143\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\langle f(t) \\rangle$$\\end{document}</tex-math><mml:math id=\"M144\"><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>f</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq64\"><alternatives><tex-math id=\"M145\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\langle (f(t)- \\langle f(t) \\rangle )^2 \\rangle$$\\end{document}</tex-math><mml:math id=\"M146\"><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>f</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>f</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq65\"><alternatives><tex-math id=\"M147\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t&lt;&lt;\\tau$$\\end{document}</tex-math><mml:math id=\"M148\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>&lt;</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ10\"><label>10</label><alternatives><tex-math id=\"M149\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\langle f(t) \\rangle = \\frac{N f_0}{f_0 + (N-f_0) e^{- r N t}} \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M150\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>f</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>N</mml:mi><mml:msub><mml:mi>f</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>r</mml:mi><mml:mi>N</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq66\"><alternatives><tex-math id=\"M151\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\langle f(t) \\rangle$$\\end{document}</tex-math><mml:math id=\"M152\"><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>f</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq67\"><alternatives><tex-math id=\"M153\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\langle (f(t)- \\langle f(t) \\rangle )^2 \\rangle = N \\cdot \\Xi (t)$$\\end{document}</tex-math><mml:math id=\"M154\"><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>f</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>f</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">⟩</mml:mo><mml:mo>=</mml:mo><mml:mi>N</mml:mi><mml:mo>·</mml:mo><mml:mi mathvariant=\"normal\">Ξ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq68\"><alternatives><tex-math id=\"M155\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Xi (t)$$\\end{document}</tex-math><mml:math id=\"M156\"><mml:mrow><mml:mi mathvariant=\"normal\">Ξ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq69\"><alternatives><tex-math id=\"M157\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Xi (0) = 0$$\\end{document}</tex-math><mml:math id=\"M158\"><mml:mrow><mml:mi mathvariant=\"normal\">Ξ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq70\"><alternatives><tex-math id=\"M159\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=0$$\\end{document}</tex-math><mml:math id=\"M160\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq71\"><alternatives><tex-math id=\"M161\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t&lt;&lt;\\tau$$\\end{document}</tex-math><mml:math id=\"M162\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>&lt;</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ11\"><label>11</label><alternatives><tex-math id=\"M163\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\langle (f(t)- \\langle f(t) \\rangle )^2 \\rangle \\approx f_0 e^{2 r N t}\\left( 1-e^{- r N t}\\right) \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M164\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>f</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>f</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow><mml:mo>≈</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>r</mml:mi><mml:mi>N</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>r</mml:mi><mml:mi>N</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq72\"><alternatives><tex-math id=\"M165\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f_i(t)$$\\end{document}</tex-math><mml:math id=\"M166\"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq73\"><alternatives><tex-math id=\"M167\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f_i(t)$$\\end{document}</tex-math><mml:math id=\"M168\"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq74\"><alternatives><tex-math id=\"M169\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p_i(t) = (r \\cdot f_i(t) + r \\epsilon N) \\cdot \\Delta t$$\\end{document}</tex-math><mml:math id=\"M170\"><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>r</mml:mi><mml:mo>·</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>r</mml:mi><mml:mi>ϵ</mml:mi><mml:mi>N</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>·</mml:mo><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq75\"><alternatives><tex-math id=\"M171\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\epsilon$$\\end{document}</tex-math><mml:math id=\"M172\"><mml:mi>ϵ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq76\"><alternatives><tex-math id=\"M173\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\epsilon N$$\\end{document}</tex-math><mml:math id=\"M174\"><mml:mrow><mml:mi>ϵ</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq77\"><alternatives><tex-math id=\"M175\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f_0$$\\end{document}</tex-math><mml:math id=\"M176\"><mml:msub><mml:mi>f</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq78\"><alternatives><tex-math id=\"M177\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f_i$$\\end{document}</tex-math><mml:math id=\"M178\"><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq79\"><alternatives><tex-math id=\"M179\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\epsilon N$$\\end{document}</tex-math><mml:math id=\"M180\"><mml:mrow><mml:mi>ϵ</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq80\"><alternatives><tex-math id=\"M181\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f_0$$\\end{document}</tex-math><mml:math id=\"M182\"><mml:msub><mml:mi>f</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq81\"><alternatives><tex-math id=\"M183\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\epsilon$$\\end{document}</tex-math><mml:math id=\"M184\"><mml:mi>ϵ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq82\"><alternatives><tex-math id=\"M185\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f_i(t)$$\\end{document}</tex-math><mml:math id=\"M186\"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq83\"><alternatives><tex-math id=\"M187\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha$$\\end{document}</tex-math><mml:math id=\"M188\"><mml:mi>α</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ12\"><alternatives><tex-math id=\"M189\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\frac{d F(t)}{dt}&amp;= r \\cdot F(t) \\left( N - F(t)\\right) - \\alpha F(t) \\\\&amp;= r \\cdot F(t) \\left( N - \\alpha /r - F(t) \\right) \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M190\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mo>=</mml:mo><mml:mi>r</mml:mi><mml:mo>·</mml:mo><mml:mi>F</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mfenced><mml:mo>-</mml:mo><mml:mi>α</mml:mi><mml:mi>F</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow/></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mo>=</mml:mo><mml:mi>r</mml:mi><mml:mo>·</mml:mo><mml:mi>F</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:mi>α</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>r</mml:mi><mml:mo>-</mml:mo><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq84\"><alternatives><tex-math id=\"M191\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(N-\\alpha /r)$$\\end{document}</tex-math><mml:math id=\"M192\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:mi>α</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>r</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq85\"><alternatives><tex-math id=\"M193\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$10^{6}$$\\end{document}</tex-math><mml:math id=\"M194\"><mml:msup><mml:mn>10</mml:mn><mml:mn>6</mml:mn></mml:msup></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51669_Article_Equ1.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq2.gif\"/>", "<graphic xlink:href=\"41598_2024_51669_Fig1_HTML\" id=\"MO2\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq5.gif\"/>", "<graphic xlink:href=\"41598_2024_51669_Article_Equ2.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq8.gif\"/>", "<graphic xlink:href=\"41598_2024_51669_Article_Equ3.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51669_Article_Equ4.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq9.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq10.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq11.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq12.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq13.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq14.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq15.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq16.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq17.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq18.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq19.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq20.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq21.gif\"/>", "<graphic xlink:href=\"41598_2024_51669_Fig2_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"41598_2024_51669_Article_Equ5.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq22.gif\"/>", "<graphic xlink:href=\"41598_2024_51669_Article_Equ6.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51669_Article_Equ7.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq23.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq24.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq25.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq26.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq27.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq28.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq29.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq30.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq31.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq32.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq33.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq34.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq35.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq36.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq37.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq38.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq39.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq40.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq41.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq42.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq43.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq44.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq45.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq46.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq47.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq48.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq49.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq50.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq51.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq52.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq53.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq54.gif\"/>", "<graphic xlink:href=\"41598_2024_51669_Fig3_HTML\" id=\"MO10\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq55.gif\"/>", "<graphic xlink:href=\"41598_2024_51669_Article_Equ8.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq56.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq57.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq58.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq59.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq60.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq61.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq62.gif\"/>", "<graphic xlink:href=\"41598_2024_51669_Article_Equ9.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq63.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq64.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq65.gif\"/>", "<graphic xlink:href=\"41598_2024_51669_Article_Equ10.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq66.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq67.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq68.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq69.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq70.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq71.gif\"/>", "<graphic xlink:href=\"41598_2024_51669_Article_Equ11.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq72.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq73.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq74.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq75.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq76.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq77.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq78.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq79.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq80.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq81.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq82.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq83.gif\"/>", "<graphic xlink:href=\"41598_2024_51669_Article_Equ12.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq84.gif\"/>", "<graphic xlink:href=\"41598_2024_51669_Fig4_HTML\" id=\"MO16\"/>", "<inline-graphic xlink:href=\"41598_2024_51669_Article_IEq85.gif\"/>" ]
[ "<media xlink:href=\"41598_2024_51669_MOESM1_ESM.pdf\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["3."], "surname": ["Palmer"], "given-names": ["RD"], "article-title": ["Aging clocks and mortality timers, methylation, glycomic, telomeric and more. A window to measuring biological age"], "source": ["Aging Med."], "year": ["2022"], "volume": ["5"], "fpage": ["120"], "lpage": ["125"], "pub-id": ["10.1002/agm2.12197"]}, {"label": ["6."], "surname": ["Farrell", "Mitnitski", "Theou", "Rockwood", "Rutenberg"], "given-names": ["SG", "AB", "O", "K", "AD"], "article-title": ["Probing the network structure of health deficits in human aging"], "source": ["Phys. Rev. E"], "year": ["2018"], "volume": ["98"], "fpage": ["032302"], "pub-id": ["10.1103/PhysRevE.98.032302"]}, {"label": ["11."], "surname": ["Gompertz"], "given-names": ["B"], "article-title": ["On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies"], "source": ["Philos. Trans. R. Soc."], "year": ["1825"], "volume": ["2"], "fpage": ["513"], "lpage": ["585"]}, {"label": ["12."], "surname": ["Finch"], "given-names": ["CE"], "source": ["Longevity, Senescence, and the Genome"], "year": ["1990"], "publisher-name": ["The University of Chicago Press"]}, {"label": ["14."], "surname": ["Beard"], "given-names": ["RE"], "source": ["Appendix: Note on Some Mathematical Mortality Models"], "year": ["1959"], "publisher-name": ["Wiley"], "fpage": ["302"], "lpage": ["311"]}, {"label": ["15."], "surname": ["Yashin", "Stallard", "Land"], "given-names": ["AI", "E", "KC"], "source": ["Biodemography of Aging: Determinants of Healthy Life Span and Longevity"], "year": ["2017"], "publisher-name": ["Springer"]}, {"label": ["22."], "surname": ["Ohishi", "Okamura", "Dohi"], "given-names": ["K", "H", "T"], "article-title": ["Gompertz software reliability model: Estimation algorithm and empirical validation"], "source": ["J. Syst. Softw."], "year": ["2009"], "volume": ["82"], "fpage": ["535"], "lpage": ["543"], "pub-id": ["10.1016/j.jss.2008.11.840"]}, {"label": ["23."], "surname": ["Tishby", "Biham", "Katzav"], "given-names": ["I", "O", "E"], "article-title": ["The distribution of path lengths of self avoiding walks on erds-r\u00e9nyi networks"], "source": ["J. Phys. A Math. Theor."], "year": ["2016"], "volume": ["49"], "fpage": ["285002"], "pub-id": ["10.1088/1751-8113/49/28/285002"]}, {"label": ["27."], "surname": ["Anderson"], "given-names": ["JJ"], "article-title": ["A vitality-based model relating stressors and environmental properties to organism survival"], "source": ["Ecol. Monogr."], "year": ["2000"], "volume": ["70"], "fpage": ["445"], "pub-id": ["10.1890/0012-9615(2000)070[0445:AVBMRS]2.0.CO;2"]}, {"label": ["30."], "surname": ["Ledberg"], "given-names": ["A"], "article-title": ["Exponential increase in mortality with age is a generic property of a simple model system of damage accumulation and death"], "source": ["PLoS One"], "year": ["2020"], "volume": ["15"], "fpage": ["1"], "lpage": ["17"], "pub-id": ["10.1371/journal.pone.0233384"]}, {"label": ["32."], "surname": ["Cohen", "Havlin"], "given-names": ["R", "S"], "source": ["Complex Networks: Structure, Robustness and Function"], "year": ["2010"], "publisher-name": ["Cambridge University Press"]}, {"label": ["33."], "surname": ["Rothman", "Greenland", "Lash"], "given-names": ["KJ", "S", "TL"], "source": ["Modern Epidemiology"], "year": ["2008"], "publisher-name": ["Wolters Kluwer Health"]}, {"label": ["34."], "surname": ["Holm", "Fr\u00f8lich", "Andersen", "Juul-Larsen", "Stockmarr"], "given-names": ["NN", "A", "O", "HG", "A"], "article-title": ["Longitudinal models for the progression of disease portfolios in a nationwide chronic heart disease population"], "source": ["PLoS One"], "year": ["2023"], "volume": ["18"], "fpage": ["1"], "lpage": ["26"], "pub-id": ["10.1371/journal.pone.0284496"]}, {"label": ["39."], "surname": ["Van Kampen"], "given-names": ["NG"], "source": ["Stochastic Processes in Physics and Chemistry"], "year": ["1992"], "publisher-name": ["Elsevier"]}]
{ "acronym": [], "definition": [] }
44
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1196
oa_package/0b/da/PMC10786855.tar.gz
PMC10786856
38216582
[ "<title>Introduction</title>", "<p id=\"Par2\">In the face of rapid global economic expansion, energy scarcity has emerged as a significant issue to global growth<sup>##UREF##0##1##–##REF##36696423##6##</sup>. Currently, there is a growing tension between the consumption and supply of traditional energy sources<sup>##UREF##4##7##,##REF##33932666##8##</sup>, which is having an enormous impact on the global economy and society<sup>##REF##34655627##9##</sup>. The use of traditional energy sources is also an important factor contributing to the deterioration of the human habitat and the frequency of extreme global climate events, which threaten the long-term development of humankind<sup>##UREF##5##10##,##REF##28275731##11##</sup>. On the other hand, China's per capita oil reserves are significantly below the global average, and it exhibits a pronounced dependence on oil imports<sup>##REF##29348468##12##</sup>. Addressing this severe shortage in oil resources and implementing an oil substitution strategy is crucial for China's sustainable economic development. Biofuel crops are widely recognized as the most important resource for sustainable energy production due to their broad source, environmental friendliness, and renewability<sup>##REF##29348468##12##–##UREF##7##14##</sup>, and they hold great advantages in oil substitutes<sup>##UREF##8##15##</sup>.</p>", "<p id=\"Par3\"><italic>Triadica sebifera</italic>, also known as the Chinese tallow tree, is a deciduous tree belonging to the genus<italic> Ocimum</italic> in the family <italic>Euphorbiaceae</italic> (Fig. ##FIG##0##1##). It is an important energy tree species with the title of specialty oil crop<sup>##UREF##9##16##–##UREF##11##18##</sup>. <italic>Triadica sebifera</italic> boasts historical mentions within ancient agricultural treatises such as the \"Qi Min Yao Shu\" and the “Nong Zheng Quan Shu.” It enjoyed widespread cultivation, particularly within China's southwestern and central regions. This tree displays remarkable adaptability, thriving in diverse soil types, including calcareous and acidic soils. Remarkably, it is one of the few oil-bearing crops that can flourish in high-salinity soils<sup>##UREF##10##17##,##UREF##12##19##</sup>. Its seeds possess an extraordinarily high oil content, yielding upwards of 40%<sup>##UREF##12##19##,##UREF##13##20##</sup>. Given China's limited petroleum resources, the development of woody biomass diesel requires a comprehensive understanding of its ecological requirements and potential distribution areas. As a special class of plant resources, the growth and development of energy tree species are influenced by a variety of factors such as climate, geomorphology, hydrology, and soil type<sup>##REF##34655627##9##,##UREF##14##21##</sup>. Studies have shown that non-climatic factors dominate only short-term biological changes, and that climate change is the most important factor influencing growth, development and distributional suitability<sup>##UREF##15##22##–##UREF##17##25##</sup>. Therefore, it is of great significance to explore the distributional response of <italic>Triadica sebifera</italic> to climate change, which is crucial for its rational cultivation and energy development in China.</p>", "<p id=\"Par4\">To investigate the impact of climate change on the potential geographical distribution of species, Species Distribution Models (SDMs) have been extensively employed<sup>##REF##36427731##26##–##UREF##19##29##</sup>. Species Distribution Models (SDMs), as the predominant tool for studying species' responses to climate change, have been extensively employed via ecological modeling techniques to predict suitable habitats for energy crops. Such endeavors aim to delineate their ecological prerequisites, offering insights for practical cultivation, such as in the cases of <italic>Miscanthus lutarioriparius</italic><sup>##UREF##14##21##</sup>, <italic>Manihot esculenta</italic><sup>##REF##34655627##9##</sup>, <italic>Brassica napus</italic><sup>##REF##34655627##9##</sup>, and <italic>Jatropha curcas</italic><sup>##UREF##20##30##</sup>. Currently, the mainstream species distribution models include Bioclim, Domain, GARP and MaxEnt, which have been widely used in the fields of plant conservation and utilization, and prevention of invasive pests<sup>##UREF##21##31##–##REF##31341749##33##</sup>. Due to the differing theoretical foundations of these various models, their simulation effectiveness and predictive performance exhibit substantial variations. Research indicates that the MaxEnt model exhibits the best simulation results among the many species distribution models, and is widely recognized for its robustness and generalizability to incomplete data, which is particularly important in many research areas where data availability is variable. The model is based on the principle of “maximum entropy” and aims to use known distribution points to predict the potential distribution of a target species without making strong assumptions about the completeness of the background data. This is particularly important for species such as <italic>Triadica sebifera</italic>, which are distributed over a wide area but for which habitat data may be incomplete. In addition, MaxEnt's ability to effectively handle nonlinearities and complex interactions in ecological niche modeling allows for more accurate model predictions<sup>##UREF##23##34##</sup>. <italic>Triadica sebifera</italic>, as an energy crop, the accurate portrayal of its potential habitat is important for guiding practical cultivation. Therefore, it is appropriate to choose MaxEnt model to determine the potential geographic distribution of <italic>Triadica sebifera</italic>.</p>", "<p id=\"Par5\">Currently, research on energy tree species focuses on the extraction process, but concerning the optimal distribution of energy tree species are notably scarce<sup>##REF##34655627##9##,##REF##29348468##12##</sup>. The cultivation of <italic>Triadica sebifera</italic> also face number of practical difficulties: (1) some of the potential cultivation areas are still unknown; (2) there is an urgent need to know the relationship between the distribution of <italic>Triadica sebifera</italic> and its response to climate change under the stress of global warming. To address the problems above, this research predict the potential geographical distribution zones of <italic>Triadica sebifera</italic> across various time intervals within China. and to provide theoretical references for the cultivation of <italic>Triadica sebifera</italic>, which is described in Fig. ##FIG##1##2##. The main tasks of this study include: (1) to reveal the current and future distribution patterns of <italic>Triadica sebifera</italic>; (2) illustrating the trends in potential distribution of <italic>Triadica sebifera</italic> under the background of climate change; (3) investigating the relationship between <italic>Triadica sebifera</italic> distribution and its response to climate change.</p>" ]
[ "<title>Materials and methods</title>", "<title>Source of distribution data for <italic>Triadica sebifera</italic></title>", "<p id=\"Par6\">In this study, the geographic coordinates of <italic>Triadica sebifera</italic> were confirmed and screened by accessing relevant websites such as the National Plant Specimen Resource Center (NPSRC, <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.cvh.ac.cn/\">http://www.cvh.ac.cn/</ext-link>) and removing distribution records with insufficiently specific descriptions and duplicate distributions<sup>##REF##36427731##26##,##REF##36502977##27##</sup>. The concentration of distribution data in an area can overfit the model and bring uncertainty. Therefore, this study utilized the buffer tool in ArcGIS 10.2 to create a buffer zone with a radius of 5 km around each distribution point according to the resolution of the environmental variables, and only one distribution point was kept within 5 km. Eventually 462 distribution points of <italic>Triadica sebifera</italic> were collected and their distribution is shown in Fig. ##FIG##2##3##.</p>", "<title>Sources of environment variables</title>", "<p id=\"Par7\">Climate data and digital elevation data (DEM, <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.worldclim.org/\">http://www.worldclim.org/</ext-link>) were downloaded from the World Clim database, which contains 19 current 4 future emission scenarios (SSP5-8.5, SSP3-7.0, SSP2-4.5, SSP1-2.6). The current climate database collects detailed meteorological information recorded at weather stations around the world from 1970 to 2000. The future climate data are based on the BCC-CSM2-MR climate system model developed by the National Climate Center. Soil data were obtained from the Harmonized World Soil Database (HWSD V1.2, <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.fao.org/\">https://www.fao.org/</ext-link>). UV-B radiation data were downloaded from the Global UV-B Download Radiation Dataset (gIUV, <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ufz.de/gluv/index.php\">https://www.ufz.de/gluv/index.php</ext-link>). China administrative maps were downloaded from the National Science and Technology Infrastructure System Science Data Center (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.geodata.cn\">http://www.geodata.cn</ext-link>). The spatial resolution used to standardize all environmental variables was set to 5 arcmin through ArcGIS software (version 10.2).</p>", "<p id=\"Par8\">Since there is a certain correlation between environmental variables, correlation analysis of environmental variables is needed to be used in the MaxEnt model. In this study, Spearman correlation analysis was performed on the environmental factors, and the results are shown in Fig. ##FIG##3##4##. When the correlation coefficient of two environmental factors is ≥ 0.8, the higher contribution was retained. Twelve environmental factors were finally obtained for MaxEnt modeling (Table ##TAB##0##1##).</p>", "<title>Model construction and evaluation</title>", "<p id=\"Par9\">Distribution point data and environmental factor data for <italic>Triadica sebifera</italic> were imported into MaxEnt software for modeling operations, respectively. 75% of the sample points were randomly selected as the training dataset for modeling, and the remaining 25% of the distribution was used as the test dataset to validate the model. The MaxEnt model requires the user to specify a set of parameters including: the test training (i.e., percentage of locations used for model development and internal testing), the number of background points, the clamp position (i.e., whether to limit the prediction to the variability of the input predicted environmental factors), and the regular multiplier (i.e., to avoid overfitting of the response curve). To evaluate the performance of the parameter configurations, different combinations were selected for trial runs to adjust the optimal parameters of the model. The MaxEnt model regularization level consists of 2 parameters, the modulation multiplicity (RM) and the feature combination (FC). Based on <italic>Triadica sebifera</italic> distribution points and their corresponding environmental factors, the RM was set to 0.5 to 4, respectively. Six sets of FC are set up for optimizing the model parameters to select the best combination of parameters: L (linear feature); LQ (linear feature + quadratic feature), H (hinge feature), LQH (linear feature + quadratic feature + hinge feature), LQHP (linear feature + quadratic feature + product feature) and LQHP (linear feature + quadratic feature + product feature). LQHP (linear features + secondary features + hinge features + product features) and LQHPT (linear features + secondary features + hinge features + product features + threshold features). Finally, the optimized parameters are RM set to 1 and FC to LQHPT.</p>", "<p id=\"Par10\">Species distributions are usually over- or under-estimated when using species distribution models to predict species distributions. Therefore, assessing the accuracy of model simulations using effective evaluation metrics is an important step in determining the accuracy and usability of models. Commonly used theoretical evaluation indexes for species distribution models include overall accuracy, sensitivity, specificity, AUC value, TSS value, Kappa statistic, and different indexes have different judging methods and standards. Among them, AUC, TSS value and Kappa statistic are more widely used. Therefore, to improve the credibility of the validation indexes, this study chooses three assessment methods of AUC, TSS values and Kappa statistic for model accuracy evaluation, and the specific evaluation criteria are shown in Table ##TAB##1##2##.</p>", "<title>Classification of potentially suitable areas</title>", "<p id=\"Par11\">In the output file, the average of 10 replications was selected as the simulation result for this study. The results were generated as an ASCII raster layer based on the logical value of the probability of species' existence (P), which ranges from 0 to 1. A larger P value indicates a higher likelihood of species' existence. The prediction results were converted into raster format using ArcGIS 10.2 software to classify and visualize suitable habitats. Based on the P-value, the natural discontinuity point method was used to classify the suitable habitat into four grades, and the specific classification criteria are shown in Table ##TAB##2##3##.</p>" ]
[ "<title>Analysis of results</title>", "<title>Evaluation of model accuracy</title>", "<p id=\"Par12\">Simulation prediction of potential habitat of <italic>Triadica sebifera</italic> in China using MaxEnt model based on 462 distribution records. As observed from Fig. ##FIG##4##5##, the AUC value of the contemporary MaxEnt model established for <italic>Triadica sebifera</italic> stands at 0.965. For the decades of 2050 and 2070, the AUC values under scenarios SSP1-2.6, SSP2-4.5, SSP3-7.0, and SSP5-8.5 range from 0.96 to 0.967. These results suggest that the AUC values of all models significantly surpass that of a random model, all achieving high accuracy rates. The Kappa statistic for the contemporary model is 0.755. The Kappa statistics for the decades of 2050 and 2070 under the scenarios above are in the range of 0.648 to 0.759, indicating that all models' Kappa statistics are superior to \"Ordinary,\" and the predictive results are reliable. Upon comparing the TSS values, the TSS value for the contemporary model is 0.842. The TSS values for the 2050 and 2070 decades range from 0.839 to 0.905 under the scenarios above. The TSS values suggest that the predictive results of all models achieve a \"Good\" rating or above. All three evaluation indicators demonstrate that the MaxEnt model for <italic>Triadica sebifera</italic> established in this study is reasonably configured, reliable, and suitable for subsequent analysis.</p>", "<title>Environmental factors affecting the potential geographic distribution of <italic>Triadica sebifera</italic></title>", "<p id=\"Par13\">Currently, academics lack a uniform methodology for determining the number of major factors, with most advocating a contribution-based assessment. But the choice of degree is subjective, leading to the emergence of different criteria. This study selects the top four environmental factors in terms of contribution rate as the dominant environmental factor combinations. Quantitative statistics for environmental variables in terms of contribution rate (Fig. ##FIG##5##6##) show that among the modeled environmental factors, Min Temperature of Coldest (Bio6), Precipitation of Coldest (Bio19), Intensity of Human Activity (hf) and Precipitation of Wettest Month (Bio13) contributed much more than the other variables in the top four positions in any period and in any concentration emission context, which were used as the dominant environmental factor combination in this study.</p>", "<title>Current potential geographic distribution of <italic>Triadica sebifera</italic></title>", "<p id=\"Par14\">The current potential distribution area of <italic>Triadica sebifera</italic> was simulated as shown in Fig. ##FIG##6##7##. The total suitable area of <italic>Triadica sebifera</italic> was 233.64 × 10<sup>4</sup> km<sup>2</sup> (Fig. ##FIG##8##9##), which is mainly located in Yunnan, Hubei, Guizhou and Jiangxi Province, and the eastern part of Sichuan Province and Guangdong Province and Guangxi Zhuang Autonomous Region. The high suitable area of <italic>Triadica sebifera</italic> was 30.89 × 10<sup>4</sup> km<sup>2</sup>, accounting for 13.22% of the total suitable area (Fig. ##FIG##8##9##), part of which was mainly distributed in Jiangxi, Hunan, Guangdong Province and Sichuan Province, and Guangxi Zhuang Autonomous Region and other provinces (Fig. ##FIG##6##7##). The medium suitable area of <italic>Triadica sebifera</italic> was 77.26 × 10<sup>4</sup> km<sup>2</sup>, accounting for 33.07% of the total suitable area (Fig. ##FIG##8##9##), mainly distributed in Hunan, Sichuan, Hubei, Guizhou, Jiangxi, Guangdong and Yunnan Province and Guangxi Zhuang Autonomous Region (Fig. ##FIG##6##7##). The low suitable area of <italic>Triadica sebifera</italic> was 125.49 × 10<sup>4</sup> km<sup>2</sup>, accounting for 53.71% of the total suitable area (Fig. ##FIG##8##9##), and was mainly distributed in Yunnan, Henan, Guizhou, Hubei, Anhui and Hunan Province, and Guangxi Zhuang Autonomous Region, (Fig. ##FIG##6##7##).</p>", "<p id=\"Par15\">In summary, the Maxent model predictions show that the potential geographic distribution of <italic>Triadica sebifera</italic> is very large, and the potential geographic distribution range is much larger than the modern geographic distribution range of <italic>Triadica sebifera</italic> as described by the Chinese Plant Wisdom (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.iplant.cn\">http://www.iplant.cn</ext-link>) (Fig. ##FIG##6##7##).</p>", "<title>Future potential geographical distributions of <italic>Triadica sebifera</italic></title>", "<p id=\"Par16\">The model predicted the potential suitable habitat areas for <italic>Triadica sebifera</italic> under four (SSP1-2.6, SSP2-4.5, SSP3-7.0 and SSP5-8.5) different emission scenarios in 2050s and 2070s. Potential suitable areas for <italic>Triadica sebifera</italic> under climate change scenarios and changes in the center of gravity of suitable habitats based on modern climate conditions and future climate change scenarios were obtained (Fig. ##FIG##7##8##). Compared with the current climate conditions, the area of high and medium suitable zones of <italic>Triadica sebifera</italic> increased and the area of low suitable zones decreased under all four scenarios in the 2050s and 2070s, with very little change in the areas of total suitable zones. Only the SSP3-7.0 emission scenario at the 2050s, the SSP3-7.0 emission scenario at the 2050s, and the SSP5-8.5 emission scenario at the 2070s showed a slight decrease in total suitable area in both time periods, and the total suitable area increased in all other platoon scenarios (Figs. ##FIG##7##8## and ##FIG##8##9##).</p>", "<p id=\"Par17\">Compared to the current distribution, under the SSP5-8.5 emission scenario for the 2050s period, the total suitable area decreased by 0.89%, the high suitable area increased by 1.52%, the medium suitable area increased by 6.52%, and the low suitable area decreased by 6.05% (Fig. ##FIG##8##9##). Under the SSP3-7.0 emission scenario at the 2050s period, the total fitness zone area decreased by 0.60%, the high fitness zone area increased by 13.37%, the medium fitness zone area increased by 1.20%, and the low fitness zone area decreased by 5.15% (Fig. ##FIG##8##9##). Under the SSP2-4.5 emission scenario at the 2050s period, the total suitable area increased by 3.50%, the high suitable area increased by 16.12%, the medium suitable area increased by 10.59%, and the low suitable area decreased by 3.98% (Fig. ##FIG##8##9##). Under the SSP1-2.6 emission scenario at the 2050s period, the total suitable area increased by 0.83%, the high suitable area increased by 0.10%, the medium suitable area increased by 4.06%, and the low suitable area decreased by 0.99% (Fig. ##FIG##8##9##).</p>", "<p id=\"Par18\">Compared to the current distribution, under the SSP5-8.5 emission scenario for the 2070s period, the total suitable area decreased by 0.55 percent, the high suitable area increased by 5.41 percent, the medium suitable area increased by 5.28 percent, and the low suitable area decreased by 5.60 percent (Fig. ##FIG##8##9##). Under the SSP3-7.0 emissions scenario for the 2070s period, the total suitable area increased by 1.36 percent, the high suitable area increased by 10.68 percent, the medium suitable area increased by 4.25 percent, and the low suitable area decreased by 2.72 percent (Fig. ##FIG##8##9##). Under the SSP2-4.5 emissions scenario for the 2070s period, the total suitable area increased by 1.49%, the high suitable area increased by 6.38%, the medium suitable area increased by 9.51%, and the low suitable area decreased by 4.66% (Fig. ##FIG##8##9##). Under the SSP1-2.6 emission scenario for the 2070s period, the total suitable area increased by 1.47%, the high suitable area increased by 23.11%, the medium suitable area increased by 5.98%, and the low suitable area decreased by 6.67% (Fig. ##FIG##8##9##).</p>", "<p id=\"Par19\">The centers of gravity of suitable habitats for <italic>Triadica sebifera</italic> under modern climate conditions and future climate change scenarios reveal the trajectories and trends of its potential suitable habitats. As shown in Fig. ##FIG##7##8##, the center of gravity of the potential suitable habitat of <italic>Triadica sebifera</italic> tends to shift to the southeast and low latitude under all four emission scenarios in 2050 and 2070. Under the 2050 SSP3-7.0 emission scenario, the trend of shifting the center of gravity of potentially suitable habitat for <italic>Triadica sebifera</italic> is the most significant, and in general, the magnitude of the shift is not significant.</p>", "<p id=\"Par20\">In summary, the center of gravity of <italic>Triadica sebifera</italic>’s suitable areas and changes in the center of gravity under the climate change scenarios are not significant. Potential suitable habitats for <italic>Triadica sebifera</italic> do not change much under different concentration emission scenarios in the 2050s and 2070s. Some low and medium suitable areas were converted to high suitable areas, and some low and unsuitable areas were converted to medium suitable areas. Still, some suitable areas disappeared (Figs. ##FIG##7##8## and ##FIG##8##9##).</p>" ]
[ "<title>Discussion</title>", "<title>Effects of environmental variables on the potential geographic distribution of <italic>Triadica sebifera</italic></title>", "<p id=\"Par21\">The important environmental factors limiting the potential geographic distribution of <italic>Triadica sebifera</italic>, as predicted by the MaxEnt model, are the temperature factor (mean air temperature of the driest quarter), the precipitation factor (precipitation of the coldest quarter, precipitation of the wettest month), and the intensity of human activities (hf). The probability of presence of <italic>Triadica sebifera</italic> increased to some extent as the mean temperature of the driest quarter increased, which may be related to the fact that <italic>Triadica sebifera</italic> prefers hot, humid, and sunny temperatures. Pattison and Mack showed that minimum temperature and limited precipitation were the main climatic constraints to <italic>Triadica sebifera</italic> in the eastern and western United States, respectively<sup>##UREF##24##35##</sup>. The increase in precipitation in the coldest season somewhat reduced the probability of <italic>Triadica sebifera</italic>’s presence; with the increase in precipitation in the wettest month, the probability of <italic>Triadica sebifera</italic>’s presence increased. Gu et al. explored the correlation between environmental factors and seed yield and quality of <italic>Triadica sebifera</italic>. They showed that as the precipitation increased in the coldest season, the seed yield of <italic>Triadica sebifera</italic> was lower, and the quality was poorer<sup>##UREF##24##35##</sup>. Studies by Wang<sup>##UREF##25##36##</sup> and Rong et al.<sup>##UREF##26##37##</sup> also showed that temperature and precipitation factors are important environmental factors limiting the potential geographic distribution of <italic>Triadica sebifera</italic>, which corroborates with the present study. The intensity of human activity is strongly linked to the probability of presence of <italic>Triadica sebifera</italic>, which is also related to the fact that humans have been utilizing <italic>Triadica sebifera</italic>. Related studies have shown that humans have been utilizing <italic>Triadica sebifera</italic> since prehistoric times<sup>##UREF##27##38##</sup>, so human activities should also be considered in cultivating <italic>Triadica sebifera</italic>.</p>", "<p id=\"Par22\">This study predicts the potential geographic distribution of <italic>Triadica sebifera</italic> in China and identifies the climatic factors that limit the potential geographic distribution of <italic>Triadica sebifera</italic>. Expansion of the study area may make the range of environmental factors limiting the growth of <italic>Triadica sebifera</italic> change. Other environmental factors, such as vegetation cover and other data, influence the potential geographic distribution of <italic>Triadica sebifera</italic>. Since it is impossible to accurately predict the vegetation cover in China in the future, it was not included in the prediction of the potential geographic distribution of <italic>Triadica sebifera</italic>. Therefore, some potential geographic distribution areas in this study may not be suitable for <italic>Triadica sebifera</italic> and must be adapted to the local hydrogeological conditions when applied in practice. However, the results of this study are the first step of macro-planning, which is crucial for the scientific management and exploitation of <italic>Triadica sebifera</italic>.</p>", "<title>Changes in the potential geographic distribution of <italic>Triadica sebifera</italic> under future climate change scenarios</title>", "<p id=\"Par23\">The potential geographic distribution of <italic>Triadica sebifera</italic> in China under future climate change scenarios was predicted using the MaxEnt model based on the environmental factors under four emission scenarios in 2050 and 2070 combined with modern climate conditions (Fig. ##FIG##7##8##). The results were spatially overlaid and analyzed in ArcGIS to obtain changes in the potential distribution of <italic>Triadica sebifera</italic> under future climate change scenarios (Fig. ##FIG##9##10##).</p>", "<p id=\"Par24\">Predictive outcomes indicate that, under four emission scenarios in 2050 and 2070, the potential geographic distribution of <italic>Triadica sebifera</italic> displays negligible overall alterations compared to its distribution under modern climate conditions, exhibiting a minor increasing trend. Only under the 2070’s SSP5-8.5 emission scenario and the 2050’s SSP5-8.5 and SSP3-7.0 emission scenarios does the total area of suitable habitats present a slight downward trend (Fig. ##FIG##9##10##). The results suggest that temperature and precipitation constrain the survival of <italic>Triadica sebifera</italic>, probably because the temperature and precipitation under the high emission scenario exceed the thresholds suitable for the survival of <italic>Triadica sebifera</italic>, which decreases the probability of its survival in some areas. Under the other emission scenarios, the temperature and precipitation were within the range suitable for the survival of <italic>Triadica sebifera</italic>, which resulted in an increasing trend of potential suitable habitat for <italic>Triadica sebifera</italic>. The center of gravity of potentially suitable habitat shifted to the southeast and lower latitudes (Fig. ##FIG##6##7##), but to a lesser extent, possibly implying that some areas become unsuitable for <italic>Triadica sebifera</italic> under future climate change scenarios. There will be areas suitable for <italic>Triadica sebifera</italic>, but the area of change is not large. Thomas et al., on the extinction risk of organisms in an area covering 20% of the Earth's surface, suggests that 15–37% of species will be at risk of extinction under the medium emissions scenario in 2050. Other species are at less risk of extinction, and some species will benefit from warming, suggesting that the effects of warming on the potential geographic distribution of species are twofold and that not all species will be at risk of extinction or will benefit equally from climate change<sup>##REF##14712274##39##</sup>.</p>", "<p id=\"Par25\">Under the four emission scenarios in 2050 and 2070, suitable habitat for <italic>Triadica sebifera</italic> increased to different degrees in central and southern China and decreased to different degrees in high latitude and high altitude areas in northern and northwestern China, with little change in general (Fig. ##FIG##9##10##). Under the emission scenario SSP2-4.5 in 2050, the area of habitat loss for <italic>Triadica sebifera</italic> is minimal, encompassing a region of 6.67 × 10<sup>4</sup> km<sup>2</sup>. In contrast, under the SSP5-8.5 emission scenario in 2070, the habitat loss for <italic>Triadica sebifera</italic> extends to its maximum, a substantial area of 13.19 × 10<sup>4</sup> km<sup>2</sup> (Fig. ##FIG##10##11##). The principal regions of habitat loss for <italic>Triadica sebifera</italic> are found in Yunnan Province, Shandong Province, Henan Province, Guangxi Zhuang Autonomous Region, and Sichuan Province. This mainly manifests as losing low-suitability habitats, with some regions transitioning between medium and high-suitability habitats (Figs. ##FIG##7##8## and ##FIG##9##10##).</p>", "<p id=\"Par26\">Under the SSP5-8.5 emission scenario in 2050, the least expansion of suitable habitats for <italic>Triadica sebifera</italic> is observed, covering an area of 7.68 × 10<sup>4</sup> km<sup>2</sup>. Conversely, under the SSP2-4.5 emission scenario in 2050, the largest expansion of suitable habitats for <italic>Triadica sebifera</italic> is noted, encompassing an area of 14.89 × 10<sup>4</sup> km<sup>2</sup> (Fig. ##FIG##10##11##). The expansion areas of <italic>Triadica sebifera</italic> predominantly lie in provinces of Yunnan, Shandong, Shaanxi, Sichuan, and Hebei (Fig. ##FIG##9##10##). A significant reason for the increased suitability of <italic>Triadica sebifera</italic> in Yunnan, Shaanxi, and Sichuan provinces is that the Qinling and Bashan regions of China are located on the northern edge of the subtropics, serving as the convergence zone of subtropical and warm temperate climates. The immense barrier of the Qinling-Bashan region impedes the northward progression of the southeast monsoon and the southern invasion of cold northern air, thus providing an ideal environment for various species to thrive and multiply<sup>##REF##33391701##40##</sup>. As indicated by the Shared Socioeconomic Pathways scenarios proposed in the Sixth Assessment Report (AR6). (2021) by the Intergovernmental Panel on Climate Change, global warming trends and temperature increases are becoming more pronounced<sup>##UREF##28##41##</sup>. Given that temperature significantly impacts <italic>Triadica</italic>\n<italic>sebifera</italic>'s growth, elevated temperatures resulting from high emission scenarios could potentially lead to the expansion of unsuitable habitats for <italic>Triadica sebifera</italic>. This could explain the greatest loss of habitat under high-emission scenarios and shifts in the distribution of centroids. The influence of global warming on the potential geographical distribution of species manifests primarily in the migration of species to different latitudes or altitudes and the expansion or contraction of potential geographical distribution areas. The trends observed in this study regarding the migration of potentially suitable habitats for <italic>Triadica sebifera</italic> under future climate change conditions align with these characteristics<sup>##UREF##29##42##</sup>.</p>", "<p id=\"Par27\">Climate change indirectly affects the population and distribution characteristics of <italic>Triadica sebifera</italic> by directly affecting the ecosystem. In addition to the important impacts of climate change on the potential geographic distribution of <italic>Triadica sebifera</italic>, irrational agricultural development, the rise of tourism activities, hydropower development, and other industrial behaviors may also lead to changes in the geographic distribution of <italic>Triadica sebifera</italic>. In this study, only two time periods, 2050 and 2070, were used for the environmental factor variables, so in future studies on the response of the potential geographic distribution of species to climate change, multiple study periods can be chosen to derive the overall trend of the potential geographic distribution of the study population.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par28\">This study identifies the dominant environmental factors affecting the potential geographic distribution of <italic>Triadica sebifera</italic>, including temperature (mean air temperature in the driest season), precipitation (precipitation in the coldest season and precipitation in the wettest month), and the intensity of human activities. Under modern climatic conditions, this plant is mainly found in provinces and regions south of the Yellow River and north of Shaanxi and Gansu. Projections for four climate scenarios in the 2050s and 2070s indicate that the area of highly and moderately suitable habitat areas for <italic>Triadica sebifera</italic> will increase, while the area of low suitable habitat areas will decrease. Although there is little change in overall suitable habitat areas, there is a trend toward a slight shift toward lower latitudes and the Southeast. These findings have important applications for predicting and planning the cultivation of <italic>Triadica sebifera</italic> and the development of biofuels, and are equally instructive in the fields of ecological restoration, biodiversity conservation, and the sustainable development of energy crops.</p>", "<p id=\"Par29\"><italic>Triadica sebifera</italic> is not only an important woody oilseed species, but also has ornamental and medicinal values. Therefore, its cultivation and utilization in the field of bioenergy is promising. Future research should focus on the following aspects: first, long-term field trials to validate the model predictions of this study, especially to the potential for biofuel production. Second, in-depth exploration of the long-term impacts of climate change on <italic>Triadica sebifera</italic> and its associated ecosystem services. In addition, the growth performance and oil yield of <italic>Triadica sebifera</italic> under different cultivation conditions are investigated to determine optimal cultivation management strategies. Finally, considering the potential risk of plant invasions, future research should also assess the ecological impacts of the spread of <italic>Triadica sebifera</italic> and develop effective risk management measures. These studies will not only help to maximize the economic value of <italic>Triadica sebifera</italic> as a bioenergy source as well as other uses, but also ensure environmental protection and ecological balance.</p>" ]
[ "<p id=\"Par1\">As an important woody oilseed species in China, <italic>Triadica sebifera</italic> is not only concerned with the substitution of traditional energy sources, but also plays a considerable role in coping with energy shortages. Accurately predicting the potential geographic distribution of <italic>Triadica sebifera</italic> in China and understanding its ecological needs are crucial for alleviating the energy crisis and effectively implementing energy substitution strategies. In this study, the potential geographic distribution of <italic>Triadica sebifera</italic> in China at contemporary and future periods was predicted based on the distribution data of <italic>Triadica sebifera</italic> in China and the environmental factor variables by Maxent model and ArcGIS software. The combination of important factors governing the potential geographic distribution of <italic>Triadica sebifera</italic> was assessed by the contribution of environmental factor variables. The accuracy of Maxent model's predictions was assessed by AUC values, TSS values and Kappa statistics. The results show that: High AUC and TSS values indicate high accuracy and performance of the model. The crucial environmental factors limiting the potential geographic distribution of <italic>Triadica sebifera</italic> are the temperature factor (mean air temperature of the driest quarter), precipitation factor (precipitation of the coldest quarter, precipitation of the wettest month), and the intensity of human activities (hf). The total suitable area for <italic>Triadica sebifera</italic> is 233.64 × 10<sup>4</sup> km<sup>2</sup>, primarily located in Yunnan, Sichuan, Hubei, Guizhou, Jiangxi, Guangdong province and Guangxi Zhuang Autonomous Region; its high suitability area is 30.89 × 10<sup>4</sup> km<sup>2</sup>, accounting for 13.22% of the total suitable area, mainly distributed in Jiangxi, Sichuan and Hunan provinces in the shape of a cake. Under the four typical greenhouse gas emission concentration patterns in the 2050s and 2070s, the areas of high and medium suitable areas for <italic>Triadica sebifera</italic> will increase, while the area of its low suitable area will decrease. However, the total suitable area will remain relatively unchanged. Its potential suitable habitats show a trend of shifting towards lower latitudes and southeast regions. The study predicted the pattern of <italic>Triadica sebifera</italic> under different climate change conditions, which can provide guidance for future cultivation of <italic>Triadica sebifera</italic> as well as for biofuel development and utilization.</p>", "<title>Subject terms</title>" ]
[]
[ "<title>Author contributions</title>", "<p>All authors contributed to the study concept and design. Conceptualization: M.L., L.Y. and Y.H.; Methodology: M.L. and M.S.; Writing—Original Draft: M.L. and C.Z.; Formal analysis: M.L. and Y.J.; Resources: M.L. and M.S.; Data Curation: Y.J.; Investigation: M.L., M.S., W.G. and Y.L.; Funding acquisition: Y.J., Y.H. and L.Y.; Writing—Reviewing and Editing: Y.J., Y.H. and C.Z. All authors read and approved the final manuscript.</p>", "<title>Funding</title>", "<p>This work was supported by the Scientific research initiation project of Mianyang Normal University (QD2021A37, QD2023A01), the Foundation of Key Laboratory of Southwest China Wildlife Resources Conservation (Ministry of Education) (XNYB22-05), Natural Science Foundation of Sichuan, China (2023NSFSC0140), the open project from the Ecological Security and Protection Key Laboratory of Sichuan Province (ESP201302), Ecological Security and Protection Key Laboratory of Sichuan Province, Mianyang Normal University (ESP2204), Sichuan Science and Technology Program (2023ZYD0102), Luo Yao took wild photos of <italic>Triadica sebifera.</italic></p>", "<title>Data availability</title>", "<p>All data included in this study are available upon request by contact with the corresponding author.</p>", "<title>Competing interests</title>", "<p id=\"Par30\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p><italic>Triadica sebifera</italic> photographed from wild habitat.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Flowchart displaying the steps of the present study.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Occurrence records of <italic>Triadica sebifera.</italic></p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Heat map for correlation analysis of environmental variables.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>AUC, Kappa and TSS values of MaxEnt.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Environmental variables and their contributions of <italic>Triadica sebifera</italic>, (<bold>a</bold>) 2050s, SSP1-2.6; (<bold>b</bold>) 2050s, SSP2-4.5g; (<bold>c</bold>) 2050s, SSP3-7.0; (<bold>d</bold>) 2050s SSP5-8.5; (<bold>e</bold>) 2070s, SSP1-2.6; (<bold>f</bold>) 2070s, SSP2-4.5g; (<bold>g</bold>) 2070s, SSP3-7.0; (<bold>h</bold>) 2070s SSP5-8.5; (<bold>i</bold>) current.</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>Current geographical distributions of <italic>Triadica sebifera.</italic></p></caption></fig>", "<fig id=\"Fig8\"><label>Figure 8</label><caption><p>Potential geographical distribution of <italic>Triadica sebifera</italic> in the 2050s and 2070s predicted using MaxEnt and Variations of the centroids of total suitability habitat area of <italic>Triadica sebifera</italic> under climate change scenarios. (<bold>a</bold>) 2050s, SSP1-2.6; (<bold>b</bold>) 2050s, SSP2-4.5g; (<bold>c</bold>) 2050s, SSP3-7.0; (<bold>d</bold>) 2050s SSP5-8.5; (<bold>e</bold>) 2070s, SSP1-2.6; (<bold>f</bold>) 2070s, SSP2-4.5g; (<bold>g</bold>) 2070s, SSP3-7.0; (<bold>h</bold>) 2070s SSP5-8.5; (<bold>i</bold>) current; (<bold>j,k</bold>) center of gravity of a suitable habitat.</p></caption></fig>", "<fig id=\"Fig9\"><label>Figure 9</label><caption><p>Suitable areas for <italic>Triadica sebifera</italic> under different climate change scenarios.</p></caption></fig>", "<fig id=\"Fig10\"><label>Figure 10</label><caption><p>Changes in the potential geographical distribution of <italic>Triadica sebifera</italic> under climate change scenarios in the future.</p></caption></fig>", "<fig id=\"Fig11\"><label>Figure 11</label><caption><p>Changes of <italic>Triadica sebifera</italic> in suitable habitat areas in the future.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>List of the environmental variables used to develop the model of <italic>Triadica sebifera.</italic></p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Variables</th><th align=\"left\">Description</th><th align=\"left\">Interpretations</th></tr></thead><tbody><tr><td align=\"left\">Bio6</td><td align=\"left\">Min temperature of coldest</td><td align=\"left\">Reflecting the effects of temperature extremes</td></tr><tr><td align=\"left\">Bio19</td><td align=\"left\">Precipitation of coldest</td><td align=\"left\">Reflects whether water and heat are synchronized</td></tr><tr><td align=\"left\">hf</td><td align=\"left\">Intensity of human activity</td><td align=\"left\">Reflecting the intensity of human activity</td></tr><tr><td align=\"left\">Bio13</td><td align=\"left\">Precipitation of wettest month</td><td align=\"left\">Reflects extreme moisture conditions</td></tr><tr><td align=\"left\">Bio7</td><td align=\"left\">Temperature annual range</td><td align=\"left\">Reflecting the effects of temperature extremes</td></tr><tr><td align=\"left\">slope</td><td align=\"left\">Slope</td><td align=\"left\">slope</td></tr><tr><td align=\"left\">aspect</td><td align=\"left\">Aspect</td><td align=\"left\">Aspect</td></tr><tr><td align=\"left\">Bio5</td><td align=\"left\">Max temperature of warmest</td><td align=\"left\">Reflects the average temperature and its variability</td></tr><tr><td align=\"left\">Bio2</td><td align=\"left\">Mean diurnal range (mean of monthly)</td><td align=\"left\">Reflecting the characteristics of temperature differences</td></tr><tr><td align=\"left\">Bio9</td><td align=\"left\">Mean temperature of driest</td><td align=\"left\">Reflects whether water and heat are synchronized</td></tr><tr><td align=\"left\">UV-B3</td><td align=\"left\">Mean UV-B of highest month</td><td align=\"left\">Reflects the intensity of ultraviolet radiation</td></tr><tr><td align=\"left\">Bio15</td><td align=\"left\">Precipitation seasonality (coefficient of variation)</td><td align=\"left\">Reflects rainfall and seasonal distribution</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Relationship between the values of kappa, TSS, and AUC and model precision.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Indicator</th><th align=\"left\">Excellent</th><th align=\"left\">Good</th><th align=\"left\">Ordinary</th><th align=\"left\">Poor</th></tr></thead><tbody><tr><td align=\"left\">Kappa</td><td align=\"left\">0.85–1.00</td><td align=\"left\">0.70–0.85</td><td align=\"left\">0.55–0.70</td><td align=\"left\">0.00–0.55</td></tr><tr><td align=\"left\">TSS</td><td align=\"left\">0.85–1.00</td><td align=\"left\">0.70–0.85</td><td align=\"left\">0.55–0.70</td><td align=\"left\">0.00–0.55</td></tr><tr><td align=\"left\">AUC</td><td align=\"left\">0.90–1.00</td><td align=\"left\">0.80–0.90</td><td align=\"left\">0.70–0.80</td><td align=\"left\">0.00–0.70</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Range of P-values for different suitable habitat area classes.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">P-value range</th><th align=\"left\">Suitable habitat area classes</th></tr></thead><tbody><tr><td align=\"left\">0.6 ≤ P ≤ 1.0</td><td align=\"left\">High suitable habitat area</td></tr><tr><td align=\"left\">0.3 ≤ P &lt; 0.6</td><td align=\"left\">Medium suitable habitat area</td></tr><tr><td align=\"left\">0.1 ≤ P &lt; 0.3</td><td align=\"left\">Low suitable habitat area</td></tr><tr><td align=\"left\">0.0 ≤ P &lt; 0.1</td><td align=\"left\">Unsuitable habitat area</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2023_51035_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2023_51035_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2023_51035_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2023_51035_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2023_51035_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2023_51035_Fig6_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"41598_2023_51035_Fig7_HTML\" id=\"MO7\"/>", "<graphic xlink:href=\"41598_2023_51035_Fig8_HTML\" id=\"MO9\"/>", "<graphic xlink:href=\"41598_2023_51035_Fig9_HTML\" id=\"MO8\"/>", "<graphic xlink:href=\"41598_2023_51035_Fig10_HTML\" id=\"MO10\"/>", "<graphic xlink:href=\"41598_2023_51035_Fig11_HTML\" id=\"MO11\"/>" ]
[]
[{"label": ["1."], "mixed-citation": ["New Members of the Chinese Academy of Sciences. "], "italic": ["Angew. Chem. Int. Ed."], "bold": ["59"]}, {"label": ["2."], "surname": ["Liu", "Wang", "Yin", "Yang", "Jiang"], "given-names": ["C", "C", "Y", "P", "H"], "article-title": ["Bi-level dispatch and control strategy based on model predictive control for community integrated energy system considering dynamic response performance"], "source": ["Appl. Energy"], "year": ["2022"], "volume": ["310"], "fpage": ["118641"], "pub-id": ["10.1016/j.apenergy.2022.118641"]}, {"label": ["3."], "surname": ["Rodionova"], "given-names": ["MV"], "article-title": ["A comprehensive review on lignocellulosic biomass biorefinery for sustainable biofuel production"], "source": ["Int. J. Hydrog. Energy"], "year": ["2022"], "volume": ["47"], "fpage": ["1481"], "lpage": ["1498"], "pub-id": ["10.1016/j.ijhydene.2021.10.122"]}, {"label": ["4."], "surname": ["Yang", "Wang", "Hong"], "given-names": ["D", "W", "T"], "article-title": ["A historical weather forecast dataset from the European Centre for Medium-Range Weather Forecasts (ECMWF) for energy forecasting"], "source": ["Sol Energy"], "year": ["2022"], "volume": ["232"], "fpage": ["263"], "lpage": ["274"], "pub-id": ["10.1016/j.solener.2021.12.011"]}, {"label": ["7."], "surname": ["Newell", "Raimi", "Aldana"], "given-names": ["RG", "D", "G"], "article-title": ["Global energy outlook 2019: The next generation of energy"], "source": ["Resour. Future"], "year": ["2019"], "volume": ["1"], "fpage": ["8"], "lpage": ["19"]}, {"label": ["10."], "surname": ["Tokarska", "Gillett"], "given-names": ["KB", "NP"], "article-title": ["Cumulative carbon emissions budgets consistent with 1.5 \u00b0C global warming"], "source": ["Nat. Clim. Change"], "year": ["2018"], "volume": ["8"], "fpage": ["296"], "lpage": ["299"], "pub-id": ["10.1038/s41558-018-0118-9"]}, {"label": ["13."], "surname": ["Debnath", "Mourshed"], "given-names": ["KB", "M"], "article-title": ["Challenges and gaps for energy planning models in the developing-world context"], "source": ["Nat. Energy"], "year": ["2018"], "volume": ["3"], "fpage": ["172"], "lpage": ["184"], "pub-id": ["10.1038/s41560-018-0095-2"]}, {"label": ["14."], "surname": ["Paul", "Bhagobaty", "Nihalani", "Joshi"], "given-names": ["S", "RK", "MC", "SR"], "article-title": ["Characterization of oleaginous endophytic fungi of biodiesel plants as potential biofuel minifactories"], "source": ["Biomass Bioenergy"], "year": ["2020"], "volume": ["142"], "fpage": ["105750"], "pub-id": ["10.1016/j.biombioe.2020.105750"]}, {"label": ["15."], "surname": ["Zhang", "Zhang", "Han"], "given-names": ["W-H", "Y", "X"], "article-title": ["Major advances in plant ecology research in China (2020)"], "source": ["J. Plant Ecol."], "year": ["2021"], "volume": ["14"], "fpage": ["995"], "lpage": ["1001"], "pub-id": ["10.1093/jpe/rtab047"]}, {"label": ["16."], "surname": ["Gao"], "given-names": ["H"], "article-title": ["The conversion of woody oils into E-octadec-9-enedioic acid and multiple-shape memory polyamides"], "source": ["Ind. Crops Prod."], "year": ["2023"], "volume": ["191"], "fpage": ["115879"], "pub-id": ["10.1016/j.indcrop.2022.115879"]}, {"label": ["17."], "surname": ["Hou"], "given-names": ["J"], "article-title": ["A high throughput plant regeneration system from shoot stems of "], "italic": ["Sapium", "sebiferum"], "source": ["Ind. Crops Prod."], "year": ["2020"], "volume": ["154"], "fpage": ["112653"], "pub-id": ["10.1016/j.indcrop.2020.112653"]}, {"label": ["18."], "surname": ["Liu", "Bai", "Zhu", "Li", "Jiang"], "given-names": ["Y", "SL", "Y", "GL", "P"], "article-title": ["Promoting seedling stress resistance through nursery techniques in China"], "source": ["New Forests"], "year": ["2012"], "volume": ["43"], "fpage": ["639"], "lpage": ["649"], "pub-id": ["10.1007/s11056-012-9341-9"]}, {"label": ["19."], "surname": ["Su", "Peng", "Li", "Xu", "Yan"], "given-names": ["F", "C", "G-L", "L", "Y-J"], "article-title": ["Biodiesel production from woody oil catalyzed by "], "italic": ["Candida", "rugosa"], "source": ["Renew. Energy"], "year": ["2016"], "volume": ["90"], "fpage": ["329"], "lpage": ["335"], "pub-id": ["10.1016/j.renene.2016.01.029"]}, {"label": ["20."], "surname": ["Zhou", "Zhou", "Dong", "Shen", "Li"], "given-names": ["P", "Q", "F", "X", "Y"], "article-title": ["Study on the genetic variation of "], "italic": ["Triadica sebifera"], "source": ["Forests"], "year": ["2022"], "volume": ["13"], "fpage": ["1330"], "pub-id": ["10.3390/f13081330"]}, {"label": ["21."], "surname": ["Xue"], "given-names": ["S"], "article-title": ["Mapping current distribution and genetic diversity of the native "], "italic": ["Miscanthus", "lutarioriparius"], "source": ["Renew. Sustain. Energy Rev."], "year": ["2020"], "volume": ["134"], "fpage": ["110386"], "pub-id": ["10.1016/j.rser.2020.110386"]}, {"label": ["22."], "surname": ["Liu"], "given-names": ["L"], "article-title": ["Simulation of potential suitable distribution of original species of "], "italic": ["Fritillariae Cirrhosae Bulbus"], "source": ["Environ. Sci. Pollut. Res."], "year": ["2022"], "volume": ["29"], "fpage": ["22237"], "lpage": ["22250"], "pub-id": ["10.1007/s11356-021-17338-0"]}, {"label": ["24."], "surname": ["Yang"], "given-names": ["J"], "article-title": ["Potential geographical distribution of the endangered plant "], "italic": ["Isoetes"], "source": ["Glob. Ecol. Conserv."], "year": ["2022"], "volume": ["38"], "fpage": ["e02186"]}, {"label": ["25."], "surname": ["Wang"], "given-names": ["R"], "article-title": ["Potential distribution of "], "italic": ["Spodoptera", "frugiperda"], "source": ["Glob. Ecol. Conserv."], "year": ["2020"], "volume": ["21"], "fpage": ["e00865"]}, {"label": ["28."], "surname": ["Liu"], "given-names": ["L"], "article-title": ["Modeling habitat suitability of Houttuynia cordata "], "italic": ["Thunb", "Ceercao"], "source": ["Ecol. Inform."], "year": ["2021"], "volume": ["63"], "fpage": ["101324"], "pub-id": ["10.1016/j.ecoinf.2021.101324"]}, {"label": ["29."], "surname": ["Liu"], "given-names": ["L"], "article-title": ["Simulation of potential suitable distribution of "], "italic": ["Alnus", "cremastogyne"], "source": ["Ecol. Indic."], "year": ["2021"], "volume": ["133"], "fpage": ["108396"], "pub-id": ["10.1016/j.ecolind.2021.108396"]}, {"label": ["30."], "surname": ["Hu"], "given-names": ["J"], "article-title": ["Decreasing desired opportunity for energy supply of a globally acclaimed biofuel crop in a changing climate"], "source": ["Renew. Sustain. Energy Rev."], "year": ["2017"], "volume": ["76"], "fpage": ["857"], "lpage": ["864"], "pub-id": ["10.1016/j.rser.2017.03.093"]}, {"label": ["31."], "surname": ["Huang", "Zeng", "Jiang", "Chen", "Yang"], "given-names": ["Y", "Y", "P", "H", "J"], "article-title": ["Prediction of potential geographic distribution of endangered relict tree species "], "italic": ["Dipteronia sinensis"], "source": ["Pol. J. Environ. Stud."], "year": ["2022"], "volume": ["31"], "fpage": ["3597"], "lpage": ["3609"], "pub-id": ["10.15244/pjoes/146936"]}, {"label": ["32."], "surname": ["Lan", "Chen", "Lin", "Huang", "Wang"], "given-names": ["R", "R", "H", "Y", "R"], "article-title": ["Suitable area of invasive species "], "italic": ["Alexandrium"], "source": ["Pol. J. Environ. Stud."], "year": ["2023"], "volume": ["32"], "fpage": ["1199"], "lpage": ["1217"], "pub-id": ["10.15244/pjoes/156471"]}, {"label": ["34."], "surname": ["Yang"], "given-names": ["J-T"], "article-title": ["Predicting the potential distribution of the endangered plant "], "italic": ["Magnolia wilsonii"], "source": ["Pol. J. Environ. Stud."], "year": ["2022"], "volume": ["31"], "fpage": ["4435"], "lpage": ["4445"], "pub-id": ["10.15244/pjoes/148187"]}, {"label": ["35."], "surname": ["Pattison", "Mack"], "given-names": ["RR", "RN"], "article-title": ["Potential distribution of the invasive tree "], "italic": ["Triadica sebifera"], "source": ["Glob. Change Biol."], "year": ["2008"], "volume": ["14"], "fpage": ["813"], "lpage": ["826"], "pub-id": ["10.1111/j.1365-2486.2007.01528.x"]}, {"label": ["36."], "surname": ["Wang"], "given-names": ["H"], "source": ["Response of native and invasive Triadica sebiferato major global change factors"], "year": ["2016"], "publisher-name": ["Nanjing Agricultural University"]}, {"label": ["37."], "surname": ["Rong"], "given-names": ["W"], "source": ["Research from Chinese Academy of Sciences Provides New Data on Plant Science"], "year": ["2020"], "publisher-name": ["Zhongkai University of Agriculture and Engineering"]}, {"label": ["38."], "mixed-citation": ["Ge, W. "], "italic": ["Investigation and Research on Ethnobotany in Southeast China"]}, {"label": ["41."], "collab": ["Intergovernmental Panel on Climate Change"], "source": ["Climate Change 2021\u2014The Physical Science Basis: Working Group I Contribution to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change"], "year": ["2023"], "publisher-name": ["Cambridge University Press"]}, {"label": ["42."], "surname": ["Thuiller"], "given-names": ["W"], "article-title": ["BIOMOD\u2014Optimizing predictions of species distributions and projecting potential future shifts under global change"], "source": ["Glob. Change Biol."], "year": ["2003"], "volume": ["9"], "fpage": ["1353"], "lpage": ["1362"], "pub-id": ["10.1046/j.1365-2486.2003.00666.x"]}]
{ "acronym": [], "definition": [] }
42
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1220
oa_package/c3/6d/PMC10786856.tar.gz
PMC10786857
38216576
[ "<title>Introduction</title>", "<p id=\"Par3\"><italic>Mycobacterium tuberculosis</italic> (Mtb) caused an estimated 10 million new cases of tuberculosis (TB) and 1.4 million deaths in 2019<sup>##UREF##0##1##</sup>. Of particular concern are the estimated 465,000 rifampicin resistant (RR) cases, 78% of which were multi-drug resistant (MDR, resistant to both rifampicin and isoniazid)<sup>##UREF##0##1##</sup>. Drug resistance poses two major challenges to the successful treatment of TB, as it is both underdiagnosed (only 38% of RR/MDR cases in 2019)—leading to under-treatment—and has poor treatment success rates even when identified (57% globally in 2019)<sup>##UREF##0##1##</sup>. Despite attempts to move to shorter and all-oral MDR TB regimens using new drugs, most patients are still receiving toxic regimens that decrease patient adherence<sup>##UREF##0##1##,##REF##28419314##2##</sup>. Collectively, the failure to identify and successfully treat these cases leads to onward transmission and amplification of drug resistant strains</p>", "<p id=\"Par4\">The WHO has identified better diagnosis and treatment of drug resistant tuberculosis as a key part of the global tuberculosis eradication strategy<sup>##UREF##0##1##</sup>. Rapid genetics-based diagnostic tools, such as GeneXpert, have been widely adopted as they are faster and cheaper than traditional culture-based diagnostic susceptibility testing (DST). However, outbreaks caused by drug-resistant strains with mutations not detected by such assays reveal the importance of developing assays that include a wider range of resistance determinants<sup>##REF##27998822##3##</sup>. Some approaches incorporate whole-genome sequencing (WGS) or targeted next generation sequencing to identify all possible resistant variants and recently these methods have proven to be capable of replacing culture-based DST for the first line drugs; however, implementation of this technology is not yet feasible globally due to cost and technical expertise constraints<sup>##REF##29548923##4##–##REF##26116186##6##</sup>.</p>", "<p id=\"Par5\">Most current culture and genetics-based DST approaches generate binary results—”resistant” or “susceptible”—and thus fail to consistently report elevations in minimum inhibitory concentration (MIC) below or around the critical concentration<sup>##UREF##1##7##</sup>. These sub-threshold elevations in MIC may nevertheless be clinically meaningful, as the combination of significant interpatient pharmacokinetic variability and elevated MICs predisposes Mtb strains to development of higher-level resistance, risking treatment failure and worse patient outcomes<sup>##REF##30157391##8##,##REF##30283633##9##</sup>. A binary system also hampers the wider implementation of informed high-dose regimens which have been trialed to extend the clinical utility of relatively less toxic and more widely available drugs such as rifampicin and isoniazid<sup>##REF##31247337##10##–##REF##32130864##12##</sup>. While some previous efforts have attempted to use quantitative MICs to identify these lower-level resistance variants, they were limited by smaller sample sizes and combined heterogenous methods of resistance determination<sup>##UREF##2##13##</sup>. Additionally, relatively few studies have had adequate sample sizes to investigate drugs such as bedaquiline, linezolid, clofazimine and delamanid that are poised to become the new “front-line” drugs for the MDR-TB treatment.</p>", "<p id=\"Par6\">To resolve these issues, we performed WGS and determined the MICs of 13 drugs for 15,211 Mtb isolates selected from patient samples gathered from 23 countries over five continents using a previously validated microtiter plate<sup>##UREF##3##14##</sup>. This data covers all first-line drugs (except pyrazinamide), as well as eight drugs from the new MDR-TB treatment guidelines (all Group A, one Group B, and four Group C)<sup>##UREF##4##15##</sup>. Overall, we identify 492 unique mutations that are associated with elevated MICs across 13 drugs as well as mutations that are associated with increased susceptibility to bedaquiline, clofazimine, and the aminoglycosides. The results serve as guides for pharmacokinetic and dosing studies to extend the clinical utility of less toxic and more widely available drugs for the treatment of drug-resistant tuberculosis, as well as help to improve the design of genetics-based rapid diagnostics for MDR-TB and the recently published WHO genetic catalog for tuberculosis<sup>##UREF##5##16##</sup>. They also provide a large, quality-controlled dataset for development of drug resistance prediction algorithms using machine-learning and other approaches.</p>" ]
[ "<title>Methods</title>", "<title>Ethics statement</title>", "<p id=\"Par32\">Approval for CRyPTIC study was obtained by Taiwan Centers for Disease Control IRB No. 106209, University of KwaZulu Natal Biomedical Research Ethics Committee (UKZN BREC) (reference BE022/13) and University of Liverpool Central University Research Ethics Committees (reference 2286), Institutional Research Ethics Committee (IREC) of The Foundation for Medical Research, Mumbai (Ref nos. FMR/IEC/TB/01a/2015 and FMR/IEC/TB/01b/2015), Institutional Review Board of P.D. Hinduja Hospital and Medical Research Centre, Mumbai (Ref no. 915-15-CR [MRC]), scientific committee of the Adolfo Lutz Institute (CTC-IAL 47-J / 2017) and in the Ethics Committee (CAAE: 81452517.1.0000.0059) and Ethics Committee review by Universidad Peruana Cayetano Heredia (Lima, Peru) and LSHTM (London, UK).</p>", "<title>Dataset collection</title>", "<p id=\"Par33\">The CRyPTIC dataset collection and processing has been previously described in detail<sup>##UREF##6##17##</sup>. Briefly, clinical isolates were sub-cultured before inoculation of a single biological replicate into CRyPTIC-designed 96-well microtiter plates manufactured by ThermoFisher. Plates contained doubling-dilution ranges for 14 different antibiotics (para-aminosalicylic acid was excluded from the study due to poor-quality results on the plate). Isolate MICs were read after 14 days by a laboratory scientist using a Thermo Fisher Sensititre Vizion digital MIC viewing system and an image of the plate was also uploaded to a bespoke web server, allowing for additional MIC measurements by an automated computer vision system (AMYGDA) and by citizen science volunteers (Bash the Bug Zooniverse project) as previously described<sup>##UREF##26##57##,##UREF##27##58##</sup>. MIC measurements were classified as high (all three methods agree), medium (only two methods agree), or low (no methods agree). Previous work has shown that using multiple methods catches cases where either the laboratory scientist or software have made an error in calling the MIC<sup>##UREF##6##17##</sup>. While sequencing processes differed slightly between CRyPTIC laboratories, all sequencing was performed using Illumina. The Clockwork sequence processing pipeline took in paired FASTQ files before filtering, mapping, and providing variant calls for each isolate (Clockwork available from: <ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/iqbal-lab-org/clockwork\">https://github.com/iqbal-lab-org/clockwork</ext-link>, more detailed description of pipeline available in<sup>##UREF##5##16##</sup>). Isolates that had both phenotypic and whole-genome sequencing data were used as a starting dataset for this study<sup>##UREF##6##17##</sup>. ECOFFs were defined in Cryptic Consortium et al 2022 and are provided in Supplementary Data ##SUPPL##3##1##<sup>##UREF##6##17##</sup>.</p>", "<title>Target gene selection</title>", "<p id=\"Par34\">Target genes were selected based on the results of a prior study and through a literature search for each drug<sup>##UREF##28##59##</sup>. Mutations occurring in genes and the 100 bp directly upstream of each gene were considered as candidates for inclusion in this study. Genomic positions for each gene considered (not including 100 bp upstream) are provided from the H37Rv v3 genbank file in Supplementary Data ##SUPPL##3##9##.</p>", "<title>Statistical modeling</title>", "<p id=\"Par35\">All genetic variations smaller than 50 bp occurring in the target genes for each drug (Supplementary Data ##SUPPL##3##1##) were included as candidates for effects in this study. Large insertions, deletions, and other structural changes larger than 50 bp were not included in this study, due to limitations with the re-genotyping approach employed across all isolates. Both in-frame and frameshifting insertion/deletion (indel) mutations occurred in the dataset; however, only two positions harbored indels of both types (the in-frame deletions being 3 bp and 12 bp in rpoB). As the phenotypes of these isolates carrying in-frame deletions were similar to the frameshifting indels occurring at the same site, these indels were pooled as one candidate effect. Other indel mutations that occurred at the same position (either all in-frame or all frameshifting) were also pooled as one candidate effect to boost statistical power given their likely shared mechanism and size of effect. Mutations that always co-occurred in the dataset were combined into one candidate effect with all mutations named. Isolates were excluded from analysis if they contained evidence for mixed alleles at positions previously associated with resistance to that drug (i.e., a mixed allele call for position S450 in <italic>rpoB</italic> for rifampicin) to reduce potential instances of hetero-resistant isolates<sup>##REF##30280646##22##</sup>. Interval regression was performed in Stata version 16.1 with a genomic cluster variable as a random effect to control for population structure. Cluster ID was determined by performing agglomerative clustering with complete linkage criterion using Scikit-learn in Python on a whole-genome SNP distance array of all isolates in the dataset<sup>##UREF##29##60##</sup>. A sensitivity analysis was performed to compare the effects of clustering at 12, 25, 50, and 100 single nucleotide polymorphism (SNP) distances (100 used for all results shown). Lineage and laboratory performing the MICs (SITEID variable) were included as fixed effect, factor variables to control for genetic and technical variation in each individual drug model. MICs were encoded as the interval with upper bound log2(MIC) and lower bound log2(MIC minus 1 doubling dilution). The bottom and top wells were extended by three doubling dilutions to account for censoring. The generalized form of the equation for the interval regression model is below:Where <bold>X</bold><sub><bold>i</bold></sub> denotes the variable list, with lineage and technical site being fixed, factor variables and all other mutations tested being fixed binary variables. <italic>Z</italic><sub>i</sub> is the random effects groupings, which were defined by cluster ID. <italic>B</italic> and <italic>u</italic><sub>i</sub> denote the calculated fixed and random effects, respectively.</p>", "<p id=\"Par36\">The Benjamini-Hochberg correction was used to adjust raw p-values and the false discovery rate was set at 5% for each drug based on the number of variants considered, including all variants in one mutually adjusted multivariable model. Mutations that have statistically significant effects on log2MIC &gt; 0 are defined as resistance-associated for the purposes of this study. Mutation effect size relative to the ECOFF is noted where relevant. Pairs of mutations that occurred in at least five isolates with each individual mutation occurring at least five times were subsequently tested for interactions in a mixed effect interval regression model containing all other variants for that drug reaching the significance threshold (Benjamini-Hochberg adjusted <italic>p</italic> value &lt; 0.05).</p>", "<title>Data preparation, analysis, and figure-making</title>", "<p id=\"Par37\">Data was prepared for analysis using Python, statistical outputs were analyzed using R, and figures were made using ggPlot2 in R<sup>##UREF##30##61##</sup>. Homoplasy was calculated using HomoplasyFinder, with a mutation considered homoplastic if it had evolved in at least two independent occurences<sup>##UREF##31##62##</sup>. A R file that recapitulates all the post-model analysis and figures is available<sup>##UREF##30##61##</sup> in the ##SUPPL##0##Supplemental material## (Supplemental Code). Structural modeling was done using UCSF Chimera<sup>##REF##15264254##63##</sup>.</p>", "<title>Reporting summary</title>", "<p id=\"Par38\">Further information on research design is available in the ##SUPPL##4##Nature Portfolio Reporting Summary## linked to this article.</p>" ]
[ "<title>Results</title>", "<title>Dataset description</title>", "<p id=\"Par7\">Bacterial isolates were collected from patient samples from 23 different countries and were over-sampled for drug resistance. Of the 15,211 isolates included in the initial CRyPTIC dataset, 5541 were phenotypically susceptible to isoniazid, rifampicin, and ethambutol, 5602 were isoniazid resistant, 5261 were rifampicin resistant, and 4,125 were multidrug-resistant (MDR, resistant to both rifampicin and isoniazid) based on previously published epidemiological cutoffs (ECOFF, MIC that encompasses 99% of wild type) for the microtiter plates used in this study<sup>##UREF##6##17##</sup>. Binary phenotypic resistance to the newer drugs was observed at a lower prevalence, with 71 bedaquiline resistant isolates, 106 clofazimine-resistant isolates, 76 linezolid resistant isolates, and 85 delamanid resistant isolates (Supplementary Data ##SUPPL##3##1##). Isolate lineages were determined using a published SNP-based protocol from WGS data and the lineage distribution across countries reflects previously described phylogeographic distributions<sup>##REF##30789126##18##–##REF##32055708##20##</sup>. Five out of eight major lineages of Mtb were represented in the dataset, with most isolates mapping to L4 (6572 isolates) and L2 (5598 isolates), while L3 (1850), L1 (1150), and L6 (6) comprised the remainder. A complete description of the CRyPTIC dataset and determination of the ECOFFs have been previously published (also see Methods)<sup>##UREF##6##17##,##REF##35944069##21##</sup>. After the removal of isolates due to errors in phenotyping and sequencing across sites, the final genotype/phenotype intersection for all drugs was ~12,350 isolates (Fig. ##FIG##0##1##).</p>", "<title>Genetic resistance determinants in Mycobacterium tuberculosis</title>", "<p id=\"Par8\">Previous studies have shown that the majority of genetic determinants of resistance to most anti-tuberculosis drugs are related to a relatively small number of genes<sup>##REF##26116186##6##,##REF##30280646##22##</sup>. We thus employed a candidate gene approach and restricted our investigation of genomic variation to previously identified genes and the 100 bp directly upstream of each gene for each drug (Table ##TAB##0##1##). All unique variation in the target genes and upstream regions (SNPs, both synonymous and nonsynonymous, as well as insertions and deletions &lt;50 base pairs in length) that occurred in isolates with matched high-quality phenotypic data was included in a separate multivariable linear mixed model controlling for population structure and technical variation between sites for each drug, after removing isolates with evidence for mixed allele calls at sites previously identified as resistant (e.g., <italic>rpoB</italic> S450X, Methods). Final sample sizes per drug ranged from 6681 for moxifloxacin to 10,042 for rifabutin (mean sample size 8353, Fig. ##FIG##0##1##, Methods). Most isolates had less than five nonsynonymous mutations across all target genes for each drug (Supplementary Data ##SUPPL##3##2##).</p>", "<p id=\"Par9\">Across thirteen drugs, 584 mutations in 40 genes (out of 4,778 mutations and 50 genes tested) were found to have independent effects on MIC after correction for multiple testing (Benjamini-Hochberg correction, false discovery rate &lt;0.05, Fig. ##FIG##1##2##, Table ##TAB##0##1##, Supplementary Data ##SUPPL##3##3##). Ethionamide had the most unique variants associated with reduced susceptibility (163), while linezolid had the least (8). Effect sizes were measured in log2MIC (where an increase in 1 log2MIC was equivalent to a doubling of the MIC) and positive effects for estimates derived from at least three observations ranged from a 0.22 increase in kanamycin log2(MIC) for <italic>rrs</italic> c492t to a 10.1 increase in isoniazid log2(MIC) for <italic>katG</italic> W477Stop. To facilitate comparison with previously published ECOFF values, we report mutational effects relative to the difference between the ECOFF MIC and the baseline MIC calculated by the model for each drug. Thus, if a mutation is associated with an effect larger than the ECOFF minus baseline, it is associated with an increase in resistance that would be above what is considered wildtype on the plate. Multiple promoter mutations were implicated in resistance to isoniazid, ethionamide, amikacin, kanamycin, and ethambutol (Fig. ##FIG##1##2B##). The effects of promoter mutations varied widely, with mutations upstream of <italic>eis</italic> and <italic>embA</italic> being almost exclusively associated with sub-ECOFF elevations in MIC for amikacin and ethambutol respectively, while most promoter mutations for the isoniazid and ethionamide-related <italic>fabG1</italic> resulted in MICs above the ECOFF<sup>##UREF##6##17##</sup>. While a prior study found that common promoter mutations tended to be associated with lower-level resistance than their corresponding common gene-body counterparts (e.g., <italic>fabG1</italic> c-15 vs <italic>inhA</italic> I21), we found that mutations affecting coding sequences vs mutations affecting promoters/intergenic regions were only associated with significantly different effects on MIC for isoniazid, ethambutol, and kanamycin (Supplementary Data ##SUPPL##3##4##)<sup>##UREF##2##13##</sup>. In fact, we found that the widespread <italic>fabG1</italic> c-15t promoter mutation was associated with higher-level and equivalent-level resistance to its gene body counterparts <italic>inhA</italic> I21V and I21T respectively (Fig. ##FIG##1##2B##, Wald test for equality of coefficients <italic>p</italic> = 0.0006, <italic>p</italic> = 0.24, respectively). Resistance-associated promoter mutations were enriched in the region around each gene’s respective −10 element, which is consistent with the essentiality of the −10 hexamer and increased variability around the −35 position in mycobacterial promoters (Fig. S1, ±5 nucleotides, Mantel-Haenszel common OR = 4.5, <italic>p</italic> = 0.0007)<sup>##REF##23017770##23##,##REF##31217290##24##</sup>. Multiple insertion/deletion mutations were associated with resistance to isoniazid, rifampicin, rifabutin, ethionamide, ethambutol, bedaquiline, clofazimine, and delamanid (Supplementary Data ##SUPPL##3##3##, Fig. ##FIG##1##2##). Homoplastic mutations (multiple evolutionarily independent occurrences) were more likely to be associated with resistance for all drugs except amikacin, kanamycin, clofazimine, linezolid, and delamanid (Woolf test for homogeneity of ORs <italic>p</italic> = 0.0004, Supplementary Data ##SUPPL##3##5##). The relative lack of homoplasy in the newer drugs may reflect the lower prevalence of resistant isolates observed for these drugs as opposed to lack of convergent evolution.</p>", "<p id=\"Par10\">One notable advantage of quantitative MIC measurements is that they also enable investigation of variants associated with MIC decreases. We identified 63 increased susceptibility-associated mutations (with at least three occurrences) whose effect sizes ranged from −4.3 rifampicin log2(MIC) for <italic>Rv2752c</italic> H371Y to −0.23 kanamycin log2(MIC) for <italic>eis</italic> V163I (Fig. ##FIG##1##2A##, Supplementary Data ##SUPPL##3##6##). Eight of these mutations were homoplastic with at least three independent occurrences, which raises the intriguing possibility of a selective pressure for mutations associated with increases in drug susceptibility; however, this remains to be verified experimentally.</p>", "<title>First-line drugs</title>", "<p id=\"Par11\">Rifampicin is a critical first line drug and resistance to it is almost entirely mediated by mutations within an 81-base pair region of the <italic>rpoB</italic> gene (<underline>r</underline>ifampicin <underline>r</underline>esistance <underline>d</underline>etermining <underline>r</underline>egion, RRDR). Most molecular assays target mutations in this region for rapid prediction of rifampicin resistance, however, mutations outside this region have been associated with outbreaks<sup>##UREF##8##25##,##UREF##9##26##</sup>. We identified 35 mutations in <italic>rpoB</italic> occurring at least three times whose effects collectively ranged from 1.0 to 9.0 increases in log2MIC (Fig. ##FIG##2##3A##). Notably, seven unique resistance-associated mutations occurred outside the RRDR, at positions V170, Q172, I491, and L731; however, only V170F was associated with high-level resistance (8.37 increased log2MIC). Although disparate in primary sequence from the RDRR, positions V170, Q172 and I491 are all near the drug-binding pocket structurally (Fig. ##FIG##2##3B##). Interestingly, a homoplastic in-frame deletion 12 bp in size in the RRDR was also associated with rifampicin resistance (Fig. ##FIG##2##3C##, Supplementary Data ##SUPPL##3##3##). Several types of insertion/deletion mutations in the RDRR have previously been reported, although they are rare, consistent with their greater structural consequences for the essential RNA polymerase<sup>##REF##29311619##27##</sup>.</p>", "<p id=\"Par12\">Prior studies have identified seven “borderline” mutations in <italic>rpoB</italic> (L430P, D435Y, H445L, H445N, H445S, L452P, and I491F) for rifampicin; resistant isolates with these mutations are often missed by phenotypic methods such as the Mycobacterial Growth Indicator Tube (MGIT), possibly due to slower growth rates, which has led to a reduction in the critical concentration for MGIT in the latest WHO guidelines<sup>##UREF##10##28##–##UREF##11##30##</sup>. These mutations’ MICs range on the plate from 5.1 log2MIC for H445L to 2.3 log2MIC for L430P (rifampicin ECOFF minus baseline MIC = 3.3, Supplementary Data ##SUPPL##3##3##). Here, we identify thirteen additional <italic>rpoB</italic> mutations independently associated with elevated MICs that are less than 5.1 log2MIC (8/13 located in the RDRR, Supplementary Data ##SUPPL##3##3##). Sixteen <italic>rpoB</italic> mutations in total were independently associated with elevated MICs at or below the rifampicin ECOFF, including <italic>rpoB</italic> L430P, a variant that has been successfully treated with a high dose rifampicin-containing regimen clinically<sup>##REF##29984742##31##</sup>. Several <italic>rpoB</italic> positions (Q432, D435, H445) harbored both high and low-level resistance-associated alleles, while others (L430, L452, I491) were associated exclusively with lower-level resistance regardless of the amino acid substitution (Fig. ##FIG##2##3B, C## orange and yellow shading respectively). Mapping these mutations onto the rpoB protein structure revealed that high-level resistance often involves disruption of the interactions with the rigid napthol ring while mutations at positions that contact the ansa bridge had more variable effects, potentially due to increased structural flexibility in this region of the drug (Fig. ##FIG##2##3B##). Low-level resistance mutations often co-occurred with other low-level resistance mutations, producing high-level resistance additively (Fig. ##SUPPL##0##S4##).</p>", "<p id=\"Par13\">Rifabutin (a structural analog to rifampicin) is associated with a lower ECOFF (2.2 vs 3.3 log2MIC after subtraction of baseline) and mutations in <italic>rpoB</italic> were associated with lower elevations in rifabutin MIC compared to rifampicin MIC (paired Wilcoxon <italic>p</italic> = 3.7e-9, Fig. ##FIG##2##3A##, Supplementary Data ##SUPPL##3##3##). Interestingly however, all structural features contacted by these mutations were shared between rifampicin and rifabutin (Fig. ##FIG##2##3B##). A single mutation, <italic>rpoB</italic> Q409R (<italic>n</italic> = 24, <italic>p</italic> = 5.0e-3 after Benjamini-Hochberg (BH) correction), was associated with decreased rifampicin and rifabutin MICs; interestingly, this mutation has been proposed as a compensatory mutation that may alter the rate of transcription initiation and resulting transcription efficiency for isolates that harbor other RDRR mutations<sup>##REF##33775224##32##</sup>.</p>", "<p id=\"Par14\">Resistance to isoniazid is mediated primarily through loss-of-function mutations in the prodrug-converting enzyme <italic>katG</italic>, with canonical high-level resistance caused by the S315T mutation, which was associated with a 6.2 log2 increase in MIC (Fig. ##FIG##3##4A##, compared to 2.1 log2MIC ECOFF minus baseline). Not all <italic>katG</italic> mutations were associated with high-level resistance, nearly half (15/31) being associated with increases in MIC at or below the ECOFF. No mutations likely to result in severe loss of function were associated with sub-ECOFF resistance, supporting the consensus of treating presumptive loss-of-function mutants in <italic>katG</italic> as resistant. The other canonical isoniazid-related genes, <italic>inhA</italic> and <italic>fabG1</italic>, tended to be associated with lower-level resistance, with 4/6 and 5/6 mutations associated with sub-ECOFF increases in MIC, respectively (Fig. ##FIG##3##4A##, Supplementary Data ##SUPPL##3##3##). While <italic>fabG1</italic> L203L was previously the only synonymous mutation known to be associated with resistance to isoniazid, here we identify a synonymous mutation in the first codon of <italic>katG</italic> that confers high-level resistance to isoniazid, potentially by reducing the rate of translation initiation and subsequent production of katG enzyme required for activation of isoniazid, although this is a mechanistic hypothesis that requires biochemical confirmation (4.5 log2MIC, <italic>n</italic> = 3, <italic>p</italic> = 1.4e-8 after Benjamini-Hochberg (BH) correction, Supplementary Data ##SUPPL##3##3##).</p>", "<p id=\"Par15\">Most isoniazid resistance-associated mutations in <italic>katG</italic> occurred in the N-terminal lobe responsible for heme-binding and pro-drug conversion (Fig. ##FIG##3##4B##). Most isolates harbored variation at position S315, located in the primary isoniazid-binding pocket on the δ edge of the heme; interestingly however, another cluster of resistance-associated mutations occurred in the helix made up of residues 138–155. Some structural evidence exists for promiscuous isoniazid binding at this site and mutations of this region in <italic>Escherichia coli</italic> cause reduced catalase/peroxidase activity and heme binding; however the precise mechanism of effect of these mutations in Mtb is unknown<sup>##REF##2223011##33##,##UREF##12##34##</sup>. Intriguingly, one mutation in this region, <italic>katG</italic> S140N, was associated with decreased isoniazid MIC (<italic>n</italic> = 9, <italic>p</italic> = 5.4e-4 after BH correction, Fig. ##FIG##3##4B##).</p>", "<p id=\"Par16\">Non-canonical isoniazid resistance-associated variants were identified in <italic>ahpC</italic>, <italic>ndh</italic>, and <italic>Rv1258c</italic> (<italic>tap</italic>) (Fig. ##FIG##3##4A##). Mutations in <italic>ahpC</italic> were associated with increased MICs; however, these mutations almost always co-occurred with mutations in canonical isoniazid genes and investigation of the interaction between these co-occurring mutation pairs revealed that <italic>ahpC</italic> mutations did not result in additive resistance, consistent with their proposed compensatory role (Fig. ##FIG##3##4A##). Further investigation of these apparent discrepant isolates using an improved version of the Clockwork variant calling pipeline that detected deletions larger than 50 bp identified nine isolates with apparent resistance-associated <italic>ahpC</italic> mutations that harbored large deletions in <italic>katG</italic> not reported in the original variant set used for the model. Thus, the apparent effect of these mutations is likely due to isolates with undetected mutations in the canonical resistance genes as opposed to a bona fide individual effect on isoniazid MIC by mutations in <italic>ahpC</italic>. Several recent genome-wide association studies (GWAS) have implicated mutations in the ribonuclease/beta-lactamase <italic>Rv2752c</italic> in resistance and tolerance to both rifampicin and isoniazid; however, they also identified convergent mutations in drug-susceptible strains<sup>##UREF##2##13##,##UREF##13##35##</sup>. While we identified nine nonsynonymous mutations with significant effects on log2MIC, only one, V218L, was shared between isoniazid and rifampicin, causing a 3.2 elevation in log2MIC for both drugs (Supplementary Data ##SUPPL##3##3##). Only one other <italic>Rv2752c</italic> variant was associated with elevated rifampicin MICs, while four variants in this gene were associated with elevated isoniazid MICs (Fig. ##FIG##3##4A##).</p>", "<p id=\"Par17\">Canonical ethambutol resistance is mediated by mutations in <italic>embA</italic> or <italic>embB</italic>. We identified 45 variants, 12 in the <italic>embC-embA</italic> intergenic region, five in <italic>embA</italic>, and 28 in <italic>embB</italic>, that were independently associated with elevated ethambutol MICs (Fig. ##FIG##3##4C##). Mutations in the <italic>embC-embA</italic> intergenic region have been proposed to upregulate production of embA and embB by altered promoter structure. Most <italic>embC-embA</italic> intergenic variants were in the upstream region from −16 to −8, however three were located upstream around the −35 element (Fig. ##SUPPL##0##S1##). All <italic>embC-embA</italic> intergenic and <italic>embA</italic> gene body mutations were associated with MIC increases below the ECOFF (EMB ECOFF = 2 log2MIC minus baseline, Fig. ##FIG##3##4C##, Supplementary Data ##SUPPL##3##3##). Interestingly, 22/28 mutations in <italic>embB</italic> were also associated with sub-ECOFF increases in MIC, including the canonical <italic>embB</italic> M306I. Low-level resistance mutations often co-occurred, resulting in high-level additive resistance, consistent with previous studies (Supplementary Data ##SUPPL##3##6##)<sup>##REF##23995136##36##</sup>. Mutations associated with resistance in <italic>embB</italic> were clustered around the drug-binding pocket (Fig. ##FIG##3##4D##)<sup>##UREF##14##37##</sup>. We also identified resistance-associated variants in <italic>embC</italic> and <italic>ubiA</italic>, although these occur less frequently and require further validation.</p>", "<title>Group A and B MDR drugs</title>", "<p id=\"Par18\">The principal mechanism of resistance to fluoroquinolones is mutations in either subunit of DNA gyrase (<italic>gyrA</italic> or <italic>gyrB</italic>). We identified 22 mutations (12 <italic>gyrA</italic>, 10 <italic>gyrB</italic>) and 19 mutations (10 <italic>gyrA</italic>, 9 <italic>gyrB</italic>) that were independently associated with increased levofloxacin and moxifloxacin MICs respectively (Fig. ##FIG##4##5A##). Resistance-associated mutations in <italic>gyrB</italic> occurred without an accompanying <italic>gyrA</italic> mutation ~65% of the time (29/44 isolates LEV, 35/54 isolates MXF) but were associated with lower overall—and in some cases sub-ECOFF—changes in MIC (LEV ECOFF = 1.6 log2MIC, MXF ECOFF = 2.3 log2MIC, minus baseline, Fig. ##FIG##4##5A##, Supplementary Data ##SUPPL##3##3##, ##SUPPL##3##6##). Most mutations associated with increased fluoroquinolone MICs were within 10 Å of the drug binding pocket (Fig. ##FIG##4##5B##). Intriguingly, two positions—gyrB R446 and gyrB S447—each harbored two unique resistance-associated missense mutations despite being over 25 Å from the bound fluoroquinolone. Both residues make contacts with the gyrB protein backbone at positions 473–475, suggesting they may exert an allosteric effect by either influencing protein folding and/or the position of residues (notably D461 and R482) that make up part of the fluoroquinolone binding pocket (Fig. ##FIG##4##5B##). Interestingly, while <italic>gyrB</italic> E501D was associated with resistance 1 log2MIC above the moxifloxacin ECOFF, it did not cause a similar elevation for levofloxacin (only 0.1 log2MIC above ECOFF), consistent with previous studies<sup>##UREF##1##7##,##REF##27297489##38##,##REF##22279180##39##</sup>. We speculate this could be due to alteration in the coordination of gyrB R482—which must shift to accommodate the bulkier side group of moxifloxacin—although this remains to be shown experimentally (Fig. ##FIG##4##5B##).</p>", "<p id=\"Par19\">While initial studies on bedaquiline and clofazimine resistance highlighted <italic>atpE</italic> (bedaquiline), <italic>pepQ</italic>, <italic>Rv0678</italic>, and <italic>Rv1979c</italic> as mediating resistance, surveillance of clinical samples has revealed the importance of the efflux mechanism mediated by the <italic>mmpL5</italic> membrane transporter, which is controlled by the transcriptional regulator <italic>Rv0678</italic>. Consistent with this, we identified sixteen and four mutations in <italic>Rv0678</italic> that were associated with elevated bedaquiline and clofazimine MICs, respectively, of which four were shared (Fig. ##SUPPL##0##S2##, Supplementary Data ##SUPPL##3##3##). We also identified two <italic>mmpL5</italic> mutations that were associated with increased MICs for each drug which were not shared between the two drugs. Finally, we identified both the <italic>atpE</italic> E61D (<italic>n</italic> = 3) drug binding site mutation associated with bedaquiline resistance and two mutations in <italic>Rv1979c</italic> associated with clofazimine resistance. No mutations in <italic>pepQ</italic> were associated with resistance to either drug. Importantly, five unique nonsense and frameshift mutations in <italic>mmpL5</italic> increased susceptibility to bedaquiline by −1.9 to −4.0 log2MIC, of which one, <italic>mmpL5</italic> Y300Stop, was also shared with clofazimine (Fig. ##FIG##1##2A##). Inactivating mutations in <italic>mmpL5</italic> abrogated resistance mediated by co-occurring <italic>Rv0678</italic> mutations, consistent with a hypothesis proposed by a prior study<sup>##UREF##15##40##</sup>.</p>", "<p id=\"Par20\">Resistance to linezolid is mediated by mutations in <italic>rplC</italic> and <italic>rrl</italic>, which tend to cause higher- and lower-level resistance, respectively. We identified the classical <italic>rplC</italic> C154R (<italic>n</italic> = 43) mutation and five variants in <italic>rrl</italic> associated with elevated linezolid MICs (Fig. ##SUPPL##0##S2##, Supplementary Data ##SUPPL##3##3##).</p>", "<title>Group C MDR drugs</title>", "<p id=\"Par21\">Aminoglycoside resistance is canonically mediated by mutations in the 16s rRNA encoded by <italic>rrs</italic>. We identified five and six mutations in <italic>rrs</italic> that were independently associated with elevated MICs for amikacin and kanamycin respectively (Fig. ##FIG##4##5C##). Multiple promoter mutations in <italic>eis</italic> were associated with elevated MICs to kanamycin (7) and amikacin (3). Interestingly, <italic>eis</italic> promoter mutations were associated with sub-ECOFF elevations in MIC for amikacin, while being associated with elevations in MIC comparable to <italic>rrs</italic> mutations for kanamycin (AMI ECOFF = 2.3 log2MIC minus baseline). A deletion in <italic>eis</italic> leading to loss of function was also associated with increased susceptibility to kanamycin, consistent with an epistatic interaction abrogating the resistance gained from <italic>eis</italic> overproduction. Variants in <italic>aftB</italic>, <italic>ccsA</italic>, <italic>whiB6</italic> and <italic>whiB7</italic> were also associated with elevated MICs for at least one aminoglycoside, however they were infrequent and require further investigation (Fig. ##FIG##4##5C## and Supplementary Data ##SUPPL##3##3##).</p>", "<p id=\"Par22\">Ethionamide is a prodrug that is activated by the monooxygenases <italic>ethA</italic>, <italic>mymA</italic> (<italic>Rv3083</italic>), and <italic>Rv0565c</italic><sup>##UREF##16##41##</sup>. More variants (135) were associated with increased ethionamide resistance than any other drug, with the majority (103) occurring in <italic>ethA</italic>. Notably however, most (97/103) MIC-elevating <italic>ethA</italic> variants did not raise the ethionamide MIC above the ECOFF (ETH ECOFF = 2 log2MIC minus baseline). Variants in <italic>fabG1</italic> and <italic>inhA</italic> were common and strongly associated with elevated ethionamide MICs (Fig. ##SUPPL##0##S2##). Seven resistance-associated variants were identified in the alternative activating enzymes for ethionamide, <italic>Rv3083</italic> (5) and <italic>Rv0565c</italic> (2), and three resistance-associated variants were found in the non-canonical ethionamide gene <italic>mshA</italic>. The relative lack of mutations with significant effects identified in the alternate monooxygenases may reflect their decreased relative abundance as a proportion of the total monooxygenase pools of the strains sampled in this study, as found in a previous study, although this was not biochemically verified here<sup>##UREF##16##41##</sup>. Two mutations in <italic>ethR we</italic>re associated with decreased ethionamide MICs, consistent with its role as a regulator of the prodrug-activating enzyme <italic>ethA</italic>.</p>", "<p id=\"Par23\">Resistance to delamanid is mediated by inactivating mutations in <italic>ddn</italic> or by mutations that affect the cofactor F<sub>420</sub> biosynthesis pathway (namely <italic>fgd1</italic> and <italic>fbiA-D</italic>). We identified eleven mutations in <italic>ddn</italic>, seven in <italic>fbiA</italic>, and one in <italic>fbiC</italic> that were associated with increases in delamanid MIC (Fig. ##SUPPL##0##S2##, Supplementary Data ##SUPPL##3##3##). Over half (6/11) of the mutations in <italic>ddn</italic> were nonsense or frameshift mutations.</p>", "<title>Effect of genetic background on MIC</title>", "<p id=\"Par24\">Several studies have noted that the strain genetic background can influence MICs in addition to primary resistance mutations<sup>##REF##23995136##36##,##REF##30793747##42##,##REF##24055765##43##</sup>. In this study, we found that the effects of lineage on isolate MIC tended to be small compared to primary resistance allele effects for most drugs (mean lineage effect 0.41 log2MIC, mean lineage effect to median primary resistance allele effect ratio 0.15), yet still statistically significant (Fig. ##SUPPL##0##S3##). Notably however, lineage three was associated with a 1.5 lower moxifloxacin log2MIC compared to lineage four after controlling for primary resistance alleles in <italic>gyrA</italic> and <italic>gyrB</italic>.</p>", "<title>Interactions beyond additivity</title>", "<p id=\"Par25\">We also sought to identify whether there were any effects beyond additivity for co-occurring mutation pairs. Out of 96 pairs tested across 13 drugs, we identified three mutation pairs with greater than additive effects on ethambutol resistance and two pairs with greater than additive rifampicin resistance (Fig. ##SUPPL##0##S4##, Supplementary Data ##SUPPL##3##10##). The interaction of these mutations resulted in log2MICs increased beyond additivity by 1.4–2.4 log2MIC, which resulted in MICs well beyond that of the strongest individual mutations for ethambutol and <italic>rpoB</italic> S450L for rifampicin. Interestingly, we also identified a mutation pair in rifabutin (<italic>rpoB</italic> L430P with <italic>rpoB</italic> D435G) where, in our interaction model, the individual mutations were no longer associated with resistance to rifabutin when occurring individually but are associated with resistance when co-occurring (Supplementary Data ##SUPPL##3##10##). These mutations are in sites previously associated with low-level resistance to rifampicin, so it is possible that the combined disturbance to the drug binding site is required to mediate their resistance-causing potential for rifabutin, although this remains to be experimentally verified. The remaining significant mutation-pairs either consisted of a known resistance mutation with a putative compensatory mutation (such as <italic>rpoB</italic> with <italic>rpoC</italic>) or had additive MICs that were in the tails of the distribution, suggesting that interaction effects were reflecting assay thresholds, at least in part, as opposed to true effects.</p>", "<title>Extension beyond the 2021 WHO catalog</title>", "<p id=\"Par26\">To assess how measurement of MICs improves our ability to detect meaningful genetic associations with resistance/susceptibility, we compared our MIC-based catalog with the recently published 2021 WHO catalog for tuberculosis (Supplementary Data ##SUPPL##3##7##)<sup>##UREF##5##16##</sup>. 179 unique mutation-phenotype associations were found in both catalogs, with nearly a third (59/179) classified as “resistant – interim”. Our model finds that 61% (36/59) of these mutations are associated with significant elevations in MIC in our data, of which 14 were sub-ECOFF and therefore unlikely to be confidently identified by binary methods. The inability of binary methods to detect these smaller but significant elevations in MIC is also shown by the lack of associations in <italic>Rv0678</italic> for bedaquiline and clofazimine in the WHO catalog, although this is mentioned as a limitation. Notably, we have shown in a separate work that the heritability of resistance for bedaquiline and clofazimine improves dramatically when we detect MICs as opposed to binary phenotypes, consistent with our findings here that many of <italic>Rv0678</italic> mutations result in sub-ECOFF elevations in MIC<sup>##REF##35944070##44##</sup>.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par27\">In this study, we used WGS combined with high throughput MIC measurements to develop a quantitative catalog of resistance to thirteen anti-tuberculosis drugs. Linking mutations to MICs allows for a rapid and reliable alternative to phenotypic DST for individual isolates that does not rely on critical concentrations that may be revised. These results can help to improve diagnostics and guide future study designs trialing high dose therapies of less toxic and more effective drugs (e.g., rifampicin, isoniazid and moxifloxacin)<sup>##REF##31247337##10##,##REF##30698688##11##,##UREF##8##25##</sup>.</p>", "<p id=\"Par28\">Notably, we identified 321 mutations whose effects on MIC are entirely or partially below their respective ECOFF. Further work is needed to understand whether these mutations lead to increased treatment failure and/or relapse rates as is the case for the “borderline” mutations in <italic>rpoB</italic> for rifampicin<sup>##UREF##10##28##</sup>. If so, rapid molecular assays should be employed to detect these variants.</p>", "<p id=\"Par29\">We also found mutations associated with increased susceptibility to bedaquiline, clofazimine, and aminoglycosides, which raises the intriguing possibility of optimizing regimens based on hypersensitivity as opposed to resistance. Given the relatively common rate of inactivating mutations in <italic>mmpL5</italic>, rapid molecular tests should be developed to ensure that these isolates are not falsely identified as resistant. Deletion of other transcriptional regulators has also been shown to increase bedaquiline susceptibility, suggesting other sensitizing mutations may also occur<sup>##UREF##17##45##</sup>. Further work to understand the distribution and frequency of these mutations may help elucidate their clinical relevance globally.</p>", "<p id=\"Par30\">Our new catalog was unable to explain most binary resistance to ethionamide, bedaquiline, clofazimine, linezolid and delamanid, implying that many new variants and loci remain to be discovered (Fig. ##SUPPL##0##S5##)<sup>##UREF##18##46##</sup>. More widespread use of these drugs clinically will facilitate collection of resistant strains for use in GWAS to identify other genetic loci involved in resistance; however, high levels of inactivating variation were observed in <italic>ethA</italic> (ethionamide), <italic>ddn</italic> (delamanid) and <italic>Rv0678</italic> (bedaquiline/clofazimine), suggesting that many isolates will need to be sampled to achieve saturation for these drugs, similar to pyrazinamide. Alternative approaches relying on random mutagenesis, directed evolution, and machine learning have been employed to generate predictions for mutations that have never been observed in a patient, however these may not always identify mutations that are competitive in vivo<sup>##UREF##19##47##–##UREF##23##54##</sup>. The database generated by CRyPTIC can be used as a resource for these approaches by highlighting which mutations actually occur in patients and acting as a training set for machine learning algorithms.</p>", "<p id=\"Par31\">Limitations to this study include the lower number of isolates resistant to newer drugs, the lack of isolates from lineages 5 and 6, which are responsible for a significant proportion of cases in sub-Saharan Africa, potential misattribution of mutational effects outside our target genes or due to exclusion of insertions/deletions &gt;50 bp in size from our model, and the use of ECOFFs that have not yet been extensively validated against other methods, although we have shown good concordance with MGIT and MODS results<sup>##UREF##6##17##</sup>. In addition, it has been shown that minor alleles at sites associated with resistance can influence MIC<sup>##UREF##24##55##</sup>. While we have tried to limit this effect by removing isolates for which we could not confidently call a variant at a site previously associated with resistance, it is possible that novel resistance-associated sites with minor alleles could affect our model. We have attempted to limit erroneous associations through controlling for lineage and population structure in our modeling approach as well as by validating mutations through structural mapping and degree of homoplasy where possible. Finally, changes in transcription or translation may also mediate antibiotic tolerance and persistence states to impact the efficacy of antibiotics in vivo<sup>##UREF##25##56##</sup>.</p>" ]
[]
[ "<p id=\"Par1\">The World Health Organization has a goal of universal drug susceptibility testing for patients with tuberculosis. However, molecular diagnostics to date have focused largely on first-line drugs and predicting susceptibilities in a binary manner (classifying strains as either susceptible or resistant). Here, we used a multivariable linear mixed model alongside whole genome sequencing and a quantitative microtiter plate assay to relate genomic mutations to minimum inhibitory concentration (MIC) in 15,211 <italic>Mycobacterium tuberculosis</italic> clinical isolates from 23 countries across five continents. We identified 492 unique MIC-elevating variants across 13 drugs, as well as 91 mutations likely linked to hypersensitivity. Our results advance genetics-based diagnostics for tuberculosis and serve as a curated training/testing dataset for development of drug resistance prediction algorithms.</p>", "<p id=\"Par2\">Molecular diagnostics for tuberculosis have focused on predicting drug susceptibilities in a binary manner (i.e., strains are either susceptible or resistant). Here, CRyPTIC Consortium researchers use whole genome sequencing and a quantitative assay to identify associations between genomic mutations and minimum inhibitory concentrations in over 15,000 <italic>Mycobacterium tuberculosis</italic> clinical isolates.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n\n\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s41467-023-44325-5.</p>", "<title>Acknowledgements</title>", "<p>J.C. would like to thank Spencer Dunleavy (University of Pennsylvania Medical School, Philadephia, USA). We thank Faisal Masood Khanzada and Alamdar Hussain Rizvi (NTRL, Islamabad, Pakistan), Angela Starks and James Posey (Centers for Disease Control and Prevention, Atlanta, USA), and Juan Carlos Toro and Solomon Ghebremichael (Public Health Agency of Sweden, Solna, Sweden). This work was supported by Wellcome Trust/Newton Fund-MRC Collaborative Award (200205/Z/15/Z); and Bill &amp; Melinda Gates Foundation Trust (OPP1133541). Oxford CRyPTIC consortium members are funded/supported by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University in partnership with the UK Health Security Agency (NIHR200915), and the NIHR Biomedical Research Centre, Oxford. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health or the UK Health Security Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. J.M. is supported by the Wellcome Trust (203919/Z/16/Z). Z.Y. is supported by the National Science and Technology Major Project, China Grant No. 2018ZX10103001. K.M.M. is supported by EMBL’s EIPOD3 program funded by the European Union’s Horizon 2020 research and innovation program under Marie Skłodowska Curie Actions. T.C.R. is funded in part by funding from Unitaid Grant No. 2019-32-FIND MDR. R.S.O. is supported by FAPESP Grant No. 17/16082-7. L.F. received financial support from FAPESP Grant No. 2012/51756-5. B.Z. is supported by the National Natural Science Foundation of China (81991534) and the Beijing Municipal Science &amp; Technology Commission (Z201100005520041). N.T.T.T. is supported by the Wellcome Trust International Intermediate Fellowship (206724/Z/17/Z). G.T. is funded by the Wellcome Trust. R.W. is supported by the South African Medical Research Council. J.C. is supported by the Rhodes Trust and Stanford Medical Scientist Training Program (T32 GM007365). A.L. is supported by the National Institute for Health Research (NIHR) Health Protection Research Unit in Respiratory Infections at Imperial College London. S.G.L. is supported by the Fonds de Recherche en Santé du Québec. C.N. is funded by Wellcome Trust Grant No. 203583/Z/16/Z. A.V.R. is supported by Research Foundation Flanders (FWO) under Grant No. G0F8316N (FWO Odysseus). G.M. was supported by the Wellcome Trust (098316, 214321/Z/18/Z, and 203135/Z/16/Z), and the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation (NRF) of South Africa (Grant No. 64787). The funders had no role in the study design, data collection, data analysis, data interpretation, or writing of this report. The opinions, findings and conclusions expressed in this manuscript reflect those of the authors alone. L.G. was supported by the Wellcome Trust (201470/Z/16/Z), the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number 1R01AI146338, the GOSH Charity (VC0921) and the GOSH/ICH Biomedical Research Centre (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.nihr.ac.uk\">www.nihr.ac.uk</ext-link>). A.B. is funded by the NDM Prize Studentship from the Oxford Medical Research Council Doctoral Training Partnership and the Nuffield Department of Clinical Medicine. D.J.W. is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant No. 101237/Z/13/B) and by the Robertson Foundation. A.S.W. is an NIHR Senior Investigator. T.M.W. is a Wellcome Trust Clinical Career Development Fellow (214560/Z/18/Z). A.S.L. is supported by the Rhodes Trust. R.J.W. receives funding from the Francis Crick Institute which is supported by Wellcome Trust, (FC0010218), UKRI (FC0010218), and CRUK (FC0010218). T.C. has received grant funding and salary support from US NIH, CDC, USAID and Bill and Melinda Gates Foundation. The computational aspects of this research were supported by the Wellcome Trust Core Award Grant Number 203141/Z/16/Z and the NIHR Oxford BRC. Parts of the work were funded by the German Center of Infection Research (DZIF). The Scottish Mycobacteria Reference Laboratory is funded through National Services Scotland. The Wadsworth Center contributions were supported in part by Cooperative Agreement No. U60OE000103 funded by the Centers for Disease Control and Prevention through the Association of Public Health Laboratories and NIH/NIAID grant AI-117312. Additional support for sequencing and analysis was contributed by the Wadsworth Center Applied Genomic Technologies Core Facility and the Wadsworth Center Bioinformatics Core. SYNLAB Holding Germany GmbH for its direct and indirect support of research activities in the Institute of Microbiology and Laboratory Medicine Gauting. N.R. thanks the Programme National de Lutte contre la Tuberculose de Madagascar. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.</p>", "<title>Author contributions</title>", "<p>Members of the CRyPTIC consortium collected, phenotyped, and sequenced all isolates in the CRyPTIC dataset. J.C., A.S.W., and T.M.W. designed this study, JC performed statistical analyses and structural mapping, J.C. wrote the manuscript, J.C., P.W.F., Z.I., T.E.A.P., T.M.W., and A.S.W. revised the manuscript with all partners providing feedback, and P.W.F., T.M.W.,. A.S.W., and D.W.C. supervised the work.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par39\"><italic>Nature Communications</italic> thanks the anonymous reviewers for their contribution to the peer review of this work. A peer review file is available.</p>", "<title>Data availability</title>", "<p>The ENA IDs, variant call files, and MICs are all available at a permanent ftp site at EMBL-EBI (<ext-link ext-link-type=\"uri\" xlink:href=\"http://ftp.ebi.ac.uk/pub/databases/cryptic/release_june2022/\">http://ftp.ebi.ac.uk/pub/databases/cryptic/release_june2022/</ext-link>). This site also includes processed tables with unique IDs that match genotype and phenotype information for facile use.</p>", "<title>Code availability</title>", "<p>The Clockwork variant calling pipeline is available from: <ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/iqbal-lab-org/clockwork\">https://github.com/iqbal-lab-org/clockwork</ext-link>. Scripts used for statistical analysis in Stata and analysis of results in R are available from: <ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/carterjosh/cryptic-mic\">https://github.com/carterjosh/cryptic-mic</ext-link>. DOI for Github repository: <ext-link ext-link-type=\"uri\" xlink:href=\"https://zenodo.org/doi/10.5281/zenodo.10065150\">https://zenodo.org/doi/10.5281/zenodo.10065150</ext-link><sup>##UREF##32##64##</sup>.</p>", "<title>Competing interests</title>", "<p id=\"Par40\">E.R. is employed by Public Health England and holds an honorary contract with Imperial College London. I.F.L. is Director of the Scottish Mycobacteria Reference Laboratory. S.N. receives funding from German Center for Infection Research, Excellenz Cluster Precision Medicine in Chronic Inflammation, Leibniz Science Campus Evolutionary Medicine of the LUNG (EvoLUNG)tion EXC 2167. P.S. is a consultant at Genoscreen. T.R. is funded by NIH and DoD and receives salary support from the non-profit organization FIND. T.R. is a co-founder, board member and shareholder of Verus Diagnostics Inc, a company that was founded with the intent of developing diagnostic assays. Verus Diagnostics was not involved in any way with data collection, analysis or publication of the results. T.R. has not received any financial support from Verus Diagnostics. UCSD Conflict of Interest office has reviewed and approved T.R.’s role in Verus Diagnostics Inc. T.R. is a co-inventor of a provisional patent for a TB diagnostic assay (provisional patent #: 63/048.989). T.R. is a co-inventor on a patent associated with the processing of TB sequencing data (European Patent Application No. 14840432.0 and USSN 14/912,918). T.R. has agreed to “donate all present and future interest in and rights to royalties from this patent” to UCSD to ensure that he does not receive any financial benefits from this patent. S.S. is working and holding ESOPs at HaystackAnalytics Pvt. Ltd. (Product: Using whole genome sequencing for drug susceptibility testing for <italic>Mycobacterium tuberculosis</italic>). The remaining authors declare no competing interest.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Data flow and sample sizes for CRyPTIC MIC models.</title><p>Numbers in brackets represent the number of variables (mutations plus lineage and site effects) included in the final model.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>Variation in effect size by mutation type and drug.</title><p><bold>A</bold> Effects on log2MIC for the 540 variants significant after false discovery rate correction using the Benjamini-Hochberg method. Mutation types are delineated by color. Homoplastic mutations are shown as solid circles. ECOFF (minus baseline MIC) is shown as tan line. Common resistance mutations are highlighted. <bold>B</bold> Comparison of effects on log2MIC for promoter and corresponding gene body variants for ethambutol (EMB) and isoniazid (INH). ECOFF (minus baseline MIC) is shown as a tan line. Points are the mean effect in the interval regression model with error bar representing the 95% confidence interval. Exact effects, sample sizes and <italic>p</italic> values are provided in Supplementary Data ##SUPPL##3##3##.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Heterogenous effects of <italic>rpoB</italic> mutations on rifampicin resistance.</title><p><bold>A</bold> Mean effects of target gene variants on rifampicin (blue) and rifabutin (gray) log2MIC. ECOFFs (minus baseline MICs) are highlighted as lines. <bold>B</bold> Rifampicin (blue) and rifabutin (gray) bound to rpoB with resistance-associated variants highlighted (red-high, orange-variable, yellow-low). <bold>C</bold> Mean effects on rifampicin MIC of mutations in <italic>rpoB</italic> with error bars representing 95% confidence interval. Exact sample size for each mutation is shown at the bottom of panel B. Colored shading highlights “borderline” variants. P-threshold is the value reaching significance after Bejamini-Hochberg correction for multiple testing. Sample sizes and p-values for each mutation effect are provided in Supplementary Data ##SUPPL##3##3##.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>Resistance to isoniazid and ethambutol is a multi-gene phenomenon.</title><p><bold>A</bold> Independent effects of variants in target genes on isoniazid log2MIC. ECOFF (minus baseline MIC) is denoted in red. <bold>B</bold> KatG dimer with isoniazid (blue) modeled and resistance-associated positions highlighted in orange. <bold>C</bold> Independent effects of variants in target genes on ethambutol log2MIC. ECOFF (minus baseline MIC) is denoted in red. <bold>D</bold> EmbA-embB complex bound to ethambutol (blue) with resistant mutations highlighted in orange. Sample sizes and <italic>p</italic> values for all effects are provided in Supplementary Data ##SUPPL##3##3##.</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><title>Resistance to second line drugs.</title><p><bold>A</bold> Effects of mutations in <italic>gyrA</italic> and <italic>gyrB</italic> on levofloxacin (pink) and moxifloxacin (green) log2MIC. <bold>B</bold> Structural mapping of fluoroquinolone resistance-associated variants reveal that majority lie within 10 Å of the drug binding site. Positions gyrB R446 and S447 are not shown. <bold>C</bold> Effects of mutations in aminoglycoside target genes on amikacin and kanamycin log2MIC. ECOFFs (minus baseline MIC) are shown for comparison. Sample sizes and <italic>p</italic> values for all effects are provided in Supplementary Data ##SUPPL##3##3##.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Candidate genes used in this study</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Drug</th><th>Abbrev.</th><th>Candidate genes</th></tr></thead><tbody><tr><td>Isoniazid</td><td>INH</td><td><italic>katG, fabG1, inhA, ahpC, ndh, kasA, Rv1258c, Rv2752c</italic></td></tr><tr><td>Ethionamide</td><td>ETH</td><td><italic>ethA, ethR, fabG1, inhA, mshA, Rv3083, Rv0565c</italic></td></tr><tr><td>Rifampicin</td><td>RIF</td><td><italic>rpoA, rpoB, rpoC, rpoZ, Rv2752c</italic></td></tr><tr><td>Rifabutin</td><td>RFB</td><td><italic>rpoA, rpoB, rpoC, rpoZ, Rv2752c</italic></td></tr><tr><td>Ethambutol</td><td>EMB</td><td><italic>embA, embB, embC, embR, rmlD, iniA, iniC, manB, ubiA</italic></td></tr><tr><td>Amikacin</td><td>AMI</td><td><italic>rrs, eis, ccsA, whiB6, whiB7, aftB, fprA</italic></td></tr><tr><td>Kanamycin</td><td>KAN</td><td><italic>rrs, eis, ccsA, whiB6, whiB7, aftB, fprA</italic></td></tr><tr><td>Levofloxacin</td><td>LEV</td><td><italic>gyrA, gyrB</italic></td></tr><tr><td>Moxifloxacin</td><td>MXF</td><td><italic>gyrA, gyrB</italic></td></tr><tr><td>Bedaquiline</td><td>BDQ</td><td><italic>atpE, Rv0678, mmpL5, mmpS5, pepQ, Rv3249c</italic></td></tr><tr><td>Clofazimine</td><td>CFZ</td><td><italic>Rv1979c, pepQ, Rv0678, mmpL5, mmpS5, Rv3249c</italic></td></tr><tr><td>Linezolid</td><td>LZD</td><td><italic>rplC, rrl, Rv3249c</italic></td></tr><tr><td>Delamanid</td><td>DLM</td><td><italic>ddn, fgd1, fbiA, fbiB, fbiC, fbiD, Rv3249c</italic></td></tr></tbody></table></table-wrap>" ]
[ "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{{{{{\\rm{Censored}}}}}}\\log }_{2}({{{{{\\rm{MIC}}}}}})={{{{{{\\bf{X}}}}}}}_{{{{{{\\bf{i}}}}}}}{{{{{\\bf{B}}}}}}+{{{{{{\\bf{Z}}}}}}}_{{{{{{\\bf{i}}}}}}}{{{{{{\\bf{u}}}}}}}_{{{{{{\\bf{i}}}}}}}$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">Censored</mml:mi><mml:mi>log</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant=\"normal\">MIC</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"bold\">X</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant=\"bold\">i</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant=\"bold\">B</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"bold\">Z</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant=\"bold\">i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant=\"bold\">u</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant=\"bold\">i</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM5\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>A list of authors and their affiliations appears at the end of the paper.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41467_2023_44325_Fig1_HTML\" id=\"d32e1345\"/>", "<graphic xlink:href=\"41467_2023_44325_Fig2_HTML\" id=\"d32e1612\"/>", "<graphic xlink:href=\"41467_2023_44325_Fig3_HTML\" id=\"d32e1700\"/>", "<graphic xlink:href=\"41467_2023_44325_Fig4_HTML\" id=\"d32e1845\"/>", "<graphic xlink:href=\"41467_2023_44325_Fig5_HTML\" id=\"d32e2100\"/>", "<graphic xlink:href=\"41467_2023_44325_Article_Equ1.gif\" position=\"anchor\"/>" ]
[ "<media xlink:href=\"41467_2023_44325_MOESM1_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>", "<media xlink:href=\"41467_2023_44325_MOESM2_ESM.pdf\"><caption><p>Peer Review File</p></caption></media>", "<media xlink:href=\"41467_2023_44325_MOESM3_ESM.pdf\"><caption><p>Description of Additional Supplementary Files</p></caption></media>", "<media xlink:href=\"41467_2023_44325_MOESM4_ESM.xlsx\"><caption><p>Supplementary Data 1-10</p></caption></media>", "<media xlink:href=\"41467_2023_44325_MOESM5_ESM.pdf\"><caption><p>Reporting Summary</p></caption></media>" ]
[{"label": ["1."], "mixed-citation": ["WHO. "], "italic": ["Global Tuberculosis Report 2020"]}, {"label": ["7."], "mixed-citation": ["World Health Organization. Technical Report on Critical Concentrations for TB Drug Susceptibility Testing of Medicines Used in the Treatment of Drug-Resistant TB. 106 (WHO, 2018)."]}, {"label": ["13."], "mixed-citation": ["Farhat, M. R. et al. GWAS for quantitative resistance phenotypes in Mycobacterium tuberculosis reveals resistance genes and regulatory regions. "], "italic": ["Nat. Commun"], "bold": ["10"]}, {"label": ["14."], "mixed-citation": ["Rancoita, P. M. V. et al. Validating a 14-drug microtiter plate containing bedaquiline and delamanid for large-scale research susceptibility testing of mycobacterium tuberculosis. "], "italic": ["Antimicrob. Agents Chemother"]}, {"label": ["15."], "mixed-citation": ["Falzon, D. et al. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. "], "italic": ["Eur. Respir. J"], "bold": ["49"]}, {"label": ["16."], "mixed-citation": ["WHO. "], "italic": ["Catalogue of Mutations in Mycobacterium Tuberculosis Complex and Their Association with Drug Resistance"]}, {"label": ["17."], "mixed-citation": ["Epidemiological cutoff values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis. "], "italic": ["Eur. Respir. J"]}, {"label": ["19."], "surname": ["Bradley"], "given-names": ["P"], "article-title": ["Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis"], "source": ["Nat. Commun."], "year": ["2015"], "volume": ["6"], "fpage": ["1"], "lpage": ["14"], "pub-id": ["10.1038/ncomms10063"]}, {"label": ["25."], "mixed-citation": ["Makhado, N. A. et al. Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study. "], "italic": ["Lancet Infect. Dis"]}, {"label": ["26."], "mixed-citation": ["Beckert, P. et al. MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era. "], "italic": ["Genome Med"], "bold": ["12"]}, {"label": ["28."], "mixed-citation": ["World Health Organization. "], "italic": ["Technical Report on Critical Concentrations for Drug Susceptibility Testing of Isoniazid and the Rifamycins (Rifampicin, Rifabutin and Rifapentine)"]}, {"label": ["30."], "surname": ["Miotto", "Cabibbe", "Borroni", "Degano", "Cirilloa"], "given-names": ["P", "AM", "E", "M", "DM"], "article-title": ["Role of disputed mutations in the rpoB gene in interpretation of automated liquid MGIT culture results for rifampin susceptibility testing of mycobacterium tuberculosis"], "source": ["J. Clin. Microbiol."], "year": ["2018"], "volume": ["56"], "fpage": ["1"], "lpage": ["9"], "pub-id": ["10.1128/JCM.01599-17"]}, {"label": ["34."], "surname": ["Munir"], "given-names": ["A"], "article-title": ["Using cryo-EM to understand antimycobacterial resistance in the catalase-peroxidase (KatG) from Mycobacterium tuberculosis"], "source": ["Structure"], "year": ["2020"], "volume": ["29"], "fpage": ["1"], "lpage": ["14"]}, {"label": ["35."], "surname": ["Hicks"], "given-names": ["ND"], "article-title": ["Clinically prevalent mutations in Mycobacterium tuberculosis alter propionate metabolism and mediate multidrug tolerance"], "source": ["Physiol. Behav."], "year": ["2019"], "volume": ["176"], "fpage": ["139"], "lpage": ["148"]}, {"label": ["37."], "surname": ["Zhang"], "given-names": ["L"], "article-title": ["Structures of cell wall arabinosyltransferases with the anti-tuberculosis drug ethambutol"], "source": ["Science"], "year": ["2020"], "volume": ["9102"], "fpage": ["eaba9102"]}, {"label": ["40."], "mixed-citation": ["Vargas, R. et al. Role of epistasis in amikacin, kanamycin, bedaquiline, and clofazimine resistance in mycobacterium tuberculosis complex. "], "italic": ["Antimicrob. Agents Chemother"], "bold": ["65"]}, {"label": ["41."], "mixed-citation": ["Hicks, N. D., Carey, A. F., Yang, J., Zhao, Y. & Fortunea, S. M. Bacterial genome-wide association identifies novel factors that contribute to ethionamide and prothionamide susceptibility in mycobacterium tuberculosis. "], "italic": ["MBio"], "bold": ["10"]}, {"label": ["45."], "surname": ["Peterson", "Ma", "Sherman", "Baliga"], "given-names": ["EJR", "S", "DR", "NS"], "article-title": ["Network analysis identifies Rv0324 and Rv0880 as regulators of bedaquiline tolerance in Mycobacterium tuberculosis"], "source": ["Nat. Microbiol."], "year": ["2016"], "volume": ["1"], "fpage": ["6"], "lpage": ["12"], "pub-id": ["10.1038/nmicrobiol.2016.78"]}, {"label": ["46."], "mixed-citation": ["Kadura, S. et al. Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid, and pretomanid. "], "italic": ["J. Antimicrob. Chemother"]}, {"label": ["47."], "surname": ["Lee"], "given-names": ["BM"], "article-title": ["Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering"], "source": ["PLoS Pathog"], "year": ["2020"], "volume": ["16"], "fpage": ["1"], "lpage": ["27"], "pub-id": ["10.1371/journal.ppat.1008287"]}, {"label": ["48."], "mixed-citation": ["Sonnenkalb, L. et al. Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis. "], "italic": ["Lancet Microbe."], "bold": ["4"]}, {"label": ["51."], "mixed-citation": ["Carter, J. J. et al. Prediction of pyrazinamide resistance in Mycobacterium tuberculosis using structure-based machine learning approaches. "], "italic": ["bioRxiv"]}, {"label": ["53."], "surname": ["Karmakar"], "given-names": ["M"], "article-title": ["Empirical ways to identify novel Bedaquiline resistance mutations in AtpE"], "source": ["PLoS One"], "year": ["2019"], "volume": ["14"], "fpage": ["1"], "lpage": ["14"], "pub-id": ["10.1371/journal.pone.0217169"]}, {"label": ["54."], "surname": ["Battaglia"], "given-names": ["S"], "article-title": ["Characterization of genomic variants associated with resistance to bedaquiline and delamanid in na\u00efve Mycobacterium tuberculosis clinical strains."], "source": ["J. Clin. Microbiol."], "year": ["2020"], "volume": ["58"], "fpage": ["1"], "lpage": ["16"], "pub-id": ["10.1128/JCM.01304-20"]}, {"label": ["55."], "surname": ["Brankin", "Fowler"], "given-names": ["AE", "PW"], "article-title": ["Inclusion of minor alleles improves catalogue-based prediction of fluoroquinolone resistance in Mycobacterium tuberculosis"], "source": ["JAC-Antimicrob. Resist."], "year": ["2023"], "volume": ["5"], "fpage": ["1"], "lpage": ["5"]}, {"label": ["56."], "mixed-citation": ["Harms, A., Maisonneuve, E. & Gerdes, K. Mechanisms of bacterial persistence during stress and antibiotic exposure. "], "italic": ["Science"], "bold": ["354"]}, {"label": ["57."], "mixed-citation": ["Rancoita, P. M. V. et al. Validating a 14-drug microtitre plate containing bedaquiline and delamanid for large-scale research susceptibility testing of "], "italic": ["Mycobacterium tuberculosis", "Antimicrob. Agents Chemother"]}, {"label": ["58."], "mixed-citation": ["Fowler, P. W. et al. Automated detection of bacterial growth on 96-well plates for high-throughput drug susceptibility testing of Mycobacterium tuberculosis. "], "italic": ["Microbiology"]}, {"label": ["59."], "mixed-citation": ["The CRyPTIC Consortium and the 100,000 Genomes Project. Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing. "], "italic": ["N. Engl. J. Med."], "bold": ["379"]}, {"label": ["60."], "surname": ["Pedregosa"], "given-names": ["F"], "article-title": ["Scikit-learn: machine learning in Python"], "source": ["J. Mach. Learn. Res."], "year": ["2011"], "volume": ["12"], "fpage": ["2825"], "lpage": ["2830"]}, {"label": ["61."], "mixed-citation": ["Wickam, H. "], "italic": ["ggplot2: Elegant Graphics for Data Analysis"]}, {"label": ["62."], "mixed-citation": ["Crispell, J., Balaz, D. & Gordon, S.V. Homoplasyfinder: A simple tool to identify homoplasies on a phylogeny. "], "italic": ["Microb. Genom."], "bold": ["5"]}, {"label": ["64."], "mixed-citation": ["The CRyPTIC Consortium. Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach. 10.1101/2021.09.14.460353 (2021)."]}]
{ "acronym": [], "definition": [] }
64
CC BY
no
2024-01-14 23:40:16
Nat Commun. 2024 Jan 12; 15:488
oa_package/34/53/PMC10786857.tar.gz
PMC10786858
38216657
[ "<title>Introduction</title>", "<p id=\"Par2\">The concept of universality in biological and social systems is highly debated<sup>##UREF##0##1##–##REF##37238490##7##</sup>. Although many areas of science are keen to uncover universal statistical features of their studied systems, biology, and sociology are usually focusing on quite the opposite, i.e. the contextual specificities of the investigated problem. Besides this dominating trend, in ecology, there are many attempts for a unified statistical description of large plant or animal ensembles. Examples are population abundance studies<sup>##UREF##3##8##–##UREF##7##12##</sup>, scaling laws for size<sup>##REF##15505224##13##</sup>, life expectancy or motion trajectories<sup>##REF##11396846##4##,##REF##25411406##6##</sup>, topological features of food and metabolic networks, and emerging patterns. In such a line of studies tree size evolution and the resulting statistics have been intensively studied in the past decades<sup>##UREF##8##14##,##UREF##9##15##</sup>. Most of the models used in the literature are motivated by applications in sustainable forest management plans<sup>##UREF##10##16##</sup> , or by tree demographic studies<sup>##UREF##11##17##</sup>.</p>", "<p id=\"Par3\">Tree growth and mortality play a fundamental role in the ecosystem identity as well as the dynamics of forests and woodlands<sup>##UREF##12##18##</sup>. Exploring the potential universality of the dynamical mechanisms of tree ensembles (compact tree stocks) with different management and natural histories, but belonging to the same bioclimatic region, through simple variables such as the tree size remains an important statistical and modeling challenge<sup>##UREF##13##19##</sup>. Besides this, there is a general trend in focusing on forest ecosystems, while it is known that trees can take important role in the identity of the open landscapes (see e.g. wood-pasture systems of Europe<sup>##UREF##14##20##</sup>). With this study we aim to address tree size distribution in two ecologically contrasting ecosystem types from Eastern Europe: semi-natural forests with mature trees and ancient wood-pastures. We selected tree species with different ecological recruitments but that occurs in both ecosystem types. By validating the models and their assumptions on such statistical data one can then step further with the models and study the response of the system to environmental changes and human influence. Assuming argumentable growth, mortality and recruitment rates, here we consider an analytically solvable evolutionary equation to model tree-size statistics in temperate zone woodlands.</p>", "<p id=\"Par4\">Earlier statistical studies revealed that a Gamma distribution describes well tree diameter distribution in deciduous forests, although many other fitting functions were proposed<sup>##UREF##9##15##,##UREF##15##21##,##UREF##16##22##</sup>. A particular example of an alternative result is the Weibull distribution applied to DBH distribution of deciduous forests in North America<sup>##UREF##17##23##</sup>. Building on this finding, we employ a newly developed Local Growth and Global Reset (LGGR)<sup>##UREF##18##24##</sup> model which is a simple evolutionary master equation with realistic dynamical assumptions<sup>##UREF##18##24##,##UREF##19##25##</sup> to test the region-specific generality of tree diameter distribution originating from closed canopy mature semi-natural forests and ancient wood-pastures from the continental biogeographic region of Central Europe. Our data on individual tree diameters originates from temperate deciduous forests and wood-pastures covering a complete gradient of management history, from plantation forests (full human control), through semi-natural forests (reduced human interventions, multi-century continuity) to ancient wood-pastures with large old trees (Fig. ##FIG##0##1##). In the following, first, we provide a description of the study sites, the particularities of the systems, and the origin of the tree size data and then we will apply our model to analytically approximate the observed distributions and the real-life processes that are incorporated in the model.</p>" ]
[ "<title>Materials and methods</title>", "<title>Tree-size distribution revealed by the experiments</title>", "<p id=\"Par5\">Three different temperate zone woodland ecosystem types were selected for the tree-size measurements, with the aim of mapping various contributions to tree growth, mortality and recruitment processes. We determined the mean Diameter at Breast Height (DBH) for all trees in compact, well-delimited regions for all the studied ecosystems.</p>", "<p id=\"Par6\">Below we describe the three studied systems while the descriptive statistics of the trees are presented in Table ##TAB##0##1##. The first sample of trees originates from semi-natural, mature, deciduous forest plots (hereafter ,,forest”) from Central Romania (cca 400–600 m asl, Fig. ##FIG##0##1##a). The dominant native tree taxa that provides identity for these forests are the Oak (<italic>Quercus</italic> sp., hereafter <italic>Quercus</italic>), the Hornbeam (<italic>Carpinus</italic> sp., hereafter <italic>Carpinus</italic>), and the Beech (<italic>Fagus</italic> sp., hereafter <italic>Fagus</italic>). From the perspective of the management history of these forests, only <italic>Quercus</italic> was planted by the Transylvanian Saxons, the other two species were naturally regenerated (intentionally in the case of<italic>Fagus</italic> and unintentionally in the case of <italic>Carpinus</italic>). The natural values of these forests are exceptionally high due to the low human interventions in the past century which allowed the accumulation of dead wood and also the presence of large old trees<sup>##REF##23840322##26##</sup>. Forests from this region are covered by Natura 2000 protected area regulations. Grazing has been prohibited in these forests since cca one century while the main economic use of the trees is the timber<sup>##UREF##20##27##</sup>. The density of trees is typically higher than 600 trees/hectare<sup>##REF##23840322##26##</sup>. The circumference of trees having at least 3 m height was measured at 130 cm from the ground<sup>##UREF##21##28##</sup>. Trees from 15 forest plots were measured. Only the measurements from the dominant tree taxa (see above) were used in this study in order to ensure an adequate sample size.</p>", "<p id=\"Par7\">In order to avoid the forest edge effects on tree size the tree measurement plots were situated at a distance of 270–850 m from the forest edge<sup>##UREF##21##28##</sup>. Based on the in situ age estimation on ring counts, the trees in our sample had between 15 and 250 years. Other, naturally established tree species that could present competition for the modeled trees are: <italic>Acer pseudoplatanus, Acer platanoides, Tilia cordata</italic> and in lesser extent <italic>Prunus avium, Fraxinus excelsior</italic> and <italic>Acer campestre</italic>.</p>", "<p id=\"Par8\">The second sample of trees originates from an ancient, traditionally managed wood-pasture (hereafter wood-pasture) from Central Romania (cca 400–600 m asl, Fig. ##FIG##0##1##b). The dominant <italic>native</italic> tree taxa in the wood-pasture systems contains the three taxa mentioned above (<italic>Quercus, Fagus, Carpinus</italic>), and measurements of trees belonging to these taxa were used in this analysis. The origin of these wood-pastures is the centuries-long silvopastoral use, when trees regenerated naturally, facilitated by thorny shrubs and periodical reduction of grazing pressure. Similarly to forests, the wood-pastures from this region are covered by Natura 2000 regulations. Unlike in the case of the forests (see above), the main use of trees historically and now is the shade for livestock, fruits, and erosion control for the soil<sup>##UREF##20##27##</sup>. The density of trees is much below that of forests, being around 7-25 trees/hectare<sup>##UREF##21##28##</sup>. The circumference of trees having at least 3 m height was measured at 130 cm from the ground<sup>##UREF##21##28##</sup> in 40 plots. The age of the trees based on ring counts ranges between cca 10 years to up to 300 years. Other, naturally established tree species that are commonly accompanying the above trees are <italic>Acer campestre, Pyrus pyraster, P. communis, Malus sylvestris, Prunus avium</italic><sup>##UREF##21##28##</sup>. For simplicity, whenever we refer to the forest and wood-pasture systems together, we use the term <italic>woodland</italic> in the following.</p>", "<p id=\"Par9\">Finally, in order to have a sharply contrasting system for comparison, we considered monocultures of hybrid Poplar tree (hereafter <italic>Populus</italic>) plantations with a density of approx. 400 trees/hectare, where all trees were planted in the same year and where no human intervention was considered since. The latter measurements aimed to illustrate disparities in tree size distribution within controlled ecosystems that had not achieved statistical stationarity, as opposed to mature natural forest environments characterized by uncontrolled tree diversity and growth, where it is presumed that the tree-size distribution is in a stationary state. Another reason for studying such systems was to have information on the growth dynamics of genetically identical trees in controlled environments. The trees were planted in a regular square grid with an approximate distance of 5 m between each other as it is illustrated in an aerial perspective in Fig. ##FIG##0##1##c. We made measurements for two plantations of different ages (approximately 10 and 15 years). Since virtually no other tree species were present in the plantations, we assume no interspecific competition in this system.</p>", "<p id=\"Par10\">All three databases constructed by us contain exhaustive measurements in a compact tree ensemble for DBH values<sup>##UREF##22##29##</sup>. From the collected data we constructed the normalized probability density function for the tree size distribution. Tree sizes, <italic>x</italic>, are quantified with their DBH values, and in our statistics, these were normalized to the mean for the specific tree ensemble: . The probability densities computed from the data are shown in Fig. ##FIG##1##2##. The tree size distributions for semi-natural forests and wood-pastures collapse on a master trend which can be well approximated with a Gamma distribution. Our finding on the goodness of the Gamma distribution is in agreement with earlier studies on tree-size distribution in forest environment<sup>##UREF##9##15##,##UREF##16##22##</sup>. As expected, the statistics for the plantation is strikingly different, resembling a Gaussian trend (Fig. ##FIG##1##2##b–d), and the distributions in <italic>y</italic> for two different aged poplar plantations collapse again (Fig. ##FIG##1##2##b). The Gaussian nature of the distribution in the plantation seems consistent with what one would expect from simple analogies with similar statistics in other controlled biological systems<sup>##UREF##23##30##</sup>. The Gamma-type tree-size distribution in the forest is however a more complex problem, and in understanding it one should follow the dynamical evolution of the tree ensemble, the interplay of growth and mortality processes. Due to the mature nature of the forest and wood-pasture, one can then assume that the observed distributions are stationary ones, so the stationary limit of such an evolutionary equation should describe the observed distributions, which is a helpful assumption for modeling purposes. In the following we will look deeper into the available statistical data on such systems and try to understand them through mean-field-like evolutionary models.</p>", "<title>The LGGR modeling framework</title>", "<p id=\"Par11\">For modeling purposes we used the Local Growth and Global Reset (LGGR) master-equation framework. This evolutionary type equation is a mean-field-like description of an ensemble where individuals are subject to the same probabilistic local growth and global reset processes<sup>##UREF##18##24##,##REF##28415222##31##</sup>. Reset is a process where an individual with a given state leaves the considered ensemble (either by mortality or some equivalent process) and it is replaced by a different individual in the ground state. For a unidirectional growth process, this reset is needed in order, to achieve a stationary state. It has been proven to be appropriate for explaining various distributions that are characteristic of different complex systems<sup>##UREF##18##24##,##UREF##24##32##,##UREF##25##33##</sup>. For illustrating such a dynamics let us consider that the states of the elements are characterized by a quantity <italic>x</italic>, in our case this quantity can be the size quantified by DBH.</p>", "<p id=\"Par12\">In a first approach let us discretize the trees’ diameter in well-distinguishable states, described by an integer number of corresponding DBH quanta, <italic>n</italic> (). In this discrete scenario we denote by the number of elements in state <italic>n</italic> at time <italic>t</italic>. Assuming local probabilistic changes for the states of the elements and a probabilistic resetting process to the state, an evolutionary master equation can be considered:Here is the state-dependent local growth rate (probability per unit time) of going from state <italic>n</italic> to state , is the local decrease rate of going from state <italic>n</italic> to state , and is the reset rate for going from state <italic>n</italic> to state 0. The system preserves the elements in the system by the last term, which is nonzero for ( being the Kronecker delta symbol). We have thus:For many real-world processes, like the case of trees, the local dynamics is unidirectional. The living tree’s diameter can only increase, with state-dependent growth rates. This means that in Eq. (##FORMU##9##1##) for all <italic>n</italic> states and the process becomes the one we named Local Growth and Global Reset (LGGR) dynamics:We can switch now the description from the occupancy numbers to the probabilities that a tree’s DBH is <italic>n</italic> quanta at time moment <italic>t</italic>. Naturally, normalization of satisfies: . The evolutionary master equation describing the local unidirectional transitions and a random resetting process is also a system of coupled first-order differential equations:The last term in Eq. (##FORMU##25##4##) maintaining the normalization of is :Based on the mathematical form of the reset rate, , two different dynamical scenarios can be distinguished. The simplest case is when for all <italic>n</italic> values the state-dependent reset rate, , is positive. Reset means that the element disappears from state <italic>n</italic> and reapers in state 0. For trees this simple reset describes tree mortality, and consequently the replacement of a tree with a new individual with 0 size. This dynamics is represented in Fig. ##FIG##2##3##a. A more complicated dynamical scenario is when the reset rate, , can be both positive and negative as a function of the <italic>n</italic> value. A scenario of this type is represented in Fig. ##FIG##2##3##b. One should keep in mind that a negative reset is an inverse process to the ordinary reset, it means that an element is appearing in state <italic>n</italic> and disappears from another state, preserving the total balance. In the case of tree ecosystems this would mean that a new tree that appears in our statistics is characterized not by a 0 size, but it appears in the bin, usually <italic>n</italic> smaller than a critical value. Simultaneously, large trees are dying out or get harvested so they disappear from states with . This second scenario considering a state-dependent smart reset rate offers much more flexibility and it is more appropriate for modeling the tree growth dynamics in the ecosystems where our data was collected from. Such an attempt was considered recently for modeling the distribution of wealth and income in human societies<sup>##UREF##25##33##,##UREF##26##34##</sup>.</p>", "<p id=\"Par13\">Another possibility to include additional terms in the evolutionary equation is by considering the case when the number of elements is also changing in the system. For example, in the case when the number of elements (trees) is increasing (or decreasing) multiplicativelyone getsleading to an extra reset-type term in the master equation for :Such kind of process was recently considered for explaining the universal statistics of citations and Facebook shares<sup>##REF##28678796##35##</sup>.</p>", "<p id=\"Par14\">Handling mathematically the coupled differential equations from Eq. (##FORMU##41##8##) in the discrete dynamical picture is quite tedious. The discrete process described by Eq. (##FORMU##41##8##) can be generalized to continuous states () in the limit <sup>##UREF##19##25##</sup>. In such a picture, instead of the discrete state probabilities we will have the continuous probability densities with the normalization condition . The growth and reset rates are written as functions of the state variable <italic>x</italic>:By taking this continuous state generalization, the master equation written in Eq. (##FORMU##25##4##) transforms into a partial differential equation:In this continuous limit, the last term is again the feeding at imposed by the Dirac delta function . This term allows to preserve the normalization of . The mean value of the reset rate () is given as:In the stationary limitthe evolution equation for the probability density of having a tree size described by Eq. (##FORMU##48##10##) simplifies into:Equation (##FORMU##56##13##) has a compact analytical solution that depends only on the form of the chosen growth and reset rates<sup>##UREF##18##24##,##UREF##19##25##,##REF##28415222##31##</sup>:with <italic>C</italic> being a normalization constant. This closely resembles the formulation proposed by Van Sickle et al.<sup>##REF##839821##36##</sup> widely used in demographic modeling for biological systems<sup>##UREF##27##37##,##REF##16643304##38##</sup>.</p>", "<p id=\"Par15\">Based on the form of the growth- and reset rates, the LGGR model is able to reproduce stationary probability distributions, , that are frequently encountered in complex systems<sup>##UREF##18##24##,##UREF##19##25##,##UREF##24##32##,##UREF##25##33##</sup>. The LGGR’s mathematical apparatus has been comprehensively studied in recent years<sup>##UREF##18##24##,##UREF##19##25##,##REF##28415222##31##,##UREF##28##39##,##UREF##29##40##</sup>, encompassing aspects of convergence and applicability to various fields of science<sup>##UREF##18##24##,##UREF##24##32##–##REF##28678796##35##,##UREF##30##41##</sup>.</p>", "<title>Compliance statement</title>", "<p id=\"Par16\">Our research, involving non-invasive measurements, fully adheres to the regulations of the International Union for Conservation of Nature (IUCN) Policy on Species at Risk of Extinction and the Convention on the Trade in Endangered Species of Wild Fauna and Flora (CITES) to ensure the ethical treatment and protection of endangered plant species.</p>" ]
[ "<title>Results</title>", "<p id=\"Par17\">We apply now the LGGR modeling framework to describe the dynamics of tree-size distribution. There are three main processes that drive this dynamics: a monotonic growth, the possibility of a reset (natural mortality or exploitation followed by the recruitment of new trees), and a multiplicative change in the number of trees belonging to one species. These stochastic processes are mathematically quantified by the growth rate, the reset rate and dilution rate. Once the needed kernel functions are realistically defined, the dynamics given by the LGGR model should yield the time evolution of the tree-size distribution function. In a general study of the LGGR dynamics it was previously shown<sup>##UREF##29##40##</sup>, that apart from some pathologic cases, such systems are indeed converging to the stationary distribution. Depending on the starting condition, the mean of the distribution might converge slowly to a stationary value, however, the distribution of converges quickly to a stationary distribution. Given that the considered ecosystems (forest and wood-pasture) are determined largely by mature trees, we can assume that the DBH distributions that we see in the forest and wood-pasture correspond to the stationary distribution. This is different for even-aged plantations, which are still in continuous development. Interestingly however, even in this clearly non-stationary case, their size distribution during the growth process can be rescaled if we normalize the sizes to the mean value. This is what we see in Fig. ##FIG##1##2##b for the plantations: although the diameters are continuously increasing, the statistics in is only slightly different for a plantation that is 10 or 15 years old. This scaling, suggests that the growth speed of the trees has to increase as a function of the tree diameter, i.e. larger trees have to grow faster.</p>", "<p id=\"Par18\">For choosing the right functional form for the growth and reset rates we take into account empirical knowledge of the tree life cycle, diversity dynamics in natural forest environments, previous experimental observations on such processes, and aim for a mathematical simplicity that allows compact analytical results. We follow here a physicist approach for such complex systems, using a small number of model parameters, and by simple, yet realistic, assumptions we aim to describe the main elements and universal features in the observed statistics. The confirmation of our model will not focus thus on the statistical goodness of the fit as it was done in the work of Lima<sup>##UREF##15##21##</sup> for example, but rather on the desire to understand by a simple analytical model the dynamical mechanism leading to the universal form of the tree-size distribution in the studied forest and wood-pasture ecosystems.</p>", "<title>Growth rate</title>", "<p id=\"Par19\">Both our measurement data on the Populus plantations (demonstrating an increasing standard deviation with mean size increment; see Fig. ##FIG##1##2##d) and the data available in the literature<sup>##UREF##6##11##,##REF##15505224##13##,##UREF##31##42##–##REF##35779141##49##</sup> supports the assumption that the growth rate () of deciduous trees monotonically increases with the tree diameter. Even without a reset process, this increase cannot go on indefinitely, therefore for large trees, it has to saturate. A mathematical form that can accommodate such a growth rate is:The specific functional form, Eq. (##FORMU##67##15##, for the growth rate was taken by aiming to mathematical simplicity. However, its form and the involved <italic>b</italic> parameter value are consistent with all experimental data (supporting information also for a similar sub-linear growth rate from Moore et al.<sup>##UREF##6##11##</sup>). The growth rate given in Eq. (##FORMU##67##15##) is supported by the data provided by the United States National Park Service (NPS)<sup>##UREF##38##50##,##UREF##39##51##</sup>, where we have identified the annual growth rate from the diameter of the tree rings. For three tree genera (<italic>Quercus sp., Liriodendron sp., and Acer sp.</italic>) in Fig. ##FIG##3##4##a we plot the averaged annual growth rate as a function of (<italic>DBH</italic> measured here approximately 1 m above the ground). The numbers of trees by genera that were considered for computing these growth rates were: for <italic>Quercus genus</italic> 545 trees (<italic>(Quercus alba, Quercus rubra, Quercus montana</italic> species); for <italic>Liriodendron genus</italic> 210 trees (<italic>Liriodendron tulipifera species</italic>); for <italic>Acer genus</italic> 64 trees (<italic>Acer negundo, Acer rubrum, Acer saccharinum</italic> species). In Fig. ##FIG##3##4##a, we also indicate the trend that is given by the kernel function for the growth rate, Eq. (##FORMU##67##15##), with a parameter set that gives a reasonable description of the data.</p>", "<title>Reset rate</title>", "<p id=\"Par20\">Unlike the growth rate, the reset rate is much more difficult to measure experimentally. In the LGGR framework the reset rate, characterizing the transitions from large to small DBH categories, incorporates the combination of the mortality (caused either by natural mortality or forest exploitation) and the recruitment (appearance of young and small trees) processes. This corresponds to the replacement of dead trees with new ones. To realistically choose the form of the reset kernel function (), one should consider both, the form of the mortality rate and the recruitment rate in the function of tree size. The recruitment rate acts as a negative reset rate in this context. Similarly with the increasing growth rate as a function of tree sizes, assuming an increasing reset rate would be natural. One would expect that the reset rate is also converging to a constant value for very large trees. Deriving a reasonable kernel function for the reset rate can adhere to the following logic:</p>", "<p id=\"Par21\"><italic>First</italic>, in all tree census data there is an minimal diameter under which trees do not enter in the statistics both for the dead and living trees. This means that from the viewpoint of the detected dynamics the reset should be negative (trees are just entering in the statistics) for . The recruitment of new trees happens in this experimentally less tracked DBH region. Thus, the available data does not reflect the reset rate () itself, it yields instead the probability that a dead tree with a given diameter exists in an ecosystem. Therefore, this probability is rather related to the mortality component of the reset rate<sup>##UREF##40##52##–##REF##30418996##55##</sup>. In the framework of our modeling, this quantity is proportional to the product of the reset rate and probability density function, . As the recruitment rate presents a substantial negative reset for small tree sizes () and the mortality rate exhibits a declining pattern<sup>##UREF##40##52##,##REF##33782580##53##</sup> for , the cumulative impact of these functions can indeed be approximated as an increasing but converging function. These facts are all in agreement with an increasing reset rate in the form:Here <italic>r</italic>, <italic>g</italic> and , are positive constants. In further calculations we will assume , reducing the number of model parameters and making the mathematics simpler.</p>", "<p id=\"Par22\"><italic>Second</italic>, it is known that tree diversity increases with time in both forests and wood-pastures. In closed canopy mature forests key drivers for the establishment of new tree species are the intermediate-level disturbances (typically affecting both the tree stands and the individual mature trees, creating gaps of various sizes), which results in a diversification of the biotic (e.g. herbaceous plants) and abiotic (light, microclimate) conditions at local and plot levels<sup>##UREF##42##56##</sup>, in the benefit of both shade tolerant and light-demanding trees<sup>##UREF##43##57##</sup>. In wood-pasture systems, light is rarely a limiting factor for tree establishment. Here the species diversification in time depends on the herbivore density and dynamics as well as the existence of protecting structures for individual trees across the grazed land (e.g. associational resistance assured by unpalatable plants)<sup>##UREF##44##58##</sup>. Besides the local factors, the natural establishment of new tree species in the two ecosystem types depends on the regional species pool (referred to as ‘external memory’ in<sup>##UREF##45##59##</sup>). The existing diversification means, that whenever a tree is dying, its place can be overtaken by an individual from another species. In the case of <italic>Quercus</italic> trees, for example, the establishment of young individuals to replace the mature <italic>Quercus</italic> trees in forests is hampered by improper light conditions. In such systems the likelihood for other, shade-tolerant trees to replace the <italic>Quercus</italic> is high. In the case of <italic>Fagus</italic> and <italic>Carpinus</italic>, both species tolerate and regenerate in shade - in these cases, the replacement of old individuals can happen by the same or different species. Additionally, the removal of mature trees represents a diversification of the forest stand for the semi-natural forest. Since the diversity is increasing, this effect will lead to a multiplicative decrease in the number of individuals for a species, which is equivalent (as we have shown in the previous section) with a state independent reset term. Taking all these effects into account, we propose that the reset rate should be taken in the form,with:Using data for the size distribution of dead trees in several mature deciduous forests we can also verify whether the form of the proposed reset rate is a reasonable hypothesis. If we denote by the stationary limit of the probability density for the DBH of the trees, the size distribution of the dead trees should follow the distribution with given by Eq. (##FORMU##82##16##). For testing this reset rate we can use again the data from NPS<sup>##UREF##38##50##,##UREF##39##51##</sup> for dead trees diameter, which should be fitted as . The data provided by the United States National Park Service contains the diameter of dead trees within a number of 320 plots from 10 national parks in the USA. For consistency, and for putting together several data from different forests, the trees’ diameter is normalized to the mean value of tree diameters in the forest (taking now only the living trees). Considering the <italic>Quercus</italic> genus, the data for the histogram of the dead trees is plotted in Fig. ##FIG##3##4##b. The dashed line indicates a fit based on Eq. (##FORMU##111##25##) with the parameters , , and for the experimentally observed probability density and in the reset rate.</p>", "<p id=\"Par23\">Concerning the three investigated ecosystems with the applied cultivation approaches, the main triggering conditions for the tree mortality (reset) are summarized in Table ##TAB##1##2##.</p>", "<title>Stationary size distribution</title>", "<p id=\"Par24\">Once we accept the form given by Eqs. (##FORMU##67##15##) and (##FORMU##86##17##) for the growth and reset rates, respectively, it is straightforward to compute the stationary probability density, . Since the value has been now incorporated in the reset rate (Eq. ##FORMU##86##17##), according to Eq. (##FORMU##57##14##) we getwhere and <italic>C</italic> is a normalization constant. If the distribution is defined on the interval, the normalization constant becomes:The first moment of the distribution (average) is also analytical:We write now the distribution function for the tree-sizes normalized relative to the mean value:Assuming that , it resultstherefore the probability density function will have only two parameters to fit the experimental results for :As Fig. ##FIG##1##2##a shows, the probability density for the distribution of on forests and wood-pastures collapse, and it can be well approximated by the form given in Eq. (##FORMU##111##25##), with parameters and , leading to .</p>", "<p id=\"Par25\"><bold>Consistency in the model parameters.</bold> To ensure consistency in the model parameters, we simultaneously considered the goodness of fit for both the experimentally observed probability density functions and the data related to growth and reset processes. The optimal fit parameters were established by minimizing the Root Mean Squared Logarithmic Error through iteration across a fine grid within the parameter space. When selecting the parameters, equal weight was given to the fitting of the growth data in Fig. ##FIG##3##4##a, the data concerning the reset rate in Fig. ##FIG##3##4##b, and the DBH distribution data in Fig. ##FIG##1##2##a. We concurrently minimized the Root Mean Squared Logarithmic Error for all three quantities. Doing so, the fit parameters for the experimentally observed probability density function are in agreement with the data that we have on growth and reset processes. The values of the coefficients of determination () for the obtained fittings are listed in Table ##TAB##2##3##. Also in agreement with our prediction and imposed restrictions, we find that the best <italic>r</italic> parameter value for fitting the reset data satisfies the condition. Because we have no information on when these trees dried out, no direct values of the rates can be estimated and as a consequence, one cannot determine the parameter that would allow estimation of the parameter as well.</p>", "<p id=\"Par26\">Accepting the parameter from the fit in Fig. ##FIG##3##4##b, we can also predict the reset rate over growth rate ratio () as a function of tree diameters (all sizes taken relative to the mean value). We get:Using the <italic>d</italic> value obtained through fitting the experimental data, , and the value the <italic>q</italic>(<italic>y</italic>) trend is plotted in Fig. ##FIG##3##4##c. From this figure we learn, that the ratio <italic>q</italic> is monotonically increasing as a function of tree sizes and for trees over the reset process is more probable than growth. This intuitively explains why despite the monotonically increasing growth rate the forest does not get filled up by very large trees.</p>", "<p id=\"Par27\">In the preceding section, we highlighted the necessity of integrating diversification into the model. Equation ##FORMU##111##25## defines a stationary probability density function that exhibits its peaks around the value represented by the parameter <italic>c</italic>. When , as established, the density function shows its highest concentration around this value, closely resembling the experimental data (refer to Fig. ##FIG##1##2##a). Considering the relationship between the parameter <italic>r</italic> (fixed at 0.22) and , if were 0, indicating the absence of diversification, Eq. (##FORMU##111##25##) would exhibit a peak around 0.22. However, this projection does not align well with the experimental size distributions presented in Fig. ##FIG##1##2##a. This reasoning underscores the indispensability of incorporating the diversification process into the model.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par28\">Tree size diversity patterns in natural deciduous forest and wood-pasture environments is a complex problem, where new data and simple realistic mathematical models are needed for its better understanding. It has been conjectured that the diameter distribution of trees belonging to given deciduous species follows a Gamma distribution in a mature natural forest<sup>##UREF##9##15##,##UREF##15##21##,##UREF##16##22##</sup>. Here we brought new evidence supporting this hypothesis, considering new exhaustive measurement data for three tree taxa in two different environments: mature semi-natural forests and wood-pastures located in central Romania.</p>", "<p id=\"Par29\">Apart from the generality for the Gamma distribution, our data suggests an intriguing statistical universality: rescaling the tree diameters with the average tree diameter for that species in the given ecosystem type, all the data collapsed on the very same distribution. This intriguing universality across these sites is captured by our model if we assume the same <italic>c</italic> and <italic>d</italic> parameters (Eq. ##FORMU##111##25##) for all taxa and for the different environments (forest and wood-pastures). This means that in the tree census one has to consider the same lower limits for recording a tree, the same dilution rate, , due to diversification, and the ratio of the reset and growth rates should be similar for the same relative diameter values. These are all in agreement with the fact that the considered three deciduous genera dominate quite equally these treed environments and they are ecologically equally fit. Seemingly we deal thus with some interesting stylized facts in tree-size diversity patterns for deciduous temperate climate woodlands (forests and wood-pastures), allowing also a useful rescaling among different species and different semi-natural ecosystems. Data collected on relatively young (up to 15 years) tree plantations reveal different size diversity patterns (i.e. Normal distribution). These plantations clearly did not reach maturity and a stationary state, therefore the difference relative to what is observed in the other two environments should not be a surprise at all. These findings suggest that the Gamma type fit for the tree-size distribution can be used as a simple proxy to infer natural or close-to-natural dynamics of tree establishment and growth. Asymmetric competition (characteristic of natural ecosystems) can result in higher tree size inequality (as found by us for the forest and wood-pasture compared to plantations) where the tree regeneration and growth patterns are determined by largely natural interactions between the trees<sup>##UREF##46##60##</sup>.</p>", "<p id=\"Par30\">In order to understand theoretically the tree-size distribution in semi-natural woodland environments the main processes that govern the evolution of the tree ensemble have to be considered. The first process is a <italic>monotonic growth</italic>, which was assumed to increase with tree size and saturate in the limit of large diameters. For analytical simplicity and in agreement with supporting information from literature<sup>##UREF##6##11##,##UREF##31##42##,##UREF##32##43##,##UREF##34##45##,##UREF##35##46##,##REF##35779141##49##</sup>, we chose a simple sub-linear function for the above (Eq. ##FORMU##67##15##). The second and third processes that complement this growth and allow for developing a stationary distribution are <italic>tree mortality</italic> and <italic>recruitment</italic>, captured by our reset rate. In order to derive a mathematical form for this rate, we considered a process where there is a lower <italic>r</italic> limit for detecting a new or dead tree in the census (trees below this size are not measured). According to this methodology below the <italic>r</italic> size, trees appear in the statistics, known as the phenomenon of recruitment, a process that can be taken into account with a negative reset rate. It is assumed that the tree mortality rate should decrease in a woodland environment with tree sizes due to both endogenous and exogenous effects<sup>##UREF##40##52##–##REF##30418996##55##</sup>. As a combination of these two ecological processes, we assumed that, similarly to the growth rate, the reset rate should increasingly saturate to a constant value for large trees. A mathematically simple reset rate that could reproduce these features was proposed in the form given by Eq. (##FORMU##82##16##). As we have emphasized in the previous section, this reset rate together with the proposed form of the probability density function (Eq. ##FORMU##111##25##) leads to results that are in agreement with observations (Fig. ##FIG##3##4##b). Finally, in order to explain the large value in the final form of the reset rate (Eq. ##FORMU##86##17##), which is necessary for a reasonably good fit of the diameter distributions, we had to assume another reset-like process, due to the <italic>diversification process</italic> implying competitive exclusion of certain species by other species. As it was shown in the general discussion (The LGGR modeling framework), a multiplicative growth or dilution in the total tree number belonging to a species is equivalent to a reset term in the master equation for the probability density function.</p>", "<p id=\"Par31\">The easiest way to elaborate a model that is able to predict a stationary tree-size distribution is to incorporate these probabilistic processes in an evolutionary master equation. This has been done here, in the framework of the previously introduced LGGR model<sup>##UREF##18##24##</sup>. We considered mathematically simple yet realistic forms for growth () and reset () rates, as convenient first-order approximations supported also by experimental data. The stationary distribution provided by the LGGR model reproduced successfully the experimental results. Our main interest focused on unveiling some interesting universality and showing the visually acceptable collapse of the renormalized data. In fitting the experimental data and analyzing the goodness of the fit our aims were quite modest and we followed basically a physicist modeling methodology. Instead of a rigorous quantitative modeling with many unknown parameters, we opted for an analytically solvable model with basically two free parameters. Based on the literature, similar elegant approaches have been favored by others as well<sup>##UREF##6##11##,##UREF##17##23##</sup>. By doing this we concentrated less on the statistical goodness of the provided fit and insisted more on modeling consistency and the usefulness of analytical results in a compact mathematical form. Definitely, one can come up with other, more accurate forms for these kernel functions, describing better the experimental data. The drawback of such an attempt will be the more complicated form for the stationary probability density and the inevitable increase in the number of model parameters. The available DBH data itself was barely enough to construct the qualitative form of the probability density functions, and as it is visible in Fig. ##FIG##1##2##a it has large deviations from a smooth trend. Taking into account also that the experimental data used for testing the growth and reset rate is quite poor and their sources are diverse, we consider that this consistent theoretical description is more fruitful for understanding the experimentally observed universal shape of tree-size distributions across these sites.</p>", "<p id=\"Par32\">Naturally, in order to get further confidence in the proposed model, new and good-quality data should still be gathered. It would be interesting to test in the very same forest and wood-pasture environment the growth and reset dynamics of the considered tree species. Within the same woodland ecosystem, it would be also interesting to gather quantitative data on the diversification process for the tree species. To do this, however, controlled tree census measurements have to be planned and continuously repeated.</p>" ]
[]
[ "<p id=\"Par1\">The diameter distribution of a given species of deciduous trees is well approximated by a Gamma distribution. Here we give new experimental evidence for this conjecture by analyzing deciduous tree size data in mature semi-natural forest and ancient, traditionally managed wood-pasture from Central Europe. These distribution functions collapse on a universal shape if the tree sizes are normalized to the mean value in the considered sample. A new evolutionary master equation is used to model the observed distribution. The model incorporates four ecological processes: tree growth, mortality, recruitment, and diversification. Utilizing simple and realistic kernel functions describing the first three, along with an assumed multiplicative dilution due to diversification, the stationary solution of the master equation yields the experimentally observed Gamma distribution. The model as it is formulated allows an analytically compact solution and has only two fitting parameters whose values are consistent with the experimental data related to these processes. We found that the equilibrium size distribution of tree species with different ecology, originating from two contrastingly different semi-natural ecosystem types can be accurately described by a single dynamical mean-field model.</p>", "<title>Subject terms</title>" ]
[]
[ "<title>Acknowledgements</title>", "<p>Work supported by the UEFISCDI PN-III-P4-ID-PCE-2020-0647 research grant. The work of Sz.K. and M.J. is also supported by the Collegium Talentum Program of Hungary. The contribution of T.H. was made under a Deutsche Bundesstiftung Umwelt (DBU) project on Transylvanian wood-pastures. We are thankful to E. Gabnai for helping us to choose the hybrid poplar plantations as well as to Zs. Néda, M. Paulin and Cs. Gáspár for their help in the fieldwork.</p>", "<title>Author contributions</title>", "<p>Z.N. conceived the model and designed the study, Sz.K. made the data analyses, unified the experimental data and constructed the figures, M.J. participated in data analyzes and model validation, T.H. and Gy.Cs. provided the experimental data and consultancy from the biological and ecological perspective. First draft of the manuscript by Z.N and Sz.K. All authors reviewed the manuscript.</p>", "<title>Data availability</title>", "<p>The data collected by the authors (summarized in Table ##TAB##0##1##) are freely available for download from <sup>##UREF##22##29##</sup>. The data used for plotting Figs. ##FIG##3##4## and ##FIG##3##4##b are from the mentioned sources, and can be obtained by request.</p>", "<title>Competing interests</title>", "<p id=\"Par33\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Aerial (upper row) and ground level (bottom row) perspective image of the three ecosystems: semi-natural forest (<bold>a</bold>), semi-natural wood-pasture (<bold>b</bold>), plantation (<bold>c</bold>). Source: Authors.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>DBH distributions, represented as probability density functions, derived from experimental data. In the first column (<bold>a</bold>, <bold>c</bold>), the distributions for natural forests (in red) and wood-pastures (in green) are depicted alongside the Gamma fit obtained from the LGGR model (Equation ##FORMU##111##25##). The second column (<bold>b</bold>, <bold>d</bold>) shows the DBH distribution within a 10- (in yellow) and a 15-year-old (in blue) <italic>Populus</italic> tree plantation, both with very similar ecological backgrounds, fitted with Gaussian distributions. The lower panels (<bold>c</bold>, <bold>d</bold>) provide an additional visual representation highlighting differences in mean DBH values and illustrating the presence of empty bins.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Schematic illustration of the growth and reset process for two scenarios based on the form of the reset rate: (<bold>a</bold>) simple mechanism with only positive reset rate, (<bold>b</bold>) the reset rate can be both negative and positive ( if , and for ).</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Supporting data and illustrations for the modeling assumptions: (<bold>a</bold>) Growth rate determined from the width of tree rings. The panel illustrates on log-log scale the width of tree rings as a function of stem diameter at one meter above the ground for three tree genera as indicated in the legend. The trend illustrated by the dashed line is given by Eq. (##FORMU##67##15##) with parameters indicated in the figure. The error bars around the data points illustrate the standard error. (<bold>b</bold>) Consistency between the dead trees size distribution, the considered reset rate, and fitted tree-size distribution. Histogram of the size distribution (sizes normalized to the mean) of dead Quercus trees from censused forests plotted together with the fit given by with and parameters estimated from the probability density function. <italic>H</italic> is a proportionality constant needed to fit the experimental histogram. The data used for figures in panels (<bold>a</bold>) and (<bold>b</bold>) was provided by<sup>##UREF##38##50##,##UREF##39##51##</sup>. (<bold>c</bold>) Reset over growth rates probability for the genus Quercus as a function of the trees relative size. The trend of for and .</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Statistical overview of the processed semi-natural woodland and plantation data.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Woodland type</th><th align=\"left\">Species/stand age</th><th align=\"left\">Nr. of trees</th><th align=\"left\">Lowest DBH [cm]</th><th align=\"left\">Greatest DBH [cm]</th><th align=\"left\"> DBH [cm]</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"3\">Semi-natural forest</td><td align=\"left\"><italic>Quercus</italic></td><td align=\"left\">883</td><td align=\"left\">3.2</td><td align=\"left\">122.5</td><td align=\"left\">38.1</td></tr><tr><td align=\"left\"><italic>Fagus</italic></td><td align=\"left\">1782</td><td align=\"left\">3.2</td><td align=\"left\">115.2</td><td align=\"left\">31.5</td></tr><tr><td align=\"left\"><italic>Carpinus</italic></td><td align=\"left\">1994</td><td align=\"left\">1.6</td><td align=\"left\">76.4</td><td align=\"left\">20.1</td></tr><tr><td align=\"left\" rowspan=\"3\">Wood-pasture</td><td align=\"left\"><italic>Quercus</italic></td><td align=\"left\">1013</td><td align=\"left\">4.1</td><td align=\"left\">248.3</td><td align=\"left\">87.0</td></tr><tr><td align=\"left\"><italic>Fagus</italic></td><td align=\"left\">100</td><td align=\"left\">10.2</td><td align=\"left\">136.9</td><td align=\"left\">74.1</td></tr><tr><td align=\"left\"><italic>Carpinus</italic></td><td align=\"left\">255</td><td align=\"left\">4.8</td><td align=\"left\">202.1</td><td align=\"left\">54.0</td></tr><tr><td align=\"left\" rowspan=\"2\">Poplar plantation</td><td align=\"left\"></td><td align=\"left\">1076</td><td align=\"left\">5.7</td><td align=\"left\">36.0</td><td align=\"left\">18.3</td></tr><tr><td align=\"left\"></td><td align=\"left\">1613</td><td align=\"left\">5.1</td><td align=\"left\">54.7</td><td align=\"left\">27.5</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Type of management control and main causes of tree mortality in the considered woodland areas.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">System</th><th align=\"left\">Management control</th><th align=\"left\">Main drivers of tree mortality (interpretable as a contribution to reset in our modeling)</th></tr></thead><tbody><tr><td align=\"left\">Mature forest with high natural values</td><td align=\"left\">Weak, reduced to an initial <italic>Quercus</italic> plantation in the first part of the 1900s. The subsequent increase in the abundance of <italic>Carpinus</italic>, <italic>Fagus</italic>, and other tree species happened naturally. Natural regeneration and the accumulation of dead trees in the forest are accentuated. While timber exploitation happens (the <italic>Quercus</italic> and <italic>Fagus</italic> being valued), this is never at large scale, only at parcels of cca 1-3 hectares and when the trees have cca 90-120 years. Grazing is prohibited by law<sup>##UREF##21##28##</sup>.</td><td align=\"left\">Mostly inter- and intraspecific competition for light. To a lesser extent extreme meteorological conditions, pest outbreaks, fire, and illegal cutting<sup>##UREF##21##28##</sup>.</td></tr><tr><td align=\"left\">Ancient wood-pasture</td><td align=\"left\">Weak, represented by traditional grazing with sheep, cattle, buffalo, and other livestock as well as scrub clearance in the central parts of the pasture. Tree regeneration happens in pulses through associative resistance and in pulses after temporary grazing pressure reductions<sup>##UREF##21##28##</sup>. The oldest trees in such a system have over 300 years.</td><td align=\"left\"><p>Mostly extreme weather conditions (strong winds, lightning, and recently increasing drought)</p><p>weakening or damaging individual mature trees</p><p>which will be subsequently removed with formal</p><p>permit. Illegal fires set by shepherds can be also</p><p>a cause of mortality for old trees. Grazing prohibits tree regeneration in areas without shrubs. In a lesser extent competition and pests or diseases<sup>##UREF##21##28##</sup>.</p></td></tr><tr><td align=\"left\">Plantation under strong management</td><td align=\"left\">In the case of our two plantations no direct human intervention has happened since the establishment.</td><td align=\"left\">The intraspecific (or even intraclonal) competition can be significant. As clone origin, the trees are almost identical genetically. Abiotic factors (wind/storms/snow) caused some level of disturbances.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Coefficient of determination () calculated for the Gamma fit (Eq. ##FORMU##111##25##) of the tree-size distribution in natural woodlands represented in Fig. ##FIG##1##2##a; the fitting of the experimentally obtained growth rates by Eq. (##FORMU##67##15##) in Fig. ##FIG##3##4##a; and the fitting of the size distribution of dead trees by in Fig. ##FIG##3##4##b.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Species</th><th align=\"left\" colspan=\"2\">DBH distributions</th><th align=\"left\" rowspan=\"2\">Growth kernel</th><th align=\"left\" rowspan=\"2\">Reset kernel</th></tr><tr><th align=\"left\">Forest</th><th align=\"left\">Wood-pasture</th></tr></thead><tbody><tr><td align=\"left\"><italic>Fagus</italic></td><td align=\"left\">0.80</td><td align=\"left\">0.47</td><td align=\"left\">–</td><td align=\"left\">–</td></tr><tr><td align=\"left\"><italic>Carpinus</italic></td><td align=\"left\">0.97</td><td align=\"left\">0.85</td><td align=\"left\">–</td><td align=\"left\">–</td></tr><tr><td align=\"left\"><italic>Quercus</italic></td><td align=\"left\">0.91</td><td align=\"left\">0.80</td><td align=\"left\">0.78</td><td align=\"left\">0.60</td></tr><tr><td align=\"left\"><italic>Liriodendron</italic></td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">0.81</td><td align=\"left\">–</td></tr><tr><td align=\"left\"><italic>Acer</italic></td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">0.72</td><td align=\"left\">–</td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\langle$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mo stretchy=\"false\">⟨</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rangle$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mo stretchy=\"false\">⟩</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\simeq 10 years$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mrow><mml:mo>≃</mml:mo><mml:mn>10</mml:mn><mml:mi>y</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\simeq 15 years$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:mrow><mml:mo>≃</mml:mo><mml:mn>15</mml:mn><mml:mi>y</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x \\rightarrow y=\\frac{x}{&lt;x&gt;}$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mrow><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mi>y</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mi>x</mml:mi><mml:mrow><mml:mo>&lt;</mml:mo><mml:mi>x</mml:mi><mml:mo>&gt;</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho (y)$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mrow><mml:mi>ρ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x\\rightarrow n$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mrow><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$N_n(t)$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=0$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\frac{dN_n(t)}{dt}=\\mu _{n-1} N_{n-1}+\\lambda _{n+1}N_{n+1}-(\\mu _n+\\lambda _n+\\gamma _n)N_n(t)+ N_{total} \\delta _{n,0}\\langle \\gamma \\rangle (t). \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M20\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>N</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">total</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>δ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu _n$$\\end{document}</tex-math><mml:math id=\"M22\"><mml:msub><mml:mi>μ</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n+1$$\\end{document}</tex-math><mml:math id=\"M24\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq12\"><alternatives><tex-math id=\"M25\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda _n$$\\end{document}</tex-math><mml:math id=\"M26\"><mml:msub><mml:mi>λ</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq13\"><alternatives><tex-math id=\"M27\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n-1$$\\end{document}</tex-math><mml:math id=\"M28\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq14\"><alternatives><tex-math id=\"M29\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma _n$$\\end{document}</tex-math><mml:math id=\"M30\"><mml:msub><mml:mi>γ</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq15\"><alternatives><tex-math id=\"M31\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$N_{total}=\\sum _{i} N_i$$\\end{document}</tex-math><mml:math id=\"M32\"><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">total</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mo>∑</mml:mo><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq16\"><alternatives><tex-math id=\"M33\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=0$$\\end{document}</tex-math><mml:math id=\"M34\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq17\"><alternatives><tex-math id=\"M35\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\delta _{n,0}$$\\end{document}</tex-math><mml:math id=\"M36\"><mml:msub><mml:mi>δ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M37\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\langle \\gamma \\rangle (t) =\\sum _{j} \\gamma _j \\frac{N_j(t)}{N_{total}}. \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M38\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:munder><mml:mo>∑</mml:mo><mml:mi>j</mml:mi></mml:munder><mml:msub><mml:mi>γ</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">total</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq18\"><alternatives><tex-math id=\"M39\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda _n=0$$\\end{document}</tex-math><mml:math id=\"M40\"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M41\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\frac{dN_n(t)}{dt}=\\mu _{n-1} N_{n-1}-(\\mu _n+\\gamma _n)N_n(t)+ N_{total} \\delta _{n,0}\\langle \\gamma \\rangle (t). \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M42\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>N</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">total</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>δ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq19\"><alternatives><tex-math id=\"M43\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$N_n$$\\end{document}</tex-math><mml:math id=\"M44\"><mml:msub><mml:mi>N</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq20\"><alternatives><tex-math id=\"M45\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P_n=N_n/N_{total}$$\\end{document}</tex-math><mml:math id=\"M46\"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">total</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq21\"><alternatives><tex-math id=\"M47\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P_n(t)$$\\end{document}</tex-math><mml:math id=\"M48\"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq22\"><alternatives><tex-math id=\"M49\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\sum _{\\{n\\}} P_n(t)=1$$\\end{document}</tex-math><mml:math id=\"M50\"><mml:mrow><mml:msub><mml:mo>∑</mml:mo><mml:mrow><mml:mo stretchy=\"false\">{</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">}</mml:mo></mml:mrow></mml:msub><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ4\"><label>4</label><alternatives><tex-math id=\"M51\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\frac{dP_n(t)}{dt}=\\mu _{n-1}P_{n-1}(t)-\\mu _n P_n(t)-\\gamma _nP_n(t) + \\delta _{n,0}\\langle \\gamma \\rangle (t) . \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M52\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>δ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq23\"><alternatives><tex-math id=\"M53\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P_n(t)$$\\end{document}</tex-math><mml:math id=\"M54\"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ5\"><label>5</label><alternatives><tex-math id=\"M55\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\langle \\gamma \\rangle (t) =\\sum _{j} \\gamma _j P_j(t). \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M56\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:munder><mml:mo>∑</mml:mo><mml:mi>j</mml:mi></mml:munder><mml:msub><mml:mi>γ</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>P</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq24\"><alternatives><tex-math id=\"M57\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma _n$$\\end{document}</tex-math><mml:math id=\"M58\"><mml:msub><mml:mi>γ</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq25\"><alternatives><tex-math id=\"M59\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma _n$$\\end{document}</tex-math><mml:math id=\"M60\"><mml:msub><mml:mi>γ</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq26\"><alternatives><tex-math id=\"M61\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma _n$$\\end{document}</tex-math><mml:math id=\"M62\"><mml:msub><mml:mi>γ</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq27\"><alternatives><tex-math id=\"M63\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n&gt;0$$\\end{document}</tex-math><mml:math id=\"M64\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq28\"><alternatives><tex-math id=\"M65\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n_r$$\\end{document}</tex-math><mml:math id=\"M66\"><mml:msub><mml:mi>n</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq29\"><alternatives><tex-math id=\"M67\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n&gt;n_r$$\\end{document}</tex-math><mml:math id=\"M68\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq30\"><alternatives><tex-math id=\"M69\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma _n&lt;0$$\\end{document}</tex-math><mml:math id=\"M70\"><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq31\"><alternatives><tex-math id=\"M71\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n&lt;n_r$$\\end{document}</tex-math><mml:math id=\"M72\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq32\"><alternatives><tex-math id=\"M73\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma _n&gt;0$$\\end{document}</tex-math><mml:math id=\"M74\"><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq33\"><alternatives><tex-math id=\"M75\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n&gt;n_r$$\\end{document}</tex-math><mml:math id=\"M76\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ6\"><label>6</label><alternatives><tex-math id=\"M77\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\frac{dN_{total}}{dt}=\\kappa _0 N_{total}(t), \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M78\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">total</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>κ</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">total</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ7\"><label>7</label><alternatives><tex-math id=\"M79\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\frac{dN_n(t)}{dt}=\\frac{d\\, (N_{total}(t) P_n(t))}{dt}=N_{total}(t)\\frac{dP_n(t)}{dt}+P_n(t)\\frac{dN_{total}(t)}{dt}=N_{total}(t)\\frac{dP_n(t)}{dt}+\\kappa _0 N_{total}(t){P_n(t)}, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M80\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>N</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">total</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">total</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">total</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">total</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>κ</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">total</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq34\"><alternatives><tex-math id=\"M81\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P_n(t)$$\\end{document}</tex-math><mml:math id=\"M82\"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ8\"><label>8</label><alternatives><tex-math id=\"M83\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\frac{dP_n(t)}{dt}=\\mu _{n-1}P_{n-1}(t)-\\mu _n P_n(t)-(\\gamma _n+\\kappa _0)P_n(t) + \\delta _{n,0}\\langle \\gamma \\rangle (t). \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M84\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>κ</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>δ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq35\"><alternatives><tex-math id=\"M85\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n \\rightarrow x$$\\end{document}</tex-math><mml:math id=\"M86\"><mml:mrow><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq36\"><alternatives><tex-math id=\"M87\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dt \\rightarrow 0$$\\end{document}</tex-math><mml:math id=\"M88\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq37\"><alternatives><tex-math id=\"M89\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P_n(t)$$\\end{document}</tex-math><mml:math id=\"M90\"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq38\"><alternatives><tex-math id=\"M91\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho (x,t)$$\\end{document}</tex-math><mml:math id=\"M92\"><mml:mrow><mml:mi>ρ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq39\"><alternatives><tex-math id=\"M93\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\int _{\\{x\\}} \\rho (x,t) dx=1$$\\end{document}</tex-math><mml:math id=\"M94\"><mml:mrow><mml:msub><mml:mo>∫</mml:mo><mml:mrow><mml:mo stretchy=\"false\">{</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">}</mml:mo></mml:mrow></mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ9\"><label>9</label><alternatives><tex-math id=\"M95\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\begin{aligned} \\mu _{n}&amp;\\rightarrow \\mu (x) \\\\ \\gamma _n&amp;\\rightarrow \\gamma (x) \\\\ \\kappa _0&amp;\\rightarrow \\kappa . \\end{aligned} \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M96\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:msub><mml:mi>μ</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mo stretchy=\"false\">→</mml:mo><mml:mi>μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow/><mml:msub><mml:mi>γ</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mo stretchy=\"false\">→</mml:mo><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow/><mml:msub><mml:mi>κ</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mo stretchy=\"false\">→</mml:mo><mml:mi>κ</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ10\"><label>10</label><alternatives><tex-math id=\"M97\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\frac{\\partial \\rho (x,t)}{\\partial t}=-\\frac{\\partial }{\\partial x} \\left[ \\mu (x) \\rho (x,t) \\right] - (\\gamma (x)+\\kappa ) \\rho (x,t) +\\langle \\gamma (x) \\rangle (t) \\delta (x). \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M98\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>ρ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfrac><mml:mi>∂</mml:mi><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mfenced close=\"]\" open=\"[\"><mml:mi>μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mi>ρ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mfenced><mml:mo>-</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>γ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>κ</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>ρ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>γ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>δ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq40\"><alternatives><tex-math id=\"M99\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x=0$$\\end{document}</tex-math><mml:math id=\"M100\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq41\"><alternatives><tex-math id=\"M101\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\delta (x)$$\\end{document}</tex-math><mml:math id=\"M102\"><mml:mrow><mml:mi>δ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq42\"><alternatives><tex-math id=\"M103\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho (x,t)$$\\end{document}</tex-math><mml:math id=\"M104\"><mml:mrow><mml:mi>ρ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq43\"><alternatives><tex-math id=\"M105\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\langle \\gamma \\rangle$$\\end{document}</tex-math><mml:math id=\"M106\"><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ11\"><label>11</label><alternatives><tex-math id=\"M107\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\langle \\gamma (x) \\rangle (t) = \\int _{\\{x\\}} (\\gamma (x)+\\kappa ) \\rho (x,t) dx \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M108\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>γ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mo>∫</mml:mo><mml:mrow><mml:mo stretchy=\"false\">{</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">}</mml:mo></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>γ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>κ</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>ρ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ12\"><label>12</label><alternatives><tex-math id=\"M109\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\frac{\\partial \\rho (x,t)}{\\partial t}=0, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M110\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>ρ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq44\"><alternatives><tex-math id=\"M111\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x&gt;0$$\\end{document}</tex-math><mml:math id=\"M112\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ13\"><label>13</label><alternatives><tex-math id=\"M113\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\frac{\\partial }{\\partial x} \\left[ \\mu (x) \\rho (x,t) \\right] =- (\\gamma (x)+\\kappa ) \\rho (x,t)). \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M114\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfrac><mml:mi>∂</mml:mi><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mfenced close=\"]\" open=\"[\"><mml:mi>μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mi>ρ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mfenced><mml:mrow><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>γ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>κ</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>ρ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ14\"><label>14</label><alternatives><tex-math id=\"M115\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\rho _s(x) \\, = \\, \\frac{C}{\\mu (x)} \\, \\textrm{e}^{-\\int _{\\{x\\}}\\frac{(\\gamma (u)+\\kappa )}{\\mu (u)}du} , \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M116\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mspace width=\"0.166667em\"/><mml:mo>=</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mfrac><mml:mi>C</mml:mi><mml:mrow><mml:mi>μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac><mml:mspace width=\"0.166667em\"/><mml:msup><mml:mtext>e</mml:mtext><mml:mrow><mml:mo>-</mml:mo><mml:msub><mml:mo>∫</mml:mo><mml:mrow><mml:mo stretchy=\"false\">{</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">}</mml:mo></mml:mrow></mml:msub><mml:mfrac><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>u</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>+</mml:mo><mml:mi>κ</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi>μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>u</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac><mml:mi>d</mml:mi><mml:mi>u</mml:mi></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq45\"><alternatives><tex-math id=\"M117\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu (x)$$\\end{document}</tex-math><mml:math id=\"M118\"><mml:mrow><mml:mi>μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq46\"><alternatives><tex-math id=\"M119\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma (x)$$\\end{document}</tex-math><mml:math id=\"M120\"><mml:mrow><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq47\"><alternatives><tex-math id=\"M121\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho _s(x)$$\\end{document}</tex-math><mml:math id=\"M122\"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq48\"><alternatives><tex-math id=\"M123\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu (x)$$\\end{document}</tex-math><mml:math id=\"M124\"><mml:mrow><mml:mi>μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq49\"><alternatives><tex-math id=\"M125\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma (x)$$\\end{document}</tex-math><mml:math id=\"M126\"><mml:mrow><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq50\"><alternatives><tex-math id=\"M127\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\kappa$$\\end{document}</tex-math><mml:math id=\"M128\"><mml:mi>κ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq51\"><alternatives><tex-math id=\"M129\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x/\\langle x \\rangle$$\\end{document}</tex-math><mml:math id=\"M130\"><mml:mrow><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq52\"><alternatives><tex-math id=\"M131\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x/\\langle x \\rangle$$\\end{document}</tex-math><mml:math id=\"M132\"><mml:mrow><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq53\"><alternatives><tex-math id=\"M133\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu (x)$$\\end{document}</tex-math><mml:math id=\"M134\"><mml:mrow><mml:mi>μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ15\"><label>15</label><alternatives><tex-math id=\"M135\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\mu (x) = d_{1}\\frac{x}{x+b}, \\quad b \\ge 0 \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M136\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>μ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfrac><mml:mi>x</mml:mi><mml:mrow><mml:mi>x</mml:mi><mml:mo>+</mml:mo><mml:mi>b</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width=\"1em\"/><mml:mi>b</mml:mi><mml:mo>≥</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq54\"><alternatives><tex-math id=\"M137\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$DBH/\\langle DBH\\rangle$$\\end{document}</tex-math><mml:math id=\"M138\"><mml:mrow><mml:mi>D</mml:mi><mml:mi>B</mml:mi><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>D</mml:mi><mml:mi>B</mml:mi><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq55\"><alternatives><tex-math id=\"M139\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H \\cdot \\rho _s(y) \\gamma '(y)$$\\end{document}</tex-math><mml:math id=\"M140\"><mml:mrow><mml:mi>H</mml:mi><mml:mo>·</mml:mo><mml:msub><mml:mi>ρ</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msup><mml:mi>γ</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq56\"><alternatives><tex-math id=\"M141\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$r=0.22$$\\end{document}</tex-math><mml:math id=\"M142\"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0.22</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq57\"><alternatives><tex-math id=\"M143\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$y=x/\\langle x \\rangle$$\\end{document}</tex-math><mml:math id=\"M144\"><mml:mrow><mml:mi>y</mml:mi><mml:mo>=</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq58\"><alternatives><tex-math id=\"M145\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$q(y)=\\gamma '(y)/\\mu (y)=d(y-r)/y$$\\end{document}</tex-math><mml:math id=\"M146\"><mml:mrow><mml:mi>q</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msup><mml:mi>γ</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>μ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>d</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mo>-</mml:mo><mml:mi>r</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>y</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq59\"><alternatives><tex-math id=\"M147\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$r=0.22$$\\end{document}</tex-math><mml:math id=\"M148\"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0.22</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq60\"><alternatives><tex-math id=\"M149\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d=4.8$$\\end{document}</tex-math><mml:math id=\"M150\"><mml:mrow><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:mn>4.8</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq61\"><alternatives><tex-math id=\"M151\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma (x)$$\\end{document}</tex-math><mml:math id=\"M152\"><mml:mrow><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq62\"><alternatives><tex-math id=\"M153\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x_{min}$$\\end{document}</tex-math><mml:math id=\"M154\"><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">min</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq63\"><alternatives><tex-math id=\"M155\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x&lt;x_{min}$$\\end{document}</tex-math><mml:math id=\"M156\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">min</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq64\"><alternatives><tex-math id=\"M157\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma (x)$$\\end{document}</tex-math><mml:math id=\"M158\"><mml:mrow><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq65\"><alternatives><tex-math id=\"M159\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$~ \\gamma '(x) \\cdot \\rho (x)$$\\end{document}</tex-math><mml:math id=\"M160\"><mml:mrow><mml:mspace width=\"3.33333pt\"/><mml:msup><mml:mi>γ</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>·</mml:mo><mml:mi>ρ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq66\"><alternatives><tex-math id=\"M161\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x &lt; x_{\\text {min}}$$\\end{document}</tex-math><mml:math id=\"M162\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mtext>min</mml:mtext></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq67\"><alternatives><tex-math id=\"M163\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x &gt; x_{\\text {min}}$$\\end{document}</tex-math><mml:math id=\"M164\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mtext>min</mml:mtext></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ16\"><label>16</label><alternatives><tex-math id=\"M165\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\gamma '(x)=f_1 \\frac{x-r}{x+g} \\quad r \\ge 0; \\quad g&gt;0 \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M166\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msup><mml:mi>γ</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfrac><mml:mrow><mml:mi>x</mml:mi><mml:mo>-</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi><mml:mo>+</mml:mo><mml:mi>g</mml:mi></mml:mrow></mml:mfrac><mml:mspace width=\"1em\"/><mml:mi>r</mml:mi><mml:mo>≥</mml:mo><mml:mn>0</mml:mn><mml:mo>;</mml:mo><mml:mspace width=\"1em\"/><mml:mi>g</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq68\"><alternatives><tex-math id=\"M167\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f_1$$\\end{document}</tex-math><mml:math id=\"M168\"><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq69\"><alternatives><tex-math id=\"M169\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$g=b$$\\end{document}</tex-math><mml:math id=\"M170\"><mml:mrow><mml:mi>g</mml:mi><mml:mo>=</mml:mo><mml:mi>b</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq70\"><alternatives><tex-math id=\"M171\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\kappa &lt;0$$\\end{document}</tex-math><mml:math id=\"M172\"><mml:mrow><mml:mi>κ</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ17\"><label>17</label><alternatives><tex-math id=\"M173\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\gamma (x) = \\gamma '(x) + \\kappa \\equiv d_2\\frac{x-c}{x+b}, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M174\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>γ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msup><mml:mi>γ</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>κ</mml:mi><mml:mo>≡</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfrac><mml:mrow><mml:mi>x</mml:mi><mml:mo>-</mml:mo><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi><mml:mo>+</mml:mo><mml:mi>b</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ18\"><label>18</label><alternatives><tex-math id=\"M175\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} c= &amp; {} \\frac{f_1r-b\\kappa }{f_1+\\kappa }&gt; r &gt;0, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M176\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>c</mml:mi><mml:mo>=</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:mfrac><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>r</mml:mi><mml:mo>-</mml:mo><mml:mi>b</mml:mi><mml:mi>κ</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mi>κ</mml:mi></mml:mrow></mml:mfrac><mml:mo>&gt;</mml:mo><mml:mi>r</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ19\"><label>19</label><alternatives><tex-math id=\"M177\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} d_2= &amp; {} (f_1+\\kappa )&lt;f_1; \\quad \\text {and} \\quad d_2 &gt;0. \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M178\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mi>κ</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>;</mml:mo><mml:mspace width=\"1em\"/><mml:mtext>and</mml:mtext><mml:mspace width=\"1em\"/><mml:msub><mml:mi>d</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq71\"><alternatives><tex-math id=\"M179\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho _s(x)$$\\end{document}</tex-math><mml:math id=\"M180\"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq72\"><alternatives><tex-math id=\"M181\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho _s(x) \\cdot \\gamma '(x)$$\\end{document}</tex-math><mml:math id=\"M182\"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>·</mml:mo><mml:msup><mml:mi>γ</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq73\"><alternatives><tex-math id=\"M183\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma '(x)$$\\end{document}</tex-math><mml:math id=\"M184\"><mml:mrow><mml:msup><mml:mi>γ</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq74\"><alternatives><tex-math id=\"M185\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho _s(y) \\cdot \\gamma '(y)$$\\end{document}</tex-math><mml:math id=\"M186\"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>·</mml:mo><mml:msup><mml:mi>γ</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq75\"><alternatives><tex-math id=\"M187\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c=0.8$$\\end{document}</tex-math><mml:math id=\"M188\"><mml:mrow><mml:mi>c</mml:mi><mml:mo>=</mml:mo><mml:mn>0.8</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq76\"><alternatives><tex-math id=\"M189\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$b=0.033$$\\end{document}</tex-math><mml:math id=\"M190\"><mml:mrow><mml:mi>b</mml:mi><mml:mo>=</mml:mo><mml:mn>0.033</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq77\"><alternatives><tex-math id=\"M191\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d=4.8$$\\end{document}</tex-math><mml:math id=\"M192\"><mml:mrow><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:mn>4.8</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq78\"><alternatives><tex-math id=\"M193\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$r=0.22$$\\end{document}</tex-math><mml:math id=\"M194\"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0.22</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq79\"><alternatives><tex-math id=\"M195\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma '(y)$$\\end{document}</tex-math><mml:math id=\"M196\"><mml:mrow><mml:msup><mml:mi>γ</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq80\"><alternatives><tex-math id=\"M197\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho _s(x)$$\\end{document}</tex-math><mml:math id=\"M198\"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq81\"><alternatives><tex-math id=\"M199\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\kappa$$\\end{document}</tex-math><mml:math id=\"M200\"><mml:mi>κ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq82\"><alternatives><tex-math id=\"M201\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma (x)$$\\end{document}</tex-math><mml:math id=\"M202\"><mml:mrow><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ20\"><label>20</label><alternatives><tex-math id=\"M203\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\rho _s(x) \\, = \\, \\frac{\\mu (0) \\rho _s(0)}{\\mu (x)} \\, \\textrm{e}^{-\\int _{\\{x\\}} \\frac{\\gamma (u)}{\\mu (u)}du} = C x^{d \\,c-1} (x+b)\\, \\textrm{e}^{-d \\,x} , \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M204\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mspace width=\"0.166667em\"/><mml:mo>=</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mfrac><mml:mrow><mml:mi>μ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac><mml:mspace width=\"0.166667em\"/><mml:msup><mml:mtext>e</mml:mtext><mml:mrow><mml:mo>-</mml:mo><mml:msub><mml:mo>∫</mml:mo><mml:mrow><mml:mo stretchy=\"false\">{</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">}</mml:mo></mml:mrow></mml:msub><mml:mfrac><mml:mrow><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>u</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi>μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>u</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac><mml:mi>d</mml:mi><mml:mi>u</mml:mi></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mi>C</mml:mi><mml:msup><mml:mi>x</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>c</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>+</mml:mo><mml:mi>b</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mspace width=\"0.166667em\"/><mml:msup><mml:mtext>e</mml:mtext><mml:mrow><mml:mo>-</mml:mo><mml:mi>d</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>x</mml:mi></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq83\"><alternatives><tex-math id=\"M205\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d=d_2/d_1$$\\end{document}</tex-math><mml:math id=\"M206\"><mml:mrow><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq84\"><alternatives><tex-math id=\"M207\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x \\in [0,\\infty )$$\\end{document}</tex-math><mml:math id=\"M208\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>∈</mml:mo><mml:mo stretchy=\"false\">[</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>∞</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ21\"><label>21</label><alternatives><tex-math id=\"M209\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} C=\\frac{d^{c\\, d}}{(b+c)\\Gamma [c\\,d]}. \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M210\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>C</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:msup><mml:mi>d</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>d</mml:mi></mml:mrow></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>b</mml:mi><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo stretchy=\"false\">[</mml:mo><mml:mi>c</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>d</mml:mi><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ22\"><label>22</label><alternatives><tex-math id=\"M211\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\langle x \\rangle =c \\left( 1+\\frac{1}{(b+c)d} \\right) . \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M212\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>c</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>b</mml:mi><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mi>d</mml:mi></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq85\"><alternatives><tex-math id=\"M213\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$y=x/\\langle x \\rangle$$\\end{document}</tex-math><mml:math id=\"M214\"><mml:mrow><mml:mi>y</mml:mi><mml:mo>=</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ23\"><label>23</label><alternatives><tex-math id=\"M215\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\rho _s(y)=\\frac{d^{c\\, d}}{(b+c)\\Gamma [c\\,d]} \\langle x \\rangle ^{d c} \\textrm{e}^{-d \\langle x \\rangle y} y^{dc-1} (y \\langle x \\rangle +b). \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M216\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:msup><mml:mi>d</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>d</mml:mi></mml:mrow></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>b</mml:mi><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo stretchy=\"false\">[</mml:mo><mml:mi>c</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>d</mml:mi><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:mfrac><mml:msup><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">dc</mml:mi></mml:mrow></mml:msup><mml:msup><mml:mtext>e</mml:mtext><mml:mrow><mml:mo>-</mml:mo><mml:mi>d</mml:mi><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo><mml:mi>y</mml:mi></mml:mrow></mml:msup><mml:msup><mml:mi>y</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>c</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>b</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq86\"><alternatives><tex-math id=\"M217\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\langle x \\rangle =1$$\\end{document}</tex-math><mml:math id=\"M218\"><mml:mrow><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ24\"><label>24</label><alternatives><tex-math id=\"M219\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} b=\\frac{c}{(1-c)d}-c, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M220\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>b</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mi>c</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mi>d</mml:mi></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq87\"><alternatives><tex-math id=\"M221\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$y=x/\\langle x \\rangle$$\\end{document}</tex-math><mml:math id=\"M222\"><mml:mrow><mml:mi>y</mml:mi><mml:mo>=</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ25\"><label>25</label><alternatives><tex-math id=\"M223\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\rho _s(y)=\\frac{d^{c\\, d}}{(\\frac{c}{(1-c)d})\\Gamma [c\\,d]} \\textrm{e}^{-d y} y^{dc-1} \\left( y+\\frac{c}{(1-c)d}-c\\right) . \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M224\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:msup><mml:mi>d</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>d</mml:mi></mml:mrow></mml:msup><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mfrac><mml:mi>c</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mi>d</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mi>c</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>d</mml:mi><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:msup><mml:mtext>e</mml:mtext><mml:mrow><mml:mo>-</mml:mo><mml:mi>d</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msup><mml:msup><mml:mi>y</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>c</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>y</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:mi>c</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mi>d</mml:mi></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mi>c</mml:mi></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq88\"><alternatives><tex-math id=\"M225\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x/\\langle x \\rangle$$\\end{document}</tex-math><mml:math id=\"M226\"><mml:mrow><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq89\"><alternatives><tex-math id=\"M227\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c=0.8$$\\end{document}</tex-math><mml:math id=\"M228\"><mml:mrow><mml:mi>c</mml:mi><mml:mo>=</mml:mo><mml:mn>0.8</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq90\"><alternatives><tex-math id=\"M229\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d=4.8$$\\end{document}</tex-math><mml:math id=\"M230\"><mml:mrow><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:mn>4.8</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq91\"><alternatives><tex-math id=\"M231\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$b=0.033$$\\end{document}</tex-math><mml:math id=\"M232\"><mml:mrow><mml:mi>b</mml:mi><mml:mo>=</mml:mo><mml:mn>0.033</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq92\"><alternatives><tex-math id=\"M233\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R^2$$\\end{document}</tex-math><mml:math id=\"M234\"><mml:msup><mml:mi>R</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq93\"><alternatives><tex-math id=\"M235\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$r&lt; c$$\\end{document}</tex-math><mml:math id=\"M236\"><mml:mrow><mml:mi>r</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq94\"><alternatives><tex-math id=\"M237\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f_1$$\\end{document}</tex-math><mml:math id=\"M238\"><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq95\"><alternatives><tex-math id=\"M239\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\kappa$$\\end{document}</tex-math><mml:math id=\"M240\"><mml:mi>κ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq96\"><alternatives><tex-math id=\"M241\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R^2$$\\end{document}</tex-math><mml:math id=\"M242\"><mml:msup><mml:mi>R</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq97\"><alternatives><tex-math id=\"M243\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma '(y)\\cdot \\rho _s(y)$$\\end{document}</tex-math><mml:math id=\"M244\"><mml:mrow><mml:msup><mml:mi>γ</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>·</mml:mo><mml:msub><mml:mi>ρ</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq98\"><alternatives><tex-math id=\"M245\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$r=0.22$$\\end{document}</tex-math><mml:math id=\"M246\"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0.22</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq99\"><alternatives><tex-math id=\"M247\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$q=\\gamma '(y)/\\mu (y)$$\\end{document}</tex-math><mml:math id=\"M248\"><mml:mrow><mml:mi>q</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mi>γ</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>μ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ26\"><label>26</label><alternatives><tex-math id=\"M249\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} q=d\\, \\frac{y-r}{y} \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M250\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>q</mml:mi><mml:mo>=</mml:mo><mml:mi>d</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mfrac><mml:mrow><mml:mi>y</mml:mi><mml:mo>-</mml:mo><mml:mi>r</mml:mi></mml:mrow><mml:mi>y</mml:mi></mml:mfrac></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq100\"><alternatives><tex-math id=\"M251\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d=4.8$$\\end{document}</tex-math><mml:math id=\"M252\"><mml:mrow><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:mn>4.8</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq101\"><alternatives><tex-math id=\"M253\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$r=0.22$$\\end{document}</tex-math><mml:math id=\"M254\"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0.22</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq102\"><alternatives><tex-math id=\"M255\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$y&gt;0.28$$\\end{document}</tex-math><mml:math id=\"M256\"><mml:mrow><mml:mi>y</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0.28</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq103\"><alternatives><tex-math id=\"M257\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c=0.8$$\\end{document}</tex-math><mml:math id=\"M258\"><mml:mrow><mml:mi>c</mml:mi><mml:mo>=</mml:mo><mml:mn>0.8</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq104\"><alternatives><tex-math id=\"M259\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\kappa$$\\end{document}</tex-math><mml:math id=\"M260\"><mml:mi>κ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq105\"><alternatives><tex-math id=\"M261\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\kappa$$\\end{document}</tex-math><mml:math id=\"M262\"><mml:mi>κ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq106\"><alternatives><tex-math id=\"M263\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\kappa$$\\end{document}</tex-math><mml:math id=\"M264\"><mml:mi>κ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq107\"><alternatives><tex-math id=\"M265\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$y=x/\\langle x \\rangle$$\\end{document}</tex-math><mml:math id=\"M266\"><mml:mrow><mml:mi>y</mml:mi><mml:mo>=</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mo stretchy=\"false\">⟨</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">⟩</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq108\"><alternatives><tex-math id=\"M267\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c=0.8$$\\end{document}</tex-math><mml:math id=\"M268\"><mml:mrow><mml:mi>c</mml:mi><mml:mo>=</mml:mo><mml:mn>0.8</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq109\"><alternatives><tex-math id=\"M269\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu (x)$$\\end{document}</tex-math><mml:math id=\"M270\"><mml:mrow><mml:mi>μ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq110\"><alternatives><tex-math id=\"M271\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma (x)$$\\end{document}</tex-math><mml:math id=\"M272\"><mml:mrow><mml:mi>γ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51553_Fig1_HTML\" id=\"MO1\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq6.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Fig2_HTML\" id=\"MO2\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq9.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ1.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq10.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq11.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq12.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq13.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq14.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq15.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq16.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq17.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ2.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq18.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ3.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq19.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq20.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq21.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq22.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ4.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq23.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ5.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq24.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq25.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq26.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq27.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq28.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq29.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq30.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq31.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq32.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq33.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ6.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ7.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq34.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ8.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq35.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq36.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq37.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq38.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq39.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ9.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ10.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq40.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq41.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq42.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq43.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ11.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ12.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq44.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ13.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ14.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq45.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq46.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq47.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq48.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq49.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq50.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq51.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq52.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq53.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ15.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq54.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq55.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq56.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq57.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq58.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq59.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq60.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Fig4_HTML\" id=\"MO4\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq61.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq62.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq63.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq64.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq65.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq66.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq67.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ16.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq68.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq69.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq70.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ17.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ18.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ19.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq71.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq72.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq73.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq74.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq75.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq76.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq77.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq78.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq79.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq80.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq81.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq82.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ20.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq83.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq84.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ21.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ22.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq85.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ23.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq86.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ24.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq87.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ25.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq88.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq89.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq90.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq91.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq92.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq93.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq94.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq95.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq96.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq97.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq98.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq99.gif\"/>", "<graphic xlink:href=\"41598_2024_51553_Article_Equ26.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq100.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq101.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq102.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq103.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq104.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq105.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq106.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq107.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq108.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq109.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51553_Article_IEq110.gif\"/>" ]
[]
[{"label": ["1."], "surname": ["Wood", "Kojouharov", "Dimitrov"], "given-names": ["DT", "HV", "DT"], "article-title": ["Universal approaches to approximate biological systems with nonstandard finite difference methods"], "source": ["Math. Comput. Simul."], "year": ["2017"], "volume": ["133"], "fpage": ["337"], "lpage": ["350"], "pub-id": ["10.1016/j.matcom.2016.04.007"]}, {"label": ["2."], "surname": ["Braun", "Marom"], "given-names": ["E", "S"], "article-title": ["Universality, complexity and the praxis of biology: Two case studies"], "source": ["Stud. History Philos. Sci. Part C: Stud. History Philos. Biol. Biomed. Sci."], "year": ["2015"], "volume": ["53"], "fpage": ["68"], "lpage": ["72"], "pub-id": ["10.1016/j.shpsc.2015.03.007"]}, {"label": ["3."], "surname": ["Kr\u00f3l", "Schumann", "Bielas"], "given-names": ["J", "A", "K"], "article-title": ["Brain and its universal logical model of multi-agent biological systems"], "source": ["Log. Univ."], "year": ["2022"], "volume": ["16"], "fpage": ["671"], "lpage": ["687"], "pub-id": ["10.1007/s11787-022-00319-3"]}, {"label": ["8."], "mixed-citation": ["O\u2019Brien, T.\u00a0G. Abundance, density and relative abundance: A conceptual framework. In "], "italic": ["Camera Traps in Animal Ecology"]}, {"label": ["9."], "surname": ["Hanya", "Chapman"], "given-names": ["G", "CA"], "article-title": ["Linking feeding ecology and population abundance: A review of food resource limitation on primates"], "source": ["Ecol. Res."], "year": ["2012"], "volume": ["28"], "fpage": ["183"], "lpage": ["190"], "pub-id": ["10.1007/s11284-012-1012-y"]}, {"label": ["10."], "surname": ["Coomes", "Duncan", "Allen", "Truscott"], "given-names": ["DA", "RP", "RB", "J"], "article-title": ["Disturbances prevent stem size-density distributions in natural forests from following scaling relationships"], "source": ["Ecol. Lett."], "year": ["2003"], "volume": ["6"], "fpage": ["980"], "lpage": ["989"], "pub-id": ["10.1046/j.1461-0248.2003.00520.x"]}, {"label": ["11."], "surname": ["Moore", "Argles", "Zhu", "Huntingford", "Cox"], "given-names": ["JR", "APK", "K", "C", "PM"], "article-title": ["Validation of demographic equilibrium theory against tree-size distributions and biomass density in amazonia"], "source": ["Biogeosciences"], "year": ["2020"], "volume": ["17"], "fpage": ["1013"], "lpage": ["1032"], "pub-id": ["10.5194/bg-17-1013-2020"]}, {"label": ["12."], "surname": ["Lima", "Muller-Landau", "Prado", "Condit"], "given-names": ["RA", "HC", "PI", "R"], "article-title": ["How do size distributions relate to concurrently measured demographic rates? Evidence from over 150 tree species in panama"], "source": ["J. Trop. Ecol."], "year": ["2016"], "volume": ["32"], "fpage": ["179"], "lpage": ["192"], "pub-id": ["10.1017/s0266467416000146"]}, {"label": ["14."], "surname": ["Duncanson", "Dubayah", "Enquist"], "given-names": ["LI", "RO", "BJ"], "article-title": ["Assessing the general patterns of forest structure: Quantifying tree and forest allometric scaling relationships in the united states"], "source": ["Glob. Ecol. Biogeogr."], "year": ["2015"], "volume": ["24"], "fpage": ["1465"], "lpage": ["1475"], "pub-id": ["10.1111/geb.12371"]}, {"label": ["15."], "surname": ["Larsary"], "given-names": ["MK"], "article-title": ["Comparison of probability distribution functions applied to tree diameter and height of three development stages in a mixed beech (fagus orientalis lipsky) forest in hyrcanean region of iran"], "source": ["Forestry Ideas"], "year": ["2016"], "volume": ["22"], "fpage": ["65"], "lpage": ["84"]}, {"label": ["16."], "surname": ["M\u00e4kel\u00e4"], "given-names": ["A"], "article-title": ["Using stand-scale forest models for estimating indicators of sustainable forest management"], "source": ["For. Ecol. Manage."], "year": ["2012"], "volume": ["285"], "fpage": ["164"], "lpage": ["178"], "pub-id": ["10.1016/j.foreco.2012.07.041"]}, {"label": ["17."], "surname": ["Fisher"], "given-names": ["RA"], "article-title": ["Vegetation demographics in earth system models: A review of progress and priorities"], "source": ["Glob. Change Biol."], "year": ["2017"], "volume": ["24"], "fpage": ["35"], "lpage": ["54"], "pub-id": ["10.1111/gcb.13910"]}, {"label": ["18."], "surname": ["Yamamoto"], "given-names": ["S-I"], "article-title": ["Forest gap dynamics and tree regeneration"], "source": ["J. For. Res."], "year": ["2000"], "volume": ["5"], "fpage": ["223"], "lpage": ["229"], "pub-id": ["10.1007/bf02767114"]}, {"label": ["19."], "surname": ["Volkov"], "given-names": ["I"], "article-title": ["Seeing the forest for the trees through metabolic scaling"], "source": ["PNAS Nexus"], "year": ["2022"], "volume": ["1"], "fpage": ["151"], "pub-id": ["10.1093/pnasnexus/pgac008"]}, {"label": ["20."], "surname": ["Plieninger"], "given-names": ["T"], "article-title": ["Wood-pastures of europe: Geographic coverage, social-ecological values, conservation management, and policy implications"], "source": ["Biol. Cons."], "year": ["2015"], "volume": ["190"], "fpage": ["70"], "lpage": ["79"], "pub-id": ["10.1016/j.biocon.2015.05.014"]}, {"label": ["21."], "surname": ["de Lima", "Batista", "Prado"], "given-names": ["RAF", "JLF", "PI"], "article-title": ["Modeling tree diameter distributions in natural forests: An evaluation of 10 statistical models"], "source": ["Forest Sci."], "year": ["2015"], "volume": ["61"], "fpage": ["320"], "lpage": ["327"], "pub-id": ["10.5849/forsci.14-070"]}, {"label": ["22."], "surname": ["Podlaski"], "given-names": ["R"], "article-title": ["Forest modelling: The gamma shape mixture model and simulation of tree diameter distributions"], "source": ["Ann. For. Sci."], "year": ["2017"], "volume": ["74"], "fpage": ["29"], "pub-id": ["10.1007/s13595-017-0629-y"]}, {"label": ["23."], "surname": ["Moore", "Zhu", "Huntingford", "Cox"], "given-names": ["JR", "K", "C", "PM"], "article-title": ["Equilibrium forest demography explains the distribution of tree sizes across north america"], "source": ["Environ. Res. Lett."], "year": ["2018"], "volume": ["13"], "fpage": ["084019"], "pub-id": ["10.1088/1748-9326/aad6d1"]}, {"label": ["24."], "surname": ["Bir\u00f3", "N\u00e9da"], "given-names": ["T", "Z"], "article-title": ["Unidirectional random growth with resetting"], "source": ["Phys. A"], "year": ["2018"], "volume": ["499"], "fpage": ["335"], "lpage": ["361"], "pub-id": ["10.1016/j.physa.2018.02.078"]}, {"label": ["25."], "surname": ["Bir\u00f3", "N\u00e9da"], "given-names": ["TS", "Z"], "article-title": ["Entropic divergence and entropy related to nonlinear master equations"], "source": ["Entropy"], "year": ["2019"], "volume": ["21"], "fpage": ["993"], "pub-id": ["10.3390/e21090993"]}, {"label": ["27."], "mixed-citation": ["Hartel, T., Plieninger, T. & Varga, A. Wood-pastures in Europe. In "], "italic": ["Europe\u2019s Changing Woods and Forests: From Wildwood to Managed Landscapes"]}, {"label": ["28."], "surname": ["Hartel"], "given-names": ["T"], "article-title": ["Wood-pastures in a traditional rural region of eastern Europe: Characteristics, management and status"], "source": ["Biol. Cons."], "year": ["2013"], "volume": ["166"], "fpage": ["267"], "lpage": ["275"], "pub-id": ["10.1016/j.biocon.2013.06.020"]}, {"label": ["29."], "mixed-citation": ["Kelemen, S., J\u00f3zsa, M., Hartel, T., Cs\u00f3ka, G. & N\u00e9da, Z. Diameter at breast height (dbh) data of temperate zone trees from different woodland types. figshare "], "ext-link": ["https://figshare.com/articles/dataset/Diameter_at_Breast_Height_DBH_data_of_temperate_zone_trees_from_different_woodland_types_/24039429"]}, {"label": ["30."], "surname": ["Tebug"], "given-names": ["SF"], "article-title": ["Using body measurements to estimate live weight of dairy cattle in low-input systems in senegal"], "source": ["J. Appl. Anim. Res."], "year": ["2016"], "volume": ["46"], "fpage": ["87"], "lpage": ["93"], "pub-id": ["10.1080/09712119.2016.1262265"]}, {"label": ["32."], "surname": ["N\u00e9da", "Gere", "Bir\u00f3", "T\u00f3th", "Derzsy"], "given-names": ["Z", "I", "TS", "G", "N"], "article-title": ["Scaling in income inequalities and its dynamical origin"], "source": ["Phys. A"], "year": ["2020"], "volume": ["549"], "fpage": ["124491"], "pub-id": ["10.1016/j.physa.2020.124491"]}, {"label": ["33."], "surname": ["Gere", "Kelemen", "T\u00f3th", "Bir\u00f3", "N\u00e9da"], "given-names": ["I", "S", "G", "TS", "Z"], "article-title": ["Wealth distribution in modern societies: Collected data and a master equation approach"], "source": ["Phys. A"], "year": ["2021"], "volume": ["581"], "fpage": ["126194"], "pub-id": ["10.1016/j.physa.2021.126194"]}, {"label": ["34."], "surname": ["Gere", "Kelemen", "Bir\u00f3", "N\u00e9da"], "given-names": ["I", "S", "TS", "Z"], "article-title": ["Wealth distribution in villages transition from socialism to capitalism in view of exhaustive wealth data and a master equation approach"], "source": ["Front. Phys."], "year": ["2022"], "volume": ["10"], "fpage": ["153"], "pub-id": ["10.3389/fphy.2022.827143"]}, {"label": ["37."], "surname": ["Kohyama", "Suzuki", "Partomihardjo", "Yamada", "Kubo"], "given-names": ["T", "E", "T", "T", "T"], "article-title": ["Tree species differentiation in growth, recruitment and allometry in relation to maximum height in a bornean mixed dipterocarp forest"], "source": ["J. Ecol."], "year": ["2003"], "volume": ["91"], "fpage": ["797"], "lpage": ["806"], "pub-id": ["10.1046/j.1365-2745.2003.00810.x"]}, {"label": ["39."], "surname": ["Bir\u00f3", "Telcs", "N\u00e9da"], "given-names": ["T", "A", "Z"], "article-title": ["Entropic distance for nonlinear master equation"], "source": ["Universe"], "year": ["2018"], "volume": ["4"], "fpage": ["10"], "pub-id": ["10.3390/universe4010010"]}, {"label": ["40."], "surname": ["In\u00e1cio", "Velhinho"], "given-names": ["I", "J"], "article-title": ["Comments on mathematical aspects of the Bir\u00f3-N\u00e9da model"], "source": ["Mathematics"], "year": ["2022"], "volume": ["10"], "fpage": ["644"], "pub-id": ["10.3390/math10040644"]}, {"label": ["41."], "surname": ["Bir\u00f3", "N\u00e9da"], "given-names": ["TS", "Z"], "article-title": ["Thermodynamical aspects of the lggr approach for hadron energy spectra"], "source": ["Symmetry"], "year": ["2022"], "volume": ["14"], "fpage": ["1807"], "pub-id": ["10.3390/sym14091807"]}, {"label": ["42."], "surname": ["Ligot"], "given-names": ["G"], "article-title": ["Tree growth and mortality of 42 timber species in central africa"], "source": ["For. Ecol. Manage."], "year": ["2022"], "volume": ["505"], "fpage": ["119889"], "pub-id": ["10.1016/j.foreco.2021.119889"]}, {"label": ["43."], "mixed-citation": ["Bragg, D. C. Optimal tree increment models for the northeastern united states. In "], "italic": ["Proceedings of the Fifth Annual Forest Inventory and Analysis Symposium"]}, {"label": ["44."], "surname": ["Miranda", "Guedes", "Rosa", "Sch\u00f6ngart"], "given-names": ["ZP", "MC", "SA", "J"], "article-title": ["Volume increment modeling and subsidies for the management of the tree mora paraensis (ducke) ducke based on the study of growth rings"], "source": ["Trees"], "year": ["2017"], "volume": ["32"], "fpage": ["277"], "lpage": ["286"], "pub-id": ["10.1007/s00468-017-1630-7"]}, {"label": ["45."], "surname": ["Seo", "Lee", "Choi"], "given-names": ["Y", "D", "J"], "article-title": ["Growth analysis of red pine (pinus densiflora) by stem analysis in the eastern region of korea"], "source": ["J. Forest Env. Sci."], "year": ["2015"], "volume": ["31"], "fpage": ["47"], "lpage": ["54"], "pub-id": ["10.7747/JFES.2015.31.1.47"]}, {"label": ["46."], "surname": ["Seo", "Lee", "Choi"], "given-names": ["Y", "D", "J"], "article-title": ["Developing and comparing individual tree growth models of major coniferous species in south korea based on stem analysis data"], "source": ["Forests"], "year": ["2023"], "volume": ["14"], "fpage": ["115"], "pub-id": ["10.3390/f14010115"]}, {"label": ["47."], "surname": ["Castedo-Dorado", "G\u00f3mez-Garc\u00eda", "Di\u00e9guez-Aranda", "Barrio-Anta", "Crecente-Campo"], "given-names": ["F", "E", "U", "M", "F"], "article-title": ["Aboveground stand-level biomass estimation: A comparison of two methods for major forest species in northwest spain"], "source": ["Ann. For. Sci."], "year": ["2012"], "volume": ["69"], "fpage": ["735"], "lpage": ["746"], "pub-id": ["10.1007/s13595-012-0191-6"]}, {"label": ["48."], "surname": ["Zhu"], "given-names": ["LW"], "article-title": ["Individual- and stand-level stem co"], "tex-math": ["\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}"], "{http://www.w3.org/1998/Math/MathML}mn": ["2"], "source": ["Biogeosciences"], "year": ["2012"], "volume": ["9"], "fpage": ["3729"], "lpage": ["3737"], "pub-id": ["10.5194/bg-9-3729-2012"]}, {"label": ["50."], "mixed-citation": ["Service, N.\u00a0P. Ncrn forest vegetation monitoring data 2006\u20132022. National Capital Region Network I &M Program, Washington, DC. "], "ext-link": ["https://irma.nps.gov/DataStore/Reference/Profile/2296604"]}, {"label": ["51."], "mixed-citation": ["Schmit, J.\u00a0P., Sanders, G.\u00a0M., Lehman, M., Paradis, T. & Matthews, E. National capital region network long-term forest vegetation monitoring protocol: Version 2.1 (march, 2014). In "], "italic": ["Tech. Rep., Natural Resource Report. NPS/NCRN/NRR\u20132009/113. National Park Service, Fort Collins, Colorado"]}, {"label": ["52."], "surname": ["Coomes", "Allen"], "given-names": ["DA", "RB"], "article-title": ["Mortality and tree-size distributions in natural mixed-age forests"], "source": ["J. Ecol."], "year": ["2006"], "volume": ["95"], "fpage": ["27"], "lpage": ["40"], "pub-id": ["10.1111/j.1365-2745.2006.01179.x"]}, {"label": ["54."], "surname": ["Hilbert", "Roman", "Koeser", "Vogt", "Doorn"], "given-names": ["D", "L", "AK", "J", "NSV"], "article-title": ["Urban tree mortality: A literature review"], "source": ["Arboric. Urban For."], "year": ["2019"], "volume": ["45"], "fpage": ["846"], "pub-id": ["10.13140/RG.2.2.25953.15204"]}, {"label": ["56."], "surname": ["White", "Jentsch"], "given-names": ["PS", "A"], "source": ["The Search for Generality in Studies of Disturbance and Ecosystem Dynamics\u201d, 399\u2013450"], "year": ["2001"], "publisher-name": ["Springer"]}, {"label": ["57."], "surname": ["Chamagne"], "given-names": ["J"], "article-title": ["Forest diversity promotes individual tree growth in central european forest stands"], "source": ["J. Appl. Ecol."], "year": ["2016"], "volume": ["54"], "fpage": ["71"], "lpage": ["79"], "pub-id": ["10.1111/1365-2664.12783"]}, {"label": ["58."], "surname": ["Smit", "Den Ouden", "M\u00fcller-Sch\u00e4rer"], "given-names": ["C", "J", "H"], "article-title": ["Unpalatable plants facilitate tree sapling survival in wooded pastures"], "source": ["J. Appl. Ecol."], "year": ["2006"], "volume": ["43"], "fpage": ["305"], "lpage": ["312"], "pub-id": ["10.1111/j.1365-2664.2006.01147.x"]}, {"label": ["59."], "surname": ["Bengtsson"], "given-names": ["J"], "article-title": ["Reserves, resilience and dynamic landscapes"], "source": ["AMBIO J. Hum. Env."], "year": ["2003"], "volume": ["32"], "fpage": ["389"], "lpage": ["396"], "pub-id": ["10.1579/0044-7447-32.6.389"]}, {"label": ["60."], "surname": ["Cordonnier", "Kunstler"], "given-names": ["T", "G"], "article-title": ["The gini index brings asymmetric competition to light"], "source": ["Perspect. Plant Ecol. Evol. Syst."], "year": ["2015"], "volume": ["17"], "fpage": ["107"], "lpage": ["115"], "pub-id": ["10.1016/j.ppees.2015.01.001"]}]
{ "acronym": [], "definition": [] }
60
CC BY
no
2024-01-14 23:40:16
Sci Rep. 2024 Jan 12; 14:1168
oa_package/c2/0a/PMC10786858.tar.gz
PMC10786859
38216631
[ "<title>Introduction</title>", "<p id=\"Par3\">In primates, the cerebral cortex is the center for higher-order cognition such as logical thinking or self-recognition. However, some birds, such as corvids and parrots, demonstrate comparable cognitive functions, even though they do not possess this six-layered cortical structure<sup>##REF##15591194##1##,##REF##18440242##2##</sup>. Remarkable behaviors indicative of so-called higher-order cognition include tool use<sup>##REF##15101428##3##,##REF##23137681##4##</sup>, which requires abilities of causal reasoning, planning, as well as fine object manipulation.</p>", "<p id=\"Par4\">Encephalization, the increased relative mass of the brain compared to body mass<sup>##REF##30104752##5##</sup>, has long been used as a proxy for intelligence in vertebrates, with highly encephalized species considered more intelligent<sup>##REF##24753565##6##,##REF##26811470##7##</sup>. Despite the high degree of encephalization in corvids and parrots, cognitive abilities in birds have long been underestimated due to their rather small brains compared to mammals. A more recent cell counting study has in fact revealed that the brains of parrots and songbirds are extremely neuron-dense and contain on average twice as many neurons as primate brains of the same mass<sup>##REF##27298365##8##</sup>. Thus, some species of corvids and parrots have as many neurons in their pallium (the dorsal telencephalon that contains the cerebral cortex in mammals) as some species of primates<sup>##REF##27298365##8##</sup>. This strongly suggests that mammals and birds have followed two independent trajectories of encephalization: an increase in cortical surface in mammals (with the cortex reaching a very large size in humans), and an increase in the neuronal density of the pallium in birds. Both trajectories led to an increase in the absolute number of telencephalic neurons in highly encephalized species of mammals and birds compared to poorly encephalized ones. In other words, encephalization in amniotes (the clade containing mammals and birds) is mostly a process of “telencephalization“<sup>##REF##27298365##8##–##UREF##1##10##</sup>.</p>", "<p id=\"Par5\">Teleost brains are generally much less encephalized compared to amniotes<sup>##REF##30104752##5##</sup>. Nonetheless, some teleost fishes belonging to the family of wrasses (<italic>Labridae</italic>) exhibit tool use-like behavior<sup>##UREF##2##11##</sup>. Due to the lack of grasping appendages in teleosts, the only way of using a “tool” is holding it in their mouth. In most cases of tool use by wrasses, the fish grasps a shellfish (bivalves) in its jaws, takes it to a feeding station that is equipped with appropriate “anvils” embedded in the substrate (corals or rocks), and then crushes it open by repeated slamming against the anvil<sup>##UREF##3##12##–##UREF##5##14##</sup>. Such behavior does not appear to be a genetically programmed “fixed action pattern”, since it can be observed also in captivity, in a slightly modified form. For example, some individuals of <italic>Thalassoma hardwicke</italic> held in an aquarium use an anvil to smash a large pellet of food into more manageable pieces<sup>##REF##20095003##15##</sup>. Interestingly, these tool use-like behaviors are observed uniquely in the group of wrasses (the family of <italic>Labridae</italic>) in teleosts. Thus, the brain anatomy of wrasses and their close relatives is of great interest to understand the evolution of tool-using behavior and its related higher-order cognitive functions.</p>", "<p id=\"Par6\">Our developmental studies have shown that the telencephalon, hypothalamus, and sensory nuclei of teleosts<sup>##UREF##6##16##–##REF##25965960##20##</sup> differ greatly from amniotes. Indeed, teleost brain organization appears to be much less conserved than previously thought. Notably, teleosts possess a remarkable ventral structure called the inferior lobe, which is absent in tetrapod brains and whose functions remain largely unknown<sup>##REF##30849972##21##</sup>. At a gross morphological level, the ventral parts of the teleost brain appear much more developed in comparison to amniote brains.</p>", "<p id=\"Par7\">These observations raise the question of how encephalization occurred in the teleost lineage, and how the brains of teleosts with remarkable cognitive abilities, such as wrasses, may differ from other species. Is the teleost pallium the brain center that is responsible for higher-order cognitive functions, similar to the amniote brain?</p>", "<p id=\"Par8\">In order to uncover which brain structures are expanded in teleost species demonstrating complex behavioral repertoires, we examined the cellular composition of their major brain regions and compared them with other teleost species located at various phylogenetic positions. We also compared the connectivity of the pallium in encephalized and poorly encephalized species. Our quantitative and qualitative study revealed that, unlike in amniotes, the ventral part of the brain including the inferior lobe is significantly developed in the brains of tool-using species, in which the inferior lobe is heavily connected to the pallium. This illustrates how encephalization in teleosts and amniotes followed different evolutionary paths.</p>" ]
[ "<title>Methods</title>", "<title>Study animals and brain sampling</title>", "<p id=\"Par50\">11 species of teleost were examined: a group of 3 wrasse species (<italic>Choerodon anchorago</italic>, <italic>Labroides dimidiatus, Thalassoma hardwicke</italic>), for which complex behaviors (tool use and social cognition) have been reported, 4 cichlid species (<italic>Maylandia zebra</italic>, <italic>Neolamprologus brichardi</italic>, <italic>Ophthalmotilapia boops</italic>, <italic>Amatitlania nigrofasciata</italic>), which are capable to a lesser extent of complex behaviors, and a group of 4 other species (the medaka (<italic>Oryzias latipes</italic>), zebrafish (<italic>Danio rerio</italic>), <italic>Astyanax</italic> surface fish (<italic>Astyanax mexicanus</italic>), and trout (<italic>Salmo trutta</italic>)).</p>", "<p id=\"Par51\">Adult individuals of zebrafish (<italic>Danio rerio</italic>), medaka (<italic>Oryzia latipes</italic>) and <italic>Astyanax mexicanus</italic> were obtained from the animal facility in NeuroPSI (Saclay, France). Adult trouts (<italic>Salmo trutta</italic>) were sourced from the animal facility at INRAE (Jouy-en-Josas, France). <italic>Neolamprologus brichardi</italic>, <italic>Amatitlania nigrofasciata</italic> and <italic>Danio rerio</italic> individuals used for tract-tracing with BDA and biocytin were obtained from local dealers in Japan.</p>", "<p id=\"Par52\">Sexually mature individuals of both sexes of wrasse and cichlid species were sourced from commercial providers (<italic>Choerodon anchorago</italic>, <italic>Labroides dimidiatus</italic>, <italic>Thalassoma hardwicke</italic>: Marine Life (Paris, France); <italic>Maylandia zebra</italic> and <italic>Ophthalmotilapia boops</italic>: Abysses (Boissy-Saint-Léger, France); <italic>Amatitlania nigrofasciata</italic>: Abysses, Aquariofil.com (Nîmes, France), <italic>Neolamprologus brichardi</italic>: Abysses, Aquariofil.com). Wrasses were wild caught and tended to be young adults, but one large adult of <italic>Choerodon anchorago</italic> weighing around ten times as much as the other individuals was also sampled. Statistical analysis showed that the data from this large individual did not impact the statistical significance of our results (see Supplementary File ##SUPPL##0##1##).</p>", "<p id=\"Par53\">Zebrafish and medaka specimens were anesthetized and euthanized in ice-cold water, weighed on a precision scale and fixed in ice-cold 4% paraformaldehyde (PFA) in 0.01 M phosphated buffer saline containing 0.1% Tween 20 (PBST). All other fish specimens were euthanized by an overdose of MS222, weighed, and immediately perfused transcardially with 4% PFA in PBS. 24 h post-fixation, brains were dissected, weighed on a precision scale, and kept in 4% PFA in PBS for another 24 h before being transferred in anti-freeze solution (30% glycerol, 30% ethylene glycol, 30% H<sub>2</sub>0, 10% PBS 10X) and kept at −20 °C for later use. Brains used for NeuroVue tract-tracing were kept in 4% PFA at 4 °C until use.</p>", "<p id=\"Par54\">All procedures were conducted in compliance with the official regulatory standards of the French Government and in compliance with the official Japanese regulations for research on animal, and the regulations on Animal Experiments in Nagoya University.</p>", "<title>Isotropic fractionator</title>", "<p id=\"Par55\">The medaka brains (<italic>n</italic> = 5) were left undissected.</p>", "<p id=\"Par56\">The brains of <italic>n</italic> = 5 individuals of each species, except the trout (<italic>n</italic> = 4), <italic>M. zebra</italic> (<italic>n</italic> = 3), <italic>C. anchorago</italic> (<italic>n</italic> = 4), <italic>L. dimidiatus</italic> (n = 3), <italic>T. hardwicke</italic> (<italic>n</italic> = 3) and <italic>O. boops</italic> (<italic>n</italic> = 3) were rinsed in PBS and embedded in 3% agarose containing 1% Tween 20 and sectioned at 300 µm in the frontal plane with a vibratome (Leica VT 1200 S). Under a stereomicroscope (Olympus SZX7), the brain was manually dissected using a microsurgical knife into five regions following the rostro-caudal and dorso-ventral axis (Fig. ##FIG##3##4##).</p>", "<p id=\"Par57\">The dorsal part of the secondary prosencephalon, which includes the telencephalon and the dorso-rostral part of the optic recess region (ORR)<sup>##UREF##7##17##,##REF##28470718##18##</sup>, was excised. This region was labeled “telencephalon” (Tel). The second region dissected was the dorsal part of the mesencephalon, which includes the tectum opticum and the torus semicircularis and was labeled “optic tectum” (TeO). The third region included the ventral part of the secondary prosencephalon (i.e., the hypothalamus), the diencephalon and the ventral part of the mesencephalon (i.e., the tegmentum and the inferior lobe) and was labeled “rest of the forebrain/midbrain” (rForeMid). The fourth excised region was the dorsal part of the rhombencephalon (i.e., the cerebellum) (Cb). Finally, all the other hindbrain structures, including the medulla oblongata, were labeled “rest of the hindbrain” (rHind). Sections were dried with a paper towel, weighed on a precision scale and kept in 4% PFA for later use.</p>", "<p id=\"Par58\">The number of cells in the five main regions of the teleost brain was determined using the isotropic fractionator method<sup>##REF##15758160##34##</sup>. This method produces results similar to unbiased stereology<sup>##REF##24904305##74##</sup>. Each structure was manually homogenized in 40 mM sodium citrate with 1% Triton X-100 using a Tenbroeck tissue grinder (Ningbo Ja-Hely Technology Co., Ningbo, China). Once an isotropic suspension of isolated cell nuclei was obtained, the suspension was then centrifuged, and the supernatant was collected. The cell nuclei in both the suspension pellet and the supernatant were stained by adding PBS with 1% diamino-phenyl-indol (DAPI). Additionally, a predetermined volume of PBS was added to the suspension to adjust the nuclei density for counting.</p>", "<p id=\"Par59\">To determine the total number of cells in the tissue, four 10 µL aliquots of the suspension and of the supernatant were counted under an epifluorescence microscope (Axio Imager, Zeiss) with X200 magnification using a Blaubrand Malassez counting chamber (Brand Gmbh, Wertheim, Germany). Mean nuclear density in the suspension and the supernatant was multiplied by their total volume and added up to determine the total number of cells in the brain tissue.</p>", "<p id=\"Par60\">To determine the total number of neurons in each sample, we initially aimed at performing an anti-NeuN immunoreaction in PBS using anti-NeuN antibodies. However, after testing multiple antibodies (anti-NeuN rabbit Antibody, ABN78 &amp; ABN78C3, Merck; anti-NeuN rabbit Antibody, ab177487, Abcam; anti-NeuN mouse Antibody, MAB377, Merck) and increasing antibody concentrations (up to 1:50), we were unable to obtain reliable neuronal nuclear staining. Further tests on brain sections also failed to label teleost neuronal nuclei with NeuN in a consistent manner, suggesting that this tool was not appropriate for teleost tissues. Consequently, we decided to present data on total cell numbers for our brain samples.</p>", "<title>Whole-brain clearing and fiber staining</title>", "<p id=\"Par61\">Lipophilic dye was applied to <italic>n</italic> = 2 whole brains of <italic>D. rerio</italic>, <italic>A. mexicanus</italic>, <italic>N. brichardi</italic>, <italic>C. anchorago</italic> and <italic>S. trutta</italic> for fiber bundles tracing.</p>", "<p id=\"Par62\">Brains stored in anti-freeze solution at −20 °C were washed with PBST for at least 1 day. Samples were bleached for 2 h under intense lighting (&gt;10,000 lux, GVL-SPOT-50-FIXV4-230VAC, GreenVisuaLED) in a fresh depigmentation solution of 5% H<sub>2</sub>O<sub>2</sub>, 0.05% sodium azide in PBS. The bleached samples were thoroughly washed with PBST overnight and were then subjected to a size-dependent delipidation step in CUBIC-L<sup>##REF##30134179##75##</sup>. They were first immersed in a mixture of 50% PBST/50% CUBIC-L overnight under gentle shaking followed by an incubation in CUBIC-L at 37 °C under agitation for 1–2 days for <italic>D. rerio</italic>, 3 days for <italic>A. mexicanus</italic>, 4 days for <italic>N. brichardi</italic> and 6 days for <italic>C. anchorago</italic> and <italic>S. trutta</italic> with solution renewed once. Delipidated specimens were washed with PBST for at least 4 h prior to staining.</p>", "<p id=\"Par63\">Staining was performed in solutions that were originally designed for immunostaining of zebrafish larvae<sup>##REF##35841952##76##</sup>. Samples were immersed in a blocking solution of 10% normal goat serum, 10% DMSO, 5% 1 M PBS-glycine, 0.5% Triton X-100, 0.1% sodium deoxycholate, 0.1% IGEPAL CA-630 and 0.1% saponin in PBST overnight at 37 °C under gentle shaking. Subsequently, specimens were stained with 2 µg/ml of DiI (D282) in a solution of 2% NGS, 20% DMSO, 0.05% sodium azide, 0.2% Triton-X100, 10 µg/mL heparin and 0.1% saponin at 37 °C under rotation for a specimen-dependent duration.</p>", "<p id=\"Par64\">After a last washing step in PBST, refractive index matching was carried out in weakly basic CUBIC-R solution<sup>##REF##30134179##75##</sup>. Brains were soaked in a mixture of 50% PBST/50% CUBIC-R overnight under agitation and then kept in CUBIC-R (refractive index = 1.52) prior to mounting.</p>", "<title>Whole-brain 3D imaging</title>", "<p id=\"Par65\">Refractive index matched samples were embedded in a filtered (pore size 5.0 µm) melted agarose solution containing 2% agarose, 70% CUBIC-R in distilled H<sub>2</sub>O. CUBIC/agarose gels were immersed in CUBIC-R at room temperature for a minimum of 1 day to homogenize refractive indices.</p>", "<p id=\"Par66\">Images were acquired with two commercial light-sheet fluorescence microscopes. Acquisitions were performed with an Ultramicroscope II (Miltenyi Biotec) using a 1.1x NA 0.1 MI PLAN objective and a DC57 WD17 0 dipping cap coupled to a 2x magnification lens, or a LVMI-Fluor 4x/0.3 WD6 objective without additional magnification. A Lightsheet 7 (Zeiss) equipped with 10 × 0.2 foc illumination and 5 × 0.16 foc detection optics was also used. According to their size and the type of microscope images were acquired from dorsal or sagittal view. Cotton seed oil was poured on the surface of the imaging medium as an impermeable layer to avoid evaporation-induced refractive index changes during imaging. 16-bit images were acquired by a pco.edge 5.5 sCMOS camera (2560 × 2160 pixels, pixel size 6.5 µm × 6.5 µm) on the Ultramicroscope II or a pco.edge 4.2 sCMOS camera (1920 × 1920 pixels, pixel size 6.5 µm × 6.5 µm) on the Lightsheet 7, following sample excitation with laser 488 and 561 nm. The z-step size was fixed to 6 µm on the Ultramicroscope II and 5.176 µm on the Lightsheet 7, which represents nearly half of the theoretical lightsheet thickness.</p>", "<title>3D image reconstruction and manual segmentation</title>", "<p id=\"Par67\">For the inter-species comparison of the anatomy of the tracts connecting the Tel with the rForeMid, these structures were segmented manually using the 3D visualization and reconstruction software Amira 2019 (Thermo Fisher Scientific).</p>", "<p id=\"Par68\">The combination of the overall size of the specimens and the required resolution/voxel size demanded tiled image acquisition. The resulting image stacks were merged using the Grid/Collection stitching plugin<sup>##REF##19346324##77##</sup> in Fiji.</p>", "<p id=\"Par69\">In preparation for the manual segmentation, the signal-to-noise ratio of the merged data was improved by subtracting the gaussian noise (Fiji, Gaussian Blur 3D, Kernel 10,10,10) from the original data. After manual segmentation of the original data and the denoised data by an unbiased researcher, the defined regions were refined by multiplying the denoised data with the individual binary masks of the segmentations.</p>", "<p id=\"Par70\">The 3D reconstructions in Fig. ##FIG##5##6## were produced on <italic>n</italic> = 2 brains for each species by selective visualization of the denoised features under investigation in this study within the framework of the overall anatomy of the corresponding brains.</p>", "<title>Tract-tracing with NeuroVue</title>", "<p id=\"Par71\">In order to confirm the presence of the inferior lobe fiber tracts visualized with DiI staining, tract-tracing experiments were performed using NeuroVue (Polysciences), a lipophilic dye which allows both retrograde and anterograde tracing and can be used on fixed brain tissue<sup>##UREF##17##78##</sup>. Small triangular pieces of NeuroVue filter paper were inserted into the inferior lobe of <italic>n</italic> = 3 specimens of <italic>A. mexicanus</italic>, <italic>N. brichardi</italic> and <italic>C. anchorago</italic>, and into the pallium of <italic>n</italic> = 3 specimens of <italic>N. brichardi</italic>. Brains were then incubated at 36 °C in 4% PFA in PBS for 4 (<italic>A. mexicanus</italic>) to 12 days (<italic>C. anchorago</italic>).</p>", "<p id=\"Par72\">Following incubation, 80 µm sections were cut with a vibratome (Leica VT1200S), both in frontal and sagittal planes in order to visualize the fiber tracts’ orientation in 3D. Sections were then treated with DAPI before being mounted on glass slides with VectaShield mounting medium (Vector Laboratories). Sections were imaged using a Leica SP8 confocal microscope.</p>", "<title>Tract-tracing with BDA and biocytin</title>", "<p id=\"Par73\">BDA (molecular weight 3000) or biocytin was injected in vivo into the pallium of two species of cichlids of both sexes, <italic>N. brichardi</italic> (<italic>n</italic> = 5; standard length: 30–49 mm), <italic>A. nigrofasciata</italic> (<italic>n</italic> = 5; standard length: 45–55 mm) and zebrafish <italic>D. rerio</italic> (<italic>n</italic> = 2; standard length: 30 and 35 mm). Fish were anesthetized by immersion in water containing 150–180 mg/L MS222 and set in a device for physical restraint. Water containing 70–80 mg/L MS222 was perfused through the gill for aeration and to maintain the anesthetic condition. A dorsal portion of the cranium was opened to expose the brain. For BDA injections, a glass microelectrode (tip diameters: 12–16 µm) filled with 0.75% BDA solution in 0.05 M Tris-HCl-buffered saline (TBS; pH 7.4) was driven into the pallium with a manipulator (MN-3; Narishige). BDA was injected iontophoretically with square current pulses (+5 µA, 0.5 Hz, 50% duty cycle) passed through the electrodes at three to six places of the pallium each for 5 min with a stimulator (SEN-3301; Nihon Kohden, Japan). For biocytin injections, crystals of biocytin were inserted with a minute insect pin into three to six places of the pallium. After the injection, the cranial opening was closed with either plastic wrap (small fish) or dental cement (Ostron II; GC Dental Products, Japan). Postoperative fish were maintained in aquaria for 21–30 h. The fish were then deeply anesthetized with MS222 (over 200 mg/L) and perfused through the heart with 2% PFA and 1% glutaraldehyde in 0.1 M phosphate buffer (PB), pH 7.4. The brains were removed from the skull and post-fixed in the same fixative at 4 °C for 6–8 h.</p>", "<p id=\"Par74\">The fixed brains were cryo-protected by immersion in 0.1 M PB containing 20% sucrose at 4 °C. Cryo-protected brains were embedded in 5% agarose (type IX, ultra-low gelling temperature) containing 20% sucrose and frozen in n-hexane at −60 °C. Then, frontal sections were cut at a thickness of 40 µm on a cryostat and mounted on gelatin-coated glass slides. The sections were dried and washed once with 0.05 M TBS containing 0.1% Tween 20 (TBST) and twice with TBS. To quench non-specific peroxidase activities, sections were steeped in methanol containing 0.3% H<sub>2</sub>O<sub>2</sub> and washed three times with TBS and once with 0.03% TBST. Sections were then incubated with a solution of avidin-biotin-peroxidase complex (1:100; VECTASTAIN Elite ABC Standard Kit, Vector Laboratories) overnight. Afterwards, sections were incubated for one hour with 0.05% 3,3’-diaminobenzidine solution in 0.1 M PB containing 0.04% nickel ammonium sulfate and 0.01% H<sub>2</sub>O<sub>2</sub>. The reaction was stopped by washing four times with TBS, and the sections were counterstained with 0.05–0.1% cresyl violet, dehydrated, and coverslipped with Permount (Fisher Scientific).</p>", "<title>Statistics and reproducibility</title>", "<p id=\"Par75\">To determine whether brain mass, body mass, and total number of cells in the brain are correlated in teleosts, a nonparametric Spearman rank correlation test was used on log-transformed data. Previously published data on birds<sup>##REF##27298365##8##</sup> and mammals<sup>##REF##26418466##38##</sup> were used for comparison. If a <italic>P</italic> &lt; 0.05 value was found, reduced major axis (RMA) regressions were calculated using the SMATR package<sup>##UREF##18##79##</sup> in RStudio v.1.2.5033 and fitted RMA regression lines were added to the plots (Fig. ##FIG##1##2##). To compare scaling among taxonomic groups, an analysis of covariance (ANCOVA) with post-hoc Sidak corrected pairwise comparisons was used to check for significant differences in the slopes of the regression lines. In groups for which the slopes were statistically homogeneous, the regression lines were compared based on the differences in their intercepts. Body mass and Brain mass, Total number of cells in the brain and Brain mass, and Body mass and Total number of cells in the brain were significantly correlated in all groups (Spearman r ranging from 0.945 to 1; <italic>p</italic> &lt; 0.0001 in all cases). Data on Columbiformes and Galliformes<sup>##REF##27298365##8##</sup> was plotted as illustration but wasn’t included in the statistical analysis due to the small sample size.</p>", "<p id=\"Par76\">Regression lines for Body mass and Brain mass (Fig. ##FIG##1##2a##) had significantly different slopes (ANCOVA, <italic>p</italic> &lt; 0.0001). Pairwise comparisons found significant differences in the slopes of Glires and Primates (<italic>p</italic> &lt; 0.001), Primates and Psittacopasserae (<italic>p</italic> = 0.0001) and Primates and Teleosts (<italic>p</italic> &lt; 0.0001). ANCOVA revealed significant differences in the intercepts of the regression lines for Brain mass and Body mass for groups with statistically homogenous slopes (<italic>p</italic> &lt; 0.0001). Pairwise comparisons found significant differences in the intercepts of Glires, Teleosts and Psittacopasserae (<italic>p</italic> &lt; 0.0001 in all cases). Regression lines for Body mass and Total number of cells in the brain (Fig. ##FIG##1##2b##) had significantly different slopes (ANCOVA, <italic>p</italic> &lt; 0.0001). Pairwise comparisons found significant differences in the slopes of Glires and Primates (<italic>p</italic> &lt; 0.001), Primates and Psittacopasserae (<italic>p</italic> &lt; 0.0001) and Primates and Teleosts (<italic>p</italic> &lt; 0.001). ANCOVA revealed significant differences in the intercepts of the regression lines for Body mass and Total number of cells in the brain for groups with statistically homogenous slopes (<italic>p</italic> &lt; 0.0001). Pairwise comparisons found significant differences in the intercepts of Glires, Teleosts and Psittacopasserae (<italic>p</italic> &lt; 0.05 in all cases). Regression lines for Total number of cells in the brain and Brain mass (Fig. ##FIG##1##2c##) had significantly different slopes (ANCOVA, <italic>p</italic> &lt; 0.0001). Pairwise comparisons found significant differences in the slopes of Glires and Primates (<italic>p</italic> &lt; 0.01) and Primates and Psittacopasserae (<italic>p</italic> &lt; 0.01). ANCOVA revealed significant differences in the intercepts of the regression lines (<italic>p</italic> &lt; 0.0001). Pairwise comparisons found significant differences in the intercepts of the regression lines for Glires, Teleosts, Primates and Psittacopasserae (<italic>p</italic> &lt; 0.0001 in all cases), with the exception of the intercepts of Glires and Primates (<italic>p</italic> = 0.08). In order to determine the degree of encephalization of the teleost species sampled in this study, a phylogenetically corrected brain-body allometric slope was estimated using PGLS at the Class level on species means of log<sub>10</sub> brain and log<sub>10</sub> body mass data of the species sampled in this study along with previously published actynopterygian data by Tsuboi et al. <sup>##REF##30104752##5##</sup> using RStudio v.1.2.5033 with the CAPER package v.1.0.1 (Fig. ##FIG##2##3##). Residual variance was modeled according to Brownian motion<sup>##UREF##19##80##</sup> and phylogenetic signal was estimated using Pagel’s λ<sup>##REF##28564168##81##</sup>. Phylogenetic relationships between teleost species were based on previously published phylogenetic trees<sup>##REF##23739623##82##</sup>. The phylogenetic regression slope for actinopterygians was of 0.50 ± 0.01 (Adjusted R<sup>2</sup>: 0.8382, <italic>t</italic> = 65.978, <italic>p</italic> &lt; 0.0001). Encephalization was then determined by extracting the residuals of log<sub>10</sub>-log<sub>10</sub> brain and body mass for each species of the dataset to remove allometry in brain size<sup>##REF##26926277##83##</sup>. The 11 species studied were ranked based on the value of their residual (Supplementary Table ##SUPPL##0##1##).</p>", "<p id=\"Par77\">To determine whether there exists a correlation between the degree of encephalization and relative mass and relative number of cells (expressed as the percentage of total brain mass and percentage of total brain cells, respectively) of the five major brain structures dissected, a nonparametric Spearman rank correlation test was used, as there was no way to ascertain the normal distribution of these data. We arranged species by decreasing order of encephalization (Supplementary Fig. ##SUPPL##0##4##). The test was performed in GraphPad Prism v.9.0.0 (GraphPad Software) on species means. A significant negative correlation was found between encephalization and the relative mass and relative number of cells in the rHind (Supplementary Fig. ##SUPPL##0##4e##, Spearman r: −0.7091, <italic>p</italic> = 0.0268 and Spearman r: −0.6727, <italic>p</italic> = 0.039, respectively). No significant correlation with encephalization was found in the four other brain structures for either relative mass or relative number of cells (Supplementary Fig. ##SUPPL##0##4a–d##, Tel relative mass: Spearman r: 0.4788, <italic>p</italic> = 0.1663; relative number of cells: Spearman r: 0.01818, <italic>p</italic> = 0.973; TeO relative mass: Spearman r: −0.1394, <italic>p</italic> = 0.7072; relative number of cells: Spearman r: 0.1394, <italic>p</italic> = 0.7072; rForeMid relative mass: Spearman r: 0.3333, <italic>p</italic> = 0.3487; relative number of cells: Spearman r: −0.4788, <italic>p</italic> = 0.1663; Cb relative mass: Spearman r: −0.1273, <italic>p</italic> = 0.7330; relative number of cells: Spearman r: 0.4545, <italic>p</italic> = 0.1912).</p>", "<p id=\"Par78\">In order to compare species to species the relative mass, absolute and relative number of cells in major brain structures, normality of the data was tested using Shapiro-Wilk’s test. As normality was not verified for all the species studied, and considering the small sample size, nonparametric Kruskal-Wallis and Dunn’s post hoc tests were used to assess the inter-species differences in relative mass, absolute and relative number of cells in the five dissected brain structures. All tests were performed in GraphPad Prism v. 9.0.0. Significant differences were found in the absolute number of cells in all five structures (Kruskal-Wallis, <italic>p</italic> &lt; 0.001 in all cases). However, post-hoc pairwise comparisons revealed significant differences that were inconsistent across species and brain structures, the only consistently found difference across all structures being between <italic>D. rerio</italic> and <italic>C. anchorago</italic> (Dunn’s test, <italic>p</italic> &lt; 0.05 in all cases). Significant differences were found in the relative number of cells in all five structures (Kruskal-Wallis, <italic>p</italic> &lt; 0.05 in all cases). However, post-hoc pairwise comparisons revealed significant differences that were inconsistent across species and brain structures. Significant differences were found in the relative mass in all five structures (Kruskal-Wallis, <italic>p</italic> &lt; 0.05 in all cases). However, post-hoc pairwise comparisons didn’t reveal significant differences between species across the five structures, except for a modest difference in the relative mass of the rHind between <italic>A. mexicanus</italic>, <italic>C. anchorago</italic> and <italic>T. hardwicke</italic> (Dunn’s test, <italic>p</italic> = 0.0307 and <italic>p</italic> = 0.0317, respectively), and in the relative mass of the Tel between <italic>C. anchorago</italic> and <italic>S. trutta</italic> (Dunn’s test, <italic>p</italic> = 0.0254).</p>", "<p id=\"Par79\">Among the teleost species studied, wrasses display the most complex behavioral phenotypes. To determine whether this behavioral repertoire is associated with differences in relative mass and relative number of cells in the five major brain structures compared to other teleosts, the three species of wrasse (<italic>C. anchorago</italic> (<italic>n</italic> = 4), <italic>T. hardwicke</italic> (<italic>n</italic> = 3) and <italic>L. dimidiatus</italic> (<italic>n</italic> = 3)) were grouped together (<italic>n</italic> = 10) and compared to all the other species (<italic>M. zebra</italic> (<italic>n</italic> = 3), <italic>N. brichardi</italic> (<italic>n</italic> = 5), <italic>O. boops</italic> (<italic>n</italic> = 3), <italic>A. nigrofasciata</italic> (<italic>n</italic> = 5), <italic>A. mexicanus</italic> (<italic>n</italic> = 5), <italic>D. rerio</italic> (<italic>n</italic> = 5) and <italic>S. trutta</italic> (<italic>n</italic> = 4), grouped as “other fish” (<italic>n</italic> = 30)) (Fig. ##FIG##4##5##). Regarding the relative mass, wrasses had a significantly larger Tel (Fig. ##FIG##4##5a##) and rForeMid (Fig. ##FIG##4##5c##) compared to other teleosts (Mann-Whitney’s test, <italic>p</italic> &lt; 0.0001 and <italic>p</italic> = 0.0031, respectively), and a significantly smaller Cb (Fig. ##FIG##4##5d##) and rHind (Fig. ##FIG##4##5e##) (<italic>p</italic> = 0.0011 and <italic>p</italic> &lt; 0.0001, respectively). No significant differences were found in the relative mass of the TeO (Fig. ##FIG##4##5b##, <italic>p</italic> = 0.5483). Regarding the relative number of cells, Wrasses had a significantly lower relative number of cells in the rHind (Fig. ##FIG##4##5j##) compared to the other teleosts (Mann-Whitney’s test, <italic>p</italic> &lt; 0.0001). No significant differences were found in the relative number of cells of the other four structures (Fig. ##FIG##4##5f–i##, Tel: <italic>p</italic> = 0.0538; TeO: <italic>p</italic> = 0.3626; rForeMid: <italic>p</italic> = 0.1983; Cb: <italic>p</italic> = 0.8658). Normality and Mann-Whitney tests were performed in GraphPad Prism v. 9.0.0.</p>", "<p id=\"Par80\">Another analysis was done in order to assess the differences in relative mass and relative number of cells in the brain structures: as cichlids appeared to have a large rForeMid, we decided to compare them to wrasses and to the other species of teleosts studied here (Supplementary Fig. ##SUPPL##0##6##). <italic>A. mexicanus</italic> (<italic>n</italic> = 5), <italic>D. rerio</italic> (<italic>n</italic> = 5) and <italic>S. trutta</italic> (<italic>n</italic> = 4), were grouped together as an “outgroup” (<italic>n</italic> = 14). In both cases, as normality could not be satisfied for all structures in all groups, a nonparametric Kruskal-Wallis test was used. All tests were performed in GraphPad Prism v. 9.0.0. Regarding the relative mass, wrasses and cichlids had a significantly larger Tel (Supplementary Fig. ##SUPPL##0##6a##) and rForeMid (Supplementary Fig. ##SUPPL##0##6c##) compared to the “outgroup” (Kruskal-Wallis test, <italic>p</italic> &lt; 0.01 in both structures), and a significantly smaller TeO (Supplementary Fig. ##SUPPL##0##6b##) (<italic>p</italic> &lt; 0.05 in all cases). Additionally, wrasses had a larger Tel compared to cichlids (Supplementary Fig. ##SUPPL##0##6a##) (<italic>p</italic> = 0.0324). Regarding the relative number of cells, wrasses had a significantly lower relative number of cells in the rHind (Supplementary Fig. ##SUPPL##0##6j##) while cichlids had a significantly higher relative number of cells in the rForeMid (Supplementary Fig. ##SUPPL##0##6h##) compared to the “outgroup” (Kruskal-Wallis test, <italic>p</italic> &lt; 0.0001 and <italic>p</italic> = 0.0137, respectively). No significant differences were found in the relative number of cells in the rForeMid between wrasses and cichlids (<italic>p</italic> = 0.0506).</p>", "<title>Reporting summary</title>", "<p id=\"Par81\">Further information on research design is available in the ##SUPPL##8##Nature Portfolio Reporting Summary## linked to this article.</p>" ]
[ "<title>Results</title>", "<title>The tool-using wrasse <italic>Choerodon anchorago</italic> has more cells in its brain than a hamster twice its body mass</title>", "<p id=\"Par9\">The body mass and brain mass were measured for 11 species of teleost: a group of three wrasse species (<italic>Choerodon anchorago</italic>, <italic>Labroides dimidiatus, Thalassoma hardwicke</italic>), a group of four cichlid species (<italic>Maylandia zebra</italic>, <italic>Neolamprologus brichardi</italic>, <italic>Ophthalmotilapia boops</italic>, <italic>Amatitlania nigrofasciata</italic>), and a group of four other species (the medaka (<italic>Oryzias latipes</italic>), zebrafish (<italic>Danio rerio</italic>), <italic>Astyanax</italic> surface fish (<italic>Astyanax mexicanus</italic>), and trout (<italic>Salmo trutta</italic>), hereafter referred to as the “outgroup”) (Fig. ##FIG##0##1##, see “Methods” section). Total number of cells in the brain was determined using the isotropic fractionator (see “Methods” section).</p>", "<p id=\"Par10\">Remarkably complex behaviors have been reported in the group of wrasses: tool use in the case of <italic>C. anchorago</italic><sup>##UREF##4##13##</sup> and <italic>T. hardwicke</italic><sup>##REF##20095003##15##</sup>, and complex social cognition (e.g., altruism and punishment) in the case of <italic>L. dimidiatus</italic><sup>##REF##12396482##22##–##REF##27016339##25##</sup>. In cichlids, although no instances of tool use have been observed, many species demonstrate complex social interaction with parental care<sup>##UREF##8##26##–##REF##33362975##28##</sup>, and there are several studies reporting cognitive abilities such as individual recognition, quantity discrimination, and transitive inference<sup>##REF##35361791##29##–##REF##17251980##33##</sup>.</p>", "<p id=\"Par11\">Among the wrasses studied, body mass ranged from 1.55 to 91.52 g, brain mass from 34.62 to 338.8 mg, and total number of cells in the brain from 45.7 to 185.08 million (Table ##TAB##0##1##). Wrasses were wild caught and were generally young adults (estimated by morphology); however, one large adult of <italic>C. anchorago</italic>, weighing around ten times as much as the other individuals, was also sampled. Excluding this large specimen from the analyses did not affect the statistical significance of the observed results, so we included it in the main analyses presented here (Supplementary Figs. ##SUPPL##0##1##–##SUPPL##0##3## show the data excluding the large specimen; see also Table ##TAB##0##1##, Supplementary Table ##SUPPL##0##1##, and Supplementary File ##SUPPL##0##1##). In cichlids, body mass ranged from 5.15 to 20.28 g, brain mass from 42.43 to 96.94 mg and total number of cells in the brain from 37.54 to 61.78 million (Table ##TAB##0##1##). In the “outgroup”, body mass ranged from 0.492 to 177.15 g, brain mass from 8.38 to 354.73 mg, and total number of cells in the brain from 6.66 to 100.84 million (Table ##TAB##0##1##). Overall, the specimens used in this study were rather small, and future studies using larger indidivuals would be useful to confirm our results.</p>", "<p id=\"Par12\">Compared to previously published data, teleosts have smaller brains than birds, primates or rodents of similar body mass (Fig. ##FIG##1##2a##). By contrast, teleost brains contain more cells than the brains of rodents of similar body mass, albeit not as many as birds and primates, (Fig. ##FIG##1##2b##). For instance, the brain of the tool-using wrasse <italic>C. anchorago</italic> contains on average more cells than the brain of the nearly two times heavier hamster (<italic>Cricetus cricetus</italic>).</p>", "<p id=\"Par13\">Cellular density inside the teleost brain is higher than in birds and mammals, with teleosts having as many cells as rodent brains more than four times larger (Fig. ##FIG##1##2c##). For example, the large <italic>C. anchorago</italic> individual sampled had 301.9 million cells in its brain, nearly as many cells as a rat (<italic>Rattus norvegicus</italic>), even though its brain is 2.6 times lighter.</p>", "<title>Encephalization and relative mass or number of cells in the telencephalon of teleosts are not correlated</title>", "<p id=\"Par14\">Residuals obtained by fitting a log<sub>10</sub>-log<sub>10</sub> regression of brain mass against body mass data from this dataset with previously published data on actinopterygians (Fig. ##FIG##2##3##) using a phylogenetic generalized least square (PGLS) model ranged from −0.142 (<italic>D. rerio</italic>) to 0.38 (the wrasse <italic>T. hardwicke</italic>), with only one other species (<italic>C. anchorago</italic>) with a residual &gt;0.30 (Fig. ##FIG##2##3##, Supplementary Table ##SUPPL##0##1##). Excluding the large <italic>C. anchorago</italic> from our analysis gave a residual of 0.488 for <italic>C. anchorago</italic>, placing it above <italic>T. hardwicke</italic> (Supplementary Table ##SUPPL##0##1##, see Supplementary File ##SUPPL##0##1##). Overall, these two tool-using species were the most encephalized of our dataset.</p>", "<p id=\"Par15\">In order to compare the degree of encephalization with the relative mass and cellular composition of major brain regions, the brains of ten species were dissected into five parts (Fig. ##FIG##3##4a##): the telencephalon (Tel), the optic tectum (TeO), the rest of the Forebrain/Midbrain (rForeMid; which includes the inferior lobe), the cerebellum (Cb) and the rest of the Hindbrain (rHind) following the rostro-caudal and dorso-ventral axis (Fig. ##FIG##3##4b–e##, See “Methods” section). These structures were weighed and the number of cells contained in each structure was determined using the isotropic fractionator<sup>##REF##15758160##34##</sup>. No statistically significant correlations were found between encephalization and the relative mass and relative number of cells of the Tel, TeO, rForeMid, Cb (Supplementary Fig. ##SUPPL##0##4a–d##). The only structure that showed a statistically significant correlation with encephalization was the rHind (Supplementary Fig. ##SUPPL##0##4e##), with a negative correlation for both the relative mass and relative number of cells (See Methods). This indicates that more encephalized species of teleosts have a relatively smaller rHind containing a relatively smaller number of cells.</p>", "<p id=\"Par16\">These results suggest that teleost brains have evolved very differently from amniote brains. Unlike in mammals and birds, encephalized species of teleosts don’t have an extremely large Tel.</p>", "<title>Wrasses have a relatively larger Tel and rForeMid, but not a larger relative number of cells compared to other teleosts</title>", "<p id=\"Par17\">Comparing species in a one-to-one manner didn’t reveal any consistent differences in either the relative mass or relative number of cells across structures (Supplementary Fig. ##SUPPL##0##5##, See Methods). However, a trend towards larger Tel and rForeMid was observed when examining wrasses as a whole (Supplementary Fig. ##SUPPL##0##5##). Wrasses have large brains and display the most flexible behavioral repertoires, including tool use. We thus aimed to investigate any differences in their brain morphology compared to the other teleosts. To this end, the relative mass and number of cells in the five major regions of the brains of all wrasse species were compared with those of the other species of teleosts sampled in this study (Fig. ##FIG##4##5##).</p>", "<p id=\"Par18\">The relative mass of the Tel and rForeMid was significantly higher in wrasses compared to other teleosts, with the Tel accounting for 24.11% ± 3.78% of total brain mass in wrasses compared to 15.43% ± 3.74% in other species (Fig. ##FIG##4##5a##). While the Tel in wrasses is larger than in other teleosts, it remains modest when compared to amniotes. The rForeMid accounted for 28.82% ± 2.46% of total brain mass in wrasses compared to 24.72% ± 3.43% in other species (Fig. ##FIG##4##5c##). The relative mass of the Cb and rHind were significantly lower in wrasses compared to other teleosts (Fig. ##FIG##4##5d, e##). No significant difference was found in the relative mass of the TeO between the two groups (Fig. ##FIG##4##5b##).</p>", "<p id=\"Par19\">Despite the larger size of the Tel and rForeMid in wrasses, isotropic fractionator data revealed that there is no significant difference in the relative number of cells in these two structures compared to other species. The Tel accounted for 12.02% ± 6.04% of total brain cells in wrasses compared to 8.49% ± 2.54% in other species (Fig. ##FIG##4##5f##), while the rForeMid accounted for 12.04% ± 2.76% of total brain cells in wrasses and 12.39% ± 2.47% in other species (Fig. ##FIG##4##5h##). No significant difference in relative number of cells was found in either the Cb (Fig. ##FIG##4##5i##) or TeO (Fig. ##FIG##4##5g##), whereas the rHind (Fig. ##FIG##4##5j##) accounted for a significantly smaller relative number of cells in wrasses compared to other species (2.18% ± 0.64% and 5.41% ± 1.64%, respectively).</p>", "<p id=\"Par20\">Similar results were obtained when comparing cichlids to the “outgroup” (Supplementary Fig. ##SUPPL##0##6##, See «Methods» section). Cichlids had a slightly larger relative number of cells in the rForeMid compared to the “outgroup”, but there was no significant difference with wrasses.</p>", "<p id=\"Par21\">Overall, these results show that wrasses have a relatively larger Tel and rForeMid compared to other teleosts. However, these two structures do not contain a larger proportion of cells than in other teleosts.</p>", "<title>Pallium and inferior lobe display increased connectivity in wrasses compared to other teleosts</title>", "<p id=\"Par22\">We hypothesized that the increase in mass observed in the Tel and rForeMid of wrasses is due to an increase in the neuropil of these structures. To verify this hypothesis, we performed selective visualization of the fibers in the Tel and rForeMid. Whole brains of the wrasse <italic>C. anchorago</italic>, the cichlid <italic>N. brichardi</italic>, the trout <italic>S. trutta</italic>, the <italic>Astyanax</italic> surface fish <italic>A. mexicanus</italic>, and the zebrafish <italic>D. rerio</italic> were cleared, stained with DiI, and imaged on a light-sheet microscope (Fig. ##FIG##5##6##, Supplementary Movies ##SUPPL##2##1##–##SUPPL##6##5##, See «Methods» section).</p>", "<p id=\"Par23\">3D reconstruction of the DiI-stained fibers in the Tel and rForeMid of wrasses and cichlids revealed the presence of enriched fiber labeling in the Tel and rForeMid. Most of the inferior lobe, the ventral-most part of the rForeMid, exhibited high fiber density in wrasses (Fig. ##FIG##5##6a##, Supplementary Movie ##SUPPL##2##1##; in purple), while fiber labeling was sparse in the other species examined (trout, Fig. ##FIG##5##6c##, Supplementary Movie ##SUPPL##3##2##; <italic>Astyanax</italic> surface fish, Fig. ##FIG##5##6d##, Supplementary Movie ##SUPPL##4##3##; zebrafish, Fig. ##FIG##5##6e##, Supplementary Movie ##SUPPL##5##4##; in purple).</p>", "<p id=\"Par24\">The telencephalic fibers in the wrasse almost completely occupy the entire pallium. These fibers converge onto the lateral forebrain bundle as they exit the telencephalon and then split again into two major tracts (Fig. ##FIG##5##6a##, Supplementary Movie ##SUPPL##2##1##; in green and magenta). These connect the pallium and the structures in and around the inferior lobe (in an area which we refer to as the lobar region, Fig. ##FIG##3##4f,g##), and we thus refer to these two tracts as “pallio-lobar tracts”. The ventrally located tract (Fig. ##FIG##5##6a##, Supplementary Movie ##SUPPL##2##1##; in green) directly connects the pallium and the ventral inferior lobe ipsilaterally. The dorsally located tract (Fig. ##FIG##5##6a##, Supplementary Movie ##SUPPL##2##1##; in magenta) courses near the midline ipsilaterally and connects the pallium with a structure called the nucleus preglomerulosus pars commissuralis (PGc) in the lobar region, as well as sending minute fibers to the inferior lobe that run through the periphery of an oval-shaped structure called the corpus glomerulosum pars rotunda (GR). The same tracts are also present in the cichlid brain, albeit more modestly, with a much smaller fiber arborization in both the pallium and inferior lobe (Fig. ##FIG##5##6b##, Supplementary Movie ##SUPPL##6##5##; in green and magenta). Strikingly, in trout, zebrafish, and <italic>Astyanax</italic> surface fish, these tracts were not detectable, and only minimal arborization was found in the pallium and the inferior lobe (Fig. ##FIG##5##6c–e##, Supplementary Movies ##SUPPL##3##2##–##SUPPL##5##4##). Both PGc and GR are absent in those species, indicative of the poor development of their lobar region.</p>", "<p id=\"Par25\">Tract tracing studies using the lipophilic dye NeuroVue, biocytin, and biotinylated dextran amine (BDA molecular weight 3000) confirmed the presence of connectivity between the pallium and the lobar region in the wrasse and cichlid brains (Supplementary Fig. ##SUPPL##0##7##, See «Methods» section). Biocytin injections in the telencephalon (Supplementary Fig. ##SUPPL##0##7a##, white asterisk) allowed us to identify the direction of the projections. Abundant labeled fibers were found in the inferior lobe (Supplementary Fig. ##SUPPL##0##7b##), while very few cell bodies were labeled (Supplementary Fig. ##SUPPL##0##7c##, white arrows). This suggests that the majority of projections are descending fibers from the pallium to the inferior lobe, with only few ascending fibers from the inferior lobe to the pallium. These fibers reached the inferior lobe through the ventral branch of the lateral forebrain bundle mentioned above.</p>", "<p id=\"Par26\">While pallio-lobar tracts were not detectable in zebrafish with 3D reconstruction of DiI labeled fibers, biocytin injections into the dorsal telencephalon resulted in labeled fibers in the lateral forebrain bundle and terminal labeling in the inferior lobe of zebrafish. This indicates that pallial connectivity with the inferior lobe is present in this species, albeit to a lesser extent than in wrasses and cichlids.</p>", "<p id=\"Par27\">There are two additional fiber tracts observable in all species examined. One contains projections from the sensory preglomerular complex to the pallium (Fig. ##FIG##5##6##, Supplementary Movies ##SUPPL##2##1##–##SUPPL##6##5##; in orange)<sup>##UREF##6##16##,##REF##18381599##35##</sup>, coursing rostrally and joining the lateral forebrain bundle. The most distinct branch of this tract terminates in the lateral zone of the dorsal telencephalic area (Dl) carrying visual information<sup>##UREF##6##16##</sup>. In the pallium of wrasses and cichlids, these visual terminals (Fig. ##FIG##5##6a, b##; orange) are embedded in the arborization of the ventral pallio-lobar tract (Fig. ##FIG##5##6a, b##; green).</p>", "<p id=\"Par28\">The other tract present in all species is the one connecting the inferior lobe with the pretectum (Fig. ##FIG##5##6##, Supplementary Movies ##SUPPL##2##1##–##SUPPL##6##5##; in blue). In the trout, zebrafish, and <italic>Astyanax</italic> surface fish, this is the major tract connecting the inferior lobe with the rostral aspect of the brain. In the wrasse and cichlid brain, the pretectal pathway to the inferior lobe is mediated by the GR (Fig. ##FIG##5##6a##, Supplementary Movie ##SUPPL##2##1##; in blue). This only represents a small proportion of inferior lobe connectivity in those species, as the inferior lobe is also heavily connected with the pallium.</p>", "<p id=\"Par29\">The presence of very developed pallio-lobar tracts is unrelated to absolute or relative brain size, as these tracts were not detectable in the large brained trout. Thus, the large quantity of fibers connecting the inferior lobe and the pallium in wrasses and cichlids appears to be remarkable feature of their brain organization compared to other species.</p>", "<p id=\"Par30\">Overall, the presence of the pallio-lobar tracts and their extreme enlargement in wrasses may thus explain the expansion of their Tel and rForeMid without a corresponding increase in the relative number of cells in those structures. This increase in the relative quantity of fibers in tool-using teleost species also parallels what has been observed in the mammalian telencephalon, where primates have a larger proportion of white matter compared to rodents<sup>##REF##10792049##36##,##UREF##9##37##</sup>.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par31\">Mammals and birds have taken two different trajectories of encephalization that have converged onto a process of “telencephalization”, whereby the telencephalon (and in particular the pallium) becomes massively enlarged in highly encephalized species. Our study shows that this is not the case in teleosts.</p>", "<p id=\"Par32\">Sampling of a phylogenetically broad range of teleost species revealed that encephalization in teleosts does not lead to an enlargement of most of the examined brain regions, both in terms of mass and relative number of cells. That is, there was no single particularly prominent structure in highly encephalized teleosts compared to less encephalized ones. Even in the tool-using species (<italic>C. anchorago</italic>), the telencephalon is of a modest size, representing only 27.8% of total brain mass. This is in stark contrast to amniotes, where the telencephalon makes up 80% of total brain mass in tool-using species of primates, parrots and corvids<sup>##REF##27298365##8##,##REF##26418466##38##</sup>.</p>", "<p id=\"Par33\">Compared to amniotes, the rForeMid of teleosts is remarkably large. In previous amniote studies<sup>##REF##27298365##8##,##REF##26418466##38##</sup>, the brain structures corresponding to rForeMid, TeO and rHind were pooled together and called the “rest of brain” on account of their small relative size compared to the telencephalon and cerebellum. While this “rest of brain” represents merely 10–25% of total brain mass in primates, parrots and corvids<sup>##REF##27298365##8##,##REF##26418466##38##</sup>, it does represent 61.1% in the tool-using wrasse <italic>C. anchorago</italic>. The modest telencephalon and the large “rest of brain” of teleosts, even in relatively highly encephalized tool-using species, indicates that unlike in amniotes, encephalization in teleosts is not a process of telencephalization.</p>", "<p id=\"Par34\">In contrast to these differences, mammalian and teleost brains have in common an increase in white matter volume in tool-using species. In mammals, primates have a significantly higher white matter volume to gray matter volume ratio in the telencephalon compared to rodents<sup>##REF##10792049##36##,##UREF##9##37##</sup>. However, when compared to the number of neurons, rodents actually have more white matter per neuron than primates<sup>##UREF##9##37##</sup>. This is in part due to the axonal caliber increasing in rodents as neurons are added to the cortex, while axonal caliber remains constant in primates<sup>##REF##20956290##39##,##UREF##10##40##</sup>. On top of this, as neurons are added to the cortex, cortical connectivity (the fraction of gray matter neurons connected through the white matter) remains constant in rodents, while it decreases in primates. Such a decrease in connectivity in primates as the network grows is indicative of a small-world network, while the rodent cortex appears to be organized as a uniform network<sup>##UREF##9##37##,##REF##15319512##41##</sup>.</p>", "<p id=\"Par35\">We found wrasses to have much larger amounts of fibers in both their telencephalon and lobar region compared to other species, due to their very large pallio-lobar tracts. The functional significance of this feature of brain organization in teleosts is unclear. As we could only assess fiber tract volume qualitatively rather than quantitatively, we cannot evaluate white matter per neuron values in teleosts. It would be interesting to know whether the increased volume of white matter in wrasses compared to trouts is due to the axonal caliber of neurons increasing (as in rodents) or rather to the increase in the absolute number of neurons, with axonal caliber remaining similar (as in primates). Similarly, connectomics data in tool-using teleosts would help understand the nature of their network architecture: do wrasses possess a uniform network brain like rodents, or a small-world network brain like primates ?</p>", "<p id=\"Par36\">One limitation of our results describing the cellular composition of the teleost brain is that we were only able to obtain total cell numbers for each structure, and we thus could not distinguish between neuronal and non-neuronal cell numbers like in the rest of the isotropic fractionator literature<sup>##REF##27298365##8##,##REF##26418466##38##</sup>. One interesting finding from these studies is that non-neuronal cell density varies at most by one order of magnitude in amniotes, while neuronal density varies by three orders of magnitude<sup>##UREF##11##42##</sup>. If this non-neuronal density also holds for teleosts, it would indicate that teleosts have neuronal densities in their pallium higher or similar to those of certain songbirds and parrots<sup>##REF##27298365##8##,##REF##26418466##38##,##REF##35254911##43##</sup>. Future studies in teleosts should help verify this hypothesis and shed more light on the functional consequences of high neuronal densities.</p>", "<p id=\"Par37\">The rForeMid corresponds to the ventral part of the forebrain and midbrain, while the Tel and TeO represent the dorsal parts of the forebrain and midbrain respectively. As the rForeMid is large in teleosts, accounting for a quarter to a third of total brain mass, it appears that teleost brains are a lot more “ventralized” compared to amniote brains.</p>", "<p id=\"Par38\">The lobar region (which includes the inferior lobe, GR, and PGc) in particular appeared to account for most of the rForeMid volume. The inferior lobe was long considered to be of hypothalamic origin and used to be named the “inferior lobe of the hypothalamus” as a result. A recent study<sup>##REF##30849972##21##</sup> has demonstrated that the developmental origin of the inferior lobe is in fact mainly mesencephalic, while the cell populations surrounding the lateral recess of the hypothalamic ventricle, which represent a small part of the inferior lobe, are of hypothalamic origin. Bloch et al. <sup>##REF##30849972##21##</sup> has suggested that in the species with a large inferior lobe, it is mainly this mesencephalic part that becomes enlarged, and not the hypothalamic part.</p>", "<p id=\"Par39\">The inferior lobe is especially enlarged in wrasses and cichlids. The interpretation on the evolution of this structure largely depends on the phylogenetic relationship of these groups. Wrasses and cichlids have been considered as closest relatives, forming the group of “labroids”<sup>##UREF##12##44##</sup>. However, the divergence time obtained by TIMETREE5 (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.timetree.org\">www.timetree.org</ext-link>), as well as other publications, show that they are relatively close, but not the closest, and that cichlids are in fact closer to medaka<sup>##REF##22744773##45##,##REF##28683774##46##</sup> (Fig. ##FIG##0##1##). As the medaka does not appear to have a particularly developed inferior lobe, this raises the possibility that the enlargement of the inferior lobe may have occurred independently in different groups of teleosts.</p>", "<p id=\"Par40\">GR forms the root of the lobar region in wrasses and cichlids. It is considered to have important sensory (especially visual) functions, and to project almost exclusively to the inferior lobe<sup>##REF##7076899##47##–##REF##10559551##49##</sup>. Not only does GR have no homolog in tetrapod brains, it has only evolved in some groups of teleosts<sup>##REF##1159793##50##</sup>. This also appears to be the case for PGc, and we thus consider GR and PGc as specialized nuclei present only in groups of teleosts which possess large connectivity between the pallium and lobar region.</p>", "<p id=\"Par41\">Another structure of the rForeMid that is also involved in sensory processing is the preglomerular complex, which is considered to play a role equivalent to the amniote thalamic nucleus. As our previous study has shown, it is mostly made up of cells of a mesencephalic origin<sup>##UREF##6##16##</sup>. In that sense, it appears that teleost brains are largely more mesencephalized than amniote brains. Altogether, sensory systems in teleosts and tetrapods are not as conserved as previously thought but have evolved independently in each lineage.</p>", "<p id=\"Par42\">Teleosts thus display marked differences in the organization of their brains compared to amniotes, with mesencephalic structures accounting for a much larger proportion of total brain mass and playing a prominent role in sensory processing.</p>", "<p id=\"Par43\">Our current study revealed that in the wrasse and cichlid brains, the inferior lobe is highly connected with the pallium. This seems to be especially apparent in tool-using species. As some previous studies already suggested<sup>##REF##30849972##21##,##REF##32203953##51##</sup>, this challenges the previous notion that the inferior lobe is merely a food motivation center<sup>##REF##4938346##52##–##REF##273462##55##</sup>. The inferior lobe receives gustatory information<sup>##REF##17278137##48##,##REF##7400389##56##–##REF##6619321##58##</sup>, and due to its position directly next to the hypothalamus, it was thought to be homologous to the lateral hypothalamus of mammals<sup>##REF##273462##55##</sup>. Direct electrical stimulation of the inferior lobe resulted in behaviors such as biting on a mirror or snapping at objects in freely moving fish<sup>##REF##4938346##52##,##REF##4146618##53##</sup>, and inferior lobe activation was found during detection of moving objects in larval zebrafish<sup>##REF##28425439##54##</sup>. With the assumption that the inferior lobe was homologous to the mammalian hypothalamus, these functional data have been interpreted as the inferior lobe playing a role in feeding behaviors. However, since this previous view of inferior lobe homology has been shown to be erroneous<sup>##REF##30849972##21##</sup>, a reinterpretation of this data is necessary.</p>", "<p id=\"Par44\">In addition to gustatory inputs, the inferior lobe receives visual inputs from the TeO via the pretectum<sup>##REF##7076899##47##–##REF##10559551##49##,##REF##28425439##54##</sup>. In the species where GR is present, it has been suggested that the inferior lobe also receives auditory<sup>##REF##7076899##47##</sup> and somatosensory<sup>##REF##10559551##49##</sup> information. As a result, the inferior lobe has also been proposed to be a multi-sensory integration center<sup>##REF##17278137##48##,##REF##10559551##49##,##REF##9552123##57##,##REF##12115692##59##</sup>. In addition, since its main output is to the lateral valvular nucleus, which projects to the cerebellum<sup>##REF##17278137##48##,##REF##15164423##60##</sup>, its functions may be motor-related. This sensory input and motor output connectivity pattern in the inferior lobe is rather similar to what has been found in the amniote pallium. As the teleost pallium itself receives sensory information of different modalities (e.g., auditory and visual inputs via the preglomerular complex), the inferior lobe seems to serve as another sensory integration center in the teleost brain (Fig. ##FIG##6##7##).</p>", "<p id=\"Par45\">The presence of multimodal inputs to the inferior lobe is likely to be a common feature in teleosts, but the particularity of the wrasse and cichlid brains is the inferior lobe’s intense connectivity with the pallium. The major connectivity of the inferior lobe of other fish like trout, <italic>Astyanax</italic> surface fish, and zebrafish is with the pretectum, which is involved in stereotyped movements such as the optokinetic response<sup>##REF##24656253##61##,##REF##24656252##62##</sup> or the prey detection J-turn in larval zebrafish<sup>##REF##23641200##63##</sup>. Those types of movements are sufficient for simple foraging behaviors without flexibility. It is then possible that the elaborated connectivity with the pallium present in wrasses and cichlids may have allowed for the emergence of their complex behavioral repertoire. The large gustatory inputs of the inferior lobe may for instance be involved in different functions than simply eating in these species.</p>", "<p id=\"Par46\">As fish do not have hands, they use their mouth to manipulate objects, and could likely have fine discriminative touch and motor control via the lips and oral cavity, functions which could involve the inferior lobe. Apart from tool use in wrasses, cichlids display object play and elaborate nest building behaviors<sup>##UREF##13##64##–##REF##33239639##66##</sup>, which also require this kind of precise motor control. Thus, one possibility is that the inferior lobe plays a role in motor cortex-like functions. Hodological data showing that the inferior lobe receives descending projections from the pallium (Supplementary Fig. ##SUPPL##0##7##) and projects to the lateral valvular nucleus projecting to the cerebellum<sup>##REF##10559551##49##,##REF##15164423##60##</sup> rather support the idea that the inferior lobe is involved in a motor aspect.</p>", "<p id=\"Par47\">Another possibility is that the inferior lobe may also be a part of the higher-order areas, like the executive area (prefrontal cortex-like area). The presence of a higher-order association center in the teleost pallium has hardly been investigated so far. In mammals and birds, the sensory association areas are located in the periphery of the primary sensory areas, and project to the executive area<sup>##REF##16263260##67##–##UREF##15##72##</sup>. If the teleost association areas are organized in the same manner, the area where the arborization of the ventral pallio-lobar tract is located (Fig. ##FIG##5##6a, b##; green) would be a good candidate for the visual association area. The dorsal telencephalic area (Dl), the putative teleost primary visual area (Fig. ##FIG##5##6a, b##; orange pallial arborizations), projects to the surrounding pallial areas including the central part of the pallium<sup>##REF##18381599##35##,##UREF##16##73##</sup>, which in turn project to the IL. This projection pattern is similar to the “primary sensory → sensory association → executive“ pattern observed in amniotes.</p>", "<p id=\"Par48\">In any case, the ability to use tools requires both fine motor skills and executive functions (e.g., long working memory). These functions should reside in the pallium and/or inferior lobe of wrasses, unless this tool use by wrasses is a stereotyped behavior and not context dependent flexibility, in which case a large executive area would not be required. Additional connectivity and functional studies are required to verify how higher-order areas are organized in the teleost brain.</p>", "<p id=\"Par49\">In conclusion, our findings revealed that the encephalization process in teleosts is different from what has previously been described in amniotes. While the pallium also appears to be important for higher-order cognitive functions in teleosts, the large pallio-lobar tracts in the tool-using fishes demonstrate the functional importance of the inferior lobe in relation to the pallium, which may be critical for such complex behaviors. Since the inferior lobe has no homolog in amniotes, at least three different brain organizations enabling higher-order cognitive functions may have evolved independently in mammals, birds and teleosts.</p>" ]
[]
[ "<p id=\"Par1\">In mammals and birds, tool-using species are characterized by their relatively large telencephalon containing a higher proportion of total brain neurons compared to other species. Some teleost species in the wrasse family have evolved tool-using abilities. In this study, we compared the brains of tool-using wrasses with various teleost species. We show that in the tool-using wrasses, the telencephalon and the ventral part of the forebrain and midbrain are significantly enlarged compared to other teleost species but do not contain a larger proportion of cells. Instead, this size difference is due to large fiber tracts connecting the dorsal part of the telencephalon (pallium) to the inferior lobe, a ventral mesencephalic structure absent in amniotes. The high degree of connectivity between these structures in tool-using wrasses suggests that the inferior lobe could contribute to higher-order cognitive functions. We conclude that the evolution of non-telencephalic structures might have been key in the emergence of these cognitive functions in teleosts.</p>", "<p id=\"Par2\">A neuroanatomical study of the brains of tool-using teleost fishes highlights the pallium and inferior lobe as the putative structures responsible for this behavior, and suggests that there are multiple ways of evolving tool-using brains.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n\n\n\n\n\n\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s42003-023-05663-8.</p>", "<title>Acknowledgements</title>", "<p>We thank Jean-Michel Hermel and Naomie Pradère (NeuroPSI, CNRS/Université Paris-Saclay) for their help with brain sampling. We thank Dimitri Rigaudeau (INRAE, Jouy-en-Josas) for providing us trouts and zebrafish, the DECA team (NeuroPSI) for <italic>Astyanax</italic> specimens, Joël Attia (Université de Saint-Etienne) for cichlids, Anthony Herrel (Muséum National d’Histoire Naturelle, Paris) for wrasses, as well as the members of the animal facility of TEFOR Paris-Saclay and NeuroPSI, especially Krystel Saroul and Christophe de Medeiros for fish care. We thank members of NeuroPSI for technical support, and the MIMA2 platform (10.15454/1.5572348210007727E12; INRAE, Jouy-en-Josas) for access to their lightsheet microscope. Finally, we thank Florian Razy-Krajka and Rose Tatarsky for their help in improving the manuscript. This study was supported by CNRS, Université Paris-Saclay, Fondation pour la Recherche Médicale en France, and INSB/CNRS Call “Diversity of Biological Mechanisms” (K.Y.), and in part by Tokai Pathways to Global Excellence (T-GEx), part of MEXT Strategic Professional Development Program for Young Researchers to H.H. It also has benefited from the facilities and expertize of TEFOR - Investissement d’avenir - ANR-II-INBS-0014.</p>", "<title>Author contributions</title>", "<p>Conceptualization, K.Y. and P.E.; methodology, K.Y., P.E., M.S., A.J., H.H., N.Y.; funding acquisition and supervision, K.Y.; validation and visualization, K.Y., P.E., M.S. and A.J.; first draft of manuscript, P.E. and K.Y.; all authors contributed to data analysis, interpretation, and revision of the manuscript.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par82\"><italic>Communications Biology</italic> thanks Katja Heuer and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editors: Michel Thiebaut de Schotten and Luke Grinham.</p>", "<title>Data availability</title>", "<p>Data reported in this paper is accessible in Supplementary Data ##SUPPL##7##1##. This paper does not report original code.</p>", "<title>Competing interests</title>", "<p id=\"Par83\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Phylogenetic tree of the teleost species sampled in this study.</title><p>In this study, we refer to the medaka, trout, <italic>Astyanax</italic>, and zebrafish as the “outgroup”. Numbers at the root of each tree branches represent the estimated time of divergence (MYA: million years ago). The last common ancestor of these species can be traced back to 224 million years ago (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.timetree.org\">http://www.timetree.org</ext-link><sup>##REF##35932227##84##</sup>).</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>Teleosts have small, cell-dense brains that contain more cells than the brains of rodents of similar body mass.</title><p>The fitted reduced major axis (RMA) regression lines are displayed only for correlations that are significant. Each point represents the mean value of a species. X and y axes are in log<sub>10</sub> scales. All regression lines are significantly different, except for the regression lines of Glires and Primates in (<bold>c</bold>). <bold>a</bold> Brain mass plotted as a function of body mass. Teleosts have smaller brains than birds and mammals of similar body mass. <bold>b</bold> Total number of cells in the brain plotted as a function of body mass. Teleost brains contain less cells than bird and primate brains, but more cells than the brains of rodents of similar body mass. <bold>c</bold> Brain mass plotted as a function of total number of cells in the brain. Cellular density inside the teleost brain is higher than in birds and mammals. Columbiformes include pigeons, Galliformes include chickens, Glires include rodents, Psittacopasserae include Passeriformes (songbirds) and Psittaciformes (parrots). See also Table ##TAB##0##1##. For statistics, see «Methods» section.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Encephalization in 11 species of teleosts (red) compared to a large dataset of actinopterygians (blue).</title><p>Brain mass is plotted as a function of body mass, and the phylogenetically corrected (phylogenetically generalized least squares regression test, PGLS) allometric line is shown. Each point represents the mean value of a species. X and y axes are in log<sub>10</sub> scales. The phylogenetic regression slope for actinopterygians is of 0.50 ± 0.01. Adjusted R<sup>2</sup>: 0.8382, <italic>t</italic> = 65.978, <italic>p</italic> &lt; 0.0001. See also Supplementary Table ##SUPPL##0##1## and «Methods» section.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>Illustration of brain structures of teleosts.</title><p><bold>a</bold>–<bold>e</bold> Dissection of the five major structures for the isotropic fractionator visualized on the brain of the cichlid <italic>Neolamprologus brichardi</italic>. <bold>a</bold> Lateral external view of the brain of the cichlid <italic>Neolamprologus brichardi</italic>. The different brain regions are color-coded. The uncolored regions are the olfactory bulbs and cranial nerves. <bold>b</bold>–<bold>e</bold> 300 µm frontal sections of the brain of <italic>Neolamprologus brichardi</italic> from rostral to caudal, showing the boundaries of the five major brain regions. The regions are highlighted following the color code in (<bold>a</bold>). <bold>f</bold>, <bold>g</bold> Illustration of the lobar region of the brain of the wrasse <italic>Choerodon anchorago</italic>. <bold>f</bold> Lateral external view of the brain of the wrasse <italic>Choerodon anchorago</italic> indicating the level of the frontal section shown in (<bold>g</bold>). We collectively refer to the area containing the PGc, GR, and inferior lobe as the lobar region, which is a teleost-specific structure absent in the tetrapod brain. Brain regions: Cb cerebellum, Die diencephalon, GR corpus glomerulosum pars rotunda, Hy hypothalamus, IL inferior lobe, ORRd dorsal optic recess region, PGc preglomerular nucleus pars commisuralis, rForeMid: rest of the forebrain/midbrain, rHind rest of the hindrain, Tel telencephalon, Tg tegmentum, TeO optic tectum, TS torus semicircularis. Scale bars: 1 mm. R: rostral; C: caudal; D: dorsal; V: ventral. See also «Methods» section.</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><title>Relatively larger Tel and rForeMid without a corresponding increase in the relative number of cells in wrasses compared to other teleosts.</title><p>Three species of wrasses (« Wrasses »: <italic>Choerodon anchorago</italic>, <italic>Labroides dimidiatus</italic>, <italic>Thalassoma hardwicke</italic>) were compared with seven other teleost species from various orders (« Other fish »: <italic>Astyanax</italic> mexicanus, <italic>Amatitlania nigrofasciata, Danio rerio, Maylandia zebra, Neolamprologus brichardi, Ophtalmotilapia boops, Salmo</italic> trutta). Top panel (<bold>a</bold>–<bold>e</bold>): Comparison of the relative mass of the Tel (<bold>a</bold>), TeO (<bold>b</bold>), rForeMid (<bold>c</bold>), Cb (<bold>d</bold>), and rHind (<bold>e</bold>). Wrasses have a relatively larger Tel and rForeMid compared to other teleosts. Bottom panel (<bold>f</bold>–<bold>j</bold>): Comparison of the relative number of cells in the Tel (<bold>f</bold>), TeO (<bold>g</bold>), rForeMid (<bold>h</bold>), Cb (<bold>i</bold>), and rHind (<bold>j</bold>). Despite having a relatively larger Tel and rForeMid, wrasses don’t have a larger proportion of cells in those structures compared to other teleosts. Statistical analysis: Mann-Whitney’s test. Each point represents individual values. Error bars: mean ± SD. ns: non significant, **<italic>p</italic> &lt; 0.01, ****<italic>p</italic> &lt; 0.0001. Brain regions: Cb: cerebellum, rForeMid: rest of the forebrain/midbrain; rHind: rest of the hindrain; Tel: telencephalon; TeO: optic tectum. For statistics, see «Methods» section.</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><title>The pallio-lobar tracts are massively enlarged in the wrasse and cichlid, while they are absent in the trout, the <italic>Astyanax</italic> surface fish and the zebrafish.</title><p>3D selective visualization of inferior lobe fiber tracts comparing the wrasse (<italic>C. anchorago</italic>; <bold>a</bold>), the cichlid (<italic>N. brichardi</italic>; <bold>b</bold>), the trout (<italic>S. trutta</italic>; <bold>c</bold>), the <italic>Astyanax</italic> surface fish (<italic>A. mexicanus</italic>; <bold>d</bold>), and the zebrafish (<italic>D</italic>. rerio; <bold>e</bold>). Lateral views are shown in (<bold>a</bold>–<bold>e</bold>), while a dorsal view of one side of the wrasse brain is shown in (<bold>f</bold>). Homologous tracts are shown in the same color across species. Besides wrasses and cichlids, no fibers connecting the pallium to the inferior lobe were detected in the other species of teleosts examined, irrespective of brain size. The main connections of the inferior lobe in these species are with the pretectum (blue), whereas they are with the pallium in wrasses and cichlids (ventral tract in green, dorsal tract in magenta). Local inferior lobe networks are shown in purple, and preglomerular complex projections to the pallium are shown in orange. Brain regions: GR:corpus glomerulosum pars rotunda, IL inferior lobe. R:rostral, C:caudal; D: dorsal; V: ventral; L: lateral ; M: medial.</p></caption></fig>", "<fig id=\"Fig7\"><label>Fig. 7</label><caption><title>Comparison of functional connectivity in relation to sensory inputs and motor outputs in amniotes and teleosts.</title><p><bold>a</bold> Simplified diagram showing input/output connectivity of the pallium commonly found in mammals and birds (analogous, not necessarily homologous). Sensory inputs are shown in red, while motor outputs are shown in blue. The primary sensory areas in the pallium receive modal-specific sensory inputs from subtelencephalic sensory nuclei, mainly through the thalamus in the case of tetrapods. Note that there are two major visual pathways terminating in the pallium both in mammals and birds. The diagram is modified from Yamamoto and Bloch (2017)<sup>##UREF##7##17##</sup>. <bold>b</bold> Simplified diagram showing input/output connectivity of the pallium and inferior lobe (IL) in teleosts. The sensory afferents to the pallium in teleosts are mainly mediated via the preglomerular complex (PG) instead of the thalamus. In addition to the pallium, the inferior lobe receives sensory inputs of different modalities, here showing only visual and gustatory, which are the dominant ones. The pallium and the inferior lobe are highly connected in some teleost groups such as wrasses and cichlids. Sensory modalites: A: auditory, G: gustatory, S: somatosensory, Vte: visual (tectofugal), Vth: visual (thalamofugal).</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Cellular composition of the brains of 11 teleost species.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Species</th><th><italic>n</italic></th><th>Body mass (g)</th><th>Brain mass (mg)</th><th>Total cells (x10<sup>6</sup>)</th></tr></thead><tbody><tr><td colspan=\"5\">Wrasses</td></tr><tr><td><italic> Labroides dimidiatus</italic></td><td>3</td><td>1.55 ± 0.35</td><td>34.62 ± 5.62</td><td>45.7 ± 6.67</td></tr><tr><td><italic> Thalassoma hardwicke</italic></td><td>3</td><td>12.07 ± 4.14</td><td>132.82 ± 23.49</td><td>116.78 ± 25.62</td></tr><tr><td><italic> Choerodon anchorago</italic></td><td>4</td><td>91.52 ± 137.39</td><td>338.80 ± 206.95</td><td>185.08 ± 78.73</td></tr><tr><td><italic> Choerodon anchorago*</italic></td><td>3</td><td>22.85 ± 4.54</td><td>235.44 ± 11.67</td><td>146.11 ± 13.59</td></tr><tr><td colspan=\"5\">Cichlids</td></tr><tr><td><italic> Neolamprologus brichardi</italic></td><td>5</td><td>5.15 ± 1.53</td><td>42.43 ± 4.26</td><td>37.54 ± 7.08</td></tr><tr><td><italic> Amatitlania nigrofasciata</italic></td><td>5</td><td>20.28 ± 7.85</td><td>75.05 ± 12.4</td><td>56.62 ± 6.37</td></tr><tr><td><italic> Opthalmotilapia boops</italic></td><td>3</td><td>7.04 ± 2.39</td><td>80.32 ± 7.27</td><td>56.37 ± 6.35</td></tr><tr><td><italic> Maylandia zebra</italic></td><td>3</td><td>14.59 ± 2.58</td><td>96.94 ± 6.62</td><td>61.78 ± 3.72</td></tr><tr><td colspan=\"5\">Others</td></tr><tr><td><italic> Oryzias latipes</italic></td><td>5</td><td>0.492 ± 0.07</td><td>8.38 ± 1.12</td><td>6.66 ± 0.54</td></tr><tr><td><italic> Danio rerio</italic></td><td>5</td><td>0.73 ± 0.21</td><td>9.74 ± 0.2</td><td>8.92 ± 0.69</td></tr><tr><td><italic> Astyanax mexicanus</italic></td><td>5</td><td>3.7 ± 1.17</td><td>43.55 ± 4.35</td><td>26.09 ± 2.74</td></tr><tr><td><italic> Salmo trutta</italic></td><td>4</td><td>177.15 ± 45.05</td><td>354.73 ± 33.16</td><td>100.84 ± 8.58</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM5\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM6\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM7\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM8\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM9\"></supplementary-material>" ]
[ "<table-wrap-foot><p><italic>Choerodon anchorago</italic>* data when a large individual of <italic>Choerodon anchorago</italic> is excluded.</p><p>All values are mean ± SD.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"42003_2023_5663_Fig1_HTML\" id=\"d32e381\"/>", "<graphic xlink:href=\"42003_2023_5663_Fig2_HTML\" id=\"d32e694\"/>", "<graphic xlink:href=\"42003_2023_5663_Fig3_HTML\" id=\"d32e770\"/>", "<graphic xlink:href=\"42003_2023_5663_Fig4_HTML\" id=\"d32e844\"/>", "<graphic xlink:href=\"42003_2023_5663_Fig5_HTML\" id=\"d32e934\"/>", "<graphic xlink:href=\"42003_2023_5663_Fig6_HTML\" id=\"d32e1061\"/>", "<graphic xlink:href=\"42003_2023_5663_Fig7_HTML\" id=\"d32e1460\"/>" ]
[ "<media xlink:href=\"42003_2023_5663_MOESM1_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>", "<media xlink:href=\"42003_2023_5663_MOESM2_ESM.pdf\"><caption><p>Description of Additional Supplementary Files</p></caption></media>", "<media xlink:href=\"42003_2023_5663_MOESM3_ESM.mp4\"><caption><p>Supplementary Movies 1</p></caption></media>", "<media xlink:href=\"42003_2023_5663_MOESM4_ESM.mp4\"><caption><p>Supplementary Movies 2</p></caption></media>", "<media xlink:href=\"42003_2023_5663_MOESM5_ESM.mp4\"><caption><p>Supplementary Movies 3</p></caption></media>", "<media xlink:href=\"42003_2023_5663_MOESM6_ESM.mp4\"><caption><p>Supplementary Movies 4</p></caption></media>", "<media xlink:href=\"42003_2023_5663_MOESM7_ESM.mp4\"><caption><p>Supplementary Movies 5</p></caption></media>", "<media xlink:href=\"42003_2023_5663_MOESM8_ESM.xlsx\"><caption><p>Supplementary Data 1</p></caption></media>", "<media xlink:href=\"42003_2023_5663_MOESM9_ESM.pdf\"><caption><p>Reporting Summary</p></caption></media>" ]
[{"label": ["9."], "mixed-citation": ["Str\u00f6ckens, F. et al. High associative neuron numbers could drive cognitive performance in corvid species. "], "italic": ["J. Comp. Neurol."]}, {"label": ["10."], "mixed-citation": ["von Eugen, K., Tabrik, S., G\u00fcnt\u00fcrk\u00fcn, O. & Str\u00f6ckens, F. A comparative analysis of the dopaminergic innervation of the executive caudal nidopallium in pigeon, chicken, zebra finch, and carrion crow. "], "italic": ["J. Comp. Neurol."], "bold": ["528"]}, {"label": ["11."], "surname": ["Brown"], "given-names": ["C"], "article-title": ["Tool use in fishes"], "source": ["Fish. Fish."], "year": ["2012"], "volume": ["13"], "fpage": ["105"], "lpage": ["115"], "pub-id": ["10.1111/j.1467-2979.2011.00451.x"]}, {"label": ["12."], "surname": ["Jones", "Brown", "Gardner"], "given-names": ["AM", "C", "S"], "article-title": ["Tool use in the tuskfish Choerodon schoenleinii?"], "source": ["Coral Reefs"], "year": ["2011"], "volume": ["30"], "fpage": ["865"], "lpage": ["865"], "pub-id": ["10.1007/s00338-011-0790-y"]}, {"label": ["13."], "surname": ["Bernardi"], "given-names": ["G"], "article-title": ["The use of tools by wrasses (Labridae)"], "source": ["Coral Reefs"], "year": ["2012"], "volume": ["31"], "fpage": ["39"], "lpage": ["39"], "pub-id": ["10.1007/s00338-011-0823-6"]}, {"label": ["14."], "surname": ["Coyer"], "given-names": ["JA"], "article-title": ["Use of a rock as an anvil for breaking scallops by the yellowhead wrasse, Halichoeres garnoti (Labridae)"], "source": ["Bull. Mar. Sci."], "year": ["1995"], "volume": ["57"], "fpage": ["548"], "lpage": ["549"]}, {"label": ["16."], "mixed-citation": ["Bloch, S. et al. Non-thalamic origin of zebrafish sensory nuclei implies convergent evolution of visual pathways in amniotes and teleosts. "], "italic": ["eLife"], "bold": ["9"]}, {"label": ["17."], "mixed-citation": ["Yamamoto, K. & Bloch, S. Overview of brain evolution: lobe-finned fish vs. ray-finned fish. in "], "italic": ["Evolution of the Brain, Cognition, and Emotion in Vertebrates"]}, {"label": ["26."], "mixed-citation": ["Balshine, S. & Abate, M. E. Parental Care in Cichlid Fishes. in "], "italic": ["The Behavior, Ecology and Evolution of Cichlid Fishes"]}, {"label": ["37."], "mixed-citation": ["Ventura-Antunes, L., Mota, B. & Herculano-Houzel, S. Different scaling of white matter volume, cortical connectivity, and gyrification across rodent and primate brains. "], "italic": ["Front. Neuroanat"], "bold": ["7"]}, {"label": ["40."], "mixed-citation": ["Mota, B. & Herculano-Houzel, S. How the cortex gets its folds: an inside-out, connectivity-driven model for the scaling of mammalian cortical folding. "], "italic": ["Front. Neuroanat"], "bold": ["6"]}, {"label": ["42."], "surname": ["Herculano-Houzel", "Dos Santos"], "given-names": ["S", "S"], "article-title": ["You do not mess with the glia"], "source": ["Neuroglia"], "year": ["2018"], "volume": ["1"], "fpage": ["193"], "lpage": ["219"], "pub-id": ["10.3390/neuroglia1010014"]}, {"label": ["44."], "surname": ["Streelman", "Karl"], "given-names": ["JT", "SA"], "article-title": ["Reconstructing labroid evolution with single\u2013copy nuclear DNA"], "source": ["Proc. R. Soc. Lond. B"], "year": ["1997"], "volume": ["264"], "fpage": ["1011"], "lpage": ["1020"], "pub-id": ["10.1098/rspb.1997.0140"]}, {"label": ["64."], "surname": ["Burghardt", "Dinets", "Murphy"], "given-names": ["GM", "V", "JB"], "article-title": ["Highly repetitive object play in a cichlid fish (Tropheus duboisi)"], "source": ["Ethology"], "year": ["2015"], "volume": ["121"], "fpage": ["38"], "lpage": ["44"], "pub-id": ["10.1111/eth.12312"]}, {"label": ["65."], "mixed-citation": ["York, R. A. et al. Evolution of bower building in Lake Malawi cichlid fish: phylogeny, morphology, and behavior. "], "italic": ["Front. Ecol. Evol."], "bold": ["3"]}, {"label": ["72."], "mixed-citation": ["Swenson, R. S. & Gulledge, A. T. Chapter 12 - The Cerebral Cortex. in "], "italic": ["Conn\u2019s Translational Neuroscience"]}, {"label": ["73."], "mixed-citation": ["Hagio, H. & Yamamoto, N. Ascending visual pathways to the telencephalon in teleosts with special focus on forebrain visual centers, associated neural circuitries, and evolution. "], "italic": ["Zool. Sci"], "bold": ["40"]}, {"label": ["78."], "mixed-citation": ["Duncan, J., Kersigo, J., Gray, B. & Fritzsch, B. Combining lipophilic dye, in situ hybridization, immunohistochemistry, and histology. "], "italic": ["J. Vis. Exp"]}, {"label": ["79."], "surname": ["Warton", "Duursma", "Falster", "Taskinen"], "given-names": ["DI", "RA", "DS", "S"], "article-title": ["Smatr 3\u2013 an R package for estimation and inference about allometric lines"], "source": ["Methods Ecol. Evol."], "year": ["2012"], "volume": ["3"], "fpage": ["257"], "lpage": ["259"], "pub-id": ["10.1111/j.2041-210X.2011.00153.x"]}, {"label": ["80."], "surname": ["Felsenstein"], "given-names": ["J"], "article-title": ["Phylogenies and the comparative method"], "source": ["Am. Nat."], "year": ["1985"], "volume": ["125"], "fpage": ["1"], "lpage": ["15"], "pub-id": ["10.1086/284325"]}]
{ "acronym": [], "definition": [] }
84
CC BY
no
2024-01-14 23:40:16
Commun Biol. 2024 Jan 12; 7:88
oa_package/32/b5/PMC10786859.tar.gz
PMC10786860
38216563
[ "<title>Introduction</title>", "<p id=\"Par2\">X-ray free-electron lasers (XFEL) have transformed the study of ultrafast phenomena at the atomic level, from transient room-temperature superconductivity<sup>##REF##25471882##1##</sup> to the fastest processes following water ionisation<sup>##REF##31919219##2##</sup>. This has also been the case in structural biology with the birth of serial femtosecond crystallography (SFX)<sup>##REF##21293373##3##</sup> and more recently the development of time-resolved SFX<sup>##REF##25477465##4##</sup>. Yet the requirement of crystals is limiting as demonstrated by the spectacular development in cryo-electron microscopy (cryo-EM)<sup>##REF##27110629##5##</sup>. More importantly, the need to synchronise all unit cells in a crystal makes photo-activation the only feasible trigger for ultrashort timescales. It also prevents the observation of individual molecular behaviour, e.g., multiple conformations. Currently, cryo-EM is the method of choice for high-resolution single-molecule time-resolved studies, but it is limited to millisecond timescales due to the time it takes to freeze the sample and collect the data<sup>##REF##28625887##6##</sup>. By bypassing these limitations, femtosecond X-ray diffractive imaging (FXI)<sup>##REF##10963603##7##</sup> has the potential to observe single-molecules with sub-picosecond time resolution and, due to the higher sample temperature, may allow sampling from a broader conformational landscape.</p>", "<p id=\"Par3\">The chaperonin GroEL is an abundant molecular chaperone and, together with its cofactor GroES, is important in the folding of a large range of proteins<sup>##REF##26422689##8##</sup>. <italic>Escherichia coli</italic> GroEL is a 14-mer formed by two heptameric subunit rings<sup>##REF##7935790##9##</sup>, totalling ~800 kDa and arguably the most studied chaperonin. It was also one of the first large macromolecular complexes to be successfully measured by native mass spectrometry<sup>##UREF##0##10##</sup> and is nowadays often used as a benchmark to demonstrate the resolution of new systems<sup>##REF##23064518##11##–##UREF##1##13##</sup>. Its size and availability also made it an early target for single-particle cryo-EM studies<sup>##REF##8861908##14##,##REF##15242589##15##</sup>. These characteristics along with the extensive body of available knowledge and distinctive shape, recognisable even at low resolution, make GroEL an ideal prototype system for single-particle X-ray diffraction.</p>", "<p id=\"Par4\">Despite continuous progress in FXI<sup>##REF##21293374##16##–##REF##31878556##19##</sup>, no single-protein diffraction has ever been measured, and studies have been limited to more strongly diffracting samples, such as viruses<sup>##REF##25793853##20##</sup> and cells<sup>##REF##25669616##21##</sup>. In this paper, we present the first interpretable X-ray diffraction signal from a protein complex, the chaperonin GroEL, an order of magnitude lighter than the smallest biological sample previously reported<sup>##REF##31058226##22##</sup>, the ~9 MDa Tomato bushy stunt virus. With it we demonstrate the principle of diffraction before destruction<sup>##UREF##3##23##</sup> at the protein scale. This opens the doors to ultrafast studies on single-protein molecules making use of the extraordinary brightness and time resolution of XFELs.</p>" ]
[ "<title>Materials and methods</title>", "<title>Beamline and instrument setup</title>", "<p id=\"Par28\">The EuXFEL was tuned to a photon energy of 1200 eV corresponding to a wavelength of 1.03 nm. The focus size was estimated to be 2 μm × 2 μm based on wavefront sensor measurements (Supplementary Fig. ##SUPPL##0##S8##). The total energy of each X-ray pulse was measured before any beamline optical element using one of the X-ray gas detectors available at the beamline<sup>##REF##31274426##38##</sup> and found to hover around 6.5 mJ. Using the wavefront sensor measurements (Supplementary Fig. ##SUPPL##0##S8##), we estimated the fluence at the interaction region. We assumed that the field of view of the sensor captures the vast majority of the photons present in the beam. Using the measured pulse energy and a beamline transmission of 46% (measured subsequently), we estimated the maximum fluence across the sensor for each of the five different wavefront measurements. The average of those estimates was 232 ± 62 μJ/μm<sup>2</sup>. The XFEL was run at one pulse per train giving a repetition rate of 10 Hz.</p>", "<title>Sample injection</title>", "<p id=\"Par29\">Individual proteins were transferred into the gas phase and transported into the X-ray interaction region as described in Bielecki et al.<sup>##REF##31058226##22##</sup>. The sample solution consisted of GroEL proteins with a concentration of about 150 nM in an ammonium acetate buffer. Nebulization of the protein solution took place with an electrospray nozzle which produces initial droplets with diameters between 80 and 400 nm depending on the sample flow rate. The charged droplets emanating from the electrospray nozzle were neutralised by an X-ray source (Hamamatsu L12645) that ionised the sheath gas transporting the droplets.</p>", "<p id=\"Par30\">The electrospray capillary had an inner diameter of 40 µm, an outer diameter of 360 µm, and the sample flow rate was adjusted by controlling the overpressure in the sample compartment with a remotely controllable differential pressure regulator (Bronkhorst P-506C-4K0D-TGD-33-V delta P pressure gauge controlling an F-001AI-IIU-33-V regulating valve). The tip of the capillary had been ground to a 30-degree cone with a final tip diameter of 100 µm. The droplet diameter could be controlled from 80 nm at 0.25 psi overpressure to 400 nm at 10 psi overpressure.</p>", "<p id=\"Par31\">Monodispersity and size of the sample after nebulisation were both monitored before, and during the measurements, with an SMPS (TSI SMPS 3938) consisting of a DMA coupled to a condensation particle counter. To minimise the salt layer on the sample surface, while still maintaining a stable Taylor cone, an overpressure of 1 psi had to be applied to the sample reservoir used, resulting in initial droplets with a diameter of approximately 110 nm.</p>", "<p id=\"Par32\">The neutralised droplets were transported into the X-ray interaction region through an aerodynamic lens, creating a particle beam as described in Hantke et al.<sup>##UREF##5##25##</sup>. Excessive gas flow from running the electrospray was removed in two skimmer stages. As a result, the 1 bar pressure at the electrospray was reduced to 30 mbar after the first skimmer, and the entrance pressure to the aerodynamic lens was 0.6 mbar after the second skimmer stage.</p>", "<p id=\"Par33\">The beam of injected particles was intercepted by the pulse train of the XFEL. To optimise the position of the particle beam, a sucrose solution was injected, creating tiny sucrose spheres, and the hit rate on the spheres was used as a feedback parameter<sup>##REF##27275147##39##</sup>.</p>", "<title>Detector and data processing</title>", "<p id=\"Par34\">Diffraction data were collected with the EuXFEL pnCCD detector<sup>##REF##33650570##26##</sup> running in high-gain mode. This setup allows for a maximum full-period resolution of 4 nm determined by the scattering-angle at the edge of the detector. Since the detector cannot keep up with the pulse frequency within the pulse trains, we were limited to the 10 Hz frequency of the pulse trains themselves. Each pnCCD sensor panel is made up of a grid of 512 × 1024 pixels each with a size of 75 µm × 75 µm. The two panels were both placed 15 cm downstream of the interaction region and with a gap of 3.7 mm to allow the direct beam to pass through. The exact translation of the detector panels was optimised using strongly diffracting sucrose particles and the understanding that this diffraction adheres to Friedel symmetry.</p>", "<p id=\"Par35\">Detector readout baseline, called pedestal data, were collected regularly throughout the experiment when the beam was off and were subtracted from each readout. In addition, a common mode correction was applied to each line of each detection plane for each individual image. This correction is performed by subtracting the median of the pixel values in each line from all values of the same line and is possible when the photon density is low, like in our case.</p>", "<p id=\"Par36\">The slope of the relation between photon energy and ADU of each detector pixel, called the gain, varies slightly from line to line since each line has its own amplifier. In addition, along a line, the measured energy might decline due to the charge transfer inefficiency. To handle both these effects we determined a unique gain for each pixel. This value was found by constructing a histogram of the signal detected in all images in a particular pixel (Supplementary Fig. ##SUPPL##0##S6##) and subsequently fitting a Gaussian function to the peak corresponding to zero photons and subsequently fitting another Gaussian function to the much smaller peak corresponding to a single photon. The distance between the peaks must then correspond to the photon energy of 1200 eV.</p>", "<p id=\"Par37\">The detector signal provided in units of ADU was converted into photon counts by dividing each pixel readout with the gain retrieved above and rounding to its closest integer. To filter out the contribution from fluorescence in the range from 200 to 600 eV readout values up to 900 eV were rounded down to zero instead of up.</p>", "<p id=\"Par38\">For each readout, the number of lit pixels was calculated as the number of pixels with a photon count of 3 or higher. Hits were identified as any readout where the number of lit pixels was larger than 16.</p>", "<p id=\"Par39\">The average background was estimated from 32,000 readouts (Supplementary Fig. ##SUPPL##0##S9##) where the injector was running but without any sample, thus including the contribution of the scattering from the gas used for injection.</p>", "<p id=\"Par40\">Before analysis, each diffraction pattern was downsampled to a size of 128 × 128 pixels. The downsampling was done after the conversion to discrete photons since the combined readout noise in one superpixel would otherwise be much larger than the photon energy. Additional downsampling to a final size of 64 × 64 was performed before plotting to make the features of the diffraction patterns clearer.</p>", "<p id=\"Par41\">Water models were generated by solvating the GroEL structure (PDB entry 1SS8<sup>##REF##15313620##29##</sup>) using the gmx solvate function in GROMACS<sup>##UREF##13##40##</sup>. Water molecules were removed if they fell outside of a cylinder of varying size. The top and bottom of the cylinders were also pruned to match the shape of the protein. The code for generating these models and the PDB files for them are made available (see Code availability).</p>", "<p id=\"Par42\">Template diffraction patterns were simulated with Condor<sup>##REF##27504081##41##</sup> using the wavelength and detector geometry from the experiment. The output without Poisson noise was used in the further analysis. The protein orientations were distributed evenly in rotation space by choosing quaternions that evenly sample the cells of the 600-cell, similarly to Loh et al.<sup>##UREF##14##42##</sup>. Each edge in the 600-cell was subdivided 8 times, which yields 25,680 different orientations and corresponds to an angle of 6.8 degrees between adjacent orientations. The simulated patterns were then translated both horizontally and vertically, in a 13 × 13 pixel search grid, to cover the different possible centre positions, which arises due to the pointing uncertainty of the X-rays. This resulted in a total of 4,339,920 simulated patterns for each model structure.</p>", "<p id=\"Par43\">For the template matching, each template was combined with the average background with a variable scaling term for the fluence of the signal and background, respectively. These scaling terms were used as fitting parameters in a least-square optimisation implemented in the scipy function leastsq<sup>##REF##32015543##43##</sup>. The goodness of fit was then compared between all templates to identify the best orientation.</p>", "<p id=\"Par44\">The residual error, , or goodness of fit, is defined aswhere is the pixel index and is the simulated template, is the average measured background and is the measured pattern. The parameters and are the fitting parameters and describe respectively the intensity of the pulse at the sample and total intensity of the pulse.</p>", "<title>Sample purification</title>", "<p id=\"Par45\">Lyophilised <italic>E. coli</italic> GroEL (C7688) was purchased from Sigma–Aldrich (Solna, Sweden), purified and prepared for electrospray injection as described in Freeke et al.<sup>##UREF##15##44##</sup>, but with no acetone precipitation step and with one step of size exclusion chromatography.</p>", "<title>Characterisation of GroEL samples by DMA</title>", "<p id=\"Par46\">The stability of GroEL against dissociation was determined using DMA combined with the same electrospray conditions as the particle injection for the main experiment. Here, a narrow peak at 16 nm was recorded which suggests that GroEL is stable under the XFEL injection conditions. A second larger peak was also detected at a smaller diameter that corresponds to contaminants from empty droplets aggregating to a ball (Supplementary Fig. ##SUPPL##0##S3##).</p>", "<title>Characterisation of GroEL samples by cryo-EM</title>", "<p id=\"Par47\">For cryo-EM, vitrified grids were prepared by applying 4 μl of the GroEL sample onto glow-discharged, 200 mesh R2/2 Quantifoil grids, blotted for 4 s at blotforce 4. Grids were plunge-frozen into a 37:63 (v/v) mixture of ethane/propane cooled to liquid nitrogen temperature using a Vitrobot Mark IV instrument (Thermo Fisher Scientific) at 95% humidity and 4 °C. Samples were imaged at a nominal magnification of ×120,000 using a Talos Arctica (Thermo Fisher Scientific) transmission electron microscope operating at 200 kV accelerating voltage from a field emission gun (X-FEG) source. Movies were recorded on a Falcon 3EC electron counting direct detector (Thermo Fisher Scientific) yielding a final pixel size of 0.96 Å<sup>2</sup> on the specimen level. A total of 497 movies were collected in dose-fractionation mode using EPU software (Thermo Fisher Scientific) with a total dose of 40 e<sup>-</sup>/Å<sup>2</sup> for each micrograph, and 1 e<sup>-</sup>/Å<sup>2</sup>/frame.</p>", "<title>Cryo-EM data processing</title>", "<p id=\"Par48\">Image processing was done in a combination of RELION 3.1<sup>##REF##30412051##45##</sup> and cryoSPARC<sup>##REF##28165473##46##</sup>. Movies were processed using MotionCorr 2<sup>##REF##28250466##47##</sup> as implemented in RELION 3.1 for motion correction and gCTF<sup>##REF##26592709##48##</sup> for CTF correction.</p>", "<title>Cryo-EM data analysis: sample composition analysis</title>", "<p id=\"Par49\">Laplacian picking in RELION 3.1 considers the fact that for a quality assessment, a bias-free, reference-free particle picking is needed. For this both threshold and particle size were optimised until nearly all particles, visible by eye, were picked up by the programme, and as little as possible noise was included, although some error was still present (see Supplementary Fig. ##SUPPL##0##S2## for an example). This resulted in a total of 47,154 particles picked with a threshold of 2 and a picked particle size between 120 and 900 Å. These particles were subsequently classified into 200 classes in cryoSPARC<sup>##REF##28165473##46##</sup>.</p>", "<p id=\"Par50\">Only classes containing GroEL particles were submitted to heterogeneous refinement in cryoSPARC. For this, two references were supplied, one for the dual- and one for the single-ring complex. The first was an intermediate low-resolution map that was constructed during this project (see next section), aligned to D7 symmetry. The second was created based on a single-ring from the PDB structure 5W0S<sup>##REF##28710336##49##</sup> by using the molmap function in Chimera 1.15<sup>##REF##15264254##50##</sup> with a resolution of 20 Å. This map was subsequently resampled to the correct box and pixel size in Chimera 1.15, followed by alignment in RELION 3.1 to C7 symmetry (to centre and prepare for symmetry application). Following heterogeneous refinement, the two groups of particles were submitted to another round of 2D classification, to make sure that the separation had been thorough (see Supplementary Fig. ##SUPPL##0##S3##). No classes belonging to the other complex were detected, but a few classes containing noise and smaller pieces of the complex were removed prior to calculating the ratio between single- and dual-ring particles in the sample. A selection of top views from the 2D classes of the dual-ring group of particles was used for Supplementary Fig. ##SUPPL##0##S4##.</p>", "<p id=\"Par51\">Those classes containing small proteins were 2D cleaned and the more prominent classes were subjected to initial 3D model generation in cryoSPARC. Ten low-quality 3D models were generated and they were all of similar size. Since this size was comparable to monomeric GroEL, a 3D refinement in cryoSPARC and a 3D classification in RELION 3.1 was performed. The reference was created based on a monomer from the PDB structure 5W0S by using the molmap function in Chimera 1.15 with a resolution of 20 Å. This map was subsequently resampled to the correct box and pixel size in Chimera 1.15. Neither analysis yielded a map with improved density. As the identity of these small particles is not relevant to the XFEL experiments, they were not further analysed.</p>", "<title>Cryo-EM data analysis: high-resolution model</title>", "<p id=\"Par52\">A deep-learning-based picking in crYOLO<sup>##REF##31240256##51##</sup> to allow for precise picking of intact GroEL particles, resulted in a total of 14,232 particles that were imported into RELION 3.1. These were subjected to 2D classification into 50 classes and the best 10 classes were used for 3D classification into four classes with D7 symmetry in RELION 3.1. The best class included 1929 particles corresponding to the dual-ring complex and was refined with D7 symmetry and postprocessing leading to a final map resolved to 4.6 Å as shown in Supplementary Fig. ##SUPPL##0##S5##.</p>" ]
[ "<title>Results</title>", "<p id=\"Par5\">The experiment was performed at the Small Quantum Systems (SQS) scientific instrument of the European XFEL (EuXFEL) facility in Schenefeld, Germany<sup>##UREF##4##24##</sup>. GroEL particles were exposed to femtosecond soft X-ray pulses from the EuXFEL at a photon energy of 1200 eV and an average pulse energy of 6.5 mJ.</p>", "<p id=\"Par6\">Individual GroEL particles, characterised by a differential mobility analyzer (DMA) (Supplementary Fig. ##SUPPL##0##S1##) and cryo-EM (Supplementary Figs. ##SUPPL##0##S2##–##SUPPL##0##S5##), were transferred from solution to the gas phase using an electrospray setup<sup>##REF##31058226##22##</sup> in which a charged jet of the sample in liquid generated droplets of around 110 nm in diameter in the presence of an inert gas mixture of CO<sub>2</sub> and N<sub>2</sub> surrounding the jet (Fig. ##FIG##0##1##). These droplets were then neutralised and focused through an aerodynamic lens<sup>##UREF##5##25##</sup> creating a thin stream of particles. Most or all of the volatile buffer solution evaporated during the process and a stream of mostly dry particles reached the interaction region.</p>", "<p id=\"Par7\">Diffraction data were collected with a pnCCD detector consisting of two detection planes<sup>##REF##33650570##26##</sup> placed 150 mm downstream of the interaction region (Fig. ##FIG##0##1##). The resolution limit of this setup is 4 nm due to the detector’s numerical aperture. Only a small fraction of the X-ray pulses will intersect with one of the injected particles in what is called a hit. The majority of the detector readouts therefore only contain background, which arises mainly from the injection gas but also from the beamline itself.</p>", "<p id=\"Par8\">The gas used in the electrospray injection setup created two types of experimental background: fluorescence and elastically scattered photons. The fluorescence has a photon energy of 277, 392 and 525 eV, respectively, from the carbon, nitrogen and oxygen K-shell, compared to the incoming photons of 1200 eV. The energy resolution of the pnCCD detector of 40 eV<sup>##UREF##6##27##</sup> allows us to discriminate between the fluorescence and elastic scattering for all pixels that receive at most one photon (Supplementary Fig. ##SUPPL##0##S6##), a condition that was generally fulfilled in this experiment.</p>", "<p id=\"Par9\">In contrast to the fluorescence background, it was not possible to filter out the elastic scattering from the gas since it has the same photon energy as the signal. The same is also true for the so-called beamline background—photons resulting from the interaction of the X-rays with elements of the beamline. To quantify the different sources of background we collected data both with the injection off and the injection turned on but without a supply of sample. This showed that the injection gas contributed on average 17,600 photons per diffraction pattern, compared to the beamline contribution of only 86 photons per diffraction pattern on average (Fig. ##FIG##1##2##).</p>", "<p id=\"Par10\">The EuXFEL delivers its pulses in 10 pulse trains per second and with a MHz repetition rate within each train<sup>##UREF##4##24##,##UREF##7##28##</sup>. Because a detector based on CCD technology is not capable of providing an MHz image readout rate within the pulse train, we were limited to one readout per train, which severely limited the data collection rate. As a consequence, from 84,000 readouts only 816 patterns matched our initial hit-detection (see Methods for details). In Fig. ##FIG##2##3a## we can see the number of photons in each of these patterns. Further inspection reveals that most of the major peak is actually non-hits caused by stochastic variations in the background triggering our hit-detection. The 172 patterns that contain a signal that is larger than 19,000 photons do however mostly consist of actual hits. We compared the diffraction of spheres of different sizes to the patterns to identify their most likely size. The size histogram for all patterns with more than 19,000 photons is shown in Fig. ##FIG##2##3b##. The histogram peaks at 15 nm which matches the expected size of GroEL with very few particles of smaller sizes than this. As expected, there is a longer tail towards larger sizes that most likely contains samples with aggregations of either water, salt or broken proteins, and towards the end of the tail, clusters of several GroEL complexes. Inspection shows that the small peak below 5 nm does not originate from our sample but is made up of strong background shots and all have photon counts lower than 20,500.</p>", "<p id=\"Par11\">To further verify that the collected diffraction is indeed from GroEL samples, we will focus our analysis to a single diffraction pattern with the combination of a very high signal-strength and favourable orientation that made it deviate from the spherical symmetry (Fig. ##FIG##1##2c##). The deviation from the circular symmetry in the first fringe is clear and consistent with the barrel-shaped structure of GroEL. To verify that the pattern originates from a GroEL particle, we compared it with simulated diffraction data from the structure of GroEL, shown in Fig. ##FIG##3##4a##, determined by X-ray crystallography<sup>##REF##15313620##29##</sup>. This comparison does however have three problems: (1) the orientation of the molecule that gave rise to our pattern is unknown; (2) the centre of the diffraction pattern is uncertain; (3) our diffraction data is a combination of signal and background.</p>", "<p id=\"Par12\">We addressed problems (1) and (2) by applying a template matching scheme where many diffraction patterns were simulated in orientations sampling the full three-dimensional diffraction space with an accuracy of 7 degrees. These patterns were then translated both horizontally and vertically to cover the different possible centre positions. In total, the experimental pattern was compared to 4.3 million simulated and translated patterns.</p>", "<p id=\"Par13\">To handle problem (3), we first summed up the average background from one of the runs where gas but no sample was injected. For each comparison under the template matching, the pattern was fitted to a linear combination of the average background and the template pattern. The best-fitting background-template combination is shown in Fig. ##FIG##4##5a##.</p>", "<p id=\"Par14\">Even this best-fitting background-template combination does not match the experimental pattern very well. The sum of the residual error between the pattern and the simulation is 180 photons compared to 143 photons which would have been expected if Poisson noise was the only cause for the discrepancy. A hint at an explanation can be found by observing that the first fringe in the simulation is significantly stronger than in the experimental pattern. This indicates that the simulation has too many low-resolution, high-contrast elements. This suggests that the hollow centre of the barrel-shaped protein in the simulation is fully or partially filled in the particle that gave rise to the pattern.</p>", "<p id=\"Par15\">We identify three possible origins for this density: (1) It is possible that not all of the water evaporated from the sample during injection, in particular water molecules that are less exposed to the surface. (2) 2D class averages from our cryo-EM measurements (Supplementary Fig. ##SUPPL##0##S4##) show some density inside the barrel higher than the surrounding water. This density is most likely protein. (3) Depending on the size of the initial solvent droplet there will be a considerable amount of contaminants left on the sample after evaporation. This contributes to the peak at 11 nm observed in DMA data (Supplementary Fig. ##SUPPL##0##S1##) and could explain the extra density. At the resolution available in this experiment, we cannot determine if any of these hypotheses is correct. We can, however, test the theory that extra density within the centre of the protein can explain the observed data.</p>", "<p id=\"Par16\">To do this, we created six different density models (Fig. ##FIG##3##4##) by adding varying amounts of water to the hollow centre or the surrounding groves in the protein. We then repeated the template matching with each of them, knowing that similar models filled with broken proteins or salt would give indistinguishable results. Five of the models fill up the hollow core of the protein at varying proportions, which is what our earlier interpretation of the data suggests. As a control, we also include a density model where only the barrel edges are hydrated and the core is empty.</p>", "<p id=\"Par17\">The radial average of the pattern and the best fit for the different density models showed a better fit for all new models compared to the original structure, with models 2, 3 and 4 giving the best results (Fig. ##FIG##4##5e##). The total residual error between the simulation and the experimental pattern also confirmed that model 3 was the best fit with an error of 160 photons. The simulation from model 3 is shown in Fig. ##FIG##4##5b## and the oriented model is shown in Supplementary Fig. ##SUPPL##0##S7##. The signal in the radial average of the pattern drops down to the background level at a resolution of about 6 nm. We also performed phase retrieval of the pattern (Supplementary Fig. ##SUPPL##0##S10##) but the resulting map is of too low resolution to allow any further conclusions to be drawn.</p>", "<p id=\"Par18\">We then checked if the hydrated model was supported by the rest of our data. We summed up all the patterns with sizes between 10 and 20 nm from the histogram shown in Fig. ##FIG##2##3b##, excluding the strong one shown in Fig. ##FIG##1##2c##. The resulting virtual powder pattern is in strikingly good agreement with the simulated powder diffraction from a hydrated GroEL, unlike for a dry GroEL particle or a water sphere (Supplementary Fig. ##SUPPL##0##S11##).</p>", "<p id=\"Par19\">Not only are these results consistent with diffraction from a GroEL molecule, which is the first example of interpretable X-ray diffraction being collected from a single protein, but they also suggest that the aerosolized GroEL particle contained an extra density in the otherwise hollow centre at the time of interaction.</p>", "<p id=\"Par20\">The overall size and shape of our sample match that of the crystal structure quite well, unlike earlier studies using a combination of ion mobility analysis and mass spectrometry<sup>##REF##21395304##30##</sup> which have observed an unusually high compaction of GroEL in the gas phases. The difference is likely due to the different experimental conditions. In our case GroEL was quickly neutralised after electrospray and not actively dried, while the compaction was seen for dry particles with charges up to <italic>z</italic> = 70, which is likely to affect the structure. This suggests that hydration and charge state are important to preserve the GroEL structure in FXI experiments.</p>", "<p id=\"Par21\">From our modelling, we also concluded that of the 30,500 photons in the pattern, only 13,800 originated from the sample and 16,700 originated from the background scattering. This highlights the importance of continued efforts to further reduce background scattering from the injection gas in such experiments.</p>", "<p id=\"Par22\">The pattern fittings showed that the photon fluence at the sample was 280 μJ/μm<sup>2</sup>. This aligns well with the maximum fluence expected from the pulse given a measured pulse energy of 6.6 mJ before the focusing optics and the focus profile and transmission of the beamline (see Methods). It suggests that this particular GroEL molecule interacted with a region of the pulse that was almost at the peak.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par23\">When the first XFELs were constructed, one of the main promises was the prospect of diffraction studies of single proteins using the so-called “diffraction before destruction method” that could take advantage of the ultrafast time resolution enabled by this new generation of light sources. However, concerns were raised on whether the proteins’ structure would survive the transition to the gas phase and, even if it did, whether the signal would be strong enough to be visible above the background noise. In this paper, we have been able to address these concerns by reporting the first X-ray diffraction pattern collected from a single protein.</p>", "<p id=\"Par24\">The signal in this pattern is weak, but the distinct geometry of the GroEL complex is distinguishable above the background noise. Furthermore, the signal matches well with the predicted signal from a model of GroEL with extra density added to the central cavity. At this resolution, it cannot be determined if the extra density is made up of water or something else.</p>", "<p id=\"Par25\">Simulations have shown that residual water molecules are vital for the stability of proteins in the gas phase<sup>##REF##19727514##31##</sup>. A significant amount of water attached to GroEL in our experiment would, without doubt, contribute to keeping its structure preserved during the transition to the gas phase. It was recently shown to be possible to obtain high-resolution structures of proteins after they have been electrosprayed and soft-landed on a cryo-EM grid<sup>##UREF##8##32##</sup>. The resulting structure is relatively similar to the one in solution, despite the particles having been dried and charged. Still, the amount of solvent remaining after electrospray is likely to be crucial to determine how close the conformational landscape of the protein is to the one in its native conditions. The presence of water around the sample is also predicted to delay radiation damage to the sample by acting as a sacrificial tamper<sup>##REF##20366823##33##</sup>. Large amounts of solvent might introduce problems for 3D orientation recovery and subsequent merge of a large dataset. These problems will however be limited to the same resolution as the size of the fluctuations in solvent distribution between the samples, which for water is expected to be small<sup>##UREF##9##34##</sup>.</p>", "<p id=\"Par26\">The factors that currently prevent FXI from determining full 3D structures are the low signal-to-noise ratio due to the strong background and the low data rate. Since most of the background originated from the injection gas, we identify this as a major target for future development. Potentially, better shielding of the gas and a transition to a low-Z alternative such as helium could improve the signal-to-background ratio by more than tenfold. The availability of a 4.5 MHz DSSC imaging detector of megapixel size<sup>##UREF##10##35##</sup> at the SQS instrument will allow us to exploit the 4.5 MHz pulse repetition frequency within one pulse train of the XFEL, yielding multiple opportunities for a hit in each pulse train. Furthermore, the vetoing capability<sup>##UREF##11##36##,##UREF##12##37##</sup> of the DSSC detector has the potential to improve the fraction of interpretable diffraction images from a few per cent to around 30% when EuXFEL is running at its full capacity of 27 kHz.</p>", "<p id=\"Par27\">Here we have presented the first interpretable X-ray diffraction pattern from a single protein, frozen in time by the femtosecond X-ray pulse, and experimentally demonstrated that the concept of diffraction before destruction extends to single proteins. This single pattern represents an important step towards solving 3D protein structures with the method of diffraction before destruction and shows that several of the hurdles can indeed be overcome. With higher data rates, many such patterns can map out the structure and function of dynamic proteins with the staggering time resolution enabled by XFELs.</p>" ]
[]
[ "<p id=\"Par1\">The idea of using ultrashort X-ray pulses to obtain images of single proteins frozen in time has fascinated and inspired many. It was one of the arguments for building X-ray free-electron lasers. According to theory, the extremely intense pulses provide sufficient signal to dispense with using crystals as an amplifier, and the ultrashort pulse duration permits capturing the diffraction data before the sample inevitably explodes. This was first demonstrated on biological samples a decade ago on the giant mimivirus. Since then, a large collaboration has been pushing the limit of the smallest sample that can be imaged. The ability to capture snapshots on the timescale of atomic vibrations, while keeping the sample at room temperature, may allow probing the entire conformational phase space of macromolecules. Here we show the first observation of an X-ray diffraction pattern from a single protein, that of <italic>Escherichia coli</italic> GroEL which at 14 nm in diameter is the smallest biological sample ever imaged by X-rays, and demonstrate that the concept of diffraction before destruction extends to single proteins. From the pattern, it is possible to determine the approximate orientation of the protein. Our experiment demonstrates the feasibility of ultrafast imaging of single proteins, opening the way to single-molecule time-resolved studies on the femtosecond timescale.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s41377-023-01352-7.</p>", "<title>Acknowledgements</title>", "<p>We acknowledge European XFEL in Schenefeld, Germany, for provision of X-ray free-electron laser beam time at the SQS instrument and would like to thank the staff for their assistance. We acknowledge the use of the XBI biological sample preparation laboratory, enabled by the XBI User Consortium. We acknowledge valuable discussions with Erik G. Marklund. The results of the work were obtained using Maxwell computational resources operated at Deutsches Elektronen-Synchrotron (DESY), Hamburg, Germany. Part of this work was performed at the Multi-User CryoEM Facility at the Centre for Structural Systems Biology, Hamburg, supported by the Universität Hamburg and DFG grant numbers (INST 152/772-1|152/774-1|152/775-1|152/776-1|152/777-1 FUGG). We acknowledge the support of funding from: Cluster of Excellence ‘CUI: Advanced Imaging of Matter’ of the Deutsche Forschungsgemeinschaft (DFG) – EXC 2056 – project ID 390715994; ERC-2013-CoG COMOTION 614507; NFR 240770; Fellowship from the Joachim Herz Stiftung (P.L.X.). P.L.X. and H.N.C. acknowledge support from the Human Frontiers Science Program (RGP0010/2017). J.H. acknowledges support from the European Development Fund: Structural dynamics of biomolecular systems (ELIBIO) (CZ.02.1.01/0.0/0.0/15_003/ 0000447) EMBO long-term fellowship (ALTF 356-2018) awarded to L.E.F.; the Röntgen-Ångström Cluster (2015-06107 and 2019-06092); the Swedish Research Council (2017-05336, 2018-00234 and 2019-03935); the Swedish Foundation for Strategic Research (ITM17-0455).</p>", "<title>Author contributions</title>", "<p>T.E., K.A., H.N.C., Lars.G., J.H., J.K., D.W. and F.R.N.C.M. conceived and designed the experiment. L.A.E., L.H.G., D.H., A.K.S. and P.L.X. prepared and characterised the sample. L.E.F, W.L. and C.S. performed cryo-EM measurements and analysis. J.B., J.K., O.K, J.L., A.P.M., A.K.S. and L.W. developed and operated the sample delivery equipment. D.A., K.A., B.J.D., T.E., D.E.G., Luca.G., A.I., J.K., R.K., F.R.N.C.M., C.N., M.R., E.S., J.A.S., N.T., I.A.V., and T.W. contributed to software development, data processing and analysis. R.B., M.M., T.M., Y.O., D.R., P.S. and S.U. designed and operated the SQS instrument at EuXFEL. R.H., H.Y. and M.K. integrated and operated the pnCCD detector. The manuscript was written by T.E. and F.R.N.C.M. with input from all authors.</p>", "<title>Funding</title>", "<p>Open access funding provided by Uppsala University.</p>", "<title>Data availability</title>", "<p>A total of 94,750 detector images were deposited on the Coherent X-ray Imaging Data Bank (CXIDB)<sup>##REF##22936162##52##</sup> under <ext-link ext-link-type=\"uri\" xlink:href=\"https://cxidb.org/id-187.html\">ID 187</ext-link>. This includes sample runs (83,600 images), detector calibration runs (3750 images), runs with only the X-ray beam (1200 images) and X-ray beam, sample delivery gas but without sample (6200 images). The DOI for the original data at the EuXFEL is 10.22003/XFEL.EU-DATA-002146-00.</p>", "<title>Code availability</title>", "<p>Simulations were performed with the open-source software package Condor<sup>##REF##27504081##41##</sup>. Software to perform the template matching and all auxiliary software for gain correction, and hit finding are available at <ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/ekeberg/Ekeberg2022GroEL\">https://github.com/ekeberg/Ekeberg2022GroEL</ext-link>.</p>", "<title>Conflict of interest</title>", "<p id=\"Par53\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Experimental setup.</title><p>A solution containing GroEL particles, each roughly a cylinder 14 nm in diameter and height, is aerosolized, using electrospray ionisation followed by neutralisation, and focused into a thin stream using an aerodynamic lens. The stream is then intersected with the path of the XFEL beam and the diffracted signal is collected on a pair of pnCCD detectors downstream of the interaction region. To minimise the amount of background, the beam is cleaned up by apertures both before and after the interaction region<sup>##REF##29091073##53##</sup></p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>Experimental diffraction data.</title><p><bold>a</bold> Average beamline background, i.e., background with gas from injection turned off, plotted after Poisson sampling. <bold>b</bold> Average measured background, plotted after Poisson sampling. <bold>c</bold> Measured single diffraction pattern of a single GroEL particle. All patterns are downsampled to 64 × 64 to make features more visible on this figure. In (<bold>a</bold>) and (<bold>b</bold>), Poisson sampling is used to make the patterns comparable with the single pattern shown in (<bold>c</bold>)</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Data classification.</title><p><bold>a</bold> Histogram showing the number of photons per pattern. The dotted line marks the average strength of the background. The strong peak around 17,000 contains mainly pure-background shots, but most diffraction patterns above 19,000, marked in blue, have diffraction signal from a sample. <bold>b</bold> Histogram of the size of the sample in all patterns with more than 19,000 photons. The peak at 15 nm matches the size of GroEL and the second smaller peak below 5 nm consists of particularly strong pure-background shots</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>Density models.</title><p>The original structure (<bold>a</bold>) and six models with added density (<bold>b</bold>) were compared to the recorded diffraction intensity. The density is modelled as water. The weight of water, in relation to the weight of the protein, for models 1–6 is 13%, 24%, 37%, 51%, 69% and 54% respectively. All models fill the hollow core of GroEL except for model 6</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><title>Pattern comparisons.</title><p><bold>a</bold> Simulated diffraction from the dry GroEL particle in the orientation that best matches the measured pattern. Patterns are plotted after Poisson sampling to make the patterns comparable with the single pattern shown in Fig. ##FIG##1##2c##. <bold>b</bold> A significantly better fit is achieved from density model 3. <bold>c</bold>, <bold>d</bold> Fit error between the measured pattern compared to <bold>c</bold> the simulated diffraction from the dry GroEL particle and <bold>d</bold> model 3. <bold>e</bold> Radial average of the background to illustrate the difference between the models, the best-fitting diffraction from the crystal structure of GroEL (dotted green line), each density model (solid coloured lines) and the measured pattern (dotted black line). The dry molecule predicts too much intensity outside of the central speckle, whereas water models 2, 3 and 4 follow the data much closer. The images (<bold>a</bold>–<bold>d</bold>) and the pixels of (<bold>e</bold>) correspond to 64 × 64 downsampled patterns</p></caption></fig>" ]
[]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha 1$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mrow><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$E$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mi>E</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equa\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$E={\\sum }_{i}{(s{S}_{i}+b{B}_{i}-{K}_{i})}^{2}$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mrow><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mi>s</mml:mi><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>b</mml:mi><mml:msub><mml:mrow><mml:mi>B</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$i$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:mi>i</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$S$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mi>S</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$B$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mi>B</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$K$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mi>K</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$s$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mi>s</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$b$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:mi>b</mml:mi></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[]
[ "<graphic xlink:href=\"41377_2023_1352_Fig1_HTML\" id=\"d32e810\"/>", "<inline-graphic xlink:href=\"41377_2023_1352_Article_IEq1.gif\"/>", "<graphic xlink:href=\"41377_2023_1352_Fig2_HTML\" id=\"d32e870\"/>", "<graphic xlink:href=\"41377_2023_1352_Fig3_HTML\" id=\"d32e899\"/>", "<graphic xlink:href=\"41377_2023_1352_Fig4_HTML\" id=\"d32e926\"/>", "<graphic xlink:href=\"41377_2023_1352_Fig5_HTML\" id=\"d32e975\"/>", "<inline-graphic xlink:href=\"41377_2023_1352_Article_IEq2.gif\"/>", "<graphic xlink:href=\"41377_2023_1352_Article_Equa.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41377_2023_1352_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41377_2023_1352_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41377_2023_1352_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41377_2023_1352_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"41377_2023_1352_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41377_2023_1352_Article_IEq8.gif\"/>" ]
[ "<media xlink:href=\"41377_2023_1352_MOESM1_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>" ]
[{"label": ["10."], "surname": ["Rostom", "Robinson"], "given-names": ["AA", "CV"], "article-title": ["Detection of the intact groel chaperonin assembly by mass spectrometry"], "source": ["J. Am. Chem. Soc."], "year": ["1999"], "volume": ["121"], "fpage": ["4718"], "lpage": ["4719"], "pub-id": ["10.1021/ja990238r"]}, {"label": ["13."], "surname": ["Sobott", "Robinson"], "given-names": ["F", "CV"], "article-title": ["Characterising electrosprayed biomolecules using tandem-MS\u2014the noncovalent GroEL chaperonin assembly"], "source": ["Int. J. Mass Spectrom."], "year": ["2004"], "volume": ["236"], "fpage": ["25"], "lpage": ["32"], "pub-id": ["10.1016/j.ijms.2004.05.010"]}, {"label": ["18."], "surname": ["Daurer"], "given-names": ["BJ"], "article-title": ["Experimental strategies for imaging bioparticles with femtosecond hard X-ray pulses"], "source": ["IUCrJ"], "year": ["2017"], "volume": ["4"], "fpage": ["251"], "lpage": ["262"], "pub-id": ["10.1107/S2052252517003591"]}, {"label": ["23."], "surname": ["Chapman"], "given-names": ["HN"], "article-title": ["Femtosecond diffractive imaging with a soft-X-ray free-electron laser"], "source": ["Nat. Phys."], "year": ["2006"], "volume": ["2"], "fpage": ["839"], "lpage": ["843"], "pub-id": ["10.1038/nphys461"]}, {"label": ["24."], "surname": ["Tschentscher"], "given-names": ["T"], "article-title": ["Photon beam transport and scientific instruments at the european XFEL"], "source": ["Appl. Sci."], "year": ["2017"], "volume": ["7"], "fpage": ["592"], "pub-id": ["10.3390/app7060592"]}, {"label": ["25."], "surname": ["Hantke"], "given-names": ["MF"], "article-title": ["Rayleigh-scattering microscopy for tracking and sizing nanoparticles in focused aerosol beams"], "source": ["IUCrJ"], "year": ["2018"], "volume": ["5"], "fpage": ["673"], "lpage": ["680"], "pub-id": ["10.1107/S2052252518010837"]}, {"label": ["27."], "surname": ["Str\u00fcder"], "given-names": ["L"], "article-title": ["Large-format, high-speed, X-ray pnCCDs combined with electron and ion imaging spectrometers in a multipurpose chamber for experiments at 4th generation light sources"], "source": ["Nucl. Instrum. Methods Phys. Res. Sect. A: Accel. Spectrom. Detect. Assoc. Equip."], "year": ["2010"], "volume": ["614"], "fpage": ["483"], "lpage": ["496"], "pub-id": ["10.1016/j.nima.2009.12.053"]}, {"label": ["28."], "surname": ["Decking"], "given-names": ["W"], "article-title": ["A MHz-repetition-rate hard X-ray free-electron laser driven by a superconducting linear accelerator"], "source": ["Nat. Photonics"], "year": ["2020"], "volume": ["14"], "fpage": ["391"], "lpage": ["397"], "pub-id": ["10.1038/s41566-020-0607-z"]}, {"label": ["32."], "mixed-citation": ["Esser, T. K. et al. Cryo-EM of soft-landed \u03b2-galactosidase: Gas-phase and native structures are remarkably similar. Preprint at "], "italic": ["BioRxiv"]}, {"label": ["34."], "surname": ["Maia", "Ekeberg", "T\u00eemneanu", "van der Spoel", "Hajdu"], "given-names": ["FRNC", "T", "N", "D", "J"], "article-title": ["Structural variability and the incoherent addition of scattered intensities in single-particle diffraction"], "source": ["Phys. Rev. E"], "year": ["2009"], "volume": ["80"], "fpage": ["031905"], "pub-id": ["10.1103/PhysRevE.80.031905"]}, {"label": ["35."], "surname": ["Porro"], "given-names": ["M"], "article-title": ["The MiniSDD-based 1-Megapixel Camera of the DSSC Project for the European XFEL"], "source": ["IEEE Trans. Nucl. Sci."], "year": ["2021"], "volume": ["68"], "fpage": ["1334"], "lpage": ["1350"], "pub-id": ["10.1109/TNS.2021.3076602"]}, {"label": ["36."], "mixed-citation": ["Gessler, P. et al. Overview of acquisition and control electronics and concepts for experiments and beam transport at the European XFEL. In "], "italic": ["Proceedings of the 17th Biennial International Conference on Accelerator and Large Experimental Physics Control Systems"]}, {"label": ["37."], "surname": ["Motuk"], "given-names": ["E"], "article-title": ["Design and development of electronics for the EuXFEL clock and control system"], "source": ["J. Instrum."], "year": ["2012"], "volume": ["7"], "fpage": ["C01062"], "pub-id": ["10.1088/1748-0221/7/01/C01062"]}, {"label": ["40."], "surname": ["Abraham"], "given-names": ["MJ"], "article-title": ["GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers"], "source": ["SoftwareX"], "year": ["2015"], "volume": ["1\u20132"], "fpage": ["19"], "lpage": ["25"], "pub-id": ["10.1016/j.softx.2015.06.001"]}, {"label": ["42."], "surname": ["Loh", "Elser"], "given-names": ["N-TD", "V"], "article-title": ["Reconstruction algorithm for single-particle diffraction imaging experiments"], "source": ["Phys. Rev. E"], "year": ["2009"], "volume": ["80"], "fpage": ["026705"], "pub-id": ["10.1103/PhysRevE.80.026705"]}, {"label": ["44."], "surname": ["Freeke", "Robinson", "Ruotolo"], "given-names": ["J", "CV", "BT"], "article-title": ["Residual counter ions can stabilise a large protein complex in the gas phase"], "source": ["Int. J. Mass Spectrom."], "year": ["2010"], "volume": ["298"], "fpage": ["91"], "lpage": ["98"], "pub-id": ["10.1016/j.ijms.2009.08.001"]}]
{ "acronym": [], "definition": [] }
53
CC BY
no
2024-01-14 23:40:16
Light Sci Appl. 2024 Jan 12; 13:15
oa_package/9d/3b/PMC10786860.tar.gz
PMC10786861
38216571
[ "<title>Introduction</title>", "<p id=\"Par3\">The amide bond is a ubiquitous and vital structural motif in biological and chemical systems, as it constitutes the backbone of peptides, proteins, pharmaceuticals and polymers<sup>##UREF##0##1##–##REF##23726889##5##</sup>. Developing efficient and selective methods for the formation and cleavage of amide species is a primary research goal in various fields of chemistry and biology<sup>##REF##22193101##6##–##REF##33868770##9##</sup>. However, the amide C–N bond cleavage is exceptionally challenging owing to the resonance stabilization (19-26 kcal mol<sup>−1</sup>) of the amide group<sup>##REF##16807968##10##–##REF##17295481##12##</sup>. Most current catalytic methods for this transformation employ transition metal complexes as catalysts<sup>##REF##30240190##7##–##REF##33868770##9##,##REF##26200342##13##–##REF##31833633##15##</sup>, whereas only a few examples use organocatalysts that activate amides through a dual hydrogen-bonding mode<sup>##REF##32075976##16##,##UREF##5##17##</sup>. Nevertheless, hardly any method can achieve a direct nucleophilic substitution at the amide carbon to break the C–N bond. The main reason for this is the relatively short C–N bond distance (about 1.3 Å), which prevents the access of organocatalysts to the reaction centre<sup>##UREF##3##11##</sup>. N-heterocyclic carbene (NHC) is a promising organocatalyst owing to its high nucleophilicity and ability to activate carbonyl compounds<sup>##REF##24965649##18##–##REF##37118184##21##</sup>. Various acyl derivatives, such as anhydrides, imides and esters, have been successfully transformed by NHC-mediated catalysis, forming acyl-azolium intermediates via nucleophilic substitution mechanisms<sup>##REF##35831292##22##–##REF##27219078##27##</sup>. However, the application of NHCs to amide substrates has not been reported yet (Fig. ##FIG##0##1a##). In 2005, Movassaghi et al.<sup>##REF##15932221##28##</sup> disclosed an amidation protocol for unactivated esters using hydroxy-tethered amines as transacylation agents. This method involves a non-covalent hydroxy activation for an initial transesterification followed by a fast O-to-N acyl transfer. This example implies that the amide C–N bond is resistant to cleavage even in the presence of intramolecular hydroxy groups and free carbene species.</p>", "<p id=\"Par4\">To address this problem, we explore two aspects. On the one hand, we combine the axial chiral construction logic and use lactam as the amide precursor, introducing ring strain to lower the activation energy barrier of the amide bond itself<sup>##REF##32075976##16##,##UREF##5##17##,##REF##36649301##29##–##UREF##8##31##</sup>. In recent years, NHC-catalyzed axially chiral molecules have made significant progress<sup>##UREF##9##32##,##UREF##10##33##</sup>. On this basis, we aim to broaden this area to an atroposelective ring-opening scenario (Fig. ##FIG##0##1b##). On the other hand, the chimera strategy of fusing NHC with an H-bonding donor (HBD) has emerged as an intriguing and influential research direction<sup>##UREF##11##34##–##UREF##12##36##</sup>. The simultaneous non-covalent interaction of HBD with the substrate effectively lowers the activation barrier and stabilizes a more spatially-ordered transition state<sup>##UREF##13##37##–##REF##35322485##42##</sup>. Connon’s group designed an amide-tethered triazolium NHC for an asymmetric benzoin condensation reaction<sup>##REF##19675916##43##</sup>. Ye’s group introduced a new series of NHC derivatives bearing a free hydroxyl group and successfully achieved various enantioselective transformations<sup>##REF##32142245##35##,##UREF##15##44##,##UREF##16##45##</sup>. Recently, our group showed that by incorporating a tethered urea or thiourea moiety, the NHC catalysts could enable a new range of asymmetric reactions<sup>##UREF##17##46##,##UREF##18##47##</sup>. To enhance the H-bonding donor ability, we hypothesized that squaramide could be attached to the NHC framework to activate the amide for C–N bond cleavage (Fig. ##FIG##0##1c##)<sup>##UREF##13##37##,##REF##32886474##40##,##REF##35322485##42##</sup>. Based on this hypothesis, we designed and synthesized an aminoindanol-derived triazolium NHC catalyst fused with a squaramide unit and applied it in dynamic kinetic resolution (DKR) of cyclic biaryl lactams<sup>##REF##32075976##16##,##REF##27218264##48##</sup>. The preliminary mechanistic studies by theoretical calculations and control experiments confirmed the essential role of H-bonding interaction between the amide substrate and the HBD moiety, and also verified the direct cleavage of the amide C–N bond by nucleophilic substitution of the free NHC species. This reaction exhibits mild conditions and broad substrate scope, affording atropisomeric biaryls. It also achieves the N-to-O/N-to-S acyl transfers as less conventional conversion modes (Fig. ##FIG##0##1d##).</p>" ]
[ "<title>Methods</title>", "<title>General method for the NHC-HBD catalyzed atroposelective ring-opening of biaryl lactams</title>", "<p id=\"Par13\">The catalyst precursor <bold>3k</bold> (7.4 mg, 0.01 mmol, 20 mol%) and cyclic biaryl lactam <bold>1a</bold> (19.7 mg, 0.05 mmol, 1.0 eq.) were mixed in anhydrous DCM (0.5 mL, 0.1 M) in an oven-dried test tube (20-mL). The mixture was degassed and backfilled with argon (3x) before adding LiHMDS (1.0 M in THF, 8 μL, 16 mol%). The test tube was stirred at −20 °C for 10 min. Benzyl alcohol <bold>2a</bold> (10 μL, 0.1 mmol, 2.0 eq.) was directly added, and the mixture was stirred at -20 °C for 15 hours. Upon complete consumption of <bold>1a</bold>, the reaction was purified by flash column chromatography (eluent: PE/EA = 10/1 to 4/1) to afford product <bold>4a</bold> as a white solid (24.8 mg, 99% yield, 95% ee). The ee was determined by chiral HPLC, conditions: Chiralpak-AS-H column, hexane/iPrOH = 95/5, 1.0 mL/min: t<sub>major</sub> = 21.300 min; t<sub>minor</sub> = 24.717 min. [α] = +5.0 (c = 0.5 in CHCl<sub>3</sub>). <bold>m.p</bold>. 81-82 °C. <sup><bold>1</bold></sup><bold>H NMR</bold> (400 MHz, CDCl<sub>3</sub>) δ 7.59 (dd, <italic>J</italic> = 7.9, 5.6 Hz, 3H), 7.46 (t, <italic>J</italic> = 8.1 Hz, 1H), 7.38 (d, <italic>J</italic> = 8.2 Hz, 1H), 7.32–7.22 (m, 3H), 7.15 (d, <italic>J</italic> = 8.0 Hz, 2H), 7.13 – 7.00 (m, 4H), 6.83 (d, <italic>J</italic> = 7.6 Hz, 1H), 6.18 (s, 1H), 4.97 (d, <italic>J</italic> = 12.2 Hz, 1H), 4.80 (d, <italic>J</italic> = 12.3 Hz, 1H), 3.54 (s, 3H), 2.34 (s, 3H), 1.72 (s, 3H). <sup><bold>13</bold></sup><bold>C NMR</bold> (101 MHz, CDCl<sub>3</sub>) δ 166.5, 157.1, 143.4, 137.5, 137.3, 135.3, 134.7, 132.8, 130.1, 129.5, 128.5, 128.4, 128.3, 128.1, 127.6, 127.5, 125.8, 124.9, 123.0, 116.8, 114.9, 67.1, 56.1, 21.6, 20.2. <bold>HRMS</bold> (ESI-TOF) [M + H]<sup>+</sup> calculated for [C<sub>29</sub>H<sub>28</sub>NO<sub>5</sub>S]<sup>+</sup> 502.1683, found 502.1684.</p>" ]
[ "<title>Results and discussion</title>", "<p id=\"Par5\">We initiated our investigation with cyclic biaryl lactam <bold>1a</bold> and benzyl alcohol <bold>2a</bold> in the presence of the NHC precursor <bold>3</bold> (Table. ##TAB##0##1##). The reaction using <italic>C</italic><sub>2</sub>-symmetric imidazolium pre-catalyst <bold>3a</bold> gave a low enantioselectivity of 2% ee, although an 85% yield was obtained. The aminoindanol-derived triazolium NHC pre-catalyst <bold>3b</bold> afforded the desired product in only 56% yield and 2% ee. In contrast, the Waser-type bifunctional NHC pre-catalyst <bold>3c</bold> achieved moderate enantioselectivity with good conversion (70%, −36% ee)<sup>##UREF##11##34##,##REF##12197730##49##</sup>. The enantiocontrol was significantly improved when a squaramide unit was first fused with NHC on the same skeleton (cat. <bold>3d</bold>, 99%, −66% ee). This suggested that the chimeric NHCs might be effective for the C–N cleavage of lactam and that the enhanced H-bonding strength might improve both the reactivity and enantiocontrol. We then evaluated a series of aminoindanol-derived NHC-thiourea chimeras and found that the 3,5-(CF<sub>3</sub>)<sub>2</sub>-phenyl substituted pre-catalyst <bold>3e</bold> gave an excellent result (99%, 94% ee). We also tried to further increase the H-bonding donor ability by replacing the thiourea with a selenourea analogue <bold>3j</bold>, which could roughly maintain the reaction performance (99%, 92% ee). When the squaramide group was used as an HBD moiety (<bold>3k</bold>), the enantiomeric excess slightly increased to 95%, and it was chosen as the optimal catalyst. A solvent, base and temperature screening indicated that the standard conditions in entry 7 gave the best outcome.</p>", "<title>Substrate scope</title>", "<p id=\"Par6\">We then explored the substrate scope of alcohols under the optimized reaction conditions. As shown in Fig. ##FIG##1##2##, various substituted benzyl and heteroaryl alcohol derivatives efficiently afforded the corresponding products with high yields and excellent enantioselectivities (<bold>4a</bold>-<bold>4f</bold>). Primary alcohols, including the simplest methanol and ethanol, were suitable catalyst turnover agents (<bold>4g</bold>-<bold>4k</bold>). However, secondary and tertiary alcohols failed to complete the catalytic cycle mainly owing to steric hindrance. Some functional groups, such as cyclopropane, primary halides, and ester, were well-tolerated under the reaction conditions (<bold>4k</bold>-<bold>4n</bold>). Unsaturated bonds attached to alcohols did not affect the reaction performance (<bold>4q</bold>-<bold>4s</bold>). When a diol was used, exclusive chemoselectivity of the primary hydroxyl end was observed, which could be rationalized by the kinetic factor (<bold>4t</bold>). The allyl alcohol with a long flexible chain, phytol, was also a compatible substrate for the target atropisomeric biaryl with excellent yield and ee value (<bold>4v</bold>). The crystal structure of compound <bold>4h</bold> was determined by X-ray diffraction, confirming the axially chiral biaryl with <italic>R</italic>-configuration.</p>", "<p id=\"Par7\">We then examined the scope of cyclic biaryl lactams (Fig. ##FIG##2##3##). Cyclic biphenyl lactams bearing different substituents (Me, OMe or OBn) on either aromatic ring gave the target products nearly quantitative yields and ee values ranging from 86% to 99% (<bold>5a</bold>-<bold>5i</bold>). The rotational barrier did not require substituents on both 2’- and 6-positions, as a 2’,5-disubstituted analogue could still afford the desired product and maintain conformational stability (<bold>5</bold> <bold>g</bold>, 98%, 96% ee). Two more complex moieties were also attached to the lactam skeletons, showing a slight decrease in the reaction performance, which further demonstrated the functional group tolerance (<bold>5j</bold> and <bold>5k</bold>). This atroposelective ring-opening protocol could also handle the phenyl-naphthyl- or phenyl-benzofuranyl-type lactams, leading to similar outcomes for both reaction efficiency and enantiocontrol (<bold>5l</bold>-<bold>5o</bold>).</p>", "<p id=\"Par8\">Mercaptans could also act as catalyst turnover agents to afford various thioester products (Fig. ##FIG##3##4##). Benzyl thiols bearing electron-donating groups on the aromatic ring were well tolerated to give both high yield and enantioselectivities; in contrast, the electron-withdrawing group tethered analogue declined on both counts mainly owing to the occurrence of side reaction (<bold>6a</bold>-<bold>6d</bold>). Both primary and secondary thiols were compatible with the presented protocol, affording the corresponding axially chiral biaryl compounds with satisfactory results (<bold>6e</bold>-<bold>6h</bold>). When cholesterol was used, slightly lower enantioselectivity was obtained due to the chirality mismatch of the secondary thiol (<bold>6i</bold>, 95%, 86% de). The structural variations of the biaryl scaffold were also examined, most of which efficiently gave the desired products in good yields with enantiomeric excesses ranging from 88% to 99% (<bold>6j</bold>-<bold>6s</bold>). Attempts to construct atropisomers with complex skeletons showed that the reaction efficiency and enantioselectivity were slightly reduced; however, it still demonstrated the potential as a late-stage modification method (<bold>6t</bold>-<bold>6w</bold>).</p>", "<title>Synthetic applications and mechanistic studies</title>", "<p id=\"Par9\">We then scaled up the model reaction tenfold to demonstrate the synthetic utility of the protocol, which still performed well (product <bold>6r</bold>, 74%, 92% ee). The resulting thioester synthon could be reduced by Et<sub>3</sub>SiH/Pd or NaBH<sub>4</sub>, affording axially chiral aldehyde <bold>7a</bold> or alcohol <bold>7b</bold> with preserved chirality. It also enabled rapid access to the oxadiazole motif <bold>7c</bold> via a one-pot protocol (Fig. ##FIG##4##5a##). We then designed some experiments for mechanistic elucidation based on the concept of an acyl-azolium intermediate. The high-resolution mass spectroscopy (HRMS) analysis showed that the exact mass for the direct adduct of lactam <bold>1a</bold> and bifunctional NHC catalyst <bold>3k</bold> could be detected (Fig. ##FIG##4##5b##, left). This suggested that the free carbene could initiate the amide C–N bond cleavage via nucleophilic attack, forming the chirality-determining acyl-azolium intermediate. Meanwhile, the mass spectrum signal for the protonation of nitrogen anion was observed, indicating the covalent linkage mode between the lactam substrate and NHC catalyst (Fig. ##FIG##4##5b##, right). Our previous reports have shown that a proton shuttle might operate when the protonation step is a critical catalytic step. Based on this hypothesis, we tried introducing H<sub>2</sub>O or PhCO<sub>2</sub>H as an additive and found that both could improve the enantioselectivity (Fig. ##FIG##4##5c##). Even 10.0 equivalents of H<sub>2</sub>O could be tolerated to give a similar result. In contrast, the acidic additive did not show such high compatibility. Moreover, the conformational effect of the amide on the C–N bond cleavage reaction was investigated. The control experiment showed that the torsional strain induced by the 2’,6-disubstituted pattern was an essential activation factor. Under standard conditions, the reaction was completely suppressed for unsubstituted cyclic biaryl lactams. The C–N bond also remained intact during the reaction period for acyclic amide (Fig. ##FIG##4##5d##).</p>", "<p id=\"Par10\">The hybrid skeleton composed of triazolium NHC and squaramide as HBD was examined. As shown in Table. ##TAB##1##2##, the simultaneous use of conventional triazolium NHC <bold>3b</bold> with squaramide as a separate HBD additive could significantly increase the conversion from 56% to 98%, compared with the case without HBD additive (entries 2 and 3). Adding bifunctional NHC catalyst <bold>3k</bold> or squaramide alone did not trigger the reaction (entries 4–6). A catalytic amount of LiHMDS could only afford a similar ring-opening product <bold>4a</bold>, failing to achieve the catalytic version of the whole reaction cycle (entry 7). The result confirmed the unique activation ability of the newly designed NHC-HBD chimera, offering completely different catalytic properties from either NHC or HBD individual components.</p>", "<p id=\"Par11\">Based on the above mechanistic studies, we proposed the catalytic cycle of the NHC-HBD chimera catalyzed C–N bond cleavage of lactam (Fig. ##FIG##5##6##). The deprotonated carbene pre-catalyst initially interacted with lactam via H-bonding interaction. Theoretical calculations were then performed to determine which mode was more favorable. Three possible forms of interaction were considered, and the diplex H-bonding with amide carbonyl was slightly preferred (<bold>Int-1A</bold>, −5.4 kcal mol<sup>−1</sup>; <bold>Int-1B</bold>, −5.3 kcal mol<sup>−1</sup>; <bold>Int-1C</bold>, −4.5 kcal mol<sup>−1</sup>). The energy barriers for transition states guided by these intermediates have a more pronounced difference, further verifying <bold>Int-1A</bold> as the reaction intermediate with an energy advantage (<bold>TS-1A</bold>, 19.3 kcal mol<sup>−1</sup>; <bold>TS-1B</bold>, 24.2 kcal mol<sup>−1</sup>; <bold>TS-1C</bold>, 37.3 kcal mol<sup>−1</sup>). It resulted in spatial alignment for the nucleophilic carbene centre to attack the amide, followed by a protonation step to afford the axially chiral acyl-azolium intermediate <bold>Int-2</bold>. Finally, acyl transfer by nucleophilic reagents regenerated the NHC catalyst and gave the ring-opening product <bold>4</bold>. In this stage, other possible non-covalent interactions between catalyst and substrate skeletons are not involved or discussed<sup>##UREF##19##50##</sup>.</p>", "<p id=\"Par12\">In summary, we have developed a bifunctional chimera combining triazolium NHC with squaramide as HBD, which was shown to be effective in the atroposelective ring-opening of biaryl lactams. This organocatalytic protocol formally achieved a unique amide C–N bond cleavage mode via nucleophilic attack of free carbene species. Various axially chiral biaryl amines could be readily accessed by the proposed methodology with up to 99% ee and 99% yield. By using mercaptan as a catalyst turnover agent, the resulting thioester synthon could be generated and quickly transformed into several interesting atropisomers. Both control experiments and theoretical calculations revealed the crucial role of the hybrid NHC-HBD skeleton. The squaramide moiety initially activated the amide via H-bonding, bringing it spatially close to the carbene centre. The targeted C–N bond broke via a direct NHC nucleophilic attack on the amide carbonyl. The present discovery illustrates the potential of the NHC-HBD chimera, and further application scenarios are under investigation in our laboratory.</p>" ]
[ "<title>Results and discussion</title>", "<p id=\"Par5\">We initiated our investigation with cyclic biaryl lactam <bold>1a</bold> and benzyl alcohol <bold>2a</bold> in the presence of the NHC precursor <bold>3</bold> (Table. ##TAB##0##1##). The reaction using <italic>C</italic><sub>2</sub>-symmetric imidazolium pre-catalyst <bold>3a</bold> gave a low enantioselectivity of 2% ee, although an 85% yield was obtained. The aminoindanol-derived triazolium NHC pre-catalyst <bold>3b</bold> afforded the desired product in only 56% yield and 2% ee. In contrast, the Waser-type bifunctional NHC pre-catalyst <bold>3c</bold> achieved moderate enantioselectivity with good conversion (70%, −36% ee)<sup>##UREF##11##34##,##REF##12197730##49##</sup>. The enantiocontrol was significantly improved when a squaramide unit was first fused with NHC on the same skeleton (cat. <bold>3d</bold>, 99%, −66% ee). This suggested that the chimeric NHCs might be effective for the C–N cleavage of lactam and that the enhanced H-bonding strength might improve both the reactivity and enantiocontrol. We then evaluated a series of aminoindanol-derived NHC-thiourea chimeras and found that the 3,5-(CF<sub>3</sub>)<sub>2</sub>-phenyl substituted pre-catalyst <bold>3e</bold> gave an excellent result (99%, 94% ee). We also tried to further increase the H-bonding donor ability by replacing the thiourea with a selenourea analogue <bold>3j</bold>, which could roughly maintain the reaction performance (99%, 92% ee). When the squaramide group was used as an HBD moiety (<bold>3k</bold>), the enantiomeric excess slightly increased to 95%, and it was chosen as the optimal catalyst. A solvent, base and temperature screening indicated that the standard conditions in entry 7 gave the best outcome.</p>", "<title>Substrate scope</title>", "<p id=\"Par6\">We then explored the substrate scope of alcohols under the optimized reaction conditions. As shown in Fig. ##FIG##1##2##, various substituted benzyl and heteroaryl alcohol derivatives efficiently afforded the corresponding products with high yields and excellent enantioselectivities (<bold>4a</bold>-<bold>4f</bold>). Primary alcohols, including the simplest methanol and ethanol, were suitable catalyst turnover agents (<bold>4g</bold>-<bold>4k</bold>). However, secondary and tertiary alcohols failed to complete the catalytic cycle mainly owing to steric hindrance. Some functional groups, such as cyclopropane, primary halides, and ester, were well-tolerated under the reaction conditions (<bold>4k</bold>-<bold>4n</bold>). Unsaturated bonds attached to alcohols did not affect the reaction performance (<bold>4q</bold>-<bold>4s</bold>). When a diol was used, exclusive chemoselectivity of the primary hydroxyl end was observed, which could be rationalized by the kinetic factor (<bold>4t</bold>). The allyl alcohol with a long flexible chain, phytol, was also a compatible substrate for the target atropisomeric biaryl with excellent yield and ee value (<bold>4v</bold>). The crystal structure of compound <bold>4h</bold> was determined by X-ray diffraction, confirming the axially chiral biaryl with <italic>R</italic>-configuration.</p>", "<p id=\"Par7\">We then examined the scope of cyclic biaryl lactams (Fig. ##FIG##2##3##). Cyclic biphenyl lactams bearing different substituents (Me, OMe or OBn) on either aromatic ring gave the target products nearly quantitative yields and ee values ranging from 86% to 99% (<bold>5a</bold>-<bold>5i</bold>). The rotational barrier did not require substituents on both 2’- and 6-positions, as a 2’,5-disubstituted analogue could still afford the desired product and maintain conformational stability (<bold>5</bold> <bold>g</bold>, 98%, 96% ee). Two more complex moieties were also attached to the lactam skeletons, showing a slight decrease in the reaction performance, which further demonstrated the functional group tolerance (<bold>5j</bold> and <bold>5k</bold>). This atroposelective ring-opening protocol could also handle the phenyl-naphthyl- or phenyl-benzofuranyl-type lactams, leading to similar outcomes for both reaction efficiency and enantiocontrol (<bold>5l</bold>-<bold>5o</bold>).</p>", "<p id=\"Par8\">Mercaptans could also act as catalyst turnover agents to afford various thioester products (Fig. ##FIG##3##4##). Benzyl thiols bearing electron-donating groups on the aromatic ring were well tolerated to give both high yield and enantioselectivities; in contrast, the electron-withdrawing group tethered analogue declined on both counts mainly owing to the occurrence of side reaction (<bold>6a</bold>-<bold>6d</bold>). Both primary and secondary thiols were compatible with the presented protocol, affording the corresponding axially chiral biaryl compounds with satisfactory results (<bold>6e</bold>-<bold>6h</bold>). When cholesterol was used, slightly lower enantioselectivity was obtained due to the chirality mismatch of the secondary thiol (<bold>6i</bold>, 95%, 86% de). The structural variations of the biaryl scaffold were also examined, most of which efficiently gave the desired products in good yields with enantiomeric excesses ranging from 88% to 99% (<bold>6j</bold>-<bold>6s</bold>). Attempts to construct atropisomers with complex skeletons showed that the reaction efficiency and enantioselectivity were slightly reduced; however, it still demonstrated the potential as a late-stage modification method (<bold>6t</bold>-<bold>6w</bold>).</p>", "<title>Synthetic applications and mechanistic studies</title>", "<p id=\"Par9\">We then scaled up the model reaction tenfold to demonstrate the synthetic utility of the protocol, which still performed well (product <bold>6r</bold>, 74%, 92% ee). The resulting thioester synthon could be reduced by Et<sub>3</sub>SiH/Pd or NaBH<sub>4</sub>, affording axially chiral aldehyde <bold>7a</bold> or alcohol <bold>7b</bold> with preserved chirality. It also enabled rapid access to the oxadiazole motif <bold>7c</bold> via a one-pot protocol (Fig. ##FIG##4##5a##). We then designed some experiments for mechanistic elucidation based on the concept of an acyl-azolium intermediate. The high-resolution mass spectroscopy (HRMS) analysis showed that the exact mass for the direct adduct of lactam <bold>1a</bold> and bifunctional NHC catalyst <bold>3k</bold> could be detected (Fig. ##FIG##4##5b##, left). This suggested that the free carbene could initiate the amide C–N bond cleavage via nucleophilic attack, forming the chirality-determining acyl-azolium intermediate. Meanwhile, the mass spectrum signal for the protonation of nitrogen anion was observed, indicating the covalent linkage mode between the lactam substrate and NHC catalyst (Fig. ##FIG##4##5b##, right). Our previous reports have shown that a proton shuttle might operate when the protonation step is a critical catalytic step. Based on this hypothesis, we tried introducing H<sub>2</sub>O or PhCO<sub>2</sub>H as an additive and found that both could improve the enantioselectivity (Fig. ##FIG##4##5c##). Even 10.0 equivalents of H<sub>2</sub>O could be tolerated to give a similar result. In contrast, the acidic additive did not show such high compatibility. Moreover, the conformational effect of the amide on the C–N bond cleavage reaction was investigated. The control experiment showed that the torsional strain induced by the 2’,6-disubstituted pattern was an essential activation factor. Under standard conditions, the reaction was completely suppressed for unsubstituted cyclic biaryl lactams. The C–N bond also remained intact during the reaction period for acyclic amide (Fig. ##FIG##4##5d##).</p>", "<p id=\"Par10\">The hybrid skeleton composed of triazolium NHC and squaramide as HBD was examined. As shown in Table. ##TAB##1##2##, the simultaneous use of conventional triazolium NHC <bold>3b</bold> with squaramide as a separate HBD additive could significantly increase the conversion from 56% to 98%, compared with the case without HBD additive (entries 2 and 3). Adding bifunctional NHC catalyst <bold>3k</bold> or squaramide alone did not trigger the reaction (entries 4–6). A catalytic amount of LiHMDS could only afford a similar ring-opening product <bold>4a</bold>, failing to achieve the catalytic version of the whole reaction cycle (entry 7). The result confirmed the unique activation ability of the newly designed NHC-HBD chimera, offering completely different catalytic properties from either NHC or HBD individual components.</p>", "<p id=\"Par11\">Based on the above mechanistic studies, we proposed the catalytic cycle of the NHC-HBD chimera catalyzed C–N bond cleavage of lactam (Fig. ##FIG##5##6##). The deprotonated carbene pre-catalyst initially interacted with lactam via H-bonding interaction. Theoretical calculations were then performed to determine which mode was more favorable. Three possible forms of interaction were considered, and the diplex H-bonding with amide carbonyl was slightly preferred (<bold>Int-1A</bold>, −5.4 kcal mol<sup>−1</sup>; <bold>Int-1B</bold>, −5.3 kcal mol<sup>−1</sup>; <bold>Int-1C</bold>, −4.5 kcal mol<sup>−1</sup>). The energy barriers for transition states guided by these intermediates have a more pronounced difference, further verifying <bold>Int-1A</bold> as the reaction intermediate with an energy advantage (<bold>TS-1A</bold>, 19.3 kcal mol<sup>−1</sup>; <bold>TS-1B</bold>, 24.2 kcal mol<sup>−1</sup>; <bold>TS-1C</bold>, 37.3 kcal mol<sup>−1</sup>). It resulted in spatial alignment for the nucleophilic carbene centre to attack the amide, followed by a protonation step to afford the axially chiral acyl-azolium intermediate <bold>Int-2</bold>. Finally, acyl transfer by nucleophilic reagents regenerated the NHC catalyst and gave the ring-opening product <bold>4</bold>. In this stage, other possible non-covalent interactions between catalyst and substrate skeletons are not involved or discussed<sup>##UREF##19##50##</sup>.</p>", "<p id=\"Par12\">In summary, we have developed a bifunctional chimera combining triazolium NHC with squaramide as HBD, which was shown to be effective in the atroposelective ring-opening of biaryl lactams. This organocatalytic protocol formally achieved a unique amide C–N bond cleavage mode via nucleophilic attack of free carbene species. Various axially chiral biaryl amines could be readily accessed by the proposed methodology with up to 99% ee and 99% yield. By using mercaptan as a catalyst turnover agent, the resulting thioester synthon could be generated and quickly transformed into several interesting atropisomers. Both control experiments and theoretical calculations revealed the crucial role of the hybrid NHC-HBD skeleton. The squaramide moiety initially activated the amide via H-bonding, bringing it spatially close to the carbene centre. The targeted C–N bond broke via a direct NHC nucleophilic attack on the amide carbonyl. The present discovery illustrates the potential of the NHC-HBD chimera, and further application scenarios are under investigation in our laboratory.</p>" ]
[]
[ "<p id=\"Par1\">We report an organocatalyst that combines a triazolium N-heterocyclic carbene (NHC) with a squaramide as a hydrogen-bonding donor (HBD), which can effectively catalyze the atroposelective ring-opening of biaryl lactams via a unique amide C–N bond cleavage mode. The free carbene species attacks the amide carbonyl, forming an axially chiral acyl-azolium intermediate. Various axially chiral biaryl amines can be accessed by this methodology with up to 99% ee and 99% yield. By using mercaptan as a catalyst turnover agent, the resulting thioester synthon can be transformed into several interesting atropisomers. Both control experiments and theoretical calculations reveal the crucial role of the hybrid NHC-HBD skeleton, which activates the amide via H-bonding and brings it spatially close to the carbene centre. This discovery illustrates the potential of the NHC-HBD chimera and demonstrates a complementary strategy for amide bond activation and manipulation.</p>", "<p id=\"Par2\">Developing efficient methods for the formation and cleavage of amide species is a primary research goal, but the amide C–N bond cleavage is exceptionally challenging. Here, the authors report the development of an organocatalyst that can effectively catalyze the atroposelective ring-opening of biaryl lactams via amide C–N bond cleavage.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s41467-024-44756-8.</p>", "<title>Acknowledgements</title>", "<p>This work was financially supported by the National Natural Science Foundation of China (21825101, Y.H.), Hong Kong RGC (16300320, Y.H.), Shenzhen Science and Technology Innovation Commission (SGDX2019081623241924, Y.H.; KCXFZ20201221173404013, J.C.). We are grateful to the Shenzhen Bay Laboratory Supercomputing Center for the assistance in DFT calculation.</p>", "<title>Author contributions</title>", "<p>Y.H. and J.C. conceived and directed the project. Y.C., Y.Z., K.T., H.Z. and X.M. performed the experiments and analyzed the experimental data. K.T. performed the DFT calculations. Y.H. and J.C. wrote the manuscript with input from all authors. All authors have read and approved the final manuscript.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par14\"><italic>Nature Communications</italic> thanks the anonymous reviewer(s) for their contribution to the peer review of this work. A peer review file is available.</p>", "<title>Data availability</title>", "<p>The X-ray structure data generated in this methodology have been deposited in the Cambridge Crystallographic Data Centre (CCDC: 2252560 for <bold>4h</bold>, 2263709 for <bold>7b</bold>). Copies of the data can be obtained free of charge via <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ccdc.cam.ac.uk/structures/\">https://www.ccdc.cam.ac.uk/structures/</ext-link>. Experimental procedures, characterizations of new compounds and DFT calculation results are included in the ##SUPPL##0##Supplementary Methods##. For NMR and HPLC spectra of structurally novel compounds, see ##SUPPL##0##Supplementary Figures##. All other data are available from the authors upon request.</p>", "<title>Competing interests</title>", "<p id=\"Par15\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Catalytic amide C–N bond cleavage via bifunctional NHCs.</title><p><bold>a</bold> NHC activation for the non-aldehyde substrate. <bold>b</bold> Atroposelective ring-opening activation of amide. <bold>c</bold> Integration with non-covalent activation module. <bold>d</bold> NHC-mediated C–N activation (this work).</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>The reaction scope of alcohols.</title><p>Reactions were performed using cyclic biaryl lactams <bold>1</bold> (0.05 mmol), alcohols <bold>2</bold> (0.1 mmol), NHC precursor <bold>3k</bold> (20 mol%), and LiHMDS (16 mol%) in DCM (0.5 mL) at −20 °C under argon for 15 h. Yields refer to isolated products. Ee was determined by chiral HPLC. <sup>a</sup>Cyclic biaryl lactam <bold>1b</bold> was used as substrate. <sup>b</sup>After stirring for 15 hours at −20 °C, the reaction period was prolonged for another 5 h at 0 °C. See Supplementary Methods for experimental details.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>The scope of cyclic biaryl lactams.</title><p>See ##SUPPL##0##Supplementary Methods## for experimental details.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>The scope of thiols and cyclic biaryl lactams.</title><p>See ##SUPPL##0##Supplementary Methods## for experimental details.</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><title>Synthetic application and mechanism study.</title><p><bold>a</bold> Synthetic applications of axially chiral biaryl thioester. <bold>b</bold> HRMS analysis of intermediate species. <bold>c</bold> proton shuttle experiments. <bold>d</bold> Control experiments.</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><title>Proposed catalytic cycle for the ring-opening reaction.</title><p>See ##SUPPL##0##Supplementary Methods## for experimental details.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table. 1</label><caption><p>Optimization of the reaction conditions</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th colspan=\"7\"></th></tr><tr><th>Entry</th><th>Catalyst</th><th>Solvent</th><th>Base</th><th>T (°C)</th><th>yield (%)</th><th>ee (%)</th></tr></thead><tbody><tr><td>1</td><td><bold>3k</bold></td><td><italic>n</italic>-hexane</td><td>LiHMDS</td><td>r.t.</td><td>99</td><td>66</td></tr><tr><td>2</td><td><bold>3k</bold></td><td>toluene</td><td>LiHMDS</td><td>r.t.</td><td>94</td><td>62</td></tr><tr><td>3</td><td><bold>3k</bold></td><td>DMSO</td><td>LiHMDS</td><td>r.t.</td><td>94</td><td>76</td></tr><tr><td>4</td><td><bold>3k</bold></td><td>MTBE</td><td>LiHMDS</td><td>r.t.</td><td>99</td><td>75</td></tr><tr><td>5</td><td><bold>3k</bold></td><td>CDCl<sub>3</sub></td><td>LiHMDS</td><td>r.t.</td><td>99</td><td>76</td></tr><tr><td>6</td><td><bold>3k</bold></td><td>DCM</td><td>LiHMDS</td><td>r.t.</td><td>88</td><td>78</td></tr><tr><td>7</td><td><bold>3k</bold></td><td>DCM</td><td>LiHMDS</td><td>−20</td><td>99</td><td>95</td></tr><tr><td>8</td><td><bold>3k</bold></td><td>DCM</td><td>DBU</td><td>−20</td><td>93</td><td>94</td></tr><tr><td>9</td><td><bold>3k</bold></td><td>DCM</td><td>DIPEA</td><td>−20</td><td>99</td><td>92</td></tr><tr><td>10</td><td><bold>3k</bold></td><td>DCM</td><td>Et<sub>3</sub>N</td><td>−20</td><td>99</td><td>90</td></tr><tr><td>11</td><td><bold>3k</bold></td><td>DCM</td><td>K<sub>2</sub>CO<sub>3</sub></td><td>−20</td><td>89</td><td>84</td></tr><tr><td>12</td><td><bold>3k</bold></td><td>DCM</td><td>K<sub>3</sub>PO<sub>4</sub></td><td>−20</td><td>99</td><td>74</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table. 2</label><caption><p>The control experiments</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th colspan=\"6\"></th></tr><tr><th>Entry</th><th>Catalyst</th><th>Base</th><th>Additive</th><th>Yield (%)</th><th>ee (%)</th></tr></thead><tbody><tr><td>1</td><td><bold>3k</bold></td><td>LiHMDS</td><td>–</td><td>99</td><td>95</td></tr><tr><td>2</td><td><bold>3b</bold></td><td>LiHMDS</td><td>–</td><td>56</td><td>2</td></tr><tr><td>3</td><td><bold>3b</bold></td><td>LiHMDS</td><td><bold>√</bold></td><td>98</td><td>4</td></tr><tr><td>4</td><td>–</td><td>–</td><td><bold>√</bold></td><td>NR</td><td>–</td></tr><tr><td>6</td><td><bold>3k</bold></td><td>–</td><td>–</td><td>NR</td><td>–</td></tr><tr><td>5</td><td>–</td><td>–</td><td>–</td><td>NR</td><td>–</td></tr><tr><td>7</td><td>–</td><td>LiHMDS</td><td><bold>-</bold></td><td>56</td><td>–</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>" ]
[ "<table-wrap-foot><p>Reaction conditions: cyclic biaryl lactam <bold>1a</bold> (0.05 mmol), benzyl alcohol <bold>2a</bold> (0.1 mmol), NHC precursor <bold>3</bold> (20 mol%), and base (16 mol%) were stirred in a solvent (0.5 mL) at −20 °C under argon for 15 h. Yields were determined by NMR using 1,3,5-trimethoxybenzene as an internal standard. The enantiomeric excess (ee) was determined by chiral HPLC.</p></table-wrap-foot>", "<table-wrap-foot><p>Reaction conditions: cyclic biaryl lactam <bold>1a</bold> (0.05 mmol), benzyl alcohol <bold>2a</bold> (0.1 mmol), NHC precursor <bold>3</bold> (20 mol%), LiHMDS (16 mol%), and additive (20 mol%) were stirred in DCM (0.5 mL) at −20 °C under argon for 15 h. Yields were determined by NMR using 1,3,5-trimethoxybenzene as an internal standard. The enantiomeric excess (ee) was determined by chiral HPLC.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Yuxing Cai, Yuxin Zhao.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41467_2024_44756_Fig1_HTML\" id=\"d32e289\"/>", "<inline-graphic xlink:href=\"41467_2024_44756_Taba_HTML.gif\" id=\"d32e447\"/>", "<graphic xlink:href=\"41467_2024_44756_Fig2_HTML\" id=\"d32e767\"/>", "<graphic xlink:href=\"41467_2024_44756_Fig3_HTML\" id=\"d32e809\"/>", "<graphic xlink:href=\"41467_2024_44756_Fig4_HTML\" id=\"d32e854\"/>", "<graphic xlink:href=\"41467_2024_44756_Fig5_HTML\" id=\"d32e923\"/>", "<inline-graphic xlink:href=\"41467_2024_44756_Tabb_HTML.gif\" id=\"d32e955\"/>", "<graphic xlink:href=\"41467_2024_44756_Fig6_HTML\" id=\"d32e1149\"/>" ]
[ "<media xlink:href=\"41467_2024_44756_MOESM1_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>", "<media xlink:href=\"41467_2024_44756_MOESM2_ESM.pdf\"><caption><p>Peer Review File</p></caption></media>" ]
[{"label": ["1."], "mixed-citation": ["Greenberg, A., Breneman, C. M. & Liebman, J. F. "], "italic": ["The Amide Linkage: Selected Structural Aspects In Chemistry, Biochemistry, And Materials Science"]}, {"label": ["2."], "mixed-citation": ["Hughes, A. B. "], "italic": ["Amino Acids, Peptides And Proteins In Organic Chemistry"]}, {"label": ["3."], "surname": ["Marchildon"], "given-names": ["K"], "article-title": ["Polyamides \u2013 still strong after seventy years"], "source": ["Macromol. React. Eng."], "year": ["2011"], "volume": ["5"], "fpage": ["22"], "lpage": ["54"], "pub-id": ["10.1002/mren.201000017"]}, {"label": ["11."], "surname": ["Li", "Ma", "Szostak"], "given-names": ["G", "S", "M"], "article-title": ["Amide bond activation: the power of resonance"], "source": ["Trends Chem."], "year": ["2020"], "volume": ["2"], "fpage": ["914"], "lpage": ["928"], "pub-id": ["10.1016/j.trechm.2020.08.001"]}, {"label": ["14."], "mixed-citation": ["Malyk, K. R. et al. Distinguishing competing mechanistic manifolds for C(acyl)\u2013N functionalization by a Ni/N-heterocyclic carbene catalyst system. "], "italic": ["JACS Au"]}, {"label": ["17."], "surname": ["Wang"], "given-names": ["WT"], "article-title": ["Cooperative catalysis-enabled C-N bond cleavage of biaryl lactams with activated isocyanides"], "source": ["Chem. Commun."], "year": ["2022"], "volume": ["58"], "fpage": ["6292"], "lpage": ["6295"], "pub-id": ["10.1039/D2CC01625G"]}, {"label": ["23."], "surname": ["Zhang", "Hooper", "Lupton"], "given-names": ["C", "JF", "DW"], "article-title": ["N-heterocyclic carbene catalysis via the \u03b1,\u03b2-unsaturated acyl azolium"], "source": ["ACS Catal."], "year": ["2017"], "volume": ["7"], "fpage": ["2583"], "lpage": ["2596"], "pub-id": ["10.1021/acscatal.6b03663"]}, {"label": ["30."], "surname": ["Wang", "Huang", "Zhang", "Fu"], "given-names": ["G", "J", "J", "Z"], "article-title": ["Catalytically atroposelective ring-opening of configurationally labile compounds to access axially chiral biaryls"], "source": ["Org. Chem. Front."], "year": ["2022"], "volume": ["9"], "fpage": ["4507"], "lpage": ["4521"], "pub-id": ["10.1039/D2QO00946C"]}, {"label": ["31."], "surname": ["Zhao"], "given-names": ["K"], "article-title": ["Enhanced reactivity by torsional strain of cyclic diaryliodonium in Cu-catalyzed enantioselective ring-opening reaction"], "source": ["Chem"], "year": ["2018"], "volume": ["4"], "fpage": ["599"], "lpage": ["612"], "pub-id": ["10.1016/j.chempr.2018.01.017"]}, {"label": ["32."], "surname": ["Song", "Xie", "Jin", "Chi"], "given-names": ["R", "Y", "Z", "YR"], "article-title": ["Carbene-catalyzed asymmetric construction of atropisomers"], "source": ["Angew. Chem. Int. Ed"], "year": ["2021"], "volume": ["60"], "fpage": ["26026"], "lpage": ["26037"], "pub-id": ["10.1002/anie.202108630"]}, {"label": ["33."], "surname": ["Wang", "Zhao", "Wang"], "given-names": ["J", "C", "J"], "article-title": ["Recent progress toward the construction of axially chiral molecules catalyzed by an N-heterocyclic carbene"], "source": ["ACS Catal"], "year": ["2021"], "volume": ["11"], "fpage": ["12520"], "lpage": ["12531"], "pub-id": ["10.1021/acscatal.1c03459"]}, {"label": ["34."], "surname": ["Brand", "Siles", "Waser"], "given-names": ["JP", "JIO", "J"], "article-title": ["Synthesis of chiral bifunctional (thio)urea N-heterocyclic carbenes"], "source": ["Synlett"], "year": ["2010"], "volume": ["2010"], "fpage": ["881"], "lpage": ["884"], "pub-id": ["10.1055/s-0029-1219543"]}, {"label": ["36."], "surname": ["Wang", "Chi", "Huang"], "given-names": ["H", "YR", "X"], "article-title": ["Enantioselective dual catalysis of N\u2010heterocyclic carbene and hydrogen\u2010bond donor organocatalysts"], "source": ["Eur. J. Org. Chem."], "year": ["2022"], "volume": ["2022"], "fpage": ["e202200548"], "pub-id": ["10.1002/ejoc.202200548"]}, {"label": ["37."], "surname": ["Phillips", "Prechtl", "Pombeiro"], "given-names": ["AMF", "MHG", "AJL"], "article-title": ["Non-covalent interactions in enantioselective organocatalysis: theoretical and mechanistic studies of reactions mediated by dual H-bond donors, bifunctional squaramides, thioureas and related catalysts"], "source": ["Catalysts"], "year": ["2021"], "volume": ["11"], "fpage": ["569"], "pub-id": ["10.3390/catal11050569"]}, {"label": ["41."], "surname": ["Sun", "Wei", "Shi"], "given-names": ["Y-L", "Y", "M"], "article-title": ["Applications of chiral thiourea-amine/phosphine organocatalysts in catalytic asymmetric reactions"], "source": ["ChemCatChem"], "year": ["2017"], "volume": ["9"], "fpage": ["718"], "lpage": ["727"], "pub-id": ["10.1002/cctc.201601144"]}, {"label": ["44."], "surname": ["Huang", "He", "Shao", "Ye"], "given-names": ["XL", "L", "PL", "S"], "article-title": ["[4+2] cycloaddition of ketenes with N-benzoyldiazenes catalyzed by N-heterocyclic carbenes"], "source": ["Angew. Chem. Int. Ed"], "year": ["2009"], "volume": ["48"], "fpage": ["192"], "lpage": ["195"], "pub-id": ["10.1002/anie.200804487"]}, {"label": ["45."], "surname": ["Gao", "Zhang", "Jin", "Gao", "Ye"], "given-names": ["Y-Y", "C-L", "M-L", "Z-H", "S"], "article-title": ["Bifunctional NHC-catalyzed remote enantioselective mannich-type reaction of 5-(chloromethyl)furfural via trienolate intermediates"], "source": ["Angew. Chem. Int. Ed."], "year": ["2023"], "volume": ["62"], "fpage": ["e202301126"], "pub-id": ["10.1002/anie.202301126"]}, {"label": ["46."], "surname": ["Guo", "Chen", "Huang"], "given-names": ["F", "J", "Y"], "article-title": ["A Bifunctional N-heterocyclic carbene as a noncovalent organocatalyst for enantioselective aza-Michael addition reactions"], "source": ["ACS Catal."], "year": ["2021"], "volume": ["11"], "fpage": ["6316"], "lpage": ["6324"], "pub-id": ["10.1021/acscatal.1c01908"]}, {"label": ["47."], "surname": ["Li", "Chen", "Huang"], "given-names": ["E", "J", "Y"], "article-title": ["Enantioselective seleno-Michael addition reactions catalyzed by a chiral bifunctional N-heterocyclic carbene with noncovalent activation"], "source": ["Angew. Chem. Int. Ed."], "year": ["2022"], "volume": ["61"], "fpage": ["e202202040"], "pub-id": ["10.1002/anie.202202040"]}, {"label": ["50."], "surname": ["Xi", "Ng", "Ho"], "given-names": ["J", "EWH", "C-Y"], "article-title": ["Unsymmetric N-aryl substituent effects on chiral NHC-Cu: enantioselectivity and reactivity enhancement by ortho-H and syn-configuration"], "source": ["ACS Catal."], "year": ["2023"], "volume": ["13"], "fpage": ["407"], "lpage": ["421"], "pub-id": ["10.1021/acscatal.2c03942"]}]
{ "acronym": [], "definition": [] }
50
CC BY
no
2024-01-14 23:40:16
Nat Commun. 2024 Jan 12; 15:496
oa_package/4c/c5/PMC10786861.tar.gz
PMC10786862
38216606
[ "<title>Background &amp; Summary</title>", "<p id=\"Par2\">Barley is one of the most important crops worldwide (5<sup>th</sup> in 2020 on area harvested, FAOSTAT<sup>##UREF##0##1##</sup>) and has a high value in the European agricultural sector underpinning the beer and whisky industries<sup>##UREF##1##2##</sup>. New barley cultivars are introduced to the market every year, after being evaluated for multiple traits e.g., disease resistance, yield, and malting quality traits<sup>##REF##25605349##3##</sup>. Barley breeding and the introduction of barley cultivars started at the beginning of the 19<sup>th</sup> century in the UK and by the end of the 19<sup>th</sup> century all over Europe<sup>##UREF##2##4##</sup>. Instead of seeds being grown by the farmer with some saved for subsequent sowing the following year, breeding institutes were established, with the mission to develop improved seed stocks. Early cultivars were developed through mass selection and later followed by line selection from landraces. Initial breeding efforts focused on increasing yield<sup>##UREF##3##5##</sup>. Due to the considerable success of these breeding efforts, seed stocks soon became distributed across the continent and each country started their own breeding program by incorporating local landraces in crosses with these generally higher yielding genotypes. This cross-breeding technique of simple crosses followed by selection quickly led to an increase in yield as shown for spring barley in Germany with a doubling of yield from 1800 to 1900<sup>##UREF##4##6##</sup>. Breeding developed further by intentionally mutating seeds with chemicals or radiation to induce higher genetic variation in the offspring<sup>##REF##24430352##7##</sup>. One of the most notable results from mutation breeding were the dwarfing genes which were critical for the green revolution<sup>##REF##25332507##8##</sup>. Shorter stature cultivars provided the advantage of preventing lodging which was crucial for the development of high-yielding cultivars with heavy spikes. Complementing traditional to cross- and mutation-breeding, molecular technologies developed further and were quickly adopted. One of the most successful advances was marker-assisted selection (MAS) which deploys molecular markers to detect allelic variations within a genome. The most common markers used in breeding nowadays are single nucleotide polymorphisms (SNPs)<sup>##REF##23316221##9##</sup>. MAS is used for rapid and high-throughput selection of new genotypes and has matured from single marker analysis to genome-wide selection approaches. While SNPs are a key component of the genotyping platforms used in plant breeding purposes, they can also be used for gene discovery. Quantitative trait locus (QTL) mapping and genome wide association studies (GWAS) are valuable to identify alleles for genes underpinning genetically complex traits<sup>##REF##21115826##10##–##REF##21217754##13##</sup>. High throughput genetic markers are however only one of a number of genetic and genomic resources that have effectively revolutionised genetics and breeding. Next generation sequence data formed the basis of the first linear barley genome published in 2017 from the cultivar Morex<sup>##REF##28447635##14##</sup> which has been followed quickly by additional genomes from other cultivars<sup>##REF##33239781##15##</sup>. The availability of “reference genome sequences” has both simplified the process and allowed a more precise identification of the causative genes controlling phenotypic traits.</p>", "<p id=\"Par3\">Here we introduce new genetic and genomic datasets assembled from a European two-row spring barley population that is representative of pan-European breeding progress across the years from 1830 to 2014. A total of 209 50 K SNP-array<sup>##REF##29089957##16##</sup> genotyped barley cultivars were selected and grown in replicated field trials across three contrasting environments and for two years to score agronomic traits. Six different tissues from each cultivar were harvested and RNA was isolated for the collection of tissue and genotype specific transcript abundance (RNA-seq) data. Using both this RNA-seq data and whole genome shotgun sequence data from all individuals in the population, an exhaustive collection of high confidence SNP markers was assembled. We describe these datasets and provide examples of how they can be used.</p>" ]
[ "<title>Methods</title>", "<title>Barley material and field trials</title>", "<p id=\"Par4\">We assembled a collection of 209 European two-row spring barley cultivars (Supplemental Table ##SUPPL##1##1##), which is a representative subset of previously described two-row spring European barley populations<sup>##REF##21115826##10##,##REF##23160098##11##,##UREF##5##17##–##UREF##6##19##</sup> that show a significant increase in yield over time. A small number of seed are available on request from the corresponding author and after signing a Standard Material Transfer Agreement (SMTA). Pedigree data was collected from publications<sup>##UREF##5##17##,##UREF##7##20##</sup>, and the following two websites: <ext-link ext-link-type=\"uri\" xlink:href=\"https://grinczech.vurv.cz/gringlobal/search.aspx\">https://grinczech.vurv.cz/gringlobal/search.aspx</ext-link> and <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.lfl.bayern.de/mam/cms07/ipz/dateien/abst_gerste.pdf\">https://www.lfl.bayern.de/mam/cms07/ipz/dateien/abst_gerste.pdf</ext-link>. Field experiments were conducted at the Leibniz Institute of Plant Genetics and Crop Plant Research (<bold>IPK</bold>) in Gatersleben, Germany, the James Hutton Institute (<bold>JHI</bold>) in Dundee, UK and the University of Minnesota (<bold>UMN</bold>) in St. Paul, USA in 2019 and 2020. At IPK and UMN, 100 grains of each genotype were sown in 1 m long double-rows in a completely random design with three replications in both years. At JHI, a seed density estimated to produce 350 plants per m<sup>2</sup> for plot sizes of 2 m × 1.5 m was established. In 2019 a single replicate was grown and in 2020 a completely random design with two replicates. In addition, a polytunnel trial was included at JHI in 2019. Plant material was grown in 7 litre sized pots, 4 seeds per pot, in 3 replicate sets in a completely random design. Each replicate set had 8 columns and 30 rows and contained a replicate of each of the 209 genotypes.</p>", "<title>Phenotyping</title>", "<p id=\"Par5\">In total, 29 phenotypes were recorded on a per-plot basis in the field trials or on a per-pot basis in the polytunnel experiment. Developmental traits, growth habit and plant height measurements were recorded in the trials as described in Table ##TAB##0##1##. To measure spike and grain traits, ten to 15 main tiller spikes were harvested at full maturity (Zadoks stage 92) per plot, excluding the outermost plants of each row to avoid edge effects. After recording of all spike traits, spikes were hand-threshed, and grains were subjected to size and weight measurements on a Marvin SeedAnalyzer 6 (MARViTECH GmbH, Germany). Samples were first weighted and then added on to the Marvin tray for optical measurements of the grain size.</p>", "<title>Tissue sampling for RNA-seq</title>", "<p id=\"Par6\">Six different tissues were sampled for RNA-seq analysis: crown, root, inflorescence, peduncle, spikelet and grain. For each tissue one RNA-seq sample per genotype was generated. At UMN, crown and root tissues were sampled from seven-day-old seedlings (GRO:0007060, first leaf unfolded). Ten seeds per genotype were surface sterilized and planted in moist vermiculite in individual Cone-tainers (6000 RLC3 size, Ray Leach, Tangent, OR). The Cone-tainers were put into a dark cold room for four days to achieve more consistent germination. Then they were moved into a growth chamber at 20 °C with 16 hours of light for seven days. Tissues were harvested within three hours, starting at 9:00 am USA Central Time Zone to reduce the circadian effect on gene expression. Roots were sampled by cutting the longest root from each seedling adjacent to the germinated seed, and crowns by removing the roots and keeping the 1 cm shoot tissue immediately above. For each individual genotype five plants were combined and snap frozen in liquid nitrogen.</p>", "<p id=\"Par7\">At JHI, the barley plants grown in 2019 under polytunnel conditions were used for tissue sampling. When plants reached the booting stage, which was 84–85 days after germination, 3 – 5 cm whole developing inflorescence tissue was taken, two from each replicate per genotype per sample. Whole peduncles were taken at 2–5 cm in length, three from each replicate per genotype per sample when plants were 88–90 days old. Sampling took place in a two-hour period between 10:00 and 12:00 Western European Summer Time and samples were snap frozen in liquid nitrogen and stored at −80 °C.</p>", "<p id=\"Par8\">At IPK, barley plants grown in the 2019 field trial were monitored daily by dissecting single spikelets and recording the date of green anther stage and flowering stage on paper tags attached to the spikes. Sampling was limited to a two-hour period between 10:00 and 12:00 am Central European Summer Time each day to reduce the circadian effect on gene expression. Three spikes per plot of one repetition were selected at green anther stage and two central spikelets from the centre of each spike were sampled. At 5 days post anthesis, three spikes per plot of one repetition were selected and six developing grains per spike were sampled from the central region of each spike. All samples were snap-frozen in liquid nitrogen and stored at −80 °C until RNA extraction.</p>", "<title>RNA extraction and RNA sequencing</title>", "<p id=\"Par9\">RNA was extracted using the RNeasy Plant Mini Kit (Qiagen) with all buffers provided and treated with DnaseI following the manufacturer’s instructions. Buffer RLC was used for seedling root extractions, and Buffer RLT was used for all other tissue extractions. To ensure a high purity of spikelet and grain samples, a more rigorous cleanup using 700 µl RW1 and three wash steps with RPE was performed. The integrity of samples was determined using an Agilent 2100 Bioanalyzer, an Agilent 4200 TapeStation or a 1% agarose gel. All tested samples had a RNA integrity number (RIN) factor of &gt; = 8 and were suitable for further processing. Paired-end libraries were constructed from spikelet and grain samples (IPK Gatersleben) and seedling root and crown samples (University of Minnesota Genomics Center, Minneapolis, MN, USA) using the Illumina TruSeq Stranded Total RNA Library Prep Plant with Ribo-Zero Plant kit and sequenced on the NovaSeq 6000 platform with a read length of 150 bp. For the inflorescence and peduncle samples (JHI) Illumina RNA-seq library preparation and RNA-seq was carried out by Novogene (Company Limited, Hong Kong). The libraries were prepared using NEBNext® Ultra™ Directional RNA Library Prep Kit and sequenced using Illumina NovaSeq 6000 (PE 150).</p>", "<title>Bioinformatics</title>", "<title>Read quantification</title>", "<p id=\"Par10\">We generated 77.95 billion raw reads from RNA-seq of the six different tissues (Supplemental Table ##SUPPL##2##2##). Raw reads were trimmed with Trimmomatic 0.39<sup>##REF##24695404##21##</sup> to remove adapters and reads shorter than 60 bp. Salmon 1.3.0<sup>##REF##28263959##22##</sup> was used for expression quantification including the gcBias setting to align trimmed reads to the transcriptome. We followed the approach of selective alignments by generating a decoy-aware transcriptome from the barley reference transcript dataset V2 (BaRTv2)<sup>##UREF##8##23##</sup> and the reference genome of <italic>cv</italic> Barke<sup>##REF##33239781##15##</sup>. This approach is recommended<sup>##REF##32894187##24##</sup> to reduce inaccurate transcript quantification caused by unannotated genomic loci that have a high sequence similarity to annotated transcripts.</p>", "<title>Expression analysis</title>", "<p id=\"Par11\">Tissue-specific genes were identified using different R packages<sup>##UREF##9##25##</sup>. For each tissue the raw counts were imported and combined to gene expression counts using tximport<sup>##UREF##10##26##</sup>. Raw counts were normalised (calcNormFactor), and log transformed to counts per million (cpm) using edgeR<sup>##REF##19910308##27##</sup>. The tissue-specific expressed genes were identified by filtering for an average cpm of above 1 across all samples in this tissue and an average cpm of below −1 for all the other tissues. In addition, gene expression for two and more tissues were filtered with the same parameters to build the intersection sets required to create an UpSet<sup>##REF##28645171##28##,##UREF##11##29##</sup> plot of expressed genes in the different tissues. Gene ontology (GO) enrichment for the identified genes and visualisation were done as previously described<sup>##REF##35461459##30##</sup>.</p>", "<title>Variant calling</title>", "<p id=\"Par12\">For variant calling, the trimmed RNA-seq reads were mapped to the reference genome of <italic>cv</italic> Barke<sup>##REF##33239781##15##</sup> using the two-pass mode implemented in STAR v. 2.7.5<sup>##REF##23104886##31##</sup> allowing 6% mismatches normalized to read length, intron lengths between 60 and 15000 bp, a maximum distance of 2000 bp between mates and a maximum number of 30,000 transcripts per window. Due to the high number of reads in the grain and spikelet tissue the splice junction files were filtered for at least one uniquely-mapped read in more than one sample, with non-canonical splice sites removed and then used to generate a new genome index for the second mapping run. For the other tissues, the splice junction files from the first pass were provided as part of the input for the second mapping step. Duplicated reads were marked with Picard 2.18.29<sup>##UREF##12##32##</sup> followed by filtering with bamtools 2.5.1<sup>##REF##21493652##33##</sup> to remove reads with &gt; = 2% mismatches and a mapping quality &lt; = 50.The legacy algorithm of Freebayes 1.3.2<sup>##UREF##13##34##</sup> was used to call variants with a minimum fraction of alternate allele observations of 20%, a minimum alternate allele count of 2, a minimum coverage of 4, and minimum base and mapping qualities of 30.</p>", "<title>Whole genome shotgun (WGS) approach</title>", "<p id=\"Par13\">DNA was extracted from snap-frozen second leaves of greenhouse-grown (21 °C/18 °C day/night temperature) two-week old seedlings using a guanidinium thiocyanate-NaCl-based method as described<sup>##REF##30420647##35##</sup>. DNA quality and quantity were assessed by agarose gel electrophoresis. The Nextera DNA kit (Illumina) was used for constructing libraries which were multiplexed and sequenced on a NovaSeq 6000 platform at IPK Gatersleben to generate 150-bp paired-end reads. A total of 12.16 billion raw paired-end reads (Supplemental Table ##SUPPL##3##3##) were trimmed with Cutadapt 1.15<sup>##UREF##14##36##</sup> to remove adapters and reads shorter than 30 bp. Trimmed reads were mapped to the reference genome of <italic>cv</italic> Barke using Minimap2 2.11<sup>##REF##29750242##37##</sup>. The resulting alignment files were sorted and duplicate-marked using Novosort 3.06.05<sup>##UREF##15##38##</sup> and converted to cram files using samtools 1.8<sup>##REF##19505943##39##,##UREF##16##40##</sup>. On average the coverage was 4x across all samples with the lowest at 1.5x to the highest at 6.5x coverage (Supplemental Table ##SUPPL##3##3##). The ‘call’ function of Bcftools<sup>##UREF##16##40##</sup> was used to call variants using genotype likelihoods calculated from alignments with a minimum quality score of 20 with the ‘mpileup function of BCFtools. Variants were re-called based on read depth ratios using a custom awk script similar to the one at <ext-link ext-link-type=\"uri\" xlink:href=\"https://bitbucket.org/ipk_dg_public/vcf_filtering/src/master/\">https://bitbucket.org/ipk_dg_public/vcf_filtering/src/master/</ext-link> with the following parameters modified: dphom = 1, dphet = 2, minhomn = 10, tol = 0.249, minmaf = 0.1, minpresent = 0.01.</p>", "<title>Genotype marker file</title>", "<p id=\"Par14\">The final genotype file was generated by filtering and merging multiple files. First all RNA-seq vcf files from the six tissues were filtered to remove insertions and deletions (Indels). SNPs corresponding to the robust BOPA markers<sup>##UREF##21##50##</sup> were extracted from all six RNA-seq files. Pearson correlation between the markers and RNA seq files was calculated and VCFtools v0.1.16 with the parameter--diff-in-site was used to identify identical variants between the sets and those which differed. These two methods allowed for the identification of switched samples, those which did not correlate and SNPs which were inconsistent across the datasets. Swapped samples were renamed and those which did not correlate removed from further analyses. In addition, samples with a high number of heterogeneous SNPs (above 10%) were removed. RNA-seq SNPs from individual tissues were then merged, prioritizing homozygous calls while retaining heterozygous calls only if no homozygous calls were present in any of the tissues. After merging the six RNA-seq SNP datasets, the other two datasets first the WGS SNPs followed by the 50 K array SNPs<sup>##REF##29089957##16##</sup> were compared and added in the same manner. Calculating the Pearson correlation coefficient between the datasets and running VCFtools with the parameter --diff-in-site, removing or swapping samples if applicable.</p>", "<p id=\"Par15\">The resulting unfiltered dataset contained 209 cultivars and 32,484,981 bi-allelic SNPs. The merged SNP dataset was filtered using TASSEL5<sup>##REF##17586829##41##</sup> to remove SNPs with more than 20% missing data, minor allele frequency (MAF) &lt; 0.01, heterozygosity &gt;0.02, and only keeping bi-allelic SNPs. Missing data was imputed using the FILLIN plugin<sup>##UREF##17##42##</sup> in TASSEL5 by first identifying haplotypes. For haplotype identification each chromosome was split into 500 blocks. The number of markers per haplotype block (-hapSize) was the total number of markers per chromosome divided by 500 and rounded to be divisible by 64 (TASSEL5 software requirement). Haplotypes were identified for each block with a maximum number of haplotypes of 20 (-maxHap 20) and at least five different genotypes per haplotype (-minTaxa 5). Haplotype information was used as input for the imputation. Further filtering removed seven lines that had more than 30% missing data after imputation (Aramir, Balder J, Dallas, KWS Irina, Power, Proctor and Spey), and one line was removed that had more than 2% heterozygosity (Rika). In a last filtering step, we removed SNPs which still had more than 20% missing data, MAF &lt; 0.025 or heterozygosity &gt; 0.02. SNPs were LD pruned with PLINK (v1.9)<sup>##REF##17701901##43##</sup> using a window size of 5000, a step size of 50 and an r<sup>2</sup> threshold of 0.99. The final SNP dataset after pruning contained 201 cultivars and 1,509,447 SNPs. In the final SNP file 0.25% of markers represented markers from the 50k array, 25.1% from the RNA-seq data and 98.5% from the WGS data. The overlap between RNA-seq and WGS data is considerable with 98.6% of the RNA-seq markers also being identified by the WGS dataset.</p>", "<title>Variant effect using SnpEff</title>", "<p id=\"Par16\">To identify the effect of variants on the protein, we filtered the raw vcf files in a different way to generate an input file for SnpEff<sup>##REF##22728672##44##</sup>. The aim for the genotype marker set explained above was to reduce the number of SNPs with pruning to a size which can be used for association analysis. For the variant effect we needed all the available SNP information and more importantly did not want to lose any SNPs due to pruning in gene space. For SNPs, the merged unfiltered vcf file containing RNA-seq, WGS and 50k data was filtered by removing heterozygous calls, removing SNPs with missing data in more than 20% of the samples and a minor allele frequency of &lt;0.025. In addition, a dataset containing Indels was created by using the six vcf output files from the RNA-seq data after variant calling with Freebayes. All were filtered to keep Indels only, remove heterozygous calls, remove variants with missing data in more than 20% of the samples and a MAF of &lt;0.025. The six Indel vcf files were combined into one. A SnpEff database was built based on BaRTv2 and the Barke reference genome.</p>", "<title>Statistical analysis of phenotypic data, calculation of Best linear unbiased predictions (BLUPs) and heritability</title>", "<p id=\"Par17\">Statistical analysis was performed using R 3.6.1<sup>##UREF##9##25##</sup>. The Pearson correlation coefficient between experiments was calculated for each phenotypic trait and datasets showing an insignificant correlation (p &gt; 0.05) with at least one other dataset of the same trait were removed before calculating BLUPs. The datasets being used in each of the BLUP calculations are listed in Supplemental Table ##SUPPL##4##4##. BLUPs were calculated across experiments using a randomized complete block model in META-R with experiments set as a random factor following formula 3 in Alvarado <italic>et al</italic>.<sup>##UREF##18##45##</sup>.</p>", "<title>Genome wide association studies (GWAS)</title>", "<p id=\"Par18\">Association between phenotype and genotype was done using the Mixed Linear Model (MLM)<sup>##REF##16380716##46##</sup> with GAPIT (version 3)<sup>##REF##22796960##47##</sup>. As input, we used the genotype marker file of 201 cultivars and 1,509,447 SNPs. The BLUP values of Awn length were used to provide an example of the process. Three principal components (PCs) were calculated within GAPIT and model selection set to TRUE to enable GAPIT to select the optimal number of PCs for the individual phenotype based on a Bayesian information criterion (BIC).</p>" ]
[]
[]
[]
[ "<p id=\"Par1\">Barley genomic resources are increasing rapidly, with the publication of a barley pangenome as one of the latest developments. Two-row spring barley cultivars are intensely studied as they are the source of high-quality grain for malting and distilling. Here we provide data from a European two-row spring barley population containing 209 different genotypes registered for the UK market between 1830 to 2014. The dataset encompasses RNA-sequencing data from six different tissues across a range of barley developmental stages, phenotypic datasets from two consecutive years of field-grown trials in the United Kingdom, Germany and the USA; and whole genome shotgun sequencing from all cultivars, which was used to complement the RNA-sequencing data for variant calling. The outcomes are a filtered SNP marker file, a phenotypic database and a large gene expression dataset providing a comprehensive resource which allows for downstream analyses like genome wide association studies or expression associations.</p>", "<title>Subject terms</title>" ]
[ "<title>Data Records</title>", "<p id=\"Par19\">All raw data files for both raw RNA sequencing data and whole genome shotgun data have been deposited at the European Nucleotide Archive (ENA) under the following project number: PRJEB49069<sup>##UREF##19##48##</sup> for the RNA-sequencing reads and PRJEB48903<sup>##UREF##20##49##</sup> for the whole genome shotgun sequencing reads.</p>", "<p id=\"Par20\">Phenotypic data and the SNP marker file are available through Germinate<sup>##UREF##21##50##</sup>: <ext-link ext-link-type=\"uri\" xlink:href=\"https://ics.hutton.ac.uk/germinate-barn/\">https://ics.hutton.ac.uk/germinate-barn/</ext-link></p>", "<p id=\"Par21\">The database contains the raw data by year and by site plus the calculated BLUP dataset.</p>", "<p id=\"Par22\">The SNP marker file has been deposited in the European Variant Archive<sup>##REF##34718739##51##</sup> under the following project number: PRJEB65875<sup>##UREF##22##52##</sup>.</p>", "<p id=\"Par23\">Derived datasets are available through e!Dal<sup>##REF##24958009##53##</sup> with the following 10.5447/ipk/2023/15 The datasets consist of two sets of gene expression files per tissue; one for the raw read counts and one for the TPM values mapped against BaRTv2. In addition, the data has been uploaded to ArrayExpress<sup>##REF##30357387##54##</sup> with the following accession numbers: E-MTAB-13231 (spikelet tissue)<sup>##UREF##23##55##</sup>, E-MTAB-13236 (grain tissue)<sup>##UREF##24##56##</sup>, E-MTAB-13235 (root tissue)<sup>##UREF##25##57##</sup>, E-MTAB-13234 (crown tissue)<sup>##UREF##26##58##</sup>, E-MTAB-13233 (inflorescence tissue)<sup>##UREF##27##59##</sup> and E-MTAB-13232 (peduncle tissue)<sup>##UREF##28##60##</sup>.</p>", "<p id=\"Par24\">Two further files containing variant identification are available through e!Dal. The first contains the SNPs and the second the Indel information with SnpEff annotation.</p>", "<title>Technical Validation</title>", "<title>Population</title>", "<p id=\"Par25\">The 209 two-row spring barley population was selected from previously established datasets containing 647 cultivars<sup>##REF##21115826##10##,##REF##23160098##11##,##UREF##5##17##–##UREF##6##19##</sup>. To include a wide range of genetically representative individuals, we used available BOPA SNP data (as previously described)<sup>##REF##19961604##61##</sup> and did a multi-dimensional scaling plot (Fig. ##FIG##0##1a##). Dimension 1 showed the progression from the oldest to the newest cultivars. Genotypes were then chosen to be spread across year of registration as a cultivar to the UK market. Except for the first time-range which encompassed 130 years (1830–1959) of cultivar releases, all other ranges were split into decades and each time-range is represented by a similar number of genotypes (Fig. ##FIG##0##1b##). The final population was representative of breeding progress in cultivated barley for improved yield over time.</p>", "<p id=\"Par26\">Pedigree data showed that modern barley germplasm is highly connected with most current genotypes’ descendants of a small number of “founder” genotypes (Pedigree file: Supplemental File 1, Pedigree attributes: Supplemental File 2). These supplemental pedigree files can be used as input for the pedigree visualisation tool Helium (<ext-link ext-link-type=\"uri\" xlink:href=\"https://helium.hutton.ac.uk/\">https://helium.hutton.ac.uk/</ext-link>)<sup>##REF##25085009##62##</sup>. Intermediate crosses were omitted from the file to be able to display the pedigree and produce a tree which is both readable and navigable. Using the pedigree data within Helium allows for further analyses.</p>", "<title>Phenotyping</title>", "<p id=\"Par27\">Field trials were done in 2019 and 2020 in three different locations: Minneapolis (Lat. 44.987, Long: −93.258; MN, USA), Dundee (Lat. 56.462, Long. −2.971; UK) and Gatersleben (Lat. 51.823, Long. 11.287; Germany). In total 29 agronomic traits were scored associated with development (earliness and growth habit traits), grain and height measurements. All the phenotypic data can be viewed and studied in a Germinate database: <ext-link ext-link-type=\"uri\" xlink:href=\"https://ics.hutton.ac.uk/germinate-barn/\">https://ics.hutton.ac.uk/germinate-barn/</ext-link>. Across years and sites, the results were consistent except for a few traits. All earliness traits showed a faster development to awn tipping all the way to peduncle senescence in Minnesota and slowest in Dundee. Outliers in the phenotypic scoring were the grain fertility measurements in Minnesota in 2019 where the spikes got stuck in the flag leaf sheath due to high temperatures during the growing season and did not emerge fully which led to a higher number of infertile florets. All phenotypic information was combined into BLUPs except for 24 out of 165 phenotype datasets which did not correlate with the rest (Supplemental Table ##SUPPL##4##4## shows which phenotype values were combined; Supplemental Fig. ##SUPPL##0##1## for distribution of BLUP values per phenotype). A strong positive correlation among the five different height measurements illustrate the robustness of the phenotypic dataset (Fig. ##FIG##1##2##).</p>", "<title>Genotyping</title>", "<p id=\"Par28\">To achieve the most extensive genotypic information for our population, variant calling from RNA-seq data, whole genome shotgun data and previously established 50 K SNP data was combined (32,484,981 raw SNPs). For RNA-seq and WGS, the data was filtered to keep only biallelic SNPs. We extracted the SNPs corresponding to the previous described BOPA markers across all 1463 sequencing datasets (six tissue-specific RNA-seq datasets with 209 genotypes each and one WGS dataset with 209 genotypes) for quality control. The Pearson correlation coefficient for all genotypes between datasets was calculated. This identified mixed-up samples where the genotype showed high correlation with a differently named sample and therefore allowed for correction of the genotypic information. Samples with a high number of heterogenous SNPs (above 10%) were removed as this pointed towards issues during sample preparation. The filtering step reduced the number of genotypes per tissue. The final numbers of genotypes per tissue varied between 191 to 199 (Supplemental Table ##SUPPL##2##2## shows which genotypes per tissue where retained). The merged SNP file was filtered to remove highly heterozygous sites or those containing more than 20% missing data. The remaining sites were imputed using haplotype imputation. SNPs were pruned by LD using Plink to reduce the dataset size to the final 1,509,447 SNPs<sup>##UREF##22##52##</sup>. SNP distribution along the 7 chromosomes is shown in Fig. ##FIG##2##3##.</p>", "<title>Gene expression</title>", "<p id=\"Par29\">RNA-seq data for six different tissues (crown, grain, inflorescence, peduncle, root, spikelet) was mapped against the BaRTv2 transcriptome using Salmon<sup>##REF##28263959##22##</sup>. The expression of all 39,434 genes in transcript per million (TPM)<sup>##UREF##23##55##–##UREF##28##60##</sup> for each tissue were used as input to generate a multidimensional scaling plot (MDS). The MDS shows all 209 genotypes cluster together by tissue type (Fig. ##FIG##3##4##). The tissue furthest separated by the first dimension from the rest was the root tissue. The two tissues sampled from the spikelet at green anther stages (spikelet) and developing grain at five days post anthesis (grain) show the highest overlap.</p>", "<title>Data use-case scenarios</title>", "<p id=\"Par30\">In the following three examples we show how the above datasets can be used.</p>", "<p id=\"Par31\">In the first example the expression data has been used to filter for tissue-specific gene expression. Tissue-specific genes showed that the root tissue was the most distinct with 776 genes identified as root specific (Fig. ##FIG##4##5##). Overall, of the tissue specific genes, 572 genes were only expressed in grain, 437 in spikelet, 198 in inflorescence, 86 in peduncle and 64 in crown. Inflorescence and peduncle shared the highest overlap of expressed genes with 927 genes and 13,215 genes were expressed in all six tissues. While the MDS plot shows a high overlap of samples between spikelet and grain in the first two dimensions, the third dimension divides those tissues which fits with these two tissues showing the second and third highest tissue-specific gene expression. Gene ontology for the peduncle resulted in no significant terms. The Gene ontology results for all remaining five tissues are shown in Fig. ##FIG##5##6##. The associated terms were generally comparable to those previously identified in maize<sup>##REF##31878892##63##</sup>.</p>", "<p id=\"Par32\">In the second example, we illustrate how the data can be used to explore the potential impact of genetic variation on gene activity or protein function by identifying premature stop codons or frameshift mutations in a high confidence variant dataset. For the SNP dataset we started with 32 million SNPs, removed heterozygous SNPs and filtered for variants with less than 20% missing data and a minor allele frequency of 2.5% which resulted in 4,012,229 SNPs<sup>##UREF##29##64##</sup>. Those were used as input into SnpEff which identified 9,219,271 effects (as described by SnpEff: <ext-link ext-link-type=\"uri\" xlink:href=\"http://pcingola.github.io/SnpEff/se_inputoutput/#eff-field-vcf-output-files\">http://pcingola.github.io/SnpEff/se_inputoutput/#eff-field-vcf-output-files</ext-link>) caused by those 4 million SNPs. Of those effects, 4% (368,650) were in exons, with 53.78% synonymous variants, corresponding to 199,545 effects in 17,446 genes. The non-synonymous variants represented 45.57% (169,105 effects) of the exon effects in 19,057 genes and 0.65% classified as nonsense. The 0.65% corresponded to 2,425 transcripts and 1,105 genes with a premature stop codon in the sequence. For the Indel identification only the RNA-seq variant files were considered as those provided higher read depth for the genic regions. They were also filtered by removing heterozygous variants, keeping those with less than 20% missing data and a minor allele frequency of 2.5%. A total of 50,865 variants remained<sup>##UREF##22##52##</sup> which SnpEff predicted to cause 558,991 effects. 50.31% (281,228 effects) were upstream or downstream of the gene and 41.81% (233,706 effects) in the intronic region. After filtering for disruptive frame shifts caused by insertions or deletions resulting in changes to the protein sequence, 1,912 genes remained which we designated as potentially non-functional in some of the cultivars<sup>##UREF##29##64##</sup>. Such structural variation can be explored in relation to gene expression. For example, Fig. ##FIG##6##7## shows the expression of two genes BaRT2v18chr5HG260690 and BaRT2v18chr2HG058650 with frameshift mutations in comparison to the Barke reference allele. The consequence of all such observed variation still needs to be explored.</p>", "<p id=\"Par33\">Third, we show a genome wide association study (GWAS) using the 1,509,447 SNP markers and the morphological character “awn length” as a phenotype. We used the Mixed Linear Model (MLM) in GAPIT<sup>##REF##22796960##47##</sup> to identify associations in the genome. Using a -log10(p) cut-off of 5 resulted in 6 significant peaks (Fig. ##FIG##7##8##). The most significant SNP was found on chromosome 5H at position 441 Mb within 1 kb of <italic>HvDep1</italic> (BaRT2v18chr5HG247460) previously shown to influence awn length<sup>##REF##28005988##65##</sup>. The other associations and traits remain to be explored.</p>", "<title>Usage Notes</title>", "<p id=\"Par34\">To perform the analysis using the Snakemake<sup>##REF##34035898##66##</sup> pipeline (see code availability) a high-performance computing (HPC) cluster is needed. For example, the Salmon indexing step in this setup needed 56 Gb of memory using 16 cores, mapping of each individual sample needed 31 Gb of memory using 8 cores. Downstream analyses like the genome wide association studies can be performed by downloading the BLUPs of the phenotypes and the marker file from Germinate.</p>", "<title>Supplementary information</title>", "<p>\n\n\n\n\n\n\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s41597-023-02850-4.</p>", "<title>Acknowledgements</title>", "<p>The authors would like to acknowledge Richard Keith and Chris Warden for maintaining the JHI field trials, Nicola McCallum and Ruth Hamilton for the help with phenotypic scoring and John Fuller for the RNA-seq library preparation. We thank Micha Bayer, Runxuan Zhang, John Brown and Wenbin Guo for advice on the project design and bioinformatics. We would like to acknowledge Shane Heinen, Yadong Huang, Ismaél Pfeifer, and Letícia Pasqualino for the help in the lab and field work at the University of Minnesota. We acknowledge current and former members of the Genomics of Genetic Resources research group at IPK Gatersleben: Mary Ziems for planning and maintaining field trials, phenotypic scoring and tissue sampling; Mark Timothy Rabanus-Wallace, Hélène Pidon, Sudharsan Padmarasu, Mingjiu Li, Jayavardhan Reddy Kunam, Mohammed Rafaqat, Mohammad Awais, Jaqueline Pohl, Susanne König, Ines Walde, Manuela Knauft, Manuela Kretschmann and Beate Kamm for phenotypic scoring and tissue sampling. We thank Ines Walde and Susanne König at IPK for preparing sequencing libraries and generating sequencing data. Thanks are also given to the Research/Scientific Computing teams at The James Hutton Institute and NIAB for providing computational resources and technical support for the “UK’s Crop Diversity Bioinformatics HPC” (BBSRC grant BB/S019669/1), use of which has contributed to the results reported. The work was supported by funding from the Rural and Environment Science and Analytical Services Division of the Scottish Government. The authors acknowledge the Minnesota Supercomputing Institute at the University of Minnesota. The project received funding in frame of the ERA-CAPS Research Programme with funding (i) of the German partners through German Research Foundation (DFG) to NS under the project references MU 3589/1-1 | STE 1102/15-1 | WA 3336/4-1, (ii) the Scottish partner to RW through BBSRC (award number BB/S004610/1), (iii) the US partner to GJM through NSF (award number 1844331)</p>", "<title>Author contributions</title>", "<p>M.S. wrote the manuscript, conducted data collection and analysis. R.Wo. conducted RNA-seq and W.G.S., data collection and analysis. AHa conducted RNA-seq data collection and analysis. M.C. did RNA-seq and data collection. J.R. provided seed material and did field trials. A.Hi. conducted RNA sequencing, whole genome shotgun sequencing and primary data analysis. AF did data management. G.J.M., N.S. and R.Wa. designed the experiment, supervised the work and edited the manuscript.</p>", "<title>Code availability</title>", "<p>The code for analysing the RNA-sequencing data from mapping to genome and transcriptome to variant calling was combined into a Snakemake<sup>##REF##34035898##66##</sup> pipeline and is available on GitHub: <ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/SchreiberM/BARN\">https://github.com/SchreiberM/BARN</ext-link>.</p>", "<title>Competing interests</title>", "<p id=\"Par35\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>Selection of a two-row spring population. (<bold>a</bold>) Multidimensional scaling plot of 647 European two-row spring cultivars. Genotype information came from 2,336 previously published BOPA markers. The 209 selected cultivars forming the population in this study are shown as triangles. The year range represents the year each individual cultivar was registered. (<bold>b</bold>) Distribution of the selected population of 209 cultivars (orange) as part of the total 647 European two-row spring cultivars (green) by year of registration.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>Pearson correlation coefficient between the 29 scored phenotypes and, as a 30th variable, the year of registration. Phenotypic values were provided as best linear unbiased predictions for each phenotype for each of the 209 cultivars.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p>SNP and gene distribution along the seven barley chromosomes (<bold>a</bold>) SNP distribution and density of the final 1,509,447 SNPs in the genotypic marker file along the seven barley chromosomes in 1 Mb bins. The SNPs were identified from the 50k SNP array, RNA-sequencing and whole genome shotgun sequencing datasets and filtered to remove missing values and heterozygosity. (<bold>b</bold>) Gene density along the seven barley chromosomes.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><p>Gene expression of 209 cultivars across six tissues. Multidimensional scaling plot of all genes expressed in any of the six studied tissues: root, crown, peduncle, inflorescence, spikelet and grain.</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><p>An UpSet plot showing the overlap of the expressed genes for each of the tissues and tissue combinations.</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><p>Gene ontology (GO) enrichment for the tissue-specific genes in (<bold>a</bold>) root, (<bold>b</bold>) grain, (<bold>c</bold>) inflorescence, (<bold>d</bold>) spikelet and (<bold>e</bold>) crown. X-axis shows the percentage of genes associated with the GO term out of all genes in BaRTv2 associated with this term. Y-axis shows the significance as FDR adjusted -log(p-value) of the GO term. The area of the circle corresponds to the number of genes associated with the GO term.</p></caption></fig>", "<fig id=\"Fig7\"><label>Fig. 7</label><caption><p>Gene expression in TPM (transcripts per million) for two genes identified with changes in the protein sequence. (<bold>a</bold>) BaRT2v18chr5HG260690 and (<bold>b</bold>) BaRT2v18chr2HG058650 split by haplotype on the x-axis. The first haplotype always represents the reference allele from the genotype Barke, and the second allele represents the alternative.</p></caption></fig>", "<fig id=\"Fig8\"><label>Fig. 8</label><caption><p>Genome wide association of awn length showing a high significant association on chromosome 5H.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>A summary of the phenotypic traits and a description on how they were scored.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Trait</th><th>Method</th></tr></thead><tbody><tr><td colspan=\"2\"><bold>Developmental traits</bold></td></tr><tr><td>Days to awn tipping</td><td>50% of the main tiller awns per plot have emerged up to 1 cm out of the flag leaf sheath. Recorded as days since sowing</td></tr><tr><td>Days to heading</td><td>50% of the main tiller spikes per plot have emerged halfway out of the flag leaf sheath. Recorded as days since sowing</td></tr><tr><td>Days to senescence</td><td>50% of the main tiller peduncles per plot are senescent (yellow). Recorded as days since sowing</td></tr><tr><td>Days from awn tipping to heading</td><td>Derived from days to awn tipping and days to heading</td></tr><tr><td>Days from awn tipping to senescence</td><td>Derived from days to awn tipping and days to senescence</td></tr><tr><td>Days from heading to senescence</td><td>Derived from days to heading and days to senescence</td></tr><tr><td>Growth habit (GH)</td><td>Visual evaluation using a scale of 1 (erect), 2 (intermediate) and 3 (prostrate). Recorded at the onset of stem elongation</td></tr><tr><td colspan=\"2\"><bold>Height and length traits</bold></td></tr><tr><td>Peduncle base height</td><td>Height of the base of the peduncle in cm</td></tr><tr><td>Flag leaf blade height</td><td>Height of the flag leaf sheath in cm</td></tr><tr><td>Culm height</td><td>Height of the base of the spike in cm</td></tr><tr><td>Plant height</td><td>Height of the top of the spike in cm</td></tr><tr><td>Awn tip height</td><td>Height of the tip of the awns in cm</td></tr><tr><td>Spike base to flag leaf</td><td>Calculated distance from base of spike to flag leaf sheath (auricle) in cm</td></tr><tr><td>Peduncle length</td><td>Calculated distance from base of spike to base of peduncle in cm</td></tr><tr><td>Awn length</td><td>Calculated distance from tip of awns to top of spike in cm</td></tr><tr><td>Spike culm ratio</td><td>Spike length divided by culm height</td></tr><tr><td colspan=\"2\"><bold>Spike traits (recorded on 10–15 main tiller traits per plot after harvest)</bold></td></tr><tr><td>Rachis node number</td><td>Number of rachis nodes</td></tr><tr><td>Spike length</td><td>Spike length in cm</td></tr><tr><td>Spike density</td><td>Rachis node number divided by spike length</td></tr><tr><td colspan=\"2\"><bold>Grain traits (recorded on 10–15 main tiller traits per plot after harvest) using a Marvin Seed Analyzer 6</bold></td></tr><tr><td>Grain area</td><td>Area of all kernels per spike in mm<sup>2</sup>. Recorded using the automatic grain area calculation function in the Marvin SeedAnalyzer 6 software</td></tr><tr><td>Kernel roundness</td><td>Roundness of all kernels per spike. Recorded using the automatic kernel roundness calculation function in the Marvin SeedAnalyzer 6 software</td></tr><tr><td>Thousand kernel weight</td><td>Calculated from the number and weight of the kernels using the Marvin SeedAnalyzer 6 software</td></tr><tr><td>Grain length</td><td>Length of all kernels per spike in cm</td></tr><tr><td>Grain width</td><td>Width of all kernels per spike in cm</td></tr><tr><td colspan=\"2\"><bold>Spike traits (recorded on 10–15 main tiller traits per plot after harvest)</bold></td></tr><tr><td>Infertile florets at top and bottom ( = edges) of spike</td><td>Number of infertile florets at the top of spike down to first fertile floret + number of infertile florets at the base of spike up to first fertile floret</td></tr><tr><td>Infertile florets in the middle of the spike</td><td>Number of infertile florets in the centre of the spike</td></tr><tr><td>Number of fertile grain</td><td>Total number of fertile florets per spike</td></tr><tr><td>Percent of fertile florets</td><td>Total number of fertile florets per spike divided by rachis node number</td></tr><tr><td>Number infertile florets</td><td>Total number of infertile florets per spike</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM5\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM6\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM7\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Miriam Schreiber, Ronja Wonneberger, Allison M. Haaning.</p></fn><fn><p>These authors jointly supervised this work: Gary J. Muehlbauer, Nils Stein, Robbie Waugh.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41597_2023_2850_Fig1_HTML\" id=\"d32e899\"/>", "<graphic xlink:href=\"41597_2023_2850_Fig2_HTML\" id=\"d32e933\"/>", "<graphic xlink:href=\"41597_2023_2850_Fig3_HTML\" id=\"d32e961\"/>", "<graphic xlink:href=\"41597_2023_2850_Fig4_HTML\" id=\"d32e986\"/>", "<graphic xlink:href=\"41597_2023_2850_Fig5_HTML\" id=\"d32e1009\"/>", "<graphic xlink:href=\"41597_2023_2850_Fig6_HTML\" id=\"d32e1032\"/>", "<graphic xlink:href=\"41597_2023_2850_Fig7_HTML\" id=\"d32e1068\"/>", "<graphic xlink:href=\"41597_2023_2850_Fig8_HTML\" id=\"d32e1091\"/>" ]
[ "<media xlink:href=\"41597_2023_2850_MOESM1_ESM.docx\"><caption><p>Supplemental Figure 1</p></caption></media>", "<media xlink:href=\"41597_2023_2850_MOESM2_ESM.docx\"><caption><p>Supplemental Table 1</p></caption></media>", "<media xlink:href=\"41597_2023_2850_MOESM3_ESM.xlsx\"><caption><p>Supplemental Table 2</p></caption></media>", "<media xlink:href=\"41597_2023_2850_MOESM4_ESM.xlsx\"><caption><p>Supplemental Table 3</p></caption></media>", "<media xlink:href=\"41597_2023_2850_MOESM5_ESM.xlsx\"><caption><p>Supplemental Table 4</p></caption></media>", "<media xlink:href=\"41597_2023_2850_MOESM6_ESM.pdf\"><caption><p>Supplemental files 1</p></caption></media>", "<media xlink:href=\"41597_2023_2850_MOESM7_ESM.pdf\"><caption><p>Supplemental files 2</p></caption></media>" ]
[{"label": ["1."], "mixed-citation": ["FAO.FAOstat. "], "italic": ["License: CC BY-NC-SA 3.0 IGO"], "ext-link": ["https://www.fao.org/faostat/"]}, {"label": ["2."], "mixed-citation": ["O\u2019Connor, A. Brewing and distilling in Scotland\u2013economic facts and figures. "], "italic": ["Scottish Parliament Information Centre"]}, {"label": ["4."], "mixed-citation": ["Fischbeck, G. in "], "italic": ["Developments in Plant Genetics and Breeding"]}, {"label": ["5."], "surname": ["Ortiz", "Nurminiemi", "Madsen", "Rognli", "Bj\u00f8rnstad"], "given-names": ["R", "M", "S", "OA", "\u00c5"], "article-title": ["Genetic gains in Nordic spring barley breeding over sixty years"], "source": ["Euphytica"], "year": ["2002"], "volume": ["126"], "fpage": ["283"], "lpage": ["289"], "pub-id": ["10.1023/A:1016302626527"]}, {"label": ["6."], "surname": ["Schuster"], "given-names": ["WH"], "article-title": ["Welchen Beitrag leistet die Pflanzenz\u00fcchtung zur Leistungssteigerung von Kulturpflanzenarten?"], "source": ["Pflanzenbauwissenschaften"], "year": ["1997"], "volume": ["1"], "fpage": ["9"], "lpage": ["18"]}, {"label": ["17."], "mixed-citation": ["Tondelli, A. "], "italic": ["et al", "The Plant Genome"], "bold": ["6"]}, {"label": ["19."], "mixed-citation": ["Thomas, W. "], "italic": ["et al"]}, {"label": ["20."], "surname": ["Russell"], "given-names": ["JR"], "article-title": ["A retrospective analysis of spring barley germplasm development from \u2018foundation genotypes\u2019 to currently successful cultivars"], "source": ["Molecular Breeding"], "year": ["2000"], "volume": ["6"], "fpage": ["553"], "lpage": ["568"], "pub-id": ["10.1023/A:1011372312962"]}, {"label": ["23."], "surname": ["Coulter"], "given-names": ["M"], "year": ["2022"], "data-title": ["BaRTv2: a highly resolved barley reference transcriptome for accurate transcript-specific RNA-seq quantification"], "source": ["Plant J"], "pub-id": ["10.1111/tpj.15871"]}, {"label": ["25."], "mixed-citation": ["R Core Team. (R Foundation for Statistical Computing, 2021)."]}, {"label": ["26."], "mixed-citation": ["Soneson, C., Love, M. & Robinson, M. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences [version 2; referees: 2 approved]. "], "italic": ["F1000Research"], "bold": ["4"]}, {"label": ["29."], "surname": ["Gu"], "given-names": ["Z"], "article-title": ["Complex heatmap visualization"], "source": ["iMeta"], "year": ["2022"], "volume": ["1"], "fpage": ["e43"], "pub-id": ["10.1002/imt2.43"]}, {"label": ["32."], "mixed-citation": ["Broad Institute. Picard tools. "], "italic": ["Broad Institute, GitHub repository"], "bold": ["Version 2.18.4"], "ext-link": ["http://broadinstitute.github.io/picard/"]}, {"label": ["34."], "mixed-citation": ["Garrison, E. M. G. Haplotype-based variant detection from short-read sequencing. "], "italic": ["ArXiv e-prints"], "bold": ["9"]}, {"label": ["36."], "mixed-citation": ["Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. 2011 "], "bold": ["17"]}, {"label": ["38."], "mixed-citation": ["Novocraft Technologies Sdn Bhd. Novosort. "], "bold": ["Version 3.06.05"], "ext-link": ["https://www.novocraft.com/products/novosort/"]}, {"label": ["40."], "mixed-citation": ["Danecek, P. "], "italic": ["et al", "Gigascience"], "bold": ["10"]}, {"label": ["42."], "mixed-citation": ["Swarts, K. "], "italic": ["et al", "The Plant Genome"], "bold": ["7"]}, {"label": ["45."], "surname": ["Alvarado"], "given-names": ["G"], "article-title": ["META-R: A software to analyze data from multi-environment plant breeding trials"], "source": ["The Crop Journal"], "year": ["2020"], "volume": ["8"], "fpage": ["745"], "lpage": ["756"], "pub-id": ["10.1016/j.cj.2020.03.010"]}, {"label": ["48."], "italic": ["ENA European Nucleotide Archive"], "ext-link": ["https://identifiers.org/ena.embl:PRJEB49069"]}, {"label": ["49."], "italic": ["ENA European Nucleotide Archive"], "ext-link": ["https://identifiers.org/ena.embl:PRJEB48903"]}, {"label": ["50."], "surname": ["Raubach"], "given-names": ["S"], "article-title": ["From bits to bites: Advancement of the Germinate platform to support prebreeding informatics for crop wild relatives"], "source": ["Crop Science"], "year": ["2021"], "volume": ["61"], "fpage": ["1538"], "lpage": ["1566"], "pub-id": ["10.1002/csc2.20248"]}, {"label": ["52."], "italic": ["EVA European Variation Archive"], "ext-link": ["https://identifiers.org/ebi/bioproject:PRJEB65875"]}, {"label": ["55."], "surname": ["Schreiber"], "given-names": ["M"], "year": ["2023"], "data-title": ["RNA-seq data from spikelet tissues of cultivated two-row European spring barley genotypes"], "source": ["ArrayExpress"], "pub-id": ["10.1101/2023.03.06.531259"]}, {"label": ["56."], "surname": ["Schreiber"], "given-names": ["M"], "year": ["2023"], "data-title": ["RNA-seq data from grain tissue of cultivated two-row European spring barley genotypes"], "source": ["ArrayExpress"], "pub-id": ["E-MTAB-13236"]}, {"label": ["57."], "surname": ["Schreiber"], "given-names": ["M"], "year": ["2023"], "data-title": ["RNA-seq data from root tissue of cultivated two-row European spring barley genotypes"], "source": ["ArrayExpress"], "pub-id": ["E-MTAB-13235"]}, {"label": ["58."], "surname": ["Schreiber"], "given-names": ["M"], "year": ["2023"], "data-title": ["RNA-seq data from crown tissue of cultivated two-row European spring barley genotypes"], "source": ["ArrayExpress"], "pub-id": ["E-MTAB-13234"]}, {"label": ["59."], "surname": ["Schreiber"], "given-names": ["M"], "year": ["2023"], "data-title": ["RNA-seq data from inflorescence tissue of cultivated two-row European spring barley genotypes"], "source": ["ArrayExpress"], "pub-id": ["E-MTAB-13233"]}, {"label": ["60."], "surname": ["Schreiber"], "given-names": ["M"], "year": ["2023"], "data-title": ["RNA-seq data from peduncle tissue of cultivated two-row European spring barley genotypes"], "source": ["ArrayExpress"], "pub-id": ["10.1101/2023.03.06.531259"]}, {"label": ["64."], "surname": ["Schreiber"], "given-names": ["M"], "year": ["2023"], "data-title": ["Data record for the genomic resources of cultivated European two-rowed spring barley genotypes"], "source": ["e!Dal"], "pub-id": ["10.5447/ipk/2023/15"]}]
{ "acronym": [], "definition": [] }
66
CC BY
no
2024-01-14 23:40:17
Sci Data. 2024 Jan 12; 11:66
oa_package/93/90/PMC10786862.tar.gz
PMC10786863
38216703
[ "<title>Introduction</title>", "<p id=\"Par2\">Precipitation significantly affects many sectors of society and the environment, and understanding it is crucial to addressing environmental, social, and economic issues. Accurately representing precipitation in numerical models is essential for assessing potential climate change impacts, including rainfed agriculture, water resource management, and hydroelectric power generation<sup>##UREF##0##1##–##UREF##4##5##</sup>.</p>", "<p id=\"Par3\">However, typical general circulation models (GCMs) with coarse resolution (60–300 km) cannot resolve the small-scale processes of convection or complex terrain features, which limits their ability to provide detailed information at regional and local scales. To address these limitations, downscaling techniques<sup>##UREF##5##6##–##UREF##9##10##</sup> have been developed over the years to bridge the gap between the climate scale at which synoptic climatology is studied and the scale necessary for regional or local assessment. One of these approaches is called dynamical downscaling; this involves using GCMs or reanalysis to provide the initial and lateral boundary conditions for regional climate models (RCMs). RCM simulations, conducted at high resolutions over specific regions, typically excel in resolving clouds, orography, coastal zones, land use/land cover effects, and local-scale circulations that are often beyond the capability of GCMs<sup>##UREF##10##11##–##UREF##16##17##</sup>.</p>", "<p id=\"Par4\">Increasing the horizontal resolution at which an RCM can explicitly resolve convection (~ 4 km; convection-permitting [CP] resolution) is becoming more common. At this resolution and finer, cumulus parameterizations can be switched off, enabling a large part of atmospheric deep convection to be explicitly resolved. Recent advances in computer capacity have led to more studies running RCM simulations at CP scales, and representations of precipitation have greatly improved across many regions<sup>##UREF##17##18##–##UREF##25##27##</sup>. In particular, several CP-scale RCM simulations have been conducted over the contiguous United States (CONUS) in recent years (e.g.,<sup>##UREF##23##25##–##UREF##25##27##</sup>), showing potential in accurately representing precipitation systems and processes and providing fine-scale climate datasets. However, these simulations were limited in geographic coverage and/or temporal length/resolution. As a result, they may not fully capture some high-impact weather events in which atmosphere–ocean interaction is important, such as tropical cyclones and atmospheric rivers. In addition, regions beyond the CONUS, such as Alaska and Puerto Rico, are underrepresented in both model simulations and observations; only a limited number of high-resolution gridded observation-based datasets are available for them (e.g.,<sup>##UREF##26##28##,##UREF##27##29##</sup>). Consequently, capacity to assess regional climate statistics, study long-term trends, explore local-dependent weather regimes, and provide valuable insights into climate extremes and risk assessments remains constrained.</p>", "<p id=\"Par5\">Our study builds on previous efforts in order to produce an hourly dataset spanning a 20-year period (2001–2020) at the CP scale. Specifically, our simulation domain covers nearly all of North America and a large portion of the North Atlantic and Eastern North Pacific Oceans, including Alaska, Mexico, and neighboring Caribbean islands, such as Puerto Rico (Fig. ##FIG##0##1##a). Note that we use a series of 14-month runs with 20 reinitializations rather than a continuous run (see Methods section for details). This new dataset is referred to as Argonne Dynamic Downscaled Achieve V2 (ADDA_V2).</p>", "<p id=\"Par6\">It is important to include all these regions because climate change manifests differently across geographic areas. For example, Alaska has experienced a warming trend over the past decades that is more than twice as rapid as that over the CONUS<sup>##UREF##28##30##</sup>. Puerto Rico exhibits vast spatial variability, particularly in multi-decadal precipitation trends across the island, which may be due to its complex terrain and heterogeneity<sup>##UREF##29##31##</sup>. Furthermore, our extended coverage of the North Atlantic and Eastern North Pacific ocean basins will enable researchers to study high-impact weather systems and phenomena, including atmospheric rivers, tropical and extratropical cyclones, and precipitation associated with moisture transport from the Gulf of Mexico.</p>", "<p id=\"Par7\">The objective of this study is to evaluate the performance of an RCM explicitly resolving convection at a very high resolution (4 km) in simulating precipitation characteristics, including mean and 95th percentile precipitation, and climate extreme indices (Table ##TAB##0##1##). This study also examines the multi-decadal CP simulation’s ability to represent diurnal precipitation patterns and associated convective processes through hourly mean precipitation (e.g., intensity, duration, timing, downstream propagation). Throughout the investigation, we explore the model bias compared to high-resolution gridded observations, such as PRISM and Daymet. We also highlight the potential added value (AV) of CP simulation compared to its driving data (European Centre for Medium-Range Forecast Reanalysis v5 [ERA5] reanalysis<sup>##UREF##30##32##</sup>) over the CONUS, Alaska, and Puerto Rico. This analysis provides valuable insights for qualitatively evaluating model performance and detecting model biases when compared to its forcing data (ERA5) and observations. It helps identify regions, seasons, and variables where the model excels, enabling users to make informed decisions about when and where to rely on the model’s output.</p>" ]
[ "<title>Methods</title>", "<title>Model description</title>", "<p id=\"Par43\">In this study, we used the Weather and Research Forecasting (WRF) version 4.2.1<sup>##UREF##48##50##</sup> to examine a single domain of 2050 × 1750 horizontal grid points (8200 km × 7000 km) at 4-km grid spacing. This domain has more than 1.79 million grid cells, which cover almost all of North America and the Caribbean islands, including Puerto Rico (Fig. ##FIG##0##1##a). In the vertical, 50 unevenly spaced σ levels from the surface up to 50 hPa with 18 σ levels below 1 km and approximately 200 m resolution in the upper troposphere<sup>##UREF##49##51##</sup>. The model featured explicit convection, the Morrison microphysics<sup>##UREF##50##52##</sup>, the Yonsei University (YSU) planetary boundary layer<sup>##UREF##51##53##</sup>, the rapid radiative transfer model (RRTMG<sup>##UREF##52##54##</sup>) for long and short wave radiations, and the Unified Noah land-surface model<sup>##UREF##53##55##</sup>. Single-domain model simulations were integrated with output saved every 1 h.</p>", "<p id=\"Par44\">We did not employ any convective parameterization, because previous studies have documented that clouds and deep convection can be reasonably resolved at a spatial resolution of 4 km or higher (e.g.,<sup>##UREF##23##25##,##UREF##54##56##–##UREF##57##59##</sup>). The initial and lateral boundary conditions are specified by the European Centre for Medium-Range Weather Forecast reanalysis product (ERA5<sup>##UREF##30##32##</sup>) for a period from 2001 to 2020. We use five variables at 37 pressure levels (i.e., geopotential, temperature, meridional and zonal wind vectors, relative humidity) and 26 single-level variables (e.g., 2-m temperature, 10-m meridional and zonal wind vectors, surface pressure), as outlined in Table ##SUPPL##0##S1##, to provide initial and lateral boundary conditions. The ocean and lake temperatures were prescribed to be the same as the ERA5, and updated every 6 h. The one-dimensional lake model available in WRF was not implemented in this study.</p>", "<p id=\"Par45\">In accordance with prior studies<sup>##UREF##14##15##,##UREF##58##60##–##UREF##61##63##</sup>, a series of 14-month runs with 20 reinitializations were performed. That is, rather than running the simulations continuously for 20 years, the model is initialized on November 1st of the previous year and is continued all the way to the end of the current year. The applicability of reinitialization in long-term simulations is discussed in more detail in the supplementary information.</p>", "<p id=\"Par46\">To minimize imbalances and adjustment issues that arise from the reinitialization of each year, a 2-month spin-up period (November and December) is excluded from analysis in this study. No internal grid nudging or spectral nudging technique is applied, so that the model can develop its own variability (e.g., spatial and internal variability) across the domain. The output data includes hourly variables near the surface and in vertical profiles of the most frequently used variables (e.g., temperature, winds, moisture, pressure, precipitation, and geopotential). Other variables that are used less often, based on our previous experience, are output every 3 h.</p>", "<p id=\"Par47\">The simulations were performed at the Argonne Leadership Computing Facility (ALCF) on the Theta cluster, using the computational power of 64-core, 1.3-GHz Intel Xeon Phi 7230 processors. The simulations required a total of 500,000 node hours and 6400 h of wall clock time to complete the 20-year simulation. This extensive simulation generated approximately 1.7 petabytes of data, which are stored in the ALCF’s high-performance storage system.</p>", "<title>Datasets for evaluation</title>", "<p id=\"Par48\">The simulation was evaluated by focusing on comparing the CONUS, Alaska, and Puerto Rico against the high-resolution (4 km, daily) observation-based gridded dataset PRISM<sup>##UREF##31##33##</sup>; the National Centers for Environmental Prediction (NCEP) Stage IV hourly radar-gauge based precipitation product<sup>##UREF##62##64##</sup>; Daily Surface Weather Data on a 1-km Grid for North America, Version 4 (Daymet<sup>##UREF##32##34##</sup>); and the simulation’s forcing data, ERA 5 reanalysis<sup>##UREF##30##32##</sup>.</p>", "<p id=\"Par49\">Daily aggregates of PRISM, Daymet, and ERA5 daily precipitation from 2001 to 2020 were used to compute the precipitation mean and extreme indices, including annual and seasonal (i.e., winter: December–January–February, DJF; spring: March–April–May, MAM; summer: June–July–August, JJA; fall: September–October–November, SON) mean values, the 95th percentile of precipitation, and three extreme indices defined by the Expert Team on Climate Change Detection and Indices (ETCCDI, Table ##TAB##0##1##). The ETCCDI includes CDDs, very heavy rainfall days (R20mm), and RX5day.</p>", "<p id=\"Par50\">The process of creating the averages involved calculating the 95th percentile precipitation and three extreme indices for each individual year. Then, we computed their averages over the 20-year period. All the temporal averages were computed using the native resolution of each dataset.</p>", "<p id=\"Par51\">NCEP Stage IV hourly data (mm hr<sup>−1</sup>) for the summer (i.e., June–August) from 2002 to 2020 were used to validate model–observation discrepancies in the diurnal pattern of precipitation and examine the intensity and propagation of convective systems that are initiated on the complex terrain of the Rocky Mountains. Note that NCEP Stage IV is available starting from 2002, and has issues over regions west of 114°W, according to Chang et al.<sup>##UREF##63##65##</sup> and Nelson et al.<sup>##UREF##64##66##</sup> Therefore, we only looked at regions east of 114°W for validation of diurnal pattern. For direct comparison between the 4-km simulation, PRISM, and ERA5, all the calculated statistics were regridded to a 0.25° × 0.25° resolution (the lowest ERA5 reanalysis resolution) by using bilinear interpolation. Despite aggregating high-resolution data to coarse resolution to match the reanalysis data, the high-resolution data still exhibit superior performance in capturing spatial features, compared to the low-resolution data (e.g.,<sup>##UREF##65##67##</sup>). Therefore, this method enables us to make a fair comparison between the three datasets, ADDA_V2, PRISM_4km, and ERA5_30km.</p>", "<title>Metrics for evaluation</title>", "<p id=\"Par52\">The performance of ADDA_V2 is quantified based on a suit of statistical metrics presented below. It includes RMSE and pattern correlation coefficient (PCC), respectively:where and are model and observation data at each point. and are model and observation means, respectively. The n represents the number of observations.</p>", "<p id=\"Par53\">The model evaluation focuses on mean and 95th percentile precipitation and their spatial variabilities and magnitude over each grid cell. These later two aspects are important because even data with low spatial resolution can produce small RMSE with very smooth spatial patterns. High-spatial-resolution data, however, can produce high spatial variabilities that need to be measured in ways other than RMSE. Following Hirota et al.<sup>##UREF##66##68##</sup>, TSS<sup>##UREF##67##69##</sup> was computed to evaluate the performance of the 4-km simulation in annual and seasonal mean precipitation over the CONUS. The skill score is defined as:where PCC indicates the pattern correlation coefficient between the models and reference data and SDR is the ratio of the spatial standard deviations of the models against that of reference data. Therefore, this score measures how closely the spatial pattern and amplitude of the model match those of the observation. A score of 1 indicates a perfect match between the model and observation, while a value of 0 represents no skill in the model. The score is computed based on the PCC and SDR of the seasonal mean over the CONUS. RMSE, PCC, and the AV approach are also used to assess the performance of the 4-km simulation. The AV approach proposed by Di Luca et al.<sup>##UREF##68##70##</sup> is designed to quantify the downscaled output performance compared with its coarse forcing data (ERA5). The AV is defined here according to Dosio et al.<sup>##UREF##69##71##</sup> and Akinsanola and Zhou<sup>##UREF##70##72##</sup>:where <italic>X</italic><sub>ERA5</sub>, <italic>X</italic><sub>OBS</sub>, and <italic>X</italic><sub>ADDA_V2</sub> indicate values from ERA5 (forcing data), observation (PRISM/Daymet), and ADDA_V2. The value falls within the range of − 1 to 1, based on prior work<sup>##UREF##68##70##</sup> and is computed on every grid cell. AV becomes positive when the squared error of the 4-km simulation is smaller than that of the corresponding ERA5 reanalysis, indicating that the 4-km model generates results that are closer to the observations compared to ERA5. AV indicates the percentage of grid cells that show improvement out of the total grid cells.</p>" ]
[ "<title>Results</title>", "<title>Seasonal mean daily precipitation</title>", "<p id=\"Par8\">We evaluated the ability of ADDA_V2, driven by ERA5 reanalysis, to reproduce seasonal mean daily precipitation over the CONUS, Alaska, and Puerto Rico (see Fig. ##FIG##1##2##). Precipitation simulated by ADDA_V2 over the CONUS is evaluated with PRISM<sup>##UREF##31##33##</sup> (Precipitation-Elevation Regressions on Independent Slopes Model); that over Alaska and Puerto Rico is evaluated using Daymet V4<sup>##UREF##32##34##</sup> (Daily Meteorological Surface Data).</p>", "<p id=\"Par9\">During winter over the CONUS (Fig. ##FIG##1##2##b), the maximum (minimum) precipitation occurs in the northwestern and southeastern CONUS (the northern and southern Great Plains). An intense precipitation center in the northwest decreases significantly during the transition to spring (Fig. ##FIG##1##2##b,f), and there is evidence of the northward advancement of the precipitation band from the southeast.</p>", "<p id=\"Par10\">In summer (Fig. ##FIG##1##2##j), the eastern half of the CONUS experiences high precipitation (&gt; 4 mm day<sup>−1</sup>). Maximum precipitation occurs over Florida and the Gulf Coast, while both the northwest and southwest are dry (&lt; 1 mm day<sup>−1</sup>). Intense precipitation occurs in the northwest in the fall (Fig. ##FIG##1##2##n), with moderate precipitation in the southeast.</p>", "<p id=\"Par11\">Over Alaska, seasonal precipitation generally exhibits a north–south gradient, with pronounced precipitation peaks during fall and winter over southern Alaska. Similarly, Puerto Rico exhibits a meridional gradient of precipitation that is strongly related to regional orography. During winter, the entire island experiences significantly drier conditions compared to other seasons; fall is its wettest season.</p>", "<p id=\"Par12\">ERA5 reanalysis (Fig. ##FIG##1##2##d,h,l,p) does a relatively good job capturing the spatial distribution of seasonal mean daily precipitation observed in PRISM and Daymet; however, there is a pronounced bias across the three regions (i.e., CONUS, Alaska, Puerto Rico). Specifically, over the CONUS, it underestimates summer precipitation in the eastern half, showing a maximum dry bias of − 3.2 mm day<sup>−1</sup> on the West Coast of Florida. It slightly overestimates winter and spring precipitation over the northern Great Plains, Midwest, and parts of the Northeast while underestimation is prevalent in the Southeast and West Coast. However, the bias is relatively low in fall (Fig. ##FIG##1##2##m–p). ERA5 grossly overestimates daily precipitation across all seasons in most of Alaska, with up to 38.1% more spatial-averaged rain in MAM; the overestimation is particularly pronounced in southern Alaska. Furthermore, in Puerto Rico, ERA5 is not capable of capturing details in orographic rainfall due to its coarse resolution; it significantly underestimates daily precipitation over all of Puerto Rico across all seasons, with a maximum spatial-averaged seasonal mean rain deficiency of 50.5% observed during DJF. ADDA_V2 (Figs. ##FIG##1##2##; first and third row) generally does a better job representing high-precipitation centers in most seasons across the three regions. This improvement, compared with ERA5, is particularly evident in the hatched areas across all seasons in the top row of Figs. ##FIG##1##2## and ##FIG##2##3##. However, ADDA_V2 overestimates (underestimates) CONUS winter and summer precipitation over the northern and southern Great Plains, as well as spring precipitation over the northwestern and northeastern (fall precipitation over the southwestern) CONUS. These biases in ADDA_V2 are sometimes larger than those in ERA5 (for example, fall in the Southeast and summer in the Rockies). Nevertheless, based on AV analysis, ADDA_V2 shows improvement compared to ERA5 (Fig. ##FIG##1##2##a,e,i,m); hatched areas, indicating grid points with value added by dynamical downscaling, cover 46.9%, 48.2%, 46.7%, and 43.0% of all grid points in the CONUS in winter, spring, summer, and fall, respectively.</p>", "<p id=\"Par13\">Over Alaska, ADDA_V2 captures pronounced peaks in seasonal precipitation, primarily in southern Alaska, better than ERA5 (Fig. ##FIG##1##2##a,e,i,m; hatched areas). In addition, ADDA_V2 mostly alleviates the biases evident across all seasons in ERA5, which improves representations of daily precipitation; AVs are 24.1%, 55.1%, 68.8%, and 42.4% across all grid points during winter, spring, summer, and fall, respectively.</p>", "<p id=\"Par14\">Similar improvements by ADDA_V2 over the driving ERA5 are also evident over Puerto Rico. Although ADDA_V2 notably overestimates (underestimates) in the western (eastern) side of the island, it considerably mitigates the biases observed in ERA5 across all seasons in the region. There, AVs are 55.3%, 61.8%, 51.7%, and 75.1% during the winter, spring, summer, and fall, respectively (Fig. ##FIG##1##2##a,e,i,m).</p>", "<p id=\"Par15\">Table ##TAB##1##2## shows additional information on how ADDA_V2 performs compared to ERA5 and observations. Over the CONUS, the Taylor Skill Score (TSS) during winter, spring, summer, and fall is 0.951, 0.977, 0.972, and 0.968 for ERA5 and 0.995, 0.999, 0.995, and 0.986 for ADDA_V2. In Alaska, ADDA_V2 outperforms ERA5 in all seasons except winter. Conversely, ADDA_V2 exhibits lower scores than ERA5 in all seasons except winter in Puerto Rico.</p>", "<p id=\"Par16\">As described in the Methods section, TSS depends upon spatial standard deviations. An overestimate of precipitation heterogeneity in ADDA_V2, possibly due to high spatial resolution, can result in higher spatial variabilities and lower TSS scores, even though ADDA_V2 demonstrates AV in many regions compared with ERA5.</p>", "<p id=\"Par17\">In the CONUS, there are relatively large biases over the West Coast and Cascade Mountains during fall–spring, and the Southeast in the summer. However, ADDA_V2’s AV in those regions suggests it better represents mean daily precipitation over its forcing data. Compared to ERA5 reanalysis, ADDA_V2 better represents the location and intensity of the fall–spring heavy precipitation along the western coastline of the CONUS and over the Cascade and Sierra Nevada Mountains (Figs. ##FIG##1##2## and ##SUPPL##0##S1##). This improvement could be due to ADDA_V2’s ability to realistically resolve orography and orographically driven precipitation (more detailed discussions are provided in the supplementary information).</p>", "<p id=\"Par18\">A noticeable dipole pattern of precipitation biases (i.e., a wet bias in the eastern Rocky Mountains and a dry bias in the central CONUS) is presented in Liu et al.<sup>##UREF##23##25##</sup> is not present in summer and fall in our simulation. This is likely due to our simulation’s enhancements in realistically representing mountainous convection and the eastward propagation of associated systems. This, in turn, improves precipitation modeled in downstream regions, such as central and midwestern CONUS. This hypothesis is further discussed later in “Diurnal cycle of summer mean over the CONUS.”</p>", "<p id=\"Par19\">Furthermore, ADDA_V2 better represents summer precipitation in the Southeast, particularly in Florida (Fig. ##FIG##1##2##i). Prior studies emphasized the significance of local environmental conditions and processes in summer total precipitation (e.g., sea-breeze in mesoscale convective systems and isolated storm development in the Southeast<sup>##UREF##33##35##,##UREF##34##36##</sup>). Florida experiences the most intense summer precipitation in the CONUS due to a distinctive process known as “cumulus-merger,”<sup>##UREF##35##37##</sup> which is caused by its unique geographical location—surrounded by the ocean on three sides. During summer, peak precipitation occurs in the afternoon due to cumulus-merger (the convergence of sea breezes from the east and west coasts of the peninsula), causing strong convection over the peninsula. The improved representation of summer precipitation in Florida might be due to an enhanced representation of such local circulations. This process is further discussed in more detail in “Diurnal cycle of summer mean precipitation over the CONUS.”</p>", "<p id=\"Par20\">For a more comprehensive examination, we used the probability density function to assess the precipitation distribution over the CONUS, Alaska, and Puerto Rico (Fig. ##FIG##2##3##) and the seven CONUS subregions (see Figs. ##FIG##0##1##b and ##SUPPL##0##S2##). ADDA_V2 generally outperforms the ERA5 reanalysis, better capturing the overall distribution of mean daily precipitation (Fig. ##FIG##2##3## and Table ##SUPPL##0##S2##). In particular, for the CONUS, ADDA_V2 reasonably captures two observed distinct precipitation peaks in spring and fall. Table ##SUPPL##0##S2## demonstrates its superior performance in statistics, including average and variance, although ERA5 exhibits better skewness during these seasons. ADDA_V2 also better represents precipitation in intense ranges during winter. During summer, PRISM shows a more spread-out distribution of precipitation over the CONUS. ADDA_V2 not only simulates this distribution relatively well, but also better captures the intensity of summer precipitation compared to ERA5 reanalysis, which is displayed in statistics (Table ##SUPPL##0##S2##). This improvement is particularly notable in regions with intense precipitation, such as the Southeast (Figure S2; JJA mean in the Southeast). There are also important discrepancies between ADDA_V2 and observations. For example, ADDA_V2 overestimates daily precipitation across all intensity levels, leading to a distribution shift toward more intense ranges in the Northeast in winter and spring (see Figure S2 and associated discussion). Conversely, ADDA_V2 underestimates precipitation, causing a bias toward moderate-to-low precipitation in the Southeast in spring (see Figure S2 and associated discussion). Over Alaska, ADDA_V2 is comparable to ERA5 across all seasons; both are similar to Daymet observations, although ERA5 exhibits overall better performance in winter, while ADDA_V2 is closer to observations in summer (Fig. ##FIG##2##3##e–h and Table ##SUPPL##0##S2##). In Puerto Rico, ADDA_V2 tends to overestimate both intense and light precipitation, showing larger variances than Daymet (Fig. ##FIG##2##3##h–k and Table ##SUPPL##0##S2##). This likely results in a noticeable contrasting bias on the western and eastern sides of the island across all seasons, as described above (Fig. ##FIG##1##2##c,g,k,o). This contrasting bias is likely attributed to an overestimation of orographic uplift associated with local circulation, such as sea-breeze trade wind convergence in western Puerto Rico, and an underestimation of trade wind driven orographic lift in the eastern portion<sup>##UREF##36##38##</sup>. Nevertheless, ADDA_V2 demonstrates superior performance over ERA5, especially in capturing topographic effects on precipitation; the northern two-thirds of the island is wetter than the southern portion<sup>##UREF##36##38##,##UREF##37##39##</sup>. ERA5, hindered by its coarse resolution, faces limitations in representing such intricate features compared to observation, leading to considerably narrower variances (Table ##SUPPL##0##S2##).</p>", "<title>Diurnal cycle of summer mean precipitation over the CONUS</title>", "<p id=\"Par21\">Recent studies have shown promising advances in representing the diurnal cycle of precipitation by explicitly resolving convection at CP resolution, providing notable AV over GCMs and convection-parameterized RCMs (e.g.,<sup>##UREF##13##14##,##UREF##38##40##,##UREF##39##41##</sup>). Here we focus on the June–August period because the diurnal pattern of precipitation is typically more pronounced during summer, and it can reflect the propagation of convective systems. For example, prior modeling studies documented that the failure of convection-parameterization can cause early onset of convection, increasing bias in timing and intensity of precipitation in the mid-to-late afternoon (e.g.,<sup>##UREF##40##42##</sup>).</p>", "<p id=\"Par22\">Figure ##FIG##3##4## illustrates the summer mean diurnal cycle of hourly accumulated precipitation over the fourth National Climate Assessment CONUS subregions, as presented in Fig. ##FIG##0##1##b for ADDA_V2, compared to ERA5 reanalysis and NCEP Stage IV analysis (Stage IV hereafter). Here, we excluded the Northwest and Southwest due to a known issue in Stage IV in these regions (see “<xref rid=\"Sec9\" ref-type=\"sec\">Datasets for evaluation</xref>” for more details). ADDA_V2 outperforms its forcing data (ERA5) over all subregions in terms of temporal pattern correlation and root mean square error (RMSE) of the precipitation diurnal cycle (Fig. ##FIG##3##4##; Table ##TAB##2##3##) because it reasonably captures the timing and variation of mid-to-late afternoon precipitation (local time) in all five subregions, compared to Stage IV. However, note that the ADDA_V2 tends to overestimate overall afternoon precipitation, especially over complex terrains (Fig. ##FIG##3##4##), indicating the model may overestimate the duration and intensity of precipitation events.</p>", "<p id=\"Par23\">We further examine the process underlying ADDA_V2’s improved representation of summer precipitation by using the Hovmöller diagram (Fig. ##FIG##4##5##) and spatial diurnal cycle distribution (Fig. ##FIG##5##6##). Our focus extends from the Rocky Mountains and the Great Plains to the East Coast (zonally averaged area between 38 and 42N) in the Hovmöller diagram and encompasses the Southeast where ADDA_V2 outperforms ERA5 in summer precipitation in the spatial diurnal cycle distribution. As previously discussed, ADDA_V2 adds value in summer precipitation compared to ERA5 reanalysis, especially in the eastern half of the CONUS (Fig. ##FIG##1##2##i, hatched areas). ERA5 reanalysis broadly underestimates summer precipitation in the central and eastern CONUS, while a wet bias is obvious in the eastern Rocky Mountains (Fig. ##FIG##1##2##l). This suggests that there may be stationary mountain-generated convection that dissipates near its origin, often failing to form mesoscale convective systems that propagate off the Rocky Mountains to areas such as the Great Plains (e.g.,<sup>##UREF##23##25##,##UREF##41##43##</sup>).</p>", "<p id=\"Par24\">To test this hypothesis, we use the Hovmöller diagram of the diurnal cycle of summer mean precipitation averaged between 38 and 42N in June–August 2002–2020 (Fig. ##FIG##4##5##). Figure ##FIG##4##5## clearly depicts how different summer convective systems are presented in ADDA_V2 and ERA reanalysis. As we hypothesized, in ERA5 reanalysis, there is strong stationary mountainous convection organized over the Rocky Mountains in the late afternoon (local time ; Fig. ##FIG##4##5##c, black dashed box). The system fails to propagate downstream due to early dissipation near its origin. This causes precipitation to be underestimated overall downstream, as we discussed (Fig. ##FIG##4##5##c). Near the Appalachian plateau (876W), ERA5 reanalysis reveals early onset and dissipation of relatively intense precipitation (&gt; 0.14 mm day<sup>−1</sup>) around 13 and 02 UTC, respectively (Fig. ##FIG##4##5##c, red dashed boxes). These timings are approximately 3 h earlier than in Stage IV and ADDA_V2.</p>", "<p id=\"Par25\">ADDA_V2 better represents the eastward propagation of mountainous convection that originates over the Rockies. This improves simulations of precipitation in downstream regions. In addition, ADDA_V2 captures the onset and dissipation of relatively intense precipitation (&gt; 0.14 mm day<sup>−1</sup>) around 16 and 05 UTC, respectively, in the Appalachian plateau; these timings closely align with the observation from Stage IV despite an overestimation of peak intensity (Fig. ##FIG##4##5##a,b, red dashed boxes). ADDA_V2 also realistically simulates the suppression of convection over the Great Plains (10498W) from afternoon to early evening (local time: 16–21 UTC). This suppression is likely caused by the downward return flow of the upslope wind in the upstream Rockies.</p>", "<p id=\"Par26\">Tian et al.<sup>##UREF##42##44##</sup> argued that the suppression of afternoon convection combines with the nighttime arrival of eastward-migrating convective storms generated the previous afternoon over the Rocky Mountains to produce precipitation that reaches its maxima near midnight over the Great Plains. This phenomenon is clearly illustrated in Figs. ##FIG##3##4##d and ##FIG##4##5##a. Specifically, over the Great Plains, diurnal precipitation peaks occur during late night and early morning hours, around 03–10 UTC.</p>", "<p id=\"Par27\">As discussed, ADDA_V2 captures both the suppression of afternoon convection and the eastward propagation of the mountainous convective system better than the ERA5 reanalysis. However, the simulated mountainous convective system greatly decreases in intensity as it migrates east, which produces biases in downstream regions such as the northern Great Plains and Midwest. This early weakening of the system may contribute to early peaks in the simulated diurnal precipitation over the northern and southern Great Plains, as depicted in Fig. ##FIG##3##4##d–e. These findings suggest that topography and its associated impact on weather systems play a significant role in modulating the diurnal cycle of precipitation in these regions.</p>", "<p id=\"Par28\">ADDA_V2 also shows a tendency to produce overly intense daily precipitation over complex terrains, such as the Rocky Mountains (104106W) and Appalachian plateau (8176W), which causes the maximum diurnal precipitation in the Northeast to be overestimated (Figs. ##FIG##3##4##b and ##FIG##4##5##b). This could be due to several factors, such as observational uncertainties (e.g.,<sup>##UREF##43##45##,##UREF##44##46##</sup>) or the limitations of our simulation’s horizontal grid spacing, which may not be fine enough to accurately capture the heterogeneity of the complex terrains. It may also depend on the representation of atmosphere–groundwater coupling, which plays an important role in evapotransportation and thus precipitation, as noted in Barlage et al.<sup>##UREF##45##47##</sup>.</p>", "<p id=\"Par29\">On the other hand, in the coastal area of the Southeast, a robust diurnal cycle is present and is associated with local circulation (i.e., sea-breeze, resulting in a strong diurnal pattern of precipitation during summer). The diurnal precipitation distribution is presented in Fig. ##FIG##5##6##; ADDA_V2, Stage IV, and ERA5 all show the afternoon intensification of precipitation and its nighttime dissipation in regions such as Florida, the Gulf Coast, and the East Coast. However, when we focus on Florida alone, ERA5 reanalysis does not accurately depict the timing of precipitation dissipation (Fig. ##FIG##5##6##). More specifically, intense precipitation (&gt; 0.4 mm/hr) is absent from the Florida peninsula during the late evening hours (19–22 LDT); however, both ADDA_V2 and Stage-IV capture this distinctive feature well (Fig. ##FIG##5##6##a,i,q). This finding suggests that ADDA_V2 reasonably represents local circulation and subsequent physical processes (e.g., sea-breeze convergence, cumulus-merger) taking place in the Florida peninsula, which leads to an enhancement in representing precipitation in the region over its forcing data (ERA5).</p>", "<title>The 95<sup>th</sup> percentile and extreme precipitation</title>", "<p id=\"Par30\">To evaluate the model’s ability to capture intense precipitation, we investigate the 95th percentile of daily precipitation across all seasons. Results are presented in Fig. ##FIG##6##7##. Similar to the distribution of seasonal mean daily precipitation, the heaviest 95<sup>th</sup> percentile precipitation is concentrated in the Southeast and Pacific Northwest CONUS, and southern Alaska. Mountainous areas spanning the middle of Puerto Rico also exhibit this pattern, which varies by season, as presented in Fig. ##FIG##6##7## (second row).</p>", "<p id=\"Par31\">Over the CONUS, both ERA5 (Fig. ##FIG##6##7##; fourth row) and ADDA_V2 (Fig. ##FIG##6##7##; first and third rows) capture the spatial pattern of 95th percentile precipitation. However, they both underestimate precipitation in many parts of the Southeast, West Coast, and Central United States compared to observations across all seasons. PRISM indicates that the magnitude of 95th percentile precipitation in the spring and fall is considerably lower than that in the winter; ADDA_V2 reproduces these spatial distributions, with improvements observed in hatched areas as depicted in Fig. ##FIG##6##7##a,e,m. There, AVs are 42.8%, 50.5%, and 48.4% for fall, spring, and winter, respectively. In summer, intense 95th percentile precipitation centers dominate the southeastern CONUS, especially along the coastlines. No intense precipitation centers are visible in the Northwest or Southwest in PRISM. Compared to ERA5 reanalysis, which considerably underestimates 95<sup>th</sup> percentile precipitation with a spatial-averaged absolute bias of 4.66 mm day<sup>−1</sup> over the Southeast, ADDA_V2 markedly reduces this bias in this region, yielding a spatial-averaged absolute bias of 0.67 mm day<sup>−1</sup>. Over Puerto Rico, ERA5 (ADDA_V2) grossly underestimated (overestimated) 95th percentile precipitation over the entire island (western half of the island) throughout all seasons. The bias exceeded ± 12 mm day<sup>−1</sup>, with a maximum dry bias of 65.4% and wet bias of 26.3% in ERA5 and ADDA_V2, respectively (Fig. ##FIG##6##7##, third and fourth rows). Over Alaska, the representation of 95th percentile precipitation by ERA5 and ADDA_V2 is quite robust; however, there is still a notable bias that is spatially consistent in both datasets. For instance, both ERA5 and ADDA_V2 overestimate 95th percentile precipitation over the southern coast of Alaska, with the bias more pronounced in the winter (11.9% overestimation for ERA5 and 27.8% for ADDA_V2) and fall (15.4% overestimation for ERA5 and 15.2% for ADDA_V2). Nevertheless, based on AV analysis, ADDA_V2 improves noticeably over the driving ERA5 in many grid points across all seasons in all three regions: up to 53.8%, 57.2%, and 85.6% of the total grid points in the CONUS, Alaska, and Puerto Rico, respectively.</p>", "<p id=\"Par32\">However, note that ERA5 performance is better than ADDA_V2 over some grid points or regions. The improved representation of summer heavy precipitation by ADDA_V2, especially over the southeastern CONUS, may be due to improved simulation of local circulations and their associated processes, as discussed in “Summer mean diurnal precipitation over the CONUS,” above. This result may provide insights for further research in the field; improving heavy precipitation in climate models is crucial for effective flood management and water resource planning.</p>", "<p id=\"Par33\">In addition, we evaluate the spatial distribution of the three extreme indices: annual mean consecutive dry days (CDDs, number of consecutive days with precipitation &lt; 1 mm), maximum five-consecutive-day precipitation (RX5day), and very heavy precipitation days (R20mm) defined in Table ##TAB##0##1##. Results are presented in Fig. ##FIG##7##8##. These indices have been extensively used to indirectly assess the potential occurrence of drought and flood events in many regions.</p>", "<p id=\"Par34\">Over the CONUS, as in observations, the Southwest has the most CDDs (&gt; 140 per year) and the Northeast and Midwest have the fewest CDDs (&lt; 20 per year) (Fig. ##FIG##7##8##b). Over Alaska, the minimum (maximum) CDD occurs over the southern part (northern part) of the state. Values range from 10 to 100 days. In Puerto Rico, most regions experience fewer than 20 CDDs, and southwestern areas have 30–40 dry days.</p>", "<p id=\"Par35\">Relative to the observations, the ADDA_V2 realistically reproduces the spatial pattern of CDDs. It captures regions of maximum and minimum values across all three regions, although a noticeable bias still exists. For instance, ADDA_V2 underestimated CDD over most of Alaska, northern and western/southwestern Puerto Rico, and southwestern CONUS (Fig. ##FIG##7##8##a,c). This indicates that it produces more wet days, consistent with the wet bias over these regions.</p>", "<p id=\"Par36\">However, in comparison to ERA5 reanalysis (Fig. ##FIG##7##8##d), ADDA_V2 improves slightly by reducing the spatial bias over several grid points. This improvement is clearly evident in the hatched areas in Fig. ##FIG##7##8##a, primarily across the northern and southern Great Plains, southwestern CONUS, wide areas of Alaska (excluding the middle region), and Puerto Rico (except the western part of the island). ADDA_V2 demonstrates improvement over about 60.0% of all grid points in the CONUS, 66.8% in Alaska, and 74.1% in Puerto Rico (Fig. ##FIG##7##8##a).</p>", "<p id=\"Par37\">For the RX5day, the maximum center seen in the observations primarily occurs over the southeastern and northwestern CONUS, mountainous areas in the middle and northeastern part of Puerto Rico, and southern parts of Alaska, with values reaching 240 mm (Fig. ##FIG##7##8##f). In contrast, the state of Nevada, western Puerto Rico, and northern Alaska experience the minimum values, which do not exceed 100 mm. Relative to observations, ERA5 reanalysis (Fig. ##FIG##7##8##h) captures the spatial pattern over CONUS and Alaska. However, the magnitude is considerably lower in the eastern half of the CONUS, resulting in a pronounced underestimation over the Southeast, the West Coast, and the Cascade and Sierra-Nevada Mountains. Similarly, ERA5 grossly underestimates RX5day, with a spatial-averaged bias of 45.2% over the entire region of Puerto Rico. ADDA_V2, on the other hand (Fig. ##FIG##7##8##e,g), reasonably captures the observed pattern. However, it tends to overestimate RX5day in the Northeast, Cascade Mountains, western parts of the southern Great Plains by up to 21.3% in the regions, and most of Puerto Rico with a spatial-average bias of 24.6% across the island; it underestimates RX5day along the West Coast and Gulf Coast near Texas and Louisiana. Nevertheless, ADDA_V2 demonstrates improvement over about 49% of all grid points in the CONUS, 51.2% in Alaska, and 80.8% in Puerto Rico (Fig. ##FIG##7##8##e).</p>", "<p id=\"Par38\">Over the CONUS, the R20mm is greatest (smallest) over the Southeast, the West Coast, and the Cascade Mountains (the western half of the United States); values reach 25 days or more per year (Fig. ##FIG##7##8##j). Heavy R20mm is most frequent over southern coastal Alaska, central parts of the western half of Puerto Rico, and Fajardo (Fig. ##FIG##6##7##j). ERA5 reanalysis reproduces the observed distribution of R20mm over the CONUS and Alaska (Fig. ##FIG##7##8##l), but it significantly underestimates the magnitude of R20mm over the northwestern and southeastern CONUS and overestimates it over coastal Alaska. Similar to daily mean precipitation and RX5day, ERA5 grossly underestimates R20mm over all of Puerto Rico, with a spatial-average bias of 43.2% across the island. ADDA_V2, on the other hand, shows lower bias in R20mm over central Puerto Rico, the northern and southern Great Plans, and central-northern Alaska (Fig. ##FIG##7##8##i,k). However, ADDA_V2 grossly overestimates R20mm by 40.2% over the western half of Puerto Rico and underestimates it by 43.8% over the eastern half. Overall, ADDA_V2 improves on the ERA5 results across more than 44.7% of all grid points in the CONUS (mostly over the western half and East Coast), 53.4% in Alaska, and 93.2% in Puerto Rico.</p>" ]
[]
[ "<title>Summary and conclusions</title>", "<p id=\"Par39\">In this study, we assess a 20-year dynamically downscaled climate simulation at 4-km CP resolution across the CONUS, Alaska, and Puerto Rico. We evaluate its performance in representing mean and heavy precipitation characteristics across time scales in these regions during 2001–2020. In addition to comparing the results with high-resolution PRISM over the CONUS and with Daymet over Alaska and Puerto Rico, we explore the AV of the CP simulation in reproducing mean and heavy precipitation, and discuss the potential processes that may contribute to this AV.</p>", "<p id=\"Par40\">Our findings reveal that, compared with forcing data from ERA5 reanalysis, CP simulation with explicit convection improves representations of seasonal mean precipitation over a large portion of the CONUS, Alaska, and Puerto Rico, particularly in the areas where precipitation is heaviest. Overall, the simulation better captures the 95th percentile and extreme indices, such as CDD, RX5day, and R20mm across the three regions and seasons, exhibiting greater consistency with PRISM and Daymet. Also, note that ERA5 results are better than ADDA_V2 in some instances.</p>", "<p id=\"Par41\">When evaluating summer mean hourly precipitation, ADDA_V2 has the following added values compared to ERA5 analysis: (1) improved representation of precipitation intensity at hourly time scales; (2) accurate timing (onset and peak) of the diurnal cycle of summer precipitation; (3) better representation of the eastward-propagating convective precipitation that originates over the Rockies, which produces better simulations of downstream precipitation; (4) a more accurate depiction of the downward return flow of upslope wind in the Rockies, which produces better representations of the daytime suppression of convection over downstream regions (i.e., the Great Plains); and (5) realistic representations of local circulation and subsequent physical processes (e.g., sea-breeze convergence, cumulus-merger) over Florida.</p>", "<p id=\"Par42\">Our findings align with previous studies that employed a CP approach for various regions<sup>##UREF##19##20##,##UREF##23##25##,##UREF##24##26##,##UREF##46##48##,##UREF##47##49##</sup>. This consistency highlights the benefits of using CP scale to accurately represent seasonal mean and extreme precipitation. It enhances confidence in the potential for studying climate change and its impact assessment utilizing CP simulations. The quantitative bias and bias distribution for ADDA_V2 reported herein will provide WRF model developers with a roadmap for needed model improvements. It also offers valuable insights to guide the design of future model experiments aimed at enhancing the accuracy of local and regional-scale precipitation projections in a warming climate.</p>" ]
[ "<p id=\"Par1\">This study is an early effort to generate a multi-decadal convection-permitting regional climate dataset that covers nearly the entire North American continent. We assessed a 20 year dynamically downscaled regional climate simulation at a 4 km spatial resolution with explicit convection across the contiguous United States (CONUS), Alaska, and Puerto Rico. Specifically, we evaluated the model’s performance in representing mean, 95th percentile, and extreme precipitation across regions. Our findings indicate that when compared with ERA5 reanalysis, the forcing data, convection-permitting simulation improves representations of seasonal, 95th percentile, and extreme precipitation over a large portion of the CONUS, Alaska, and Puerto Rico, particularly in areas where precipitation is heaviest. The simulation adds value over its forcing data (ERA5) in up to 53% of all grid cells in the CONUS, 68.8% in Alaska, and 84.0% in Puerto Rico. It is important to note that, however, despite improvements, model errors in Puerto Rico remain large. Similar improvements are observed in extreme indices, including consecutive dry days, maximum 5 days precipitation, and extreme precipitation. Analysis of the diurnal cycle of mean hourly precipitation suggests that representations of convective processes—including onset, dissipation, suppression, downstream propagation, and local circulation—improved overall.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51714-3.</p>", "<title>Acknowledgements</title>", "<p>This work has been supported by the Laboratory Directed Research and Development (LDRD) Program at Argonne National Laboratory through the U.S. Department of Energy (DOE) contract DE-AC02-06CH11357. The WRF model was made available by National Center for Atmospheric Research, which is sponsored by NSF. High-Performance Computing support from the Theta cluster operated by Argonne Leadership Computing Facility (ALCF), the Cori provided by the National Energy Research Scientific Computing Center (NERSC), and the Eagle operated by National Renewable Energy Laboratory (NREL). Figures for this paper were created using the NCAR Command Language (NCL V6.6.2) software package from CISL at NCAR (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncl.ucar.edu/\">https://www.ncl.ucar.edu/</ext-link>). Jiali Wang and V. Rao Kotamarthi also acknowledge support from the Tools Assessing Performance (TAP) project, funded by the Wind Energy Technology Office at Office of Energy Efficiency and Renewable Energy, DOE.</p>", "<title>Author contributions</title>", "<p>A.A.A. and C.J. conceived the idea. A.A.A. and C.J. interpreted the results. V.R.K. and J.W. supervised the work. C.J. performed the model runs and processed the data used for this study. A.A.A. and C.J. prepared the manuscript, and all authors contributed to writing the manuscript.</p>", "<title>Data availability</title>", "<p>All datasets used in this study are freely available. ERA5 reanalysis data are publicly available through Climate Data Store: <ext-link ext-link-type=\"uri\" xlink:href=\"https://cds.climate.copernicus.eu/\">https://cds.climate.copernicus.eu/</ext-link>. PRISM data are obtained from <ext-link ext-link-type=\"uri\" xlink:href=\"https://prism.oregonstate.edu/\">https://prism.oregonstate.edu/</ext-link>. Stage IV data are retrieved from Earth Observing Laboratory: <ext-link ext-link-type=\"uri\" xlink:href=\"https://data.eol.ucar.edu/dataset/21.093\">https://data.eol.ucar.edu/dataset/21.093</ext-link>. The ADDA V2 data generated for the study are located on the ALCF high-performance storage system and are being uploaded to the Climate Risk &amp; Resilience Portal (<ext-link ext-link-type=\"uri\" xlink:href=\"https://disgeoportal.egs.anl.gov/ClimRR/\">https://disgeoportal.egs.anl.gov/ClimRR/</ext-link>) for public use.</p>", "<title>Competing interests</title>", "<p id=\"Par54\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>(<bold>a</bold>) WRF model domain with terrain height elevations (in meters) and (<bold>b</bold>) seven U.S. subregions defined by the fourth National Climate Assessment.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Spatial distribution of seasonal mean daily precipitation (mm day<sup>−1</sup>) for the CONUS, Alaska, and Puerto Rico during the 2001–2020 period. The data is sourced from ADDA_V2 (first row), Observation-based gridded dataset (second row), ADDA_V2 minus Observation-based gridded dataset (third row), and ERA5 minus Observation-based gridded dataset (fourth row). PRISM (Daymet) is utilized for CONUS (Alaska and Puerto Rico) as the observation-based gridded dataset. Hatches on the first row indicate grid points with value added by dynamical downscaling. On the third and fourth rows, grid points with statistically significant differences at 95% confidence level are marked with hatches.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Probability density function of the seasonal mean daily precipitation (mm day<sup>−1</sup>) for the CONUS (first row), Alaska (AK, middle row), and Puerto Rico (PR, bottom row) for DJF (first column), MAM (second column), JJA (third column), and SON (fourth column). The data is derived from observations (black lines), ADDA_V2 (red lines), and ERA5 reanalysis (blue lines) averaged over the CONUS for the period of 2001–2020.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Mean diurnal cycle of hourly accumulated precipitation (mm hr<sup>−1</sup>) area-averaged over the five NCA subregions for JJA for the period of 2001–2020.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Hovmöller diagram of JJA mean hourly accumulated precipitation (mm hr<sup>−1</sup>) diurnal variations averaged between 38 and 42N for the period of 2002–2020 for (<bold>a</bold>) Stage IV, (<bold>b</bold>) ADDA_V2, and (<bold>c</bold>) ERA5 reanalysis. Red dashed boxes timings onset and dissipation of relatively intense precipitation (&gt; 0.14 mm day<sup>−1</sup>) over the Appalachian plateau. Black dashed box indicates timings of the onset and dissipation of mountainous convection organized over the Rocky Mountains.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>JJA diurnal cycle of hourly precipitation (mm hr<sup>−1</sup>) for (<bold>a</bold>)–(<bold>h</bold>) ADDA_V2, (<bold>i</bold>)–(<bold>p</bold>) Stage IV, and (<bold>q</bold>)–(<bold>x</bold>) ERA5 reanalysis for the period of 2002–2020. LDT indicates U.S. Eastern Time (i.e., local daylight time), which is 5 h behind than the Coordinated Universal Time (UTC). Subfigures display 3-hourly average precipitation rate (mm hr<sup>−1</sup>) during 00–03, 03–06, 06–09, 09–12, 12–15, 15–18, 18–21, and 21–00 UTC, respectively.</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>Spatial distribution of seasonal 95th percentile of daily precipitation (mm/day) for the CONUS, Alaska, and Puerto Rico during the 2001–2020 period. The data is sourced from ADDA_V2 (first row), Observation-based gridded dataset (second row), ADDA_V2 minus Observation-based gridded dataset (third row), and ERA5 minus Observation-based gridded dataset (fourth row). PRISM (Daymet) is utilized for CONUS (Alaska and Puerto Rico) as the observation-based gridded dataset. Hatches on the first row indicate grid points with value added by dynamical downscaling. In the third and fourth rows, grid points with statistically significant differences at 95% confidence level are marked with hatches.</p></caption></fig>", "<fig id=\"Fig8\"><label>Figure 8</label><caption><p>Spatial distribution of annual CDDs (first column; days), RX5day (second column; mm), and R20mm (third column; days) for the period of 2001–2020 for ADDA_V2 (first row), PRISM (second row), ADDA_V2 minus PRISM (third row), ERA5 reanalysis minus PRISM (fourth row). Cross-hatches in the first row indicate grid points with value added by dynamical downscaling. In the third and fourth rows, grid points with statistically significant differences at 95% confidence level are marked with hatches.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Precipitation extreme indices used in this study.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">No.</th><th align=\"left\">Extreme indices</th><th align=\"left\">Name</th><th align=\"left\">Definition</th><th align=\"left\">Units</th></tr></thead><tbody><tr><td align=\"left\">1</td><td align=\"left\">CDD</td><td align=\"left\">Consecutive dry days</td><td align=\"left\"><italic>PR</italic><sub><italic>ij</italic></sub> is the daily precipitation amount on day <italic>i</italic> in period <italic>j</italic>. Count the largest number of consecutive days where <italic>PR</italic><sub><italic>ij</italic></sub> &lt; 1 mm</td><td align=\"left\">days</td></tr><tr><td align=\"left\">2</td><td align=\"left\">RX5 day</td><td align=\"left\">Maximum consecutive 5-day precipitation</td><td align=\"left\"><italic>PR</italic><sub><italic>kj</italic></sub> is the precipitation amount for the 5-day interval ending <italic>k</italic>, period <italic>j</italic>. Then maximum 5 d values for period <italic>j</italic> are: RX5day<sub>j</sub> = max (<italic>PR</italic><sub><italic>kj</italic></sub>)</td><td align=\"left\">mm</td></tr><tr><td align=\"left\">3</td><td align=\"left\">R20 mm</td><td align=\"left\">Very heavy precipitation days</td><td align=\"left\">PR<sub>ij</sub> is the daily precipitation amount on day <italic>i</italic> in period <italic>j</italic>. Count the number of days where PR<sub>ij</sub> &gt; 20 mm</td><td align=\"left\">days</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Descriptive statistics for daily mean seasonal precipitation.*</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" colspan=\"2\">Precipitation<break/>(mm day<sup>−1</sup>)</th><th align=\"left\">DJF<break/>(CONUS/AK/PR)</th><th align=\"left\">MAM<break/>(CONUS/AK/PR)</th><th align=\"left\">JJA<break/>(CONUS/AK/PR)</th><th align=\"left\">SON<break/>(CONUS/AK/PR)</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"3\">Standard deviation</td><td align=\"left\">Obs</td><td align=\"left\">1.749/2.610/1.148</td><td align=\"left\">1.328/1.544/1.260</td><td align=\"left\">1.469/1.544/1.266</td><td align=\"left\">1.314/3.174/1.293</td></tr><tr><td align=\"left\">ADDA_V2</td><td align=\"left\">1.624/2.952/1.309</td><td align=\"left\">1.370/1.506/2.461</td><td align=\"left\">1.367/1.506/3.413</td><td align=\"left\">1.168/3.128/2.906</td></tr><tr><td align=\"left\">ERA5</td><td align=\"left\">1.398/2.586/0.432</td><td align=\"left\">1.138/1.259/0.652</td><td align=\"left\">1.241/1.259/0.650</td><td align=\"left\">1.097/2.762/0.638</td></tr><tr><td align=\"left\" rowspan=\"2\">Taylor Skill Score (TSS)</td><td align=\"left\">ADDA_V2</td><td align=\"left\">0.995/0.985/0.983</td><td align=\"left\">0.9990.999/0.658</td><td align=\"left\">0.995/0.999/0.425</td><td align=\"left\">0.986/0.999/0.552</td></tr><tr><td align=\"left\">ERA5</td><td align=\"left\">0.951/0.999/0.436</td><td align=\"left\">0.977/0.959/0.667</td><td align=\"left\">0.972/0.959/0.661</td><td align=\"left\">0.968/0.981/0.629</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>PCC and RMSE of the JJA mean diurnal pattern of hourly precipitation averaged over the five NCA subregions for the period of 2002–2020.*</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" colspan=\"2\">Metrics/data</th><th align=\"left\">Northeast</th><th align=\"left\">Southeast</th><th align=\"left\">Midwest</th><th align=\"left\">Northern great plains</th><th align=\"left\">Southern great plains</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"2\">Patt. Corr.</td><td align=\"left\">ADDA_V2</td><td char=\".\" align=\"char\">0.98</td><td char=\".\" align=\"char\">0.99</td><td char=\".\" align=\"char\">0.83</td><td char=\".\" align=\"char\">0.84</td><td char=\".\" align=\"char\">0.63</td></tr><tr><td align=\"left\">ERA5</td><td char=\".\" align=\"char\">0.63</td><td char=\".\" align=\"char\">0.88</td><td char=\".\" align=\"char\">0.62</td><td char=\".\" align=\"char\">0.60</td><td char=\".\" align=\"char\">0.34</td></tr><tr><td align=\"left\" rowspan=\"2\">RMSE</td><td align=\"left\">ADDA_V2</td><td char=\".\" align=\"char\">0.03</td><td char=\".\" align=\"char\">0.02</td><td char=\".\" align=\"char\">0.02</td><td char=\".\" align=\"char\">0.02</td><td char=\".\" align=\"char\">0.03</td></tr><tr><td align=\"left\">ERA5</td><td char=\".\" align=\"char\">0.03</td><td char=\".\" align=\"char\">0.05</td><td char=\".\" align=\"char\">0.02</td><td char=\".\" align=\"char\">0.03</td><td char=\".\" align=\"char\">0.04</td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^\\circ $$\\end{document}</tex-math><mml:math id=\"M2\"><mml:msup><mml:mrow/><mml:mo>∘</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq15\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^\\circ $$\\end{document}</tex-math><mml:math id=\"M4\"><mml:msup><mml:mrow/><mml:mo>∘</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^\\circ $$\\end{document}</tex-math><mml:math id=\"M6\"><mml:msup><mml:mrow/><mml:mo>∘</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$2-$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:mrow><mml:mn>2</mml:mn><mml:mo>-</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^\\circ $$\\end{document}</tex-math><mml:math id=\"M10\"><mml:msup><mml:mrow/><mml:mo>∘</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^\\circ $$\\end{document}</tex-math><mml:math id=\"M14\"><mml:msup><mml:mrow/><mml:mo>∘</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^\\circ $$\\end{document}</tex-math><mml:math id=\"M18\"><mml:msup><mml:mrow/><mml:mo>∘</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-$$\\end{document}</tex-math><mml:math id=\"M20\"><mml:mo>-</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^\\circ $$\\end{document}</tex-math><mml:math id=\"M22\"><mml:msup><mml:mrow/><mml:mo>∘</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equa\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{RMSE}}=\\sqrt{\\frac{1}{n}{\\sum }_{i=1}^{n}{\\left({M}_{i}-{O}_{i}\\right)}^{2}}$$\\end{document}</tex-math><mml:math id=\"M24\" display=\"block\"><mml:mrow><mml:mtext>RMSE</mml:mtext><mml:mo>=</mml:mo><mml:msqrt><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mi>n</mml:mi></mml:mfrac><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msubsup><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>M</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>O</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equb\"><alternatives><tex-math id=\"M25\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathrm{PCC }\\left(M,O\\right)=\\frac{\\sum ({M}_{i}-\\overline{M })({O}_{i}-\\overline{O })}{\\sqrt{\\sum {({M}_{i}-\\overline{M })}^{2}{({O}_{i}-\\overline{O })}^{2}}}$$\\end{document}</tex-math><mml:math id=\"M26\" display=\"block\"><mml:mrow><mml:mi mathvariant=\"normal\">PCC</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>M</mml:mi><mml:mo>,</mml:mo><mml:mi>O</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>∑</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>M</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:mover><mml:mi>M</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>O</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:mover><mml:mi>O</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:msqrt><mml:mrow><mml:mo>∑</mml:mo><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>M</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:mover><mml:mi>M</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>O</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:mover><mml:mi>O</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M27\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${M}_{i}$$\\end{document}</tex-math><mml:math id=\"M28\"><mml:msub><mml:mi>M</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq12\"><alternatives><tex-math id=\"M29\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${O}_{i}$$\\end{document}</tex-math><mml:math id=\"M30\"><mml:msub><mml:mi>O</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq13\"><alternatives><tex-math id=\"M31\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{M }$$\\end{document}</tex-math><mml:math id=\"M32\"><mml:mover><mml:mi>M</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq14\"><alternatives><tex-math id=\"M33\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{O }$$\\end{document}</tex-math><mml:math id=\"M34\"><mml:mover><mml:mi>O</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equc\"><alternatives><tex-math id=\"M35\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$S\\equiv \\frac{{(1+{\\text{PCC}})}^{4}}{{4\\left({\\text{SDR}}+\\frac{1}{{\\text{SDR}}}\\right)}^{2}}$$\\end{document}</tex-math><mml:math id=\"M36\" display=\"block\"><mml:mrow><mml:mi>S</mml:mi><mml:mo>≡</mml:mo><mml:mfrac><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mtext>PCC</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>4</mml:mn></mml:msup><mml:msup><mml:mrow><mml:mn>4</mml:mn><mml:mfenced close=\")\" open=\"(\"><mml:mtext>SDR</mml:mtext><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mtext>SDR</mml:mtext></mml:mfrac></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equd\"><alternatives><tex-math id=\"M37\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{AV}}=\\frac{{\\left({X}_{{\\text{ERA}}5}-{X}_{{\\text{OBS}}}\\right)}^{2}-{\\left({X}_{{\\text{ADDA}}\\_{\\text{V}}2}-{X}_{{\\text{OBS}}}\\right)}^{2}}{{\\text{Max}}\\left({\\left({X}_{{\\text{ERA}}5}-{X}_{{\\text{OBS}}}\\right)}^{2},{\\left({X}_{{\\text{ADDA}}\\_{\\text{V}}2}-{X}_{{\\text{OBS}}}\\right)}^{2}\\right)}$$\\end{document}</tex-math><mml:math id=\"M38\" display=\"block\"><mml:mrow><mml:mtext>AV</mml:mtext><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mtext>ERA</mml:mtext><mml:mn>5</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mtext>OBS</mml:mtext></mml:msub></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mtext>ADDA</mml:mtext><mml:mi>_</mml:mi><mml:mtext>V</mml:mtext><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mtext>OBS</mml:mtext></mml:msub></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:mtext>Max</mml:mtext><mml:mfenced close=\")\" open=\"(\"><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mtext>ERA</mml:mtext><mml:mn>5</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mtext>OBS</mml:mtext></mml:msub></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>,</mml:mo><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mtext>ADDA</mml:mtext><mml:mi>_</mml:mi><mml:mtext>V</mml:mtext><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mtext>OBS</mml:mtext></mml:msub></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>*AK indicates Alaska and PR represents Puerto Rico.</p></table-wrap-foot>", "<table-wrap-foot><p>*PCC and RMSE are computed for ADDA_V2 and ERA5 reanalysis against Stage IV.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51714_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51714_Fig2a_HTML\" id=\"d32e392\"/>", "<graphic xlink:href=\"41598_2024_51714_Fig2b_HTML\" id=\"d32e393\"/>", "<graphic xlink:href=\"41598_2024_51714_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51714_Fig4_HTML\" id=\"MO4\"/>", "<inline-graphic xlink:href=\"41598_2024_51714_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51714_Article_IEq15.gif\"/>", "<graphic xlink:href=\"41598_2024_51714_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2024_51714_Fig6_HTML\" id=\"MO6\"/>", "<inline-graphic xlink:href=\"41598_2024_51714_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51714_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51714_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51714_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51714_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51714_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51714_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51714_Article_IEq9.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51714_Article_IEq10.gif\"/>", "<graphic xlink:href=\"41598_2024_51714_Fig7a_HTML\" id=\"d32e1066\"/>", "<graphic xlink:href=\"41598_2024_51714_Fig7b_HTML\" id=\"d32e1067\"/>", "<graphic xlink:href=\"41598_2024_51714_Fig8_HTML\" id=\"MO8\"/>", "<graphic xlink:href=\"41598_2024_51714_Article_Equa.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51714_Article_Equb.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51714_Article_IEq11.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51714_Article_IEq12.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51714_Article_IEq13.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51714_Article_IEq14.gif\"/>", "<graphic xlink:href=\"41598_2024_51714_Article_Equc.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51714_Article_Equd.gif\" position=\"anchor\"/>" ]
[ "<media xlink:href=\"41598_2024_51714_MOESM1_ESM.docx\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["1."], "surname": ["Jin"], "given-names": ["Z"], "article-title": ["The combined and separate impacts of climate extremes on the current and future US rainfed maize and soybean production under elevated CO"], "sub": ["2"], "source": ["Global Change Biol."], "year": ["2017"], "volume": ["23"], "fpage": ["2687"], "lpage": ["2704"], "pub-id": ["10.1111/gcb.13617"]}, {"label": ["2."], "surname": ["Raymondi", "Dalton", "Mote", "Snover"], "given-names": ["RR", "MM", "PW", "AK"], "article-title": ["Water resources: Implications of changes in temperature and precipitation"], "source": ["Climate Change in the Northwest: Implications for Our Landscapes, Waters, and Communities"], "year": ["2013"], "publisher-name": ["Island Press"], "fpage": ["41"], "lpage": ["66"]}, {"label": ["3."], "surname": ["Akinsanola", "Zhou", "Zhou", "Keenlyside"], "given-names": ["AA", "W", "T", "N"], "article-title": ["Amplification of synoptic to annual variability of West African summer monsoon rainfall under global warming"], "source": ["Npj Clim. Atmos. Sci."], "year": ["2020"], "volume": ["3"], "fpage": ["21"], "pub-id": ["10.1038/s41612-020-0125-1"]}, {"label": ["4."], "surname": ["Akinsanola", "Kooperman", "Reed", "Pendergrass", "Hannah"], "given-names": ["AA", "GJ", "KA", "AG", "WM"], "article-title": ["Projected changes in seasonal precipitation extremes over the United States in CMIP6 simulations"], "source": ["Environ. Res. Lett."], "year": ["2020"], "volume": ["15"], "fpage": ["104078"], "pub-id": ["10.1088/1748-9326/abb397"]}, {"label": ["5."], "surname": ["Akinsanola", "Kooperman", "Pendergrass", "Hannah", "Reed"], "given-names": ["AA", "GJ", "AG", "WM", "KA"], "article-title": ["Seasonal representation of extreme precipitation indices over the United States in CMIP6 present-day simulations"], "source": ["Environ. Res. Lett."], "year": ["2020"], "volume": ["15"], "fpage": ["094003"], "pub-id": ["10.1088/1748-9326/ab92c1"]}, {"label": ["6."], "surname": ["Wood", "Leung", "Sridhar", "Lettenmaier"], "given-names": ["AW", "LR", "V", "DP"], "article-title": ["Hydrologic implications of dynamical and statistical approaches to downscaling climate model outputs"], "source": ["Climatic Change"], "year": ["2004"], "volume": ["62"], "fpage": ["189"], "lpage": ["216"], "pub-id": ["10.1023/B:CLIM.0000013685.99609.9e"]}, {"label": ["7."], "surname": ["Maurer", "Hidalgo"], "given-names": ["EP", "HG"], "article-title": ["Utility of daily versus monthly large-scale climate data: An intercomparison of two statistical downscaling methods"], "source": ["Hydrol. Earth Syst. Sci."], "year": ["2008"], "volume": ["12"], "fpage": ["551"], "lpage": ["563"], "pub-id": ["10.5194/hess-12-551-2008"]}, {"label": ["8."], "surname": ["Christensen", "Boberg", "Christensen", "Lucas-Picher"], "given-names": ["JH", "F", "OB", "P"], "article-title": ["On the need for bias correction of regional climate change projections of temperature and precipitation"], "source": ["Geophys. Res. Lett."], "year": ["2008"], "volume": ["35"], "fpage": ["L20709"], "pub-id": ["10.1029/2008GL035694"]}, {"label": ["9."], "surname": ["Gutowski"], "given-names": ["J"], "suffix": ["Jr"], "article-title": ["Regional extreme monthly precipitation simulated by NARCCAP RCMs"], "source": ["J. Hydrometeorol."], "year": ["2010"], "volume": ["11"], "fpage": ["1373"], "lpage": ["1379"], "pub-id": ["10.1175/2010JHM1297.1"]}, {"label": ["10."], "surname": ["Wehner"], "given-names": ["MF"], "article-title": ["Very extreme seasonal precipitation in the NARCCAP ensemble: Model performance and projections"], "source": ["Clim. Dyn."], "year": ["2013"], "volume": ["40"], "fpage": ["59"], "lpage": ["80"], "pub-id": ["10.1007/s00382-012-1393-1"]}, {"label": ["11."], "surname": ["Antic", "Laprise", "Denis", "De El\u00eda"], "given-names": ["S", "R", "B", "R"], "article-title": ["Testing the downscaling ability of a one-way nested regional climate model in regions of complex topography"], "source": ["Clim. Dyn."], "year": ["2006"], "volume": ["26"], "fpage": ["305"], "lpage": ["325"], "pub-id": ["10.1007/s00382-005-0046-z"]}, {"label": ["12."], "surname": ["Laprise"], "given-names": ["RR"], "article-title": ["Canadian network for regional climate modelling and diagnostics challenging some tenets of regional climate modelling"], "source": ["Meteorol. Atmos. Phys."], "year": ["2008"], "volume": ["100"], "fpage": ["3"], "lpage": ["22"], "pub-id": ["10.1007/s00703-008-0292-9"]}, {"label": ["13."], "surname": ["Castro"], "given-names": ["CL"], "article-title": ["Can a regional climate model improve the ability to forecast the North American monsoon?"], "source": ["J. Clim."], "year": ["2012"], "volume": ["25"], "fpage": ["8212"], "lpage": ["8237"], "pub-id": ["10.1175/JCLI-D-11-00441.1"]}, {"label": ["14."], "surname": ["Fosser", "Khodayar", "Berg"], "given-names": ["G", "S", "P"], "article-title": ["Benefit of convection permitting climate model simulations in the representation of convective precipitation"], "source": ["Clim. Dyn."], "year": ["2015"], "volume": ["44"], "fpage": ["45"], "lpage": ["60"], "pub-id": ["10.1007/s00382-014-2242-1"]}, {"label": ["15."], "surname": ["Wang", "Kotamarthi"], "given-names": ["J", "VR"], "article-title": ["High-resolution dynamically downscaled projections of precipitation in the mid and late twenty first century over North America"], "source": ["Earth\u2019s Future"], "year": ["2015"], "volume": ["3"], "fpage": ["268"], "lpage": ["288"], "pub-id": ["10.1002/2015EF000304"]}, {"label": ["16."], "mixed-citation": ["Doblas-Reyes, F. J. "], "italic": ["et al.", "Climate Change 2021\u2014The Physical Science Basis: Contribution of Working Group I to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change", "et al"]}, {"label": ["17."], "surname": ["Wang", "Xue", "Pringle", "Yang", "Qian"], "given-names": ["J", "P", "W", "Z", "Y"], "article-title": ["Impacts of lake surface temperature on the summer climate over the Great Lakes Region"], "source": ["J. Geophys. Res. Atmos."], "year": ["2022"], "volume": ["127"], "fpage": ["e2021JD036231"], "pub-id": ["10.1029/2021JD036231"]}, {"label": ["18."], "surname": ["Chang", "Wang", "Marohnic", "Kotamarthi", "Moyer"], "given-names": ["W", "J", "J", "VR", "EJ"], "article-title": ["Diagnosing added value of convection-permitting regional models using precipitation event identification and tracking"], "source": ["Clim. Dyn."], "year": ["2018"], "volume": ["55"], "fpage": ["175"], "lpage": ["192"], "pub-id": ["10.1007/s00382-018-4294-0"]}, {"label": ["19."], "surname": ["Guo", "Fang", "Sun", "Yang", "Tang"], "given-names": ["Z", "J", "X", "Y", "J"], "article-title": ["Sensitivity of summer precipitation simulation to microphysics parameterization over eastern China: Convection-permitting regional climate simulation"], "source": ["J. Geophys. Res. Atmos."], "year": ["2019"], "volume": ["124"], "fpage": ["9183"], "lpage": ["9204"], "pub-id": ["10.1029/2019JD030295"]}, {"label": ["20."], "surname": ["Kendon", "Roberts", "Senior", "Roberts"], "given-names": ["EJ", "NM", "CA", "MJ"], "article-title": ["Realism of rainfall in a very high-resolution regional climate model"], "source": ["J. Clim."], "year": ["2012"], "volume": ["25"], "fpage": ["5791"], "lpage": ["5806"], "pub-id": ["10.1175/JCLI-D-11-00562.1"]}, {"label": ["22."], "mixed-citation": ["Kendon, M., MacCarthy, M., & Jevrejeva, S. "], "italic": ["State of the UK Climate 2014"], "ext-link": ["https://www.metoffice.gov.uk/binaries/content/assets/metofficegovuk/pdf/weather/learn-about/uk-past-events/state-of-uk-climate/state-of-the-uk-climate-2014-v3.pdf"]}, {"label": ["23."], "surname": ["Stratton"], "given-names": ["RA"], "article-title": ["A Pan-African convection-permitting regional climate simulation with the met office unified model: CP4-Africa"], "source": ["J. Clim."], "year": ["2018"], "volume": ["31"], "fpage": ["3485"], "lpage": ["3508"], "pub-id": ["10.1175/JCLI-D-17-0503.1"]}, {"label": ["24."], "surname": ["Lucas-Picher"], "given-names": ["P"], "article-title": ["Convection-permitting modeling with regional climate models: Latest developments and next steps"], "source": ["WIREs Clim. Change"], "year": ["2021"], "volume": ["12"], "fpage": ["e731"], "pub-id": ["10.1002/wcc.731"]}, {"label": ["25."], "surname": ["Liu"], "given-names": ["C"], "article-title": ["Continental-scale convection-permitting modeling of the current and future climate of North America"], "source": ["Clim. Dyn."], "year": ["2017"], "volume": ["49"], "fpage": ["71"], "lpage": ["95"], "pub-id": ["10.1007/s00382-016-3327-9"]}, {"label": ["26."], "surname": ["Gensini", "Haberlie", "Ashley"], "given-names": ["VA", "AM", "WS"], "article-title": ["Convection-permitting simulations of historical and possible future climate over the contiguous United States"], "source": ["Clim. Dyn."], "year": ["2023"], "volume": ["60"], "fpage": ["109"], "lpage": ["126"], "pub-id": ["10.1007/s00382-022-06306-0"]}, {"label": ["27."], "surname": ["Rasmussen"], "given-names": ["RM"], "article-title": ["CONUS404: The NCAR\u2013USGS 4-km long-term regional hydroclimate reanalysis over the CONUS"], "source": ["Bull. Am. Meteorol. Soc."], "year": ["2023"], "volume": ["104"], "fpage": ["E1382"], "lpage": ["E1408"], "pub-id": ["10.1175/BAMS-D-21-0326.1"]}, {"label": ["28."], "surname": ["Monaghan", "Clark", "Barlage", "Newman", "Xue", "Arnold", "Rasmussen"], "given-names": ["AJ", "MP", "MP", "AJ", "L", "JR", "RM"], "article-title": ["High-resolution historical climate simulations over Alaska"], "source": ["J. Appl. Meteorol. Climatol."], "year": ["2018"], "volume": ["57"], "fpage": ["709"], "lpage": ["731"], "pub-id": ["10.1175/JAMC-D-17-0161.1"]}, {"label": ["29."], "mixed-citation": ["Sengupta, M., Yang J. & Xie Y. "], "italic": ["High-Resolution Wind Resource Data Set of the Greater Puerto Rico Region"], "ext-link": ["https://www.nrel.gov/docs/fy23osti/84223.pdf"]}, {"label": ["30."], "surname": ["Thoman", "Walsh"], "given-names": ["R", "J"], "source": ["Alaska\u2019s Changing Environment"], "year": ["2019"], "publisher-name": ["University of Alaska Fairbanks"]}, {"label": ["31."], "mixed-citation": ["Puleikis, K. & Wang, J. "], "italic": ["Puerto Rico Historical Climate Analysis. A closer look at complex tropical terrain"], "ext-link": ["https://publications.anl.gov/anlpubs/2023/05/182533.pdf"]}, {"label": ["32."], "surname": ["Hersbach"], "given-names": ["H"], "article-title": ["The ERA5 global reanalysis"], "source": ["Q. J. R. Meteorol. Soc."], "year": ["2020"], "volume": ["146"], "fpage": ["1999"], "lpage": ["2049"], "pub-id": ["10.1002/qj.3803"]}, {"label": ["33."], "surname": ["Daly"], "given-names": ["C"], "article-title": ["Physiographically sensitive mapping of climatological temperature and precipitation across the conterminous United States"], "source": ["Int. J. Climatol."], "year": ["2008"], "volume": ["28"], "fpage": ["2031"], "lpage": ["2064"], "pub-id": ["10.1002/joc.1688"]}, {"label": ["34."], "mixed-citation": ["Thornton, M. M. "], "italic": ["et al", "Daymet: Daily Surface Weather Data on a 1-km Grid for North America, Version 4 R1"]}, {"label": ["35."], "surname": ["Qian", "Viner", "Noble", "Werth"], "given-names": ["J-H", "B", "S", "D"], "article-title": ["Precipitation characteristics of warm season weather types in the Southeastern United States of America"], "source": ["Atmos."], "year": ["2021"], "volume": ["12"], "fpage": ["1001"], "pub-id": ["10.3390/atmos12081001"]}, {"label": ["36."], "surname": ["Feng"], "given-names": ["Z"], "article-title": ["Spatiotemporal characteristics and large-scale environments of mesoscale convective systems east of the Rocky Mountains"], "source": ["J. Clim."], "year": ["2019"], "volume": ["32"], "fpage": ["7303"], "lpage": ["7328"], "pub-id": ["10.1175/JCLI-D-19-0137.1"]}, {"label": ["37."], "surname": ["Simpson", "Westcott", "Clerman", "Pielke"], "given-names": ["J", "NE", "RJ", "RA"], "article-title": ["On cumulus mergers"], "source": ["Arch. Meteor. Geophys. Bioklim"], "year": ["1980"], "volume": ["29"], "fpage": ["1"], "lpage": ["40"], "pub-id": ["10.1007/BF02247731"]}, {"label": ["38."], "surname": ["Hosannah", "Gonz\u00e1lez", "Lunger", "Niyogi"], "given-names": ["N", "JE", "C", "D"], "article-title": ["Impacts of local convective processes on rain on the Caribbean Island of Puerto Rico"], "source": ["J. Geophys. Res. Atmos."], "year": ["2019"], "volume": ["124"], "fpage": ["6009"], "lpage": ["6026"], "pub-id": ["10.1029/2018JD029825"]}, {"label": ["39."], "mixed-citation": ["Runkle, J., Kunkel, K. E., Stevens, L. E., Champion, S. M., Easterling, D. R. Terando, A., Sun, L., Stewart, B. C., Landers, G. & Rayne, S. Puerto Rico and the U.S. Virgin Islands State Climate Summary 2022. In "], "italic": ["NOAA Technical Report NESDIS 150-PR. NOAA/NESDIS, Silver Spring, MD"]}, {"label": ["40."], "surname": ["Baldauf"], "given-names": ["M"], "article-title": ["Operational convective-scale numerical weather prediction with the COSMO model: Description and sensitivities"], "source": ["Mon. Weather Rev."], "year": ["2011"], "volume": ["139"], "fpage": ["3887"], "lpage": ["3905"], "pub-id": ["10.1175/MWR-D-10-05013.1"]}, {"label": ["41."], "surname": ["Langhans", "Schmidli", "Fuhrer", "Bieri", "Sch\u00e4r"], "given-names": ["W", "J", "O", "S", "C"], "article-title": ["Long-term simulations of thermally driven flows and orographic convection at convection-parameterizing and cloud-resolving resolutions"], "source": ["J. Appl. Meteorol. Climatol."], "year": ["2013"], "volume": ["52"], "fpage": ["1490"], "lpage": ["1510"], "pub-id": ["10.1175/JAMC-D-12-0167.1"]}, {"label": ["42."], "surname": ["Dai", "Trenberth"], "given-names": ["A-G", "KE"], "article-title": ["The diurnal cycle and its depiction in the community climate system model"], "source": ["J. Clim."], "year": ["2004"], "volume": ["17"], "fpage": ["930"], "lpage": ["950"], "pub-id": ["10.1175/1520-0442(2004)017<0930:TDCAID>2.0.CO;2"]}, {"label": ["43."], "surname": ["Prein"], "given-names": ["AF"], "article-title": ["Simulating North American mesoscale convective systems with a convection-permitting climate model"], "source": ["Clim. Dyn."], "year": ["2020"], "volume": ["55"], "fpage": ["95"], "lpage": ["110"], "pub-id": ["10.1007/s00382-017-3993-2"]}, {"label": ["44."], "surname": ["Tian", "Held", "Lau", "Soden"], "given-names": ["B", "IM", "N-C", "BJ"], "article-title": ["Diurnal cycle of summertime deep convection over North America: A satellite perspective"], "source": ["J. Geophys. Res."], "year": ["2005"], "volume": ["110"], "fpage": ["D08108"], "pub-id": ["10.1029/2004JD005275"]}, {"label": ["45."], "surname": ["Frei", "Sch\u00e4r"], "given-names": ["C", "C"], "article-title": ["A precipitation climatology of the alps from high-resolution rain-gauge observations"], "source": ["Int. J. Climatol."], "year": ["1998"], "volume": ["18"], "fpage": ["873"], "lpage": ["900"], "pub-id": ["10.1002/(SICI)1097-0088(19980630)18:8<873::AID-JOC255>3.0.CO;2-9"]}, {"label": ["46."], "surname": ["Isotta"], "given-names": ["FA"], "article-title": ["The climate of daily precipitation in the Alps: Development and analysis of a high-resolution grid dataset from pan-Alpine rain-gauge data"], "source": ["Int. J. Climatol."], "year": ["2014"], "volume": ["34"], "fpage": ["1657"], "lpage": ["1675"], "pub-id": ["10.1002/joc.3794"]}, {"label": ["47."], "surname": ["Barlage", "Chen", "Rasmussen", "Zhang", "Miguez-Macho"], "given-names": ["M", "F", "R", "Z", "G"], "article-title": ["The importance of scale-dependent groundwater processes in land-atmosphere interactions over the central United States"], "source": ["Geophys. Res. Lett."], "year": ["2021"], "volume": ["48"], "issue": ["e2020092171"], "fpage": ["e2020092171"], "pub-id": ["10.1029/2020GL092171"]}, {"label": ["48."], "surname": ["Wallace", "Minder"], "given-names": ["B", "JR"], "article-title": ["The North American Monsoon precipitation response to climate warming at convection-permitting scales"], "source": ["Clim. Dyn."], "year": ["2023"], "pub-id": ["10.1007/s00382-023-06920-6"]}, {"label": ["49."], "mixed-citation": ["Fumi\u00e8re, Q., Somot, S., Caillaud, C. & Alias, A. Climate change and heavy precipitation events in South-Eastern France. In "], "italic": ["Geophysical Research Abstracts"]}, {"label": ["50."], "mixed-citation": ["Skamarock, W. C"], "italic": [". et al. A description of the advanced research WRF model version 4"]}, {"label": ["51."], "surname": ["Aligo", "Gallus", "Segal"], "given-names": ["EA", "WA", "M"], "article-title": ["On the impact of WRF model vertical grid resolution on midwest summer rainfall forecasts"], "source": ["Weather Forecast."], "year": ["2009"], "volume": ["24"], "fpage": ["575"], "lpage": ["594"], "pub-id": ["10.1175/2008WAF2007101.1"]}, {"label": ["52."], "surname": ["Morrison", "Curry", "Khvorostyanov"], "given-names": ["HC", "JA", "VI"], "article-title": ["A new double-moment microphysics parameterization for application in cloud and climate models Part I: Description"], "source": ["J. Atmos. Sci."], "year": ["2005"], "volume": ["62"], "fpage": ["1665"], "lpage": ["1677"], "pub-id": ["10.1175/JAS3446.1"]}, {"label": ["53."], "surname": ["Hong", "Lim"], "given-names": ["SY", "JOJ"], "article-title": ["The WRF single-moment 6-class microphysics scheme (WSM6)"], "source": ["Asia-Pacific J. Atmos. Sci."], "year": ["2006"], "volume": ["42"], "fpage": ["129"], "lpage": ["151"]}, {"label": ["54."], "surname": ["Iacono"], "given-names": ["MJ"], "article-title": ["Radiative forcing by long-lived greenhouse gases: Calculations with the AER radiative transfer models"], "source": ["J. Geophys. Res. Atmos."], "year": ["2008"], "volume": ["113"], "fpage": ["D13"], "pub-id": ["10.1029/2008JD009944"]}, {"label": ["55."], "mixed-citation": ["Tewari, M. "], "italic": ["et al", "20th conference on weather analysis and forecasting/16th conference on numerical weather prediction"]}, {"label": ["56."], "surname": ["Prein"], "given-names": ["AF"], "article-title": ["The future intensification of hourly precipitation extremes"], "source": ["Nat. Clim. Change"], "year": ["2017"], "volume": ["7"], "fpage": ["48"], "lpage": ["52"], "pub-id": ["10.1038/nclimate3168"]}, {"label": ["57."], "surname": ["Prein"], "given-names": ["A"], "article-title": ["Added value of convection permitting seasonal simulations"], "source": ["Clim. Dyn."], "year": ["2013"], "volume": ["41"], "fpage": ["2655"], "lpage": ["2677"], "pub-id": ["10.1007/s00382-013-1744-6"]}, {"label": ["58."], "surname": ["Prein", "Rasmussen", "Stephens"], "given-names": ["AF", "R", "G"], "article-title": ["Challenges and advances in convection-permitting climate modeling"], "source": ["Bull. Am. Meteor. Soc."], "year": ["2017"], "volume": ["98"], "fpage": ["1027"], "lpage": ["1030"], "pub-id": ["10.1175/BAMS-D-16-0263.1"]}, {"label": ["59."], "surname": ["Takayabu"], "given-names": ["I"], "article-title": ["Convection-permitting models for climate research"], "source": ["Bull. Am. Meteor. Soc."], "year": ["2022"], "volume": ["103"], "fpage": ["E77"], "lpage": ["E82"], "pub-id": ["10.1175/BAMS-D-21-0043.1"]}, {"label": ["60."], "surname": ["Pan", "Takle", "Gutowski", "Turner"], "given-names": ["Z", "E", "W", "R"], "article-title": ["Long simulation of regional climate as a sequence of short segments"], "source": ["Mon. Weather Rev."], "year": ["1999"], "volume": ["127"], "fpage": ["308"], "lpage": ["321"], "pub-id": ["10.1175/1520-0493(1999)127<0308:LSORCA>2.0.CO;2"]}, {"label": ["61."], "surname": ["Qian", "King", "Richardson"], "given-names": ["SS", "RS", "CJ"], "article-title": ["Two statistical methods for the detection of environmental thresholds"], "source": ["Ecol. Model."], "year": ["2003"], "volume": ["166"], "fpage": ["87"], "lpage": ["97"], "pub-id": ["10.1016/S0304-3800(03)00097-8"]}, {"label": ["62."], "surname": ["Conil", "Hall"], "given-names": ["S", "A"], "article-title": ["Local regimes of atmospheric variability: A case study of Southern California"], "source": ["J. Clim."], "year": ["2006"], "volume": ["19"], "fpage": ["4308"], "lpage": ["4325"], "pub-id": ["10.1175/JCLI3837.1"]}, {"label": ["63."], "surname": ["Lucas-Picher", "Boberg", "Christensen", "Berg"], "given-names": ["P", "F", "JH", "P"], "article-title": ["Dynamical downscaling with reinitializations: A method to generate fine scale climate datasets suitable for impact studies"], "source": ["J. Hydrometeorol."], "year": ["2013"], "volume": ["14"], "fpage": ["1159"], "lpage": ["1174"], "pub-id": ["10.1175/JHM-D-12-063.1"]}, {"label": ["64."], "mixed-citation": ["Lin, Y. & Mitchell, K. E. The NCEP stage II/IV hourly precipitation analyses: Development and applications in "], "italic": ["Proceedings of the 19th Conference Hydrology, American Meteorological Society, San Diego, CA, USA"], "ext-link": ["https://ams.confex.com/ams/pdfpapers/83847.pdf"]}, {"label": ["65."], "surname": ["Chang", "Stein", "Wang", "Kotamarthi", "Moyer"], "given-names": ["W", "ML", "J", "VR", "EJ"], "article-title": ["Changes in spatiotemporal precipitation patterns in changing climate conditions"], "source": ["J. Clim."], "year": ["2016"], "volume": ["29"], "fpage": ["8355"], "lpage": ["8376"], "pub-id": ["10.1175/JCLI-D-15-0844.1"]}, {"label": ["66."], "surname": ["Nelson"], "given-names": ["B"], "article-title": ["Assessment and implications of NCEP stage IV quantitative precipitation estimates for product comparisons"], "source": ["Wea. Forecast."], "year": ["2016"], "volume": ["31"], "fpage": ["371"], "lpage": ["394"], "pub-id": ["10.1175/WAF-D-14-00112.1"]}, {"label": ["67."], "surname": ["Wang", "Swati", "Stein", "Kotamarthi"], "given-names": ["J", "FNU", "ML", "VR"], "article-title": ["Model performance in spatiotemporal patterns of precipitation: New methods for identifying value added by a regional climate model"], "source": ["J. Geophys. Res. Atmos."], "year": ["2015"], "volume": ["120"], "fpage": ["1239"], "lpage": ["1259"], "pub-id": ["10.1002/2014JD022434"]}, {"label": ["68."], "surname": ["Hirota", "Takayabu", "Watanabe", "Kimoto"], "given-names": ["N", "YN", "M", "M"], "article-title": ["Precipitation reproducibility over tropical oceans and its relationship to the double ITCZ problem in CMIP3 and MIROC5 climate models"], "source": ["J. Clim."], "year": ["2011"], "volume": ["24"], "fpage": ["4859"], "lpage": ["4873"], "pub-id": ["10.1175/2011JCLI4156.1"]}, {"label": ["69."], "surname": ["Taylor"], "given-names": ["KE"], "article-title": ["Summarizing multiple aspects of model performance in a single diagram"], "source": ["J. Geophys. Res. Atmos."], "year": ["2001"], "volume": ["106"], "fpage": ["7183"], "lpage": ["7192"], "pub-id": ["10.1029/2000JD900719"]}, {"label": ["70."], "surname": ["Di Luca", "de El\u00eda", "Laprise"], "given-names": ["A", "R", "R"], "article-title": ["Potential for added value in precipitation simulated by high-resolution nested regional climate models and observations"], "source": ["Clim. Dyn."], "year": ["2012"], "volume": ["38"], "fpage": ["1229"], "lpage": ["1247"], "pub-id": ["10.1007/s00382-011-1068-3"]}, {"label": ["71."], "surname": ["Dosio", "Panitz", "Schubert-Frisius", "L\u00fcthi"], "given-names": ["A", "HJ", "M", "D"], "article-title": ["Dynamical downscaling of CMIP5 global circulation models over CORDEX-Africa with COSMO-CLM: Evaluation over the present climate and analysis of the added value"], "source": ["Clim. Dyn."], "year": ["2015"], "volume": ["44"], "fpage": ["2637"], "lpage": ["2661"], "pub-id": ["10.1007/s00382-014-2262-x"]}, {"label": ["72."], "surname": ["Akinsanola", "Zhou"], "given-names": ["AA", "W"], "article-title": ["Projections of West African summer monsoon rainfall extremes from two CORDEX models"], "source": ["Clim. Dyn."], "year": ["2019"], "volume": ["52"], "fpage": ["2017"], "lpage": ["2028"], "pub-id": ["10.1007/s00382-018-4238-8"]}]
{ "acronym": [], "definition": [] }
72
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1238
oa_package/6d/7d/PMC10786863.tar.gz
PMC10786864
38216592
[ "<title>Introduction</title>", "<p id=\"Par17\">Drug repurposing or drug repositioning, using a drug for an indication other than its original purpose, is an attractive option compared to the long and costly process of developing a new drug<sup>##REF##21091654##1##,##REF##34368939##2##</sup>. The drug to be repurposed has already been studied for its safety and has extensive data on its pharmacokinetics. As a result, many stages of drug development can be omitted<sup>##REF##15286734##3##</sup>. Some examples of successfully repurposed drugs are thalidomide and sildenafil. Thalidomide, an antiemetic drug for pregnant women that was subsequently proven to have teratogenic effects, has been repurposed to be used in leprosy and sildenafil, a drug originally developed for angina, has been used in erectile dysfunction<sup>##UREF##0##4##</sup>. Current drug repurposing cases typically follow a disease-centric approach, but when disease-focused repurposing reaches its limits, target-centric and drug-centric repurposing relying on structural data will be crucial<sup>##REF##32032699##5##</sup>. Docking and virtual screening are some of the most common methods in computational drug repurposing for preliminary studies<sup>##REF##32187356##6##</sup>. Some of the structure-based virtual screening web servers for drug repurposing are ACID (using inverse docking approach<sup>##REF##33430982##7##</sup>), DRDOCK (combining docking and molecular dynamic simulations for a target protein<sup>##REF##34341789##8##</sup>), and MTiOpenScreen (using docking or blind docking<sup>##REF##25855812##9##</sup>).</p>", "<p id=\"Par18\">Cell signaling is the transmission of an external signal to activate certain mechanisms in the cell<sup>##REF##31277491##10##</sup>. Ras/Raf/MEK/ERK signaling pathway plays a role in the transduction of a signal received from an extracellular receptor to the cell nucleus to regulate biological functions, including cell proliferation, differentiation, apoptosis, and stress response<sup>##REF##32104259##11##–##REF##17496909##14##</sup>. Dysregulation of this pathway is associated with diseases such as inflammation, developmental disorders, neurodegenerative disorders<sup>##REF##32104259##11##,##REF##32586047##15##–##REF##31382554##17##</sup> and is observed in approximately one-third of all human cancers<sup>##REF##17496922##18##</sup>. Consequently, various drugs targeting this pathway have been developed. Vemurafenib, dabrafenib, and trametinib are some examples of MAPK inhibitors used in cancer therapy<sup>##REF##33396939##19##</sup>. Proteins in this pathway interact with other proteins and these interactions take place through protein–protein interfaces<sup>##UREF##3##20##</sup>. Hence, protein–protein interfaces are critical targets for drugs to regulate abnormal protein–protein interactions (PPIs) in this pathway<sup>##REF##15993577##21##,##REF##18075579##22##</sup>. Disruption of a PPI by targeting the interface with a drug may interrupt the transduction of a signal that promotes tumorigenesis, thereby being beneficial in cancer therapy<sup>##REF##23725674##23##</sup>. From our previous studies, we know different proteins can form similar protein–protein interface architectures<sup>##UREF##4##24##–##REF##24475173##26##</sup>. Using similar interfaces, Engin et al.<sup>##REF##22817115##27##</sup> proposed that drugs binding to an interface might also bind to another interface with a similar structure. Their case study showed that the drugs binding to the interface between CDK6 and CDKN2D also bind to the interface between CDK4 and CDKN2D, which has a similar interface, with comparable binding energies.</p>", "<p id=\"Par19\">Here, our aim is to use a non-redundant protein–protein interface dataset that is clustered based on structural similarity for drug repurposing. We preferred studying protein–protein interfaces rather than the binding pockets because target proteins may sometimes lack binding pockets, limiting their druggability, such as in the case of RAS protein family<sup>##REF##27775829##28##–##REF##26527069##30##</sup>. Moreover, molecular glue is a new concept that may be used to make the targets druggable, which were once considered as undruggable and the protein–protein interfaces are perfect for this approach<sup>##UREF##5##31##</sup>. In this study, we focused on protein–protein interfaces of Ras/Raf/MEK/ERK signaling pathway. We studied interfaces that are available in Protein Data Bank (PDB)<sup>##REF##10592235##32##</sup> and used PRISM web server<sup>##REF##24829450##33##,##REF##21886100##34##</sup>, a prediction tool for protein–protein interactions at the structural level, to predict the interfaces between any two physically interacting proteins of Ras/Raf/MEK/ERK signaling pathway when there is no experimental data. Proteins are dynamic and the conformational space is diverse. The availability of different conformations is crucial to finding the right one that fits the drug molecule and PDB is getting richer with many conformations for a single protein. Here, we used an ensemble of conformations rather than taking a single structure in the predictions (Fig. ##FIG##0##1##). Considering alternative conformations of each protein, the number of successfully predicted interactions increases<sup>##REF##23590674##35##</sup>. We extracted drugs already bound to the interfaces as candidates of drug repurposing for target proteins with structurally similar interfaces. Finally, we performed docking to propose drugs to be repurposed and found literature evidence showing that the algorithm we used here can be promising in suggesting new uses for already known drugs.</p>" ]
[ "<title>Materials and methods</title>", "<p id=\"Par46\">The basis of this study is that if a drug can bind to a protein–protein interface, it may also bind to another interface that is structurally similar to the protein–protein interface that the drug is originally bound to. Since our study focuses on Ras/Raf/MEK/ERK signaling pathway, we extracted the structures of the proteins in this pathway. Then, the alternative conformations of these proteins are determined and used in the prediction of the complexes of physically interacting proteins using PRISM<sup>##REF##24829450##33##</sup>, a prediction tool for protein–protein interactions at the structural level, if they are not available in the literature. Following that, protein–protein interfaces with drugs are filtered to suggest new targets for these drugs using a structurally similar protein–protein interface dataset and docking. Figure ##FIG##6##7## illustrates the workflow of this study.</p>", "<title>Protein structures of Ras/Raf/MEK/ERK signaling pathway</title>", "<p id=\"Par47\">The gene list for the EGF–EGFR–RAS–ERK signaling pathway (N00001) under MAPK signaling pathway is obtained from the Kyoto Encyclopedia of Genes and Genomes (KEGG)<sup>##REF##31441146##36##–##REF##10592173##38##</sup>. KEGG identifiers for these genes are mapped to UniProt identifiers. If more than one UniProt identifier is associated with the gene, the UniProtKB/Swiss-Prot identifier (reviewed, manually annotated) is selected. Physical interactions for the 16 proteins in the EGF–EGFR–RAS–ERK signaling pathway with the highest confidence score (≥ 0.900) and their top 10 interactors (Supplementary Table ##SUPPL##0##S10##) are imported from the STRING database<sup>##UREF##7##39##</sup>. The proteins in EGF–EGFR–RAS–ERK signaling pathway and their top 10 interactors form our set of pathway proteins.</p>", "<p id=\"Par48\">Following that, PDB entries for these UniProt identifiers are found using “idmapping_selected.tab.gz” file from the UniProt website<sup>##UREF##24##132##</sup>. Since PDB is redundant and some PDB entries are very similar, proteins with 95% sequence identity and 2 Å RMSD value are grouped for each UniProt identifier. One representative is kept for each group. Proteins having less than 30 residues are eliminated<sup>##UREF##25##133##</sup>. These steps provided us with multiple conformations of the pathway proteins introducing dynamics in the predictions.</p>", "<title>Protein–protein interfaces in the pathway</title>", "<p id=\"Par49\">Protein–protein interfaces used in this work are either predicted by the PRISM web server or found in PDB. PRISM predicts interactions between two proteins according to the similarity between the surfaces of target proteins and each side of a template interface. Physically interacting protein pairs according to STRING are sent to the PRISM web server as target proteins. PRISM results consist of an interface template, binding energy, protein complex structure and interface residues. PRISM may give none or multiple results for each target protein pair.</p>", "<p id=\"Par50\">Additionally, PDB entries involving one of the proteins in the EGF–EGFR–RAS–ERK signaling pathway are found. Only the proteins listed under the EGF–EGFR–RAS–ERK signaling pathway in KEGG are included to avoid 2nd shell interactors. Protein–protein interfaces formed in these PDB entries are used in the following steps. If the distance between two atoms is less than the sum of their van der Waals radii plus a tolerance of 0.5 Å, they are considered contacting. If there are at least five contacting residues at each protein chain, they are considered to be forming an interface.</p>", "<title>Filtering of protein–protein interfaces with Food and Drug Administration (FDA) approved drugs</title>", "<p id=\"Par51\">FDA-approved drugs are listed in the ZINC database<sup>##REF##26479676##134##</sup> and those in PDB are identified to form the FDA-approved drugs dataset used in this work (Supplementary Dataset ##SUPPL##0##S1##)<sup>##REF##37808700##135##</sup>. Glycerol (PDB Ligand ID:GOL) and isopropyl alcohol (PDB Ligand ID:IPA) that are present in FDA-approved drugs dataset are highly observed in PDB entries. However, these molecules are mostly used in the structure determination step as precipitant or to protect proteins when frozen<sup>##REF##24419610##136##,##UREF##26##137##</sup>. Hence, glycerol and isopropyl alcohol are excluded from the FDA-approved drugs dataset in this step.</p>", "<p id=\"Par52\">Protein–protein interfaces in the EGF–EGFR–RAS–ERK signaling pathway with FDA-approved drugs are filtered by mapping and combining ligands at the interface residues using data from PDBsum<sup>##REF##28875543##138##</sup> with the FDA-approved drug dataset (Supplementary Dataset ##SUPPL##0##S2##)<sup>##REF##37808700##135##</sup>. Protein–protein interfaces predicted by PRISM and interfaces from the PDB are studied separately.</p>", "<title>Identification of new drug–target pairs</title>", "<p id=\"Par53\">To propose new drug target pairs, a dataset consisting of clusters of structurally similar protein–protein interfaces is used (Supplementary Dataset ##SUPPL##0##S3##)<sup>##UREF##10##43##</sup>. This dataset is constructed by clustering protein interfaces in PDB entries with an Interface-Similarity score (IS-score) of 0.311 according to iAlign<sup>##REF##20624782##139##</sup>. SparseHC<sup>##UREF##27##140##</sup>, a hierarchical clustering algorithm, is used in the clustering.</p>", "<p id=\"Par54\">Two cases are considered to propose new drug–target pairs (Fig. ##FIG##2##3##):<list list-type=\"bullet\"><list-item><p id=\"Par55\">Repurposing To: A drug bound to one of the interfaces in a protein–protein interface cluster may bind to an interface in the same cluster, and the protein is in the Ras/Raf/MEK/ERK pathway.</p></list-item><list-item><p id=\"Par56\">Repurposing From: A drug bound to a protein interface in Ras/Raf/MEK/ERK pathway may also bind to another protein interface that is in the same cluster, and the protein is not in the Ras/Raf/MEK/ERK pathway.</p></list-item></list></p>", "<title>Docking</title>", "<p id=\"Par57\">Python package of AutoDock Vina<sup>##REF##19499576##141##</sup> is used in this work for docking. Additionally BioPython<sup>##REF##19304878##142##</sup> and NumPy packages<sup>##REF##32939066##143##</sup> in Python, Chimera<sup>##REF##15264254##48##</sup> and Open Babel<sup>##REF##21982300##144##</sup> are used. The 3-dimensional structures of drugs at reference pH are downloaded from ZINC database<sup>##REF##26479676##134##</sup>. Both receptor and ligand structures are prepared for docking using codes in MGL Tools<sup>##REF##19399780##145##</sup>. The size and the center of the docking box is adjusted to include interface residues (Supplementary Dataset ##SUPPL##0##S4##) in the box. Docking is performed with exhaustiveness of 8 because it is the best option for the prediction of binding energy considering the increased computation time with a higher exhaustiveness<sup>##REF##31887035##44##</sup>. Details are presented in Supplementary Text ##SUPPL##0##S2##.</p>", "<title>Control set for docking</title>", "<p id=\"Par58\">A control set of drugs are randomly selected to evaluate their energy. 35 drugs are selected from the FDA-approved drugs dataset (Supplementary Dataset ##SUPPL##0##S1##) using random.sample() function in random module of Python. The list of drugs can be found in Supplementary Table ##SUPPL##0##S11##. These selected drugs are docked to the interfaces that the drug repurposing candidates are reported to be binding (i.e., EGFR-ERBB2, EGFR-ERBB3 and BRAF-RAF1 interfaces). The docking procedure has been explained in the “<xref rid=\"Sec10\" ref-type=\"sec\">Docking</xref>” section of “<xref rid=\"Sec5\" ref-type=\"sec\">Materials and methods</xref>”.</p>", "<title>Cancer mutations</title>", "<p id=\"Par59\">For the somatic mutations in cancer, missense and nonsense mutations from the COSMIC (v97) database are used<sup>##UREF##12##49##</sup>. Human proteins included in the proteome UP000005640<sup>##UREF##24##132##</sup> are considered. Using PDBe API<sup>##REF##36173162##112##</sup>, UniProt mappings for each PDB ID from SIFTS<sup>##UREF##22##111##</sup> are obtained. For the start and end residue numbers, author residue numbers are considered. The residue names are compared, the start and end residues are manually adjusted to be consistent if they do not match. The mutations in the whole chain are listed and compared with interface residues to find the ones that are at the interface. For the mutations located at the interfaces where the drug repurposing candidates are proposed to be binding, SIFT<sup>##REF##12824425##50##</sup> is used to predict the functional effect of the mutation on the protein function.</p>", "<title>Experimental data of drug sensitivity</title>", "<p id=\"Par60\">Drug sensitivities of cancer cell lines to selected drugs are extracted from DepMap<sup>##REF##32613204##51##</sup> (<ext-link ext-link-type=\"uri\" xlink:href=\"https://depmap.org/portal/\">https://depmap.org/portal/</ext-link>). If the sensitivity data of a cell line is not available for all of the drugs, that cell line is omitted. Negative values suggest that the growth of treated cells is less than that of the control cells. The data on DepMap was obtained using PRISM viability assay where barcoded cell lines were exposed to the compound for five days and the abundance of mRNA barcodes was detected using Luminex MagPlex Microspheres to estimate cell viability in comparison to the control group<sup>##REF##32613204##51##</sup>. PRISM Repurposing Primary Screen dataset is used in this study.</p>" ]
[ "<title>Results</title>", "<p id=\"Par20\">The Ras/Raf/MEK/ERK signaling pathway is reconstructed by 16 proteins in the KEGG database<sup>##REF##31441146##36##–##REF##10592173##38##</sup> under the EGF–EGFR–RAS–ERK signaling pathway and their top 10 interactors according to STRING database<sup>##UREF##7##39##</sup>. All available structures of these 26 proteins in PDB<sup>##REF##10592235##32##</sup> are grouped based on sequence and structural similarity. The representatives of the alternative conformation groups of these proteins can be found in Supplementary Table ##SUPPL##0##S1##. These conformations either correspond to the alternative conformations of the same region or may correspond to different parts of a protein. The pathway proteins have 4.56 ± 5.20 conformations on average. The structures of GAB2 in PDB have less than 30 amino acids and are eliminated in the grouping process. Its AlphaFold<sup>##REF##34265844##40##,##UREF##8##41##</sup> model is used in the following steps.</p>", "<p id=\"Par21\">The network of Ras/Raf/MEK/ERK signaling pathway consists of 26 proteins and 72 interactions. When the alternative conformations of each protein are considered, there are 2564 possible interactions in theory, resulting from 72 interactions between 26 proteins. Figure ##FIG##0##1## shows this concept: one interaction results in six interactions in theory between alternative conformations in Fig. ##FIG##0##1##. Interacting protein pairs considering alternative conformations are submitted to the PRISM web server<sup>##REF##24829450##33##,##REF##21886100##34##</sup>. PRISM simulations predicted 3309 complexes for 66 of 72 interactions reported in STRING. The number of the predicted complexes is more than the number of possible interactions because PRISM may predict more than one protein–protein complex structure for a pair of proteins. These interactions can be seen in Fig. ##FIG##1##2##. With the PRISM predictions, the structural coverage of protein–protein complexes formed by physically interacting proteins of this pathway has been increased from 15 to 66 out of 72 interactions found on STRING<sup>##UREF##7##39##</sup> with the highest confidence score (≥ 0.900). These results correspond to 999 of all 2564 possible interactions among alternative conformations and through 630 unique protein interface templates (Supplementary Text ##SUPPL##0##S1##). The results involve some complexes for the same protein structures with different binding energy predictions. All the predictions are used in the next steps to avoid missing any new targets.</p>", "<p id=\"Par22\">Additionally, there are 994 PDB structures, 521 of which have more than one chain, involving at least one of the 16 proteins in the EGF–EGFR–RAS–ERK signaling pathway. In total, 1296 protein interfaces were formed in these PDB entries. These interfaces are combined with the interfaces predicted by PRISM.</p>", "<p id=\"Par23\">A structurally non-redundant dataset of protein–protein interface clusters (Supplementary Dataset ##SUPPL##0##S3##)<sup>##UREF##10##43##</sup> is used to find possible new drug–target pairs. A schematic representation of two scenarios is shown in Fig. ##FIG##2##3##. The first one is “Repurposing To”, where a drug bound to one of the interfaces in a protein–protein interface cluster may bind to an interface in the same cluster that belongs to the Ras/Raf/MEK/ERK pathway. In the second scenario of “Repurposing From”, a drug bound to a protein interface in Ras/Raf/MEK/ERK pathway may also bind to another protein interface that is in the same cluster, and the protein is not in the Ras/Raf/MEK/ERK pathway.</p>", "<p id=\"Par24\">We filtered the clusters that contain all the template interfaces of the PRISM predictions and experimental PDB structures for the “Repurposing To” strategy. With the approach of “Repurposing To”, there are 441 and 71 possible new drug–target pairs from PRISM results and PDB entries of pathway proteins, respectively (Supplementary Table ##SUPPL##0##S2##).</p>", "<p id=\"Par25\">Considering unique protein interfaces of PRISM predictions, there are five different FDA-approved drugs bound to six different protein interfaces. In contrast, there are eight protein interfaces with three different FDA-approved drugs among the interfaces related to EGF–EGFR–RAS–ERK signaling pathway in PDB entries. The mentioned interfaces and drugs can be seen in Supplementary Table ##SUPPL##0##S3##. These protein interfaces are used for the “Repurposing From” strategy (see “<xref rid=\"Sec5\" ref-type=\"sec\">Methods</xref>” for details). With the approach explained as “Repurposing From”, we have 72 possible new drug–target pairs from PRISM predictions and 120 from protein interfaces in pathway PDB entries (Supplementary Table ##SUPPL##0##S4##).</p>", "<p id=\"Par26\">We further performed docking for these drug–target pairs and the results were analyzed according to the binding free energy (Supplementary Table ##SUPPL##0##S5##). A previous study proposed an average binding energy of − 7.75 ± 0.06 kcal/mol<sup>##REF##31887035##44##</sup>. Accordingly, new targets are presented in Table ##TAB##0##1##. These proteins contain both intracellular domains or extracellular domains and a result between intra- and extracellular regions is not biologically meaningful. Therefore, we eliminated such cases.</p>", "<p id=\"Par27\">To compare the binding energies of randomly selected drugs to these interfaces, a control set of 35 drugs is docked to the interfaces presented in Table ##TAB##0##1##. The average binding energy of these drugs to the protein–protein interfaces is − 5.57 kcal/mol, whereas the median is − 5.52 kcal/mol. When the distribution of the binding energies is assessed (Supplementary Fig. ##SUPPL##1##S1##), it is seen that there is a drastic decrease in the number of docking scores below − 7.33 kcal/mol, which is consistent with our cut-off value for the proposed drug repurposing candidates.</p>", "<p id=\"Par28\">Table ##TAB##0##1## presents the protein–protein interfaces proposed for drug repurposing (columns 1 and 2) and the protein complexes (column 5) with a drug bound to their interfaces that have structural similarity to the proposed interfaces. These protein–protein interfaces, the drug binding protein chain of the protein–protein interface, the protein that the drug is originally bound to and the structural alignment<sup>##UREF##11##45##</sup> of their interfaces can be seen in Fig. ##FIG##3##4##. Tipranavir and indinavir form two hydrogen bonds with EGFR, while saquinavir forms four hydrogen bonds with ERBB3 at the ERBB3–EGFR interface<sup>##REF##21919503##46##</sup>. Tipranavir and indinavir at the interface of ERBB2–EGFR have one and two hydrogen bonds with ERBB2, respectively<sup>##REF##21919503##46##</sup>. The hydrogen bond between indinavir and ASP29 of HIV protease is maintained between indinavir and ASP360 of ERBB2. Moreover, the hydrogen bond between the galantamine and its original interface is also present between galantamine and BRAF-RAF1 interface<sup>##REF##21919503##46##</sup>. Lastly, granisetron interacts with BRAF through hydrophobic contacts<sup>##REF##21919503##46##</sup> as it does with mutant binding protein (5HTBP-AChBP), which is the protein that it is originally bound to in PDB. Furthermore, the interfaces of the original targets and the proposed new targets of the drugs are structurally aligned according to MultiProt<sup>##UREF##11##45##</sup> results. The RMSD of the matched interface residues are 1.72 Å, 1.85 Å, 1.88 Å, 1.88 Å, 1.74 Å, 1.53 Å and 1.53 Å for the structural alignments in Fig. ##FIG##3##4##c, Fig. ##FIG##3##4##,e,g,i,k,m,o, respectively. In Fig. ##FIG##3##4##, it can be seen that the drugs are binding to the same region of the aligned structures.</p>", "<p id=\"Par29\">Since mutations at the interface may alter the protein–protein interactions and the interaction with ligands, residues where cancer mutations are observed are extracted from the COSMIC database<sup>##UREF##12##49##</sup>. Then, they are mapped to the interface residues and the effect of the mutations on the protein function is predicted by SIFT<sup>##REF##12824425##50##</sup>. The cancer mutations located at the interfaces (of the protein–protein complexes in Table ##TAB##0##1##) can be seen in Fig. ##FIG##4##5##. At the interface of the ERBB3–EGFR complex, ERBB3 has two mutations predicted as deleterious to the protein function out of six mutations located at the interface, but only one of the deleterious mutations (Q138L) is at the ligand contacting residues (i.e., with a distance of less than 5 Å) of the proposed drug repurposing candidates. On the other hand, EGFR has eight residues at the interface where cancer mutations are observed, but none of them are predicted to be deleterious by SIFT. There are four residues of RAF1 and thirteen residues of BRAF related to cancer mutations at the interface of BRAF–RAF1 complex. The mutations of RAF1 are predicted as functionally neutral, but six of BRAF mutations are predicted to be deleterious by SIFT. However, these deleterious mutations are not at the contacting residues of galantamine or granisetron. Moreover, ERBB2 has one deleterious mutation (P416T or P416L) at the contacting residues of indinavir and tipranavir among the three mutations located at the interface of ERBB2–EGFR complex. Lastly, one of the eight mutations located at the interface residues of EGFR is predicted to be deleterious (N444I) in addition to being one of the contacting residues of indinavir and tipranavir. Mapped mutations for all the complexes used in this study are presented in Supplementary Table ##SUPPL##0##S7## and Supplementary Table ##SUPPL##0##S8##. The frequency and tissue information of the mutations from COSMIC database<sup>##UREF##12##49##</sup> that are located at the interface of the protein–protein complexes in Table ##TAB##0##1## and their predicted SIFT score can be found in Supplementary Table ##SUPPL##0##S9##.</p>", "<p id=\"Par30\">The sensitivities of cancer cells to our proposed drug repurposing candidates and to the drugs that are used in cancer treatment are extracted from DepMap<sup>##REF##32613204##51##</sup>. Erlotinib, gefitinib, lapatinib, afatinib, dacomitinib, and osimertinib are EGFR inhibitors, whereas lapatinib and afatinib also target ERBB2<sup>##UREF##13##52##</sup>. Cancer cells exposed to our proposed drug repurposing candidates tipranavir and saquinavir binding to EGFR-ERBB3 and/or EGFR-ERBB2 interfaces had less viability than the control group. Moreover, cancer cells were more sensitive to tipranavir and saquinavir than to erlotinib and afatinib, which are cancer drugs (Fig. ##FIG##5##6##a). Furthermore, higher drug sensitivity is observed with tipranavir on cancer cells compared to dacomitinib and osimertinib. Vemurafenib is a BRAF inhibitor, whereas dabrafenib targets both BRAF and RAF1. Granisetron, which is suggested to be binding to BRAF-RAF1 interface, leads to higher sensitivity in cancer cells than cancer drugs vemurafenib and dabrafenib (Fig. ##FIG##5##6##b). When the cell lines used in this analysis are grouped by their primary diseases, the group with the highest number of cell lines is non-small cell lung cancer, followed by melanoma and diffuse glioma (Supplementary Fig. ##SUPPL##1##S2##).</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par31\">Drug repurposing may adopt a ligand-based approach or target-based approach. Here, we used a new concept, the structural similarities of the protein–protein interfaces to propose new targets for the FDA-approved drugs in Ras signaling pathway. This method required the 3-dimensional structures of the protein–protein complexes. However, only 21% of the physically interacting protein complexes on STRING<sup>##UREF##7##39##</sup> with the highest confidence score were available in PDB for our network. Using PRISM, a template-based structural prediction tool, structural coverage of the network is increased to 92% for these protein–protein interactions on STRING<sup>##UREF##7##39##</sup>. Thus, we could use more protein–protein interfaces in our further steps, such as filtering the interfaces with FDA-approved drugs and identifying new drug–target pairs to search for drug repurposing candidates. Here, the conformational diversity of proteins is integrated by using multiple conformations of the pathway proteins. For instance, if just one structure (PDB ID:3KSY Chain ID:A) of SOS1 had been used, protein–protein complex structures for only 60% of the listed interactions would have been found, but the value is increased to 90% using multiple conformations. After the prediction of the complexes that are not available in the literature, new drug–target pairs are identified using a structurally clustered protein–protein interface dataset. Drugs that are suggested for repurposing are determined according to their binding free energy prediction via docking (Table ##TAB##0##1##) to similar interfaces. The protein chain having a favorable binding energy for target–ligand complex is stated as the new target.</p>", "<p id=\"Par32\">Three of the results involve EGFR-ERBB3 protein interface formed by structures with PDB IDs of 4UIP and 4LEO with chain IDs of A and C, respectively. EGFR is a transmembrane protein of ErbB family of tyrosine kinase receptors<sup>##UREF##14##53##</sup>. EGFR, also known as HER1, involves extracellular region comprising four domains, transmembrane region and intracellular region with tyrosine kinase domain<sup>##REF##18573086##54##,##REF##9496384##55##</sup>. Domain III of the extracellular region plays a role in ligand binding<sup>##UREF##14##53##</sup>. ERBB3, also known as HER3, is also a member of ErbB family and consists of three regions, namely extracellular, transmembrane and intracellular regions. Its extracellular region also has four domains among which domains I and III are involved in binding of its natural ligand heregulin<sup>##REF##34196609##56##</sup>. EGFR and ERBB3 can form heterodimers as well as homodimers resulting in activation of MAPK/ERK and PI3K/Akt signaling pathways that are responsible for cell migration and proliferation<sup>##REF##21303969##57##–##REF##26000702##59##</sup>. Previous studies showed that EGFR-ERBB3 heterodimer is involved in signaling which promotes metastasis in melanoma cells and activation of MAPK<sup>##REF##18398842##60##</sup>. According to another study, upregulation, mutation or catalytic activation of ErbB family proteins are associated with breast, ovarian, colorectal, pancreatic, and lung cancer. Moreover, targeting a single protein in therapy might fail because of the crosstalk between ErbB family that activates downstream pathways. In that study, it is also reported that targeting the EGFR-ERBB3 interface for breast cancer is an improved strategy where malignancies exhibit resistance to treatment that targets a single protein<sup>##UREF##15##61##</sup>.</p>", "<p id=\"Par33\">Structures with PDB IDs of 4LEO and 4UIP are extracellular domains of ERBB3 and EGFR, respectively. A previous study suggested that targeting the extracellular domain of EGFR is promising in colorectal cancer treatment where there is resistance to EGFR inhibitors cetuximab and panitumumab<sup>##UREF##16##62##,##REF##27775071##63##</sup>. In our results, tipranavir and indinavir bind to EGFR with favorable binding energy at the interface formed between EGFR and ERBB3 (Fig. ##FIG##3##4##b,d). Both indinavir and tipranavir are drugs used in the treatment of HIV infection<sup>##UREF##13##52##</sup>. Tipranavir and indinavir were approved by FDA in 2005 and 1996, respectively<sup>##REF##16060700##64##,##REF##11363592##65##</sup>. They both bind to the active site of HIV protease enzyme to prevent hydrolysis of peptide bonds which is necessary for the life cycle of HIV<sup>##REF##12929379##66##</sup>. According to docking results, tipranavir and indinavir are bound to domain III of EGFR extracellular domain. In another study, cetuximab which is an EGFR inhibitor is also bound to the domain III<sup>##REF##26888827##67##</sup> suggesting that these HIV protease inhibitors might be used in cancer treatment.</p>", "<p id=\"Par34\">The other drug that binds to the same interface formed by these protein structures is saquinavir which is also an HIV protease inhibitor. Saquinavir binds to ERBB3 with a lower (better) energy. Saquinavir was approved in 1995, being the first HIV protease inhibitor approved by FDA<sup>##UREF##17##68##</sup>. Saquinavir is bound to the domain I of ERBB3 extracellular domain (Fig. ##FIG##3##4##f), which is one of the domains involved in ligand binding and inhibition may prevent activation of downstream signaling pathways that play a role in the growth of cancer cells.</p>", "<p id=\"Par35\">Tipranavir and indinavir also bind to the interface formed between EGFR and ERBB2, with a lower binding energy to ERBB2 protein chain (Fig. ##FIG##3##4##h,j). The complex consists of chain A of structure with PDB ID 1YY9 and chain A of structure with PDB ID 3N85 representing EGFR extracellular domain and ERBB2 extracellular domain, respectively. ERBB2, also known as HER2, is another member of ErbB family. Thus, its extracellular domain consists of four subdomains where subdomains I and III are involved in ligand binding<sup>##REF##3260004##69##</sup> and subdomains II and IV play roles in homodimerization and heterodimerization<sup>##REF##7784095##70##</sup>. EGFR-ERBB2 heterodimer activates MAPK pathway, preventing apoptosis<sup>##REF##20385184##71##</sup>. Overexpression of ERBB2 is highly related to breast cancer and is observed in 20–30% of all breast cancers<sup>##REF##17547474##72##</sup>. Upregulation of ERBB2 expression may promote cell proliferation and can further lead to tumorigenesis<sup>##REF##20951604##73##</sup>. Amplification of ERBB2 also occurs in 10–30% of gastric cancers and has been associated with different types of cancer, such as ovary, colon, and bladder cancers<sup>##REF##17143264##74##–##REF##25276427##76##</sup>. Consequently, ERBB2 has become a therapeutic target of interest. Trastuzumab is a monoclonal antibody used in breast and gastric cancer and targets ERBB2<sup>##REF##19916733##77##,##REF##17096862##78##</sup>. There are also other therapeutic strategies that are developed for patients with trastuzumab resistance. Dual tyrosine kinase inhibitor lapatinib is one of them and targets both EGFR and ERBB2<sup>##REF##16894399##79##</sup>. Moreover, recombinant humanized ERBB2 monoclonal antibody pertuzumab prevents dimerization of ERBB2 with EGFR and ERBB3 to prevent activation of downstream pathways, which is demonstrated to be inhibiting breast and prostate tumor growth<sup>##REF##17096862##78##,##REF##12204533##80##</sup>. Since tipranavir and indinavir bind to the domain III of ERBB2 extracellular domain and are at the EGFR-ERBB2 interface according to our results, they may disrupt the heterodimer and prevent the cell signaling. Therefore, these HIV protease inhibitors may be repurposed for tumor growth inhibition. There have been studies on repurposing of HIV protease inhibitor nelfinavir for cancer, suggesting its mechanism of action involves inhibition of MAPK signaling pathway<sup>##REF##33228205##81##,##REF##28137980##82##</sup>. Moreover, the phase II clinical trial of indinavir for non-HIV associated classic Kaposi’s Sarcoma reported positive outcome after receiving treatment for 61.5% of the patients<sup>##REF##19169139##83##</sup>. Furthermore, a study demonstrated that tipranavir induced apoptosis of gastric cancer stem cells by targeting PRSS23-IL24 pathway<sup>##UREF##18##84##</sup>. Hence, the HIV protease inhibitors that we reported in our results may be repurposing candidates for cancer.</p>", "<p id=\"Par36\">Regarding the toxicity of HIV protease inhibitors in combination with chemotherapies or radiotherapy, the clinical trials of nelfinavir for cancer therapy might give insight. In the phase I trial of nelfinavir in combination with chemoradiotherapy on unresectable stage IIIa/IIIb non-small cell lung cancer (NSCLC), Rengan et al. reported that nelfinavir administered 7 to 14 days before or at the same time with cisplatin, etoposide, and radiotherapy at a dose of 66.6 Gy resulted in no predetermined dose-limiting toxicity<sup>##REF##33228205##81##,##REF##22425919##85##</sup>. In the phase II trial conducted by 35 patients with IIIa/IIIb NSCLC by Rengan et al., no unexpected grade 3 or 4 toxicities were observed apart from those of standard chemoradiotherapy<sup>##REF##33228205##81##,##REF##31436839##86##</sup>. Moreover, Brunner et al. reported that nelfinavir with concurrent chemoradiotherapy did not exhibit any additional toxicity in the phase I clinical trial in inoperable locally advanced pancreatic cancer patients<sup>##REF##33228205##81##,##REF##18509182##87##</sup>.</p>", "<p id=\"Par37\">The interface formed between RAF1 and BRAF also has drugs that have low binding energy. RAF1, also known as CRAF, and BRAF are both members of Raf kinase family along with ARAF. Their structure is comprised of three conserved regions (CR), namely, C1 with Ras-binding domain and cysteine-rich domain; CR2 with serine/threonine-rich region; and CR3 involving kinase domain<sup>##REF##15943972##88##</sup>. Heterodimer of BRAF and RAF1 formation is induced by growth factor-stimulated RAS and activates MEK and ERK to promote cell proliferation, differentiation, survival, and migration<sup>##REF##11325826##89##,##REF##25907612##90##</sup>. BRAF-RAF1 heterodimer is the most active dimer compared to their homodimers in MEK1/2 activation<sup>##REF##29992710##91##,##UREF##19##92##</sup>. BRAF mutation is observed in nearly 8% of all cancers and is mostly associated with melanoma<sup>##REF##12068308##93##</sup>. Mutated RAF1 is less common in human cancers but mutation in RAF1 may lead to Noonan syndrome which is a disorder that includes short stature, facial dysmorphology, and congenital heart defects<sup>##REF##24957944##94##,##REF##17222357##95##</sup>. Also, it is reported that increased BRAF heterodimerization with RAF1 is associated with RAF1 mutations related to Noonan syndrome<sup>##REF##22826437##96##</sup>. Since mutation in BRAF also promotes MAPK signaling pathway activation and tumorigenesis, it has been identified as a target in cancer therapy<sup>##REF##29992710##91##</sup>.</p>", "<p id=\"Par38\">According to our results, granisetron and galantamine bind to BRAF with favorable energy at the interface formed between BRAF (PDB ID:6Q0K Chain ID:A) and Ras binding domain and cysteine-rich domain of RAF1 (PDB ID:6XGU Chain ID:B) (Fig. ##FIG##3##4##l,n). Granisetron is a serotonin type 3 (5-HT3) receptor antagonist used as an antinauseant for cancer chemotherapy patients<sup>##UREF##20##97##</sup>. There are several studies where some other drugs binding to a serotonin receptor are proposed as anticancer agents. For example, tegaserod which is a serotonin receptor 4 (HTR4) agonist is reported to be inducing apoptosis in B16F10 murine melanoma cell line and some human melanoma cell lines by perturbing PI3K/Akt/mTOR pathway<sup>##REF##32085796##98##</sup>. In another study, methiothepin which is a nonselective serotonin 5-HT receptor antagonist is reported to be increasing the efficacy of chemotherapy when used along with doxorubicin, against melanoma cells<sup>##REF##33810240##99##</sup>. The same study shows that methiothepin also enhances the efficacy of BRAF inhibitor vemurafenib and MEK inhibitor trametinib, used against resistant BRAFV600E melanoma cells.</p>", "<p id=\"Par39\">Galantamine is an acetylcholinesterase inhibitor used in the treatment of Alzheimer’s disease<sup>##REF##18088197##100##</sup>. Abnormal expression of acetylcholinesterase is observed in several tumors, therefore, is associated with tumor development<sup>##REF##12889604##101##–##REF##2394839##106##</sup>. As a result, some acetylcholinesterase inhibitors may be considered as possible anti-cancer agents for the cancer types where increased activity of acetylcholinesterase is observed<sup>##REF##28685687##107##</sup>. Inhibition of the MAPK pathway may be another mechanism when using acetylcholinesterase inhibitor galantamine as an anti-cancer agent.</p>", "<p id=\"Par40\">Both granisetron and galantamine are bound to the kinase domains<sup>##REF##24293656##108##,##UREF##21##109##</sup> according to our results. BRAF inhibitors such as sorafenib also bind to the kinase domain of BRAF (PDB ID:1UWH) and if these drugs also act as BRAF inhibitors or disrupt the BRAF-RAF1 protein interface, they can be potential anti-cancer drugs. However, in some cases, a BRAF inhibitor such as vemurafenib, binding to BRAF leads to inhibition of BRAF but transactivation of RAF1 further leads to activation of MEK and ERK. To prevent paradoxical activation, a high level of RAF inhibitor that acts on both BRAF and RAF1 may be used<sup>##REF##22340588##110##</sup>.</p>", "<p id=\"Par41\">Additionally, somatic mutations in human cancers are mapped to interfaces of the 3-dimensional structures of the protein complexes used in this study via COSMIC database<sup>##UREF##12##49##</sup> and SIFTS UniProt-PDB mappings<sup>##UREF##22##111##</sup> on PDBe API<sup>##REF##36173162##112##</sup>. COSMIC database<sup>##UREF##12##49##</sup> provides manually curated mutation information of tumor samples including mutation types. Here, nonsense mutations that stop the translation prematurely and missense mutations that result in encoding of different amino acids at that location are mapped. For the ERBB3–EGFR complex, the interface mutation with the highest frequency for ERBB3 is observed in 0.006% of the samples and they are from endometrium, large intestine, and bile duct tumors. In contrast, the highest frequency for the interface mutations of EGFR is 0.007%, from the samples of large intestine and lung carcinoma (Supplementary Table ##SUPPL##0##S9##). Recurrent ERBB3 mutations are observed in colon and gastric cancers and there are various studies on characterization of ERBB3 mutations in cancer<sup>##REF##23680147##113##,##REF##31519989##114##</sup>. However, the mapped ERBB3 mutations located at the interface of ERBB3–EGFR complex have not been characterized as oncogenic mutations in these studies<sup>##REF##23680147##113##,##REF##31519989##114##</sup>. Considering EGFR mutations at the interface, G465R and S492R are identified to be related to cetuximab resistance, while S492R does not affect panitumumab binding in colorectal cancer treatment<sup>##REF##25623215##115##,##UREF##23##116##</sup>. Residue G465 of EGFR is one of the contacting residues of indinavir at ERBB3–EGFR interface in our study and might affect the binding. For the BRAF-RAF1 complex, the highest frequency of mapped mutations is 0.005% for RAF1 and they are from various tissues such as large intestine, brain, and endometrium. RAF1 mutations located at the interface of BRAF–RAF1 complex are checked in PanCancer Studies<sup>##REF##32025007##117##–##REF##28481359##126##</sup> on cBioPortal<sup>##REF##22588877##127##</sup> and it is seen that their oncogenic effects are marked as unknown<sup>##REF##22588877##127##</sup>. For BRAF, the highest frequency is 0.003% from mutations in the samples of ovary, lung, kidney, skin and lymphoid at the E586 position. The BRAF mutation E586K has been identified to be related to lung adenocarcinoma<sup>##REF##31534501##128##</sup> and kinase activity is increased in COS cells that exhibit this mutation<sup>##REF##15035987##129##</sup>. Moreover, it is reported that HEK293 cells with BRAF E586K showed sensitivity to pan-RAF inhibitor (LY3009120) by inhibited phospho-MEK and -ERK activities<sup>##REF##26343583##130##</sup>. The mutations E586K, H725Y, and H725Q are marked as likely to be oncogenic on cBioPortal<sup>##REF##22588877##127##</sup> but these mutations are not located at the contacting residues of granisetron or galantamine in our study. At the interface of ERBB2–EGFR complex, ERBB2 has mutations with the frequency of 0.002% observed in tissues like skin, ovary, and stomach. In contrast, the highest mutation frequency for EGFR is 0.007%, observed in large intestine and lung tissues. The ERBB2 mutations at the interface of ERBB2–EGFR complex are not mentioned as one of the activating/oncogenic mutations of ERBB2<sup>##REF##30951733##131##</sup> or available in cBioPortal<sup>##REF##22588877##127##</sup>. On the other hand, EGFR mutations S464L, G465R, K467T, and S492R observed in cetuximab resistance in colorectal cancer treatment<sup>##REF##25623215##115##,##UREF##23##116##</sup> are located at the contacting residues of tipranavir and indinavir while I491M is also a contacting residue of indinavir in our study. The protein structures that we used in our studies do not exhibit these mutations and the mutations may change the protein–protein interactions and the interaction with the drug. However, not all of the people with cancer have these mutations considering the frequency of the mutations among the tumor samples, and not all of the mutations have a functional effect on the protein (Supplementary Table ##SUPPL##0##S9##).</p>", "<p id=\"Par42\">This study relying on structural similarities of protein–protein interfaces revealed that indinavir, tipranavir, and saquinavir originally used for HIV infection treatment may bind to EGFR-ERBB3 and/or EGFR-ERBB2 interfaces and can be repurposed for cancer treatment. Additionally, the Alzheimer’s disease drug galantamine and antiemetic drug granisetron may bind to BRAF-RAF1 interface and can be used as anti-cancer agents to prevent tumor growth. Even though these results present candidates for drug repurposing, they should be validated by experiments and clinical trials.</p>" ]
[ "<title>Conclusions</title>", "<p id=\"Par43\">Drug repurposing is a strategy that can be adopted to save time and money by reducing drug development timeline and research and development process cost. Hence, it is an effective alternative to conventional drug development. Different approaches for drug repurposing involve methods based on similarities in drugs, targets, or diseases. Here, we focused on the structural target similarities considering protein–protein interfaces formed by proteins involved in Ras/Raf/MEK/ERK signaling pathway. This pathway plays a role in cell signaling that regulates cell proliferation, differentiation, and apoptosis; therefore, it is highly related to cancer and tumor progression. The protein–protein interfaces studied in this work either have been predicted by PRISM according to physically interacting proteins in STRING database or obtained from Protein Data Bank. Candidates for drug repurposing are suggested considering the binding free energy prediction of the drug to the protein interface that is structurally similar to its original target by docking.</p>", "<p id=\"Par44\">We report that HIV protease inhibitors tipranavir, indinavir, and saquinavir can bind to EGFR-ERBB3 interface. Additionally, tipranavir and indinavir can bind to EGFR-ERBB2 interface. Furthermore, we report that galantamine used in Alzheimer’s disease treatment and the antiemetic drug granisetron can bind to RAF1–BRAF interface. These protein interfaces are involved in signal transduction that activates Ras/Raf/MEK/ERK signaling pathway leading to biological processes that promote tumor growth. Hence, disruption of these interfaces may interrupt the transduction of the signals associated with cancer. Consequently, these drugs are proposed to be repurposed as anti-cancer agents.</p>", "<p id=\"Par45\">Although our results present some candidates for drug repurposing and are important in identification of the compound to be repurposed, in-silico drug repurposing approach needs to be supported by experimental data that shows the complete effect of the drug. Thus, candidates suggested in this work should be validated experimentally and by clinical trials in future studies.</p>" ]
[ "<p id=\"Par1\">We focus on drug repurposing in the Ras signaling pathway, considering structural similarities of protein–protein interfaces. The interfaces formed by physically interacting proteins are found from PDB if available and via PRISM (PRotein Interaction by Structural Matching) otherwise. The structural coverage of these interactions has been increased from 21 to 92% using PRISM. Multiple conformations of each protein are used to include protein dynamics and diversity. Next, we find FDA-approved drugs bound to structurally similar protein–protein interfaces. The results suggest that HIV protease inhibitors tipranavir, indinavir, and saquinavir may bind to EGFR and ERBB3/HER3 interface. Tipranavir and indinavir may also bind to EGFR and ERBB2/HER2 interface. Additionally, a drug used in Alzheimer's disease can bind to RAF1 and BRAF interface. Hence, we propose a methodology to find drugs to be potentially used for cancer using a dataset of structurally similar protein–protein interface clusters rather than pockets in a systematic way.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-023-50913-8.</p>", "<title>Acknowledgements</title>", "<p>We would like to thank Prof. Ruth Nussinov, Dr. Hyunbum Jang and Assoc. Prof. Nurcan Tuncbag for their valuable comments. This project has been partially funded by TUSEB 4448/4081 and TUBITAK 2247-120C120.</p>", "<title>Author contributions</title>", "<p>A.Z.S. did all the calculations and wrote the original draft of the manuscript, A.G. and O.K. designed, analyzed the data and edited the manuscript. A.Z.S., O.K. and A.G. edited the manuscript. Z.A., S.S. and F.C. provided data.</p>", "<title>Data availability</title>", "<p>PRISM is accessible through the PRISM webserver (<ext-link ext-link-type=\"uri\" xlink:href=\"https://cosbi.ku.edu.tr/prism/\">https://cosbi.ku.edu.tr/prism/</ext-link>). The codes for grouping the alternative conformations are available on GitHub (<ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/ku-cosbi/ppi-network-alternative\">https://github.com/ku-cosbi/ppi-network-alternative</ext-link>). All PRISM results and docking results of the proposed drugs are available on GitHub (<ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/ku-cosbi/RasPathwayDrugRepurposing\">https://github.com/ku-cosbi/RasPathwayDrugRepurposing</ext-link>). Drug sensitivity data can be accessed from DepMap portal (<ext-link ext-link-type=\"uri\" xlink:href=\"https://depmap.org/portal/\">https://depmap.org/portal/</ext-link>) (Accessed 18 Aug. 2023). Other data used in this work can be found in ##SUPPL##0##supplementary materials##.</p>", "<title>Competing interests</title>", "<p id=\"Par61\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Protein–protein interactions with multiple conformations. Interacting proteins, Protein 1 (P1) and Protein 2 (P2) have three and two conformations, respectively. Considering the multiple conformations of each protein, there are six possible interactions in theory (represented with grey edges) but in reality, only some of these interactions can be found (three of them in this case).</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Protein–protein interaction network of Ras/Raf/MEK/ERK signaling pathway. Nodes represent proteins and proteins connected by edges represent the interaction between those proteins. If the edge is black, the complex of interacting proteins is available in PDB. If the edge is purple, the complex is not available in PDB but is predicted by PRISM. If the edge is a dashed line, the complex is neither available in PDB nor predicted by PRISM<sup>##UREF##9##42##</sup>.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Identification of new drug–target pairs. A solid line represents a drug bound to an interface. Identified new drug–target pairs are represented with a dotted line with an arrow.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>ERBB3–EGFR, ERBB2–EGFR, RAF1–BRAF interface results. (<bold>a</bold>) ERBB3–EGFR, ERBB2–EGFR and BRAF–RAF1 complexes. (<bold>b</bold>) Tipranavir with EGFR (4UIP_A), represented in pink with domain III in darker shade<sup>##REF##10592235##32##,##REF##20368142##47##</sup>, and its original target HIV protease (1D4S_A). (<bold>c</bold>) Structural alignment of EGFR and HIV protease interfaces with tipranavir<sup>##UREF##11##45##</sup>. (<bold>d</bold>) Indinavir with EGFR (4UIP_A), represented in pink with domain III in darker shade<sup>##REF##10592235##32##,##REF##20368142##47##</sup>, and its original target HIV protease (1HSH_A). (<bold>e</bold>) Structural alignment of EGFR and HIV protease interfaces with indinavir<sup>##UREF##11##45##</sup>. (<bold>f</bold>) Saquinavir with ERBB3 (4LEO_C), represented in orange with domain I in darker shade<sup>##REF##10592235##32##,##REF##20368142##47##</sup>, and its original target HIV protease (1HXB_A). (<bold>g</bold>) Structural alignment of ERBB3 and HIV protease interfaces with saquinavir<sup>##UREF##11##45##</sup>. (<bold>h</bold>) Tipranavir with ERBB2 (3N85_A), represented in blue with domain III in darker shade<sup>##REF##10592235##32##,##REF##20368142##47##</sup>, and its original target HIV protease (1D4S_B). (<bold>i</bold>) Structural alignment of ERBB2 and HIV protease interfaces with tipranavir<sup>##UREF##11##45##</sup>. (<bold>j</bold>) Indinavir with ERBB2 (3N85_A), represented in blue with domain III in darker shade<sup>##REF##10592235##32##,##REF##20368142##47##</sup>, and its original target HIV protease (1HSH_A). (<bold>k</bold>) Structural alignment of ERBB2 and HIV protease interfaces with indinavir<sup>##UREF##11##45##</sup>. (<bold>l</bold>) Galantamine with BRAF (6Q0K_A) and its original target acetylcholine binding protein (2PH9_C). (<bold>m</bold>) Structural alignment of BRAF and acetylcholine binding protein with galantamine<sup>##UREF##11##45##</sup>. (<bold>n</bold>) Granisetron with BRAF (6Q0K_A) and its original target mutant binding protein (2YME_A). (<bold>o</bold>) Structural alignment of BRAF and mutant binding protein with granisetron<sup>##UREF##11##45##</sup> (Molecular graphics performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, supported by NIH P41-GM103311.0<sup>##REF##15264254##48##</sup>. Ligand–protein interactions and structural alignment are performed with LigPlot<sup>##REF##21919503##46##</sup> and MultiProt<sup>##UREF##11##45##</sup>, respectively).</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Cancer mutations at the interface of the protein–protein complexes (<bold>a</bold>) ERBB3–EGFR complex with cancer mutation residues colored according to frequency. (<bold>b</bold>) BRAF–RAF1 complex with cancer mutation residues colored according to frequency. (<bold>c</bold>) ERBB2–EGFR complex with cancer mutation residues colored according to frequency.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Sensitivity of cancer cells to cancer drugs and proposed drug repurposing candidates. (<bold>a</bold>) Sensitivity of cancer cells to EGFR/ERBB2 inhibitors erlotinib, gefitinib, lapatinib, afatinib, dacomitinib, and osimertinib in comparison to drug repurposing candidates tipranavir, indinavir, and saquinavir with their mean sensitivity, 95% confidence interval (CI) and standard deviation (SD). (<bold>b</bold>) Sensitivity of cancer cells to BRAF/RAF1 inhibitors dabrafenib and vemurafenib compared with drug repurposing candidates galantamine and granisetron and their mean sensitivity, 95% CI and SD.</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>Workflow of the study. A list of proteins in the Ras/Raf/MEK/ERK signaling pathway is constructed from the KEGG and STRING databases. Their three-dimensional structures are found in the Protein Data Bank (PDB). These structures are grouped to obtain alternative conformations. The protein–protein interfaces formed by these proteins in PDB entries are determined or predicted via a template-based protein–protein docking tool. The interfaces with approved drugs are filtered using the FDA-approved drugs dataset and new drug–target pairs are identified using a structurally clustered protein–protein interface dataset. Then, docking is performed to propose drug repurposing candidates.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Proposed drug repurposing candidates.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Chain 1<sup>a</sup></th><th align=\"left\">Chain 2<sup>a</sup></th><th align=\"left\">Drug name</th><th align=\"left\">Ligand ID</th><th align=\"left\">Original interfaces with the drug<sup>b</sup></th><th align=\"left\">ΔG (kcal/mol)</th></tr></thead><tbody><tr><td align=\"left\"><p>ERBB3</p><p>(4LEO_C)</p></td><td align=\"left\"><p><bold>EGFR</bold></p><p><bold>(4UIP_A)</bold></p></td><td align=\"left\">Tipranavir</td><td align=\"left\">TPV</td><td align=\"left\"><p>HIV-1 Protease</p><p>(1D4S_A_B)</p></td><td align=\"left\">− 7.334</td></tr><tr><td align=\"left\"><p>RAF1</p><p>(6XGU_B)</p></td><td align=\"left\"><p><bold>BRAF</bold></p><p><bold>(6Q0K_A)</bold></p></td><td align=\"left\">Granisetron</td><td align=\"left\">CWB</td><td align=\"left\"><p>Mutant Binding Protein</p><p>(5HTBP-AchBP)</p><p>(2YME_A_B)</p></td><td align=\"left\">− 7.580</td></tr><tr><td align=\"left\"><p>ERBB3</p><p>(4LEO_C)</p></td><td align=\"left\"><p><bold>EGFR</bold></p><p><bold>(4UIP_A)</bold></p></td><td align=\"left\">Indinavir</td><td align=\"left\">MK1</td><td align=\"left\"><p>HIV-II Protease</p><p>(1HSH_A_B)</p></td><td align=\"left\">− 7.532</td></tr><tr><td align=\"left\"><p>RAF1</p><p>(6XGU_B)</p></td><td align=\"left\"><p><bold>BRAF</bold></p><p><bold>(6Q0K_A)</bold></p></td><td align=\"left\">Galantamine</td><td align=\"left\">GNT</td><td align=\"left\"><p>Ach-binding Protein</p><p>(2PH9_C_D)</p></td><td align=\"left\">− 7.382</td></tr><tr><td align=\"left\"><p><bold>ERBB3</bold></p><p><bold>(4LEO_C)</bold></p></td><td align=\"left\"><p>EGFR</p><p>(4UIP_A)</p></td><td align=\"left\">Saquinavir</td><td align=\"left\">ROC</td><td align=\"left\"><p>HIV-1 Protease</p><p>(1HXB_A_B)</p></td><td align=\"left\">− 7.379</td></tr><tr><td align=\"left\"><p><bold>ERBB2</bold></p><p><bold>(3N85_A)</bold></p></td><td align=\"left\"><p>EGFR</p><p>(1YY9_A)</p></td><td align=\"left\">Tipranavir</td><td align=\"left\">TPV</td><td align=\"left\"><p>HIV-1 Protease</p><p>(1D4S_A_B)</p></td><td align=\"left\">− 7.351</td></tr><tr><td align=\"left\"><p><bold>ERBB2</bold></p><p><bold>(3N85_A)</bold></p></td><td align=\"left\"><p>EGFR</p><p>(1YY9_A)</p></td><td align=\"left\">Indinavir</td><td align=\"left\">MK1</td><td align=\"left\"><p>HIV-II Protease</p><p>(1HSH_A_B)</p></td><td align=\"left\">− 7.302</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>" ]
[ "<table-wrap-foot><p><sup>a</sup>The chains that the drug is bound are in bold.</p><p><sup>b</sup>Only one of the interfaces that the drug is originally bound to is provided in the table. All interfaces are presented in Supplementary Table ##SUPPL##0##S6##.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2023_50913_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2023_50913_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2023_50913_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2023_50913_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2023_50913_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2023_50913_Fig6_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"41598_2023_50913_Fig7_HTML\" id=\"MO7\"/>" ]
[ "<media xlink:href=\"41598_2023_50913_MOESM1_ESM.xlsx\"><caption><p>Supplementary Information.</p></caption></media>", "<media xlink:href=\"41598_2023_50913_MOESM2_ESM.docx\"><caption><p>Supplementary Figures.</p></caption></media>" ]
[{"label": ["4."], "surname": ["Pushpakom"], "given-names": ["S"], "source": ["Drug Repurposing"], "year": ["2022"], "publisher-name": ["The Royal Society of Chemistry"], "fpage": ["1"], "lpage": ["13"]}, {"label": ["12."], "surname": ["Plotnikov", "Zehorai", "Procaccia", "Seger"], "given-names": ["A", "E", "S", "R"], "article-title": ["The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation"], "source": ["Biochim. Biophys. Acta BBA Mol. Cell Res."], "year": ["2011"], "volume": ["1813"], "fpage": ["1619"], "lpage": ["1633"], "pub-id": ["10.1016/j.bbamcr.2010.12.012"]}, {"label": ["13."], "surname": ["Shaul", "Seger"], "given-names": ["YD", "R"], "article-title": ["The MEK/ERK cascade: From signaling specificity to diverse functions"], "source": ["Biochim. Biophys. Acta (BBA) Mol. Cell Res."], "year": ["2007"], "volume": ["1773"], "fpage": ["1213"], "lpage": ["1226"], "pub-id": ["10.1016/j.bbamcr.2006.10.005"]}, {"label": ["20."], "surname": ["Schreiber"], "given-names": ["G"], "source": ["Protein\u2013Protein Interaction Regulators"], "year": ["2021"], "publisher-name": ["The Royal Society of Chemistry"], "fpage": ["1"], "lpage": ["24"]}, {"label": ["24."], "mixed-citation": ["Keskin, O., Haliloglu, T., Ma, B. & Nussinov, R. in "], "italic": ["Biophysical Journal"]}, {"label": ["31."], "surname": ["Weagel", "Foulks", "Siddiqui", "Warner"], "given-names": ["EG", "JM", "A", "SL"], "article-title": ["Molecular glues: Enhanced protein-protein interactions and cell proteome editing"], "source": ["Med. Chem. Res."], "year": ["2022"], "volume": ["31"], "fpage": ["1068"], "lpage": ["1087"], "pub-id": ["10.1007/s00044-022-02882-2"]}, {"label": ["37."], "surname": ["Kanehisa", "Furumichi", "Sato", "Ishiguro-Watanabe", "Tanabe"], "given-names": ["M", "M", "Y", "M", "M"], "article-title": ["KEGG: Integrating viruses and cellular organisms"], "source": ["Nucleic Acids Res."], "year": ["2020"], "volume": ["49"], "fpage": ["D545"], "lpage": ["D551"], "pub-id": ["10.1093/nar/gkaa970"]}, {"label": ["39."], "surname": ["Szklarczyk"], "given-names": ["D"], "article-title": ["STRING v11: Protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets"], "source": ["Nucleic Acids Res."], "year": ["2018"], "volume": ["47"], "fpage": ["D607"], "lpage": ["D613"], "pub-id": ["10.1093/nar/gky1131"]}, {"label": ["41."], "surname": ["Varadi"], "given-names": ["M"], "article-title": ["AlphaFold protein structure database: Massively expanding the structural coverage of protein-sequence space with high-accuracy models"], "source": ["Nucleic Acids Res."], "year": ["2021"], "volume": ["50"], "fpage": ["D439"], "lpage": ["D444"], "pub-id": ["10.1093/nar/gkab1061"]}, {"label": ["42."], "mixed-citation": ["Perrone, G., Unpingco, J. & Lu, H.-M. "], "italic": ["Network visualizations with Pyvis and VisJS"]}, {"label": ["43."], "surname": ["Abali"], "given-names": ["Z"], "source": ["A data-centric approach for investigation of protein-protein interfaces in Protein Data Bank Data Science thesis"], "year": ["2021"], "publisher-name": ["Koc University"]}, {"label": ["45."], "surname": ["Shatsky", "Nussinov", "Wolfson"], "given-names": ["M", "R", "HJ"], "article-title": ["A method for simultaneous alignment of multiple protein structures"], "source": ["Proteins Struct. Funct. Bioinform."], "year": ["2004"], "volume": ["56"], "fpage": ["143"], "lpage": ["156"], "pub-id": ["10.1002/prot.10628"]}, {"label": ["49."], "surname": ["Tate"], "given-names": ["JG"], "article-title": ["COSMIC: The catalogue of somatic mutations in cancer"], "source": ["Nucleic Acids Res."], "year": ["2018"], "volume": ["47"], "fpage": ["D941"], "lpage": ["D947"], "pub-id": ["10.1093/nar/gky1015"]}, {"label": ["52."], "surname": ["Wishart"], "given-names": ["DS"], "article-title": ["DrugBank 5.0: A major update to the DrugBank database for 2018"], "source": ["Nucleic Acids Res."], "year": ["2017"], "volume": ["46"], "fpage": ["D1074"], "lpage": ["D1082"], "pub-id": ["10.1093/nar/gkx1037"]}, {"label": ["53."], "surname": ["Herbst"], "given-names": ["RS"], "article-title": ["Review of epidermal growth factor receptor biology"], "source": ["Int. J. Radiat. Oncol. Biol. Phys."], "year": ["2004"], "volume": ["59"], "fpage": ["S21"], "lpage": ["S26"], "pub-id": ["10.1016/j.ijrobp.2003.11.041"]}, {"label": ["61."], "surname": ["Jena"], "given-names": ["B"], "article-title": ["Specifically targeting the interface between HER1-HER3 heterodimer on breast cancer to limit off-target effects using chimeric antigen receptor designs with improved T-cell energy balance"], "source": ["Blood"], "year": ["2014"], "volume": ["124"], "fpage": ["2151"], "pub-id": ["10.1182/blood.V124.21.2151.2151"]}, {"label": ["62."], "surname": ["Arena"], "given-names": ["S"], "article-title": ["MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations"], "source": ["Sci. Transl. Med."], "year": ["2016"], "volume": ["8"], "fpage": ["324ra314"], "pub-id": ["10.1126/scitranslmed.aad5640"]}, {"label": ["68."], "surname": ["Scholar", "Enna", "Bylund"], "given-names": ["E", "SJ", "DB"], "source": ["xPharm: The Comprehensive Pharmacology Reference"], "year": ["2007"], "publisher-name": ["Elsevier"], "fpage": ["1"], "lpage": ["5"]}, {"label": ["84."], "mixed-citation": ["Xiong, J. "], "italic": ["et al."]}, {"label": ["92."], "surname": ["Cook", "Cook"], "given-names": ["FA", "SJ"], "article-title": ["Inhibition of RAF dimers: It takes two to tango"], "source": ["Biochem. Soc. Trans."], "year": ["2020"], "volume": ["49"], "fpage": ["237"], "lpage": ["251"], "pub-id": ["10.1042/bst20200485"]}, {"label": ["97."], "surname": ["Aapro"], "given-names": ["MS"], "article-title": ["Review of experience with ondansetron and granisetron"], "source": ["Ann. Oncol."], "year": ["1993"], "volume": ["4"], "fpage": ["S9"], "lpage": ["S14"], "pub-id": ["10.1093/annonc/4.suppl_3.S9"]}, {"label": ["109."], "surname": ["Andreeva", "Kulesha", "Gough", "Murzin"], "given-names": ["A", "E", "J", "AG"], "article-title": ["The SCOP database in 2020: Expanded classification of representative family and superfamily domains of known protein structures"], "source": ["Nucleic Acids Res."], "year": ["2019"], "volume": ["48"], "fpage": ["D376"], "lpage": ["D382"], "pub-id": ["10.1093/nar/gkz1064"]}, {"label": ["111."], "surname": ["Dana"], "given-names": ["JM"], "article-title": ["SIFTS: Updated Structure Integration with Function, Taxonomy and Sequences resource allows 40-fold increase in coverage of structure-based annotations for proteins"], "source": ["Nucleic Acids Res."], "year": ["2018"], "volume": ["47"], "fpage": ["D482"], "lpage": ["D489"], "pub-id": ["10.1093/nar/gky1114"]}, {"label": ["116."], "surname": ["Newhall"], "given-names": ["K"], "article-title": ["Frequency of S492R mutations in the epidermal growth factor receptor: Analysis of plasma Dna from metastatic colorectal cancer patients treated with panitumumab or cetuximab monotherapy"], "source": ["Ann. Oncol."], "year": ["2014"], "volume": ["25"], "fpage": ["ii109"], "pub-id": ["10.1093/annonc/mdu193.11"]}, {"label": ["132."], "collab": ["UniProt Consortium"], "article-title": ["UniProt: The universal protein knowledgebase in 2021"], "source": ["Nucleic Acids Res."], "year": ["2020"], "volume": ["49"], "fpage": ["D480"], "lpage": ["D489"], "pub-id": ["10.1093/nar/gkaa1100"]}, {"label": ["133."], "surname": ["Halakou", "Gursoy", "Keskin", "Canzar", "Ringeling"], "given-names": ["F", "A", "O", "S", "FR"], "source": ["Protein-Protein Interaction Networks: Methods and Protocols"], "year": ["2020"], "publisher-name": ["Springer, US"], "fpage": ["113"], "lpage": ["124"]}, {"label": ["137."], "surname": ["Vera", "Czarny", "Georgiadis", "Dive", "Stura"], "given-names": ["L", "B", "D", "V", "EA"], "article-title": ["Practical use of glycerol in protein crystallization"], "source": ["Crystal Growth Design"], "year": ["2011"], "volume": ["11"], "fpage": ["2755"], "lpage": ["2762"], "pub-id": ["10.1021/cg101364m"]}, {"label": ["140."], "surname": ["Nguyen", "Schmidt", "Kwoh"], "given-names": ["T-D", "B", "C-K"], "article-title": ["SparseHC: A memory-efficient online hierarchical clustering algorithm"], "source": ["Procedia Comput. Sci."], "year": ["2014"], "volume": ["29"], "fpage": ["8"], "lpage": ["19"], "pub-id": ["10.1016/j.procs.2014.05.001"]}]
{ "acronym": [ "CDK4", "CDK6", "CDKN2D", "EGF", "EGFR", "ERK", "FDA", "HIV", "HTR4", "MAPK", "MEK", "mTOR", "PDB", "PI3K", "PPI" ], "definition": [ "Cyclin-dependent kinase 4", "Cyclin-dependent kinase 6", "Cyclin-dependent kinase inhibitor 2D", "Epidermal growth factor", "Epidermal growth factor receptor", "Extracellular signal-regulated kinase", "Food and Drug Administration", "Human immunodeficiency virus", "Human serotonin receptor 4", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "Mammalian target of rapamycin", "Protein Data Bank", "Phosphatidylinositol-3 kinase", "Protein–protein interaction" ] }
145
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1239
oa_package/22/70/PMC10786864.tar.gz
PMC10786865
38216605
[ "<title>Introduction</title>", "<p id=\"Par2\">Cardiovascular diseases (CVD) continue to be the leading cause of unprecedented global public health and economic implications<sup>##REF##27500157##1##</sup>. In fact, CVD mortalities represent approximately one-third of all deaths worldwide annually<sup>##REF##36517116##2##–##UREF##0##4##</sup>. This is particularly true for Acute coronary syndromes (ACS), which constitute most of the mortalities caused by CVDs<sup>##REF##35078371##3##</sup>. Cardiac catheterization, percutaneous coronary intervention (PCI), and angiography are considered the gold standards in ACS diagnosis and intervention among clinicians<sup>##REF##28884447##5##</sup>. Among these tools, cardiac catheterization is the most common cardiac intervention approach used worldwide, with more than 1 million procedures being performed annually in the United States alone<sup>##UREF##1##6##</sup>. Yet, the complexity of the epidemiology of ACS poses a remarkable challenge to the intervention capacity of primary and secondary care clinicians, leading to patient-related and procedure-related complications. However, risk stratification tools developed in the past few decades remarkably helped clinicians improve their diagnostic and prognostic efforts. These risk stratification tools were derived from large population-based studies and traditional statistical methods designed to capture comparisons and insights into the risk factors that predict ACS adverse events resulting from patient clinical conditions and in-hospital procedures. Yet, most of these tools neglect complex interactions and non-linear relationships between such risk factors, which are the primary cause for hindering their prediction’s accuracy on the individual level and, hence, their epidemiological plausibility. Machine learning (ML) models do not assume linear relationships and flexibly accommodate higher-order interactions to make more robust individualized predictions<sup>##REF##31535314##7##,##REF##35073375##8##</sup>.</p>", "<p id=\"Par3\">Accounting for interactions in clinical predictions is statistically and epidemiologically critical, as the range of complications is multifactorial, which, for example, depends on whether the procedure is diagnostic or interventional, patient demographics, comorbidities, clinical symptoms at the time of presentation, and experience of the operating clinician<sup>##UREF##1##6##</sup>. Also, complications can be either minor, such as discomfort at the operating site or significant such as myocardial infarction or death. Patients with severe comorbidities such as congestive heart failure or chronic renal failure are at higher risk of complications<sup>##REF##31284736##9##</sup>. Furthermore, the long-term benefits and complications from highly invasive interventions combined with the patient's risk status, such as their age or comorbidities, need to be considered. Clinicians commonly resort to early risk stratification tools which are commonly used to classify patients’ susceptibility to different ACS events according to their individual risk profile at the time of presentation. Popular risk stratification includes thrombolysis in myocardial infarction (TIMI)<sup>##REF##10938172##10##</sup> or global registry of acute coronary events (GRACE)<sup>##REF##17032691##11##</sup>, which provides an overall quantitative prognosis for patients with ACS. Further, most interventional cardiologists resort to the National Cardiovascular Data Registry (NCDR) for catheterization percutaneous coronary intervention (NCDR-CathPCI) contemporary mortality risk model to predict potential adverse events resulting from their intervention procedures<sup>##REF##20430263##12##</sup>.</p>", "<p id=\"Par4\">The intrinsic limitation of inferences derived from population-based data, such as registries or randomized clinical trials in terms of generalizability, may represent a critical challenge for improving cardiac intervention outcomes. For example, the emergency department's patient population or those excluded from the clinical trials might be underrepresented in such data<sup>##REF##15632888##13##,##REF##25954467##14##</sup>. Similarly, susceptible populations from certain geographical regions with specific genetic and environmental risk factors might also be unrepresented. Furthermore, in emergency or busy clinical settings, the early risk stratification of ACS patients may make intervention-related decisions fallible, leading to serious in or out-hospital implications<sup>##REF##35577964##15##</sup>. Standard risk stratification tools can be used to customize personalized clinical interventions based on individual patient-specific predictions, and they mostly rely on a scoring system derived from a traditional statistical framework. However, these statistical frameworks mainly comprise stepwise regression models with many fixed assumptions on the nature of the data, including randomness, independence, and linear relationships between the risk factors and the outcome. These assumptions may make their generalizability to external cohorts unreliable in some circumstances, particularly when they require a preselected set of variables in the development stage, resulting in potential critical loss of information<sup>##REF##28867023##16##,##REF##33453782##17##</sup>.</p>", "<p id=\"Par5\">Additionally, traditional regression models are highly susceptible to overfitting due to collinearity issues that arise between the risk factors when their dimension is significantly large (e.g., large population-based registry data)<sup>##REF##27406289##18##</sup>. In contrast, ML models are remarkably flexible because they depend on minimal statistical assumptions and can robustly explore large volumes of data and a variety of variables (e.g., medical images and signals). Additionally, in the recent decade, a variety of modern statistical methods have been introduced that safeguard ML models from overfitting (e.g., k-fold cross-validation and feature selection)<sup>##REF##33661899##19##</sup>. Therefore, they are more capable of capturing multidimensional non-linear complex relationships within clinical data and, thus, able to produce data-driven generalizable predictions<sup>##REF##25954467##14##,##REF##28867023##16##,##REF##33453782##17##</sup>. Also, because ML-driven risk stratification approaches outperformed traditional scoring scales<sup>##REF##31535314##7##,##REF##35073375##8##,##REF##25954467##14##,##REF##28867023##16##,##REF##33453782##17##</sup>, and the United States Food and Drug Administration has already approved the use of a few learning algorithms for intervention and diagnostic cardiology<sup>##REF##19143739##20##</sup>. Here, we use a multi-algorithm ML ensemble statistical framework on a multicenter registry of ACS patients to investigate the factors that shaped the risk of in-hospital and 30 days adverse events. We used patient demographic, clinical characteristics, and clinicians’ intervention data to build two interpretable predictive risk models for short and long-term ACS adverse events. Moreover, we integrated and evaluated our models in the context of individual patient-level prognosis to address the advantages and limitations of our data-driven ML models in contrast to using traditional risk approaches in a clinical setting.</p>" ]
[ "<title>Methods</title>", "<title>Data source</title>", "<p id=\"Par6\">We retrieved our data from a prospective, multicenter, cohort-based registry, formally known as the Kuwait catheterization laboratory project (Kuwait CLAP) registry. The data comprises 1,976 records of all ACS patients undergoing coronary angiograms in two central and high-volume hospitals in Kuwait enrolled between February 16, 2020, and February 22, 2021. The first participating hospital has 500 beds and serves approximately 600,000 patients on an annual basis. At the same time the second hospital has 700 beds and serves approximately 1 million people. Patients were followed prospectively for the duration of their admission. A case report form was used to collect data that mainly included elements from the 2013 report of American College of Cardiology (i.e., ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease). The key data elements included definitions for measuring patients' clinical management and outcomes with acute coronary syndrome<sup>##REF##23680811##21##</sup>. The form also had information about patient demographics, medical history, home medications, clinical management, in-hospital course, discharge, and 30-day follow-up data. The included patients ' follow-up data (mainly rehospitalization status) were collected via the hospital electronic records and telephone interviews after 30 days of discharge.</p>", "<p id=\"Par7\">The Kuwait CLAP involving human subjects were reviewed and approved by each participating hospital's Ministry of Health central ethics committee and conformed to the ethical guidelines of the 1975 Declaration of Helsinki. In accordance with ethical guidelines for medical and health research involving human subjects in Kuwait, the requirement for written informed consent from the participants was waived by the review committee.</p>", "<p id=\"Par8\">Here, we refer to our selected variables as ‘features’. We selected features thought to be relevant with a direct link to risk to the study outcomes. Thus, we reduced our data dimensionality to remove redundant information and improve computational efficiency, classification precision, data visualization and interpretation<sup>##UREF##2##22##</sup>. The final set of features included patient demographics, past medical history, presenting symptoms on admission, medication administered in the first 24 h from admission, in-hospital Cath-lab procedures, laboratory values before and after the In-hospital procedure, and discharge characteristics (Supplementary Table ##SUPPL##0##1##). We used in-hospital and 30 days of discharge adverse events as our study outcomes (Table ##TAB##0##1##). However, because many adverse events were rare and observed in the patients simultaneously (i.e., more than 85% of the affected patients had more than one adverse event), we aggregated them to compose our two defined outcomes. Thus, our first outcome is defined as patients who had one or more in-hospital adverse events post-catheterization/PCI, while the second outcome is defined as patients who were rehospitalized within 30 days after discharge due to an ACS event and/or related conditions (Table ##TAB##0##1##). Also, we used in-hospital adverse events as an independent predictor of adverse events 30 days after discharge. Additionally, discharge characteristics were excluded from the 30-day model (Supplementary Table ##SUPPL##0##1##). In this dataset, the aggregated prevalence of in-hospital and 30-day adverse events were 13.6% and 7.7%, respectively (Table ##TAB##0##1##).</p>", "<title>Data processing</title>", "<p id=\"Par9\">We used R software environmental and multiple R statistical packages for all the subsequent statistical analyses. We used a multi-algorithm ML ensemble statistical framework<sup>##REF##35073375##8##,##REF##31330063##23##</sup>, that constructs predictive models by comparing the performance of five supervised algorithms, including random forest (RF), gradient boosting (GB), extreme gradient boosting (XGB), support vector machine (SVM), and logistic regression (LR). Features were included in the models using their original forms (i.e., continuous variables were not converted into a different form and included as they are). We reduced the data dimensionality by excluding features with the largest mean absolute correlation (ρ &gt; 0.9). Then, we used the ‘Boruta’ R package to control for feature multicollinearity by reducing the features to a final set of variables relevant to the subsequent prediction to help improve the performance of the ML models<sup>##UREF##3##24##</sup>. We used a down-sampling strategy to control for class imbalance which may bias the predictive performance of the algorithms toward the majority class (i.e., patients with no adverse events)<sup>##UREF##4##25##</sup>. Briefly, this strategy down-samples the majority class to match its frequency with the minority class (i.e., patients with adverse events). For example, for the in-hospital model, we randomly downsampled the majority class by a factor of 5 (i.e., 269 patients with adverse events to 341 patients with no adverse events). However, for the 30 day model we down sampled the major class by a factor of 10 (see Supplementary File ##SUPPL##1##1## &amp; ##SUPPL##2##2##) At the same time, we randomly partitioned the data into training (80%) and testing (20%) testing sets using the K-fold cross-validation (CV) method (K = 10) to train and evaluate the ML models. Using the K-fold CV approach, we further split our data into 10 subsets (or folds) and iteratively trained (80% of the fold) and tested (20% of the fold) the model on each fold. Unlike the common cross-validation approach, which divides the data into single training and testing sets, the K-fold CV procedure can guard against overfitting and artificial inflation of the validation parameters described below<sup>##UREF##5##26##</sup>.</p>", "<title>Model training and evaluation</title>", "<p id=\"Par10\">We trained and created ML predictive models for post-catheterization adverse events using the set of features summarized in Supplementary Table ##SUPPL##0##1##. We used the ‘Random Forest’ R package<sup>##UREF##6##27##</sup> to run the RF algorithm while we ran the GB, XGB, SVM, and LR using the ‘Caret’ R package<sup>##REF##27774042##28##</sup>. We used the tenfold cross-validation methods to estimate the validation parameters of each algorithm and evaluate their predictive performance. The validation parameters were estimated by averaging the confusion matrix across all of the 10 folds (described above) and included the receiver operator characteristic (ROC), accuracy (Acc), sensitivity (Se), specificity (Sp), and Matthew’s correlation coefficient (MCC). We used the for the training process of all models. The Caret R has been designed to accommodate the Tidyverse R coding structure and workflow (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.tidyv\">https://www.tidyv</ext-link> erse.org/), which is also the basis for our statistical framework implemented in this study (see Supplementary Files ##SUPPL##1##1## &amp; ##SUPPL##2##2##). The Tidymodels coding structure intuitively allows users to utilize a variety of data preprocessing steps, such as data imputation and dealing with imbalanced datasets (as described above). Also, the Caret package (based on the Tidymodels approach) provides a semi-automatic streamlined approach for tuning and optimizing models’ hyperparameters. Because it is difficult to determine priori the exact hyperparameter values<sup>##REF##34448358##29##</sup>, for all of the selected ML algorithms, we used default grid parameter setting in the Tydimodels syntax to train and select the best-performing model automatically. More specifically, we used the “train” function, implemented in the Caret package, which extensively resamples the grid, to evaluate how the selected values of each tuning parameter, such as learning rate, can improve model prediction<sup>##REF##18397250##30##</sup>. A comprehensive guide to the default hyperparameters used in our selected ML algorithms is provided at <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.tidymodels.org/find/parsnip/\">www.tidymodels.org/find/parsnip/</ext-link>. We then selected the best predictive model for the probability of post-catheterization adverse events by comparing the estimated validation parameters of each algorithm using the testing dataset.</p>", "<title>Model interpretation</title>", "<p id=\"Par11\">We used the best-performing predictive model of each outcome to infer feature importance, partial dependence, interaction strength, and relationships between the features and the adverse events in randomly selected individual patients. Feature importance was computed using Breiman’s method implemented in ‘iml’ R package<sup>##UREF##7##31##,##UREF##8##32##</sup>. We then calculated the global and individual effects of each feature on the outcome and each observation from the dataset for the top six important features. We plotted these effects using partial dependence (PD) plots and centered individual conditional expectation (cICE), respectively<sup>##UREF##9##33##</sup>. We used Friedman’s <italic>H</italic>-statistic to infer feature interaction strength<sup>##UREF##10##34##</sup>. Briefly, Friedman’s <italic>H</italic>-statistic utilizes the partial dependency decomposition to flexibly quantify feature interaction strength, which represents the proportion of the variance in the data explained by the interaction<sup>##UREF##10##34##</sup>. Finally, we computed Shapley values (<italic>φ</italic>) to estimate individual-level risk predictions for randomly selected patients and the contribution of each feature to those predictions<sup>##REF##16589380##35##</sup>, which are based on a game theory approach.</p>" ]
[ "<title>Results</title>", "<p id=\"Par12\">For the in-hospital adverse events model, the RF algorithm outperformed (AUC = 0.84; Table ##TAB##1##2##) other algorithms in terms of predictive performance (i.e., AUC, Acc, Se, Sp, MCC; Table ##TAB##1##2##) and correctly predicted 84% of the events (Acc = 0.81). However, the XGB algorithm outperformed other algorithms (AUC = 0.79; Table ##TAB##1##2##) in correctly predicting adverse events 30 days after discharge (Acc = 0.78; Table ##TAB##1##2##). Notably, while the LR model performance was fair for predicting in-hospital adverse events, it had the poorest predictive performance for the 30 days adverse events model (AUC = 0.58; Table ##TAB##1##2##).</p>", "<p id=\"Par13\">Our ML statistical framework showed that left ventricular ejection fraction (LVEF), followed by furosemide administrated in the first 24 h after catheterization, heart failure, right ventricular systolic pressure (RVSP), systolic blood pressure, and age were the top six important features for predicting in-hospital adverse events (Fig. ##FIG##0##1##A). Nevertheless, the 30 days adverse events model revealed that urgent coronary artery bypass graft (CABD) followed by the type of culprit artery, percutaneous coronary intervention (PCI) with stents places, RVSP, the post-catheterization platelets lowest concentration, and the occurrence of an in-hospital adverse event were the most important predictors for the 30 days model (Fig. ##FIG##0##1##B).</p>", "<p id=\"Par14\">PD plots revealed that the risk of in-hospital adverse events increased when patients had an approximate LVEF value of less than 40% (Fig. ##FIG##1##2##A), furosemide in the first 24 h after catheterization (Fig. ##FIG##1##2##B), heart failure at presentation (Fig. ##FIG##1##2##C), an RVSP value greater than 40 mmHg (Fig. ##FIG##1##2##D), systolic blood pressure less than 100 and greater than 200 mmHg (Fig. ##FIG##1##2##E), and aged above 60 years old (Fig. ##FIG##1##2##F). However, patients who had urgent CABG (Fig. ##FIG##1##2##G), multiple culprit arteries (Fig. ##FIG##1##2##H), PCI with stents placed (F##FIG##1##i##g. ##FIG##1##2##I), RVSP value greater than 40 mmHg (Fig. ##FIG##1##2##J), lowest post catheterization platelets concentrations greater than 400 × 10<sup>9</sup>/L (Fig. ##FIG##1##2##K) and an ACS post catheterization in-hospital adverse event (Fig. ##FIG##1##2##L) are more likely to experience a 30 days adverse event after discharge.</p>", "<p id=\"Par15\">We inferred that LVEF on admission had the strongest overall interactions with other features in shaping the risk of in-hospital post-catheterization adverse events (Fig. ##FIG##2##3##A). Also, we found that medications administrated in the first 24 h after catheterization, such as furosemide (Fig. ##FIG##2##3##B,C) and aldosterone (Fig. ##FIG##2##3##B,C) were the top two interacting predictors with LVEF. This is followed by age, in which patients above 60 years old with LVEF values below 40% aggravate the risk of in-hospital adverse events (Fig. ##FIG##2##3##E). Additionally, our in-hospital adverse events model showed that interactions between patients’ prior history of heart failure, chronic renal failure, and diabetes, on one side and LVEF on other, are significant in increasing the risk of in-hospital adverse events (Fig. ##FIG##2##3##F–H). Nevertheless, the 30-days adverse events model indicated that the prior median creatinine concentration has the strongest overall interactions with other features (Fig. ##FIG##3##4##A). Top six most important interacting features are illustrated in Fig. ##FIG##3##4##B. The model shows that patients undergoing urgent CABG with a prior median blood creatinine concentration greater than 100 µmol/L slightly elevated their risk of 30-day adverse events (Fig. ##FIG##3##4##C). While the interaction between creatinine concentration and receiving angiotensin-converting enzyme inhibitor (ACEI) on discharge was important (Fig. ##FIG##3##4##D), the difference in the risk of adverse events for patients receiving it and not receiving was inconclusive (i.e., had no distinct trends). However, patients with prior creatinine greater than 100 µmol/L and on angiotensin receptor blocker (ARB) and insulin injection were more likely to experience an adverse event 30 days after discharge (Fig. ##FIG##3##4##E,F). Further, our model captured a significant interaction between prior creatinine and post-catheterization lowest platelet concentrations (Fig. ##FIG##3##4##G). Here, we found that the risk is remarkably increased at prior creatinine greater than 100 µmol/L with either platelet concentrations above 18 × 10<sup>9</sup>/L and less than 8 × 10<sup>9</sup>/L. Also, like the in-hospital adverse events model, the 30-days model suggests significant interaction between creatinine concentration and receiving furosemide within 24 h after catheterization (Fig. ##FIG##3##4##H).</p>", "<p id=\"Par16\">Our Shapley value estimates by our final models suggest that a patient is more likely to experience several in-hospital adverse events simultaneously, including contrast-induced nephropathy, heart failure, arterial fibrillation, new requirement for dialysis, and RBC whole blood transfusion (probability = 0.79), when their RVSP is equal to 55 mmHg, with chronic renal failure, aged 75 (Fig. ##FIG##4##5##A). While a patient observed with in-hospital acute thrombosis (probability = 0.28), was characterized by the RVSP is equal to 35 mmHg, with prior CVA and PCI performed (Fig. ##FIG##4##5##B). In contrast, in an observed patient with LVEF equal to 58% at presentation, no PCI was performed, aged 52 is less likely to experience in-hospital adverse events (probability = 0.04) after catheterization (Fig. ##FIG##4##5##C). Also, we inferred that patient had urgent CABG with multiple culprit arteries and stent placed are most likely to be re-hospitalized 30 days after discharge, due to reoccurring ACS event, that require another CABG, (probability = 0.72; Fig. ##FIG##5##6##A). However, if an observed patient had no need for urgent CABG, but performed a PCI with stents placed is less likely to experience adverse events after discharge (probability = 0.09; Fig. ##FIG##5##6##B).</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par17\">We used an interpretable ML statistical framework and the Kuwait CLAP registry data to reveal deeper insights into the risk factors that shape the outcomes of admitted patients with ACS during hospital stay and at 30 days from discharge. Also, we demonstrated how our ML analytical pipeline could untangle the unique and complex relationships between the different risk factors related to patient characteristics and in-hospital clinical procedures. Also, we showed that our most important predicting features had remarkable non-linear relationships with other baseline characteristics in shaping the risk of clinical outcomes. These findings not only support and improve clinical practice but assist with alleviating the public health and economic implications of ACSs.</p>", "<p id=\"Par18\">Our in-hospital adverse events ML model identified LVEF as the most important risk factor (Fig. ##FIG##0##1##) with the highest interaction strength with other features (Fig. ##FIG##2##3##). This is unsurprising since many past studies highlighted the critical role of low LVEF values in influencing the risk of post-catheterization in-hospital adverse events<sup>##REF##21638985##36##–##REF##36927935##39##</sup>. Here, our cICE plot demonstrated that LVEF values on the admission of less than 40% increase the risk of post-catheterization in-hospital events (Fig. ##FIG##1##2##A). However, this risk is aggravated particularly in older patients (Figs. ##FIG##1##2##F and ##FIG##2##3##E) with heart failure (Figs. ##FIG##1##2##C and ##FIG##2##3##F), high RVSP (Fig. ##FIG##1##2##D) and irregular systolic blood pressure (Fig. ##FIG##1##2##E). All these features represent severe cardiac insufficiency leading to poor long-term prognosis, and thus, need to be taken into consideration when performing any catheterization procedure in ACS patients<sup>##REF##36927935##39##</sup>. Further, our results showed that patients receiving furosemide within 24 h of admission are at elevated risk of in-hospital adverse events (Fig. ##FIG##1##2##B).</p>", "<p id=\"Par19\">Also, interaction plots illustrated a significant non-linear relationship between low LVEF values and receiving furosemide in amplifying the risk of adverse events (Fig. ##FIG##2##3##C)<sup>##REF##36648467##40##</sup>. Furosemide is commonly used as a loop diuretic for patients with heart failure. Therefore, our results reflect that patients with severe cardiac outcomes (such as low LVEF) requiring a high dose of furosemide may have a poor prognosis<sup>##REF##32673497##41##</sup>. The same may also be implied in patients receiving high doses of aldosterone within 24 h of their admission, as shown in Fig. ##FIG##2##3##D. Moreover, adverse events may also result from the rare side effect of these medications, thus combining them with other medications may improve their therapeutic outcomes<sup>##REF##32964717##42##</sup>. Additionally, our model not only demonstrated that patients with chronic renal failure and diabetes are at high risk of adverse events as suggested elsewhere<sup>##REF##32991776##38##,##REF##19695543##43##–##REF##11923033##45##</sup>, but revealed significant interactions with low LVEF values (Fig. ##FIG##2##3##G,H). These findings agree with the notion that the combination of hyperglycemia and renal insufficiency associated with low LVEF values is the leading cause of in-hospital adverse events, particularly in patients who have undergone a PCI operation<sup>##REF##32991776##38##</sup>. Also, these poor outcomes might reflect the low cardiac output, hemodynamic instability, and reduced renal blood flow, which leads to hypoxia and the generation of reactive oxygen species<sup>##REF##26277092##46##</sup>.</p>", "<p id=\"Par20\">Nevertheless, the 30-days adverse event model inferred that highly invasive intervention procedures, such as performing urgent CABG, having multiple culprit arteries, with stents placed during PCI, are significant predictors of poor outcomes after discharge (Fig. ##FIG##1##2##G–I). These findings confirm the results of past studies in terms of reflecting the severity of the patient's ACS condition<sup>##REF##28867023##16##,##REF##28052754##47##</sup>. Also, this is evidenced by the importance of the cardiological and hematological indicators such as RVSP and platelets, respectively (Fig. ##FIG##1##2##J,K), as well as having an in-hospital adverse event (Fig. ##FIG##1##2##L). However, unlike previous inferences<sup>##REF##35078371##3##,##UREF##1##6##,##REF##28052754##47##</sup>, our model uncovered the strong non-linear relationships between admission creatinine levels (Fig. ##FIG##3##4##A) and other features (Fig. ##FIG##3##4##B) in shaping the risk of adverse events after discharge (Fig. ##FIG##3##4##A). Here, our inferences demonstrate that patients requiring urgent CABG with creatinine levels less than 50 µmol/L or greater than 100 µmol/L are more likely to experience a poor post-operative prognosis (Fig. ##FIG##2##3##C). This result is expected since abnormal serum creatinine levels correspond to other comorbidities, particularly chronic kidney disease, exacerbating the long-term risk of postoperative adverse events<sup>##REF##26195967##48##</sup>. Similarly, serum creatinine had a strong non-linear relationship with ACEI and ARB intake after discharge (Fig. ##FIG##3##4##D,E) in hypertensive patients.</p>", "<p id=\"Par21\">Nonetheless, our results show minor discrimination in the risk between patients discharged with and without ACEI (Fig. ##FIG##3##4##D). In contrast, remarkable discrimination was inferred between patients discharged with and without ARB medication (Fig. ##FIG##3##4##E). These findings quantify the notion that ARB may increase the risk of myocardial infarction (MI) in hypertensive patients, and therefore, dispensing ACEI to control their blood pressure may be more appropriate, particularly for acute MI patients, as suggested elsewhere<sup>##REF##36893150##49##</sup>. Also, our model was able to discriminate the broad spectrum of risk of poor outcomes among diabetic patients with abnormal serum creatinine levels (Fig. ##FIG##3##4##F). These results suggest that severely diabetic patients (i.e., who are under insulin injection as a proxy) are more likely to experience adverse events than moderately diabetic patients (i.e., who are under oral medication). Indeed, the complex angiographic pattern extending between the mid and distal arteries of ACS patients with severe diabetes is characterized by a multivessel diffuse plaque, making revascularization quite challenging for clinicians<sup>##REF##23973040##50##</sup>. Thus, interventional cardiologists and cardiothoracic surgeons might need to implement an individualized approach with a multidisciplinary heart team on severely diabetic patients to minimize poor outcomes after discharge<sup>##REF##23973040##50##</sup>.</p>", "<p id=\"Par22\">One limitation of this study is the aggregation of positive outcomes into one category in our cohort. Yet, the rarity, complexity and broad spectrum of outcomes (Table ##TAB##0##1##) made it difficult for us to generate a representative model for each adverse event. However, the aggregation of the adverse events increased our computational efficiency, substantially improved the predictive performance of our ML algorithms, and facilitated the practical interpretation of our models. A second limitation of the Kuwait CLAP registry is the population size, and therefore generalizability of our inferences might be biased toward the population that comprised our analyses. That said, many of our findings agree with past studies regarding short- and long-term adverse events resulting from post-catheterization. Furthermore, our analysis mainly focuses on revealing complex relationships in the available data that might be useful for improving clinical decision-making related to the diagnostic and prognostic efforts in the same population where the data were retrieved. This is in addition to the fact that data is being collected from only sites that provide cardiological services in the country, as described above, making it representative of the whole population of Kuwait. Also, our k-fold cross-validation procedure lessens the chances of overfitting, increasing the robustness of its subsequent inferences. Nevertheless, future studies will be aimed at applying our analytical pipeline on a larger sample size and will be focused on building specific models for the most prevalent adverse events.</p>", "<p id=\"Par23\">The complexity of ACSs epidemiology, the growing volume of cardiac intervention procedures with their related data, and the highly non-linear relationships between patient baseline characteristics, clinical procedures, and interventions highlight the utility and robustness of our ML statistical framework. One important highlight of our analytical pipeline is the ability to flexibly explore heterogeneous treatment effects (i.e., effect modification and beyond) comprising multiple features simultaneously rather than overall average intervention effects using one-way or more interaction terms as in traditional regression models<sup>##REF##31577910##51##</sup>. Due to the tedious task of modelling and interpreting all possible interaction terms, rigorous evaluation of heterogeneous treatment effects has yet to be widely explored in clinical epidemiology<sup>##UREF##11##52##</sup>. As shown in Figs. ##FIG##2##3## and ##FIG##3##4##, investigators can intuitively interrogate multiple interactions to capture clusters of subgroups showing different feature-outcome effects. For example, Fig. ##FIG##2##3##G simultaneously shows how the risk of adverse in-hospital events has distinct patterns of over six significant interactions. In these interactions, the highest risk of adverse events notably peaks over certain clusters of patients with specific interrelated features (Fig. ##FIG##2##3##C–H). This allows clinicians to assess the effectiveness of their interventions and formulation of targeted approaches for reducing cardiovascular adverse events for individual clusters of patients. Wiemken and Kelley., 2020 extensively discussed the advantage of the ML algorithmic approach in dealing with interactions, as well as how traditional stratified regression models and the inclusion of interaction terms can lead epidemiologists to the issue of multiple testing bias<sup>##REF##31577910##51##</sup>.</p>", "<p id=\"Par24\">Here, our ML models had good and similar predictive performance compared to past studies in terms of evaluation parameters (e.g., AUCs = 0.84 &amp; 0.79 for the in-hospital and 30-day adverse events models, respectively, Table ##TAB##1##2##)<sup>##REF##31535314##7##,##REF##25954467##14##,##REF##31815192##53##–##UREF##12##55##</sup>. Further, we showed how RF and XGM algorithms can remarkably outperform traditional models such as logistic regression (Table ##TAB##1##2##). Subsequently, many studies also demonstrated that our statistical approach outperforms standard risk stratification tools such as TIMI and GRACE<sup>##REF##31535314##7##,##REF##33453782##17##,##REF##28978948##54##</sup>. However, many of these ML studies mainly focused on their models' predictive power (i.e., using a black-box approach), which they did not embrace their interpretability in a clinical setting. Hence, a readily interpretable model will provide new insights into the complex epidemiology of adverse events and be easily adopted by cardiologists to be implemented in their practice. Given that the Middle East has the highest incidence of CADs on a global scale<sup>##UREF##0##4##</sup>, our study represents the first attempt to utilize an interpretable ML statistical framework focused on uncovering complex relationships to improve clinicians’ intervention efforts.</p>", "<p id=\"Par25\">Besides the inherent limitations of the statistical framework used to build standard risk stratification tools, the generalizability of their inferences might also be restricted to specific populations. Indeed, the environmental, genetic, and clinical settings and resources might differ substantially between countries and regions worldwide. Thus, a customized risk stratification tool based on local data will provide more plausible and generalizable inferences for its source population than global-based tools. Therefore, we further elucidate the remarkable applicability of Shapley values, a game theoretic approximation, to interrogate in finer scales what each model represents regarding the predicted risk of adverse events (e.g., why a particular patient had a poor post-catheterization outcome, while the other did not?). For example, the in-hospital model inferred remarkably different magnitudes of risk for different types of adverse events in individual patients instead of averaging over the risk profiles of these patients (Fig. ##FIG##4##5##). Here, our model predicted high probabilities for specific adverse events (P = 0.79; Fig. ##FIG##4##5##A), such as in-hospital heart failure and contrast-induced nephropathy in older patients with chronic renal failure who had an urgent CABG. However, midrange probabilities were predicted for other adverse events, such as acute thrombosis (P = 0.28; Fig. ##FIG##4##5##B), in younger patients with prior CVA and who had a basic PCI. Thus, both types of patients had notably distinct demographics and clinical features with different requirements for in-hospital procedures. Additionally, for a randomly selected patient who had an adverse event 30 days after discharge, having an urgent CABG with multiple culprit arteries and stents placed during PCI put that patient at high risk of having a poor outcome (i.e., 72% chance; Fig. ##FIG##5##6##A). In contrast, under the same predictive model, the other selected patient who had no adverse events 30 days after discharge, entirely lacks such risk profile (Fig. ##FIG##5##6##B).</p>", "<p id=\"Par26\">Finally, the Shapely statistical procedure assigns positive and negative values for the features that increased and/or decreased the probability of adverse events in individual patients, respectively (Figs. ##FIG##4##5## and ##FIG##5##6##). Hence, using such an intuitive approach can provide additional guidance to the clinician’s diagnostic and prognostic efforts and aid in allocating intervention resources to patients at higher risk, whether in-hospital or after discharge. Yet, additional evaluation of the technical feasibility and clinical plausibility are crucial steps before integrating such predictive models into the standard healthcare systems<sup>##REF##35577964##15##</sup>.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par27\">The incidence of ACS has startlingly doubled over the past few years, and thus, the unparalleled rising demand for cardiological interventions is increasingly prompting healthcare professionals to seek novel methods of anticipating adverse events and accordingly better allocate their limited resources to enhance patient outcomes and decrease long-term public health and economic implications. Further applications of our interpretable ML statistical framework to guide interventions will help improve the quality of life for both health professionals and their patients. In this study, we generally found that presenting symptoms on admission and catheterization procedures were the important variables shaping the risk of in-hospital and 30-day adverse events, respectively. While worth noting that these two sets of features are considered proxies for the severity of the patient's condition. We illustrated how our models outperformed traditional statistical and risk stratification methods due to their minimal statistical assumptions, ability to quantify complex non-linear relationships and elucidate individual patient-predicted risk based on their unique characteristics in finer scales. To our knowledge, fully interpretable ML models have not been widely used in the Middle East. Thus, our ML-based risk stratification approach can improve clinicians’ intervention efforts by providing precise epidemiological insights into ACS adverse events.</p>" ]
[ "<p id=\"Par1\">The relationships between acute coronary syndromes (ACS) adverse events and the associated risk factors are typically complicated and nonlinear, which poses significant challenges to clinicians' attempts at risk stratification. Here, we aim to explore the implementation of modern risk stratification tools to untangle how these complex factors shape the risk of adverse events in patients with ACS. We used an interpretable multi-algorithm machine learning (ML) approach and clinical features to fit predictive models to 1,976 patients with ACS in Kuwait. We demonstrated that random forest (RF) and extreme gradient boosting (XGB) algorithms, remarkably outperform traditional logistic regression model (AUCs = 0.84 &amp; 0.79 for RF and XGB, respectively). Our in-hospital adverse events model identified left ventricular ejection fraction as the most important predictor with the highest interaction strength with other factors. However, using the 30-days adverse events model, we found that performing an urgent coronary artery bypass graft was the most important predictor, with creatinine levels having the strongest overall interaction with other related factors. Our ML models not only untangled the non-linear relationships that shape the clinical epidemiology of ACS adverse events but also elucidated their risk in individual patients based on their unique features.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51604-8.</p>", "<title>Acknowledgements</title>", "<p>This study was funded by part by the Sabah Al Ahmed Cardiac Center, Ministry of Health, Kuwait.</p>", "<title>Author contributions</title>", "<p>The study was designed by M.A.A. and M.Z. The data were collected and organized by M.A.J. and S.A. All statistical analyses were conducted by M.A.A. All authors contributed to writing the first draft of the manuscript.</p>", "<title>Data availability</title>", "<p>All of the data relevant to this study were summarized in the body of the manuscript, figures and tables. Original raw data can be provided upon a reasonable request by the corresponding author Moh A. Alkhamis ([email protected]).</p>", "<title>Competing interests</title>", "<p id=\"Par28\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Relative importance of the features in their contribution to the study outcomes. (<bold>A</bold>) In-hospital adverse events. (<bold>B</bold>) 30 days adverse events. ce = classification error loss function (“ce”) used to compute feature importance. Black dots indicate median “ce”. <italic>CATH</italic> Catheterization, <italic>CAD</italic> Coronary Artery Disease, <italic>ACS</italic> Acute Coronary Syndrome, <italic>CCS</italic> Canadian Cardiovascular Society, <italic>LVEF</italic> Left Ventricular Ejection Fraction, <italic>RVSP</italic> Right Ventricular Systolic Pressure, <italic>AF</italic> Atrial Fibrillation, <italic>MI</italic> Myocardial Infarction, <italic>PCI</italic> Percutaneous Coronary Intervention, <italic>CABG</italic> Coronary Artery Bypass Graft, <italic>TIA</italic> Transient Ischemic Attack, <italic>CVA</italic> Cerebrovascular Accident, <italic>STEMI</italic> ST-segment Elevated Myocardial Infarction, <italic>NSTE-ACS</italic> Non ST-segment Elevation Acute Coronary Syndrome, <italic>ACEI</italic> Angiotensin Converting Enzyme Inhibitor, <italic>ARB</italic> Angiotensin Receptor Blocker, Coronary Artery, <italic>CABG</italic> Coronary Artery Bypass Graft, <italic>Hb</italic> Hemoglobin, <italic>BMI</italic> body mass index.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Centered Individual Conditional Expectation (cICE) summary plots for the top six important features that contributed to predicted risk of each outcome. (<bold>A</bold>–<bold>F</bold>) In-hospital adverse events. (<bold>G</bold>–<bold>L</bold>) 30 days adverse events. <italic>CATH</italic> Catheterization, <italic>LVEF</italic> Left Ventricular Ejection Fraction, <italic>RVSP</italic> Right Ventricular Systolic Pressure, <italic>CABG</italic> Coronary Artery Bypass Graft, <italic>PCI</italic> Percutaneous Coronary Intervention.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Plots showing important feature interactions that shape the risk of in-hospital adverse events after catheterization are calculated using Friedman’s H-statistic. (<bold>A</bold>) Ranks the overall strength of interaction of each feature with other features; (<bold>B</bold>) Ranks the overall strength of interaction of each feature with % left ventricular ejection fraction (LVEF); (<bold>C</bold>–<bold>H</bold>) Partial dependence plots at the right represent the top six interactions that shaped the risk of in-hospital adverse events. (<bold>C</bold>) interaction between 24 h furosemide and LVEF; (<bold>D</bold>) interaction between 24 h aldosterone and LVEF; (<bold>E</bold>) interaction between Age and LVEF; the heat matrix corresponds to the risk of in-hospital adverse effects, in which lighter shades of red indicate lower risks, and darker shades of reds indicate higher risks; (<bold>F</bold>) interaction between prior history of heart failure and LVEF; (<bold>G</bold>) interaction between chronic renal failure and LVEF; (<bold>H</bold>) interaction between diabetes and LVEF. (<bold>C</bold>–<bold>H</bold>) tick marks on the x-axis show the observed individual values of the patients enrolled in the study. <italic>CAD</italic> Coronary Artery Disease, <italic>ACS</italic> Acute Coronary Syndrome, <italic>CCS</italic> Canadian Cardiovascular Society, <italic>LVEF</italic> Left Ventricular Ejection Fraction, <italic>RVSP</italic> Right Ventricular Systolic Pressure, <italic>AF</italic> Atrial Fibrillation, <italic>MI</italic> Myocardial Infarction, <italic>PCI</italic> Percutaneous Coronary Intervention, <italic>CABG</italic> Coronary Artery Bypass Graft, <italic>TIA</italic> Transient Ischemic Attack, <italic>CVA</italic> Cerebrovascular Accident, <italic>STEMI</italic> ST-segment Elevated Myocardial Infarction, <italic>ACEI</italic> Angiotensin Converting Enzyme Inhibitor, <italic>ARB</italic> Angiotensin Receptor Blocker, Coronary Artery, <italic>Hb</italic> Hemoglobin, <italic>BMI</italic> body mass index.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Plots showing important feature interactions that shape the 30-day adverse events after discharge calculated using Friedman’s H-statistic. (<bold>A</bold>) Ranks the overall strength of interaction of each feature with other features; (<bold>B</bold>) Ranks the overall strength of interaction of each feature with prior creatinine median; (<bold>C</bold>–<bold>H</bold>) Partial dependence plots at the right represent the top six interactions that shaped the risk of the 30-days adverse events. (<bold>C</bold>) interaction between urgent CABG and prior creatinine median; (<bold>D</bold>) interaction between discharge ACEI and prior creatinine median; (<bold>E</bold>) interaction between discharge ARB and prior creatinine median; (<bold>F</bold>) interaction between discharge type of antidiabetic medication and prior creatinine median; (<bold>G</bold>) interaction between post platelets lowest and prior creatinine median; the heat matrix corresponds to the risk of 30-days adverse effects, in which lighter shades of red indicate lower risks and darker shades of reds indicate higher risks. (<bold>H</bold>) interaction between 24 h furosemide and prior creatinine median. (<bold>C</bold>–<bold>H</bold>) tick marks on the x-axis show the observed individual values of the patients enrolled in the study. <italic>CATH</italic> Catheterization, <italic>CAD</italic> Coronary Artery Disease, <italic>ACS</italic> Acute Coronary Syndrome, <italic>CCS</italic> Canadian Cardiovascular Society, <italic>LVEF</italic> Left Ventricular Ejection Fraction, <italic>RVSP</italic> Right Ventricular Systolic Pressure, <italic>AF</italic> Atrial Fibrillation, <italic>MI</italic> Myocardial Infarction, <italic>PCI</italic> Percutaneous Coronary Intervention, <italic>CABG</italic> Coronary Artery Bypass Graft, <italic>TIA</italic> Transient Ischemic Attack, <italic>CVA</italic> Cerebrovascular Accident, <italic>STEMI</italic> ST-segment Elevated Myocardial Infarction, <italic>NSTE-ACS</italic> Non ST-segment Elevation Acute Coronary Syndrome, <italic>ACEI</italic> Angiotensin Converting Enzyme Inhibitor, <italic>ARB</italic> Angiotensin Receptor Blocker, <italic>LAD</italic> Left Anterior Descending, <italic>LCX</italic> Left Circumflex, <italic>RCA</italic> Right Coronary Artery, <italic>LIMA</italic> Left Internal Mammary Artery, <italic>RIMA</italic> Right Internal Mammary Artery, <italic>Hb</italic> = Hemoglobin.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Feature value contributions for the respective risk of in-hospital adverse events based on Shapley Values (φ) for three individual patients. (<bold>A</bold>) a patient who had multiple severe in-hospital adverse events; (<bold>B</bold>) a patient who had moderate in-hospital adverse events; (<bold>C</bold>) a patient who did not have an in-hospital adverse event after catheterization; Red bars represent positive Shapley values and indicate that this feature increased the risk of the outcome, while blue bars represent negative Shapley values and suggest that this feature decreased the risk of the outcome. The values next to each feature represent the observed value of that feature for that patient. <italic>CCS</italic> Canadian Cardiovascular Society, <italic>LVEF</italic> Left Ventricular Ejection Fraction, <italic>RVSP</italic> Right Ventricular Systolic Pressure, <italic>AF</italic> Atrial Fibrillation, <italic>MI</italic> Myocardial Infarction, <italic>PCI</italic> Percutaneous Coronary Intervention, <italic>TIA</italic> Transient Ischemic Attack, <italic>CVA</italic> Cerebrovascular Accident, <italic>STEMI</italic> ST-segment Elevated Myocardial Infarction, <italic>NSTE-ACS</italic> Non ST-segment Elevation Acute Coronary Syndrome, <italic>ACEI</italic> Angiotensin Converting Enzyme Inhibitor, <italic>ARB</italic> Angiotensin Receptor Blocker, <italic>CABG</italic> Coronary Artery Bypass Graft, <italic>Hb</italic> Hemoglobin, <italic>BMI</italic> body mass index.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Feature value contributions for the respective risk of 30-days adverse events based on Shapley Values (φ) for two individual patients. (<bold>A</bold>) a patient who had an adverse event 30 days after discharge; (<bold>B</bold>) a patient who did not have an adverse event 30 days after discharge. Red bars represent positive Shapley values and indicate that this feature increased the risk of the outcome, while blue bars represent negative Shapley values and suggest that this feature decreased the risk of the outcome. The values next to each feature represent the observed value of that feature for that patient. <italic>CCS</italic> Canadian Cardiovascular Society, <italic>LVEF</italic> Left Ventricular Ejection Fraction, <italic>RVSP</italic> Right Ventricular Systolic Pressure, <italic>AF</italic> Atrial Fibrillation, <italic>MI</italic> Myocardial Infarction, <italic>PCI</italic> Percutaneous Coronary Intervention, <italic>TIA</italic> Transient Ischemic Attack, <italic>CVA</italic> Cerebrovascular Accident, <italic>STEMI</italic> ST-segment Elevated Myocardial Infarction, <italic>NSTE-ACS</italic> Non ST-segment Elevation Acute Coronary Syndrome, <italic>ACEI</italic> Angiotensin Converting Enzyme Inhibitor, <italic>ARB</italic> Angiotensin Receptor Blocker, <italic>CABG</italic> Coronary Artery Bypass Graft, <italic>Hb</italic> Hemoglobin, <italic>BMI</italic> body mass index.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Summary profile of the observed adverse events in the patients’ cohort.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\"/><th align=\"left\">*n<sub>i</sub> (n<sub>i</sub>%)</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"2\">Post CATH/PCI clinical events (*n = 269; 13.6%)</td></tr><tr><td align=\"left\"> Recurrent angina</td><td align=\"left\">59 (21.9%)</td></tr><tr><td align=\"left\"> Infarction/reinfarction</td><td align=\"left\">19 (7.1%)</td></tr><tr><td align=\"left\"> Cardiogenic shock</td><td align=\"left\">43 (16.0%)</td></tr><tr><td align=\"left\"> Pericarditis</td><td align=\"left\">10 (3.7%)</td></tr><tr><td align=\"left\"> Active endocarditis</td><td align=\"left\">1 (0.4%)</td></tr><tr><td align=\"left\"> Contrast induced nephropathy</td><td align=\"left\">75 (27.9%)</td></tr><tr><td align=\"left\"> Mechanical complications</td><td align=\"left\">4 (1.5%)</td></tr><tr><td align=\"left\"> Temporary pacemaker</td><td align=\"left\">12 (4.5%)</td></tr><tr><td align=\"left\"> Heart failure</td><td align=\"left\">86 (32.0%)</td></tr><tr><td align=\"left\"> Cardiac arrest</td><td align=\"left\">24 (8.9%)</td></tr><tr><td align=\"left\"> CVA/stroke</td><td align=\"left\">12 (4.5%)</td></tr><tr><td align=\"left\"> Atrial fibrillation</td><td align=\"left\">42 (15.6%)</td></tr><tr><td align=\"left\"> Ventricular tachycardia</td><td align=\"left\">28 (10.4%)</td></tr><tr><td align=\"left\"> Mechanical ventilation</td><td align=\"left\">44 (16.4%)</td></tr><tr><td align=\"left\"> New requirement for dialysis</td><td align=\"left\">11 (4.1%)</td></tr><tr><td align=\"left\"> Bleeding</td><td align=\"left\">14 (5.2%)</td></tr><tr><td align=\"left\"> RBC whole blood transfusion</td><td align=\"left\">12 (4.5%)</td></tr><tr><td align=\"left\"> Acute stent thrombosis</td><td align=\"left\">12 (4.5%)</td></tr><tr><td align=\"left\" colspan=\"2\">30 days outcomes after discharge/rehospitalization (n = 148; 7.7%)</td></tr><tr><td align=\"left\"> ACS</td><td align=\"left\">27 (18.0%)</td></tr><tr><td align=\"left\"> LVF</td><td align=\"left\">21 (14.0%)</td></tr><tr><td align=\"left\"> PCI</td><td align=\"left\">20 (14.0%)</td></tr><tr><td align=\"left\"> CABG</td><td align=\"left\">81 (55.0%)</td></tr><tr><td align=\"left\"> Arrhythmia</td><td align=\"left\">1 (0.7%)</td></tr><tr><td align=\"left\"> Other cardiac events</td><td align=\"left\">7 (4.7%)</td></tr><tr><td align=\"left\"> Stroke</td><td align=\"left\">1 (0.7%)</td></tr><tr><td align=\"left\"> Bleeding</td><td align=\"left\">4 (2.7%)</td></tr><tr><td align=\"left\"> Other non-cardiac</td><td align=\"left\">16 (11.0%)</td></tr><tr><td align=\"left\"> Unknown</td><td align=\"left\">1 (0.7%)</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Comparative cross-validation performance parameters for the machine learning models of each outcome.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Model</th><th align=\"left\">AUC ± SE</th><th align=\"left\">Accuracy (%) ± SE</th><th align=\"left\">Specificity (%) ± SE</th><th align=\"left\">Sensitivity (%) ± SE</th><th align=\"left\">MCC ± SE</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"6\">In-hospital adverse events</td></tr><tr><td align=\"left\"> RF</td><td char=\".\" align=\"char\">0.84 ± 0.16</td><td char=\".\" align=\"char\">80.92 ± 1.27</td><td char=\".\" align=\"char\">81.29 ± 1.31</td><td char=\".\" align=\"char\">66.86 ± 1.56</td><td char=\".\" align=\"char\">0.40 ± 0.00</td></tr><tr><td align=\"left\"> GB</td><td char=\".\" align=\"char\">0.71 ± 0.01</td><td char=\".\" align=\"char\">71.15 ± 2.16</td><td char=\".\" align=\"char\">64.12 ± 2.25</td><td char=\".\" align=\"char\">64.12 ± 3.88</td><td char=\".\" align=\"char\">0.28 ± 0.00</td></tr><tr><td align=\"left\"> XGB</td><td char=\".\" align=\"char\">0.65 ± 1.01</td><td char=\".\" align=\"char\">67.19 ± 1.46</td><td char=\".\" align=\"char\">68.67 ± 1.49</td><td char=\".\" align=\"char\">67.70 ± 0.49</td><td char=\".\" align=\"char\">0.23 ± 0.00</td></tr><tr><td align=\"left\"> SVM</td><td char=\".\" align=\"char\">0.78 ± 0.03</td><td char=\".\" align=\"char\">73.83 ± 1.76</td><td char=\".\" align=\"char\">73.90 ± 1.82</td><td char=\".\" align=\"char\">69.62 ± 1.74</td><td char=\".\" align=\"char\">0.37 ± 0.00</td></tr><tr><td align=\"left\"> LR</td><td char=\".\" align=\"char\">0.72 ± 0.40</td><td char=\".\" align=\"char\">74.80 ± 2.33</td><td char=\".\" align=\"char\">75.97 ± 2.38</td><td char=\".\" align=\"char\">66.71 ± 1.55</td><td char=\".\" align=\"char\">0.19 ± 0.00</td></tr><tr><td align=\"left\" colspan=\"6\">30 Days adverse events</td></tr><tr><td align=\"left\"> RF</td><td char=\".\" align=\"char\">0.68 ± 0.00</td><td char=\".\" align=\"char\">62.24 ± 1.39</td><td char=\".\" align=\"char\">62.18 ± 1.42</td><td char=\".\" align=\"char\">65.92 ± 1.25</td><td char=\".\" align=\"char\">0.33 ± 0.00</td></tr><tr><td align=\"left\"> GBM</td><td char=\".\" align=\"char\">0.77 ± 0.01</td><td char=\".\" align=\"char\">68.76 ± 1.69</td><td char=\".\" align=\"char\">69.67 ± 1.74</td><td char=\".\" align=\"char\">70.66 ± 1.71</td><td char=\".\" align=\"char\">0.36 ± 0.00</td></tr><tr><td align=\"left\"> XGB</td><td char=\".\" align=\"char\">0.79 ± 1.06</td><td char=\".\" align=\"char\">78.01 ± 1.80</td><td char=\".\" align=\"char\">74.06 ± 1.83</td><td char=\".\" align=\"char\">71.7 ± 1.98</td><td char=\".\" align=\"char\">0.38 ± 0.00</td></tr><tr><td align=\"left\"> SVM</td><td char=\".\" align=\"char\">0.71 ± 0.02</td><td char=\".\" align=\"char\">62.55 ± 1.76</td><td char=\".\" align=\"char\">62.46 ± 1.82</td><td char=\".\" align=\"char\">67.50 ± 1.59</td><td char=\".\" align=\"char\">0.34 ± 0.00</td></tr><tr><td align=\"left\"> LR</td><td char=\".\" align=\"char\">0.58 ± 0.10</td><td char=\".\" align=\"char\">63.89 ± 2.66</td><td char=\".\" align=\"char\">61.79 ± 1.34</td><td char=\".\" align=\"char\">58.15 ± 1.88</td><td char=\".\" align=\"char\">0.32 ± 0.00</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>" ]
[ "<table-wrap-foot><p>Summary statistics presented as n (%).</p><p><italic>CATH</italic> Catheterization, <italic>ACS</italic> Acute Coronary Syndrome, <italic>LVEF</italic> Left Ventricular Ejection Fraction, <italic>MI</italic> Myocardial Infarction, <italic>PCI</italic> Percutaneous Coronary Intervention, <italic>CABG</italic> Coronary Artery Bypass Graft, <italic>CVA</italic> Cerebrovascular Accident, <italic>PCI</italic> Percutaneous Coronary Intervention, <italic>RBC</italic> Red Blood Cells, <italic>LVF</italic> Left Ventricular Failure.</p><p>*n = total number of adverse events; n<sub>i</sub> = individual adverse event.</p></table-wrap-foot>", "<table-wrap-foot><p>MCC = Matthew’s correlation coefficient. Model highlighted in gray is the best performing model.</p><p><italic>AUC</italic> Area Under the Curve, <italic>SE</italic> Standard Error, <italic>RF</italic> Random Forest, <italic>GM</italic> Gradient Boosting, <italic>XGB</italic> Extreme Gradient Boosting, <italic>SVM</italic> Support Vector Machine, <italic>LR</italic> Logistic Regression.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51604_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51604_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51604_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51604_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51604_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2024_51604_Fig6_HTML\" id=\"MO6\"/>" ]
[ "<media xlink:href=\"41598_2024_51604_MOESM1_ESM.docx\"><caption><p>Supplementary Table S1.</p></caption></media>", "<media xlink:href=\"41598_2024_51604_MOESM2_ESM.r\"><caption><p>Supplementary Information 1.</p></caption></media>", "<media xlink:href=\"41598_2024_51604_MOESM3_ESM.r\"><caption><p>Supplementary Information 2.</p></caption></media>", "<media xlink:href=\"41598_2024_51604_MOESM4_ESM.docx\"><caption><p>Supplementary Legends.</p></caption></media>" ]
[{"label": ["4."], "mixed-citation": ["Feberation, W. H. "], "italic": ["World health report 2023: Confronting the world\u2019s number one killer"], "ext-link": ["https://world-heart-federation.org/wp-content/uploads/World-Heart-Report-2023.pdf"]}, {"label": ["6."], "mixed-citation": ["Manda, Y. R. & Baradhi, K. M. in "], "italic": ["StatPearls"]}, {"label": ["22."], "surname": ["Hall", "Holmes"], "given-names": ["MA", "G"], "article-title": ["Benchmarking attribute selection techniques for discrete class data mining"], "source": ["IEEE Trans. Knowl. Data Eng."], "year": ["2003"], "volume": ["15"], "fpage": ["1437"], "lpage": ["1447"], "pub-id": ["10.1109/TKDE.2003.1245283"]}, {"label": ["24."], "surname": ["Kursa", "Rudnicki"], "given-names": ["MB", "WR"], "article-title": ["Feature selection with the Boruta package"], "source": ["J. Stat. Softw."], "year": ["2010"], "volume": ["36"], "fpage": ["1"], "lpage": ["13"], "pub-id": ["10.18637/jss.v036.i11"]}, {"label": ["25."], "surname": ["Haibo He", "Garcia"], "given-names": ["H", "EA"], "article-title": ["Learning from imbalanced data"], "source": ["IEEE Trans. Knowl. Data Eng."], "year": ["2009"], "volume": ["21"], "fpage": ["1263"], "lpage": ["1284"], "pub-id": ["10.1109/TKDE.2008.239"]}, {"label": ["26."], "surname": ["Cawley", "Talbot"], "given-names": ["GC", "NLC"], "article-title": ["On over-fitting in model selection and subsequent selection bias in performance evaluation"], "source": ["J. Mach. Learn. Res."], "year": ["2010"], "volume": ["11"], "fpage": ["2079"], "lpage": ["2107"]}, {"label": ["27."], "mixed-citation": ["R Package \u2018randomForest\u2019 v. 4.6-14 (2018)."]}, {"label": ["31."], "surname": ["Breiman"], "given-names": ["L"], "article-title": ["Random forests"], "source": ["Mach. Learn."], "year": ["2001"], "volume": ["45"], "fpage": ["5"], "lpage": ["32"], "pub-id": ["10.1023/A:1010933404324"]}, {"label": ["32."], "surname": ["Molnar"], "given-names": ["C"], "article-title": ["iml: An R package for interpretable machine learning"], "source": ["J. Open Source Softw."], "year": ["2018"], "volume": ["3"], "fpage": ["786"], "pub-id": ["10.21105/joss.00786"]}, {"label": ["33."], "surname": ["Goldstein", "Kapelner", "Bleich", "Pitkin"], "given-names": ["A", "A", "J", "E"], "article-title": ["Peeking inside the black box: Visualizing statistical learning with plots of individual conditional expectation"], "source": ["J. Comput. Graph. Stat."], "year": ["2015"], "volume": ["24"], "fpage": ["44"], "lpage": ["65"], "pub-id": ["10.1080/10618600.2014.907095"]}, {"label": ["34."], "surname": ["Friedman", "Popescu"], "given-names": ["JH", "BE"], "article-title": ["Predictive learning via rule ensembles"], "source": ["Ann. Appl. Stat."], "year": ["2008"], "volume": ["2"], "fpage": ["916"], "lpage": ["954"], "pub-id": ["10.1214/07-AOAS148"]}, {"label": ["52."], "surname": ["Baum"], "given-names": ["A"], "article-title": ["Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: A machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial"], "source": ["Lancet Diabet. Endocrinol."], "year": ["2017"], "volume": ["5"], "fpage": ["808"], "lpage": ["815"], "pub-id": ["10.1016/S2213-8587(17)30176-6"]}, {"label": ["55."], "surname": ["Sherazi", "Jeong", "Jae", "Bae", "Lee"], "given-names": ["SWA", "YJ", "MH", "JW", "JY"], "article-title": ["A machine learning-based 1-year mortality prediction model after hospital discharge for clinical patients with acute coronary syndrome"], "source": ["Health Inform. J."], "year": ["2019"], "pub-id": ["10.1177/1460458219871780"]}]
{ "acronym": [], "definition": [] }
55
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1243
oa_package/e8/47/PMC10786865.tar.gz
PMC10786866
38216663
[ "<title>Introduction</title>", "<p id=\"Par3\">The biological functions of many proteins require transitions between conformational substates<sup>##REF##1749933##1##–##UREF##0##3##</sup>. Despite their functional importance, protein conformational substates are often difficult to characterize. X-ray crystallography can prove useful in this regard by revealing alternate conformations that coexist in crystals at partial occupancy, as shown by electron density maps<sup>##REF##20499387##4##</sup>. Such conformational ensembles can be shifted by discrete, localized, targeted perturbations like ligands<sup>##UREF##1##5##</sup> or mutations<sup>##REF##19956261##6##</sup>, revealing insights into allostery and enzyme catalysis. However, known ligands are unavailable for most sites in most proteins, and predicting the effects of mutations is difficult. By contrast, continuous, global, generic biophysical perturbations offer advantages: they can be applied to any protein, affect the entire structure simultaneously, and can be titrated to shift conformational distributions and map correlated conformational changes relevant to function<sup>##REF##30821702##7##</sup>.</p>", "<p id=\"Par4\">One such biophysical perturbation, which has gained traction as a valuable experimental variable in structural biology and biophysics, is temperature (T). Room-temperature (RT) X-ray crystallography<sup>##REF##33413726##8##</sup> avoids structural biases of cryogenic-temperature crystallography, revealing differences in protein conformation<sup>##REF##21918110##9##–##UREF##3##12##</sup>, ligand binding<sup>##REF##26032594##13##,##UREF##4##14##</sup>, and solvation layers<sup>##REF##24882744##10##,##UREF##4##14##</sup>. Multitemperature crystallography provides additional insights into conformational coupling<sup>##UREF##2##11##,##UREF##3##12##,##UREF##5##15##</sup>. Notably, crystal structures at physiological temperature (37 °C, 310 K) can reveal unique protein conformations<sup>##UREF##3##12##,##REF##33312102##16##</sup>. RT crystallography methods are rapidly improving<sup>##REF##33413726##8##</sup>, including serial crystallography<sup>##REF##30821704##17##</sup>. RT crystal structures are also increasingly used in computational simulations<sup>##REF##24950326##18##–##UREF##6##20##</sup>.</p>", "<p id=\"Par5\">Complementary to temperature, but relatively underexplored, is pressure (P). Whereas high temperature stabilizes states with high entropy, high pressure stabilizes states with low volume, isolating distinct excited states that may have unique links to biological function<sup>##UREF##7##21##–##REF##33524371##25##</sup>. Importantly, pressure-induced structural changes on the sub-angstrom level observed by high-pressure X-ray crystallography have been shown to be directly related to protein function<sup>##REF##18768811##26##</sup>. Other past high-pressure protein crystallography studies showed non-uniform responses of coordinates and B-factors<sup>##REF##3586017##27##</sup>, non-compressive conformational shifts mirroring those induced by pH change<sup>##REF##11796110##28##</sup>, water infiltration into engineered<sup>##REF##16269539##29##,##REF##17292912##30##</sup> and natural cavities<sup>##REF##25849385##31##</sup>, crystal phase transitions<sup>##REF##25849385##31##,##REF##35308861##32##</sup>, conformational shifts of functional residues in an allosteric network<sup>##REF##35308861##32##</sup>, and changes in ligand affinity<sup>##REF##35102882##33##</sup>.</p>", "<p id=\"Par6\">Despite this foundation, relatively few studies have explored the detailed effects of pressure on protein conformational ensembles using crystallography. While a few studies have highlighted protein alternate conformations for isolated residues<sup>##REF##25849385##31##,##REF##35308861##32##</sup>, to our knowledge no study has comprehensively explored the effects of pressure on detailed conformational ensembles of all residues throughout a protein structure. Moreover, very few studies<sup>##REF##11796110##28##</sup> have compared the atomic-level effects of elevated temperature vs. pressure on protein crystal structures. It thus remains unclear whether, and how, these two fundamental thermodynamic perturbations differentially affect protein conformational ensembles, which limits our toolkit for probing fundamental connections between conformational heterogeneity and biological function.</p>", "<p id=\"Par7\">An attractive system to investigate the differential effects of temperature vs. pressure on protein conformational ensembles is the protein tyrosine phosphatase (PTP) enzyme STEP (PTPN5). STEP is a brain-specific PTP, and a validated therapeutic target for Alzheimer’s disease<sup>##REF##20699650##34##</sup>, Fragile X syndrome<sup>##REF##22405502##35##</sup>, and Parkinson’s disease<sup>##REF##25583483##36##</sup>. The public Protein Data Bank<sup>##REF##10592235##37##</sup> includes 8 high-resolution (1.66–2.15 Å) crystal structures of STEP (7 human, 1 mouse) with different ligands, demonstrating its tractability with crystallography. Of these structures, 3 are in an inactive-like state, either bound to a competitive inhibitor<sup>##REF##29116812##38##</sup> or inactivated through the acetylation of the catalytic cysteine<sup>##REF##16441242##39##</sup>, while another 3 are in an active-like state, either bound to an allosteric small-molecule activator<sup>##REF##30207464##40##</sup> or in a Michaelis-like complex with a pTyr substrate bound to a catalytic C472S mutant<sup>##REF##19167335##41##</sup>. As revealed in these structures, STEP has several unusual features among PTPs, including an atypically open active-site WPD loop conformation<sup>##REF##19167335##41##</sup> and an allosteric site with a small-molecule activator (not inhibitor)<sup>##REF##30207464##40##</sup>. However, all existing STEP structures are at cryogenic temperature and ambient pressure.</p>", "<p id=\"Par8\">Here we report high-resolution (&lt;2 Å) crystal structures of unliganded STEP at high temperature (HiT) and at high pressure (HiP), along with a reference structure at low temperature and low pressure (LoTP). To our knowledge, these new structures of STEP represent several firsts. Our high-temperature structure is only the eleventh crystal structure of any protein, and the first of any phosphatase, at physiological temperature or above (≥310 K). Our high-pressure structure of STEP is also the first of any phosphatase at high pressure. Together, our new structures make STEP the first protein with crystal structures at both physiological temperature and high pressure, presenting a unique opportunity to compare the effects of these two distinct perturbations on protein conformational ensembles.</p>", "<p id=\"Par9\">By quantitatively interrogating these data, we reveal that temperature and pressure have complementary effects on the conformational landscape of STEP. These two perturbations have opposite effects on the crystal lattice but surprisingly similar effects on the protein molecular volume, stabilize distinct ordered water molecules throughout the protein, induce backbone shifts in non-overlapping regions of the structure, and rearrange different sets of side chains. We observe a previously unseen arrangement of product-like anions in the active-site pocket, new conformations of conserved catalytic residues only at high temperature, and an active-like conformation of an active-site loop only at high pressure. Surprisingly, using a new computational method for analyzing distributions of protein structures<sup>##UREF##9##42##</sup>, we find that high temperature in the unliganded state induces a coordinated global shift toward previous ligand-bound active-like structures, whereas high pressure shifts the protein toward a previously unseen region of conformational space. Overall, our results illustrate the potential of manipulating protein structures with a broad spectrum of physical perturbations to gain unique insights into their mechanical coupling and biological function.</p>" ]
[ "<title>Methods</title>", "<title>Molecular biology</title>", "<p id=\"Par46\">A plasmid containing the catalytic domain [258–539] of STEP (PTPN5) with an N-terminal 6xHis &amp; TEV cleavage site was obtained via Addgene from Nicola Burgess-Brown (Addgene plasmid #39166; <ext-link ext-link-type=\"uri\" xlink:href=\"http://n2t.net/addgene:39166\">http://n2t.net/addgene:39166</ext-link>; RRID:Addgene_39166). This was transformed into BL21(DE3) Rosetta2 (pRARE2) cells (MilliporeSigma). The sequence of the insert was independently verified using Sanger sequencing, with standard T7 promoter primers.</p>", "<title>Protein expression</title>", "<p id=\"Par47\">In all steps, the antibiotics chloramphenicol (Cam) and ampicillin (Amp) were used to maintain selection at working concentrations of 30 μg/mL and 100 μg/mL respectively. Previously transformed cells from glycerol stocks were plated on an LB-Agar + Amp + Cam plate and incubated overnight at 37 °C. Individual colonies were picked and grown up overnight at 18 °C in LB + Amp + Cam starter cultures (10 mL), shaking at 180 rpm. This starter culture was then added into baffled flasks containing 1 L of LB+Amp+Cam media, and incubated to OD 0.6–0.8 at 37 °C, with shaking at 180 rpm. Expression was then induced by adding IPTG to a final concentration of 0.2 mM; cultures were then incubated overnight at 18 °C, shaking at 180 rpm, before cells were harvested by centrifugation at 3000 rpm for 45 min, snap frozen in liquid N<sub>2</sub> and stored at -80 °C.</p>", "<title>Protein purification</title>", "<p id=\"Par48\">Frozen cellets (cell pellets) were thawed on ice, then 30 mL lysis buffer (50 mM HEPES pH 7.5, 500 mM NaCl, 5 mM imidazole, 5% v/v glycerol, 2 mM DTT) was added. One Pierce EDTA-free protease inhibitor mini-tablet per cellet was also added, and resuspended in a vortexer. Cells in the slurry were then lysed by 3 passages through a cell homogenizer (Avestin) operating with 1000 bar peak. Lysate was then centrifuged for 45 min at 50,000×<italic>g</italic> to spin down the cell fragments. The supernatant was filtered through a 0.22 μm filter to remove final cell debris.</p>", "<p id=\"Par49\">A 5 mL Ni-NTA column (Cytiva) was equilibrated in freshly prepared low-imidazole buffer (50 mM HEPES pH 7.5, 500 mM NaCl, 30 mM imidazole, 5% v/v glycerol, 2 mM DTT). The lysate supernatant was applied to this column, washed with 2 column volumes (CV) of low-imidazole buffer, then gradient-eluted over 10 CV to 100% high-imidazole buffer (50 mM HEPES pH 7.5, 500 mM NaCl, 500 mM imidazole, 5% v/v glycerol, 2 mM DTT), collecting in 5 mL fractions. The STEP-containing fractions eluted around the 40% gradient mark were collected, concentrated using a 15 mL Centriprep 10 K spin-concentrator (Millipore) to a final volume of 5 mL, and filtered through a syringe-mount 0.22 μm filter to remove unidentified precipitate.</p>", "<p id=\"Par50\">A Sephadex 20/200 column (Cytiva) was equilibrated with 2 CV of SEC buffer (50 mM HEPES pH 7.5, 500 mM NaCl, 5% v/v glycerol, 2 mM DTT). The concentrated, filtered Ni-binding fraction was injected onto a 5 mL loop, loaded onto the column, and fractionated over 2 CV, collecting 1 mL fractions. Two peaks were observed, and the fractions corresponding to the largest, STEP-containing peak were pooled.</p>", "<p id=\"Par51\">A HiTrap Q HP anion-exchange column (Cytiva) was equilibrated with 2 CV of low-salt buffer (50 mM HEPES pH 7.5, 10 mM DTT). The pooled peak from size-exclusion chromatography was diluted to a final volume of 100 mL by addition of low-salt buffer, and filtered through a 0.22 μm bottle-top vacuum filter (Celltreat). This was then applied to the Q column, washed with 2 CV of low-salt buffer, and then gradient-eluted over 5 CV to 100% high-salt buffer (50 mM HEPES pH 7.5, 1000 mM NaCl, 10 mM DTT) collecting 5 mL fractions. A single STEP-containing peak was collected at 40% gradient mark.</p>", "<p id=\"Par52\">This final STEP protein was concentrated in Centriprep 10 K spin-concentrators to 3 mL volume, and then further concentrated in Amicon 10 K spin-concentrators to a final concentration of 10 mg/mL, as measured by Nanodrop, and used fresh as the protein sample in crystallography. The identity of STEP vs. other proteins/contaminants was confirmed using SDS-PAGE gels at each step of the purification.</p>", "<title>Crystallization and crystal preparation</title>", "<p id=\"Par53\">Precipitant well solution (30% PEG 3350, 200 mM Li<sub>2</sub>SO<sub>4</sub>, 100 mM bis-tris pH 5.65) was prepared fresh. A Mosquito (SPT Labtech) was used to prepare 96-well 3-drop Intelliplate Low-profile (Art Robbins Instruments) plates. 80 μL well solution was placed into the reservoir. Three 1 μL drops at a protein concentration of 10 mg/mL were placed per well, using 2:1, 1:1, and 1:2 ratios of well solution to protein sample. Crystallization drops were incubated at room temperature. Crystals nucleated within 3 days, mostly in 1:1 droplets, and grew over a week to around 80 × 80 x 20 μm.</p>", "<p id=\"Par54\">For the ambient-pressure low-temperature 100 K (LoTP) dataset, the crystal was soaked in cryoprotectant (mother liquor + 15% v/v glycerol), and cryocooled with liquid nitrogen.</p>", "<p id=\"Par55\">For the high-pressure (205 MPa) cryogenic-temperature dataset (HiP), the crystal was looped in a 100 μm loop, soaked in cryoprotectant (mother liquor + 15% v/v glycerol), and placed in a capillary with cryoprotectant at the end of the tube for shipping to CHESS. At CHESS, the capillary was removed, and the crystal was coated in NVH oil. The crystal was pressurized for 20 min at 205 MPa, cryocooled with liquid nitrogen under pressure, and stored under liquid nitrogen thereafter.</p>", "<p id=\"Par56\">High-temperature diffraction required larger crystals, and so were prepared in Nextal EasyXtal 15-well hanging-drop trays. Precipitant well solution was prepared with the same composition as above (pH 5.5). In all, 400 μL well solution was placed into the reservoirs. Three 3 μL drops at a protein concentration of 10 mg/mL were placed per well, using 1:1 ratios of well solution to protein sample each. Crystallization drops were incubated at room temperature. Crystals nucleated within 3 days, and grew over a week to around 140 × 70 × 40 μm.</p>", "<p id=\"Par57\">For the high-temperature ambient-pressure 310 K (HiT) dataset, the crystal was soaked in cryoprotectant (mother liquor + 15% v/v glycerol), coated in NVH oil, and placed in a capillary with cryoprotectant at the end of the tube for shipping to CHESS.</p>", "<title>X-ray data collection</title>", "<p id=\"Par58\">All X-ray diffraction datasets were collected at the ID7B2 (FlexX) beamline for macromolecular X-ray science at the Cornell High Energy Synchrotron Source (MacCHESS), Ithaca, New York, USA, using an X-ray beam energy of 12 keV and corresponding wavelength of 1.033 Å. The LoTP dataset was collected using beam dimensions of 30 × 20 µm, flux of 5 × 10<sup>11</sup> ph/s, rotation rate of 2°/s, and no translation. The HiT dataset was collected using beam dimensions of 30 × 20 µm, flux flux of 1.6 × 10<sup>10</sup> ph/s, rotation rate of 10°/s, and translation (i.e. helical/vector data collection) along the length of the approximately 140 × 70 x 40 µm crystal. The HiP dataset was collected using beam dimensions of 100 × 100 µm, flux of 2 × 10<sup>10</sup> ph/s, rotation rate of 1°/s, and no translation.</p>", "<title>X-ray data reduction and modeling</title>", "<p id=\"Par59\">Data reduction and modeling was performed similarly for all three datasets, with the data reduction pipeline DIALS<sup>##REF##34747533##60##</sup>. The LoTP dataset was trimmed to the first 130 (out of 180) frames due to increased ice inclusions in later frames. Resolution cutoffs were determined automatically by DIALS based on a combination of CC<sub>1/2</sub>, I/sigma(I), R<sub>merge</sub>, and completeness<sup>##REF##34747533##60##</sup>. Molecular replacement was performed via Dimple<sup>##UREF##11##61##</sup>, with subsequent refinement performed using REFMAC<sup>##REF##15299926##62##</sup> and phenix.refine<sup>##REF##22505256##63##</sup>, with models manually adjusted between rounds of refinement using COOT<sup>##REF##15572765##64##</sup>. Hydrogens were added using phenix.ready_set<sup>##REF##31588918##65##</sup>. X-ray/stereochemistry weight, X-ray ADP weight, and occupancies were all refined and optimized during the final rounds of refinement. Model validation statistics were generated using MolProbity<sup>##REF##29067766##66##</sup>. Solvent content was calculated via MATTPROB<sup>##REF##5700707##67##,##REF##24914969##68##</sup>. Ramachandran outliers (%) are 1.07, 0.36, and 0.71 for LoTP, HiT, and HiP, while Ramachandran favored (%) values are 95.00, 95.00, and 93.21, respectively. Data collection and refinement statistics can be found in Table ##TAB##0##1##.</p>", "<p id=\"Par60\">To complement/validate the conclusions from the manually modeled waters in the deposited models, automated analysis of structural waters was performed by truncating our datasets to the same resolution (1.96 Å) in the PHENIX GUI reflection file editor. After removing all manually modeled heteroatoms including waters, our models were subjected to refinement with default settings, followed by both Cartesian and torsion angle simulated annealing refinement with a start temperature of 4000 K. Waters were automatically added based on real space density using the Coot “find waters” tool. Finally, the models were refined with phenix.refine, first without then with automatic water updating.</p>", "<p id=\"Par61\">Polder maps and omit maps were calculated using the phenix.polder utility from the PHENIX GUI<sup>##REF##28177311##45##</sup>.</p>", "<title>Model analysis</title>", "<p id=\"Par62\">Cɑ distances between structures were calculated using VMD<sup>##UREF##12##69##</sup>. Rotamer names were calculated using phenix.rotalyze<sup>##REF##29067766##66##</sup> based on the latest rotamer distributions from MolProbity<sup>##REF##27018641##70##</sup>.</p>", "<p id=\"Par63\">Protein volumes were calculated using the ProteinVolume software<sup>##UREF##13##71##</sup>. Values for the “total volume” output were nearly identical whether waters were included or not, and were similar (conclusions did not change) when state A vs. state B of the HiP structure were analyzed.</p>", "<p id=\"Par64\">Ringer<sup>##REF##20499387##4##</sup> was run on models that only contained a single conformation for each residue, with alternate conformations removed using phenix.pdbtools. For HiP, each E-loop conformation was treated individually. The single-conformer models each underwent multiple cycles of refinement using phenix.refine. The refined models and maps were then used as input to Ringer. Plots were generated using <italic>ggplot2</italic> and <italic>ggbreak</italic>.</p>", "<p id=\"Par65\">For RoPE analysis, all structures were pre-processed with PDB-REDO<sup>##UREF##14##72##</sup> to ensure consistent treatment, as recommended<sup>##UREF##9##42##</sup>. The different HiP points in Fig. ##FIG##5##6## correspond to different preparations of the model: run PDB-REDO for deposited model; extract each state, run PDB-REDO, then set all occupancies to unity; or extract each state, set all occupancies to unity, then run PDB-REDO.</p>", "<title>Statistics and reproducibility</title>", "<p id=\"Par66\">Calculation of correlation coefficients for Ringer analysis in Fig. ##FIG##4##5## and Supplementary Figs. ##SUPPL##0##11## and ##SUPPL##0##12## was performed using the Pearson correlation method and Supplementary Data ##SUPPL##3##2##, and Supplementary Fig. ##SUPPL##0##4## was performed using Supplementary Data ##SUPPL##4##3##. The analysis of the effects on pockets and cavities in Supplementary Fig. ##SUPPL##0##10## was performed using a Welch’s two-sample <italic>t</italic>-test with the pocket information in Supplementary Data ##SUPPL##5##4##. Two comparisons were made: one between HiP and LoTP, and the other between HiT and LoTP.</p>", "<title>Reporting summary</title>", "<p id=\"Par67\">Further information on research design is available in the ##SUPPL##6##Nature Portfolio Reporting Summary## linked to this article.</p>" ]
[ "<title>Results</title>", "<title>X-ray datasets at high temperature vs. pressure</title>", "<p id=\"Par10\">To compare the effects of temperature vs. pressure on the STEP catalytic domain, we used similarly prepared crystals to obtain three complementary crystal structures: one at cryogenic temperature (100 K) and ambient pressure (0.1 MPa), one at physiological temperature (310 K) but ambient pressure, and one at high pressure (205 MPa) but cryogenic temperature via high-pressure cryocooling<sup>##REF##15983410##43##</sup>. For the remainder of this paper, we refer to the structure at low temperature and low pressure as LoTP, the structure at high temperature as HiT, and the structure at high pressure as HiP. The diffraction datasets and resulting refined structures were of high quality, including acceptably similar resolutions (Table ##TAB##0##1##). Therefore, these datasets can be directly compared to gain insights into the differential effects of temperature vs. pressure on the conformational ensemble of STEP.</p>", "<p id=\"Par11\">All three structures have the expected PTP catalytic domain architecture (Fig. ##FIG##0##1a, b##), including several key loops surrounding the active site region (Fig. ##FIG##0##1c##). Broadly speaking, they are similar to the 7 previously published structures of human STEP (8 including 1 structure of mouse STEP; Supplementary Fig. ##SUPPL##0##1##).</p>", "<p id=\"Par12\">However, the unit cell dimensions differed from the LoTP reference dataset in opposing ways: at HiT the unit cell volume expanded by 3.9%, whereas at HiP the unit cell was instead compressed by 2.1% (Table ##TAB##1##2##). Comparatively, the protein molecule itself was more robust, but was still affected by temperature and pressure: at HiT the protein volume expanded by 1.1%, whereas at HiP it still expanded, but by only 0.4%. Thus elevated temperature expands the unit cell and, to a lesser extent, the protein itself; by contrast, elevated pressure compresses the unit cell, but still allows the protein itself to slightly expand. These observations suggest that temperature vs. pressure has more complex effects on STEP than might be naïvely expected from the unit cell changes alone. Indeed, these distinct perturbations induce a variety of conformational changes distributed throughout the structure of STEP, including some with potential biological relevance, as shown below.</p>", "<title>Unique arrangement in STEP active site</title>", "<p id=\"Par13\">One notable feature of our new structures differs from the previous STEP structures: the active site binds two sulfate molecules (Fig. ##FIG##0##1c, d## and Supplementary Fig. ##SUPPL##0##2a##). The top sulfate sits just beneath the catalytic WPD loop, where a lone sulfate has been observed previously in PDB ID 2bv5, 2bij<sup>##REF##16441242##39##</sup>, and 6h8r<sup>##REF##30207464##40##</sup>, and inhibitors with negatively charged moieties have been observed in PDB ID 5ovr, 5ovx, and 5ow1<sup>##REF##29116812##38##</sup> (Supplementary Fig. ##SUPPL##0##2b##).</p>", "<p id=\"Par14\">The bottom sulfate is well-coordinated by the catalytic P loop, analogous to the phosphate group in the phosphotyrosine (pTyr) substrate in PDB ID 2cjz<sup>##REF##19167335##41##</sup> (Supplementary Fig. ##SUPPL##0##2c##). A phosphocysteine reaction intermediate with a covalent bond to Cys472 is an unlikely explanation of our data, as refining such a putative model resulted in strong negative difference density peaks (Supplementary Fig. ##SUPPL##0##3##), our crystals contained high concentrations of lithium sulfate but not any phosphate-containing compounds, and previous intermediate-bound PTP structures used inactivating mutations to capture such intermediates<sup>##REF##19167335##41##,##REF##9553104##44##</sup> whereas our structure is wildtype. In our structures, as supported by strong electron density, Cys472 predominantly adopts a side-chain rotamer that points away from the sulfate, thus avoiding a steric clash. This rotamer in our new structures is rare for STEP: it was previously only seen as a partial-occupancy alternate conformation in an allosterically activated structure (PDB ID 6h8r) (Supplementary Fig. ##SUPPL##0##2b##). Further supporting this primary rotamer, Ringer curves<sup>##REF##20499387##4##</sup> for Cys472 for all three datasets have a dominant peak for the χ1 side-chain dihedral angle near 180°. In addition, Ringer curves from different model preparations for all three datasets also have a secondary χ1 peak near +60°, suggesting sensitivity of Ringer to precise input coordinates and/or subtle sensitivity to our global perturbations (Supplementary Fig. ##SUPPL##0##4##). This secondary Ringer peak is consistent with an alternate rotamer conformation for Cys472, which is further supported by unbiased Polder<sup>##REF##28177311##45##</sup> (Supplementary Fig. ##SUPPL##0##5##) and omit (Supplementary Fig. ##SUPPL##0##6##) electron density maps. Moreover, the backbone density for Cys472 is consistent with multiple positions, suggesting Cα displacements that are perpendicular to the chain direction (Supplementary Figs. ##SUPPL##0##5## and ##SUPPL##0##6##) and similar in magnitude (0.44–0.93 Å) to those seen between alternate conformations in a previous structure of STEP (0.73 Å for PDB ID 2bv5, although Cys472 is acetylated in that structure and does not change rotamer). Taken together, these observations support the interpretation that Cys472 samples both a rare primary rotamer and a low-occupancy alternate rotamer that is sterically mutually exclusive with a fortuitously observed sulfate bound at high but non-unity occupancy.</p>", "<p id=\"Par15\">Thus, although previous structures of STEP have sulfates or phosphate-like chemical groups independently in each of these sites, no previous structure has them in both sites simultaneously. The closest comparison is PDB ID 2bv5, in which the catalytic Cys472 is modeled as acetylated in the bottom site and a sulfate is in the top site (Supplementary Fig. ##SUPPL##0##2d##), but this arrangement differs in chemical character from what we observe.</p>", "<title>Alterations to ordered solvent</title>", "<p id=\"Par16\">In addition to global changes to the crystal lattice, high temperature, and pressure have striking effects on the solvation layer surrounding the protein. In our manually modeled, deposited structures, LoTP has by far the most waters, HiT has by far the fewest, and HiP has an intermediate number (Supplementary Table ##SUPPL##0##1## and Fig. ##FIG##1##2##). To confirm that this result is not due to the small differences in resolution between datasets (Table ##TAB##0##1##), we truncated the LoTP and HiP diffraction data to match the resolution of the HiT dataset (1.96 Å), then performed fully automated, unbiased water placement for all three structures (see “Methods” section). The resulting water counts are similar to the counts of manually placed waters in our deposited structures (Supplementary Table ##SUPPL##0##1##), thus validating the conclusions derived from the latter.</p>", "<p id=\"Par17\">Turning to specific water positions in our deposited structures, 17 (24.6%) of the HiT waters and 23 (23.5%) of the HiP waters were distinct from any LoTP water (&gt; 2 Å, accounting for crystal symmetry) (Fig. ##FIG##1##2##). Of these 40 new positions, only 1 (2.5%) is common to both HiT and HiP. This suggests that high temperature and high pressure do not merely retain a subset of ordered waters, but rather stabilize new water positions, resulting in a distinct pattern of solvation. As shown below, some of these unique waters are located at functional sites in STEP (Fig. ##FIG##2##3##). In total, we reveal 67 (LoTP) + 16 (HiT) + 22 (HiP) = 105 waters that are unique to one structure (Fig. ##FIG##1##2##), further underscoring the value of crystallography with different axes of perturbations for mapping accessible patterns of protein solvation.</p>", "<title>Global effects on protein conformation</title>", "<p id=\"Par18\">To explore differential effects of high temperature vs. pressure on the protein molecule itself, we examined Cɑ displacements in the HiT and HiP structures relative to the reference LoTP structure. A global plot of this Cɑ distance vs. amino acid sequence (Fig. ##FIG##2##3a##) reveals that most regions are similar in the three structures, with Cɑ distances &lt;0.3 Å, but several local regions shift relative to the reference structure. These shifts tend to occur either only at high temperature or only at high pressure, suggesting that the protein responds to these different perturbations in distinct ways.</p>", "<p id=\"Par19\">Our structures were obtained in the same crystal form as PDB ID 2bv5, which, like our LoTP structure, is a cryogenic-temperature, ambient-pressure dataset. Cɑ distance analysis shows that for many key regions, 2bv5 is similar to our LoTP structure, whereas our HiT and HiP structures are more different (Supplementary Fig. ##SUPPL##0##7##). Thus the effects of temperature and pressure are generally greater than the variability inherent to determining structures of the same protein in similar conditions by different scientists at different times.</p>", "<p id=\"Par20\">Beyond 2bv5, all other previous human STEP structures were in a different crystal form (same space group but longer a and shorter c axes). These exhibit similar or greater Cɑ distances than do our HiT and HiP structures at several sites in STEP (Supplementary Fig. ##SUPPL##0##7b##). All previous STEP structures were determined at cryogenic temperature and ambient pressure. This indicates that, at least at a gross level, differences in crystal contacts may elicit protein structural variability<sup>##REF##21073878##46##</sup> that encompass much of the variability elicited by experimental perturbations such as temperature and pressure. Nonetheless, as shown below, temperature and pressure each induce unique conformational states of STEP.</p>", "<title>Local effects on key structural regions</title>", "<p id=\"Par21\">To explore the basis of these global structural differences, we examined several local areas with distinct conformations in the HiT vs. HiP structures. One local region that responds strongly to pressure — but not to temperature — is the E loop (Fig. ##FIG##2##3a## region (iii)). The E loop of PTPs, containing several Glu (E) residues, is located adjacent to the catalytic WPD loop and P loop (Fig. ##FIG##0##1##). Among previous structures of STEP, the E loop exhibited substantial variability (Supplementary Figs. ##SUPPL##0##1## and ##SUPPL##0##7##). The two main states previously modeled for this loop were the inactive-like state in 2bv5 (with an acetylated catalytic Cys472), and the active-like state in 6h8r (bound to a distal allosteric small-molecule activator). To validate these previous models, we inspected the electron density maps for all previous STEP crystal structures (7 human, 1 mouse). We determined that all of these structures besides 6h8r were either already modeled with a 2bv5-like conformation, or were unmodeled but could be better explained by a 2bv5-like conformation than by a 6h8r-like conformation. Thus, the active-like state of the E loop was only legitimately observed in the allosterically activated structure 6h8r, even though the density was somewhat noisy (Supplementary Fig. ##SUPPL##0##8##).</p>", "<p id=\"Par22\">In contrast to previous STEP structures, our HiP electron density for the E loop, albeit also noisy, is consistent with the presence of both an inactive-like state as in 2bv5 and an active-like state as in 6h8r. We therefore modeled both states as alternate conformations (Fig. ##FIG##3##4a, b##). Deletion of either of these conformations and calculation of omit maps results in positive Fo-Fc difference density peaks for the omitted model (Fig. ##FIG##3##4c, d##), suggesting both are present. The 6h8r-like conformation exists in our HiP structure despite having a different crystal form than 6h8r. By contrast to HiP, our crystallographically isomorphous LoTP and HiT structures are essentially identical to 2bv5 for the E loop. Therefore, high pressure appears to uniquely stabilize a conformation of a key active-site loop that is correlated with an allosterically activated state of human STEP.</p>", "<p id=\"Par23\">Another region that responds to pressure is residues 287-306, encompassing the pTyr loop, also known as the substrate-binding loop (SBL) (Fig. ##FIG##2##3a, b## region (ii)). Backbone shifts in this region play a crucial role in defining the depth of the catalytic pocket<sup>##REF##23860656##47##</sup>. In our models, the backbone of this region, particularly the N-terminal portions, shifts &gt;1 Å from LoTP to HiP (Fig. ##FIG##2##3c##). In addition, the backbone of the C-terminal portions of this region, corresponding to the pTyr loop itself, shifts by up to ~0.7 Å from LoTP to HiT (Fig. ##FIG##2##3c##). Notably, the backbone for the pTyr loop residue Tyr304, whose side chain directly interacts with and helps position the pTyr substrate during catalysis, shifts at both HiP and HiT, yet its side chain remains in place. Overall, these observations suggest a degree of plasticity in the substrate-binding region, which we speculate may help accommodate different pTyr-containing substrates.</p>", "<p id=\"Par24\">In contrast to these regions that respond to pressure, other regions of STEP respond only to temperature. The backbone of the ɑ1′-ɑ2′ helical region near the N-terminus (residues 266-284) shifts by up to ~0.7 Å at HiT but not HiP (Fig. ##FIG##2##3a, b## region (i)). In addition, the junction between the active-site Q loop and the ɑ6 helix (residues 514-524) shifts by up to ~0.4 Å, also at HiT but not HiP (Fig. ##FIG##2##3a, b## region (v)). These new HiT conformations differ not only from our HiP and LoTP structures, but also from the only previous STEP structure with the same crystal form, 2bv5, which was at cryogenic temperature (Supplementary Fig. ##SUPPL##0##7a##).</p>", "<p id=\"Par25\">These backbone shifts are coupled to other notable changes to side-chain conformational ensembles (Fig. ##FIG##2##3c##). In concert with the Q loop backbone shift in this interface, the side chain of Cys518 (from the Q loop) switches from two rotamers to one. The disappearance of the alternate rotamer for Cys518 eliminates a hydrogen bond to the adjacent Glu519, causing the latter to switch to a new rotamer (see also Fig. ##FIG##4##5b##). The new Glu519 rotamer engages in a previously unseen interaction with Lys439 from the catalytic WPD loop, which coordinates the top sulfate (Fig. ##FIG##2##3c##). This conformation of Glu519 is not present in any previous STEP structures: it is unique to our HiT structure. Several of these changes are also correlated with shifts or disordering of nearby water molecules (Fig. ##FIG##2##3c##), illustrating an interplay between protein and solvent structure.</p>", "<p id=\"Par26\">The Q loop backbone shift is also correlated with an alternate side-chain rotamer for Gln516 (Fig. ##FIG##2##3c##) that has only been seen in two previous structures: bound to a pTyr substrate (2cjz; Supplementary Fig. ##SUPPL##0##2c##), and bound to a distal allosteric activator (6h8r; Supplementary Fig. ##SUPPL##0##9##). In particular, this new rotamer avoids what would otherwise be a steric clash with the pTyr substrate, which binds immediately adjacent to Gln516 (Fig. ##FIG##2##3c##). These observations suggest that HiT may capture an active-like conformation of STEP, even in the unliganded form, that is more compatible with formation of the Michaelis complex. Interestingly, Gln516 is immediately adjacent to Ile515, which is the only residue in STEP to have an unavoidable but real Ramachandran outlier — consistent with previous observations that validated, geometrically strained residues, while rare, occur preferentially at active sites<sup>##REF##12557186##48##</sup>.</p>", "<p id=\"Par27\">In the context of the crystal lattice, ɑ1′-ɑ2′ also abuts the distal S loop (residues 462-465), parts of which shift by &gt;0.5 Å at HiT but not HiP (Supplementary Fig. ##SUPPL##0##9##). Interestingly, the S loop forms part of the binding site for a class of allosteric small-molecule activators that are unique to STEP<sup>##REF##30207464##40##</sup> (Supplementary Fig. ##SUPPL##0##9##). This coincidence of temperature-sensitive regions in 3D space suggests that subtle lattice expansion at elevated temperature can allow a protein “breathing room” to adopt subtly different conformations, including at functionally important regions.</p>", "<title>Effects on pockets and cavities</title>", "<p id=\"Par28\">To assess how temperature vs. pressure affect various packing defects in the structure of STEP, we used the program CASTp<sup>##REF##29860391##49##</sup> to measure the volumes of all pockets and/or cavities in each structure (Supplementary Fig. ##SUPPL##0##10##). Interestingly, the largest pocket in each of the three structures was the allosteric activator site. Relative to the LoTP structure (128.7 Å<sup>3</sup>), the volume of this pocket increased at HiT (140.0 Å<sup>3</sup>) but decreased at HiP (74.8 Å<sup>3</sup>), consistent with general expectations of expansion with increasing temperature and compression with increasing pressure.</p>", "<p id=\"Par29\">Considering all pockets/cavities in each structure, the mean volume relative to LoTP (7.8 Å<sup>3</sup>) increases for HiT (11.3 Å<sup>3</sup>) and slightly decreases for HiP (7.5 Å<sup>3</sup>). However, relative to LoTP, we observe no statistically significant difference in the distribution of these volumes for either HiT or HiP (Welch’s two-sample <italic>t</italic>-test, <italic>p</italic> = 0.598 and <italic>p</italic> = 0.951, respectively). Thus, although some individual pockets react differently to different perturbations, at least by some measures the overall packing in the protein is not dramatically different.</p>", "<title>Widespread changes to torsion angles</title>", "<p id=\"Par30\">We next examined in detail how temperature vs. pressure affected conformations throughout the entirety of the STEP catalytic domain, using torsion angles in several ways. First, we performed Ringer analysis for each side chain in each structure by rotating around the Cα-Cβ vector (χ1 torsion angle) and measuring the 2Fo-Fc electron density value at each possible γ heavy atom position<sup>##REF##20499387##4##</sup>. For each residue, we then calculated a correlation coefficient (CC) between Ringer curves for each pair of datasets<sup>##UREF##5##15##</sup>. Relative to the reference LoTP dataset, a substantial number of residues had low CC for either HiT or for HiP (Supplementary Fig. ##SUPPL##0##11##), suggesting differences in side-chain conformational ensembles due to these perturbations. For example, 19 (6.7%) residues had CC &lt; 0.5 in HiT, and 22 (7.8%) residues had CC &lt; 0.5 in HiP. Excluding the flexible E loop (residues 375-383), 18 (6.6%) residues had CC &lt; 0.5 in HiT, and 14 (5.1%) residues had CC &lt; 0.5 in HiP. If high temperature vs. high pressure had similar structural effects, a similar set of residues would be expected to have low CC for both HiT and HiP (each relative to LoTP). However, relatively few residues fall into this category (purple bars in Supplementary Fig. ##SUPPL##0##11##), suggesting that temperature vs. pressure are complementary perturbations that affect different areas of the protein.</p>", "<p id=\"Par31\">To validate these quantitative Ringer results, we examined the models and density maps in detail for several examples. For most residues, the Ringer curves are indeed similar across all three datasets (Fig. ##FIG##4##5a##). For other residues, by contrast, the curves differ in one or more datasets, indicating perturbation-induced changes to side-chain conformations. For example, Glu519 adopts the same χ1 rotamer for LoTP and HiP, but a different χ1 rotamer at HiT (Fig. ##FIG##4##5b##; see also Fig. ##FIG##2##3c##), involving <italic>a</italic> ~ 0.3 Å backbone shift (Fig. ##FIG##2##3a##). By contrast, Ser327 adopts different primary χ1 rotamers for LoTP, HiT, and HiP (Fig. ##FIG##4##5c##). Some residues had distinct Ringer curves at HiP relative to LoTP and HiT (Supplementary Fig. ##SUPPL##0##12##) but were associated with distinct backbone positions of the E loop that occurred only at HiP (Figs. ##FIG##2##3a## and ##FIG##3##4##).</p>", "<p id=\"Par32\">As the Ringer curves above only account for the first side-chain torsion angle (χ1), we also compared rotamer names, which account for all side-chain torsion angles<sup>##REF##10861930##50##</sup> (see ”Methods” section). Excluding the flexible E loop, relatively few residues had different rotamers as alternate conformations in the same model: 7 for LoTP, 7 for HiT, and 7 for HiP. However, compared to LoTP, 50 residues (18%) had a different rotamer in HiT, and 38 residues (14%) had a different rotamer in HiP. Thus, by contrast to only the side-chain base as measured by Ringer, temperature, and pressure both have greater effects on the overall conformations of side chains, stabilizing distinct energy basins. Moreover, of the residues that differed from LoTP, 29 were unique to either only HiT or only HiP, indicating distinct conformational effects from temperature vs. pressure.</p>", "<p id=\"Par33\">Finally, beyond just torsion angles for individual side chains, we explored whether many torsion angles distributed throughout the protein structure may undergo correlated changes in response to temperature vs. pressure. A recent tool called RoPE showed that linear combinations of backbone and side-chain torsion angles in a reduced-dimensionality space can help reveal new insights into the key differences between sets of structural models<sup>##UREF##9##42##</sup>. Using RoPE analysis, we examined our three new structures relative to all previous STEP structures (Fig. ##FIG##5##6##), leading to several interesting observations.</p>", "<p id=\"Par34\">First, the STEP structures generally cluster based on resolution, as noted previously for other proteins<sup>##UREF##9##42##</sup>, with our new structures at intermediate-to-high resolution compared to prior structures. Second, each set of structures with a consistent crystal form clusters together: (i) our new structures plus 2bv5, (ii) most remaining structures, and (iii) the mouse STEP structure 6h8s. Third, most of the previous structures segregate into an active-like cluster (either allosterically activated or bound to a substrate peptide) or an inactive-like cluster (bound to orthosteric inhibitors), indicating that subtle signatures of the protein’s functional state are embedded in torsion-angle space. The allosterically activated structure (6h8s) is nearest to other active-like structures, despite it being mouse-derived (91% sequence identity to human STEP) and having a unique crystal form; hence, signatures of the protein’s inherent functional state appear to persist in this space despite differences in amino acid sequence and crystal lattice.</p>", "<p id=\"Par35\">Fourth, whereas our LoTP structure is near the most analogous previous structure (2bv5) in torsion-angle space as expected, our HiT and HiP structures move in distinct directions from this reference point (Fig. ##FIG##5##6##). Notably, HiT moves toward the active-like structures, whereas HiP moves away from all known STEP structures. This is despite only HiP featuring a conformation of the E loop resembling the allosterically activated structure 6h8r (Fig. ##FIG##3##4## and Supplementary Fig. ##SUPPL##0##8##), but consistent with only HiT featuring side-chain and backbone conformations of the active-site Q loop in a putatively active-like state (Figs. ##FIG##2##3c## and ##FIG##4##5b##). HiP models with significantly different E-loop conformations and prepared for analysis in different ways have similar positions in torsion-angle space, confirming that RoPE analysis highlights structurally distributed as opposed to localized features. Relative to LoTP, the coordinated torsion-angle changes in HiT and HiP detected by RoPE visually correspond to hinging of the first half of the primary structure (initial α-helices + loops) relative to the second half (β-sheet + α-helical bundle), albeit with apparently meaningful differences between them given their large separation in RoPE space. Overall, these results indicate that although high pressure induces an active-like conformation locally in the E loop, high temperature induces a more global, distributed active-like state of the protein.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par36\">While temperature is growing in use as an experimental perturbation in macromolecular crystallography, pressure has received less attention for such applications. Here we show that both temperature and pressure enact distinct and significant effects on the conformational ensemble of STEP, not only globally but also locally at several key functional areas.</p>", "<p id=\"Par37\">In our structures, high temperature increases both unit cell volume and protein molecular volume (Table ##TAB##1##2##) as seen previously<sup>##REF##21918110##9##</sup>. High pressure decreases unit cell volume as seen previously<sup>##REF##3586017##27##,##REF##11524565##51##,##REF##20516618##52##</sup>, yet still slightly increases protein molecular volume (Table ##TAB##1##2##). Thus, intriguingly, when subjected to pressure, the STEP protein molecule itself slightly expands, even as its environment is compressed. This differs from previous high-pressure crystal structures of other proteins with a decreased protein molecular volume<sup>##REF##3586017##27##,##REF##16269539##29##,##REF##25849385##31##</sup>, but agrees with a high-pressure NMR solution structure with a slightly increased protein molecular volume<sup>##REF##12930996##53##</sup>. The slight increase in molecular volume of the protein itself that we observe upon pressurization may be initially unintuitive, but can likely be explained by counterbalancing decreases in the volume of the bulk solvent (which is invisible to crystallography) within the crystal lattice, and is thus consistent with the thermodynamic expectation that pressurization decreases the molar volume of the protein-solvent system. Nonetheless, our observations suggest that the mechanisms by which pressure impacts the detailed conformational landscapes of different proteins are complex and potentially context-sensitive.</p>", "<p id=\"Par38\">Although many of the structural changes we see could be considered small, it is important to remember that sub-angstrom shifts can be directly relevant to protein function<sup>##REF##18768811##26##</sup>. This is consistent with our RoPE results, in which HiT vs. HiP have very distinct characteristics despite the overall structures being apparently similar. Crucially, the difference in the E loop at HiP does not dominate the signal (see Fig. ##FIG##5##6## and Methods), indicating that the differences between high temperature vs. pressure are driven by smaller, subtler conformational changes distributed throughout the tertiary structure.</p>", "<p id=\"Par39\">The largest conformational changes we observe in STEP are in the E loop (Fig. ##FIG##3##4a##), a conserved loop in PTPs that plays a critical role in regulation<sup>##REF##21094165##54##</sup>. Only at HiP do we see evidence in the electron density for a dual-conformation E loop (Fig. ##FIG##3##4b–d##). Both conformations were individually evident in previous structures of STEP with different chemical modifications or allosteric ligands (Supplementary Fig. ##SUPPL##0##8##). Our data indicate that applying a physical perturbation (pressure) is sufficient to induce these conformations to coexist in a single crystal of the unliganded protein, which has implications for accessing excited states of other proteins.</p>", "<p id=\"Par40\">Beyond the E loop, we observe new conformations not captured in previous structures of STEP. For instance, only at HiT, we see Glu519 of the active-site Q loop adopt a new side-chain rotamer that engages in an interaction with Lys439. Notably, Lys439 follows the WPD sequence, forming a WPDQK sequence. Recently, a conserved PDFG motif was proposed to underlie the ability of the WPD loop to toggle between discrete open vs. closed states in PTPs<sup>##UREF##10##55##</sup>. However, the corresponding residues in STEP are PDQK — and, as revealed by our HiT structure, the final K (Lys439) engages with the Q loop nearby. Perhaps not coincidentally given these idiosyncratic features, the WPD loop of STEP has not been observed in the usual open or closed states as with most other PTPs, but only in the atypically open state<sup>##REF##16441242##39##,##REF##19167335##41##</sup>. Together, these observations suggest that the STEP active site does not adhere to expectations from the rest of the PTP family, and points to specific amino acids and conformations that may encode its unusual behavior. We speculate that these unique structural properties of STEP likely underlie its substantially lower catalytic activity relative to other PTPs like PTP1B<sup>##UREF##2##11##,##REF##30207464##40##,##REF##23970698##56##</sup> and may be related to its unique physiological roles in neuronal development<sup>##REF##16806510##57##</sup>.</p>", "<p id=\"Par41\">It is plausible that this unresponsive, atypically open state could be modulated by binding of regulators or alterations in the cellular environment, creating a way to regulate catalysis. In this light, we observe two sulfates simultaneously bound within the active site. The biological significance of this observation for STEP is not immediately clear. It is likely that binding of sulfate-like moieties in the top site, as in several orthosteric inhibitors (Supplementary Fig. ##SUPPL##0##2b##), blocks closure of the WPD loop, effectively wedging it atypically open (Supplementary Fig. ##SUPPL##0##2e##). However, even with the top site free and substrate bound only to the bottom site, the WPD loop still remains atypically open in crystals<sup>##REF##19167335##41##</sup> (Supplementary Fig. ##SUPPL##0##2c##). Removing all tightly bound molecules from the active site of STEP in future crystallographic studies could provide more definitive answers about the conformational landscape of this functionally critical but unusual catalytic loop.</p>", "<p id=\"Par42\">Previously, based on computational simulations, a small-molecule allosteric activator for STEP was reported to enact its effects via a pair of allosteric pipelines<sup>##REF##30207464##40##</sup>. We do not observe obvious shifts along these pathways at high temperature or pressure. However, we do observe shifts in the activator binding pocket itself (Supplementary Fig. ##SUPPL##0##9##). Although subtle, these conformational shifts may be sufficient to influence ligand-binding energetics, and therefore may aid structure-based drug design efforts to improve upon the relatively weak reported activator.</p>", "<p id=\"Par43\">Beyond the reported allosteric activator site, we also observe perturbation-sensitive shifts at other known or putative ligand binding sites. First, at LoTP and HiP, an ordered glycerol molecule is bound near α2′ and the Q loop. By contrast, at HiT, ordered waters are present instead, and α1′-α2′ and the Q loop undergo conformational shifts (Fig. ##FIG##2##3c##). Importantly, all three structures are from crystals treated with similar glycerol-containing cryoprotectant solutions. It is thus plausible that crystal cryocooling induces the glycerol to bind<sup>##UREF##4##14##</sup>, preventing nearby conformations with potential functional relevance seen at physiological temperature (Fig. ##FIG##2##3c## and ##FIG##5##6##). Second, in the paralogous PTP SHP2, the α1′-α2′ region helps form the binding site for the potent allosteric inhibitor SHP099, although the mechanism also involves additional domains<sup>##REF##27362227##58##</sup>. The corresponding α1′-α2′ region in STEP is not known to be allosteric. However, the subtle but coordinated conformational changes we observe here at physiological temperature raise the enticing possibility that some aspects of the allosteric capacity demonstrated in SHP2 are also present in STEP, and perhaps even other PTPs.</p>", "<p id=\"Par44\">In general, allostery in STEP remains poorly understood, hindering efforts to elucidate this important protein’s endogenous regulatory mechanisms and to develop specific allosteric modulators. To address this important gap, several approaches should be considered. First, exploiting different crystal forms, including those in the allosteric-activator-bound structures for human and mouse STEP<sup>##REF##30207464##40##</sup>, may provide new windows into conformational mobility otherwise masked by crystal contacts. Second, higher pressures than those reported here<sup>##REF##35308861##32##</sup> may enable access to additional excited states. Third, X-ray diffraction at high pressure and physiological temperature simultaneously has the potential to reveal unique aspects of conformational landscapes not evident from a single perturbation alone. More broadly, the avant-garde crystallographic and computational methods outlined here should prove useful tools to investigate allosteric mechanisms in a variety of other proteins, including but not limited to other PTP family members that also exhibit an atypically open WPD loop such as LYP<sup>##REF##18056643##59##</sup>.</p>", "<p id=\"Par45\">Overall, the work reported here is consistent with the notion that proteins sample conformations from a multifaceted energy landscape, and that different physical perturbations such as temperature and pressure can access distinct, complementary features of this landscape, thus opening doors to elucidating fundamental connections between protein structural dynamics and function.</p>" ]
[]
[ "<p id=\"Par1\">Protein function hinges on small shifts of three-dimensional structure. Elevating temperature or pressure may provide experimentally accessible insights into such shifts, but the effects of these distinct perturbations on protein structures have not been compared in atomic detail. To quantitatively explore these two axes, we report the first pair of structures at physiological temperature versus. high pressure for the same protein, STEP (PTPN5). We show that these perturbations have distinct and surprising effects on protein volume, patterns of ordered solvent, and local backbone and side-chain conformations. This includes interactions between key catalytic loops only at physiological temperature, and a distinct conformational ensemble for another active-site loop only at high pressure. Strikingly, in torsional space, physiological temperature shifts STEP toward previously reported active-like states, while high pressure shifts it toward a previously uncharted region. Altogether, our work indicates that temperature and pressure are complementary, powerful, fundamental macromolecular perturbations.</p>", "<p id=\"Par2\">A multi-perturbation crystallographic study on the atypical phosphatase STEP reveals that temperature and pressure are powerful macromolecular perturbations, with distinct effects on protein backbone, side-chain conformations, and ordered solvent.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n\n\n\n\n\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s42003-023-05609-0.</p>", "<title>Acknowledgements</title>", "<p>DAK is supported by NIH R35 GM133769. We thank Helen Ginn for help with RoPE analysis, members of the CUNY Advanced Science Research Center (ASRC) Structural Biology Initiative (SBI) for helpful discussions, Akshay Raju and Shivani Sharma for help with PTP bioinformatics, and Marian Szebenyi for help with arranging our X-ray beamtime. This work is based upon research conducted at the Center for High Energy X-ray Sciences (CHEXS), which is supported by the National Science Foundation under award DMR-1829070, and the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by award 1-P30-GM124166-01A1 from the National Institute of General Medical Sciences, National Institutes of Health, and by New York State’s Empire State Development Corporation (NYSTAR).</p>", "<title>Author contributions</title>", "<p>L.G. analyzed data and wrote the manuscript. A.E. analyzed data and wrote the manuscript. B.T.R. designed experiments, performed experiments, and edited the manuscript. M.K. designed experiments and performed experiments. Q.H. designed experiments and edited the manuscript. A.D.F. performed experiments and edited the manuscript. D.A.K. conceived the study, designed experiments, analyzed data, and wrote the manuscript.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par68\"><italic>Communications Biology</italic> thanks the anonymous reviewers for their contribution to the peer review of this work. Primary Handling Editors: Isabelle Lucet and Gene Chong. A peer review file is available.</p>", "<title>Data availability</title>", "<p>Coordinates and structure factors that were generated during the course of this study have been deposited in the Protein Data Bank with the accession codes 8sls (STEP at cryogenic temperature and ambient pressure), 8slt (STEP at physiological temperature and ambient pressure), and 8slu (STEP at cryogenic temperature and high pressure). The protein structure used as a search model for molecular replacement is accessible in the Protein Data Bank under accession codes 2bv5.</p>", "<title>Competing interests</title>", "<p id=\"Par69\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Structural overview of STEP, including two sulfates in active site.</title><p><bold>a</bold> Overview of STEP catalytic domain, centered on active site. <bold>b</bold> 180° rotation of (<bold>a</bold>) to show allosteric activator binding site<sup>##REF##30207464##40##</sup>, with key residues highlighted in pink. <bold>c</bold> Zoom-in of (<bold>a</bold>) showing several key active-site loops and two sulfates bound in the active site cleft. Key catalytic residues are denoted with an asterisk. <bold>d</bold> Interactions between two sulfates and nearby residues in the active site of our LoTP structure.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>Ordered water molecules are sensitive to temperature and pressure.</title><p><bold>a</bold>–<bold>c</bold> All ordered water molecules at (<bold>a</bold>) LoTP, (<bold>b</bold>) HiT, and (<bold>c</bold>) HiP are shown. <bold>d</bold> Only the waters unique to each structure, i.e. &gt;2 Å from any water in the other two structures. Coloring for active-site loops as in Fig. ##FIG##0##1##.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Global backbone displacements due to high temperature vs. pressure.</title><p><bold>a</bold> Cɑ distances for the HiT and HiP structures relative to the reference LoTP structure are plotted vs. amino acid sequence. The two alternate conformations for the E loop in the HiP structure are separated, although both have high Cɑ distance to LoTP. See also Supplementary Fig. ##SUPPL##0##3##. Regions with interesting backbone differences are highlighted; those highlighted with the same color are adjacent in the tertiary structure. The data for generating this graph is available in Supplementary Data ##SUPPL##2##1##. <bold>b</bold> Structure of STEP with color and cartoon width corresponding to Cɑ root-mean-square fluctuation (RMSF) between our HiT, HiP, and LoTP structures. Same highlighted regions as in <bold>a</bold>. <bold>c</bold> Zoom-in of active-site area including region (i) (residues 267-282, ɑ1′-ɑ2′ helices), region (v) (residues 515-531, Q loop), and region (ii) (residues 287-306, pTyr loop). Catalytic WPD loop and top sulfate are shown nearby. Magenta disks show putative steric clashes between Gln516 and an aligned pTyr substrate from PDB ID 2cjz (not in our structures) which is included for context. See Fig. ##FIG##3##4## for zoom-in of region (iii), and Supplementary Fig. ##SUPPL##0##9## for zoom-in of region (iv).</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>The E loop is reorganized uniquely at high pressure.</title><p><bold>a</bold> Overlay of all three new STEP structures. The conformation of the E loop is nearly identical at LoTP (blue) and HiT (red), but deviates into two distinct conformations at HiP (cyan, green). Glu379 remains within the same conformational space regardless of E-loop conformation. <bold>b</bold> HiP dual E loop (cyan, green sticks) with 2Fo-Fc (blue mesh, 1 σ) and Fo-Fc difference (green mesh, +3 σ; red mesh, -3 σ) electron density maps. Thr375 is the first full amino acid where the E loop completely separates into two distinct conformations (black arrows). <bold>c</bold> HiP_A conformation of E loop with 2Fo-Fc and Fo-Fc difference electron density maps, omitting the HiP_B state. Arrows indicate Thr375 deviation. <bold>d</bold> HiP_B conformation of E loop with 2Fo-Fc and Fo-Fc difference electron density maps, omitting the HiP_A state. Arrows indicate Thr375 deviation.</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><title>Examples of different side-chain conformations at high temperature and/or pressure.</title><p>For each example residue, the following panels are shown: (<italic>Left</italic>) Overlaid Ringer curves for our three datasets<sup>##REF##20499387##4##</sup>. (<italic>Middle</italic>) Our three structures with 2Fo-Fc (contoured at 1 σ) and Fo-Fc (contoured at ±3 σ) density maps. <italic>(Right)</italic> Our three structures overlaid. LoTP in blue, HiT in red, HiP in green. Examples: (<bold>a</bold>) Met373 has the same χ1 peak (<italic>t</italic>, near 180°) for LoTP, HiT, and HiP. <bold>b</bold> Glu519 has similar χ1 peaks for LoTP and HiP (<italic>m</italic>, near -60°), but a different peak for HiT (<italic>p</italic>, near +60°). <bold>c</bold> Ser327 has different χ1 peaks for LoTP (<italic>t</italic>), HiT (<italic>p</italic>), and HiP (<italic>m</italic>). χ1 rotamer nomenclature from<sup>##REF##10861930##50##</sup>. The data for generating the Ringer curves in <bold>a</bold>–<bold>c</bold> is available in Supplementary Data ##SUPPL##3##2##.</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><title>Dimensionality reduction in torsion-angle space reveals clustering based on several factors including temperature vs. pressure.</title><p>Our new structures (LoTP, HiT, HiP) are shown relative to all previous STEP structures from the PDB in RoPE reduced-dimensionality torsion-angle space<sup>##UREF##9##42##</sup>. Horizontal and vertical axes correspond to different combinations of the top principal component analysis (PCA) modes. Apparent inactive-like vs. active-like clusters are highlighted. Different icon shapes indicate distinct crystal forms (unit cell parameters). Resolution is shown by color. Arrows indicate the effects of high temperature vs. pressure relative to our reference structure. HiP* indicates several HiP models with the E loop prepared in different ways; see Methods. 6h8s: mouse STEP; all other structures: human STEP. All models were prepared for RoPE with PDB-REDO<sup>##UREF##14##72##</sup> to ensure consistent treatment<sup>##UREF##9##42##</sup>.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Crystallographic statistics.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>PDB ID</th><th>8SLS</th><th>8SLT</th><th>8SLU</th></tr></thead><tbody><tr><td>Dataset name</td><td>LoTP</td><td>HiT</td><td>HiP</td></tr><tr><td colspan=\"4\">Data collection<sup>a</sup></td></tr><tr><td> Temperature (K)</td><td>100</td><td>310</td><td>100</td></tr><tr><td> Pressure (MPa)</td><td>0.1 (ambient)</td><td>0.1 (ambient)</td><td>205</td></tr><tr><td> Space group</td><td>P212121</td><td>P212121</td><td>P212121</td></tr><tr><td colspan=\"4\"> Cell dimensions</td></tr><tr><td>  <italic>  a</italic>, <italic>b</italic>, <italic>c</italic> (Å)</td><td>39.67, 63.51, 135.16</td><td>39.98, 64.49, 137.21</td><td>39.14, 63.47, 134.20</td></tr><tr><td>    <italic>ɑ</italic>, <italic>β</italic>, <italic>ɣ</italic> (°)</td><td>90, 90, 90</td><td>90, 90, 90</td><td>90, 90, 90</td></tr><tr><td> Resolution (Å)</td><td>1.71–67.58</td><td>1.96–68.61</td><td>1.84–57.37</td></tr><tr><td><italic> R</italic><sub>merge</sub></td><td>0.108 (2.37)<sup>b</sup></td><td>0.170 (2.398)</td><td>0.114 (2.127)</td></tr><tr><td><italic> I</italic> / σ<italic>I</italic></td><td>10.23 (0.59)</td><td>7.79 (0.63)</td><td>10.71 (0.64)</td></tr><tr><td> Completeness (%)</td><td>98.64 (93.42)</td><td>99.80 (99.03)</td><td>99.45 (99.12)</td></tr><tr><td> Redundancy</td><td>4.7 (4.8)</td><td>6.7 (6.9)</td><td>6.6 (6.6)</td></tr><tr><td colspan=\"4\">Refinement</td></tr><tr><td> Resolution (Å)</td><td>1.71–67.58</td><td>1.96–68.61</td><td>1.84–57.37</td></tr><tr><td> No. reflections</td><td>37,552 (3655)</td><td>26,353 (2573)</td><td>29,880 (2949)</td></tr><tr><td><italic> R</italic><sub>work</sub>/<italic>R</italic><sub>free</sub></td><td>19.15/22.44</td><td>17.44/20.57</td><td>19.48/23.66</td></tr><tr><td> No. atoms</td><td>4871</td><td>4721</td><td>4920</td></tr><tr><td>    Protein</td><td>4700</td><td>4643</td><td>4799</td></tr><tr><td>    Ligand/ion</td><td>23</td><td>10</td><td>23</td></tr><tr><td>    Water</td><td>149</td><td>69</td><td>98</td></tr><tr><td><italic> B</italic>-factors</td><td>41.46</td><td>51.61</td><td>45.55</td></tr><tr><td>    Protein</td><td>41.45</td><td>51.71</td><td>45.63</td></tr><tr><td>    Ligand/ion</td><td>34.43</td><td>43.79</td><td>41.57</td></tr><tr><td>    Water</td><td>42.65</td><td>46.43</td><td>42.34</td></tr><tr><td colspan=\"4\"> R.M.S. deviations</td></tr><tr><td>    Bond lengths (Å)</td><td>0.01</td><td>0.02</td><td>0.01</td></tr><tr><td>    Bond angles (°)</td><td>1.20</td><td>1.40</td><td>1.24</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Change in unit cell and protein volume at high temperature vs. high pressure.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th/><th/><th>LoTP</th><th>HiT</th><th>HiP</th></tr></thead><tbody><tr><td>Unit Cell</td><td>a (Å)</td><td>39.67</td><td>39.98 (+0.8%)</td><td>39.15 (−1.3%)</td></tr><tr><td/><td>b (Å)</td><td>63.51</td><td>64.49 (+1.5%)</td><td>63.45 (−0.1%)</td></tr><tr><td/><td>c (Å)</td><td>135.16</td><td>137.21 (+1.5%)</td><td>134.22 (−0.7%)</td></tr><tr><td/><td>Cell Volume (Å<sup>3</sup>)</td><td>340527.7</td><td>353769.9 (+3.9%)</td><td>333411.5 (−2.1%)</td></tr><tr><td>Protein</td><td>Protein Volume (A<sup>3</sup>)</td><td>37632.6</td><td>38039.1 (+1.1%)</td><td>37783.3 (+0.4%)</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM5\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM6\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM7\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM8\"></supplementary-material>" ]
[ "<table-wrap-foot><p><sup>a</sup>One crystal was used for each dataset.</p><p><sup>b</sup>Values in parentheses are for the highest-resolution shell.</p></table-wrap-foot>", "<table-wrap-foot><p>Absolute number given first (% change relative to LoTP given in parentheses. Protein total volume calculated by the ProteinVolume software<sup>##UREF##14##72##</sup>.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Liliana Guerrero, Ali Ebrahim.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"42003_2023_5609_Fig1_HTML\" id=\"d32e805\"/>", "<graphic xlink:href=\"42003_2023_5609_Fig2_HTML\" id=\"d32e1021\"/>", "<graphic xlink:href=\"42003_2023_5609_Fig3_HTML\" id=\"d32e1065\"/>", "<graphic xlink:href=\"42003_2023_5609_Fig4_HTML\" id=\"d32e1133\"/>", "<graphic xlink:href=\"42003_2023_5609_Fig5_HTML\" id=\"d32e1237\"/>", "<graphic xlink:href=\"42003_2023_5609_Fig6_HTML\" id=\"d32e1386\"/>" ]
[ "<media xlink:href=\"42003_2023_5609_MOESM1_ESM.pdf\"><caption><p>Supplementary Table and Figures</p></caption></media>", "<media xlink:href=\"42003_2023_5609_MOESM2_ESM.pdf\"><caption><p>Description of Additional Supplementary Files</p></caption></media>", "<media xlink:href=\"42003_2023_5609_MOESM3_ESM.xlsx\"><caption><p>Supplementary Data 1</p></caption></media>", "<media xlink:href=\"42003_2023_5609_MOESM4_ESM.xlsx\"><caption><p>Supplementary Data 2</p></caption></media>", "<media xlink:href=\"42003_2023_5609_MOESM5_ESM.xlsx\"><caption><p>Supplementary Data 3</p></caption></media>", "<media xlink:href=\"42003_2023_5609_MOESM6_ESM.xlsx\"><caption><p>Supplementary Data 4</p></caption></media>", "<media xlink:href=\"42003_2023_5609_MOESM7_ESM.pdf\"><caption><p>Reporting Summary</p></caption></media>", "<media xlink:href=\"42003_2023_5609_MOESM8_ESM.pdf\"><caption><p>Peer Review File</p></caption></media>" ]
[{"label": ["3."], "mixed-citation": ["Xie, T., Saleh, T., Rossi, P. & Kalodimos, C. G. Conformational states dynamically populated by a kinase determine its function. "], "italic": ["Science"], "bold": ["370"]}, {"label": ["5."], "mixed-citation": ["Wankowicz, S. A., de Oliveira, S. H., Hogan, D. W., van den Bedem, H. & Fraser, J. S. Ligand binding remodels protein side-chain conformational heterogeneity. "], "italic": ["Elife"], "bold": ["11"]}, {"label": ["11."], "mixed-citation": ["Keedy, D. A. et al. An expanded allosteric network in PTP1B by multitemperature crystallography, fragment screening, and covalent tethering. "], "italic": ["Elife"], "bold": ["7"]}, {"label": ["12."], "mixed-citation": ["Ebrahim, A. et al. The tem\u00adper\u00adature-dependent conformational ensemble of SARS-CoV-2 main protease (Mpro). "], "italic": ["IUCrJ"], "bold": ["9"]}, {"label": ["14."], "mixed-citation": ["Skaist Mehlman, T. et al. Room-temperature crystallography reveals altered binding of small-molecule fragments to PTP1B. "], "italic": ["Elife"], "bold": ["12"]}, {"label": ["15."], "mixed-citation": ["Keedy, D. A. et al. Mapping the conformational landscape of a dynamic enzyme by multitemperature and XFEL crystallography. "], "italic": ["Elife"], "bold": ["4"]}, {"label": ["20."], "mixed-citation": ["Cavender, C. E. et al. Structure-based experimental datasets for benchmarking of protein simulation force fields. "], "italic": ["arXiv"]}, {"label": ["21."], "surname": ["Kurpiewska", "Lewi\u0144ski"], "given-names": ["K", "K"], "article-title": ["High pressure macromolecular crystallography for structural biology: a review"], "source": ["Open Life Sci."], "year": ["2010"], "volume": ["5"], "fpage": ["531"], "lpage": ["542"], "pub-id": ["10.2478/s11535-010-0044-y"]}, {"label": ["23."], "mixed-citation": ["Dhaussy, A.-C. & Girard, E. "], "italic": ["High Pressure Bioscience: Basic Concepts, Applications and Frontiers"]}, {"label": ["42."], "mixed-citation": ["Ginn, H. M. Torsion angles to map and visualize the conformational space of a protein. "], "italic": ["Protein Sci"], "bold": ["32"]}, {"label": ["55."], "mixed-citation": ["Yeh, C. Y. et al. A conserved local structural motif controls the kinetics of PTP1B catalysis. "], "italic": ["bioRxiv"]}, {"label": ["61."], "surname": ["Wojdyr", "Keegan", "Winter", "Ashton"], "given-names": ["M", "R", "G", "A"], "article-title": ["DIMPLE - a pipeline for the rapid generation of difference maps from protein crystals with putatively bound ligands"], "source": ["Acta Crystallogr. A"], "year": ["2013"], "volume": ["69"], "fpage": ["299"], "lpage": ["299"], "pub-id": ["10.1107/S0108767313097419"]}, {"label": ["69."], "surname": ["Humphrey", "Dalke", "Schulten"], "given-names": ["W", "A", "K"], "article-title": ["VMD: visual molecular dynamics"], "source": ["J. Mol. Graph."], "year": ["1996"], "volume": ["14"], "fpage": ["27"], "lpage": ["28"], "pub-id": ["10.1016/0263-7855(96)00018-5"]}, {"label": ["71."], "surname": ["Chen", "Makhatadze"], "given-names": ["CR", "GI"], "article-title": ["ProteinVolume: calculating molecular van der Waals and void volumes in proteins"], "source": ["BMC Bioinform."], "year": ["2015"], "volume": ["16"], "fpage": ["101"], "pub-id": ["10.1186/s12859-015-0531-2"]}, {"label": ["72."], "surname": ["Joosten", "Long", "Murshudov", "Perrakis"], "given-names": ["RP", "F", "GN", "A"], "article-title": ["The PDB_REDO server for macromolecular structure model optimization"], "source": ["IUCrJ"], "year": ["2014"], "volume": ["1"], "fpage": ["213"], "lpage": ["220"], "pub-id": ["10.1107/S2052252514009324"]}]
{ "acronym": [], "definition": [] }
72
CC BY
no
2024-01-14 23:40:17
Commun Biol. 2024 Jan 12; 7:59
oa_package/ef/77/PMC10786866.tar.gz
PMC10786867
38216589
[ "<title>Introduction</title>", "<p id=\"Par2\">In recent years, the introduction of alien insect pests into new areas has caused major economic damage to agriculture. These intrusions are generally due to anthropic activities such as global trading and increased human travel<sup>##UREF##0##1##,##UREF##1##2##</sup>. On a worldwide scale, biological invasions are responsible for weighty economic losses estimated at approximately US$ 1.288 trillion (2017 US dollars), in addition to significant biodiversity declines<sup>##REF##33790468##3##</sup>. <italic>Halyomorpha halys</italic> (Heteroptera: Pentatomidae) is among these intruders. This Asian species is a notorious invasive pest that has emerged as a phytosanitary threat, causing significant economic losses to crops in Europe and the United States of America (USA)<sup>##REF##29068708##4##</sup>. The spread of <italic>H. halys</italic> first started with its accidental introduction into North America and Europe, and at present, its expansion has reached at least 41 different countries<sup>##UREF##2##5##</sup>. The invasiveness of this pest is ensured by its high dispersal capabilities<sup>##REF##26074338##6##</sup> and hitchhiker behavior, as it can exploit cargo shipments or other transportation means for passive movement<sup>##UREF##3##7##</sup>. Moreover, given their strong flying capacity, the adults display an escape behavior when disturbed, making the effectiveness of chemical control with pesticide applications uncertain<sup>##REF##23905725##8##</sup>. Recently, more efforts have been made with respect to sustainable control of <italic>H. halys</italic>, mainly exploiting the potential effectiveness of native and/or exotic parasitoids and their potential inclusion within classical biological control programs<sup>##REF##30991646##9##–##REF##35621775##11##</sup>. Furthermore, higher attention is being dedicated to research on other important aspects of <italic>H. halys</italic> biology, including vibrational communication<sup>##UREF##5##12##,##REF##33391809##13##</sup>. Biotremology is a recently recognized scientific discipline<sup>##UREF##6##14##</sup> that has shown great potential for its application in control programs to manage various pests and vectors<sup>##REF##32408539##15##–##REF##35636340##19##</sup>. Interestingly, applied biotremology techniques proved to be efficient as control measures against <italic>H. halys</italic><sup>##REF##34357680##20##</sup>. In the Pentatomidae family, vibrational communication is common and mediates short-range communication during mating behavior<sup>##REF##12414736##21##</sup>. In a typical scheme, females begin emitting low-frequency vibrational signals once prompted by male pheromones<sup>##UREF##9##22##</sup>. Males respond with their own signals<sup>##REF##12414736##21##</sup> while producing larger pheromone quantities<sup>##REF##12757319##23##</sup>, and will then start searching for a stationary female that is emitting her signal<sup>##UREF##10##24##,##REF##10600150##25##</sup>. Regarding <italic>H. halys</italic>, males and females emit sex-specific courtship signals<sup>##UREF##5##12##</sup>. Male Signal 1 (MS1) is a relatively long vibrational emission with a peak frequency in the range of 50 Hz, whereas Male Signal 2 (MS2) consists of a train of short pulses with a decreasing frequency modulation from 85 to 40 Hz<sup>##UREF##5##12##</sup>. Female signals have similar characteristics and are thus called Female Signals 1 (FS1) and 2 (FS2). The dynamics of signal emission are largely unknown, however, the main known difference between sexes lies in males emitting their signals spontaneously, even if alone, whereas females emit their signals only in the presence of other individuals (e.g., responding to male signals). Furthermore, males predominantly emit MS1, while females mostly emit FS2<sup>##UREF##5##12##</sup>. Under natural conditions, the mating behavior of <italic>H. halys</italic> occurs from spring, after overwintering when the species survives in a diapause state, to late summer<sup>##REF##23905725##8##,##UREF##11##26##</sup>. Temperature is a key parameter that regulates the activity of <italic>H. halys</italic><sup>##UREF##12##27##</sup>. In particular, under 14 °C the adults tend to stay within the wintering phase while the peak egg-laying activity takes place between 23.5 and 28.4 °C<sup>##UREF##11##26##</sup>. According to Fisher et al.<sup>##REF##33891675##28##</sup>, events including high temperatures and low humidity can significantly reduce <italic>H. halys</italic> survival over time. Most studies evaluating the effects of temperature on this species have focused on the reproductive season; hence, little is known on how these insects recommence their vibrational signaling in the post-dormancy phase and how it can affect their survival.</p>", "<p id=\"Par3\">In the present study, we examined the influence of three different temperatures (10 °C, 18 °C, and 25 °C) on restoring the vibrational calling activity and motility of <italic>H. halys</italic> adults for a better understanding of their phenology after diapause. Given that 14 °C is the threshold above which the diapause is broken, we chose 10 °C as the negative control in the range of temperatures corresponding to inactivity. In contrast, 18 °C and 25 °C were chosen in temperature ranges of suboptimal (i.e., 14–23.5 °C) and optimal mating and egg-laying activity (i.e., 23.5–28.4 °C). Our research aimed to describe the post-diapause vibrational behavior and motility of overwintered <italic>H. halys</italic> adults at these temperatures. Additionally, we examined the survival of the insects and correlated it with the recorded vibrational communication at each temperature. Given the gap of knowledge on the sex-related vibrational emission of <italic>H. halys</italic> adults, the insects were recorded in their respective cages within different settings for each temperature treatment. As a result, the recordings were performed on control cages (i.e., five males and five females together, hereinafter “CCg”), single cages (hereinafter “SCg”), and joined cages (hereinafter “JCg”). The latter recording setting was achieved by clipping single cages of opposite sexes on the side.</p>" ]
[ "<title>Methods</title>", "<title>Insect sample and rearing</title>", "<p id=\"Par15\">Adult insects at the verge of dormancy were collected throughout the end of November 2020 within the surrounding hedgerows of Fondazione Edmund Mach, in Northern Italy (46° 11' 34.8\" N 11° 08' 08.9\" E), using dark live traps as described in Suckling et al.<sup>##REF##31671778##42##</sup>. At the beginning of December 2020, they were transferred to artificial overwintering conditions (i.e., 9 °C; RH 65 ± 5%) for a 7-week period, which is essential for obtaining sexually mature <italic>H. halys</italic> adults<sup>##UREF##20##43##</sup>. After this 7-week period, the insects were randomly segregated into three climatic chambers (Angelantoni Test Technologies Srl, Italy). Each chamber was set at one of the chosen temperatures (10 °C, 18 °C or 25 °C), with a constant RH of 65 ± 5% and a fixed photoperiod of 16L: 8D. A data logger (model EL-USB-2, Lascar electronics, Whiteparish, United Kingdom) was employed beside the cages to monitor the temperature (ºC) within each climatic chamber. The tested individuals for each temperature treatment consisted of five insect cages, four of which contained at least ten (12 maximum) sexed adults in each cage, corresponding to two male cages and two female cages (Fig. ##SUPPL##0##S1##). The fifth cage corresponded to the control cage (CCg) containing five males and five females together, hence, without any copulation prevention (Fig. ##SUPPL##0##S1##). Consequently, the total number of the experimented insects was 168 individuals. The insects were maintained in 22 × 22 × 22 cm fine mesh cages (BugDorm<sup>®</sup>, MegaView, Taiwan) on green beans (<italic>Phaseolus vulgaris</italic> L.), cashew nuts (<italic>Anacardium occidentale</italic>), and carrots (<italic>Daucus carota</italic> subsp. <italic>sativus</italic>). Food was replaced once a week and water was added ad libitum as soaked cotton.</p>", "<title>Insect recording</title>", "<p id=\"Par16\">To guarantee spontaneous (i.e., without elicitation from the other sex) <italic>H. halys</italic> calling activity, we kept the males and females separated and recorded them in distinct cages (SCg). On the other hand, to assess whether the presence of nearby opposite sex stimulated calling, we made another setup where a male’s cage was joined to a female’s cage (JCg). Joining the opposite sex cages was achieved by linking two sides of male and female cages (Fig. ##FIG##5##6##) using a clip, which guaranteed that vibrational signals were perceived by the insects without leading them to copulation. In this trial, odors (e.g., pheromones or other volatiles) could freely travel in the air through the cages and physical contact (on the net) was not prevented, thus simulating a natural condition. Given the impossibility of copulation within sexed cages (SCg and JCg), the vibrational communication could be artificially prolonged compared to natural conditions. Therefore, <italic>H. halys</italic> adults were also recorded within mixed-sex cages as control (CCg) to ascertain whether our single-sex cages contained vibrational peculiarities associated with impossibility to achieve mating. The cumulative calling (i.e., Signal 1 and Signal 2) and walking periods were calculated per recording. This was obtained by calculating the sum of the total period of each activity indicator of interest (i.e., Signal 1, Signal 2, and Walking) within each recording. In the case of recording separate cages, a laser Doppler vibrometer (Polytec PDV 100, sensitivity = 5 mm/s/V) was used. When recording the joined cages, two laser Doppler vibrometers (Ometron VQ-500-D-V and Polytec PDV 100) adjusted to the same sensitivity were used simultaneously. Each was pointed at the reflective tape stuck to the upper net of the respective cage (s) and connected to a LAN-XI data acquisition system (type 3050-B-040, Brüel &amp; Kjær sound and vibration A/S) (Fig. ##FIG##5##6##). When using two lasers, both outputs were assessed simultaneously for differences in amplitude to avoid accounting for a certain signal twice, and to distinguish the source of the signals (i.e., the male cage or the female cage). The cages were placed on an anti-vibrational table (Astel s.a.s, Ivrea, Italy) during recordings. When the cages were not being recorded, they were placed at least 50 cm away from one another in their respective climatic chambers (i.e., each cage on a different rack), to exclude substrate-borne vibrational interference prior to the recordings. All recordings took place between 0800 and 1700 hours. In the 25 °C treatment, the insects were either recorded in their respective rearing climatic chamber or in the biotremology laboratory at Fondazione Edmund Mach (San Michele all’Adige, Italy) inside an acoustic insulated chamber at 25 °C. The insects in the other two temperature treatments were recorded in their respective climatic chambers. The recordings were digitized and stored at a 48kHz sample rate and 24-bit resolution on a laptop computer (HP, EliteBook 8560 p) using “B&amp;K connect” software (Brüel &amp; Kjær sound and vibration A/S). When necessary, the collected data were filtered for noise reduction using the Audacity software (Softonic International, Barcelona, Spain). The recordings were then analyzed using Raven Pro 1.6.1 (The Cornell Lab of Ornithology, Ithaca, NY, USA). Signal 1 cues were selected manually whereas Signal 2 and walking noise were identified through the batch detector feature by specifying the values of the relevant parameters (e.g., minimum or maximum frequencies) (Table ##SUPPL##0##S2##). Further, to ensure the accuracy of the batch detector, all false detections or undetected signals and walking noise were removed or added manually. The duration of each recording was fixed at 10 minutes. Data acquisition lasted for four months, from February to May 2021. The cages were repeatedly recorded at intervals of two to three days until the insects died.</p>", "<title>Statistical analyses</title>", "<p id=\"Par17\">Statistical analyses were all performed using R version 4.1.1 (R Core Team 2021, Vienna, Austria). The effect of copulation inhibition (JCg) on the vibrational calling and motility of <italic>H. halys</italic> compared to the other cage state categories, was analyzed using Wilks’ Lambda type nonparametric multivariate inference with the package “npmv”<sup>##REF##36568334##44##</sup>. The same package was used to identify significant subsets of variables and factor levels that controlled the family wise error rate, which served as a post hoc analysis. Signals 1 and 2 were considered in the analyses without sex attribution (i.e., MS1, MS2, FS1, and FS2). To assess the differences between male and female signaling within the different cage states, a Kruskal–Wallis test was conducted. The influence of temperature on the cumulative calling periods of each type of signaling activity (i.e., signal 1 and signal 2) and motility (vibrational noise associated with walking) was assessed by fitting zero-inflated generalized linear mixed models (GLMM) with a linear parameterization negative binomial error dispersion for signal 1 and a Tweedie dispersion for signal 2 and walking. To overcome pseudo-replication, the factor “cage number” was used as a random factor in all models which were calculated using the “glmmTMB” package<sup>##UREF##21##45##</sup>. The covariates were optimized using a stepwise algorithm. For signals 1 and 2, the explanatory variables were temperature, sex, and cage state, whereas for motility, the explanatory variables were temperature and cage state (Table ##TAB##1##2##). The residual distribution and fitness of the models were evaluated using the DHARMa package<sup>##UREF##22##46##</sup>. The Akaike information criterion (AIC)<sup>##UREF##23##47##</sup> was used to select the best-fitting model. Data exploration plots were built using “tidyverse” package<sup>##UREF##24##48##</sup>.</p>", "<p id=\"Par18\">Overall survival (OS) was described using Kaplan-Meier curves<sup>##UREF##25##49##</sup> for the three temperature categories (10 °C, 18 °C, and 25 °C) for each sex. To simulate the time until insects’ death, Cox’s proportional hazards (PH) model (Cox, 1972) was performed only for males using the median survival time and temperature categories, with “10 °C” as the reference category (negative control). The Cox PH model was then adjusted considering the repetition of insects by cages, as well as a 2-sided 5% significance level. For females, the proportional hazard assumption was not met in the model, indicating that a single hazard ratio would not be adequate to represent the effect of temperature on their survival. Survival analyses were done following Moore<sup>##UREF##26##50##</sup> with packages ‘survival’<sup>##UREF##27##51##</sup> and ‘survminer’<sup>##UREF##28##52##</sup>. AIC<sup>##UREF##23##47##</sup> was used to select the best-fitting model.</p>" ]
[ "<title>Results</title>", "<p id=\"Par4\">The experimental differences resulting from the different cage state recording settings are summarized in Table ##TAB##0##1##.</p>", "<p id=\"Par5\">The temperature had various effects on the cumulative periods of calling and motility (measured as vibrational noise associated with walking). At 10 °C, no signaling activity of any type was registered, while a minimum amount of motility was observed (Figs. ##FIG##0##1##, ##FIG##1##2##, ##FIG##2##3##). In contrast, 18 °C and 25 °C were the temperatures at which <italic>H. halys</italic> was active; however, some discrepancies were found in signal calling between the two temperatures. Within the 18 °C treatment, females emitted FS2 prevalently when they were recorded in JCg. However, they were also found to be active when recorded in SCg, especially from mid-March onwards, accounting for a delay of 15 days compared with JCg (Fig. ##FIG##1##2##). Moreover, they only started signaling 35 days after diapause, while the males were found to be signaling within the first week after diapause. Within the 25 °C treatment, both males and females were active immediately after diapause (01 days). The effect of temperature on signaling was also statistically evident as the significant factors of signal 1’s GLMM were temperature 18 °C (z = 0.923, <italic>P </italic>= 0.00656), temperature 25 °C (z = 2.14277, <italic>P </italic>= 0.02641), and sex male (z = 4.928, <italic>P </italic>= 8.31e−07) (Table ##TAB##1##2##). The model further confirmed the higher tendency of males to emit signal 1 compared to females (Fig. ##FIG##0##1## &amp; Fig. ##SUPPL##0##S2##). The significant factors of signal 2’s GLMM were temperature 18 °C (z = 15.935, <italic>P </italic>= 2e−16), temperature 25 °C (z = 19.653, <italic>P</italic> = 2e−16), and sex male (z = − 4.049, <italic>P</italic> = 5.13e−05) (Table ##TAB##1##2##). The model confirmed the higher tendency of females to emit signal 2 compared to males (Fig. ##FIG##1##2## &amp; Fig. S2). The significant factors of motility’s GLMM were temperature 18 °C (z = 4.380, <italic>P</italic> = 1.19e−05) and temperature 25 °C (z =5.004, <italic>P</italic> = 5.62e−07) (Table ##TAB##1##2##).</p>", "<p id=\"Par6\">Regarding cage state treatment, our results indicated a significant effect of copulation inhibition (JCg) on the signaling and motility of <italic>H. halys</italic> (Wilks’ Lambda = 10.010, df = 6, 622, <italic>P </italic>&lt; 0.001) (Fig. ##FIG##3##4##). In particular, higher values of both signals 1 and 2 emission were recorded for JCg compared to CCg and SCg (Fig. ##FIG##3##4##). The post-hoc test showed that the cumulative signal emission and motility times were significantly higher for JCg than for CCg and SCg (Fig. ##FIG##3##4##). Moreover, the females spent significantly higher cumulative periods emitting signal 1 in JCg compared to SCg (χ2 = 12.21, df = 1, <italic>p </italic>&lt; 0.001) (Fig. ##SUPPL##0##S2##). Males spent higher cumulative periods emitting Signal 1 in JCg; however, the difference was not statistically significant. Both females (χ2 = 10.46, df = 1, <italic>p</italic> &lt; 0.001) and males (χ2 = 7.1891, df=1, <italic>p </italic>&lt; 0.01) spent significantly higher cumulative periods emitting Signal 2 in JCg (Fig. ##SUPPL##0##S2##). The same was applied to motility, as the highest cumulative walking time was recorded when the cages were joined. Only males spent significantly higher cumulative walking periods in JCg (χ2 = 4.23, df = 1, <italic>p</italic> = 0.04) (Fig. ##SUPPL##0##S2##).</p>", "<p id=\"Par7\">To describe insect survival period at each temperature, the Overall Survival (OS) was measured from the date of first observation (day 1) to the date of death (event) until the last follow-up date (day 34). Regarding the overall survival analysis, a total of 107 individuals were considered, with 100% deaths occurring until the end of the study. Looking at the total deaths separated by temperature and sex (Table ##SUPPL##0##S1##), the median overall survival was higher at 10 °C than at 18 °C and 25 °C. This was further confirmed in the Kaplan-Meier plot, where a lower survival probability was registered at higher temperatures (Fig. ##FIG##4##5##). Moreover, Table ##TAB##2##3## shows the results of the Cox model for males, with a significant difference between the survival at temperature 10 °C against 18 °C (HR = 5.28, 95% CI (2.28–12.2); <italic>p </italic>= 0.0001) and 25 °C (HR = 27.7, 95% CI (12.5–76.6); <italic>p</italic> = 1.54e−10). The survival distribution of events within the female group showed that at 25 °C, all deaths occurred within the first 10 days (Fig. ##FIG##4##5##B), whereas at 10 °C and 18 °C, the overall survival was higher, with deaths occurring between 3 and 5 weeks.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par8\">Knowledge of phenology is a key factor in the efficient control of invasive pests. Phenological modeling of <italic>H. halys</italic> suggested that the expansion and population size of this pest are largely prone to temperature and photoperiod<sup>##REF##27242539##29##</sup>. Previous studies have also suggested that diapause is likely initiated and terminated by the photoperiod<sup>##UREF##13##30##,##REF##35886756##31##</sup>. With this in mind, here the exposure of <italic>H. halys</italic> adults to three different temperatures following their dormancy phase gave further insight into the phenology of this species. In accordance with the literature, we observed a significant effect of temperature on termination of diapause. In addition, given that the photoperiod was fixed for all treatments in our study, temperature might be the abiotic factor of major importance in orchestrating the termination of overwintering. Interestingly, it also appears to play a significant role in restoring the vibrational communication of <italic>H. halys</italic> post-dormancy. Given the previously reported evidence of the photoperiod’s influence on the phenology of <italic>H. halys</italic>, its interaction with temperature and the resulting effect on reinstating vibrational behavior is a theme that deserves further investigation. In our study, the temperatures at which the post-diapause activity and vibrational communication of <italic>H. halys</italic> occurred were consistent with the activity range previously reported in the literature<sup>##UREF##11##26##</sup>, as the insects only emitted signals at 18 °C and 25 °C. In particular, the MS1 emission was consistent with that previously reported<sup>##UREF##5##12##</sup>, since males signaled spontaneously even without perceiving female signals (SCg). However, the total signaling time for MS2 was significantly amplified in conditions of joined cages (JCg) at both active temperatures (18 °C and 25 °C). It is imperative to note that within courtship between stink bug adults, multimodal communication could take place including visual stimuli which might in turn result in a higher vibrational communication<sup>##UREF##14##32##</sup>. As for walking, it is indicative of <italic>H. halys</italic> motility. In fact, higher temperatures (18 °C and 25 °C) were favorable for higher cumulative walking periods, especially for males, which spent significantly longer periods of walking when recorded in JCg. This confirms the mating strategy of males<sup>##UREF##5##12##</sup> that dedicate a greater amount of searching behavior when they retrieve nearby female signals to locate them. Our results also confirm that females are significantly more triggered to emit FS2 when MS1 is perceived, that is, when recorded in JCg. The vibrational calling activity differed significantly between the different cage state categories. In fact, within the control cage treatment (CCg), where the insects were not withheld from copulation, we recorded a significantly lower emission of vibrational signals compared with JCg, where insects were physically separated by a net. It should be noted that the main signal type representing this difference was FS2. This could suggest that sexually-mature female <italic>H. halys</italic> in conditions with low likelihood of copulation, might significantly extend the time of their callings to increase their chances of mating.</p>", "<p id=\"Par9\">Regarding the vibrational activity of <italic>H. halys</italic> at 18 °C and 25 °C, we noted some peculiar differences between the two temperatures, which were significantly more apparent in the case of FS2. At 18 °C, FS2 was prevalently emitted in JCg until mid-March, which further confirmed that they were triggered to engage in vibrational communication when they perceived MS1<sup>##UREF##5##12##</sup> and pheromones secreted by males<sup>##REF##12757319##23##</sup>. This phenomenon was also observed at 25 °C. However, females emitted FS2 even in the absence of males (SCg) from mid-March onwards at 18 °C, suggesting that they can also emit FS2 spontaneously, albeit with a certain delay with respect to males’ emission of MS1.</p>", "<p id=\"Par10\">Despite this spontaneous calling among females, this phenomenon might have been due to copulation abstinence for over a month after the end of the overwintering phase and/or reaching a certain age. According to Polajnar et al.<sup>##UREF##5##12##</sup>, females were never found to emit FS2 spontaneously; however, in that study, it was only reported that females were at least seven days old, without specifying whether there were any individuals aged 30 days or older among those tested. In addition, these individuals did not belong to the overwintering generations. In our experiment, the insects were not recorded singularly but in groups of 10 sexed insects per cage, which might have also played a role in eliciting this behavior. For example, the perception of incidental vibrations due to the walking activity could be potentially associated with the presence of conspecifics. The use of incidental vibrations to orientate towards possible prey is well documented in insects and spiders<sup>##UREF##15##33##</sup>, as well as it is known that aphids react to the approach of a predator by dropping<sup>##UREF##16##34##</sup>. However, little is known on the interpretation and reaction of phytophagous insects to the incidental vibrations of conspecifics, a theme that deserves further research.</p>", "<p id=\"Par11\">Notwithstanding, it is important to note that we cannot exclude an effect of pheromones because the sexed cages were kept within the same ventilated climatic chamber. In fact, even if pheromones cover an aggregation function in <italic>H. halys</italic> as well as in other stinkbugs, it is also known that their perception can elicit vibrational signaling in males<sup>##UREF##17##35##,##REF##34940147##36##</sup>. It is also important to note that females at 25 °C, not different from males, were directly active in terms of vibrational calling on the day following the end of diapause. In contrast, it took 35 days for those at 18 °C to become active. This could be attributed to several reasons. First, it suggests that from the end of the diapause, females require time before being vibrationally active, and that this time strongly depends on temperature. Second, females are potentially ready to interact with males for mating immediately after the end of diapause, which means that their reproductive organs do not need any further development. Our results suggest that they are directly active if they encounter favorable conditions immediately after diapause, but their life expectancy will be shorter. Despite active signaling in such conditions, it remains uncertain whether they can reproduce because it is strongly related to the vitellogenic state of females.</p>", "<p id=\"Par12\">Previous studies have suggested that the state of vitellogenesis in female <italic>H. halys</italic> entering overwintering may be related to abiotic factors in the collection area<sup>##REF##28904750##37##</sup>. Moreover, a significant positive correlation was found between collected mated females and the use of pheromone traps<sup>##REF##28904750##37##</sup>. Here, all the studied specimens were collected using pheromone traps, which might indicate that the collected females had already mated prior to entering the overwintering phase. Accordingly, it is important to note that a successful engagement in vibrational duets is only an indicator of mating readiness and does not confirm reproductive maturity, as <italic>H. halys</italic> females may copulate before reaching it<sup>##REF##28904750##37##</sup>.</p>", "<p id=\"Par13\">Given our interest in investigating the post-diapause temperature effect on <italic>H. halys</italic>, the insects were immediately segregated into different temperature treatments after the overwintering phase. This sudden exposure to different temperatures could have affected insect survival rate. Previous studies showed that <italic>H. halys</italic> is susceptible to high temperatures, i.e., up to 36 °C<sup>##REF##32046093##38##</sup> and even up to 42 °C<sup>##REF##33891675##28##</sup>, whereas the insects fared best at optimal temperatures, such as 25 °C. In this study, the short latency time prior to vibrational calling at 25 °C correlated with a short period of survival, whereas a longer latency time at 18 °C correlated with a longer overall survival of the insects. Because they lived longer, the total signaling activity was higher than that at 25 °C and 10 °C, where no vibrational activity was registered. The individuals we used were overwintered insects, which could explain the discrepancy between our findings and those of Govindan and Hutchison<sup>##REF##32046093##38##</sup> and Fisher et al.<sup>##REF##33891675##28##</sup>, who used active insects. It is possible that the low overall survival observed at 25 °C is correlated with the abrupt physiological changes that were induced at this temperature. As a result, the insects were immediately ready to start their vibrational communication prematurely. Another explanation could be linked to the energy expenditure for calling emission for mating<sup>##UREF##18##39##</sup>. In previous studies, signaling effort revealed that indirect costs associated with vibrational signaling had a negative effect on male survival<sup>##UREF##19##40##,##REF##11569789##41##</sup>.These findings indicate that climate change might affect <italic>H. halys</italic> when encountering high temperatures shortly after diapause. Our results also suggest that the dormancy phase will be shortened with insects becoming prematurely active, but their life expectancy will be shorter.</p>", "<p id=\"Par14\">In view of the above, this study provides further insights into the post-diapause vibrational behavior of <italic>H. halys</italic>. We can conclude that temperature is unquestionably a main factor influencing the emission of vibrational cues, which could lead to significant effects on life span. The sudden exposure at 25 °C resulted in a faster readiness for vibrational calling emission, which led to a shorter lifespan due to energy expenditure for calling emission. Climate change is likely to affect the behavior and distribution of many invasive pests, but further studies of the temperature ranges that influence reproductive behavior are still needed for many species, including <italic>H. halys</italic>. Our results provide further insights into the potential effects of climate change on the vibrational calling activity and motility of <italic>H. halys</italic> after the overwintering phase. Hence, it could set up the basis for further bioclimatic modeling of the climate change effect on <italic>H. halys</italic>, where further studies are needed for extended ranges of suboptimal and extreme temperatures. Moreover, our results grant further insight into biorational control techniques that employ vibrational playbacks for mass trapping and monitoring purposes. That being said, further understanding of the quality of the emitted vibrational signals in different climatic scenarios is required to better replicate them (i.e., playbacks) for monitoring and biorational control techniques. Nevertheless, our results were obtained under laboratory conditions, which may not fully depict what could happen in an open field.</p>" ]
[]
[ "<p id=\"Par1\">Substrate-borne vibrational communication is common in pentatomids. Although several works exist on the vibrational communication of <italic>Halyomorpha halys</italic>, its vibrational behavior post diapause has not been investigated. In this study, we recorded <italic>H. halys</italic> overwintered adults using laser doppler vibrometers at three temperatures: 10 °C (inactivity), 18 °C (breaking of diapause), and 25 °C (peak of mating activity). The aim was to assess the effect of temperature on the signaling, motility, and survival of <italic>H. halys</italic>. The insects were sexed into different cages and recorded separately or joined with a cage of the opposite sex. We calculated the total time spent on signaling and walking per replica. The males predominantly emitted male signal 1 (MS1) throughout the four months of recordings. The females exclusively emitted female signal 2 (FS2) when joined with the opposite sex cage the first two months of recordings. Interestingly, they also started FS2 signaling when recorded separately, after two months. No signaling was recorded at 10 °C. At 25 °C, the signaling latency time before vibrational signaling was 24 h compared to 23 days at 18 °C. The short latency time at 25 °C correlated with a higher death rate in early stages of recording. Male walking activity was significantly higher in joined cages at 18 °C and 25 °C, suggesting the increased searching behavior near the opposite sex. Overwintered <italic>H. halys</italic> could adapt to different conditions whereas low temperatures maintain the diapause which is characterized by no signaling activity. Our results provide a foundation for bioclimatic modeling of climate change effects on <italic>H. halys</italic> and insights into the use of vibrational playbacks for mass trapping and monitoring as control techniques.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-023-50480-y.</p>", "<title>Acknowledgements</title>", "<p>J.M.F.’s Ph.D. scholarship was funded by the Mediterranean Agronomic Institute of Bari (CIHEAM Bari). Gerardo Roselli’s help was crucial to collect the insects for the experiment.</p>", "<title>Author contributions</title>", "<p>J.M.F. and M.S. designed and conceived the experiment; J.M.F. and M.S. conducted the experiment; J.M.F. and V.Z.C. analyzed the results; J.M.F. wrote the first draft; V.V., G.A., and V.M critically revised successive drafts of the manuscript and supervised the experiment. All authors reviewed and commented on the manuscript.</p>", "<title>Data availability</title>", "<p>All the relevant data are presented in the manuscript. The datasets generated and analyzed during the current study are available from the corresponding author upon request.</p>", "<title>Competing interests</title>", "<p id=\"Par19\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Cumulative Signal 1 emission for each recording of male and female <italic>Halyomorpha halys</italic> in joined (JCg) and separated (SCg) cages at all temperatures.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Cumulative Signal 2 emission for each recording of male and female <italic>Halyomorpha halys</italic> in joined (JCg) and separated (SCg) cages at all temperatures.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Cumulative walking time for each recording of male and female <italic>Halyomorpha halys</italic> in joined (JCg) and separated (SCg) cages at all temperatures.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Barplots showing the mean signaling and walking differences when cages were recorded separately (SCg) or joined (JCg) vs the control (CCg). Recording condition groups indicated by different letters show significant differences (Wilks’ Lambda type non-parametric interference at <italic>p</italic> &lt; 0.001). The error bars represent the standard errors.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Kaplan–Meier plot describing the survival curves for <italic>Halyomorpha halys</italic> at all temperatures for (<bold>A</bold>) males and (<bold>B</bold>) females. The curves represent the estimated survival probability at each time point. Y-axis shows the probability of being alive at each time point, while X-axis shows the time-points. The shaded areas around the lines represent 95% CI.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Scheme of the experimental setup. (<bold>a</bold>) Recordings of single cages (i.e., SCg). (<bold>b</bold>) Recordings of joined cages(i.e., JCg).</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Summary of experimental differences resulting from cage recording settings.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Cage state treatment</th><th align=\"left\">Copulation</th><th align=\"left\">Vibrational signals</th><th align=\"left\">Pheromones</th></tr></thead><tbody><tr><td align=\"left\">Control (CCg)</td><td align=\"left\">Can occur</td><td align=\"left\">Perceived</td><td align=\"left\">Perceived</td></tr><tr><td align=\"left\">Single (SCg)</td><td align=\"left\">Cannot occur</td><td align=\"left\">Not perceived</td><td align=\"left\">Not perceived</td></tr><tr><td align=\"left\">Joined (JCg)</td><td align=\"left\">Cannot occur</td><td align=\"left\">Perceived</td><td align=\"left\">Perceived</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Results of generalized linear mixed-effects model (GLMM) for signaling and walking.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">A</th><th align=\"left\">Model synthesis</th><th align=\"left\">AIC</th><th align=\"left\">BIC</th><th align=\"left\">LogLik</th><th align=\"left\">Dev</th><th align=\"left\">df</th><th align=\"left\">Distribution</th></tr></thead><tbody><tr><td align=\"left\">(Signal 1)</td><td align=\"left\">Signal1 ~ temperature + sex + state + (1|cage)</td><td align=\"left\">1358.3</td><td align=\"left\">1412.8</td><td align=\"left\">− 666.1</td><td align=\"left\">1332.3</td><td align=\"left\">477</td><td align=\"left\">Negative binomial</td></tr><tr><td align=\"left\">(Signal 2)</td><td align=\"left\">Signal2 ~ temperature + sex + state + (1|cage)</td><td align=\"left\">1497.1</td><td align=\"left\">1547.5</td><td align=\"left\">− 736.6</td><td align=\"left\">1437.1</td><td align=\"left\">477</td><td align=\"left\">Tweedie</td></tr><tr><td align=\"left\">(Motility)</td><td align=\"left\">walking ~ temperature + state + (1|cage)</td><td align=\"left\">2600.9</td><td align=\"left\">2651.2</td><td align=\"left\">− 1288.5</td><td align=\"left\">2576.9</td><td align=\"left\">478</td><td align=\"left\">Tweedie</td></tr></tbody></table><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">B</th><th align=\"left\">Fixed effects</th><th align=\"left\">Estimate</th><th align=\"left\">Std. Error</th><th align=\"left\">Z value</th><th align=\"left\" colspan=\"3\">Pr ( &gt;|z|)</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"4\">(Signal 1)</td><td align=\"left\">(Intercept)</td><td align=\"left\">0.90958</td><td align=\"left\">0.98523</td><td align=\"left\">0.923</td><td align=\"left\" colspan=\"3\">0.35589</td></tr><tr><td align=\"left\">Temperature 18 °C</td><td align=\"left\">2.61910</td><td align=\"left\">0.96350</td><td align=\"left\">2.718</td><td align=\"left\" colspan=\"3\">0.00656 **</td></tr><tr><td align=\"left\">Temperature 24 °C</td><td align=\"left\">2.14277</td><td align=\"left\">0.96513</td><td align=\"left\">2.220</td><td align=\"left\" colspan=\"3\">0.02641 *</td></tr><tr><td align=\"left\">Sex male</td><td align=\"left\">1.09746</td><td align=\"left\">0.22270</td><td align=\"left\">4.928</td><td align=\"left\" colspan=\"3\">8.31e−07 ***</td></tr><tr><td align=\"left\" rowspan=\"4\">(Signal 2)</td><td align=\"left\">(Intercept)</td><td align=\"left\">− 3.695e+01</td><td align=\"left\">6.116e+03</td><td align=\"left\">− 0.006</td><td align=\"left\" colspan=\"3\">0.995</td></tr><tr><td align=\"left\">Temperature 18 °C</td><td align=\"left\">4.586</td><td align=\"left\">2.878e−01</td><td align=\"left\">15.935</td><td align=\"left\" colspan=\"3\"> &lt; 2e−16 ***</td></tr><tr><td align=\"left\">Temperature 24 °C</td><td align=\"left\">5.516</td><td align=\"left\">2.807e−01</td><td align=\"left\">19.653</td><td align=\"left\" colspan=\"3\"> &lt; 2e−16 ***</td></tr><tr><td align=\"left\">Sex male</td><td align=\"left\">− 1.251</td><td align=\"left\">3.090e−01</td><td align=\"left\">–4.049</td><td align=\"left\" colspan=\"3\">5.13e−05 ***</td></tr><tr><td align=\"left\" rowspan=\"3\">(Motility)</td><td align=\"left\">(Intercept)</td><td align=\"left\">2.86618</td><td align=\"left\">0.36129</td><td align=\"left\">7.933</td><td align=\"left\" colspan=\"3\">2.13e−15***</td></tr><tr><td align=\"left\">Temperature 18 °C</td><td align=\"left\">1.50367</td><td align=\"left\">0.34329</td><td align=\"left\">4.380</td><td align=\"left\" colspan=\"3\">1.19e−05 ***</td></tr><tr><td align=\"left\">Temperature 24 °C</td><td align=\"left\">1.78674</td><td align=\"left\">0.35707</td><td align=\"left\">5.004</td><td align=\"left\" colspan=\"3\">5.62e−07 ***</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Cox regression model for male—temperature; Hazard ratio and 95% confidence interval.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Variables</th><th align=\"left\">Hazard ratio (CI 95%)</th><th align=\"left\"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"3\">Ref level 10 °C</td></tr><tr><td align=\"left\">18 °C</td><td align=\"left\">5.28 (2.3–12.2)</td><td align=\"left\">0.000102***</td></tr><tr><td align=\"left\">25 °C</td><td align=\"left\">27.7 (10–76.6)</td><td align=\"left\">1.54e−10***</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>A) The best explanatory model for each dependent variable. B) The significant independent variables of the chosen models. Dev (deviance), Est (estimate), df (df residuals). *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001.</p></table-wrap-foot>", "<table-wrap-foot><p>*** p &lt; 0.001.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2023_50480_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2023_50480_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2023_50480_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2023_50480_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2023_50480_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2023_50480_Fig6_HTML\" id=\"MO6\"/>" ]
[ "<media xlink:href=\"41598_2023_50480_MOESM1_ESM.pdf\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["1."], "surname": ["Meyerson", "Mooney"], "given-names": ["LA", "HA"], "article-title": ["Invasive alien species in an era of globalization"], "source": ["Front. Ecol. Environ."], "year": ["2007"], "volume": ["5"], "fpage": ["199"], "lpage": ["208"], "pub-id": ["10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2"]}, {"label": ["2."], "surname": ["Cini"], "given-names": ["A"], "article-title": ["Tracking the invasion of the alien fruit pest "], "italic": ["Drosophila suzukii"], "source": ["J Pest Sci"], "year": ["2014"], "volume": ["87"], "fpage": ["559"], "lpage": ["566"], "pub-id": ["10.1007/s10340-014-0617-z"]}, {"label": ["5."], "mixed-citation": ["European and Mediterranean Plant Protection Organization (EPPO). EPPO Global Database. "], "ext-link": ["https://gd.eppo.int/"]}, {"label": ["7."], "surname": ["Haye"], "given-names": ["T"], "article-title": ["Range expansion of the invasive brown marmorated stinkbug, "], "italic": ["Halyomorpha halys"], "source": ["J. Pest Sci."], "year": ["2015"], "volume": ["88"], "fpage": ["665"], "lpage": ["673"], "pub-id": ["10.1007/s10340-015-0670-2"]}, {"label": ["10."], "surname": ["Malek"], "given-names": ["R"], "italic": ["Trissolcus japonicus"], "source": ["Biol. Control"], "year": ["2021"], "volume": ["161"], "fpage": ["104700"], "pub-id": ["10.1016/j.biocontrol.2021.104700"]}, {"label": ["12."], "surname": ["Polajnar", "Maistrello", "Bertarella", "Mazzoni"], "given-names": ["J", "L", "A", "V"], "article-title": ["Vibrational communication of the brown marmorated stink bug ("], "italic": ["Halyomorpha halys"], "source": ["Physiol. Entomol."], "year": ["2016"], "volume": ["41"], "fpage": ["249"], "lpage": ["259"], "pub-id": ["10.1111/phen.12150"]}, {"label": ["14."], "surname": ["Hill"], "given-names": ["PS"], "source": ["Biotremology: Studying Vibrational Behavior"], "year": ["2019"], "publisher-loc": ["Berlin"], "publisher-name": ["Springer International Publishing"]}, {"label": ["16."], "surname": ["Mazzoni"], "given-names": ["V"], "article-title": ["Use of substrate-borne vibrational signals to attract the Brown Marmorated Stink Bug, "], "italic": ["Halyomorpha halys"], "source": ["J Pest Sci"], "year": ["2017"], "volume": ["90"], "fpage": ["1219"], "lpage": ["1229"], "pub-id": ["10.1007/s10340-017-0862-z"]}, {"label": ["18."], "surname": ["Nieri", "Anfora", "Mazzoni", "Rossi Stacconi"], "given-names": ["R", "G", "V", "MV"], "article-title": ["Semiochemicals, semiophysicals and their integration for the development of innovative multi-modal systems for agricultural pests\u2019 monitoring and control"], "source": ["Entomol. Gen."], "year": ["2022"], "pub-id": ["10.1127/entomologia/2021/1236"]}, {"label": ["22."], "surname": ["Zgonik", "\u010cokl"], "given-names": ["V", "A"], "article-title": ["The role of signals of different modalities in initiating vibratory communication in "], "italic": ["Nezara viridula"], "source": ["Open Life Sci."], "year": ["2014"], "volume": ["9"], "fpage": ["200"], "lpage": ["211"], "pub-id": ["10.2478/s11535-013-0253-2"]}, {"label": ["24."], "surname": ["Ota", "\u010cokl"], "given-names": ["D", "A"], "article-title": ["Mate location in the southern green stink bug, "], "italic": ["Nezara Viridula"], "source": ["J. Insect Behav."], "year": ["1991"], "volume": ["4"], "fpage": ["441"], "lpage": ["447"], "pub-id": ["10.1007/BF01049329"]}, {"label": ["26."], "surname": ["Costi", "Haye", "Maistrello"], "given-names": ["E", "T", "L"], "article-title": ["Biological parameters of the invasive brown marmorated stink bug, "], "italic": ["Halyomorpha halys"], "source": ["J. Pest Sci."], "year": ["2017"], "volume": ["90"], "fpage": ["1059"], "lpage": ["1067"], "pub-id": ["10.1007/s10340-017-0899-z"]}, {"label": ["27."], "surname": ["Haye", "Abdallah", "Gariepy", "Wyniger"], "given-names": ["T", "S", "T", "D"], "article-title": ["Phenology, life table analysis and temperature requirements of the invasive brown marmorated stink bug, "], "italic": ["Halyomorpha halys"], "source": ["J. Pest Sci."], "year": ["2014"], "volume": ["87"], "fpage": ["407"], "lpage": ["418"], "pub-id": ["10.1007/s10340-014-0560-z"]}, {"label": ["30."], "surname": ["Tauber", "Tauber"], "given-names": ["MJ", "CA"], "article-title": ["Insect seasonality: Diapause maintenance, termination, and postdiapause development"], "source": ["Ann. Rev. Entomol."], "year": ["1976"], "volume": ["21"], "fpage": ["81"], "lpage": ["107"], "pub-id": ["10.1146/annurev.en.21.010176.000501"]}, {"label": ["32."], "surname": ["\u010cokl", "Blassioli-Moraes", "Laumann", "\u017duni\u010d", "Borges", "Hill"], "given-names": ["A", "MC", "RA", "A", "M", "PSM"], "article-title": ["Stinkbugs: Multisensory communication with chemical and vibratory signals transmitted through different media"], "source": ["Biotremology: Studying Vibrational Behavior"], "year": ["2019"], "publisher-loc": ["Berlin"], "publisher-name": ["Springer International Publishing"], "fpage": ["91"], "lpage": ["122"]}, {"label": ["33."], "surname": ["Virant-Doberlet", "Cocroft", "Gogala", "Hill", "Wessel"], "given-names": ["M", "RB", "M", "PSM", "A"], "article-title": ["Vibrational communication networks: Eavesdropping and biotic noise"], "source": ["Studying Vibrational Communication"], "year": ["2014"], "publisher-loc": ["Berlin"], "publisher-name": ["Springer"], "fpage": ["93"], "lpage": ["123"]}, {"label": ["34."], "mixed-citation": ["Cocroft, R. B. & Hamel, J. A. 4. Vibrational communication in the \u201cother insect societies\u201d: A diversity of ecology, signals and signal functions."]}, {"label": ["35."], "surname": ["Amon"], "given-names": ["T"], "article-title": ["Electrical brain stimulation elicits singing in the bug "], "italic": ["Nezara viridula"], "source": ["Naturwissenschaften"], "year": ["1990"], "volume": ["77"], "fpage": ["291"], "lpage": ["292"], "pub-id": ["10.1007/BF01131229"]}, {"label": ["39."], "surname": ["Kuhelj", "Virant-Doberlet", "Hill", "Mazzoni", "Stritih-Peljhan", "Virant-Doberlet", "Wessel"], "given-names": ["A", "M", "PSM", "V", "N", "M", "A"], "article-title": ["Energetic costs of vibrational signaling"], "source": ["Biotremology: Physiology, ecology, and evolution"], "year": ["2022"], "publisher-loc": ["Berlin"], "publisher-name": ["Springer International Publishing"], "fpage": ["67"], "lpage": ["91"]}, {"label": ["40."], "surname": ["Kotiaho"], "given-names": ["JS"], "article-title": ["Testing the assumptions of conditional handicap theory: Costs and condition dependence of a sexually selected trait"], "source": ["Behav. Ecol. Sociobiol."], "year": ["2000"], "volume": ["48"], "fpage": ["188"], "lpage": ["194"], "pub-id": ["10.1007/s002650000221"]}, {"label": ["43."], "surname": ["Taylor", "Coffey", "Hamby", "Dively"], "given-names": ["CM", "PL", "KA", "GP"], "article-title": ["Laboratory rearing of "], "italic": ["Halyomorpha halys"], "source": ["J. Pest Sci."], "year": ["2017"], "volume": ["90"], "fpage": ["1069"], "lpage": ["1077"], "pub-id": ["10.1007/s10340-017-0881-9"]}, {"label": ["45."], "surname": ["Brooks"], "given-names": ["ME"], "article-title": ["glmmTMB balances speed and flexibility among packages for zero-inflated generalized linear mixed modeling"], "source": ["R J."], "year": ["2017"], "volume": ["9"], "fpage": ["378"], "lpage": ["400"], "pub-id": ["10.32614/RJ-2017-066"]}, {"label": ["46."], "mixed-citation": ["Florian Hartig. Package \u2018DHARMa\u2019: Residual Diagnostics for Hierarchical (Multi-Level / Mixed) Regression Models. (2020)."]}, {"label": ["47."], "mixed-citation": ["Book Reviews. J. Am. Stat. Assoc. "], "bold": ["83"]}, {"label": ["48."], "surname": ["Wickham"], "given-names": ["H"], "article-title": ["Welcome to the Tidyverse"], "source": ["J. Open Source Softw."], "year": ["2019"], "volume": ["4"], "fpage": ["1686"], "pub-id": ["10.21105/joss.01686"]}, {"label": ["49."], "surname": ["Kaplan", "Meier"], "given-names": ["EL", "P"], "article-title": ["Nonparametric estimation from incomplete observations"], "source": ["J. Am. Stat. Assoc."], "year": ["1958"], "volume": ["53"], "fpage": ["457"], "lpage": ["481"], "pub-id": ["10.1080/01621459.1958.10501452"]}, {"label": ["50."], "surname": ["Moore", "Moore"], "given-names": ["DF", "DF"], "article-title": ["Model Selection and Interpretation"], "source": ["Applied Survival Analysis Using R"], "year": ["2016"], "publisher-loc": ["Berlin"], "publisher-name": ["Springer International Publishing"], "fpage": ["73"], "lpage": ["86"]}, {"label": ["51."], "mixed-citation": ["Terry M Therneau. Package \u2018survival\u2019: Survival Analysis. (2023)."]}, {"label": ["52."], "mixed-citation": ["Alboukadel Kassambara & Marcin Kosinski. Package \u2018survminer\u2019."]}]
{ "acronym": [], "definition": [] }
52
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1198
oa_package/29/f4/PMC10786867.tar.gz
PMC10786868
38216610
[ "<title>Introduction</title>", "<p id=\"Par2\">Rice (<italic>Oryza sativa</italic>) is one of the major staple food and widely cultivated throughout the world, and about half of the world population is depends upon rice<sup>##UREF##0##1##</sup>. As the population of world is increasing gradually, therefore the demand for the rice production is also increasing<sup>##REF##30460692##2##</sup>. 21% of the calorific needs to the population of the world is provided by rice and south east Asia depends upon more than 76% for their calorific intake upon rice<sup>##REF##19230745##3##</sup>. Continuous and rapid change in the climate may have serious impacts on the agricultural crops in the tropics and subtropics region by the end of this century<sup>##REF##19131626##4##</sup>. Climate change is one of the major notable problem that alter the climate pattern, resulting droughts and extreme weather events<sup>##UREF##1##5##</sup>. Among the natural disasters, drought is one of the most dangerous disaster throughout the World, causing a significant ruin to ecosystems, agriculture and human societies<sup>##UREF##2##6##</sup>.</p>", "<p id=\"Par3\">The major consequences of climate change are droughts which are tragic threat to water supplies, agriculture crops, food production and causing ecological disturbance and famine in the World<sup>##UREF##3##7##</sup>. Climate change and global warming are intensively affecting the regional and Worldwide hydrological cycle leading to the frequency of drought events<sup>##UREF##4##8##</sup>. Rice (<italic>Oryza sativa</italic>) as a paddy field agriculture crop which is significantly susceptible to droughts, and it is estimated that drought affected the World rice production nearly by 50%<sup>##UREF##5##9##</sup>. In Asia 75% of the total rice production comes from traditionally irrigated areas, which is facing the problem of droughts and water scarcity<sup>##UREF##6##10##</sup>.</p>", "<p id=\"Par4\">At the same time salinity is an another environmental factor increasing in magnitude in the rice growing areas, due to the combine effects of high temperature, drought, sea level rising, and inferior agriculture practices<sup>##UREF##7##11##</sup>. In irrigated land, salt stress has been a serious threat to rice cultivation, and expected to be more than 20% in the near future, while it is estimated to reach 50% by 2050<sup>##UREF##8##12##</sup>. Salt stress reduce the rate of net carbon dioxide assimilation, growth of the leaf, enlargement of the leaf cell, accumulation of dry matter and relative growth<sup>##UREF##9##13##</sup>. The stress of salinity is dominated by sodium (Na<sup>+</sup>) and chloride (Cl<sup>–</sup>)<sup>##UREF##9##13##</sup>, negatively affecting rice growth and development due to creating ionic, osmotic and oxidative stress<sup>##UREF##9##13##–##REF##16690163##15##</sup>. High level of salt in rice plant increase the toxicity level, leading to early leaf senescence and ultimately resulting the decrease in the photosynthetic leaf area<sup>##REF##11841667##16##,##UREF##11##17##</sup>.</p>", "<p id=\"Par5\">Melatonin (N-acetyl-5-methoxytryptamine) is common biological hormone that plays an important role in biological functions<sup>##REF##25180262##18##</sup>, like circadian rhythms<sup>##REF##22034907##19##</sup>, immunomodulation<sup>##REF##23889107##20##</sup>, and oxidative stress reduction<sup>##REF##8272286##21##</sup>. Hence during the past half century, it received great attention due to its anti-aging properties<sup>##REF##7776176##22##</sup>. Recent studies showed that melatonin is present in a large number of vascular plants<sup>##REF##7776176##22##</sup>, having an important role in germination<sup>##REF##22747917##23##</sup>, lateral root formation, plant growth and defense against biotic and abiotic stresses<sup>##REF##22747917##23##,##REF##24350934##24##</sup>. Being a growth regulator, melatonin showed a great potential for enhancing plant drought resistance<sup>##REF##31248005##25##</sup>. Melatonin has attracted the researcher to have an effective strategy to induce the crop tolerance against drought, salt, heavy metals, high temperature, low temperature, nutritional deficiencies and different types of diseases<sup>##REF##33305363##26##</sup>. Melatonin can induce plant antioxidant system, help in plant photosynthesis improvement, enhance ion homeostasis and regulate plant hormone metabolism under the salt stress condition<sup>##REF##25156541##27##</sup>. Pretreatment of rice with melatonin showed improvement in tolerance to salt stress by increasing plant’s fresh and dry weight and minimize plasma membrane damage<sup>##UREF##12##28##</sup>. Exogenous melatonin enhanced catalase (CAT), peroxidase (POD), superoxide dismutase (SOD) and ascorbate peroxidase (APX) activities in maize (<italic>Zea mays</italic>)<sup>##UREF##13##29##</sup>.</p>", "<p id=\"Par6\">There is very limited information regarding the combined effects of salt and drought stress on rice plants, however salt and drought stress and its effects on rice were studied individually. A recent study on cotton (<italic>Gossypium hirsutum</italic>) shows that salt and drought combine stress cause significant reduction in plant growth, chlorophyll content and photosynthesis in cotton<sup>##REF##30006979##30##</sup>. Combined stress reduced the activity of antioxidant enzymes which ultimately decreased the physiological performance of sunflower plants. Salinity and drought change the osmotic and ionic signal pathways in different crops<sup>##REF##34204152##31##</sup>\n<italic>Salt Overly Sensitive</italic> (<italic>SOS</italic>) pathway plays a key role in maintaining cellular ion homeostasis during salinity stress<sup>##REF##35092312##32##</sup>. <italic>OsNHX1</italic> (Na<sup>+</sup>/H<sup>+</sup><italic> Exchanger</italic>) is a transcription factor that regulates Na<sup>+</sup> and K<sup>+</sup> concentration of rice plants when exposed to NaCL and KCl stress<sup>##REF##14988485##33##</sup>. Overexpression of <italic>NHX1</italic> in tobacco has been shown to confer salt tolerance<sup>##UREF##14##34##</sup>. Numerous transcription factors such as <italic>DREB,</italic> (<italic>Dehydration-Responsive Element-Binding</italic>) <italic>ABRE</italic> (<italic>ABA-responsive element</italic>) and <italic>ERF</italic> (<italic>Ethylene Responsive Factor</italic>) have been identified playing an important role in transcriptional regulation under drought stress<sup>##REF##26579147##35##,##REF##27471513##36##</sup>. Overexpression of <italic>HSF2</italic> (<italic>Heat Shock Transcription Factor</italic>) improved drought tolerance at the seedling stage in Arabidopsos<sup>##REF##22330896##37##</sup>. <italic>HSFA3</italic> and <italic>HSFA1b</italic> take part in different signaling pathways to enhance the plant’s tolerance to drought stress while, the expression of <italic>HSFA3</italic> in response to drought stress is dependent upon the expression of <italic>DREB2A</italic><sup>##UREF##15##38##</sup>.</p>", "<p id=\"Par7\">Our study hypothesized that induction of melatonin enhances tolerance to individual as well as combined drought and salt stress in the rice plant. The aim of our study is to evaluate the role of melatonin in rice plants in response to drought and salt stress individually and when they are combined. We focused on the effects of melatonin on morphological parameters, antioxidants and transcriptional regulation of salt and drought responsive genes in response to salt and drought combined stress.</p>" ]
[ "<title>Materials and methods</title>", "<title>Plant material and growth conditions</title>", "<p id=\"Par8\">Ilmi rice cultivar (<italic>Oryza sativa</italic> L.) seeds were used in this experiment, provided by Plant Molecular Breeding Laboratory, Kyungpook National University, Korea<sup>##REF##32895423##39##</sup>. Rice seeds were sterilized with fungicides for a night followed by washing with double distilled water three times. Then, the rice seeds were kept in water for 4 days in an incubator in the dark condition at 32 °C, changing the water after each 24 h as previously reported by Ref.<sup>##REF##32895423##39##</sup>. After germinating for three days, the seeds were transplanted into plastic pots having I L capacity filled with specialized soil mix (Doobaena plus) consisting of cocopeat (27%), peat moss (10%), vermiculite (34%), Masato (10%), diatomite (13%), bara mesh (5.5%), fertilizer (0.48%), and humectant (0.2%), provided by Nongkyung Co. Ltd, Korea, to foster their growth. The seeds were grown for three weeks in greenhouse for further experiments.</p>", "<title>Experimental design</title>", "<p id=\"Par9\">In this experiment, a total of eight groups of rice plants were involved. Each of these groups had three replicates, and within each replicate, there were five plants. The experimental groups were control plants (C), melatonin treated plants (M), salt treated plants (S), drought treated plants (D), salt<bold> + </bold>drought treated (S + D), salt + melatonin treated plants (S + M), drought + melatonin treated plants (D + M) and salt + drought + melatonin treated (S + D + M). Water was applied on daily basis. Before 1 week the salt and drought stress exposure plants were treated with 100 µM of melatonin at alternative days as described by Ref.<sup>##REF##31616591##40##</sup>, and our preliminary screening. For the salt stress, plants were treated with 100 mM of NaCl at three days interval for 3 weeks<sup>##REF##23800963##41##</sup>. For drought stress 10% PEG polyethylene glycol 6000 (PEG 6000; a product of Sigma-Aldrich, Seoul, Korea) was applied, according to method used by Ref.<sup>##REF##35624781##42##</sup>. The experiment involved the random selection of the young fully expanded leaves from each experimental group.</p>", "<title>Analysis of morphological parameters and biomass</title>", "<p id=\"Par10\">After 35 days of plant growth, shoot length, root length, height of shoot, and fresh weight (FW) of the rice plants were measured. For the determination of the dry weight (DW) of seedlings, the roots and shoots were dried by oven at 200 ℃ for 30 min and maintained at 60 ℃ for 48 h to obtain DW. The fresh leaves were put into a petri dish filled with distilled water and the petri dishes were placed in a dark environment for 4 h, and then their turgid weight (TW) was recorded, after that the leaves were oven dried to obtain DW. Finally, relative water content (RWC) was quantified using formula: <sup>##UREF##16##43##</sup>.</p>", "<title>Chlorophyll contents</title>", "<p id=\"Par11\">Chlorophyll contents were measured after 1 week of stress exposure by using portable chlorophyll meter (SPAD 502, Konica Minolta, Japan). The second last fully mature leaf was selected for chlorophyll measurement and the reading was taken from leaf base, middle and near the leaf tip. Five leaves were measured from each treatment group for chlorophyll contents and the average value was taken as SPAD value as mentioned previously<sup>##UREF##17##44##</sup>.</p>", "<title>Electrolyte leakage</title>", "<p id=\"Par12\">For determination of electrolyte leakage, fresh leaves samples were cut into 5 mm and placed in test tubes containing 10 mL deionized water. The tubes were covered with plastic caps and placed in a water bath maintained at the constant temperature of 32 °C. The initial electrical conductivity (ECI) was measured after 2 h by electrical conductivity meter (CM-115, Kyoto Electronics, Kyoto, Japan). Then the samples were autoclaved at 121 °C for 20 min to release all electrolytes and kill the tissues. For measurement of final electrical conductivity (EC2), samples were cooled to 25 °C. Electrolyte leakage (EL) was find out using formula: .</p>", "<title>Determination of H<sub>2</sub>O<sub>2</sub> and MDA contents</title>", "<p id=\"Par13\">H<sub>2</sub>O<sub>2</sub> contents were measured using previously described method<sup>##UREF##18##45##</sup>. Briefly, fresh leaves of 0.1 g were ground in liquid nitrogen, extracted in 5 mL of 0.1% TCA and centrifuged at 12,000×<italic>g</italic> for 15 min. Supernatant of 0.5 mL was taken, potassium iodide 1 mL (1 mM) and potassium phosphate buffer (pH 7.0) 0.5 mL of (10 mM) were added, and the absorbance was measured at 390 nm. Using the extinction coefficient (ɛ) 0.28 mM cm<sup>−1</sup>, H<sub>2</sub>O<sub>2</sub> content was estimated and expressed as µmol g<sup>−1</sup> of FW. MDA contents were determined as previously described by Ref.<sup>##UREF##19##46##</sup>. In brief, fresh plant leaves of 0.1 g were ground in 10 mL of TCA 5% and centrifuged at 4000×<italic>g</italic> for 10 min at 4 °C. The supernatant was taken in 4 mL of TBA, incubated at 90 °C for 25 min and then cooled down at 4 °C. The supernatant was read at of 532 and 600 nm. The MDA content was measured as µmol g<sup>−1</sup> of FW.</p>", "<title>Determination of antioxidative activities</title>", "<p id=\"Par14\">Catalase activity was find out by the method of Ref.<sup>##UREF##20##47##</sup> briefly, crude enzymes was treated with 0.5 mL of 0.2 mM H<sub>2</sub>O<sub>2</sub> using sodium phosphate buffer with 7 pH. The activity of catalase was determined by the decrease in the absorbance of H<sub>2</sub>O<sub>2</sub> at 240 nm, and CAT one unit was defined as micromoles of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) decomposed per minute per milligram of protein. Reduced glutathione contents were determined using the protocol of Ref.<sup>##REF##13650640##48##</sup>, in brief, fresh leaves were ground in liquid nitrogen, 2 mL 10% (v/v) trichloroacetic acid was added and centrifuged at 4 °C for 13 min at 10,000×<italic>g</italic>. The supernatant was combined with 3 mL of 150 mM NaH<sub>2</sub>PO<sub>4</sub> (pH 7.4). Then nitrobenzoic acid (75.3 mg of DTNB dissolved in 30 mL of 100 Mm sodium phosphate buffer, pH 6.8) was added, followed by incubation for 5 min at 30 °C. At 412 nm the absorbance of the samples was measured, with reference to standard curve, reduced glutathione concentration was calculated and expressed as (nmol g<sup>−1</sup> FW). All the experiments were performed three times.</p>", "<title>RNA isolation and qRT-PCR</title>", "<p id=\"Par15\">To determine expression level of <italic>OsHSF, OsDREB, OsNHX</italic> and <italic>OsSOS</italic> gene, from each group rice leaves were collected randomly at 0, 12, 24 and 48 h after the plants were exposed to stress. Using RNeasy Plant Mini Kits (50) Qiagen, RNA was extracted, cDNA was synthesized using qPCRBIO kits, while using qPCRBIO SYBR Green kits, qRT-PCR was performed. Primer sequence and accession number of each gene are shown in Table ##TAB##0##1##. 20 µL of reaction was started using 10 µL SYBR green, 7 µL ddH2O, 1 µL template DNA, and 1 µL of each primer. The reaction was incubated at 95 °C for 2 min, followed by thirty-five cycles at 94 °C for 10 s, and 60 °C and 72 °C for 10 and 40 s, respectively. Each reaction was performed three time using actin as an internal reference gene.</p>", "<title>Statistical analysis</title>", "<p id=\"Par16\">All experiments were performed three time. Data were analyzed using two-way ANOVA with Bonferroni post hoc tests (*shows p &lt; 0.05 and **shows p &lt; 0.01 significant difference). For the comparison of the mean values of different treatments completely randomized design was used. Data were graphically presented, and statistical analyses were calculated using the GraphPad Prism software (version 5.01, GraphPad, San Diego, CA, USA) and Statistical Analysis System (SAS 64 bit, developed by North Carolina State University, Raleigh, NC, USA) (Fig. ##FIG##0##1##).</p>" ]
[ "<title>Results</title>", "<title>Plant growth under salt/drought stress and effects of melatonin</title>", "<p id=\"Par17\">In this experiment, we evaluated various growth parameters of rice plants in response to salt and drought combined and individual stress as shown in (Fig. ##FIG##1##2##A). Both salt and drought stress significantly reduced plant shoot length by 23% in (S), 20% in (D), and 32% in (S + D), and root length by 25% (S), 18% (D), and 32% (S + D) compared to (C). However, melatonin treated plants (M) resulted in a 22% increase in plant height compared to (S + M), 16% to (D + M), and 28% to (S + D + M) and increase in root length by 29% to (S + M), 22% to (D + M), and 33% to (S + D + M) respectively. Additionally, the application of exogenous melatonin notably raised plant shoot length by 53% in (S + M), 75% in (D + M), and 80% in (S + D + M), respectively. Likewise, melatonin showed an increase in plant root length by 21% in (S + M), 24% in (D + M), and 24% in (S + D + M) as compared to their respective stress (S), (D), and (S + D) conditions (Fig. ##FIG##1##2##B). Salt and drought stress significantly declined shoot fresh weight (43%, 31%, and 59%), shoot dry weight (48%, 40%, and 54%), root fresh weight (39%, 27%, and 25%), and root dry weight (60%, 53%, and 73%) in (S), (D), and (S + D) when compared to (C). Plants treated exclusively with melatonin (M) exhibited enhanced shoot fresh weight (36%, 24%, and 69%), shoot dry weight (31%, 36%, and 42%), root fresh weight (27%, 33%, and 45%), and root dry weight (23%, 31%, and 39%) in comparison to (S + M), (D + M), and (S + D + M). Similarly exogenous application of melatonin significantly induced increases in both fresh and dry weights of the shoot and root. Shoot fresh weight saw increments of 30.16% in (S + M), 34.25% in (D + M), and 82.05% in (S + D + M), while root fresh weight exhibited increases of 37.12% in (S), 9.35% in (D), and 26.80% in (S + D) compared to (S), (D), and (S + D) (Fig. ##FIG##1##2##C). Moreover, the dry weight of the shoot was enhanced by 37.83% in (S + M), 14.35% in (D + M), and 26.15% in (S + D + M), while the dry weight of the root experienced increments of 16.10% in (S + M), 41.30% in (D + M), and 42.85% in (S + D + M) as compared to (S), (D), and (S + D) (Fig. ##FIG##1##2##D).</p>", "<title>Effects of exogenous melatonin on chlorophyll contents</title>", "<p id=\"Par18\">Salt and drought stress resulted in a significant decrease in chlorophyll contents by 31%, 22%, and 38% in (S), (D), and (S + D) compared to the control (C). However, 29%, 16%, and 27% of increment was observed in melatonin treated plants (M) as compared to (S + M), (D + M), and (S + D + M). Likewise, melatonin treatment led to a notable increase in chlorophyll contents, with increments of 20.33% in (S + M), 13.20% in (D + M), and 30.23% in (S + D + M) compared to (S), (D), and (S + D) conditions (Fig. ##FIG##2##3##A).</p>", "<title>Effects of exogenous melatonin on electrolyte leakage</title>", "<p id=\"Par19\">Membrane permeability, as indicated by electrolyte leakage, is notably influenced by both salt and drought stress by 220% in (S), 190% in (D), and 410% in (S + D) as compared to (C). Although Melatonin treatment (M) markedly decreased electrolyte leakage by 65%, 68%, and 77% compared to (S + M), (D + M), and (S + D + M), respectively. Furthermore, exogenous melatonin treatment significantly decreased the electrolyte leakage by 44.51% in (S + M), 48.57% in (D + M) and 51.35% in (S + D + M) respectively as compared to (S), (D), and (S + D) (Fig. ##FIG##2##3##B).</p>", "<title>Effects of exogenous melatonin on relative water contents</title>", "<p id=\"Par20\">As a measure of plant water status, Relative Water Content (RWC) not only provides insights into the hydration level of a plant but also serves as a reflection of its metabolic activity<sup>##UREF##21##49##</sup>. RWC is closely related to physiological function of plants, and it also indicates the ability of plant to sustain its water contents and wilting degree of leaves<sup>##UREF##22##50##</sup>. A significant reduction of 24% under salt stress (S), 22% under drought stress (D), and 32% under combined salt and drought stress (S + D) was recorded compared to the control (C). While RLW contents were 16% 19% and 24% higher in melatonin-treated plants (M) as compared with (S + M), (D + M), and (S + D + M). Similarly, melatonin-treated plants exhibited a significant increase in relative water contents, registering a rise of 17.76% in (S + M), 11.92% in (D + M), and 22.82% in (S + D + M) when compared to (S), (D), and (S + D) conditions (Fig. ##FIG##2##3##C).</p>", "<title>Effects of exogenous melatonin on H<sub>2</sub>O<sub>2</sub> and MDA contents</title>", "<p id=\"Par21\">Hydrogen peroxide serves as an indicator of the reactive oxygen species (ROS) scavenging capacity in plants under various stresses, and it is generated as a byproduct of cellular metabolism. The results show that H<sub>2</sub>O<sub>2</sub> showed a substantial increase of 131% under salt stress (S), 112% under drought stress (D), and 206% under combined salt and drought stress (S + D) compared to the control (C). Melatonin-treated plants (M) exhibited a reduction in H<sub>2</sub>O<sub>2</sub> contents by 43%, 45%, and 56% compared to the levels observed in plants under salt stress (S), drought stress (D), and combined salt and drought stress (S + D), respectively. Furthermore, exogenous application of melatonin demonstrated a substantial reduction in H<sub>2</sub>O<sub>2</sub> accumulation, showing decreases by 37% in (S + M), 31% in (D + M), and 39% in (S + D + M) compared to (S), (D), and (S + D) (Fig. ##FIG##3##4##A).</p>", "<p id=\"Par22\">Salt and drought stress demonstrated a notable impact on Malondialdehyde (MDA) contents, elevating the levels by 210%, 250%, and 370% in salt-stressed (S), drought-stressed (D), and combined salt and drought-stressed (S + D) plants, respectively, compared to the control (C). In contrast, melatonin-treated plants (M) exhibited a significant reduction in MDA levels by 45%, 38%, and 55% compared to plants under salt and melatonin treatment (S + M), drought and melatonin treatment (D + M), and combined salt, drought, and melatonin treatment (S + D + M), respectively. Similarly, MDA contents were significantly decreased by melatonin treatment, recording reductions of 46% in (S + M), 56% in (D + M), and 55% in (S + D + M) compared to plants under salt stress (S), drought stress (D), and combined salt and drought stress (S + D) conditions, respectively (Fig. ##FIG##3##4##B).</p>", "<title>Melatonin reduce oxidative stress via regulation of GR and CAT</title>", "<p id=\"Par23\">Melatonin provides protection to plants from oxidative damage through the activation of antioxidants. In this study, the effects of salt and drought stress on the antioxidant activities of glutathione (GSH) and catalase (CAT) in rice plants were investigated, with and without melatonin treatment. The results revealed a significant reduction in glutathione (GSH) by 56%, 53%, and 66% in salt-stressed (S), drought-stressed (D), and combined salt and drought-stressed (S + D) plants compared to the control (C). In contrast, melatonin-treated plants (M) exhibited a rise in glutathione (GSH) levels by 70%, 47%, and 80% compared to plants under salt and melatonin treatment (S + M), drought and melatonin treatment (D + M), and combined salt, drought, and melatonin treatment (S + D + M), respectively. Similarly, melatonin increased glutathione (GSH) activities by 40% in (S + M), 36% in (D + M), and 72% in (S + D + M) compared to plants under salt stress (S), drought stress (D), and combined salt and drought stress (S + D) (Fig. ##FIG##3##4##C).</p>", "<p id=\"Par24\">The catalase (CAT) activity showed a gradual increase due to salt and drought stress; however, melatonin treatment accelerated its activity. The catalase (CAT) activity increased by 16% under salt stress (S), 14% under drought stress (D), and 25% under combined salt and drought stress (S + D) compared to the control (C). Catalase (CAT) was also recorded higher by 26%, 27%, and 34% in salt and melatonin-treated (S + M), drought and melatonin-treated (D + M), and combined salt, drought, and melatonin-treated (S + D + M) conditions compared to melatonin-treated plants (M). Exogenous melatonin treatment significantly increased catalase (CAT) activity by 17.64% in (S), 21.80% in (D), and 20.40% in (S + D) respectively (Fig. ##FIG##3##4##D).</p>", "<title>Melatonin regulates the salt and drought stress responsive genes</title>", "<p id=\"Par25\">The combined effects of salt and drought stress exert a considerable influence on the expression of genes associated with these stressors. The expression of <italic>OsSOS</italic> was observed as 60%, 110%, and 150% under salt stress (S), and 70%, 109%, and 190% under combined salt and drought stress (S + D) at 6, 24, and 48 h following the application of stress, in comparison to control plants (C). Additionally, <italic>OsSOS</italic> exhibited a significant increase by 155%, 311%, and 340% in (S + M), and 100%, 240%, and 300% in (S + D + M) after 6, 24, and 48 h, respectively, following stress application, in comparison to the expression in melatonin-treated plants (M). Melatonin demonstrated a significant up-regulation in the expression of <italic>OsSOS</italic> by 43%, 63%, and 76% in (S + M) after 6, 24, and 48 h following stress application. Additionally, in (S + D + M), the expression was increased by 35%, 104%, and 151% after 6, 24, and 48 h following stress application, respectively, when compared to (S) and (S + D) (Fig. ##FIG##4##5##A). Similarly, salt and drought stress induced the expression of <italic>OsNHX</italic> by 50%, 70%, and 170% in (S), and 130%, 221%, and 350% in S + D after 6, 24, and 48 h of stress, respectively, compared to control (C) plants. <italic>OsNHX</italic> displayed a notable increase of 80%, 140%, and 193% in (S + M), and 113%, 220%, and 333% in (S + D + M) after 6, 24, and 48 h, respectively, subsequent to stress exposure, in contrast to the expression observed in plants treated solely with melatonin (M) Melatonin up-regulated the expression of OsNHX by 50.25%, 71.54%, and 51.56% in (Salt + Melatonin) after 6, 24, and 48 h, and 53.25%, 75.64%, and 88.69% in (S + D + M) after 6, 24, and 48 h following stress application, respectively, as compared to (S) and (S + D) (Fig. ##FIG##4##5##B).</p>", "<p id=\"Par26\">Similarly, the treatment of exogenous melatonin also induced the expression of drought responsive genes <italic>OsHSF</italic> and <italic>OsDREB</italic>. <italic>OsHSF</italic> exhibited a significant increment of 80%, 220%, and 269% in drought-stressed (D), and 133%, 206%, and 260% in salt and drought-stressed (S + D) after 6, 12, and 24 h of stress, respectively, compared to (C). OsHSF exhibited a substantial increase of 80%, 188%, and 217% in (S + M), and 147%, 248%, and 423% in (S + D + M) after 6, 24, and 48 h, respectively, following stress exposure, compared to the expression observed in plants treated solely with melatonin (M). Melatonin treatment increased the expression of <italic>OsHSF</italic> by 50%, 47%, and 38% in (D + M) after 6, 24 and 48 h and 82%, 95% and 147% in (S + D + M) after 6, 24 and 48 h of applying the stress respectively as compared to (D) and (S + D) (Fig. ##FIG##4##5##C). Salt and drought stress resulted in a significant increase in <italic>OsDREB</italic> expression, with increments of 80%, 117%, and 285% in drought-stressed (D), and 140%, 184%, and 212% in salt and drought-stressed (S + D) after 6, 12, and 24 h of stress, respectively, compared to control (C). OsDREB exhibited a significant increase of 130%, 135%, and 380% in (S + M), and 191%, 266%, and 342% in (S + D + M) after 6, 24, and 48 h, respectively, following stress exposure, compared to the expression observed in plants treated solely with melatonin (M). Similarly, melatonin significantly increased the expression of <italic>OsDRED</italic> by 27%, 9% and 28.% in (D + M) after 6, 24 and 48 h and 48%, 78% and 98% in (S + D + M) after 6, 24 and 48 h respectively as compared to (D) and (S + D) (Fig. ##FIG##4##5##D).</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par27\">In this study, both salt and drought stress, either independently or in combination, resulted in a substantial depletion in rice growth (Fig. ##FIG##1##2##). The inhibition of new leaf growth and the development of the root system due to drought and salt stress are widely acknowledged factors contributing to the reduction in biomass accumulation<sup>##REF##23800963##41##,##UREF##23##51##</sup>. Salinity and drought stress significantly reduce seed germination rates, shoot, and root length, as well as the overall biomass of rice seedlings, resulting in hindering plant growth<sup>##REF##27847508##52##,##REF##36292930##53##</sup>. This study confirms that both salinity and drought stress severely restricted the growth and development of rice, as shown in (Fig. ##FIG##1##2##A,B). And these stressors significantly reduced both above-ground fresh weight and dry weight, as depicted in (Fig. ##FIG##1##2##C,D). Moreover, the inhibitory effect on plant growth and biomass was more pronounced under salt stress compared to drought stress. Furthermore, chlorophyll plays essential roles in plant growth, development, and the synthesis of photosynthetic products. Salt stress hinders chlorophyll synthesis, directly impacting photosynthesis, retarding plant growth, and diminishing yield<sup>##UREF##24##54##,##UREF##25##55##</sup>. In this experiment, during salt and drought stress, chlorophyll contents were significantly reduced (Fig. ##FIG##2##3##A). This may be due to rise in the level of Na<sup>+</sup>, MDA, and H<sub>2</sub>O<sub>2</sub>, disrupting chloroplast membrane stability and causing degradation of the protein-pigment-lipid complex<sup>##UREF##26##56##</sup>. Exogenous application of melatonin reversed the downward trend and promoted plant growth, biomass, and chlorophyll contents (Fig. ##FIG##2##3##C,D). These findings align with prior research<sup>##UREF##27##57##</sup>, suggesting the potential impact of melatonin on enzymes contributes to the enhancement of chlorophyll level<sup>##REF##18691358##58##</sup>, thereby promoting plant growth and development.</p>", "<p id=\"Par28\">The findings from this study indicate that elevated salt and drought stress levels led to a decrease in RLWC (Relative Leaf Water Content). This decline in RLWC may have contributed to a reduction in various plant growth factors<sup>##UREF##28##59##</sup>. Prior treatment with melatonin notably enhanced Relative Leaf Water Content (RLWC) in rice plants under both salt and drought stress conditions (Fig. ##FIG##2##3##C). These outcomes are consistent with earlier findings from Ref.<sup>##UREF##29##60##</sup>, the observed rise in RLWC could be attributed to melatonin’s potential involvement in modulating stomatal behavior, effectively regulating their opening and closure to prevent undue water loss from leaves<sup>##UREF##30##61##</sup>. Electrolyte Leakage (EL) serves as an indicator of alterations in cell membrane structure during high salt and water deficit conditions. Our results show a notable increment in electrolyte leakage during salt and drought stress (Fig. ##FIG##2##3##B). Utilizing its relative conductivity allows for the assessment of damage to both the structure and function of cell membranes under various stresses<sup>##REF##30294219##62##</sup>. Melatonin pre-treatment significantly decreased electrolyte leakage during salt and drought stress in rice plants. Similar results were obtained by Ref.<sup>##REF##28633086##63##</sup> in drought and Ref.<sup>##UREF##31##64##</sup> in salt stress conditions. Consequently, the decrease in electrolyte leakage may be associated with elevated levels of CAT (catalase) and GSH (glutathione) by melatonin treatment during salt and drought stress conditions. This indicates that the utilization of melatonin might mitigate oxidative harm induced by salinity and drought stress.</p>", "<p id=\"Par29\">Both salt and drought stress in rice plants trigger the excessive production of reactive oxygen species (ROS), which then leads to damage within various biomolecules. This disruption in the equilibrium between ROS generation and elimination adds to the overall oxidative stress within the plant’s system<sup>##UREF##32##65##</sup>. Melatonin is believed to act as an antioxidant in plants, aiding in cellular redox regulation, scavenging reactive oxygen species (ROS), and stabilizing plant cell membranes, thus offering protection against various environmental stressors<sup>##REF##25156541##27##,##REF##11899100##66##</sup>. Our results show that melatonin pre-treatment in rice suppressed the accumulation of ROS during salt and drought stress (Fig. ##FIG##3##4##A,B). These findings align with previous observations indicating that melatonin reduces ROS accumulation in watermelon and cucumber subjected to salt stress<sup>##REF##28298921##67##,##REF##27999581##68##</sup> in maize and soybean subjected to drought stress<sup>##REF##31616591##40##,##UREF##27##57##</sup> with respect to non-treated plants.</p>", "<p id=\"Par30\">Moreover, Li et al.<sup>##UREF##33##69##</sup> reported that the application of exogenous melatonin enhanced plants’ tolerance to cold, drought, and salt stress. This effect was attributed to a reduction in reactive oxygen species (ROS) burst, maintenance of photosynthetic efficiency, decrease in malondialdehyde (MDA) levels, and enhancement of antioxidant activity in tea plants. Melatonin may have the capacity to enhance cellular redox homeostasis by stimulating the entire antioxidant system, encompassing both antioxidant enzymes (e.g., catalase, superoxide dismutase, peroxidase, ascorbate peroxidase, and monodehydroascorbate reductase) and non-enzymatic antioxidants (such as glutathione and ascorbate)<sup>##REF##16098085##70##</sup>, as well as elevating levels of polyphenols<sup>##REF##14740000##71##</sup>, carotenoids<sup>##UREF##34##72##</sup>, and anthocyanins<sup>##REF##27047496##73##</sup>, to protect plants from abiotic stress-induced oxidative stress. Nonetheless, the precise mechanisms underlying this stimulatory action remain unclear. It is yet to be determined whether melatonin’s effect results from a direct interaction with existing enzymes or if it involves signal transduction mechanisms that regulate gene expression, leading to increased enzyme production.</p>", "<p id=\"Par31\">During normal conditions, plants effectively neutralize reactive oxygen species (ROS) through both non-enzymatic and enzymatic antioxidants. However, under salt and drought conditions, the ROS production surpasses the capacity of the antioxidant defense systems, resulting in oxidative stress within the plant<sup>##UREF##35##74##</sup>. Catalase (CAT) and glutathione (GSH) are crucial antioxidants involved in vital processes within plant cells. Several studies on plants with altered levels of CAT and GSH proved the important roles of CAT and GSH in the tolerance of plants to environmental stresses<sup>##REF##15308753##75##</sup>. The results of our study show that salt and drought stress slightly increase the level of CAT as shown in the (Fig. ##FIG##3##4##D). This slight increase in CAT activity may be due to its activation to encounter the accumulation of H<sub>2</sub>O<sub>2</sub> induced by water shortage and salinity stress<sup>##UREF##36##76##</sup>. The findings from this study align with previous research indicating that plants respond to oxidative damage induced by various stressors by deploying mechanisms to maintain cellular equilibrium and withstand abiotic stress<sup>##UREF##17##44##,##UREF##37##77##</sup>. When the levels of glutathione within cells become more oxidized or decrease due to environmental factors, it triggers a signaling process, which prompts cells to react as though their glutathione levels are persistently low, assisting in their adaptation to changes in the environment<sup>##REF##11368918##78##</sup>. The metabolism of glutathione (GSH) and the maintenance of the GSH pool are integral to plant responses to various abiotic stresses<sup>##UREF##38##79##</sup>. Several studies have highlighted a reduction in glutathione (GSH) levels in various plant species under stress conditions like salinity, extreme temperatures, and heavy metal exposure<sup>##UREF##39##80##–##REF##16668756##82##</sup>. The study’s findings indicate a decline in GSH levels during salt and drought stress, as depicted in (Fig. ##FIG##3##4##C). This trend might be attributed to the activation of NADPH oxidase, which has a direct correlation with both ROS production and GSH levels<sup>##REF##34725879##83##</sup>. However exogenous treatment of melatonin significantly increased the CAT and GSH activity during salt and drought stress (Fig. ##FIG##3##4##D). The results obtained in this study align with previous findings. Exogenous application of melatonin significantly boosted the activity of CAT in <italic>Zea mays</italic> L. and <italic>Cynodon dactylon</italic> L. when subjected to salinity stress<sup>##UREF##32##65##,##REF##29633289##84##</sup>. Additionally, melatonin treatment has also shown an increase in CAT activity under various combined stresses like salinity and heat, drought, and cold stress<sup>##REF##25156541##27##,##REF##29509672##85##,##REF##31178885##86##</sup>. In a plant cell, superoxide anion (O2<sup>−</sup>) can be rapidly converted to hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) by superoxide dismutase (SOD), while H<sub>2</sub>O<sub>2</sub> can be scavenged by catalase (CAT)<sup>##REF##21205630##87##</sup>, and melatonin’s involvement in boosting CAT activity contributes to maintaining the balance of reactive oxygen species (ROS) within the plant system. Similarly, melatonin plays a significant role in modulating glutathione (GSH) activity during abiotic stress conditions. Melatonin application appears to elevate the levels of Glutathione (GSH) in different plants after exposure to salt<sup>##REF##28298921##67##</sup>, drought<sup>##REF##31178885##86##</sup>, and heat stress<sup>##REF##29509672##85##</sup>. Our study’s findings align with these results, as depicted in (Fig. ##FIG##3##4##C), which underscores the role of melatonin in enhancing GSH activity during stress conditions. The elevated GSH levels attributed to melatonin may indicate its role in modulating the AsA-GSH cycle, which plays a crucial role to detoxify the H<sub>2</sub>O<sub>2</sub> and provide protection to plants from environmental stresses<sup>##REF##29702752##88##</sup>.</p>", "<p id=\"Par32\">Further we studied <italic>OsSOS, NHX, HSF</italic> and <italic>DREB’</italic>s expression level under salt and drought stress with different time points in response to melatonin. These genes are extensively studied and regarded as controllers of drought and salt stress response in rice plants. Different concentration of salt influence gene expression in rice, such as <italic>SOS2</italic>, and <italic>NHX</italic> were over expressed and directly activated the expression of K<sup>+</sup>/Na<sup>+</sup> transporters, and regulate salt tolerance<sup>##REF##23918260##89##</sup>. The expression of <italic>OsSOS1</italic> and <italic>OsNHX1</italic> was up-regulated in rice seedling by applying 100 mM of NaCl<sup>##REF##22214433##90##</sup>. Overexpression of <italic>OsSOS</italic> under 150 mM of NaCl treatment showed improvement in growth parameters and retain relative water contents<sup>##REF##35092312##32##</sup>. <italic>OsNHX</italic> genes play a crucial role in regulating the sodium (Na<sup>+</sup>) and potassium (K<sup>+</sup>) concentrations within the rice cytoplasm, aiding in the plant’s ability to manage and withstand salinity stress<sup>##UREF##41##91##</sup>. The <italic>OsNHX</italic> family genes exhibit regulation in salinity stressed rice plants, and the overexpression of <italic>OsNHX1</italic> imparts resistance to salinity stress in transgenic rice<sup>##REF##14988485##33##</sup>. In accordance with Cattarin et al.<sup>##REF##32205927##92##</sup>, who noted an increase in <italic>OsNHX1</italic> expression in the leaves of Pokkali and IR29 rice seedlings under 200 mM salinity stress, our study observed up-regulation of OsSOS and OsNHX in plants subjected to both salt stress and combined salt and drought stress (Fig. ##FIG##4##5##A,B). Exogenous melatonin improved salt tolerance by up-regulating the expression of <italic>SOS</italic> pathway in <italic>Malus hupehensis</italic> and <italic>SOS1</italic>, <italic>SOS2</italic>, and <italic>SOS3</italic> genes under salinity stress in Chinese medicinal herbs<sup>##REF##25481689##93##,##REF##12726883##94##</sup>. Melatonin treated plants showed over expression of ion transport proteins <italic>NHX1</italic> and <italic>AKT1</italic> during exposure to salt stress<sup>##UREF##42##95##</sup>. Consistent with previous findings, this study affirms that the external application of melatonin significantly contributes to alleviating salt stress by modulating the expression of <italic>SOS</italic> and <italic>NHX</italic> genes (Fig. ##FIG##4##5##A,B). Pretreatment with melatonin has been shown to boost the transcription of <italic>OsSOS</italic> and <italic>OsNHX</italic> in rice plants during salt stress, aiding in the removal of Na<sup>+</sup> and maintaining plant resistance<sup>##UREF##42##95##</sup>.</p>", "<p id=\"Par33\">Studies show that different transcription factors were identified which play an important role in the regulation of plants responses to different stresses<sup>##REF##12183182##96##</sup>. In rice cultivar AP2 transcription activators <italic>OsDREB1A</italic> is up-regulated during drought and high salt stress<sup>##REF##12609047##97##</sup>. <italic>OsDREB1B</italic> and <italic>DREB1A</italic> were up-regulated in <italic>Arabidopsis</italic> to enhanced dehydration and high salinity<sup>##REF##10096298##98##</sup>. Over expression of <italic>HSFA1</italic> and <italic>HSFA2</italic> genes have been reported in soyabean, tomato and <italic>Arabidopsis</italic> to improve plant heat resistance<sup>##REF##19192388##99##,##REF##17085506##100##</sup>. A recent study showed that <italic>OsHSFC1b</italic> is overexpressed to improve salt tolerance in rice plants<sup>##REF##32153617##101##</sup>. Moreover Scharf et al.<sup>##UREF##15##38##</sup> confirmed that <italic>HSFA3</italic> is a part of drought stress signaling. The results of our study demonstrated that <italic>OsHSF</italic> and <italic>DREB</italic> are up-regulated in individual drought stress and drought, salinity combined stress (Fig. ##FIG##4##5##C,D), that show that <italic>OsHSF</italic> and <italic>DREB</italic> are the important transcriptional regulator during drought stress in rice plants. Exogenous treatment of melatonin enhanced carbohydrate metabolism and up-regulated transcription factors such as <italic>DREB</italic>, <italic>HSF</italic>, <italic>WRKY</italic>, and <italic>MYB</italic> in different plants<sup>##REF##27512404##102##</sup>. Melatonin regulates various transcription factors like <italic>DREB</italic> in cotton<sup>##REF##21590508##103##</sup>, and <italic>DREB2A</italic> in <italic>Arabidopsis</italic> under salinity and drought stress conditions<sup>##REF##21590508##103##</sup>. In our study, melatonin treatment significantly elevated the expression of <italic>OsHSF</italic> and <italic>DREB</italic> genes in rice plants subjected to salt, drought stress individually, and their combined stress conditions (Fig. ##FIG##4##5##C,D). To summarize, there is a hypothesis that melatonin enhances rice plants’ response to salt and drought stress. In summary, it is hypothesized that melatonin improves the response of rice plants to salt and drought stress. Melatonin encounters the production of ROS within cells. As ROS levels rise, melatonin acts as an antioxidant, scavenging these ROS and boosting antioxidant activities. Melatonin seems to induce or activate the expression of specific resistance genes, thereby enhancing the plant’s ability to tolerate salt and drought stress. Further investigation is needed to comprehensively understand the mechanisms and signaling pathways involved in melatonin’s response under salt and drought stress in rice plants.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par34\">Our study showed that both the salt and drought stresses induced oxidative damage by generation of ROS and membrane damage due to lipid peroxidation, which leads to reduction in rice plant growth and development. Exogenous melatonin application reduces salt, drought stress individually as well as in combine. Melatonin increased fresh and dry weight of rice under salt and drought stress. Similarly, melatonin treatment significantly reduced the accumulation of ROS and increased the antioxidant activity. Moreover, melatonin up-regulated the genes expression that are responsible for ion homeostasis. Future perspectives entail unraveling melatonin’s precise mechanisms, optimizing its application strategies, and validating its effectiveness in field trials for sustainable crop resilience under salt and drought stresses.</p>", "<title>Statement of adherence of the study to IUCN guidelines</title>", "<p id=\"Par35\">The current study complies with relevant guidelines of IUCN Policy Statement on Research Involving Species at Risk of Extinction and Convention on the Trade in Endangered Species of Wild Fauna and Flora.</p>" ]
[ "<p id=\"Par1\">Due to global climate change, crops are certainly confronted with a lot of abiotic and biotic stress factors during their growth that cause a serious threat to their development and overall productivity. Among different abiotic stresses, salt and drought are considered the most devastating stressors with serious impact on crop’s yield stability. Here, the current study aimed to elucidate how melatonin works in regulating plant biomass, oxidative stress, antioxidant defense system, as well as the expression of genes related to salt and drought stress in rice plants. Eight groups of rice plants (3 replicates, 5 plants each) underwent varied treatments: control, melatonin, salt, drought, salt + drought, salt + melatonin, drought + melatonin, and salt + drought + melatonin. Melatonin (100 µM) was alternately applied a week before stress exposure; salt stress received 100 mM NaCl every 3 days for 3 weeks, and drought stress involved 10% PEG. Young leaves were randomly sampled from each group. The results showed that melatonin treatment markedly reduces salt and drought stress damage by promoting root, shoot length, fresh and dry weight, increasing chlorophyll contents, and inhibiting excessive production of oxidative stress markers. Salt and drought stress significantly decreased the water balance, and damaged cell membrane by reducing relative water contents and increasing electrolyte leakage. However, melatonin treated rice plants showed high relative water contents and low electrolyte leakage. Under salt and drought stress conditions, exogenous application of melatonin boosted the expression level of salt and drought stress responsive genes like <italic>OsSOS</italic>, <italic>OsNHX</italic>, <italic>OsHSF</italic> and <italic>OsDREB</italic> in rice plants. Taken together, our results reveal that melatonin treatment significantly increases salt and drought tolerance of rice plants, by increasing plant biomass, suppressing ROS accumulation, elevating antioxidants defense efficiency, and up-regulating the expression of salt and drought stress responsive genes.</p>", "<title>Subject terms</title>" ]
[]
[ "<title>Author contributions</title>", "<p>Z.K., R.J., and K.-M.K.; designed the study; Z.K., R.J., S.A., and M.-F., performed the experiments; E.-G.K., Y.-H.J., and N.K., contributed to statistical analysis; Z.K., R.J., and K.-M.K.; wrote the manuscript. All authors have read and agreed to the published version of the manuscript.</p>", "<title>Funding</title>", "<p>This work was conducted with the support of “Cooperative Research Program for Agriculture Science and Technology Development (Project No. RS-2022-RD010034)” Rural Development Administration, Republic of Korea. The funding was also provided by Cooperative Research Program for Agriculture Science and Technology Rural Development Administration, Republic of Korea Development, Project No. RS-2023-00217583.</p>", "<title>Data availability</title>", "<p>The data presented in this study are available on request from the corresponding author.</p>", "<title>Competing interests</title>", "<p id=\"Par36\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Experimental design of the experiment, indicating the eight experimental boxes and application of drought and salt stress. Box (<bold>A</bold>) shows control plants. Box (<bold>B</bold>) shows plants treated with melatonin only. Box (<bold>C</bold>) shows the plants exposed to salt stress. Box (<bold>D</bold>) shows melatonin treated plants exposed to salt stress. Box (<bold>E</bold>) shows plants exposed to drought stress. Box (<bold>F</bold>) shows melatonin treated plants exposed to drought stress. Box (<bold>G</bold>) shows plants exposed to salt and drought combined stress. Box (<bold>H</bold>) melatonin treated plants exposed to salt and drought combined stress.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Evaluation of growth parameters in rice plants under salt and drought stress. Figures show that melatonin increased the root shoot length and plant biomass in salt and drought stress individually as well as in combined. (<bold>A</bold>) Shows the salt and drought stress damage. (<bold>B</bold>) Shoot length, (<bold>C</bold>) root length, (<bold>D</bold>) fresh and dry weight. Data were analyzed in three independent biological replicates (± standard deviation, SD), and the means were compared using Dunnett tests. *Indicates p and &lt; 0.05, **indicates p &lt; 0.01. Whereas C is control, M is melatonin, S is salt, (S + M) is salt + melatonin, D is drought, (D + M) is drought + melatonin, (S + D) is salt + drought and (S + D + M) is salt + drought + melatonin.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Melatonin application reduces salt and drought stress effects on chlorophyll contents. (<bold>A</bold>) Shows chlorophyll contents SPAD values. (<bold>B</bold>) Electrolyte leakage and (<bold>C</bold>) relative water contents which are regulated by exogenous treatment of melatonin. Data were analyzed in three independent biological replicates (± standard deviation, SD), and the means were compared using Dunnett tests. *Indicates p &lt; 0.05 and **indicates p &lt; 0.01.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Melatonin application alleviates salt and drought stress by scavenging ROS accumulation. (<bold>A,B</bold>) Shows H<sub>2</sub>O<sub>2</sub> and MDA contents. Melatonin also regulates the activities of antioxidants. (<bold>C</bold>) Shows the activities of Glutathione reductase (GR) and (<bold>D</bold>) shows the activities of catalase (CAT). Data was analyzed in three independent biological replicates (± standard deviation, SD), and the means were compared using Bonferroni post hoc tests. *Indicates p &lt; 0.05 and **indicates p &lt; 0.01.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Melatonin reduces salt and drougth stress via regulation of drought and salt stress responsive genes. (<bold>A,B</bold>) Show the relative expression of <italic>OsSOS</italic> and <italic>OsNHX</italic> salt stress responsive gene while, (<bold>C,D</bold>) show the relative expresssion of <italic>OsHSF</italic> and <italic>OsDREB</italic> drought responsive genes in rice plant respectively. Data were analyzed in three independent biological replicates (± standard deviation, SD), and the means were compared using Bonferroni post hoc tests. *Indicates p &lt; 0.05 and **indicates p &lt; 0.01.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Primers and accession numbers of selected genes designed by NCBI for qRT-PCR.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Gene</th><th align=\"left\">Forward primers</th><th align=\"left\">Reverse primers</th><th align=\"left\">Accession no</th></tr></thead><tbody><tr><td align=\"left\"><italic>OsActin</italic></td><td align=\"left\">CTGCGGGTATCCATGAGACT</td><td align=\"left\">GGAGCAAGGCAGTGATCTTC</td><td align=\"left\">X16280.1</td></tr><tr><td align=\"left\"><italic>OsHSF</italic></td><td align=\"left\">GCGAGAGAAGCTCAGCTAGG</td><td align=\"left\">CCCAGACGTAGAATCCGGTG</td><td align=\"left\">AK101182</td></tr><tr><td align=\"left\"><italic>OsDREB</italic></td><td align=\"left\">AGGAGGGAGAAATCTGGCAC</td><td align=\"left\">CGCACTGAAAAGTGTGGACA</td><td align=\"left\">AK062422</td></tr><tr><td align=\"left\"><italic>OsNHX</italic></td><td align=\"left\">GCGGTGCATTTTGCTCTCAA</td><td align=\"left\">CCTGCTTCAGATCAGGGTGG</td><td align=\"left\">AK104336</td></tr><tr><td align=\"left\"><italic>OsSOS</italic></td><td align=\"left\">TCGCAGACAGGGTGTTTGAT</td><td align=\"left\">CGCTTTTGGGTGGAACACAC</td><td align=\"left\">AK101368</td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$RW=\\frac{FW-DW}{TW-DW}\\times 100$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mrow><mml:mi>R</mml:mi><mml:mi>W</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>F</mml:mi><mml:mi>W</mml:mi><mml:mo>-</mml:mo><mml:mi>D</mml:mi><mml:mi>W</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>W</mml:mi><mml:mo>-</mml:mo><mml:mi>D</mml:mi><mml:mi>W</mml:mi></mml:mrow></mml:mfrac><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$EL=\\frac{EC1}{EC2}\\times 100$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mrow><mml:mi>E</mml:mi><mml:mi>L</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>E</mml:mi><mml:mi>C</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>E</mml:mi><mml:mi>C</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<inline-graphic xlink:href=\"41598_2024_51369_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51369_Article_IEq2.gif\"/>", "<graphic xlink:href=\"41598_2024_51369_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51369_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51369_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51369_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51369_Fig5_HTML\" id=\"MO5\"/>" ]
[]
[{"label": ["1."], "surname": ["Sen", "Chakraborty", "Kalita"], "given-names": ["S", "R", "P"], "article-title": ["Rice-not just a staple food: A comprehensive review on its phytochemicals and therapeutic potential"], "source": ["Trends Food Sci. Technol."], "year": ["2020"], "volume": ["97"], "fpage": ["265"], "lpage": ["285"], "pub-id": ["10.1016/j.tifs.2020.01.022"]}, {"label": ["5."], "surname": ["Nam", "Hayes", "Svoboda", "Tadesse", "Wilhite"], "given-names": ["W-H", "MJ", "MD", "T", "DA"], "article-title": ["Drought hazard assessment in the context of climate change for South Korea"], "source": ["Agric. Water Manag."], "year": ["2015"], "volume": ["160"], "fpage": ["106"], "lpage": ["117"], "pub-id": ["10.1016/j.agwat.2015.06.029"]}, {"label": ["6."], "surname": ["Cook", "Mankin", "Anchukaitis"], "given-names": ["BI", "JS", "K"], "article-title": ["Climate change and drought: From past to future"], "source": ["Curr. Clim. Change Rep."], "year": ["2018"], "volume": ["4"], "fpage": ["164"], "lpage": ["179"], "pub-id": ["10.1007/s40641-018-0093-2"]}, {"label": ["7."], "surname": ["Sheffield", "Wood"], "given-names": ["J", "EF"], "source": ["Drought: Past Problems and Future Scenarios"], "year": ["2012"], "publisher-name": ["Routledge"]}, {"label": ["8."], "surname": ["Allen"], "given-names": ["RG"], "article-title": ["Crop evapotranspiration\u2014Guideline for computing crop water requirements"], "source": ["Irrig. Drain"], "year": ["1998"], "volume": ["56"], "fpage": ["300"]}, {"label": ["9."], "surname": ["Mostajeran", "Rahimi-Eichi"], "given-names": ["A", "V"], "article-title": ["Effects of drought stress on growth and yield of rice ("], "italic": ["Oryza sativa"], "source": ["Agric. Environ. Sci."], "year": ["2009"], "volume": ["5"], "fpage": ["264"], "lpage": ["272"]}, {"label": ["10."], "surname": ["Pandey", "Bhandari", "Hardy"], "given-names": ["S", "HS", "B"], "source": ["Economic Costs of Drought and Rice Farmers\u2019 Coping Mechanisms: A Cross-Country Comparative Analysis"], "year": ["2007"], "publisher-name": ["International Rice Research Institute"]}, {"label": ["11."], "surname": ["Thitisaksakul", "Tananuwong", "Shoemaker", "Chun", "Tanadul", "Labavitch", "Beckles"], "given-names": ["M", "K", "CF", "A", "OU", "JM", "DM"], "article-title": ["Effects of timing and severity of salinity stress on rice ("], "italic": ["Oryza sativa"], "source": ["J. Agric. Food Chem."], "year": ["2015"], "volume": ["68"], "fpage": ["2296"], "lpage": ["2304"], "pub-id": ["10.1021/jf503948p"]}, {"label": ["12."], "surname": ["Hussain"], "given-names": ["S"], "article-title": ["Effects of salt stress on rice growth, development characteristics, and the regulating ways: A review"], "source": ["J. Integr. Agric."], "year": ["2017"], "volume": ["16"], "fpage": ["2357"], "lpage": ["2374"], "pub-id": ["10.1016/S2095-3119(16)61608-8"]}, {"label": ["13."], "surname": ["Hussain"], "given-names": ["S"], "article-title": ["Effects of 1-methylcyclopropene on rice growth characteristics and superior and inferior spikelet development under salt stress"], "source": ["J. Plant Growth Regul."], "year": ["2018"], "volume": ["37"], "fpage": ["1368"], "lpage": ["1384"], "pub-id": ["10.1007/s00344-018-9800-4"]}, {"label": ["14."], "surname": ["Tarakcioglu", "Inal"], "given-names": ["C", "A"], "article-title": ["Changes induced by salinity, demarcating specific ion ratio (Na/Cl) and osmolality in ion and proline accumulation, nitrate reductase activity, and growth performance of lettuce"], "source": ["J. Plant Nutr."], "year": ["2002"], "volume": ["25"], "fpage": ["27"], "lpage": ["41"], "pub-id": ["10.1081/PLN-100108778"]}, {"label": ["17."], "surname": ["Shereen", "Mumtaz", "Raza", "Khan", "Solangi"], "given-names": ["A", "S", "S", "M", "S"], "article-title": ["Salinity effects on seedling growth and yield components of different inbred rice lines"], "source": ["Pak. J. Bot."], "year": ["2005"], "volume": ["37"], "fpage": ["131"], "lpage": ["139"]}, {"label": ["28."], "surname": ["Yan"], "given-names": ["F"], "article-title": ["Melatonin regulates antioxidant strategy in response to continuous salt stress in rice seedlings"], "source": ["Plant Physiol."], "year": ["2021"], "volume": ["165"], "fpage": ["239"], "lpage": ["250"]}, {"label": ["29."], "surname": ["Alharby", "Fahad"], "given-names": ["HF", "S"], "article-title": ["Melatonin application enhances biochar efficiency for drought tolerance in maize varieties: Modifications in physio-biochemical machinery"], "source": ["Agron. J."], "year": ["2020"], "volume": ["112"], "fpage": ["2826"], "lpage": ["2847"], "pub-id": ["10.1002/agj2.20263"]}, {"label": ["34."], "surname": ["L\u00fc"], "given-names": ["SY"], "article-title": ["Antiporter gene from "], "italic": ["Hordum brevisubulatum"], "source": ["J. Integr. Plant Biol."], "year": ["2005"], "volume": ["47"], "fpage": ["343"], "lpage": ["349"], "pub-id": ["10.1111/j.1744-7909.2005.00027.x"]}, {"label": ["38."], "surname": ["Scharf", "Berberich", "Ebersberger", "Nover"], "given-names": ["K-D", "T", "I", "L"], "article-title": ["The plant heat stress transcription factor (Hsf) family: Structure, function and evolution"], "source": ["Biochim. Biophys. Acta Gene Regul. Mech."], "year": ["2012"], "volume": ["1819"], "fpage": ["104"], "lpage": ["119"], "pub-id": ["10.1016/j.bbagrm.2011.10.002"]}, {"label": ["43."], "surname": ["Bastam", "Baninasab", "Ghobadi"], "given-names": ["N", "B", "C"], "article-title": ["Improving salt tolerance by exogenous application of salicylic acid in seedlings of pistachio"], "source": ["Plant Growth Regul."], "year": ["2013"], "volume": ["69"], "fpage": ["275"], "lpage": ["284"], "pub-id": ["10.1007/s10725-012-9770-7"]}, {"label": ["44."], "surname": ["Khan"], "given-names": ["MA"], "article-title": ["Halotolerant rhizobacterial strains mitigate the adverse effects of NaCl stress in soybean seedlings"], "source": ["BioMed Res. Int."], "year": ["2019"], "volume": ["2019"], "fpage": ["1"]}, {"label": ["45."], "surname": ["Velikova", "Yordanov", "Edreva"], "given-names": ["V", "I", "A"], "article-title": ["Oxidative stress and some antioxidant systems in acid rain-treated bean plants: Protective role of exogenous polyamines"], "source": ["Plant Sci."], "year": ["2000"], "volume": ["151"], "fpage": ["59"], "lpage": ["66"], "pub-id": ["10.1016/S0168-9452(99)00197-1"]}, {"label": ["46."], "surname": ["Khan"], "given-names": ["MA"], "article-title": ["Halo-tolerant rhizospheric "], "italic": ["Arthrobacter woluwensis"], "source": ["Symbiosis"], "year": ["2019"], "volume": ["77"], "fpage": ["9"], "lpage": ["21"], "pub-id": ["10.1007/s13199-018-0562-3"]}, {"label": ["47."], "surname": ["Johansson", "Borg"], "given-names": ["LH", "LH"], "article-title": ["A spectrophotometric method for determination of catalase activity in small tissue samples"], "source": ["Arch. Biochem."], "year": ["1988"], "volume": ["174"], "fpage": ["331"], "lpage": ["336"]}, {"label": ["49."], "surname": ["Huang"], "given-names": ["C"], "article-title": ["Alteration in chlorophyll fluorescence, lipid peroxidation and antioxidant enzymes activities in hybrid ramie ("], "italic": ["Boehmeria nivea"], "source": ["Austral. J. Crop Sci."], "year": ["2013"], "volume": ["7"], "fpage": ["594"], "lpage": ["599"]}, {"label": ["50."], "surname": ["Yang", "Deng"], "given-names": ["S", "X"], "article-title": ["Effects of drought stress on antioxidant enzymes in seedlings of different wheat genotypes"], "source": ["Pak. J. Bot."], "year": ["2015"], "volume": ["47"], "fpage": ["49"], "lpage": ["56"]}, {"label": ["51."], "surname": ["Xiaoqin", "Jianzhou", "Guangyin"], "given-names": ["Y", "C", "W"], "article-title": ["Effects of drought stress and selenium supply on growth and physiological characteristics of wheat seedlings"], "source": ["Acta Physiol. Plant."], "year": ["2009"], "volume": ["31"], "fpage": ["1031"], "lpage": ["1036"], "pub-id": ["10.1007/s11738-009-0322-3"]}, {"label": ["54."], "surname": ["Talubaghi", "Daliri", "Mazloum", "Rameeh", "Mousavi"], "given-names": ["MJ", "MS", "P", "V", "A"], "article-title": ["Effect of salt stress on growth, physiological and biochemical parameters and activities of antioxidative enzymes of rice cultivars"], "source": ["Cereal Res. Commun."], "year": ["2023"], "volume": ["51"], "fpage": ["403"], "lpage": ["411"], "pub-id": ["10.1007/s42976-022-00314-w"]}, {"label": ["55."], "surname": ["Shahid"], "given-names": ["MA"], "article-title": ["Insights into the physiological and biochemical impacts of salt stress on plant growth and development"], "source": ["Agron. J."], "year": ["2020"], "volume": ["10"], "fpage": ["938"]}, {"label": ["56."], "surname": ["Mushtaq"], "given-names": ["Z"], "article-title": ["Changes in growth, photosynthetic pigments, cell viability, lipid peroxidation and antioxidant defense system in two varieties of chickpea ("], "italic": ["Cicer arietinum"], "source": ["Phyton"], "year": ["2022"], "volume": ["91"], "fpage": ["149"], "pub-id": ["10.32604/phyton.2022.016231"]}, {"label": ["57."], "surname": ["Imran"], "given-names": ["M"], "article-title": ["Exogenous melatonin induces drought stress tolerance by promoting plant growth and antioxidant defence system of soybean plants"], "source": ["AoB Plants"], "year": ["2021"], "volume": ["13"], "fpage": ["026"], "pub-id": ["10.1093/aobpla/plab026"]}, {"label": ["59."], "surname": ["Ghanbari", "Sayyari"], "given-names": ["F", "M"], "article-title": ["Controlled drought stress affects the chilling-hardening capacity of tomato seedlings as indicated by changes in phenol metabolisms, antioxidant enzymes activity, osmolytes concentration and abscisic acid accumulation"], "source": ["Sci. Hortic."], "year": ["2018"], "volume": ["229"], "fpage": ["167"], "lpage": ["174"], "pub-id": ["10.1016/j.scienta.2017.10.009"]}, {"label": ["60."], "surname": ["Turk"], "given-names": ["H"], "article-title": ["The regulatory effect of melatonin on physiological, biochemical and molecular parameters in cold-stressed wheat seedlings"], "source": ["Plant Growth Regul."], "year": ["2014"], "volume": ["74"], "fpage": ["139"], "lpage": ["152"], "pub-id": ["10.1007/s10725-014-9905-0"]}, {"label": ["61."], "surname": ["Xu", "Sun", "Sun", "Zhang", "Guo"], "given-names": ["XD", "Y", "B", "J", "XQ"], "article-title": ["Effects of exogenous melatonin on active oxygen metabolism of cucumber seedlings under high temperature stress"], "source": ["J. Appl. Ecol."], "year": ["2010"], "volume": ["21"], "fpage": ["1295"], "lpage": ["1300"]}, {"label": ["64."], "surname": ["Altaf"], "given-names": ["M"], "article-title": ["Exogenous melatonin enhances salt stress tolerance in tomato seedlings"], "source": ["Biol. Plant."], "year": ["2020"], "volume": ["64"], "fpage": ["604"], "lpage": ["615"], "pub-id": ["10.32615/bp.2020.090"]}, {"label": ["65."], "surname": ["Das", "Roychoudhury"], "given-names": ["K", "A"], "article-title": ["Reactive oxygen species (ROS) and response of antioxidants as ROS-scavengers during environmental stress in plants"], "source": ["Front. Environ. Sci."], "year": ["2014"], "volume": ["2"], "fpage": ["53"], "pub-id": ["10.3389/fenvs.2014.00053"]}, {"label": ["69."], "surname": ["Li"], "given-names": ["J"], "article-title": ["Alleviation of cold damage by exogenous application of melatonin in vegetatively propagated tea plant ("], "italic": ["Camellia sinensis"], "source": ["Sci. Hortic."], "year": ["2018"], "volume": ["238"], "fpage": ["356"], "lpage": ["362"], "pub-id": ["10.1016/j.scienta.2018.04.068"]}, {"label": ["72."], "surname": ["Wu"], "given-names": ["S"], "article-title": ["Drought stress tolerance mediated by zinc-induced antioxidative defense and osmotic adjustment in cotton ("], "italic": ["Gossypium hirsutum"], "source": ["Acta Physiol. Plant."], "year": ["2015"], "volume": ["37"], "fpage": ["1"], "lpage": ["9"], "pub-id": ["10.1007/s11738-015-1919-3"]}, {"label": ["74."], "surname": ["Morales", "Abad\u00eda", "Abad\u00dea"], "given-names": ["F", "A", "J"], "source": ["Photoprotection, Photoinhibition, Gene Regulation, and Environment"], "year": ["2008"], "publisher-name": ["Springer"], "fpage": ["65"], "lpage": ["85"]}, {"label": ["76."], "surname": ["Pan", "Wu", "Yu"], "given-names": ["Y", "LJ", "ZL"], "article-title": ["Effect of salt and drought stress on antioxidant enzymes activities and SOD isoenzymes of liquorice ("], "italic": ["Glycyrrhiza uralensis"], "source": ["Plant Growth Regul."], "year": ["2006"], "volume": ["49"], "fpage": ["157"], "lpage": ["165"], "pub-id": ["10.1007/s10725-006-9101-y"]}, {"label": ["77."], "surname": ["Yildiztugay", "Ozfidan-Konakci", "Kucukoduk", "Tekis", "Science"], "given-names": ["E", "C", "M", "SA", "S"], "article-title": ["The impact of selenium application on enzymatic and non-enzymatic antioxidant systems in "], "italic": ["Zea mays"], "source": ["Arch. Agron."], "year": ["2017"], "volume": ["63"], "fpage": ["261"], "lpage": ["275"]}, {"label": ["79."], "surname": ["Zhang", "Tian", "Pan", "Zhao", "Wang"], "given-names": ["W", "Z", "X", "X", "F"], "article-title": ["Oxidative stress and non-enzymatic antioxidants in leaves of three edible canna cultivars under drought stress"], "source": ["Hortic. Environ. Biotechnol."], "year": ["2013"], "volume": ["54"], "fpage": ["1"], "lpage": ["8"], "pub-id": ["10.1007/s13580-013-0070-6"]}, {"label": ["80."], "surname": ["Tepe", "Harms"], "given-names": ["M", "H"], "article-title": ["Influence of abiotic stress on the GSH/GSSG system of plant cell cultures"], "source": ["Mol. Biol. Plants"], "year": ["1995"], "volume": ["158"], "fpage": ["75"], "lpage": ["78"]}, {"label": ["81."], "surname": ["Dash", "Mohanty"], "given-names": ["S", "N"], "article-title": ["Response of seedlings to heat-stress in cultivars of wheat: Growth temperature-dependent differential modulation of photosystem 1 and 2 activity, and foliar antioxidant defense capacity"], "source": ["J. Plant Physiol."], "year": ["2002"], "volume": ["159"], "fpage": ["49"], "lpage": ["59"], "pub-id": ["10.1078/0176-1617-00594"]}, {"label": ["91."], "surname": ["Fukuda", "Nakamura", "Hara", "Toki", "Tanaka"], "given-names": ["A", "A", "N", "S", "Y"], "article-title": ["Molecular and functional analyses of rice NHX-type Na+/H+ antiporter genes"], "source": ["Plant Physiol."], "year": ["2011"], "volume": ["233"], "fpage": ["175"], "lpage": ["188"]}, {"label": ["95."], "surname": ["Yan"], "given-names": ["F"], "article-title": ["Melatonin enhances Na+/K+ homeostasis in rice seedlings under salt stress through increasing the root H+-pump activity and Na+/K+ transporters sensitivity to ROS/RNS"], "source": ["Environ. Exp. Bot."], "year": ["2021"], "volume": ["182"], "fpage": ["104328"], "pub-id": ["10.1016/j.envexpbot.2020.104328"]}]
{ "acronym": [], "definition": [] }
103
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1214
oa_package/e2/8a/PMC10786868.tar.gz
PMC10786869
38216604
[ "<title>Introduction</title>", "<p id=\"Par2\">Climate change affects the physics and biology of marine ecosystems through warming, acidification, deoxygenation, and changes in productivity (e.g., chlorophyll concentration). Ocean observations suggest that these changes have taken place at a more rapid pace than previously expected<sup>##UREF##0##1##</sup> and can manifest in a range of ways. For example, there is evidence of increased frequencies of extreme heatwaves in the Pacific Ocean<sup>##REF##34912083##2##</sup> and expansion of deoxygenated zones, which can be attributed to eutrophication<sup>##REF##24706804##3##,##REF##18703733##4##</sup>, warming (decreased oxygen saturation), and stratification (decreased mixing and ventilation)<sup>##UREF##1##5##</sup>. Combined stressor impacts can change species distribution, phenology, survival, and growth, as well as habitat and spawning conditions. Effective decision-making on how to mitigate or adapt to climate change requires detailed data on future ocean temperatures, acidification, changes in oxygen, and ocean productivity.</p>", "<p id=\"Par3\">Scientific analysis and conclusions featured in the sixth assessment report of the IPCC are based largely on the critically important output from the Coupled Model Intercomparison Project (CMIP6) and historical observations. CMIP6 uses Earth System Models (ESMs) or General Circulation Models (GCMs) that can simulate the various physical, biological, and chemical processes within the atmosphere, ocean, ice, and land and how those processes combine to affect the global climate. These models provide possible climate trajectories for the future based on a range of greenhouse gas concentration scenarios and Shared Socioeconomic Pathways (SSP), which provide a wealth of information at large spatial scales<sup>##UREF##2##6##</sup>. Still, working with CMIP6 model outputs can be technically challenging<sup>##REF##37179171##7##</sup>. For example, the grid structure of CMIP6 models can be complex with non-uniform representation of longitude and latitude grid points, which are used to avoid singularities at the poles and to enhance resolution closer to the equator. In addition, a single model variable may be split into hundreds of files that need to be concatenated in time. Modelled variables may also be biased compared to observations. Working with these global datasets presents several logistical challenges. They require large storage space and cannot be sub-sampled prior to downloading from the original data archives, although both Google Cloud and Amazon Web Services now provide a subset of the model data improving their accessibility. CMIP6 associated terminology can also be impenetrable to non-experts<sup>##REF##37179171##7##</sup>. As a result, the outputs of CMIP6 across a range of spatial and temporal scales often prohibit the use by non-experts, limiting their use for further ecosystem impact analysis.</p>", "<p id=\"Par4\">The coarse resolution of the CMIP6 models (most models represent the ocean at roughly 1 × 1 resolution in longitude and latitude grid) does not resolve mesoscale features (e.g., eddies) essential to understanding dynamical processes in coastal regions. Higher resolution climate projections for coastal and shelf areas are increasingly needed as inputs to adaptation and mitigation planning as well as management of marine resources<sup>##UREF##3##8##</sup>. Downscaling global climate projections to a higher resolution can preserve the large-scale climate signal while capturing local variability and dynamics<sup>##UREF##4##9##</sup>. While several dynamical downscaling products exist for regional ocean domains<sup>##UREF##5##10##,##UREF##6##11##</sup>, these products lack the conceptual and standardized approach of the CMIP experiments, or the Coordinated REgional Downscaling Experiment (CORDEX) program for regional atmospheric models. Dynamically downscaled products often focus on a single or limited set of climate models and scenarios<sup>##UREF##7##12##,##UREF##8##13##</sup>. The lack of consistent ensembles with diversity in models and scenarios strongly limits the comparability of results across different systems and does not adequately quantify the uncertainty in the physical and biogeochemical projections<sup>##UREF##3##8##</sup>, which is critical for risk assessment, ecosystem-based management, and informing mitigation and adaptation policies.</p>", "<p id=\"Par5\">The EU-funded research project FutureMARES aims to provide socially and economically viable actions and strategies that support Nature-based Solutions (NBS) for climate change adaptation and mitigation across Europe. To meet these ambitious goals, the datasets developed here were explicitly designed to deliver consistent climate-driven projections of change in physical and biogeochemical factors at the spatial scales relevant for planning and management across European regional seas. To do this, we bias-corrected and statistically downscaled individual CMIP6 models to provide an ensemble of high-resolution climate projections for different IPCC scenarios. Here, we present the methodology, evaluation, and uncertainty analysis of the downscaled dataset products made publicly available through Zenodo (zenodo.org). The ensemble high-resolution climate dataset provides projections for 1993–2100 (monthly) at roughly 8 km (1/12th degree) resolution for four European regions: the North Sea, the Baltic Sea, the Bay of Biscay, and the Mediterranean Sea (Fig. ##FIG##0##1##).</p>" ]
[ "<title>Methods</title>", "<p id=\"Par6\">The methodology applied to statistically bias-correct and downscale large-scale CMIP6 climate projections to the regional level was conducted in four steps: (1) preparing the input data, (2) bias-correcting with respect to observations, (3) statistically downscaling the bias-corrected fields to higher resolution, and (4) creating ensemble statistics of the downscaled models.</p>", "<title>Preparation of global climate data</title>", "<p id=\"Par7\">The raw data from global climate models (GCM) and Earth System Models (ESMs) can be represented on various global ocean grids. Some of these grids have higher resolution in one part of the world, e.g., around the equator, while others can have three poles to avoid the singularity in the ocean at 90° N. To be able to work consistently with these model outputs, we interpolated the data to a uniform cartesian grid of 0.5° × 0.5° longitude-latitude. We employed the Earth System Modelling Framework (ESMF)<sup>##UREF##9##14##</sup> to allow fast interpolation within a tested framework. We also use the Python xesmf interface<sup>##UREF##10##15##</sup> to the ESMF package, which further simplified the conversion from the native to a uniform grid. We used the xMIP package for pre-processing the CMIP6 data<sup>##UREF##11##16##</sup>. Once the GCM/ESM data were converted to a standard grid, we performed a bias-corrected statistical downscaling of the data, a two-step process: (1) bias-correction and (2) statistical downscaling.</p>", "<title>Bias-correction</title>", "<p id=\"Par8\">The GCMs and ESMs within CMIP6 were designed to represent the probability distributions, variability, and observed trends in physical and biological variables and not to exactly replicate individual features in time and space as reanalysis systems would do for the past or forecasting systems for the near future. For this reason, GCMs and ESMs are inherently biased from historical observations. To correct the offset in the global models, we performed a bias-correction where the large-scale climate signal was constrained to observed values of the range and variability using detrended quantile mapping (DQM) transformations<sup>##UREF##12##17##,##UREF##13##18##</sup>. The DQM is designed to remove biases across all quantiles, effectively aligning the data distribution of the model data relative to the observed values<sup>##UREF##13##18##</sup>. Here, we use the ocean reanalysis GLORYS12V1<sup>##UREF##5##10##</sup> as observations to quantify the biases present in the GCM/ESMs. The DQM method was trained with the historical (1993–2020) GLORYS12V1 reanalysis and applied to the historical GCM/ESM data to calculate the transform function which was used to adjust the detrended quantiles for the future projections (2020–2100). Once the timeseries had been adjusted using the DQM methodology, the trend was added back to the timeseries<sup>##UREF##4##9##</sup>. This approach ensures that the trend from the GCMs and ESMs is preserved in the downscaled product. The bias-correction was performed at the resolution of the interpolated GCM or ESM, which is 0.5° × 0.5° latitude-longitude. The global ocean physics of the GLORYS12V1 reanalysis at 1/12th degrees resolution have been thoroughly validated against observations<sup>##UREF##5##10##,##UREF##14##19##</sup>. The GLORYS12V1 reanalysis assimilates available historical data (e.g., satellite, CTD, XBT, buoys) for 1993-01-01 to 2019-12-31 and represents state-of-the-art hydrodynamic modeling. GLORYS12V1<sup>##UREF##14##19##</sup> is developed by Mercator Ocean and is an operational service from the Copernicus Marine Service Center (marine.copernicus.eu).</p>", "<p id=\"Par9\">Historical biogeochemical data such as oxygen, chlorophyll, and pH were obtained from the biological model Global Ocean Biogeochemistry hindcast (GOBH) from Mercator Ocean distributed via the Copernicus Marine Service. The GOBH model<sup>##UREF##15##20##</sup> uses the PISCES model to represent biogeochemistry and physics from the FREEGLORYS2V4 model, which is a non-assimilative version of the GLORYS2V4 reanalysis model. The GOBH and FREEGLORYS2V4 models were run at a resolution of 1/4th degree. To align the downscaled physical and biogeochemical results directly, we interpolated (bilinear) and extrapolated these model data onto the physical model grid, allowing the final biological downscaled data to be at 1/12th degree resolution. As the bathymetry along the coastline of the biological model is coarser than the physical model, we extrapolated to the destination point by using the weighted average of the eight nearest source points. The weight is the reciprocal of the distance of the source point from the destination point raised to a power 2 (the inverse weighted distance method)<sup>##UREF##9##14##</sup>. The documentation for GOBH states that the model holds a global bias in pH of 0.02, making it slightly more acidic compared to observations. The model is able to reproduce observed surface and sub-surface oxygen concentrations including the oxygen minimum zone<sup>##UREF##15##20##</sup>. However, being a hindcast, as all dynamic ocean models, this dataset contains some biases with respect to the real world which will be inherited by the downscaled products.</p>", "<title>Statistical downscaling</title>", "<p id=\"Par10\">The statistical downscaling (SD) allowed us to establish an empirical relationship between high-resolution historical and large-scale climate indicators and apply these statistics to produce local climate projections. The bias-corrected fields at 0.5° × 0.5° longitude-latitude resolution were used as input to the DQM statistical downscaling algorithm together with the high-resolution GLORYS12V1 reanalysis to provide ESM sub-grid variability. This involved (1) determine a scaling factor that allow the mean of the historical bias-corrected CMIP6 projection to be equal to the mean of the historical GLORYS12V1/GOBH timeseries, (2) remove the trend from both timeseries (3) calculate the adjustment factors between the quantiles of the two timeseries, (4) apply the scaling factor to the future projections, (5) match the quantiles of the detrended projections and apply the adjustment factor, and (6) add back the trend to the projections<sup>##UREF##13##18##</sup>. The GLORYS12V1 and GOBH models have 50 and 75 vertical depth levels, respectively, which were linearly interpolated if the bias correction and downscaling were performed at an intermediate depth level. Linear interpolation was also performed on the global climate model outputs as downscaling was done at individual, fixed depth levels (e.g., 5 m, 25 m). The exception was the bottom depth, where each grid point had a unique depth level, and the ESMs were interpolated to the GLORYS bathymetry.</p>", "<title>Ensemble product</title>", "<p id=\"Par11\">This downscaling was performed for a range of CMIP6 models (3 to 7) per variable per climate scenario (see Table ##TAB##0##1## for an overview), and the final product to be used by researchers was the ensemble of these individual downscaled models. The ensemble provides datasets for five indicators of marine habitat conditions (temperature (°C), salinity, pH, dissolved oxygen (ml/l), chlorophyll (kg/m<sup>##REF##24706804##3##</sup>)). These data were provided at three distinct depth levels (surface (5 m), sub-surface (25 m), and seafloor) for 1993–2100 under three different future scenarios (SSP1-2.6, SSP2-4.5, and SSP5-8.5). Within the datasets, the ensemble mean is provided along with standard deviations and 2.5, 50, and 97.5 percentiles, depicting the spread of the ensemble at each point in space and time. Although some of the CMIP6 models were downscaled for multiple model realizations (Table ##TAB##0##1##), each downscaled realization held equal weight when calculating the ensemble product which may favour these models results compared to single variant models, a weakness that can potentially be addressed by ensemble weighting based on model independence and performance<sup>##UREF##16##21##</sup>. This approach will be attempted in a future iteration of this dataset. The downscaled results were stored as compressed NetCDF4 files containing self-describing metadata of the downscaled variable.</p>", "<title>Climate scenarios</title>", "<p id=\"Par12\">Global climate models are complex tools that allow researchers to explore how combinations of stressors interact and affect the Earths’ climate system. These models use global greenhouse gas concentrations emerging for the radiative forcing targets of the Representative Concentration Pathways—RCPs, under different shared socioeconomic pathways (SSPs) up to 2100 according to the ScenarioMIP protocol<sup>##UREF##17##22##</sup>. For the sixth Intergovernmental Panel on Climate Change (IPCC) report, five narratives provided alternative socio-economic developments for the world, including sustainable development (SSP1), regional rivalry (SSP3), regional inequality (SSP4), fossil-fuelled development (SSP5), and middle-of-the-road development (SSP2). While, in principle, the two development streams of climate and socio-economic scenarios are independent, some combinations are more likely than others. This dataset focuses on the combinations SSP1-RCP2.6, SSP2-RCP4.5, and SSP5-RCP8.5 which are part of the ScenarioMIP Tier 1 simulations and available across various ESMs. The selection of CMIP6 models and variants was made based on each model's overall performance and skill<sup>##REF##35835803##23##</sup>, and model availability across variables and scenarios.</p>", "<title>Evaluation of ensemble</title>", "<p id=\"Par13\">Several techniques and datasets were applied to validate the ensemble downscaled climate projections. This involved comparing the ensemble results with comprehensive observational datasets, focusing on temperature, and oxygen as key variables. First, we compared the ensemble and its members against the spatially continuous World Ocean Atlas (WOA) climatology for surface temperature (WOA23, 1/4° degree resolution) and dissolved oxygen (WOA18, 1° degree resolution) to obtain a spatially continuous gapless comparison<sup>##UREF##18##24##</sup>. The World Ocean Atlas is a collection of objectively analysed profile data (e.g., temperature, oxygen) from the World Ocean Database. The performance of the downscaled product with respect to the original GCMs and ESMs was assessed using several standard metrics. Each metric was computed for the spatial fields of the seasonal climatology of surface temperature and surface dissolved oxygen. The seasonal climatologies were compared against the WOA climatology and the metrics averaged over seasons. These datasets come at a resolution that is comparable to the original ESM data and allows us to compare the SD with the raw ESM outputs and identify the improvements of the downscaled product beyond the added value of increased resolution.</p>", "<p id=\"Par14\">The metrics calculated and compared were:<list list-type=\"bullet\"><list-item><p id=\"Par15\">the ratio of the model mean over the mean of observations (α) which assessed the overall bias of the model fields for each season;</p></list-item><list-item><p id=\"Par16\">the ratio of the model standard deviation over the standard deviation of observations (β) which assessed the overall spread of the model fields for each season;</p></list-item><list-item><p id=\"Par17\">the Pearson correlation coefficient (<italic>ρ</italic>) of the spatial fields from the model and from the observations which estimated the spatial mismatch of local features and bias.</p></list-item></list></p>", "<p id=\"Par18\">These three metrics were also combined into a summary metric providing a single number for model skill. Several approaches have been previously used to report model skill<sup>##UREF##19##25##–##UREF##21##27##</sup>. We chose the Liu-mean efficiency skill score (LSE), which provides a more balanced representation of the individual components that have been shown to yield superior results to the previous methods when used in model optimizations<sup>##UREF##21##27##</sup>. This skill score combines the individual metrics according to:</p>", "<p id=\"Par19\">A Liu skill score of 1 represents a perfect comparison with observations, while values below 1 indicate a diminishing level of comparison between ensemble and observations. Specifically, the first component of the skill score combining the correlation coefficient and the ratio of the standard deviations evaluates the distance of the linear regression slope between the ensemble dataset and the reference observations to 1. The second component is the non-dimensional measure of the overall bias of the two datasets. To illustrate the numerical values of the skill score, here are a few examples: a completely uncorrelated relationship of the two datasets would yield 0 for the first component of the skill score leading to negative values of the skill score for any further deficiency in the second component. Similarly, if the standard deviations or the mean of the ensemble would reach twice that of the observations, the skill would become 0 or smaller even for perfect correlation between model and observations.</p>", "<p id=\"Par20\">In addition, to best validate surface and bottom values of temperature, and oxygen, we compared the ensemble data with in-situ observations obtained from a variety of platforms (e.g., buoys, profiles, and shipboard CTD, pump data, mooring data,) available from the ICES online database (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ices.dk\">www.ices.dk</ext-link>) that has extensive coverage of North Sea, Baltic Sea and the North-Eastern Atlantic. For the Mediterranean Sea we used the GLODAP<sup>##UREF##22##28##,##UREF##23##29##</sup> database instead of the ICES database as it provides better coverage of the basin. The comparisons between ensemble values and observations from either ICES or GLODAP were done by identifying observations located within 100 m horizontal distance from any downscaled grid locations and ± 1 m vertically up or down from the depth of the ensemble grid location. This allowed us to compare the nearest observations in space (latitude, longitude, and depth) to the downscaled data point, while also being agnostic with respect to seasonality. Hence we did not compare the timestamp of ensemble versus observation but rather collected all data within the 27-year time period to assess overall distributions. The ensemble and observed distributions of the range in values with depth of both temperature and oxygen for each of the four regions for the period 1993–2020 were quantified.</p>", "<title>Uncertainty assessment</title>", "<p id=\"Par21\">The uncertainties in the downscaled ensemble product were assessed by evaluating the three principal categories of uncertainty in these types of simulations<sup>##UREF##24##30##</sup>.<list list-type=\"bullet\"><list-item><p id=\"Par22\">Scenario uncertainty is the uncertainty related to the different greenhouse gas concentrations and shared socioeconomic pathways affecting the global climate;</p></list-item><list-item><p id=\"Par23\">Model uncertainty, the uncertainty related to the different structures, and parametrization of the GCMs and ESMs;</p></list-item><list-item><p id=\"Par24\">Internal variability, the uncertainty related to the natural variability of the climate system in the absence of external forcing caused by intrinsic processes of the ocean, atmosphere, and land.</p></list-item></list></p>", "<p id=\"Par25\">These three components have different relative importance at different lead times of a climate projection, with the latter two generally dominating at shorter time scales. The scenario uncertainty tends to become increasingly important as the projection evolves with time due to the increasing spread in greenhouse gas forcing among the scenario pathways<sup>##UREF##25##31##</sup>.</p>", "<p id=\"Par26\">Our uncertainty assessment illustrated the spatial distribution of changes in three key ecosystem indicators induced by anthropogenic greenhouse gas emissions, relating them to each source of uncertainty via their ratio (change/uncertainty). Changes are considered significant where the ratio exceeds 1.</p>", "<p id=\"Par27\">In our assessment, future changes were computed from the ensemble mean for the middle of the road Scenario (SSP2-4.5) for the mid- and long-term IPCC assessment periods (2041–2060 and 2081–2100, respectively) by subtracting the mean conditions of the present-day time slice (1995–2014) from the mean conditions of the future time slice.</p>", "<p id=\"Par28\">The uncertainty fields used to compute the significance ratios for each source of uncertainty were computed as follows:<list list-type=\"bullet\"><list-item><p id=\"Par29\">Scenario uncertainty: changes were computed for each scenario as for the baseline scenario SSP2-4.5 described above. The uncertainty was then determined as the min–max range of all scenarios in each spatial pixel.</p></list-item><list-item><p id=\"Par30\">Model uncertainty: changes were computed for each individual model realization of the baseline scenario SSP2-4.5 as for the ensemble mean described above. The uncertainty was then determined as the min–max range of all model realizations in each spatial pixel.</p></list-item><list-item><p id=\"Par31\">Internal variability was estimated by the difference between the maximum and minimum value of the annual mean time series of the ensemble mean of the baseline scenario projection with long-term trends removed, which was achieved by applying a running average filter with a 21-year window over the original time series.</p></list-item></list></p>", "<p id=\"Par32\">The results from the uncertainty assessment were provided as spatial maps of the change in each variable and its magnitude relative to each source of uncertainty. This spatial representation illustrates the differences in importance of the three sources of uncertainty at different locations.</p>" ]
[ "<title>Results</title>", "<title>Evaluation</title>", "<p id=\"Par33\">The statistical downscaling improved model skill for oxygen and temperature when comparing SD products and the original ESMs (Tables ##TAB##1##2##, ##TAB##2##3##; see Tables ##SUPPL##0##S1##–##SUPPL##0##S10## for more details) across all regions. Temperature shows a higher skill than oxygen, with a difference of around 0.2–0.4 points between the ESM Liu-mean efficiency skill score and the SD. It is worth noting that the SD significantly reduced model differences in performance, while for the original ESMs, the inter-model differences can be substantial.</p>", "<p id=\"Par34\">The decomposition of the performance analysis into its components (Tables ##SUPPL##0##S1##–##SUPPL##0##S10##) suggests that, for the SD products, reduced model skill was attributable to the spatial correlation coefficient (Table ##SUPPL##0##S1##–##SUPPL##0##S2##), while the ratio of means and ratio of standard deviations showed close to perfect matches for these products (Table ##SUPPL##0##S3##–##SUPPL##0##S5##). For the original GCM and ESM simulations, the ratio of means was also generally very close to 1 (Tables ##SUPPL##0##S9##, ##SUPPL##0##S10##). Still, both the Pearson correlation and the ratio of standard deviation indicate substantial shortcomings in skill (Table ##SUPPL##0##S6##, ##SUPPL##0##S9##). For the SD products, the main driver for lack of skill was a weak correlation which is significantly stronger than the mismatches of standard deviations.</p>", "<p id=\"Par35\">The relatively coarse resolution of the WOA data, particularly oxygen, is a challenge for representing enclosed regions such as the Baltic Sea. For that reason, the ensemble downscaled data for bottom temperature (Fig. ##FIG##1##2##) and oxygen (Fig. ##FIG##2##3##) were compared with observations from the ICES database for the Baltic Sea, the Bay of Biscay and for the North Sea, while data for the Mediterranean were compared against the GLODAP database. In total, we extracted a large number of observations totaling 39,797 data points for the Baltic Sea, 126,401 for the North Sea, 9,385 for the Bay of Biscay, and 6,306 for the Mediterranean (Fig. ##SUPPL##0##S1##). The depth and range distributions of bottom temperature (Fig. ##FIG##1##2##) are comparable to the observations for all regions. For the Mediterranean, the bifurcation between the Eastern and Western Mediterranean basins can be identified in both the temperature and oxygen data. When compared with observations, the downscaled temperature data realistically captured the value range as a function of depth (Fig. ##FIG##1##2##) for all regions. The oxygen data in the ensemble exhibited a narrower range across all depths compared to the observed values in the Baltic and North Sea (Fig. ##FIG##2##3##). Conversely, in the Bay of Biscay, the available oxygen observations were limited and dispersed over a wider area, making direct comparison with the ensemble data more challenging. In the Baltic Sea, the ensemble data show higher oxygen concentrations than the observations, especially in the waters shallower than 100 m (Fig. ##FIG##2##3##). This difference is also seen in the upper 100 m in the North Sea where values below 1.4 ml/L is typically classified as hypoxic conditions can be found in the observations (Fig. ##FIG##2##3##). The bottom pH from the ensemble products were compared with the ICES and GLODAP databases but very few observations matched our filtering criteria, although the ones that did compared reasonably well (Fig. ##SUPPL##0##S2##).</p>", "<title>Uncertainty across regions</title>", "<p id=\"Par36\">In this section, we illustrate the changes induced by anthropogenic greenhouse gas emissions for the three variables previously evaluated, sea surface temperature representing warming, surface pH representing acidification, and bottom dissolved oxygen representing deoxygenation. The significance of the induced changes was further analysed by comparing them to three separate sources of uncertainty in climate projections: (1) internal variability, (2) model uncertainty, and (3) scenario uncertainty. In the following subsections, we present the results of this analysis by region.</p>", "<title>Mediterranean Sea</title>", "<p id=\"Par37\">Figure ##FIG##3##4## shows the Mediterranean Sea basin average time series of the three ecosystem indicators from 1993 up to the end of this century for the three scenarios represented by the SD ensemble product. The patterns are qualitatively comparable to those observed for the global mean trajectories<sup>##UREF##26##32##,##UREF##27##33##</sup>. For the no-mitigation scenario SSP5-8.5, the bulk surface temperature of the Mediterranean Sea gradually increases to 5 °C higher than the present day. For the middle of the road scenario SSP2-4.5, the increase in temperature from present-day is lower, reaching approximately 2 °C. For the strongly mitigated scenario SSP1-2.6, the temperature initially increases and then stabilizes towards the middle of the century at around 1.5 °C of warming. The model spread is moderately high (2.5 to 3.0 °C), so the differences between the two scenarios producing weaker warming partially overlap. In contrast, for the high emissions scenario (SSP5-8.5), there is stronger warming and the difference in temperature emerges from the model uncertainty. Interannual variability is low compared to long-term changes. Regarding ocean acidification, in SSP5-8.5 a strong, gradual decrease in ocean pH occurs to about 0.4 units from present-day conditions, while the decline in SSP2-4.5 is less marked, and pH stabilizes by the end of the century in SSP2-4.5, after a 0.15 unit decrease. The SSP1-2.6 scenario suggests a slightly reversing trend, limiting the overall decrease in pH to less than 0.1 units. Uncertainty for this pressure is inherently low, and differences in the changes among the scenarios are clear. For bottom oxygen, uncertainty is highest relative to the changes observed among the three scenarios. For all three scenarios, oxygen decreases by approximately 0.5, 0.2, and 0.1 ml/l for SSP5-8.5, SSP2-4.5, and SSP1-2.6, respectively.</p>", "<p id=\"Par38\">To give a clearer picture of the relative importance of the different sources of uncertainty and their role in different locations, Figs. ##FIG##4##5## and ##FIG##5##6## show maps of the changes of the three indicators for the ensemble average of scenario SSP2-4.5 as absolute values and relative to the uncertainties. The increase in surface temperature is strongest in the Adriatic and Aegean Seas, with higher changes in the Eastern compared to the Western Basin of the Mediterranean Sea. Warming almost doubles from mid to the end of the century with no major difference in the spatial distribution of change. Mid-century interannual variability and model uncertainty are of the order of the changes across the basin, while the differences between the scenarios are significantly lower than the changes induced. This situation reverses for long-term changes, which become more significant with respect to interannual variability. At the same time, the difference between the scenarios has become larger in relative terms and is comparable to the magnitude of the change.</p>", "<p id=\"Par39\">Acidification in the Mediterranean Sea is strongest in the Northern Adriatic, with a generally slightly higher decrease in pH in the Northern parts compared to the Southern coast of the basin. As can be inferred from the basin mean time series, changes are strongly significant for both time slices with respect to interannual variability and model uncertainty. At the same time, the difference between the mitigation pathways is on the order of the changes at mid-century and is much larger towards the end of the century.</p>", "<p id=\"Par40\">For bottom dissolved oxygen, the situation is much less clear. While, on average, a decrease in seafloor oxygen is visible from the time series, some areas show an increase in oxygen for the ensemble mean (most evident in the Aegean Sea); interannual variability and, particularly, model uncertainty is high in these areas. Areas of oxygen decrease, on the contrary, emerge from interannual variability with changes slightly higher than the model uncertainty, although with some regional exceptions. Similarly, changes in scenario play a much more important role in areas of oxygen increase compared to areas of decrease. In the latter areas, differences among the scenarios were relatively small compared to the magnitude of the induced decrease in oxygen.</p>", "<title>North Sea</title>", "<p id=\"Par41\">The basin-scale mean evolution of greenhouse gas-induced changes in physical and biogeochemical pressures of the wider North Sea area (Fig. ##FIG##6##7##) is comparable to the Mediterranean Sea. Warming is, however, less accentuated in the North Sea compared to the Mediterranean Sea, with only a 3.0 °C increase projected at the end of the century for the no-mitigation scenario SSP5-8.5 and &lt; 1.0 °C for the moderate and strong mitigation scenarios. Acidification ranges from slightly less than 0.1 units (SSP1-2.6) to around 0.5 units of decrease in surface pH (SPP5-8.5), while seafloor oxygen decrease by ~ 0.1–0.3 ml/l) with interannual variability up to ~ 0.2 ml/l).</p>", "<p id=\"Par42\">Considering the spatial distribution of changes and uncertainties (Figs. ##FIG##7##8##, ##FIG##8##9##) warming is strongest towards the Eastern parts of the European shelf and comparatively weak towards the open Atlantic Ocean. On most of the continental shelf, however, these trends are comparatively weak with respect to interannual variability and model uncertainty (ratio is only slightly &gt; 1). The differences between the scenario pathways are only of minor importance at mid-century (approximately 1/3 of the change signal across the basin) but eventually reach about the same order of magnitude as those induced by long-term changes. Seafloor oxygen in the ensemble average changes noticeably only in the open ocean areas along the shelf break, where dissolved oxygen declines by up to 1 ml/l. These changes begin to emerge at mid-century but only become significant towards the end of the century. The difference in changes between greenhouse gas scenarios is minor, even towards the end of the century.</p>", "<title>Bay of Biscay</title>", "<p id=\"Par43\">In the area around the Bay of Biscay, the domain averages roughly followed the patterns observed in the two previous regions with strong continuous warming up to 3.0 °C by 2100 and acidification of 0.4 pH units for SSP5-8.5 (Fig. ##FIG##9##10##). These changes are attenuated in the other two (moderate to strong mitigation) scenarios. For example, pH does not decrease but increases somewhat in the second half of the century for SSP1-2.6. Acidification trends were strongly significant, while the warming trends emerged less clearly due to considerable model uncertainty (~ 1.5° to 3.5°), particularly for the two pathways producing weaker changes. Deoxygenation shows considerable model (~ 0.4–0.5 ml/l) and interannual (up to 0.2 ml/l) variability. The trend in deoxygenation are minimal or absent for the strongest (SSP5-8.5) scenario through 2040, followed by a few years of strong interannual variability and a rapid decline that continues through the end of this century. There is a weaker, more continuous deoxygenation in the other two scenarios, similar to patterns in the North and Mediterranean Seas. The unexpected observed climate variability across scenarios could be indicative of infrequent and quasi-stochastic regime shifts which are an expected component of natural variability<sup>##UREF##28##34##</sup>. Still, filtering out the inter-annual variability suggests that the trend is consistent across the scenarios.</p>", "<p id=\"Par44\">The spatial distribution of these average patterns in the domain (Figs. ##FIG##10##11##, ##FIG##11##12##) indicated the Northern coast of the Iberian Peninsula and the northern coast of Brittany as hotspots of surface warming, with the former particularly strong in the mid-term (up to 1°) and the latter particularly strong in the long-term (almost 2°). Relative to interannual variability and model uncertainty, however, this warming is only slightly emergent in the mid-term, while both interannual and model uncertainties are high in the deeper Atlantic waters. In the long-term, changes become significant with respect to interannual variability, while model uncertainty remains persistent through the end of the century. Consistent with patterns in the other regional seas, differences in scenario pathways in warming are small in the mid-term, while in the long-term, the different mitigation strategies will lead to differences in warming of the same order of magnitude as the change itself. Oxygen is expected to increase on the Celtic and Armorican shelfs although the three sources of uncertainty remain high for both mid and long term. While in the deeper Atlantic waters and the coastal waters of northern Spain and the western coast of Portugal oxygen will decrease, and changes are significant with respect to interannual variability. For model and scenario uncertainty changes in oxygen are pre-dominantly significant with exceptions such as the inner coastal domain of Portugal which is dominated by upwelling and more complex oceanographic processes. Acidification trends are comparatively homogeneous across the domain, with somewhat stronger trends in the off-shelf areas of the North-Eastern Atlantic. This pattern is consistent between the two time slices; however, acidification is about 50% higher at the end of the century compared to the mid-century. The trends are strongly significant with respect to model uncertainty and interannual variability for both time slices. The difference between scenarios is of the same order of magnitude as the induced changes at mid-century, while at the end of the century, the mitigation pathways become increasingly important as the difference between scenarios reaches twice the magnitude of the change signal.</p>", "<title>Baltic Sea</title>", "<p id=\"Par45\">While the basin mean warming, acidification, and deoxygenation trends are also present in the Baltic Sea, their behaviour and relation to uncertainty are substantially different in this coastal, semi-enclosed basin compared to the other regions. A fundamental difference is the large model uncertainty (up to 0.8 pH units) and increased interannual variability (up to 0.05 units) of surface pH with respect to the induced changes (0.1–0.5 pH units) (Fig. ##FIG##12##13##). In addition, the deoxygenation change (~ 0.2 ml/l) here is significantly weaker, and interannual variability is significantly higher (up to 0.5 ml/l). Warming trends (2–5 °C), by contrast, are comparable to the other basins.</p>", "<p id=\"Par46\">Looking at regional differences in these trends (Figs. ##FIG##13##14##, ##FIG##14##15##), warming in the ensemble average of the Baltic Sea for scenario SSP2-4.5 at mid-century is strongest in the Bothnian Sea and the Gulf of Riga and weakest at the margins of the Bothnian Bay and the Southern Baltic Proper. This pattern also persists at the end of the century with the two warming hotspots spreading into the Northern Baltic Proper. Compared to interannual variability and model uncertainty, the trends only weakly emerge across the basin. Differences between mitigation pathways are negligible at mid-century but reach the order of magnitude of the induced changes by 2100. For acidification, which is strongest in the Bothnian Bay, there is a clear distinction in the impact of interannual variability and model uncertainty on the significance of the mid-and long-term trend. While trends clearly emerge from interannual variability, they are subject to model uncertainty, as was visible already in the basin average time series that reaches more than twice the level of the trend.</p>", "<p id=\"Par47\">The bottom oxygen concentration at mid-century reveals deoxygenation across the whole basin except for a small region of increase in oxygen north of Gotland that extends to the whole Gotland Basin at the end of the century. It should be noted, however, that these changes are comparatively uncertain with respect to interannual variability and model uncertainty across the entire Baltic Sea and are particularly uncertain in oxygen increase. This area is also the only area in which scenario differences in oxygen trends are larger than the actual oxygen trend, making it an area of uncertain outcome in all aspects.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par48\">Many governments have made Nature-based Solutions ecosystem-based management, habitat restoration, and adaptive marine spatial planning a core part of their climate adaptation and planning<sup>##UREF##29##35##</sup>. However, such efforts demand accounting for impacts of costal biological and physical ocean dynamics and variability which further requires biophysical model results that are at a finer resolution than the CMIP outputs. Statistical downscaling can provide the necessary data to perform rapid analysis including estimates of the uncertainties involved while ensuring high skill when compared with historical observations. Our results suggest warming is evident across all regions, fully emerging from the background uncertainties related to internal variability and model differences in the second half of the century, with substantial differences between the mitigation pathways. Acidification significantly emerges from model uncertainty and internal variability in the historical climate, while the different climate mitigation scenarios lead to distinct trajectories in surface pH before mid-century. Although deoxygenation appears to be present across all domains, the signal is weaker compared to temperature and pH in terms of model uncertainty and internal variability, and the impact of different greenhouse gas trajectories is much less distinct. These qualitative characteristics vary considerably in extent and exhibit substantial local heterogeneity within each domain, underlining the importance of a spatially explicit and high-resolution approach to providing projections of the impacts of anthropogenic climate change on marine ecosystem components, functions, and services.</p>", "<p id=\"Par49\">Statistically downscaled ensemble products, such as the one presented here, can be useful for calculating exposure terms for climate risk assessments performed across large areas, such as that conducted for threatened species within marine protected areas throughout the Mediterranean<sup>##UREF##30##36##</sup> or for fisheries across European regional seas<sup>##REF##34583987##37##</sup>. Ongoing studies along the European coastline are utilizing downscaled climate data to better understand how preservation of natural habitat-forming species such as mangroves, seagrasses, kelp forests, or coral reefs can buffer impacts from storms, and sea-level rise, as well as contribute as carbon sinks. In some cases, first-hand knowledge of the oceanography and marine biogeochemistry of an area is essential to decide whether an ensemble climate product is representative of an area. Here we use a model reanalysis, the GLORYS12V1 at 1/12th degree resolution, for the ocean physics and a model hindcast, the GOBH at ¼ degree resolution, for the biogeochemistry as a baseline for the bias-correction and downscaling, which particularly in the Baltic Sea is too coarse to resolve many of the local features. In addition, the performance of the downscaling will be limited by the skill of the hindcast GOBH model. Still, we argue that, for biogeochemical variables, model hindcasts are currently the only comprehensive datasets consistently available across the regions and vertical layers of this study, even though efforts to fill this gap are ongoing, e.g., via reanalysis products and extrapolation of observational datasets using artificial intelligence. We believe that the downscaled product nevertheless substantially improves upon the original CMIP6 models for the same region. Future improvements can be made if an enhanced biological hindcast, reanalysis or observational products are developed at sufficient resolution and time coverage.</p>", "<p id=\"Par50\">Generally, the utilization of ocean biogeochemical models for understanding the fluctuations and transformations in marine environments, arising from both natural and human-induced influences, has surged in recent decades. The growth in the use of these tools can be attributed to the emergence of computers capable of executing trillions of calculations within seconds, resulting in global high-resolution ocean reanalyses such as GLORYS12V1, providing researchers detailed information on the marine environment. Still, to perform global future projections at high spatial resolution, the cost and time required is considerable. In fact, an increase in horizontal resolution by a factor of two increases the computational cost by ten<sup>##UREF##31##38##</sup>. Instead, we rely on global coarse resolution models that provide less detail but are faster to run, which can be further downscaled locally to hold a proper resolution useful for projecting coastal processes. Most often, these downscaled models are dynamic, meaning that they calculate the full set of hydrodynamic equations for a limited domain and use the coarse-resolution global models as boundary forcing. Using dynamical models for simulating one model domain is time-consuming and expensive. As a result, dynamical models are often constrained to downscale a few, or a small subset, of global climate models and scenarios, which limits their flexibility and hampers an assessment of sources of uncertainty. Alternatively, the statistical downscaling described in this study, provides a more rapid way of assessing local coastal impacts of climate change for a subset of relevant variables. While both dynamic and statistical approaches have their advantages and disadvantages, they are complementary. For example, one can apply a statistical downscaling approach to effectively gain an understanding of expected coastal climate impacts across a range of scenarios and climate models as has been done here for European regional seas. These findings can inform the selection of locations that require a more refined dynamical model for a comprehensive assessment of the three-dimensional effects of climate change on local ecosystems. This knowledge facilitates the optimal utilization of models and strategic application to enhance scientific efforts in understanding and addressing future ecological impacts.</p>", "<p id=\"Par51\">Statistical downscaling has shortcomings that must be recognized when using the ensemble data. First, for the dataset presented here, we limit downscaling to individual depth levels. This limits analysis to two dimensions instead of three, which, as one example, is acceptable if you are analysing shellfish distributions under changing environmental conditions<sup>##UREF##32##39##</sup>, but inadequate if you need to understand the vertical distribution of a diel vertical migrator like krill. The DQM methodology also assumes that the biases at quantiles are stationary in time i.e., the functional relationship between the observed values and the GCM/ESM for the historical time period holds for the future<sup>##UREF##4##9##</sup>. This assumption can cause problems with extreme values as their historical distribution is expected to continue in the future when we know that climate change can lead to novel non-linear states<sup>##REF##35973999##40##</sup>. In a recent paper the DQM approach was a favoured methodology as it preserved the climate change signal and trend<sup>##UREF##33##41##</sup> compared to other methods like traditional Quantile Mapping (QM<sup>##UREF##4##9##</sup>) where the mean of the raw climate change signal (CCS) is not preserved but altered to correct for biases in the GCM/ESM. Choosing DQM suggests that you have confidence in the GCM/ESM circulation pattern and skill, as the resulting downscaling will maintain the inherent CCS<sup>##UREF##4##9##</sup>. Challenges with statistical downscaling, such as inflating or deflating extreme values during downscaling, and considerations as what should be regarded as best practice is an ongoing process where new developments and approaches are published frequently<sup>##UREF##34##42##–##UREF##36##44##</sup>. In addition, dynamical downscaling becomes fundamental when dynamic consistency across multiple variables is required in the downstream applications, such as subsequent modelling studies that require the coherent representation of dynamic features that may be lost across variables applying statistical approaches.</p>", "<p id=\"Par52\">Regional downscaling provides detailed local climate projections for researchers, stakeholders, and management entities to understand, mitigate, and adapt to climate change. Choosing between dynamical and statistical downscaling depends on the application and research question(s). A dynamical model is effective for understanding a region's structure and dynamics under climate change but is subject to bias<sup>##UREF##3##8##</sup> and lacks the breadth and coordinated protocols of global experiments. These characteristics hinder the ability to conduct a thorough evaluation of sources for proper uncertainty assessment, thereby limiting confidence in the projections. Statistical downscaling is a good alternative, particularly when applied to individual variables or depth levels, but lacks dynamic consistency and probably will not predict unobserved phenomena (e.g., synergistic, or antagonistic multivariate processes). Despite its widespread use in atmospheric science<sup>##UREF##34##42##,##UREF##35##43##,##UREF##37##45##</sup>, statistical downscaling is rarely applied to ocean models<sup>##UREF##38##46##</sup>. In fact, to our knowledge, this is the first ocean downscaling that uses a detrended quantile mapping approach to downscale both physical and biogeochemical ocean properties. This downscaling provided climate projections at a regional scale across all European waters across a range of climate models and scenarios at reasonable computational cost.</p>" ]
[]
[ "<p id=\"Par1\">Climate change impact studies need climate projections for different scenarios and at scales relevant to planning and management, preferably for a variety of models and realizations to capture the uncertainty in these models. To address current gaps, we statistically downscaled (SD) 3–7 CMIP6 models for five key indicators of marine habitat conditions: temperature, salinity, pH, oxygen, and chlorophyll across European waters for three climate scenarios SSP1-2.6, SSP2-4.5, and SSP5-8.5. Results provide ensemble averages and uncertainty estimates that can serve as input data for projecting the potential success of a range of Nature-based Solutions, including the restoration of habitat-forming species such as seagrass in the Mediterranean and kelp in coastal areas of Portugal and Norway. Evaluation of the ensemble with observations from four European regions (North Sea, Baltic Sea, Bay of Biscay, and Mediterranean Sea) indicates that the SD projections realistically capture the climatological conditions of the historical period 1993–2020. Model skill (Liu-mean efficiency, Pearson correlation) clearly improves for both surface temperature and oxygen across all regions with respect to the original ESMs demonstrating a higher skill for temperature compared to oxygen. Warming is evident across all areas and large differences among scenarios fully emerge from the background uncertainties related to internal variability and model differences in the second half of the century. Scenario-specific differences in acidification significantly emerge from model uncertainty and internal variability leading to distinct trajectories in surface pH starting before mid-century (in some cases starting from present day). Deoxygenation is also present across all domains, but the climate signal was significantly weaker compared to the other two indicators when compared to model uncertainty and internal variability, and the impact of different greenhouse gas trajectories is less distinct. The substantial regional and local heterogeneity in these three abiotic indicators underscores the need for highly spatially resolved physical and biogeochemical projections to understand how climate change may impact marine ecosystems.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51160-1.</p>", "<title>Acknowledgements</title>", "<p>We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP. The SD dataset was produced as an EU deliverable from the FutureMARES—Climate Change and Future Marine Ecosystem Services and Biodiversity (869300) European Commission grant. The dataset was generated using E.U. Copernicus Marine Service Information; 10.48670/moi-00021, 10.48670/moi-00019. Version 1 was distributed on May 24, 2022, and version 2 is planned to be distributed in spring 2024. The datasets are distributed under Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.</p>", "<title>Author contributions</title>", "<p>We declare that all the authors contributed to preparing the manuscript. T.K. prepared the downscaled data, T.K., M.B., and M.P. analyzed the data, prepared the figures, wrote the manuscript, and formatted the final NetCDF files.</p>", "<title>Data availability</title>", "<p>The ensemble projections datasets covering European waters for three scenarios, SSP1-2.6, SSP2-4.5, and SSP5-8.5, are available on Zenodo DOI: 10.5281/zenodo.6523925<sup>##UREF##39##47##</sup> and from individual DOIs for each region: (1) North Sea: 10.5281/zenodo.6523926 (2) Mediterranean Sea: 10.5281/zenodo.6523899 (3) Baltic Sea: 10.5281/zenodo.6524111 (4) Bay of Biscay: 10.5281/zenodo.6524142.</p>", "<title>Competing interests</title>", "<p id=\"Par53\">TK is a co-founder and the CTO of Actea Inc (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.actea.earth/\">https://www.actea.earth/</ext-link>), which performed the downscaling of the data on behalf of the Norwegian Institute for Water Research (NIVA) as part of the EU FutureMARES project. The statistical downscaling methods are the patent-pending intellectual property of Actea, Inc. All other authors declare that they do not have any competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Map showing the four European focus regions of FutureMARES where statistical downscaling of CMIP6 projections was applied: the Baltic Sea, the North Sea, the Bay of Biscay, and the Mediterranean Sea. The Black Sea is not included in the Mediterranean region.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Comparison between the ensemble (blue) downscaled bottom temperature (thetao (°C)) and observations (orange) extracted from the ICES (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ices.dk\">www.ices.dk</ext-link>) and GLODAP databases<sup>##UREF##23##29##</sup>. For the Baltic Sea (upper left), the North Sea (upper right), and the Bay of Biscay (lower left) we used data from ICES for the comparison, while for the Mediterranean Sea we used GLODAP<sup>##UREF##22##28##</sup>. The comparison used all available data for the period 1993–2020. The frequency diagrams indicate the overlap in distributional value range (top) and depth (left side) between the observations and the downscaled data.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Comparison between the ensemble (blue) downscaled bottom oxygen (O<sub>2</sub> (ml/l)) and shipboard observations (orange) extracted from the ICES (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ices.dk\">www.ices.dk</ext-link>) and the GLODAP databases<sup>##UREF##22##28##</sup>. For the Baltic Sea (upper left), the North Sea (upper right), and the Bay of Biscay (lower left) we used data from ICES for the comparison, while for the Mediterranean Sea we used GLODAP. The comparison uses all available data for the period 1993–2020. The frequency diagrams indicate the overlap in distributional value range (top) and depth (left side) between the observations and the downscaled data.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Time series of Mediterranean Sea average surface temperature (°C), pH, and bottom oxygen (ml/l) over the historical time period and the three scenarios. Solid lines show the ensemble, and shaded areas show the ensemble spread based on the 2.5 and 97.5 percentiles of the model distributions.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>The magnitude of mid-term changes in the Mediterranean Sea under SSP2-4.5, against three sources of uncertainty for three ecosystem indicators. From left to right: changes between mid-term conditions (2041–2060 mean) and present-day conditions (1995–2014); changes relative to internal variability; changes relative to model uncertainty; changes relative to scenario uncertainty. Top to bottom: Surface Temperature (K); surface pH; bottom dissolved oxygen (ml/l).</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Strength of long-term climate-driven changes in the Mediterranean Sea under SSP2-4.5, against three sources of uncertainty for three ecosystem variables. From left to right: changes between long-term conditions (2081–2100 mean) and present-day conditions (1995–2014); changes relative to internal variability; changes relative to model uncertainty; changes relative to scenario uncertainty. Top to bottom: Surface Temperature (K); surface pH; bottom dissolved oxygen (ml/l).</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>Time series of North Sea average surface temperature (°C), pH, and bottom oxygen (ml/l) over the historical time period and the three scenarios. Solid lines show the ensemble, and shaded areas show the ensemble spread based on the 2.5 and 97.5 percentiles of the model distributions.</p></caption></fig>", "<fig id=\"Fig8\"><label>Figure 8</label><caption><p>Significance of mid-term changes in the North Sea under SSP2-4.5, against three sources of uncertainty for three ecosystem indicators. From left to right: changes between mid-term conditions (2041–2060 mean) and present-day conditions (1995–2014); changes relative to internal variability; changes relative to model uncertainty; changes relative to scenario uncertainty. Top to bottom: Surface Temperature (K); surface pH; bottom dissolved oxygen (ml/l).</p></caption></fig>", "<fig id=\"Fig9\"><label>Figure 9</label><caption><p>Significance of long-term changes in the North Sea under SSP2-4.5, against three sources of uncertainty for three ecosystem indicators. From left to right: changes between long-term conditions (2081–2100 mean) and present-day conditions (1995–2014); changes relative to internal variability; changes relative to model uncertainty; changes relative to scenario uncertainty. Top to bottom: Surface Temperature (K); surface pH; bottom dissolved oxygen (ml/l).</p></caption></fig>", "<fig id=\"Fig10\"><label>Figure 10</label><caption><p>Time series of the Bay of Biscay average surface temperature (°C), pH, and bottom oxygen (ml/l) over the historical time period and the three scenarios. Solid lines show the ensemble, and shaded areas show the ensemble spread based on the 2.5 and 97.5 percentiles of the model distributions.</p></caption></fig>", "<fig id=\"Fig11\"><label>Figure 11</label><caption><p>Significance of mid-term changes in the Bay of Biscay under SSP2-4.5, against three sources of uncertainty for three ecosystem indicators. From left to right: changes between mid-term conditions (2041–2060 mean) and present-day conditions (1995–2014); changes relative to internal variability; changes relative to model uncertainty; changes relative to scenario uncertainty. Top to bottom: Surface Temperature (K); surface pH; bottom dissolved oxygen (ml/l).</p></caption></fig>", "<fig id=\"Fig12\"><label>Figure 12</label><caption><p>Significance of long-term changes in the Bay of Biscay under SSP2-4.5, against three sources of uncertainty for three ecosystem indicators. From left to right: changes between long-term conditions (2081–2100 mean) and present-day conditions (1995–2014); changes relative to internal variability; changes relative to model uncertainty; changes relative to scenario uncertainty. Top to bottom: Surface Temperature (K); surface pH; bottom dissolved oxygen (ml/l).</p></caption></fig>", "<fig id=\"Fig13\"><label>Figure 13</label><caption><p>Time series of Baltic Sea average surface temperature (॰C), pH, and bottom oxygen (ml/l) over the historical time slice and the three scenarios. Full lines show the ensemble, and shaded areas show the ensemble spread based on the 2.5 and 97.5 percentiles of the model distribution.</p></caption></fig>", "<fig id=\"Fig14\"><label>Figure 14</label><caption><p>Significance of mid-term changes in the Baltic Sea under SSP2-4.5, against three sources of uncertainty for three ecosystem indicators. From left to right: changes between mid-term conditions (2041–2060 mean) and present-day conditions (1995–2014); changes relative to internal variability; changes relative to model uncertainty; changes relative to scenario uncertainty. Top to bottom: Surface Temperature (K); surface pH; bottom dissolved oxygen (ml/l).</p></caption></fig>", "<fig id=\"Fig15\"><label>Figure 15</label><caption><p>Significance of long-term changes in the Baltic Sea under SSP2-4.5, against three sources of uncertainty for three ecosystem indicators. From left to right: changes between long-term conditions (2081–2100 mean) and present-day conditions (1995–2014); changes relative to internal variability; changes relative to model uncertainty; changes relative to scenario uncertainty. Top to bottom: Surface Temperature (K); surface pH; bottom dissolved oxygen (ml/l).</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Climate scenarios, realizations, and variables downscaled for each CMIP6 model used to create the ensembles.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Model name</th><th align=\"left\" rowspan=\"2\">Realization</th><th align=\"left\" colspan=\"15\">SSP1-2.6, SSP2-4.5, and SSP5-8.5</th></tr><tr><th align=\"left\" colspan=\"3\">O<sub>2</sub></th><th align=\"left\" colspan=\"3\">Temperature</th><th align=\"left\" colspan=\"3\">Chlorophyll</th><th align=\"left\" colspan=\"3\">pH</th><th align=\"left\" colspan=\"3\">Salinity</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"2\"><p>IPSL-CM6A-LR</p><p>(Boucher et al., 2020)</p></td><td align=\"left\">r1i1p1f1</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td></tr><tr><td align=\"left\">r3i1p1f1</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td></tr><tr><td align=\"left\" rowspan=\"2\"><p>MPI-ESM1-2-LR</p><p>(Mauritsen et al., 2019)</p></td><td align=\"left\">r1i1p1f1</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\"/><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td></tr><tr><td align=\"left\">r2i1p1f1</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td></tr><tr><td align=\"left\"><p>GFDL-ESM4</p><p>(Dunne et al., 2020)</p></td><td align=\"left\">r1i1p1f1</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td></tr><tr><td align=\"left\"><p>CMCC-ESM2</p><p>(Lovato et al., 2022)</p></td><td align=\"left\">r1i1p1f1</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td></tr><tr><td align=\"left\"><p>CMCC-CM2-SR5</p><p>(Cherchi et al., 2018)</p></td><td align=\"left\">r1i1p1f1</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/><td align=\"left\">x</td><td align=\"left\">x</td><td align=\"left\">x</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Liu-mean efficiency of the statistical downscaling products for surface temperature (thetao (°C)) and surface oxygen (O<sub>2</sub> (ml/l)) for each basin.</p></caption></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Liu-mean efficiency of the original earth system models for surface temperature (thetao (°C)) and surface oxygen (O<sub>2</sub> (ml/l)) for each basin.</p></caption></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^\\circ$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:msup><mml:mrow/><mml:mo>∘</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^\\circ$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:msup><mml:mrow/><mml:mo>∘</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equa\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$LSE = 1 - \\sqrt {\\left( {\\rho \\alpha - 1} \\right)^{2} + \\left( {\\beta - 1} \\right)^{2} } ,$$\\end{document}</tex-math><mml:math id=\"M6\" display=\"block\"><mml:mrow><mml:mi>L</mml:mi><mml:mi>S</mml:mi><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msqrt><mml:mrow><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>ρ</mml:mi><mml:mi>α</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>β</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>The evaluation is based on present-day seasonal averages against WOA climatology.</p></table-wrap-foot>", "<table-wrap-foot><p>The evaluation is based on present-day seasonal averages against WOA climatology.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<inline-graphic xlink:href=\"41598_2024_51160_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51160_Article_IEq2.gif\"/>", "<graphic xlink:href=\"41598_2024_51160_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51160_Article_Equa.gif\" position=\"anchor\"/>", "<graphic position=\"anchor\" xlink:href=\"41598_2024_51160_Tab2_HTML\" id=\"MO2\"/>", "<graphic position=\"anchor\" xlink:href=\"41598_2024_51160_Tab3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51160_Fig2_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51160_Fig3_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2024_51160_Fig4_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"41598_2024_51160_Fig5_HTML\" id=\"MO7\"/>", "<graphic xlink:href=\"41598_2024_51160_Fig6_HTML\" id=\"MO8\"/>", "<graphic xlink:href=\"41598_2024_51160_Fig7_HTML\" id=\"MO9\"/>", "<graphic xlink:href=\"41598_2024_51160_Fig8_HTML\" id=\"MO10\"/>", "<graphic xlink:href=\"41598_2024_51160_Fig9_HTML\" id=\"MO11\"/>", "<graphic xlink:href=\"41598_2024_51160_Fig10_HTML\" id=\"MO12\"/>", "<graphic xlink:href=\"41598_2024_51160_Fig11_HTML\" id=\"MO13\"/>", "<graphic xlink:href=\"41598_2024_51160_Fig12_HTML\" id=\"MO14\"/>", "<graphic xlink:href=\"41598_2024_51160_Fig13_HTML\" id=\"MO15\"/>", "<graphic xlink:href=\"41598_2024_51160_Fig14_HTML\" id=\"MO16\"/>", "<graphic xlink:href=\"41598_2024_51160_Fig15_HTML\" id=\"MO17\"/>" ]
[ "<media xlink:href=\"41598_2024_51160_MOESM1_ESM.docx\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["1."], "mixed-citation": ["IPCC, 2019: Summary for Policymakers. In: "], "italic": ["IPCC Special Report on the Ocean and Cryosphere in a Changing Climate"]}, {"label": ["5."], "surname": ["Breitburg"], "given-names": ["D"], "article-title": ["Declining oxygen in the global ocean and coastal waters"], "source": ["Science"], "year": ["2018"], "volume": ["359"], "fpage": ["7240"], "pub-id": ["10.1126/science.aam7240"]}, {"label": ["6."], "surname": ["Tebaldi"], "given-names": ["C"], "article-title": ["Climate model projections from the scenario model intercomparison project (ScenarioMIP) of CMIP6"], "source": ["Earth Syst. Dyn."], "year": ["2021"], "volume": ["12"], "fpage": ["253"], "lpage": ["293"], "pub-id": ["10.5194/esd-12-253-2021"]}, {"label": ["8."], "surname": ["Drenkard"], "given-names": ["EJ"], "article-title": ["Next-generation regional ocean projections for living marine resource management in a changing climate"], "source": ["ICES J. Mar. Sci."], "year": ["2021"], "volume": ["78"], "fpage": ["1969"], "lpage": ["1987"], "pub-id": ["10.1093/icesjms/fsab100"]}, {"label": ["9."], "surname": ["Lehner", "Nadeem", "Formayer"], "given-names": ["F", "I", "H"], "year": ["2021"], "data-title": ["Evaluating quantile-based bias adjustment methods for climate change scenarios"], "source": ["Hydrol. Earth Syst. Sci. Discuss."], "pub-id": ["10.5194/hess-2021-498"]}, {"label": ["10."], "surname": ["Jean-Michel"], "given-names": ["L"], "article-title": ["The copernicus global 1/12\u00b0 oceanic and sea ice GLORYS12 reanalysis"], "source": ["Front Earth Sci. Chin."], "year": ["2021"], "volume": ["9"], "fpage": ["698876"], "pub-id": ["10.3389/feart.2021.698876"]}, {"label": ["11."], "surname": ["Asplin", "Albretsen", "Johnsen", "Sandvik"], "given-names": ["L", "J", "IA", "AD"], "article-title": ["The hydrodynamic foundation for salmon lice dispersion modeling along the Norwegian coast"], "source": ["Ocean Dyn."], "year": ["2020"], "volume": ["70"], "fpage": ["1151"], "lpage": ["1167"], "pub-id": ["10.1007/s10236-020-01378-0"]}, {"label": ["12."], "surname": ["Pozo Buil"], "given-names": ["M"], "article-title": ["A dynamically downscaled ensemble of future projections for the California current system"], "source": ["Front. Mar. Sci."], "year": ["2021"], "volume": ["8"], "fpage": ["612874"], "pub-id": ["10.3389/fmars.2021.612874"]}, {"label": ["13."], "surname": ["Alexander", "Shin", "Scott", "Curchitser", "Stock"], "given-names": ["MA", "S-I", "JD", "E", "C"], "article-title": ["The response of the Northwest Atlantic Ocean to climate change"], "source": ["J. Clim."], "year": ["2020"], "volume": ["33"], "fpage": ["405"], "lpage": ["428"], "pub-id": ["10.1175/JCLI-D-19-0117.1"]}, {"label": ["14."], "mixed-citation": ["Jones, B. "], "italic": ["et al."]}, {"label": ["15."], "mixed-citation": ["Zhuang, J. "], "italic": ["et al. pangeo-data/xESMF: v0.7.1"]}, {"label": ["16."], "mixed-citation": ["Busecke, J., Ritschel, M., Maroon, E., Nicholas, T. & Readthedocs-Assistant. "], "italic": ["jbusecke/xMIP: v0.7.1"]}, {"label": ["17."], "surname": ["Hempel", "Frieler", "Warszawski", "Schewe", "Piontek"], "given-names": ["S", "K", "L", "J", "F"], "article-title": ["A trend-preserving bias correction\u2014The ISI-MIP approach"], "source": ["Earth Syst. Dyn."], "year": ["2013"], "volume": ["4"], "fpage": ["219"], "lpage": ["236"], "pub-id": ["10.5194/esd-4-219-2013"]}, {"label": ["18."], "surname": ["Cannon", "Sobie", "Murdock"], "given-names": ["AJ", "SR", "TQ"], "article-title": ["Bias correction of GCM precipitation by quantile mapping: How well do methods preserve changes in quantiles and extremes?"], "source": ["J. Clim."], "year": ["2015"], "volume": ["28"], "fpage": ["6938"], "lpage": ["6959"], "pub-id": ["10.1175/JCLI-D-14-00754.1"]}, {"label": ["19."], "mixed-citation": ["Dr\u00e9villon, M. "], "italic": ["et al.", "copernicus.eu"]}, {"label": ["20."], "mixed-citation": ["Perruche, C., Szczypta, C., Paul, J. & Dr\u00e9villon, M. QUID for Global Ocean Biogeochemistry Hindcast (2019)."]}, {"label": ["21."], "surname": ["Brunner", "Lorenz", "Zumwald", "Knutti"], "given-names": ["L", "R", "M", "R"], "article-title": ["Quantifying uncertainty in European climate projections using combined performance-independence weighting"], "source": ["Environ. Res. Lett."], "year": ["2019"], "volume": ["14"], "fpage": ["124010"], "pub-id": ["10.1088/1748-9326/ab492f"]}, {"label": ["22."], "surname": ["O\u2019Neill"], "given-names": ["BC"], "article-title": ["The scenario model intercomparison project (ScenarioMIP) for CMIP6"], "source": ["Geosci. Model Dev."], "year": ["2016"], "volume": ["9"], "fpage": ["3461"], "lpage": ["3482"], "pub-id": ["10.5194/gmd-9-3461-2016"]}, {"label": ["24."], "mixed-citation": ["Boyer, T. P. "], "italic": ["et al."], "ext-link": ["https://www.ncei.noaa.gov/archive/accession/ncei-woa18"]}, {"label": ["25."], "surname": ["Nash", "Sutcliffe"], "given-names": ["JE", "JV"], "article-title": ["River flow forecasting through conceptual models part I\u2014A discussion of principles"], "source": ["J. Hydrol. (Amst.)"], "year": ["1970"], "volume": ["10"], "fpage": ["282"], "lpage": ["290"], "pub-id": ["10.1016/0022-1694(70)90255-6"]}, {"label": ["26."], "surname": ["Gupta", "Kling", "Yilmaz", "Martinez"], "given-names": ["HV", "H", "KK", "GF"], "article-title": ["Decomposition of the mean squared error and NSE performance criteria: Implications for improving hydrological modelling"], "source": ["J. Hydrol. (Amst.)"], "year": ["2009"], "volume": ["377"], "fpage": ["80"], "lpage": ["91"], "pub-id": ["10.1016/j.jhydrol.2009.08.003"]}, {"label": ["27."], "surname": ["Liu"], "given-names": ["D"], "article-title": ["A rational performance criterion for hydrological model"], "source": ["J. Hydrol."], "year": ["2020"], "volume": ["590"], "fpage": ["125488"], "pub-id": ["10.1016/j.jhydrol.2020.125488"]}, {"label": ["28."], "surname": ["Lauvset"], "given-names": ["SK"], "article-title": ["GLODAPv2.2022: the latest version of the global interior ocean biogeochemical data product"], "source": ["Earth Syst. Sci. Data"], "year": ["2022"], "volume": ["14"], "fpage": ["5543"], "lpage": ["5572"], "pub-id": ["10.5194/essd-14-5543-2022"]}, {"label": ["29."], "surname": ["Lauvset"], "given-names": ["SK"], "year": ["2022"], "data-title": ["GLODAPv2.2022: The latest version of the global interior ocean biogeochemical data product"], "source": ["Earth Syst. Data Discuss."], "pub-id": ["10.5194/essd-2022-293"]}, {"label": ["30."], "surname": ["Hawkins", "Sutton"], "given-names": ["E", "R"], "article-title": ["The potential to narrow uncertainty in regional climate predictions"], "source": ["Bull. Am. Meteorol. Soc."], "year": ["2009"], "volume": ["90"], "fpage": ["1095"], "lpage": ["1108"], "pub-id": ["10.1175/2009BAMS2607.1"]}, {"label": ["31."], "surname": ["Fr\u00f6licher", "Rodgers", "Stock", "Cheung"], "given-names": ["TL", "KB", "CA", "WWL"], "article-title": ["Sources of uncertainties in 21st century projections of potential ocean ecosystem stressors"], "source": ["Glob. Biogeochem. Cycles"], "year": ["2016"], "volume": ["30"], "fpage": ["1224"], "lpage": ["1243"], "pub-id": ["10.1002/2015GB005338"]}, {"label": ["32."], "mixed-citation": ["P\u00f6rtner, H. O., Roberts, D. C., Poloczanska, E. S., Mintenbeck, K., Tignor, M., Alegr\u00eda, A., Craig, M., Langsdorf, S., L\u00f6schke, S., M\u00f6ller, V., Okem, A. (eds.). IPCC, 2022: Summary for Policymakers. In:"], "italic": [" Climate Change 2022: Impacts, Adaptation, and Vulnerability. Contribution of Working Group II to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change"], "ext-link": ["https://report.ipcc.ch/ar6wg2/pdf/IPCC_AR6_WGII_SummaryForPolicymakers.pdf"]}, {"label": ["33."], "surname": ["Kwiatkowski"], "given-names": ["L"], "article-title": ["Twenty-first century ocean warming, acidification, deoxygenation, and upper-ocean nutrient and primary production decline from CMIP6 model projections"], "source": ["Biogeosciences"], "year": ["2020"], "volume": ["17"], "fpage": ["3439"], "lpage": ["3470"], "pub-id": ["10.5194/bg-17-3439-2020"]}, {"label": ["34."], "surname": ["Rudnick", "Davis"], "given-names": ["DL", "RE"], "article-title": ["Red noise and regime shifts"], "source": ["Deep Sea Res. Part I"], "year": ["2003"], "volume": ["50"], "fpage": ["691"], "lpage": ["699"], "pub-id": ["10.1016/S0967-0637(03)00053-0"]}, {"label": ["35."], "surname": ["O\u2019Leary"], "given-names": ["BC"], "article-title": ["Embracing nature-based solutions to promote resilient marine and coastal ecosystems"], "source": ["Nat. Based Solut."], "year": ["2023"], "volume": ["3"], "fpage": ["100044"], "pub-id": ["10.1016/j.nbsj.2022.100044"]}, {"label": ["36."], "surname": ["Chatzimentor", "Doxa", "Katsanevakis", "Mazaris"], "given-names": ["A", "A", "S", "AD"], "article-title": ["Are mediterranean marine threatened species at high risk by climate change?"], "source": ["Glob. Change Biol."], "year": ["2023"], "volume": ["29"], "fpage": ["1809"], "lpage": ["1821"], "pub-id": ["10.1111/gcb.16577"]}, {"label": ["38."], "surname": ["Chassignet", "Xu"], "given-names": ["EP", "X"], "article-title": ["On the importance of high-resolution in large-scale ocean models"], "source": ["Adv. Atmos. Sci."], "year": ["2021"], "volume": ["38"], "fpage": ["1621"], "lpage": ["1634"], "pub-id": ["10.1007/s00376-021-0385-7"]}, {"label": ["39."], "surname": ["Laurel"], "given-names": ["BJ"], "article-title": ["Pacific cod in the anthropocene: An early life history perspective under changing thermal habitats"], "source": ["Fish Fish (Oxf.)"], "year": ["2023"], "pub-id": ["10.1111/faf.12779"]}, {"label": ["41."], "surname": ["Casanueva"], "given-names": ["A"], "article-title": ["Testing bias adjustment methods for regional climate change applications under observational uncertainty and resolution mismatch"], "source": ["Atmos. Sci. Lett."], "year": ["2020"], "volume": ["21"], "fpage": ["e978"], "pub-id": ["10.1002/asl.978"]}, {"label": ["42."], "surname": ["Lange"], "given-names": ["S"], "article-title": ["Trend-preserving bias adjustment and statistical downscaling with ISIMIP3BASD (v1.0)"], "source": ["Geosci. Model Dev."], "year": ["2019"], "volume": ["12"], "fpage": ["3055"], "lpage": ["3070"], "pub-id": ["10.5194/gmd-12-3055-2019"]}, {"label": ["43."], "surname": ["Maraun", "Widmann"], "given-names": ["D", "M"], "source": ["Statistical Downscaling and Bias Correction for Climate Research"], "year": ["2018"], "publisher-name": ["Cambridge University Press"]}, {"label": ["44."], "surname": ["Maraun"], "given-names": ["D"], "article-title": ["Bias correction, quantile mapping, and downscaling: revisiting the inflation issue"], "source": ["J. Clim."], "year": ["2013"], "volume": ["26"], "fpage": ["2137"], "lpage": ["2143"], "pub-id": ["10.1175/JCLI-D-12-00821.1"]}, {"label": ["45."], "surname": ["Pierce", "Cayan", "Maurer", "Abatzoglou", "Hegewisch"], "given-names": ["DW", "DR", "EP", "JT", "KC"], "article-title": ["Improved bias correction techniques for hydrological simulations of climate change"], "source": ["J. Hydrometeorol."], "year": ["2015"], "volume": ["16"], "fpage": ["2421"], "lpage": ["2442"], "pub-id": ["10.1175/JHM-D-14-0236.1"]}, {"label": ["46."], "surname": ["Hermann"], "given-names": ["AJ"], "article-title": ["Projected biophysical conditions of the Bering Sea to 2100 under multiple emission scenarios"], "source": ["ICES J. Mar. Sci."], "year": ["2019"], "volume": ["76"], "fpage": ["1280"], "lpage": ["1304"], "pub-id": ["10.1093/icesjms/fsz111"]}, {"label": ["47."], "mixed-citation": ["Kristiansen, T. & Butensch\u00f6n, M. An ensemble of trend preserving statistically downscaled projections for key marine variables under three different future scenarios for the North Sea (2022). 10.5281/ZENODO.6523926"]}]
{ "acronym": [], "definition": [] }
47
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1209
oa_package/86/ad/PMC10786869.tar.gz
PMC10786870
38216622
[ "<title>Introduction</title>", "<p id=\"Par42\">Free convection relies on inherent buoyancy forces generated by thermal gradients to drive fluid motion and enable efficient heat transfer. Free convection optimizes the heat transfer processes in energy systems like solar collectors and power plants, reducing energy consumption and increasing system effectiveness. Industrial drying, cooling, and casting operations are made more efficient by free convection, in which molten metal is cast and solidified under better control. The electronics industry takes advantage of free convection by providing an innovative solution for reliable thermal management, effectively regulating the temperature of electronic components. Moreover, free convection is essential to the design and operation of heat exchangers and ventilation systems and contributes to our comprehension of complex environmental and geophysical phenomena<sup>##UREF##0##1##–##UREF##3##4##</sup>. Magnetohydrodynamics (MHD) represents an intriguing scientific field that improves the regulation of heat transmission, particularly in liquid metal cooling. MHD enables the use of magnetic fields to control electrically conducting fluids and enhance heat transfer processes. By applying a magnetic field, MHD induces electric currents that interact with the magnetic field, generating Lorentz forces that regulate fluid motion. The effective heat transfer made possible by this controlled fluid motion makes MHD a crucial component of advanced cooling systems for high-temperature applications. In several fields, such as nuclear power, aeronautical engineering, and advanced materials processing, where conventional cooling techniques may have limitations, MHD-based cooling systems have found applications<sup>##UREF##4##5##,##UREF##5##6##</sup>. On the other hand, the applications of thermal radiation span numerous sectors and industries. For the power sector, high-temperature operation, and aerospace applications, it is essential. Thermal radiation also plays a critical role in regulating energy transport, especially in polymer manufacturing. Furthermore, in solar energy-based industries, thermal radiation is employed in many applications, like solar energy collectors. Given the vast array of possibilities arising from the applications of free convection as well as the crucial functions of magnetic fields and thermal radiation in the realm of energy transfer, a multitude of numerical studies have delved into this issue. The findings of Sheikholeslami et al.’s<sup>##UREF##6##7##</sup> study demonstrated that an improvement in energy transport has a direct relationship with the radiation parameter. Additionally, the study found that the radiation parameter has a positive correlation with the Nusselt number. The results of El-Kabeir et al.<sup>##UREF##7##8##</sup> confirmed that as the magnetic force increases, both the skin-friction coefficient and heat transport rate decrease, while a contrasting pattern emerges when it comes to thermal radiation. As thermal radiation intensifies, an increase in the skin-friction coefficient and heat transport rate occurs. In a numerical study performed by Lone et al.<sup>##UREF##8##9##</sup>, it was revealed that an increase in the magnetic parameter amplifies velocity profiles in the x-direction while simultaneously diminishing them in the z-direction. The study also observed a correlation between an escalation in the magnetic field parameter and a decrease in skin friction, specifically along the x-direction. Additionally, the study found that the Nusselt number experienced a notable increase with an elevation in the thermal radiation parameter. See these intriguing numerical studies<sup>##UREF##9##10##–##UREF##12##13##</sup>.</p>", "<p id=\"Par43\">Polar microfluids are frequently characterized as polar, isotropic liquids with no consideration for molecular deformation. Erringen<sup>##UREF##13##14##</sup> introduced the micropolar theory in 1966. His simple model, commonly referred to as the “micropolar model”, has gained considerable acceptance and has been adopted to describe the thermal behavior of actual liquids with an internal structure. The flow behavior of liquid crystals, suspension solutions, animal blood, and many other fluids can be characterized by a micropolar fluid model. In recent years, numerous research projects have focused on energy transport characteristics using the micropolar model. Nazar et al.<sup>##UREF##14##15##,##UREF##15##16##</sup> relied on the micropolar model to predict and analyze the thermal behavior of the fluid moving around a spherical object, considering constant wall temperature and heat flux. The findings of their studies indicate that as the micropolar factor increases, both wall temperature and skin friction exhibit a rising trend. Swalmeh et al.<sup>##UREF##16##17##,##UREF##17##18##</sup> extended the studies of Nazar et al. by considering nanofluid issues through the single-phase model. Their findings reveal that the temperature and velocity of Al<sub>2</sub>O3-H<sub>2</sub>O surpass those of Al<sub>2</sub>O<sub>3</sub>-kerosene oil. Furthermore, the energy transport rate of Cu-H2O exhibits a noticeable decline compared to Al<sub>2</sub>O3-H<sub>2</sub>O as the micro-rotation factor escalates. Nabwey et al.<sup>##UREF##18##19##</sup> examine the influence of Newtonian heating on magnetohydrodynamic heat transfer induced by natural means of polar nanoliquids across a spherical object. Their validated findings support the notion that the presence of the micropolar factor diminishes skin friction and the energy transport rate. Likewise, their observations indicate that incorporating the Newtonian heating factor enhances both skin friction and the energy transport rate. Other related studies can be found in Refs.<sup>##UREF##19##20##–##UREF##21##22##</sup>.</p>", "<p id=\"Par44\">Control and management of energy and their related issues are increasingly recognized as one of mankind’s greatest challenges in the coming years to keep pace with the surge in industrialization and technology<sup>##UREF##22##23##,##UREF##23##24##</sup>. One of the innovative proposals is to optimize the performance of energy-transport fluids through the incorporation of metallic and ceramic ultrafine particles into the original fluid to form nanofluid. It all began with the study of Choi and Eastman<sup>##UREF##24##25##</sup>, who theoretically confirmed that the thermal conductivity of H2O can be markedly enhanced by including copper nanosolids. Afterwards, experimental and numerical studies continued, confirming that the thermal behavior of the reference fluid is significantly affected by nanosolids<sup>##UREF##25##26##–##UREF##31##32##</sup>. At present, nanofluids are evidently employed in a wide array of manufacturing and engineering applications, such as solar energy, heat exchangers, and cooling systems<sup>##UREF##32##33##–##UREF##36##37##</sup>. Hybrid nanomaterials are a developed class of nanomaterials fabricated from two nanoparticles to obtain the properties of their constituent materials. That is, the main objective of their synthesis is to create a compound with properties that combine thermal and rheological efficiency, as no single nanosolid can possess these properties<sup>##UREF##37##38##–##REF##36823230##43##</sup>. To acquire features that are more integrated, ternary hybrid nanosolids have been fabricated. Several studies have shown the thermal advantages of these upgraded nanocomposites over the previous class<sup>##UREF##42##44##–##UREF##45##47##</sup>. For numerical studies, Mahmood et al.<sup>##UREF##46##48##</sup> computationally simulated the unsteady magneto-flow of polymer trihybrid nanofluid around a sphere under the impact of ohmic heating. According to their findings, the magnetic factor and nanosolids concentration enhance heat distribution, while unsteadiness and rotation factors reduce it. In comparison to hybrid and original nanoliquids, tri-hybrid nanoliquids transport energy more rapidly. AlBaidani et al.<sup>##UREF##47##49##</sup> conducted a computational simulation to predict the enhancement of fin performance due to the use of tri-hybrid nanosolids, considering the shape factor of nanosolids and free convection. Their key findings indicate that the efficiency of energy performance is significantly influenced by thermal conductivity and free convection. Utilizing magnetic fields and thermal radiation proves to be effective in cooling fins. Tri-hybrid nanosolids enhance the efficiency of fins as opposed to hybrid nanosolids. See also<sup>##UREF##48##50##,##UREF##49##51##</sup>.</p>", "<p id=\"Par45\">As a control parameter, the shape of the suspended nanoparticles is among the critical parameters that affect the thermophysical features of nanoliquids. Numerous earlier experimental and numerical publications have highlighted the influence of nanosolid shapes. A numerical study was carried out by Kumar et al.<sup>##UREF##50##52##</sup> to explore the flow and thermal features of nanoliquid in a thermally driven cavity. It was found that an increment in the values of the shape factor was accompanied by a significant enhancement in thermal conductivity. Sheikholeslami and Shamlooei<sup>##UREF##51##53##</sup> examined the flow of magnetized iron oxide–H2O nanoliquid in a permeable medium, considering the shape factor. Their study showed that platelet-shaped iron oxide nanoparticles achieved the maximum energy transfer rate. Khashi’ie et al.<sup>##UREF##52##54##</sup> analyzed the thermal characteristics of Cu–Al2O3/H2O hybrid nanoliquid flow past an EMHD sheet, considering the impact of radiation. Their results supported the idea that as the volume fraction factor values rise, blade-shaped nanosolids exhibit the maximum energy transport rate, while spherical nanosolids exhibit the lowest energy transport rate. Ghobadi and Hassankolaei<sup>##UREF##53##55##</sup> carried out a numerical simulation of magnetohydrodynamic hybrid nanoliquid flow across a stretching cylinder. They observed that lamina nanomaterials have a greater effect on the Nusselt number than hexagonal nanomaterials. Shanmugapriya et al.<sup>##UREF##54##56##</sup> presented a numerical simulation to explore the efficiency of energy transfer in MHD tri-hybrid nanoliquid on a radiative moving wedge. In their study, they compared the efficiency of energy transfer between different shapes of nanosolids. See<sup>##UREF##55##57##–##UREF##57##59##</sup> for more related studies.</p>", "<p id=\"Par46\">By drawing upon the insights gained from previous studies. This work represents a natural progression from the investigations conducted by Nazar et al.<sup>##UREF##14##15##,##UREF##15##16##</sup> on micropolar fluid flow around a sphere to the more recent advances made by Swalmeh et al.<sup>##UREF##16##17##,##UREF##17##18##</sup> on micropolar nanofluids, along with the expansion that takes into account the micropolar hybrid nanofluid examined by Alkasasbeh et al.<sup>##UREF##58##60##</sup>. The novelty of the current study is to expand upon these findings by investigating the new problem of a micropolar tri-hybrid nanoliquid moving around a radiative spherical object with the application of a magnetic field. In addition to considering the impacts of a nanosolid’s shape on flow properties and energy transport and highlighting the influences of control factors on some physical groups associated with energy transit. Furthermore, this consideration plays an essential role in numerous physical and engineering applications that rely on heat transmission primarily via electrically conductive fluids. Its applications are considerably obvious, with biomedical applications and flow control around hypersonic and re-entry vehicles. Also, its outcomes could provide new insights into the design and optimization of energy transport systems that use ternary nanoliquids with tailored shapes of the nanosolids. It is anticipated and hoped that the results of this analysis will be beneficial for upcoming academic studies and, additionally, for engineering and practical applications. More precisely, this investigation will demonstrate the following issues:<list list-type=\"order\"><list-item><p id=\"Par47\">How do the magnetohydrodynamics (MHD) and micropolar tri-hybrid nanoliquid models construct the problem of free convection flow moving around a radiative spherical object?</p></list-item><list-item><p id=\"Par48\">How can a mathematical model for the problem of MHD micropolar tri-hybrid nanoliquid be derived over a radiative spherical object?</p></list-item><list-item><p id=\"Par49\">How does the MHD micropolar tri-hybrid nanoliquid model compare with the published natural heat transfer flow problems?</p></list-item><list-item><p id=\"Par50\">How does the analysis of the numerical outcomes that can be obtained from the effects of MHD micropolar tri-hybrid parameters on the interested engineering physical quantities?</p></list-item><list-item><p id=\"Par51\">How do the heat transfer behaviors of the utilized nanoparticles suspended in the original fluid change under the influence of the studied parameters?</p></list-item></list></p>", "<title>Thermophysical properties of mono nanoliquid and ternary hybrid nanoliquid</title>", "<p id=\"Par52\">Employing Hamilton and Crosser’s extended Maxwell model<sup>##UREF##59##61##</sup>, mono nanoliquids’ thermal conductivity, containing similar nanosolids of any shape, is calculated:</p>", "<p id=\"Par53\">The mathematical expression for the viscosity of mono-nanoliquids, which takes into account the shape of nanosolids, is as follows (see<sup>##UREF##60##62##</sup>):where is the empirical shape factor, and is the particle’s sphericity, which is defined as the ratio of its spherical surface area to another shape’s surface area, considering both shapes have the same volumes. are the vicosity coefficients, which are calculated experimentally at room temperature. The coefficients of viscosity and shape factor of the nanoparticles employed in the current study are listed in Table ##TAB##0##1##.\n</p>", "<p id=\"Par54\">The density, specific heat capacity, and thermal expansion of tri-hybrid nanoliquids can be evaluated based on the model presented by Refs.<sup>##UREF##57##59##,##UREF##62##64##</sup> as follows:</p>", "<p id=\"Par55\">Using the interpolation method, the viscosity, thermal conductivity, and electrical conductivity of tri-hybrid nanoliquids can be calculated by employing the following formulas (see<sup>##UREF##57##59##</sup>):</p>", "<p id=\"Par56\">The subscriptions 1 and 2 indicate Al<sub>2</sub>O<sub>3</sub> and Cu, respectively, while subscription 3 indicates graphene or MWCNT. is the accumulation nanoparticle volume fraction factor. The thermophysical features of the original fluid and the nanosolids utilized in the current study are presented in Table ##TAB##1##2##.\n</p>", "<p id=\"Par57\">Figure ##FIG##0##1## presents a visualization of the relationship between the nanosolids shape and the thermal conductivity ratio. The thermal conductivity ratio exhibits an upward trend as the surface area of nanosolids grows. Blade-shaped nanosolids demonstrate the highest thermal conductivity ratio, whilst spherical nanoparticles exhibit the lowest ratio. This confirms that the higher shape factor of nanosolids produces the highest ratio of thermal conductivity. Figure ##FIG##1##2## presents a visualization of the relationship between the nanosolids shape and the dynamic viscosity ratio. It is noted that nanosolids with larger elongations (like platelets and cylinders) give kerosene oil the maximum dynamic viscosity ratio due to the structure of these shapes. Therefore, relying on these nanosolid shapes gives the original fluid a higher boiling point, which, of course, enhances its energy-carrying capacity.</p>", "<title>Model’s description</title>", "<p id=\"Par58\">Suppose we have a two-dimensional free convection boundary layer flow of kerosene oil containing Al<sub>2</sub>O<sub>3</sub> + Cu + graphene or Al<sub>2</sub>O<sub>3</sub> + Cu + MWCNT around a solid sphere of radius <italic>a</italic> considering a thermal radiation effect and a magnetic field of strength <italic>B</italic><sub>0</sub>. The first-dimensional variable is taken into consideration along the solid sphere’s circumference surface, and the second-dimensional variable is presented perpendicular to it, as offered in Fig. ##FIG##2##3##. The wall temperature <italic>T</italic><sub><italic>w</italic></sub> is assumed to be lower than the ambient medium <italic>T</italic><sub><italic>∞</italic></sub>.</p>", "<p id=\"Par59\">In light of the previous considerations and the Boussinesq boundary layer approximations, as well as employing the ternary hybrid nanofluids model, regarding magnetic, thermal radiation, and micropolar impacts, the continuity, momentum, energy, and micropolar equations are developed<sup>##UREF##19##20##,##UREF##58##60##,##UREF##66##68##</sup>:</p>", "<p id=\"Par60\">It is noted that the vector g (gravity acceleration), that exists in Eq. (##FORMU##19##6##), is implicitly expressed in (<italic>x, y</italic>)-direction, which is defined as two components and . Depending on the boundary approximations of the free convection case, the Grashof number <italic>Gr</italic> → ∞, which is equivalent to (1/<italic>Gr</italic>) → 0, the gravity component () has been neglected. The constant wall temperature boundary conditions are defined as<sup>##UREF##19##20##</sup>:where , and . are the Stefan–Boltzmann and mean absorption coefficients, respectively. The appropriate non-dimensional variables are<sup>##UREF##15##16##</sup>:where is micro-inertia density, <italic>Gr</italic> = is the Grashof number, and is the radial distance. Substituting the variables (##FORMU##29##10##) into Eqs. (##FORMU##18##5##)–(##FORMU##25##9##), yields the following nondimensional equations: where , , , and are the micropolar factor, radiation factor, magnetic factor, and Prandtl number, respectively.</p>", "<p id=\"Par61\">The mathematical model (##FORMU##33##11##)–(##FORMU##36##14##) can be reduced using the following non-similar transformation (stream function ):where .</p>", "<p id=\"Par62\">Utilizing the non-similar transformations (##FORMU##42##15##) and using Eqs. (##FORMU##0##1##)–(##FORMU##1##4##) yields: subject to:</p>", "<p id=\"Par63\">The skin friction <italic>C</italic><sub><italic>f</italic></sub> and the Nusselt number <italic>Nu</italic> are (see<sup>##UREF##15##16##,##UREF##19##20##</sup>):where</p>", "<p id=\"Par64\">Using the Eqs. (##FORMU##49##21##), (##FORMU##29##10##), and (##FORMU##42##15##), we get:</p>", "<title>Hybrid linearization spectral collection method</title>", "<p id=\"Par65\">In this section, the hybrid linearization spectral collocation technique (HLSC) combined Newton’s linearization method (NLM) with Chebyshev spectral collocation method (CSCM) in -direction. Firstly, NLM is utilized to linearize and decouple the nonlinear PDEs which are solved using Chebyshev spectral method (see<sup>##UREF##67##69##–##REF##31913322##71##</sup>).</p>", "<p id=\"Par66\">System (##FORMU##44##16##)–(##FORMU##47##19##) can be written as:with the boundary conditions:where , , \n, , \n.</p>", "<p id=\"Par67\">Applying, NLM<sup>##UREF##69##72##</sup> to the nonlinear PDEs (##FORMU##52##23##)–(##FORMU##56##27##) results in:where and BCs are:where the coefficients in the system (##FORMU##64##28##)–(##FORMU##67##31##) are defined as:where</p>", "<p id=\"Par68\">In Eqs. (##FORMU##64##28##)–(##FORMU##65##33##) are a decoupled linear PDEs system where the terms subscripted by n are known from the previous iteration level, and the terms subscripted by n + 1 are the current approximation. The linearized system (##FORMU##64##28##)–(##FORMU##70##33##) is solved by CSCM in -direction and the two-point implicit finite difference approach in -direction, where Chebyshev polynomials are typically selected with their corresponding collocation points in the interval [− 1<italic>,</italic>1]. The points are (see<sup>##UREF##70##73##–##UREF##72##75##</sup>):where is the step-size in -direction, is the initial approximation of , are the number of subintervals in and directions, respectively. The following linear differential transformation is applied to convert the system (##FORMU##64##28##)–(##FORMU##70##33##) into algebraic systems of equations in the y-direction:where are the 1st and 2nd derivatives Chebyshev differentiation matrices, respectively, given in Refs.<sup>##UREF##70##73##–##UREF##72##75##</sup>, that are converted into our entire physical domain , , , and . While , , and are the derivative vectors of , , and , respectively. In the -direction, the two-point backward difference scheme looks like:</p>", "<p id=\"Par69\">The first order derivatives with respect to are discretized using or or . The following system for each line is obtained by applying CSCM to Eqs. (##FORMU##64##28##)–(##FORMU##70##33##):</p>", "<p id=\"Par70\">Subject to boundary conditions:</p>", "<p id=\"Par71\">Here, Eq. (##FORMU##105##38##)s coefficients are the coefficients stated in system (##FORMU##70##33##) expressed in vectors form. The system (##FORMU##105##38##) and (##FORMU##107##39##) is solved iteratively at , . The above Eqs. (##FORMU##105##38##) and (##FORMU##107##39##), at the point (), , can be determined as the following:</p>", "<p id=\"Par72\">Subject to boundary conditions where the coefficients in system (##FORMU##113##40##) are defined as:</p>", "<p id=\"Par73\">The iterative process of each the systems (##FORMU##113##40##), (##FORMU##114##41##) and (##FORMU##105##38##), (##FORMU##107##39##) is terminated if there is a difference of less than between the outcomes of two successive iterations. Subject to the BCs (32) hence, suitable initial approximations are:</p>", "<p id=\"Par74\">Once the MATLAB program has been established, we need to set the convergence standards. This requires identifying some important calculations: the proper step sizes (∆<italic>x</italic> and ∆<italic>y</italic>) and the boundary layer thickness (<italic>y</italic> = ∞). In this study, <italic>y</italic> = ∞ should be set between 3 and 8 to achieve boundary layer convergence. Once we choose the appropriate value of <italic>y</italic> = ∞, we can determine the step sizes: ∆<italic>x</italic> = 0.005 and <italic>y</italic> = 0.02. These step sizes will give us valid approximate numerical results that agree with previous research. To ensure the precision of the current technique, the present outcomes are compared with the results provided by Nazar et al.<sup>##UREF##15##16##</sup> when the factors where set to zero. See Table ##TAB##2##3##.\n</p>" ]
[ "<title>Hybrid linearization spectral collection method</title>", "<p id=\"Par65\">In this section, the hybrid linearization spectral collocation technique (HLSC) combined Newton’s linearization method (NLM) with Chebyshev spectral collocation method (CSCM) in -direction. Firstly, NLM is utilized to linearize and decouple the nonlinear PDEs which are solved using Chebyshev spectral method (see<sup>##UREF##67##69##–##REF##31913322##71##</sup>).</p>", "<p id=\"Par66\">System (##FORMU##44##16##)–(##FORMU##47##19##) can be written as:with the boundary conditions:where , , \n, , \n.</p>", "<p id=\"Par67\">Applying, NLM<sup>##UREF##69##72##</sup> to the nonlinear PDEs (##FORMU##52##23##)–(##FORMU##56##27##) results in:where and BCs are:where the coefficients in the system (##FORMU##64##28##)–(##FORMU##67##31##) are defined as:where</p>", "<p id=\"Par68\">In Eqs. (##FORMU##64##28##)–(##FORMU##65##33##) are a decoupled linear PDEs system where the terms subscripted by n are known from the previous iteration level, and the terms subscripted by n + 1 are the current approximation. The linearized system (##FORMU##64##28##)–(##FORMU##70##33##) is solved by CSCM in -direction and the two-point implicit finite difference approach in -direction, where Chebyshev polynomials are typically selected with their corresponding collocation points in the interval [− 1<italic>,</italic>1]. The points are (see<sup>##UREF##70##73##–##UREF##72##75##</sup>):where is the step-size in -direction, is the initial approximation of , are the number of subintervals in and directions, respectively. The following linear differential transformation is applied to convert the system (##FORMU##64##28##)–(##FORMU##70##33##) into algebraic systems of equations in the y-direction:where are the 1st and 2nd derivatives Chebyshev differentiation matrices, respectively, given in Refs.<sup>##UREF##70##73##–##UREF##72##75##</sup>, that are converted into our entire physical domain , , , and . While , , and are the derivative vectors of , , and , respectively. In the -direction, the two-point backward difference scheme looks like:</p>", "<p id=\"Par69\">The first order derivatives with respect to are discretized using or or . The following system for each line is obtained by applying CSCM to Eqs. (##FORMU##64##28##)–(##FORMU##70##33##):</p>", "<p id=\"Par70\">Subject to boundary conditions:</p>", "<p id=\"Par71\">Here, Eq. (##FORMU##105##38##)s coefficients are the coefficients stated in system (##FORMU##70##33##) expressed in vectors form. The system (##FORMU##105##38##) and (##FORMU##107##39##) is solved iteratively at , . The above Eqs. (##FORMU##105##38##) and (##FORMU##107##39##), at the point (), , can be determined as the following:</p>", "<p id=\"Par72\">Subject to boundary conditions where the coefficients in system (##FORMU##113##40##) are defined as:</p>", "<p id=\"Par73\">The iterative process of each the systems (##FORMU##113##40##), (##FORMU##114##41##) and (##FORMU##105##38##), (##FORMU##107##39##) is terminated if there is a difference of less than between the outcomes of two successive iterations. Subject to the BCs (32) hence, suitable initial approximations are:</p>", "<p id=\"Par74\">Once the MATLAB program has been established, we need to set the convergence standards. This requires identifying some important calculations: the proper step sizes (∆<italic>x</italic> and ∆<italic>y</italic>) and the boundary layer thickness (<italic>y</italic> = ∞). In this study, <italic>y</italic> = ∞ should be set between 3 and 8 to achieve boundary layer convergence. Once we choose the appropriate value of <italic>y</italic> = ∞, we can determine the step sizes: ∆<italic>x</italic> = 0.005 and <italic>y</italic> = 0.02. These step sizes will give us valid approximate numerical results that agree with previous research. To ensure the precision of the current technique, the present outcomes are compared with the results provided by Nazar et al.<sup>##UREF##15##16##</sup> when the factors where set to zero. See Table ##TAB##2##3##.\n</p>" ]
[ "<title>Results and discussion</title>", "<p id=\"Par75\">In this part, the simulation results are graphically presented, elaborated upon, and analyzed in order to offer a comprehensive grasp on the issue. In addition to providing physical explanations for the responses and behaviors of physical groups when affected by the key factors and analyzing their reflections on flow characteristics and energy transport by natural means. Al<sub>2</sub>O<sub>3</sub> + Cu + Graphene/KO and Al<sub>2</sub>O<sub>3</sub> + Cu + MWCNT/KO are the used ternary hybrid nanofluids, assuming the graphene nanosolids are shaped like platelets, MWCNT is cylindrical, and the other nanosolids are spherical. Figure ##FIG##3##4## describes the influence of augmentation of the volume fraction factor of nanosolids on the Nusselt number. The rise in the factor ameliorates the Nusselt number in response to the remarkable improvement in the thermal conductivity of kerosene oil when the values of this factor are increased. This means the augmentation of the volume fraction factor enhances the convective heat transfer process in the kerosene oil. Likewise, skin friction adopts the same behavior when affected by increasing the volume fraction factor, as shown in Fig. ##FIG##4##5##. This implies that there is a stronger resistance to the flow of fluid over a surface, indicating a higher drag force or frictional force acting on the fluid. Figure ##FIG##5##6## shows a visualization of the relationship between the increase in magnetic field strength and the Nusselt number. Augmentation of the magnetic factor triggers a brake in fluid motion, which is followed by a diminished convective heat transport, and this means that the Nusselt number will minimize. In consideration of the fact that the magnetic factor is inversely related to the motion of fluids, the drag forces experienced by the fluid also diminish, which negatively affects the values of skin friction, which in turn tends to reduce; this behavior is clearly shown in Fig. ##FIG##6##7##. Figure ##FIG##7##8## depicts the extent of the change in the Nusselt number if the micropolar factor values are raised. An increase in the polar factor raises the viscosity of the tri-hybrid nanoliquid, which inhibits its motion and, as a result, reduces its ability to transmit heat. Figure ##FIG##8##9## clarifies the opposite response of skin friction caused by elevated micropolar factor values. In situations where the micropolar factor is elevated, the result is a liquid with a higher viscosity, as previously stated. This restricts liquid motion and actually weakens frictional forces. Figures ##FIG##9##10## and ##FIG##10##11## illustrate how the Nusselt number and drag force depend on the radiation factor. The radiation factor serves as an auxiliary energy source, enhancing the efficacy of both heat transmission and frictional forces. Thereby, it can be indicated that the energy transport and frictional forces of the tri-hybrid polar liquid increase as the amount of emitted thermal radiation increases. The dependence of velocity profiles, angular velocity profiles, and temperature profiles on the magnetic factor is shown in Figs. ##FIG##11##12##, ##FIG##12##13## and ##FIG##13##14##, respectively. The increment in the magnetic factor means that the magnetic field strength will increase, and this causes a brake in the flow process, or, in other words, it strengthens the resistance of the tri-hybrid liquid’s particles to movement, which will diminish its velocity and angular velocity, while raising its temperature. Figures ##FIG##14##15##, ##FIG##15##16## and ##FIG##16##17## are plotted to explore the behaviors of velocity profiles, angular velocity profiles, and temperature profiles under the impact of the volume fraction parameter, respectively. According to the results of the current study and previous studies, elevating the volume fraction values increases the thermal conductivity of the original fluid. This enhances the fluid’s heat-transporting efficiency. Consequently, its velocity and temperature will increase. On the contrary, Fig. ##FIG##15##16## reveals a negative relationship between the angular velocity of the original fluid and the volume fraction factor. Figures ##FIG##17##18##, ##FIG##18##19## and ##FIG##19##20## visualize the trends of the velocity profiles, angular velocity profiles, and temperature profiles under the influence of the polar factor. By increasing the polar factor values, the temperature and angular velocity contours tend to rise, whereas the velocity contours tend to decline. This generally happens since increasing the polar factor enhances nanofluid viscosity. The positive effect of the thermal radiation factor on velocity and temperature and its negative effect on angular velocity are clearly shown in Figs. ##FIG##20##21##, ##FIG##21##22## and ##FIG##22##23##. This behavior may be explained by the fact that an increase in the amount of radiation emitted results in adding additional energy sources to the micropolar liquid, which in turn enhances its velocity and temperature.</p>" ]
[ "<title>Results and discussion</title>", "<p id=\"Par75\">In this part, the simulation results are graphically presented, elaborated upon, and analyzed in order to offer a comprehensive grasp on the issue. In addition to providing physical explanations for the responses and behaviors of physical groups when affected by the key factors and analyzing their reflections on flow characteristics and energy transport by natural means. Al<sub>2</sub>O<sub>3</sub> + Cu + Graphene/KO and Al<sub>2</sub>O<sub>3</sub> + Cu + MWCNT/KO are the used ternary hybrid nanofluids, assuming the graphene nanosolids are shaped like platelets, MWCNT is cylindrical, and the other nanosolids are spherical. Figure ##FIG##3##4## describes the influence of augmentation of the volume fraction factor of nanosolids on the Nusselt number. The rise in the factor ameliorates the Nusselt number in response to the remarkable improvement in the thermal conductivity of kerosene oil when the values of this factor are increased. This means the augmentation of the volume fraction factor enhances the convective heat transfer process in the kerosene oil. Likewise, skin friction adopts the same behavior when affected by increasing the volume fraction factor, as shown in Fig. ##FIG##4##5##. This implies that there is a stronger resistance to the flow of fluid over a surface, indicating a higher drag force or frictional force acting on the fluid. Figure ##FIG##5##6## shows a visualization of the relationship between the increase in magnetic field strength and the Nusselt number. Augmentation of the magnetic factor triggers a brake in fluid motion, which is followed by a diminished convective heat transport, and this means that the Nusselt number will minimize. In consideration of the fact that the magnetic factor is inversely related to the motion of fluids, the drag forces experienced by the fluid also diminish, which negatively affects the values of skin friction, which in turn tends to reduce; this behavior is clearly shown in Fig. ##FIG##6##7##. Figure ##FIG##7##8## depicts the extent of the change in the Nusselt number if the micropolar factor values are raised. An increase in the polar factor raises the viscosity of the tri-hybrid nanoliquid, which inhibits its motion and, as a result, reduces its ability to transmit heat. Figure ##FIG##8##9## clarifies the opposite response of skin friction caused by elevated micropolar factor values. In situations where the micropolar factor is elevated, the result is a liquid with a higher viscosity, as previously stated. This restricts liquid motion and actually weakens frictional forces. Figures ##FIG##9##10## and ##FIG##10##11## illustrate how the Nusselt number and drag force depend on the radiation factor. The radiation factor serves as an auxiliary energy source, enhancing the efficacy of both heat transmission and frictional forces. Thereby, it can be indicated that the energy transport and frictional forces of the tri-hybrid polar liquid increase as the amount of emitted thermal radiation increases. The dependence of velocity profiles, angular velocity profiles, and temperature profiles on the magnetic factor is shown in Figs. ##FIG##11##12##, ##FIG##12##13## and ##FIG##13##14##, respectively. The increment in the magnetic factor means that the magnetic field strength will increase, and this causes a brake in the flow process, or, in other words, it strengthens the resistance of the tri-hybrid liquid’s particles to movement, which will diminish its velocity and angular velocity, while raising its temperature. Figures ##FIG##14##15##, ##FIG##15##16## and ##FIG##16##17## are plotted to explore the behaviors of velocity profiles, angular velocity profiles, and temperature profiles under the impact of the volume fraction parameter, respectively. According to the results of the current study and previous studies, elevating the volume fraction values increases the thermal conductivity of the original fluid. This enhances the fluid’s heat-transporting efficiency. Consequently, its velocity and temperature will increase. On the contrary, Fig. ##FIG##15##16## reveals a negative relationship between the angular velocity of the original fluid and the volume fraction factor. Figures ##FIG##17##18##, ##FIG##18##19## and ##FIG##19##20## visualize the trends of the velocity profiles, angular velocity profiles, and temperature profiles under the influence of the polar factor. By increasing the polar factor values, the temperature and angular velocity contours tend to rise, whereas the velocity contours tend to decline. This generally happens since increasing the polar factor enhances nanofluid viscosity. The positive effect of the thermal radiation factor on velocity and temperature and its negative effect on angular velocity are clearly shown in Figs. ##FIG##20##21##, ##FIG##21##22## and ##FIG##22##23##. This behavior may be explained by the fact that an increase in the amount of radiation emitted results in adding additional energy sources to the micropolar liquid, which in turn enhances its velocity and temperature.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par76\">Centralizing on filling the research gap by considering the effect of MHD micropolar ternary hybrid nanofluids, the current study considers the nanosolids’ shapes via a mathematical model of the flow of the magnetized micropolar ternary nanoliquid around a spherical shape with thermal radiation effects, which was successfully constructed. On the other hand, the spectral collocation technique (HLSC) has been employed to solve the PDEs and get new numerical outcomes that combine the effects of MHD micropolar ternary hybrid nanofluid parameters that were not studied in the same model. Consequently, we obtained new results that were compared with previous literature and came to an excellent agreement. Moreover, it can contribute to the establishment of future studies based on this study. Depending on that, this study has drawn the following key conclusions:<list list-type=\"order\"><list-item><p id=\"Par77\">Blade nanosolids give the maximal thermal conductivity ratio, while spherical nanosolids give the minimal ratio.</p></list-item><list-item><p id=\"Par78\">Nanosolids with larger elongations offer kerosene oil the greatest dynamic viscosity ratio.</p></list-item><list-item><p id=\"Par79\">The fluid velocity, frictional forces, and energy transport rate are all suppressed when the micropolar or magnetic factor values rise.</p></list-item><list-item><p id=\"Par80\">As the volume fraction factor values get higher, temperature, velocity, and angular velocity all rise.</p></list-item><list-item><p id=\"Par81\">All examined physical quantities elevate due to the augmentation in radiation factor values.</p></list-item><list-item><p id=\"Par82\">As the volume fraction factor increases, the average percentage improvement in convective heat transfer for Al<sub>2</sub>O<sub>3</sub> + Cu + MWCNT/kerosene oil compared to Al<sub>2</sub>O<sub>3</sub> + Cu + graphene/kerosene oil approximately ranges from 0.8 to 2.6%.</p></list-item></list></p>", "<p id=\"Par83\">Depending on this investigation, there is a lot of future research that can be examined for coming studies. The same problem can be expanded in future work utilizing other mathematical models, such as the Casson model, and it can also develop to comprise ternary hybrid nanofluids with viscous dissipation and Joule heating impacts and incorporated.</p>" ]
[ "<p id=\"Par1\">The control and management of energy and their associated issues are increasingly recognized as one of mankind’s greatest challenges in the coming years to keep pace with the surge in industrialization and technology. Free convection optimizes the heat transfer processes in energy systems like solar collectors and power plants, reducing energy consumption and increasing system effectiveness. Further, studying and analyzing critical factors like magnetic fields, thermal radiation, and the shape of nanoparticles can assist in the control of fluid motion and improve the efficiency of heat transfer processes in a wide range of real-world applications, such as the power sector, aerospace applications, molten metal, nuclear power, and aeronautical engineering. This study aims to scrutinize the thermal performance of a magneto tri-hybrid polar nanoliquid flowing over a radiative sphere, considering the nanosolids’ shape. The single-phase model is developed to acquire the problems governing equations, and the hybrid linearization spectral collection approach is utilized to approximate the solution. The present findings reveal that blade-shaped nanosolids exhibit the highest thermal conductivity ratio when incorporated into the base fluid, whereas spherical nanosolids exhibit the lowest ratio. Volume fraction and thermal radiation factors have an effective role in raising fluid velocity and thermal performance. The magnetic and microapolar factors significantly suppress fluid velocity and energy transfer. As the volume fraction factor increases, the average percentage improvement in convective heat transfer for Al<sub>2</sub>O<sub>3</sub> + Cu + MWCNT/kerosene oil compared to Al<sub>2</sub>O<sub>3</sub> + Cu + graphene/kerosene oil approximately ranges from 0.8 to 2.6%.</p>", "<title>Subject terms</title>" ]
[]
[ "<title>Acknowledgements</title>", "<p>This project was fully implemented at Suez University Egypt.</p>", "<title>Author contributions</title>", "<p>E.A.E. methodology, software  and validation F.A.A. and F.A. formal analysis, investigation, and  resources, M.Z.S. writing—original draft preparation. All authors reviewed the final version of the manuscript.</p>", "<title>Data availability</title>", "<p>The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.</p>", "<title>Competing interests</title>", "<p id=\"Par84\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Thermal conductivity versus shape factor.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Dynamic viscosity versus shape factor.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Physical configuration.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Nusselt number vs. volume fraction factor.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Skin friction vs. volume fraction factor.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Nusselt number vs magnetic factor.</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>Skin friction vs magnetic factor.</p></caption></fig>", "<fig id=\"Fig8\"><label>Figure 8</label><caption><p>Nusselt number vs micropolar factor.</p></caption></fig>", "<fig id=\"Fig9\"><label>Figure 9</label><caption><p>Skin friction vs micropolar factor.</p></caption></fig>", "<fig id=\"Fig10\"><label>Figure 10</label><caption><p>Nusselt number vs radiation factor.</p></caption></fig>", "<fig id=\"Fig11\"><label>Figure 11</label><caption><p>Skin friction vs radiation factor.</p></caption></fig>", "<fig id=\"Fig12\"><label>Figure 12</label><caption><p>Velocity vs magnetic factor.</p></caption></fig>", "<fig id=\"Fig13\"><label>Figure 13</label><caption><p>Angular velocity vs magnetic factor.</p></caption></fig>", "<fig id=\"Fig14\"><label>Figure 14</label><caption><p>Temperature vs magnetic factor.</p></caption></fig>", "<fig id=\"Fig15\"><label>Figure 15</label><caption><p>Velocity vs volume fraction factor.</p></caption></fig>", "<fig id=\"Fig16\"><label>Figure 16</label><caption><p>Angular velocity vs volume fraction factor.</p></caption></fig>", "<fig id=\"Fig17\"><label>Figure 17</label><caption><p>Temperature vs volume fraction factor.</p></caption></fig>", "<fig id=\"Fig18\"><label>Figure 18</label><caption><p>Velocity vs micropolar factor.</p></caption></fig>", "<fig id=\"Fig19\"><label>Figure 19</label><caption><p>Angular velocity vs micropolar factor.</p></caption></fig>", "<fig id=\"Fig20\"><label>Figure 20</label><caption><p>Temperature vs micropolar factor.</p></caption></fig>", "<fig id=\"Fig21\"><label>Figure 21</label><caption><p>Velocity vs radiation factor.</p></caption></fig>", "<fig id=\"Fig22\"><label>Figure 22</label><caption><p>Angular velocity vs radiation factor.</p></caption></fig>", "<fig id=\"Fig23\"><label>Figure 23</label><caption><p>Temperature vs radiation factor.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Coefficients of viscosity and shape factor<sup>##UREF##60##62##,##UREF##61##63##</sup>.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Shape of nanosolid</th><th align=\"left\" colspan=\"2\">Viscosity coefficient</th><th align=\"left\" rowspan=\"2\">Sphericity \n</th><th align=\"left\" rowspan=\"2\">Shape factor (\n</th></tr><tr><th align=\"left\">\n\n</th><th align=\"left\">\n\n</th></tr></thead><tbody><tr><td align=\"left\">Platelets</td><td char=\".\" align=\"char\">37.1</td><td char=\".\" align=\"char\">612.6</td><td align=\"left\">0.52</td><td align=\"left\">5.7</td></tr><tr><td align=\"left\">Blades</td><td char=\".\" align=\"char\">14.6</td><td char=\".\" align=\"char\">123.3</td><td align=\"left\">0.36</td><td align=\"left\">8.6</td></tr><tr><td align=\"left\">Cylinders</td><td char=\".\" align=\"char\">13.5</td><td char=\".\" align=\"char\">904.4</td><td align=\"left\">0.62</td><td align=\"left\">4.9</td></tr><tr><td align=\"left\">Bricks</td><td char=\".\" align=\"char\">1.9</td><td char=\".\" align=\"char\">471.4</td><td align=\"left\">0.81</td><td align=\"left\">3.7</td></tr><tr><td align=\"left\">Sphere</td><td char=\".\" align=\"char\">2.5</td><td char=\".\" align=\"char\">6.2</td><td align=\"left\">1</td><td align=\"left\">3</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Thermophysical features of original fluid and nanosolids<sup>##UREF##57##59##,##UREF##63##65##–##UREF##65##67##</sup>.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Thermo-physical feature</th><th align=\"left\">Kerosene Oil (KO)</th><th align=\"left\">Al<sub>2</sub>O<sub>3</sub></th><th align=\"left\">Cu</th><th align=\"left\">Graphene</th><th align=\"left\">MWCNT</th></tr></thead><tbody><tr><td align=\"left\">\n(J/kg K) </td><td align=\"left\">2090</td><td align=\"left\">773</td><td align=\"left\">385</td><td align=\"left\">790</td><td align=\"left\">740</td></tr><tr><td align=\"left\">\n×10<sup>−5</sup> (K<sup>−1</sup>) </td><td align=\"left\">22.85</td><td align=\"left\">0.85</td><td align=\"left\">1.67</td><td align=\"left\"> − 0.8</td><td align=\"left\">44</td></tr><tr><td align=\"left\"><italic>ρ</italic> (kg/m<sup>3</sup>)</td><td align=\"left\">783</td><td align=\"left\">3970</td><td align=\"left\">8933</td><td align=\"left\">2200</td><td align=\"left\">2600</td></tr><tr><td align=\"left\"><italic>k</italic> (W/m K)</td><td align=\"left\">0.15</td><td align=\"left\">40</td><td align=\"left\">401</td><td align=\"left\">5000</td><td align=\"left\">3000</td></tr><tr><td align=\"left\"><italic>σ</italic>(s/m)</td><td align=\"left\">5 × 10<sup>–11</sup></td><td align=\"left\">1.12 10<sup>5</sup></td><td align=\"left\">3.5 × 10<sup>7</sup></td><td align=\"left\">1 × 10<sup>–7</sup></td><td align=\"left\">1.9 10<sup>–4</sup></td></tr><tr><td align=\"left\">Pr</td><td align=\"left\">22.85</td><td align=\"left\">…</td><td align=\"left\">…</td><td align=\"left\">…</td><td align=\"left\">…</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Comparison of Nazar et al.<sup>##UREF##15##16##</sup> results with the current results for .</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\"><italic>x</italic></th><th align=\"left\">Nazar et al. <sup>##UREF##15##16##</sup> results Pr = 7</th><th align=\"left\">Present results Pr = 7</th></tr></thead><tbody><tr><td align=\"left\">0°</td><td align=\"left\">0.9595</td><td char=\".\" align=\"char\">0.9575</td></tr><tr><td align=\"left\">10°</td><td align=\"left\">0.9572</td><td char=\".\" align=\"char\">0.9553</td></tr><tr><td align=\"left\">20°</td><td align=\"left\">0.9506</td><td char=\".\" align=\"char\">0.9489</td></tr><tr><td align=\"left\">30°</td><td align=\"left\">0.9397</td><td char=\".\" align=\"char\">0.9382</td></tr><tr><td align=\"left\">40°</td><td align=\"left\">0.9243</td><td char=\".\" align=\"char\">0.9230</td></tr><tr><td align=\"left\">50°</td><td align=\"left\">0.9045</td><td char=\".\" align=\"char\">0.9034</td></tr><tr><td align=\"left\">60°</td><td align=\"left\">0.8801</td><td char=\".\" align=\"char\">0.8793</td></tr><tr><td align=\"left\">70°</td><td align=\"left\">0.8510</td><td char=\".\" align=\"char\">0.8503</td></tr><tr><td align=\"left\">80°</td><td align=\"left\">0.8168</td><td char=\".\" align=\"char\">0.8163</td></tr><tr><td align=\"left\">90°</td><td align=\"left\">0.7792</td><td char=\".\" align=\"char\">0.7770</td></tr><tr><td align=\"left\">100°</td><td align=\"left\">–</td><td char=\".\" align=\"char\">0.7321</td></tr><tr><td align=\"left\">110°</td><td align=\"left\">–</td><td char=\".\" align=\"char\">0.6808</td></tr><tr><td align=\"left\">120°</td><td align=\"left\">–</td><td char=\".\" align=\"char\">0.6226</td></tr></tbody></table></table-wrap>" ]
[ "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{{k}_{nf}}{{k}_{f}}=\\frac{{ k}_{s}+(n-1){ k}_{f}-(n-1) {\\chi }_{s} ( { k}_{f}- { k}_{s} )}{{ k}_{s}+(n-1){ k}_{f} + {\\chi }_{s} ( { k}_{f}- { k}_{s} )}.$$\\end{document}</tex-math><mml:math id=\"M2\" display=\"block\"><mml:mrow><mml:mfrac><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">nf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msub><mml:mi>χ</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{{\\mu }_{nf}}{{\\mu }_{f}}=1+{C}_{1}{\\chi }_{s} +{C}_{2}{\\chi }_{s}^{2}.$$\\end{document}</tex-math><mml:math id=\"M4\" display=\"block\"><mml:mrow><mml:mfrac><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">nf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>μ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>χ</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msubsup><mml:mi>χ</mml:mi><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=3/\\omega$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>3</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>ω</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:mi>ω</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${C}_{1}\\text{ and }{C}_{2}$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mspace width=\"0.333333em\"/><mml:mtext>and</mml:mtext><mml:mspace width=\"0.333333em\"/><mml:msub><mml:mi>C</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(\\omega )$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n)$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mrow><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${C}_{1}$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:msub><mml:mi>C</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${C}_{2}$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:msub><mml:mi>C</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{array}{*{20}l} \\rho_{thnf} = \\chi_{1} \\rho_{1} + \\chi_{2} \\rho_{2} + \\chi_{3} \\rho_{3} + \\left[ {\\left( {1 - \\chi_{1} - \\chi_{2} - \\chi_{3} } \\right)\\rho_{f} } \\right], \\hfill \\\\ (\\rho c_{p} )_{thnf} = \\chi_{1} (\\rho c_{p} )_{1} + \\chi_{2} (\\rho c_{p} )_{2} + \\chi_{3} (\\rho c_{p} )_{3} + [\\left( {1 - \\chi_{1} - \\chi_{2} - \\chi_{3} } \\right)\\left( {\\rho c_{p} )_{f} } \\right], \\hfill \\\\ (\\rho \\beta )_{thnf} = \\chi_{1} (\\rho \\beta )_{1} + \\chi_{2} (\\rho \\beta )_{2} + \\chi_{3} (\\rho \\beta )_{3} + [\\left( {1 - \\chi_{1} - \\chi_{2} - \\chi_{3} } \\right)\\left( {\\rho \\beta )_{f} } \\right]. \\hfill \\\\ \\end{array}$$\\end{document}</tex-math><mml:math id=\"M20\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"left\"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mfenced close=\"]\" open=\"[\"><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:mrow><mml:mo>+</mml:mo><mml:mo stretchy=\"false\">[</mml:mo></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mfenced close=\"]\" open=\"(\"><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>f</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ρ</mml:mi><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ρ</mml:mi><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ρ</mml:mi><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ρ</mml:mi><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:mrow><mml:mo>+</mml:mo><mml:mo stretchy=\"false\">[</mml:mo></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mfenced close=\"]\" open=\"(\"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>f</mml:mi></mml:msub></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ4\"><label>4</label><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{array}{*{20}l} \\frac{{\\mu_{thnf} }}{{\\mu_{f} }} = \\frac{{ \\mu_{nf1} \\chi_{1} + \\mu_{nf2} \\chi_{2} + \\mu_{nf3} \\chi_{3} }}{{\\chi \\mu_{f} }}, \\frac{{k_{thnf} }}{{k_{f} }} = \\frac{{ k_{nf1} \\chi_{1} + k_{nf2} \\chi_{2} + k_{nf3} \\chi_{3} }}{{\\chi k_{f} }}, \\hfill \\\\ \\frac{{\\sigma_{thnf} }}{{\\sigma_{f} }} = \\frac{{3\\left( {\\frac{{\\chi_{1} \\sigma_{1} + \\chi_{2} \\sigma_{2} + \\chi_{3} \\sigma_{3} }}{{\\sigma_{f} }} - \\chi } \\right)}}{{\\left( {\\frac{{\\chi_{1} \\sigma_{1} + \\chi_{2} \\sigma_{2} + \\chi_{3} \\sigma_{3} }}{{\\chi \\sigma_{f} }} + 2} \\right) - \\left( {\\frac{{\\chi_{1} \\sigma_{1} + \\chi_{2} \\sigma_{2} + \\chi_{3} \\sigma_{3} }}{{\\sigma_{f} }} - \\chi } \\right)}} . \\hfill \\\\ \\end{array}$$\\end{document}</tex-math><mml:math id=\"M22\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"left\"><mml:mrow><mml:mfrac><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>μ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mi>χ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mi>χ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:mi>χ</mml:mi><mml:msub><mml:mi>μ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mfrac><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mi>χ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mi>χ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:mi>χ</mml:mi><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:mfrac><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>3</mml:mn><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>χ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>-</mml:mo><mml:mi>χ</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>χ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:mi>χ</mml:mi><mml:msub><mml:mi>σ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:mfenced><mml:mo>-</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>χ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>-</mml:mo><mml:mi>χ</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\chi ={\\chi }_{1}+{\\chi }_{2}+{\\chi }_{3}$$\\end{document}</tex-math><mml:math id=\"M24\"><mml:mrow><mml:mi>χ</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M25\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho {c}_{p}$$\\end{document}</tex-math><mml:math id=\"M26\"><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq12\"><alternatives><tex-math id=\"M27\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho \\beta$$\\end{document}</tex-math><mml:math id=\"M28\"><mml:mrow><mml:mi>ρ</mml:mi><mml:mi>β</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq13\"><alternatives><tex-math id=\"M29\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\times$$\\end{document}</tex-math><mml:math id=\"M30\"><mml:mo>×</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq14\"><alternatives><tex-math id=\"M31\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\times$$\\end{document}</tex-math><mml:math id=\"M32\"><mml:mo>×</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq15\"><alternatives><tex-math id=\"M33\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{x }$$\\end{document}</tex-math><mml:math id=\"M34\"><mml:mover><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq16\"><alternatives><tex-math id=\"M35\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{y }$$\\end{document}</tex-math><mml:math id=\"M36\"><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ5\"><label>5</label><alternatives><tex-math id=\"M37\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{\\partial {\\overline {r} }{\\overline {z}} }{\\partial {\\overline x} }+\\frac{\\partial {\\overline {r} }{\\overline {w}} }{\\partial \\overline{y} }=0,$$\\end{document}</tex-math><mml:math id=\"M38\" display=\"block\"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>r</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mover><mml:mi>z</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>r</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mover><mml:mi>w</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ6\"><label>6</label><alternatives><tex-math id=\"M39\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\rho }_{thnf} \\left(\\overline{z } \\frac{\\partial \\overline{z} }{\\partial \\overline{x} }+\\overline{w }\\frac{\\partial \\overline{z} }{\\partial \\overline{y} }\\right)=\\left( {\\mu }_{thnf}+\\kappa \\right) \\left( \\frac{{\\partial }^{2}\\overline{z} }{\\partial {\\overline{y} }^{2}} \\right) +(\\rho {\\beta )}_{thnf} {\\rho }_{thnf}\\mathrm{ g}(T-{T}_{\\infty }){\\text{sin}}\\frac{\\overline{x}}{a }+\\kappa \\left( \\frac{\\partial \\overline{G} }{\\partial \\overline{y} } \\right)-{\\sigma }_{thnf}{B}_{0}^{2}\\overline{z },$$\\end{document}</tex-math><mml:math id=\"M40\" display=\"block\"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mover><mml:mi>z</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>z</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mover><mml:mi>w</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>z</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>κ</mml:mi></mml:mfenced><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mover><mml:mi>z</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac></mml:mfenced><mml:mrow><mml:mo>+</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ρ</mml:mi></mml:mrow><mml:msub><mml:mrow><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>T</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mi>∞</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mtext>sin</mml:mtext><mml:mfrac><mml:mover><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>a</mml:mi></mml:mfrac><mml:mo>+</mml:mo><mml:mi>κ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>G</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>-</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mi>B</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mover><mml:mi>z</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ7\"><label>7</label><alternatives><tex-math id=\"M41\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{z} \\frac{\\partial T}{\\partial x }+\\overline{w} \\frac{\\partial T }{\\partial \\overline{y} }={\\alpha }_{thnf}\\left(\\frac{{\\partial }^{2}\\overline{T} }{\\partial {\\overline{y} }^{2}} \\right)-\\frac{1}{({\\rho {c}_{p})}_{thnf}} \\frac{1}{({\\rho {c}_{p})}_{thnf}} \\frac{\\partial T}{\\partial \\overline{y}}\\frac{\\partial {q }_{r} }{\\partial y},$$\\end{document}</tex-math><mml:math id=\"M42\" display=\"block\"><mml:mrow><mml:mover><mml:mi>z</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mover><mml:mi>w</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mover><mml:mi>T</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>-</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>q</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ8\"><label>8</label><alternatives><tex-math id=\"M43\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\rho }_{thnf} j\\left(\\overline{z } \\frac{\\partial \\overline{G} }{\\partial \\overline{x} }+\\overline{w }\\frac{\\partial \\overline{G} }{\\partial \\overline{y} }\\right)={\\phi }_{thnf} \\left( \\frac{{\\partial }^{2}\\overline{G} }{\\partial {\\overline{y} }^{2}} \\right)-\\kappa \\left( 2\\overline{G }+\\frac{\\partial \\overline{z} }{\\partial \\overline{y} } \\right).$$\\end{document}</tex-math><mml:math id=\"M44\" display=\"block\"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:mi>j</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mover><mml:mi>z</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>G</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mover><mml:mi>w</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>G</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mover><mml:mi>G</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>-</mml:mo><mml:mi>κ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn><mml:mover><mml:mi>G</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>z</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq17\"><alternatives><tex-math id=\"M45\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\mathrm{g}}_{x}=\\mathrm{g} {\\text{si}}{\\text{n}}\\left(\\frac{\\overline{x}}{a }\\right)$$\\end{document}</tex-math><mml:math id=\"M46\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mtext>sin</mml:mtext><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mover><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>a</mml:mi></mml:mfrac></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq18\"><alternatives><tex-math id=\"M47\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\mathrm{g}}_{y}=\\mathrm{g cos}\\left(\\frac{\\overline{x}}{a }\\right)$$\\end{document}</tex-math><mml:math id=\"M48\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mi mathvariant=\"normal\">cos</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mover><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>a</mml:mi></mml:mfrac></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq19\"><alternatives><tex-math id=\"M49\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\mathrm{g}}_{y}=\\mathrm{g cos}\\left(\\frac{\\overline{x}}{a }\\right)$$\\end{document}</tex-math><mml:math id=\"M50\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mi>y</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mi mathvariant=\"normal\">cos</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mover><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>a</mml:mi></mml:mfrac></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ9\"><label>9</label><alternatives><tex-math id=\"M51\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{array}{*{20}l} \\overline{z} = \\overline{w} = 0 ,\\;T = T_{w} , \\;\\overline{G} = - \\left( {1/2} \\right)\\frac{{\\partial \\overline{z}}}{{\\partial \\overline{y}}},\\; {\\text{as }}\\overline{y} = 0, \\hfill \\\\ \\overline{w} \\to 0, \\;T \\to T_{\\infty } , \\;\\overline{G} \\to 0, \\;{\\text{as }}\\overline{y}{ } \\to \\infty , \\hfill \\\\ \\end{array}$$\\end{document}</tex-math><mml:math id=\"M52\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"left\"><mml:mrow><mml:mover><mml:mi>z</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mover><mml:mi>w</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width=\"0.277778em\"/><mml:mi>T</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mi>w</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mspace width=\"0.277778em\"/><mml:mover><mml:mi>G</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:mfenced><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>z</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width=\"0.277778em\"/><mml:mrow><mml:mtext>as</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:mover><mml:mi>w</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width=\"0.277778em\"/><mml:mi>T</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mi>∞</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mspace width=\"0.277778em\"/><mml:mover><mml:mi>G</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width=\"0.277778em\"/><mml:mrow><mml:mtext>as</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mrow/><mml:mo stretchy=\"false\">→</mml:mo><mml:mi>∞</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq20\"><alternatives><tex-math id=\"M53\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${q}_{r}=-\\frac{4{\\sigma }^{*}}{3{k}^{*}}{\\left(\\frac{\\partial {T}^{4}}{\\partial \\overline{y} }\\right)}_{\\overline{y }= 0}$$\\end{document}</tex-math><mml:math id=\"M54\"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mn>4</mml:mn><mml:msup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mrow/><mml:mo>∗</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:msup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mrow/><mml:mo>∗</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:mfrac><mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow></mml:mfrac></mml:mfenced><mml:mrow><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq21\"><alternatives><tex-math id=\"M55\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${T}^{4}\\cong 4{T}_{\\infty }^{3}T-3{T}_{\\infty }^{4}$$\\end{document}</tex-math><mml:math id=\"M56\"><mml:mrow><mml:msup><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mn>4</mml:mn></mml:msup><mml:mo>≅</mml:mo><mml:mn>4</mml:mn><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>∞</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msubsup><mml:mi>T</mml:mi><mml:mo>-</mml:mo><mml:mn>3</mml:mn><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>∞</mml:mi></mml:mrow><mml:mn>4</mml:mn></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq22\"><alternatives><tex-math id=\"M57\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }^{*},\\,and\\, {k}^{*}$$\\end{document}</tex-math><mml:math id=\"M58\"><mml:mrow><mml:msup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mrow/><mml:mo>∗</mml:mo></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mspace width=\"0.166667em\"/><mml:msup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mrow/><mml:mo>∗</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ10\"><label>10</label><alternatives><tex-math id=\"M59\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{gathered} x = \\frac{{\\overline{x}}}{a}, y = Gr^{1/4} a^{ - 1} \\overline{y,} \\,\\,\\,\\,\\,\\,r\\left( x \\right) = \\overline{r}\\left( {\\overline{x}} \\right)/a, \\theta = \\frac{{\\left( {T - T_{\\infty } } \\right)}}{{{ } T_{w} - { } T_{\\infty } }}, \\hfill \\\\ z = \\frac{a}{{v_{f} }}Gr^{ - 1/2} \\overline{z}, \\,\\,\\,\\,\\,\\,\\,w = \\frac{a}{{v_{f} }}Gr^{ - 1/4} \\overline{w}, \\hfill \\\\ \\end{gathered}$$\\end{document}</tex-math><mml:math id=\"M60\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>x</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mover><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>a</mml:mi></mml:mfrac><mml:mo>,</mml:mo><mml:mi>y</mml:mi><mml:mo>=</mml:mo><mml:mi>G</mml:mi><mml:msup><mml:mi>r</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup><mml:msup><mml:mi>a</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mover><mml:mrow><mml:mi>y</mml:mi><mml:mo>,</mml:mo></mml:mrow><mml:mo>¯</mml:mo></mml:mover><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mi>r</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mover><mml:mi>r</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mfenced close=\")\" open=\"(\"><mml:mover><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mfenced><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>a</mml:mi><mml:mo>,</mml:mo><mml:mi>θ</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>T</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mi>∞</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mrow><mml:mrow/><mml:msub><mml:mi>T</mml:mi><mml:mi>w</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:mrow/><mml:msub><mml:mi>T</mml:mi><mml:mi>∞</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mi>a</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mi>G</mml:mi><mml:msup><mml:mi>r</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mover><mml:mi>z</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo>,</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mi>w</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mi>a</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mi>G</mml:mi><mml:msup><mml:mi>r</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup><mml:mover><mml:mi>w</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq23\"><alternatives><tex-math id=\"M61\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$j= {a}^{2}/G{r}^{1/2}$$\\end{document}</tex-math><mml:math id=\"M62\"><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>G</mml:mi><mml:msup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq24\"><alternatives><tex-math id=\"M63\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$g{a}^{3}(T-{T}_{\\infty })(\\rho {\\beta )}_{f}/{{v}_{f}}^{2}$$\\end{document}</tex-math><mml:math id=\"M64\"><mml:mrow><mml:mi>g</mml:mi><mml:msup><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>T</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mi>∞</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ρ</mml:mi></mml:mrow><mml:msub><mml:mrow><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>f</mml:mi></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:msup><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq25\"><alternatives><tex-math id=\"M65\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{r }\\left(\\overline{x }\\right)=a \\mathrm{sin}\\left(\\frac{\\overline{x}}{a }\\right)$$\\end{document}</tex-math><mml:math id=\"M66\"><mml:mrow><mml:mover><mml:mi>r</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mfenced close=\")\" open=\"(\"><mml:mover><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mfenced><mml:mo>=</mml:mo><mml:mi>a</mml:mi><mml:mi mathvariant=\"normal\">sin</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mover><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>a</mml:mi></mml:mfrac></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ11\"><label>11</label><alternatives><tex-math id=\"M67\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{\\partial rz}{\\partial x}+\\frac{\\partial rw}{\\partial y}=0,$$\\end{document}</tex-math><mml:math id=\"M68\" display=\"block\"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>r</mml:mi><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ12\"><label>12</label><alternatives><tex-math id=\"M69\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z \\frac{\\partial z}{\\partial x}+w\\frac{\\partial z}{\\partial y}=\\frac{{\\rho }_{f}}{{\\rho }_{thnf}}\\left( \\frac{{\\mu }_{thnf}}{{\\mu }_{f}}+K \\right)\\frac{{\\partial }^{2}z}{\\partial {y}^{2}}+\\frac{({\\rho \\beta )}_{thnf}}{({\\rho \\beta )}_{f}}\\theta {\\text{sin}}x+\\frac{{\\rho }_{f}}{{\\rho }_{thnf}}K \\frac{\\partial G}{\\partial y}-\\frac{{\\rho }_{f}}{{\\rho }_{thnf}} \\frac{{\\sigma }_{thnf}}{{\\sigma }_{f}}\\mathrm{M}z,$$\\end{document}</tex-math><mml:math id=\"M70\" display=\"block\"><mml:mrow><mml:mi>z</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mi>w</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>μ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mi>K</mml:mi></mml:mfenced><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>f</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mi>θ</mml:mi><mml:mtext>sin</mml:mtext><mml:mi>x</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mi>K</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mfrac><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mi mathvariant=\"normal\">M</mml:mi><mml:mi>z</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ13\"><label>13</label><alternatives><tex-math id=\"M71\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z\\frac{\\partial \\theta }{\\partial x} +w \\frac{\\partial \\theta }{\\partial y}=\\frac{1}{Pr}\\frac{({\\rho {c}_{p})}_{f}}{({\\rho {c}_{p})}_{thnf}}\\left(\\frac{{k}_{thnf}}{{k}_{f}}+\\frac{4}{3}L\\right)\\frac{{\\partial }^{2}\\theta }{\\partial {y}^{2}} ,$$\\end{document}</tex-math><mml:math id=\"M72\" display=\"block\"><mml:mrow><mml:mi>z</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mi>w</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant=\"italic\">Pr</mml:mi></mml:mrow></mml:mfrac><mml:mfrac><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mi>f</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>4</mml:mn><mml:mn>3</mml:mn></mml:mfrac><mml:mi>L</mml:mi></mml:mfenced><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ14\"><label>14</label><alternatives><tex-math id=\"M73\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z\\frac{\\partial G}{\\partial x}+w\\frac{\\partial G}{\\partial y}=\\frac{{\\rho }_{f}}{{\\rho }_{thnf}} \\left(\\frac{{ \\mu }_{thnf}}{{\\mu }_{f}}+\\frac{K}{2 }\\right) \\frac{{\\partial }^{2}G}{\\partial {y}^{2}}-\\frac{{\\rho }_{f}}{{\\rho }_{thnf}}K\\left( 2G+\\frac{\\partial z}{\\partial y} \\right).$$\\end{document}</tex-math><mml:math id=\"M74\" display=\"block\"><mml:mrow><mml:mi>z</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mi>w</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>μ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mi>K</mml:mi><mml:mn>2</mml:mn></mml:mfrac></mml:mfenced><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mi>K</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn><mml:mi>G</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq26\"><alternatives><tex-math id=\"M75\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$K=\\kappa /{\\mu }_{f}$$\\end{document}</tex-math><mml:math id=\"M76\"><mml:mrow><mml:mi>K</mml:mi><mml:mo>=</mml:mo><mml:mi>κ</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq27\"><alternatives><tex-math id=\"M77\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$L={4\\sigma }^{*}{T}_{\\infty }^{3}/{k}_{f}4{k}^{*}$$\\end{document}</tex-math><mml:math id=\"M78\"><mml:mrow><mml:mi>L</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mn>4</mml:mn><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mrow/><mml:mo>∗</mml:mo></mml:mrow></mml:msup><mml:msubsup><mml:mi>T</mml:mi><mml:mrow><mml:mi>∞</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msubsup><mml:mo stretchy=\"false\">/</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mn>4</mml:mn><mml:msup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mrow/><mml:mo>∗</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq28\"><alternatives><tex-math id=\"M79\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathrm{M}={{\\sigma }_{f} a}^{2}{B}_{0}^{2}{Gr}^{-1/2}/{\\rho }_{f}{v}_{f}$$\\end{document}</tex-math><mml:math id=\"M80\"><mml:mrow><mml:mi mathvariant=\"normal\">M</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mi>a</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msubsup><mml:mi>B</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:msup><mml:mrow><mml:mi mathvariant=\"italic\">Gr</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:msub><mml:mi>v</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq29\"><alternatives><tex-math id=\"M81\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathrm{Pr}={(v}_{f}/{\\alpha }_{f})$$\\end{document}</tex-math><mml:math id=\"M82\"><mml:mrow><mml:mi mathvariant=\"normal\">Pr</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>v</mml:mi></mml:mrow><mml:mi>f</mml:mi></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq30\"><alternatives><tex-math id=\"M83\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\psi$$\\end{document}</tex-math><mml:math id=\"M84\"><mml:mi>ψ</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ15\"><label>15</label><alternatives><tex-math id=\"M85\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z=\\frac{1}{r}\\frac{\\partial \\psi }{\\partial y},\\mathrm{ \\,and\\, }w=-\\frac{1}{r}\\frac{\\partial \\psi }{\\partial x},$$\\end{document}</tex-math><mml:math id=\"M86\" display=\"block\"><mml:mrow><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>r</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mrow><mml:mspace width=\"0.166667em\"/><mml:mi mathvariant=\"normal\">and</mml:mi><mml:mspace width=\"0.166667em\"/></mml:mrow><mml:mi>w</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>r</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq31\"><alternatives><tex-math id=\"M87\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\psi =x r(x)f\\left( x, y \\right),\\theta =\\theta \\left( x,y \\right),G=x h\\left( x, y\\right)$$\\end{document}</tex-math><mml:math id=\"M88\"><mml:mrow><mml:mi>ψ</mml:mi><mml:mo>=</mml:mo><mml:mi>x</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>f</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mfenced><mml:mo>,</mml:mo><mml:mi>θ</mml:mi><mml:mo>=</mml:mo><mml:mi>θ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mfenced><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo>=</mml:mo><mml:mi>x</mml:mi><mml:mi>h</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ16\"><label>16</label><alternatives><tex-math id=\"M89\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{{\\rho }_{f}}{{\\rho }_{thnf}}\\left( \\frac{{\\mu }_{thnf}}{{\\mu }_{f}}+K \\right)\\frac{{\\partial }^{3}f}{\\partial {y}^{3}}+\\left(1+x\\mathrm{cot}x\\right)f\\frac{{\\partial }^{2}f}{\\partial {y}^{2}}-{\\left(\\frac{\\partial f}{\\partial y}\\right)}^{2}+\\frac{({\\rho \\beta )}_{thnf}}{({\\rho \\beta )}_{f}}\\theta \\frac{{\\text{sin}}x}{x}+\\frac{{\\rho }_{f}}{{\\rho }_{thnf}}K \\frac{\\partial h}{\\partial y}-\\frac{{\\rho }_{f}}{{\\rho }_{thnf}} \\frac{{\\sigma }_{thnf}}{{\\sigma }_{f}}M\\,\\frac{\\partial f}{\\partial y}= x\\,\\left(\\frac{\\partial f}{\\partial y}\\frac{{\\partial }^{2}f}{\\partial x\\partial y}- \\,\\frac{\\partial f}{\\partial x}\\frac{{\\partial }^{2}f}{\\partial {y}^{2}}\\right),$$\\end{document}</tex-math><mml:math id=\"M90\" display=\"block\"><mml:mrow><mml:mfrac><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>μ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mi>K</mml:mi></mml:mfenced><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msup><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mi>x</mml:mi><mml:mi mathvariant=\"normal\">cot</mml:mi><mml:mi>x</mml:mi></mml:mfenced><mml:mi>f</mml:mi><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>f</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mi>θ</mml:mi><mml:mfrac><mml:mrow><mml:mtext>sin</mml:mtext><mml:mi>x</mml:mi></mml:mrow><mml:mi>x</mml:mi></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mi>K</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mfrac><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mi>M</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>x</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ17\"><label>17</label><alternatives><tex-math id=\"M91\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{1}{Pr}\\frac{({\\rho {c}_{p})}_{f}}{({\\rho {c}_{p})}_{thnf}}\\left(\\frac{{k}_{thnf}}{{k}_{f}}+\\frac{4}{3}L\\right)\\frac{{\\partial }^{2}\\theta }{\\partial {y}^{2}} +\\left(1+x{\\text{cot}}\\,x\\right)f\\frac{\\partial \\theta }{ \\partial y}=x\\left(\\frac{\\partial f}{\\partial y}\\frac{\\partial \\theta }{\\partial x}- \\frac{\\partial f}{\\partial x}\\frac{\\partial \\theta }{\\partial y}\\right),$$\\end{document}</tex-math><mml:math id=\"M92\" display=\"block\"><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant=\"italic\">Pr</mml:mi></mml:mrow></mml:mfrac><mml:mfrac><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mi>f</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>4</mml:mn><mml:mn>3</mml:mn></mml:mfrac><mml:mi>L</mml:mi></mml:mfenced><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mi>x</mml:mi><mml:mtext>cot</mml:mtext><mml:mspace width=\"0.166667em\"/><mml:mi>x</mml:mi></mml:mfenced><mml:mi>f</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ18\"><label>18</label><alternatives><tex-math id=\"M93\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{{\\rho }_{f}}{{\\rho }_{thnf}}\\left(\\frac{{ \\mu }_{thnf}}{{\\mu }_{f}}+\\frac{K}{2 }\\right) \\frac{{\\partial }^{2}h}{\\partial {y}^{2}}+\\left(1+x\\mathrm{cot}x\\right)f\\frac{\\partial h}{\\partial y}-\\frac{\\partial f}{\\partial y}h-\\frac{{\\rho }_{f}}{{\\rho }_{thnf}}K\\left( 2h+\\frac{{\\partial }^{2}f}{\\partial {y}^{2}} \\right)=x\\left(\\frac{\\partial f}{\\partial y} \\frac{\\partial h}{\\partial x}- \\frac{\\partial f}{\\partial x}\\frac{\\partial h}{\\partial y}\\right),$$\\end{document}</tex-math><mml:math id=\"M94\" display=\"block\"><mml:mrow><mml:mfrac><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>μ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mi>K</mml:mi><mml:mn>2</mml:mn></mml:mfrac></mml:mfenced><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mi>x</mml:mi><mml:mi mathvariant=\"normal\">cot</mml:mi><mml:mi>x</mml:mi></mml:mfenced><mml:mi>f</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mi>h</mml:mi><mml:mo>-</mml:mo><mml:mfrac><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mi>K</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn><mml:mi>h</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>=</mml:mo><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ19\"><label>19</label><alternatives><tex-math id=\"M95\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{array}{l}f=\\frac{\\partial f}{\\partial y}=0, \\theta =1 , h=-(1/2) \\frac{{\\partial }^{2}f}{\\partial {y}^{2}},\\mathrm{ as\\,}y=0,\\\\ \\frac{\\partial f}{\\partial y}\\to 0, \\theta \\to 0, h\\to 0,\\mathrm{ as}\\,y \\to \\infty .\\end{array}$$\\end{document}</tex-math><mml:math id=\"M96\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"left\"><mml:mrow><mml:mi>f</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>θ</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>h</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mrow><mml:mi mathvariant=\"normal\">as</mml:mi><mml:mspace width=\"0.166667em\"/></mml:mrow><mml:mi>y</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>θ</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>h</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">as</mml:mi><mml:mspace width=\"0.166667em\"/><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mi>∞</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ20\"><label>20</label><alternatives><tex-math id=\"M97\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$Nu=\\left(\\frac{a{q}_{w}}{{k}_{f}({T}_{w}-{T}_{\\infty})}\\right), {C}_{f}=\\frac{{\\tau }_{w}}{{{ U}_{\\infty }^{2} \\rho }_{f}},$$\\end{document}</tex-math><mml:math id=\"M98\" display=\"block\"><mml:mrow><mml:mi>N</mml:mi><mml:mi>u</mml:mi><mml:mo>=</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>a</mml:mi><mml:msub><mml:mi>q</mml:mi><mml:mi>w</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mi>w</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mi>∞</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>,</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mi>w</mml:mi></mml:msub><mml:msub><mml:mrow><mml:msubsup><mml:mi>U</mml:mi><mml:mrow><mml:mi>∞</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mi>ρ</mml:mi></mml:mrow><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ21\"><label>21</label><alternatives><tex-math id=\"M99\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{array}{*{20}l} q_{w} = - k_{thnf} \\left( {\\frac{\\partial T}{{\\partial y^{*} }}} \\right)_{{\\overline{y} = \\,0}} \\,{ + }\\left( {q_{r} } \\right)_{{\\overline{y} = \\,0}} , \\hfill \\\\ U_{\\infty }^{2} = \\frac{{ Gr v_{f}^{2} }}{{a^{2} }}, \\tau_{w} = { }\\left( {\\mu_{thnf} + \\frac{\\kappa }{2}} \\right)\\left( {\\frac{\\partial z}{{\\partial y^{*} }}} \\right)_{{\\overline{y} = \\,0}} . \\hfill \\\\ \\end{array}$$\\end{document}</tex-math><mml:math id=\"M100\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"left\"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>w</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mi>y</mml:mi><mml:mrow><mml:mrow/><mml:mo>∗</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mfenced><mml:mrow><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mspace width=\"0.166667em\"/><mml:mo>+</mml:mo><mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>q</mml:mi><mml:mi>r</mml:mi></mml:msub></mml:mfenced><mml:mrow><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:msubsup><mml:mi>U</mml:mi><mml:mrow><mml:mi>∞</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>G</mml:mi><mml:mi>r</mml:mi><mml:msubsup><mml:mi>v</mml:mi><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow><mml:msup><mml:mi>a</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mfrac><mml:mo>,</mml:mo><mml:msub><mml:mi>τ</mml:mi><mml:mi>w</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mrow/><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mfrac><mml:mi>κ</mml:mi><mml:mn>2</mml:mn></mml:mfrac></mml:mrow></mml:mfenced><mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mi>y</mml:mi><mml:mrow><mml:mrow/><mml:mo>∗</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mfenced><mml:mrow><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ22\"><label>22</label><alternatives><tex-math id=\"M101\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${Gr}^{-1/4}Nu=-\\left( \\frac{{k}_{thnf}}{{k}_{f}}+\\frac{4}{3}L\\right)\\frac{\\partial \\theta }{\\partial y}\\left(x,0\\right), {Gr}^{1/4}{C}_{f}=\\left(\\frac{{\\mu }_{thnf }}{{\\mu }_{f}}+\\frac{\\mathrm{K}}{2}\\right) x\\frac{{\\partial }^{2}f}{\\partial {y}^{2}} \\left(x,0\\right).$$\\end{document}</tex-math><mml:math id=\"M102\" display=\"block\"><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant=\"italic\">Gr</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup><mml:mi>N</mml:mi><mml:mi>u</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>4</mml:mn><mml:mn>3</mml:mn></mml:mfrac><mml:mi>L</mml:mi></mml:mfenced><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced><mml:mo>,</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant=\"italic\">Gr</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup><mml:msub><mml:mi>C</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>μ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mi mathvariant=\"normal\">K</mml:mi><mml:mn>2</mml:mn></mml:mfrac></mml:mfenced><mml:mi>x</mml:mi><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>∂</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq32\"><alternatives><tex-math id=\"M103\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathrm{y}$$\\end{document}</tex-math><mml:math id=\"M104\"><mml:mi mathvariant=\"normal\">y</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ23\"><label>23</label><alternatives><tex-math id=\"M105\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${f}^{\\prime}=g,$$\\end{document}</tex-math><mml:math id=\"M106\" display=\"block\"><mml:mrow><mml:msup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:mi>g</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ24\"><label>24</label><alternatives><tex-math id=\"M107\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${A}_{1}{\\mathrm{g}}^{{\\prime}{\\prime}}+ \\left(1+x\\mathrm{cot}x\\right)f^{\\prime}{\\mathrm{g}}-{\\left(\\mathrm{g}\\right)}^{2} +{A}_{2}\\theta \\frac{{\\text{sin}}x}{x}+{A}_{3} \\frac{\\partial h}{\\partial y}+{A}_{4}=x\\left(\\mathrm{g}\\frac{\\partial \\mathrm{g}}{\\partial x}-\\frac{\\partial f}{\\partial x}{\\mathrm{g}}^{\\prime}\\right),$$\\end{document}</tex-math><mml:math id=\"M108\" display=\"block\"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">g</mml:mi></mml:mrow><mml:mrow><mml:mo>′</mml:mo><mml:mo>′</mml:mo></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mi>x</mml:mi><mml:mi mathvariant=\"normal\">cot</mml:mi><mml:mi>x</mml:mi></mml:mfenced><mml:msup><mml:mi>f</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi mathvariant=\"normal\">g</mml:mi></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>θ</mml:mi><mml:mfrac><mml:mrow><mml:mtext>sin</mml:mtext><mml:mi>x</mml:mi></mml:mrow><mml:mi>x</mml:mi></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi mathvariant=\"normal\">g</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ25\"><label>25</label><alternatives><tex-math id=\"M109\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${A}_{5}{\\theta }^{{\\prime}{\\prime}}+\\left(1+x{\\text{cot}} x\\right)f^{\\prime}{\\theta }=x\\left(\\mathrm{g}\\frac{\\partial \\theta }{\\partial x}- \\frac{\\partial f}{\\partial x}{\\theta }^{\\prime}\\right),$$\\end{document}</tex-math><mml:math id=\"M110\" display=\"block\"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mn>5</mml:mn></mml:msub><mml:msup><mml:mrow><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mo>′</mml:mo><mml:mo>′</mml:mo></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mi>x</mml:mi><mml:mtext>cot</mml:mtext><mml:mi>x</mml:mi></mml:mfenced><mml:msup><mml:mi>f</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mi>θ</mml:mi><mml:mo>=</mml:mo><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:msup><mml:mrow><mml:mi>θ</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ26\"><label>26</label><alternatives><tex-math id=\"M111\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${A}_{6} {h}^{{\\prime}{\\prime}}+\\left(1+x\\mathrm{cot}x\\right)f^{\\prime}{h}-\\mathrm{g}h+{A}_{7}\\left( 2h+{\\mathrm{g}}^{\\prime} \\right)=x\\left(\\mathrm{g} \\frac{\\partial h}{\\partial x}- \\frac{\\partial f}{\\partial x}{h}^{\\prime}\\right),$$\\end{document}</tex-math><mml:math id=\"M112\" display=\"block\"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mn>6</mml:mn></mml:msub><mml:msup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mo>′</mml:mo><mml:mo>′</mml:mo></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mi>x</mml:mi><mml:mi mathvariant=\"normal\">cot</mml:mi><mml:mi>x</mml:mi></mml:mfenced><mml:msup><mml:mi>f</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mi>h</mml:mi><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mi>h</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn><mml:mi>h</mml:mi><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mfenced><mml:mo>=</mml:mo><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:msup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ27\"><label>27</label><alternatives><tex-math id=\"M113\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left.\\begin{array}{c}y=0: f=0, \\mathrm{g}=0, \\,\\,\\,\\,\\,\\,\\,\\theta =1 ,\\,\\,\\,\\,\\,\\,\\,h=-(1/2) {\\mathrm{g}}^{\\prime}\\\\ y\\to \\infty : \\,\\,\\,\\,\\,\\,\\,\\mathrm{g}\\to 0,\\,\\,\\,\\,\\,\\,\\,\\theta \\to 0, h\\to 0\\end{array}\\right\\} ,$$\\end{document}</tex-math><mml:math id=\"M114\" display=\"block\"><mml:mrow><mml:mfenced close=\"}\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>y</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>:</mml:mo><mml:mi>f</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mi>θ</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mi>h</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mi>∞</mml:mi><mml:mo>:</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mi>θ</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>h</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq33\"><alternatives><tex-math id=\"M115\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${A}_{1}=\\frac{{\\rho }_{f}}{{\\rho }_{thnf}}\\left( \\frac{{\\mu }_{thnf}}{{\\mu }_{f}}+K\\right)$$\\end{document}</tex-math><mml:math id=\"M116\"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>μ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mi>K</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq34\"><alternatives><tex-math id=\"M117\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${A}_{2}=({\\chi }_{1}({\\rho \\beta )}_{1}/({\\rho \\beta )}_{f}+{\\chi }_{2}({\\rho \\beta )}_{2}/({\\rho \\beta )}_{f}+{\\chi }_{3}({\\rho \\beta )}_{3}/({\\rho \\beta )}_{f}+[(1-\\chi )])$$\\end{document}</tex-math><mml:math id=\"M118\"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo>=</mml:mo><mml:mo stretchy=\"false\">(</mml:mo></mml:mrow><mml:msub><mml:mi>χ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo stretchy=\"false\">/</mml:mo><mml:mo stretchy=\"false\">(</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>f</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>f</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo stretchy=\"false\">(</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:mi>β</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>f</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>χ</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq35\"><alternatives><tex-math id=\"M119\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${A}_{3}=\\frac{{\\rho }_{f}}{{\\rho }_{thnf}}K,$$\\end{document}</tex-math><mml:math id=\"M120\"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mi>K</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq36\"><alternatives><tex-math id=\"M121\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${A}_{4}= \\frac{-{\\rho }_{f}}{{\\rho }_{thnf}} \\frac{{\\sigma }_{thnf}}{{\\sigma }_{f}}M$$\\end{document}</tex-math><mml:math id=\"M122\"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>-</mml:mo><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mfrac><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>σ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mi>M</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq37\"><alternatives><tex-math id=\"M123\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${A}_{6}=\\frac{{\\rho }_{f}}{{\\rho }_{thnf}} \\left(\\frac{{ \\mu }_{thnf}}{{\\mu }_{f}}+\\frac{K}{2}\\right)$$\\end{document}</tex-math><mml:math id=\"M124\"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mn>6</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>ρ</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>μ</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mi>K</mml:mi><mml:mn>2</mml:mn></mml:mfrac></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq38\"><alternatives><tex-math id=\"M125\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${A}_{7}=\\frac{{-\\rho }_{f}}{{\\rho }_{thnf}}K,$$\\end{document}</tex-math><mml:math id=\"M126\"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mrow><mml:mo>-</mml:mo><mml:mi>ρ</mml:mi></mml:mrow><mml:mi>f</mml:mi></mml:msub><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mi>K</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq39\"><alternatives><tex-math id=\"M127\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${A}_{5}=\\frac{1}{Pr}\\frac{1}{{(\\chi }_{1}({\\rho {c}_{p})}_{1}/({\\rho {c}_{p})}_{f}+{\\chi }_{2}({\\rho {c}_{p})}_{2}/({\\rho {c}_{p})}_{f}+{\\chi }_{3}({\\rho {c}_{p})}_{3}/({\\rho {c}_{p})}_{f}+\\left[\\left(1-\\chi \\right)\\right]}\\left(\\frac{{k}_{thnf}}{{k}_{f}}+\\frac{4}{3}L\\right)$$\\end{document}</tex-math><mml:math id=\"M128\"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mn>5</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant=\"italic\">Pr</mml:mi></mml:mrow></mml:mfrac><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>χ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo stretchy=\"false\">/</mml:mo><mml:mo stretchy=\"false\">(</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mi>f</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo stretchy=\"false\">/</mml:mo><mml:mo stretchy=\"false\">(</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mi>f</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:mo stretchy=\"false\">(</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>ρ</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mi>f</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mfenced close=\"]\" open=\"[\"><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>χ</mml:mi></mml:mfenced></mml:mfenced></mml:mrow></mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">thnf</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>k</mml:mi><mml:mi>f</mml:mi></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>4</mml:mn><mml:mn>3</mml:mn></mml:mfrac><mml:mi>L</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ28\"><label>28</label><alternatives><tex-math id=\"M129\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${f}^{\\prime}_{n+1}={\\mathrm{g}}_{n },$$\\end{document}</tex-math><mml:math id=\"M130\" display=\"block\"><mml:mrow><mml:msubsup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ29\"><label>29</label><alternatives><tex-math id=\"M131\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{{\\mathrm{A}}_{1}\\mathrm{g}}_{n+1}^{{\\prime}{\\prime}}+\\mathrm{a}1}_{n}{\\mathrm{g}}^{\\prime}_{n+1}+{a2}_{n}{\\mathrm{g}}_{n+1}={a3}_{n}+{a4}_{n}\\frac{\\partial {\\mathrm{g}}_{n+1}}{\\partial x},$$\\end{document}</tex-math><mml:math id=\"M132\" display=\"block\"><mml:mrow><mml:msub><mml:mrow><mml:msubsup><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">A</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mo>′</mml:mo><mml:mo>′</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:msubsup><mml:mrow><mml:mi mathvariant=\"normal\">g</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>′</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>a</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>a</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>a</mml:mi><mml:mn>4</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ30\"><label>30</label><alternatives><tex-math id=\"M133\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{{\\mathrm{A}}_{5}\\theta }_{n+1}^{{\\prime}{\\prime}}+b1}_{n}{\\theta^{\\prime} }_{n+1}+{b2}_{n}{\\theta }_{n+1}={b3}_{n}+{b4}_{n}\\frac{\\partial {\\theta }_{n+1}}{\\partial x},$$\\end{document}</tex-math><mml:math id=\"M134\" display=\"block\"><mml:mrow><mml:msub><mml:mrow><mml:msubsup><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">A</mml:mi><mml:mn>5</mml:mn></mml:msub><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mo>′</mml:mo><mml:mo>′</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:mi>b</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:msub><mml:mrow><mml:msup><mml:mi>θ</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>b</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:msub><mml:mi>θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>b</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>b</mml:mi><mml:mn>4</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ31\"><label>31</label><alternatives><tex-math id=\"M135\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{{\\mathrm{A}}_{6}h}_{n+1}^{{\\prime}{\\prime}}+c1}_{n}{h^{\\prime}}_{n+1}+{c2}_{n}{h}_{n+1}={c3}_{n}+{c4}_{n}\\frac{\\partial {h}_{n+1}}{\\partial x},$$\\end{document}</tex-math><mml:math id=\"M136\" display=\"block\"><mml:mrow><mml:msub><mml:mrow><mml:msubsup><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">A</mml:mi><mml:mn>6</mml:mn></mml:msub><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mo>′</mml:mo><mml:mo>′</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:msub><mml:mrow><mml:msup><mml:mi>h</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>c</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>c</mml:mi><mml:mn>4</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq40\"><alternatives><tex-math id=\"M137\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=\\mathrm{0,1},2,\\dots ,$$\\end{document}</tex-math><mml:math id=\"M138\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mo>⋯</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ32\"><label>32</label><alternatives><tex-math id=\"M139\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left.\\begin{array}{c}{f}_{n+1}\\left(x,0\\right)={g}_{n+1}\\left(x,0\\right)=0, {\\theta }_{n+1}\\left(x,0\\right)=1, {h}_{n+1}\\left(x,0\\right)=-\\left(1/2\\right){g^{\\prime}}_{n+1}\\left(x,0\\right)\\\\ {g}_{n+1}\\left(x,{y}_{\\infty }\\right)\\to 0, {\\theta }_{n+1}\\left({x,y}_{\\infty }\\right)\\to 0, {h}_{n+1}\\left({x,y}_{\\infty }\\right)\\to 0 \\end{array}\\right\\},$$\\end{document}</tex-math><mml:math id=\"M140\" display=\"block\"><mml:mrow><mml:mfenced close=\"}\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn></mml:mfenced><mml:msub><mml:mrow><mml:msup><mml:mi>g</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mi>g</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>y</mml:mi><mml:mi>∞</mml:mi></mml:msub></mml:mfenced><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>∞</mml:mi></mml:msub></mml:mfenced><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>∞</mml:mi></mml:msub></mml:mfenced><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ33\"><label>33</label><alternatives><tex-math id=\"M141\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left.\\begin{array}{c}{\\mathrm{a}1}_{\\mathrm{n}}=\\left(1+{x}_{k}\\mathrm{cot}{x}_{k}\\right){f}_{n}+{x}_{k}\\frac{\\partial {f}_{n}}{\\partial x}, {\\mathrm{a}2}_{\\mathrm{n}}=-2{\\mathrm{g}}_{n}+{A}_{4 }-{x}_{k}\\frac{\\partial {\\mathrm{g}}_{n}}{\\partial x}, {\\mathrm{a}4}_{\\mathrm{n}}={x}_{k}{\\mathrm{g}}_{n}\\\\ {\\mathrm{a}3}_{\\mathrm{n}}=-\\left({\\mathrm{g}}_{\\mathrm{n}}^{2}+{A}_{2}{\\uptheta }_{n}\\frac{\\mathrm{sin}{x}_{k}}{{x}_{k}}+{A}_{3}{h^{\\prime}}_{n}+{x}_{k}{\\mathrm{g}}_{n}\\frac{\\partial {\\mathrm{g}}_{n}}{\\partial x}\\right), {b1}_{n}={\\mathrm{a}1}_{\\mathrm{n}}, {b2}_{n}=0 , {\\mathrm{b}3}_{\\mathrm{n}}=0\\\\ {{\\mathrm{b}4}_{\\mathrm{n}}=\\mathrm{a}4}_{\\mathrm{n}}{, c1}_{n}={\\mathrm{a}1}_{\\mathrm{n}}, {c2}_{n}=2{A}_{7}-\\mathrm{g}, {c3}_{n}={-\\mathrm{g^{\\prime}}}{A}_{7}, {\\mathrm{ c}4}_{\\mathrm{n}}={\\mathrm{a}4}_{\\mathrm{n}}\\end{array}\\right\\},$$\\end{document}</tex-math><mml:math id=\"M142\" display=\"block\"><mml:mrow><mml:mfenced close=\"}\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mi mathvariant=\"normal\">cot</mml:mi><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mfenced><mml:msub><mml:mi>f</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi>f</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>4</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi mathvariant=\"normal\">θ</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi mathvariant=\"normal\">sin</mml:mi><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mrow><mml:msup><mml:mi>h</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>b</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>b</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">b</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">b</mml:mi><mml:mn>4</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>4</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi>A</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>c</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>-</mml:mo><mml:msup><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">c</mml:mi><mml:mn>4</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>4</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ34\"><label>34</label><alternatives><tex-math id=\"M143\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${f}_{n}={f}_{n}\\left({x}_{k}{,y}_{j}\\right), {\\mathrm{g}}_{\\mathrm{n}}={\\mathrm{g}}_{n}\\left({x}_{k}{,y}_{j}\\right), {\\theta }_{n}={\\theta }_{n}\\left({x}_{k}{,y}_{j}\\right), {\\mathrm{h}}_{\\mathrm{n}}={\\mathrm{h}}_{n}\\left({x}_{k}{,y}_{j}\\right).$$\\end{document}</tex-math><mml:math id=\"M144\" display=\"block\"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>,</mml:mo><mml:msub><mml:mi>θ</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>θ</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">h</mml:mi><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">h</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq41\"><alternatives><tex-math id=\"M145\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$y$$\\end{document}</tex-math><mml:math id=\"M146\"><mml:mi>y</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq42\"><alternatives><tex-math id=\"M147\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x$$\\end{document}</tex-math><mml:math id=\"M148\"><mml:mi>x</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq43\"><alternatives><tex-math id=\"M149\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left({x}_{k}, {y}_{j}\\right)$$\\end{document}</tex-math><mml:math id=\"M150\"><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>y</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ35\"><label>35</label><alternatives><tex-math id=\"M151\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${x}_{k}=k{\\Delta x}_{k}\\mathrm{\\,and\\,}{y}_{j}=\\frac{1}{2}\\left[1-\\mathrm{cos}\\frac{j\\pi }{{N}_{{\\overline{y} }_{\\infty }}}\\right]{\\overline{y} }_{\\infty }, k=\\mathrm{0,1},\\dots , {N}_{x} , j=\\mathrm{0,1},\\dots , {N}_{{\\overline{y} }_{\\infty }},$$\\end{document}</tex-math><mml:math id=\"M152\" display=\"block\"><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi>k</mml:mi><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>x</mml:mi></mml:mrow><mml:mi>k</mml:mi></mml:msub><mml:mrow><mml:mspace width=\"0.166667em\"/><mml:mi mathvariant=\"normal\">and</mml:mi><mml:mspace width=\"0.166667em\"/></mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:mfrac><mml:mfenced close=\"]\" open=\"[\"><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">cos</mml:mi><mml:mfrac><mml:mrow><mml:mi>j</mml:mi><mml:mi>π</mml:mi></mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:msub><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub></mml:msub></mml:mfrac></mml:mfenced><mml:msub><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>,</mml:mo><mml:mo>⋯</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>,</mml:mo><mml:mo>⋯</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:msub><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq44\"><alternatives><tex-math id=\"M153\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\Delta x}_{k}$$\\end{document}</tex-math><mml:math id=\"M154\"><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>x</mml:mi></mml:mrow><mml:mi>k</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq45\"><alternatives><tex-math id=\"M155\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathrm{x}$$\\end{document}</tex-math><mml:math id=\"M156\"><mml:mi mathvariant=\"normal\">x</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq46\"><alternatives><tex-math id=\"M157\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\overline{\\mathrm{y}} }_{\\infty }$$\\end{document}</tex-math><mml:math id=\"M158\"><mml:msub><mml:mover><mml:mi mathvariant=\"normal\">y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq47\"><alternatives><tex-math id=\"M159\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${y}_{\\infty }$$\\end{document}</tex-math><mml:math id=\"M160\"><mml:msub><mml:mi>y</mml:mi><mml:mi>∞</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq48\"><alternatives><tex-math id=\"M161\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${N}_{x}\\, and\\, { N}_{{\\overline{y} }_{\\infty }}$$\\end{document}</tex-math><mml:math id=\"M162\"><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mspace width=\"0.166667em\"/><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mspace width=\"0.166667em\"/><mml:msub><mml:mi>N</mml:mi><mml:msub><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq49\"><alternatives><tex-math id=\"M163\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x$$\\end{document}</tex-math><mml:math id=\"M164\"><mml:mi>x</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq50\"><alternatives><tex-math id=\"M165\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$y$$\\end{document}</tex-math><mml:math id=\"M166\"><mml:mi>y</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ36\"><label>36</label><alternatives><tex-math id=\"M167\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left.\\begin{array}{c}{F}_{n+1}^{\\left(m\\right)}\\left({x}_{k}{,y}_{j}\\right)={D}^{m}{F}_{n+1}\\left({x}_{k}{,y}_{j}\\right)\\\\ {G}_{n+1}^{\\left(m\\right)}\\left({x}_{k}{,y}_{j}\\right)={D}^{m}{G}_{n+1}\\left({x}_{k}{,y}_{j}\\right)\\\\ {\\Theta }_{n+1}^{\\left(m\\right)}\\left({x}_{k}{,y}_{j}\\right)={D}^{m}{\\Theta }_{n+1}\\left({x}_{k}{,y}_{j}\\right)\\\\ {H}_{n+1}^{\\left(m\\right)}\\left({x}_{k}{,y}_{j}\\right)={D}^{m}{H}_{n+1}\\left({x}_{k}{,y}_{j}\\right)\\end{array}\\right\\} k=0:{N}_{x}, j=0:{N}_{{\\overline{y} }_{\\infty }}, m=\\mathrm{1,2},$$\\end{document}</tex-math><mml:math id=\"M168\" display=\"block\"><mml:mrow><mml:mfenced close=\"}\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msubsup><mml:mi>F</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>m</mml:mi></mml:mfenced></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msup><mml:msub><mml:mi>F</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msubsup><mml:mi>G</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>m</mml:mi></mml:mfenced></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msup><mml:msub><mml:mi>G</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msubsup><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>m</mml:mi></mml:mfenced></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msubsup><mml:mi>H</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>m</mml:mi></mml:mfenced></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mi>m</mml:mi></mml:msup><mml:msub><mml:mi>H</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>:</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>:</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:msub><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub></mml:msub><mml:mo>,</mml:mo><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq51\"><alternatives><tex-math id=\"M169\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\mathrm{D}}^{1},\\mathrm{\\, and\\, }{\\mathrm{D}}^{2}$$\\end{document}</tex-math><mml:math id=\"M170\"><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">D</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msup><mml:mo>,</mml:mo><mml:mrow><mml:mspace width=\"0.166667em\"/><mml:mi mathvariant=\"normal\">and</mml:mi><mml:mspace width=\"0.166667em\"/></mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">D</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq52\"><alternatives><tex-math id=\"M171\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$[0,{\\overline{\\mathrm{y}} }_{\\infty } ]$$\\end{document}</tex-math><mml:math id=\"M172\"><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mover><mml:mi mathvariant=\"normal\">y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq53\"><alternatives><tex-math id=\"M173\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${F}_{n+1}=\\left[{f}_{n+1}\\left({x}_{k}{,y}_{j}\\right)\\right]$$\\end{document}</tex-math><mml:math id=\"M174\"><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=\"]\" open=\"[\"><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq54\"><alternatives><tex-math id=\"M175\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${G}_{n+1}=\\left[{\\mathrm{g}}_{n+1}\\left({x}_{k}{,y}_{j}\\right)\\right]$$\\end{document}</tex-math><mml:math id=\"M176\"><mml:mrow><mml:msub><mml:mi>G</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=\"]\" open=\"[\"><mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq55\"><alternatives><tex-math id=\"M177\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\Theta }_{n+1}=\\left[{\\theta }_{n+1}\\left({x}_{k}{,y}_{j}\\right)\\right]$$\\end{document}</tex-math><mml:math id=\"M178\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=\"]\" open=\"[\"><mml:msub><mml:mi>θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq56\"><alternatives><tex-math id=\"M179\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${H}_{n+1}=\\left[{h}_{n+1}\\left({x}_{k}{,y}_{j}\\right)\\right]$$\\end{document}</tex-math><mml:math id=\"M180\"><mml:mrow><mml:msub><mml:mi>H</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=\"]\" open=\"[\"><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq57\"><alternatives><tex-math id=\"M181\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${F}_{n+1}^{\\left(m\\right)}$$\\end{document}</tex-math><mml:math id=\"M182\"><mml:msubsup><mml:mi>F</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>m</mml:mi></mml:mfenced></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq58\"><alternatives><tex-math id=\"M183\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${G}_{n+1}^{\\left(m\\right)}$$\\end{document}</tex-math><mml:math id=\"M184\"><mml:msubsup><mml:mi>G</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>m</mml:mi></mml:mfenced></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq59\"><alternatives><tex-math id=\"M185\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\Theta }_{n+1}^{\\left(m\\right)}$$\\end{document}</tex-math><mml:math id=\"M186\"><mml:msubsup><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>m</mml:mi></mml:mfenced></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq60\"><alternatives><tex-math id=\"M187\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${H}_{n+1}^{\\left(m\\right)}$$\\end{document}</tex-math><mml:math id=\"M188\"><mml:msubsup><mml:mi>H</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>m</mml:mi></mml:mfenced></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq61\"><alternatives><tex-math id=\"M189\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left[{f}_{n+1}^{\\left(m\\right)}\\left({x}_{k}{,y}_{j}\\right)\\right]$$\\end{document}</tex-math><mml:math id=\"M190\"><mml:mfenced close=\"]\" open=\"[\"><mml:msubsup><mml:mi>f</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>m</mml:mi></mml:mfenced></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mfenced></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq62\"><alternatives><tex-math id=\"M191\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left[{\\mathrm{g}}_{n+1}^{\\left(m\\right)}\\left({x}_{k}{,y}_{j}\\right)\\right]$$\\end{document}</tex-math><mml:math id=\"M192\"><mml:mfenced close=\"]\" open=\"[\"><mml:msubsup><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>m</mml:mi></mml:mfenced></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mfenced></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq63\"><alternatives><tex-math id=\"M193\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left[{\\theta }_{n+1}^{\\left(m\\right)}\\left({x}_{k}{,y}_{j}\\right)\\right]$$\\end{document}</tex-math><mml:math id=\"M194\"><mml:mfenced close=\"]\" open=\"[\"><mml:msubsup><mml:mi>θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>m</mml:mi></mml:mfenced></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mfenced></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq64\"><alternatives><tex-math id=\"M195\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left[{h}_{n+1}^{\\left(m\\right)}\\left({x}_{k}{,y}_{j}\\right)\\right]$$\\end{document}</tex-math><mml:math id=\"M196\"><mml:mfenced close=\"]\" open=\"[\"><mml:msubsup><mml:mi>h</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>m</mml:mi></mml:mfenced></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mfenced></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq65\"><alternatives><tex-math id=\"M197\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x$$\\end{document}</tex-math><mml:math id=\"M198\"><mml:mi>x</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ37\"><label>37</label><alternatives><tex-math id=\"M199\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\left.\\frac{\\partial\\Gamma }{\\partial x}\\right|}_{{n+1 (x}_{k}{,y}_{j)}}=\\frac{{\\Gamma }_{n+1}\\left({x}_{k}{,y}_{j}\\right)-{\\Gamma }_{n+1}\\left({x}_{k-1}{,y}_{j}\\right)}{\\Delta x}, k=1:{N}_{x}, j=0:{N}_{{\\overline{y} }_{\\infty }}.$$\\end{document}</tex-math><mml:math id=\"M200\" display=\"block\"><mml:mrow><mml:msub><mml:mfenced close=\"|\"><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi mathvariant=\"normal\">Γ</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac></mml:mfenced><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi></mml:mrow><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>-</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>:</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>:</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:msub><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq66\"><alternatives><tex-math id=\"M201\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x$$\\end{document}</tex-math><mml:math id=\"M202\"><mml:mi>x</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq67\"><alternatives><tex-math id=\"M203\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma \\left({x}_{k}{,y}_{j}\\right)=\\mathrm{g}\\left({x}_{k}{,y}_{j}\\right)$$\\end{document}</tex-math><mml:math id=\"M204\"><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq68\"><alternatives><tex-math id=\"M205\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\theta \\left({x}_{k}{,y}_{j}\\right),$$\\end{document}</tex-math><mml:math id=\"M206\"><mml:mrow><mml:mi>θ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq69\"><alternatives><tex-math id=\"M207\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$h\\left({x}_{k}{,y}_{j}\\right)$$\\end{document}</tex-math><mml:math id=\"M208\"><mml:mrow><mml:mi>h</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq70\"><alternatives><tex-math id=\"M209\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${x}_{k}$$\\end{document}</tex-math><mml:math id=\"M210\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ38\"><label>38</label><alternatives><tex-math id=\"M211\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left.\\begin{array}{c}\\begin{array}{c}{\\mathrm{D}}^{1}{F}_{n+1}\\left({x}_{k}{,y}_{j}\\right)={\\mathrm{G}}_{n }\\left({x}_{k}{,y}_{j}\\right)\\\\ \\left[{\\mathrm{A}}_{1}{{D}^{2}{G}_{n+1}+\\mathrm{a}1}_{\\mathrm{n}}{\\mathrm{D}}^{1}{G}_{n+1}+{\\mathrm{a}2}_{\\mathrm{n}}{\\mathrm{G}}_{\\mathrm{n}+1}\\right]\\left({x}_{k}{,y}_{j}\\right)={\\mathrm{a}3}_{\\mathrm{n}}+{a4}_{n}\\frac{{\\mathrm{G}}_{\\mathrm{n}+1}\\left({x}_{k}{,y}_{j}\\right)-{\\mathrm{G}}_{\\mathrm{n}+1}\\left({x}_{k-1}{,y}_{j}\\right)}{\\Delta x}\\\\ \\left[{\\mathrm{A}}_{5}{{D}^{2}{\\Theta }_{n+1}+\\mathrm{b}1}_{\\mathrm{n}}{\\mathrm{D}}^{1}{\\Theta }_{n+1}+{\\mathrm{b}2}_{\\mathrm{n}}{\\Theta }_{n+1}\\right]\\left({x}_{k}{,y}_{j}\\right)={\\mathrm{b}3}_{\\mathrm{n}}+{b4}_{n}\\frac{{\\Theta }_{\\mathrm{n}+1}\\left({x}_{k}{,y}_{j}\\right)-{\\Theta }_{\\mathrm{n}+1}\\left({x}_{k-1}{,y}_{j}\\right)}{\\Delta x}\\\\ \\left[{\\mathrm{A}}_{6}{{D}^{2}{\\mathrm{H}}_{n+1}+\\mathrm{c}1}_{\\mathrm{n}}{\\mathrm{D}}^{1}{\\mathrm{H}}_{n+1}+{\\mathrm{c}2}_{\\mathrm{n}}{\\mathrm{H}}_{\\mathrm{n}+1}\\right]\\left({x}_{k}{,y}_{j}\\right)={\\mathrm{c}3}_{\\mathrm{n}}+{c4}_{n} \\frac{{\\mathrm{H}}_{\\mathrm{n}+1}\\left({x}_{k}{,y}_{j}\\right)-{\\mathrm{H}}_{\\mathrm{n}+1}\\left({x}_{k-1}{,y}_{j}\\right)}{\\Delta x} \\end{array}\\end{array}\\right\\} ,$$\\end{document}</tex-math><mml:math id=\"M212\" display=\"block\"><mml:mrow><mml:mfenced close=\"}\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">D</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msup><mml:msub><mml:mi>F</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">G</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mfenced close=\"]\" open=\"[\"><mml:msub><mml:mi mathvariant=\"normal\">A</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi>G</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">D</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msup><mml:msub><mml:mi>G</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:msub><mml:mi mathvariant=\"normal\">G</mml:mi><mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mfenced><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>a</mml:mi><mml:mn>4</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">G</mml:mi><mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>-</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">G</mml:mi><mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mfenced close=\"]\" open=\"[\"><mml:msub><mml:mi mathvariant=\"normal\">A</mml:mi><mml:mn>5</mml:mn></mml:msub><mml:msub><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">b</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">D</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">b</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:msub><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mfenced><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">b</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>b</mml:mi><mml:mn>4</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>-</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mfenced close=\"]\" open=\"[\"><mml:msub><mml:mi mathvariant=\"normal\">A</mml:mi><mml:mn>6</mml:mn></mml:msub><mml:msub><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">H</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">c</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">D</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">H</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">c</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:msub><mml:mi mathvariant=\"normal\">H</mml:mi><mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mfenced><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">c</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>c</mml:mi><mml:mn>4</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">H</mml:mi><mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>-</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">H</mml:mi><mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equa\"><alternatives><tex-math id=\"M213\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k=1:{N}_{x}, j=0:{N}_{{\\overline{y} }_{\\infty }}.$$\\end{document}</tex-math><mml:math id=\"M214\" display=\"block\"><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>:</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>:</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:msub><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ39\"><label>39</label><alternatives><tex-math id=\"M215\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left.\\begin{array}{c}{F}_{n+1}\\left({x}_{k},0\\right)={\\mathrm{G}}_{n+1}\\left({x}_{k},0\\right)=0 , {\\Theta }_{n+1}\\left({x}_{k},0\\right)=1, { H}_{n+1}\\left({x}_{k},0\\right)=-\\left({\\mathrm{D}}^{1}{G}_{n+1}\\left({x}_{k},0\\right)/2\\right), \\\\ {\\mathrm{ G}}_{n+1}\\left({x}_{k}{,N}_{{\\overline{y} }_{\\infty }}\\right)\\to 0, {\\Theta }_{n+1}\\left({x}_{k}{,N}_{{\\overline{y} }_{\\infty }}\\right)\\to 0, {\\mathrm{ H}}_{n+1}\\left({x}_{k}{,N}_{{\\overline{y} }_{\\infty }}\\right)\\to 0\\end{array}\\right\\}$$\\end{document}</tex-math><mml:math id=\"M216\" display=\"block\"><mml:mfenced close=\"}\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">G</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>H</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">D</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msup><mml:msub><mml:mi>G</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mi mathvariant=\"normal\">G</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>N</mml:mi></mml:mrow><mml:msub><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub></mml:msub></mml:mfenced><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>N</mml:mi></mml:mrow><mml:msub><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub></mml:msub></mml:mfenced><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">H</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>N</mml:mi></mml:mrow><mml:msub><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub></mml:msub></mml:mfenced><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq71\"><alternatives><tex-math id=\"M217\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${x}_{k}$$\\end{document}</tex-math><mml:math id=\"M218\"><mml:msub><mml:mi>x</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq72\"><alternatives><tex-math id=\"M219\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k=1:{N}_{x}$$\\end{document}</tex-math><mml:math id=\"M220\"><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>:</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>x</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq73\"><alternatives><tex-math id=\"M221\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${x}_{0}\\approx 0$$\\end{document}</tex-math><mml:math id=\"M222\"><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>≈</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq74\"><alternatives><tex-math id=\"M223\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k=0$$\\end{document}</tex-math><mml:math id=\"M224\"><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq75\"><alternatives><tex-math id=\"M225\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$j=0:{N}_{{\\overline{y} }_{\\infty }}$$\\end{document}</tex-math><mml:math id=\"M226\"><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>:</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:msub><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ40\"><label>40</label><alternatives><tex-math id=\"M227\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left.\\begin{array}{c}\\begin{array}{c}{\\mathrm{D}}^{1}{F}_{n+1}\\left({x}_{0}{,y}_{j}\\right)={\\mathrm{G}}_{n }\\left({x}_{0}{,y}_{j}\\right)\\\\ \\left[{\\mathrm{A}}_{1}{{D}^{2}{G}_{n+1}+\\mathrm{a}1}_{\\mathrm{n}}{\\mathrm{D}}^{1}{G}_{n+1}+{\\mathrm{a}2}_{\\mathrm{n}}{\\mathrm{G}}_{\\mathrm{n}+1}\\right]\\left({x}_{0}{,y}_{j}\\right)={\\mathrm{a}3}_{\\mathrm{n}}\\\\ \\left[{\\mathrm{A}}_{5}{{D}^{2}{\\Theta }_{n+1}+\\mathrm{b}1}_{\\mathrm{n}}{\\mathrm{D}}^{1}{\\Theta }_{n+1}\\left({x}_{0}{,y}_{j}\\right)+{\\mathrm{b}2}_{\\mathrm{n}}{\\Theta }_{n+1}\\right]\\left({x}_{0}{,y}_{j}\\right)={\\mathrm{b}3}_{\\mathrm{n}}\\\\ \\left[{\\mathrm{A}}_{6}{{D}^{2}{\\mathrm{H}}_{n+1}+\\mathrm{c}1}_{\\mathrm{n}}{\\mathrm{D}}^{1}{\\mathrm{H}}_{n+1}+{\\mathrm{c}2}_{\\mathrm{n}}{\\mathrm{H}}_{\\mathrm{n}+1}\\right]\\left({x}_{0}{,y}_{j}\\right)={\\mathrm{c}3}_{\\mathrm{n}} \\end{array}\\end{array}\\right\\}.$$\\end{document}</tex-math><mml:math id=\"M228\" display=\"block\"><mml:mrow><mml:mfenced close=\"}\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">D</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msup><mml:msub><mml:mi>F</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">G</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mfenced close=\"]\" open=\"[\"><mml:msub><mml:mi mathvariant=\"normal\">A</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi>G</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">D</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msup><mml:msub><mml:mi>G</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:msub><mml:mi mathvariant=\"normal\">G</mml:mi><mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mfenced><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mfenced close=\"]\" open=\"[\"><mml:msub><mml:mi mathvariant=\"normal\">A</mml:mi><mml:mn>5</mml:mn></mml:msub><mml:msub><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">b</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">D</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">b</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:msub><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mfenced><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">b</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mfenced close=\"]\" open=\"[\"><mml:msub><mml:mi mathvariant=\"normal\">A</mml:mi><mml:mn>6</mml:mn></mml:msub><mml:msub><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">H</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">c</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">D</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">H</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">c</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:msub><mml:mi mathvariant=\"normal\">H</mml:mi><mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mfenced><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>x</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">c</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ41\"><label>41</label><alternatives><tex-math id=\"M229\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left.\\begin{array}{c}{F}_{n+1}\\left(0,0\\right)={\\mathrm{G}}_{n+1}\\left(0,0\\right)=0 , {\\Theta }_{n+1}\\left(0,0\\right)=1, {, H}_{n+1}\\left(0,0\\right)=-\\left({\\mathrm{D}}^{1}{G}_{n+1}\\left(0,0\\right)/2\\right) \\\\ {\\mathrm{ G}}_{n+1}\\left(0{,N}_{{\\overline{y} }_{\\infty }}\\right)\\to 0, {\\Theta }_{n+1}\\left(0{,N}_{{\\overline{y} }_{\\infty }}\\right)\\to 0, {\\mathrm{ H}}_{n+1}\\left(0{,N}_{{\\overline{y} }_{\\infty }}\\right)\\to 0\\end{array}\\right\\} ,$$\\end{document}</tex-math><mml:math id=\"M230\" display=\"block\"><mml:mrow><mml:mfenced close=\"}\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">G</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:msup><mml:mrow><mml:mi mathvariant=\"normal\">D</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msup><mml:msub><mml:mi>G</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mfenced><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mi mathvariant=\"normal\">G</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mn>0</mml:mn><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>N</mml:mi></mml:mrow><mml:msub><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub></mml:msub></mml:mfenced><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mn>0</mml:mn><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>N</mml:mi></mml:mrow><mml:msub><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub></mml:msub></mml:mfenced><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">H</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mn>0</mml:mn><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>N</mml:mi></mml:mrow><mml:msub><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub></mml:msub></mml:mfenced><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ42\"><label>42</label><alternatives><tex-math id=\"M231\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left.\\begin{array}{c}{\\mathrm{a}1}_{\\mathrm{n}}=2{f}_{n}, {\\mathrm{a}2}_{\\mathrm{n}}=-2{\\mathrm{g}}_{n}+{A}_{4 }, {\\mathrm{a}4}_{\\mathrm{n}}=0, {\\mathrm{a}3}_{\\mathrm{n}}=-\\left({\\mathrm{g}}_{\\mathrm{n}}^{2}+{A}_{2}{\\uptheta }_{n}+{A}_{3}{h}^{\\prime}_{n}\\right), {b1}_{n}={\\mathrm{a}1}_{\\mathrm{n}}\\\\ {b2}_{n}={\\mathrm{b}3}_{\\mathrm{n}}={\\mathrm{b}4}_{\\mathrm{n}}=0{, c1}_{n}={\\mathrm{a}1}_{\\mathrm{n}}, {c2}_{n}=2{A}_{7}-\\mathrm{g}, {c3}_{n}={-\\mathrm{g}}^{\\prime}{A}_{7} , {\\mathrm{c}4}_{\\mathrm{n}}=0\\end{array}\\right\\}.$$\\end{document}</tex-math><mml:math id=\"M232\" display=\"block\"><mml:mrow><mml:mfenced close=\"}\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi>f</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>4</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi mathvariant=\"normal\">θ</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msubsup><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mi>n</mml:mi><mml:mo>′</mml:mo></mml:msubsup></mml:mfenced><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>b</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mrow><mml:mi>b</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">b</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">b</mml:mi><mml:mn>4</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">a</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi>A</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">g</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>c</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">g</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msup><mml:msub><mml:mi>A</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant=\"normal\">c</mml:mi><mml:mn>4</mml:mn></mml:mrow><mml:mi mathvariant=\"normal\">n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq76\"><alternatives><tex-math id=\"M233\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${10}^{-6}$$\\end{document}</tex-math><mml:math id=\"M234\"><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ43\"><label>43</label><alternatives><tex-math id=\"M235\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left.\\begin{array}{c}{F}_{0}\\left(0{,y}_{j}\\right)=-1+{e}^{-{y}_{j}^{2}}, {\\mathrm{G}}_{0}\\left(0{,y}_{j}\\right)=-2{{,y}_{j}e}^{-{y}_{j}^{2}}\\\\ {\\Theta }_{0}\\left(0{,y}_{j}\\right)={e}^{-{y}_{j}}, and {H}_{0}\\left(0{,y}_{j}\\right)=\\left(1-2{y}_{j}^{2}\\right){e}^{-{y}_{j}^{2}}\\end{array}\\right\\} , j=0:{N}_{{\\overline{y} }_{\\infty }}.$$\\end{document}</tex-math><mml:math id=\"M236\" display=\"block\"><mml:mrow><mml:mfenced close=\"}\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mn>0</mml:mn><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:msubsup><mml:mi>y</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">G</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mn>0</mml:mn><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:msubsup><mml:mi>y</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:msup></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mi mathvariant=\"normal\">Θ</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mn>0</mml:mn><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:msub><mml:mi>y</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:msub><mml:mi>H</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mn>0</mml:mn><mml:msub><mml:mrow><mml:mo>,</mml:mo><mml:mi>y</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:msubsup><mml:mi>y</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:msubsup><mml:mi>y</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:msup></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>:</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:msub><mml:mover><mml:mi>y</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>∞</mml:mi></mml:msub></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq77\"><alternatives><tex-math id=\"M237\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$K, \\mathrm{L}, M, {\\chi }_{1}, { \\chi }_{2},\\mathrm{ \\,and\\, }{\\chi }_{3}$$\\end{document}</tex-math><mml:math id=\"M238\"><mml:mrow><mml:mi>K</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">L</mml:mi><mml:mo>,</mml:mo><mml:mi>M</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mrow><mml:mspace width=\"0.166667em\"/><mml:mi mathvariant=\"normal\">and</mml:mi><mml:mspace width=\"0.166667em\"/></mml:mrow><mml:msub><mml:mi>χ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq78\"><alternatives><tex-math id=\"M239\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${Gr}^{-1/4}Nu$$\\end{document}</tex-math><mml:math id=\"M240\"><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant=\"italic\">Gr</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup><mml:mi>N</mml:mi><mml:mi>u</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq79\"><alternatives><tex-math id=\"M241\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\chi$$\\end{document}</tex-math><mml:math id=\"M242\"><mml:mi>χ</mml:mi></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2023_47853_Article_Equ1.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ2.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq9.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ3.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ4.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq10.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq11.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq12.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq13.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq14.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig2_HTML\" id=\"MO2\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq15.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq16.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ5.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ6.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ7.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ8.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq17.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq18.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq19.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ9.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq20.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq21.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq22.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ10.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq23.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq24.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq25.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ11.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ12.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ13.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ14.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq26.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq27.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq28.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq29.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq30.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ15.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq31.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ16.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ17.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ18.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ19.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ20.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ21.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ22.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq32.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ23.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ24.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ25.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ26.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ27.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq33.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq34.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq35.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq36.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq37.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq38.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq39.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ28.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ29.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ30.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ31.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq40.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ32.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ33.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ34.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq41.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq42.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq43.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ35.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq44.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq45.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq46.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq47.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq48.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq49.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq50.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ36.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq51.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq52.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq53.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq54.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq55.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq56.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq57.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq58.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq59.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq60.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq61.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq62.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq63.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq64.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq65.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ37.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq66.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq67.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq68.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq69.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq70.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ38.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equa.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ39.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq71.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq72.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq73.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq74.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq75.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ40.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ41.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ42.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq76.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Article_Equ43.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq77.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq78.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_47853_Article_IEq79.gif\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig6_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig7_HTML\" id=\"MO7\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig8_HTML\" id=\"MO8\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig9_HTML\" id=\"MO9\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig10_HTML\" id=\"MO10\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig11_HTML\" id=\"MO11\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig12_HTML\" id=\"MO12\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig13_HTML\" id=\"MO13\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig14_HTML\" id=\"MO14\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig15_HTML\" id=\"MO15\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig16_HTML\" id=\"MO16\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig17_HTML\" id=\"MO17\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig18_HTML\" id=\"MO18\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig19_HTML\" id=\"MO19\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig20_HTML\" id=\"MO20\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig21_HTML\" id=\"MO21\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig22_HTML\" id=\"MO22\"/>", "<graphic xlink:href=\"41598_2023_47853_Fig23_HTML\" id=\"MO23\"/>" ]
[]
[{"label": ["1."], "surname": ["Amraqui", "Mezrhab", "Abid"], "given-names": ["S", "A", "C"], "article-title": ["Combined natural convection and surface radiation in solar collector equipped with partitions"], "source": ["Appl. Solar Energy"], "year": ["2011"], "volume": ["47"], "fpage": ["36"], "lpage": ["47"], "pub-id": ["10.3103/S0003701X11010051"]}, {"label": ["2."], "surname": ["Tien", "Wang"], "given-names": ["H-C", "C"], "article-title": ["Solidification of a liquid metal with natural convection in a thick-walled container"], "source": ["J. Mech."], "year": ["1999"], "volume": ["15"], "fpage": ["47"], "lpage": ["55"], "pub-id": ["10.1017/S1727719100000320"]}, {"label": ["3."], "surname": ["Syah", "Davarpanah", "Elveny", "Ramdan"], "given-names": ["R", "A", "M", "D"], "article-title": ["Natural convection of water and nano-emulsion phase change material inside a square enclosure to cool the electronic components"], "source": ["Int. J. Energy Res."], "year": ["2022"], "volume": ["46"], "fpage": ["2403"], "lpage": ["2417"], "pub-id": ["10.1002/er.7316"]}, {"label": ["4."], "surname": ["Garoosi", "Jahanshaloo", "Rashidi", "Badakhsh", "Ali"], "given-names": ["F", "L", "MM", "A", "ME"], "article-title": ["Numerical simulation of natural convection of the nanofluid in heat exchangers using a Buongiorno model"], "source": ["Appl. Math. Comput."], "year": ["2015"], "volume": ["254"], "fpage": ["183"], "lpage": ["203"]}, {"label": ["5."], "surname": ["Al-Habahbeh", "Al-Saqqa", "Safi", "Khater"], "given-names": ["O", "M", "M", "TA"], "article-title": ["Review of magnetohydrodynamic pump applications"], "source": ["Alexand. Eng. J."], "year": ["2016"], "volume": ["55"], "fpage": ["1347"], "lpage": ["1358"], "pub-id": ["10.1016/j.aej.2016.03.001"]}, {"label": ["6."], "mixed-citation": ["Qiu, H. "], "italic": ["Feasibility Study on MHD Energy Conversion for Applications in Liquid Metal Cooled Nuclear Reactors"]}, {"label": ["7."], "surname": ["Sheikholeslami", "Hayat", "Alsaedi"], "given-names": ["M", "T", "A"], "article-title": ["MHD free convection of Al2O3\u2013water nanofluid considering thermal radiation: A numerical study"], "source": ["Int. J. Heat Mass Transf."], "year": ["2016"], "volume": ["96"], "fpage": ["513"], "lpage": ["524"], "pub-id": ["10.1016/j.ijheatmasstransfer.2016.01.059"]}, {"label": ["8."], "surname": ["El-Kabeir", "Rashad", "Khan", "Abdelrahman"], "given-names": ["S", "A", "W", "ZM"], "article-title": ["Micropolar ferrofluid flow via natural convective about a radiative isoflux sphere"], "source": ["Adv. Mech. Eng."], "year": ["2021"], "volume": ["13"], "fpage": ["1687814021994392"], "pub-id": ["10.1177/1687814021994392"]}, {"label": ["9."], "surname": ["Lone", "Anwar", "Raizah", "Kumam", "Seangwattana", "Saeed"], "given-names": ["SA", "S", "Z", "P", "T", "A"], "article-title": ["Analysis of the time-dependent magnetohydrodynamic Newtonian fluid flow over a rotating sphere with thermal radiation and chemical reaction"], "source": ["Heliyon"], "year": ["2023"], "volume": ["9"], "fpage": ["7"], "pub-id": ["10.1016/j.heliyon.2023.e17751"]}, {"label": ["10."], "surname": ["Ali", "Liu", "Ali", "Mujeed", "Abdal"], "given-names": ["L", "X", "B", "S", "S"], "article-title": ["Finite element simulation of multi-slip effects on unsteady MHD bioconvective micropolar nanofluid flow over a sheet with solutal and thermal convective boundary conditions"], "source": ["Coatings"], "year": ["2019"], "volume": ["9"], "fpage": ["842"], "pub-id": ["10.3390/coatings9120842"]}, {"label": ["11."], "surname": ["Ali", "Ali", "Ghori"], "given-names": ["L", "B", "MB"], "article-title": ["Melting effect on Cattaneo-Christov and thermal radiation features for aligned MHD nanofluid flow comprising microorganisms to leading edge: FEM approach"], "source": ["Comput. Math. Appl."], "year": ["2022"], "volume": ["109"], "fpage": ["260"], "lpage": ["269"], "pub-id": ["10.1016/j.camwa.2022.01.009"]}, {"label": ["12."], "surname": ["Kumar", "Poonia", "Ali", "Areekara"], "given-names": ["P", "H", "L", "S"], "article-title": ["The numerical simulation of nanoparticle size and thermal radiation with the magnetic field effect based on tangent hyperbolic nanofluid flow"], "source": ["Case Stud. Therm. Eng."], "year": ["2022"], "volume": ["37"], "fpage": ["102247"], "pub-id": ["10.1016/j.csite.2022.102247"]}, {"label": ["13."], "surname": ["Kumar", "Poonia", "Ali", "Shah", "Chung"], "given-names": ["P", "H", "L", "NA", "JD"], "article-title": ["Significance of Weissenberg number, Soret effect and multiple slips on the dynamic of biconvective magnetohydrodynamic carreau nanofuid flow"], "source": ["Mathematics"], "year": ["2023"], "volume": ["11"], "fpage": ["1685"], "pub-id": ["10.3390/math11071685"]}, {"label": ["14."], "surname": ["Eringen"], "given-names": ["AC"], "article-title": ["Theory of micropolar fluids"], "source": ["J. Math. Mech."], "year": ["1966"], "volume": ["16"], "fpage": ["1"], "lpage": ["18"]}, {"label": ["15."], "surname": ["Nazar", "Amin", "Gro\u015fan", "Pop"], "given-names": ["R", "N", "T", "I"], "article-title": ["Free convection boundary layer on a sphere with constant surface heat flux in a micropolar fluid"], "source": ["Int. Commun. Heat Mass Transf."], "year": ["2002"], "volume": ["29"], "fpage": ["1129"], "lpage": ["1138"], "pub-id": ["10.1016/S0735-1933(02)00441-4"]}, {"label": ["16."], "surname": ["Nazar", "Amin"], "given-names": ["R", "N"], "article-title": ["Free convection boundary layer on an isothermal sphere in a micropolar fluid"], "source": ["Int. Commun. Heat Mass Transf."], "year": ["2002"], "volume": ["29"], "fpage": ["377"], "lpage": ["386"], "pub-id": ["10.1016/S0735-1933(02)00327-5"]}, {"label": ["17."], "surname": ["Swalmeh", "Alkasasbeh", "Hussanan", "Mamat"], "given-names": ["MZ", "HT", "A", "M"], "article-title": ["Heat transfer flow of Cu-water and Al2O3-water micropolar nanofluids about a solid sphere in the presence of natural convection using Keller-box method"], "source": ["Res. Phys."], "year": ["2018"], "volume": ["9"], "fpage": ["717"], "lpage": ["724"]}, {"label": ["18."], "surname": ["Swalmeh", "Alkasasbeh", "Hussanan", "Nguyen Thoi", "Mamat"], "given-names": ["MZ", "HT", "A", "T", "M"], "article-title": ["Microstructure and inertial effects on natural convection micropolar nanofluid flow about a solid sphere"], "source": ["Int. J. Ambient Energy"], "year": ["2022"], "volume": ["43"], "fpage": ["666"], "lpage": ["677"], "pub-id": ["10.1080/01430750.2019.1665582"]}, {"label": ["19."], "surname": ["Nabwey", "Rashad", "El-Hakiem", "Alshber"], "given-names": ["HA", "AM", "AM", "SI"], "article-title": ["Effectiveness of Newtonian heating on magneto-free convective flow of polar nanofluid across a solid sphere"], "source": ["Fractal Fract."], "year": ["2022"], "volume": ["6"], "fpage": ["57"], "pub-id": ["10.3390/fractalfract6020057"]}, {"label": ["20."], "surname": ["Swalmeh", "Shatat", "Alwawi", "Ibrahim", "Sulaiman", "Yaseen", "Naser"], "given-names": ["MZ", "F", "FA", "MAH", "IM", "N", "MF"], "article-title": ["Effectiveness of radiation on magneto-combined convective boundary layer flow in polar nanofluid around a spherical shape"], "source": ["Fractal Fract."], "year": ["2022"], "volume": ["6"], "fpage": ["383"], "pub-id": ["10.3390/fractalfract6070383"]}, {"label": ["21."], "surname": ["Alwawi", "Yaseen", "Swalmeh", "Qazaq"], "given-names": ["FA", "N", "MZ", "AS"], "article-title": ["A computational numerical simulation of free convection catalysts for magnetized micropolar ethylene glycol via copper and graphene oxide nanosolids"], "source": ["Proc. Inst. Mech. Eng. E."], "year": ["2022"], "pub-id": ["10.1177/09544089221146157"]}, {"label": ["22."], "surname": ["Ibrahim", "Zemedu"], "given-names": ["W", "C"], "article-title": ["MHD nonlinear mixed convection flow of micropolar nanofluid over nonisothermal sphere"], "source": ["Math. Probl. Eng."], "year": ["2020"], "volume": ["2020"], "fpage": ["1"], "lpage": ["20"]}, {"label": ["23."], "surname": ["Smalley"], "given-names": ["RE"], "article-title": ["Future global energy prosperity: The terawatt challenge"], "source": ["MRS Bull."], "year": ["2005"], "volume": ["30"], "fpage": ["412"], "lpage": ["417"], "pub-id": ["10.1557/mrs2005.124"]}, {"label": ["24."], "surname": ["Wen", "Lin", "Vafaei", "Zhang"], "given-names": ["D", "G", "S", "K"], "article-title": ["Review of nanofluids for heat transfer applications"], "source": ["Particuology"], "year": ["2009"], "volume": ["7"], "fpage": ["141"], "lpage": ["150"], "pub-id": ["10.1016/j.partic.2009.01.007"]}, {"label": ["25."], "surname": ["Choi", "Eastman"], "given-names": ["SU", "JA"], "source": ["Enhancing Thermal Conductivity of Fluids with Nanoparticles"], "year": ["1995"], "publisher-name": ["Argonne National Lab"]}, {"label": ["26."], "surname": ["Ali", "Ali", "Liaquat", "Maqsood", "Nadir"], "given-names": ["HM", "H", "H", "HTB", "MA"], "article-title": ["Experimental investigation of convective heat transfer augmentation for car radiator using ZnO\u2013water nanofluids"], "source": ["Energy"], "year": ["2015"], "volume": ["84"], "fpage": ["317"], "lpage": ["324"], "pub-id": ["10.1016/j.energy.2015.02.103"]}, {"label": ["27."], "surname": ["Heris", "Etemad", "Esfahany"], "given-names": ["SZ", "SG", "MN"], "article-title": ["Experimental investigation of oxide nanofluids laminar flow convective heat transfer"], "source": ["Int. Commun. Heat Mass Transf."], "year": ["2006"], "volume": ["33"], "fpage": ["529"], "lpage": ["535"], "pub-id": ["10.1016/j.icheatmasstransfer.2006.01.005"]}, {"label": ["28."], "surname": ["Ma", "Wilson", "Yu", "Park", "Choi", "Tirumala"], "given-names": ["H", "C", "Q", "K", "U", "M"], "article-title": ["An experimental investigation of heat transport capability in a nanofluid oscillating heat pipe"], "source": ["Appl. Phys. Lett."], "year": ["2006"], "volume": ["88"], "fpage": ["2971"], "pub-id": ["10.1063/1.2192971"]}, {"label": ["29."], "surname": ["Ho", "Liu", "Chang", "Lin"], "given-names": ["C", "W", "Y", "C"], "article-title": ["Natural convection heat transfer of alumina-water nanofluid in vertical square enclosures: An experimental study"], "source": ["Int. J. Therm. Sci."], "year": ["2010"], "volume": ["49"], "fpage": ["1345"], "lpage": ["1353"], "pub-id": ["10.1016/j.ijthermalsci.2010.02.013"]}, {"label": ["30."], "surname": ["Labib", "Nine", "Afrianto", "Chung", "Jeong"], "given-names": ["MN", "MJ", "H", "H", "H"], "article-title": ["Numerical investigation on effect of base fluids and hybrid nanofluid in forced convective heat transfer"], "source": ["Int. J. Therm. Sci."], "year": ["2013"], "volume": ["71"], "fpage": ["163"], "lpage": ["171"], "pub-id": ["10.1016/j.ijthermalsci.2013.04.003"]}, {"label": ["31."], "surname": ["Alwawi", "Sulaiman", "Swalmeh", "Yaseen"], "given-names": ["F", "IM", "MZ", "N"], "article-title": ["Energy transport boosters of magneto micropolar fluid flowing past a cylinder: A case of laminar combined convection"], "source": ["Proc. Inst. Mech. Eng. C. J. Mech. Eng. Sci."], "year": ["2022"], "volume": ["236"], "fpage": ["10902"], "lpage": ["10913"], "pub-id": ["10.1177/09544062221111055"]}, {"label": ["32."], "surname": ["Zhang", "He", "Guan", "Tang", "Shen"], "given-names": ["D", "Z", "J", "S", "C"], "article-title": ["Heat transfer and flow visualization of pulsating heat pipe with silica nanofluid: An experimental study"], "source": ["Int. J. Heat Mass Transf."], "year": ["2022"], "volume": ["183"], "fpage": ["122100"], "pub-id": ["10.1016/j.ijheatmasstransfer.2021.122100"]}, {"label": ["33."], "surname": ["Sharma"], "given-names": ["A"], "article-title": ["A comprehensive study of solar power in India and World"], "source": ["Renew. Sustain. Energy Rev."], "year": ["2011"], "volume": ["15"], "fpage": ["1767"], "lpage": ["1776"], "pub-id": ["10.1016/j.rser.2010.12.017"]}, {"label": ["34."], "surname": ["Thirugnanasambandam", "Iniyan", "Goic"], "given-names": ["M", "S", "R"], "article-title": ["A review of solar thermal technologies"], "source": ["Renew. Sustain. Energy Rev."], "year": ["2010"], "volume": ["14"], "fpage": ["312"], "lpage": ["322"], "pub-id": ["10.1016/j.rser.2009.07.014"]}, {"label": ["35."], "surname": ["Saidur", "Leong", "Mohammed"], "given-names": ["R", "K", "HA"], "article-title": ["A review on applications and challenges of nanofluids"], "source": ["Renew. Sustain. Energy Rev."], "year": ["2011"], "volume": ["15"], "fpage": ["1646"], "lpage": ["1668"], "pub-id": ["10.1016/j.rser.2010.11.035"]}, {"label": ["36."], "surname": ["Jajja", "Ali", "Ali"], "given-names": ["SA", "W", "HM"], "article-title": ["Multiwalled carbon nanotube nanofluid for thermal management of high heat generating computer processor"], "source": ["Heat Transf. Asian Res."], "year": ["2014"], "volume": ["43"], "fpage": ["653"], "lpage": ["666"], "pub-id": ["10.1002/htj.21107"]}, {"label": ["37."], "surname": ["Awan", "Majeed", "Ali", "Ali"], "given-names": ["AU", "S", "B", "L"], "article-title": ["Significance of nanoparticles aggregation and Coriolis force on the dynamics of Prandtl nanofluid: The case of rotating flow"], "source": ["Chin. J. Phys."], "year": ["2022"], "volume": ["79"], "fpage": ["264"], "lpage": ["274"], "pub-id": ["10.1016/j.cjph.2022.07.008"]}, {"label": ["38."], "surname": ["Leong", "Ahmad", "Ong", "Ghazali", "Baharum"], "given-names": ["K", "KK", "HC", "M", "A"], "article-title": ["Synthesis and thermal conductivity characteristic of hybrid nanofluids\u2014A review"], "source": ["Renew. Sustain. Energy Rev."], "year": ["2017"], "volume": ["75"], "fpage": ["868"], "lpage": ["878"], "pub-id": ["10.1016/j.rser.2016.11.068"]}, {"label": ["39."], "surname": ["Muneeshwaran", "Srinivasan", "Muthukumar", "Wang"], "given-names": ["M", "G", "P", "C-C"], "article-title": ["Role of hybrid-nanofluid in heat transfer enhancement\u2014A review"], "source": ["Int. Commun. Heat Mass Transf."], "year": ["2021"], "volume": ["125"], "fpage": ["105341"], "pub-id": ["10.1016/j.icheatmasstransfer.2021.105341"]}, {"label": ["40."], "surname": ["Turcu", "Darabont", "Nan", "Aldea", "Macovei", "Bica", "Vekas", "Pana", "Soran", "Koos"], "given-names": ["R", "A", "A", "N", "D", "D", "L", "O", "M", "A"], "article-title": ["New polypyrrole-multiwall carbon nanotubes hybrid materials"], "source": ["J. Optoelectron. Adv. Mater."], "year": ["2006"], "volume": ["8"], "fpage": ["643"], "lpage": ["647"]}, {"label": ["41."], "surname": ["Suresh", "Venkitaraj", "Selvakumar", "Chandrasekar"], "given-names": ["S", "K", "P", "M"], "article-title": ["Synthesis of Al2O3\u2013Cu/water hybrid nanofluids using two step method and its thermo physical properties"], "source": ["Colloids Surf. A Physicochem. Eng. Asp."], "year": ["2011"], "volume": ["388"], "fpage": ["41"], "lpage": ["48"], "pub-id": ["10.1016/j.colsurfa.2011.08.005"]}, {"label": ["42."], "surname": ["Baghbanzadeh", "Rashidi", "Rashtchian", "Lotfi", "Amrollahi"], "given-names": ["M", "A", "D", "R", "A"], "article-title": ["Synthesis of spherical silica/multiwall carbon nanotubes hybrid nanostructures and investigation of thermal conductivity of related nanofluids"], "source": ["Thermochim. Acta"], "year": ["2012"], "volume": ["549"], "fpage": ["87"], "lpage": ["94"], "pub-id": ["10.1016/j.tca.2012.09.006"]}, {"label": ["44."], "surname": ["Adun", "Kavaz", "Dagbasi"], "given-names": ["H", "D", "M"], "article-title": ["Review of ternary hybrid nanofluid: Synthesis, stability, thermophysical properties, heat transfer applications, and environmental effects"], "source": ["J. Clean. Prod."], "year": ["2021"], "volume": ["328"], "fpage": ["129525"], "pub-id": ["10.1016/j.jclepro.2021.129525"]}, {"label": ["45."], "surname": ["Rekha Sahoo"], "given-names": ["R"], "article-title": ["Effect of various shape and nanoparticle concentration based ternary hybrid nanofluid coolant on the thermal performance for automotive radiator"], "source": ["Heat Mass Transf."], "year": ["2021"], "volume": ["57"], "fpage": ["873"], "lpage": ["887"], "pub-id": ["10.1007/s00231-020-02971-1"]}, {"label": ["46."], "surname": ["Kumar", "Sahoo"], "given-names": ["V", "RR"], "article-title": ["Experimental and numerical study on cooling system waste heat recovery for engine air preheating by ternary hybrid nanofluid"], "source": ["J. Enhanc. Heat Transf."], "year": ["2021"], "volume": ["28"], "fpage": ["1"], "lpage": ["29"], "pub-id": ["10.1615/JEnhHeatTransf.2020035491"]}, {"label": ["47."], "surname": ["Dezfulizadeh", "Aghaei", "Hassani Joshaghani", "Najafizadeh"], "given-names": ["A", "A", "A", "MM"], "article-title": ["Exergy efficiency of a novel heat exchanger under MHD effects filled with water-based Cu\u2013SiO2-MWCNT ternary hybrid nanofluid based on empirical data"], "source": ["J. Therm. Anal. Calorim."], "year": ["2022"], "volume": ["147"], "fpage": ["4781"], "lpage": ["4804"], "pub-id": ["10.1007/s10973-021-10867-3"]}, {"label": ["48."], "surname": ["Mahmood", "Alhazmi", "Khan", "Bani-Fwaz", "Galal"], "given-names": ["Z", "SE", "U", "MZ", "AM"], "article-title": ["Unsteady MHD stagnation point flow of ternary hybrid nanofluid over a spinning sphere with Joule heating"], "source": ["Int. J. Mod. Phys. B"], "year": ["2022"], "volume": ["36"], "fpage": ["2250230"], "pub-id": ["10.1142/S0217979222502307"]}, {"label": ["49."], "surname": ["AlBaidani", "Mishra", "Alam", "Eldin", "Al-Zahrani", "Akgul"], "given-names": ["MM", "NK", "MM", "SM", "AA", "A"], "article-title": ["Numerical analysis of magneto-radiated annular fin natural-convective heat transfer performance using advanced ternary nanofluid considering shape factors with heating source"], "source": ["Case Stud. Therm. Eng."], "year": ["2023"], "volume": ["44"], "fpage": ["102825"], "pub-id": ["10.1016/j.csite.2023.102825"]}, {"label": ["50."], "surname": ["Adnan"], "given-names": ["AW"], "article-title": ["Thermal efficiency in hybrid (Al2O3-CuO/H2O) and ternary hybrid nanofluids (Al2O3-CuO-Cu/H2O) by considering the novel effects of imposed magnetic field and convective heat condition"], "source": ["Waves Random Complex Media"], "year": ["2022"], "volume": ["1"], "fpage": ["1"], "lpage": ["16"]}, {"label": ["51."], "surname": ["Animasaun", "Yook", "Muhammad", "Mathew"], "given-names": ["I", "S-J", "T", "A"], "article-title": ["Dynamics of ternary-hybrid nanofluid subject to magnetic flux density and heat source or sink on a convectively heated surface"], "source": ["Surf. Interfaces"], "year": ["2022"], "volume": ["28"], "fpage": ["101654"], "pub-id": ["10.1016/j.surfin.2021.101654"]}, {"label": ["52."], "surname": ["Kumar", "Prasad", "Banerjee"], "given-names": ["S", "SK", "J"], "article-title": ["Analysis of flow and thermal field in nanofluid using a single phase thermal dispersion model"], "source": ["Appl. Math. Model."], "year": ["2010"], "volume": ["34"], "fpage": ["573"], "lpage": ["592"], "pub-id": ["10.1016/j.apm.2009.06.026"]}, {"label": ["53."], "surname": ["Sheikholeslami", "Shehzad"], "given-names": ["M", "S"], "article-title": ["Numerical analysis of Fe3O4\u2013H2O nanofluid flow in permeable media under the effect of external magnetic source"], "source": ["Int. J. Heat Mass Transf."], "year": ["2018"], "volume": ["118"], "fpage": ["182"], "lpage": ["192"], "pub-id": ["10.1016/j.ijheatmasstransfer.2017.10.113"]}, {"label": ["54."], "surname": ["Khashiie", "Arifin", "Sheremet", "Pop"], "given-names": ["NS", "NM", "M", "I"], "article-title": ["Shape factor effect of radiative Cu\u2013Al2O3/H2O hybrid nanofluid flow towards an EMHD plate"], "source": ["Case Stud. Therm. Eng."], "year": ["2021"], "volume": ["26"], "fpage": ["101199"], "pub-id": ["10.1016/j.csite.2021.101199"]}, {"label": ["55."], "surname": ["Ghobadi", "Hassankolaei"], "given-names": ["AH", "MG"], "article-title": ["A numerical approach for MHD Al2O3\u2013TiO2/H2O hybrid nanofluids over a stretching cylinder under the impact of shape factor"], "source": ["Heat Transf. Asian Res."], "year": ["2019"], "volume": ["48"], "fpage": ["4262"], "lpage": ["4282"], "pub-id": ["10.1002/htj.21591"]}, {"label": ["56."], "surname": ["Shanmugapriya", "Sundareswaran", "Kumar", "Rangasamy"], "given-names": ["M", "R", "PS", "G"], "article-title": ["Impact of nanoparticle shape in enhancing heat transfer of magnetized ternary hybrid nanofluid"], "source": ["Sustain. Energy Technol. Assess."], "year": ["2022"], "volume": ["53"], "fpage": ["102700"]}, {"label": ["57."], "surname": ["Zahan", "Nasrin", "Khatun"], "given-names": ["I", "R", "S"], "article-title": ["Thermal performance of ternary-hybrid nanofluids through a convergent-divergent nozzle using distilled water-ethylene glycol mixtures"], "source": ["Int. Commun. Heat Mass Transf."], "year": ["2022"], "volume": ["137"], "fpage": ["106254"], "pub-id": ["10.1016/j.icheatmasstransfer.2022.106254"]}, {"label": ["58."], "surname": ["Sahoo"], "given-names": ["RR"], "article-title": ["Heat transfer and second law characteristics of radiator with dissimilar shape nanoparticle-based ternary hybrid nanofluid"], "source": ["J. Therm. Anal. Calorim."], "year": ["2021"], "volume": ["146"], "fpage": ["827"], "lpage": ["839"], "pub-id": ["10.1007/s10973-020-10039-9"]}, {"label": ["59."], "surname": ["Sahoo"], "given-names": ["RR"], "article-title": ["Thermo-hydraulic characteristics of radiator with various shape nanoparticle-based ternary hybrid nanofluid"], "source": ["Powder Technol."], "year": ["2020"], "volume": ["370"], "fpage": ["19"], "lpage": ["28"], "pub-id": ["10.1016/j.powtec.2020.05.013"]}, {"label": ["60."], "surname": ["Alkasasbeh", "AlFaqih", "Alizadeh", "Fazilati", "Zekri", "Toghraie", "Mourad", "Guedri", "Younis"], "given-names": ["HT", "FM", "AA", "MA", "H", "D", "A", "K", "O"], "article-title": ["Computational modeling of hybrid micropolar nanofluid flow over a solid sphere"], "source": ["J. Magn. Magn. Mater."], "year": ["2023"], "volume": ["569"], "fpage": ["170444"], "pub-id": ["10.1016/j.jmmm.2023.170444"]}, {"label": ["61."], "surname": ["Hamilton", "Crosser"], "given-names": ["RL", "O"], "article-title": ["Thermal conductivity of heterogeneous two-component systems"], "source": ["Ind. Eng. Chem. Fund."], "year": ["1962"], "volume": ["1"], "fpage": ["187"], "lpage": ["191"], "pub-id": ["10.1021/i160003a005"]}, {"label": ["62."], "surname": ["Timofeeva", "Routbort", "Singh"], "given-names": ["EV", "JL", "D"], "article-title": ["Particle shape effects on thermophysical properties of alumina nanofluids"], "source": ["J. Appl. Phys."], "year": ["2009"], "volume": ["106"], "fpage": ["014304"], "pub-id": ["10.1063/1.3155999"]}, {"label": ["63."], "surname": ["Liu", "Cai", "Wang", "Zhao"], "given-names": ["F", "Y", "L", "J"], "article-title": ["Effects of nanoparticle shapes on laminar forced convective heat transfer in curved ducts using two-phase model"], "source": ["Int. J. Heat Mass Transf."], "year": ["2018"], "volume": ["116"], "fpage": ["292"], "lpage": ["305"], "pub-id": ["10.1016/j.ijheatmasstransfer.2017.08.097"]}, {"label": ["64."], "surname": ["Sundar", "Sharma", "Singh", "Sousa"], "given-names": ["LS", "KV", "MK", "A"], "article-title": ["Hybrid nanofluids preparation, thermal properties, heat transfer and friction factor\u2013a review"], "source": ["Renew. Sustain. Energy Rev."], "year": ["2017"], "volume": ["68"], "fpage": ["185"], "lpage": ["198"], "pub-id": ["10.1016/j.rser.2016.09.108"]}, {"label": ["65."], "surname": ["Hamarsheh", "Alwawi", "Alkasasbeh", "Rashad", "Idris"], "given-names": ["AS", "FA", "HT", "AM", "R"], "article-title": ["Heat transfer improvement in MHD natural convection flow of graphite oxide/carbon nanotubes-methanol based casson nanofluids past a horizontal circular cylinder"], "source": ["Processes"], "year": ["2020"], "volume": ["8"], "fpage": ["1444"], "pub-id": ["10.3390/pr8111444"]}, {"label": ["66."], "surname": ["Alwawi", "Hamarsheh", "Alkasasbeh", "Idris"], "given-names": ["FA", "AS", "HT", "R"], "article-title": ["Mixed convection flow of magnetized Casson nanofluid over a cylindrical surface"], "source": ["Coatings"], "year": ["2022"], "volume": ["12"], "fpage": ["296"], "pub-id": ["10.3390/coatings12030296"]}, {"label": ["67."], "surname": ["Alwawi", "Alkasasbeh", "Rashad", "Idris"], "given-names": ["FA", "HT", "AM", "R"], "article-title": ["Natural convection flow of Sodium Alginate based Casson nanofluid about a solid sphere in the presence of a magnetic field with constant surface heat flux"], "source": ["Proc. J. Phys. Conf. Ser."], "year": ["2019"], "volume": ["1366"], "fpage": ["012005"], "pub-id": ["10.1088/1742-6596/1366/1/012005"]}, {"label": ["68."], "surname": ["Alwawi", "Swalmeh", "Hamarsheh"], "given-names": ["FA", "MZ", "AS"], "article-title": ["Computational simulation and parametric analysis of the effectiveness of ternary nano-composites in improving magneto-micropolar liquid heat transport performance"], "source": ["Symmetry"], "year": ["2023"], "volume": ["15"], "fpage": ["429"], "pub-id": ["10.3390/sym15020429"]}, {"label": ["69."], "surname": ["El-Zahar", "Algelany", "Rashad"], "given-names": ["ER", "A", "AM"], "article-title": ["Sinusoidal natural convective flow of non-Newtonian nanoliquid over a radiative vertical plate in a saturated porous medium"], "source": ["IEEE Access"], "year": ["2020"], "volume": ["8"], "fpage": ["136131"], "lpage": ["136140"], "pub-id": ["10.1109/ACCESS.2020.3009197"]}, {"label": ["70."], "surname": ["El-Zahar", "Rashad", "Seddek"], "given-names": ["ER", "AM", "LF"], "article-title": ["The impact of sinusoidal surface temperature on the natural convective flow of a ferrofluid along a vertical plate"], "source": ["Mathematics"], "year": ["2019"], "volume": ["7"], "fpage": ["1014"], "pub-id": ["10.3390/math7111014"]}, {"label": ["72."], "surname": ["Sheu", "Lin"], "given-names": ["TW", "R-K"], "article-title": ["Newton linearization of the incompressible Navier\u2013Stokes equations"], "source": ["Int. J. Numer. Methods Fluids"], "year": ["2004"], "volume": ["44"], "fpage": ["297"], "lpage": ["312"], "pub-id": ["10.1002/fld.639"]}, {"label": ["73."], "surname": ["Martinez", "Esperan\u00e7a"], "given-names": ["JDJ", "PDTT"], "article-title": ["A chebyshev collocation spectral method for numerical simulation of incompressible flow problems"], "source": ["J. Braz. Soc. Mech. Sci. Eng."], "year": ["2007"], "volume": ["29"], "fpage": ["317"], "lpage": ["328"], "pub-id": ["10.1590/S1678-58782007000300013"]}, {"label": ["74."], "surname": ["Peyret"], "given-names": ["R"], "source": ["Spectral Methods for Incompressible Viscous Flow"], "year": ["2002"], "publisher-name": ["Springer"]}, {"label": ["75."], "surname": ["Weideman", "Reddy"], "given-names": ["JA", "SC"], "article-title": ["A MATLAB differentiation matrix suite"], "source": ["ACM Trans. Math. Softw."], "year": ["2000"], "volume": ["26"], "fpage": ["465"], "lpage": ["519"], "pub-id": ["10.1145/365723.365727"]}]
{ "acronym": [ "a", "B0", "Cf.", "G", "Gr", "χ", "M", "Nu", "Pr", "σ", "x,y", "N", "ρcp", "qr", "j", "r(x)", "ψ", "T∞", "z", "w", "vf", "k.", "β", "Tw", "κ", "µ", "ρ", "\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$T$$\\end{document}T", "C1, C2", "ω", "ϕ", "σ*, k*", "θ", "K", "L", "nf", "f", "thnf", "hnf" ], "definition": [ "Radius of the sphere", "Magnetic field", "Skin friction coefficient", "Gravity vector", "Grashof number", "Volume fraction factor", "Magnetic parameter", "Nusselt number", "Prandtl number", "Electrical conductivity", "Dimensional variables along velocity component z, w", "Shape factor", "Heat capacity", "Rosseland diffusion approximation for radiation", "Micro-inertia density", "The radial distance", "Stream function", "Ambient temperature", "Component of velocity", "Component of velocity", "Kinematic viscosity", "Thermal conductivity", "Thermal expansion coefficient", "Wall temperature \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(K)$$\\end{document}(K)", "Vortex viscosity", "Dynamic viscosity", "Density", "Temperature of the fluid", "Viscosity coefficient", "Particle’s sphericity", "Spin gradient viscosity", "Stefan–Boltzmann, mean absorption coefficients", "Temperature", "Micropolar parameter", "The thermal radiation parameter", "Nanoliquid", "Original liquid", "Ternary hybrid nanoliquid", "Hybrid nanoliquid" ] }
75
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1225
oa_package/38/e2/PMC10786870.tar.gz
PMC10786871
38216579
[ "<title>Introduction</title>", "<p id=\"Par2\">Lung Cancer has the second-highest incidence rate and the highest mortality rate in the world<sup>##REF##33433946##1##</sup>, and it is the most common cancer in China with new cases and deaths accounting for nearly 40% in the whole world<sup>##UREF##0##2##</sup>. Early detection is important for lung cancer prevention and management. Results of the National Lung Screening Trial (NLST) showed that screening with low-dose computed tomography (LDCT) can reduce lung cancer mortality by 20%<sup>##REF##21714641##3##</sup>. The latest study shows that one-off LDCT screening in high-risk populations in China can reduce lung cancer mortality by 30%<sup>##REF##35276087##4##</sup>. In 2012, the Chinese government launched a key national plan for public health, Cancer Screening Program in Urban China (CANSPUC), in which participants at high risk aged 40–74 were provided free LDCT test for lung cancer screening<sup>##REF##33141158##5##</sup>.</p>", "<p id=\"Par3\">With the widespread use of computed tomography (CT) technology, pulmonary nodules are becoming more common. Nearly 26.3% of pulmonary nodules were found on annual routine checkups<sup>##REF##29748006##6##</sup>. After being diagnosed, patients have questions about the meaning of the nodules.</p>", "<p id=\"Par4\">With the increasing prevalence of non-smoking related lung cancer in Asian countries, LDCT screening for non-smoking population is widely utilized in Asian countries and regions, such as China, Taiwan (province of China), Korea, Japan. Population anxiety about lung cancer was high in China due to patients died of stage IV lung cancer, unknown risk factors for non-smoking lung cancer, and safe strategies culture in Asian population culture, especially in non-smoking and female populations<sup>##REF##35055341##7##</sup>.</p>", "<p id=\"Par5\">Since pulmonary nodules have the potential to become early lung cancer lesions, patients may become anxious and depressed. Harris et al. believed that this \"near cancer\" diagnosis would bring various harms to patients, including physical harms, psychological harms, financial strain, and opportunity costs<sup>##REF##24322781##8##</sup>. It is worth noting that very few patients benefit from lung cancer screening (most of them are benign), but nearly all patients are at risk of different types of harms from detection and evaluation of a pulmonary nodule<sup>##REF##21714641##3##,##REF##35926265##9##</sup>.</p>", "<p id=\"Par6\">It is difficult to make an accurate judgment of benign and malignant after the first detection of pulmonary nodules. Patients care about the next step in the diagnosis and treatment plan<sup>##REF##32081651##10##</sup>. Common options for the management of pulmonary nodules in the guidelines include CT surveillance, biopsy, and excision. However, each option has its advantages and disadvantages<sup>##UREF##1##11##</sup>, and it is a challenge for doctors and patients to choose which one to use. It involves the characteristics of the nodule itself, the patient's history of exposure to lung cancer risk factors, the doctor's judgment, and the patient's personal preference. Patients may be caught in a decision-making dilemma.</p>", "<p id=\"Par7\">Decision conflict is when individuals face choices involving risks or unknown outcomes, they need to evaluate the potential benefits and risks corresponding to the options, weigh the value of making a decision, and prepare for losing the advantages of the rejected options<sup>##REF##7898294##12##</sup>. Decision conflict can lead to delayed decision-making, reduce treatment compliance, and affect the patient's psychology. Studies on breast cancer and diabetes patients have shown that there is a positive correlation between decision conflict and distress, and the uncertainty in decision-making can lead to individual psychological and emotional distress<sup>##REF##31048410##13##,##REF##23167846##14##</sup>. Communication between doctors and patients is very important for this kind of decision conflict faced by patients. This communication is not just the simple transmission of medical information, but also requires emotional exchange. Some researchers believe that high-quality communication can effectively alleviate the distress level of patients.</p>", "<p id=\"Par8\">In the context of the high incidence of lung cancer, the distress level of patients with pulmonary nodules in China is unknown. Since the nature of pulmonary nodules requires the patient to further choose a certain way to determine, the patient needs to communicate with the medical staff during the decision-making process, and decisional conflict, communication quality with doctor, and lung cancer worry are closely related to the patient in this process. The purpose of this study was to investigate the distress level and its influencing factors in Chinese patients with incidental pulmonary nodules.</p>" ]
[ "<title>Method</title>", "<title>Aim</title>", "<p id=\"Par9\">The study aims to investigate the distress level and its influencing factors in Chinese pulmonary nodules patients.</p>", "<title>Design</title>", "<p id=\"Par10\">This is a cross-sectional study and adhered to the STROBE checklist for observational research.</p>", "<title>Sample</title>", "<p id=\"Par11\">Participants were eligible for this study if they were 18 years of age or older with a diagnosis of pulmonary nodule (with diameter less than 30 mm) after opportunistic CT examination for the first time. People who had mental illnesses or any type of cancer were excluded. Kendall et al.<sup>##UREF##2##15##</sup> suggested that the study sample size should be 5–10 times of the study factors. This study contains 12 variables, considering the sample loss of 20%, the sample size of this study needs to be at least 150 participants. Using convenience sampling, 165 pulmonary patients at the respiratory clinic of a tertiary hospital in Xi’an were recruited from July 2021 to October 2021. Two patients declined to participate for time reasons, and 163 participants were eventually included in the study.</p>", "<title>Data collection</title>", "<p id=\"Par12\">All the questionnaire and scales were completed by the patient alone. After the participants completed the questionnaire, the researchers immediately checked the questionnaire and collected it on the spot. The data collection timing flow chart see Fig. ##FIG##0##1##.</p>", "<title>Social-demographic characteristics</title>", "<p id=\"Par13\">Socio-demographic questionnaire included age, gender, education level, marital status, employment status, income level, residence, smoking history, relatives with lung cancer, if the patients worried about getting lung cancer someday, and if the patients anxious about the results of future tests/treatments.</p>", "<title>Distress</title>", "<p id=\"Par14\">Impact of Event Scale (IES) was used to measure distress. IES, originally designed by Horowitz in 1979, measures an individual's current level of subjective distress due to the impact of a specific event. In 2003, Zhao et al. translated it into a Chinese version<sup>##UREF##3##16##</sup>. The scale contains 15 items and 2 dimensions, including intrusion (7 items) and avoidance (8 items). Each item was scored on a 4-point scale (0 = not at all, 1 = rarely, 3 = sometimes, and 5 = often). The total scale score ranges from 0 to 75<sup>##REF##10761177##17##</sup>, with higher scores indicating a greater frequency of intrusive thoughts and attempts at avoidance. In this study, according to other research, a total score of 0–25 was classified as mild or below level, and above 26 was considered moderate or high level<sup>##REF##27144794##18##</sup>.</p>", "<title>Decision conflict</title>", "<p id=\"Par15\">The Decision Conflict Scale (DCS) was used to measure the decision conflict of patients with pulmonary nodules when deciding the next treatment or surveillance plan. DCS was originally designed by O’Connor in <sup>##REF##7898294##12##</sup> and was later translated into a Chinese version by Li et al.<sup>##UREF##4##19##</sup> The scale contains 16 items divided into 3 subscales: including information and values, decision support and effectiveness and decision uncertainty. The scale was scored using the Likert 5-level scoring method, and the initial score was converted into 0–100 points to obtain the total score.</p>", "<title>Communication quality with doctor</title>", "<p id=\"Par16\">Consultation Care Measure (CCM) is used to measure the quality of communication between doctors and patients about pulmonary nodules. The CCM is designed based on a patient-centered communication model<sup>##REF##11005395##20##,##REF##19150197##21##</sup> to measure patients' perceptions of communication quality after communicating with doctors. The primary measure of the perception of communication was the statement, “The overall quality of communication with your provider (who is caring for your nodule) is excellent,” rated on a 7-point Likert scale from “very strongly disagree” to “very strongly disagree” strongly agree.”<sup>##REF##27144794##18##</sup>. Higher scores indicate that patients perceive the higher quality of communication.</p>", "<title>Lung cancer worry</title>", "<p id=\"Par17\">The Lung cancer worry scale (LCWS)was used to measure fear and anxiety in patients with pulmonary nodules about being diagnosed with lung cancer in the future. The scale was modified from the cancer worry scale by changing breast cancer to lung cancer and by changing mammograms to future tests/treatments<sup>##REF##8515494##22##</sup>. Clark et al. applied it for the first time in patients with pulmonary nodules, and there were four questions in the scale. Since we included patients diagnosed for the first time, only two questions were included: “How worried are you about getting lung cancer someday?” and “What is your current anxiety level about the results of future tests/treatments?\" These two questions were dichotomized as \"not worried\" vs. \"worried\" and \"not anxious\" vs. \"anxious\".</p>", "<title>Ethics and consent statement</title>", "<p id=\"Par18\">Our research was approved by the Medical Ethics Review Committee of the First Affiliated Hospital of Xian Jiaotong University, and all methods were performed in accordance with the relevant guidelines and regulations. Patients were informed about the study and invited to participate the survey. The data were anonymous, and coded using participant-created codes.</p>", "<title>Data analyses</title>", "<p id=\"Par19\">IBM SPSS Statistics software version 26.0 was used to analyse data. The demographic data were summarized as the means, standard deviations, and ranges for continuous variables and as frequency counts (percentages) for categorical variables. We calculated the means and standard deviations of distress and 2 dimensions, and reported low or mild and moderate or high levels using frequencies and percentages. The differences in distress according to demographic characteristics were analysed using t-tests and one-way analysis of variance (ANOVA). Pearson's correlation analyses were used to investigate the correlations between distress and both decision conflict and communication quality score. Multivariate logistic regression model was constructed to explore the influencing factors of distress among pulmonary nodules patients. All socio-demographic factors, decision conflict, communication quality, lung cancer worry were included in the multilevel analysis. An alpha level of 0.05 was used for the assessment of statistical significance.</p>", "<title>Validity and reliability</title>", "<p id=\"Par20\">All manually entered data were double-checked. The Cronbach’s α of IES, the intrusion and avoidance subscale are 0.90, 0.88 and 0.81, respectively<sup>##UREF##3##16##</sup>. DCS has good reliability and validity, with Cronbach’s α coefficient of 0.897 and content validity index of 0.950<sup>##UREF##5##23##</sup>. Cronbach’s α for LCWS used in relation to breast and prostate cancer ranges from 0.71 to 0.86.</p>" ]
[ "<title>Results</title>", "<title>Demographic characteristics</title>", "<p id=\"Par21\">A total of 163 patients with incidental pulmonary nodules were included in this study, with an average age of 54 years (SD = 12.9, range 27–85), of whom 91 (55.8%) were female. Most participants were married (93.9%). Nearly half (47.2%) of patients with pulmonary nodules were worried about being diagnosed with lung cancer in the future, and about 33.7% were worried about the results of their next test. Detailed demographic characteristics are shown in Table ##TAB##0##1##.</p>", "<title>Distress, decision conflict, and communication quality</title>", "<p id=\"Par22\">The mean and standard deviation of distress, decision conflict, and communication quality scores were 37.6 (SD = 16.7), 51.32 (SD = 19.5), and 3.3 (SD = 1.7), respectively.</p>", "<p id=\"Par23\">About 73.6% (n = 120) of patients reported a moderate or high level of distress. (Table ##TAB##1##2##).</p>", "<title>Relationships among distress, demographic characteristics, decision conflict, lung cancer worry, and communication quality</title>", "<p id=\"Par24\">Table ##TAB##0##1## shows the relationship between distress and demographic characteristics and lung cancer worry. The correlation analyses showed that decision conflict was positive associated with distress (<italic>r</italic> = 0.597, <italic>p</italic> &lt; 0.001) while communication quality was negatively associated with distress (<italic>r</italic> = 0.403, <italic>p</italic> &lt; 0.001).</p>", "<title>Influencing factors of distress among incidental pulmonary nodules patients</title>", "<p id=\"Par25\">The logistic regression results showed that decision conflict, age, communication quality, and anxiety level about future test results were the main factors that influenced distress among incidental pulmonary nodules patients. (Table ##TAB##2##3##).</p>" ]
[ "<title>Discussion</title>", "<title>Distress level of pulmonary nodule patients</title>", "<p id=\"Par26\">This study investigated the distress level and its influencing factors in Chinese patients with incidental pulmonary nodules. It was found that the vast majority of patients developed a certain level of distress after being diagnosed with a pulmonary nodule. This result is similar to that of Moseson and Slatore, who used IES to investigate patients with pulmonary nodules<sup>##REF##27144794##18##,##REF##25521482##24##</sup>.</p>", "<p id=\"Par27\">Many patients with pulmonary nodules have certain anxiety and distress emotions<sup>##UREF##6##25##</sup>. Although only about 4% of pulmonary nodules will eventually be diagnosed as lung cancer<sup>##REF##21714641##3##</sup>, it is difficult to make an accurate judgment immediately<sup>##REF##29066390##26##</sup>, so the “near-cancer” diagnosis is a big burden to patients. Some patients even thought they had cancer immediately after being diagnosed with a pulmonary nodule<sup>##REF##22814873##27##</sup>.</p>", "<p id=\"Par28\">Horowitz described the connotations of the 2 dimensions of event impact. Intrusions are thoughts and images that spontaneously, involuntarily appear in the mind, with troubled dreams, strong pangs, and waves of feelings. Avoidance responses include ideational constriction, denial of the meaning and outcome of events, numbness of sensations, inhibition of behavior, or counterphobic activity <sup>##REF##472086##28##</sup>. This study showed that patients with pulmonary nodules have moderate scores in both dimensions, suggesting that the two types of thoughts exist in patients. When a patient is diagnosed with a pulmonary nodule, there is a spot in the lung, which reminds the patient from time to time that he has a pulmonary nodule and it has the potential to become lung cancer. However, since most pulmonary nodules require regular follow-up, under the advice of doctors, patients will take the initiative to suggest to themselves and try to avoid thinking about it.</p>", "<title>Influencing factors of distress</title>", "<p id=\"Par29\">Decision conflict is an important influencing factor of patients' distress. Pulmonary nodules are poorly understood by patients<sup>##REF##22814873##27##</sup>, and their decisions require a wealth of information from their doctors, as well as an understanding of the pros and cons of each option. However, doctors give patients less information due to several factors. This may be related to the fact that pulmonary nodules are very common, doctors need to deal with a large number of patients, and their time and energy are limited<sup>##REF##29066390##26##</sup>. In addition, physicians may be worried that giving too much information would be overwhelming and might actually increase patient distress, so they seldom directly inform the risk of lung cancer and other details about surveillance to their patients<sup>##REF##25790082##29##</sup>. Based on the current context, the British Thoracic Society guidelines suggest that the involvement of lung cancer nurses in further communication with patients would be beneficial<sup>##REF##25870317##30##</sup>. However, these nurses need to be skilled in the prevention and management of lung cancer and pulmonary nodules, such as epidemiology, risk factors, screening methods, and further management of pulmonary nodules (including advantages and disadvantages). In this process, the idea of shared decision-making can be applied. In addition, since in-depth conversation with patients may involve patients in decision-making, nurses need to receive specialized training to provide decision-making Support for patients, such as The Ottawa Decision Support Tutorial<sup>##REF##30224274##31##</sup>.</p>", "<p id=\"Par30\">The communication quality score was also entered into the regression model. It is similar to the results of Slatore et al., the higher the quality of patient self-rated communication, the lower the distress level<sup>##REF##25521482##24##</sup>. In the current clinical decision-making, the paternalistic or informed model is mostly used, which has problems such as low degree of information sharing and low decision satisfaction<sup>##UREF##5##23##</sup>. A core criterion for high-quality decision-making is whether the choice is in line with the patient's values, goals, and preferences. This requires medical staff to learn more about patients' thoughts and consider personal preferences during the communication process. In addition, the communication between doctors and patients about the decision-making of the next diagnosis and treatment plan is not only a one-way information transfer of medical knowledge, but also an emotional exchange. Patients’ distress decreases when their clinicians were empathic and generated trust<sup>##REF##22814873##27##,##REF##23952851##32##</sup>.</p>", "<p id=\"Par31\">The regression results showed that age is also a factor affecting distress. Compared with people younger than 50 years old, patients aged 50–60 years have a higher risk of distress. This may be because the age of 50–60 is still the backbone of the society and the family in the current Chinese society, bearing the heavy burden of the society and the family. When a certain disease is diagnosed, the negative emotions caused by it are heavier. Bivariable analysis by Freiman et al. showed that age over 65 years was a protective factor for distress in patients with pulmonary nodules<sup>##REF##26961390##33##</sup>. Similarly, the results of Li et al. showed that patients with pulmonary nodules between the ages of 40 and 60 had the highest proportion of anxiety, but it was not statistically significant<sup>##REF##32212379##34##</sup>. Further research is needed on the association of age with distress in patients with pulmonary nodules.</p>", "<p id=\"Par32\">We found that anxiety about the next test result, but not worry about lung cancer, was an influencing factor of distress. Similar to breast cancer screening, when an individual has a false-positive screening result, it may experience a period of distress. The difference is that distress in false-positive individuals of breast cancer screening is transient, and it disappears immediately after a negative biopsy result<sup>##REF##29066390##26##</sup>. Many patients with pulmonary nodules may be required to follow regular surveillance, leaving them in a state of uncertainty for months or even years. Consequently, the next test results were more closely and directly related to their mood compared with cancer.</p>", "<title>Limitations</title>", "<p id=\"Par33\">We should mention that this study has several limitations. Since the design is a cross-sectional study, there may be attentional bias and selection bias in the study. The researchers investigated outpatient patients with pulmonary nodules in a tertiary hospital of a provincial capital city. The level of medical care varies among hospitals of different levels, which may affect the distress among patients with pulmonary nodules. Due to differences in the description of pulmonary nodules in imaging reports among different physicians, the characteristics of individual pulmonary nodules were not included in this study. In addition, the quality of doctor-patient communication is measured through patient self-assessment. To truly reflect the quality of communication, it is beneficial to comprehensively consider the evaluation of communication quality by doctors and third parties. Due to the limited sample size, the odds ratio of age group 50–60 might inflated<sup>##REF##34043251##35##</sup>. Finally, Due to the limitations of the cross-sectional study, the causal relationship between the variables needs to be further investigated.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par34\">We found that distress levels were moderate in patients with pulmonary nodules. Age, higher decision conflicts scores, lower physician–patient communication quality score, and being anxious about the results of future tests or treatments are influencing factors of distress among pulmonary nodule patients.</p>", "<title>Practice implications</title>", "<p id=\"Par35\">In the screening process, in addition to the patients who are finally diagnosed with lung cancer, patients with positive results after screening also need more attention. Due to the heavy clinical tasks of doctors, nurses may play an important role in the health guidance of patients with pulmonary nodules. In this process, patients are informed of the alternative pulmonary nodules management options and the pros and cons of each option. Patient's own decision-making preferences needs more attention, and therapeutic alliance needs to be established between doctor, nurse and patients. This patient-centered communication method can not only effectively eliminate the decision conflicts, but also allow patients to participate in decision-making, which greatly improves the quality of communication and decision. Of course, the feasibility and effectiveness of this model need further experiments to confirm.</p>" ]
[ "<p id=\"Par1\">The study aims to investigate the distress level and its influencing factors in Chinese pulmonary nodules patients. A total of 163 outpatients in a tertiary hospital in Xi'an, China, were recruited and investigated by using the Impact of Event Scale, Decision Conflict Scale, Consultation Care Measure, Lung Cancer Worry Scale and a demographic questionnaire. The logistic regression model was used to identify the factors of distress. The mean IES score was 37.35 ± 16.65, which was a moderate level. Patients aged 50–60 years, with higher decision conflicts scores, lower physician–patient communication quality score, and who are anxious about the results of future tests or treatments had higher distress score. Distress levels were moderate in patients with pulmonary nodules. Communication between medical staff and patients is extremely important for the management of pulmonary nodules, which affects the quality of the patient's decision-making and his level of distress.</p>", "<title>Subject terms</title>" ]
[]
[ "<title>Acknowledgements</title>", "<p>The authors thank all the participants for their time and efforts and for revealing their experiences with frankness during the interviews.</p>", "<title>Author contributions</title>", "<p>All authors had a substantial contribution to the manuscript. JY: Conceptualisation, Study design, Data collection, Data analysis, Data interpretation, Writing—original draft, Review and editing, Final approval; FX: Conceptualisation, Study design; MC and HR: Study design, Review and editing; SF: Study design, Review and editing.</p>", "<title>Data availability</title>", "<p>The data that support the findings of this study are available on request from the corresponding author.</p>", "<title>Competing interests</title>", "<p id=\"Par36\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Data collection timing flow chart.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Summary of the associations between demographic and distress (n = 163).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Characteristic</th><th align=\"left\">n</th><th align=\"left\">Distress Mean ± SD</th><th align=\"left\"><italic>t/F</italic></th><th align=\"left\"><italic>p</italic></th></tr></thead><tbody><tr><td align=\"left\" colspan=\"3\">Age</td><td char=\".\" align=\"char\">2.026</td><td char=\".\" align=\"char\">0.135</td></tr><tr><td align=\"left\"> 18–49</td><td align=\"left\">52</td><td align=\"left\">33.5 ± 18.9</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> 50–60</td><td align=\"left\">69</td><td align=\"left\">39.1 ± 15.8</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> ≥ 60</td><td align=\"left\">42</td><td align=\"left\">39.1 ± 14.5</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\" colspan=\"3\">Gender</td><td char=\".\" align=\"char\">− 0.623</td><td char=\".\" align=\"char\">0.534</td></tr><tr><td align=\"left\"> Female</td><td align=\"left\">91</td><td align=\"left\">36.6 ± 17.6</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Male</td><td align=\"left\">72</td><td align=\"left\">38.3 ± 15.4</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\" colspan=\"3\">Educational level</td><td char=\".\" align=\"char\">1.354</td><td char=\".\" align=\"char\">0.261</td></tr><tr><td align=\"left\"> Primary school and below</td><td align=\"left\">39</td><td align=\"left\">38.6 ± 12.6</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Middle/high/technical secondary school</td><td align=\"left\">78</td><td align=\"left\">38.7 ± 18.7</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> College and above</td><td align=\"left\">46</td><td align=\"left\">33.9 ± 15.7</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\" colspan=\"3\">Marital status</td><td char=\".\" align=\"char\">0.846</td><td char=\".\" align=\"char\">0.416</td></tr><tr><td align=\"left\"> Married</td><td align=\"left\">153</td><td align=\"left\">37.5 ± 16.9</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Unmarried and others</td><td align=\"left\">10</td><td align=\"left\">33.9 ± 13.1</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\" colspan=\"3\">Employment status</td><td char=\".\" align=\"char\">0.958</td><td char=\".\" align=\"char\">0.341</td></tr><tr><td align=\"left\"> Employed</td><td align=\"left\">113</td><td align=\"left\">38.3 ± 15.3</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Unemployed/retired/other</td><td align=\"left\">50</td><td align=\"left\">35.3 ± 19.3</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\" colspan=\"3\">Income (RMB per person per month,equivalent to US$)</td><td char=\".\" align=\"char\">1.078</td><td char=\".\" align=\"char\">0.343</td></tr><tr><td align=\"left\"> ≤ 4000 $580)</td><td align=\"left\">69</td><td align=\"left\">35.6 ± 19.6</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> 4001–5000 ($581–725)</td><td align=\"left\">40</td><td align=\"left\">40.5 ± 13.9</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> &gt; 5000 ($725)</td><td align=\"left\">54</td><td align=\"left\">37.2 ± 14.2</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\" colspan=\"3\">Residence</td><td char=\".\" align=\"char\">2.188</td><td char=\".\" align=\"char\">0.031*</td></tr><tr><td align=\"left\"> Urban</td><td align=\"left\">108</td><td align=\"left\">39.3 ± 16.8</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Urban to rural/Rural</td><td align=\"left\">55</td><td align=\"left\">33.5 ± 15.8</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\" colspan=\"3\">History of smoking</td><td char=\".\" align=\"char\">0.393</td><td char=\".\" align=\"char\">0.696</td></tr><tr><td align=\"left\"> No</td><td align=\"left\">130</td><td align=\"left\">37.6 ± 15.9</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Yes</td><td align=\"left\">33</td><td align=\"left\">36.2 ± 19.2</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\" colspan=\"3\">First degree relative with lung cancer</td><td char=\".\" align=\"char\">− 4.177</td><td char=\".\" align=\"char\">0.000**</td></tr><tr><td align=\"left\"> No</td><td align=\"left\">145</td><td align=\"left\">35.6 ± 16.1</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Yes</td><td align=\"left\">18</td><td align=\"left\">51.2 ± 14.8</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\" colspan=\"3\">Lung Cancer Worry Scale1: How worried are you about getting lung cancer someday?</td><td align=\"left\">− 3.815</td><td char=\".\" align=\"char\">0.000**</td></tr><tr><td align=\"left\"> Not worried</td><td align=\"left\">86</td><td align=\"left\">32.8 ± 17.4</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Worried</td><td align=\"left\">77</td><td align=\"left\">42.4 ± 14.3</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\" colspan=\"3\">Lung Cancer Worry Scale2: What is your current anxiety level about the results of future tests/treatments?</td><td align=\"left\">2.904</td><td align=\"left\">0.004**</td></tr><tr><td align=\"left\"> Not anxious</td><td align=\"left\">108</td><td align=\"left\">34.8 ± 16.9</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Anxious</td><td align=\"left\">55</td><td align=\"left\">42.3 ± 15.1</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Distress among incidental pulmonary nodules patients scale scores (n = 163).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Variables</th><th align=\"left\" rowspan=\"2\">Scale level Mean ± SD</th><th align=\"left\" rowspan=\"2\">Item level Mean ± SD</th><th align=\"left\" colspan=\"2\">N (%)</th></tr><tr><th align=\"left\">Low/mild level</th><th align=\"left\">Moderate/high level</th></tr></thead><tbody><tr><td align=\"left\">Distress</td><td char=\".\" align=\"char\">37.4 ± 16.6</td><td char=\".\" align=\"char\">2.5 ± 1.1</td><td align=\"left\">43 (26.3)</td><td align=\"left\">120 (73.6)</td></tr><tr><td align=\"left\">Intrusion</td><td char=\".\" align=\"char\">17.9 ± 8.4</td><td char=\".\" align=\"char\">2.5 ± 1.2</td><td align=\"left\">–</td><td align=\"left\">–</td></tr><tr><td align=\"left\">Avoidance</td><td char=\".\" align=\"char\">19.3 ± 9.0</td><td char=\".\" align=\"char\">2.4 ± 1.1</td><td align=\"left\">–</td><td align=\"left\">–</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Factors influencing distress among patients with incidental pulmonary nodules.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Variables</th><th align=\"left\">B</th><th align=\"left\">OR</th><th align=\"left\">95% CI</th><th align=\"left\"><italic>p</italic></th></tr></thead><tbody><tr><td align=\"left\">Intercept</td><td align=\"left\">− 9.312</td><td align=\"left\">0</td><td align=\"left\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\">Decision conflict</td><td align=\"left\">0.112</td><td align=\"left\">1.118</td><td align=\"left\">(1.068, 1.187)</td><td char=\".\" align=\"char\">0.000**</td></tr><tr><td align=\"left\" colspan=\"5\">Gender</td></tr><tr><td align=\"left\"> Female</td><td align=\"left\"/><td align=\"left\">1</td><td align=\"left\">Reference</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Male</td><td align=\"left\">1.218</td><td align=\"left\">3.381</td><td align=\"left\">(0.779, 18.277)</td><td char=\".\" align=\"char\">0.123</td></tr><tr><td align=\"left\" colspan=\"5\">Age</td></tr><tr><td align=\"left\"> 18–49</td><td align=\"left\"/><td align=\"left\">1</td><td align=\"left\">Reference</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> 50–60</td><td align=\"left\">1.606</td><td align=\"left\">4.984</td><td align=\"left\">(1.17, 25.392)</td><td char=\".\" align=\"char\">0.038*</td></tr><tr><td align=\"left\"> ≥ 60</td><td align=\"left\">0.746</td><td align=\"left\">2.109</td><td align=\"left\">(0.255, 21.249)</td><td char=\".\" align=\"char\">0.498</td></tr><tr><td align=\"left\" colspan=\"5\">Educational level</td></tr><tr><td align=\"left\"> Primary school and below</td><td align=\"left\"/><td align=\"left\">1</td><td align=\"left\">Reference</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Middle/High/technical secondary school</td><td align=\"left\">0.485</td><td align=\"left\">1.624</td><td align=\"left\">(0.187, 17.374)</td><td char=\".\" align=\"char\">0.670</td></tr><tr><td align=\"left\"> College and above</td><td align=\"left\">− 1.339</td><td align=\"left\">0.262</td><td align=\"left\">(0.016, 3.691)</td><td char=\".\" align=\"char\">0.325</td></tr><tr><td align=\"left\" colspan=\"5\">Marital status</td></tr><tr><td align=\"left\"> Married</td><td align=\"left\"/><td align=\"left\">1</td><td align=\"left\">Reference</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Unmarried and others</td><td align=\"left\">1.575</td><td align=\"left\">4.832</td><td align=\"left\">(0.438, 83.365)</td><td char=\".\" align=\"char\">0.234</td></tr><tr><td align=\"left\" colspan=\"5\">Income</td></tr><tr><td align=\"left\"> ≤ 4000 ($580)</td><td align=\"left\"/><td align=\"left\">1</td><td align=\"left\">Reference</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> 4001–5000 ($581–725)</td><td align=\"left\">0.263</td><td align=\"left\">1.301</td><td align=\"left\">(0.246, 7.412)</td><td char=\".\" align=\"char\">0.758</td></tr><tr><td align=\"left\"> &gt; 5000 ($725)</td><td align=\"left\">2.131</td><td align=\"left\">8.426</td><td align=\"left\">(1.164, 91.808)</td><td char=\".\" align=\"char\">0.053</td></tr><tr><td align=\"left\" colspan=\"5\">Residence</td></tr><tr><td align=\"left\"> Urban</td><td align=\"left\"/><td align=\"left\">1</td><td align=\"left\">Reference</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Urban to rural/Rural</td><td align=\"left\">0.521</td><td align=\"left\">1.684</td><td align=\"left\">(0.358, 8.778)</td><td char=\".\" align=\"char\">0.516</td></tr><tr><td align=\"left\" colspan=\"5\">History of smoking</td></tr><tr><td align=\"left\"> No</td><td align=\"left\"/><td align=\"left\">1</td><td align=\"left\">Reference</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Yes</td><td align=\"left\">− 1.214</td><td align=\"left\">0.297</td><td align=\"left\">(0.04, 2.009)</td><td char=\".\" align=\"char\">0.217</td></tr><tr><td align=\"left\" colspan=\"5\">First degree relative with lung cancer</td></tr><tr><td align=\"left\"> No</td><td align=\"left\"/><td align=\"left\">1</td><td align=\"left\">Reference</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Yes</td><td align=\"left\">2.079</td><td align=\"left\">7.997</td><td align=\"left\">(0.476, 407.07)</td><td char=\".\" align=\"char\">0.215</td></tr><tr><td align=\"left\">Communication quality score</td><td align=\"left\">− 0.705</td><td align=\"left\">0.494</td><td align=\"left\">(0.291, 0.777)</td><td char=\".\" align=\"char\">0.004**</td></tr><tr><td align=\"left\" colspan=\"5\">Lung Cancer Worry Scale1: How worried are you about getting lung cancer someday?</td></tr><tr><td align=\"left\"> Not worried</td><td align=\"left\"/><td align=\"left\">1</td><td align=\"left\">Reference</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Worried</td><td align=\"left\">0.909</td><td align=\"left\">2.482</td><td align=\"left\">(0.694, 9.696)</td><td char=\".\" align=\"char\">0.171</td></tr><tr><td align=\"left\" colspan=\"5\">Lung Cancer Worry Scale2: What is your current anxiety level about the results of future tests/treatments?</td></tr><tr><td align=\"left\"> Not anxious</td><td align=\"left\"/><td align=\"left\">1</td><td align=\"left\">Reference</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Anxious</td><td align=\"left\">2.602</td><td align=\"left\">13.484</td><td align=\"left\">(2.633, 98.982)</td><td char=\".\" align=\"char\">0.004**</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[]
[ "<table-wrap-foot><p>*<italic>p</italic> &lt; .05. **<italic>p</italic> &lt; .01.</p></table-wrap-foot>", "<table-wrap-foot><p>*<italic>p</italic> &lt; .05. **<italic>p</italic> &lt; .01.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Jingmin Yuan and Fenglin Xu.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2023_45708_Fig1_HTML\" id=\"MO1\"/>" ]
[]
[{"label": ["2."], "surname": ["Yuan", "Sun", "Wang", "Wang", "Li", "Fan"], "given-names": ["J", "Y", "K", "Z", "D", "M"], "article-title": ["Cost effectiveness of lung cancer screening with low-dose CT in heavy smokers in China"], "source": ["Cancer Prev. Res."], "year": ["2022"], "volume": ["15"], "fpage": ["37"], "lpage": ["44"], "pub-id": ["10.1158/1940-6207.CAPR-21-0155"]}, {"label": ["11."], "surname": ["Bai", "Choi", "Chu", "Anantham", "Chung-Man", "Khan"], "given-names": ["C", "CM", "CM", "D", "HJ", "AZ"], "article-title": ["Evaluation of pulmonary nodules: Clinical practice consensus guidelines for Asia"], "source": ["Ches."], "year": ["2016"], "volume": ["150"], "fpage": ["877"], "lpage": ["893"], "pub-id": ["10.1016/j.chest.2016.02.650"]}, {"label": ["15."], "surname": ["Bonett", "Wright"], "given-names": ["DG", "TA"], "article-title": ["Sample size requirements for estimating pearson, kendall and spearman correlations"], "source": ["Psychometrika"], "year": ["2000"], "volume": ["65"], "fpage": ["23"], "lpage": ["28"], "pub-id": ["10.1007/BF02294183"]}, {"label": ["16."], "surname": ["Zhao", "Wang", "Chang", "Jin", "Tian"], "given-names": ["C", "X", "L", "Y", "F"], "article-title": ["Reliability and validity of the impact of event scale in Chinese traumatic event suffers"], "source": ["Chin. Mental Health J."], "year": ["2003"], "volume": ["17"], "fpage": ["679"], "lpage": ["681"]}, {"label": ["19."], "surname": ["Li"], "given-names": ["Y"], "source": ["Construction and Application of Treatment Decision Aids for Early-Stage Primary Liver Cancer Patients"], "year": ["2017"], "publisher-name": ["Naval Medical University"]}, {"label": ["23."], "surname": ["Zheng", "Hu", "Dong", "Yang"], "given-names": ["H", "J", "B", "Y"], "article-title": ["Research progress on the messurements of Shared Decision Making among physicians and patients"], "source": ["Chin. J. Nurs."], "year": ["2018"], "volume": ["53"], "fpage": ["622"], "lpage": ["625"]}, {"label": ["25."], "surname": ["Wang", "Wei", "Hu", "Zhang", "Zheng", "Fei"], "given-names": ["L", "Y", "H", "X", "M", "G"], "article-title": ["Correlation between anxiety, depression and changes in Th17/Treg and inflammatory levels in patients with pulmonary nodules"], "source": ["Chin. J. Lung Cancer"], "year": ["2020"], "volume": ["23"], "fpage": ["554"], "lpage": ["560"]}]
{ "acronym": [], "definition": [] }
35
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1189
oa_package/4e/02/PMC10786871.tar.gz
PMC10786872
38216708
[ "<title>Introduction</title>", "<p id=\"Par2\">Coronary artery bypass grafting (CABG) remains the gold standard for treating patients with complex multivessel coronary artery disease and/or left main disease, diabetes or reduced left ventricular function, according to US and European guidelines<sup>##REF##25077860##1##,##REF##30165437##2##</sup>. Saphenous vein grafts (SVGs) are the most frequently used conduits for CABG, but their use is associated with a 10-year vein graft restenosis rate of 40–50%<sup>##REF##31455868##3##</sup>. However, the mechanism of vein graft restenosis remains unclear, although it is widely thought to be related to multiple factors and mechanisms that cause intimal hyperplasia (IH), mainly involving the proliferation and migration of human vein smooth muscle cells (HVSMCs). Therefore, it is essential to further study the molecular mechanisms of IH following CABG.</p>", "<p id=\"Par3\">Bioinformatics is a discipline based on integration of life sciences and computer sciences that involves the collection, processing, storage, transmission, analysis and interpretation of biological information<sup>##REF##28252089##4##</sup>. Regarding currently available Gene Expression Omnibus (GEO) datasets associated with graft restenosis, most studies with uploaded data were on plasma from patients with in-stent restenosis, and three studies were about grafts in animals<sup>##UREF##0##5##–##REF##29558369##7##</sup>. At this time, no studies about vein graft restenosis in human samples are included.</p>", "<p id=\"Par4\">Herein, clinical samples of occluded vein grafts were collected for transcriptome sequencing and bioinformatics analysis to screen for key genes or proteins affecting the occurrence of vein graft restenosis. We found that ITGB2 was one of the key genes in this process. Silencing of ITGB2 inhibited the proliferation and migration of HVSMCs stimulated by PDGF-BB. Overall, our study demonstrates that ITGB2 is a regulator of HVSMC growth and an essential factor contributing to IH.</p>" ]
[ "<title>Material and methods</title>", "<title>Occluded vein grafts and great saphenous veins</title>", "<p id=\"Par18\">In the present study, a total of fifteen pairs of occluded vein grafts and intraoperative spare great saphenous veins were obtained from patients undergoing clinical redo-CABG; three pairs were used for transcriptome sequencing, and the remaining pairs were used for experimental validation of the hub genes. In addition, the intraoperative spare great saphenous veins of CABG patients were used for primary HVSMC culture. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the ethics committee of Tianjin Chest Hospital (No. IRB-SOP-016(F)-001-02), and informed consent was obtained from all individual participants.</p>", "<title>Identification of DEGs from our sequencing data files</title>", "<p id=\"Par19\">After transcriptome sequencing, we obtained the transcriptome expression profiles of three pairs of vessels. The expression profiles were normalized with the R package “limma”. The differentially expressed genes (DEGs) were screened by the R package “limma” based on the cutoff criteria of |log<sub>2</sub>FC|&gt; 1 and <italic>P</italic> value &lt; 0.05.</p>", "<title>Weighted gene co-expression network analysis (WGCNA)</title>", "<p id=\"Par20\">WGCNA was performed with the R package “WGCNA” (<ext-link ext-link-type=\"uri\" xlink:href=\"https://cran.r-project.org/web/packages/WGCNA/index.html)\">https://cran.r-project.org/web/packages/WGCNA/index.html)</ext-link><sup>##UREF##2##21##,##UREF##3##22##</sup>. First, a co-expression network containing all genes was constructed, and the 20% of genes with the highest variance were used for further analysis. Samples were used to construct the adjacency matrix. Then, the adjacency matrix was transformed into a topological overlap matrix (TOM). Genes were classified into different modules by measurement of differences based on the TOM. In this study, we set the minimal gene module size as 30 and the threshold to merge similar modules as 0.25 to explore modules significantly correlated with clinical traits.</p>", "<title>Identification of upregulated DEGs in the floralwhite module and construction of protein–protein interaction (PPI) networks</title>", "<p id=\"Par21\">First, a Venn diagram was used to determine the intersection of the set of genes in the module with the highest correlation with clinical traits and the set of upregulated DEGs to identify upregulated DEGs in the floralwhite module; this was performed with FunRich, a biological analysis software (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.funrich.org/\">http://www.funrich.org/</ext-link>). The STRING database (<ext-link ext-link-type=\"uri\" xlink:href=\"http://string-db.org/\">http://string-db.org/</ext-link><sup>##UREF##4##23##</sup> is widely recognized to collect, store and integrate publicly available sources of protein–protein interaction information and supplement these sources through computational predictions. In this study, PPI networks of the upregulated DEGs in the floralwhite module were analyzed through the STRING database (confidence score &gt; 0.9)<sup>##UREF##4##23##</sup>. Subsequently, the PPI networks were visualized and analyzed with Cytoscape software and the cytoHubba plugin. All algorithms were applied to screen for hub genes. The top 6 genes were regarded as hub genes.</p>", "<title>Functional annotation of the hub genes</title>", "<p id=\"Par22\">The Gene Ontology (GO) database is a comprehensive resource of calculable knowledge about the functions of genes that is widely used by the biomedical research community to analyze omics and related data<sup>##UREF##5##24##</sup>. The Kyoto Encyclopedia of Genes and Genomes (KEGG) database has been reported to link genomic information with higher-order functional information<sup>##REF##9847135##25##</sup>. In addition, the Database for Annotation, Visualization and Integrated Discovery (DAVID, <ext-link ext-link-type=\"uri\" xlink:href=\"https://david.ncifcrf.gov/\">https://david.ncifcrf.gov/</ext-link>) provides a comprehensive set of functional annotation tools for investigators to understand the biological meaning behind large lists of genes<sup>##REF##22543366##26##</sup>. In our study, GO and KEGG analyses of the hub genes were performed with the online DAVID tool (genes with the 10 highest −log<sub>10</sub>\n<italic>p</italic> values).</p>", "<title>Real-time quantitative PCR (RT-qPCR)</title>", "<p id=\"Par23\">Total RNA was isolated from the occluded vein grafts and intraoperative spare great saphenous veins of patients using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocol. Total RNA from primary HVSMCs was isolated using a Takara reagent according to the manufacturer’s protocol (Takara, Shiga, Japan). Complementary DNA (cDNA) was reverse transcribed from 2 μg of RNA by using the Takara reverse transcription system (Takara), and real-time PCR was performed with SYBR Green mix on the 7500 real-time PCR system (Applied Biosystems; ABI, Waltham, Ma, USA). ITGB2 expression was normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression, and relative expression levels were calculated with the 2-<sup>ΔΔCT</sup> method.</p>", "<p id=\"Par24\">The primer sequences were as follows: ITGB2 forward: 5′-GAGTGCCTGAAGTTCGAAAAG-3′, reverse 5′- TCATCCACATAGATGAGGTAGC-3′; GAPDH forward: 5′- AAAAGCATCACCCGGAGGAGAA-3′, reverse 5′- AAGGAAATGAATGGGCAGCCG-3′.</p>", "<title>Western blot (WB) analysis</title>", "<p id=\"Par25\">Proteins from occluded vein grafts and intraoperative spare great saphenous veins of patients were extracted following the kit instructions (Solarbio, Beijing, China). Then, the proteins were separated by SDS‒PAGE and electrophoretically transferred to PVDF membranes (Millipore, Burlington, MA, USA), which were incubated with gentle shaking overnight at 4 °C with a primary antibody against ITGB2 (Santa Cruz, TX, USA) or GAPDH (Proteintech, Wuhan, China) and were then incubated with horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature (Proteintech). Bands were visualized with ECL reagents (Thermo Fisher Scientific, Waltham, MA, USA).</p>", "<title>Primary HVSMC culture and identification</title>", "<p id=\"Par26\">As previously described<sup>##REF##32216529##27##</sup>, HVSMCs were isolated from intraoperative spare great saphenous vein segments obtained from patients undergoing CABG. For cell culture, HVSMC medium (ScienCell, USA) supplemented with 20% fetal bovine serum (FBS, Gibco, USA), 1% growth factors (ScienCell), and 1% penicillin/streptomycin (Gibco) was used. HVSMCs were characterized by immunofluorescence staining for smooth muscle-specific α-SMA. All experiments employed HVSMCs at passages 3–5.</p>", "<title>siRNA transfection and knockdown efficiency of si-ITGB2</title>", "<p id=\"Par27\">Primary HVSMCs were transfected with a specific small interfering RNA (siRNA) or control siRNA using Lipo3000 transfection reagent (Thermo Fisher Scientific, China) following the manufacturer’s instructions. The siRNA targeting ITGB2 was purchased from Santa Cruz Biotechnology (TX, USA). The knockdown efficiency was verified 24 h post-transfection by RT‒qPCR and WB analyses. After 24–48 h of transfection, HVSMCs were used for subsequent experiments. For PDGF-BB treatment, after 24 h of transfection, HVSMCs were serum-starved for 12 h before incubation with 20 ng/ml PDGF-BB for 24 h.</p>", "<title>EdU incorporation assay</title>", "<p id=\"Par28\">The EdU incorporation assay was conducted using the BeyoClick™ EdU Cell Proliferation Kit with Alexa Fluor 594 (Beyotime, China). After transfection for 24 h and serum starvation for 12 h, HVSMCs were washed with PBS. Then, medium supplemented with or without 20 ng/ml PDGF-BB was added to the wells. After 24 h of incubation, half of the medium was kept, and EdU was added to the medium to maintain a concentration of 10 μM per well. The HVSMCs were incubated for 2 h at 37 °C in a 5% CO<sub>2</sub> atmosphere. After incubation, the HVSMCs were washed with PBS and fixed with 4% paraformaldehyde at room temperature for 15 min before being stained with DAPI for 10 min. After an additional wash in PBS, the cells were observed under an inverted microscope.</p>", "<title>Wound healing assay</title>", "<p id=\"Par29\">After 48 h of transfection, HVSMCs were serum-starved for 12 h. A linear wound was made with a 200 μl pipette tip in the middle of each well of a six-well plate. After washing with PBS, 2 ml of serum-free medium with or without 20 ng/ml PDGF-BB was added, and continuous imaging was initiated. This time was recorded as 0 h. After 8 h, images were acquired continuously in each group. The differences between each group at 0 h and 8 h were quantified using ImageJ software, and the rate of wound healing was calculated using the following formula: Wound healing rate = ((area of scratch at 0 h –area of scratch at 8 h)/area of scratch at 0 h) × 100%. Each experiment was repeated three times.</p>", "<title>Transwell migration assay</title>", "<p id=\"Par30\">Transwell chambers (24-well Transwell chambers, Corning Inc., NY, USA) were used for the migration assay. After transfection for 48 h, HVSMCs were resuspended in serum-free medium, and the cell density was adjusted to 2 × 10<sup>4</sup> cells/ml. Moreover, 200 µL of the cell suspension was seeded into the upper chambers. The lower chambers contained 600 µL of 10% FBS medium with or without 20 ng/ml PDGF-BB. Following 24 h of incubation, the cells that invaded into the lower surface of the membrane were fixed with 4% paraformaldehyde, stained with 0.1% crystal violet, and counted in five random fields under a bright field microscope. Each experiment was repeated three times.</p>", "<title>Statistical analysis</title>", "<p id=\"Par31\">All data are expressed as the means ± SEMs, and all statistical analyses were performed with GraphPad Prism 7.0 software using Student’s unpaired t test when comparing the two groups. A <italic>P</italic> value of &lt; 0.05 was considered to indicate statistical significance.</p>" ]
[ "<title>Results</title>", "<title>Identification of DEGs</title>", "<p id=\"Par5\">A flowchart describing the methodology of the present study is shown in Fig. ##FIG##0##1##. In this study, fifteen patients were included, and more details on their characteristics are shown in Table ##TAB##0##1##.</p>", "<p id=\"Par6\">After sequencing, 58,939 genes in our sequencing files were identified. A total of 4479 DEGs in the occluded grafts were identified, namely, 3075 upregulated and 1404 downregulated genes (Fig. ##FIG##1##2##A,B).</p>", "<title>WGCNA</title>", "<p id=\"Par7\">In our study, WGCNA was conducted with the R package “WGCNA”. Clustering of the patients is shown in Supplemental Fig. ##SUPPL##0##1##, where red represents patients with occluded grafts. The key step in WGCNA is the selection of the soft-thresholding power. In our study, the soft-thresholding power was identified by network topology analysis. For WGCNA of vascular restenosis datasets, the soft-thresholding power was 12, and the lowest power of the scale-free topology fitting index was 0.8 (Fig. ##FIG##2##3##A). A hierarchical clustering tree of all genes in the vascular restenosis database was produced, and 10 important modules were generated (Fig. ##FIG##2##3##B). Moreover, the dendrogram and heatmap of the genes showed no significant difference in interactions among the modules, demonstrating a high degree of independence between these modules (Supplemental Fig. ##SUPPL##0##2##). The floralwhite module had the highest correlation with the of occluded graft status, with a correlation coefficient of 0.94 and a P value of 0.006 (Fig. ##FIG##3##4##).</p>", "<title>Upregulated DEGs and protein–protein interaction network analysis</title>", "<p id=\"Par8\">The Venn diagram of the DEGs in the floralwhite module and the upregulated DEGs is shown in Supplemental Fig. ##SUPPL##0##3## and contains 615 genes.</p>", "<p id=\"Par9\">The PPI network of the upregulated DEGs in the floralwhite module was constructed by the STRING online database and visualized by Cytoscape software (Fig. ##FIG##4##5##). Eleven algorithms were independently used to identify hub genes, and the 6 hub genes identified by the most algorithms were obtained: ITGAM, PTPRC, TLR4, TYROBP, ITGB2 and CD4. A summary of the hub genes is shown in Table ##TAB##1##2##.</p>", "<title>Functional and pathway enrichment analyses of the common hub genes</title>", "<p id=\"Par10\">GO and KEGG analyses of the common hub genes were performed to improve our understanding of the biological functions of these genes. GO analysis of the common hub genes by DAVID showed significant enrichment in components associated with the cell membrane, and the enriched biological processes included neutrophil degranulation and receptor binding, etc. (Fig. ##FIG##5##6##A). KEGG enrichment analysis showed significant enrichment in the intercellular adhesion pathway, innate immune deficiency pathway and other signaling pathways (Fig. ##FIG##5##6##B).</p>", "<title>Validation of ITGB2 expression in occluded grafts</title>", "<p id=\"Par11\">Based on the literature and the GO and KEGG analysis results, we finally selected ITGB2 as the target gene, and the expression of ITGB2 in occluded vein grafts and intraoperative spare great saphenous veins was validated by RT-qPCR and WB analyses. The results showed that ITGB2 expression in occluded vein grafts was significantly higher than that in intraoperative spare great saphenous veins (Fig. ##FIG##6##7##A–C).</p>", "<title>Silencing of ITGB2 significantly decreases HVSMC proliferation and migration stimulated by PDGF-BB</title>", "<p id=\"Par12\">To study the function of ITGB2 in vessels, primary HVSMCs were generated as previously described and characterized by an immunofluorescence assay (Supplemental Fig. ##SUPPL##0##4##). To investigate whether the proliferation and migration functions are regulated by ITGB2, we conducted EdU incorporation, wound healing and transwell assays. First, primary HVSMCs were transduced with si-ITGB2, and the knockdown efficiency was determined (Supplemental Fig. ##SUPPL##0##5##). Silencing of ITGB2 significantly decreased cell proliferation by approximately 50% in both the no-stimulation group and PDGF-BB group (Fig. ##FIG##7##8##A and Supplemental Fig. ##SUPPL##0##6##). Likewise, si-ITGB2 inhibited cell migration and invasion compared with that in the si-con group (Fig. ##FIG##7##8##B–D and Supplemental Fig. ##SUPPL##0##7##). Together, these results showed the function of ITGB2 in the proliferation and migration of HVSMCs. Silencing of ITGB2 may inhibit the PDGF-BB-stimulated proliferation and migration of HVSMCs.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par13\">Abnormal proliferation of HVSMCs is a major cause of cardiovascular diseases and conditions, such as atherosclerosis, graft restenosis and aneurysm. To our knowledge, no study has assessed graft restenosis with human samples. In the present study, occluded vein grafts and intraoperative spare great saphenous veins were obtained from redo-CABG patients for transcriptome sequencing, and hub genes (ITGAM, PTPRC, TLR4, TYROBP, ITGB2 and CD4) were identified by bioinformatics analysis. GO and KEGG enrichment analyses revealed that the hub genes were associated with cell membrane components, intercellular adhesion and innate immune deficiency.</p>", "<p id=\"Par14\">Atherosclerosis is observed during the late stage of graft restenosis and in the native coronary artery. Atherosclerosis is widely thought to result from abnormal lipid metabolism and chronic inflammation<sup>##REF##33758323##8##</sup>. The ITGAM (also called CR3A, MO1A, CD11B, MAC-1, MAC1A, and SLEB6) gene, located on chromosome 16p11.2, encodes integrin-α M, which is an essential adhesion molecule and might promote the development and progression of abdominal aortic aneurysm by mediating the endothelial cell adhesion and transendothelial migration of circulating monocytes/macrophages<sup>##REF##33749307##9##</sup>. One study showed that CD40L can interact with integrins to elicit monocyte adhesion and migration, representing a novel mechanism of inflammatory signaling in atherosclerosis<sup>##REF##37210082##10##</sup>. TYROBP (also called DAP12, KARAP, PLOSL, and PLOSL1) encodes a transmembrane signaling polypeptide that is a type of transmembrane receptor ubiquitously expressed in macrophages/monocytes, natural killer (NK) cells and neutrophils<sup>##REF##33758323##8##</sup>, and a recent study found that TYROBP promotes atherosclerosis<sup>##REF##37218975##11##</sup>. In recent years, the involvement of NK cells has been documented in various inflammatory responses and early atherosclerosis<sup>##REF##29595698##12##</sup>. Wang et al. revealed that atherosclerotic plaques in APOE mice exhibited high expression of TYROBP<sup>##REF##30070336##13##</sup>. Vein graft restenosis is a chronic process involving atherosclerosis and inflammation. Consistent with these observations, we identified two genes significantly related to these processes.</p>", "<p id=\"Par15\">PTPRC (also known as CD45) is an essential surface protein on hematopoietic and immune cells<sup>##REF##34039664##14##</sup>. PTPRC controls immune function by regulating lymphocyte survival, cytokine responses, and TCR signaling<sup>##REF##34039664##14##</sup>. Deficiency or altered expression of PTPRC is associated with various diseases, including leukemia and lymphoma<sup>##REF##29366662##15##</sup>. PTPRC exerts effects through many mechanisms, including modulating apoptosis and cell survival<sup>##REF##34039664##14##</sup>. In the present study, in silico analysis showed that PTPRC is related to vein graft restenosis, possibly through control of immune function and apoptosis.</p>", "<p id=\"Par16\">Based on the literature, ITGB2 (also known as CD18) was selected as the target gene. The results showed that the expression of ITGB2 in occluded vein grafts was significantly higher than that in intraoperative spare great saphenous veins. An increasing body of evidence suggests that ITGB2 mutation may cause leukocyte adhesion defect type 1 (LAD-1)<sup>##REF##34333755##16##,##REF##29139565##17##</sup>. In recent years, it has been found that ITGB2 mediates a metabolic switch in cancer-associated fibroblasts, promoting oral squamous cell carcinoma proliferation<sup>##REF##33204328##18##</sup>. In a study on myocardial infarction, overexpression of ITGB2 increased the migration and improved the engraftment of adipose-derived stem cells and augmented angiogenesis<sup>##UREF##1##19##</sup>. Sequencing of carotid atherosclerosis samples showed that ITGB2 was a key gene<sup>##REF##34140767##20##</sup>. The above studies suggest that ITGB2 is tightly associated with the proliferation and migration of cells, in accordance with our results. Next, we found that silencing ITGB2 inhibited the proliferation and migration of HVSMCs.</p>", "<p id=\"Par17\">In summary, our study demonstrates that the key genes related to graft restenosis include ITGAM, PTPRC, TLR4, TYROBP, ITGB2 and CD4. Moreover, ITGB2 knockdown can reduce the proliferation and migration of HVSMCs, a finding that offers novel insights into the prevention of restenosis following CABG.</p>" ]
[]
[ "<p id=\"Par1\">The great saphenous vein is the most commonly used vessel for coronary artery bypass grafting (CABG), but its use has been associated with a high restenosis rate at 10-year follow-up. This study sought to determine the key genes associated with vein graft restenosis that could serve as novel therapeutic targets. A total of 3075 upregulated and 1404 downregulated genes were identified after transcriptome sequencing of three pairs of restenosed vein grafts and intraoperative spare great saphenous veins. Weighted gene co-expression network analysis showed that the floralwhite module had the highest correlation with vein graft restenosis. The intersection of the floralwhite module gene set and the upregulated gene set contained 615 upregulated genes strongly correlated with vein graft restenosis. Protein–protein interaction network analysis identified six hub genes (ITGAM, PTPRC, TLR4, TYROBP, ITGB2 and CD4), which were obtained using the STRING database and CytoHubba. Gene Ontology term and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses showed that the common hub genes were mainly involved in the composition of the cell membrane; in biological processes such as neutrophil degranulation, receptor binding and intercellular adhesion, innate immune deficiency; and other signaling pathways. Finally, ITGB2 was selected as the target gene, and its expression was verified in tissues. The results showed that ITGB2 was significantly overexpressed in occluded vein grafts. To study the function of ITGB2 in HVSMCs, primary HVSMCs were cultured and successfully identified. EdU incorporation, wound healing and transwell assays showed that ITGB2 silencing significantly inhibited the proliferation and migration of HVSMCs stimulated by PDGF-BB. Overall, our study provides a basis for future studies on preventing restenosis following CABG.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51564-z.</p>", "<title>Acknowledgements</title>", "<p>This research was funded by Tianjin Key Medical Discipline(Specialty) Construction Project(NO.TJYXZDXK-042A) and Science and Technology Program of Tianjin, China(NO.22JCYBJC01430).</p>", "<title>Author contributions</title>", "<p>Research idea and study design: Y.B., Z.G.; data acquisition: X.L., M.Q., Y.B.; data analysis/interpretation: Q.C., N.J., L.W.; statistical analysis: X.L., M.Q., Y.B., supervision or mentorship of the findings: N.J., Z.G. All authors reviewed the manuscript.</p>", "<title>Data availability</title>", "<p>The datasets generated and analysed during the current study are available in the Gene Expression Omnibus (GEO) repository, GSE241205.</p>", "<title>Competing interests</title>", "<p id=\"Par32\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>The methodology of the present study.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Volcano plot and heatmap of DEGs.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Determination of the soft threshold of the gene coexpression network and module generation based on gene clustering dendrograms. (<bold>A</bold>) Determination of the soft threshold. (<bold>B</bold>) Module generation based on gene clustering dendrograms.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Module-trait associations revealed by Pearson correlation analysis. The colors in the leftmost column indicate different coexpression modules. The numbers in the figure indicate the correlation coefficients between the modules and traits, and the numbers in parentheses are the correlation <italic>P</italic> values.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>The PPI network of the DEGs_up gene set in the floralwhite module constructed via the STRING online database.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Functional and pathway enrichment analyses of the common hub genes. (<bold>A</bold>) GO analysis of the common hub genes. (<bold>B</bold>) KEGG analysis of the common hub genes.</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>Validation of ITGB2 expression in occluded grafts. (<bold>A</bold>) Relative expression of ITGB2 in occluded vein grafts, as measured by RT-qPCR. (<bold>B</bold>, <bold>C</bold>) Protein expression of ITGB2 in occluded vein grafts, as measured by WB. Control and C group represent the intraoperative spare great saphenous vein samples, and resentosis and T group represent the occluded vein grafts samples. Significance was indicated as *p &lt; 0.05, ***p &lt; 0.001.</p></caption></fig>", "<fig id=\"Fig8\"><label>Figure 8</label><caption><p>Effect of ITGB2 on HVSMCs stimulated with PDGF-BB. (<bold>A</bold>) EdU incorporation assay to evaluate HVSMC proliferation in the indicated groups 24 h after PDGF-BB stimulation (n = 3). (<bold>B</bold>, <bold>C</bold>) Representative images and migration rates of HVSMCs 0 and 8 h after PDGF-BB stimulation (n = 3). Scale = 100 μm. (<bold>D</bold>) Migration rates of HVSMCs after 24 h of PDGF-BB stimulation. Significance was indicated as *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Characteristics of the fifteen redo-CABG patients.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Parameter</th><th align=\"left\">Total (n = 15)</th></tr></thead><tbody><tr><td align=\"left\">Male sex</td><td align=\"left\">11 (73.3%)</td></tr><tr><td align=\"left\">Hypertension</td><td align=\"left\">9 (60%)</td></tr><tr><td align=\"left\">Diabetes</td><td align=\"left\">2 (13.3%)</td></tr><tr><td align=\"left\">Smoking</td><td align=\"left\">6 (40%)</td></tr><tr><td align=\"left\">Age (years)</td><td align=\"left\">67.6 ± 1.158</td></tr><tr><td align=\"left\">Postsurgical time (years)</td><td align=\"left\">9.267 ± 1.274</td></tr><tr><td align=\"left\">Regraft number</td><td align=\"left\">2.133 ± 0.1652</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Top 10 hub genes identified by 11 algorithms.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Algorithm</th><th align=\"left\">MCC</th><th align=\"left\">DMNC</th><th align=\"left\">MNC</th><th align=\"left\">Degree</th><th align=\"left\">EPC</th><th align=\"left\">BottleNeck</th><th align=\"left\">EcCentricity</th><th align=\"left\">Closeness</th><th align=\"left\">Radiality</th><th align=\"left\">Betweenness</th><th align=\"left\">Stress</th></tr></thead><tbody><tr><td align=\"left\">1</td><td align=\"left\">PTPRC</td><td align=\"left\">C3AR1</td><td align=\"left\">PTPRC</td><td align=\"left\">PTPRC</td><td align=\"left\">PTPRC</td><td align=\"left\">PTPRC</td><td align=\"left\">NRAS</td><td align=\"left\">PTPRC</td><td align=\"left\">CD4</td><td align=\"left\">CD4</td><td align=\"left\">CD4</td></tr><tr><td align=\"left\">2</td><td align=\"left\">ITGAM</td><td align=\"left\">HLA-DOA</td><td align=\"left\">CD4</td><td align=\"left\">CD4</td><td align=\"left\">TYROBP</td><td align=\"left\">TFRC</td><td align=\"left\">ITGAM</td><td align=\"left\">CD4</td><td align=\"left\">PTPRC</td><td align=\"left\">PTPRC</td><td align=\"left\">PTPRC</td></tr><tr><td align=\"left\">3</td><td align=\"left\">CYBB</td><td align=\"left\">HLA-DMA</td><td align=\"left\">TYROBP</td><td align=\"left\">TYROBP</td><td align=\"left\">SPI1</td><td align=\"left\">ITGB2</td><td align=\"left\">PLA2G15</td><td align=\"left\">TYROBP</td><td align=\"left\">TYROBP</td><td align=\"left\">PLEK</td><td align=\"left\">PLEK</td></tr><tr><td align=\"left\">4</td><td align=\"left\">SPI1</td><td align=\"left\">MRC1</td><td align=\"left\">ITGAM</td><td align=\"left\">ITGAM</td><td align=\"left\">ITGAM</td><td align=\"left\">TYROBP</td><td align=\"left\">RAC2</td><td align=\"left\">ITGB2</td><td align=\"left\">ITGB2</td><td align=\"left\">ITGB2</td><td align=\"left\">TLR4</td></tr><tr><td align=\"left\">5</td><td align=\"left\">FCGR2B</td><td align=\"left\">MPEG1</td><td align=\"left\">SPI1</td><td align=\"left\">SPI1</td><td align=\"left\">CD86</td><td align=\"left\">TLR4</td><td align=\"left\">CD86</td><td align=\"left\">ITGAM</td><td align=\"left\">ITGAM</td><td align=\"left\">TYROBP</td><td align=\"left\">TYROBP</td></tr><tr><td align=\"left\">6</td><td align=\"left\">TYROBP</td><td align=\"left\">CCR1</td><td align=\"left\">ITGB2</td><td align=\"left\">ITGB2</td><td align=\"left\">ITGB2</td><td align=\"left\">TLR7</td><td align=\"left\">P4HB</td><td align=\"left\">SPI1</td><td align=\"left\">SPI1</td><td align=\"left\">TLR4</td><td align=\"left\">ITGB2</td></tr><tr><td align=\"left\">7</td><td align=\"left\">FCGR3A</td><td align=\"left\">CCL4</td><td align=\"left\">CD86</td><td align=\"left\">CD86</td><td align=\"left\">CD4</td><td align=\"left\">HEXB</td><td align=\"left\">MARCO</td><td align=\"left\">TLR4</td><td align=\"left\">TLR4</td><td align=\"left\">RAC2</td><td align=\"left\">TFRC</td></tr><tr><td align=\"left\">8</td><td align=\"left\">CSF1R</td><td align=\"left\">HLA-DMB</td><td align=\"left\">TLR4</td><td align=\"left\">TLR4</td><td align=\"left\">TLR4</td><td align=\"left\">CEBPB</td><td align=\"left\">DMXL2</td><td align=\"left\">CD86</td><td align=\"left\">CD86</td><td align=\"left\">TFRC</td><td align=\"left\">ITGAM</td></tr><tr><td align=\"left\">9</td><td align=\"left\">TLR4</td><td align=\"left\">FOLR2</td><td align=\"left\">PLEK</td><td align=\"left\">PLEK</td><td align=\"left\">CSF1R</td><td align=\"left\">PLEK</td><td align=\"left\">CTSB</td><td align=\"left\">PLEK</td><td align=\"left\">PLEK</td><td align=\"left\">CTSD</td><td align=\"left\">CSF1R</td></tr><tr><td align=\"left\">10</td><td align=\"left\">CCR1</td><td align=\"left\">LY86</td><td align=\"left\">CSF1R</td><td align=\"left\">CSF1R</td><td align=\"left\">FCGR3A</td><td align=\"left\">ITGAM</td><td align=\"left\">MAPK13</td><td align=\"left\">CSF1R</td><td align=\"left\">CSF1R</td><td align=\"left\">APOE</td><td align=\"left\">RAC2</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Xiankun Liu and Mingzhen Qin.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51564_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51564_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51564_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51564_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51564_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2024_51564_Fig6_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"41598_2024_51564_Fig7_HTML\" id=\"MO7\"/>", "<graphic xlink:href=\"41598_2024_51564_Fig8_HTML\" id=\"MO8\"/>" ]
[ "<media xlink:href=\"41598_2024_51564_MOESM1_ESM.pdf\"><caption><p>Supplementary Figures.</p></caption></media>" ]
[{"label": ["5."], "surname": ["Shen", "Zhang", "Lu"], "given-names": ["J", "H", "C"], "article-title": ["Microarray analysis of the time-dependent expression profiles of long non-coding RNAs in the progression of vein graft stenotic disease"], "source": ["Exp. Therapeutic Med."], "year": ["2021"], "volume": ["21"], "issue": ["6"], "fpage": ["635"], "pub-id": ["10.3892/etm.2021.10067"]}, {"label": ["19."], "surname": ["Yuan", "Yan", "Wang"], "given-names": ["Z", "K", "J"], "article-title": ["Overexpression of integrin \u03b2 2 improves migration and engraftment of adipose-derived stem cells and augments angiogenesis in myocardial infarction"], "source": ["Annals Translat. Med."], "year": ["2022"], "volume": ["10"], "issue": ["16"], "fpage": ["863"], "pub-id": ["10.21037/atm-22-3339"]}, {"label": ["21."], "surname": ["Langfelder", "Horvath"], "given-names": ["P", "S"], "article-title": ["WGCNA: An R package for weighted correlation network analysis"], "source": ["BMC Bioinform."], "year": ["2008"], "volume": ["9"], "fpage": ["559"], "pub-id": ["10.1186/1471-2105-9-559"]}, {"label": ["22."], "surname": ["Zhang", "Horvath"], "given-names": ["B", "S"], "article-title": ["A general framework for weighted gene co-expression network analysis"], "source": ["Stat. Appl. Genet. Mol. Biol."], "year": ["2005"], "volume": ["4"], "fpage": ["17"], "pub-id": ["10.2202/1544-6115.1128"]}, {"label": ["23."], "surname": ["Crosara", "Moffa", "Xiao"], "given-names": ["KTB", "EB", "Y"], "article-title": ["Merging in-silico and in vitro salivary protein complex partners using the STRING database: A tutorial"], "source": ["J. Proteom."], "year": ["2018"], "volume": ["171"], "fpage": ["87"], "lpage": ["94"], "pub-id": ["10.1016/j.jprot.2017.08.002"]}, {"label": ["24."], "mixed-citation": ["MA, H., J, C., A, I., "], "italic": ["et al", "Nucleic Acids Res.", "32"]}]
{ "acronym": [], "definition": [] }
27
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1237
oa_package/d7/5e/PMC10786872.tar.gz
PMC10786873
38216707
[ "<title>Introduction</title>", "<p id=\"Par2\">As a pressing concern, water contamination by antibiotics has detrimental impacts on human health and ecosystems, fuelling the proliferation of antibiotic-resistant bacteria and ecological imbalance<sup>##REF##36978308##1##</sup>. Pharmaceutical industries<sup>##UREF##0##2##</sup>, healthcare facilities<sup>##REF##31234491##3##</sup>, agricultural practices<sup>##UREF##1##4##</sup>, and wastewater treatment systems<sup>##UREF##2##5##,##REF##34974049##6##</sup> are known as major contributors to waterborne antibiotic pollution. Water treatment plants are now grappling with an overwhelming influx of antibiotics in water bodies, exacerbated by population growth and disease outbreaks, thereby necessitating the development of sustainable methods to ensure antibiotic-free water<sup>##UREF##2##5##</sup>. Tetracycline holds a distinction among antibiotic compounds as the world's second most-used antibiotic, making it widely discharged in wastewater<sup>##UREF##3##7##</sup>. The chemical stability, solubility, mobility, degradation resistance, and low-concentration activity of tetracycline in water have made its selective removal a challenge, requiring the use of sensitive techniques for its detection and capture<sup>##REF##36978308##1##</sup>. Various treatment methods, such as adsorption, coagulation, chemical precipitation, ion exchange, biodegradation, ozonation, etc., have been widely employed to eliminate pharmaceutical contaminants from water<sup>##UREF##4##8##</sup>. Nevertheless, the generation of harmful by-products, poor biodegradability and stability, and high operational and maintenance costs hinder their widespread industrial application<sup>##UREF##5##9##,##UREF##6##10##</sup>. Consequently, the development of robust technologies is essential to effectively break down these pollutants into non-toxic compounds before their release into the environment<sup>##UREF##7##11##,##UREF##8##12##</sup>. A few innovative technologies, such as advanced oxidation processes (AOPs) in<sup>##UREF##9##13##</sup> and membrane separation techniques in<sup>##REF##35595150##14##</sup>, are now at the forefront of exploration for proposing antibiotic-free clean water due to their operational efficiency and adaptability.</p>", "<p id=\"Par3\">Photocatalytic membrane reactors (PMRs), combining photocatalysis and membrane technology, is an emerging AOP technology to simultaneously carry out chemical reactions and separation which can be used for removing organic pollutants from water<sup>##REF##37176408##15##–##REF##37377880##18##</sup>. The PMRs initial idea was to overcome the challenge of post-photocatalysis collection of suspended photocatalysts, especially at nanometres dimensions, from water using membranes, also offering higher selectivity and efficiency (enhanced reaction rates, reduced catalyst loss, and simplified separation), long-term stability and eco-friendly operation<sup>##REF##34974049##6##,##UREF##12##19##,##UREF##13##20##</sup>. PMRs can be divided into two general types based on the way that photocatalysts and membranes are structurally incorporated (suspended or immobilised). Suspended PMRs can be further categorised into three groups: slurry PMRs with an external membrane module, slurry PMRs with a submerged membrane module (external UV lamps), and slurry PMRs with an immersed membrane module and light source<sup>##UREF##14##21##</sup>. However, immobilised PMRs can perform enhanced reactivity, better selectivity, and simple catalyst recovery for capturing organic compounds; they may be susceptible to catalyst detachment and membrane fouling<sup>##REF##34879511##22##</sup>. Membrane-immobilized PMRs can also improve mass transfer and stability in the longer run but with limited catalyst loading and potential membrane degradation<sup>##UREF##15##23##</sup>. Suspended PMRs, on the other hand, can offer efficient catalyst utilisation and anti-fouling properties but are prone to the separation of suspended catalyst particles in severe operating conditions<sup>##UREF##16##24##</sup>. Hollow fibre and tubular PMRs with better porosity and selectivity, efficient separation and light utilisation may suffer from fouling and scalability limitations. The design of an effective PMR method for purification purposes is mainly controlled by the intended outcomes and trade-offs between reaction rate, selectivity, mass transfer efficiency, catalyst stability, and operational ease<sup>##REF##34879511##22##</sup>. However, PMRs have been reported as a promising approach for capturing organic compounds from water; their sustainable applications for antibiotic removal face a few challenges of antibiotic-specific removal mechanisms, optimal synergic effect, impact of water matrix and coexisting compounds, limited stability and fouling resistance, and scale-up challenges<sup>##UREF##17##25##</sup>. Further studies are needed to offer innovative formulations for PMRs with efficient synergic effects between photocatalytic reactions and membrane-based separation to fill the gaps for sustainable performance in real applications.</p>", "<p id=\"Par4\">Graphitic carbon nitride (g-C<sub>3</sub>N<sub>4</sub>) as a layered polymeric and metal-free semiconductor is an appealing photocatalyst to be incorporated in PMRs with advantages of nontoxicity, affordability, separability, production simplicity, chemical and thermal stability, excellent visible light absorption, and suitable band structure for photocatalysis<sup>##UREF##18##26##</sup>. However, it has been extensively studied for applications such as organic pollutant degradation, water disinfection, hydrogen production, and environmental remediation; there are still challenges and opportunities for further exploration to enhance the photocatalytic performance of g-C<sub>3</sub>N<sub>4</sub> through modifications, heteroatom doping, and hybridisation with other materials<sup>##REF##37049963##27##,##REF##36812729##28##</sup>. In this study, for the first time in the removal of tetracycline (TC) from aqueous solutions, a novel formulation for split-type PMR is developed, utilising nanosheets of g-C<sub>3</sub>N<sub>4</sub> and a commercial type of polyethersulfone (PES)/polystyrene (PS)/polyamide (PA) membranes. The synthesised PMRs were characterised using BET, TEM, FTIR, XRD, FESEM, EDS, AFM and UV–Vis in TC removal. A systematic experimental approach is employed to investigate the impact of key parameters in PMR-based removal of TC from water, including irradiation duration, pH level, catalyst amount, TC concentration, and filtration iterations. To ensure a robust optimisation of multiple-parameter experimental design and analysis, the combination of the Response Surface Method (RSM) and Central Composite Design (CCD) is also used. The reusability of g-C<sub>3</sub>N<sub>4</sub>/PES/PS/PA-based PMR is also monitored to test the promising stability of the proposed formulation for practical applications of TC removal from waterways. Supplementary information ##SUPPL##0##S1## is also provided separately for further details wherever needed.</p>" ]
[ "<title>Materials and methods</title>", "<title>Materials</title>", "<p id=\"Par5\">Melamine (2,4,6-Triamino-1,3,5-triazine, 99%), hydrochloric acid (HCl, 37%), sodium hydroxide (NaOH, 97%) and ethanol (C<sub>2</sub>H<sub>5</sub>OH, &gt; 99.8%) were purchased from Merck Co. Tetracycline hydrochloride (C<sub>22</sub>H<sub>24</sub>N<sub>2</sub>O<sub>8</sub>·HCl, &lt;  = 100) was obtained from Sigma-Aldrich Co. The double distilled water (DDW) was a product of Zolal Iran Co. (Tehran, Iran). All the chemicals were used as received without any further purifications. To prepare TC stock solution (50 mg/L), 10 mg of TC powder was dissolved in 200 mL of DDW and stirred at 200 rpm for 60 min. The solution was then filtered and stored in a sealed, non-transparent container as stock to prepare TC solutions with concentrations of 10, 15, 20, 25, and 30 mg/L.</p>", "<title><italic>Synthesis of g-C</italic><sub><italic>3</italic></sub><italic>N</italic><sub><italic>4</italic></sub></title>", "<p id=\"Par6\">For g-C<sub>3</sub>N<sub>4</sub> synthesis, melamine was initially subjected to direct furnace heating. In a pot, 5g of melamine was placed and securely sealed with thick aluminium foil. The furnace temperature was then gradually increased at 10 °C/min up to 520 °C and maintained constant for two h. The resulting yellowish mass (g-C<sub>3</sub>N<sub>4</sub>) was grounded using a mortar. The sieved materials were immersed in DDW, ultrasonicated for 90 min in three stages (to prevent agglomeration, particle stability, and increase specific surface area), and oven-dried at 70 °C for 24 h, as also confirmed by<sup>##UREF##19##29##</sup>. The resulting g-C<sub>3</sub>N<sub>4</sub> were kept in a sealed container for characterisation and testing purposes.</p>", "<title>Characterization techniques</title>", "<p id=\"Par7\">Field Emission Scanning Electron Microscope (FE-SEM, MIRA3 TESCAN-XMU, Czech Republic) was utilised for morphological assessment of the synthesised g-C<sub>3</sub>N<sub>4</sub> and used membrane, at a beam energy level of 30.00 kV under high vacuum conditions. The porous structure of the used materials was analysed based on the Brunauer Emmett Teller (BET) method by the use of the Micromeritics apparatus (ASAP2020, USA). The material's crystallinity was investigated using an X-ray diffractometer (XRD, PANalytical X’Pert Pro-MPD Powder Diffractometer, UK), by which the data were collected in the 2θ range of 5–70°. Fourier-transform infrared spectrometry (FTIR, Bruker TENSOR II, USA) was used to record the surface functional group spectra of the materials over 400–4000 cm<sup>−1</sup>. g-C<sub>3</sub>N<sub>4</sub> surface charge was evaluated by a Zeta-potential device (Photon Correlation Spectroscopy (VASCO), France). The hydrophilicity of the membrane was studied by the contact angle device (Contact Angle CAG-20) along with the AFM device (PK NanoWizard ULTRA Speed 2), which also determined the surface roughness and morphology of the membrane. UV-DRS device (JASCO V-730) was employed to perform Ultraviolet–Visible spectrophotometry (UV–Vis), obtaining diffuse reflectance spectrum (DRS) and band gap energy in the wavelength range of 200–400nm. The calibration curve for UV absorption by the TC solution can be found in Fig. ##SUPPL##0##S1## in the supplementary data.</p>", "<title>Experimental testing and optimisation</title>", "<p id=\"Par8\">The schematic diagram of the bespoke laboratory-scale slurry PMR system developed for this study is presented in Fig. ##FIG##0##1## and Fig. ##SUPPL##0##S1##. The membrane with a layered structure made of polyester, polysulfone, and polyamide was purchased from Sepanta Polymer Sharif Co. (Tehran, Iran). Table ##SUPPL##0##S1## presents the main properties of the commercial membrane. In each test, a predetermined amount of g-C<sub>3</sub>N<sub>4</sub> (0.2–1 g/L) was dispersed in a solution with specific pH and TC concentrations. Before being exposed to irradiation, the sample was magnetically stirred for 30min in a dark environment to establish an adsorption–desorption equilibrium. Photocatalytic degradation tests were carried out under visible light irradiation for a specific time (60-120min) using a 300W Xenon lamp (TACPRO, WLY202009) with a 420nm cut-off filter. The solution was centrifuged at 7500rpm for 8 min to take photocatalyst-free samples. A cylindrical module with a 5-bar retentate static N<sub>2</sub> pressure was used to perform the membrane separation process. The UV–Vis spectrophotometer was employed to detect TC concentration in the permeate solution at = 356.5 nm and determine TC removal (%) using the following equation:where and are initial and final TC concentrations, respectively.</p>", "<p id=\"Par9\">The response surface methodology (RSM), based on a central composite design (CCD), was used in this study for optimisation purposes, using design-expert software (Ver. 12.0.3, USA). The main objective was to analyse the effects of intended independent parameters, develop regression models, and determine the optimal conditions for PMR-based removal of TC from water. The experimental designs were randomised, and mean values were used. The ranges for the independent factors determined based on the existing literature, preliminary tests, and material properties were as follows: irradiation time (60–120 min), initial pH level (7–13), catalyst concentration (0.2–1 g/L), initial TC concentration (10–30 mg/L), and filtration cycles (2–6 times). In total, 50 tests were carried out, and a summary of experimental conditions and their corresponding responses is provided in Table ##TAB##0##1## for photocatalytic degradation and PMR removal. The relationship between the independent variables and responses was analysed via fitting a quadratic polynomial function. The significance and precision of the model were then evaluated through variance analysis (ANOVA), and the fitness of the model was expressed using the coefficients of determination (R<sup>2</sup>, R<sup>2</sup><sub>adj,</sub> and R<sup>2</sup><sub>pred</sub>).</p>" ]
[ "<title>Results and discussion</title>", "<title>XRD and FTIR analysis</title>", "<p id=\"Par10\">The g-C<sub>3</sub>N<sub>4</sub> nanosheets’ XRD patterns are depicted in Fig. ##FIG##1##2##a. The peaks at 27.66° and 13° can be associated with the (002) and (100) crystal planes of the g-C<sub>3</sub>N<sub>4</sub> structure, respectively<sup>##UREF##20##30##</sup>. The sharp peak at 27.66° may indicate the interlayer distance of the g-C<sub>3</sub>N<sub>4</sub> nanosheets, also known as graphitic carbon nitride, which can be influenced by intercalation, doping, or modification of g-C<sub>3</sub>N<sub>4</sub>. The presence of the (100) crystal plane can confirm that the synthesised materials is in the form of nanoplates rather than bulk material<sup>##UREF##21##31##</sup>. The (100) plane corresponds to a parallel layer arrangement held together by weak van der Waals forces<sup>##UREF##22##32##</sup>. The obtained X-ray diffraction spectrum aligns with findings reported in other studies<sup>##UREF##23##33##–##UREF##25##36##</sup>. Figure ##FIG##1##2##b presents the FTIR spectrum of the synthesised g-C<sub>3</sub>N<sub>4</sub> materials. The wide peak at 3152 cm<sup>−1</sup> can be related to the N–H stretching of s-triazine rings<sup>##UREF##26##37##</sup>, while, the peaks ranging 1628–1231 cm<sup>−1</sup> are attributed to the stretching vibrations of the aromatic C-N heterocycle<sup>##REF##37080974##38##</sup>. The sharp peak at 804 cm<sup>−1</sup> points to the presence of 3D heptazine structures within the g-C<sub>3</sub>N<sub>4</sub> nanosheets<sup>##UREF##23##33##,##REF##37080974##38##,##REF##36979485##39##</sup>.</p>", "<title>FE-SEM, BET and zeta potential analysis</title>", "<p id=\"Par11\">The morphology and nanostructured skeleton of the synthesised g-C<sub>3</sub>N<sub>4</sub> were studied through a FE-SEM analysis and presented in Fig. ##FIG##2##3##. The FESEM image can provide further evidence of the two-dimensional layered structure of g-C<sub>3</sub>N<sub>4</sub>, appearing as sheets with wrinkles. It can be attributed to the polycondensation of melamine molecules, leading to the formation of g-C<sub>3</sub>N<sub>4</sub> sheets. The nanostructures of g-C<sub>3</sub>N<sub>4</sub> tend to have a sheet-like appearance due to their graphite-like structure. Moreover, the FESEM image demonstrated the presence of a porous g-C3N4 structure, with numerous pores observed on the surface as well as within the nanostructure itself.</p>", "<p id=\"Par12\">The porosity of the g-C<sub>3</sub>N<sub>4</sub> nanosheets was analysed using BET technique based on N<sub>2</sub> adsorption–desorption isotherm as shown in Fig. ##FIG##3##4##a and Table ##SUPPL##0##S2##. The g-C<sub>3</sub>N<sub>4</sub> average pore size is less than 50 nm (9.04 nm), showing a mesoporous material according to the IUPAC classification. The specific surface area is 36.31 m<sup>2</sup>/g, significantly higher than the reported values in the literature for pure g-C<sub>3</sub>N<sub>4</sub>: 8.56 m<sup>2</sup>/g<sup>##UREF##27##40##</sup> and 14.67 m<sup>2</sup>/g<sup>##REF##28335187##41##</sup>. The elevated specific surface area of the g-C<sub>3</sub>N<sub>4</sub> synthesised in this study may be related to the additional sonication step during the thermal polycondensation of melamine. The characteristic hysteresis isotherm of type IV in the P/P<sub>0</sub> range of 0.4–1.0 can indicate a uniform pore size distribution<sup>##UREF##26##37##</sup>.</p>", "<p id=\"Par13\">Zeta potential analysis was conducted at various pH levels at the room temperature to assess the surface charge and stability of g-C<sub>3</sub>N<sub>4</sub> (Fig. ##FIG##3##4##b). The synthesised photocatalyst showed a relatively low stability at higher pH levels, as evidenced by its low zeta potential, and the maximum stability can be seen at a pH of 10. It was also reported that the emulsion of the g-C<sub>3</sub>N<sub>4</sub> photocatalyst maintained its stability at neutral pH<sup>##UREF##28##42##</sup>. The detailed data of Zeta potential analysis can be found in Table ##SUPPL##0##S3## in the supplementary data.</p>", "<title>Membrane characterisation</title>", "<p id=\"Par14\">The membrane's porosity, pore size distribution, specific surface area, and total pore volume were determined using BET analysis and provided in Table ##SUPPL##0##S4##. The membrane average pore diameter about 4.75 nm, placing it in the category of mesoporous materials<sup>##UREF##29##43##</sup>. Figure ##FIG##3##4##c displays N<sub>2</sub> adsorption–desorption isotherm for the membrane, corresponding to type VI of the IUPAC classification. The isotherm shows that the membrane is composed of multiple layers of different pore sizes<sup>##UREF##30##44##</sup>. According to Fig. ##FIG##3##4##d, most of the pores have a diameter between 2.4 to 5.4 nm. The number of pores with a size larger than 5.4 nm decreases drastically. The membrane morphology evaluated by FESEM can be seen in Fig. ##FIG##4##5##a–c showing the groove like pores of the membrane.</p>", "<p id=\"Par15\">Figure ##FIG##4##5##e–h displays the cross-section images of the membrane. The membrane displayed a characteristic asymmetrical shape, with sponge-like structures in the intermediate layers of the membrane and a dense skin layer on the top and bottom. Furthermore, it was clear that each membrane exhibited a uniformly porous interior structure. The results of the analysis of the membrane's contact angle are shown in Fig. ##SUPPL##0##S3##. Higher membrane hydrophilicity results from a lower contact angle. These were determined by measuring the contact angle of a static water drop at 25 °C room temperature. The contact angle measurements showed that the membrane has a water contact angle of 0° (after three independent experiments), indicating the super hydrophilic property of this membrane.</p>", "<p id=\"Par16\">Figure ##FIG##5##6##a,b displays the membrane's 2 and 3D dimensional AFM images at scan sizes of 1.16 µm × 1.6µm. In order to precisely assess the roughness, Table ##SUPPL##0##S5## provides the mean distance (Rq) between peaks and valleys, the average roughness (Ra), and the difference (Rz) between high peaks and low valleys that were calculated from AFM analysis. The results, which show Ra = 16.23, Rq = 20.53, and Rz = 130.0 nm, imply that a smoother membrane surface (which is shown in Figs. ##FIG##4##5## and ##FIG##5##6##a,b) reduces the severity of fouling and increases permeate flux because fewer foulants would be absorbed within the valleys and deposited on the membrane surface. Additionally, Fig. ##FIG##5##6##c displays the histograms of peak distribution and roughness and Fig. ##FIG##5##6##d displays Particle Size Distribution of membrane sample.</p>", "<title>Preliminary control testing</title>", "<p id=\"Par17\">To assess the potential adsorption of TC on g-C<sub>3</sub>N<sub>4</sub>, the strategy of dark control test was followed. A 100 ml emulsion of 20 mg/L TC and 0.5 g/L g-C<sub>3</sub>N<sub>4</sub> was prepared in a beaker. The beaker was then tightly covered with thick aluminium foil to ensure a dark environment and kept undisturbed for 24 h. The initial pH of the sample was about 6.6. TC concentration in the sample was recorded using UV–Vis spectroscopy, and just 2.2% of TC was removed through dark adsorption which can be attributed to the limited electrostatic interaction between TC and g-C<sub>3</sub>N<sub>4</sub> at a pH of 6.6. The photocatalytic degradation of TC was tested with varying parameters of the irradiation time (60–120 min), initial pH (7–13), catalyst concentration (0.2–1 g/L), and initial TC concentration (10–30 mg/L). The reaction mixture was sampled, centrifuged, and analysed using UV–Vis spectroscopy as summarised in Table ##SUPPL##0##S6##. The highest TC degradation of 63% was achieved in run number of 4, as determined by the Design-Expert software and based on the proposed operating conditions. The separability of the used membrane for TC was evaluated via 15 filtration cycles of 20 mg/L TC aqueous solution analysed by UV–Vis spectroscopy (Fig. ##SUPPL##0##S4## in supplementary information). The maximum TC removal achieved was 74.4%, mainly due to adsorption and size exclusion mechanisms. The molecular weight of TC is 480.9 g/mol, which is close to the membrane molecular weight cut-off (MWCO) of 400 Da can indirectly points to the size exclusion as a crucial role in removing TC from the aqueous solution<sup>##UREF##31##45##,##UREF##32##46##</sup>.</p>", "<title>PMR-based removal of TC</title>", "<p id=\"Par18\">In this study, the performance of a split-type PMR in removal of TC from water was optimised using Design-Expert software based on CCD-based RSM optimization, in terms of five independent parameters of irradiation time, pH, catalyst dosage, TC initial concentration, and filtration iteration. This approach effectively minimises the number of experiments required, simplifies the identification of synergistic or antagonistic effects among factors, validates the obtained data, and quantifies the interactions between different factors. Based on the optimisation outcome, 50 tests were carried out and their results are tabulated in Tables ##SUPPL##0##S5##. The maximum and minimum removal of TC using the split-type PMR were reported as 92% and 57%, respectively.</p>", "<title>ANOVA analysis</title>", "<p id=\"Par19\">The results of ANOVA analysis for removal of TC from water are provided in Table ##TAB##0##1## and Table ##SUPPL##0##S7##. Following PMR-based removal of TC, regression models were developed using CCD method to determine the relationship between removal efficiency and five independent variables. The variables, namely irradiation time, pH, catalyst dosage, TC initial concentration, and filtration cycles, were noted as A, B, C, D, and E, respectively, in the proposed equation (Eq. ##FORMU##8##2##). The equation includes a constant value, linear terms, and quadratic terms to show the individual effects of each parameter, as well as cross product terms to evaluate the interactive effects of parameters on the response. After removing insignificant terms, the regression model was obtained, and the results are presented in Table ##TAB##0##1##. In this model, positive and negative coefficients represent a synergistic and antagonistic effect between the variables, respectively. Table ##TAB##0##1## can confirm that each parameter individually played a significant role in PMR-based TC removal. The interaction of pH with catalyst dosage, TC initial concentration, and filtration cycles showed significant effects on the model. The variance analysis in Table ##SUPPL##0##S7## demonstrates the suitability of the proposed models with the Model F-value of 205.52 which indicates its significance. However, the lack of model fit is not significant which indicates that the model is capable of calculating random errors for the experimental data<sup>##UREF##33##47##</sup>. The plots of Predicted-vs-actual, normal probability, residuals vs run number, and box-cox are shown in Fig. ##SUPPL##0##S5## of supplementary information. Actual values were determined experimentally and predicted values were provided by the RSM model (Fig. ##SUPPL##0##S5##a). Predicted-vs-Actual plot indicates that the model is adequate, ensuring the acceptability of the predicted model since almost all the points in both the plots lie on or in the vicinity of the diagonal line. The normal probability distribution of residuals is shown in Fig. ##SUPPL##0##S5##b which depicts a high degree of fitness due to a linear profile with a minimal error; hence, the errors are distributed normally. In this study, based on the ANOVA results for responses in Table ##SUPPL##0##S7##, the obtained R<sup>2</sup>, R<sup>2</sup><sub>adj</sub>, and R<sup>2</sup><sub>pred</sub> values for the removal of TC by split-type PMR are 0.98, 0.98, and 0.96, respectively. This indicates the adequacy of the suggested quadratic model. As observed, the adequate precision of the model is 55.83. The adequate precision measures the signal to noise ratio. A signal to noise ratio larger than 4 indicates that the model is able to navigate the design space<sup>##UREF##34##48##</sup>.</p>", "<title>Effect of irradiation time and pH</title>", "<p id=\"Par20\">Increasing the irradiation time initially enhanced TC removal due to the presence of empty active sites (Fig. ##FIG##6##7##a). However, as the irradiation duration increases and the active sites of the photocatalyst are being occupied, the impact of irradiation time diminishes<sup>##UREF##35##49##,##UREF##36##50##</sup>. The irradiation time has an optimal value, after which TC removal does not change. The maximum TC removal of 88.5% was achieved after 113.77 min at pH of 10, photocatalyst dosage of 0.6 g/L, TC initial concentration of 20 ppm, and 4 passes through the membrane. The impact of pH on TC removal using PMRs, as depicted in Fig. ##FIG##6##7##b, illustrates that TC removal initially increases with pH level, reaching its peak at 9.78. However, beyond that point, TC removal starts to decline with further increase in pH. The instability in photocatalyst reaction may be attributed to the change in surface electric charge of g-C<sub>3</sub>N<sub>4</sub> nanosheets at varied pH level as also observed by Zeta potential analysis. g-C<sub>3</sub>N<sub>4</sub> nanosheets had a negative electric charge over the pH range of 7–13, and particularly, at pH 10–13, it is lower in comparison to pH of 7–10. It is worth noting that, in the photocatalysis process, hydroxyl radicals play a crucial role<sup>##UREF##37##51##</sup>. At a higher pH, there are more hydroxide ions available within the solution, leading to increased production of hydroxyl radicals in the environment. However, as the pH continues to rise, hydroxide ions begin competing with TC molecules to occupy the photocatalyst active sites which negatively affects the photocatalytic removal of TC from aqueous solutions<sup>##UREF##38##52##</sup>. Overall, the maximum TC removal of 87% was achieved at specific operating conditions: pH level of 9.78, irradiation time of 90 min, photocatalyst dosage of 0.6 g/L, TC initial concentration of 20 ppm, and after 4 filtration cycles. As seen in Fig. ##FIG##5##6##a, the degradation efficiency of TC increases as the irradiation time increases from 60 to 105 min due to the enhanced interactions between TC and the photocatalyst, leading to the attack of hydroxyl radicals on TC and consequently degradation increase. However, when the irradiation time increased to 110min, degradation efficiency remains constant. This is likely due to the decrease in the number of active sites available for photocatalytic interactions. Beyond 110min, the degradation efficiency decreases as all available active sites become saturated, leading to no further increase and negative effect on degradation efficiency.</p>", "<title>Effect of catalyst dosage</title>", "<p id=\"Par21\">Figure ##FIG##6##7##c presents the impact of catalyst dosage on the PMR-based removal of TC. In essence, augmenting the photocatalyst concentration can enhance surface area availability for photon absorption, thereby accelerating oxidation reactions<sup>##UREF##39##53##</sup>. However, a higher chemical density of photocatalyst in the reactor can also lead to the development of a turbid suspension, diminishing its transparency and photo penetration depth<sup>##UREF##40##54##</sup>. Furthermore, adding photocatalyst in a turbid suspension may result in photocatalyst aggregation and limit photocatalyst activities. Consequently, initially, raising the photocatalyst concentration linearly elevates photocatalytic removal rate; however, surpassing the optimal concentration of photocatalyst may not only fail to further increase TC removal but actually diminish it<sup>##REF##33066241##55##</sup>. It is evident that the optimal photocatalyst loading should be determined as a very crucial parameter controlling photocatalyst activities from operational and economic viewpoints. The maximum TC removal of 87.5% was recorded at the photocatalyst dosage of 0.56 g/L, irradiation time of 90 min, pH of 10, TC initial concentration of 20ppm, and after 4 filtration iterations. This study discloses that increasing the amount of photocatalyst from 0.2 up to 0.6 g/L can effectively elevate the rate of degradation. However, at higher concentrations, beyond 0.6 g/L, light scattering can occur, reducing the transparency of the solution and decreasing photon access to the photocatalyst surface. Another reason for the efficiency reduction is the accumulation of catalysts in a clustered form, leading to a decrease in photon adsorption in the photocatalytic process. Therefore, the efficiency of photocatalytic degradation decreases with an increase in the amount of photocatalyst (&gt; 6 g/L).</p>", "<title>Effect of TC initial concentration</title>", "<p id=\"Par22\">Figure ##FIG##6##7##d showcases the effects of pollutant initial concentration on the overall performance of PMR system. Within a certain range, elevating the pollutant primary concentration enhances the collision rate and oxidation reaction, leading to a better degradation up to an optimal dosage after which a relatively lower degradation rate is probable<sup>##REF##34879511##22##</sup> due to increased emulsion turbidity and limited light absorbency. TC molecules at high concentrations may occupy the active sites of the photocatalyst, exerting a negative influence on the photocatalytic degradation process<sup>##UREF##9##13##,##UREF##41##56##</sup>. The maximum removal of TC (88.5%) was recorded at a TC concentration of 22.16 ppm, with an irradiation time of 90 min, pH of 10, photocatalyst dosage of 0.6 g/L, and after four membrane filtration cycles. As the initial concentration of TC increases, the electron–hole pair ratio decreases, and active sites on the surface of the photocatalyst become saturated by TC molecules. This leads to less light entering the photocatalytic degradation system, and the efficiency of TC photocatalytic degradation decreases. Another reason may be the turbidity of the solution in which the photocatalytic reactions take place. The solution becomes cloudy, making it difficult for light to pass through, which reduces the amount of light irradiation on the photocatalyst surface and consequently reduces photocatalytic degradation efficiency.</p>", "<title>Effect of membrane filtration cycle</title>", "<p id=\"Par23\">Figure ##FIG##6##7##e provides some insight into the impact of membrane separation iterations on the TC removal using the developed PMR system. It is evident that more cycles of membrane filtration can result in higher amount of captured TC mainly due to size exclusion as evidenced based in the outcome of BET analysis. The maximum TC removal rate of 94.8% was achieved following an irradiation time of 90 min, at a pH level of 10, with a photocatalyst dosage of 0.6 g/L, an initial TC concentration of 20 ppm, and a total of six passes through the membrane.</p>", "<title>Optimization of process operational parameters</title>", "<p id=\"Par24\">The operating conditions yielding maximum PMR-based TC removal were determined based a CCD-based RSM optimisation carried out by Design-Expert software. The optimal range of parameters considered are provided in Table ##SUPPL##0##S8##, leading to a set of conditions exhibiting greater desirability and feasibility (Table ##SUPPL##0##S9##). To ensure accuracy, reliability, and reproducibility, the optimal points were experimentally tested three times. The results presented in Table ##SUPPL##0##S9## highlight a maximum degradation of 94.8%, closely aligning with the predicted software value of 96.2%. The concordance between the predicted and experimental outcomes underscores the model's reliability and its ability to accurately anticipate the maximum degradation of TC. Furthermore, the photocatalytic performance of TC photodegradation in this study has been systematically compared with pertinent literature Table ##TAB##1##2##.</p>", "<title>Photocatalyst reusability and mechanism</title>", "<p id=\"Par25\">The reusability of the synthesised photocatalyst in TC removal was analysed at optimal operating conditions (irradiation time of 113.77 min, pH level of 9.78, photocatalyst dosage of 0.56 g/L and TC concentration of 22.16 ppm) as an important marketability index as shown in Fig. ##FIG##7##8##. In brief, in each cycle, the used materials were recovered as follows. The photocatalyst was initially separated using centrifugation (at 7500 rpm for 7 min), then washed twice with 50 mL of ethanol (15 min magnetic stirring plus 6 min probe sonication at 100 watts), and followed by a complete DDW washing. The clean photocatalyst was oven-dried at 70 °C for 24 h. In order to investigate the economic justification of the g-C<sub>3</sub>N<sub>4</sub> photocatalyst for TC removal from aqueous solutions<sup>##UREF##51##70##–##UREF##53##72##</sup>. After seven cycles, the photocatalyst's TC removal efficiency, as shown in Fig. ##FIG##7##8##, reached 74.2%. It can be mainly attributed to two primary factors of blockage and degradation of active sites. The superficial active sites of the photocatalyst may become partially blocked by remaining TC molecules and reaction products, interrupting the photocatalytic interaction. Cyclic photocatalysis can also lead to the degradation or alteration of some active sites. Surface fouling, catalyst aging, and exposure to reactive species may also contribute to the active sites’ deterioration, effectively diminishing their catalytic activities. These clues can highlight the importance of understanding the long-term challenges of photocatalysis. It also necessitates exploration of strategies for photocatalyst regeneration and optimisation to mitigate the decline in their removal efficiency<sup>##UREF##54##73##</sup>. The most crucial issue with fouling, degradation, or loss of photocatalytic activity over seven cycles is accumulation of TC molecules which may partially block the superficial active sites of the photocatalyst, impeding photocatalytic interactions. To mitigate the issues associated with the decline in photocatalyst efficiency after multiple cycles, it is required to improve the regeneration method to restore the photocatalyst's active sites after they have become partially blocked by TC molecules and reaction products over several cycles without causing significant damage or alteration to its structure. In addition, modification of the surface of the photocatalyst to make it less prone to blockage by TC molecules and reaction by-products can greatly contribute to addressing this challenge. According to previous works, <sup>##UREF##55##74##–##UREF##58##77##</sup> and h<sup>+</sup><sup>##UREF##55##74##,##UREF##59##78##</sup>, respectively, plays a key role in the g-C<sub>3</sub>N<sub>4</sub> photodegradation of TC. The potential g-C<sub>3</sub>N<sub>4</sub> for TC degradation pathways are shown in Fig. ##FIG##8##9## based on the reactive species mentioned above. Upon irradiation of visible light on the g-C<sub>3</sub>N<sub>4</sub> photocatalyst, electrons and holes generate in the conduction and valence bands, respectively. As a result of the produced electrons and holes, TC is degraded down into CO<sub>2</sub> and H<sub>2</sub>O by reduction and oxidation processes with oxygen and water, respectively.</p>", "<p id=\"Par26\">It is also worth mentioning that the cost analysis, scaling viewpoints, and commercialisation aspects are all outside of the scope of this paper since the finalisation of scaling up/piloting is an imperative step before any valid cost analysis. However, cost analysis and feasibility study are recommended as topics for future research to pinpoint this technique. This study also does not discuss the environmental impact and sustainability issues of the photocatalyst and membrane used in the PMR system. It is crucial as topic for future research to assess the lifecycle impact of their synthesis, disposal, and potential release of harmful substances/by-products. Despite the promising performance, addressing these environmental impacts is vital in assessing the long-term sustainability of PMR technologies in practical settings.</p>" ]
[ "<title>Results and discussion</title>", "<title>XRD and FTIR analysis</title>", "<p id=\"Par10\">The g-C<sub>3</sub>N<sub>4</sub> nanosheets’ XRD patterns are depicted in Fig. ##FIG##1##2##a. The peaks at 27.66° and 13° can be associated with the (002) and (100) crystal planes of the g-C<sub>3</sub>N<sub>4</sub> structure, respectively<sup>##UREF##20##30##</sup>. The sharp peak at 27.66° may indicate the interlayer distance of the g-C<sub>3</sub>N<sub>4</sub> nanosheets, also known as graphitic carbon nitride, which can be influenced by intercalation, doping, or modification of g-C<sub>3</sub>N<sub>4</sub>. The presence of the (100) crystal plane can confirm that the synthesised materials is in the form of nanoplates rather than bulk material<sup>##UREF##21##31##</sup>. The (100) plane corresponds to a parallel layer arrangement held together by weak van der Waals forces<sup>##UREF##22##32##</sup>. The obtained X-ray diffraction spectrum aligns with findings reported in other studies<sup>##UREF##23##33##–##UREF##25##36##</sup>. Figure ##FIG##1##2##b presents the FTIR spectrum of the synthesised g-C<sub>3</sub>N<sub>4</sub> materials. The wide peak at 3152 cm<sup>−1</sup> can be related to the N–H stretching of s-triazine rings<sup>##UREF##26##37##</sup>, while, the peaks ranging 1628–1231 cm<sup>−1</sup> are attributed to the stretching vibrations of the aromatic C-N heterocycle<sup>##REF##37080974##38##</sup>. The sharp peak at 804 cm<sup>−1</sup> points to the presence of 3D heptazine structures within the g-C<sub>3</sub>N<sub>4</sub> nanosheets<sup>##UREF##23##33##,##REF##37080974##38##,##REF##36979485##39##</sup>.</p>", "<title>FE-SEM, BET and zeta potential analysis</title>", "<p id=\"Par11\">The morphology and nanostructured skeleton of the synthesised g-C<sub>3</sub>N<sub>4</sub> were studied through a FE-SEM analysis and presented in Fig. ##FIG##2##3##. The FESEM image can provide further evidence of the two-dimensional layered structure of g-C<sub>3</sub>N<sub>4</sub>, appearing as sheets with wrinkles. It can be attributed to the polycondensation of melamine molecules, leading to the formation of g-C<sub>3</sub>N<sub>4</sub> sheets. The nanostructures of g-C<sub>3</sub>N<sub>4</sub> tend to have a sheet-like appearance due to their graphite-like structure. Moreover, the FESEM image demonstrated the presence of a porous g-C3N4 structure, with numerous pores observed on the surface as well as within the nanostructure itself.</p>", "<p id=\"Par12\">The porosity of the g-C<sub>3</sub>N<sub>4</sub> nanosheets was analysed using BET technique based on N<sub>2</sub> adsorption–desorption isotherm as shown in Fig. ##FIG##3##4##a and Table ##SUPPL##0##S2##. The g-C<sub>3</sub>N<sub>4</sub> average pore size is less than 50 nm (9.04 nm), showing a mesoporous material according to the IUPAC classification. The specific surface area is 36.31 m<sup>2</sup>/g, significantly higher than the reported values in the literature for pure g-C<sub>3</sub>N<sub>4</sub>: 8.56 m<sup>2</sup>/g<sup>##UREF##27##40##</sup> and 14.67 m<sup>2</sup>/g<sup>##REF##28335187##41##</sup>. The elevated specific surface area of the g-C<sub>3</sub>N<sub>4</sub> synthesised in this study may be related to the additional sonication step during the thermal polycondensation of melamine. The characteristic hysteresis isotherm of type IV in the P/P<sub>0</sub> range of 0.4–1.0 can indicate a uniform pore size distribution<sup>##UREF##26##37##</sup>.</p>", "<p id=\"Par13\">Zeta potential analysis was conducted at various pH levels at the room temperature to assess the surface charge and stability of g-C<sub>3</sub>N<sub>4</sub> (Fig. ##FIG##3##4##b). The synthesised photocatalyst showed a relatively low stability at higher pH levels, as evidenced by its low zeta potential, and the maximum stability can be seen at a pH of 10. It was also reported that the emulsion of the g-C<sub>3</sub>N<sub>4</sub> photocatalyst maintained its stability at neutral pH<sup>##UREF##28##42##</sup>. The detailed data of Zeta potential analysis can be found in Table ##SUPPL##0##S3## in the supplementary data.</p>", "<title>Membrane characterisation</title>", "<p id=\"Par14\">The membrane's porosity, pore size distribution, specific surface area, and total pore volume were determined using BET analysis and provided in Table ##SUPPL##0##S4##. The membrane average pore diameter about 4.75 nm, placing it in the category of mesoporous materials<sup>##UREF##29##43##</sup>. Figure ##FIG##3##4##c displays N<sub>2</sub> adsorption–desorption isotherm for the membrane, corresponding to type VI of the IUPAC classification. The isotherm shows that the membrane is composed of multiple layers of different pore sizes<sup>##UREF##30##44##</sup>. According to Fig. ##FIG##3##4##d, most of the pores have a diameter between 2.4 to 5.4 nm. The number of pores with a size larger than 5.4 nm decreases drastically. The membrane morphology evaluated by FESEM can be seen in Fig. ##FIG##4##5##a–c showing the groove like pores of the membrane.</p>", "<p id=\"Par15\">Figure ##FIG##4##5##e–h displays the cross-section images of the membrane. The membrane displayed a characteristic asymmetrical shape, with sponge-like structures in the intermediate layers of the membrane and a dense skin layer on the top and bottom. Furthermore, it was clear that each membrane exhibited a uniformly porous interior structure. The results of the analysis of the membrane's contact angle are shown in Fig. ##SUPPL##0##S3##. Higher membrane hydrophilicity results from a lower contact angle. These were determined by measuring the contact angle of a static water drop at 25 °C room temperature. The contact angle measurements showed that the membrane has a water contact angle of 0° (after three independent experiments), indicating the super hydrophilic property of this membrane.</p>", "<p id=\"Par16\">Figure ##FIG##5##6##a,b displays the membrane's 2 and 3D dimensional AFM images at scan sizes of 1.16 µm × 1.6µm. In order to precisely assess the roughness, Table ##SUPPL##0##S5## provides the mean distance (Rq) between peaks and valleys, the average roughness (Ra), and the difference (Rz) between high peaks and low valleys that were calculated from AFM analysis. The results, which show Ra = 16.23, Rq = 20.53, and Rz = 130.0 nm, imply that a smoother membrane surface (which is shown in Figs. ##FIG##4##5## and ##FIG##5##6##a,b) reduces the severity of fouling and increases permeate flux because fewer foulants would be absorbed within the valleys and deposited on the membrane surface. Additionally, Fig. ##FIG##5##6##c displays the histograms of peak distribution and roughness and Fig. ##FIG##5##6##d displays Particle Size Distribution of membrane sample.</p>", "<title>Preliminary control testing</title>", "<p id=\"Par17\">To assess the potential adsorption of TC on g-C<sub>3</sub>N<sub>4</sub>, the strategy of dark control test was followed. A 100 ml emulsion of 20 mg/L TC and 0.5 g/L g-C<sub>3</sub>N<sub>4</sub> was prepared in a beaker. The beaker was then tightly covered with thick aluminium foil to ensure a dark environment and kept undisturbed for 24 h. The initial pH of the sample was about 6.6. TC concentration in the sample was recorded using UV–Vis spectroscopy, and just 2.2% of TC was removed through dark adsorption which can be attributed to the limited electrostatic interaction between TC and g-C<sub>3</sub>N<sub>4</sub> at a pH of 6.6. The photocatalytic degradation of TC was tested with varying parameters of the irradiation time (60–120 min), initial pH (7–13), catalyst concentration (0.2–1 g/L), and initial TC concentration (10–30 mg/L). The reaction mixture was sampled, centrifuged, and analysed using UV–Vis spectroscopy as summarised in Table ##SUPPL##0##S6##. The highest TC degradation of 63% was achieved in run number of 4, as determined by the Design-Expert software and based on the proposed operating conditions. The separability of the used membrane for TC was evaluated via 15 filtration cycles of 20 mg/L TC aqueous solution analysed by UV–Vis spectroscopy (Fig. ##SUPPL##0##S4## in supplementary information). The maximum TC removal achieved was 74.4%, mainly due to adsorption and size exclusion mechanisms. The molecular weight of TC is 480.9 g/mol, which is close to the membrane molecular weight cut-off (MWCO) of 400 Da can indirectly points to the size exclusion as a crucial role in removing TC from the aqueous solution<sup>##UREF##31##45##,##UREF##32##46##</sup>.</p>", "<title>PMR-based removal of TC</title>", "<p id=\"Par18\">In this study, the performance of a split-type PMR in removal of TC from water was optimised using Design-Expert software based on CCD-based RSM optimization, in terms of five independent parameters of irradiation time, pH, catalyst dosage, TC initial concentration, and filtration iteration. This approach effectively minimises the number of experiments required, simplifies the identification of synergistic or antagonistic effects among factors, validates the obtained data, and quantifies the interactions between different factors. Based on the optimisation outcome, 50 tests were carried out and their results are tabulated in Tables ##SUPPL##0##S5##. The maximum and minimum removal of TC using the split-type PMR were reported as 92% and 57%, respectively.</p>", "<title>ANOVA analysis</title>", "<p id=\"Par19\">The results of ANOVA analysis for removal of TC from water are provided in Table ##TAB##0##1## and Table ##SUPPL##0##S7##. Following PMR-based removal of TC, regression models were developed using CCD method to determine the relationship between removal efficiency and five independent variables. The variables, namely irradiation time, pH, catalyst dosage, TC initial concentration, and filtration cycles, were noted as A, B, C, D, and E, respectively, in the proposed equation (Eq. ##FORMU##8##2##). The equation includes a constant value, linear terms, and quadratic terms to show the individual effects of each parameter, as well as cross product terms to evaluate the interactive effects of parameters on the response. After removing insignificant terms, the regression model was obtained, and the results are presented in Table ##TAB##0##1##. In this model, positive and negative coefficients represent a synergistic and antagonistic effect between the variables, respectively. Table ##TAB##0##1## can confirm that each parameter individually played a significant role in PMR-based TC removal. The interaction of pH with catalyst dosage, TC initial concentration, and filtration cycles showed significant effects on the model. The variance analysis in Table ##SUPPL##0##S7## demonstrates the suitability of the proposed models with the Model F-value of 205.52 which indicates its significance. However, the lack of model fit is not significant which indicates that the model is capable of calculating random errors for the experimental data<sup>##UREF##33##47##</sup>. The plots of Predicted-vs-actual, normal probability, residuals vs run number, and box-cox are shown in Fig. ##SUPPL##0##S5## of supplementary information. Actual values were determined experimentally and predicted values were provided by the RSM model (Fig. ##SUPPL##0##S5##a). Predicted-vs-Actual plot indicates that the model is adequate, ensuring the acceptability of the predicted model since almost all the points in both the plots lie on or in the vicinity of the diagonal line. The normal probability distribution of residuals is shown in Fig. ##SUPPL##0##S5##b which depicts a high degree of fitness due to a linear profile with a minimal error; hence, the errors are distributed normally. In this study, based on the ANOVA results for responses in Table ##SUPPL##0##S7##, the obtained R<sup>2</sup>, R<sup>2</sup><sub>adj</sub>, and R<sup>2</sup><sub>pred</sub> values for the removal of TC by split-type PMR are 0.98, 0.98, and 0.96, respectively. This indicates the adequacy of the suggested quadratic model. As observed, the adequate precision of the model is 55.83. The adequate precision measures the signal to noise ratio. A signal to noise ratio larger than 4 indicates that the model is able to navigate the design space<sup>##UREF##34##48##</sup>.</p>", "<title>Effect of irradiation time and pH</title>", "<p id=\"Par20\">Increasing the irradiation time initially enhanced TC removal due to the presence of empty active sites (Fig. ##FIG##6##7##a). However, as the irradiation duration increases and the active sites of the photocatalyst are being occupied, the impact of irradiation time diminishes<sup>##UREF##35##49##,##UREF##36##50##</sup>. The irradiation time has an optimal value, after which TC removal does not change. The maximum TC removal of 88.5% was achieved after 113.77 min at pH of 10, photocatalyst dosage of 0.6 g/L, TC initial concentration of 20 ppm, and 4 passes through the membrane. The impact of pH on TC removal using PMRs, as depicted in Fig. ##FIG##6##7##b, illustrates that TC removal initially increases with pH level, reaching its peak at 9.78. However, beyond that point, TC removal starts to decline with further increase in pH. The instability in photocatalyst reaction may be attributed to the change in surface electric charge of g-C<sub>3</sub>N<sub>4</sub> nanosheets at varied pH level as also observed by Zeta potential analysis. g-C<sub>3</sub>N<sub>4</sub> nanosheets had a negative electric charge over the pH range of 7–13, and particularly, at pH 10–13, it is lower in comparison to pH of 7–10. It is worth noting that, in the photocatalysis process, hydroxyl radicals play a crucial role<sup>##UREF##37##51##</sup>. At a higher pH, there are more hydroxide ions available within the solution, leading to increased production of hydroxyl radicals in the environment. However, as the pH continues to rise, hydroxide ions begin competing with TC molecules to occupy the photocatalyst active sites which negatively affects the photocatalytic removal of TC from aqueous solutions<sup>##UREF##38##52##</sup>. Overall, the maximum TC removal of 87% was achieved at specific operating conditions: pH level of 9.78, irradiation time of 90 min, photocatalyst dosage of 0.6 g/L, TC initial concentration of 20 ppm, and after 4 filtration cycles. As seen in Fig. ##FIG##5##6##a, the degradation efficiency of TC increases as the irradiation time increases from 60 to 105 min due to the enhanced interactions between TC and the photocatalyst, leading to the attack of hydroxyl radicals on TC and consequently degradation increase. However, when the irradiation time increased to 110min, degradation efficiency remains constant. This is likely due to the decrease in the number of active sites available for photocatalytic interactions. Beyond 110min, the degradation efficiency decreases as all available active sites become saturated, leading to no further increase and negative effect on degradation efficiency.</p>", "<title>Effect of catalyst dosage</title>", "<p id=\"Par21\">Figure ##FIG##6##7##c presents the impact of catalyst dosage on the PMR-based removal of TC. In essence, augmenting the photocatalyst concentration can enhance surface area availability for photon absorption, thereby accelerating oxidation reactions<sup>##UREF##39##53##</sup>. However, a higher chemical density of photocatalyst in the reactor can also lead to the development of a turbid suspension, diminishing its transparency and photo penetration depth<sup>##UREF##40##54##</sup>. Furthermore, adding photocatalyst in a turbid suspension may result in photocatalyst aggregation and limit photocatalyst activities. Consequently, initially, raising the photocatalyst concentration linearly elevates photocatalytic removal rate; however, surpassing the optimal concentration of photocatalyst may not only fail to further increase TC removal but actually diminish it<sup>##REF##33066241##55##</sup>. It is evident that the optimal photocatalyst loading should be determined as a very crucial parameter controlling photocatalyst activities from operational and economic viewpoints. The maximum TC removal of 87.5% was recorded at the photocatalyst dosage of 0.56 g/L, irradiation time of 90 min, pH of 10, TC initial concentration of 20ppm, and after 4 filtration iterations. This study discloses that increasing the amount of photocatalyst from 0.2 up to 0.6 g/L can effectively elevate the rate of degradation. However, at higher concentrations, beyond 0.6 g/L, light scattering can occur, reducing the transparency of the solution and decreasing photon access to the photocatalyst surface. Another reason for the efficiency reduction is the accumulation of catalysts in a clustered form, leading to a decrease in photon adsorption in the photocatalytic process. Therefore, the efficiency of photocatalytic degradation decreases with an increase in the amount of photocatalyst (&gt; 6 g/L).</p>", "<title>Effect of TC initial concentration</title>", "<p id=\"Par22\">Figure ##FIG##6##7##d showcases the effects of pollutant initial concentration on the overall performance of PMR system. Within a certain range, elevating the pollutant primary concentration enhances the collision rate and oxidation reaction, leading to a better degradation up to an optimal dosage after which a relatively lower degradation rate is probable<sup>##REF##34879511##22##</sup> due to increased emulsion turbidity and limited light absorbency. TC molecules at high concentrations may occupy the active sites of the photocatalyst, exerting a negative influence on the photocatalytic degradation process<sup>##UREF##9##13##,##UREF##41##56##</sup>. The maximum removal of TC (88.5%) was recorded at a TC concentration of 22.16 ppm, with an irradiation time of 90 min, pH of 10, photocatalyst dosage of 0.6 g/L, and after four membrane filtration cycles. As the initial concentration of TC increases, the electron–hole pair ratio decreases, and active sites on the surface of the photocatalyst become saturated by TC molecules. This leads to less light entering the photocatalytic degradation system, and the efficiency of TC photocatalytic degradation decreases. Another reason may be the turbidity of the solution in which the photocatalytic reactions take place. The solution becomes cloudy, making it difficult for light to pass through, which reduces the amount of light irradiation on the photocatalyst surface and consequently reduces photocatalytic degradation efficiency.</p>", "<title>Effect of membrane filtration cycle</title>", "<p id=\"Par23\">Figure ##FIG##6##7##e provides some insight into the impact of membrane separation iterations on the TC removal using the developed PMR system. It is evident that more cycles of membrane filtration can result in higher amount of captured TC mainly due to size exclusion as evidenced based in the outcome of BET analysis. The maximum TC removal rate of 94.8% was achieved following an irradiation time of 90 min, at a pH level of 10, with a photocatalyst dosage of 0.6 g/L, an initial TC concentration of 20 ppm, and a total of six passes through the membrane.</p>", "<title>Optimization of process operational parameters</title>", "<p id=\"Par24\">The operating conditions yielding maximum PMR-based TC removal were determined based a CCD-based RSM optimisation carried out by Design-Expert software. The optimal range of parameters considered are provided in Table ##SUPPL##0##S8##, leading to a set of conditions exhibiting greater desirability and feasibility (Table ##SUPPL##0##S9##). To ensure accuracy, reliability, and reproducibility, the optimal points were experimentally tested three times. The results presented in Table ##SUPPL##0##S9## highlight a maximum degradation of 94.8%, closely aligning with the predicted software value of 96.2%. The concordance between the predicted and experimental outcomes underscores the model's reliability and its ability to accurately anticipate the maximum degradation of TC. Furthermore, the photocatalytic performance of TC photodegradation in this study has been systematically compared with pertinent literature Table ##TAB##1##2##.</p>", "<title>Photocatalyst reusability and mechanism</title>", "<p id=\"Par25\">The reusability of the synthesised photocatalyst in TC removal was analysed at optimal operating conditions (irradiation time of 113.77 min, pH level of 9.78, photocatalyst dosage of 0.56 g/L and TC concentration of 22.16 ppm) as an important marketability index as shown in Fig. ##FIG##7##8##. In brief, in each cycle, the used materials were recovered as follows. The photocatalyst was initially separated using centrifugation (at 7500 rpm for 7 min), then washed twice with 50 mL of ethanol (15 min magnetic stirring plus 6 min probe sonication at 100 watts), and followed by a complete DDW washing. The clean photocatalyst was oven-dried at 70 °C for 24 h. In order to investigate the economic justification of the g-C<sub>3</sub>N<sub>4</sub> photocatalyst for TC removal from aqueous solutions<sup>##UREF##51##70##–##UREF##53##72##</sup>. After seven cycles, the photocatalyst's TC removal efficiency, as shown in Fig. ##FIG##7##8##, reached 74.2%. It can be mainly attributed to two primary factors of blockage and degradation of active sites. The superficial active sites of the photocatalyst may become partially blocked by remaining TC molecules and reaction products, interrupting the photocatalytic interaction. Cyclic photocatalysis can also lead to the degradation or alteration of some active sites. Surface fouling, catalyst aging, and exposure to reactive species may also contribute to the active sites’ deterioration, effectively diminishing their catalytic activities. These clues can highlight the importance of understanding the long-term challenges of photocatalysis. It also necessitates exploration of strategies for photocatalyst regeneration and optimisation to mitigate the decline in their removal efficiency<sup>##UREF##54##73##</sup>. The most crucial issue with fouling, degradation, or loss of photocatalytic activity over seven cycles is accumulation of TC molecules which may partially block the superficial active sites of the photocatalyst, impeding photocatalytic interactions. To mitigate the issues associated with the decline in photocatalyst efficiency after multiple cycles, it is required to improve the regeneration method to restore the photocatalyst's active sites after they have become partially blocked by TC molecules and reaction products over several cycles without causing significant damage or alteration to its structure. In addition, modification of the surface of the photocatalyst to make it less prone to blockage by TC molecules and reaction by-products can greatly contribute to addressing this challenge. According to previous works, <sup>##UREF##55##74##–##UREF##58##77##</sup> and h<sup>+</sup><sup>##UREF##55##74##,##UREF##59##78##</sup>, respectively, plays a key role in the g-C<sub>3</sub>N<sub>4</sub> photodegradation of TC. The potential g-C<sub>3</sub>N<sub>4</sub> for TC degradation pathways are shown in Fig. ##FIG##8##9## based on the reactive species mentioned above. Upon irradiation of visible light on the g-C<sub>3</sub>N<sub>4</sub> photocatalyst, electrons and holes generate in the conduction and valence bands, respectively. As a result of the produced electrons and holes, TC is degraded down into CO<sub>2</sub> and H<sub>2</sub>O by reduction and oxidation processes with oxygen and water, respectively.</p>", "<p id=\"Par26\">It is also worth mentioning that the cost analysis, scaling viewpoints, and commercialisation aspects are all outside of the scope of this paper since the finalisation of scaling up/piloting is an imperative step before any valid cost analysis. However, cost analysis and feasibility study are recommended as topics for future research to pinpoint this technique. This study also does not discuss the environmental impact and sustainability issues of the photocatalyst and membrane used in the PMR system. It is crucial as topic for future research to assess the lifecycle impact of their synthesis, disposal, and potential release of harmful substances/by-products. Despite the promising performance, addressing these environmental impacts is vital in assessing the long-term sustainability of PMR technologies in practical settings.</p>" ]
[ "<title>Conclusions</title>", "<p id=\"Par27\">This study investigated the degradation of tetracycline from water using a lab-scale photocatalytic membrane reactor (PMR) with a suspended graphitic carbon nitride (g-C3N4) photocatalyst and a layered polymeric polyester/polysulfone/polyamide membrane. A range of operating conditions were explored, and optimal parameters of irradiation time: 113.77min, pH: 9.78, photocatalyst dosage: 0.56g/L, tetracycline initial concentration: 22.16 mg/L, and 6 membrane passes resulted in a tetracycline removal efficiency of about 95%. The proposed hybrid approach, compared to individual photocatalysis and membrane processes, was confirmed to have about 32% and 20% higher removal efficiency, respectively. The designed PMR showed reasonable photocatalyst reusability, reaching 74% of maximum removal efficiency after seven cycles. Overall, the study's outcomes support the efficacy of the proposed PMR for tetracycline removal, offering a sustainable water treatment solution with a feasible hybrid photocatalyst-membrane process.</p>" ]
[ "<p id=\"Par1\">In this study, a split-type photocatalytic membrane reactor (PMR), incorporating suspended graphitic carbon nitride (g-C3N4) as photocatalyst and a layered polymeric composite (using polyamide, polyethersulfone and polysulfone polymers) as a membrane was fabricated to remove tetracycline (TC) from aqueous solutions as the world's second most used and discharged antibiotic in wastewater. The photocatalyst was synthesised from melamine by ultrasonic-assisted thermal polymerisation method and, along with the membrane, was characterised using various methods, including Brunauer–Emmett–Teller analysis (BET), Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction analysis (XRD), Field emission scanning electron microscopy (FESEM), and Ultraviolet–visible spectroscopy (UV–Vis). The PMR process was optimised, using Design-Expert software for tetracycline removal in terms of UV irradiation time, pH, photocatalyst loading, tetracycline concentration, and membrane separation iteration. It was revealed that a membrane-integrated reactor as a sustainable system could effectively produce clean water by simultaneous removal of tetracycline and photocatalyst from aqueous solution. The maximum removal of 94.8% was obtained at the tetracycline concentration of 22.16 ppm, pH of 9.78 with 0.56 g/L of photocatalyst in the irradiation time of 113.77 min after six times of passing membrane. The PMR system showed reasonable reusability by about a 25.8% drop in TC removal efficiency after seven cycles at optimal conditions. The outcomes demonstrate the promising performance of the proposed PMR system in tetracycline removal from water and suggest that it can be scaled as an effective approach for a sustainable supply of antibiotic-free clean water.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51847-5.</p>", "<title>Author contributions</title>", "<p>M.E.: conceptualization, methodology, formal analysis, investigation, validation, original draft writing. M.B.: conceptualization (membrane part), methodology, formal analysis, writing-review and editing, supervision, project administration, funding acquisition. S.S.: conceptualization (photocatalysis part), methodology, formal analysis, writing—review and editing, supervision, project administration, funding acquisition. M.M.: methodology, formal analysis, validation, original draft writing. S.G.: methodology, formal analysis, validation, original draft writing. Writing—review and editing. H.R.: conceptualization, methodology, formal analysis, validation, project administration, writing—review and editing.</p>", "<title>Data availability</title>", "<p>The datasets employed or examined in the present study can be obtained from the corresponding authors upon reasonable request.</p>", "<title>Competing interests</title>", "<p id=\"Par28\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Schematic diagram of a laboratory scale split-type PMR with suspended photocatalyst.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>(<bold>a</bold>) XRD pattern and (b) FT-IR absorption spectrum of synthesized .</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>FE-SEM image of synthesised .</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>(<bold>a</bold>) Nitrogen adsorption–desorption isotherms of , (<bold>b</bold>) Average values of zeta potential in aqueous suspensions at different pH, (<bold>c</bold>) nitrogen adsorption–desorption isotherms and (<bold>d</bold>) pore size distribution of the membrane.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>(<bold>a</bold>–<bold>c</bold>) FESEM images of the surface and (<bold>d</bold>–<bold>h</bold>) FESEM cross-section images of the membrane of membrane.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>(<bold>a</bold>,<bold>b</bold>) AFM images of Membrane, (<bold>c</bold>) particle size distribution histogram for membrane (average of particle size = 95.6 nm) and (<bold>d</bold>) histograms of roughness for membrane (pick to valley roughness = 130.0 nm<bold>).</bold></p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>Effect of (<bold>a</bold>) irradiation time, (<bold>b</bold>) pH, (<bold>c</bold>) catalyst dosage, (<bold>d</bold>) TC initial concentration, and (<bold>e</bold>) number of passes through membrane on TC removal from aqueous solutions. Fixed parameters, if applicable, were irradiation time = 90 min, pH = 10, photocatalyst dosage = 0.6 g/L, TC initial concentration = 20 ppm, number of passes through membrane = 4.</p></caption></fig>", "<fig id=\"Fig8\"><label>Figure 8</label><caption><p>Photocatalyst removal efficiency in continuous cycles at optimum conditions.</p></caption></fig>", "<fig id=\"Fig9\"><label>Figure 9</label><caption><p>Schematic diagram for the possible g-C<sub>3</sub>N<sub>4</sub> photodegradation mechanisms under visible-light irradiation.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>ANOVA results of quadratic model for TC Removal.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Source</th><th align=\"left\">Sum of squares</th><th align=\"left\">df</th><th align=\"left\">Mean square</th><th align=\"left\">F-value</th><th align=\"left\">P-value</th><th align=\"left\">Comment</th></tr></thead><tbody><tr><td align=\"left\">Model</td><td char=\".\" align=\"char\">4008.07</td><td align=\"left\">13</td><td char=\".\" align=\"char\">308.31</td><td char=\".\" align=\"char\">205.52</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td align=\"left\">Significant</td></tr><tr><td align=\"left\">A-Irradiation time</td><td char=\".\" align=\"char\">176.40</td><td align=\"left\">1</td><td char=\".\" align=\"char\">176.40</td><td char=\".\" align=\"char\">117.59</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td align=\"left\"/></tr><tr><td align=\"left\">B-pH</td><td char=\".\" align=\"char\">176.40</td><td align=\"left\">1</td><td char=\".\" align=\"char\">176.40</td><td char=\".\" align=\"char\">117.59</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td align=\"left\"/></tr><tr><td align=\"left\">C-Cat. dosage</td><td char=\".\" align=\"char\">57.60</td><td align=\"left\">1</td><td char=\".\" align=\"char\">57.60</td><td char=\".\" align=\"char\">38.40</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td align=\"left\"/></tr><tr><td align=\"left\">D-TC initial concentration</td><td char=\".\" align=\"char\">739.60</td><td align=\"left\">1</td><td char=\".\" align=\"char\">739.60</td><td char=\".\" align=\"char\">493.02</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td align=\"left\"/></tr><tr><td align=\"left\">E-Number of passes</td><td char=\".\" align=\"char\">960.40</td><td align=\"left\">1</td><td char=\".\" align=\"char\">960.40</td><td char=\".\" align=\"char\">640.21</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td align=\"left\"/></tr><tr><td align=\"left\">BC</td><td char=\".\" align=\"char\">8.00</td><td align=\"left\">1</td><td char=\".\" align=\"char\">8.00</td><td char=\".\" align=\"char\">5.33</td><td char=\".\" align=\"char\">0.0268</td><td align=\"left\"/></tr><tr><td align=\"left\">BD</td><td char=\".\" align=\"char\">6.13</td><td align=\"left\">1</td><td char=\".\" align=\"char\">6.13</td><td char=\".\" align=\"char\">4.08</td><td char=\".\" align=\"char\">0.0508</td><td align=\"left\"/></tr><tr><td align=\"left\">BE</td><td char=\".\" align=\"char\">6.13</td><td align=\"left\">1</td><td char=\".\" align=\"char\">6.13</td><td char=\".\" align=\"char\">4.08</td><td char=\".\" align=\"char\">0.0508</td><td align=\"left\"/></tr><tr><td align=\"left\">A<sup>2</sup></td><td char=\".\" align=\"char\">14.05</td><td align=\"left\">1</td><td char=\".\" align=\"char\">14.05</td><td char=\".\" align=\"char\">9.36</td><td char=\".\" align=\"char\">0.0042</td><td align=\"left\"/></tr><tr><td align=\"left\">B<sup>2</sup></td><td char=\".\" align=\"char\">658.85</td><td align=\"left\">1</td><td char=\".\" align=\"char\">658.85</td><td char=\".\" align=\"char\">439.19</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td align=\"left\"/></tr><tr><td align=\"left\">C<sup>2</sup></td><td char=\".\" align=\"char\">372.64</td><td align=\"left\">1</td><td char=\".\" align=\"char\">372.64</td><td char=\".\" align=\"char\">248.41</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td align=\"left\"/></tr><tr><td align=\"left\">D<sup>2</sup></td><td char=\".\" align=\"char\">812.05</td><td align=\"left\">1</td><td char=\".\" align=\"char\">812.05</td><td char=\".\" align=\"char\">541.31</td><td char=\".\" align=\"char\"> &lt; 0.0001</td><td align=\"left\"/></tr><tr><td align=\"left\">E<sup>2</sup></td><td char=\".\" align=\"char\">19.85</td><td align=\"left\">1</td><td char=\".\" align=\"char\">19.85</td><td char=\".\" align=\"char\">13.23</td><td char=\".\" align=\"char\">0.0009</td><td align=\"left\"/></tr><tr><td align=\"left\">Residual</td><td char=\".\" align=\"char\">54.01</td><td align=\"left\">36</td><td char=\".\" align=\"char\">1.50</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td align=\"left\"/></tr><tr><td align=\"left\">Lack of fit</td><td char=\".\" align=\"char\">45.13</td><td align=\"left\">29</td><td char=\".\" align=\"char\">1.56</td><td char=\".\" align=\"char\">1.23</td><td char=\".\" align=\"char\">0.4174</td><td align=\"left\">Not significant</td></tr><tr><td align=\"left\">Pure error</td><td char=\".\" align=\"char\">8.88</td><td align=\"left\">7</td><td char=\".\" align=\"char\">1.27</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td align=\"left\"/></tr><tr><td align=\"left\">Cor total</td><td char=\".\" align=\"char\">4062.08</td><td align=\"left\">49</td><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td char=\".\" align=\"char\"/><td align=\"left\"/></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Comparison of TC photocatalytic-degradation efficiency of this work with other visible-light-driven catalytic systems from recent literatures.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">TC Con. (ppm)</th><th align=\"left\">Photocatalyst/membrane</th><th align=\"left\">Light source</th><th align=\"left\">Irradiation time (min)</th><th align=\"left\">Removal of TC (%)</th><th align=\"left\">Ref</th></tr></thead><tbody><tr><td align=\"left\">40</td><td align=\"left\">SnO<sub>2</sub>-modified-g-C<sub>3</sub>N<sub>4</sub></td><td align=\"left\">Three 50 W fluorescent lamps</td><td align=\"left\">120</td><td align=\"left\">90.29</td><td align=\"left\"><sup>##UREF##42##57##</sup></td></tr><tr><td align=\"left\">10</td><td align=\"left\">Au-TiO2/pDA-PVDF</td><td align=\"left\">300W xenon</td><td align=\"left\">120</td><td align=\"left\">92</td><td align=\"left\"><sup>##REF##28656749##58##</sup></td></tr><tr><td align=\"left\">10</td><td align=\"left\">cobalt-doped ZnTiO<sub>3</sub>/Ti<sub>3</sub>C2Tx MXene</td><td align=\"left\">300 W xenon</td><td align=\"left\">1440</td><td align=\"left\"> ~ 80</td><td align=\"left\"><sup>##REF##36272372##59##</sup></td></tr><tr><td align=\"left\">20</td><td align=\"left\">MnFe<sub>2</sub>O<sub>4</sub>/BiOI</td><td align=\"left\">500 W xenon</td><td align=\"left\">200</td><td align=\"left\">83.04</td><td align=\"left\"><sup>##UREF##43##60##</sup></td></tr><tr><td align=\"left\">0.1</td><td align=\"left\">ZnIn2S4/PVDF</td><td align=\"left\">150W halogen</td><td align=\"left\">2160</td><td align=\"left\">92</td><td align=\"left\"><sup>##UREF##44##61##</sup></td></tr><tr><td align=\"left\">30</td><td align=\"left\">Type-1 α-Fe<sub>2</sub>O<sub>3</sub>/TiO<sub>2</sub></td><td align=\"left\">500 W halogen</td><td align=\"left\">120</td><td align=\"left\">97.5</td><td align=\"left\"><sup>##REF##37356592##62##</sup></td></tr><tr><td align=\"left\">20</td><td align=\"left\">Bi<sub>2</sub>WO<sub>6</sub>-CeO<sub>2</sub>/PVDF MoO<sub>3</sub>/g-C<sub>3</sub>N<sub>4</sub> Z-scheme</td><td align=\"left\">Visible light</td><td align=\"left\">200</td><td align=\"left\">82</td><td align=\"left\"><sup>##UREF##45##63##</sup></td></tr><tr><td align=\"left\">20</td><td align=\"left\">TiO2-BiOBr-NCQDs/PVDF</td><td align=\"left\">300W xenon</td><td align=\"left\">120</td><td align=\"left\">77</td><td align=\"left\"><sup>##UREF##46##64##</sup></td></tr><tr><td align=\"left\">20</td><td align=\"left\">AgBr nanoparticles decorated 2D/2D GO/Bi<sub>2</sub>WO<sub>6</sub></td><td align=\"left\">350 W xenon</td><td align=\"left\">60</td><td align=\"left\">84</td><td align=\"left\"><sup>##UREF##47##65##</sup></td></tr><tr><td align=\"left\">20</td><td align=\"left\">AgI/BiVO<sub>4</sub> p–n junction</td><td align=\"left\">500 W xenon</td><td align=\"left\">100</td><td align=\"left\"> ~ 85</td><td align=\"left\"><sup>##UREF##48##66##</sup></td></tr><tr><td align=\"left\">5</td><td align=\"left\">Au-TiO2/PVDF</td><td align=\"left\">300W xenon</td><td align=\"left\">120</td><td align=\"left\">75</td><td align=\"left\"><sup>##UREF##49##67##</sup></td></tr><tr><td align=\"left\">10</td><td align=\"left\">AgBr–TiO<sub>2</sub>-Palygorskite</td><td align=\"left\">300W xenon</td><td align=\"left\">90</td><td align=\"left\">90</td><td align=\"left\"><sup>##UREF##50##68##</sup></td></tr><tr><td align=\"left\">20</td><td align=\"left\">Bi2WO6-CeO2/PVDF</td><td align=\"left\">Visible light</td><td align=\"left\">200</td><td align=\"left\">82</td><td align=\"left\"><sup>##REF##34364210##69##</sup></td></tr><tr><td align=\"left\">22.16</td><td align=\"left\">g-C<sub>3</sub>N<sub>4</sub> membrane reactor</td><td align=\"left\">300W xenon</td><td align=\"left\">143.776</td><td align=\"left\">94.8%</td><td align=\"left\">This work</td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda_{\\max }$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:msub><mml:mi>λ</mml:mi><mml:mo movablelimits=\"true\">max</mml:mo></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ {\\text{Removal efficiency }}\\left( {\\text{\\% }} \\right) = \\frac{{{\\text{C}}_{{0}} - {\\text{ C}}_{{\\text{t}}} }}{{{\\text{C}}_{{0}} }} \\times {100} $$\\end{document}</tex-math><mml:math id=\"M4\" display=\"block\"><mml:mrow><mml:mrow><mml:mtext>Removal efficiency</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtext>\\%</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mtext>C</mml:mtext><mml:mn>0</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>C</mml:mtext></mml:mrow><mml:mtext>t</mml:mtext></mml:msub></mml:mrow><mml:msub><mml:mtext>C</mml:mtext><mml:mn>0</mml:mn></mml:msub></mml:mfrac><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{C}}_{0}$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:msub><mml:mtext>C</mml:mtext><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{C}}_{\\text{t}}$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:msub><mml:mtext>C</mml:mtext><mml:mtext>t</mml:mtext></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text{g} - {\\text{C}}_{3}{\\text{N}}_{4}$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mrow><mml:mtext>g</mml:mtext><mml:mo>-</mml:mo><mml:msub><mml:mtext>C</mml:mtext><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mtext>N</mml:mtext><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text{g} - {\\text{C}}_{3}{\\text{N}}_{4}$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mrow><mml:mtext>g</mml:mtext><mml:mo>-</mml:mo><mml:msub><mml:mtext>C</mml:mtext><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mtext>N</mml:mtext><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text{g} - {\\text{C}}_{3}{\\text{N}}_{4}$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mrow><mml:mtext>g</mml:mtext><mml:mo>-</mml:mo><mml:msub><mml:mtext>C</mml:mtext><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mtext>N</mml:mtext><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text{g} - {\\text{C}}_{3}{\\text{N}}_{4}$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mrow><mml:mtext>g</mml:mtext><mml:mo>-</mml:mo><mml:msub><mml:mtext>C</mml:mtext><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mtext>N</mml:mtext><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{Removal}}=-304.3991+(0.6700\\times {\\text{A}})+(39.9333\\times {\\text{B}})+(113.0416\\times {\\text{C}})+(9.5033\\times {\\text{D}})+(8.2833\\times {\\text{E}})+(-1.6666\\times {\\text{B}}\\times {\\text{C}})+(-0.0583\\times {\\text{B}}\\times {\\text{D}})+(0.2916\\times {\\text{B}}\\times {\\text{E}})+(-0.0029\\times {\\text{A}}^{2})+(-2.0166\\times {\\text{B}}^{2})+(-85.3125\\times {\\text{C}}^{2})+(-0.2015\\times {\\text{D}}^{2})+(-0.7875\\times {\\text{E}}^{2})$$\\end{document}</tex-math><mml:math id=\"M18\" display=\"block\"><mml:mrow><mml:mtext>Removal</mml:mtext><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>304.3991</mml:mn><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0.6700</mml:mn><mml:mo>×</mml:mo><mml:mtext>A</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>39.9333</mml:mn><mml:mo>×</mml:mo><mml:mtext>B</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>113.0416</mml:mn><mml:mo>×</mml:mo><mml:mtext>C</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>9.5033</mml:mn><mml:mo>×</mml:mo><mml:mtext>D</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>8.2833</mml:mn><mml:mo>×</mml:mo><mml:mtext>E</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mo>-</mml:mo><mml:mn>1.6666</mml:mn><mml:mo>×</mml:mo><mml:mtext>B</mml:mtext><mml:mo>×</mml:mo><mml:mtext>C</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mo>-</mml:mo><mml:mn>0.0583</mml:mn><mml:mo>×</mml:mo><mml:mtext>B</mml:mtext><mml:mo>×</mml:mo><mml:mtext>D</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0.2916</mml:mn><mml:mo>×</mml:mo><mml:mtext>B</mml:mtext><mml:mo>×</mml:mo><mml:mtext>E</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mo>-</mml:mo><mml:mn>0.0029</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mtext>A</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mo>-</mml:mo><mml:mn>2.0166</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mtext>B</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mo>-</mml:mo><mml:mn>85.3125</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mtext>C</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mo>-</mml:mo><mml:mn>0.2015</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mtext>D</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mo>-</mml:mo><mml:mn>0.7875</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mtext>E</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\text{O}}}_{2}^{-}$$\\end{document}</tex-math><mml:math id=\"M20\"><mml:msubsup><mml:mtext>O</mml:mtext><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mo>-</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<inline-graphic xlink:href=\"41598_2024_51847_Article_IEq1.gif\"/>", "<graphic xlink:href=\"41598_2024_51847_Article_Equ1.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51847_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51847_Article_IEq3.gif\"/>", "<graphic xlink:href=\"41598_2024_51847_Fig1_HTML\" id=\"MO1\"/>", "<inline-graphic xlink:href=\"41598_2024_51847_Article_IEq5.gif\"/>", "<graphic xlink:href=\"41598_2024_51847_Fig2_HTML\" id=\"MO2\"/>", "<inline-graphic xlink:href=\"41598_2024_51847_Article_IEq6.gif\"/>", "<graphic xlink:href=\"41598_2024_51847_Fig3_HTML\" id=\"MO3\"/>", "<inline-graphic xlink:href=\"41598_2024_51847_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51847_Article_IEq8.gif\"/>", "<graphic xlink:href=\"41598_2024_51847_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51847_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2024_51847_Fig6_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"41598_2024_51847_Article_Equ2.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51847_Fig7_HTML\" id=\"MO7\"/>", "<inline-graphic xlink:href=\"41598_2024_51847_Article_IEq4.gif\"/>", "<graphic xlink:href=\"41598_2024_51847_Fig8_HTML\" id=\"MO8\"/>", "<graphic xlink:href=\"41598_2024_51847_Fig9_HTML\" id=\"MO9\"/>" ]
[ "<media xlink:href=\"41598_2024_51847_MOESM1_ESM.docx\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["2."], "mixed-citation": ["\u0160imatovi\u0107, A. & Udikovi\u0107-Koli\u0107, N. Antibiotic resistance in pharmaceutical industry effluents and effluent-impacted environments. In "], "italic": ["Antibiotic resistance in the environment: A worldwide overview"]}, {"label": ["4."], "surname": ["Evans", "Mateo-Sagasta", "Qadir", "Boelee", "Ippolito"], "given-names": ["AE", "J", "M", "E", "A"], "article-title": ["Agricultural water pollution: Key knowledge gaps and research needs"], "source": ["Curr. Opin. Environ. Sustain."], "year": ["2019"], "volume": ["36"], "fpage": ["20"], "lpage": ["27"], "pub-id": ["10.1016/j.cosust.2018.10.003"]}, {"label": ["5."], "surname": ["Soni", "Jyoti", "Chandra", "Chandra"], "given-names": ["K", "K", "H", "R"], "article-title": ["Bacterial antibiotic resistance in municipal wastewater treatment plant; mechanism and its impacts on human health and economy"], "source": ["Bioresour. Technol. Rep."], "year": ["2022"], "volume": ["19"], "fpage": ["101080"], "pub-id": ["10.1016/j.biteb.2022.101080"]}, {"label": ["7."], "surname": ["Leichtweis"], "given-names": ["J"], "article-title": ["A review of the occurrence, disposal, determination, toxicity and remediation technologies of the tetracycline antibiotic"], "source": ["Process Saf. Environ. Protect."], "year": ["2022"], "volume": ["160"], "fpage": ["25"], "lpage": ["40"], "pub-id": ["10.1016/j.psep.2022.01.085"]}, {"label": ["8."], "mixed-citation": ["Samy, M. "], "italic": ["et al."]}, {"label": ["9."], "surname": ["Salama", "Mensah", "ElKady", "Shokry", "Samy"], "given-names": ["E", "K", "M", "H", "M"], "article-title": ["Effective degradation of tetracycline via persulfate activation using silica-supported zero-valent iron: Process optimization, mechanism, degradation pathways and water matrices"], "source": ["Environ. Sci. Pollut. Res."], "year": ["2023"], "volume": ["30"], "fpage": ["87449"], "lpage": ["87464"], "pub-id": ["10.1007/s11356-023-28510-z"]}, {"label": ["10."], "surname": ["Mensah", "Samy", "Mahmoud", "Fujii", "Shokry"], "given-names": ["K", "M", "H", "M", "H"], "article-title": ["Rapid adsorption of sulfamethazine on mesoporous graphene produced from plastic waste: Optimization, mechanism, isotherms, kinetics, and thermodynamics"], "source": ["Int. J. Environ. Sci. Technol."], "year": ["2023"], "volume": ["20"], "fpage": ["9717"], "lpage": ["9732"], "pub-id": ["10.1007/s13762-022-04646-2"]}, {"label": ["11."], "surname": ["Samy", "Mensah", "Alalm"], "given-names": ["M", "K", "MG"], "article-title": ["A review on photodegradation mechanism of bio-resistant pollutants: Analytical methods, transformation products, and toxicity assessment"], "source": ["J. Water Process Eng."], "year": ["2022"], "volume": ["49"], "fpage": ["103151"], "pub-id": ["10.1016/j.jwpe.2022.103151"]}, {"label": ["12."], "surname": ["Samy"], "given-names": ["M"], "article-title": ["Novel biosynthesis of graphene-supported zero-valent iron nanohybrid for efficient decolorization of acid and basic dyes"], "source": ["Sustainability"], "year": ["2022"], "volume": ["14"], "fpage": ["14188"], "pub-id": ["10.3390/su142114188"]}, {"label": ["13."], "mixed-citation": ["Mohammadi, M., Sabbaghi, S., Binazadeh, M., Ghaedi, S. & Rajabi, H. Type-1 \u03b1-Fe2O3/TiO2 photocatalytic degradation of tetracycline from wastewater using CCD-based RSM optimization. "], "italic": ["Chemosphere"]}, {"label": ["16."], "surname": ["Guesmi"], "given-names": ["A"], "article-title": ["Disinfection of corona and myriad viruses in water by non-thermal plasma: A review"], "source": ["Environ. Sci. Pollut. Res."], "year": ["2022"], "volume": ["29"], "fpage": ["55321"], "lpage": ["55335"], "pub-id": ["10.1007/s11356-022-21160-7"]}, {"label": ["17."], "surname": ["Baaloudj", "Nasrallah", "Kenfoud", "Bourkeb", "Badawi"], "given-names": ["O", "N", "H", "KW", "AK"], "article-title": ["Polyaniline/Bi12TiO20 hybrid system for cefixime removal by combining adsorption and photocatalytic degradation"], "source": ["Chem. Eng."], "year": ["2023"], "volume": ["7"], "fpage": ["4"]}, {"label": ["19."], "mixed-citation": ["Santos, \u00c9. N., L\u00e1szl\u00f3, Z., Hod\u00far, C., Arthanareeswaran, G. & Ver\u00e9b, G. Photocatalytic membrane filtration and its advantages over conventional approaches in the treatment of oily wastewater: A review. "], "italic": ["Methods"], "bold": ["13"]}, {"label": ["20."], "surname": ["Rajabi"], "given-names": ["H"], "article-title": ["Nano-ZnO embedded mixed matrix polyethersulfone (PES) membrane: Influence of nanofiller shape on characterization and fouling resistance"], "source": ["Appl. Surf. Sci."], "year": ["2015"], "volume": ["349"], "fpage": ["66"], "lpage": ["77"], "pub-id": ["10.1016/j.apsusc.2015.04.214"]}, {"label": ["21."], "surname": ["Rani", "Karthikeyan"], "given-names": ["CN", "S"], "article-title": ["Feasibility study of acenaphthene degradation in a novel slurry UV photocatalytic membrane reactor: effect of operating parameters and optimization using response surface modeling"], "source": ["Chem. Eng. Process. Proc. Intensif."], "year": ["2020"], "volume": ["155"], "fpage": ["108051"], "pub-id": ["10.1016/j.cep.2020.108051"]}, {"label": ["23."], "mixed-citation": ["Yang, C. "], "italic": ["et al.", "Chem. Eng. J."]}, {"label": ["24."], "surname": ["Kusworo", "Kumoro", "Utomo"], "given-names": ["TD", "AC", "DP"], "article-title": ["Photocatalytic nanohybrid membranes for highly efficient wastewater treatment: A comprehensive review"], "source": ["J. Environ. Manag."], "year": ["2022"], "volume": ["317"], "fpage": ["115357"], "pub-id": ["10.1016/j.jenvman.2022.115357"]}, {"label": ["25."], "surname": ["Wu"], "given-names": ["C-J"], "article-title": ["Removal of tetracycline by a photocatalytic membrane reactor with MIL-53 (Fe)/PVDF mixed-matrix membrane"], "source": ["Chem. Eng. J."], "year": ["2023"], "volume": ["451"], "fpage": ["138990"], "pub-id": ["10.1016/j.cej.2022.138990"]}, {"label": ["26."], "surname": ["Hayat"], "given-names": ["A"], "article-title": ["State of the art advancement in rational design of g-C3N4 photocatalyst for efficient solar fuel transformation, environmental decontamination and future perspectives"], "source": ["Int. J. Hydrogen Energy"], "year": ["2022"], "volume": ["47"], "fpage": ["10837"], "lpage": ["10867"], "pub-id": ["10.1016/j.ijhydene.2021.11.252"]}, {"label": ["29."], "surname": ["Liang", "Han", "Sun", "Zhang", "Qin"], "given-names": ["B", "D", "C", "W", "Q"], "article-title": ["Synthesis of SnO/g-C3N4 visible light driven photocatalysts via grinding assisted ultrasonic route"], "source": ["Ceram. Int."], "year": ["2018"], "volume": ["44"], "fpage": ["7315"], "lpage": ["7318"], "pub-id": ["10.1016/j.ceramint.2018.01.093"]}, {"label": ["30."], "surname": ["Lei", "Xu", "Zhou", "Xia", "Hao"], "given-names": ["W", "Y", "T", "M", "Q"], "article-title": ["Determination of trace uric acid in serum using porous graphitic carbon nitride (g-C3N4) as a fluorescent probe"], "source": ["Microchim. Acta"], "year": ["2018"], "volume": ["185"], "fpage": ["1"], "lpage": ["9"]}, {"label": ["31."], "surname": ["Fan"], "given-names": ["C"], "article-title": ["Graphitic carbon nitride nanosheets obtained by liquid stripping as efficient photocatalysts under visible light"], "source": ["RSC Adv."], "year": ["2017"], "volume": ["7"], "fpage": ["37185"], "lpage": ["37193"], "pub-id": ["10.1039/C7RA05732F"]}, {"label": ["32."], "surname": ["Qin"], "given-names": ["Y"], "article-title": ["Synergy between van der waals heterojunction and vacancy in ZnIn2S4/g-C3N4 2D/2D photocatalysts for enhanced photocatalytic hydrogen evolution"], "source": ["Appl. Catal. B Environ."], "year": ["2020"], "volume": ["277"], "fpage": ["119254"], "pub-id": ["10.1016/j.apcatb.2020.119254"]}, {"label": ["33."], "surname": ["Wen", "Xie", "Chen", "Li"], "given-names": ["J", "J", "X", "X"], "article-title": ["A review on g-C3N4-based photocatalysts"], "source": ["Appl. Surf. Sci."], "year": ["2017"], "volume": ["391"], "fpage": ["72"], "lpage": ["123"], "pub-id": ["10.1016/j.apsusc.2016.07.030"]}, {"label": ["35."], "surname": ["Du"], "given-names": ["R"], "article-title": ["Controlled oxygen doping in highly dispersed Ni-loaded g-C3N4 nanotubes for efficient photocatalytic H2O2 production"], "source": ["Chem. Eng. J."], "year": ["2022"], "volume": ["441"], "fpage": ["135999"], "pub-id": ["10.1016/j.cej.2022.135999"]}, {"label": ["36."], "surname": ["Meena", "Poswal", "Surela", "Saini"], "given-names": ["PL", "K", "AK", "JK"], "article-title": ["Synthesis of graphitic carbon nitride/zinc oxide (g-C3N4/ZnO) hybrid nanostructures and investigation of the effect of ZnO on the photodegradation activity of g-C3N4 against the brilliant cresyl blue (BCB) dye under visible light irradiation"], "source": ["Adv. Compos. Hybrid Mater."], "year": ["2023"], "volume": ["6"], "fpage": ["16"], "pub-id": ["10.1007/s42114-022-00577-1"]}, {"label": ["37."], "surname": ["Ramesh", "Da", "Manigandan", "Bhargav", "Nguyen-Le"], "given-names": ["A", "CT", "R", "PB", "M-T"], "article-title": ["Selectivity oxidation of benzyl alcohol using mesoporous g-C3N4 catalysts prepared by hard template method"], "source": ["Colloid Interface Sci. Commun."], "year": ["2022"], "volume": ["48"], "fpage": ["100608"], "pub-id": ["10.1016/j.colcom.2022.100608"]}, {"label": ["40."], "surname": ["Kumar", "Kumar", "Baruah", "Shanker"], "given-names": ["S", "B", "A", "V"], "article-title": ["Synthesis of magnetically separable and recyclable g-C3N4\u2013Fe3O4 hybrid nanocomposites with enhanced photocatalytic performance under visible-light irradiation"], "source": ["J. Phys. Chem. C"], "year": ["2013"], "volume": ["117"], "fpage": ["26135"], "lpage": ["26143"], "pub-id": ["10.1021/jp409651g"]}, {"label": ["42."], "surname": ["Jourshabani", "Shariatinia", "Badiei"], "given-names": ["M", "Z", "A"], "article-title": ["In situ fabrication of SnO2/S-doped g-C3N4 nanocomposites and improved visible light driven photodegradation of methylene blue"], "source": ["J. Mol. Liquids"], "year": ["2017"], "volume": ["248"], "fpage": ["688"], "lpage": ["702"], "pub-id": ["10.1016/j.molliq.2017.10.110"]}, {"label": ["43."], "surname": ["Zdravkov", "\u010cerm\u00e1k", "\u0160efara", "Jank\u016f"], "given-names": ["B", "J", "M", "J"], "article-title": ["Pore classification in the characterization of porous materials: A perspective"], "source": ["Open Chem."], "year": ["2007"], "volume": ["5"], "fpage": ["385"], "lpage": ["395"], "pub-id": ["10.2478/s11532-007-0017-9"]}, {"label": ["44."], "surname": ["Thommes"], "given-names": ["M"], "article-title": ["Physisorption of gases, with special reference to the evaluation of surface area and pore size distribution (IUPAC Technical Report)"], "source": ["Pure Appl. Chem."], "year": ["2015"], "volume": ["87"], "fpage": ["1051"], "lpage": ["1069"], "pub-id": ["10.1515/pac-2014-1117"]}, {"label": ["45."], "surname": ["Liu"], "given-names": ["Z"], "article-title": ["Aqueous tetracycline degradation by coal-based carbon electrocatalytic filtration membrane: effect of nano antimony-doped tin dioxide coating"], "source": ["Chem. Eng. J."], "year": ["2017"], "volume": ["314"], "fpage": ["59"], "lpage": ["68"], "pub-id": ["10.1016/j.cej.2016.12.093"]}, {"label": ["46."], "surname": ["Rani", "Karthikeyan"], "given-names": ["CN", "S"], "article-title": ["Investigation of naphthalene removal from aqueous solutions in an integrated slurry photocatalytic membrane reactor: Effect of operating parameters, identification of intermediates, and response surface approach"], "source": ["Polycyclic Arom. Compounds"], "year": ["2021"], "volume": ["41"], "fpage": ["805"], "lpage": ["824"], "pub-id": ["10.1080/10406638.2019.1622135"]}, {"label": ["47."], "surname": ["Greenland"], "given-names": ["S"], "article-title": ["Valid p-values behave exactly as they should: Some misleading criticisms of p-values and their resolution with s-values"], "source": ["Am. Stat."], "year": ["2019"], "volume": ["73"], "fpage": ["106"], "lpage": ["114"], "pub-id": ["10.1080/00031305.2018.1529625"]}, {"label": ["48."], "surname": ["Liu"], "given-names": ["Y"], "article-title": ["Optimization of parameters in laser powder deposition AlSi10Mg alloy using Taguchi method"], "source": ["Optics Laser Technol."], "year": ["2019"], "volume": ["111"], "fpage": ["470"], "lpage": ["480"], "pub-id": ["10.1016/j.optlastec.2018.10.030"]}, {"label": ["49."], "surname": ["Rafiq"], "given-names": ["A"], "article-title": ["Photocatalytic degradation of dyes using semiconductor photocatalysts to clean industrial water pollution"], "source": ["J. Ind. Eng. Chem."], "year": ["2021"], "volume": ["97"], "fpage": ["111"], "lpage": ["128"], "pub-id": ["10.1016/j.jiec.2021.02.017"]}, {"label": ["50."], "surname": ["Khaki", "Shafeeyan", "Raman", "Daud"], "given-names": ["MRD", "MS", "AAA", "WMAW"], "article-title": ["Evaluating the efficiency of nano-sized Cu doped TiO2/ZnO photocatalyst under visible light irradiation"], "source": ["J. Mol. Liquids"], "year": ["2018"], "volume": ["258"], "fpage": ["354"], "lpage": ["365"], "pub-id": ["10.1016/j.molliq.2017.11.030"]}, {"label": ["51."], "surname": ["Hou"], "given-names": ["J"], "article-title": ["Narrowing the band gap of BiOCl for the hydroxyl radical generation of photocatalysis under visible light"], "source": ["ACS Sustain. Chem. Eng."], "year": ["2019"], "volume": ["7"], "fpage": ["16569"], "lpage": ["16576"], "pub-id": ["10.1021/acssuschemeng.9b03885"]}, {"label": ["52."], "surname": ["Mendret", "Hatat-Fraile", "Rivallin", "Brosillon"], "given-names": ["J", "M", "M", "S"], "article-title": ["Influence of solution pH on the performance of photocatalytic membranes during dead-end filtration"], "source": ["Sep. Purif. Technol."], "year": ["2013"], "volume": ["118"], "fpage": ["406"], "lpage": ["414"], "pub-id": ["10.1016/j.seppur.2013.07.025"]}, {"label": ["53."], "surname": ["Anwer"], "given-names": ["H"], "article-title": ["Photocatalysts for degradation of dyes in industrial effluents: Opportunities and challenges"], "source": ["Nano Res."], "year": ["2019"], "volume": ["12"], "fpage": ["955"], "lpage": ["972"], "pub-id": ["10.1007/s12274-019-2287-0"]}, {"label": ["54."], "surname": ["de Moraes"], "given-names": ["NP"], "article-title": ["Methylene blue photodegradation employing hexagonal prism-shaped niobium oxide as heterogeneous catalyst: Effect of catalyst dosage, dye concentration, and radiation source"], "source": ["Mater. Chem. Phys."], "year": ["2018"], "volume": ["214"], "fpage": ["95"], "lpage": ["106"], "pub-id": ["10.1016/j.matchemphys.2018.04.063"]}, {"label": ["56."], "surname": ["Nasrollahi", "Ghalamchi", "Vatanpour", "Khataee"], "given-names": ["N", "L", "V", "A"], "article-title": ["Photocatalytic-membrane technology: A critical review for membrane fouling mitigation"], "source": ["J. Ind. Eng. Chem."], "year": ["2021"], "volume": ["93"], "fpage": ["101"], "lpage": ["116"], "pub-id": ["10.1016/j.jiec.2020.09.031"]}, {"label": ["57."], "surname": ["Nguyen-Dinh", "Bui", "Bansal", "Jourshabani", "Lee"], "given-names": ["M-T", "TS", "P", "M", "B-K"], "article-title": ["Photocatalytic and photo-electrochemical behavior of novel SnO2-modified-g-C3N4 for complete elimination of tetracycline under visible-light irradiation: Slurry and fixed-bed approach"], "source": ["Sep. Purif. Technol."], "year": ["2021"], "volume": ["267"], "fpage": ["118607"], "pub-id": ["10.1016/j.seppur.2021.118607"]}, {"label": ["60."], "surname": ["Golrizkhatami", "Taghavi", "Nasseh", "Panahi"], "given-names": ["F", "L", "N", "HA"], "article-title": ["Synthesis of novel MnFe2O4/BiOI green nanocomposite and its application to photocatalytic degradation of tetracycline hydrochloride: (LC-MS analyses, mechanism, reusability, kinetic, radical agents, mineralization, process capability, and purification of actual pharmaceutical wastewater)"], "source": ["J. Photochem. Photobiol. A Chem."], "year": ["2023"], "volume": ["444"], "fpage": ["114989"], "pub-id": ["10.1016/j.jphotochem.2023.114989"]}, {"label": ["61."], "surname": ["Gao"], "given-names": ["B"], "article-title": ["Continuous removal of tetracycline in a photocatalytic membrane reactor (PMR) with ZnIn2S4 as adsorption and photocatalytic coating layer on PVDF membrane"], "source": ["J. Photochem. Photobiol. A Chem."], "year": ["2018"], "volume": ["364"], "fpage": ["732"], "lpage": ["739"], "pub-id": ["10.1016/j.jphotochem.2018.07.008"]}, {"label": ["63."], "surname": ["Xie"], "given-names": ["Z"], "article-title": ["Construction of carbon dots modified MoO3/g-C3N4 Z-scheme photocatalyst with enhanced visible-light photocatalytic activity for the degradation of tetracycline"], "source": ["Appl. Catal. B Environ."], "year": ["2018"], "volume": ["229"], "fpage": ["96"], "lpage": ["104"], "pub-id": ["10.1016/j.apcatb.2018.02.011"]}, {"label": ["64."], "surname": ["Luo", "Yan", "Wu", "Lin", "Yan"], "given-names": ["H", "M", "Y", "X", "Y"], "article-title": ["Facile synthesis of PVDF photocatalytic membrane based on NCQDs/BiOBr/TiO2 heterojunction for effective removal of tetracycline"], "source": ["Mater. Sci. Eng. B"], "year": ["2021"], "volume": ["265"], "fpage": ["114996"], "pub-id": ["10.1016/j.mseb.2020.114996"]}, {"label": ["65."], "surname": ["Guan"], "given-names": ["Z"], "article-title": ["AgBr nanoparticles decorated 2D/2D GO/Bi2WO6 photocatalyst with enhanced photocatalytic performance for the removal of tetracycline hydrochloride"], "source": ["Chem. Eng. J."], "year": ["2021"], "volume": ["410"], "fpage": ["128283"], "pub-id": ["10.1016/j.cej.2020.128283"]}, {"label": ["66."], "surname": ["Zhao"], "given-names": ["W"], "article-title": ["Simultaneous removal of tetracycline and Cr(VI) by a novel three-dimensional AgI/BiVO4 p-n junction photocatalyst and insight into the photocatalytic mechanism"], "source": ["Chem. Eng. J."], "year": ["2019"], "volume": ["369"], "fpage": ["716"], "lpage": ["725"], "pub-id": ["10.1016/j.cej.2019.03.115"]}, {"label": ["67."], "surname": ["Yan", "Wu", "Liu"], "given-names": ["M", "Y", "X"], "article-title": ["Photocatalytic nanocomposite membranes for high-efficiency degradation of tetracycline under visible light: An imitated core-shell Au-TiO2-based design"], "source": ["J. Alloys Compounds"], "year": ["2021"], "volume": ["855"], "fpage": ["157548"], "pub-id": ["10.1016/j.jallcom.2020.157548"]}, {"label": ["68."], "surname": ["Shi"], "given-names": ["Y"], "article-title": ["Visible-light-driven AgBr\u2013TiO2-Palygorskite photocatalyst with excellent photocatalytic activity for tetracycline hydrochloride"], "source": ["J. Clean. Prod."], "year": ["2020"], "volume": ["277"], "fpage": ["124021"], "pub-id": ["10.1016/j.jclepro.2020.124021"]}, {"label": ["70."], "surname": ["Munusamy", "Yee", "Khan"], "given-names": ["TD", "CS", "MMR"], "article-title": ["Construction of hybrid g-C3N4/CdO nanocomposite with improved photodegradation activity of RhB dye under visible light irradiation"], "source": ["Adv. Powder Technol."], "year": ["2020"], "volume": ["31"], "fpage": ["2921"], "lpage": ["2931"], "pub-id": ["10.1016/j.apt.2020.05.017"]}, {"label": ["71."], "mixed-citation": ["Balakrishnan, A. & Chinthala, M. Comprehensive review on advanced reusability of g-C3N4 based photocatalysts for the removal of organic pollutants. "], "italic": ["Chemosphere"]}, {"label": ["72."], "mixed-citation": ["Rasouli, K., Alamdari, A. & Sabbaghi, S. Ultrasonic-assisted synthesis of \u03b1-Fe2O3@ TiO2 photocatalyst: Optimization of effective factors in the fabrication of photocatalyst and removal of non-biodegradable cefixime via response surface methodology-central composite design. "], "italic": ["Sep. Purif. Technol"]}, {"label": ["73."], "surname": ["Chu"], "given-names": ["Y-C"], "article-title": ["Influence of P, S, O-Doping on g-C3N4 for hydrogel formation and photocatalysis: An experimental and theoretical study"], "source": ["Carbon"], "year": ["2020"], "volume": ["169"], "fpage": ["338"], "lpage": ["348"], "pub-id": ["10.1016/j.carbon.2020.07.053"]}, {"label": ["74."], "surname": ["Shi", "He", "Li", "He", "Luo"], "given-names": ["H", "Y", "Y", "T", "P"], "article-title": ["Efficient degradation of tetracycline in real water systems by metal-free g-C3N4 microsphere through visible-light catalysis and PMS activation synergy"], "source": ["Sep. Purif. Technol."], "year": ["2022"], "volume": ["280"], "fpage": ["119864"], "pub-id": ["10.1016/j.seppur.2021.119864"]}, {"label": ["75."], "surname": ["Li", "Wang", "Zhang", "Wang", "Liu"], "given-names": ["G", "B", "J", "R", "H"], "article-title": ["Er-doped g-C3N4 for photodegradation of tetracycline and tylosin: high photocatalytic activity and low leaching toxicity"], "source": ["Chem. Eng. J."], "year": ["2020"], "volume": ["391"], "fpage": ["123500"], "pub-id": ["10.1016/j.cej.2019.123500"]}, {"label": ["76."], "surname": ["Hu", "Lyu", "Ge"], "given-names": ["Z", "J", "M"], "article-title": ["Role of reactive oxygen species in the photocatalytic degradation of methyl orange and tetracycline by Ag3PO4 polyhedron modified with g-C3N4"], "source": ["Mater. Sci. Semicond. Process."], "year": ["2020"], "volume": ["105"], "fpage": ["104731"], "pub-id": ["10.1016/j.mssp.2019.104731"]}, {"label": ["77."], "surname": ["Wu"], "given-names": ["Z"], "article-title": ["Efficient degradation of tetracycline by persulfate activation with Fe, Co and O co\u2212 doped g\u2212 C3N4: Performance, mechanism and toxicity"], "source": ["Chem. Eng. J."], "year": ["2022"], "volume": ["434"], "fpage": ["134732"], "pub-id": ["10.1016/j.cej.2022.134732"]}, {"label": ["78."], "surname": ["Ren", "Chen", "Wen", "Lu"], "given-names": ["Z", "F", "K", "J"], "article-title": ["Enhanced photocatalytic activity for tetracyclines degradation with Ag modified g-C3N4 composite under visible light"], "source": ["J. Photochem. Photobiol. A Chem."], "year": ["2020"], "volume": ["389"], "fpage": ["112217"], "pub-id": ["10.1016/j.jphotochem.2019.112217"]}]
{ "acronym": [], "definition": [] }
78
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1163
oa_package/70/5d/PMC10786873.tar.gz
PMC10786874
38216687
[ "<title>Introduction</title>", "<p id=\"Par2\">Cervical cancer is the fourth most common cancer and the fourth leading cause of cancer-related deaths in women worldwide, as reported in the 2020 Global Cancer Statistics Report<sup>##REF##33538338##1##</sup>. Concurrent chemoradiotherapy (CRT) is the standard treatment for locally advanced diseases, while patients with early lesions can be treated with surgery. However, the current CRT regimen, consisting of external beam radiotherapy (EBRT) and intracavitary brachytherapy (ICR) with concurrent cisplatin, is quite uniform despite the substantial diversity of treatment responsiveness<sup>##REF##10202165##2##,##REF##19001332##3##</sup>. A reliable tool for predicting CRT responses may help identify patients who are most likely to have a good response and enable personalized treatment according to each patient’s given probability of treatment success.</p>", "<p id=\"Par3\">Recently, considerable advancements have been achieved in medical imaging, which has resulted in the emergence of computational techniques that extract information hidden from the human eye. Radiomics, the extraction of quantitative features from medical images, has emerged as a promising tool for assisting clinical care, particularly in cancer diagnosis and prognosis prediction. Conventional handcrafted radiomics (HCR) and deep learning-based radiomics (DLR) are currently available for radiomic analysis. In contrast to HCR, which requires ROI segmentation, feature extraction, and feature selection, DLR can omit some of these steps in its pipeline; thus, it requires relatively less time and effort for both feature extraction and selection processes, and simplifying the pipeline.</p>", "<p id=\"Par4\">Our study aimed to predict CRT response in locally advanced cervical cancer (LACC) with both HCR and DLR analysis using pretreatment MR scans. By comparing the prediction performance of these models, we aimed to determine which model performed better. Additionally, we investigated the potential improvement in prediction performance by incorporating clinical data into radiomics models.</p>" ]
[ "<title>Methods</title>", "<title>Study population</title>", "<p id=\"Par19\">We retrospectively reviewed the medical records of 506 consecutive patients with cervical cancer treated with CRT at our institution between 2006 and 2019. The institutional review board of Kyungpook National University Chilgok hospital approved this study and waived the requirement for informed consent because anonymized data were used retrospectively (IRB No. KNUCH 2017-06-032). Among records initially screened, 246 patients were excluded for the following reasons: 208 underwent surgery before CRT, 9 had distant metastases at diagnosis, 3 were diagnosed with vaginal stump cancer, 1 received CRT for salvage purposes, and 25 were not evaluated by pretreatment MRI. Patients who underwent upfront surgery prior to radiation do not have any gross lesions suitable for imaging analysis. In addition, patients with distant metastases were treated with palliative aim of treatment to relieve cancer-related symptoms. Of the remaining 260 patients, 4 were treated with ICR alone, 2 refused ICR, and contrast-enhanced images were not taken for 2 patients. Finally, 252 patients were included in the analysis (Fig. ##FIG##3##4##). The dataset was randomly divided into two independent groups for the training (176 patients) and test (76 patients) datasets to get an equal frequency of cases (chemoradiotherapy response) in each dataset. The partitioning was done using ‘createDataPartition’ function from the ‘caret’ package in R. Contrast-enhanced T1-weighted fast spin-echo (FSE) images (CE-T1WI) and T2-weighted FSE images (T2WI) were obtained using various MR scanners. Baseline patient characteristics were collected from the electronic medical records. Before image segmentation, the patient-sensitive information was anonymized. Detailed information about image acquisition process was described in Supplementary material.</p>", "<title>Treatment characteristics and response evaluation</title>", "<p id=\"Par20\">All patients were treated with EBRT and ICR with concurrent chemotherapy. EBRT was delivered to the entire pelvis using a three-dimensional (3D) conformal radiation therapy four-field box technique (1.8 Gy daily fractions, 5 times a week, for a total dose of 45 Gy). A parametrial boost of 10 Gy in 5 fractions was additionally administered to patients with parametrial involvement. ICR was delivered twice a week in five fractions with a fractional dose of 6 Gy. Weekly cisplatin at a dose of 40 mg/m<sup>2</sup> was administered during radiotherapy. Patients were divided into complete response (CR) group or non-CR group according to the CRT response which was assessed 3 months after CRT by pelvic MRI and biopsy using the Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1<sup>##REF##19097774##33##</sup>. A total 195 out of 252 patients (77.4%) met the criteria of complete response.</p>", "<title>Radiomics modelling</title>", "<p id=\"Par21\">The key steps of the radiomics pipelines are illustrated in Fig. ##FIG##4##5##. The HCR pipeline included segmentation of tumor, feature extraction, feature selection, model building, and model validation. Primary tumor was semi-manually segmented on axial CE-T1WI and T2WI by two radiation oncologists (S.H and J.K) using the Eclipse treatment planning system, version 13.7 (Varian Medical Systems, Palo Alto, CA, USA). Clinical factors and HCR features were fed into SVM models. Among potential clinical factors, the three clinical factors (tumor size, FIGO stage, and HPV status) integrated into models to reduce dimensionality. Age was excluded due to its weak correlation with CRT response and the pathologic type was excluded owing to the highly imbalanced class proportion (Supplementary Table ##SUPPL##1##2##). Supplementary material provides a detailed description of how to carry out modeling process.</p>", "<p id=\"Par22\">The pipeline of DLR model consists of two branches: imaging and clinical factor branches. In the imaging branch, an inflated 3D (I3D) CNN was adopted as the base model. The I3D CNN can capture spatio-temporal information in 3D images. It extends capabilities of 2D CNNs into three dimensions (width, height, and depth), allowing it to consider the volumetric context and thereby better understand the depth dimension. This is particularly critical in medical imaging analysis where structures of interest may span across several slices or frames. The backbone network of our I3D CNN model was an ImageNet pre-trained two-dimensional CNN (ResNet-50) (Supplementary Table ##SUPPL##1##3##). Each pre-trained two-dimensional (2D) convolutional kernel with a spatial dimension of <italic>k</italic> × <italic>k</italic> was inflated, which implies that it was repeatedly stacked <italic>l</italic> times to process each 3D voxel of <italic>l</italic> × <italic>k</italic> × <italic>k</italic> (Fig. ##FIG##5##6##)<italic>.</italic> By applying inflated kernels on 3D images, the knowledge learned from the large-scale 2D image dataset (e.g., ImageNet) was transferred into our medical 3D image dataset, which is known as the transfer learning approach<sup>##UREF##0##10##</sup>. However, in transfer learning, when the target dataset is small and the number of parameters is large, fine-tuning the entire network may result in overfitting. Therefore, in this study, the I3D networks were fixed. Essentially, I3D was used for visual feature extraction, and its output did not change during the training. Herein, conv5_x feature maps that corresponded to the outputs of the last convolution blocks were extracted and average pooling was applied to obtain the imaging feature vector .</p>", "<p id=\"Par23\">In the clinical branch, a feed-forward neural network (FFNN), which consists of clinical factors, including tumor size, FIGO stage, and HPV infection status, was used. The following steps demonstrate its working. (i) Extract a bag of clinical factors, (ii) select the three most important features with the LASSO algorithm, and (iii) forward selected features to the FFNN. The clinical factor branch was inserted as an auxiliary input in the imaging branch to combine the imaging and clinical factor data. Consequently, a fusion layer, defined as I3D-fusion, was generated. A SHAP analysis was performed to identify the contribution of each clinical factor in the DLR model<sup>##UREF##9##34##</sup>. The SHAP value for each feature represents the average marginal contribution of a feature across all possible combinations of features. In other words, it quantifies how much each factor changes our prediction on average when it is included. The mean absolute SHAP values for each clinical factor were evaluated using the test dataset. The detailed methodology of HCR and DLR models is described in Supplementary material.</p>", "<p id=\"Par24\">For the SVM classifier, hyperparameters were optimized through Scikit-learn, a Python machine learning library. A fivefold cross-validated grid search obtained ‘C’: 1000; ‘gamma’: 0.001; ‘kernel’: ‘rbf’ as the best parameters. For the CNN model, we used Optuna (<ext-link ext-link-type=\"uri\" xlink:href=\"https://optuna.org/\">https://optuna.org/</ext-link>), a Python library for hyperparameter optimization. A total of 100 trials were conducted with random hyperparameter settings, and the configuration that yielded the lowest validation loss was selected. Following hyperparameters were selected as the best hyperparameters: learning rate: 10<sup>–3</sup>; the number of hidden units: 25; batch size: 8. The hyperparameter search spaces are detailed in Supplementary Table ##SUPPL##1##4##. Python (v3.6.8) was the main programming language used. The proposed model was implemented with DLR framework PyTorch (v1.7.1). For ImageNet pre-trained 2D ResNet, ResNet50 implemented in TorchVision v.0.8.2 was used. A single NVIDIA TITAN RTX GPU (24 GB) was used for DLR analysis. We assessed the model performance using an open-source performance test tool for PyTorch model (<ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/sovrasov/flops-counter.pytorch\">https://github.com/sovrasov/flops-counter.pytorch</ext-link>). This tool measures the model’s Multiply-Accumulate (MAC) operations, which are the number of floating-point multiplication and addition operations in neural networks, as well as the number of parameters. For the DLR (MR model), the computational complexity was 160.3 GMac with 525,570 parameters and the inference speed was 48.747 ms (SD, 1.951) per run for DLR (MR) model. For DLR (MR + CF) model, the computational complexity was 160.3 GMac with 546,370 parameters and the inference speed was 49.593 ms (SD, 1.910) per run. Our code is made available open-source along with our experimental results at <ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/youhs4554/radiomics_CRT\">https://github.com/youhs4554/radiomics_CRT</ext-link>.</p>", "<title>Uncertainty of model predictions</title>", "<p id=\"Par25\">In machine learning, uncertainty refers to the degree of confidence with which a model makes predictions. This aspect is particularly crucial in classification problems where an incorrect prediction can have significant consequences, such as in medical applications like ours. Quantifying the uncertainty allows us to assess the reliability of these predictions, thus highlighting their importance. We evaluated uncertainty using the Brier score<sup>##UREF##10##35##</sup>, which has been used in many studies<sup>##UREF##11##36##</sup> to quantify uncertainty. The Brier score is an evaluation metric used to measure the accuracy of predicted probabilities in binary classification problems. The low brier score (i.e., close to zero) indicates that the model has high confidence in the predicted probabilities and they are in good agreement with the actual distributions, so we can conclude that the uncertainty is low and the model's prediction is trustworthy.</p>", "<title>Statistical analysis</title>", "<p id=\"Par26\">All statistical tests were two-sided, and a <italic>p</italic>-value of &lt; 0.05 was considered significant. Model performance was measured by performing receiver operating characteristic (ROC) analysis and calculating the area under the curve (AUC)<sup>##REF##16542249##37##,##REF##18818262##38##</sup>. ROC curve plots the true-positive rate and false-positive rate corresponding to all possible binary classification that can be formed from the continuous biomarker. The AUC is a measure of the accuracy of the test. A perfect test will have a value of 1.0, while a value of 0.5 suggests the prediction results is no better than random guess. Additionally, balanced accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and F1-score were measured. The predictive performance of HCR and DLR models were compared using net reclassification improvement (NRI) and integrated discrimination improvement (IDI) indices<sup>##REF##24240655##39##,##REF##21673124##40##</sup>. The optimum cutoff of the DLR model was determined by maximizing the Youden index in the training dataset. To compare potential factors affecting CRT response, Student’s t-tests and Pearson’s chi-square tests were used to analyze continuous and categorical variables, respectively<sup>##UREF##12##41##</sup>. Statistical analyses were performed using R version 3.6.3 (R Foundation for Statistical Computing, Vienna, Austria). The R packages “caret”, “glmnet”, “pROC”, and “predictABEL” were used for analysis.</p>" ]
[ "<title>Results</title>", "<title>Patient characteristics</title>", "<p id=\"Par5\">The median age at diagnosis for all included patients was 57 years (range: 23–86 years). The FIGO stages were IIB, IIIA, IIIB, IIIC1, IIIC2, and IVA in 87 (34.5%), 1 (0.4%), 9 (3.6%), 121 (48.0%), 33 (13.1%), and 1 (0.4%) patient (s), respectively<sup>##REF##30656645##4##</sup>. Overall, 77.4% of patients achieved complete remission at 3 months after CRT. The patient characteristics in the training and test datasets are presented in Table ##TAB##0##1##. The characteristics of patients in the training and test datasets were not significantly different in terms of age, tumor size, FIGO stage, human papilloma virus (HPV) infection status, and CRT response.</p>", "<title>Handcrafted radiomics model performance</title>", "<p id=\"Par6\">By applying logistic regression and recursive feature elimination, 20 imaging features were selected for the analysis (Supplementary Table ##SUPPL##1##1##). The support vector machine (SVM) classifier used these 20 imaging features for the binary classification of CRT response (complete response or not). The AUC was 0.597 (95% CI 0.513–0.763) and balanced accuracy of the classification was 0.598 in the test dataset (Fig. ##FIG##0##1## and Table ##TAB##1##2##). When adding three clinical factors (tumor size, FIGO stage, and HPV status) into the SVM modeling, the SVM classifier exhibited the AUC of classification of 0.676 (95% CI 0.554–0.798) and balanced accuracy of 0.676 in the test dataset. The model incorporating clinical factors showed marginally significant improvement compared to the model using only MRI data (<italic>p</italic>-values; 0.096 for the DeLong test, 0.085 for the net reclassification improvement (NRI), and 0.092 for the integrated discrimination improvement (IDI)).</p>", "<title>Deep learning model performance</title>", "<p id=\"Par7\">The DLR model using MRI data (DLR (MR)) performed better than the HCR model (Fig. ##FIG##0##1## and Table ##TAB##1##2##), with AUC of 0.721 (95% CI 0.617–0.847) and a balanced accuracy of 0.732. When clinical factors were incorporated into DLR models (DLR (MR + CF)), predictive performance was further improved, with AUC of 0.782 (95% CI 0.658–0.843) and a balanced accuracy of 0.777. However, there was no statistically significant difference between DLR (MR) and DLR (MR + CF) models.</p>", "<p id=\"Par8\">Figure ##FIG##1##2## depicts the training and testing loss for DLR models with or without clinical factors. DLR models with clinical factors exhibited smaller loss values for both training and test datasets compared to those in the models without clinical factors. Through the SHapley Additive exPlanations (SHAP) analysis, which employs game theory to measure the contribution of each feature in the DLR model, it was found that the FIGO stage contributed the most substantially among clinical factors, followed by tumor size and HPV infection status (Fig. ##FIG##2##3##).</p>", "<title>Comparison between radiomics and deep learning model</title>", "<p id=\"Par9\">Comparing HCR and DLR models using MRI data, ROC analysis revealed that the DLR model tended to improve performance in terms of predicting response after CRT (0.597 vs. 0.721, <italic>p</italic> = 0.096). In addition, the NRI and IDI analyses revealed a marginal improvement in the accuracy of the association with response after CRT in the DLR model (NRI = 0.270, <italic>p</italic> = 0.070; IDI = 0.270, <italic>p</italic> = 0.077). However, when comparing HCR and DLR models using MRI data and clinical factors, neither ROC analysis nor NRI/IDI exhibited a significant difference between the two models. The sensitivity, which refers to the capability of a model to correctly predict cases not achieving a complete response after CRT, was 0.316 without clinical data and 0.474 with clinical data for the HCR models. For the DCR models, sensitivity was 0.737 without clinical data and 0.947 with clinical data.</p>", "<title>Potential factors related to CRT response</title>", "<p id=\"Par10\">None of the potential factors (tumor size, HPV status, FIGO stage, age, pathology, lymph node metastasis status, and parametrial invasion) were related to CRT response (Supplementary Table ##SUPPL##1##2##).</p>", "<title>Uncertainty quantification</title>", "<p id=\"Par11\">The experimental results comparing the Brier scores for HCR and DLR in test dataset are shown in Table ##TAB##2##3##. Our result shows that DLR had a lower Brier score than HCR both when using only MRI data (0.214 vs. 0.246) and when using both MRI data and clinical factors (0.193 vs. 0.250).</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par12\">Predicting CRT response before treatment is of clinical significance. Patients predicted to have a poor response can benefit from dose escalation or alternative treatments. Conversely, those expected to have a good response might be candidates for de-intensified treatment, thereby reducing the risk of treatment-related side effects. In other words, personalized medicine can be provided to patients with LACC. We compared prediction performance of HCR and DLR models. Our study demonstrated that DLR models generally outperformed the HCR models in predicting CRT response in LACC patients, although the difference was not statistically significant. The DLR models showed improved uncertainty estimates compared to the HCR models, suggesting their potential generalizability with unseen dataset. In addition, regarding sensitivity—defined as the capability of a model to correctly predict cases not achieving a complete response after CRT–DLR models showed superior performance. Identifying patients who were unlikely to achieve complete remission is particularly important in cancer prognosis prediction, as an initial treatment failure may lead to severe consequences for cancer patients.</p>", "<p id=\"Par13\">Incorporating clinical factors tended to improve the prediction performance of the HCR model. When using only MRI data, the DLR model showed a marginally better performance than the HCR model (AUC; 0.721 for DLR vs. 0.597 for HCR). However, when clinical factors were integrated into the MRI data, there was no significant difference between the HCR and DLR models, although the DLR model showed a higher AUC (0.782 for DLR vs. 0.676 for HCR). The lack of statistical significance might be attributed to the small number of patients in the test dataset. Another plausible reason could be that the DLR model using only MRI data may not require additional clinical data to improve its performance, possibly due to the comprehensive information embedded within the image data. Several clinical factors, such as FIGO stage, tumor size, and parametrial invasion, have been reported to correlate with the CRT response of cervical cancer. In clinical decision-making, physicians do not rely on a single piece of information. To arrive at a conclusive decision, information from different categories, including medical imaging, laboratory tests, physical examinations, histopathologic, and genomic results, is combined. Therefore, integrating these heterogeneously originated data might be pivotal, even in the case of radiomics prediction. Similar findings have been reported in other radiomic series<sup>##REF##31937925##5##–##REF##32703973##7##</sup>, where integrating clinicopathologic or genomic data enhanced prognosis prediction in various cancers. For example, in a study by Lao et al., combining deep features with clinical factors improved survival prediction performance in patients with glioblastoma multiforme<sup>##REF##28871110##8##</sup>. Similar results have been reported by Wang et al., who noted that the integration of laboratory factors (serum AFP and AST) exhibited better prediction in terms of survival in patients with hepatocellular carcinoma<sup>##REF##31937925##5##</sup>. In another study using a lung cancer dataset, Aerts et al. revealed that combining radiomic features with stage information improved the prognosis prediction<sup>##REF##24892406##9##</sup>. Our study is in line with these series, and suggests the benefit of combining clinical factors and imaging features rather than using imaging features exclusively<italic>.</italic> Summarizing previous publications and our results, imaging features and clinical data may have complementary roles in prognosis prediction in oncology.</p>", "<p id=\"Par14\">However, the methodology for combining different types of data was quite diverse in each study. In a study by Lao et al., the authors constructed a nomogram using radiomics signatures and clinical factors<sup>##REF##28871110##8##</sup>, whereas Wang et al. built a random forest model using radiomics signatures and laboratory factors as inputs simultaneously<sup>##REF##31937925##5##</sup>, which is similar to the process followed in this study for building the HCR model. Other studies implemented a similar method that Wang et al. adapted, wherein image-generated radiomics features and clinical factors were fed into a regression model to predict the survival outcomes of patients with lung cancer<sup>##REF##34229050##6##,##REF##32703973##7##</sup>. In contrast to these studies, instead of dividing the feature extraction process and machine learning model building process, the DLR analysis performed herein leveraged optimized features via a data-driven approach. To build the DLR model, we combined the convolutional neural network (CNN) architecture for image feature extraction and the fully-connected layer for target task (i.e., classification). Subsequently, the entire system was trained using a learning algorithm, called backpropagation, in an end-to-end manner to minimize classification error. Backpropagation is an application of chain rule in calculus, particularly for training deep neural network; it calculates gradient of error with respect to entire weights of neural network. By backward propagating the gradients of error with the chain rule, all weights were updated with the gradient descent algorithm for finding a minimum of a function. Our DLR model extracted compact feature vectors that represent both imaging and clinical information simultaneously; subsequently, weights were updated to obtain optimized feature vectors to minimize errors. Moreover, because the feature extraction process was optimized by the learning algorithm in our DLR model, the effort on design choices for feature extraction were considerably reduced. In addition, as demonstrated in our experiments, the DLR model using MRI data tended to have superior performance compared to the HCR model using MRI data.</p>", "<p id=\"Par15\">The choice of deep learning algorithm is a critical decision in radiomics research. We trained our CNN model using the transfer learning method<sup>##UREF##0##10##</sup>, which can consolidate general knowledge in large-scale data into specific new target tasks. Practically, the ImageNet pre-trained CNN can produce general feature representations from the natural images. Therefore, transfer learning with the pre-trained CNN has been widely applied to varied vision tasks, including object detection<sup>##UREF##1##11##,##UREF##2##12##</sup>, semantic segmentation<sup>##REF##28463186##13##,##UREF##3##14##</sup>, and video recognition<sup>##UREF##4##15##–##UREF##6##17##</sup>. Medical image analysis is not an exception. Transfer learning with pre-trained CNNs is becoming popular in medical image classification tasks<sup>##REF##27610399##18##–##REF##29428356##23##</sup>. Huynh et al.<sup>##REF##27610399##18##</sup> used this approach for a breast tumor classification study. They pre-trained CNN with AlexNet’s architecture to extract deep learning features; subsequently, features from each layer were used to train the SVM classifier. Similarly, in a lung cancer dataset study by Paul et al., the authors pre-trained a CNN to extract deep features and built various machine learning models to predict survival. In our study, we employed one of the most popular CNN architecture, Residual Network (ResNet)<sup>##UREF##8##24##</sup> proposed by Microsoft, as a backbone network. The ResNet won the 2015 ImageNet Large Scale Visual Recognition Challenge (ILSVRC) with a significantly improved error rate of 3.6%, essentially surpassing human performance. It enabled super-deep architecture by reducing the vanishing gradient phenomenon using skip connection (or residual connection) that allows gradient to always flow across extremely deep networks, improving performance significantly.</p>", "<p id=\"Par16\">One of the challenges in adapting the DLR prediction model in the clinical scenario is its poor interpretability, which is the so-called “black box”. The interpretability of the DLR model refers to the recognition of which feature contributes to the decision making and how much. This helps both improve the model by knowing what exactly is going on in the neural network model and detect the failure points of the model. In our study, because the incorporation of clinical factors improved model performance in the DLR model, SHAP analysis was performed to reveal which clinical factor was more important for the CRT response prediction. Among the three clinical factors incorporated into the model, FIGO stage was the most important, followed by tumor size and HPV infection status. Recent studies have shown that HPV DNA negativity is associated with a poor prognosis<sup>##REF##29029517##25##–##REF##19770372##27##</sup>. Although HPV infection is an established etiology of cervical cancer, some patients unexpectedly show negative HPV test results, as in our study. HPV infection status was not a significant predictive factor for CRT response in the chi-square test or the most important factor in the SHAP analysis in our study. Our findings seem to contrast with those of studies reporting treatment outcomes of HPV-positive oropharyngeal cancer<sup>##REF##20530316##28##–##REF##18474879##30##</sup>. Patients with HPV-positive oropharyngeal cancer have shown superior recurrence-free survival and favorable prognosis compared with HPV-negative patients. Nonetheless, the SHAP analysis performed in this study was a tool for comparing the relative importance between factors. Thus, we are hesitant to make a definitive statement regarding the importance of HPV infection status. We report that the relative impact of FIGO stage was larger than that of primary tumor size and HPV infection status in our DLR model.</p>", "<p id=\"Par17\">The limitations of our study include the potential selection bias associated with its retrospective nature and relatively small number of patients, which might lead to the lack of statistical difference. However, we attempted to minimize selection bias by including all consecutive cases that were homogenously treated according to a consistent protocol within an institution. Another limitation is that the data presented here were from a single institution, and external validation could not be performed. Therefore, generalizing the prediction model to an unseen dataset can be difficult. Furthermore, variability in scanners might influence the robustness of models<sup>##REF##32209816##31##,##REF##30170872##32##</sup>. Nevertheless, it is noteworthy that in real world scenario, it is common for different patients to acquire imaging examination by variable scanners, thus we still believe our findings can provide useful information for future studies. In addition, regarding HPV testing results, approximately 30% of the patients were missing, which may negatively impact the reliability of our prediction model.</p>", "<p id=\"Par18\">In conclusion, both HCR and DLR models could predict CRT responses in patients with LACC. The integration of clinical factors into radiomics prediction models tended to improve performance in HCR analysis. However, further external validation using a larger, unseen dataset is required before clinical application in the future.</p>" ]
[]
[ "<p id=\"Par1\">Concurrent chemoradiotherapy (CRT) is the standard treatment for locally advanced cervical cancer (LACC), but its responsiveness varies among patients. A reliable tool for predicting CRT responses is necessary for personalized cancer treatment. In this study, we constructed prediction models using handcrafted radiomics (HCR) and deep learning radiomics (DLR) based on pretreatment MRI data to predict CRT response in LACC. Furthermore, we investigated the potential improvement in prediction performance by incorporating clinical factors. A total of 252 LACC patients undergoing curative chemoradiotherapy are included. The patients are randomly divided into two independent groups for the training (167 patients) and test datasets (85 patients). Contrast-enhanced T1- and T2-weighted MR scans are obtained. For HCR analysis, 1890 imaging features are extracted and a support vector machine classifier with a five-fold cross-validation is trained on training dataset to predict CRT response and subsequently validated on test dataset. For DLR analysis, a 3-dimensional convolutional neural network was trained on training dataset and validated on test dataset. In conclusion, both HCR and DLR models could predict CRT responses in patients with LACC. The integration of clinical factors into radiomics prediction models tended to improve performance in HCR analysis. Our findings may contribute to the development of personalized treatment strategies for LACC patients.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51742-z.</p>", "<title>Acknowledgements</title>", "<p>This work is supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2019R1G1A1089358, 2021R1I1A3048826). The funding source for this study had no role in the experimental design of the study, data collection, data analysis, data interpretation, or writing of this report.</p>", "<title>Author contributions</title>", "<p>Conceptualization, S.P. and S.J.; Methodology, S.P. and H.Y.; Software, S.P., H.Y., D.W., and S.J.; Validation: H.Y., S.L., and D.W.; Formal Analysis: S.P., S.L., and H.Y.; Investigation: G.J., S.P., S.L, and J.K.; Resources: J.K., G.J. and H.H.; Data Curation, J.K., G.J., H.H. and S.P.; Writing—Original Draft Preparation, H.Y., S.P., and S.J.; Writing—Review and Editing, all authors; Visualization: H.Y. and S.P.; Supervision: H.H. and J.K.; Project Administration, H.Y. and D.W; Funding Acquisition, S.P.</p>", "<title>Data availability</title>", "<p>The datasets generated and/or analyzed during the current study are not publicly available due to the privacy protection policy of personal medical information at our institution, but are available from the corresponding author on reasonable request.</p>", "<title>Competing interests</title>", "<p id=\"Par27\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>(<bold>A</bold>) Receiver operating characteristic (ROC) curves and (<bold>B</bold>) confusion matrices of the prediction models constructed using handcrafted radiomics (HCR) and deep-learning radiomics (DLR) for predicting complete response (CR) after chemoradiotherapy in the test dataset.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Training (square) and testing (circle) losses for the DLR model using MRI data (cyan lines) and the model using both MRI and clinical factor data (red lines). Both training and testing losses are smaller in the model using MRI and clinical factor data, as compared to those using only MRI data.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Each bar represents the absolute value of the SHapley Additive exPlanations (SHAP) analysis, which represents the average marginal contribution of each clinical factor to the total prediction.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Flowchart of patient inclusion.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Study pipeline and model architecture of handcrafted radiomics (HCR) (top) and deep-learning radiomics (DLR) analysis (bottom). The proposed DLR model uses clinical factors as auxiliary inputs, along with MRI data. The MR branch extracts imaging features from three-dimensional (3D) MRI scans using an I3D network. The clinical branch converts clinical factors into a higher-dimensional vector using a feed-forward neural network (FFNN) with two layers. In the final step, these two representations are merged judiciously in the lateral fusion layer.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>The visualization of features maps from the first convolutional layer of the cervical tumor at superior (<bold>a</bold>, <bold>d</bold>), middle (<bold>b</bold>, <bold>e</bold>), and inferior level (<bold>c</bold>, <bold>f</bold>) on T2-weighted MR images. Notice that the model exhibits responses to low-level visual elements such as edges and textures. These elements are crucial as they serve as foundational building blocks for recognizing complex patterns within images. Edges often represent boundaries between different objects or regions, potentially identifying the morphological characteristics of tumors in this case. Textures may provide information about tumor heterogeneity. By combining these basic elements, our model could capture more complex patterns associated with tumors.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Patient characteristics of the 252 patients.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Characteristic</th><th align=\"left\">Training set</th><th align=\"left\">Test set</th><th align=\"left\"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align=\"left\">Age</td><td align=\"left\"/><td align=\"left\"/><td char=\".\" align=\"char\">0.755</td></tr><tr><td align=\"left\"> Median (range)</td><td align=\"left\">57 (24–86)</td><td align=\"left\">57 (23–84)</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\">Pathology</td><td align=\"left\"/><td align=\"left\"/><td char=\".\" align=\"char\">0.779</td></tr><tr><td align=\"left\"> Squamous cell carcinoma (SCC)</td><td align=\"left\">152 (91.0%)</td><td align=\"left\">79 (92.9%)</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Non-SCC</td><td align=\"left\">15 (9.0%)</td><td align=\"left\">6 (7.1%)</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\">Tumor size (mm)</td><td align=\"left\"/><td align=\"left\"/><td char=\".\" align=\"char\">0.323</td></tr><tr><td align=\"left\"> &lt; 50</td><td align=\"left\">93 (55.7%)</td><td align=\"left\">44 (51.8%)</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> ≥ 50</td><td align=\"left\">74 (44.3%)</td><td align=\"left\">41 (48.2%)</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\">FIGO Stage</td><td align=\"left\"/><td align=\"left\"/><td char=\".\" align=\"char\">0.676</td></tr><tr><td align=\"left\"> IIB-IIIB</td><td align=\"left\">133 (79.6%)</td><td align=\"left\">65 (76.5%)</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> IIIC1-IVA</td><td align=\"left\">34 (20.4%)</td><td align=\"left\">20 (23.5%)</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\">HPV infection status</td><td align=\"left\"/><td align=\"left\"/><td char=\".\" align=\"char\">0.267</td></tr><tr><td align=\"left\"> Positive</td><td align=\"left\">94 (56.3%)</td><td align=\"left\">39 (45.9%)</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Negative</td><td align=\"left\">25 (15.0%)</td><td align=\"left\">14 (16.5%)</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Unknown</td><td align=\"left\">48 (28.7%)</td><td align=\"left\">32 (37.6%)</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\">Chemoradiotherapy response</td><td align=\"left\"/><td align=\"left\"/><td char=\".\" align=\"char\">0.931</td></tr><tr><td align=\"left\"> Complete remission</td><td align=\"left\">130 (77.8%)</td><td align=\"left\">65 (76.5%)</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Non-complete remission</td><td align=\"left\">37 (22.2%)</td><td align=\"left\">20 (23.5%)</td><td char=\".\" align=\"char\"/></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Performance of HCR and DLR classifiers for predicting chemoradiotherapy response in test dataset.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Classifier</th><th align=\"left\">AUC</th><th align=\"left\" colspan=\"2\">Balanced accuracy</th><th align=\"left\" colspan=\"2\">Sensitivity</th><th align=\"left\">Specificity</th><th align=\"left\" colspan=\"2\">PPV</th><th align=\"left\">NPV</th><th align=\"left\">MCC</th></tr></thead><tbody><tr><td align=\"left\">HCR (MR)</td><td align=\"left\">0.597</td><td align=\"left\" colspan=\"2\">0.598</td><td align=\"left\" colspan=\"2\">0.316</td><td align=\"left\">0.879</td><td align=\"left\" colspan=\"2\">0.429</td><td align=\"left\">0.817</td><td align=\"left\">0.263</td></tr><tr><td align=\"left\">HCR (MR + CF)</td><td align=\"left\">0.676</td><td align=\"left\" colspan=\"2\">0.676</td><td align=\"left\" colspan=\"2\">0.474</td><td align=\"left\">0.879</td><td align=\"left\" colspan=\"2\">0.529</td><td align=\"left\">0.853</td><td align=\"left\">0.367</td></tr><tr><td align=\"left\">DLR (MR)</td><td align=\"left\">0.721</td><td align=\"left\" colspan=\"2\">0.732</td><td align=\"left\" colspan=\"2\">0.737</td><td align=\"left\">0.727</td><td align=\"left\" colspan=\"2\">0.438</td><td align=\"left\">0.906</td><td align=\"left\">0.399</td></tr><tr><td align=\"left\">DLR (MR + CF)</td><td align=\"left\">0.782</td><td align=\"left\" colspan=\"2\">0.777</td><td align=\"left\" colspan=\"2\">0.947</td><td align=\"left\">0.606</td><td align=\"left\" colspan=\"2\">0.409</td><td align=\"left\">0.976</td><td align=\"left\">0.461</td></tr><tr><td align=\"left\" colspan=\"11\">Comparisons between prediction models</td></tr><tr><td align=\"left\" colspan=\"3\"/><td align=\"left\" colspan=\"2\">Delong test (<italic>p</italic>-value)</td><td align=\"left\" colspan=\"3\">NRI [95% CI] (<italic>p</italic>-value)</td><td align=\"left\" colspan=\"3\">IDI [95% CI] (<italic>p</italic>-value)</td></tr><tr><td align=\"left\" colspan=\"3\">HCR (MR) versus DLR (MR)</td><td align=\"left\" colspan=\"2\">0.096</td><td align=\"left\" colspan=\"3\">0.270 [− 0.022–0.561] (0.070)</td><td align=\"left\" colspan=\"3\">0.270 [− 0.029–0.568] (0.077)</td></tr><tr><td align=\"left\" colspan=\"3\">HCR (MR + CF)  versus DLR (MR + CF)</td><td align=\"left\" colspan=\"2\">0.176</td><td align=\"left\" colspan=\"3\">0.201 [− 0.062–0.464] (0.134)</td><td align=\"left\" colspan=\"3\">0.201 [− 0.068–0.470] (0.142)</td></tr><tr><td align=\"left\" colspan=\"3\">HCR (MR) versus HCR (MR + CF)</td><td align=\"left\" colspan=\"2\">0.092</td><td align=\"left\" colspan=\"3\">0.158 [− 0.022–0.337] (0.085)</td><td align=\"left\" colspan=\"3\">0.158 [− 0.026–0.342] (0.092)</td></tr><tr><td align=\"left\" colspan=\"3\">DLR (MR) versus DLR (MR + CF)</td><td align=\"left\" colspan=\"2\">0.223</td><td align=\"left\" colspan=\"3\">0.089 [− 0.127–0.306] (0.419)</td><td align=\"left\" colspan=\"3\">0.089 [− 0.132–0.311] (0.429)</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Brier scores of HCR and DLR classifiers for uncertainty quantification.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Classifier</th><th align=\"left\">Brier score</th></tr></thead><tbody><tr><td align=\"left\">HCR (MR)</td><td char=\".\" align=\"char\">0.246</td></tr><tr><td align=\"left\">HCR (MR + CF)</td><td char=\".\" align=\"char\">0.250</td></tr><tr><td align=\"left\">DLR (MR)</td><td char=\".\" align=\"char\">0.214</td></tr><tr><td align=\"left\">DLR (MR + CF)</td><td char=\".\" align=\"char\">0.193</td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${F}_{img}$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:msub><mml:mi>F</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">img</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>" ]
[ "<table-wrap-foot><p><italic>HPV</italic> human papilloma virus.</p></table-wrap-foot>", "<table-wrap-foot><p><italic>AUC</italic> area under curve, <italic>PPV</italic> positive predictive value, <italic>NPV</italic> negative predictive value, <italic>MCC</italic> Matthew’s correlation coefficient, <italic>HCR</italic> handcrafted radiomics, <italic>MR</italic> magnetic resonance image, <italic>CF</italic> clinical factors, <italic>DLR</italic> deep learning radiomics, <italic>NRI</italic> net reclassification improvement, <italic>IDI</italic> integrated discrimination improvement.</p></table-wrap-foot>", "<table-wrap-foot><p><italic>HCR</italic> handcrafted radiomics, <italic>MR</italic> magnetic resonance image, <italic>CF</italic> clinical factors, <italic>DLR</italic> deep learning radiomics.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Sungmoon Jeong and Hosang Yu.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51742_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51742_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51742_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51742_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51742_Fig5_HTML\" id=\"MO5\"/>", "<inline-graphic xlink:href=\"41598_2024_51742_Article_IEq1.gif\"/>", "<graphic xlink:href=\"41598_2024_51742_Fig6_HTML\" id=\"MO6\"/>" ]
[ "<media xlink:href=\"41598_2024_51742_MOESM1_ESM.pdf\"><caption><p>Supplementary Information 1.</p></caption></media>", "<media xlink:href=\"41598_2024_51742_MOESM2_ESM.docx\"><caption><p>Supplementary Tables.</p></caption></media>" ]
[{"label": ["10."], "surname": ["Pan", "Yang"], "given-names": ["SJ", "QA"], "article-title": ["A survey on transfer learning"], "source": ["IEEE Trans. Knowl. Data Eng."], "year": ["2010"], "volume": ["22"], "fpage": ["1345"], "lpage": ["1359"], "pub-id": ["10.1109/Tkde.2009.191"]}, {"label": ["11."], "surname": ["Ren", "He", "Girshick", "Sun"], "given-names": ["SQ", "KM", "R", "J"], "article-title": ["Faster R-CNN: Towards real-time object detection with region proposal networks"], "source": ["IEEE T Pattern Anal."], "year": ["2017"], "volume": ["39"], "fpage": ["1137"], "lpage": ["1149"], "pub-id": ["10.1109/Tpami.2016.2577031"]}, {"label": ["12."], "surname": ["Liu"], "given-names": ["W"], "article-title": ["SSD: Single shot multibox detector"], "source": ["Lect Notes Comput Sc"], "year": ["2016"], "volume": ["9905"], "fpage": ["21"], "lpage": ["37"], "pub-id": ["10.1007/978-3-319-46448-0_2"]}, {"label": ["14."], "mixed-citation": ["Long, J., Shelhamer, E. & Darrell, T. Fully convolutional networks for semantic segmentation. in "], "italic": ["Proc Cvpr IEEE"]}, {"label": ["15."], "mixed-citation": ["Simonyan, K. & Zisserman, A. Two-stream convolutional networks for action recognition in videos. "], "italic": ["Adv. Neural Inf. Process. Syst."], "bold": ["27"]}, {"label": ["16."], "surname": ["Donahue"], "given-names": ["J"], "article-title": ["Long-term recurrent convolutional networks for visual recognition and description"], "source": ["IEEE T Pattern Anal."], "year": ["2017"], "volume": ["39"], "fpage": ["677"], "lpage": ["691"], "pub-id": ["10.1109/Tpami.2016.2599174"]}, {"label": ["17."], "mixed-citation": ["Wang, L. M. "], "italic": ["et al.", "Computer Vision\u2014Eccv 2016, Pt Viii"], "bold": ["9912"]}, {"label": ["21."], "surname": ["Gulshan"], "given-names": ["V"], "article-title": ["Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs"], "source": ["Jama-J. Am. Med. Assoc."], "year": ["2016"], "volume": ["316"], "fpage": ["2402"], "lpage": ["2410"], "pub-id": ["10.1001/jama.2016.17216"]}, {"label": ["24."], "mixed-citation": ["He, K. M., Zhang, X. Y., Ren, S. Q. & Sun, J. Deep residual learning for image recognition. in "], "italic": ["2016 IEEE Conference on Computer Vision and Pattern Recognition (Cvpr)"]}, {"label": ["34."], "mixed-citation": ["Lundberg, S. M. & Lee, S.-I. in "], "italic": ["Proceedings of the 31st International Conference on Neural Information Processing Systems."]}, {"label": ["35."], "surname": ["Brier"], "given-names": ["GW"], "article-title": ["Verification of forecasts expressed in terms of probability"], "source": ["Mon. Weather Rev."], "year": ["1950"], "volume": ["78"], "fpage": ["1"], "lpage": ["3"], "pub-id": ["10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2"]}, {"label": ["36."], "mixed-citation": ["Ovadia, Y. "], "italic": ["et al.", "Adv. Neural Inf. Process. Syst."], "bold": ["32"]}, {"label": ["41."], "surname": ["Altman"], "given-names": ["DG"], "source": ["Practical Statistics for Medical Research"], "year": ["1991"], "publisher-name": ["Chapman and Hall"]}]
{ "acronym": [], "definition": [] }
41
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1180
oa_package/1f/81/PMC10786874.tar.gz
PMC10786875
38216553
[ "<title>Introduction</title>", "<p id=\"Par3\">Vestibular schwannomas (VS) are benign tumors that arise from the Schwann cells (SCs) lining the vestibulocochlear nerve and account for 8% of all primary intracranial tumors<sup>##REF##33826821##1##</sup>. These tumors most frequently arise sporadically (&gt;90%) but are also associated with the schwannomatosis syndromes, including the autosomal dominant syndrome neurofibromatosis type 2 (NF2)-related schwannomatosis (formerly known as NF2)<sup>##REF##35674741##2##</sup>. Due to their anatomic location adjacent to the brainstem, both tumor growth and current treatment strategies (i.e., microsurgery and/or radiation therapy) can be associated with substantial, lifelong neurologic and otologic morbidity, including hearing loss, facial palsy, disequilibrium, brainstem compression, hydrocephalus, and, in extreme cases, death<sup>##REF##29490553##3##–##REF##29140965##6##</sup>. Recent epidemiologic evidence suggests that the lifetime prevalence of VS is as high as 1 in 500 adults, largely due to incidental detection of asymptomatic tumors, which has increased with increased clinical utilization of computed tomography (CT) and magnetic resonance imaging (MRI)<sup>##REF##30688755##7##</sup>. However, our knowledge of the molecular drivers of VS pathogenesis remains limited.</p>", "<p id=\"Par4\">Loss-of-function mutations in the <italic>NF2</italic> gene are believed to be the central oncogenic event in the development of VS, but it is unknown how this genetic aberration affects downstream pathways, intercellular interactions, and intertumoral heterogeneity in vivo<sup>##REF##16983642##8##–##REF##25893302##10##</sup>. First identified in patients with NF2-related schwannomatosis in the early 1990s, many studies have since sought out the pathways altered by loss of the <italic>NF2</italic> gene product Merlin and have demonstrated its role in a number of known oncogenic pathways in vitro, including Ras/Raf/MEK/ERK<sup>##REF##22886786##11##</sup>, mTORC1/2<sup>##REF##24414536##12##</sup>, Rac/p21-PAK/c-Jun Kinase<sup>##REF##12761036##13##</sup>, PI3K/AKT<sup>##REF##21178801##14##</sup>, and Wnt/β-catenin<sup>##REF##22247700##15##</sup>. However, pre-clinical and early clinical studies of targeted inhibitors of these pathways have shown negative or, at best, modest results in limiting tumor growth<sup>##REF##30615146##16##–##REF##24311643##18##</sup>. Only bevacizumab, an anti-angiogenic agent, has been shown to limit growth in a subset of NF2-related schwannomatosis patients, but not without the risk of significant side effects<sup>##UREF##1##19##</sup>. Given the low burden of genomic alterations in VS, a deeper understanding of the molecular pathogenesis of VS may be advanced through detailed investigation of the transcriptional and epigenetic alterations in these tumors.</p>", "<p id=\"Par5\">Single-cell RNA sequencing (scRNA-seq) enables characterization of the cellular compartments of tumors (e.g., malignant, stromal, immune, etc.), as well as identification of the expression heterogeneity that exists within each of these compartments, both within and across patients<sup>##REF##31689639##20##</sup>. More recently, single cell assay of transposase accessible chromatin sequencing (scATAC-seq) has emerged as a means for epigenetically profiling distinct cellular subpopulations, providing insights into gene regulation and determination of cell fate that complements expression data<sup>##REF##26083756##21##</sup>. However, no study to date has described both the transcriptional and epigenomic profile of the VS TME at single cell resolution, or more broadly, utilized a multi-omic approach to study VS.</p>", "<p id=\"Par6\">In this study, we performed scRNA-seq and scATAC-seq to characterize the expression heterogeneity and epigenetic states of cells comprising the VS TME. Within the SC compartment, we uncovered unexpected heterogeneity of SC phenotypes and found that VS-associated tumor Schwann cells (VS-SC) resemble SCs found in the setting of peripheral nerve injury. A subset of tumors was enriched for repair-like cells and antigen presenting SC (“Injury-like VS”), while other tumors were characterized by low expression of these transcriptional profiles and higher expression of core markers of non-myelinating SC (“nmSC Core VS”). We also found monocytes/macrophages (herein referred to as myeloid cells) to be the most abundant immune cells in the VS TME, with their enrichment being correlated with higher fractions of repair-like and MHC II antigen presenting VS-SCs. Through deconvolution of bulk RNA-seq and expression microarray datasets, we characterized tumors with high and low myeloid cell infiltrate as Injury-like and nmSC Core and found that Injury-like tumors were associated with larger tumor size. Epigenetic analysis of VS-SCs in these distinct tumor states identified regulatory transcription factors that are also expressed in the setting of peripheral nerve injury. Lastly, we explored the interactions between VS-SC and myeloid cells to identify candidate targets that might disrupt these interactions.</p>" ]
[ "<title>Methods</title>", "<title>Human tumor specimens</title>", "<p id=\"Par32\">Patient samples used for scRNA-seq and scATAC-seq were all derived from patients treated at Barnes-Jewish Hospital (St. Louis, MO, USA). All patients provided written informed consent to participate in the study following Institutional Review Board Approval (Protocol #201111001, #201103136, and #201409046). Patient characteristics are summarized in Fig. ##FIG##0##1b## and Supplementary Table ##SUPPL##0##1##. Tumor samples used for bulk RNA-seq analysis consisted of paraffin-embedded tissue from 22 VS patients treated at Baylor College of Medicine (BCM; Houston, TX, USA) (Supplementary Table ##SUPPL##0##5##). All patients provided written informed consent, and tumor tissues were collected under an institutional review board (IRB)-approved protocol at BCM by the Human Tissue Acquisition and Pathology Core (Protocol H-14435). All schwannomas were reviewed by a board-certified neuropathologist according the 2016 WHO guidelines. Raw data from previously published studies were obtained as follows: RNA-seq and expression microarray data that were publicly available were downloaded (GSE39645<sup>##REF##23354516##32##</sup>, GSE141801<sup>##REF##31936793##31##</sup>, GSE108524<sup>##REF##29440379##33##</sup>, EGA00001001886<sup>##REF##27723760##28##</sup>); data from Aaron et al.<sup>##REF##32176142##46##</sup> were kindly shared upon request. Clinical annotations accompanying the sample data from Torres-Marin et al.<sup>##REF##23354516##32##</sup> were also kindly shared upon request.</p>", "<title>Whole exome sequencing and analysis</title>", "<p id=\"Par33\">Whole exome sequencing (WES) was performed by Genome Access Technology Center at the McDonnell Genome Institute (GTAC at MGI, St. Louis, MO). For tumor samples, FFPE tissue scrolls were cut and submitted for sequencing. Germline variants were identified by sequencing DNA extracted from matched whole blood tissue for each tumor. Exome sequencing for SCH1 blood and SCH5 blood/tumor was performed with 100x target coverage using the IDT xGen™ Exome Hyb Panel v1. For all other samples exome sequencing was performed with 200x target coverage using the IDT xGen™ Exome Hyb Panel v2 customized to include probes for all <italic>NF2</italic> exons and all exons and introns of the <italic>SH3PXD2A</italic> and <italic>HTRA1</italic> genes (Supplementary Data ##SUPPL##4##13##). Sequencing data were analyzed using a DRAGEN Bio IT processor using DRAGEN software version 3.10 with a GRCh38 reference genome. Alignments were generated in CRAM format with duplicates marked. Each sample was processed in tumor-normal mode to filter germline variants. Structural variants and small variants were called. Variants that passed all default quality control filters in the exome target region were annotated using ANNOVAR. Normalization for copy number variant calling was performed using a panel of normals for coverage normalization. Copy number segment calls were included if they met the following criteria: CNA quality score &gt; = 5, segment length &gt; = 100,000, number of targets &gt; = 10, and segment mean in the top or bottom tenth percentile for a given tumor (Supplementary Data ##SUPPL##4##5##).</p>", "<title>Fresh tumor dissociation</title>", "<p id=\"Par34\">Fresh samples processed for scRNA-seq and scATAC-seq were collected at the time of surgical resection and immediately processed. Tumor samples were minced and dissociated using the Human Tumor Dissociation Kit (Miltenyi Biotech, Bergisch Gladbach, Germany) per manufacturer guidelines. The dissociated cell suspensions were then passed through 40 µm filter, pelleted through centrifugation, and resuspended in AutoMACS Rinsing Solution with 0.5% bovine serum albumin (BSA; Miltenyi Biotech). Red blood cell lysis was performed on all samples with Gibco ACK Lysing Buffer (ThermoFisher Scientific, Waltham Massachusetts, US) and was followed by debris removal via density gradient when necessary (Debris Removal Solution, Miltenyi Biotech, Bergisch Gladbach, Germany). Cell viability was confirmed to be &gt; 80% using 0.4% Trypan Blue staining (Invitrogen, catalog #T10282) and manual counting with a hemocytometer. For samples in which scATAC-seq was additionally performed, nuclei isolation was performed according to the 10X Demonstrated Protocol “Nuclei Isolation for Single Cell ATAC Sequencing” (Rev D).</p>", "<title>Tumor nuclei isolation for scRNA-seq</title>", "<p id=\"Par35\">Fresh frozen samples used for scRNA-seq were collected at the time of surgical resection and frozen in OCT compound embedding media (Tissue-Tek, Torrance, California) on a pre-chilled aluminum block resting on dry ice, and stored at −80 <sup>o</sup>C. Tissue scrolls were cut at 30 µm using a Cryostat (50–100 scrolls were cut per sample, depending on the tissue size) and maintained at −80 °C until the time of nuclei isolation. Lysis buffer (consisting of Tris-HCl, NaCl, MgCl<sub>2</sub>, Nonidet P40 Substitute, 0.1 M DTT, RNase inhibitor, and nuclease free water) was added to the tissue scrolls, which were homogenized using a Pellet Pestle while on ice. Additional lysis buffer was then added, and the mixture was incubated on ice for 5 min. The suspension was passed through a 70 µm strainer and centrifuged before being washed with a solution of PBS with 1% BSA and 1 U/µl Rnase inhibitor, incubated on ice for 5 min, centrifuged, and resuspended in 1 ml PBS with 1% BSA and 1 U/µl Rnase inhibitor. The nuclei were then labeled with DRAQ5 (Thermo Scientific, catalog #62251) and selected using FACS sorting performed by the Siteman Flow Cytometry Core before being carried forward for single nuclei library creation.</p>", "<title>scRNA-seq library preparation and sequencing</title>", "<p id=\"Par36\">Single cell and single nuclei suspensions were processed using 10X Chromium Next GEM Single Cell 3’ Reagent Kits v3.1 (10X Genomics, Pleasanton, CA) per manufacturer protocols. Briefly, cells were added onto the 10X Next GEM Chip G to form Gel Bead-in-Emulsions (GEMs) in the Chromium instrument followed by cell lysis, barcoding, cDNA amplification, fragmentation, adaptor ligation, and sample indexed library amplification. Completed gene expression libraries were sequenced on Illumina NovaSeq S4 flow cells at a target depth of 50,000 read pairs per cell. Single cell RNA and single nucleus RNA sequencing reads were aligned to human reference GRCh38 v2020-A from 10x Genomics using the 10x Genomics Cellranger-4.0.0 and Cellranger-6.0.0 (include-introns flag set to true) pipelines, respectively. Sequencing quality control metrics are listed in Supplementary Data ##SUPPL##4##14##.</p>", "<title>scATAC-seq library preparation and sequencing</title>", "<p id=\"Par37\">scATAC-seq libraries were prepared using the 10X Chromium Next GEM Single Cell ATAC Reagent Kits v1.1 (10X Genomics) according to the manufacturer’s protocols. In brief, nuclei were incubated in a transposition mixture including a transposase to fragment open chromatin regions. Transposed nuclei were then loaded onto the 10X Next GEM Chip H to generate GEMs, followed by sample indexed library amplification. scATAC-seq libraries were sequenced in Illumina NovaSeq S1 flow cells at a target depth of 250 M total read pairs per sample. The resulting FASTQ files were aligned to GRCh38 v2020-A using the 10x Genomics Cellranger ATAC-1.2.0 count function.</p>", "<title>scRNA-seq data preprocessing</title>", "<p id=\"Par38\">Ambient RNA removal and empty droplet calling was performed using CellBender<sup>##UREF##5##68##</sup>. Samples were processed individually and iteratively with adjustment of the parameters to achieve optimal learning curves and barcode rank plots for each sample. Final parameters used are listed in Supplementary Table ##SUPPL##0##6##. CellBender outputs consisting of counts matrices adjusted for ambient RNA and excluding empty droplets were then preprocessed for doublet calling using Scrublet<sup>##REF##30954476##69##</sup> and ScanPy<sup>##REF##29409532##70##</sup> as follows: a) Cells with &lt; 500 genes were excluded; b) Genes not expressed in at least 0.1% of cells were excluded; c) Percent mitochondrial counts was computed for each cell, Leiden clustering performed, and cells with percent mitochondrial counts greater than 2 standard deviations from their respective cluster mean percent mitochondrial counts were removed. Samples were then processed individually and iteratively, varying the n-neighbors and expected_doublet_rate and choosing the values for each that resulted in a bimodal simulated doublet histogram with a bimodal curve fit <italic>R</italic> &gt; 0.85 and the fraction of the second Gaussian less than or equal to the 99th percentile of the first.</p>", "<p id=\"Par39\">The filtered gene expression matrix was then processed and analyzed by using Seurat v4.0.0<sup>##REF##25867923##71##</sup>. To filter low-quality cells, we first removed cells for which less than 1000 genes were detected or cells that contained greater than 20% of genes from the mitochondrial genome. We included genes with ≥ 5 UMI in at least 10 cells for downstream analysis.</p>", "<title>scATAC-seq data preprocessing and clustering analysis</title>", "<p id=\"Par40\">scATAC-seq preprocessing and analysis was performed using ArchR 1.0.1 as detailed in the ArchR manual<sup>##REF##33633365##72##</sup>. Briefly, nuclei with a TSS &lt; 10 and with &lt; 1000 fragments were excluded. Doublets were identified and removed using the ArchR addDoubletScores and filterDoublets functions with filterRatio = 1.5, DoubletScore ≤ 50. Dimensional reduction was performed using the addIterativeLSI function and default ArchR values of sampleCells = 10000, n.start = 10 and varFeatures = 15000. Next, the addClusters function was used for cell clustering and the addGeneIntegrationMatrix function was used to perform unconstrained cross-platform linkage of scATAC-seq cells with cells from the scRNA-seq atlas without single nucleus samples (Supplementary Data ##SUPPL##4##15##). scATAC-seq clusters were then labeled with a cell identity by creating a confusion matrix between scATAC-seq clusters and cell identities from linked scRNA-seq cells and assigning each cluster the identity of the greatest proportion of linked scRNA-seq cells in that cluster (Supplementary Fig. ##SUPPL##0##2e##).</p>", "<title>Multiple sample integration with reciprocal principal component analysis</title>", "<p id=\"Par41\">To overcome batch effects related to freshly dissociated samples and nuclei isolated from fresh frozen samples, including higher mitochondrial and ribosomal transcripts in the fresh samples and more intronic and long non-coding reads in the frozen nuclei, Seurat’s reciprocal principal component analysis (RPCA) was used to integrate the scRNA-seq datasets<sup>##REF##34062119##73##</sup>. In brief, a SeuratObject was generated for each sample. Each sample was then normalized using Seurat’s ‘NormalizeData’ function. ‘FindVariableFeatures’ was used to identify 3000 variable features in each sample. Integration features were selected using ‘SelectIntegrationFeatures’ (nfeatures = 3000). ‘FindIntegrationAnchors’ was used to perform RPCA integration (by sample) in Seurat. The data was integrated using ‘IntegrateData’ with k-nearest neighbors (k.weight) set to 50; integrated values were returned for all genes in the SeuratObject. The integrated RPCA object was further scaled using ‘ScaleData’ function and was projected on the UMAP with 30 principal components. Graph-based clustering was performed (resolution = 0.5) on the integrated object. Differentially expressed genes were calculated for the clusters of “integrated Assay” on the “RNA Assay” using the ‘FindAllMarkers’ function with only.pos = T (i.e., only for upregulated genes). Only significant (p.adj ≤ 0.05) DEGs were used in further analysis.</p>", "<title>Gene signature scoring and cell type assignments</title>", "<p id=\"Par42\">To corroborate our cell type labels, we used the top 30 differentially expressed genes (DEGs) from each peripheral nerve cell-type cluster as defined by the original authors from each study to score each cell in our VS dataset. The mean score of each signature was calculated for each VS TME cluster using the Seurat AddModuleScore function (Supplementary Fig. ##SUPPL##0##1b##). To assess the consistency of peripheral nerve cell-type scores across studies, we assigned meta-signatures for similarly labeled cell clusters within and across the mouse nerve studies (e.g., “Schwann cells” from Carr et al. and “Nm-SCs” from Yim et al. were assigned the meta-label “Schwann”) and computed the mean score of all cluster scores per meta-signatures (Fig. ##FIG##0##1f##).</p>", "<title>Variant identification in scRNA-seq data</title>", "<p id=\"Par43\">VarTrix v1.1.22 was used to determine whether variants detected in WES analysis were present in scRNA-seq sequencing reads as per the VarTrix documentation. Briefly, for each sample WES variants were queried in all cells included after preprocessing using the VarTrix “coverage” mode, which produces two matrices: one with the number of alternate reads and another with the number of reference reads for each cell for each variant. These matrices were then used to determine which scRNA-seq cells harbored variants detected by WES.</p>", "<title>Inferred copy number alteration analysis</title>", "<p id=\"Par44\">InferCNV (v1.14.0) was used for single cell CNV analysis<sup>##UREF##2##30##</sup>. Using the initial cell type assignments, two reference sets of cells (one for fresh dissociation samples and one for frozen nuclei samples) were created by randomly sampling 600 myeloid cells, 600 non-myeloid immune cells (i.e., T cells, NK cells, etc) and 1200 stromal cells across all fresh dissociation and frozen nuclei samples, respectively. A balanced number of immune and non-immune cells was used to construct the reference set to minimize false positive CNA inferences related to true differences in gene expression (e.g., expression of the MHC complex genes on chromosome 6). Separate references were created to minimize the impact of technique-related batch effects between fresh dissociation and frozen nuclei samples. All VS-SC (nmSC and myeSC) were assumed to be potential tumor cells and therefore not included in the reference sets. Each sample was analyzed separately, with fresh dissociation samples being compared to the fresh dissociation reference and frozen nuclei samples being compared to the frozen nuclei reference. For each sample, all cells not included in the reference were treated as putative tumor cells for the purposes of inferCNV analysis to obtain CNA inferences for all cells in the dataset. Input files for inferCNV analysis were generated as per the inferCNV documentation. The inferCNV run() function was executed for each sample with default parameters with the following exceptions: cutoff = 0.1 (recommended for 10X data by inferCNV documentation), HMM = TRUE, HMM_type = “i3” (use inferCNV’s implementation of Hidden Markov Model-based CNV prediction using a three-state CNV model representing deletion, neutral, and amplification states), analysis_mode = ‘subclusters’ (recommended as ideal by inferCNV documentation), leiden_resolution = 0.001 (adjusted to minimize number of singleton clusters used in HMM predictions), denoise = TRUE. A complete list of all segments predicted to be altered by inferCNV’s HMMi3 implementation is provided in Supplementary Data ##SUPPL##4##4##. Cells with chromosome 22q loss, which were identified based on greater than 50% segmental loss of chromosome 22q, are identified in Supplementary Data ##SUPPL##4##16##.</p>", "<title>Comparison of nmSC and myeSC gene signatures of VS tumor samples to normal nerve</title>", "<p id=\"Par45\">Microarray datasets (GSE141801, GSE108524 and GSE39645) were downloaded using GEOquery’s (v2.58.0) ‘getGEO’ function. Biobase’s (v2.50.0) ‘exprs’ function was used to extract the microarray eSets (expression data from sets) object and log2 normalization was performed. The design matrix for a particular microarray dataset was constructed to compare the type of tissue (i.e., ‘Normal-nerve’ <italic>vs</italic>. ‘schwannoma’) using the ‘model.matrix’ function from stats package (v4.0.3). The eSet object was weighted based on the design matrix and a linear model was fit to the data using limma’s (v3.46.0) ‘arrayWeights’ and ‘lmFit’ functions respectively. ‘makeContrasts’ function from limma was used to extract contrasts between ‘control/normal-nerve’ and ‘tumor/schwannoma’ samples. Empirical Bayes statistics were used for differential expression analysis between normal and tumor samples using limma’s ebayes function. The resulting moderated t-statistics were classified into ‘up’, ‘down’ or ‘no change’ using limma’s ‘decideTests’ function. The scaled eSet matrix was further visualized for top 50 differentially expressed single cell markers from both ‘nmSC’ and ‘myeSC’ cells. ComplexHeatmap (v2.11.1) was used to annotate differential expression and normal-tumor groupings.</p>", "<title>VS-SC, stromal, and NK/T cell analysis</title>", "<p id=\"Par46\">Clusters were extracted from the full scRNA-seq dataset and were renormalized and reclustered using Seurat. The subclusters were corrected/integrated using RPCA, as described above (see Methods: <italic>Multiple sample integration with reciprocal principal component analysis</italic>). Samples with fewer than 40 cells for a given cell type were excluded. Clusters that were presumed residual doublets (e.g., cells expressing <italic>PTPRC</italic> in the Schwann cell subcluster) or low quality cells (i.e., high ribosomal RNA content) were manually removed and the remaining data were reprocessed, as above. Due to batch effects that were apparent at the subcluster level between the freshly dissociated cells and isolated nuclei from frozen tissue, we performed the primary subtype analysis on the freshly dissociated samples, with the fresh frozen samples serving as a validation dataset (Supplementary Fig. ##SUPPL##0##3c##). Gene Ontology Biologic Process Enrichment analysis was performed using the ‘compareCluster’ function from ClusterProfiler (v3.18.1), with the top 25 DEGs of each celltype subclassification, ranked by average Log2FC. VS-SC were scored using the mouse peripheral nerve Schwann cell-specific DEGs as defined by the original study authors’ labels with Seurat’s ‘AddModuleScore’ function.</p>", "<title>Cycling cell analysis</title>", "<p id=\"Par47\">Cells from the scRNA-seq data that clustered by expression of cell cycle markers (“Cycling Cells”, Fig. ##FIG##0##1c##) were subset from the overall dataset and scored by top 30 DEGs of all other broad cell types comprising the VS TME with Seurat’s AddModuleScore function. Cell-type frequencies were scaled to reflect cell numbers of the overall dataset. Chi-square testing was used to compare scaled expected cell-type frequencies with observed cell type frequencies across the entire dataset. Cell cycle phase assignments were made using Seurat’s CellCycleScoring function with Seurat’s included S-phase and G2M phase markers.</p>", "<p id=\"Par48\">FFPE VS specimens from included patients in scRNA-seq analysis were obtained and used to generate a tissue microarray (TMA). The TMA was designed to include four separate 2 mm cores from each FFPE block used for pathologic diagnosis at the time of surgery. Tissue arrays were cut into sections (5 μm) on positively charged slides. For IHC, sections were stained using a Bond RXm autostainer (Leica). Briefly, slides were baked at 65 °C for 4 h and automated software performed dewaxing, rehydration, antigen retrieval, blocking, primary antibody incubation, post primary antibody incubation, detection (DAB) and (RED), and counterstaining using Bond reagents (Leica). Samples were then removed from the machine, dehydrated through ethanols and xylenes, mounted and cover-slipped. Antibodies for Ki67 (Abcam, clone SP6, catalog # ab16667)) and CD45 (Agilent, clone 2B11 + PD7/26, catalogue # M0701)) were diluted 1:200 in Antibody diluent (Leica). Brightfield images of 3-4 high-power field regions (40x) per patient were obtained using a Nikon ECLIPSE Ti2 inverted microscope. Quantification of cell type marker scoring was performed in a semi-quantitative fashion using QuPath-0.3.1. The ‘Positive Cell Detection’ function was used to identify Ki67+ and Ki67- cells using the following parameters: Nucleus Parameters (Requested pixel size 0.5 µm, Background radius 8 µm, Median filter radius 0 µm, Sigma 1.5 µm, Minimum area 10 µm<sup>2</sup>, Maximum area 40 µm<sup>2</sup>), Intensity Parameters (Threshold 0.001, Max background intensity 2), Cell parameters (Cell expansion 0 µm), Intensity threshold parameters (Score compartment “Nucleus: DAB OD Mean”, Single Threshold 1.4976). CD45+ cells were manually annotated. Statistical analysis was performed using a two-sided student’s t-test to compare the means of individual sample means with a significance threshold of <italic>p</italic> &lt; 0.05.</p>", "<title>Classification of VS as injury-like and nmSC core</title>", "<p id=\"Par49\">VS-SC obtained via fresh dissociation were subset and, using the top 50 DEGs of each VS-SC subtype based on average log2FC, scored for each of the identified VS-SC subtypes with Seurat’s ‘AddModuleScore’ function. Individual cell scores were averaged across all cells of a given VS-SC subtype across all samples. Sample scores were scaled and samples were hierarchically clustered based on their scaled scores in an unsupervised manner based on Euclidean distance. The highest branchpoint of the dendrogram was used to divide the cohort into two groups, which we ultimately labeled Injury-like and nmSC Core. Mean scores for each VS-SC subtype were compared between Injury-like and Core using a student’s t-test with correction for multiple hypothesis testing using the BH method with an FDR or 20%.</p>", "<title>Myeloid cell analysis</title>", "<p id=\"Par50\">To identify cell states in Myeloid subcluster, non-negative matrix factorization was applied to each sample to identify meta-programs, as previously described in ref. <sup>##REF##33128048##42##</sup>. The data was first normalized using CPM normalization and was transformed with log2(CPM + 1) transformation. The CPM expression was then centered across each gene by subtracting the average expression of each gene across all cells. All negative values were then transformed to zero. The NMF was computed on the relative expression values with number of factors (K) ranging from 2 to 9. For each value of K, the top 100 genes (with respect to NMF score) were used to define an expression program. For each sample, we selected “robust” expression programs, which were defined as having an overlap of at least 70% (intra_min = 70) with a program obtained from the same sample using a different value of K. We removed “redundant” programs, which were defined as overlapping another program from the same sample by more than 10% (intra_max = 10). The programs were filtered based on their similarity to programs of other samples (inter_filter = True). Only those programs which had an overlap of at least 20% between programs of two samples were considered (inter_min = 20). To identify metaprograms across samples, we compared expression programs by hierarchical clustering, using 100 minus the number of overlapping genes as a distance metric. Eight clusters (i.e., metaprograms) were defined by manual inspection of the hierarchical clustering results. Final metaprogram signatures only included those genes that occurred in 50% of the constitutive programs per cluster. Individual myeloid cells were scored according to these metaprogram signatures using Seurat’s AddModuleScore function, and the cells were assigned to the metaprogram for which they scored most highly. The functional annotation of these metaprograms was done using (1) GO term enrichment (data not shown) and (2) overlap of these metaprogram genes in existing myeloid subtype markers.</p>", "<title>Bulk RNA sequencing, alignment, and preprocessing of human tumor samples</title>", "<p id=\"Par51\">Bulk RNA-sequencing of VS was performed by Tempus, Inc. (Chicago, IL, USA), which entailed sending tumor samples along with saliva for processing according to their protocol<sup>##REF##31040929##74##</sup>. RNA-seq reads were then aligned to the GRCh38 assembly with STAR version 2.7.2b (Parameters:--genomeDir Ensembl_GRCh38.fa --genomeLoad NoSharedMemory --outSAMmapqUnique 60 --outSAMunmapped Within KeepPairs --outFilterIntronMotifs RemoveNoncanonicalUnannotated --outSAMstrandField intronMotif --runThreadN 8 --outStd BAM_Unsorted --outSAMtype BAM Unsorted --alignTranscriptsPerReadNmax 100000 --outFilterMismatchNoverLmax 0.1 --sjdbGTFfile Ensembl_GRCh38_genes.gtf &gt; genome_accepted_hits.bam). Gene counts were derived from the number of uniquely aligned unambiguous reads by Picard version 2.6.0. Sequencing performance was assessed for the total number of aligned reads, total number of uniquely aligned reads, and features detected. All gene counts were then imported into the R (3.2.3). Bioconductor (3.2) package EdgeR and TMM normalization size factors were calculated to adjust for samples for differences in library size. The previously published RNA-seq datasets were aligned and processed in an identical manner.</p>", "<title>Deconvolution analysis of bulk expression data</title>", "<p id=\"Par52\">CIBERSORTx was used to build a custom signature reference from the scRNA-seq dataset and impute cell fractions from each of the RNA-seq and microarray expression datasets on a one-by-one basis to avoid confounding batch effects<sup>##REF##31061481##45##</sup>. Default CIBERSORTx parameters for generation of a scRNA-seq reference matrix were used, except for fraction of cells expressing a given gene, which was set to 0 to avoid overly aggressive filtration of genes for generation of the signature matrix given the sparse nature of 10X Chromium derived data. S-mode was used for batch correction during imputation of cell fractions from mixture (e.g., bulk sequencing) data. Unsupervised hierarchical clustering based on Euclidean distance was performed across all samples for each individual bulk expression dataset, and cohorts were grouped into “Injury-like” and “nmSC Core” Cohorts based on the first dendrogram branchpoint. Samples with available clinical data were split by Injury-like/nmSC Core groups and outcomes of interest were compared across these two groups using a Fisher’s exact test.</p>", "<title>scATAC-seq VS-SC analysis</title>", "<p id=\"Par53\">All VS-SC from the scATAC-seq dataset were subset and assigned an identity of Injury-like or nmSC Core based on the classification of the tumor from which they arose by scRNA-seq analysis. Myelinating SC arose predominantly ( &gt; 90%) from a single nmSC Core sample and were therefore excluded from further analysis. To reduce biasing by outlier cells when comparing the two groups, cells in the top and bottom 5th percentile for number of fragments, TSS enrichment, and reads in TSS were excluded from further analysis. Approximately 750 cells remained in each of the Injury-like and nmSC Core groups after filtration and were analyzed further. Pseudo-bulk replicates were created using the ArchR addGroupCoverages function with minReplicates = 3, minCells = 100, maxCells = 500, and sampleRatio = 0, and peak calling was performed using MACS2 (2.2.7.1) (<ext-link ext-link-type=\"uri\" xlink:href=\"https://pypi.org/project/MACS2/\">https://pypi.org/project/MACS2/</ext-link>) as detailed in the ArchR manual. Per-cell transcription factor motif deviations were added using the addDeviationsMatrix function and motifs annotated using the CIS-BP annotations built in to ArchR. Positive transcription factor regulators were identified using the correlateMatrices function and pairing either the gene score matrix (containing chromosomal accessibility data) or the gene integration matrix (containing gene expression data from linked scRNA-seq cells) with the transcription factor deviations matrix (see ArchR manual for details). Relevant TFs were defined based on default ArchR parameters (correlation &gt; 0.5, adjusted <italic>p</italic> &lt; 0.01 and max delta &gt; 75th percentile of all max deltas).</p>", "<title>Double stain IHC of Injury-like and nmSC Core markers</title>", "<p id=\"Par54\">Double stain IHC was performed for comparison of Injury-like and nmSC Core markers as follows. FFPE blocks from patient tumors were obtained from the Washington University Department of Pathology and were sectioned onto slides at 5 μm. Slides were baked at 60 degrees Celsius for 30 min followed by deparaffinization with xylene and graded ethanol. Antigen Decloaker (Biocare Medical) was used for heat-mediated antigen retrieval for all stains. Blocking was performed with Dual Endogenous Enzyme Block (DEEB, Agilent Dako) for 5 min. The first antibody was applied and incubated for 1 h. First antibodies included MHC II (1:400 dilution, Cell Signaling Technologies, clone LGII-612.4, catalog # 68258), Ngfr (1:100, abcam, clone NGFR/1965, catalog # ab224651), and S100 (1:25, Invitrogen, clone PA1-26313, catalog # PA1-26313). Sections were incubated with HRP Labeled Polymer (Dako) for 30 min followed by DAB staining for 5 min. Blocking was then repeated with DEEB. The second antibody was incubated for 1 h, then 30 min with Rabbit Polymer AP (Dako), and lastly AP Blue substrate for 15 min. Second antibodies included Sox10 (1:100, Cell Signaling Technology, clone E6B6I, catalog # 69661), SMARCC1 (1:800, Cell Signaling Technology, clone D7F8S, catalog # 11956), and CTCF (Cell Signaling Technology, clone D31H2, catalog #3418).</p>", "<title>Ligand-receptor analysis</title>", "<p id=\"Par55\">Cell-cell communication networks were inferred using the standard CellChat inference and analysis of cell-cell communication workflow CellChat (1.5.0)<sup>##REF##33597522##51##</sup>. In brief, the scRNA-seq was divided into two cohorts (Injury-like and Core), each individual dataset then underwent library size normalization followed by log transformation using <italic>Seurat’s</italic> ‘NormalizeData’ function. The CellChatDB curated database of ligand-receptor interactions was used, over-expressed ligand/receptor genes were identified within each broad cell group (e.g., nmSC, fibroblasts, etc.) using the ‘identifyOverExpressedGenes’ function, and then each ligand-receptor interaction were identified using the ‘identifyOverExpressedInteractions’ function. Communication probabilities were calculated for both ligand-receptor pairs and pathway level interactions using the ‘computeCommunProb’ and ‘computeCommunProbPathway’ functions, respectively. The cell-cell communication networks were then summarized using the ‘aggregateNet’ function to determine the number of unique links and overall communication probability. The two communication networks (i.e., Injury-like VS and nmSC Core VS) were compared following the CellChat manual for comparison analysis of multiple datasets. Functions were performed with default parameters unless otherwise stated. Total interactions and interaction strength were determined using the ‘compareInteractions’ function and visualized on a cell-type level as a heatmap using the newVisual_heatmap’ function. Joint manifold learning and classification of the inferred communication networks based on their functional similarity was performed using the ‘computeNetSimilarityPairwise’, ‘netEmbedding’, and ‘netClustering’ functions. Conserved and context-specific signaling pathways for each communication network were compared using the ‘rankNet’ function and a Wilcoxon rank-sum testing was performed with <italic>p</italic> cutoff of 0.05. Cell-type population level signaling was visualized in a heatmap using the ‘netAnalysis_signalingRole_heatmap’ function for those pathways that were most specific to Injury-like tumors (Fig. ##FIG##4##5a##).</p>", "<p id=\"Par56\">Specific interactions between VS-SC and myeloid cells were determined in the following manner. First, we used an extensive, previously described ligand-receptor database to identify potential signaling pairs (NicheNet v1.1.1)<sup>##REF##31819264##75##</sup>. We identified ligands expressed in the VS-SC populations with an average Log2FC of 0.5 and expression in at least 5% of VS-SC and with similarly expressed cognate receptors in the myeloid cells. This list was further refined by only including ligand and associated receptor genes that were differentially expressed by tumors relative to normal nerve controls in the expression microarray datasets, as described above. Lastly, the resulting list was filtered to only include those ligands that were known to be secreted molecules by review of the existing literature. Data visualization performed with ComplexHeatmap (v2.11.1), circlize (v0.4.12), and ggplot2 (v3.3.3).</p>", "<title>Bulk RNA-sequencing of cell lines</title>", "<p id=\"Par57\">HSC cells were obtained from the lab of Dr. Gelareh Zadeh. HSC cells were plated at a density of 10,000 cells per ml of growth media in a 6-well plate and expanded for 2 days prior to RNA extraction. RNA extraction was performed with RNeasy Mini (Qiagen) per manufacturer protocol. Samples were submitted to the GTAC core laboratory at Washington University. Total RNA integrity was determined using Agilent Bioanalyzer or 4200 Tapestation. Library preparation was performed with 500 ng to 1 ug of total RNA. Ribosomal RNA was removed by an RNase-H method using RiboErase kits (Kapa Biosystems). mRNA was then fragmented in reverse transcriptase buffer and heated to 94 degrees for 8 min. mRNA was reverse transcribed to yield cDNA using SuperScript III RT enzyme (Life Technologies, per manufacturer’s instructions) and random hexamers. A second strand reaction was performed to yield ds-cDNA. cDNA was blunt ended, had an A base added to the 3’ ends, and then had Illumina sequencing adapters ligated to the ends. Ligated fragments were then amplified for 12–15 cycles using primers incorporating unique dual index tags. Fragments were sequenced on an Illumina NovaSeq-6000 using paired end reads extending 150 bases. Base calls and demultiplexing were performed with Illumina’s bcl2fastq software and a custom python demultiplexing program with a maximum of one mismatch in the indexing read. RNA-seq reads were then aligned to the Ensembl release 76 primary assembly with STAR version 2.5.1a1. Gene counts were derived from the number of uniquely aligned unambiguous reads by Subread:featureCount version 1.4.6-p52.</p>", "<title>CD14+ monocyte isolation</title>", "<p id=\"Par58\">Peripheral blood mononuclear cells (PBMC) were obtained from leukocyte reduction system cones that are classified as non-human research under the Washington University Human Research Protection Office. PBMCs were isolated using SepMate tubes (StemCell Technologies) and Ficoll-Paque density gradient medium (Fisher Scientific) and immediately cryopreserved in FBS supplemented with 10% DMSO. PBMCs were then thawed and incubated for 12–16 h. Subsequently, CD14+ monocytes were positively selected using anti-CD14-conjugated magnetic microbeads (Miltenyi Biotec, 130-050-201) by applying the cell suspension to two consecutive magnetic columns to maximize purity of the CD14+ fraction.</p>", "<title>Migration assay with conditioned media</title>", "<p id=\"Par59\">Conditioned media (CM) was obtained as follows: HSC cells were plated at a density of 5 × 105 cells/10 cm tissue culture plate in 10 mL of their growth media containing 2.5% FBS. CM was collected at 72 h after plating, centrifuged at 500 x g for 10 min, filtered through a 0.45 µM polyethersulfone (PES) syringe filter (MidSci), and used fresh. Base media (BM) consisted of 10 mL of growth media/10 cm tissue culture plate for each respective line with 2.5% FBS that was placed in an empty tissue culture plate in parallel to the CM plates and processed identically as the CM. The CM was supplemented with protein A purified rabbit IgG (Cell Sciences, CSI20228) as isotype control or rabbit anti-human CSF1 antibody (Cell Sciences, PA0922) at the indicated concentrations. 150 µL of CM or BM was added per well to the bottom chamber of a 96-well transwell plate (5 µm pore polycarbonate membrane, Corning, 3388). Isolated CD14+ monocytes were resuspended in serum free RPMI1640 media (ThermoFisher Scientific) supplemented with protein A purified rabbit IgG (Cell Sciences, CSI20228) or rabbit anti-human CSF1 antibody (Cell Sciences, PA0922) at 0.50 µg/µl. 5 × 10<sup>4</sup> CD14+ monocytes in 100 µl were added to the upper chamber of the transwell plate. Plates were incubated at 37 °C for 24 h. CellTitre-Glo (CTG, Promega) was used to quantify the luminescence in the bottom chamber according to manufacturer protocols. The Biotek Cytation 5 (BioTek, Winooski, VT) was used to measure luminescence. Each condition was performed in technical triplicates, and the experiment was repeated three times to ensure biologic validity.</p>", "<title>Cell proliferation with conditioned media</title>", "<p id=\"Par60\">CellTitre-Glo (CTG, Promega) was used to quantify proliferation according to manufacturer protocols. Isolated CD14+ monocytes were resuspended at 2.5 × 10<sup>4</sup> cells/mL in BM or CM prepared as above except that the media contained 10% FBS. The CM cell suspension was supplemented with protein A purified rabbit IgG (Cell Sciences, CSI20228) as isotype control or rabbit anti-human CSF1 antibody (Cell Sciences, PA0922) at 0.50 µg/µl. 100 μL of the cell suspensions containing 2.5 × 103 CD14+ monocytes were seeded per well in a 96 well tissue culture plate. CTG quantification was performed at 1 h and 48 h after seeding, and luminescence was measured using the Biotek Cytation 5 (BioTek, Winooski, VT). Luminescence values were adjusted based on the average luminescence value for three control wells containing 40 nM adenosine triphosphate (ATP) measured on the same plate for each recording. Each condition was performed in technical triplicates, and the experiment was repeated three times to ensure biologic validity.</p>", "<title>Statistics &amp; reproducibility</title>", "<p id=\"Par61\">Given the exploratory design of our study, aimed at exploring the VS TME and the association of VS-SC states with immune cell populations, no statistical method was used to predetermine sample size and datasets were integrated as they became available. Cell line experiments were performed in technical and biological replicates, as described above.</p>", "<title>Reporting summary</title>", "<p id=\"Par62\">Further information on research design is available in the ##SUPPL##2##Nature Portfolio Reporting Summary## linked to this article.</p>" ]
[ "<title>Results</title>", "<title>Single cell transcriptional and epigenetic profiling identifies cellular diversity across the vestibular schwannoma tumor ecosystem</title>", "<p id=\"Par7\">We performed scRNA-seq transcriptional profiling of 15 sporadic VS (11 freshly dissociated samples and 4 samples from extracted frozen nuclei) with paired scATAC-seq profiling of six tumors to capture a detailed portrait of the human VS tumor ecosystem (Fig. ##FIG##0##1a, b##, Supplementary Table ##SUPPL##0##1##). After correcting for ambient RNA and removing doublets, low quality cells, lowly expressed genes and batch effects (Supplementary Fig. ##SUPPL##0##1a##), we retained 112,728 high quality cells and 9524 genes for downstream transcriptional analysis, and 31,578 cells with a median of 5957 fragments per cell for downstream epigenetic analysis (Fig. ##FIG##0##1c, d##). We also performed whole exome sequencing (WES) on tumor and matched blood tissue for 12 of the 15 scRNA-seq samples with available tumor tissue (Fig. ##FIG##0##1b##, Supplementary Table ##SUPPL##0##2##).</p>", "<p id=\"Par8\">We first assigned cell-type labels to cells within the scRNA-seq dataset using a cluster-based approach. We annotated clusters using differentially expressed genes and visualized them with Uniform Manifold Approximation and Projection (UMAP) (Fig. ##FIG##0##1c##). This analysis revealed five overarching classes of cells: Schwann cells (SC), fibroblasts, vascular (e.g., pericytes and endothelial cells), immune (e.g., myeloid cells, T cells, NK cells, and small populations of mast cells and B cells) and cycling cells. One additional cluster was characterized by expression of epithelial markers (<italic>KRT1, SLPI</italic>) and was almost exclusively derived from one tumor (SCH4). These cells were likely derived from temporal bone mucosa in the surgical field that were incidentally captured during specimen collection and were excluded from further analysis. Among VS-SCs, there were two distinct clusters: One characterized by typical markers of myelinating SCs (myeSC), including <italic>PRX</italic> and <italic>MPZ</italic><sup>##REF##35115729##22##</sup>, and another, larger SC cluster expressing genes associated with VS and a non-myelinating SC identity (nmSC), including <italic>S100B, SOX10</italic>, <italic>NRXN1, SCN7A</italic> with lack of <italic>PRX</italic> expression (Fig. ##FIG##0##1e##, Supplementary Data ##SUPPL##4##1##)<sup>##REF##12007148##23##</sup>. To confirm our cell type classifications, we scored all cells in our data with gene signatures derived from published scRNA-seq peripheral nerve transcriptomic atlases<sup>##REF##35115729##22##,##REF##30503141##24##–##REF##33890853##27##</sup>. We found strong concordance between our cell-type labels and both the individual prior study labels (Supplementary Fig. ##SUPPL##0##1b##, Supplementary Data ##SUPPL##4##2##) as well as the aggregated meta-signature scores for these cell-type signatures (Fig. ##FIG##0##1f##).</p>", "<p id=\"Par9\">Next, we analyzed the six samples with paired scATAC-seq data. After filtering for low quality cells and doublets (Supplementary Fig. ##SUPPL##0##2a–c##), we performed dimensionality reduction (Fig. ##FIG##0##1d##) and an initial cluster-based analysis using marker genes derived from gene accessibility, as was performed with scRNA-seq data (Supplementary Fig. ##SUPPL##0##2d##). Unconstrained pairing of scRNA-seq cells with cells in the scATAC-seq atlas based on shared transcriptional and gene score profiles showed excellent overlap with the a priori scATAC cluster-based assignments (Supplementary Fig. ##SUPPL##0##2e–h##), suggesting that we retained all major VS TME cell-type classes in the scATAC-seq data and allowing us to reliably perform integrative downstream analysis combining transcriptional and epigenetic data on an individual cell basis.</p>", "<title>VS-SC adopt diverse functional states</title>", "<p id=\"Par10\">We next sought to confirm that the VS-SC in our dataset were indeed the neoplastic cells of interest. VS typically have a low tumor mutational burden, with the most common genetic aberrations being <italic>NF2</italic> loss of function mutations and loss of chromosomal arm 22q (chr22q loss)<sup>##REF##27723760##28##</sup>. We first attempted to detect any <italic>NF2</italic> or other somatic variants identified using our WES analysis (Supplementary Table ##SUPPL##0##2## and Supplementary Data ##SUPPL##4##3##) in our scRNA-seq data. No <italic>NF2</italic> variants identified by WES were detected in our scRNA-seq data. Other somatic variants were detected in only 1013 cells out of a possible 97,396 cells (~1%) from samples with WES data available, only 234 of which were SCs (the majority, 582, were myeloid cells). These variant calls likely represent noise from reverse transcription or sequencing errors rather than true somatic mutations. Indeed, several properties of the scRNA-seq technology used in this study present challenges to SNV detection including sparse transcript capture, short reads heavily biased toward the 3’ end of detected transcripts, low coverage, and similar challenges to identifying mutations from bulk RNA sequencing data, such as missing mutations due to alternate splicing or false positive mutation detection due to errors introduced by reverse transcription<sup>##REF##31413257##29##</sup>. We therefore turned our attention to analysis of copy number alterations (CNA) in the single cell data to identify neoplastic cells.</p>", "<p id=\"Par11\">To identify CNA in single cells we used inferCNV to analyze our fresh and frozen data (Fig. ##FIG##1##2a##, Supplementary Fig. ##SUPPL##0##3a##, Supplementary Data ##SUPPL##4##4##) and corroborated these results using CNA analysis of our WES data (Supplementary Fig. ##SUPPL##0##1c##, Supplementary Data ##SUPPL##4##5##)<sup>##UREF##2##30##</sup>. Besides chr22q loss, no other arm-level chromosomal alterations were detected using WES. All three tumors found to have chr22q loss in WES analysis were predicted to have chr22q loss by inferCNV analysis. All nine tumors without chr22q loss in WES analysis were also predicted not to have chr22q loss by inferCNV analysis. Of the three tumors without available tissue for WES, one (SCH2) was predicted to have chr22q loss by inferCNV. At the single cell level, all VS-SCs from samples with predicted chr22 loss were predicted as having chr22 loss, and only seventeen immune/stromal (i.e., non-Schwann) cells were predicted to have chr22 loss, nine of which were from samples without chr22 loss in any VS-SCs (false positives) (Fig. ##FIG##1##2b##, Supplementary Table ##SUPPL##0##3##). Thus, in all samples with chr22q loss detected on the WES level, inferred chr22q loss was also detected specifically in all cells within the VS-SC compartment. Together, these findings suggested that the VS-SCs in our dataset were truly the neoplastic cells of interest.</p>", "<p id=\"Par12\">Next, we obtained publicly available RNA microarray expression datasets that compared gene expression in VS samples relative to control nerves (<italic>n</italic> = 125 tumors and 20 controls; GSE141801<sup>##REF##31936793##31##</sup>, GSE39645<sup>##REF##23354516##32##</sup>, and GSE108524<sup>##REF##29440379##33##</sup>) and compared expression of the top 50 differentially expressed genes (DEGs) defining the nmSC and myeSC clusters between tumors and normal nerves in the microarray data (Fig. ##FIG##1##2c##, Supplementary Fig. ##SUPPL##0##3b##). The gene signature defining VS-nmSC was markedly enriched in tumors relative to normal nerves across all 3 datasets, consistent with prior work suggesting VS-SCs lose their differentiated, myelinating phenotype in favor of a less differentiated, non-myelinating phenotype<sup>##REF##32616891##34##</sup>. Interestingly, there was mixed upregulation and downregulation of VS-myeSC associated genes in tumors relative to normal nerve controls, with a notable decrease in expression of canonical myelination markers (<italic>e.g</italic>., <italic>PRX, MLIP, NFASC, NCMAP, FGFBP2</italic>). The mixed expression pattern of myeSC markers in tumors relative to normal nerve may represent the capture of normal bystander myeSCs or may suggest that VSs harbor a subpopulation of SCs that exist in an intermediate state before losing their myelination phenotype. Overall, this analysis served as further evidence that the VS-SCs in the scRNA-seq data were indeed the neoplastic cells of interest.</p>", "<p id=\"Par13\">Next, we characterized the functional states of the VS SCs both <italic>within</italic> and <italic>across</italic> tumors. We selected the myeSC and nmSC clusters from the full scRNA-seq dataset and reanalyzed them by performing dimensionality reduction and batch correction, revealing ten VS-SC subclusters, which we narrowed down to eight meta-clusters based on transcriptional similarities identified using hierarchical clustering (Supplementary Fig. ##SUPPL##0##3c##), differential expression analysis (Fig. ##FIG##1##2d, e##, Supplemental Data ##SUPPL##4##6##), and gene ontology enrichment analysis for biologic processes (GOBP, Supplementary Fig. ##SUPPL##0##3d##, Supplementary Data ##SUPPL##4##7##). A similar approach was taken to classify VS-SCs from the frozen nuclei dataset (Supplementary Fig. ##SUPPL##0##3c##, ##SUPPL##0##e##), revealing the same transcriptional programs seen in the fresh sample dataset. We characterized the other cell types comprising the VS TME with a similar approach (Supplementary Fig. ##SUPPL##0##4##, Supplementary Data ##SUPPL##4##8## and ##SUPPL##4##9##).</p>", "<p id=\"Par14\">Among the VS-SC clusters, we identified gene signatures associated with myelination (e.g., <italic>PRX, NCMAP</italic>), hypoxia (e.g., <italic>VEGFA</italic>, <italic>HILDPA</italic>), cell stress (e.g., <italic>JUNB, FOSB</italic>), and interferon-response (e.g., <italic>ISG15, IFIT1</italic>). Two clusters of cells expressed core markers of nmSC identity, including <italic>NRXN1</italic>, <italic>SCN7A</italic>, and <italic>NCAM1</italic>, and largely lacked expression of the other VS-SC clusters (“core”). Interestingly, we noted cells enriched for genes associated with MHC class II antigen presentation (e.g., <italic>CD74, HLA-DRB1</italic>), consistent with SCs in the post-nerve injury setting, which are known to upregulate the antigen-presenting machinery to recruit circulating immune cells and promote their proliferation<sup>##REF##28970572##35##</sup>. Furthermore, two clusters had increased expression of <italic>NGFR, RUNX2</italic>, <italic>SPP1</italic>, and <italic>GAP43</italic>, all of which are upregulated in the setting of peripheral nerve injury (“repair-like”)<sup>##REF##8787152##36##–##REF##1531832##39##</sup>. When inspecting cells with and without chr22q loss at the Schwann cell subcluster level, we found that cells with chr22q loss (30.2% of SCs) clustered with cells with balanced chr22q (69.8% of SCs) and shared the same transcriptional metaprograms rather than forming a unique cluster based on chr22q copy number in both the fresh and frozen datasets, suggesting that VS-SC functional states overlap regardless of CNA status (Fig. ##FIG##1##2f##, Supplementary Fig. ##SUPPL##0##3f##, Supplementary Table ##SUPPL##0##4##).</p>", "<p id=\"Par15\">Prior studies of VS have suggested that tumorigenic SCs adopt a de-differentiated, immature SC phenotype, while others have suggested that VS-SCs resemble “repair Schwann cells” in the setting of an acute nerve injury<sup>##REF##16432850##40##</sup>. To better understand the phenotypes of VS-SC, we used transcriptional signatures from murine Schwann cells reported in scRNA-seq analyses of peripheral nerves in multiple contexts, including steady-state adult, early development, and post-injury<sup>##REF##30503141##24##, ##REF##33263277##25##,##REF##33890853##27##</sup>. Scoring the VS-SCs for each of these signatures indicated that VS-SCs most closely resemble SCs after peripheral nerve injury (Fig. ##FIG##1##2g##). Interestingly, VS-SCs scored low for cycling SC markers seen in these settings. Together, these findings suggest that VS-SCs downregulate myelination-associated genes, upregulate gene expression programs that promote nerve repair and immune cell recruitment, and largely remain in a non-proliferative state.</p>", "<title>VS TME immune cells are disproportionately cycling</title>", "<p id=\"Par16\">The observation that VS-SCs do not strongly express markers of proliferation motivated us to return to our analysis of the broader cell type composition of the VS TME, in which we observed a distinct cluster of cells that was driven by cell cycle marker expression (Fig. ##FIG##0##1c##). After assigning these cells to the VS cell type they most closely resembled, we found that VS-SC and stromal cells were underrepresented whereas immune cells were overrepresented in the cycling cell cluster (Chi-squared test, <italic>p</italic> &lt; 0.001; Fig. ##FIG##2##3a##). Next, we turned our attention to all cells across the entire dataset, excluding the cycling cell cluster. We scored each cell type for cell cycle markers and found that immune cells collectively scored higher for both S-Phase and G2M-Phase markers (ANOVA <italic>p</italic> &lt; 0.001; Fig. ##FIG##2##3b##). To validate these observations, we performed immunohistochemical (IHC) staining of the same tumors used for scRNA-seq. We used CD45 to identify immune cells and Ki67 to identify cycling cells (Fig. ##FIG##2##3c##). Consistent with our scRNA-seq analyses, we found that a higher proportion (3.4-fold more) of CD45 positive cells were Ki67 positive than CD45 negative cells (Fig. ##FIG##2##3d##). Together, these findings suggested that immune cells in the VS TME are disproportionately proliferative and therefore may play a vital role in tumor progression.</p>", "<title>VS tumors enriched for nerve injury-related subtypes are associated with increased myeloid cell infiltrate</title>", "<p id=\"Par17\">We next sought to characterize the degree to which VS-SC subtypes varied across samples (i.e., <italic>inter</italic>-tumoral heterogeneity). We assigned subtype scores to each sample by first scoring all VS-SCs for each meta-cluster signature and then taking the mean for each signature. Unsupervised hierarchical clustering of these sample scores revealed two groups of tumors, one enriched for repair-like and MHC II signatures (“Injury-like”) and the other enriched for the core signature (“nmSC Core”) (Fig. ##FIG##3##4a##). These groups differed most by their expression of the repair-like, MHC II, and core programs (Fig. ##FIG##3##4b##; multiple comparisons corrected for with BH method, FDR &lt; 0.2). We confirmed enrichment for repair-like and MHC II VS-SCs in Injury-like tumors by immunohistochemistry (Fig. ##FIG##3##4c##). Interestingly, we found that both the repair-like (<italic>R</italic> = 0.77, <italic>p</italic> &lt; 0.05) and MHC II (<italic>R</italic> = 0.61, <italic>p</italic> &lt; 0.05) scores were associated with an increased fraction of myeloid cells (Fig. ##FIG##3##4d##). In contrast, the core meta-signature scores did not correlate with degree of myeloid infiltrate. These findings suggest that the VS can be broadly divided into two groups – Injury-like VS and nmSC Core VS – based on the composition of their TME.</p>", "<title>VS-associated myeloid cells have properties of tumor-associated macrophages and acute inflammatory cells</title>", "<p id=\"Par18\">Since myeloid cells were the most abundant immune cell type in our dataset and therefore might play a role in the pathogenesis of VS, we sought to better characterize the diversity of their functional phenotypes. Given their lack of discrete states, as has been observed in other scRNA-seq studies of human tumors<sup>##REF##33545035##41##</sup>, we utilized a previously described implementation of non-negative matrix factorization (NMF) to identify gene expression programs that recurred across samples (i.e., “metaprograms”)<sup>##REF##33128048##42##</sup>. Using this approach, we identified 69 distinct gene expression programs across patients, of which eight metaprograms exhibited similar expression across patient samples (Supplementary Fig. ##SUPPL##0##4e, f##, Supplementary Data ##SUPPL##4##10##). Each metaprogram was then annotated according to its functional enrichment. We used gene signatures from recently published pan-cancer and pan-tissue scRNA-seq atlases of myeloid cell phenotypes to evaluate the VS myeloid metaprogram signatures in the context of these integrative resources<sup>##REF##33545035##41##, ##REF##34331874##43##</sup>. As expected, we saw marked overlap between the VS myeloid inflammatory metaprogram and pan-cancer M1 signature, the VS angiogenic metaprogram and pan-cancer angiogenic signatures, and the VS phagocytic metaprogram and pan-cancer phagocytic signatures (Supplementary Fig. ##SUPPL##0##4g##). The pan-cancer M2 signature was less specific, with pan-cancer M2-associated genes expressed across several VS myeloid metaprograms (e.g., phagocytic, angiogenic, migratory, and granulocytic). This is consistent with more recent observations that macrophages take on a variety of transcriptional states in vivo beyond the traditional M1/M2 states<sup>##REF##26681460##44##</sup>. Interestingly, when looking at pan-tissue signatures comparing cancer and inflammatory associated monocytes and macrophages, some VS myeloid cells (e.g., granulocytic, angiogenic, and inflammatory) expressed markers associated with the <italic>inflammatory</italic> monocytic signature while others (e.g., phagocytic, migratory, and oxidative phosphorylation) expressed <italic>cancer</italic> monocyte/macrophage signature genes (Supplementary Fig. ##SUPPL##0##4h##). Our analysis suggests that many VS myeloid cells are monocytic in origin with pro-inflammatory signatures, while other subsets appear to adopt a spectrum of anti-inflammatory phenotypes, including migration, phagocytosis, and angiogenesis.</p>", "<title>Myeloid cell infiltration varies across tumors and is associated with tumor size</title>", "<p id=\"Par19\">To assess the cellular composition of the TME in a larger cohort of patients, we performed deconvolution analysis on VS tumors characterized with bulk transcriptomic approaches (i.e., RNA-seq and expression microarray)<sup>##REF##31061481##45##</sup>. Using our scRNA-seq gene expression data to define a cell-type signature matrix, we performed digital cytometry using CIBERSORTx on a cohort of 22 newly sequenced tumors combined with bulk transcriptomic data (153 tumors) from published reports (Supplementary Data ##SUPPL##4##11##)<sup>##REF##27723760##28##,##REF##31936793##31##–##REF##29440379##33##,##REF##32176142##46##</sup>. Interestingly, we noticed a marked variability in the proportion of immune cells across tumors (Fig. ##FIG##3##4e##). Furthermore, increasing immune cell infiltrate was strongly correlated with the imputed fraction of myeloid cells (<italic>R</italic> = 0.93, <italic>p</italic> = 7.2e<sup>−80</sup>) and only weakly correlated with the fraction of T cells (<italic>R</italic> = 0.26, <italic>p</italic> = 0.00021; Supplementary Fig. ##SUPPL##0##5a##), suggesting that variability in immune cell composition is primarily driven by the fraction of myeloid cells. Inversely, the fraction of nmSC was anti-correlated with the fraction of immune cells (<italic>R</italic> = −0.8, <italic>p</italic> = 1.8e<sup>−46</sup> Supplementary Fig. ##SUPPL##0##5a##).</p>", "<p id=\"Par20\">Next, we performed unsupervised hierarchical clustering of the imputed cell fractions from each cohort of bulk expression samples. We found that each dataset could be classified into two distinct cohorts of tumors. One group was characterized by a lower proportion of nmSCs and high myeloid cell infiltrate, reminiscent of the Injury-like VSs in the scRNA-seq analysis, which we labeled “Injury-like”. The other group was characterized by a predominance of nmSCs and low imputed fractions for all other cell types including macrophages, which we labeled “nmSC Core” (Fig. ##FIG##3##4f##, Supplementary Fig. ##SUPPL##0##5b–f##). We then assessed whether the Injury-like and nmSC Core cohorts were associated with any clinical parameters of interest. Notably, the nmSC Core tumor group was overrepresented in NF2 syndrome-associated tumors (Fig. ##FIG##3##4g##, Fisher’s exact test, <italic>p</italic> = 0.01149). Furthermore, large tumors (≥2 cm in greatest axial dimension or Hannover Scale ≥ 3a) were disproportionately associated with the Injury-like cohort, while small tumors were disproportionately classified as nmSC Core (Fig. ##FIG##3##4g##, Fisher’s exact test, <italic>p</italic> = 0.01361). Comparison of other clinical parameters of interest (prior radiation, hearing loss, tinnitus, vertigo, and tumor consistency) did not reveal any significant associations (data not shown). Thus, across a large cohort of patients, the Injury-like tumor composition is associated with larger tumor size.</p>", "<title>Analysis of chromatin accessibility in Injury-like VS-SC identifies TFs enriched in peripheral nerve injury</title>", "<p id=\"Par21\">Given that Injury-like and nmSC Core VS-SCs differ transcriptionally, we wanted to characterize how these cells might differ epigenetically. We therefore turned our attention to the VS-SCs in the scATAC-seq dataset, which was comprised of three Injury-like and three nmSC Core tumors based on scRNA-seq analysis (Fig. ##FIG##3##4a##). Indeed, after selecting scATAC-seq VS-SCs, and assigning them to either Injury-like or nmSC Core groups based on the tumor from which they were derived, we observed that the Injury-like and nmSC Core cells were distributed differently across UMAP space (Fig. ##FIG##3##4h##). Accordingly, analysis of differentially accessible peaks (DAPs) identified 5616 statistically significant marker peaks with Log2FC ≥ 2 differentiating the two groups of VS-SCs (Supplementary Fig. ##SUPPL##0##6a, b##), further suggesting that these two groups of VS-SCs differ from each other significantly at the epigenetic level. Next, we performed TF motif enrichment analysis on a per-cell level based on accessibility of TF binding sites from CIS-BP. We then identified relevant TFs, defined as TFs with gene expression (either inferred from scATAC-seq data or measured from scRNA-seq data) that is positively correlated with increased accessibility of their motif, for Injury-like and nmSC Core SCs (examples of relevant TFs are shown in Supplementary Fig. ##SUPPL##0##6b##). Because of the correlation between motif accessibility and associated TF expression, these TFs may be most critical to defining cell state. Indeed, we identified several enriched TF motifs with corresponding increased TF expression among Injury-like (e.g., <italic>BACH1</italic>, <italic>SMARCC1</italic>, <italic>FOSL1</italic>, <italic>FOSL2, RUNX2</italic>) and nmSC Core (e.g., <italic>CTCF</italic>, <italic>NFYC</italic>, <italic>KLF7</italic>) SCs (Fig. ##FIG##3##4i##) and confirmed increased expression of <italic>SMARCC1</italic> and <italic>CTCF</italic> by immunohistochemistry in Injury-like and nmSC Core tumors, respectively (Supplementary Fig. ##SUPPL##0##6c##). Interestingly, many Injury-like TFs have been strongly implicated in the normal SC response to nerve injury<sup>##REF##28903050##47##–##REF##27581455##50##</sup>. For example, an increase in both FOSL2 binding motifs and <italic>FOSL2</italic> gene expression have been found in repair SCs<sup>##REF##28903050##47##</sup>, reminiscent of the repair-like expression profile found in Injury-like VS. In contrast, CTCF was found to be critical for SC differentiation into myelinating SCs, the most mature SC state, consistent with the decreased repair-like expression profile in nmSC Core VSs<sup>##REF##32807777##49##</sup>.</p>", "<title>Injury-like VS-SCs secrete ligands that promote myeloid cell migration and proliferation</title>", "<p id=\"Par22\">We next sought to characterize the signaling pathways by which VS tumor cells might communicate with other cell populations in the VS TME in Injury-like and nmSC Core tumors. We first focused on tumor-wide patterns of intercellular communication. We inferred network-wide ligand-receptor interactions using CellChat<sup>##REF##33597522##51##</sup> and found that Injury-like tumors had a higher total number of inferred intercellular interactions and overall higher imputed interaction strength, largely driven by stromal and SC interactions (Supplementary Fig. ##SUPPL##0##7a##, Supplementary Data ##SUPPL##4##12##).</p>", "<p id=\"Par23\">Next, we sought to better understand the specific signaling pathways upregulated and downregulated in Injury-like VSs. Notably, <italic>CCL</italic>, <italic>LIGHT, NECTIN, PERIOSTIN, HGF</italic>, <italic>PTN</italic>¸ and <italic>CSF</italic> signaling pathways had stronger and more abundant interactions in Injury-like tumors (Fig. ##FIG##4##5a##). A relative increase in outgoing <italic>CCL</italic> signals was observed across all cell types in Injury-like tumors except for mast cells and B cells, with endothelial cells being the primary receiver of these signals via <italic>ACKR1</italic> expression (Supplementary Fig. ##SUPPL##0##7b##). <italic>ACKR1</italic> encodes the Duffy antigen receptor, which mediates chemokine transcytosis and enhances leukocyte migration and may therefore promote immune cell recruitment in Injury-like VSs<sup>##REF##19060902##52##</sup>. Interestingly, Injury-like fibroblasts and SCs had increased expression of <italic>HGF</italic> and its receptor, <italic>MET</italic>, respectively. Prior work has established <italic>HGF</italic> as a crucial activator of repair Schwann cells in peripheral nerve injury models, suggesting that this signaling may induce the VS-SC states seen in Injury-like VSs<sup>##REF##29844434##53##</sup>. Lastly, <italic>CSF</italic> signaling distinctly arose from both myeSC and nmSC in Injury-like tumors, with myeloid cells and cycling cells receiving these signals. Both <italic>IL-34</italic> and <italic>CSF1</italic>, which are ligands for <italic>CSF1R</italic>, are known chemotactic factors for circulating monocytes secreted by SCs, and previous work has shown that both <italic>IL-34</italic> and <italic>CSF1</italic> are expressed in VSs, with a weak correlation between tumor growth and <italic>CSF1</italic> levels described<sup>##REF##30580386##54##,##REF##31859421##55##</sup>. These results suggest that <italic>CSF1R</italic> signaling is increased in Injury-like tumors.</p>", "<p id=\"Par24\">Given the abundance of myeloid cells in Injury-like VS, we sought to further characterize VS-SC to myeloid signaling at the cell subtype level. We sought to identify secreted ligands that were 1) strongly expressed by VS-SC in the scRNA-seq data, 2) differentially expressed in tumors relative to healthy nerve controls in the bulk expression data, 3) and had cognate receptors expressed in the VS myeloid cells. Our search identified seven candidate ligands with 10 predicted receptors (Fig. ##FIG##4##5b##). Of note, <italic>IL34</italic> and <italic>CSF1</italic> were highly expressed by repair-like SCs and MHC II SCs, with the cognate receptor <italic>CSF1R</italic> most strongly expressed in migratory myeloid cells. Furthermore, Injury-like VS had significantly higher <italic>CSF1</italic> expression compared to nmSC Core VS (Fig. ##FIG##4##5c##).</p>", "<p id=\"Par25\">We therefore hypothesized that VS-SCs promote myeloid cell migration and proliferation via <italic>CSF1-CSFlR</italic> signaling. To test this hypothesis, we developed a model system using conditioned media from a previously utilized cell line model of schwannoma (immortalized human Schwann cells; HSC) and human CD14+ peripheral blood monocytes<sup>##REF##27723760##28##</sup>. We first performed bulk RNA-sequencing analysis of the HSC line, which showed enrichment for the Hypoxia, Repair-like, and MHC II VS-SC signatures, suggesting that these cells are similar to Injury-like VS-SC (Supplementary Fig. ##SUPPL##0##7c##). We also confirmed that the HSC line expresses 5 of the 7 candidate ligands (Supplementary Fig. ##SUPPL##0##7d##). Intriguingly, we found that conditioned media from the HSC line promoted the migration and proliferation of monocytes in vitro, suggesting that secreted SC factors may influence both processes (Fig. ##FIG##4##5d##). We then tested whether SC-derived CSF1 mediates these effects on monocytes using a CSF1 function blocking antibody. CSF1 inhibition significantly decreased both monocyte proliferation and migration in response to HSC conditioned media (Fig. ##FIG##4##5d##). Together these findings suggest that VS-SCs secrete ligands that recruit monocytes and drive their proliferation, potentially contributing to the growth of VS (see model in Fig. ##FIG##4##5e##).</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par26\">The fundamental factors driving VS tumor progression and unfavorable clinical outcomes remain poorly understood. Consequently, accurate biomarkers to predict growth and effective medical therapies to limit VS growth remain elusive. Our single-cell multi-omic analysis of sporadic VS represents an important step in understanding the <italic>intra-</italic> and <italic>inter-</italic>tumoral heterogeneity underlying their pathogenesis and progression. Recent studies have also profiled sporadic VS with scRNA-seq<sup>##REF##35750260##56##,##REF##36304995##57##</sup>. Similar to these recent reports, we found an unexpected diversity within the SC compartment of these tumors, with loss of the myelinating phenotype and varying degrees of myeloid cell infiltrate being consistent findings across studies. Xu et al. additionally described variability of SC-fibroblast signaling across their cohort of 3 tumors<sup>##REF##35750260##56##</sup>. Yidian et al. also profiled a cohort of 3 patient tumors and used their scRNA-seq dataset to identify potential targets of drug therapy, namely <italic>TGFBR1</italic>, <italic>VISG4</italic>, and <italic>HLA-DPB1</italic><sup>##REF##36304995##57##</sup>. Our work adds to this growing body of knowledge in several important ways. Using transcriptional signatures derived from the peripheral nerves of mice under steady state, post-injury, and developmental conditions, we found that VS-SCs most resemble SCs in the setting of peripheral nerve injury, with subpopulations of VS-SC adopting transcriptional states similar to repair-type SCs. Interestingly, we noted that, in select tumors, enrichment of repair-like VS-SCs correlated with VS-SCs that express the MHC class II antigen presentation machinery. Furthermore, this group of tumors also had disproportionately higher fractions of cells of myeloid lineage (e.g., monocytes and macrophages) comprising the TME. In the setting of peripheral nerve injury, SCs are believed to be the initial recruiters of monocytes and macrophages, which then contribute to breakdown of myelin and recruitment of additional leukocytes<sup>##REF##18803324##58##</sup>. Accordingly, our findings suggest that the TME of Injury-like VSs resembles the cellular microenvironment of a peripheral nerve in the initial days after injury.</p>", "<p id=\"Par27\">In contrast to damaged peripheral nerves, where SCs proliferate along the trajectory of regenerating axons, we observed low proliferative capacity among VS-SCs in our data, which is consistent with the typical slow growth of these lesions<sup>##REF##30983565##59##</sup>. Interestingly, we found that infiltrating immune cells expressed markers of cell cycle progression at a higher rate than VS-SC or VS stromal cells, which suggests that cues within the VS TME promote this immune cell turnover and renewal. In particular, our ligand-receptor analysis and functional in vitro experiments suggest that <italic>CSF1</italic> may be among the key signals driving this proliferation. Our findings are consistent with a prior study of VS tumors with sudden growth, which found that tumor-associated macrophages (TAM) comprised 50–70% of all proliferating cells in situ<sup>##REF##30388263##60##</sup>. Thus, our analysis extends on these findings and converges on the overarching principle that myeloid cell proliferation and infiltration may be key cell biological processes that underlie tumor growth.</p>", "<p id=\"Par28\">In our deconvolution analysis of 175 tumors characterized by bulk expression sequencing, we found that Injury-like tumors were associated with larger tumor size. The variable presence of TAMs in the VS TME has been previously described, but their role in VS pathogenesis and their functional phenotypes have been poorly characterized<sup>##REF##30580386##54##,##REF##30388263##60##,##UREF##3##61##</sup>. For example, increased presence of macrophage markers on histology has been associated with tumor growth, poor post-operative facial nerve outcomes, and poor pre-operative hearing<sup>##REF##30388263##60##,##UREF##4##62##,##REF##23295727##63##</sup>. Other reports have suggested that an inflammatory dimension of VSs may contribute to adverse outcomes in these patients and have served as the basis for ongoing trials evaluating the potential of aspirin to mitigate sudden tumor growth<sup>##REF##27631829##64##</sup>. Interestingly, among this broad cohort of patients, NF2-associated VS tumors were almost exclusively low in macrophage infiltrate. Why these lesions harbor fewer infiltrating immune cells remains an important question, as our cohort of patient samples characterized by scRNA-seq did not include any syndromic NF2 patient tumors. Future work characterizing both sporadic and syndromic VS will help elucidate the differences in microenvironmental cues that promote myeloid cell recruitment in specific tumors.</p>", "<p id=\"Par29\">Given that Injury-like VSs may be associated with worse patient outcomes, we sought to characterize the transcriptional regulation and cell-to-cell signaling of these tumors relative to nmSC Core VSs to identify potential therapeutic targets. We found that VS-SCs from Injury-like and nmSC Core tumors bear different epigenetic profiles. Furthermore, we identified several relevant TFs that not only have accessible motifs in both Injury-like and nmSC Core cells but also demonstrated increased gene expression of the relevant TF in the respective VS-SC groups (e.g., <italic>RUNX1</italic>, <italic>FOSL1</italic>, <italic>FOSL2</italic>, etc.). Regarding cell-to-cell signaling, there were multiple pathways more highly expressed in Injury-like tumors (e.g., CCL, <italic>MIF</italic>, etc.). In particular, <italic>CSF1R</italic> signaling appeared to be specific between VS-SC and myeloid cells and appeared to be enriched in Injury-like tumors. This signaling axis is seen in inflammatory neuropathies, and our results suggest its role may extend to VS tumor progression<sup>##REF##31859421##55##,##REF##33097690##65##</sup>. Our experiments using an in vitro VS model and healthy donor CD14+ monocytes further support the hypothesis that VS-SCs promote monocyte migration and proliferation and suggest an important causal role for CSF1. Taken together, our findings uncover potential pathophysiological mechanisms that may drive tumor growth and require further investigation, including future pre-clinical work to screen regulatory transcription factors and/or receptor-ligand pathways for their effects on tumor behavior.</p>", "<p id=\"Par30\">There are several limitations of this study. Patients in our scRNA-seq cohort were limited to sporadic VS, and our findings pertaining to the TME composition and SC states may not be generalizable to patients with schwannoma of other sites or patients with syndromic NF2-related schwannomatosis. Our patient cohort was also restricted to patients who underwent surgery, and thus we were unable to characterize small, asymptomatic tumors since such lesions are routinely observed radiographically or treated with stereotactic radiosurgery. Additionally, although several recent studies have suggested that glial cell gene signatures are highly conserved across species, there are inherent limitations to our use of murine gene signatures to explore VS-SC phenotypes<sup>##REF##35503034##66##,##REF##36690629##67##</sup>. Lastly, our cell line model lacked expression of <italic>IL34</italic>, which is also a ligand for the receptor <italic>CSF1R</italic>. Future work should more broadly study the clinical relevance of <italic>CSF1R</italic> signaling, both as a predictor of poor outcomes (e.g., hearing loss, rapid tumor growth) as well as its potential targetability.</p>", "<p id=\"Par31\">In summary, our work provides important insights into VS biology as well as a detailed transcriptomic and epigenetic single cell atlas of the Schwann, stromal, and immune cells that comprise the VS TME. Our analysis suggests that VSs can be categorized based on nerve Injury-like VS-SC gene expression programs and associated myeloid cell infiltrate. Furthermore, Injury-like tumors appear to be associated with larger tumor size, and chemokines secreted by VS-SCs may recruit circulating monocytes. These findings uncover previously undescribed mechanisms of pathogenesis and tumor progression in VS and suggest biomarkers and therapeutic targets to be explored in future studies.</p>" ]
[]
[ "<p id=\"Par1\">Vestibular schwannomas (VS) are benign tumors that lead to significant neurologic and otologic morbidity. How VS heterogeneity and the tumor microenvironment (TME) contribute to VS pathogenesis remains poorly understood. In this study, we perform scRNA-seq on 15 VS, with paired scATAC-seq (<italic>n</italic> = 6) and exome sequencing (<italic>n</italic> = 12). We identify diverse Schwann cell (SC), stromal, and immune populations in the VS TME and find that repair-like and MHC-II antigen-presenting SCs are associated with myeloid cell infiltrate, implicating a nerve injury-like process. Deconvolution analysis of RNA-expression data from 175 tumors reveals Injury-like tumors are associated with larger tumor size, and scATAC-seq identifies transcription factors associated with nerve repair SCs from Injury-like tumors. Ligand-receptor analysis and in vitro experiments suggest that Injury-like VS-SCs recruit myeloid cells via CSF1 signaling. Our study indicates that Injury-like SCs may cause tumor growth via myeloid cell recruitment and identifies molecular pathways that may be therapeutically targeted.</p>", "<p id=\"Par2\">Vestibular schwannomas are benign tumours which can lead to neurological symptoms and morbidity. Here, the authors use single cell RNA-seq and ATAC-seq to identify Schwann cell subtypes in the tumour microenvironment which mimic a nerve injury phenotype.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n\n\n\n</p>", "<title>Source data</title>", "<p>\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s41467-023-42762-w.</p>", "<title>Acknowledgements</title>", "<p>We would like to acknowledge: Gelareh Zadeh and her laboratory for providing HSC cell lines, cell culture methods and sequencing data, Zarko Manojlovic for providing bulk RNA sequencing data, Miguel Torres-Martin for providing clinical data, Travis Law for assistance in implementation of scRNA-seq preprocessing methods, and Raleigh Kladney for immunohistochemistry assistance. S.M.K. and R.D.Z.M. contributed equally to this study as co-second authors. Portions of Figs. ##FIG##0##1a## and ##FIG##4##5e## were created with BioRender.com. Funding sources for this project include: NIDCD (T32DC000022) to T.F.B., NIH (5R25NS090978-08) to B.P., K08 CA237732/CA/NCI NIH HHS to S.V.P., Doris Duke Foundation Clinical Scientist Development Award to S.V.P., Barnes Jewish Hospital Foundation to S.V.P. and C.A.B., Barnes Jewish Hospital Foundation Brain Tissue Core and The Christopher Davidson and Knight Family Fund to A.H.K.; and the Duesenberg Research Fund to A.H.K.</p>", "<title>Author contributions</title>", "<p>S.M.K. and R.D.Z.M. were equal co-secondary authors who made substantial contributions to the work. T.F.B. and B.P. performed experiments, data analysis, and manuscript and figure preparation. S.M.K., A.K.Y.Y., and S.P. assisted with data analysis. R.D.Z.M. performed in vitro experiments. T.M. assisted with methods development. G.J.Z., J.A.H., M.R.C., C.C.W., N.D., J.W.O., M.S., A.D.S., A.J.P., and A.H.K. contributed samples and performed manuscript review/editing.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par63\"><italic>Nature Communications</italic> thanks Alain Charest, Lincoln Stein, Nadia Tsankova and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.</p>", "<title>Data availability</title>", "<p>All scRNA-seq, scATAC-seq, and new bulk RNA-seq data is available through the Gene Expression Omnibus with GEO accession “<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE216784\">GSE216784</ext-link>”. All WES data is available through the database of Genotypes and Phenotypes (dbGaP) with accession “<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs003318.v1.p1\">phs003318.v1.p1</ext-link>”. Raw data from previously published studies were obtained as follows: RNA-seq and expression microarray data that were publicly available were downloaded (“<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE39645\">GSE39645</ext-link>”, “<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE141801\">GSE141801</ext-link>”, “<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE108524\">GSE108524</ext-link>”, “<ext-link ext-link-type=\"uri\" xlink:href=\"https://ega-archive.org/studies/EGAS00001001886\">EGAS00001001886</ext-link>”); data from Aaron et al. (Otol Neurotol, 2020) were kindly shared upon request. <xref ref-type=\"sec\" rid=\"Sec42\">Source data</xref> are provided with this paper.</p>", "<title>Code availability</title>", "<p>Data analysis was performed with publicly available packages, as described in the Methods. No custom code was generated in this study.</p>", "<title>Competing interests</title>", "<p id=\"Par64\">Regarding potential conflicts of interest, A.H.K. is a consultant for Monteris Medical and has received non-related research grants from Stryker and Collagen Matrix for study of a dural substitute. C.C.W. is a consultant for Stryker and Cochlear Ltd. C.A.B. is a consultant for Advanced Bionics, Cochlear, Envoy, and IotaMotion, and also has equity interest in Advanced Cochlear Diagnostics L.L.C. The remaining authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>scRNA-seq and scATAC-seq atlas of vestibular schwannoma (VS).</title><p><bold>a</bold> Schematic of study design. <bold>b</bold> Clinical and molecular characteristics of tumors included in scRNA-seq and scATAC-seq datasets. Discrete values for patient characteristics are provided in Supplementary Table ##SUPPL##0##1##. See also Supplementary Fig. ##SUPPL##0##1a## for additional copy number alteration data derived from exome sequencing and Supplementary Table ##SUPPL##0##2## for detailed annotation of <italic>NF2</italic> mutations. WES, whole exome seq; CN, copy number; AAO-HNS Hearing, American Association of Otolaryngology Head and Neck hearing score; EOR, extent of resection; FN, facial nerve. Size, greatest axial dimension in cm. <bold>c</bold> UMAP plot of cell types identified in the VS TME via scRNA-seq analysis. NK, natural killer cells; VSMC, vascular smooth muscle cells; nmSC, non-myelinating Schwann cells; myeSC, myelinating Schwann cells. Colors correspond to clusters identified using Seurat. <bold>d</bold> UMAP plot of cell types identified in the VS TME via scATAC-seq. NK, natural killer cells; VSMC, vascular smooth muscle cells; nmSC, non-myelinating Schwann cells; myeSC, myelinating Schwann cells. Colors correspond to clusters identified using ArchR. <bold>e</bold> Dot plot of expression levels of selected marker genes (x-axis) for each VS cell subpopulation depicted in <bold>c</bold> (y-axis). <bold>f</bold> Heatmap of meta-signature scores from gene signatures of previously published mouse peripheral nerve studies (see also Supplementary Fig. ##SUPPL##0##1b##). Source data are provided as a Source Data file.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>VS-SC have heterogeneous transcriptional profiles.</title><p><bold>a</bold> InferCNV residual gene expression heatmap of VS-SC from freshly dissociated samples showing decreased expression of genes on chromosome 22q (chr22q), indicative of chr22q loss, in VS-SC from three tumors (SCH1, SCH2, SCH13). See also Supplementary Fig. ##SUPPL##0##3a## for a heatmap of VS-SC from frozen samples which were analyzed independently. Rows represent cells and columns represent genes arranged by chromosomal position. <bold>b</bold> UMAP demonstrating cells with inferred chr22q loss are only present in the nmSC and myeSC clusters. <bold>c</bold> Heatmaps comparing expression of top 50 differentially expressed genes (DEGs) in nmSC (top) and myeSC (bottom) to expression observed in microarray data of normal nerve and VS tumors from Gugel et al. (GSE141801). See also Supplementary Fig. ##SUPPL##0##3b##. <bold>d</bold> Heatmap of expression of DEGs from each SC meta-cluster. Two hundred randomly sampled cells from each meta-cluster are displayed. <bold>e</bold> UMAP representation of VS Schwann cells subset from the scRNA-seq data with meta-clusters labeled. See also Supplementary Fig. ##SUPPL##0##3e## for a similar UMAP representation of frozen sample VS-SC subclusters. <bold>f</bold> UMAP plot of scRNA-seq VS-SC highlighting cells with inferred chr22q loss. Cells with chr22q loss do not form a discrete cluster but instead cluster with cells without chr22q loss that share the same metaprogram. See also Supplementary Fig. ##SUPPL##0##3e## for a similar UMAP plot for frozen sample Schwann cells. <bold>g</bold> Heatmap depicting scoring of each VS-SC cluster using signatures from murine adult normal nerve, adult injured nerve and developing nerve scRNA-seq atlases. Source data are provided as a Source Data file.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Immune cells are disproportionately cycling in the VS TME.</title><p><bold>a</bold> Cycling cells (Fig. ##FIG##0##1c##) were scored based on gene signatures of all other cell types in the VS TME (e.g., nmSC, T cells, etc.) and assigned to the cell type for which they scored highest. Frequencies of each cell type observed in this cluster were compared to expected rates. <bold>b</bold> Violin plots of G2M and S-phase scores for Schwann, stromal, and immune cells. <bold>c</bold> Double-stain IHC of representative high-power field (HPF) from VS tumor FFPE samples. Cycling cells are labeled Ki67 and immune cells are labeled with CD45. Arrowhead indicates a representative CD45-Ki67+ cell. Arrows indicate representative CD45 + Ki67+ cells (scale bar = 50 μm). <bold>d</bold> Barplot showing the fraction of CD45+ (red) and CD45- (green) cells that are Ki67+ within available samples (left) and averaged across all samples (right). Error bars on left show standard error for quantification of each group across 3–6 HPF. Error bars on the right represent standard error of mean measurements across samples (<italic>n</italic> = 9 samples). Two-sided t-test was used for comparison. Source data are provided as a Source Data file.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>Injury-like VS tumors are associated with increased myeloid cell infiltrate.</title><p><bold>a</bold> Heatmap displaying results of hierarchical clustering of VS-SC subtype mean signature scores shows two distinct groups of tumors (“Injury-like” and “nmSC Core”). <bold>b</bold> Box-and-whisker plot comparing mean scores of repair-like, MHC II, and Core signatures in Injury-like (<italic>n</italic> = 6) and nmSC Core (<italic>n</italic> = 5) tumors (groups defined in <bold>a</bold>.) Two-sided t-testing was performed with correction for multiple comparisons via BH method with FDR of 0.2. Center lines of the boxplots reflect the mean, upper and lower borders reflect the 75th and 25th percentiles, respectively, whiskers are the highest and lowest points at most 1.5 times the inter-quartile range from the hinge, and outliers are represented as dots. See the Source Data file for exact values. <bold>c</bold> Double-stain IHC images show VS classified as Injury-like have enriched staining for Ngfr (Repair-like SC) and MHC II (MHC II SC), while these markers are largely absent from tumors classified as nmSC Core. Sox10 (blue) labels tumor cells. DAB stains Ngfr (left column) and MHC II (right column). Scale bar = 100 μm. Four HPFs were evaluated from each available patient sample. <bold>d</bold> Scatterplots with Pearson linear regression demonstrate strong correlation of mean repair-like (left) and MHC II (right) scores with fraction of myeloid cells across samples. Error bands represent 95% confidence interval of the linear model. There was no correction for multiple comparisons. <bold>e</bold> Barplot of imputed cell-type fractions from 175 VS tumors shows high variability in degree of myeloid cell composition. Only fractions of immune cells are displayed. <bold>f</bold> Representative heatmap demonstrating classification of our cohort of 22 VS tumors into Injury-like and nmSC Core categories based on hierarchical clustering of imputed cell fractions. Remaining results shown in Supplementary Fig. ##SUPPL##0##5b–f##. <bold>g</bold> Bar plots showing number of tumor samples classified as Injury-like or nmSC Core and clinically classified by size (<italic>n</italic> = 122) and NF2-syndrome status (<italic>n</italic> = 89). Two-sided Fischer’s exact test used for comparison. <bold>h</bold> UMAP of all VS-SC from the scATAC-seq dataset with cells colored based on the type of VS, Injury-like (red) and nmSC Core (blue), from which they arose as determined by clustering in (A). <bold>i</bold> Scatter plot depicting transcription factor (TF) motif deviation delta between Injury-like and nmSC Core VS-SC and correlation to gene expression (left) and gene score based on accessibility (right). Relevant TFs (correlation &gt; 0.5, adjusted <italic>p</italic> &lt; 0.01 and max delta &gt; 75th percentile of all max deltas) are labeled and colored. Source data are provided as a Source Data file.</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><title>Ligand-receptor interactions in the VS-TME distinguish Injury-like from nmSC Core tumors, and promote myeloid cell proliferation and migration.</title><p><bold>a</bold> Bar plot showing the relative information flow of select signaling pathways. Pathway names in red are enriched in Injury-like VS and those in blue are enriched in Core VS. Information flow is defined as the sum of communication probability among all pairs of cell groups in each inferred network. See Supplementary Data ##SUPPL##4##9##. <bold>b</bold> Heatmap showing relative expression of VS-SC ligands (left) with receptors expressed on myeloid cells (right). <bold>c</bold> Box-and-whisker plots showing the mean log-normalized expression of candidate ligands in VS-SC from Fig. 5b. CSF1 expression is higher in Injury-like VS (two-sided t-test, multiple testing correction with Benjamini Hochberg Method and FDR of 20%. Inury-like (<italic>n</italic> = 6) and nmSC Core (<italic>n</italic> = 5) groups defined in (<bold>a</bold>). Center lines of the boxplots reflect the mean, upper and lower borders reflect the 75th and 25th percentiles, respectively, whiskers are the highest and lowest points at most 1.5 times the inter-quartile range from the hinge, and outliers are represented as dots. See the Source Data file for exact values. <bold>d</bold> Bar plots showing relative proliferation (left) and transwell migration (right) of CD14+ monocytes from healthy donors in Basal Media (BM), HSC Conditioned Media (CM), CM with isotype IgG control, and CM with anti-CSF1. Each bar represents the normalized mean of all technical replicates (<italic>n</italic> = 3 per assay) across biological replicates (<italic>n</italic> = 3) and error bars are SEM. <bold>e</bold> Model of Injury-like VS. VS-SC undergo a critical stressor that triggers subpopulations to adopt repair-like and antigen presenting states. Myeloid cells are recruited to the VS TME and proliferate locally, leading to tumor progression. Source data are provided as a Source Data file.</p></caption></fig>" ]
[]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM5\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM6\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Thomas F. Barrett, Bhuvic Patel.</p></fn><fn><p>These authors jointly supervised this work: Allegra A. Petti, Sidharth V. Puram, Albert H. Kim.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41467_2023_42762_Fig1_HTML\" id=\"d32e542\"/>", "<graphic xlink:href=\"41467_2023_42762_Fig2_HTML\" id=\"d32e711\"/>", "<graphic xlink:href=\"41467_2023_42762_Fig3_HTML\" id=\"d32e916\"/>", "<graphic xlink:href=\"41467_2023_42762_Fig4_HTML\" id=\"d32e1006\"/>", "<graphic xlink:href=\"41467_2023_42762_Fig5_HTML\" id=\"d32e1336\"/>" ]
[ "<media xlink:href=\"41467_2023_42762_MOESM1_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>", "<media xlink:href=\"41467_2023_42762_MOESM2_ESM.pdf\"><caption><p>Peer Review File</p></caption></media>", "<media xlink:href=\"41467_2023_42762_MOESM3_ESM.pdf\"><caption><p>Reporting Summary</p></caption></media>", "<media xlink:href=\"41467_2023_42762_MOESM4_ESM.pdf\"><caption><p>Description of Additional Supplementary Files</p></caption></media>", "<media xlink:href=\"41467_2023_42762_MOESM5_ESM.xlsx\"><caption><p>Supplementary Data 1-16</p></caption></media>", "<media xlink:href=\"41467_2023_42762_MOESM6_ESM.xlsx\"><caption><p>Source Data</p></caption></media>" ]
[{"label": ["4."], "surname": ["Yang"], "given-names": ["I"], "article-title": ["A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma: Clinical article"], "source": ["JNS"], "year": ["2010"], "volume": ["112"], "fpage": ["851"], "lpage": ["859"], "pub-id": ["10.3171/2009.8.JNS0985"]}, {"label": ["19."], "surname": ["Plotkin"], "given-names": ["SR"], "article-title": ["Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma"], "source": ["JCO"], "year": ["2019"], "volume": ["37"], "fpage": ["3446"], "lpage": ["3454"], "pub-id": ["10.1200/JCO.19.01367"]}, {"label": ["30."], "mixed-citation": ["inferCNV of the Trinity CTAT Project. "], "ext-link": ["https://github.com/broadinstitute/inferCNV"]}, {"label": ["61."], "mixed-citation": ["Breun, M. et al. CXCR4: A new player in vestibular schwannoma pathogenesis. "], "italic": ["Oncotarget"], "bold": ["9"]}, {"label": ["62."], "surname": ["Hannan"], "given-names": ["CJ"], "article-title": ["The inflammatory microenvironment in vestibular schwannoma"], "source": ["Neuro-Oncol. Adv."], "year": ["2020"], "volume": ["2"], "fpage": ["vdaa023"], "pub-id": ["10.1093/noajnl/vdaa023"]}, {"label": ["68."], "mixed-citation": ["Fleming, S. J. et al. "], "italic": ["Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender"]}]
{ "acronym": [], "definition": [] }
75
CC BY
no
2024-01-14 23:40:17
Nat Commun. 2024 Jan 12; 15:478
oa_package/e6/48/PMC10786875.tar.gz
PMC10786876
38216747
[ "<title>Introduction</title>", "<p id=\"Par3\">Invasive alien species pose a major global problem, profoundly impacting natural and anthropized ecosystems. Ants have emerged as especially damaging<sup>##UREF##0##1##,##REF##33545436##2##</sup>. Over 200 ant species have established populations beyond their native ranges<sup>##UREF##0##1##,##UREF##1##3##</sup>. Of these, 19 are listed in the IUCN’s database of invasive species, with five species ranking among the “100 worst invasive alien species”<sup>##UREF##2##4##</sup>. The economic cost of invasions is staggering, estimated at 52,000,000,000 US dollars<sup>##UREF##3##5##</sup>, affecting agricultural production, causing infrastructure damage, disrupting electrical equipment, and potentially acting as a disease vector in hospitals<sup>##UREF##0##1##,##UREF##4##6##–##UREF##6##9##</sup>. However, their ecological effects may be even more profound<sup>##UREF##7##10##</sup>.</p>", "<p id=\"Par4\">Invasive ants strongly displace native ant communities<sup>##UREF##8##11##</sup>, cascading up trophic levels and affecting native vertebrates, including birds, reptiles, and amphibians<sup>##REF##32812277##12##–##UREF##10##14##</sup>. These invasions disrupt ecosystem functions by altering trophic web dynamics, modifying nutrient cycling, and diminishing pollination services<sup>##UREF##11##15##–##REF##12604772##17##</sup>. Improving our understanding of invasive ants, and addressing the challenges posed by them, should thus be a priority for conservation efforts. This is doubly true, considering that around two thirds of eradication attempts have failed<sup>##UREF##13##18##,##UREF##14##19##</sup>.</p>", "<p id=\"Par5\">Among invasive ant species, <italic>Linepithema humile</italic> (the Argentine ant) stands out as a particularly notable invader (see <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.issg.org/database\">http://www.issg.org/database</ext-link>), especially in Europe, where it is the most important invasive ant<sup>##UREF##15##20##,##REF##22776029##21##</sup>. Originally native to South America, it has been introduced globally<sup>##REF##11158600##22##</sup>. Although initially recognized as an urban pest<sup>##UREF##16##23##</sup>, the Argentine ant’s adverse impacts extend well beyond urban settings and permeate natural and agricultural systems<sup>##UREF##17##24##–##UREF##19##26##</sup>. In invaded natural areas, the Argentine ant can profoundly impact native fauna, leading to disruptions in essential ecological processes such as seed dispersal<sup>##UREF##20##27##,##UREF##21##28##</sup> and pollination<sup>##UREF##22##29##,##UREF##23##30##</sup>, thereby exerting negative effects on native biodiversity. Their unicolonial population structure allows a high population density, and therefore efficient resource utilization. Argentine ants thus gain a competitive advantage over other ant species<sup>##UREF##24##31##,##REF##28307114##32##</sup>, leading to displacement of native ants, disruption of invertebrates, and even adverse effects on vertebrates<sup>##REF##11158600##22##,##UREF##25##33##–##REF##17877449##35##</sup>. In agricultural systems, Argentine ants are associated with outbreaks of phloem-feeding hemipterans, affecting the growth and productivity of host plants<sup>##UREF##17##24##,##UREF##26##36##</sup> and disruption of the activity of the natural enemies of these agricultural pests<sup>##UREF##27##37##</sup>.</p>", "<p id=\"Par6\">Traditionally, control methods for Argentine ants have relied on contact insecticides acting as barriers, which only offer partial suppression and have limited efficacy against the queens and brood sheltered within the nests<sup>##UREF##28##38##</sup>. Furthermore, the rapid degradation of chemical barriers necessitates frequent reapplications<sup>##UREF##29##39##</sup>. By contrast, toxic baits have several advantages: They are less ecologically damaging, since they require smaller amounts of insecticide and thus minimize unwanted effects<sup>##UREF##30##40##</sup>. Locating the nests is not necessary, since the ants locate the bait, return it to the nest, and distribute it to the rest of the colony, including the queens. As invasive ant species commonly show mass recruitment, they often monopolize resources, which in the case of toxic baits minimizes impact on non-target species<sup>##UREF##31##41##,##UREF##32##42##</sup>.</p>", "<p id=\"Par7\">Thus, modern control methods predominantly rely on toxic baits, with liquid sucrose baits being especially attractive to this species<sup>##UREF##33##43##,##UREF##34##44##</sup>. However, in spite of impressive technological innovations, such as the development of hydrogel beads to broadly deploy liquid baits<sup>##UREF##32##42##,##UREF##35##45##–##UREF##38##48##</sup>, eliminating established populations of Argentine ants has proven challenging, with only limited success reported<sup>##UREF##31##41##</sup>. In field studies, baits often fail to control Argentine ants for more than 60 days, and there is often a resurgence of ant populations thereafter, or reinvasion after treatment by ants from nearby untreated areas<sup>##UREF##31##41##</sup>.</p>", "<p id=\"Par8\">The effectiveness of toxic baits depends heavily on the attractiveness of the bait to foraging ants so as to ensure sufficient, sustained consumption<sup>##UREF##33##43##,##UREF##39##49##–##UREF##41##51##</sup>. However, the acceptance of toxic baits by ants may be influenced by changes in the availability of alternative natural food sources<sup>##REF##17877449##35##,##UREF##31##41##,##UREF##42##52##,##UREF##43##53##</sup>. Therefore, the acceptance of a toxic bait observed in a specific situation may not necessarily reflect its acceptance in other scenarios<sup>##UREF##44##54##</sup> or the effectiveness when used in a control program. Formulating toxicants into consistently acceptable baits has proven to be one of the most challenging aspects of invasive ant control<sup>##UREF##33##43##,##UREF##41##51##,##UREF##45##55##</sup>.</p>", "<p id=\"Par9\">While much research effort has been devoted to developing attractive and effective baits, there is a paucity of studies examining the potential behavioural mechanisms ants may use to evade toxic baits. This may be an important oversight. Ants are known to deploy a variety of behavioural strategies for avoiding dangerous substances and situations. For example, ants, including <italic>Linepithema</italic> ants, abandon foraging paths or food resources when phorid parasitoid flies are present and tend to avoid areas or times of the day frequented by these flies<sup>##UREF##46##56##–##REF##28307922##58##</sup>. Likewise, ants begin to avoid paths associated with mortality risk, while continuing to forage in safe areas<sup>##UREF##48##59##,##UREF##49##60##</sup>. Leaf-cutter ants quickly learn to avoid leaves bearing fungicides which damage their fungal gardens<sup>##UREF##50##61##,##UREF##51##62##</sup>. Dangerous substances, such as sticky surfaces, may be covered with dirt and debris, to make the areas safe<sup>##REF##33247536##63##,##UREF##52##64##</sup>, and ants avoid moving into nests which contain conspecific corpses<sup>##REF##17148163##65##</sup>. Indeed, ants display a wide variety of social immunity behaviours to avoid disease. Spore-laden pupae are disinfected, or if too infected, destroyed<sup>##REF##29310753##66##</sup>. When ants detect a pathogen in the environment, they modify the interaction network of the colony so as to isolate foragers from the critical queens<sup>##REF##30467168##67##</sup>.</p>", "<p id=\"Par10\">Here we ask: do invasive ants possess behavioural mechanisms, potentially similar to social immunity behaviours, which allow them to evade toxic baits? Specifically—can ants abandon otherwise palatable toxic bait?</p>" ]
[ "<title>Methods</title>", "<title>Sampling area and times</title>", "<p id=\"Par43\">The experiments were carried out on the campus of the University of Buenos Aires. This area is heavily infested by <italic>Linepithema humile</italic>, with many active trunk trails. The experiments were conducted during the warmer months of December – April 2021, 2022 and 2023, when ants are most active and many trunk trails can be located around the perimeter of buildings.</p>", "<title>Solution and toxicant</title>", "<p id=\"Par44\">A 20% (w/w) sucrose solution was used, as this is well accepted by ants and is the most commonly used bait for this species<sup>##REF##17877449##35##,##UREF##71##93##,##UREF##79##102##</sup>. The toxic bait was prepared by adding 3% w/w boric acid (Biopack) to the sucrose solution. Boric acid was chosen because Argentine ants respond well to this bait<sup>##UREF##44##54##,##UREF##80##103##</sup>. Additionally, it causes delayed mortality, which is critical for effective control<sup>##UREF##45##55##</sup>. The solutions were made with table sugar and tap water. We employed a relatively high concentration of boric acid, exceeding the recommended levels<sup>##UREF##70##92##</sup>. This decision was based on preliminary tests that demonstrated its acceptance on trunk trails. Additionally, we aimed to expedite the abandonment dynamics.</p>", "<title>Palatability test</title>", "<p id=\"Par45\">First, we needed to confirm that the toxic bait to use in the experiments is palatable to this ant species under field conditions, to differentiate a potential abandonment effect from unpalatability. Previous laboratory studies on individual ants under controlled conditions showed that boric acid baits are palatable for the Argentine ants<sup>##UREF##44##54##,##UREF##80##103##</sup>. The palatability test evaluates the immediate response of the ant upon encountering the bait. Responses to toxic bait (20% sucrose + 3% boric acid), 20% sucrose solution, and, in order to visualize effective rejections a negative control of 20% sucrose and saturated quinine (c. 0.26 g/L) solution were evaluated. For that, a 1cm<sup>2</sup> piece of plastic sheet with a drop of the solution to be tested was placed next to a highly active <italic>L. humile</italic> trunk trail. The response of the ants that touched the drop with their antennae or mouthparts was recorded for a minute. If they remained drinking (mandibles in contact with solution) for more than 4 consecutive seconds after contacting the drop, this was considered an acceptance. By contrast, if the ant quickly withdrew, this was considered a rejection<sup>##UREF##56##71##</sup>. This methodology enables us to promptly assess the instant and spontaneous responses of ants in the field without disturbing their trails.</p>", "<title>Experiment overview and general experimental design</title>", "<p id=\"Par46\">We ran two field experiments (1 and 2) in this study:<list list-type=\"order\"><list-item><p id=\"Par47\">Day-wise dynamics and spatial extent of trail abandonment</p></list-item><list-item><p id=\"Par48\">Hour-wise dynamics of trail abandonment</p></list-item></list></p>", "<p id=\"Par49\">Both experiments involve first offering trunk trails of the ant <italic>L. humile</italic> an unadulterated sucrose solution via a bridge to a set of feeders. This resulted in a new foraging trail leading from the trunk trail to the feeders. After some time (depending on the experiment) feeders were replaced with a palatable toxic bait (sucrose solution containing boric acid). We define <italic>Trunk trails</italic> as long paths with high ant activity which tend to persist over months or even years. We define <italic>Foraging trails</italic> as newly established paths that branch off from trunk trails towards a food source we provide (bridges; see Fig. ##FIG##4##5##)<sup>##REF##23967129##104##</sup>. Only trunk trails at least 12 m long and with bi-directional traffic of more than 100 ants / minute, measured by counting ants crossing a fixed point on the trail, were used in the experiments.</p>", "<p id=\"Par50\">Foraging trails were established by providing a food source (20% w/w sucrose in 4 cotton-plugged 9 ml tubes, henceforth: feeder tubes) on a foraging platform (8 × 5.5 cm) at the end of a bridge (Fig. ##FIG##4##5##). The bridges were made using light wooden slats (300 mm long, 10 mm wide, 5 mm thick). Each bridge was composed of two slats (30 cm each, 60 in total), one horizontal, and one articulated, angling downwards to allow access from the trunk trail. The bridge was raised on vertical posts (c. 25 cm high) surrounded by a water-and-detergent moat, to ensure that access to the platform was exclusively via the bridge entrance. The bridge was covered with painters’ tape which was replaced when starting each experiment and replicate.</p>", "<p id=\"Par51\">Bridges were positioned in pre-established locations, contacting a point on a trunk trail so that the bridge entrance abutted an active trunk trail (Fig. ##FIG##4##5##). Feeder tubes were renewed at the beginning and at the end of each day of the experiments. Nonetheless, occasionally in the morning the sucrose tubes were empty.</p>", "<title>Initiation of foraging</title>", "<p id=\"Par52\">To stimulate the ants to climb the bridge and begin foraging, a plastic sheet (2×7 cm) with drops of 20% w/w sucrose was placed beside the trunk trail, directly beside the bridge entrance. Once filled with foraging ants, the sheets were carefully placed on the foraging arena. This caused the ants, after feeding, to descend from the bridge through the ramp, depositing pheromone and initiating a foraging trail on the bridges. During this phase, the feeder tubes were blocked.</p>", "<title>Data collection</title>", "<p id=\"Par53\">the main variable measured was <italic>ant activity</italic>, defined as the average number of ants crossing the measurement point over one minute. For the bridges, we counted the ants toward the foraging arena over 3 min, and on the trunk trail we counted ants in both directions for a minute. Before every activity measurement, we also recorded substrate temperature using a laser thermometer.</p>", "<p id=\"Par54\">To demonstrate that any observed reduction in ant activity on the bridge was not caused by sugar satiation, we simultaneous offered a second bridge and feeder setup (Sucrose bridge) on the same trunk as the treatment setup (Toxicant bridge), with identical sham manipulations, offering unadulterated sucrose solution. For an overview of the experimental procedure, see Fig. ##FIG##5##6##.</p>", "<p id=\"Par55\">To determine if trail abandonment is determined by population decline, activity on the trunk trail was measured at the two points where the bridges contacted it (and at other points in Experiment 1).</p>", "<title>Experiment 1: Day-wise dynamics and spatial extent of trail abandonment</title>", "<p id=\"Par56\">The aim of this experiment was to experimentally demonstrate that ants respond to the toxic bait presence by abandoning the foraging trail, to describe spatial scale of this abandonment, and its temporal dynamics at a time scale of days.</p>", "<p id=\"Par57\">This experiment began in the afternoon, to coincide with the time of increasing foraging activity (R. Josens and D. Zanola, pers. obs.). Two points on a trunk trail separated from each other by at least 7 meters were chosen, and a bridge was placed at each point. During the foraging initiation phase, activity on both bridges was measured. Adjusting the amount of sucrose solution offered allowed us to balance foraging activity on both bridges, except in one highly active replicate, where equalizing activity in both bridges was not possible.</p>", "<p id=\"Par58\">One hour later (at 3 pm), the initial activity or <italic>baseline</italic> (time 0) on both bridges was recorded. Immediately after this measurement the main feeder tubes were unblocked. One bridge offered unadulterated sucrose (sucrose bridge), the other toxicant-laced sucrose (toxicant bridge). An hour later, three measurements were taken over a ~2-h period, (in fact 125 min) at one-hour intervals (4, 5, and 6 p.m.) to obtain the ant activity of this afternoon by averaging these values. Over the next two days, we recorded activity over 2-h periods in the morning (9–11 a.m.) and in the afternoon (4–6 p.m.). This provided a mean activity measurement for afternoon day 1, morning day 2, afternoon day 2, etc. (times 1, 2, 3, etc. in Fig. ##FIG##5##6##).</p>", "<p id=\"Par59\">To determine if abandonment is limited to the foraging trail or if it also affects overall trunk trail activity, we also measured trunk trail activity during this experiment at different distances around the toxicant bridge (every meter up to 4 meters on either side). This allowed us to determine the spatial extent of the foraging decline and also to characterize its temporal dynamics.</p>", "<p id=\"Par60\">Measurements on the trunk trail were also taken one day before placing the bridges (afternoon, day 0) and in the morning before placing the bridges (morning, day 1). The average of these measurements constitutes the <italic>baseline activity</italic> for the trunk trail (Time 0 in Fig. ##FIG##1##2##). Trunk trail activity was then measured at the same times as the foraging trail measurements (Times 1, 2, 3, etc. See Experiment 1 in Fig. ##FIG##1##2##).</p>", "<p id=\"Par61\">This experiment was replicated 5 times on 5 different trunk trails.</p>", "<title>Experiment 2: Hour-wise dynamics of trail abandonment</title>", "<p id=\"Par62\">Results from experiment 1 indicated that trail abandonment occurs rapidly, within 18 h of access to toxic bait. The aim of experiment 2 was to define the dynamics of abandonment at a higher temporal resolution. The methods were identical to experiment 1, with two differences. Firstly, after the activity initiation phase there was a <italic>foraging increase phase</italic> of two days, in order to generate a higher initial activity by offering sucrose solutions in both bridges over a longer time. Secondly, activity measurements were taken every hour, the baseline at 9 am with both bridges offering sucrose solutions, changing the feeder tubes immediately thereafter: plain sucrose on the <italic>sucrose bridge</italic>, and toxicant-laced sucrose in the <italic>toxicant bridge</italic>. One hour later, measurements began, at 10 am (time 1), and continued hourly until 5 pm (time 8) (see Fig. ##FIG##1##2##, Experiment 2). In light of the results of the trunk path in experiment 1, measurements of trunk trail activity were only performed at 2 places and only at 3 times: Trunk trail activity was recorded at 9 am, 1 pm, and 5 pm (day 2 and day 3) (Fig. ##FIG##1##2##). Activity on the trunk trail was measured adjacent to the bridges´ locations.</p>", "<p id=\"Par63\">This experiment was replicated 6 times on 6 different trunk trails.</p>", "<title>Assessing mortality</title>", "<p id=\"Par64\">Finally, in order to assess whether the reduction observed in the field could have been due to rapid mortality caused by ingestion of the toxic bait, we conducted a laboratory test. We evaluate individual ants from three laboratory nests of <italic>L. humile</italic> after depriving them of carbohydrates for 48 h. We placed 5 worker ants in 5 cm diameter plastic containers with fluon-coated walls. Half of the groups received a droplet of sugar solution on a small plastic sheet, while the other half received the boric acid bait, prepared in the same manner as in the field trials. We left the drop for 10 minutes, verifying that all ants ingested the solution. Then, the sheet with the drop was carefully removed. From there, we let an hour pass and then counted the number of dead ants every hour for 6 hours.</p>", "<title>Statistics and reproducibility</title>", "<p id=\"Par65\">For experiments 1 and 2, we recorded the activity of ants at different time points: 1) mornings and afternoons over several days and 2) hourly on the foraging trails (bridges) and at various locations along the trunk trail. We focused only on a few key time points and locations along the trunk trail for statistical analyses (repeated measures design). We used GLMMs for the analysis of all experiments data. In all cases the response variable was Ant activity, measured as the average ants crossing a line per minute. For the bridges, only traffic in the direction of the foraging arena was counted; for the trunk trail both directions were included. Homoscedasticity assumption was assessed using a standardized residuals vs predicted values plot (Supplementary Fig. ##SUPPL##0##S1##, ##SUPPL##0##S5##, ##SUPPL##0##S7##, ##SUPPL##0##S9##, ##SUPPL##0##S13##). The best-fitting distribution for the data was determined by the dispersion index (the ratio between the residuals and the predicted variance), which was found to be the negative binomial distribution in all cases. Pairwise comparisons of activity were conducted using the emmeans package<sup>##UREF##81##105##</sup> (Supplementary Fig. ##SUPPL##0##S2##, ##SUPPL##0##S3##, ##SUPPL##0##S6##, ##SUPPL##0##S8##, ##SUPPL##0##S10##, ##SUPPL##0##S11##, ##SUPPL##0##S14##). P value adjustment was applied by using dunnettx method. Statistical analyses were performed in R Studio using the glmmTMB, nlme, and multcomp packages<sup>##UREF##82##106##–##UREF##84##108##</sup>.</p>", "<p id=\"Par66\">A detailed description of the statistical analysis approach taken and the entire code and statistical output are provided in the ##SUPPL##0##Supplementary Material##. In short, for all analyses we compare the number of ants on sucrose and toxicant bridges at various time points after provision of the toxic bait to the number of ants present just before toxic bait provision (which we consider the baselines).</p>", "<title>Reporting summary</title>", "<p id=\"Par67\">Further information on research design is available in the ##SUPPL##1##Nature Portfolio Reporting Summary## linked to this article.</p>" ]
[ "<title>Results</title>", "<title>Palatability test</title>", "<p id=\"Par11\">We assessed the palatability of the harmful food, (hereafter referred to as ‘toxic bait’) for our upcoming trials, specifically evaluating whether ants drink it. We presented individual drops of sucrose solution (positive control), sucrose solution containing our toxicant (3% boric acid), and sucrose solution with c. 0.26 g/L quinine (a distasteful substance which is expected to be rejected, as a negative control) at different locations alongside <italic>Linepithema humile</italic> trunk trails.</p>", "<p id=\"Par12\">Almost all ants that touched the drop of sucrose solution with their antenna fed on it (98.4% ±0.6, mean ±s.e.). In total 399 ants over 19 drops were tested. A similar result was obtained with boric acid-sucrose solution (toxic bait) (97.8% ± 1.2), based on 167 ants over 9 drops. However, the sucrose-quinine solution was accepted by only 15.7% (±6.6) of the ants that touched the drop (from 206 ants over 9 drops). Therefore, we can confirm that this toxic bait is palatable for this species under the natural conditions of our study.</p>", "<title>Experiment 1: Day-wise dynamics and spatial extent of trail abandonment</title>", "<p id=\"Par13\">To investigate whether ants employ a behavioural strategy of abandoning foraging trails in response to toxic baits, we established two new foraging trails by installing two bridges, both initially offering sucrose solution. Once foraging was established, and foraging activity equalized between the two foraging trails, we recorded the ants’ activity at this point as a baseline measurement (referred to as ‘time 0’). Immediately after baseline recording, we introduced permanent feeders, one containing the same sucrose solution and the other containing sucrose with added toxicant (toxic bait). We monitored activity levels on both the toxicant and sucrose bridges, as well as at various points along the trunk trail both in the afternoon (averaging three recordings at 4 pm, 5 pm, and 6 pm) and the morning (averaging three recordings at 9 am, 10 am, and 11 am) over a four-day period (referred to as ‘time 1’ through ‘time 6’). For example, time 1 encompassed the average activity recorded one, two, and three hours after the access of the final feeders. (For a schematic timeline of the experiment, see Methods).</p>", "<title>Foraging trail</title>", "<p id=\"Par14\">Both bridges initially showed similar activity levels when offering sucrose drops (baseline at time 0: estimate = -0.07; p = 0.79). There is a clear interaction effect between the solution offered on the bridge and time (from time 2 to 6) (see ##SUPPL##0##Supplementary Material##). Activity begins to diverge between both bridges within the first 3 hours after the feeders were opened (time 1: estimate = -0.62; p = 0.026), with a slight tendency to increase in the sucrose bridge and to decrease in the toxicant bridge. Starting from the next morning (time 2), this difference in activity between the two bridges becomes much more pronounced, and persists throughout the following days (see Fig. ##FIG##0##1## and ##SUPPL##0##Supplementary Material##).</p>", "<p id=\"Par15\">For the toxicant bridge, over the 1- to 3-h interval after the toxic bait tubes were made available (time 1), activity did not differ from the baseline activity of that bridge (time 0 vs. 1, estimate= 0.34; p = 0.647). In the subsequent period, time 2, corresponding to the next morning (i.e., 18 to 20 h after bait availability), activity on the toxicant bridge significantly decreased compared to its initial activity (time 0 vs. 2, estimate=1.4; <italic>p</italic> = 0.004). The activity on this bridge remained at low levels, with slight fluctuations, all significantly different from its baseline (Fig. ##FIG##0##1##, red).</p>", "<p id=\"Par16\">By contrast, for the sucrose bridge, activity at times 1 and 2 did not differ from its initial level. Then, the activity increased slightly and remained high throughout the experiment, with fluctuations that were mostly not significantly different from their baseline (Fig. ##FIG##0##1##, blue).</p>", "<p id=\"Par17\">The reduction in foraging activity observed at the toxicant bridge occurred within the first 18 hours of access to toxic bait. The mean activity recorded at this time was 12.4 ants per min, which represents 24.5% of the mean baseline. In other words, at time 2 the activity is 75.5% lower than its mean baseline, and remained at these levels with minimal variation (73% to 88%) throughout the duration of the experiment.</p>", "<p id=\"Par18\">As activity at the sucrose bridge never drops, we can exclude satiate or a reduction in foraging motivation as explanation of the decrease in the toxicant bridge.</p>", "<p id=\"Par19\">Considering that activity on the toxicant bridge was lower than baseline by time 2 but not by time 1, we wondered whether any trend within the time range encompassing time 1 could be observed—remember that time 1 is composed of three measurements, one hour apart. When analyzing each of these 3 h separately to determine if they differ from the baseline (time 0), we observe that there is no difference from the baseline during the first two hours of bait consumption. However, after 3 h of bait consumption, a trend emerges, showing a marginally significant decrease in activity (15hs-18hs: estimate= 0.61; <italic>p</italic> = 0.057). As expected, during this period, the sucrose bridge, which offers sucrose, exhibits activity very similar to its baseline (Supplementary Fig. ##SUPPL##0##S4##).</p>", "<title>Trunk trail</title>", "<p id=\"Par20\">To study activity dynamics on the trunk trail, activity was measured at different locations: the toxicant bridge site (0 m), the sucrose bridge site (~7 m from the toxicant bridge), and 2 m and 4 m on each side of the toxicant bridge site (averaging left and right at each of both distances).</p>", "<p id=\"Par21\">There is an interaction effect between sites (at least one) and time (see ##SUPPL##0##Supplementary Material##). Figure ##FIG##1##2## shows that at time 1 (between 1 and 3 h after the feeders were made available on the bridges), the activity of the trunk trail did not vary at any site compared to the baseline activity of each site. This baseline activity refers to the activity at time 0, which was prior to the placement of the bridges.</p>", "<p id=\"Par22\">At time 2 (which corresponds to the morning of day 2), activity also did not differ at any location along the trunk trail. At time 3 (corresponds to the following afternoon, day 2, approximately 25 to 27 h after the feeders were opened on the bridges), activity began to significantly decrease only at the toxicant bridge site (0 m; time 0 vs time 3: estimate= 0.37; <italic>p</italic> = 0.048. Fig. ##FIG##1##2##), and marginally significant within a 2 m radius (2 m; time 0 vs. time 3: estimate= 0.34; <italic>p</italic> = 0.067). Activity remained similar to the corresponding baselines beyond 2 meters of the toxicant bridge site at that time. The situation remained similar in time 4. The low activity persisted at the toxicant bridge site and 2 m, resulting in significant or marginal differences from baseline thereafter. Only from time 5 onwards (49 to 51 h of foraging on the toxic bait) did the decrease in activity became significant beyond 2 m (4 m; time 0 vs. time 5: estimate= 0.36; <italic>p</italic> = 0.042).</p>", "<p id=\"Par23\">Finally, at time 6 (morning day 4), activity showed higher significant differences in the area around the toxicant bridge, extending up to 4 m on both sides (4 m; time 0 vs. time 6: estimate= 0.43; <italic>p</italic> = 0.013).</p>", "<p id=\"Par24\">In contrast, activity on the trunk trail at the sucrose bridge site did not vary at any time relative to the baseline. It is worth noting that this bridge is located on the same trunk trail, over 7 meters away from toxicant bridge (see also ##SUPPL##0##Supplementary Materal##).</p>", "<p id=\"Par25\">Also important is that while activity directly on the toxicant bridges significantly decreased by time 2 (Fig. ##FIG##0##1##), activity on the trunk trail in the vicinity of these bridges (toxicant bridge and 2 m) remained unchanged at that time, and only began to exhibit a slight decrease starting from time 3 (Fig. ##FIG##1##2##). This demonstrates that the approximately 75% decline in the toxicant bridge activity at time 2 cannot be attributed to a decrease in the ant population. While activity on the toxic bait decreased by around 80% after 6 h, activity on the trunk trail ultimately decreased by a maximum of 43%, and did so only by the end of the study, 3 days after the toxic bait was presented. Indeed, at more distant locations (4 m from the toxicant bridge), activity only began to decrease at time 5, half way through day 2. This demonstrates a progressive abandonment that initially starts at very close proximity to the bait and gradually expands outwards, involving the trunk trail.</p>", "<title>Experiment 2: Hour-wise dynamics of trail abandonment</title>", "<p id=\"Par26\">Experiment 1 revealed that abandonment of foraging trails at the toxicant bridge had already occurred 18 hours after the toxic bait became available. In this experiment, we examined abandonment dynamics in a similar manner but with higher temporal resolution during the first day, recording ant activity on both bridges (sucrose and toxicant) every hour (time 1 to time 8). Here, again the initial measurement was with both bridges offering sucrose solution (time 0 = baseline).</p>", "<title>Foraging trail</title>", "<p id=\"Par27\">There is a strong interaction between the solution offered on the bridge (toxicant or sucrose) and time (from time 2 to time 8) (see ##SUPPL##0##Supplementary Materal##). Ant activity on the bridge offering the toxic bait began to show a significant decrease after 3 hours of foraging on the bait (time 0 vs. time 3: estimate=0.56; <italic>p</italic> = 0.04. Fig. ##FIG##2##3##), with a 43% reduction relative to its baseline activity. This reduction increased, becoming more strongly significant over the next two hours, reaching 58% after 4 h and 70% after 5 h. Thereafter, this reduction in activity remained essentially constant, reaching 79% by hour 6 and remaining at 80% for the next two hours measured. Such a reduction in foraging activity never occurred in the sucrose bridge, located on the same trunk trail about 7 meters away. On the contrary, activity on the sucrose bridge tended to increase and remained high throughout the experiment, with fluctuations that were occasionally marginally significantly higher from the baseline activity of that bridge (Fig. ##FIG##2##3##). Again, this demonstrates that the ants were not satiated, not killed, and continued actively foraging throughout the experiment.</p>", "<p id=\"Par28\">Six hours after toxic bait presentation, an approximately 80% reduction in ant activity on the toxicant bridge was achieved, and this reduction was maintained until the end of the experiment. This value is close to the percentage of reduction of Experiment 1, even though in Experiment 2 the initial activity was much higher than in Experiment 1, achieved by offering sugar for a whole day prior to the experiment. To provide a visual representation of this, Fig. ##FIG##3##4## integrates the activity data from both experiments on the two bridges. The activity change is expressed as the percentage change obtained from the average activity for each timepoint with respect to the average activity of its baseline. Thus, the baseline is always zero, values close to zero mean that the activity was similar to its baseline, positive values indicate an increase in activity, and negative values indicate a decrease in activity.</p>", "<title>Mortality assay</title>", "<p id=\"Par29\">To test whether the 80% reduction in activity at the toxic bait bridge may be a result of mortality, we conducted a laboratory test. This involved offering the same toxic bait or sucrose solution to groups of 5 ants from a nest starved for 48 h and assessing their mortality every hour for 6 h.</p>", "<p id=\"Par30\">Twenty-four groups, each composed of 5 ants, were given a sucrose solution, while another 24 groups were provided with the toxic bait (resulting in 120 ants per treatment). At the end of the experiment, nearly all ants survived during the 6-hour measurement period (see Fig. ##SUPPL##0##S15##). All the control ants remained alive and only 7 ants that had consumed the toxic bait had died after the six hours of the experiment, which represents 5.8% of the total.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par31\">We demonstrated that the presence of a toxic bait led to active abandonment of the foraging trail. This abandonment was highly spatially localized and began approximately 3 h after bait placement, resulting in a 70-80% decrease in activity on the bridge after 6 hours. Regardless of the initial population of foraging ants, the percentage decrease was consistent and persisted for several days. Activity remained high on the control sucrose bridge, indicating that the abandonment was not due to satiety or lack of motivation to forage. The trunk trail adjacent to the toxic bridge initially maintained similar activity levels, thus excluding population decline as an explanation. The abandonment gradually spread to the trunk trail but only in the vicinity of the toxic bait, not extending to areas located approximately more than 5 meters away where the sucrose bridge was placed for the period studied. The observed decrease in activity on the toxicant bridge and within the trunk trail cannot be attributed to a population decline, as the employed toxicant does not induce mortality at such a rapid rate. Taken together, these results unequivocally demonstrate a targeted behavioural abandonment of a toxic bait by this invasive ant.</p>", "<p id=\"Par32\">The percentage reduction we report is consistent with what is frequently mentioned in the literature when evaluating the efficacy of bait treatments in various settings, such as urban areas, orchards, and vineyards: mean from week 2 to 11 = 79.4%<sup>##UREF##53##68##</sup>, 80% reduction after 8-10 weeks<sup>##UREF##54##69##</sup>, 78% of average reduction<sup>##UREF##31##41##</sup>; 85% reduction at day 1, averaging 81% during the 1st week<sup>##UREF##35##45##</sup>. Klotz et al. (1998) reported that, after toxicant deployment inside a building, ant foraging activity had been redirected to the outside<sup>##UREF##54##69##</sup>. Ant populations around the buildings treated with boric acid bait showed a continuous reduction over the duration of the test, reaching 81% around the treated buildings. Nevertheless, the typical interpretation accompanying a decline in ant presence attributes it solely to the mortality induced by the bait. This interpretation can be ruled out in our study. Note that we do not claim that baits did not kill ants in the other studies mentioned above. It is likely that both mortality and abandonment contribute to the reductions observed in those studies, making it challenging to determine the relative roles of each factor.</p>", "<p id=\"Par33\">Similarly, Boser et al.<sup>##UREF##55##70##</sup> examined the control of Argentine ants using sucrose-solution with thiamethoxam (0.006%) soaked hydrogel beads, and reported a gradual reduction of ants beginning 2 hours after bait placement, with a significant reduction by 6 h post-treatment. These authors report that traffic reduction at that time reached 78% - remarkably similar to the 79% reduction 6 h post-treatment we report. It is particularly noteworthy that in the Boser et al. study a different toxicant was used, yielding similar outcomes in both the percentage reduction in activity and the timeframes within which these reductions were achieved. This suggests that the observed effects are not solely attributable to the specific chemical compound employed but rather stem from the introduction of harmful food to the colony.</p>", "<p id=\"Par34\">In our long-term experiment (exp 1), we observed a gradual expansion of abandonment along the trunk trail. After 4 days of toxic bait presentation, the decrease in activity extended up to 4 meters on either side of the toxicant bridge. This suggests that as long as a small percentage of ants continue to forage on the bait, the area abandoned will continue to increase over time. Counterintuitively, the decrease in trunk trail activity only occurred around the toxicant bridge, while remaining unchanged some meters to either side. How can that be, if the ants must pass by the bridge to reach the other side? In several trials, we observed that a secondary path had formed, deviating from the trunk trail and re-joining it a couple of meters after passing the point of contact with the toxicant bridge. A similar behaviour has been reported in carpenter ants, which bypassed a toxic bait by modifying the path of their trail, forming a semicircle about 30 cm away from the bait<sup>##UREF##56##71##</sup>. It is worth noting that in that study, a small volume (5 ml) of toxic bait was offered, whereas in our current study, our feeder provided about 36 ml of toxic bait. We propose that the volume of toxic bait accessible, the capacity for simultaneous access by ants, and the resultant rate of toxicant ingress into the colony collectively influence the scale and dynamics of abandonment, coupled with the area it encompasses. This could also explain the slight variations in dynamics between experiments 1 and 2. In experiment 2, both the toxicant bridge and trunk trail showed a more rapid decline in traffic (Fig. ##FIG##1##2## and Supplementary Fig. ##SUPPL##0##S12##), possibly due to the higher number of ants foraging on the bait.</p>", "<p id=\"Par35\">Abandonment of food sources or foraging trails in response to parasitoids has already been described in different ant species<sup>##UREF##46##56##–##REF##28307922##58##</sup>. Ant colonies change their foraging patterns in response to worker loss or to avoid aggressive competitors<sup>##UREF##57##72##</sup>. However, in these cases, the risk is due to natural enemies, suggesting that rapid detection and behavioural responses could have been shaped by co-evolution. In contrast, the harm caused by a palatable toxic bait may only begin well after consumption, although it is unclear how rapidly malaise begins. Somehow, the ants must associate the bait with its negative consequence, either directly or indirectly. Further research is required to clarify both the mechanism by which harm is detected and connected with a location, and the mechanism by which abandonment is triggered. It seems likely that detection of harm involves conditioned taste aversion, due to malaise caused by the toxicant. Conditioned taste aversion has been reported widely in vertebrates in response to malaise, and in several invertebrates<sup>##REF##14396377##73##–##REF##22539738##78##</sup>, but not found in others<sup>##UREF##60##79##</sup>. Such aversions can form even when the resultant malaise only occurs many hours post-ingestion<sup>##UREF##61##80##,##UREF##62##81##</sup>. Another potential abandonment mechanism is the association between the corpses of ants that died from the toxic bait, acting as a negative stimulus, and cues from the bait itself. This effect has been shown in lab experiments with Argentine ants<sup>##UREF##63##82##</sup>. However, it is unlikely that this explains the abandonment in the current study as boric acid is considered to have a delayed toxicity<sup>##UREF##44##54##,##UREF##45##55##</sup>, while we observed a decrease in activity on the bridge after only 3-4 hours.</p>", "<p id=\"Par36\">We cannot attribute the initial 80% reduction in traffic to mortality. Most studies on mortality are conducted over a span of days, and those involving boric acid consistently report mortality rates below 55% within 24 hours after bait ingestion (delayed toxicity)<sup>##UREF##44##54##,##UREF##45##55##</sup>. In contrast, our field data revealed an 80% reduction in activity on the toxicant bridge within a 6-hour timeframe. Hence, it is unlikely that the reduction observed is solely a result of mortality. Nevertheless, in an effort to validate this claim and considering the absence of available literature regarding boric acid mortality within the initial 6-hour post-ingestion period, we conducted a straightforward laboratory test. Remarkably, even without nestmates to receive crop unloading and thus dilute the toxic bait among individuals, most ants which fed to satiation on toxic bait remained alive after 6 hours. Thus, it appears highly improbable that the 80% initial reduction in the toxic bait bridge can be attributed to ant mortality.</p>", "<p id=\"Par37\"><italic>L. humile</italic> has been described as having a high fidelity to well-established trails<sup>##UREF##64##83##,##UREF##65##84##</sup>. However, contrary to typical ant behaviour characterized by resource fidelity, our observations in this study showed a distinct pattern. While some ant species display a strong fidelity for stable food sources, often ignoring alternative food sources, we found that <italic>L. humile</italic> ants readily engaged with both sucrose solution and toxic bait, rapidly establishing new foraging trails. They also fully accepted the drops offered in the palatability test. These behaviours challenge the notion that the ants’ reluctance to return to the toxicant bridge is solely due to fidelity to other food sources.</p>", "<p id=\"Par38\">An interesting situation that is related to our results is the finding that leafcutter ants exhibit a delayed avoidance response to leaves that damage the fungus they cultivate. Specifically, once the ants realize that the collected plant material is detrimental to the fungus, they learn to associate its scent (and probably additional plant cues) with harm and cease collecting that resource for several weeks, even if it no longer contains the fungus-damaging compound<sup>##UREF##51##62##</sup>. In laboratory colonies, the tendency to this rejection starts 6 h and becomes significant from 10 h after incorporation of treated leaves into the fungus garden<sup>##UREF##66##85##</sup>. In the field the rejection was evaluated and observed at 24 and 48 h, so no information is available with more temporal resolution<sup>##UREF##50##61##</sup>. Interesting, the item rejection last for 17 weeks.</p>", "<p id=\"Par39\">As the term ‘avoidance learning’ typically refers to a particular resource being rejected based on previous experience, and is often triggered by the resource’s odour, we introduce the broader term; “abandonment”. Abandonment refers to a reduction in the overall ant presence within the area where the danger was located, while being neutral about the mechanism involved. It is likely that some sort of learning process is involved, wherein food-related cues are associated with harm in some way—potentially via malaise and a subsequent avoidance of the most recent feeding area. In addition, it seems likely that some sort of communication is involved, amplifying avoidance beyond only the ants which directly fed on the bait. Ants might modulate activity on the trail towards a harmful food through the use of pheromones, for example by employing a negative chemical mark<sup>##REF##16306981##86##</sup> or by varying the balance of different pheromones to locally discourage exploration<sup>##REF##19617426##87##</sup>. Again, however, the mechanisms behind this are not clear. Further investigation of the underlying mechanisms of this complex and highly adaptive behaviour will be critical to fully understanding, and perhaps, overcome it.</p>", "<p id=\"Par40\">The rapid active abandonment of toxic baits we observed has large implications for ant control, and for toxicological research. In terms of concrete implications for control or eradication programs, maximizing bait consumption within the first two hours of discovery is key. It is essential to maximize the toxicant’s entry into the nests within the narrow timeframe between bait placement and ants recognizing its effects. This may be achieved by placing baits densely across an area and using bait stations that ensure unlimited simultaneous access for the ants. Using behaviour-modulating molecules to manipulate decision-making and enhance recruitment or quicker return to the feeder could be beneficial. For instance, synthetic pheromones added to bait stations may be helpful<sup>##UREF##67##88##</sup>; this has also been shown to be effective when added to toxic sprays<sup>##UREF##36##46##,##UREF##68##89##</sup>. The use of substances such as ketanserin, which increases toxic bait consumption<sup>##REF##34584123##90##</sup>, or caffeine, which improves memory formation<sup>##UREF##69##91##</sup>, have been explored and may be helpful in improving bait uptake. Modifications to deployment protocols could also manipulate ant behaviour. Field and lab studies have revealed that an alternative two-step protocol with added odour enhances bait acceptance and ingestion of toxic baits<sup>##UREF##56##71##</sup>. Two-step protocols might also involve altering the characteristics and location of the baits after the initial 3 hours, so that they represent a new source for the ants rather than the previously abandoned one.</p>", "<p id=\"Par41\">In terms of toxicological research, our results imply that palatability assays should only assess immediate responses to baits, or quantify consumption within the first two hours. Past this point, palatability may be masked by abandonment. This may in fact be good news: toxic bait formulations previously determined to be unpalatable on the basis of long-term consumption data may in fact not be unpalatable, but only seem to be so due to an abandonment effect<sup>##UREF##70##92##</sup>. Finally, our results have large implications for assessing the efficacy of control and eradication attempts. The field efficacy of toxic baits is usually measured by monitoring bait stations located in proximity to the toxic baits<sup>##UREF##31##41##,##UREF##53##68##,##UREF##71##93##,##UREF##72##94##</sup>. A decrease in ant activity at these monitoring stations is interpreted as being due to a mortality-based reduction in the population<sup>##UREF##54##69##</sup>. When ants reappear after a certain period, it is usually assumed that there was a reinvasion from the periphery<sup>##UREF##71##93##,##UREF##73##95##,##UREF##74##96##</sup>. However, it is not yet clear how long the abandonment effect lasts. Thus, a reduction of consumption at monitoring stations located close to the baits or a decrease in ant activity in the baited area may not be due entirely to mortality, but rather a combination of mortality and active abandonment. Unfortunately, even search and scan sampling may not be effective if the ants remain in the nest due to the abandonment behaviour. In field control situations, simultaneous toxic baits are numerous and broadly distributed. Ants may well avoid foraging in the whole area, or remain in their nests while the risk persists. For example, when parasitoid phorid flies are present, ants may remain underground<sup>##UREF##75##97##–##UREF##77##99##</sup>, and reduce foraging<sup>##UREF##78##100##,##REF##28307879##101##</sup> in response.</p>", "<p id=\"Par42\">Our study demonstrated rapid active toxic bait abandonment by invasive ants. This has large implications for control efforts, bait assessment, and monitoring. Gaining a deeper understanding of the mechanisms that drive this collective response will provide insights into the mechanisms and strategies of behavioural immunity that social insects can deploy. Perhaps more crucially, a deeper understanding of these processes will be crucial for effectively addressing this complex behaviour. Recognizing that ants may remain present but evade baits until the perceived risk has subsided, we can implement modifications in order to boost toxicant entry into the nest, thereby improving efficacy. Social insects possess intricate and effective behavioural protection mechanisms. Understanding these will be a key step in grasping their social organization, and in controlling them when necessary.</p>" ]
[]
[ "<p id=\"Par1\">Invasive ants, such as the Argentine ant, pose a severe economic and ecological threat. Despite advancements in baiting techniques, effectively managing established ant populations remains a daunting challenge, often ending in failure. Ant colonies employ behavioural immunity against pathogens, raising the question of whether ants can collectively respond to toxic baits. This study investigates whether ant colonies actively abandon palatable but harmful food sources. We provided two sucrose feeders, each generating a new foraging trail, with one transitioning to offering toxic food. Six hours later, ant activity on that path decreases, while activity on the non-toxic food and the trunk trail remains unaffected, excluding factors like population decline or satiation as reasons for the activity decline. Laboratory experiments confirmed that ants remained alive six hours after ingesting toxic food. Ant presence remains low on the toxic food path for days, gradually decreasing along the nearest section of the trunk trail. This abandonment behaviour minimises the entry of harmful food into the nest, acting as a protective social mechanism. The evasion of toxic bait-treated areas likely contributes considerably to control failures. Understanding the behavioural response to toxic baits is essential for developing effective strategies to combat invasive ant species.</p>", "<p id=\"Par2\">Ants exhibit a behavioural strategy of actively abandoning toxic foods and gradually avoiding the area to protect the colony, reducing the entry of harmful foods. This behavior threatens invasive ant control measures, since the ants abandon the baits.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s42003-023-05729-7.</p>", "<title>Acknowledgements</title>", "<p>Many thanks to Michael Rust for comments on a previous version of this manuscript. RJ was supported by the National Council for Scientific and Technical Research (Argentina. PIP 2021: 11220200102201CO) and the National Agency for the Promotion of Research, Technological Development and Innovation (PICT 2016-1676; PICT S-up 2017-9). TJC was supported by a Starter grant from the European Research Council (Cognitive Control: 948181) and a Heisenberg grant from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—Projektnummer 462101190.</p>", "<title>Author contributions</title>", "<p>R.J. proposed the hypothesis, conceived the study, designed the experiment, supervised the project, and acquired funding. T.J.C. and D.Z. contributed to the experimental design. D.Z. collected and analyzed the data. R.J. and T.J.C. jointly wrote the manuscript. All authors have reviewed and approved the final version for publication.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par68\"><italic>Communications Biology</italic> thanks Chris Reid and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editor: Luke R. Grinham.</p>", "<title>Data availability</title>", "<p>The data supporting the findings of this study are available from <ext-link ext-link-type=\"uri\" xlink:href=\"https://figshare.com/s/18abcfa3e89b5dd68d00\">https://figshare.com/s/18abcfa3e89b5dd68d00</ext-link><sup>##UREF##85##109##</sup>.</p>", "<title>Competing interests</title>", "<p id=\"Par69\">The authors declare no competing interest.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Temporal dynamics of ant foraging activity on bridges over days.</title><p>Ant activity measured as the mean number of ants crossing a line on the bridge (foraging trail) toward the foraging arena over a minute, in two bridges connected to the same trunk trail, separated by at least 7 m. Each bridge had its own baseline measured at time 0, when both offered drops of sucrose solution. Immediately after the baseline recording, the feeders were opened, offering sucrose with a toxicant on one bridge (Toxicant bridge, in red, dashed line) and sucrose solution on the other (Sucrose bridge, in blue, solid line). Activity is shown as a function of the hours after feeders were opened, i.e., when the ants began to forage on the toxic bait. Squares are means ± SE. Circles are data of each replicate. Significant differences are shown for each bridge by comparing the activity at each time to the baseline of the same bridge. <italic>n</italic> = 5. (*<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.001; no symbol: no significant differences).</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>Temporal dynamics of ant activity along the trunk trail at multiple locations over days.</title><p>Activity measured at different locations along the trunk trail at (<bold>a</bold>) a bridge offering a toxic bait, and at 2 (<bold>b</bold>) and 4 (<bold>c</bold>) meters either side of this (2 m and 4 m; right-left averaged) and by a sucrose bridge offering unadulterated sucrose over 7 meters away of the toxicant bridge (<bold>d</bold>). Squares are means ± SE. (n = 5). Circles are data of each replicate. Significant differences for each location comparing activity at each time point to the baseline for the same site are shown: *<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.001; no symbol: not significant; <sup><bold>(</bold></sup><bold>*</bold><sup><bold>)</bold></sup>: 0.05 &lt; <italic>p</italic> &lt; 0.087. See also Sup. Mat. for more details.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Dynamics of toxic bait abandonment over 8 hours.</title><p>Ant foraging activity on the bridges as a function of time (h) over 8 hours. Baseline ant activity was measured at time 0 with both bridges offering sucrose solution. Immediately thereafter, the feeders were opened, offering sucrose solution in the sucrose bridge (in blue, solid line) and the toxic bait in the toxicant bridge (in red. dashed line). For each bridge the activity of each time (from time 1 to time 8) was compared with the corresponding baseline. Squares are means ± SE (<italic>n</italic> = 6). Circles are data of each replicate. Significant differences are shown for each time compared to baseline; for the sucrose bridge above the curve and in blue, and for the toxicant bridge under the curve and in red. (*<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.001; no symbol: no significant differences). See also Sup. Mat. for more details.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>Activity change over time in the bridges integrating both experiments.</title><p>Activity change is expressed as the percentage change obtained from the average activity for each timepoint with respect to the average activity of its baseline, (and thus, there is no variance). The dashed red curve represents the bridge offering toxic bait after time 0, the solid blue curve represents the bridge offering sucrose solution. Blue shapes represent sucrose solution being offered; red represents toxic bait being offered. This figure integrates two experiments: the left panel shows the high-resolution temporal dynamics over one day post bait presentation (Experiment 2, circles). The right panel shows the temporal dynamics over 4 days post bait presentation (Experiment 1, squares). Note one datum of Experiment 1 in the left panel (square at time 1: i.e., 1, 2, and 3 h since bait access). Each square represents the pooling of three measurements taken 1 h apart. Vertical dashed line indicates the opening of the final main feeders. Horizontal dashed line at zero indicates no change in the activity.</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><title>Experimental setup.</title><p>Depiction of one of two identical bridges linked to a common trunk trail, spaced at least 7 meters apart (ants not to scale). Initially, both bridges offered sucrose solutions, allowing the formation of new foraging trails, with one later replaced to provide toxic bait.</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><title>Timeline of Experiments 1 (day-wise dynamics) and 2 (hour-wise dynamics).</title><p>The green bar represents the trunk trail, purple and red bars represent the bridges; purple when offering sucrose and red when offering toxic bait. In both experiments, initial activity was established by placing drops of sucrose solution on the foraging arena of both bridges while the tubes (main feeders) were blocked (thus both bridges offer plain sucrose, in purple). Braces and arrows indicate the time of ant activity measurements. This variable is, for the bridges, the average number of ants per minute crossing an imaginary line halfway across the bridge in the direction to the foraging arena, and for the trunk trail, in both directions. Time 0 represent the baseline just before opening the main feeders, i.e., when both bridges offered sucrose solution; at 9 am for the foraging trails (bridges), and the average of measurements of day 0 and morning day 1 for the trunk trail. Similarly, time 1, time 2, etc. represent the times when the ant activity was measured on the trunk trail, and at the foraging trails, after toxic bait became available. For Experiment 1, each time is an average of counts made over a ~2-h period, thus each time represents a morning or an afternoon, over four days. For Experiment 2 (hour-wise dynamics), the activity was measured hourly over a single day, each time representing an hour.</p></caption></fig>" ]
[]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"42003_2023_5729_Fig1_HTML\" id=\"d32e505\"/>", "<graphic xlink:href=\"42003_2023_5729_Fig2_HTML\" id=\"d32e585\"/>", "<graphic xlink:href=\"42003_2023_5729_Fig3_HTML\" id=\"d32e658\"/>", "<graphic xlink:href=\"42003_2023_5729_Fig4_HTML\" id=\"d32e671\"/>", "<graphic xlink:href=\"42003_2023_5729_Fig5_HTML\" id=\"d32e990\"/>", "<graphic xlink:href=\"42003_2023_5729_Fig6_HTML\" id=\"d32e1024\"/>" ]
[ "<media xlink:href=\"42003_2023_5729_MOESM1_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>", "<media xlink:href=\"42003_2023_5729_MOESM2_ESM.pdf\"><caption><p>Reporting Summary</p></caption></media>" ]
[{"label": ["1."], "surname": ["Holway", "Lach", "Suarez", "Tsutsui", "Case"], "given-names": ["DA", "L", "AV", "ND", "TJ"], "article-title": ["The causes and consequences of ant invasions"], "source": ["Annu. Rev. Ecol. Syst."], "year": ["2002"], "volume": ["33"], "fpage": ["181"], "lpage": ["233"], "pub-id": ["10.1146/annurev.ecolsys.33.010802.150444"]}, {"label": ["3."], "mixed-citation": ["Suarez, A. V., McGlynn, T. P. & Tsutsui, N. D. in "], "italic": ["Ant Ecology"]}, {"label": ["4."], "mixed-citation": ["Lowe, S., Browne, M., Boudjelas, S. & De Poorter, M. "], "italic": ["100 of the World\u00b4s Worst Invasive Alien Species A Selection from the Global Invasive Species Database"]}, {"label": ["5."], "surname": ["Angulo"], "given-names": ["E"], "article-title": ["Economic costs of invasive alien ants worldwide"], "source": ["Biol. Invasions"], "year": ["2022"], "volume": ["24"], "fpage": ["2041"], "lpage": ["2060"], "pub-id": ["10.1007/s10530-022-02791-w"]}, {"label": ["6."], "mixed-citation": ["McDonald, D. L. et al. "], "italic": ["Investigation of an Invasive Ant Species: Nylanderia fulva Colony Extraction, Management, Diet Preference, Fecundity, and Mechanical Vector Potential"]}, {"label": ["7."], "surname": ["Baker"], "given-names": ["LF"], "article-title": ["Pests in hospitals"], "source": ["J. R. Soc. Promotion Health"], "year": ["1982"], "volume": ["102"], "fpage": ["251"], "lpage": ["254"]}, {"label": ["9."], "surname": ["Lise", "Garcia", "Lutinski"], "given-names": ["F", "FRM", "JA"], "article-title": ["Association of ants (Hymenoptera: Formicidae) with bacteria in hospitals in the State of Santa Catarina"], "source": ["Rev. Soc. Brasileira Med. Tropical"], "year": ["2006"], "volume": ["39"], "fpage": ["523"], "lpage": ["526"], "pub-id": ["10.1590/S0037-86822006000600002"]}, {"label": ["10."], "surname": ["Tercel", "Cuff", "Symondson", "Vaughan"], "given-names": ["MPTG", "JP", "WOC", "IP"], "article-title": ["Non-native ants drive dramatic declines in animal community diversity: a meta-analysis"], "source": ["Insect Conserv. Diversity"], "year": ["2023"], "volume": ["16"], "fpage": ["1"], "lpage": ["12"], "pub-id": ["10.1111/icad.12672"]}, {"label": ["11."], "surname": ["Porter", "Savignano"], "given-names": ["SD", "DA"], "article-title": ["Invasion of polygyne fire ants decimates native ants and disrupts arthropod community"], "source": ["Ecology"], "year": ["1990"], "volume": ["71"], "fpage": ["2095"], "lpage": ["2106"], "pub-id": ["10.2307/1938623"]}, {"label": ["13."], "surname": ["Suarez", "Yeh", "Case"], "given-names": ["AV", "P", "TJ"], "article-title": ["Impacts of Argentine ants on avian nesting success"], "source": ["Insectes Sociaux"], "year": ["2005"], "volume": ["52"], "fpage": ["378"], "lpage": ["382"], "pub-id": ["10.1007/s00040-005-0824-y"]}, {"label": ["14."], "surname": ["Cole", "Medeiros", "Loope", "Zuehlke"], "given-names": ["FR", "AC", "LL", "WW"], "article-title": ["Effects of the Argentine ant on arthropod fauna of Hawaiian high\u2010elevation shrubland"], "source": ["Ecology"], "year": ["1992"], "volume": ["73"], "fpage": ["1313"], "lpage": ["1322"], "pub-id": ["10.2307/1940678"]}, {"label": ["15."], "surname": ["Hansen", "M\u00fcller"], "given-names": ["DM", "CB"], "article-title": ["Invasive ants disrupt gecko pollination and seed dispersal of the endangered plant "], "italic": ["Roussea simplex"], "source": ["Biotropica"], "year": ["2009"], "volume": ["41"], "fpage": ["202"], "lpage": ["208"], "pub-id": ["10.1111/j.1744-7429.2008.00473.x"]}, {"label": ["16."], "surname": ["Angulo", "Caut", "Cerd\u00e1"], "given-names": ["E", "S", "X"], "article-title": ["Scavenging in Mediterranean ecosystems: effect of the invasive Argentine ant"], "source": ["Biol. Invasions"], "year": ["2011"], "volume": ["13"], "fpage": ["1183"], "lpage": ["1194"], "pub-id": ["10.1007/s10530-011-9953-6"]}, {"label": ["18."], "surname": ["Hoffmann", "Luque", "Bellard", "Holmes", "Donlan"], "given-names": ["BD", "GM", "C", "ND", "CJ"], "article-title": ["Improving invasive ant eradication as a conservation tool: a review"], "source": ["Biol. Conserv."], "year": ["2016"], "volume": ["198"], "fpage": ["37"], "lpage": ["49"], "pub-id": ["10.1016/j.biocon.2016.03.036"]}, {"label": ["19."], "surname": ["Hoffmann"], "given-names": ["BD"], "article-title": ["Eradication of populations of an invasive ant in northern Australia: successes, failures and lessons for management"], "source": ["Biodivers. Conserv."], "year": ["2011"], "volume": ["20"], "fpage": ["3267"], "lpage": ["3278"], "pub-id": ["10.1007/s10531-011-0106-0"]}, {"label": ["20."], "mixed-citation": ["Kenis, M. & Branco, M. in "], "italic": ["Alien Terrestrial Arthropods of Europe. BioRisk"]}, {"label": ["23."], "surname": ["Knight", "Rust"], "given-names": ["RL", "MK"], "article-title": ["The urban ants of California with distribution notes of imported species"], "source": ["Southwest. Entomologist"], "year": ["1990"], "volume": ["15"], "fpage": ["167"], "lpage": ["178"]}, {"label": ["24."], "surname": ["Daane"], "given-names": ["KM"], "article-title": ["Testing baits to control Argentine ants (Hymenoptera: Formicidae) in vineyards"], "source": ["J. Economic Entomol."], "year": ["2008"], "volume": ["101"], "fpage": ["699"], "lpage": ["709"], "pub-id": ["10.1093/jee/101.3.699"]}, {"label": ["25."], "surname": ["Song", "Benson", "Zungoli", "Gerard", "Scott"], "given-names": ["J", "EP", "PA", "P", "SW"], "article-title": ["Using the DAS-ELISA test to establish an effective distance between bait stations for control of "], "italic": ["Linepithema humile"], "source": ["J. Economic Entomol."], "year": ["2015"], "volume": ["108"], "fpage": ["1961"], "lpage": ["1971"], "pub-id": ["10.1093/jee/tov152"]}, {"label": ["26."], "surname": ["Buczkowski", "Mothapo", "Wossler"], "given-names": ["G", "NP", "TC"], "article-title": ["Let them eat termites\u2014prey-baiting provides effective control of Argentine ants, "], "italic": ["Linepithema humile"], "source": ["J. Appl. Entomol."], "year": ["2018"], "volume": ["142"], "fpage": ["504"], "lpage": ["512"], "pub-id": ["10.1111/jen.12501"]}, {"label": ["27."], "surname": ["Bond", "Slingsby"], "given-names": ["W", "P"], "article-title": ["Collapse of an ant-plant mutalism: the Argentine ant ("], "italic": ["Iridomyrmex humilis"], "source": ["Ecology"], "year": ["1984"], "volume": ["65"], "fpage": ["1031"], "lpage": ["1037"], "pub-id": ["10.2307/1938311"]}, {"label": ["28."], "surname": ["G\u00f3mez", "Oliveras"], "given-names": ["C", "J"], "article-title": ["Can the Argentine ant ("], "italic": ["Linepithema humile"], "source": ["Acta Oecologica"], "year": ["2003"], "volume": ["24"], "fpage": ["47"], "lpage": ["53"], "pub-id": ["10.1016/S1146-609X(03)00042-0"]}, {"label": ["29."], "surname": ["Visser", "Wright", "Giliomee"], "given-names": ["D", "MG", "JH"], "article-title": ["The effect of the Argentine ant, "], "italic": ["Linepithema humile", "Protea nitida"], "source": ["Afr. Entomol."], "year": ["1996"], "volume": ["4"], "fpage": ["285"], "lpage": ["287"]}, {"label": ["30."], "surname": ["Blancafort", "G\u00f3mez"], "given-names": ["X", "C"], "article-title": ["Consequences of the Argentine ant, "], "italic": ["Linepithema humile", "Euphorbia characias"], "source": ["Acta Oecologica"], "year": ["2005"], "volume": ["28"], "fpage": ["49"], "lpage": ["55"], "pub-id": ["10.1016/j.actao.2005.02.004"]}, {"label": ["31."], "surname": ["Chen", "Nonacs"], "given-names": ["JSC", "P"], "article-title": ["Nestmate recognition and intraspecific aggression based on environmental cues in Argentine ants (Hymenoptera: Formicidae)"], "source": ["Ann. Entomological Soc. Am."], "year": ["2000"], "volume": ["93"], "fpage": ["1333"], "lpage": ["1337"], "pub-id": ["10.1603/0013-8746(2000)093[1333:NRAIAB]2.0.CO;2"]}, {"label": ["33."], "surname": ["Suarez", "Case"], "given-names": ["AV", "TJ"], "article-title": ["Bottom-up effects on persistence of a specialist predator: ant invasions and horned lizards"], "source": ["Ecol. Appl."], "year": ["2002"], "volume": ["12"], "fpage": ["291"], "lpage": ["298"], "pub-id": ["10.1890/1051-0761(2002)012[0291:BUEOPO]2.0.CO;2"]}, {"label": ["36."], "surname": ["Ness", "Bronstein"], "given-names": ["JH", "JL"], "article-title": ["The effects of invasive ants on prospective ant mutualists"], "source": ["Biol. Invasions"], "year": ["2004"], "volume": ["6"], "fpage": ["445"], "lpage": ["461"], "pub-id": ["10.1023/B:BINV.0000041556.88920.dd"]}, {"label": ["37."], "surname": ["Daane", "Sime", "Fallon", "Cooper"], "given-names": ["KM", "KR", "J", "ML"], "article-title": ["Impacts of Argentine ants on mealybugs and their natural enemies in California\u2019s coastal vineyards"], "source": ["Ecol. Entomol."], "year": ["2007"], "volume": ["32"], "fpage": ["583"], "lpage": ["596"], "pub-id": ["10.1111/j.1365-2311.2007.00910.x"]}, {"label": ["38."], "surname": ["Knight", "Rust"], "given-names": ["RL", "MK"], "article-title": ["Repellency and efficacy of insecticides against foraging workers in laboratory colonies of Argentine ants (Hymenoptera: Formicidae)"], "source": ["J. Economic Entomol."], "year": ["1990"], "volume": ["83"], "fpage": ["1402"], "lpage": ["1408"], "pub-id": ["10.1093/jee/83.4.1402"]}, {"label": ["39."], "surname": ["Rust", "Haagsma", "Reierson"], "given-names": ["MK", "K", "DA"], "article-title": ["Barrier sprays to control Argentine ants (Hymenoptera: Formicidae)"], "source": ["J. Economic Entomol."], "year": ["1996"], "volume": ["89"], "fpage": ["134"], "lpage": ["137"], "pub-id": ["10.1093/jee/89.1.134"]}, {"label": ["40."], "surname": ["Rust", "Reierson", "Klotz"], "given-names": ["MK", "DA", "JH"], "article-title": ["Pest management of Argentine ants (Hymenoptera: Formicidae)"], "source": ["J. Entomological Sci."], "year": ["2003"], "volume": ["38"], "fpage": ["159"], "lpage": ["169"], "pub-id": ["10.18474/0749-8004-38.2.159"]}, {"label": ["41."], "surname": ["Vega", "Rust"], "given-names": ["SY", "MK"], "article-title": ["Determining the foraging range and origin of resurgence after treatment of Argentine ant (Hymenoptera: Formicidae) in urban areas"], "source": ["J. Economic Entomol."], "year": ["2003"], "volume": ["96"], "fpage": ["844"], "lpage": ["849"], "pub-id": ["10.1093/jee/96.3.844"]}, {"label": ["42."], "surname": ["Cabrera", "Rivas Fontan", "Hoffmann", "Josens"], "given-names": ["ME", "I", "BD", "R"], "article-title": ["Laboratory and field insights into the dynamics and behavior of Argentine ants, "], "italic": ["Linepithema humile"], "source": ["Pest Manag. Sci."], "year": ["2021"], "volume": ["85"], "fpage": ["161"], "lpage": ["177"]}, {"label": ["43."], "surname": ["Baker", "Van Vorhis Key", "Gaston"], "given-names": ["TC", "SE", "LK"], "article-title": ["Bait-preference tests for the Argentine ant (Hymenoptera: Formicidae)"], "source": ["J. Economic Entomol."], "year": ["1985"], "volume": ["78"], "fpage": ["1083"], "lpage": ["1088"], "pub-id": ["10.1093/jee/78.5.1083"]}, {"label": ["44."], "surname": ["Rust", "Reierson", "Paine", "Blum"], "given-names": ["MK", "DA", "E", "LJ"], "article-title": ["Seasonal activity and bait preferences of the Argentine ant (Hymenoptera: Formicidae)"], "source": ["J. Agric. Urban Entomol."], "year": ["2000"], "volume": ["17"], "fpage": ["201"], "lpage": ["212"]}, {"label": ["45."], "surname": ["Buczkowski", "Roper", "Chin", "Mothapo", "Wossler"], "given-names": ["G", "E", "D", "N", "T"], "article-title": ["Hydrogel baits with low-dose thiamethoxam for sustainable Argentine ant management in commercial orchards"], "source": ["Entomologia Experimentalis Applicata"], "year": ["2014"], "volume": ["153"], "fpage": ["183"], "lpage": ["190"], "pub-id": ["10.1111/eea.12239"]}, {"label": ["46."], "surname": ["Choe"], "given-names": ["D-H"], "article-title": ["Development and demonstration of low-impact IPM strategy to control Argentine ants (Hymenoptera: Formicidae) in urban residential settings"], "source": ["J. Economic Entomol."], "year": ["2021"], "volume": ["114"], "fpage": ["1752"], "lpage": ["1757"], "pub-id": ["10.1093/jee/toab079"]}, {"label": ["47."], "surname": ["Rust"], "given-names": ["MK"], "article-title": ["Laboratory and field evaluations of polyacrylamide hydrogel baits against Argentine ants (Hymenoptera: Formicidae)"], "source": ["J. Economic Entomol."], "year": ["2015"], "volume": ["108"], "fpage": ["1228"], "lpage": ["1236"], "pub-id": ["10.1093/jee/tov044"]}, {"label": ["48."], "mixed-citation": ["Tay, J.-W., Hoddle, M. S., Ashok, M. & Choe, D.-H. In: "], "italic": ["Proc. 9th International Conference on Urban Pests"]}, {"label": ["49."], "surname": ["Krushelnycky", "Reimer"], "given-names": ["PD", "NJ"], "article-title": ["Efficacy of Maxforce Bait for Control of the Argentine Ant (Hymenoptera: Formicidae) in Haleakala National Park, Maui, Hawaii"], "source": ["Environ. Entomol."], "year": ["1998"], "volume": ["27"], "fpage": ["1473"], "lpage": ["1481"], "pub-id": ["10.1093/ee/27.6.1473"]}, {"label": ["50."], "surname": ["Krushelnycky", "Reimer"], "given-names": ["PD", "NJ"], "article-title": ["Bait Preference by the Argentine Ant (Hymenoptera: Formicidae) in Haleakala National Park, Hawaii"], "source": ["Environ. Entomol."], "year": ["1998"], "volume": ["27"], "fpage": ["1482"], "lpage": ["1487"], "pub-id": ["10.1093/ee/27.6.1482"]}, {"label": ["51."], "surname": ["Silverman", "Roulston"], "given-names": ["J", "TaH"], "article-title": ["Acceptance and intake of gel and liquid sucrose compositions by the Argentine ant (Hymenoptera: Formicidae)"], "source": ["J. Economic Entomol."], "year": ["2001"], "volume": ["94"], "fpage": ["511"], "lpage": ["515"], "pub-id": ["10.1603/0022-0493-94.2.511"]}, {"label": ["52."], "surname": ["Sudd", "Sudd"], "given-names": ["JH", "ME"], "article-title": ["Seasonal changes in the response of wood-ants ("], "italic": ["Formica lugubris"], "source": ["Ecol. Entomol."], "year": ["1985"], "volume": ["10"], "fpage": ["89"], "lpage": ["97"], "pub-id": ["10.1111/j.1365-2311.1985.tb00538.x"]}, {"label": ["53."], "surname": ["Kay"], "given-names": ["A"], "article-title": ["Applying optimal foraging theory to assess nutrient availability ratios for ants"], "source": ["Ecology"], "year": ["2002"], "volume": ["83"], "fpage": ["1935"], "lpage": ["1944"], "pub-id": ["10.1890/0012-9658(2002)083[1935:AOFTTA]2.0.CO;2"]}, {"label": ["54."], "surname": ["Sola", "Falibene", "Josens"], "given-names": ["F", "A", "R"], "article-title": ["Asymmetrical behavioral response towards two boron toxicants depends on the ant species (Hymenoptera: Formicidae)"], "source": ["J. Economic Entomol."], "year": ["2013"], "volume": ["106"], "fpage": ["929"], "lpage": ["938"], "pub-id": ["10.1603/EC12246"]}, {"label": ["55."], "surname": ["Rust", "Reierson", "Klotz"], "given-names": ["MK", "DA", "JH"], "article-title": ["Delayed toxicity as a critical factor in the efficacy of aqueous baits for controlling Argentine ants (Hymenoptera: Formicidae)"], "source": ["J. Economic Entomol."], "year": ["2004"], "volume": ["97"], "fpage": ["1017"], "lpage": ["1024"], "pub-id": ["10.1093/jee/97.3.1017"]}, {"label": ["56."], "surname": ["Folgarait", "Gilbert"], "given-names": ["PJ", "LE"], "article-title": ["Phorid parasitoids affect foraging activity of "], "italic": ["Solenopsis richteri"], "source": ["Ecol. Entomol."], "year": ["1999"], "volume": ["24"], "fpage": ["163"], "lpage": ["173"], "pub-id": ["10.1046/j.1365-2311.1999.00180.x"]}, {"label": ["57."], "surname": ["Guillade", "Folgarait"], "given-names": ["AC", "PJ"], "article-title": ["Effect of phorid fly density on the foraging of "], "italic": ["Atta vollenweideri"], "source": ["Entomologia Experimentalis Applicata"], "year": ["2015"], "volume": ["154"], "fpage": ["53"], "lpage": ["61"], "pub-id": ["10.1111/eea.12255"]}, {"label": ["59."], "surname": ["Nonacs", "Dill"], "given-names": ["P", "LM"], "article-title": ["Mortality risk vs. food quality trade-offs in a common currency: ant patch preferences"], "source": ["Ecology"], "year": ["1990"], "volume": ["71"], "fpage": ["1886"], "lpage": ["1892"], "pub-id": ["10.2307/1937596"]}, {"label": ["60."], "surname": ["Nonacs", "Dill"], "given-names": ["P", "LM"], "article-title": ["Mortality risk versus food quality trade-offs in ants: patch use over time"], "source": ["Ecol. Entomol."], "year": ["1991"], "volume": ["16"], "fpage": ["73"], "lpage": ["80"], "pub-id": ["10.1111/j.1365-2311.1991.tb00194.x"]}, {"label": ["61."], "surname": ["Saverschek", "Herz", "Wagner", "Roces"], "given-names": ["N", "H", "M", "F"], "article-title": ["Avoiding plants unsuitable for the symbiotic fungus: learning and long-term memory in leaf-cutting ants"], "source": ["Anim. Behav."], "year": ["2010"], "volume": ["79"], "fpage": ["689"], "lpage": ["698"], "pub-id": ["10.1016/j.anbehav.2009.12.021"]}, {"label": ["62."], "surname": ["Saverschek", "Roces"], "given-names": ["N", "F"], "article-title": ["Foraging leafcutter ants: olfactory memory underlies delayed avoidance of plants unsuitable for the symbiotic fungus"], "source": ["Anim. Behav."], "year": ["2011"], "volume": ["82"], "fpage": ["453"], "lpage": ["458"], "pub-id": ["10.1016/j.anbehav.2011.05.015"]}, {"label": ["64."], "mixed-citation": ["Wheeler, W. M. "], "italic": ["Ants: their structure, development and behavior"]}, {"label": ["68."], "surname": ["Greenberg", "Klotz", "Rust"], "given-names": ["L", "JH", "MK"], "article-title": ["Liquid borate bait for control of the Argentine ant, "], "italic": ["Linepithema humile"], "source": ["Fla. Entomologist"], "year": ["2006"], "volume": ["89"], "fpage": ["469"], "lpage": ["474"], "pub-id": ["10.1653/0015-4040(2006)89[469:LBBFCO]2.0.CO;2"]}, {"label": ["69."], "surname": ["Klotz", "Greenberg", "Venn"], "given-names": ["J", "L", "EC"], "article-title": ["Liquid boric acid bait for control of the Argentine ant (Hymenoptera: Formicidae)"], "source": ["J. Economic Entomol."], "year": ["1998"], "volume": ["91"], "fpage": ["910"], "lpage": ["914"], "pub-id": ["10.1093/jee/91.4.910"]}, {"label": ["70."], "surname": ["Boser"], "given-names": ["CL"], "article-title": ["Argentine ant management in conservation areas: results of a pilot study"], "source": ["Monogr. West. North Am. Naturalist"], "year": ["2014"], "volume": ["7"], "fpage": ["518"], "lpage": ["530"], "pub-id": ["10.3398/042.007.0140"]}, {"label": ["71."], "surname": ["Josens", "Mattiacci", "Lois-Milevicich", "Giacometti"], "given-names": ["R", "A", "J", "A"], "article-title": ["Food information acquired socially overrides individual food assessment in ants"], "source": ["Behav. Ecol. Sociobiol."], "year": ["2016"], "volume": ["70"], "fpage": ["2127"], "lpage": ["2138"], "pub-id": ["10.1007/s00265-016-2216-x"]}, {"label": ["72."], "surname": ["Traniello"], "given-names": ["JFA"], "article-title": ["Foraging strategies of ants"], "source": ["Annu. Rev. Entomol."], "year": ["1989"], "volume": ["34"], "fpage": ["191"], "lpage": ["210"], "pub-id": ["10.1146/annurev.en.34.010189.001203"]}, {"label": ["75."], "surname": ["Hurst", "Stevenson", "Wright"], "given-names": ["V", "PC", "GA"], "article-title": ["Toxins induce \u2018malaise\u2019 behaviour in the honeybee ("], "italic": ["Apis mellifera"], "source": ["J. Comp. Physiol. A"], "year": ["2014"], "volume": ["200"], "fpage": ["881"], "lpage": ["890"], "pub-id": ["10.1007/s00359-014-0932-0"]}, {"label": ["77."], "surname": ["Bernays", "Lee"], "given-names": ["EA", "JC"], "article-title": ["Food aversion learning in the polyphagous grasshopper "], "italic": ["Schistocerca americana"], "source": ["Physiol. Entomol."], "year": ["1988"], "volume": ["13"], "fpage": ["131"], "lpage": ["137"], "pub-id": ["10.1111/j.1365-3032.1988.tb00916.x"]}, {"label": ["79."], "surname": ["Ghumare", "Mukherjee"], "given-names": ["SS", "SN"], "article-title": ["Absence of food aversion learning in the polyphagous noctuid, "], "italic": ["Spodoptera litura"], "source": ["J. Insect Behav."], "year": ["2005"], "volume": ["18"], "fpage": ["105"], "lpage": ["114"], "pub-id": ["10.1007/s10905-005-9350-z"]}, {"label": ["80."], "surname": ["Garcia", "Ervin", "Koelling"], "given-names": ["J", "FR", "RA"], "article-title": ["Learning with prolonged delay of reinforcement"], "source": ["Psychonomic Sci."], "year": ["1966"], "volume": ["5"], "fpage": ["121"], "lpage": ["122"], "pub-id": ["10.3758/BF03328311"]}, {"label": ["81."], "surname": ["Etscorn", "Stephens"], "given-names": ["F", "R"], "article-title": ["Establishment of conditioned taste aversions with a 24-hour CS-US interval"], "source": ["Physiol. Psychol."], "year": ["1973"], "volume": ["1"], "fpage": ["251"], "lpage": ["253"], "pub-id": ["10.3758/BF03326916"]}, {"label": ["82."], "mixed-citation": ["Wagner, T. & Czaczkes, T. J. Corpse-associated odours elicit avoidance in invasive ants. "], "italic": ["Pest Manag. Sci."]}, {"label": ["83."], "surname": ["Goss", "Aron", "Deneubourg", "Pasteels"], "given-names": ["S", "S", "JL", "JM"], "article-title": ["Self-organized shortcuts in the Argentine ant"], "source": ["Naturwissenschaften"], "year": ["1989"], "volume": ["76"], "fpage": ["579"], "lpage": ["581"], "pub-id": ["10.1007/BF00462870"]}, {"label": ["84."], "surname": ["Fernandes", "Rust"], "given-names": ["NG", "MK"], "article-title": ["Site fidelity in foraging Argentine ants (Hymenoptera: Formicidae)"], "source": ["Sociobiology"], "year": ["2003"], "volume": ["41"], "fpage": ["625"], "lpage": ["632"]}, {"label": ["85."], "surname": ["Herz", "Hoelldobler", "Roces"], "given-names": ["H", "B", "F"], "article-title": ["Delayed rejection in a leaf-cutting ant after foraging on plants unsuitable for the symbiotic fungus"], "source": ["Behav. Ecol."], "year": ["2008"], "volume": ["19"], "fpage": ["575"], "lpage": ["582"], "pub-id": ["10.1093/beheco/arn016"]}, {"label": ["88."], "surname": ["Greenberg", "Klotz"], "given-names": ["L", "JH"], "article-title": ["Argentine ant (Hymenoptera: Formicidae) trail pheromone enhances consumption of liquid sucrose solution"], "source": ["J. Economic Entomol."], "year": ["2000"], "volume": ["93"], "fpage": ["119"], "lpage": ["122"], "pub-id": ["10.1603/0022-0493-93.1.119"]}, {"label": ["89."], "surname": ["Choe", "Tsai", "Lopez", "Campbell"], "given-names": ["DH", "K", "CM", "K"], "article-title": ["Pheromone-assisted techniques to improve the efficacy of insecticide sprays against "], "italic": ["Linepithema humile"], "source": ["J. Economic Entomol."], "year": ["2014"], "volume": ["107"], "fpage": ["319"], "lpage": ["325"], "pub-id": ["10.1603/EC13262"]}, {"label": ["91."], "mixed-citation": ["Galante, H., Agr\u00f2, M. D., Koch, A., Kau, S. & Czaczkes, T. J. Acute exposure to caffeine improves navigation in an invasive ant. "], "italic": ["bioRxiv"]}, {"label": ["92."], "surname": ["Klotz", "Greenberg", "Amrhein", "Rust"], "given-names": ["JH", "L", "C", "MK"], "article-title": ["Toxicity and repellency of borate-sucrose water baits to Argentine ants (Hymenoptera: Formicidae)"], "source": ["J. Economic Entomol."], "year": ["2000"], "volume": ["93"], "fpage": ["1256"], "lpage": ["1258"], "pub-id": ["10.1603/0022-0493-93.4.1256"]}, {"label": ["93."], "surname": ["McCalla", "Tay", "Mulchandani", "Choe", "Hoddle"], "given-names": ["KA", "J-W", "A", "D-H", "MS"], "article-title": ["Biodegradable alginate hydrogel bait delivery system effectively controls high-density populations of Argentine ant in commercial citrus"], "source": ["J. Pest Sci."], "year": ["2020"], "volume": ["93"], "fpage": ["1031"], "lpage": ["1042"], "pub-id": ["10.1007/s10340-019-01175-9"]}, {"label": ["94."], "surname": ["Klotz", "Vail", "Willams"], "given-names": ["JH", "KM", "DF"], "article-title": ["Liquid boric acid bait for control of structural infestations of Pharaoh ants (Hymenoptera: Formicidae)"], "source": ["J. Economic Entomol."], "year": ["1997"], "volume": ["90"], "fpage": ["523"], "lpage": ["526"], "pub-id": ["10.1093/jee/90.2.523"]}, {"label": ["95."], "surname": ["Knight", "Rust"], "given-names": ["RL", "MK"], "article-title": ["Efficacy of Formulated Baits for Control of Argentine Ant (Hymenoptera: Formicidae)"], "source": ["J. Economic Entomol."], "year": ["1991"], "volume": ["84"], "fpage": ["510"], "lpage": ["514"], "pub-id": ["10.1093/jee/84.2.510"]}, {"label": ["96."], "mixed-citation": ["Krushelnycky, P. D. Evaluation of water-storing granules as a promising new baiting tool for the control of invasive ants in Hawaii. 40pp (University of Hawaii at Manoa, 2019)."]}, {"label": ["97."], "surname": ["Feener"], "given-names": ["DH"], "article-title": ["Effects of parasites on foraging and defense behavior of a termitophagous ant, "], "italic": ["Pheidole titanis"], "source": ["Behav. Ecol. Sociobiol."], "year": ["1988"], "volume": ["22"], "fpage": ["421"], "lpage": ["427"], "pub-id": ["10.1007/BF00294980"]}, {"label": ["98."], "surname": ["Orr"], "given-names": ["MR"], "article-title": ["Parasitic flies (Diptera: Phoridae) influence foraging rhythms and caste division of labor in the leaf-cutter ant, "], "italic": ["Atta cephalotes"], "source": ["Behav. Ecol. Sociobiol."], "year": ["1992"], "volume": ["30"], "fpage": ["395"], "lpage": ["402"], "pub-id": ["10.1007/BF00176174"]}, {"label": ["99."], "surname": ["Orr", "Seike", "Benson", "Gilbert"], "given-names": ["MR", "SH", "WW", "LE"], "article-title": ["Flies suppress fire ants"], "source": ["Nature"], "year": ["1995"], "volume": ["373"], "fpage": ["292"], "lpage": ["293"], "pub-id": ["10.1038/373292a0"]}, {"label": ["100."], "surname": ["Feener", "Brown"], "given-names": ["DH", "BV"], "suffix": ["Jr."], "article-title": ["Reduced foraging of "], "italic": ["Solenopsis geminata", "Pseudacteon"], "source": ["Ann. Entomological Soc. Am."], "year": ["1992"], "volume": ["85"], "fpage": ["80"], "lpage": ["84"], "pub-id": ["10.1093/aesa/85.1.80"]}, {"label": ["102."], "surname": ["Sola", "Josens"], "given-names": ["FJ", "R"], "article-title": ["Feeding behavior and social interactions of the Argentine ant "], "italic": ["Linepithema humile"], "source": ["Bull. Entomological Res."], "year": ["2016"], "volume": ["106"], "fpage": ["522"], "lpage": ["529"], "pub-id": ["10.1017/S0007485316000201"]}, {"label": ["103."], "surname": ["Moauro", "Josens"], "given-names": ["M", "R"], "article-title": ["Differential feeding responses in two species of nectivorous ants: Understanding bait palatability preferences of Argentine ants"], "source": ["J. Appl. Entomol."], "year": ["2023"], "volume": ["147"], "fpage": ["520"], "lpage": ["529"], "pub-id": ["10.1111/jen.13126"]}, {"label": ["105."], "mixed-citation": ["Lenth, R. et al. Estimated marginal means, aka least-squares means. (Version 1.9.0). (ed Russell, V. Lenth) "], "italic": ["R Core Team"]}, {"label": ["106."], "mixed-citation": ["Hothorn, T. et al. Simultaneous Inference in General Parametric Models. (Version 1.4-25). "], "italic": ["R Core Team"]}, {"label": ["107."], "mixed-citation": ["Brooks, M. et al. Package \u2018glmmTMB\u2019. Generalized Linear Mixed Models using Template Model Builder. (Version 1.1.8). "], "italic": ["R Core Team"]}, {"label": ["108."], "mixed-citation": ["Pinheiro, J. et al. Package \u2018nlme\u2019. Linear and Nonlinear Mixed Effects Models. (Version 3.1-164). "], "italic": ["R Core Team"]}, {"label": ["109."], "mixed-citation": ["Zanola, D., Czaczkes, T. J. & Josens, R. "], "italic": ["Dataset of \u201cAnts evade harmful food by active abandonment\u201d"]}]
{ "acronym": [], "definition": [] }
109
CC BY
no
2024-01-14 23:40:17
Commun Biol. 2024 Jan 12; 7:84
oa_package/05/1d/PMC10786876.tar.gz
PMC10786877
38216593
[ "<title>Introduction</title>", "<p id=\"Par3\">The cellular architecture of the human nervous system provides the foundations of our cognitive skills and disease susceptibility. In particular, the cerebral cortex is the most complex structure known in biology. Although base architecture seems to be preserved across mammals [##REF##21647212##1##], different studies have suggested significant differences in the cellular composition of the human nervous system [##REF##29694902##2##]. Specifically, marked variations were observed in the proportions of neuronal and non-neuronal cells and in the transcription of genes associated with neuronal structure and activity [##REF##31435019##3##]. These species-specific discrepancies are reflected in neuronal function and raise doubts about using in vivo murine models to study neuronal disorders, microenvironment, and drug design. Nowadays, human neuron usage is restricted by ethical and technical reasons [##REF##32017900##4##–##REF##23975816##7##], thus different immortalized cell lines are used as alternatives. The main problem with the use of cell lines is that, currently, there are not any relevant in vitro models able to reflect the functional activity of mature neurons; for this reason, many areas in the field of neuroscience are hindered by this missing. Human induced pluripotent stem cells (iPSCs) are currently the most used approach to modeling human neuronal microenvironment in physiological and pathological conditions to discover and screen new potential drugs [##REF##18035408##8##]. The possibility to fully reprogram cells from patients with neurological disorders to obtain neuronal cultures has allowed neuroscientists to recapitulate in the dish phenotypes associated with a particular disease [##REF##21490598##9##–##REF##21362567##12##]. However, although iPSCs are extensively used for the discovery and validation of new pharmacological treatments without ethical restrictions, human neuronal cultures achieved after differentiation in vitro have not been updated to reflect fundamental principles of brain physiology. Moreover, incomplete cellular reprogramming and the genetic and epigenetic changes that can occur with prolonged culturing of iPSCs further limit the usage of this in vitro model [##REF##28731526##13##–##REF##25431601##15##]. iPSC-derived neurons (iPSCNs) show heterogeneous electrophysiological properties (action potential firing frequency, action potential amplitude, resting membrane potential). Several reports have demonstrated that the resting membrane potential of human iPSCN hyperpolarizes over prolonged periods in culture and can reach relatively mature values after several months [##REF##27274733##16##]. However, in standard conditions, some populations of iPSC neurons generate spontaneous activity at a very low frequency and only for a few days, limiting their use for short-term experiments [##UREF##0##17##].</p>", "<p id=\"Par4\">Likewise iPSCs, neural stem cells (NSCs) are a promising approach to modeling neurological disorders, designing and screening new drugs, studying human embryonic neurogenesis, and providing the application in regenerative medicine. Induced pluripotent stem cells or embryonic stem cells are the most acceptable sources of NSCs [##REF##33117792##18##]. However, to date, NSCs differentiation protocols drive the generation of a wide range of NSC phenotypes that exhibit different differentiation potentials and proliferative capacities [##REF##33117792##18##]. Furthermore, many studies demonstrated that NSCs are more prone to differentiate into glial than neuronal phenotypes in systems reproducing pathological conditions [##REF##36624495##19##]. This aspect, together with the lack of reproducibility and standardization of differentiation protocols, makes the use of NSC lines critical for disease modeling and even more so for cell therapy.</p>", "<p id=\"Par5\">The most common immortalized human cell line used to obtain neuronal culture in vitro is SH-SY5Y. SH-SY5Y is a subclone of the SK-N-SH neuroblastoma that, depending on treatments/culture conditions, can be differentiated into various neuronal phenotypes. Currently, the most used agents to differentiate these cells include retinoic acid (RA) [##REF##7576944##20##], administered in different concentrations and incubation times, and neurotrophic factors such as nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neuregulins, GLP-1, and phorbol esters [##REF##10936180##21##–##REF##15555917##23##]. Furthermore, several methods to improve neuronal differentiation involve the usage of an extracellular matrix (ECM) gel to reproduce a three-dimensional (3D) environment [##REF##18672002##24##–##REF##20413890##26##]. The advantages of the adoption of differentiated SH-SY5Y cells as a neuronal model comprise large-scale amplification before differentiation, low cost, straightforward to culture compared to primary neurons, expression of human-specific proteins and their isoforms that would not be genetically present in murine primary cultures, and achievement of a homogenous neuronal cell population [##REF##10936180##21##, ##REF##6137586##27##, ##REF##23975817##28##]. However, electrophysiological analyses are scarce and show that the functional properties of differentiated SH-SY5Y cells do not correlate with morphological differentiation and the expression of markers of neuronal maturation. In the majority of papers that functionally investigated differentiated SH-SY5Y cells, electrical activity was limited to induced action potentials, which were discharged at low frequencies [##REF##9463428##29##–##REF##34826533##32##], whereas a faint spontaneous spiking activity has been shown only by one research group [##REF##36066699##33##, ##REF##35987975##34##]. However, the characterization and quantification of this activity have not been performed.</p>", "<p id=\"Par6\">Since the presence of neuronal electrical properties is the core of nervous system activity, here we report a new differentiation protocol to obtain a 3D culture of electrically functional cholinergic-like neurons, starting from a readily available human neuroblastoma cell line. Hence we provide an easily accessible, reproducible, and reasonable technique that empowers studies of neurophysiological activity, synaptic function, vesicle trafficking, metabolism, and events that play a critical role in neuroscience. The improvements made in this differentiation protocol could narrow the gap between in vitro neuronal models and in vivo neuronal physiological conditions. Furthermore, improving electrical and synaptic activity in vitro allows for modeling the physiological behavior of neuronal networks, from which to derive neurological disorders in a dish with more realistic conditions.</p>" ]
[ "<title>Materials and Methods</title>", "<title>Cell culture and differentiation</title>", "<p id=\"Par28\">SH-SY5Y cells [##REF##8847640##94##] were recently authenticated through genetic characteristic determination by PCR-single-locus-technology (Eurofins Genomics, Ebersberg, Germany). SH-SY5Y were cultured in RPMI-1640 supplemented with 10% fetal bovine serum (FBS, Gibco-ThermoFisher, Waltham, MA, USA), 2 mM glutamine (Euroclone, Pero, Italy), and 0.25% micozap prophylactic (Lonza, Walkersville, MD, USA) at 37 °C in a humidified atmosphere of 5% CO<sub>2</sub>. Cells were differentiated using the Agholme protocol [##REF##20413890##26##] (3D Literature) or four new differentiation protocols. The first one was called 2D DMAP1 (D’Aloia Modified Agholme Protocol). In 2D DMAP1 cells were seeded at a density of 1×10<sup>4</sup> cells/mL in a 35 mm dish (Corning) in RPMI-1640 with 10% FBS. The next day, the medium was changed to induce pre-differentiation. The pre-differentiation medium contains Optimem (Gibco-ThermoFisher, Waltham, MA, USA) supplemented with 10 µM retinoic acid (RA) (Merck Life Science, Darmstadt, Germany), 2 mM glutamine (Euroclone, Pero, Italy) and 0.25% micozap prophylactic; the duration of pre-differentiation phase was 7 days. Subsequently, the medium was replaced to induce differentiation. Differentiation medium contains Optimem with 50 ng/mL BDNF (ImmunoTools, Friesoythe, Germany), 10 ng/mL NGF (ImmunoTools, Friesoythe, Germany), 10 ng/mL neuregulin β1 (NRG) (ImmunoTools, Friesoythe, Germany), 24 nM vitamin D<sub>3</sub> (VitD<sub>3</sub>) (Merck Life Science, Darmstadt, Germany), 2 mM glutamine and 0.25% micozap prophylactic. The duration of the differentiation phase was 10 days. The second one was called 3D DMAP1 Mix. In 3D DMAP1 Mix cells were harvested by Optimem with 2 mM glutamine, and the cell suspension was mixed with a pre-cooled Growth Factor Reduced (GFR) basement membrane matrix (ratio used for experiments 1:20) (Matrigel, Corning, New York, USA). Cells were seeded at a density of 1×10<sup>4</sup> cells/mL in a 35 mm dish. The matrix was left to set at 37 °C until the day after. The next day, the medium was changed to induce pre-differentiation, as described above. In particular, the composition of the pre-differentiation medium and pre-differentiation duration were the same for all our design protocols. After 7 days, the medium was replaced to induce differentiation. The composition of the differentiation medium was the same described above for the 2D DMAP1 protocol. The duration of the differentiation phase was 20 days. The third one was called 3D DMAP1 Coating. This protocol is similar to 3D DMAP1 Mix; the only difference is that, in this case, the cell suspension was not mixed with the GFR matrix; but the dish was pre-coated with pre-chilled basement membrane matrix (1:20) and left to set at 37 °C until the day after. The next day, cells were seeded at a density of 1×10<sup>4</sup> cells/mL in Optimem with 2 mM glutamine. After 24 hours, the medium was changed to induce pre-differentiation and differentiation as described for the 3D DMAP1 Mix. The duration of the differentiation phase was 10 days. The fourth one was called 3D DMAP2 Mix. The procedure for 3D DMAP2 Mix was the same as 3D DMAP1 Mix the only difference was the composition of the differentiation medium. In this case, after 7 days of pre-differentiation, the medium was not replaced, but NGF (10 ng/mL), NRG (10 ng/mL), and VitD3 (24 nM) were directly added to the pre-differentiation medium (containing 10 µM RA). The duration of the differentiation phase was 40 days. In all the protocols described above, the culture medium was changed every 3–4 days by removing 30% of the total volume and adding fresh medium corresponding to 40% of the total volume.</p>", "<title>Electrophysiological analysis</title>", "<p id=\"Par29\">SHSY-5Y electrical activity was elucidated by using the Patch-Clamp technique in the whole-cell configuration through the pClamp8.2 software (pClamp, RRID:SCR_011323) and the MultiClamp 700 A amplifier (Axon Instruments; Molecular Devices, LLC, San Jose, CA, USA). The voltage-clamp mode was used to investigate currents through voltage-dependent sodium and potassium channels, whereas the current-clamp mode was used to measure resting membrane potential and to record induced and spontaneous electrical activity. Cells that did not generate spontaneous firing were depolarized with 1 s-current pulses, under conditioning hyperpolarization at -70 mV, to verify their capability to exhibit multiple and repetitive action potentials. The standard voltage protocol used to elicit sodium and potassium currents started from a holding potential of -60 mV, preconditioned the cells at -90 mV for 500 ms, and clamped the membrane at depolarizing steps from -80 to +40 mV, with 10 mV-increments. The standard extracellular solution, which culture medium has been replaced with, contained (mM): NaCl 135, KCl 2, CaCl<sub>2</sub> 2, MgCl<sub>2</sub> 2, Hepes 10, and glucose 5, pH 7.3. Recording pipettes of borosilicate glass had a resistance of 4 MΩ and were filled with a standard pipette solution, containing (mM): potassium aspartate 130, NaCl 10, MgCl<sub>2</sub> 2, CaCl<sub>2</sub> 1.3, EGTA 10, and Hepes 10, pH 7.3. In the voltage-clamp mode, resistance compensation was applied to obtain an error &lt;10 mV. Experiments were performed at room temperature.</p>", "<title>Cell viability and cytotoxicity</title>", "<title>Trypan blue exclusion assay</title>", "<p id=\"Par30\">SH-SY5Y cells were seeded in 24-well plates (Euroclone, Pero, Italy) at a density of 1.2 ×10<sup>4</sup> cells/well and were differentiated as described above (3D DMAP1 Mix, 3D DMAP2 Mix) or left undifferentiated (Control). At each time point (4, 7, 17, 27, 37, 47 days), cells were detached and counted as previously described [##REF##29208460##95##]. In particular, in the trypan blue exclusion assay, we also considered pre-differentiation days (time points 4 and 7 days); therefore, differentiation days were expressed as progressive numbers (17, 27, 37, and 47 days).</p>", "<title>LDH assay</title>", "<p id=\"Par31\">Cells were seeded in 96-well plates (Euroclone, Pero, Italy) at a density of 1 × 10<sup>3</sup> cells/well and were differentiated as described above (3D DMAP2 Mix) or left undifferentiated (Control). At each time point (10, 20, 30, and 40 days of differentiation), supernatants were collected (The control supernatant was collected 7 days after plating). According to the manufacturer’s instructions, the lactate dehydrogenase (LDH) levels released into the culture medium were quantified using the CytoTox 96® Non-Radioactive Cytotoxicity Assay kit (Promega). The data were expressed as the ratio between the optical density (OD) of LDH and the number of cells of each corresponding well.</p>", "<title>MTT assay</title>", "<p id=\"Par32\">Cells were plated and differentiated as described above (Cytotoxicity assay). At each time point (7 days of predifferentiation, and 10, 20, 30, and 40 days of differentiation) 10 µL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) stock solution (0.5 mg/mL; Sigma-Aldrich, St. Louis, MO, USA) was directly added to each well. Cells were incubated at 37 °C for 4 h after formazan crystals were dissolved as previously described [##UREF##7##96##].</p>", "<title>Antibodies and reagents</title>", "<p id=\"Par33\">Mouse monoclonal anti-β-tubulin (used 1:150) was obtained from Sigma-Aldrich. Monoclonal anti-NeuN/Fox3 (used 1:150) produced in mouse primary antibody was purchased from Immunological Sciences. Rabbit monoclonal anti-Synapsin 1 (used 1:200), rabbit monoclonal anti-Synaptophysin (used 1:100), and rabbit monoclonal anti-Complexin 1/2 (used 1:800) were purchased from Cell Signaling (Synaptic Neuron Marker Antibody Sampler kit). Mouse monoclonal anti-PSD95 (used 1:100) was obtained from Cell Signaling. TRITC-labeled phalloidin (used 1:1000) was from Sigma Aldrich. Alexa Fluor 488 mouse anti-Choline Acetyltransferase (ChaT) (used 1:100) was obtained from Abcam. Mouse monoclonal anti-Tyrosine Hydroxylase (TH) (used 1:300) was purchased from Cell Signaling. Alexa Fluor 488 goat anti-rabbit (used 1:200), and Cy3 goat anti-mouse (used 1:200) were purchased from Life Technologies. PhenoVue 641 Mitochondrial Stain (used 100 nM) was obtained from PerkinElmer. Hoechst 33342 (working concentration 1 µg/mL) was purchased from ThermoFisher.</p>", "<title>Immunofluorescence and Operetta CLS™</title>", "<p id=\"Par34\">SH-SY5Y cells were plated in 96-well plates (uClear, lid black, Greiner Bio-One, Kremsmünster, Austria) at a density of 1×10<sup>3</sup> cells/well and were differentiated as described above (3D DMAP2 Mix). After 10 or 40 days of differentiation (DIV), cells were fixed with 3.7% paraformaldehyde (Sigma-Aldrich, St. Louis, MO, USA) in phosphate-buffered saline (PBS) (Euroclone, Pero, Italy) for 10 min, permeabilized for 4 min with 0.1% Triton X-100 in PBS, blocked with 1% bovine serum albumin (BSA) (Merck Life Science, Darmstadt, Germany) in PBS for 1 h, and stained with primary antibodies for 1 h at 37 °C, followed by secondary antibodies for 45 min at 37 °C and nucleus-stained with Hoechst 33342 for 10 min. Fluorescence images were captured with Operetta CLS™ (PerkinElmer, Inc, Waltham, MA, USA) equipped with a 63× immersion objective. Since this protocol allows to obtain 3D cultures, different z-stacks were captured at Operetta CLS™ and maximum projection was shown.</p>", "<title>Live-cell imaging and time-lapse</title>", "<p id=\"Par35\">SH-SY5Y cells were seeded in 96-well plates (uClear, lid black, Greiner Bio-One, Kremsmünster, Austria) at a density of 1×10<sup>3</sup> cells/well and were differentiated as described above (3D DMAP2 Mix or 3D DMAP1 Mix) or left undifferentiated (Control). <italic>Neuronal network evaluation</italic>. After 0, 7 days of pre-differentiation, and 10, 20, 30, and 40 DIV cell images were acquired using Operetta CLS™ equipped with a 20× immersion objective in Digital Phase Contrast (DPC) at 37 °C and 5% CO<sub>2</sub>. <italic>Time-lapse neuronal network formation</italic>. After 10 or 40 DIV time-lapse imaging was performed using Operetta CLS™ at 63× magnification as previously described [##UREF##7##96##, ##UREF##8##97##]. Images of each chosen field were captured every 5 min, in DPC, for 18 h at 37 °C and 5% CO<sub>2</sub>. <italic>Vesicle trafficking</italic>. After 40 DIV time-lapse imaging was performed using Operetta CLS™ at 63× magnification as previously described [##UREF##7##96##, ##UREF##8##97##]. Images of each chosen field were captured every 2 s, in DPC, for 10 min at 37 °C and 5% CO<sub>2</sub>. <italic>Mitochondria transport and imaging</italic>. After 10, 20, 30, and 40 DIV cells were stained (Control cells were stained one day after plating) with 100 nM PhenoVue 641 Mitochondrial Stain and Hoechst 33342 for 20 min. Before image acquisition, the staining medium was replaced with a fresh one without phenol red. Cell images were acquired using Operetta CLS™ equipped with a 63× immersion objective in fluorescence to detect mitochondria (PhenoVue 641 Mitochondrial Stain) and nuclei (Hoechst 33342).</p>", "<title>Seahorse</title>", "<p id=\"Par36\">All the reagents and consumables were purchased from Agilent Technologies (Santa Clara, CA, USA) unless otherwise indicated. SH-SY5Y cells were seeded in Seahorse XF96 Cell Culture Microplates at a density 5 × 10<sup>2</sup> cells/well and were differentiated as described above (3D DMAP2 Mix) or at a density of 5 × 10<sup>4</sup> cells/well left undifferentiated (Control), in a volume of 200 μL/well. The day of the assay, the cells were washed twice 180 μL/well with Seahorse XF DMEM Medium, pH 7.4, supplemented with 10 mM D-Glucose, 2 mM L-Glutamine, and 1 mM Na-Pyruvate and finally, the cells were allowed to equilibrate in 180 μl/well of complete Seahorse XF medium for 1 h at 37 °C in a no-CO<sub>2</sub> incubator. The assays were performed by means of Agilent Seahorse XFe96 Analyzer using the Mito Stress Test protocol.</p>", "<p id=\"Par37\">The day before the assay, the XF Sensor Cartridge was hydrated with 200 µL/well of milliQ water and incubated overnight at 37 °C in a no-CO<sub>2</sub> humidified incubator. The day after, the Seahorse XF Calibrant solution was used to replace milliQ water in the XF Sensor Cartridge, and the lyophilized drugs Oligomycin (150 µM), FCCP (100 µM) and Rotenone/Antimycin A (50 µM) were rehydrated in complete Seahorse XF DMEM Medium. The drugs were loaded in the corresponding ports of the sensor cartridge after being diluted 1:10 in complete Seahorse XF DMEM Medium, as indicated in Mito Stress Test Kit user guide, in order to reach the final concentrations of 1.5 µM Oligomycin, 3 µM FCCP, and 2 µM Rotenone/Antimycin A once injected into the Seahorse microplate. At the end of the Seahorse assay, Hoechst 33342 (H3570, Gibco-ThermoFisher, Waltham, MA, USA) was added to each well at a final concentration of 1 µg/mL, and after 15 min incubation at 37 °C, the images of nuclei were acquired by the Operetta CLS™ at 20× magnification. Seahorse parameters were normalized on the number of cells/well calculated using Harmony software, as reported previously [##UREF##9##98##, ##UREF##10##99##].</p>", "<p id=\"Par38\">The analysis of respiratory parameters was performed using Wave 2.6.1 software and calculated using the following formulas:<list list-type=\"bullet\"><list-item><p id=\"Par39\">Basal respiration = OCR<sub>Basal</sub> – OCR<sub>Rot/AA</sub></p></list-item><list-item><p id=\"Par40\">Maximal respiration = OCR<sub>FCCP</sub> – OCR<sub>Rot/AA</sub></p></list-item><list-item><p id=\"Par41\">Spare respiratory capacity = OCR<sub>FCCP</sub> – OCR<sub>Basal</sub></p></list-item><list-item><p id=\"Par42\">ATP-linked respiration = OCR<sub>Basal</sub> – OCR<sub>Oligomycin</sub></p></list-item><list-item><p id=\"Par43\">Proton leak = OCR<sub>Oligomycin</sub> – OCR<sub>Rot/AA</sub></p></list-item></list></p>", "<title>Analysis of network complexity</title>", "<p id=\"Par44\">The network complexity analysis was performed with Harmony software (PerkinElmer, Inc, Waltham, MA, USA). Cell segmentation was performed based on Hoechst and Tubulin staining to detect nuclei and neurites. Neurites were detected by using the Find Neurites building block. Neurite properties were calculated and parameters taken into account in our study were: the number of extremities, number of roots, number of segments, number of nodes type I, and number of nodes type II (corresponding to “number of segments” divided by “number of roots”) (Fig. ##FIG##1##2B##). The process length per cell (µm/cell) was calculated following the procedure previously described by Morrison [##REF##29038483##100##].</p>", "<title>NeuN positive cells analysis</title>", "<p id=\"Par45\">Cells were examined for the expression of NeuN. The percentage of NeuN-positive cells was calculated. About 99 neurons, derived from 12 different fields, were analyzed.</p>", "<title>Synaptic marker analysis</title>", "<p id=\"Par46\">The number, size, and colocalization of pre- and postsynaptic puncta were analyzed using Fiji software and the Synapse Counter plug-in for ImageJ, developed by Egor Dzyubenko (Ruhr-University Bochum, Faculty of Biology and Biotechnology, Department of Cell Morphology and Molecular Neurobiology, Head: Prof. Dr. Andreas Faissner) and Andrey Rozenberg. Puncta per 50 µm of neurites and 0.043 mm<sup>2</sup> area were analyzed.</p>", "<title>Vesicle trafficking analysis (single particle tracking analysis)</title>", "<p id=\"Par47\">Single particle tracking was performed using Fiji software and the Manual Tracking plug-in for ImageJ. Each particle was tracked frame-by-frame to calculate mean velocity; in particular, for reversing behavior, we considered only particles within the initial 20 µm segments of neurites, and the percentage of vesicles, which reverse their trajectory (from anterograde to retrograde) was calculated.</p>", "<title>Mitochondrial morphology analysis</title>", "<p id=\"Par48\">Quantitative image analysis was performed on both Harmony software and the Mitochondrial Analyzer plug-in for ImageJ (Fiji software). Harmony analysis was performed following the procedure previously described by Douida [##UREF##11##101##]. The Mitochondria Analyzer plug-in was used to confirm results obtained from Harmony, in particular, the parameters taken into account in our study were: mean aspect ratio [(major axis)/(minor axis)], form factor [(perimeter<sup>2</sup>)/(4π·surface area)], branches length/mito (the mean value of the total length of branches of each mitochondrion in a cell), the total area of mitochondria per 0.043 mm<sup>2</sup> region /n° of cells (the total area of the mitochondria in one cell).</p>", "<title>Neuronal phenotype analysis (ChaT and TH expression and localization)</title>", "<p id=\"Par49\">Quantitative image analysis was performed on both Harmony software and Fiji software. In particular, the ratio between the fluorescence intensity of ChaT and TH in the cell body and ChaT fluorescence intensity in the nuclei were calculated using the Harmony software (cell segmentation was performed based on Hoechst and ChaT or TH staining). Besides, the size and the number of ChaT and TH puncta within neurites (considering an area of 0.043 mm<sup>2</sup>) were analyzed using Fiji software and the Synapse Counter plug-in. To obtain only puncta parameters (number and size) within neurites; before starting the analysis, particles inside cell bodies were manually edited: puncta within the cell body were selected (freehand section) and cleared.</p>", "<title>Statistical analysis</title>", "<p id=\"Par50\">Statistical analysis was performed using GraphPad Prism 8 software. Data were expressed as a mean ± standard error of the mean (SEM). <italic>P</italic> value lower than 0.5 was considered statistically significant (*<italic>p</italic> &lt; 0.5, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001, ****<italic>p</italic> &lt; 0.0001). <italic>N</italic> value, <italic>p</italic> value, and statistical tests used for each experiment are reported in the corresponding figure legend and in Table ##TAB##0##1##.</p>" ]
[ "<title>Results</title>", "<title>3D DMAP2 Mix condition induces functional differentiation in SH-SY5Y cells</title>", "<p id=\"Par7\">An electrophysiological investigation was performed to evaluate the functional properties of SH-SY5Y cells in the different culture conditions we applied to promote neuronal differentiation (Fig. ##FIG##0##1A## and Materials and Methods section). Cells were analyzed by studying the main parameters related to the electrical activity of differentiated neurons, such as current densities through voltage-dependent Na<sup>+</sup> and K<sup>+</sup> channels, resting membrane potential, and action potential firing frequency, which are representative of the intrinsic neuronal membrane properties. Na<sup>+</sup> and K<sup>+</sup> currents were recorded using the protocol described in the Materials and Methods section and were identified as inward transients (I<sub>Na</sub>) and outward steady-state signals (I<sub>K</sub>) respectively (Fig. ##FIG##0##1B##). The maximum values of current intensity recorded by each cell were normalized on cell capacitance to obtain current densities. Action potential frequencies were calculated on the activity generated by the cell in response to depolarizing currents injected by the patch micropipette. On the contrary, the ability to generate spontaneous activity was recorded without any current injection; this parameter was also investigated because it reflects the establishment of synaptic connections in the neuronal networks.</p>", "<p id=\"Par8\">Results showed that, at 10 DIV, 3D cultures had significantly higher Na<sup>+</sup> and K<sup>+</sup> current densities compared to 2D cultures. In particular, the 3D Coating cultures had higher Na<sup>+</sup> current density compared to 3D cultures prepared as described in the literature (Fig. ##FIG##0##1C, D##). Moreover, cells in 3D cultures showed a trend to have more hyperpolarized resting membrane potentials (Fig. ##FIG##0##1E##) and higher action potential firing frequencies compared to 2D cultures (Fig. ##FIG##0##1F, G##). Furthermore, 3D Coating and 3D Mix cultures exhibited a significantly higher percentage of cells with multiple induced action potentials (Fig. ##FIG##0##1H##). Thus, 3D Coating and 3D Mix cultures were maintained until 15 DIV, when the 3D Mix cultures showed an improvement in the overall functional properties compared to 3D Coating cultures (Supplementary Fig. ##SUPPL##0##S1A-E##). 2D cultures were analyzed starting from 5 DIV (as described in the literature) until 10 DIV. Data showed that over this culture period, the action potential firing frequency and the ability of cells to generate multiple action potentials showed a decreasing trend (Supplementary Fig. ##SUPPL##0##S1F-J##), and for this reason, this condition was excluded. 3D cultures described in the literature were analyzed at 10 and 20 DIV and results showed no significant differences over this culture period, suggesting that a stationary state in the electrophysiological properties was reached by the cells. Moreover, their phenotype was less differentiated compared to that of 3D Coating and 3D Mix cultures; thus, this condition was not investigated further (Supplementary Fig. ##SUPPL##0##S1K-O##).</p>", "<p id=\"Par9\">Since these results indicated that 3D culture conditions were promising for inducing SH-SY5Y functional differentiation, further electrophysiological characterizations of these cultures at different times of differentiation were performed (results at 10, 20, 30, and 40 DIV are shown in Fig. ##FIG##0##1I, M##; at 25 DIV in Supplementary Fig. ##SUPPL##0##S1R-W##). Cells in the DMAP1 Mix condition seemed to exhibit a differentiated phenotype; however, their viability decreased after 20 DIV. Thus, the DMAP2 Mix condition was developed to try to maintain cultures for longer periods. This condition allowed an improvement in cell functional properties up to 40 DIV compared to 10 DIV. In fact, in the DMAP2 Mix condition, spontaneous action potentials could be recorded starting from 20 DIV (Fig. ##FIG##0##1N##), and the percentage of cells with spontaneous activity increased from 12% at 20 DIV to 37% at 40 DIV (Fig. ##FIG##0##1O##). Furthermore, no detrimental effects on cell viability and cytotoxicity were found in this condition (Fig. ##FIG##0##1P, Q##, Supplementary Fig. ##SUPPL##0##S1V##). Besides, in the DMAP2 Mix condition, cells stopped growing from 10 DIV (indicated in the graph as 17 days, which corresponds to 7 days of pre-differentiation followed by 10 days of differentiation) reaching a plateau that held up to 40 DIV (indicated in the graph as 47 days) (Fig. ##FIG##0##1P##). In particular, starting from 10 DIV (17 days), there were significantly more cells in the DMAP1 Mix group than in the DMAP2 Mix group; the difference was maintained until 20 DIV when the viability of the DMAP1 Mix dropped (Fig. ##FIG##0##1P##). Taken together these results suggest that the DMAP2 Mix could be a promising culture condition to induce functional neuronal differentiation in SH-SY5Y cells.</p>", "<title>SH-SY5Y cells in 3D DMAP2 Mix condition express neural markers and display complex neuritic arborization before functional maturation</title>", "<p id=\"Par10\">To investigate the complexity of neuronal networks during differentiation with 3D DMAP2 Mix, cultures were immuno-labeled with an antibody against β-tubulin. In particular, the totality of cells expressed β-tubulin since 10 days of differentiation (10 DIV), mainly in the cell body and the leading neurite. With time in culture, notably after 40 days of differentiation (40 DIV), all cells displayed more complex neuritic arborizations (Fig. ##FIG##1##2A##). Figure ##FIG##1##2B## summarizes some of the parameters considered in our study to quantify this aspect. This analysis showed an improvement in the numbers of neurites (roots), branching nodes (type I nodes), branching (segments), terminal nodes (extremities), and trees (type II nodes) between 10 and 40 DIV (Fig. ##FIG##1##2C–G##). Appropriate growth and branching of neurites are essential for neurons and nervous system functions. Neurite development determines the number and the pattern of synapses received by each neuron [##REF##11007547##35##]. Therefore, designing a differentiation protocol that promotes neurite arborization is essential for studies directly focusing on neuronal morphology and potentially critical for disease-modeling studies. Defects in neurites outgrowth are often associated with a severe neurodevelopmental disorder [##REF##11007547##35##]. Digital phase contrast (DPC) images of live cells at different differentiation stages were analyzed to further demonstrate the improvement of neural network complexity during differentiation. In particular, an increase in process length (µm) per cell was tracked by monitoring each large image (25 fields) considered (6 large images) in the analysis during differentiation (Supplementary Fig. ##SUPPL##0##S2##). Moreover, the increase in differentiation time matched the enhancement in process length (Supplementary Fig. ##SUPPL##0##S2##). Time-lapse imaging of living cells at 10 and 40 DIV confirmed this data (Video ##SUPPL##2##1## and ##SUPPL##3##2##) and highlighted changes in neurites dynamics, consistent with a physiological neuronal maturation. During 10 days of differentiation, neurites increased rapidly and were more dynamic; afterward, they grew more slowly, and around 40 DIV became structurally stable. Neurite formation has been described to occur in three stages: protrusion, arborization, and consolidation [##REF##24002528##36##, ##REF##10341248##37##]. The switching in neurite growth rate and arbor dynamics from stage 2 to stage 3 corresponds to improved synaptic establishment and strength in neurons. The data support the idea that weaker synaptic inputs, as suggested at 10 DIV by electrophysiological recordings, allow a greater degree of dynamic rearrangements and a faster growth rate in the neurite arbor; otherwise, strong synaptic inputs, as observed at 40 DIV, stabilize neurite arbor structures and decrease arbor dynamism [##REF##10341248##37##]. Finally, to extend and more precisely characterize differentiating cells, cultures were immuno-labeled with an antibody against the neuronal-specific nuclear marker NeuN. Differentiated SH-SY5Y stained positively for NeuN (~96%, 95 out of 99 neurons analyzed from 12 different fields) already at 10 DIV (Fig. ##FIG##1##2H, I##). These results, together with β-tubulin-staining, confirm that the expression of neuronal markers arises before the acquisition of the complete functional maturation.</p>", "<title>SH-SY5Y cells in 3D DMAP2 Mix condition express synapse-specific proteins and develop mature synaptic ultrastructures</title>", "<p id=\"Par11\">The capability of a neuron to form synaptic connections is an essential requisite for functional maturation. Therefore, the expression of presynaptic markers and quantification of pre-synaptic puncta were investigated. Cultures at 10 and 40 DIV were immune-labeled with antibodies against synapsin 1, synaptophysin, or complexin 1/2. Until 10 DIV, the totality of cells expressed presynaptic markers mainly in the soma and the neurites (Fig. ##FIG##2##3A##). At a longer time, notably after 40 DIV, the entire culture displayed an increase in presynaptic protein localization at sites of neurite contacts (Fig. ##FIG##2##3A##). In particular, quantitative analysis revealed that synaptophysin and complexin 1/2 boutons number per 50 µm of neurites grew from 10 to 40 DIV while synapsin 1 puncta number did not change (Fig. ##FIG##2##3B, D, F##). Moreover, the size of synapsin 1 and synaptophysin boutons was enhanced from 10 to 40 DIV (Fig. ##FIG##2##3C, E##). To further study synaptic connections, we decided to quantify the number of pre-synaptic puncta per 0.043 mm<sup>2</sup> area. Supplementary Fig. ##SUPPL##0##S3## shows that all presynaptic proteins considered in our study increased considerably from 10 to 40 DIV. These data are in agreement with the improvement in neural network complexity and the enhancement in process length we have observed during differentiation (Fig. ##FIG##1##2A–G##). Notably, synaptic maturation involves the increase of both synapse size and the amount of pre- and postsynaptic proteins [##REF##17417940##38##]. Besides, despite the initial assembly of a synapse can be fairly rapid (just a few minutes), the establishment of a mature synapse is generally prolonged, as highlighted by the lag between the formation of mature ultrastructures [##REF##11988164##39##] and the development of mature electrophysiological properties [##REF##17417940##38##, ##REF##7569903##40##–##REF##10234045##44##]. Finally, we investigated the presence and the number of synaptic densities. In particular, synaptic density was assessed as colocalization between the pre- and post-synaptic markers synapsin 1 and PSD95 at 40 DIV. The totality of cells expressed PSD95 mainly in the cell body, whereas we observed weak synaptic staining within neurites or at sites of neurite contacts (Fig. ##FIG##2##3H##). Quantitative analysis revealed that the PSD95-positive puncta number was lower than the synapsin 1-positive puncta (Fig. ##FIG##2##3I##). Furthermore, we noticed that about 46% of PSD95-positive boutons are also synapsin 1-positive instead only about 6% of synapsin 1-positive boutons are also PSD95-positive (Fig. ##FIG##2##3I##), suggesting that PSD95 is weakly expressed in our neuronal cultures.</p>", "<title>SH-SY5Y cells generate vesicles with directional sorting trafficking in 3D DMAP2 Mix condition</title>", "<p id=\"Par12\">Vesicle trafficking was investigated using a single particle-tracking analysis. Digital phase contrast (DPC) live cell imaging of differentiating cells (40 DIV) clearly showed the presence of vesicles inside neurites. Time-lapse imaging of living cells revealed that these vesicles were carried through neurites with anterograde, retrograde, or stationary movement. Moreover, in the initial 20 µm segments of neurites, it was highlighted a peculiar behavior of certain vesicles: they moved with an anterograde trajectory, paused, and reversed backwards to the soma (~5%, 164 vesicles analyzed from 20 neurons) (Fig. ##FIG##3##4A–D## and Video ##SUPPL##4##3##). Karasmanis et al. demonstrated that due to the microtubule network of mixed polarity, membrane trafficking in dendrites appears without any capacity for directional sorting. Indeed, there is a clear check-point mechanism able to directional sorting vesicles. Entering into dendrites, axonally destined cargos pause and reverse backwards to the cell body, moving with a retrograde bias, while dendritically destined cargos are polarized in the anterograde direction [##REF##30016622##45##]. A similar attitude was observed in the axonally sorting mechanism [##REF##26527003##46##]. During entry into axonal, polarized sorting of somatodendritic and axonal vesicles occurs at the pre-axonal exclusion zone (PAEZ) and depends on the capability of vesicles to gain an appropriately directed microtubule motor protein [##REF##26527003##46##].</p>", "<p id=\"Par13\">To further study vesicle trafficking, functional vesicle motility along neurites was analyzed by taking pictures every 2 s for 10 min. Frame-by-frame analysis revealed that the mean velocity of vesicles was about 0.43 µm/s (Fig. ##FIG##3##4E##), in agreement with the literature [##REF##30016622##45##]. Thus, during entry into neurites, vesicles undergo a sorting check-point mechanism. These data indicate that the proposed new differentiation protocol allows for a generation of cells with not only well-developed neuritic networks and synaptic structures but also with vesicles with directional sorting trafficking (Fig. ##REF##32017900##4##B); this feature is important for the correct transmission of neural signals.</p>", "<title>Mitochondrial metabolism and morphology of SH-SY5Y cells are rearranged in 3D DMAP2 Mix condition</title>", "<p id=\"Par14\">Since metabolic reprogramming is a key step of neuronal differentiation [##UREF##2##47##, ##REF##27058317##48##], we analyzed cellular bioenergetics in SH-SY5Y cells subjected to our differentiation protocol, using the Seahorse eXtracellular Flux analyzer XFe96 (Agilent), which allows simultaneous real-time measurements on living cells seeded on 96 well-plates of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), parameters respectively related to mitochondrial and glycolytic capacity. In this work, we decided to focus on the analysis of mitochondrial bioenergetics, since the 3D structure of the cultures variably affects the buffer factor required for the calculation of the proton efflux rate (PER), a parameter directly proportional to lactate secreted in the culture medium, from the measured ECAR values also containing the contribution of CO<sub>2</sub> produced by mitochondrial respiration.</p>", "<p id=\"Par15\">To assess mitochondrial bioenergetics we used the mito stress test protocol consisting of the OCR measurement under basal conditions and after the treatment with different drugs, including the ATP synthase inhibitor oligomycin, the ETC accelerator ionophore FCCP, and an ETC inhibitors mixture (rotenone and antimycin A) (mito stress test profile, Fig. ##FIG##4##5A##), from which the mitochondrial parameters were calculated (Fig. ##FIG##4##5B##) as described in Materials and Methods Section.</p>", "<p id=\"Par16\">Seahorse analysis highlighted a significant increase in maximal respiration and spare respiratory capacity in differentiated neurons starting from 20 DIV. No significant differences emerged in basal respiration, ATP-linked respiration, and proton leak. Notably from 20 to 40 DIV the maximal respiratory capacity is maintained at similar levels of oxygen consumption per cell suggesting that at 20 DIV cells have reached the mitochondrial rearrangement required for neuron maturation.</p>", "<p id=\"Par17\">Mitochondria are highly dynamic organelles able to change their shape. In particular, mitochondria morphology is tightly related to their functionality. During neuronal differentiation mitochondria morphology changes from mixed globular and tubular structure to more elongated tubular structure, and this reflects the metabolic shift of cells from glycolysis to OXPHOS for an increase in bioenergetics [##REF##30269744##49##]. Furthermore, the increase in mitochondria biogenesis is another important process that occurs during neural differentiation [##UREF##2##47##].</p>", "<p id=\"Par18\">To further corroborate data obtained by seahorse analysis, mitochondria morphology was analyzed. We quantified mitochondrial phenotypes during differentiation using live-cell high-content-imaging analysis with PhenoVue 641 Mitochondrial Stain (Fig. ##FIG##4##5C##). In particular, we classified mitochondria as compact tubular, tubular, or round using Harmony and PhenLogic machine-learning software. Our analysis revealed that, during differentiation, there was a significant increase in the proportion of cells with a tubular mitochondria phenotype: 10.8 ± 1% control (25 fields analyzed, with about 30 cells for each field), 28.1 ± 1.9% 10 DIV (17 fields analyzed, with about 15 cells for each field), 42 ± 1.2% 20 DIV (67 fields analyzed, with about 19 cells for each field), 38.2 ± 3.5% 30 DIV (26 fields analyzed, with about 20 cells for each filed), and 52.5 ± 1.7% 40 DIV (30 fields analyzed, with about 15 cells for each filed) (Fig. ##FIG##4##5C and D##). Additional analysis using Fiji software and the Mitochondria Analyzer plug-in confirmed results obtained by Harmony software (Fig. ##FIG##4##5E and F##). Furthermore, during differentiation, we also observed a significant enhancement of branches length per mitochondrion (Fig. ##FIG##4##5G##) and an improvement in mitochondria biogenesis (Fig. ##FIG##4##5H##). Notably, all mitochondria parameters calculated (shape, network, and mitochondria biogenesis) were maintained at similar levels from 20 to 40 DIV as observed in seahorse analysis.</p>", "<title>SH-SY5Y cells differentiate towards a cholinergic-like phenotype in 3D DMAP2 Mix condition</title>", "<p id=\"Par19\">Depending on culture conditions, SH-SY5Y cells can be differentiated into several adult neuronal phenotypes, including cholinergic, dopaminergic, or adrenergic [##REF##20497720##50##]. Undifferentiated SH-SY5Y cells express low levels of both endogenous tyrosine hydroxylase (TH) and choline acetyltransferase (ChaT), enzymes involved respectively in dopamine (DA) and acetylcholine (ACh) synthesis [##REF##23975817##28##]. To figure out which neuronal phenotypes our differentiation protocol can drive, cultures at 10 and 40 DIV were immune-labeled with antibodies against TH and ChaT. As shown in Fig. ##FIG##5##6A##, since 10 DIV, the totality of cells expressed both TH and ChaT, mainly in the cell body and the leading neurites. In particular, ChaT showed a nuclear localization both at 10 and 40 DIV. With time in culture, notably after 40 DIV, all cells displayed an increase of ChaT localization within neurites and at the sites of neurite contacts. Quantitative analysis revealed that the expression of ChaT in cell bodies was higher than TH-expression since 10 DIV, although this ratio decreased at 40 DIV (Fig. ##FIG##5##6B##). Furthermore, ChaT nuclear localization dropped from 10 to 40 DIV (Fig. ##FIG##5##6C##). ChaT expression reduction, both in the soma and nucleus at 40 DIV can be attributed to the sharp increase of ChaT localization within neurites at 40 DIV (Fig. ##FIG##5##6D##). Moreover, the size of ChaT-positive boutons was enhanced from 10 to 40 DIV, while TH puncta size decreased during differentiation (Supplementary Fig. ##SUPPL##0##S4##). In general, we observed that in our cultures ChaT was more expressed than TH. Thus, we can conclude that neurons obtained during our differentiation protocol acquired a cholinergic-like phenotype.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par20\">The current lack of cellular models capable of recapitulating the characteristics of mature human neurons makes studies on neurodegenerative diseases and the design of new drugs for these pathologies very difficult/tricky. Specifically, the currently most promising cell models available (iPSCN, NSC) did not exhibit the electrical activity typical of a mature neuron, and the protocols developed to differentiate them are difficult to reproduce and standardize. Given the above, we developed a human 3D neuronal cell culture, starting from a readily available human neuroblastoma cell line, SH-SY5Y cells [##REF##4748425##51##]. In this culture, neurons were able to establish functional networks, active synaptic structures, and vesicles with directional sorting trafficking, and showed properties of cholinergic neurons.</p>", "<p id=\"Par21\">Several research groups have tried to differentiate SH-SY5Y by a combination of neurodifferentiative factors and scaffolds/gels to reproduce the extracellular matrix of the neural microenvironment [##REF##20413890##26##, ##UREF##3##52##, ##REF##34907283##53##]. Being inspired by the success in generating cells with morphological and biochemical characteristics of mature neurons [##REF##20413890##26##], we designed a new culture protocol by combining three-dimensional culturing with the synergistic effects of multiple neurotrophic factors, such as Retinoic acid (RA), NGF, NRG1, VitD3, and BDNF. RA is a derivative of retinol (Vitamin A) which supports the differentiation of human neuroblastoma cells, iPSCs, and NSCs [##REF##25558812##54##, ##REF##20427117##55##]. The addition of retinoic acid to the cell culture medium is the most common procedure to induce neuronal differentiation. Many papers have demonstrated the efficacy of retinoic acid to derive neurons expressing phenotypic cholinergic or dopaminergic markers from SH-SY5Y cells [##REF##31037648##56##–##REF##15111235##58##]. The mechanism by which RA exerts its differentiative effect involves the switch from proliferation to differentiation by stimulating the expression of the nerve growth factor (NGF) receptor and by increasing cell sensitivity to the same factor [##REF##1325442##59##]. NGF is a neurotrophin essential for neuronal differentiation and neurites outgrowth by activating the tyrosine kinase TrkA and the p75 receptors [##REF##12671646##60##]. NGF-induced differentiation is caused by an increased mitochondrial remodeling, which regulates mitochondria biogenesis and metabolism and sustains mitochondrial mass, potential, and bioenergetics [##REF##29523844##61##]. In fact, extensive metabolic reprogramming occurs during cell differentiation [##UREF##2##47##–##REF##30269744##49##], and derivative metabolites play a key role in modulating the epigenetic status of cells, and thus altering gene expression patterns [##REF##30814486##62##, ##REF##26359776##63##]. In our work, seahorse experiments demonstrated that, during differentiation, SH-SY5Y cells acquire a greater mitochondrial respiratory capacity, which is reflected in a significant increase in FCCP-uncoupled maximal respiration, in mitochondrial mass and branching starting from 20 DIV. This functional metabolic rearrangement is in agreement with the enhancement of PGC1a-promoted mitochondrial biogenesis occurring during neural differentiation, which is extensively described in the literature [##UREF##2##47##]. It is noteworthy that right at 20 DIV, where the maximum mitochondrial respiration capacity and the maximum extension of the mitochondrial network have been reached, the cells behave as functionally mature neurons, capable of synthesizing acetylcholine.</p>", "<p id=\"Par22\">NRG1 and Vitamin D are involved in neuronal differentiation, neurite outgrowth, neurotransmission, and in the synthesis of growth factors (i.e., NGF) and several neurotransmitters such as acetylcholine (ACh), dopamine (DA), and gamma-aminobutyric acid (GABA) [##REF##11399426##64##–##UREF##4##66##]. In our cultures, the synergy of these compounds, together with the use of Growth Factor Reduced (GFR) basement membrane extract matrix and Optimem medium, enhances neuronal maturation, supporting differentiation instead of proliferation. In fact, GFR matrix provides components crucial for neuronal differentiation and high levels of brain extracellular matrix proteins, such as laminin. In our protocol, we set up a thin-layer (100-300 µm) 3D culture model. This thickness allows to perform analysis as in vitro cultures (e.g., real-time imaging, immunofluorescence, and biochemical assays), but mimicking the cytoarchitecture of brain tissue in its physiological environment. Furthermore, compared to 2D cell cultures, 3D cultures show longer viability, various differentiation patterns, longer neurite extension, and formation of higher-density networks [##REF##7622552##67##–##REF##28064005##70##]. Our data show that both 2D (2D DMAP1) and 3D Coating (3D DMAP1 coating) cultures were not able to reach complete neural maturation. In the first case, cells could establish 3D interactions neither with other cells nor with the extracellular matrix, whereas in the second case, although cells could assess interactions with the extracellular basement, they could not establish a 3D network. The use of Optimem medium to support neuronal differentiation and electrical and synaptic activity is one of the major novelties of our differentiation protocol. Hu et al. demonstrated that, compared to the conventional RPMI-1640 medium, the use of the Optimem improved minimum essential medium to differentiate PC12 cells, increased neurite length, adhesion rate, differentiation, expression of synapsin 1, and induced action potentials [##REF##29115371##71##]. Here, we demonstrated that our method sustained the development of functional and active neuronal networks. By the approaches described in the literature, cells achieved a stationary state in the electrophysiological properties starting from 10 DIV; furthermore, the phenotype of cells treated with the literature approach (3D literature) was less differentiated concerning morphology, network extension, complexity, and especially for the absence of spontaneous activity. This could be caused not only by the lack of supplements in these cultures but also by the breaking of interactions established in the early stage of the differentiation process (pre-differentiation state) since the Agholme protocol required cells harvested by trypsinization to switch from the pre-differentiation (2D culture) to the differentiation phase (3D culture) [##REF##20413890##26##]. Moreover, since the Optimem medium contains more hypoxanthine and thymine than other media, we supposed that these nutrients could sustain cell functional maturation. Purine and pyrimidine nucleotides are essential precursors for nucleic acid synthesis, but their functions are not limited to this [##UREF##5##72##], because purines act as metabolic signals, provide energy [##REF##15665829##73##, ##REF##16981043##74##], and participate in the synaptic process particularly associated with ACh, GABA, and glutamate neurotransmission [##REF##18404445##75##]; whereas pyrimidines are involved in polysaccharide and phospholipid biosynthesis, detoxification processes [##UREF##5##72##, ##REF##18261711##76##], and neurotransmission [##REF##23040806##77##]. BDNF could support both cell proliferation [##REF##34026357##78##] and differentiation [##REF##10936180##21##, ##REF##20413890##26##, ##REF##32389647##79##]. Since the Agholme protocol also used BDNF instead of RA to induce cell differentiation, in our study the same protocol was employed to verify the eventual effects of this factor on SH-SY5Y cells. Although, in the early stage of differentiation, BDNF in 3D DMAP1 Mix seemed to support functional neuronal maturation, after 20 DIV cell viability decreased.</p>", "<p id=\"Par23\">The synergistic effects of combining multiple factors allow us to obtain cells that show properties of cholinergic neurons. Choline acetyl-transferase (ChAT) and acetylcholine esterase (AChE), respectively involved in the synthesis and degradation of ACh, are markers of cholinergic neurons [##REF##31551706##80##]. In neuronal cells, nuclear ChaT activates the transcription of selected genes, including the high-affinity choline transporter (CHT1) [##REF##21163949##81##], which is responsible for the reuptake of choline in presynaptic terminals. Considering our model, at the early stage of the differentiating protocol (10 DIV), cells express ChaT mainly in the cell body and the leading neurites. Since at the beginning of the differentiation process cells need to synthesize CHT1, the amount of ChaT in the nucleus is higher than at the end of differentiation, when the synaptic activity is predominant and ChaT localizes mainly in the presynaptic terminal. In our cells, the nuclear localization of ChaT is reduced but maintained also at 40 DIV, and this reduction corresponds to an increase within neurites and at the sites of neurite contacts, with an enhancement of the size of ChaT-positive boutons. Moreover, we observed that our cultures expressed TH in addition to ChaT. Besides, Jeong et al. [##REF##27611685##82##] have shown that about 70% of cholinergic neurons in the arcuate nucleus (ARC) of the mouse brain express both TH mRNA and the GABA synthesizing enzyme, glutamate decarboxylase, and vesicular GABA transporter transcripts. The key factor in human cholinergic mature neurons is synaptic density marker expression. In our cultures, at the beginning of the differentiation protocol, synapsin 1, synaptophysin, and complexin 1/2 were mainly expressed in the soma and the neurites while, when maturation was completed, they were principally localized at presynaptic terminus. This is fully in agreement with the increase in neural network complexity. On the other hand, to analyze the colocalization between the pre- and post-synaptic markers (synaptic densities) we used synapsin 1 and PSD95, but while synapsin 1 localized in neurite contacts, PSD95 presented weak staining within neurites. This data is not surprising since cholinergic neurons predominantly express PSD93, which is the paralog of PSD95 [##REF##14724236##83##].</p>", "<p id=\"Par24\">Electrophysiological properties of cholinergic neurons are quite heterogeneous depending on the brain region and the species they are isolated from [##REF##31551706##80##]. For instance, adult mouse basal forebrain cholinergic neurons, serving as a primary source of cholinergic inputs to the cerebral cortex, have been differentiated into two identifiable subtypes, according to their excitability (“early” and “late” firing) [##REF##22586380##84##]. Moreover, cholinergic neurons in the brainstem pedunculopontine nucleus have been divided into four groups for the presence or absence of the transient outward potassium A-current, low threshold spikes, and spike latency [##REF##30734834##85##], and striatal cholinergic interneurons have shown diversity in their spontaneous firing frequency, which was related to the single (ACh) or dual (ACh and GABA) neurotransmitter release [##REF##29651049##86##].</p>", "<p id=\"Par25\">A detailed analysis of some electrophysiological parameters, extrapolated from our recordings from neurons in 3D DMAP2 Mix cultures at 30 and 40 DIV, showed that our data were consistent with the results obtained by Unal et al. [##REF##22586380##84##], for adult mouse basal forebrain cholinergic neurons [##REF##22586380##84##]. For instance, for the amplitude of the first action potential, the delay of the first action potential, and the amplitude of the after hyperpolarization, the values we calculated were: 69 ± 3 mV, 129 ± 32 ms, 12 ± 1 mV (<italic>n</italic> = 13–14 cells) <italic>versus</italic> 71 ± 9 mV, 107 ± 53 ms and 18 ± 10 mV, from Unal et al. [##REF##22586380##84##]. This comparison supports that the electrophysiological parameters of neurons in our culture model were in line with the one described in the literature for certain subtypes of cholinergic neurons.</p>", "<p id=\"Par26\">Cholinergic dysfunction has very severe and large effects on cognition and behavior [##REF##25386136##87##]. Different patterns of alteration and/or degeneration of cholinergic neurons have been highlighted in various pathologies such as Alzheimer’s disease, Dementia with Lewy Bodies (DLB), Parkinson’s disease (PD), and atypical parkinsonian diseases (APD) and Huntington disease; further, a loss of cholinergic neurons has been found in dementias induced by exogenous causes (i.e Chronic alcohol abuse) [##REF##24894464##88##, ##REF##28652219##89##].</p>", "<p id=\"Par27\">Since many cognitive dysfunctions have as common trait alterations in the cholinergic system, our novel differentiation protocol could represent an innovative procedure to induce functional maturation of neuronal cultures for the study of pathological models of neurodegeneration, such as Alzheimer’s disease [##REF##3538164##90##]. Of course, to better mimic the complex neurophysiological environment, it will be of fundamental importance to set up a co-culture with the glial components. Glial cells are key modulators of neuronal function either in physiological conditions or in neurodegenerative diseases [##REF##35493929##91##, ##REF##15707899##92##]. The in vitro models available today are too sophisticated or lack physiological complexity, are expensive, or are based on murine cells and therefore do not have the specific characteristics of human neurons; moreover, in vivo models require high financial efforts, are time-consuming, and require the sacrifice of many animals. In this study, we developed and characterized a human 3D culture model of cholinergic-like neurons that can be used to study different aspects of cellular pathologies related to the functional impairment or degeneration of these neurons. This model is inexpensive, easily reproducible, and is based on human cells. Moreover, it is an ethical alternative to the use of animals by fully respecting the 3 R principles: Reduction, Refinement, and Replacement in product testing and scientific research [##UREF##6##93##]. Further physiological studies would provide a reliable investigation of the molecular mechanisms of this method; however, for therapeutic perspectives, this approach could represent a suitable model to study neuronal development and to investigate molecular mechanisms responsible for neurodegeneration.</p>" ]
[]
[ "<p id=\"Par1\">Modeling human neuronal properties in physiological and pathological conditions is essential to identify novel potential drugs and to explore pathological mechanisms of neurological diseases. For this purpose, we generated a three-dimensional (3D) neuronal culture, by employing the readily available human neuroblastoma SH-SY5Y cell line, and a new differentiation protocol. The entire differentiation process occurred in a matrix and lasted 47 days, with 7 days of pre-differentiation phase and 40 days of differentiation, and allowed the development of a 3D culture in conditions consistent with the physiological environment. Neurons in the culture were electrically active, were able to establish functional networks, and showed features of cholinergic neurons. Hence here we provide an easily accessible, reproducible, and suitable culture method that might empower studies on synaptic function, vesicle trafficking, and metabolism, which sustain neuronal activity and cerebral circuits. Moreover, this novel differentiation protocol could represent a promising cellular tool to study physiological cellular processes, such as migration, differentiation, maturation, and to develop novel therapeutic approaches.</p>", "<p id=\"Par2\">\n\n</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n\n\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s41420-023-01790-7.</p>", "<title>Acknowledgements</title>", "<p>The authors would like to thank the Project of Excellence CHRONOS (CHRonical multifactorial disorders explored by NOvel integrated Strategies) for providing advanced technologies used in this study. Alessia D’Aloia was supported by Fondazione Umberto Veronesi. The authors also warmly thank Jasmine Marciali, Elena Lombardini, Stefano La Magra and Selene Lorenzin for experimental support.</p>", "<title>Author contributions</title>", "<p>Conceptualization, AD, ML, MC, BC; methodology, AD, ES and ML; investigation, AD, VP, SB, GC and ES, ML; data curation, AD; writing—original draft preparation AD, ML, ES, MC, SB; writing—review and editing AD, SB, ML, MC, ES, BC, bibliographic research, AD, MC, ML; supervision ML, MC and BC; administration and funding acquisition, MC, ES, BC, ML and FP. All authors have read and agreed to the published version of the manuscript.</p>", "<title>Funding</title>", "<p>This work was supported by funds from the Italian Ministry of University and Research (MIUR) through grants “Research facilitation fund (Fondo per le Agevolazioni alla Ricerca—FAR)” to B.C., E.S., M.C and M.L., F.P. received fund MiSE - Ministero dello Sviluppo Economico, grant Power Innovation – PoC 2020,.ES received from Btbs funds from European Union – NextGenerationEU through the Italian Ministry of University and Research under PNRR - M4C2-I1.3 Project PE_00000019 “HEAL ITALIA”.</p>", "<title>Data availability</title>", "<p>The authors declare that all data supporting the findings of this study are available within this article, or are available from the corresponding author.</p>", "<title>Competing interests</title>", "<p id=\"Par51\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Functional properties and viability of SH-SY5Y cells cultured in different 2D and 3D conditions at different days of differentiation.</title><p><bold>A</bold> Schematic representation of diverse protocols used to promote differentiation in SH-SY5Y cells (described in the Materials and Methods section). The main electrophysiological parameters of a mature neuron were measured in cells at 10 DIV; they were: densities of sodium and potassium currents evoked by a standard voltage protocol (<bold>B</bold>, <bold>C</bold>, <bold>D</bold>), resting membrane potential (<bold>E</bold>), and induced action potential firing frequency (<bold>F</bold>, <bold>G</bold>, <bold>H</bold>). The same parameters were measured for the conditions 3D DMAP1 Mix and 3D DMAP2 Mix, which turned out to be promising for inducing SH-SY5Y functional differentiation. (<bold>I</bold>–<bold>M</bold>) Evaluation of the different electrophysiological parameters at 10, 20, 30, and 40 DIV. <bold>N</bold> Representative spontaneous activity recorded from a differentiated SH-SY5Y cell. The percentage of cells with spontaneous activity in the 3D DMAP2 Mix increased up to 37% at 40 DIV (<bold>O</bold>). <bold>P</bold> SH-SY5Y cells were plated on 24‐well plates in the Growth Factor Reduced (GFR) basement membrane matrix. After 24 h, cells were differentiated using the 3D DMAP1 Mix or 3D DMAP2 Mix protocols, or left undifferentiated (Control). The number of viable cells was determined at 4, 7, 17, 27, 37, and 47 days for 3D DMAP1 Mix and 3D DMAP2 mix cultures; and at 4, 7, and 17 days for control cultures. The numbers of total samples analyzed for each time point described above were: 3, 4, 13, 2, and 4, samples for the 3D DMAP1 Mix condition; 3, 4, 11, 3, 3, and 13 samples, for the 3D DMAP2 Mix condition samples; 4 samples for the control condition. <bold>Q</bold> SH-SY5Y cells were plated on 96-well plates and differentiated as described in the Materials and Methods section (3D DMAP2 Mix) or left undifferentiated (Control). Cell cytotoxicity was quantified after 10, 20, 30, and 40 days of differentiation or after 7 days in culture for the control sample. The numbers of samples analyzed for each time point in two independent experiments were: control (<italic>n</italic> = 3), 10 DIV (<italic>n</italic> = 4), 20 DIV (<italic>n</italic> = 4), 30 DIV (<italic>n</italic> = 5), and 40 DIV (<italic>n</italic> = 13). Further details are described in the Materials and Methods section. Statistical tests used to determine the significance of differences among the conditions were: One-way ANOVA followed by Tukey’s multiple comparisons test, for data in panels <bold>C</bold>, <bold>D</bold>, <bold>H</bold>, and <bold>Q</bold>; Multiple t-tests, in panels <bold>K</bold>, <bold>M</bold>, and <bold>P</bold> (3D DMAP1 vs 3D DMAP2); Chi-Square test, in panel <bold>O</bold>. Significance is indicated as *<italic>p</italic> &lt; 0.5, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001, ****<italic>p</italic> &lt; 0.0001.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>Morphological analysis revealed complex neuronal networks and high expression of NeuN in SH-SY5Y cells cultured in 3D DMAP2 Mix at 10 DIV and/or 40 DIV.</title><p><bold>A</bold> SH-SY5Y cells were plated and differentiated in 3D DMAP2 Mix condition as described in the Materials and Methods section. Cells were fixed, permeabilized, and immunostained with either the anti-β-tubulin (orange) antibody and Hoechst (blue) to detect neurite networks and nuclei, respectively. A total of 10 z-stacks images for each condition were taken. Maximum projection and large images (6 fields) are shown. Scale bar: 200 µm. <bold>B</bold> Schematic representation of some parameters taken into account during neuronal arborization analysis. In particular, the main parameters measured were: the number of extremities (<bold>C</bold>), the number of roots (<bold>D</bold>), the number of segments (<bold>E</bold>), the number of nodes type I (<bold>F</bold>), and the number of nodes type II (<bold>G</bold>). <bold>H</bold> The panel illustrates the NeuN (orange) and Hoechst (blue) merged staining at 10 DIV; the overlay is represented in pink. A total of 10 z-stacks images for each condition were taken. Maximum projection and large images (4 fields) are shown on the left. Scale bar: 100 µm. One representative field is shown on the right. Scale bar: 50 µm. <bold>I</bold> Quantification of NeuN positive cells (histogram); 95 positive neurons out of 99 neurons analyzed from 12 different fields. The totality of fluorescence images was captured using Operetta CLS™ equipped with a 63× immersion objective. Mann-Whitney test was used to determine the significance of differences among the conditions analyzed. Significance was set as *<italic>p</italic> &lt; 0.5, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001, ****<italic>p</italic> &lt; 0.0001.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Expression of pre and postsynaptic markers.</title><p><bold>A</bold> SH-SY5Y cells were plated and differentiated as described in the Materials and Methods section (3D DMAP2 Mix). Cells were fixed, permeabilized, and immunostained with anti-synapsin 1 (green) or anti-synaptophysin (green), or complexin 1/2 (green) in combination with TRITC-phalloidin (orange) and Hoechst (blue) to detect presynaptic density, actin, and nuclei respectively. A total of 10 z-stacks images for each condition were taken. Maximum projections are shown. Magnifications of 50 µm of neurites are also shown in the images below. Scale bar: 50 µm. The number and the size of synaptic boutons per 50 µm of neurites positive for (<bold>B</bold>, <bold>C</bold>) synapsin 1, (<bold>D</bold>, <bold>E</bold>) synaptophysin, (<bold>F</bold>, <bold>G</bold>) complexin 1/2 were determined. For Synapsin 1, at 10 and 40 DIV, <italic>n</italic> = 32 derived from 8 fields; for synaptophysin at 10 DIV, <italic>n</italic> = 33 derived from 8 fields, and at 40 DIV, <italic>n</italic> = 31 derived from 8 fields; for complexin 1/2 at 10 and 40 DIV, <italic>n</italic> = 30 derived from 8 fields. <bold>H</bold> Evaluation of the number of synaptic densities. Cells were immunostained with either anti-synapsin 1 (green) and anti-PSD95 to detect synaptic density. The color of PSD95-staining was changed from orange to red. A total of 10 z-stacks images for each condition were taken. Maximum projections are shown. Magnifications of 50 µm of neurites are shown in the images below (the first magnification derived from the original picture without any adjustment, while in the second one, the contrast was adjusted). Scale bar: 50 µm. <bold>I</bold> Number of synaptic boutons per 50 µm of neurites, positive for synapsin 1, PSD95, and for synapsin 1 and PSD95 in colocalization (<italic>n</italic> = 24 derived from 6 fields). The totality of fluorescence images was captured using Operetta CLS™ equipped with a 63× immersion objective. Differences among groups were tested for significance by: Unpaired t-test, in panels <bold>B</bold>–<bold>G</bold>; One-way ANOVA followed by Tukey’s multiple comparisons test in panel <bold>I</bold>. Significance was set as *<italic>p</italic> &lt; 0.5, **<italic>p</italic> &lt; 0.01, **<italic>*p</italic> &lt; 0.001, ****<italic>p</italic> &lt; 0.0001.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>Vesicle trafficking.</title><p><bold>A</bold> SH-SY5Y cells were plated and differentiated as described in the Materials and Methods section (3D DMAP2 Mix). After 40 DIV, time-lapse imaging was performed using Operetta CLS™ at 63× magnification in Digital Phase Contrast (DPC) to detect neurites and vesicles. Magnifications of the time-lapse image at different time points are shown. The red arrow indicates the vesicle, which moved with an anterograde trajectory. In contrast, the yellow arrow indicates the vesicle moving with an anterograde trajectory, pausing, and reversing backwards to the soma. Scale bar: 30 µm. <bold>B</bold> Schematic representation of vesicle sorting check-point. Changing of velocity over time for vesicles marked with the yellow arrow (<bold>C</bold>) and red arrow (<bold>D</bold>). <bold>E</bold> The mean velocity was calculated for 21 vesicles (six neurons).</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><title>Metabolic characterization.</title><p><bold>A</bold> Representative Oxygen Consumption Rate (OCR) profile of SH-SY5Y cells cultured at different days of differentiation. The samples were subjected to XF Mito Stress Test with XFe96 Agilent Seahorse under sequential injections of 1.5 µM oligomycin A, 3 µM FCCP and 2 µM Rotenone + 2 µM Antimycin A. <bold>B</bold> Respiratory bioenergetics parameters measured from Seahorse results: Basal mitochondrial respiration, Maximal mitochondrial respiration, Spare respiratory capacity, ATP-linked respiration, and Proton leak. OCR values were normalized on cell number obtained by imaging analysis of nuclei stained with Hoechst 33342 immediately after the assay. <italic>P</italic> values were obtained by two-way ANOVA followed by Tukey’s multiple comparison test. The number of biological replicates analyzed, each one composed of at least 5 technical replicates, was: 3 for the control, 3 for 10 DIV, 3 for 20 DIV, 3 for 30 DIV, and 2 for 40 DIV. <bold>C</bold> Mitochondria morphologies. SH-SY5Y cells were plated and differentiated as described in the Materials and Methods section (3D DMAP2 Mix) or left undifferentiated. Live cells were stained with PhenoVue 641 Mitochondrial Stain (red) and Hoechst (blue) to detect mitochondria and nuclei respectively. Here, a total of 10 z-stacks images for each condition were taken and maximum projections are shown. Magnification of mitochondrion at 40 DIV is also shown in the last image. The totality of fluorescence images was captured using Operetta CLS™ equipped with a 63× immersion objective. Scale bar: 50 µm. <bold>D</bold> Harmony and PhenLogic machine-learning software were used to quantify the mitochondrial classes. Mitochondria were categorized as round area, long area, and compact tubular area. N values are reported in the main text or results. To corroborate data obtained by Harmony software additional analysis was performed by using Fiji software and the Mitochondria Analyzer plug-in. We analyzed (<bold>E</bold>) the mean aspect ratio, (<bold>F</bold>) form factor, (<bold>G</bold>) branches length/mito, and (<bold>H</bold>) total mitochondria area/cell. Control (<italic>n</italic> = 13 fields for panels <bold>E, F, G,</bold> while <italic>n</italic> = 12 panel <bold>H</bold>), 10 DIV (<italic>n</italic> = 17 fields), 20 DIV (<italic>n</italic> = 15 fields), 30 DIV (<italic>n</italic> = 20 fields), 40 DIV (<italic>n</italic> = 19 fields for panels <bold>E</bold>, <bold>F</bold>, <bold>G</bold>, while <italic>n</italic> = 17 panel <bold>H</bold>). Differences among groups were tested for significance by: Two-way ANOVA followed by Tukey’s multiple comparisons test in panel <bold>D</bold>; One-way ANOVA following by Tukey’s multiple comparisons test in panels <bold>E</bold>, <bold>F</bold>, and <bold>G</bold>; Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Significance was set as *<italic>p</italic> &lt; 0.5, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001, ****<italic>p</italic> &lt; 0.0001.</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><title>Characterization of neuronal phenotype.</title><p><bold>A</bold> SH-SY5Y cells were plated and differentiated as described in the Materials and Methods section (3D DMAP2 Mix). Cells were fixed, permeabilized, and immunostained with either the anti-ChaT (green) or the anti-TH (orange) antibodies. A total of 10 z-stacks images for each condition were taken. Maximum projections of overlay are shown. The totality of fluorescence images was captured using Operetta CLS™ equipped with a 63× immersion objective. Scale bar: 50 µm. Quantification of (<bold>B</bold>) the ChaT/TH ratio in the cell body at 10 DIV (<italic>n</italic> = 528 cells) and 40 DIV (<italic>n</italic> = 951 cells). <bold>C</bold> The percentage of ChaT in the nucleus at 10 DIV (<italic>n</italic> = 433 cells) and 40 DIV (<italic>n</italic> = 743 cells) was performed using Harmony software, while quantification of (<bold>D</bold>) the number of ChaT and TH vesicles in neurites per 0.043 mm<sup>2</sup> region at 10 DIV (ChaT <italic>n</italic> = 17 fields, TH <italic>n</italic> = 18 fields) and 40 DIV (ChaT <italic>n</italic> = 18 fields, TH = 17 fields) was performed using Fiji software. Statistical tests used to determine the significance of differences among the conditions were: Unpaired t-test, in panels <bold>B</bold> and <bold>C;</bold> Multiple t-tests, in panel <bold>D.</bold> Significance, was set as *<italic>p</italic> &lt; 0.5, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001, ****<italic>p</italic> &lt; 0.0001.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Data (mean ± S.E.) related to the electrophysiological properties of SH-SY5Y cells in different culture conditions and days of differentiation.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th/><th>DIV</th><th>I<sub>Na</sub> (pA/pF)</th><th><italic>N</italic></th><th>I<sub>K</sub> (pA/pF)</th><th><italic>N</italic></th><th>V<sub>rest</sub> (mV)</th><th><italic>N</italic></th><th>AP Frequency (Hz)</th><th><italic>N</italic></th><th>Spontaneous Activity (%)</th><th><italic>N</italic></th></tr></thead><tbody><tr><td><bold>2D DMAP1</bold></td><td>5 DIV</td><td>153 ± 25</td><td>19</td><td>108 ± 14</td><td>19</td><td>−28 ± 2</td><td>20</td><td>3,6 ± 0,8</td><td>18</td><td>0%</td><td>8</td></tr><tr><td/><td>10 DIV</td><td>57 ± 6</td><td>13</td><td>53 ± 6</td><td>13</td><td>−24 ± 2</td><td>12</td><td>1,4 ± 0,4</td><td>9</td><td>0%</td><td>nd</td></tr><tr><td><bold>3D Literature</bold></td><td>10 DIV</td><td>115 ± 10</td><td>33</td><td>120 ± 7</td><td>31</td><td>−28 ± 1</td><td>42</td><td>2 ± 0,3</td><td>38</td><td>0%</td><td>10</td></tr><tr><td/><td>20 DIV</td><td>114 ± 12</td><td>5</td><td>97 ± 13</td><td>5</td><td>−30 ± 4</td><td>5</td><td>3,2 ± 1,4</td><td>5</td><td>0%</td><td>nd</td></tr><tr><td><bold>3D DMAP1 Coating</bold></td><td>10 DIV</td><td>215 ± 31</td><td>21</td><td>118 ± 11</td><td>21</td><td>−32 ± 2</td><td>21</td><td>3 ± 0,4</td><td>20</td><td>0%</td><td>12</td></tr><tr><td/><td>15 DIV</td><td>218 ± 36</td><td>10</td><td>101 ± 15</td><td>10</td><td>−31 ± 3</td><td>9</td><td>3 ± 1</td><td>9</td><td>0%</td><td>6</td></tr><tr><td><bold>3D DMAP1 Mix</bold></td><td>10 DIV</td><td>187 ± 23</td><td>13</td><td>118 ± 19</td><td>13</td><td>−32 ± 4</td><td>9</td><td>3,5 ± 0,5</td><td>10</td><td>0%</td><td>7</td></tr><tr><td/><td>15 DIV</td><td>306 ± 31</td><td>20</td><td>141 ± 21</td><td>20</td><td>−39 ± 2</td><td>21</td><td>4 ± 0,6</td><td>21</td><td>0%</td><td>5</td></tr><tr><td/><td>20 DIV</td><td>273 ± 35</td><td>12</td><td>120 ± 6</td><td>12</td><td>−45 ± 2</td><td>13</td><td>5 ± 0,7</td><td>14</td><td>7%</td><td>13</td></tr><tr><td/><td>25 DIV</td><td>211 ± 93</td><td>4</td><td>46 ± 12</td><td>4</td><td>−39 ± 2</td><td>3</td><td>4 ± 1</td><td>4</td><td>0%</td><td>3</td></tr><tr><td><bold>3D DMAP2 Mix</bold></td><td>10 DIV</td><td>154 ± 32</td><td>25</td><td>89 ± 12</td><td>25</td><td>−24 ± 2</td><td>29</td><td>2 ± 0,5</td><td>15</td><td>0%</td><td>26</td></tr><tr><td/><td>20 DIV</td><td>171 ± 45</td><td>8</td><td>125 ± 24</td><td>8</td><td>−34 ± 4</td><td>12</td><td>4,5 ± 0,7</td><td>11</td><td>12%</td><td>8</td></tr><tr><td/><td>25 DIV</td><td>275 ± 30</td><td>19</td><td>134 ± 8</td><td>19</td><td>−37 ± 3</td><td>18</td><td>5 ± 0,5</td><td>16</td><td>25%</td><td>16</td></tr><tr><td/><td>30 DIV</td><td>392 ± 186</td><td>16</td><td>102 ± 11</td><td>16</td><td>−29 ± 2</td><td>18</td><td>3,7 ± 0,9</td><td>14</td><td>33%</td><td>18</td></tr><tr><td/><td>40 DIV</td><td>225 ± 27</td><td>12</td><td>85 ± 17</td><td>12</td><td>−30 ± 1</td><td>16</td><td>4 ± 0,8</td><td>15</td><td>37%</td><td>16</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM5\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Valentina Pastori, Stefania Blasa.</p></fn><fn><p>These authors jointly supervised this work: Michela Ceriani, Marzia Lecchi, Barbara Costa.</p></fn></fn-group>" ]
[ "<graphic position=\"anchor\" xlink:href=\"41420_2023_1790_Figa_HTML\" id=\"d32e257\"/>", "<graphic xlink:href=\"41420_2023_1790_Fig1_HTML\" id=\"d32e489\"/>", "<graphic xlink:href=\"41420_2023_1790_Fig2_HTML\" id=\"d32e640\"/>", "<graphic xlink:href=\"41420_2023_1790_Fig3_HTML\" id=\"d32e764\"/>", "<graphic xlink:href=\"41420_2023_1790_Fig4_HTML\" id=\"d32e807\"/>", "<graphic xlink:href=\"41420_2023_1790_Fig5_HTML\" id=\"d32e940\"/>", "<graphic xlink:href=\"41420_2023_1790_Fig6_HTML\" id=\"d32e1060\"/>" ]
[ "<media xlink:href=\"41420_2023_1790_MOESM1_ESM.pdf\"><caption><p>Supplemental text and figures</p></caption></media>", "<media xlink:href=\"41420_2023_1790_MOESM2_ESM.pdf\"><caption><p>Supplemental video legends</p></caption></media>", "<media xlink:href=\"41420_2023_1790_MOESM3_ESM.avi\"><caption><p>Video 1</p></caption></media>", "<media xlink:href=\"41420_2023_1790_MOESM4_ESM.avi\"><caption><p>Video 2</p></caption></media>", "<media xlink:href=\"41420_2023_1790_MOESM5_ESM.avi\"><caption><p>Video 3</p></caption></media>" ]
[{"label": ["17."], "mixed-citation": ["Halliwell RF, Salmanzadeh H, Coyne L, Cao WS. An Electrophysiological and Pharmacological Study of the Properties of Human iPSC-Derived Neurons for Drug Discovery. Cells. 2021;31:10. Available from: 10.3390/cells10081953"]}, {"label": ["30."], "mixed-citation": ["Yang JL, Lin YT, Chen WY, Yang YR, Sun SF, Chen SD The Neurotrophic Function of Glucagon-Like Peptide-1 Promotes Human Neuroblastoma Differentiation via the PI3K-AKT Axis. Biology [Internet]. 2020 Oct 22;9. Available from: 10.3390/biology9110348"]}, {"label": ["47."], "mixed-citation": ["Zheng X, Boyer L, Jin M, Mertens J, Kim Y, Ma L, et al. Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation. Elife. 2016;10:5. Available from: 10.7554/eLife.13374"]}, {"label": ["52."], "mixed-citation": ["Li ZF, Cui L, Jin MM, Hu DY, Hou XG, Liu SS, et al. A Matrigel-based 3D construct of SH-SY5Y cells models the \u03b1-synuclein pathologies of Parkinson\u2019s disease. Dis Model Mech. 2022:1;15. Available from: 10.1242/dmm.049125"]}, {"label": ["66."], "mixed-citation": ["Moretti R, Morelli ME, Caruso P Vitamin D in Neurological Diseases: A Rationale for a Pathogenic Impact. Int J Mol Sci. 2018;31:19. Available from: 10.3390/ijms19082245"]}, {"label": ["72."], "surname": ["Fumagalli", "Lecca", "Abbracchio", "Ceruti"], "given-names": ["M", "D", "MP", "S"], "article-title": ["Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases"], "source": ["Front Pharm"], "year": ["2017"], "volume": ["8"], "fpage": ["941"], "pub-id": ["10.3389/fphar.2017.00941"]}, {"label": ["93."], "ext-link": ["https://www.nc3rs.org.uk/"]}, {"label": ["96."], "mixed-citation": ["D\u2019Aloia A, Ceriani M, Tisi R, Stucchi S, Sacco E, Costa B. Cannabidiol Antiproliferative Effect in Triple-Negative Breast Cancer MDA-MB-231 Cells Is Modulated by Its Physical State and by IGF-1. Int J Mol Sci. 2022;27:23. Available from: 10.3390/ijms23137145"]}, {"label": ["97."], "mixed-citation": ["D\u2019Aloia A, Arrigoni E, Costa B, Berruti G, Martegani E, Sacco E, et al. RalGPS2 Interacts with Akt and PDK1 Promoting Tunneling Nanotubes Formation in Bladder Cancer and Kidney Cells Microenvironment. Cancers. 2021;16:13. Available from: 10.3390/cancers13246330"]}, {"label": ["98."], "mixed-citation": ["Pasquale V, Ducci G, Campioni G, Ventrici A, Assalini C, Busti S, et al. Profiling and Targeting of Energy and Redox Metabolism in Grade 2 Bladder Cancer Cells with Different Invasiveness Properties. Cells. 2020;11:9. Available from: 10.3390/cells9122669"]}, {"label": ["99."], "mixed-citation": ["Campioni G, Pasquale V, Busti S, Ducci G, Sacco E, Vanoni M. An Optimized Workflow for the Analysis of Metabolic Fluxes in Cancer Spheroids Using Seahorse Technology. Cells. 2022:2;11. Available from: 10.3390/cells11050866"]}, {"label": ["101."], "mixed-citation": ["Douida A, Batista F, Boto P, Regdon Z, Robaszkiewicz A, Tar K. Cells Lacking PA200 Adapt to Mitochondrial Dysfunction by Enhancing Glycolysis via Distinct Opa1 Processing. Int J Mol Sci. 2021;5:22. Available from: 10.3390/ijms22041629"]}]
{ "acronym": [], "definition": [] }
101
CC BY
no
2024-01-14 23:40:17
Cell Death Discov. 2024 Jan 12; 10:24
oa_package/19/3b/PMC10786877.tar.gz
PMC10786878
38216744
[ "<title>Introduction</title>", "<p id=\"Par3\">CAD is the leading global cause of morbidity and mortality with high heritability<sup>##REF##28286336##1##</sup>. While large-scale population-based association studies have identified many genetic risk loci for CAD, key challenges exist in understanding how and which genes within these loci contribute to CAD pathogenesis<sup>##REF##30901535##2##</sup>. Despite the widely established role of lipid metabolism in CAD, most CAD-risk loci are unrelated to traditional lipid risk factors but instead point to arterial wall-specific processes<sup>##REF##28530674##3##,##REF##28714975##4##</sup>. Therefore, exploring the “non-lipid” pathways implicated by CAD genetic signals may unlock opportunities for new therapeutics.</p>", "<p id=\"Par4\">Mass spectrometry-based interaction proteomics enables systematic mapping of PPIs in a quantitative, scalable, and cell-type-specific manner and offers great potential for establishing mechanistic connections from disease risk genes to function. Indeed, numerous studies have used PPI data to functionally interpret results from large-scale genetic studies and elucidate the etiology of complex diseases such as arrhythmia and type 2 diabetes<sup>##REF##24892209##5##–##UREF##0##7##</sup>. However, little is known about the cell-type-specific PPIs of CAD-risk genes within the vascular tissue, and how these PPIs may represent biological pathways and networks that contribute to CAD pathogenesis.</p>", "<p id=\"Par5\">In the current work, we sought to characterize the protein interactomes of the non-lipid CAD-risk genes in the most disease-relevant tissue, the human vasculature. We performed immunoprecipitation experiments coupled with mass spectrometry (IP-MS) for 11 CAD-risk genes in two primary human vascular cell types, endothelial cells or smooth muscle cells, and constructed cell-type-specific PPI networks using 20 high-quality IP-MS datasets. By integrating the PPI networks with other data types, we show that they contain extensive interactions that have not been reported in the literature, capture both cell-type-specific and shared biology across the two cell types, and are enriched for genetic risks of CAD-related phenotypes. Therefore, the PPI networks can be used to prioritize causal candidate genes within CAD-risk loci, provide insights into the non-lipid CAD pathogenesis, and nominate promising targets for further mechanistic and therapeutic studies.</p>" ]
[ "<title>Methods</title>", "<title>Cell culture</title>", "<p id=\"Par27\">To resemble the tissue basis for CAD, primary human coronary artery endothelial cells (HCAEC) and smooth muscle cells (HCASMC) were the preferred cell types. However, our preliminary study showed that HCAEC lacks sufficient proliferative capacity to support scalable yield of proteomic samples, particularly with regard to epitope-tagged index protein production by expression vector transfection. As an alternative, we identified a more proliferative EC type with a transcriptional profile that resembles HCAEC, human aortic endothelial cell (HAEC)<sup>##REF##12963823##85##</sup>. HAEC and HCASMC were then used to carry out all proteomic experiments.</p>", "<p id=\"Par28\">HAEC and HCASMC from multiple healthy donors were pooled and maintained in VascuLife EnGS and SMC media, respectively (cell and medium purchased from Lifeline Cell Technology), and used at passage &lt;8 for all experiments. HEK293 cell was from ATCC and maintained in high-glucose Dulbecco’s Modified Eagle Medium (DMEM) with GlutaMAX supplement and 10% fetal bovine serum (FBS; Thermo Fisher Scientific). All cell culture was maintained free of antibiotics in a humidified incubator at 37 °C with 5% CO<sub>2</sub>.</p>", "<title>Selection of index proteins</title>", "<p id=\"Par29\">We aggregated 69 genetic loci that have been associated with CAD from CARDIoGRAM GWAS<sup>##REF##21378990##8##</sup>, C4D GWAS<sup>##REF##21378988##9##</sup>, CARDIoGRAMplusC4D Metabochip<sup>##REF##23202125##10##</sup>, CARDIoGRAMplusC4D 1000 Genomes-based GWAS<sup>##REF##26343387##11##</sup>, and Myocardial Infarction Genetics and CARDIoGRAM Exome study<sup>##REF##28209224##12##</sup> (Supplementary Data ##SUPPL##3##2##). We noted 17 loci were located near genes with known roles in regulating traditional lipid risk factors for CAD: LDL, triglyceride-rich lipoproteins, or lipoprotein(a), and may therefore be contributing to CAD-risk via the well-studied lipid metabolism<sup>##REF##28286336##1##</sup>. These loci were removed, leaving 52 “non-lipid” CAD-risk loci that are likely to represent vascular-specific pathways of CAD pathogenesis. Next, we defined linkage disequilibrium (LD) boundaries for the leading CAD-risk SNP in each of the remaining loci, which span SNPs with <italic>r</italic><sup>2</sup> &gt;0.6 ± 50 kb on either end. We then searched for protein-coding genes within each LD locus to identify a subset of 13 loci containing only a single protein-coding gene (i.e., single-gene loci, or SGL). The 13 SGL contain 10 unique genes (<italic>BCAS3</italic>, <italic>EDNRA</italic>, <italic>FLT1</italic>, <italic>FN1</italic>, <italic>HDAC9</italic>, <italic>JCAD</italic>, <italic>KCNK5</italic>, <italic>KSR2</italic>, <italic>PHACTR1</italic>, <italic>PLPP3</italic>) that are possible CAD-causal genes in these loci, and thus their encoded proteins were used as the “index proteins” in our study. We also included three additional index proteins encoded by genes that have been previously implicated in CAD, including 1 gene with a known causal role in CAD (<italic>ADAMTS7</italic>)<sup>##REF##25712206##13##</sup>, 1 gene with exome evidence and functional support (<italic>ARHGEF26</italic>)<sup>##REF##28714974##14##</sup>, and a distal regulatory target of the <italic>PHACTR1</italic> locus, <italic>EDN1</italic>, which has been nominated as a CAD-causal gene with strong biological plausibility<sup>##REF##28753427##15##</sup>.</p>", "<p id=\"Par30\">We surveyed RNA-seq data generated by the ENCODE project<sup>##REF##22955616##86##</sup> to confirm the endogenous expression of the selected index proteins in HAEC (GEO accession: GSE78613) and HCASMC (GEO accession: GSE78534; Supplementary Data ##SUPPL##3##3##). We found that KCNK5 was the only index protein with no detectable RNA expression, and thus excluded it from further experiments. Furthermore, we compared the expression levels of different transcripts to identify the dominant transcript variant for each index gene, and by inference, the dominant protein isoform for each index protein. These dominant transcript variants serve as the template sequences for constructing overexpression vectors, as described below.</p>", "<title>Construction of mammalian expression vectors for index proteins</title>", "<p id=\"Par31\">The cDNA containing the open-reading frame (ORF) of the endothelial <italic>ARHGEF26</italic> transcript (<italic>NM_015595</italic>) was obtained from the Mammalian Gene Collection and cloned with a 3×FLAG tag and a GGGS linker sequence into a pcDNA3.4 mammalian expression vector (Thermo Fisher Scientific). The ORF sequences carrying a 3×FLAG tag for ADAMTS7, BCAS3, EDN1, FLT1, HDAC9, PHACTR1, and PLPP3 were constructed by GeneArt Gene Synthesis (Thermo Fisher Scientific) using customized DNA constructs and cloned onto the pcDNA3.4 vector. All vector sequences have been validated by Sanger sequencing, and protein expression at the expected molecular weight was confirmed by Western blot using HEK293 cell lysate overexpressing the respective vectors. The remaining index proteins have commercially available IP-competent antibodies, and therefore do not require mammalian expression vectors.</p>", "<title>Overexpression of index proteins by consecutive transfection</title>", "<p id=\"Par32\">For optimal expression of FLAG-tagged index proteins in primary cells, we performed two rounds of consecutive transfection in HAEC and HCASMC, respectively.</p>", "<p id=\"Par33\">Transfection in HAEC was performed with 5 μg plasmid DNA per 1 × 10<sup>6</sup> cells in 100 μL P5 Primary Cell Solution using an Amaxa 4D-Nucleofector (Lonza). A pcDNA3.4 vector without insert was used as empty control for the same number of cells as “mock” transfection. In total, 8–10 × 10<sup>6</sup> cells at 70–80% confluence were nucleofected with the index protein vector or empty vector (mock transfection), respectively. Nucleofected HAEC was immediately plated in prewarmed Opti-MEM I reduced serum media (Thermo Fisher Scientific) for 2–3 h, followed by replacement with complete EnGS medium after cell attachment. Three days after the first round of nucleofection, cells were digested by Trypsin-EDTA (0.5%), washed in PBS, and underwent a second round of nucleofection (5 μg plasmid DNA per 1 × 10<sup>6</sup> cells) and plating. HAEC was harvested 3–4 days after the second round of nucleofection.</p>", "<p id=\"Par34\">Transfection in HCASMC was performed with Lipofectamine LTX with PLUS Reagent (Invitrogen) following the manufacturer’s instruction. Briefly, cells were plated on five 15-cm dishes 1–2 days before transfection at 70% confluency. Prior to transfection, cells were carefully rinsed with prewarmed Opti-MEM I media to reduce cell-derived polyanions that inhibit transfection, and gently replaced with 14 mL Opti-MEM I media. For each 15-cm dish, 20 µg plasmid DNA (for index protein or empty vector) was combined with 60 µL Lipofectamine LTX and 60 µL PLUS Reagent in 3.6 mL Opti-MEM I media, incubated for 5 min at room temperature, and added dropwise to each dish. HCASMC was incubated with the transfection mixture at 37 °C for 4 h, which was gently replaced by fresh, prewarmed Opti-MEM I media and incubated for another 2–3 h to terminate the transfection reaction and minimize DNA toxicity. Cells were then replaced with complete SMC medium. A second round of transfection was performed in 2–3 days with identical protocols. Complete SMC medium was replaced every 2–3 days. HCASMC was harvested 3–4 days after the second round of nucleofection.</p>", "<title>Co-immunoprecipitation using index proteins as baits</title>", "<p id=\"Par35\">Co-immunoprecipitation (Co-IP) was carried out by either (1) using commercial antibodies to the endogenous index proteins, if such antibodies were proven IP-competent and target-specific by a pilot IP followed by probing the immunoprecipitant with a different antibody, or (2) pulling down of overexpressed, FLAG-tagged index proteins with an antibody against the FLAG tag, if IP-competent antibodies to endogenous proteins were unavailable. The control IP was performed as either a pull-down using normal isotype IgG (control for endogenous index proteins) or a pull-down of cell lysate receiving empty-vector transfections (“mock” transfection; control for FLAG-tagged index proteins).</p>", "<p id=\"Par36\">Cells were lysed in ice-cold Pierce IP Lysis Buffer (Thermo Fisher Scientific) supplemented with fresh protease inhibitors (Pierce Mini Tablet, EDTA free), passed through a 25G syringe, and spun for 15 min at 21,000 × <italic>g</italic> at 4 °C. The supernatant was collected and normalized for protein concentration using a bicinchoninic acid (BCA) assay (Thermo Fisher Scientific). For pull-down of FLAG-tagged index proteins (i.e., baits), normalized cell lysate from bait- or mock transfection was incubated with washed anti-FLAG M2 magnetic beads (Sigma-Aldrich, M8823) or anti-FLAG M2 Affinity Agarose Gel (Sigma-Aldrich, A2220) at 1mg lysate per 25 μL beads ratio overnight at 4 °C with mixing. For pull-down of endogenous baits, cell lysate was pre-cleared by incubation with normal mouse IgG conjugated to agarose (Santa Cruz Biotechnology, sc-2343) or normal rabbit IgG (R&amp;D Systems, AB-105-C) conjugated to Protein A/G Magnetic Beads (Pierce, 88802) at 1mg lysate per 10 μg IgG ratio for 1 h at 4 °C. The pre-cleared supernatant was then split into two equal halves that were combined with primary antibody or isotype IgG and beads (1mg lysate per 10 μg antibody/IgG) and incubated at 4 °C overnight with mixing. The sources of antibodies and normal IgG for Co-IP are listed in Supplementary Data ##SUPPL##3##6##.</p>", "<p id=\"Par37\">After overnight incubation, each bait or control IP mixture was carefully split into three identical replicates using wide bore pipette tips. The supernatant was discarded, and the beads were washed once with ice-cold IP buffer, and three times with 100 mM triethylammonium bicarbonate (TEAB) buffer. Two of the three replicates were stored in 100 μL 100 mM TEAB buffer, pH 8.5, and snap-frozen until processed for mass spectrometry. The remaining one replicate was saved for quality control by eluting in 2× Laemmli Sample Buffer and boiling followed by Western blot analyses.</p>", "<title>Western blot</title>", "<p id=\"Par38\">Reduced protein samples were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 4–20% or 8–16% Mini-PROTEAN TGX precast gels (Bio-Rad Laboratories), transferred to a nitrocellulose membrane, and blocked with 5% nonfat milk in Tris-buffered saline supplemented with 0.05% Tween-20 (TBST) at room temperature for 1 hour. The membrane was then incubated with primary antibodies in 1% nonfat milk in TBST overnight at 4 °C. To avoid interference from denatured heavy or light chains of IP antibodies eluted from pull-down samples, two approaches were employed: (1) blots for FLAG-tagged baits were detected by incubation directly with HRP-conjugated anti-FLAG primary antibody (Sigma-Aldrich, A8592) without using secondary antibodies; or (2) blots for endogenous baits were incubated with Clean-Blot IP reagent (Thermo Fisher Scientific 21230) in 1% nonfat milk in TBST for 1 h at room temperature, which specifically binds to whole IgG but not IgG fragments, except for blots where the signals from Clean-Blot IP reagent were undetectable or too weak, in which case conventional HRP-conjugated anti-rabbit (R&amp;D Systems, HAF-008) or anti-mouse (R&amp;D Systems, HAF-007) secondary antibodies were used. After extensive washing, the membranes were developed in an enhanced chemiluminescence substrate (EMD Millipore) and imaged on Amersham Imager 600 (GE Healthcare).</p>", "<p id=\"Par39\">The non-FLAG primary antibodies used in Western blot were as follows: ADAMTS7 (Abcam, Ab28557), ATXN2 (Novus Biologicals, NBP1-90063), EDNRA (Abcam, ab242440), FLT1 (Thermo Fisher Scientific, PA5-16493), FN1 (Sigma-Aldrich, AB1945), FNDC3B (Novus Biologicals, NBP1-90495), HSPA9 (Cell Signaling Technology, 3593T), IGF2BP1 (Cell Signaling Technology, 8482), JCAD (Sigma-Aldrich, HPA017956), MAP4 (Proteintech, 11229-1-AP), PDIA6 (Sigma-Aldrich, HPA034652), RPL7A (Cell Signaling Technology, 2415), and TNS1 (Novus Biologicals, NBP1-84130). Reciprocal IPs of selected interactors (Supplementary Fig. ##SUPPL##0##10##) prior to western blot analysis were performed using the same antibodies as indicated above.</p>", "<title>Mass spectrometry and protein quantification (Whitehead)</title>", "<title>Sample preparation</title>", "<p id=\"Par40\">Starting with IP samples on beads supplied in 100 μL of 100 mM TEAB buffer, reduction and alkylation of disulfide bonds were carried out by addition of 2 μL of 50 mM Tris(2-carboxyethyl) phosphine (TCEP) in 100 mM TEAB (Sciex 4326685) for 60 min at 60 °C, followed by addition of 1 μL of 2% S-methyl methanethiosulphonate in isopropanol (Sciex 4352159) for 10 min at room temperature. Proteins in this solution were then digested by the addition of 250 ng of TPCK-treated trypsin in 50 mM TEAB (Sciex 4352157) and overnight incubation at 37 °C with gentle shaking. iTRAQ4-plex (Sciex) or TMT 6-plex (Thermo Fisher Scientific) reagents were resuspended in 50 µL isopropanol and added to each sample followed by vortex and spin; the specific iTRAQ or TMT labels used for each pair of bait or control IP replicates are indicated in Supplementary Data ##SUPPL##3##6##. The samples were combined and incubated at room temperature for 2 h, and then washed, extracted, and concentrated by solid phase extraction using Waters Sep-Pak Plus C18 cartridges. Organic solvent was removed, and the volumes were reduced to 80 μL via speed vacuum.</p>", "<title>Chromatographic separations</title>", "<p id=\"Par41\">The labeled tryptic peptides were subjected to basic (high pH) reversed-phase high-performance liquid chromatography (HPLC) with fraction collection using Shimadzu LC-20AD pumps and a FRC-10A fraction collector. Samples were loaded on a 10 cm × 2.1 mm column packed with 2.6 μm Aeris PEPTIDE XB-C18 media (Phenomenex). The initial gradient condition was isocratic 1% buffer A (20 mM ammonium formate in water, pH = 10) at 150 µL min<sup>−1</sup>, with increasing buffer B (acetonitrile) concentrations to 16.7% B at 20.5 min, 30% B at 31 min, and 45% B at 36 min. The column was washed with high percent B and re-equilibrated between analytical runs for a total cycle time of ~55 min. Sixteen 450 µL fractions (fx) were collected, combined into eight samples (fx1+2, fx3+9, fx4+10, fx5+11, fx6+12, fx7+13, fx8+14, fx15+16), then reduced to 20 µL via speed vacuum. The combined samples were subjected to reversed-phase HPLC using Thermo EASY-nLC 1200 pumps and autosampler, followed by mass spectrometry using a Thermo Q Exactive HF-X Hybrid Quadrupole-Orbitrap mass spectrometer and a nanoflow configuration. Samples were loaded on a 6 cm × 100 μm column packed with 10 μm ODS-A C18 material (YMC), washed with 4 μL total volume to trap and wash peptides, then eluted onto the analytical column packed with 1.7 μm Aeris C18 material (Phenomenex) in a fritted 14 cm × 75 μm fused silica tubing pulled to a 5-μm tip. The initial gradient condition was 1% buffer A (1% formic acid in water) at 300 nL min<sup>−1</sup>, with increasing buffer B (1% formic acid in acetonitrile) concentrations to 6% B at 1 min, 21% B at 42.5 min, 36% B at 63.15 min, and 50% B at 73 min. The column was washed with high percent B and re-equilibrated between analytical runs for a total cycle time of ~97 min.</p>", "<title>Mass spectrometry</title>", "<p id=\"Par42\">The mass spectrometer was operated in a data-dependent acquisition mode where the 20 most abundant peptides detected in the Orbitrap using full scan mode with a resolution of 60,000 were subjected to daughter ion fragmentation using a resolution of 15,000. A running list of parent ions was tabulated to an exclusion list to increase the number of peptides analyzed throughout the chromatographic run.</p>", "<title>Protein quantification</title>", "<p id=\"Par43\">Mass spectra were analyzed using PEAKS Studio X+ (Bioinformatics Solutions). For peptide and protein identification, mass spectra were searched against the <italic>Homo sapiens</italic> UniProtKB/TrEMBL database (release 2019_01) containing isoforms and a set of common laboratory contaminants. Positive identification was used and quantitation was based on the top three total ion current (TIC) method, with a maximum FDR of 1% at the spectrum level. Tolerance on the precursor was 10 ppm, on the fragments 0.01 Da, with carboxymethylation (C) as fixed modification and oxidation (M), deamidation (NQ), phosphorylation (STY), and acetylation (N-Ter) as variable modifications. Relative ratios of the iTRAQ or TMT reporter ions were used for protein-level quantitation across bait and control IP replicates.</p>", "<title>Mass spectrometry and protein quantification (Broad)</title>", "<title>Sample preparation</title>", "<p id=\"Par44\">Proteins were digested on beads using 90 µl of digestion buffer (2 M urea/50 mM Tris buffer with 1 mM DTT and 5 µg/mL Trypsin) for 1 h, shaking at 1000 rpm. The suspension was then transferred to a new tube, and the beads were washed twice with 60 µL of wash buffer (2 M urea/50 mM Tris buffer). The wash buffer was added to the suspension with digestion. The digestion and wash process was repeated a second time pooling the suspensions with the suspensions from the first round. The pooled solution was reduced using 4 mM DTT for 30 min at 25 °C shaking at 1000 rpm. The proteins were then alkylated using 10 mM iodoacetamide and incubating for 45 min at 25 °C shaking at 1000 rpm and protected from light. Proteins were then digested with 0.5 µg of trypsin overnight at 25 °C shaking at 700 rpm. The next day proteins were quenched using 40 µL of 10% formic acid and desalted using an Oasis Cartridge. Samples were vacuum-dried and labeled with iTRAQ4 (Sciex) kits; the specific iTRAQ labels used for each pair of bait or control IP replicates are indicated in Supplementary Data ##SUPPL##3##6##.</p>", "<title>Liquid chromatography-tandem mass spectrometry (LC-MS/MS; for “mB.SMC.ADAMTS7” and “mB.SMC.EDN1” datasets)</title>", "<p id=\"Par45\">Reconstituted peptides were separated on an online nanoflow EASY-nLC 1000 UHPLC system (Thermo Scientific) and analyzed on a benchtop Orbitrap Q Exactive Plus mass spectrometer (Thermo Scientific). The peptide samples were injected onto a capillary column (Picofrit with 10 μm tip opening/75 μm diameter, New Objective, PF360-75-10-N-5) packed in-house with 20 cm C18 silica material (1.9 μm ReproSil-Pur C18-AQ medium, Dr. Maisch GmbH, r119.aq). The UHPLC setup was connected with a custom-fit microadapting tee (360 μm, IDEX Health &amp; Science, UH-753), and capillary columns were heated to 50 °C in column heater sleeves (Phoenix-ST) to reduce backpressure during UHPLC separation. Injected peptides were separated at a flow rate of 200 nL/min with a linear 150 min gradient from 94% solvent A (3% acetonitrile, 0.1% formic acid) to 35% solvent B (90% acetonitrile, 0.1% formic acid), followed by a linear 8 min gradient from 35% solvent B to 60% solvent B and a 3 min ramp to 90% B. The Q Exactive instrument was operated in the data-dependent mode acquiring HCD MS/MS scans (<italic>R</italic>=17,500) after each MS1 scan (<italic>R</italic>=70,000) on the 12 most abundant ions using an MS1 ion target of 3 × 10<sup>6</sup> ions and an MS2 target of 5 × 10<sup>4</sup> ions. The maximum ion time utilized for the MS/MS scans was 120 ms; the HCD-normalized collision energy was set to 28; the dynamic exclusion time was set to 20 s, and the peptide match and isotope exclusion functions were enabled.</p>", "<title>Basic reversed-phase (BRP) fractionation followed by LC-MS/MS (for “mB.EC.ARHGEF26” dataset)</title>", "<p id=\"Par46\">To reduce sample complexity, iTRAQ labeled peptide samples were separated by high pH reversed-phase separation as previously described<sup>##REF##27251275##87##</sup>, but scaled down to use a 2.1 mm inner diameter RP Zorbax 300 A Extend-C18 column. All fractions were acidified to a final concentration of 1% formic acid and recombined by pooling every 6th fraction in a step-wise concatenation. Reconstituted peptides from each of the 6 BRP fractions were separated on an online nanoflow EASY-nLC 1000 UHPLC system (Thermo Fisher Scientific) and analyzed on a benchtop Orbitrap Q Exactive plus mass spectrometer (Thermo Fisher Scientific). The ~1 μg peptide samples were injected onto a capillary column (Picofrit with 10-μm tip opening/75 μm diameter, New Objective, PF360-75-10-N-5) packed in-house with 20 cm C18 silica material (1.9 μm ReproSil-Pur C18-AQ medium, Dr. Maisch GmbH, r119.aq). The UHPLC setup was connected with a custom-fit microadapting tee (360 μm, IDEX Health &amp; Science, UH-753), and capillary columns were heated to 50 °C in column heater sleeves (Phoenix-ST) to reduce backpressure during UHPLC separation. Injected peptides were separated at a flow rate of 200 nL/min with a linear 84 min gradient from 94% solvent A (3% acetonitrile, 0.1% formic acid) to 35% solvent B (90% acetonitrile, 0.1% formic acid), followed by a linear 8 min gradient from 35% solvent B to 60% solvent B and a 3 min ramp to 90% B. The Q Exactive instrument was operated in the data-dependent mode acquiring HCD MS/MS scans (<italic>R</italic>=17,500) after each MS1 scan (<italic>R</italic>=70,000) on the 12 top most abundant ions using an MS1 ion target of 3 × 10<sup>6</sup> ions and an MS2 target of 5 × 10<sup>4</sup> ions. The maximum ion time utilized for the MS/MS scans was 120 ms; the HCD-normalized collision energy was set to 29; the dynamic exclusion time was set to 20 s, and the peptide match and isotope exclusion functions were enabled.</p>", "<title>Protein quantification</title>", "<p id=\"Par47\">Mass spectra were analyzed using Spectrum Mill (v7.0; <ext-link ext-link-type=\"uri\" xlink:href=\"https://proteomics.broadinstitute.org\">https://proteomics.broadinstitute.org</ext-link>). For peptide identification, MS/MS spectra were searched against the human UniProt database to which a set of common laboratory contaminant proteins was appended. Search parameters included: ESI-QEXACTIVE-HCD scoring parameters, trypsin enzyme specificity with a maximum of two missed cleavages, 40% minimum matched peak intensity, ± 20 ppm precursor mass tolerance, ± 20 ppm product mass tolerance. Carbamidomethylation of cysteines and iTRAQ4 full labeling of lysines and peptide n-termini were set as fixed modifications. Allowed variable modifications were oxidation of methionine (M), acetyl (ProtN-term), and deamidated (N), with a precursor MH+ shift range of −18 to 64 Da. Identities interpreted for individual spectra were automatically designated as valid by optimizing score and delta rank1-rank2 score thresholds separately for each precursor charge state in each LC-MS/MS while allowing a maximum target-decoy-based FDR of 1.0% at the spectrum level. Identified peptides were organized into protein groups and subgroups (isoforms and family members) with Spectrum Mill’s subgroup-specific option enabled, so that peptides shared between subgroups were ignored when using report ion intensities to perform protein-level quantitation.</p>", "<title>IP-MS data processing and analysis</title>", "<title>Data processing</title>", "<p id=\"Par48\">Starting with the protein-level quantification report for each IP-MS experiment, we performed data processing as follows: (1) log<sub>2</sub> transformation and median normalization of the protein intensity values in each bait (i.e., index protein) or control IP sample; (2) removal of non-human and uncharacterized proteins, contaminants (e.g., keratins, keratin-associated proteins, trypsins, etc.), unresolved isoforms (i.e., multiple isoforms of the same protein that showed up with identical intensity values in MS), and proteins supported by &lt;2 unique peptides; (3) mapping the remaining proteins to their corresponding HGNC gene symbols and GRCh37/hg19 genomic positions using Ensembl<sup>##REF##31691826##88##</sup>; (4) imputing missing intensity values in each sample by randomly sampling from a normal distribution with a width of 0.3 standard deviation (SD) and downshift of 1.8 SD compared to the observed intensity distribution<sup>##REF##33972534##16##,##REF##27348712##89##</sup>; (5) calculated protein log<sub>2</sub> fold change (FC) values for each pair of bait vs. control replicate samples.</p>", "<title>Genoppi analysis</title>", "<p id=\"Par49\">We used the Genoppi R package<sup>##REF##33972534##16##</sup> (v1.0) to perform QC and analyze each processed IP-MS dataset. Pearson’s correlation of log<sub>2</sub> FC values between replicates was calculated to assess overall robustness of the IP-MS experiment. Average log<sub>2</sub> FC, <italic>P</italic> value, and Benjamini-Hochberg false discovery rate (FDR) for each protein were calculated using a one-sample moderated t-test from limma<sup>##REF##25605792##90##</sup> to identify significant proteins with log<sub>2</sub> FC &gt;0 and FDR ≤0.1 (i.e., proteins with significantly higher abundance in the bait IPs compared to the controls); these proteins were defined as significant interactors of the index protein in downstream analyses. Using these statistics, we performed QC to identify a subset of high-quality datasets in which the replicate log<sub>2</sub> FC correlation was &gt;0.6 and the index protein itself was significant at log<sub>2</sub> FC &gt;0 and FDR ≤0.1, and restricted all subsequent analyses to these datasets. We also assessed the overlap between significant proteins in each dataset and known interactors of the index protein in the InWeb database<sup>##REF##27892958##17##</sup> (as curated in the Genoppi R package) to distinguish between published vs. potentially novel interactions in our results. Analysis results, experimental details, and summary statistics for the subset of datasets that passed QC are provided in Supplementary Data ##SUPPL##3##5## and ##SUPPL##3##6##.</p>", "<title>Comparing IP-MS datasets</title>", "<title>Across experimental conditions</title>", "<p id=\"Par50\">In order to compare IP-MS datasets generated using different IP methods (endogenous or overexpression/tagging), MS facilities (Broad or Whitehead), or cell types (HAEC or HCASMC), we calculated various QC metrics for each dataset, including: replicate log<sub>2</sub> FC correlation, number of detected and significant (log<sub>2</sub> FC &gt;0 and FDR ≤0.1) proteins, number of detected and significant ribosomal proteins (i.e., proteins with RPL- or RPS- prefix in gene symbols), and overlap enrichment between significant proteins and known InWeb interactors. We then performed two-tailed Wilcoxon rank sum tests to assess if the distribution of each metric is significantly different between datasets generated under different conditions.</p>", "<title>Overlap of interactors</title>", "<p id=\"Par51\">For IP-MS datasets of the same index protein, we used the ggVennDiagram R package (v1.2.2) to visualize the number of interactors that overlap between the datasets. In addition, we performed a one-tailed hypergeometric test to assess the significance of overlap between each pair of IPs using the following definitions: (1) the total “population” (<italic>N</italic>) consists of all genes that were detected in both IPs; (2) the “success in population” (<italic>k</italic>) is the subset of <italic>N</italic> that are significant interactors in IP1; (3) the “sample” (<italic>n</italic>) is the subset of <italic>N</italic> that are significant interactors in IP2; (4) the “success in sample” (<italic>x</italic>) is the overlap between <italic>k</italic> and <italic>n</italic>.</p>", "<title>Defining interactors and non-interactors in the PPI networks</title>", "<p id=\"Par52\">Using the IP-MS analysis results, we defined lists of interactors vs. non-interactors for each index protein to generate combined PPI networks and to perform downstream enrichment analyses. Specifically, the non-interactors were used as background controls in conditional enrichment analyses, in which we aimed to identify significant biology captured by the index protein interactors while accounting for the cell-type-specific nature of our PPI data. For each individual IP-MS dataset, significant proteins with log<sub>2</sub> FC &gt;0 and FDR ≤0.1 were defined as “interactors” while other detected proteins were defined as “non-interactors”; the index protein used as the bait in the IP was excluded from these lists. When combining results from multiple IP-MS datasets (e.g., all IPs for the same index protein, all IPs performed in the same cell type, etc.), proteins that were significant in ≥1 dataset were defined as “interactors”; proteins that were detected in ≥1 dataset but were not significant in any dataset were defined as “non-interactors”; all index proteins for the source IPs were excluded. Furthermore, for index proteins with IP-MS data in both EC and SMC, we subsetted the data by cell type to define additional networks that contain interactors identified exclusively in EC (EC only), exclusively in SMC (SMC only), in both cell types (Intersect), or in either cell type (Union). Supplementary Data ##SUPPL##3##8## provides additional details on the generated PPI networks, including the summary counts and the full lists of interactors vs. non-interactors in each network.</p>", "<title>Assessing overlap with PPI databases</title>", "<p id=\"Par53\">To further assess whether the identified PPIs have been reported in the literature, we compared them against data from six PPI databases/datasets (Supplementary Data ##SUPPL##3##8##). Three datasets are curated and described in the Genoppi R package (v1.0): (1) InWeb<sup>##REF##27892958##17##</sup>; (2) BioPlex<sup>##REF##33961781##18##</sup> (v3.0, HEK293T); and (3) iRefIndex<sup>##UREF##1##19##</sup> (v17.0). The other three datasets are: (4) the HuRI HI-union network, from Supplementary Table 11 of ref. <sup>##REF##32296183##20##</sup>; (5) the STRING<sup>##REF##33237311##21##</sup> (v11.5) human physical subnetwork, downloaded from <ext-link ext-link-type=\"uri\" xlink:href=\"https://string-db.org/cgi/download?sessionId=bpij0JN28bsF\">https://string-db.org/cgi/download?sessionId=bpij0JN28bsF</ext-link>; and (6) the PCNet<sup>##REF##29605183##22##</sup> network, retrieved from the Network Data Exchange (NDEx) with UUID f93f402c-86d4-11e7-a10d-0ac135e8bacf.</p>", "<title>Generating PPI network plots</title>", "<p id=\"Par54\">To visualize the combined PPI networks containing all index proteins and their interactors identified in EC or SMC, we used the igraph (v1.2.5) and qgraph (v1.6.5) R packages to generate undirected network graphs, in which a vertex represents an index or interactor protein and an edge represents a significant index protein-interactor interaction observed in our IP-MS data.</p>", "<title>Tissue and gene set enrichment analysis</title>", "<p id=\"Par55\">We performed one-tailed hypergeometric tests to assess the significance of overlap between the interactors in our PPI networks and various gene sets. The gene sets we tested have all been curated in the Genoppi R package (v1.0) and include: (1) tissue-specific gene sets defined using GTEx RNA-seq data<sup>##REF##29632380##40##</sup>; (2) tissue-specific gene sets defined using GTEx proteomic data<sup>##REF##32916130##44##</sup>; (3) MSigDB Hallmark and Reactome gene sets<sup>##REF##16199517##45##,##REF##26771021##46##</sup>; and (4) GO BP, CC, and MF terms<sup>##REF##10802651##47##,##REF##30395331##48##</sup>. To assess GTEx tissue enrichment using RNA or proteomic data, we first performed a global enrichment analysis between each tissue-specific gene set and each PPI network using the following definitions: (1) the total “population” (<italic>N</italic>) consists of all genes that have been annotated in ≥1 gene sets; (2) the “success in population” (<italic>k</italic>) is the subset of <italic>N</italic> that are interactors in the PPI network; (3) the “sample” (<italic>n</italic>) is the subset of <italic>N</italic> that are in the current gene set; (4) the “success in sample” (<italic>x</italic>) is the overlap between <italic>k</italic> and <italic>n</italic>. As comparison, we also performed the analogous global analysis for the non-interactors linked to each network, as well as a conditional analysis in which we compared the interactors against the non-interactors (i.e., by further restricting the “population” defined above to genes encoded by interactors or non-interactors in the network). For the MSigDB and GO analyses, we performed analogous conditional tests that compared the interactors against the non-interactors, to identify gene sets that are significantly enriched even when accounting for the background cellular context of our data.</p>", "<title>Whole proteome analysis</title>", "<p id=\"Par56\">Protein expression values were derived from the whole proteome dataset in Supplementary Data 7 of ref. <sup>##REF##29133944##49##</sup>, which analyzed cardiac fibroblasts (CF), endothelial cells (EC), and smooth muscle cells (SMC) collected during cardiovascular surgery and adipose fibroblasts (AF) as a control cell type. We compared the expression of index protein interactors, non-interactors, and other proteins found in the whole proteome dataset using two-tailed Wilcoxon rank sum tests.</p>", "<title>Genetic risk enrichment analysis</title>", "<p id=\"Par57\">We used MAGMA<sup>##REF##25885710##50##</sup> (v1.09) and CAD GWAS summary statistics from a meta-analysis of the UK Biobank and CARDIoGRAMplusC4D<sup>##REF##29212778##51##</sup> to assess whether the interactor genes in our PPI networks are enriched for polygenic risk of CAD. We also performed analogous MAGMA analyses using GWAS summary statistics of aortic size<sup>##REF##34837083##56##</sup> (ascending aortic (AA) or descending aortic (DA) diameter) and stroke<sup>##REF##29531354##57##</sup> (any stroke (AS), any ischemic stroke (AIS), large-artery atherosclerotic stroke (LAS), cardioembolic stroke (CES), or small-vessel stroke (SVS)). First, we annotated protein-coding genes in the Ensembl<sup>##REF##31691826##88##</sup> GRCh37 database with variants in the 1000 Genomes<sup>##REF##26432245##91##</sup> (phase 3) EUR panel using a flanking window of ± 50 kb; variants in the major histocompatibility complex region (chr6:28.5M–33.4M) were excluded due to its complex LD structure. Next, for each GWAS dataset, gene-based <italic>P</italic> values were calculated using the SNP-wise Mean model and the 1000 Genomes EUR panel. Then, for each GWAS dataset and each PPI network, the gene set analysis model was used to compare the interactor genes in the network against the rest of the genome (for the global enrichment tests) or the non-interactor genes (for the conditional enrichment tests), computing a one-tailed <italic>P</italic> value that indicates whether the interactors are more strongly associated with the GWAS phenotype.</p>", "<title>Using PPI networks to prioritize additional CAD-risk genes from GWAS data</title>", "<p id=\"Par58\">Starting with 157 genome-wide significant index variants reported in the UK Biobank and CARDIoGRAMplusC4D GWAS<sup>##REF##29212778##51##</sup>, we used PLINK<sup>##REF##25722852##92##</sup> (v1.9) and the 1000 Genomes<sup>##REF##26432245##91##</sup> (phase 3) EUR panel to define LD locus boundaries for each variant, which span SNPs with <italic>r</italic><sup>2</sup> &gt;0.6 ± 50 kb on either end. Next, we used gene annotations from Ensembl<sup>##REF##31691826##88##</sup> to extract all protein-coding genes overlapping the LD loci and intersected them with index genes and interactors derived from our IP-MS data. We plotted the resulting list of prioritized genes in a “social Manhattan plot” where the chromosomal position of each gene is shown on the <italic>x</italic> axis and the GWAS <italic>P</italic> value of its tagging SNP is shown on the <italic>y</italic> axis, while the edges connecting the genes represent observed protein interactions between them.</p>", "<title>Statistics and reproducibility</title>", "<p id=\"Par59\">The genetic risk enrichment analysis was performed using MAGMA (v1.09). Other statistical analyses were performed in R. Analysis scripts with package and version documentation are deposited at GitHub (<ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/lagelab/CAD_PPI\">https://github.com/lagelab/CAD_PPI</ext-link>). Statistical tests and significance cutoffs used are described in “Methods” and figure legends.</p>", "<p id=\"Par60\">The IP-MS experimental replicates are described in “Methods” under “Co-immunoprecipitation using index proteins as baits”. Briefly, for each experiment, each bait or control IP mixture was split into three replicates. Two of the three replicates were submitted for mass spectrometry and the remaining replicate was used for quality control by western blot analyses (Supplementary Figs. ##SUPPL##0##1## and ##SUPPL##0##2##).</p>", "<title>Reporting summary</title>", "<p id=\"Par61\">Further information on research design is available in the ##SUPPL##4##Nature Portfolio Reporting Summary## linked to this article.</p>" ]
[ "<title>Results</title>", "<title>Study design and quality control</title>", "<p id=\"Par6\">We designed a three-stage study to (1) select high-confidence CAD-risk genes (termed “index genes”) from CAD-risk loci; (2) map the PPIs of the corresponding “index proteins” in vascular cells by IP-MS experiments; and (3) integrate the resulting PPI networks with other data types to uncover CAD-relevant biology (Fig. ##FIG##0##1a##).</p>", "<p id=\"Par7\">To select the index genes in Stage 1, we first aggregated a comprehensive list of 69 CAD-associated loci that reached genome-wide significance in the CARDIoGRAM GWAS<sup>##REF##21378990##8##</sup>, C4D GWAS<sup>##REF##21378988##9##</sup>, CARDIoGRAMplusC4D Metabochip<sup>##REF##23202125##10##</sup>, CARDIoGRAMplusC4D 1000 Genomes-based GWAS<sup>##REF##26343387##11##</sup>, or Myocardial Infarction Genetics and CARDIoGRAM Exome study<sup>##REF##28209224##12##</sup> (Fig. ##FIG##0##1b## and Supplementary Data ##SUPPL##3##2##). We removed 17 loci with known roles in regulating traditional lipid risk factors to focus on the non-lipid aspects of CAD. Among the remaining 52 non-lipid loci, we identified 12 protein-coding genes that are the likely CAD-causal candidates to be taken forward to subsequent proteomic experiments. These include ten genes from single-gene loci (Supplementary Data ##SUPPL##3##2##), 1 gene with a known causal role in CAD (<italic>ADAMTS7</italic>)<sup>##REF##25712206##13##</sup>, and one gene with exome evidence and functional support (<italic>ARHGEF26</italic>)<sup>##REF##28714974##14##</sup>. Additionally, we included a target gene that is under distal regulation of the <italic>PHACTR1</italic> locus, <italic>EDN1</italic>, which has been nominated as a CAD-causal gene with strong biological plausibility<sup>##REF##28753427##15##</sup>. Among the 13 index genes, endogenous expression in the vasculature was confirmed for all except <italic>KCNK5</italic> (Supplementary Data ##SUPPL##3##3##), yielding 12 usable index proteins for Stage 2 of the study (Fig. ##FIG##0##1b##). An orthogonal survey of the literature on the 12 index genes showed extensive genetic and experimental evidence supporting that all these index genes are indeed implicated in the pathogenesis of CAD (Supplementary Data ##SUPPL##3##4##).</p>", "<p id=\"Par8\">In Stage 2, we used each of the index proteins as bait to perform co-immunoprecipitation (co-IP) experiments in primary human aortic endothelial cells (HAEC; EC, hereafter) and human coronary artery smooth muscle cells (HCASMC; SMC, hereafter), followed by tandem mass spectrometry (MS) to identify and quantify proteins in the index protein IPs (or “bait IPs”) relative to control IPs (Fig. ##FIG##0##1a##). We used Genoppi<sup>##REF##33972534##16##</sup> to perform quality control (QC) and analyze data from &gt;60 IP-MS experiments, identifying significant protein interactors of the index protein in each experiment (i.e., proteins with log<sub>2</sub> fold change [FC] &gt;0 and false discovery rate [FDR] ≤0.1 in bait vs. control IPs). We identified a subset of 20 high-quality IP-MS datasets for 11 index proteins (ADAMTS7, ARHGEF26, BCAS3, EDN1, EDNRA, FLT1, FN1, HDAC9, JCAD, PHACTR1, PLPP3), in which the replicate log<sub>2</sub> FC correlation was &gt;0.6 and the index protein itself was significant at log<sub>2</sub> FC &gt;0 and FDR ≤0.1, and restricted all subsequent analyses to these datasets (Supplementary Figs. ##SUPPL##0##1##–##SUPPL##0##3## and Supplementary Data ##SUPPL##3##5## and ##SUPPL##3##6##). Although some of the 20 datasets were generated under variable experimental conditions (i.e., different IP approaches, MS facilities, or cell types), an examination of their QC metrics confirmed that they were overall technically robust and comparable despite these differences (Supplementary Figs. ##SUPPL##0##4##–##SUPPL##0##6##).</p>", "<title>IP-MS data of JCAD yield mechanistic insights to vascular biology</title>", "<p id=\"Par9\">The individual IP-MS datasets we generated could link the respective index proteins to undiscovered biology through newly identified interactions. As an example, we highlight the IP of endogenous JCAD performed in EC, in which the log<sub>2</sub> FC correlation between IP replicates is 0.823, and JCAD itself is one of the most enriched proteins (log<sub>2</sub> FC = 1.81 and FDR = 1.40e-3; Supplementary Fig. ##SUPPL##0##3h## and Supplementary Data ##SUPPL##3##5## and ##SUPPL##3##6##). Out of the 35 significant interactors identified in this dataset, only one (FLNC) had been reported in PPI databases, including InWeb<sup>##REF##27892958##17##</sup>, BioPlex<sup>##REF##33961781##18##</sup>, iRefIndex<sup>##UREF##1##19##</sup>, HuRI<sup>##REF##32296183##20##</sup>, STRING<sup>##REF##33237311##21##</sup>, and PCNet<sup>##REF##29605183##22##</sup>, illustrating the potential for biological discovery using our approach.</p>", "<p id=\"Par10\">Prior studies showed that JCAD regulates Hippo signaling in endothelial cells<sup>##REF##29794114##23##</sup>; reports from non-vascular cells further implied that the interaction between the PY motif of JCAD and the WW domain of Hippo proteins may underlie its role in Hippo signaling<sup>##UREF##2##24##,##UREF##3##25##</sup>. Surprisingly, in our JCAD IP-MS results, while several WW domain-containing proteins were detected, none were identified as significant interactors of JCAD (Supplementary Fig. ##SUPPL##0##7##), suggesting that the reported interactions between JCAD and the WW domains of Hippo proteins may not drive the specific role of JCAD in endothelial Hippo signaling. In contrast, among the 35 significant interactors of JCAD in EC, 9 (25.7%) are either centrosomal proteins or proteins with known roles in cytokinesis (Supplementary Fig. ##SUPPL##0##7##). Pathway analyses of the JCAD interactors also revealed significant enrichment of GO terms related to centrosomal components and cell cycle (Supplementary Data ##SUPPL##3##7##). These results strongly support the role of JCAD in endothelial cell proliferation, a key phenotype related to vascular injury response, including atherosclerosis. Importantly, this critical insight has been experimentally corroborated by several previous studies, which reported reduced proliferation and angiogenesis upon targeted disruption of JCAD in endothelial cells<sup>##REF##29794114##23##,##REF##28705794##26##</sup>. Together, these results support the hypothesis that the interaction between JCAD and the centrosomal proteins may connect endothelial dysfunction to CAD pathogenesis.</p>", "<title>Construction of de novo cell-type-specific PPI networks in human vasculature</title>", "<p id=\"Par11\">In Stage 3 of our study, we assembled the 20 high-quality IP-MS datasets into cell-type-specific PPI networks and intersected them with other data types to extract biological insights (Fig. ##FIG##0##1a##). First, we generated the combined PPI networks for EC and SMC using all IP-MS data derived from the respective cell type (Fig. ##FIG##1##2a, d## and Supplementary Data ##SUPPL##3##8##). The EC network contains 9 index proteins and 1190 significant interactors, while the SMC network contains 10 index proteins and 1122 interactors. Over 90% of the interactions in our data have not been reported in the literature according to InWeb (Fig. ##FIG##1##2b, e##) and 5 other PPI databases (Supplementary Fig. ##SUPPL##0##8## and Supplementary Data ##SUPPL##3##8##) and thus represent potentially novel biology. Furthermore, there is substantial convergence among the interactomes of individual index proteins in both cell types, with &gt;30% of the interactors being linked to multiple index proteins (Fig. ##FIG##1##2c, f##) and many index proteins sharing a significant number of common interactors (Fig. ##FIG##1##2a, d## and Supplementary Data ##SUPPL##3##9##). In fact, we observed several interactions between the index proteins themselves: FN1 was identified as an interactor of EDN1 in SMC and of PLPP3 in both cell types. Such convergent patterns suggest that some of the index proteins may participate in common vascular pathways or recurring processes that are CAD-relevant yet need to be defined functionally.</p>", "<p id=\"Par12\">Importantly, the interactions in our de novo PPI networks are experimentally reproducible. For instance, we have validated the interactions of several recurrent interactors (i.e., interactors linked to multiple index proteins) identified in both EC and SMC, including PDIA6, RPL7A, and HSPA9 (Supplementary Data ##SUPPL##3##8##), in individual IPs followed by western blotting (IP-WB; Supplementary Fig. ##SUPPL##0##9##<bold>)</bold>. In parallel, we also performed reciprocal IPs in SMC using several newly discovered protein interactors of ADAMTS7 and JCAD as baits, and successfully detected the presence of ADAMTS7 or JCAD in these reciprocal IPs by western blot (Supplementary Fig. ##SUPPL##0##10##). Overall, our validation results are comparable with previous reports that demonstrate up to ~90% validation rate for PPIs identified by IP-MS<sup>##REF##33972534##16##,##UREF##4##27##,##REF##37207277##28##</sup>, and indicate that our vascular PPI networks contain high-confidence interactions.</p>", "<title>Shared and cell-type-specific PPIs in endothelial cells vs. smooth muscle cells</title>", "<p id=\"Par13\">We compared the PPIs observed in endothelial cells vs. smooth muscle cells to identify common or cell-type-specific CAD-relevant biology. Globally, about half of all protein interactors from the EC and SMC networks are shared by the two cell types (49.5% in EC and 52.5% in SMC; Fig. ##FIG##2##3a##). While this overlap is statistically significant (<italic>P</italic> = 1.49e-24), it also indicates that ~50% of the interactors are specific to one cell type but not the other. To explore this in more detail, we stratified the overlap analysis by each of the 8 index proteins that have IP-MS data in both cell types (ARHGEF26, BCAS3, EDN1, FN1, HDAC9, JCAD, PHACTR1, PLPP3), and found significant overlap between the EC and SMC interactors of FN1 (<italic>P</italic> = 1.59e-8), PHACTR1 (<italic>P</italic> = 0.0317), and PLPP3 (<italic>P</italic> = 3.52e-12), but not for the other five index proteins (Supplementary Fig. ##SUPPL##0##11## and Supplementary Data ##SUPPL##3##9##<bold>)</bold>. Our observations are in line with publications demonstrating distinct roles in EC vs. SMC for ARHGEF26<sup>##UREF##5##29##,##REF##27622243##30##</sup>, BCAS3<sup>##UREF##6##31##</sup>, EDN1<sup>##REF##11067800##32##</sup>, JCAD<sup>##REF##31539914##33##</sup>, and HDAC9<sup>##REF##26865248##34##–##UREF##7##36##</sup>, but partially shared functions in EC and SMC for FN1 (to modulate extracellular matrix<sup>##REF##30016219##37##</sup>) and PLPP3 (to attenuate inflammation and permeability following vascular injury<sup>##REF##23104851##38##,##REF##24504738##39##</sup>). Together, these results highlight both the functional commonality represented by the overlapping interactors, as well as the divergent roles of cell-type-specific interactors in the two cell types.</p>", "<title>Vascular PPI networks are enriched for tissue types and pathways related to CAD</title>", "<p id=\"Par14\">One way to explore the causal mechanisms implicated by the PPI networks is to examine whether the networks are enriched for genes specifically expressed in disease-relevant tissues or cell types. Therefore, we assessed the overlap enrichment between interactor genes in the networks and tissue-specific genes derived from RNA sequencing data of GTEx tissues<sup>##REF##29632380##40##</sup>. Both the EC and SMC networks are significantly enriched (<italic>P</italic> &lt; 0.05/53, adjusting for 53 tissues) for genes specific to cardiovascular tissues, and as expected, tissues containing rich SMC (e.g., digestive organs and uterus; Supplementary Fig. ##SUPPL##0##12a## and Supplementary Data ##SUPPL##3##10##). Notably, genes specific to adipose tissue are also significantly enriched, which highlights the indispensable role of adipose tissue in vascular homeostasis that are tightly coupled to EC and SMC<sup>##UREF##8##41##,##UREF##9##42##</sup>. To further compare the EC and SMC networks, we analyzed sub-networks consisting of interactors found in only one cell type (“EC only” or “SMC only”) or interactors shared by both cell types (“Intersect”; Supplementary Fig. ##SUPPL##0##12a## and Supplementary Data ##SUPPL##3##10##). Among the cardiovascular tissues, all three sub-networks show significant enrichment for genes specific to aortic, coronary, and tibial artery tissues, while the “EC only” network is additionally enriched for genes specific to left ventricle tissue (Fig. ##FIG##2##3b##). Since mRNA and protein abundance show variable correlation across tissues<sup>##REF##32709985##43##</sup>, we also repeated the analysis using tissue-specific genes defined from proteomic data of GTEx tissues<sup>##REF##32916130##44##</sup>. The results derived from these data have weaker significance overall but show similar enrichment patterns in the cardiovascular tissues (Supplementary Figs. ##SUPPL##0##13a##, ##SUPPL##0##14## and Supplementary Data ##SUPPL##3##10##). These findings reaffirm that our de novo PPI networks point to vascular-specific genes and further support the use of both cell types to understand the genetic basis of CAD.</p>", "<p id=\"Par15\">We next assessed whether our PPI networks are enriched for biological pathways represented by the MSigDB<sup>##REF##16199517##45##,##REF##26771021##46##</sup> Hallmark and Reactome gene sets and Gene Ontology<sup>##REF##10802651##47##,##REF##30395331##48##</sup> (GO) terms. In these pathway analyses, instead of comparing the interactor genes in our networks to the rest of the genome, we compared them to other genes that were detected in our IP-MS experiments (i.e., the “non-interactors” in Supplementary Data ##SUPPL##3##8##). We reasoned that since both the interactors and non-interactors show elevated protein expression in human heart cell types<sup>##REF##29133944##49##</sup> (Supplementary Fig. ##SUPPL##0##15##) and are enriched for tissue-specific genes in cardiovascular tissues (Supplementary Figs. ##SUPPL##0##12## and ##SUPPL##0##13## and Supplementary Data ##SUPPL##3##10##), comparing the interactors against the non-interactors would allow us to assess the conditional enrichment of the networks in a way that accounts for the cellular context of our data. In the MSigDB Hallmark analysis, the “EC only” and “Intersect” networks show significant (<italic>P</italic> &lt;0.05/50, adjusting for 50 gene sets) or nominal (<italic>P</italic> &lt;0.05) enrichment for similar gene sets, including “MYC targets” and immunity-related pathways (“interferon gamma response”, “interferon alpha response”, and “allograft rejection”; Fig. ##FIG##2##3c## and Supplementary Data ##SUPPL##3##11##). In contrast, the “SMC only” network is most enriched for processes broadly related to the arterial wall, including “epithelial mesenchymal transition”, “hypoxia”, and “angiogenesis”. In the Reactome and GO analyses, we also observed some divergent patterns between these networks (Supplementary Fig. ##SUPPL##0##16## and Supplementary Data ##SUPPL##3##11## and ##SUPPL##3##12##). Overall, the tissue and pathway enrichment results show that the EC and SMC PPI networks capture both shared and cell-type-specific biology related to CAD.</p>", "<title>Linking vascular PPI networks to genetic risks of CAD and related phenotypes</title>", "<p id=\"Par16\">To assess whether the PPI networks are associated with genetic risk factors of CAD, we used MAGMA<sup>##REF##25885710##50##</sup> to evaluate the genetic risk enrichment within the networks relative to other protein-coding genes (“global” analysis) or to the non-interactors identified by IP-MS (“conditional” analysis). Using CAD GWAS summary statistics from a meta-analysis of the UK Biobank and CARDIoGRAMplusC4D<sup>##REF##29212778##51##</sup>, we found the ADAMTS7 (<italic>P</italic> &lt; 1.37e-3) and JCAD (<italic>P</italic> &lt; 3.11e-4) networks in SMC to be significantly enriched (<italic>P</italic> &lt; 0.05/29, adjusting for 29 networks) for CAD risk in the global analysis (Fig. ##FIG##3##4a##, Supplementary Fig. ##SUPPL##0##17a##, and Supplementary Data ##SUPPL##3##13##). In the more conservative conditional analysis, the ADAMTS7 network remained nominally significant, suggesting that the observed enrichment signal is robust and that genes in this network may confer risk above what one would expect for genes generally expressed in SMC (Supplementary Fig. ##SUPPL##0##17b##). Indeed, ADAMTS7 mediates vascular SMC migration and neointimal formation in animal carotid artery injury models, and the CAD-risk coding variant rs3825807 within the <italic>ADAMTS7</italic> locus affects patient-derived vascular SMC migration<sup>##REF##19168437##52##–##REF##25712208##54##</sup>. For JCAD, its interactors in SMC have no overlap with those identified in EC; thus the enrichment of CAD-risk GWAS signal among JCAD interactors appears to be specific to SMC (Supplementary Fig. ##SUPPL##0##17a##). Corroborating with this MAGMA result are the observations that JCAD is expressed in vascular SMC<sup>##REF##31584065##55##</sup>, and that depletion of JCAD inhibited vascular maturation by depleting SMC in neovessels<sup>##REF##28705794##26##</sup>. Although a role of JCAD in endothelial cells has been connected to atherosclerosis<sup>##REF##31539914##33##,##REF##31584065##55##</sup>, its role in vascular SMC has been less well understood. Our data support the role of JCAD in vascular SMC that may be critical to CAD.</p>", "<p id=\"Par17\">We also performed analogous MAGMA analyses using GWAS summary statistics of other vascular phenotypes, including aortic size<sup>##REF##34837083##56##</sup> (ascending thoracic aortic diameter (AA), descending thoracic aortic diameter (DA)) and stroke subtypes<sup>##REF##29531354##57##</sup> (any stroke (AS), any ischemic stroke (AIS), large-artery atherosclerotic stroke (LAS), cardioembolic stroke (CES), small-vessel stroke (SVS)). We found the combined PPI network in SMC to be significantly enriched (<italic>P</italic> = 8.77e-5) for genetic variants associated with DA in the global analysis (Fig. ##FIG##3##4a##, Supplementary Fig. ##SUPPL##0##17a##, and Supplementary Data ##SUPPL##3##13##). The pathogenic basis of aortic aneurysm differs between ascending and descending aortas. Atherosclerosis is the predominant driving etiology leading to aneurysms of the descending aorta, but rarely causes ascending aortic aneurysms<sup>##REF##15710776##58##,##REF##21593863##59##</sup>. Therefore, the significant enrichment for genetic variants associated with DA in the SMC network highlights the cell type and proteins that may contribute to both CAD and descending thoracic aneurysms. In fact, among the index proteins whose networks show nominal enrichment for DA, ADAMTS7<sup>##REF##28849199##60##</sup> and EDN1<sup>##REF##23887640##61##,##REF##28323184##62##</sup> have been linked to aortic aneurysms in previous studies. Taken together, we observed enrichment of CAD-risk GWAS variants among the ADAMTS7 and JCAD PPI networks derived from SMC, and an association between the combined SMC PPI network and descending aortic size. As better-powered GWAS datasets become available, the suggestively significant enrichment for other networks and phenotypes reported here could be validated in the future.</p>", "<title>Using vascular PPI networks to prioritize candidate CAD-risk genes</title>", "<p id=\"Par18\">After establishing that some of our PPI networks are enriched for genetic risks of CAD-related phenotypes, we used the networks to prioritize additional CAD-risk genes from GWAS data. Given that the evidence for the causal gene(s) within a GWAS locus are often absent, ambiguous, or conflicting, physical interactions with known or high-confidence risk genes may serve as an important functional indicator of the potentially causal gene(s) for a given locus. When we intersected our PPI networks with genes found in genome-wide significant GWAS loci for CAD<sup>##REF##29212778##51##</sup>, we found that the index proteins in the combined EC network interact with 43 proteins encoded by genes in the CAD-risk loci (termed “locus proteins”), while the index proteins in the SMC network are linked to 41 locus proteins (Fig. ##FIG##3##4b##, Supplementary Fig. ##SUPPL##0##18a##, and Supplementary Data ##SUPPL##3##14##). Together, our PPI data prioritize 61 unique genes within CAD-risk loci across the two cell types. We confirmed the reproducibility of a subset of the PPIs between index and locus proteins by independent IP-WB or reciprocal IP-WB (Supplementary Figs. ##SUPPL##0##10## and ##SUPPL##0##19##). For instance, we were able to validate several interactions involving IGF2BP1, MAP4, and TNS1, which are all located within CAD-risk loci containing multiple candidate genes and are also found to be recurring interactors in our networks.</p>", "<p id=\"Par19\">When selecting the index proteins in this study, we included two index proteins from the multi-gene chromosome <italic>6p24</italic> locus, which contains <italic>EDN1</italic> and <italic>PHACTR1</italic> in a 1-Mb region around the sentinel variant rs9349379<sup>##REF##28753427##15##</sup>. There is uncertainty regarding which of these genes is causal for the multiple vascular diseases associated with this locus. Therefore, we compared the overlaps between genes in GWAS loci and EDN1 or PHACTR1 interactomes in vascular cells to see if they could help prioritize one of the genes over the other. We observed that EDN1 interacts with many more locus proteins compared to PHACTR1 in both EC and SMC (Supplementary Fig. ##SUPPL##0##18b## and Supplementary Data ##SUPPL##3##14##). Across both cell types, EDN1 is linked to 11 locus proteins and 1 other index protein (FN1), while PHACTR1 is only associated with 2 locus proteins that are also EDN1 interactors. There is substantial evidence supporting the critical roles of several locus proteins that interact with EDN1 in the vasculature, including MAP4<sup>##UREF##10##63##</sup>, SRSF3<sup>##REF##30835716##64##</sup>, LOX<sup>##REF##31504232##65##–##REF##12417550##67##</sup>, and TOP1<sup>##REF##19168442##68##</sup>. Furthermore, consistent with the known role of EDN1 in mediating proliferation and vasoconstriction in smooth muscle cells, its interactors in SMC include many extracellular matrix proteins (i.e., COL6A3, FN1, and LOX). Finally, we also mapped the PPIs of the major receptor for EDN1, EDNRA, in SMC: we found EDNRA to interact with 8 locus proteins, including PALLD, which is also an interactor of EDN1 in SMC (Fig. ##FIG##3##4b## and Supplementary Data ##SUPPL##3##14##). In agreement with these observations, both the EDN1 and EDNRA PPI networks in SMC show nominally significant enrichment for aortic size in our genetic analysis, while the PHACTR1 network shows no enrichment (Fig. ##FIG##3##4a##). Together, these findings support the hypothesis that EDN1, rather than PHACTR1, is a more likely driver of the GWAS signal for CAD risk observed in the <italic>6p24</italic> locus.</p>", "<p id=\"Par20\">The recent development of large-scale CRISPR perturbation screens have allowed experimental validation of plausible causal genes in a high-throughput, unbiased manner. To further assess the functional relevance of the index and locus proteins prioritized by our PPI data in the context CAD, we examined data from a recent study that performed pooled CRISPR screens targeting CAD GWAS loci in immortalized human aortic endothelial cells (teloHAEC)<sup>##UREF##11##69##</sup>. The study used CRISPR knockout, inhibition, and activation to target 1998 potential causal variants in 83 CAD loci and identified 26 loci significantly associated with endothelial phenotypes related to CAD. Five of these significant loci mapped to genes (<italic>FGD5, LOX, MAT2A, NT5C2, SMG6</italic>) that were also prioritized by our PPI data (Fig. ##FIG##3##4b##, Supplementary Fig. ##SUPPL##0##18a##, and Supplementary Data ##SUPPL##3##15##). Specifically, perturbing the variants in these loci affected the levels of adhesion proteins (E-Selectin, ICAM1, VCAM1) and/or signaling molecules (nitric oxide, reactive oxygen species, calcium) in endothelial cells, which have all been directly implicated in the pathology of CAD. In line with the positive CRISPR screen hits and the nomination by our PPI network, there is the abundance of genetic and experimental evidence directly implicating FGD5<sup>##UREF##12##70##</sup>, LOX<sup>##UREF##13##71##,##UREF##14##72##</sup>, MAT2A<sup>##UREF##15##73##</sup>, NT5C2<sup>##UREF##16##74##–##REF##32984406##76##</sup>, and SMG6<sup>##REF##21378990##8##,##UREF##18##77##–##UREF##20##79##</sup> in CAD pathogenesis. These results provide concrete examples of how combining our PPI-nominated candidate proteins with phenotypic perturbation screens can help accelerate rapid functional validation of candidate CAD-causal genes in disease-relevant cell types.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par21\">The success of large-scale, population-based association studies in mapping susceptibility loci for CAD has been eclipsed by the herculean efforts to pinpoint the causal genes within these loci and to understand their biological and clinical relevance. To help fill in the gaps in the “variant-to-function” relationships, we performed interaction proteomics to map the PPIs of 11 non-lipid CAD-risk genes in two disease-relevant vascular cell types, endothelial and smooth muscle cells. The resulting PPI networks capture both cell-type-specific and shared biology between the two cell types and overlap with genetic signals of CAD and related vascular phenotypes. These results demonstrate the capacity of using PPIs to dissect the genetic basis of CAD and indicate that our PPI data can serve as a rich resource for accelerating the translation of GWAS signals into biological insights.</p>", "<p id=\"Par22\">A particular strength of our work lies in our vascular-specific approach, as mapping pathogenic processes in defined primary cells could offer new insights into the molecular basis of disease<sup>##REF##22446964##80##</sup>. For CAD, understanding the tissue-specific pathology holds translation value for highly specific intervention strategies to target organs, as demonstrated by recent development of gene editing in the liver to lower cholesterol<sup>##UREF##21##81##</sup> or gene silencing in the vasculature to suppress endothelial genes<sup>##UREF##22##82##</sup>. Furthermore, given that most CAD-risk loci are unrelated to lipid risk factors, understanding the non-lipid pathways of CAD is imperative for developing novel, efficacious therapeutics. Therefore, mechanistic insights inspired by this work will be an informative first step to begin functionally annotating the non-lipid CAD susceptibility loci that are poorly understood.</p>", "<p id=\"Par23\">Our findings need to be interpreted with its limitations. First, our PPI networks were derived from only 11 index proteins that can be confidently linked to CAD in two vascular cell types, and therefore represent only a small fraction of CAD biology. As the fuller spectrum of genotypes and CAD phenotypes are becoming available through population-based biobanks such as the UK Biobank, the framework described here can be applied to generate broader PPI networks with substantially higher scale and resolution in the future. In addition, the studied index proteins may have CAD-relevant roles outside of the vasculature (e.g., ADAMTS7 is a secreted enzyme) that are not accounted for by the PPI networks derived from vascular cell lysates.</p>", "<p id=\"Par24\">Second, the IP-MS approach for identifying PPIs has various caveats that may influence the reproducibility of the data. For instance, the quality of IP antibodies, overexpression of FLAG-tagged proteins, and incomplete coverage of proteins during MS analysis<sup>##REF##17668192##83##,##REF##28569762##84##</sup> could all contribute to variability in the IP-MS experiments. We partially accounted for this issue by using two bait vs. control IP replicates in each IP-MS experiment to define statistically significant protein interactions. We independently replicated a subset of the interactions by western blotting (Supplementary Figs. ##SUPPL##0##9##, ##SUPPL##0##10##, and ##SUPPL##0##19##) and observed significant overlaps between several IPs for the same index protein (Supplementary Fig. ##SUPPL##0##11##), both of which support a degree of robustness in our data. However, other IPs for the same index protein have limited agreement, either due to experimental variability or due to true biological differences between cell types. Moreover, it is important to note that even when an interaction is reproducible biochemically, additional experiments beyond IP-MS will be needed to investigate if it plays a functional role in biological processes. Therefore, the putative CAD-relevant PPIs, genes, and pathways nominated by our data require further replication and functional validation before causal links to vascular biology can be established.</p>", "<p id=\"Par25\">Third, we recognize that methods such as CRISPR perturbation screens will be crucial for the systematic functional validation of our results. Reassuringly, recent CRISPR knockout, inhibition, and/or activation experiments in immortalized teloHAEC<sup>##UREF##11##69##</sup> already linked several of our prioritized CAD-risk genes to endothelial cell phenotypes, providing orthogonal support that these PPI network genes may be involved in CAD-relevant biology (Supplementary Data ##SUPPL##3##15##). However, this kind of in vitro perturbation approaches also has fundamental caveats that need to be considered when designing a systematic validation experiment, including the inherently variable efficiency of gene inhibition/activation, the poorly characterized off-target effect, and most importantly, the lack of correlation between protein expression level and the mRNA level of particular genes. Specific to our work, there are also considerable transcriptomic differences between the primary HAEC used in our experiments and the immortalized teloHAEC used in the CRISPR screens, and CRISPR gene editing in primary human vascular SMC has not been amenable. Thus, while CRISPR technology represents a promising avenue for functional validation of our PPI networks in human cell models, it is beyond the scope of the current study and warrants a separate effort to properly leverage its strengths in the future.</p>", "<p id=\"Par26\">In conclusion, our work showcases how cell-type-specific interaction proteomics is a powerful approach for characterizing CAD-risk genes in an unbiased, scalable fashion. Genes and pathways prioritized by our vascular-specific PPI networks can provide initial clues on how particular genetic risk factors may lead to CAD and other vascular pathology, thereby nominating potential therapeutic targets for functional validation studies. Lastly, going beyond CAD, functional PPI networks can serve as a general framework for systematic prioritization of candidate genes in GWAS loci of complex diseases.</p>" ]
[]
[ "<p id=\"Par1\">Population-based association studies have identified many genetic risk loci for coronary artery disease (CAD), but it is often unclear how genes within these loci are linked to CAD. Here, we perform interaction proteomics for 11 CAD-risk genes to map their protein-protein interactions (PPIs) in human vascular cells and elucidate their roles in CAD. The resulting PPI networks contain interactions that are outside of known biology in the vasculature and are enriched for genes involved in immunity-related and arterial-wall-specific mechanisms. Several PPI networks derived from smooth muscle cells are significantly enriched for genetic variants associated with CAD and related vascular phenotypes. Furthermore, the networks identify 61 genes that are found in genetic loci associated with risk of CAD, prioritizing them as the causal candidates within these loci. These findings indicate that the PPI networks we have generated are a rich resource for guiding future research into the molecular pathogenesis of CAD.</p>", "<p id=\"Par2\">Protein-protein interaction networks of coronary artery disease (CAD) risk genes in human vascular cells are enriched for genetic variants associated with CAD and can be used to guide future research into the molecular pathogenesis of CAD.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n\n\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s42003-023-05705-1.</p>", "<title>Acknowledgements</title>", "<p>We thank Eric Spooner and Edward Dudek for the discussion and generation of IP-MS data, and Fabian Schulte and Karl Clauser for assistance in data management. This work was supported by the Broad Institute Broadnext10 Round 2 (K.L.) and Round 3 (Q.M.Z.) Awards and the Precision Cardiology Laboratory, which is a joint effort between the Broad Institute and Bayer AG. Y.H.H. was supported by the US National Institute of Diabetes and Digestive and Kidney Diseases (T32DK110919). P.T.E. was supported by the Fondation Leducq (14CVD01), the US National Heart, Lung, and Blood Institute (R01HL092577 and K24HL105780), and the American Heart Association Strategically Focused Research Networks (18SFRN34110082). R.M.G. was supported by the US National Heart, Lung, and Blood Institute (K08HL128810, R03HL148483, and DP2HL152423). K.L. was supported by grants from the Stanley Center for Psychiatric Research, the US National Institute of Mental Health (R01MH109903 and U01MH121499), the Simons Foundation Autism Research Initiative (awards 515064 and 735604), the Lundbeck Foundation (R223-2016-721 and R350-2020-963), the Novo Nordisk Foundation (NNF21SA0072102), the Augustinus Foundation, the Knud Højgaard Foundation, the Reinholdt W. Jorck og Hustrus Foundation, and the US National Institute of Diabetes and Digestive and Kidney Diseases (U01DK078616).</p>", "<title>Author contributions</title>", "<p>Concept and design: Q.M.Z., Y.H.H., F.H.L., R.M.G., P.T.E., and K.L. Acquisition, analysis, or interpretation of the data: Q.M.Z., Y.H.H., F.H.L., B.T.M., S.S., E.M., A.K., T.L., T.M., M.S., G.G., B.T., R.M.G., P.T.E., and K.L. Drafting of the manuscript: Q.M.Z., Y.H.H., F.H.L., and P.T.E. Critical revision of the manuscript for important intellectual content: Q.M.Z., Y.H.H., F.H.L., B.T.M., S.C., R.M.G., P.T.E., and K.L. Administrative, technical, or material support: Q.M.Z., Y.H.H., F.H.L., S.S., M.S., N.F., S.C., R.M.G., P.T.E., and K.L.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par62\">This manuscript has been previously reviewed at another Nature Portfolio journal. The manuscript was considered suitable for publication without further review at <italic>Communications Biology</italic>. Primary Handling Editor: Joao Valente.</p>", "<title>Data availability</title>", "<p>The mass spectra from IP-MS experiments and the protein sequence databases used for searches have been deposited at MassIVE (<ext-link ext-link-type=\"uri\" xlink:href=\"https://massive.ucsd.edu\">https://massive.ucsd.edu</ext-link>) with identifiers MSV000091373 (data from Whitehead Proteomics Core Facility) and MSV000091699 (data from Broad Proteomics Platform). Source data for figures are documented in Supplementary Data ##SUPPL##2##1##.</p>", "<title>Code availability</title>", "<p>Original code has been deposited at GitHub (<ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/lagelab/CAD_PPI\">https://github.com/lagelab/CAD_PPI</ext-link>) and Zenodo (10.5281/zenodo.8415025).</p>", "<title>Competing interests</title>", "<p id=\"Par63\">The authors declare the following competing interests: P.T.E. receives sponsored research support from Bayer AG and IBM Health and has served on advisory boards or consulted for Bayer AG, MyoKardia, Quest Diagnostics, and Novartis. T.M. is an employee and may have equity interest in Verve Therapeutics.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Mapping protein-protein interactions (PPIs) of coronary artery disease (CAD)-risk genes in human vascular cells.</title><p><bold>a</bold> Overview of the 3-stage study workflow consisting of: (1) selection of index genes in CAD-risk loci pooled from genome-wide association studies (GWAS); (2) mapping PPIs of the corresponding index proteins using immunoprecipitation coupled with mass spectrometry (IP-MS); and (3) analysis of the resulting PPI networks to uncover CAD-relevant biology. <bold>b</bold> Details on the selected index genes, which include ten genes from non-lipid, single-gene loci (all expressed in vascular cells except <italic>KCNK5</italic>), 1 gene with a confirmed causal functional role in CAD (<italic>ADAMTS7</italic>), 1 gene nominated by exome chip data (<italic>ARHGEF26</italic>), and 1 gene identified as a distal regulatory target of the <italic>PHACTR1</italic> locus (<italic>EDN1</italic>). Artery image by courtesy of Encyclopædia Britannica, Inc., copyright 2007; used with permission.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>Combined PPI network in endothelial or smooth muscle cells.</title><p><bold>a</bold> The combined PPI network of 9 index proteins derived from IP-MS experiments in endothelial cells. Index proteins and their interactors are shown as red and purple nodes, respectively, and the edges between them indicate significant interactions in the IPs. The size and color of the interactor nodes indicate interactor frequency (i.e., the number of index proteins linked to each interactor), with larger and darker nodes representing more recurrent interactors. Color of the edges indicates whether each interaction is a known interaction in InWeb (blue) or a potentially novel interaction not found in InWeb (gray). <bold>b</bold> Distribution of InWeb vs. non-InWeb interactions in the network in (<bold>a</bold>). <bold>c</bold> Distribution of interactor frequency in the network in (<bold>a</bold>). <bold>d</bold>–<bold>f</bold> Characteristics of the combined PPI network of 10 index proteins derived from IP-MS experiments in smooth muscle cells. The same legends for (<bold>a</bold>–<bold>c</bold>) apply here.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Comparison of PPIs in the endothelial cell (EC) vs. smooth muscle cell (SMC) networks.</title><p><bold>a</bold> Overlap between interactors in the EC and SMC PPI networks. <bold>b</bold> Cardiovascular tissue enrichment calculated using GTEx tissue-specific genes based on RNA-seq data. Interactors found exclusively in the EC (EC only) or SMC (SMC only) network and interactors found in both networks (Intersect) were analyzed separately and compared against the rest of the genome. <bold>c</bold> Gene set enrichment calculated using MSigDB Hallmark gene sets. EC only, SMC only, and Intersect interactors were compared against the non-interactors detected by IP-MS; only the top ten gene sets are shown for each analysis. All <italic>P</italic> values were calculated using one-tailed hypergeometric tests. For (<bold>b</bold>, <bold>c</bold>), nominally (<italic>P</italic>&lt;0.05) or Bonferroni-significant (<italic>P</italic> &lt;0.05/number of tissues or gene sets) results are shown in orange or red, respectively; gene counts used for analysis are shown in Supplementary Data ##SUPPL##3##10## and ##SUPPL##3##11##.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>Genetic risk enrichment in the PPI networks.</title><p><bold>a</bold> Common variant enrichment of the PPI networks calculated using MAGMA and GWAS summary statistics of CAD, aorta size, and stroke. Index protein interactors identified in EC or SMC were compared against the rest of the protein-coding genome. Nominal (<italic>P</italic>&lt;0.05) or Bonferroni (<italic>P</italic>&lt;0.05/29) significance is indicated by single or double asterisks, respectively; gene counts used for analysis are shown in Supplementary Data ##SUPPL##3##13##. AA ascending aorta, DA descending aorta, AS any stroke, AIS any ischemic stroke, LAS large-artery atherosclerotic stroke, CES cardioembolic stroke, SVS small-vessel stroke. <bold>b</bold> Social Manhattan plot of genes encoding the index proteins (red) and their SMC interactors (black) in genome-wide significant CAD GWAS loci. Links between genes indicate observed protein-protein interactions; interactions validated by western blots are highlighted in blue.</p></caption></fig>" ]
[]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM5\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Qiuyu Martin Zhu, Yu-Han H. Hsu, Frederik H. Lassen.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"42003_2023_5705_Fig1_HTML\" id=\"d32e507\"/>", "<graphic xlink:href=\"42003_2023_5705_Fig2_HTML\" id=\"d32e751\"/>", "<graphic xlink:href=\"42003_2023_5705_Fig3_HTML\" id=\"d32e879\"/>", "<graphic xlink:href=\"42003_2023_5705_Fig4_HTML\" id=\"d32e1075\"/>" ]
[ "<media xlink:href=\"42003_2023_5705_MOESM1_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>", "<media xlink:href=\"42003_2023_5705_MOESM2_ESM.pdf\"><caption><p>Description of Additional Supplementary Files</p></caption></media>", "<media xlink:href=\"42003_2023_5705_MOESM3_ESM.xlsx\"><caption><p>Supplementary Data 1</p></caption></media>", "<media xlink:href=\"42003_2023_5705_MOESM4_ESM.xlsx\"><caption><p>Supplementary Data 2–15</p></caption></media>", "<media xlink:href=\"42003_2023_5705_MOESM5_ESM.pdf\"><caption><p>Reporting Summary</p></caption></media>" ]
[{"label": ["7."], "mixed-citation": ["Fern\u00e1ndez-Tajes, J. et al. Developing a network view of type 2 diabetes risk pathways through integration of genetic, genomic and functional data. "], "italic": ["Genome Med"], "bold": ["11"]}, {"label": ["19."], "mixed-citation": ["Razick, S., Magklaras, G. & Donaldson, I. M. iRefIndex: a consolidated protein interaction database with provenance. "], "italic": ["BMC Bioinforma."], "bold": ["9"]}, {"label": ["24."], "mixed-citation": ["Lin, Z. et al. Decoding WW domain tandem-mediated target recognitions in tissue growth and cell polarity. "], "italic": ["eLife"], "bold": ["8"]}, {"label": ["25."], "surname": ["Wang"], "given-names": ["W"], "article-title": ["Defining the protein-protein interaction network of the human hippo pathway"], "source": ["Mol. Cell Proteom."], "year": ["2014"], "volume": ["13"], "fpage": ["119"], "lpage": ["131"], "pub-id": ["10.1074/mcp.M113.030049"]}, {"label": ["27."], "mixed-citation": ["Pintacuda, G. et al. Protein interaction studies in human induced neurons indicate convergent biology underlying autism spectrum disorders. "], "italic": ["Cell Genomics."]}, {"label": ["29."], "mixed-citation": ["Samson, T. et al. The guanine-nucleotide exchange factor SGEF plays a crucial role in the formation of atherosclerosis. "], "italic": ["PLoS ONE"], "bold": ["8"]}, {"label": ["31."], "mixed-citation": ["Siva, K., Venu, P., Mahadeva, A., Shankar, S. K. & Inamdaar, M. S. Human BCAS3 expression in embryonic stem cells and vascular precursors suggests a role in human embryogenesis and tumor angiogenesis. "], "italic": ["PLoS ONE"], "bold": ["2"]}, {"label": ["36."], "mixed-citation": ["Lino Cardenas, C. L. et al. HDAC9 complex inhibition improves smooth muscle-dependent stenotic vascular disease. "], "italic": ["JCI Insight"], "bold": ["4"]}, {"label": ["41."], "mixed-citation": ["Wang, D., Wang, Z., Zhang, L. & Wang, Y. Roles of cells from the arterial vessel wall in atherosclerosis. "], "italic": ["Mediators Inflamm"], "bold": ["2017"]}, {"label": ["42."], "mixed-citation": ["M\u00e4kinen, V. P. et al. Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease. "], "italic": ["PLoS Genet."], "bold": ["10"]}, {"label": ["63."], "mixed-citation": ["Li, L., Zhang, Q., Lei, X., Huang, Y. & Hu, J. MAP4 as a new candidate in cardiovascular disease. "], "italic": ["Front. Physiol"], "bold": ["11"]}, {"label": ["69."], "mixed-citation": ["W\u00fcnnemann, F. et al. Multimodal CRISPR perturbations of GWAS loci associated with coronary artery disease in vascular endothelial cells. "], "italic": ["PLoS Genet."], "bold": ["19"]}, {"label": ["70."], "mixed-citation": ["Kurogane, Y. et al. FGD5 mediates proangiogenic action of vascular endothelial growth factor in human vascular endothelial cells. "], "italic": ["Arterioscler. Thromb. Vasc. Biol."], "bold": ["32"]}, {"label": ["71."], "mixed-citation": ["Guo, D. C. et al. LOX mutations predispose to thoracic aortic aneurysms and dissections. "], "italic": ["Circ. Res"], "bold": ["118"]}, {"label": ["72."], "mixed-citation": ["Leea, V. S. et al. Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans. "], "italic": ["Proc. Natl. Acad. Sci. USA"], "bold": ["113"]}, {"label": ["73."], "mixed-citation": ["Herre, C., Nshdejan, A., Klopfleisch, R., Corte, G. M. & Bahramsoltani, M. Expression of vimentin, TPI and MAT2A in human dermal microvascular endothelial cells during angiogenesis in vitro. "], "italic": ["PLoS ONE"], "bold": ["17"]}, {"label": ["74."], "mixed-citation": ["Chen, X., Zhang, Z., Wang, X., Chen, Y. & Wang, C. NT5C2 gene polymorphisms and the risk of coronary heart disease. "], "italic": ["Public Health Genomics"], "bold": ["23"]}, {"label": ["75."], "mixed-citation": ["Sorriento, D. & Iaccarino, G. Commentary: studies in zebrafish demonstrate that CNNM2 and NT5C2 are most likely the causal genes at the blood pressure-associated locus on human chromosome 10q24.32. "], "italic": ["Front. Cardiovasc. Med."]}, {"label": ["77."], "mixed-citation": ["Mega, J. L. et al. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. "], "italic": ["Lancet"], "bold": ["385"]}, {"label": ["78."], "mixed-citation": ["Guo, Y. et al. A genome-wide cross-phenotype meta-analysis of the association of blood pressure with migraine. "], "italic": ["Nat. Commun."], "bold": ["11"]}, {"label": ["79."], "mixed-citation": ["Lindstr\u00f6m, S. et al. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism. "], "italic": ["Blood"], "bold": ["134"]}, {"label": ["81."], "mixed-citation": ["Musunuru, K. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. "], "italic": ["Nature"], "bold": ["593"]}, {"label": ["82."], "mixed-citation": ["Khan, O. F. et al. Endothelial siRNA delivery in nonhuman primates using ionizable low-molecular weight polymeric nanoparticles. "], "italic": ["Sci. Adv."], "bold": ["4"]}]
{ "acronym": [], "definition": [] }
92
CC BY
no
2024-01-14 23:40:17
Commun Biol. 2024 Jan 12; 7:87
oa_package/3b/22/PMC10786878.tar.gz
PMC10786880
38216551
[ "<title>Introduction</title>", "<p id=\"Par3\">The human KRAS protein is both friend and foe; the non-mutated form is indispensable in diverse physiological processes, whereas the mutated versions directly underlie multistep processes of tumorigenesis and progression in ~30% of all cancers. Targeting KRAS is considered one of the optimal strategies to combat KRAS-driven tumors and improve advanced cancer patients’ outcomes<sup>##REF##26960760##1##,##REF##24304874##2##</sup>. Despite advances in KRAS inhibitors, decades of efforts hitherto did not bring them to the clinic<sup>##REF##34759319##3##,##REF##37258666##4##</sup>. Recent studies revealed that mutant KRAS could be exploited by cancers to orchestrate an immune-suppressive tumor microenvironment (TME)<sup>##REF##31951548##5##,##REF##33116132##6##</sup>. The Cancer Genome Atlas also indicated KRAS mutant colorectal cancer (CRC) are closely associated with decreased immune infiltration and reactivity<sup>##REF##29061646##7##</sup>. In addition, KRAS inhibition endowed tumors with a remarkable increase in anti-tumor immunity<sup>##REF##31666701##8##</sup>. Therefore, KRAS mutant tumors are especially immune-excluded, and therapeutic approaches aimed at activating anti-tumor immune program might be essential to eliminate the disease.</p>", "<p id=\"Par4\">Cancer pathologies are often orchestrated by various metabolites, and KRAS mutant tumors are especially exposed to dramatically increased levels of lactic acid<sup>##UREF##0##9##,##REF##22541435##10##</sup>. Cancer-generated lactic acid endows malignancies with an acidic TME, and also acts as a primary carbon fuel source and signaling molecule involved in oncogenic pathways<sup>##REF##32791100##11##,##REF##36729274##12##</sup>. Current researches have also yielded evidence that lactic acid in the TME was an impediment towards providing an effective anti-tumor immunity<sup>##REF##33171818##13##</sup>. In this respect, tumor-derived lactic acid was found to take effects on tumor-associated macrophages<sup>##REF##25043024##14##,##REF##33833221##15##</sup>, regulatory T cells<sup>##REF##33589820##16##</sup>, myeloid-derived suppressor cells<sup>##REF##35263597##17##</sup>, natural killer cells<sup>##REF##27641098##18##</sup>, or dendritic cells<sup>##REF##16278308##19##</sup>. In particular, Kreutz and colleagues pointed to an impact of lactic acid on cytolytic T lymphocytes (CTLs)<sup>##REF##17255361##20##</sup>, which directly identify and destroy nascent tumor cells during cancer immunosurveillance. Our previous study significantly advanced our understanding for the involvement of lactic acid in CTL fate decisions and subsequent support for tumor progress<sup>##UREF##0##9##</sup>. These insights highlighted an intense engagement between lactic acid and CTLs, but the intracellular mechanism of lactic acid action in CTLs remains poorly defined.</p>", "<p id=\"Par5\">Activation-induced cell death (AICD), firstly described in 1987, has been characterized as a mechanistic link with immunological homeostasis<sup>##REF##35032297##21##,##REF##24210163##22##</sup>. Under physiological conditions, AICD is able to eradicate activated T lymphocytes presumed to be no longer required<sup>##REF##18289867##23##</sup>. Abnormality in AICD was discovered in diverse pathological situations, such as viral infection, inflammatory and autoimmune disorders<sup>##REF##33093334##24##–##UREF##1##26##</sup>. In the context of many cancer types, AICD deregulation was also frequently identified<sup>##REF##22159518##27##–##REF##25745993##29##</sup>. Aberrant AICD of tumor-specific CTLs can be used by cancers to evade immune elimination<sup>##REF##30224822##28##</sup>, which accounts for the paradoxical fact that, although the patients mount a specific T cell response against neoplasm, these CTLs fail to control the disease. It is now widely understood that AICD is of much value to decipher cancer pathologies as well as present prognostic insights, or even develop alternative treatments for cancer patients. Along this line, we previously found mutant KRAS-expressing CRC cells exploited tumor-derived lactic acid to sensitize tumor-specific CTLs to AICD, thereby fostering tumor immune escape and immunotherapy resistance<sup>##UREF##0##9##</sup>. Multiple molecular players, including mitochondrio-nuclear translocation of AIF<sup>##REF##17109472##30##</sup>, CD158 receptor<sup>##REF##14612548##31##</sup>, or NKILA<sup>##REF##30224822##28##</sup>, were identified to participate in an abnormal sensitivity of tumor-specific CTLs to AICD. Despite this knowledge, how lactic acid reprograms AICD of tumor-specific CTLs warrants under further investigation.</p>", "<p id=\"Par6\">Circular RNAs (circRNAs) emerge as a unique class of RNA molecules characterized by their covalently closed ring structure. The interest in studying circRNAs is raised because of several peculiar features, such as evolutionary conservation and tissue-specific expression, but above all, because their deregulated expression was linked to many pathological conditions, particularly cancers<sup>##REF##32366901##32##,##REF##30057200##33##</sup>. Mounting data suggest these molecules are of potential clinical relevance and utility<sup>##REF##35584701##34##,##REF##37365670##35##</sup>. Notably, circRNAs have been identified to be participants in the regulatory networks of tumor immunity<sup>##UREF##2##36##</sup>. Wang and colleagues demonstrated overexpression of hsa_circ_0020397 in CRC cells could promote the upregulation of PD-L1 by binding and inhibiting miR-138 expression, thereby resulting in tumor immune escape<sup>##REF##28707774##37##</sup>. Furthermore, there is evidence of a correlation between circRNAs and immune cell infiltration in several cancers<sup>##REF##36433954##38##–##UREF##3##40##</sup>. Recently, a study by Ye et al. identified circRNA profiles and regulatory networks in melanoma patients treated with immune checkpoint blockades, highlighting the clinical application potential of circRNAs as predictive biomarkers for immunotherapeutic efficacy<sup>##REF##37137884##41##</sup>. These advances underscored the link between circRNAs and cancer immunology, yet knowledge of the role played by circRNAs and the mechanism of circRNAs’ action in CTLs is limited.</p>", "<p id=\"Par7\">Here, we show that tumor-mediated AICD can be exploited by oncogenic KRAS to dictate the formation of an immune-suppressive tumor microenvironment. In the tumor-specific CTLs of KRAS<sup>MUT</sup> CRC, histone lactylation turns on the transcription of circATXN7, an NF-κB-interacting circular RNA. The upregulation of circATXN7 increases the sensitivity to AICD of tumor-specific CTLs by binding to NF-κB p65 subunit and masking the p65 nuclear localization signal motif, thereby sequestering it in the cytoplasm. In KRAS<sup>MUT</sup> tumors-bearing mice, genetic ablation of circAtxn7 in CD8<sup>+</sup> T cells leads to mutant-selective tumor inhibition, while also increases anti-PD1 efficacy. Administering tumor-reactive CTLs with circATXN7 knockdown effectively suppresses tumor growth by improving CTL accumulation in CRC patient-derived xenografts in NOD.SCID mice. Clinically, increased circATXN7 in tumor-specific CTLs is associated with adverse clinical outcomes and immunotherapeutic resistance. Together, our findings highlight the importance of circular RNAs in T cell fate decisions and suggest engineering them in T cells represents an exploitable approach for anticancer immunotherapies.</p>" ]
[ "<title>Methods</title>", "<title>Patients and tissue samples</title>", "<p id=\"Par36\">The experiments related to human samples were performed with the approval of the Institutional Review Board of The Sixth Affiliated Hospital of Sun Yat-sen University (Guangzhou, China; approval number: G2020008 and G2022024) and Sun Yat-sen University Cancer Center (Guangzhou, China; approval number: G2021-088-01 and B2022-025-01), covering the collection of formalin-fixed, paraffin-embedded tissues, PBMCs and primary CRC specimens. Informed consent was waived for the collection of formalin-fixed, paraffin-embedded tissues, whereas informed consent was obtained from each patient for the collection of PBMCs and primary CRC specimens. Paraffin-embedded tumor samples were obtained from 269 patients with stage I–III CRC and 101 patients with stage IV CRC. Paraffin-embedded biopsy specimens were harvested from 45 patients who underwent ICIs at The Sixth Affiliated Hospital, Sun Yat-sen University. Patient who received radical surgery was managed per local guidelines, and the cohort receiving ICIs was managed according to the most appropriate approach decided by the multi-disciplinary team and specific needs of each patient. KRAS status was assessed by Sanger sequencing, and pathologists determined patients’ mismatch repair status according to the immunohistochemistry (IHC) staining for four proteins (MLH1, MSH2, MSH6 or PMS2). Shanghai Outdo Biotech (Shanghai, China) provided pancreatic cancer tissues from 87 patients under the approval of the internal ethics review board (approval number: SHYJS-CP-1901008), in which anonymized data were analyzed, and waived the requirement for informed consent.</p>", "<title>Mouse strain generation and experiments</title>", "<p id=\"Par37\"><italic>CircAtxn7</italic><sup><italic>loxp/loxp</italic></sup> mice were generated using CRISPR-Cas9-mediated genome editing by Cyagen Biosciences Inc. (China). Immunocompromised NOD.SCID mice were obtained from GemPharmatech (China) and used to establish patient-derived xenograft models. OT-I (C57BL/6-Tg (TcraTcrb)1100Mjb/J), <italic>Cd8a</italic>-Cre (C57BL/6-Tg (Cd8a-cre)1Itan/J) were provided by the Jackson Laboratory. To generate mice with circAtxn7 conditional deletion in CD8<sup>+</sup> T cells, <italic>CircAtxn7</italic><sup><italic>loxp/loxp</italic></sup> mice were crossed with <italic>Cd8a</italic>-Cre mice. Conditional knockout of circAtxn7 was confirmed by qRT-PCR using T cells puried from the spleen. We genotyped these experiment cohort strains by PCR amplification methods. PCR primers used in genotyping are listed in Supplementary Table ##SUPPL##0##2##. Animals were bred under specific pathogen-free conditions at the Experimental Animal Center of Sun Yat-sen University. Female mice were used for all animal work under the protocols approved by the Institutional Animal Care and Use Committee (IACUC), Sun Yat-sen University (approval number: SYSU-IACUC-2020-000438, SYSU-IACUC-2021-000285 and SYSU-IACUC-2021-000642).</p>", "<title>AICD induction and determination</title>", "<p id=\"Par38\">An ex vivo model system was established to mimic AICD according to previous reports with modification<sup>##REF##30224822##28##,##REF##16341093##76##</sup>. Briefly, purified T cells were activated by PHA (1 μg/ml; Sigma) for 18 h and then cultured with the cytokine IL-2 (25 U/ml; PeproTech) for an additional 5 days. To induce AICD, activated T cells were stimulated with anti-CD3 (10 μg/mL; BD Bioscience), and tumor-specific CTLs were treated with anti-CD3 (10 μg/mL; BD Bioscience) or autologous tumor cells pre-dyed by CellTtracker Deep Red Dye (Thermo Fisher Scientific) at a 1:1 ratio for 18 h at 37 °C. Anti-CD3-induced T cell apoptosis was determined by flow cytometry analysis using annexin V/7-AAD staining kits (MULTISCIENCES). For tumor cell-induced AICD, cocultures of tumor-specific CTLs and autologous tumor cells were subjected to flow cytometric cell sorting to exclude tumor cells and retrieve tumor-specific CTLs. Afterwards, purified CTLs were stained with annexin V/7-AAD, followed by flow cytometry analysis. Apoptotic cell percentages included the percentages of early (annexin V<sup>+</sup> 7-AAD<sup>–</sup>) and late apoptotic cells (annexin V<sup>+</sup> 7-AAD<sup>+</sup>). Specific apoptosis was calculated as: (induced apoptosis percentage minus spontaneous apoptosis percentage) / (100% minus percentage of spontaneous apoptosis) × 100%. To evaluate specific signaling pathways effects on AICD, T cells were treated with vehicle, 2 mM Bay11-7082 (MedChemExpress), or 6 mM JSH-23 (MedChemExpress) for 1 h, or 10 mM lactic acid (Sigma) for 12 h prior to AICD induction. To inhibit tumor-mediated AICD, tumor cells were incubated with HLA class I blocking antibodies (10 μg/ml, Thermo Fisher Scientific), or isotype antibodies for 2 h at 37 °C before the addition of tumor-specific CTLs. In some experiments, T cells were treated with 3 mM 3-hydroxy-butyrate (3-OBA; Sigma), or 10 nM AZD3965 (MedChemExpress) for 4 h, followed by 10 mM lactic acid stimulation for 12 h before AICD induction.</p>", "<title>circRNA profile</title>", "<p id=\"Par39\">For circRNA-sequencing, total RNA was extracted from PHA-activated CD8<sup>+</sup> T cells with 10 mM lactic acid (Sigma) or PBS treatment using Trizol (Invitrogen). The rRNA and linear RNA were removed using an epicenter Ribo-Zero rRNA Removal Kit (Illumina) and RNAse R (Epicenter), respectively. Afterwards, a cDNA library was constructed, followed by deep sequencing using an Illumina HiSeq 3000 (Illumina) at RiboBio Co. Ltd (Guangzhou, China). circRNAs were identified using CIRI2 and CIRCexplorer2 software.</p>", "<title>Chromatin immunoprecipitation sequencing</title>", "<p id=\"Par40\">The ChIP assay was performed using a Pierce™ Magnetic ChIP Kit (Thermo Fisher Scientific) according to the manufacturer’s instructions. Briefly, after cross-linking and chromatin digestion, digested chromatin was incubated with 5 μg anti-H3K18la (PTM Bio), anti-EP300 (Cell Signaling Technology), or anti-IgG (Cell Signaling Technology) antibodies at 4 °C overnight. Protein A/G magnetic beads were then added into the lysate the following morning and incubated for another 4 h. The immunoprecipitated DNA was purified and then used to perform qRT-PCR or RNA sequencing.</p>", "<title>RNA sequencing</title>", "<p id=\"Par41\">For RNA-Seq, tumor-infiltrating CD8<sup>+</sup> T cells purified by flow cytometry (<italic>n</italic>  =  600–800 cells per samples) from WT or <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> MC38K tumor-bearing mice were captured directly into lysis buffer containing 10 μM dNTP mix, 10 μM Oligo dT primer, 1% Triton X-100, and 40 IU/ml RNase inhibitor. Full-length mRNA was reverse transcribed, amplified, and sequenced using the Smart-seq2 protocol. Reads were aligned to the mouse reference genome version mm10 using STAR (version 2.6.1b) and quantified using HTSeq (version 0.11.0). Gene counts were normalized using DESeq2 (version 1.32.0) to estimate gene expression levels and identify differentially expressed genes.</p>", "<title>Cell lines</title>", "<p id=\"Par42\">The murine colon carcinoma cell line MC38 were obtained from Kerast Inc. The murine pancreatic adenocarcinoma cell line Pan02 were kindly provided by Prof. Qiongcong Xu (The First Affiliated Hospital, Sun Yat-sen University). The murine melanoma cell line B16F10, and human embryonic kidney 293 T (HEK293T) and T2 cells were originally obtained from the American Type Culture Collection. Cells were cultured in DMEM medium (Gibco) supplemented with 10% fetal bovine serum (Gibco or Nanjing Ozfan Biotechnology Co., Ltd.). All cell lines were identified by short tandem repeat profiling, tested negative for mycoplasma contamination, and grown according to standard protocols.</p>", "<title>Primary cells</title>", "<p id=\"Par43\">Human peripheral blood mononuclear cells (PBMCs) were donated by healthy donors or CRC patients, and isolated using Ficoll-Paque (GE Healthcare) according to the manufacturer’s instructions. CD8<sup>+</sup> T cells were obtained from PBMCs using CD8<sup>+</sup> T cell Isolation Kits (Miltenyi Biotec). Primary CRC cells and tumor-specific CTLs were purified from freshly resected tumor samples of HLA-A2<sup>+</sup> patients with CRC expressing CEA using EpCAM<sup>+</sup> microbeads (Miltenyi Biotec) and anti-CEA Pentamer-PE (YLSGANLNL; ProImmune), respectively. OT-I cells were acquired with the spleens from transgenic OT-I expressing mice using CD8<sup>+</sup> T cell Isolation Kits (Miltenyi Biotec). Cell populations were confirmed to be &gt; 90% pure by flow cytometric analysis.</p>", "<title>Dendritic cell (DC) and tumor-reactive T cell preparation</title>", "<p id=\"Par44\">The isolated PBMCs were cultured in RPMI-1640 medium supplemented with 1% fetal bovine serum for 1 h, after which adherent monocytes were cultured for 5 days in VIVO medium (Lonza Walkersville) containing 100 ng/mL GM-CSF (PeproTech) and 30 ng/mL IL-4 (PeproTech). Half of the culture medium was replaced with fresh medium and cytokines every two days. Afterwards, the obtained DCs were matured through incubation with 10 ng/mL TNF-α (Peprotech) for 24 h and then pulsed for 24 h with autologous primary tumor cell lysates by freeze-thawing with liquid nitrogen (200 μg protein/1 × 10<sup>6</sup> cells/ml) to generate autologous tumor-antigen-loaded DCs. CD8<sup>+</sup> T cells purified from PBMCs of the same donors were activated by co-culture with autologous tumor-antigen-loaded DCs at a ratio of 5:1 in VIVO medium supplemented with 25 IU/ml IL-2 (Peprotech) for 5 days to obtain tumor-reactive T cells.</p>", "<title>T cell transduction</title>", "<p id=\"Par45\">Lentivirus was used for T cell transduction. To produce lentivirus, packaging vectors and lentiviral transfer vectors were transfected into 293 T cells using polyethyleneimine (Polysciences). After 48 h and 72 h post-transfection, viral supernatants were collected and filtered using a 0.45 μm syringe filter (Millipore), and then they were concentrated by centrifugation at 1600 × <italic>g</italic> in ultrafiltration tubes (Millipore). Activated T cells were cultured with concentrated lentivirus (multiplicity of infection of 25) supplemented with 8 µg/ml polybrene (Sigma), centrifuged at 850 × <italic>g</italic> for 80 min at 32 °C, and cultured for 9 h. The transduction was repeated on two consecutive days and cells were cultured in X-VIVO medium supplemented with 100 IU/ml IL-2. For OT-I T cell transductions, total splenocytes from OT-I mice were stimulated with 10 nM peptide (OVA)<sub>257–264</sub> (SIINFEKL; Sigma) in the presence of 100 IU/ml IL-2 for 5 days. Afterwards, they were purified and subjected to lentivirus transduction as described above.</p>", "<title>Plasmids construction and lentivirus infection</title>", "<p id=\"Par46\">Lentiviral vectors with or without Luc, mCherry or GFP expression were used to transduce shRNAs against circATXN7 (human), circAtxn7 (mouse), or scrambled vectors into T cells. To generate the circATXN7 or circAtxn7 overexpression plasmid, the full-length circATXN7 or circAtxn7 with or without p65-binding site mutant cDNA (5′ GGTCGGGG 3′ were altered to 5′ AAAAAAAA 3′) was cloned into the pLO-ciR vector (Guangzhou Bioyard Biotechnology Development Co., Ltd). A series of human p65 gene deletion mutations with flag-tag were cloned into the pSin-puro vector (Guangzhou Bioyard Biotechnology Development Co., Ltd). The circATXN7-binding site-mutated p65 (R303A) were generated as well. The above plasmids were used for T cell transduction as described above.</p>", "<p id=\"Par47\">To generate constructs for mutant Kras overexpression, the coding sequence of <italic>Kras</italic><sup><italic>G12D</italic></sup>, <italic>Kras</italic><sup><italic>G12V</italic></sup>, or <italic>Kras</italic><sup><italic>G13D</italic></sup> was amplified using ClonExpress II One Step Cloning Kit (Vazyme), and then the cDNA was inserted into the lentiviral expression vector pCDH-CMV-Puro. The constructs were verified by DNA sequencing. For stable transfection, the pCDH-CMV-Puro lentiviral vectors encoded <italic>Kras</italic><sup><italic>G12D</italic></sup>, <italic>Kras</italic><sup><italic>G12V</italic></sup>, or <italic>Kras</italic><sup><italic>G13D</italic></sup> were adopted to produce lentiviral particles carrying the above-mentioned vectors in HEK293T cells using Lipofectamine 3000 (Invitrogen). MC38, Pan02, and B16F10 cells were infected with lentivirus followed by selection with puromycin to generate the cells expressing mutant Kras (designated as MC38K, Pan02K, and B16F10K, respectively), while cells with transfection of the corresponding empty vectors were used as controls (MC38, Pan02, and B16F10 hereafter, respectively). The successful generation of Kras mutant cells was confirmed by Sanger sequencing. In addition, to generate MC38K-OVA and Pan02K-OVA cell lines, the MC38K and Pan02K were infected with lentivirus produced by HEK293T cells using pLEX307 lentiviral vector encoded OVA and selected by neomycin.</p>", "<title>RNA isolation and qRT-PCR</title>", "<p id=\"Par48\">Total RNA was extracted from cells using TRIzol (Invitrogen). The nuclear and cytoplasmic fractions were purified by NE-PER™ Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher Scientific) as per the manufacturer’s protocol. Total RNAs were then reverse-transcribed using a reverse transcription kit (Takara). We performed qRT-PCR using a SYBR Green PCR Kit (Takara). All reactions were performed in a 10 μl reaction volume in triplicate and GAPDH or served as the reference. The 2<sup>-∆∆CT</sup> method was applied to calculate relative expression. The primer sequences are shown in Supplementary Table ##SUPPL##0##2##.</p>", "<title>RNase R treatment</title>", "<p id=\"Par49\">RNase R (Epicentre Technologies, Madison, WI, USA) was used to assess the stability of circRNA. Total RNA (2 μg) was mixed with 0.6 μl 10 × RNase R Reaction Buffer and 0.2 μl RNase R or DEPC-treated water (control group). The samples were then incubated at 37 °C for 15 min. The circATXN7 and linear ATXN7 expression levels were determined by qRT-PCR.</p>", "<title>Actinomycin D assay</title>", "<p id=\"Par50\">To assess circRNA half-life, gene transcription was blocked by adding 2 mg/mL Actinomycin D (Sigma) to the cell culture medium. DMSO was used as a negative control. Cells were harvested at 0, 4, 8, 12, and 24 h, and circATXN7 and linear <italic>ATXN7</italic> stabilities were analyzed by qRT-PCR.</p>", "<title>circATXN7-p65 structure modeling</title>", "<p id=\"Par51\">The p65 crystal structure was downloaded from the Protein Data Bank. The secondary structure of circATXN7 was formed using the Vienna RNA web server, and 3dRNA predicted the 3D structure of circATXN7. Protein-nucleic acid structures interaction sites were calculated using HDOCK and visualized by chimera.</p>", "<title>FISH assay</title>", "<p id=\"Par52\">The FISH assay was carried out using a Fluorescent In Situ Hybridization Kit (RiboBio) as per the manufacturer’s protocols. Hybridization was performed with fluorescence-labeled circATXN7 probes (GenePharma), followed by analysis using confocal microscopy. The probe sequences are shown in Supplementary Table ##SUPPL##0##2##.</p>", "<title>Immunoblots</title>", "<p id=\"Par53\">Cells were collected, washed, and lysed in radioimmunoprecipitation assay (RIPA) lysis buffer containing Protease and Phosphatase Inhibitor (Thermo Fisher Scientific). A bicinchoninic acid (BCA) kit (CWBio) was then used to detect the concentration of protein. Equivalent amounts of protein were separated on 10% SDS-PAGE and then transferred to a polyvinylidene fluoride (PVDF) membrane (Millipore). The membrane was then blocked with Tris-buffered saline with Tween 20 (TBST) buffer containing 5% skim milk powder and incubated with corresponding primary antibodies at 4 °C overnight. The primary antibodies used were anti-p65 (Cell Signaling Technology), anti-IκBα (Cell Signaling Technology), anti-p50 (Cell Signaling Technology), anti-Histone-H3 (Abcam), anti-β-actin (Abcam), anti-Flag (Cell Signaling Technology), GAPDH (Cell Signaling Technology), anti-L-Lactyl Lysine (PTM Bio Inc), anti-Lactyl-Histone H3 (Lys18) Rabbit mAb (PTM Bio Inc), anti-KRAS (Abcam), anti-KRAS<sup>G12D</sup> (Abcam), anti-Lamin A (Abcam). Membranes were then washed with TBST three times and incubated with horseradish peroxidase (HRP)-conjugated anti-rabbit or anti-mouse secondary antibody (Cell Signaling Technology) for 1 h at room temperature. Signals were developed with ECL Blotting Detection Reagents (Thermo Fisher Scientific).</p>", "<title>Immunohistochemistry (IHC)</title>", "<p id=\"Par54\">IHC was performed on formalin-fixed, paraffin-embedded (FFPE) tissue sections. The primary antibodies in this work were anti-human CD8 (Abcam), anti-mouse CD8 (BD Bioscience). Tissue sections were incubated with primary antibodies at 4 °C overnight and then incubated with secondary antibody. DAB complex was used as the chromogen. The nuclei were counterstained with hematoxylin. For quantification, the slides were assessed by two independent pathologists who were blinded to the patients’ clinical information. The CD8<sup>+</sup> cell density was calculated as the number per mm<sup>2</sup> of CD8<sup>+</sup> cells on each slide.</p>", "<title>Transwell migration assay</title>", "<p id=\"Par55\">Cell migration assays were performed using a 5 μm pore Transwell filter system (BD Biosciences).1 × 10<sup>5</sup> T cells transduced with GFP-shcircATXN7 (in human cells) or GFP-shcircAtxn7 (in murine cells) were mixed with 1 × 10<sup>5</sup> T cells transduced with mCherry-shVec and seeded on the upper chambers. Media containing recombinant human or murine CXCL10 was placed in the lower well. Following an incubation period of 3 h, the migrated cells were collected and analyzed by flow cytometry.</p>", "<title>RNA in situ hybridization (ISH) assay</title>", "<p id=\"Par56\">The circATXN7<sup>+</sup> cells in paraffin-embedded CRC tissues were detected using digoxin-labeled circATXN7 probes and an ISH Detection Kit (BosterBio) on the basis of the manufacturer’s instructions. The sections were dewaxed and rehydrated, followed by digestion with pepsin. The sections were hybridized with circATXN7 probes at 37 °C overnight. The sections were incubated with an anti-digoxin monoclonal antibody conjugated with alkaline phosphatase and then incubated with 3, 3′-diaminobenzidine (DAB). For quantification, the slides were assessed by two independent pathologists who were blinded to the patients’ clinical information. The circATXN7<sup>+</sup> cell density was calculated as the number per mm<sup>2</sup> of circATXN7<sup>+</sup> cells on each slide.</p>", "<title>Immunofluorescence (IF)</title>", "<p id=\"Par57\">Cells were fixed with 4% paraformaldehyde for 15 min at room temperature and permeabilized using 0.2% Triton X-100. Frozen sections were obtained from fresh tissues after surgery. Paraffin-embedded tumor sections were deparaffinized and antigen repaired. Afterwards, the tissue sections or cell-adherent slides were blocked with 10% bovine serum albumin (BSA; Sigma) for 1 h and incubated with anti-human CD8 (Abcam) and anti-p65 (Cell Signaling Technology). After rigorous washing with PBS, sections or slides were incubated with fluorescently conjugated secondary antibodies (Thermo Fisher Scientific). Isotype matched antibodies were used as controls. After counterstaining with DAPI (Abcam), we acquired images using a confocal laser-scanning microscope (Leica TCS-SP8) with a core data acquisition system (Applied Precision).</p>", "<title>RNA Immunoprecipitation (RIP)</title>", "<p id=\"Par58\">Anti-p65 (Cell Signaling Technology) and anti-Flag (Cell Signaling Technology) were used for the p65 and Flag RIP assays, respectively. RIP was done using the Magna RIP RNA-binding protein immunoprecipitation kit (Millipore) in light of the manufacturer’s introductions. The isolated RNA was purified and then subjected to qRT-PCR. The enrichment values were normalized to the level of background RIP, as detected by IgG isotype control.</p>", "<title>circRNA pull-down</title>", "<p id=\"Par59\">Biotin-labeled circATXN7 probes and control probes were used for circRNA pull-down. In brief, the cells were lysed in co-immunoprecipitation (CoIP) buffer and incubated with the circATXN7 probe at room temperature for 2 h. Then, the cell lysate was incubated with 50 μl of Streptavidin C1 magnetic beads (Invitrogen) at room temperature for 1 h. The beads were washed briefly five times with co-IP buffer, and the bound proteins in the pull-down material were analyzed by immunoblots.</p>", "<title>In vitro transcription and cyclization of circATXN7</title>", "<p id=\"Par60\">The DNA template used for biotinylated circATXN7 in vitro synthesis was generated by PCR and purified using a DNA Gel Extraction Kit (Axygen). In vitro transcription was performed using the T7-Flash BiotinRNA Transcription Kit (Epicentre, biotin labeling) according to the manufacturer’s instructions. RNA was subsequently purified by phenol-chloroform extraction. For linear RNA in vitro cyclization, the RNA products were incubated with the indicated DNA splints (molar ratio = 1:1.5) at 90 °C for 5 min, and then cooled to room temperature over 20 min. Ligation to form circRNAs was then performed overnight at 16 °C with T4 DNA ligase (NEB). The sample was then treated with RNase R and DNase I at 37 °C for 30 min and subsequently purified by phenol-chloroform extraction.</p>", "<title>Determination of NF-κB activity</title>", "<p id=\"Par61\">NF-κB activity was measured using a NF-κB p65 Transcription Factor Assay Kit (Abcam) as per the manufacturer’s instructions. NF-κB p65 contained in a nuclear extract, binds to the NF-κB p65 response element, and is detected using an anti-NF-κB p65 antibody. A secondary antibody conjugated to HRP is added to provide a colorimetric readout at 450 nm using a Microplate Reader. Each sample was determined in triplicate.</p>", "<title>In vitro circRNA-protein binding assay</title>", "<p id=\"Par62\">For the in vitro binding assay, His-labeled p65, p50, or IκBα and biotinylated circATXN7 were incubated in 500 µl RIP buffer at room temperature for 1 h. Afterwards, we added 50 μl of washed Dynabeads M-280 Streptavidin (Invitrogen) to each binding reaction and incubated at room temperature for another 1 h. The beads were washed briefly five times with RIP buffer and then boiled in SDS buffer. The bound proteins were detected by immunoblots.</p>", "<title>Lactic acid and cytokine detection</title>", "<p id=\"Par63\">Fresh tumor tissues were collected from CRC patients and homogenized. In light of the manufacturer’s introductions, the protein concentrations in each homogenized tissue sample were determined and the lactic acid, CXCL9, CXCL10 and CXCL12 level equal of sample each was determined using a Lactate Assay Kit (BioVision), Human CXCL9 ELISA Kit (Abcam,), Human IP-10 ELISA Kit (Abcam) and Human SDF1 alpha ELISA Kit (Abcam), respectively.</p>", "<title>PCR and Agarose gel electrophoresis</title>", "<p id=\"Par64\">PCR assays were conducted using Premix Taq (Ex Taq II) (Takara) according to the manufacturer’s instructions. The PCR products were then submitted to agarose gel electrophoresis in 2% agarose with TAE buffer by using an electrophoresis system (BIO-RAD) and visualized by using an imaging system (BIO-RAD).</p>", "<title>Clinical response assessment</title>", "<p id=\"Par65\">The clinical response for CRC patients receiving immune checkpoint inhibitors (ICIs) was evaluated by computed tomography or magnetic resonance imaging radiologic data according to Formal Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1, as follow: complete response (CR), disappearance of all target lesions; partial response (PR), ≥30% decrease; PD, ≥20% increase over smallest sum observed; and SD, meeting none of the other criteria. Responders were defined as patients achieving PR or CR.</p>", "<title>Subcutaneous xenografts</title>", "<p id=\"Par66\">To generate subcutaneous xenografts, MC38 (5 × 10<sup>5</sup> cells per mouse), MC38K (5 × 10<sup>5</sup> cells per mouse), Pan02 (3 × 10<sup>5</sup> cells per mouse), Pan02K (3 × 10<sup>5</sup> cells per mouse), and B16F10K (2 × 10<sup>5</sup> cells per mouse) cells were subcutaneously injected into dorsal part of wild-type C57BL/6 J mice or age- and sex- <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> mice (~6–8 weeks old). Each group consisted of five mice. Tumor growth was monitored by digital calipers, and tumor volumes were recorded using the following formula: Volume = (longer diameter × shorter diameter<sup>2</sup>)/2. If animals appeared moribund or the diameter of the tumors reached 15 mm, the mice were sacrificed. In some cases, the maximal tumor burden permitted has been exceeded the last day of measurement and the mice were immediately euthanized. At the indicated endpoints, mice were sacrificed and tumors or tumor-infiltrating T cells were subjected to gross inspection, IHC analysis, flow cytometry, qRT-PCR, or RNA-seq.</p>", "<title>Genetically engineered CRC mouse model</title>", "<p id=\"Par67\">To generate the genetically engineered CRC mouse model, the <italic>Villin-Cre</italic><sup><italic>ERT2</italic></sup> mice were crossed with <italic>LSL-Kras</italic><sup><italic>G12D/+</italic></sup> mice and <italic>Apc</italic><sup><italic>flox/+</italic></sup> mice to obtain <italic>Villin-Cre</italic><sup><italic>ERT2</italic></sup><italic>Apc</italic><sup><italic>flox/+</italic></sup> (Kras<sup>WT</sup>) or <italic>Villin-Cre</italic><sup><italic>ERT2</italic></sup>\n<italic>Kras</italic><sup><italic>G12D/+</italic></sup><italic>Apc</italic><sup><italic>flox/+</italic></sup> (Kras<sup>MUT</sup>) mice. Each group consisted of five mice. When mice were at the age of 8 weeks, 1 mg/mL 4-hydroxytamoxifen (4-OHT) was introduced into the adult colon via enema. All mice were sacrificed 10 weeks later, and the colonic tumors were for IHC analysis and flow cytometry.</p>", "<title>Orthotopic xenograft CRC mouse model</title>", "<p id=\"Par68\">For the construction of the orthotopic xenograft CRC mouse model, the cecum of anesthetized <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> or WT mice was exteriorized through an abdominal laparotomy. MC38 (5 × 10<sup>5</sup> cells per mouse), MC38K (5 × 10<sup>5</sup> cells per mouse) in 50 μl PBS were injected into the cecum submucosa using 30-G insulin-gauge syringe. Each group consisted of five mice. Mice were sacrificed 24 days after injection. Intestines, livers, and lungs were harvested to assess the tumor burden. Cryosections of the harvested organs were stained using H&amp;E for histological assessment. Genomic DNAs were isolated from the rest of the organs for qRT-PCR analysis of CMV (only present in the injected cells transduced with the pCDH-CMV-Puro lentiviral vectors). In some experiments, to deplete CD8<sup>+</sup> or CD4<sup>+</sup> T cells in mice in vivo, two doses (150 μg/dose) of either YTS-191 (anti-CD4 depletion antibody) or YTS-169 (anti-CD8 depletion antibody) were injected intraperitoneally before orthotopic injection of MC38K cells, followed by eight consecutive injections every three days.</p>", "<title>Tumor-infiltrating T cell isolation in mice</title>", "<p id=\"Par69\">To isolate tumor-infiltrating T cells in mouse tumor models, subcutaneous or orthotopic xenografts were harvested, minced and digested with 0.5 mg/ml Collagenase IV (Sigma) plus 200 IU/ml DNase I (Sigma) for 1 h at 37 °C, and then passed through 40 μm filters to remove undigested tumor tissues. Tumor-infiltrating T cells were then isolated by Ficoll-Paque PLUS (GE Healthcare) density gradient separation and purified by CD8<sup>+</sup> T cell Isolation Kits (Miltenyi Biotec) or Fluorescence Activating Cell Sorter. Purified cells were subjected to further analyses as indicated.</p>", "<title>Anti-PD1 therapy</title>", "<p id=\"Par70\">The effects of circATXN7 on anti-PD1 therapy were assessed using subcutaneous xenografts generated from MC38K, Pan02K, and B16F10K cells in wild-type C57BL/6 J mice or age- and sex- <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> mice (~6–8 weeks old). When the tumors were palpable, the mice were randomly assigned to the indicated groups, and anti-PD1 monoclonal antibody (BioXcell) or IgG isotype control antibody (BioXcell) was intraperitoneally injected every 3 days at a dose of 100 μg/injection (<italic>n</italic> = 5 mice per group). Tumor volume was measured as described above, and mice were sacrificed when the tumor longer diameter reached 15 mm, recorded as death for survival curve.</p>", "<title>Patient-derived-xenograft implantation</title>", "<p id=\"Par71\">Primary CRC specimens were collected from treatment-naive patients with CRC cancer who received tumor resection at The Sixth Affiliated Hospital of Sun Yat-sen University. NOD.SCID mice (5–7 weeks old) under pathogen-free conditions were used for patient-derived xenograft transplantation, with a minimum of five mice per group. The time from patient collection to mouse implantation did not exceed 120 min. Tumor formation was monitored weekly with calipers in the three months following implantation. When tumors reached ~15 mm, the mice were killed, and tissue fragments were retransplanted into another cohort of mice. After 3–5 repeated cycles, no lymphocytes could be found in the PDX tumor grafts, which were used here for further experiments.</p>", "<title>PDX dissociation</title>", "<p id=\"Par72\">PDX tumors were cut into ~1 mm<sup>3</sup> fragments and incubated for 20 min with collagenase type III (Sigma), in RPMI-1640 medium containing 2% FBS (5 ml/g tumor tissue) at 37 °C. The tumor pieces were transferred to a tissue digestion C-tube (Miltenyi Biotec) and further dissociated enzymatically and mechanically on a gentleMACS Dissociator (Miltenyi Biotec) to generate a single-cell suspension. Afterwards, CD8<sup>+</sup> T cells were purified with human CD8 Microbeads (Miltenyi Biotec) or Fluorescence Activating Cell Sorter. Purified cells were subjected to flow cytometry, qRT-PCR, immunoblots, or NF-κB activity assay.</p>", "<title>Adoptive T cell transfer (ACT) therapy</title>", "<p id=\"Par73\">Adoptive T cell transfer therapy was performed in PDX tumors, MC38K and Pan02K tumors. In ACT therapy for PDX tumors, we firstly prepared tumor-reactive T cells and autologous tumor-antigen-loaded DCs as indicated above. Then, tumor-reactive T cells were transduced with GFP-tagged circAtxn7 shRNA or mCherry-tagged empty vector before transfer. After tumor formation, 2.5 × 10<sup>6</sup> tumor-reactive T cells were co-injected with 0.5 × 10<sup>6</sup> antigen-loaded DCs into the PDX-bearing mice via the tail vein. Each group consisted of five mice. Tumor growth was monitored and recorded every week and the tumor volume was recorded. At 3 weeks after transfer, mice were sacrificed and tumors or tumor-infiltrating T cells were subjected to further analysis.</p>", "<p id=\"Par74\">In ACT therapy against MC38K and Pan02K tumors, we firstly generated MC38K and Pan02K cells expressing the cognate antigen (MC38K-OVA and Pan02K-OVA). Then MC38K-OVA (5 × 10<sup>5</sup> cells per mouse) and Pan02K-OVA (3 × 10<sup>5</sup> cells per mouse) cells were used to establish subcutaneous xenografts. Purified OT-I cells were activated by cognate SIINFEKL peptide, and then were transduced with GFP-tagged circAtxn7 shRNA or mCherry-tagged empty vector. When MC38K-OVA or Pan02K-OVA tumors were palpable, tumor-bearing mice were intravenously injected with 1.5 × 10<sup>6</sup> OT-I CD8<sup>+</sup> T cells. Each group consisted of five mice. Tumor growth was monitored and the tumor volume was recorded. On 20 days after transfer, mice were sacrificed and tumors or tumor-infiltrating T cells were subjected to further analysis.</p>", "<title>Monitoring transferred T cell distribution in PDX tumors</title>", "<p id=\"Par75\">We monitored transferred T cell distribution using in vivo bioluminescent imaging as well as flow cytometry analysis. Firstly, lentiviruses carrying luciferase plasmids were pretransduced into tumor-reactive T cells to determine the distribution of transferred T cells in vivo via bioluminescent flux in PDX-bearing mice by IVIS Lumina imaging (Xenogen IVIS Lumina System). One minute before imaging, mice were injected intraperitoneally with D-luciferin (PerkinElmer) and anesthetized with 3% isoflurane. Living Image software version 3.0 (Caliper Life Sciences) was used for image analysis.</p>", "<p id=\"Par76\">Then, in some experiments with PDX tumors, tumor-reactive T cells transduced with GFP-shcircATXN7 and mCherry-shVector were mixed in vitro at a 1:1 ratio and then injected intravenously into PDX-bearing mice after palpable tumor formation. In subcutaneous xenografts generated from MC38K-OVA cells, activated OT-I CD8<sup>+</sup> T cells transduced with GFP-shcircAtxn7 were mixed with OT-I CD8<sup>+</sup> T cells transduced with mCherry-shVector at a 1:1 ratio and then co-injected intravenously into MC38K-OVA-bearing mice. At 1, 3, 5, 7, 14, and 21 days after transfer, CD8<sup>+</sup> T cells in PDX tumors or MC38K-OVA tumors were purified as described above, and then the purified cells were subjected to flow cytometry to analyze the disruption difference between GFP- and mCherry-tagged T cells.</p>", "<title>Statistics and reproducibility</title>", "<p id=\"Par77\">No statistical methods were used to predetermine sample size. Data were presented as mean ± standard deviation (SD) except were stated otherwise. Statistical analysis was conducted using SPSS statistical software (version 16.0; SPSS Inc., Chicago, Illinois) or GraphPad Prism (version 8.0.2; GraphPad Software, San Diego, CA, USA). Microscopy images shown are representative of at least 3 independent experiments. Western Blot images are representative of three independent experiments. Detailed data processing, sample size and statistical methods for each result were shown in the corresponding figure legends. All <italic>p</italic> values were two-sided and <italic>p</italic> value ≤ 0.05 was considered as statistically significant.</p>", "<title>Reporting summary</title>", "<p id=\"Par78\">Further information on research design is available in the ##SUPPL##2##Nature Portfolio Reporting Summary## linked to this article.</p>" ]
[ "<title>Results</title>", "<title>Tumor-mediated AICD in KRAS<sup>MUT</sup> CRC</title>", "<p id=\"Par8\">We previously found an inverse association between mutant KRAS and cytotoxic CD8<sup>+</sup> T cell (CTL) tumor infiltrate in stage I–III colorectal cancer (CRC) from the Sixth Affiliated Hospital of Sun Yat-sen University (SYSU-6thAH)<sup>##UREF##0##9##</sup>, which was confirmed herein using a different cohort from Sun Yat-sen University Cancer Center (SYSUCC) containing 101 patients with stage IV CRC (Supplementary Fig. ##SUPPL##0##1A##). This work further assessed the prognostic value of CTL tumor infiltrate. In SYSU-6thAH cohort, Kaplan–Meier survival curve analysis found KRAS<sup>MUT</sup> patients with high versus low CTL-abundance had prolonged disease-free survival (DFS), an effect which was not seen in KRAS<sup>WT</sup> patients (Supplementary Fig. ##SUPPL##0##1B##). Likewise, progression-free survival (PFS) was significantly longer in KRAS<sup>MUT</sup> patients with high versus low CTL-abundance in the SYSUCC cohort (Supplementary Fig. ##SUPPL##0##1D##). Overall survival (OS) analysis showed similar results in the two independent cohorts (Supplementary Fig. ##SUPPL##0##1C, E##). Of the patients with low CTL-abundance, KRAS<sup>MUT</sup> indicated poor patient prognosis (Supplementary Fig. ##SUPPL##0##2A, B##), whereas KRAS<sup>WT</sup> versus KRAS<sup>MUT</sup> patients displayed comparable prognosis in those with high CTL-abundance (Supplementary Fig. ##SUPPL##0##2A, B##). Furthermore, KRAS<sup>MUT</sup> patients with high CTL-infiltrated tumors did not show a survival disadvantage in comparison with KRAS<sup>WT</sup> patients (Supplementary Fig. ##SUPPL##0##2C##). These prognostic findings suggested the oncogenic effects of the KRAS<sup>MUT</sup> were related to its capacity to elicit poor immunity.</p>", "<p id=\"Par9\">Our previous findings ascribed the decreased CTLs occurred in KRAS<sup>MUT</sup> stage I-III CRC to the increased susceptibility to tumor-mediated activation-induced cell death (AICD) of tumor-specific CTLs<sup>##UREF##0##9##</sup>. A similar phenomenon was observed in a different patient cohort with stage IV CRC (Fig. ##FIG##0##1A##, Supplementary Fig. ##SUPPL##0##2D##). Considering the role of TCR engagement with the MHC-antigen complex, we further tested its contribution to tumor-mediated AICD in KRAS<sup>MUT</sup> CRC. To this end, CD8<sup>+</sup> T cells were activated by autologous dendritic cells (DCs) pulsed with autologous tumor-lysate or CEA peptide (Fig. ##FIG##0##1B##). Re-stimulation with anti-CD3 or coculturing with autologous tumor cells led to substantial apoptosis in the tumor-antigen-activated CTLs primed by autologous tumor-lysate-pulsed DCs for 6 days, but not those primed for 1 day (Fig. ##FIG##0##1C##, Supplementary Fig. ##SUPPL##0##2E##). In parallel, re-stimulation with anti-CD3 or CEA-loaded T2 cells, a human HLA-A2<sup>+</sup> hybridoma cell line used for antigen-specific cytotoxic assays, triggered significant apoptosis of the day-6 CEA-specific CTLs (Fig. ##FIG##0##1D##, Supplementary Fig. ##SUPPL##0##2F##). Furthermore, anti-HLA class I blocking antibodies effectively eliminated the apoptosis of the CTLs induced by coculturing with autologous tumor cells or CEA-loaded T2 cells (Fig. ##FIG##0##1E, F##). These findings suggested autologous tumor cells elicited AICD in activated CTLs from KRAS<sup>MUT</sup> tumors through repeated TCR stimulation.</p>", "<p id=\"Par10\">The above findings showed that ACID was significantly increased in T cells exposed to CEA antigen. Yet it is unclear whether the increase in ACID is a CEA-specific mechanism. To address this, the link between AICD sensitivity and CEA expression was further analyzed, and results demonstrated the AICD sensitivity had no significant correlation with CEA expression levels (Fig. ##FIG##0##1G##). These findings suggested that the increase in AICD in KRAS<sup>MUT</sup> tumors might be independent of CEA expression. To further confirm this, tumor-specific CTLs were purified from CEA positive and negative expressing tumors using anti-MUC1 tetramer as described previously<sup>##REF##30536960##42##</sup>. After coculturing with autologous tumor cells, comparable apoptosis was found in the tumor-specific CTLs from CEA-positive versus negative expressing tumors (Fig. ##FIG##0##1H, I##). Together, these results indicated the increase in AICD in KRAS<sup>MUT</sup> tumors was independent of CEA expression. In addition to AICD increase in KRAS<sup>MUT</sup> tumors, we found that tumor-specific CTLs from KRAS<sup>MUT</sup> versus KRAS<sup>WT</sup> tumors exhibited a significant increase in the expression of perforin and CD107a (Supplementary Fig. ##SUPPL##0##2G##), markers associated with cytotoxic activity. Yet the markers of exhaustion (PD1 and TIGIT) and activation (CD25 and CD69) were comparably expressed between the two groups (Supplementary Fig. ##SUPPL##0##2H##). These findings suggested the increase in ACID was not correlated with differentiation towards an exhausted subset, but appeared to indicate an impaired anti-tumor immunity.</p>", "<title>Histone lactylation-activated circATXN7 is upregulated in AICD-sensitive T cells</title>", "<p id=\"Par11\">In light of our above results, we set out to understand how KRAS<sup>MUT</sup> sensitized tumor-specific CTLs to AICD. We previously showed bountiful lactic acid in KRAS<sup>MUT</sup> stage I-III tumors contributed to the AICD susceptibility via NF-κB inactivation<sup>##UREF##0##9##</sup>. Using a different patient cohort with stage IV CRC, a lactic acid production advantage was confirmed in KRAS<sup>MUT</sup> tumors (Supplementary Fig. ##SUPPL##0##3A##). Ex vivo administration of lactic acid significantly increased the AICD sensitivity of tumor-specific CTLs from stage IV CRC (Supplementary Fig. ##SUPPL##0##3B##). Further investigation demonstrated CTLs from KRAS<sup>MUT</sup> stage IV tumors had an obvious decrease in NF-κB activity (Supplementary Fig. ##SUPPL##0##3C, D##). Moreover, NF-κB inhibitors BAY or JSH-23 almost completely abrogated the ability of lactic acid to regulate AICD (Supplementary Fig. ##SUPPL##0##3E##). Together, these findings established the lactic acid/NF-κB/AICD axis in stage IV CRC. Yet how lactic acid regulates NF-κB/AICD axis remains unclear. Lactic acid can stimulate cells via the receptor GPR81<sup>##REF##20374963##43##,##REF##19047060##44##</sup> or enter cells via monocarboxylate transport 1 (MCT1)<sup>##REF##26181372##45##,##REF##8557697##46##</sup>. These findings inspired us to test the roles of GPR81 and MCT1 in lactic acid/NF-κB/AICD axis. Results showed MCT1 blockade by AZD3965 significantly reversed the effects of lactic acid on NF-κB/AICD axis, and its combo inhibition of GPR81 with 3-OBA was obviously better than AZD3965 alone (Supplementary Fig. ##SUPPL##0##3F, G##). To distinguish their contribution to the difference in NF-κB/AICD axis between KRAS<sup>MUT</sup> versus KRAS<sup>WT</sup> tumors, the expression levels of <italic>MCT1</italic> and <italic>GPR81</italic> were further assessed. Results found that <italic>MCT1</italic> had significantly higher expression abundance than <italic>GPR81</italic> in tumor-specific CTLs from both KRAS<sup>MUT</sup> and KRAS<sup>WT</sup> tumors (Supplementary Fig. ##SUPPL##0##3H##). Moreover, the expression levels of <italic>MCT1</italic>, but not <italic>GPR81</italic>, was positively associated with NF-κB activity (Supplementary Fig. ##SUPPL##0##3I, J##), and NF-κB activity correlated well with intracellular lactic acid concentration in tumor-specific CTLs of KRAS<sup>MUT</sup> tumors (Supplementary Fig. ##SUPPL##0##3K##), but not in those of KRAS<sup>WT</sup> tumors (Supplementary Fig. ##SUPPL##0##3L–N##). More importantly, as the key downstream element in lactic acid/GPR81 axis, cAMP and <italic>TCF-1</italic> in tumor-specific CTLs were well balanced between KRAS<sup>MUT</sup> versus KRAS<sup>WT</sup> tumors (Supplementary Fig. ##SUPPL##0##3O, P##). Taken together, these results suggested that MCT1-mediated lactic acid input, but not activating GPR81, contributed to the difference in NF-κB/AICD axis between KRAS<sup>MUT</sup> versus KRAS<sup>WT</sup> tumors.</p>", "<p id=\"Par12\">To explore the mechanism underlying the difference in NF-κB/AICD axis between KRAS<sup>MUT</sup> versus KRAS<sup>WT</sup> tumors, several NF-κB signaling-related factors reported in literatures (Supplementary Table ##SUPPL##0##1##) were tested. Results found (Supplementary Fig. ##SUPPL##0##4A–L##) suggested the differential NF-κB/AICD axis between KRAS<sup>MUT</sup> versus KRAS<sup>WT</sup> tumors was not governed by the above-mentioned factors, but is likely to be controlled by other factors. CircRNAs, a subclass of endogenous non-coding RNAs, are implicated in numerous pathophysiological conditions, including adaptive immune responses. We next sought to explore whether circRNAs contributed to the lactic acid/NF-κB/AICD axis. To this end, we stimulated peripheral blood (PB) CD8<sup>+</sup> T cells with phytohaemagglutinin (PHA) for 18 h (Day-1) and then cultured them with IL-2 for an additional 5 days (Day-6) (Supplementary Fig. ##SUPPL##0##5A##). In line with our previous reports<sup>##UREF##0##9##,##REF##32343772##25##</sup>, re-stimulation with anti-CD3 led to substantial apoptosis of Day-6 T cells (AICD-sensitive), but not Day-1 T cells (AICD-resistant) (Supplementary Fig. ##SUPPL##0##5B##). We then preformed circRNA profile analysis in AICD-resistant T cells after lactic acid or vehicle treatment. After filtering differentially expressed circRNAs (fold change (FC) &gt; 2 or &lt;0.5 and false discovery rate (FDR) &lt; 0.05), we identified 130 upregulated and 153 down-regulated circRNAs upon lactic acid treatment (Fig. ##FIG##1##2A, B##). We further tested the top 10 upregulated circRNA (ranked by <italic>p</italic>-value) expression in Day-6 versus Day-1 T cells (Fig. ##FIG##1##2B##). A consistent expression trend was seen in 4 circRNAs (circGSE1, circATXN7, circPOLD1, and circPRKAR18) (Supplementary Fig. ##SUPPL##0##5C##). Given the crucial role of NF-κB in AICD, we set out to screen circRNAs related to the NF-κB/AICD axis. Through RNA immunoprecipitation (RIP) against p65, 2 circRNAs (circGSE1, circATXN7) were identified as p65-bound circRNAs (Supplementary Fig. ##SUPPL##0##5D##). Using lentiviral vectors expressing shRNAs that target the backsplice junction of the circRNAs and deplete the circular rather than their linear transcripts (Supplementary Fig. ##SUPPL##0##5E##), functional assays demonstrated that only circATXN7 had the ability to regulate AICD (Fig. ##FIG##1##2C##, Supplementary Fig. ##SUPPL##0##5F##). circATXN7 interference nearly abrogated lactic acid-induced AICD increase (Fig. ##FIG##1##2D##), but had little effects on T cell proliferation (Supplementary Fig. ##SUPPL##0##5G##) and migration (Supplementary Fig. ##SUPPL##0##5H##). As compared to the tumor infiltrated CD8<sup>+</sup> T cells, only a slight circATXN7 expression was detected in peripheral CD8<sup>+</sup> T cells (Supplementary Fig. ##SUPPL##0##5I##). Clinically, a significant increased expression level of circATXN7 in tumor-specific CTLs derived from KRAS<sup>MUT</sup> versus KRAS<sup>WT</sup> CRC tissues (Supplementary Fig. ##SUPPL##0##5J##), whereas a comparable circATXN7 expression was found in tumor non-specific CTLs from KRAS<sup>MUT</sup> versus KRAS<sup>WT</sup> CRC tissues (Supplementary Fig. ##SUPPL##0##5K##). In addition, none of the 10 down-regulated circRNAs were identified as eligible candidates for further studies through the screening schematic diagram (Supplementary Fig. ##SUPPL##0##6A–E##).</p>", "<p id=\"Par13\">CircATXN7 was formed by the back-splicing of two exons (exon 2 and exon 3) of the <italic>ATXN7</italic> gene (chr3: 63898263-638989011) with 405 nt, and highly conserved between human and mouse (85%). Given the lack of open reading frame (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.circbank.cn/\">http://www.circbank.cn/</ext-link>), circRNAs have no protein-coding ability. The divergent and convergent primers were adopted to amplify the <italic>ATNX7</italic> circular and linear transcripts using genomic DNA (gDNA) and complementary DNA (cDNA), and found that we could only amplify the <italic>ATXN7</italic> circular transcript from cDNA with divergent primers (Supplementary Fig. ##SUPPL##0##6F##). The back-spliced junctions were then confirmed by Sanger sequencing (Supplementary Fig. ##SUPPL##0##6F##). The circATXN7 level was significantly lower in oligo dT constructed cDNA than in that of random primers constructed cDNA as a result of 3′ polyadenylated tail deficiency (Supplementary Fig. ##SUPPL##0##6G##). RNase R treatment and a half-life assay demonstrated that circATXN7 was more stable than <italic>ATXN7</italic> linear mRNA (Supplementary Fig. ##SUPPL##0##6H, I##). Nuclear mass separation assays identified its predominantly cytoplasmic localization (Supplementary Fig. ##SUPPL##0##6J##).</p>", "<p id=\"Par14\">We subsequently explored how MCT1-mediated lactic acid uptake induced circATXN7 expression. In view of its contribution of lactic acid-derived histone lactylation to transcription activation<sup>##REF##31645732##47##</sup>, we hypothesized that lactic acid-derived histone lactylation might contribute to circATXN7 expression in AICD-sensitive T cells. Interestingly, we found CTLs from KRAS<sup>MUT</sup> tumors exhibited high global histone lactylation levels (Fig. ##FIG##1##2E##), and subsequent immunoprecipitation (IP) identified histone H3K18la as the main target (Fig. ##FIG##1##2F##). Chromatin immunoprecipitation with sequencing (ChIP-seq) assays demonstrated an obvious enrichment of H3K18la in the <italic>ATNX7</italic> genomic position (Fig. ##FIG##1##2G##). ChIP-qPCR confirmed H3K18la enrichment in <italic>ATXN7</italic> promoter regions, which could be abolished by blocking lactic acid uptake using MCT1 inhibitor AZD3965 (Fig. ##FIG##1##2H##). Furthermore, lactic acid increased histone lactylation writer EP300 binding to the <italic>ATXN7</italic> promoter, and this effect could also be eliminated by AZD3965 (Fig. ##FIG##1##2I##). In addition, circATNX7 expression was induced in a dose-dependent manner by lactic acid treatment (Fig. ##FIG##1##2J##). Collectively, our results indicated that lactic acid-derived histone lactylation activates circATXN7 transcription, thereby sensitizing T cells to AICD.</p>", "<title>circATXN7 expression in tumor-specific T cells correlates with adverse clinical outcomes</title>", "<p id=\"Par15\">Next, we sought to evaluate the clinical significance of circATXN7 expression in CRC patients. Using a specific probe to detect the circular rather than known linear transcript of <italic>ATXN7</italic> (Supplementary Fig. ##SUPPL##0##7A, B##), RNA in situ hybridization (ISH) assays for circATXN7 expression were performed in paraffin-embedded CRC sections from 269 CRC patients from the SYSU-6thAH cohort. Results demonstrated that circATXN7-positive (circATXN7<sup>+</sup>) cells were noted scattered in the tumor stroma of 84 out of 87 cases of KRAS<sup>MUT</sup> CRC (Fig. ##FIG##2##3A##), but almost no staining was seen in the tumor cells (Fig. ##FIG##2##3A##). Additionally, they were noted in the stroma of 93 out of 182 KRAS<sup>WT</sup> cases (Supplementary Fig. ##SUPPL##0##7C##), whereas circATXN7<sup>+</sup> cells were absent in normal adjacent tissues (Supplementary Fig. ##SUPPL##0##7D##, Supplementary Fig. ##SUPPL##0##7E##). By sorting each tumor infiltration cell type, RT-PCR (Supplementary Fig. ##SUPPL##0##7F##) as well as qRT-PCR (Supplementary Fig. ##SUPPL##0##7G##) analysis demonstrated only the whole tumor tissues and CD8 cells had circATXN7 expression, but other components including CD4, macrophages, endothelial cells, and fibroblasts displayed negligible expression of circATXN7. Furthermore, we co-stained frozen sections of CRC tissues using circATXN7 fluorescence in situ hybridization (FISH) and a pentamer carrying the HLA-A2-restricted peptide of human CEA (YLSGANLNL) that indicates tumor-specific CTLs, and observed circATXN7 and tumor-specific CTLs to be colocalized (Fig. ##FIG##2##3B##). These results were confirmed by circATXN7 FISH co-stained with CD8, CD4, or EpCAM (Supplementary Fig. ##SUPPL##0##7H##). Collectively, we concluded circATXN7 is mainly expressed in tumor-specific CTLs.</p>", "<p id=\"Par16\">We subsequently correlated circATXN7 expression with patient clinicopathological status. In addition to greater circATXN7<sup>+</sup> cell counts in KRAS<sup>MUT</sup> tumors (Fig. ##FIG##2##3C##) we found that they increased with more advanced TNM stages, and disease relapse recorded within 3 years, and yet this pattern was not seen in KRAS<sup>WT</sup> cases (Supplementary Fig. ##SUPPL##0##8A, B##). Moreover, we identified a negative link between circATXN7<sup>+</sup> cells and CTL-abundance in tumors with KRAS<sup>MUT</sup>, but not KRAS<sup>WT</sup> (Fig. ##FIG##2##3D##). Tumors with different types of KRAS mutations displayed comparable densities of circATXN7<sup>+</sup> cells (Supplementary Fig. ##SUPPL##0##8C##). Kaplan–Meier analysis with a follow-up period of 36 months indicated patients with high density of circATXN7<sup>+</sup> cells had shortened DFS (Fig. ##FIG##2##3E##) and OS (Supplementary Fig. ##SUPPL##0##8D##). Stratification of the cohort into patients with and without mutant KRAS demonstrated high density of circATXN7<sup>+</sup> cells correlated with poor clinical outcomes in KRAS<sup>MUT</sup> cases, but not in KRAS<sup>WT</sup> cases (Fig. ##FIG##2##3E##, Supplementary Fig. ##SUPPL##0##8D##). Likewise, KRAS<sup>MUT</sup> patients with high circATXN7<sup>+</sup> cell counts had significantly shortened PFS and OS in the SYSUCC cohort (Fig. ##FIG##2##3F##, Supplementary Fig. ##SUPPL##0##8E##). The clinical significance of circATXN7 was further assessed using circATXN7 ISH staining (Supplementary Fig. ##SUPPL##0##8F##) in pancreatic cancer, ~90% of which had KRAS<sup>MUT</sup><sup>##REF##16169155##48##</sup>. Consistent with the results in CRC, we observed that pancreatic cancer patients with high density of circATXN7<sup>+</sup> cells were more likely to have advanced disease (Supplementary Fig. ##SUPPL##0##8G##) and poor prognosis (Supplementary Fig. ##SUPPL##0##8H##).</p>", "<p id=\"Par17\">On the basis of the link between circATXN7 expression and CTL-abundance, we tried to gain insights into the potential correlation between circATXN7 expression and the clinical efficacy of immune checkpoint inhibitors (ICIs). To address this, we performed circATXN7 ISH staining in paraffin-embedded treatment-naive biopsy samples from 45 CRC patients receiving ICIs, and looked for whether there was an association between circATXN7 expression and their clinical response. In the cohort, 21 (46.7%) patients were non-responders, including 4 (8.9%) with progressive disease (PD) and 17 (37.8%) with stable disease (SD), while 24 (53.3%) patients including 13 (28.9%) with partial response (PR) and 11 (24.4%) with complete response (CR) were identified as responders. Based on the clinical response assessment, we found responder rates were adversely associated with circATXN7 expression (Fig. ##FIG##2##3G–J##). According to the median level of circATXN7<sup>+</sup> cell counts, the cohort was stratified into two categories (patients with circATXN7-low versus -high group). In the circATXN7-high group, 3 (13.6%), 12 (54.5%), 5 (22.7%), and 2 (9.1%) patients had PD, SD, PR, and CR, respectively (Fig. ##FIG##2##3K##). PD, SD, PR, and CR were recorded in 1 (4.3%), 5 (21.9%), 8 (34.8%), and 9 (39.1%) patients in the circATXN7-low group, respectively (Fig. ##FIG##2##3K##). These clinical data suggested that high circATXN7 expression might confer resistance to ICIs for patients with CRC.</p>", "<title>circATXN7 controls AICD by sequestering p65 in the cytoplasm</title>", "<p id=\"Par18\">In light of our findings described above, we aimed to elucidate the contribution of circATXN7 to AICD sensitivity. To this end, circATXN7 expression was firstly monitored in tumor-specific CTLs from KRAS<sup>MUT</sup> versus KRAS<sup>WT</sup> tumors, and results showed the former had markedly higher circATXN7 expression levels (Supplementary Fig. ##SUPPL##0##9A##). Silencing of circATXN7 in tumor-specific CTLs from KRAS<sup>MUT</sup> tumors decreased their sensitivity to AICD (Fig. ##FIG##3##4A##, Supplementary Fig. ##SUPPL##0##9B##), whereas circATXN7 loss in tumor-specific CTLs from KRAS<sup>WT</sup> tumors exerted no effects on their sensitivity to AICD (Supplementary Fig. ##SUPPL##0##9C, D##). Conversely, ectopic expression of circATXN7 in tumor-specific CTLs from KRAS<sup>WT</sup> tumors significantly sensitized them to AICD (Fig. ##FIG##3##4A##, Supplementary Fig. ##SUPPL##0##9E##). In addition, tumor-specific CTL apoptosis induced by coculturing them with autologous tumor cells was abrogated by HLA class I blocking antibodies (Supplementary Fig. ##SUPPL##0##9F##). Together, circATXN7 determines the AICD sensitivity of tumor-specific CTLs.</p>", "<p id=\"Par19\">Considering the cytoplasmic localization of circATXN7 (Supplementary Fig. ##SUPPL##0##6J##), the copies of circATXN7 and p65 in the cytoplasm of each tumor-specific CTL were further quantified. Results demonstrated that the cytoplasm of each tumor-specific CTL from KRAS<sup>MUT</sup> tumors contained 1072.4 ± 676.3 and 1978.4 ± 1122.3 copies of circATXN7 and p65 protein, which would allow for an approximately equimolar interaction (Supplementary Fig. ##SUPPL##0##9G, H##). However, circATXN7 was 33.8 ± 20.3 copies in the cytoplasm of each tumor-specific CTL from KRAS<sup>WT</sup> tumors, which was significantly lower than p65 (536.1 ± 171.5 copies per cell; Supplementary Fig. ##SUPPL##0##9G, H##). On the basis of the stoichiometry of circATXN7 versus p65 and the fact that each circATXN7 contains one p65-binding motif, we concluded that tumor-specific CTLs of KRAS<sup>MUT</sup> tumors, but not those of KRAS<sup>WT</sup> tumors, had sufficient circATXN7 to directly bind p65 for inhibition. Knocking down circATXN7 increased p65 nuclear translocation (Fig. ##FIG##3##4B##, Supplementary Fig. ##SUPPL##0##9J, K##), whereas ectopic expression of circATXN7 prevented p65 nuclear translocation (Supplementary Fig. ##SUPPL##0##9I–K##). Subsequent RNA pull-down and western blotting showed p65 was pulled-down by biotinylated probes specific for circATXN7 (Fig. ##FIG##3##4C##). In vitro RNA/protein interaction analysis indicated the direct interaction of circATXN7 with p65, but not IκBα or p50 (Fig. ##FIG##3##4D##), which was further confirmed by 3D-structured illumination microscopy (Fig. ##FIG##3##4E##). We therefore concluded that circATXN7 directly binds to p65.</p>", "<p id=\"Par20\">To identify the structural determinants of the association between circATXN7 and NF-κB p65, we constructed p65 truncates (Fig. ##FIG##3##4F##). RNA pull-down and RIP assays showed that nuclear localization signal (NLS) motif was essential for the interactions between p65 and circATXN7 (Fig. ##FIG##3##4G##, Supplementary Fig. ##SUPPL##0##9L##). To explore the binding sides of circATXN7 with p65, a computational docking approach was used to show the hydrogen bonds and non-bonded interactions between circATXN7 and p65 (Fig. ##FIG##3##4H##). To corroborate this prediction, we synthesized blocking oligos that were complimentary to the p65 protein binding sites in circATXN7. RNA pull-down indicated the blocking oligos decreased the interactions between circATXN7 and p65 (Fig. ##FIG##3##4I##), which was confirmed by RIP assays (Supplementary Fig. ##SUPPL##0##9M##). By construction of a flag-tagged p65 with circATXN7-binding site mutation, we found mutated p65 could not be pulled-down by circATXN7 (Fig. ##FIG##3##4J##). Furthermore, transfection with the blocking oligos significantly abolished the ability of circATXN7 to block p65 subunit translocation (Fig. ##FIG##3##4K##). Ectopic overexpression of circATXN7 with p65-binding site mutation lost the ability to sequester p65 in the cytoplasm (Fig. ##FIG##3##4L##). These findings indicated circATXN7 sequesters p65 in the cytoplasm by directly masking its NLS motif, thereby inactivating NF-κB.</p>", "<p id=\"Par21\">Subsequently, we evaluated whether circATXN7 exerts its effect on AICD by inhibiting NF-κB. In KRAS<sup>MUT</sup> tumors-derived tumor-specific CTLs, blocking p65 nuclear translocation using NF-κB inhibitors BAY or JSH-23 abolished the AICD reduction upon circATXN7 silencing (Supplementary Fig. ##SUPPL##0##9N##). Moreover, BAY or JSH-23 blocked the AICD increase resulting from circATXN7 overexpression in KRAS<sup>WT</sup> tumors-derived tumor-specific CTLs (Supplementary Fig. ##SUPPL##0##9N##). In addition, there were no AICD-promoting effects when tumor-specific CTLs from KRAS<sup>WT</sup> tumors and the Day-1 T cells overexpressed a mutant circATXN7 version that could not bind to p65 (Supplementary Fig. ##SUPPL##0##9O, P##). A similar pattern was observed when p65 blocking oligos were transfected (Supplementary Fig. ##SUPPL##0##9Q, R##). These results suggested that interacting with p65 is indispensable for circATXN7 to sensitize T cells to AICD.</p>", "<title>Targeting circATXN7 in CD8<sup>+</sup> T cells selectively inhibits KRAS<sup>MUT</sup> tumors</title>", "<p id=\"Par22\">To determine the in vivo function of circATXN7 in T cells, genetically engineered <italic>circAtxn7</italic><sup><italic>loxp/loxp</italic></sup> mice were crossed with <italic>CD8a</italic><sup><italic>cre</italic></sup> mice (Fig. ##FIG##4##5A##). We genotyped the progenies to obtain <italic>CD8a</italic><sup><italic>cre</italic></sup><italic>; circAtxn7</italic><sup><italic>loxp/loxp</italic></sup> mice (Supplementary Fig. ##SUPPL##0##10A##) (termed <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> mice). As expected, these mice lacked the circular form <italic>circAtxn7</italic> while the levels of the linear host gene <italic>Atxn7</italic> mRNA and ATXN7 protein were unaltered (Supplementary Fig. ##SUPPL##0##10B, C##), and these mice exhibited no marked abnormalities in gestation, birth, development or growth. Moreover, the numbers of thymocytes and peripheral CD4<sup>+</sup> and CD8<sup>+</sup> T cells were unchanged upon ablation of <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> mice (Supplementary Fig. ##SUPPL##0##10D##), as were the frequencies of their corresponding subsets (Supplementary Fig. ##SUPPL##0##10E–H##). Therefore, circAtxn7 appears to be dispensable for mouse T cell development. Next, MC38 cells expressing wild-type <italic>Kras</italic> were stably transfected with cDNA encoding Kras<sup>G12D</sup> to generate MC38-Kras<sup>G12D</sup> cells (designated MC38K). Then MC38 and MC38K cells were subcutaneously grafted into <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> mice or wild-type (WT) control littermates. MC38K tumor growth in <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> mice expanded more slowly and was markedly smaller at the endpoint (Fig. ##FIG##4##5B##). A similar pattern was obtained using MC38 cells expressing <italic>Kras</italic><sup><italic>G12V</italic></sup> (Supplementary Fig. ##SUPPL##0##11A##), or <italic>Kras</italic><sup><italic>G13D</italic></sup>, (Supplementary Fig. ##SUPPL##0##11B##). By contrast, loss of circAtxn7 in CD8<sup>+</sup> T cells had little effects on MC38 tumors (Fig. ##FIG##4##5C##). Similar results were obtained in investigations determining effects of targeting circAtxn7 with a different murine pancreatic model (Supplementary Fig. ##SUPPL##0##11C, D##). These findings indicated that genetic ablation of circAtxn7 selectively suppresses KRAS<sup>MUT</sup> tumors.</p>", "<p id=\"Par23\">The subcutaneous xenograft results inspired us to further explore the in vivo role of circATXN7 by tumor cell orthotopic injection into the cecum wall of <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> and WT mice. Although <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> and WT mice exhibited similar MC38K orthotopic tumor formation incidence, the former had significantly decreased tumor burden as indicated by ~3-fold reduction in the orthotopic tumor sizes (Fig. ##FIG##4##5D, E##). Gross inspection at the endpoint of 24 days identified no liver metastasis in either group of mice, but hematoxylin-eosin (H&amp;E) staining found a significant decrease in the tumor burden of liver micro-metastasis in <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> mice (Fig. ##FIG##4##5D##). Furthermore, we performed qRT-PCR using primers that specifically amplify the CMV promoter of the stably integrated vector. Results demonstrated that circAtxn7 deletion in CD8<sup>+</sup> T cells decreased the disseminated MC38K burdens in the livers (Fig. ##FIG##4##5E##). Analogous to MC38 subcutaneous tumor model results, we observed insignificant anti-tumor activity of circAtxn7 ablation in MC38 orthotopic tumor models (Fig. ##FIG##4##5F, G##). Of note, CD8<sup>+</sup> T cells contributed to the anti-tumor effects of targeting circAtxn7, as evidenced by equal susceptibility to MC38K tumor inoculation in <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> and WT mice after CD8<sup>+</sup> T cell depletion (Supplementary Fig. ##SUPPL##0##11E, F##). In contrast, CD4<sup>+</sup> T cells were of little importance to the anti-tumor activity of circAtxn7 ablation (Supplementary Fig. ##SUPPL##0##5E, G##). These data confirmed the mutant-selective tumor inhibition of circATXN7 deletion in CD8<sup>+</sup> T cells.</p>", "<p id=\"Par24\">Subsequently, we conducted RNA sequencing of bulk RNA extracted from tumor-infiltrating CD8<sup>+</sup> T cells sorted from WT and <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> MC38K tumor-bearing mice. Based on the transcriptional changes, gene set enrichment analysis (GSEA) identified a significant enrichment related to NF-kB signaling in circAtxn7-deficient tumor-infiltrating CD8<sup>+</sup> T cells (Fig. ##FIG##4##5H##). Subsequent assays confirmed a NF-κB activation increase in circAtxn7-deficient CD8<sup>+</sup> T cells (Supplementary Fig. ##SUPPL##0##11H, I##). Moreover, we observed an apoptosis-associated gene signature in circAtxn7-deficient CD8<sup>+</sup> T cells (Fig. ##FIG##4##5H##). Further findings that circAtxn7-deficient CD8<sup>+</sup> T cells had higher antiapoptotic gene expression (<italic>Bcl2</italic>, <italic>Bcl2l1</italic>, <italic>Ier3</italic> and <italic>Gadd45b</italic>) characterized these cells as having dampened apoptosis (Supplementary Fig. ##SUPPL##0##11J##). Therefore, circAtxn7-deficient CD8<sup>+</sup> T cells are reprogrammed to enhance NF-κB activation and decrease apoptosis, further testifying the involvement of circATXN7 in NF-κB/AICD axis. More importantly, we found a substantial increase in tumor-infiltrating CD8<sup>+</sup> T cell density in MC38K tumors from <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> mice than those from WT littermates (Fig. ##FIG##4##5I, J##), as well as in cytotoxic cytokine IFN-γ production (Fig. ##FIG##4##5K##) and the expression of perforin and CD107a, markers related to cytotoxic activity (Supplementary Fig. ##SUPPL##0##11K##), but no significant effects on the exhausted phenotype (Supplementary Fig. ##SUPPL##0##11L##). These results demonstrated that circAtxn7 deletion in T cells could shift KRAS<sup>MUT</sup> tumors from immunologically “cold” to “hot” by increasing T cell resistance to apoptotic programs, which correlates with a reduction in tumor progression parameters.</p>", "<title>Loss of circATXN7 improves immunotherapy efficacy</title>", "<p id=\"Par25\">Given that targeting circAtxn7 shifted KRAS<sup>MUT</sup> tumors from immunologically “cold” to “hot”, we therefore questioned whether circATXN7 interference could potentiate ICI responses. To address this, we first performed anti-PD1 treatment in <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> and WT mice with MC38K subcutaneous tumors, an MSI-H model but resistant to immunotherapies<sup>##UREF##0##9##,##REF##30905761##49##</sup>. As anticipated, anti-PD1 treatment in WT mice had no significant anti-tumor activity against MC38K tumors (Fig. ##FIG##5##6A##). By contrast, anti-PD1 therapy in <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> mice exhibited significant tumor inhibitory effects, as shown by the smaller tumor size and improved survival (Fig. ##FIG##5##6B##). These results suggested blocking circAtxn7 expression in CD8<sup>+</sup> T cells could be an effective strategy for improving anti-PD1 efficacy. Further support for this possibility comes from experiments assessing anti-PD1 efficacy with two different KRAS<sup>MUT</sup> tumor models, including murine pancreatic cancer (Supplementary Fig. ##SUPPL##0##12A, B##), and melanoma (Supplementary Fig. ##SUPPL##0##12C, D##). We thus concluded circATXN7 represents a key determinant in maintaining anti-PD1 therapy resistance in KRAS<sup>MUT</sup> tumors, and targeting circATXN7 might help overcome resistance to PD1 blockade therapy.</p>", "<p id=\"Par26\">We further assessed whether circATXN7 interference in adoptively transferred T cells might prevent AICD and increase adoptive T cell therapy (ACT) efficacy in combating KRAS<sup>MUT</sup> tumors. To this end, we used transgenic OT-I expressing mice to purify OT-I cells. After activated by cognate SIINFEKL peptide, OT-I cells were transduced with shRNAs specifically targeting circAtxn7 to dampen its expression (Supplementary Fig. ##SUPPL##0##12E##). In vitro experiments demonstrated that although circATXN7 silencing in OT-I cells did not have significant effects on their proliferation (Supplementary Fig. ##SUPPL##0##12F##), migration (Supplementary Fig. ##SUPPL##0##12G##), exhausted phenotype (Supplementary Fig. ##SUPPL##0##12H##) or activation (Supplementary Fig. ##SUPPL##0##12I##), it increased the expression of perforin and CD107a, markers related to cytotoxic activity (Supplementary Fig. ##SUPPL##0##12J##) and NF-κB activation (Supplementary Fig. ##SUPPL##0##12K##), but decreased AICD sensitivity (Supplementary Fig. ##SUPPL##0##12L##). OT-I cells transduced with GFP-tagged circAtxn7 shRNA or mCherry-tagged empty vector were intravenously transferred into MC38K-OVA tumor-bearing mice (Fig. ##FIG##5##6C##). In light of monitoring by flow cytometry, the transferred cell distribution at 1, 3, 5, and 7 days after transfer showed comparable GFP- versus mCherry-tagged cell recruitment (Fig. ##FIG##5##6D, E##). However, at later time points of 14 and 21 days after transfer, mCherry-tagged cells declined dramatically, whereas circAtxn7 silencing significantly prolonged GFP-tagged cell persistence (Fig. ##FIG##5##6D, E##). At endpoint, loss of circAtxn7 did not alter the transferred cells’ exhausted phenotype and activation (Supplementary Fig. ##SUPPL##0##12M##), but endowed the tumors with substantially increased CTL densities (Fig. ##FIG##5##6F##) and increased the expression of perforin and CD107a, markers related to cytotoxic activity (Supplementary Fig. ##SUPPL##0##12M##), which correlated with improved circAtxn7-silenced T cell anti-tumor activities (Fig. ##FIG##5##6G, H##).</p>", "<p id=\"Par27\">According to our findings described above, we sought to recapitulate the results in more humanized models. Therefore, we established CRC patient-derived xenograft (PDX) models implanted in NOD.SCID mice. Tumor-reactive T cells were obtained by co-incubation of PB CD8<sup>+</sup> T cells with autologous dendritic cells (DCs) primed by tumor lysates from the same donors, followed by GFP-tagged circATXN7 shRNA or with mCherry-tagged empty vector transduction (Fig. ##FIG##5##6I##, Supplementary Fig. ##SUPPL##0##13A##). When the tumors were palpable, GFP- or mCherry-tagged tumor-reactive T cells were injected intravenously into PDX-bearing mice (Fig. ##FIG##5##6I##). In PDX tumors generated from CRC patients with KRAS<sup>G12D</sup> (Supplementary Fig. ##SUPPL##0##13B##), flow cytometric analysis revealed that loss of circATXN7 (Supplementary Fig. ##SUPPL##0##13C##) endowed T cells with greatly improved persistence in tumors (Supplementary Fig. ##SUPPL##0##13D##). At endpoint, we observed a significant improvement in circATXN7-silenced T cell accumulation (Fig. ##FIG##5##6J, K##), as well as an increase in NF-κB activity (Fig. ##FIG##5##6L##, Supplementary Fig. ##SUPPL##0##13E##) and antiapoptotic gene expression (Supplementary Fig. ##SUPPL##0##13F–I##). These results suggested that circATXN7 deletion in transferred T cells could overcome tumor immune evasion by preventing AICD, thereby allowing them to exert stronger anti-tumor activity (Fig. ##FIG##5##6M, N##). The above observations were faithfully recapitulated by another PDX model generated from CRC patients with KRAS<sup>G13D</sup> (Supplementary Fig. ##SUPPL##0##13J–M##). Together, our results pointed to an encouraging anti-tumor avenue to improve immunotherapy efficacy.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par28\">While immunotherapy exhibits anti-tumor activity in some patients with MSI-H CRC, approximately 85% among all CRC patients, the therapeutic benefit is largely restricted, highlighting an unmet need for the study of mechanisms and combination regimens with immunotherapies. Here, our findings demonstrated a clear CTL reduction in KRAS<sup>MUT</sup> tumors that correlated with shortened survival and poor ICI efficacy. This clinical phenomenon was linked to KRAS<sup>MUT</sup>-driven lactic acid that acted as a precursor to stimulating histone lactylation. As an epigenetic modification, histone lactylation directly elicited circATXN7 expression, which sensitized tumor-specific CTLs to tumor-mediated AICD by sequestering the NF-κB p65 subunit in the cytoplasm (Fig. ##FIG##6##7##). This represents a hitherto undescribed causative factor for the inverse association between CTLs and KRAS<sup>MUT</sup>.</p>", "<p id=\"Par29\">The AICD sensitivity can be reprogrammed by several diseases including neoplasia and autoimmune diseases. Current research indicates different T cell subsets display distinct AICD sensitivity. In breast and lung cancer microenvironments, Huang and colleagues demonstrated that tumor-infiltrating CTLs and type 1 T helper (Th1) cells were more sensitive to AICD than Tregs and type 2 T helper cells<sup>##REF##30224822##28##</sup>. Our previous work showed that Th1 and type 17 helper T cells, but not regulatory T cells, were able to evade AICD in patients with Crohn’s disease<sup>##REF##32343772##25##</sup>. This study found tumor-specific CTLs in KRAS<sup>MUT</sup> tumors were susceptible to tumor-mediated AICD. The increase in ACID has also been noted in various conditions. A study by Tan et al. suggested Th1 cells were susceptible to AICD in the context of mouse eye inflammation<sup>##REF##21903206##50##</sup>. Also, virus infections could induce apoptosis in T cells by AICD<sup>##REF##12032674##51##–##REF##7751644##53##</sup>. The increase in AICD of activated CD8<sup>+</sup> T cells generated during a viral infection serves to maintain homeostasis of the immune system, so that during the resolution phase of infection, excess activated T cells are deleted<sup>##REF##26655144##54##–##REF##7793322##56##</sup>. These findings indicated that the increase in ACID seemed not to be a tumor-specific mechanism, but appeared to be disease context-dependent.</p>", "<p id=\"Par30\">A salient feature of most solid tumors with KRAS<sup>MUT</sup> is elevated lactic acid production. This characteristic endows these tumors with lactic acid accumulation and increased tumor acidity. As a common metabolite, lactic acid has been shown to promote tumor immune evasion related to regulatory T cells<sup>##REF##33589820##16##</sup>, tumor-associated macrophages<sup>##REF##25043024##14##</sup>, and myeloid-derived suppressor cells<sup>##REF##35263597##17##</sup>. Further evidence linking lactic acid with tumor immunoescape comes from our present data in which we showed that elevated lactic acid in KRAS<sup>MUT</sup> tumors could sensitize tumor-specific CTLs to AICD. The results from our study, as well as previous reports<sup>##REF##33589820##16##,##REF##27641098##18##,##REF##35090594##57##</sup>, indicated immune-suppressive roles of lactic acid in the process of tumor immunosurveillance. Furthermore, we illustrated MCT1-mediated lactic acid uptake, but not lactic acid/GPR81 signaling, plays a major role in regulating AICD. In contrast, a study by Renner et al. reported that MCT1 contributes to the export of lactic acid<sup>##REF##31577944##58##</sup>. It is conceivable that MCT1-mediated lactic acid transport might have distinct context-dependent effects because it is a passive process that depends on the lactic acid gradient over cell membrane.</p>", "<p id=\"Par31\">Since its first description as an epigenetic modification in 2019<sup>##REF##31645732##47##</sup>, the contribution of lactic acid-derived histone lactylation to gene transcription has come to light. Subsequent studies have implicated various cell types in histone lactylation, such as monocytes<sup>##REF##36268709##59##</sup>, macrophages<sup>##REF##33199625##60##</sup>, and myeloid cells<sup>##REF##35320754##61##</sup>. We recently demonstrated histone lactylation boosted oncogene transcription activation in malignant cells<sup>##REF##35637958##62##</sup>. These pioneering reports have moved this relatively young field of research forward. However, whether histone lactylation contributes to T cell-mediated cancer immunology remains an important knowledge gap. Here, we reported the involvement of histone lactylation in regulating T cell-mediated tumor immunological escape by showing that histone lactylation-activated circATXN7 sensitized tumor-specific CTLs to AICD. These findings enable a better understanding of the link between epigenetic modification and tumor immunology. However, it is worthy of further efforts to understand the roles of lactate-lactylation in other cell types in tumor microenvironment.</p>", "<p id=\"Par32\">The emerging roles of circRNAs in cancer and oncology bring them to the forefront of clinical practice. Current research indicates that circRNAs can control various aspects of cancer immunology<sup>##REF##35970825##63##</sup>. A study by Jia and colleagues showed circFAT1 reduced CD8<sup>+</sup> T cell infiltration by binding to STAT3 in the cytoplasm in squamous cell carcinoma<sup>##UREF##4##64##</sup>. In non-small cell lung cancer cells, tumor cell-expressed circIGF2BP3 caused immune escape from CD8<sup>+</sup> T cell-mediated tumor killing<sup>##REF##34416901##65##</sup>. These insights shed light on an association between circRNAs and CTL dysfunction. Nevertheless, there is a lack of research focusing on how circRNAs in tumor-infiltrating T cells involve in tumor immunology. Against this background, we determined circRNA expression profile in AICD-sensitive versus -resistant T cells. Subsequent assays provided evidence demonstrating the contribution of tumor-specific CTLs-expressed circATXN7 to tumor immune escape and anti-PD1 therapy resistance. The present work deciphers the role and targeted therapeutic potential of circRNAs in tumor-infiltrating T cells per se, which might advance cancer immunotherapies.</p>", "<p id=\"Par33\">The interaction between proteins and circRNAs can be often seen in the current literatures<sup>##REF##32931733##66##,##REF##36961927##67##</sup>. For instance, Guarnerio and colleagues found that circCsnk1g3 and circAnkib1 can interact with RIG-I at a close molar ratio in the sarcoma cells<sup>##REF##36433954##38##</sup>. The present study proposed a model in which circATXN7 directly binds with p65 in the tumor-specific CD8<sup>+</sup> T cells of KRAS<sup>MUT</sup> CRC. Furthermore, the stoichiometry of the circATXN7 versus that of p65 indicated that the interaction between circATXN7 and p65 was approximately equimolar. Although Mann et al. estimated that each HeLa cell contained &gt;180,000 copies of p65<sup>##REF##26496610##68##</sup>, this work demonstrated p65 protein was expressed in the tumor-specific CD8<sup>+</sup> T cells of KRAS<sup>MUT</sup> CRC at ~2000 copies per cell. These findings suggested a cell type specific protein expression pattern. One protein might have different abundance in different cells. Additional support for this possibility comes from previous studies<sup>##REF##33436560##69##,##REF##29706547##70##</sup> in which they are demonstrated that each A549 cell, and VSV-infected macrophage contained 50, ~1000 copies of RIG-I, respectively. On the other hand, the protein copy number range can span several orders of magnitude in one specific type of cell<sup>##REF##25470552##71##</sup>. It has been reported that the protein copies per HeLa cell vary from 3 to &gt;80,000,000<sup>##REF##26496610##68##</sup>. These findings confirmed the protein abundance was cell context-dependent, but not a general feature in different types of cells.</p>", "<p id=\"Par34\">Therapeutic attempts to tackle KRAS<sup>MUT</sup> have been continuing for decades. Due to the benefits of ACT in a subset of cancer patients, much interest is dedicated to the study of T cell receptors targeting KRAS<sup>MUT</sup><sup>##REF##32461371##72##,##REF##36088370##73##</sup>. Along this line, Rosenberg and colleagues<sup>##REF##27959684##74##</sup> demonstrated the tumor regression of metastatic CRC after the administration of cytotoxic T cells targeting mutant KRAS<sup>G12D</sup>. A similar pattern in pancreatic cancer was showed in a recent study by Tran et al.<sup>##REF##35648703##75##</sup>. These insights suggest that KRAS-driven tumors can be targeted efficiently by reprogramming immune program. A study by DePinho et al. reinforced this therapeutic strategy by showing that inhibition of myeloid-derived suppressor cell recruitment could overcome resistance of tumors expressing KRAS<sup>G12D</sup> to anti-PD1 therapy<sup>##REF##30905761##49##</sup>. These therapeutics, however, require the expression of KRAS<sup>G12D</sup> and cannot be used against non-G12C mutants. As such, efforts to seek approach that enables broad inhibition of KRAS<sup>MUT</sup> or its related downstream signaling are continuing. Our work here identified a KRAS<sup>MUT</sup>-activated circATXN7 program as an exploitable therapeutic approach to combat KRAS<sup>MUT</sup> tumors, which did not correlate with the KRAS mutation type and appeared to be a general feature of KRAS<sup>MUT</sup> tumors. In vitro and in vivo experiments showed targeting circATXN7 in T cells protected T cells from tumor-mediated AICD. Accordingly, circATXN7 ablation shifts KRAS<sup>MUT</sup> tumors from immunologically “cold” to “hot” and consequently improves immunotherapeutic efficacy. Although emerging data suggest the potential of cancer cell-expressed oncogenic circRNAs as therapeutic targets, this study provides insight into targeting immunocyte-located circRNAs for cancer immunotherapies. The clinical relevance of this therapeutic strategy is further supported by ACT success in PDX models, as well as our findings that high circATXN7 expression in CRC patients correlates with poor response to ICIs.</p>", "<p id=\"Par35\">In summary, this work identified circATXN7 as a major driver of tumor immune evasion that sensitized tumor-specific CTLs to AICD. These findings define a therapeutic strategy by demonstrating that circATXN7-deficient CD8<sup>+</sup> T cells are reprogrammed to long-lived cells by preventing their AICD, thereby improving the therapeutic efficacy of ICIs and ACT.</p>" ]
[]
[ "<p id=\"Par1\">Mutant KRAS (KRAS<sup>MUT</sup>) is often exploited by cancers to shape tumor immunity, but the underlying mechanisms are not fully understood. Here we report that tumor-specific cytotoxic T lymphocytes (CTLs) from KRAS<sup>MUT</sup> cancers are sensitive to activation-induced cell death (AICD). circATXN7, an NF-κB-interacting circular RNA, governs T cell sensitivity to AICD by inactivating NF-κB. Mechanistically, histone lactylation derived from KRAS<sup>MUT</sup> tumor cell-produced lactic acid directly activates transcription of circATXN7, which binds to NF-κB p65 subunit and masks the p65 nuclear localization signal motif, thereby sequestering it in the cytoplasm. Clinically, circATXN7 upregulation in tumor-specific CTLs correlates with adverse clinical outcomes and immunotherapeutic resistance. Genetic ablation of circAtxn7 in CD8<sup>+</sup> T cells leads to mutant-selective tumor inhibition, while also increases anti-PD1 efficacy in multiple tumor models in female mice. Furthermore, targeting circATXN7 in adoptively transferred tumor-reactive CTLs improves their antitumor activities. These findings provide insight into how lymphocyte-expressed circRNAs contribute to T-cell fate decisions and anticancer immunotherapies.</p>", "<p id=\"Par2\">Oncogenic KRAS mutations can dictate the formation of an immune-suppressive tumor microenvironment. Here the authors report that, in KRAS mutant colorectal cancer, the upregulation of circATXN7 in tumor-specific cytotoxic T lymphocytes is associated with increased sensitivity to activation-induced cell death and resistance to immunotherapy.”</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n\n</p>", "<title>Source data</title>", "<p>\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s41467-024-44779-1.</p>", "<title>Acknowledgements</title>", "<p>This work was supported by grants from the National Natural Science Foundation of China (82200569, 82103273, 82203626, 82303440, 82303060, 82000515 and 82370675), Guangdong Basic and Applied Basic Research Foundation (2023A1515010523, 2023A1515010473, 2021A1515110509, 2019A1515110043, 2021A1515111011, 2019A1515110144 and 2022A1515012498), China Postdoctoral Science Foundation (2021M703723 and 2022M723616), the Open Fund of Guangdong Provincial Key Laboratory of Digestive Cancer Research (2021B1212040006), Science and Technology Projects in Guangzhou (202206010062), Medical Scientific Research Foundation of Guangdong Province, China (no. A2021130), Sun Yat-sen University Clinical Research 5010 Program (2016005), Natural Science Basic Research Program of Shaanxi Province (2022JQ-825), Shenzhen “San Ming Projects” Research (Grant No.lc202002), Key Research and Development Program of Guangzhou (No. SL2024B03J00078), Fundamental Research Funds for the Central Universities, Sun Yat-sen University (No. 23xkjc023) and National Key Clinical Discipline.</p>", "<title>Author contributions</title>", "<p>H.S.L., Y.X., L.K., and C.Z. conceived the ideas and designed the experiments. H.S.L., W.X.L., Z.X.L., S.J.C., J.H.P., K.X.Z., W.H.L., X.Y., Z.W.Z., X.B.Z., and L.X. performed the experiments. H.S.L., X.R.W., L.X., L.K., and C.Z. analyzed and interpreted the data. H.S.L., W.X.L., and C.Z. wrote the manuscript. H.S.L., W.X.L., Z.X.L., Y.X., S.J.C., J.H.P., K.X.Z., W.H.L., Z.W.Z., X.B.Z., W.H.F., L.H., Z.Z.L., X.R.W., P.L., Y.X., L.K. and C.Z. revised the paper. Z.W.Z., X.Y., X.B.Z., and L.K. performed the statistical analysis. All authors read and approved the final paper.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par79\"><italic>Nature Communications</italic> thanks Di Zhang, Xiongbin Lu, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.</p>", "<title>Data availability</title>", "<p>Source data for the circRNA-seq, ChIP-seq, and RNA-seq have been deposited in the Genome Sequence Archive under the accession numbers <ext-link ext-link-type=\"uri\" xlink:href=\"https://ngdc.cncb.ac.cn/gsa-human/browse/HRA003320\">HRA003320</ext-link>, <ext-link ext-link-type=\"uri\" xlink:href=\"https://ngdc.cncb.ac.cn/gsa-human/browse/HRA003223\">HRA003223</ext-link>, and <ext-link ext-link-type=\"uri\" xlink:href=\"https://ngdc.cncb.ac.cn/gsa/browse/CRA007181\">CRA007181</ext-link>, respectively. Datasets HRA003320 and HRA003223 are available under restricted access for research purposes only, access can be obtained by the DAC (Data Access Committees) of the GSA-human database. The approximate response time for accession requests is about two weeks. Once access has been approved, the data will be available to download for research purpose, and can only be used for the research group and its research collaborators. The user can also contact the corresponding author directly upon request. The remaining data generated in this study are provided in the Article, its ##SUPPL##0##Supplementary Information## and Source Data file. <xref ref-type=\"sec\" rid=\"Sec52\">Source data</xref> are provided with this paper.</p>", "<title>Competing interests</title>", "<p id=\"Par80\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Tumor-mediated AICD in KRAS<sup>MUT</sup> versus KRAS<sup>WT</sup> CRC.</title><p><bold>A</bold> Tumor-specific CTLs were freshly isolated from KRAS<sup>MUT</sup> versus KRAS<sup>WT</sup> stage IV CRCs. Apoptosis of CTLs induced by autologous tumor cells or anti-CD3 (<italic>n</italic> = 5 samples; ****<italic>p</italic> ≤ 0.0001 compared with the untreated CTLs by one-way ANOVA; <sup>####</sup><italic>p</italic> ≤ 0.0001 compared with KRAS<sup>WT</sup> tumors-derived CTLs with the indicated treatments by two-tailed Student’s <italic>t</italic>-test). <bold>B</bold> Scheme of the induction of tumor-antigen-activated CTLs and AICD sensitivity switch during T cell activation. CRC patients-derived peripheral CD8<sup>+</sup> T cells were activated by autologous DCs pulsed with tumor lysate (<bold>C</bold>, <bold>E</bold>), or CEA peptide (<bold>D</bold>, <bold>F</bold>) for the indicated number of days. <bold>C</bold> Apoptosis of CTLs induced by anti-CD3 or autologous tumor cells (<italic>n</italic> = 4 samples; ****<italic>p</italic> ≤ 0.0001 compared with untreated day-6 CTLs by one-way ANOVA). <bold>D</bold> Apoptosis of CTLs induced by anti-CD3 or CEA-loaded T2 cells (T2/CEA) (<italic>n</italic> = 4 samples; ****<italic>p</italic> ≤ 0.0001 compared with untreated day-6 CTLs by one-way ANOVA). <bold>E</bold> Apoptosis of the CRC antigen-activated CTLs induced by autologous tumor cells preincubated with anti-HLA-I or IgG (<italic>n</italic> = 4 samples; ****<italic>p</italic> ≤ 0.0001 compared with IgG by one-way ANOVA). <bold>F</bold> Apoptosis of the CEA-specific CTLs induced by CEA-loaded T2 cells (T2/CEA) preincubated with anti-HLA-I or IgG (<italic>n</italic> = 4 samples; ****<italic>p</italic> ≤ 0.0001 compared with IgG by one-way ANOVA). <bold>G</bold> Correlation between CEA levels and AICD sensitivity of tumor-specific CTLs in KRAS<sup>MUT</sup> CRCs (<italic>n</italic> = 15 patients; tested by Pearman correlation). <bold>H</bold>, <bold>I</bold> Tumor-specific CTLs were isolated from CEA positive and negative expressing CRCs. <bold>H</bold> Representative plots showing autologous tumor cell-induced apoptosis of CTLs (****<italic>p</italic> ≤ 0.0001 compared with the untreated CTLs by two-tailed Student’s <italic>t</italic>-test). <bold>I</bold> Statistical comparison of tumor cell-induced AICD in CTLs (<italic>n</italic> = 5 samples; ns indicates <italic>p</italic> &gt; 0.05 by two-tailed Student’s <italic>t</italic>-test). Numerical values (mean ± SD) denote annexin V<sup>+</sup> cell percentages (<bold>A</bold>, <bold>C</bold>–<bold>F</bold>, <bold>H</bold>). Source data and exact <italic>p</italic> values are provided as a Source Data file.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>circATXN7 identification and its involvement in AICD.</title><p><bold>A</bold> The schematic of screening target circRNA which was related to NF-κB/AICD axis. <bold>B</bold> Heatmap of differentially expressed circRNAs in lactic acid- versus PBS-treated Day-1 T cells (<italic>n</italic> = 3 independent samples). <bold>C</bold> Statistics of anti-CD3-induced specific apoptosis for Day-6 T cells transduced with lentivirus carrying an expression cassette for circATXN7 shRNA (sh1 or sh2) or shRNA control vector (shVec) (<italic>n</italic> = 3 independent experiments). Ut, Day-6 T cells without any treatment. <bold>D</bold> Statistics of anti-CD3-induced specific apoptosis for Day-6 T cells transduced with lentivirus carrying an expression cassette for sh1 or shVec, with or without lactic acid (10 mM) treatment (<italic>n</italic> = 3 independent experiments). <bold>E</bold> Western blots showing global histone lactylation and H3K18la levels in tumor-specific CTLs from KRAS<sup>WT</sup> or KRAS<sup>MUT</sup> CRCs (<italic>n</italic> = 3 samples). <bold>F</bold> Immunoprecipitated lactylated proteins determined by western blots for H3K18la. Three independent experiments were performed and similar results were obtained. <bold>G</bold> Representative IGV tracks showing enriched H3K18la modification at the <italic>ATXN7</italic> promotor by ChIP-seq analysis of 10 mM lactic acid-treated Day-1 T cells. <bold>H</bold> ChIP-qPCR analysis for H3K18la status at the <italic>ATXN7</italic> promotor of Day-1 T cells treated with 10 mM lactic acid, or lactic acid (10 mM) in combination with 10 nM AZD3965 (<italic>n</italic> = 3 independent experiments). Ut, Day-1 T cells without any treatment. <bold>I</bold> ChIP-qPCR analysis for EP300 status at the <italic>ATXN7</italic> promotor of Day-1 T cells treated with 10 mM lactic acid, or lactic acid (10 mM) in combination with 10 nM AZD3965 (<italic>n</italic> = 3 independent experiments). Ut, Day-1 T cells without any treatment. <bold>J</bold> circATXN7 expression levels in Day-1 T cells treated with indicated concentrations of lactic acid (<italic>n</italic> = 3 independent experiments). Statistical data presented in this figure show mean values ± SD (<bold>C</bold>, <bold>D</bold>, <bold>H</bold>–<bold>J</bold>). **<italic>p</italic> ≤ 0.01, ***<italic>p</italic> ≤ 0.001, ****<italic>p</italic> ≤ 0.0001 and ns indicates <italic>p</italic> &gt; 0.05, by one-way ANOVA (<bold>C</bold>, <bold>D</bold>, <bold>H</bold>–<bold>J</bold>). Source data and exact <italic>p</italic> values are provided as a Source Data file.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Clinical significance of circATXN7 expression.</title><p><bold>A</bold> Representative images of circATXN7 ISH staining in KRAS<sup>MUT</sup> CRC tissues. Scale bars: 200 μm (left), 50 μm (middle and right). <bold>B</bold> circATXN7 fluorescence in situ hybridization (green) and CEA pentamer fluorescence (pink) imaged using confocal microscopy demonstrating circATXN7 and tumor-specific CTL colocalization. Scale bars: 50 μm. <bold>C</bold> Statistics of circATXN7<sup>+</sup> cell density in KRAS<sup>WT</sup> (<italic>n</italic> = 182 patients) and KRAS<sup>MUT</sup> (<italic>n</italic> = 87 patients) CRC tumor tissues from SYSU-6thAH. <bold>D</bold> Pearson’s correlation analysis between circATXN7<sup>+</sup> cell and CD8<sup>+</sup> T cell density in KRAS<sup>WT</sup> (<italic>n</italic> = 182 patients) and KRAS<sup>MUT</sup> (<italic>n</italic> = 87 patients) CRC tumor tissues from SYSU-6thAH. <bold>E</bold> Kaplan–Meier curves for DFS layered by circATXN7<sup>+</sup> cell density in KRAS<sup>WT</sup> (<italic>n</italic> = 182 patients) and KRAS<sup>MUT</sup> (n = 87 patients) CRC cases from SYSU-6thAH. <bold>F</bold> Kaplan–Meier survival curves for PFS layered by circATXN7<sup>+</sup> cell density in KRAS<sup>WT</sup> (<italic>n</italic> = 65 patients) and KRAS<sup>MUT</sup> (n = 36 patients) CRC patients from SYSUCC. <bold>G</bold> Representative images of circATXN7 ISH staining in tumor biopsy specimens from CRC patients who then received ICIs (<italic>n</italic> = 45 patients). Scale bars: 200 μm (left), 50 μm (right). <bold>H</bold> Representative computed tomography (left), magnetic resonance imaging (right), and <bold>I</bold> endoscopic images from high- or low- circATXN7<sup>+</sup> cell density CRC patients before and after ICIs (<italic>n</italic> = 45 patients). <bold>J</bold> Statistics of circATXN7<sup>+</sup> cells in CRC patients with CR/PR (<italic>n</italic> = 24 patients) or SD/PD (<italic>n</italic> = 21 patients). <bold>K</bold> Number of CRC patients with CR/PR or SD/PD in circATXN7-low and -high groups. **<italic>p</italic> ≤ 0.01, and ****<italic>p</italic> ≤ 0.0001, by two-sided Mann–Whitney test (<bold>C</bold> and <bold>J</bold>), Person’s correlation analysis (<bold>D</bold>), two-sided log-rank test (<bold>E</bold>, <bold>F</bold>), or two-sided Chi-Square test (<bold>K</bold>). Source data and exact <italic>p</italic> values are provided as a Source Data file.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>circATXN7 inactivates NF-κB by sequestering p65 in the cytoplasm.</title><p><bold>A</bold> Apoptosis of the indicated tumor-specific CTLs induced by autologous tumor cells or anti-CD3 (<italic>n</italic> = 4 samples). Ut, cells without any treatment. Numerical values (mean ± SD) denote annexin V<sup>+</sup> cell percentages (*<italic>p</italic> ≤ 0.05, **<italic>p</italic> ≤ 0.01, ***<italic>p</italic> ≤ 0.001, ****<italic>p</italic> ≤ 0.0001 and ns indicates <italic>p</italic> &gt; 0.05 compared with shVec or Vector by one-way ANOVA). <bold>B</bold> Immunofluorescent staining for p65 (green) nuclear translocation in KRAS<sup>MUT</sup> tumor-derived tumor-specific CTLs with the indicated treatments (<italic>n</italic> = 3 patients). Nuclei were stained with DRAQ5 (red). Ut, cells without any treatment. Scale bars: 10 μm. <bold>C</bold> circRNA pull-down assays using biotin-labeled circATXN7 probes indicating circATXN7 binding to p65, IκBα, and p50 in Day-6 T cells. <bold>D</bold> In vitro circRNA-protein binding assay demonstrating circATXN7 directly binding to p65. <bold>E</bold> Representative 3D images for circATXN7 FISH (red) and p65 IF (green) staining showing the colocalization of circATXN7 with p65 in tumor-specific CTLs. Nuclei were stained with DAPI (blue). Scale bar: 10 μm. <bold>F</bold> Schematic illustration of p65 functional domains and corresponding truncation constructs. <bold>G</bold> circRNA pull-down assays were conducted using biotin-labeled circATXN7 probes against cell lysates from Day-6 T cells transfected with full-length p65 or the indicated deletion mutants. Co-precipitated proteins were detected by immunoblots using anti-Flag antibodies. <bold>H</bold> circATXN7 and p65 docking model. <bold>I</bold> circRNA pull-down assays were conducted using biotin-labeled NC or circATXN7 probes against cell lysates from Day-6 T cells transfected with blocking oligo (5′ CTCCCCGACCGTCGCCATTGCGGCGGCCGAG 3′ complimentary to 5′ CUCGGCCGCCGCAAUGGCGACG 3′ of circATXN7) or NC oligo. Co-precipitated proteins were detected by immunoblots using anti-p65 antibodies. <bold>J</bold> circRNA pull-down assays were done using biotin-labeled circATXN7 probes against cell lysates from Day-6 T cells transfected with vector, p65, or binding site-mutated p65 (p65<sup>MUT</sup>). Co-precipitated proteins were detected by western blot using anti-Flag antibodies. <bold>K</bold> Immunoblots showing p65 nuclear translocation in circATXN7 overexpressed Day-1 T cells transfected with blocking oligo or NC oligo. <bold>L</bold> Immunoblots showing p65 nuclear translocation in Day-1 T cells transfected with circATXN7 or p65-binding site-mutated circATXN7. In panels <bold>C</bold>, <bold>D</bold>, <bold>G</bold>, <bold>I</bold>–<bold>L</bold>, three independent experiments were performed and similar results were obtained. Source data and exact <italic>p</italic> values are provided as a Source Data file.</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><title>Mutant-selective tumor inhibition in vivo by targeting circATXN7.</title><p><bold>A</bold> Schematic diagram demonstrating targeted genome editing at the <italic>Atxn7</italic> gene, followed by intercross with <italic>CD8a</italic><sup><italic>cre</italic></sup> mice to generate <italic>CD8a</italic><sup><italic>cre</italic></sup><italic>; circAtxn7</italic><sup><italic>loxp/loxp</italic></sup> (<italic>circAtxn7</italic><sup><italic>CKO</italic></sup>) mice. MC38K (G12D; <bold>B</bold>) or MC38 cells (<bold>C</bold>) were subcutaneously injected into WT or <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> mice. During the course of each group (<italic>n</italic> = 5 animals), tumor volumes were monitored, and tumor weights were measured at day 32. <bold>D</bold>–<bold>G</bold> 5 × 10<sup>5</sup> MC38K(G12D) or MC38 cells were injected into the cecum submucosa of WT or <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> mice to generate orthotropic xenograft CRC models (<italic>n</italic> = 5 animals). Mice were sacrificed 24 days after injection. Gross inspection of MC38K (<bold>D</bold>) or MC38 (<bold>F</bold>) orthotopic tumors and representative H&amp;E staining of liver micro-metastasis. Scale bars: 1 cm (left panel); 200 μm (right panel). <bold>E</bold>–<bold>G</bold> At day 24, MC38K or MC38 orthotropic xenografts were subjected to analyses of tumor volumes, liver metastasis rate, and liver CMV expression. <bold>H</bold> At day 24, CD8<sup>+</sup> T cells were purified from MC38K orthotropic xenografts in WT or <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> mice, and then subjected to RNA-seq (<italic>n</italic> = 3 samples). GSEA analysis showing an enrichment related to NF-kB signaling and apoptosis in circAtxn7-deficient tumor-infiltrating CD8<sup>+</sup> T cells. <bold>I</bold> IHC staining for CD8 and relative CD8<sup>+</sup> cell density in MC38K orthotropic xenografts in WT or <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> mice at day 24 (<italic>n</italic> = 5 samples). Scale bars, 50 μm. <bold>J</bold> MC38K orthotropic tumors in WT or <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> mice at day 24 were subjected to flow cytometry analysis for CD8<sup>+</sup> cell density (<italic>n</italic> = 5 samples). <bold>K</bold> CD8<sup>+</sup> T cells were purified from WT and <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> MC38K orthotropic tumor-bearing mice at day 24, and then subjected to flow cytometry analysis for IFN-γ expression (<italic>n</italic> = 5 samples). Numerical values denote IFN-γ<sup>+</sup> CD8<sup>+</sup> T cell percentages relative to total CD8<sup>+</sup> cells. Statistical data presented in this figure show mean ± SD (<bold>B</bold>, <bold>C</bold>, <bold>E</bold>–<bold>G, I</bold>–<bold>K</bold>). ***<italic>p</italic> ≤ 0.001, ****<italic>p</italic> ≤ 0.0001, and ns indicates <italic>p</italic> &gt; 0.05, by two-sided Student’s <italic>t</italic>-test (<bold>B</bold>, <bold>C</bold>, right panel of <bold>E</bold>, <bold>G</bold>, <bold>K</bold>, <bold>I</bold>, and <bold>J</bold>), or two-sided Mann–Whitney <italic>U</italic> test (left panel of <bold>E</bold>). Source data and exact <italic>p</italic> values are provided as a Source Data file.</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><title>Effects of circATXN7 on immunotherapy efficacy.</title><p><bold>A</bold>, <bold>B</bold> Tumor growth and survival curves of MC38K subcutaneous xenografts in WT (<bold>A</bold>) or <italic>circAtxn7</italic><sup><italic>CKO</italic></sup> (<bold>B</bold>) mice treated with anti-PD1 antibodies or IgG isotype control antibodies (<italic>n</italic> = 5 animals). <bold>C</bold> Schematic diagram showing circAtxn7 silencing in OT-I CD8<sup>+</sup> T cells and ACT therapy against MC38K-OVA tumors. <bold>D</bold> 7.5 × 10<sup>5</sup> OT-I cells transduced with GFP-tagged shcircAtxn7 were mixed with 7.5 × 10<sup>5</sup> OT-I cells transduced with mCherry-tagged shVec, and co-injected intravenously into MC38K-OVA tumor-bearing mice, followed by flow cytometric analyses of the proportion of OT-I cells in total CD8<sup>+</sup> cells at the indicated time points. <bold>E</bold> Quantification of OT-I cell number relative to total CD8<sup>+</sup> cells (<italic>n</italic> = 3 samples). <bold>F</bold>–<bold>H</bold> 1.5 × 10<sup>6</sup> OT-I cells with circAtxn7 silencing or shVec were transferred into MC38K-OVA tumor-bearing mice (<italic>n</italic> = 5 animals). At 20 days after transfer, MC38K-OVA tumors were subjected to analyses of CD8 IHC staining (<bold>F</bold>), tumor growth curves during the course (<bold>G</bold>), and weights (<bold>H</bold>). Scale bars, 50 μm. <bold>I</bold> Scheme of the preparation and adoptive transfer of tumor-reactive CD8<sup>+</sup> T cells into autologous CRC PDXs. <bold>J</bold> Biodistribution of tumor-reactive CD8<sup>+</sup> T cells 21 days after transfer. <bold>K</bold> Representative IHC staining for CD8 in harvested CRC PDX samples 21 days after transfer. Scare bars: 50 μm. <bold>L</bold> NF-κB activity in tumor-infiltrating CD8<sup>+</sup> T cells purified from ACT-treated PDXs 21 days after transfer (<italic>n</italic> = 3 samples). <bold>M</bold> Growth curves of ACT-treated PDXs (<italic>n</italic> = 5 animals). <bold>N</bold> Weights of ACT-treated PDXs measured 21 days after transfer (<italic>n</italic> = 5 animals). Ut, cells without any treatment (<bold>G</bold>, <bold>H</bold>, and <bold>M</bold>, <bold>N</bold>). Statistical data presented in this figure show mean values ± SD (<bold>A</bold>, <bold>B</bold>, <bold>E</bold>, <bold>G</bold>, <bold>H, M</bold>, <bold>N</bold>). ***<italic>p</italic> ≤ 0.001, ****<italic>p</italic> ≤ 0.0001 and ns indicates <italic>p</italic> &gt; 0.05, by two-tailed Student’s <italic>t</italic>-test (left panels of <bold>A</bold>, <bold>B</bold>, and <bold>E</bold>), one-way ANOVA (<bold>G</bold>, <bold>H</bold>, and <bold>M</bold>, <bold>N</bold>), or two-sided log-rank test (right panels of <bold>A</bold>, <bold>B</bold>). Source data and exact <italic>p</italic> values are provided as a Source Data file.</p></caption></fig>", "<fig id=\"Fig7\"><label>Fig. 7</label><caption><title>The scheme of the mechanism underlying circATXN7 expression and contribution to the tumor-infiltrating T cell fate decisions.</title><p>An NF-κB-interacting circRNA that is activated by histone lactylation sensitizes tumor-specific CTLs to AICD by sequestering p65 in the cytoplasm, thereby causing adverse clinical outcomes and immunotherapeutic resistance.</p></caption></fig>" ]
[]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Chi Zhou, Wenxin Li, Zhenxing Liang, Xianrui Wu.</p></fn><fn><p>These authors jointly supervised this work: Yue Xing, Liang Kang, Huashan Liu.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41467_2024_44779_Fig1_HTML\" id=\"d32e795\"/>", "<graphic xlink:href=\"41467_2024_44779_Fig2_HTML\" id=\"d32e1139\"/>", "<graphic xlink:href=\"41467_2024_44779_Fig3_HTML\" id=\"d32e1393\"/>", "<graphic xlink:href=\"41467_2024_44779_Fig4_HTML\" id=\"d32e1614\"/>", "<graphic xlink:href=\"41467_2024_44779_Fig5_HTML\" id=\"d32e2041\"/>", "<graphic xlink:href=\"41467_2024_44779_Fig6_HTML\" id=\"d32e2396\"/>", "<graphic xlink:href=\"41467_2024_44779_Fig7_HTML\" id=\"d32e2514\"/>" ]
[ "<media xlink:href=\"41467_2024_44779_MOESM1_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>", "<media xlink:href=\"41467_2024_44779_MOESM2_ESM.pdf\"><caption><p>Peer Review File</p></caption></media>", "<media xlink:href=\"41467_2024_44779_MOESM3_ESM.pdf\"><caption><p>Reporting Summary</p></caption></media>", "<media xlink:href=\"41467_2024_44779_MOESM4_ESM.xlsx\"><caption><p>Source Data</p></caption></media>" ]
[{"label": ["9."], "surname": ["Liu"], "given-names": ["H"], "article-title": ["Mutant KRAS drives immune evasion by sensitizing cytotoxic T-cells to activation-induced cell death in colorectal cancer"], "source": ["Adv. Sci."], "year": ["2023"], "volume": ["10"], "fpage": ["e2203757"], "pub-id": ["10.1002/advs.202203757"]}, {"label": ["26."], "mixed-citation": ["Yamada T, et al. TIGIT mediates activation-induced cell death of ILC2s during chronic airway allergy. "], "italic": ["J. Exp. Med."], "bold": ["220"]}, {"label": ["36."], "mixed-citation": ["Kristensen LS, Jakobsen T, Hager H, Kjems J. The emerging roles of circRNAs in cancer and oncology. "], "italic": ["Nat. Rev. Clin. Oncol."], "bold": ["19"]}, {"label": ["40."], "mixed-citation": ["Zou Y, et al. The role of circular RNA CDR1as/ciRS-7 in regulating tumor microenvironment: a pan-cancer analysis. "], "italic": ["Biomolecules"], "bold": ["9"]}, {"label": ["64."], "surname": ["Jia", "Wang", "Wang"], "given-names": ["L", "Y", "CY"], "article-title": ["circFAT1 promotes cancer stemness and immune evasion by promoting STAT3 activation"], "source": ["Adv. Sci."], "year": ["2021"], "volume": ["8"], "fpage": ["2003376"], "pub-id": ["10.1002/advs.202003376"]}]
{ "acronym": [], "definition": [] }
76
CC BY
no
2024-01-14 23:40:17
Nat Commun. 2024 Jan 12; 15:499
oa_package/f2/a6/PMC10786880.tar.gz
PMC10786881
38216644
[ "<title>Introduction</title>", "<p id=\"Par2\">Phosphorus is a vital element that supports life in the earth’s system and plays a fundamental role in the growth of plants and animals<sup>##UREF##0##1##</sup>. However, excessive phosphorus can lead to eutrophication in water bodies. This phenomenon triggers the rapid proliferation of algae and other planktonic organisms, resulting in foul-smelling and odorous water, reduced transparency, decreased dissolved oxygen concentration, deteriorated water quality, and even mass mortality of fish and other organisms. Furthermore, the excessive consumption of high-quality commercial phosphorus mines has created an urgent need to develop new methods that can effectively remove wastewater phosphorus pollution and recover phosphorus<sup>##REF##31905557##2##</sup>.</p>", "<p id=\"Par3\">In recent years, various methods have been employed to treat phosphorus-containing wastewater. These methods include chemical precipitation<sup>##REF##37263468##3##</sup>, membrane separation<sup>##UREF##1##4##</sup>, ion exchange<sup>##UREF##2##5##</sup>, biological processes<sup>##UREF##3##6##</sup>, photocatalysis<sup>##REF##37393809##7##</sup>, constructed wetlands<sup>##UREF##4##8##</sup>, and adsorption<sup>##UREF##5##9##</sup>. Among these techniques, ion exchange, ultrafiltration, membrane separation, and reverse osmosis are adequate for phosphorus removal. However, they have high operating costs and require significant financial investment and operational expenses<sup>##REF##28972907##10##</sup>. Notably, adsorption is a widely used method for treating phosphorus-containing wastewater. It offers several advantages, including excellent adsorption performance, recyclability, low cost, simplicity of operation, and the ability to remove and recover target substances through adsorption–desorption processes<sup>##UREF##6##11##–##UREF##8##13##</sup>.</p>", "<p id=\"Par4\">Over 6 million tons of mulberry branches are harvested annually in the Guangxi region. Unfortunately, these branches are often burned, causing atmospheric pollution, resource wastage and environmental harm<sup>##UREF##9##14##</sup>. It is imperative to find an economical utilization of this abundant agro-waste. However, the adsorption and removal of pollutants by pristine mulberry branch biochar is relatively poor, so developing modified biochar with higher adsorption capacity has always been people’s goal.</p>", "<p id=\"Par5\">Iron and manganese oxides possess unique surface activity, allowing them to adsorb and degrade various inorganic and organic environmental pollutants<sup>##UREF##10##15##</sup>. Iron and manganese oxides tend to aggregate, which poses challenges for their practical applications. To overcome this limitation, researchers have recently focused on combining iron and manganese oxides with other adsorbents, such as bio-apatite-based material<sup>##UREF##8##13##</sup>, biochar and chitosan to create composite adsorbents. This approach not only enhances their adsorption performance through synergistic effects but also resolves the issue of oxide aggregation.</p>", "<p id=\"Par6\">The study indicates that previous studies have primarily focused on the static adsorption of phosphorus using pristine biochar and modified biochar<sup>##REF##37742963##16##,##UREF##11##17##</sup>. Dynamic adsorption is often preferred for removing contaminants from industrial effluents due to its operational simplicity, high pollutant removal efficiency, and ease of scale-up from laboratory processes. The choice of material for the packed column is crucial in dynamic adsorption. Importantly, obtaining a reliable prediction of the breakthrough curve under specified operating conditions can effectively design and operate the packing adsorption process. However, a limited number of reports are available concerning the utilization of a composite material consisting of Fe–Mn oxides and mulberry branch biochar (FM-MBC) for investigating the dynamic adsorption behavior of phosphorus.</p>", "<p id=\"Par7\">This study used mulberry branches as the pristine material to prepare FM-MBC. The dynamic adsorption experiments investigated the impact of solution pH, initial phosphorus concentration, bed height, and flow rate on the adsorption breakthrough curve. To predict the breakthrough curve, the experimental data obtained from the dynamic adsorption experiments were fitted with four different models: Adams-Bohart, Thomas, Yoon Nelson, and BDST. These models were used to evaluate the parameters of the fixed bed and provide insights into the adsorption process. Finally, a combination of dynamic adsorption experiments and characterization results was used to investigate the potential mechanisms of phosphate elimination by the FM-MBC composite.</p>" ]
[ "<title>Materials and methods</title>", "<title>Preparation and characterization of FM-MBC</title>", "<p id=\"Par8\">The method for preparing the FM-MBC is based on our previous works<sup>##REF##31972981##18##</sup>. Various analytical techniques were employed to characterize the structure of the FM-MBC material, including SEM with Energy Dispersive X-ray Spectroscopy (SEM-EDS), Brunauer–Emmett–Teller (BET) surface area and pore size analysis, X-ray Diffraction (XRD), and X-ray Photoelectron Spectroscopy (XPS).</p>", "<title>Column adsorption experiment</title>", "<p id=\"Par9\">A glass column with a diameter of 1 cm and a length of 15 cm was chosen as the adsorption column (Fig. ##FIG##0##1##). The dynamic experimental setup is shown in the diagram (Fig. ##FIG##0##1##). The chromatographic column was filled with 1.0 ~ 2.0 g of FM-MBC material, and the nuts at both ends were tightened. The pipeline was connected according to the illustration. Following this, the peristaltic pump was activated, and the column was flushed with ultrapure water for 3 ~ 5 min to eliminate any bubbles present. Afterward, the pump was stopped. To conduct the dynamic adsorption experiments, the inlet pipe was placed into the phosphate solution. The experimental conditions involved variations in the bed height (1.0, 1.5, and 2.0 g FM-MBC), flow rate (1 ~ 3 mL min<sup>−1</sup>), and initial phosphorus concentration (10 ~ 30 mg L<sup>−1</sup>). The dynamic adsorption experiments were performed at a temperature of 25 °C. At specific time intervals (5, 10, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180, 210, 240, 270, 300, 360, 420, 480, 540, 600, 720, 840, 960, 1080, 1200, 1320, and 1440 min), 10 mL samples were collected, ensuring equal sample volumes each time.</p>", "<title>Determination of phosphorus concentration</title>", "<p id=\"Par10\">The concentration of total phosphorus in solution was measured by the ammonium molybdate spectrophotometric method.</p>", "<title>Breakthrough curve performance analysis</title>", "<p id=\"Par11\">The breakthrough curve represents the adsorption performance of a fixed bed. In general engineering, the breakthrough point is defined as the moment when the mass concentration of the target solution in the effluent reaches 2–5% of the mass concentration of the influent. On the other hand, the adsorption saturation point is reached when the mass concentration of the solution in the effluent comes to 95–98% of the mass concentration of the influent<sup>##REF##20099810##19##</sup>. In this study, the breakthrough point is determined by selecting the time point at which the mass concentration of the solution in the effluent reaches 5% of the influent concentration (C<sub>t</sub>/C<sub>0</sub> = 5%)<sup>##UREF##12##20##,##REF##18249492##21##</sup>. The time taken to get to this point is defined as the breakthrough time. Similarly, the adsorption saturation point is determined by selecting the time point at which the mass concentration of the influent solution reaches 95% of the influent concentration (C<sub>t</sub>/C<sub>0</sub> = 95%)<sup>##REF##20099810##19##</sup>.</p>", "<title>Regeneration research</title>", "<p id=\"Par12\">The regenerants included 0.1 mol L<sup>−1</sup> HCl and 0.1 mol L<sup>−1</sup> NaOH solution. Firstly, when the adsorption reaction reached equilibrium, the saturated biochar was separated from the solution. Subsequently, the regeneration experiment of the saturated biochar was conducted. 0.1 g saturated biochar was added to a conical flask containing 100 mL of regeneration solution. The flask was then placed in a thermostatic shaker and Oscillate in a water bath constant temperature shaker at 25 °C and 180 r min<sup>−1</sup> for 48 h. Once the regeneration reaction was completed, the regenerated biochar was removed from the regeneration solution and subjected to washing and drying processes for subsequent experiments. The regeneration efficiency (%) was calculated using Eqs. (##SUPPL##0##S1##) in the Supplementary Material ##SUPPL##0##S1##.</p>" ]
[ "<title>Results and discussions</title>", "<title>Material characterizations</title>", "<p id=\"Par13\">The SEM images of the FM-MBC at 1000 × and 5000 × magnification are presented in Fig. ##FIG##1##2##a, b, respectively. The surface appears flat, and the pore structure exhibits a honeycomb pattern. The internal structure of the pore was observed clearly in Fig. ##FIG##1##2##b. Upon closer examination, it is evident that there are substances loaded on both the surface and pores of FM-MBC. These substances have been identified as iron and manganese oxides, as confirmed by EDS analysis (Fig. ##FIG##1##2##b). The properties of FM-MBC are summarized in Table ##SUPPL##0##S1##. The XPS and XRD of FM-MBC are shown in Fig. ##SUPPL##0##S1##a, b. Notably, the surface area of FM-MBC is remarkably high 318.53 m<sup>2</sup> g<sup>−1</sup>, which indicates that FM-MBC is an excellent adsorbent. The pore size distribution of FM-MBC is primarily concentrated in the range of 2 ~ 40 nm (Fig. ##FIG##1##2##d), with a majority of mesopores and a smaller proportion of micropores and macropores, indicating a typical mixed structure. It is worth noting that the surface area of an adsorbent is a key determinant of its sorption capacity.</p>", "<title>Effects of operating parameters</title>", "<title>Effect of solution pH</title>", "<p id=\"Par14\">The solution pH is a crucial parameter in the adsorption process, which influences the physicochemical properties of the interaction between substances and the adsorbent in the solution. The solution pH affects the mechanism by which the solid adsorbent interacts with the concrete surface<sup>##REF##22189077##22##</sup>. The charge properties of the adsorbent surface play a significant role in determining the ionization state of the functional groups on the adsorbent surface. The zero point charge (pH<sub>pzc</sub>) of FM-MBC was measured to be 5.64 (Fig. ##SUPPL##0##S2##). The pH<sub>pzc</sub> is the pH at which the adsorbent surface has no net charge. With conditions of pH &lt; pHpzc, the functional groups on the FM-MBC surface are protonated and carry positive charges, which is favorable for the adsorption of the anionic phosphate species (mainly H<sub>2</sub>PO<sub>4</sub><sup>-</sup>). The effect of pH on the dynamic adsorption of phosphate by FM-MBC is shown in Fig. ##FIG##2##3##. When the solution pH is 3.0, 4.5, and 6.0, and the breakthrough time (<italic>t</italic><sub><italic>b</italic></sub>) is 124, 53, and 17 min, and then the exhaustion time (<italic>t</italic><sub><italic>e</italic></sub>) is 397, 200, and 126 min (Fig. ##FIG##2##3##a), respectively. When the pH increases from 3.0 to 6.0, both <italic>t</italic><sub><italic>b</italic></sub> and <italic>t</italic><sub><italic>e</italic></sub> of the adsorption column are shorter. This indicates that acidic conditions are favorable for phosphorus adsorption, which is consistent with the batch adsorption experimental results reported by Nguyen<sup>##REF##25847314##23##</sup>. This may be because, in an acidic medium (pH = 3), phosphate species mainly exist in the form of H<sub>2</sub>PO<sub>4</sub><sup>-</sup> / HPO<sub>4</sub><sup>2−</sup>, and H<sub>2</sub>PO<sub>4</sub><sup>−</sup> / HPO<sub>4</sub><sup>2−</sup> are adsorbed on the FM-MBC surface due to electrostatic interactions with the cationic functional groups<sup>##REF##25847314##23##</sup>. Electrostatic attraction is one of the adsorption mechanisms of FM-MBC for phosphate<sup>##REF##25847314##23##</sup>.</p>", "<title>Initial phosphorus concentration</title>", "<p id=\"Par15\">It has been reported that the initial phosphorus concentration of the influent also affects the breakthrough curve<sup>##UREF##13##24##</sup>. The effect of initial phosphorus concentration (10, 20, and 30 mg L<sup>−1</sup>) on the breakthrough curve (C<sub>t</sub>/C<sub>0</sub>) is shown in Fig. ##FIG##2##3##b. As shown in Fig. ##FIG##2##3##b, when the initial phosphorus concentration is 10, 20, and 30 mg L<sup>−1</sup>, and <italic>t</italic><sub><italic>b</italic></sub> is 484, 124, and 90 min, and then <italic>t</italic><sub><italic>e</italic></sub> is 785, 397, and 255 min, respectively. Within the range of initial phosphorus concentration of 10–30 mg L<sup>−1</sup>, the breakthrough time slightly decreases with increasing phosphorus concentration. When the initial phosphorus concentration of the influent is low, the breakthrough curve is more dispersed and the breakthrough rate is slower. This may be due to the decrease in diffusion coefficient or mass transfer coefficient caused by a lower concentration gradient, resulting in a slower rate of mass transfer. The higher the initial phosphorus concentration of the influent, the steeper the slope of the breakthrough curve and the shorter the breakthrough time<sup>##REF##25847314##23##</sup>. The results indicate that the change in concentration gradient affects the saturation and breakthrough time of the reaction; in other words, the diffusion process is related to the initial solution concentration. With the increase in the initial influent concentration, the loading rate of phosphate increases, and the driving force for mass transfer increases. The adsorption capacity increases with the addition of influent concentration because the high concentration difference provides a more significant driving force for the adsorption process<sup>##REF##19883979##25##</sup>.</p>", "<title>Effect of flow rate</title>", "<p id=\"Par16\">The breakthrough curves (C<sub>t</sub>/C<sub>0</sub>) of phosphate on FM-MBC at different solution flow rates are shown in Fig. ##FIG##2##3##c. With the increase in solution flow rate, the slope of the effluent curve increases and the time to reach the breakthrough point and saturation point decreases. When the solution flow rate is 1.0, 2.0, and 3.0 mL min<sup>−1</sup>, and <italic>t</italic><sub><italic>b</italic></sub> is 469, 124, and 76 min, and then <italic>t</italic><sub><italic>e</italic></sub> is 808, 397, and 151 min, respectively. This may be due to the difference in solution flow rate leading to changes in Reynolds number. The Reynolds number increases with the increase in solution flow rate. When the Reynolds number is high, the residence time of the adsorbate in the column is insufficient to establish adsorption equilibrium, so the solution leaves the fixed bed before reaching equilibrium, resulting in a shorter breakthrough time. On the other hand, a lower flow rate provides a longer contact time between the phosphate and the adsorbent, resulting in better removal of phosphate in the column<sup>##UREF##14##26##</sup>.</p>", "<title>Effect of bed height</title>", "<p id=\"Par17\">The effect of adsorbent bed height on the breakthrough curve of dynamic adsorption of phosphate by FM-MBC is shown in Fig. ##FIG##2##3##d. The breakthrough curve changes with the variation of bed height, and the change in the breakthrough curve conforms to the S-shaped curve characteristic of an ideal adsorption system. In addition, at a bed height of 2 cm, the effluent concentration increases rapidly, while at a bed height of 4 cm, the S-profile is more pronounced. When the bed height decreases, the axial dispersion phenomenon dominates the mass transfer process, reducing the diffusion of ions, and the solute does not have enough time to diffuse into the entire mass of the adsorbent. With the increase in adsorbent bed height, the adsorption rate of phosphate decreases, the slope of the effluent curve decreases, the contact time between FM-MBC and phosphate increases, and the time to reach the breakthrough point and saturation point is prolonged, thereby increasing the removal efficiency of phosphate in the column. The bed height is 2.0, 3.0, and 4.0 cm, and <italic>t</italic><sub><italic>b</italic></sub> is 58, 124, and 321 min, and then <italic>t</italic><sub><italic>e</italic></sub> is 961, 397, and 273 min, respectively. The reason is that the increase in bed height increases the specific surface area and the tortuosity of the fluid channels in the fixed bed, providing more active sites for the adsorption process. The experimental adsorption capacities have been compared with those reported by other authors in similar studies are presented in Table ##TAB##0##1##.</p>", "<title>Breakthrough curve modeling</title>", "<p id=\"Par18\">In dynamic adsorption studies for industrial applications, various mathematical models have been developed to describe and analyze the adsorption process. These mathematical models provide a simplified representation of the adsorption behavior and can be used to fit experimental data and predict the breakthrough curve and adsorption capacity<sup>##REF##22189077##22##</sup>. In this study, the Adams-Bohart, Thomas, and Yoon-Nelson models were used to fit the experimental data and predict the breakthrough curve and adsorption capacity.</p>", "<title>Adams-Bohart model</title>", "<p id=\"Par19\">Adams-Bohart established an equation based on surface reaction theory to describe the relationship between the concentration ratio (<italic>C</italic><sub><italic>0</italic></sub>/<italic>C</italic><sub><italic>t</italic></sub>) and time (<italic>t</italic>) in a continuous system<sup>##REF##22189077##22##</sup>. According to Eq. (##SUPPL##0##S2##), nonlinear regression was performed using the sampling time (t) as the x-axis and the natural logarithm of the concentration ratio (<italic>C</italic><sub><italic>t</italic></sub>/<italic>C</italic><sub><italic>0</italic></sub>) as the y-axis (Fig. ##FIG##3##4##a–d). The Adams-</p>", "<p id=\"Par20\">Bohart model parameters (K<sub>AB</sub> and N<sub>0</sub>) were obtained at different process variables, which are listed in Table ##TAB##1##2##. As the flow rate increases from 1.0 to 3.0 mL min<sup>-1</sup>, the K<sub>AB</sub> increases with the flow rate but decreases with the addition of adsorbent bed height. The range of R<sup>2</sup> obtained in this study (0.9249–0.9819) is similar to the results reported by the Chen group<sup>##REF##22189077##22##</sup> and Ramirez et al.<sup>##UREF##18##31##</sup>. This indicates that in the initial stage of adsorption in the column, the overall system dynamics are primarily controlled by external mass transfer<sup>##REF##19883979##25##</sup>. The correlation coefficient of the nonlinear model was greater than 0.9249 in most cases, which implies an excellent similarity with the experimental data.</p>", "<title>Thomas model</title>", "<p id=\"Par21\">The Thomas model is a widely used dynamic adsorption model for describing breakthrough curves and predicting the adsorption capacity of adsorbents in fixed-bed systems. It assumes no axial diffusion in the adsorption process<sup>##REF##31030076##32##</sup>. According to Eq. (##SUPPL##0##S3##), nonlinear regression was performed using the sampling time as the x-axis and the natural logarithm of the concentration ratio <italic>C</italic><sub><italic>t</italic></sub>/<italic>C</italic><sub><italic>0</italic></sub> as the y-axis (Fig. ##FIG##3##4##e–h). The parameters (K<sub>TH</sub> and q<sub>0</sub>) of the nonlinear regression analysis are presented in Table ##TAB##1##2##. The results show that the fitting effect of the Thomas model (R<sup>2</sup> range: 0.9684–0.9963) was better than that of the Adams-Bohart model. According to Table ##TAB##1##2##, as the solution flow rate increases from 1.0 to 3.0 mL min<sup>−1</sup>, the K<sub>TH</sub> increases with the flow rate, while the q<sub>0</sub> decreases with the addition in flow rate. The decrease in q<sub>0</sub> can be attributed to the lower availability of active sites at higher flow rates<sup>##UREF##18##31##</sup>.</p>", "<title>Yoon-Nelson model</title>", "<p id=\"Par22\">The Yoon-Nelson model is a classic dynamic adsorption model with a simple expression<sup>##UREF##18##31##</sup>. However, it is only applicable for describing the adsorption process of simple component adsorption systems. According to Eq. (##SUPPL##0##S4##), nonlinear regression was performed with sampling time t as the x-axis and C<sub>t</sub>/C<sub>0</sub> as the y-axis (Fig. ##FIG##3##4##i–l). The Yoon-Nelson model parameters obtained by the nonlinear regression are presented in Table ##TAB##1##2##. As the flow rate increases from 1.0 to 3.0 mL min<sup>−1</sup>, the <italic>K</italic><sub><italic>YN</italic></sub> decreases with the increase of bed height but increases with the addition of flow rate. The adsorbent material quickly reaches saturation as the flow rate increases<sup>##UREF##18##31##</sup>. The <italic>τ</italic> decreases with the addition of flow rate and initial phosphate concentration, then increases with the addition of adsorbent bed height. This is because the column reaches saturation faster at a higher initial phosphate concentration and flow rate<sup>##REF##31030076##32##</sup>. The range of <italic>R</italic><sup><italic>2</italic></sup> is 0.9684–0.9999, which is lower than that of the Thomas model.</p>", "<title>BDST model analysis</title>", "<p id=\"Par23\">The relationship between fixed-bed breakthrough time and adsorbent bed height was investigated further in this study (Supplementary Material ##SUPPL##0##S4##). The variation in the service time of the column was studied for two different values of C<sub>t</sub>/C<sub>0</sub> (0.05 and 0.95), as shown in Fig. ##FIG##4##5##. The high correlation coefficients (R<sup>2</sup> &gt; 0.9119) indicate that the BDST model accurately interprets the breakthrough characteristics of phosphate on the FM-MBC adsorbent. The results of each parameter are summarized in Table ##SUPPL##0##S3##.</p>", "<p id=\"Par24\">At a flow rate of 2.0 mL min<sup>−1</sup>, the measured breakthrough time had the most average relative error (23.39%) compared to the predicted breakthrough time. Conversely, the flow rate of 2.0 mL min<sup>-1</sup> had the lowest error (5.83%). This discrepancy can be attributed to the increased contact time between the phosphate and FM-MBC at low flow rates, allowing sufficient time for internal diffusion. However, it should be noted that the BDST model is established based on the assumption of ignoring internal diffusion.</p>", "<title>Comparative analysis of breakthrough models</title>", "<p id=\"Par25\">Linear and nonlinear fitting methods were employed in the aforementioned Adams-Bohart, Thomas, and Yoon-Nelson models, and their correlation coefficients (0.9249 ≤ R<sup>2</sup> ≤ 0.9999) were subsequently compared, which showed that nonlinear regression is most appropriate for the analysis of the dynamic adsorption models<sup>−</sup><sup>##REF##22189077##22##</sup>. The range of R<sup>2</sup> values obtained for the Thomas model indicates a better fit than the Adams-Bohart model. Moreover, the BDST model also correlated well with the experimental data (Table ##SUPPL##0##S3##). In contrast, the R<sup>2</sup> values of the Thomas and Yoon-Nelson models showed slight variation (0.9684 ≤ R<sup>2</sup> ≤ 0.9963 and 0.9819 ≤ R<sup>2</sup> ≤ 0.9999), indicating that the dynamic adsorption process of FM-MBC was more complex. Comprehensive comparison, and complete consideration of the breakthrough properties and parameters were necessary, rather than relying solely on one model. Furthermore, the outcomes of the linear fitting method were contrasted with the Supplementary Materials (Fig. ##SUPPL##0##S3## and Table ##SUPPL##0##S2##), along with their corresponding parameters.</p>", "<title>Regeneration performance</title>", "<p id=\"Par26\">The saturated adsorbent was recycled four times using 0.1 mol L<sup>−1</sup> NaOH and HCl, as shown in Fig. ##SUPPL##0##S4##. After each desorption, the adsorption capacity of phosphorus decreased to some extent. This decrease can be attributed to the strong binding of some phosphate ions, which penetrate the interior of the adsorbent, making it difficult to achieve 100% desorption efficiency<sup>##UREF##19##33##</sup>. Specifically, after three consecutive cycles, the adsorption capacity of FM-MBC for phosphate ions decreased from 96.08 to 72.88% (Fig. ##SUPPL##0##S4##). This decrease may be attributed to attractive sites that cannot be completely reversed during desorption. Specifically, some adsorbed phosphate ions are located deep inside the FM-MBC and exhibit strong adhesion to the adsorbent, decreasing the number of effective active adsorption sites<sup>##UREF##20##34##</sup>. Although the adsorption capacity of FM-MBC decreases with the increase of recycling times, the phosphorus removal efficiency after four consecutive recoveries is more than 72%, indicating that iron-manganese-modified biochar has high reusability and is a promising phosphorus adsorbent.</p>", "<title>Phosphorus removal from actual wastewater</title>", "<p id=\"Par27\">In this study, we aim to investigate the suitability of the FM-MBC composite for widespread phosphorus adsorption. Actual samples were taken from four different sources, including river water (RW), agricultural wastewater (AW), municipal wastewater (MW), and pharmaceutical wastewater (PW). After filtration, each sample, with initial phosphate concentrations of 10 and 30 mg L<sup>−1</sup>, was treated with 2.0 g of the FM-MBC composite. Subsequently, we assessed the efficacy of phosphate ion removal.</p>", "<p id=\"Par28\">The percentage of phosphate removal from the collected samples followed a specific order: river water &gt; agricultural wastewater &gt; municipal wastewater &gt; pharmaceutical wastewater. As depicted in Fig. ##FIG##5##6##a, the FM-MBC composite showed high adsorption capabilities, removing more than 98.1%, 95.5%, 92.6%, and 89.3% of 10 mg L<sup>−1</sup> phosphorus after 240 min for samples obtained from river water, agricultural wastewater, municipal wastewater, and pharmaceutical wastewater, respectively. However, when the initial phosphorus concentration increased to 30 mg L<sup>−1</sup>, the percentage of phosphorus removal decreased in the same pattern for all sources. The above results suggest that the FM-MBC composite exhibits promising potential for efficiently removing phosphate from water samples.</p>", "<title>Phosphorus removal mechanism</title>", "<p id=\"Par29\">The EDS spectrum depicted in Fig. ##FIG##5##6##b illustrates the changes in the elemental composition of FM-MBC following phosphorus adsorption. A comparison with Fig. ##FIG##1##2##b reveals a significant increase in the oxygen percentage from 7.02 to 22.31% in FM-MBC. Additionally, the ratio of Mn and Fe decreased from 15.57 to 9.88% and from 47.62 to 34.24%, respectively. Notably, the EDS spectrum of FM-MBC did not exhibit any phosphorus peak; While, a distinct peak characteristic of phosphorus is observed after phosphorus adsorption. This confirms the presence of phosphorus on the surface of FM-MBC following the adsorption process. These findings suggest that surface adsorption or ion exchange may account for removing phosphorus from the solution. Under acidic conditions, FM-MBC illustrates effective adsorption of phosphate ions, primarily through electrostatic attraction. The XRD pattern of the FM-MBC composite was obtained after impregnation in a phosphate solution (Fig. ##FIG##5##6##c). The three peaks observed at 2θ = 25.7°, 29.5°, and 34.1° correspond to Fe<sub>3</sub>(PO<sub>4</sub>)<sub>2</sub>·H<sub>2</sub>O, indicating the formation of iron phosphate precipitation. Although manganese phosphate precipitation could also theoretically form, its content may be low and undetectable by XRD.</p>", "<p id=\"Par30\">It can be seen from the XPS spectrum (Fig. ##SUPPL##0##S1##a and Table ##TAB##2##3##) before adsorption that the prominent element peaks are Fe2p (7.19%), Mn2p (3.16%), O1s (26.98%), C1s (60.72%), and no phosphorus is detected. There are more phosphorus peaks on the FM-MBC after phosphorus adsorption, which indicates that a certain amount of phosphorus is adsorbed on the surface of the adsorbent. It can be seen from Table ##TAB##2##3## that the surface elements of FM-MBC after phosphorus adsorption have specific changes, which are Fe2p (5.29%), Mn2p (1.3%), O1s (27.31%), C1s (60.72%) and P2p (3.29%), respectively. At high pH, the content of Fe and Mn decreased, and carbon elements remained unchanged, indicating that iron and manganese oxides participated in the chemical reaction during the adsorption process (Fig. ##FIG##5##6##d). The result was consistent with the results of EDS spectra of FM-MBC.</p>" ]
[ "<title>Results and discussions</title>", "<title>Material characterizations</title>", "<p id=\"Par13\">The SEM images of the FM-MBC at 1000 × and 5000 × magnification are presented in Fig. ##FIG##1##2##a, b, respectively. The surface appears flat, and the pore structure exhibits a honeycomb pattern. The internal structure of the pore was observed clearly in Fig. ##FIG##1##2##b. Upon closer examination, it is evident that there are substances loaded on both the surface and pores of FM-MBC. These substances have been identified as iron and manganese oxides, as confirmed by EDS analysis (Fig. ##FIG##1##2##b). The properties of FM-MBC are summarized in Table ##SUPPL##0##S1##. The XPS and XRD of FM-MBC are shown in Fig. ##SUPPL##0##S1##a, b. Notably, the surface area of FM-MBC is remarkably high 318.53 m<sup>2</sup> g<sup>−1</sup>, which indicates that FM-MBC is an excellent adsorbent. The pore size distribution of FM-MBC is primarily concentrated in the range of 2 ~ 40 nm (Fig. ##FIG##1##2##d), with a majority of mesopores and a smaller proportion of micropores and macropores, indicating a typical mixed structure. It is worth noting that the surface area of an adsorbent is a key determinant of its sorption capacity.</p>", "<title>Effects of operating parameters</title>", "<title>Effect of solution pH</title>", "<p id=\"Par14\">The solution pH is a crucial parameter in the adsorption process, which influences the physicochemical properties of the interaction between substances and the adsorbent in the solution. The solution pH affects the mechanism by which the solid adsorbent interacts with the concrete surface<sup>##REF##22189077##22##</sup>. The charge properties of the adsorbent surface play a significant role in determining the ionization state of the functional groups on the adsorbent surface. The zero point charge (pH<sub>pzc</sub>) of FM-MBC was measured to be 5.64 (Fig. ##SUPPL##0##S2##). The pH<sub>pzc</sub> is the pH at which the adsorbent surface has no net charge. With conditions of pH &lt; pHpzc, the functional groups on the FM-MBC surface are protonated and carry positive charges, which is favorable for the adsorption of the anionic phosphate species (mainly H<sub>2</sub>PO<sub>4</sub><sup>-</sup>). The effect of pH on the dynamic adsorption of phosphate by FM-MBC is shown in Fig. ##FIG##2##3##. When the solution pH is 3.0, 4.5, and 6.0, and the breakthrough time (<italic>t</italic><sub><italic>b</italic></sub>) is 124, 53, and 17 min, and then the exhaustion time (<italic>t</italic><sub><italic>e</italic></sub>) is 397, 200, and 126 min (Fig. ##FIG##2##3##a), respectively. When the pH increases from 3.0 to 6.0, both <italic>t</italic><sub><italic>b</italic></sub> and <italic>t</italic><sub><italic>e</italic></sub> of the adsorption column are shorter. This indicates that acidic conditions are favorable for phosphorus adsorption, which is consistent with the batch adsorption experimental results reported by Nguyen<sup>##REF##25847314##23##</sup>. This may be because, in an acidic medium (pH = 3), phosphate species mainly exist in the form of H<sub>2</sub>PO<sub>4</sub><sup>-</sup> / HPO<sub>4</sub><sup>2−</sup>, and H<sub>2</sub>PO<sub>4</sub><sup>−</sup> / HPO<sub>4</sub><sup>2−</sup> are adsorbed on the FM-MBC surface due to electrostatic interactions with the cationic functional groups<sup>##REF##25847314##23##</sup>. Electrostatic attraction is one of the adsorption mechanisms of FM-MBC for phosphate<sup>##REF##25847314##23##</sup>.</p>", "<title>Initial phosphorus concentration</title>", "<p id=\"Par15\">It has been reported that the initial phosphorus concentration of the influent also affects the breakthrough curve<sup>##UREF##13##24##</sup>. The effect of initial phosphorus concentration (10, 20, and 30 mg L<sup>−1</sup>) on the breakthrough curve (C<sub>t</sub>/C<sub>0</sub>) is shown in Fig. ##FIG##2##3##b. As shown in Fig. ##FIG##2##3##b, when the initial phosphorus concentration is 10, 20, and 30 mg L<sup>−1</sup>, and <italic>t</italic><sub><italic>b</italic></sub> is 484, 124, and 90 min, and then <italic>t</italic><sub><italic>e</italic></sub> is 785, 397, and 255 min, respectively. Within the range of initial phosphorus concentration of 10–30 mg L<sup>−1</sup>, the breakthrough time slightly decreases with increasing phosphorus concentration. When the initial phosphorus concentration of the influent is low, the breakthrough curve is more dispersed and the breakthrough rate is slower. This may be due to the decrease in diffusion coefficient or mass transfer coefficient caused by a lower concentration gradient, resulting in a slower rate of mass transfer. The higher the initial phosphorus concentration of the influent, the steeper the slope of the breakthrough curve and the shorter the breakthrough time<sup>##REF##25847314##23##</sup>. The results indicate that the change in concentration gradient affects the saturation and breakthrough time of the reaction; in other words, the diffusion process is related to the initial solution concentration. With the increase in the initial influent concentration, the loading rate of phosphate increases, and the driving force for mass transfer increases. The adsorption capacity increases with the addition of influent concentration because the high concentration difference provides a more significant driving force for the adsorption process<sup>##REF##19883979##25##</sup>.</p>", "<title>Effect of flow rate</title>", "<p id=\"Par16\">The breakthrough curves (C<sub>t</sub>/C<sub>0</sub>) of phosphate on FM-MBC at different solution flow rates are shown in Fig. ##FIG##2##3##c. With the increase in solution flow rate, the slope of the effluent curve increases and the time to reach the breakthrough point and saturation point decreases. When the solution flow rate is 1.0, 2.0, and 3.0 mL min<sup>−1</sup>, and <italic>t</italic><sub><italic>b</italic></sub> is 469, 124, and 76 min, and then <italic>t</italic><sub><italic>e</italic></sub> is 808, 397, and 151 min, respectively. This may be due to the difference in solution flow rate leading to changes in Reynolds number. The Reynolds number increases with the increase in solution flow rate. When the Reynolds number is high, the residence time of the adsorbate in the column is insufficient to establish adsorption equilibrium, so the solution leaves the fixed bed before reaching equilibrium, resulting in a shorter breakthrough time. On the other hand, a lower flow rate provides a longer contact time between the phosphate and the adsorbent, resulting in better removal of phosphate in the column<sup>##UREF##14##26##</sup>.</p>", "<title>Effect of bed height</title>", "<p id=\"Par17\">The effect of adsorbent bed height on the breakthrough curve of dynamic adsorption of phosphate by FM-MBC is shown in Fig. ##FIG##2##3##d. The breakthrough curve changes with the variation of bed height, and the change in the breakthrough curve conforms to the S-shaped curve characteristic of an ideal adsorption system. In addition, at a bed height of 2 cm, the effluent concentration increases rapidly, while at a bed height of 4 cm, the S-profile is more pronounced. When the bed height decreases, the axial dispersion phenomenon dominates the mass transfer process, reducing the diffusion of ions, and the solute does not have enough time to diffuse into the entire mass of the adsorbent. With the increase in adsorbent bed height, the adsorption rate of phosphate decreases, the slope of the effluent curve decreases, the contact time between FM-MBC and phosphate increases, and the time to reach the breakthrough point and saturation point is prolonged, thereby increasing the removal efficiency of phosphate in the column. The bed height is 2.0, 3.0, and 4.0 cm, and <italic>t</italic><sub><italic>b</italic></sub> is 58, 124, and 321 min, and then <italic>t</italic><sub><italic>e</italic></sub> is 961, 397, and 273 min, respectively. The reason is that the increase in bed height increases the specific surface area and the tortuosity of the fluid channels in the fixed bed, providing more active sites for the adsorption process. The experimental adsorption capacities have been compared with those reported by other authors in similar studies are presented in Table ##TAB##0##1##.</p>", "<title>Breakthrough curve modeling</title>", "<p id=\"Par18\">In dynamic adsorption studies for industrial applications, various mathematical models have been developed to describe and analyze the adsorption process. These mathematical models provide a simplified representation of the adsorption behavior and can be used to fit experimental data and predict the breakthrough curve and adsorption capacity<sup>##REF##22189077##22##</sup>. In this study, the Adams-Bohart, Thomas, and Yoon-Nelson models were used to fit the experimental data and predict the breakthrough curve and adsorption capacity.</p>", "<title>Adams-Bohart model</title>", "<p id=\"Par19\">Adams-Bohart established an equation based on surface reaction theory to describe the relationship between the concentration ratio (<italic>C</italic><sub><italic>0</italic></sub>/<italic>C</italic><sub><italic>t</italic></sub>) and time (<italic>t</italic>) in a continuous system<sup>##REF##22189077##22##</sup>. According to Eq. (##SUPPL##0##S2##), nonlinear regression was performed using the sampling time (t) as the x-axis and the natural logarithm of the concentration ratio (<italic>C</italic><sub><italic>t</italic></sub>/<italic>C</italic><sub><italic>0</italic></sub>) as the y-axis (Fig. ##FIG##3##4##a–d). The Adams-</p>", "<p id=\"Par20\">Bohart model parameters (K<sub>AB</sub> and N<sub>0</sub>) were obtained at different process variables, which are listed in Table ##TAB##1##2##. As the flow rate increases from 1.0 to 3.0 mL min<sup>-1</sup>, the K<sub>AB</sub> increases with the flow rate but decreases with the addition of adsorbent bed height. The range of R<sup>2</sup> obtained in this study (0.9249–0.9819) is similar to the results reported by the Chen group<sup>##REF##22189077##22##</sup> and Ramirez et al.<sup>##UREF##18##31##</sup>. This indicates that in the initial stage of adsorption in the column, the overall system dynamics are primarily controlled by external mass transfer<sup>##REF##19883979##25##</sup>. The correlation coefficient of the nonlinear model was greater than 0.9249 in most cases, which implies an excellent similarity with the experimental data.</p>", "<title>Thomas model</title>", "<p id=\"Par21\">The Thomas model is a widely used dynamic adsorption model for describing breakthrough curves and predicting the adsorption capacity of adsorbents in fixed-bed systems. It assumes no axial diffusion in the adsorption process<sup>##REF##31030076##32##</sup>. According to Eq. (##SUPPL##0##S3##), nonlinear regression was performed using the sampling time as the x-axis and the natural logarithm of the concentration ratio <italic>C</italic><sub><italic>t</italic></sub>/<italic>C</italic><sub><italic>0</italic></sub> as the y-axis (Fig. ##FIG##3##4##e–h). The parameters (K<sub>TH</sub> and q<sub>0</sub>) of the nonlinear regression analysis are presented in Table ##TAB##1##2##. The results show that the fitting effect of the Thomas model (R<sup>2</sup> range: 0.9684–0.9963) was better than that of the Adams-Bohart model. According to Table ##TAB##1##2##, as the solution flow rate increases from 1.0 to 3.0 mL min<sup>−1</sup>, the K<sub>TH</sub> increases with the flow rate, while the q<sub>0</sub> decreases with the addition in flow rate. The decrease in q<sub>0</sub> can be attributed to the lower availability of active sites at higher flow rates<sup>##UREF##18##31##</sup>.</p>", "<title>Yoon-Nelson model</title>", "<p id=\"Par22\">The Yoon-Nelson model is a classic dynamic adsorption model with a simple expression<sup>##UREF##18##31##</sup>. However, it is only applicable for describing the adsorption process of simple component adsorption systems. According to Eq. (##SUPPL##0##S4##), nonlinear regression was performed with sampling time t as the x-axis and C<sub>t</sub>/C<sub>0</sub> as the y-axis (Fig. ##FIG##3##4##i–l). The Yoon-Nelson model parameters obtained by the nonlinear regression are presented in Table ##TAB##1##2##. As the flow rate increases from 1.0 to 3.0 mL min<sup>−1</sup>, the <italic>K</italic><sub><italic>YN</italic></sub> decreases with the increase of bed height but increases with the addition of flow rate. The adsorbent material quickly reaches saturation as the flow rate increases<sup>##UREF##18##31##</sup>. The <italic>τ</italic> decreases with the addition of flow rate and initial phosphate concentration, then increases with the addition of adsorbent bed height. This is because the column reaches saturation faster at a higher initial phosphate concentration and flow rate<sup>##REF##31030076##32##</sup>. The range of <italic>R</italic><sup><italic>2</italic></sup> is 0.9684–0.9999, which is lower than that of the Thomas model.</p>", "<title>BDST model analysis</title>", "<p id=\"Par23\">The relationship between fixed-bed breakthrough time and adsorbent bed height was investigated further in this study (Supplementary Material ##SUPPL##0##S4##). The variation in the service time of the column was studied for two different values of C<sub>t</sub>/C<sub>0</sub> (0.05 and 0.95), as shown in Fig. ##FIG##4##5##. The high correlation coefficients (R<sup>2</sup> &gt; 0.9119) indicate that the BDST model accurately interprets the breakthrough characteristics of phosphate on the FM-MBC adsorbent. The results of each parameter are summarized in Table ##SUPPL##0##S3##.</p>", "<p id=\"Par24\">At a flow rate of 2.0 mL min<sup>−1</sup>, the measured breakthrough time had the most average relative error (23.39%) compared to the predicted breakthrough time. Conversely, the flow rate of 2.0 mL min<sup>-1</sup> had the lowest error (5.83%). This discrepancy can be attributed to the increased contact time between the phosphate and FM-MBC at low flow rates, allowing sufficient time for internal diffusion. However, it should be noted that the BDST model is established based on the assumption of ignoring internal diffusion.</p>", "<title>Comparative analysis of breakthrough models</title>", "<p id=\"Par25\">Linear and nonlinear fitting methods were employed in the aforementioned Adams-Bohart, Thomas, and Yoon-Nelson models, and their correlation coefficients (0.9249 ≤ R<sup>2</sup> ≤ 0.9999) were subsequently compared, which showed that nonlinear regression is most appropriate for the analysis of the dynamic adsorption models<sup>−</sup><sup>##REF##22189077##22##</sup>. The range of R<sup>2</sup> values obtained for the Thomas model indicates a better fit than the Adams-Bohart model. Moreover, the BDST model also correlated well with the experimental data (Table ##SUPPL##0##S3##). In contrast, the R<sup>2</sup> values of the Thomas and Yoon-Nelson models showed slight variation (0.9684 ≤ R<sup>2</sup> ≤ 0.9963 and 0.9819 ≤ R<sup>2</sup> ≤ 0.9999), indicating that the dynamic adsorption process of FM-MBC was more complex. Comprehensive comparison, and complete consideration of the breakthrough properties and parameters were necessary, rather than relying solely on one model. Furthermore, the outcomes of the linear fitting method were contrasted with the Supplementary Materials (Fig. ##SUPPL##0##S3## and Table ##SUPPL##0##S2##), along with their corresponding parameters.</p>", "<title>Regeneration performance</title>", "<p id=\"Par26\">The saturated adsorbent was recycled four times using 0.1 mol L<sup>−1</sup> NaOH and HCl, as shown in Fig. ##SUPPL##0##S4##. After each desorption, the adsorption capacity of phosphorus decreased to some extent. This decrease can be attributed to the strong binding of some phosphate ions, which penetrate the interior of the adsorbent, making it difficult to achieve 100% desorption efficiency<sup>##UREF##19##33##</sup>. Specifically, after three consecutive cycles, the adsorption capacity of FM-MBC for phosphate ions decreased from 96.08 to 72.88% (Fig. ##SUPPL##0##S4##). This decrease may be attributed to attractive sites that cannot be completely reversed during desorption. Specifically, some adsorbed phosphate ions are located deep inside the FM-MBC and exhibit strong adhesion to the adsorbent, decreasing the number of effective active adsorption sites<sup>##UREF##20##34##</sup>. Although the adsorption capacity of FM-MBC decreases with the increase of recycling times, the phosphorus removal efficiency after four consecutive recoveries is more than 72%, indicating that iron-manganese-modified biochar has high reusability and is a promising phosphorus adsorbent.</p>", "<title>Phosphorus removal from actual wastewater</title>", "<p id=\"Par27\">In this study, we aim to investigate the suitability of the FM-MBC composite for widespread phosphorus adsorption. Actual samples were taken from four different sources, including river water (RW), agricultural wastewater (AW), municipal wastewater (MW), and pharmaceutical wastewater (PW). After filtration, each sample, with initial phosphate concentrations of 10 and 30 mg L<sup>−1</sup>, was treated with 2.0 g of the FM-MBC composite. Subsequently, we assessed the efficacy of phosphate ion removal.</p>", "<p id=\"Par28\">The percentage of phosphate removal from the collected samples followed a specific order: river water &gt; agricultural wastewater &gt; municipal wastewater &gt; pharmaceutical wastewater. As depicted in Fig. ##FIG##5##6##a, the FM-MBC composite showed high adsorption capabilities, removing more than 98.1%, 95.5%, 92.6%, and 89.3% of 10 mg L<sup>−1</sup> phosphorus after 240 min for samples obtained from river water, agricultural wastewater, municipal wastewater, and pharmaceutical wastewater, respectively. However, when the initial phosphorus concentration increased to 30 mg L<sup>−1</sup>, the percentage of phosphorus removal decreased in the same pattern for all sources. The above results suggest that the FM-MBC composite exhibits promising potential for efficiently removing phosphate from water samples.</p>", "<title>Phosphorus removal mechanism</title>", "<p id=\"Par29\">The EDS spectrum depicted in Fig. ##FIG##5##6##b illustrates the changes in the elemental composition of FM-MBC following phosphorus adsorption. A comparison with Fig. ##FIG##1##2##b reveals a significant increase in the oxygen percentage from 7.02 to 22.31% in FM-MBC. Additionally, the ratio of Mn and Fe decreased from 15.57 to 9.88% and from 47.62 to 34.24%, respectively. Notably, the EDS spectrum of FM-MBC did not exhibit any phosphorus peak; While, a distinct peak characteristic of phosphorus is observed after phosphorus adsorption. This confirms the presence of phosphorus on the surface of FM-MBC following the adsorption process. These findings suggest that surface adsorption or ion exchange may account for removing phosphorus from the solution. Under acidic conditions, FM-MBC illustrates effective adsorption of phosphate ions, primarily through electrostatic attraction. The XRD pattern of the FM-MBC composite was obtained after impregnation in a phosphate solution (Fig. ##FIG##5##6##c). The three peaks observed at 2θ = 25.7°, 29.5°, and 34.1° correspond to Fe<sub>3</sub>(PO<sub>4</sub>)<sub>2</sub>·H<sub>2</sub>O, indicating the formation of iron phosphate precipitation. Although manganese phosphate precipitation could also theoretically form, its content may be low and undetectable by XRD.</p>", "<p id=\"Par30\">It can be seen from the XPS spectrum (Fig. ##SUPPL##0##S1##a and Table ##TAB##2##3##) before adsorption that the prominent element peaks are Fe2p (7.19%), Mn2p (3.16%), O1s (26.98%), C1s (60.72%), and no phosphorus is detected. There are more phosphorus peaks on the FM-MBC after phosphorus adsorption, which indicates that a certain amount of phosphorus is adsorbed on the surface of the adsorbent. It can be seen from Table ##TAB##2##3## that the surface elements of FM-MBC after phosphorus adsorption have specific changes, which are Fe2p (5.29%), Mn2p (1.3%), O1s (27.31%), C1s (60.72%) and P2p (3.29%), respectively. At high pH, the content of Fe and Mn decreased, and carbon elements remained unchanged, indicating that iron and manganese oxides participated in the chemical reaction during the adsorption process (Fig. ##FIG##5##6##d). The result was consistent with the results of EDS spectra of FM-MBC.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par31\">The study investigated the dynamic adsorption of phosphate ions in aqueous solution using the FM-MBC. Iron and manganese oxides loaded on both the surface and pores of FM-MBC by SEM-EDS, XPS and BET analysis. The removal of phosphate ions from water through fixed-bed dynamic adsorption was influenced by several factors, including solution pH, adsorbent bed height, initial phosphate concentration, and flow rate. Under the optimal condition (initial phosphate concentration = 30 mg L<sup>−1</sup>, pH = 3.0, bed height = 2.0 cm, and flow rate = 3.0 mL min<sup>−1</sup>), the phosphate adsorption capacity was found to be 22.11 mg g<sup>-1</sup>. Furthermore, the solution pH significantly influenced the adsorption capacity of FM-MBC for phosphate ions.</p>", "<p id=\"Par32\">The dynamic adsorption experimental data were fitted with four different models: Thomas, Yoon-Nelson, Adams-Bohart, and BDST. The R<sup>2</sup> values for the nonlinear regression ranged from 0.9249 to 0.9999, which showed that nonlinear regression is most appropriate for analyzing the dynamic adsorption models. The R<sup>2</sup> values of the Thomas and Yoon-Nelson models showed slight variation (0.9684 ≤ R<sup>2</sup> ≤ 0.9963 and 0.9819 ≤ R<sup>2</sup> ≤ 0.9999), indicating that the dynamic adsorption process of FM-MBC was more complex. Additionally, the study evaluated the regeneration performance of FM-MBC. After four desorption and regeneration cycles, the result suggests that FM-MBC can be effectively regenerated and reused using 0.1 mol L<sup>−1</sup> NaOH solution. The XRD analysis demonstrated that the reaction product between FM-MBC composite and phosphate anions was Fe<sub>3</sub>(PO<sub>4</sub>)<sub>2</sub>·H<sub>2</sub>O, with the dominant adsorption mechanism being a chemical adsorption reaction. Lastly, the present study proposes that FM-MBC composite is a recyclable adsorbent for removing phosphorus-containing wastewater.</p>" ]
[ "<p id=\"Par1\">In this study, the Fe–Mn oxide/mulberry stem biochar composite adsorbent (FM-MBC) was prepared and fully characterized by SEM-EDS, XRD, BET, and XPS. The solution pH (3.0, 4.5, and 6.0), initial concentration of phosphorus (10, 20, and 30 mg L<sup>−1</sup>), adsorbent bed height (2, 3, and 4 cm), and solution flow rate (1, 2, and 3 mL min<sup>−1</sup>) were investigated to analyze the breakthrough curves. The results showed that the breakthrough time was shortened as the initial phosphorus concentration, the flow rate increased and the bed height decreased. Higher initial phosphorus concentrations, flow rates, and lower bed heights, led to a faster breakthrough of phosphate ions in the FM-MBC adsorbent. Additionally, it was observed that increasing the pH value was not conducive to the adsorption of phosphorus by the FM-MBC adsorbent. Dynamic adsorption data were fitted to four models (Yoon-Nelson, Thomas, Adams-Bohart, and Bed Depth Service Time), and the R<sup>2</sup> values of the Thomas and Yoon-Nelson models exhibited minimal variation, suggesting that the dynamic adsorption process of FM-MBC was rather intricate. The saturated fixed-bed column (including FM-MBC) was regenerated with NaOH or HCl, and it was found that a 0.1 mol L<sup>−1</sup> NaOH solution had the best regeneration effect. XRD analysis showed that the reaction product between the FM-MBC composite and phosphate anions was Fe<sub>3</sub>(PO<sub>4</sub>)<sub>2</sub>·H<sub>2</sub>O. Moreover, the experimental results that FM-MBC can successfully be used to remove phosphorus from actual wastewater.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51416-w.</p>", "<title>Acknowledgements</title>", "<p>The research was financially supported by the Natural Science Foundation of China (52260024) and the Guangxi Key Research and Development Program (Guike AB21220006).</p>", "<title>Author contributions</title>", "<p>M.L.: Resources, Investigation, Project administration, Funding acquisition. M.Q.: Experimental, Investigation. Q.Z.: Conceptualization, Writing-original draft, Formal analysis, Visualization, Investigation, Writing-review &amp; editing. S.X.: Experimental, Investigation. D.W.: Resources, Funding acquisition.</p>", "<title>Data availability</title>", "<p>The datasets supporting the study's findings are available from the corresponding author upon reasonable request.</p>", "<title>Competing interests</title>", "<p id=\"Par33\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Dynamic adsorption experiment equipment.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>The SEM images at 1000x (<bold>a</bold>) and 5000x (<bold>b</bold>), N<sub>2</sub> adsorption–desorption isotherms and pore size distribution (<bold>c</bold>, <bold>d</bold>).</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Effect of pH (<bold>a</bold>), initial P concentration (<bold>b</bold>), flow rate (<bold>c</bold>), and bed height (<bold>d</bold>) in the breakthrough curves for the adsorption of phosphorus in FM-MBC.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Adams-Bohart, Thomas model and Yoon-Nelson model fitting curves of different solution pH, initial phosphorus concentration, bed height and flow rates (<bold>a</bold>–<bold>d</bold>: Adams-Bohart model, <bold>e</bold>–<bold>h</bold>: Thomas model, <bold>i</bold>–<bold>l</bold>: Yoon-Nelson model).</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>BDST model fitting for C<sub>t</sub>/C<sub>0</sub> = 0.05 and C<sub>t</sub>/C<sub>0</sub> = 0.95 saturation at various bed depths.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Removal efficiency of phosphorus from actual samples (<bold>a</bold>), phosphorus removal mechanisms by FM-MBC composite (<bold>b</bold>, <bold>c</bold>, <bold>d</bold>). <italic>Note</italic> river water (RW), agricultural wastewater (AW), municipal wastewater (MW), and pharmaceutical wastewater (PW).</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Comparison of adsorption capacity of phosphorus for various adsorbent materials.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Adsorbent</th><th align=\"left\">Pollutant</th><th align=\"left\">q<sub>e</sub> (mg g<sup>-1</sup>)</th><th align=\"left\">References</th></tr></thead><tbody><tr><td align=\"left\">FM-MBC</td><td align=\"left\">Phosphorus</td><td char=\".\" align=\"char\">21.11</td><td align=\"left\">Present work</td></tr><tr><td align=\"left\">MgCl<sub>2</sub>-CeCl<sub>3</sub> modified wheat straw biochar</td><td align=\"left\">Phosphorus</td><td char=\".\" align=\"char\">7.74</td><td align=\"left\"><sup>##UREF##15##27##</sup></td></tr><tr><td align=\"left\">Epigallocatechin gallate-iron biochar</td><td align=\"left\">Phosphorus</td><td char=\".\" align=\"char\">4.61</td><td align=\"left\"><sup>##UREF##16##28##</sup></td></tr><tr><td align=\"left\">Ca-MBCs</td><td align=\"left\">Phosphorus</td><td char=\".\" align=\"char\">25.60</td><td align=\"left\"><sup>##UREF##17##29##</sup></td></tr><tr><td align=\"left\">Eupatorium adenophorum biochar</td><td align=\"left\">Phosphorus</td><td char=\".\" align=\"char\">2.32</td><td align=\"left\"><sup>##REF##34385126##30##</sup></td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Parameters of Adams-Bohart, Thomas, Yoon-Nelson and BDST model and model for dynamic adsorption of phosphate.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">C<sub>0</sub> (mg/L)</th><th align=\"left\" rowspan=\"2\">u (mL/min)</th><th align=\"left\" rowspan=\"2\">Z (cm)</th><th align=\"left\" rowspan=\"2\">pH</th><th align=\"left\" colspan=\"3\">Adams-Bohart model</th><th align=\"left\" colspan=\"3\">Thomas model</th><th align=\"left\" colspan=\"3\">Yoon-Nelson model</th></tr><tr><th align=\"left\">K<sub>AB</sub> × 10<sup>–3</sup> (mL/mg·min)</th><th align=\"left\">N<sub>0</sub> (mg/mL)</th><th align=\"left\">R<sup>2</sup></th><th align=\"left\">K<sub>TH</sub> × 10<sup>–3</sup> (mL/mg min)</th><th align=\"left\">q<sub>TH</sub> (mg/g)</th><th align=\"left\">R<sup>2</sup></th><th align=\"left\">K<sub>YN</sub> × 10<sup>–3</sup> (min<sup>-1</sup>)</th><th align=\"left\">τ (min)</th><th align=\"left\">R<sup>2</sup></th></tr></thead><tbody><tr><td align=\"left\">20</td><td align=\"left\">2</td><td align=\"left\">3</td><td char=\".\" align=\"char\">3.0</td><td char=\".\" align=\"char\">2.02</td><td char=\".\" align=\"char\">2.51</td><td char=\".\" align=\"char\">0.9835</td><td char=\".\" align=\"char\">1.65</td><td char=\".\" align=\"char\">4.94</td><td char=\".\" align=\"char\">0.9892</td><td char=\".\" align=\"char\">3.31</td><td char=\".\" align=\"char\">185.22</td><td char=\".\" align=\"char\">0.9892</td></tr><tr><td align=\"left\">20</td><td align=\"left\">2</td><td align=\"left\">3</td><td char=\".\" align=\"char\">4.5</td><td char=\".\" align=\"char\">1.61</td><td char=\".\" align=\"char\">1.60</td><td char=\".\" align=\"char\">0.9249</td><td char=\".\" align=\"char\">2.09</td><td char=\".\" align=\"char\">2.63</td><td char=\".\" align=\"char\">0.9883</td><td char=\".\" align=\"char\">4.19</td><td char=\".\" align=\"char\">98.50</td><td char=\".\" align=\"char\">0.9883</td></tr><tr><td align=\"left\">20</td><td align=\"left\">2</td><td align=\"left\">3</td><td char=\".\" align=\"char\">6.0</td><td char=\".\" align=\"char\">2.63</td><td char=\".\" align=\"char\">0.96</td><td char=\".\" align=\"char\">0.9504</td><td char=\".\" align=\"char\">3.22</td><td char=\".\" align=\"char\">1.57</td><td char=\".\" align=\"char\">0.9928</td><td char=\".\" align=\"char\">6.54</td><td char=\".\" align=\"char\">59.05</td><td char=\".\" align=\"char\">0.9928</td></tr><tr><td align=\"left\">10</td><td align=\"left\">2</td><td align=\"left\">3</td><td char=\".\" align=\"char\">3.0</td><td char=\".\" align=\"char\">2.77</td><td char=\".\" align=\"char\">1.71</td><td char=\".\" align=\"char\">0.9432</td><td char=\".\" align=\"char\">1.81</td><td char=\".\" align=\"char\">7.78</td><td char=\".\" align=\"char\">0.9892</td><td char=\".\" align=\"char\">1.94</td><td char=\".\" align=\"char\">582.77</td><td char=\".\" align=\"char\">0.9823</td></tr><tr><td align=\"left\">30</td><td align=\"left\">2</td><td align=\"left\">3</td><td char=\".\" align=\"char\">3.0</td><td char=\".\" align=\"char\">1.40</td><td char=\".\" align=\"char\">3.06</td><td char=\".\" align=\"char\">0.9818</td><td char=\".\" align=\"char\">1.34</td><td char=\".\" align=\"char\">5.77</td><td char=\".\" align=\"char\">0.9928</td><td char=\".\" align=\"char\">4.04</td><td char=\".\" align=\"char\">144.14</td><td char=\".\" align=\"char\">0.9915</td></tr><tr><td align=\"left\">20</td><td align=\"left\">1</td><td align=\"left\">3</td><td char=\".\" align=\"char\">3.0</td><td char=\".\" align=\"char\">1.29</td><td char=\".\" align=\"char\">2.76</td><td char=\".\" align=\"char\">0.9672</td><td char=\".\" align=\"char\">4.36</td><td char=\".\" align=\"char\">7.35</td><td char=\".\" align=\"char\">0.9963</td><td char=\".\" align=\"char\">3.71</td><td char=\".\" align=\"char\">551.32</td><td char=\".\" align=\"char\">0.9971</td></tr><tr><td align=\"left\">20</td><td align=\"left\">3</td><td align=\"left\">3</td><td char=\".\" align=\"char\">3.0</td><td char=\".\" align=\"char\">1.34</td><td char=\".\" align=\"char\">5.65</td><td char=\".\" align=\"char\">0.9818</td><td char=\".\" align=\"char\">3.95</td><td char=\".\" align=\"char\">3.95</td><td char=\".\" align=\"char\">0.9819</td><td char=\".\" align=\"char\">8.18</td><td char=\".\" align=\"char\">98.86</td><td char=\".\" align=\"char\">0.9819</td></tr><tr><td align=\"left\">20</td><td align=\"left\">2</td><td align=\"left\">2</td><td char=\".\" align=\"char\">3.0</td><td char=\".\" align=\"char\">1.66</td><td char=\".\" align=\"char\">3.07</td><td char=\".\" align=\"char\">0.9819</td><td char=\".\" align=\"char\">1.96</td><td char=\".\" align=\"char\">5.42</td><td char=\".\" align=\"char\">0.9922</td><td char=\".\" align=\"char\">3.94</td><td char=\".\" align=\"char\">135.54</td><td char=\".\" align=\"char\">0.9922</td></tr><tr><td align=\"left\">20</td><td align=\"left\">2</td><td align=\"left\">4</td><td char=\".\" align=\"char\">3.0</td><td char=\".\" align=\"char\">2.43</td><td char=\".\" align=\"char\">5.02</td><td char=\".\" align=\"char\">0.9621</td><td char=\".\" align=\"char\">0.76</td><td char=\".\" align=\"char\">9.02</td><td char=\".\" align=\"char\">0.9684</td><td char=\".\" align=\"char\">2.42</td><td char=\".\" align=\"char\">430.66</td><td char=\".\" align=\"char\">0.9999</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>The XPS peak spectral analysis before and after adsorption.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\"/><th align=\"left\" colspan=\"5\">Bond Energy (eV)</th><th align=\"left\" colspan=\"5\">Composition (%)</th></tr><tr><th align=\"left\">C1s</th><th align=\"left\">Fe2p</th><th align=\"left\">Mn2p</th><th align=\"left\">P2p</th><th align=\"left\">O1s</th><th align=\"left\">C1s</th><th align=\"left\">Fe2p</th><th align=\"left\">Mn2p</th><th align=\"left\">P2p</th><th align=\"left\">O1s</th></tr></thead><tbody><tr><td align=\"left\">Before</td><td char=\".\" align=\"char\">283.92</td><td char=\".\" align=\"char\">710.25</td><td char=\".\" align=\"char\">710.25</td><td char=\".\" align=\"char\">–</td><td char=\".\" align=\"char\">529.37</td><td char=\".\" align=\"char\">60.72</td><td char=\".\" align=\"char\">7.19</td><td char=\".\" align=\"char\">3.16</td><td char=\".\" align=\"char\">–</td><td char=\".\" align=\"char\">26.98</td></tr><tr><td align=\"left\">After</td><td char=\".\" align=\"char\">284.15</td><td char=\".\" align=\"char\">711.13</td><td char=\".\" align=\"char\">711.13</td><td char=\".\" align=\"char\">133.27</td><td char=\".\" align=\"char\">530.96</td><td char=\".\" align=\"char\">60.72</td><td char=\".\" align=\"char\">5.29</td><td char=\".\" align=\"char\">1.30</td><td char=\".\" align=\"char\">3.29</td><td char=\".\" align=\"char\">27.31</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>C<sub>0</sub> (mg L<sup>-1</sup>): initial concentration; u (mL min<sup>-1</sup>): flow rate; Z (cm): bed height; K<sub>AB</sub> (mL min<sup>-1</sup>mg<sup>-1</sup>): Adams-Bohart constant rate; N<sub>0</sub> (mg mL<sup>-1</sup>): saturation concentration of the column; q<sub>TH</sub> (mg g<sup>-1</sup>): adsorption capacity; K<sub>TH</sub> (mL mg<sup>-1</sup> h<sup>-1</sup>): Thomas constant rate; K<sub>YN</sub> (mL mg<sup>-1</sup> h<sup>-1</sup>): Yoon-Nelson constant rate.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51416_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51416_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51416_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51416_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51416_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2024_51416_Fig6_HTML\" id=\"MO6\"/>" ]
[ "<media xlink:href=\"41598_2024_51416_MOESM1_ESM.docx\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["1."], "surname": ["Ajmal", "Muhmood", "Dong"], "given-names": ["Z", "A", "R"], "article-title": ["Probing the efficiency of magnetically modified biomass-derived biochar for effective phosphate removal"], "source": ["J. Environ. Manag."], "year": ["2020"], "volume": ["253"], "fpage": ["109730"], "pub-id": ["10.1016/j.jenvman.2019.109730"]}, {"label": ["4."], "surname": ["Zhao", "Lai", "Li"], "given-names": ["Y", "GS", "C"], "article-title": ["Acid-resistant polyamine hollow fiber nanofiltration membrane for selective separation of heavy metals and phosphorus"], "source": ["Chem. Eng. J."], "year": ["2023"], "volume": ["453"], "fpage": ["139825"], "pub-id": ["10.1016/j.cej.2022.139825"]}, {"label": ["5."], "surname": ["Guida", "Rubertelli", "Jefferson"], "given-names": ["S", "G", "B"], "article-title": ["Demonstration of ion exchange technology for phosphorus removal and recovery from municipal wastewater"], "source": ["Chem. Eng. J."], "year": ["2021"], "volume": ["420"], "fpage": ["129913"], "pub-id": ["10.1016/j.cej.2021.129913"]}, {"label": ["6."], "surname": ["Preisner", "Smol"], "given-names": ["M", "M"], "article-title": ["Investigating phosphorus loads removed by chemical and biological methods in municipal wastewater treatment plants in Poland"], "source": ["J. Environ. Manag."], "year": ["2022"], "volume": ["322"], "fpage": ["116058"], "pub-id": ["10.1016/j.jenvman.2022.116058"]}, {"label": ["8."], "surname": ["Vymazal", "L\u00e1ska", "Hn\u00e1tkov\u00e1"], "given-names": ["J", "J", "T"], "article-title": ["The retention of nitrogen and phosphorus in aboveground biomass of plants growing in constructed wetlands treating agricultural drainage"], "source": ["Ecol. Eng."], "year": ["2023"], "volume": ["194"], "fpage": ["107044"], "pub-id": ["10.1016/j.ecoleng.2023.107044"]}, {"label": ["9."], "surname": ["Li", "Pang", "He"], "given-names": ["L", "H", "J"], "article-title": ["Characterization of phosphorus species distribution in waste activated sludge after anaerobic digestion and chemical precipitation with Fe"], "sup": ["3+", "2+"], "source": ["Chem. Eng. J."], "year": ["2019"], "volume": ["373"], "fpage": ["1279"], "lpage": ["1285"], "pub-id": ["10.1016/j.cej.2019.05.146"]}, {"label": ["11."], "surname": ["Cui", "Meng", "Zheng"], "given-names": ["L", "Q", "J"], "article-title": ["Adsorption of Cr(VI) on 1,2-ethylenediamine-aminated macroporous polystyrene particles"], "source": ["Vacuum"], "year": ["2013"], "volume": ["89"], "fpage": ["1"], "lpage": ["6"], "pub-id": ["10.1016/j.vacuum.2012.08.012"]}, {"label": ["12."], "surname": ["Li", "Gao", "Zhang"], "given-names": ["G", "S", "G"], "article-title": ["Enhanced adsorption of phosphate from aqueous solution by nanostructured iron(III)\u2013copper(II) binary oxides"], "source": ["Chem. Eng. J."], "year": ["2014"], "volume": ["235"], "fpage": ["124"], "lpage": ["131"], "pub-id": ["10.1016/j.cej.2013.09.021"]}, {"label": ["13."], "surname": ["Amiri"], "given-names": ["MJ"], "article-title": ["Synthesis and optimization of spherical nZVI (20\u201360nm) immobilized in bio-apatite-based material for efficient removal of phosphate: Box-Behnken design in a fixed-bed column"], "source": ["Environ. Sci. Pollut. Res."], "year": ["2022"], "volume": ["29"], "fpage": ["67751"], "lpage": ["67764"], "pub-id": ["10.1007/s11356-022-20565-8"]}, {"label": ["14."], "surname": ["Liao", "Yang", "Li"], "given-names": ["F", "L", "Q"], "article-title": ["Characteristics and inorganic N holding ability of biochar derived from the pyrolysis of agricultural and forestal residues in the southern China"], "source": ["J. Anal. Appl. Pyrolysis"], "year": ["2018"], "volume": ["134"], "fpage": ["544"], "lpage": ["551"], "pub-id": ["10.1016/j.jaap.2018.08.001"]}, {"label": ["15."], "surname": ["Breytus", "Hasson", "Semiat"], "given-names": ["A", "D", "R"], "article-title": ["Ion exchange membrane adsorption in Donnan dialysis"], "source": ["Sep. Purif. Technol."], "year": ["2019"], "volume": ["226"], "fpage": ["252"], "lpage": ["258"], "pub-id": ["10.1016/j.seppur.2019.05.084"]}, {"label": ["17."], "surname": ["Luo", "Wei", "Guo"], "given-names": ["Q", "J", "Z"], "article-title": ["Adsorption and immobilization of phosphorus from water and sediments using a lanthanum-modified natural zeolite: Performance, mechanism and effect"], "source": ["Sep. Purif. Technol."], "year": ["2024"], "volume": ["329"], "fpage": ["125187"], "pub-id": ["10.1016/j.seppur.2023.125187"]}, {"label": ["20."], "surname": ["Chatterjee", "Schiewer"], "given-names": ["A", "S"], "article-title": ["Biosorption of Cadmium(II) ions by citrus peels in a packed bed column: Effect of process parameters and comparison of different breakthrough curve models"], "source": ["CLEAN Soil Air Water"], "year": ["2011"], "volume": ["39"], "fpage": ["874"], "lpage": ["881"], "pub-id": ["10.1002/clen.201000482"]}, {"label": ["24."], "surname": ["Awual", "Jyo"], "given-names": ["MR", "A"], "article-title": ["Assessing of phosphorus removal by polymeric anion exchangers"], "source": ["Desalination"], "year": ["2011"], "volume": ["281"], "fpage": ["111"], "lpage": ["117"], "pub-id": ["10.1016/j.desal.2011.07.047"]}, {"label": ["26."], "surname": ["Khan", "Nazir"], "given-names": ["TA", "M"], "article-title": ["Enhanced adsorptive removal of a model acid dye bromothymol blue from aqueous solution using magnetic chitosan-bamboo sawdust composite: Batch and column studies"], "source": ["Environ. Prog. Sustain. Energy"], "year": ["2015"], "volume": ["34"], "fpage": ["1444"], "lpage": ["1454"], "pub-id": ["10.1002/ep.12147"]}, {"label": ["27."], "surname": ["Pan", "Xie", "Zhou"], "given-names": ["W", "H", "Y"], "article-title": ["Simultaneous adsorption removal of organic and inorganic phosphorus from discharged circulating cooling water on biochar derived from agricultural waste"], "source": ["J. Clean. Prod."], "year": ["2023"], "volume": ["383"], "fpage": ["135496"], "pub-id": ["10.1016/j.jclepro.2022.135496"]}, {"label": ["28."], "surname": ["Zhang", "Fan", "Wang"], "given-names": ["R", "Y", "L"], "article-title": ["Rapid adsorption of phosphorus at low concentration from water using a novel green organometallic material EGCG-Fe"], "source": ["J. Environ. Chem. Eng."], "year": ["2021"], "volume": ["9"], "fpage": ["106242"], "pub-id": ["10.1016/j.jece.2021.106242"]}, {"label": ["29."], "surname": ["Hu", "Wu", "Pang"], "given-names": ["Z", "R", "X"], "article-title": ["Adsorption of phosphorus in water by metal-modified large-size biochar: Realizing the recovery and recycling of phosphorus"], "source": ["Sustain. Chem. Pharm."], "year": ["2023"], "volume": ["36"], "fpage": ["101279"], "pub-id": ["10.1016/j.scp.2023.101279"]}, {"label": ["31."], "surname": ["Ramirez", "Giraldo", "Garc\u00eda-Nunez"], "given-names": ["A", "S", "J"], "article-title": ["Phosphate removal from water using a hybrid material in a fixed-bed column"], "source": ["J. Water Process Eng."], "year": ["2018"], "volume": ["26"], "fpage": ["131"], "lpage": ["137"], "pub-id": ["10.1016/j.jwpe.2018.10.008"]}, {"label": ["33."], "surname": ["Sun", "Feng", "Zhang"], "given-names": ["H", "D", "Y"], "article-title": ["Regeneration of deactivated biochar for catalytic tar reforming by partial oxidation: Effect of oxygen concentration and regeneration time"], "source": ["Fuel"], "year": ["2022"], "volume": ["330"], "fpage": ["125572"], "pub-id": ["10.1016/j.fuel.2022.125572"]}, {"label": ["34."], "surname": ["Deng", "Fang", "Hou"], "given-names": ["J", "Y", "C"], "article-title": ["Ultrasonic assisted activation of persulfate for the treatment of spent porous biochar: Degradation of adsorbed PFOA and adsorbent regeneration"], "source": ["J. Environ. Chem. Eng."], "year": ["2023"], "volume": ["11"], "fpage": ["111146"], "pub-id": ["10.1016/j.jece.2023.111146"]}]
{ "acronym": [], "definition": [] }
34
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1235
oa_package/ae/df/PMC10786881.tar.gz
PMC10786882
38216608
[ "<title>Introduction</title>", "<p id=\"Par2\">Biologics are genetically engineered drugs used as vaccines, therapeutic proteins, monoclonal antibodies, immunomodulators, and growth factors<sup>##UREF##0##1##</sup>. They can be composed of sugars, proteins, nucleic acids, or complex combinations of these substances<sup>##UREF##1##2##</sup>. These agents are generally well tolerated; however, serious and unexpected adverse drug reactions have been reported, affecting various organ systems at different stages of biologic therapy<sup>##REF##25112605##3##</sup>. Such adverse drug events are often target-related and may be explained by the actions of the biological drug<sup>##REF##22819590##4##</sup>.</p>", "<p id=\"Par3\">Secukinumab is a fully humanized immunoglobulin G1 (IgG1) κ monoclonal antibody that inhibits the proinflammatory cytokine interleukin-17A (will be henceforth referred to as IL-17). The normal physiological and immunological functions of IL-17 include mucocutaneous defense<sup>##REF##19710487##5##</sup> and immunity against extracellular pathogens<sup>##REF##28713557##6##</sup>. However, autoimmunity is observed with unregulated levels of IL-17, which are observed in conditions such as psoriasis and the spondylarthritis family of diseases<sup>##REF##31278139##7##,##REF##30181299##8##</sup>. Unregulated levels of IL-17 have also been documented in immunopathological conditions and cancer progression<sup>##REF##25398491##9##</sup>. IL-17 as a novel pharmacological target has expanded the scope of drug development for various autoimmune diseases<sup>##UREF##2##10##</sup>, of which, secukinumab has proven efficacy in psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondylarthritis, and enthesis-related arthritis. Off-label use of secukinumab has also been reported in certain non-psoriatic dermatological conditions, such as hidradenitis suppurativa, pityriasis rubra pilaris, refractory spontaneous chronic urticaria, papulopustular rosacea, ABCA12 deficiency-related ichthyosis, and Bechet’s disease<sup>##REF##36355537##11##</sup>. Secukinumab has elicited a favorable safety profile in clinical trials, but concerns have been raised with higher incidences of inflammatory bowel disease (IBD) and candida infection<sup>##REF##31785165##12##</sup>. As the potential of IL-17 in other diseases is still being discovered, it is necessary to establish the safety profile of secukinumab comprehensively and address the adverse events that have occurred across all organ systems.</p>", "<p id=\"Par4\">Post-marketing studies using real-world data are a powerful tool for evaluating the safety profile of medications. Spontaneous reporting databases can be used to detect safety signals, especially for serious and rare adverse events<sup>##REF##16689555##13##</sup>. Performing a disproportionality analysis using the data from these databases can aid in establishing hypotheses of causality between the adverse event and the medication<sup>##REF##32008183##14##</sup>. The United States Food and Drug Administration Adverse Event Reporting System (FAERS) is one such spontaneous reporting system that contains publicly accessible data and is a good source for such disproportionality studies. Our study aimed to identify the potential signals of adverse events of secukinumab in a real-world scenario using the FAERS database. To differentiate the adverse events which are common to all antipsoriatic biologics from those specific to secukinumab, we compared the adverse event data for secukinumab with those of other biological and non-biological drugs used for treating psoriasis.</p>" ]
[ "<title>Methods</title>", "<p id=\"Par5\">This is a retrospective, case-non-case study using the US FAERS database. FAERS is a public database containing adverse event reports submitted by healthcare professionals, drug manufacturers, and consumers. The database contains individual case safety reports (ICSR) in ASCII and XML file formats, and these are updated quarterly<sup>##UREF##3##15##</sup>. Each quarterly ASCII file contains dollar sign delimited text files containing information on demographics (DEMO), drugs (DRUG), indication for drug use (INDI), outcome of the adverse event (OUTC), the adverse event (REAC), report source (RPSR), and therapy dates (THER)<sup>##UREF##3##15##</sup>. Since secukinumab was released in the year 2015<sup>##UREF##4##16##</sup>, the ASCII quarterly files from the years 2015 to 2021 were downloaded from the FAERS website for data mining and analysis. The downloaded text files were then exported to Microsoft Excel® (2019). The methodology of our study is summarized in Fig. ##FIG##0##1##. The study protocol was approved by Kasturba Medical College Institutional Ethics Committee (IEC KMC MLR 10/2021/318).</p>", "<title>Indications and suspect medications</title>", "<p id=\"Par6\">For this study, we included all ICSRs in which the suspected medications were indicated for treating psoriasis. The indication terms included were psoriasis, guttate psoriasis, pustular psoriasis, nail psoriasis, and erythrodermic psoriasis. The ICSRs containing these indication terms were identified from the INDI file. The Case IDs so obtained were used to identify the relevant ICSRs in the DRUG file. The drugs considered in this study were those recommended by the Joint American Academy of Dermatology-National Psoriasis Foundation Guidelines for the management of psoriasis; these consisted of biologics and systemic non-biologics that were approved by the US FDA for use in psoriasis<sup>##REF##30772098##17##,##REF##32119894##18##</sup>. The medications include biologics (adalimumab, brodalumab, certolizumab, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, secukinumab, tildrakizumab and ustekinumab) and non-biologics (acitretin, apremilast, cyclosporine, methotrexate/methotrexate sodium). The ICSRs containing one or more of these drugs listed as the primary or secondary suspect medication were identified, and the information for these case reports was consolidated from the various files to obtain complete information on each ICSR.</p>", "<title>Identification and grouping of adverse event terms of interest</title>", "<p id=\"Par7\">In the FAERS database, adverse events are listed using the Medical Dictionary for Regulatory Activities (MedDRA) Preferred Term (PT). PT is a distinct descriptor for a symptom, sign, disease diagnosis, therapeutic indication, investigation, surgical or medical procedure, and medical, social, or family history characteristic. There are 25,077 preferred terms coded by MedDRA. For analysis, the PTs were grouped based on the system organ class (SOC) and standardised MedDRA query (SMQ) terms. We used the MedDRA Desktop Browser (MedDRA Version 24.1) for grouping the PTs. Hence, each ICSR had one or more SOC and SMQ term(s) associated with it. SOCs function at the highest level of the adverse event term reporting hierarchy and provide the broadest concept for data retrieval based on aetiology, manifestation site, and purposes. An adverse event term may be assigned to multiple SOCs; only the primary SOC was considered for analysis. There are 27 SOC terms available, and disproportionality analysis was performed for each of these terms.</p>", "<p id=\"Par8\">SMQs are re-grouping of adverse event terms, ordinarily, at the PT level, that relate to a defined medical condition or area of interest. There are 109 individual SMQ terms available in MedDRA version 24.1. Sometimes, a certain adverse event may fit the criteria of more than one SMQ. This is handled by MedDRA by assigning different levels (level 1–level 5) of SMQ to an adverse event. In addition, each SMQ term has a narrow or broad scope. A narrow scope is highly likely to represent the condition of interest, whereas a broad scope is less specific. To avoid ambiguity between different levels of SMQs and their scope, we considered SMQ Level 1 terms with narrow scope for analysis (Supplementary Table ##SUPPL##0##S1##)<sup>##REF##36355537##11##</sup>. We also performed analysis at the PT level. We included only those PTs in the analysis that were reported in ≥ 100 ICSRs with secukinumab as a suspect medication.</p>", "<title>Deduplication</title>", "<p id=\"Par9\">In the data files, each ICSR is assigned a Primary ID, which is a concatenation of the case ID and the case version. To cleanse the consolidated data from duplicates, only the latest version of each ICSR was retained<sup>##UREF##3##15##</sup>. Furthermore, to avoid including duplicates of case reports that were reported by different sources and at different periods, thereby having been assigned different case IDs, deduplication was performed based on matching data for the following variables: event date, age, sex, reporter country, suspect drugs, and adverse event terms reported<sup>##REF##34552181##19##</sup>. Following deduplication, the ICSRs were divided into three groups for conducting disproportionality analysis based on the suspected medication: the first group consisted of ICSRs wherein secukinumab was a suspect medication, irrespective of the presence of other anti-psoriatic drugs; the second group consisted of ICSRs containing rest of the biologics of interest; the third group consisted of ICSRs for non-biological agents as a suspect medication. The deduplication and group-wise consolidation of the ICSRs were done using RStudio (Version 1.4.1717).</p>", "<title>Disproportionality analysis</title>", "<p id=\"Par10\">A disproportionality analysis determines whether there is disproportional reporting of a drug-adverse event combination compared with the occurrence of the adverse event with other drugs in the database<sup>##REF##21658092##20##</sup>. Our study objective was to determine whether the reporting of any SOC term/SMQ term/PT was disproportionately high in association with secukinumab use. This was determined by calculating the proportional reporting ratio (PRR) and reporting odds ratio (ROR). PRR is the proportion of specific reactions (or groups of reactions) for drugs of interest, where the comparator is all other drugs in the database<sup>##REF##11828828##21##</sup>. ROR is the ratio of an adverse event being reported in those who received the suspected medication to those who did not receive the suspected medication<sup>##REF##15317032##22##</sup>. The calculation of disproportionality was performed using a two-by-two contingency table (Table ##TAB##0##1##). PRR and ROR are analogous to relative risk and odds ratio<sup>##REF##15317032##22##</sup>. PRR &gt; 2 and ROR &gt; 2 with a lower bound 95% CI &gt; 1 were considered significant<sup>##REF##11828828##21##</sup>.</p>", "<title>Statistical analysis</title>", "<p id=\"Par11\">The clinical and demographic characteristics of the cases have been reported as median (interquartile range [IQR]). Categorical variables are reported as proportions and percentages. The data were analyzed using Microsoft Excel® (2019). In FAERS, age can be reported in multiple formats (year, decade, month, days); we only included those ICSRs where age was reported in years. The proportion of the male and female population along with their age characteristics was also analyzed. ICSRs with missing values for the variable of interest were excluded. Serious adverse event outcomes were acquired from the OUTC file; the outcomes could be death, life-threatening, hospitalization (initial or prolonged), disability, congenital anomaly, required intervention to prevent permanent impairment or damage (devices), and other serious (important medical events). A single ICSR may contain two or more reported outcomes; in such cases, each outcome was calculated separately.</p>" ]
[ "<title>Results</title>", "<title>Demographic and clinical characteristics</title>", "<p id=\"Par12\">During the period 2015–2021, 365,590 adverse event reports were received by FAERS from the use of drugs indicated in systemic therapy for psoriasis. Following case ID deduplication and multifield deduplication, the total number of reports was 319,345 and 256,337, respectively. Among these, 44,761 (17.45%), 144,725 (56.42%), and 67,005 (26.12%) ICSRs were associated with secukinumab, other biologics, and non-biologics, respectively. The distribution of ICSRs throughout the years is depicted in Fig. ##FIG##1##2##.</p>", "<p id=\"Par13\">The age and gender distribution of the 44,761 cases of adverse events associated with secukinumab use are shown in Table ##TAB##1##2##. The median age of the patients was 54 years (IQR, 44–63). Females represented 25,826 (56.49%) of the cases. 5124 (11.44%) cases were reported in the elderly population (≥ 65 years). The median duration of onset of AE from the time of initiation of secukinumab was 92 days (IQR, 21–326). Concomitant suspect medications were present in 4229 (9.4%) cases in the secukinumab group. Death was reported in 949 (2.1%) cases, 6591 (14.72%) were hospitalized, disability occurred in 586 (1.30%) cases, congenital anomaly in 14 (0.03%) cases, 11 (0.02%) cases required intervention, and 14,962 (33.42%) other serious adverse events were reported with the use of secukinumab. Of the 44,761 secukinumab-associated event reports, 8.24% were direct reports, 39.41% were expedited, and 52.35% were non-expedited; 58.75% reports were from consumers, 15.18% were from physicians, 2.79% were from pharmacists, and 23.28% were from others. Of the 144,725 aadverse event reports associated with other biologics, 9.30% were direct reports, 40.09% were expedited, and 50.61% were non-expedited; 49.64% reports were from consumers, 27.23% from physicians, 3.49% from pharmacists, and 19.64% from others. Of the 67,005 non-biologics-associated adverse event reports, 5.59% were direct reports, 17.06% were expedited, and 77.35% were non-expedited; 23.15% reports were from consumers, 18.96% from physicians, 16.74% from pharmacists, and 41.15% from others.</p>", "<p id=\"Par14\">The most commonly reported adverse events at the SOC level (Fig. ##FIG##2##3##a) were general disorders and administrative site conditions (18%) and skin and subcutaneous tissue disorder (13%); at the SMQ level (Fig. ##FIG##2##3##b), immune-mediated/autoimmune disorders (25%) and gastrointestinal nonspecific inflammation and dysfunctional conditions (12%). The most commonly reported adverse events at the preferred term level are shown in Fig. ##FIG##3##4##.</p>", "<title>Disproportionality analysis</title>", "<title>System organ class terms</title>", "<p id=\"Par15\">No disproportionate signal was observed when comparing secukinumab with other biologics (Supplementary Table ##SUPPL##0##S2##). When compared with non-biologics (Fig. ##FIG##4##5##, Supplementary Table ##SUPPL##0##S3##), disproportionate reporting (ROR) was observed in immune system disorders 3.84 (95% CI, 3.55–4.16); infections and infestations 3.55 (3.44–3.66); endocrine disorders 3.49 (2.79–4.38); congenital, familial and genetic disorders 2.63 (1.79–3.86); vascular disorders 2.56 (2.37–2.76); respiratory, thoracic and mediastinal disorders 2.56 (2.45–2.67); general disorders and administration site conditions 2.52 (2.46–2.59); pregnancy, puerperium and perinatal conditions 2.48 (2–3.08); and eye disorders 2.34 (2.15–2.55).</p>", "<title>Standardised MedDRA query terms</title>", "<p id=\"Par16\">A disproportionality signal (ROR) was observed in ocular infections 2.31 (95% CI, 1.96–2.74) and gastrointestinal nonspecific inflammation and dysfunctional conditions 2.16 (2.08–2.24) compared with the other biologics group (Supplementary Table ##SUPPL##0##S4##). When compared with non-biologics (Fig. ##FIG##5##6##, Supplementary Table ##SUPPL##0##S5##), several SMQs showed disproportionality. The SMQ terms with ROR &gt; 3 are extravasation events (injections, infusions and implants) 24.36 (8.87–66.87), ischaemic colitis 10.3 (4.91–21.63), haemolytic disorders 6.74 (2.78–16.33), systemic lupus erythematosus 5.78 (4.34–7.7), cardiomyopathy 5.76 (3.13–10.61), Guillain–Barre syndrome 5.69 (2.84–11.43), arthritis 4.73 (4.34–5.15), ocular infections 4.71 (3.63–6.12), premalignant disorders 4.56 (3.89–5.35), and haemorrhages 4.03 (3.77–4.31).</p>", "<title>Preferred terms</title>", "<p id=\"Par17\">The results of disproportionality analysis for preferred terms comparing secukinumab with other biologics and non-biologics are given in Supplementary Table ##SUPPL##0##S6##. Adverse events having the strongest signals (ROR &gt; 7) when compared with other biologics included concomitant disease aggravated with ROR 210.57 (95% CI, 78.43–565.32), macule 15.99 (12.49–20.47), pigmentation disorder 13.79 (9.59–19.82), movement disorder 13.54 (10.03–18.28), blood pressure systolic increased 11.73 (7.78–17.7), anosmia 10.56 (8.11–13.75), rebound psoriasis 9.91 (7.29–13.48), product prescribing error 9.41 (7.92–11.18), hypokinesia 8.47 (6.27–11.43), and aphthous ulcer 7.32 (5.18–10.37).</p>", "<p id=\"Par18\">The strongest disproportionality signals when compared with other non-biologics included (ROR &gt; 50) injection site bruising 216.91 (95% CI, 145.14–324.16), injection site haemorrhage 173.61 (98.34–306.52), injection site pruritus 210.02 (67.46–653.9), injection site pain77.22 (58.01–102.8), device malfunction 88.3 (43.89–177.62), product storage error 84.96 (37.9–190.48), therapeutic response shortened 54.41 (30.65–96.56), injection site erythema 47.8 (28.58–79.93), injection site swelling 51.28 (27.34–96.18), and device issue 51.07 (26.32–99.11).</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par19\">Our study assessed the safety profile of secukinumab using the FAERS database from 2015 to 2021. A steady increase in adverse event reports was observed year-on-year, which probably reflects the increasing use of the drug since its approval. Since an array of biological and non-biological drugs are used in the treatment of psoriasis, ICSRs containing secukinumab were compared with those of other biologicals approved for psoriasis and non-biological agents. Age distribution was similar among all the groups. Females represented approximately 55% of all safety reports. We performed disproportionality analysis at three levels: SOC, SMQ, and PT. Previous studies either focused on a specific adverse effect of secukinumab or analyzed the ICSRs irrespective of the indication for which the drug was used<sup>##REF##36569299##23##</sup>.</p>", "<p id=\"Par20\">Our study, which specifically looked at ICSRs reported in patients with psoriasis or related disorders, showed that, based on SOC, no disproportional reporting was observed when comparing secukinumab with other biological drugs. However, disproportional reporting was seen in comparison to non-biologics in the following: infection and infestation, immune system disorder, eye disorders, vascular disorder, endocrine disorder, general and administrative site disorders, and respiratory, thoracic, and mediastinal disorders. On analysis based on SMQ, although a large number of disproportionate reporting was seen compared to non-biologics, the disproportionate reporting was confined to gastrointestinal nonspecific inflammation and dysfunction conditions compared with other biologicals. These findings suggest that most of the adverse events with disproportionate reporting compared to the non-biologics are common to all biologics because there are no significant differences in the events reported with secukinumab and other biologics, except for certain gastrointestinal conditions and ocular disorders.</p>", "<p id=\"Par21\">Comparison at the PT level showed disproportionate reporting of several adverse event terms. In comparison with other biologicals, AE terms suggestive of infection, such as pyrexia, COVID-19, oral candidiasis, and erysipelas; AE terms suggestive of gastrointestinal disorders, such as diarrhoea, abdominal discomfort, haematochezia, diarrhoea haemorrhagic, colitis, colitis ulcerative, inflammatory bowel disease, irritable bowel syndrome; AE terms for ocular disorders, such as conjunctivitis and ocular hyperaemia; and AE terms suggestive of musculoskeletal/neurological disorders, such as musculoskeletal stiffness, spinal pain, dysstasia, ankylosing spondylitis, movement disorder, and hypokinesia, showed disproportionately high reporting. Other terms with high reporting included blood pressure systolic increased, panniculitis, angioedema, and liver injury.</p>", "<p id=\"Par22\">Among the ocular disorders, uveitis is of particular interest. Clinical trials and post-marketing studies have shown an exposure-adjusted incident rate of 0.01–0.02 per 100 patient-years in patients with psoriasis<sup>##UREF##5##24##,##REF##35146532##25##</sup>. Our study revealed disproportionate reporting of uveitis (ROR 13.98 [8.81–22.17]) in comparison with non-biologic drugs. It is unclear whether these cases can be ascribed to drug-induced infection, inflammation, or abnormal immune reaction. A disproportionate reporting of ocular infections was seen in comparison with other biologics as well as non-biologics; there is scarce literature on the occurrence of ocular infections associated with secukinumab or other interleukin-17 inhibitors. However, there are a few case reports of ocular infection caused by a virus (<italic>Herpes Simplex</italic>)<sup>##REF##34877851##26##</sup><italic>,</italic> fungus (<italic>Histoplasma capsulatum</italic>) <sup>##REF##34278048##27##</sup>, and bacteria (<italic>Staphylococcus aureus</italic> and nontuberculous mycobacterium)<sup>##REF##28947425##28##,##REF##35295037##29##</sup> manifesting as keratitis, scleritis, endophthalmitis, and uveitis, respectively. Interestingly, all the causative organisms from these case reports are known to be opportunistic pathogens, which further suggests the immunosuppressive actions of secukinumab to have possibly played a role in worsening or manifesting these infections. This fact is also supported by the finding in our study of decreased immune response with an ROR of 7.91 (6.69–9.35).</p>", "<p id=\"Par23\">The risk of infections with IL-17 inhibitors and other monoclonal antibodies is well documented. IL-17 is a proinflammatory cytokine involved in extracellular immunity and mucocutaneous defense<sup>##REF##28713557##6##</sup>. Our study showed disproportionate reporting of coronavirus infection in comparison with both other biologics and non-biologics. However, existing literature suggests secukinumab to be safe, and the incidence was similar to that in the general population<sup>##REF##33369063##30##,##REF##32510244##31##</sup>. Two case reports describe patients having recovered from COVID-19 without having to discontinue treatment<sup>##REF##32406078##32##,##REF##33368887##33##</sup>. In addition, a study showed that lower angiotensin converting enzyme-2 levels due to IL-17 inhibition may lower the risk of contracting COVID-19<sup>##REF##33002515##34##</sup>. These studies suggest that secukinumab is safe even during the active infection phase of COVID-19. However, more studies are needed to identify the true associations between monoclonal antibodies and their use in patients with COVID-19. Higher reporting of fungal infections, especially candidiasis (oral candidiasis and oropharyngeal candidiasis), was found in our study. The incidence of candidiasis with IL-17 inhibitors is well established in the literature<sup>##REF##27545070##35##</sup>. The imbalance of IL-17 secretion is associated with higher incidences of candidiasis and <italic>Staphylococcus aureus</italic> infection<sup>##REF##28713557##6##</sup>. Disproportionate signals were also identified with other oral adverse events, including aphthous ulcer, oral pain, oropharyngeal pain, oropharyngeal discomfort, glossodynia, tonsillitis, mouth ulcerations, dysphagia, stomatitis, swollen tongue, swollen lip, and dry throat. Whether these events were associated infections is unknown. Post-marketing studies in patients with psoriasis have estimated the incidence of candidiasis to be 2.2/100 patient-years<sup>##REF##30606217##36##</sup>. Opportunistic infections are another concern with the use of monoclonal antibodies for the treatment of autoimmune diseases<sup>##UREF##6##37##</sup>. A Vigibase study found a strong relationship between secukinumab use and herpes simplex virus with an ROR of 4.80 (3.78–6.10)<sup>##REF##35088874##38##</sup>. Our study also found a disproportionate signal for oral herpes (ROR, 2.67 [2.33–3.06]). No safety signal was established for tuberculosis in any of the study groups. Besides the findings regarding coronavirus and herpes virus, the reporting of other viral infections was not significantly high, except for influenza in comparison to the non-biologics.</p>", "<p id=\"Par24\">No new risks were identified with respect to malignancies apart from a signal for basal cell carcinoma in comparison with the non-biologics group. No increased risk was seen in pooled clinical trials and post-marketing studies of patients on secukinumab, with an exposure-adjusted incident rate of 0.83/100 patient-years in the psoriasis group<sup>##REF##33829482##39##</sup>. However, it must be noted that psoriasis by itself is a risk factor for malignancy, particularly keratinocyte cancer and lymphomas<sup>##REF##32074260##40##</sup>. The role of IL-17 is controversial and attributed to both tumour immunity and tumour proliferation<sup>##REF##20336152##41##</sup>.</p>", "<p id=\"Par25\">The SMQ vasculitis was another safety signal detected with the use of secukinumab. On the PT level, hypersensitivity vasculitis did not show increased reporting. Case reports exist in the literature on the occurrence of vasculitis with secukinumab: one case of IgA-vasculitis<sup>##UREF##7##42##</sup> and another of cutaneous vasculitis with gut involvement<sup>##UREF##8##43##</sup>. A disproportionate signal was also found for Bechet’s disease. Case reports of occurrence of Bechet’s disease are available<sup>##UREF##9##44##,##REF##28471836##45##</sup>, and interestingly enough, secukinumab has been used off-label for Bechet’s disease<sup>##UREF##10##46##</sup>. A clinical trial of secukinumab on aortic vascular inflammation in patients with psoriasis showed a neutral effect on aortic vascular inflammation and biomarkers of cardiometabolic disease<sup>##REF##32088207##47##</sup>. The occurrence of Bechet’s syndrome may be a paradoxical effect of IL-17 inhibitors, and more studies are required to understand the actions of IL-17 inhibition on the blood vessels. A disproportionate signal was identified in comparison with the combined drug group for angina pectoris and decreased systolic blood pressure. The incidence of MACE in clinical settings has been low, with exposure-adjusted incidence rates of 0.3–0.4/100 patient-years in psoriasis<sup>##REF##35146532##25##,##REF##30606217##36##</sup>. IL-17 is seen to be involved in most cardiac and metabolic chronic diseases, including obesity and non‐alcoholic fatty liver<sup>##REF##32022950##48##</sup>. However, the cardiometabolic effects of IL-17 inhibition are not well established.</p>", "<p id=\"Par26\">The use of biologics may affect normal immune function and response, precipitating autoimmune conditions<sup>##REF##23114587##49##</sup>. Our study showed increased reporting of rebound psoriasis, ankylosing spondylitis, and rheumatoid nodules; however, it is unclear whether these represent true events or are just associations, given that secukinumab is indicated in these conditions. Angioedema at the SMQ and PT levels was observed to have a safety signal. The incidence of angioedema is not well established in the literature. There exists a case report of a patient having recurrent angioedema with severe urticaria<sup>##UREF##11##50##</sup>. Another study also concluded that IL-17 inhibitors have a higher likelihood of precipitating immunological adverse events<sup>##REF##35188599##51##</sup>.</p>", "<p id=\"Par27\">Safety signals were identified for several dermatological events at the PT level, such as macule, pigmentation disorder, skin lesion, skin fissures, skin exfoliation, skin plaque, erysipelas, scratch, skin haemorrhage, pain of skin, and blister. At the SOC level (skin and subcutaneous tissue disorders), no disproportionality signal was observed in comparison with other biologics and non-biologics. At the SMQ level, the reporting of extravasation events is particularly high; however, no disproportionate reporting of severe cutaneous adverse reactions is seen in comparison to other biologics and non-biologics. Dermatological manifestations such as pemphigus, eczema, psoriasiform eruptions, hidradenitis suppurativa, and atopic dermatitis are observed with the use of secukinumab<sup>##REF##36355537##11##</sup>. The role of IL-17 in the pathogenesis of the aforementioned adverse events has been described<sup>##UREF##12##52##</sup>; however, these seemingly paradoxical inflammation of the skin may have developed due to the immune imbalance between Th1 and Th2 secretions, implying that the manifestations may be due to Th2-derived secretions<sup>##REF##32045273##53##</sup>. Further investigations are necessary to delineate whether the higher rates of dermatological adverse events observed are drug-induced or due to the disease for which the drug is indicated.</p>", "<p id=\"Par28\">Pharyngitis, nasopharyngitis, and cough were common adverse events in clinical trials along with headache, pruritis, diarrhoea, arthralgia, back pain, and upper respiratory tract infections<sup>##REF##29344327##54##</sup>. IL-17A and IL-17F have the potential to control the influx of neutrophils in conditions such as asthma, lung allograft rejection, and cystic fibrosis<sup>##REF##19075995##55##</sup>. There is a need for studies to understand the inhibition of IL-17 in the respiratory system. The findings of our study also indicate a higher reporting of these common respiratory adverse events with secukinumab.</p>", "<p id=\"Par29\">Gastrointestinal adverse events are a concern with the use of IL-17 inhibitors. In the current study, compared with biologics, secukinumab showed higher reporting of the SMQ gastrointestinal nonspecific inflammation and dysfunctional conditions; compared with non-biologics, disproportionate reporting was seen for gastrointestinal perforation, ulceration, haemorrhage, or obstruction, and ischaemic colitis. A phase-II clinical trial was stopped due to the worsening of Crohn’s disease<sup>##REF##22595313##56##</sup>. In this trial, four of seven drug-related adverse events were worsening of Crohn’s disease. A retrospective study of pooled data from 21 clinical trials showed low incidences (&lt; 1%) of inflammatory bowel disease across all indications<sup>##REF##30674475##57##</sup>. Another meta-analysis also arrived at similar conclusions (2.4 cases per 1000 patient‐year)<sup>##REF##31309607##58##</sup>, and the same was concluded from a real-world study<sup>##UREF##13##59##</sup>. Analysis at the PT level showed disproportionate reporting of colitis ulcerative, inflammatory bowel disease, and irritable bowel syndrome, among others, with secukinumab compared with biologics. These findings are in line with that of another study conducted using the WHO database, Vigibase, where inflammatory bowel disease and colitis had an ROR value of 3.36 (3.19–3.55)<sup>##REF##33411953##60##</sup>. The cause of IBD in patients receiving IL-17 inhibitors may be due to the protective role of IL-17 in the gastric mucosa<sup>##REF##32719044##61##</sup>. The magnitude and mechanism behind the manifestation of IBD need more clarity, and physicians must be well-informed of this association prior to prescribing anti-IL-17 agents. In addition, other gastrointestinal adverse events such as gastroenteritis, haematochezia, and haemorrhagic diarrhoea also showed safety signals. Disproportionate reporting was also observed for liver injury and pyelonephritis. The drug label mentions that phase 3 trials have shown elevation of hepatic transaminases, similar to the comparator etanercept group but more than that reported with placebo<sup>##UREF##4##16##</sup>. FDA medical review of secukinumab mentions grade 1 elevations in serum creatinine, more than placebo or etanercept group, which are transient and reversible, not requiring treatment discontinuation<sup>##UREF##14##62##</sup>. In comparison with placebo-treated patients, the changes in laboratory values from baseline or outliers were not considered to be clinically significant. Ageusia, anosmia, ascites, eating disorder, and speech disorders have also shown safety signals. The role of IL-17 in these cases, if at all a causal relationship exists, is yet to be determined.</p>", "<p id=\"Par30\">Our study described the safety profile of secukinumab by mining real-world data from the FAERS database. For the analysis, we compared the adverse event reports with secukinumab use with those reported with other biologics and non-biologics used to treat psoriasis; this helped identify disproportionate signaling and place it in the context of other drugs. Accordingly, many secukinumab-associated events with disproportionate reporting were identified as those common to all antipsoriatic biologics, whereas a few were exclusive to secukinumab. We included primary and secondary suspect medications indicated in the treatment of psoriasis; hence, the study results describe the safety concerns with secukinumab therapy in psoriasis more accurately. In addition, our method of extensive deduplication reduces the likelihood of duplicates existing in our study data. Thus, our study differs from earlier studies evaluating secukinumab safety, which either focused on specific categories of adverse events<sup>##REF##33411953##60##,##UREF##15##63##,##REF##37033665##64##</sup> and did not use specific comparators or additional deduplication steps<sup>##REF##36106653##65##</sup>.</p>", "<p id=\"Par31\">Our study has limitations. Our study was limited to analyzing the adverse events of secukinumab in patients with psoriasis with or without comorbidities. Hence, adverse events reported more frequently in patients with other indications may have been missed. The number of reports based on which a disproportionate reporting is identified can vary to a large extent, from fewer than hundred to thousands of reports, based on several factors. Because the number of reports containing the various preferred terms varied widely in our study, this can affect the study results. Also, a significant disproportionality statistic does not necessarily indicate causality given the presence of multiple factors that could have contributed to the occurrence of the adverse event. Given the limited data available in the ICSRs, it is not possible to adjust for these factors. There are known limitations with the use of FAERS data, considering that it is a spontaneous reporting AE database, which makes the findings hypothesis-generating but not confirmatory. Time on market is another potential confounder given that secukinumab, relative to other biologics and non-biologics used as comparators, is a new drug. All the non-biologics, except for apremilast, were approved for the treatment of psoriasis in the US prior to 2000. However, the findings of this study, considered together with earlier literature from clinical trials and real-world data, provide a more complete picture of the safety of secukinumab and areas requiring further studies. The presence of duplicate case reports is an important drawback of FAERS. We screened for duplicate reports by comparing multiple data fields. Although this approach can identify a large number of duplicate reports, it cannot identify all such reports, which require the implementation of complex algorithms for identification.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par32\">Our study supports the safety findings of secukinumab described in earlier literature with regard to candidiasis, oral herpes, inflammatory bowel disease, and injection site reactions. In addition, new safety signals were identified, such as eye infection, synovitis, pyelonephritis, ascites, spinal pain, dysstasia, and hypokinesia. While many reported events seem to be common to all antipsoriatic biologics, in that no significant differences were observed between secukinumab and other biologicals, some were seen to have disproportionate reporting with secukinumab, such as ischemic colitis, ocular infections, gastrointestinal nonspecific inflammation and dysfunctional conditions, and gastrointestinal perforation, ulceration, haemorrhage or obstruction. Further clinical studies are required to determine the relatedness of these events to secukinumab and their characteristics.</p>" ]
[ "<p id=\"Par1\">Secukinumab is an anti-IL-17 monoclonal antibody approved for treating psoriasis and various arthritides. A comprehensive evaluation of its safety, especially in a real-world setting, is necessary. This study aimed to describe the adverse events (AE) associated with secukinumab use using the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database. FAERS data files containing AE reports from 2015 to 2021 were downloaded for data mining. Primary or secondary suspect medications indicated for psoriasis were identified and analyzed. Medical dictionary for regulatory activities (MedDRA version 24.1) was used to analyze the AE terms. To detect potential safety signals of AE from secukinumab use, disproportionality analysis was used. A total of 365,590 adverse event reports were identified; of these, 44,761 reports involved the use of secukinumab. Safety signals were identified for ocular infections and gastrointestinal adverse events at the standardised MedDRA query level. Safety signals for oral candidiasis, oral herpes, conjunctivitis, eye infections, and ulcerative colitis were identified at the preferred term level. The findings of our study are consistent with those of earlier studies, such as the increased risk of infections and inflammatory bowel disease. However, our study also identified additional safety signals that need to be further evaluated.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-023-50013-7.</p>", "<title>Author contributions</title>", "<p>A.K. and V.E. conceived the study protocol. V.E. and A.K. collected the study data. A.K. analyzed the data. V.E. prepared the draft manuscript. A.K. critically reviewed the manuscript. The final draft of the manuscript was prepared and approved by V.E. and A.K.</p>", "<title>Data availability</title>", "<p>All data pertaining to this study is based on the data available in the US FDA Adverse Event Reporting System database which is open to public.</p>", "<title>Competing interests</title>", "<p id=\"Par33\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Study workflow for conducting disproportionality analysis. <italic>FAERS</italic> United States Food and Drug Administration adverse event reporting system, <italic>ICSRs</italic> individual case safety reports, <italic>MedDRA</italic> medical dictionary for regulatory activities, <italic>SOC</italic> system organ class, <italic>SMQ</italic> standardised MedDRA query, <italic>PT</italic> preferred term.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Yearly reporting of individual case safety reports (ICSR) of secukinumab, other biologics, and non-biologics, expressed as percentage of total in each group.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Most common adverse events reported in patients with psoriasis or related disorders following secukinumab use categorized according to the (<bold>a</bold>) MedDRA system organ class (<bold>b</bold>) standardised MedDRA query. <italic>MedDRA</italic> medical dictionary for regulatory activities.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Most common MedDRA preferred terms reported in patients with psoriasis or related disorders following secukinumab use expressed as percentage of total number of ICSRs (N = 44,761; excludes the preferred terms psoriasis, psoriatic arthropathy, and drug ineffective which were reported in 36.50%, 16.72%, and 14.76% of ICSRs, respectively). <italic>MedDRA</italic> medical dictionary for regulatory activities, <italic>ICSR</italic> individual case safety report.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Reporting odds ratio of adverse events at the MedDRA system organ class level reported in patients with psoriasis or related disorders receiving secukinumab or non-biologics. <italic>MedDRA</italic> medical dictionary for regulatory activities, <italic>CI</italic> confidence interval.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Reporting odds ratio of adverse events at the standardised MedDRA query level reported in patients with psoriasis or related disorders receiving secukinumab or non-biologics. <italic>MedDRA</italic> medical dictionary for regulatory activities, <italic>CI</italic> confidence interval.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Contingency table for disproportionality analysis.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\"/><th align=\"left\">Adverse event of interest</th><th align=\"left\">All other adverse events</th><th align=\"left\">Total</th></tr></thead><tbody><tr><td align=\"left\">Medication of interest</td><td align=\"left\">A</td><td align=\"left\">B</td><td align=\"left\">A + B</td></tr><tr><td align=\"left\">All other medications</td><td align=\"left\">C</td><td align=\"left\">D</td><td align=\"left\">C + D</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Demographic characteristics of patients with psoriasis or related disorders with adverse events following use of a biologic or non-biologic drug.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Characteristics</th><th align=\"left\" colspan=\"3\">Suspect drug</th></tr><tr><th align=\"left\">Secukinumab, N = 44,761</th><th align=\"left\">Other biologics, N = 144,725</th><th align=\"left\">Non-biologics, N = 67,005</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"4\">Age in years, median (IQR)</td></tr><tr><td align=\"left\"> All</td><td align=\"left\">54 (44–63)</td><td align=\"left\">55 (44–63)</td><td align=\"left\">56 (46–64)</td></tr><tr><td align=\"left\"> Female</td><td align=\"left\">54 (43–63)</td><td align=\"left\">54 (43–63)</td><td align=\"left\">56 (47–64)</td></tr><tr><td align=\"left\"> Male</td><td align=\"left\">55 (43–63)</td><td align=\"left\">55 (45–64)</td><td align=\"left\">56 (47–64)</td></tr><tr><td align=\"left\"> Unknown*</td><td align=\"left\">53 (41–61)</td><td align=\"left\">52 (38–63)</td><td align=\"left\">56 (40–65)</td></tr><tr><td align=\"left\" colspan=\"4\">Gender, N (%)</td></tr><tr><td align=\"left\"> Female</td><td align=\"left\">25,826 (56.49)</td><td align=\"left\">82,690 (57.13)</td><td align=\"left\">42,452 (63.32)</td></tr><tr><td align=\"left\"> Male</td><td align=\"left\">17,168 (38.35)</td><td align=\"left\">58,776 (40.16)</td><td align=\"left\">23,528 (35.11)</td></tr><tr><td align=\"left\"> Unknown*</td><td align=\"left\">1767 (3.94)</td><td align=\"left\">3259 (2.71)</td><td align=\"left\">1025 (1.52)</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>Proportional reporting ratio = (A/A + B)/(C/C + D), Reporting odds ratio = (A/B)/(C/D).</p></table-wrap-foot>", "<table-wrap-foot><p><italic>IQR</italic> interquartile range.</p><p>*Information regarding gender not available in the adverse event report.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2023_50013_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2023_50013_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2023_50013_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2023_50013_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2023_50013_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2023_50013_Fig6_HTML\" id=\"MO6\"/>" ]
[ "<media xlink:href=\"41598_2023_50013_MOESM1_ESM.docx\"><caption><p>Supplementary Tables.</p></caption></media>" ]
[{"label": ["1."], "mixed-citation": ["Biological Product Definitions | FDA. "], "ext-link": ["https://www.fda.gov/files/drugs/published/Biological-Product-Definitions.pdf"]}, {"label": ["2."], "mixed-citation": ["What Are \u2018Biologics\u2019 Questions and Answers | FDA. "], "ext-link": ["https://www.fda.gov/about-fda/center-biologics-evaluation-and-research-cber/what-are-biologics-questions-and-answers"]}, {"label": ["10."], "mixed-citation": ["Targeting IL-17 in inflammatory disease. "], "italic": ["Nature"], "ext-link": ["https://www.nature.com/collections/vzdlng"]}, {"label": ["15."], "mixed-citation": ["FDA Adverse Event Reporting System (FAERS) Public Dashboard | FDA. "], "ext-link": ["https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-public-dashboard"]}, {"label": ["16."], "mixed-citation": ["(secukinumab) injection, for subcutaneous use COSENTYX (2015)."]}, {"label": ["24."], "surname": ["Foley"], "given-names": ["P"], "article-title": ["Effectiveness and safety of secukinumab for psoriasis in a real-world clinical setting in the Asia-Pacific and Middle East regions: Results from the REALIA study"], "source": ["Dermatol. Ther."], "year": ["2022"], "volume": ["12"], "fpage": ["511"], "lpage": ["527"], "pub-id": ["10.1007/s13555-021-00675-w"]}, {"label": ["37."], "surname": ["Bryant", "Baddley"], "given-names": ["PA", "JW"], "article-title": ["Opportunistic infections in biological therapy, risk and prevention"], "source": ["Rheum. Dis. Clin. N. Am."], "year": ["2017"], "volume": ["43"], "fpage": ["27"], "lpage": ["41"], "pub-id": ["10.1016/j.rdc.2016.09.005"]}, {"label": ["42."], "surname": ["Perkovic", "Simac", "Katic"], "given-names": ["D", "P", "J"], "article-title": ["IgA vasculitis during secukinumab therapy"], "source": ["Clin. Rheumatol."], "year": ["2020"], "volume": ["2020"], "issue": ["40"], "fpage": ["2071"], "lpage": ["2073"]}, {"label": ["43."], "surname": ["Chelli"], "given-names": ["C"], "article-title": ["Cutaneous vasculitis with gut involvement during secukinumab treatment for psoriatic arthritis"], "source": ["Acta Derm. Venereol."], "year": ["2020"], "volume": ["100"], "fpage": ["1"], "lpage": ["2"], "pub-id": ["10.2340/00015555-3435"]}, {"label": ["44."], "surname": ["Dincses"], "given-names": ["E"], "article-title": ["Secukinumab induced Beh\u00e7et\u2019s syndrome: A report of two cases"], "source": ["Oxf. Med. Case Rep."], "year": ["2019"], "volume": ["2019"], "fpage": ["239"], "lpage": ["241"], "pub-id": ["10.1093/omcr/omz041"]}, {"label": ["46."], "surname": ["Wu", "Dao"], "given-names": ["KK", "H"], "article-title": ["Off-label dermatologic uses of IL-17 inhibitors"], "source": ["J. Dermatol. Treat."], "year": ["2022"], "volume": ["33"], "fpage": ["41"], "lpage": ["47"], "pub-id": ["10.1080/09546634.2020.1737638"]}, {"label": ["50."], "surname": ["Bekkali", "Simon", "Binois", "Est\u00e8ve"], "given-names": ["N", "C", "R", "\u00c9"], "article-title": ["Urticaire s\u00e9v\u00e8re avec r\u00e9cidive compliqu\u00e9e d\u2019angi\u0153d\u00e8me sous s\u00e9cukinumab: \u00c0 propos d\u2019un cas"], "source": ["Therapies"], "year": ["2020"], "volume": ["75"], "fpage": ["509"], "lpage": ["511"], "pub-id": ["10.1016/j.therap.2019.10.003"]}, {"label": ["52."], "surname": ["Liu"], "given-names": ["T"], "article-title": ["The IL-23/IL-17 pathway in inflammatory skin diseases: from bench to bedside"], "source": ["Front. Immunol."], "year": ["2020"], "volume": ["11"], "fpage": ["2971"], "pub-id": ["10.3389/fimmu.2020.594735"]}, {"label": ["59."], "surname": ["Onac"], "given-names": ["IA"], "article-title": ["Secukinumab as a potential trigger of inflammatory bowel disease in ankylosing spondylitis or psoriatic arthritis patients"], "source": ["Rheumatol. Oxf. Engl."], "year": ["2021"], "volume": ["60"], "fpage": ["5233"], "lpage": ["5238"], "pub-id": ["10.1093/rheumatology/keab193"]}, {"label": ["62."], "mixed-citation": ["Medical Review(s). "], "ext-link": ["https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/125504Orig1s000MedR.pdf"]}, {"label": ["63."], "surname": ["Grace"], "given-names": ["E"], "article-title": ["Injection site reactions in the federal adverse event reporting system (FAERS) post-marketing database vary among biologics approved to treat moderate-to-severe psoriasis"], "source": ["Dermatol. Ther."], "year": ["2020"], "volume": ["10"], "fpage": ["99"], "lpage": ["106"], "pub-id": ["10.1007/s13555-019-00341-2"]}]
{ "acronym": [], "definition": [] }
65
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1222
oa_package/b9/fb/PMC10786882.tar.gz
PMC10786883
38216702
[ "<title>Introduction</title>", "<p id=\"Par2\">Obesity is a major risk factor for several chronic diseases. It is associated with many systemic micro inflammation, as the major risk factor for different metabolic syndromes, as dyslipidaemia and type 2- diabetes, due to the secretion of specific pro-inflammatory peptides from the visceral adipose tissue<sup>##REF##28008865##1##</sup>. In Egypt, Hassan et al.<sup>##UREF##0##2##</sup>, ported that the prevalence of obesity among Egyptian school students was 8.0% in 2011; and increase to 19.5% in 2018. The rapid increase in the prevalence of obesity among children and adolescents, made it the most important worldwide problem of the twenty-first century. So, it became necessary to encounter new biomarkers for both obesity and its associated metabolic disorders<sup>##REF##32809080##3##</sup>.</p>", "<p id=\"Par3\">Adipokines secretions, of the adipose tissue, are regarded as mechanisms relating obesity to comorbidities. However, such adipokines regulate a number of systemic processes, as inflammations, nutrient metabolism, food intake and insulin sensitivity<sup>##REF##32443588##4##</sup>. Of the adipokines that may be responsible for such co- morbidities is the adipokines Visfatin through a variety of mechanisms<sup>##REF##29974830##5##</sup>. It has been suggested that Visfatin might have both endocrine and paracrine effects<sup>##REF##21266955##6##</sup>, mostly related to obesity and insulin sensitivity although there are important discrepancies in the literature<sup>##REF##31771561##7##</sup>.</p>", "<p id=\"Par4\">Fibroblast growth factor-21 (FGF-21); a stress-inducible hormone primarily produced by the liver in response to ketosis, and crosses the blood–brain barrier (as metabolic stressful stimuli). Such FGF-21 activates numerous brain areas including “PVN” the hypothalamic paraventricular nucleus, in turn it plays a role in regulating of the hypothalamic pituitary adrenal (HPA) axis<sup>##REF##32764725##8##</sup>. Moreover, FGF-21 was initially proposed as a lipolysis inducer in fat tissue. Animal studies have shown that FGF-21, when given to diabetic transgenic mice, and hence its level is overexpressed in their bodies, and as a result it lowers their blood glucose and triacylglycerol levels, thus it protects them from diet-induced obesity<sup>##REF##32922298##9##</sup>. Higher levels of serum FGF-21 were found to be related to obesity in children<sup>##REF##31089518##10##</sup>, and with disturbed metabolic parameter such as dyslipidaemia and insulin resistance<sup>##REF##22438225##11##</sup>. Moreover, FGF-21 has been proposed as a possible biomarker for the components of the metabolic syndrome (Mets), as well as Type II diabetes mellitus (TII DM)<sup>##REF##18252893##12##</sup>.</p>", "<p id=\"Par5\">Reviewing literature, no studies were found to assess the relation between FGF-21 and Visfatin as potential markers for obesity and its metabolic disorders in both children and adolescents. Therefore, the purpose of this study was to assess the relations between both serum FGF-21 and Visfatin with the obesity and its metabolic disorders, and their use as potential predictors for metabolic risk factors in a sample of Egyptian obese and non-obese children.</p>" ]
[ "<title>Subjects and methods</title>", "<title>Subjects</title>", "<p id=\"Par6\">The present study was a cross-sectional one that was conducted in the “Visceral Obesity and Growth Disturbances Management clinic” in “Medical Research Centre of Excellence (MRCE)”, National Research Centre (Egypt), during the period between December 2018 and February 2021. It was conducted on 2 groups of children N = 111; with their ages ranging 6–10 years (45 males; mean age 8.74 ± 1.60 years and 66 females; with mean age 8.78 ± 1.73 years to exclude the possible effects of puberty. The exclusion criteria (by full History taking and clinical examination) were the presence of any sign of puberty according to Tanner stage, presence of identified causes of obesity (genetic syndromes, chromosomal or endocrinal disorders), chronic diseases (cardiovascular, gastrointestinal, and respiratory), or drug use like steroids; that would interfere with the type of obesity and affect the normal growth of the children. Also, any child with a BMI between 85 to 95th percentiles (overweight) was excluded from the study. All participating obese children were suffering from exogenous simple obesity. They were classified according to their BMI percentiles into: 72 obese (BMI ≥ 95th), and 39 control non-obese ones (BMI &gt; 15th to &lt; 85th), based on the Egyptian Growth Charts for children and adolescents<sup>##UREF##1##13##</sup>.</p>", "<p id=\"Par7\">Ethical approval were granted from both the Ethics Committee of the “National Research Centre” (Approval No. 17/125). And that from the Ethics Committee of “Faculty of Postgraduate Childhood Studies”.</p>", "<p id=\"Par8\">Also, after clarifying the main objectives of the research and its conceivable benefits in identifying the risks of obesity on family health, an informed written consent was taken from either of the parents and an assent from the participated children (both signed in and dated).</p>", "<title>Methods</title>", "<p id=\"Par9\">Each child was subjected to blood pressure assessment, anthropometric measurements and laboratory investigations.<list list-type=\"bullet\"><list-item><p id=\"Par10\">Blood pressure assessment</p></list-item></list></p>", "<p id=\"Par11\">Using a standardized mercury sphygmomanometer, while sitting in a proper position, both systolic and diastolic blood pressures were measured. Applying appropriate blood pressure cuff that did not encroach on the antecubital space. Three successive readings were measured, and the mean was recorded if the error was satisfactory.<list list-type=\"bullet\"><list-item><p id=\"Par12\">Anthropometric evaluation</p></list-item></list></p>", "<p id=\"Par13\">The following anthropometric parameters were recorded, using identical equipment’s and following the recommendations of the “IBP” International Biological Program, including: bodyweight “Wt”, height “Ht”, waist and hip circumferences “WC” and “HC”;<sup>##UREF##2##14##</sup>.</p>", "<p id=\"Par14\">Digital standing SECA scale balance (Model 707) was used to measure body weight that was recorded to the nearest 0.01 kg. Height, that was recorded to the nearest 0.1 cm, was measured using a wall mounted Holtain Stadiometer. Waist circumference (WC) was done using a non-stretchable plastic measuring tape, all around the body in horizontal position, and at a level midway between the lower rib margin and iliac crest and at the end of normal expiration. The observer held the measuring tape firmly, to ensure a horizontal position on the subject’s body. The WC measure was approximated to the nearest 0.1 cm. Hip circumference (HC) was measured using flexible non-stretchable plastic tape, which was held horizontally around the maximum extension of the buttocks, the reading was approximated to the nearest 0.1 cm. BMI was calculated using the formula: BMI = Weight (kg)/[Height (m<sup>2</sup>)]. According to their BMI percentile; based on the Egyptian Growth Charts for children and adolescents<sup>##UREF##1##13##</sup>; obesity was diagnosed more than or equal to 95% and healthy weight 15%–less than 85%.<list list-type=\"bullet\"><list-item><p id=\"Par15\">Laboratory investigations</p></list-item></list></p>", "<p id=\"Par16\">After fasting for 12 h, a 5 ml venous blood sample (between 9–11 am) was obtained from every child by professional venepuncture staff. After being clotted, it was centrifuged and its serum was obtained to be kept at − 80 °C, to be further assessed. Fasting blood glucose (FBG), insulin, lipid profile, Visfatin and FGF21 were then assessed.</p>", "<p id=\"Par17\">FBG was assessed using GOD-POD enzymatic colorimetric method, and serum insulin was assessed using Enzyme Immunoassay, according to the method of Tietz<sup>##UREF##3##15##</sup>. HOMA-IR was calculated as follows: “HOMA-IR = fasting glucose (mg/dl) × fasting insulin (μIU/ml)/405”.</p>", "<p id=\"Par18\">The Beckman Coulter/Olympus AU480 Random Access Chemistry Analyzer was used to evaluate the levels of serum lipid. Using quantitative enzymatic colorimetric methods were used to assess both serum Triglycerides level “TG” (test kit code no: SU033, SU034, SU035 (CHEMELEX, S.A., Barcelona), and total cholesterol (kit Ref: 101-0440/101-0526 (CHRONOLAB SYSTEMS, Barcelona). HDL was assessed using kit code no: SU014 (CHEMELEX, S.A., Barcelona). Serum triglycerides, total cholesterol and HDL were assessed according to the method of Tietz<sup>##UREF##3##15##</sup>. While LDL was assessed using kit REF: 99 06 10 (QUIMICA CLINICA APLICADA S.A., Spain) according to Polvinyl Sulphate method of Demacker et al.<sup>##REF##6593139##16##</sup>. The metabolic disturbances criteria ; were defined by Wasilewski et al.<sup>##REF##26232615##17##</sup>, as elevated systolic or diastolic blood pressure, or disturbed any parameter of lipid profile, or elevated fasting blood glucose, or elevated fasting insulin or increased the homeostatic model assessment of insulin resistance HOMA-IR).</p>", "<p id=\"Par19\">Based on the principle of competitive enzyme immunoassay, the Enzyme Linked Immunosorbent Assay (ELISA) kits were used to assess both serum Visfatin and FGF21 levels.</p>", "<title>Statistical analysis</title>", "<p id=\"Par20\">For the present study, the computer program SPSS version 18 (Statistical package for social science) was used to do all the statistical analyses. The Kolmogorov–Smirnov test was used to examine data normality. Most of the studied variables were not normally distributed (for example: BMI, WC Visfatin and FGF-21), therefor non-parametric tests were used to analyse them.</p>", "<p id=\"Par21\">For all anthropometric and laboratory parameters, the descriptive statistics (mean ± SD) were calculated. Mann–Whitney test was carried out, to reveal group differences (between any two groups of parametric (quantitative) data. The association between either Visfatin or FGF-21 with all the examined parameters was done using Spearman’s correlation. In all analyses, the statistical standard probability <italic>P</italic> &lt; 0.01 is regarded as highly significant and <italic>P</italic> &lt; 0.05 is regarded as statistically significant.</p>", "<title>Ethics approval and consent to participate</title>", "<p id=\"Par22\">The study protocol was conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Ethics Committee of both Faculty of Postgraduate Childhood Studies, and the “National Research Centre; Egypt” (Approval No. 17/125). After explaining the promising benefits of the study in ascertaining the impact of obesity on health, informed written consents were obtained from either parent.</p>" ]
[ "<title>Results</title>", "<p id=\"Par23\">The results of this study have revealed that all the studied parameters; including age, clinical, anthropometric and laboratory variables such as FGF-21 and Visfatin showed insignificant sex differences. Subsequently, both sexes were gathered in one group (with no sex differentiation) to do all statistical analyses.</p>", "<p id=\"Par24\">The obese children had highly significant higher values than control ones regarding all the studied clinical (SBP, DBP) and anthropometric parameters (Wt, Ht, BMI, WC and HC) (Table ##TAB##0##1##). They also had highly significant higher values regarding HOMA-IR and FGF-21, and significant higher values than control ones regarding FBG, Insulin and Visfatin. Moreover, obese children had highly significant lower value regarding HDL, and significant lower value in Cholesterol (Table ##TAB##1##2##). There were insignificant differences between obese and control in TG and LDL.</p>", "<p id=\"Par25\">Table ##TAB##2##3## shows Spearman’s correlation analysis between both Visfatin and FGF-21 and the studied variables among the obese group children. In Serum Visfatin had significant negative correlations with BMI and HC only. While serum FGF-21 had highly significant negative correlation with BMI, significant negative correlation with HC, and highly significant positive correlation with HDL. Visfatin and FGF-21 had highly significant positive correlations with each other. There were insignificant correlations between either Visfatin or FGF-21with any of the following laboratory investigations: FBG, insulin, HOMA, Triglycerides, Cholesterol and LDL.</p>", "<p id=\"Par26\">While Spearman’s correlation analysis among control group (Table ##TAB##3##4##), revealed that both serum Visfatin or FGF-21 had insignificant positive correlations with each other and with all the studied clinical and anthropometric parameters. Serum FGF-21 had significant positive correlation with Cholesterol, while Serum Visfatin had significant positive correlation with Cholesterol and HDL, and significant negative correlation with FBG.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par27\">In the current study, the obese children had highly significant higher values than control ones regarding all the studied clinical and anthropometric parameters. Regarding laboratory investigations, they also had significant higher values regarding FBG, Insulin, HOMA-IR, Visfatin, FGF-21 and C-Peptide, significant lower value regarding Cholesterol and HDL, and insignificant differences regarding LDL and TG.</p>", "<p id=\"Par28\">Coinciding with current laboratory findings, Li et al.<sup>##REF##29891216##18##</sup>, declared that the obese group had high circulating FGF-21, and it was characterized by elevated fasting insulin and HOMA-IR. Martin et al.<sup>##REF##34895801##19##</sup>, also found that HOMA-IR were significantly higher in obese children and adolescents than normal weight ones. Mohamed et al.<sup>##UREF##4##20##</sup>, also found that anthropometric variables (weight, BMI, WC and HC) were significantly higher, and HDL level was significantly lower in obese group than normal weight (<italic>P</italic> value &lt; 0.05). The significant lower value of Cholesterol among obese than control children can be explained by the fact that total cholesterol levels in the blood are greatly affected by a person’s food intake. Diets high in saturated fat and carbohydrates can raise the levels of total cholesterol in the blood stream<sup>##REF##23584084##21##</sup>.</p>", "<p id=\"Par29\">In contrary to the current results; which reported insignificant differences between obese and control children regarding LDL and TG; Küme et al.<sup>##REF##28008865##1##</sup> and Martin et al.<sup>##REF##34895801##19##</sup>, found significantly higher triglycerides and LDL-C in obese children, adolescents and adults. Martin et al.<sup>##REF##34895801##19##</sup>, also reported significant higher total cholesterol, and insignificant differences in insulin and blood glucose in obese and normal weight children and adolescents. This can be attributed to age differences as well as the effects of puberty. Li et al.<sup>##REF##29891216##18##</sup>, found elevated triglycerides levels among the obese group.</p>", "<p id=\"Par30\">The current study reported that obese children had significant higher values of serum Visfatin and FGF21 than control ones. In addition, Visfatin and FGF-21 had highly significant positive correlations with each other among the obese group and insignificant correlation with each other among the control group.</p>", "<p id=\"Par31\">In line to current results, significant higher serum FGF-21 levels in obese children than in lean ones was reported previously by Zhang et al.<sup>##REF##18252893##12##</sup>, Baek et al.<sup>##REF##31089518##10##</sup>, and Christaki et al.<sup>##REF##35740758##22##</sup>. Moreover, Baek et al.<sup>##REF##31089518##10##</sup>, found that serum FGF21 levels were also higher in obese children with metabolic syndrome than children without.</p>", "<p id=\"Par32\">Many authors as Elkabany et al.<sup>##REF##31834057##23##</sup>, and Serbis et al.<sup>##REF##34023981##24##</sup>, have concluded that, in obese children group, the serum Visfatin level was higher than that in control group one. In addition, Catalán et al.<sup>##REF##20106640##25##</sup>, reported that circulating Visfatin concentrations and mRNA expression levels in peripheral blood cells were increased in patients with obesity and are related to inflammation, lipid metabolism and hepatic enzymes suggesting a potential involvement in fatty liver disease and in the obesity-associated inflammatory state.</p>", "<p id=\"Par33\">In the present study; Among obese children; both Visfatin and FGF-21 had significant negative correlations with BMI and HC, and insignificant correlations with FBG, insulin, HOMA-IR, and lipid profile; except that serum FGF-21 had highly significant positive correlation with HDL. While among control group, both serum Visfatin or FGF-21 had significant positive correlation with Cholesterol, and insignificant correlations with all the studied clinical and anthropometric parameters, insulin, HOMA, triglycerides and LDL. In addition, serum Visfatin had significant positive correlation with HDL, and significant negative correlation with FBG.</p>", "<p id=\"Par34\">Concurrent with the current results, Reinehr et al.<sup>##REF##22438225##11##</sup>, found that FGF-21 was not related to any parameter of metabolic syndrome in obese children. In the control group, Christaki et al.<sup>##REF##31834057##23##</sup>, have also reported insignificant associations between the metabolic biomarkers and the levels circulating FGF-21, whereas the levels of serum FGF-21 was significantly correlated with the levels of HDL (r =  − 0.294, <italic>P</italic> &lt; 0.05) in the obese group. In contrary to current results, Zhang et al.<sup>##REF##18252893##12##</sup>, found that serum FGF-21 correlated positively with fasting insulin, and triglycerides but negatively with HDL, after adjusting for age and BMI. Christaki et al.<sup>##REF##31834057##23##</sup>, found that FGF21 levels were negatively correlated with insulin and HOMA-IR levels after adjusting for age, gender, puberty and lifestyle factors in the obese group. In addition, Akduman et al.<sup>##UREF##5##26##</sup>, found no relation between FGF-21 level and age, body weight, BMI, waist circumference, hip circumference, fasting blood sugar, fasting insulin, total cholesterol, HDL-C, LDL-C, in obese and control groups (<italic>P</italic> &gt; 0.05).</p>", "<p id=\"Par35\">In agreement with our results, Ugur et al.<sup>##REF##35363362##27##</sup>, have concluded that, obese group with metabolic syndrome has shown statistically significant negative correlation between Visfatin and BMI (<italic>P</italic> &lt; 0.05). Kamińska et al.<sup>##UREF##6##28##</sup>, in addition they did not find any significant association between Visfatin levels and any of the following parameters (Weight, height, BMI, WC, HC, WHR and FBG) in the control group. Elkabany et al.<sup>##REF##34023981##24##</sup>, found significant positive correlations between serum Visfatin and total cholesterol, and insignificant correlations with blood pressure or fasting insulin. Ooi et al.<sup>##REF##23447513##29##</sup> found that serum Visfatin correlated with some obesity markers: BMI, percentage body fat, and fasting triglyceride level. Moreover, increased Visfatin level was recorded among obese children, who had abnormal glucose tolerance and NAFLD. So, they established the association between Visfatin and its genetic variants with the obesity-related morbidities and adverse cardio metabolic parameters.</p>", "<p id=\"Par36\">In contrary to current results, Alnowihi et al.<sup>##UREF##7##30##</sup>, found that Visfatin levels had significant positive correlations with waist and hip circumferences, BMI, blood pressure (DBP and SBP), insulin, HOMA, and LDL-C levels, and significant negative correlation with HDL-C. Elkabany et al.<sup>##REF##34023981##24##</sup>, reported that Visfatin had significant positive correlations with BMI and waist circumference, and insignificant correlation with FBG. While Ugur et al.<sup>##REF##35363362##27##</sup>, found significant negative correlation between Visfatin and waist circumference in the obese group with metabolic syndrome.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par37\">Among the obese prepubertal Egyptian children, Fibroblast Growth Factor-21 (FGF21) and Visfatin were highly significant higher than control ones, and they have highly significant positive correlations with each other. Both of them are related to the obesity markers, but they cannot be used as potential predictors for metabolic disturbance in obese prepubertal children; as both of them had insignificant correlations with the metabolic risk factors (WC, BP, FBG, insulin, HOMA-IR, and lipid profile).</p>" ]
[ "<p id=\"Par1\">Fibroblast growth factor-21 (FGF-21) and Visfatin are associated with obesity. However; reviewing the literature; no studies were found to assess their role as potential markers for the metabolic disorders related to obesity in children. Assess the relations between serum FGF-21 and Visfatin with obesity and its metabolic disorders, and their use as potential predictors for metabolic risk factors in a sample of Egyptian obese children. This cross-sectional study included 111 Egyptian children (45 males and 66 females); aged 6–10 years to avoid the effect of puberty (prepubertal). The exclusion criteria (by full History taking and clinical examination) were the presence of any sign of puberty according to Tanner stage, the presence of identified causes of obesity (genetic syndromes, chromosomal or endocrinal disorders), chronic diseases (cardiovascular, gastrointestinal, and respiratory), or drug use like steroids; that would interfere with the type of obesity and affect the normal growth of the children. Also, any child with a BMI between 85 and 95th percentiles (overweight) was excluded from the study. All participating obese children were suffering from exogenous simple obesity. They were classified according to their body mass index (BMI) percentiles into 72 obese (BMI ≥ 95th), and 39 control non-obese ones (BMI &gt; 15th to &lt; 85th), based on the Egyptian Growth Charts for children and adolescents. Ethical approvals were granted from both the Ethics Committee of the “National Research Centre” and the “Faculty of Postgraduate Childhood Studies” (Approval No. 17/125). Also, informed written consent was taken from either of the parents and assent from the participating children. They were subjected to blood pressure assessment, anthropometric measurements (weight [Wt], height [Ht], BMI, waist [WC], and hip [HC] circumferences), and laboratory evaluation (Visfatin, FGF-21, LDL, HDL, TG, cholesterol, fasting glucose, insulin, and calculation of HOMA-IR). Mann–Whitney test and Spearman’s correlation test were applied. Obese children had significantly higher values than control ones regarding all the studied clinical (SBP, DBP), anthropometric parameters (Wt, Ht, BMI, WC, and HC), FBG, Insulin, HOMA-IR, Visfatin, and FGF-21, and had significantly lower values regarding HDL and Cholesterol. Among obese children, both FGF-21 and Visfatin had significant negative correlations with BMI and HC. At the same time, serum FGF-21 had a highly significant positive correlation with HDL. Visfatin and FGF-21 had highly significant positive correlations with each other. In the control group, both serum Visfatin or FGF-21 had insignificant correlations with each other and with all the studied clinical and anthropometric parameters. FGF-21 and Visfatin are related to the obesity markers, but they cannot be used as potential predictors for metabolic disturbance in obese prepubertal children; both had insignificant correlations with the metabolic risk factors.</p>", "<title>Subject terms</title>", "<p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p>" ]
[]
[ "<title>Acknowledgements</title>", "<p>We would like to acknowledge our institute “National Research Centre’; Egypt”; without its fund this study could not be done. Authors are also grateful to everybody participated in this study; the children who were the participants of this study, the technicians who helped in the laboratory analysis and the doctors who participated in collection of the data. Without their help, this study couldn’t have been completed.</p>", "<title>Author contributions</title>", "<p>S.A.E.-M. and M.N.F. conceived and designed the study. S.A.E.-M.: analysis and interpretation of the data. S.N.A.E.-F. is responsible for laboratory investigations. N.E.H. and M.A.S. supervision data collection, L.H.M. participated in the collection of the references. G.I.E. collected the data. All authors contributed to the collection of references, drafting of the article and final approval of the version to be submitted. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.</p>", "<title>Funding</title>", "<p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p>", "<title>Data availability</title>", "<p>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request, after taking the permission of our institute “National Research Centre”.</p>", "<title>Competing interests</title>", "<p id=\"Par38\">The authors declare no competing interests.</p>" ]
[]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Comparison of obese and control non obese children regarding the clinical and anthropometric parameters.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Parameters</th><th align=\"left\">CONTROL<break/>(N = 39)</th><th align=\"left\">OBESE<break/>(N = 72)</th><th align=\"left\" rowspan=\"2\"><italic>P</italic></th></tr><tr><th align=\"left\">Mean ± SD</th><th align=\"left\">Mean ± SD</th></tr></thead><tbody><tr><td align=\"left\">Age (years)</td><td char=\".\" align=\"char\">7.97 ± 1.60</td><td char=\".\" align=\"char\">9.20 ± 1.55</td><td char=\".\" align=\"char\"><bold>0.000**</bold></td></tr><tr><td align=\"left\" colspan=\"4\">Blood pressure</td></tr><tr><td align=\"left\"> SBP (mmHg)</td><td char=\".\" align=\"char\">94.87 ± 9.63</td><td char=\".\" align=\"char\">106.97 ± 15.42</td><td char=\".\" align=\"char\"><bold>0.000**</bold></td></tr><tr><td align=\"left\"> DBP (mmHg)</td><td char=\".\" align=\"char\">58.72 ± 3.19</td><td char=\".\" align=\"char\">66.11 ± 10.95</td><td char=\".\" align=\"char\"><bold>0.000**</bold></td></tr><tr><td align=\"left\" colspan=\"4\">Anthropometry</td></tr><tr><td align=\"left\"> Weight (Kg)</td><td char=\".\" align=\"char\">23.59 ± 8.80</td><td char=\".\" align=\"char\">58.29 ± 11.22</td><td char=\".\" align=\"char\"><bold>0.000**</bold></td></tr><tr><td align=\"left\"> Height (cm)</td><td char=\".\" align=\"char\">120.15 ± 16.70</td><td char=\".\" align=\"char\">140.65 ± 11.38</td><td char=\".\" align=\"char\"><bold>0.000**</bold></td></tr><tr><td align=\"left\"> BMI(kg/m<sup>2</sup>)</td><td char=\".\" align=\"char\">15.73 ± 1.71</td><td char=\".\" align=\"char\">29.28 ± 2.55</td><td char=\".\" align=\"char\"><bold>0.000**</bold></td></tr><tr><td align=\"left\"> WC (cm)</td><td char=\".\" align=\"char\">58.13 ± 7.15</td><td char=\".\" align=\"char\">90.31 ± 9.74</td><td char=\".\" align=\"char\"><bold>0.000**</bold></td></tr><tr><td align=\"left\"> HC (cm)</td><td char=\".\" align=\"char\">65.46 ± 8.87</td><td char=\".\" align=\"char\">99.60 ± 13.34</td><td char=\".\" align=\"char\"><bold>0.000**</bold></td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Comparison of obese and control non obese children regarding the laboratory investigations.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Parameters</th><th align=\"left\">CONTROL<break/>(N = 39)</th><th align=\"left\">OBESE<break/>(N = 72)</th><th align=\"left\" rowspan=\"2\"><italic>P</italic></th></tr><tr><th align=\"left\">Mean ± SD</th><th align=\"left\">Mean ± SD</th></tr></thead><tbody><tr><td align=\"left\">FBG (mg/dl)</td><td char=\"±\" align=\"char\">86.51 ± 15.54</td><td char=\".\" align=\"char\">94.57 ± 16.77</td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>029*</bold></td></tr><tr><td align=\"left\">Insulin(uIU/mL)</td><td char=\"±\" align=\"char\">5.27 ± 5.12</td><td char=\".\" align=\"char\">10.23 ± 11.59</td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>010*</bold></td></tr><tr><td align=\"left\">HOMA-IR</td><td char=\"±\" align=\"char\">1.08 ± 1.06</td><td char=\".\" align=\"char\">2.84 ± 5.25</td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>007*</bold></td></tr><tr><td align=\"left\" colspan=\"4\">Lipid profile</td></tr><tr><td align=\"left\"> Cholesterol (mg/dl)</td><td char=\"±\" align=\"char\">175.33 ± 30.64</td><td char=\".\" align=\"char\">161.34 ± 29.45</td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>030*</bold></td></tr><tr><td align=\"left\"> TG (mg/dl)</td><td char=\"±\" align=\"char\">85.05 ± 26.74</td><td char=\".\" align=\"char\">88.08 ± 28.79</td><td char=\".\" align=\"char\">0.387</td></tr><tr><td align=\"left\"> HDL (mg/dl)</td><td char=\"±\" align=\"char\">54.85 ± 14.4</td><td char=\".\" align=\"char\">46.18 ± 20.57</td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>000**</bold></td></tr><tr><td align=\"left\"> LDL (mg/dl)</td><td char=\"±\" align=\"char\">68.15 ± 8.86</td><td char=\".\" align=\"char\">66.14 ± 9.29</td><td char=\".\" align=\"char\">0.320</td></tr><tr><td align=\"left\">Visfatin (ng/ml)</td><td char=\"±\" align=\"char\">2. 60 ± 2.91</td><td char=\".\" align=\"char\">3.00 ± 2.80</td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>011*</bold></td></tr><tr><td align=\"left\">FGF-21 (pg/ml)</td><td char=\"±\" align=\"char\">40.46 ± 31.81</td><td char=\".\" align=\"char\">53.90 ± 39.66</td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>000**</bold></td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Spearman’s correlation of Visfatin and FGF-21 with clinical and anthropometric parameters among obese children.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Parameters</th><th align=\"left\" colspan=\"2\">Visfatin ng/ml</th><th align=\"left\" colspan=\"2\">FGF-21 pg/ml</th></tr><tr><th align=\"left\">r</th><th align=\"left\"><italic>P</italic> value</th><th align=\"left\">r</th><th align=\"left\"><italic>P</italic> value</th></tr></thead><tbody><tr><td align=\"left\">Age (years)</td><td align=\"left\"> − 0.028</td><td char=\".\" align=\"char\">0.818</td><td align=\"left\"> − 0.067</td><td char=\".\" align=\"char\">0.583</td></tr><tr><td align=\"left\">SBP (mmHg)</td><td align=\"left\"> − 0.100</td><td char=\".\" align=\"char\">0.405</td><td align=\"left\"> − 0.026</td><td char=\".\" align=\"char\">0.834</td></tr><tr><td align=\"left\">DBP (mmHg)</td><td align=\"left\">0.021</td><td char=\".\" align=\"char\">0.864</td><td align=\"left\"> − 0.001</td><td char=\".\" align=\"char\">0.994</td></tr><tr><td align=\"left\">BMI (kg/m2)</td><td align=\"left\"> − <bold>0</bold>.<bold>288</bold></td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>015*</bold></td><td align=\"left\"> − <bold>0</bold>.<bold>308</bold></td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>009**</bold></td></tr><tr><td align=\"left\">WC (cm)</td><td align=\"left\"> − 0.121</td><td char=\".\" align=\"char\">0.314</td><td align=\"left\"> − 0.075</td><td char=\".\" align=\"char\">0.538</td></tr><tr><td align=\"left\">HC (cm)</td><td align=\"left\"> − <bold>0</bold>.<bold>283</bold></td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>017*</bold></td><td align=\"left\"> − <bold>0</bold>.<bold>263</bold></td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>028*</bold></td></tr><tr><td align=\"left\">FBG (mg/dl)</td><td align=\"left\">0.019</td><td char=\".\" align=\"char\">0.873</td><td align=\"left\">0.033</td><td char=\".\" align=\"char\">0.786</td></tr><tr><td align=\"left\">Insulin (uIU/mL)</td><td align=\"left\">0.019</td><td char=\".\" align=\"char\">0.878</td><td align=\"left\">0.075</td><td char=\".\" align=\"char\">0.543</td></tr><tr><td align=\"left\">HOMA-IR</td><td align=\"left\">0.017</td><td char=\".\" align=\"char\">0.891</td><td align=\"left\">0.052</td><td char=\".\" align=\"char\">0.672</td></tr><tr><td align=\"left\">Cholesterol (mg/dl)</td><td align=\"left\"> − 0.209</td><td char=\".\" align=\"char\">0.080</td><td align=\"left\"> − 0.121</td><td char=\".\" align=\"char\">0.317</td></tr><tr><td align=\"left\">TG (mg/dl)</td><td align=\"left\">0.100</td><td char=\".\" align=\"char\">0.407</td><td align=\"left\">0.234</td><td char=\".\" align=\"char\">0.051</td></tr><tr><td align=\"left\">HDL (mg/dl)</td><td align=\"left\">0.227</td><td char=\".\" align=\"char\">0.057</td><td align=\"left\"><bold>0</bold>.<bold>316</bold></td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>008**</bold></td></tr><tr><td align=\"left\">LDL (mg/dl)</td><td align=\"left\"> − 0.008</td><td char=\".\" align=\"char\">0.945</td><td align=\"left\">0.012</td><td char=\".\" align=\"char\">0.922</td></tr><tr><td align=\"left\">Visfatin (ng/ml)</td><td align=\"left\"/><td char=\".\" align=\"char\"/><td align=\"left\"><bold>0</bold>.<bold>738</bold></td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>000</bold></td></tr><tr><td align=\"left\">FGF-21 (pg/ml)</td><td align=\"left\"><bold>0</bold>.<bold>738</bold></td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>000</bold></td><td align=\"left\"/><td char=\".\" align=\"char\"/></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab4\"><label>Table 4</label><caption><p>Spearman’s correlation of Visfatin and FGF-21 with clinical and anthropometric parameters among <italic>control</italic> children.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Parameters</th><th align=\"left\" colspan=\"2\">Visfatin ng/ml</th><th align=\"left\" colspan=\"2\">FGF-21 pg/ml</th></tr><tr><th align=\"left\">r</th><th align=\"left\"><italic>P</italic> value</th><th align=\"left\">r</th><th align=\"left\"><italic>P</italic> value</th></tr></thead><tbody><tr><td align=\"left\">Age (years)</td><td align=\"left\"> − 0.176</td><td char=\".\" align=\"char\">0.283</td><td align=\"left\"> − 0.143</td><td char=\".\" align=\"char\">0.385</td></tr><tr><td align=\"left\">SBP (mmHg)</td><td align=\"left\">0.032</td><td char=\".\" align=\"char\">0.849</td><td align=\"left\"> − 0.179</td><td char=\".\" align=\"char\">0.276</td></tr><tr><td align=\"left\">DBP (mmHg)</td><td align=\"left\">0.097</td><td char=\".\" align=\"char\">0.556</td><td align=\"left\"> − 0.185</td><td char=\".\" align=\"char\">0.260</td></tr><tr><td align=\"left\">BMI (kg/m2)</td><td align=\"left\">0.079</td><td char=\".\" align=\"char\">0.632</td><td align=\"left\">0.099</td><td char=\".\" align=\"char\">0.550</td></tr><tr><td align=\"left\">WC (cm)</td><td align=\"left\"> − 0.102</td><td char=\".\" align=\"char\">0.535</td><td align=\"left\">0.046</td><td char=\".\" align=\"char\">0.779</td></tr><tr><td align=\"left\">HC (cm)</td><td align=\"left\"> − 0.129</td><td char=\".\" align=\"char\">0.434</td><td align=\"left\"> − 0.007</td><td char=\".\" align=\"char\">0.968</td></tr><tr><td align=\"left\">FBG (mg/dl)</td><td align=\"left\"> − <bold>0</bold>.<bold>357</bold></td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>026*</bold></td><td align=\"left\">0.005</td><td char=\".\" align=\"char\">0.976</td></tr><tr><td align=\"left\">Insulin (uIU/mL)</td><td align=\"left\"> − 0.075</td><td char=\".\" align=\"char\">0.648</td><td align=\"left\">0.188</td><td char=\".\" align=\"char\">0.252</td></tr><tr><td align=\"left\">HOMA-IR</td><td align=\"left\"> − 0.088</td><td char=\".\" align=\"char\">0.593</td><td align=\"left\">0.222</td><td char=\".\" align=\"char\">0.174</td></tr><tr><td align=\"left\">Cholesterol (mg/dl)</td><td align=\"left\"><bold>0</bold>.<bold>375</bold></td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>019*</bold></td><td align=\"left\"><bold>0</bold>.<bold>327</bold></td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>042*</bold></td></tr><tr><td align=\"left\">TG (mg/dl)</td><td align=\"left\"> − 0.103</td><td char=\".\" align=\"char\">0.531</td><td align=\"left\">0.035</td><td char=\".\" align=\"char\">0.834</td></tr><tr><td align=\"left\">HDL (mg/dl)</td><td align=\"left\"><bold>0</bold>.<bold>383</bold></td><td char=\".\" align=\"char\"><bold>0</bold>.<bold>016*</bold></td><td align=\"left\">0.206</td><td char=\".\" align=\"char\">0.208</td></tr><tr><td align=\"left\">LDL (mg/dl)</td><td align=\"left\">0.266</td><td char=\".\" align=\"char\">0.102</td><td align=\"left\">0.188</td><td char=\".\" align=\"char\">0.251</td></tr><tr><td align=\"left\">Visfatin (ng/ml)</td><td align=\"left\"/><td char=\".\" align=\"char\"/><td align=\"left\">0.236</td><td char=\".\" align=\"char\">0.149</td></tr><tr><td align=\"left\">FGF-21 (pg/ml)</td><td align=\"left\">0.236</td><td char=\".\" align=\"char\">0.149</td><td align=\"left\"/><td char=\".\" align=\"char\"/></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[]
[ "<table-wrap-foot><p>N.B.: <italic>p</italic> &lt; 0.05 = Significant differences. <italic>SBP</italic> systolic blood pressure, <italic>DBP</italic> diastolic blood pressure, <italic>BMI</italic> body mass index, <italic>WC</italic> waist circumference, <italic>HC</italic> hip circumference.</p><p>*p &lt; 0.05 = significant differences; ** p &lt; 0.01 = highly significant differences.</p></table-wrap-foot>", "<table-wrap-foot><p>N.B.: <italic>p</italic> &lt; 0.05 = Significant differences. <italic>FBG</italic> fasting blood glucose, <italic>HOMA-IR</italic> homeostasis model assessment- insulin resistance, <italic>TG</italic> triglycerides, <italic>HDL</italic> high-density lipoprotein, <italic>LDL</italic> low-density lipoprotein, <italic>FGF-21</italic> fibroblast growth factor 21.</p><p>*p &lt; 0.05 = significant differences; ** p &lt; 0.01 = highly significant differences.</p></table-wrap-foot>", "<table-wrap-foot><p>N.B.: <italic>p</italic> &lt; 0.01 = highly significant differences, <italic>p</italic> &lt; 0.05 = Significant differences. <italic>SBP</italic> systolic blood pressure, <italic>DBP</italic> diastolic blood pressure, <italic>NC</italic> neck circumference, <italic>WC</italic> waist circumference, <italic>HC</italic> hip circumference, <italic>FBG</italic> fasting blood glucose, <italic>HOMA-IR</italic> homeostasis model assessment-insulin resistance, <italic>TG</italic> triglycerides, <italic>HDL</italic> high-density lipoprotein, <italic>LDL</italic> low-density lipoprotein, <italic>FGF-21</italic> fibroblast growth factor 21.</p><p>*p &lt; 0.05 = significant differences; ** p &lt; 0.01 = highly significant differences.</p></table-wrap-foot>", "<table-wrap-foot><p>N.B.: <italic>p</italic> &lt; 0.01 = highly significant differences, <italic>p</italic> &lt; 0.05 = Significant differences. <italic>SBP</italic> systolic blood pressure, <italic>DBP</italic> diastolic blood pressure, <italic>NC</italic> neck circumference, <italic>WC</italic> waist circumference, <italic>HC</italic> hip circumference, <italic>FBG</italic> fasting blood glucose, <italic>HOMA-IR</italic> homeostasis model assessment-insulin resistance, <italic>TG</italic> triglycerides, <italic>HDL</italic> high-density lipoprotein, <italic>LDL</italic> low-density lipoprotein, <italic>FGF-21</italic> fibroblast growth factor 21.</p><p>*p &lt; 0.05 = significant differences; ** p &lt; 0.01 = highly significant differences.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[]
[]
[{"label": ["2."], "surname": ["Hassan", "El-Masry", "El Batrawy", "Khalil", "Ali", "Al Tohamy", "Abo"], "given-names": ["NE", "SA", "SR", "A", "MM", "M", "HM"], "article-title": ["Relationship between breast feeding duration and risk of overweight/obesity among Egyptian children"], "source": ["Egypt. Pediatr. Assoc. Gaz."], "year": ["2018"], "volume": ["66"], "issue": ["1"], "fpage": ["9"], "lpage": ["14"]}, {"label": ["13."], "surname": ["Ghalli", "Salah", "Hussien", "Satorio", "Buckler", "Marazzi"], "given-names": ["I", "N", "F", "A", "JMH", "N"], "article-title": ["Egyptian growth curves for infants, children and adolescents"], "source": ["Crecere Nel Mondo"], "year": ["2008"], "publisher-name": ["Ferring Publisher"]}, {"label": ["14."], "surname": ["Hiernaux", "Tanner", "Weiner", "Lourie"], "given-names": ["J", "JM", "JS", "SA"], "article-title": ["Growth and physical studies"], "source": ["Human Biology: Guide to Field Methods"], "year": ["1969"], "publisher-loc": ["London"], "publisher-name": ["IBP"]}, {"label": ["15."], "surname": ["Tietz"], "given-names": ["NW"], "source": ["Clinical Guide to Laboratory Tests"], "year": ["1995"], "edition": ["3"], "publisher-name": ["WB Saunders Co."]}, {"label": ["20."], "surname": ["Mohamed", "Maher", "Abozaid", "Moenes"], "given-names": ["NS", "SE", "SM", "HM"], "article-title": ["Anthropometric and metabolic pattern in obese Egyptian children: Its association with C-reactive protein"], "source": ["Egypt. Pediatr. Assoc. Gaz."], "year": ["2020"], "volume": ["68"], "issue": ["1"], "fpage": ["1"], "lpage": ["6"]}, {"label": ["26."], "surname": ["Akduman", "\u015e\u0131klar", "\u00d6zsu", "Do\u011fan", "K\u0131r", "Berbero\u011flu"], "given-names": ["F", "Z", "E", "\u00d6", "MK", "M"], "article-title": ["FGF21 levels and bone mineral density in metabolically healthy and metabolically unhealthy obese children"], "source": ["J. Clin. Res. Perdiatr. Endocrinol."], "year": ["2022"], "volume": ["14"], "issue": ["4"], "fpage": ["433"], "lpage": ["443"], "pub-id": ["10.4274/jcrpe.galenos.2022.2022-1-15"]}, {"label": ["28."], "surname": ["Kami\u0144ska", "Kopczy\u0144ska", "Bronisz", "Zmudzi\u0144ska", "Bieli\u0144ski", "Borkowska", "Tyrakowski", "Junik"], "given-names": ["A", "E", "A", "M", "M", "A", "T", "R"], "article-title": ["An evaluation of visfatin levels in obese subjects"], "source": ["Endokrynol. Polska"], "year": ["2010"], "volume": ["61"], "issue": ["2"], "fpage": ["169"], "lpage": ["173"]}, {"label": ["30."], "surname": ["Alnowihi", "Al Doghaither", "Osman"], "given-names": ["SM", "HA", "NN"], "article-title": ["Serum visfatin concentration and its relationship with sex hormones in obese Saudi women"], "source": ["Int. J. Health Sci."], "year": ["2020"], "volume": ["14"], "issue": ["3"], "fpage": ["9"], "lpage": ["13"]}]
{ "acronym": [], "definition": [] }
30
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1190
oa_package/a1/16/PMC10786883.tar.gz
PMC10786884
38216654
[ "<title>Introduction</title>", "<p id=\"Par2\">European peatlands cover approximately 60 million ha<sup>##UREF##0##1##,##UREF##1##2##</sup>, and a substantial proportion of this has been degraded by unsustainable land use practices, such as agriculture, forestry, and peat extraction. Consequently, almost 44% can no longer accumulate peat<sup>##UREF##2##3##</sup>. Tanneberger et al.<sup>##UREF##3##4##</sup> indicated that degraded peatlands in the European Union (EU) represent half of the globally degraded peatlands. In Ireland, peatlands cover ~ 1.46 million ha (21% of Ireland) and consist of two types of bogs: blanket bogs (~ 900,000 ha) and the globally rare Oceanic raised bog (~ 530,000 ha)<sup>##UREF##4##5##,##UREF##5##6##</sup>. It is estimated that they store between 60 and 75% of the national Soil Organic Carbon (SOC) stock<sup>##UREF##6##7##–##UREF##8##9##</sup> but land use practices have led to the degradation of about 95% of these peatlands<sup>##UREF##5##6##,##UREF##9##10##–##REF##36755174##13##</sup>.</p>", "<p id=\"Par3\">These land use activities harm the hydrological and ecological functioning of peatland ecosystems, turning them from a net sink to a source of C<sup>##UREF##12##14##</sup>. It also results in a consistently lowered water table, which accelerates peat decomposition, releases dissolved organic carbon (DOC) and particulate organic carbon (POC) and alters carbon and greenhouse gas (C and GHG) fluxes<sup>##UREF##13##15##,##UREF##14##16##</sup>. Hence, these ecosystems, which in their natural condition are significant C stores and are crucial to the prevention of natural disasters such as landslides, fires, and floods<sup>##UREF##15##17##</sup>, become susceptible to them<sup>##UREF##16##18##–##UREF##18##20##</sup>. Despite this, Irish peatlands still contribute to various hydrological and ecological functions and cultural, and socio-economic values<sup>##UREF##5##6##,##UREF##19##21##</sup>.</p>", "<p id=\"Par4\">The land use practices on peatlands in Ireland are similar to those in Europe, including drainage for industrial and domestic peat extraction, agriculture (mostly grasslands), afforestation and infrastructure development (roads, wind farms, airports etc.)<sup>##UREF##11##12##,##UREF##20##22##,##UREF##21##23##</sup>. As a result, it is estimated that less than 1% of raised bogs in Ireland are actively forming peat as of 2017<sup>##UREF##22##24##</sup>. This is particularly due to the intensification of land use through industrial peat extraction, afforestation and agriculture, which is a relatively recent development (since the 1940s), but has caused more damage in a short period of time<sup>##UREF##20##22##</sup>. The establishment of Bord na Móna (BnM), a semi-state-owned company, in 1946 for industrial peat extraction had a notable impact on raised bogs. Approximately 90% of the BnM landholdings are situated on raised bogs, and the majority of those (~ 90%) have been drained and/or opened for peat extraction<sup>##UREF##59##62##</sup>. BnM ceased extraction activities in 2021<sup>##UREF##23##25##</sup>, however, there are still several medium-sized companies engaged in industrial peat extraction, including Harte, Klasmann-Deilmann, Bulrush, Clover, Erin, and Westland, as well as ~ 30 other small producers<sup>##UREF##10##11##,##UREF##12##14##</sup>. Coillte, a semi-private afforestation company established in 1989, has afforested approximately 31,000 ha of raised bogs. The provision of grants through the Common Agricultural Policy (CAP) for the reclamation of raised bog edges for agriculture has also contributed to the intensification of land use in these ecosystems. However, spatially explicit data on the extent of these activities (especially non-BnM industrial activities) and domestic peat extraction activities is non-existent<sup>##UREF##24##26##</sup>. The absence of such data prevents accurate quantification of emissions from managed peatlands and hinders the formulation of effective conservation strategies.</p>", "<p id=\"Par5\">As a signatory to the United Nations Framework Convention on Climate Change (UNFCCC), Ireland has an obligation to report and account for its GHG emissions and removals and meet its emission targets for Land Use, Land Use Change, and Forestry (LULUCF), including wetlands, as outlined in the EU's 2030 climate change framework<sup>##UREF##25##27##</sup>. Several studies have been conducted on Irish raised bogs at small spatial scales to gain insights into the effect of land use conversion activities on C and GHG dynamics, such as losses through land, atmospheric, and fluvial emissions<sup>##UREF##26##28##,##UREF##27##29##</sup>. These local-scale effects can have regional and global consequences; yet information on land use status and associated emissions from these ecosystems remains poorly understood at the national, regional, and global levels<sup>##UREF##28##30##</sup>. To propagate local-scale emission measurements to a national scale and accurately account for peatland emissions, spatially explicit information on peatland land use is essential<sup>##UREF##12##14##,##UREF##24##26##</sup>. Andersen et al.<sup>##UREF##29##31##</sup> emphasise the importance of land use/cover data in understanding degradation and restoration. However, national and global land-use/cover maps often exclude activities such as peat extraction, forest and abandoned peat extraction sites<sup>##UREF##3##4##</sup>. This makes these datasets inadequate for understanding degradation through land use, monitoring conservation activities (rehabilitation, restoration, and rewetting), and assessing C and GHG emission dynamics.</p>", "<p id=\"Par6\">To report emissions from wetlands, the Intergovernmental Panel on Climate Change (IPCC) has proposed a system consisting of three tiers: Tier 1 (T1) includes default EF and is specifically for wetlands and Tier 2 (T2) EFs are country specific and based on the emission data from case studies. The Tier 3 (T3) EFs use more complex and dynamic models. The default T1 EFs are derived from limited data available from sites with different geographical, climatic, and ecological conditions. Ireland reports emissions from peatlands based on T1 EFs except for industrial peat extraction sites and forests on drained peatlands, where country-specific EF values are being used<sup>##UREF##30##32##</sup>. However, the reliance on coarse spatial resolution (25 ha) CORINE (Co-ordinated Information on the Environment) land cover data and non-spatially explicit information for reporting purposes make the national emission estimates less accurate. Given these limitations, it is essential to develop peatland-specific land use maps that can be used for more accurate upscaling of emissions from site to regional, national, and global scales using IPCC methods. Furthermore, these maps are vital for supporting conservation activities, sustainable land management practices, and policy-related decision making.</p>", "<p id=\"Par7\">This study aims to map the much-needed spatial distribution of land use on raised bogs in Ireland and quantify the corresponding C and GHG emissions<sup>##UREF##4##5##,##UREF##31##33##,##UREF##32##34##</sup>. The spatial extent of raised bogs was based on the DIPMv2 (Derived Irish Peat Map version 2), which is the latest peatland extent map integrating data from multiple sources<sup>##UREF##4##5##</sup>. Spatially explicit information on land use can be obtained using remote sensing methods. However, the persistent cloud cover inherent to the temperate maritime climate of Ireland poses a challenge to the acquisition of frequent cloud-free optical remote sensing images<sup>##UREF##34##36##</sup>. Consequently, it is particularly difficult to map national-scale land cover and land use. Previous attempts to map land cover at a national scale in Ireland have encountered similar difficulties and full coverage has not been achieved<sup>##UREF##34##36##–##UREF##37##39##</sup>. Connolly<sup>##UREF##11##12##</sup> successfully mapped industrial, grassland and forestry on peatlands in Ireland, including raised bogs, but was unable to map domestic peat extraction, because of medium spatial resolution of the data (23 m) and cloud cover issues.</p>", "<p id=\"Par8\">Google Earth Engine (GEE), a planetary-scale cloud computing platform<sup>##UREF##38##40##</sup>, integrates freely available high-resolution satellite imagery such as Sentinel-2, as well as machine learning algorithms such as random forest. By leveraging a vast archive of satellite imagery and employing temporal mosaicking functions within GEE, it is possible to obtain cloud-free imagery with wall-to-wall coverage and use it to map land use in areas where cloud cover impedes optical remote sensing<sup>##UREF##39##41##–##REF##37745890##43##</sup>. This approach was used in this study to obtain cloud-free imagery by mosaicking annual images acquired for three years i.e., from 1st January 2018 to 31st December 2020. As a result, the first national-scale land use map of raised bog with seven classes was developed. The classes were derived from the Land Use Classification of Irish Peatlands (LUCIP), which was developed for this study through discussions with various stakeholders including NPWS (National Parks and Wildlife Service), BnM, and an ecologist. The classes in LUCIP includes cutover, cutaway, grassland, forestry, remnant peatlands, water bodies, and built-up areas. The map enabled the assessment of the spatial extent of land use in raised bogs. It is further used to estimate CO<sub>2</sub> emissions using site-specific EFs from case studies in Ireland<sup>##UREF##24##26##</sup>, which are then presented along with IPCC T1 EFs. This work will provide better insight into C dynamics at the site scale, with an emphasis on the importance of high-resolution maps for area estimation and country specific EFs.</p>" ]
[ "<title>Material and methods</title>", "<title>Study area</title>", "<p id=\"Par9\">The study area for this research was based on the spatial extent of raised bogs derived from the DIPMv2<sup>##UREF##4##5##</sup>. Raised bogs are predominantly situated in the midlands of Ireland and are a distinctive feature of this inland region. They cover ~ 530,000 ha of the surface area and constitute ~ 35% of the total peatland area in Ireland and 8% of the total land surface area. Irish raised bogs represent more than 50% of oceanic-raised bogs in the EU<sup>##UREF##33##35##</sup>.</p>", "<title>Satellite image data</title>", "<p id=\"Par10\">Copernicus Sentinel-2-MSI (Multi-Spectral Instrument) optical remote sensing satellite images were used in this study and the images were acquired by Sentinel 2- A and B. The Sentinel-2 sensor has 13 spectral bands, 10 of which were used in this study: Red (R), Green (G), Blue (B), Near Infrared (NIR) and Narrow NIR, three of the Vegetation Red Edge, and two of the Short-Wave Infrared (SWIR)<sup>##UREF##41##44##</sup>. Table ##TAB##0##1## shows the spectral and spatial resolutions of the bands used in this study. The RGB and NIR bands have a spatial resolution of 10 m while the rest were resampled from 20 to 10 m. The sensor has a swath width of 290 km<sup>##UREF##41##44##</sup>.</p>", "<p id=\"Par11\">GEE provides the Sentinel-2-MSI Level-2A (L2A) image archive dating back to March 2017. This study used the atmospherically corrected products:L2AS2_SR (Sentinel-2 Surface Reflectance). They are corrected for atmospheric, slope and adjacency effects. L2A processing is based on a two-step process i.e., (1) scene classification (SC), which is used to derive a pixel classification map for vegetation, snow, soil, cloud shadows and cloud and (2) Sentinel-2 Atmospheric Correction (S2AC) which is used to convert the Top of Atmosphere (TOA) reflectance to BOA (Bottom of Atmosphere) values. The S2AC process is based on the library for Radiative transfer (libRadtran) model<sup>##UREF##43##46##,##UREF##44##47##</sup>. It provides cloud, haze, and water removal methods. To enhance the classification process, the vegetation and water indices were calculated and included as additional bands. The Normalised Difference Vegetation Index (NDVI) with values ranging from 0.1 to 1 indicates the presence and health of vegetation<sup>##UREF##45##48##</sup> (Eq. ##FORMU##0##1##), while the Normalised Difference Water Index (NDWI) with values ≥ 0.5 indicating the presence of open water<sup>##UREF##46##49##</sup> (Eq. ##FORMU##1##2##).</p>", "<title>Image classification methods</title>", "<p id=\"Par12\">A remote sensing image classification-based approach was used in this study and implemented in GEE and ArcGIS Pro desktop version 2.7 (ArcPro from here onwards). The approach consisted of accessing, pre-processing, and classifying land use using LUCIP in GEE. Accuracy assessment was conducted using ArcPro. The imagery was accessed on a national scale and constrained to Irish-raised bogs using the DIPMv2. An overview of this process is shown in Fig. ##FIG##0##1##.</p>", "<title>Image pre-processing</title>", "<p id=\"Par13\">Despite the high temporal resolution (five days) of Sentinel-2 (A and B), obtaining a cloud-free mosaic for wall-to-wall coverage of raised bogs in Ireland was challenging. To address this, it is important to develop an efficient cloud removal methodology. Accordingly, a temporal filter was applied to obtain imagery over three years (1st January 2018 – 31st December 2020). A selection criterion to obtain images with less than 10% cloud cover was also applied; a percentage greater than this would return cloud-contaminated images that were not useful for analysis. Based on these criteria, 1483 images were available. The remaining cloudy pixels were masked out using a cloud masking function (<italic>masksS2clouds)</italic> which is based on the ‘QA60’ quality flag band used for cloud and cirrus. Finally, the images were stacked together to generate a single cloud-free composite using the median (<italic>ee.reducer</italic>) composite function available in GEE. This also helped eliminate pixels with extreme values, thus removing the remaining artefacts. The final image was composed of pixels with minimal or no cloud cover.</p>", "<title>Training sample data</title>", "<p id=\"Par14\">The training and validation data used in this study were independent of each other. The training data was based on randomly generated sample polygons created within GEE for each land use class (Table ##TAB##1##2##). Validation sample points were generated using ArcPro. A classification schema (LUCIP) was developed to identify seven land-use classes: cutover, cutaway, grassland, forestry, remnant peatlands (high bog), and built-up/infrastructure areas (Table ##TAB##1##2##).</p>", "<p id=\"Par15\">The collection of training data was based on the visual interpretation technique, which was used by an expert operator to generate randomly distributed sample polygons for each land use class<sup>##UREF##47##50##</sup>. The training data consisted of 366 polygons (148405 pixels) that were randomly distributed across the study area (Table ##TAB##2##3##).</p>", "<p id=\"Par16\">The spectral signature of each land use class is shown in Fig. ##FIG##1##2##. The mean reflectance values across multiple Sentinel-2 bands demonstrate significant spectral separability in the visible and NIR range i.e., 0.49 to 0.78 µm. Notably, built-up areas exhibit high reflectance, whereas water has low reflectance, making them significantly distinguishable. Cutaway and grassland show high reflectance in the NIR region. Cutover and remnant peatlands, however, may exhibit some similarities, given that the cutover class includes dynamic vegetation environment. The spectral separability for most classes diminishes for longer wavelength bands, specifically at 1.61 and 2.19 µm. Nevertheless, differences in spectral reflectance between all the classes remain prominently discernible, underscoring the effectiveness of the sampling procedure employed for land use classification.</p>", "<title>Classification of satellite imagery</title>", "<p id=\"Par17\">The random forest classification model, an ensemble classifier<sup>##UREF##48##51##,##UREF##49##52##</sup>, was trained using training data. The random forest algorithm is based on an ensemble of several decision trees, each with multiple nodes<sup>##UREF##48##51##</sup>. Classification was implemented using the GEE platform. A slightly improved version of the random forest model known as the Statistical Machine Intelligence and Learning Engine (SMILE) random forest algorithm was used in this study<sup>##UREF##50##53##</sup>. The classification model was trained using the training data, with the number of variables and number of trees being the two critical parameters. The optimal values of these parameters were determined using the square root of the number of features and trial-and-error method. Based on these procedures, the optimal number of trees was determined as 20. Each tree in the model consists of multiple nodes, and each pixel is assigned a label by each tree. The final label for each pixel is determined by aggregating the labels assigned by all trees through a majority vote<sup>##UREF##48##51##</sup>. The random forest model and its optimisation procedures were implemented using the GEE. The variable importance for all spectral bands, NDVI, and NDWI were also assessed. Spectral reflectance bands (2, 5, 12, and 11) were ranked higher, while NDVI and NDWI were ranked lower (see Supplementary Fig. ##SUPPL##0##S1## online). The accuracy of the final output map was assessed using the validation data.</p>", "<title>Validation (accuracy assessment)</title>", "<p id=\"Par18\">After conducting a qualitative accuracy assessment (visual evaluation), the final map was downloaded from GEE and imported into ArcPro. An overall quantitative accuracy assessment was conducted using ArcPro, with independent validation point sample data (Table ##TAB##2##3##). Yelena and Antonia<sup>##UREF##51##54##</sup> emphasise the importance of using higher-quality reference data derived through a sampling approach to assess the accuracy of land use maps. They further noted that the data could be based on field sampling or a higher resolution spatial resolution aerial imagery. The latter approach was used in this study since the first approach could be laborious and time-consuming for national scale mapping. The “create accuracy assessment tool” in ArcPro was used with a stratified random sampling strategy<sup>##UREF##52##55##</sup>. The tool generates random points, and the sample size is based on the proportion of the area for each class. This process ensures that a sufficient number of reference samples is created for each stratum (class)<sup>##UREF##52##55##</sup>. A total of 1460 points were obtained (Table ##TAB##2##3##). Each validation sample data point was assessed and manually labelled through the visual interpretation of very high-resolution aerial imagery (25 cm) by a single expert operator. After completion of manual labelling, a confusion matrix for accuracy assessment was generated using the “compute confusion matrix” tool in ArcPro. This was performed by comparing the classes obtained using the classification model with the ground truth data. Multiple statistics were derived from the confusion matrix to quantify the map accuracy. These include the Overall Accuracy (OA), overall agreement between classification (map), and ground truth for all classes. The User's accuracy (UA) measures the agreement between the classified pixels and the ground-truth data for a specific class from the user's perspective, whereas the Producer's accuracy (PA) measures the agreement between the classified pixels and the ground-truth data for a specific class from the producer's perspective<sup>##UREF##53##56##</sup>. Lastly, owing to the presence of errors in the classification results, a simple pixel counting method to calculate the land use area is not adequate. Therefore, ‘good practices’, as suggested by Olofsson et al.<sup>##UREF##52##55##</sup> were used to generate an area-based error matrix and calculate the unbiased land-use area for each class.</p>", "<title>CO<sub>2</sub> emission calculations</title>", "<p id=\"Par19\">CO<sub>2</sub> emissions were calculated using the IPCC T1 EFs and literature-based T2 EFs using Eq. (##FORMU##2##3##). Four dominant land use classes (cutaway, cutover, forestry, and grassland), which cover ~ 85% of the total raised bog land use area (Fig. ##FIG##2##3##) were used for emission estimation. For the remaining classes (remnant peatlands, water bodies, and built-up areas), neither T1 nor T2 emission factors were available; therefore, CO<sub>2</sub> emissions could not be estimated. T1 default EFs from the IPCC Wetland Supplement (2013) and T2 EFs by Aitova et al.<sup>##UREF##24##26##</sup> which are based on case studies in Ireland for grasslands, cutover and cutaway sites were used. The EF for forestry is based on eight drained and afforested peatland sites in Ireland<sup>##UREF##54##57##</sup>.where <italic>t</italic> is tons, ha is hectares, <italic>y</italic> represents a year, and EF is the land use specific emission factor.</p>" ]
[ "<title>Results</title>", "<p id=\"Par20\">The statistics for the area of each land use class in raised bogs obtained using the error matrix (see Supplementary Table ##SUPPL##0##S1## online) are presented in Fig. ##FIG##2##3##. Almost half of the raised bogs mapped in this study are covered by grassland i.e., 43% (244,100 ha). Forest covers about 21% (116,427 ha), cutaway 10% (54,302 ha) and cutover cover 11% (646,99 ha). Remnant peatlands (high bog) area covers about 13% (73,795) ha. Water bodies and built-up areas account for about 1% (1542 ha and 1358 ha, respectively). The water bodies here constitute both natural waterways included in the coarse resolution DIPMv2 and surface water on raised bog appearing possibly after rewetting activities.</p>", "<p id=\"Par21\">The prevalence of land use activities can be seen across all raised bogs in the midlands of Ireland Fig. ##FIG##3##4##. Industrial peatland extraction sites are primarily located in the midlands (Fig. ##FIG##3##4##a) and some parts of the north (Fig. ##FIG##3##4##b and c) and south (Fig. ##FIG##3##4##f) of the midlands. Approximately 65% of these industrial extraction sites are owned by BnM. The other 35% constitute non-BnM peat extraction carried out on an industrial scale similar to BnM (Fig. ##FIG##3##4##d and e). BnM landholding and Special Area of Conservation (SAC) boundary data were used to further examine the distribution of land use to better understand the status and condition of raised bogs under different management regimes, i.e., industrial and protected (Table ##TAB##3##4##). Additionally, Coillte landholding boundary data was also used to assess land use. It owns ~ 31,000 ha of raised bog areas accounting for about one-third of the total forestry on these bogs.</p>", "<p id=\"Par22\">The exposed peat on BnM landholdings amounts to around 42,264 ha. The rest of the cutaway bogs, totalling about 2,460 ha, are in SAC, highlighting the existence of a substantial amount of bare peat on these “protected” bogs with active cutting also taking place<sup>##UREF##55##58##</sup>. Cutaway bogs in midlands have interspersed forestry (Fig. ##FIG##3##4##a). The areas on the edges of these bogs represent agricultural grasslands. The remnant peatlands in the midlands and are mostly on SAC sites such as Clara Bog, Ferbane Bog, Moyclare Bog, and Raheenmore Bog (Fig. ##FIG##3##4##a). Overall, there is about 13,053 ha of the remnant peatlands located on the SAC, which is approximately 1% of the total peatland area and most of the “actively forming raised bogs” are possibly located in these sites<sup>##UREF##56##59##</sup>. The majority of the remnant peatlands are in the west of the midlands and are surrounded by peat-extraction activities (Fig. ##FIG##3##4##d and e). Lastly, the scattered water bodies on cutaway sites in the Midlands and some parts in the North are possible signs of some of the rewetting activities being carried out by BnM (Fig. ##FIG##3##4##a and b).</p>", "<title>CO<sub>2</sub> emissions</title>", "<p id=\"Par23\">CO<sub>2</sub> emissions presented in Table ##TAB##4##5## are calculated using Eq. (##FORMU##0##1##) for the four land use classes. The area (ha) is estimated from the land use map (Fig. ##FIG##3##4##). T1 emissions were ranging between 303,710 and 1,293,730 t CO<sub>2</sub>-C ha<sup>−1</sup> y<sup>−1</sup> with grassland being the highest emitters followed by forestry, cutover, and cutaway. T2 emissions were in the range of 65,705–317,330 t CO<sub>2</sub>-C ha<sup>−1</sup> y<sup>−1</sup>, with the highest emissions in grassland and the lowest emissions in cutaway. The T1 emissions for grassland were four-fold higher than T2 emissions. The total CO<sub>2</sub> emissions from Irish-raised bogs based on the four land use classes mapped here account for 0.68 Mt CO<sub>2</sub>-C ha<sup>−1</sup> y<sup>−1</sup> as per T2 and 1.92 Mt CO<sub>2</sub>-C y<sup>−1</sup> as per T1.</p>", "<title>Accuracy assessment</title>", "<p id=\"Par24\">The OA of the final land use map was 89% which is computed from the diagonal line of the confusion matrix (Table ##TAB##5##6##), representing the number of correctly classified classes. A total of 1303 of 1460 points were correctly classified. The UA ranges from 70% (water and cutover) to 96% (forest), and PA ranges from 64% (built-up) to 97% (cutaway).</p>", "<p id=\"Par25\">The results show the highest PA for cutaway (97%) and grassland classes (93%) while remnant peatlands (75%) and built-up (64%) have the lowest PA. Forestry (97%), grassland (94%) and remnant peatlands (91%) all show high UA, while built-up (68%), cutover and water (70%) show low UA. The lower UA of the cutover class (70%) can be attributed to the presence of heterogeneous vegetation, resulting in a mosaic landscape following the abandonment of extraction sites. As a result, this class is prone to misclassification, particularly with remnant peatlands (another landscape characterised by heterogeneity) (Fig. ##FIG##1##2##). The lower UA of water bodies (70%) and misclassification with forestry can be attributed to overlap in spectral signatures in partially vegetated and surface water areas, as shown in Fig. ##FIG##3##4##.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par26\">The degradation of Irish-raised bogs due to centuries of human exploitation is widely acknowledged<sup>##UREF##5##6##,##UREF##11##12##,##REF##36755174##13##</sup>. Nevertheless, a significant knowledge gap exists in the absence of “robust aerial data” for accurate assessment of land use on the raised bog<sup>##UREF##12##14##,##UREF##24##26##</sup>. This gap in spatial data is addressed through the development of the LUCIP taxonomy and its implementation in GEE using Sentinel-2 data. This study provides the first high-resolution wall-to-wall coverage of land use on raised bogs in Ireland. The robust methodology presented here facilitates an accurate assessment of the magnitude and extent of land use and CO<sub>2</sub> emissions on these ecosystems. It utilises cloud computing (GEE), temporal mosaicking, and machine learning (random forest and high-resolution remote sensing imagery (Sentinel-2)) to overcome the issue of persistent cloud cover in Ireland. The accuracy assessment results (overall accuracy of 89%) showed good agreement between the map and the reference data.</p>", "<p id=\"Par27\">Currently, the Irish National Inventory Report (NIR) only considers peat extraction activities (industrial/domestic) in the “managed wetlands” category for all peatlands (blanket and raised bogs). This area is reported as 70,020 ha, of which 400 ha is domestic cutover with the remainder being industrial cutaway, and emissions calculations in the NIR are also reliant on these area estimates<sup>##UREF##30##32##</sup>. In literature, this figure is ~ 80,000 ha, which is mainly the BnM landholding<sup>##UREF##11##12##,##UREF##12##14##,##UREF##30##32##,##UREF##57##60##</sup>. However, the findings of our study which focused only on raised bogs, indicate that peat extraction (cutaways and cutovers) is considerably more prevalent than currently reported and extends to approximately 119,000 ha. This is 70% higher than the NIR-reported “managed wetland” area figures for all peatlands. Hence, we address the overall ambiguity in exisiting land use estimates by providing accurate spatially explicit land use information derived from robust remote sensing methods.</p>", "<p id=\"Par28\">The results depict heterogeneous land use in raised bogs across Ireland. The midland raised bogs (Fig. ##FIG##3##4##a, b, c, and f) are dominated by industrial mining activities as well as conversion to grassland and forestry. The more peripheral raised bog areas to the west, northwest, and southwest of the midlands are dominated by conversion to grassland and forestry. In general, the most extensive land use on raised bogs is agricultural grassland which is distributed across the region. Grasslands mainly occur on the margins of cutaway, cutover and remnant peatlands. The remnant peatland class, which represents the remaining areas of the raised bogs, are not in pristine condition, and are more abundant towards the North and West of the midlands, away from the areas of intensive industrial peat extraction activities. The BnM Peatland Climate Action Scheme (PCAS) aims to restore degraded peatlands within BnM landholding and is a good start for mitigation and adaptation, which are more intact raised bogs in the north and west that could be targeted for active restoration by policymakers, facilitating carbon retention in these ecosystems. It is also pertinent to mention that the PCAS was initiated at some of the former industrial peat extraction sites during the timeframe of this study. Most of these areas are still bare peat which means the data produced in this study could be used as baseline data for tracking and monitoring the PCAS over time. Overall, the maps show that the current level of human-induced degradation of these raised bogs through land-use change requires immediate action for sustainable management of these ecosystems.</p>", "<p id=\"Par29\">On BnM landholdings, industrial extraction activities have gradually ceased over the past two decades, with an announcement of complete cessation in 2021. The results of this are beginning to be observed in the data. At the Blackwater site (Co. Offaly) site (Fig. ##FIG##4##5##), areas are classified as remnant peatlands, which is an indication of revegetation after the cessation of extraction activities (pre-2000) and subsequent rewetting in 1999<sup>##UREF##58##61##</sup>. These sites are going through a transformation with land use conversion to forestry or a diverse mosaic of vegetation communities composed of heather, shrubs, grasses, and interspersed larger plants. The forestry areas in Fig. ##FIG##4##5##, are on Coillte landholdings and are highlighted with a grey outline. Other areas with surface water are possibly signs of rewetting activities and are represented by surface water here (Fig. ##FIG##4##5##). Vegetation cover at Blackwater has increased over the years, albeit slowly, with Sphagnum mosses and other bog species recolonising the area i.e., sparse remnant peatlands patches among the prevalent bare peat (cutaway) (Fig. ##FIG##4##5##). This recovery process is not only important for carbon sequestration and climate change mitigation but also for the restoration of the unique biodiversity and ecosystem services provided by peatlands. An SAC site is outlined (white dotted line) in the bottom right (Fig. ##FIG##4##5##) and shows a good example of what is considered a “near natural” raised bog e.g., intact centre but degraded margins where substantial cutting has taken place and areas converted to grassland. These changes can be seen using Sentinel-2 which demonstrates the utility of this methodology for tracking and monitoring land use change in raised bogs over time.</p>", "<p id=\"Par30\">The EU has established a range of regulations and initiatives that directly or indirectly require restoration and sustainable management of peatlands. These include the Habitats Directive (Council Directive 92/43/EEC), Water Framework Directive (Directive 2000/60/EC), EU Biodiversity Strategy for 2030, Common Agricultural Policy (CAP), Natura 2000 Network (Directive 2009/147/EC), LIFE Programme, EU Climate Adaptation Strategy, and more recently the Nature Restoration Law which includes restoration of peatlands by binding targets and net zero CO<sub>2</sub> emissions from these ecosystems by 2050. The effective implementation of these initiatives is only possible through robust mapping, tracking, and monitoring<sup>##UREF##59##62##</sup> methodologies such as those proposed in this study.</p>", "<p id=\"Par31\">The map produced here serve as an important indicator for determining the baseline status and condition of these ecosystems as well as providing a quantification of CO<sub>2</sub> emissions hotspots. By providing a detailed map of BnM/non-BnM industrial activities and domestic extraction activities, this study not only highlights these activities in a spatial context but also estimates emissions from them. The emissions calculated in this study based on IPCC T1 and Ireland-specific T2 EF show a substantial difference. The IPCC default emission factor is higher than the Irish T2 EF resulting in higher emission estimation. One of the limitations of using IPCC T1 EFs is that these EF are based on limited case studies with diverse geographical locations, climatic conditions and ecology not necessarily suited to Irish Peatlands. The EFs proposed by Aitova et al.<sup>##UREF##24##26##</sup> and the EFs from the study by Jovani‐Sancho<sup>##UREF##54##57##</sup> are based on measurements from specific sites in Ireland, the United Kingdom and Germany, and may not be a true representatives of other sites in the country. For example, T1 EFs for grasslands (5.3 t CO<sub>2</sub>-C ha<sup>−1</sup> y<sup>−1</sup>) are mostly based on study sites from Germany, which are under more intensive management practices compared to Ireland<sup>##UREF##24##26##,##UREF##60##63##</sup>. This may lead to a substantial difference when comparing T2 EFs for grasslands in Ireland (1.30 t CO<sub>2</sub>-C ha<sup>−1</sup> y<sup>−1</sup>)<sup>##UREF##24##26##</sup>. While these EFs could be refined specifically for Ireland, their use by Aitova et al.<sup>##UREF##24##26##</sup> is a significant improvement compared to the T1 EFs. Finally, the delineation of raised bogs in this study relies on an existing peatland extent map i.e., DIPMv2. Although, DIPMv2 is most current peatland map in Ireland, with an overall accuracy of 88%, it tends to underestimate the presence of peatlands with areas smaller than 7 ha<sup>##UREF##4##5##</sup>. This study can be expanded to these missing areas if the DIPMv2 is updated in the future.</p>", "<p id=\"Par32\">Nevertheless, this study demonstrates the robustness and utility of remote sensing methods to accurately map the land use on peatlands and to integrate these data with the latest T2 EFs thus refining estimates of CO<sub>2</sub> emissions from different land use on Irish peatlands. The LUCIP implemented in GEE facilitates the development of highly accurate land use maps that can aid the refinement of national-scale T2 reporting in these globally rare ecosystems. These integrated spatial datasets can help inform decision-making for sustainable land management practices and conservation. Furthermore, detailed habitat mapping of the remnant peatland class using a high-resolution dataset and integrated Sentinel-1 and 2 approach could be useful for monitoring active raised bog areas in SAC<sup>##UREF##40##42##,##REF##37491422##64##</sup>. Future work using the LUCIP could address the large knowledge gap regarding land use type and extent on blanket bogs, which account for ~ 70% of peatlands in Ireland and have not been studied at this level in Ireland. It is important that the EFs and emissions are assessed for these areas to identify C and GHG emission hotspots and areas for targeted restoration.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par33\">In this study, a spatially explicit dataset of land use on Irish raised bogs was created by integrating the DIPMv2 and Sentinel-2 satellite images collected between 2018 and 2020. Overall, the accurate results (OA = 89%) of this study provide valuable insights into the spatial extent of land use in raised bogs in Ireland. These data were integrated with T2 EFs to refine the estimation of CO<sub>2</sub> emissions from the four major land classes on raised bogs. These spatial data on land use can inform policies on land use and emissions at a national scale. The map also enhances the current understanding of the extent and scale of different land uses (especially peat-extraction activities) in a spatial context. The state and condition of raised bogs in Ireland present a pressing concern due to their substantial CO<sub>2</sub> emissions. Urgent measures are required to address this issue, including (i). mitigating emissions and (ii). implementing sustainable management practices to promote carbon sequestration within these ecosystems and prevent additional degradation. This spatial information can be used to inform the development of more sustainable approaches to peatland management in the country, the decision-making process for developing such policies and effective strategies to mitigate these management impacts.</p>" ]
[ "<p id=\"Par1\">Ireland has &gt; 50% of the EU’s ocean-raised bogs; however, degradation through land-use activities has transformed them from carbon (C) sinks to sources. Given their significant role in climate mitigation, it is essential to quantify the emissions resulting from land use degradation of these ecosystems. A seven-class land-use classification system for Irish peatlands (LUCIP) was developed and mapped using Sentinel-2 imagery, random forest machine learning and Google Earth Engine. The results revealed that agricultural grassland comprised 43% of the land use on raised bogs, followed by, forestry (21%), cutover (11%), cutaway (10%) remnant peatlands (13%), waterbodies and built-up ~ 1% each. The overall accuracy of the map was 89%. The map was used to estimate CO<sub>2</sub> emissions for four classes constituting 85% of raised bogs: cutover, cutaway, grassland, and forestry using the IPCC wetlands supplement and literature-based emission factors, we estimated emissions at ~ 1.92 (± 1.58–2.27 Mt CO<sub>2</sub>-C-yr<sup>−1</sup>) and ~ 0.68 Mt CO<sub>2</sub>-C-yr<sup>−1</sup> (± 0.44–0.91 Mt CO<sub>2</sub>-C-yr<sup>−1</sup>) respectively. This is the first study to spatially quantify land use and related emissions from raised bogs. The results have revealed widespread degradation of these globally rare habitats, making them net emitters of CO<sub>2</sub>. The map is vital for the conservation of these ecosystems through restoration efforts, and the methodology can also be applied to other regions with similar peatland land use issues.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51660-0.</p>", "<title>Acknowledgements</title>", "<p>The work presented in this paper is part of the Smart Observation of Management Impacts on Peatland Function (SmartBog) project. The project is funded under the EPA Research Programme 2014-2020 (Grant no. 2018-CCRP-LS-2). The EPA Research Programme is a Government of Ireland initiative funded by the Department of Communications, Climate Action and Environment. The authors would also like to gratefully acknowledge the contribution of Dr. Catherine Farrell to the development of LUCIP.</p>", "<title>Author contributions</title>", "<p>W.H. lead the preparation, creation and/or presentation of the published work, specifically writing the initial draft. He took a lead role in the development and design of the methodology using Remote Sensing and GIS analysis in both GEE and ArcPro as well as in data curation. Both W.H. and J.C. conceptualised the study. R.I. contributed to the emission calculations. Both M.S. and J.C. contributed to the review and editing of the manuscript.</p>", "<title>Data availability</title>", "<p>The datasets used and/or analysed during the current study are available from the corresponding author upon reasonable request.</p>", "<title>Competing interests</title>", "<p id=\"Par34\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Data processing workflow. NIR (Near Infrared), SWIR (Shortwave Infrared), NDVI (Normalised Difference Vegetation Index), Normalised Difference Water Index (NDWI), QA60 (Quality Assessment) band for cloud and cirrus masking, and DIPMv2 (Derived Irish Peat Map version 2).</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Spectral reflectance of the land use types across the ten spectral bands (Sentinel-2).</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Land use area in kilo hectares (kha) for each class, error bars for standard errors in kha.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Land use on raised bogs. (<bold>a</bold>), (<bold>b</bold>), (<bold>c</bold>) and (<bold>f</bold>) are dominated by industrial peat extraction sites (mostly Bord na Móna), whereas (<bold>d</bold>) and (<bold>e</bold>) have a mix of remnant peatland, cutover, grassland, and forest.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Typical example of a former industrial bog complex mapped in this study. The areas outlined by the black dotted lines are within the BnM (Bord na Móna) landholdings, whereas the white dotted lines in the southeast section of the map show a bog under SAC (Moyclare Bog). The grey boundaries in the BnM landholdings and outside of it are Coillte landholdings.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Characteristics of sentinel-2 bands<sup>##UREF##42##45##</sup>.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Bands</th><th align=\"left\">Central wavelength (µm)</th><th align=\"left\">Spatial resolution (m)</th></tr></thead><tbody><tr><td align=\"left\">Band 2—Blue</td><td char=\".\" align=\"char\">0.490</td><td align=\"left\">10</td></tr><tr><td align=\"left\">Band 3—Green</td><td char=\".\" align=\"char\">0.560</td><td align=\"left\">10</td></tr><tr><td align=\"left\">Band 4—Red</td><td char=\".\" align=\"char\">0.665</td><td align=\"left\">10</td></tr><tr><td align=\"left\">Band 5—Vegetation red edge</td><td char=\".\" align=\"char\">0.705</td><td align=\"left\">20</td></tr><tr><td align=\"left\">Band 6—Vegetation red edge</td><td char=\".\" align=\"char\">0.740</td><td align=\"left\">20</td></tr><tr><td align=\"left\">Band 7—Vegetation red edge</td><td char=\".\" align=\"char\">0.783</td><td align=\"left\">20</td></tr><tr><td align=\"left\">Band 8—NIR</td><td char=\".\" align=\"char\">0.842</td><td align=\"left\">10</td></tr><tr><td align=\"left\">Band 8a—NNIR</td><td char=\".\" align=\"char\">0.865</td><td align=\"left\">20</td></tr><tr><td align=\"left\">Band 11—SWIR</td><td char=\".\" align=\"char\">1.610</td><td align=\"left\">20</td></tr><tr><td align=\"left\">Band 12—SWIR</td><td char=\".\" align=\"char\">2.190</td><td align=\"left\">20</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Description of land use classes based on Land Use Classification for Irish Peatland (LUCIP) developed in this study.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Land use class</th><th align=\"left\">Description</th></tr></thead><tbody><tr><td align=\"left\">Cutaway</td><td align=\"left\">Land that has been subjected to industrial peat extraction, with the peat removed and/or left with a thin layer of soil, managed by BnM and other private companies with large-scale mechanised peat extraction.</td></tr><tr><td align=\"left\">Cutover</td><td align=\"left\">Land that has been subjected to domestic peat extraction, hand-cut, small-scale mechanised, includes bare peat, interspersed woodland, heath, and scrub.</td></tr><tr><td align=\"left\">Grassland</td><td align=\"left\">Agriculture grassland that is used for pasture or hay, silage, and grazing.</td></tr><tr><td align=\"left\">Forestry</td><td align=\"left\">Land covered with trees; afforested areas are mostly covered by evergreen tree species</td></tr><tr><td align=\"left\">Remnant Peatland</td><td align=\"left\">Land that has a high percentage of peat (near natural and high bog areas,) and is characterised by the presence of sphagnum mosses and other bog flora, not directly affected by human intervention. Revegetated areas of post-extraction activities.</td></tr><tr><td align=\"left\">Water bodies</td><td align=\"left\">Land covered with water, including natural waterways and surface water on raised bogs that have appeared after rewetting activities and/or abandonment.</td></tr><tr><td align=\"left\">Built-up/Infrastructure</td><td align=\"left\">Land used for human settlements and infrastructure, such as buildings, roads, windfarms etc.,</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Characteristics of randomly distributed training and validation sample data.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Land use class</th><th align=\"left\">No. of training polygons</th><th align=\"left\">No. of training pixels (sum per training polygon)</th><th align=\"left\">No. of validation points</th></tr></thead><tbody><tr><td align=\"left\">Cutaway</td><td align=\"left\">37</td><td align=\"left\">94,672</td><td align=\"left\">197</td></tr><tr><td align=\"left\">Cutover</td><td align=\"left\">45</td><td align=\"left\">4345</td><td align=\"left\">130</td></tr><tr><td align=\"left\">Grassland</td><td align=\"left\">32</td><td align=\"left\">7320</td><td align=\"left\">660</td></tr><tr><td align=\"left\">Forestry</td><td align=\"left\">100</td><td align=\"left\">11,627</td><td align=\"left\">252</td></tr><tr><td align=\"left\">Remnant Peatland</td><td align=\"left\">62</td><td align=\"left\">28,038</td><td align=\"left\">121</td></tr><tr><td align=\"left\">Water bodies</td><td align=\"left\">64</td><td align=\"left\">1816</td><td align=\"left\">50</td></tr><tr><td align=\"left\">Built-up/Infrastructure</td><td align=\"left\">26</td><td align=\"left\">587</td><td align=\"left\">50</td></tr><tr><td align=\"left\">Total</td><td align=\"left\">366</td><td align=\"left\">148,405</td><td align=\"left\">1460</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab4\"><label>Table 4</label><caption><p>Proportion of each land use on Bord Na Mónaa (BnM) and Special Area of Conservation (SAC) under the national parks and wildlife services (NPWS). All areas are in hectares (ha).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Class</th><th align=\"left\">BnM (ha)</th><th align=\"left\">SAC (ha)</th></tr></thead><tbody><tr><td align=\"left\">Cutaway</td><td align=\"left\">42,264</td><td align=\"left\">2460</td></tr><tr><td align=\"left\">Cutover</td><td align=\"left\">7303</td><td align=\"left\">4907</td></tr><tr><td align=\"left\">Grassland</td><td align=\"left\">2379</td><td align=\"left\">7318</td></tr><tr><td align=\"left\">Forestry</td><td align=\"left\">9067</td><td align=\"left\">3490</td></tr><tr><td align=\"left\">Remnant Peatland</td><td align=\"left\">6491</td><td align=\"left\">13,053</td></tr><tr><td align=\"left\">Water bodies</td><td align=\"left\">1580</td><td align=\"left\">1340</td></tr><tr><td align=\"left\">Built-up/Infrastructure</td><td align=\"left\">388</td><td align=\"left\">197</td></tr><tr><td align=\"left\">Total</td><td align=\"left\">69,472</td><td align=\"left\">32,568</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab5\"><label>Table 5</label><caption><p>Emissions from four dominant land use classes, with Intergovernmental Panel on Climate Change (IPCC) Tier 1 and 2 (T1 and T2) Emission Factors (EFs) with 95% confidence intervals values are shown in brackets, Emissions based on the area in hectares (ha) and EFs (in tonnes of CO<sub>2</sub>-C per hectare per year).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Land Use</th><th align=\"left\">Area (ha)</th><th align=\"left\">T1 (IPCC) EFs</th><th align=\"left\">T1 Emissions (t CO<sub>2</sub>-C ha<sup>−1</sup> y<sup>−1</sup>)</th><th align=\"left\">T2 (literature) EFs</th><th align=\"left\">T2 Emissions (t CO<sub>2</sub>-C ha<sup>−1</sup> y<sup>−1</sup>)</th><th align=\"left\">No. of sites for T2 EFs</th><th align=\"left\">References</th></tr></thead><tbody><tr><td align=\"left\">Cutover</td><td align=\"left\">64,699</td><td char=\"–\" align=\"char\">2.8 (1.1–4.2)</td><td align=\"left\">181,157</td><td char=\"–\" align=\"char\">1.21 (0.4 – 2.0)</td><td align=\"left\">102,871</td><td align=\"left\">3</td><td align=\"left\"><sup>##UREF##24##26##</sup></td></tr><tr><td align=\"left\">Cutaway</td><td align=\"left\">54,302</td><td char=\"–\" align=\"char\">2.8 (1.1–4.2)</td><td align=\"left\">152,046</td><td char=\"–\" align=\"char\">1.59 (1.2 – 2.0)</td><td align=\"left\">65,705</td><td align=\"left\">4</td><td align=\"left\"><sup>##UREF##24##26##</sup></td></tr><tr><td align=\"left\">Forestry</td><td align=\"left\">116,427</td><td char=\"–\" align=\"char\">2.6 (2.0–3.3)</td><td align=\"left\">302,710</td><td char=\"–\" align=\"char\">1.68 (1.04 – 2.32)</td><td align=\"left\">195,597</td><td align=\"left\">8</td><td align=\"left\"><sup>##UREF##54##57##</sup></td></tr><tr><td align=\"left\">Grassland</td><td align=\"left\">244,100</td><td char=\"–\" align=\"char\">5.3 (3.7–6.9)</td><td align=\"left\">1,293,730</td><td char=\"–\" align=\"char\">1.3 (0.04 – 2.55)</td><td align=\"left\">317,330</td><td align=\"left\">3</td><td align=\"left\"><sup>##UREF##24##26##</sup></td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab6\"><label>Table 6</label><caption><p>Result of accuracy assessment for the seven land use classes, including Overall Accuracy (OA), User's Accuracy (UA), and Producer's Accuracy (PA).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Class</th><th align=\"left\">A</th><th align=\"left\">B</th><th align=\"left\">C</th><th align=\"left\">D</th><th align=\"left\">E</th><th align=\"left\">F</th><th align=\"left\">G</th><th align=\"left\">Total</th><th align=\"left\">UA (%)</th></tr></thead><tbody><tr><td align=\"left\">Cutaway (A)</td><td align=\"left\"><bold>164</bold></td><td align=\"left\">12</td><td align=\"left\">1</td><td align=\"left\">8</td><td align=\"left\">2</td><td align=\"left\">10</td><td align=\"left\">0</td><td align=\"left\">197</td><td align=\"left\">83</td></tr><tr><td align=\"left\">Cutover (B)</td><td align=\"left\">0</td><td align=\"left\"><bold>91</bold></td><td align=\"left\">0</td><td align=\"left\">4</td><td align=\"left\">15</td><td align=\"left\">19</td><td align=\"left\">1</td><td align=\"left\">130</td><td align=\"left\">70</td></tr><tr><td align=\"left\">Water (C)</td><td align=\"left\">1</td><td align=\"left\">0</td><td align=\"left\"><bold>35</bold></td><td align=\"left\">8</td><td align=\"left\">2</td><td align=\"left\">0</td><td align=\"left\">4</td><td align=\"left\">50</td><td align=\"left\">70</td></tr><tr><td align=\"left\">Forest (D)</td><td align=\"left\">1</td><td align=\"left\">2</td><td align=\"left\">0</td><td align=\"left\"><bold>244</bold></td><td align=\"left\">4</td><td align=\"left\">1</td><td align=\"left\">0</td><td align=\"left\">252</td><td align=\"left\">96</td></tr><tr><td align=\"left\">Grassland (E)</td><td align=\"left\">2</td><td align=\"left\">1</td><td align=\"left\">1</td><td align=\"left\">12</td><td align=\"left\"><bold>624</bold></td><td align=\"left\">6</td><td align=\"left\">14</td><td align=\"left\">660</td><td align=\"left\">94</td></tr><tr><td align=\"left\">Remnant Peatland/High Bog (F)</td><td align=\"left\">1</td><td align=\"left\">2</td><td align=\"left\">0</td><td align=\"left\">2</td><td align=\"left\">5</td><td align=\"left\"><bold>111</bold></td><td align=\"left\">0</td><td align=\"left\">121</td><td align=\"left\">91</td></tr><tr><td align=\"left\">Built-up (G)</td><td align=\"left\">0</td><td align=\"left\">0</td><td align=\"left\">0</td><td align=\"left\">3</td><td align=\"left\">13</td><td align=\"left\">0</td><td align=\"left\"><bold>34</bold></td><td align=\"left\">50</td><td align=\"left\">68</td></tr><tr><td align=\"left\">Total</td><td align=\"left\">169</td><td align=\"left\">108</td><td align=\"left\">37</td><td align=\"left\">281</td><td align=\"left\">665</td><td align=\"left\">147</td><td align=\"left\">53</td><td align=\"left\"><bold>1303</bold></td><td align=\"left\"><bold>OA (%)</bold></td></tr><tr><td align=\"left\">PA (%)</td><td align=\"left\">97</td><td align=\"left\">84</td><td align=\"left\">94</td><td align=\"left\">86</td><td align=\"left\">93</td><td align=\"left\">75</td><td align=\"left\">64</td><td align=\"left\"/><td align=\"left\">89.2</td></tr></tbody></table></table-wrap>" ]
[ "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$NDVI=\\frac{NIR-Red}{NIR+Red}$$\\end{document}</tex-math><mml:math id=\"M2\" display=\"block\"><mml:mrow><mml:mi>N</mml:mi><mml:mi>D</mml:mi><mml:mi>V</mml:mi><mml:mi>I</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>N</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi><mml:mo>-</mml:mo><mml:mi>R</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi><mml:mo>+</mml:mo><mml:mi>R</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$NDWI=\\frac{NNIR-SWIR1}{NNIR+SWIR1}$$\\end{document}</tex-math><mml:math id=\"M4\" display=\"block\"><mml:mrow><mml:mi>N</mml:mi><mml:mi>D</mml:mi><mml:mi>W</mml:mi><mml:mi>I</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>N</mml:mi><mml:mi>N</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi><mml:mo>-</mml:mo><mml:mi>S</mml:mi><mml:mi>W</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>N</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi><mml:mo>+</mml:mo><mml:mi>S</mml:mi><mml:mi>W</mml:mi><mml:mi>I</mml:mi><mml:mi>R</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{CO}}_{{2}} \\;{\\text{emission }}\\left( {{\\text{tCO}}_{2} - {\\text{C}}\\;{\\text{ha}}^{ - 1} {\\text{y}}^{ - 1} } \\right) = {\\text{land}}\\;{\\text{use}}\\;{\\text{area}}\\;\\left( {{\\text{ha}}} \\right) \\, \\times {\\text{ EF }}\\left( {{\\text{tCO}}_{2} - {\\text{C ha}}^{ - 1} {\\text{y}}^{ - 1} } \\right)$$\\end{document}</tex-math><mml:math id=\"M6\" display=\"block\"><mml:mrow><mml:msub><mml:mtext>CO</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mspace width=\"0.277778em\"/><mml:mrow><mml:mtext>emission</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mtext>tCO</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:mtext>C</mml:mtext><mml:mspace width=\"0.277778em\"/><mml:msup><mml:mrow><mml:mtext>ha</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mtext>y</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mtext>land</mml:mtext><mml:mspace width=\"0.277778em\"/><mml:mtext>use</mml:mtext><mml:mspace width=\"0.277778em\"/><mml:mtext>area</mml:mtext><mml:mspace width=\"0.277778em\"/><mml:mfenced close=\")\" open=\"(\"><mml:mtext>ha</mml:mtext></mml:mfenced><mml:mspace width=\"0.166667em\"/><mml:mo>×</mml:mo><mml:mrow><mml:mspace width=\"0.333333em\"/><mml:mtext>EF</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mtext>tCO</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mtext>C ha</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mtext>y</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>" ]
[ "<table-wrap-foot><p>The emboldened diagonal elements represent accurately classified areas.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51660_Article_Equ1.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51660_Article_Equ2.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51660_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51660_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51660_Article_Equ3.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51660_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51660_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51660_Fig5_HTML\" id=\"MO5\"/>" ]
[ "<media xlink:href=\"41598_2024_51660_MOESM1_ESM.docx\"><caption><p>Supplementary Information 1.</p></caption></media>", "<media xlink:href=\"41598_2024_51660_MOESM2_ESM.zip\"><caption><p>Supplementary Information 2.</p></caption></media>" ]
[{"label": ["1."], "surname": ["Xu", "Morris", "Liu", "Holden"], "given-names": ["J", "PJ", "J", "J"], "article-title": ["PEATMAP: Refining estimates of global peatland distribution based on a meta-analysis"], "source": ["CATENA"], "year": ["2018"], "volume": ["160"], "fpage": ["134"], "lpage": ["140"], "pub-id": ["10.1016/j.catena.2017.09.010"]}, {"label": ["2."], "surname": ["Tanneberger"], "given-names": ["F"], "article-title": ["The peatland map of Europe"], "source": ["Mires Peat"], "year": ["2017"], "volume": ["19"], "fpage": ["1"], "lpage": ["17"]}, {"label": ["3."], "surname": ["Joosten"], "given-names": ["H"], "article-title": ["Peatlands across the globe"], "source": ["Peatl. Restor. Ecosyst. Serv. Sci. Policy Pract."], "year": ["2017"], "pub-id": ["10.1017/CBO9781139177788.003"]}, {"label": ["4."], "surname": ["Tanneberger"], "given-names": ["F"], "article-title": ["Mires in Europe\u2014Regional diversity, condition and protection"], "source": ["Diversity"], "year": ["2021"], "volume": ["13"], "fpage": ["381"], "pub-id": ["10.3390/d13080381"]}, {"label": ["5."], "surname": ["Connolly", "Holden"], "given-names": ["J", "NM"], "article-title": ["Mapping peat soils in Ireland: Updating the derived Irish peat map"], "source": ["Irish Geogr."], "year": ["2009"], "volume": ["42"], "fpage": ["343"], "lpage": ["352"], "pub-id": ["10.1080/00750770903407989"]}, {"label": ["6."], "surname": ["Bullock", "Collier", "Convery"], "given-names": ["CH", "MJ", "F"], "article-title": ["Peatlands, their economic value and priorities for their future management\u2013The example of Ireland"], "source": ["Land Use Policy"], "year": ["2012"], "volume": ["29"], "fpage": ["921"], "lpage": ["928"], "pub-id": ["10.1016/j.landusepol.2012.01.010"]}, {"label": ["7."], "surname": ["Tomlinson"], "given-names": ["RW"], "article-title": ["Soil carbon stocks and changes in the Republic of Ireland"], "source": ["J. Environ. Manag."], "year": ["2005"], "volume": ["76"], "fpage": ["77"], "lpage": ["93"], "pub-id": ["10.1016/j.jenvman.2005.02.001"]}, {"label": ["8."], "surname": ["Eaton", "McGoff", "Byrne", "Leahy", "Kiely"], "given-names": ["JM", "NM", "KA", "P", "G"], "article-title": ["Land cover change and soil organic carbon stocks in the Republic of Ireland 1851\u20132000"], "source": ["Clim. Change"], "year": ["2008"], "volume": ["91"], "fpage": ["317"], "lpage": ["334"], "pub-id": ["10.1007/s10584-008-9412-2"]}, {"label": ["9."], "mixed-citation": ["Renou-Wilson, F. "], "italic": ["et al."], "ext-link": ["https://www.researchgate.net/publication/220048938%0AProtocol"]}, {"label": ["10."], "mixed-citation": ["Davies, H. J., Edwards, R. & Forster, C. Ireland\u2019s Forestry Programme 2014\u20132020. "], "ext-link": ["https://irishriverproject.com/wp-content/uploads/2022/03/forestryprogramme20142020naturaimpactstatement230215.pdf"]}, {"label": ["11."], "mixed-citation": ["Malone, S. & O\u2019Connell, C. Ireland\u2019s Peatland Conservation Action Plan. "], "ext-link": ["https://www.ipcc.ie/a-to-z-peatlands/irelands-peatland-conservation-action-plan/"]}, {"label": ["12."], "surname": ["Connolly"], "given-names": ["J"], "article-title": ["Mapping land use on Irish peatlands using medium resolution satellite imagery"], "source": ["Irish Geogr."], "year": ["2018"], "volume": ["51"], "fpage": ["187"], "lpage": ["204"], "pub-id": ["10.55650/igj.2018.1371"]}, {"label": ["14."], "surname": ["Wilson", "M\u00fcller", "Renou-Wilson"], "given-names": ["D", "C", "F"], "article-title": ["Carbon emissions and removals from irish peatlands: Present trends and future mitigation measures"], "source": ["Irish Geogr."], "year": ["2013"], "volume": ["46"], "fpage": ["1"], "lpage": ["23"], "pub-id": ["10.1080/00750778.2013.848542"]}, {"label": ["15."], "surname": ["Holden", "Gascoign", "Bosanko"], "given-names": ["J", "M", "NR"], "article-title": ["Erosion and natural revegetation associated with surface land drains in upland peatlands"], "source": ["Earth Surf. Process. Landforms J. Br. Geomorphol. Res. Gr."], "year": ["2007"], "volume": ["32"], "fpage": ["1547"], "lpage": ["1557"], "pub-id": ["10.1002/esp.1476"]}, {"label": ["16."], "mixed-citation": ["Mackin, F., Flynn, R., Arbuckle, L. & Barr, A G. The Role of Hydrology in Restoring Ireland\u2019s Raised Bogs: A Review of a Nationwide Study 83\u201394 (2015)."]}, {"label": ["17."], "surname": ["Tanneberger"], "given-names": ["F"], "article-title": ["The power of nature-based solutions: how peatlands can help us to achieve key EU sustainability objectives"], "source": ["Adv. Sustain. Syst."], "year": ["2021"], "volume": ["5"], "fpage": ["2000146"], "pub-id": ["10.1002/adsu.202000146"]}, {"label": ["18."], "surname": ["Turetsky"], "given-names": ["MR"], "article-title": ["Global vulnerability of peatlands to fire and carbon loss"], "source": ["Nat. Geosci."], "year": ["2015"], "volume": ["8"], "fpage": ["11"], "pub-id": ["10.1038/ngeo2325"]}, {"label": ["19."], "mixed-citation": ["Connolly, J. "], "italic": ["et al.", "EGU General Assembly Conference Abstracts"]}, {"label": ["20."], "surname": ["Islam"], "given-names": ["MT"], "article-title": ["Potential use of APSIS-InSAR measures of the range of vertical surface motion to improve hazard assessment of peat landslides"], "source": ["Mires Peat"], "year": ["2022"], "volume": ["28"], "fpage": ["21"]}, {"label": ["21."], "surname": ["Flood", "Mahon", "McDonagh"], "given-names": ["K", "M", "J"], "article-title": ["Assigning value to cultural ecosystem services: the significance of memory and imagination in the conservation of Irish peatlands"], "source": ["Ecosyst. Serv."], "year": ["2021"], "volume": ["50"], "fpage": ["101326"], "pub-id": ["10.1016/j.ecoser.2021.101326"]}, {"label": ["22."], "surname": ["Connolly", "Holden"], "given-names": ["J", "NM"], "article-title": ["Classification of peatland disturbance"], "source": ["L. Degrad. Dev."], "year": ["2013"], "volume": ["24"], "fpage": ["548"], "lpage": ["555"], "pub-id": ["10.1002/ldr.1149"]}, {"label": ["23."], "mixed-citation": ["Joosten, H., Tanneberger, F. & Moen, A. Peatland use in Europe. In "], "italic": ["Mires and Peatlands of Europe: Status, Distribution and Conservation"]}, {"label": ["24."], "mixed-citation": ["NPWS. "], "italic": ["National raised bog special areas of conservation management plan "]}, {"label": ["25."], "mixed-citation": ["BnM. Bord na M\u00f3na announce formal end to all peat harvesting on its lands. Bord na M\u00f3na. "], "ext-link": ["https://www.bordnamona.ie/bord-na-mona-announce-formal-end-to-all-peat-harvesting-on-its-lands/"]}, {"label": ["26."], "surname": ["Aitova", "Morley", "Wilson", "Renou-wilson"], "given-names": ["E", "T", "D", "F"], "article-title": ["A review of greenhouse gas emissions and removals from Irish peatlands"], "source": ["Mires Peat"], "year": ["2023"], "volume": ["29"], "fpage": ["1"], "lpage": ["17"]}, {"label": ["27."], "mixed-citation": ["EU. Regulation of the European parliament and of the council on nature restoration Vol. 15 1\u201323. "], "ext-link": ["https://www.europarl.europa.eu/doceo/document/A-9-2023-0220_EN.html"]}, {"label": ["28."], "surname": ["Swenson"], "given-names": ["MM"], "article-title": ["Carbon balance of a restored and cutover raised bog: implications for restoration and comparison to global trends"], "source": ["Biogeosciences"], "year": ["2019"], "volume": ["16"], "fpage": ["713"], "lpage": ["731"], "pub-id": ["10.5194/bg-16-713-2019"]}, {"label": ["29."], "surname": ["Wilson"], "given-names": ["D"], "article-title": ["Carbon and climate implications of rewetting a raised bog in Ireland"], "source": ["Glob. Change Biol."], "year": ["2022"], "volume": ["28"], "fpage": ["6349"], "lpage": ["6365"], "pub-id": ["10.1111/gcb.16359"]}, {"label": ["30."], "surname": ["Page", "Baird"], "given-names": ["SE", "AJ"], "article-title": ["Peatlands and global change: Response and resilience"], "source": ["Annu. Rev. Environ. Resour."], "year": ["2016"], "volume": ["41"], "fpage": ["35"], "lpage": ["57"], "pub-id": ["10.1146/annurev-environ-110615-085520"]}, {"label": ["31."], "surname": ["Andersen"], "given-names": ["R"], "article-title": ["An overview of the progress and challenges of peatland restoration in Western Europe"], "source": ["Restor. Ecol."], "year": ["2017"], "volume": ["25"], "fpage": ["271"], "lpage": ["282"], "pub-id": ["10.1111/rec.12415"]}, {"label": ["32."], "mixed-citation": ["Duffy, P. "], "italic": ["et al."]}, {"label": ["33."], "surname": ["Feehan", "O\u2019Donovan"], "given-names": ["J", "G"], "source": ["The Bogs of Ireland"], "year": ["1996"], "publisher-name": ["University College Dublin"]}, {"label": ["34."], "mixed-citation": ["Hammond, R. F. "], "italic": ["The Peatlands of Ireland"]}, {"label": ["35."], "surname": ["Bullock", "Collier", "Convery"], "given-names": ["CH", "MJ", "F"], "article-title": ["Peatlands, their economic value and priorities for their future management\u2014The example of Ireland"], "source": ["Land Use Policy"], "year": ["2012"], "volume": ["29"], "fpage": ["921"], "lpage": ["928"], "pub-id": ["10.1016/j.landusepol.2012.01.010"]}, {"label": ["36."], "mixed-citation": ["Fealy Stuart Green, R. "], "italic": ["et al."], "ext-link": ["https://t-stor.teagasc.ie/handle/11019/361"]}, {"label": ["37."], "surname": ["Walsh", "Bessardon", "Gleeson", "Ulmas"], "given-names": ["E", "G", "E", "P"], "article-title": ["Using machine learning to produce a very high resolution land-cover map for Ireland"], "source": ["Adv. Sci. Res."], "year": ["2021"], "volume": ["18"], "fpage": ["65"], "lpage": ["87"], "pub-id": ["10.5194/asr-18-65-2021"]}, {"label": ["38."], "mixed-citation": ["Cawkwell, F., Raab, C., Barrett, B., Green, S. & Finn, J. TaLAM: Mapping land cover in lowlands and uplands with satellite imagery. "], "ext-link": ["https://www.epa.ie/publications/research/waste/Research_Report_254.pdf"]}, {"label": ["39."], "mixed-citation": ["Cawkwell, F., Dwyer, N. & Scarrott, R. Industrialised Peat Extraction Scoping Project. UCC, Cork. "], "ext-link": ["https://www.researchgate.net/publication/228787304_Industrialised_Peat_Extraction_Scoping_Project"]}, {"label": ["40."], "surname": ["Gorelick"], "given-names": ["N"], "article-title": ["Google Earth Engine: Planetary-scale geospatial analysis for everyone"], "source": ["Remote Sens. Environ."], "year": ["2017"], "volume": ["202"], "fpage": ["18"], "lpage": ["27"], "pub-id": ["10.1016/j.rse.2017.06.031"]}, {"label": ["41."], "surname": ["Amani"], "given-names": ["M"], "article-title": ["Canadian wetland inventory using Google Earth Engine: The first map and preliminary results"], "source": ["Remote Sens."], "year": ["2019"], "volume": ["11"], "fpage": ["842"], "pub-id": ["10.3390/rs11070842"]}, {"label": ["42."], "mixed-citation": ["Mahdianpari, M. "], "italic": ["et al.", "Can. J. Remote Sens."]}, {"label": ["44."], "surname": ["Drusch"], "given-names": ["M"], "article-title": ["Sentinel-2: ESA\u2019s optical high-resolution mission for GMES operational services"], "source": ["Remote Sens. Environ."], "year": ["2012"], "volume": ["120"], "fpage": ["25"], "lpage": ["36"], "pub-id": ["10.1016/j.rse.2011.11.026"]}, {"label": ["45."], "mixed-citation": ["ESA. "], "italic": ["ESA\u2019s Optical High-Resolution Mission for GMES Operational Services"]}, {"label": ["46."], "surname": ["Mayer", "Kylling"], "given-names": ["B", "A"], "article-title": ["The libRadtran software package for radiative transfer calculations-description and examples of use"], "source": ["Atmos. Chem. Phys."], "year": ["2005"], "volume": ["5"], "fpage": ["1855"], "lpage": ["1877"], "pub-id": ["10.5194/acp-5-1855-2005"]}, {"label": ["47."], "mixed-citation": ["Richter, R. & Schl\u00e4pfer, D. Atmospheric/topographic correction for satellite imagery. DLR Report DLR-IB (2005)."]}, {"label": ["48."], "surname": ["Liu", "Huete"], "given-names": ["HQ", "A"], "article-title": ["A feedback based modification of the NDVI to minimize canopy background and atmospheric noise"], "source": ["IEEE Trans. Geosci. Remote Sens."], "year": ["1995"], "volume": ["33"], "fpage": ["457"], "lpage": ["465"], "pub-id": ["10.1109/TGRS.1995.8746027"]}, {"label": ["49."], "surname": ["Gao"], "given-names": ["B-C"], "article-title": ["NDWI\u2014A normalized difference water index for remote sensing of vegetation liquid water from space"], "source": ["Remote Sens. Environ."], "year": ["1996"], "volume": ["58"], "fpage": ["257"], "lpage": ["266"], "pub-id": ["10.1016/S0034-4257(96)00067-3"]}, {"label": ["50."], "surname": ["Richards"], "given-names": ["JA"], "source": ["Remote sensing digital image analysis: An introduction"], "year": ["2013"], "publisher-name": ["Springer"], "fpage": ["1"], "lpage": ["494"]}, {"label": ["51."], "surname": ["Breiman"], "given-names": ["L"], "article-title": ["Random forests"], "source": ["Mach. Learn."], "year": ["2001"], "volume": ["45"], "fpage": ["5"], "lpage": ["32"], "pub-id": ["10.1023/A:1010933404324"]}, {"label": ["52."], "surname": ["Pal"], "given-names": ["M"], "article-title": ["Random forest classifier for remote sensing classification"], "source": ["Int. J. Remote Sens."], "year": ["2005"], "volume": ["26"], "fpage": ["217"], "lpage": ["222"], "pub-id": ["10.1080/01431160412331269698"]}, {"label": ["53."], "mixed-citation": ["Li, H. Smile\u2014Statistical Machine Intelligence and Learning Engine. "], "ext-link": ["https://haifengl.github.io/classification.html#random-forest"]}, {"label": ["54."], "surname": ["Yelena", "Antonia"], "given-names": ["F", "O"], "source": ["A Practical Guide Map Accuracy Assessment and Area Estimation"], "year": ["2016"], "publisher-name": ["FAO"]}, {"label": ["55."], "surname": ["Olofsson"], "given-names": ["P"], "article-title": ["Good practices for estimating area and assessing accuracy of land change"], "source": ["Remote Sens. Environ."], "year": ["2014"], "volume": ["148"], "fpage": ["42"], "lpage": ["57"], "pub-id": ["10.1016/j.rse.2014.02.015"]}, {"label": ["56."], "surname": ["Story", "Congalton"], "given-names": ["M", "RG"], "article-title": ["Accuracy assessment: A user\u2019s perspective"], "source": ["Photogramm. Eng. Remote Sens."], "year": ["1986"], "volume": ["52"], "fpage": ["397"], "lpage": ["399"]}, {"label": ["57."], "surname": ["Jovani-Sancho"], "given-names": ["AJ"], "article-title": ["Soil carbon balance of afforested peatlands in the maritime temperate climatic zone"], "source": ["Glob. Change Biol."], "year": ["2021"], "volume": ["27"], "fpage": ["3681"], "lpage": ["3698"], "pub-id": ["10.1111/gcb.15654"]}, {"label": ["58."], "mixed-citation": ["O\u2019Sullivan, K. Government failing to prevent illegal turf cutting 12 years after ban, says conservation group. The Irish Times (2023)."]}, {"label": ["59."], "mixed-citation": ["Mackin, F. "], "italic": ["et al."]}, {"label": ["60."], "mixed-citation": ["Malone, S. & O\u2019Connell, C. Ireland\u2019s Peatland Conservation Action Plan 2020\u2013halting the loss of peatland biodiversity. Irish Peatland Conservation Council, Kildare. "], "ext-link": ["https://www.ipcc.ie/a-to-z-peatlands/irelands-peatland-conservation-action-plan/"]}, {"label": ["61."], "surname": ["Renou-Wilson"], "given-names": ["F"], "article-title": ["Rewetting degraded peatlands for climate and biodiversity benefits: Results from two raised bogs"], "source": ["Ecol. Eng."], "year": ["2019"], "volume": ["127"], "fpage": ["547"], "lpage": ["560"], "pub-id": ["10.1016/j.ecoleng.2018.02.014"]}, {"label": ["62."], "surname": ["Minasny"], "given-names": ["B"], "article-title": ["Mapping and monitoring peatland conditions from global to field scale"], "source": ["Biogeochemistry"], "year": ["2023"], "pub-id": ["10.1007/s10533-023-01084-1"]}, {"label": ["63."], "surname": ["Renou-Wilson", "Barry", "M\u00fcller", "Wilson"], "given-names": ["F", "C", "C", "D"], "article-title": ["The impacts of drainage, nutrient status and management practice on the full carbon balance of grasslands on organic soils in a maritime temperate zone"], "source": ["Biogeosciences"], "year": ["2014"], "volume": ["11"], "fpage": ["4361"], "lpage": ["4379"], "pub-id": ["10.5194/bg-11-4361-2014"]}]
{ "acronym": [], "definition": [] }
64
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1171
oa_package/a5/65/PMC10786884.tar.gz
PMC10786885
38216572
[ "<title>Introduction</title>", "<p id=\"Par3\">The neural crest-derived Schwann cell lineage gives rise to schwannomas, neurofibromas, and malignant peripheral nerve sheath tumors (MPNSTs), which comprise the most common cancers of the peripheral nervous system<sup>##REF##36196752##1##</sup>. Despite their shared embryonic origin, the clinical course and molecular drivers of Schwann cell tumors are distinct. Neurofibromas and schwannomas are benign tumors that can be cured with surgery or radiotherapy, but MPNSTs metastasize and are often incurable<sup>##REF##24470531##2##</sup>. Neurofibromas and MPNSTs are associated with the loss of <italic>NF1</italic>, a tumor suppressor that inhibits Ras/Raf/MEK/ERK signaling<sup>##REF##33094349##3##</sup>. Schwannomas are associated with loss of <italic>NF2</italic>, a tumor suppressor that modulates numerous downstream effectors including PAK signaling, the Hippo pathway, apoptosis, contact inhibition, and the proteasome<sup>##REF##33094349##3##,##REF##35534562##4##</sup>. Germline loss of <italic>NF1</italic> causes neurofibromatosis type-1 (NF-1)<sup>##UREF##0##5##</sup>, and germline loss of <italic>NF2</italic> causes neurofibromatosis type-2 (NF-2)<sup>##REF##19476995##6##</sup>, which are among the most common cancer predisposition syndromes in humans.</p>", "<p id=\"Par4\">MPNSTs are the most aggressive Schwann cell tumors and can arise sporadically or from <italic>NF1-</italic>mutant plexiform neurofibromas in patients with clinical diagnoses of NF-1. <italic>NF1</italic> loss is sufficient for plexiform neurofibroma formation, but subsequent <italic>CDKN2A/B</italic> loss leads to the transitory premalignant stage defined as atypical neurofibromatous neoplasm of uncertain biologic potential (ANNUBP), and further hits disrupting the epigenetic regulator Polycomb Repressive Complex 2 (PRC2) lead to MPNST<sup>##REF##25240281##7##–##REF##25305755##9##</sup>. Although rare, <italic>NF2-</italic>mutant schwannomas can also undergo malignant transformation<sup>##REF##25434949##10##</sup>, and it is unclear if <italic>NF1</italic> and <italic>NF2</italic> interact during tumorigenesis or treatment response. Despite the recent approval of the MEK inhibitor selumetinib to treat neurofibromas in patients with NF-1<sup>##REF##28029918##11##,##UREF##2##12##</sup>, there are currently no effective therapies for patients with MPNSTs<sup>##UREF##3##13##</sup>.</p>", "<p id=\"Par5\">Here, to address gaps in our understanding of Schwann cell biology and the unmet translational need for new therapies to treat malignant Schwann cell tumors, we perform multiplatform bulk and single-cell molecular profiling combined with biochemical, pharmacologic, and functional genomic interrogation of human Schwann cell tumors, patient-derived cell lines, and mouse allografts. Our results show <italic>NF2</italic> inactivation leads to PAK activation, which drives <italic>NF1</italic>-mutant Schwann cell tumor de-differentiation and resistance to selumetinib. These data reveal a functional interaction between neurofibromatosis tumor suppressors that underlies Schwann cell tumor biology and represents a druggable dependency for combination molecular therapy.</p>" ]
[ "<title>Methods</title>", "<p id=\"Par19\">This study complied with all relevant ethical regulations and was approved by the UCSF Institutional Review Board (13-12587, 17-22324, 17-23196, 18-24633). As part of routine clinical practice at UCSF, all patients or legally authorized guardians of patients included in this study signed an informed waiver of consent to contribute de-identified data to scientific research projects and patient compensation was not provided. Due to the de-identified data, sex and gender information was not routinely collected and thus this analysis was not performed.</p>", "<title>Nucleic acid extraction for DNA methylation profiling, whole exome sequencing, or bulk RNA sequencing</title>", "<p id=\"Par20\">DNA and RNA were isolated from cell lines, human samples, or mouse allografts using the All-Prep Universal Kit (#80224, QIAGEN). For fresh frozen human samples or mouse allografts, specimens were thawed in RLT Plus Buffer with beta-mercaptoethanol. Formalin fixed paraffin embedded tissue was de-paraffinized. All tumor or tissue samples were mechanically lysed using a TissueLyser II (QIAGEN) with stainless steel beads at 30 Hz for 90 seconds. QiaCubes were used for standardized automated nucleic acid extraction per the manufacturer’s protocol. For cell line samples, pellets were directly lysed in RLT Plus buffer with beta-mercaptoethanol. RNA quality was assessed by chip-based electrophoresis on a BioAnalyzer 2100 using the RNA 6000 Nano Kit (#5067-1511, Agilent Technologies), and clean-up was performed as needed using the RNeasy kit (QIAGEN). DNA quality was assessed by spectrophotometry, and clean-up was performed as needed using DNA precipitation. Only samples with high-quality DNA (A260/280 &gt; 1.8, A260/230 &gt; 1.6) and/or RNA (RIN &gt; 8) were used for DNA methylation profiling, whole exome sequencing, or bulk RNA sequencing.</p>", "<title>DNA methylation profiling and analysis</title>", "<p id=\"Par21\">Genomic DNA from human tumors were processed for methylation analysis using the Illumina Methylation EPIC Beadchip (#WG-317-1003, Illumina) according to the manufacturer’s instructions. Preprocessing and normalization were performed in R using the minfi Bioconductor package<sup>##REF##24478339##46##,##REF##28035024##47##</sup>. Only probes with detection p &lt; 0.05 in all samples were included for further analysis. Additional preprocessing, beta value calculation, and normalization were performed using functional normalization<sup>##REF##24478339##46##</sup>. Probes were filtered based on the following criteria: (i) removal of probes mapping to the X or Y chromosomes, (ii) removal of probes containing a common single nucleotide polymorphism (SNP) within the targeted CpG site or on an adjacent base pair, and (iii) removal of probes not mapping uniquely to the hg19 human reference genome. DNA methylation-based molecular neuropathology brain tumor classification<sup>##REF##29539639##14##</sup> or CNV estimation<sup>##REF##29539639##14##</sup> were performed as previously described. To identify DNA methylation groups, ConsensusClusterPlus (Bioconductor v3.10) was used. Spearmen’s correlation was selected as a distance metric due to the non-normally distributed beta values obtained from DNA methylation array profiling, which comprises a potential limitation of applying typical distance metrics and clustering methods to non-normally distributed data. In order to determine the validity and stability of cluster grouping in light of these limitations, the continuous distribution function (CDF) was evaluated, which showed minimal change in the area under the curve for greater than 3 clusters using Spearman’s correlation (Supplementary Fig. ##SUPPL##0##1a##). Moreover, iterative K means clustering showed loss in coherence beyond 3 groups (Supplementary Fig. ##SUPPL##0##1b##), and the 3 clusters obtained from k-means = 3 was thus used to assign methylation groups to Schwann cell tumors. Using the top 1000, 10,000, or 15,000 most variable probes did not affect the clustering dendrogram, suggesting the precise number of probes was not a significant contributor to methylation clustering. Unsupervised hierarchical clustering (Spearman’s correlation, Ward’s method) was performed using the top 5,000 most variable probes and also demonstrated 3 clusters. Silhouette analysis showed decreased silhouette scores for cluster cut points greater than 3. Dendrograms and probe intensities were visualized using the Heatmap.2 R package (gplots v3.13).</p>", "<title>Whole exome sequencing and analysis</title>", "<p id=\"Par22\">Library preparation, exome capture, and sequencing were performed at the Institute for Human Genetics at UCSF. Sequencing libraries were prepared using the Kapa Hyper Prep Kit (#07962312001, Roche) and exome capture was performed using the Nimblegen SeqCap EZ Human Exome Kit v3.0 (Roche). Paired end sequencing with read length 100 base pairs was performed on an Illumina HiSeq4000. Whole exome data were analyzed following Genome Analysis Toolkit (GATK) best practices<sup>##REF##21478889##48##,##UREF##11##49##</sup>. Raw FASTQ files were aligned to the reference genome with Bowtie2<sup>##REF##22388286##50##</sup>. Only uniquely aligned reads were included for further processing using the Genome Analysis Toolkit to carry out de-duplication, local realignment, and base quality score recalibration. Alignment quality metrics and header information were determined using the Picard suite. Somatic variants (point mutations, small indels) were identified from matched tumor-normal samples (<italic>n</italic> = 15) and using a panel of normal (PoN) samples with Mutect2, per GATK best practices, when a matched normal sample was not available (<italic>n</italic> = 19). Variants were annotated using Snpeff <sup>##REF##22728672##51##</sup> and were further filtered to include only those marked as high/moderate/low priority, only those occurring in protein coding or splice site locations, and only those meeting the following hard filters: (i) &gt;5 reads in tumor compared to normal samples, (ii) &gt;10% variant reads in tumor, and (iii) &gt;90% reference reads in normal. The full list of parameters and filters can be found in the headers of the VCF files that are deposited in GEO, as described in the data availability statement.</p>", "<title>RNA sequencing</title>", "<p id=\"Par23\">Library preparation was performed using the TruSeq RNA Library Prep Kit v2 (#RS-122- 2001, Illumina) and 50 bp single end reads were sequenced on an Illumina HiSeq 2500 or NovaSeq to a minimum depth of 25 M reads per sample at Medgenome, Inc. Quality control of FASTQ files was performed with FASTQC, and after trimming of adapter sequences, reads were filtered to remove bases that did not have an average quality score of 20 within a sliding window across 4 bases (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.bioinformatics.babraham.ac.uk/projects/fastqc/\">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>). Reads were mapped to the appropriate reference genome (hg19) using HISAT2 with default parameters<sup>##REF##25751142##52##</sup>. Transcript abundance estimation in transcripts per million (TPM) and differential expression analysis were performed using DESeq2<sup>##REF##25516281##53##</sup>. Differentially expressed transcripts with an adjusted p-value &lt; 0.1 were identified and filtered based on an expression cutoff (TPM &gt; 1) and a fold change threshold (log2FC &gt; 1) to prioritize biologically relevant gene sets. Clustering dendrograms and heatmaps were generated in R using TPM values and plotted as normalized row expression values with the heatmaps.2 function.</p>", "<title>Immunohistochemistry (IHC)</title>", "<p id=\"Par24\">IHC was performed as previously described<sup>##REF##32642726##54##</sup> using formalin-fixed, paraffin-embedded tissue sections from tumor resection specimens on a combination of whole slide sections or tissue microarrays using the following primary antibodies: H3K27me3 (Cell Signaling Technology, #9733, clone C36B11, 1:50 dilution), SOX10 (Cell Marque, #383R-1, clone EP268, 1:50 dilution), or S100B (Ventana, #760-2523, 1:2 dilution). All IHC was performed on a Ventana Benchmark XT automated stainer (Roche) using standard techniques. IHC studies that were previously performed as part of clinical diagnostic workup, or stains obtained as part of prior research studies were reviewed for protein expression concordance<sup>##REF##32642726##54##</sup>. For quantitative analysis, percent staining for H3K27me3, SOX10, or S100B was estimated as the percentage of positive tumor cells on available stained tissue.</p>", "<title>Single-nuclear or single-cell RNA sequencing and analysis</title>", "<p id=\"Par25\">Frozen human neurofibroma or MPNST resection specimens were thawed on ice, minced with sterile razor blades, and mechanically dounced on ice in cell lysis nuclei extraction buffer until all macroscopically visible tissue dissolved into suspension. Cell suspensions were filtered through a 50 μm filter, centrifuged at 500 g for 5 min at 4 °C and resuspended in 0.1% BSA in PBS. Nuclei were stained using DAPI (#D3571, Thermo Fisher Scientific) and counted. A total of 10,000 nuclei were loaded per single-nuclei RNA sequencing sample.</p>", "<p id=\"Par26\">For mouse allograft single-cell RNA sequencing, tumors were minced with sterile razor blades and enzymatically dissociated with papain (#LS003, Worthington) at 37 °C for 45 min. Samples were centrifuged at 500 g for 5 min, resuspended in RBC lysis buffer (#00-4300-54, eBioscience), incubated for 10 min at room temperature, and resuspended in 5% FBS in PBS. Cell suspensions were serially filtered through 70 μm and 40 μm filters before being resuspended again in 5% FBS in PBS for manual cell counting using a hemacytometer. A total of 10,000 cells were loaded per single-cell RNA sequencing sample.</p>", "<p id=\"Par27\">Single-nuclei or single-cell RNA sequencing was performed using the Chromium Single Cell 3′ Library &amp; Gel Bead Kit v3.1 on a 10× Chromium controller (10× Genomics) using the manufacturer recommended default protocol and settings. Samples were sequenced on an Illumina NovaSeq at the UCSF Center for Advanced Technology, and the resulting FASTQ files were processed using the CellRanger analysis suite for alignment to the hg38 reference genome, identification of empty droplets, and determination of a count threshold. All downstream analyses were performed in Seurat using the default pipeline. In brief, data were empirically filtered on a per sample basis to remove outliers with regard to gene count, UMI count, or mitochondrial genes followed by cluster identification, UMAP generation, and marker gene list generation using computed highly variable features and the top ten principal component dimensions as previously described<sup>##UREF##9##43##,##UREF##12##55##</sup>. Cellranger generated filtered feature matrices were imported into a Seurat object (arguments: min.cells=3, min.features=100), and the individual count matrices were normalized by nFeature_RNA count (subset = nFeature_RNA &gt; 1500 &amp; nFeature_RNA &lt; 9500). Harmony was used to perform data integration across datasets within a given experiment<sup>##REF##31740819##19##</sup> and cluster number optimization was performed by comparing multiple cluster resolutions (resolutions 5, 2, 1.2, 1.0, 0.8, 0.7, 0.6, 0.6, 0.5, 0.4, 0.3, 0.2, 0.1, 0.0) using Clustree (<ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/lazappi/clustree\">https://github.com/lazappi/clustree</ext-link>). Cell cluster and tumor versus non-tumor cell designation was performed through a combination of manual marker gene inspection, gene ontology analysis<sup>##UREF##13##56##</sup>, automated cell type classification<sup>##REF##34983933##20##</sup>, and cell cycle phase classification. InferCNV was used in an attempt to delineate tumor from non-tumor cells based on single-nuclear CNVs but was complicated by the fact that our cohort includes patients with a diagnosis of neurofibromatosis type I who harbor a germline mutations in the <italic>NF1</italic> gene, and in this specific biologic context ‘normal’ non-tumor cell genotypes can harbor chromosomally abnormalities.</p>", "<title>Cell culture, cell viability assays, and in vitro pharmacology</title>", "<p id=\"Par28\">Patient-derived neurofibroma (NF95.11b, NF95.6) or MPNST (SNF02.2, SNF94.3, SNF96.2, ST88-14) cell lines<sup>##REF##27617404##57##</sup> were obtained from the Neurofibromatosis Therapeutic Acceleration Program or American Type Culture Collection and validated by bulk RNA-sequencing. Cell lines were grown in Dulbecco’s Modified Eagle Medium (#11960069, Life Technologies) with 10% FBS and 1× Pen-Strep (#15140122, Life Technologies). Cell lines were regularly tested and verified to be mycoplasma negative (#LT07-218, Lonza). Viability assays were carried out with the CellTiter 96 Non-Radioactive Cell Proliferation Assay (#G410, Promega) and a Glomax Discovery Multimode Microplate Reader (Promega). For pharmacologic assays, cells were seeded at a density of 5000 cells per well in a 96 well plate the night prior to treatment, after which cells were treated with drugs at the indicated concentrations for the indicated periods (or 48 h if not otherwise indicated) prior to experimentation.</p>", "<title>Immunoblotting</title>", "<p id=\"Par29\">Whole cell lysates were harvested using RIPA buffer (50 mM Tris-HCl at pH 8.0, 150 mM NaCl, 0.5% Deoxycholate, 0.1% SDS, 1% IGEPAL CA-630) with fresh protease (#P8340, Sigma) and phosphatase inhibitor (#P2850, Sigma) cocktails. A total of 10–20 μg of protein was loaded into pre-cast NuPAGE electrophoresis gels (Life Technologies). Samples were separated by SDS-PAGE, transferred to nitrocellulose or PVDF membranes, and blocked in either 5% bovine serum albumin or 5% skim milk in TBS buffer for 1 hour at room temperature. Primary antibodies were incubated overnight at the indicated dilutions at 4 degrees Celsius and HRP conjugated secondary antibodies were incubated for 1 h at room temperature followed by ECL based detection on film. The following antibodies were used: pERK (Cell Signaling Technologies, #4370, 1:1000 dilution), total ERK (Cell Signaling Technologies, #4695, 1:1000 dilution), beta tubulin (Developmental Hybridoma Studies Bank, #E7, 1:10,000 dilution), pAKT (Cell Signaling Technologies, #4060, 1:1000 dilution), total AKT (Cell Signaling Technologies, # 4685, 1:1000 dilution), pMEK (Cell Signaling Technologies, #9121, 1:1000 dilution), total MEK (Cell Signaling Technologies, #8727, 1:1000 dilution) pPAK (Cell Signaling Technologies, #2601, 1:1000 dilution), Caspase-3 (Cell Signaling Technologies, #9662, 1:1000 dilution), Caspase-7 (Cell Signaling Technologies, #9492, 1:1,000 dilution), or NF2/Merlin (Abcam, #ab88957, clone AF1G4, 1:2000 dilution). Quantification was performed in ImageJ (NIH) using the relative densitometry between phosphorylated and total protein abundance from immunoblotting.</p>", "<title>Quantitative reverse transcription polymerase chain reaction (QPCR)</title>", "<p id=\"Par30\">RNA was extracted from cell lines using the RNeasy Mini Kit (#74106, QIAGEN) according to manufacturer’s instructions, and cDNA was synthesized from RNA using iScript cDNA Synthesis kit (#1708891, Bio-Rad). Real-time QPCR was performed using PowerUp SYBR Green Master Mix (#A25918, Thermo Fisher Scientific) on a QuantStudio 6 Flex Real Time PCR system (Life Technologies). The following QPCR primers were used: <italic>GAPDH</italic>-F (5′-GTCTCCTCTGACTTCAACAGCG-3′)<italic>, GAPDH</italic>-R (5′-ACCACCCTGTTGCTGTAGCCAA-3′), <italic>SUZ12</italic>-F (5′-AGGCTGACCACGAGCTTTTC-3′), <italic>SUZ12</italic>-R (5′-GGTGCTATGAGATTCCGAGTTC-3′), <italic>EED</italic>-F (5′-GTGACGAGAACAGCAATCCAG-3′), <italic>EED</italic>-R (5′-TATCAGGGCGTTCAGTGTTTG-3′), <italic>NF2</italic>-F (5′-TTGCGAGATGAAGTGGAAAGG-3′), <italic>NF2</italic>-R (5′-CAAGAAGTGAAAGGTGACTGGTT-3′), <italic>S100B</italic>-F (5′-TGGCCCTCATCGACGTTTTC-3′), <italic>S100B</italic>-R (5′-ATGTTCAAAGAACTCGTGGCA-3′), <italic>KEAP1</italic>-F (5′-CTGGAGGATCATACCAAGCAGG-3′), <italic>KEAP1</italic>-R (5′-GGATACCCTCAATGGACACCAC-3′), <italic>RASA2</italic>-F (5′-AGAGGTTCAGGGTAAAGTTCACC-3′), or <italic>RASA2</italic>-R (5′-GAGAAACTGTTGCATAAGGGTCA-3′).</p>", "<title>CRISPRi cell line generation and genome-wide screening</title>", "<p id=\"Par31\">Lentivirus containing pMH0001 (UCOE-SFFV-dCas9-BFP-KRAB, #85969, Addgene) was produced from transfected HEK293T cells with packaging vectors (pMD2.G #12259, Addgene, and pCMV-dR8.91, Trono Lab) following the manufacturers protocol (#MIR6605, Mirus). Neurofibroma NF95.11b cells were stably transduced to generate parental NF95.11b<sup>dCas9-KRAB-BFP</sup> cells and selected by flow cytometry using a SH800 sorter (Sony). Subsequent gene specific knockdowns were achieved by individually cloning single-guide RNA (sgRNA) protospacer sequences into the pCRISPRia-v2 vector (#84832, Addgene) between BstXI and BlpI restriction sites. All constructs were validated by Sanger sequencing of the protospacer region. The following protospacers were used: sgNTC (GTGCACCCGGCTAGGACCGG), sg<italic>SUZ12</italic>−1 (GCTGAAACGTCTTTGGAAGG), sg<italic>SUZ12</italic>−2 (GGCAGCGGGTCGGAGATCGA), sg<italic>EED</italic>−1 (GAGTCTAGAGCCACCGTCCA), sg<italic>EED</italic>−2 (GCAGGGAGCAGGTAGCTGCT), <italic>sgRPA3-1</italic> (GGCGATCACAGGATTCCCGG), <italic>sgRPA3-2</italic> (GGAATCCTGTGATCGCAGAA), <italic>sgNF2</italic>−1 (GTCGGGACGGGACCCCTAGA), sg<italic>NF2</italic>−2 (GGACTCCGCGCGCCTCTCAG), sgKEAP1-1 (GGCCCTGGCCTCAGGCGGTA), sgKEAP1-2 (GTGGAGCCGAGGCCCCCCGA), sgRASA2-1 (GCACGGGCCGGGCGGCACCA) or sgRASA2-2 (GCCTCGCCCGGCTACGCAGG). Lentivirus was generated as described above and cells were selected to purity using 1 μg/mL puromycin for at least 5 days.</p>", "<p id=\"Par32\">For genome wide CRISPRi screens, we used a compact and highly active sgRNA library that was optimized through aggregation of 126 genome wide CRISPRi screens, established sgRNAs targeting essential genes, and machine learning prediction algorithms<sup>##UREF##5##25##</sup>. This genome-wide dual sgRNA library has been previously validated through multiple growth-based screens as well as through confirmation of on-target gene repression using perturb-seq, exhibiting 82–92% median target knockdown<sup>##UREF##5##25##</sup>. This genome-wide dual sgRNA library containing the top 2 on-target sgRNAs for 23,483 genes was cloned into the library expression vector pU6-sgRNA Ef1alpha Puro-T2A-GFP derived from pJR85 (#140095, Addgene) and modified to express a second sgRNA using the human U6 promoter as previously described<sup>##UREF##5##25##,##REF##35688146##58##</sup>. Knockdown efficiency of all guide sequences in this genome-wide sgRNA library was previously validated in K562 cells as part of a genome wide Perturb-seq database<sup>##UREF##5##25##</sup>. 1137 non-targeting sgRNA pairs were also included as negative controls in the screen. To generate lentiviral pools, HEK293T cells were transfected with the sgRNA library along with packaging plasmids as described above, and viral supernatant was collected 72 h following transfection. Lentiviral libraries were infected into NF95.11b<sup>dCas9-KRAB-BFP</sup> cells, cultured for 2 days following infection, selected in 1 μg/mL puromycin for 2 days, and then allowed to recover in 10% FBS in DMEM for 1 day. Infection efficiency was evaluated by measuring GFP positivity on flow cytometry, and cell pellets were subsequently frozen down at this “T0” timepoint. The screen was subsequently carried out in biologic triplicate, with cells cultured in either 1 μM selumetinib or vehicle (DMSO) control for 10 days. Cell pellets were frozen down at this “T10” timepoint and processed for sgRNA abundance library preparation using Q5 High-Fidelity DNA Polymerase (NEB) and sequenced on an Illumina NextSeq-500, as previously described<sup>##REF##35688146##58##</sup>.</p>", "<p id=\"Par33\">Enrichment or depletion of sgRNA abundances were determined by down sampling trimmed sequencing reads to equivalent amounts across all samples, and then calculating the log2 ratio of sgRNA abundance in experimental conditions to sgRNA abundance in control conditions at T10, or between sequencing reads from T10 and T0 timepoints within experimental or control conditions. Specifically, we computed normalized log2 ratios for selumetinib-treated sgRNA abundance at T10 compared to T0 in order to identify mediators of selumetinib responses and computed normalized log2 ratios for vehicle-treated sgRNA abundance at T10 compared to T0 to identify regulators of cell fitness independent of treatment. Any sgRNA’s not represented with an average of at least 50 normalized sequencing reads across all replicates were excluded from analysis<sup>##UREF##5##25##</sup>. Statistical significance was calculated using Wald test comparing replicates across conditions without a log2 fold change threshold. The screen was analyzed to identify significantly enriched or depleted guides with either vehicle treatment or selumetinib with the latter being the focus for genetic mediators of selumetinib response. Hits were prioritized by normalizing log2 ratios to the total number of population doublings in the screen and the standard deviations of the non-targeting control sgRNAs. These phenotype log2 ratios were used for subsequent analysis and visualization. Genes were filtered at an adjusted <italic>p</italic>-value &lt; 0.05 for statistical significance were used for analysis of genes affecting cell fitness in the vehicle condition and for comparison to common essential genes from the Cancer DepMap for quality control. Genomic loci for screen hits selected for further mechanistic validation were manually inspected to evaluate for the possibility of bidirectional promoters, which was identified for <italic>CDKN2A</italic> but not for any candidate mediators of selumetinib responses.</p>", "<title>Mouse tumor allografts and in vivo pharmacology</title>", "<p id=\"Par34\">The study was approved by the UCSF Institutional Animal Care and Use Committee (AN174769) and all experiments were conducted in compliance with institutional and governmental regulations. Subcutaneous allografts were performed by implanting 5 million JW18.2 or JW23.3 MPNST allografts cells into the flanks of 5–6-week-old female NU/NU mice (Harlan Sprague Dawley) housed in a 12:12 light/dark cycle at average temperature of 73 degrees F and 50% humidity. Only female recipient mice were used for subcutaneous xenograft experiments in accordance with institutional practice. For pharmacologic experiments, mice were treated with 25 mg/kg selumetinib twice-daily by oral gavage in 0.5% methylcellulose solution with 0.2% v/v Tween-80, 100 mg/kg 1-ABT followed by 10 mg/kg NVS-PAK1-1 2 h later in 60% PEG400/40% water, or vehicle control gavaged once daily. Tumors were measured using calipers 3 times per week. The maximum permitted tumor diameter was 2 cm on our IACUC protocol, and this was not exceeded in our study.</p>", "<title>Statistical analysis</title>", "<p id=\"Par35\">All experiments were performed as repeated, independent biologic replicates, and statistics were derived from biologic replicates. The number of biologic replicates is indicated in each panel or figure legend. No statistical methods were used to predetermine sample sizes. Considering the rarity of MPNSTs and accounting for the number of genomic approaches used in this study, our total cohort size is similar to prior publications<sup>##REF##25240281##7##–##REF##25305755##9##</sup>. The clinical samples used were retrospective and non-randomized, and all samples were equally interrogated within the constraints of sufficient tissue for each analytical method. Cells and animals were randomized to experimental conditions, and no clinical, molecular, cellular, or animal data points were excluded from analysis. Unless otherwise specified, data are plotted as mean with error bars representing the standard error of the mean. The statistical tests of choice were selected based on the input data and are noted in the methods and figure legends. All statistical tests were one-sided. Where appropriate, multiple hypothesis testing corrections were performed. Statistical significance thresholds are indicated in each figure legend and exact p-values are provided when possible.</p>", "<title>Reporting summary</title>", "<p id=\"Par36\">Further information on research design is available in the ##SUPPL##4##Nature Portfolio Reporting Summary## linked to this article.</p>" ]
[ "<title>Results</title>", "<title>Multiplatform bulk and single-cell molecular profiling reveals de-differentiation underlies malignant transformation of Schwann cell tumors</title>", "<p id=\"Par6\">DNA methylation profiling provides robust classification of central nervous system tumors, but how this approach applies to peripheral nervous system tumors is incompletely understood<sup>##REF##29539639##14##</sup>. To elucidate the epigenetic landscape of Schwann cell tumors, DNA methylation profiling was performed on histological schwannomas (n = 67), plexiform neurofibromas from patients with clinical diagnoses of NF-1 (<italic>n</italic> = 10), or MPNSTs (<italic>n</italic> = 42), all from patients who were treated at a single institution from 1991 to 2021. Neuropathology review using the most recent World Health Organization criteria was used to assign histological diagnoses of schwannoma, neurofibroma, or MPNST for all samples<sup>##REF##34185076##15##</sup>. Consensus k-means clustering using Spearman’s correlation revealed 3 DNA methylation groups (Fig. ##FIG##0##1a##, Supplementary Fig. ##SUPPL##0##1a-c##, and Supplementary Data ##SUPPL##3##1##). Group 1 and Group 2 tumors were exclusively comprised of histological MPNSTs, with Group 1 tumors demonstrating significantly greater CNVs and loss of <italic>SUZ12</italic> or <italic>EED</italic>, obligate members of the PRC2 epigenetic complex that is recurrently lost in MPNSTs<sup>##REF##25240281##7##–##REF##25305755##9##</sup> (Fig. ##FIG##0##1a## and Supplementary Fig. ##SUPPL##0##1d–g##). Both Group 1 and 2 tumors harbored CNVs deleting <italic>CDKN2A/B</italic>, a tumor suppressor implicated in Ras-induced senescence that can be lost in ANNUBPs, a premalignant transitory lesion preceding transformation to MPNST<sup>##REF##25240281##7##,##REF##25305755##9##,##REF##31091306##16##–##REF##30722027##18##</sup> (Fig. ##FIG##0##1a## and Supplementary Fig. ##SUPPL##0##1d–g##). Group 3 tumors were enriched for schwannomas but also contained all histological neurofibromas (n = 10) and a small number of histological MPNSTs (<italic>n</italic> = 9), and Group 3 tumors contained significantly fewer CNVs compared to Group 1 or Group 2 tumors (Fig. ##FIG##0##1a## and Supplementary Fig. ##SUPPL##0##1d–g##). Group 3 histological schwannomas were associated with recurrent CNVs deleting chromosome 22q (including the <italic>NF2</italic> locus) but no other CNVs (Fig. ##FIG##0##1a## and Supplementary Fig. ##SUPPL##0##1f–g##). Given the disparate clinical trajectories of schwannomas, which entirely classified to Group 3, compared to neurofibromas that can transform into MPNSTs<sup>##REF##33094349##3##</sup>, we focused on Group 1 (<italic>n</italic> = 25), Group 2 (<italic>n</italic> = 8), and Group 3 (<italic>n</italic> = 19 of 86) histological neurofibromas and MPNSTs (total <italic>n</italic> = 52 tumors) to investigate mechanisms underlying malignant transformation of the Schwann cell lineage. When comparing Group 1 to Group 2 tumors, all of which were histologic MPNSTs, Group 1 tumors alone were significantly enriched for CNVs deleting the PRC2 components <italic>SUZ12</italic> (<italic>p</italic> &lt; 0.0001) or <italic>EED</italic> (<italic>p</italic> &lt; 0.0001), but not for CNVs deleting <italic>CDKN2A/B</italic> (<italic>p</italic> &gt; 0.05), which were found in both Group 1 and Group 2 tumors (Fisher’s exact tests) (Supplementary Fig. ##SUPPL##0##1g##). In histological neurofibromas and MPNSTs across all 3 DNA methylation groups, CNVs deleting <italic>NF2</italic> on chromosome 22q were enriched in Group 1 and Group 2 compared to Group 3 histologic neurofibromas or MPNSTs (60% versus 50% versus 11%, <italic>p</italic> = 0.02, Chi-squared test), typically in combination with <italic>NF1</italic> or PRC2 alterations (Fig. ##FIG##0##1a##). These data suggest CNV burden, loss of PRC2, and loss of <italic>NF2</italic> distinguish DNA methylation groups of histological neurofibromas and MPNSTs.</p>", "<p id=\"Par7\">To understand genetic and gene expression features distinguishing DNA methylation groups of Schwann cell tumors, whole exome sequencing (<italic>n</italic> = 34 histological MPNSTs), RNA sequencing (<italic>n</italic> = 10 histological MPNSTs, <italic>n</italic> = 8 histological neurofibromas, and <italic>n</italic> = 23 histological schwannomas), or immunohistochemistry (<italic>n</italic> = 36 histological MPNSTs) was performed on Schwann cell tumors. Whole exome sequencing identified recurrent somatic short variants (SSVs) in the core PRC2 components <italic>SUZ12</italic> or <italic>EED</italic> in Group 1 but not Group 2 or Group 3 histological neurofibromas and MPNSTs (Fig. ##FIG##0##1a##, Supplementary Fig. ##SUPPL##0##2##, and Supplementary Data ##SUPPL##3##2##). RNA sequencing revealed transcriptomic signatures separated according to DNA methylation groups (Supplementary Fig. ##SUPPL##0##3a## and Supplementary Data ##SUPPL##3##3##). Differential expression analysis of Group 1 versus Group 2/3 histological neurofibromas and MPNSTs showed enrichment of Schwann cell differentiation genes (<italic>S100B, SOX10</italic>) and SUZ12 target genes (<italic>SOX18, POU3F1</italic>) in Group 2/3 compared to Group 1 tumors (Fig. ##FIG##0##1a##, Supplementary Fig. ##SUPPL##0##3b–d##, and Supplementary Data ##SUPPL##3##3##). Immunohistochemistry for H3K27 trimethylation, an epigenetic marker of PRC2 activity, and immunohistochemistry for the Schwann cell differentiation marker S100B demonstrated loss of each in Group 1 tumors compared to Group 2/3 histological neurofibromas and MPNSTs (Fig. ##FIG##0##1a, b## and Supplementary Fig. ##SUPPL##0##3e##). Thus, whole exome sequencing, RNA sequencing, and immunohistochemistry integrated with histological analyses (Fig. ##FIG##0##1a##) suggest Group 1 Schwann cell tumors are de-differentiated and Group 2/3 Schwann cell tumors are differentiated. Taken together, Group 1 Schwann cell tumors are malignant and de-differentiated with high mutational burden. Group 3 Schwann cell tumors are benign and differentiated with limited mutational burden. Group 2 Schwann cell tumors comprise a transitory state with loss of tumor suppressors such as <italic>CDKN2A/B</italic> potentially consistent with ANNUBPs that have not yet fully progressed to a malignant, de-differentiated state. These data suggest Schwann cell tumors exist along a molecular continuum comprised of genetic, epigenetic, and gene expression programs that may influence histological or cellular features of the most common tumors of the peripheral nervous system.</p>", "<p id=\"Par8\">To define the cellular architecture across groups of Schwann cell tumors, single-nuclear RNA sequencing was performed on 19,276 nuclei from Group 1 MPNSTs (<italic>n</italic> = 3) or Group 3 neurofibromas (<italic>n</italic> = 3) from patients with clinical diagnoses of NF-1 (Fig. ##FIG##0##1c## and Supplementary Fig. ##SUPPL##0##4a##). Datasets were integrated using Harmony<sup>##REF##31740819##19##</sup>, and uniform manifold approximation and projection (UMAP) revealed a total of 18 cell clusters that were defined using a combination of automated cell type classification<sup>##REF##34983933##20##</sup>, cell signature gene sets from MSigDB<sup>##REF##16199517##21##</sup>, cell cycle phase estimation, and cell cluster marker genes (Fig. ##FIG##0##1d, e##, Supplementary Fig. ##SUPPL##0##4a–f## and Supplementary Data ##SUPPL##3##4##). A total of 14 cell clusters were shared across all tumors, and all tumors harbored a diversity of cell types (Supplementary Fig. ##SUPPL##0##4a##). The 4 least common clusters (C14-C17), which cumulatively accounted for 2.78% of cells, were largely restricted to individual tumors (Supplementary Fig. ##SUPPL##0##4a–d##). A total of 10 tumor cell clusters and 8 non-tumor cell clusters were identified. Non-tumor cell clusters included endothelia (C2, C17), T-cells (C10), macrophages (C5, C8), myelinating Schwann cells (C12) that were enriched in differentiated Group 3 neurofibromas, pericytes (C13), and muscle cells (C16) (Fig. ##FIG##0##1d## and Supplementary Fig. ##SUPPL##0##4b–d##). Shared tumor cell clusters were distinguished by expression of Hedgehog signaling (C0, <italic>PTCH1</italic>), immature Schwann cell (C1, <italic>PDGFRA</italic>), extracellular matrix (C3, <italic>LUM</italic>), growth factor signaling (C4, <italic>FGFR1</italic>), non-myelinating Schwann cell (C6, <italic>NGFR</italic>), mesodermal (C7, <italic>SFRP4</italic>), cell proliferation (C9, <italic>MKI67</italic>, <italic>TOP2A</italic>), and steroid signaling genes (C11, <italic>PTGDS</italic>) (Fig. ##FIG##0##1d## and Supplementary Fig. ##SUPPL##0##4b##). Differentiated Group 3 neurofibromas were enriched in non-tumor cells, non-proliferating cells, and non-myelinating Schwann cells. De-differentiated Group 1 MPNSTs were enriched in proliferating tumor cells, immature Schwann cells, and growth factor stimulated tumor cells (Fig. ##FIG##0##1c–f## and Supplementary Fig. ##SUPPL##0##4d–f##). In sum, multiplatform bulk and single-cell molecular profiling demonstrate that genetic, epigenetic, transcriptomic, protein expression, and cellular differences distinguish malignant, de-differentiated Group 1 tumors, transitory Group 2 tumors, and benign, differentiated Group 3 histological neurofibromas and MPNSTs.</p>", "<title>Schwann cell de-differentiation underlies MEK inhibitor resistance</title>", "<p id=\"Par9\">The distinct genomic, histological, and cellular architecture of Group 1 tumors suggests PRC2 loss may underlie Schwann cell tumor de-differentiation (Fig. ##FIG##0##1a##). To test this hypothesis, we analyzed a panel of patient-derived neurofibroma or MPNST cells with inactivating <italic>NF1, CDKN2A/B</italic>, or PRC2 mutations (Supplementary Fig. ##SUPPL##0##5a##). RNA sequencing showed enrichment of PRC2 target genes consistent with PRC2 loss and suppression of differentiation genes in MPNST cells compared to neurofibroma cells (Supplementary Fig. ##SUPPL##0##5b## and Supplementary Data ##SUPPL##3##5##). Integrating RNA sequencing data from neurofibroma cells with CRISPR knockout of PRC2 components<sup>##UREF##4##22##</sup> revealed both MPNST and PRC2-mutant neurofibroma cells demonstrated suppression of Schwann cell differentiation markers (<italic>S100B, SOX10</italic>), enrichment of de-differentiated early neural crest markers (<italic>EN1, SOX9, FOXF1</italic>), and enrichment of Ras/Raf/MEK/ERK target genes (<italic>DUSP6, SPRY2, ETV4</italic>) (Supplementary Fig. ##SUPPL##0##5c–e##). Hierarchical clustering of RNA sequencing data from all 16 patient-derived neurofibroma or MPNST cell lines based on a consensus PRC2 target gene set comprised of 24 differentiation, early neural crest, or Ras/Raf/MEK/ERK target genes segregated PRC2-intact cell lines from PRC2-mutant cell lines (Fig. ##FIG##1##2a##). Moreover, analysis of published H3K27 trimethylation ChIP-seq data<sup>##UREF##4##22##</sup> revealed epigenetic de-repression of early neural crest markers (<italic>EN1, SOX9, FOXF1)</italic> but not Ras/Raf/MEK/ERK target genes (<italic>DUSP4, SPRY2, ETV4)</italic> in PRC2-mutant cells (Supplementary Fig. ##SUPPL##0##5f##). These data suggest epigenetic mechanisms may account for some but not all changes during Schwann cell tumor transformation to MPNST.</p>", "<p id=\"Par10\">The MEK inhibitor selumetinib is an effective treatment for neurofibromas in patients with NF-1 but shows mixed results for MPNSTs<sup>##REF##28029918##11##–##UREF##3##13##</sup>. Thus, we examined the relationship between Schwann cell differentiation and selumetinib response across patient-derived neurofibroma and MPNST cells. PRC2<italic>-</italic>mutant ST88-14 MPNST cells demonstrated resistance to selumetinib compared to PRC2-intact cells (Supplementary Fig. ##SUPPL##0##5g##). To determine if PRC2 inactivation was sufficient for selumetinib resistance, we used CRISPR interference (CRISPRi) to suppress <italic>SUZ12</italic> or <italic>EED</italic> in <italic>NF1</italic>-mutant NF95.11b neurofibroma cells (Fig. ##FIG##1##2b##). Consistent with CRISPR PRC2 knockout data<sup>##UREF##4##22##</sup> (Fig. ##FIG##1##2a## and Supplementary Fig. ##SUPPL##0##5c–e##), CRISPRi suppression of the PRC2 components <italic>SUZ12</italic> or <italic>EED</italic> inhibited Schwann cell differentiation marker expression and attenuated selumetinib responses compared to non-targeted control sgRNAs (sgNTC), but did not render NF95.11b cells insensitive to selumetinib (Fig. ##FIG##1##2b##). Thus, to interrogate additional cellular mechanisms underlying MEK inhibitor responses, we performed biochemical and transcriptomic analyses of NF95.11b cells after treatment with selumetinib. Bulk RNA sequencing confirmed repression of Ras/Raf/MEK/ERK target genes (<italic>DUSP4, SPRY2)</italic> and revealed loss of Schwann cell differentiation markers after selumetinib compared to vehicle treatment (Supplementary Fig. ##SUPPL##0##6a-b## and Supplementary Data ##SUPPL##3##6##). Immunoblotting of neurofibroma cell lysates after selumetinib treatment showed initial repression of ERK phosphorylation (pERK) and early induction of apoptosis (cleaved Caspase-3, cleaved Caspase-7), followed by recovery of pERK with no change in total protein or mRNA of Ras pathway effectors in cells that persisted despite continued selumetinib treatment (Fig. ##FIG##1##2c## and Supplementary Fig. ##SUPPL##0##6c##). These data suggest NF95.11b cells represent a suitable model for studying selumetinib responses in the context of Schwann cell tumor de-differentiation in vitro.</p>", "<p id=\"Par11\">To define cellular mechanisms underlying MEK inhibitor resistance in vivo, single-cell RNA sequencing was performed on male JW23.3 MPNST allografts<sup>##REF##31278855##23##</sup> implanted into athymic female recipient mice that were treated with selumetinib or vehicle control. Female microenvironment cells were filtered using <italic>Xist</italic> expression from the X chromosome, leading to the identification of 26,608 male allograft MPNST tumor cells (Supplementary Fig. ##SUPPL##0##7a##). Datasets were integrated using Harmony<sup>##REF##31740819##19##</sup>, and UMAP analysis revealed 3 tumor cell clusters that were defined using a combination of automated cell type classification<sup>##REF##34983933##20##</sup>, cell signature gene sets from MSigDB<sup>##REF##16199517##21##</sup>, cell cycle phase estimation, and cell cluster marker genes<sup>##REF##31278855##23##</sup> (Fig. ##FIG##1##2d## and Supplementary Data ##SUPPL##3##7##). Selumetinib resistant tumor cells (C0), defined as the single cell cluster that was enriched in allografts after selumetinib treatment compared to vehicle control, showed reduced expression of cell proliferation genes compared to proliferating tumor cells (C1, <italic>Mki67, Top2a</italic>) and decreased expression of cell differentiation markers (C2, <italic>Mgp</italic>, <italic>Postn, Pdgfra</italic>) and <italic>Suz12</italic> in selumetinib resistant cells (Fig. ##FIG##1##2d, e## and Supplementary Fig. ##SUPPL##0##7b##). Moreover, proliferating tumor cells (Fig. ##FIG##1##2e##) and <italic>Nf2</italic> (Fig. ##FIG##1##2f##) were reduced in JW23.3 MPNST allografts after selumetinib compared to vehicle control treatment. These data are consistent with the observation that CNVs deleting <italic>NF2</italic> on chromosome 22q are enriched in histological neurofibromas and MPNSTs from Group 1 or Group 2 versus differentiated Group 3 histological neurofibromas and MPNSTs (Fig. ##FIG##0##1a##).</p>", "<title>NF2 inactivation drives de-differentiation and MEK inhibitor resistance in NF1-mutant Schwann cell tumors</title>", "<p id=\"Par12\">Integrating data from human patients (Fig. ##FIG##0##1##) and preclinical models (Fig. ##FIG##1##2##), we hypothesized that multiple and perhaps convergent genetic and epigenetic mechanisms may underlie de-differentiation and MEK inhibitor resistance in Schwann cell tumors. Loss of obligate PRC2 members is a well-described and recurrent finding in MPNSTs<sup>##REF##25240281##7##–##REF##25305755##9##</sup>. However, epigenetic mechanisms regulating cell differentiation remain challenging pharmacologic targets<sup>##REF##30842676##24##</sup>, and MPNSTs show mixed results with MEK inhibitor treatment<sup>##REF##28029918##11##–##UREF##3##13##</sup>. PRC2-intact neurofibromas may respond to selumetinib<sup>##REF##28029918##11##,##UREF##2##12##</sup>, but responses are often partial, suggesting that resistance mechanisms can develop without inactivation of PRC2. Thus, to identify druggable mechanisms underlying the early stages of Schwann cell tumor malignant transformation that may modify MEK inhibitor response prior to PRC2 mutation in patients with <italic>NF1-</italic>mutant, PRC2-intact neurofibromas, we performed genome-wide CRISPRi screens in <italic>NF1-</italic>mutant, PRC2-intact NF95.11b neurofibroma cells (Fig. ##FIG##2##3a## and Supplementary Data ##SUPPL##3##8##). CRISPRi activity in NF95.11b cells was validated by transducing sgRNAs targeting <italic>SUZ12</italic> or <italic>EED</italic> and confirming gene suppression using QPCR (Fig. ##FIG##1##2b##), or by transducing sgRNAs targeting the core essential gene <italic>RPA3</italic> followed by assessment of cell survival over time (Supplementary Fig. ##SUPPL##0##8a##). Triplicate screens with selumetinib or vehicle control treatment were performed by transducing NF95.11b cells with a genome-wide dual sgRNA library comprised of the top on-target sgRNAs for 23,483 genes plus 1137 non-targeting sgRNA pairs that were included as negative controls<sup>##UREF##5##25##</sup> (Supplementary Fig. ##SUPPL##0##8b##). In vehicle treated conditions, sgRNAs targeting core essential genes were predominantly depleted (493 significantly depleted, 19 significantly enriched), an internal benchmark for CRISPRi screen quality control (Supplementary Fig. ##SUPPL##0##8c##).</p>", "<p id=\"Par13\">To identify additional genes underlying growth or selumetinib responses in <italic>NF1-</italic>mutant, PRC2-intact neurofibroma cells, sgRNA enrichment or depletion after vehicle control or selumetinib treatment (T10) was compared to sgRNA abundance prior to treatment (T0) (Fig. ##FIG##2##3a##, Table ##TAB##0##1##, and Supplementary Data ##SUPPL##3##8##). sgRNAs targeting tumor suppressor genes such as <italic>TP53</italic> or <italic>NF2</italic> that were lost in Schwann cell tumors (Fig. ##FIG##0##1a##) were significantly enriched in both selumetinib and vehicle control conditions, suggesting tumor suppressor loss promotes cell growth and may also mediate selumetinib responses in <italic>NF1-</italic>mutant, PRC2-intact neurofibroma cells. Analysis of sgRNAs that were enriched upon selumetinib treatment identified negative regulators of the Ras pathway such as <italic>RASA2</italic> and <italic>SPRY2</italic> and negative regulators of the cell cycle such as <italic>RB1</italic>, <italic>CDKN1A</italic>, and <italic>RNF167</italic>. Analysis of sgRNAs that were depleted upon selumetinib treatment identified positive regulators of the Ras pathway such as <italic>KRAS</italic>, <italic>BRAF</italic>, <italic>RAF1</italic>, and <italic>PAK2</italic>, and positive cell cycle regulators such as <italic>CCNE1</italic>, <italic>CCND3</italic>, and <italic>CDC14B</italic>. sgRNAs targeting cell differentiation genes such as <italic>CDH2</italic> or <italic>KDM1B</italic> were significantly depleted in both selumetinib and vehicle control conditions, suggesting cell differentiation may contribute to both cell growth and selumetinib responses in <italic>NF1-</italic>mutant, PRC2-intact neurofibroma cells.</p>", "<p id=\"Par14\">Gene ontology analysis of sgRNAs that were selectively depleted in selumetinib but not in vehicle control conditions (<italic>n</italic> = 307 sgRNAs) showed positive Ras pathway regulators (<italic>p</italic> = 0.005, Panther pathway analysis) such as <italic>KRAS, BRAF, RAF1</italic>, and <italic>PAK2</italic> and positive cell cycle regulators and mitotic spindle components (<italic>p</italic> = 0.007, GO Cellular Component) such as <italic>CCNE1, CCND3</italic>, and <italic>CDC14B</italic> (Supplementary Data ##SUPPL##3##8##). Gene ontology analysis of sgRNAs that were selectively enriched in selumetinib but not in vehicle conditions (<italic>n</italic> = 284 sgRNAs) showed negative cell cycle regulators (<italic>p</italic> = 0.005, Panther pathway analysis) such as <italic>RB1, CDKN1A</italic>, and <italic>RNF167</italic> (Supplementary Data ##SUPPL##3##8##). sgRNAs targeting 2 distinct transcription start sites in the <italic>CDKN2A</italic> locus resulted in divergent phenotypes (Supplementary Data ##SUPPL##3##8##), likely due to the multiple start sites of the <italic>CDKN2A</italic> promoter, a known limitation of CRISPRi<sup>##REF##25307932##26##,##UREF##6##27##</sup>. Thus, to further validate CRISPRi screen results, we directly tested 2 of the top sgRNAs that were enriched after selumetinib treatment (T10/T0), <italic>RASA2</italic> or <italic>KEAP1</italic>, which were suppressed in <italic>NF1-</italic>mutant, PRC2-intact neurofibroma cells using 2 independent sgRNA protospacer sequences (Supplementary Fig. ##SUPPL##0##8e##). Suppression of either <italic>RASA2</italic> or <italic>KEAP1</italic> promoted selumetinib resistance in <italic>NF1-</italic>mutant, PRC2-intact cells compared to sgNTC (Supplementary Fig. ##SUPPL##0##8f##). In sum, these data suggest that Ras pathway and cell cycle regulators regulate selumetinib responses in <italic>NF1-</italic>mutant, PRC2-intact neurofibroma cells, while tumor suppressor genes and genes affecting cell differentiation may underlie more general growth responses as well as selumetinib responses.</p>", "<p id=\"Par15\">sgRNAs suppressing <italic>NF2</italic> were among the strongest drivers of both growth and selumetinib responses in our CRISPRi screening data (Fig. ##FIG##2##3a##), and <italic>NF2</italic> loss was significantly increased in histological neurofibromas and MPNSTs from Group 1/2 versus Group 3 (Fig. ##FIG##0##1a## and Supplementary Fig. ##SUPPL##0##1g##). To validate <italic>NF2</italic> as a driver of MEK inhibitor resistance and elucidate functional consequences of combined <italic>NF1</italic> and <italic>NF2</italic> loss in Schwann cell tumors, <italic>NF2</italic> was suppressed in <italic>NF1-</italic>mutant NF95.11b neurofibroma cells using CRISPRi. RNA sequencing validated <italic>NF2</italic> suppression and revealed loss of expression of Schwann cell differentiation markers as well as the PRC2 component <italic>SUZ12</italic> and SUZ12 target genes upon <italic>NF2</italic> suppression (Fig. ##FIG##2##3b##, Supplementary Fig. ##SUPPL##0##9a, b## and Supplementary Data ##SUPPL##3##9##). Moreover, NF95.11b cells with combined loss of <italic>NF1</italic> and <italic>NF2</italic> were resistant to selumetinib compared to <italic>NF1</italic>-mutant, <italic>NF2-</italic>intact NF95.11b cells (Fig. ##FIG##2##3b##).</p>", "<p id=\"Par16\">PAK activation following <italic>NF2</italic> loss represents a druggable dependency that can be inhibited using small molecules which are currently under clinical development<sup>##REF##14580336##28##–##REF##34075397##30##</sup>, and sgRNAs targeting <italic>PAK</italic> genes were associated with selumetinib sensitization in our CRISPRi screening data (Table ##TAB##0##1## and Supplementary Data ##SUPPL##3##8##). CRISPRi suppression of <italic>NF2</italic> in <italic>NF1-</italic>mutant NF95.11b neurofibroma cells induced PAK1 phosphorylation (pPAK1) without significantly affecting pMEK, pERK, or pAKT compared to sgNTC (Fig. ##FIG##2##3c## and Supplementary Fig. ##SUPPL##0##9c##). High pPAK1 was observed in <italic>NF1</italic>-mutant, <italic>SUZ12-</italic>mutant ST88-14 MPNST cells independent of CRISPRi suppression of <italic>NF2</italic> (Supplementary Fig. ##SUPPL##0##9d, e## and Supplementary Data ##SUPPL##3##10##), suggesting PAK1 activation may be conserved across de-differentiated Schwann cell tumors after loss of either tumor suppressors or epigenetic regulators. <italic>NF2</italic> also regulates the Hippo pathway<sup>##REF##24012335##31##</sup>, but in contrast to conserved changes in pPAK1 status across <italic>NF1</italic>-mutant Schwann cell tumors lines after suppression of <italic>NF2</italic>, core Hippo pathway components and Hippo target genes<sup>##REF##30380420##32##</sup> were variably enriched or suppressed following <italic>NF2</italic> suppression in <italic>NF1</italic>-mutant NF95.11b cells (Supplementary Data ##SUPPL##3##11##). <italic>NF1</italic>-mutant, <italic>NF2-</italic>mutant NF95.11b cells maintained pERK in response to selumetinib monotherapy compared to <italic>NF1</italic>-mutant, <italic>NF2</italic>-intact NF95.11b cells, again suggesting loss of <italic>NF2</italic> is sufficient to drive selumetinib resistance. Treatment with the small molecule PAK1 inhibitor NVS-PAK1-1 blocked pPAK1 in <italic>NF1</italic>-mutant, <italic>NF2-</italic>mutant NF95.11b cells (Supplementary Fig. ##SUPPL##0##9f, g##). Moreover, combination treatment with selumetinib and NVS-PAK1-1 showed greater initial repression of pERK and sustained repression of pPAK1 after compared to control NF95.11b cells (Fig. ##FIG##2##3d## and Supplementary Fig. ##SUPPL##0##9h##). To determine if PAK1 inhibition could potentiate selumetinib responses in vivo, 2 MPNST allograft models, JW23.3 and JW18.2, were treated with vehicle, selumetinib, NVS-PAK1-1, or selumetinib plus NVS-PAK1-1. In support of the hypothesis that PAK1 inhibition can overcome selumetinib resistance, combination molecular therapy additively inhibited JW23.3 and JW18.2 allograft growth compared to vehicle or selumetinib or NVS-PAK1-1 monotherapy (Fig. ##FIG##2##3e##).</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par17\">Neurofibromatosis was first reported over 140 years ago<sup>##UREF##8##33##</sup>, and the <italic>NF1</italic> gene product’s function as a Ras GAP was determined 30 years ago<sup>##REF##2121371##34##,##REF##2121370##35##</sup>. Molecular therapies have only recently become standard of care for patients with neurofibromatosis<sup>##REF##28029918##11##,##UREF##2##12##,##REF##23221341##36##</sup>, and with recent reports of the NF1 protein structure, additional therapeutic strategies may be on the horizon<sup>##REF##35353986##37##–##REF##34707296##39##</sup>. Given the fact that components of growth factor signaling and the Ras pathway, such as <italic>NF1</italic>, are mutated in nearly half of human cancers<sup>##REF##29625050##40##</sup>, such translational insights may be transformative for clinical oncology. Here we identify 3 DNA methylation groups of neurofibromatosis-associated peripheral nervous system tumors that are distinguished by differences in H3K27 trimethylation and Schwann cell differentiation. We find loss of the epigenetic regulator PRC2 is sufficient to drive Schwann cell tumor de-differentiation and attenuates response to selumetinib, linking tumorigenesis to treatment resistance. Although epigenetic cell differentiation mechanisms remain challenging pharmacologic targets<sup>##REF##30842676##24##</sup>, we find <italic>NF2</italic> inactivation in <italic>NF1-</italic>mutant, PRC2-intact neurofibroma cells leads to PAK activation, underlies de-differentiation, and correlates with selumetinib resistance in <italic>NF1-</italic>mutant Schwann cell tumors, elucidating a druggable dependency for combination molecular therapy (Fig. ##FIG##2##3f##).</p>", "<p id=\"Par18\">Despite the clinical success of selumetinib<sup>##REF##28029918##11##,##UREF##2##12##</sup>, additional therapies for patients with MPNSTs or recurrent neurofibromas are needed. Our identification of PAK as a target for combination molecular therapy to treat Schwann cell tumors has potential clinical implications, particularly given the challenges of directly targeting epigenetic mechanisms in patients<sup>##REF##30842676##24##</sup>. Beyond PAK, other signaling mechanisms downstream of <italic>NF2</italic> loss such as the Hippo pathway<sup>##REF##29438698##41##</sup>, the Rho/Rac/Cdc42 family of small GTPases<sup>##REF##32471868##42##</sup>, or IRF-mediated apoptosis<sup>##UREF##9##43##</sup> may also be candidates for combination molecular therapy to treat neurofibromatosis-associated tumors. Additional genetic drivers not overtly related to loss of <italic>NF2</italic>, such as recurrently amplified genes on chromosome 8<sup>##UREF##10##44##</sup> (Fig. ##FIG##0##1a##), may also contribute to selumetinib responses in de-differentiated Schwann cell tumors and could be targeted to develop new combination molecular therapies to improve treatments for patients with Schwann cell tumors. As MEK inhibition becomes more common for patients with NF-1, serial molecular analyses of patient samples will be critical to unravel mechanisms of treatment response and optimize molecular therapies for NF-1-associated peripheral nervous tumors and NF-1-associated central nervous system tumors, such as gliomas. Ongoing clinical trials are evaluating the efficacy of MEK inhibition for gliomas in patients with NF-1 (ClinicalTrials.gov NCT03871257). Multiplatform molecular profiling of human samples from these trials will no doubt help determine if the relationships between MEK activation following <italic>NF1</italic> loss and PAK activation following <italic>NF2</italic> loss are conserved across oncologic contexts. The Cancer DepMap (<ext-link ext-link-type=\"uri\" xlink:href=\"https://depmap.org/\">https://depmap.org/</ext-link>) shows significant correlation between functional dependence of cancer cell lines with loss of <italic>NF1</italic> and loss of <italic>NF2</italic> (Pearson correlation 0.23, slope=0.42, <italic>p</italic> = 4.22 × 10<sup>−14</sup>), but published screens with the MEK inhibitor trametinib suggest mixed results for sgRNAs targeting <italic>NF2</italic> in pancreatic or lung cancer cells<sup>##REF##31577942##45##</sup>. Thus, the effect of <italic>NF2</italic> loss on MEK inhibitor response may be cell- or tumor-type specific, and concurrent epigenetic mechanisms such as PRC2 loss in de-differentiated Schwann cell tumors may contribute to these responses. Although our genome-wide CRISPRi screens in <italic>NF1-</italic>mutant, <italic>NF2</italic>-intact, PRC2-intact NF95.11b neurofibroma cells did not identify sgRNAs targeting <italic>SUZ12</italic>, <italic>EED</italic>, or other core PRC2 components as drivers of selumetinib resistance in vitro, the time course of epigenetic cellular de-differentiation may not be compatible with the time course of in vitro genome-wide screens. These data demonstrate the importance of serial molecular analyses of patient samples integrated with mechanistic and functional approaches in preclinical models to address the unmet translational need for new therapies to treat malignant Schwann cell tumors.</p>" ]
[]
[ "<p id=\"Par1\">Schwann cell tumors are the most common cancers of the peripheral nervous system and can arise in patients with neurofibromatosis type-1 (NF-1) or neurofibromatosis type-2 (NF-2). Functional interactions between NF1 and NF2 and broader mechanisms underlying malignant transformation of the Schwann lineage are unclear. Here we integrate bulk and single-cell genomics, biochemistry, and pharmacology across human samples, cell lines, and mouse allografts to identify cellular de-differentiation mechanisms driving malignant transformation and treatment resistance. We find DNA methylation groups of Schwann cell tumors can be distinguished by differentiation programs that correlate with response to the MEK inhibitor selumetinib. Functional genomic screening in NF1-mutant tumor cells reveals NF2 loss and PAK activation underlie selumetinib resistance, and we find that concurrent MEK and PAK inhibition is effective in vivo. These data support a de-differentiation paradigm underlying malignant transformation and treatment resistance of Schwann cell tumors and elucidate a functional link between NF1 and NF2.</p>", "<p id=\"Par2\">The molecular mechanisms underlying malignant transformation of the Schwann lineage in Schwann cell tumours remain to be explored. Here, the authors suggest that NF2 inactivation leads to PAK activation leading to NF1-mutant Schwann cell tumour de-differentiation and resistance to selumetinib.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n\n\n\n</p>", "<title>Source data</title>", "<p>\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s41467-024-44755-9.</p>", "<title>Acknowledgements</title>", "<p>We thank Angie Hirbe from the Washington University in St. Louis for providing JW23.3 and JW18.2 mouse allograft cells, Tomoko Ozawa and the staff of the UCSF Brain Tumor Center Preclinical Therapeutics Core for assistance with mouse experiments, Anny Shai and the staff of the UCSF Brain Tumor Center Biospecimen and Pathology Core for histological staining, Eric Chow and the staff of the UCSF Center for Advanced Technology for sequencing, and Ken Probst and Noel Sirivansanti from the UCSF Department of Neurological Surgery for illustrations. We appreciate the thoughtful comments and critiques from members of the McCormick and Raleigh laboratories during the inception, execution, and dissemination of this study. This work was supported by a Children’s Tumor Foundation Young Investigator Award and a Francis Collins Scholar Award to H.N.V., NIH grant R35 CA197709 and DOD/CMRP award WH2010129 to F.M., and DOD/CDMRP award NF200021 to D.R.R.</p>", "<title>Author contributions</title>", "<p>All authors made substantial contributions to the conception or design of the study; the acquisition, analysis, or interpretation of data; or drafting or revising the manuscript. All authors approved the manuscript. All authors agree to be personally accountable for individual contributions and to ensure that questions related to the accuracy or integrity of any part of the work are appropriately investigated, resolved, and the resolution documented in the literature. H.N.V. designed, performed, and analyzed all experiments and bioinformatic analyses. E.P. performed biochemistry, QPCR, cell viability assays, and mouse allograft experiments. C.D. performed single-cell RNA sequencing and assisted with bioinformatic analysis. S.J.L. assisted with bioinformatic analysis, CRISPRi cell line generation, and genome-wide screening. K.M. performed pathology review and assisted with performing bioinformatic analysis. M.J.S. performed biochemistry, pharmacology, and helped with experimental design. S.L. performed QPCR analysis and provided critical mouse support. M.S.N. performed cell culture, biochemistry, and QPCR experiments. C.H.L. performed pathology review and assisted with processing human tumor samples for genomic analyses. C.D.E performed biochemistry and assisted with mouse allograft experiments. T.C.C. performed QPCR, immunofluorescence, and assisted with mouse allograft experiments. S.T.M. extracted nucleic acids from tumor specimens and guided experimental design from patient samples. W.C.C. helped assemble human tumor resection specimens and assisted with bioinformatic analyses. A.T.R., S.E.B. and L.J. provided key insight into study design and provided clinical data. A.P. and M.P. assembled tumor resection specimens, provided clinical data, supervised C.H.L. and K.M. for pathologic review and assisted with study design. A.R.A. supervised H.N.V. and C.D. for single cell sequencing experiments and aided with genomic analysis. F.M. and D.R.R. conceived, designed, and supervised the study.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par37\"><italic>Nature Communications</italic> thanks the anonymous reviewers for their contribution to the peer review of this work. A peer review file is available.</p>", "<title>Data availability</title>", "<p>The raw human tumor DNA methylation has been deposited in the NCBI Gene Expression Omnibus under accession code <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE212963\">GSE212963</ext-link> and the raw RNA sequencing, or single-cell RNA sequencing data, cell line RNA-sequencing, selumetinib-treated cell line RNA-sequencing, CRISPRi <italic>NF2-</italic>deficient cell line RNA-sequencing, single-cell RNA sequencing of mouse allograft data reported in this manuscript have been deposited in the NCBI Gene Expression Omnibus under accession code <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE212964\">GSE212964</ext-link>. Whole exome sequencing data has been deposited in the Sequence Read Archive (SRA) under accession code SUB11950417 (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/sra/PRJNA871281\">https://www.ncbi.nlm.nih.gov/sra/PRJNA871281</ext-link>), and the CRISPRi screen raw FASTQ data has been deposited to the SRA under accession code SUB12985587 (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/sra/PRJNA948468\">https://www.ncbi.nlm.nih.gov/sra/PRJNA948468</ext-link>). Additional RNA-sequencing and H3K27 trimethylation ChIP sequencing data from previously reported PRC2-intact or PRC2-mutant neurofibroma cell lines is available under <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118185\">GSE 118185</ext-link> or <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118183\">GSE118183</ext-link>, respectively<sup>##UREF##4##22##</sup>. The publicly available GRCh37 (hg19, <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.13/\">https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.13/</ext-link>) and GRCm38 datasets (mm10, <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ncbi.nlm.nih.gov/assembly/GCF_000001635.20/\">https://www.ncbi.nlm.nih.gov/assembly/GCF_000001635.20/</ext-link>) were used in this study. The processed genomic data generated in this study, along with all individual replicate values, are provided in the Supplementary Information and Source Data file. <xref ref-type=\"sec\" rid=\"Sec22\">Source data</xref> are provided with this paper.</p>", "<title>Code availability</title>", "<p>The open-source software, tools, and packages used for data analysis in this study, as well as the version of each program, were ImageJ (v2.1.0), R (v3.5.3 and v3.6.1), FASTQC (v0.11.9), HISAT2 (v2.1.0), featureCounts (v2.0.1), Bowtie2 (v2.3), snpEff (v5.1), Mutect2 (v4.0), picard (v2.2), cellranger (v6.1.2), Seurat R package (v3.0.1), Clustree (v0.5.0), Harmony (v3.8), DESeq2 (Bioconductor v3.10), minfi (Bioconductor v3.10), ConsensusClusterPlus (Bioconductor v3.10), Heatmap.2 R package (gplots v3.13), and ggplot2 (v3.3.6). No custom software, tools, or packages were used. CRISPRi screen analysis code is available at <ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/liujohn/CRISPRi-dual-sgRNA-screens/blob/main/module2/PhenotypeScores.R\">https://github.com/liujohn/CRISPRi-dual-sgRNA-screens/blob/main/module2/PhenotypeScores.R</ext-link>.</p>", "<title>Competing interests</title>", "<p id=\"Par38\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Multiplatform bulk and single-cell molecular profiling reveals de-differentiation underlies malignant transformation of human Schwann cell tumors.</title><p><bold>a</bold> DNA methylation profiling and consensus k-means clustering using Spearman’s correlation of human schwannomas (<italic>n</italic> = 67), neurofibromas (<italic>n</italic> = 10), and malignant peripheral nerve sheath tumors (MPNSTs) (<italic>n</italic> = 42) reveals 3 Schwann cell tumor groups. Whole exome sequencing (<italic>n</italic> = 34), RNA sequencing (RNA-seq, <italic>n</italic> = 18), or immunohistochemistry (IHC, <italic>n</italic> = 36) of histological neurofibromas and MPNSTs shows distinct mutational patterns underlying epigenetic dysregulation and loss of Schwann cell differentiation markers (<italic>S100B</italic>, <italic>SOX10</italic>). MNP, molecular neuropathology classification<sup>##REF##29539639##14##</sup>. <bold>b</bold> Representative IHC images showing loss of Schwann cell differentiation markers or loss H3K27me<sup>##REF##33094349##3##</sup> in Group 1 compared to Group 2/3 histological neurofibromas and MPNSTs and repeated independently on all 36 tumor samples analyzed (scale bar, 100 μm). <bold>c</bold> Harmonized single-nuclear RNA sequencing uniform manifold approximation and projection (UMAP) of 19,276 nuclei annotated by tumor of origin from Group 1 MPNSTs (blue, <italic>n</italic> = 3) or Group 3 neurofibromas (black, <italic>n</italic> = 3). <bold>d</bold> Tumor and non-tumor cell types from single-nuclear RNA sequencing of Schwann cell tumors defined using a combination of automated cell type classification<sup>##REF##24470531##2##</sup>, cell signature gene sets from MSigDB<sup>##REF##16199517##21##</sup>, cluster marker genes, and cell cycle phase estimation. <bold>e</bold> Single-nuclear RNA sequencing cell cycle phase estimation demonstrating Group 1 MPNSTs are enriched in actively dividing cells (green, blue) while Group 3 neurofibromas are enriched for non-dividing cells (pink).</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>Schwann cell differentiation underlies MEK inhibitor response.</title><p><bold>a</bold> RNA sequencing and hierarchical clustering using consensus PRC2 target genes distinguishes patient-derived neurofibroma or MPNST cells by PRC2-intact (red) or PRC2-mutant (blue) status with loss of Schwann cell differentiation markers (<italic>S100B, SOX10</italic>) in PRC2-mutant cells. <bold>b</bold> CRISPRi suppression of the PRC2 components <italic>SUZ12</italic> (sg<italic>SUZ12</italic>) or <italic>EED</italic> (sg<italic>EED</italic>) using 2 separate sgRNAs each inhibits Schwann cell differentiation marker expression and leads to selumetinib resistance in <italic>NF1-</italic>mutant NF95.11b neurofibroma cells compared to non-targeted sgRNAs (sgNTC). <italic>SUZ12, EED</italic>, and <italic>S100B</italic> expression were analyzed using QPCR. Cell viability after 48 h of 1 μM selumetinib treatment was assessed using MTT assays and normalized to vehicle control treatments for each cell line (dotted line) (<italic>n</italic> = 3 biologically independent experiments for all conditions). <bold>c</bold> NF95.11b neurofibroma cell immunoblots reveal 1 μM selumetinib treatment transiently inhibits pERK and induces pMEK and apoptosis over time (<italic>n</italic> = 2 biologically independent experiments). <bold>d</bold> Single-cell RNA sequencing UMAP analysis of 26,608 cells from JW23.3 male MPNST allografts in NU/NU female recipient mice treated with 25 mg/kg selumetinib twice daily by oral gavage (<italic>n</italic> = 3) or vehicle control (<italic>n</italic> = 2) for 21 days. Non-tumor cells were filtered using <italic>Xist</italic> expression to identify female host cells. Tumor cells were defined using automated cell type classification, cell signature gene sets, cell cycle phase estimation, and cluster marker genes. <bold>e</bold> C0 (selumetinib resistant cells) and C1 (proliferating tumor cells) were enriched in selumetinib (<italic>n</italic> = 3 biologically independent mice) or vehicle (<italic>n</italic> = 2 biologically independent mice) treated allograft single-cell RNA sequencing samples, respectively. <bold>f</bold>\n<italic>Nf2</italic> expression was significantly decreased in selumetinib compared to vehicle treated allograft single-cell RNA sequencing samples (<italic>p</italic> = 2.2 × 10<sup>−16</sup>, Wilcoxon rank sum test). Lines represent means. Error bars represent standard error of the means. *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> ≤ 0.0001, two sided Student’s <italic>t</italic> tests.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title><italic>NF2</italic> inactivation drives de-differentiation and MEK inhibitor resistance in <italic>NF1</italic>-mutant Schwann cell tumors.</title><p><bold>a</bold> Volcano plot depicting significantly enriched sgRNAs (<italic>n</italic> = 563, red) or depleted sgRNAs (<italic>n</italic> = 608, blue) from triplicate genome-wide CRISPRi screens in <italic>NF1-</italic>mutant NF95.11b neurofibroma cells stably expressing dCas9-KRAB and treated with 1 μM selumetinib for 10 days compared to baseline transduction pre-treatment at T0. Significant hits mediating selumetinib resistance (red) or selumetinib sensitivity (blue) are shown. X-axis is normalized log2 sgRNA abundance count. <bold>b</bold> CRISPRi suppression of <italic>NF2</italic> using 2 independent sgRNAs (gray, sg<italic>NF2</italic>) inhibits Schwann cell differentiation and drives selumetinib resistance in <italic>NF1-</italic>mutant NF95.11b neurofibroma cells stably expressing dCas9-KRAB compared to sgRNA non-targeting controls (sgNTC). <italic>NF2</italic> or <italic>S100B</italic> expression were analyzed using RNA sequencing (TPM, transcripts per million) (<italic>n</italic> = 2 biologically independent experiments per sgRNA). Cell viability after 48 h of 1 μM selumetinib treatment was assessed using MTT assays and normalized to vehicle control treatments for each cell line (dotted line) (<italic>n</italic> = 4 biologically independent experiments). <bold>c</bold> NF95.11b neurofibroma cell immunoblots reveal sgRNAs suppressing <italic>NF2</italic> induce PAK1 phosphorylation without altering pERK, pMEK, or pAKT compared to sgNTCs (<italic>n</italic> = 2 biologically independent experiments). <bold>d</bold> NF95.11b neurofibroma cell immunoblots from cells treated with combination molecular therapy inhibiting MEK (selumetinib) and PAK1 (NVS-PAK1-1) reveals robust biochemical repression of pERK in <italic>NF1-</italic>mutant<italic>, NF2</italic>-mutant cells. <bold>e</bold> Treatment of either JW23.3 or JW18.2 MPNST allografts in NU/NU mice with 25 mg/kg selumetinib twice daily by oral gavage (<italic>n</italic> = 6 biologically independent JW23.3 allografts, <italic>n</italic> = 10 biologically independent JW18.2 allografts) or 10 mg/kg NVS-PAK1-1 once daily by oral gavage (<italic>n</italic> = 4 biologically independent JW23.3 allografts, <italic>n</italic> = 10 biologically independent JW18.2 allografts) or combined selumetinib and NVS-PAK1-1 (<italic>n</italic> = 5 biologically independent JW23.3 allografts, <italic>n</italic> = 10 biologically independent JW18.2 allografts), or vehicle control (<italic>n</italic> = 5 JW23.3 allografts, <italic>n</italic> = 10 biologically independent JW18.2 allografts) for 21 days demonstrates combination molecular therapy blocks MPNST allograft growth compared to vehicle control or molecular monotherapy. <bold>f</bold> Schematic model summarizing genetic, biologic, and therapeutic mechanisms underlying Schwann cell tumor transformation. Lines represent means. Error bars represent standard error of the means. *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> ≤ 0.0001, two sided Student’s t tests.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Enrichment or depletion of select sgRNAs targeting tumor suppressors, the Ras pathway, the cell cycle, or cell differentiation from genome-wide CRISPRi screens of <italic>NF1</italic>-mutant, PRC2-intact neurofibroma cells</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th/><th colspan=\"2\">Vehicle</th><th colspan=\"2\">Selumetinib</th><th/></tr><tr><th>sgRNA</th><th>T10/T0 log<sub>2</sub> FC</th><th>T10/T0 padj</th><th>T10/T0 log<sub>2</sub> FC</th><th>T10/T0 padj</th><th>Abs(Selumetinib/Vehicle log<sub>2</sub> FC) T10/T0</th></tr></thead><tbody><tr><td><italic>TP53</italic></td><td>2.95</td><td>2.78 × 10<sup>−88</sup></td><td>3.51</td><td>1.57 × 10<sup>−126</sup></td><td>1.19</td></tr><tr><td><italic>NF2</italic></td><td>3.57</td><td>8.10 × 10<sup>−86</sup></td><td>2.18</td><td>6.33 × 10<sup>−31</sup></td><td>0.61</td></tr><tr><td><italic>RASA2</italic></td><td>2.04</td><td>2.83 × 10<sup>−35</sup></td><td>2.23</td><td>2.15 × 10<sup>−42</sup></td><td>1.09</td></tr><tr><td><italic>SPRY2</italic></td><td>0.79</td><td>0.0005</td><td>1.34</td><td>9.24 × 10<sup>−11</sup></td><td>1.7</td></tr><tr><td><italic>KRAS</italic></td><td>−0.63</td><td>0.38</td><td>−2.12</td><td>0.0001</td><td>3.37</td></tr><tr><td><italic>BRAF</italic></td><td>0.36</td><td>0.84</td><td>−3.04</td><td>0.008</td><td>8.44</td></tr><tr><td><italic>RAF1</italic></td><td>−0.53</td><td>0.66</td><td>−3.26</td><td>0.0002</td><td>6.15</td></tr><tr><td><italic>PAK2</italic></td><td>−0.98</td><td>0.42</td><td>−4.47</td><td>1.46 × 10<sup>−6</sup></td><td>4.52</td></tr><tr><td><italic>RB1</italic></td><td>1.01</td><td>0.24</td><td>1.66</td><td>0.04</td><td>1.64</td></tr><tr><td><italic>CDKN1A</italic></td><td>0.22</td><td>0.56</td><td>1.02</td><td>0.0001</td><td>4.64</td></tr><tr><td><italic>RNF167</italic></td><td>0.28</td><td>0.71</td><td>1.38</td><td>0.01</td><td>4.93</td></tr><tr><td><italic>CCNE1</italic></td><td>−1.53</td><td>0.09</td><td>−3.55</td><td>8.80×10<sup>−6</sup></td><td>2.32</td></tr><tr><td><italic>CCND3</italic></td><td>−1.04</td><td>0.17</td><td>−1.67</td><td>0.02</td><td>1.61</td></tr><tr><td><italic>CDC14B</italic></td><td>−0.83</td><td>0.12</td><td>−1.57</td><td>0.001</td><td>1.89</td></tr><tr><td><italic>CDH2</italic></td><td>−3.57</td><td>1.12 × 10<sup>−6</sup></td><td>−3.47</td><td>2.08 × 10<sup>−6</sup></td><td>0.97</td></tr><tr><td><italic>KDM1B</italic></td><td>−1.99</td><td>3.36 × 10<sup>−6</sup></td><td>−2.51</td><td>1.92 × 10<sup>−9</sup></td><td>1.26</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM5\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM6\"></supplementary-material>" ]
[ "<table-wrap-foot><p>Adjusted <italic>p</italic>-value (padj) from Wald test. <italic>Abs</italic> absolute. <italic>FC</italic> fold change. See also Supplementary Data ##SUPPL##3##8##.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Frank McCormick, David R. Raleigh.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41467_2024_44755_Fig1_HTML\" id=\"d32e661\"/>", "<graphic xlink:href=\"41467_2024_44755_Fig2_HTML\" id=\"d32e967\"/>", "<graphic xlink:href=\"41467_2024_44755_Fig3_HTML\" id=\"d32e1288\"/>" ]
[ "<media xlink:href=\"41467_2024_44755_MOESM1_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>", "<media xlink:href=\"41467_2024_44755_MOESM2_ESM.pdf\"><caption><p>Peer Review File</p></caption></media>", "<media xlink:href=\"41467_2024_44755_MOESM3_ESM.pdf\"><caption><p>Description of Additional Supplementary Files</p></caption></media>", "<media xlink:href=\"41467_2024_44755_MOESM4_ESM.xlsx\"><caption><p>Supplementary Data 1-11</p></caption></media>", "<media xlink:href=\"41467_2024_44755_MOESM5_ESM.pdf\"><caption><p>Reporting Summary</p></caption></media>", "<media xlink:href=\"41467_2024_44755_MOESM6_ESM.xlsx\"><caption><p>Source Data</p></caption></media>" ]
[{"label": ["5."], "surname": ["Gutmann"], "given-names": ["DH"], "article-title": ["Neurofibromatosis type 1"], "source": ["Nat. Rev. Dis. Prim."], "year": ["2017"], "volume": ["3"], "fpage": ["1"], "lpage": ["17"]}, {"label": ["8."], "mixed-citation": ["De Raedt, T. et al. PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies. "], "italic": ["Nature"]}, {"label": ["12."], "mixed-citation": ["Gross, A. M. et al. Selumetinib in children with inoperable plexiform neurofibromas. "], "italic": ["N. Engl. J. Med."]}, {"label": ["13."], "mixed-citation": ["Wu, L. M. N. & Lu, Q. R. Therapeutic targets for malignant peripheral nerve sheath tumors. "], "italic": ["Fut. Neurol."], "bold": ["14"]}, {"label": ["22."], "mixed-citation": ["Wassef, M. et al. EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer. 10.1073/pnas.1814634116 (2019)."]}, {"label": ["25."], "surname": ["Replogle"], "given-names": ["JM"], "article-title": ["Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors"], "source": ["Elife"], "year": ["2022"], "volume": ["11"], "fpage": ["1"], "lpage": ["32"], "pub-id": ["10.7554/eLife.81856"]}, {"label": ["27."], "surname": ["Liu"], "given-names": ["SJ"], "article-title": ["CRISPRi-based genome-scale identification of functional long non-coding RNA loci in human cells"], "source": ["Science (1979)"], "year": ["2017"], "volume": ["06"], "fpage": ["1"], "lpage": ["19"]}, {"label": ["29."], "surname": ["Radu", "Semenova", "Kosoff", "Chernoff"], "given-names": ["M", "G", "R", "J"], "article-title": ["PAK signalling during the development and progression of cancer"], "source": ["Nat. Rev. Cancer"], "year": ["2013"], "volume": ["14"], "fpage": ["13"], "lpage": ["25"], "pub-id": ["10.1038/nrc3645"]}, {"label": ["33."], "mixed-citation": ["Von Recklinghausen, F. D. Uber ide multiplen Fibrome der Haut und ihre beziehung zu den multiplen Neuromen. "], "italic": ["Berlin: Hirschwald"]}, {"label": ["43."], "mixed-citation": ["Choudhury, A. et al. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. "], "italic": ["Nat. Genet."], "bold": ["54"]}, {"label": ["44."], "mixed-citation": ["Dehner, C. et al. Chromosome 8 gain is associated with high-grade transformation in MPNST. "], "italic": ["JCI Insight"], "bold": ["6"]}, {"label": ["49."], "mixed-citation": ["Van der Auwera, G. A. et al. From fastQ data to high-confidence variant calls: The genome analysis toolkit best practices pipeline. "], "italic": ["Curr. Protoc. Bioinf."]}, {"label": ["55."], "mixed-citation": ["Magill, S. T. et al. Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma. "], "italic": ["Nat. Commun."]}, {"label": ["56."], "mixed-citation": ["Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. "], "italic": ["BMC Bioinformatics"]}]
{ "acronym": [], "definition": [] }
58
CC BY
no
2024-01-14 23:40:17
Nat Commun. 2024 Jan 12; 15:477
oa_package/77/08/PMC10786885.tar.gz
PMC10786886
38216596
[ "<title>Introduction</title>", "<p id=\"Par2\">A recent narrative review explored the effects of high-velocity, low-amplitude (HVLA) thrusts delivered to vertebral segments<sup>##REF##34164712##1##</sup>. The article differentiated between HVLA thrusts applied to clinician chosen vertebral segment based on clinical indicators of vertebral dysfunction, in short segments considered as “relevant” vs HVLA thrusts delivered to predetermined vertebral segments not based on clinical indicators of vertebral dysfunction or segments considered as “non-relevant”<sup>##REF##34164712##1##</sup>. Four of the eight included studies (i.e., 50%), which examined the effects of HVLA thrusts on segments considered as “non-relevant”, found a positive change in neuromuscular control measures<sup>##REF##34164712##1##</sup>. In contrast, 14 of the 18 (i.e., 78%) of the studies which examined HVLA thrust to segment considered as “relevant” reported improvements in measures of neuromuscular control<sup>##REF##34164712##1##</sup>. This raises the interesting question of whether the site of a HVLA thrust matters, and if so, how it might matter.</p>", "<p id=\"Par3\">The term joint dysfunction is an umbrella term that can encompass anything from a infected joint to an arthritic join. However, for the purposes of this study the type of vertebral dysfunction we are talking about are the type of biomechanical lesions of the vertebral column that chiropractors and other manual therapists might apply their HVLA thrusts. Chiropractors do not usually randomly apply HVLA thrust at a segment of the spine. Usually, they will assess the spine for areas of the spine characterized by tight vertebral muscles, reduced intervertebral movement and tenderness to touch<sup>##UREF##0##2##</sup>. This type of joint dysfunction is often referred to as a vertebral subluxation in chiropractic profession<sup>##UREF##1##3##–##UREF##2##6##</sup>. Vertebral subluxation is a term recognised as biomechanical lesions of the vertebral column by the World Health Organization (ICD-10-CM code M99.1)<sup>##UREF##3##7##</sup>. However, other professions have used many other names, thus for the purposes of this study we will simply refer to it as joint dysfunction.</p>", "<p id=\"Par4\">Neurophysiological measures are a novel and attractive means of examining the importance of applying HVLA vertebral thrusts to a segment considered as “relevant” vs segment considered as “non-relevant”. Electroencephalography (EEG) represents a low-cost, non-invasive, and safe neurophysiological measurement tool to examine brain activity related to HVLA vertebral thrusts administration. EEG enables virtually real-time assessment of central nervous system changes induced by HVLA thrusts and has been used in previous studies examining the changes of HVLA vertebral thrusts directed at segments considered as “relevant”<sup>##REF##32349288##8##,##REF##30626917##9##</sup>. Numerous other studies have also used EEG in combination with somatosensory stimulation before and after HVLA thrusts directed at segments considered as “relevant”<sup>##REF##32349288##8##,##REF##17137836##10##–##UREF##5##13##</sup>. These studies found that HVLA thrusts applied to segments considered as “relevant” alter the amplitudes of several SEP peaks, in particular, the N20 and N30 peaks<sup>##REF##32349288##8##,##REF##17137836##10##–##UREF##5##13##</sup>. The most consistent change following HVLA thrusts directed at vertebrae considered as “relevant” is a reduction in the amplitude of the N30 SEP peak<sup>##REF##32349288##8##,##REF##17137836##10##–##UREF##5##13##</sup>.</p>", "<p id=\"Par5\">Animal studies have clearly shown that the contact site for an HVLA thrust can have a significant effect on the magnitude of sensory input arising from muscle spindles in the paraspinal muscles<sup>##REF##25841562##14##</sup>. However, it is also important to take into account the known alterations that occur to these paraspinal muscles and other tissues around a dysfunctional vertebral segment in humans, which may influence the neurophysiological effects of an HVLA thrust directed at a “relevant” vs “non-relevant” vertebra. There are, for example, known maladaptive plastic changes in the deep paraspinal muscles following a spinal injury in animal models<sup>##REF##21301396##15##–##REF##27135642##20##</sup>. Rapid atrophy<sup>##REF##17139223##16##,##REF##19519631##17##</sup>, muscle fibrosis, extensive fatty infiltration, changes in muscle fibre types<sup>##REF##21301396##15##,##REF##24718080##18##–##REF##30261870##21##</sup>, and even changes to muscle spindles<sup>##REF##35618974##22##</sup> have all been found within the deep paraspinal muscles at various time-frames after a spinal injury in various animal models. Multiple studies in humans support such maladaptive plastic changes also occur in humans when their spines dysfunction or are injured<sup>##REF##28480978##23##–##REF##30611236##26##</sup>. These local paraspinal muscle changes coincide with 'smudging' within the primary sensorimotor cortices<sup>##REF##26913474##27##,##REF##30660764##28##</sup> and have led scientists to conclude that disrupted or reduced proprioceptive signaling from deep paraspinal muscles likely plays a pivotal role in driving the long-term cortical reorganization and changes in the top-down control of the sensorimotor systems, and that this plays a vital role in driving the recurrence and chronicity of spinal pain<sup>##REF##30387689##29##</sup>. With such clear evidence that maladaptive dysfunction of the deep paraspinal muscles can occur<sup>##REF##21301396##15##–##REF##27135642##20##,##REF##35618974##22##</sup>, an HVLA thrust directed at such a dysfunctional vertebral segment that is surrounded by poorly functioning paraspinal muscles could produce a different physiological response compared to an HVLA thrust applied to a fully functioning vertebral segment with healthy paraspinal muscles and tissues. To test this hypothesis, the present study aimed to compare the changes in response to HVLA thrust directed to a vertebral segment considered as “relevant” with the changes in response to an HVLA thrust directed to a segment considered as “non-relevant”, using the most consistent neurophysiological measure, i.e., the N30 SEP amplitude, in adults with subclinical neck pain. We hypothesized that the group receiving HVLA thrust directed at a “relevant” vertebra would show a significant decrease in N30 SEP complex amplitude<sup>##REF##32349288##8##,##REF##17137836##10##–##UREF##5##13##</sup>.</p>" ]
[ "<title>Methods</title>", "<title>Design and setting</title>", "<p id=\"Par6\">This study was a double-blinded, randomized, active-controlled, parallel study conducted at the New Zealand College of Chiropractic, New Zealand. The study was approved by the New Zealand Health and Disability Ethics Committees (19/CEN/202), and the protocol was prospectively registered with the Australian New Zealand Clinical Trials Registry (ACTRN12620000175976, 17/02/2020). All participants gave written informed consent, which conformed to the Declaration of Helsinki.</p>", "<title>Participants</title>", "<p id=\"Par7\">Participants were recruited through convenience sampling targeting the student and staff population at the New Zealand College of Chiropractic. Participants were included if they had a history of recurring and ongoing neck pain, aches, stiffness, or discomfort for which they had not sought treatment and were between the ages of 18 and 50 years. All participants were required to be pain-free at the time of the study. This requirement was intended to (1) avoid the confounding effect of current pain, (2) avoid any confounding effect from current or past treatment for more severe spinal problems and (3) ensure they were likely to actually need HVLA thrusts i.e., without a history of spinal problems there may not be any clinical reason to provide HVLA to their spines. Participants were excluded if they had no evidence of spinal dysfunction upon assessment by the chiropractor, had metal implants in their skull, had a history of severe neck pain (i.e., numeric pain rating scale ≥ 7/10), or had serious spinal pathology (i.e., malignancy, fracture, infection, hematoma, or cervical arterial dissection). If any of the participants had received previous chiropractic care for anything other than their neck pain, ache or tension, they were excluded if they had received HVLA thrusts within seven days of the day of data collection. Those who had received previous HVLA thrusts greater than seven days for anything other than their neck pain prior to data collection were not excluded.</p>", "<p id=\"Par8\">Sample size calculations were made based on data from our unpublished pilot study wherein we investigated changes in SEPs before and after a single session of relevant HVLA thrust using a similar protocol. We calculated a required sample size of 84 using G*Power (version 3.1.9.4) based on the statistical t-tests (Means: Difference between two independent means [two groups]) to observe an Effect size d of 0.6212775 with α = 0.05, power β = 0.8, and an allocation ratio of 1. To compensate for  the dropouts, we recruited 96 participants.</p>", "<title>Randomization and blinding</title>", "<p id=\"Par9\">Participants were allocated to either the “relevant” HVLA thrust or the “non-relevant” HVLA thrust group using an online randomization program (QMinim, Microsoft Corp., Redmond, WA, USA). A randomization sequence with 1:1 allocation was done with age (&lt; 35 years or ≥ 35) and gender as a priori covariates. Participants and the investigators who collected or analyzed the data were blinded to group allocation, while the chiropractors who delivered the intervention were unable to be blinded due to the nature of the intervention. To ensure effective blinding of investigators, all recorded data were anonymized and given a code a priori. The investigators were kept blinded until the final analysis was completed.</p>", "<title>Study procedure</title>", "<p id=\"Par10\">Following an initial screening, each participant’s cervical spine was assessed by a registered and experienced (&gt; 10 years) chiropractor for the presence and site of spinal dysfunction/subluxation (i.e., “relevant” sites)<sup>##UREF##0##2##</sup>. Eligible participants came in for a single session comprising of SEP recording before and immediately after the HVLA thrust intervention. During the session, the participants were seated comfortably in a chair and were asked to focus their gaze on a fixed target on the wall and be relaxed to minimize the contamination of EEG signals.</p>", "<title>Somatosensory evoked potentials</title>", "<p id=\"Par11\">SEPs were evoked by stimulating the median nerve of the dominant hand using electrical pulses from an electrical stimulator (Digitimer DS7AH, Hertfordshire, UK). After positioning the stimulating electrodes (Neuroline 700, AMBU A/S, Ballerup, DK) on the wrist, the intensity was slowly increased until the motor threshold, the lowest current intensity that produces a visible twitch of the thumb, was reached. A total of 1000 monophasic electrical pulses at a frequency of 2.3 Hz having 0.2 ms width were given to the median nerve.</p>", "<title>EEG</title>", "<p id=\"Par12\">The EEG from 25 channels (frontal and frontal-central: FP1, FPz, FP2, F7, F3, Fz, F4, F8, FC5, FC1, FC2, FC6, AF7, AF3, AF4, AF8, F5, F1, F2, F6, FC3, FCZ, FC4, FT7, FT8) was recorded at a sampling rate of 2048 Hz using REFA amplifier (TMSi, Twente, NL). The ground electrode was placed at AFz. The electrode impedance was kept below 10 kΩ. During EEG recording, participants were asked to reduce eye blinks, eye movements and facial movements. Offline analysis of the EEG data was performed using custom scripts in MATLAB 2020a (The MathWorks, Inc., Natick, MA, USA) that utilised EEGLAB (version 2019)<sup>##REF##15102499##30##</sup>, ERPLAB (version 2019)<sup>##REF##24782741##31##</sup>, FieldTrip (version 20180912)<sup>##REF##21253357##32##</sup>, and MATLAB functions<sup>##REF##31181744##33##</sup>. At the start and end of the EEG recording, an additional 10 s of data was recorded to minimize the filtering artefacts in preprocessing. The standardized early-stage EEG processing pipeline (PREP) pipeline<sup>##REF##26150785##34##</sup> was utilized to determine faulty channels, discard line noise and acquire the average referenced data.</p>" ]
[ "<title>Results</title>", "<p id=\"Par19\">Ninety-six participants met the eligibility criteria and were enrolled in the study between February 2020 and March 2020. The participant recruitment flow diagram is given in Fig. ##FIG##1##2##. The demographic characteristics of included participants in each group are given in Table ##TAB##0##1##.</p>", "<title>HVLA thrust site selection</title>", "<p id=\"Par20\">The cervical spinal site of HVLA thrust administration in the “relevant” HVLA thrust group was most often C1 (n = 25), followed by C2 (n = 14) and C3 (n = 4). No patient in this group received HVLA thrust at a cervical spinal level caudal to C3. In the “non-relevant” HVLA thrust group, the most common site of HVLA thrust was C3 (n = 17), followed by C2 (n = 16), C1 (n = 8), C5 (n = 1), and C6 (n = 1). In the “non-relevant” HVLA thrust group, the maximum distance from the dysfunctional segment to the non-dysfunctional, manipulated segment was two vertebral segments.</p>", "<title>N30 complex amplitude</title>", "<p id=\"Par21\">The mixed model showed a significant interaction between the site of intervention and session (F<sub>1,84</sub> = 9.89, <italic>p</italic> = 0.002) (Table ##TAB##1##2##).</p>", "<p id=\"Par22\">Pairwise comparisons (Table ##TAB##2##3##) revealed that there was a significant decrease in the N30 amplitude immediately after HVLA thrust was applied to segments considered as “relevant” (N30 complex difference % =  − 16.76 ± 28.32%, <italic>p</italic> = 0.005), whereas the N30 amplitude displayed a non-significant increase after HVLA thrust was applied to segments considered as “non-relevant” (N30 complex difference % = 19.58 ± 55.09%, <italic>p</italic> = 0.0757).</p>", "<p id=\"Par23\">Figure ##FIG##2##3## shows the distribution and differences of the N30 amplitude before and immediately after the interventions such that the N30 amplitude significantly decreased immediately after HVLA thrust was applied to segment considered as relevant.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par24\">This randomized controlled trial was the first study to compare the immediate changes in response to the application of an HVLA thrust at a cervical vertebra considered as “relevant” versus an HVLA thrust directed at a cervical vertebra considered as “non-relevant” on human brain activity as measured by the N30 SEP complex amplitude. The present study found a significant decrease in the N30 SEP complex amplitude (about − 17%) immediately after an HVLA thrust applied to a cervical segment considered as “relevant” (i.e., a dysfunctional segment), whereas a non-significant increase in the N30 SEP complex amplitude was recorded immediately after an HVLA thrust applied to a cervical segment considered as “non-relevant” (i.e., a non-dysfunctional segment). According to previous research, a decrease in the N30 SEP complex amplitude is suggestive of changes in sensorimotor function occurring within the prefrontal cortex<sup>##REF##27047694##12##</sup>. Therefore, the current study findings suggest that applying the HVLA thrust at a dysfunctional segment may induce greater level of sensorimotor integrative changes than applying an HVLA thrust at a non-dysfunctional site.</p>", "<title>Comparison with the literature</title>", "<p id=\"Par25\">The present study adds to the limited research regarding HVLA thrust site selection<sup>##REF##34862434##39##</sup>. Studies using animal models have demonstrated one can maximize proprioceptive afferent inputs and muscle spindle responses coming from a specific spinal segment when HVLA thrusts are directed at that same spinal segment with velocities greater than 20–30 mm/s and with thrust rates greater than 300N/s<sup>##REF##25841562##14##,##UREF##10##40##</sup>. In one animal study, the authors created spinal dysfunction with a facet fixation model<sup>##UREF##11##41##</sup> and found that such spinal fixations altered paraspinal sensory responses during “relevant” HVLA thrusts at these levels. However, there is paucity of evidence of differences in neurophysiologic changes in humans following HVLA thrust applied to segments considered as “relevant” versus HVLA thrust applied to segments considered as “non-relevant”. The current study, therefore, adds to the limited research regarding HVLA thrust site selection in the cervical spine in humans. The present study has the potential to offer insights into practical decision-making for chiropractors when choosing between HVLA thrust at one cervical site versus another. The current findings support that chiropractors' selection of which cervical site to apply HVLA thrust may be relevant with respect to subsequent sensorimotor changes. A recent systematic review reported that spinal manipulation applied to suspected relevant sites did not yield a superior result for clinical outcome measures compared to spinal manipulation applied to non-relevant sites in nine of 10 included studies<sup>##REF##34862434##39##</sup>. However, the study was limited in that the included studies demonstrated variability in what constituted a relevant site of spinal manipulation, and in some instances, both the treatment and control groups received a potentially relevant HVLA thrust. In three of the included studies<sup>##REF##29456442##42##–##REF##19685848##44##</sup>, two different HVLA techniques were compared, yet potentially targeted dysfunctional, hypomobile, or symptomatic spinal segments, resulting in improved pain and disability outcomes. Although the between-group HVLA techniques varied, the segment(s) to which HVLA thrust was applied could represent relevant sites<sup>##REF##29456442##42##–##REF##19685848##44##</sup>.</p>", "<p id=\"Par26\">Two of the nine studies<sup>##REF##32393074##45##,##REF##28215058##46##</sup> compared two groups receiving HVLA thrust manipulation of spinal levels pre-determined by the experimental design rather than clinical context. For example, Romero del Rey et al.<sup>##REF##32393074##45##</sup> compared HVLA manipulation of either C1-C2 with HVLA thrust manipulation C3-4, C7-T1 and T5-6, while Bautista-Aguirre et al.<sup>##REF##28215058##46##</sup> compared HVLA thrust manipulation of C7 with HVLA manipulation of T1. In both of these studies, the sites of HVLA thrusts were therefore not chosen according to patient-specific clinical findings; hence all groups potentially received non-relevant HVLA manipulations<sup>##REF##32393074##45##,##REF##28215058##46##</sup>. In these studies, there were no significant between-group differences in pain outcome scores, pressure pain thresholds, or upper extremity grip strength.</p>", "<p id=\"Par27\">Four of the nine studies<sup>##REF##32660919##47##–##REF##12782973##50##</sup> tested whether applying an HVLA thrust to the most tender lumbar<sup>##REF##32660919##47##,##REF##23431209##48##</sup> or cervical<sup>##REF##22711239##49##</sup> segment, or hypomobile segment based on end play assessment<sup>##REF##12782973##50##</sup> (i.e., HVLA thrust on “relevant” vertebral segment would lead to better clinical outcomes compared to applying a general HVLA thrust at a pre-determined cervical or thoracic spinal segment (i.e., HVLA thrust on “non-relevant” vertebral segment). In all four of these studies, there were no differences in pain scores (pain intensity, pressure pain threshold, disability and global perceived change) or stiffness after the relevant HVLA lumbar or cervical segment manipulation compared with the non-relevant HVLA thoracic manipulation<sup>##REF##32660919##47##–##REF##22711239##49##</sup> or cervical manipulation<sup>##REF##12782973##50##</sup>. For all HVLA groups, the pain measures improved<sup>##REF##32660919##47##–##REF##22711239##49##</sup>. In the tenth study<sup>##REF##24976754##51##</sup>, the authors compared an HVLA thrust aiming to improve the mobility of a dysfunctional (hypomobile) thoracic segment with a less specific thoracic HVLA manipulation provided in the direction of normal mobility. In this study, the relevant thrust significantly reduced cervical pain compared to the non-relevant HVLA manipulative thrust<sup>##REF##24976754##51##</sup>. Given the above limited and conflicting findings, it remains unclear whether it is therapeutically important to aim to apply HVLA thrust to a “relevant” or “non-relevant” vertebral site when treating spinal pain or dysfunction.</p>", "<p id=\"Par28\">Previous measures used in studies examining the relevance of HVLA thrusts site selection have had inherent limitations. The most commonly measured outcomes, such as pain intensity, range of motion, or disability, may be influenced by patient expectations or may not be expected to change with only a single application of HVLA vertebral thrusts<sup>##REF##34862434##39##</sup>. Few studies have used imaging tests to examine this question, and while study designs using radiography to examine changes in intervertebral motion may be useful<sup>##REF##30142458##52##</sup>, these are hindered by the necessity of exposure of participants to ionizing radiation. Newer magnetic resonance imaging studies (e.g. examining disc diffusion) are promising<sup>##REF##24261925##53##</sup> but may be limited by cost.</p>", "<title>Possible mechanisms</title>", "<p id=\"Par29\">The present findings provide evidence that cervical HVLA thrust directed to a vertebral segment considered as “relevant” produces distinct neurophysiological changes evident via EEG via decreased N30 SEP complex amplitude. Previous studies have shown decreases in N30 SEP peak amplitudes following relevant HVLA thrust in subclinical spinal pain populations<sup>##REF##17137836##10##,##UREF##4##11##,##UREF##12##54##</sup>. This amplitude reduction is attributed to changes in somatosensory processing at the cortical level, particularly within the prefrontal cortex<sup>##REF##27047694##12##</sup>. Other neural generators of the N30 amplitude complex include the primary sensory cortex, basal ganglia, thalamus, premotor areas, and primary motor cortex<sup>##REF##2769354##55##–##REF##10479026##61##</sup>. The frontal N30 peak is thought to reflect early sensorimotor integration<sup>##REF##12842734##62##,##REF##20813188##63##</sup>.</p>", "<p id=\"Par30\">Drawing from the insights in the literature on animal fixation model<sup>##UREF##11##41##</sup>, where spinal fixations were observed to modify sensory responses in paraspinal muscles during “relevant” HVLA thrusts, along with our current findings, we infer that the neurophysiological mechanisms associated with these “relevant” HVLA thrusts likely involve the activation of these paraspinal proprioceptive sensory responses, particularly in the presence of dysfunction. Paraspinal tissue dysfunction has, as discussed earlier, been noted to occur following a spinal injury<sup>##REF##21301396##15##–##REF##27135642##20##</sup>. This paraspinal tissue dysfunction includes rapid atrophy of deep paraspinal muscles<sup>##REF##17139223##16##,##REF##19519631##17##</sup>, deep paraspinal muscle fibrosis, extensive fatty infiltration of such muscles, changes in muscle fibre types within such muscles<sup>##REF##21301396##15##,##REF##24718080##18##–##REF##30261870##21##</sup> and even changes to muscle spindles themselves within the deep paraspinal muscles at the injured segment<sup>##REF##35618974##22##</sup>. These local paraspinal muscle changes coincide with 'smudging' within the primary sensorimotor cortices<sup>##REF##26913474##27##,##REF##30660764##28##</sup> and have led scientists to conclude that disrupted or reduced proprioceptive signalling from deep paraspinal muscles likely plays a pivotal role in driving the long-term cortical reorganisation and changes in the top-down control of the sensorimotor systems and that this plays a vital role in driving the recurrence and chronicity of back pain<sup>##REF##30387689##29##</sup>. As applying an HVLA thrust is known to activate muscle spindles in surrounding paraspinal muscles<sup>##REF##25841562##14##,##UREF##10##40##</sup>, it, therefore, seems plausible that applying the HVLA thrust at such dysfunctional segments could result in different clinical effects, as compared to applying an HVLA manipulation to a healthy vertebral segment, with non-fibrotic, non-fatty infiltrated paraspinal segments. The current study would support this notion.</p>", "<title>Clinical and research implications</title>", "<p id=\"Par31\">The decrease in N30 amplitude noted in the present study suggests that the neurological activity within the network responsible for generating the N30 component (i.e., basal ganglia, thalamus, premotor cortex, prefrontal cortex and motor-cortex) decreases in response to HVLA thrust applied to cervical segment considered as “relevant”<sup>##REF##2769354##55##–##REF##10479026##61##</sup>. However, in light of the findings by Lelic et al.<sup>##REF##27047694##12##</sup> that showed when relevant HVLA thrusts were applied to research participants, the decrease in the N30 SEP complex amplitude appeared to reflect mainly changes in sensorimotor function occurring within the prefrontal cortex, the decrease in the N30 SEP complex amplitude found in the current study most likely also reflects alterations in sensorimotor function within the prefrontal cortex. Accordingly, relevant HVLA thrust may influence sensorimotor integration and related neuromuscular functions. Future studies can explore the clinical relevance of these findings.</p>", "<title>Strengths, limitations and future research</title>", "<p id=\"Par32\">A strength of the study was the large sample size which supports the fact that is unlikely that the observed reduction in N30 complex amplitude in the relevant HVLA thrust group occurred by chance. Limitations of the study include that a single cervical HVLA thrust application may not reflect the long-term care performed in clinical practice. However, this protocol design was intended to avoid repeatedly exposing the “non-relevant” HVLA thrust group to HVLA thrust directed at the non-dysfunctional segment for a longer period. Another limitation is that the changes in N30 SEP complex amplitudes were only measured immediately after one thrust application and not several time periods after the HVLA thrust application. Therefore, it is unclear how long the effects on N30 complex amplitude last after the HVLA thrust.</p>", "<p id=\"Par33\">There are several potentially important differences between spinal regions that preclude our ability to generalize the current study findings to other regions of the spine (i.e., thoracic, lumbar, or sacroiliac joints). Importantly, the density of mechanoreceptors is higher in the cervical region<sup>##UREF##13##64##,##REF##12991237##65##</sup>. HVLA thrust is known to activate muscle spindles in surrounding paraspinal muscles<sup>##REF##25841562##14##,##UREF##10##40##</sup>. Therefore, mechanoreceptors such as muscle spindles are believed to sense the impulse provided by HVLA thrust and trigger subsequent neurophysiological changes<sup>##REF##34164712##1##</sup> and thus may produce greater responses, as evident via EEG. The height of cervical vertebrae and, therefore, the corresponding motion segments are smaller, thus potentially requiring a greater degree of precision or lower degree of force application with HVLA thrust. There is also a difference in innervation; for example, cranial nerve five has an anatomical relationship to the upper cervical spine and may be implicated in cases of neck pain<sup>##REF##36117309##66##</sup>, whereas cranial nerves are unrelated to the other spinal regions. The current study should therefore be replicated in other regions of the spine to determine if the findings are consistent or dependent upon the spinal region.</p>", "<p id=\"Par34\">The results of this study may not be generalizable to other methods of HVLA thrust administration. As the current study used an instrument to administer HVLA thrust (Activator), the delivery of force could be both lower in magnitude and/or more localized to a specific vertebrae or motion segment. While little is known about this topic, it is possible that other forms of HVLA thrust applied manually could lead to a broader biomechanical effect on the spinal target<sup>##REF##24261925##53##</sup> and potentially a less predictable neurophysiological response. However, in the current study, the HVLA thrust delivered via the Activator instrument led to a significant decrease in the N30 SEP peak complex, similar to what has been found following HVLA thrusts delivered manually as well<sup>##REF##32349288##8##,##REF##17137836##10##–##UREF##5##13##</sup>. In these previous studies, HVLA thrusts were likewise targeted at dysfunctional segments, thus representing HVLA thrusts. The current study did not measure several clinical variables, such as baseline or post-HVLA thrust changes in pain severity or range of motion. Accordingly, it is not known if the observed changes in N30 amplitude correlate with measures of clinical improvement such as reduced pain, pain pressure thresholds, reduced stiffness, or improved mobility. Future studies could replicate the present design while including clinical outcomes alongside EEG. In addition, a longitudinal design with multiple HVLA thrust interventions may enable the examination of potential long-term or progressive changes in neurophysiological measures.</p>", "<p id=\"Par35\">The present study may only be generalizable to younger adults as the mean age for each group was 24 to 25 years. It is unknown if age-related degenerative changes in the cervical spine would interfere with mechanoreception related to HVLA thrust or the observed subsequent neurophysiological changes. In addition, the current study may not be generalizable to people with severe neck pain, such as cervical radiculopathy or disc herniation, as only individuals with milder symptoms were included. The current study could be replicated in an older population or individuals with more severe neck pain syndromes for comparison.</p>", "<p id=\"Par36\">Regarding the blinding of the chiropractor providing the HVLA thrust, it could be noted that an alternative approach could have involved a different chiropractor conducting the assessments on all participants and subsequently informing the treating chiropractor about the specific site for the HVLA thrust without disclosing its relevance. However, for the sake of maintaining consistency and minimizing potential variability in technique application, the same chiropractor was deliberately chosen to perform both the assessments and the HVLA thrust intervention. This decision was further supported by the utilization of standardized instrument-assisted thrusting with Activator, which aimed to reduce potential sources of variation. Despite this, it is important to acknowledge that not blinding the treating chiropractor may introduce a source of bias. In order to mitigate potential bias, we took measures to blind both the participants and the assessors involved in the study. This additional step was implemented to enhance the rigor and integrity of our methodology.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par37\">This randomized controlled trial was the first to investigate the immediate changes in response to an HVLA thrust site selection in the cervical spine using a neurophysiological EEG outcome measure and found evidence that HVLA thrust directed at a cervical site considered as dysfunctional significantly reduces N30 amplitude immediately after such intervention. In contrast, HVLA thrust directed at a cervical site considered as non-dysfunctional causes no significant change. The present findings suggest that clinicians' selection of where to apply cervical HVLA thrust is likely to be relevant with regards to affecting the subsequent sensorimotor response. Further research is needed to correlate these changes with clinical outcomes, repeat the study design in other spinal regions and patient populations, and examine both potential changes at short, medium and long terms, as well as the longitudinal response to multiple HVLA thrust sessions.</p>" ]
[ "<p id=\"Par1\">Increasing evidence suggests that a high-velocity, low-amplitude (HVLA) thrust directed at a dysfunctional vertebral segment in people with subclinical spinal pain alters various neurophysiological measures, including somatosensory evoked potentials (SEPs). We hypothesized that an HVLA thrust applied to a clinician chosen vertebral segment based on clinical indicators of vertebral dysfunction, in short, segment considered as “relevant” would significantly reduce the N30 amplitude compared to an HVLA thrust applied to a predetermined vertebral segment not based on clinical indicators of vertebral dysfunction or segment considered as “non-relevant”. In this double-blinded, active-controlled, parallel-design study, 96 adults with recurrent mild neck pain, ache, or stiffness were randomly allocated to receiving a single thrust directed at either a segment considered as “relevant” or a segment considered as “non-relevant\" in their upper cervical spine. SEPs of median nerve stimulation were recorded before and immediately after a single HVLA application delivered using an adjusting instrument (Activator). A linear mixed model was used to assess changes in the N30 amplitude. A significant interaction between the site of thrust delivery and session was found (F<sub>1,840</sub> = 9.89, <italic>p</italic> &lt; 0.002). Pairwise comparisons showed a significant immediate decrease in the N30 complex amplitude after the application of HVLA thrust to a segment considered “relevant” (− 16.76 ± 28.32%, <italic>p</italic> = 0.005). In contrast, no significant change was observed in the group that received HVLA thrust over a segment considered “non-relevant” (<italic>p</italic> = 0.757). Cervical HVLA thrust applied to the segment considered as “relevant” altered sensorimotor parameters, while cervical HVLA thrust over the segment considered as “non-relevant” did not. This finding supports the hypothesis that spinal site targeting of HVLA interventions is important when measuring neurophysiological responses. Further studies are needed to explore the potential clinical relevance of these findings.</p>", "<title>Subject terms</title>" ]
[ "<title>Interventions</title>", "<title>HVLA thrust directed at cervical vertebrae considered as “relevant”</title>", "<p id=\"Par13\">We defined the “relevant” HVLA thrust intervention as a high-velocity, low-amplitude thrust directed at a dysfunctional cervical spinal segment. The chiropractor determined each cervical spinal site to be “relevant” (i.e. dysfunctional) based on an examination which identified restricted intervertebral motion and pain provocation with motion palpation and palpable, asymmetric local hypertonic musculature, and any blocked or unusual joint play/end-feel of the spinal joints<sup>##REF##34164712##1##,##UREF##6##35##</sup>. Participants in this group were eligible to have more than one site of dysfunction, yet only a single site was chosen for the HVLA thrust. In the instance of multiple sites of dysfunction, the chiropractor always defaulted to choose the more superior/cranial HVLA thrust to establish consistency with the HVLA thrust methodology.</p>", "<p id=\"Par14\">The “relevant” HVLA thrust intervention involved the chiropractor delivering a single administration of HVLA thrust with an Activator instrument on the site of “relevant” cervical dysfunction (Fig. ##FIG##0##1##). The Activator instrument is a hand-held device that delivers fast, precise, and low-force thrust to the spine<sup>##UREF##7##36##</sup>. This device was preferred over manual delivery of HVLA thrust for the purposes of consistency with HVLA thrust administration, as its use would reduce the amount of variability in HVLA thrust parameters (i.e., force, amplitude, and duration).</p>", "<title>HVLA thrusts directed at cervical vertebrae considered as “non-relevant”</title>", "<p id=\"Par15\">The “non-relevant” HVLA thrust intervention refers to a thrust directed at a non-dysfunctional spinal segment that had no signs of dysfunction upon examination by a chiropractor<sup>##REF##34164712##1##</sup>. This intervention involved the delivery of a single HVLA thrust application via the Activator instrument. The non-dysfunctional vertebra targeted was always the one that was furthest away from the dysfunctional vertebra, yet within the cervical spinal region. In the event that there was more than one site of cervical dysfunction, the chiropractor avoided providing HVLA thrust at any site of dysfunction yet aimed to be furthest from the relevant segment. HVLA thrust was delivered by the same chiropractor who provided the relevant HVLA thrust intervention to ensure consistency.</p>", "<p id=\"Par16\">Both groups received HVLA thrusts directed at a vertebra in the upper cervical spine. The main reason for this is that there are differences in the physiology of the upper and lower cervical spine that could introduce confounding variables that we wanted to avoid. Unlike the lower cervical spine, where muscles span multiple segments, the upper cervical spine has many small deep paraspinal muscles that cross individual spinal segments. Additionally, the deep paraspinal muscles of the upper cervical spine are rich in muscle spindles, which a crucial for mechanoreception and known to respond to the HVLA thrust. Therefore, to maintain as much consistency in the intervention level across groups the most cephalic segment was chosen for both groups, i.e., the most cephalic segment that either was or was not deemed dysfunctional.</p>", "<title>Data processing</title>", "<p id=\"Par17\">Most of the GUIs and codes used were the same as in Navid et al.<sup>##REF##32349288##8##,##REF##31181744##33##</sup>. The mastoid channel ipsilateral to the dominant hand was used as the reference channel. The data was filtered with a 2nd order Butterworth band-pass filter with a frequency range from 1 to 500 Hz. SEPs were extracted from − 100 ms to 150 ms with respect to the stimulus. The pre-stimulus period was used for baseline correction. The post-stimulus period used was 150 ms and entails the cortex's response this study concentrates on. Contralaterally to the dominant hand, the trial-rejected, averaged, eyeblink-cleaned, and noise-cleaned event-related potential of either F3 for right-handed or F4 for left-handed participants was plotted and scanned for the components P22 and N30. This was done with a GUI for component marking.</p>", "<title>Statistical analysis</title>", "<p id=\"Par18\">A linear mixed model was used to identify the effects of intervention site selection on the N30 amplitude. The intervention (“relevant” and “non-relevant”) and session (pre and post) were used as fixed factors. The between-paticipant variance was estimated using random intercept in the model. The models were implemented using lme4 package (version 1.1.23) in R (version 3.5.1)<sup>##UREF##8##37##</sup>. The pairwise comparisons were obtained using the emmeans package version 1.4.8<sup>##UREF##9##38##</sup>, adjusted for multiple comparisons using Tukey's honestly significant difference test. The significance threshold was set at <italic>p</italic> &lt; 0.05.</p>" ]
[ "<title>Acknowledgements</title>", "<p>The authors thank all the students and staff from the New Zealand College of Chiropractic who volunteered to participate in this study.</p>", "<title>Author contributions</title>", "<p>Conceptualisation: I.K.N., K.H., H.H.; data curation: I.K.N., C.M., I.A.; formal analysis: M.S.N., C.M.; funding acquisition: H.H.; investigation: I.K.N., C.M., I.A.; methodology: M.S.N., C.M.; project administration: I.K.N., M.S.N., K.H., H.H.; resources: I.K.N., K.H., H.H.; software, M.S.N., C.M.; supervision: I.K.N., M.S.N., I.A.,K.H., H.H.; validation: M.S.N., C.M.; visualisation: M.S.N.; writing—original draft preparation, I.K.N.,M.S.N., C.M., N.K., R.J.T., K.H.; writing—review and editing, I.K.N., M.S.N., C.M., I.A., N.K., K.H., R.J.T., H.H.</p>", "<title>Funding</title>", "<p>This study was funded by Australian Spinal Research Foundation (ASRF) (Grant no. TRG2019-3) and the Centre for Chiropractic Research Supporters Program at the New Zealand College of Chiropractic.</p>", "<title>Data availability</title>", "<p>The numerical data supporting the conclusions of this article will be made available by the authors without undue reservation. Interested individuals can obtain this data by making a reasonable request to the corresponding author, Imran Khan Niazi. The Local Ethics Committee adhering to local data protection laws, does not allow the sharing of individuals’ raw data.</p>", "<title>Competing interests</title>", "<p id=\"Par38\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>(<bold>a</bold>) Demonstration of the experimental setup involving the participant with EEG cap and the Activator instrument illustrated in the posterior cervical spine region. (<bold>b</bold>) Shows a section of the graphic user interface used for marking epochs. (<bold>c</bold>) Indicates graphic user interface (GUI) for accepting or rejecting independent components. (<bold>d</bold>) Graphic user interface for marking somatosensory evoked potentials.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>CONSORT study flow diagram.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>N30 amplitude. (<bold>A</bold>) Dots represent the N30 amplitude of individual subjects. Boxplots show the median, 25th and 75th percentiles. The distribution plots show the density distribution estimated by a Gaussian kernel with an SD of 1.5. (<bold>B</bold>) The error bars represent the estimated mean ± 95% CI from the statistical model.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Demographic characteristics of participants in each group.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Variables</th><th align=\"left\">HVLA thrust applied to segments considered as “relevant”</th><th align=\"left\">HVLA thrust applied to segments considered as “non-relevant”</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"3\">Gender</td></tr><tr><td align=\"left\"> Male, number (%)</td><td align=\"left\">20 (47)</td><td align=\"left\">17 (40)</td></tr><tr><td align=\"left\"> Female, number (%)</td><td align=\"left\">23 (53)</td><td align=\"left\">26 (60)</td></tr><tr><td align=\"left\">Age, years (mean ± SD)</td><td align=\"left\">24.41 ± 5.05</td><td align=\"left\">24.83 ± 5.57</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Model results.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\"/><th align=\"left\">F</th><th align=\"left\">Df</th><th align=\"left\">Df.res</th><th align=\"left\">Pr (&gt; F)</th></tr></thead><tbody><tr><td align=\"left\">Intervention</td><td char=\".\" align=\"char\">1.28</td><td align=\"left\">1</td><td align=\"left\">84</td><td char=\".\" align=\"char\">0.262</td></tr><tr><td align=\"left\">Session</td><td char=\".\" align=\"char\">3.06</td><td align=\"left\">1</td><td align=\"left\">84</td><td char=\".\" align=\"char\">0.084</td></tr><tr><td align=\"left\">Intervention: session</td><td char=\".\" align=\"char\">9.89</td><td align=\"left\">1</td><td align=\"left\">84</td><td char=\".\" align=\"char\">0.002</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Within-group differences based on estimated N30 amplitude from the statistical model.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Contrast</th><th align=\"left\">Estimate ± SE</th><th align=\"left\">95% CI</th><th align=\"left\">t. ratio</th><th align=\"left\"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align=\"left\">“Non-relevant” post – “non-relevant” pre</td><td char=\".\" align=\"char\">0.12 ± 0.12</td><td align=\"left\">[− 0.19, 0.43]</td><td char=\".\" align=\"char\">0.99</td><td char=\".\" align=\"char\">0.757</td></tr><tr><td align=\"left\">“Relevant” post – “relevant” pre</td><td char=\".\" align=\"char\">− 0.41 ± 0.12</td><td align=\"left\">[− 0.72, − 0.10]</td><td char=\".\" align=\"char\">− 3.46</td><td char=\".\" align=\"char\">0.005</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[]
[ "<table-wrap-foot><p><italic>SD</italic> standard deviation.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Imran Khan Niazi and Muhammad Samran Navid.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51201_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51201_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51201_Fig3_HTML\" id=\"MO3\"/>" ]
[]
[{"label": ["2."], "surname": ["Triano"], "given-names": ["JJ"], "article-title": ["Review of methods used by chiropractors to determine the site for applying manipulation"], "source": ["Chiropr. Man. Ther."], "year": ["2013"], "volume": ["21"], "fpage": ["36"], "pub-id": ["10.1186/2045-709X-21-36"]}, {"label": ["3."], "mixed-citation": ["Cooperstein, R., Haneline, M. & Young, M. In "], "italic": ["Association of Chriopractic Colleges Educational Conference - Research Agenda Conference (ACC-RAC)"]}, {"label": ["6."], "surname": ["Holt"], "given-names": ["K"], "article-title": ["Interexaminer reliability of a multidimensional battery of tests used to assess for vertebral subluxations"], "source": ["Chiropr. J. Aust."], "year": ["2018"], "volume": ["46"], "fpage": ["100"], "lpage": ["117"]}, {"label": ["7."], "mixed-citation": ["Organization, W. H. WHO guidelines on basic training and safety in chiropractic (2005)."]}, {"label": ["11."], "surname": ["Haavik Taylor", "Murphy"], "given-names": ["H", "B"], "article-title": ["The effects of spinal manipulation on central integration of dual somatosensory input observed following motor training: A crossover study"], "source": ["J. Manip. Physiol. Ther."], "year": ["2010"], "volume": ["33"], "fpage": ["261"], "lpage": ["272"], "pub-id": ["10.1016/j.jmpt.2010.03.004"]}, {"label": ["13."], "surname": ["Haavik"], "given-names": ["H"], "article-title": ["Impact of spinal manipulation on cortical drive to upper and lower limb muscles"], "source": ["Brain Sci."], "year": ["2017"], "volume": ["7"], "fpage": ["2"], "pub-id": ["10.3390/brainsci7010002"]}, {"label": ["35."], "surname": ["Triano"], "given-names": ["JJ"], "article-title": ["Review of methods used by chiropractors to determine the site for applying manipulation"], "source": ["Chiropr. Man. Ther."], "year": ["2013"], "volume": ["21"], "fpage": ["36"], "pub-id": ["10.1186/2045-709x-21-36"]}, {"label": ["36."], "surname": ["Fuhr", "Menke"], "given-names": ["AW", "JM"], "article-title": ["Status of activator methods chiropractic technique, theory, and practice"], "source": ["J. Manip. Physiol. Ther."], "year": ["2005"], "volume": ["28"], "fpage": ["e1"], "lpage": ["e20"], "pub-id": ["10.1016/j.jmpt.2005.01.001"]}, {"label": ["37."], "mixed-citation": ["R: A language and environment for statistical computing (R Foundation for Statistical Computing, 2013)."]}, {"label": ["38."], "mixed-citation": ["Emmeans: Estimated Marginal Means, aka Least-Squares Means v. 1.4. 8 (cran.r-project.org, 2022)."]}, {"label": ["40."], "surname": ["Reed", "Cao", "Long", "Kawchuk", "Pickar"], "given-names": ["WR", "D-Y", "CR", "GN", "JG"], "article-title": ["Relationship between biomechanical characteristics of spinal manipulation and neural responses in an animal model: Effect of linear control of thrust displacement versus force, thrust amplitude, thrust duration, and thrust rate"], "source": ["Evid. Based Complement. Altern. Med."], "year": ["2013"], "volume": ["2013"], "fpage": ["492039"], "pub-id": ["10.1155/2013/492039"]}, {"label": ["41."], "surname": ["Reed", "Long", "Pickar"], "given-names": ["WR", "CR", "JG"], "article-title": ["Effects of unilateral facet fixation and facetectomy on muscle spindle responsiveness during simulated spinal manipulation in an animal model"], "source": ["J. Manip. Physiol. Ther."], "year": ["2013"], "volume": ["36"], "fpage": ["585"], "lpage": ["594"], "pub-id": ["10.1016/j.jmpt.2013.08.007"]}, {"label": ["54."], "surname": ["Haavik Taylor", "Murphy"], "given-names": ["H", "B"], "article-title": ["Altered central integration of dual somatosensory input following cervical spine manipulation"], "source": ["J. Manip. Physiol. Ther."], "year": ["2010"], "volume": ["33"], "fpage": ["178"], "lpage": ["188"], "pub-id": ["10.1016/j.jmpt.2010.01.005"]}, {"label": ["64."], "surname": ["Gilroy", "MacPherson", "Wikenheiser", "Voll", "Wesker"], "given-names": ["AM", "BR", "JC", "MM", "K"], "source": ["Atlas of anatomy"], "year": ["2021"], "publisher-name": ["Thieme"]}]
{ "acronym": [], "definition": [] }
66
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1159
oa_package/03/85/PMC10786886.tar.gz
PMC10786887
38216609
[ "<title>Introduction</title>", "<p id=\"Par2\">The theme of <italic>Chirality in Nanomaterials</italic> covers a range of physical phenomena at different scales: atomic scale (elementary particles), molecular scale (chemistry), macroscale (mechanical lattices in physics and engineering) as well as megascale (planetary systems and galaxies). Spiral galaxies are among the most common types of galaxies in the universe, and they exhibit a distinct handedness (chirality) in their shape and rotation. We note the diversity and complexity of chirality phenomena across different scales and disciplines. A formal link between models of galaxies and microscopic systems, such as aminoacids, sugars, neutrinos, was discussed by Capozziello and Lattanzi<sup>##UREF##0##1##</sup>.</p>", "<p id=\"Par3\">Often, chiral systems are considered as geometrical objects which are non-superimposable on their mirror image. Examples of such systems are widely available in molecular structures. On the other hand, the fundamental laws of physics include examples of dynamic chirality (also referred to as physical chirality) associated with the spiral motion of charged particles in an ambient magnetic field. Such a spiral motion is induced by the Lorentz force (see<sup>##UREF##1##2##</sup>), which is orthogonal to the velocity vector of the moving particle. In mechanics, the gyroscopic force produces an effect similar to that of the Lorentz force in problems of electromagnetism. The direction of the gyroscopic motion is linked to the orientation of the mechanical spinner. An important example of a multi-scale rotational gyroscopic system is the Solar System, which also incorporates the force of gravity.</p>", "<p id=\"Par4\">The phenomenon of physical chirality is investigated in the present paper. The emphasis is on the dynamic response of a multi-body gyroscopic system, which can be considered at different scales and for different types of motion. This is in contrast with geometrical chirality of static objects. The force of gravity has a pronounced effect on the motion of a spinner or a cluster of connected spinners, and this is in the main focus of the paper.</p>", "<p id=\"Par5\">The notion of gravitational spinners takes into consideration the combined action of gyroscopic forces and gravity. In mechanics, the transient processes for such systems are of particular interest, due to formal connections with a range of natural phenomena, linked to planetary rotational motions. Well-known examples include the Foucault pendulum<sup>##UREF##2##3##</sup>, polygonal patterns of Rossby waves<sup>##UREF##3##4##</sup>, hexagonal shape of vortex flows at the North Pole of Saturn<sup>##REF##35027776##5##</sup> and polygonal patterns of cyclones in polar observations of Jupiter<sup>##UREF##4##6##</sup>. Additionally, the notion of chirality in physics and mechanics has been established in the classical literature, such as the books by Lord Kelvin<sup>##UREF##5##7##</sup>, Webster<sup>##UREF##6##8##</sup> and Gray<sup>##UREF##7##9##</sup>. The recent monograph by Kirillov<sup>##UREF##8##10##</sup> has addressed chiral motion in the context of non-conservative stability problems.</p>", "<p id=\"Par6\">In 1851, Foucault proposed a mechanical system, incorporating a pendulum of sixty-seven metres in length<sup>##UREF##2##3##</sup>, which could be used to demonstrate rotation of Earth. The Foucault pendulum shows precession, similar to that observed in a gyroscope. Although the precession of the Foucault pendulum is very slow, with the overall period being , where is the latitude relative to the equator, the linearised governing equations are similar to those describing the pendulum with the gyroscope attached at its end (as in<sup>##UREF##7##9##</sup>). In the latter case, the motion can be controlled by changing the rate of spin of the gyroscope, the moments of inertia and the initial conditions. As discussed by Nash et al.<sup>##REF##26561580##11##</sup>, for a cluster of gyroscopic pendulums, the transient behaviour of the mechanical system is more complex and may show preferential directions of the edge wave along the boundary of the cluster.</p>", "<p id=\"Par7\">The theoretical background for modelling the dynamic response of elastic multi-structures, combined with the gyroscopic spinners, is included in Carta et al.<sup>##UREF##9##12##–##UREF##12##15##</sup>, Nieves et al.<sup>##UREF##13##16##</sup>, and Kandiah et al.<sup>##UREF##14##17##</sup>. In particular, the articles<sup>##UREF##9##12##–##UREF##13##16##</sup> focus on the analysis of effective boundary conditions, which produce the gyroscopic action, for elastic systems such as flexural beams, in the cases of time-harmonic and transient motion. These papers have no gravity terms in the governing equations, and the main results combine the elastic response of the overall structure and the gyroscopic moment incorporated into the boundary conditions. The article<sup>##UREF##14##17##</sup> takes into account gravity in combination with the angular momentum for the chiral systems.</p>", "<p id=\"Par8\">In the present paper, we discuss the classification of chiral waveguides, periodic and non-periodic, as well as the methods of controlling dynamics of gravitational spinners: firstly, by analysing the wave dispersion and Green’s kernels for a periodic cluster of gravitational spinners, and secondly, by classifying all possible trajectories of individual gravitational spinners using the angular momentum method. Experimental measurements are compared with the analytical approximations. In addition to the analytical work and numerical illustrations, the paper also includes electronic supplementary materials with animated motions (Supplementary Videos ##SUPPL##0##V1##, ##SUPPL##1##V2##, ##SUPPL##2##V3##).</p>" ]
[]
[]
[]
[]
[ "<p id=\"Par1\">In this paper we present a mathematical modelling framework for chiral phenomena associated with rotational motions, highlighting the combination of gyroscopic action with gravity. We discuss new ideas of controlling gravity-induced waves by a cluster of gyroscopic spinners. For an elementary gravitational spinner, the transient oscillations are accompanied by a full classification and examples, linked to natural phenomena observed in planetary motion. Applications are presented in the theory of chiral metamaterials, and of the dynamic response of such materials to external loads.</p>", "<title>Subject terms</title>" ]
[ "<title>Chiral waveguides: classification and control of the wave dispersion</title>", "<p id=\"Par9\">The discrete models of elastic chiral metamaterials are presented in<sup>##UREF##11##14##,##UREF##15##18##</sup>. Gyroscopic spinners are embedded into a doubly periodic triangular elastic lattice, in the absence of gravity. In statics, no chirality whatsoever is observed in such a system. However, the gyroscopic spinners embedded into the triangular lattice deliver strong dynamic anisotropy for Floquet-Bloch waves, and their dispersion is affected significantly by the dynamic chirality of the system. A special type of standing wave, called a <italic>vortex wave</italic>, emerges in the two-dimensional elastic lattice with identical gyroscopic spinners. These waves are characterized by a circular motion of the lattice nodes, which matches the rotation of the gyroscopic spinners.</p>", "<p id=\"Par10\">The effect of gravity is often neglected in many mathematical models of waves in elastic systems. We show the importance of the combined contribution from gravity and gyroscopic chirality for the propagation of waves. Here, we focus on the uniaxial waveguides, where the waves travel along one direction, but with a “twist”: these waveguides are gyroscopic, and there is a chiral coupling between the velocity components.</p>", "<title>Continuous chiral waveguides subjected to gravity</title>", "<p id=\"Par11\">Two types of continuous chiral gyroscopic waveguides are outlined here: horizontal uniaxial waveguides orthogonal to the direction of the force of gravity, and vertical uniaxial waveguides aligned with the direction of the force of gravity. In both cases, the rotational motion occurs due to the presence of gyroscopic spinners, but gravity makes a significant difference between these two cases.</p>", "<title>Uniaxial gyroscopic elastic waveguides orthogonal to the direction of the force of gravity</title>", "<p id=\"Par12\">The governing equations are obtained as a result of the homogenisation procedure for a periodic system of vertically suspended gyroscopic pendulums, connected by horizontal massless pre-stressed elastic springs, along the <italic>x</italic>-axis. Assuming that <italic>u</italic>(<italic>x</italic>, <italic>t</italic>) and are the longitudinal and transverse displacement components in the horizontal plane, in the linear approximation the governing equations have the formwhere are normalised stiffness coefficients, is the gyroscopic chirality parameter, is the mass density, and <italic>G</italic> is the normalised gravity parameter (for the case of a pendulum, , where <italic>g</italic> is the gravity acceleration, and <italic>L</italic> is the arm length of the pendulum); the variable <italic>t</italic> represents time. We note that when , i.e. no gyroscopic chirality and gravity are present, Eq. (##FORMU##3##1##) becomes a system of decoupled wave equations. The terms representing the gyroscopic action, couple the components of the velocity in the horizontal plane, due to the gyroscopic force being orthogonal to the velocity vector.</p>", "<p id=\"Par13\">It is also noted that when the parameter is increasing, over a finite time interval the solution becomes confined in the spatial dimension, and rapid temporal variations are observed. Here, gravity appears to be an important control parameter, which enables one to control the oscillatory character of the coupled displacement components.</p>", "<title>Non-elastic gyroscopic waveguides aligned with gravity</title>", "<p id=\"Par14\">The problem becomes very different when the waveguide is positioned vertically, being aligned with the direction of the force of gravity. If one thinks of a vertical chain of gyroscopic pendulums along the <italic>z</italic>-axis, with the positive direction of the <italic>z</italic>-axis aligned with the direction of the force of gravity, in the homogenisation limit the governing equations for the transverse displacements <italic>u</italic>(<italic>z</italic>, <italic>t</italic>) and becomewhere <italic>u</italic>(<italic>z</italic>, <italic>t</italic>) and are the transverse displacement components of a <italic>gyroscopic vertical rope of length</italic>\n, and <italic>g</italic> is the gravity acceleration. In Eqs. (##FORMU##13##2##), the quantity is referred to as the chirality control parameter, which can be positive or negative, depending on the orientation of the gyroscopic spin.</p>", "<p id=\"Par15\">Equation (##FORMU##13##2##) describe waves, which are induced by gravity: no elastic resistance is present in the waveguide. Compared to (##FORMU##3##1##), the differential equations governing the motion of a gyroscopic, vertically hanging rope, include variable coefficients, which depend on the spatial variable along the rope. The gyroscopic coupling between the transverse displacement components induces rotational motions of points along the rope, as the wave propagates, with a variable speed, along the waveguide. Also, the gravity-dependent terms in (##FORMU##13##2##) are proportional to the spatial derivatives of the transverse displacements <italic>u</italic> and , in contrast with (##FORMU##3##1##) where the gravity is represented by the terms <italic>Gu</italic> and .</p>", "<p id=\"Par16\">Equation (##FORMU##13##2##) are related to the classical problem of a vertically suspended rope, subjected to gravity, which in the absence of gyroscopic chirality is well-known and its study was initiated by the work of Bernoulli and Euler (see the historical account in<sup>##UREF##16##19##</sup>). The new chiral terms bring an additional feature of rotational motion, illustrated in Fig. ##FIG##0##1##. Also, solutions of (##FORMU##13##2##) may exhibit a logarithmic singularity at The Dirichlet boundary conditions can be prescribed at and and such a problem is singularly perturbed in the limit as .</p>", "<p id=\"Par17\">An illustrative example of a transient motion of the gravity-induced wave is shown in Fig. ##FIG##0##1##. The end of the rope at the pivot point is fixed, and the rope is also fixed at , where is a small positive parameter. The model represents a singular perturbation problem, with the boundary layer observed near the end of the rope. At the initial time , an exponentially localised velocity along the <italic>x</italic>-axis is set to trigger the wave. Accordingly, the boundary conditions, used in the numerical simulation, are and where and . The initial conditions are and </p>", "<p id=\"Par18\">In Fig. ##FIG##0##1##a, the chirality control parameter is set to be zero (no gyroscopic coupling), and the wave of the same polarisation, characterised by the deflection in the (<italic>x</italic>, <italic>z</italic>)-plane moves along the <italic>z</italic>-axis. In part (b) of the same figure, where , the gyroscopic chirality leads to the rotation of the wave as it propagates along the <italic>z</italic>-axis. The videos, which include the animation of the gravity-induced waves, are in the electronic supplementary material available with this paper.</p>", "<title>Chiral structured waveguides: gravity control of the wave dispersion</title>", "<p id=\"Par19\">It is known that continuous and discrete (also referred to as “structured”) waveguides show different dynamic responses in the context of the wave dispersion.</p>", "<p id=\"Par20\">Here, instead of the continuous system, described by (##FORMU##3##1##), we consider a periodic chain of gravitational spinners, as shown in Fig. ##FIG##1##2##, which forms a chiral structured waveguide. Such a structure is relevant to the theory of chiral metamaterials, subjected to the control of the wave localisation and wave dispersion.</p>", "<p id=\"Par21\">The connections between the spinners are maintained by massless springs, and the gyropendulums are positioned at , The Fourier transform in time is formally applied, and here we assume that the chiral system is active, similar to that in<sup>##UREF##14##17##,##UREF##15##18##,##UREF##17##20##</sup>, with the chirality parameter , the vector amplitude of the time-harmonic motion at the nodal point , and the radian frequency . The system of governing equations, written in the vector form, becomeswhere <italic>G</italic> is the normalised gravity parameter, the rotation matrix is given byand the stiffness matrix is The quantity denotes the elastic stiffness of the springs and similar to<sup>##UREF##17##20##</sup>, we also allow for a pre-tension in the springs, which is represented by an effective transverse stiffness </p>", "<p id=\"Par22\">Assuming that the distance between neighbouring nodal points is <italic>a</italic>, and <italic>k</italic> is the wave number, the Floquet-Bloch condition is and the system (##FORMU##40##3##) is reduced to the formIt is also convenient to use non-dimensional variables, defined by</p>", "<p>Dropping tilde (for the sake of convenience) in the following text, the dispersion equation can be written in the formHere, it is assumed that . This gives two dispersion curves defined bywhere</p>", "<title>Gravity and gyricity: control of dispersion</title>", "<p id=\"Par23\">For the chiral waveguide, gravity and gyricity, acting together, control the dispersion of the Floquet-Bloch waves, which also includes wave localisation and formation of standing vortex waves.</p>", "<p id=\"Par24\">For the waveguide, subjected to gravity, with pre-tension but without spinners (), the equations describing the dispersion curves reduce to an elementary formwhich also show that when , there is a finite width band gap adjacent to . When and , it follows that . Introducing the non-zero chirality parameter , and using (##FORMU##50##7##), (##FORMU##52##8##), we observe that for any <italic>k</italic>, provided that and . The surfaces for and two values of <italic>c</italic> are shown in Fig. ##FIG##2##3##; the change in the dispersion curves can be seen as variations of cross-sections when <italic>G</italic> is fixed.</p>", "<p id=\"Par25\">A special feature of the chiral waveguide, formed by gravitational spinners, is in the presence of several frequency regimes, which we refer to as “total pass band”, “partial pass band”, and “stop band”.</p>", "<p id=\"Par26\">The term <italic>total pass band</italic> corresponds to an interval of values of the radian frequency where both types of Floquet-Bloch waves corresponding to the branches (##FORMU##52##8##) occur, i.e. . The frequency interval is referred to as <italic>partial pass band</italic> when only one type of the Floquet-Bloch wave (corresponding to one of the branches ) can propagate. For intervals of frequencies, where there are no propagating waves, and all waveforms are evanescent, the term <italic>stop band</italic> is used.</p>", "<p id=\"Par27\">In Fig. ##FIG##3##4##, we show examples of dispersion diagrams where and . It is convenient to introduce the parameter and observe the following two cases: <list list-type=\"alpha-lower\"><list-item><p id=\"Par28\">The case of corresponds to (see Fig. ##FIG##3##4##a–c); when we observe one stop band, one total pass band and one partial pass band, when we have two stop bands, one total pass band and two partial pass bands, and when the dispersion diagram is shown in Fig. ##FIG##3##4##c.</p></list-item><list-item><p id=\"Par29\">The case of corresponds to ; in this case there are three stop bands and two partial pass bands (see Fig. ##FIG##3##4##d).</p></list-item></list></p>", "<title>Green’s matrix for a gravitational spinner waveguide</title>", "<p id=\"Par30\">Assuming that a time-harmonic force with components is applied at the origin, where the inhomogeneous governing equations are given byHere and The discrete Fourier Transform of Eq. (##FORMU##94##10##) with respect to the Fourier variable <italic>k</italic> leads towhere are components of the Green’s matrix. According to<sup>##UREF##14##17##</sup>, it can be represented aswhere is the identity matrix, the rotation matrix is given in (##FORMU##42##4##), andHere, we note that the simplified expression for depends on the frequency regime, i.e. stop band, partial pass band or total pass band. It is convenient to introduce the quantities:</p>", "<title>The stop band regime</title>", "<p id=\"Par31\">In the <italic>stop band</italic> regime we have . The components of Green’s matrix are exponentially localised. The function in the stop band may be written as</p>", "<title>The partial pass band regime</title>", "<p id=\"Par32\">For this regime, the quantities satisfy the constraints and or and The additional partial pass band region is a special feature that is introduced by gravity. We first consider the case when and . Taking into account the radiation condition at infinity, the function in the partial pass band is given bywhereThe first term in (##FORMU##118##17##) represents the evanescent solution corresponding to the eigenfrequency and the second term represents the propagating solution corresponding to the eigenfrequency Similarly, for and , we can represent the function in the partial pass band aswhere the first term in (##FORMU##125##19##) represents the propagating solution corresponding to the eigenfrequency and the second term represents the evanescent solution corresponding to the eigenfrequency </p>", "<title>The total pass band regime</title>", "<p id=\"Par33\">In the <italic>total pass band</italic> regime, the time-harmonic point force generates two types of outgoing propagating waves. In this region . The function is given in the total pass band byBoth terms in (##FORMU##134##20##) represent propagating solutions that obey the radiation condition at infinity.</p>", "<title>Transient motion of an elementary gravitational spinner</title>", "<p id=\"Par34\">Although gyroscopic multi-structures bring a significant insight into the methods of control of dispersive waves, the transient motion of an elementary gravitational spinner shows counter-intuitive shapes, which can be described analytically. For an elementary single gravitational spinner, a combination of the gyroscopic action and gravity, enable the spinner to “go around the corner”, following trajectories, which approximate polygonal shapes. We demonstrate that other shapes also include cusps, self-intersecting loops and smooth curves, assembled in three classes. In some particular cases, the bounded motions of a gravitational spinner can exhibit trajectories similar to those of the Foucault pendulum, as well as the stable motion of a Brouwer particle moving on a surface rotating with a constant angular velocity as noted in<sup>##UREF##8##10##,##UREF##18##21##–##UREF##21##24##</sup>.</p>", "<p id=\"Par35\">In this section, a model will be described for a gravitational spinner which incorporates both the effect of gravity, as in a pendulum, and a rotational element, as in a gyroscope. The gravitational spinner is shown in Fig. ##FIG##4##5##a. It consists of a rigid, massless rod of length <italic>L</italic>,  suspended from a pivot at , so that it can swing freely under gravity. At , the rod is connected to a thin uniform disc of mass <italic>m</italic> and radius <italic>R</italic>,  which acts as a gyroscopic spinner. The spinner is axisymmetric, with centre of mass placed at the end of the rod. There is no external energy flux within the gyroscopic system under gravity and it will be referred to as a passive gyroscopic system. For such a system, the energy is conserved.</p>", "<p id=\"Par36\">The motion of gyroscopic spinners is usually characterised by the angular coordinates , and They are the angles of nutation, precession and spin, respectively. The analysis here is limited to the regime where the nutation angle and its derivatives are considered to be small, resulting in a linearised model. For , the transverse displacements in the <italic>x</italic> and <italic>y</italic> directions are <italic>u</italic>(<italic>z</italic>, <italic>t</italic>) and ,  respectively, and are linear functions of <italic>z</italic>,where <italic>U</italic>(<italic>t</italic>) and <italic>V</italic>(<italic>t</italic>) are time-dependent non-dimensional coefficients associated with the transverse displacement components. In the linearised model, the quantity , which is referred to as <italic>gyricity</italic>, can be approximated as for a rapidly rotating spinner. The positive direction of spin is chosen as in Fig. ##FIG##4##5##, i.e. anticlockwise relative to the -axis, where are the local coordinates (see Fig. ##FIG##4##5##a).</p>", "<p id=\"Par37\">The equations of motion for the transverse displacement components at have the formwhere the rotation matrix , which couples <italic>U</italic>(<italic>t</italic>) and <italic>V</italic>(<italic>t</italic>), is given by (##FORMU##42##4##). Here, <italic>g</italic> is the acceleration due to gravity, is the transverse moment of inertia, relative to the pivot point at , of the rigid rod combined with the spinner with respect to the -axis, which is assumed to be the same as for the -axis; the quantity is the moment of inertia of the spinner relative to its -axis.</p>", "<p id=\"Par38\">Figure ##FIG##4##5##b shows an illustrative comparison between experimental measurements and the analytical solution, based on the linearised model. The movie of the motion of the gyropendulum is taken from underneath the gyropendulum, with the initial velocities being zero. The trajectory is shown in white, and, as discussed in <xref rid=\"Sec15\" ref-type=\"sec\">Full classification for the transient motion of the gravitational spinner</xref> section, this case corresponds to Class 2 of transient motions with cusps. The parameter values used in the experimental setup are: the length of the pendulum arm is 0.58 m, and the radius, gyricity and mass of the disc are 0.06 m, rad/s and kg, respectively. In addition, the initial displacement prescribed along the <italic>x</italic>-direction is m, while the initial displacement in the <italic>y</italic>-direction is set to m. As seen from Fig. ##FIG##4##5##b, the agreement with the analytical results is very good.</p>", "<title>Normalisation and chirality of the system</title>", "<p id=\"Par39\">Assuming that the length of the arm of the pendulum is much larger than the radius of the spinner and that the spinner is represented by a uniform thin disc, the system (##FORMU##149##22##) becomesIt is noted in passing that Eq. (##FORMU##162##23##) are analogous to those which describe the vibrations of an electron in a magnetic field as pointed out in<sup>##UREF##5##7##,##UREF##7##9##</sup>, in the context of the gyrostatic analogue of the Lorentz force (see<sup>##UREF##1##2##</sup>). It is convenient to introduce the dimensionless time to discuss the general motion of the gyropendulum for a variety of different initial conditions at the end of the rod (). Equation (##FORMU##162##23##) then becomewhere , and </p>", "<p id=\"Par40\">Assuming solutions of the form , , and substituting into the system (##FORMU##165##24##), then the solvability condition to find non-trivial solutions of the system gives four discrete dimensionless frequencies asFor any real value of , the quantities and are negative while and are positive. By choosing the positive eigenfrequencies and , we write the corresponding eigenvectors and , respectively. Here, the general solution of (##FORMU##165##24##) is a linear combination of four complex exponential functions; each depending on one of the four eigenvalues (##FORMU##171##25##), with two of the eigenvalues being positive and two negative. In view of (##FORMU##171##25##), the solution has been reduced to a form dependent on only two of these eigenvalues. The choice made in the text below (see (##FORMU##199##27##)), is to use the two positive eigenvalues since these physically may be interpreted as real positive frequencies.</p>", "<p id=\"Par41\">For the two positive values and it may be seen from (##FORMU##171##25##) that in the absence of gyricity (i.e. when ), Hence, in this particular case the motion becomes time-harmonic with the unit radian frequency, and the corresponding trajectory of the motion has an elliptical shape. Conversely, with the introduction of non-zero gyricity (i.e. when ), the values of and become different. Furthermore, the difference between and grows with increasing gyricity, i.e. </p>", "<p id=\"Par42\">The general solution of (##FORMU##165##24##) may be found as a linear combination of the normal mode solutions. Applying the initial conditionswhere and are given values of the normalised initial displacements and initial velocities, then the solution of (##FORMU##165##24##) with the initial conditions (##FORMU##196##26##) becomeswhereThus each component of the displacement consists of a linear combination of two sinusoidal motions. It may also be seen from (##FORMU##171##25##) to (##FORMU##200##28##) that the initial conditions do not influence the frequency components, but they define the coefficients for (see (##FORMU##200##28##)). The chirality parameter affects the frequency components and hence the coefficients and </p>", "<title>“Paradox” of pentagonal and hexagonal shapes</title>", "<p id=\"Par43\">The longstanding Voyager programme, together with the Cassini programme, have delivered interesting observations of the hexagonal patterns on the North Pole of Saturn. In 2012, the NASA Cassini probe captured a fascinating movie of a storm at the North Pole of Saturn. Despite an expectation of circular profiles of vortex motion, the shape captured by the probe was hexagonal<sup>##REF##35027776##5##</sup>. The analysis of these observations was published in<sup>##UREF##22##25##,##REF##17800063##26##</sup>. Furthermore, Rossby wave patterns in the higher levels of the Earth’s atmosphere resembled a perturbed pentagon<sup>##UREF##3##4##</sup>. Both pentagonal and hexagonal patterns were observed at the South Pole of Jupiter<sup>##UREF##4##6##</sup>. An experimental demonstration<sup>##UREF##23##27##,##REF##16712302##28##</sup>, of liquid vortex sloshing in a rotating cylindrical container, has also confirmed the presence of polygonal patterns, including pentagonal and hexagonal shapes. Although looking like a paradox, the question of formation of polygonal shapes can be answered. Without going into complexity of rotational fluid flows, we can simply note that in addition to a rotational action, there is also an additional force, which is gravity.</p>", "<p id=\"Par44\">The elementary gravitational spinner (or a gyropendulum), in the linearised settings, takes into account both the rotational action as well as the action of gravity. Can a gyropendulum be designed so that it traces a prescribed periodic trajectory possessing a degree of rotational symmetry? The answer is in the affirmative.</p>", "<p id=\"Par45\">In order to cause the gyropendulum to move in a prescribed trajectory, the parameter needs to be determined together with the knowledge of how to set the gyropendulum in motion, i.e. the initial conditions. For polygonal shapes, this may be done to a very good degree of approximation. The solution (##FORMU##199##27##) may be regarded as a Fourier series with two frequency components and without the frequency-independent term. It is convenient to write this in complex notation asand require that the ratio is an integer related to the degree of rotational symmetry of the polygon. This requirement fixes the value of the parameter . Suitable initial conditions may be found such that the complex constants and in (##FORMU##207##29##) correspond to the Fourier coefficients for the particular polygon, as illustrated in Fig. ##FIG##5##6##.</p>", "<p id=\"Par46\">Two examples are shown in Fig. ##FIG##5##6## where a prescribed (a) hexagon and (b) pentagon may be seen together with their approximating trajectories.</p>", "<p id=\"Par47\">The Fourier coefficients in these two cases are (a) and , and (b) and . The consequent values of the parameter together with the initial conditions are shown in the figure caption. There is very good agreement between the two prescribed shapes and their approximating trajectories considering a two component truncated Fourier series only is available from the analytical solution. It is also noted that the ratio is small in both cases illustrating how these polygonal shapes are a perturbation of the basic circular motion.</p>", "<title>Full classification for the transient motion of the gravitational spinner</title>", "<p id=\"Par48\">The trajectories of the gyropendulum may have different shapes, including smooth curves, self-intersecting loops, cusps, and they are dependent on the initial conditions and the given value of .</p>", "<p id=\"Par49\">Based on the consideration of the angular momentum of a unit mass (with no gyricity) moving in the same plane as the pendulum at , the scalar quantity is introduced to characterise the orientation of the motion of the gyropendulum:where is the basis vector along the <italic>z</italic>-axis, and The scalar quantity is related to the magnitude of the angular momentum of the system. Whilst the position and velocity at any time in the motion are clearly seen on the trajectory, the quantity is a characterising single measure, reliant on both the position and velocity at any time.</p>", "<p id=\"Par50\">Substituting the solution (##FORMU##199##27##) and (##FORMU##200##28##) into (##FORMU##246##30##), leads to the following sinusoidal form for the function whereThe sign of determines the orientation of the gyropendulum trajectory about the origin.</p>", "<p id=\"Par51\">It is noted that when , the function becomes constant and , indicating the conservation of angular momentum for a particle of unit mass moving in the plane as expected.</p>", "<p id=\"Par52\">The question arises as to whether the quantity may be constant for any non-zero value of . This happens for the special case of degeneracy, when , the quantity <italic>H</italic> is independent of , i.e. , as follows. When , one can identify the initial displacement and velocity, for which <italic>H</italic> remains constant for any value of In this case, it follows from (##FORMU##246##30##) and (##FORMU##253##32##) that for non-zero <italic>H</italic>, and , the vectors and are orthogonal, and . Furthermore, it follows from (##FORMU##253##32##) and that , which leads to The corresponding trajectories of the gyropendulum have circular shapes (of different orientations depending on ), and the quantity <italic>H</italic> is constant.</p>", "<p id=\"Par53\">The sign of the product of the maximum and minimum values of is used to determine the classes of trajectories for given values of and It may be shown that this product is given byHence the classification of the forms of the trajectories is linked to the initial value <italic>H</italic>(0) and to the interval where</p>", "<p id=\"Par54\">The characterising function (see (##FORMU##246##30##)), whilst always sinusoidal, may be always positive, always negative or zero at its maximum or minimum. This function is strongly influenced by the value of the gyricity through the solution for the displacement (##FORMU##171##25##)–(##FORMU##200##28##) and the corresponding velocity. Such differences in behaviour of this characterising function leads to different types of motion. <italic>Three classes of trajectories</italic> can be identified as follows. <bold>Class 1</bold> incorporates the cases when , <bold>Class 2</bold> corresponds to , and <bold>Class 3</bold> includes all configurations where . It should be noted that <italic>H</italic>(0), <italic>M</italic> and <italic>N</italic>,  which feature in the classification constraints, indicate the allowable combinations of the fundamental parameters , , , and for the various classes.<list list-type=\"bullet\"><list-item><p id=\"Par55\"><italic>Class 1</italic>: <italic>self-intersecting loops of variable orientation</italic> occur when The motion of the gyropendulum corresponds to the alternating orientation about the origin during the motion. An example of such a trajectory with self-intersecting loops and the corresponding graph of are shown in Fig. ##FIG##6##7##. The orientation of the trajectory of the gyropendulum will alternate between clockwise and anticlockwise motion relative to the origin according to the sign changes of the function .</p></list-item><list-item><p id=\"Par56\"><italic>Class 2</italic>: For this class, the quantity (##FORMU##277##33##) equals zero. There are two sub-classes:</p><p id=\"Par57\"><bold>(a)</bold> Trajectories have <italic>cusps</italic> when the motion does not change its orientation (i.e. does not change sign), and the following condition is satisfied The trajectories of the gyropendulum, which contain cusps, do not pass through the origin. The function equals zero only at the points corresponding to the cusps, where the velocity vanishes. Two typical trajectories involving cusps, together with the corresponding graphs of , are shown in Fig. ##FIG##7##8##a–d, with clockwise and anticlockwise trajectories around the origin, respectively.</p><p id=\"Par58\"><bold>(b)</bold>\n<italic>Loops passing through the origin</italic> occur when the motion does not change its orientation (i.e. does not change sign), and the following condition is satisfied The trajectories have no cusps present, and the function vanishes only at the points corresponding to the origin. A typical trajectory is shown in Fig. ##FIG##8##9##a with the corresponding function shown in Fig. ##FIG##8##9##b.</p></list-item><list-item><p id=\"Par59\"><italic>Class 3</italic>: Trajectories in this class are smooth curves, which do not pass through the origin, have no cusps (, and do not change their orientation. They are characterised by either or with clockwise or anticlockwise trajectories about the origin depending on the value of <italic>H</italic>(0) (see (##FORMU##279##34##), (##FORMU##280##35##)). Two related examples are shown in Fig. ##FIG##9##10##. Both have the same gyricity parameters and initial displacements, except for initial velocities in opposite directions resulting in opposite orientations about the origin. Class 3 also includes the case of polygonal trajectories, discussed in Sect. <xref rid=\"Sec14\" ref-type=\"sec\">3.2</xref>, with the examples of pentagonal and hexagonal shapes shown in Fig. ##FIG##5##6##.</p></list-item></list></p>", "<title>Concluding remarks</title>", "<p id=\"Par60\">The study of gravitational spinners provides a formal connection between mechanical models and the models of electromagnetism and solid state physics, with similar phenomena being observed at different time scales and a different spatial scale. Chiral motion of planetary systems is similar to the motion of atomic structures within solids. Mathematical models, although limited on full generality of natural phenomena, can demonstrate formal connections between chiral features of gyroscopic forces combined with gravity at different scales.</p>", "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-023-50052-0.</p>", "<title>Acknowledgements</title>", "<p>A.K. gratefully acknowledges the financial support of the EPSRC through the Mathematics DTP grant EP/V52007X/1, project reference 2599756. I.S.J. is grateful to the Department of Mathematical Sciences, University of Liverpool and the Liverpool Research Centre for Mathematics and Modelling for the provision of the research infrastructure and computational facilities. N.V.M. and A.B.M. would like to acknowledge the support of Simons Fellowships and to thank the Isaac Newton Institute for Mathematical Sciences, Cambridge, for support and hospitality during the <italic>Multiple Wave Scattering</italic> programme where a part of the work on this paper was undertaken. This work was supported by EPSRC grant EP/R014604/1.</p>", "<title>Author contributions</title>", "<p>All the authors of the article, A.K., I.S.J., N.V.M, A.B.M., have contributed to the conception of the work, analysis, interpretation of data, and writing the text of the article. A.K. and A.B.M. have designed the experiment, shown in Fig. ##FIG##4##5##b. A.K. has provided the acquisition of the experimental data. All the authors have approved the submitted version of the article.</p>", "<title>Data availability</title>", "<p>All analytical data analysed during this study are included in this published article. The experimental data and video, related to Fig. ##FIG##4##5##b, are included in the electronic supplementary material provided for this article.</p>", "<title>Competing interests</title>", "<p id=\"Par64\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Gravity-induced waves in a gyroscopic waveguide: (<bold>a</bold>) , no chirality; (<bold>b</bold>) , rotational motion is observed along the waveguide—the arrow shows the orientation of the rope rotation.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Gyroscopic structured chiral waveguide.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>The graphs of as functions of <italic>k</italic> and <italic>G</italic> for ; (<bold>a</bold>) and (<bold>b</bold>) .</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Dispersion diagrams for (<bold>a</bold>) , (<bold>b</bold>) , (<bold>c</bold>) and (<bold>d</bold>) . In the calculations the following parameters are chosen: , and and 2.5 [in parts (<bold>a</bold>–<bold>d</bold>), respectively]. Note that .</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>(<bold>a</bold>) A gyropendulum includes a gyroscopic spinner connected to the tip of a rod. The rod is hinged at its base which is located at the origin of the fixed coordinate system <italic>Oxyz</italic>. The gyroscopic spinner is shown in the local coordinate system , which moves with the spinner as it nutates through an angle , precesses through an angle and spins through an angle . The axes of the rod and the spinner are assumed to be aligned at any instant of time. (<bold>b</bold>) Experimental observation and analytical prediction for cusp-shaped trajectories; the video of the motion is provided in the electronic supplementary material.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>The approximations to the prescribed hexagonal and pentagonal orbits. The calculated values of and the initial conditions to generate these orbits are (<bold>a</bold>) , , and (<bold>b</bold>) , . The solid arrows show the direction of spin of the gyroscopic spinner, and the hollow arrows show the orientation of motion for each respective polygonal orbit of the gyropendulum.</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>Class 1 example. Gyropendulum trajectory with and initial conditions , , , . (<bold>a</bold>) The self-intersecting trajectories around the origin of variable orientation. (<bold>b</bold>) The corresponding function . Here the calculated class values are , and in accordance with (##FORMU##298##36##).</p></caption></fig>", "<fig id=\"Fig8\"><label>Figure 8</label><caption><p>Class 2(a) examples. (<bold>a</bold>) Cusp trajectory of the gyropendulum and (<bold>b</bold>) the function with and initial conditions , , , . The condition for cusps is satisfied with . Here (<bold>c</bold>) Cusp trajectory of the gyropendulum and (<bold>d</bold>) the function with and initial conditions , , , . The condition for cusps is satisfied with . Here .</p></caption></fig>", "<fig id=\"Fig9\"><label>Figure 9</label><caption><p>Class 2(b) example. (<bold>a</bold>) Trajectory of the gyropendulum with smooth loops passing through the origin and (<bold>b</bold>) the function with and initial conditions , , , . The condition for Class 2(b) is satisfied with . In addition .</p></caption></fig>", "<fig id=\"Fig10\"><label>Figure 10</label><caption><p>Class 3 examples. (<bold>a</bold>) Smooth trajectories of the gyropendulum not passing through the origin, and (<bold>b</bold>) the function with parameter values and initial conditions , , , . The Class 3 conditions are satisfied with , and (<bold>c</bold>) Smooth trajectories of the gyropendulum not passing through the origin, and (<bold>d</bold>) the function with parameter values and initial conditions , , , . The Class 3 conditions are satisfied with , and The solid arrows indicate the direction of spin of the gyroscopic spinner, and the hollow arrows show the orientation of motion for each respective trajectory of the gyropendulum.</p></caption></fig>" ]
[]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(24~ \\text{ h})/\\sin (\\phi )$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>24</mml:mn><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"0.333333em\"/><mml:mtext>h</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo><mml:mo stretchy=\"false\">/</mml:mo><mml:mo>sin</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ϕ</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\phi $$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mi>ϕ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq06\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$v(x,t)$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mrow><mml:mi>v</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{\\partial ^2 u}{\\partial t^2}-\\frac{c_1}{\\rho }\\frac{\\partial ^2 u}{\\partial x^2} -\\alpha \\frac{\\partial v}{\\partial t}+Gu = 0 , ~~ \\frac{\\partial ^2 v}{\\partial t^2}-\\frac{c_2}{\\rho } \\frac{\\partial ^2 v}{\\partial x^2} +\\alpha \\frac{\\partial u}{\\partial t}+Gv = 0, $$\\end{document}</tex-math><mml:math id=\"M8\" display=\"block\"><mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mi>∂</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>u</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mi>t</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:msub><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>ρ</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:msup><mml:mi>∂</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>u</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mi>x</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mi>α</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mi>G</mml:mi><mml:mi>u</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mfrac><mml:mrow><mml:msup><mml:mi>∂</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mi>t</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:msub><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>ρ</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:msup><mml:mi>∂</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mi>x</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mi>α</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>u</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mi>G</mml:mi><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c_1, c_2$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha $$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mi>α</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho $$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mi>ρ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$G= g/L$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mrow><mml:mi>G</mml:mi><mml:mo>=</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha =G=0$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:mrow><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:mi>G</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha $$\\end{document}</tex-math><mml:math id=\"M20\"><mml:mi>α</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\beta =0$$\\end{document}</tex-math><mml:math id=\"M22\"><mml:mrow><mml:mi>β</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\beta =2$$\\end{document}</tex-math><mml:math id=\"M24\"><mml:mrow><mml:mi>β</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq03\"><alternatives><tex-math id=\"M25\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$v(z,t)$$\\end{document}</tex-math><mml:math id=\"M26\"><mml:mrow><mml:mi>v</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M27\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\frac{\\partial ^2 u}{\\partial t^2} - g(L_0 - z)\\frac{\\partial ^2 u}{\\partial z^2}+\\beta \\frac{\\partial v}{\\partial t}+g\\frac{\\partial u}{\\partial z} = 0, ~~ \\frac{\\partial ^2 v}{\\partial t^2} - g(L_0-z)\\frac{\\partial ^2 v}{\\partial z^2}-\\beta \\frac{\\partial u}{\\partial t}+ g \\frac{\\partial v}{\\partial z} = 0, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M28\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mi>∂</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>u</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mi>t</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mi>g</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>L</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:mi>z</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mi>∂</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>u</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mi>z</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mi>β</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mi>g</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>u</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mfrac><mml:mrow><mml:msup><mml:mi>∂</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mi>t</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mi>g</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>L</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:mi>z</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mi>∂</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:msup><mml:mi>z</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mi>β</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>u</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mi>g</mml:mi><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>z</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq02\"><alternatives><tex-math id=\"M29\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$v(z,t)$$\\end{document}</tex-math><mml:math id=\"M30\"><mml:mrow><mml:mi>v</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M31\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$L_0$$\\end{document}</tex-math><mml:math id=\"M32\"><mml:msub><mml:mi>L</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq12\"><alternatives><tex-math id=\"M33\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\beta $$\\end{document}</tex-math><mml:math id=\"M34\"><mml:mi>β</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq04\"><alternatives><tex-math id=\"M35\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$v$$\\end{document}</tex-math><mml:math id=\"M36\"><mml:mi>v</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq05\"><alternatives><tex-math id=\"M37\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$Gv$$\\end{document}</tex-math><mml:math id=\"M38\"><mml:mrow><mml:mi mathvariant=\"italic\">Gv</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq13\"><alternatives><tex-math id=\"M39\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z=L_0.$$\\end{document}</tex-math><mml:math id=\"M40\"><mml:mrow><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>L</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq14\"><alternatives><tex-math id=\"M41\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z=0$$\\end{document}</tex-math><mml:math id=\"M42\"><mml:mrow><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq15\"><alternatives><tex-math id=\"M43\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z=L_0-\\epsilon , ~ 0&lt; \\epsilon \\ll 1,$$\\end{document}</tex-math><mml:math id=\"M44\"><mml:mrow><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>L</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:mi>ϵ</mml:mi><mml:mo>,</mml:mo><mml:mspace width=\"3.33333pt\"/><mml:mn>0</mml:mn><mml:mo>&lt;</mml:mo><mml:mi>ϵ</mml:mi><mml:mo>≪</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq16\"><alternatives><tex-math id=\"M45\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\epsilon \\rightarrow 0$$\\end{document}</tex-math><mml:math id=\"M46\"><mml:mrow><mml:mi>ϵ</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq17\"><alternatives><tex-math id=\"M47\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z=0$$\\end{document}</tex-math><mml:math id=\"M48\"><mml:mrow><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq18\"><alternatives><tex-math id=\"M49\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z=L_0 - \\epsilon $$\\end{document}</tex-math><mml:math id=\"M50\"><mml:mrow><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>L</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:mi>ϵ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq19\"><alternatives><tex-math id=\"M51\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\epsilon $$\\end{document}</tex-math><mml:math id=\"M52\"><mml:mi>ϵ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq20\"><alternatives><tex-math id=\"M53\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t=0$$\\end{document}</tex-math><mml:math id=\"M54\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq21\"><alternatives><tex-math id=\"M55\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$u(0, t) = v(0, t) = 0,$$\\end{document}</tex-math><mml:math id=\"M56\"><mml:mrow><mml:mi>u</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>=</mml:mo><mml:mi>v</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq22\"><alternatives><tex-math id=\"M57\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$u(L_0-\\epsilon , t) = v(L_0-\\epsilon , t) = 0,$$\\end{document}</tex-math><mml:math id=\"M58\"><mml:mrow><mml:mi>u</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>L</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:mi>ϵ</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>v</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>L</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:mi>ϵ</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq23\"><alternatives><tex-math id=\"M59\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\epsilon = 0.1$$\\end{document}</tex-math><mml:math id=\"M60\"><mml:mrow><mml:mi>ϵ</mml:mi><mml:mo>=</mml:mo><mml:mn>0.1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq24\"><alternatives><tex-math id=\"M61\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$L_0=10$$\\end{document}</tex-math><mml:math id=\"M62\"><mml:mrow><mml:msub><mml:mi>L</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>10</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq25\"><alternatives><tex-math id=\"M63\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$u(z, 0) = v(z,0) = 0$$\\end{document}</tex-math><mml:math id=\"M64\"><mml:mrow><mml:mi>u</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>=</mml:mo><mml:mi>v</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq26\"><alternatives><tex-math id=\"M65\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{\\partial u}{\\partial t} (z, 0) = 2 \\exp (-z^2), \\frac{\\partial v}{\\partial t} (z, 0) = 0.$$\\end{document}</tex-math><mml:math id=\"M66\"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>u</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mo>exp</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mo>-</mml:mo><mml:msup><mml:mi>z</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mfrac><mml:mrow><mml:mi>∂</mml:mi><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq27\"><alternatives><tex-math id=\"M67\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\beta =2$$\\end{document}</tex-math><mml:math id=\"M68\"><mml:mrow><mml:mi>β</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq28\"><alternatives><tex-math id=\"M69\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x=n$$\\end{document}</tex-math><mml:math id=\"M70\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>=</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq29\"><alternatives><tex-math id=\"M71\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n\\in \\mathbb {Z}.$$\\end{document}</tex-math><mml:math id=\"M72\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>∈</mml:mo><mml:mi mathvariant=\"double-struck\">Z</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq30\"><alternatives><tex-math id=\"M73\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha $$\\end{document}</tex-math><mml:math id=\"M74\"><mml:mi>α</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq31\"><alternatives><tex-math id=\"M75\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\textbf {U}}^{(n)} =(U_1^{(n)},U_2^{(n)})^{T}$$\\end{document}</tex-math><mml:math id=\"M76\"><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant=\"bold\">U</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msubsup><mml:mi>U</mml:mi><mml:mn>1</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi>U</mml:mi><mml:mn>2</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>T</mml:mi></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq32\"><alternatives><tex-math id=\"M77\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x=n$$\\end{document}</tex-math><mml:math id=\"M78\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>=</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq33\"><alternatives><tex-math id=\"M79\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega $$\\end{document}</tex-math><mml:math id=\"M80\"><mml:mi>ω</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M81\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} -m\\omega ^2 {\\textbf {U}}^{(n)}={\\textbf {C}}({\\textbf {U}}^{(n-1)}+{\\textbf {U}}^{(n+1)}-2{\\textbf {U}}^{(n)})+i\\alpha m\\omega ^2{\\textbf {R}}{} {\\textbf {U}}^{(n)}-mG{\\textbf {U}}^{(n)}, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M82\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mo>-</mml:mo><mml:mi>m</mml:mi><mml:msup><mml:mi>ω</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:msup><mml:mrow><mml:mi mathvariant=\"bold\">U</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mi mathvariant=\"bold\">C</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant=\"bold\">U</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant=\"bold\">U</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:msup><mml:mrow><mml:mi mathvariant=\"bold\">U</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>i</mml:mi><mml:mi>α</mml:mi><mml:mi>m</mml:mi><mml:msup><mml:mi>ω</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi mathvariant=\"bold\">R</mml:mi><mml:mrow/><mml:msup><mml:mrow><mml:mi mathvariant=\"bold\">U</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:mi>m</mml:mi><mml:mi>G</mml:mi><mml:msup><mml:mrow><mml:mi mathvariant=\"bold\">U</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq34\"><alternatives><tex-math id=\"M83\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\textbf {R}}$$\\end{document}</tex-math><mml:math id=\"M84\"><mml:mi mathvariant=\"bold\">R</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ4\"><label>4</label><alternatives><tex-math id=\"M85\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} {\\textbf {R}}=\\begin{pmatrix} 0 &amp;{} 1\\\\ -1 &amp;{} 0 \\end{pmatrix}, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M86\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi mathvariant=\"bold\">R</mml:mi><mml:mo>=</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mrow><mml:mrow/><mml:mn>1</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mrow/><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq35\"><alternatives><tex-math id=\"M87\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\textbf {C}}= \\text{ diag }\\{ c_1, c_2 \\}.$$\\end{document}</tex-math><mml:math id=\"M88\"><mml:mrow><mml:mi mathvariant=\"bold\">C</mml:mi><mml:mo>=</mml:mo><mml:mspace width=\"0.333333em\"/><mml:mtext>diag</mml:mtext><mml:mspace width=\"0.333333em\"/><mml:mo stretchy=\"false\">{</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">}</mml:mo><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq36\"><alternatives><tex-math id=\"M89\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c_1&gt;0$$\\end{document}</tex-math><mml:math id=\"M90\"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq37\"><alternatives><tex-math id=\"M91\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c_{2} \\ge 0.$$\\end{document}</tex-math><mml:math id=\"M92\"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>≥</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq38\"><alternatives><tex-math id=\"M93\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ {\\textbf {U}}^{(n+1)}=e^{ika}{} {\\textbf {U}}^{(n)}, $$\\end{document}</tex-math><mml:math id=\"M94\"><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant=\"bold\">U</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">ika</mml:mi></mml:mrow></mml:msup><mml:mrow/><mml:msup><mml:mrow><mml:mi mathvariant=\"bold\">U</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ5\"><label>5</label><alternatives><tex-math id=\"M95\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\left[ m(G-\\omega ^2){\\textbf {I}}-2(\\cos (ka)-1){\\textbf {C}}-i\\alpha \\omega ^2 {\\textbf {R}}\\right] {\\textbf {U}}^{(n)}={\\textbf {0}}. \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M96\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfenced close=\"]\" open=\"[\"><mml:mi>m</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>G</mml:mi><mml:mo>-</mml:mo><mml:msup><mml:mi>ω</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi mathvariant=\"bold\">I</mml:mi><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mo>cos</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>k</mml:mi><mml:mi>a</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi mathvariant=\"bold\">C</mml:mi><mml:mo>-</mml:mo><mml:mi>i</mml:mi><mml:mi>α</mml:mi><mml:msup><mml:mi>ω</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi mathvariant=\"bold\">R</mml:mi></mml:mfenced><mml:msup><mml:mrow><mml:mi mathvariant=\"bold\">U</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mn mathvariant=\"bold\">0</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ6\"><label>6</label><alternatives><tex-math id=\"M97\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\tilde{{\\textbf {U}}}^{(n)}=\\frac{1}{a}{} {\\textbf {U}}^{(n)}, \\quad \\tilde{k}=ka, \\quad \\tilde{\\omega }=\\omega \\sqrt{\\frac{m}{c_1}}, \\quad \\tilde{c}=\\frac{c_2}{c_1}, \\quad \\tilde{G}=\\frac{mG}{c_1}. \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M98\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msup><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>a</mml:mi></mml:mfrac><mml:mrow/><mml:msup><mml:mrow><mml:mi mathvariant=\"bold\">U</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:mspace width=\"1em\"/><mml:mover accent=\"true\"><mml:mi>k</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mi>k</mml:mi><mml:mi>a</mml:mi><mml:mo>,</mml:mo><mml:mspace width=\"1em\"/><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mi>ω</mml:mi><mml:msqrt><mml:mfrac><mml:mi>m</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfrac></mml:msqrt><mml:mo>,</mml:mo><mml:mspace width=\"1em\"/><mml:mover accent=\"true\"><mml:mi>c</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width=\"1em\"/><mml:mover accent=\"true\"><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant=\"italic\">mG</mml:mi></mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ39\"><alternatives><tex-math id=\"M99\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} (1-\\alpha ^2)\\omega ^4-2((c+1)(1-\\cos k)+G)\\omega ^2+G^2 \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M100\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msup><mml:mi>ω</mml:mi><mml:mn>4</mml:mn></mml:msup><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>c</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mo>cos</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msup><mml:mi>ω</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mi>G</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ7\"><label>7</label><alternatives><tex-math id=\"M101\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} +2(1-\\cos k)(c+1)G+4c(1-\\cos k)^2 =0. \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M102\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mo>cos</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>c</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>G</mml:mi><mml:mo>+</mml:mo><mml:mn>4</mml:mn><mml:mi>c</mml:mi><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mo>cos</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq39\"><alternatives><tex-math id=\"M103\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$0 \\le \\alpha &lt; 1$$\\end{document}</tex-math><mml:math id=\"M104\"><mml:mrow><mml:mn>0</mml:mn><mml:mo>≤</mml:mo><mml:mi>α</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ8\"><label>8</label><alternatives><tex-math id=\"M105\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\omega ^{\\pm }=\\Big (Q^{\\pm }(\\alpha ,c,k,G)\\Big )^{1/2}, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M106\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msup><mml:mi>ω</mml:mi><mml:mo>±</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">(</mml:mo></mml:mrow><mml:msup><mml:mi>Q</mml:mi><mml:mo>±</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msup><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">)</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ40\"><alternatives><tex-math id=\"M107\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} Q^{\\pm }(\\alpha ,c,k,G)= \\frac{1}{(1-\\alpha ^2)}\\Big (G+(1-\\cos k)(c+1) \\pm \\Big \\{(G+(1-\\cos k)(c+1))^2 \\nonumber \\\\ -(1-\\alpha ^2)(G^2+2G(1-\\cos k)(c+1)+4c(1-\\cos k)^2)\\Big \\}^{1/2} \\Big ). \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M108\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msup><mml:mi>Q</mml:mi><mml:mo>±</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">(</mml:mo></mml:mrow><mml:mi>G</mml:mi><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mo>cos</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>c</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>±</mml:mo><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">{</mml:mo></mml:mrow><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>G</mml:mi><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mo>cos</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>c</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow/><mml:mo>-</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>G</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:mi>G</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mo>cos</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>c</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mn>4</mml:mn><mml:mi>c</mml:mi><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mo>cos</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msup><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">}</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq40\"><alternatives><tex-math id=\"M109\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega ^{\\pm }$$\\end{document}</tex-math><mml:math id=\"M110\"><mml:msup><mml:mi>ω</mml:mi><mml:mo>±</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq41\"><alternatives><tex-math id=\"M111\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha =0.5$$\\end{document}</tex-math><mml:math id=\"M112\"><mml:mrow><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq42\"><alternatives><tex-math id=\"M113\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c=0$$\\end{document}</tex-math><mml:math id=\"M114\"><mml:mrow><mml:mi>c</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq43\"><alternatives><tex-math id=\"M115\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c=0.7$$\\end{document}</tex-math><mml:math id=\"M116\"><mml:mrow><mml:mi>c</mml:mi><mml:mo>=</mml:mo><mml:mn>0.7</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq44\"><alternatives><tex-math id=\"M117\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha =0$$\\end{document}</tex-math><mml:math id=\"M118\"><mml:mrow><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ9\"><label>9</label><alternatives><tex-math id=\"M119\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\omega ^{+}=\\sqrt{G+2(1-\\cos k)}, \\quad \\omega ^{-}=\\sqrt{G+2c(1-\\cos k)}, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M120\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msup><mml:mi>ω</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:msqrt><mml:mrow><mml:mi>G</mml:mi><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mo>cos</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msqrt><mml:mo>,</mml:mo><mml:mspace width=\"1em\"/><mml:msup><mml:mi>ω</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:msqrt><mml:mrow><mml:mi>G</mml:mi><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:mi>c</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mo>cos</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msqrt><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq45\"><alternatives><tex-math id=\"M121\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$G&gt;0$$\\end{document}</tex-math><mml:math id=\"M122\"><mml:mrow><mml:mi>G</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq46\"><alternatives><tex-math id=\"M123\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega =0$$\\end{document}</tex-math><mml:math id=\"M124\"><mml:mrow><mml:mi>ω</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq47\"><alternatives><tex-math id=\"M125\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha =0$$\\end{document}</tex-math><mml:math id=\"M126\"><mml:mrow><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq48\"><alternatives><tex-math id=\"M127\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k=0$$\\end{document}</tex-math><mml:math id=\"M128\"><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq49\"><alternatives><tex-math id=\"M129\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega ^{+}=\\omega ^{-}= \\sqrt{G}$$\\end{document}</tex-math><mml:math id=\"M130\"><mml:mrow><mml:msup><mml:mi>ω</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:msup><mml:mi>ω</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:msqrt><mml:mi>G</mml:mi></mml:msqrt></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq50\"><alternatives><tex-math id=\"M131\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$0&lt;\\alpha &lt;1$$\\end{document}</tex-math><mml:math id=\"M132\"><mml:mrow><mml:mn>0</mml:mn><mml:mo>&lt;</mml:mo><mml:mi>α</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq51\"><alternatives><tex-math id=\"M133\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega ^{+}&gt;\\omega ^{-}&gt;0$$\\end{document}</tex-math><mml:math id=\"M134\"><mml:mrow><mml:msup><mml:mi>ω</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo>&gt;</mml:mo><mml:msup><mml:mi>ω</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq52\"><alternatives><tex-math id=\"M135\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$0\\le c&lt;1$$\\end{document}</tex-math><mml:math id=\"M136\"><mml:mrow><mml:mn>0</mml:mn><mml:mo>≤</mml:mo><mml:mi>c</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq53\"><alternatives><tex-math id=\"M137\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$G&gt;0$$\\end{document}</tex-math><mml:math id=\"M138\"><mml:mrow><mml:mi>G</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq54\"><alternatives><tex-math id=\"M139\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega = \\omega ^\\pm (k, G)$$\\end{document}</tex-math><mml:math id=\"M140\"><mml:mrow><mml:mi>ω</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mi>ω</mml:mi><mml:mo>±</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq55\"><alternatives><tex-math id=\"M141\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha =0.5$$\\end{document}</tex-math><mml:math id=\"M142\"><mml:mrow><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq56\"><alternatives><tex-math id=\"M143\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega $$\\end{document}</tex-math><mml:math id=\"M144\"><mml:mi>ω</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq57\"><alternatives><tex-math id=\"M145\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega ^{+}|_{k=0}\\le \\omega \\le \\omega ^{-}|_{k=\\pi }$$\\end{document}</tex-math><mml:math id=\"M146\"><mml:mrow><mml:msup><mml:mi>ω</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:msub><mml:mrow><mml:msub><mml:mo stretchy=\"false\">|</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:mi>ω</mml:mi><mml:mo>≤</mml:mo><mml:msup><mml:mi>ω</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mi>π</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq58\"><alternatives><tex-math id=\"M147\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega ^{\\pm }$$\\end{document}</tex-math><mml:math id=\"M148\"><mml:msup><mml:mi>ω</mml:mi><mml:mo>±</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq59\"><alternatives><tex-math id=\"M149\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma =0$$\\end{document}</tex-math><mml:math id=\"M150\"><mml:mrow><mml:mi>γ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq60\"><alternatives><tex-math id=\"M151\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma =0.563$$\\end{document}</tex-math><mml:math id=\"M152\"><mml:mrow><mml:mi>γ</mml:mi><mml:mo>=</mml:mo><mml:mn>0.563</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq61\"><alternatives><tex-math id=\"M153\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma =1$$\\end{document}</tex-math><mml:math id=\"M154\"><mml:mrow><mml:mi>γ</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq62\"><alternatives><tex-math id=\"M155\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma =1.406$$\\end{document}</tex-math><mml:math id=\"M156\"><mml:mrow><mml:mi>γ</mml:mi><mml:mo>=</mml:mo><mml:mn>1.406</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq63\"><alternatives><tex-math id=\"M157\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c=0.8$$\\end{document}</tex-math><mml:math id=\"M158\"><mml:mrow><mml:mi>c</mml:mi><mml:mo>=</mml:mo><mml:mn>0.8</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq64\"><alternatives><tex-math id=\"M159\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha =0.5$$\\end{document}</tex-math><mml:math id=\"M160\"><mml:mrow><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq65\"><alternatives><tex-math id=\"M161\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$G=0, 1, 1.778$$\\end{document}</tex-math><mml:math id=\"M162\"><mml:mrow><mml:mi>G</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>1.778</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq66\"><alternatives><tex-math id=\"M163\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma = G\\alpha (c+1)/(4c(1-\\alpha ))$$\\end{document}</tex-math><mml:math id=\"M164\"><mml:mrow><mml:mi>γ</mml:mi><mml:mo>=</mml:mo><mml:mi>G</mml:mi><mml:mi>α</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>c</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo><mml:mo stretchy=\"false\">/</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>4</mml:mn><mml:mi>c</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>α</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq67\"><alternatives><tex-math id=\"M165\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c=0.8$$\\end{document}</tex-math><mml:math id=\"M166\"><mml:mrow><mml:mi>c</mml:mi><mml:mo>=</mml:mo><mml:mn>0.8</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq68\"><alternatives><tex-math id=\"M167\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha =0.5$$\\end{document}</tex-math><mml:math id=\"M168\"><mml:mrow><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq69\"><alternatives><tex-math id=\"M169\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma =G\\alpha (c+1)/(4 c(1-\\alpha )),$$\\end{document}</tex-math><mml:math id=\"M170\"><mml:mrow><mml:mi>γ</mml:mi><mml:mo>=</mml:mo><mml:mi>G</mml:mi><mml:mi>α</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>c</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo><mml:mo stretchy=\"false\">/</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>4</mml:mn><mml:mi>c</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>α</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq70\"><alternatives><tex-math id=\"M171\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$0\\le \\gamma \\le 1$$\\end{document}</tex-math><mml:math id=\"M172\"><mml:mrow><mml:mn>0</mml:mn><mml:mo>≤</mml:mo><mml:mi>γ</mml:mi><mml:mo>≤</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq71\"><alternatives><tex-math id=\"M173\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ 0\\le \\omega ^{+}|_{k=0}\\le \\omega ^{-}|_{k=\\pi }$$\\end{document}</tex-math><mml:math id=\"M174\"><mml:mrow><mml:mn>0</mml:mn><mml:mo>≤</mml:mo><mml:msup><mml:mi>ω</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:msub><mml:mrow><mml:msub><mml:mo stretchy=\"false\">|</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msup><mml:mi>ω</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mi>π</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq72\"><alternatives><tex-math id=\"M175\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma =0,$$\\end{document}</tex-math><mml:math id=\"M176\"><mml:mrow><mml:mi>γ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq73\"><alternatives><tex-math id=\"M177\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$0&lt;\\gamma &lt;1,$$\\end{document}</tex-math><mml:math id=\"M178\"><mml:mrow><mml:mn>0</mml:mn><mml:mo>&lt;</mml:mo><mml:mi>γ</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq74\"><alternatives><tex-math id=\"M179\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma =1$$\\end{document}</tex-math><mml:math id=\"M180\"><mml:mrow><mml:mi>γ</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq75\"><alternatives><tex-math id=\"M181\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma &gt;1$$\\end{document}</tex-math><mml:math id=\"M182\"><mml:mrow><mml:mi>γ</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq76\"><alternatives><tex-math id=\"M183\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\omega ^{+}|_{k=0}&gt;\\omega ^{-}|_{k=\\pi }&gt;0$$\\end{document}</tex-math><mml:math id=\"M184\"><mml:mrow><mml:msup><mml:mi>ω</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:msub><mml:mrow><mml:msub><mml:mo stretchy=\"false\">|</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msup><mml:mi>ω</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mi>π</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq77\"><alternatives><tex-math id=\"M185\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f_{j} e^{-i\\omega t}, ~ j=1,2,$$\\end{document}</tex-math><mml:math id=\"M186\"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>i</mml:mi><mml:mi>ω</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:mspace width=\"3.33333pt\"/><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq78\"><alternatives><tex-math id=\"M187\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=0,$$\\end{document}</tex-math><mml:math id=\"M188\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ10\"><label>10</label><alternatives><tex-math id=\"M189\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\begin{aligned} (G-\\Omega ){U}^{(n)}_1=\\left( U^{(n+1)}_1+U^{(n-1)}_1-2U^{(n)}_1\\right) +i\\alpha {\\Omega } U^{(n)}_2+\\tilde{f}_{1}\\delta _{n0}, \\\\ (G-\\Omega ){U}^{(n)}_2=c\\left( U^{(n+1)}_2+U^{(n-1)}_2-2U^{(n)}_2\\right) -i\\alpha \\Omega U^{(n)}_1+\\tilde{f}_{2}\\delta _{n0}. \\end{aligned} \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M190\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>G</mml:mi><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msubsup><mml:mrow><mml:mi>U</mml:mi></mml:mrow><mml:mn>1</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>U</mml:mi><mml:mn>1</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>U</mml:mi><mml:mn>1</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:msubsup><mml:mi>U</mml:mi><mml:mn>1</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup></mml:mfenced><mml:mo>+</mml:mo><mml:mi>i</mml:mi><mml:mi>α</mml:mi><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:msubsup><mml:mi>U</mml:mi><mml:mn>2</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>f</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>δ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow/><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>G</mml:mi><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msubsup><mml:mrow><mml:mi>U</mml:mi></mml:mrow><mml:mn>2</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mi>c</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>U</mml:mi><mml:mn>2</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>U</mml:mi><mml:mn>2</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:msubsup><mml:mi>U</mml:mi><mml:mn>2</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup></mml:mfenced><mml:mo>-</mml:mo><mml:mi>i</mml:mi><mml:mi>α</mml:mi><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:msubsup><mml:mi>U</mml:mi><mml:mn>1</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>f</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>δ</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq79\"><alternatives><tex-math id=\"M191\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Omega =\\omega ^2$$\\end{document}</tex-math><mml:math id=\"M192\"><mml:mrow><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mi>ω</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq80\"><alternatives><tex-math id=\"M193\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{f}_{i}=f_{i}/ac_{1}.$$\\end{document}</tex-math><mml:math id=\"M194\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>f</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>a</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ11\"><label>11</label><alternatives><tex-math id=\"M195\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} U_{i}^{(n)}=\\sum _{j=1,2}{\\mathscr {G}}^{(n)}_{ij}\\tilde{f}_{j}, ~ i=1,2, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M196\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msubsup><mml:mi>U</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:munder><mml:msubsup><mml:mrow><mml:mi mathvariant=\"script\">G</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">ij</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:msub><mml:mover accent=\"true\"><mml:mi>f</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mspace width=\"3.33333pt\"/><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq81\"><alternatives><tex-math id=\"M197\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\mathscr {G}}^{(n)}_{ij}$$\\end{document}</tex-math><mml:math id=\"M198\"><mml:msubsup><mml:mrow><mml:mi mathvariant=\"script\">G</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">ij</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ12\"><label>12</label><alternatives><tex-math id=\"M199\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} {{{\\varvec{\\mathscr {G}}}}}^{(n)}=F(n,\\Omega ,\\alpha ,c,G)\\left[ (G-\\Omega ){\\textbf {I}}+i\\alpha \\Omega {\\textbf {R}})\\right] -\\mathfrak {F}(n,\\Omega ,\\alpha ,c,G)\\text {diag}\\{c,1\\}, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M200\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msup><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-script\">G</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mi>F</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mfenced close=\"]\" open=\"[\"><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>G</mml:mi><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mi mathvariant=\"bold\">I</mml:mi><mml:mo>+</mml:mo><mml:mi>i</mml:mi><mml:mi>α</mml:mi><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mi mathvariant=\"bold\">R</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mfenced><mml:mo>-</mml:mo><mml:mi mathvariant=\"fraktur\">F</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mtext>diag</mml:mtext><mml:mrow><mml:mo stretchy=\"false\">{</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">}</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq82\"><alternatives><tex-math id=\"M201\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\textbf {I}}$$\\end{document}</tex-math><mml:math id=\"M202\"><mml:mi mathvariant=\"bold\">I</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq83\"><alternatives><tex-math id=\"M203\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$2\\times 2$$\\end{document}</tex-math><mml:math id=\"M204\"><mml:mrow><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq84\"><alternatives><tex-math id=\"M205\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\textbf {R}}$$\\end{document}</tex-math><mml:math id=\"M206\"><mml:mi mathvariant=\"bold\">R</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ13\"><label>13</label><alternatives><tex-math id=\"M207\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned}{} &amp; {} F(n,\\Omega ,\\alpha ,c,G)=\\frac{1}{2\\pi }\\int _{-\\pi }^{\\pi }\\frac{e^{ikn}}{\\sigma (\\alpha ,\\omega ,c,k,G)}dk, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M208\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow/></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:mi>F</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mn>2</mml:mn><mml:mi>π</mml:mi></mml:mrow></mml:mfrac><mml:msubsup><mml:mo>∫</mml:mo><mml:mrow><mml:mo>-</mml:mo><mml:mi>π</mml:mi></mml:mrow><mml:mi>π</mml:mi></mml:msubsup><mml:mfrac><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">ikn</mml:mi></mml:mrow></mml:msup><mml:mrow><mml:mi>σ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>ω</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac><mml:mi>d</mml:mi><mml:mi>k</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ14\"><label>14</label><alternatives><tex-math id=\"M209\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned}{} &amp; {} \\mathfrak {F}(n,\\Omega ,\\alpha ,c,G)=\\frac{1}{\\pi }\\int _{-\\pi }^{\\pi }\\frac{(\\cos k-1)e^{ikn}}{\\sigma (\\alpha ,\\omega ,c,k,G)}dk \\nonumber \\\\{} &amp; {} =F(n+1,\\Omega ,\\alpha ,c,G)-2F(n,\\Omega ,\\alpha ,c,G) +F(n-1,\\Omega ,\\alpha ,c,G), ~\\text{ where } \\nonumber \\\\{} &amp; {} \\sigma (\\alpha ,\\omega ,c,k,G)=(1-\\alpha ^2)\\omega ^4-2((c+1)(1-\\cos k)+G)\\omega ^2+G^2+2(1-\\cos k)(c+1)G+4c(1-\\cos k)^2. \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M210\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow/></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:mi mathvariant=\"fraktur\">F</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>π</mml:mi></mml:mfrac><mml:msubsup><mml:mo>∫</mml:mo><mml:mrow><mml:mo>-</mml:mo><mml:mi>π</mml:mi></mml:mrow><mml:mi>π</mml:mi></mml:msubsup><mml:mfrac><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mo>cos</mml:mo><mml:mi>k</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">ikn</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mi>σ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>ω</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac><mml:mi>d</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow/><mml:mrow/></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:mo>=</mml:mo><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>,</mml:mo><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"0.333333em\"/><mml:mtext>where</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow/><mml:mrow/></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mrow/><mml:mi>σ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>ω</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msup><mml:mi>ω</mml:mi><mml:mn>4</mml:mn></mml:msup><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>c</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mo>cos</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msup><mml:mi>ω</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mi>G</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mo>cos</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>c</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>G</mml:mi><mml:mo>+</mml:mo><mml:mn>4</mml:mn><mml:mi>c</mml:mi><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mo>cos</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq85\"><alternatives><tex-math id=\"M211\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F(n,\\Omega ,\\alpha ,c,G)$$\\end{document}</tex-math><mml:math id=\"M212\"><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ15\"><label>15</label><alternatives><tex-math id=\"M213\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} b^{\\pm }=\\Bigg (1-\\frac{(c+1)(\\Omega -G)\\mp \\sqrt{\\Omega ^2(4\\alpha ^2c+c^2-2c+1)+G^2(c-1)^2-2G\\Omega (c-1)^2}}{4c}\\Bigg )^{-1}. \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M214\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>±</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:mrow><mml:mo maxsize=\"2.470em\" minsize=\"2.470em\" stretchy=\"true\">(</mml:mo></mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>c</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>-</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>∓</mml:mo><mml:msqrt><mml:mrow><mml:msup><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>4</mml:mn><mml:msup><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>c</mml:mi><mml:mo>+</mml:mo><mml:msup><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:mi>c</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msup><mml:mi>G</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>c</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:mi>G</mml:mi><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>c</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt></mml:mrow><mml:mrow><mml:mn>4</mml:mn><mml:mi>c</mml:mi></mml:mrow></mml:mfrac><mml:msup><mml:mrow><mml:mo maxsize=\"2.470em\" minsize=\"2.470em\" stretchy=\"true\">)</mml:mo></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq86\"><alternatives><tex-math id=\"M215\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$|b^{\\pm }|&lt;1$$\\end{document}</tex-math><mml:math id=\"M216\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>±</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq87\"><alternatives><tex-math id=\"M217\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F(n,\\Omega ,\\alpha ,c,G)$$\\end{document}</tex-math><mml:math id=\"M218\"><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ16\"><label>16</label><alternatives><tex-math id=\"M219\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} F(n,\\Omega , \\alpha ,c,G) = \\frac{b^- b^+}{4c(b^{-}-b^{+})} \\left[ \\frac{b^{-}}{\\sqrt{1-(b^{-})^2}} \\left( \\frac{1-\\sqrt{1-(b^{-})^2}}{b^{-}}\\right) ^{|n|} \\right. \\nonumber \\\\ \\left. -\\frac{b^{+}}{\\sqrt{1-(b^{+})^2}}\\left( \\frac{1-\\sqrt{1-(b^{+})^2}}{b^{+}}\\right) ^{|n|} \\right] . \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M220\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>F</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup></mml:mrow><mml:mrow><mml:mn>4</mml:mn><mml:mi>c</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mo>-</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac><mml:mfenced open=\"[\"><mml:mfrac><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:msqrt><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt></mml:mfrac><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msqrt><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt></mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup></mml:mfrac></mml:mfenced><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow></mml:msup></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow/><mml:mfenced close=\"]\"><mml:mo>-</mml:mo><mml:mfrac><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:msqrt><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt></mml:mfrac><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msqrt><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt></mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup></mml:mfrac></mml:mfenced><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow></mml:msup></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq88\"><alternatives><tex-math id=\"M221\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$b^\\pm $$\\end{document}</tex-math><mml:math id=\"M222\"><mml:msup><mml:mi>b</mml:mi><mml:mo>±</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq89\"><alternatives><tex-math id=\"M223\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$|b^{+}|&gt;1$$\\end{document}</tex-math><mml:math id=\"M224\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mo>&gt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq90\"><alternatives><tex-math id=\"M225\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$|b^{-}|&lt;1,$$\\end{document}</tex-math><mml:math id=\"M226\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq91\"><alternatives><tex-math id=\"M227\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$|b^{+}|&lt;1$$\\end{document}</tex-math><mml:math id=\"M228\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq92\"><alternatives><tex-math id=\"M229\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$|b^{-}|&gt;1.$$\\end{document}</tex-math><mml:math id=\"M230\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mo>&gt;</mml:mo><mml:mn>1</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq93\"><alternatives><tex-math id=\"M231\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$|b^{+}|&gt;1$$\\end{document}</tex-math><mml:math id=\"M232\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mo>&gt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq94\"><alternatives><tex-math id=\"M233\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$|b^{-}|&lt;1$$\\end{document}</tex-math><mml:math id=\"M234\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq95\"><alternatives><tex-math id=\"M235\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F(n,\\Omega , \\alpha , c, G)$$\\end{document}</tex-math><mml:math id=\"M236\"><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ17\"><label>17</label><alternatives><tex-math id=\"M237\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} F(n,\\Omega , \\alpha ,c,G) = \\frac{b^- b^+}{4c(b^{-}-b^{+})}\\left[ \\frac{b^{-}}{\\sqrt{1-(b^{-})^2}} \\left( \\frac{1-\\sqrt{1-(b^{-})^2}}{b^{-}}\\right) ^{|n|} -\\frac{ie^{i|n|\\theta ^{+}}}{\\sin (\\theta ^{+})}\\right] , \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M238\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>F</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup></mml:mrow><mml:mrow><mml:mn>4</mml:mn><mml:mi>c</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mo>-</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac><mml:mfenced close=\"]\" open=\"[\"><mml:mfrac><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:msqrt><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt></mml:mfrac><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msqrt><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt></mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup></mml:mfrac></mml:mfenced><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mi>i</mml:mi><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy=\"false\">|</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:msup><mml:mi>θ</mml:mi><mml:mo>+</mml:mo></mml:msup></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mo>sin</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>θ</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ18\"><label>18</label><alternatives><tex-math id=\"M239\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\cos \\theta ^{\\pm }=\\frac{1}{b^{\\pm }}. \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M240\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mo>cos</mml:mo><mml:msup><mml:mi>θ</mml:mi><mml:mo>±</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msup><mml:mi>b</mml:mi><mml:mo>±</mml:mo></mml:msup></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq96\"><alternatives><tex-math id=\"M241\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega ^-$$\\end{document}</tex-math><mml:math id=\"M242\"><mml:msup><mml:mi>ω</mml:mi><mml:mo>-</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq97\"><alternatives><tex-math id=\"M243\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega ^+.$$\\end{document}</tex-math><mml:math id=\"M244\"><mml:mrow><mml:msup><mml:mi>ω</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq98\"><alternatives><tex-math id=\"M245\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$|b^{+}|&lt;1$$\\end{document}</tex-math><mml:math id=\"M246\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq99\"><alternatives><tex-math id=\"M247\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$|b^{-}|&gt;1$$\\end{document}</tex-math><mml:math id=\"M248\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mo>&gt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq100\"><alternatives><tex-math id=\"M249\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F(n,\\Omega ,\\alpha ,c,G)$$\\end{document}</tex-math><mml:math id=\"M250\"><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ19\"><label>19</label><alternatives><tex-math id=\"M251\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} F(n,\\Omega , \\alpha ,c,G) = \\frac{b^- b^+}{4c(b^{-}-b^{+})}\\left[ \\frac{ie^{i|n|\\theta ^{-}}}{\\sin (\\theta ^{-})}-\\frac{b^{+}}{\\sqrt{1-(b^{+})^2}} \\left( \\frac{1-\\sqrt{1-(b^{+})^2}}{b^{+}}\\right) ^{|n|}\\right] , \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M252\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>F</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup></mml:mrow><mml:mrow><mml:mn>4</mml:mn><mml:mi>c</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mo>-</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac><mml:mfenced close=\"]\" open=\"[\"><mml:mfrac><mml:mrow><mml:mi>i</mml:mi><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy=\"false\">|</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:msup><mml:mi>θ</mml:mi><mml:mo>-</mml:mo></mml:msup></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mo>sin</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>θ</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:msqrt><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt></mml:mfrac><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msqrt><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt></mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup></mml:mfrac></mml:mfenced><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow></mml:msup></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq101\"><alternatives><tex-math id=\"M253\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega ^-$$\\end{document}</tex-math><mml:math id=\"M254\"><mml:msup><mml:mi>ω</mml:mi><mml:mo>-</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq102\"><alternatives><tex-math id=\"M255\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\omega ^+.$$\\end{document}</tex-math><mml:math id=\"M256\"><mml:mrow><mml:msup><mml:mi>ω</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq103\"><alternatives><tex-math id=\"M257\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$O'x'y'z'$$\\end{document}</tex-math><mml:math id=\"M258\"><mml:mrow><mml:msup><mml:mi>O</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:msup><mml:mi>x</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:msup><mml:mi>y</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:msup><mml:mi>z</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq104\"><alternatives><tex-math id=\"M259\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\theta $$\\end{document}</tex-math><mml:math id=\"M260\"><mml:mi>θ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq105\"><alternatives><tex-math id=\"M261\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\phi $$\\end{document}</tex-math><mml:math id=\"M262\"><mml:mi>ϕ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq106\"><alternatives><tex-math id=\"M263\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\psi $$\\end{document}</tex-math><mml:math id=\"M264\"><mml:mi>ψ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq107\"><alternatives><tex-math id=\"M265\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$|b^{\\pm }|&gt;1$$\\end{document}</tex-math><mml:math id=\"M266\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>±</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mo>&gt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq108\"><alternatives><tex-math id=\"M267\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$F(n,\\Omega ,\\alpha ,c,G)$$\\end{document}</tex-math><mml:math id=\"M268\"><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ20\"><label>20</label><alternatives><tex-math id=\"M269\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} F(n,\\Omega , \\alpha ,c,G) = \\frac{b^- b^+}{4c(b^{-}-b^{+})} \\left[ \\frac{ie^{i|n|\\theta ^{-}}}{\\sin (\\theta ^{-})} -\\frac{ie^{i|n|\\theta ^{+}}}{\\sin (\\theta ^{+})}\\right] . \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M270\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>F</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>,</mml:mo><mml:mi>α</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup></mml:mrow><mml:mrow><mml:mn>4</mml:mn><mml:mi>c</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mo>-</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac><mml:mfenced close=\"]\" open=\"[\"><mml:mfrac><mml:mrow><mml:mi>i</mml:mi><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy=\"false\">|</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:msup><mml:mi>θ</mml:mi><mml:mo>-</mml:mo></mml:msup></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mo>sin</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>θ</mml:mi><mml:mo>-</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mi>i</mml:mi><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy=\"false\">|</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:msup><mml:mi>θ</mml:mi><mml:mo>+</mml:mo></mml:msup></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mo>sin</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>θ</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq109\"><alternatives><tex-math id=\"M271\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z=0$$\\end{document}</tex-math><mml:math id=\"M272\"><mml:mrow><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq110\"><alternatives><tex-math id=\"M273\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z=L$$\\end{document}</tex-math><mml:math id=\"M274\"><mml:mrow><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq111\"><alternatives><tex-math id=\"M275\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\theta $$\\end{document}</tex-math><mml:math id=\"M276\"><mml:mi>θ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq112\"><alternatives><tex-math id=\"M277\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\phi $$\\end{document}</tex-math><mml:math id=\"M278\"><mml:mi>ϕ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq113\"><alternatives><tex-math id=\"M279\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\psi .$$\\end{document}</tex-math><mml:math id=\"M280\"><mml:mrow><mml:mi>ψ</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq114\"><alternatives><tex-math id=\"M281\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\theta $$\\end{document}</tex-math><mml:math id=\"M282\"><mml:mi>θ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq115\"><alternatives><tex-math id=\"M283\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$0\\le z\\le L$$\\end{document}</tex-math><mml:math id=\"M284\"><mml:mrow><mml:mn>0</mml:mn><mml:mo>≤</mml:mo><mml:mi>z</mml:mi><mml:mo>≤</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq01\"><alternatives><tex-math id=\"M285\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$v(z,t)$$\\end{document}</tex-math><mml:math id=\"M286\"><mml:mrow><mml:mi>v</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ21\"><label>21</label><alternatives><tex-math id=\"M287\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} u(z,t)=zU(t), \\quad v(z,t)=zV(t), \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M288\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>u</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>=</mml:mo><mml:mi>z</mml:mi><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>,</mml:mo><mml:mspace width=\"1em\"/><mml:mi>v</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>z</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>=</mml:mo><mml:mi>z</mml:mi><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq116\"><alternatives><tex-math id=\"M289\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Omega = \\dot{\\phi }+\\dot{\\psi }$$\\end{document}</tex-math><mml:math id=\"M290\"><mml:mrow><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>=</mml:mo><mml:mover accent=\"true\"><mml:mi>ϕ</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mo>+</mml:mo><mml:mover accent=\"true\"><mml:mi>ψ</mml:mi><mml:mo>˙</mml:mo></mml:mover></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq117\"><alternatives><tex-math id=\"M291\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Omega \\approx \\dot{\\psi }$$\\end{document}</tex-math><mml:math id=\"M292\"><mml:mrow><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mo>≈</mml:mo><mml:mover accent=\"true\"><mml:mi>ψ</mml:mi><mml:mo>˙</mml:mo></mml:mover></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq118\"><alternatives><tex-math id=\"M293\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z'$$\\end{document}</tex-math><mml:math id=\"M294\"><mml:msup><mml:mi>z</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq119\"><alternatives><tex-math id=\"M295\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(x',y',z')$$\\end{document}</tex-math><mml:math id=\"M296\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>x</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mo>,</mml:mo><mml:msup><mml:mi>y</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mo>,</mml:mo><mml:msup><mml:mi>z</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq120\"><alternatives><tex-math id=\"M297\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z=L$$\\end{document}</tex-math><mml:math id=\"M298\"><mml:mrow><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ22\"><label>22</label><alternatives><tex-math id=\"M299\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\begin{pmatrix} \\ddot{U}(t)\\\\ \\ddot{V}(t) \\end{pmatrix}+ \\frac{I_1}{I_0}\\Omega {\\textbf {R}}\\begin{pmatrix} \\dot{U}(t)\\\\ \\dot{V}(t) \\end{pmatrix}+ \\frac{mgL}{I_0}\\begin{pmatrix} U(t)\\\\ V(t) \\end{pmatrix}= \\begin{pmatrix} 0 \\\\ 0 \\end{pmatrix}, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M300\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo>¨</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo>¨</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfrac><mml:msub><mml:mi>I</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfrac><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:mi mathvariant=\"bold\">R</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant=\"italic\">mgL</mml:mi></mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq121\"><alternatives><tex-math id=\"M301\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$90^\\circ $$\\end{document}</tex-math><mml:math id=\"M302\"><mml:msup><mml:mn>90</mml:mn><mml:mo>∘</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq122\"><alternatives><tex-math id=\"M303\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\textbf {R}}$$\\end{document}</tex-math><mml:math id=\"M304\"><mml:mi mathvariant=\"bold\">R</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq123\"><alternatives><tex-math id=\"M305\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$I_0$$\\end{document}</tex-math><mml:math id=\"M306\"><mml:msub><mml:mi>I</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq124\"><alternatives><tex-math id=\"M307\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z=0$$\\end{document}</tex-math><mml:math id=\"M308\"><mml:mrow><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq125\"><alternatives><tex-math id=\"M309\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x'$$\\end{document}</tex-math><mml:math id=\"M310\"><mml:msup><mml:mi>x</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq126\"><alternatives><tex-math id=\"M311\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$y'$$\\end{document}</tex-math><mml:math id=\"M312\"><mml:msup><mml:mi>y</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq127\"><alternatives><tex-math id=\"M313\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$I_1$$\\end{document}</tex-math><mml:math id=\"M314\"><mml:msub><mml:mi>I</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq128\"><alternatives><tex-math id=\"M315\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z'$$\\end{document}</tex-math><mml:math id=\"M316\"><mml:msup><mml:mi>z</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq129\"><alternatives><tex-math id=\"M317\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-172$$\\end{document}</tex-math><mml:math id=\"M318\"><mml:mrow><mml:mo>-</mml:mo><mml:mn>172</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq130\"><alternatives><tex-math id=\"M319\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$m=0.032$$\\end{document}</tex-math><mml:math id=\"M320\"><mml:mrow><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mn>0.032</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq131\"><alternatives><tex-math id=\"M321\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-0.12857$$\\end{document}</tex-math><mml:math id=\"M322\"><mml:mrow><mml:mo>-</mml:mo><mml:mn>0.12857</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq132\"><alternatives><tex-math id=\"M323\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$-0.00602$$\\end{document}</tex-math><mml:math id=\"M324\"><mml:mrow><mml:mo>-</mml:mo><mml:mn>0.00602</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ23\"><label>23</label><alternatives><tex-math id=\"M325\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\begin{pmatrix} \\ddot{U}(t)\\\\ \\ddot{V}(t) \\end{pmatrix}+ \\frac{\\Omega R^2}{2 L^2} {\\textbf {R}}\\begin{pmatrix} \\dot{U}(t)\\\\ \\dot{V}(t) \\end{pmatrix}+ \\frac{g}{L}\\begin{pmatrix} U(t)\\\\ V(t) \\end{pmatrix}= \\begin{pmatrix} 0 \\\\ 0 \\end{pmatrix}. \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M326\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo>¨</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo>¨</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:msup><mml:mi>R</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:msup><mml:mi>L</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mi mathvariant=\"bold\">R</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfrac><mml:mi>g</mml:mi><mml:mi>L</mml:mi></mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq133\"><alternatives><tex-math id=\"M327\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{t}=t\\sqrt{g/L}$$\\end{document}</tex-math><mml:math id=\"M328\"><mml:mrow><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mi>t</mml:mi><mml:msqrt><mml:mrow><mml:mi>g</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:msqrt></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq134\"><alternatives><tex-math id=\"M329\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z=L$$\\end{document}</tex-math><mml:math id=\"M330\"><mml:mrow><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ24\"><label>24</label><alternatives><tex-math id=\"M331\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\frac{d^2}{d\\tilde{t}^2}\\begin{pmatrix} \\tilde{U}\\\\ \\tilde{V} \\end{pmatrix}+ \\Gamma \\begin{pmatrix} 0 &amp;{} 1\\\\ -1 &amp;{} 0 \\end{pmatrix} \\frac{d}{d\\tilde{t}}\\begin{pmatrix} \\tilde{U}\\\\ \\tilde{V} \\end{pmatrix}+ \\begin{pmatrix} \\tilde{U}\\\\ \\tilde{V} \\end{pmatrix}= \\begin{pmatrix} 0 \\\\ 0 \\end{pmatrix}, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M332\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfrac><mml:msup><mml:mi>d</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mrow><mml:mi>d</mml:mi><mml:msup><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mrow><mml:mrow/><mml:mn>1</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mrow/><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover></mml:mrow></mml:mfrac><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq135\"><alternatives><tex-math id=\"M333\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma =\\Omega R^2/2\\sqrt{gL^3}$$\\end{document}</tex-math><mml:math id=\"M334\"><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant=\"normal\">Ω</mml:mi><mml:msup><mml:mi>R</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:msqrt><mml:mrow><mml:mi>g</mml:mi><mml:msup><mml:mi>L</mml:mi><mml:mn>3</mml:mn></mml:msup></mml:mrow></mml:msqrt></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq136\"><alternatives><tex-math id=\"M335\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{U}(\\tilde{t})=U(\\tilde{t}\\sqrt{L/g})$$\\end{document}</tex-math><mml:math id=\"M336\"><mml:mrow><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>U</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:msqrt><mml:mrow><mml:mi>L</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>g</mml:mi></mml:mrow></mml:msqrt><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq137\"><alternatives><tex-math id=\"M337\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{V}(\\tilde{t})=V(\\tilde{t}\\sqrt{L/g}).$$\\end{document}</tex-math><mml:math id=\"M338\"><mml:mrow><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:msqrt><mml:mrow><mml:mi>L</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>g</mml:mi></mml:mrow></mml:msqrt><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq138\"><alternatives><tex-math id=\"M339\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{U}=A\\exp (i \\tilde{\\omega } \\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M340\"><mml:mrow><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mi>A</mml:mi><mml:mo>exp</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>i</mml:mi><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq139\"><alternatives><tex-math id=\"M341\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{V}=B\\exp (i \\tilde{\\omega } \\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M342\"><mml:mrow><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mi>B</mml:mi><mml:mo>exp</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>i</mml:mi><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ25\"><label>25</label><alternatives><tex-math id=\"M343\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\begin{gathered} \\tilde{\\omega }_{1}=-\\frac{1}{2}\\Big (\\Gamma +\\sqrt{\\Gamma ^2+4}\\Big ), ~ \\tilde{\\omega }_{2}=\\frac{1}{2}\\Big (\\Gamma -\\sqrt{\\Gamma ^2+4}\\Big ), \\\\ \\tilde{\\omega }_{3}=\\frac{1}{2}\\Big (-\\Gamma +\\sqrt{\\Gamma ^2+4}\\Big ),~ \\tilde{\\omega }_{4}=\\frac{1}{2}\\Big (\\Gamma +\\sqrt{\\Gamma ^2+4}\\Big ). \\end{gathered} \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M344\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:mfrac><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">(</mml:mo></mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>+</mml:mo><mml:msqrt><mml:mrow><mml:msup><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msqrt><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mspace width=\"3.33333pt\"/><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:mfrac><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">(</mml:mo></mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>-</mml:mo><mml:msqrt><mml:mrow><mml:msup><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msqrt><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:mfrac><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">(</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>+</mml:mo><mml:msqrt><mml:mrow><mml:msup><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msqrt><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mspace width=\"3.33333pt\"/><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:mfrac><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">(</mml:mo></mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>+</mml:mo><mml:msqrt><mml:mrow><mml:msup><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msqrt><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq140\"><alternatives><tex-math id=\"M345\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma $$\\end{document}</tex-math><mml:math id=\"M346\"><mml:mi mathvariant=\"normal\">Γ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq141\"><alternatives><tex-math id=\"M347\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{\\omega }_{1}$$\\end{document}</tex-math><mml:math id=\"M348\"><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq142\"><alternatives><tex-math id=\"M349\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{\\omega }_{2}$$\\end{document}</tex-math><mml:math id=\"M350\"><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq143\"><alternatives><tex-math id=\"M351\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{\\omega }_{3}$$\\end{document}</tex-math><mml:math id=\"M352\"><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq144\"><alternatives><tex-math id=\"M353\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{\\omega }_{4}$$\\end{document}</tex-math><mml:math id=\"M354\"><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq145\"><alternatives><tex-math id=\"M355\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{\\omega }_3$$\\end{document}</tex-math><mml:math id=\"M356\"><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq146\"><alternatives><tex-math id=\"M357\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{\\omega }_4$$\\end{document}</tex-math><mml:math id=\"M358\"><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq147\"><alternatives><tex-math id=\"M359\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\textbf{u}_{3}=(1, i)^T$$\\end{document}</tex-math><mml:math id=\"M360\"><mml:mrow><mml:msub><mml:mi mathvariant=\"bold\">u</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>T</mml:mi></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq148\"><alternatives><tex-math id=\"M361\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\textbf{u}_{4}=(1, - i)^T$$\\end{document}</tex-math><mml:math id=\"M362\"><mml:mrow><mml:msub><mml:mi mathvariant=\"bold\">u</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>-</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi>T</mml:mi></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq149\"><alternatives><tex-math id=\"M363\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{\\omega }_{3}$$\\end{document}</tex-math><mml:math id=\"M364\"><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq150\"><alternatives><tex-math id=\"M365\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{\\omega }_{4},$$\\end{document}</tex-math><mml:math id=\"M366\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq151\"><alternatives><tex-math id=\"M367\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma =0$$\\end{document}</tex-math><mml:math id=\"M368\"><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq152\"><alternatives><tex-math id=\"M369\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{\\omega }_{3}=\\tilde{\\omega }_{4}=1.$$\\end{document}</tex-math><mml:math id=\"M370\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq153\"><alternatives><tex-math id=\"M371\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma \\ne 0$$\\end{document}</tex-math><mml:math id=\"M372\"><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>≠</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq154\"><alternatives><tex-math id=\"M373\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{\\omega }_{3}$$\\end{document}</tex-math><mml:math id=\"M374\"><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq155\"><alternatives><tex-math id=\"M375\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{\\omega }_{4}$$\\end{document}</tex-math><mml:math id=\"M376\"><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq156\"><alternatives><tex-math id=\"M377\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{\\omega }_{3}$$\\end{document}</tex-math><mml:math id=\"M378\"><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq157\"><alternatives><tex-math id=\"M379\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{\\omega }_{4}$$\\end{document}</tex-math><mml:math id=\"M380\"><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq158\"><alternatives><tex-math id=\"M381\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$|\\tilde{\\omega }_{4} - \\tilde{\\omega }_{3}| = |\\Gamma |.$$\\end{document}</tex-math><mml:math id=\"M382\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy=\"false\">|</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo stretchy=\"false\">|</mml:mo><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq159\"><alternatives><tex-math id=\"M383\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma $$\\end{document}</tex-math><mml:math id=\"M384\"><mml:mi mathvariant=\"normal\">Γ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq160\"><alternatives><tex-math id=\"M385\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma =1.78885, U_0=0.9484 $$\\end{document}</tex-math><mml:math id=\"M386\"><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>=</mml:mo><mml:mn>1.78885</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.9484</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq1600\"><alternatives><tex-math id=\"M387\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$V_0=0, \\dot{U_0}=0, \\dot{V_0}= -0.326248$$\\end{document}</tex-math><mml:math id=\"M388\"><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mover accent=\"true\"><mml:msub><mml:mi>U</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>˙</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mover accent=\"true\"><mml:msub><mml:mi>V</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>˙</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>0.326248</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq161\"><alternatives><tex-math id=\"M389\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma =3/2, U_0=0.9298, V_0=0$$\\end{document}</tex-math><mml:math id=\"M390\"><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>=</mml:mo><mml:mn>3</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.9298</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq1610\"><alternatives><tex-math id=\"M391\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{U_0}=0, \\dot{V_0}= -0.3282$$\\end{document}</tex-math><mml:math id=\"M392\"><mml:mrow><mml:mover accent=\"true\"><mml:msub><mml:mi>U</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>˙</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mover accent=\"true\"><mml:msub><mml:mi>V</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>˙</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>0.3282</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ26\"><label>26</label><alternatives><tex-math id=\"M393\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\tilde{U}(0)=\\tilde{U}_{0}, \\quad \\tilde{V}(0)=\\tilde{V}_0, \\quad \\frac{d {\\tilde{U}}}{d \\tilde{t}}(0)=\\dot{\\tilde{U}}_{0},\\quad \\frac{d {\\tilde{V}}}{d \\tilde{t}}(0)=\\dot{\\tilde{V}}_{0}, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M394\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mspace width=\"1em\"/><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mspace width=\"1em\"/><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover></mml:mrow></mml:mfrac><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mspace width=\"1em\"/><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover></mml:mrow></mml:mfrac><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq162\"><alternatives><tex-math id=\"M395\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{U}_0,\\tilde{V}_0,\\dot{\\tilde{U}}_{0}$$\\end{document}</tex-math><mml:math id=\"M396\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq163\"><alternatives><tex-math id=\"M397\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{V}}_{0}$$\\end{document}</tex-math><mml:math id=\"M398\"><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ27\"><label>27</label><alternatives><tex-math id=\"M399\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\begin{pmatrix} \\tilde{U} \\\\ \\tilde{V} \\end{pmatrix} = \\tilde{A}_1\\begin{pmatrix} \\cos (\\tilde{\\omega }_4 \\tilde{t}) \\\\ \\sin (\\tilde{\\omega }_4 \\tilde{t}) \\end{pmatrix}+ \\tilde{A}_2\\begin{pmatrix} -\\sin (\\tilde{\\omega }_4 \\tilde{t}) \\\\ \\cos (\\tilde{\\omega }_4 \\tilde{t}) \\end{pmatrix} + \\tilde{A}_3\\begin{pmatrix} \\cos (\\tilde{\\omega }_3 \\tilde{t}) \\\\ -\\sin (\\tilde{\\omega }_3 \\tilde{t}) \\end{pmatrix}+ \\tilde{A}_4\\begin{pmatrix} \\sin (\\tilde{\\omega }_3 \\tilde{t}) \\\\ \\cos (\\tilde{\\omega }_3 \\tilde{t}) \\end{pmatrix}, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M400\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>A</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mo>cos</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mo>sin</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>A</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mo>-</mml:mo><mml:mo>sin</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mo>cos</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>A</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mo>cos</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mo>-</mml:mo><mml:mo>sin</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>A</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mo>sin</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mo>cos</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ28\"><label>28</label><alternatives><tex-math id=\"M401\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\tilde{A}_1 = \\frac{\\dot{\\tilde{V}}_{0}+\\tilde{\\omega }_3 \\tilde{U}_{0}}{\\tilde{\\omega }_3+\\tilde{\\omega }_4}, \\quad \\tilde{A}_2 = \\frac{-\\dot{\\tilde{U}}_{0}+\\tilde{\\omega }_3 \\tilde{V}_0}{\\tilde{\\omega }_3+\\tilde{\\omega }_4}, ~~~\\tilde{A}_3 = \\frac{-\\dot{\\tilde{V}}_{0}+\\tilde{\\omega }_4 \\tilde{U}_{0}}{\\tilde{\\omega }_3+\\tilde{\\omega }_4}, \\quad \\tilde{A}_4 = \\frac{\\dot{\\tilde{U}}_{0}+\\tilde{\\omega }_4 \\tilde{V}_{0}}{\\tilde{\\omega }_3+\\tilde{\\omega }_4}. \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M402\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>A</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width=\"1em\"/><mml:msub><mml:mover accent=\"true\"><mml:mi>A</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>-</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:msub><mml:mover accent=\"true\"><mml:mi>A</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>-</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub><mml:msub><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width=\"1em\"/><mml:msub><mml:mover accent=\"true\"><mml:mi>A</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub><mml:msub><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq164\"><alternatives><tex-math id=\"M403\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{A}_{j},$$\\end{document}</tex-math><mml:math id=\"M404\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>A</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq165\"><alternatives><tex-math id=\"M405\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$j=1,2,3,4$$\\end{document}</tex-math><mml:math id=\"M406\"><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mn>3</mml:mn><mml:mo>,</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq166\"><alternatives><tex-math id=\"M407\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma $$\\end{document}</tex-math><mml:math id=\"M408\"><mml:mi mathvariant=\"normal\">Γ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq167\"><alternatives><tex-math id=\"M409\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{A}_{1},\\tilde{A}_{2},\\tilde{A}_{3}$$\\end{document}</tex-math><mml:math id=\"M410\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>A</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>A</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>A</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq168\"><alternatives><tex-math id=\"M411\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{A}_{4}.$$\\end{document}</tex-math><mml:math id=\"M412\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>A</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq169\"><alternatives><tex-math id=\"M413\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma $$\\end{document}</tex-math><mml:math id=\"M414\"><mml:mi mathvariant=\"normal\">Γ</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ29\"><label>29</label><alternatives><tex-math id=\"M415\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} z(\\tilde{t})=c_1 e^{-i\\tilde{\\omega }_3\\tilde{t}}+c_2 e^{i\\tilde{\\omega }_4\\tilde{t}}, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M416\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>z</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>i</mml:mi><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq170\"><alternatives><tex-math id=\"M417\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{\\omega }_4/\\tilde{\\omega }_3$$\\end{document}</tex-math><mml:math id=\"M418\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>4</mml:mn></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:msub><mml:mover accent=\"true\"><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq171\"><alternatives><tex-math id=\"M419\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma $$\\end{document}</tex-math><mml:math id=\"M420\"><mml:mi mathvariant=\"normal\">Γ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq172\"><alternatives><tex-math id=\"M421\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c_1$$\\end{document}</tex-math><mml:math id=\"M422\"><mml:msub><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq173\"><alternatives><tex-math id=\"M423\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c_2$$\\end{document}</tex-math><mml:math id=\"M424\"><mml:msub><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq174\"><alternatives><tex-math id=\"M425\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c_1=0.9119$$\\end{document}</tex-math><mml:math id=\"M426\"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.9119</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq175\"><alternatives><tex-math id=\"M427\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c_2=0.0365$$\\end{document}</tex-math><mml:math id=\"M428\"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.0365</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq176\"><alternatives><tex-math id=\"M429\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c_1=0.8751$$\\end{document}</tex-math><mml:math id=\"M430\"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.8751</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq177\"><alternatives><tex-math id=\"M431\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c_2=0.0547$$\\end{document}</tex-math><mml:math id=\"M432\"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.0547</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq178\"><alternatives><tex-math id=\"M433\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma $$\\end{document}</tex-math><mml:math id=\"M434\"><mml:mi mathvariant=\"normal\">Γ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq179\"><alternatives><tex-math id=\"M435\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$c_2/c_1$$\\end{document}</tex-math><mml:math id=\"M436\"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq180\"><alternatives><tex-math id=\"M437\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma =0.5$$\\end{document}</tex-math><mml:math id=\"M438\"><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq181\"><alternatives><tex-math id=\"M439\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{U}_0 = 1$$\\end{document}</tex-math><mml:math id=\"M440\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq182\"><alternatives><tex-math id=\"M441\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{V}_0 = -1$$\\end{document}</tex-math><mml:math id=\"M442\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq183\"><alternatives><tex-math id=\"M443\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{U}}_0 = 2$$\\end{document}</tex-math><mml:math id=\"M444\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq184\"><alternatives><tex-math id=\"M445\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{V}}_0 = -5$$\\end{document}</tex-math><mml:math id=\"M446\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq185\"><alternatives><tex-math id=\"M447\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M448\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq186\"><alternatives><tex-math id=\"M449\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$M=-7.25$$\\end{document}</tex-math><mml:math id=\"M450\"><mml:mrow><mml:mi>M</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>7.25</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq187\"><alternatives><tex-math id=\"M451\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$N=0.5$$\\end{document}</tex-math><mml:math id=\"M452\"><mml:mrow><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq188\"><alternatives><tex-math id=\"M453\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(0)=-3$$\\end{document}</tex-math><mml:math id=\"M454\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq189\"><alternatives><tex-math id=\"M455\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma $$\\end{document}</tex-math><mml:math id=\"M456\"><mml:mi mathvariant=\"normal\">Γ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq190\"><alternatives><tex-math id=\"M457\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M458\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq191\"><alternatives><tex-math id=\"M459\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma =2.8$$\\end{document}</tex-math><mml:math id=\"M460\"><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>=</mml:mo><mml:mn>2.8</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq192\"><alternatives><tex-math id=\"M461\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{U}_0 =2$$\\end{document}</tex-math><mml:math id=\"M462\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq193\"><alternatives><tex-math id=\"M463\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{V}_0 = 3$$\\end{document}</tex-math><mml:math id=\"M464\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq194\"><alternatives><tex-math id=\"M465\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{U}}_0 =1$$\\end{document}</tex-math><mml:math id=\"M466\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq195\"><alternatives><tex-math id=\"M467\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{V}}_0 = -2$$\\end{document}</tex-math><mml:math id=\"M468\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq196\"><alternatives><tex-math id=\"M469\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(0)=-\\Gamma |\\dot{\\tilde{{\\textbf {Q}}}}(0)|^2/2=-7$$\\end{document}</tex-math><mml:math id=\"M470\"><mml:mrow><mml:mrow><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq197\"><alternatives><tex-math id=\"M471\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})\\le 0.$$\\end{document}</tex-math><mml:math id=\"M472\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>≤</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq198\"><alternatives><tex-math id=\"M473\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M474\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq199\"><alternatives><tex-math id=\"M475\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma =-0.4$$\\end{document}</tex-math><mml:math id=\"M476\"><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>0.4</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq200\"><alternatives><tex-math id=\"M477\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{U}_0 =2$$\\end{document}</tex-math><mml:math id=\"M478\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq201\"><alternatives><tex-math id=\"M479\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{V}_0 = 3$$\\end{document}</tex-math><mml:math id=\"M480\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq202\"><alternatives><tex-math id=\"M481\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{U}}_0 =1$$\\end{document}</tex-math><mml:math id=\"M482\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq203\"><alternatives><tex-math id=\"M483\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{V}}_0 = 2$$\\end{document}</tex-math><mml:math id=\"M484\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq204\"><alternatives><tex-math id=\"M485\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(0)=-\\Gamma |\\dot{\\tilde{{\\textbf {Q}}}}(0)|^2/2=1$$\\end{document}</tex-math><mml:math id=\"M486\"><mml:mrow><mml:mrow><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq205\"><alternatives><tex-math id=\"M487\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})\\ge 0$$\\end{document}</tex-math><mml:math id=\"M488\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>≥</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq206\"><alternatives><tex-math id=\"M489\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z=L$$\\end{document}</tex-math><mml:math id=\"M490\"><mml:mrow><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq207\"><alternatives><tex-math id=\"M491\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M492\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ30\"><label>30</label><alternatives><tex-math id=\"M493\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} H(\\tilde{t}){\\textbf {k}}= (\\tilde{U}(\\tilde{t})\\dot{\\tilde{V}}(\\tilde{t})-\\tilde{V}(\\tilde{t})\\dot{\\tilde{U}}(\\tilde{t})) {\\textbf {k}}= \\tilde{{\\textbf {Q}}}(\\tilde{t})\\times \\dot{\\tilde{{\\textbf {Q}}}}(\\tilde{t}), \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M494\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi mathvariant=\"bold\">k</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi mathvariant=\"bold\">k</mml:mi><mml:mo>=</mml:mo><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq208\"><alternatives><tex-math id=\"M495\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\textbf {k}}$$\\end{document}</tex-math><mml:math id=\"M496\"><mml:mi mathvariant=\"bold\">k</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq209\"><alternatives><tex-math id=\"M497\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{{\\textbf {Q}}}(\\tilde{t})=(\\tilde{U}(\\tilde{t}),\\tilde{V}(\\tilde{t})).$$\\end{document}</tex-math><mml:math id=\"M498\"><mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq210\"><alternatives><tex-math id=\"M499\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M500\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq211\"><alternatives><tex-math id=\"M501\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M502\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq212\"><alternatives><tex-math id=\"M503\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M504\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ31\"><label>31</label><alternatives><tex-math id=\"M505\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} H(\\tilde{t})=a+b \\cos (\\Xi \\tilde{t} -\\chi ), \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M506\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:mi>b</mml:mi><mml:mo>cos</mml:mo><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi mathvariant=\"normal\">Ξ</mml:mi><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>-</mml:mo><mml:mi>χ</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ32\"><label>32</label><alternatives><tex-math id=\"M507\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\begin{gathered} a=\\frac{[|\\dot{\\tilde{{\\textbf {Q}}}}(0)|^2-|\\tilde{{\\textbf {Q}}}(0)|^2]\\Gamma +4H(0)}{\\Xi ^2}, ~~~~b=\\frac{\\sqrt{P^2+R^2}}{\\Xi ^2}, \\\\ \\Xi =\\sqrt{\\Gamma ^2+4}, ~~~~P=\\Gamma (\\Xi \\tilde{{\\textbf {Q}}}(0) \\cdot \\dot{\\tilde{{\\textbf {Q}}}}(0)),~~~~~R=\\Gamma (H(0)\\Gamma +|\\tilde{{\\textbf {Q}}}(0)|^2-|\\dot{\\tilde{{\\textbf {Q}}}}(0)|^2), \\\\ \\chi =\\tan ^{-1}\\Bigg ({ \\frac{P}{R}\\Bigg ) ~ \\text{ for }~ ~~R &gt; 0, ~~~\\chi =\\pi +\\tan ^{-1}\\Bigg (\\frac{P}{R}\\Bigg ) ~ \\text{ for } ~~ R &lt; 0, ~~\\chi = {\\text {sgn}}(P) \\frac{\\pi }{2} ~\\text{ for } ~ R=0.} \\end{gathered} \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M508\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>a</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mo stretchy=\"false\">|</mml:mo><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msup><mml:mo stretchy=\"false\">|</mml:mo><mml:mn>2</mml:mn></mml:msup><mml:mo>-</mml:mo><mml:mo stretchy=\"false\">|</mml:mo><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msup><mml:mo stretchy=\"false\">|</mml:mo><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">]</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>+</mml:mo><mml:mn>4</mml:mn><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:msup><mml:mi mathvariant=\"normal\">Ξ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mfrac><mml:mo>,</mml:mo><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mi>b</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:msqrt><mml:mrow><mml:msup><mml:mi>P</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mi>R</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt><mml:msup><mml:mi mathvariant=\"normal\">Ξ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mi mathvariant=\"normal\">Ξ</mml:mi><mml:mo>=</mml:mo><mml:msqrt><mml:mrow><mml:msup><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msqrt><mml:mo>,</mml:mo><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi mathvariant=\"normal\">Ξ</mml:mi><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>·</mml:mo><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>+</mml:mo><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mrow><mml:mo>-</mml:mo><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:msup><mml:mo stretchy=\"false\">|</mml:mo><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mi>χ</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mo>tan</mml:mo><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mrow><mml:mo maxsize=\"2.470em\" minsize=\"2.470em\" stretchy=\"true\">(</mml:mo></mml:mrow><mml:mrow><mml:mfrac><mml:mi>P</mml:mi><mml:mi>R</mml:mi></mml:mfrac><mml:mrow><mml:mo maxsize=\"2.470em\" minsize=\"2.470em\" stretchy=\"true\">)</mml:mo></mml:mrow><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"0.333333em\"/><mml:mtext>for</mml:mtext><mml:mspace width=\"0.333333em\"/><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mi>R</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mi>χ</mml:mi><mml:mo>=</mml:mo><mml:mi>π</mml:mi><mml:mo>+</mml:mo><mml:msup><mml:mo>tan</mml:mo><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mrow><mml:mo maxsize=\"2.470em\" minsize=\"2.470em\" stretchy=\"true\">(</mml:mo></mml:mrow><mml:mfrac><mml:mi>P</mml:mi><mml:mi>R</mml:mi></mml:mfrac><mml:mrow><mml:mo maxsize=\"2.470em\" minsize=\"2.470em\" stretchy=\"true\">)</mml:mo></mml:mrow><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"0.333333em\"/><mml:mtext>for</mml:mtext><mml:mspace width=\"0.333333em\"/><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mi>R</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mi>χ</mml:mi><mml:mo>=</mml:mo><mml:mtext>sgn</mml:mtext><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>P</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mfrac><mml:mi>π</mml:mi><mml:mn>2</mml:mn></mml:mfrac><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"0.333333em\"/><mml:mtext>for</mml:mtext><mml:mspace width=\"0.333333em\"/><mml:mspace width=\"3.33333pt\"/><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq213\"><alternatives><tex-math id=\"M509\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M510\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq214\"><alternatives><tex-math id=\"M511\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma =0$$\\end{document}</tex-math><mml:math id=\"M512\"><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq215\"><alternatives><tex-math id=\"M513\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M514\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq216\"><alternatives><tex-math id=\"M515\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t}){\\textbf {k}}=H(0){\\textbf {k}}=\\tilde{{\\textbf {Q}}}(0)\\times \\dot{\\tilde{{\\textbf {Q}}}}(0)$$\\end{document}</tex-math><mml:math id=\"M516\"><mml:mrow><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi mathvariant=\"bold\">k</mml:mi><mml:mo>=</mml:mo><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mi mathvariant=\"bold\">k</mml:mi><mml:mo>=</mml:mo><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq217\"><alternatives><tex-math id=\"M517\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z=L$$\\end{document}</tex-math><mml:math id=\"M518\"><mml:mrow><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq218\"><alternatives><tex-math id=\"M519\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M520\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq219\"><alternatives><tex-math id=\"M521\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma $$\\end{document}</tex-math><mml:math id=\"M522\"><mml:mi mathvariant=\"normal\">Γ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq220\"><alternatives><tex-math id=\"M523\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P=R=0$$\\end{document}</tex-math><mml:math id=\"M524\"><mml:mrow><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq221\"><alternatives><tex-math id=\"M525\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{t}$$\\end{document}</tex-math><mml:math id=\"M526\"><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq222\"><alternatives><tex-math id=\"M527\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H=a$$\\end{document}</tex-math><mml:math id=\"M528\"><mml:mrow><mml:mi>H</mml:mi><mml:mo>=</mml:mo><mml:mi>a</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq223\"><alternatives><tex-math id=\"M529\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma \\ne 0$$\\end{document}</tex-math><mml:math id=\"M530\"><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>≠</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq224\"><alternatives><tex-math id=\"M531\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{t}.$$\\end{document}</tex-math><mml:math id=\"M532\"><mml:mrow><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq225\"><alternatives><tex-math id=\"M533\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$P=0$$\\end{document}</tex-math><mml:math id=\"M534\"><mml:mrow><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq226\"><alternatives><tex-math id=\"M535\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{{\\textbf {Q}}}(0)$$\\end{document}</tex-math><mml:math id=\"M536\"><mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq227\"><alternatives><tex-math id=\"M537\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{{\\textbf {Q}}}}(0)$$\\end{document}</tex-math><mml:math id=\"M538\"><mml:mrow><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq228\"><alternatives><tex-math id=\"M539\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$|H(0)| = |\\tilde{{\\textbf {Q}}}(0)| |\\dot{\\tilde{{\\textbf {Q}}}}(0)|$$\\end{document}</tex-math><mml:math id=\"M540\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq229\"><alternatives><tex-math id=\"M541\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R=0$$\\end{document}</tex-math><mml:math id=\"M542\"><mml:mrow><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq230\"><alternatives><tex-math id=\"M543\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$|\\tilde{{\\textbf {Q}}}(0)| |\\dot{\\tilde{{\\textbf {Q}}}}(0)| \\Gamma {\\text {sgn}}(H(0)) +|\\tilde{{\\textbf {Q}}}(0)|^2 - |\\dot{\\tilde{{\\textbf {Q}}}}(0)|^2 = 0$$\\end{document}</tex-math><mml:math id=\"M544\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mtext>sgn</mml:mtext><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq231\"><alternatives><tex-math id=\"M545\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$|\\tilde{{\\textbf {Q}}}(0)| /|\\dot{\\tilde{{\\textbf {Q}}}}(0)|=\\frac{1}{2} (\\omega - \\Gamma {\\text {sgn}}(H(0))).$$\\end{document}</tex-math><mml:math id=\"M546\"><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mo stretchy=\"false\">/</mml:mo><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mo>=</mml:mo></mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:mfrac><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ω</mml:mi><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mtext>sgn</mml:mtext><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq232\"><alternatives><tex-math id=\"M547\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text {sgn}}(H(0))$$\\end{document}</tex-math><mml:math id=\"M548\"><mml:mrow><mml:mtext>sgn</mml:mtext><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq233\"><alternatives><tex-math id=\"M549\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M550\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq234\"><alternatives><tex-math id=\"M551\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma , \\tilde{{\\textbf {Q}}}(0)$$\\end{document}</tex-math><mml:math id=\"M552\"><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>,</mml:mo><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq235\"><alternatives><tex-math id=\"M553\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{{\\textbf {Q}}}}(0).$$\\end{document}</tex-math><mml:math id=\"M554\"><mml:mrow><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ33\"><label>33</label><alternatives><tex-math id=\"M555\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} a^2-b^2 = -\\frac{\\Big (\\Gamma |\\tilde{{\\textbf {Q}}}(0)|^2-2H(0)\\Big )\\Big (\\Gamma |\\dot{\\tilde{{\\textbf {Q}}}}(0)|^2+2H(0)\\Big )}{\\Gamma ^2+4}. \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M556\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msup><mml:mi>a</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>-</mml:mo><mml:msup><mml:mi>b</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">(</mml:mo></mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">)</mml:mo></mml:mrow><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">(</mml:mo></mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:msup><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mo maxsize=\"1.623em\" minsize=\"1.623em\" stretchy=\"true\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msup><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq236\"><alternatives><tex-math id=\"M557\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Upsilon =(M,N)$$\\end{document}</tex-math><mml:math id=\"M558\"><mml:mrow><mml:mi mathvariant=\"normal\">Υ</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>M</mml:mi><mml:mo>,</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ34\"><label>34</label><alternatives><tex-math id=\"M559\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} M = -\\Gamma |\\dot{\\tilde{{\\textbf {Q}}}}(0)|^2/2, ~~N= \\Gamma |\\tilde{{\\textbf {Q}}}(0)|^2/2,&amp;~~ \\Gamma &gt;0, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M560\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow><mml:mi>M</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:msup><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ35\"><label>35</label><alternatives><tex-math id=\"M561\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} M= \\Gamma |\\tilde{{\\textbf {Q}}}(0)|^2/2, ~~N= -\\Gamma |\\dot{\\tilde{{\\textbf {Q}}}}(0)|^2/2,&amp;~~\\Gamma &lt; 0. \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M562\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow><mml:mi>M</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:msup><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign=\"left\"><mml:mrow><mml:mspace width=\"3.33333pt\"/><mml:mspace width=\"3.33333pt\"/><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq237\"><alternatives><tex-math id=\"M563\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M564\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq238\"><alternatives><tex-math id=\"M565\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma =-1.077$$\\end{document}</tex-math><mml:math id=\"M566\"><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>1.077</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq239\"><alternatives><tex-math id=\"M567\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{U}_0 =2$$\\end{document}</tex-math><mml:math id=\"M568\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq240\"><alternatives><tex-math id=\"M569\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{V}_0 = 3$$\\end{document}</tex-math><mml:math id=\"M570\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq241\"><alternatives><tex-math id=\"M571\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{U}}_0 =1$$\\end{document}</tex-math><mml:math id=\"M572\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq242\"><alternatives><tex-math id=\"M573\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{V}}_0 = -2$$\\end{document}</tex-math><mml:math id=\"M574\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq243\"><alternatives><tex-math id=\"M575\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(0)=\\Gamma |\\tilde{{\\textbf {Q}}}(0)|^2/2=-7$$\\end{document}</tex-math><mml:math id=\"M576\"><mml:mrow><mml:mrow><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq244\"><alternatives><tex-math id=\"M577\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t}) \\le 0$$\\end{document}</tex-math><mml:math id=\"M578\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>≤</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq245\"><alternatives><tex-math id=\"M579\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M580\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq246\"><alternatives><tex-math id=\"M581\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(0) \\in \\Upsilon $$\\end{document}</tex-math><mml:math id=\"M582\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>∈</mml:mo><mml:mi mathvariant=\"normal\">Υ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq247\"><alternatives><tex-math id=\"M583\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(0) \\in \\partial \\Upsilon $$\\end{document}</tex-math><mml:math id=\"M584\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>∈</mml:mo><mml:mi>∂</mml:mi><mml:mi mathvariant=\"normal\">Υ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq248\"><alternatives><tex-math id=\"M585\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(0) \\notin \\overline{\\Upsilon }$$\\end{document}</tex-math><mml:math id=\"M586\"><mml:mrow><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>∉</mml:mo><mml:mover><mml:mi mathvariant=\"normal\">Υ</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq249\"><alternatives><tex-math id=\"M587\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma $$\\end{document}</tex-math><mml:math id=\"M588\"><mml:mi mathvariant=\"normal\">Γ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq250\"><alternatives><tex-math id=\"M589\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{U}_0$$\\end{document}</tex-math><mml:math id=\"M590\"><mml:msub><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq251\"><alternatives><tex-math id=\"M591\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{V}_0 $$\\end{document}</tex-math><mml:math id=\"M592\"><mml:msub><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq252\"><alternatives><tex-math id=\"M593\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{U}}_0$$\\end{document}</tex-math><mml:math id=\"M594\"><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq253\"><alternatives><tex-math id=\"M595\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{V}}_0$$\\end{document}</tex-math><mml:math id=\"M596\"><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ36\"><label>36</label><alternatives><tex-math id=\"M597\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} M&lt;H(0)&lt;N . \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M598\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mi>M</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>&lt;</mml:mo><mml:mi>N</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq254\"><alternatives><tex-math id=\"M599\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M600\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq255\"><alternatives><tex-math id=\"M601\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M602\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq256\"><alternatives><tex-math id=\"M603\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M604\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ37\"><label>37</label><alternatives><tex-math id=\"M605\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} H(0)=-\\Gamma |\\dot{\\tilde{{\\textbf {Q}}}}(0)|^2/2. \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M606\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq257\"><alternatives><tex-math id=\"M607\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M608\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq258\"><alternatives><tex-math id=\"M609\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M610\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq259\"><alternatives><tex-math id=\"M611\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M612\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ38\"><label>38</label><alternatives><tex-math id=\"M613\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} H(0)=\\Gamma |\\tilde{{\\textbf {Q}}}(0)|^2/2. \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M614\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow><mml:mi>H</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq260\"><alternatives><tex-math id=\"M615\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M616\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq261\"><alternatives><tex-math id=\"M617\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M618\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq262\"><alternatives><tex-math id=\"M619\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t}) \\ne 0)$$\\end{document}</tex-math><mml:math id=\"M620\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>≠</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq263\"><alternatives><tex-math id=\"M621\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(0)&lt;M$$\\end{document}</tex-math><mml:math id=\"M622\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>&lt;</mml:mo><mml:mi>M</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq264\"><alternatives><tex-math id=\"M623\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(0)&gt;N$$\\end{document}</tex-math><mml:math id=\"M624\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>&gt;</mml:mo><mml:mi>N</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq265\"><alternatives><tex-math id=\"M625\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M626\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq266\"><alternatives><tex-math id=\"M627\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma =1$$\\end{document}</tex-math><mml:math id=\"M628\"><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq267\"><alternatives><tex-math id=\"M629\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{U}_0 =2$$\\end{document}</tex-math><mml:math id=\"M630\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq268\"><alternatives><tex-math id=\"M631\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{V}_0 = 3$$\\end{document}</tex-math><mml:math id=\"M632\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq269\"><alternatives><tex-math id=\"M633\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{U}}_0 =-1$$\\end{document}</tex-math><mml:math id=\"M634\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq270\"><alternatives><tex-math id=\"M635\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{V}}_0 = 2$$\\end{document}</tex-math><mml:math id=\"M636\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq271\"><alternatives><tex-math id=\"M637\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(0)=7$$\\end{document}</tex-math><mml:math id=\"M638\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>=</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq272\"><alternatives><tex-math id=\"M639\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$- \\Gamma |\\dot{\\tilde{{\\textbf {Q}}}}(0)|^2/2=-2.5$$\\end{document}</tex-math><mml:math id=\"M640\"><mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>2.5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq273\"><alternatives><tex-math id=\"M641\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma |{\\tilde{{\\textbf {Q}}}}(0)|^2/2=6.5.$$\\end{document}</tex-math><mml:math id=\"M642\"><mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:mo>=</mml:mo><mml:mn>6.5</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq274\"><alternatives><tex-math id=\"M643\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(\\tilde{t})$$\\end{document}</tex-math><mml:math id=\"M644\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq275\"><alternatives><tex-math id=\"M645\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma =1$$\\end{document}</tex-math><mml:math id=\"M646\"><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq276\"><alternatives><tex-math id=\"M647\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{U}_0 =2$$\\end{document}</tex-math><mml:math id=\"M648\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq277\"><alternatives><tex-math id=\"M649\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tilde{V}_0 = 3$$\\end{document}</tex-math><mml:math id=\"M650\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq278\"><alternatives><tex-math id=\"M651\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{U}}_0 =1$$\\end{document}</tex-math><mml:math id=\"M652\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq279\"><alternatives><tex-math id=\"M653\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\dot{\\tilde{V}}_0 = -2$$\\end{document}</tex-math><mml:math id=\"M654\"><mml:mrow><mml:msub><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq280\"><alternatives><tex-math id=\"M655\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$H(0)=-7$$\\end{document}</tex-math><mml:math id=\"M656\"><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq281\"><alternatives><tex-math id=\"M657\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$- \\Gamma |\\dot{\\tilde{{\\textbf {Q}}}}(0)|^2/2=-2.5$$\\end{document}</tex-math><mml:math id=\"M658\"><mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:mo>˙</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>2.5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq282\"><alternatives><tex-math id=\"M659\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma |{\\tilde{{\\textbf {Q}}}}(0)|^2/2=6.5.$$\\end{document}</tex-math><mml:math id=\"M660\"><mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"bold\">Q</mml:mi><mml:mo stretchy=\"false\">~</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn><mml:mo>=</mml:mo><mml:mn>6.5</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq06.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ1.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq9.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq10.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Fig1_HTML\" id=\"MO1\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq03.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ2.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq02.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq11.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq12.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq04.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq05.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq13.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq14.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq15.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq16.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq17.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq18.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq19.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq20.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq21.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq22.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq23.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq24.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq25.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq26.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq27.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Fig2_HTML\" id=\"MO2\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq28.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq29.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq30.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq31.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq32.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq33.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ3.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq34.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ4.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq35.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq36.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq37.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq38.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ5.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ6.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ39.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ7.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq39.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ8.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ40.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq40.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq41.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq42.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq43.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Fig3_HTML\" id=\"MO3\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq44.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ9.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq45.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq46.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq47.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq48.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq49.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq50.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq51.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq52.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq53.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq54.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq55.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq56.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq57.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq58.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq59.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq60.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq61.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq62.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq63.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq64.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq65.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq66.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Fig4_HTML\" id=\"MO4\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq67.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq68.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq69.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq70.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq71.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq72.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq73.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq74.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq75.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq76.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq77.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq78.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ10.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq79.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq80.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ11.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq81.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ12.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq82.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq83.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq84.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ13.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ14.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq85.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ15.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq86.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq87.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ16.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq88.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq89.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq90.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq91.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq92.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq93.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq94.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq95.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ17.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ18.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq96.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq97.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq98.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq99.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq100.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ19.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq101.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq102.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq103.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq104.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq105.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq106.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Fig5_HTML\" id=\"MO5\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq107.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq108.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ20.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq109.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq110.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq111.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq112.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq113.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq114.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq115.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq01.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ21.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq116.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq117.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq118.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq119.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq120.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ22.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq121.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq122.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq123.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq124.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq125.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq126.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq127.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq128.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq129.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq130.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq131.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq132.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ23.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq133.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq134.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ24.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq135.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq136.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq137.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq138.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq139.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ25.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq140.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq141.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq142.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq143.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq144.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq145.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq146.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq147.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq148.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq149.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq150.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq151.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq152.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq153.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq154.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq155.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq156.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq157.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq158.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq159.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq160.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq1600.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq161.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq1610.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Fig6_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ26.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq162.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq163.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ27.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ28.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq164.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq165.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq166.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq167.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq168.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq169.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ29.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq170.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq171.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq172.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq173.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq174.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq175.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq176.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq177.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq178.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq179.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq180.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq181.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq182.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq183.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq184.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq185.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq186.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq187.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq188.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Fig7_HTML\" id=\"MO7\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq189.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq190.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq191.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq192.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq193.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq194.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq195.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq196.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq197.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq198.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq199.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq200.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq201.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq202.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq203.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq204.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq205.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Fig8_HTML\" id=\"MO8\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq206.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq207.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ30.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq208.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq209.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq210.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq211.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq212.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ31.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ32.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq213.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq214.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq215.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq216.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq217.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq218.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq219.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq220.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq221.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq222.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq223.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq224.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq225.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq226.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq227.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq228.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq229.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq230.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq231.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq232.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq233.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq234.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq235.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ33.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq236.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ34.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ35.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq237.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq238.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq239.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq240.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq241.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq242.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq243.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq244.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Fig9_HTML\" id=\"MO9\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq245.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq246.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq247.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq248.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq249.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq250.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq251.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq252.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq253.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ36.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq254.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq255.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq256.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ37.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq257.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq258.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq259.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Article_Equ38.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq260.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq261.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq262.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq263.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq264.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq265.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq266.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq267.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq268.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq269.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq270.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq271.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq272.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq273.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq274.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq275.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq276.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq277.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq278.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq279.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq280.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq281.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50052_Article_IEq282.gif\"/>", "<graphic xlink:href=\"41598_2023_50052_Fig10_HTML\" id=\"MO10\"/>" ]
[ "<media xlink:href=\"41598_2023_50052_MOESM1_ESM.mp4\"><caption><p>Supplementary Information 1.</p></caption></media>", "<media xlink:href=\"41598_2023_50052_MOESM2_ESM.mp4\"><caption><p>Supplementary Information 2.</p></caption></media>", "<media xlink:href=\"41598_2023_50052_MOESM3_ESM.mp4\"><caption><p>Supplementary Information 3.</p></caption></media>", "<media xlink:href=\"41598_2023_50052_MOESM4_ESM.docx\"><caption><p>Supplementary Information 4.</p></caption></media>" ]
[{"label": ["1."], "surname": ["Capozziello", "Lattanzi"], "given-names": ["S", "A"], "article-title": ["Spiral galaxies as chiral objects?"], "source": ["Astrophys. Space Sci."], "year": ["2006"], "volume": ["301"], "fpage": ["189"], "lpage": ["193"], "pub-id": ["10.1007/s10509-006-1984-6"]}, {"label": ["2."], "surname": ["Lorentz"], "given-names": ["HA"], "source": ["Versuch einer Theorie der Electrischen und Optischen Erscheinungen in Bewegten K\u00f6rpern"], "year": ["1895"], "publisher-name": ["BG Teubner"]}, {"label": ["3."], "surname": ["Foucault"], "given-names": ["JBL"], "article-title": ["D\u00e9monstration physique du mouvement de rotation de la terre au moyen du pendule"], "source": ["C. R. S\u00e9ances L\u2019Acad. Sci."], "year": ["1851"], "volume": ["32"], "fpage": ["135"], "lpage": ["138"]}, {"label": ["4."], "surname": ["Shepherd"], "given-names": ["TG"], "article-title": ["Rossby waves and two-dimensional turbulence in a large-scale zonal jet"], "source": ["J. Fluid Mech."], "year": ["1987"], "volume": ["183"], "fpage": ["467"], "lpage": ["509"], "pub-id": ["10.1017/S0022112087002738"]}, {"label": ["6."], "surname": ["Tabataba-Vakili", "Rogers", "Eichst\u00e4dt", "Orton", "Hansen", "Momary", "Sinclair", "Giles", "Caplinger", "Ravine", "Bolton"], "given-names": ["F", "JH", "G", "GS", "CJ", "TW", "JA", "RS", "MA", "MA", "SJ"], "article-title": ["Long-term tracking of circumpolar cyclones on Jupiter from polar observations with JunoCam"], "source": ["ICARUS"], "year": ["2020"], "volume": ["335"], "fpage": ["113405"], "pub-id": ["10.1016/j.icarus.2019.113405"]}, {"label": ["7."], "surname": ["Kelvin"], "given-names": ["Lord"], "source": ["The Molecular Tactics of a Crystal"], "year": ["1894"], "publisher-name": ["Clarendon Press"]}, {"label": ["8."], "surname": ["Webster"], "given-names": ["AG"], "source": ["The Dynamics of Particles and of Rigid, Elastic, and Fluid Bodies"], "year": ["1904"], "publisher-name": ["B. G. Teubner"]}, {"label": ["9."], "surname": ["Gray"], "given-names": ["A"], "source": ["A Treatise on Gyrostatics and Rotational Motion: Theory and Applications"], "year": ["1918"], "publisher-name": ["Macmillan and Co. Ltd"]}, {"label": ["10."], "surname": ["Kirillov"], "given-names": ["O"], "source": ["Nonconservative Stability Problems of Modern Physics"], "year": ["2021"], "publisher-name": ["Walter de Gruyter GmbH & Co KG"]}, {"label": ["12."], "surname": ["Carta", "Nieves", "Jones", "Movchan", "Movchan"], "given-names": ["G", "MJ", "IS", "NV", "AB"], "article-title": ["Elastic chiral waveguides with gyro-hinges"], "source": ["Q. J. Mech. Appl. Math."], "year": ["2018"], "volume": ["71"], "fpage": ["157"], "lpage": ["185"], "pub-id": ["10.1093/qjmam/hby001"]}, {"label": ["13."], "surname": ["Carta", "Nieves", "Jones", "Movchan", "Movchan"], "given-names": ["G", "MJ", "IS", "NV", "AB"], "article-title": ["Flexural vibration systems with gyroscopic spinners"], "source": ["Philos. Trans. R. Soc. A"], "year": ["2019"], "volume": ["377"], "fpage": ["20190154"], "pub-id": ["10.1098/rsta.2019.0154"]}, {"label": ["14."], "surname": ["Carta", "Jones", "Movchan", "Movchan"], "given-names": ["G", "IS", "NV", "AB"], "article-title": ["Wave polarization and dynamic degeneracy in a chiral elastic lattice"], "source": ["Proc. R. Soc. Lond. A"], "year": ["2019"], "volume": ["475"], "fpage": ["20190313"]}, {"label": ["15."], "surname": ["Carta", "Nieves"], "given-names": ["G", "MJ"], "article-title": ["Analytical treatment of the transient motion of inertial beams attached to coupling inertial resonators"], "source": ["J. Eng. Math."], "year": ["2021"], "volume": ["127"], "fpage": ["20"], "pub-id": ["10.1007/s10665-021-10110-w"]}, {"label": ["16."], "surname": ["Nieves", "Carta", "Jones", "Movchan", "Movchan"], "given-names": ["MJ", "G", "IS", "AB", "NV"], "article-title": ["Vibrations and elastic waves in chiral multi-structures"], "source": ["J. Mech. Phys. Solids"], "year": ["2018"], "volume": ["121"], "fpage": ["387"], "lpage": ["408"], "pub-id": ["10.1016/j.jmps.2018.07.020"]}, {"label": ["17."], "surname": ["Kandiah", "Jones", "Movchan", "Movchan", "Altenbach", "Bruno", "Eremeyev", "Gutkin", "M\u00fcller"], "given-names": ["A", "IS", "NV", "AB", "H", "G", "VA", "MY", "WH"], "article-title": ["Effect of gravity on the dispersion and wave localisation in gyroscopic elastic systems"], "source": ["Mechanics of Heterogeneous Materials"], "year": ["2023"], "publisher-name": ["Springer"], "fpage": ["219"], "lpage": ["274"]}, {"label": ["18."], "surname": ["Brun", "Jones", "Movchan"], "given-names": ["M", "IS", "AB"], "article-title": ["Vortex-type elastic structured media and dynamic shielding"], "source": ["Proc. R. Soc. Lond. A."], "year": ["2012"], "volume": ["468"], "fpage": ["3027"], "lpage": ["3046"]}, {"label": ["19."], "surname": ["Cannon", "Dostrovsky"], "given-names": ["J", "S"], "source": ["The Evolution of Dynamics: Vibration Theory from 1687 to 1742"], "year": ["2012"], "publisher-name": ["Springer"]}, {"label": ["20."], "surname": ["Jones", "Movchan", "Movchan"], "given-names": ["IS", "NV", "AB"], "article-title": ["Two-dimensional waves in a chiral elastic chain: Dynamic Green\u2019s matrices and localised defect modes"], "source": ["Q. J. Mech. Appl. Math."], "year": ["2020"], "volume": ["73"], "fpage": ["305"], "lpage": ["328"], "pub-id": ["10.1093/qjmam/hbaa014"]}, {"label": ["21."], "surname": ["Kirillov"], "given-names": ["O"], "article-title": ["Brouwer\u2019s problem on a heavy particle in a rotating vessel: Wave propagation, ion traps, and rotor dynamics"], "source": ["Phys. Lett. A"], "year": ["2011"], "volume": ["375"], "fpage": ["1653"], "lpage": ["1660"], "pub-id": ["10.1016/j.physleta.2011.02.056"]}, {"label": ["22."], "surname": ["Whipple"], "given-names": ["F"], "article-title": ["The motion of a particle on the surface of a smooth rotating globe"], "source": ["Lond. Edinb. Dublin Philos. Mag. J. Sci."], "year": ["1917"], "volume": ["33"], "fpage": ["457"], "lpage": ["471"], "pub-id": ["10.1080/14786440608635660"]}, {"label": ["23."], "surname": ["Bottema"], "given-names": ["O"], "article-title": ["Stability of equilibrium of a heavy particle on a rotating surface"], "source": ["Z. Angew. Math. Phys. ZAMP"], "year": ["1976"], "volume": ["27"], "fpage": ["663"], "lpage": ["669"], "pub-id": ["10.1007/BF01591177"]}, {"label": ["24."], "surname": ["Brouwer"], "given-names": ["LEJ"], "article-title": ["Beweging van een materieel punt op den bodem eener draaiende vaas onder den invloed der zwaartekracht"], "source": ["Nieuw Archief voor Wiskunde 2e reeks"], "year": ["1918"], "volume": ["12"], "fpage": ["407"], "lpage": ["419"]}, {"label": ["25."], "surname": ["Godfrey"], "given-names": ["DA"], "article-title": ["A hexagonal feature around Saturn\u2019s north pole"], "source": ["ICARUS"], "year": ["1988"], "volume": ["76"], "fpage": ["335"], "lpage": ["356"], "pub-id": ["10.1016/0019-1035(88)90075-9"]}, {"label": ["27."], "surname": ["Vatistas"], "given-names": ["GH"], "article-title": ["A note on liquid vortex sloshing and Kelvin\u2019s equilibria"], "source": ["J. Fluid Mech."], "year": ["1990"], "volume": ["217"], "fpage": ["241"], "lpage": ["248"], "pub-id": ["10.1017/S0022112090000702"]}]
{ "acronym": [], "definition": [] }
28
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1203
oa_package/bc/c4/PMC10786887.tar.gz
PMC10786888
38216630
[ "<title>Introduction</title>", "<p id=\"Par2\">Metaplastic breast cancer (MpBC) is a rare histologic subtype of breast cancers, which accounts for 0.2–1% of invasive breast carcinoma<sup>##REF##32047541##1##–##REF##31675684##3##</sup>. It has a more aggressive clinical course and poorer survival outcomes compared with invasive ductal carcinoma (IDC)<sup>##REF##17066230##4##,##REF##16469754##5##</sup>. Two recent studies of the National Cancer Database (NCDB) reported that MpBC was the histologic subtype associated with the worst overall survival<sup>##REF##32047541##1##,##REF##29855830##2##</sup>.</p>", "<p id=\"Par3\">Due to its rarity and heterogeneity, there are currently no standard treatment strategies for MpBC<sup>##REF##25012264##6##–##REF##25691085##8##</sup>. Many researches demonstrated poor response to chemotherapy in MpBC, especially low pCR rate in neoadjuvant chemotherapy (NAC). In their opinion, a radical surgery is of first priority for MpBC and the significance of chemotherapy (CT) is under doubt. However, as MpBC generally presents with higher histologic grade, tumor stage, Ki-67 index, and with triple negative (TN) phenotype, chemotherapy, both neoadjuvant and adjuvant, is still considered essential. As a result, there is still much controversy in the significance of chemotherapy for the improvement of survival outcomes for MpBC. Optimizing systemic therapy options is considered a priority for managing MpBC in clinical practice.</p>", "<p id=\"Par4\">Furthermore, MpBC most commonly shows a TN phenotype (MpBC-TNBC). Contradictory results exist whether this histology of MpBC is correlated with a significantly poorer prognosis compared with classical triple negative IDC (IDC-TNBC). The use of chemotherapy in MpBC is mostly extrapolated from clinical trial results involving typical IDC. Although MpBC is believed to be chemoresistance to some extent, the survival differences between MpBC-TNBC and IDC-TNBC based on chemotherapy response are still unknown.</p>", "<p id=\"Par5\">This study aimed to evaluate the significance of chemotherapy among MpBC, and to compare the survival outcomes between MpBC-TNBC and IDC-TNBC.</p>" ]
[ "<title>Methods</title>", "<title>Patient cohort and stratification</title>", "<p id=\"Par21\">The patient population in this study used data derived from the Surveillance, Epidemiology, and End Results (SEER) database released in 2021. Female unilateral primary MpBC of no special type (MpBC-NST) (coded as 8575) between 2010 and 2017 were enrolled. Besides, some special subtypes of MpBC were also collected, that was, spindle cell carcinoma (coded as 8032), squamous cell carcinoma (8070), low-grade adenosquamous carcinoma (8560), sarcomatoid carcinoma (8033), MpBC with chondroid differentiation (8571), fibromatosis-like MpBC (8572) and myoepithelial carcinoma (8982). Invasive ductal breast cancer with triple negative subtype (IDC-TNBC) which met the inclusion criteria above were also enrolled for comparison with MpBC-TNBC. Patients who had more than one primary cancer, metastasis disease at diagnosis or no surgery performed or no record of surgery, who were diagnosed at death or autopsy alone, missing during follow up or less than 12 months follow-up without death event were excluded. Patients with unknown race, histologic grade, T or N category, ER or PR or HER2 status were also excluded. Histologic grade III was defined as poorly differentiated and anaplastic histologic grades disease. CT status ‘yes’ together with response information to neoadjuvant therapy was defined as neoadjuvant CT (NAC), among which response to NAC stated as ‘complete response’, ‘partial response’ and ‘response to treatment, but not noted if complete or partial’ was defined as ‘NAC-response’, while ‘no response’ was defined as ‘NAC-no response’. CT status ‘yes’ together with ‘systemic therapy after surgery’ was defined as adjuvant CT. CT status ‘no or unknown’ together with no systemic therapy was defined as ‘no CT’. The patient cohort selection process and study consort diagram were shown in Fig. ##FIG##4##5##.</p>", "<p id=\"Par22\">We had the permission to SEER data access. As SEER database is an open public database without involving personal information, our institution review board (IRB) has determined that no ethical approval is required.</p>", "<title>Statistical analysis</title>", "<p id=\"Par23\">The proportions of clinical-pathological characteristics of MpBC stratified by NAC, adjuvant CT or no CT were compared by means of Pearson’s Chi square. The follow-up was calculated till 31 December 2019. Breast cancer-specific survival (BCSS) was defined as the interval from breast cancer diagnosis to death from breast cancer or the last follow-up. Overall survival (OS) was defined as the interval from diagnosis to death from any cause or the last follow-up. The Kaplan–Meier method was used to construct survival curves, and the log-rank test was used to estimate the differences in survival outcomes between groups. Significant independent prognostic factors were evaluated by means of Cox hazards model in the format of adjusted hazard ratios (HRs) with 95% confidence intervals (CIs). In order to overcome the effects of baseline differences on survival outcomes in the MpBC-TNBC and IDC-TNBC groups, PSM method was adopted with factors such as diagnosis year stage, age, race, tumor stage, breast surgery, chemotherapy types and radiation therapy enrolled. All the statistical tests were two sided, and statistical significance was defined as P value less than 0.05. SPSS 22.0 and R statistics 4.2.2 were used for statistical calculations. </p>", "<title>Ethics declarations and consent to participate</title>", "<p id=\"Par24\">All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors. As SEER database is an open public database without involving personal information, informed consent was consequently not required. The Obstetrics and Gynecology Hospital of Fudan University IRB has reviewed the project and has determined this project does not meet the definition of human subject research under the purview of the IRB according to the national regulations.</p>" ]
[ "<title>Results</title>", "<title>Baseline characteristics among metaplastic carcinoma of the breast receiving chemotherapy (neoadjuvant or adjuvant) or not</title>", "<p id=\"Par6\">Altogether 1186 patients with MpBC were enrolled based on the inclusion criteria between 2010 and 2017. Among them, there were 1023 cases with no special type of MpBC (MpBC-NST) and 163 cases with definite subgroup of MpBC (31 with spindle cell carcinoma, 46 with squamous cell carcinoma, 50 with low-grade adenosquamous carcinoma, 19 with sarcomatoid carcinoma, four with chondroid differentiation and 13 with fibromatosis).</p>", "<p id=\"Par7\">Median age of the 1186 MpBC cases was 61 years old (22–100 years old). The majority of them had histologic grade III disease (978 patients, 82.5%) and TN subtype (844 patients, 71.2%). There were 303 patients (25.5%) in stage I, 725 patients (61.1%) in stage II and 158 patients (13.3%) in stage III. Most patients (828 cases, 69.8%) received chemotherapy, among whom, 181 patients (15.3%) received NAC and 647 patients (54.6%) received adjuvant CT. Only 358 patients (30.2%) did not receive any CT. Among patients receiving NAC, 22 cases (12.2%) achieved CR, 67 cases (37.0%) achieved PR, 48 cases (26.5%) achieved CR or PR and 44 cases (24.3%) showed no response to NAC. A higher proportion of older patients, grade I-II and N0 disease were observed among patients who did not receive CT. On the contrary, patients who received NAC had a higher proportion of T4 and N2-3 disease. Patients who underwent NAC or adjuvant CT were more likely to receive radiation therapy (69.6% in NAC and 54.1% in adjuvant CT). The clinical-pathological characteristics were summarized in Table ##TAB##0##1##.</p>", "<title>Factors associated with chemotherapy among MpBC patients</title>", "<p id=\"Par8\">As the significance of chemotherapy for MpBC was still somewhat controversial, the factors associated chemotherapy among MpBC were then explored. Variables with statistically significant difference (P &lt; 0.05) in the one-way logistic regression associated with chemotherapy were younger age, non-white race, higher histologic grade or stage and radiation therapy. Based on the multivariate logistic regression model, age less than 60 years, histologic grade II–III, stage II–III and radiation therapy were independently correlated with chemotherapy (Table ##TAB##1##2##) (Hosmer Lemeshow P = 0.123).</p>", "<title>Survival outcomes stratified by chemotherapy in MpBC</title>", "<p id=\"Par9\">After a median follow-up of 48 months (1–119 months), 321 MpBC patients died, among whom, 239 patients died due to breast cancer. There were statistically significant differences in BCSS and OS among MpBC patients with NAC-response, NAC-non response, adjuvant CT or without CT (P &lt; 0.001) (Fig. ##FIG##0##1##). According to COX multivariate analysis, chemotherapy was the independent prognostic factor for both BCSS (P = 0.009) and OS (P &lt; 0.001). Compared with no CT, NAC-response and adjuvant CT had a significant or an obvious trend of survival improvement (no CT as reference, HR for NAC-response was 0.691 (0.444–1.077) for BCSS and 0.479 (0.321–0.715) for OS; HR for adjuvant CT was 0.658 (0.480–0.902) for BCSS and 0.451 (0.346–0.587) for OS), while NAC-no response did not improve survival outcomes compared with no CT (no CT as reference, HR for NAC-no response was 1.266 (0.744–2.155) for BCSS and 0.984 (0.610–1.587) for OS) (Table ##TAB##2##3##).</p>", "<p id=\"Par10\">There were significant differences in survival outcomes among NAC, adjuvant CT or no CT in the subgroup analyses when stratified by stage. Among MpBC patients in stage I, there were only six cases with NAC-response. Although a similar BCSS was observed between adjuvant CT and no CT (P = 0.588), those with adjuvant CT did have an improved OS (P = 0.017) (Fig. ##FIG##1##2##a,b). Among MpBC patients in stage II, those with NAC-response or adjuvant CT had a significant improved BCSS and OS compared with NAC-no response or no CT (Fig. ##FIG##1##2##c,d). Among MpBC patients in stage III, chemotherapy lost its prognostic significance as patients with NAC-response, NAC-no response, adjuvant CT and no CT had similar BCSS in most comparisons (Fig. ##FIG##1##2##e). However, chemotherapy still improved OS as patients with NAC-response and adjuvant CT had a significant or trend of improved OS compared with those with NAC-no response or no CT (Fig. ##FIG##1##2##f) (Table ##TAB##3##4##).</p>", "<title>Survival outcomes comparisons between MpBC-TNBC and IDC-TNBC</title>", "<p id=\"Par11\">There were 844 MpBC-TNBC cases and 21260 IDC-TNBC cases met the inclusion criteria between 2010 and 2017. A 1:4 propensity score matching (PSM) was conducted, and as a result, 844 MpBC-TNBC cases were matched with 3376 IDC-TNBC. The clinical-pathological characteristics were well-balanced between two groups after PSM (##SUPPL##0##Supplementary Table##). After a median 50 months (0–119 months) follow-up, IDC-TNBC had an improved BCSS (P = 0.017) and OS (P = 0.003) compared with MpBC-TNBC (Fig. ##FIG##2##3##a,b). There were statistically significant differences in BCSS (P &lt; 0.001) and OS (P &lt; 0.001) among chemotherapy types (NAC-response or no response, adjuvant CT or no CT) for both MpBC-TNBC and IDC-TNBC. According to COX multivariate analysis, MpBC-TNBC was an independent unfavorable prognostic factor for both BCSS (HR = 1.239 (1.046–1.468), P = 0.013) and OS (HR = 1.277 (1.104–1.477), P = 0.001) when compared with IDC-TNBC (Table ##TAB##4##5##). Meanwhile, chemotherapy was also a favorable prognostic factor for both of them. There was significant or trend of improvement for BCSS and OS among patients receiving NAC or adjuvant CT compared with no CT (Table ##TAB##4##5##).</p>", "<p id=\"Par12\">When stratified by chemotherapy types, MpBC-TNBC and IDC-TNBC had similar survival outcomes among those with NAC-response and adjuvant CT (Fig. ##FIG##3##4##a–d). Among those with NAC-no response, IDC-TNBC had significant improved BCSS and OS compared with MpBC-TNBC (Fig. ##FIG##3##4##e,f). Among those with no CT, IDC-TNBC had a similar BCSS but an improved OS compared with MpBC-TNBC (Fig. ##FIG##3##4##g,h).</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par13\">Evidence on treatment strategies for MpBC is limited, as management of MpBC is largely paralleled that of IDC and adopts a comprehensive therapy including surgery, chemotherapy, radiotherapy, endocrine therapy, and targeted therapy based on clinical-pathological characteristics and tumor stage. In particular, the efficacy of adjuvant chemotherapy and neoadjuvant chemotherapy is still controversial. Our study was among the largest population-based study to explore the prognostic significance of chemotherapy among MpBC receiving adjuvant CT, NAC or not any CT, and to compare the long-term survival difference between MpBC-TNBC and IDC-TNBC based on PSM.</p>", "<p id=\"Par14\">MpBC generally has aggressive clinical and pathological features. The clinical‐pathological characteristics of the cohort of MpBCs in the current study was in line with those reported in the literature<sup>##REF##32047541##1##,##REF##29855830##2##,##REF##30872384##7##,##REF##30350370##9##–##REF##30723293##14##</sup>, in which most MpBCs were presented in larger tumor, higher histologic grade, higher number of positive lymph nodes and majority of TN phenotype. In this study, 82.5% MpBC cases had histologic grade III, 19.6% had positive lymph nodes, 21.2% had T3 or T4 disease, and 13.3% were in stage III. Besides, 71.2% cases were in TN phenotype, which was consistent with previous studies<sup>##REF##29855830##2##,##REF##30723293##14##</sup>. The rate of HER2 overexpression (5.7%) and positive hormone receptor (HR) status (24.9%) was in accord with previous reports<sup>##UREF##0##15##,##UREF##1##16##</sup>. However, HR and HER2 status remained no impact on prognosis of MpBC. In patients with or without HER2 overexpression, the prognosis of single HR + tumor was similar to single HR + or double HR- tumor<sup>##UREF##0##15##</sup>. The role of HER2 in MpBC patients remains unclear<sup>##UREF##1##16##,##REF##24838367##17##</sup>. Based on multivariate analysis in this study, molecular subtype (TN as reference) was not an independent prognostic factor of BCSS or OS for MpBC.</p>", "<p id=\"Par15\">In spite of high proportion of aggressive characteristics, the effectiveness of standard chemotherapy regimens for MpBC was controversial, as in most studies MpBC was considered in part chemo-resistant<sup>##REF##20585866##18##–##REF##21792625##20##</sup>. The poor response to anthracyclines and taxanes suggested chemoresistance probably associated to epithelial-mesenchymal transition (EMT)<sup>##REF##16469754##5##,##REF##30925636##10##,##REF##27124919##21##</sup> which was frequently observed upregulated in these tumors<sup>##REF##31488082##22##–##REF##25677743##24##</sup>. Despite the traditional notion that MpBC is resistant to chemotherapy, systemic chemotherapy is administered to 53.4–73.1% MpBC patients<sup>##REF##17066230##4##,##REF##29870876##25##</sup>. A recent study by Ong et al. reviewed 2500 patients with MpBC and found that chemotherapy use versus no chemotherapy was significantly associated with improved survival, although the specific chemotherapy regimens utilized were not reported<sup>##REF##29855830##2##</sup>. Several studies also conducted prognostic nomograms for predicting the OS for MpBC, in which chemotherapy was a favorable prognostic factor<sup>##REF##35961861##26##–##REF##35814407##28##</sup>.</p>", "<p id=\"Par16\">The role of chemotherapy in MpBC has been confirmed in this study, and the potential subgroups benefiting from CT was also explored. MpBC patients who received adjuvant CT and NAC with response had an improved BCSS and OS compared with those without CT. Due to limited cases, patients with NAC-response only had an obvious trend of BCSS improvement. However, the HR value in the multivariate analysis was similar to that of adjuvant CT group, indicating that it reduced the death risk to the same extent. Among patients in stage I, those with adjuvant CT did not show significant survival benefit compared with those without CT. It could be postulated that surgery still remained to be the standard therapy in most early-stage MpBC case such as stage I, which had a favorable prognosis and a radical surgery might be adequate for cure with systemic therapy exempt safely. Likewise, according to Chen’s study, among node-negative MpBC, CT improved the prognosis of T1c MpBC patients but not T1a and T1b patients to a beneficial extent<sup>##REF##35042902##29##</sup>. Meanwhile, among locally advanced disease such as stage III, patients with adjuvant CT, no CT, NAC with or without response had similar BCSS in most cases. However, CT showed OS improvement compared with no CT or NAC-no response in stage I and stage III. It was suggested that when MpBC progressed to an advanced stage, CT might have limited benefit for significant survival improvement. Perhaps the limited cases in stage III might restrict the statistical efficacy to tell the difference. Several studies have reported that the effect of CT associated with better outcome was limited in early-stage cases<sup>##REF##27124919##21##,##REF##25422911##30##</sup>. However, only among stage II disease for which systemic therapy was essential, patients with adjuvant CT or NAC with response had better prognosis than those without CT or receiving NAC without response. It could be postulated from our study that chemotherapy should be included as the multi-disciplinary treatment for MpBC patients with high-risk features, and early screening was also of first-priority for MpBC.</p>", "<p id=\"Par17\">One of the strengths of this study was that it distinguished the response to NAC to explore respectively the significance of NAC for MpBC. Although the response to NAC can predict clinical outcome, there is a dearth of studies evaluating response to NAC in MpBC. In this study, 15.3% MpBC patients received NAC while 54.6% received adjuvant CT. A study from the European Institute of Oncology revealed that just 7.8% of MpBC received NAC and the majority undergoing adjuvant CT<sup>##REF##33047318##31##</sup>. An earlier NCDB study demonstrated that NAC was used in only 15.5% of patients with MpBC<sup>##REF##32047541##1##</sup>. MpBC has been considered poorly responsive to NAC. Previous small case series demonstrated pathological complete response (pCR) rates of approximately 10%, substantially lower than that of classic IDC<sup>##REF##31119569##32##,##REF##33526302##33##</sup>. As a result, some argued that MpBC should not receive NAC<sup>##REF##33047318##31##,##REF##31119569##32##</sup>. In this study, only 12.2% MpBC patients receiving NAC achieved CR while 75.7% showed response to NAC. According to multivariate analysis, NAC-response showed an obvious improvement for BCSS and OS, just like adjuvant CT. However, NAC-no response could not improve survival outcomes. Based on Haque’s study, there was significantly improved 5-year OS among MpBC patients with pCR<sup>##REF##35193807##34##</sup>. It suggested that CT had important prognostic significance for MpBC and the response to NAC could help select favorable subsets which may experience long-term favorable prognosis<sup>##REF##30723293##14##,##REF##34294707##35##,##REF##28689362##36##</sup>. Further researches are warranted to explore biomarkers to ensure appropriate patient selection<sup>##REF##35507014##37##</sup>.</p>", "<p id=\"Par18\">Although the majority of MpBC is presented with TN phenotype, the survival difference between MpBC-TNBC and IDC-TNBC is still controversial. Many retrospective studies with small sample size agreed that the prognosis of MpBC-TNBC was significantly worse than that of IDC-TNBC<sup>##REF##29855830##2##,##REF##31675684##3##,##REF##30872384##7##,##REF##31491663##13##</sup>, while other research indicated that these two had similar overall and disease‐free survival<sup>##REF##33047318##31##,##REF##28913760##38##</sup>. Larger studies documented a significant worse prognosis of MpBC-TNBC than other IDC-TNBC from the NCDB database, and the significant survival difference was maintained at multivariable analysis. As MpBC tended to present with more locally advanced disease in comparison to IDC-TNBC<sup>##REF##21792625##20##</sup>, PSM was adopted to balance the baseline differences in this study. Yet MpBC was confirmed as an independent unfavorable prognostic factor compared with IDC-TNBC based on multivariate COX regression after a successful PSM. Furthermore, chemotherapy was also a favorable prognostic factor for BCSS and OS among MpBC-TNBC and IDC-TNBC based on the multivariate analysis in this study. Subgroup analysis indicated that MpBC-TNBC had similar survival outcomes compared with IDC-TNBC when they received adjuvant CT or NAC with response. It suggested that chemotherapy was of most importance to these two aggressive subtypes. The current standard of care for MpBC follows the same guidelines as IDC-TNBC. According to Polamraju’s study, CT was associated with improved OS among MpBC and IDC-TNBC<sup>##REF##31675684##3##</sup>. On the contrary, IDC-TNBC had significant improved BCSS and OS compared with MpBC-TNBC when they receiving NAC but with no response, and it still had an improved OS compared with MpBC-TNBC when they did not receive CT. It further suggested that the histology of MpBC might confer an additional survival disadvantage. Mutations in <italic>PIK3CA, PIK3R1, ARID1A, FAT1</italic>, and <italic>PTEN</italic> were more frequently harbored in MpBC in comparison to IDC-TNBC, which may contribute to the poor clinical outcomes in MpBC<sup>##REF##28153863##39##,##REF##30979740##40##</sup> and warrant further research.</p>", "<p id=\"Par19\">The strengths of this study were obvious, such as large sample size, classification of chemotherapy types of NAC-response, NAC-no response, adjuvant CT and no CT in all analyses, and comparison with IDC-TNBC based on PSM. However, some limitations should also be addressed. Firstly, although chemotherapy was confirmed of great significance to MpBC, the chemotherapy regimens, duration and response was unavailable in the SEER database. Secondly, MpBC has been shown to be extremely heterogeneous in morphology and in survival outcomes<sup>##REF##24838367##17##,##REF##33389291##41##</sup>. However, in this study, all MpBC cases together with the special subtypes were included, and chemotherapy was confirmed as an independent favorable prognostic factor for BCSS and OS. Lastly, the intrinsic bias could not be avoided in spite of the large sample size.</p>", "<p id=\"Par20\">In conclusion, chemotherapy was of important significance to the prognosis of MpBC and should be integrated in the comprehensive treatment for MpBC. Further researches are warranted to explore the potential biomarkers in MpBC to predict response to chemotherapy.</p>" ]
[]
[ "<p id=\"Par1\">This study aimed to evaluate the significance of chemotherapy (CT) among metaplastic breast cancer (MpBC), and to compare the survival outcomes between triple negative MpBC (MpBC-TNBC) and triple negative invasive ductal carcinoma (IDC-TNBC). SEER database was indexed to identify female unilateral primary MpBC diagnosed from 2010 to 2017. Patients were classified into neoadjuvant chemotherapy (NAC) with response (NAC-response), NAC-no response, adjuvant chemotherapy, and no CT. Breast cancer-specific survival (BCSS) and overall survival (OS) was estimated using the Kaplan–Meier method and compared by log-rank test. Cox regression was used to evaluate the independent prognostic factors. A 1:4 propensity score matching method was adopted to balance baseline differences. Altogether 1186 MpBC patients were enrolled, among them 181 received NAC, 647 received adjuvant CT and 358 did not receive any CT. Chemotherapy was an independent favorable prognostic factor. NAC-response and adjuvant CT had a significant or an obvious trend of survival improvement compared with NAC-no response or no CT. MpBC-TNBC was an independent unfavorable prognostic factor compared with IDC-TNBC. Among them, there was significant or trend of survival improvement among all TNBCs receiving NAC or adjuvant CT compared with no CT. Chemotherapy was of important significance to MpBC prognosis and should be integrated in comprehensive treatment for MpBC.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51627-1.</p>", "<title>Author contributions</title>", "<p>M.Z., J.Y. and H.C. collected data, wrote the main manuscript text, prepared Figs. ##FIG##0##1##, ##FIG##1##2##, ##FIG##2##3##, ##FIG##3##4## and ##FIG##4##5##, Tables ##TAB##0##1##, ##TAB##1##2##, ##TAB##2##3##, ##TAB##3##4## and ##TAB##4##5##, Supplementary material and performed the statistical analysis. M.W. collected data and performed statistical analysis. M.Z. collected data and performed statistical analysis. H.C. wrote the main manuscript text and performed the statistical analysis. All authors reviewed the manuscript and approved the final manuscript. The manuscript is approved by all authors for publication.</p>", "<title>Funding</title>", "<p>This work was supported by Science and Technology Innovation Plan of Shanghai Science and Technology Commission (21Y11912100) and a project to foster clinical research from Obstetrics and Gynecology Hospital of Fudan University (075_ZC).</p>", "<title>Data availability</title>", "<p>Publicly available datasets were analyzed in this study. The data can be found here: <ext-link ext-link-type=\"uri\" xlink:href=\"https://seer.cancer.gov/data/\">https://seer.cancer.gov/data/</ext-link>.</p>", "<title>Competing interests</title>", "<p id=\"Par25\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Kaplan–Meier survival curves of BCSS and OS among MpBC stratified by chemotherapy types ((<bold>a</bold>) KM curves of BCSS; (<bold>b</bold>) KM curves of OS).</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Subgroup analyses of Kaplan–Meier survival curves of BCSS and OS in MpBC based on tumor stage stratified by chemotherapy types ((<bold>a</bold>) KM curves of BCSS in stage I; (<bold>b</bold>) KM curves of OS in stage I; (<bold>c</bold>) KM curves of BCSS in stage II; (<bold>d</bold>) KM curves of OS in stage II; (<bold>e</bold>) KM curves of BCSS in stage III; (<bold>f</bold>) KM curves of OS in stage III).</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Kaplan–Meier survival curves of BCSS and OS stratified by MpBC-TNBC and IDC-TNBC ((<bold>a</bold>) KM curves of BCSS; (<bold>b</bold>) KM curves of OS).</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Subgroup analyses of Kaplan–Meier survival curves of BCSS and OS based on chemotherapy types stratified by MpBC-TNBC and IDC-TNBC ((<bold>a</bold>) KM curves of BCSS in NAC-response; (<bold>b</bold>) KM curves of OS in NAC-response; (<bold>c</bold>) KM curves of BCSS in adjuvant CT; (<bold>d</bold>) KM curves of OS in adjuvant CT; (<bold>e</bold>) KM curves of BCSS in NAC-no response; (<bold>f</bold>) KM curves of OS in NAC-no response; (<bold>g</bold>) KM curves of BCSS in no CT; (<bold>h</bold>) KM curves of OS in no CT.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>The diagram of patient cohort selection process and the overview of the study consort.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Clinical-pathological characteristics of MpBC among (neo) adjuvant CT or no CT groups.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\"/><th align=\"left\" colspan=\"2\">Neoadjuvant CT</th><th align=\"left\" colspan=\"2\">Adjuvant CT</th><th align=\"left\" colspan=\"2\">No CT</th><th align=\"left\" rowspan=\"2\">P</th></tr><tr><th align=\"left\">No</th><th align=\"left\">%</th><th align=\"left\">No</th><th align=\"left\">%</th><th align=\"left\">No</th><th align=\"left\">%</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"8\">Year of diagnosis</td></tr><tr><td align=\"left\"> 2010–2011</td><td align=\"left\">34</td><td char=\".\" align=\"char\">18.8%</td><td align=\"left\">140</td><td align=\"left\">21.6%</td><td align=\"left\">93</td><td align=\"left\">26.0%</td><td align=\"left\" rowspan=\"4\">0.286</td></tr><tr><td align=\"left\"> 2012–2013</td><td align=\"left\">38</td><td char=\".\" align=\"char\">21.0%</td><td align=\"left\">157</td><td align=\"left\">24.3%</td><td align=\"left\">82</td><td align=\"left\">22.9%</td></tr><tr><td align=\"left\"> 2014–2015</td><td align=\"left\">44</td><td char=\".\" align=\"char\">24.3%</td><td align=\"left\">161</td><td align=\"left\">24.9%</td><td align=\"left\">87</td><td align=\"left\">24.3%</td></tr><tr><td align=\"left\"> 2016–2017</td><td align=\"left\">65</td><td char=\".\" align=\"char\">35.9%</td><td align=\"left\">189</td><td align=\"left\">29.2%</td><td align=\"left\">96</td><td align=\"left\">26.8%</td></tr><tr><td align=\"left\" colspan=\"8\">Age</td></tr><tr><td align=\"left\">  ≤ 60</td><td align=\"left\">124</td><td char=\".\" align=\"char\">68.5%</td><td align=\"left\">354</td><td align=\"left\">54.7%</td><td align=\"left\">86</td><td align=\"left\">24.0%</td><td align=\"left\" rowspan=\"2\"> &lt; 0.001</td></tr><tr><td align=\"left\">  &gt; 60</td><td align=\"left\">57</td><td char=\".\" align=\"char\">31.5%</td><td align=\"left\">293</td><td align=\"left\">45.3%</td><td align=\"left\">272</td><td align=\"left\">76.0%</td></tr><tr><td align=\"left\" colspan=\"8\">Race</td></tr><tr><td align=\"left\"> White</td><td align=\"left\">131</td><td char=\".\" align=\"char\">72.4%</td><td align=\"left\">486</td><td align=\"left\">75.1%</td><td align=\"left\">299</td><td align=\"left\">83.5%</td><td align=\"left\" rowspan=\"3\">0.009</td></tr><tr><td align=\"left\"> Black</td><td align=\"left\">35</td><td char=\".\" align=\"char\">19.3%</td><td align=\"left\">112</td><td align=\"left\">17.3%</td><td align=\"left\">36</td><td align=\"left\">10.1%</td></tr><tr><td align=\"left\"> Others*</td><td align=\"left\">15</td><td char=\".\" align=\"char\">8.3%</td><td align=\"left\">49</td><td align=\"left\">7.6%</td><td align=\"left\">23</td><td align=\"left\">6.4%</td></tr><tr><td align=\"left\" colspan=\"8\">Histology</td></tr><tr><td align=\"left\"> Others</td><td align=\"left\">22</td><td char=\".\" align=\"char\">12.2%</td><td align=\"left\">67</td><td align=\"left\">10.4%</td><td align=\"left\">74</td><td align=\"left\">20.7%</td><td align=\"left\" rowspan=\"2\"> &lt; 0.001</td></tr><tr><td align=\"left\"> NST</td><td align=\"left\">159</td><td char=\".\" align=\"char\">87.8%</td><td align=\"left\">580</td><td align=\"left\">89.6%</td><td align=\"left\">284</td><td align=\"left\">79.3%</td></tr><tr><td align=\"left\" colspan=\"8\">Histologic grade</td></tr><tr><td align=\"left\"> I</td><td align=\"left\">1</td><td char=\".\" align=\"char\">0.6%</td><td align=\"left\">18</td><td align=\"left\">2.8%</td><td align=\"left\">35</td><td align=\"left\">9.8%</td><td align=\"left\" rowspan=\"3\"> &lt; 0.001</td></tr><tr><td align=\"left\"> II</td><td align=\"left\">20</td><td char=\".\" align=\"char\">11.0%</td><td align=\"left\">74</td><td align=\"left\">11.4%</td><td align=\"left\">60</td><td align=\"left\">16.8%</td></tr><tr><td align=\"left\"> III</td><td align=\"left\">160</td><td char=\".\" align=\"char\">88.4%</td><td align=\"left\">555</td><td align=\"left\">85.8%</td><td align=\"left\">263</td><td align=\"left\">73.5%</td></tr><tr><td align=\"left\" colspan=\"8\">Stage</td></tr><tr><td align=\"left\"> I</td><td align=\"left\">7</td><td char=\".\" align=\"char\">3.9%</td><td align=\"left\">181</td><td align=\"left\">28.0%</td><td align=\"left\">115</td><td align=\"left\">32.1%</td><td align=\"left\" rowspan=\"6\"> &lt; 0.001</td></tr><tr><td align=\"left\"> IIA</td><td align=\"left\">60</td><td char=\".\" align=\"char\">33.1%</td><td align=\"left\">306</td><td align=\"left\">47.3%</td><td align=\"left\">146</td><td align=\"left\">40.8%</td></tr><tr><td align=\"left\"> IIB</td><td align=\"left\">48</td><td char=\".\" align=\"char\">26.5%</td><td align=\"left\">102</td><td align=\"left\">15.8%</td><td align=\"left\">63</td><td align=\"left\">17.6%</td></tr><tr><td align=\"left\"> IIIA</td><td align=\"left\">31</td><td char=\".\" align=\"char\">17.1%</td><td align=\"left\">33</td><td align=\"left\">5.1%</td><td align=\"left\">11</td><td align=\"left\">3.1%</td></tr><tr><td align=\"left\"> IIIB</td><td align=\"left\">28</td><td char=\".\" align=\"char\">15.5%</td><td align=\"left\">21</td><td align=\"left\">3.2%</td><td align=\"left\">17</td><td align=\"left\">4.7%</td></tr><tr><td align=\"left\"> IIIC</td><td align=\"left\">7</td><td char=\".\" align=\"char\">3.9%</td><td align=\"left\">4</td><td align=\"left\">0.6%</td><td align=\"left\">6</td><td align=\"left\">1.7%</td></tr><tr><td align=\"left\" colspan=\"8\">T</td></tr><tr><td align=\"left\"> T1</td><td align=\"left\">13</td><td char=\".\" align=\"char\">7.2%</td><td align=\"left\">196</td><td align=\"left\">30.3%</td><td align=\"left\">120</td><td align=\"left\">33.5%</td><td align=\"left\" rowspan=\"5\"> &lt; 0.001</td></tr><tr><td align=\"left\"> T2</td><td align=\"left\">84</td><td char=\".\" align=\"char\">46.4%</td><td align=\"left\">362</td><td align=\"left\">56.0%</td><td align=\"left\">159</td><td align=\"left\">44.4%</td></tr><tr><td align=\"left\"> T3</td><td align=\"left\">54</td><td char=\".\" align=\"char\">29.8%</td><td align=\"left\">68</td><td align=\"left\">10.5%</td><td align=\"left\">60</td><td align=\"left\">16.8%</td></tr><tr><td align=\"left\"> T4a–c</td><td align=\"left\">26</td><td char=\".\" align=\"char\">14.4%</td><td align=\"left\">20</td><td align=\"left\">3.1%</td><td align=\"left\">17</td><td align=\"left\">4.7%</td></tr><tr><td align=\"left\"> T4d</td><td align=\"left\">4</td><td char=\".\" align=\"char\">2.2%</td><td align=\"left\">1</td><td align=\"left\">0.2%</td><td align=\"left\">2</td><td align=\"left\">0.6%</td></tr><tr><td align=\"left\" colspan=\"8\">N</td></tr><tr><td align=\"left\"> N0</td><td align=\"left\">101</td><td char=\".\" align=\"char\">55.8%</td><td align=\"left\">529</td><td align=\"left\">81.8%</td><td align=\"left\">324</td><td align=\"left\">90.5%</td><td align=\"left\" rowspan=\"4\"> &lt; 0.001</td></tr><tr><td align=\"left\"> N1</td><td align=\"left\">53</td><td char=\".\" align=\"char\">29.3%</td><td align=\"left\">95</td><td align=\"left\">14.7%</td><td align=\"left\">22</td><td align=\"left\">6.1%</td></tr><tr><td align=\"left\"> N2</td><td align=\"left\">20</td><td char=\".\" align=\"char\">11.0%</td><td align=\"left\">19</td><td align=\"left\">2.9%</td><td align=\"left\">6</td><td align=\"left\">1.7%</td></tr><tr><td align=\"left\"> N3</td><td align=\"left\">7</td><td char=\".\" align=\"char\">3.9%</td><td align=\"left\">4</td><td align=\"left\">0.6%</td><td align=\"left\">6</td><td align=\"left\">1.7%</td></tr><tr><td align=\"left\" colspan=\"8\">Surgery</td></tr><tr><td align=\"left\"> BCS</td><td align=\"left\">52</td><td char=\".\" align=\"char\">28.7%</td><td align=\"left\">331</td><td align=\"left\">51.2%</td><td align=\"left\">161</td><td align=\"left\">45.0%</td><td align=\"left\" rowspan=\"2\"> &lt; 0.001</td></tr><tr><td align=\"left\"> Mastectomy</td><td align=\"left\">129</td><td char=\".\" align=\"char\">71.3%</td><td align=\"left\">316</td><td align=\"left\">48.8%</td><td align=\"left\">197</td><td align=\"left\">55.0%</td></tr><tr><td align=\"left\" colspan=\"8\">Radiation therapy</td></tr><tr><td align=\"left\"> Yes</td><td align=\"left\">126</td><td char=\".\" align=\"char\">69.6%</td><td align=\"left\">350</td><td align=\"left\">54.1%</td><td align=\"left\">120</td><td align=\"left\">33.5%</td><td align=\"left\" rowspan=\"2\"> &lt; 0.001</td></tr><tr><td align=\"left\"> No or unknown</td><td align=\"left\">55</td><td char=\".\" align=\"char\">30.4%</td><td align=\"left\">297</td><td align=\"left\">45.9%</td><td align=\"left\">238</td><td align=\"left\">66.5%</td></tr><tr><td align=\"left\" colspan=\"8\">ER</td></tr><tr><td align=\"left\"> Positive</td><td align=\"left\">51</td><td char=\".\" align=\"char\">28.2%</td><td align=\"left\">119</td><td align=\"left\">18.4%</td><td align=\"left\">60</td><td align=\"left\">16.8%</td><td align=\"left\">0.004</td></tr><tr><td align=\"left\"> Negative</td><td align=\"left\">130</td><td char=\".\" align=\"char\">71.8%</td><td align=\"left\">528</td><td align=\"left\">81.6%</td><td align=\"left\">298</td><td align=\"left\">83.2%</td><td align=\"left\">0.004</td></tr><tr><td align=\"left\" colspan=\"8\">PR</td></tr><tr><td align=\"left\"> Positive</td><td align=\"left\">31</td><td char=\".\" align=\"char\">17.1%</td><td align=\"left\">76</td><td align=\"left\">11.7%</td><td align=\"left\">40</td><td align=\"left\">11.2%</td><td align=\"left\" rowspan=\"2\">0.107</td></tr><tr><td align=\"left\"> Negative</td><td align=\"left\">150</td><td char=\".\" align=\"char\">82.9%</td><td align=\"left\">571</td><td align=\"left\">88.3%</td><td align=\"left\">318</td><td align=\"left\">88.8%</td></tr><tr><td align=\"left\" colspan=\"8\">HER2</td></tr><tr><td align=\"left\"> Positive</td><td align=\"left\">17</td><td char=\".\" align=\"char\">9.4%</td><td align=\"left\">40</td><td align=\"left\">6.2%</td><td align=\"left\">11</td><td align=\"left\">3.1%</td><td align=\"left\" rowspan=\"2\">0.009</td></tr><tr><td align=\"left\"> Negative</td><td align=\"left\">164</td><td char=\".\" align=\"char\">90.6%</td><td align=\"left\">607</td><td align=\"left\">93.8%</td><td align=\"left\">347</td><td align=\"left\">96.9%</td></tr><tr><td align=\"left\" colspan=\"8\">Subtype</td></tr><tr><td align=\"left\"> HR + /HER2–</td><td align=\"left\">52</td><td char=\".\" align=\"char\">28.7%</td><td align=\"left\">147</td><td align=\"left\">22.7%</td><td align=\"left\">75</td><td align=\"left\">20.9%</td><td align=\"left\" rowspan=\"4\">0.003</td></tr><tr><td align=\"left\"> HR + /HER2 + </td><td align=\"left\">8</td><td char=\".\" align=\"char\">4.4%</td><td align=\"left\">11</td><td align=\"left\">1.7%</td><td align=\"left\">2</td><td align=\"left\">0.6%</td></tr><tr><td align=\"left\"> HR–/HER2 + </td><td align=\"left\">9</td><td char=\".\" align=\"char\">5.0%</td><td align=\"left\">29</td><td align=\"left\">4.5%</td><td align=\"left\">9</td><td align=\"left\">2.5%</td></tr><tr><td align=\"left\"> TNBC</td><td align=\"left\">112</td><td char=\".\" align=\"char\">61.9%</td><td align=\"left\">460</td><td align=\"left\">71.1%</td><td align=\"left\">272</td><td align=\"left\">76.0%</td></tr><tr><td align=\"left\" colspan=\"8\">Response to NAC</td></tr><tr><td align=\"left\"> CR</td><td align=\"left\">22</td><td char=\".\" align=\"char\">12.2%</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\"/></tr><tr><td align=\"left\"> PR</td><td align=\"left\">67</td><td char=\".\" align=\"char\">37.0%</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\"/></tr><tr><td align=\"left\"> CR or PR</td><td align=\"left\">48</td><td char=\".\" align=\"char\">26.5%</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\"/></tr><tr><td align=\"left\"> No response</td><td align=\"left\">44</td><td char=\".\" align=\"char\">24.3%</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\">–</td><td align=\"left\"/></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Multivariate logistic regression of factors associated with chemotherapy among MpBC.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Factors</th><th align=\"left\" colspan=\"3\">One-way logistic regression</th><th align=\"left\" colspan=\"3\">Multivariate logistic regression</th></tr><tr><th align=\"left\">OR</th><th align=\"left\">95% CI</th><th align=\"left\">P</th><th align=\"left\">OR</th><th align=\"left\">95% CI</th><th align=\"left\">P</th></tr></thead><tbody><tr><td align=\"left\">Year of diagnosis</td><td char=\".\" align=\"char\">1.052</td><td align=\"left\">0.997–1.109</td><td char=\".\" align=\"char\">0.064</td><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\" colspan=\"7\">Age</td></tr><tr><td align=\"left\">  ≤ 60y vs. &gt; 60y</td><td char=\".\" align=\"char\">4.319</td><td align=\"left\">3.268–5.709</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td char=\".\" align=\"char\">4.100</td><td align=\"left\">3.052–5.509</td><td char=\".\" align=\"char\"> &lt; 0.001</td></tr><tr><td align=\"left\">Race</td><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\">0.002</td><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\">0.237</td></tr><tr><td align=\"left\"> Black vs. white</td><td char=\".\" align=\"char\">1.979</td><td align=\"left\">1.340–2.922</td><td char=\".\" align=\"char\">0.001</td><td char=\".\" align=\"char\">1.423</td><td align=\"left\">0.930–2.180</td><td char=\".\" align=\"char\">0.104</td></tr><tr><td align=\"left\"> Others* vs. white</td><td char=\".\" align=\"char\">1.348</td><td align=\"left\">0.821–2.215</td><td char=\".\" align=\"char\">0.238</td><td char=\".\" align=\"char\">1.202</td><td align=\"left\">0.695–2.077</td><td char=\".\" align=\"char\">0.510</td></tr><tr><td align=\"left\">Histologic grade</td><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\"> &lt; 0.001</td><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\">0.001</td></tr><tr><td align=\"left\"> II vs. I</td><td char=\".\" align=\"char\">2.886</td><td align=\"left\">1.153–5.504</td><td char=\".\" align=\"char\">0.001</td><td char=\".\" align=\"char\">3.361</td><td align=\"left\">1.658–6.815</td><td char=\".\" align=\"char\">0.001</td></tr><tr><td align=\"left\"> III vs. I</td><td char=\".\" align=\"char\">5.008</td><td align=\"left\">2.815–8.910</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td char=\".\" align=\"char\">4.685</td><td align=\"left\">2.462–8.913</td><td char=\".\" align=\"char\"> &lt; 0.001</td></tr><tr><td align=\"left\">Stage</td><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\">0.001</td><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\">0.014</td></tr><tr><td align=\"left\"> II vs. I</td><td char=\".\" align=\"char\">1.510</td><td align=\"left\">1.139–2.003</td><td char=\".\" align=\"char\">0.004</td><td char=\".\" align=\"char\">1.539</td><td align=\"left\">1.114–2.126</td><td char=\".\" align=\"char\">0.009</td></tr><tr><td align=\"left\"> III vs. I</td><td char=\".\" align=\"char\">2.231</td><td align=\"left\">1.430–3.480</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td char=\".\" align=\"char\">1.792</td><td align=\"left\">1.099–2.921</td><td char=\".\" align=\"char\">0.019</td></tr><tr><td align=\"left\" colspan=\"7\">Radiation therapy</td></tr><tr><td align=\"left\"> Yes vs. no or unknown</td><td char=\".\" align=\"char\">2.682</td><td align=\"left\">2.070–3.475</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td char=\".\" align=\"char\">2.710</td><td align=\"left\">2.041–3.599</td><td char=\".\" align=\"char\"> &lt; 0.001</td></tr><tr><td align=\"left\" colspan=\"7\">Surgery</td></tr><tr><td align=\"left\"> BCS vs. mastectomy</td><td char=\".\" align=\"char\">1.053</td><td align=\"left\">0.821–1.351</td><td char=\".\" align=\"char\">0.684</td><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\">Subtype</td><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\">0.031</td><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\">0.323</td></tr><tr><td align=\"left\"> HR–/HER2 + vs. TNBC</td><td char=\".\" align=\"char\">2.008</td><td align=\"left\">0.957–4.211</td><td char=\".\" align=\"char\">0.065</td><td char=\".\" align=\"char\">1.596</td><td align=\"left\">0.725–3.515</td><td char=\".\" align=\"char\">0.246</td></tr><tr><td align=\"left\"> HR + /HER2 + vs. TNBC</td><td char=\".\" align=\"char\">4.517</td><td align=\"left\">1.045–19.533</td><td char=\".\" align=\"char\">0.044</td><td char=\".\" align=\"char\">3.136</td><td align=\"left\">0.666–14.772</td><td char=\".\" align=\"char\">0.148</td></tr><tr><td align=\"left\"> HR + /HER2– vs. TNBC</td><td char=\".\" align=\"char\">1.262</td><td align=\"left\">0.933–1.707</td><td char=\".\" align=\"char\">0.132</td><td char=\".\" align=\"char\">1.099</td><td align=\"left\">0.785–1.538</td><td char=\".\" align=\"char\">0.582</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Multivariate COX regression of independent prognostic factors for MpBC.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"3\"/><th align=\"left\" colspan=\"4\">BCSS</th><th align=\"left\" colspan=\"4\">OS</th></tr><tr><th align=\"left\" colspan=\"2\">Univariate regression</th><th align=\"left\" colspan=\"2\">Multivariate regression</th><th align=\"left\" colspan=\"2\">Univariate regression</th><th align=\"left\" colspan=\"2\">Multivariate regression</th></tr><tr><th align=\"left\">HR (95% CI)</th><th align=\"left\">P</th><th align=\"left\">HR (95% CI)</th><th align=\"left\">P</th><th align=\"left\">HR (95% CI)</th><th align=\"left\">P</th><th align=\"left\">HR (95% CI)</th><th align=\"left\">P</th></tr></thead><tbody><tr><td align=\"left\">Year of diagnosis</td><td align=\"left\">0.956 (0.902–1.013)</td><td align=\"left\">0.125</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\">0.965 (0.917–1.015)</td><td align=\"left\">0.166</td><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\" colspan=\"9\">Age</td></tr><tr><td align=\"left\">  &gt; 60y</td><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/></tr><tr><td align=\"left\">  ≤ 60y</td><td align=\"left\">0.748 (0.579–0.966)</td><td align=\"left\">0.026</td><td align=\"left\">0.762 (0.577–1.005)</td><td align=\"left\">0.054</td><td align=\"left\">0.527 (0.419–0.664)</td><td align=\"left\"> &lt; 0.001</td><td align=\"left\">0.606 (0.472–0.777)</td><td align=\"left\"> &lt; 0.001</td></tr><tr><td align=\"left\">Race</td><td align=\"left\"/><td align=\"left\">0.716</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/><td align=\"left\">0.716</td><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\"> White</td><td align=\"left\">Ref.</td><td align=\"left\">0.495</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\"> Black</td><td align=\"left\">1.221 (0.875–1.704)</td><td align=\"left\">0.239</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\">1.123 (0.836–1.507)</td><td align=\"left\">0.441</td><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\"> Others*</td><td align=\"left\">1.079 (0.664–1.751)</td><td align=\"left\">0.760</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\">0.961 (0.621–1.487)</td><td align=\"left\">0.858</td><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\">Grade</td><td align=\"left\"/><td align=\"left\">0.013</td><td align=\"left\"/><td align=\"left\">0.165</td><td align=\"left\"/><td align=\"left\">0.009</td><td align=\"left\"/><td align=\"left\">0.048</td></tr><tr><td align=\"left\"> III</td><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/></tr><tr><td align=\"left\"> I</td><td align=\"left\">0.453 (0.201–1.019)</td><td align=\"left\">0.056</td><td align=\"left\">0.848 (0.368–1.953)</td><td align=\"left\">0.699</td><td align=\"left\">0.451 (0.223–0.910)</td><td align=\"left\">0.026</td><td align=\"left\">0.634 (0.308–1.306)</td><td align=\"left\">0.217</td></tr><tr><td align=\"left\"> II</td><td align=\"left\">0.587 (0.375–0.919)</td><td align=\"left\">0.020</td><td align=\"left\">0.645 (0.409–1.019)</td><td align=\"left\">0.060</td><td align=\"left\">0.656 (0.453–0.950)</td><td align=\"left\">0.026</td><td align=\"left\">0.651 (0.446–0.951)</td><td align=\"left\">0.026</td></tr><tr><td align=\"left\">Stage</td><td align=\"left\"/><td align=\"left\"> &lt; 0.001</td><td align=\"left\"/><td align=\"left\"> &lt; 0.001</td><td align=\"left\"/><td align=\"left\"> &lt; 0.001</td><td align=\"left\"/><td align=\"left\"> &lt; 0.001</td></tr><tr><td align=\"left\"> IIIC</td><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/></tr><tr><td align=\"left\"> I</td><td align=\"left\">0.082 (0.036–0.189)</td><td align=\"left\"> &lt; 0.001</td><td align=\"left\">0.099 (0.042–0.234)</td><td align=\"left\"> &lt; 0.001</td><td align=\"left\">0.098 (0.051–0.190)</td><td align=\"left\"> &lt; 0.001</td><td align=\"left\">0.113 (0.057–0.224)</td><td align=\"left\"> &lt; 0.001</td></tr><tr><td align=\"left\"> IIA</td><td align=\"left\">0.249 (0.121–0.515)</td><td align=\"left\"> &lt; 0.001</td><td align=\"left\">0.271 (0.128–0.571)</td><td align=\"left\">0.001</td><td align=\"left\">0.220 (0.121–0.398)</td><td align=\"left\"> &lt; 0.001</td><td align=\"left\">0.239 (0.129–0.441)</td><td align=\"left\"> &lt; 0.001</td></tr><tr><td align=\"left\"> IIB</td><td align=\"left\">0.502 (0.240–1.047)</td><td align=\"left\">0.066</td><td align=\"left\">0.537 (0.255–1.134)</td><td align=\"left\">0.103</td><td align=\"left\">0.427 (0.233–0.783)</td><td align=\"left\">0.006</td><td align=\"left\">0.469 (0.253–0.868)</td><td align=\"left\">0.016</td></tr><tr><td align=\"left\"> IIIA</td><td align=\"left\">0.816 (0.376–1.770)</td><td align=\"left\">0.606</td><td align=\"left\">0.921 (0.421–2.016)</td><td align=\"left\">0.837</td><td align=\"left\">0.583 (0.303–1.123)</td><td align=\"left\">0.107</td><td align=\"left\">0.736 (0.378–1.431)</td><td align=\"left\">0.366</td></tr><tr><td align=\"left\"> IIIB</td><td align=\"left\">1.024 (0.472–2.223)</td><td align=\"left\">0.951</td><td align=\"left\">0.950 (0.433–2.084)</td><td align=\"left\">0.899</td><td align=\"left\">0.812 (0.424–1.553)</td><td align=\"left\">0.529</td><td align=\"left\">0.756 (0.391–1.462)</td><td align=\"left\">0.406</td></tr><tr><td align=\"left\">Subtype</td><td align=\"left\"/><td align=\"left\">0.864</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/><td align=\"left\">0.626</td><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\"> TNBC</td><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\"> HR–/HER2 + </td><td align=\"left\">0.779 (0.384–1.583)</td><td align=\"left\">0.491</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\">0.704 (0.374–1.327)</td><td align=\"left\">0.278</td><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\"> HR + /HER2 + </td><td align=\"left\">1.130 (0.464–2.748)</td><td align=\"left\">0.788</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\">0.825 (0.340–2.000)</td><td align=\"left\">0.670</td><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\"> HR + /HER2–</td><td align=\"left\">0.930 (0.683–1.265)</td><td align=\"left\">0.642</td><td align=\"left\"/><td align=\"left\"/><td align=\"left\">0.900 (0.690–1.176)</td><td align=\"left\">0.441</td><td align=\"left\"/><td align=\"left\"/></tr><tr><td align=\"left\" colspan=\"9\">Surgery</td></tr><tr><td align=\"left\"> BCS</td><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/></tr><tr><td align=\"left\"> Mastectomy</td><td align=\"left\">2.452 (1.847–3.257)</td><td align=\"left\"> &lt; 0.001</td><td align=\"left\">1.369 (1.001–1.872)</td><td align=\"left\">0.049</td><td align=\"left\">2.112 (1.666–2.676)</td><td align=\"left\"> &lt; 0.001</td><td align=\"left\">1.244 (0.956–1.619)</td><td align=\"left\">0.105</td></tr><tr><td align=\"left\" colspan=\"9\">Radiation therapy</td></tr><tr><td align=\"left\"> No or unknown</td><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/></tr><tr><td align=\"left\"> Yes</td><td align=\"left\">0.771 (0.598–0.995)</td><td align=\"left\">0.046</td><td align=\"left\">0.756 (0.566–1.010)</td><td align=\"left\">0.058</td><td align=\"left\">0.694 (0.556–0.865)</td><td align=\"left\">0.001</td><td align=\"left\">0.765 (0.596–0.983)</td><td align=\"left\">0.036</td></tr><tr><td align=\"left\">Chemotherapy</td><td align=\"left\"/><td align=\"left\"> &lt; 0.001</td><td align=\"left\"/><td align=\"left\">0.009</td><td align=\"left\"/><td align=\"left\"> &lt; 0.001</td><td align=\"left\"/><td align=\"left\"> &lt; 0.001</td></tr><tr><td align=\"left\"> No CT</td><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/><td align=\"left\">Ref.</td><td align=\"left\"/></tr><tr><td align=\"left\"> NAC- non response</td><td align=\"left\">2.502 (1.533–4.081)</td><td align=\"left\"> &lt; 0.001</td><td align=\"left\">1.266 (0.744–2.155)</td><td align=\"left\">0.384</td><td align=\"left\">1.691 (1.088–2.628)</td><td align=\"left\">0.019</td><td align=\"left\">0.984 (0.610–1.587)</td><td align=\"left\">0.947</td></tr><tr><td align=\"left\"> NAC- response</td><td align=\"left\">1.039 (0.700–1.544)</td><td align=\"left\">0.849</td><td align=\"left\">0.691 (0.444–1.077)</td><td align=\"left\">0.102</td><td align=\"left\">0.632 (0.440–0.907)</td><td align=\"left\">0.013</td><td align=\"left\">0.479 (0.321–0.715)</td><td align=\"left\"> &lt; 0.001</td></tr><tr><td align=\"left\"> Adjuvant CT</td><td align=\"left\">0.618 (0.462–0.827)</td><td align=\"left\">0.001</td><td align=\"left\">0.658 (0.480–0.902)</td><td align=\"left\">0.009</td><td align=\"left\">0.401 (0.314–0.512)</td><td align=\"left\"> &lt; 0.001</td><td align=\"left\">0.451 (0.346–0.587)</td><td align=\"left\"> &lt; 0.001</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab4\"><label>Table 4</label><caption><p>Pairwise survival comparisons among different chemotherapy types for MpBC stratified by tumor stage.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">Stage</th><th align=\"left\">Chemotherapy types</th><th align=\"left\">BCSS</th><th align=\"left\">OS</th></tr><tr><th align=\"left\">Comparisons</th><th align=\"left\">Log rank P</th><th align=\"left\">Log rank P</th></tr></thead><tbody><tr><td align=\"left\">Stage I</td><td align=\"left\">Adjuvant CT vs. no CT</td><td char=\".\" align=\"char\">0.588</td><td char=\".\" align=\"char\">0.017</td></tr><tr><td align=\"left\" rowspan=\"6\">Stage II</td><td align=\"left\">NAC-response vs. adjuvant CT</td><td char=\".\" align=\"char\">0.137</td><td char=\".\" align=\"char\">0.163</td></tr><tr><td align=\"left\">NAC-response vs. NAC-no response</td><td char=\".\" align=\"char\">0.004</td><td char=\".\" align=\"char\">0.010</td></tr><tr><td align=\"left\">NAC-response vs. no CT</td><td char=\".\" align=\"char\">0.001</td><td char=\".\" align=\"char\"> &lt; 0.001</td></tr><tr><td align=\"left\">Adjuvant CT vs. NAC-no response</td><td char=\".\" align=\"char\">0.032</td><td char=\".\" align=\"char\">0.061</td></tr><tr><td align=\"left\">Adjuvant CT vs. no CT</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td char=\".\" align=\"char\"> &lt; 0.001</td></tr><tr><td align=\"left\">NAC-no response vs. no CT</td><td char=\".\" align=\"char\">0.614</td><td char=\".\" align=\"char\">0.397</td></tr><tr><td align=\"left\" rowspan=\"6\">Stage III</td><td align=\"left\">NAC-response vs. adjuvant CT</td><td char=\".\" align=\"char\">0.239</td><td char=\".\" align=\"char\">0.343</td></tr><tr><td align=\"left\">NAC-response vs. NAC-no response</td><td char=\".\" align=\"char\">0.251</td><td char=\".\" align=\"char\">0.060</td></tr><tr><td align=\"left\">NAC-response vs. no CT</td><td char=\".\" align=\"char\">0.548</td><td char=\".\" align=\"char\">0.035</td></tr><tr><td align=\"left\">Adjuvant CT vs. NAC-no response</td><td char=\".\" align=\"char\">0.046</td><td char=\".\" align=\"char\">0.009</td></tr><tr><td align=\"left\">Adjuvant CT vs. no CT</td><td char=\".\" align=\"char\">0.154</td><td char=\".\" align=\"char\">0.003</td></tr><tr><td align=\"left\">NAC-no response vs. no CT</td><td char=\".\" align=\"char\">0.623</td><td char=\".\" align=\"char\">0.989</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab5\"><label>Table 5</label><caption><p>Multivariate COX regression of independent prognostic factors of MpBC-TNBC and IDC-TNBC.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"3\"/><th align=\"left\" colspan=\"4\">BCSS</th><th align=\"left\" colspan=\"4\">OS</th></tr><tr><th align=\"left\" colspan=\"2\">Univariate regression</th><th align=\"left\" colspan=\"2\">Multivariate regression</th><th align=\"left\" colspan=\"2\">Univariate regression</th><th align=\"left\" colspan=\"2\">Multivariate regression</th></tr><tr><th align=\"left\">HR (95% CI)</th><th align=\"left\">P</th><th align=\"left\">HR (95% CI)</th><th align=\"left\">P</th><th align=\"left\">HR (95% CI)</th><th align=\"left\">P</th><th align=\"left\">HR (95% CI)</th><th align=\"left\">P</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"9\">Histology</td></tr><tr><td align=\"left\"> IDC-TNBC</td><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> MpBC-TNBC</td><td align=\"left\">1.227 (1.036–1.453)</td><td char=\".\" align=\"char\">0.018</td><td align=\"left\">1.239 (1.046–1.468)</td><td char=\".\" align=\"char\">0.013</td><td align=\"left\">1.245 (1.077–1.440)</td><td char=\".\" align=\"char\">0.003</td><td align=\"left\">1.277 (1.104–1.477)</td><td char=\".\" align=\"char\">0.001</td></tr><tr><td align=\"left\">Year of diagnosis</td><td align=\"left\">1.030 (0.999–1.063)</td><td char=\".\" align=\"char\">0.058</td><td align=\"left\"/><td char=\".\" align=\"char\"/><td align=\"left\">1.029 (1.002–1.057)</td><td char=\".\" align=\"char\">0.037</td><td align=\"left\">1.045 (1.017–1.075)</td><td char=\".\" align=\"char\">0.001</td></tr><tr><td align=\"left\" colspan=\"9\">Age</td></tr><tr><td align=\"left\">  &gt; 60y</td><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\"/><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\">  ≤ 60y</td><td align=\"left\">0.970 (0.842–1.118)</td><td char=\".\" align=\"char\">0.678</td><td align=\"left\"/><td char=\".\" align=\"char\"/><td align=\"left\">0.840 (0.743–0.951)</td><td char=\".\" align=\"char\">0.006</td><td align=\"left\">0.914 (0.800–1.044)</td><td char=\".\" align=\"char\">0.183</td></tr><tr><td align=\"left\">Race</td><td align=\"left\"/><td char=\".\" align=\"char\">0.388</td><td align=\"left\"/><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\">0.124</td><td align=\"left\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> White</td><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\"/><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Black</td><td align=\"left\">1.125 (0.931–1.359)</td><td char=\".\" align=\"char\">0.223</td><td align=\"left\"/><td char=\".\" align=\"char\"/><td align=\"left\">1.124 (0.955–1.322)</td><td char=\".\" align=\"char\">0.160</td><td align=\"left\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Others*</td><td align=\"left\">0.926 (0.684–1.253)</td><td char=\".\" align=\"char\">0.618</td><td align=\"left\"/><td char=\".\" align=\"char\"/><td align=\"left\">0.832 (0.633–1.093)</td><td char=\".\" align=\"char\">0.185</td><td align=\"left\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\">Stage</td><td align=\"left\"/><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\"/><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\"/><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\"/><td char=\".\" align=\"char\"> &lt; 0.001</td></tr><tr><td align=\"left\"> IIIC</td><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> I</td><td align=\"left\">0.086 (0.055–0.136)</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\">0.102 (0.064–0.163)</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\">0.119 (0.080–0.176)</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\">0.131 (0.087–0.195)</td><td char=\".\" align=\"char\"> &lt; 0.001</td></tr><tr><td align=\"left\"> IIA</td><td align=\"left\">0.188 (0.124–0.286)</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\">0.217 (0.142–0.332)</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\">0.212 (0.146–0.307)</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\">0.228 (0.156–0.333)</td><td char=\".\" align=\"char\"> &lt; 0.001</td></tr><tr><td align=\"left\"> IIB</td><td align=\"left\">0.422 (0.277–0.643)</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\">0.458 (0.299–0.702)</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\">0.405 (0.278–0.592)</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\">0.431 (0.294–0.631)</td><td char=\".\" align=\"char\"> &lt; 0.001</td></tr><tr><td align=\"left\"> IIIA</td><td align=\"left\">0.507 (0.316–0.815)</td><td char=\".\" align=\"char\">0.005</td><td align=\"left\">0.553 (0.342–0.894)</td><td char=\".\" align=\"char\">0.016</td><td align=\"left\">0.477 (0.311–0.732)</td><td char=\".\" align=\"char\">0.001</td><td align=\"left\">0.510 (0.331–0.788)</td><td char=\".\" align=\"char\">0.002</td></tr><tr><td align=\"left\"> IIIB</td><td align=\"left\">0.902 (0.580–1.403)</td><td char=\".\" align=\"char\">0.648</td><td align=\"left\">0.885 (0.568–1.380)</td><td char=\".\" align=\"char\">0.590</td><td align=\"left\">0.797 (0.534–1.190)</td><td char=\".\" align=\"char\">0.267</td><td align=\"left\">0.767 (0.512–1.147)</td><td char=\".\" align=\"char\">0.196</td></tr><tr><td align=\"left\" colspan=\"9\">Surgery</td></tr><tr><td align=\"left\"> BCS</td><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Mastectomy</td><td align=\"left\">2.094 (1.801–2.434)</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\">1.333 (1.136–1.564)</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\">1.815 (1.599–2.060)</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\">1.268 (1.108–1.451)</td><td char=\".\" align=\"char\">0.001</td></tr><tr><td align=\"left\" colspan=\"9\">Radiation therapy</td></tr><tr><td align=\"left\"> No or unknown</td><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\"/><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> Yes</td><td align=\"left\">0.979 (0.851–1.127)</td><td char=\".\" align=\"char\">0.772</td><td align=\"left\"/><td char=\".\" align=\"char\"/><td align=\"left\">0.895 (0.793–1.010)</td><td char=\".\" align=\"char\">0.073</td><td align=\"left\"/><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\">Chemotherapy</td><td align=\"left\"/><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\"/><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\"/><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\"/><td char=\".\" align=\"char\"> &lt; 0.001</td></tr><tr><td align=\"left\"> No CT</td><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/><td align=\"left\">Ref.</td><td char=\".\" align=\"char\"/></tr><tr><td align=\"left\"> NAC- non response</td><td align=\"left\">1.799 (1.277–2.535)</td><td char=\".\" align=\"char\">0.001</td><td align=\"left\">0.801 (0.564–1.139)</td><td char=\".\" align=\"char\">0.217</td><td align=\"left\">1.400 (1.015–1.931)</td><td char=\".\" align=\"char\">0.040</td><td align=\"left\">0.683 (0.488–0.956)</td><td char=\".\" align=\"char\">0.026</td></tr><tr><td align=\"left\"> NAC- response</td><td align=\"left\">1.336 (1.070–1.668)</td><td char=\".\" align=\"char\">0.011</td><td align=\"left\">0.841 (0.668–1.059)</td><td char=\".\" align=\"char\">0.141</td><td align=\"left\">1.120 (0.918–1.365)</td><td char=\".\" align=\"char\">0.264</td><td align=\"left\">0.759 (0.611–0.942)</td><td char=\".\" align=\"char\">0.012</td></tr><tr><td align=\"left\"> Adjuvant CT</td><td align=\"left\">0.686 (0.587–0.803)</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\">0.702 (0.598–0.823)</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\">0.634 (0.556–0.725)</td><td char=\".\" align=\"char\"> &lt; 0.001</td><td align=\"left\">0.656 (0.570–0.755)</td><td char=\".\" align=\"char\"> &lt; 0.001</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>*American Indian/AK native, Ascian/Pacific Islander.</p></table-wrap-foot>", "<table-wrap-foot><p>*American Indian/AK native, Ascian/Pacific Islander.</p><p>Hosmer and Lemeshow P = 0.123.</p></table-wrap-foot>", "<table-wrap-foot><p>*American Indian/AK native, Ascian/Pacific Islander.</p></table-wrap-foot>", "<table-wrap-foot><p>*American Indian/AK native, Ascian/Pacific Islander.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Meilin Zhang and Jingjing Yuan.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51627_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51627_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51627_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51627_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51627_Fig5_HTML\" id=\"MO5\"/>" ]
[ "<media xlink:href=\"41598_2024_51627_MOESM1_ESM.docx\"><caption><p>Supplementary Tables.</p></caption></media>" ]
[{"label": ["15."], "surname": ["Mao"], "given-names": ["J"], "article-title": ["Single hormone receptor-positive metaplastic breast cancer: Similar outcome as triple-negative subtype"], "source": ["Front. Endocrinol."], "year": ["2021"], "volume": ["12"], "fpage": ["628939"], "pub-id": ["10.3389/fendo.2021.628939"]}, {"label": ["16."], "surname": ["Hu"], "given-names": ["J"], "article-title": ["The effect of HER2 status on metaplastic breast cancer a propensity score-matched analysis"], "source": ["Front. Endocrinol."], "year": ["2022"], "volume": ["13"], "fpage": ["874815"], "pub-id": ["10.3389/fendo.2022.874815"]}]
{ "acronym": [], "definition": [] }
41
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1210
oa_package/b8/50/PMC10786888.tar.gz
PMC10786889
38216612
[ "<title>Introduction</title>", "<p id=\"Par2\">As energy is the first demand for major world powers, researchers have an interest in developing and producing materials that are used as clean, lightweight energy storage materials. Therefore, Li-ion batteries (LIBs), and supercapacitors are “superstars” in the investigation fields<sup>##UREF##0##1##–##UREF##3##4##</sup>. Long time for discharge, short time for charging and high capacity for storage are from the suggested properties of these materials<sup>##UREF##3##4##</sup>. Different materials have been explored to achieve some of these properties like polymers, glasses, ceramics, glass ceramics, and their composites. High breakdown strength of polymers (&gt; 5 MV/cm) despite relatively low <italic>ε</italic><sub><italic>r</italic></sub> (&lt; 5) suggest their use for capacitors<sup>##UREF##4##5##</sup>. Particularly, Poly (3,4-ethylene dioxythiophene) (PEDOT), polyaniline (PANi), and polypyrrole (PPy) as conducting polymers (CPs), have been considered as good materials for energy storage devices since the discovery in 1960<sup>##UREF##5##6##</sup> because of their high conductivity, high specific capacitance, faster kinetics than most inorganic batteries<sup>##UREF##6##7##,##UREF##7##8##</sup>. In addition, glass materials have high breakdown strength and low <italic>ε</italic><sub><italic>r</italic></sub><sup>##REF##17831984##9##</sup>, since many tries have been made to raise <italic>ε</italic><sub><italic>r</italic></sub> of the glass without changing its high breakdown strength. Different properties of phosphate glasses make their use in technological purposes easy such as simple composition, strong glass-forming character, high thermal expansion coefficient, and low glass transition temperature<sup>##UREF##8##10##,##UREF##9##11##</sup>. Doping of these glasses with different agents expands their potential applications such as ionic and optoelectrical devices, and laser host materials<sup>##UREF##10##12##</sup>. The extraordinary physical properties of phosphate-based glasses such as low melting temperature, high conductivity to electricity, high thermal coefficient, and UV transmission give them scientific and technological importance<sup>##UREF##2##3##,##UREF##11##13##–##UREF##13##15##</sup>. The composite matrices fabricated from conductive polymers and glass were found to have desirable mixed candidates due to their wide range of applications, particularly as antimicrobial or biomaterial candidates<sup>##UREF##8##10##–##UREF##10##12##</sup>. The combination of polymers with glasses, ceramics, and glass ceramics can improve the workability and enhance the mechanical properties of the formed composites<sup>##REF##28917940##16##,##UREF##14##17##</sup>. Recently, the antimicrobial activity for some phosphate glass/polyaniline composites in the presence of ZnO or CuO was reported, and the studied composites showed different responses to microorganisms. Their antimicrobial activity was found to be increased with increasing the content of CuO or ZnO and attained a maximum of 7 mol%<sup>##UREF##15##18##</sup>.</p>", "<p id=\"Par3\">Now-a-days, there is a high demand for producing echo-friendly and nontoxic materials for every field application. Therefore, the combination of conducting polymers, phosphate glasses, and metal oxides, is quite popular, taking advantage of each component that helps produce a composite with excellent electrical performance that could be useful for electric energy storage applications. Therefore, the current article aims to fabricate and investigate the optical, electrical, and electrochemical properties of phosphate-based glasses (PBG) doped with metal oxides (CuO, ZnO) in the absence and existence of conductive polyaniline (PANI). Characterization of these composites was carried out using diffuse reflectance spectrophotometer (DRS), broadband dielectric spectrometer (BDS), cyclic voltammetry (CV), and charge–discharge technique. The combination of particular features leads us to determine the optimal use of these composites in the appropriate areas of application.</p>" ]
[]
[ "<title>Results and discussion</title>", "<title>Optical properties</title>", "<title>Theoretical optical basicity</title>", "<p id=\"Par12\">In glass oxides, the identification of the negative charge that results from the presence of oxygen ions can be estimated by calculating the theoretical optical basicity ). It can be calculated by considering the individual optical basicity of each oxide and the proportion of oxygen atoms in the oxide according to the following equation<sup>##UREF##17##20##</sup>:where , and are the equivalent fractions, the valence cation, and the optical basicity of each oxide, respectively. For the studied glass system, it can be correlated as:</p>", "<p id=\"Par13\">The values of optical basicity for , , CaO, ZnO, and CuO are 0.4, 1.4, 0.95, 1.04, and 1.03, respectively<sup>##UREF##17##20##–##UREF##19##22##</sup>. The calculated values listed in Table ##TAB##1##2## show that doping with ZnO and CuO increases the theoretical optical basicity, which means an increase in the polarizability of the oxide ion ( as in the following equation:</p>", "<p id=\"Par14\">The increase of optical basicity values with doping is evidence of an increase in the ionic character of the glass samples doped with ZnO or CuO, which subsequently facilitates transferring electrons from the oxide ions to the cations surrounding it. Therefore, it is possible to use this kind of glass in the design of novel optical materials<sup>##UREF##20##23##</sup>.</p>", "<title>Diffuse-reflectance spectra (DRS)</title>", "<p id=\"Par15\">The diffuse-reflectance spectra of PBG, 3Zn/PBG, 7Zn/PBG, 3Cu/PBG, and 7Cu/PBG in the range of 200 to 2500 nm are illustrated in Fig. ##FIG##0##1##a. The reflectance increases suddenly at about 250 nm and then decreases slightly with increasing wavelength. Figure ##FIG##0##1##b represents the corresponding absorbance spectra, which show a sharp peak at about 304 nm for BC and Zn/BC while it broadens and appears at higher wavelength of 345–555 nm for Cu/BC due to the electronic transition of the d–d transition in the Cu ions<sup>##UREF##21##24##</sup>.</p>", "<p id=\"Par16\">The direct and indirect band gaps were evaluated for PBG, 3Zn/PBG, 7Zn/PBG, 3Cu/PBG, and 7Cu/PBG by using Tauc’s plots<sup>##UREF##16##19##,##UREF##22##25##</sup> as in Fig. ##FIG##1##2##a–e. The direct and indirect band gaps for PBG, 3Zn/PBG, 7Zn/PBG, 3Cu/PBG, and 7Cu/PBG are presented in Table ##TAB##1##2##. Notably, the direct and indirect band gaps decreased by doping with ZnO while they increased by doping with CuO. The rise in the direct and indirect band gap values was related to the compactness of the network structure where increasing the number of bridging atoms leads to increasing the glass network compactness<sup>##UREF##19##22##,##UREF##23##26##</sup>. It was noted that the bandgap was widened by doping of ZnO and CuO on the PBG glass, which enhanced the transport of electrons and increased the growth of electroactive sites. This suggests the use of these materials for electronic and photo applications.</p>", "<title>Dielectric study</title>", "<p id=\"Par17\">The dielectric properties (i.e. alternating-current conductivity <italic>σ</italic><sub>ac</sub>, the permittivity , and the dielectric loss tangent <italic>tanδ</italic>, electric loss modulus <italic>M''</italic>) of the phosphate-based glasses (PBG) doped with metal oxides and mixed with polyaniline were firstly evaluated over a wide frequency range (10<sup>–1</sup>-10<sup>6</sup> Hz) at room temperature. Although these properties are equivalent, i.e. directly related to each other, they provide different aspects of the underlying molecular dynamics and charge transport. The frequency dependencies of these properties are illustrated in Figs. ##FIG##2##3##, ##FIG##3##4##, and ##FIG##4##5##, respectively. Secondly, their glass composition dependence is evaluated at a constant frequency value (10<sup>3</sup>Hz) as listed in Table ##TAB##2##3##.</p>", "<title>Frequency dependency</title>", "<p id=\"Par18\">Alternating-current conductivity (σ<sub>ac</sub>) is an essential electrical property that determines the electrical conduction of a material upon applying an electrical field<sup>##UREF##24##27##</sup>. Furthermore, an increase in the concentration and mobility of ions leads to a conductivity increase<sup>##UREF##25##28##</sup>. The frequency dependence of AC conductivity (σ<sub>ac</sub>) is usually expressed by the Jonscher relation<sup>##UREF##26##29##</sup>:where ω (= 2πf) is the angular frequency, A and s are constants, σ(ω) is the frequency-dependent conductivity measured under an AC field and σ<sub>dc</sub> is the DC conductivity (σ<sub>dc</sub>). The frequency exponent (0 &lt; s ≤ 1) is estimated from the slopes of the conductivity vs temperature plot (not presented here) and is used for determining the conduction mechanism<sup>##UREF##27##30##–##UREF##29##32##</sup> as well as the modification of the glass network structure<sup>##UREF##30##33##</sup>. Generally speaking, the relationship (2) is valid for several low-mobility amorphous and even crystalline materials<sup>##UREF##31##34##</sup>. This relation was found to be valid for phosphate-based glasses (PBG) and those doped with 7 mol % metal oxides, i.e. 7Zn/PBG, and 7Cu/PBG, see Fig. ##FIG##2##3##a. For both glasses, σ<sub>ac</sub> decreases towards frequencies lower than 1Hz, indicating the contribution of the electrode polarization (EP) phenomenon that arises from the building up of free charge carriers (electrons, ions, holes. etc.) on a macroscopic scale at the sample/electrode interface<sup>##UREF##32##35##</sup>. This phenomenon is manifested by the high values in both (Fig. ##FIG##3##4##) and tanδ (Fig. ##FIG##4##5##). Further, the plateau-like behavior in conductivity within the frequency range (1–50 Hz) indicates the direct current or dc conductivity (σ<sub>dc</sub>) which arises from the random diffusion of the ionic charge carriers or/and jumping of ions to its neighboring vacant site<sup>##UREF##33##36##</sup>. At f &gt; 50 Hz, the plateau-like behavior vanishes and the conductivity increases considerably, obeying the universal power law; σ<sub>ac</sub> (ω) = Aω<sup>s</sup>. On the other hand, the remaining samples show a conductivity increase with low and high rates in the low and high -frequency regions, respectively. It can also be noticed that the conductivity of most glass compositions, particularly Zn/PBG and Cu/PBG, have semiconducting features at f ≥ 10<sup>3</sup> Hz.</p>", "<p id=\"Par19\">The permittivity or the real part of complex permittivity () measures the energy stored from the applied electric field in the material and identifies the strength of alignment of dipoles in the dielectric. It is a function of an electrical capacitance (C) and is given as:where ω is the angular frequency (= 2πf) where f is the frequency of the applied electric field in Hertz and ε<sub>o</sub> = 8.85 × 10<sup>–12</sup> F/m is the vacuum permittivity. The sample geometry is denoted as d (thickness) and A (sample surface area). In Fig. ##FIG##3##4##, the permittivity () of all glass compositions shows high values due to the contribution of all polarization components<sup>##UREF##34##37##,##UREF##35##38##</sup>, causing an overall polarization increase<sup>##UREF##36##39##</sup>. In the present study, two polarization mechanisms, i.e. space charge (Ps) and dipolar (Pd) dominate the dielectric properties of the glass compositions at low (up to 10<sup>3</sup>Hz) and higher frequency (up to ~ 10<sup>10</sup>Hz), respectively. Ps arises from the separation of charge carriers at interfaces. When the charge carriers separate on a macroscopic scale at the sample/electrode interface, an electrode polarization is obtained which displays extremely high values in both and dielectric loss ( =  × tanδ). When the charge carriers separate on a microscopic scale at the internal layers or interfaces of an inhomogeneous system, an interfacial or Maxwell–Wagner Sillars (MWS) polarization is obtained. The dipolar polarization (Pd) arises from the orientation of the electric dipole moment towards an electric field. The observed permittivity decrease with frequency is due to a decrease in overall polarization. This can also be explained based on the well-known dielectric relaxation phenomenon which suggests that the charge carrier localization is unstable and easily affected by the frequency of the electric field<sup>##UREF##37##40##</sup>.</p>", "<p id=\"Par20\">The permittivity of BC and 7Zn/BC samples (Fig. ##FIG##3##4##b) show typical permittivity decreases with frequency. It shows a frequency independence or a plateau-like behavior at f &lt; 10 Hz for 7Cu/BC which could be possibly due to the coexistence of electrode polarization and DC conductivity. Then, it decreases sharply at f &gt; 10<sup>3</sup> Hz, indicating the predominance of dipolar polarization. From above, the conductivity, space charge, and dipolar polarization may dominate the dielectric behavior of the presented samples.</p>", "<p id=\"Par21\">Compared to the permittivity (), the dielectric loss tangent loss (tanδ) measures the energy dissipated in the dielectric materials that are associated with the frictional dampening, which prevents the displacement of bound charge from keeping in phase with the field change. Its relationship with dielectric loss () and permittivity () is given as:</p>", "<p id=\"Par22\">Figure ##FIG##4##5## shows the frequency-dependent tanδ of PBG, 7Zn/PBG, 7Cu/PBG, BC (PBG/PANI), 7Zn/BC, 7Cu/BC, and PANI. So, the loss spectra of all samples except BC and 7Zn/BC, show a low-frequency relaxation peak (LFRP) connected to a shoulder. The average peak width is higher than the Debye peak width (1.14 orders)<sup>##UREF##38##41##</sup>, due to the distribution of relaxation times. It is believed in dielectric analysis that LFRP is mainly attributed to the contributions of interfacial polarization, or/and DC conductivity. Interfacial or Maxwell Wagner Sillar (MWS) polarization arises mainly from the existence of polar and conductive regions dispersed in a relatively less polar and insulating matrix<sup>##UREF##34##37##,##UREF##35##38##</sup>. Because of this, one can attribute LFRP to the building up of free ions (Cu or Zn) at interfaces between metal oxides (ZnO or CuO) and PBG due to the conductive difference between them. This peak shifts to higher positions upon doping with metal oxides and/or mixing with PANI, indicating enhancement of mobility and/or concentration of free ions, i.e. a conductivity increase<sup>##UREF##34##37##</sup>. As a representative example, the low-frequency relaxation peak position of the pure PBG (~ 2 Hz) shifts to 4 Hz and 18 Hz upon doping with ZnO and CuO, respectively, due to the coexistence of electrode polarization and DC conductivity. On the other hand, the high-frequency relaxation peak (HFRP) positioned at ~ 10<sup>5</sup> Hz of BC, PANI, 7Zn/BC, and 7Cu/BC could correspond to the dipolar polarization, i.e. rotation of the amino group (NH<sub>2</sub>). Compared to all the glass compositions, the dielectric loss tangent (tanδ) for both PANI and 7Cu/BC sharply decreases with increasing frequency up to 56 and 317 Hz, respectively. One may attribute this behavior to the DC conductivity contribution.</p>", "<p id=\"Par23\">To understand deeply the relaxation process in the low-frequency region, the frequency dependence of electric loss modulus () instead of tanδ is recommended, see Fig. ##FIG##5##6##. This is because M''-f representation is useful to suppress the capacitance effects of electrode polarization and provide a clear view DC conduction and dipole relaxation<sup>##UREF##39##42##,##UREF##40##43##</sup>. From the figure, M'' shows a very small value ≈ 0, indicating the absence of electrode polarization effect. Further, it shows a new relaxation peak in the low-frequency region whose maximum is positioned at the same frequency value (~ 4 Hz) for both PANI and 7Cu/BC. According to the Kramers–Kronig relationship<sup>##UREF##41##44##</sup> the appearance of such a peak confirms the contribution of DC conductivity.</p>", "<title>The glass compositions dependent electric properties</title>", "<p id=\"Par24\">To understand deeply the effect of PANI, ZnO, and CuO on the dielectric properties of phosphate-based glasses (PBG), the electrical properties of all samples measured at 10<sup>3</sup> Hz are summarized in Table ##TAB##2##3##. As clear, the pure PBG exhibits the lowest electric properties (σ<sub>ac</sub> = 7.6 × 10<sup>–8</sup> S/cm,  = 1.4 and tanδ = 0.22) compared to the remaining glass samples due to its insulating nature. When it is doped with the semiconducting metal oxides (ZnO or CuO), its properties show an increase due to a polarizability increase that agrees with the theoretical optical basicity increase mentioned above (\"<xref rid=\"Sec11\" ref-type=\"sec\">Theoretical optical basicity</xref>\"). Further, in doping with these oxides, the bandgap is widened, causing an enhancement of electronic transportation which in turn increases the growth of electroactive sites. One can also notice that the electrical properties are higher in CuO-doped glasses than in ZnO-doped glasses. This behavior could be related to the changes in the direct and indirect band gap as reported by the optical properties mentioned above in \"<xref rid=\"Sec12\" ref-type=\"sec\">Diffuse-reflectance spectra (DRS)</xref>\". So, the direct and indirect band gap was found to have higher values in CuO-doped glasses than in ZnO-doped glasses. In addition, Copper is a semiconducting transition metal, its ions exist in two valence states (Cu<sup>+1</sup>, Cu<sup>+2</sup>), through which the electrical conduction occurs by hopping of polarons from ions of a lower valence state (Cu<sup>+1</sup>) to ions of a higher valence state (Cu<sup>+2</sup>)<sup>##UREF##42##45##,##UREF##43##46##</sup>. These states encourage the replacement of P–O–P bonds with P–O–Cu<sup>+</sup> or P–O–Cu<sup>2+</sup> bonds, which significantly improves the conductivity and electric properties of CuO-based composites Cu/PBG<sup>##UREF##44##47##,##UREF##45##48##</sup>. Further, doping with CuO leads to the existence of mixed electronic–ionic electrical conduction. Another advantage of CuO over ZnO is Cu<sup>+</sup> ions incorporated or housed into the glass network, which in turn expands into voids, reducing the pathways in the network. Consequently, the activation energy became lower, causing the mobile Cu<sup>+</sup> ions to migrate easily<sup>##UREF##46##49##,##REF##10062253##50##</sup>. Besides, the electrical properties of glasses were found to be highly enhanced upon mixing with polyaniline (PANI), particularly for those doped with CuO. For instance, 7Cu/BC shows a semiconducting feature (<italic>σ</italic><sub><italic>ac</italic></sub> = 6.8 × 10<sup>–4</sup> S/cm), giant (186,000), and lower <italic>tanδ</italic> = 0.11. These values are common in ionic conducting materials in which the mobile ions reach both electrodes at very low frequencies, making a thin and poor conducting space charge region, which acts as massive capacitors. It is worth mentioning that the magnitude of the room temperature permittivity of this glass sample demonstrates the potential advantage for energy storage over pure PBG (ε ~ 1.4).</p>", "<title>The electrochemical studies</title>", "<p id=\"Par25\">The cyclic voltammetry graphs for BC, 7Zn/BC, and 7Cu/BC in 1.0 M KOH aqueous solution using Ag/AgCl as a reference electrode at different scan rates (0.01–0.1 V/s) over the potential window (−0.5–1.0 V) were observed in Fig. ##FIG##6##7##a–c. The CV curves for BC, 7Zn/BC, and 7Cu/BC at scan rate 0.01 V/s (Fig. ##FIG##6##7##a–c) show one oxidation peak at potential 0.48 V, and the corresponding reduction peak at 0.15 V, the redox peak is due to the redox reaction of polyaniline from leucoemeraldine to the emeraldine<sup>##REF##36365554##51##</sup>. The behavior of the CV curves for the samples indicates the pseudo-capacitive behavior. A shift in the anodic and cathodic peaks (<italic>i</italic><sub><italic>p</italic></sub>) is observed for the three samples to more positive and negative potential values, respectively, as the scan rate () increases which indicates low resistance of the materials and the acceleration in the diffusion of ions<sup>##UREF##47##52##</sup>. Furthermore, the peak current values also increase with increasing the scan rate and accordingly, the area under the CV curves was enlarged due to the improvement in the transfer of the electron through the material.</p>", "<p id=\"Par26\">The specific capacitance (<italic>C</italic><sub><italic>s</italic></sub>) of BC, 7Zn/BC, and 7Cu/Bc was calculated with the aid of the area under the CV curve , using the following relation,where is the potential window (−0.5 to 1.0 V), <italic>m</italic> is the active mass of the material in gm and is the scan rate (V/s). The relation between the calculated specific capacitance and the scan rate is shown in Fig. ##FIG##6##7##d, where a reduction in the value of the specific capacitance occurs with increasing the scan rate because of the decrease in the active sites with decreasing the scan rate where there is enough time for the ions to get up at the surface of the electrode and to interact with it<sup>##UREF##16##19##,##UREF##48##53##,##UREF##49##54##</sup>. It was noted from Fig. ##FIG##6##7##d that the values of C<sub>s</sub> for 7Cu/CB at nearly all the scan rates are higher than C<sub>s</sub> for CB and 7Zn/CB, since the highest value for 7Cu/CB is 100 F/g at a scan rate of 0.01 V/s. The ion transfer mechanism for the studied materials (BC, 7Zn/BC, and 7Cu/Bc) can be estimated from the linear relation between log and for both the anodic and cathodic peaks according to the following equation:</p>", "<p id=\"Par27\">The slope of the straight line was represented by b (Fig. ##FIG##6##7##e), and the value of b can help in suggesting the mechanism of ion transfer. When b is close to or equal to 0.5, the ion transfer was suggested to be diffusion controlled and the capacitance behavior of the material is like battery type-one, and when it is equal to or close to 1.0, the mechanism was controlled by surface process and the material showed capacitive type nature. The value of b for BC, 7Zn/BC, and 7Cu/BC is close to 0.5, which suggests the battery type-one nature of the three materials, and the ion transfer occurs through a diffusion- controlled mechanism<sup>##UREF##50##55##,##REF##35203028##56##</sup>.</p>", "<p id=\"Par28\">The galvanostatic charge–discharge curves conducted for BC, 7Zn/BC, and 7Cu/BC in a potential range of −0.3 to 0.6 V (vs. Ag/AgCl) in 1.0 M KOH at different current densities (1–10 A/g) as shown in Fig. ##FIG##7##8##a–c where the curves are nonlinear, which confirms the pseudocapacitive behavior (faradic) as in CV measurement. Therefore, the specific capacitances of the studied materials were calculated via the following equation by integrating the area under the discharge curve( )<sup>##UREF##50##55##</sup>:where m is the active mass, I; is the current density, and the difference in the potential window. Figure ##FIG##7##8##d shows the effect of the applied current densities on the specific capacitance values. It is noted that applying a large current results in decreasing the specific capacitance values due to the decrease in the ions of the electrolyte at the surface active area because the time is insufficient at high current density<sup>##UREF##51##57##</sup>. At a current density value of 1.0 A/g, the highest value of specific capacitance is 82.3 F/g. The value of the specific capacitance for 7Cu/BC is larger than BC and 7Zn/BC because of the improvement in both conductivity and dielectric properties by doping with CuO, as the values of ac-conductivity, dielectric constant and dielectric loss for 7Cu/BC are common in ionic conducting materials as illustrated in the electrical studies section. In addition, the presence of two valence states (Cu<sup>+1</sup>, Cu<sup>+2</sup>) leads to the hopping of polarons from ions of a lower valence state (Cu<sup>+1</sup>) to ions of a higher valence state (Cu<sup>+2</sup>)<sup>##UREF##42##45##,##UREF##43##46##</sup>. Also, the presence of PANI with the metal oxide enhanced the mobility and/or concentration of free ions in the composite<sup>##UREF##34##37##</sup>.</p>", "<p id=\"Par29\">Long-term cycling is important in showing the stability of the materials used as supercapacitors. Therefore, 4500 charge–discharge cycles for 7Cu/CB at 8 A/g were performed in the potential windows (-0.3 to 0.8 V). Figure ##FIG##8##9## shows the capacitance retention change with the number of cycles slightly. It is noted an increase in the specific capacitance during the first 200 cycles to 113% for the first cycle, then decreased to about 55% after 2500 cycles and increased again to reach 77% after 4500 cycles, indicating good stability of 7Cu/BC. The increase in the retention is due to increasing the electrolyte temperature with increasing the time of operation<sup>##UREF##52##58##</sup>.</p>" ]
[ "<title>Results and discussion</title>", "<title>Optical properties</title>", "<title>Theoretical optical basicity</title>", "<p id=\"Par12\">In glass oxides, the identification of the negative charge that results from the presence of oxygen ions can be estimated by calculating the theoretical optical basicity ). It can be calculated by considering the individual optical basicity of each oxide and the proportion of oxygen atoms in the oxide according to the following equation<sup>##UREF##17##20##</sup>:where , and are the equivalent fractions, the valence cation, and the optical basicity of each oxide, respectively. For the studied glass system, it can be correlated as:</p>", "<p id=\"Par13\">The values of optical basicity for , , CaO, ZnO, and CuO are 0.4, 1.4, 0.95, 1.04, and 1.03, respectively<sup>##UREF##17##20##–##UREF##19##22##</sup>. The calculated values listed in Table ##TAB##1##2## show that doping with ZnO and CuO increases the theoretical optical basicity, which means an increase in the polarizability of the oxide ion ( as in the following equation:</p>", "<p id=\"Par14\">The increase of optical basicity values with doping is evidence of an increase in the ionic character of the glass samples doped with ZnO or CuO, which subsequently facilitates transferring electrons from the oxide ions to the cations surrounding it. Therefore, it is possible to use this kind of glass in the design of novel optical materials<sup>##UREF##20##23##</sup>.</p>", "<title>Diffuse-reflectance spectra (DRS)</title>", "<p id=\"Par15\">The diffuse-reflectance spectra of PBG, 3Zn/PBG, 7Zn/PBG, 3Cu/PBG, and 7Cu/PBG in the range of 200 to 2500 nm are illustrated in Fig. ##FIG##0##1##a. The reflectance increases suddenly at about 250 nm and then decreases slightly with increasing wavelength. Figure ##FIG##0##1##b represents the corresponding absorbance spectra, which show a sharp peak at about 304 nm for BC and Zn/BC while it broadens and appears at higher wavelength of 345–555 nm for Cu/BC due to the electronic transition of the d–d transition in the Cu ions<sup>##UREF##21##24##</sup>.</p>", "<p id=\"Par16\">The direct and indirect band gaps were evaluated for PBG, 3Zn/PBG, 7Zn/PBG, 3Cu/PBG, and 7Cu/PBG by using Tauc’s plots<sup>##UREF##16##19##,##UREF##22##25##</sup> as in Fig. ##FIG##1##2##a–e. The direct and indirect band gaps for PBG, 3Zn/PBG, 7Zn/PBG, 3Cu/PBG, and 7Cu/PBG are presented in Table ##TAB##1##2##. Notably, the direct and indirect band gaps decreased by doping with ZnO while they increased by doping with CuO. The rise in the direct and indirect band gap values was related to the compactness of the network structure where increasing the number of bridging atoms leads to increasing the glass network compactness<sup>##UREF##19##22##,##UREF##23##26##</sup>. It was noted that the bandgap was widened by doping of ZnO and CuO on the PBG glass, which enhanced the transport of electrons and increased the growth of electroactive sites. This suggests the use of these materials for electronic and photo applications.</p>", "<title>Dielectric study</title>", "<p id=\"Par17\">The dielectric properties (i.e. alternating-current conductivity <italic>σ</italic><sub>ac</sub>, the permittivity , and the dielectric loss tangent <italic>tanδ</italic>, electric loss modulus <italic>M''</italic>) of the phosphate-based glasses (PBG) doped with metal oxides and mixed with polyaniline were firstly evaluated over a wide frequency range (10<sup>–1</sup>-10<sup>6</sup> Hz) at room temperature. Although these properties are equivalent, i.e. directly related to each other, they provide different aspects of the underlying molecular dynamics and charge transport. The frequency dependencies of these properties are illustrated in Figs. ##FIG##2##3##, ##FIG##3##4##, and ##FIG##4##5##, respectively. Secondly, their glass composition dependence is evaluated at a constant frequency value (10<sup>3</sup>Hz) as listed in Table ##TAB##2##3##.</p>", "<title>Frequency dependency</title>", "<p id=\"Par18\">Alternating-current conductivity (σ<sub>ac</sub>) is an essential electrical property that determines the electrical conduction of a material upon applying an electrical field<sup>##UREF##24##27##</sup>. Furthermore, an increase in the concentration and mobility of ions leads to a conductivity increase<sup>##UREF##25##28##</sup>. The frequency dependence of AC conductivity (σ<sub>ac</sub>) is usually expressed by the Jonscher relation<sup>##UREF##26##29##</sup>:where ω (= 2πf) is the angular frequency, A and s are constants, σ(ω) is the frequency-dependent conductivity measured under an AC field and σ<sub>dc</sub> is the DC conductivity (σ<sub>dc</sub>). The frequency exponent (0 &lt; s ≤ 1) is estimated from the slopes of the conductivity vs temperature plot (not presented here) and is used for determining the conduction mechanism<sup>##UREF##27##30##–##UREF##29##32##</sup> as well as the modification of the glass network structure<sup>##UREF##30##33##</sup>. Generally speaking, the relationship (2) is valid for several low-mobility amorphous and even crystalline materials<sup>##UREF##31##34##</sup>. This relation was found to be valid for phosphate-based glasses (PBG) and those doped with 7 mol % metal oxides, i.e. 7Zn/PBG, and 7Cu/PBG, see Fig. ##FIG##2##3##a. For both glasses, σ<sub>ac</sub> decreases towards frequencies lower than 1Hz, indicating the contribution of the electrode polarization (EP) phenomenon that arises from the building up of free charge carriers (electrons, ions, holes. etc.) on a macroscopic scale at the sample/electrode interface<sup>##UREF##32##35##</sup>. This phenomenon is manifested by the high values in both (Fig. ##FIG##3##4##) and tanδ (Fig. ##FIG##4##5##). Further, the plateau-like behavior in conductivity within the frequency range (1–50 Hz) indicates the direct current or dc conductivity (σ<sub>dc</sub>) which arises from the random diffusion of the ionic charge carriers or/and jumping of ions to its neighboring vacant site<sup>##UREF##33##36##</sup>. At f &gt; 50 Hz, the plateau-like behavior vanishes and the conductivity increases considerably, obeying the universal power law; σ<sub>ac</sub> (ω) = Aω<sup>s</sup>. On the other hand, the remaining samples show a conductivity increase with low and high rates in the low and high -frequency regions, respectively. It can also be noticed that the conductivity of most glass compositions, particularly Zn/PBG and Cu/PBG, have semiconducting features at f ≥ 10<sup>3</sup> Hz.</p>", "<p id=\"Par19\">The permittivity or the real part of complex permittivity () measures the energy stored from the applied electric field in the material and identifies the strength of alignment of dipoles in the dielectric. It is a function of an electrical capacitance (C) and is given as:where ω is the angular frequency (= 2πf) where f is the frequency of the applied electric field in Hertz and ε<sub>o</sub> = 8.85 × 10<sup>–12</sup> F/m is the vacuum permittivity. The sample geometry is denoted as d (thickness) and A (sample surface area). In Fig. ##FIG##3##4##, the permittivity () of all glass compositions shows high values due to the contribution of all polarization components<sup>##UREF##34##37##,##UREF##35##38##</sup>, causing an overall polarization increase<sup>##UREF##36##39##</sup>. In the present study, two polarization mechanisms, i.e. space charge (Ps) and dipolar (Pd) dominate the dielectric properties of the glass compositions at low (up to 10<sup>3</sup>Hz) and higher frequency (up to ~ 10<sup>10</sup>Hz), respectively. Ps arises from the separation of charge carriers at interfaces. When the charge carriers separate on a macroscopic scale at the sample/electrode interface, an electrode polarization is obtained which displays extremely high values in both and dielectric loss ( =  × tanδ). When the charge carriers separate on a microscopic scale at the internal layers or interfaces of an inhomogeneous system, an interfacial or Maxwell–Wagner Sillars (MWS) polarization is obtained. The dipolar polarization (Pd) arises from the orientation of the electric dipole moment towards an electric field. The observed permittivity decrease with frequency is due to a decrease in overall polarization. This can also be explained based on the well-known dielectric relaxation phenomenon which suggests that the charge carrier localization is unstable and easily affected by the frequency of the electric field<sup>##UREF##37##40##</sup>.</p>", "<p id=\"Par20\">The permittivity of BC and 7Zn/BC samples (Fig. ##FIG##3##4##b) show typical permittivity decreases with frequency. It shows a frequency independence or a plateau-like behavior at f &lt; 10 Hz for 7Cu/BC which could be possibly due to the coexistence of electrode polarization and DC conductivity. Then, it decreases sharply at f &gt; 10<sup>3</sup> Hz, indicating the predominance of dipolar polarization. From above, the conductivity, space charge, and dipolar polarization may dominate the dielectric behavior of the presented samples.</p>", "<p id=\"Par21\">Compared to the permittivity (), the dielectric loss tangent loss (tanδ) measures the energy dissipated in the dielectric materials that are associated with the frictional dampening, which prevents the displacement of bound charge from keeping in phase with the field change. Its relationship with dielectric loss () and permittivity () is given as:</p>", "<p id=\"Par22\">Figure ##FIG##4##5## shows the frequency-dependent tanδ of PBG, 7Zn/PBG, 7Cu/PBG, BC (PBG/PANI), 7Zn/BC, 7Cu/BC, and PANI. So, the loss spectra of all samples except BC and 7Zn/BC, show a low-frequency relaxation peak (LFRP) connected to a shoulder. The average peak width is higher than the Debye peak width (1.14 orders)<sup>##UREF##38##41##</sup>, due to the distribution of relaxation times. It is believed in dielectric analysis that LFRP is mainly attributed to the contributions of interfacial polarization, or/and DC conductivity. Interfacial or Maxwell Wagner Sillar (MWS) polarization arises mainly from the existence of polar and conductive regions dispersed in a relatively less polar and insulating matrix<sup>##UREF##34##37##,##UREF##35##38##</sup>. Because of this, one can attribute LFRP to the building up of free ions (Cu or Zn) at interfaces between metal oxides (ZnO or CuO) and PBG due to the conductive difference between them. This peak shifts to higher positions upon doping with metal oxides and/or mixing with PANI, indicating enhancement of mobility and/or concentration of free ions, i.e. a conductivity increase<sup>##UREF##34##37##</sup>. As a representative example, the low-frequency relaxation peak position of the pure PBG (~ 2 Hz) shifts to 4 Hz and 18 Hz upon doping with ZnO and CuO, respectively, due to the coexistence of electrode polarization and DC conductivity. On the other hand, the high-frequency relaxation peak (HFRP) positioned at ~ 10<sup>5</sup> Hz of BC, PANI, 7Zn/BC, and 7Cu/BC could correspond to the dipolar polarization, i.e. rotation of the amino group (NH<sub>2</sub>). Compared to all the glass compositions, the dielectric loss tangent (tanδ) for both PANI and 7Cu/BC sharply decreases with increasing frequency up to 56 and 317 Hz, respectively. One may attribute this behavior to the DC conductivity contribution.</p>", "<p id=\"Par23\">To understand deeply the relaxation process in the low-frequency region, the frequency dependence of electric loss modulus () instead of tanδ is recommended, see Fig. ##FIG##5##6##. This is because M''-f representation is useful to suppress the capacitance effects of electrode polarization and provide a clear view DC conduction and dipole relaxation<sup>##UREF##39##42##,##UREF##40##43##</sup>. From the figure, M'' shows a very small value ≈ 0, indicating the absence of electrode polarization effect. Further, it shows a new relaxation peak in the low-frequency region whose maximum is positioned at the same frequency value (~ 4 Hz) for both PANI and 7Cu/BC. According to the Kramers–Kronig relationship<sup>##UREF##41##44##</sup> the appearance of such a peak confirms the contribution of DC conductivity.</p>", "<title>The glass compositions dependent electric properties</title>", "<p id=\"Par24\">To understand deeply the effect of PANI, ZnO, and CuO on the dielectric properties of phosphate-based glasses (PBG), the electrical properties of all samples measured at 10<sup>3</sup> Hz are summarized in Table ##TAB##2##3##. As clear, the pure PBG exhibits the lowest electric properties (σ<sub>ac</sub> = 7.6 × 10<sup>–8</sup> S/cm,  = 1.4 and tanδ = 0.22) compared to the remaining glass samples due to its insulating nature. When it is doped with the semiconducting metal oxides (ZnO or CuO), its properties show an increase due to a polarizability increase that agrees with the theoretical optical basicity increase mentioned above (\"<xref rid=\"Sec11\" ref-type=\"sec\">Theoretical optical basicity</xref>\"). Further, in doping with these oxides, the bandgap is widened, causing an enhancement of electronic transportation which in turn increases the growth of electroactive sites. One can also notice that the electrical properties are higher in CuO-doped glasses than in ZnO-doped glasses. This behavior could be related to the changes in the direct and indirect band gap as reported by the optical properties mentioned above in \"<xref rid=\"Sec12\" ref-type=\"sec\">Diffuse-reflectance spectra (DRS)</xref>\". So, the direct and indirect band gap was found to have higher values in CuO-doped glasses than in ZnO-doped glasses. In addition, Copper is a semiconducting transition metal, its ions exist in two valence states (Cu<sup>+1</sup>, Cu<sup>+2</sup>), through which the electrical conduction occurs by hopping of polarons from ions of a lower valence state (Cu<sup>+1</sup>) to ions of a higher valence state (Cu<sup>+2</sup>)<sup>##UREF##42##45##,##UREF##43##46##</sup>. These states encourage the replacement of P–O–P bonds with P–O–Cu<sup>+</sup> or P–O–Cu<sup>2+</sup> bonds, which significantly improves the conductivity and electric properties of CuO-based composites Cu/PBG<sup>##UREF##44##47##,##UREF##45##48##</sup>. Further, doping with CuO leads to the existence of mixed electronic–ionic electrical conduction. Another advantage of CuO over ZnO is Cu<sup>+</sup> ions incorporated or housed into the glass network, which in turn expands into voids, reducing the pathways in the network. Consequently, the activation energy became lower, causing the mobile Cu<sup>+</sup> ions to migrate easily<sup>##UREF##46##49##,##REF##10062253##50##</sup>. Besides, the electrical properties of glasses were found to be highly enhanced upon mixing with polyaniline (PANI), particularly for those doped with CuO. For instance, 7Cu/BC shows a semiconducting feature (<italic>σ</italic><sub><italic>ac</italic></sub> = 6.8 × 10<sup>–4</sup> S/cm), giant (186,000), and lower <italic>tanδ</italic> = 0.11. These values are common in ionic conducting materials in which the mobile ions reach both electrodes at very low frequencies, making a thin and poor conducting space charge region, which acts as massive capacitors. It is worth mentioning that the magnitude of the room temperature permittivity of this glass sample demonstrates the potential advantage for energy storage over pure PBG (ε ~ 1.4).</p>", "<title>The electrochemical studies</title>", "<p id=\"Par25\">The cyclic voltammetry graphs for BC, 7Zn/BC, and 7Cu/BC in 1.0 M KOH aqueous solution using Ag/AgCl as a reference electrode at different scan rates (0.01–0.1 V/s) over the potential window (−0.5–1.0 V) were observed in Fig. ##FIG##6##7##a–c. The CV curves for BC, 7Zn/BC, and 7Cu/BC at scan rate 0.01 V/s (Fig. ##FIG##6##7##a–c) show one oxidation peak at potential 0.48 V, and the corresponding reduction peak at 0.15 V, the redox peak is due to the redox reaction of polyaniline from leucoemeraldine to the emeraldine<sup>##REF##36365554##51##</sup>. The behavior of the CV curves for the samples indicates the pseudo-capacitive behavior. A shift in the anodic and cathodic peaks (<italic>i</italic><sub><italic>p</italic></sub>) is observed for the three samples to more positive and negative potential values, respectively, as the scan rate () increases which indicates low resistance of the materials and the acceleration in the diffusion of ions<sup>##UREF##47##52##</sup>. Furthermore, the peak current values also increase with increasing the scan rate and accordingly, the area under the CV curves was enlarged due to the improvement in the transfer of the electron through the material.</p>", "<p id=\"Par26\">The specific capacitance (<italic>C</italic><sub><italic>s</italic></sub>) of BC, 7Zn/BC, and 7Cu/Bc was calculated with the aid of the area under the CV curve , using the following relation,where is the potential window (−0.5 to 1.0 V), <italic>m</italic> is the active mass of the material in gm and is the scan rate (V/s). The relation between the calculated specific capacitance and the scan rate is shown in Fig. ##FIG##6##7##d, where a reduction in the value of the specific capacitance occurs with increasing the scan rate because of the decrease in the active sites with decreasing the scan rate where there is enough time for the ions to get up at the surface of the electrode and to interact with it<sup>##UREF##16##19##,##UREF##48##53##,##UREF##49##54##</sup>. It was noted from Fig. ##FIG##6##7##d that the values of C<sub>s</sub> for 7Cu/CB at nearly all the scan rates are higher than C<sub>s</sub> for CB and 7Zn/CB, since the highest value for 7Cu/CB is 100 F/g at a scan rate of 0.01 V/s. The ion transfer mechanism for the studied materials (BC, 7Zn/BC, and 7Cu/Bc) can be estimated from the linear relation between log and for both the anodic and cathodic peaks according to the following equation:</p>", "<p id=\"Par27\">The slope of the straight line was represented by b (Fig. ##FIG##6##7##e), and the value of b can help in suggesting the mechanism of ion transfer. When b is close to or equal to 0.5, the ion transfer was suggested to be diffusion controlled and the capacitance behavior of the material is like battery type-one, and when it is equal to or close to 1.0, the mechanism was controlled by surface process and the material showed capacitive type nature. The value of b for BC, 7Zn/BC, and 7Cu/BC is close to 0.5, which suggests the battery type-one nature of the three materials, and the ion transfer occurs through a diffusion- controlled mechanism<sup>##UREF##50##55##,##REF##35203028##56##</sup>.</p>", "<p id=\"Par28\">The galvanostatic charge–discharge curves conducted for BC, 7Zn/BC, and 7Cu/BC in a potential range of −0.3 to 0.6 V (vs. Ag/AgCl) in 1.0 M KOH at different current densities (1–10 A/g) as shown in Fig. ##FIG##7##8##a–c where the curves are nonlinear, which confirms the pseudocapacitive behavior (faradic) as in CV measurement. Therefore, the specific capacitances of the studied materials were calculated via the following equation by integrating the area under the discharge curve( )<sup>##UREF##50##55##</sup>:where m is the active mass, I; is the current density, and the difference in the potential window. Figure ##FIG##7##8##d shows the effect of the applied current densities on the specific capacitance values. It is noted that applying a large current results in decreasing the specific capacitance values due to the decrease in the ions of the electrolyte at the surface active area because the time is insufficient at high current density<sup>##UREF##51##57##</sup>. At a current density value of 1.0 A/g, the highest value of specific capacitance is 82.3 F/g. The value of the specific capacitance for 7Cu/BC is larger than BC and 7Zn/BC because of the improvement in both conductivity and dielectric properties by doping with CuO, as the values of ac-conductivity, dielectric constant and dielectric loss for 7Cu/BC are common in ionic conducting materials as illustrated in the electrical studies section. In addition, the presence of two valence states (Cu<sup>+1</sup>, Cu<sup>+2</sup>) leads to the hopping of polarons from ions of a lower valence state (Cu<sup>+1</sup>) to ions of a higher valence state (Cu<sup>+2</sup>)<sup>##UREF##42##45##,##UREF##43##46##</sup>. Also, the presence of PANI with the metal oxide enhanced the mobility and/or concentration of free ions in the composite<sup>##UREF##34##37##</sup>.</p>", "<p id=\"Par29\">Long-term cycling is important in showing the stability of the materials used as supercapacitors. Therefore, 4500 charge–discharge cycles for 7Cu/CB at 8 A/g were performed in the potential windows (-0.3 to 0.8 V). Figure ##FIG##8##9## shows the capacitance retention change with the number of cycles slightly. It is noted an increase in the specific capacitance during the first 200 cycles to 113% for the first cycle, then decreased to about 55% after 2500 cycles and increased again to reach 77% after 4500 cycles, indicating good stability of 7Cu/BC. The increase in the retention is due to increasing the electrolyte temperature with increasing the time of operation<sup>##UREF##52##58##</sup>.</p>" ]
[ "<title>Conclusion</title>", "<p id=\"Par30\">In the current study, the electrical, optical, and electrochemical behavior of the phosphate-based glasses (PBG), containing ZnO or CuO in the absence and existence of conductive polyaniline (PANI). The glass and the glass doped with 3ZnO, 7ZnO, 3CuO, and 7CuO exhibit both direct and indirect transition with values of transition gap of (4.04 and 4.4), (3.8 and 3.8), (4.04 and 4.49), (4.28 and 4.76) and (4.18 and 4.59), respectively. The dielectric measurements were carried out over a wide frequency range at room temperature. The dielectric properties of PBG have been enhanced upon doping with metal oxides and/or mixing with PANI. Particularly, the <italic>AC</italic> conductivity of PBG doped with 7 mol% CuO and mixed with PANI exhibited a semiconducting feature (6.8 × 10<sup>–4</sup> S/cm), lower dielectric loss tangent (0.11), and giant permittivity (186,000). The cyclic voltammetry of the studied composites shows one redox couple that demonstrates the pseudo-capacitive behavior of the material. The reaction through the studied materials was diffusion-controlled, and the material exhibited battery type-one in nature. The highest value of the specific capacitance is 82.3 F/g at 1.0 A/g for 7Cu/BC, and the initial specific capacitance was increased to about 113% in its first cycle, then decreased to about 55% after 2500 cycles, and increased again to reach 77% after 4500 cycles indicating good stability of 7Cu/BC. The combination of optical, electrical, and electrochemical features of these composites leads to several unique advantages for energy generation and/or storage devices.</p>" ]
[ "<p id=\"Par1\">Phosphate-based glasses (PBG) with appropriate doping agents have been used as solid electrolytes in solid-state ionic devices. Therefore, more light was shed on the electrical, optical, and electrochemical behavior of the phosphate-based glasses (PBG), containing ZnO or CuO in the absence and existence of conductive polyaniline (PANI), since no publications are available concerning this work. The glass samples were prepared by the rapid quenching method, then mixing phosphate glass and polyaniline (PANI) with metal oxide (ZnO, CuO). They were characterized by different techniques; diffuse reflectance spectrophotometer (DRS), broadband dielectric spectrometer (BDS), cyclic voltammetry (CV), and charge–discharge techniques. In the DRS study, the direct and indirect band gap were calculated from Tauc’s relationship where CuO-doped glasses have higher values than ZnO-doped glasses. In the BDS study, the permittivity of all glass compositions decreased while AC conductivity increased with increasing frequency. AC conductivity of PBG doped with metal oxides and mixed with PANI exhibited semiconducting features (6.8 × 10<sup>–4</sup> S/cm). Further, these composites exhibited lower loss tangent (0.11), and giant permittivity (186,000) compared to the pure PBG. Also, the electrochemical study exhibited that the composite with 7% CuO content has the highest specific capacitance value (82.3 F/g at 1.0 A/g) which increased to about 113% of its first cycle and then decreased to about 55% after 2500 cycles and finally increased again to 77% after 4500 cycles, indicating its good stability. The combination of optical, electrical, and electrochemical features of these composites suggests their use for energy generation and storage devices.</p>", "<title>Subject terms</title>", "<p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p>" ]
[ "<title>Experimental procedure</title>", "<title>Samples preparation</title>", "<p id=\"Par4\">The studied phosphate-based glasses (50 mol% P<sub>2</sub>O<sub>5</sub>—30 mol% K<sub>2</sub>O—(20-x) mol% CaO, where x is CuO or ZnO, were prepared from pure chemical materials. Ammonium dihydrogen orthophosphate (NH<sub>4</sub>H<sub>2</sub>PO<sub>4</sub>), anhydrous potassium carbonate (K<sub>2</sub>CO<sub>3</sub>), and calcium carbonate (CaCO<sub>3</sub>) were used as sources of P<sub>2</sub>O<sub>5</sub>, K<sub>2</sub>O, and CaO, respectively. However, copper and zinc ions were introduced as their respective oxides directly (CuO, ZnO). The composition of the prepared glasses and the codes used are listed in Table ##TAB##0##1##. In covered porcelain crucibles, the weighed batches were melted in an electric furnace (Vecstar, UK) at 500 °C to expel ammonia and water, after that, the temperature was raised and fixed at 1000 °C for 60 min with frequent rotation of the crucibles at intervals to promote homogeneity and complete mixing. The melts were poured on slightly warmed stainless steel molds and the prepared samples were immediately transferred to a muffle regulated at 285 °C. Then the annealing muffle was left to cool after 1 h to room temperature.</p>", "<p id=\"Par5\">The polymer was prepared by oxidation of 5 ml of liquid aniline monomer in an acidic medium (HCl/1.25 M) by using potassium dichromate solution (K<sub>2</sub>Cr<sub>2</sub>O<sub>7</sub>/0.44 M) as an oxidant. The formed precipitate was washed with distilled water and dried in an autoclave at 70 °C for 2 h. To prepare the composite, 5 gm of the phosphate glass was ground to fine powder dissolved in distilled water and added to the polymerization bath.</p>", "<p id=\"Par6\">The glasses and the glass/polymer composites as well as their surface morphology, structure, and crystalline structure were investigated in more detail in a recently published work<sup>##UREF##15##18##</sup>.</p>", "<title>Characterization</title>", "<p id=\"Par7\">Different techniques were used to characterize the optical, electrical, and electrochemical properties of the prepared phosphate-based glasses.</p>", "<title>Diffuse reflectance spectrometer (DRS)</title>", "<p id=\"Par8\">The Diffuse reflectance spectrometer (DRS) is used to detect the direct and indirect forbidden band gap by measuring the diffuse reflectance in the wavelength range of 200–2500 nm through a double-beam spectrophotometer (JASCO: V-570 model).</p>", "<title>Broadband dielectric spectrometer (BDS)</title>", "<p id=\"Par9\">For the electric measurements, each sample was placed between the two electrodes of the measuring cell connected to a High-resolution impedance analyzer spectrometer (Schlumberger Solartron 1260). The measurements were carried out over a wide frequency range (10<sup>–1</sup> to 10<sup>6</sup> Hz) at room temperature.</p>", "<title>Electrochemical studies</title>", "<p id=\"Par10\">The electrochemical performance of phosphate-based glasses is performed by using Origalys OGS 200 potentiostat/galvanostat where the working electrode was prepared by mixing the active material, carbon black, PVDF (polyvinylidene fluoride) at the weight ratio of 80:10:10 using DMF (N, N-Dimethyl formamide) as a solvent to form a slurry and mixed by ultra-sonication for 30 min. Then 10μl of the suspension was dropped onto the surface of nickel foam with a micropipette, and then it dried at 60 °C for 40 min and then at room temperature overnight. Before that, the Ni foam was cleaned by degreasing in acetone, etching in 1 M HCl for 15 min, and subsequently washed with water and ethanol for 5 min each. The electrochemical investigations, such as cyclic voltammetry (CV) and galvanostatic charge–discharge (GCD), were carried out in a three-electrode conventional glass cell containing the electrolyte solution, which is 1.0 M KOH aqueous solution. The working electrode potential was measured against an Ag/AgCl reference electrode (<italic>E</italic>° = 0.203 V versus SHE), while pure Pt-wire was used as a counter electrode. Cyclic voltammetry curves were used to characterize the electrochemical behavior of our electrodes at different scan rates from 0.01 to 0.1V/s, covering a potential window (-0.5–1.0 V) (versus Ag/AgCl). Galvanostatic charge/discharge measurements were run in the potential window (−0.3 to 0.5 V) at current densities of 1, 3, 5, 8, and 10 A/g. All the previous methods were investigated in a recently published work<sup>##UREF##16##19##</sup>.</p>", "<title>Consent to participate</title>", "<p id=\"Par11\">The authors agree to the journal’s policy.</p>" ]
[ "<title>Author contributions</title>", "<p>R.M. Conceptualization, Formal analysis, Funding acquisition, Writing-review &amp; editing, A.Kh.H. Preparation and characterization. A.M.F. Conceptualization, Formal analysis, Funding acquisition, Writing-review &amp; editing, Writing. The authors agree to the journal’s policy.</p>", "<title>Funding</title>", "<p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p>", "<title>Data availability</title>", "<p>Data will be available from the corresponding author upon reasonable request.</p>", "<title>Competing interests</title>", "<p id=\"Par31\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>(<bold>a</bold>) The diffuse reflectance spectra, (<bold>b</bold>) the absorbance spectra of different glasses.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Tauc’s plots of different glasses (<bold>a</bold>) PBG, (<bold>b</bold>) 3Zn/PBG, (<bold>c</bold>) 7Zn/PBG, (<bold>d</bold>) 3Cu/PBG, and (<bold>e</bold>) 7Cu/PBG in the range of 200 to 2500 nm for direct and indirect cases.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>The frequency dependence of <italic>ac</italic> conductivity (<italic>σ</italic><sub><italic>ac</italic></sub>) for (<bold>a</bold>) PBG, 7Zn/PBG, 7Cu/PBG, and (<bold>b</bold>) BC, 7Zn/BC, 7Cu/BC, and PANI.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>The frequency dependence of permittivity () for (<bold>a</bold>) PBG, 7Zn/PBG, 7Cu/PBG, and (<bold>b</bold>) BC, 7Zn/BC, 7Cu/BC, and PANI.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>The frequency dependence of loss tangent (<italic>tanδ</italic>) for (<bold>a</bold>) PBG, 7Zn/PBG, 7Cu/PBG, and (<bold>b</bold>) BC, 7Zn/BC, 7Cu/BC, and PANI.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>The frequency dependence of the electric loss modulus for PBG, 7Zn/PBG, 7Cu/PBG, BC, 7Zn/BC, 7Cu/BC, and PANI.</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>Cyclic voltammetry for (<bold>a</bold>) BC, (<bold>b</bold>) 7Zn/BC, (<bold>c</bold>) 7Cu/BC in 1.0 M KOH aqueous solution at different scan rates (0.01–0.1 V/s), (<bold>d</bold>) the relation between the scan rate and the specific capacitance for the three samples, (<bold>e</bold>) the relation between logarithm scan rate and logarithm current for the three samples.</p></caption></fig>", "<fig id=\"Fig8\"><label>Figure 8</label><caption><p>Galvanostatic charge–discharge curves in 1.0 M KOH (<bold>a</bold>) BC, (<bold>b</bold>) 7Zn/BC, and (<bold>c</bold>) 7Cu/BC at various current densities and (<bold>d</bold>) the relation between the applied current density and the specific capacitance for the three samples.</p></caption></fig>", "<fig id=\"Fig9\"><label>Figure 9</label><caption><p>Charge–discharge cycling stability curve for 7Cu/BC at a current density of 8 A/g (the inset figures is for the first 10 cycle and the charge–discharge of the first and the 4500 the cycle).</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Codes of the prepared samples.</p></caption><table frame=\"hsides\" rules=\"groups\"><tbody><tr><td align=\"left\">PBG</td><td align=\"left\">(P<sub>2</sub>O<sub>5</sub> 50 mol%–K<sub>2</sub>O 30 mol%–CaO 20 mol%)</td></tr><tr><td align=\"left\">3Zn/PBG</td><td align=\"left\">(P<sub>2</sub>O<sub>5</sub> 50 mol%–K<sub>2</sub>O 30 mol%–CaO 17 mol%–ZnO 3mol%)</td></tr><tr><td align=\"left\">7Zn/PBG</td><td align=\"left\">(P<sub>2</sub>O<sub>5</sub> 50 mol%–K<sub>2</sub>O 30 mol%–CaO 13 mol%–ZnO 7mol%)</td></tr><tr><td align=\"left\">3Cu/PBG</td><td align=\"left\">(P<sub>2</sub>O<sub>5</sub> 50 mol%–K<sub>2</sub>O 30 mol%–CaO 17 mol%–CuO 3mol%)</td></tr><tr><td align=\"left\">7Cu/PBG</td><td align=\"left\">(P<sub>2</sub>O<sub>5</sub> 50 mol%–K<sub>2</sub>O 30 mol%–CaO 13 mol%–CuO 7mol%)</td></tr><tr><td align=\"left\">BC</td><td align=\"left\">PBG/PANi</td></tr><tr><td align=\"left\">7Zn/BC</td><td align=\"left\">PBG/PANi/7Zn</td></tr><tr><td align=\"left\">7Cu/BC</td><td align=\"left\">PBG/PANi/7Cu</td></tr><tr><td align=\"left\">PANI</td><td align=\"left\">Polyaniline (PANi)</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>The theoretical optical basicity, direct and indirect band gap energy for some of the prepared glasses.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Sample</th><th align=\"left\"></th><th align=\"left\">E<sub>g</sub> (direct), eV</th><th align=\"left\">E<sub>g</sub> (indirect), eV</th></tr></thead><tbody><tr><td align=\"left\">PBG</td><td char=\".\" align=\"char\">1.80</td><td char=\".\" align=\"char\">4.04</td><td char=\".\" align=\"char\">4.40</td></tr><tr><td align=\"left\">3Zn/PBG</td><td char=\".\" align=\"char\">1.80</td><td char=\".\" align=\"char\">3.80</td><td char=\".\" align=\"char\">3.80</td></tr><tr><td align=\"left\">7Zn/PBG</td><td char=\".\" align=\"char\">1.81</td><td char=\".\" align=\"char\">4.04</td><td char=\".\" align=\"char\">4.49</td></tr><tr><td align=\"left\">3Cu/PBG</td><td char=\".\" align=\"char\">1.80</td><td char=\".\" align=\"char\">4.28</td><td char=\".\" align=\"char\">4.76</td></tr><tr><td align=\"left\">7Cu/PBG</td><td char=\".\" align=\"char\">1.81</td><td char=\".\" align=\"char\">4.18</td><td char=\".\" align=\"char\">4.59</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>The dielectric properties measured at 10<sup>3</sup> Hz for the pure PANI, and different glass compositions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Samples</th><th align=\"left\"><italic>σ</italic><sub><italic>ac</italic></sub> (S/cm)</th><th align=\"left\"></th><th align=\"left\"><italic>tanδ</italic></th></tr></thead><tbody><tr><td align=\"left\">Base Glass</td><td align=\"left\">7.6 × 10<sup>–8</sup></td><td align=\"left\">1.4</td><td char=\".\" align=\"char\">0.22</td></tr><tr><td align=\"left\">7 Zn/PBG</td><td align=\"left\">3.5 × 10<sup>–7</sup></td><td align=\"left\">15</td><td char=\".\" align=\"char\">0.43</td></tr><tr><td align=\"left\">7 Cu/PBG</td><td align=\"left\">9.2 × 10<sup>–7</sup></td><td align=\"left\">24</td><td char=\".\" align=\"char\">0.7</td></tr><tr><td align=\"left\">BC</td><td align=\"left\">4.2 × 10<sup>–5</sup></td><td align=\"left\">1664</td><td char=\".\" align=\"char\">1.02</td></tr><tr><td align=\"left\">7 Zn/BC</td><td align=\"left\">7.2 × 10<sup>–5</sup></td><td align=\"left\">3655</td><td char=\".\" align=\"char\">0.8</td></tr><tr><td align=\"left\">7 Cu/BC</td><td align=\"left\">6.8 × 10<sup>–4</sup></td><td align=\"left\">186,000</td><td char=\".\" align=\"char\">0.11</td></tr><tr><td align=\"left\">PANI</td><td align=\"left\">3 × 10<sup>–4</sup></td><td align=\"left\">14,735</td><td char=\".\" align=\"char\">0.36</td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$({\\Lambda }_{{\\text{th}}}$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mtext>th</mml:mtext></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\Lambda }_{{\\text{i}}}$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:msub><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mtext>i</mml:mtext></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\mathbf{X}}_{\\mathbf{i}}$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:msub><mml:mi mathvariant=\"bold\">X</mml:mi><mml:mi mathvariant=\"bold\">i</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\Lambda }_{{\\text{th}}} = \\sum {{Z}_{i}{\\text{X}}}_{{\\text{i}}}{\\Lambda }_{{\\text{i}}}$$\\end{document}</tex-math><mml:math id=\"M8\" display=\"block\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mtext>th</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:mo>∑</mml:mo><mml:msub><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mtext>X</mml:mtext></mml:mrow><mml:mtext>i</mml:mtext></mml:msub><mml:msub><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mtext>i</mml:mtext></mml:msub></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\text{X}}}_{{\\text{i}}}$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:msub><mml:mtext>X</mml:mtext><mml:mtext>i</mml:mtext></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${Z}_{i,}$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\Lambda }_{{\\text{i}}}$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:msub><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mtext>i</mml:mtext></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equb\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\Lambda }_{{\\text{th}}/{\\text{BC}}}=[\\mathrm{X }\\left({{\\text{P}}}_{2}{{\\text{O}}}_{5}\\right)\\Lambda \\left({{\\text{P}}}_{2}{{\\text{O}}}_{5} \\right)+\\mathrm{ X }\\left({{\\text{K}}}_{2}O\\right)\\Lambda \\left({{\\text{K}}}_{2}O \\right)+\\mathrm{ X }\\left({\\text{CaO}}\\right)\\Lambda \\left(\\mathrm{CaO }\\right)]$$\\end{document}</tex-math><mml:math id=\"M16\" display=\"block\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mrow><mml:mtext>th</mml:mtext><mml:mo stretchy=\"false\">/</mml:mo><mml:mtext>BC</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mi mathvariant=\"normal\">X</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mtext>P</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mtext>O</mml:mtext><mml:mn>5</mml:mn></mml:msub></mml:mfenced><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mtext>P</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mtext>O</mml:mtext><mml:mn>5</mml:mn></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">X</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mtext>K</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mi>O</mml:mi></mml:mfenced><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mtext>K</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mi>O</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">X</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mtext>CaO</mml:mtext></mml:mfenced><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi mathvariant=\"normal\">CaO</mml:mi></mml:mfenced><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equc\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\Lambda }_{{\\text{th}}/{\\text{Zn}}}=[\\mathrm{X }\\left({{\\text{P}}}_{2}{{\\text{O}}}_{5}\\right)\\Lambda \\left({{\\text{P}}}_{2}{{\\text{O}}}_{5} \\right)+\\mathrm{ X }\\left({{\\text{K}}}_{2}O\\right)\\Lambda \\left({{\\text{K}}}_{2}O \\right)+\\mathrm{ X }\\left({\\text{CaO}}\\right)\\Lambda \\left(\\mathrm{CaO }\\right)+\\mathrm{X }\\left(ZnO\\right)\\Lambda \\left(ZnO \\right)]$$\\end{document}</tex-math><mml:math id=\"M18\" display=\"block\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mrow><mml:mtext>th</mml:mtext><mml:mo stretchy=\"false\">/</mml:mo><mml:mtext>Zn</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mi mathvariant=\"normal\">X</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mtext>P</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mtext>O</mml:mtext><mml:mn>5</mml:mn></mml:msub></mml:mfenced><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mtext>P</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mtext>O</mml:mtext><mml:mn>5</mml:mn></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">X</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mtext>K</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mi>O</mml:mi></mml:mfenced><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mtext>K</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mi>O</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">X</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mtext>CaO</mml:mtext></mml:mfenced><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi mathvariant=\"normal\">CaO</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">X</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>Z</mml:mi><mml:mi>n</mml:mi><mml:mi>O</mml:mi></mml:mfenced><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>Z</mml:mi><mml:mi>n</mml:mi><mml:mi>O</mml:mi></mml:mfenced><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equd\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\Lambda }_{{\\text{th}}/{\\text{Cu}}}=[\\mathrm{X }\\left({{\\text{P}}}_{2}{{\\text{O}}}_{5}\\right)\\Lambda \\left({{\\text{P}}}_{2}{{\\text{O}}}_{5} \\right)+\\mathrm{ X }\\left({{\\text{K}}}_{2}O\\right)\\Lambda \\left({{\\text{K}}}_{2}O \\right)+\\mathrm{ X }\\left({\\text{CaO}}\\right)\\Lambda \\left(\\mathrm{CaO }\\right)+\\mathrm{X }\\left(CuO\\right)\\Lambda \\left(CuO \\right)]$$\\end{document}</tex-math><mml:math id=\"M20\" display=\"block\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mrow><mml:mtext>th</mml:mtext><mml:mo stretchy=\"false\">/</mml:mo><mml:mtext>Cu</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mi mathvariant=\"normal\">X</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mtext>P</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mtext>O</mml:mtext><mml:mn>5</mml:mn></mml:msub></mml:mfenced><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mtext>P</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mtext>O</mml:mtext><mml:mn>5</mml:mn></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">X</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mtext>K</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mi>O</mml:mi></mml:mfenced><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mtext>K</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mi>O</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">X</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mtext>CaO</mml:mtext></mml:mfenced><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi mathvariant=\"normal\">CaO</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">X</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>C</mml:mi><mml:mi>u</mml:mi><mml:mi>O</mml:mi></mml:mfenced><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>C</mml:mi><mml:mi>u</mml:mi><mml:mi>O</mml:mi></mml:mfenced><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\text{P}}}_{2}{{\\text{O}}}_{5}$$\\end{document}</tex-math><mml:math id=\"M22\"><mml:mrow><mml:msub><mml:mtext>P</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mtext>O</mml:mtext><mml:mn>5</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\text{K}}}_{2}{\\text{O}}$$\\end{document}</tex-math><mml:math id=\"M24\"><mml:mrow><mml:msub><mml:mtext>K</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mtext>O</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M25\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\Lambda }_{{\\text{th}}}$$\\end{document}</tex-math><mml:math id=\"M26\"><mml:msub><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mtext>th</mml:mtext></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M27\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\alpha }_{o}^{2-})$$\\end{document}</tex-math><mml:math id=\"M28\"><mml:mrow><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>o</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>-</mml:mo></mml:mrow></mml:msubsup><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq18\"><alternatives><tex-math id=\"M29\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\Lambda }_{th}$$\\end{document}</tex-math><mml:math id=\"M30\"><mml:msub><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">th</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M31\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\Lambda }_{th}=1.67[1-\\left(\\frac{1}{{\\alpha }_{o}^{2-}}\\right)]$$\\end{document}</tex-math><mml:math id=\"M32\" display=\"block\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">Λ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">th</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1.67</mml:mn><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mfrac><mml:mn>1</mml:mn><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>o</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>-</mml:mo></mml:mrow></mml:msubsup></mml:mfrac></mml:mfenced><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq400\"><alternatives><tex-math id=\"M33\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varepsilon^{\\prime}$$\\end{document}</tex-math><mml:math id=\"M34\"><mml:msup><mml:mi>ε</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq415\"><alternatives><tex-math id=\"M35\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varepsilon^{\\prime}$$\\end{document}</tex-math><mml:math id=\"M36\"><mml:msup><mml:mi>ε</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq416\"><alternatives><tex-math id=\"M37\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varepsilon^{\\prime}$$\\end{document}</tex-math><mml:math id=\"M38\"><mml:msup><mml:mi>ε</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M39\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{ac}=\\sigma \\left(\\omega \\right)-{\\sigma }_{dc}=A{\\omega }^{s}$$\\end{document}</tex-math><mml:math id=\"M40\" display=\"block\"><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">ac</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>σ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>ω</mml:mi></mml:mfenced><mml:mo>-</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">dc</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>A</mml:mi><mml:msup><mml:mrow><mml:mi>ω</mml:mi></mml:mrow><mml:mi>s</mml:mi></mml:msup></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq401\"><alternatives><tex-math id=\"M41\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varepsilon^{\\prime}$$\\end{document}</tex-math><mml:math id=\"M42\"><mml:msup><mml:mi>ε</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq402\"><alternatives><tex-math id=\"M43\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varepsilon^{\\prime}$$\\end{document}</tex-math><mml:math id=\"M44\"><mml:msup><mml:mi>ε</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ4\"><label>4</label><alternatives><tex-math id=\"M45\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varepsilon^{\\prime} (\\omega )=C(\\omega )\\frac{d}{{\\varepsilon }_{o}A}$$\\end{document}</tex-math><mml:math id=\"M46\" display=\"block\"><mml:mrow><mml:msup><mml:mi>ε</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>C</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>ω</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:msub><mml:mi>ε</mml:mi><mml:mi>o</mml:mi></mml:msub><mml:mi>A</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq403\"><alternatives><tex-math id=\"M47\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varepsilon^{\\prime}$$\\end{document}</tex-math><mml:math id=\"M48\"><mml:msup><mml:mi>ε</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq404\"><alternatives><tex-math id=\"M49\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varepsilon^{\\prime}$$\\end{document}</tex-math><mml:math id=\"M50\"><mml:msup><mml:mi>ε</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq405\"><alternatives><tex-math id=\"M51\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varepsilon^{\\prime\\prime}$$\\end{document}</tex-math><mml:math id=\"M52\"><mml:msup><mml:mi>ε</mml:mi><mml:mo>″</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq406\"><alternatives><tex-math id=\"M53\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varepsilon^{\\prime}$$\\end{document}</tex-math><mml:math id=\"M54\"><mml:msup><mml:mi>ε</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq407\"><alternatives><tex-math id=\"M55\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varepsilon^{\\prime}$$\\end{document}</tex-math><mml:math id=\"M56\"><mml:msup><mml:mi>ε</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq408\"><alternatives><tex-math id=\"M57\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varepsilon^{\\prime\\prime}$$\\end{document}</tex-math><mml:math id=\"M58\"><mml:msup><mml:mi>ε</mml:mi><mml:mo>″</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq409\"><alternatives><tex-math id=\"M59\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varepsilon^{\\prime}$$\\end{document}</tex-math><mml:math id=\"M60\"><mml:msup><mml:mi>ε</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ5\"><label>5</label><alternatives><tex-math id=\"M61\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$tan\\delta \\left(\\omega \\right)=\\frac{\\varepsilon ^{\\prime\\prime} \\left(\\omega \\right)}{\\varepsilon^{\\prime} \\left(\\omega \\right)}$$\\end{document}</tex-math><mml:math id=\"M62\" display=\"block\"><mml:mrow><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>δ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>ω</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>ε</mml:mi><mml:mo>″</mml:mo></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>ω</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:msup><mml:mi>ε</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>ω</mml:mi></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq410\"><alternatives><tex-math id=\"M63\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text{M}^{\\prime\\prime}=\\varepsilon^{\\prime\\prime} / \\varepsilon^{\\prime{2}} + \\varepsilon^{\\prime\\prime{2}}$$\\end{document}</tex-math><mml:math id=\"M64\"><mml:mrow><mml:msup><mml:mtext>M</mml:mtext><mml:mo>″</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:msup><mml:mi>ε</mml:mi><mml:mo>″</mml:mo></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:msup><mml:mi>ε</mml:mi><mml:mrow><mml:mo>′</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mi>ε</mml:mi><mml:mrow><mml:mo>″</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq417\"><alternatives><tex-math id=\"M65\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varepsilon^{\\prime}$$\\end{document}</tex-math><mml:math id=\"M66\"><mml:msup><mml:mi>ε</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq418\"><alternatives><tex-math id=\"M67\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varepsilon^{\\prime}$$\\end{document}</tex-math><mml:math id=\"M68\"><mml:msup><mml:mi>ε</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M69\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upsilon$$\\end{document}</tex-math><mml:math id=\"M70\"><mml:mi>υ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq12\"><alternatives><tex-math id=\"M71\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(\\int IdV)$$\\end{document}</tex-math><mml:math id=\"M72\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mo>∫</mml:mo><mml:mi>I</mml:mi><mml:mi>d</mml:mi><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ6\"><label>6</label><alternatives><tex-math id=\"M73\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${C}_{s}= \\frac{\\int IdV}{2m\\upsilon \\Delta V}$$\\end{document}</tex-math><mml:math id=\"M74\" display=\"block\"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>∫</mml:mo><mml:mi>I</mml:mi><mml:mi>d</mml:mi><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mi>m</mml:mi><mml:mi>υ</mml:mi><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>V</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq13\"><alternatives><tex-math id=\"M75\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta V$$\\end{document}</tex-math><mml:math id=\"M76\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>V</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq14\"><alternatives><tex-math id=\"M77\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upsilon$$\\end{document}</tex-math><mml:math id=\"M78\"><mml:mi>υ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq15\"><alternatives><tex-math id=\"M79\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${i}_{p}$$\\end{document}</tex-math><mml:math id=\"M80\"><mml:msub><mml:mi>i</mml:mi><mml:mi>p</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq16\"><alternatives><tex-math id=\"M81\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$log \\upsilon$$\\end{document}</tex-math><mml:math id=\"M82\"><mml:mrow><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>g</mml:mi><mml:mi>υ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ7\"><label>7</label><alternatives><tex-math id=\"M83\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{log}}{i}_{p}={\\text{log}}a+b log \\upsilon$$\\end{document}</tex-math><mml:math id=\"M84\" display=\"block\"><mml:mrow><mml:mtext>log</mml:mtext><mml:msub><mml:mi>i</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mtext>log</mml:mtext><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>g</mml:mi><mml:mi>υ</mml:mi></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq17\"><alternatives><tex-math id=\"M85\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\int V(t)dt$$\\end{document}</tex-math><mml:math id=\"M86\"><mml:mrow><mml:mo>∫</mml:mo><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ8\"><label>8</label><alternatives><tex-math id=\"M87\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${C}_{s}=\\frac{I\\int V(t)dt}{m (\\Delta V{)}^{2}}$$\\end{document}</tex-math><mml:math id=\"M88\" display=\"block\"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mi>s</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>I</mml:mi><mml:mo>∫</mml:mo><mml:mi>V</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>V</mml:mi><mml:msup><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq3.gif\"/>", "<graphic xlink:href=\"41598_2023_51065_Article_Equ1.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq6.gif\"/>", "<graphic xlink:href=\"41598_2023_51065_Article_Equb.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_51065_Article_Equc.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_51065_Article_Equd.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq9.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq10.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq18.gif\"/>", "<graphic xlink:href=\"41598_2023_51065_Article_Equ2.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_51065_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2023_51065_Fig2_HTML\" id=\"MO2\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq400.gif\"/>", "<graphic xlink:href=\"41598_2023_51065_Fig3_HTML\" id=\"MO3\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq415.gif\"/>", "<graphic xlink:href=\"41598_2023_51065_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2023_51065_Fig5_HTML\" id=\"MO5\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq416.gif\"/>", "<graphic xlink:href=\"41598_2023_51065_Article_Equ3.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq401.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq402.gif\"/>", "<graphic xlink:href=\"41598_2023_51065_Article_Equ4.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq403.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq404.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq405.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq406.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq407.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq408.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq409.gif\"/>", "<graphic xlink:href=\"41598_2023_51065_Article_Equ5.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq410.gif\"/>", "<graphic xlink:href=\"41598_2023_51065_Fig6_HTML\" id=\"MO6\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq417.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq418.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq11.gif\"/>", "<graphic xlink:href=\"41598_2023_51065_Fig7_HTML\" id=\"MO7\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq12.gif\"/>", "<graphic xlink:href=\"41598_2023_51065_Article_Equ6.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq13.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq14.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq15.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq16.gif\"/>", "<graphic xlink:href=\"41598_2023_51065_Article_Equ7.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_51065_Article_IEq17.gif\"/>", "<graphic xlink:href=\"41598_2023_51065_Article_Equ8.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_51065_Fig8_HTML\" id=\"MO8\"/>", "<graphic xlink:href=\"41598_2023_51065_Fig9_HTML\" id=\"MO9\"/>" ]
[]
[{"label": ["1."], "surname": ["Karabulut", "Melnik", "Stefan", "Marasinghe", "Ray", "Kurkjian", "Day"], "given-names": ["M", "E", "R", "G", "C", "C", "D"], "article-title": ["Mechanical and structural properties of phosphate glasses"], "source": ["J. Non-Cryst. Solids"], "year": ["2001"], "volume": ["288"], "fpage": ["8"], "lpage": ["17"], "pub-id": ["10.1016/S0022-3093(01)00615-9"]}, {"label": ["2."], "surname": ["Rao", "Kumar", "Babu", "Jayasankar"], "given-names": ["CS", "KU", "P", "C"], "article-title": ["Optical properties of Ho"], "sup": ["3+"], "source": ["Opt. Mater."], "year": ["2012"], "volume": ["35"], "fpage": ["102"], "lpage": ["107"], "pub-id": ["10.1016/j.optmat.2012.07.023"]}, {"label": ["3."], "surname": ["Brow"], "given-names": ["RK"], "article-title": ["The structure of simple phosphate glasses"], "source": ["J. Non-Cryst. Solids"], "year": ["2000"], "volume": ["263"], "fpage": ["1"], "lpage": ["28"], "pub-id": ["10.1016/S0022-3093(99)00620-1"]}, {"label": ["4."], "surname": ["Najjar", "Katourani", "Hosseini"], "given-names": ["R", "S", "M"], "article-title": ["Self-healing and corrosion protection performance of organic [email protected] resin core-shell nanoparticles in epoxy/PANI/ZnO nanocomposite coatings on anodized aluminum alloy"], "source": ["Prog. Org. Coat"], "year": ["2018"], "volume": ["124"], "fpage": ["110"], "lpage": ["121"], "pub-id": ["10.1016/j.porgcoat.2018.08.015"]}, {"label": ["5."], "surname": ["Du", "Zhang", "Liu", "Deng"], "given-names": ["X", "Z", "W", "Y"], "article-title": ["Nanocellulose-based conductive materials and their emerging applications in energy devices\u2014A review"], "source": ["Nano Energy"], "year": ["2017"], "volume": ["35"], "fpage": ["299"], "lpage": ["320"], "pub-id": ["10.1016/j.nanoen.2017.04.001"]}, {"label": ["6."], "surname": ["Liao", "Chen", "Zeng", "Yu", "Yi", "Xu"], "given-names": ["G", "J", "W", "C", "C", "Z"], "article-title": ["Facile preparation of uniform nanocomposite spheres with loading silver nanoparticles on polystyrene-methyl acrylic acid spheres for catalytic reduction of 4-nitrophenol"], "source": ["J. Phys. Chem. C"], "year": ["2016"], "volume": ["120"], "fpage": ["25935"], "lpage": ["25944"], "pub-id": ["10.1021/acs.jpcc.6b09356"]}, {"label": ["7."], "surname": ["Liao", "Li", "Zhao", "Pang", "Gao", "Xu"], "given-names": ["G", "Q", "W", "Q", "H", "Z"], "article-title": ["In-situ construction of novel silver nanoparticle decorated polymeric spheres as highly active and stable catalysts for reduction of methylene blue dye"], "source": ["Appl. Catal. A Gen."], "year": ["2018"], "volume": ["549"], "fpage": ["102"], "lpage": ["111"], "pub-id": ["10.1016/j.apcata.2017.09.034"]}, {"label": ["8."], "surname": ["Gustafsson", "Cao", "Treacy", "Klavetter", "Colaneri", "Heeger"], "given-names": ["G", "Y", "G", "F", "N", "A"], "article-title": ["Flexible light-emitting diodes made from soluble conducting polymers"], "source": ["Nature"], "year": ["1992"], "volume": ["357"], "fpage": ["477"], "lpage": ["479"], "pub-id": ["10.1038/357477a0"]}, {"label": ["10."], "mixed-citation": ["Gough, J. Cartilage tissue engineering. In "], "italic": ["Tissue Engineering Using Ceramics and Polymers"]}, {"label": ["11."], "mixed-citation": ["El-Meliegy, E., van Noort, R., El-Meliegy, E. & van Noort, R. "], "italic": ["History, Market and Classification of Bioceramics, Glasses and Glass Ceramics for Medical Applications"]}, {"label": ["12."], "surname": ["Farag", "Yun"], "given-names": ["M", "H-S"], "article-title": ["Effect of gelatin addition on fabrication of magnesium phosphate-based scaffolds prepared by additive manufacturing system"], "source": ["Mater. Lett."], "year": ["2014"], "volume": ["132"], "fpage": ["111"], "lpage": ["115"], "pub-id": ["10.1016/j.matlet.2014.06.055"]}, {"label": ["13."], "surname": ["Abrahams", "Hadzifejzovic"], "given-names": ["I", "E"], "article-title": ["Lithium ion conductivity and thermal behaviour of glasses and crystallised glasses in the system Li"], "sub": ["2", "2", "3", "2", "2", "5"], "source": ["Solid State Ionics"], "year": ["2000"], "volume": ["134"], "fpage": ["249"], "lpage": ["257"], "pub-id": ["10.1016/S0167-2738(00)00768-2"]}, {"label": ["14."], "surname": ["Bhide", "Hariharan"], "given-names": ["A", "K"], "article-title": ["Sodium ion transport in NaPO"], "sub": ["3", "2", "4"], "source": ["Mater. Chem. Phys."], "year": ["2007"], "volume": ["105"], "fpage": ["213"], "lpage": ["221"], "pub-id": ["10.1016/j.matchemphys.2007.04.044"]}, {"label": ["15."], "surname": ["Proulx", "Cormier", "Capobianco", "Champagnon", "Bettinelli"], "given-names": ["P", "G", "J", "B", "M"], "article-title": ["Raman and low frequency Raman spectroscopy of lead, zinc and barium metaphosphate glasses doped with Eu"], "sup": ["3+"], "source": ["J. Phys. Condens. Matter"], "year": ["1994"], "volume": ["6"], "fpage": ["275"], "pub-id": ["10.1088/0953-8984/6/1/027"]}, {"label": ["17."], "mixed-citation": ["V. Stani\u0107, Variation in properties of bioactive glasses after surface modification. In "], "italic": ["Clinical Applications of Biomaterials: State-of-the-Art Progress, Trends, and Novel Approaches"]}, {"label": ["18."], "surname": ["Helmy", "ElBatal", "ElBatal", "Ouis", "Gamal", "El-Salam"], "given-names": ["AK", "H", "F", "M", "A", "A"], "article-title": ["Preparation and characterization of some composite phosphate glass-polyaniline derivatives studying their antimicrobial activity"], "source": ["Egypt. J. Chem."], "year": ["2021"], "volume": ["64"], "fpage": ["5315"], "lpage": ["5326"]}, {"label": ["19."], "surname": ["Mansour", "Fathi", "AbouHammad", "El Nahrawy"], "given-names": ["A", "A", "AB", "AM"], "article-title": ["Microstructures, optical and electrochemical properties of advanced Fe"], "sub": ["0.8", "0.14", "0.06", "4"], "source": ["Physica Scripta"], "year": ["2023"], "volume": ["98"], "fpage": ["055922"], "pub-id": ["10.1088/1402-4896/acc9ea"]}, {"label": ["20."], "mixed-citation": ["Uhlmann, D.R. & Kreidl, N.J. "], "italic": ["Optical Properties of Glass"]}, {"label": ["21."], "surname": ["Dimitrov", "Komatsu"], "given-names": ["V", "T"], "article-title": ["Classification of oxide glasses: A polarizability approach"], "source": ["J. Solid State Chem."], "year": ["2005"], "volume": ["178"], "fpage": ["831"], "lpage": ["846"], "pub-id": ["10.1016/j.jssc.2004.12.013"]}, {"label": ["22."], "surname": ["Abdel-Hameed", "Fathi", "Eltohamy"], "given-names": ["S", "A", "M"], "article-title": ["Structure, optical and electrical behaviour of x (2Bi"], "sub": ["2", "3", "2", "3"], "source": ["J. Non-Cryst. Solids"], "year": ["2019"], "volume": ["510"], "fpage": ["71"], "lpage": ["80"], "pub-id": ["10.1016/j.jnoncrysol.2019.01.010"]}, {"label": ["23."], "mixed-citation": ["Allibert, M. & Eisenh\u00fcttenleute, V.D. "], "italic": ["Slag Atlas"]}, {"label": ["24."], "surname": ["Samir", "Hassan", "Abokhadra", "Soliman", "Elokr"], "given-names": ["A", "MA", "A", "L", "M"], "article-title": ["Characterization of borate glasses doped with copper oxide for optical application"], "source": ["Opt. Quantum Electron."], "year": ["2019"], "volume": ["51"], "fpage": ["1"], "lpage": ["13"], "pub-id": ["10.1007/s11082-019-1819-7"]}, {"label": ["25."], "surname": ["Mansour", "Abou Hammad", "Bakr", "El Nahrawy"], "given-names": ["A", "AB", "AM", "AM"], "article-title": ["Silica zinc titanate wide bandgap semiconductor nanocrystallites: Synthesis and characterization"], "source": ["Silicon"], "year": ["2022"], "volume": ["14"], "fpage": ["11715"], "lpage": ["11729"], "pub-id": ["10.1007/s12633-022-01886-2"]}, {"label": ["26."], "surname": ["Salem", "Abou-Elnasr", "El-Gammal", "Mahmoud", "Saudi", "Mostafa"], "given-names": ["SM", "TZ", "WA", "AS", "HA", "AG"], "article-title": ["Optical parameters and electrical transport properties of some barium-sodium-borate glasses doped bismuth oxide"], "source": ["Am. J. Aerosp. Eng."], "year": ["2018"], "volume": ["5"], "fpage": ["1"], "lpage": ["8"], "pub-id": ["10.11648/j.ajae.20180501.11"]}, {"label": ["27."], "surname": ["Tan", "Hassan", "Wahab"], "given-names": ["FK", "J", "ZA"], "article-title": ["Electrical conductivity and dielectric behaviour of manganese and vanadium mixed oxide prepared by conventional solid state method"], "source": ["Eng. Sci. Technol. Int. J."], "year": ["2016"], "volume": ["19"], "fpage": ["2081"], "lpage": ["2087"]}, {"label": ["28."], "surname": ["Jlassi", "Sdiri", "Elhouichet"], "given-names": ["I", "N", "H"], "article-title": ["Electrical conductivity and dielectric properties of MgO doped lithium phosphate glasses"], "source": ["J. Non-Cryst. Solids"], "year": ["2017"], "volume": ["466"], "fpage": ["45"], "lpage": ["51"], "pub-id": ["10.1016/j.jnoncrysol.2017.03.042"]}, {"label": ["29."], "surname": ["Jonscher"], "given-names": ["AK"], "article-title": ["The \u2018universal\u2019 dielectric response"], "source": ["Nature"], "year": ["1977"], "volume": ["267"], "fpage": ["673"], "lpage": ["679"], "pub-id": ["10.1038/267673a0"]}, {"label": ["30."], "surname": ["Elliott"], "given-names": ["S"], "article-title": ["A theory of ac conduction in chalcogenide glasses"], "source": ["Philos. Mag."], "year": ["1977"], "volume": ["36"], "fpage": ["1291"], "lpage": ["1304"], "pub-id": ["10.1080/14786437708238517"]}, {"label": ["31."], "surname": ["Long"], "given-names": ["A"], "article-title": ["Electronic transport in amorphous semiconductors"], "source": ["Adv. Phys."], "year": ["1982"], "volume": ["31"], "fpage": ["553"], "pub-id": ["10.1080/00018738200101418"]}, {"label": ["32."], "surname": ["Ghosh"], "given-names": ["A"], "article-title": ["Frequency-dependent conductivity in bismuth-vanadate glassy semiconductors"], "source": ["Phys. Rev. B"], "year": ["1990"], "volume": ["41"], "fpage": ["1479"], "pub-id": ["10.1103/PhysRevB.41.1479"]}, {"label": ["33."], "surname": ["El-Desoky", "Tahoon", "Hassaan"], "given-names": ["M", "K", "M"], "article-title": ["Conductivity and dielectric behaviour of iron sodium phosphate glasses"], "source": ["Mater. Chem. Phys."], "year": ["2001"], "volume": ["69"], "fpage": ["180"], "lpage": ["185"], "pub-id": ["10.1016/S0254-0584(00)00387-4"]}, {"label": ["34."], "surname": ["Mott", "Davis"], "given-names": ["NF", "EA"], "source": ["Electronic Processes in Non-Crystalline Materials"], "year": ["2012"], "publisher-name": ["Oxford University Press"]}, {"label": ["35."], "surname": ["Dyre"], "given-names": ["JC"], "article-title": ["The random free-energy barrier model for ac conduction in disordered solids"], "source": ["J. Appl. Phys."], "year": ["1988"], "volume": ["64"], "fpage": ["2456"], "lpage": ["2468"], "pub-id": ["10.1063/1.341681"]}, {"label": ["36."], "surname": ["Clark"], "given-names": ["MJ"], "source": ["Electricity and Magnetism"], "year": ["1873"], "publisher-name": ["Clarendon Press"]}, {"label": ["37."], "surname": ["Wagner"], "given-names": ["KW"], "article-title": ["Erkl\u00e4rung der dielektrischen nachwirkungsvorg\u00e4nge auf grund maxwellscher vorstellungen"], "source": ["Arch. Elektrotech."], "year": ["1914"], "volume": ["2"], "fpage": ["371"], "lpage": ["387"], "pub-id": ["10.1007/BF01657322"]}, {"label": ["38."], "surname": ["Sillars"], "given-names": ["R"], "article-title": ["The properties of a dielectric containing semiconducting particles of various shapes"], "source": ["J. Inst. Electric. Eng."], "year": ["1937"], "volume": ["80"], "fpage": ["378"], "lpage": ["394"]}, {"label": ["39."], "surname": ["Barsoum"], "given-names": ["MW"], "source": ["Fundamentals of Ceramics"], "year": ["2019"], "publisher-name": ["CRC Press"]}, {"label": ["40."], "surname": ["Nelson", "Fothergill"], "given-names": ["JK", "JC"], "article-title": ["Internal charge behaviour of nanocomposites"], "source": ["Nanotechnology"], "year": ["2004"], "volume": ["15"], "fpage": ["586"], "pub-id": ["10.1088/0957-4484/15/5/032"]}, {"label": ["41."], "mixed-citation": ["Debye, P. "], "italic": ["Polar Molecules Chemical Catalog 22"]}, {"label": ["42."], "surname": ["Papathanassiou", "Mykhailiv", "Echegoyen", "Sakellis", "Plonska-Brzezinska"], "given-names": ["AN", "O", "L", "I", "ME"], "article-title": ["Electric properties of carbon nano-onion/polyaniline composites: A combined electric modulus and ac conductivity study"], "source": ["J. Phys. D Appl. Phys."], "year": ["2016"], "volume": ["49"], "fpage": ["285305"], "pub-id": ["10.1088/0022-3727/49/28/285305"]}, {"label": ["43."], "surname": ["Kolonelou", "Papathanassiou", "Sakellis"], "given-names": ["E", "AN", "E"], "article-title": ["Evidence of local softening in glassy poly (vinyl alcohol)/poly (vinyl pyrrolidone)(1/1, w/w) nano-graphene platelets composites"], "source": ["Mater. Chem. Phys."], "year": ["2019"], "volume": ["223"], "fpage": ["140"], "lpage": ["144"], "pub-id": ["10.1016/j.matchemphys.2018.10.058"]}, {"label": ["44."], "surname": ["Elissalde", "Ravez"], "given-names": ["B", "J"], "article-title": ["Ferroelectric ceramics: Defects and dielectric relaxations"], "source": ["J. Mater. Chem."], "year": ["2001"], "volume": ["11"], "fpage": ["1957"], "lpage": ["1967"], "pub-id": ["10.1039/b010117f"]}, {"label": ["45."], "surname": ["Austin", "Mott"], "given-names": ["I", "NF"], "article-title": ["Polarons in crystalline and non-crystalline materials"], "source": ["Adv. Phys."], "year": ["1969"], "volume": ["18"], "fpage": ["41"], "lpage": ["102"], "pub-id": ["10.1080/00018736900101267"]}, {"label": ["46."], "surname": ["Molt"], "given-names": ["NF"], "article-title": ["Conduction in glasses containing transition metal ions"], "source": ["J. Noncryst. Solid"], "year": ["1986"], "volume": ["1"], "fpage": ["1"]}, {"label": ["47."], "surname": ["Choudhary"], "given-names": ["BP"], "article-title": ["Electrical and dielectric behavior of zinc phosphate glasses"], "source": ["Mater. Today Proc."], "year": ["2017"], "volume": ["4"], "fpage": ["5706"], "lpage": ["5714"], "pub-id": ["10.1016/j.matpr.2017.06.034"]}, {"label": ["48."], "surname": ["Broglia", "Mugoni", "Siligardi", "Montorsi"], "given-names": ["G", "C", "C", "M"], "article-title": ["Lithium and copper transport properties in phosphate glasses: A molecular dynamics study"], "source": ["J. Non-Cryst. Solids"], "year": ["2018"], "volume": ["481"], "fpage": ["522"], "lpage": ["529"], "pub-id": ["10.1016/j.jnoncrysol.2017.11.032"]}, {"label": ["49."], "surname": ["Langar", "Sdiri", "Elhouichet", "Ferid"], "given-names": ["A", "N", "H", "M"], "article-title": ["Structure and electrical characterization of ZnO\u2013Ag phosphate glasses"], "source": ["Results Phys."], "year": ["2017"], "volume": ["7"], "fpage": ["1022"], "lpage": ["1029"], "pub-id": ["10.1016/j.rinp.2017.02.028"]}, {"label": ["52."], "surname": ["Yan", "Fan", "Sun", "Ning", "Wei", "Zhang", "Zhang", "Zhi", "Wei"], "given-names": ["J", "Z", "W", "G", "T", "Q", "R", "L", "F"], "article-title": ["Advanced asymmetric supercapacitors based on Ni (OH)"], "sub": ["2"], "source": ["Adv. Funct. Mater."], "year": ["2012"], "volume": ["22"], "fpage": ["2632"], "lpage": ["2641"], "pub-id": ["10.1002/adfm.201102839"]}, {"label": ["53."], "surname": ["Vidhyadharan", "Misnon", "Abd Aziz", "Padmasree", "Yusoff", "Jose"], "given-names": ["B", "II", "R", "K", "MM", "R"], "article-title": ["Superior supercapacitive performance in electrospun copper oxide nanowire electrodes"], "source": ["J. Mater. Chem. A"], "year": ["2014"], "volume": ["2"], "fpage": ["6578"], "lpage": ["6588"], "pub-id": ["10.1039/C3TA15304E"]}, {"label": ["54."], "surname": ["Fathi", "Abdel-Hameed", "Margha", "Abdel Ghany"], "given-names": ["AM", "SA", "FH", "NA"], "article-title": ["Electrocatalytic oxygen evolution on nanoscale crednerite (CuMnO"], "sub": ["2"], "source": ["Z. Phys. Chem."], "year": ["2016"], "volume": ["230"], "fpage": ["1519"], "lpage": ["1530"], "pub-id": ["10.1515/zpch-2015-0627"]}, {"label": ["55."], "surname": ["Yang", "Han", "Sun", "Yang", "Hu", "Li", "Cao"], "given-names": ["S", "Z", "J", "X", "X", "C", "B"], "article-title": ["Controllable ZnFe"], "sub": ["2", "4"], "source": ["Electrochim. Acta"], "year": ["2018"], "volume": ["268"], "fpage": ["20"], "lpage": ["26"], "pub-id": ["10.1016/j.electacta.2018.02.028"]}, {"label": ["57."], "surname": ["Handal", "Mohamed", "Labib", "Moustafa", "Sery"], "given-names": ["HT", "WA", "AA", "SA", "AA"], "article-title": ["The influence of surface modification on the optical and capacitive properties of NiO nanoparticles synthesized via surfactant-assisted coprecipitation"], "source": ["J. Energy Storage"], "year": ["2021"], "volume": ["44"], "fpage": ["103321"], "pub-id": ["10.1016/j.est.2021.103321"]}, {"label": ["58."], "surname": ["El-Gendy", "Ghany", "Allam"], "given-names": ["DM", "NAA", "NK"], "article-title": ["Green, single-pot synthesis of functionalized Na/N/P co-doped graphene nanosheets for high-performance supercapacitors"], "source": ["J. Electroanal. Chem."], "year": ["2019"], "volume": ["837"], "fpage": ["30"], "lpage": ["38"], "pub-id": ["10.1016/j.jelechem.2019.02.009"]}]
{ "acronym": [], "definition": [] }
58
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1169
oa_package/25/67/PMC10786889.tar.gz
PMC10786890
38216581
[ "<title>Introduction</title>", "<p id=\"Par2\">Organizational dyes are widely used in the textile, leather, printing, and cosmetic industries, and these industries produce large amounts of dye wastewater every year, which enters the surrounding ecosystem and causes various adverse consequences while posing serious threats to both human health and the aquatic environment<sup>##UREF##0##1##–##REF##11699627##3##</sup>. Methyl orange (MO) is a typical anionic dye<sup>##REF##20933323##4##,##UREF##1##5##</sup>, and the need for reasonable wastewater treatment processes is particularly important because of the complex structure of methyl orange (MO), which is not easily biodegradable or photodegradable. Various wastewater treatment technologies have received increasing attention, and the current methods used in treating wastewater include photodegradation<sup>##UREF##2##6##</sup>, electrochemical methods<sup>##REF##29669626##7##</sup>, biological methods<sup>##REF##16904258##8##</sup>, precipitation, filtration and oxidation<sup>##REF##12685738##9##</sup>; these all have high operating costs and poor adsorption capacities, and they generate waste causing secondary pollution. Adsorption<sup>##UREF##3##10##</sup> is one of the most effective dye removal methods, and adsorption is a simple, efficient, green and recyclable treatment technology that is widely used in wastewater treatment. Among the adsorbents used are chitosan<sup>##UREF##4##11##</sup>, zeolite<sup>##REF##29127821##12##</sup>, activated carbon<sup>##UREF##5##13##</sup>, cellulose aerogel<sup>##REF##28732868##14##</sup> etc., but they have poor selectivities, high costs, low reuse rates and poor adsorption capacities. Nanosorbents<sup>##UREF##6##15##</sup> have received much attention due to their large specific surface areas, abundant active groups or active atoms on their surfaces, high mechanical and thermal stabilities, abundant adsorption sites and high adsorption capacities, but they are also difficult to regenerate and separate.</p>", "<p id=\"Par3\">Magnetic nanoparticles with their small particle sizes, large surface areas and unique magnetic separation properties have solved the difficult separation problems of nanosorbents and are increasingly widely used. However, bare magnetic nanoparticles exhibit poor particle dispersions and stabilities, and they are prone to agglomerate. In addition, they are easily oxidized in air or acidic solutions, which reduces the adsorption performance<sup>##REF##20041633##16##</sup>. To solve these problems, modifications have applied to the magnetic nanomaterials. These modifications involve two process, chemical modification and surface covering, and surface covering is most commonly used. Using Fe<sub>3</sub>O<sub>4</sub> as the magnetic core and covering the surface to prepare nanomaterials with core–shell structures improves the stability and dispersion of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles, and modifications of the protective shell can also extend the range of applications for the adsorbent<sup>##UREF##7##17##</sup>. Mesoporous silica is often used to encapsulate the magnetic nanomaterials due to the many silica hydroxyl groups present on the surface and the high specific surface areas, large pore sizes, and biocompatibilities<sup>##UREF##8##18##</sup>, and the absence of redox reactions on the nanoparticle surfaces make it the preferred stabilizer<sup>##UREF##9##19##</sup>. Lee et al<sup>##REF##21848274##20##</sup>.modified Fe<sub>3</sub>O<sub>4</sub> nanoparticles with TEOs for adsorption of organic dyes from water. There are many synthetic routes to mesoporous silica, of which sol–gel chemistry<sup>##UREF##10##21##</sup> is most commonly used due to the mild reaction conditions, low cost and homogeneity of the resulting product<sup>##REF##15969545##22##</sup>.</p>", "<p id=\"Par4\">Therefore, in this study, the SiO<sub>2</sub>-coated core–shell structured magnetic nanocomposite material Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> was synthesized via the sol–gel method and used to adsorb methyl orange (MO) from solution. The constructed magnetic nanocomposites have magnetic dipole interactions that inhibit agglomeration, facilitate dispersion of the nanoparticles in liquids and preclude corrosion in acidic environments, so the new composites have the advantages of both magnetic nanoparticles and mesoporous silica<sup>##UREF##11##23##</sup>. The adsorption properties of the synthesized Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles were investigated by XPS, XRD, TEM, SEM, VSM, Zeta and BET characterizations to determine the factors that affect the adsorption properties, such as the temperature and reaction time, and then the kinetic model, isothermal adsorption model, internal diffusion model, and adsorption thermodynamics were used to analyze the mechanism and performance of the reaction. Finally, we found that Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles exhibited excellent adsorption of MO, which lays a foundation for preparation of magnetic nanomaterials designed to adsorb MO from wastewater.</p>" ]
[ "<title>Materials and methods</title>", "<title>Materials</title>", "<p id=\"Par5\">Methyl orange (C<sub>14</sub>H<sub>14</sub>N<sub>3</sub>SO<sub>3</sub>Na), ferric chloride hexahydrate (FeCl<sub>3</sub>·6H<sub>2</sub>O), concentrated ammonia (NH<sub>3</sub>·H<sub>2</sub>O), methanol (CH<sub>3</sub>OH), ethyl orthosilicate (TEOS), polyethylene glycol 4000 (PEG4000), powdered ferric tetroxide (Fe<sub>3</sub>O<sub>4</sub>), hydrochloric acid (HCl), and sodium hydroxide (NaOH) were purchased from Sinopharm Chemical Reagent Co, Ltd. and were analytically pure. The water used in the experiments was deionized water.</p>", "<title>Magnetic mesoporous silica nanoparticles</title>", "<title>Synthesis of Fe<sub>3</sub>O<sub>4</sub> nanoparticles by chemical precipitation</title>", "<p id=\"Par6\">FeCl<sub>3</sub>·6H<sub>2</sub>O (16 g) was added to 100 mL of water and poured into a conical flask, and then 12.8 g of Fe<sub>3</sub>O<sub>4</sub>·7H<sub>2</sub>O was added, shaken and split into two iron solutions. Then, 0.1 mol/L PEG-4000 and 6 mol/L NH<sub>3</sub>·H<sub>2</sub>O solutions were prepared. Twenty-five milliliters of PEG4000 solution and 25 mL of 6 mol/L NH<sub>3</sub>·H<sub>2</sub>O were added to the four flasks under a N<sub>2</sub> atmosphere with stirring, and after 10 min, the two iron solutions were added to the four flasks with a peristaltic pump at a flow rate of 0.1 L/h. The solutions were allowed to react for 5 min, and the magnetic nanoparticles were obtained by warming at 60 °C for 1 h in a constant temperature water bath and adding deionized water after maturation at 80°C for 0.5 h<sup>##UREF##12##24##</sup>. The reaction is shown in Eq. ##FORMU##0##1##:</p>", "<title>Preparation of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub></title>", "<p id=\"Par7\">In this experiment, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> was prepared via the sol–gel method, and 2 g of the wet nanoparticles were sonicated in 40 mL of water. Since ethyl orthosilicate (TEOS) produces SiO<sub>2</sub> under base catalysis, TEOS was used to introduce the silica groups. TEOS (1.76 mL) was sonicated in 80 mL of methanol, and the two previous solutions were added to a four-necked flask and sonicated for 15 min. Then, 4 mL of NH<sub>3</sub>·H<sub>2</sub>O was added, sonicated for 15 min and stirred for 4 h. After stirring, the magnetic material was separated, washed with methanol and deionized water until neutral, and soaked in HCl at pH = 1 for 24 h to remove the excess silicon coating on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> surface. Finally, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles were obtained after washing with methanol and water to neutral and drying in a freeze-dryer for 24 h. The reaction is shown schematically in Fig. ##FIG##0##1##.</p>", "<title>Characterization</title>", "<p id=\"Par8\">The crystal structures of the prepared materials were analyzed by X-ray diffraction (XRD, Panalytical X'Pert Pro, NL). Transmission electron microscopy (TEM, FEI Tecnai F20, US) and scanning electron microscopy (SEM, JEOL JSM-7401F, US) were used to analyze the surface morphologies and microscopic features of the prepared materials. Fourier infrared spectroscopy (FTIR, Thermo Scientific Nicolet iS20, US) was used to determine the main chemical components of the materials. The magnetic properties were determined with the VSM hysteresis line test (VSM, LakeShore7404, US). The specific surface areas, pore sizes and pore volumes of the material were determined with a fully automated specific surface and porosity analyzer (BET, Micromeritics ASAP 2460, US). X-ray electron spectroscopy (XPS, Thermo Scientific K-Alpha, US) was used to detect the chemical elements and electronic states of the prepared materials. The zeta potential analysis and particle size analysis of adsorbents were carried out by Malvern Zetasizer Nano ZS90 (Malvern Instruments Ltd.). Before testing, it is necessary to adjust the pH of MO (50ml) solution to 2, 4, 6, 8, and 10 by using 0.1M HCl and 0.1M NaOH, and add them to each solution 20mg Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> Ultrasound for 30 min.</p>", "<title>Adsorption experiments</title>", "<p id=\"Par9\">In this paper, MO adsorption with different influencing factors was investigated by UV‒visible spectrophotometry. Methyl orange solutions are commonly used as an acid‒base indicator, and the absorbance changes at different pHs. In this study, the absorbance of methyl orange was measured at different pHs, and it was found that the absorbance changes were very small and could therefore be neglected. A spectral scan of MO revealed that the maximum adsorbance occurred 464 nm, so 464 nm was used as the wavelength of MO in these experiments. Under the condition of room temperature 20 ℃, 1mg/L, 5mg/L, 10mg/L, 15mg/L, 25mg/L, 50mg/L concentration of MO solution was selected to measure the absorbance, and the MO concentration was taken as the horizontal coordinate, absorbance as the vertical coordinate to make the standard curve, and the curve was made a univariate linear regression curve to get the standard curve: y = 0.0772x + 0.0007, in which R<sup>2</sup> was 0.9997, after comprehensive consideration, the concentration of the absorbance measurement was uniformly diluted to 2–5 mg/L, to reduce the influence of the reduction of solution volume on the experiment. 0.9997, after comprehensive consideration, the concentration of absorbance measurement in the experiment was uniformly diluted to 2–5 mg/L, to reduce the impact of the reduction of the amount of solution on the experiment.</p>", "<p id=\"Par10\">The effects of the initial concentration, pH, reaction time and temperature on MO adsorption were investigated. For the pH adsorption study, the pH ranged from 2 to 10, the MO concentration was 100 mg/L, different pH were established with 0.1 mol/L HCl and NaOH solutions, the temperature was 298 K, and samples were taken at different times within 150 min. For the reaction time adsorption study, the initial concentration of MO was 100 mg/L, and the reaction time was 150 min with samples taken at different times. For studies of the initial MO concentration and temperature, 100 mL solutions with different concentrations ranging from 10 to 120 mg/L were kept at 298 K, 308 K and 318 K, and the reaction times were 30 min. The national standards (GB 8978-8, GB 18,918–202) indicate that the allowed pH range for discharged waste solutions is 6–9. In this study, the pH of the 100 mg/L MO solution was approximately 6.43 at room temperature, which was consistent with the emission standard, so there was no need to adjust the pH when investigating influencing factors other than the pH. Different amounts of the simulated MO wastewater were added to 150 mL conical flasks with 25 mg of adsorbent and then shaken in a constant temperature water bath shaker, and the supernatant was taken after shaking for an appropriate period to determine the absorbance A at 464 nm. The MO concentrations were measured photometrically with an ultraviolet spectrophotometer(UV, AIpha1506,CHN).</p>", "<p id=\"Par11\">The absorbance A and a standard curve were used to calculate the concentration of methyl orange, and then the amount adsorbed, η<sub>e</sub> (Eq. ##FORMU##1##2##), and removal rate, Q<sub>e</sub> (Eq. ##FORMU##2##3##), were calculated with the following equations based on the change in the MO concentration after adsorption:where Q<sub>e</sub> (mg/g) is the unit amount of MO solution adsorbed, C<sub>0</sub> (mg/L) is the initial concentration of the MO solution, C<sub>e</sub> (mg/L) is the final concentration of the MO solution, V (L) and m (g) are the volume and mass of the MO solution, and η<sub>e</sub> is the removal rate of the MO in solution.</p>", "<title>Regeneration study</title>", "<p id=\"Par12\">To investigate the reusability of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial, a 0.5 mol/L NaOH solution was used as the desorption solution because the adsorbent surface was negatively charged under strongly alkaline conditions, and the amount of MO adsorbed decreased sharply, which facilitated desorption. The Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-MO material was placed in a 0.5 mol/L NaOH solution, oscillated in a constant temperature water bath for 1 h, freeze-dried after magnetic separation, and cross-washed with methanol and deionized water 3 times. The adsorption process was performed again with T = 25 °C, t = 30 min, and C<sub>0</sub> = 100 mg/L, and the adsorption–desorption cycle was repeated 5 times.</p>", "<title>Real sample preparation</title>", "<p id=\"Par13\">In order to verify the adsorption capacity of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> in real water samples, precipitation samples were collected from Fujin City (FJ) and Kedong (KD) County, Heilongjiang Province, respectively. Before use, all water samples were filtered through a 0.45 μm membrane filter (Tianjin Jinteng Instrument Factory, Tianjin, China). Experimentally, 100 mL of water sample was selected for each point sample, and 0.1 g of MO was added to formulate a 100 mg/L MO solution, and 20 mg of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> was added, respectively, and the unit adsorption and desorption rates were measured after 30 min.</p>", "<title>Ethics approval </title>", "<p id=\"Par14\">This work does not contain any research involving humans or animals. </p>", "<title>Consent to participate </title>", "<p id=\"Par15\">The work described has not been published before; that it is not under consideration for publication anywhere else; that written informed consent was obtained from individual or guardian participants. </p>", "<title>Consent to publish </title>", "<p id=\"Par16\">The publishment consent was obtained from all co-authors.</p>" ]
[ "<title>Results and discussion</title>", "<title>Characterization</title>", "<p id=\"Par17\">Figure ##FIG##1##2##a shows the XRD patterns for the adsorbents Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>. As seen from the figure, the diffraction peaks at 30.1°, 35.4°, 43.1°, 53.4°, 56.9°, and 62.5° corresponded to the standard pattern (PDF#79-0419) and the (220), (311), (400), (422), (511), and (440) crystalline planes of the cubic Fe<sub>3</sub>O<sub>4</sub> nanoparticles; there were no impurity peaks, such as those for FeO and Fe<sub>2</sub>O<sub>3</sub>, proving that the resulting product was single-phase cubic crystalline Fe<sub>3</sub>O<sub>4</sub>. Additionally, the XRD pattern for Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> showed the same crystalline planes as Fe<sub>3</sub>O<sub>4</sub>, but the peak intensities were lower, indicating that the crystalline structure of Fe<sub>3</sub>O<sub>4</sub> was not changed and was successfully encapsulated. A broad absorption peak appeared at 2θ = 20° for amorphous SiO<sub>2</sub>, proving that SiO<sub>2</sub> was successfully coated on Fe<sub>3</sub>O<sub>4</sub> and that the composite material Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> was prepared successfully.</p>", "<p id=\"Par18\">To determine the material structure and the functional groups of Fe<sub>3</sub>O<sub>4</sub>, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-MO, they were analyzed by FT-IR, and the results are shown in Fig. ##FIG##1##2##b. The figure shows that the three adsorbents exhibited absorption bands near 570 cm<sup>−1</sup> for the Fe–O stretching vibration<sup>##UREF##13##25##</sup>, and the stretching vibration band for –OH appeared at 3428.57 cm<sup>−1</sup>. The Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> absorption band at 995.92 cm<sup>−1</sup> was a bending vibrational absorption band for Si–O–H. The bending vibrational absorption band of Si–OH appears near 1634.69 cm<sup>−1</sup> .The strong Si–O–Si antisymmetric stretching vibrational band at 1072.67 cm<sup>−1</sup> indicated that silica had successfully encapsulated the Fe<sub>3</sub>O<sub>4</sub> particles<sup>##UREF##14##26##</sup>. The characteristic peaks for the surfactant PEG-4000 did not appear because the surfactant was removed during several washes with methanol and deionized water before freeze-drying. Therefore, the characteristic peaks for Fe<sub>3</sub>O<sub>4</sub> were still present after introduction of the SiO<sub>2</sub> shell as well as adsorption of MO from solution, and the main difference was the introduction of SiO<sub>2</sub> characteristic peaks.</p>", "<p id=\"Par19\">Additionally, the Fe–O stretching vibration band of Fe<sub>3</sub>O<sub>4</sub> shifted from 571.43 to 573.43 cm<sup>−1</sup>, probably due to the formation of new Si–O–Fe bonds during the reaction in which Si combined with Fe through the O atom to form a new complex. In contrast to Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-MO spectrum showed a shift of the OH stretching band from 3438.38 to 3448.98 cm<sup>−1</sup>, indicating that MO underwent hydrogen bonding and formed electrostatic interactions with Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub><sup>##UREF##15##27##</sup>.</p>", "<p id=\"Par20\">N<sub>2</sub> adsorption–desorption is often used with mesoporous substances to determine the nature and surface areas of the pores. BET measurements were performed with Fe<sub>3</sub>O<sub>4</sub>, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, BTT, and CAC, and the results are shown in Fig. ##FIG##1##2##c and Table ##TAB##0##1##. The figure shows that the isotherms for the Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> adsorbents were type II isotherms based on the IUPAC classification, and obvious hysteresis loops appeared with increasing relative pressures, indicating that the synthesized materials were mesoporous. As seen from the figure, P/P<sub>0</sub> was less than 0.6. The adsorption process was weakly affected by P/P<sub>0</sub>, indicating that adsorption coalescence occurred on the pore walls during this process. The adsorption capacity increased significantly when P/P<sub>0</sub> was greater than 0.6, at which time the adsorption and desorption curves of Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> were no longer coincident; this may have resulted from capillary coalescence, indicating that the mesopores of the two synthesized materials were small and had uniform size distributions. Based on the BJH method, most of the pore sizes of Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> were concentrated<sup>##UREF##16##28##</sup> in the 2–5 nm range, which indicated a mesoporous material. Table ##TAB##0##1## shows that the pores of Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> were larger than those of BTT and CAC, and the surface area, pore size and pore volume of Fe3O4@SiO2 were larger than those of Fe<sub>3</sub>O<sub>4,</sub> implying more adsorption sites and enhanced adsorption capacity.</p>", "<p id=\"Par21\">Figure ##FIG##1##2##d shows the hysteresis lines of the Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> adsorbents measured at 300 K, as shown in Fig. ##FIG##1##2##a,b. The hysteresis lines were symmetric about the origin, the magnetization intensities increased rapidly with increases in the applied magnetic field, and the magnetic properties of the magnetic nanomaterials weakened rapidly until zero when the magnetic field was weakened. The hysteresis lines of the two adsorbents showed typical S-shapes, and the residual magnetization intensities tended toward zero, indicating super paramagnetism. Additionally, the saturation magnetization intensity was 75.96 emu g<sup>−1</sup> for Fe<sub>3</sub>O<sub>4</sub>, and the saturation magnetization intensity was 72.08 emu g<sup>−1</sup>, as seen from the figure. Since the magnetic saturation intensity of the Fe<sub>3</sub>O<sub>4</sub> nanoparticles was reduced after the outer layer was coated with SiO<sub>2</sub>, it still had strong magnetic separation properties and could be separated by an external magnetic field, which was used in the adsorption tests of the organic dye.</p>", "<p id=\"Par22\">To further confirm the XRD and FT-IR results for both adsorbents, morphological analyses of Fe<sub>3</sub>O<sub>4</sub>, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-MO were performed with TEM, and the results are shown in Fig. ##FIG##2##3## and Fig. ##SUPPL##0##S2##. The Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles presented spherical shapes with uniform sizes and an average particle size of approximately 100 nm, and it is clear that the Fe<sub>3</sub>O<sub>4</sub> nanoparticles exhibited a black color encapsulated by the gray SiO<sub>2</sub> shell, and the composite nanoparticles presented obvious core–shell structures, which indicated that polymer formation was successful. A comparison of the Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> data showed that Fe<sub>3</sub>O<sub>4</sub> agglomeration was significantly inhibited and the dispersion was enhanced after encapsulation by SiO<sub>2</sub>; the number of pores present on the surface was increased and the particle sizes were increased, so there were more adsorption sites and the adsorption performance was enhanced. A comparison of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> images obtained before and after adsorption showed that the core–shell structure remained unchanged, but the pores were significantly reduced and showed uneven surfaces because the MO adsorbed by the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> adsorbent filled the pores but did not destroy the core–shell structure, proving that the adsorbent pore channels were highly ordered, relatively stable and not easily destroyed. In addition, both adsorbents were found to undergo agglomeration and exhibit particle size inhomogeneity.</p>", "<p id=\"Par23\">Scanning electron microscopy and energy spectrum line sweeps were performed with Fe<sub>3</sub>O<sub>4</sub>, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>–MO to analyze the surface morphologies and particle sizes of the synthesized products, and the results are shown in Fig. ##FIG##3##4##. In addition, the particle size statistics were generated with SEM maps and Nanomeasure particle size annotation, and the results are shown in Fig. ##FIG##3##4##e,f. The decrease in mesopores from the comparison of b and c was due to the adsorbed mass of MO in the mesopores, which was consistent with the TEM results. From Fig.##SUPPL##0##S1## (a), (b) and (c), it can be seen that Fe<sub>3</sub>O<sub>4</sub> presents a regular spherical shape, the magnetic particles have no breakage phenomenon, and the surface is clearly visible and angular, and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> still presents a spherical shape but the surface contour is more blurred. It is obvious from Fig. ##FIG##3##4##d that three peaks for S, N and Na with contents of 1.2%, 1.5% and 0.16%, respectively, appeared after the adsorption of MO by Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, indicating that the MO was successfully adsorbed on the surface of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>. In addition, Fig. ##FIG##3##4##e,f shows that the average particle size for Fe<sub>3</sub>O<sub>4</sub> was 109.843 nm. The average particle size increase for Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> was 120.09 nm, so the thickness of the SiO<sub>2</sub> layer was approximately 10 nm, the surface area increased, the number of adsorption sites increased, and adsorption was enhanced.</p>", "<p id=\"Par24\">XPS is commonly used to determine the elemental composition, content, chemical valence, and chemical bonding properties of materials. XPS was used to determine the surface species and adsorption mechanism for the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> mesoporous nanomaterial before and after MO adsorption.</p>", "<p id=\"Par25\">The XPS spectra of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> before and after adsorption are shown in Fig. ##FIG##4##5##, and the results of split peak fitting and the functional groups are shown in Table ##TAB##1##2##. Figure ##FIG##4##5##a shows that Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> contained C, O, Fe, and Si elements, and after adsorption, the absorption peaks for S, Na, and N exhibited increased intensities; the atomic ratio of N 1s element was 1.32%, the atomic ratio of S2p element was 1.88%, and the atomic ratio of Na 1s element was 0.3%, and the N 1s spectrum generated the N=N absorption peak for MO at 399.90 eV. This showed that the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterials had adsorbed the MO. The C 1s, O 1s, Fe 2p, and Si 2p binding energies were 284.80, 531.92, 710.49, and 102.73 eV, respectively, and these were obtained with a peak search of the total spectrum after correcting the binding energies with the 284.80 eV binding energy for the C 1s peak. Table ##TAB##2##3## shows that Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> had the highest C content and the lowest Fe content. The peaks at 711.99 eV and 718.83 eV corresponded to the Fe<sup>3+</sup> 2p<sub>3/2</sub> and Fe<sup>2+</sup> 2p<sub>1/2</sub> binding and moved to 711.55 eV and 723.46 eV, respectively, indicating a surface complexation reaction between Fe and O<sup>##REF##26177491##29##</sup>. The O 1s binding energies for C–O and H–O–C changed, indicating that –OHs on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> surface were involved in the adsorption process. Therefore, there was coordination with the adsorbent, and the adsorption mechanism included electrostatic interactions and coordination.</p>", "<title>Adsorption and desorption study</title>", "<title>Effect of pH</title>", "<p id=\"Par26\">As seen in Fig. ##FIG##5##6##a, the pH of the solution had a significant effect on the adsorption process. The amount of MO adsorbed by Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> decreased with increasing pH, and the best adsorption effect was achieved at pH = 2, where the amount adsorbed reached 182.503 mg/g. The equilibrium amount of MO adsorbed by Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> is shown in Eq. ##FORMU##5##4##.</p>", "<p id=\"Par27\">Figure ##FIG##5##6##b Analysis of the potential maps for different pH values. The potential value of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial decreased with increasing solution pH, and the equipotential point was approximately 4. When the solution pH &lt; 4, the surface of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> material was protonated and positively charged, which enhanced adsorption of negatively charged species, and the density of the –OH<sub>2</sub><sup>+</sup> ions on the adsorbent surface was gradually increased<sup>##UREF##17##30##</sup>. Strong electrostatic attractions occurred with the –SO<sub>3</sub><sup>−</sup> groups of anionic MO, which increased the adsorption efficiency. At neutral pH, the negative surface charges of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> adsorbent were dispersed in the aqueous solution due to particle-to-particle electrostatic repulsions, and good dispersion inhibits magnetic separation and reduces the adsorption efficiency. The –OH<sup>–</sup> groups present in the solution at high pH compete with the anionic MO for the positively charged adsorption sites and reduce the adsorption efficiency. In addition, the pH also affects the chemical structure of MO; when the pH &lt; 3.4, MO exhibits a red quinone-like structure, and the sulfonic acid end of the molecule is negatively charged, which favors binding to –OH<sub>2</sub><sup>+</sup> on the surface, and when the pH &gt; 3.4, MO exhibits a yellow azo structure, which is more stable and difficult to remove than the quinone-like structure<sup>##UREF##18##31##</sup>. The above analysis is consistent with the effect of pH on Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, confirming that MO was adsorbed through electrostatic interactions.</p>", "<title>Effect of adsorption time</title>", "<p id=\"Par28\">The adsorption time is an important variable in the adsorption process, and Fig. ##FIG##5##6##d shows that the equilibrium times for adsorption of MO on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial were 15 min, 20 min, and 30 min for concentrations of 30 mg/L, 50 mg/L, and 100 mg/L, respectively. At lower concentrations, the adsorption of MO on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial reached equilibrium in a shorter time, and at higher concentrations, the adsorption process was more active, the adsorbent surface was blocked by dye molecules, and the required adsorption time was longer. In addition, we found that the adsorption capacity was significantly higher at the initial stage of the reaction, indicating that there were still many empty spaces on the adsorbent surface at this time, and the interaction between the MO and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial was not optimal at this time. As the reaction time increased, the adsorption sites on the adsorbent surface were continuously occupied by MO, the number of available adsorption sites gradually decreased, and the adsorption rate gradually decreased until the saturation point<sup>##UREF##19##32##</sup>.</p>", "<title>Effects of temperature and initial concentration</title>", "<p id=\"Par29\">Figure ##FIG##5##6##c shows that at the same temperature, the adsorption capacity increases continuously with increasing concentration, and the adsorption rate reaches a maximum at an MO concentration of 100 mg/L. The maximum adsorption capacity reached 89.882 mg/g at T = 45°C, while the removal rate decreased continuously. This occurred because when the MO concentration was low, there were excess adsorbent binding sites and the adsorption capacity increased significantly, but as the MO concentration increased, more adsorption sites were filled, and the adsorption capacity did not increase significantly.</p>", "<p id=\"Par30\">Additionally, the figure shows that the adsorption and removal rates increased with increasing temperatures at the same concentration, which indicated that the adsorption of MO on the adsorbent was an endothermic process and that higher temperatures activated the adsorption sites and increased the kinetic energy for adsorption by Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>. Since the adsorption capacity increased with increasing temperature, it occurred via chemisorption. Conversely, if the adsorption had decreased with increasing temperature, physisorption would have been indicated <sup>.</sup> Thus, this results is consistent with the adsorption kinetics and indicated that chemisorption drove the adsorption process.</p>", "<title>Adsorption kinetics</title>", "<p id=\"Par31\">To investigate the effect of the initial concentration as well as the adsorption time, 20 mg of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> adsorbent was added to 30, 50 and 100 mg/L MO solutions, and the absorbance was measured by sample the supernatant at after 1, 3, 5, 15, 20, 30, 40, 60 and 150 min.</p>", "<p id=\"Par32\">The adsorption rate is a key parameter used to explore the performance of the adsorbent and elucidate the adsorption process, so the pseudo-first-order model, pseudo-second-order model and the intraparticle diffusion model were used to fit the experimental data and determine the process of MO adsorption by the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterials; the fitted data are shown in Tables ##TAB##3##4## and ##TAB##4##5##, and the fitted results are shown in Fig. ##FIG##6##7##a–c.</p>", "<p id=\"Par33\">The pseudo-first-order equation is<sup>##UREF##20##33##</sup>:</p>", "<p id=\"Par34\">The pseudo-second-order equation is<sup>##UREF##21##34##</sup>:where q<sub>e</sub> and q<sub>t</sub> (mg/g) are the adsorption capacities at adsorption equilibrium and at time t (min), respectively; k<sub>1</sub> (1/min) and k<sub>2</sub> (g/mg.min) are the adsorption rate constants for the pseudo-first-order model and pseudo-second-order model, respectively, and were calculated from the slope of the linear fit; finally, t is the reaction time (min).The kinetic model is chosen based on the deviation of q<sub>e</sub> obtained from Eqs. ##FORMU##6##5## and ##FORMU##7##6## (calculated q<sub>e</sub>) and the q<sub>e</sub> obtained from the experiment. Normalized standard deviation (ε%) is used to compare the applicability of either of these models. Commonly, the kinetic model which gives a smaller normalized standard deviation is used to describe the adsorption<sup>##REF##19879046##35##</sup> . The normalized standard deviation (ε %) is given by Eq. ##FORMU##8##7##:</p>", "<p id=\"Par35\">The intraparticle diffusion model was used to determine the rate-limiting step of the adsorption process. The expression for the intraparticle diffusion model is shown in Eq. ##FORMU##9##8##<sup>##UREF##22##36##</sup>:where k<sub>di</sub> (mg.g<sup>−1</sup>·min<sup>−1/2</sup>) is the internal diffusion rate constant and C (mg g<sup>−1</sup>) is the thickness of the boundary layer.</p>", "<p id=\"Par37\">Figure ##FIG##6##7##a,b and Table ##TAB##3##4## show that for different MO concentrations, the correlation coefficient R<sup>2</sup> of Pseudo-second-order model is higher and the range of relative deviation coefficients ε% is smaller for different concentrations of MO solutions, so the adsorption process of MO adsorption by Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterials is more consistent with pseudo-second-order model. To further confirm the kinetic behavior of anionic dye adsorption on Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, an internal diffusion model was used to fit the adsorption data. From the fitted plots for the internal diffusion model in Fig. ##FIG##6##7##c, the MO adsorption process occurred in three stages for all three concentrations. The first stage involved diffusion of the MO molecules from the solution to the adsorbent surface, which corresponded to surface diffusion, and the adsorption rate was faster in this stage due to the high adsorption driving force. The second stage involved diffusion of the MO from the surface of the adsorbent to the inner surfaces of the mesopores, which corresponded to the internal diffusion process. The third stage involved slowing of the diffusion rate due to the low concentration of residual dye, and this constituted the adsorption equilibrium stage. Additionally, Table ##TAB##4##5## shows that for the three different concentrations, K<sub>d3</sub> &lt; K<sub>d2</sub> &lt; K<sub>d1</sub> and C ≠ 0, indicating that internal diffusion was the main, but not the only, rate-controlling step. The curve fits did not pass through the origin, indicating that diffusion from the boundary layer to the adsorbent surface cannot be neglected, so the adsorption of MO on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial was determined by several rate-controlling steps<sup>##UREF##23##37##</sup>.</p>", "<title>Adsorption isotherms</title>", "<p id=\"Par38\">The Langmuir and Freundlich models were used to fit the adsorption data and analyze the adsorption process. The Langmuir model assumes single layer adsorption, in which the adsorbent molecules are in one-to-one correspondence with the adsorbent surface, and each occupied adsorption site cannot be used by another adsorbent molecule. Additionally, the odds that different sites on the adsorbent surface are used by the adsorbate are almost the same, and the Langmuir expression is shown below<sup>##REF##20041633##16##</sup> Eq. ##FORMU##10##9##:where C<sub>e</sub> (mg/L) is the concentration at adsorption equilibrium, q<sub>e</sub> (mg/g) is the amount adsorbed when the adsorption process reaches equilibrium, K<sub>L</sub>(L/mg) is the Langmuir constant related to the adsorption binding energy, and q<sub>m</sub> (mg/g) is the maximum amount of adsorbate on the adsorbent. K<sub>L</sub> and q<sub>m</sub> can be calculated by plotting against C<sub>e</sub>. There is also a parameter R<sub>L</sub> in the Langmuir model, which can be used for determining the adsorption behavior and is defined by<sup>##UREF##24##38##</sup> Eq. ##FORMU##11##10##:where C<sub>0</sub> is the actual concentration of the adsorbent solution. When 0 &lt; R<sub>L</sub> &lt; 1, adsorption of the adsorbate occurs smoothly; when 1 &lt; R<sub>L</sub>, the adsorption process is inhibited and when R<sub>L</sub> = 0, adsorption does not occur.</p>", "<p id=\"Par39\">The Freundlich model describes multilayer adsorption, the adsorption sites on the material surface are heterogeneous, and the expression is shown below<sup>##UREF##25##39##</sup> Eq. ##FORMU##12##11##:where and n are the Freundlich constants, and the values are determined by fitting. When 2 &lt; n &lt; 10, adsorption occurs easily, and when n &lt; 1, adsorption is difficult or some difficulties are encountered.</p>", "<p id=\"Par40\">To choose between the Langmuir and Freundlich adsorption models, MO solutions with concentrations of 10, 30, 50, 70, 80, 90, 100,120 and 200 mg/L were added to 20 mg of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> adsorbent at a constant temperature of 25 °C and stirred at 200 r/min and shaken. The absorbance was measured by sampling the supernatant after 30 min, and the isotherm fitting plots and data are shown in Fig. ##FIG##6##7##d and Table ##TAB##5##6##. In addition to the R<sup>2</sup> table fitting accuracy, and were further evaluated by the root mean square error (RMSE), as shown in Eq. ##FORMU##14##12##.</p>", "<p id=\"Par41\">As seen from Table ##TAB##5##6##<bold>,</bold> the Langmuir isothermal model provided better fits at all three temperatures, so the Langmuir isothermal adsorption model better described the adsorption of MO on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial, and the process involved monolayer adsorption. The saturation adsorption amount increased from 57.164 to 116.624 mg/g as the temperature was increased from 25 to 45 °C, which also proved that adsorption of MO on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial was an endothermic process. In addition, the Freundlich constants n &gt; 1 and =0.963 &lt; 1 are provided in Table ##TAB##5##6##, which indicated that adsorption of MO was favorable.</p>", "<title>Comparison of adsorption by different adsorbents</title>", "<p id=\"Par42\">As shown in Table ##TAB##6##7##, the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial exhibited strong adsorption, and the magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles showed a nanosize effect and adsorbed MO via surface electrostatic attraction, and the adsorption capacity was enhanced after modification with the SiO<sub>2</sub> coating. In addition, the adsorption capacity of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> was significantly higher than those of other adsorbents, indicating that Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> has potential for use in treating organic dye wastewaters.</p>", "<title>Adsorption thermodynamics</title>", "<p id=\"Par43\">The adsorption thermodynamics indicate whether energy is released or absorbed during a reaction. To explore the mechanism for adsorption of MO on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial, the adsorption data were analyzed thermodynamically at three different temperatures, 25 °C, 35 °C and 45 °C, to simulate the enthalpy and entropy changes. The thermodynamic parameters were the Gibbs free energy (△G<sup>0</sup>, KJ/mol), the enthalpy of absorption and (△H<sup>0</sup>, KJ/mol) and the entropy of absorption (△S<sup>0</sup>, J/(mol. K)). where since K<sub>L</sub> has a magnitude in L/mg and the equilibrium constant Kc is dimensionless<sup>##REF##28478298##43##</sup>, Eq. ##FORMU##18##15## was used for the transformation. and these are related as shown below.where R is the molar gas constant, 8.3145 J mol<sup>−1</sup>K<sup>−1</sup>; T is the absolute temperature; K<sub>L</sub> is Langmuir’s constant and the equilibrium constant Kc is a dimensionless parameter; Qe is the equilibrium adsorption volume; and Ce is the equilibrium adsorption concentration.</p>", "<p id=\"Par44\">The calculated thermodynamic parameters are shown in Table ##TAB##7##8##. When △H<sup>0</sup> &gt; 0, the reaction is endothermic; when △H<sup>0</sup> &lt; 0, the reaction is exothermic; △S<sup>0</sup> &gt; 0 indicates that the reaction increases the entropy and △S<sup>0</sup> = 0 indicates that the reaction is at equilibrium. In addition, if △G<sup>0</sup> &lt; 0, the reaction proceeds spontaneously; if △G<sup>0</sup> = 0, the reaction is at equilibrium and if △G<sup>0</sup> &gt; 0, the reaction cannot proceed spontaneously. From the data in the table, we can see that the positive value of △S<sup>0</sup> indicates that the randomness increases at the solid–liquid interface during the adsorption of the three anionic dyes in aqueous solution onto the adsorbent,△G<sup>0</sup> was negative and decreased with increasing temperature, which indicated that the adsorption process was spontaneous; also, △H<sup>0</sup> was positive, which indicated the adsorption process was endothermic and higher temperatures favored adsorption; this was consistent with the results for isothermal adsorption line fitting.</p>", "<title>Reusability study</title>", "<p id=\"Par45\">Regeneration experiments are important for probing reuse or recovery of an adsorbent. The experimental results shown in Fig. ##FIG##6##7##d indicated that after five desorption-adsorption cycles, the adsorption amount decreased from 53.278 to 44.221 mg/g, and the adsorption capacity was reduced, which may be attributed to incomplete desorption of the adsorbed MO from some of the adsorption sites. However, the amount adsorbed exceeded 80% of the initial amount adsorbed, so the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial was effectively recycled.</p>", "<title>Adsorption of MO in real water samples</title>", "<p id=\"Par46\">After treating as described in Sect. “<xref rid=\"Sec10\" ref-type=\"sec\">Real Sample Preparation</xref>”, the results are shown in Table ##TAB##8##9##, from which it can be seen that the q<sub>e</sub> of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> was 47.382 and 46.897 mg g<sup>−1</sup> in the 100 mg/L MO solution configured for the water samples of FJ and KD, respectively, and the desorption rates were 78% and 80%, which were decreased, but the adsorption and desorption performances were still excellent, which proves that Fe3O4 can be used for the adsorption of the MO dye effluent from the real water samples.</p>", "<title>Exploration of the adsorption mechanism</title>", "<p id=\"Par47\">According to the previous analysis, the increases in the average particle size and surface area of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial formed more adsorption sites and increased the adsorption capacity. The physical properties of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> indicated that the ferromagnetic nanoparticles on the surface of the material provided a good magnetic response, and this enabled fast and controlled separation of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> with an applied magnetic field to improve the adsorption efficiency. Second, the mesoporous structure of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial had an important impact on adsorption. Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterials usually have highly ordered pore structures, and these pores provide larger surface areas and more adsorption sites, and the pore sizes can be tuned to achieve efficient adsorption of MO. For chemisorption of MO on Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, the appearance of amorphous SiO<sub>2</sub> in the XRD pattern and S, Na, and N in the EDS spectra and XPS data indicated successful adsorption of MO on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>. The FT-IR spectrum of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-MO showed a shift in the position of the –OH vibrational band at 3428 cm<sup>−1</sup>, which indicated hydrogen bonding and electrostatic interactions between the MO and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>. Additionally, the C–O and H–O-C binding energies were shifted in the XPS spectra, indicating the involvement of –OH on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> surface in the adsorption process. This was also confirmed by the pH experiments. Electrostatic interactions also played important roles in the adsorption of MO by Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>. The pH of the solution was altered to control the charge on the adsorbent surface, which affected the interactions between the adsorbent and the dye molecules, so hydrogen bonding and electrostatic interactions were involved in adsorption of MO by Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, and the –OH groups played an important role in the adsorption process. The adsorption mechanism is shown in Fig. ##FIG##7##8##.</p>" ]
[ "<title>Results and discussion</title>", "<title>Characterization</title>", "<p id=\"Par17\">Figure ##FIG##1##2##a shows the XRD patterns for the adsorbents Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>. As seen from the figure, the diffraction peaks at 30.1°, 35.4°, 43.1°, 53.4°, 56.9°, and 62.5° corresponded to the standard pattern (PDF#79-0419) and the (220), (311), (400), (422), (511), and (440) crystalline planes of the cubic Fe<sub>3</sub>O<sub>4</sub> nanoparticles; there were no impurity peaks, such as those for FeO and Fe<sub>2</sub>O<sub>3</sub>, proving that the resulting product was single-phase cubic crystalline Fe<sub>3</sub>O<sub>4</sub>. Additionally, the XRD pattern for Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> showed the same crystalline planes as Fe<sub>3</sub>O<sub>4</sub>, but the peak intensities were lower, indicating that the crystalline structure of Fe<sub>3</sub>O<sub>4</sub> was not changed and was successfully encapsulated. A broad absorption peak appeared at 2θ = 20° for amorphous SiO<sub>2</sub>, proving that SiO<sub>2</sub> was successfully coated on Fe<sub>3</sub>O<sub>4</sub> and that the composite material Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> was prepared successfully.</p>", "<p id=\"Par18\">To determine the material structure and the functional groups of Fe<sub>3</sub>O<sub>4</sub>, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-MO, they were analyzed by FT-IR, and the results are shown in Fig. ##FIG##1##2##b. The figure shows that the three adsorbents exhibited absorption bands near 570 cm<sup>−1</sup> for the Fe–O stretching vibration<sup>##UREF##13##25##</sup>, and the stretching vibration band for –OH appeared at 3428.57 cm<sup>−1</sup>. The Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> absorption band at 995.92 cm<sup>−1</sup> was a bending vibrational absorption band for Si–O–H. The bending vibrational absorption band of Si–OH appears near 1634.69 cm<sup>−1</sup> .The strong Si–O–Si antisymmetric stretching vibrational band at 1072.67 cm<sup>−1</sup> indicated that silica had successfully encapsulated the Fe<sub>3</sub>O<sub>4</sub> particles<sup>##UREF##14##26##</sup>. The characteristic peaks for the surfactant PEG-4000 did not appear because the surfactant was removed during several washes with methanol and deionized water before freeze-drying. Therefore, the characteristic peaks for Fe<sub>3</sub>O<sub>4</sub> were still present after introduction of the SiO<sub>2</sub> shell as well as adsorption of MO from solution, and the main difference was the introduction of SiO<sub>2</sub> characteristic peaks.</p>", "<p id=\"Par19\">Additionally, the Fe–O stretching vibration band of Fe<sub>3</sub>O<sub>4</sub> shifted from 571.43 to 573.43 cm<sup>−1</sup>, probably due to the formation of new Si–O–Fe bonds during the reaction in which Si combined with Fe through the O atom to form a new complex. In contrast to Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-MO spectrum showed a shift of the OH stretching band from 3438.38 to 3448.98 cm<sup>−1</sup>, indicating that MO underwent hydrogen bonding and formed electrostatic interactions with Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub><sup>##UREF##15##27##</sup>.</p>", "<p id=\"Par20\">N<sub>2</sub> adsorption–desorption is often used with mesoporous substances to determine the nature and surface areas of the pores. BET measurements were performed with Fe<sub>3</sub>O<sub>4</sub>, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, BTT, and CAC, and the results are shown in Fig. ##FIG##1##2##c and Table ##TAB##0##1##. The figure shows that the isotherms for the Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> adsorbents were type II isotherms based on the IUPAC classification, and obvious hysteresis loops appeared with increasing relative pressures, indicating that the synthesized materials were mesoporous. As seen from the figure, P/P<sub>0</sub> was less than 0.6. The adsorption process was weakly affected by P/P<sub>0</sub>, indicating that adsorption coalescence occurred on the pore walls during this process. The adsorption capacity increased significantly when P/P<sub>0</sub> was greater than 0.6, at which time the adsorption and desorption curves of Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> were no longer coincident; this may have resulted from capillary coalescence, indicating that the mesopores of the two synthesized materials were small and had uniform size distributions. Based on the BJH method, most of the pore sizes of Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> were concentrated<sup>##UREF##16##28##</sup> in the 2–5 nm range, which indicated a mesoporous material. Table ##TAB##0##1## shows that the pores of Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> were larger than those of BTT and CAC, and the surface area, pore size and pore volume of Fe3O4@SiO2 were larger than those of Fe<sub>3</sub>O<sub>4,</sub> implying more adsorption sites and enhanced adsorption capacity.</p>", "<p id=\"Par21\">Figure ##FIG##1##2##d shows the hysteresis lines of the Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> adsorbents measured at 300 K, as shown in Fig. ##FIG##1##2##a,b. The hysteresis lines were symmetric about the origin, the magnetization intensities increased rapidly with increases in the applied magnetic field, and the magnetic properties of the magnetic nanomaterials weakened rapidly until zero when the magnetic field was weakened. The hysteresis lines of the two adsorbents showed typical S-shapes, and the residual magnetization intensities tended toward zero, indicating super paramagnetism. Additionally, the saturation magnetization intensity was 75.96 emu g<sup>−1</sup> for Fe<sub>3</sub>O<sub>4</sub>, and the saturation magnetization intensity was 72.08 emu g<sup>−1</sup>, as seen from the figure. Since the magnetic saturation intensity of the Fe<sub>3</sub>O<sub>4</sub> nanoparticles was reduced after the outer layer was coated with SiO<sub>2</sub>, it still had strong magnetic separation properties and could be separated by an external magnetic field, which was used in the adsorption tests of the organic dye.</p>", "<p id=\"Par22\">To further confirm the XRD and FT-IR results for both adsorbents, morphological analyses of Fe<sub>3</sub>O<sub>4</sub>, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-MO were performed with TEM, and the results are shown in Fig. ##FIG##2##3## and Fig. ##SUPPL##0##S2##. The Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles presented spherical shapes with uniform sizes and an average particle size of approximately 100 nm, and it is clear that the Fe<sub>3</sub>O<sub>4</sub> nanoparticles exhibited a black color encapsulated by the gray SiO<sub>2</sub> shell, and the composite nanoparticles presented obvious core–shell structures, which indicated that polymer formation was successful. A comparison of the Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> data showed that Fe<sub>3</sub>O<sub>4</sub> agglomeration was significantly inhibited and the dispersion was enhanced after encapsulation by SiO<sub>2</sub>; the number of pores present on the surface was increased and the particle sizes were increased, so there were more adsorption sites and the adsorption performance was enhanced. A comparison of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> images obtained before and after adsorption showed that the core–shell structure remained unchanged, but the pores were significantly reduced and showed uneven surfaces because the MO adsorbed by the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> adsorbent filled the pores but did not destroy the core–shell structure, proving that the adsorbent pore channels were highly ordered, relatively stable and not easily destroyed. In addition, both adsorbents were found to undergo agglomeration and exhibit particle size inhomogeneity.</p>", "<p id=\"Par23\">Scanning electron microscopy and energy spectrum line sweeps were performed with Fe<sub>3</sub>O<sub>4</sub>, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>–MO to analyze the surface morphologies and particle sizes of the synthesized products, and the results are shown in Fig. ##FIG##3##4##. In addition, the particle size statistics were generated with SEM maps and Nanomeasure particle size annotation, and the results are shown in Fig. ##FIG##3##4##e,f. The decrease in mesopores from the comparison of b and c was due to the adsorbed mass of MO in the mesopores, which was consistent with the TEM results. From Fig.##SUPPL##0##S1## (a), (b) and (c), it can be seen that Fe<sub>3</sub>O<sub>4</sub> presents a regular spherical shape, the magnetic particles have no breakage phenomenon, and the surface is clearly visible and angular, and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> still presents a spherical shape but the surface contour is more blurred. It is obvious from Fig. ##FIG##3##4##d that three peaks for S, N and Na with contents of 1.2%, 1.5% and 0.16%, respectively, appeared after the adsorption of MO by Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, indicating that the MO was successfully adsorbed on the surface of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>. In addition, Fig. ##FIG##3##4##e,f shows that the average particle size for Fe<sub>3</sub>O<sub>4</sub> was 109.843 nm. The average particle size increase for Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> was 120.09 nm, so the thickness of the SiO<sub>2</sub> layer was approximately 10 nm, the surface area increased, the number of adsorption sites increased, and adsorption was enhanced.</p>", "<p id=\"Par24\">XPS is commonly used to determine the elemental composition, content, chemical valence, and chemical bonding properties of materials. XPS was used to determine the surface species and adsorption mechanism for the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> mesoporous nanomaterial before and after MO adsorption.</p>", "<p id=\"Par25\">The XPS spectra of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> before and after adsorption are shown in Fig. ##FIG##4##5##, and the results of split peak fitting and the functional groups are shown in Table ##TAB##1##2##. Figure ##FIG##4##5##a shows that Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> contained C, O, Fe, and Si elements, and after adsorption, the absorption peaks for S, Na, and N exhibited increased intensities; the atomic ratio of N 1s element was 1.32%, the atomic ratio of S2p element was 1.88%, and the atomic ratio of Na 1s element was 0.3%, and the N 1s spectrum generated the N=N absorption peak for MO at 399.90 eV. This showed that the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterials had adsorbed the MO. The C 1s, O 1s, Fe 2p, and Si 2p binding energies were 284.80, 531.92, 710.49, and 102.73 eV, respectively, and these were obtained with a peak search of the total spectrum after correcting the binding energies with the 284.80 eV binding energy for the C 1s peak. Table ##TAB##2##3## shows that Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> had the highest C content and the lowest Fe content. The peaks at 711.99 eV and 718.83 eV corresponded to the Fe<sup>3+</sup> 2p<sub>3/2</sub> and Fe<sup>2+</sup> 2p<sub>1/2</sub> binding and moved to 711.55 eV and 723.46 eV, respectively, indicating a surface complexation reaction between Fe and O<sup>##REF##26177491##29##</sup>. The O 1s binding energies for C–O and H–O–C changed, indicating that –OHs on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> surface were involved in the adsorption process. Therefore, there was coordination with the adsorbent, and the adsorption mechanism included electrostatic interactions and coordination.</p>", "<title>Adsorption and desorption study</title>", "<title>Effect of pH</title>", "<p id=\"Par26\">As seen in Fig. ##FIG##5##6##a, the pH of the solution had a significant effect on the adsorption process. The amount of MO adsorbed by Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> decreased with increasing pH, and the best adsorption effect was achieved at pH = 2, where the amount adsorbed reached 182.503 mg/g. The equilibrium amount of MO adsorbed by Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> is shown in Eq. ##FORMU##5##4##.</p>", "<p id=\"Par27\">Figure ##FIG##5##6##b Analysis of the potential maps for different pH values. The potential value of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial decreased with increasing solution pH, and the equipotential point was approximately 4. When the solution pH &lt; 4, the surface of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> material was protonated and positively charged, which enhanced adsorption of negatively charged species, and the density of the –OH<sub>2</sub><sup>+</sup> ions on the adsorbent surface was gradually increased<sup>##UREF##17##30##</sup>. Strong electrostatic attractions occurred with the –SO<sub>3</sub><sup>−</sup> groups of anionic MO, which increased the adsorption efficiency. At neutral pH, the negative surface charges of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> adsorbent were dispersed in the aqueous solution due to particle-to-particle electrostatic repulsions, and good dispersion inhibits magnetic separation and reduces the adsorption efficiency. The –OH<sup>–</sup> groups present in the solution at high pH compete with the anionic MO for the positively charged adsorption sites and reduce the adsorption efficiency. In addition, the pH also affects the chemical structure of MO; when the pH &lt; 3.4, MO exhibits a red quinone-like structure, and the sulfonic acid end of the molecule is negatively charged, which favors binding to –OH<sub>2</sub><sup>+</sup> on the surface, and when the pH &gt; 3.4, MO exhibits a yellow azo structure, which is more stable and difficult to remove than the quinone-like structure<sup>##UREF##18##31##</sup>. The above analysis is consistent with the effect of pH on Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, confirming that MO was adsorbed through electrostatic interactions.</p>", "<title>Effect of adsorption time</title>", "<p id=\"Par28\">The adsorption time is an important variable in the adsorption process, and Fig. ##FIG##5##6##d shows that the equilibrium times for adsorption of MO on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial were 15 min, 20 min, and 30 min for concentrations of 30 mg/L, 50 mg/L, and 100 mg/L, respectively. At lower concentrations, the adsorption of MO on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial reached equilibrium in a shorter time, and at higher concentrations, the adsorption process was more active, the adsorbent surface was blocked by dye molecules, and the required adsorption time was longer. In addition, we found that the adsorption capacity was significantly higher at the initial stage of the reaction, indicating that there were still many empty spaces on the adsorbent surface at this time, and the interaction between the MO and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial was not optimal at this time. As the reaction time increased, the adsorption sites on the adsorbent surface were continuously occupied by MO, the number of available adsorption sites gradually decreased, and the adsorption rate gradually decreased until the saturation point<sup>##UREF##19##32##</sup>.</p>", "<title>Effects of temperature and initial concentration</title>", "<p id=\"Par29\">Figure ##FIG##5##6##c shows that at the same temperature, the adsorption capacity increases continuously with increasing concentration, and the adsorption rate reaches a maximum at an MO concentration of 100 mg/L. The maximum adsorption capacity reached 89.882 mg/g at T = 45°C, while the removal rate decreased continuously. This occurred because when the MO concentration was low, there were excess adsorbent binding sites and the adsorption capacity increased significantly, but as the MO concentration increased, more adsorption sites were filled, and the adsorption capacity did not increase significantly.</p>", "<p id=\"Par30\">Additionally, the figure shows that the adsorption and removal rates increased with increasing temperatures at the same concentration, which indicated that the adsorption of MO on the adsorbent was an endothermic process and that higher temperatures activated the adsorption sites and increased the kinetic energy for adsorption by Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>. Since the adsorption capacity increased with increasing temperature, it occurred via chemisorption. Conversely, if the adsorption had decreased with increasing temperature, physisorption would have been indicated <sup>.</sup> Thus, this results is consistent with the adsorption kinetics and indicated that chemisorption drove the adsorption process.</p>", "<title>Adsorption kinetics</title>", "<p id=\"Par31\">To investigate the effect of the initial concentration as well as the adsorption time, 20 mg of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> adsorbent was added to 30, 50 and 100 mg/L MO solutions, and the absorbance was measured by sample the supernatant at after 1, 3, 5, 15, 20, 30, 40, 60 and 150 min.</p>", "<p id=\"Par32\">The adsorption rate is a key parameter used to explore the performance of the adsorbent and elucidate the adsorption process, so the pseudo-first-order model, pseudo-second-order model and the intraparticle diffusion model were used to fit the experimental data and determine the process of MO adsorption by the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterials; the fitted data are shown in Tables ##TAB##3##4## and ##TAB##4##5##, and the fitted results are shown in Fig. ##FIG##6##7##a–c.</p>", "<p id=\"Par33\">The pseudo-first-order equation is<sup>##UREF##20##33##</sup>:</p>", "<p id=\"Par34\">The pseudo-second-order equation is<sup>##UREF##21##34##</sup>:where q<sub>e</sub> and q<sub>t</sub> (mg/g) are the adsorption capacities at adsorption equilibrium and at time t (min), respectively; k<sub>1</sub> (1/min) and k<sub>2</sub> (g/mg.min) are the adsorption rate constants for the pseudo-first-order model and pseudo-second-order model, respectively, and were calculated from the slope of the linear fit; finally, t is the reaction time (min).The kinetic model is chosen based on the deviation of q<sub>e</sub> obtained from Eqs. ##FORMU##6##5## and ##FORMU##7##6## (calculated q<sub>e</sub>) and the q<sub>e</sub> obtained from the experiment. Normalized standard deviation (ε%) is used to compare the applicability of either of these models. Commonly, the kinetic model which gives a smaller normalized standard deviation is used to describe the adsorption<sup>##REF##19879046##35##</sup> . The normalized standard deviation (ε %) is given by Eq. ##FORMU##8##7##:</p>", "<p id=\"Par35\">The intraparticle diffusion model was used to determine the rate-limiting step of the adsorption process. The expression for the intraparticle diffusion model is shown in Eq. ##FORMU##9##8##<sup>##UREF##22##36##</sup>:where k<sub>di</sub> (mg.g<sup>−1</sup>·min<sup>−1/2</sup>) is the internal diffusion rate constant and C (mg g<sup>−1</sup>) is the thickness of the boundary layer.</p>", "<p id=\"Par37\">Figure ##FIG##6##7##a,b and Table ##TAB##3##4## show that for different MO concentrations, the correlation coefficient R<sup>2</sup> of Pseudo-second-order model is higher and the range of relative deviation coefficients ε% is smaller for different concentrations of MO solutions, so the adsorption process of MO adsorption by Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterials is more consistent with pseudo-second-order model. To further confirm the kinetic behavior of anionic dye adsorption on Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, an internal diffusion model was used to fit the adsorption data. From the fitted plots for the internal diffusion model in Fig. ##FIG##6##7##c, the MO adsorption process occurred in three stages for all three concentrations. The first stage involved diffusion of the MO molecules from the solution to the adsorbent surface, which corresponded to surface diffusion, and the adsorption rate was faster in this stage due to the high adsorption driving force. The second stage involved diffusion of the MO from the surface of the adsorbent to the inner surfaces of the mesopores, which corresponded to the internal diffusion process. The third stage involved slowing of the diffusion rate due to the low concentration of residual dye, and this constituted the adsorption equilibrium stage. Additionally, Table ##TAB##4##5## shows that for the three different concentrations, K<sub>d3</sub> &lt; K<sub>d2</sub> &lt; K<sub>d1</sub> and C ≠ 0, indicating that internal diffusion was the main, but not the only, rate-controlling step. The curve fits did not pass through the origin, indicating that diffusion from the boundary layer to the adsorbent surface cannot be neglected, so the adsorption of MO on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial was determined by several rate-controlling steps<sup>##UREF##23##37##</sup>.</p>", "<title>Adsorption isotherms</title>", "<p id=\"Par38\">The Langmuir and Freundlich models were used to fit the adsorption data and analyze the adsorption process. The Langmuir model assumes single layer adsorption, in which the adsorbent molecules are in one-to-one correspondence with the adsorbent surface, and each occupied adsorption site cannot be used by another adsorbent molecule. Additionally, the odds that different sites on the adsorbent surface are used by the adsorbate are almost the same, and the Langmuir expression is shown below<sup>##REF##20041633##16##</sup> Eq. ##FORMU##10##9##:where C<sub>e</sub> (mg/L) is the concentration at adsorption equilibrium, q<sub>e</sub> (mg/g) is the amount adsorbed when the adsorption process reaches equilibrium, K<sub>L</sub>(L/mg) is the Langmuir constant related to the adsorption binding energy, and q<sub>m</sub> (mg/g) is the maximum amount of adsorbate on the adsorbent. K<sub>L</sub> and q<sub>m</sub> can be calculated by plotting against C<sub>e</sub>. There is also a parameter R<sub>L</sub> in the Langmuir model, which can be used for determining the adsorption behavior and is defined by<sup>##UREF##24##38##</sup> Eq. ##FORMU##11##10##:where C<sub>0</sub> is the actual concentration of the adsorbent solution. When 0 &lt; R<sub>L</sub> &lt; 1, adsorption of the adsorbate occurs smoothly; when 1 &lt; R<sub>L</sub>, the adsorption process is inhibited and when R<sub>L</sub> = 0, adsorption does not occur.</p>", "<p id=\"Par39\">The Freundlich model describes multilayer adsorption, the adsorption sites on the material surface are heterogeneous, and the expression is shown below<sup>##UREF##25##39##</sup> Eq. ##FORMU##12##11##:where and n are the Freundlich constants, and the values are determined by fitting. When 2 &lt; n &lt; 10, adsorption occurs easily, and when n &lt; 1, adsorption is difficult or some difficulties are encountered.</p>", "<p id=\"Par40\">To choose between the Langmuir and Freundlich adsorption models, MO solutions with concentrations of 10, 30, 50, 70, 80, 90, 100,120 and 200 mg/L were added to 20 mg of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> adsorbent at a constant temperature of 25 °C and stirred at 200 r/min and shaken. The absorbance was measured by sampling the supernatant after 30 min, and the isotherm fitting plots and data are shown in Fig. ##FIG##6##7##d and Table ##TAB##5##6##. In addition to the R<sup>2</sup> table fitting accuracy, and were further evaluated by the root mean square error (RMSE), as shown in Eq. ##FORMU##14##12##.</p>", "<p id=\"Par41\">As seen from Table ##TAB##5##6##<bold>,</bold> the Langmuir isothermal model provided better fits at all three temperatures, so the Langmuir isothermal adsorption model better described the adsorption of MO on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial, and the process involved monolayer adsorption. The saturation adsorption amount increased from 57.164 to 116.624 mg/g as the temperature was increased from 25 to 45 °C, which also proved that adsorption of MO on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial was an endothermic process. In addition, the Freundlich constants n &gt; 1 and =0.963 &lt; 1 are provided in Table ##TAB##5##6##, which indicated that adsorption of MO was favorable.</p>", "<title>Comparison of adsorption by different adsorbents</title>", "<p id=\"Par42\">As shown in Table ##TAB##6##7##, the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial exhibited strong adsorption, and the magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles showed a nanosize effect and adsorbed MO via surface electrostatic attraction, and the adsorption capacity was enhanced after modification with the SiO<sub>2</sub> coating. In addition, the adsorption capacity of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> was significantly higher than those of other adsorbents, indicating that Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> has potential for use in treating organic dye wastewaters.</p>", "<title>Adsorption thermodynamics</title>", "<p id=\"Par43\">The adsorption thermodynamics indicate whether energy is released or absorbed during a reaction. To explore the mechanism for adsorption of MO on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial, the adsorption data were analyzed thermodynamically at three different temperatures, 25 °C, 35 °C and 45 °C, to simulate the enthalpy and entropy changes. The thermodynamic parameters were the Gibbs free energy (△G<sup>0</sup>, KJ/mol), the enthalpy of absorption and (△H<sup>0</sup>, KJ/mol) and the entropy of absorption (△S<sup>0</sup>, J/(mol. K)). where since K<sub>L</sub> has a magnitude in L/mg and the equilibrium constant Kc is dimensionless<sup>##REF##28478298##43##</sup>, Eq. ##FORMU##18##15## was used for the transformation. and these are related as shown below.where R is the molar gas constant, 8.3145 J mol<sup>−1</sup>K<sup>−1</sup>; T is the absolute temperature; K<sub>L</sub> is Langmuir’s constant and the equilibrium constant Kc is a dimensionless parameter; Qe is the equilibrium adsorption volume; and Ce is the equilibrium adsorption concentration.</p>", "<p id=\"Par44\">The calculated thermodynamic parameters are shown in Table ##TAB##7##8##. When △H<sup>0</sup> &gt; 0, the reaction is endothermic; when △H<sup>0</sup> &lt; 0, the reaction is exothermic; △S<sup>0</sup> &gt; 0 indicates that the reaction increases the entropy and △S<sup>0</sup> = 0 indicates that the reaction is at equilibrium. In addition, if △G<sup>0</sup> &lt; 0, the reaction proceeds spontaneously; if △G<sup>0</sup> = 0, the reaction is at equilibrium and if △G<sup>0</sup> &gt; 0, the reaction cannot proceed spontaneously. From the data in the table, we can see that the positive value of △S<sup>0</sup> indicates that the randomness increases at the solid–liquid interface during the adsorption of the three anionic dyes in aqueous solution onto the adsorbent,△G<sup>0</sup> was negative and decreased with increasing temperature, which indicated that the adsorption process was spontaneous; also, △H<sup>0</sup> was positive, which indicated the adsorption process was endothermic and higher temperatures favored adsorption; this was consistent with the results for isothermal adsorption line fitting.</p>", "<title>Reusability study</title>", "<p id=\"Par45\">Regeneration experiments are important for probing reuse or recovery of an adsorbent. The experimental results shown in Fig. ##FIG##6##7##d indicated that after five desorption-adsorption cycles, the adsorption amount decreased from 53.278 to 44.221 mg/g, and the adsorption capacity was reduced, which may be attributed to incomplete desorption of the adsorbed MO from some of the adsorption sites. However, the amount adsorbed exceeded 80% of the initial amount adsorbed, so the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial was effectively recycled.</p>", "<title>Adsorption of MO in real water samples</title>", "<p id=\"Par46\">After treating as described in Sect. “<xref rid=\"Sec10\" ref-type=\"sec\">Real Sample Preparation</xref>”, the results are shown in Table ##TAB##8##9##, from which it can be seen that the q<sub>e</sub> of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> was 47.382 and 46.897 mg g<sup>−1</sup> in the 100 mg/L MO solution configured for the water samples of FJ and KD, respectively, and the desorption rates were 78% and 80%, which were decreased, but the adsorption and desorption performances were still excellent, which proves that Fe3O4 can be used for the adsorption of the MO dye effluent from the real water samples.</p>", "<title>Exploration of the adsorption mechanism</title>", "<p id=\"Par47\">According to the previous analysis, the increases in the average particle size and surface area of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial formed more adsorption sites and increased the adsorption capacity. The physical properties of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> indicated that the ferromagnetic nanoparticles on the surface of the material provided a good magnetic response, and this enabled fast and controlled separation of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> with an applied magnetic field to improve the adsorption efficiency. Second, the mesoporous structure of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial had an important impact on adsorption. Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterials usually have highly ordered pore structures, and these pores provide larger surface areas and more adsorption sites, and the pore sizes can be tuned to achieve efficient adsorption of MO. For chemisorption of MO on Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, the appearance of amorphous SiO<sub>2</sub> in the XRD pattern and S, Na, and N in the EDS spectra and XPS data indicated successful adsorption of MO on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>. The FT-IR spectrum of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-MO showed a shift in the position of the –OH vibrational band at 3428 cm<sup>−1</sup>, which indicated hydrogen bonding and electrostatic interactions between the MO and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>. Additionally, the C–O and H–O-C binding energies were shifted in the XPS spectra, indicating the involvement of –OH on the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> surface in the adsorption process. This was also confirmed by the pH experiments. Electrostatic interactions also played important roles in the adsorption of MO by Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>. The pH of the solution was altered to control the charge on the adsorbent surface, which affected the interactions between the adsorbent and the dye molecules, so hydrogen bonding and electrostatic interactions were involved in adsorption of MO by Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, and the –OH groups played an important role in the adsorption process. The adsorption mechanism is shown in Fig. ##FIG##7##8##.</p>" ]
[ "<title>Conclusions</title>", "<p id=\"Par48\">In this thesis, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> core–shell nanomaterials with good adsorption capacities were obtained by using sol–gel chemistry to encapsulate the magnetic Fe<sub>3</sub>O<sub>4</sub> with mesoporous SiO<sub>2</sub>, and the increased adsorption efficiency was attributed to the increased surface area of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>. The results showed that the highest MO adsorption capacity for Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> was 182.503 mg/g, far more than that for unmodified Fe<sub>3</sub>O<sub>4</sub>, 15.5 mg/g. The adsorption data for the adsorbent were fitted with the pseudo-second-order kinetic model, and the intraparticle diffusion kinetics indicated that the adsorption process was determined by multiple rate-controlling steps. Thermodynamic studies showed that the adsorption of MO on Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> was endothermic and spontaneous, and the MO interacted with the adsorbent via electrostatic interactions and hydrogen bonding. In addition, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> showed good regeneration ability, and the adsorption capacity reached 83% of the initial adsorption capacity after 5 reuse cycles. Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> core–shell nanomaterials for treating real water samples still have superior unit adsorption and desorption rates .Therefore, the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial exhibited good adsorption performance and was safe, efficient and reusable, so it is an ideal adsorbent for treating MO dye wastewater.</p>" ]
[ "<p id=\"Par1\">Magnetic core–shell Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles were synthesized by sol–gel method. Based on the characterization and experimental results, the adsorbent was found to have an average particle size of approximately 120 nm, a pore size range of 2–5 nm and superparamagnetic properties. It exhibited electrostatic and hydrogen bonding interactions during adsorption of methyl orange (MO). The adsorption of MO on the magnetic Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles exhibited pseudo-second-order kinetics, the adsorption process is a spontaneous endothermic adsorption process, which conforms to the Langmuir adsorption isotherm model. he maximum amount of MO was adsorbed at pH = 2, T = 45 °C and t = 30 min, and the highest adsorption capacity was 182.503 mg/g; The unit adsorption capacity of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles still reached 83% of the original capacity after 5 cycles, so the material was reusable and met the requirements of environmental protection. This study reveals the great potential of magnetic mesoporous nanoparticles for removal of dyes from wastewater.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-023-50368-x.</p>", "<title>Author contributions</title>", "<p>All authors contributed to the study , conceptualization and funding acquisition was performed by H.L. Experiment analysis were performed by H.J. , J.H. and Z.Z. Writing—original draft were performed by H.J. Conception design and experimental test were performed by H.L., H.J. and R.L., and all authors commented on the previous version of the manuscript. All authors read and approved the final manuscript. The publishment consent was obtained from all co-authors.</p>", "<title>Funding</title>", "<p>This research was supported by the Natural Science Foundation of Heilongjiang Province of China (jointly guided), grant number LH2020E003 and Ministry of Agriculture and Rural Affairs of the People’s Republic of China, grant number 125A0605.</p>", "<title>Data availability</title>", "<p>Data will be made available on request. If anyone would like to receive data from this study, please contact Huanhuan Jin at 3,518,623,[email protected].</p>", "<title>Competing interests</title>", "<p id=\"Par49\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Synthetic process for Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>(<bold>a</bold>) XRD patterns for Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>; (<bold>b</bold>) IR spectra of Fe<sub>3</sub>O<sub>4</sub>, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-MO; (<bold>c</bold>) adsorption–desorption isotherms of Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> and the pore size distributions; (<bold>d</bold>) VSM diagrams for Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>TEM images of Fe<sub>3</sub>O<sub>4</sub>, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-MO.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>(<bold>a</bold>), (<bold>b</bold>), and (<bold>c</bold>) SEM images of Fe<sub>3</sub>O<sub>4</sub>, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2,</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-MO, respectively; (<bold>d</bold>) EDS spectra of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-MO; and (<bold>e</bold>) and (<bold>f</bold>) particle size distributions for Fe<sub>3</sub>O<sub>4</sub> and Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, respectively.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>XPS spectra of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>; (<bold>a</bold>) Total elemental spectrum; (<bold>b</bold>) C peaks; (<bold>c</bold>) Si peaks; (<bold>d</bold>) O peaks; (<bold>e</bold>) Fe peaks and (<bold>f</bold>) N peaks.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>(<bold>a</bold>) Effect of the initial solution pH on adsorption of MO by the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial; (<bold>b</bold>) Effect of the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> zeta potential at different pH values and the effect of the pH at t = 30 min on adsorption by Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>; (<bold>c</bold>) Effects of temperature and the initial MO concentration on adsorption by the nanomaterial; (<bold>d</bold>) Effect of reaction time on the adsorption of MO by the Fe3O4@SiO2 nanomaterial.</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>(<bold>a</bold>) Fit of the kinetic data with the pseudo-first-order model; (<bold>b</bold>) fit of the kinetic data with the pseudo-second-order model; (<bold>c</bold>) fit of kinetic data with the intraparticle diffusion model; (<bold>d</bold>) Isotherm model for MO adsorption by the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial;</p></caption></fig>", "<fig id=\"Fig8\"><label>Figure 8</label><caption><p>The adsorption mechanism of Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> for MO.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>BET parameters for Fe<sub>3</sub>O<sub>4</sub>, Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>, BTT and CAC.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Sample</th><th align=\"left\">BET area ()</th><th align=\"left\">Pore size (nm)</th><th align=\"left\">Pore volume </th></tr></thead><tbody><tr><td align=\"left\">Fe<sub>3</sub>O<sub>4</sub></td><td char=\".\" align=\"char\">11.5093</td><td char=\".\" align=\"char\">7.4349</td><td char=\".\" align=\"char\">0.021998</td></tr><tr><td align=\"left\">Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub></td><td char=\".\" align=\"char\">17.7188</td><td char=\".\" align=\"char\">7.7382</td><td char=\".\" align=\"char\">0.029849</td></tr><tr><td align=\"left\">BTT</td><td char=\".\" align=\"char\">61.2236</td><td char=\".\" align=\"char\">6.5024</td><td char=\".\" align=\"char\">0.099525</td></tr><tr><td align=\"left\">CAC</td><td char=\".\" align=\"char\">170.0739</td><td char=\".\" align=\"char\">3.3696</td><td char=\".\" align=\"char\">0.143268</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>XPS spectral parameters for Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-MO.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Type</th><th align=\"left\">Peak position eV</th><th align=\"left\">Area CPS.eV</th><th align=\"left\">Atomic ratio %</th></tr></thead><tbody><tr><td align=\"left\">C 1s</td><td char=\".\" align=\"char\">285.15</td><td char=\".\" align=\"char\">226,230.90</td><td char=\".\" align=\"char\">45.22</td></tr><tr><td align=\"left\">O 1s</td><td char=\".\" align=\"char\">532.09</td><td char=\".\" align=\"char\">506,692.57</td><td char=\".\" align=\"char\">43.12</td></tr><tr><td align=\"left\">Si 2p</td><td char=\".\" align=\"char\">103.19</td><td char=\".\" align=\"char\">39,928.07</td><td char=\".\" align=\"char\">8.10</td></tr><tr><td align=\"left\">Fe 2p</td><td char=\".\" align=\"char\">709.99</td><td char=\".\" align=\"char\">3176.64</td><td char=\".\" align=\"char\">0.06</td></tr><tr><td align=\"left\">Na 1s</td><td char=\".\" align=\"char\">1072.27</td><td char=\".\" align=\"char\">8906.92</td><td char=\".\" align=\"char\">0.30</td></tr><tr><td align=\"left\">S 2p</td><td char=\".\" align=\"char\">170.10</td><td char=\".\" align=\"char\">10,037.24</td><td char=\".\" align=\"char\">1.88</td></tr><tr><td align=\"left\">N 1s</td><td char=\".\" align=\"char\">400.76</td><td char=\".\" align=\"char\">11,231.03</td><td char=\".\" align=\"char\">1.32</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>XPS spectral parameters for Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Type</th><th align=\"left\">Peak position eV</th><th align=\"left\">Area CPS.eV</th><th align=\"left\">Atomic ratio %</th></tr></thead><tbody><tr><td align=\"left\">C 1s</td><td char=\".\" align=\"char\">284.36</td><td char=\".\" align=\"char\">328,574.50</td><td char=\".\" align=\"char\">45.77</td></tr><tr><td align=\"left\">O 1s</td><td char=\".\" align=\"char\">531.92</td><td char=\".\" align=\"char\">462,224.60</td><td char=\".\" align=\"char\">43.04</td></tr><tr><td align=\"left\">Si 2p</td><td char=\".\" align=\"char\">102.73</td><td char=\".\" align=\"char\">41,336.19</td><td char=\".\" align=\"char\">9.09</td></tr><tr><td align=\"left\">Fe 2p</td><td char=\".\" align=\"char\">710.49</td><td char=\".\" align=\"char\">109,167.94</td><td char=\".\" align=\"char\">2.8</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab4\"><label>Table 4</label><caption><p>Kinetic fitting parameters for adsorption of MO by the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">C<sub>0</sub>(mg/L)</th><th align=\"left\" colspan=\"4\">Pseudo-first-order</th><th align=\"left\" colspan=\"4\">Pseudo-second-order</th></tr><tr><th align=\"left\">K<sub>1</sub> (1/min)</th><th align=\"left\">q<sub>e.exp</sub> (mg/g)</th><th align=\"left\">R<sub>1</sub><sup>2</sup></th><th align=\"left\">ε%</th><th align=\"left\">K<sub>2</sub> (g/mg min)</th><th align=\"left\">q<sub>e.exp</sub> (mg/g)</th><th align=\"left\">R<sub>2</sub><sup>2</sup></th><th align=\"left\">ε%</th></tr></thead><tbody><tr><td align=\"left\">30</td><td char=\".\" align=\"char\">0.359</td><td char=\".\" align=\"char\">53.845</td><td char=\".\" align=\"char\">0.985</td><td char=\".\" align=\"char\">2.732</td><td char=\".\" align=\"char\">0.010</td><td char=\".\" align=\"char\">56.559</td><td char=\".\" align=\"char\">0.989</td><td char=\".\" align=\"char\">1.223</td></tr><tr><td align=\"left\">50</td><td char=\".\" align=\"char\">0.214</td><td char=\".\" align=\"char\">79.515</td><td char=\".\" align=\"char\">0.971</td><td char=\".\" align=\"char\">6.356</td><td char=\".\" align=\"char\">0.003</td><td char=\".\" align=\"char\">87.669</td><td char=\".\" align=\"char\">0.986</td><td char=\".\" align=\"char\">2.378</td></tr><tr><td align=\"left\">100</td><td char=\".\" align=\"char\">0.288</td><td char=\".\" align=\"char\">120.433</td><td char=\".\" align=\"char\">0.976</td><td char=\".\" align=\"char\">7.298</td><td char=\".\" align=\"char\">0.003</td><td char=\".\" align=\"char\">130.018</td><td char=\".\" align=\"char\">0.995</td><td char=\".\" align=\"char\">0.523</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab5\"><label>Table 5</label><caption><p>Intraparticle diffusion model for MO adsorption by the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">C<sub>0</sub>(mg/L)</th><th align=\"left\" colspan=\"9\">Intraparticle diffusion model</th></tr><tr><th align=\"left\">K<sub>d1</sub> (mg/g min<sup>1/2</sup>)</th><th align=\"left\">C (mg/g)</th><th align=\"left\">R<sup>2</sup></th><th align=\"left\">K<sub>d2</sub> (mg/g min<sup>1/2</sup>)</th><th align=\"left\">C(mg/g)</th><th align=\"left\">R<sup>2</sup></th><th align=\"left\">K<sub>d3</sub> (mg/g.min<sup>1/2</sup>)</th><th align=\"left\">C (mg/g)</th><th align=\"left\">R<sup>2</sup></th></tr></thead><tbody><tr><td align=\"left\">30</td><td char=\".\" align=\"char\">19.357</td><td char=\".\" align=\"char\">4.424</td><td char=\".\" align=\"char\">0.946</td><td char=\".\" align=\"char\">2.525</td><td char=\".\" align=\"char\">32.449</td><td char=\".\" align=\"char\">0.903</td><td char=\".\" align=\"char\">0.064</td><td char=\".\" align=\"char\">50.144</td><td char=\".\" align=\"char\">0.911</td></tr><tr><td align=\"left\">50</td><td char=\".\" align=\"char\">37.016</td><td char=\".\" align=\"char\">26.113</td><td char=\".\" align=\"char\">0.843</td><td char=\".\" align=\"char\">9.521</td><td char=\".\" align=\"char\">30.368</td><td char=\".\" align=\"char\">0.809</td><td char=\".\" align=\"char\">4.108</td><td char=\".\" align=\"char\">80.768</td><td char=\".\" align=\"char\">0.963</td></tr><tr><td align=\"left\">100</td><td char=\".\" align=\"char\">36.752</td><td char=\".\" align=\"char\">4.717</td><td char=\".\" align=\"char\">0.889</td><td char=\".\" align=\"char\">10.017</td><td char=\".\" align=\"char\">64.371</td><td char=\".\" align=\"char\">0.719</td><td char=\".\" align=\"char\">0.652</td><td char=\".\" align=\"char\">120.572</td><td char=\".\" align=\"char\">0.905</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab6\"><label>Table 6</label><caption><p>Adsorption isotherm parameters.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">T(℃)</th><th align=\"left\" colspan=\"4\">Langmuir</th><th align=\"left\" colspan=\"4\">Freundlich</th></tr><tr><th align=\"left\">q<sub>m</sub> (mg/g)</th><th align=\"left\">K<sub>L</sub> (L/mg)</th><th align=\"left\">R<sup>2</sup></th><th align=\"left\">RMSE</th><th align=\"left\">K<sub>F</sub> (mg/g)/(mg/L)<sup>n</sup></th><th align=\"left\">n</th><th align=\"left\">R<sup>2</sup></th><th align=\"left\">RMSE</th></tr></thead><tbody><tr><td align=\"left\">25℃</td><td char=\".\" align=\"char\">57.164</td><td char=\".\" align=\"char\">0.020</td><td char=\".\" align=\"char\">0.984</td><td char=\".\" align=\"char\">0.127</td><td char=\".\" align=\"char\">6.295</td><td char=\".\" align=\"char\">2.333</td><td char=\".\" align=\"char\">0.923</td><td char=\".\" align=\"char\">0.212</td></tr><tr><td align=\"left\">35℃</td><td char=\".\" align=\"char\">98.504</td><td char=\".\" align=\"char\">0.030</td><td char=\".\" align=\"char\">0.995</td><td char=\".\" align=\"char\">0.012</td><td char=\".\" align=\"char\">5.864</td><td char=\".\" align=\"char\">1.950</td><td char=\".\" align=\"char\">0.955</td><td char=\".\" align=\"char\">0.139</td></tr><tr><td align=\"left\">45 °C</td><td char=\".\" align=\"char\">116.624</td><td char=\".\" align=\"char\">0.053</td><td char=\".\" align=\"char\">0.996</td><td char=\".\" align=\"char\">0.005</td><td char=\".\" align=\"char\">12.938</td><td char=\".\" align=\"char\">2.495</td><td char=\".\" align=\"char\">0.949</td><td char=\".\" align=\"char\">0.177</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab7\"><label>Table 7</label><caption><p>Adsorption isotherm parameters.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\"><sup>Adsorption</sup> materials</th><th align=\"left\">qmax (mg/g)</th><th align=\"left\">pH</th><th align=\"left\"><sup>Contact time</sup> (min)</th><th align=\"left\">References</th></tr></thead><tbody><tr><td align=\"left\">CuO NPs</td><td char=\".\" align=\"char\">121.95</td><td align=\"left\">6.5</td><td align=\"left\">540</td><td align=\"left\"><sup>##UREF##26##40##</sup></td></tr><tr><td align=\"left\">PMOS</td><td char=\".\" align=\"char\">56.62</td><td align=\"left\">6.5</td><td align=\"left\">50</td><td align=\"left\"><sup>##UREF##27##41##</sup></td></tr><tr><td align=\"left\">Fe2O3–BC</td><td char=\".\" align=\"char\">46.6</td><td align=\"left\">3</td><td align=\"left\">90</td><td align=\"left\"><sup>##UREF##28##42##</sup></td></tr><tr><td align=\"left\">Carbon nanotubes</td><td char=\".\" align=\"char\">52.86</td><td align=\"left\">2</td><td align=\"left\">45</td><td align=\"left\"><sup>##UREF##21##34##</sup></td></tr><tr><td align=\"left\">Fe3O4@SiO2</td><td char=\".\" align=\"char\">182.503</td><td align=\"left\">2</td><td align=\"left\">30</td><td align=\"left\">Present study</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab8\"><label>Table 8</label><caption><p>Thermodynamic parameters for MO adsorption by the Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanomaterial.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"2\">T(K)</th><th align=\"left\">K<sub>L</sub></th><th align=\"left\">Kc</th><th align=\"left\">△G<sup>0</sup></th><th align=\"left\">△H<sup>0</sup></th><th align=\"left\">△S<sup>0</sup></th></tr><tr><th align=\"left\">L/mg</th><th align=\"left\"/><th align=\"left\">(KJ/mol)</th><th align=\"left\">(KJ/mol)</th><th align=\"left\">(J/(mol K))</th></tr></thead><tbody><tr><td align=\"left\">298</td><td char=\".\" align=\"char\">0.020</td><td char=\".\" align=\"char\">20,435.751</td><td align=\"left\">− 24.591</td><td align=\"left\" rowspan=\"3\">1.2417</td><td align=\"left\" rowspan=\"3\">4.2065</td></tr><tr><td align=\"left\">308</td><td char=\".\" align=\"char\">0.030</td><td char=\".\" align=\"char\">30,422.160</td><td align=\"left\">− 26.434</td></tr><tr><td align=\"left\">318</td><td char=\".\" align=\"char\">0.053</td><td char=\".\" align=\"char\">53,475.070</td><td align=\"left\">− 28.784</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab9\"><label>Table 9</label><caption><p>Adsorption of MO in different water samples on Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> in real water samples.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Water samples</th><th align=\"left\">Added/(mg L<sup>−1</sup>)</th><th align=\"left\">Q/(mg g<sup>−1</sup>)</th><th align=\"left\">D (%)</th></tr></thead><tbody><tr><td align=\"left\">Deionized water</td><td align=\"left\">100</td><td align=\"left\">53.882</td><td align=\"left\">83</td></tr><tr><td align=\"left\">FJ-SJ</td><td align=\"left\">100</td><td align=\"left\">47.382</td><td align=\"left\">78</td></tr><tr><td align=\"left\">KD-SJ</td><td align=\"left\">100</td><td align=\"left\">46.897</td><td align=\"left\">80</td></tr></tbody></table></table-wrap>" ]
[ "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ {\\text{Fe}}^{2 + } + 2{\\text{Fe}}^{3 + } + 8o{\\text{H}}^{ - } = {\\text{Fe}}_{3} {\\text{O}}_{4} \\downarrow + 4{\\text{H}}_{2} {\\text{O}}^{{}} $$\\end{document}</tex-math><mml:math id=\"M2\" display=\"block\"><mml:mrow><mml:msup><mml:mrow><mml:mtext>Fe</mml:mtext></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:msup><mml:mrow><mml:mtext>Fe</mml:mtext></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mn>8</mml:mn><mml:mi>o</mml:mi><mml:msup><mml:mrow><mml:mtext>H</mml:mtext></mml:mrow><mml:mo>-</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:msub><mml:mtext>Fe</mml:mtext><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mtext>O</mml:mtext><mml:mn>4</mml:mn></mml:msub><mml:mrow><mml:mo stretchy=\"false\">↓</mml:mo><mml:mo>+</mml:mo><mml:mn>4</mml:mn></mml:mrow><mml:msub><mml:mtext>H</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:msup><mml:mrow><mml:mtext>O</mml:mtext></mml:mrow><mml:mrow/></mml:msup></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\eta_{{\\text{e}}} = \\frac{{{\\text{C}}_{0} - {\\text{C}}_{e} }}{{{\\text{C}}_{{0}} }} \\times 100\\% $$\\end{document}</tex-math><mml:math id=\"M4\" display=\"block\"><mml:mrow><mml:msub><mml:mi>η</mml:mi><mml:mtext>e</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mtext>C</mml:mtext><mml:mn>0</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mtext>C</mml:mtext><mml:mi>e</mml:mi></mml:msub></mml:mrow><mml:msub><mml:mtext>C</mml:mtext><mml:mn>0</mml:mn></mml:msub></mml:mfrac><mml:mo>×</mml:mo><mml:mn>100</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ {\\text{Q}}_{{\\text{e}}} = \\frac{{{\\text{C}}_{0} - {\\text{C}}_{e} {\\text{V}}}}{{\\text{m}}} $$\\end{document}</tex-math><mml:math id=\"M6\" display=\"block\"><mml:mrow><mml:msub><mml:mtext>Q</mml:mtext><mml:mtext>e</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mtext>C</mml:mtext><mml:mn>0</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mtext>C</mml:mtext><mml:mi>e</mml:mi></mml:msub><mml:mtext>V</mml:mtext></mml:mrow><mml:mtext>m</mml:mtext></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{m}}^{2} {\\text{g}}^{-1}$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:mrow><mml:msup><mml:mrow><mml:mtext>m</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msup><mml:mrow><mml:mtext>g</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{(cm}}^{2} \\, {\\text{g}}^{-1})$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mrow><mml:msup><mml:mrow><mml:mtext>(cm</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mspace width=\"0.166667em\"/><mml:msup><mml:mrow><mml:mtext>g</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ4\"><label>4</label><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ R - OH\\underset{{OH^{ - } }}{\\overset{{H^{ + } }}{\\rightleftharpoons}}R - OH_{2}^{ + } $$\\end{document}</tex-math><mml:math id=\"M12\" display=\"block\"><mml:mrow><mml:mi>R</mml:mi><mml:mo>-</mml:mo><mml:mi>O</mml:mi><mml:mi>H</mml:mi><mml:munder><mml:mover><mml:mo stretchy=\"false\">⇌</mml:mo><mml:msup><mml:mi>H</mml:mi><mml:mo>+</mml:mo></mml:msup></mml:mover><mml:mrow><mml:mi>O</mml:mi><mml:msup><mml:mi>H</mml:mi><mml:mo>-</mml:mo></mml:msup></mml:mrow></mml:munder><mml:mi>R</mml:mi><mml:mo>-</mml:mo><mml:mi>O</mml:mi><mml:msubsup><mml:mi>H</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ5\"><label>5</label><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ q_{t} = q_{e} (1 - e^{{k_{1} t}} ) $$\\end{document}</tex-math><mml:math id=\"M14\" display=\"block\"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>t</mml:mi></mml:mrow></mml:msup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ6\"><label>6</label><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ q_{t} = \\frac{{q_{e}^{2} k_{2} t}}{{1 + k_{2} q_{e} t}} $$\\end{document}</tex-math><mml:math id=\"M16\" display=\"block\"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>q</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>q</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ7\"><label>7</label><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\varepsilon \\% = \\left[ {\\sqrt {\\frac{{\\Sigma [q_{t,\\exp } - q_{t,cal} /q_{t,\\exp } ]^{2} }}{n - 1}} } \\right] \\times 100\\% $$\\end{document}</tex-math><mml:math id=\"M18\" display=\"block\"><mml:mrow><mml:mi>ε</mml:mi><mml:mo>%</mml:mo><mml:mo>=</mml:mo><mml:mfenced close=\"]\" open=\"[\"><mml:msqrt><mml:mfrac><mml:mrow><mml:mi mathvariant=\"normal\">Σ</mml:mi><mml:msup><mml:mrow><mml:mo stretchy=\"false\">[</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mo>exp</mml:mo></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mo>exp</mml:mo></mml:mrow></mml:msub><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac></mml:msqrt></mml:mfenced><mml:mo>×</mml:mo><mml:mn>100</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ8\"><label>8</label><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ q_{t} = K_{di} t^{1/2} + C $$\\end{document}</tex-math><mml:math id=\"M20\" display=\"block\"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">di</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mi>t</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mi>C</mml:mi></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ9\"><label>9</label><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ q_{e} = \\frac{{q_{m} K_{L} C_{e} }}{{1 + K_{L} C_{e} }} $$\\end{document}</tex-math><mml:math id=\"M22\" display=\"block\"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:msub><mml:mi>K</mml:mi><mml:mi>L</mml:mi></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mi>L</mml:mi></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ10\"><label>10</label><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ R_{L} = \\frac{1}{{1 + K_{L} C_{0} }} $$\\end{document}</tex-math><mml:math id=\"M24\" display=\"block\"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>L</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mi>L</mml:mi></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ11\"><label>11</label><alternatives><tex-math id=\"M25\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ q_{e} = K_{F} C_{e}^{n} $$\\end{document}</tex-math><mml:math id=\"M26\" display=\"block\"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mi>F</mml:mi></mml:msub><mml:msubsup><mml:mi>C</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mi>n</mml:mi></mml:msubsup></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M27\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{K}}_{\\text{F}}$$\\end{document}</tex-math><mml:math id=\"M28\"><mml:msub><mml:mtext>K</mml:mtext><mml:mtext>F</mml:mtext></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ12\"><label>12</label><alternatives><tex-math id=\"M29\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ RMSE = \\sqrt {\\frac{{\\sum\\limits_{i = 1}^{n} {\\left( {X_{obs,i} - X_{{\\text{model,i}}} } \\right)^{2} } }}{n}} $$\\end{document}</tex-math><mml:math id=\"M30\" display=\"block\"><mml:mrow><mml:mi>R</mml:mi><mml:mi>M</mml:mi><mml:mi>S</mml:mi><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:msqrt><mml:mfrac><mml:mrow><mml:munderover><mml:mo movablelimits=\"false\">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:munderover><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mtext>model,i</mml:mtext></mml:msub></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mi>n</mml:mi></mml:mfrac></mml:msqrt></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M31\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{R}}_{\\text{L}}$$\\end{document}</tex-math><mml:math id=\"M32\"><mml:msub><mml:mtext>R</mml:mtext><mml:mtext>L</mml:mtext></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ13\"><label>13</label><alternatives><tex-math id=\"M33\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\Delta G^{0} = - RT\\ln k_{c} $$\\end{document}</tex-math><mml:math id=\"M34\" display=\"block\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msup><mml:mi>G</mml:mi><mml:mn>0</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mi>R</mml:mi><mml:mi>T</mml:mi><mml:mo>ln</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ14\"><label>14</label><alternatives><tex-math id=\"M35\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\ln k_{c} = \\Delta S^{0} /R - \\Delta H^{0} /RT $$\\end{document}</tex-math><mml:math id=\"M36\" display=\"block\"><mml:mrow><mml:mo>ln</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msup><mml:mi>S</mml:mi><mml:mn>0</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>R</mml:mi><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msup><mml:mi>H</mml:mi><mml:mn>0</mml:mn></mml:msup><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>R</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ15\"><label>15</label><alternatives><tex-math id=\"M37\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ K_{C} = 10^{6} K_{L} $$\\end{document}</tex-math><mml:math id=\"M38\" display=\"block\"><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mi>C</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mn>6</mml:mn></mml:msup><mml:msub><mml:mi>K</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2023_50368_Article_Equ1.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50368_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2023_50368_Article_Equ2.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50368_Article_Equ3.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50368_Fig2_HTML\" id=\"MO2\"/>", "<inline-graphic xlink:href=\"41598_2023_50368_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41598_2023_50368_Article_IEq4.gif\"/>", "<graphic xlink:href=\"41598_2023_50368_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2023_50368_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2023_50368_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2023_50368_Article_Equ4.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50368_Fig6_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"41598_2023_50368_Fig7_HTML\" id=\"MO7\"/>", "<graphic xlink:href=\"41598_2023_50368_Article_Equ5.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50368_Article_Equ6.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50368_Article_Equ7.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50368_Article_Equ8.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50368_Article_Equ9.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50368_Article_Equ10.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50368_Article_Equ11.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50368_Article_IEq1.gif\"/>", "<graphic xlink:href=\"41598_2023_50368_Article_Equ12.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2023_50368_Article_IEq2.gif\"/>", "<graphic xlink:href=\"41598_2023_50368_Article_Equ13.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50368_Article_Equ14.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50368_Article_Equ15.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2023_50368_Fig8_HTML\" id=\"MO8\"/>" ]
[ "<media xlink:href=\"41598_2023_50368_MOESM1_ESM.docx\"><caption><p>Supplementary Figures.</p></caption></media>" ]
[{"label": ["1."], "surname": ["Aksu", "Tezer"], "given-names": ["Z", "S"], "article-title": ["Biosorption of reactive dyes on the green alga Chlorella vulgaris"], "source": ["Process.Biochem."], "year": ["2005"], "volume": ["40"], "fpage": ["1347"], "lpage": ["1361"], "pub-id": ["10.1016/j.procbio.2004.06.007"]}, {"label": ["5."], "surname": ["Qiu", "Feng", "Zhang", "Jia", "Yao"], "given-names": ["JH", "Y", "XF", "MM", "JF"], "article-title": ["Acid-promoted synthesis of UiO-66 for highly selective adsorption of anionic dyes: Adsorption performance and mechanisms"], "source": ["J. Coll. Interface Sci."], "year": ["2017"], "volume": ["499"], "fpage": ["151"], "lpage": ["158"], "pub-id": ["10.1016/j.jcis.2017.03.101"]}, {"label": ["6."], "surname": ["Sangeeta", "Amandeep"], "given-names": ["S", "K"], "article-title": ["Various methods for removal of dyes from industrial effluents\u2014a review"], "source": ["Indian J. Sci. Technol."], "year": ["2018"], "volume": ["11"], "fpage": ["1"], "lpage": ["21"]}, {"label": ["10."], "surname": ["Zhao", "Tang", "Xi", "Kong"], "given-names": ["WF", "YS", "J", "J"], "article-title": ["Functionalized graphene sheets with poly(ionic liquid)s and high adsorption capacity of anionic dyes"], "source": ["Appl. Surf. Sci."], "year": ["2015"], "volume": ["326"], "fpage": ["276"], "lpage": ["284"], "pub-id": ["10.1016/j.apsusc.2014.11.069"]}, {"label": ["11."], "surname": ["Wan"], "given-names": ["D"], "article-title": ["Adsorption and heterogeneous degradation of rhodamine B on the surface of magnetic bentonite material"], "source": ["Appl. Surf. Sci."], "year": ["2015"], "volume": ["349"], "fpage": ["988"], "lpage": ["996"], "pub-id": ["10.1016/j.apsusc.2015.05.004"]}, {"label": ["13."], "surname": ["Gong"], "given-names": ["R"], "article-title": ["Adsorptive removal of methyl orange and methylene blue from aqueous solution with finger-citron-residue-based activated carbon"], "source": ["Indus. Eng. Chem. Res."], "year": ["2013"], "volume": ["52"], "fpage": ["14297"], "lpage": ["14303"], "pub-id": ["10.1021/ie402138w"]}, {"label": ["15."], "mixed-citation": ["FARVEH & RAOUFI. Modeling of competitive ultrasonic assisted removal of the crystal violet and Aura mineO using MWCNTs functionalized by N-(3-nitrobenzylidene)-N-trimethoxysilylpropyl-ethane-1,2-diamine: Equilibrium, kinetics and thermodynamic study. Orient. J. Chem. Int. Res. J. Pure Appl. Chem. "], "bold": ["32"]}, {"label": ["17."], "surname": ["Pu", "Zhang", "Wang"], "given-names": ["SY", "Y", "P"], "article-title": ["Research progress in preparation and application of magnetic nanosorbents in water treatment"], "source": ["Indus. Water Treat."], "year": ["2019"], "volume": ["39"], "fpage": ["1"], "lpage": ["13"]}, {"label": ["18."], "mixed-citation": ["Xiaa, L., Pei-Fenga, C., Feng-Huaa, H. & Jin-Fanga, X. U. Effects of SiO_2 Surface Coating on the Performance of Magnetic Fe_3O_4 Microspheres. Chin. J. Synth. Chem. (2010)."]}, {"label": ["19."], "surname": ["Wang"], "given-names": ["PY"], "article-title": ["Silica coated Fe"], "sub": ["3", "4"], "source": ["Chem. Eng. J."], "year": ["2016"], "volume": ["306"], "fpage": ["280"], "lpage": ["288"], "pub-id": ["10.1016/j.cej.2016.07.068"]}, {"label": ["21."], "surname": ["Lin", "Haynes"], "given-names": ["YS", "CL"], "article-title": ["Synthesis and characterization of biocompatible and size-tunable multifunctional porous silica nanoparticles"], "source": ["Chem. Mater."], "year": ["2009"], "volume": ["21"], "fpage": ["3979"], "lpage": ["3986"], "pub-id": ["10.1021/cm901259n"]}, {"label": ["23."], "mixed-citation": ["Xuepeng, L. "], "italic": ["et al."]}, {"label": ["24."], "surname": ["Lu", "Yin", "Mayers", "Xia"], "given-names": ["Y", "Y", "BT", "Y"], "article-title": ["Modifying the surface properties of superparamagnetic iron oxide nanoparticles through a sol-gel approach"], "source": ["Nano Lett."], "year": ["2002"], "volume": ["2"], "fpage": ["183"], "lpage": ["186"], "pub-id": ["10.1021/nl015681q"]}, {"label": ["25."], "surname": ["Sayin", "Yilmaz"], "given-names": ["S", "M"], "article-title": ["Synthesis of a new calixarene derivative and its immobilization onto magnetic nanoparticle surfaces for excellent extractants toward Cr(VI), As(V), and U(VI)"], "source": ["J. Chem. Eng. Data"], "year": ["2011"], "volume": ["56"], "fpage": ["2020"], "lpage": ["2029"], "pub-id": ["10.1021/je1010328"]}, {"label": ["26."], "surname": ["Fan"], "given-names": ["HT"], "article-title": ["Cd(II)-imprinted polymer sorbents prepared by combination of surface imprinting technique with hydrothermal assisted sol\u2013gel process for selective removal of cadmium(II) from aqueous solution"], "source": ["Chem. Eng. J."], "year": ["2011"], "volume": ["171"], "fpage": ["703"], "lpage": ["710"], "pub-id": ["10.1016/j.cej.2011.05.023"]}, {"label": ["27."], "surname": ["Huang", "Zing", "Feng"], "given-names": ["X", "X", "C"], "article-title": ["Measurements of magnetic parameter and calculation of anisotropy on carbon fiber with magnetic coating"], "source": ["J. Funct. Mater."], "year": ["2007"], "volume": ["38"], "fpage": ["904"]}, {"label": ["28."], "surname": ["Hu", "Quan", "Guo", "Ye", "Wu"], "given-names": ["YQ", "CM", "M", "XS", "ZJ"], "article-title": ["Competitive adsorption of methyl orange and ethyl orange by AB-8 resin"], "source": ["Emerg. Mater. Res."], "year": ["2017"], "volume": ["6"], "fpage": ["1"], "lpage": ["27"], "pub-id": ["10.1680/jemmr.15.00082"]}, {"label": ["30."], "surname": ["Nasuha", "Hameed"], "given-names": ["N", "BH"], "article-title": ["Adsorption of methylene blue from aqueous solution onto NaOH-modified rejected tea"], "source": ["Chem. Eng. J."], "year": ["2011"], "volume": ["166"], "fpage": ["783"], "lpage": ["786"], "pub-id": ["10.1016/j.cej.2010.11.012"]}, {"label": ["31."], "surname": ["Cheah", "Hosseini", "Khan", "Chuah", "Choong"], "given-names": ["W", "S", "MA", "TG", "TSY"], "article-title": ["Acid modified carbon coated monolith for methyl orange adsorption"], "source": ["Chem. Eng. J."], "year": ["2013"], "volume": ["215"], "fpage": ["747"], "lpage": ["754"], "pub-id": ["10.1016/j.cej.2012.07.004"]}, {"label": ["32."], "surname": ["Liu", "Luo", "Zhu", "Yang", "Yang"], "given-names": ["XX", "J", "YT", "Y", "SJ"], "article-title": ["Removal of methylene blue from aqueous solutions by an adsorbent based on metal-organic framework and polyoxometalate"], "source": ["J. Alloys Compd."], "year": ["2015"], "volume": ["648"], "fpage": ["986"], "lpage": ["993"], "pub-id": ["10.1016/j.jallcom.2015.07.065"]}, {"label": ["33."], "surname": ["Tanhaei", "Ayati", "Lahtinen", "Sillanpaa"], "given-names": ["B", "A", "M", "M"], "article-title": ["Preparation and characterization of a novel chitosan/Al"], "sub": ["2", "3"], "source": ["Chem. Eng. J."], "year": ["2015"], "volume": ["259"], "fpage": ["1"], "lpage": ["10"], "pub-id": ["10.1016/j.cej.2014.07.109"]}, {"label": ["34."], "surname": ["Chen"], "given-names": ["SH"], "article-title": ["Equilibrium and kinetic studies of methyl orange and methyl violet adsorption on activated carbon derived from "], "italic": ["Phragmites australis"], "source": ["Desalination"], "year": ["2010"], "volume": ["252"], "fpage": ["149"], "lpage": ["156"], "pub-id": ["10.1016/j.desal.2009.10.010"]}, {"label": ["36."], "surname": ["Ai", "Zhang", "Meng"], "given-names": ["L", "C", "L"], "article-title": ["Adsorption of methyl orange from aqueous solution on hydrothermal synthesized Mg\u2013Al layered double hydroxide"], "source": ["J. Chem. Eng. Data"], "year": ["2011"], "volume": ["56"], "fpage": ["4217"], "lpage": ["4225"], "pub-id": ["10.1021/je200743u"]}, {"label": ["37."], "surname": ["Goscianska", "Marciniak", "Pietrzak"], "given-names": ["J", "M", "R"], "article-title": ["Mesoporous carbons modified with lanthanum(III) chloride for methyl orange adsorption"], "source": ["Chem. Eng. J."], "year": ["2014"], "volume": ["247"], "fpage": ["258"], "lpage": ["264"], "pub-id": ["10.1016/j.cej.2014.03.012"]}, {"label": ["38."], "surname": ["Meitei", "Prasad"], "given-names": ["MD", "MNV"], "article-title": ["Adsorption of Cu (II), Mn (II) and Zn (II) by "], "italic": ["Spirodela polyrhiza"], "source": ["Ecol. Eng."], "year": ["2014"], "volume": ["71"], "fpage": ["308"], "lpage": ["317"], "pub-id": ["10.1016/j.ecoleng.2014.07.036"]}, {"label": ["39."], "mixed-citation": ["Pei, Y. "], "italic": ["et al.", "Chem. Ind. Eng. Prog"]}, {"label": ["40."], "surname": ["Darwish", "Rashad", "AL-Aoh"], "given-names": ["AAA", "M", "HA"], "article-title": ["Methyl orange adsorption comparison on nanoparticles: Isotherm, kinetics, and thermodynamic studies"], "source": ["Dyes Pigments"], "year": ["2019"], "volume": ["160"], "fpage": ["563"], "lpage": ["571"], "pub-id": ["10.1016/j.dyepig.2018.08.045"]}, {"label": ["41."], "surname": ["Mon"], "given-names": ["PP"], "article-title": ["Biowaste-derived Ni/NiO decorated-2D biochar for adsorption of methyl orange"], "source": ["J. Environ. Manag."], "year": ["2023"], "volume": ["344"], "fpage": ["118418"], "pub-id": ["10.1016/j.jenvman.2023.118418"]}, {"label": ["42."], "surname": ["Shahzad"], "given-names": ["K"], "article-title": ["Synthesis of nanoadsorbent entailed mesoporous organosilica for decontamination of methylene blue and methyl orange from water"], "source": ["Int. J. Environ. Anal. Chem."], "year": ["2021"], "pub-id": ["10.1080/03067319.2021.1998471"]}]
{ "acronym": [], "definition": [] }
43
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1217
oa_package/c4/e7/PMC10786890.tar.gz
PMC10786891
38216559
[ "<title>Introduction</title>", "<p id=\"Par3\">Class 2 CRISPR-Cas systems are useful for genetic engineering because they target DNA and/or RNA with a single effector protein<sup>##REF##31857715##1##</sup>. Among class 2 enzymes, Cas13 subtypes exclusively target and cleave RNA<sup>##REF##27256883##2##–##REF##26593719##9##</sup>. Cas13s process their CRISPR-RNAs (crRNAs), bind a target RNA that is complementary to the crRNA, and cleave the target RNA (<italic>cis</italic>-cleavage) and other RNA molecules via a non-specific RNase activity (<italic>trans</italic>-cleavage)<sup>##REF##29940185##10##,##REF##35244715##11##</sup>. These RNase activities are catalyzed by two Cas13-encoded higher eukaryotes and prokaryotes nucleotide-binding (HEPN) domains which can be mutagenically inactivated to convert Cas13 into an RNA-binding module<sup>##REF##29940185##10##,##REF##36027912##12##–##REF##31186424##14##</sup>. Due to these activities, Cas13 variants are broadly used in vitro and in cells<sup>##REF##29551272##5##,##REF##28408723##15##–##REF##29070703##17##</sup>. For example, Cas13d—one of the most compact and biochemically active Cas13 enzymes—can efficiently knockdown RNA in mammalian cells and animal models<sup>##REF##29551272##5##,##REF##32185621##18##–##REF##32584145##25##</sup>. Moreover, Cas13d fusions are used for RNA tracking, editing, modification, and splicing regulation<sup>##REF##29551272##5##,##REF##33941935##7##,##REF##31757757##26##,##UREF##0##27##</sup>. Cas13d has also been applied for nucleic acid detection in CRISPR diagnostics<sup>##REF##34714054##28##,##REF##34272525##29##</sup>. However, the binding and cleavage specificity of Cas13d on partially matched target RNAs has not been fully characterized, limiting our understanding and biotechnological applications of this enzyme.</p>", "<p id=\"Par4\">Biochemical studies have reported various targeting specificities across Cas13-family enzymes. Some enzymes require a protospacer flanking sequence (PFS)—a specific sequence adjacent to the target—for RNA cleavage. For example, LshCas13a prefers a non-G 3’-PFS, whereas BzCas13b favors non-C 5’-PFS and 3’PFS of NNA or NAN<sup>##REF##27256883##2##,##REF##28065598##3##,##REF##27669025##6##</sup>. However, LwaCas13a, PspCas13b, EsCas13d, RfxCas13d (CasRx), and Cas13X.1 may not require any PFS at all<sup>##REF##27256883##2##,##REF##29551514##4##,##REF##29551272##5##,##REF##33941935##7##,##REF##30241607##13##,##REF##28976959##16##,##REF##29070703##17##</sup>. The cleavage activity of LwaCas13a, LshCas13a, and LbuCas13a is sensitive to mismatches in the central region of crRNA-target RNA duplex<sup>##REF##27256883##2##,##REF##28976959##16##,##REF##32665590##30##,##REF##30044970##31##</sup>. Large-scale Cas13d screens in mammalian cells also concluded that Cas13d is largely intolerant to mismatches in the distal spacer region (positions 15-21)<sup>##REF##32518401##32##,##UREF##1##33##</sup>. Additionally, prior reports suggested that the secondary structure of the target is negatively correlated with Cas13d targeting efficiency<sup>##REF##29551514##4##,##REF##32518401##32##,##UREF##2##34##</sup>. These experiments primarily use Cas13 cleavage as an output, conflating binding, activation, and cleavage into a single reporter. Interpreting studies across different experimental conditions and target RNAs is especially challenging because RNA structure can change drastically even with a single nucleotide substitution and may also impact both binding and cleavage. A complete understanding of off-target activity requires the biochemical separation of binding and cleavage across a defined set of structural target RNA and sequence perturbations.</p>", "<p id=\"Par5\">Here, we describe RNA-CHAMP (Chip-Hybridized Association-Mapping Platform) for massively parallel profiling of RNA-protein interactions on a conventional microscope and the nearly ubiquitous chips that are discarded at the end of Illumina-based sequencing. Our approach differs from prior high-throughput methods<sup>##REF##24727714##35##,##REF##24809628##36##</sup> that repurpose the obsolete Illumina Genome Analyzer IIx instruments and require custom hardware modifications<sup>##REF##28325876##37##</sup>. Using RNA-CHAMP, we characterize how target RNA alterations impact the RNA binding by Cas13d. Contrary to other Cas13-family enzymes, Cas13d does not have a strong PFS preference. However, nucleotide substitutions that increase the overall target RNA secondary structure profoundly decrease the binding affinity. Mismatches and intramolecular base pairing in the distal region of the target RNA strongly decrease Cas13d binding. Surprisingly, mismatches in the proximal region of the target do not affect binding but inhibit nuclease activity. A series of biophysical models of increasing complexity shed insights into the mechanism of Cas13d binding. Together, our results and model suggest that Cas13d initially recognizes the target RNA in the solvent-exposed distal spacer region, followed by RNA duplex formation towards the target RNA in the proximal region. Structural elements in the distal segment impede Cas13d binding. Using these insights, we design a series of partially mismatched crRNAs to detect single nucleotide polymorphisms (SNPs) in circulating SARS-CoV-2 variants. These results will guide future RNA editing and CRISPR diagnostics applications. More broadly, RNA-CHAMP will enable high-throughput mapping of protein-RNA interactions in diverse cellular processes.</p>" ]
[ "<title>Methods</title>", "<title>Oligonucleotides and DNA libraries</title>", "<p id=\"Par29\">Primers, protospacer flanking sequence DNA libraries, crRNAs, and target RNAs were purchased from IDT. Mispaired target DNA oligonucleotide libraries were purchased from Twist or GenScript. DNA libraries for probing the protospacer flanking sequence (PFS) were generated via PCR amplification (Q5 High-Fidelity 2X Master Mix, NEB) of a 6N-oligo ordered from IDT with primers JK044 and JK045 (Table ##SUPPL##0##S3##). These mixed based oligos included three randomized bases on either end of the target RNA. After PCR, Illumina adapters and sequencing primer attachment sites were added for downstream next-generation DNA sequencing (NGS). Final amplified libraries were constructed as 5’-P5-SP1-buffer sequence-T7 promoter-PFS-target-PFS-SP2-TerB-P7-3’. P5 and P7 are Illumina adaptors, while SP1 and SP2 are Illumina sequencing primers. For mispaired DNA oligonucleotide libraries, we designed a custom oligonucleotide DNA pool (purchased from Twist or GenScript). The DNA pool was PCR amplified using primers JK044 and JK045. These primers also added adapters for Illumina-based sequencing. The PFS and mispaired DNA libraries were pooled and sequenced on a conventional MiSeq instrument using a 150-cycle reagent kit v3 (Illumina). To prevent data loss due to sequencing a low diversity library, we also spiked in sheared human cDNA and PhiX DNA to a total of 50% of the sequencing run.</p>", "<title>Protein Expression and Purification</title>", "<p id=\"Par30\"><italic>Eubacterium siraeum</italic> Cas13d (EsCas13d) was subcloned into a pET19-based plasmid with an N-terminal 6xHis-TwinStrep-SUMO fusion to generate plasmid the pIF1023 from pET28a-MH6-EsCas13d (Addgene #108303). The nuclease-dead variant (dCas13d) was generated by introducing the following mutations into the HEPN active site: R295A/H300A/R849A/H854A. The SNAP-tag was added at the N-terminus of dCas13d (pIF1024). <italic>Ruminococcus flavefaciens</italic> Cas13d (RfxCas13d, or CasRx) was subcloned into a pET19-based plasmid with an N-terminal 6xHis-TwinStrep-SUMO fusion to generate the plasmid pIF1034 from pET28b-RfxCas13d-His (Addgene #141322). The nuclease-dead variant (dRfxCas13d) was generated by cloning the R295A/H300A/R858A/H863A mutations into the HEPN active site.</p>", "<p id=\"Par31\">Catalytically active and nuclease-dead variants of EsCas13d and RfxCas13d were purified using the same protocol. Briefly, the overexpression plasmid was transformed into BL21 star (DE3) cells (Thermo Fisher). Cells were inoculated in LB containing carbenicillin to OD600 ~ 0.7 and induced with 200 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) at 18 °C for 18 h. Cells were then pelleted, resuspended in lysis buffer (50 mM HEPES pH 7.4, 500 mM NaCl, 1 mM EDTA, 5% glycerol, 0.1% Tween-20, 1 mM DTT, cOmplete-EDTA-free protease inhibitor cocktail (Sigma Aldrich), 1 mg ml<sup>−1</sup> lysozyme, 2.5 U ml<sup>−1</sup> DNaseI, 2.5 U ml<sup>−1</sup> salt active nuclease), and lysed completely by sonication. Clarified lysate was applied to a Strep-Tactin Superflow gravity column (IBA Life Sciences). The Strep-Tactin resin was washed with 20 column volumes (CVs) of wash buffer (50 mM HEPES pH 7.4, 500 mM NaCl, 5% glycerol, 1 mM DTT), eluted with 5 CVs of elution buffer (50 mM HEPES pH 7.4, 500 mM NaCl, 10% glycerol, 5 mM D-desthiobiotin, 1 mM DTT), and then concentrated by a spin concentrator (Amicon 30 kDa cutoff Ultra 15, Millipore). Concentrated samples were incubated with homemade SUMO protease for tag cleavage, and with SNAP-surface 488 dye (NEB), if used for RNA-CHAMP experiments at 4 °C for 20 h. Samples were then further purified by a size-exclusion column (Superdex 200 Increase 10/300 GL, GE Life Sciences) using SEC buffer (50 mM Tris-HCl pH 7.5, 500 mM NaCl, 10% glycerol, 2 mM DTT).</p>", "<p id=\"Par32\">For ribonuclear protein (RNP) reconstitution, purified dCas13d was incubated with a six-fold excess of CRISPR RNA (crRNA; from IDT) at 37 °C for 1 h in RNP buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 6 mM MgCl<sub>2</sub>, 1 mM DTT), and again subjected to size-exclusion column (Superdex 200 Increase 10/300 GL, GE Life Sciences) to further separate the RNP from the crRNA by using RNP SEC buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM MgCl<sub>2</sub>, 10% glycerol, 1 mM DTT). RNP fractions were pooled, spin concentrated (Amicon 30 kDa cutoff Ultra 15, Millipore), flash frozen in liquid nitrogen, and stored at −80 °C.</p>", "<title>RNA-CHAMP</title>", "<p id=\"Par33\">MiSeq chips were collected after sequencing and stored at 4 °C in storage buffer (10 mM Tris-HCL pH 8.0, 1 mM EDTA, 500 mM NaCl) until needed. The chips were placed on a custom-designed microscope stage adapter with integrated microfluidics. The buffer perfusion flow rate was controlled via an automated syringe pump (KD Scientific) and kept constant at 100 µl min<sup>−1</sup> for all washing steps. The schematics and CAD files for the microscope stage designs and all additional components are available at <ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/finkelsteinlab/RNA-CHAMP\">https://github.com/finkelsteinlab/RNA-CHAMP</ext-link>.</p>", "<p id=\"Par34\">The chip surface was regenerated after sequencing to remove leftover fluorescent nucleotides and the synthesized strand. The chip was denatured with 500 µl of 0.1 N NaOH and washed with 500 µl TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA). The chip was then incubated with 500 nM regeneration primers IF363 and IF443 (see Table ##SUPPL##0##S3##) in hybridization buffer (5X SSC [750 mM NaCl, 75 mM sodium citrate pH 7.0], 0.1% Tween-20) for 5 min at 85 °C, cooled to 65 °C over 10 min, cooled to 40 °C over 30 min, and held at 40 °C for 10 min. During the last 10 min at 40 °C, the chip was washed with 1 mL wash buffer (0.3X SSC [45 mM NaCl, 4.5 mM sodium citrate pH 7.0], 0.1% Tween-20) to remove unannealed primers.</p>", "<p id=\"Par35\">For most Cas13d binding experiments, concentration gradients of 0.125 nM, 0.25 nM, 0.5 nM, 1 nM, 2 nM, 4 nM, 8 nM, 16 nM, 32 nM, 64 nM, and 128 nM of Cas13d were sequentially incubated in the chip. At each concentration, Cas13d was incubated for 10 min at 25 °C. Then Cas13d was washed out by 300 µl of protein buffer (40 mM Tris-HCl pH 7.5, 150 mM NaCl, 6 mM MgCl<sub>2</sub>, 1 mM DTT, 0.1% Tween-20, 0.2 mg/ml BSA). The fluorescent images were acquired on a TIRF microscope as previously reported<sup>##REF##28666121##41##</sup>. After every imaging experiment, chips were treated with protease K (80 units/ml) diluted in TE buffer (10 mM Tris-HCl, 500 mM EDTA) for 30 min at 42 °C.</p>", "<title>RNA-CHAMP data analysis</title>", "<p id=\"Par36\">Raw images are run through a CHAMP alignment and intensity calculation pipeline<sup>##REF##28666121##41##</sup>. To background subtract the fluorescent buildup on the surface of the chip, the signal from clusters without a T7 promoter was subtracted from the signal for clusters corresponding to RNA library members. Sequences that were represented by five or more physical RNA clusters were globally fit via the Hill equation without cooperativity to calculate the apparent <italic>K</italic><sub><italic>d</italic></sub>, <italic>I</italic><sub><italic>max</italic></sub>, and <italic>I</italic><sub><italic>min</italic></sub>:Where <italic>I</italic><sub><italic>min</italic></sub> is the minimum intensity for the fit, <italic>I</italic><sub><italic>max</italic></sub> is the maximum intensity for the fit. is the concentration, and <italic>I</italic><sub><italic>obs</italic></sub> is the observed intensity. To prevent over-interpretting the fitting result, sequences that showed maximum fluorescence intensities below 20% of the matched target intensity were considered “weak binders” and not included in our analysis. Only sequences within our detection limit were included in the analysis (e.g., data within the dashed line in Fig. ##FIG##0##1E##). We report these as not determined (N.D.). Apparent was transformed to change in the apparent binding affinity (ΔABA) by , where is the Apparent of a library sequence and is the apparent of the matched target. Finally, all experiments were repeated two or more times. For RNA structure prediction, RNA structures were predicted by RNAfold from ViennaRNA<sup>##REF##22115189##45##</sup> using default settings.</p>", "<title>Biolayer Interferometry</title>", "<p id=\"Par37\">Binding kinetics were assessed via biolayer interferometry on an Octet RED96e (FortéBio). Biotinylated RNAs in Table ##SUPPL##0##S4## was immobilized on streptavidin biosensors (FortéBio). The biosensors were subsequently submerged in protein buffer (40 mM Tris-HCl pH 7.5, 150 mM NaCl, 6 mM MgCl<sub>2</sub>, 1 mM DTT, 0.1% Tween-20, 0.2 mg/ml BSA) containing dEsCas13d RNP complex at concentrations of 100 nM, 50 nM, and 25 nM for 600 seconds to measure association. The biosensors were transferred to protein buffer for 600 seconds to measure dissociation. The dRfxCas13d experiments were conducted using a single concentration (25 nM). We also acquired the signal from a reference sensor without any dCas13d RNP. This trace was treated as a baseline and subtracted from all other association and dissociation curves. The <italic>k</italic><sub><italic>a</italic></sub>, <italic>k</italic><sub>d</sub>, and <italic>K</italic><sub><italic>d</italic></sub> values were calculated from global fitting to all the binding curves by using Octet data analysis software v11.1. All BLI measurements are summarized in Table ##SUPPL##0##S1## and the Source Data.</p>", "<title>Collateral cleavage fluorescent assay</title>", "<p id=\"Par38\">Catalytic active Cas13d was purified as described above. 50 nM of Cas13d were incubated with 50 nM of poly-U reporter (5’−6-FAM-UUUUU-Iowa Black® FQ-3’, IDT) and 5 nM of the indicated target RNA (IDT; Table ##SUPPL##0##S4##). The reaction was incubated in a 96-well plate in the RT-PCR system (ViiA 7) at 25 °C. Fluorescent intensities were detected every minute for a total duration of 120 min. Technical duplicates were done in every plate, and two or three biological replicates were done for each sequence. The mean of the technical duplicate of one experiment was shown in the plot. A subset of the mismatch sequences was produced by in vitro transcription (IVT). The IVT templates were generated by hybridizing two oligos that contains the T7 promoter sequence (IDT; Table ##SUPPL##0##S3##). IVT reactions were performed by using the HiScribe T7 High Yield RNA Synthesis kit (NEB). IVT products were subsequently purified by RNeasy mini kit (Qiagen). The initial slope at the 20 min time point was calculated to quantitatively compare the cleavage activity. All fluorescent cleavage data are summarized in Table ##SUPPL##0##S2## and the Source Data.</p>", "<title>Computational modeling</title>", "<p id=\"Par39\">To extract mechanistic insights into off-target RNA binding, we created generalized models across all target RNA experiments. First, all ∆ABAs were normalized to be between 1 and 0 for the upper and lower detection limits, respectively. Model I solely considers intramolecular base pairing across the 22 nucleotides target RNA according to the function below. The RNA structure was predicted by ViennaRNA<sup>##REF##22115189##45##</sup>. The model adjusts the 22 parameters <italic>a</italic><sub><italic>i</italic></sub>, one for each base in the target RNA sequence:</p>", "<p id=\"Par40\">Model II includes an additional term, , the predicted minimal free energy (MFE) in kcal mol<sup>−1</sup> of sequence (predicted by RNAfold from ViennaRNA<sup>##REF##22115189##45##</sup>).</p>", "<p id=\"Par41\">Model III is the relative encoding-only model and has three main terms that summarize the relative penalties for insertions (<italic>I</italic>), deletions (<italic>D</italic>), or mismatches (<italic>M</italic>) in the target sequence relative to the matched target. As an example, consider a sequence with C2G and U10A alteration compared to the matched target strand, . These operations can be conceptually written as:</p>", "<p id=\"Par42\">Thus and would evaluate to 1 and all other inputs for would evaluate to 0. There was a total of 9 parameters for each RNA position: deletion, insertion A, insertion U, insertion G, insertion C, mismatch A, mismatch U, mismatch G, and mismatch C. Here, <italic>i</italic> denotes the sequence position, <italic>v</italic> is the altered RNA base identity, and <italic>b, c, d</italic> are the three sets of adjustable parameters.</p>", "<p id=\"Par43\">Model IV includes an additional MFE term, , as previously described.</p>", "<p id=\"Par44\">Model V is the combination of Model I and Model III that includes both intramolecular base pairing and relative mismatch/indel encoding.</p>", "<p id=\"Par45\">Model VI has the following parameters: base pairing, relative encoding, and the MFE of the predicted lowest-energy structure. The normalized ∆ABA for partially matched RNAs, , that are related to the matched target, , was modeled using a linear combination of the following features. denotes different types of sequence alteration and RNA accessibility in the model, where <italic>BP, I, D</italic>, and <italic>M</italic> were base pairing, insertions, deletions, and mismatches respectively.</p>", "<p id=\"Par46\">The weights of the terms , ,,, and <italic>e</italic> are the adjustable parameters that are used to fit the experimental data and represent the penalties of each operational transformation on altered sequences <italic>k</italic> in the library.</p>", "<p id=\"Par47\">Ridge regression was used to determine the weights of our parameters to fit the experimental training set. Ridge regression is a variant of linear regression that attempts to minimize the training loss value of the expression:Where M is defined to be the model for predicting ABA with all the weights being values in set X = {, , , , }. The predicted values from Model M are compared to the measured ∆ABA values, : the smaller the absolute difference between the two the greater the model’s accuracy. Ridge regression helps maintain the robustness of linear models and prevents overfitting by penalizing arbitrarily large weights. The parameter at which the weight values in the model appear to stabilize is around 1 which was used throughout all models.</p>", "<p id=\"Par48\">Finally, we considered a sequential convoluted neuron network (CNN) model. The model was built on a single Conv2D layer with 64 filters and a kernel size of 54 × 1<sup>##UREF##5##60##</sup>. Then, a final layer of MaxPooling2D with a pool size of 3 × 1 was added. The CNN model was trained by the same dataset used in the simple linear model. The dataset has 4862 sequences, and only half of the sequences were used for training the model. The model was trained through 1000 epochs and was tested on the rest of the sequences.</p>", "<title>Reporting summary</title>", "<p id=\"Par49\">Further information on research design is available in the ##SUPPL##1##Nature Portfolio Reporting Summary## linked to this article.</p>" ]
[ "<title>Results</title>", "<title>RNA-CHAMP measures protein-RNA interactions on sequenced Illumina chips</title>", "<p id=\"Par6\">RNA-CHAMP repurposes Illumina next-generation sequencing (NGS) chips to quantify millions of protein-RNA interactions (Fig. ##FIG##0##1A##). RNA molecules are transcribed in situ from a template DNA library that has been sequenced using an Illumina MiSeq instrument. We designed the DNA library with the T7 RNA polymerase (RNAP) promoter, a variable region of interest, and the RNAP-stalling <italic>TerB</italic> DNA sequence<sup>##REF##24809628##36##,##REF##26182240##38##</sup>. This DNA sequence is recognized by Tus, a bacterial protein that blocks T7 RNAP translocation<sup>##REF##10373601##39##,##REF##8665860##40##</sup>. The identity and physical coordinates of each DNA cluster are determined during NGS. After sequencing, the chip is regenerated to remove leftover fluorescent nucleotides and resynthesize the double-stranded (ds) DNA<sup>##REF##28666121##41##</sup>. Tus is then added to the chip to stall T7 RNAP. In vitro transcription (IVT) and subsequent stalling of T7 RNAP tethers the transcript to its DNA template. Polymerases that stall prematurely can undergo recycling or exchange with an active enzyme<sup>##REF##29775583##42##</sup>. In both scenarios, the transcript is generated after a transcribing RNAP is stalled by Tus.</p>", "<p id=\"Par7\">We first assayed the efficiency of RNA capture on the MiSeq chip. To confirm that Tus recognizes <italic>TerB-</italic>encoding DNA clusters, we purified FLAG-epitope labeled Tus and fluorescently labeled it with an ATTO488-conjugated anti-Flag antibody<sup>##REF##24768536##43##</sup> (Fig. S##SUPPL##0##1A##). We sequenced a library that included DNAs with and without the <italic>TerB</italic> sequence. Over 90% of <italic>TerB-</italic>encoding DNA clusters co-localized with fluorescent Tus (Fig. S##SUPPL##0##1A##). The remaining <italic>TerB-</italic>encoding clusters could not be resolved by our image processing software, usually due to their spatial overlap. Importantly, Tus did not bind clusters that lacked <italic>TerB</italic>. All downstream analysis was conducted on <italic>TerB</italic>-containing DNA clusters. To confirm that the RNA transcripts are stably retained after IVT, we hybridized a complementary ATTO647N-labeled oligonucleotide to the RNA transcripts in situ (Fig. S##SUPPL##0##1B##). The chip also included DNA clusters with scrambled T7 RNAP promoters as negative controls. We observed an RNA signal from ~90% of promoter-containing clusters, but not from scrambled promoter clusters (Fig. S##SUPPL##0##1B##). These results demonstrate that RNA-CHAMP can generate libraries of user-defined RNA molecules on repurposed MiSeq chips.</p>", "<p id=\"Par8\">Next, we characterized the specificity and off-target RNA binding of <italic>Eubacterium siraeum</italic> (<italic>Es</italic>) Cas13d, a prototypical member of the CRISPR RNA-guided RNA nucleases<sup>##REF##29551514##4##,##REF##29551272##5##</sup>. We purified nuclease-dead <italic>Es</italic>Cas13d with an N-terminal SNAP-tag and fluorescently labeled it with SNAP-Surface-488 (hereafter referred to as “dCas13d”; Fig. S##SUPPL##0##1C##). The ribonucleoprotein (RNP) complex was reconstituted to 100% homogeneity by incubating dCas13d with a 4-fold excess of the crRNA followed by size exclusion chromatography. Native gel electrophoresis confirmed complete RNP formation (Fig. S##SUPPL##0##1D##). This procedure was repeated for RNPs with different crRNAs and used in all subsequent experiments. The SNAP-tag did not alter the protein’s RNA-binding affinity, as measured via Biolayer Interferometry (BLI) (Fig. S##SUPPL##0##1E##).</p>", "<p id=\"Par9\">Type VI CRISPR-Cas nucleases recognize a protospacer-flanking sequence (PFS) that is immediately adjacent to the 5’ or 3’ of the target RNA<sup>##REF##27256883##2##–##REF##33941935##7##</sup>. To test whether <italic>Es</italic>Cas13d is sensitive to the PFS, we included three randomized bases on both the 5’ and 3’ of the matched target sequence. In addition, the target RNA library included up to two mismatches, insertions, or deletions relative to the crRNA (Fig. ##FIG##0##1B## &amp; Source Data). To confirm that our findings are generalizable across targets, we also prepared a second library with a different target RNA sequence but identical design characteristics (Fig. S##SUPPL##0##3## &amp; S##SUPPL##0##4##). We sequenced both RNA libraries to ensure &gt;~10–100 DNA clusters for all library members (Fig. ##FIG##0##1B##, right). We also included unrelated DNA sequences as controls or fiducial markers for downstream image analysis and spatial registration. After sequencing, the MiSeq chip was regenerated and transcribed with T7 RNAP for downstream experiments.</p>", "<p id=\"Par10\">Transcribed libraries were incubated with increasing concentrations of dCas13d (Fig. ##FIG##0##1C, D##). Clusters with T7 promoters showed dCas13d concentration-dependent increases in fluorescence intensities, whereas scrambled promoters showed no dCas13d binding (Fig. ##FIG##0##1C##). The fluorescent intensities of clusters across all concentrations were background-subtracted and fit with a Hill equation without cooperativity to determine the apparent binding affinity (ABA) (Fig. ##FIG##0##1D## &amp; Methods)<sup>##REF##28666121##41##,##REF##32895548##44##</sup>. To directly compare the relative binding affinity across the entire library, we calculated the change in the binding affinity (ΔABA) as the natural logarithm of the matched target affinity divided by partially matched RNA library members (see Methods). The ∆ABA reports the relative change in dCas13d binding affinity of every library member relative to a reference (matched target) sequence. Two biological replicates showed excellent reproducibility across the entire dynamic range of binding affinities (Fig. ##FIG##0##1E##). In a partially matched library, we measured the binding affinities for 3893 sequences from the target library out of 4936 total members (Fig. ##FIG##0##1F##). The remaining target RNA sequences had binding affinities or fluorescent signals that were below our detection limit. Using BLI, we validated a subset of 16 RNA targets across the entire dynamic range of the RNA-CHAMP experiments, including sequences with mutations in the target RNA as well as the PFS (Fig. S##SUPPL##0##2##). ABAs calculated from BLI measurements were in excellent agreement with the sequences from our library, indicating that RNA-CHAMP accurately captures the relative affinities of dCas13d to its target RNA sequences (Pearson’s <italic>r</italic> = 0.89; Fig. ##FIG##0##1G##, S##SUPPL##0##2##). Moreover, the BLI analysis indicates that the ∆ABA is dominated by <italic>k</italic><sub><italic>on</italic></sub>, likely because the target RNA-crRNA duplex is very stable after hybridization (Table ##SUPPL##0##S1##). We conclude that the massively parallel RNA-CHAMP platform can quantitatively profile protein-RNA interactions.</p>", "<title>Cas13d requires a partially unstructured target RNA in the distal region</title>", "<p id=\"Par11\">We measured dCas13d binding affinity with a PFS library consisting of three random nucleotides on the 5’ and 3’ end of the 22 nt matched target sequence (target #1) (Fig. ##FIG##1##2##). We measured ∆ABAs for a total of 1457 PFS combinations. The remaining sequences were below our detection threshold. Although dCas13d exhibited a ~ 3-fold difference in ∆ABAs across the entire PFS dataset, it did not have a strong PFS preference (Fig. ##FIG##1##2A##). We observed a similar result in a second target (target #2) library but with a slight preference for non-G 3’-PFS (position −1) (Fig. S##SUPPL##0##3##). Combining the top 25% highest ABA binding sequences in both targets confirms that Cas13d has a weak preference for the 3’-PFS (Fig. S##SUPPL##0##3D##). This weak PFS preference, however, doesn’t explain the broad range of ∆ABAs that we measured across the library of matched target RNA sequences.</p>", "<p id=\"Par12\">We reasoned that the target RNA secondary structure can regulate Cas13d binding<sup>##REF##29551514##4##,##REF##32518401##32##,##UREF##2##34##</sup>. When inspecting both high- and low-affinity target RNAs, we observed that dCas13d prefers target RNAs that are not predicted to be base paired in the distal region (positions 11-22) (Fig. ##FIG##1##2A–C## &amp; S##SUPPL##0##3A, B##)<sup>##REF##22115189##45##</sup>. For example, the 5’-PFS GUA forms a stem with the 5’ constant region and exposed positions 19-22, which resulted in ~2-fold stronger dCas13d binding than 5’-PFS UAA (Fig. ##FIG##1##2A, B##). Similarly, 3’-PFS GCU forms a stem with the 3’ constant region and exposed position 14-20. These exposed distal nucleotides in 3’-PFS GCU led to a ~ 2-fold increase in dCas13d binding affinity relative to 3’-PFS UGG (Fig. ##FIG##1##2A, C##). BLI measurements independently validated these observations (Fig. ##FIG##1##2D##). This also confirms that low-affinity PFSs have a similar off-rate (<italic>k</italic><sub><italic>d</italic></sub>), but slower on-rates (<italic>k</italic><sub><italic>a</italic></sub>) than high-affinity PFSs (Fig. ##FIG##1##2D##, Table ##SUPPL##0##S1##). These results highlight that RNA structure regulates Cas13d access to the matched target RNA.</p>", "<p id=\"Par13\">To determine how the local target RNA structure affects Cas13d binding, we computed the number of predicted intramolecular base pairs in the proximal (positions 1-11) and distal (positions 12-22) regions of the target RNA. Intramolecular base pairs can form with the RNA outside the target, or within the target itself. For example, the 3’-GCU PFS sequence in Fig. ##FIG##1##2C## has eight proximal and three distal intramolecular base pairs, whereas the 3’-UGG PFS has six proximal and nine distal intramolecular base pairs. We observed that increased intramolecular base pairing in the distal region of the target RNA decreased the ∆ABA (Fig. ##FIG##1##2E##, S##SUPPL##0##3C##). In contrast, we did not see any relationship between the number of intramolecular base pairs and the ∆ABA in the proximal region (Fig. ##FIG##1##2E##, S##SUPPL##0##3C##). We also compared the base pairing propensity of all suboptimal structures that have a free energy within 1 kcal/mol of the MFE. For example, for an RNA with a predicted MFE of −14.3 kcal/mol, we compare the average number of intramolecular base pairs of all suboptimal RNAs with an MFE of −14.3 to −13.3 kcal/mol. This analysis showed a significant correlation of intramolecular base pairing and binding affinity in the distal region in both targets but not in the proximal region (Fig S##SUPPL##0##3E, F##). Based on these results, we hypothesize that Cas13d prefers to engage the distal end of the target RNA first, and this region must remain partially unstructured for efficient binding (see Discussion). Taken together, we conclude that Cas13d does not have a PFS requirement but prefers to bind target RNAs with unpaired distal nucleotides.</p>", "<title>Cas13d binding is sensitive to mismatches in the distal region of the target RNA</title>", "<p id=\"Par14\">To determine how Cas13d binds off-target RNAs that resemble the target sequence, we constructed a library comprised of 66 single mismatches, 2079 double mismatches, and 2439 insertions &amp; deletions relative to the crRNA within the 22-nt target sequence (target #1) (see Fig. ##FIG##0##1B##). For all experiments, the 5’- and 3’-PFS remained constant. Of the 4936 library members, we measured ∆ABAs for 3893 target RNAs. 1043 sequences didn’t significantly change the dCas13d fluorescent signal, even at the highest RNP concentrations. Figure ##FIG##2##3A## summarizes two biological replicates of the ∆ABA for all possible single mismatches. We also measured ∆ABAs across a similarly designed library but with different target crRNA sequences (target #3) (Fig. S##SUPPL##0##4##). The binding trends were broadly the same across these two libraries.</p>", "<p id=\"Par15\">We first analyzed the impact of a single mismatch between the target and crRNA (Fig. ##FIG##2##3A##). Mismatches at positions 13-22 significantly decreased the ∆ABA. In contrast, single mismatches at positions 1-12 had little to no effect on binding compared to the matched target (Fig. ##FIG##2##3A##). The identity of the mismatch at the same position led to profoundly different outcomes. For example, a C21U substitution has a similar ∆ABA to the matched target, but the binding was virtually undetectable with C21G. The C21U substituted is predicted to match the structure of the matched target (Fig. ##FIG##2##3D##, middle). Moreover, C21U creates a G-U wobble base pair with the crRNA, which yields a similar binding affinity to the matched target. C21G, in contrast, creates additional intramolecular base pairs at positions 19-21 (Fig. ##FIG##2##3D, top##). In a dataset with a different crRNA-target pair, we saw a similar but slightly broader sensitivity region to mismatches at positions 9-20 (Fig. S##SUPPL##0##4A, B##). We compared our binding results to a dataset of RfxCas13d RNA cleavage activity reported in mammalian cells (Fig. ##FIG##2##3B##)<sup>##REF##32518401##32##</sup>. Because this dataset used different target RNA sequences, we compared the mean ∆ABA from all three mismatches across two targets to the mean cleavage activity at each position along the RNA target. RNA knockdown efficiency in mammalian cells is reduced when mismatches are in the distal position, analogously to our binding data (Fig. ##FIG##2##3B##). Overall, Cas13d can tolerate G-U wobble base pairs and shows a strong sensitivity to distal mismatches.</p>", "<p id=\"Par16\">Next, we analyzed the impact of two mismatches on dCas13d binding affinity (Fig. ##FIG##2##3C##). Binding was largely unaffected if both mismatches occurred in positions 1-12 (dark blue squares in Fig. ##FIG##2##3C##). We observed multiple instances where the RNA structure drastically changed the ∆ABA. Such sequences appear as “stripes” of strong color in Fig. ##FIG##2##3C##. For example, C21U with an additional substitution (highlighted in dotted line Fig. ##FIG##2##3C##) does not affect the ∆ABA compared to the matched target. However, a second mismatch (A20G) in addition to C21U ablates dCas13d binding due to increased intramolecular base pairing in the distal region of the target RNA (Fig. ##FIG##2##3C, D##). Overall, we observed that dCas13d prefers unpaired distal RNA sequences. We also observed a strong dependence on RNA structure with the second RNA library (target #3). This target RNA is highly folded, with only bases 20-22 not participating in intramolecular base pairing, reducing overall dCas13d affinity (Fig. S##SUPPL##0##4B, C##). For this RNA target, some substitutions (e.g., U2A, G4U) relax the proximal to center region of the target RNA (positions 1-13) structure and result in an increased binding affinity relative to the matched target (Fig. S##SUPPL##0##4C##). Cas13d binary structures suggest that positions 4-8 and 14-20 of the crRNA are solvent-exposed and accessible to the environment<sup>##REF##30241607##13##,##REF##31186424##14##</sup>. We speculate that the center exposed region likely contributes to the increased binding affinity. In sum, local RNA structure dominates Cas13d binding affinity. The distal segment of the target RNA must remain partially unpaired for high-affinity binding.</p>", "<p id=\"Par17\">dCas13d retains a high affinity for targets with proximal insertions or deletions (Fig. S##SUPPL##0##5##, S##SUPPL##0##6##). However, insertions and deletions at the distal side of the target RNA on both targets were not tolerated (Fig. S##SUPPL##0##5##, S##SUPPL##0##6##). We also observed a strong effect from RNA secondary structure. For example, inserting a C between positions 19 and 20 reduces the number of intramolecular base pairs at bases 13-20, which increases the ∆ABA relative to the matched target (Fig. S##SUPPL##0##5A, B##). A G-insertion at the same position leads to undetectably low binding due to newly formed intramolecular base pairings in the distal side of the target RNA (Fig. S##SUPPL##0##5B##). We observed similar effects of RNA structure on binding affinity in a second RNA target library (target #3) (Fig. S##SUPPL##0##6A, B##). A C-insertion at position 3 exposes the proximal region that retains similar affinity to the matched target, while a U-insertion increases intramolecular base pairing and results in undetectable binding. Taken together, these results again show that Cas13d binding is sensitive to distal alterations and local secondary structure. We speculate that Cas13d has a distal seed region and initiates crRNA-target RNA duplexes starting primarily from the distal region (see Discussion).</p>", "<title>Target RNA base pairing is a quantitative predictor for Cas13d binding affinity</title>", "<p id=\"Par18\">We developed a series of linear regression models of increasing complexity to quantitatively understand how mismatches and RNA structure affect Cas13d binding (Fig. ##FIG##3##4A##). Unlike machine learning approaches (also considered below), these models can elucidate the mechanism of Cas13d binding to partially matched targets. The simplest model (Model I) assigns a position-specific penalty for each intramolecular base pair in the predicted target RNA structure (see Methods &amp; Fig. S##SUPPL##0##7B##)<sup>##REF##22115189##45##</sup>. This model requires a total of 22 adjustable parameters, one for each nucleotide along the target RNA. In Model II, we add the predicted minimum free energy (MFE) of the entire 73-nt transcript RNA to capture the overall secondary structure. Model III encodes sequence changes relative to the matched target using a relative encoding strategy (see Methods &amp; Fig. S##SUPPL##0##7A##). Model IV adds the target RNA’s MFE as another parameter to the relative encoding. Model V combines the intramolecular base pairing penalty and relative encoding. Finally, Model VI includes all three components: intramolecular base pairing penalty, relative encoding, and the MFE (Fig. ##FIG##3##4B, C##). We trained each model on half of 4,862 partially matched target sequences across two RNA targets (targets #1 &amp; #3). The resulting model was tested on the withheld half of the sequences in our datasets. After fitting the data, each model’s performance was evaluated by Pearson correlation and information loss via Akaike information criterion (AIC) (Fig. ##FIG##3##4B, C##)<sup>##UREF##3##46##</sup>.</p>", "<p id=\"Par19\">Model I, which only considers intramolecular target RNA base pairing within the 22 nt target sequence results in a Pearson’s <italic>r</italic> = 0.51. Adding the MFE—a measure of the overall structural stability—only weakly improved the correlation and AIC, indicating that local RNA structure is more important than its global stability. Relative encoding has a lower AIC and a Pearson’s <italic>r</italic> = 0.65, performing better than the structure-only model. Finally, combining structural features with relative encoding (Models V) improves both the AIC and Pearson’s <italic>r</italic> to 0.75. Adding the MFE (model VI) slightly improved the AIC, indicating that position-specific mismatches and intramolecular base pairing propensity are sufficient to describe most of the variance in the ABAs. (Fig. ##FIG##3##4B–D##). We also trained a convolutional neural network machine learning (ML) model on the data (Fig. S##SUPPL##0##7C##). Despite having a much larger number of adjustable parameters, the ML model is only marginally better than model VI (Pearson’s <italic>r</italic> = 0.77). Since the ML model’s parameters are not easily interpretable, it doesn’t reveal the mechanisms of RNA binding. Therefore, we dissect Cas13d binding affinities using Model VI below.</p>", "<p id=\"Par20\">We first compared the average penalty for mismatches and indels along the 22 nt target sequence (Fig. ##FIG##3##4E, top##). Cas13d binding is heavily penalized with mismatches or indels at positions 13-22 along the target RNA. In contrast, mismatches at positions 1-12 only minimally decreased the ∆ABA. Likewise, intramolecular base pairing within the target RNA nucleotides 14-22 reduces the ∆ABA and is heavily penalized by the model (Fig. ##FIG##3##4E##, bottom). Intramolecular base pairing within positions 1-13 slightly reduced the ∆ABA in the model. Based on these results, we conclude that distal positions 12-22 of the crRNA-target RNA duplex act as an internal “seed” where Cas13d initiates target RNA recognition (see <bold>Discussion</bold>).</p>", "<title>Proximal mismatches suppress Cas13d’s nuclease activity</title>", "<p id=\"Par21\">Next, we tested how mismatches affect Cas13d’s cleavage activity. We measured the cleavage rates of nineteen single mismatched target RNAs that have also been assayed via RNA-CHAMP <bold>(</bold>Table ##SUPPL##0##S2##). Time-dependent cleavage of a reporter RNA (5’−6-FAM-UUUUU-Iowa Black FQ-3’) can be followed via an increase in the FAM signal after the fluorophore is released from the quencher (Fig. ##FIG##4##5A##)<sup>##REF##34714054##28##</sup>. The cleavage rate is monitored via the initial slope of the time-dependent fluorescent signal. Cleavage rates were generally correlated with ∆ABAs, with two distinct populations (Fig. ##FIG##4##5B–D##). Proximal mismatches (i.e., C2G, C4A, and C7A) did not impact RNA binding but only weakly cleaved the reporter RNA. In contrast, distal mismatches decrease both the binding and cleavage rates (Fig. ##FIG##4##5B–D##). We hypothesize that mismatches at proximal positions disrupt the protein-RNA interface required for activation of the HEPN domain.</p>", "<p id=\"Par22\">Next, we assayed key aspects of our mechanistic insights with <italic>Ruminococcus flavefaciens</italic> Cas13d (RfxCas13d), as this enzyme is widely used for RNA knockdown and engineering applications<sup>##REF##29551272##5##,##REF##35433685##47##,##REF##34553495##48##</sup>. RfxCas13d binding showed a marked sensitivity to RNA structure in the distal end of the target RNA (Fig. S##SUPPL##0##8A##), as measured via BLI. This binding sensitivity was strongly correlated between EsCas13d and RfxCas13d (Pearson <italic>r</italic> = 0.93), indicating a similar target recognition mechanism (Fig. S##SUPPL##0##8B##). As with EsCas13d, proximal mismatches C2G, C4A, and C7A showed very high binding affinities, but compromised cleavage (Fig. S##SUPPL##0##8C, D##). Taken together, we conclude that RfxCas13d and EsCas13d both penalize binding to target RNAs with distal mismatches and structures, and both exhibit a proximal cleavage sensitivity region.</p>", "<p id=\"Par23\">Cas13d’s mismatch sensitivity can be exploited to rationally design assays that detect single nucleotide polymorphisms (SNPs) in a target RNA<sup>##REF##33964175##49##</sup>. As a proof of principle of our analysis pipeline, we positioned the SNP in the crRNA-target RNA duplex to differentiate between two SARS-CoV-2 variants of concern (VOC) (Fig. ##FIG##4##5E##). Here, the matched target is from the spike gene of SARS-CoV-2. The G → A single nucleotide polymorphism (SNP) differentiates the original “Wuhan” strain and the Delta VOC. We designed two crRNAs: the first places this SNP within the binding sensitivity region (crRNA-1; position 17), and the second is in the cleavage sensitivity region (crRNA-2; position 1). Both crRNAs reduce Cas13d cleavage ~5-fold for the D950N RNA (Fig. ##FIG##4##5F, G## &amp; Table ##SUPPL##0##S2##). Next, we measured the binding affinity of Cas13d with crRNA-1 and crRNA-2 to both the Wuhan and Delta variants using BLI. As expected, crRNA-1 RNPs only had a weak affinity for the D950N RNA (Fig. S##SUPPL##0##8E, F##). In contrast, crRNA-2 RNPs had a comparable binding affinity for both target RNAs (Fig. S##SUPPL##0##8E, F##). To confirm that the less efficient cleavage of the Delta variant is not due to RNA structural changes, we analyzed the predicted MFE structure. The SNP in this sequence doesn’t alter the RNA structure (Fig. S##SUPPL##0##8G##). As expected, the cleavage rate of the crRNA that matches the Delta sequence is statistically indistinguishable from the cleavage rate of the original matched target crRNA (Fig. S##SUPPL##0##8H, I##). The results confirm that the SNP indeed alters the cleavage activity, and the effect is due to the position of the mismatch relative to the crRNA. These results demonstrate that our analysis pipeline can be used to design Cas13d-based diagnostics that distinguish between SNPs by precisely positioning the expected mismatched positions relative to the crRNA.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par24\">RNA-CHAMP is a massively parallel platform for probing protein-RNA interactions on used NGS chips. Unlike earlier approaches, CHAMP does not modify any Illumina hardware and is compatible with modern sequencers and chip configurations<sup>##REF##24727714##35##–##REF##26182240##38##</sup>. Imaging biomolecules on upcycled NGS chips can be adapted by any laboratory with a commercial fluorescence microscope that is capable of either TIR- or epi-illumination and a wide-field camera<sup>##REF##28666121##41##,##REF##32895548##44##,##UREF##4##50##</sup>. In addition to profiling protein-DNA and protein-RNA interactions, related methods have been adapted for peptide display and other imaging applications<sup>##REF##35332182##51##–##REF##34390675##53##</sup>. We envision that the high optical quality and surface passivation of commercial Illumina chips will extend to massively parallel single-molecule imaging.</p>", "<p id=\"Par25\">Using RNA-CHAMP and quantitative modeling, we show that Cas13d has a “seed region” that prefers a relaxed structure at the distal end of the target RNA (Fig. ##FIG##5##6##). This region is analogous—but not functionally identical—to the PAM-adjacent seed found in Cas9 and DNA-binding CRISPR enzymes<sup>##REF##21646539##54##–##REF##21536913##58##</sup>. The impact of the Cas13d seed is especially profound when the target RNA is perfectly matched with the crRNA. Strong intramolecular base pairing due to changes in the PFS reduces Cas13d binding by over 3-fold relative to a perfectly matched target. Our results highlight that future studies must also consider how the target RNA structure changes enzyme activity. Mismatches can increase the binding affinity when they coincidentally relax intramolecular base pairing within the target. By separating the effect of RNA structure on binding and cleavage, our results explain prior observations that minimal secondary structure in the target RNA correlates with higher cleavage activity in bacterial and mammalian cells<sup>##REF##29551514##4##,##REF##32665590##30##,##REF##32518401##32##,##UREF##2##34##</sup>.</p>", "<p id=\"Par26\">Here, we show that Cas13d binding to the target RNA is penalized when the distal region is structured or is mismatched relative to the crRNA. Target RNAs with the distal region occluded by intramolecular base pairing show significant binding defects. Structures of the binary RspCas13d- and EsCas13d-crRNA complexes reveal a solvent-exposed spacer region in positions 4-8 and positions 14-20 relative to the crRNA<sup>##REF##30241607##13##,##REF##31186424##14##</sup>. Based on the large effects of intramolecular base pairing in the distal position (positions 14-20), we hypothesize that Cas13d initiates target recognition in this distal region (Fig. ##FIG##5##6##). Structure of ternary EsCas13d complex suggests that the helical-1 domain has the largest conformational shift compared to other subdomains. Helical-1 domain residues K376, N377, G379, K443, and Y447 are centered around the proximal region of the crRNA (positions 3-6). Mutating residues K376, K443, and Y447 to alanine fails to activate the HEPN domains<sup>##REF##30241607##13##</sup>. Disruption of the protein-RNA interface by either a mismatched base pair or helical-1 amino acid mutations inactivates the nuclease. This indicates that the interaction of the proximal crRNA region and the helical-1 domain is critical for nuclease activation. Further kinetically resolved structural studies will be required to elucidate the mechanisms of target recognition, RNA duplex propagation, and HEPN nuclease activation.</p>", "<p id=\"Par27\">We separately dissect RNA binding and cleavage to reveal that a subset of mismatched sequences can bind with high affinity but fail to activate the nuclease domain (Fig. ##FIG##5##6##). Cas13d requires base pairing in positions 1-6 to activate its nuclease activity. We leverage this sensitivity to develop guides that can discriminate between circulating SARS-CoV-2 variants. Similarly, LbuCas13a positions 5-8 are critical for cleavage but not binding<sup>##REF##30044970##31##</sup>. This may act as an additional mechanism to suppress nuclease activation and subsequent cell death in prokaryotic hosts. Mismatch-dependent cleavage inactivation may be a universal feature of type VI effectors.</p>", "<p id=\"Par28\">We conclude that Cas13d binding and nuclease activation are governed by distinct spacer-target regions. Mismatches and structural elements in the distal region inhibit binding, whereas proximal mismatches block nuclease activation. These effects, along with the biophysical models developed here, can be selectively used to fine-tune knock-down efficiency in cells by programming mismatches along the crRNA-target RNA duplex. A similar approach has been used to fine-tune CRISPRi with nuclease-dead Cas9 in mammalian cells<sup>##REF##31932729##59##</sup>. In addition, a complete understanding of Cas13d binding and activation can be used for sensitive SNP detection in CRISPR diagnostics (Fig. ##FIG##4##5##)<sup>##REF##28408723##15##</sup>. More broadly, quantitative studies of RNA-binding CRISPR enzymes must consider the impact of RNA structure on target binding and nucleolytic activity. The structural basis for type VI nuclease activation and the implications for gene editing and prokaryotic immunity are exciting areas for future research.</p>" ]
[]
[ "<p id=\"Par1\">CRISPR-Cas13d cleaves RNA and is used in vivo and for diagnostics. However, a systematic understanding of its RNA binding and cleavage specificity is lacking. Here, we describe an RNA Chip-Hybridized Association-Mapping Platform (RNA-CHAMP) for measuring the binding affinity for &gt; 10,000 RNAs containing structural perturbations and other alterations relative to the CRISPR RNA (crRNA). Deep profiling of Cas13d reveals that it does not require a protospacer flanking sequence but is exquisitely sensitive to secondary structure within the target RNA. Cas13d binding is penalized by mismatches in the distal crRNA-target RNA region, while alterations in the proximal region inhibit nuclease activity. A biophysical model built from these data reveals that target recognition initiates in the distal end of the target RNA. Using this model, we design crRNAs that can differentiate between SARS-CoV-2 variants by modulating nuclease activation. This work describes the key determinants of RNA targeting by a type VI CRISPR enzyme.</p>", "<p id=\"Par2\">Systematic understanding of CRISPR enzyme RNA binding specificity and cleavage is lacking. Here the authors report RNA chip-hybridised association-mapping platform (RNA-CHAMP), a workflow that repurposes next generation DNA sequencing chips to measure the binding affinity for RNA targets.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n\n</p>", "<title>Source data</title>", "<p>\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s41467-024-44738-w.</p>", "<title>Acknowledgements</title>", "<p>We thank the staff of the University of Texas at Austin Genomic Sequencing and Analysis Facility, Dr. Rick Russell, and members of the Finkelstein laboratory for carefully reading the manuscript. We thank the funding agencies for supporting this work, including the College of Natural Sciences Catalyst award (to I.J.F.), the Welch Foundation (F-1808 to I.J.F.), and the National Institutes of Health (R01GM124141 to I.J.F.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p>", "<title>Author contributions</title>", "<p>H.-C.K., J.P., C.-W.C., and I.J.F. designed the research. H.-C.K. performed and analyzed the experiments, wrote the bioinformatics software, and performed biophysical modeling. J.P. implemented the biophysical models. C.-W.C. purified proteins and performed biochemical experiments. I.J.F. secured funding. H.-C.K. and I.J.F. wrote the paper with assistance from all co-authors.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par50\"><italic>Nature Communications</italic> thanks Chirlmin Joo, Wei Li and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.</p>", "<title>Data availability</title>", "<p>BLI and fluorescent cleavage data is available in the Supplementary Table ##SUPPL##0##S1##, ##SUPPL##0##S2##, and Source Data file. RNA-CHAMP data is available in the Source Data file. <xref ref-type=\"sec\" rid=\"Sec19\">Source data</xref> are provided with this paper.</p>", "<title>Code availability</title>", "<p>Source code associated with this work is available on GitHub: <ext-link ext-link-type=\"uri\" xlink:href=\"https://github.com/finkelsteinlab/RNA-CHAMP\">https://github.com/finkelsteinlab/RNA-CHAMP</ext-link>.</p>", "<title>Competing interests</title>", "<p id=\"Par51\">I.J.F. has filed a patent application titled “Chip hybridized association-mapping platform and methods of use” (US16/622,441), which is currently pending approval. Additionally, H.-C.K., C.-W.C., and I.J.F. have submitted an invention disclosure related to RNA-targeting via Cas13 enzymes. The remaining authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Massively parallel protein-RNA profiling via RNA-CHAMP.</title><p><bold>A</bold> RNA-CHAMP workflow. DNA is regenerated on the surface of a sequenced MiSeq chip and is transcribed with T7 RNA polymerase (RNAP). Tus retains T7 RNAP and the associated transcript on the DNA. Fluorescent dCas13d is incubated in the chip and the chip surface is imaged. The variable DNA region (blue) is flanked by a fixed sequence (light brown) to maintain the same context. The Tus binding site is labeled in orange. <bold>B</bold> Top: schematic of the RNA library. The 22-nucleotide target RNA (blue) is flanked on both ends by three random nucleotides (PFS, gray) and buffer sequences (light brown). Bottom: summary of the unique DNA sequences in the synthetic library (left), and the number of clusters observed via NGS for each unique library member (right). The violin plot illustrates one of the replicates for target #1, with sample sizes of <italic>n</italic> = 2083 for PFS, <italic>n</italic> = 2144 for mismatches, <italic>n</italic> = 167 for deletions, and <italic>n</italic> = 2414 for insertions. The box extends from the first quartile (Q1) to the third quartile (Q3) of the dataset, featuring a median line. The whiskers are defined as Q1-1.5IQR and Q3 + 1.5IQR, where IQR is the interquartile range of the data. <bold>C</bold> Fluorescent images of the chip surface after incubating with increasing Cas13d concentrations. White circles: library clusters. Red circles: scrambled promoters that cannot produce RNA. Orange circles: fiducial markers used for image alignment. RNA-CHAMP experiments were conducted in duplicate. <bold>D</bold> Quantification of fluorescent intensities for the indicated mismatch sequences. For example, U10G indicates a U to G substitution at the tenth position in the target RNA. Solid lines are fit to the Hill equation without cooperativity. Data are presented as median ± S.D. from all cluster intensities, with sample sizes of <italic>n</italic> = 26,760 for matched target, <italic>n</italic> = 86 for U10G, <italic>n</italic> = 88 for G13U, <italic>n</italic> = 85 for C21G, and <italic>n</italic> = 360 for non-target. <bold>E</bold> Correlation of two independent RNA-CHAMP experiments. Dashed lines denote the limit of detection. Pearson’s <italic>r</italic> = 0.97. <bold>F</bold> Rank-ordered graph of the ∆ABA for ~4000 library members. The dashed line represents the ΔABA of the matched target (MT). Sequences below our detection limit in (<bold>E</bold>) are omitted. <bold>G</bold> Correlation of the ΔABA and biolayer interferometry (BLI) - determined binding affinities. Error bars are the standard deviation of ΔABA (RNA-CHAMP) from bootstrap analysis, and 95% confidence interval of the fit (BLI) (clusters numbers for RNA-CHAMP can be found in Table ##SUPPL##0##S1##, three concentrations for BLI). The dashed line is the linear fit of data points. Pearson’s <italic>r</italic> = 0.89.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>Target RNA structure is a strong determinant of Cas13d binding affinity.</title><p><bold>A</bold> Top: schematic of the target RNA library. The target RNA is perfectly matched to the crRNA. Bottom: normalized ΔABAs for the 5’ PFS and 3’ PFS. In the plot, each block in the heat map is the mean of all detectable sequences with 5’ PFS (left) and 3’ PFS (right). All sequences were normalized to the scale of zero to 1 for easy comparison between targets. <bold>B</bold> Secondary structure predictions of two illustrative examples for 5’ PFS. Left: a low-affinity target RNA (5’-UAA). Right: a high-affinity target RNA (5’-GUA). The PFSs are boxed in blue and black in (<bold>A</bold>). <bold>C</bold> Predicted secondary structure of a low-affinity PFS (3’-UGG; left), and a high-affinity PFS (3’-GCU; right). The PFSs are boxed in green and red in (<bold>A</bold>). <bold>D</bold> BLI curves of the highlighted PFS sequences in (<bold>B</bold>) and (<bold>C</bold>). Gray lines are experimental curves. Colored lines are the global fit to a 1:1 binding model. <bold>E</bold> Normalized ΔABA of PFS sequences grouped by their number of intramolecular base pairs within the target region. Graph of the number of intramolecular base pairs in positions 12-22 (Left) and 1-11 (Right). Error bars are the standard deviation of normalized ΔABA. In the distal analysis, sample sizes (n) from left to right were 162, 26, 652, 169, 195, 40, 169, 31, 13. In the proximal analysis, corresponding sample sizes were 2, 3, 9, 103, 160, 16, 1149, 15. Swarm plots were employed when the number of sequences was less than 20. The boxplot extends from the first quartile (Q1) to the third quartile (Q3) of the dataset, featuring a median line. The whiskers are defined as Q1-1.5IQR and Q3 + 1.5IQR, where IQR is the interquartile range of the data. Statistical analysis was conducted using an unpaired two-sided Student’s t-test, with significance denoted as ***<italic>p</italic> &lt; 0.001. The corresponding <italic>p</italic>-values for the distal analysis, from left to right, were <italic>P</italic> = 0.00012, 1.2e-23, 2.0e-08, 2.4e-18, 1.8e-07, 1.1e-22, 3.9e-08, 0.00025.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Cas13d binding is sensitive to mismatches in the 5’-region of the target RNA.</title><p><bold>A</bold> Summary of single mismatch-dependent changes in the ∆ABA for two biological replicates. Upper dashed line: matched target ∆ABA. Lower dashed line: RNA-CHAMP detection limit. Solid lines: the mean of all three substitutions. Data are the mean ± S.D. from bootstrap analysis. All sequence counts are detailed in the Source Data. <bold>B</bold> Comparison of ∆ABA and cleavage of a reporter gene in mammalian cells (data adapted from ref. <sup>##REF##32518401##32##</sup>). For RNA-CHAMP, all three possible mismatches were averaged at each position along the target RNA. <bold>C</bold> Normalized ∆ABAs of all double mismatched sequences normalized to the matched target. Inset: blowup of all possible mismatches at target positions A<sub>20</sub> &amp; C<sub>21</sub>. <bold>D</bold> Secondary structure predictions of three illustrative examples. Top: C21G. Middle: C21U. Bottom: C21U, A20G. The mismatches are boxed.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>Modeling Cas13d binding.</title><p><bold>A</bold> Schematic of the three components of our quantitative Cas13d binding models. Relative encoding is the difference between a given sequence and the matched target sequence. The predicted minimum free energy (MFE) of a target RNA is generated by ViennaRNA 2.0<sup>##REF##22115189##45##</sup>. The number of intramolecular base pairing is the count of the RNA base pair in the target region. <bold>B</bold> Venn diagram of Pearson’s <italic>r</italic> correlation coefficients from three main components. Correlation between the measured and predicted data is shown in the Venn diagram. <bold>C</bold> Akaike information criterion (AIC) of the six models used in this study. ΔAIC is the difference between model I-V and model VI. <bold>D</bold> Correlation between the measured and predicted normalized ΔABAs from model VI. Pearson’s <italic>r</italic> = 0.76. <bold>E</bold> The weight penalty of all alterations (mismatches, insertions, and deletions) and intramolecular base pairing by positions in model VI.</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><title>Proximal mismatches limit Cas13d cleavage activity.</title><p><bold>A</bold> Schematic of the collateral cleavage assay. <bold>B</bold> Fluorescent cleavage time courses for matched target and nine representative mismatched target RNAs. Blue lines are distal mismatched sequences (positions 12-22). Orange lines are proximal mismatched sequences (positions 1-11). <bold>C</bold> The initial slope of 19 mismatched sequences. Slopes are calculated by the fluorescence changes during the first 20 minutes of the cleavage reaction and normalized to the matched target. Data are shown as mean and S.D. from two replicates. <bold>D</bold> Correlation of the cleavage slope with binding affinity (∆ABA). A subset of target RNAs retain strong binding but are cleavage-inactive (boxed region). Data are shown in mean ± S.D. from bootstrap analysis (y-axis). All sequence counts are detailed in the Source Data. <bold>E</bold> Schematic of mismatch-defined differentiation between SARS-CoV-2 variants of concern (VOC). <bold>F</bold> Fluorescent cleavage time courses for SARS-CoV-2 Wuhan and Delta VOCs. <bold>G</bold> The initial slope of the trace in (<bold>F</bold>). Slopes are calculated by the fluorescence changes during the first 20 minutes of the cleavage reaction. Data are shown as mean and S.D. from three replicates.</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><title>Cas13d binding and nuclease activation follow distinct rules.</title><p>Cas13d binding is penalized by distal RNA structures and mismatches. After initial distal recognition, the RNA duplex forms from the distal positions to the proximal positions. A mismatch in the proximal region fails to activate the nuclease activity, leading to a catalytically inactive enzyme. Matched target sequences that form a complete RNA duplex activate the nuclease activity.</p></caption></fig>" ]
[]
[ "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${I}_{{obs}}=\\frac{{I}_{\\max }-{I}_{\\min }}{1+\\frac{{K}_{d}}{x}}+{I}_{\\min }$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>max</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>min</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>min</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mi>x</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{d}$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\log \\left(\\frac{{K}_{d({mt})}}{{K}_{d(s)}}\\right)$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:mi>log</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{d(s)}$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{d}$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{d({mt})}$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}_{d}$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equa\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${f}_{BP}(i)=\\left\\{\\begin{array}{cc}1,&amp; if\\,position\\,i\\,was\\,based\\,paired\\,with\\,other\\,bases\\\\ 0,&amp; Otherwise \\hfill\\end{array}\\right.$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfenced open=\"{\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"center\"><mml:mn>1</mml:mn><mml:mo>,</mml:mo></mml:mtd><mml:mtd columnalign=\"center\"><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi>i</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi>w</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi>b</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi>b</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"center\"><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mtd><mml:mtd columnalign=\"center\"><mml:mi>O</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{{{{\\rm{Model}}}}}}\\,{{{{{\\rm{I}}}}}}:\\widehat{{k}_{\\varDelta ABA}}=\\mathop{\\sum }\\limits_{i=1}^{N}{a}_{i}\\ast {f}_{BP}(i)$$\\end{document}</tex-math><mml:math id=\"M20\"><mml:mi mathvariant=\"normal\">Model</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi mathvariant=\"normal\">I</mml:mi><mml:mo>:</mml:mo><mml:mover accent=\"true\"><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>Δ</mml:mi><mml:mi>A</mml:mi><mml:mi>B</mml:mi><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:munderover accent=\"false\" accentunder=\"false\"><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$g(k)$$\\end{document}</tex-math><mml:math id=\"M22\"><mml:mi>g</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k$$\\end{document}</tex-math><mml:math id=\"M24\"><mml:mi>k</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M25\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{{{{\\rm{Model}}}}}}\\,{{{{{\\rm{II}}}}}}:\\widehat{{k}_{\\varDelta ABA}}=\\mathop{\\sum }\\limits_{i=1}^{N}{a}_{i}\\ast {f}_{BP}(i)+e\\ast g(k)$$\\end{document}</tex-math><mml:math id=\"M26\"><mml:mi mathvariant=\"normal\">Model</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi mathvariant=\"normal\">II</mml:mi><mml:mo>:</mml:mo><mml:mover accent=\"true\"><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>Δ</mml:mi><mml:mi>A</mml:mi><mml:mi>B</mml:mi><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:munderover accent=\"false\" accentunder=\"false\"><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>e</mml:mi><mml:mo>*</mml:mo><mml:mi>g</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M27\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${k}_{{mt}}$$\\end{document}</tex-math><mml:math id=\"M28\"><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equb\"><alternatives><tex-math id=\"M29\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\{(Mismatch,2,{{{{{\\rm{G}}}}}}),(Mismatch,10,A)\\}$$\\end{document}</tex-math><mml:math id=\"M30\"><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>M</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi mathvariant=\"normal\">G</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>M</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mo>,</mml:mo><mml:mn>10</mml:mn><mml:mo>,</mml:mo><mml:mi>A</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M31\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${f}_{M}\\left(2,{G}\\right)$$\\end{document}</tex-math><mml:math id=\"M32\"><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>G</mml:mi></mml:mrow></mml:mfenced></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq12\"><alternatives><tex-math id=\"M33\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${f}_{M}\\left(10,{A}\\right)$$\\end{document}</tex-math><mml:math id=\"M34\"><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mn>10</mml:mn><mml:mo>,</mml:mo><mml:mi>A</mml:mi></mml:mrow></mml:mfenced></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq13\"><alternatives><tex-math id=\"M35\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${f}_{x}$$\\end{document}</tex-math><mml:math id=\"M36\"><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equc\"><alternatives><tex-math id=\"M37\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${f}_{x}(i,v)=\\left\\{\\begin{array}{cc}1,&amp; \\,if\\,oper\\,x\\,used\\,to\\,transfrom\\,{k}_{mt}\\,to\\,k\\\\ 0,&amp; Otherwise\\hfill\\end{array}\\right.$$\\end{document}</tex-math><mml:math id=\"M38\"><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfenced open=\"{\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"center\"><mml:mn>1</mml:mn><mml:mo>,</mml:mo></mml:mtd><mml:mtd columnalign=\"center\"><mml:mspace width=\"0.25em\"/><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi>o</mml:mi><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi>x</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mspace width=\"0.25em\"/><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mspace width=\"0.25em\"/><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi>k</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"center\"><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mtd><mml:mtd columnalign=\"center\"><mml:mi>O</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ4\"><label>4</label><alternatives><tex-math id=\"M39\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{{{{\\rm{Model}}}}}}\\,{{{{{\\rm{III}}}}}}:\\widehat{{k}_{\\varDelta ABA}}=\\mathop{\\sum}\\limits_{i\\,\\in \\,I}{b}_{i,v}\\ast {f}_{I}(i,v)+\\mathop{\\sum}\\limits_{i\\,\\in \\,D}{c}_{i}\\ast {f}_{D}(i,0)+\\mathop{\\sum}\\limits_{i\\,\\in \\,M}{d}_{i,v}\\ast {f}_{M}(i,v)$$\\end{document}</tex-math><mml:math id=\"M40\"><mml:mi mathvariant=\"normal\">Model</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi mathvariant=\"normal\">III</mml:mi><mml:mo>:</mml:mo><mml:mover accent=\"true\"><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>Δ</mml:mi><mml:mi>A</mml:mi><mml:mi>B</mml:mi><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:munder><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=\"0.25em\"/><mml:mo>∈</mml:mo><mml:mspace width=\"0.25em\"/><mml:mi>I</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>I</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:munder><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=\"0.25em\"/><mml:mo>∈</mml:mo><mml:mspace width=\"0.25em\"/><mml:mi>D</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:munder><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=\"0.25em\"/><mml:mo>∈</mml:mo><mml:mspace width=\"0.25em\"/><mml:mi>M</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq14\"><alternatives><tex-math id=\"M41\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$g(k)$$\\end{document}</tex-math><mml:math id=\"M42\"><mml:mi>g</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ5\"><label>5</label><alternatives><tex-math id=\"M43\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{{{{\\rm{Model}}}}}}\\,{{{{{\\rm{IV}}}}}}:\\widehat{{k}_{\\varDelta ABA}}=\t \\mathop{\\sum}\\limits_{i\\,\\in \\,I}{b}_{i,v}\\ast {f}_{I}(i,v)+\\mathop{\\sum}\\limits_{i\\,\\in \\,D}{c}_{i}\\ast {f}_{D}(i,0)\\\\ \t+\\mathop{\\sum}\\limits_{i\\,\\in \\,M}{d}_{i,v}\\ast {f}_{M}(i,v)+e\\ast g(k)$$\\end{document}</tex-math><mml:math id=\"M44\"><mml:mi mathvariant=\"normal\">Model</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi mathvariant=\"normal\">IV</mml:mi><mml:mo>:</mml:mo><mml:mover accent=\"true\"><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>Δ</mml:mi><mml:mi>A</mml:mi><mml:mi>B</mml:mi><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:munder><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=\"0.25em\"/><mml:mo>∈</mml:mo><mml:mspace width=\"0.25em\"/><mml:mi>I</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>I</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:munder><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=\"0.25em\"/><mml:mo>∈</mml:mo><mml:mspace width=\"0.25em\"/><mml:mi>D</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:munder><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=\"0.25em\"/><mml:mo>∈</mml:mo><mml:mspace width=\"0.25em\"/><mml:mi>M</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>e</mml:mi><mml:mo>*</mml:mo><mml:mi>g</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ6\"><label>6</label><alternatives><tex-math id=\"M45\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{{{{\\rm{Model}}}}}}\\,{{{{{\\rm{V}}}}}}:\\widehat{{k}_{\\varDelta ABA}}=\t \\mathop{\\sum }\\limits_{i=1}^{22}{a}_{i}\\ast {f}_{BP}(i)+\\mathop{\\sum}\\limits_{i\\,\\in \\,I}{b}_{i,v}\\ast {f}_{I}(i,v)+\\mathop{\\sum}\\limits_{i\\,\\in \\,D}{c}_{i}\\ast {f}_{D}(i,\\,0)\\\\ \t+\\mathop{\\sum}\\limits_{i\\,\\in \\,M}{d}_{i,v}\\ast {f}_{M}(i,v)$$\\end{document}</tex-math><mml:math id=\"M46\"><mml:mi mathvariant=\"normal\">Model</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi mathvariant=\"normal\">V</mml:mi><mml:mo>:</mml:mo><mml:mover accent=\"true\"><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>Δ</mml:mi><mml:mi>A</mml:mi><mml:mi>B</mml:mi><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:munderover accent=\"false\" accentunder=\"false\"><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>22</mml:mn></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:munder><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=\"0.25em\"/><mml:mo>∈</mml:mo><mml:mspace width=\"0.25em\"/><mml:mi>I</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>I</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:munder><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=\"0.25em\"/><mml:mo>∈</mml:mo><mml:mspace width=\"0.25em\"/><mml:mi>D</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mspace width=\"0.25em\"/><mml:mn>0</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:munder><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=\"0.25em\"/><mml:mo>∈</mml:mo><mml:mspace width=\"0.25em\"/><mml:mi>M</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq15\"><alternatives><tex-math id=\"M47\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k$$\\end{document}</tex-math><mml:math id=\"M48\"><mml:mi>k</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq16\"><alternatives><tex-math id=\"M49\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${k}_{{mt}}$$\\end{document}</tex-math><mml:math id=\"M50\"><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq17\"><alternatives><tex-math id=\"M51\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${f}_{x}\\left(i,v\\right)$$\\end{document}</tex-math><mml:math id=\"M52\"><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow></mml:mfenced></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ7\"><label>7</label><alternatives><tex-math id=\"M53\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{{{{\\rm{Model}}}}}}\\,{{{{{\\rm{VI}}}}}}:\\widehat{{k}_{\\varDelta ABA}}=\t \\mathop{\\sum }\\limits_{i=1}^{22}{a}_{i}\\ast {f}_{BP}(i)+\\mathop{\\sum}\\limits_{i\\,\\in \\,I}{b}_{i,v}\\ast {f}_{I}(i,v)+\\mathop{\\sum}\\limits_{i\\,\\in \\,D}{c}_{i}\\ast {f}_{D}(i,0)\\\\ \t+\\mathop{\\sum}\\limits_{i\\,\\in \\,M}{d}_{i,v}\\ast {f}_{M}(i,v)+e\\ast g(k)$$\\end{document}</tex-math><mml:math id=\"M54\"><mml:mi mathvariant=\"normal\">Model</mml:mi><mml:mspace width=\"0.25em\"/><mml:mi mathvariant=\"normal\">VI</mml:mi><mml:mo>:</mml:mo><mml:mover accent=\"true\"><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>Δ</mml:mi><mml:mi>A</mml:mi><mml:mi>B</mml:mi><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:munderover accent=\"false\" accentunder=\"false\"><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>22</mml:mn></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:munder><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=\"0.25em\"/><mml:mo>∈</mml:mo><mml:mspace width=\"0.25em\"/><mml:mi>I</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>I</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:munder><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=\"0.25em\"/><mml:mo>∈</mml:mo><mml:mspace width=\"0.25em\"/><mml:mi>D</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:munder><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=\"0.25em\"/><mml:mo>∈</mml:mo><mml:mspace width=\"0.25em\"/><mml:mi>M</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>M</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>e</mml:mi><mml:mo>*</mml:mo><mml:mi>g</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq18\"><alternatives><tex-math id=\"M55\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${a}_{i}$$\\end{document}</tex-math><mml:math id=\"M56\"><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq19\"><alternatives><tex-math id=\"M57\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{i,v}$$\\end{document}</tex-math><mml:math id=\"M58\"><mml:msub><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq20\"><alternatives><tex-math id=\"M59\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\,{c}_{i}$$\\end{document}</tex-math><mml:math id=\"M60\"><mml:mspace width=\"0.25em\"/><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq21\"><alternatives><tex-math id=\"M61\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\,{d}_{i,v}$$\\end{document}</tex-math><mml:math id=\"M62\"><mml:mspace width=\"0.25em\"/><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equd\"><alternatives><tex-math id=\"M63\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathop{\\sum}\\limits_{k\\,\\in {T}_{tr}}{(M(k)-{k}_{ABA})}^{2}+\\lambda \\mathop{\\sum}\\limits_{\\beta \\,\\in \\,X}{\\beta }^{2}\\,$$\\end{document}</tex-math><mml:math id=\"M64\"><mml:munder><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mspace width=\"0.25em\"/><mml:mo>∈</mml:mo><mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munder><mml:msup><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>M</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>B</mml:mi><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mi>λ</mml:mi><mml:munder><mml:mrow><mml:mo>∑</mml:mo></mml:mrow><mml:mrow><mml:mi>β</mml:mi><mml:mspace width=\"0.25em\"/><mml:mo>∈</mml:mo><mml:mspace width=\"0.25em\"/><mml:mi>X</mml:mi></mml:mrow></mml:munder><mml:msup><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq22\"><alternatives><tex-math id=\"M65\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\beta$$\\end{document}</tex-math><mml:math id=\"M66\"><mml:mi>β</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq23\"><alternatives><tex-math id=\"M67\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${a}_{i}$$\\end{document}</tex-math><mml:math id=\"M68\"><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq24\"><alternatives><tex-math id=\"M69\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${b}_{i}$$\\end{document}</tex-math><mml:math id=\"M70\"><mml:msub><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq25\"><alternatives><tex-math id=\"M71\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${c}_{i}$$\\end{document}</tex-math><mml:math id=\"M72\"><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq26\"><alternatives><tex-math id=\"M73\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${d}_{i}$$\\end{document}</tex-math><mml:math id=\"M74\"><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq27\"><alternatives><tex-math id=\"M75\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$e$$\\end{document}</tex-math><mml:math id=\"M76\"><mml:mi>e</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq28\"><alternatives><tex-math id=\"M77\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${k}_{\\triangle {ABA}}$$\\end{document}</tex-math><mml:math id=\"M78\"><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mo>△</mml:mo><mml:mi>A</mml:mi><mml:mi>B</mml:mi><mml:mi>A</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq29\"><alternatives><tex-math id=\"M79\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda$$\\end{document}</tex-math><mml:math id=\"M80\"><mml:mi>λ</mml:mi></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM3\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM4\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41467_2024_44738_Fig1_HTML\" id=\"d32e448\"/>", "<graphic xlink:href=\"41467_2024_44738_Fig2_HTML\" id=\"d32e646\"/>", "<graphic xlink:href=\"41467_2024_44738_Fig3_HTML\" id=\"d32e760\"/>", "<graphic xlink:href=\"41467_2024_44738_Fig4_HTML\" id=\"d32e905\"/>", "<graphic xlink:href=\"41467_2024_44738_Fig5_HTML\" id=\"d32e994\"/>", "<graphic xlink:href=\"41467_2024_44738_Fig6_HTML\" id=\"d32e1111\"/>", "<graphic xlink:href=\"41467_2024_44738_Article_Equ1.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq7.gif\"/>", "<graphic xlink:href=\"41467_2024_44738_Article_Equa.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41467_2024_44738_Article_Equ2.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq9.gif\"/>", "<graphic xlink:href=\"41467_2024_44738_Article_Equ3.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq10.gif\"/>", "<graphic xlink:href=\"41467_2024_44738_Article_Equb.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq11.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq12.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq13.gif\"/>", "<graphic xlink:href=\"41467_2024_44738_Article_Equc.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41467_2024_44738_Article_Equ4.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq14.gif\"/>", "<graphic xlink:href=\"41467_2024_44738_Article_Equ5.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41467_2024_44738_Article_Equ6.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq15.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq16.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq17.gif\"/>", "<graphic xlink:href=\"41467_2024_44738_Article_Equ7.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq18.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq19.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq20.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq21.gif\"/>", "<graphic xlink:href=\"41467_2024_44738_Article_Equd.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq22.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq23.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq24.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq25.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq26.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq27.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq28.gif\"/>", "<inline-graphic xlink:href=\"41467_2024_44738_Article_IEq29.gif\"/>" ]
[ "<media xlink:href=\"41467_2024_44738_MOESM1_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>", "<media xlink:href=\"41467_2024_44738_MOESM2_ESM.pdf\"><caption><p>Reporting Summary</p></caption></media>", "<media xlink:href=\"41467_2024_44738_MOESM3_ESM.pdf\"><caption><p>Peer Review File</p></caption></media>", "<media xlink:href=\"41467_2024_44738_MOESM4_ESM.zip\"><caption><p>Source Data</p></caption></media>" ]
[{"label": ["27."], "surname": ["Xie"], "given-names": ["S"], "article-title": ["Programmable RNA N1\u2010Methyladenosine Demethylation by a Cas13d\u2010Directed Demethylase"], "source": ["Angew. Chem. Int. Ed."], "year": ["2021"], "volume": ["60"], "fpage": ["19592"], "lpage": ["19597"], "pub-id": ["10.1002/anie.202105253"]}, {"label": ["33."], "mixed-citation": ["Wessels, H.-H. et al. Prediction of on-target and off-target activity of CRISPR\u2013Cas13d guide RNAs using deep learning. "], "italic": ["Nat. Biotechnol."]}, {"label": ["34."], "mixed-citation": ["Wei, J. et al. "], "italic": ["Deep learning and CRISPR-Cas13d ortholog discovery for optimized RNA targeting"]}, {"label": ["46."], "surname": ["Akaike"], "given-names": ["H"], "article-title": ["A new look at the statistical model identification"], "source": ["IEEE Trans. Automatic Control"], "year": ["1974"], "volume": ["19"], "fpage": ["716"], "lpage": ["723"], "pub-id": ["10.1109/TAC.1974.1100705"]}, {"label": ["50."], "surname": ["Kuo"], "given-names": ["Y"], "article-title": ["Massively Parallel Selection of NanoCluster Beacons"], "source": ["Adv. Mater."], "year": ["2022"], "volume": ["34"], "fpage": ["2204957"], "pub-id": ["10.1002/adma.202204957"]}, {"label": ["60."], "mixed-citation": ["Abadi, M. et al. TensorFlow: A system for large-scale machine learning."]}]
{ "acronym": [], "definition": [] }
60
CC BY
no
2024-01-14 23:40:17
Nat Commun. 2024 Jan 12; 15:498
oa_package/f5/46/PMC10786891.tar.gz
PMC10786892
38216695
[ "<title>Introduction</title>", "<p id=\"Par2\">Volcano monitoring and eruption forecasting have greatly benefited from recent technological advances that allow high temporal resolution measurements of volcanic gas compositions and fluxes. Volcanic gases measured at the surface are the only direct chemical probe of magma at depth and may, by their composition and/or flux, indicate movement of magma toward the surface, changes in the permeability of the shallow conduit system, or pressurization of the magma column beneath a lava dome<sup>##UREF##0##1##–##UREF##3##4##</sup>.</p>", "<p id=\"Par3\">Therefore, improving geochemical monitoring infrastructures, and enabling real-time analysis and interpretation protocols, are paramount to our understanding of pre- and syn-eruptive behavior of persistently degassing volcanoes and to mitigate the risk they pose to vulnerable communities.</p>", "<p id=\"Par4\">Nevado del Ruiz, in Colombia, is a 5.321 m-high glacier-clad andesitic volcano in the Cordillera Central of the northern Andes. The volcano erupted numerous times during the Holocene. Its 20th century eruptive history was marked by a period of unrest beginning in late November 1984 with a sharp increase in fumarolic activity<sup>##UREF##4##5##</sup>. It culminated with an eruption on 13 November 1985, which generated large lahars and killed more than 23,000 people<sup>##UREF##4##5##–##UREF##6##7##</sup>.</p>", "<p id=\"Par5\">More recently, deformation was noted in 2007, while seismicity and SO<sub>2</sub> emission rates started increasing in 2010, with SO<sub>2</sub> fluxes associated with small eruptions in May and June of that year<sup>##UREF##7##8##–##REF##28127058##10##</sup> reaching levels in excess of 20,000 t/d in 2012. In the meantime degassing rates between 2005 and 2015 remained high at Nevado del Ruiz, with satellite data showing an average SO<sub>2</sub> flux of ∼1,074 t/d<sup>##REF##28127051##11##</sup> leading up to elevated deformation and two peaks in lava dome extrusion rate: a first short-lived pulse in November 2015 and a second lasting most of 2016. By the beginning of this study, extrusion rates had decreased to 0.02m<sup>3</sup>/s (February 2018). These continued to decline until February 2019, when the dome forming eruption eventually ended<sup>##UREF##9##12##,##UREF##10##13##</sup>.</p>", "<p id=\"Par6\">Lava domes are structures that result from the extrusion and accumulation of extremely viscous, quasi solid, lava that are commonly formed at andesitic stratovolcanoes like Nevado del Ruiz. Explosive eruptions at lava domes are thought to be caused by spatial and temporal changes in their permeability and of their ability to exsolve and release volatiles<sup>##UREF##11##14##,##UREF##12##15##</sup>. Volcanic gas observations, especially if combined with thermal satellite observations<sup>##UREF##13##16##</sup>, are thus especially relevant to understanding lava dome activity and behaviour<sup>##UREF##14##17##,##REF##37277354##18##</sup>. For Nevado del Ruiz, no information on the fluxes of other major volatile species, such as H<sub>2</sub>O and CO<sub>2</sub>, was available until 2017, when the first discontinuous measurements started<sup>##UREF##15##19##</sup>.</p>", "<p id=\"Par7\">This study reports systematic volcanic gas observations (CO<sub>2</sub>/SO<sub>2</sub> ratios, CO<sub>2</sub> and SO<sub>2</sub> fluxes) taken in 2018–2021, a period of declining dome extrusion rates and negligible deformation. Nonetheless, seismicity, gas and ash emissions remained prevalent throughout this study<sup>##UREF##10##13##</sup>. Our aim is to present a model of the processes sustaining the persistent degassing, and to identify the mechanisms through which volcanic activity may escalate during periods of prolonged (slow) unrest<sup>##UREF##16##20##</sup>.</p>" ]
[ "<title>Methods</title>", "<title>Permanent MultiGAS station</title>", "<p id=\"Par29\">During operation, the MultiGAS<sup>##UREF##17##21##,##UREF##18##22##</sup> measured in-plume concentrations of CO<sub>2</sub>, SO<sub>2</sub> and H<sub>2</sub>S at 1 Hz. The permanent station worked for 4 30-min cycles every day between 2018 and 2021, at 0:00, 6:00, 12:00, 18:00 (UTC time). For details on calibration and sensor range see ref.<sup>##UREF##43##51##</sup>. Ambient pressure, temperature and relative humidity were also measured, which allowed calculation of in-plume H<sub>2</sub>O concentrations using the Arden Buck equation<sup>##UREF##44##52##</sup> (Supplementary Table ##SUPPL##0##3##). CO<sub>2</sub>/SO<sub>2</sub> and H<sub>2</sub>O/SO<sub>2</sub> ratios (supplementary Tables ##SUPPL##0##1## and ##SUPPL##0##3##) correspond to the slope of a best-fit regression line of the concentrations (in ppm) of both species in the selected temporal window (Ratiocalc<sup>##UREF##45##53##</sup>). Results (Fig. ##FIG##1##2##) are only reported for temporal windows in which the SO<sub>2</sub> concentration was above the 5 ppmv threshold, and in which correlations between CO<sub>2</sub> and SO<sub>2</sub> and H<sub>2</sub>O and SO<sub>2</sub> exceed an R<sup>2</sup> of 0.6. Despite the daily measurement routines, our volcanic gas dataset is limited to days in which wind direction favored the southwest sector of the volcano, where the sector Bruma is located (see Fig. ##FIG##0##1##). For instance, between 2018 and 2019, 1725 acquisitions (30-min each) were successfully transferred via telemetry from Bruma to OVSM, and subsequently processed at the University of Palermo. Approximately 67% of these acquisitions registered SO<sub>2</sub> concentrations above instrument noise (&gt; 0.2 ppmv), but only about 23% recorded SO<sub>2</sub> levels ≥ 5 ppm (the minimum concentration threshold here considered above which the plume is sufficiently “dense” to allow for compositional and CO<sub>2</sub> flux estimates; Fig. ##FIG##1##2##). Error are expressed as the standard error of the regression analysis and subsequent error propagation, error on inferred flux propagate error on the SO2 fluxes and gas ratios.</p>", "<title>Daily SO<sub>2</sub><bold><italic>flux estimates</italic></bold></title>", "<p id=\"Par30\">Sulfur dioxide emissions from Nevado del Ruiz are measured daily by scanning UV spectrometer systems installed through the Network for the Observation of Volcanic and Atmospheric Change project<sup>##UREF##19##23##,##UREF##46##54##</sup>. This network includes 5 different scanning locations, Bruma (4.90; − 75.33, 4878 m a.s.l.), Alfombrales (4.88; − 75.35, 4458 m a.s.l.), Azufrado/Olleta (4.89; -75.35, 4909 m a.s.l.), Inderena/El Camion (4.96; − 75.37, 4016 m a.s.l.) and Recio 3 (4.86; − 75.33, 4665 m a.s.l.; see map of Fig. ##FIG##0##1##) that provide plume scans at virtually all wind directions. The NOVAC scanning mini-DOAS (differential optical absorption spectroscopy; see ref.<sup>##UREF##47##55##</sup>) instruments scan the sky continuously during daylight hours to measure the integrated absorption of UV light by SO<sub>2</sub> in the plume. These are then combined with meteorological information to derive daily statistics of total SO<sub>2</sub> emissions. Wind speed and direction are acquired from local meteorological models from IDEAM (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ideam.gov.co/\">http://www.ideam.gov.co/</ext-link>). Daily SO<sub>2</sub> flux estimates are combined here with in tandem CO<sub>2</sub>/SO<sub>2</sub> gas ratios (converted from molar ratios to mass based on concentration ratios) measured by the permanent MultiGAS station to derive CO<sub>2</sub> flux budgets between 2018 and 2021. The SO<sub>2</sub> flux dataset assembled over the years by the OVSM highlights a dependence on wind patterns. Specifically, between May and October, westwards plume directions allow ideal scanning geometries for 4 out of the 5 stations (located on the west flank of the volcano). This ultimately translates into higher estimated fluxes comparing to periods during which the plume may become undetected in more than one scan (due to unfavorable transport directions). We here consider only SO<sub>2</sub> flux measurement scans with complete coverage of the plume (completeness &gt; 0.8), in order to minimize the effect of wind direction in our daily SO<sub>2</sub> flux estimates.</p>", "<title>CO<sub>2</sub> fluxes</title>", "<p id=\"Par31\">We derive daily averaged <bold>CO</bold><sub><bold>2</bold></sub><bold> fluxes</bold> (in t/d; Fig. ##FIG##1##2##C)by combining CO<sub>2</sub>/SO<sub>2</sub> ratios (MultiGAS station) and SO<sub>2</sub> fluxes (NOVAC network), as: .</p>", "<p id=\"Par32\"><bold>Sulfur flux</bold> (in kg/s) is calculated from the following:</p>", "<p id=\"Par33\">).</p>", "<title>Volcanic radiative power (MODIS)</title>", "<p id=\"Par34\">MIROVA<sup>##UREF##20##24##</sup> (Middle InfraRed Observation of Volcanic Activity; <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.mirovaweb.it\">www.mirovaweb.it</ext-link>) algorithm allows to detect, locate and quantify volcanic hotspots, measuring the heat flux radiated by hot (&gt; 300 °C) volcanic features (VRP ± 30%, Fig. ##FIG##3##4##A, inset of Fig. ##FIG##3##4##B). This approach provides the VRP time series (and its associated Volcanic Radiative Energy, VRE; Fig. ##FIG##3##4##A) recorded at Nevado del Ruiz between 2018 and 2021 and prior. <bold>Volumes of radiating magma (V thermal</bold>; Fig. ##FIG##3##4##C) are retrieved from the thermal approach, and are related to the measured radiant energy (VRE)<sup>##UREF##34##39##</sup> through:</p>", "<p id=\"Par35\"> , where is an empirical coefficient that takes into account the effective rheology of the emplacing lava body<sup>##UREF##34##39##</sup>. For Nevado del Ruiz we used a silica content of 62.4 wt%<sup>##UREF##26##30##</sup>, obtaining a of 2.1 × 10<sup>6</sup> J/m<sup>3</sup>.</p>", "<p id=\"Par36\">The <bold>volume of degassed magma (V degassed</bold>.; Fig. ##FIG##3##4##C) takes into account the measured S flux (see above) and calculations of magma input rates<sup>##UREF##35##40##,##UREF##48##56##</sup>. It is obtained from the following equation:</p>", "<p id=\"Par37\">, where ∆XS is the S volatile loss, derived from the difference between parental melt volatile content (440 ppm in melt inclusion data<sup>##UREF##26##30##</sup>) and the residual S content in the groundmass (as low as 70 ppm<sup>##UREF##26##30##</sup>); ϕ is the crystal fraction, assumed for Nevado del Ruiz magmas to be around 40%; and m is the melt density of the magma (2227 kg/m<sup>3(30)</sup>).</p>", "<p id=\"Par38\">Same estimates of <bold>magma input rates</bold> are used in Fig. ##FIG##6##7##. Instead, given the good agreement between VRP and output rates shown in Fig. ##FIG##3##4##B (and inset), output rates in Fig. ##FIG##6##7## are calculated as time-averaged lava discharge rates (TADR)<sup>##UREF##34##39##</sup>, by considering the following: .</p>", "<title>Ash events record</title>", "<p id=\"Par39\">Ash emission events were registered by the <italic>Observatorio Vulcanológico y Sismológico de Manizales (Servicio Geológico Colombiano)</italic> through observation of webcam video recordings and reports from local communities.</p>" ]
[ "<title>Results</title>", "<title>Volcanic gas compositions</title>", "<p id=\"Par8\">Our results are based on volcanic gas records streamed by a fully autonomous MultiGAS<sup>##UREF##17##21##,##UREF##18##22##</sup> station. The instrument was deployed at Nevado del Ruiz between 2018 and 2021, on the northwest flank of the volcano at an altitude of 4832 m a.s.l. (4.90°N, − 75.34°W; Fig. ##FIG##0##1##). The data yield<sup>##UREF##15##19##</sup> average CO<sub>2</sub>/SO<sub>2</sub> ratios of 5.4 ± 1.9 (2.8–14.3, n = 220; Fig. ##FIG##1##2##A; see “<xref rid=\"Sec10\" ref-type=\"sec\">Methods</xref>”). H<sub>2</sub>S concentrations were rarely detected at &gt; 1 ppm levels, and the H<sub>2</sub>S/SO<sub>2</sub> ratios are typically &lt;  &lt; 0.1. Volcanic H<sub>2</sub>O signal (above atmospheric background; see “<xref rid=\"Sec10\" ref-type=\"sec\">Methods</xref>”) is resolved in only 25 acquisitions, due to the very high background (ambient) air H2O concentrations (up to 16,000 ppm) recorded at such altitudes. These yield H<sub>2</sub>O/SO<sub>2</sub> and H<sub>2</sub>O/CO<sub>2</sub> ratios averaging at 32.8 (range, 9.1–56.7) and 3.9 (2.6–6.5), respectively. From these measurements, we estimate the average composition of the plume at 84.7 mol% H<sub>2</sub>O, 12.0 mol% CO<sub>2</sub>, 2.8 mol% SO<sub>2</sub>, 0.1 mol% H<sub>2</sub>S, and 0.4 mol% H<sub>2</sub>. Uncertainties in gas ratios measured by the Mulitas are reported in Supplementary Table ##SUPPL##0##1## and are far lower than the variations reported in our time series.</p>", "<title>SO<sub>2</sub> fluxes</title>", "<p id=\"Par9\">Daily average SO<sub>2</sub> fluxes (see “<xref rid=\"Sec10\" ref-type=\"sec\">Methods</xref>” for data selection criteria and details on daily statistics of SO<sub>2</sub> emission rates), obtained by the local NOVAC<sup>##UREF##19##23##</sup> network of 5 scanning spectrometers between 2018 and 2021, oscillated between 58 and 4617 tons/day, with an average of 1568 tons/day (Fig. ##FIG##2##3##A). This confirms the sustained degassing activity of Nevado del Ruiz during the investigated time interval. Annual averages show small variations, especially between 2018 (~ 1457 tons/day) and 2019 (~ 1590 tons/day). Four out of the 5 stations yield somewhat similar yearly averages, ranging from ~ 2910 (Bruma) to ~ 4031 t/day (Azufrado/Olleta), thus attesting for the uninterrupted degassing and somewhat unvarying activity at the Arenas crater.</p>", "<title>Volcanic radiative power</title>", "<p id=\"Par10\">In the temporal interval investigated, the MIROVA<sup>##UREF##20##24##</sup> system detected intermittent thermal anomalies, with a Volcanic Radiative Power (VRP) baseline below 5 MW (Fig. ##FIG##3##4##A). These relatively low VRP values attest for the overall mild lava extrusion activity registered at Nevado del Ruiz between 2018 and 2021, coupled with continuous high-temperature degassing. Periods of dome extrusion (e.g., Jan–Apr 2020) are clearly detected by MIROVA as VRP maximum values of up to 16.7 MW (see supplementary Table ##SUPPL##0##1##–##SUPPL##0##2## for detailed thermal outputs).</p>" ]
[ "<title>Discussion</title>", "<title>Shallow versus deep magmatic gas signature</title>", "<p id=\"Par11\">The near absence of H<sub>2</sub>S in the gas plume (avg. ∼0.1 mol%) suggests negligible hydrothermal contributions to volcanic gas compositions measured at Nevado del Ruiz between 2018 and 2021. The magmatic nature of the measured gas is additionally supported by the relatively low H<sub>2</sub>O concentrations (maximum 92 mol%). Therefore, we focus on the temporal variations of plume CO<sub>2</sub>/SO<sub>2</sub> ratios (Fig. ##FIG##1##2##A), and on the fluctuations of SO<sub>2</sub> and CO<sub>2</sub> fluxes (Fig. ##FIG##1##2##B, ##FIG##1##C##). The in-plume abundances of CO<sub>2</sub> and SO<sub>2</sub> both exhibit significant temporal variations. The relatively high CO<sub>2</sub>/SO<sub>2</sub> ratio range (5.4 ± 1.9) confirms the C-rich nature of Nevado del Ruiz magmatic fluids, interpreted<sup>##UREF##15##19##,##UREF##21##25##</sup> as originating from the recycling of subducted carbonate-rich sediments in the region<sup>##UREF##22##26##</sup> (see Aiuppa et al., 2017 for detailed assessment of the relationship between along-arc CO<sub>2</sub>/SO<sub>2</sub> ratios and subduction sediment compositions). Above average CO<sub>2</sub>/SO<sub>2</sub> ratios are unlikely to be caused by the scrubbing of volcanic SO<sub>2</sub> (a process that can cause CO<sub>2</sub>/SO<sub>2</sub> ratios to exceed typical magmatic values<sup>##UREF##23##27##</sup>) for two main reasons. Firstly, a typical driver of magmatic S scrubbing is the interaction of deeply ascending magmatic fluids with hydrothermal fluids/ground-water, whereby the conversion of SO<sub>2</sub> to H<sub>2</sub>S should occur; this is not observed at Nevado del Ruiz, given the negligible amounts of H<sub>2</sub>S measured. Secondly, at andesitic dome-forming volcanoes, SO<sub>2</sub> scrubbing should be favored in phases when cooling and/or mineral deposition in fractures and pores in the dome carapace<sup>##UREF##24##28##</sup> prevail. If this was the case, then high CO<sub>2</sub>/SO<sub>2</sub> ratios should systematically be associated with reduced SO<sub>2</sub> fluxes (reduced SO<sub>2</sub> fluxes have been detected prior to explosion at some dome-forming volcanoes, interpreted as caused by the decreasing in permeability of the main degassing pathways<sup>##UREF##14##17##</sup>). However, at Nevado del Ruiz, we observe persistently high SO<sub>2</sub> fluxes (Fig. ##FIG##1##2##B) that attest to an overall permeable dome, allowing efficient escape of magmatic gases to the atmosphere. We also find no significant correlation between the timing of the summit ash explosions and SO<sub>2</sub> fluxes (Fig. ##FIG##2##3##). If we concentrate on the days in which at least one explosion is observed (Fig. ##FIG##2##3##B), we note that in only 59% of these the daily recorded fluxes are below the 2018–2021 average (41% of the days with explosions recorded higher-than-average SO<sub>2</sub> fluxes). We caution that we are here interested in long-term (daily to yearly) degassing trends rather than in the driving mechanisms of ash explosions, and we cannot exclude short-term (minutes to tens of minutes) drops in SO<sub>2</sub> emissivity occur prior to individual explosions (as observed elsewhere<sup>##UREF##14##17##</sup>) that are not resolvable at the scale of our observations here. In our context, we conclude that clusters of explosions can occur in periods of either reduced (125–1000 t/d) or augmented (2000–3000 t/d, and up to 4617 t/d) daily SO<sub>2</sub> emission rates. Ultimately, we see no obvious link between compositional changes and shallow processes (scrubbing, dome permeability drop), and we find more likely that the temporally changing CO<sub>2</sub>/SO<sub>2</sub> ratios are linked to magmatic processes, and potentially to a variable input of deeply rising CO<sub>2</sub>-rich fluids<sup>##UREF##25##29##</sup> into the shallow magma plumbing system feeding the dome.</p>", "<p id=\"Par12\">Modelling magmatic degassing requires an understanding of volatile contents in the Nevado de Ruiz parental melts. Stix et al<italic>.,</italic> (ref.<sup>##UREF##26##30##</sup>) analysed juvenile material erupted at Nevado del Ruiz in November 1985 and September 1989. The authors argued that the wide range of SiO<sub>2</sub> contents (62.4–76.6 wt%) observed in melt inclusions implies two distinct magmas are at play, one more evolved than the other. This hypothesis is frequently invoked in the post-1985-eruption literature<sup>##UREF##27##31##–##UREF##29##33##</sup>. Here we interpret our volcanic gas compositions by using, as proxy for the parental (undegassed) melt composition, the measured volatile contents (2.45 wt% H<sub>2</sub>O and 440 ppm S) in the less evolved (62.4 wt% SiO<sub>2</sub>) melt inclusions<sup>##UREF##26##30##</sup>. The CO<sub>2</sub> parental melt concentration has not been characterized at Nevado del Ruiz using melt inclusions. We hence consider a range assumed to be characteristic of initial CO<sub>2</sub> contents in arc magmas by Plank &amp; Manning, 2019 (1200 ppm, ref.<sup>##REF##31619791##34##</sup>) and Wallace, 2005 (3000 ppm, ref.<sup>##UREF##30##35##</sup>).</p>", "<p id=\"Par13\">With these initial input parameters, we use a volatile saturation code<sup>##UREF##31##36##,##UREF##32##37##</sup> to calculate the pressure-dependent evolution of the magmatic gas phase exsolved from Nevado del Ruiz magmas upon their ascent and decompression (Figs. ##FIG##4##5## and ##FIG##5##6##). Our simulations are performed in both closed- and open-system conditions (250–0.1 MPa range) at a constant temperature of 900 <sup>ͦ</sup> C (1173 K)<sup>##UREF##28##32##</sup>, and exploring a redox range of 0.5 log units below the nickel-nickel oxide (NNO) buffer (see supplementary Table ##SUPPL##0##S4## for detailed input parameters). Note that the large mismatch between degassing and erupted magma volumes (see below) requires gases are separated from melt (e.g., that open system prevails) at some point in the magma ascent/decompression path. However, as the depth/pressure of closed-to-open degassing transition is undetermined, we examine the full closed and full open conditions separately as two end-member scenarios.</p>", "<p id=\"Par14\">Results (Fig. ##FIG##4##5##) show that the modeled open- and closed-system degassing trends match well the range of gas (this study, Fig. ##FIG##4##5##B, ##FIG##4##D##) and melt compositions<sup>##UREF##26##30##</sup> (Fig. ##FIG##4##5##A, ##FIG##4##C##) observed at Nevado del Ruiz. We can therefore infer the pressures/depths of gas–melt separation (final equilibration) in the plumbing system by comparing the modeled and observed gas compositions (Fig. ##FIG##5##6##).</p>", "<p id=\"Par15\">Under closed-system conditions the melt becomes volatile saturated at approximately 250 MPa and our lower/upper range of volcanic gas CO<sub>2</sub>/S<sub>T</sub> ratios would imply equilibration pressures of approximately 30–100 MPa (~ 1–4 km; Fig. ##FIG##5##6##). Beyond ~ 30 MPa pressures the magmatic gas phase would evolve to CO<sub>2</sub>/S<sub>T</sub> compositions lower than those measured in the gas plume (Fig. ##FIG##5##6##). On the other hand, for the open-system scenario, CO<sub>2</sub>/S<sub>T</sub> derived pressures/depths range from ∼20 to 93 MPa (∼0.8 to 3.7 km).</p>", "<p id=\"Par16\">Our gas-inferred depth range corresponds to those inferred form melt inclusion entrapment conditions<sup>##UREF##26##30##</sup>, and to the seismically identified active magma volume<sup>##REF##28127058##10##</sup>. Combined with existing knowledge on the shallow Nevado del Ruiz plumbing system<sup>##REF##28127058##10##,##UREF##26##30##</sup>, our results identify a main magma storage region in the 1–4 km range, where ponding magma crystallizes (eventually evolving from andesite to dacite), and where gas–melt separation takes place that sustain magmatic gas emissions at the surface. Here, the upper range of our volcanic gas compositions (CO<sub>2</sub>/S<sub>T</sub> upper range 5.4–7.3; S<sub>T</sub> stands for total sulfur, and corresponds to the sum SO<sub>2</sub>(g) and H<sub>2</sub>S(g)) may correspond to the roots of such magma storage zone (90–100 MPa pressure; Fig. ##FIG##5##6##), where separate ascent of deeply-derived CO<sub>2</sub>-rich gas (CO<sub>2</sub>-flushing) starts, eventually followed by separate gas bubble ascent and/or further bubble re-equilibration (1–3 km-depth range). In this interpretation, the shallowest (&lt; 20–40 MPa) portion of the plumbing system would then be occupied by relatively stationary (or poorly mobile), viscous andesitic magma, a very small fraction of which is finally extruded as a dome. In this portion of the reservoir, below-average volcanic gas compositions derive from low-pressure re-equilibration and partial CO<sub>2</sub> loss from the melt.</p>", "<p id=\"Par17\">Therefore, we argue that the intermittent resupply of the shallow resident conduit magma with more volatile-rich magma (rising from deep) does play a crucial role in sustaining the long-lasting degassing activity of the magmatic column (in addition to causing the brief excursions of gas compositions toward higher CO<sub>2</sub>/S<sub>T</sub> compositions). In addition, at low confining pressures and high magma viscosities, there may be sufficient strain at the conduit walls to induce brittle failure, with gas loss along permeable channels<sup>##UREF##33##38##</sup> (Fig. ##FIG##5##6##). Such lines of evidence corroborate a multistage model of magma transport and degassing, with alternating periods of magma ascent and ponding<sup>##UREF##26##30##</sup>.</p>", "<title>Dynamics of shallow ponding conduit magma</title>", "<p id=\"Par18\">Assessments of magma balances (e.g., degassed versus extruded) can provide further constraints on magma feeding processes into the shallow Nevado del Ruiz magmatic system. The volume of degassed magma between 2018 and 2021, inferred from the measured SO<sub>2</sub> fluxes and knowledge of parental melt S content (see “<xref rid=\"Sec10\" ref-type=\"sec\">Methods</xref>”), is ~ 974 mm<sup>3</sup> (Fig. ##FIG##3##4##C ). Additionally, we estimate a mean MIROVA-derived extrusion rate (TADR; see “Methods) of 0.37 m<sup>3</sup>/s (andesite), which is considerably higher than that (0.02 m<sup>3</sup>/s) reported by Ordoñez et al. (ref<sup>##UREF##10##13##</sup>) for the 2018–2021 period (Fig. ##FIG##5##6##). Following the equations provided in Coppola et al., 2013 (ref.<sup>##UREF##34##39##</sup>; see also “<xref rid=\"Sec10\" ref-type=\"sec\">Methods</xref>”), we calculate that the thermal output recorded requires surface emplacement (extrusion) of about 27.5 mm<sup>3</sup> of magma (V<sub>thermal</sub>; Fig. ##FIG##3##4##C), which is approximately 50 times higher than that of the volume extruded (0.56 mm<sup>3</sup>)<sup>##UREF##10##13##</sup> during that period.</p>", "<p id=\"Par19\">In other dome-forming volcanoes (e.g. Sabancaya<sup>##UREF##13##16##</sup> and Popocatepetl<sup>##REF##37277354##18##</sup>), V<sub>Thermal</sub> &gt; V<sub>Extruded</sub> unbalances have been ascribed to an “excess radiation” process whereby the majority of the thermal anomalies (reported as VRP) were sourced by additional processes other than surface dome extrusion<sup>##UREF##13##16##,##REF##37277354##18##</sup>. We caution that, at Nevado del Ruiz, the latter may be somewhat underestimated, considering the cycles of dome building and partial destruction (potentially sudden) can be relatively short, and hence difficult to capture with the relatively low temporal resolution measurements reported by Ordoñez et al. Short-lived dome (emplacement/destruction) cycles may, in fact, explain (i) the relatively mild explosive activity of the arenas crater and the lack of a major explosive event since the beginning of the long-lasting unrest; and (ii) the relatively efficient (partial) clearing of the top of the magma column allowing for the conduit to sustain a high level of gas permeability.</p>", "<p id=\"Par20\">In any case, the large unbalance between magma input (10 m<sup>3</sup>/s) and output (extrusion, 0.02 m<sup>3</sup>/s) rates, shown in Fig. ##FIG##3##4##C and schematically illustrated in Fig. ##FIG##5##6##, indicates that only about 0.2% of the intruded magma finally reaches the surface. Unbalance between supplied and erupted magma (and the notions of excess degassing and thermal radiation highlighted in our dataset) is typical of open-vent-like-behavior and may indicate that, throughout this study, activity (slow unrest) at Nevado del Ruiz was driven by degassing of unerupted magma (see also ref.<sup>##UREF##13##16##</sup>).</p>", "<p id=\"Par21\">We have so far established that the existing lava dome at Nevado del Ruiz is connected to deeper reservoirs (e.g., 1–3 km depth<sup>##UREF##26##30##</sup>) through a gas-permeable volcanic conduit (e.g., ref.<sup>##UREF##36##41##</sup>). On the other hand, magma supply rate and erupted magma volume suggest that less 1% of the intruded magma reaches the surface (see above). If such significant volumes of degassed magma were to be stored at shallow depths beneath Nevado del Ruiz (i.e., in the upper 2 km), measurable deformation was to be expected. On the contrary, the local <italic>Observatorio Vulcanológico y Sismológico de Manizales</italic> reported no significant anomalies (not to the scale of the volumes of non-erupted magma) between 2018 and 2021.</p>", "<p id=\"Par22\">We, therefore, argue against the possibility that large volumes of magma are being stored at shallow levels within the edifice. Models of convecting magma columns<sup>##UREF##35##40##</sup> have been evoked to explain excess degassing and thermal radiation associated with dome-forming activity at andesitic volcanoes<sup>##UREF##13##16##,##REF##37277354##18##,##UREF##37##42##</sup>. At Nevado del Ruiz, due to significant degassing-induced crystallization in the shallow part of the conduit (Fig. ##FIG##5##6##), bimodal flow and magma convection may not occur as efficiently as in low-viscosity mafic systems, especially as magma becomes more evolved and stagnant at shallower levels. During the early stages magma crystallization and bubble formation, some extent of counterflows of ascending (non-degassed) and descending (degassed) magma may coexist in the deep (&gt; 3 km) volcanic conduit, therefore boosting the continuous supply and recycling of deep magmatic fluids between reservoirs (Fig. ##FIG##5##6##).</p>", "<p id=\"Par23\">In the shallower regions of the conduit, gas–melt separation is likely driven by cooling and crystallization of stagnant, viscous andesitic magma. This process concentrates volatiles in the remaining melt phase and eventually causes them to exsolve into bubbles, which in turn propels the steady degassing behavior and gas compositions observed between 2018 and 2021, and permit large fractions of reservoir volatiles to be released without major eruption. Deeper reservoirs connected to shallower regions by dykes provide occasional inputs of CO<sub>2</sub>-rich magma (CO<sub>2</sub>-flushing) which may disturb normal rates of magma ascent and degassing and cause conduit overflow, resulting in the extrusion events recorded in this study.</p>", "<title>The eruptive cycle of Nevado del Ruiz volcano: clues on the possible activity escalation of a slow and steady system</title>", "<p id=\"Par24\">Periods of enhanced activity, such as higher rates of dome growth or explosive activity, are common at volcanoes such as Nevado del Ruiz. However, our results corroborate that “slow” silicic systems can eventually maintain a steady-state volcanic activity behavior for years, without ever transitioning into a climatic phase<sup>##UREF##16##20##</sup>. Between 2018 and 2021, this “steady-state” behavior has resulted from a complex but overall “balanced” interplay between inputs of volatile-rich magma, shallow magma crystallization and degassing, and dome extrusion, which has only produced relatively mild explosive activity. Similar slow-unrest systems<sup>##UREF##16##20##</sup>, of equally evolved magma compositions, such as Popocatépetl<sup>##UREF##14##17##,##REF##37277354##18##</sup>, in Mexico, and Sabancaya<sup>##UREF##13##16##</sup>, in Peru show similar longevity in their unrest periods and surface activity. Therefore, a crucial question for these systems, and in particular of Nevado del Ruiz, is how, and over what timescales, volcanic activity can escalate into more voluminous/energetic eruptive events of potential threat to vulnerable communities.</p>", "<p id=\"Par25\">The months preceding Nevado del Ruiz’s catastrophic November 13, 1985 eruption were characterized by minor ash emission events that culminated in a relatively small eruption (Volcanic Explosivity Index, VEI = 3)<sup>##UREF##4##5##,##UREF##38##43##</sup>. Juvenile scoria and pumices were erupted<sup>##UREF##27##31##</sup> and about 90 kt of SO<sub>2</sub> released<sup>##UREF##39##44##</sup>, suggesting that the eruption was in fact magmatic and not phreatic<sup>##REF##31007532##45##</sup>. Giggenbach et al<italic>.</italic> (ref.<sup>##UREF##40##46##</sup>; see also ref.<sup>##UREF##41##47##</sup>) reported on an extensive hydrothermal system beneath the volcano, which is manifested today entirely through springs and fumaroles spread throughout the large periphery of the volcano. Our volcanic gas data, however, shows that the present high gas and heat fluxes have most likely boiled off any meteoric water and potentially decoupled the hydrothermal and magmatic systems of Nevado del Ruiz. If Nevado del Ruiz is to sustain its current levels of unrest, the origin and nature of a future major eruptive event is therefore likely to be magmatic.</p>", "<p id=\"Par26\">Given the catastrophic consequences of the November 1985 eruption<sup>##UREF##5##6##</sup>, we must attempt to correlate the pre-, syn- and post-eruptive observations of the historical event with the current unrest signals. We emphasize two major findings: (i) Banks et al. (ref.<sup>##UREF##42##48##</sup>) reported no deformation and therefore lack of significant intrusive activity prior to and during the 1985 eruptive period; and (ii) the amount of “new” magmatic material produced during the November 1985 eruption was disproportionally small to account for the large amounts of SO<sub>2</sub><sup>##REF##17732038##49##</sup> released then and over subsequent periods (see ref.<sup>##UREF##38##43##</sup>). Based on our findings, a large degassing excess and a lack of deformation are distinctive features of present-day activity, although no major eruption has yet occurred. Our conceptual model (Fig. ##FIG##5##6##) accounts for different evolving magmas<sup>##UREF##26##30##</sup> at shallow depths, which degas extensively over time. The same magma regions were likely involved as source of the large amounts of pre- and syn-eruptive passive degassing observed from 1985 to 1990 and beyond<sup>##UREF##38##43##</sup>.</p>", "<p id=\"Par27\">The mechanisms of gas/magma transfer within the shallow magma plumbing system, and between the shallow and deep magmatic systems, are difficult to constrain. However, our results suggest that crystallization-induced (evolved magma) and CO<sub>2</sub>-rich gases (from deep) are necessary to explain the range of CO<sub>2</sub>/SO<sub>2</sub> compositions measured at the surface. Depending on magma physical properties (e.g., viscosity, vesicularity, and percentage of interconnected vesicles), each of them can dominate at specific depths or time<sup>##UREF##14##17##</sup>. In the current degassing unrest, in particular, phases of enhanced CO<sub>2</sub> flushing can be detected as periods of escalating CO<sub>2</sub> surface release (blue shaded areas; Fig. ##FIG##6##7##). Increased gas flushing may render the shallow ponding magma more buoyant, eventually leading to occasional events of dome extrusion (red shaded areas, as identified from increasing magma output/input ratios; Fig. ##FIG##6##7##) once the top of the magma column overflows. Carbon dioxide (CO<sub>2</sub>) flushing, in particular, may play a crucial role in governing degassing behavior over time. While at present shallow ponding magma may be sourcing the enhanced degassing rates recorded at Nevado del Ruiz (green shaded areas; Fig. ##FIG##6##7##), ascent of voluminous CO<sub>2</sub>-rich deep gas amounts in the conduit may eventually cause eruption<sup>##REF##34533982##50##</sup>. Volcanic gas release through permeable conduit walls and dome during times of passive degassing may be disrupted by sudden accumulation and pressurization of bubbles due to lithostatic pressure that tends to compact and close the system<sup>##UREF##14##17##</sup>. The combination of both processes may culminate in a major eruption.</p>", "<p id=\"Par28\">Therefore, monitoring the composition and mass flux of volcanic gases is critical for fully informed forecasting efforts. However, the challenges of real-time measurements of volcanic gas compositions at volcanoes such as Nevado del Ruiz are exacerbated by extreme low ambient temperature conditions and high level of volcanic activity. Nonetheless, our study attests to the advantages of combining composition, flux and satellite remote sensing measurements to efficiently address the dynamics of shallow magma transfer and extrusion at strongly degassing volcanoes. Moreover, by monitoring the Nevado del Ruiz volcanic degassing behavior over the 3-year period, this study crucially distinguishes several activity phases (e.g., CO<sub>2</sub> gas flushing, dome extrusion, persistent open-conduit degassing) within the recent unrest cycle of Nevado del Ruiz, while highlighting their specific chemical and thermal patterns to future risk assessment efforts.</p>" ]
[]
[ "<p id=\"Par1\">This study combines volcanic gas compositions, SO<sub>2</sub> flux and satellite thermal data collected at Nevado del Ruiz between 2018 and 2021. We find the Nevado del Ruiz plume to have exhibited relatively steady, high CO<sub>2</sub> compositions (avg. CO<sub>2</sub>/S<sub>T</sub> ratios of 5.4 ± 1.9) throughout. Our degassing models support that the CO<sub>2</sub>/S<sub>T</sub> ratio variability derives from volatile exsolution from andesitic magma stored in the 1–4 km depth range. Separate ascent of CO<sub>2</sub>-rich gas bubbles through shallow (&lt; 1 km depth), viscous, conduit resident magma causes the observed excess degassing. We infer that degassing of ~ 974 mm<sup>3</sup> of shallow (1–4 km) stored magma has sourced the elevated SO<sub>2</sub> degassing recorded during 2018–2021 (average flux ~ 1548 t/d). Of this, only &lt; 1 mm<sup>3</sup> of magma have been erupted through dome extrusion, highlighting a large imbalance between erupted and degassed magma. Escalating deep CO<sub>2</sub> gas flushing, combined with the disruption of passive degassing, through sudden accumulation and pressurization of bubbles due to lithostatic pressure, may accelerate volcanic unrest and eventually lead to a major eruption.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51380-5.</p>", "<title>Acknowledgements</title>", "<p>We would like to thank Gloria Patricia Cortés and all the staff from the <italic>Observatorio Vulcanológico y Sismológico de Manizales (Servicio Geológico Colombiano)</italic> for their outstanding logistical and scientific support throughout this investigation. Initial funding for producing the NOVAC data set here presented was provided by the European Commission FP5 (DORSIVA project) and FP6 (NOVAC project), and the operation of the NOVAC network is funded through initiatives of the Volcano Observatories and support from the Volcano Disaster Assistance Program of the United States Geological Survey (USGS). S.A. acknowledges support from the Swedish National Space Agency (149/18). MIROVA is a collaborative project between the Universities of Turin and Florence (Italy) and is supported by the Italian Civil Protection Department. We acknowledge the LANCE-MODIS system (<ext-link ext-link-type=\"uri\" xlink:href=\"http://lance-modis.eosdis.nasa.gov/\">http://lance-modis.eosdis.nasa.gov/</ext-link>) for providing Level 1b MODIS data, as well as the crucial support from the Alfred P. Sloan Foundation (Deep Carbon Observatory/DECADE project; UniPa‐CiW subcontract 10881‐ 1262), the MIUR (under grant PRIN2017‐2017LMNLAW) and the PE-PNRR project “Return<italic>”</italic> for funding a large portion of this investigation.</p>", "<title>Author contributions</title>", "<p>J. L., A.A. and Z.C. designed the study. J.L. drafted the manuscript with the help of all co-authors. J.L., Z.C., J.R., and G.T processed the MultiGAS data. S.A., Z.C. and J.L processed the SO2 flux data. D.C., M.L. F.M. and C.L. contributed to the analysis of MODIS satellite data. M.B., J.P. and G.G. contributed to field work, instrument maintenance and data transmission. L.C. provided ash emission records from Nevado del Ruiz between 2018 and 2021. C.L. provided logistical and scientific support.</p>", "<title>Competing interests</title>", "<p id=\"Par40\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Satellite image of Nevado del Ruiz showing the location of MultiGAS (n = 1) and NOVAC stations (n = 5) used in this study. (<bold>A</bold>) Distribution of SO<sub>2</sub> Max concentrations recorded by the MultiGAS station between 2018 and 2021; and (<bold>B</bold>) Wind direction data from the NOVAC network, showing good agreement between the location of the permanent MultiGAS station and the predominant wind direction. On the right, photos taken from the monitoring webcams between 2018 and 2021 are courtesy of the <italic>Observatorio Vulcanológico y Sismológico de Manizales (Servicio Geológico Colombiano).</italic></p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>(<bold>A</bold>) CO<sub>2</sub>/SO<sub>2</sub> compositions (molar); and (<bold>B</bold>) Daily SO<sub>2</sub> fluxes (averages in t/d; NOVAC Network). (<bold>C</bold>) CO<sub>2</sub> fluxes are derived from the combination of SO<sub>2</sub> flux estimates and MultiGAS measurements (see “<xref rid=\"Sec10\" ref-type=\"sec\">Methods</xref>”). The red lines represent a 10-pt. average (<bold>A</bold>–<bold>C</bold>).</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>(<bold>A</bold>) Relative frequency distribution of SO<sub>2</sub> fluxes between 2018–2021 (NOVAC Network; time series shown in Fig. ##FIG##1##2##B); (<bold>B</bold>) The same data is shown for days in which ash emissions were detected (total of events/days = 51; see “<xref rid=\"Sec10\" ref-type=\"sec\">Methods</xref>”). Note that in the occurrence of ash emissions approximately 59% of SO<sub>2</sub> fluxes fall below the 3-year SO<sub>2</sub> flux average of ~ 1570 t/d.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>(<bold>A</bold>) Volcanic Radiative Power (VRP; in MW) retrieved from MODIS (blue markers), and associated cumulative thermal energy (Volcanic Radiant Energy; VRE in Joule). High VRP measurements (Jan-Apr 2020) are highlighted by the shaded red area, and also on the inset for comparison with extrusive events of 2015–2016. (<bold>B</bold>) 2018–2021 Extrusion rates reported in Ordoñez et al. (ref<sup>##UREF##10##13##</sup> for details). On the inset of B, note the good agreement between VRP data (2012–2021; this study) and extrusion rates, especially for the two extrusion rate peaks detected in November 2015 and for most of 2016<sup>##UREF##10##13##</sup>. (<bold>C</bold>) Cumulative volumes of degassed (in Mm<sup>3</sup>), thermally radiant (as V<sub>Thermal</sub>) and extruded magma<sup>##UREF##10##13##</sup> (see “<xref rid=\"Sec10\" ref-type=\"sec\">Methods</xref>” for details on calculations).</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>On the left, H<sub>2</sub>O (wt.%) vs S (ppm) in melt inclusions from 1985–1989 eruptive products. Lines illustrate the model-predicted<sup>##UREF##31##36##</sup> dissolved H<sub>2</sub>O and S contents in the melt along the modelled (<bold>A</bold>) open- (in blue) and (<bold>C</bold>) closed-system (in red) degassing paths in the 250–0.1 pressure range (see supplementary Table ##SUPPL##0##4## for full input parameters). On the right, triangular plot comparing model-predicted (lines) and measured gas compositions in the H<sub>2</sub>O/10-CO<sub>2</sub>*5-S<sub>T</sub>*10 magmatic system for both open- (<bold>B</bold>) and closed-system (<bold>D</bold>) degassing. Note that model runs fit at large both melt inclusion data<sup>##UREF##26##30##</sup> and measured gas compositions.</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Schematic model of shallow conduit processes in play at Nevado del Ruiz, highlighting the discrepancy between magma input (this study) vs output<sup>##UREF##10##13##</sup> rates for the 2018–2021 period. Model-predicted, pressure-dependent evolution of the CO<sub>2</sub>/S<sub>T</sub> ratio in the magmatic gas coexisting with a Nevado del Ruiz-like melts is shown for the model runs in Fig. ##FIG##4##5##. Note that the exsolution depths yield by our model runs agree with reservoir depths inferred in the literature<sup>##REF##28127058##10##,##UREF##33##38##</sup>.</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>Magma output/input ratio (2018–2021), and CO<sub>2</sub> and SO<sub>2</sub> cumulative masses distinguish periods dominated by CO<sub>2</sub> flushing (deep) and steady-state degassing, with occasional overflow (minor dome extrusion events) of the magma column. Note that, given the good agreement between extrusion rates<sup>##UREF##10##13##</sup>and VRP data between 2012 and 2021 (see Fig. ##FIG##3##4##B), we use here magma output rate as TADR (in m/s; see “<xref rid=\"Sec10\" ref-type=\"sec\">Methods</xref>”) to identify periods of higher extrusion rates between 2018 and 2021.</p></caption></fig>" ]
[]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\text{CO}}_{2} \\,{\\text{flux}} = {\\raise0.7ex\\hbox{${{\\text{CO}}_{2} }$} \\!\\mathord{\\left/ {\\vphantom {{{\\text{CO}}_{2} } {{\\text{O}}_{2} }}}\\right.\\kern-\\nulldelimiterspace} \\!\\lower0.7ex\\hbox{${{\\text{O}}_{2} }$}} \\times {\\text{SO}}_{2} \\,{\\text{flux}}\\left( {{\\text{t}}\\,{\\text{d}}^{{ - 1}} } \\right)$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mrow><mml:msub><mml:mtext>CO</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mspace width=\"0.166667em\"/><mml:mtext>flux</mml:mtext><mml:mo>=</mml:mo><mml:mrow><mml:mfrac bevelled=\"true\"><mml:msub><mml:mtext>CO</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub></mml:mfrac></mml:mrow><mml:mo>×</mml:mo><mml:msub><mml:mtext>SO</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mspace width=\"0.166667em\"/><mml:mtext>flux</mml:mtext><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mtext>t</mml:mtext><mml:mspace width=\"0.166667em\"/><mml:msup><mml:mrow><mml:mtext>d</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\text{S}}}_{\\mathrm{flux }}\\left(\\mathrm{kg }{{\\text{s}}}^{-1}\\right)= \\frac{{\\text{M}}({\\text{S}})}{{\\text{M}}({{\\text{SO}}}_{2})} \\times (\\frac{{{\\text{SO}}}_{2 }\\mathrm{flux }\\left(\\mathrm{in t }{{\\text{d}}}^{-1}\\right) \\times 1000}{24 \\times 60 \\times 60}$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mrow><mml:msub><mml:mtext>S</mml:mtext><mml:mi mathvariant=\"normal\">flux</mml:mi></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi mathvariant=\"normal\">kg</mml:mi><mml:msup><mml:mrow><mml:mtext>s</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>M</mml:mtext><mml:mo stretchy=\"false\">(</mml:mo><mml:mtext>S</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mtext>M</mml:mtext><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mtext>SO</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mfrac><mml:mrow><mml:mo>×</mml:mo><mml:mo stretchy=\"false\">(</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mtext>SO</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mi mathvariant=\"normal\">flux</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"normal\">in</mml:mi><mml:mi mathvariant=\"normal\">t</mml:mi></mml:mrow><mml:msup><mml:mrow><mml:mtext>d</mml:mtext></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mfenced><mml:mo>×</mml:mo><mml:mn>1000</mml:mn></mml:mrow><mml:mrow><mml:mn>24</mml:mn><mml:mo>×</mml:mo><mml:mn>60</mml:mn><mml:mo>×</mml:mo><mml:mn>60</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${V }_{Thermal}=\\frac{VRE}{{C}_{rad}}$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">Thermal</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant=\"italic\">VRE</mml:mi></mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">rad</mml:mi></mml:mrow></mml:msub></mml:mfrac></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${C}_{rad}$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">rad</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${C}_{rad}$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">rad</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${V}_{degassed }= \\frac{S flux \\left(in kg {s}^{-1}\\right)}{\\Delta XS \\times \\rho m \\times \\phi }$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">degassed</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>S</mml:mi><mml:mi>f</mml:mi><mml:mi>l</mml:mi><mml:mi>u</mml:mi><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>k</mml:mi><mml:mi>g</mml:mi><mml:msup><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mfenced></mml:mrow><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>X</mml:mi><mml:mi>S</mml:mi><mml:mo>×</mml:mo><mml:mi>ρ</mml:mi><mml:mi>m</mml:mi><mml:mo>×</mml:mo><mml:mi>ϕ</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mi>ρ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$TADR=\\frac{VRP}{{C}_{rad}}$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mrow><mml:mi>T</mml:mi><mml:mi>A</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant=\"italic\">VRP</mml:mi></mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">rad</mml:mi></mml:mrow></mml:msub></mml:mfrac></mml:mrow></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51380_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51380_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51380_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51380_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51380_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2024_51380_Fig6_HTML\" id=\"MO6\"/>", "<graphic xlink:href=\"41598_2024_51380_Fig7_HTML\" id=\"MO7\"/>", "<inline-graphic xlink:href=\"41598_2024_51380_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51380_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51380_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51380_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51380_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51380_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51380_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51380_Article_IEq8.gif\"/>" ]
[ "<media xlink:href=\"41598_2024_51380_MOESM1_ESM.xlsx\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["1."], "surname": ["Aiuppa"], "given-names": ["A"], "article-title": ["Volcanic-gas monitoring"], "source": ["Volcanism and Global Environmental Change"], "year": ["2015"], "publisher-name": ["Cambridge University Press"], "fpage": ["81"], "lpage": ["96"]}, {"label": ["2."], "surname": ["Aiuppa"], "given-names": ["A"], "article-title": ["A CO"], "sub": ["2"], "source": ["Geochem. Geophys. Geosyst."], "year": ["2017"], "volume": ["18"], "fpage": ["2120"], "lpage": ["2132"], "pub-id": ["10.1002/2017GC006892"]}, {"label": ["3."], "surname": ["Edmonds", "Herd", "Galle", "Oppenheimer"], "given-names": ["M", "RA", "B", "CM"], "article-title": ["Automated, high time resolution measurements of SO"], "sub": ["2"], "source": ["Montserrat. Bull. Volcanol."], "year": ["2003"], "volume": ["65"], "fpage": ["578"], "lpage": ["586"], "pub-id": ["10.1007/s00445-003-0286-x"]}, {"label": ["4."], "surname": ["Edmonds"], "given-names": ["M"], "article-title": ["Geochemical monitoring of volcanoes and the mitigation of volcanic gas hazards"], "source": ["Forecast. Plan. Volcan. Hazards Risks Disasters"], "year": ["2021"], "volume": ["2"], "fpage": ["117"], "lpage": ["151"], "pub-id": ["10.1016/B978-0-12-818082-2.00004-4"]}, {"label": ["5."], "surname": ["Hall"], "given-names": ["ML"], "article-title": ["Chronology of the principal scientific and governmental actions leading up to the November 13, 1985 eruption of Nevado del Ruiz, Colombia"], "source": ["J. Volcanol. Geoth. Res."], "year": ["1990"], "volume": ["42"], "fpage": ["101"], "lpage": ["115"], "pub-id": ["10.1016/0377-0273(90)90072-N"]}, {"label": ["6."], "surname": ["Voight"], "given-names": ["B"], "article-title": ["The 1985 Nevado del Ruiz volcano catastrophe: anatomy and retrospection"], "source": ["J. Volcanol. Geoth. Res."], "year": ["1990"], "volume": ["42"], "fpage": ["151"], "lpage": ["188"], "pub-id": ["10.1016/0377-0273(90)90075-Q"]}, {"label": ["7."], "surname": ["Thouret", "Cantagrel", "Salinas", "Murcia"], "given-names": ["JC", "JM", "R", "A"], "article-title": ["Quaternary eruptive history of Nevado del Ruiz (Colombia)"], "source": ["J. Volcanol. Geoth. Res."], "year": ["1990"], "volume": ["41"], "fpage": ["225"], "lpage": ["251"], "pub-id": ["10.1016/0377-0273(90)90090-3"]}, {"label": ["8."], "surname": ["Casta\u00f1o"], "given-names": ["LM"], "article-title": ["Continuous monitoring of the 2015\u20132018 Nevado del Ruiz activity, Colombia, using satellite infrared images and local infrasound records"], "source": ["Earth Planets Space"], "year": ["2020"], "volume": ["72"], "fpage": ["81"], "pub-id": ["10.1186/s40623-020-01197-z"]}, {"label": ["9."], "surname": ["Federico"], "given-names": ["C"], "article-title": ["Vapour discharges on Nevado del Ruiz during the recent activity: Clues on the composition of the deep hydrothermal system and its effects on thermal springs"], "source": ["J. Volcanol. Geoth. Res."], "year": ["2017"], "volume": ["346"], "fpage": ["40"], "lpage": ["53"], "pub-id": ["10.1016/j.jvolgeores.2017.04.007"]}, {"label": ["12."], "surname": ["Londono", "Galvis"], "given-names": ["JM", "B"], "article-title": ["Seismic data, photographic images and physical modeling of volcanic plumes as a tool for monitoring the activity of Nevado del Ruiz Volcano"], "source": ["Front. Earth Sci."], "year": ["2018"], "volume": ["6"], "fpage": ["162"], "pub-id": ["10.3389/feart.2018.00162"]}, {"label": ["13."], "surname": ["Ordo\u00f1ez", "Laverde", "Battaglia"], "given-names": ["M", "C", "M"], "article-title": ["The new lava dome growth of Nevado del Ruiz (2015\u20132021)"], "source": ["J. Volcanol. Geoth. Res."], "year": ["2022"], "volume": ["430"], "fpage": ["107626"], "pub-id": ["10.1016/j.jvolgeores.2022.107626"]}, {"label": ["14."], "surname": ["Sparks"], "given-names": ["J"], "article-title": ["Causes and consequences of pressurization in lava dome eruptions"], "source": ["Earth Planet. Sci. Lett."], "year": ["1997"], "volume": ["150"], "fpage": ["177"], "lpage": ["189"], "pub-id": ["10.1016/S0012-821X(97)00109-X"]}, {"label": ["15."], "surname": ["Stix", "Calvache V", "Williams"], "given-names": ["J", "ML", "SN"], "article-title": ["Galeras volcano Colombia interdisciplinary study of a Decade Volcano"], "source": ["J. Volcanol. Geotherm. Res."], "year": ["1997"], "volume": ["77"], "fpage": ["1"], "lpage": ["4"], "pub-id": ["10.1016/S0377-0273(96)00082-0"]}, {"label": ["16."], "surname": ["Coppola"], "given-names": ["D"], "article-title": ["Shallow magma convection evidenced by excess degassing and thermal radiation during the dome-forming Sabancaya eruption (2012\u20132020)"], "source": ["Bull. Volcanol."], "year": ["2022"], "volume": ["84"], "fpage": ["16"], "pub-id": ["10.1007/s00445-022-01523-1"]}, {"label": ["17."], "surname": ["Campion"], "given-names": ["R"], "article-title": ["Breathing and coughing: The extraordinarily high degassing of popocat\u00e9petl volcano investigated with an SO"], "sub": ["2"], "source": ["Front. Earth Sci."], "year": ["2018"], "volume": ["6"], "fpage": ["163"], "pub-id": ["10.3389/feart.2018.00163"]}, {"label": ["19."], "surname": ["Lages"], "given-names": ["J"], "article-title": ["Volcanic gas emissions along the Colombian arc segment of the northern volcanic zone (CAS-NVZ): Implications for volcano monitoring and volatile budget of the Andean Volcanic Belt"], "source": ["Geochem. Geophys. Geosyst."], "year": ["2019"], "volume": ["20"], "fpage": ["5057"], "lpage": ["5081"], "pub-id": ["10.1029/2019GC008573"]}, {"label": ["20."], "surname": ["Stix"], "given-names": ["J"], "article-title": ["Understanding fast and slow unrest at volcanoes and implications for eruption forecasting"], "source": ["Front. Earth Sci."], "year": ["2018"], "volume": ["6"], "fpage": ["163"], "pub-id": ["10.3389/feart.2018.00056"]}, {"label": ["21."], "surname": ["Shinohara"], "given-names": ["H"], "article-title": ["A new technique to estimate volcanic gas composition: Plume measurements with a portable multi-sensor system"], "source": ["J. Volcanol. Geoth. Res."], "year": ["2005"], "volume": ["143"], "fpage": ["319"], "lpage": ["333"], "pub-id": ["10.1016/j.jvolgeores.2004.12.004"]}, {"label": ["22."], "surname": ["Aiuppa", "Federico", "Giudice", "Gurrieri"], "given-names": ["A", "C", "G", "S"], "article-title": ["Chemical mapping of a fumarolic field: La Fossa Crater, Vulcano Island (Aeolian Islands, Italy)"], "source": ["Geophys. Res. Lett."], "year": ["2005"], "volume": ["32"], "fpage": ["1"], "lpage": ["4"], "pub-id": ["10.1029/2005GL023207"]}, {"label": ["23."], "surname": ["Galle"], "given-names": ["B"], "article-title": ["Network for observation of volcanic and atmospheric change (NOVAC)-a global network for volcanic gas monitoring: Network layout and instrument description"], "source": ["J. Geophys. Res. Atmos."], "year": ["2010"], "volume": ["115"], "fpage": ["1"], "lpage": ["19"], "pub-id": ["10.1029/2009JD011823"]}, {"label": ["24."], "surname": ["Coppola", "Laiolo", "Cigolini", "Delle Donne", "Ripepe"], "given-names": ["D", "M", "C", "D", "M"], "article-title": ["Enhanced volcanic hot-spot detection using MODIS IR data: Results from the MIROVA system"], "source": ["Geol. Soc. Spec. Publ."], "year": ["2016"], "volume": ["426"], "fpage": ["181"], "lpage": ["205"], "pub-id": ["10.1144/SP426.5"]}, {"label": ["25."], "surname": ["Aiuppa", "Fischer", "Plank", "Robidoux", "Di Napoli"], "given-names": ["A", "TP", "T", "P", "R"], "article-title": ["Along-arc, inter-arc and arc-to-arc variations in volcanic gas CO"], "sub": ["2", "T"], "source": ["Earth Sci. Rev."], "year": ["2017"], "volume": ["168"], "fpage": ["24"], "lpage": ["47"], "pub-id": ["10.1016/j.earscirev.2017.03.005"]}, {"label": ["26."], "surname": ["Plank"], "given-names": ["T"], "article-title": ["The Chemical Composition of Subducting Sediments"], "source": ["Treatise on Geochemistry"], "year": ["2014"], "edition": ["2"], "publisher-name": ["Elsevier"], "fpage": ["607"], "lpage": ["629"]}, {"label": ["27."], "surname": ["Symonds", "Gerlach", "Reed"], "given-names": ["RB", "TM", "MH"], "article-title": ["Magmatic gas scrubbing: Implications for volcano monitoring"], "source": ["J. Volcanol. Geoth. Res."], "year": ["2001"], "volume": ["108"], "fpage": ["303"], "lpage": ["341"], "pub-id": ["10.1016/S0377-0273(00)00292-4"]}, {"label": ["28."], "surname": ["Casas"], "given-names": ["AS"], "article-title": ["SO"], "sub": ["2"], "source": ["Geochim. Cosmochim. Acta"], "year": ["2019"], "volume": ["257"], "fpage": ["150"], "lpage": ["162"], "pub-id": ["10.1016/j.gca.2019.04.013"]}, {"label": ["29."], "surname": ["Aiuppa"], "given-names": ["A"], "article-title": ["A model of degassing for Stromboli volcano"], "source": ["Earth Planet. Sci. Lett."], "year": ["2010"], "volume": ["295"], "fpage": ["195"], "lpage": ["204"], "pub-id": ["10.1016/j.epsl.2010.03.040"]}, {"label": ["30."], "surname": ["Stix", "Layne", "Williams"], "given-names": ["J", "GD", "SN"], "article-title": ["Mechanisms of degassing at Nevado del Ruiz volcano, Colombia"], "source": ["J. Geol. Soc."], "year": ["2003"], "volume": ["160"], "fpage": ["507"], "lpage": ["521"], "pub-id": ["10.1144/0016-764902-028"]}, {"label": ["31."], "surname": ["Gourgaud", "Thouret"], "given-names": ["A", "JC"], "article-title": ["Magma mixing and petrogenesis of the 13 November 1985 eruptive products at Nevado del Ruiz (Colombia)"], "source": ["J. Volcanol. Geoth. Res."], "year": ["1990"], "volume": ["41"], "fpage": ["79"], "lpage": ["96"], "pub-id": ["10.1016/0377-0273(90)90084-S"]}, {"label": ["32."], "surname": ["Melson"], "given-names": ["WG"], "article-title": ["Water contents, temperatures and diversity of the magmas of the catastrophic eruption of Nevado del Ruiz, Colombia, November 13, 1985"], "source": ["J. Volcanol. Geoth. Res."], "year": ["1990"], "volume": ["41"], "fpage": ["97"], "lpage": ["126"], "pub-id": ["10.1016/0377-0273(90)90085-T"]}, {"label": ["33."], "surname": ["Sigurdsson", "Carey", "Palais", "Devine"], "given-names": ["H", "S", "JM", "J"], "article-title": ["Pre-eruption compositional gradients and mixing of andesite and dacite magma erupted from Nevado del Ruiz Volcano, Colombia in 1985"], "source": ["J. Volcanol. Geoth. Res."], "year": ["1990"], "volume": ["41"], "fpage": ["127"], "lpage": ["151"], "pub-id": ["10.1016/0377-0273(90)90086-U"]}, {"label": ["35."], "surname": ["Wallace"], "given-names": ["PJ"], "article-title": ["Volatiles in subduction zone magmas: Concentrations and fluxes based on melt inclusion and volcanic gas data"], "source": ["J. Volcanol. Geotherm. Res."], "year": ["2005"], "volume": ["140"], "fpage": ["217"], "lpage": ["240"], "pub-id": ["10.1016/j.jvolgeores.2004.07.023"]}, {"label": ["36."], "surname": ["Moretti", "Papale", "Ottonello"], "given-names": ["R", "P", "G"], "article-title": ["A model for the saturation of C-O-H-S fluids in silicate melts"], "source": ["Geol. Soc. Spec. Publ."], "year": ["2003"], "volume": ["213"], "fpage": ["81"], "lpage": ["101"], "pub-id": ["10.1144/GSL.SP.2003.213.01.06"]}, {"label": ["37."], "surname": ["Moretti", "Papale"], "given-names": ["R", "P"], "article-title": ["On the oxidation state and volatile behavior in multicomponent gas-melt equilibria"], "source": ["Chem. Geol."], "year": ["2004"], "volume": ["213"], "fpage": ["265"], "lpage": ["280"], "pub-id": ["10.1016/j.chemgeo.2004.08.048"]}, {"label": ["38."], "surname": ["Edmonds", "Liu", "Cashman"], "given-names": ["M", "EJ", "KV"], "article-title": ["Open-vent volcanoes fuelled by depth-integrated magma degassing"], "source": ["Bull. Volcanol."], "year": ["2022"], "volume": ["84"], "fpage": ["28"], "pub-id": ["10.1007/s00445-021-01522-8"]}, {"label": ["39."], "surname": ["Coppola", "Laiolo", "Piscopo", "Cigolini"], "given-names": ["D", "M", "D", "C"], "article-title": ["Rheological control on the radiant density of active lava flows and domes"], "source": ["J. Volcanol. Geotherm. Res."], "year": ["2013"], "volume": ["249"], "fpage": ["39"], "lpage": ["48"], "pub-id": ["10.1016/j.jvolgeores.2012.09.005"]}, {"label": ["40."], "mixed-citation": ["Shinohara, H. Excess degassing from volcanoes and its role on eruptive and intrusive activity. "], "italic": ["Rev. Geophys."], "bold": ["46"]}, {"label": ["41."], "surname": ["Lopez"], "given-names": ["T"], "article-title": ["New insights into the magmatic-hydrothermal system and volatile budget of Lastarria volcano, Chile: Integrated results from the 2014 IAVCEI CCVG 12th volcanic gas workshop"], "source": ["Geosphere"], "year": ["2018"], "volume": ["14"], "fpage": ["983"], "lpage": ["1007"], "pub-id": ["10.1130/GES01495.1"]}, {"label": ["42."], "surname": ["Arellano"], "given-names": ["SR"], "article-title": ["Degassing patterns of Tungurahua volcano (Ecuador) during the 1999\u20132006 eruptive period, inferred from remote spectroscopic measurements of SO"], "sub": ["2"], "source": ["J. Volcanol. Geotherm. Res."], "year": ["2008"], "volume": ["176"], "fpage": ["151"], "lpage": ["162"], "pub-id": ["10.1016/j.jvolgeores.2008.07.007"]}, {"label": ["43."], "surname": ["Williams"], "given-names": ["SN"], "article-title": ["Sulfur dioxide from Nevado del Ruiz volcano, Colombia: Total flux and isotopic constraints on its origin"], "source": ["J. Volcanol. Geotherm. Res."], "year": ["1990"], "volume": ["42"], "fpage": ["53"], "lpage": ["68"], "pub-id": ["10.1016/0377-0273(90)90069-R"]}, {"label": ["44."], "surname": ["Krueger", "Walter", "Schnetzler", "Doiron"], "given-names": ["AJ", "LS", "CC", "SD"], "article-title": ["TOMS measurement of the sulfur dioxide emitted during the 1985 Nevado del Ruiz eruptions"], "source": ["J. Volcanol. Geotherm. Res."], "year": ["1990"], "volume": ["41"], "fpage": ["7"], "lpage": ["15"], "pub-id": ["10.1016/0377-0273(90)90081-P"]}, {"label": ["46."], "surname": ["Giggenbach"], "given-names": ["WF"], "article-title": ["The chemistry of fumarolic vapor and thermal-spring discharges from the Nevado del Ruiz volcanic-magmatic- hydrothermal system, Colombia"], "source": ["J. Volcanol. Geotherm. Res."], "year": ["1990"], "volume": ["42"], "fpage": ["13"], "lpage": ["39"], "pub-id": ["10.1016/0377-0273(90)90067-P"]}, {"label": ["47."], "surname": ["Sturchio", "Williams", "Garcia", "Londono"], "given-names": ["NC", "SN", "NP", "AC"], "article-title": ["The hydrothermal system of Nevado del Ruiz volcano Colombia"], "source": ["Bull. Volcanol."], "year": ["1988"], "volume": ["50"], "fpage": ["399"], "lpage": ["412"], "pub-id": ["10.1007/BF01050639"]}, {"label": ["48."], "surname": ["Lages"], "given-names": ["J"], "article-title": ["Noble gas magmatic signature of the Andean Northern Volcanic Zone from fluid inclusions in minerals"], "source": ["Chem. Geol."], "year": ["2021"], "volume": ["559"], "fpage": ["119966"], "pub-id": ["10.1016/j.chemgeo.2020.119966"]}, {"label": ["51."], "surname": ["Lages"], "given-names": ["J"], "article-title": ["First in-situ measurements of plume chemistry at Mount Garet volcano, island of Gaua (Vanuatu)"], "source": ["Appl. Sci."], "year": ["2020"], "volume": ["10"], "fpage": ["1"], "lpage": ["15"], "pub-id": ["10.3390/app10207293"]}, {"label": ["52."], "surname": ["Buck"], "given-names": ["AL"], "article-title": ["New equations for computing vapor pressure and enhancement factor"], "source": ["J. Appl. Meteorol. Climatol."], "year": ["1981"], "volume": ["20"], "fpage": ["1527"], "lpage": ["1532"], "pub-id": ["10.1175/1520-0450(1981)020<1527:NEFCVP>2.0.CO;2"]}, {"label": ["53."], "surname": ["Tamburello"], "given-names": ["G"], "article-title": ["Ratiocalc: Software for processing data from multicomponent volcanic gas analyzers"], "source": ["Comput. Geosci."], "year": ["2015"], "volume": ["82"], "fpage": ["63"], "lpage": ["67"], "pub-id": ["10.1016/j.cageo.2015.05.004"]}, {"label": ["54."], "surname": ["Galle"], "given-names": ["B"], "article-title": ["A miniaturised ultraviolet spectrometer for remote sensing of SO"], "sub": ["2"], "source": ["J. Volcanol. Geotherm. Res."], "year": ["2003"], "volume": ["119"], "fpage": ["241"], "lpage": ["254"], "pub-id": ["10.1016/S0377-0273(02)00356-6"]}, {"label": ["55."], "surname": ["Arellano"], "given-names": ["S"], "article-title": ["Synoptic analysis of a decade of daily measurements of SO"], "sub": ["2"], "source": ["Earth Syst. Sci. Data"], "year": ["2021"], "volume": ["13"], "fpage": ["1167"], "lpage": ["1188"], "pub-id": ["10.5194/essd-13-1167-2021"]}, {"label": ["56."], "surname": ["Laiolo"], "given-names": ["M"], "article-title": ["Shallow magma dynamics at open-vent volcanoes tracked by coupled thermal and SO"], "sub": ["2"], "source": ["Earth Planet. Sci. Lett."], "year": ["2022"], "volume": ["594"], "fpage": ["117726"], "pub-id": ["10.1016/j.epsl.2022.117726"]}]
{ "acronym": [], "definition": [] }
56
CC BY
no
2024-01-14 23:40:17
Sci Rep. 2024 Jan 12; 14:1230
oa_package/78/85/PMC10786892.tar.gz
PMC10786893
38216694
[ "<title>Introduction</title>", "<p id=\"Par2\">The analysis of stochastic processes has been a fundamental problem of interest in many research fields for decades. Examples of such processes include fluctuations of wind and solar power systems<sup>##UREF##0##1##</sup>, fluctuations in the porosity and permeability of porous media<sup>##UREF##1##2##</sup>, price fluctuations<sup>##UREF##2##3##</sup> and heart rate fluctuations<sup>##REF##19669455##4##</sup>, which range from physics to engineering, economics and medicine. The analysis and modeling of such stochastic processes is not only aimed at better understanding their physics, but also helps to predict their future state in a probabilistic sense.</p>", "<p id=\"Par3\">In order to model complex systems non-parametrically, it is necessary to determine the properties and strength of the fluctuating forces from measured time series. This leads to the question: Given a fluctuating set of experimentally measured data, how should one uncover the features of the fluctuations, and construct a dynamical stochastic equation that can describe the random variation of the measured data set? So far, considerable progress has been made to answer this question. One of the first steps was taken by presenting the Langevin equation to describe the random evolution of continuous diffusive processes<sup>##UREF##3##5##</sup>. However, the boundaries of stochastic processes extend beyond purely diffusive processes, and often include other processes with jump discontinuities<sup>##UREF##4##6##</sup>. In recent years, with the aim of going beyond the limited scope of continuous processes, Langevin modeling has been improved. In this regard, by focusing on processes involving jump discontinuities, the classical Langevin equation was extended, and discontinuous processes were modeled via the jump-diffusion equation<sup>##REF##31962437##7##,##REF##27759055##8##</sup>. A jump-diffusion equation includes both diffusion contributions as well as random jumps, and is able to describe the random evolution of discontinuous processes<sup>##UREF##5##9##</sup>. On the other hand, when dealing with data sampled at discrete times, one encounters successive discontinuities along the trajectory of the sampled time series, even when the underlying path is continuous<sup>##UREF##6##10##</sup>. Therefore, in such a case, one cannot initially be sure which equation to use for modeling, unless the diagnostic criteria presented in this context are used, which also has its own difficulties<sup>##UREF##7##11##</sup>.</p>", "<p id=\"Par4\">The aim of this article is to introduce and discuss a new dynamical stochastic equation in which any variation in the path of the sampled time series is attributed to a jump event, regardless of whether the given time series belongs to the class of continuous processes or not. We will discuss our dynamical stochastic equation in the next sections, but before that, let us first explain how continuous and discontinuous stochastic processes are defined mathematically.</p>", "<p id=\"Par5\">By definition, a process is called continuous if its Kramers-Moyal (KM) conditional moments , where denotes averaging over the conditional distribution, satisfy in the following relations for small time increments <sup>##UREF##8##12##</sup>:where contains all terms above the first-order of , which means that vanishes when . Also are known as Kramers-Moyal (KM) coefficients, and defined by the following relation:that can be estimated directly from measured data set<sup>##UREF##9##13##,##UREF##10##14##</sup>. It should be noted that these definitions of KM coefficients differ from common definitions in books or articles by a factor of <sup>##UREF##8##12##,##UREF##11##15##</sup>.</p>", "<p id=\"Par6\">It is evident from (1) that for a continuous process only two KM coefficients and are non-vanishing when . As a result, with vanishing higher-order KM coefficients, especially , one can ensure that is continuous in the statistical sense. (indeed according to the Pawula theorem when vanishes, all other KM coefficients for will also vanish<sup>##UREF##8##12##,##UREF##12##16##</sup>).</p>", "<title>The Langevin equation</title>", "<p id=\"Par7\">The Langevin Equation is a widely used equation for modeling a continuous diffusion process. The Langevin dynamics produces a continuous sample path, and has the following expression using the Itô’s calculus for stochastic integrals<sup>##UREF##13##17##,##UREF##14##18##</sup>:</p>", "<p id=\"Par8\">In this equation, is the state variable of the process, and is a scalar Wiener process. Additionally, and denote the first and second-order KM coefficients that are known as the drift and diffusion terms, respectively, and are obtained from Eq. (##FORMU##10##2##) as follows:</p>", "<p id=\"Par9\">These coefficients are estimated directly from measured time series.</p>", "<title>The jump-diffusion equation</title>", "<p id=\"Par10\">Many stochastic processes are not classified as continuous processes<sup>##REF##8971198##19##–##REF##29298987##22##</sup>, and therefore the use of the Langevin equation is not justified for them. In general, non-vanishing means that there are discontinuities in the trajectory of the time series, and jump events have a very important role in the underlying process. It is therefore necessary to improve Langevin equation to model discontinuous processes. One of the best generalizations of the classical Langevin equation that can create a discontinuous sample path is written as follows<sup>##REF##27759055##8##,##UREF##6##10##</sup>:where again is a scalar Wiener process, while and are the deterministic drift, and the diffusion coefficients (the j index denotes jumpy behavior, and is used to distinguish these KM coefficients from those defined in continuous processes), and is a Poisson jump process<sup>##UREF##17##23##</sup>. The jump has rate and size , which can have any symmetric distribution with finite even-order statistical moments, e.g. Gaussian distribution. It is shown that all the coefficients and parameters required in this modeling can be found directly from the measured time series by estimating the KM coefficients as follows<sup>##REF##27759055##8##,##UREF##6##10##</sup>:</p>", "<p id=\"Par11\">Assuming that is a random variable with a Gaussian distribution, i.e. as well as using the relation for the Gaussian random variables in the last relation in Eq. (##FORMU##34##6##) for and , the amplitude of the jump , and the rate of the jump are estimated to be as follows:</p>", "<p id=\"Par12\">By obtaining the jump parameters and and using them in the second relation of Eq. (##FORMU##34##6##), the diffusion coefficient is determined. In addition, the first relation in Eq. (##FORMU##34##6##) gives by estimating from the data. There are numerous studies regarding the use of the jump-diffusion Eq. (##FORMU##27##5##), which describe the random evolution of neuron dynamics<sup>##REF##8971198##19##,##UREF##15##20##</sup>, stochastic resonance<sup>##UREF##16##21##</sup> and climate data<sup>##REF##29298987##22##</sup>.</p>", "<title>Distinguishing between purely diffusive and jump-diffusion processes</title>", "<p id=\"Par13\">In the sample path of many empirical time series, it is often observed that fluctuations are interrupted by sudden long-amplitude jumps between different states of a system<sup>##UREF##18##24##</sup>. The studies have shown that empirical detection of jumps is difficult because, in the real world, only discrete data from continuous-time models are available. In general, when data sampled at discrete intervals a sequence of discontinuous jump events will appear in the sampled path, even though the underlying path is continuous. The study on higher-order temporal approximations of KM conditional moments has shown that a finite sampling affects all the KM coefficients<sup>##REF##11736582##25##–##UREF##20##27##</sup>. Such studies have found that even for diffusive processes, non-vanishing higher-order conditional moments (&gt; 2) can originate from a discrete sampling. Therefore, the Pawula theorem cannot be used to judge whether the given time series falls under the classification of diffusion processes or jump-diffusion processes. This means that when analyzing empirical time series, one cannot be immediately ensure which dynamical Eq. (##FORMU##10##2##) or (##FORMU##20##3##) is appropriate for modeling the corresponding time series, unless one uses the diagnostic criteria presented in this context. For Langevin and Jump-Diffusion dynamics, there are criteria that can be used to check whether a given time series is inherently continuous or discontinuous. Here are two of the widely used criteria:</p>", "<p id=\"Par14\">1- The first criterion for distinguishing between purely diffusive and jump-diffusion processes is the use of the ratio. This criterion was introduced by Lehnertz et al<italic>.</italic><sup>##UREF##7##11##</sup>. Their results show that this ratio is close to 1 for diffusive processes and for small , but for jump-diffusion processes it diverges to 1/τ, namely:</p>", "<p id=\"Par15\">As it can be seen, using and will be problematic to detect jumps in the range of small time interval τ. In such a case, the next criterion can be used.</p>", "<p id=\"Par16\">2- The second criterion to distinguish diffusive from jump-diffusion processes is based on the ratio of the fourth- and sixth-order KM conditional moments known as the Q-ratio, which was introduced in the same article<sup>##UREF##7##11##</sup> by Lehnertz et al<italic>.</italic> as follows:</p>", "<p id=\"Par17\">Using expansion of the KM conditional moments in terms of , they found that when the process is purely diffusive (Linearly dependent on ), while when the process has a jumpy behavior, (constant and independent of ), where is the diffusion coefficient, and is the jump amplitude in jump-diffusion modeling.</p>", "<p id=\"Par18\">In summary, by estimating the following -ratio from the data, one can be sure which dynamical Equation is appropriate to model the given time series:</p>", "<p id=\"Par19\">In the next sections after introducing our dynamical stochastic equation, we will also define a new criterion to differentiate diffusion processes from jump-diffusion processes.</p>" ]
[ "<title>Introducing the proposed method and results</title>", "<p id=\"Par20\">As mentioned, when analyzing a time series sampled with time intervals , successive discontinuities in the sampled path are observed, despite the fact that the underlying path is continuous<sup>##UREF##7##11##</sup>. In addition, one of the main problems when using data sampled at discrete times is the distinction between discontinuities caused by continuous stochastic processes, and genuine discontinuities in the sample path of time series that were caused by finite sampling of continuous stochastic processes<sup>##UREF##7##11##</sup>. Some points like this raise the question: <italic>Is it possible to use only jump-drift processes to describe the random evolution of a time series sampled with finite time intervals </italic><italic>?</italic> To address this question, we introduce a new modeling that attributes any stochastic variation in the sample path of a given time series to a jump event, regardless of whether the underlying trajectory is continuous or not. Based on this, we build a new dynamical stochastic equation, and call it the jump-jump equation, which in its general form includes a deterministic drift term and several stochastic terms with jumpy behaviors as follows:where indicates the deterministic part of the process and are Poisson jump processes. The jumps have rates and sizes , which we assume they have zero mean Gaussian distributions with variances (amplitudes), respectively. We start with the simplest form of Eq. (##FORMU##66##10##), which includes a drift term and only a jump process. It will be shown that such a jump-drift equation is able to model time series that are classified as continuous processes. Afterwards, we extend modeling by considering more jump processes in Eq. (##FORMU##66##10##), and use it to model time series with more varied amplitudes. In each step, we will demonstrate that all unknown coefficients and functions involved in this model can be derived directly from the measured time series data.</p>", "<title>Jump-drift modeling</title>", "<p id=\"Par21\">We now consider Eq. (##FORMU##66##10##) with a drift term and a jump process (a jump-drift equation), and show that it can be used to model time series belonging to the class of continuous processes when the data are sampled at discrete intervals. The general form of a jump-drift equation is as follows:where denotes the drift part of the process, and is a Poisson jump process characterized by the rate and the size . We assume that is a random variable, and has a zero mean Gaussian distribution, i.e. . The variance of this distribution () is called the jump amplitude, and in general may depend on and . We will show that all unknown parameters and functions required in this modeling can be estimated based on a data-driven approach from measured time series. Before doing so, it is necessary to mention two points:</p>", "<p id=\"Par22\">1) We assume the case that is a homogeneous Poisson jump process with a constant jump rate . The jump rate represents the expected number of jumps that will occur per unit time. It follows that the number of jumps occurring in the interval of follows a Poisson distribution with the associated parameter . On the other hand, a jump event has two states of occurrence 1 and non-occurrence 0, of which only one will occur in each infinitesimal . The last point shows that in the Poisson process, the occurrence of an event in each small interval of time is defined as a Bernoulli variable. That is, takes only the values 1 and 0 with probabilities and , respectively.</p>", "<p id=\"Par23\">2) Up to the first orders in the statistical moments of are given by the following relation<sup>##REF##27759055##8##,##UREF##6##10##</sup>:</p>", "<p id=\"Par24\">With these two points in mind, we now present a data-driven approach to estimate the drift and jump properties required in this modeling. This method can be used for both stationary and non-stationary time series, and the results are applicable to both.</p>", "<title>Non-parametric estimation of jump-drift processes.</title>", "<title>Theorem 1</title>", "<p id=\"Par25\">For a jump-drift process described by the dynamical Eq. (##FORMU##72##11##), all the functions and parameters required to model the process can be estimated non-parametrically by estimating KM coefficients from measured time series as follows:</p>", "<p>We have provided a proof for this theorem in the appendix. For non-stationary processes, all functions and parameters are time-dependent, but in the following, we focus on stationary processes, and omit the t-dependence in Eq. (##FORMU##93##12##) to improve readability.</p>", "<p>We can estimate the drift function using the first relation in (##FORMU##93##12##). The jump amplitude and the jump rate can be estimated using the relation for the Gaussian random variable in the last relation in Eq. (##FORMU##93##12##) with and . Therefore, we have:</p>", "<p>where </p>", "<p>We now argue that if Eq. (##FORMU##72##11##) is able to describe the random evolution of a sampled time series belonging to the class of diffusion processes, then the following conditions should be held:<list list-type=\"order\"><list-item><p id=\"Par30\"> The last relation in (##FORMU##93##12##) in terms of conditional moments is written as follows:where with and it leads to:</p><p id=\"Par31\">Extracting the ratio from these relations leads to:</p><p id=\"Par32\">On the other hand, we know from Eq. (##FORMU##51##8##) that this ratio is approximately equal to 1 in diffusion processes for small , as a result:</p><p id=\"Par33\">This criterion can be used as a possibility for numerical verification of Pawula theorem. Employing this measure, one can ensure that the given time series belongs to the class of diffusive processes or not:</p></list-item><list-item><p id=\"Par34\">Comparing presented in (14) with the second-order conditional moment used in the Langevin modeling i.e., we obtain:</p><p id=\"Par35\">Applying the condition for diffusion processes leads to the following result:</p><p id=\"Par36\">This means that if we use the drift-jump Eq. (##FORMU##72##11##) to model diffusion processes, then the estimation of the jump amplitude will lead to the estimation of the diffusion coefficient required in Langevin modeling.</p></list-item></list></p>", "<p>In order to test the validity of the proposed modeling, we reconstructed a diffusion process with preset drift and diffusion coefficients using a synthetic time series sampled with time intervals . Diffusive process generated using the discretization of Eq. (##FORMU##20##3##) in Euler–Maruyama scheme [28] with a sampling interval and with functions and (the Ornstein–Uhlenbeck process).</p>", "<p>Afterwards, the unknown parameters , and required for jump-drift modeling were estimated using the relations in (13). As explained, we expected and , which the obtained results were confirmed (see Fig. ##FIG##0##1##).</p>", "<p>Furthermore, to ensure that jump-drift modeling is capable to reconstruct a time series for that is statistically similar to the original diffusion time series, we reconstructed a data set by applying the obtained parameters to the jump-drift equation Eq. (##FORMU##72##11##). Afterwards, and were estimated from the reconstructed data, and we found a very good agreement between these estimated coefficients and the corresponding original ones (see Fig. ##FIG##1##2##).</p>", "<title>Jump-jump modeling</title>", "<p id=\"Par40\">In this section, we expand the jump-drift dynamical Eq. (##FORMU##72##11##), and do not limit it to only a jump process. We begin by considering two jump processes with two different amplitudes in Eq. (##FORMU##66##10##). Before continuing the discussion, let us explain how the idea of ​​including these two jump processes comes about.</p>", "<p id=\"Par41\">The jump-diffusion Eq. (##FORMU##27##5##) that is able to construct a trajectory with jump discontinuities consists a deterministic drift term and two stochastic terms with diffusive and jumpy behaviors. On the other hand, when data sampled at discrete time intervals from a jump-diffusion process, two types of discontinuities are observed in the path of the sampled time series. Those discontinuities that originate from finite sampling of the diffusive part of the process, and have a smaller amplitude, and those discontinuities that arise from genuine jump events and have a larger amplitude. Based on this, we build a new equation including a deterministic drift term and two stochastic terms with jumpy behavior. The aim of this article is to introduce this jump-jump equation, which enables us to generate sample paths with successive discontinuities, but with two different distributed sizes. A jump-jump equation is as follows:where indicates the deterministic part of the process and and are Poisson jump processes. The jumps have rates and , and sizes and , which we assume have zero mean Gaussian distributions with variances and , respectively (or any symmetric distribution with finite statistical moments). In general, the jump rates and and statistical moments of and may be functions of state variable and time . We also assume that any discontinuity in the sample path is caused by the occurrence of only one of the jump events or , and two jumps do not occur simultaneously. The meaning of this condition is that in the time interval , if for example occur, and takes the value 1, then does not occur, and its value becomes zero and vice versa. Applying this condition enables us to construct a time series via Eq. (##FORMU##139##17##) whose corresponding trajectory consists of successive jump discontinuities with different amplitudes and jump rates. In other words, by applying this condition, Eq. (##FORMU##139##17##) is able to describe the random evolution of a jump-jump process, a process whose corresponding time series consists of the union of two data sets belonging to two jump processes with different amplitudes and rates. We now discuss a nonparametric approach to estimating drift and jump characteristics directly from the measured time series data. This method can be applied to both stationary and non-stationary time series, and the results can be applied to both.</p>", "<title>Non-parametric estimation of jump-jump processes</title>", "<title>Theorem 2</title>", "<p id=\"Par42\">For a jump-jump process described by the dynamical Eq. (##FORMU##139##17##), all the functions and parameters required to model the process can be estimated non-parametrically by estimating KM coefficients from measured time series as follows:</p>", "<p>In the Appendix, we have presented a proof for this theorem. In this section, as before, we focus on stationary processes, and we remove the t-dependencies in Eq. (##FORMU##160##18##).</p>", "<p>The five unknown parameters required for this modeling are \n\n\n and . The first relation in this theorem gives us the estimate for the drift coefficient, which is equal to the first-order KM coefficient, namely:</p>", "<p>Additionally, from the last relation in Eq. (##FORMU##160##18##) for , we can derive a system of equations to estimate the parameters of jump processes as follows (we use the relation for the Gaussian random variables and :</p>", "<p>By solving this system of nonlinear equations, the unknowns are estimated using and , which are obtained from the data. Since the parametric solution of this system of equations leads to long and boring relations, we refrain from presenting them, and use the numerical methods.</p>", "<p>To demonstrate the validity of our approach, we estimated drift and jumps characteristics from synthetic time series generated with preset coefficients. First, we considered Eq. (##FORMU##139##17##) with as a linear drift function and two constant jump amplitudes and with constant jump rates per data point and , respectively. It is worth noting that the jump rate per data point is different from the jump rate per unit of time in a , i.e.. We generated synthetic time series by discretizing Eq. (##FORMU##139##17##) using Euler–Maruyama discretization scheme with . Afterwards, we estimated the drift function and jump characteristics from the synthetic time series using relations present in (19) and (20). Very good agreement was observed between all estimates and initial functions and parameters (see Fig. ##FIG##2##3##).</p>", "<p>As a second example, we considered Eq. (##FORMU##139##17##) with a linear drift function and two jump amplitude as ( and , with constant jump rates per data point and , respectively. We proceeded as before, and generated an exemplary synthetic time series using the discretization of Eq. (##FORMU##139##17##) in Euler–Maruyama scheme with a sampling interval . Again, a very good agreement was found between the estimated and predetermined functions and parameters (see Fig. ##FIG##3##4##).</p>", "<title>Jump-jump modeling with constant coefficients and parameters</title>", "<p id=\"Par49\">Because of its practical uses, in this section we focus on a special case of Eq. (##FORMU##139##17##), where all coefficients and parameters are assumed constant and none of them are time-dependent or state-dependent. For this purpose, we rewrite the Eq. (##FORMU##139##17##) as follows:where μ is the drift parameter and other parameters are the same as previously defined. Similar to the proof provided in Theorem <xref ref-type=\"sec\" rid=\"FPar2\">2</xref>, one can prove that all necessary parameters and coefficients in this modeling are obtained non-parametrically by estimating the statistical moments of the increments of the measured time series as follows:where are the statistical moments of the increments of the time series, namely As before, we derive the following relations from Eq. (##FORMU##203##22##):</p>", "<p id=\"Par50\">By solving this system of equations, the 5 unknown parameters, i.e. and can be obtained.</p>", "<p id=\"Par51\">Again, to investigate the validity of this approach, we estimated these parameters from synthetic time series generated with known drift and jump parameters. We considered Eq. (##FORMU##202##21##) with and two constant jump amplitudes and with two constant jump rates per data point and , respectively. We generated synthetic time series using the Euler–Maruyama scheme with a sampling interval . A sample path of is shown in Fig. ##FIG##4##5##. In addition, we constructed a new time series based on the increments of , i.e. (the trajectory of is also shown in Fig. ##FIG##4##5##).</p>", "<p id=\"Par52\">By calculating the statistical moments of for and substituting in Eqs. (##FORMU##206##23##), and then solving this system of equations, the following results were estimated, which are in very good agreement with the original values:</p>", "<p id=\"Par53\">, , , ,</p>", "<title>Expansion of the jump-jump equation</title>", "<p id=\"Par54\">The strength of jump-jump modeling is that if the amplitude of fluctuations in a given time series is so diverse that its random evolution cannot be described using only two jump processes such as seen in Eq. (##FORMU##139##17##) or (##FORMU##202##21##). Afterwards, the stochastic part of the Eq. (##FORMU##66##10##) can be expanded by considering more jump processes. For example, Eq. (##FORMU##202##21##) is expanded as follows considering three jump processes:</p>", "<p id=\"Par55\">As before, we assume that any random variation in the time series data is due to the occurrence of only one of the jump events, and that two or more jump events do not occur simultaneously. That is, when in a time step occur and takes the value 1, and do not occur and their values are zero, and so on. The following section discusses a nonparametric approach to estimate the drift parameter and the jump characteristic required in this modeling.</p>", "<title>Theorem 3: parametric estimation of jump-jump processes</title>", "<title>Theorem 3</title>", "<p id=\"Par56\">For a jump-jump process described by the dynamical Eq. (##FORMU##236##24##), all the functions and parameters required to model the process can be estimated non-parametrically by estimating KM coefficients from measured time series as follows:where all parameters and coefficients are the same as previously defined. In the Appendix, we have presented a proof for this theorem. As before, the first relation in (25) use for estimating the drift coefficient, which is equal to the first-order KM coefficient:</p>", "<p>On the other hand, using the last relation in Eq. (##FORMU##242##25##), with , and using the relation for the Gaussian random variables and , one can estimate the 6 unknown parameters by solving the following system of equations:</p>", "<p>To demonstrate the validity of this modeling we constructed a synthetic time series with a constant drift parameter and jump amplitudes and and with constant jump rates per data point and and , respectively. We generated the synthetic time series using the discretization of Eq. (##FORMU##236##24##) with a sampling interval in Euler–Maruyama scheme. A random path of , and corresponding increments are shown in Fig. ##FIG##5##6##.</p>", "<p>Afterwards, by calculating the statistical moments of for and substituting in Eqs. (##FORMU##243##26##) and (##FORMU##249##27##), we estimated the drift parameter and jumps characteristics. The obtained results confirm the effectiveness of the presented modeling:</p>" ]
[ "<title>Introducing the proposed method and results</title>", "<p id=\"Par20\">As mentioned, when analyzing a time series sampled with time intervals , successive discontinuities in the sampled path are observed, despite the fact that the underlying path is continuous<sup>##UREF##7##11##</sup>. In addition, one of the main problems when using data sampled at discrete times is the distinction between discontinuities caused by continuous stochastic processes, and genuine discontinuities in the sample path of time series that were caused by finite sampling of continuous stochastic processes<sup>##UREF##7##11##</sup>. Some points like this raise the question: <italic>Is it possible to use only jump-drift processes to describe the random evolution of a time series sampled with finite time intervals </italic><italic>?</italic> To address this question, we introduce a new modeling that attributes any stochastic variation in the sample path of a given time series to a jump event, regardless of whether the underlying trajectory is continuous or not. Based on this, we build a new dynamical stochastic equation, and call it the jump-jump equation, which in its general form includes a deterministic drift term and several stochastic terms with jumpy behaviors as follows:where indicates the deterministic part of the process and are Poisson jump processes. The jumps have rates and sizes , which we assume they have zero mean Gaussian distributions with variances (amplitudes), respectively. We start with the simplest form of Eq. (##FORMU##66##10##), which includes a drift term and only a jump process. It will be shown that such a jump-drift equation is able to model time series that are classified as continuous processes. Afterwards, we extend modeling by considering more jump processes in Eq. (##FORMU##66##10##), and use it to model time series with more varied amplitudes. In each step, we will demonstrate that all unknown coefficients and functions involved in this model can be derived directly from the measured time series data.</p>", "<title>Jump-drift modeling</title>", "<p id=\"Par21\">We now consider Eq. (##FORMU##66##10##) with a drift term and a jump process (a jump-drift equation), and show that it can be used to model time series belonging to the class of continuous processes when the data are sampled at discrete intervals. The general form of a jump-drift equation is as follows:where denotes the drift part of the process, and is a Poisson jump process characterized by the rate and the size . We assume that is a random variable, and has a zero mean Gaussian distribution, i.e. . The variance of this distribution () is called the jump amplitude, and in general may depend on and . We will show that all unknown parameters and functions required in this modeling can be estimated based on a data-driven approach from measured time series. Before doing so, it is necessary to mention two points:</p>", "<p id=\"Par22\">1) We assume the case that is a homogeneous Poisson jump process with a constant jump rate . The jump rate represents the expected number of jumps that will occur per unit time. It follows that the number of jumps occurring in the interval of follows a Poisson distribution with the associated parameter . On the other hand, a jump event has two states of occurrence 1 and non-occurrence 0, of which only one will occur in each infinitesimal . The last point shows that in the Poisson process, the occurrence of an event in each small interval of time is defined as a Bernoulli variable. That is, takes only the values 1 and 0 with probabilities and , respectively.</p>", "<p id=\"Par23\">2) Up to the first orders in the statistical moments of are given by the following relation<sup>##REF##27759055##8##,##UREF##6##10##</sup>:</p>", "<p id=\"Par24\">With these two points in mind, we now present a data-driven approach to estimate the drift and jump properties required in this modeling. This method can be used for both stationary and non-stationary time series, and the results are applicable to both.</p>", "<title>Non-parametric estimation of jump-drift processes.</title>", "<title>Theorem 1</title>", "<p id=\"Par25\">For a jump-drift process described by the dynamical Eq. (##FORMU##72##11##), all the functions and parameters required to model the process can be estimated non-parametrically by estimating KM coefficients from measured time series as follows:</p>", "<p>We have provided a proof for this theorem in the appendix. For non-stationary processes, all functions and parameters are time-dependent, but in the following, we focus on stationary processes, and omit the t-dependence in Eq. (##FORMU##93##12##) to improve readability.</p>", "<p>We can estimate the drift function using the first relation in (##FORMU##93##12##). The jump amplitude and the jump rate can be estimated using the relation for the Gaussian random variable in the last relation in Eq. (##FORMU##93##12##) with and . Therefore, we have:</p>", "<p>where </p>", "<p>We now argue that if Eq. (##FORMU##72##11##) is able to describe the random evolution of a sampled time series belonging to the class of diffusion processes, then the following conditions should be held:<list list-type=\"order\"><list-item><p id=\"Par30\"> The last relation in (##FORMU##93##12##) in terms of conditional moments is written as follows:where with and it leads to:</p><p id=\"Par31\">Extracting the ratio from these relations leads to:</p><p id=\"Par32\">On the other hand, we know from Eq. (##FORMU##51##8##) that this ratio is approximately equal to 1 in diffusion processes for small , as a result:</p><p id=\"Par33\">This criterion can be used as a possibility for numerical verification of Pawula theorem. Employing this measure, one can ensure that the given time series belongs to the class of diffusive processes or not:</p></list-item><list-item><p id=\"Par34\">Comparing presented in (14) with the second-order conditional moment used in the Langevin modeling i.e., we obtain:</p><p id=\"Par35\">Applying the condition for diffusion processes leads to the following result:</p><p id=\"Par36\">This means that if we use the drift-jump Eq. (##FORMU##72##11##) to model diffusion processes, then the estimation of the jump amplitude will lead to the estimation of the diffusion coefficient required in Langevin modeling.</p></list-item></list></p>", "<p>In order to test the validity of the proposed modeling, we reconstructed a diffusion process with preset drift and diffusion coefficients using a synthetic time series sampled with time intervals . Diffusive process generated using the discretization of Eq. (##FORMU##20##3##) in Euler–Maruyama scheme [28] with a sampling interval and with functions and (the Ornstein–Uhlenbeck process).</p>", "<p>Afterwards, the unknown parameters , and required for jump-drift modeling were estimated using the relations in (13). As explained, we expected and , which the obtained results were confirmed (see Fig. ##FIG##0##1##).</p>", "<p>Furthermore, to ensure that jump-drift modeling is capable to reconstruct a time series for that is statistically similar to the original diffusion time series, we reconstructed a data set by applying the obtained parameters to the jump-drift equation Eq. (##FORMU##72##11##). Afterwards, and were estimated from the reconstructed data, and we found a very good agreement between these estimated coefficients and the corresponding original ones (see Fig. ##FIG##1##2##).</p>", "<title>Jump-jump modeling</title>", "<p id=\"Par40\">In this section, we expand the jump-drift dynamical Eq. (##FORMU##72##11##), and do not limit it to only a jump process. We begin by considering two jump processes with two different amplitudes in Eq. (##FORMU##66##10##). Before continuing the discussion, let us explain how the idea of ​​including these two jump processes comes about.</p>", "<p id=\"Par41\">The jump-diffusion Eq. (##FORMU##27##5##) that is able to construct a trajectory with jump discontinuities consists a deterministic drift term and two stochastic terms with diffusive and jumpy behaviors. On the other hand, when data sampled at discrete time intervals from a jump-diffusion process, two types of discontinuities are observed in the path of the sampled time series. Those discontinuities that originate from finite sampling of the diffusive part of the process, and have a smaller amplitude, and those discontinuities that arise from genuine jump events and have a larger amplitude. Based on this, we build a new equation including a deterministic drift term and two stochastic terms with jumpy behavior. The aim of this article is to introduce this jump-jump equation, which enables us to generate sample paths with successive discontinuities, but with two different distributed sizes. A jump-jump equation is as follows:where indicates the deterministic part of the process and and are Poisson jump processes. The jumps have rates and , and sizes and , which we assume have zero mean Gaussian distributions with variances and , respectively (or any symmetric distribution with finite statistical moments). In general, the jump rates and and statistical moments of and may be functions of state variable and time . We also assume that any discontinuity in the sample path is caused by the occurrence of only one of the jump events or , and two jumps do not occur simultaneously. The meaning of this condition is that in the time interval , if for example occur, and takes the value 1, then does not occur, and its value becomes zero and vice versa. Applying this condition enables us to construct a time series via Eq. (##FORMU##139##17##) whose corresponding trajectory consists of successive jump discontinuities with different amplitudes and jump rates. In other words, by applying this condition, Eq. (##FORMU##139##17##) is able to describe the random evolution of a jump-jump process, a process whose corresponding time series consists of the union of two data sets belonging to two jump processes with different amplitudes and rates. We now discuss a nonparametric approach to estimating drift and jump characteristics directly from the measured time series data. This method can be applied to both stationary and non-stationary time series, and the results can be applied to both.</p>", "<title>Non-parametric estimation of jump-jump processes</title>", "<title>Theorem 2</title>", "<p id=\"Par42\">For a jump-jump process described by the dynamical Eq. (##FORMU##139##17##), all the functions and parameters required to model the process can be estimated non-parametrically by estimating KM coefficients from measured time series as follows:</p>", "<p>In the Appendix, we have presented a proof for this theorem. In this section, as before, we focus on stationary processes, and we remove the t-dependencies in Eq. (##FORMU##160##18##).</p>", "<p>The five unknown parameters required for this modeling are \n\n\n and . The first relation in this theorem gives us the estimate for the drift coefficient, which is equal to the first-order KM coefficient, namely:</p>", "<p>Additionally, from the last relation in Eq. (##FORMU##160##18##) for , we can derive a system of equations to estimate the parameters of jump processes as follows (we use the relation for the Gaussian random variables and :</p>", "<p>By solving this system of nonlinear equations, the unknowns are estimated using and , which are obtained from the data. Since the parametric solution of this system of equations leads to long and boring relations, we refrain from presenting them, and use the numerical methods.</p>", "<p>To demonstrate the validity of our approach, we estimated drift and jumps characteristics from synthetic time series generated with preset coefficients. First, we considered Eq. (##FORMU##139##17##) with as a linear drift function and two constant jump amplitudes and with constant jump rates per data point and , respectively. It is worth noting that the jump rate per data point is different from the jump rate per unit of time in a , i.e.. We generated synthetic time series by discretizing Eq. (##FORMU##139##17##) using Euler–Maruyama discretization scheme with . Afterwards, we estimated the drift function and jump characteristics from the synthetic time series using relations present in (19) and (20). Very good agreement was observed between all estimates and initial functions and parameters (see Fig. ##FIG##2##3##).</p>", "<p>As a second example, we considered Eq. (##FORMU##139##17##) with a linear drift function and two jump amplitude as ( and , with constant jump rates per data point and , respectively. We proceeded as before, and generated an exemplary synthetic time series using the discretization of Eq. (##FORMU##139##17##) in Euler–Maruyama scheme with a sampling interval . Again, a very good agreement was found between the estimated and predetermined functions and parameters (see Fig. ##FIG##3##4##).</p>", "<title>Jump-jump modeling with constant coefficients and parameters</title>", "<p id=\"Par49\">Because of its practical uses, in this section we focus on a special case of Eq. (##FORMU##139##17##), where all coefficients and parameters are assumed constant and none of them are time-dependent or state-dependent. For this purpose, we rewrite the Eq. (##FORMU##139##17##) as follows:where μ is the drift parameter and other parameters are the same as previously defined. Similar to the proof provided in Theorem <xref ref-type=\"sec\" rid=\"FPar2\">2</xref>, one can prove that all necessary parameters and coefficients in this modeling are obtained non-parametrically by estimating the statistical moments of the increments of the measured time series as follows:where are the statistical moments of the increments of the time series, namely As before, we derive the following relations from Eq. (##FORMU##203##22##):</p>", "<p id=\"Par50\">By solving this system of equations, the 5 unknown parameters, i.e. and can be obtained.</p>", "<p id=\"Par51\">Again, to investigate the validity of this approach, we estimated these parameters from synthetic time series generated with known drift and jump parameters. We considered Eq. (##FORMU##202##21##) with and two constant jump amplitudes and with two constant jump rates per data point and , respectively. We generated synthetic time series using the Euler–Maruyama scheme with a sampling interval . A sample path of is shown in Fig. ##FIG##4##5##. In addition, we constructed a new time series based on the increments of , i.e. (the trajectory of is also shown in Fig. ##FIG##4##5##).</p>", "<p id=\"Par52\">By calculating the statistical moments of for and substituting in Eqs. (##FORMU##206##23##), and then solving this system of equations, the following results were estimated, which are in very good agreement with the original values:</p>", "<p id=\"Par53\">, , , ,</p>", "<title>Expansion of the jump-jump equation</title>", "<p id=\"Par54\">The strength of jump-jump modeling is that if the amplitude of fluctuations in a given time series is so diverse that its random evolution cannot be described using only two jump processes such as seen in Eq. (##FORMU##139##17##) or (##FORMU##202##21##). Afterwards, the stochastic part of the Eq. (##FORMU##66##10##) can be expanded by considering more jump processes. For example, Eq. (##FORMU##202##21##) is expanded as follows considering three jump processes:</p>", "<p id=\"Par55\">As before, we assume that any random variation in the time series data is due to the occurrence of only one of the jump events, and that two or more jump events do not occur simultaneously. That is, when in a time step occur and takes the value 1, and do not occur and their values are zero, and so on. The following section discusses a nonparametric approach to estimate the drift parameter and the jump characteristic required in this modeling.</p>", "<title>Theorem 3: parametric estimation of jump-jump processes</title>", "<title>Theorem 3</title>", "<p id=\"Par56\">For a jump-jump process described by the dynamical Eq. (##FORMU##236##24##), all the functions and parameters required to model the process can be estimated non-parametrically by estimating KM coefficients from measured time series as follows:where all parameters and coefficients are the same as previously defined. In the Appendix, we have presented a proof for this theorem. As before, the first relation in (25) use for estimating the drift coefficient, which is equal to the first-order KM coefficient:</p>", "<p>On the other hand, using the last relation in Eq. (##FORMU##242##25##), with , and using the relation for the Gaussian random variables and , one can estimate the 6 unknown parameters by solving the following system of equations:</p>", "<p>To demonstrate the validity of this modeling we constructed a synthetic time series with a constant drift parameter and jump amplitudes and and with constant jump rates per data point and and , respectively. We generated the synthetic time series using the discretization of Eq. (##FORMU##236##24##) with a sampling interval in Euler–Maruyama scheme. A random path of , and corresponding increments are shown in Fig. ##FIG##5##6##.</p>", "<p>Afterwards, by calculating the statistical moments of for and substituting in Eqs. (##FORMU##243##26##) and (##FORMU##249##27##), we estimated the drift parameter and jumps characteristics. The obtained results confirm the effectiveness of the presented modeling:</p>" ]
[]
[ "<title>Conclusion</title>", "<p id=\"Par60\">We discussed that when one deals with data sampled at discrete times, one encounters successive discontinuities along the path of the sampled time series. The observation of such sequential discontinuities, in the sample path of empirical time series, gave us the idea to develop a new modeling in which any random variation in the path is attributed to a jump event, even if the sampled time series belongs to the class of diffusive processes. Based on this, we introduced a new dynamical stochastic equation -a jump-jump equation- including a deterministic drift term and a combination of several Poisson jump processes with different distributed sizes. The general form of this equation is as follows:</p>", "<p id=\"Par61\">In this modeling we also assumed that the jump events do not occur simultaneously so that the jumps have no overlap. We started with the simplest form of equation including a deterministic drift term and a jump process as the stochastic component, and argued that it can be used to describe the discrete time evolution of a Langevin process. We provided a measure to distinguish the type of underlying process -diffusive or jumpy- from the corresponding time series as well. Afterwards, we increased the variety of modeling by considering more jump processes with different distributed sizes. We also demonstrated that all unknown functions and parameters required for each of the modeling are estimated non-parametrically from the measured data set. It should be noted that depending on the number of data points and variety of the amplitude of fluctuations, the jump-jump equation allows one to keep a greater number of stochastic terms (jump processes) for more accurate modeling. But on the other hand, the more the number of jump processes the need to solve the system of equations with more unknowns, the cost of which should be paid in the form of longer runtime.</p>" ]
[ "<p id=\"Par1\">When analyzing the data sampled at discrete times, one encounters successive discontinuities in the trajectory of the sampled time series, even if the underlying path is continuous. On the other hand, the distinction between discontinuities caused by finite sampling of continuous stochastic process and real discontinuities in the sample path is one of the main problems. Clues like these led us to the question: Is it possible to provide a model that treats any random variation in the data set as a jump event, regardless of whether the given time series is classified as diffusion or jump-diffusion processes? To address this question, we wrote a new stochastic dynamical equation, which includes a drift term and a combination of Poisson jump processes with different distributed sizes. In this article, we first introduce this equation in its simplest form including a drift term and a jump process, and show that such a jump-drift equation is able to describe the discrete time evolution of a diffusion process. Afterwards, we extend the modeling by considering more jump processes in the equation, which can be used to model complex systems with various distributed amplitudes. At each step, we also show that all the unknown functions and parameters required for modeling can be obtained non-parametrically from the measured time series.</p>", "<title>Subject terms</title>" ]
[]
[ "<title>Appendix</title>", "<title>Proof of relations (##FORMU##93##12##)</title>", "<p id=\"Par63\">To prove the relations in Eq. (##FORMU##93##12##), we can find the conditional moments of from Eq. (##FORMU##72##11##). The first-order conditional moment of is obtained by conditional averaging of Eq. (##FORMU##72##11##) over two independent processes, i.e. Poisson-distributed jumps and jump amplitude :</p>", "<p id=\"Par64\">With assuming that has a Gaussian distribution with zero mean, i.e. , we have:which is the proof of the first relation in Eq. (##FORMU##93##12##). Similarly, the <italic>n</italic>th-order conditioned moment of for leads to:</p>", "<p id=\"Par65\">Up to order of we have:which leads to the last relation in Eq. (##FORMU##93##12##).</p>", "<title>Proof of relations (##FORMU##160##18##)</title>", "<p id=\"Par66\">To prove the relations in Eq. (##FORMU##160##18##), we can find the conditional moments of from Eq. (##FORMU##139##17##). The first-order conditional moment of is obtained by conditional averaging of Eq. (##FORMU##139##17##) over four independent processes, two Poisson-distributed jumps and (which we assume do not occur simultaneously) and two jump amplitudes and :</p>", "<p id=\"Par67\">With assuming that and have zero mean Gaussian distributions i.e. and , we have:which is the proof of the first relation in Eq. (##FORMU##160##18##). The <italic>n</italic>th-order conditioned moment of for leads to:where , so that . Up to order of we will have:using for the statistical moments of and , we will have:which leads to the second relation in Eq. (##FORMU##160##18##).</p>", "<title>Proof of relations (##FORMU##242##25##)</title>", "<p id=\"Par68\">To prove the relations in Eq. (##FORMU##242##25##), we can find the statistical moments of from Eq. (##FORMU##236##24##). The first-order conditional moment of is obtained by conditional averaging of Eq. (##FORMU##236##24##) over six independent processes, three Poisson-distributed jumps \n\n(which we assume do not occur simultaneously) and three jump amplitudes \n and :</p>", "<p id=\"Par69\">With assuming that and and have zero mean Gaussian distributions i.e. and and we have:which is the proof of the first relation in Eq. (##FORMU##242##25##). The <italic>n</italic>th-order moments of for leads to:\nwhere so that . Up to order of we have:using for the statistical moments of three Poisson Jumps, we will have:</p>", "<p id=\"Par70\">Which leads to the last relation in Eq. (##FORMU##242##25##).</p>", "<title>Author contributions</title>", "<p>A.A.M.: Conceptualization, Methodology, Experimental, Resources, Reviewing and Editing, H.N.: Conceptualization, Methodology, Experimental, Resources, Supervision, Reviewing and Editing.</p>", "<title>Data availability</title>", "<p>The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.</p>", "<title>Competing interests</title>", "<p id=\"Par62\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>(<bold>a</bold>) Synthetic time series ( data points) generated by Langevin equation with functions and and with a time interval . (<bold>b</bold>) Estimated drift, (<bold>c</bold>) estimated jump rate, and (<bold>d</bold>) estimated jump amplitude obtained using proposed jump-drift modeling. As can be seen and , which confirms correctnes of Eqs. (##FORMU##113##15##) and (##FORMU##118##16##).</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>(<bold>a</bold>) Reconstructed data by jump-drift Eq. (##FORMU##72##11##) using estimated parameters from Fig. ##FIG##0##1## with time interval ∆t = 0.001. (<bold>b</bold>) Estimated drift coefficient, and (<bold>c</bold>) estimated diffusion coefficient, obtained from reconstructed data. The red lines are the initial coefficients. As can be seen, the good agreement between the estimated coefficients, and the original coefficients confirms that the jump-drift equation is able to describe the discrete time evolution of a diffusion process.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>(<bold>a</bold>) Illustration of a synthetic time series generated using the proposed jump-jump Eq. (##FORMU##139##17##) with a time interval , a drift function and two constant jump amplitudes and with jump rates and , respectively. (<bold>b</bold>) Estimated drift term and (<bold>c</bold>–<bold>f</bold>) estimated jumps characteristics using relations in Eq. (##FORMU##171##20##). The red lines are the corresponding theoretical coefficients.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>(<bold>a</bold>) Illustration of a synthetic time series generated using the proposed jump-jump Eq. (##FORMU##139##17##) with a time interval , a linear drift and two jump amplitudes and with jump rates and , respectively. (<bold>b</bold>) Estimated drift coefficient. (<bold>c</bold>–<bold>f</bold>) Estimated jump characteristics using relations in (20). The red lines are the corresponding theoretical coefficients.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Upper panel: -step random walk generated using Eq. (##FORMU##202##21##) with constant drift parameter and constant jump components , and , with a time interval (starting from zero). Lower panel: increments of the generated time series .</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Upper panel: -step random walk generated using Eq. (##FORMU##236##24##) with constant drift parameter and constant jump components ,, and ,, with a time interval (starting from zero). Lower panel: increments of the generated time series .</p></caption></fig>" ]
[]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x(t)$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mrow><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}^{\\left(n\\right)}\\left(x,t\\right)= \\left\\langle{{\\left[x\\left(t+dt\\right)-x\\left({\\text{t}}\\right)\\right]}^{n}}\\right\\rangle{|}_{x\\left(t\\right)=x}=\\int d{x}{\\prime}{\\left({x}{\\prime}-x\\right)}^{n} p({x}{\\prime},t+dt|x,t)$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mrow><mml:msup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>n</mml:mi></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:mfenced close=\"]\" open=\"[\"><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mfenced><mml:mo>-</mml:mo><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mtext>t</mml:mtext></mml:mfenced></mml:mfenced></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:msub><mml:mo stretchy=\"false\">|</mml:mo><mml:mrow><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>∫</mml:mo><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mo>′</mml:mo><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>′</mml:mo><mml:mo>-</mml:mo><mml:mi>x</mml:mi></mml:mfenced></mml:mrow><mml:mi>n</mml:mi></mml:msup><mml:mi>p</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>′</mml:mo><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">|</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{\\dots }\\right\\rangle{|}_{x\\left(t\\right)=x}$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:mo>⋯</mml:mo></mml:mfenced><mml:msub><mml:mo stretchy=\"false\">|</mml:mo><mml:mrow><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dt$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{gathered} K^{\\left( 1 \\right)} \\left( {x,t} \\right) = M^{\\left( 1 \\right)} \\left( {x,t} \\right)dt + {\\mathcal{O}}\\left( {dt} \\right) \\hfill \\\\ K^{\\left( 2 \\right)} \\left( {x,t} \\right) = M^{\\left( 2 \\right)} \\left( {x,t} \\right)dt + {\\mathcal{O}}\\left( {dt} \\right) \\hfill \\\\ K^{\\left( n \\right)} \\left( {x,t} \\right) = {\\mathcal{O}}\\left( {dt} \\right) {\\text{for}} n \\ge 3, \\hfill \\\\ \\end{gathered} $$\\end{document}</tex-math><mml:math id=\"M10\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msup><mml:mi>K</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant=\"script\">O</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msup><mml:mi>K</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant=\"script\">O</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msup><mml:mi>K</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>n</mml:mi></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi mathvariant=\"script\">O</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfenced><mml:mtext>for</mml:mtext><mml:mi>n</mml:mi><mml:mo>≥</mml:mo><mml:mn>3</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathcal{O}\\left(dt\\right)$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mrow><mml:mi mathvariant=\"script\">O</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dt$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathcal{O}(dt)/dt$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mrow><mml:mi mathvariant=\"script\">O</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dt\\to 0$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${M}^{\\left(n\\right)}\\left(x,t\\right)$$\\end{document}</tex-math><mml:math id=\"M20\"><mml:mrow><mml:msup><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>n</mml:mi></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{(n)}\\left(x,t\\right)={M}^{(n)}\\left(x,t\\right)= \\underset{dt\\to 0}{{\\text{lim}}}\\frac{1}{dt}{K}^{\\left(n\\right)}\\left(x,t\\right),$$\\end{document}</tex-math><mml:math id=\"M22\" display=\"block\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:munder><mml:mtext>lim</mml:mtext><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:munder><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:msup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>n</mml:mi></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{1}{n!}$$\\end{document}</tex-math><mml:math id=\"M24\"><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi>n</mml:mi><mml:mo>!</mml:mo></mml:mrow></mml:mfrac></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M25\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${M}^{\\left(1\\right)}\\left(x, t\\right)$$\\end{document}</tex-math><mml:math id=\"M26\"><mml:mrow><mml:msup><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq12\"><alternatives><tex-math id=\"M27\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${M}^{\\left(2\\right)}\\left(x, t\\right)$$\\end{document}</tex-math><mml:math id=\"M28\"><mml:mrow><mml:msup><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq13\"><alternatives><tex-math id=\"M29\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dt\\to 0$$\\end{document}</tex-math><mml:math id=\"M30\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq14\"><alternatives><tex-math id=\"M31\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${M}^{\\left(4\\right)}\\left(x,t\\right)$$\\end{document}</tex-math><mml:math id=\"M32\"><mml:mrow><mml:msup><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>4</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq15\"><alternatives><tex-math id=\"M33\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x(t)$$\\end{document}</tex-math><mml:math id=\"M34\"><mml:mrow><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq16\"><alternatives><tex-math id=\"M35\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${M}^{(4)}\\left(x,t\\right)$$\\end{document}</tex-math><mml:math id=\"M36\"><mml:mrow><mml:msup><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>4</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq17\"><alternatives><tex-math id=\"M37\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${M}^{\\left(n\\right)}(x, t)$$\\end{document}</tex-math><mml:math id=\"M38\"><mml:mrow><mml:msup><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>n</mml:mi></mml:mfenced></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq18\"><alternatives><tex-math id=\"M39\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n\\ge 3$$\\end{document}</tex-math><mml:math id=\"M40\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>≥</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M41\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx\\left(t\\right)={D}^{\\left(1\\right)}\\left(x,t\\right)dt+\\sqrt{{D}^{\\left(2\\right)}\\left(x,t\\right)}dW\\left(t\\right).$$\\end{document}</tex-math><mml:math id=\"M42\" display=\"block\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:msqrt><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:msqrt><mml:mi>d</mml:mi><mml:mi>W</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq19\"><alternatives><tex-math id=\"M43\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x(t)$$\\end{document}</tex-math><mml:math id=\"M44\"><mml:mrow><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq20\"><alternatives><tex-math id=\"M45\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\{W\\left(t\\right), t\\ge 0\\}$$\\end{document}</tex-math><mml:math id=\"M46\"><mml:mrow><mml:mo stretchy=\"false\">{</mml:mo><mml:mi>W</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>≥</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">}</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq21\"><alternatives><tex-math id=\"M47\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(1\\right)}\\left(x,t\\right)$$\\end{document}</tex-math><mml:math id=\"M48\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq22\"><alternatives><tex-math id=\"M49\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(2\\right)}\\left(x,t\\right)$$\\end{document}</tex-math><mml:math id=\"M50\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ4\"><label>4</label><alternatives><tex-math id=\"M51\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{gathered} D^{\\left( 1 \\right)} \\left( {x,t} \\right) = M^{\\left( 1 \\right)} \\left( {x,t} \\right) = \\mathop {{\\text{lim}}}\\limits_{dt \\to 0} \\frac{1}{dt} \\left\\langle{ \\left[ {x\\left( {t + dt} \\right) - x\\left( {\\text{t}} \\right)} \\right]^{1} }\\right\\rangle |_{x\\left( t \\right) = x} \\hfill \\\\ D^{\\left( 2 \\right)} \\left( {x,t} \\right) = M^{\\left( 2 \\right)} \\left( {x,t} \\right) = \\mathop {{\\text{lim}}}\\limits_{dt \\to 0} \\frac{1}{dt} \\left\\langle{ \\left[ {x\\left( {t + dt} \\right) - x\\left( {\\text{t}} \\right)} \\right]^{2} }\\right\\rangle |_{x\\left( t \\right) = x} \\hfill \\\\ \\end{gathered} $$\\end{document}</tex-math><mml:math id=\"M52\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msup><mml:mi>D</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:munder><mml:mtext>lim</mml:mtext><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:munder><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mfenced close=\"]\" open=\"[\"><mml:mrow><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>-</mml:mo><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mtext>t</mml:mtext></mml:mfenced></mml:mrow></mml:mfenced><mml:mn>1</mml:mn></mml:msup></mml:mfenced><mml:msub><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mrow><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msup><mml:mi>D</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:munder><mml:mtext>lim</mml:mtext><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:munder><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mfenced close=\"]\" open=\"[\"><mml:mrow><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>-</mml:mo><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mtext>t</mml:mtext></mml:mfenced></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mfenced><mml:msub><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mrow><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq23\"><alternatives><tex-math id=\"M53\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${M}^{\\left(4\\right)}\\left(x,t\\right)$$\\end{document}</tex-math><mml:math id=\"M54\"><mml:mrow><mml:msup><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>4</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ5\"><label>5</label><alternatives><tex-math id=\"M55\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx\\left(t\\right)={D}_{j}^{(1)}\\left(x,t\\right)dt+\\sqrt{{D}_{j}^{(2)}\\left(x,t\\right)}dW\\left(t\\right)+\\xi dJ\\left(t\\right),$$\\end{document}</tex-math><mml:math id=\"M56\" display=\"block\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msubsup><mml:mi>D</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:msqrt><mml:mrow><mml:msubsup><mml:mi>D</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:msqrt><mml:mi>d</mml:mi><mml:mi>W</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mi>ξ</mml:mi><mml:mi>d</mml:mi><mml:mi>J</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq24\"><alternatives><tex-math id=\"M57\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\{W\\left(t\\right), t\\ge 0\\}$$\\end{document}</tex-math><mml:math id=\"M58\"><mml:mrow><mml:mo stretchy=\"false\">{</mml:mo><mml:mi>W</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>≥</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy=\"false\">}</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq25\"><alternatives><tex-math id=\"M59\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}_{j}^{(1)}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M60\"><mml:mrow><mml:msubsup><mml:mi>D</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq26\"><alternatives><tex-math id=\"M61\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}_{j}^{(2)}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M62\"><mml:mrow><mml:msubsup><mml:mi>D</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq27\"><alternatives><tex-math id=\"M63\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$J(t)$$\\end{document}</tex-math><mml:math id=\"M64\"><mml:mrow><mml:mi>J</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq28\"><alternatives><tex-math id=\"M65\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda (x,{\\text{t}})$$\\end{document}</tex-math><mml:math id=\"M66\"><mml:mrow><mml:mi>λ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mtext>t</mml:mtext><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq29\"><alternatives><tex-math id=\"M67\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\xi $$\\end{document}</tex-math><mml:math id=\"M68\"><mml:mi>ξ</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ6\"><label>6</label><alternatives><tex-math id=\"M69\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{gathered} M^{\\left( 1 \\right)} \\left( {x,t} \\right) = D_{j}^{\\left( 1 \\right)} \\left( {x,t} \\right) \\hfill \\\\ M^{\\left( 2 \\right)} \\left( {x,t} \\right) = D_{j}^{\\left( 2 \\right)} \\left( {x,t} \\right) + \\lambda \\left( {x,t} \\right)\\left\\langle {\\xi^{2} } \\right\\rangle \\hfill \\\\ M^{\\left( n \\right)} \\left( {x,t} \\right) = \\lambda \\left( {x,t} \\right)\\left\\langle {\\xi^{n} } \\right\\rangle {\\text{for}} n &gt; 2 \\hfill \\\\ \\end{gathered} $$\\end{document}</tex-math><mml:math id=\"M70\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msubsup><mml:mi>D</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msubsup><mml:mi>D</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>n</mml:mi></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mi>ξ</mml:mi><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:mtext>for</mml:mtext><mml:mi>n</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq30\"><alternatives><tex-math id=\"M71\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\xi $$\\end{document}</tex-math><mml:math id=\"M72\"><mml:mi>ξ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq31\"><alternatives><tex-math id=\"M73\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\xi \\sim N(0, {\\sigma }_{\\xi }^{2})$$\\end{document}</tex-math><mml:math id=\"M74\"><mml:mrow><mml:mi>ξ</mml:mi><mml:mo>∼</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq32\"><alternatives><tex-math id=\"M75\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{{\\xi }^{2l}}\\right\\rangle =\\frac{2l!}{{2}^{l}l!}\\left\\langle{{\\xi }^{2}}\\right\\rangle^{l}$$\\end{document}</tex-math><mml:math id=\"M76\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mi>l</mml:mi></mml:mrow></mml:msup></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mi>l</mml:mi><mml:mo>!</mml:mo></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mi>l</mml:mi></mml:msup><mml:mi>l</mml:mi><mml:mo>!</mml:mo></mml:mrow></mml:mfrac><mml:msup><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mfenced><mml:mi>l</mml:mi></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq33\"><alternatives><tex-math id=\"M77\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=4$$\\end{document}</tex-math><mml:math id=\"M78\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq34\"><alternatives><tex-math id=\"M79\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=6$$\\end{document}</tex-math><mml:math id=\"M80\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq35\"><alternatives><tex-math id=\"M81\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi }^{2}(x,t)$$\\end{document}</tex-math><mml:math id=\"M82\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq36\"><alternatives><tex-math id=\"M83\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda (x,t)$$\\end{document}</tex-math><mml:math id=\"M84\"><mml:mrow><mml:mi>λ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ7\"><label>7</label><alternatives><tex-math id=\"M85\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{gathered} \\sigma_{\\xi }^{2} \\left( {x,t} \\right) = \\frac{{M^{\\left( 6 \\right)} \\left( {x,t} \\right) { }}}{{5M^{\\left( 4 \\right)} \\left( {x,t} \\right) { }}} \\hfill \\\\ \\lambda \\left( {x,t} \\right) = \\frac{{M^{\\left( 4 \\right)} \\left( {x,t} \\right)}}{{3\\sigma_{\\xi }^{4} \\left( {x,t} \\right)}} \\hfill \\\\ \\end{gathered} $$\\end{document}</tex-math><mml:math id=\"M86\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>6</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mrow/></mml:mrow><mml:mrow><mml:mn>5</mml:mn><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>4</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mrow/></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>4</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>4</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq37\"><alternatives><tex-math id=\"M87\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi }^{2}(x,t)$$\\end{document}</tex-math><mml:math id=\"M88\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq38\"><alternatives><tex-math id=\"M89\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda \\left(x,t\\right)$$\\end{document}</tex-math><mml:math id=\"M90\"><mml:mrow><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq39\"><alternatives><tex-math id=\"M91\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}_{j}^{(2)}\\left(x,t\\right)$$\\end{document}</tex-math><mml:math id=\"M92\"><mml:mrow><mml:msubsup><mml:mi>D</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq40\"><alternatives><tex-math id=\"M93\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}_{j}^{(1)}\\left(x,t\\right)$$\\end{document}</tex-math><mml:math id=\"M94\"><mml:mrow><mml:msubsup><mml:mi>D</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq41\"><alternatives><tex-math id=\"M95\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${M}^{(1)}\\left(x,t\\right)$$\\end{document}</tex-math><mml:math id=\"M96\"><mml:mrow><mml:msup><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq42\"><alternatives><tex-math id=\"M97\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau $$\\end{document}</tex-math><mml:math id=\"M98\"><mml:mi>τ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq43\"><alternatives><tex-math id=\"M99\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{{K}^{\\left(4\\right)}(x,\\tau )}{3{(K}^{\\left(2\\right)}{\\left(x,\\tau \\right))}^{2}}$$\\end{document}</tex-math><mml:math id=\"M100\"><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>4</mml:mn></mml:mfenced></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>K</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi></mml:mfenced><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq44\"><alternatives><tex-math id=\"M101\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau $$\\end{document}</tex-math><mml:math id=\"M102\"><mml:mi>τ</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ8\"><label>8</label><alternatives><tex-math id=\"M103\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{array}{*{20}c} {\\frac{{K^{\\left( 4 \\right)} \\left( {x,\\tau } \\right)}}{{3(K^{\\left( 2 \\right)} \\left( {x,\\tau } \\right))^{2} }} \\approx 1,} &amp; {{\\text{diffusive}}} \\\\ {\\frac{{K_{j}^{\\left( 4 \\right)} \\left( {x,\\tau } \\right)}}{{3(K_{j}^{\\left( 2 \\right)} \\left( {x,\\tau } \\right))^{2} }}\\sim \\frac{1}{\\tau }} &amp; {{\\text{jumpy}}} \\\\ \\end{array} $$\\end{document}</tex-math><mml:math id=\"M104\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mi>K</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>4</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msup><mml:mi>K</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:mfenced><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>≈</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mtext>diffusive</mml:mtext></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mrow><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>K</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>4</mml:mn></mml:mfenced></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msubsup><mml:mi>K</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:mfenced><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>∼</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>τ</mml:mi></mml:mfrac></mml:mrow></mml:mrow></mml:mtd><mml:mtd><mml:mtext>jumpy</mml:mtext></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq45\"><alternatives><tex-math id=\"M105\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}^{(2)}(x,\\tau )$$\\end{document}</tex-math><mml:math id=\"M106\"><mml:mrow><mml:msup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq46\"><alternatives><tex-math id=\"M107\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}^{(4)}(x,\\tau )$$\\end{document}</tex-math><mml:math id=\"M108\"><mml:mrow><mml:msup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>4</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equa\"><alternatives><tex-math id=\"M109\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$Q\\left(x, \\tau \\right)=\\frac{{K}^{(6)}(x,\\tau )}{5{K}^{(4)}(x,\\tau )}$$\\end{document}</tex-math><mml:math id=\"M110\" display=\"block\"><mml:mrow><mml:mi>Q</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>6</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mn>5</mml:mn><mml:msup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>4</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq47\"><alternatives><tex-math id=\"M111\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau $$\\end{document}</tex-math><mml:math id=\"M112\"><mml:mi>τ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq48\"><alternatives><tex-math id=\"M113\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$Q\\left(x, \\tau \\right)={D}^{(2)}\\left(x\\right)\\tau $$\\end{document}</tex-math><mml:math id=\"M114\"><mml:mrow><mml:mi>Q</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>τ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq49\"><alternatives><tex-math id=\"M115\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau $$\\end{document}</tex-math><mml:math id=\"M116\"><mml:mi>τ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq50\"><alternatives><tex-math id=\"M117\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$Q\\left(x, \\tau \\right)={\\sigma }_{\\xi }^{2}$$\\end{document}</tex-math><mml:math id=\"M118\"><mml:mrow><mml:mi>Q</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq51\"><alternatives><tex-math id=\"M119\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau $$\\end{document}</tex-math><mml:math id=\"M120\"><mml:mi>τ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq52\"><alternatives><tex-math id=\"M121\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{(2)}(x)$$\\end{document}</tex-math><mml:math id=\"M122\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq53\"><alternatives><tex-math id=\"M123\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi }^{2}$$\\end{document}</tex-math><mml:math id=\"M124\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq54\"><alternatives><tex-math id=\"M125\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$Q$$\\end{document}</tex-math><mml:math id=\"M126\"><mml:mi>Q</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ9\"><label>9</label><alternatives><tex-math id=\"M127\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{array}{*{20}c} {\\frac{{K^{\\left( 6 \\right)} \\left( {x,\\tau } \\right)}}{{5K^{\\left( 4 \\right)} \\left( {x,\\tau } \\right)}} = D^{\\left( 2 \\right)} \\left( x \\right)\\tau ,} &amp; {{\\text{diffusive}}} \\\\ {\\frac{{K^{\\left( 6 \\right)} \\left( {x,\\tau } \\right)}}{{5K^{\\left( 4 \\right)} \\left( {x,\\tau } \\right)}} = \\sigma_{\\xi }^{2} ,} &amp; {{\\text{jumpy}}} \\\\ \\end{array} $$\\end{document}</tex-math><mml:math id=\"M128\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mi>K</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>6</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>5</mml:mn><mml:msup><mml:mi>K</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>4</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msup><mml:mi>D</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>τ</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mtext>diffusive</mml:mtext></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mi>K</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>6</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>5</mml:mn><mml:msup><mml:mi>K</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>4</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd><mml:mtext>jumpy</mml:mtext></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq55\"><alternatives><tex-math id=\"M129\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau $$\\end{document}</tex-math><mml:math id=\"M130\"><mml:mi>τ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq56\"><alternatives><tex-math id=\"M131\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\tau $$\\end{document}</tex-math><mml:math id=\"M132\"><mml:mi>τ</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ10\"><label>10</label><alternatives><tex-math id=\"M133\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx\\left(t\\right)={D}^{\\left(1\\right)}\\left(x\\right)dt+\\sum_{i=1}^{N}{\\xi }_{i}d{J}_{i}\\left(t\\right),$$\\end{document}</tex-math><mml:math id=\"M134\" display=\"block\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:munderover><mml:msub><mml:mi>ξ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq57\"><alternatives><tex-math id=\"M135\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(1\\right)}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M136\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq58\"><alternatives><tex-math id=\"M137\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${J}_{1 }\\left(t\\right),{J}_{2 }\\left(t\\right), etc$$\\end{document}</tex-math><mml:math id=\"M138\"><mml:mrow><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>,</mml:mo><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>,</mml:mo><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq59\"><alternatives><tex-math id=\"M139\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{1},{\\lambda }_{2 },etc$$\\end{document}</tex-math><mml:math id=\"M140\"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq60\"><alternatives><tex-math id=\"M141\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{1},{\\xi }_{2},etc$$\\end{document}</tex-math><mml:math id=\"M142\"><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq61\"><alternatives><tex-math id=\"M143\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 1}^{2},{\\sigma }_{\\xi 2}^{2}, etc$$\\end{document}</tex-math><mml:math id=\"M144\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>,</mml:mo><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ11\"><label>11</label><alternatives><tex-math id=\"M145\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx\\left(t\\right)={D}^{\\left(1\\right)}\\left(x,t\\right)dt+\\xi dJ\\left(t\\right),$$\\end{document}</tex-math><mml:math id=\"M146\" display=\"block\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mi>ξ</mml:mi><mml:mi>d</mml:mi><mml:mi>J</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq62\"><alternatives><tex-math id=\"M147\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(1\\right)}\\left(x,t\\right)$$\\end{document}</tex-math><mml:math id=\"M148\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq63\"><alternatives><tex-math id=\"M149\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$J(t)$$\\end{document}</tex-math><mml:math id=\"M150\"><mml:mrow><mml:mi>J</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq64\"><alternatives><tex-math id=\"M151\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda (x,t)$$\\end{document}</tex-math><mml:math id=\"M152\"><mml:mrow><mml:mi>λ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq65\"><alternatives><tex-math id=\"M153\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\xi $$\\end{document}</tex-math><mml:math id=\"M154\"><mml:mi>ξ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq66\"><alternatives><tex-math id=\"M155\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\xi $$\\end{document}</tex-math><mml:math id=\"M156\"><mml:mi>ξ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq67\"><alternatives><tex-math id=\"M157\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\xi \\sim N(0, {\\sigma }_{\\xi }^{2})$$\\end{document}</tex-math><mml:math id=\"M158\"><mml:mrow><mml:mi>ξ</mml:mi><mml:mo>∼</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq68\"><alternatives><tex-math id=\"M159\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi }^{2}$$\\end{document}</tex-math><mml:math id=\"M160\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq69\"><alternatives><tex-math id=\"M161\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x$$\\end{document}</tex-math><mml:math id=\"M162\"><mml:mi>x</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq70\"><alternatives><tex-math id=\"M163\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t$$\\end{document}</tex-math><mml:math id=\"M164\"><mml:mi>t</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq71\"><alternatives><tex-math id=\"M165\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$J(t)$$\\end{document}</tex-math><mml:math id=\"M166\"><mml:mrow><mml:mi>J</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq72\"><alternatives><tex-math id=\"M167\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda $$\\end{document}</tex-math><mml:math id=\"M168\"><mml:mi>λ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq73\"><alternatives><tex-math id=\"M169\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(t, t+dt]$$\\end{document}</tex-math><mml:math id=\"M170\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq74\"><alternatives><tex-math id=\"M171\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda dt$$\\end{document}</tex-math><mml:math id=\"M172\"><mml:mrow><mml:mi>λ</mml:mi><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq75\"><alternatives><tex-math id=\"M173\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dt$$\\end{document}</tex-math><mml:math id=\"M174\"><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq76\"><alternatives><tex-math id=\"M175\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dJ$$\\end{document}</tex-math><mml:math id=\"M176\"><mml:mrow><mml:mi mathvariant=\"italic\">dJ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq77\"><alternatives><tex-math id=\"M177\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda dt$$\\end{document}</tex-math><mml:math id=\"M178\"><mml:mrow><mml:mi>λ</mml:mi><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq78\"><alternatives><tex-math id=\"M179\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$1-\\lambda dt$$\\end{document}</tex-math><mml:math id=\"M180\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>λ</mml:mi><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq79\"><alternatives><tex-math id=\"M181\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dt,$$\\end{document}</tex-math><mml:math id=\"M182\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq80\"><alternatives><tex-math id=\"M183\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dJ$$\\end{document}</tex-math><mml:math id=\"M184\"><mml:mrow><mml:mi mathvariant=\"italic\">dJ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equb\"><alternatives><tex-math id=\"M185\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{{\\left(dJ\\right)}^{m}}\\right\\rangle = \\lambda dt$$\\end{document}</tex-math><mml:math id=\"M186\" display=\"block\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>d</mml:mi><mml:mi>J</mml:mi></mml:mfenced></mml:mrow><mml:mi>m</mml:mi></mml:msup></mml:mfenced><mml:mo>=</mml:mo><mml:mi>λ</mml:mi><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ12\"><label>12</label><alternatives><tex-math id=\"M187\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{gathered} M^{\\left( 1 \\right)} \\left( {x,t} \\right) = D^{\\left( 1 \\right)} \\left( {x,t} \\right) \\hfill \\\\ M^{\\left( n \\right)} \\left( {x,t} \\right) = \\lambda \\left( {x,t} \\right)\\left\\langle {\\xi^{n} } \\right\\rangle \\,{\\text{for}}\\, n \\ge 2 \\hfill \\\\ \\end{gathered} $$\\end{document}</tex-math><mml:math id=\"M188\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mi>D</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>n</mml:mi></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mi>ξ</mml:mi><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:mspace width=\"0.166667em\"/><mml:mtext>for</mml:mtext><mml:mspace width=\"0.166667em\"/><mml:mi>n</mml:mi><mml:mo>≥</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq81\"><alternatives><tex-math id=\"M189\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(1\\right)}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M190\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq82\"><alternatives><tex-math id=\"M191\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi }^{2}(x)$$\\end{document}</tex-math><mml:math id=\"M192\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq83\"><alternatives><tex-math id=\"M193\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda (x)$$\\end{document}</tex-math><mml:math id=\"M194\"><mml:mrow><mml:mi>λ</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq84\"><alternatives><tex-math id=\"M195\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{{\\xi }^{2l}}\\right\\rangle =\\frac{2l!}{{2}^{l}l!}\\left\\langle{{\\xi }^{2}}\\right\\rangle^{l}$$\\end{document}</tex-math><mml:math id=\"M196\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mi>l</mml:mi></mml:mrow></mml:msup></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mi>l</mml:mi><mml:mo>!</mml:mo></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mi>l</mml:mi></mml:msup><mml:mi>l</mml:mi><mml:mo>!</mml:mo></mml:mrow></mml:mfrac><mml:msup><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mfenced><mml:mi>l</mml:mi></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq85\"><alternatives><tex-math id=\"M197\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\xi $$\\end{document}</tex-math><mml:math id=\"M198\"><mml:mi>ξ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq86\"><alternatives><tex-math id=\"M199\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=2$$\\end{document}</tex-math><mml:math id=\"M200\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq87\"><alternatives><tex-math id=\"M201\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=4$$\\end{document}</tex-math><mml:math id=\"M202\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ13\"><label>13</label><alternatives><tex-math id=\"M203\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{gathered} D^{\\left( 1 \\right)} \\left( x \\right) = M^{\\left( 1 \\right)} \\left( x \\right) \\hfill \\\\ \\sigma_{\\xi }^{2} \\left( x \\right) = \\frac{{M^{\\left( 4 \\right)} \\left( x \\right)}}{{3M^{\\left( 2 \\right)} \\left( x \\right)}} \\hfill \\\\ \\lambda \\left( x \\right) = \\frac{{M^{\\left( 2 \\right)} \\left( x \\right)}}{{\\sigma_{\\xi }^{2} \\left( x \\right)}}, \\hfill \\\\ \\end{gathered} $$\\end{document}</tex-math><mml:math id=\"M204\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msup><mml:mi>D</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>4</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq88\"><alternatives><tex-math id=\"M205\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${M}^{(n)}\\left(x\\right)= \\underset{dt\\to 0}{{\\text{lim}}}\\frac{1}{dt}{K}^{\\left(n\\right)}\\left(x\\right).$$\\end{document}</tex-math><mml:math id=\"M206\"><mml:mrow><mml:msup><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:munder><mml:mtext>lim</mml:mtext><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:munder><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:msup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>n</mml:mi></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq89\"><alternatives><tex-math id=\"M207\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x(t)$$\\end{document}</tex-math><mml:math id=\"M208\"><mml:mrow><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq90\"><alternatives><tex-math id=\"M209\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}^{\\left(n\\right)}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M210\"><mml:mrow><mml:msup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>n</mml:mi></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equc\"><alternatives><tex-math id=\"M211\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}^{\\left(n\\right)}\\left(x\\right)=\\left\\langle{{\\xi }^{n}}\\right\\rangle\\lambda \\left(x\\right)dt,$$\\end{document}</tex-math><mml:math id=\"M212\" display=\"block\"><mml:mrow><mml:msup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>n</mml:mi></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq91\"><alternatives><tex-math id=\"M213\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=2$$\\end{document}</tex-math><mml:math id=\"M214\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq92\"><alternatives><tex-math id=\"M215\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=4$$\\end{document}</tex-math><mml:math id=\"M216\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ14\"><label>14</label><alternatives><tex-math id=\"M217\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{gathered} K^{\\left( 2 \\right)} \\left( x \\right) = \\sigma_{\\xi }^{2} \\left( x \\right)\\lambda \\left( x \\right)dt \\hfill \\\\ K^{\\left( 4 \\right)} \\left( x \\right) = 3\\left( {\\sigma_{\\xi }^{2} \\left( x \\right)} \\right)^{2} \\lambda \\left( x \\right)dt, \\hfill \\\\ \\end{gathered} $$\\end{document}</tex-math><mml:math id=\"M218\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msup><mml:mi>K</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msup><mml:mi>K</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>4</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>3</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq93\"><alternatives><tex-math id=\"M219\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{{K}^{(4)}(x)}{3{(K}^{\\left(2\\right)}{\\left(x\\right))}^{2}}$$\\end{document}</tex-math><mml:math id=\"M220\"><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mn>4</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>K</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equd\"><alternatives><tex-math id=\"M221\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\frac{{K}^{\\left(4\\right)}(x)}{3{(K}^{\\left(2\\right)}{\\left(x\\right))}^{2}}=\\frac{1}{\\lambda \\left(x\\right)dt}$$\\end{document}</tex-math><mml:math id=\"M222\" display=\"block\"><mml:mrow><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>4</mml:mn></mml:mfenced></mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>K</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq94\"><alternatives><tex-math id=\"M223\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dt$$\\end{document}</tex-math><mml:math id=\"M224\"><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Eque\"><alternatives><tex-math id=\"M225\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda \\left(x\\right)dt\\approx 1$$\\end{document}</tex-math><mml:math id=\"M226\" display=\"block\"><mml:mrow><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>≈</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ15\"><label>15</label><alternatives><tex-math id=\"M227\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{gathered} \\lambda \\left( x \\right)dt = 1,\\,\\, {\\text{diffusive}} \\hfill \\\\ \\lambda \\left( x \\right)dt \\ne 1,\\,\\, {\\text{jumpy}} \\hfill \\\\ \\end{gathered} $$\\end{document}</tex-math><mml:math id=\"M228\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mtext>diffusive</mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>≠</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mspace width=\"0.166667em\"/><mml:mspace width=\"0.166667em\"/><mml:mtext>jumpy</mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq95\"><alternatives><tex-math id=\"M229\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}^{\\left(2\\right)}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M230\"><mml:mrow><mml:msup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq96\"><alternatives><tex-math id=\"M231\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}^{\\left(2\\right)}\\left(x\\right)={D}^{\\left(2\\right)}\\left(x\\right) dt$$\\end{document}</tex-math><mml:math id=\"M232\"><mml:mrow><mml:msup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equf\"><alternatives><tex-math id=\"M233\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi }^{2}\\left(x\\right)\\lambda \\left(x\\right)dt={D}^{\\left(2\\right)}\\left(x\\right)dt$$\\end{document}</tex-math><mml:math id=\"M234\" display=\"block\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq97\"><alternatives><tex-math id=\"M235\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda \\left(x\\right)dt=1$$\\end{document}</tex-math><mml:math id=\"M236\"><mml:mrow><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ16\"><label>16</label><alternatives><tex-math id=\"M237\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi }^{2}\\left(x\\right)={D}^{\\left(2\\right)}\\left(x\\right) dt$$\\end{document}</tex-math><mml:math id=\"M238\" display=\"block\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq98\"><alternatives><tex-math id=\"M239\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi }^{2}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M240\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq99\"><alternatives><tex-math id=\"M241\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(2\\right)}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M242\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq100\"><alternatives><tex-math id=\"M243\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dt$$\\end{document}</tex-math><mml:math id=\"M244\"><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq101\"><alternatives><tex-math id=\"M245\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dt=0.001$$\\end{document}</tex-math><mml:math id=\"M246\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq102\"><alternatives><tex-math id=\"M247\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(1\\right)}\\left(x\\right)=-x$$\\end{document}</tex-math><mml:math id=\"M248\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq103\"><alternatives><tex-math id=\"M249\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(2\\right)}\\left(x\\right)=1$$\\end{document}</tex-math><mml:math id=\"M250\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq104\"><alternatives><tex-math id=\"M251\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(1\\right)}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M252\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq105\"><alternatives><tex-math id=\"M253\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda \\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M254\"><mml:mrow><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq106\"><alternatives><tex-math id=\"M255\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi }^{2}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M256\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq107\"><alternatives><tex-math id=\"M257\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda \\left(x\\right)dt\\approx 1$$\\end{document}</tex-math><mml:math id=\"M258\"><mml:mrow><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>≈</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq108\"><alternatives><tex-math id=\"M259\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi }^{2}\\left(x\\right)={D}^{\\left(2\\right)}\\left(x\\right)dt=0.001$$\\end{document}</tex-math><mml:math id=\"M260\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq109\"><alternatives><tex-math id=\"M261\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${10}^{6}$$\\end{document}</tex-math><mml:math id=\"M262\"><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>6</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq110\"><alternatives><tex-math id=\"M263\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{D}}}^{\\left(1\\right)}\\left({\\varvec{x}}\\right)=-{\\varvec{x}}$$\\end{document}</tex-math><mml:math id=\"M264\"><mml:mrow><mml:msup><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">D</mml:mi></mml:mrow></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"bold-italic\">x</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mrow><mml:mi mathvariant=\"bold-italic\">x</mml:mi></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq111\"><alternatives><tex-math id=\"M265\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{D}}}^{\\left(2\\right)}\\left({\\varvec{x}}\\right)=1$$\\end{document}</tex-math><mml:math id=\"M266\"><mml:mrow><mml:msup><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">D</mml:mi></mml:mrow></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"bold-italic\">x</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq112\"><alternatives><tex-math id=\"M267\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\varvec{d}}{\\varvec{t}}=0.001$$\\end{document}</tex-math><mml:math id=\"M268\"><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">d</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">t</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq113\"><alternatives><tex-math id=\"M269\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\varvec{\\lambda}}\\left({\\varvec{x}}\\right){\\varvec{d}}{\\varvec{t}}\\approx 1$$\\end{document}</tex-math><mml:math id=\"M270\"><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">λ</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"bold-italic\">x</mml:mi></mml:mrow></mml:mfenced><mml:mrow><mml:mi mathvariant=\"bold-italic\">d</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">t</mml:mi></mml:mrow><mml:mo>≈</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq114\"><alternatives><tex-math id=\"M271\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{\\sigma}}}_{{\\varvec{\\xi}}}^{2}\\left({\\varvec{x}}\\right)\\approx {{\\varvec{D}}}^{\\left(2\\right)}\\left({\\varvec{x}}\\right){\\varvec{d}}{\\varvec{t}}$$\\end{document}</tex-math><mml:math id=\"M272\"><mml:mrow><mml:msubsup><mml:mrow><mml:mi mathvariant=\"bold-italic\">σ</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">ξ</mml:mi></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"bold-italic\">x</mml:mi></mml:mrow></mml:mfenced><mml:mo>≈</mml:mo><mml:msup><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">D</mml:mi></mml:mrow></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"bold-italic\">x</mml:mi></mml:mrow></mml:mfenced><mml:mrow><mml:mi mathvariant=\"bold-italic\">d</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">t</mml:mi></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq115\"><alternatives><tex-math id=\"M273\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x(t)$$\\end{document}</tex-math><mml:math id=\"M274\"><mml:mrow><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq116\"><alternatives><tex-math id=\"M275\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(1\\right)}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M276\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq117\"><alternatives><tex-math id=\"M277\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(2\\right)}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M278\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ17\"><label>17</label><alternatives><tex-math id=\"M279\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx\\left(t\\right)={D}^{\\left(1\\right)}\\left(x,t\\right)dt+{\\xi }_{1}d{J}_{1}\\left(t\\right)+{\\xi }_{2}d{J}_{2}\\left(t\\right),$$\\end{document}</tex-math><mml:math id=\"M280\" display=\"block\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq118\"><alternatives><tex-math id=\"M281\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(1\\right)}\\left(x,t\\right)$$\\end{document}</tex-math><mml:math id=\"M282\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq119\"><alternatives><tex-math id=\"M283\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${J}_{1 }\\left(t\\right)$$\\end{document}</tex-math><mml:math id=\"M284\"><mml:mrow><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq120\"><alternatives><tex-math id=\"M285\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${J}_{2 }(t)$$\\end{document}</tex-math><mml:math id=\"M286\"><mml:mrow><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq121\"><alternatives><tex-math id=\"M287\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{1}$$\\end{document}</tex-math><mml:math id=\"M288\"><mml:msub><mml:mi>λ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq122\"><alternatives><tex-math id=\"M289\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{2}$$\\end{document}</tex-math><mml:math id=\"M290\"><mml:msub><mml:mi>λ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq123\"><alternatives><tex-math id=\"M291\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{1}$$\\end{document}</tex-math><mml:math id=\"M292\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq124\"><alternatives><tex-math id=\"M293\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{2}$$\\end{document}</tex-math><mml:math id=\"M294\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq125\"><alternatives><tex-math id=\"M295\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 1}^{2}$$\\end{document}</tex-math><mml:math id=\"M296\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq126\"><alternatives><tex-math id=\"M297\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 2}^{2}$$\\end{document}</tex-math><mml:math id=\"M298\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq127\"><alternatives><tex-math id=\"M299\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{1}$$\\end{document}</tex-math><mml:math id=\"M300\"><mml:msub><mml:mi>λ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq128\"><alternatives><tex-math id=\"M301\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ {\\lambda }_{2}$$\\end{document}</tex-math><mml:math id=\"M302\"><mml:msub><mml:mi>λ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq129\"><alternatives><tex-math id=\"M303\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 1}^{2}$$\\end{document}</tex-math><mml:math id=\"M304\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq130\"><alternatives><tex-math id=\"M305\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 2}^{2}$$\\end{document}</tex-math><mml:math id=\"M306\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq131\"><alternatives><tex-math id=\"M307\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x$$\\end{document}</tex-math><mml:math id=\"M308\"><mml:mi>x</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq132\"><alternatives><tex-math id=\"M309\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t$$\\end{document}</tex-math><mml:math id=\"M310\"><mml:mi>t</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq133\"><alternatives><tex-math id=\"M311\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d{J}_{1}\\left(t\\right)$$\\end{document}</tex-math><mml:math id=\"M312\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq134\"><alternatives><tex-math id=\"M313\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d{J}_{2}\\left(t\\right)$$\\end{document}</tex-math><mml:math id=\"M314\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq135\"><alternatives><tex-math id=\"M315\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(t,t+dt]$$\\end{document}</tex-math><mml:math id=\"M316\"><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">]</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq136\"><alternatives><tex-math id=\"M317\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d{J}_{1}\\left(t\\right)$$\\end{document}</tex-math><mml:math id=\"M318\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq137\"><alternatives><tex-math id=\"M319\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d{J}_{2}\\left(t\\right)$$\\end{document}</tex-math><mml:math id=\"M320\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ18\"><label>18</label><alternatives><tex-math id=\"M321\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{gathered} M^{\\left( 1 \\right)} \\left( {x,t} \\right) = D^{\\left( 1 \\right)} \\left( {x,t} \\right) \\hfill \\\\ M^{\\left( n \\right)} \\left( {x,t} \\right) = \\left\\langle {\\xi_{1}^{n} } \\right\\rangle {\\uplambda }_{1} \\left( {x,t} \\right) + \\left\\langle {\\xi_{2}^{n} } \\right\\rangle {\\uplambda }_{2} \\left( {x,t} \\right) for n \\ge 2 \\hfill \\\\ \\end{gathered} $$\\end{document}</tex-math><mml:math id=\"M322\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mi>D</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>n</mml:mi></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msubsup><mml:mi>ξ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msubsup></mml:mfenced><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msubsup><mml:mi>ξ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msubsup></mml:mfenced><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>x</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>n</mml:mi><mml:mo>≥</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq138\"><alternatives><tex-math id=\"M323\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(1\\right)}\\left(x\\right),$$\\end{document}</tex-math><mml:math id=\"M324\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq139\"><alternatives><tex-math id=\"M325\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\uplambda }_{1}\\left(x\\right),$$\\end{document}</tex-math><mml:math id=\"M326\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq140\"><alternatives><tex-math id=\"M327\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\uplambda }_{2}\\left(x\\right),$$\\end{document}</tex-math><mml:math id=\"M328\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq141\"><alternatives><tex-math id=\"M329\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 1}^{2}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M330\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq142\"><alternatives><tex-math id=\"M331\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 2}^{2}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M332\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ19\"><label>19</label><alternatives><tex-math id=\"M333\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(1\\right)}\\left(x\\right)={M}^{\\left(1\\right)}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M334\" display=\"block\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq143\"><alternatives><tex-math id=\"M335\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=2, 4, 6, 8$$\\end{document}</tex-math><mml:math id=\"M336\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mn>4</mml:mn><mml:mo>,</mml:mo><mml:mn>6</mml:mn><mml:mo>,</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq144\"><alternatives><tex-math id=\"M337\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{{\\xi }^{2l}}\\right\\rangle =\\frac{\\left(2l\\right)!}{{2}^{l}l!}\\left\\langle{{\\xi }^{2}}\\right\\rangle^{l}$$\\end{document}</tex-math><mml:math id=\"M338\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mi>l</mml:mi></mml:mrow></mml:msup></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn><mml:mi>l</mml:mi></mml:mfenced><mml:mo>!</mml:mo></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mi>l</mml:mi></mml:msup><mml:mi>l</mml:mi><mml:mo>!</mml:mo></mml:mrow></mml:mfrac><mml:msup><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mfenced><mml:mi>l</mml:mi></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq145\"><alternatives><tex-math id=\"M339\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{1}$$\\end{document}</tex-math><mml:math id=\"M340\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq146\"><alternatives><tex-math id=\"M341\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{2})$$\\end{document}</tex-math><mml:math id=\"M342\"><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ20\"><label>20</label><alternatives><tex-math id=\"M343\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{gathered} M^{\\left( 2 \\right)} \\left( x \\right) = \\sigma_{\\xi 1}^{2} \\left( x \\right){\\uplambda }_{1} \\left( x \\right) + \\sigma_{\\xi 2}^{2} \\left( x \\right){\\uplambda }_{2} \\left( x \\right) \\hfill \\\\ M^{\\left( 4 \\right)} \\left( x \\right) = 3\\left( {\\sigma_{\\xi 1}^{2} \\left( x \\right)} \\right)^{2} {\\uplambda }_{1} \\left( x \\right) + 3\\left( {\\sigma_{\\xi 2}^{2} \\left( x \\right)} \\right)^{2} {\\uplambda }_{2} \\left( x \\right) \\hfill \\\\ M^{\\left( 6 \\right)} \\left( x \\right) = 15\\left( {\\sigma_{\\xi 1}^{2} \\left( x \\right)} \\right)^{3} {\\uplambda }_{1} \\left( x \\right) + 15\\left( {\\sigma_{\\xi 2}^{2} \\left( x \\right)} \\right)^{3} {\\uplambda }_{2} \\left( x \\right) \\hfill \\\\ M^{\\left( 8 \\right)} \\left( x \\right) = 105\\left( {\\sigma_{\\xi 1}^{2} \\left( x \\right)} \\right)^{4} {\\uplambda }_{1} \\left( x \\right) + 105\\left( {\\sigma_{\\xi 2}^{2} \\left( x \\right)} \\right)^{4} {\\uplambda }_{2} \\left( x \\right) \\hfill \\\\ \\end{gathered} $$\\end{document}</tex-math><mml:math id=\"M344\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>4</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>3</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mn>3</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>6</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>15</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mn>3</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mn>15</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mn>3</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msup><mml:mi>M</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>8</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>105</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mn>4</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mn>105</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mn>4</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq147\"><alternatives><tex-math id=\"M345\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{1}(x),{\\lambda }_{2 }(x),{\\sigma }_{\\xi 1}^{2}(x),{\\sigma }_{\\xi 2}^{2}(x)$$\\end{document}</tex-math><mml:math id=\"M346\"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq148\"><alternatives><tex-math id=\"M347\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${M}^{\\left(2\\right)}\\left(x\\right),{M}^{\\left(4\\right)}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M348\"><mml:mrow><mml:msup><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>2</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>,</mml:mo><mml:msup><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>4</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq149\"><alternatives><tex-math id=\"M349\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${M}^{\\left(6\\right)}\\left(x\\right)$$\\end{document}</tex-math><mml:math id=\"M350\"><mml:mrow><mml:msup><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>6</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq150\"><alternatives><tex-math id=\"M351\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(1\\right)}\\left(x\\right)=-x$$\\end{document}</tex-math><mml:math id=\"M352\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq151\"><alternatives><tex-math id=\"M353\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 1}^{2}\\left(x\\right)=0.2$$\\end{document}</tex-math><mml:math id=\"M354\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq152\"><alternatives><tex-math id=\"M355\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 2}^{2}\\left(x\\right)=0.5$$\\end{document}</tex-math><mml:math id=\"M356\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq153\"><alternatives><tex-math id=\"M357\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\uplambda }_{1}\\left(x\\right)=0.6$$\\end{document}</tex-math><mml:math id=\"M358\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0.6</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq154\"><alternatives><tex-math id=\"M359\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\uplambda }_{2}\\left(x\\right)=0.4$$\\end{document}</tex-math><mml:math id=\"M360\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0.4</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq155\"><alternatives><tex-math id=\"M361\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dt$$\\end{document}</tex-math><mml:math id=\"M362\"><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq156\"><alternatives><tex-math id=\"M363\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda (per data point)=\\lambda \\left(per unit of time\\right)*dt$$\\end{document}</tex-math><mml:math id=\"M364\"><mml:mrow><mml:mi>λ</mml:mi><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi></mml:mfenced><mml:mrow/><mml:mo>∗</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq157\"><alternatives><tex-math id=\"M365\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dt=0.01$$\\end{document}</tex-math><mml:math id=\"M366\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq158\"><alternatives><tex-math id=\"M367\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta {\\varvec{t}}=0.01$$\\end{document}</tex-math><mml:math id=\"M368\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mrow><mml:mi mathvariant=\"bold-italic\">t</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq159\"><alternatives><tex-math id=\"M369\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{D}}}^{\\left(1\\right)}\\left({\\varvec{x}}\\right)=-{\\varvec{x}}$$\\end{document}</tex-math><mml:math id=\"M370\"><mml:mrow><mml:msup><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">D</mml:mi></mml:mrow></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"bold-italic\">x</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mrow><mml:mi mathvariant=\"bold-italic\">x</mml:mi></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq160\"><alternatives><tex-math id=\"M371\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{\\sigma}}}_{{\\varvec{\\xi}}1}^{2}\\left({\\varvec{x}}\\right)=0.2$$\\end{document}</tex-math><mml:math id=\"M372\"><mml:mrow><mml:msubsup><mml:mrow><mml:mi mathvariant=\"bold-italic\">σ</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">ξ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"bold-italic\">x</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq161\"><alternatives><tex-math id=\"M373\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{\\sigma}}}_{{\\varvec{\\xi}}2}^{2}\\left({\\varvec{x}}\\right)=0.5$$\\end{document}</tex-math><mml:math id=\"M374\"><mml:mrow><mml:msubsup><mml:mrow><mml:mi mathvariant=\"bold-italic\">σ</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"bold-italic\">x</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq162\"><alternatives><tex-math id=\"M375\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{\\lambda}}}_{1}\\left({\\varvec{x}}\\right)=0.6$$\\end{document}</tex-math><mml:math id=\"M376\"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"bold-italic\">λ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"bold-italic\">x</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0.6</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq163\"><alternatives><tex-math id=\"M377\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{\\lambda}}}_{2}\\left({\\varvec{x}}\\right)=0.4$$\\end{document}</tex-math><mml:math id=\"M378\"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"bold-italic\">λ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"bold-italic\">x</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0.4</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq164\"><alternatives><tex-math id=\"M379\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(1\\right)}\\left(x\\right)=-10x$$\\end{document}</tex-math><mml:math id=\"M380\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>10</mml:mn><mml:mi>x</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq165\"><alternatives><tex-math id=\"M381\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 1}^{2}\\left(x\\right)=b{x}^{2}$$\\end{document}</tex-math><mml:math id=\"M382\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>b</mml:mi><mml:msup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq166\"><alternatives><tex-math id=\"M383\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$b=0.001)$$\\end{document}</tex-math><mml:math id=\"M384\"><mml:mrow><mml:mi>b</mml:mi><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq167\"><alternatives><tex-math id=\"M385\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 2}^{2}\\left(x\\right)=1$$\\end{document}</tex-math><mml:math id=\"M386\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq168\"><alternatives><tex-math id=\"M387\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\uplambda }_{1}\\left(x\\right)=0.7$$\\end{document}</tex-math><mml:math id=\"M388\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0.7</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq169\"><alternatives><tex-math id=\"M389\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\uplambda }_{2}\\left(x\\right)=0.3$$\\end{document}</tex-math><mml:math id=\"M390\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0.3</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq170\"><alternatives><tex-math id=\"M391\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dt=0.001$$\\end{document}</tex-math><mml:math id=\"M392\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq171\"><alternatives><tex-math id=\"M393\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta t=0.001$$\\end{document}</tex-math><mml:math id=\"M394\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq172\"><alternatives><tex-math id=\"M395\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${D}^{\\left(1\\right)}\\left(x\\right)=-10x$$\\end{document}</tex-math><mml:math id=\"M396\"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>10</mml:mn><mml:mi>x</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq173\"><alternatives><tex-math id=\"M397\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 1}^{2}\\left(x\\right)=0.001{x}^{2}$$\\end{document}</tex-math><mml:math id=\"M398\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn><mml:msup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq174\"><alternatives><tex-math id=\"M399\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 2}^{2}\\left(x\\right)=1$$\\end{document}</tex-math><mml:math id=\"M400\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq175\"><alternatives><tex-math id=\"M401\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{1}\\left(x\\right)=0.7$$\\end{document}</tex-math><mml:math id=\"M402\"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0.7</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq176\"><alternatives><tex-math id=\"M403\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{2}\\left(x\\right)=0.3$$\\end{document}</tex-math><mml:math id=\"M404\"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0.3</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ21\"><label>21</label><alternatives><tex-math id=\"M405\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx\\left(t\\right)=\\mu dt+{\\xi }_{1}d{J}_{1}\\left(t\\right)+{\\xi }_{2}d{J}_{2}\\left(t\\right),$$\\end{document}</tex-math><mml:math id=\"M406\" display=\"block\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ22\"><label>22</label><alternatives><tex-math id=\"M407\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{gathered} M_{1} = \\mu \\hfill \\\\ M_{n} = \\left\\langle {\\xi_{1}^{n} } \\right\\rangle {\\uplambda }_{1} + \\left\\langle {\\xi_{2}^{n} } \\right\\rangle {\\uplambda }_{2} {\\text{for }}n \\ge 2, \\hfill \\\\ \\end{gathered} $$\\end{document}</tex-math><mml:math id=\"M408\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mi>μ</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mi>M</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msubsup><mml:mi>ξ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msubsup></mml:mfenced><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msubsup><mml:mi>ξ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msubsup></mml:mfenced><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mtext>for</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mi>n</mml:mi><mml:mo>≥</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq177\"><alternatives><tex-math id=\"M409\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${M}_{n}= \\underset{dt\\to 0}{{\\text{lim}}}\\frac{1}{dt}\\left\\langle{d{x}^{n}}\\right\\rangle$$\\end{document}</tex-math><mml:math id=\"M410\"><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:munder><mml:mtext>lim</mml:mtext><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">→</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:munder><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:msup><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq178\"><alternatives><tex-math id=\"M411\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx=x\\left(t+dt\\right)-x\\left(t\\right).$$\\end{document}</tex-math><mml:math id=\"M412\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mo>=</mml:mo><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mfenced><mml:mo>-</mml:mo><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ23\"><label>23</label><alternatives><tex-math id=\"M413\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{gathered} M_{1} = \\mu \\hfill \\\\ M_{2} = \\sigma_{\\xi 1}^{2} {\\uplambda }_{1} + \\sigma_{\\xi 2}^{2} {\\uplambda }_{2} \\hfill \\\\ M_{4} = 3\\left( {\\sigma_{\\xi 1}^{2} } \\right)^{2} {\\uplambda }_{1} + 3\\left( {\\sigma_{\\xi 2}^{2} } \\right)^{2} {\\uplambda }_{2} \\hfill \\\\ M_{6} = 15\\left( {\\sigma_{\\xi 1}^{2} } \\right)^{3} {\\uplambda }_{1} + 15\\left( {\\sigma_{\\xi 2}^{2} } \\right)^{3} {\\uplambda }_{2} \\hfill \\\\ M_{8} = 105\\left( {\\sigma_{\\xi 1}^{2} } \\right)^{4} {\\uplambda }_{1} + 105\\left( {\\sigma_{\\xi 2}^{2} } \\right)^{4} { \\lambda }_{2} \\hfill \\\\ \\end{gathered} $$\\end{document}</tex-math><mml:math id=\"M414\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mi>μ</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mi>M</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>3</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mn>3</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mi>M</mml:mi><mml:mn>6</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>15</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>3</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mn>15</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>3</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mi>M</mml:mi><mml:mn>8</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>105</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>4</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mn>105</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>4</mml:mn></mml:msup><mml:msub><mml:mi>λ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq179\"><alternatives><tex-math id=\"M415\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu $$\\end{document}</tex-math><mml:math id=\"M416\"><mml:mi>μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq180\"><alternatives><tex-math id=\"M417\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{1},{\\lambda }_{2 },{\\sigma }_{\\xi 1}^{2},{\\sigma }_{\\xi 2}^{2}$$\\end{document}</tex-math><mml:math id=\"M418\"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq181\"><alternatives><tex-math id=\"M419\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu =1$$\\end{document}</tex-math><mml:math id=\"M420\"><mml:mrow><mml:mi>μ</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq182\"><alternatives><tex-math id=\"M421\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 1}^{2}=1$$\\end{document}</tex-math><mml:math id=\"M422\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq183\"><alternatives><tex-math id=\"M423\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 2}^{2}=0.3$$\\end{document}</tex-math><mml:math id=\"M424\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.3</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq184\"><alternatives><tex-math id=\"M425\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{1}=0.4$$\\end{document}</tex-math><mml:math id=\"M426\"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.4</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq185\"><alternatives><tex-math id=\"M427\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{2}=0.6$$\\end{document}</tex-math><mml:math id=\"M428\"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.6</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq186\"><alternatives><tex-math id=\"M429\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x\\left(t\\right)$$\\end{document}</tex-math><mml:math id=\"M430\"><mml:mrow><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq187\"><alternatives><tex-math id=\"M431\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dt=0.001$$\\end{document}</tex-math><mml:math id=\"M432\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq188\"><alternatives><tex-math id=\"M433\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x\\left(t\\right)$$\\end{document}</tex-math><mml:math id=\"M434\"><mml:mrow><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq189\"><alternatives><tex-math id=\"M435\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$y(t)$$\\end{document}</tex-math><mml:math id=\"M436\"><mml:mrow><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq190\"><alternatives><tex-math id=\"M437\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x(t)$$\\end{document}</tex-math><mml:math id=\"M438\"><mml:mrow><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq191\"><alternatives><tex-math id=\"M439\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$y\\left(t\\right)=x\\left(t+\\Delta t\\right)-x\\left(t\\right)$$\\end{document}</tex-math><mml:math id=\"M440\"><mml:mrow><mml:mi>y</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>t</mml:mi></mml:mfenced><mml:mo>-</mml:mo><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq192\"><alternatives><tex-math id=\"M441\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$y(t)$$\\end{document}</tex-math><mml:math id=\"M442\"><mml:mrow><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq193\"><alternatives><tex-math id=\"M443\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${10}^{6}$$\\end{document}</tex-math><mml:math id=\"M444\"><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>6</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq194\"><alternatives><tex-math id=\"M445\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\varvec{\\mu}}=1$$\\end{document}</tex-math><mml:math id=\"M446\"><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">μ</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq195\"><alternatives><tex-math id=\"M447\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{\\upsigma}}}_{{\\varvec{\\upxi}}1}^{2}=1$$\\end{document}</tex-math><mml:math id=\"M448\"><mml:mrow><mml:msubsup><mml:mrow><mml:mi mathvariant=\"bold\">σ</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold\">ξ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq196\"><alternatives><tex-math id=\"M449\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{\\sigma}}}_{{\\varvec{\\xi}}2}^{2}=0.3$$\\end{document}</tex-math><mml:math id=\"M450\"><mml:mrow><mml:msubsup><mml:mrow><mml:mi mathvariant=\"bold-italic\">σ</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.3</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq197\"><alternatives><tex-math id=\"M451\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{\\uplambda}}}_{1}=0.4$$\\end{document}</tex-math><mml:math id=\"M452\"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"bold\">λ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.4</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq198\"><alternatives><tex-math id=\"M453\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{\\lambda}}}_{2}=0.6$$\\end{document}</tex-math><mml:math id=\"M454\"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"bold-italic\">λ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.6</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq199\"><alternatives><tex-math id=\"M455\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta {\\varvec{t}}=0.001$$\\end{document}</tex-math><mml:math id=\"M456\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mrow><mml:mi mathvariant=\"bold-italic\">t</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq200\"><alternatives><tex-math id=\"M457\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\varvec{y}}\\left({\\varvec{t}}\\right)={\\varvec{x}}\\left({\\varvec{t}}+\\Delta {\\varvec{t}}\\right)-{\\varvec{x}}\\left({\\varvec{t}}\\right)$$\\end{document}</tex-math><mml:math id=\"M458\"><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">y</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"bold-italic\">t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mrow><mml:mi mathvariant=\"bold-italic\">x</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"bold-italic\">t</mml:mi></mml:mrow><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mrow><mml:mi mathvariant=\"bold-italic\">t</mml:mi></mml:mrow></mml:mfenced><mml:mo>-</mml:mo><mml:mrow><mml:mi mathvariant=\"bold-italic\">x</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"bold-italic\">t</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq201\"><alternatives><tex-math id=\"M459\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$y(t)$$\\end{document}</tex-math><mml:math id=\"M460\"><mml:mrow><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq202\"><alternatives><tex-math id=\"M461\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=1, 2, 4, 6, 8$$\\end{document}</tex-math><mml:math id=\"M462\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mn>4</mml:mn><mml:mo>,</mml:mo><mml:mn>6</mml:mn><mml:mo>,</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq203\"><alternatives><tex-math id=\"M463\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu \\approx 1.04$$\\end{document}</tex-math><mml:math id=\"M464\"><mml:mrow><mml:mi>μ</mml:mi><mml:mo>≈</mml:mo><mml:mn>1.04</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq204\"><alternatives><tex-math id=\"M465\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 1}^{2}\\approx 1.0002$$\\end{document}</tex-math><mml:math id=\"M466\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>≈</mml:mo><mml:mn>1.0002</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq205\"><alternatives><tex-math id=\"M467\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 2}^{2}\\approx 0.3004$$\\end{document}</tex-math><mml:math id=\"M468\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>≈</mml:mo><mml:mn>0.3004</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq206\"><alternatives><tex-math id=\"M469\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\uplambda }_{1}\\approx 0.3992$$\\end{document}</tex-math><mml:math id=\"M470\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>≈</mml:mo><mml:mn>0.3992</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq207\"><alternatives><tex-math id=\"M471\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\uplambda }_{2}\\approx 0.6007$$\\end{document}</tex-math><mml:math id=\"M472\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>≈</mml:mo><mml:mn>0.6007</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ24\"><label>24</label><alternatives><tex-math id=\"M473\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx\\left(t\\right)=\\mu dt+{\\xi }_{1}d{J}_{1}\\left(t\\right)+{\\xi }_{2}d{J}_{2}\\left(t\\right)+{\\xi }_{3}d{J}_{3}(t)$$\\end{document}</tex-math><mml:math id=\"M474\" display=\"block\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq208\"><alternatives><tex-math id=\"M475\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d{J}_{1}\\left(t\\right)$$\\end{document}</tex-math><mml:math id=\"M476\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq209\"><alternatives><tex-math id=\"M477\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d{J}_{2}\\left(t\\right)$$\\end{document}</tex-math><mml:math id=\"M478\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq210\"><alternatives><tex-math id=\"M479\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d{J}_{3}\\left(t\\right)$$\\end{document}</tex-math><mml:math id=\"M480\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq211\"><alternatives><tex-math id=\"M481\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu $$\\end{document}</tex-math><mml:math id=\"M482\"><mml:mi>μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq212\"><alternatives><tex-math id=\"M483\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{1},{\\lambda }_{2 },{\\lambda }_{3},{\\sigma }_{\\xi 1}^{2},{\\sigma }_{\\xi 2}^{2},{\\sigma }_{\\xi 3}^{2}$$\\end{document}</tex-math><mml:math id=\"M484\"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ25\"><label>25</label><alternatives><tex-math id=\"M485\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{gathered} M_{1} = \\mu \\hfill \\\\ M_{n} = \\left\\langle {\\xi_{1}^{n} } \\right\\rangle {\\uplambda }_{1} + \\left\\langle {\\xi_{2}^{n} } \\right\\rangle {\\uplambda }_{2} + \\left\\langle {\\xi_{3}^{n} } \\right\\rangle {\\uplambda }_{3} {\\text{for }}n \\ge 2, \\hfill \\\\ \\end{gathered} $$\\end{document}</tex-math><mml:math id=\"M486\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mi>μ</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mi>M</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msubsup><mml:mi>ξ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msubsup></mml:mfenced><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msubsup><mml:mi>ξ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msubsup></mml:mfenced><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msubsup><mml:mi>ξ</mml:mi><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msubsup></mml:mfenced><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mrow><mml:mtext>for</mml:mtext><mml:mspace width=\"0.333333em\"/></mml:mrow><mml:mi>n</mml:mi><mml:mo>≥</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equ26\"><label>26</label><alternatives><tex-math id=\"M487\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu ={M}_{1}$$\\end{document}</tex-math><mml:math id=\"M488\" display=\"block\"><mml:mrow><mml:mi>μ</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>M</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq213\"><alternatives><tex-math id=\"M489\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=2, 4, 6, 8, 10, 12$$\\end{document}</tex-math><mml:math id=\"M490\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mn>4</mml:mn><mml:mo>,</mml:mo><mml:mn>6</mml:mn><mml:mo>,</mml:mo><mml:mn>8</mml:mn><mml:mo>,</mml:mo><mml:mn>10</mml:mn><mml:mo>,</mml:mo><mml:mn>12</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq214\"><alternatives><tex-math id=\"M491\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{{\\xi }^{2l}}\\right\\rangle =\\frac{2l!}{{2}^{l}l!}\\left\\langle{{\\xi }^{2}}\\right\\rangle^{l}$$\\end{document}</tex-math><mml:math id=\"M492\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mi>l</mml:mi></mml:mrow></mml:msup></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mi>l</mml:mi><mml:mo>!</mml:mo></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mi>l</mml:mi></mml:msup><mml:mi>l</mml:mi><mml:mo>!</mml:mo></mml:mrow></mml:mfrac><mml:msup><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mfenced><mml:mi>l</mml:mi></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq215\"><alternatives><tex-math id=\"M493\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{1,} {\\xi }_{2}$$\\end{document}</tex-math><mml:math id=\"M494\"><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:msub><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq216\"><alternatives><tex-math id=\"M495\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{3}$$\\end{document}</tex-math><mml:math id=\"M496\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq217\"><alternatives><tex-math id=\"M497\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{1},{\\lambda }_{2 },{\\lambda }_{3},{\\sigma }_{\\xi 1}^{2},{\\sigma }_{\\xi 2}^{2},{\\sigma }_{\\xi 3}^{2}$$\\end{document}</tex-math><mml:math id=\"M498\"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ27\"><label>27</label><alternatives><tex-math id=\"M499\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{gathered} M_{2} = \\sigma_{\\xi 1}^{2} {\\uplambda }_{1} + \\sigma_{\\xi 2}^{2} {\\uplambda }_{2} + \\sigma_{\\xi 3}^{2} {\\uplambda }_{3} \\hfill \\\\ M_{4} = 3\\left( {\\sigma_{\\xi 1}^{2} } \\right)^{2} {\\uplambda }_{1} + 3\\left( {\\sigma_{\\xi 2}^{2} } \\right)^{2} {\\uplambda }_{2} + 3\\left( {\\sigma_{\\xi 3}^{2} } \\right)^{2} {\\uplambda }_{3} \\hfill \\\\ M_{6} = 15\\left( {\\sigma_{\\xi 1}^{2} } \\right)^{3} {\\uplambda }_{1} + 15\\left( {\\sigma_{\\xi 2}^{2} } \\right)^{3} {\\uplambda }_{2} + 15\\left( {\\sigma_{\\xi 3}^{2} } \\right)^{3} {\\uplambda }_{3} \\hfill \\\\ M_{8} = 105\\left( {\\sigma_{\\xi 1}^{2} } \\right)^{4} {\\uplambda }_{1} + 105\\left( {\\sigma_{\\xi 2}^{2} } \\right)^{4} {\\uplambda }_{2} + 105\\left( {\\sigma_{\\xi 3}^{2} } \\right)^{4} {\\uplambda }_{3} \\hfill \\\\ M_{10} = 945\\left( {\\sigma_{\\xi 1}^{2} } \\right)^{5} {\\uplambda }_{1} + 945\\left( {\\sigma_{\\xi 2}^{2} } \\right)^{5} {\\uplambda }_{2} + 945\\left( {\\sigma_{\\xi 3}^{2} } \\right)^{5} {\\uplambda }_{3} \\hfill \\\\ M_{12} = 10395\\left( {\\sigma_{\\xi 1}^{2} } \\right)^{6} {\\uplambda }_{1} + 10395\\left( {\\sigma_{\\xi 2}^{2} } \\right)^{6} {\\uplambda }_{2} + 10395\\left( {\\sigma_{\\xi 3}^{2} } \\right)^{6} { \\lambda }_{3} \\hfill \\\\ \\end{gathered} $$\\end{document}</tex-math><mml:math id=\"M500\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mi>M</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>3</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mn>3</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mn>3</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mi>M</mml:mi><mml:mn>6</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>15</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>3</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mn>15</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>3</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mn>15</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>3</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mi>M</mml:mi><mml:mn>8</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>105</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>4</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mn>105</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>4</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mn>105</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>4</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mi>M</mml:mi><mml:mn>10</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>945</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>5</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mn>945</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>5</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mn>945</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>5</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msub><mml:mi>M</mml:mi><mml:mn>12</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>10395</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>6</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mn>10395</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>6</mml:mn></mml:msup><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mn>10395</mml:mn><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:mn>6</mml:mn></mml:msup><mml:msub><mml:mi>λ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq218\"><alternatives><tex-math id=\"M501\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x(t)$$\\end{document}</tex-math><mml:math id=\"M502\"><mml:mrow><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq219\"><alternatives><tex-math id=\"M503\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu =5$$\\end{document}</tex-math><mml:math id=\"M504\"><mml:mrow><mml:mi>μ</mml:mi><mml:mo>=</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq220\"><alternatives><tex-math id=\"M505\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 1}^{2}=0.2$$\\end{document}</tex-math><mml:math id=\"M506\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq221\"><alternatives><tex-math id=\"M507\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 2}^{2}=0.6$$\\end{document}</tex-math><mml:math id=\"M508\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.6</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq222\"><alternatives><tex-math id=\"M509\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\sigma }_{\\xi 3}^{2}=10$$\\end{document}</tex-math><mml:math id=\"M510\"><mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:mn>10</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq223\"><alternatives><tex-math id=\"M511\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{1}=0.3$$\\end{document}</tex-math><mml:math id=\"M512\"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.3</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq224\"><alternatives><tex-math id=\"M513\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{2}=0.2$$\\end{document}</tex-math><mml:math id=\"M514\"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq225\"><alternatives><tex-math id=\"M515\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\lambda }_{3}=0.5$$\\end{document}</tex-math><mml:math id=\"M516\"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq226\"><alternatives><tex-math id=\"M517\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x(t)$$\\end{document}</tex-math><mml:math id=\"M518\"><mml:mrow><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq227\"><alternatives><tex-math id=\"M519\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dt=0.001$$\\end{document}</tex-math><mml:math id=\"M520\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq228\"><alternatives><tex-math id=\"M521\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$x(t)$$\\end{document}</tex-math><mml:math id=\"M522\"><mml:mrow><mml:mi>x</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq229\"><alternatives><tex-math id=\"M523\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$y\\left(t\\right)=x\\left(t+\\Delta t\\right)-x\\left(t\\right)$$\\end{document}</tex-math><mml:math id=\"M524\"><mml:mrow><mml:mi>y</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mi>t</mml:mi></mml:mfenced><mml:mo>-</mml:mo><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq230\"><alternatives><tex-math id=\"M525\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${10}^{7}$$\\end{document}</tex-math><mml:math id=\"M526\"><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>7</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq231\"><alternatives><tex-math id=\"M527\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\varvec{\\mu}}=5$$\\end{document}</tex-math><mml:math id=\"M528\"><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">μ</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq232\"><alternatives><tex-math id=\"M529\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{\\sigma}}}_{{\\varvec{\\xi}}1}^{2}=0.2$$\\end{document}</tex-math><mml:math id=\"M530\"><mml:mrow><mml:msubsup><mml:mrow><mml:mi mathvariant=\"bold-italic\">σ</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">ξ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq233\"><alternatives><tex-math id=\"M531\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{\\sigma}}}_{{\\varvec{\\xi}}2}^{2}=0.6$$\\end{document}</tex-math><mml:math id=\"M532\"><mml:mrow><mml:msubsup><mml:mrow><mml:mi mathvariant=\"bold-italic\">σ</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">ξ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.6</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq234\"><alternatives><tex-math id=\"M533\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{\\sigma}}}_{{\\varvec{\\xi}}3}^{2}=10$$\\end{document}</tex-math><mml:math id=\"M534\"><mml:mrow><mml:msubsup><mml:mrow><mml:mi mathvariant=\"bold-italic\">σ</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">ξ</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:mn>10</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq235\"><alternatives><tex-math id=\"M535\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{\\lambda}}}_{1}=0.3$$\\end{document}</tex-math><mml:math id=\"M536\"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"bold-italic\">λ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.3</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq236\"><alternatives><tex-math id=\"M537\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{\\lambda}}}_{2}=0.2$$\\end{document}</tex-math><mml:math id=\"M538\"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"bold-italic\">λ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq237\"><alternatives><tex-math id=\"M539\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{\\varvec{\\lambda}}}_{3}=0.5$$\\end{document}</tex-math><mml:math id=\"M540\"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"bold-italic\">λ</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq238\"><alternatives><tex-math id=\"M541\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta {\\varvec{t}}=0.001$$\\end{document}</tex-math><mml:math id=\"M542\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mrow><mml:mi mathvariant=\"bold-italic\">t</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq239\"><alternatives><tex-math id=\"M543\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\varvec{y}}\\left({\\varvec{t}}\\right)={\\varvec{x}}\\left({\\varvec{t}}+\\Delta {\\varvec{t}}\\right)-{\\varvec{x}}\\left({\\varvec{t}}\\right)$$\\end{document}</tex-math><mml:math id=\"M544\"><mml:mrow><mml:mrow><mml:mi mathvariant=\"bold-italic\">y</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"bold-italic\">t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mrow><mml:mi mathvariant=\"bold-italic\">x</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"bold-italic\">t</mml:mi></mml:mrow><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:mrow><mml:mi mathvariant=\"bold-italic\">t</mml:mi></mml:mrow></mml:mfenced><mml:mo>-</mml:mo><mml:mrow><mml:mi mathvariant=\"bold-italic\">x</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi mathvariant=\"bold-italic\">t</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq240\"><alternatives><tex-math id=\"M545\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$y(t)$$\\end{document}</tex-math><mml:math id=\"M546\"><mml:mrow><mml:mi>y</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq241\"><alternatives><tex-math id=\"M547\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n=1, 2, 4, 6, 8, 10, 12$$\\end{document}</tex-math><mml:math id=\"M548\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mn>4</mml:mn><mml:mo>,</mml:mo><mml:mn>6</mml:mn><mml:mo>,</mml:mo><mml:mn>8</mml:mn><mml:mo>,</mml:mo><mml:mn>10</mml:mn><mml:mo>,</mml:mo><mml:mn>12</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equg\"><alternatives><tex-math id=\"M549\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu \\approx 4.9, {\\sigma }_{\\xi 1}^{2}\\approx 0.2001, {\\sigma }_{\\xi 2}^{2}\\approx 0.6010, {\\sigma }_{\\xi 3}^{2}\\approx 9.9928,$$\\end{document}</tex-math><mml:math id=\"M550\" display=\"block\"><mml:mrow><mml:mi>μ</mml:mi><mml:mo>≈</mml:mo><mml:mn>4.9</mml:mn><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>≈</mml:mo><mml:mn>0.2001</mml:mn><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>≈</mml:mo><mml:mn>0.6010</mml:mn><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>≈</mml:mo><mml:mn>9.9928</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equh\"><alternatives><tex-math id=\"M551\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\uplambda }_{1}\\approx 0.3002, {\\uplambda }_{2}\\approx 0.2010, {\\uplambda }_{3}\\approx 0.4988.$$\\end{document}</tex-math><mml:math id=\"M552\" display=\"block\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>≈</mml:mo><mml:mn>0.3002</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>≈</mml:mo><mml:mn>0.2010</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>≈</mml:mo><mml:mn>0.4988</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equi\"><alternatives><tex-math id=\"M553\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx\\left(t\\right)={D}^{\\left(1\\right)}\\left(x\\right)dt+\\sum_{i=1}^{N}{\\xi }_{i}d{J}_{i}\\left(t\\right)$$\\end{document}</tex-math><mml:math id=\"M554\" display=\"block\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:munderover><mml:msub><mml:mi>ξ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq242\"><alternatives><tex-math id=\"M555\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx$$\\end{document}</tex-math><mml:math id=\"M556\"><mml:mrow><mml:mi mathvariant=\"italic\">dx</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq243\"><alternatives><tex-math id=\"M557\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx$$\\end{document}</tex-math><mml:math id=\"M558\"><mml:mrow><mml:mi mathvariant=\"italic\">dx</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq244\"><alternatives><tex-math id=\"M559\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dJ$$\\end{document}</tex-math><mml:math id=\"M560\"><mml:mrow><mml:mi mathvariant=\"italic\">dJ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq245\"><alternatives><tex-math id=\"M561\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\xi $$\\end{document}</tex-math><mml:math id=\"M562\"><mml:mi>ξ</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equj\"><alternatives><tex-math id=\"M563\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{dx\\left(t\\right){|}_{x\\left(t\\right)=x}}\\right\\rangle ={D}^{\\left(1\\right)}\\left(x\\right)dt+\\left\\langle{\\xi dJ}\\right\\rangle$$\\end{document}</tex-math><mml:math id=\"M564\" display=\"block\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:msub><mml:mo stretchy=\"false\">|</mml:mo><mml:mrow><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>ξ</mml:mi><mml:mi>d</mml:mi><mml:mi>J</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equk\"><alternatives><tex-math id=\"M565\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$={D}^{\\left(1\\right)}\\left(x\\right)dt+\\left\\langle{\\xi }\\right\\rangle\n\\left\\langle{dJ}\\right\\rangle$$\\end{document}</tex-math><mml:math id=\"M566\" display=\"block\"><mml:mrow><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:mi>ξ</mml:mi></mml:mfenced><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi mathvariant=\"italic\">dJ</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq246\"><alternatives><tex-math id=\"M567\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\xi $$\\end{document}</tex-math><mml:math id=\"M568\"><mml:mi>ξ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq247\"><alternatives><tex-math id=\"M569\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{\\xi }\\right\\rangle =0$$\\end{document}</tex-math><mml:math id=\"M570\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:mi>ξ</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equl\"><alternatives><tex-math id=\"M571\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{dx\\left(t\\right){|}_{x\\left(t\\right)=x}}\\right\\rangle ={D}^{\\left(1\\right)}\\left(x\\right)dt,$$\\end{document}</tex-math><mml:math id=\"M572\" display=\"block\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:msub><mml:mo stretchy=\"false\">|</mml:mo><mml:mrow><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq248\"><alternatives><tex-math id=\"M573\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx$$\\end{document}</tex-math><mml:math id=\"M574\"><mml:mrow><mml:mi mathvariant=\"italic\">dx</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq249\"><alternatives><tex-math id=\"M575\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n\\ge 2$$\\end{document}</tex-math><mml:math id=\"M576\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>≥</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equm\"><alternatives><tex-math id=\"M577\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{dx{\\left(t\\right)}^{n}{|}_{x\\left(t\\right)=x}}\\right\\rangle = \\left\\langle{{\\left[{D}^{\\left(1\\right)}\\left(x\\right)dt+\\xi dJ\\right]}^{n}}\\right\\rangle$$\\end{document}</tex-math><mml:math id=\"M578\" display=\"block\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow><mml:mi>n</mml:mi></mml:msup><mml:msub><mml:mo stretchy=\"false\">|</mml:mo><mml:mrow><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:mfenced close=\"]\" open=\"[\"><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mi>ξ</mml:mi><mml:mi>d</mml:mi><mml:mi>J</mml:mi></mml:mfenced></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equn\"><alternatives><tex-math id=\"M579\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$=\\sum_{k=0}^{n}\\left\\langle{\\left[\\left(\\genfrac{}{}{0pt}{}{n}{k}\\right){\\left({D}^{\\left(1\\right)}\\left(x\\right)dt\\right)}^{n-k}{\\left(\\xi dJ\\right)}^{k}\\right]}\\right\\rangle$$\\end{document}</tex-math><mml:math id=\"M580\" display=\"block\"><mml:mrow><mml:mo>=</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:munderover><mml:mfenced close=\"〉\" open=\"〈\"><mml:mfenced close=\"]\" open=\"[\"><mml:mfenced close=\")\" open=\"(\"><mml:mfrac linethickness=\"0.0pt\"><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:mfrac></mml:mfenced><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>-</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>ξ</mml:mi><mml:mi>d</mml:mi><mml:mi>J</mml:mi></mml:mfenced></mml:mrow><mml:mi>k</mml:mi></mml:msup></mml:mfenced></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq250\"><alternatives><tex-math id=\"M581\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathcal{O}(dt)$$\\end{document}</tex-math><mml:math id=\"M582\"><mml:mrow><mml:mi mathvariant=\"script\">O</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equo\"><alternatives><tex-math id=\"M583\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{dx{\\left(t\\right)}^{n}{|}_{x\\left(t\\right)=x}}\\right\\rangle =\\left\\langle{{\\xi }^{n}}\\right\\rangle\\lambda \\left(x\\right)dt,$$\\end{document}</tex-math><mml:math id=\"M584\" display=\"block\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow><mml:mi>n</mml:mi></mml:msup><mml:msub><mml:mo stretchy=\"false\">|</mml:mo><mml:mrow><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:mi>λ</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq251\"><alternatives><tex-math id=\"M585\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx$$\\end{document}</tex-math><mml:math id=\"M586\"><mml:mrow><mml:mi mathvariant=\"italic\">dx</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq252\"><alternatives><tex-math id=\"M587\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx$$\\end{document}</tex-math><mml:math id=\"M588\"><mml:mrow><mml:mi mathvariant=\"italic\">dx</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq253\"><alternatives><tex-math id=\"M589\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d{J}_{1}$$\\end{document}</tex-math><mml:math id=\"M590\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq254\"><alternatives><tex-math id=\"M591\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d{J}_{2}$$\\end{document}</tex-math><mml:math id=\"M592\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq255\"><alternatives><tex-math id=\"M593\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{1}$$\\end{document}</tex-math><mml:math id=\"M594\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq256\"><alternatives><tex-math id=\"M595\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{2}$$\\end{document}</tex-math><mml:math id=\"M596\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equp\"><alternatives><tex-math id=\"M597\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{dx\\left(t\\right){|}_{x\\left(t\\right)=x}}\\right\\rangle ={D}^{\\left(1\\right)}\\left(x\\right)dt+\\left\\langle{{\\xi }_{1}d{J}_{1}}\\right\\rangle+\\left\\langle{{\\xi }_{2}d{J}_{2}}\\right\\rangle$$\\end{document}</tex-math><mml:math id=\"M598\" display=\"block\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:msub><mml:mo stretchy=\"false\">|</mml:mo><mml:mrow><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equq\"><alternatives><tex-math id=\"M599\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$={D}^{\\left(1\\right)}\\left(x\\right)dt+\\left\\langle{{\\xi }_{1}}\\right\\rangle\n\\left\\langle{d{J}_{1}}\\right\\rangle+\\left\\langle{{\\xi }_{2}}\\right\\rangle\n\\left\\langle{d{J}_{2}}\\right\\rangle$$\\end{document}</tex-math><mml:math id=\"M600\" display=\"block\"><mml:mrow><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mfenced><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equr\"><alternatives><tex-math id=\"M601\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$={D}^{\\left(1\\right)}\\left(x\\right)dt+\\left\\langle{{\\xi }_{1}}\\right\\rangle{\\lambda }_{1}\\left(x\\right)dt+\\left\\langle{{\\xi }_{2}}\\right\\rangle{\\lambda }_{2}\\left(x\\right)dt.$$\\end{document}</tex-math><mml:math id=\"M602\" display=\"block\"><mml:mrow><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:msub><mml:mi>λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mfenced><mml:msub><mml:mi>λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq257\"><alternatives><tex-math id=\"M603\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{1}$$\\end{document}</tex-math><mml:math id=\"M604\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq258\"><alternatives><tex-math id=\"M605\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{2}$$\\end{document}</tex-math><mml:math id=\"M606\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq259\"><alternatives><tex-math id=\"M607\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{{\\xi }_{1}}\\right\\rangle =0$$\\end{document}</tex-math><mml:math id=\"M608\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq260\"><alternatives><tex-math id=\"M609\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{{\\xi }_{2}}\\right\\rangle =0$$\\end{document}</tex-math><mml:math id=\"M610\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equs\"><alternatives><tex-math id=\"M611\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{dx\\left(t\\right){|}_{x\\left(t\\right)=x}}\\right\\rangle ={D}^{\\left(1\\right)}\\left(x\\right)dt,$$\\end{document}</tex-math><mml:math id=\"M612\" display=\"block\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:msub><mml:mo stretchy=\"false\">|</mml:mo><mml:mrow><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq261\"><alternatives><tex-math id=\"M613\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx$$\\end{document}</tex-math><mml:math id=\"M614\"><mml:mrow><mml:mi mathvariant=\"italic\">dx</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq262\"><alternatives><tex-math id=\"M615\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n\\ge 2$$\\end{document}</tex-math><mml:math id=\"M616\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>≥</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ28\"><label>28</label><alternatives><tex-math id=\"M617\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{gathered} \\left\\langle {dx\\left( t \\right)^{n} |_{x\\left( t \\right) = x} } \\right\\rangle { } = \\left\\langle {\\left[ {D^{\\left( 1 \\right)} \\left( x \\right)dt + \\xi_{1} dJ_{1} + \\xi_{2} dJ_{2} } \\right]^{n} } \\right\\rangle \\hfill \\\\ = \\mathop \\sum \\limits_{l,m} \\left\\langle {\\left[ {A_{l,m,k} \\left( {D^{\\left( 1 \\right)} \\left( x \\right)dt} \\right)^{l} \\left( {\\xi_{1} dJ_{1} } \\right)^{m} \\left( {\\xi_{2} dJ_{2} } \\right)^{k} } \\right]} \\right\\rangle , \\hfill \\\\ \\end{gathered} $$\\end{document}</tex-math><mml:math id=\"M618\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mi>n</mml:mi></mml:msup><mml:msub><mml:mrow><mml:mo stretchy=\"false\">|</mml:mo></mml:mrow><mml:mrow><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mrow/><mml:mo>=</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mfenced close=\"]\" open=\"[\"><mml:mrow><mml:msup><mml:mi>D</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mi>n</mml:mi></mml:msup></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mo>=</mml:mo><mml:munder><mml:mo movablelimits=\"false\">∑</mml:mo><mml:mrow><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>m</mml:mi></mml:mrow></mml:munder><mml:mfenced close=\"〉\" open=\"〈\"><mml:mfenced close=\"]\" open=\"[\"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msup><mml:mi>D</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mn>1</mml:mn></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mi>l</mml:mi></mml:msup><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mi>m</mml:mi></mml:msup><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mi>k</mml:mi></mml:msup></mml:mrow></mml:mfenced></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq263\"><alternatives><tex-math id=\"M619\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${A}_{l,m,k}=n!/l!m!k!$$\\end{document}</tex-math><mml:math id=\"M620\"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>n</mml:mi><mml:mo>!</mml:mo><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>l</mml:mi><mml:mo>!</mml:mo><mml:mi>m</mml:mi><mml:mo>!</mml:mo><mml:mi>k</mml:mi><mml:mo>!</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq264\"><alternatives><tex-math id=\"M621\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$l+m+k=n$$\\end{document}</tex-math><mml:math id=\"M622\"><mml:mrow><mml:mi>l</mml:mi><mml:mo>+</mml:mo><mml:mi>m</mml:mi><mml:mo>+</mml:mo><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq265\"><alternatives><tex-math id=\"M623\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathcal{O}\\left(dt\\right)$$\\end{document}</tex-math><mml:math id=\"M624\"><mml:mrow><mml:mi mathvariant=\"script\">O</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equt\"><alternatives><tex-math id=\"M625\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{ dx{\\left(t\\right)}^{n}{|}_{x\\left(t\\right)=x}}\\right\\rangle =\\left\\langle{{\\left({\\xi }_{1}d{J}_{1}\\right)}^{n}+{\\left({\\xi }_{2}d{J}_{2}\\right)}^{n}}\\right\\rangle$$\\end{document}</tex-math><mml:math id=\"M626\" display=\"block\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow><mml:mi>n</mml:mi></mml:msup><mml:msub><mml:mo stretchy=\"false\">|</mml:mo><mml:mrow><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mi>n</mml:mi></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equu\"><alternatives><tex-math id=\"M627\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$=\\left\\langle{{{\\xi }_{1}}^{n}}\\right\\rangle\n\\left\\langle{{{dJ}_{1}}^{n}}\\right\\rangle+\\left\\langle{{{\\xi }_{2}}^{n}}\\right\\rangle\n\\left\\langle{{{dJ}_{2}}^{n}}\\right\\rangle,$$\\end{document}</tex-math><mml:math id=\"M628\" display=\"block\"><mml:mrow><mml:mo>=</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"italic\">dJ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"italic\">dJ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq266\"><alternatives><tex-math id=\"M629\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{{\\left(d{J}_{i}\\right)}^{m}}\\right\\rangle = {\\lambda }_{i}dt$$\\end{document}</tex-math><mml:math id=\"M630\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow><mml:mi>m</mml:mi></mml:msup></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq267\"><alternatives><tex-math id=\"M631\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d{J}_{1}$$\\end{document}</tex-math><mml:math id=\"M632\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq268\"><alternatives><tex-math id=\"M633\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d{J}_{2}$$\\end{document}</tex-math><mml:math id=\"M634\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equv\"><alternatives><tex-math id=\"M635\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${K}^{\\left(n\\right)}\\left(x\\right)=\\left\\langle{{{\\xi }_{1}}^{n}}\\right\\rangle{\\uplambda }_{1}\\left(x\\right)dt+\\left\\langle{{{\\xi }_{2}}^{n}}\\right\\rangle{\\uplambda }_{2}\\left(x\\right)dt,$$\\end{document}</tex-math><mml:math id=\"M636\" display=\"block\"><mml:mrow><mml:msup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>n</mml:mi></mml:mfenced></mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=\")\" open=\"(\"><mml:mi>x</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq269\"><alternatives><tex-math id=\"M637\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx$$\\end{document}</tex-math><mml:math id=\"M638\"><mml:mrow><mml:mi mathvariant=\"italic\">dx</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq270\"><alternatives><tex-math id=\"M639\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx$$\\end{document}</tex-math><mml:math id=\"M640\"><mml:mrow><mml:mi mathvariant=\"italic\">dx</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq271\"><alternatives><tex-math id=\"M641\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d{J}_{1},$$\\end{document}</tex-math><mml:math id=\"M642\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq272\"><alternatives><tex-math id=\"M643\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d{J}_{2},$$\\end{document}</tex-math><mml:math id=\"M644\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq273\"><alternatives><tex-math id=\"M645\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$d{J}_{3}$$\\end{document}</tex-math><mml:math id=\"M646\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq274\"><alternatives><tex-math id=\"M647\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{1},$$\\end{document}</tex-math><mml:math id=\"M648\"><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq275\"><alternatives><tex-math id=\"M649\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{2}$$\\end{document}</tex-math><mml:math id=\"M650\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq276\"><alternatives><tex-math id=\"M651\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{3}$$\\end{document}</tex-math><mml:math id=\"M652\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equw\"><alternatives><tex-math id=\"M653\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{dx\\left(t\\right)}\\right\\rangle =\\mu dt+\\left\\langle{{\\xi }_{1}d{J}_{1}}\\right\\rangle+\\left\\langle{{\\xi }_{2}d{J}_{2}}\\right\\rangle+\\left\\langle{{\\xi }_{3}d{J}_{3}}\\right\\rangle$$\\end{document}</tex-math><mml:math id=\"M654\" display=\"block\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equx\"><alternatives><tex-math id=\"M655\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$=\\mu dt+\\left\\langle{{\\xi }_{1}}\\right\\rangle\n\\left\\langle{d{J}_{1}}\\right\\rangle+\\left\\langle{{\\xi }_{2}}\\right\\rangle\n\\left\\langle{d{J}_{2}}\\right\\rangle+\\left\\langle{{\\xi }_{3}}\\right\\rangle\n\\left\\langle{d{J}_{3}}\\right\\rangle$$\\end{document}</tex-math><mml:math id=\"M656\" display=\"block\"><mml:mrow><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mfenced><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mfenced><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq277\"><alternatives><tex-math id=\"M657\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{1}$$\\end{document}</tex-math><mml:math id=\"M658\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq278\"><alternatives><tex-math id=\"M659\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{2}$$\\end{document}</tex-math><mml:math id=\"M660\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq279\"><alternatives><tex-math id=\"M661\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\xi }_{3}$$\\end{document}</tex-math><mml:math id=\"M662\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq280\"><alternatives><tex-math id=\"M663\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle {{\\xi }_{1}}\\right\\rangle =0$$\\end{document}</tex-math><mml:math id=\"M664\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq281\"><alternatives><tex-math id=\"M665\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle {{\\xi }_{2}}\\right\\rangle =0$$\\end{document}</tex-math><mml:math id=\"M666\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq282\"><alternatives><tex-math id=\"M667\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle {{\\xi }_{3}}\\right\\rangle =0$$\\end{document}</tex-math><mml:math id=\"M668\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equy\"><alternatives><tex-math id=\"M669\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle {dx\\left(t\\right)}\\right\\rangle =\\mu dt,$$\\end{document}</tex-math><mml:math id=\"M670\" display=\"block\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq283\"><alternatives><tex-math id=\"M671\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$dx$$\\end{document}</tex-math><mml:math id=\"M672\"><mml:mrow><mml:mi mathvariant=\"italic\">dx</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq284\"><alternatives><tex-math id=\"M673\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n\\ge 2$$\\end{document}</tex-math><mml:math id=\"M674\"><mml:mrow><mml:mi>n</mml:mi><mml:mo>≥</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ29\"><label>29</label><alternatives><tex-math id=\"M675\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\begin{gathered} \\left\\langle {dx\\left( t \\right)^{n} } \\right\\rangle = \\left\\langle {\\left[ {\\mu dt + \\xi _{1} dJ_{1} + \\xi _{2} dJ_{2} + \\xi _{3} dJ_{3} } \\right]^{n} } \\right\\rangle \\hfill \\\\ = \\sum\\limits_{{l,m}} {\\left\\langle {\\left[ {A_{{l,m,k,p}} \\left( {\\mu dt} \\right)^{l} \\left( {\\xi _{1} dJ_{1} } \\right)^{m} \\left( {\\xi _{2} dJ_{2} } \\right)^{k} \\left( {\\xi _{3} dJ_{3} } \\right)^{p} } \\right]} \\right\\rangle } , \\hfill \\\\ \\end{gathered} $$\\end{document}</tex-math><mml:math id=\"M676\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced><mml:mi>n</mml:mi></mml:msup></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mfenced close=\"]\" open=\"[\"><mml:mrow><mml:mi>μ</mml:mi><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mi>n</mml:mi></mml:msup></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mo>=</mml:mo><mml:munder><mml:mo movablelimits=\"false\">∑</mml:mo><mml:mrow><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>m</mml:mi></mml:mrow></mml:munder><mml:mfenced close=\"〉\" open=\"〈\"><mml:mfenced close=\"]\" open=\"[\"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:mi>μ</mml:mi><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mi>l</mml:mi></mml:msup><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mi>m</mml:mi></mml:msup><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mi>k</mml:mi></mml:msup><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mi>p</mml:mi></mml:msup></mml:mrow></mml:mfenced></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq285\"><alternatives><tex-math id=\"M677\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${A}_{l,m,k,p}=n!/l!m!k!, $$\\end{document}</tex-math><mml:math id=\"M678\"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>n</mml:mi><mml:mo>!</mml:mo><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>l</mml:mi><mml:mo>!</mml:mo><mml:mi>m</mml:mi><mml:mo>!</mml:mo><mml:mi>k</mml:mi><mml:mo>!</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq286\"><alternatives><tex-math id=\"M679\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$l+m+k+p=n$$\\end{document}</tex-math><mml:math id=\"M680\"><mml:mrow><mml:mi>l</mml:mi><mml:mo>+</mml:mo><mml:mi>m</mml:mi><mml:mo>+</mml:mo><mml:mi>k</mml:mi><mml:mo>+</mml:mo><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq287\"><alternatives><tex-math id=\"M681\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathcal{O}\\left(dt\\right)$$\\end{document}</tex-math><mml:math id=\"M682\"><mml:mrow><mml:mi mathvariant=\"script\">O</mml:mi><mml:mfenced close=\")\" open=\"(\"><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equaa\"><alternatives><tex-math id=\"M683\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{ dx{\\left(t\\right)}^{n}}\\right\\rangle=\\left\\langle{{\\left({\\xi }_{1}d{J}_{1}\\right)}^{n}+{\\left({\\xi }_{2}d{J}_{2}\\right)}^{n}+{\\left({\\xi }_{3}d{J}_{3}\\right)}^{n}}\\right\\rangle$$\\end{document}</tex-math><mml:math id=\"M684\" display=\"block\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mi>n</mml:mi></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mi>n</mml:mi></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mfenced></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mrow></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<disp-formula id=\"Equab\"><alternatives><tex-math id=\"M685\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$=\\left\\langle{{{\\xi }_{1}}^{n}}\\right\\rangle\n\\left\\langle{{{dJ}_{1}}^{n}}\\right\\rangle+\\left\\langle{{{\\xi }_{2}}^{n}}\\right\\rangle\n\\left\\langle{{{dJ}_{2}}^{n}}\\right\\rangle+\\left\\langle{{{\\xi }_{3}}^{n}}\\right\\rangle\n\\left\\langle{{{dJ}_{3}}^{n}}\\right\\rangle$$\\end{document}</tex-math><mml:math id=\"M686\" display=\"block\"><mml:mrow><mml:mo>=</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"italic\">dJ</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msub></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"italic\">dJ</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant=\"italic\">dJ</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq288\"><alternatives><tex-math id=\"M687\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{{\\left(d{J}_{i}\\right)}^{m}}\\right\\rangle ={\\lambda }_{i}dt$$\\end{document}</tex-math><mml:math id=\"M688\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>d</mml:mi><mml:msub><mml:mi>J</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow><mml:mi>m</mml:mi></mml:msup></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equac\"><alternatives><tex-math id=\"M689\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\left\\langle{ dx{\\left(t\\right)}^{n}}\\right\\rangle= \\left\\langle{{{\\xi }_{1}}^{n}}\\right\\rangle{\\uplambda }_{1}dt+\\left\\langle{{{\\xi }_{2}}^{n}}\\right\\rangle{\\uplambda }_{2}dt+\\left\\langle{{{\\xi }_{3}}^{n}}\\right\\rangle{\\uplambda }_{3}dt,$$\\end{document}</tex-math><mml:math id=\"M690\" display=\"block\"><mml:mrow><mml:mfenced close=\"〉\" open=\"〈\"><mml:mrow><mml:mi>d</mml:mi><mml:mi>x</mml:mi><mml:msup><mml:mrow><mml:mfenced close=\")\" open=\"(\"><mml:mi>t</mml:mi></mml:mfenced></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mfenced close=\"〉\" open=\"〈\"><mml:msup><mml:mrow><mml:msub><mml:mi>ξ</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow><mml:mi>n</mml:mi></mml:msup></mml:mfenced><mml:msub><mml:mi mathvariant=\"normal\">λ</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>" ]
[]
[]
[]
[]
[]
[ "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq4.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ1.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq9.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ2.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq10.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq11.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq12.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq13.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq14.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq15.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq16.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq17.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq18.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ3.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq19.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq20.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq21.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq22.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ4.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq23.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ5.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq24.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq25.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq26.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq27.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq28.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq29.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ6.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq30.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq31.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq32.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq33.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq34.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq35.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq36.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ7.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq37.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq38.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq39.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq40.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq41.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq42.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq43.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq44.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ8.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq45.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq46.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equa.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq47.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq48.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq49.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq50.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq51.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq52.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq53.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq54.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ9.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq55.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq56.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ10.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq57.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq58.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq59.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq60.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq61.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ11.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq62.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq63.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq64.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq65.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq66.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq67.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq68.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq69.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq70.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq71.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq72.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq73.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq74.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq75.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq76.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq77.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq78.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq79.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq80.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equb.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ12.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq81.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq82.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq83.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq84.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq85.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq86.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq87.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ13.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq88.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq89.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq90.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equc.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq91.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq92.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ14.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq93.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equd.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq94.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Eque.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ15.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq95.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq96.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equf.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq97.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ16.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq98.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq99.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq100.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq101.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq102.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq103.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq104.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq105.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq106.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq107.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq108.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq109.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq110.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq111.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq112.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq113.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq114.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Fig1_HTML\" id=\"MO1\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq115.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq116.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq117.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ17.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq118.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq119.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq120.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq121.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq122.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq123.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq124.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq125.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq126.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq127.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq128.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq129.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq130.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq131.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq132.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq133.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq134.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq135.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq136.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq137.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ18.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq138.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq139.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq140.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq141.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq142.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ19.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq143.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq144.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq145.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq146.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ20.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq147.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq148.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq149.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq150.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq151.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq152.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq153.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq154.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq155.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq156.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq157.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq158.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq159.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq160.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq161.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq162.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq163.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Fig3_HTML\" id=\"MO3\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq164.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq165.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq166.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq167.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq168.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq169.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq170.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq171.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq172.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq173.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq174.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq175.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq176.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ21.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ22.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq177.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq178.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ23.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq179.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq180.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq181.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq182.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq183.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq184.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq185.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq186.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq187.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq188.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq189.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq190.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq191.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq192.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq193.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq194.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq195.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq196.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq197.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq198.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq199.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq200.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Fig5_HTML\" id=\"MO5\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq201.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq202.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq203.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq204.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq205.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq206.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq207.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ24.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq208.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq209.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq210.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq211.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq212.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ25.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ26.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq213.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq214.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq215.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq216.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq217.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ27.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq218.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq219.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq220.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq221.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq222.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq223.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq224.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq225.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq226.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq227.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq228.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq229.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq230.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq231.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq232.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq233.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq234.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq235.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq236.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq237.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq238.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq239.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Fig6_HTML\" id=\"MO6\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq240.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq241.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equg.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equh.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equi.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq242.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq243.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq244.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq245.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equj.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equk.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq246.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq247.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equl.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq248.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq249.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equm.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equn.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq250.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equo.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq251.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq252.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq253.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq254.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq255.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq256.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equp.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equq.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equr.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq257.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq258.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq259.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq260.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equs.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq261.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq262.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ28.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq263.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq264.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq265.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equt.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equu.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq266.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq267.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq268.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equv.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq269.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq270.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq271.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq272.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq273.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq274.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq275.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq276.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equw.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equx.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq277.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq278.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq279.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq280.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq281.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq282.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equy.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq283.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq284.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equ29.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq285.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq286.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq287.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equaa.gif\" position=\"anchor\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equab.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51863_Article_IEq288.gif\"/>", "<graphic xlink:href=\"41598_2024_51863_Article_Equac.gif\" position=\"anchor\"/>" ]
[]
[{"label": ["1."], "surname": ["Anvari"], "given-names": ["M"], "article-title": ["Short term fluctuations of wind and solar power systems"], "source": ["New J. Phys."], "year": ["2016"], "volume": ["18"], "issue": ["6"], "fpage": ["063027"], "pub-id": ["10.1088/1367-2630/18/6/063027"]}, {"label": ["2."], "surname": ["Sahimi"], "given-names": ["M"], "source": ["Flow and Transport in Porous Media and Fractured Rock: From Classical Methods to Modern Approaches"], "year": ["2011"], "publisher-name": ["Wiley"]}, {"label": ["3."], "surname": ["Zhou"], "given-names": ["J"], "article-title": ["Analysis of oil price fluctuation under the influence of crude oil stocks and US dollar index\u2014Based on time series network model"], "source": ["Physica A"], "year": ["2021"], "volume": ["582"], "fpage": ["126218"], "pub-id": ["10.1016/j.physa.2021.126218"]}, {"label": ["5."], "surname": ["Kalmykov", "Coffey"], "given-names": ["YP", "WT"], "source": ["Langevin Equation, The: With Applications To Stochastic Problems in Physics, Chemistry and Electrical Engineering"], "year": ["2012"], "publisher-name": ["World Scientific"]}, {"label": ["6."], "surname": ["Pascucci", "Pascucci"], "given-names": ["A", "A"], "article-title": ["Stochastic calculus for jump processes"], "source": ["PDE and Martingale Methods in Option Pricing"], "year": ["2011"], "publisher-name": ["Springer Milan"], "fpage": ["497"], "lpage": ["540"]}, {"label": ["9."], "surname": ["A\u0131t-Sahalia"], "given-names": ["Y"], "article-title": ["Disentangling diffusion from jumps"], "source": ["J. Financ. Econ."], "year": ["2004"], "volume": ["74"], "issue": ["3"], "fpage": ["487"], "lpage": ["528"], "pub-id": ["10.1016/j.jfineco.2003.09.005"]}, {"label": ["10."], "surname": ["Rahimi Tabar"], "given-names": ["MR"], "source": ["Analysis and Data-Based Reconstruction of Complex Nonlinear Dynamical Systems: Using the Methods of Stochastic Processes"], "year": ["2019"], "publisher-name": ["Springer International Publishing"]}, {"label": ["11."], "surname": ["Lehnertz", "Zabawa", "Tabar"], "given-names": ["K", "L", "MRR"], "article-title": ["Characterizing abrupt transitions in stochastic dynamics"], "source": ["New J. Phys."], "year": ["2018"], "volume": ["20"], "issue": ["11"], "fpage": ["113043"], "pub-id": ["10.1088/1367-2630/aaf0d7"]}, {"label": ["12."], "surname": ["Risken", "Risken"], "given-names": ["H", "H"], "source": ["Fokker-Planck Equation"], "year": ["1996"], "publisher-name": ["Springer"]}, {"label": ["13."], "surname": ["Friedrich"], "given-names": ["R"], "article-title": ["Approaching complexity by stochastic methods: From biological systems to turbulence"], "source": ["Phys. Rep."], "year": ["2011"], "volume": ["506"], "issue": ["5"], "fpage": ["87"], "lpage": ["162"], "pub-id": ["10.1016/j.physrep.2011.05.003"]}, {"label": ["14."], "mixed-citation": ["Gorj\u00e3o, L.R. and F. Meirinhos, "], "italic": ["kramersmoyal: Kramers--Moyal coefficients for stochastic processes."], "ext-link": ["https://arXiv.org/quant-ph/1912.09737"]}, {"label": ["15."], "surname": ["Bandi", "Nguyen"], "given-names": ["FM", "TH"], "article-title": ["On the functional estimation of jump\u2013diffusion models"], "source": ["J. Econometr."], "year": ["2003"], "volume": ["116"], "issue": ["1\u20132"], "fpage": ["293"], "lpage": ["328"], "pub-id": ["10.1016/S0304-4076(03)00110-6"]}, {"label": ["16."], "surname": ["Pawula"], "given-names": ["R"], "article-title": ["Approximation of the linear Boltzmann equation by the Fokker-Planck equation"], "source": ["Phys. Rev."], "year": ["1967"], "volume": ["162"], "issue": ["1"], "fpage": ["186"], "pub-id": ["10.1103/PhysRev.162.186"]}, {"label": ["17."], "surname": ["Van Kampen"], "given-names": ["NG"], "source": ["Stochastic Processes in Physics and Chemistry"], "year": ["1992"], "publisher-name": ["Elsevier"]}, {"label": ["18."], "surname": ["Bouchaud", "Cont"], "given-names": ["J-P", "R"], "article-title": ["A Langevin approach to stock market fluctuations and crashes"], "source": ["Eur. Phys. J. B-Condens. Matter Complex Syst."], "year": ["1998"], "volume": ["6"], "fpage": ["543"], "lpage": ["550"], "pub-id": ["10.1007/s100510050582"]}, {"label": ["20."], "surname": ["Sirovich", "Sacerdote", "Villa"], "given-names": ["R", "L", "AE"], "article-title": ["Cooperative behavior in a jump diffusion model for a simple network of spiking neurons"], "source": ["Math. Biosci. Eng."], "year": ["2013"], "volume": ["11"], "issue": ["2"], "fpage": ["385"], "lpage": ["401"], "pub-id": ["10.3934/mbe.2014.11.385"]}, {"label": ["21."], "surname": ["Gammaitoni"], "given-names": ["L"], "article-title": ["Stochastic resonance"], "source": ["Rev. Modern Phys."], "year": ["1998"], "volume": ["70"], "issue": ["1"], "fpage": ["223"], "pub-id": ["10.1103/RevModPhys.70.223"]}, {"label": ["23."], "surname": ["Stanton"], "given-names": ["R"], "article-title": ["A nonparametric model of term structure dynamics and the market price of interest rate risk"], "source": ["J. Finance"], "year": ["1997"], "volume": ["52"], "issue": ["5"], "fpage": ["1973"], "lpage": ["2002"], "pub-id": ["10.1111/j.1540-6261.1997.tb02748.x"]}, {"label": ["24."], "surname": ["Weissman"], "given-names": ["M"], "article-title": ["1 f noise and other slow, nonexponential kinetics in condensed matter"], "source": ["Rev. Modern Phys."], "year": ["1988"], "volume": ["60"], "issue": ["2"], "fpage": ["537"], "pub-id": ["10.1103/RevModPhys.60.537"]}, {"label": ["26."], "surname": ["Honisch"], "given-names": ["C"], "article-title": ["Extended Kramers-Moyal analysis applied to optical trapping"], "source": ["Phys. Rev. E"], "year": ["2012"], "volume": ["86"], "issue": ["2"], "fpage": ["026702"], "pub-id": ["10.1103/PhysRevE.86.026702"]}, {"label": ["27."], "surname": ["Tang", "Ao", "Yuan"], "given-names": ["K", "P", "B"], "article-title": ["Robust reconstruction of the Fokker-Planck equations from time series at different sampling rates"], "source": ["Europhys. Lett."], "year": ["2013"], "volume": ["102"], "issue": ["4"], "fpage": ["40003"], "pub-id": ["10.1209/0295-5075/102/40003"]}]
{ "acronym": [], "definition": [] }
27
CC BY
no
2024-01-14 23:40:18
Sci Rep. 2024 Jan 12; 14:1234
oa_package/bf/62/PMC10786893.tar.gz
PMC10786894
38216670
[ "<title>Introduction</title>", "<p id=\"Par2\">In recent times, there has been increasing interest in gas discharge processes in various gases, brought on by the requirements for miniaturization in several areas, for instance, in the power, pulsed power, semiconductor, and power electronic industries. While issues surrounding gas breakdown were once mainly confined to large-scale high voltage (HV) electrical systems, the drive towards miniaturization and compact technology and has led to two phenomena. Firstly, a growing number of low-voltage devices find themselves squarely within the domain of electrical breakdown due to new restrictions on physical dimensions, where in the past, the issue could be largely ignored. Secondly, HV systems which had previously been designed for particular ranges of electric field, may now face new and elevated levels of electrical stress, posing new challenges for insulation design and coordination. Some examples of applications include the prevention of breakdown in microelectromechanical systems (MEMS) or novel power electronic devices<sup>##UREF##0##1##</sup>, and equipment used in pulsed power or low temperature plasma (LTP) systems, e.g., plasma closing switches<sup>##UREF##1##2##</sup>, electrostatic precipitation systems<sup>##UREF##2##3##</sup>, and for pulsed electric field (PEF) treatment<sup>##UREF##3##4##</sup>.</p>", "<p id=\"Par3\">On this account, the continued development and optimization of these technologies is heavily reliant upon a deeper understanding of elementary gas discharge processes. In practice, processes under nonuniform and time-varying electric fields are of particular importance, for which the understanding is currently limited. Available literature on sub-mm gaps (but larger than that of the lower Paschen limit of 15 m at 1 atm<sup>##REF##30952912##5##</sup>) is scarce, particularly for sub-mm gaps involving nonuniform electric fields combined with fast-rising voltages. Simulation studies that investigated the role of the voltage rise time have been conducted in the past<sup>##UREF##4##6##–##UREF##6##8##</sup>, but these were under long, oil-filled, millimeter gaps over full impulses as opposed to short gas-filled sub-mm gaps with specific focus on the rising edge. Nevertheless, the authors showed that the voltage rate-of-rise may affect characteristics such as the streamer radius and velocity when in oil. Experimental studies which were conducted under a similar configuration to the present work include those by Hogg et al.<sup>##UREF##7##9##,##UREF##8##10##</sup>, where the authors investigated the breakdown of bottled air in sub-mm point-plane gaps down to 250 m, pressurized between 0.1 and 0.35 MPa. They reported an increasing breakdown strength with the decrease in gap distance for positive energization, such that the positive breakdown voltage exceeded that of its negative counterpart for smaller gaps. This contrasted with longer gaps (&gt; 4 mm), where the opposite was generally observed: positive energization typically induced breakdown at a lower voltage.</p>", "<p id=\"Par4\">In work by Liu et al.<sup>##UREF##9##11##</sup>, field-time breakdown characteristics were investigated under fast-rising nanosecond impulses, in a 100 m needle-plane gap and with a needle tip radius of approximately 80 m. Separate gaps filled with air, CO, and N were tested, from which the authors consistently observed higher breakdown voltages at shorter breakdown times in CO compared to the two other gases. This departed from classical streamer inception theory based on solely on Townsend coefficients, which in contrast, had been shown to fit experimental data under longer gaps well, e.g., as shown by Kumar et al.<sup>##UREF##10##12##</sup>. There was also a marked difference between the field-time characteristics obtained in Liu et al.<sup>##UREF##9##11##</sup> and the analytical streamer transition (Meek) criterion, to which the authors attribute mainly to statistical time lag. Moreover, both Hogg et al.<sup>##UREF##8##10##</sup> and Kumar et al.<sup>##UREF##10##12##</sup> observed higher stability in the negative breakdown of CO compared to positive breakdown, which had been attributed to negative space charge and corona stabilization effects<sup>##UREF##8##10##</sup>, or to the existence of initial electrons<sup>##UREF##10##12##</sup>. The effects observed in these studies emphasized the degree to which processes within this regime remain unknown, and that a deeper understanding must be gained to further develop systems that are reliant upon short-gap gas discharge processes.</p>", "<p id=\"Par5\">In this study, the initial discharge phase consisting of the propagation of a primary ionization front has therefore been computationally investigated. Using point-plane and point-point electrode gaps of 80 m radius and 250 m separation, the characteristics of the primary ionization front in synthetic air and in CO have been studied, under fast-rising ramp voltages of different rates-of-rise, and for both positive and negative energization. The linearly rising voltages can be considered as an approximation for <italic>overstressed</italic> or <italic>overvolted</italic> breakdown on the rising slope of an impulse, as commonly featured in pulsed power systems. These terms refer to breakdown occurring at electric fields or voltages higher than that of the static breakdown values, and is characteristic of pulsed breakdown. The <italic>overvoltage</italic> is defined as the difference between the impulsive breakdown voltage and the static breakdown voltage<sup>##UREF##11##13##</sup>. The choice to study CO was further informed by its importance in some chemical processing applications, such as CO splitting<sup>##REF##25641832##14##</sup>, and for its potential to be used in gas mixtures that may act as a replacement for the potent greenhouse gas, SF, within gas-insulated power and pulsed power equipment<sup>##UREF##12##15##–##UREF##14##17##</sup>.</p>" ]
[]
[ "<title>Results and discussion</title>", "<p id=\"Par16\">In this section, the results obtained from performing the simulations are presented. It is remarked that while the term <italic>streamer</italic> is used during discussion, the limited dimension of the inter-electrode gap means that a <italic>streamer</italic> in the traditional sense of a propagating filamentary discharge is perhaps better referred to as an <italic>ionization wave front</italic>. This is because the thin, elongated channel characteristic of a classical <italic>streamer</italic> formed in longer gaps cannot be developed over such short distances. However, the term <italic>streamer</italic> is used interchangeably here for convenience. The first section focuses initially on the <italic>dU</italic>/<italic>dt</italic> = 50 kV/ns case only, describing aspects which were generally independent of the rate-of-rise. This includes an overview of the observed streamer morphology with comparisons between point-plane and point-point gaps. The next section presents analyses on the streamer characteristics—velocity, electric field, and the developed electron density, and how these were affected by the voltage rate-of-rise. The section “<xref rid=\"Sec11\" ref-type=\"sec\">Cathode sheath</xref>” completes the results with some discussion of the cathode sheath and its behavior under differing voltage slopes.</p>", "<title>Ionization front morphology—point-plane and point-point</title>", "<p id=\"Par17\">Figure ##FIG##1##2##a–f shows the evolution of the electric field (left half of each panel) and the electron density (right half of each panel) at various times in air, near the discharge region between point-plane electrodes for the case of <italic>dU</italic>/<italic>dt</italic> = 50 kV/ns only, and for both polarities. Note that the slower rates of rise have not been shown in the main text, as the ionization fronts were morphologically identical with the exception that they were shifted in time due to the delayed initiation of the ionization wave due to the slower rising voltage. The reader is, however, directed to the additional color plots and streak images attached as Supplementary Figures ##SUPPL##0##S1## and ##SUPPL##0##S2## for a comparison of the wavefront evolution for slower rates of rise. Figure ##FIG##1##2##g–l shows the corresponding data for CO. Due to the steep voltage slope, the gap becomes highly overvolted, and the primary streamer phase occurs rapidly. The time to wavefront initiation was found to be inversely proportional to <italic>dU</italic>/<italic>dt</italic> (see Fig. ##FIG##4##5##b). The time necessary to bridge the inter-electrode gap was in the range of 30–60 picoseconds (corresponding propagation velocities are discussed in a later section), which given the gap dimension, is in fair agreement with similar simulations conducted by Höft et al.<sup>##UREF##17##20##</sup>. For the positive case in both gases, direct inception of the ionization front at the needle tip was observed, before it grew in radius and length towards the cathode. Direct contact with the cathode does not occur due to the formation of a cathode sheath with low electron density. This is contrasted with the negative fronts, which initiates ahead of the cathode sheath now formed over the needle electrode due to initial outward electron drift. Also different from the negative case is the pre-inception behavior. Prior to the inception of a negative streamer, an initial—weakly ionizing—wave of electrons was observed to move away from the needle tip. This can be seen in Fig. ##FIG##1##2## panel (d) at around 120 ps. As time advanced, the initial wave is consumed by a secondary wave which develops behind the first, which subsequently becomes the dominant ionization front (or streamer head) in the gap.</p>", "<p id=\"Par18\">Figure ##FIG##2##3## shows results under the same conditions as Fig. ##FIG##1##2## but in a point-point electrode geometry. The aforementioned phenomenon of the initial electron wave is clear in Fig. ##FIG##2##3## panels (a) and (b), which can be seen moving away from the negative point electrode. In point-point geometries, positive and negative fronts incept almost simultaneously from the electrodes of respective polarity, which propagate and eventually collide. As was similarly observed by Höft et al.<sup>##UREF##17##20##</sup>, the negative front was delayed relative to the positive, likely due to the differences in the necessary field strength required for inception, which is typically higher for negative streamers<sup>##UREF##17##20##</sup>. This is also consistent with the results of Fig. ##FIG##1##2##, where positive fronts would incept before their negative counterparts.</p>", "<p id=\"Par19\">In both point-plane and point-point simulations, there additionally existed a clear difference in the thickness of the cathode sheath between air and CO, the dynamics of which are discussed in further detail within a later section titled “<xref rid=\"Sec11\" ref-type=\"sec\">Cathode sheath</xref>”.</p>", "<title>Front velocity, electric field, and electron density dependency on rate of voltage rise</title>", "<p id=\"Par20\">The instantaneous velocities for all streamers were computed by tracking the <italic>z</italic> position of the point of maximum field strength along the axis of symmetry. Figure ##FIG##3##4## shows the results in air, for both positive and negative cases, and over all simulated rates-of-rise. It should be noted that negative fronts appear to experience an abrupt change in velocity at the first plotted data point, as the negative fronts do not develop directly at the needle tip. As a result, there is an abrupt change in the position of the maximum electric field at the point of initiation, which is manifested as a sudden increase in the front velocity. In addition, negative fronts were also observed to initially decrease in velocity, corresponding to the phase when the ionization wave begins to initiate. During this phase, the plasma channel begins to develop ahead of the needle, but the front has yet to begin propagation in a self-sustained manner driven by sufficiently intense ionization at its head. Coupled with the widening of the channel due to outward electron diffusion (and consequent lowering of the electric field at its head), it is believed that these competing mechanisms may contribute to the initial decrease in propagation velocity up to the point that ionization becomes sufficient to drive the front forward. The instantaneous velocities of ionization fronts in CO evolved similarly and followed identical trends with increasing <italic>dU</italic>/<italic>dt</italic> and are therefore not shown. Overall, the velocity of all fronts grew rapidly after inception, but negative fronts appeared to experience significantly higher acceleration than their positive counterparts, and attain a higher maximum velocity during their propagation. With a slowing rate-of-rise, the effect on the maximum attained velocity is inconclusive. However, there does appear to be a reduction in the acceleration during the propagation phase—indicated by the decreasing slope of velocity with decreasing <italic>dU</italic>/<italic>dt</italic>. The computed velocities are in fair agreement with other, similar, work<sup>##UREF##17##20##</sup>. The average velocities were also calculated, following:where <italic>d</italic> is the distance traversed by the front (gap distance minus the cathode sheath thickness), is the time of contact (determined when the front ceases to have a <italic>z</italic> velocity, indicating that it had started to spread out over the cathode sheath in a positive case, or upon contact with the anode in the negative case), and is the time of inception (defined as the moment the front begins propagation, gaining a non-zero <italic>z</italic> velocity). The streak image shown in Fig. ##FIG##4##5##a for air under three different rates-of-rise illustrates the moments when these times were recorded, and the inverse proportionality of the inception time to <italic>dU</italic>/<italic>dt</italic> is shown for all gases and polarities in Fig. ##FIG##4##5##b. The velocities according to (##FORMU##266##8##) are plotted as a function of <italic>dU</italic>/<italic>dt</italic> for both gases in Fig. ##FIG##5##6##. On average, the ionization fronts in air propagate faster than those in CO. There exists a clear difference between positive and negative fronts in air, where negative fronts were, on average, consistently faster than positive fronts under the same conditions. This did not seem to be the case for CO, which appeared to exhibit no significant differences in average velocity between positive and negative cases. This may be due to the far thicker cathode sheath developed during the simulated CO discharge (e.g., see Fig. ##FIG##1##2##) and its scaling with <italic>dU</italic>/<italic>dt</italic>. Despite the higher acceleration of the negative streamer—leading to a shorter time-of-flight—the effective distance traversed by the front is also reduced, such that the overall average velocity is the same as the positive case. In air, no such phenomenon existed, since, unlike CO, the cathode sheath thickness was small (and did not scale with <italic>dU</italic>/<italic>dt</italic>) compared to the gap distance for all <italic>dU</italic>/<italic>dt</italic>. The cathode sheath is discussed in more detail within the section titled “<xref rid=\"Sec11\" ref-type=\"sec\">Cathode sheath</xref>”. With faster rising voltage, the average velocities of all fronts increased irrespective of polarity, due to the increased background electric field developed from the greater degree of overvoltage. However, those in air appeared to exhibit a slightly greater rate of increase to average velocity relative to CO. The cause of this difference may be due to differences in the electron mobility between air and CO, though this requires further study.</p>", "<p id=\"Par21\">Figure ##FIG##6##7## shows the maximum electric field magnitude (at the streamer head) on the axis of symmetry over time between point-plane electrodes for both polarities. Initially, the electric field rises linearly, following the linearly-rising voltage applied to the electrode. In the positive case, the net field magnitude drops slightly at the moment of streamer inception as a critical charge density develops and screens the background field, before the forward propagation of the streamer is indicated by a rapid increase of the field magnitude at the streamer head. In the negative case, the maximum electric field value in the domain always remains at the needle tip due to the formation of the cathode sheath. Therefore, upon inception of the negative wavefront (ahead of the cathode sheath), the maximum electric field is instead taken as the maximum field ahead of the developed wavefront. This explains the much more significant drop in electric field magnitude in Fig. ##FIG##6##7##b. As the distance between the streamer head and the boundary decreases (on close approach to the plane electrode) the field is enhanced significantly. During this stage, some numerical oscillations were present for positive streamers (Fig. ##FIG##6##7##a), and in air only, which likely exist due to the challenge associated with resolving the thinner cathode sheath (see section named “<xref rid=\"Sec11\" ref-type=\"sec\">Cathode sheath</xref>”) and steeper density gradients found in air. In point-point configurations, similar behavior was observed at both needles, i.e., the trends of Fig. ##FIG##6##7##a were observed at the anode, while those in Fig. ##FIG##6##7##b existed at the cathode. Once the two streamers initiate, the electric field is enhanced in the space between their heads, until it ultimately collapses upon the collision and combination of the two ionization fronts, as shown in Fig. ##FIG##7##8## for air and CO under a 50 kV/ns signal. The point at which the two fronts merge is not centered in the gap (i.e., <italic>z</italic> = 0) due to the differing inception times and propagation velocities of the positive and negative fronts, which is in agreement with conclusions by Höft et al.<sup>##UREF##17##20##</sup>.</p>", "<p id=\"Par22\">The voltage rate-of-rise was also found to have a strong effect on the electron density developed in the resulting plasma channel. Figure ##FIG##8##9## shows the electron density profile along the axis of symmetry at the time of contact (for point-plane) and for <italic>dU</italic>/<italic>dt</italic> = 50, 25, 16.67, and 12.5 kV/ns. In general, a positive, nonlinear correlation between the developed electron density and the voltage rate-of-rise was observed. This is once again believed to be simply due to the increased degree of overvoltage achieved at higher <italic>dU</italic>/<italic>dt</italic>, which led to the intensification of ionization and space charge production. There may also be a type of cyclic self-fulfilling behaviour here, wherein higher electric field produces increased charge densities in the channel, which in turn causes an increase in the channel conductivity, which further enhances the electric field at the front, thus further intensifying ionization. It also appears that in general, positive discharges generate far higher electron densities compared to the negative discharges. This may be linked to the maximum electric field at the streamer head, which was found to be higher for positive fronts than for negative, and has previously been linked to the more diffuse nature of negative streamers in the past<sup>##UREF##31##34##</sup>.</p>", "<title>Cathode sheath</title>", "<p id=\"Par23\">Observed in both the point-plane and point-point studies was the development of a sheath region across the cathode. The cathode sheath is characterized by a low electron density and an intense electric field which supports much of the voltage drop across the gap, and may be formed when a discharge approaches a solid barrier, such as an electrode or solid dielectric surface<sup>##UREF##32##35##,##UREF##33##36##</sup>. Little is known regarding the cathode sheath, and studies have generally focused on the characteristics of discharges far from any physical boundary.</p>", "<p id=\"Par24\">From the simulations conducted in this work, a variation in the thickness of the cathode sheath with the voltage rate-of-rise has been observed, as shown in Fig. ##FIG##9##10##. Most interestingly, this has been observed only in CO and not in air. While the color plots of Figs. ##FIG##1##2## to ##FIG##2##3## clearly show the formation of the cathode sheath, the regions of low electron density in Fig. ##FIG##8##9## demonstrates more clearly the increasing thickness of the sheath with slowing rate of voltage rise in CO. This can be compared to those in air, which showed very little change in the cathode sheath thickness with different <italic>dU</italic>/<italic>dt</italic>. To compare across polarities, gases, and rates-of-rise, Fig. ##FIG##9##10## plots the cathode sheath thickness as a function of <italic>dU</italic>/<italic>dt</italic>. The physical mechanism behind this observation is believed to result from the presence of photoionization and the variation of the electron mobility with electron energy, and their impact on electron generation and drift under a time-increasing electric field during the pre-discharge phase. Figure ##FIG##10##11## shows the electron mobility relationships for air and CO, plotted against the electron energy. Of particular interest is the region where 0.63 5 eV, where the electron mobility of CO increases to a local maximum, and becomes significantly higher than that of air. It is important to note that the simulations indicate that electrons may enter this energy range while the electric field remained below the critical field for both CO and air, at 2.2 kV/mm and 2.8 kV/mm, respectively. With a voltage (and hence background field) which has a finite time to rise, there must exist a duration when the local mean electron energy passes through the above energy range. During this time, electron mobility is maximized in CO, allowing electrons to drift away from the cathode faster than in air, leading to the local reduction of the electron density around the cathode which eventually becomes the cathode sheath, all which occurs before intensive ionization takes place. It follows, therefore, that a slower rate of rise prolongs the time for which the field is within this critical range, allowing electrons to drift farther away from the cathode, and forming a larger sheath with slower rates of rise. The presence of significant photoionization in air compared to CO may also generate significant numbers of electrons ahead of the wavefront and injected into the sheath region, effectively decreasing the sheath thickness. For both needle-plane and needle-needle simulations, and at the slowest rate of rise simulated in this work (10 kV/ns), the cathode sheath in CO occupied almost half of the total inter-electrode gap distance. If this is indeed the case, one should expect that for sufficiently slow rising voltages (possibly kV/s, kV/ms), a similar relation would be found in air since the electron mobility in air is maximized at low electron energies. This would require significantly longer simulation times, as such, is considered an aspect for future work. It is believed that it was not observed in the present work due to the rapid rates of voltage rise used in this study, and with the monotonically decreasing electron mobility with increasing field in air, any differences in the electron traversal distance under different values of <italic>dU</italic>/<italic>dt</italic> during the pre-discharge phase would be indiscernible. It is further remarked that one should not ignore the possibility that other processes (attachment, recombination within the channel, electron emission from the electrodes, etc.) may also contribute to the cathode sheath behavior. These are aspects that would be of high interest to explore in further modelling and experimental work, but fall outside of the scope of the present study.</p>", "<p id=\"Par25\">It is believed that the dynamics of the cathode sheath observed here may have consequences for the discharge evolution in short, sub-mm gaps. For example, Fig. ##FIG##11##12## shows streak images of the electric field for point-point discharges at various rates-of-rise in CO. As described in the section “<xref rid=\"Sec9\" ref-type=\"sec\">Ionization front morphology—point-plane and point-point</xref>”, near-simultaneous positive and negative streamers propagate towards each other and merge within the gap. This was true for all <italic>dU</italic>/<italic>dt</italic> except when <italic>dU</italic>/<italic>dt</italic> was less than 25 kV/ns in CO. Under these conditions, it was found that a negative streamer simply did not appear in CO (Fig. ##FIG##11##12##). This appears to be due to the aforementioned relationship between low <italic>dU</italic>/<italic>dt</italic> and the cathode sheath, which under these conditions occupied a significant portion of the inter-electrode gap, suppressing the formation of a negative front due to the limited space. The time evolution therefore resembled more of the inception of a solitary positive streamer, which collided and spread out over a now large cathode sheath acting like an extended virtual cathode. These results may help to possibly explain some observations in short, 100 m needle-plane breakdown studies under impulsive regimes, conducted by Liu et al.<sup>##UREF##9##11##</sup>. The authors consistently found a significantly shorter time-to-breakdown at higher breakdown voltage in CO compared to air and N for nanosecond impulses, contrasting what the critical field value would suggest under classical breakdown theories. It is believed that the combination of the sub-mm gap and the enhanced electron mobility of CO during the rising impulse may act to significantly reduce the electron density in the gap during the pre-discharge phase. This may inhibit the formation of initial avalanches and ionization fronts, thereby delaying the breakdown process and increasing the overall breakdown strength. It is thought that such phenomena would be more difficult to observe in long gaps, as the field would have to remain within the critical range of enhanced electron mobility for far longer to cause a significant reduction in the electron density ahead of the streamer. That is, the increase of the breakdown strength for CO only holds when the sheath distance is able to occupy a significant proportion of the inter-electrode gap. Of course, the simulations here omit other possible electronic sources, such as charge injection at the electrodes or any secondary emission sources, and forgoes the consideration of statistical processes before—and other processes beyond—the primary ionization front. Comparison with practical breakdown data is therefore done with extreme caution, and would necessitate significant experimental and theoretical work in the future to confirm the existence of the discussed mechanisms.</p>" ]
[ "<title>Results and discussion</title>", "<p id=\"Par16\">In this section, the results obtained from performing the simulations are presented. It is remarked that while the term <italic>streamer</italic> is used during discussion, the limited dimension of the inter-electrode gap means that a <italic>streamer</italic> in the traditional sense of a propagating filamentary discharge is perhaps better referred to as an <italic>ionization wave front</italic>. This is because the thin, elongated channel characteristic of a classical <italic>streamer</italic> formed in longer gaps cannot be developed over such short distances. However, the term <italic>streamer</italic> is used interchangeably here for convenience. The first section focuses initially on the <italic>dU</italic>/<italic>dt</italic> = 50 kV/ns case only, describing aspects which were generally independent of the rate-of-rise. This includes an overview of the observed streamer morphology with comparisons between point-plane and point-point gaps. The next section presents analyses on the streamer characteristics—velocity, electric field, and the developed electron density, and how these were affected by the voltage rate-of-rise. The section “<xref rid=\"Sec11\" ref-type=\"sec\">Cathode sheath</xref>” completes the results with some discussion of the cathode sheath and its behavior under differing voltage slopes.</p>", "<title>Ionization front morphology—point-plane and point-point</title>", "<p id=\"Par17\">Figure ##FIG##1##2##a–f shows the evolution of the electric field (left half of each panel) and the electron density (right half of each panel) at various times in air, near the discharge region between point-plane electrodes for the case of <italic>dU</italic>/<italic>dt</italic> = 50 kV/ns only, and for both polarities. Note that the slower rates of rise have not been shown in the main text, as the ionization fronts were morphologically identical with the exception that they were shifted in time due to the delayed initiation of the ionization wave due to the slower rising voltage. The reader is, however, directed to the additional color plots and streak images attached as Supplementary Figures ##SUPPL##0##S1## and ##SUPPL##0##S2## for a comparison of the wavefront evolution for slower rates of rise. Figure ##FIG##1##2##g–l shows the corresponding data for CO. Due to the steep voltage slope, the gap becomes highly overvolted, and the primary streamer phase occurs rapidly. The time to wavefront initiation was found to be inversely proportional to <italic>dU</italic>/<italic>dt</italic> (see Fig. ##FIG##4##5##b). The time necessary to bridge the inter-electrode gap was in the range of 30–60 picoseconds (corresponding propagation velocities are discussed in a later section), which given the gap dimension, is in fair agreement with similar simulations conducted by Höft et al.<sup>##UREF##17##20##</sup>. For the positive case in both gases, direct inception of the ionization front at the needle tip was observed, before it grew in radius and length towards the cathode. Direct contact with the cathode does not occur due to the formation of a cathode sheath with low electron density. This is contrasted with the negative fronts, which initiates ahead of the cathode sheath now formed over the needle electrode due to initial outward electron drift. Also different from the negative case is the pre-inception behavior. Prior to the inception of a negative streamer, an initial—weakly ionizing—wave of electrons was observed to move away from the needle tip. This can be seen in Fig. ##FIG##1##2## panel (d) at around 120 ps. As time advanced, the initial wave is consumed by a secondary wave which develops behind the first, which subsequently becomes the dominant ionization front (or streamer head) in the gap.</p>", "<p id=\"Par18\">Figure ##FIG##2##3## shows results under the same conditions as Fig. ##FIG##1##2## but in a point-point electrode geometry. The aforementioned phenomenon of the initial electron wave is clear in Fig. ##FIG##2##3## panels (a) and (b), which can be seen moving away from the negative point electrode. In point-point geometries, positive and negative fronts incept almost simultaneously from the electrodes of respective polarity, which propagate and eventually collide. As was similarly observed by Höft et al.<sup>##UREF##17##20##</sup>, the negative front was delayed relative to the positive, likely due to the differences in the necessary field strength required for inception, which is typically higher for negative streamers<sup>##UREF##17##20##</sup>. This is also consistent with the results of Fig. ##FIG##1##2##, where positive fronts would incept before their negative counterparts.</p>", "<p id=\"Par19\">In both point-plane and point-point simulations, there additionally existed a clear difference in the thickness of the cathode sheath between air and CO, the dynamics of which are discussed in further detail within a later section titled “<xref rid=\"Sec11\" ref-type=\"sec\">Cathode sheath</xref>”.</p>", "<title>Front velocity, electric field, and electron density dependency on rate of voltage rise</title>", "<p id=\"Par20\">The instantaneous velocities for all streamers were computed by tracking the <italic>z</italic> position of the point of maximum field strength along the axis of symmetry. Figure ##FIG##3##4## shows the results in air, for both positive and negative cases, and over all simulated rates-of-rise. It should be noted that negative fronts appear to experience an abrupt change in velocity at the first plotted data point, as the negative fronts do not develop directly at the needle tip. As a result, there is an abrupt change in the position of the maximum electric field at the point of initiation, which is manifested as a sudden increase in the front velocity. In addition, negative fronts were also observed to initially decrease in velocity, corresponding to the phase when the ionization wave begins to initiate. During this phase, the plasma channel begins to develop ahead of the needle, but the front has yet to begin propagation in a self-sustained manner driven by sufficiently intense ionization at its head. Coupled with the widening of the channel due to outward electron diffusion (and consequent lowering of the electric field at its head), it is believed that these competing mechanisms may contribute to the initial decrease in propagation velocity up to the point that ionization becomes sufficient to drive the front forward. The instantaneous velocities of ionization fronts in CO evolved similarly and followed identical trends with increasing <italic>dU</italic>/<italic>dt</italic> and are therefore not shown. Overall, the velocity of all fronts grew rapidly after inception, but negative fronts appeared to experience significantly higher acceleration than their positive counterparts, and attain a higher maximum velocity during their propagation. With a slowing rate-of-rise, the effect on the maximum attained velocity is inconclusive. However, there does appear to be a reduction in the acceleration during the propagation phase—indicated by the decreasing slope of velocity with decreasing <italic>dU</italic>/<italic>dt</italic>. The computed velocities are in fair agreement with other, similar, work<sup>##UREF##17##20##</sup>. The average velocities were also calculated, following:where <italic>d</italic> is the distance traversed by the front (gap distance minus the cathode sheath thickness), is the time of contact (determined when the front ceases to have a <italic>z</italic> velocity, indicating that it had started to spread out over the cathode sheath in a positive case, or upon contact with the anode in the negative case), and is the time of inception (defined as the moment the front begins propagation, gaining a non-zero <italic>z</italic> velocity). The streak image shown in Fig. ##FIG##4##5##a for air under three different rates-of-rise illustrates the moments when these times were recorded, and the inverse proportionality of the inception time to <italic>dU</italic>/<italic>dt</italic> is shown for all gases and polarities in Fig. ##FIG##4##5##b. The velocities according to (##FORMU##266##8##) are plotted as a function of <italic>dU</italic>/<italic>dt</italic> for both gases in Fig. ##FIG##5##6##. On average, the ionization fronts in air propagate faster than those in CO. There exists a clear difference between positive and negative fronts in air, where negative fronts were, on average, consistently faster than positive fronts under the same conditions. This did not seem to be the case for CO, which appeared to exhibit no significant differences in average velocity between positive and negative cases. This may be due to the far thicker cathode sheath developed during the simulated CO discharge (e.g., see Fig. ##FIG##1##2##) and its scaling with <italic>dU</italic>/<italic>dt</italic>. Despite the higher acceleration of the negative streamer—leading to a shorter time-of-flight—the effective distance traversed by the front is also reduced, such that the overall average velocity is the same as the positive case. In air, no such phenomenon existed, since, unlike CO, the cathode sheath thickness was small (and did not scale with <italic>dU</italic>/<italic>dt</italic>) compared to the gap distance for all <italic>dU</italic>/<italic>dt</italic>. The cathode sheath is discussed in more detail within the section titled “<xref rid=\"Sec11\" ref-type=\"sec\">Cathode sheath</xref>”. With faster rising voltage, the average velocities of all fronts increased irrespective of polarity, due to the increased background electric field developed from the greater degree of overvoltage. However, those in air appeared to exhibit a slightly greater rate of increase to average velocity relative to CO. The cause of this difference may be due to differences in the electron mobility between air and CO, though this requires further study.</p>", "<p id=\"Par21\">Figure ##FIG##6##7## shows the maximum electric field magnitude (at the streamer head) on the axis of symmetry over time between point-plane electrodes for both polarities. Initially, the electric field rises linearly, following the linearly-rising voltage applied to the electrode. In the positive case, the net field magnitude drops slightly at the moment of streamer inception as a critical charge density develops and screens the background field, before the forward propagation of the streamer is indicated by a rapid increase of the field magnitude at the streamer head. In the negative case, the maximum electric field value in the domain always remains at the needle tip due to the formation of the cathode sheath. Therefore, upon inception of the negative wavefront (ahead of the cathode sheath), the maximum electric field is instead taken as the maximum field ahead of the developed wavefront. This explains the much more significant drop in electric field magnitude in Fig. ##FIG##6##7##b. As the distance between the streamer head and the boundary decreases (on close approach to the plane electrode) the field is enhanced significantly. During this stage, some numerical oscillations were present for positive streamers (Fig. ##FIG##6##7##a), and in air only, which likely exist due to the challenge associated with resolving the thinner cathode sheath (see section named “<xref rid=\"Sec11\" ref-type=\"sec\">Cathode sheath</xref>”) and steeper density gradients found in air. In point-point configurations, similar behavior was observed at both needles, i.e., the trends of Fig. ##FIG##6##7##a were observed at the anode, while those in Fig. ##FIG##6##7##b existed at the cathode. Once the two streamers initiate, the electric field is enhanced in the space between their heads, until it ultimately collapses upon the collision and combination of the two ionization fronts, as shown in Fig. ##FIG##7##8## for air and CO under a 50 kV/ns signal. The point at which the two fronts merge is not centered in the gap (i.e., <italic>z</italic> = 0) due to the differing inception times and propagation velocities of the positive and negative fronts, which is in agreement with conclusions by Höft et al.<sup>##UREF##17##20##</sup>.</p>", "<p id=\"Par22\">The voltage rate-of-rise was also found to have a strong effect on the electron density developed in the resulting plasma channel. Figure ##FIG##8##9## shows the electron density profile along the axis of symmetry at the time of contact (for point-plane) and for <italic>dU</italic>/<italic>dt</italic> = 50, 25, 16.67, and 12.5 kV/ns. In general, a positive, nonlinear correlation between the developed electron density and the voltage rate-of-rise was observed. This is once again believed to be simply due to the increased degree of overvoltage achieved at higher <italic>dU</italic>/<italic>dt</italic>, which led to the intensification of ionization and space charge production. There may also be a type of cyclic self-fulfilling behaviour here, wherein higher electric field produces increased charge densities in the channel, which in turn causes an increase in the channel conductivity, which further enhances the electric field at the front, thus further intensifying ionization. It also appears that in general, positive discharges generate far higher electron densities compared to the negative discharges. This may be linked to the maximum electric field at the streamer head, which was found to be higher for positive fronts than for negative, and has previously been linked to the more diffuse nature of negative streamers in the past<sup>##UREF##31##34##</sup>.</p>", "<title>Cathode sheath</title>", "<p id=\"Par23\">Observed in both the point-plane and point-point studies was the development of a sheath region across the cathode. The cathode sheath is characterized by a low electron density and an intense electric field which supports much of the voltage drop across the gap, and may be formed when a discharge approaches a solid barrier, such as an electrode or solid dielectric surface<sup>##UREF##32##35##,##UREF##33##36##</sup>. Little is known regarding the cathode sheath, and studies have generally focused on the characteristics of discharges far from any physical boundary.</p>", "<p id=\"Par24\">From the simulations conducted in this work, a variation in the thickness of the cathode sheath with the voltage rate-of-rise has been observed, as shown in Fig. ##FIG##9##10##. Most interestingly, this has been observed only in CO and not in air. While the color plots of Figs. ##FIG##1##2## to ##FIG##2##3## clearly show the formation of the cathode sheath, the regions of low electron density in Fig. ##FIG##8##9## demonstrates more clearly the increasing thickness of the sheath with slowing rate of voltage rise in CO. This can be compared to those in air, which showed very little change in the cathode sheath thickness with different <italic>dU</italic>/<italic>dt</italic>. To compare across polarities, gases, and rates-of-rise, Fig. ##FIG##9##10## plots the cathode sheath thickness as a function of <italic>dU</italic>/<italic>dt</italic>. The physical mechanism behind this observation is believed to result from the presence of photoionization and the variation of the electron mobility with electron energy, and their impact on electron generation and drift under a time-increasing electric field during the pre-discharge phase. Figure ##FIG##10##11## shows the electron mobility relationships for air and CO, plotted against the electron energy. Of particular interest is the region where 0.63 5 eV, where the electron mobility of CO increases to a local maximum, and becomes significantly higher than that of air. It is important to note that the simulations indicate that electrons may enter this energy range while the electric field remained below the critical field for both CO and air, at 2.2 kV/mm and 2.8 kV/mm, respectively. With a voltage (and hence background field) which has a finite time to rise, there must exist a duration when the local mean electron energy passes through the above energy range. During this time, electron mobility is maximized in CO, allowing electrons to drift away from the cathode faster than in air, leading to the local reduction of the electron density around the cathode which eventually becomes the cathode sheath, all which occurs before intensive ionization takes place. It follows, therefore, that a slower rate of rise prolongs the time for which the field is within this critical range, allowing electrons to drift farther away from the cathode, and forming a larger sheath with slower rates of rise. The presence of significant photoionization in air compared to CO may also generate significant numbers of electrons ahead of the wavefront and injected into the sheath region, effectively decreasing the sheath thickness. For both needle-plane and needle-needle simulations, and at the slowest rate of rise simulated in this work (10 kV/ns), the cathode sheath in CO occupied almost half of the total inter-electrode gap distance. If this is indeed the case, one should expect that for sufficiently slow rising voltages (possibly kV/s, kV/ms), a similar relation would be found in air since the electron mobility in air is maximized at low electron energies. This would require significantly longer simulation times, as such, is considered an aspect for future work. It is believed that it was not observed in the present work due to the rapid rates of voltage rise used in this study, and with the monotonically decreasing electron mobility with increasing field in air, any differences in the electron traversal distance under different values of <italic>dU</italic>/<italic>dt</italic> during the pre-discharge phase would be indiscernible. It is further remarked that one should not ignore the possibility that other processes (attachment, recombination within the channel, electron emission from the electrodes, etc.) may also contribute to the cathode sheath behavior. These are aspects that would be of high interest to explore in further modelling and experimental work, but fall outside of the scope of the present study.</p>", "<p id=\"Par25\">It is believed that the dynamics of the cathode sheath observed here may have consequences for the discharge evolution in short, sub-mm gaps. For example, Fig. ##FIG##11##12## shows streak images of the electric field for point-point discharges at various rates-of-rise in CO. As described in the section “<xref rid=\"Sec9\" ref-type=\"sec\">Ionization front morphology—point-plane and point-point</xref>”, near-simultaneous positive and negative streamers propagate towards each other and merge within the gap. This was true for all <italic>dU</italic>/<italic>dt</italic> except when <italic>dU</italic>/<italic>dt</italic> was less than 25 kV/ns in CO. Under these conditions, it was found that a negative streamer simply did not appear in CO (Fig. ##FIG##11##12##). This appears to be due to the aforementioned relationship between low <italic>dU</italic>/<italic>dt</italic> and the cathode sheath, which under these conditions occupied a significant portion of the inter-electrode gap, suppressing the formation of a negative front due to the limited space. The time evolution therefore resembled more of the inception of a solitary positive streamer, which collided and spread out over a now large cathode sheath acting like an extended virtual cathode. These results may help to possibly explain some observations in short, 100 m needle-plane breakdown studies under impulsive regimes, conducted by Liu et al.<sup>##UREF##9##11##</sup>. The authors consistently found a significantly shorter time-to-breakdown at higher breakdown voltage in CO compared to air and N for nanosecond impulses, contrasting what the critical field value would suggest under classical breakdown theories. It is believed that the combination of the sub-mm gap and the enhanced electron mobility of CO during the rising impulse may act to significantly reduce the electron density in the gap during the pre-discharge phase. This may inhibit the formation of initial avalanches and ionization fronts, thereby delaying the breakdown process and increasing the overall breakdown strength. It is thought that such phenomena would be more difficult to observe in long gaps, as the field would have to remain within the critical range of enhanced electron mobility for far longer to cause a significant reduction in the electron density ahead of the streamer. That is, the increase of the breakdown strength for CO only holds when the sheath distance is able to occupy a significant proportion of the inter-electrode gap. Of course, the simulations here omit other possible electronic sources, such as charge injection at the electrodes or any secondary emission sources, and forgoes the consideration of statistical processes before—and other processes beyond—the primary ionization front. Comparison with practical breakdown data is therefore done with extreme caution, and would necessitate significant experimental and theoretical work in the future to confirm the existence of the discussed mechanisms.</p>" ]
[ "<title>Conclusions</title>", "<p id=\"Par26\">In this work, the computational study of fast transient ionization fronts initiated in sub-millimeter point-plane and point-point gaps has been performed. Analysis has been conducted on the effects of fast-rising ramp (over)voltages on the primary discharge characteristics in synthetic air and in pure CO. It has been observed that ionization fronts initiated in air develops stronger electric fields at their heads than in CO for negative voltages, but the opposite behavior is found for positive voltages. Ionization fronts developed in CO also appear to be larger in radius and incept earlier than in air under the same conditions. The acceleration of the ionization fronts is affected by the voltage rate-of-rise, where slower rising voltages led to slower-accelerating fronts, while average propagation velocities increased with increased voltage rate-of-rise, through this was more significant in air than in CO.</p>", "<p id=\"Par27\">The developed electron density was higher for positive fronts than for negative fronts in the same gas, under the same conditions of voltage stress, and an increased rate of voltage rise increased the electron density developed inside the resulting plasma channel nonlinearly. By decreasing the rate of voltage rise, a thicker cathode sheath was developed in CO, but little change to the cathode sheath in air was observed. This is believed to be due to the enhanced electronic mobility of CO for a specific range of electron energy during the rising edge, and the presence of photoionization in air. It has been hypothesized that air would exhibit similar behaviour for voltages rising slower than those used in this study. The relationship between the rate-of-rise and the cathode sheath thickness may have consequences for the operation of systems utilizing short gaps. In a point-point simulation, this phenomenon is believed to have suppressed the formation of a negative front (and early halting of the positive front). It is believed that the ratio between the sheath thickness and the total inter-electrode gap distance is an important parameter in characterizing this process, as is the voltage rate-of-rise.</p>", "<p id=\"Par28\">In future work, further investigation of the cathode sheath development, and its relation to time-varying voltages, would be of great interest. In particular, further simulations with different gases, and under slower rates-of-rise would be necessary to fully understand the mechanism behind the observed sheath effects. Experimental work on the breakdown of ‘pre-stressed’ sub-mm gaps should also be conducted, to further understand whether the effects observed here have any tangible impact on the overall breakdown process. This could potentially be conducted using superimposed DC and impulsive voltages. Studies beyond the initial primary discharge phase would also be of great importance, especially to assess the impact of the primary ionization front on the further evolution of the discharge through to the spark stage. Developments in this direction would contribute to a deeper understanding of gas discharge processes, and be highly beneficial to the design of devices dealing with high electric field stresses, including high voltage and pulsed power equipment.</p>" ]
[ "<p id=\"Par1\">Gas discharge and breakdown phenomena have become increasingly important for the development of an ever-growing number of applications. The need for compact and miniaturized systems within power, pulsed power, semiconductor, and power electronic industries has led to the imposing of significant operating electric field stresses on components, even within applications with low operating voltages. Consequently, the interest in gas discharge processes in sub-millimeter and microscale gaps has grown, as the understanding of their initiation and propagation is critical to the further optimization of these technologies. In this work, a computational study of primary ionization fronts has been conducted, which systematically investigated the role of voltage rate-of-rise in point-plane and point-point electrode geometries with an inter-electrode gap maintained at 250 m and a needle radius of 80 m. Using the hydrodynamic approach with the local mean energy approximation, along with simplified plasma chemistry, simulations have been performed under positive and negative ramp voltages, rising at 50, 25, 16.67, 12.5, and 10 kV/ns in synthetic air and in pure CO. Results on the developed electric field, electron densities, and propagation velocities are presented and discussed. Effects on the cathode sheath thickness scaling with voltage rate-of-rise have been additionally analyzed, the mechanisms behind these effects and their potential impacts are discussed. The work conducted in this study contributes towards an increased understanding of the gas discharge process, under fast-transients and nonuniform electric fields, with relevance to microelectromechanical, power, and pulsed power system design.</p>", "<title>Subject terms</title>" ]
[ "<title>Gas discharge model</title>", "<p id=\"Par6\">This section details the mathematical model employed in this work to investigate the gas discharge process. Namely, the <italic>hydrodynamic</italic> or <italic>fluid</italic> approach has been used, which seeks self-consistent solutions to the spatiotemporal evolution of a set charged particle species by approximating them as continuous charge densities. These densities undergo advection, diffusion, and reaction, under the influence of both an external field and their own space charge induced electric fields. The hydrodynamic approach has gained popularity in recent times, favored for its faster computation times as compared with more fundamental descriptions, such as particle-based kinetic methods. There are, however, known limitations to the fluid approach, see for instance the regions of validity as outlined by Kolobov and Arslanbekov<sup>##UREF##15##18##</sup>. It is remarked that based solely on the characteristic length, <italic>L</italic>, of the domain and gas pressure used here, the present configuration remains within the region of validity for the hydrodynamic approach. That is, the mean free path of electrons in both atmospheric air and CO under the simulated conditions is far shorter than <italic>L</italic>. It is, however, also important to note that the wavefront evolutions modelled in this work take place over picosecond timescales, placing the characteristic times of the discharges close to the relaxation time of the electron energy distribution function (EEDF). Based on analysis by Zhu et al.<sup>##UREF##16##19##</sup>, the fast-discharge conditions considered in the present analyses are close the limit of validity for the hydrodynamic approach, where a kinetic approach may begin to become necessary. However, considering the uncertainty in the exact position and nature of this validity criterion (i.e, the boundary between these two approaches); the hydrodynamic approach is considered to be valid for the conditions modelled in the present paper. As further support for the validity of the fluid approach, the reader is referred to a combined experimental/simulation study by Höft et al.<sup>##UREF##17##20##</sup>, where reasonable agreement between fluid-simulated and experimentally imaged primary ionization waves was found. Those studied were developed under similarly fast-rising voltages as the present work, and occurred over comparably short (picosecond) timescales. Comparison of the resultant wavefront velocities arising from this work to those experimentally measured by Tardiveau et al.<sup>##UREF##18##21##</sup> , also under voltages rising on the order of kV/ns, supports the suggestion that the fluid model may remain a reasonable approximation of reality near this limit. The exploration of kinetic effects is left as a subject for future work to build upon the results presented here.</p>", "<title>Drift-diffusion equations</title>", "<p id=\"Par7\">Using the hydrodynamic approximation for gas discharges, and for a chemical species , where <italic>N</italic> is the set of all tracked species, the charge density evolves in space and time with:where represents the time derivative, is the volumetric density, and the total flux is characterized by the (positive) mobility, , and the diffusion coefficient, , following:given that is the signed charge of species <italic>i</italic>, and is the scalar potential field. The charge densities are coupled to the electric field through the Poisson equation:where is the permittivity of the medium. In the case of gas, this is assumed to be equal to the vacuum permittivity. A self-consistent solution can be found by solving (##FORMU##21##1##) and (##FORMU##30##3##) simultaneously with appropriate boundary and initial conditions, those used in this study are described later in the section “<xref rid=\"Sec7\" ref-type=\"sec\">Domain and boundary conditions</xref>”.</p>", "<title>Plasma chemistry</title>", "<p id=\"Par8\">This study considered two gases: synthetic air (80/20% N/O) and pure CO. For air, the simplified plasma chemistry set following Pancheshnyi and Starikovskii<sup>##UREF##19##22##</sup> has been used, while those provided by Aerts et al.<sup>##REF##25641832##14##</sup> were employed for CO. Electronic reaction rates and transport coefficients were computed using BOLSIG+<sup>##UREF##20##23##</sup>, from Phelps’ collision cross sections<sup>##UREF##21##24##</sup>, while all heavy species were considered non-diffusive and immobile over the simulated timescales. The reactions and rate coefficients are tabulated in Tables ##TAB##0##1## and ##TAB##1##2## for air and CO, respectively.</p>", "<p id=\"Par9\"> and of Table ##TAB##0##1## correspond to photoionization, which is described in more detail within the section named <xref rid=\"Sec5\" ref-type=\"sec\">photoionization and pre-ionization</xref>. The source terms of (##FORMU##21##1##) were then computed following:where is the reaction rate for reaction , <italic>r</italic> being the set of all reactions. is +1 or -1 depending if the reaction is a source or sink, while <italic>R</italic> is the set of all reactants partaking in reaction <italic>j</italic>. is therefore the density of the <italic>m</italic>-th reactant.</p>", "<title>Photoionization and pre-ionization</title>", "<p id=\"Par10\">It is known that an external source of electrons must be present ahead of positive ionization fronts for their successful development and sustained propagation. In air, this source is widely considered to be photoionization<sup>##UREF##23##26##</sup> due to the excitation and subsequent radiative de-excitation of N molecules which ionize O (following R and R of Table ##TAB##0##1##). The present model includes this process using Zheleznyak’s model<sup>##UREF##22##25##</sup>, approximated using the three-term Helmholtz approach described by Bourdon et al.<sup>##UREF##24##27##</sup>. The photoelectron source term is therefore given by:for <italic>j</italic> = 1, 2, 3, and is included as a source in Eq. (##FORMU##21##1##). Here, <italic>p</italic> is the gas pressure, is the partial pressure of oxygen, and is the collisional quenching pressure of nitrogen, which accounts for non-radiative de-excitation processes. The fitting parameters , and used throughout this study follows those given by Bagheri et al.<sup>##UREF##25##28##</sup>. In air, it is also assumed that a pre-ionization level of m (electrons and ions) exists in the domain, which represents a typical value of the background ionization level<sup>##UREF##26##29##</sup>.</p>", "<p id=\"Par11\">In CO, the role of photoionization remains largely unknown. Bagheri et al.<sup>##UREF##27##30##</sup> suggested that photoionization in CO would be negligible, based on previous experimental measurements. To date, there has been no significant findings to suggest otherwise. To alleviate the computational challenge of simulating discharges with a low electron source, an elevated level of pre-ionization ( m, electrons and ) has therefore been incorporated for CO simulations<sup>##UREF##27##30##</sup>. According to previously conducted computational tests<sup>##UREF##27##30##</sup>, streamer discharges in CO do not exhibit significant sensitivity to the level of background pre-ionization, through it may be important to branching behavior. However, the present study investigated a short gap of only 250 m, a distance for which branching is unlikely to be relevant. It was therefore concluded that this approximation would not substantially affect the obtained characteristics of the discharge evolution.</p>", "<title>Local mean energy approximation</title>", "<p id=\"Par12\">While the local field approximation (where the transport parameters are a function only of the local electric field strength) can adequately describe non-thermal gas discharges in some scenarios, this approximation becomes less applicable in high or nonuniform field regions<sup>##UREF##28##31##</sup>, such as near solid boundaries, sharp electrodes, or short gaps. To expand the range of validity of the present model, the local mean energy approximation has instead been used in this work. This incorporates an additional balance equation for the electron energy, which explicitly accounts for energy losses within chemical reactions, and the energy change relating to the field heating and cooling of electrons, given by:where is the electron energy density, from which the local electron energy, is found from . As before, is the density of reactant <italic>m</italic> in the set <italic>R</italic>. The symbol is the elementary charge, while is the electron energy change during reaction <italic>j</italic>. Transport coefficients were then set to be a function of rather than of the local electric field magnitude.</p>", "<title>Domain and boundary conditions</title>", "<p id=\"Par13\">The domain used for point-plane simulations is shown in Fig. ##FIG##0##1##. The needle was formed of a hyperbolic segment that with rotational symmetry about <italic>r</italic> = 0, and had a tip radius of 80 m. To better approximate a practical needle geometry, the hyperbola was connected to a straight segment representing the outer cylindrical face of the needle, which had a radius of 1 mm. The bounding box of the domain was made to be far larger than the discharge region, with dimensions (<italic>r</italic>, <italic>z</italic>) = [5, 3.75] mm. For the later point-point simulations, the domain was mirrored vertically, but with the needles shifted such that their tips would lie on <italic>z</italic> = ± 125 m to maintain the 250 m gap.</p>", "<p id=\"Par14\">A zero-potential Dirichlet condition was applied to the bottom plane electrode (or in the case of point–point electrodes, the corresponding needle), while a time-dependent ramp voltage of the formwas applied to the needle electrode, where the symbol <italic>dU</italic>/<italic>dt</italic> is the rate of voltage rise with units of volts per second. Neumann-zero conditions were applied to the axis of symmetry and to the outer edges, while wall conditions following Hagelaar et al.<sup>##UREF##29##32##</sup> were prescribed on the electrode surfaces for all fluxes. Since the present work was focused on the working gas type and on the effects of <italic>dU</italic>/<italic>dt</italic>, no secondary emission (SE) nor reflection at the electrodes have been considered. Besides, secondary emission coefficients remain largely unknown for many engineering materials, and a systematic study on the effects of arbitrarily varying SE would be of lesser relevance in practice, as generally, SE coefficients are not well defined nor can they be controlled. It remains, however, of high priority to study in future. Apart from the uniformly-distributed electrons and positive ions representing background pre-ionization, no additional charged seeds were necessary as initial conditions, since the discharge would initiate from the enhanced field around the needle tip.</p>", "<p id=\"Par15\">In all simulations, adaptive mesh refinement (AMR) was enabled to perform dynamic re-meshing, reaching a minimum element size of approximately 1 m. Time integration was of second-order accuracy, using a sub-picosecond step size, and standard pressure and temperature (STP) conditions (1 atm, 300 K) were maintained for both gases. The StrAFE library as developed and verified by Wong et al.<sup>##UREF##30##33##</sup> was used to perform this study. Note that this study focused on the characteristics of only the primary ionization wave, therefore, simulations were terminated upon the wavefront reaching the opposite electrode and began to spread out laterally across its surface (or in the case of positive energization, across the cathode sheath).</p>", "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51727-y.</p>", "<title>Acknowledgements</title>", "<p>T.W. was supported in part by the Engineering and Physical Science Research Council (EPSRC) under Grant number EP/T517938/1.</p>", "<title>Author contributions</title>", "<p>T.W. developed the simulation methodology, simulation code, analyzed results, and prepared the first draft manuscript. I.T. contributed to project supervision, simulation methodology, analysis of results, procurement of resources and reviewing and editing of the manuscript. S.M. contributed project supervision, procurement of resources, and review. M.W. contributed to the procurement of resources and the review and editing of the manuscript, M.G. contributed the procurement of resources and the review and editing of the manuscript. All authors reviewed and agreed to the publication of the manuscript.</p>", "<title>Data availibility</title>", "<p>All data generated or analyzed during this study are included in this published article (and its Supplementary Information files).</p>", "<title>Competing interests</title>", "<p id=\"Par29\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Diagram of the computational domain for needle-plane simulations. For needle-needle, the plane electrode was replaced with a second, identical and mirrored, needle electrode with tips placed at 125 m.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Time evolution of the ionization front in an (<bold>a</bold>)–(<bold>f</bold>) air-filled, (<bold>g</bold>)–(<bold>l</bold>) CO-filled point-plane gap. Panels have been labelled with the moment in time the image was recorded, while the symbol printed on the needle electrode indicates the polarity of the applied voltage (top rows are positive, bottom rows are negative). Showing <italic>dU</italic>/<italic>dt</italic> = 50 kV/ns only.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Time evolution of the ionization front in (<bold>a</bold>)–(<bold>d</bold>) air-filled, (<bold>e</bold>)–(<bold>h</bold>) CO-filled point-point gap. Panels have been labelled with the moment in time the image was recorded. Showing <italic>dU</italic>/<italic>dt</italic> = 50 kV/ns, the distinction between anode and cathode is indicated by the ‘+’ and ‘–’ symbols printed on the needle electrodes.</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Instantaneous velocity over time, of the (<bold>a</bold>) positive, (<bold>b</bold>) negative ionization fronts in air-filled point-plane gaps for the simulated rates of voltage rise. Negative fronts also have zero velocity before the first data-point, but markers have been removed for visibility.</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>(<bold>a</bold>) Streak images of the electric field magnitude along the axis of symmetry for air-filled point-plane gaps, at different rates of rise. Red dotted line indicates the time of inception, solid magenta lines indicate the time of contact. (<bold>b</bold>) Observed linear scaling of the inception time for all combinations of gas and polarity with .</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Average front velocities for air and CO under point-plane gaps, and for both polarities. Markers are simulated data, lines are best-fit curves.</p></caption></fig>", "<fig id=\"Fig7\"><label>Figure 7</label><caption><p>Maximum electric field over time for (<bold>a</bold>) positive, (<bold>b</bold>) negative energization, for the simulated rates-of-rise. Solid lines are for air, dashed lines are for CO.</p></caption></fig>", "<fig id=\"Fig8\"><label>Figure 8</label><caption><p>Electric field strength down the axis of symmetry for (<bold>a</bold>) air-filled, (<bold>b</bold>) CO-filled point-point gaps at various timesteps. 50 kV/ns shown only.</p></caption></fig>", "<fig id=\"Fig9\"><label>Figure 9</label><caption><p>Density along the axis of symmetry at the time of contact for point-plane gaps filled with air and CO. Sub-figures are labelled with the gas type (‘air’ or ‘CO’), and the polarity (‘+’ or ‘–’). Plotted for <italic>dU</italic>/<italic>dt</italic> of 12.5, 16.67, 25, and 50 kV/ns.</p></caption></fig>", "<fig id=\"Fig10\"><label>Figure 10</label><caption><p>Cathode sheath thickness as a function of the voltage rate-of-rise, for fronts in air- and CO-filled point-plane gaps. Markers are simulated data, lines are best-fit curves.</p></caption></fig>", "<fig id=\"Fig11\"><label>Figure 11</label><caption><p>Comparison between the electronic mobility scaled by the neutral gas density as a function of the electron energy for air and CO (as computed via BOLSIG+<sup>##UREF##20##23##</sup>). Note the critical region where 0.63 5 eV.</p></caption></fig>", "<fig id=\"Fig12\"><label>Figure 12</label><caption><p>Streak image of the electric field magnitude along the axis of symmetry for a CO-filled point-point gap, under different rates of rise. Dashed white line shows the midpoint between the two needle electrodes. Negative front did not form for <italic>dU</italic>/<italic>dt</italic> less than 25 kV/ns, as indicated.</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Table of included chemical reactions for air.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Reaction number</th><th align=\"left\">Description</th><th align=\"left\">Reaction</th><th align=\"left\">Rate</th><th align=\"left\">Unit</th><th align=\"left\">References</th></tr></thead><tbody><tr><td align=\"left\"></td><td align=\"left\">Impact ionization (15.6 eV)</td><td align=\"left\"></td><td align=\"left\">BOLSIG+</td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##20##23##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Impact ionization (18.8 eV)</td><td align=\"left\"></td><td align=\"left\">BOLSIG+</td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##20##23##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Impact ionization</td><td align=\"left\"></td><td align=\"left\">BOLSIG+</td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##20##23##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Attachment</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##20##23##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Rapid production</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##19##22##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Rapid production</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##19##22##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Rapid production</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##19##22##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\"> to conversion</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##19##22##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\"> to conversion</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##19##22##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\"> to conversion</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##19##22##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\"> to conversion</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##19##22##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Electron-ion recombination</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##19##22##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Electron-ion recombination</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##19##22##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Ion-ion recombination</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##19##22##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Ion-ion recombination</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##19##22##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Ion-ion recombination</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##19##22##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Excitation/emission</td><td align=\"left\"></td><td align=\"left\">Zheleznyak.</td><td align=\"left\">−</td><td align=\"left\"><sup>##UREF##22##25##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Photoionization</td><td align=\"left\"></td><td align=\"left\">Zheleznyak.</td><td align=\"left\">−</td><td align=\"left\"><sup>##UREF##22##25##</sup></td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Table of included chemical reactions for .</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Reaction number</th><th align=\"left\">Description</th><th align=\"left\">Reaction</th><th align=\"left\">Rate</th><th align=\"left\">Unit</th><th align=\"left\">References</th></tr></thead><tbody><tr><td align=\"left\"></td><td align=\"left\">Impact ionization</td><td align=\"left\"></td><td align=\"left\">BOLSIG+</td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##20##23##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Dissociation</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##REF##25641832##14##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Attachment</td><td align=\"left\"></td><td align=\"left\">BOLSIG+</td><td align=\"left\">ms</td><td align=\"left\"><sup>##UREF##20##23##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Dissociation</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##REF##25641832##14##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Dissociation</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##REF##25641832##14##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Dissociation</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##REF##25641832##14##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Attachment</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##REF##25641832##14##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Ion-neutral reaction</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##REF##25641832##14##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Ion-neutral reaction</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##REF##25641832##14##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Ion-neutral reaction</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##REF##25641832##14##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Electron-ion recombination</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##REF##25641832##14##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Ion-ion recombination</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##REF##25641832##14##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Neutral reaction</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##REF##25641832##14##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Neutral reaction</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##REF##25641832##14##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Neutral reaction</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##REF##25641832##14##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Neutral reaction</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##REF##25641832##14##</sup></td></tr><tr><td align=\"left\"></td><td align=\"left\">Neutral reaction</td><td align=\"left\"></td><td align=\"left\"></td><td align=\"left\">ms</td><td align=\"left\"><sup>##REF##25641832##14##</sup></td></tr></tbody></table></table-wrap>" ]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mi mathvariant=\"normal\">μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mi mathvariant=\"normal\">μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lesssim$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mo>≲</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mi mathvariant=\"normal\">μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq8\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mi mathvariant=\"normal\">μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq9\"><alternatives><tex-math id=\"M15\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document}</tex-math><mml:math id=\"M16\"><mml:mi mathvariant=\"normal\">μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq10\"><alternatives><tex-math id=\"M17\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document}</tex-math><mml:math id=\"M18\"><mml:mi mathvariant=\"normal\">μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq11\"><alternatives><tex-math id=\"M19\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M20\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq12\"><alternatives><tex-math id=\"M21\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M22\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq13\"><alternatives><tex-math id=\"M23\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M24\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq14\"><alternatives><tex-math id=\"M25\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M26\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq15\"><alternatives><tex-math id=\"M27\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document}</tex-math><mml:math id=\"M28\"><mml:mi mathvariant=\"normal\">μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq16\"><alternatives><tex-math id=\"M29\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document}</tex-math><mml:math id=\"M30\"><mml:mi mathvariant=\"normal\">μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq17\"><alternatives><tex-math id=\"M31\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M32\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq18\"><alternatives><tex-math id=\"M33\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M34\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq19\"><alternatives><tex-math id=\"M35\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M36\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq20\"><alternatives><tex-math id=\"M37\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{6}$$\\end{document}</tex-math><mml:math id=\"M38\"><mml:msub><mml:mrow/><mml:mn>6</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq21\"><alternatives><tex-math id=\"M39\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_2$$\\end{document}</tex-math><mml:math id=\"M40\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq22\"><alternatives><tex-math id=\"M41\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$i \\in N$$\\end{document}</tex-math><mml:math id=\"M42\"><mml:mrow><mml:mi>i</mml:mi><mml:mo>∈</mml:mo><mml:mi>N</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ1\"><label>1</label><alternatives><tex-math id=\"M43\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\partial _t n_i + \\nabla \\cdot \\mathbf {\\Gamma }_i = S_i, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M44\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msub><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mo>·</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq23\"><alternatives><tex-math id=\"M45\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\partial _t$$\\end{document}</tex-math><mml:math id=\"M46\"><mml:msub><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq24\"><alternatives><tex-math id=\"M47\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n_i$$\\end{document}</tex-math><mml:math id=\"M48\"><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq25\"><alternatives><tex-math id=\"M49\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mathbf {\\Gamma }_i$$\\end{document}</tex-math><mml:math id=\"M50\"><mml:msub><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq26\"><alternatives><tex-math id=\"M51\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu _i$$\\end{document}</tex-math><mml:math id=\"M52\"><mml:msub><mml:mi>μ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq27\"><alternatives><tex-math id=\"M53\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$D_i$$\\end{document}</tex-math><mml:math id=\"M54\"><mml:msub><mml:mi>D</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ2\"><label>2</label><alternatives><tex-math id=\"M55\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\mathbf {\\Gamma}_i = -\\textrm{sgn}(q_i) n_i \\mu_i \\nabla \\varphi - D_i \\nabla n_i, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M56\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msub><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mtext>sgn</mml:mtext><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>μ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mi>φ</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq28\"><alternatives><tex-math id=\"M57\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$q_i$$\\end{document}</tex-math><mml:math id=\"M58\"><mml:msub><mml:mi>q</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq29\"><alternatives><tex-math id=\"M59\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varphi$$\\end{document}</tex-math><mml:math id=\"M60\"><mml:mi>φ</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ3\"><label>3</label><alternatives><tex-math id=\"M61\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} -\\nabla \\cdot \\left( \\varepsilon \\nabla \\varphi \\right) =\\sum _{j \\in N} q_j n_j, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M62\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mo>-</mml:mo><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mo>·</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:mi>ε</mml:mi><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mi>φ</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>∈</mml:mo><mml:mi>N</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mi>q</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>n</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq30\"><alternatives><tex-math id=\"M63\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varepsilon$$\\end{document}</tex-math><mml:math id=\"M64\"><mml:mi>ε</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq31\"><alternatives><tex-math id=\"M65\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M66\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq32\"><alternatives><tex-math id=\"M67\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M68\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq33\"><alternatives><tex-math id=\"M69\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M70\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq34\"><alternatives><tex-math id=\"M71\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M72\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq35\"><alternatives><tex-math id=\"M73\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M74\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq36\"><alternatives><tex-math id=\"M75\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_1$$\\end{document}</tex-math><mml:math id=\"M76\"><mml:msub><mml:mi>R</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq37\"><alternatives><tex-math id=\"M77\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {e} + N_2 \\rightarrow N_2^+ + \\text {e} + \\text {e}$$\\end{document}</tex-math><mml:math id=\"M78\"><mml:mrow><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:msubsup><mml:mi>N</mml:mi><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:mtext>e</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq38\"><alternatives><tex-math id=\"M79\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M80\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq39\"><alternatives><tex-math id=\"M81\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M82\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq40\"><alternatives><tex-math id=\"M83\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_2$$\\end{document}</tex-math><mml:math id=\"M84\"><mml:msub><mml:mi>R</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq41\"><alternatives><tex-math id=\"M85\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {e} + N_2 \\rightarrow N_2^+ + \\text {e} + \\text {e}$$\\end{document}</tex-math><mml:math id=\"M86\"><mml:mrow><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:msubsup><mml:mi>N</mml:mi><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:mtext>e</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq42\"><alternatives><tex-math id=\"M87\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M88\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq43\"><alternatives><tex-math id=\"M89\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M90\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq44\"><alternatives><tex-math id=\"M91\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_3$$\\end{document}</tex-math><mml:math id=\"M92\"><mml:msub><mml:mi>R</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq45\"><alternatives><tex-math id=\"M93\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {e} + \\text {O}_2 \\rightarrow \\text {O}_2^+ + \\text {e} + \\text {e}$$\\end{document}</tex-math><mml:math id=\"M94\"><mml:mrow><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:mtext>e</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq46\"><alternatives><tex-math id=\"M95\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M96\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq47\"><alternatives><tex-math id=\"M97\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M98\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq48\"><alternatives><tex-math id=\"M99\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_4$$\\end{document}</tex-math><mml:math id=\"M100\"><mml:msub><mml:mi>R</mml:mi><mml:mn>4</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq49\"><alternatives><tex-math id=\"M101\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {e}+\\text {O}_2+\\text {O}_2 \\rightarrow \\text {O}_2^- + \\text {O}_2$$\\end{document}</tex-math><mml:math id=\"M102\"><mml:mrow><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>-</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq50\"><alternatives><tex-math id=\"M103\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f({\\bar{\\varepsilon }})$$\\end{document}</tex-math><mml:math id=\"M104\"><mml:mrow><mml:mi>f</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">¯</mml:mo></mml:mrow></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq51\"><alternatives><tex-math id=\"M105\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{6}$$\\end{document}</tex-math><mml:math id=\"M106\"><mml:msup><mml:mrow/><mml:mn>6</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq52\"><alternatives><tex-math id=\"M107\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M108\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq53\"><alternatives><tex-math id=\"M109\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_5$$\\end{document}</tex-math><mml:math id=\"M110\"><mml:msub><mml:mi>R</mml:mi><mml:mn>5</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq54\"><alternatives><tex-math id=\"M111\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_2^+$$\\end{document}</tex-math><mml:math id=\"M112\"><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq55\"><alternatives><tex-math id=\"M113\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$N_2^+ + N_2 + \\text {M} \\rightarrow N_4^+ + \\text {M}$$\\end{document}</tex-math><mml:math id=\"M114\"><mml:mrow><mml:msubsup><mml:mi>N</mml:mi><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext><mml:mo stretchy=\"false\">→</mml:mo><mml:msubsup><mml:mi>N</mml:mi><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq56\"><alternatives><tex-math id=\"M115\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$5\\times 10^{-41}$$\\end{document}</tex-math><mml:math id=\"M116\"><mml:mrow><mml:mn>5</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>41</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq57\"><alternatives><tex-math id=\"M117\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{6}$$\\end{document}</tex-math><mml:math id=\"M118\"><mml:msup><mml:mrow/><mml:mn>6</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq58\"><alternatives><tex-math id=\"M119\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M120\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq59\"><alternatives><tex-math id=\"M121\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_6$$\\end{document}</tex-math><mml:math id=\"M122\"><mml:msub><mml:mi>R</mml:mi><mml:mn>6</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq60\"><alternatives><tex-math id=\"M123\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_2^+$$\\end{document}</tex-math><mml:math id=\"M124\"><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq61\"><alternatives><tex-math id=\"M125\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$N_4^+ + \\text {O}_2 \\rightarrow \\text {O}_2^+ + N_2 + N_2$$\\end{document}</tex-math><mml:math id=\"M126\"><mml:mrow><mml:msubsup><mml:mi>N</mml:mi><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq62\"><alternatives><tex-math id=\"M127\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$2.5\\times 10^{-16}$$\\end{document}</tex-math><mml:math id=\"M128\"><mml:mrow><mml:mn>2.5</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>16</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq63\"><alternatives><tex-math id=\"M129\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M130\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq64\"><alternatives><tex-math id=\"M131\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M132\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq65\"><alternatives><tex-math id=\"M133\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_7$$\\end{document}</tex-math><mml:math id=\"M134\"><mml:msub><mml:mi>R</mml:mi><mml:mn>7</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq66\"><alternatives><tex-math id=\"M135\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_2^+$$\\end{document}</tex-math><mml:math id=\"M136\"><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq67\"><alternatives><tex-math id=\"M137\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$N_2^+ + \\text {O}_2 \\rightarrow \\text {O}_2^+ + N_2$$\\end{document}</tex-math><mml:math id=\"M138\"><mml:mrow><mml:msubsup><mml:mi>N</mml:mi><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq68\"><alternatives><tex-math id=\"M139\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$6\\times 10^{-17}$$\\end{document}</tex-math><mml:math id=\"M140\"><mml:mrow><mml:mn>6</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>17</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq69\"><alternatives><tex-math id=\"M141\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M142\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq70\"><alternatives><tex-math id=\"M143\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M144\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq71\"><alternatives><tex-math id=\"M145\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_8$$\\end{document}</tex-math><mml:math id=\"M146\"><mml:msub><mml:mi>R</mml:mi><mml:mn>8</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq72\"><alternatives><tex-math id=\"M147\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_2^+$$\\end{document}</tex-math><mml:math id=\"M148\"><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq73\"><alternatives><tex-math id=\"M149\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$O_4^+$$\\end{document}</tex-math><mml:math id=\"M150\"><mml:msubsup><mml:mi>O</mml:mi><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq74\"><alternatives><tex-math id=\"M151\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_2^+ + N_2 + N_2 \\rightarrow \\text {O}_2^+N_2 + N_2$$\\end{document}</tex-math><mml:math id=\"M152\"><mml:mrow><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq75\"><alternatives><tex-math id=\"M153\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$9\\times 10^{-43}$$\\end{document}</tex-math><mml:math id=\"M154\"><mml:mrow><mml:mn>9</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>43</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq76\"><alternatives><tex-math id=\"M155\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{6}$$\\end{document}</tex-math><mml:math id=\"M156\"><mml:msup><mml:mrow/><mml:mn>6</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq77\"><alternatives><tex-math id=\"M157\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M158\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq78\"><alternatives><tex-math id=\"M159\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_9$$\\end{document}</tex-math><mml:math id=\"M160\"><mml:msub><mml:mi>R</mml:mi><mml:mn>9</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq79\"><alternatives><tex-math id=\"M161\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_2^+$$\\end{document}</tex-math><mml:math id=\"M162\"><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq80\"><alternatives><tex-math id=\"M163\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$O_4^+$$\\end{document}</tex-math><mml:math id=\"M164\"><mml:msubsup><mml:mi>O</mml:mi><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq81\"><alternatives><tex-math id=\"M165\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_2^+N_2+N_2 \\rightarrow \\text {O}_2^++N_2+N_2$$\\end{document}</tex-math><mml:math id=\"M166\"><mml:mrow><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq82\"><alternatives><tex-math id=\"M167\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$4.3\\times 10^{-16}$$\\end{document}</tex-math><mml:math id=\"M168\"><mml:mrow><mml:mn>4.3</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>16</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq83\"><alternatives><tex-math id=\"M169\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M170\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq84\"><alternatives><tex-math id=\"M171\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M172\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq85\"><alternatives><tex-math id=\"M173\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{10}$$\\end{document}</tex-math><mml:math id=\"M174\"><mml:msub><mml:mi>R</mml:mi><mml:mn>10</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq86\"><alternatives><tex-math id=\"M175\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_2^+$$\\end{document}</tex-math><mml:math id=\"M176\"><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq87\"><alternatives><tex-math id=\"M177\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$O_4^+$$\\end{document}</tex-math><mml:math id=\"M178\"><mml:msubsup><mml:mi>O</mml:mi><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq88\"><alternatives><tex-math id=\"M179\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_2^+N_2+\\text {O}_2 \\rightarrow O_4^+N_2$$\\end{document}</tex-math><mml:math id=\"M180\"><mml:mrow><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:msubsup><mml:mi>O</mml:mi><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq89\"><alternatives><tex-math id=\"M181\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$1\\times 10^{-15}$$\\end{document}</tex-math><mml:math id=\"M182\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>15</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq90\"><alternatives><tex-math id=\"M183\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M184\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq91\"><alternatives><tex-math id=\"M185\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M186\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq92\"><alternatives><tex-math id=\"M187\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{11}$$\\end{document}</tex-math><mml:math id=\"M188\"><mml:msub><mml:mi>R</mml:mi><mml:mn>11</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq93\"><alternatives><tex-math id=\"M189\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_2^+$$\\end{document}</tex-math><mml:math id=\"M190\"><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq94\"><alternatives><tex-math id=\"M191\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$O_4^+$$\\end{document}</tex-math><mml:math id=\"M192\"><mml:msubsup><mml:mi>O</mml:mi><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq95\"><alternatives><tex-math id=\"M193\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_2^++\\text {O}_2+\\text {M} \\rightarrow O_4^++\\text {M}$$\\end{document}</tex-math><mml:math id=\"M194\"><mml:mrow><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext><mml:mo stretchy=\"false\">→</mml:mo><mml:msubsup><mml:mi>O</mml:mi><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq96\"><alternatives><tex-math id=\"M195\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$2.4\\times 10^{-42}$$\\end{document}</tex-math><mml:math id=\"M196\"><mml:mrow><mml:mn>2.4</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>42</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq97\"><alternatives><tex-math id=\"M197\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{6}$$\\end{document}</tex-math><mml:math id=\"M198\"><mml:msup><mml:mrow/><mml:mn>6</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq98\"><alternatives><tex-math id=\"M199\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M200\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq99\"><alternatives><tex-math id=\"M201\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{12}$$\\end{document}</tex-math><mml:math id=\"M202\"><mml:msub><mml:mi>R</mml:mi><mml:mn>12</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq100\"><alternatives><tex-math id=\"M203\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {e}+O_4^+ \\rightarrow \\text {O}_2+\\text {O}_2$$\\end{document}</tex-math><mml:math id=\"M204\"><mml:mrow><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msubsup><mml:mi>O</mml:mi><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo stretchy=\"false\">→</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq101\"><alternatives><tex-math id=\"M205\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f({\\bar{\\varepsilon }})$$\\end{document}</tex-math><mml:math id=\"M206\"><mml:mrow><mml:mi>f</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">¯</mml:mo></mml:mrow></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq102\"><alternatives><tex-math id=\"M207\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M208\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq103\"><alternatives><tex-math id=\"M209\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M210\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq104\"><alternatives><tex-math id=\"M211\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{13}$$\\end{document}</tex-math><mml:math id=\"M212\"><mml:msub><mml:mi>R</mml:mi><mml:mn>13</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq105\"><alternatives><tex-math id=\"M213\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {e}+\\text {O}_2^+ \\rightarrow \\text {O}+ \\text {O}$$\\end{document}</tex-math><mml:math id=\"M214\"><mml:mrow><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo stretchy=\"false\">→</mml:mo><mml:mtext>O</mml:mtext><mml:mo>+</mml:mo><mml:mtext>O</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq106\"><alternatives><tex-math id=\"M215\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f({\\bar{\\varepsilon }})$$\\end{document}</tex-math><mml:math id=\"M216\"><mml:mrow><mml:mi>f</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">¯</mml:mo></mml:mrow></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq107\"><alternatives><tex-math id=\"M217\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M218\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq108\"><alternatives><tex-math id=\"M219\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M220\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq109\"><alternatives><tex-math id=\"M221\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{14}$$\\end{document}</tex-math><mml:math id=\"M222\"><mml:msub><mml:mi>R</mml:mi><mml:mn>14</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq110\"><alternatives><tex-math id=\"M223\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_2^- + O_4^+ \\rightarrow \\text {O}_2+\\text {O}_2+\\text {O}_2$$\\end{document}</tex-math><mml:math id=\"M224\"><mml:mrow><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>-</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>O</mml:mi><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo stretchy=\"false\">→</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq111\"><alternatives><tex-math id=\"M225\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$1\\times 10^{-13}$$\\end{document}</tex-math><mml:math id=\"M226\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>13</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq112\"><alternatives><tex-math id=\"M227\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M228\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq113\"><alternatives><tex-math id=\"M229\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M230\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq114\"><alternatives><tex-math id=\"M231\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{15}$$\\end{document}</tex-math><mml:math id=\"M232\"><mml:msub><mml:mi>R</mml:mi><mml:mn>15</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq115\"><alternatives><tex-math id=\"M233\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_2^-+O_4^++\\text {M} \\rightarrow \\text {O}_2+\\text {O}_2+\\text {O}_2+\\text {M}$$\\end{document}</tex-math><mml:math id=\"M234\"><mml:mrow><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>-</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>O</mml:mi><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext><mml:mo stretchy=\"false\">→</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq116\"><alternatives><tex-math id=\"M235\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$2\\times 10^{-37}$$\\end{document}</tex-math><mml:math id=\"M236\"><mml:mrow><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>37</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq117\"><alternatives><tex-math id=\"M237\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{6}$$\\end{document}</tex-math><mml:math id=\"M238\"><mml:msup><mml:mrow/><mml:mn>6</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq118\"><alternatives><tex-math id=\"M239\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M240\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq119\"><alternatives><tex-math id=\"M241\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{16}$$\\end{document}</tex-math><mml:math id=\"M242\"><mml:msub><mml:mi>R</mml:mi><mml:mn>16</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq120\"><alternatives><tex-math id=\"M243\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_2^- + \\text {O}_2^+ + \\text {M} \\rightarrow \\text {O}_2 + \\text {O}_2 + \\text {M}$$\\end{document}</tex-math><mml:math id=\"M244\"><mml:mrow><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>-</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext><mml:mo stretchy=\"false\">→</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq121\"><alternatives><tex-math id=\"M245\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$2\\times 10^{-37}$$\\end{document}</tex-math><mml:math id=\"M246\"><mml:mrow><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>37</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq122\"><alternatives><tex-math id=\"M247\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{6}$$\\end{document}</tex-math><mml:math id=\"M248\"><mml:msup><mml:mrow/><mml:mn>6</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq123\"><alternatives><tex-math id=\"M249\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M250\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq124\"><alternatives><tex-math id=\"M251\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{17}$$\\end{document}</tex-math><mml:math id=\"M252\"><mml:msub><mml:mi>R</mml:mi><mml:mn>17</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq125\"><alternatives><tex-math id=\"M253\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {e}+N_2 \\rightarrow \\text {e}+N_2+\\gamma$$\\end{document}</tex-math><mml:math id=\"M254\"><mml:mrow><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mi>γ</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq126\"><alternatives><tex-math id=\"M255\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{18}$$\\end{document}</tex-math><mml:math id=\"M256\"><mml:msub><mml:mi>R</mml:mi><mml:mn>18</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq127\"><alternatives><tex-math id=\"M257\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\gamma + \\text {O}_2 \\rightarrow \\text {e}+\\text {O}_2^+$$\\end{document}</tex-math><mml:math id=\"M258\"><mml:mrow><mml:mi>γ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq128\"><alternatives><tex-math id=\"M259\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_2$$\\end{document}</tex-math><mml:math id=\"M260\"><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq129\"><alternatives><tex-math id=\"M261\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {N}_2$$\\end{document}</tex-math><mml:math id=\"M262\"><mml:msub><mml:mtext>N</mml:mtext><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq130\"><alternatives><tex-math id=\"M263\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f({\\bar{\\varepsilon }})$$\\end{document}</tex-math><mml:math id=\"M264\"><mml:mrow><mml:mi>f</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">¯</mml:mo></mml:mrow></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq131\"><alternatives><tex-math id=\"M265\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {CO}_2$$\\end{document}</tex-math><mml:math id=\"M266\"><mml:msub><mml:mtext>CO</mml:mtext><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq132\"><alternatives><tex-math id=\"M267\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_1$$\\end{document}</tex-math><mml:math id=\"M268\"><mml:msub><mml:mi>R</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq133\"><alternatives><tex-math id=\"M269\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {e} + \\text {CO}_2 \\rightarrow \\text {CO}_2^{+}+\\text {e}+\\text {e}$$\\end{document}</tex-math><mml:math id=\"M270\"><mml:mrow><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mtext>CO</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:msubsup><mml:mtext>CO</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:mtext>e</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq134\"><alternatives><tex-math id=\"M271\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M272\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq135\"><alternatives><tex-math id=\"M273\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M274\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq136\"><alternatives><tex-math id=\"M275\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_2$$\\end{document}</tex-math><mml:math id=\"M276\"><mml:msub><mml:mi>R</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq137\"><alternatives><tex-math id=\"M277\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {e}+\\text {CO}_2 \\rightarrow \\text {CO} +\\text {O}+ \\text {e}$$\\end{document}</tex-math><mml:math id=\"M278\"><mml:mrow><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mtext>CO</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:mtext>CO</mml:mtext><mml:mo>+</mml:mo><mml:mtext>O</mml:mtext><mml:mo>+</mml:mo><mml:mtext>e</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq138\"><alternatives><tex-math id=\"M279\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$5\\times 10^{-17}$$\\end{document}</tex-math><mml:math id=\"M280\"><mml:mrow><mml:mn>5</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>17</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq139\"><alternatives><tex-math id=\"M281\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M282\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq140\"><alternatives><tex-math id=\"M283\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M284\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq141\"><alternatives><tex-math id=\"M285\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_3$$\\end{document}</tex-math><mml:math id=\"M286\"><mml:msub><mml:mi>R</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq142\"><alternatives><tex-math id=\"M287\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {e}+\\text {CO}_2 \\rightarrow \\text {CO}+\\text {O}^-$$\\end{document}</tex-math><mml:math id=\"M288\"><mml:mrow><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mtext>CO</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:mtext>CO</mml:mtext><mml:mo>+</mml:mo><mml:msup><mml:mtext>O</mml:mtext><mml:mo>-</mml:mo></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq143\"><alternatives><tex-math id=\"M289\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M290\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq144\"><alternatives><tex-math id=\"M291\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M292\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq145\"><alternatives><tex-math id=\"M293\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_4$$\\end{document}</tex-math><mml:math id=\"M294\"><mml:msub><mml:mi>R</mml:mi><mml:mn>4</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq146\"><alternatives><tex-math id=\"M295\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {e}+\\text {O}_3 \\rightarrow \\text {O} + \\text {O}_2 + \\text {e}$$\\end{document}</tex-math><mml:math id=\"M296\"><mml:mrow><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>3</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:mtext>O</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mtext>e</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq147\"><alternatives><tex-math id=\"M297\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$2\\times 10^{-15}$$\\end{document}</tex-math><mml:math id=\"M298\"><mml:mrow><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>15</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq148\"><alternatives><tex-math id=\"M299\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M300\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq149\"><alternatives><tex-math id=\"M301\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M302\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq150\"><alternatives><tex-math id=\"M303\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_5$$\\end{document}</tex-math><mml:math id=\"M304\"><mml:msub><mml:mi>R</mml:mi><mml:mn>5</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq151\"><alternatives><tex-math id=\"M305\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {e}+\\text {O}_2 \\rightarrow \\text {O}+\\text {O}+\\text {e}$$\\end{document}</tex-math><mml:math id=\"M306\"><mml:mrow><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:mtext>O</mml:mtext><mml:mo>+</mml:mo><mml:mtext>O</mml:mtext><mml:mo>+</mml:mo><mml:mtext>e</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq152\"><alternatives><tex-math id=\"M307\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$2\\times 10^{-15}$$\\end{document}</tex-math><mml:math id=\"M308\"><mml:mrow><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>15</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq153\"><alternatives><tex-math id=\"M309\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M310\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq154\"><alternatives><tex-math id=\"M311\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M312\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq155\"><alternatives><tex-math id=\"M313\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_6$$\\end{document}</tex-math><mml:math id=\"M314\"><mml:msub><mml:mi>R</mml:mi><mml:mn>6</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq156\"><alternatives><tex-math id=\"M315\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {e}+\\text {O}_2 \\rightarrow \\text {O}+\\text {O}^-$$\\end{document}</tex-math><mml:math id=\"M316\"><mml:mrow><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:mtext>O</mml:mtext><mml:mo>+</mml:mo><mml:msup><mml:mtext>O</mml:mtext><mml:mo>-</mml:mo></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq157\"><alternatives><tex-math id=\"M317\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$4\\times 10^{-17}$$\\end{document}</tex-math><mml:math id=\"M318\"><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>17</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq158\"><alternatives><tex-math id=\"M319\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M320\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq159\"><alternatives><tex-math id=\"M321\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M322\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq160\"><alternatives><tex-math id=\"M323\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_7$$\\end{document}</tex-math><mml:math id=\"M324\"><mml:msub><mml:mi>R</mml:mi><mml:mn>7</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq161\"><alternatives><tex-math id=\"M325\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {e}+\\text {O}_2+\\text {M} \\rightarrow \\text {O}_2^- +\\text {M}$$\\end{document}</tex-math><mml:math id=\"M326\"><mml:mrow><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext><mml:mo stretchy=\"false\">→</mml:mo><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>-</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq162\"><alternatives><tex-math id=\"M327\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$3\\times 10^{-42}$$\\end{document}</tex-math><mml:math id=\"M328\"><mml:mrow><mml:mn>3</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>42</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq163\"><alternatives><tex-math id=\"M329\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{6}$$\\end{document}</tex-math><mml:math id=\"M330\"><mml:msup><mml:mrow/><mml:mn>6</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq164\"><alternatives><tex-math id=\"M331\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M332\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq165\"><alternatives><tex-math id=\"M333\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_8$$\\end{document}</tex-math><mml:math id=\"M334\"><mml:msub><mml:mi>R</mml:mi><mml:mn>8</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq166\"><alternatives><tex-math id=\"M335\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}^-+\\text {CO} \\rightarrow \\text {CO}_2+\\text {e}$$\\end{document}</tex-math><mml:math id=\"M336\"><mml:mrow><mml:msup><mml:mtext>O</mml:mtext><mml:mo>-</mml:mo></mml:msup><mml:mo>+</mml:mo><mml:mtext>CO</mml:mtext><mml:mo stretchy=\"false\">→</mml:mo><mml:msub><mml:mtext>CO</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mtext>e</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq167\"><alternatives><tex-math id=\"M337\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$5.5\\times 10^{-16}$$\\end{document}</tex-math><mml:math id=\"M338\"><mml:mrow><mml:mn>5.5</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>16</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq168\"><alternatives><tex-math id=\"M339\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M340\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq169\"><alternatives><tex-math id=\"M341\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M342\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq170\"><alternatives><tex-math id=\"M343\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_9$$\\end{document}</tex-math><mml:math id=\"M344\"><mml:msub><mml:mi>R</mml:mi><mml:mn>9</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq171\"><alternatives><tex-math id=\"M345\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}^-+\\text {O}_2 \\rightarrow \\text {O}_3 +\\text {e}$$\\end{document}</tex-math><mml:math id=\"M346\"><mml:mrow><mml:msup><mml:mtext>O</mml:mtext><mml:mo>-</mml:mo></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>3</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mtext>e</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq172\"><alternatives><tex-math id=\"M347\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$1\\times 10^{-18}$$\\end{document}</tex-math><mml:math id=\"M348\"><mml:mrow><mml:mn>1</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>18</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq173\"><alternatives><tex-math id=\"M349\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M350\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq174\"><alternatives><tex-math id=\"M351\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M352\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq175\"><alternatives><tex-math id=\"M353\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{10}$$\\end{document}</tex-math><mml:math id=\"M354\"><mml:msub><mml:mi>R</mml:mi><mml:mn>10</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq176\"><alternatives><tex-math id=\"M355\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}^- + \\text {O}_3 \\rightarrow \\text {O}_2 + \\text {O}_2 + \\text {e}$$\\end{document}</tex-math><mml:math id=\"M356\"><mml:mrow><mml:msup><mml:mtext>O</mml:mtext><mml:mo>-</mml:mo></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>3</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mtext>e</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq177\"><alternatives><tex-math id=\"M357\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$3\\times 10^{-16}$$\\end{document}</tex-math><mml:math id=\"M358\"><mml:mrow><mml:mn>3</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>16</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq178\"><alternatives><tex-math id=\"M359\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M360\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq179\"><alternatives><tex-math id=\"M361\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M362\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq180\"><alternatives><tex-math id=\"M363\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{11}$$\\end{document}</tex-math><mml:math id=\"M364\"><mml:msub><mml:mi>R</mml:mi><mml:mn>11</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq181\"><alternatives><tex-math id=\"M365\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {e}+\\text {CO}_2^+ \\rightarrow \\text {CO} + \\text {O}$$\\end{document}</tex-math><mml:math id=\"M366\"><mml:mrow><mml:mtext>e</mml:mtext><mml:mo>+</mml:mo><mml:msubsup><mml:mtext>CO</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo stretchy=\"false\">→</mml:mo><mml:mtext>CO</mml:mtext><mml:mo>+</mml:mo><mml:mtext>O</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq182\"><alternatives><tex-math id=\"M367\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$6.5\\times 10^{-13}$$\\end{document}</tex-math><mml:math id=\"M368\"><mml:mrow><mml:mn>6.5</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>13</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq183\"><alternatives><tex-math id=\"M369\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M370\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq184\"><alternatives><tex-math id=\"M371\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M372\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq185\"><alternatives><tex-math id=\"M373\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{12}$$\\end{document}</tex-math><mml:math id=\"M374\"><mml:msub><mml:mi>R</mml:mi><mml:mn>12</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq186\"><alternatives><tex-math id=\"M375\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_2^- + \\text {CO}_2^+ \\rightarrow \\text {CO} + \\text {O}_2 + \\text {O}$$\\end{document}</tex-math><mml:math id=\"M376\"><mml:mrow><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>-</mml:mo></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mtext>CO</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup><mml:mo stretchy=\"false\">→</mml:mo><mml:mtext>CO</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mtext>O</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq187\"><alternatives><tex-math id=\"M377\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$6\\times 10^{-13}$$\\end{document}</tex-math><mml:math id=\"M378\"><mml:mrow><mml:mn>6</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>13</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq188\"><alternatives><tex-math id=\"M379\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M380\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq189\"><alternatives><tex-math id=\"M381\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M382\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq190\"><alternatives><tex-math id=\"M383\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{13}$$\\end{document}</tex-math><mml:math id=\"M384\"><mml:msub><mml:mi>R</mml:mi><mml:mn>13</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq191\"><alternatives><tex-math id=\"M385\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}+\\text {O}+\\text {M} \\rightarrow \\text {O}_2 +\\text {M}$$\\end{document}</tex-math><mml:math id=\"M386\"><mml:mrow><mml:mtext>O</mml:mtext><mml:mo>+</mml:mo><mml:mtext>O</mml:mtext><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext><mml:mo stretchy=\"false\">→</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq192\"><alternatives><tex-math id=\"M387\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$1.04\\times 10^{-45}$$\\end{document}</tex-math><mml:math id=\"M388\"><mml:mrow><mml:mn>1.04</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>45</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq193\"><alternatives><tex-math id=\"M389\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{6}$$\\end{document}</tex-math><mml:math id=\"M390\"><mml:msup><mml:mrow/><mml:mn>6</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq194\"><alternatives><tex-math id=\"M391\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M392\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq195\"><alternatives><tex-math id=\"M393\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{14}$$\\end{document}</tex-math><mml:math id=\"M394\"><mml:msub><mml:mi>R</mml:mi><mml:mn>14</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq196\"><alternatives><tex-math id=\"M395\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}+\\text {O}_2+\\text {M} \\rightarrow \\text {O}_3+\\text {M}$$\\end{document}</tex-math><mml:math id=\"M396\"><mml:mrow><mml:mtext>O</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext><mml:mo stretchy=\"false\">→</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>3</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq197\"><alternatives><tex-math id=\"M397\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$4.42\\times 10^{-46}$$\\end{document}</tex-math><mml:math id=\"M398\"><mml:mrow><mml:mn>4.42</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>46</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq198\"><alternatives><tex-math id=\"M399\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{6}$$\\end{document}</tex-math><mml:math id=\"M400\"><mml:msup><mml:mrow/><mml:mn>6</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq199\"><alternatives><tex-math id=\"M401\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M402\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq200\"><alternatives><tex-math id=\"M403\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{15}$$\\end{document}</tex-math><mml:math id=\"M404\"><mml:msub><mml:mi>R</mml:mi><mml:mn>15</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq201\"><alternatives><tex-math id=\"M405\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}+\\text {O}_3 \\rightarrow \\text {O}_2 + \\text {O}_2$$\\end{document}</tex-math><mml:math id=\"M406\"><mml:mrow><mml:mtext>O</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>3</mml:mn></mml:msub><mml:mo stretchy=\"false\">→</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq202\"><alternatives><tex-math id=\"M407\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$7.56\\times 10^{-18}$$\\end{document}</tex-math><mml:math id=\"M408\"><mml:mrow><mml:mn>7.56</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>18</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq203\"><alternatives><tex-math id=\"M409\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{3}$$\\end{document}</tex-math><mml:math id=\"M410\"><mml:msup><mml:mrow/><mml:mn>3</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq204\"><alternatives><tex-math id=\"M411\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M412\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq205\"><alternatives><tex-math id=\"M413\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{16}$$\\end{document}</tex-math><mml:math id=\"M414\"><mml:msub><mml:mi>R</mml:mi><mml:mn>16</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq206\"><alternatives><tex-math id=\"M415\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}+\\text {CO}+\\text {M} \\rightarrow \\text {CO}_2 + \\text {M}$$\\end{document}</tex-math><mml:math id=\"M416\"><mml:mrow><mml:mtext>O</mml:mtext><mml:mo>+</mml:mo><mml:mtext>CO</mml:mtext><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext><mml:mo stretchy=\"false\">→</mml:mo><mml:msub><mml:mtext>CO</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq207\"><alternatives><tex-math id=\"M417\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$1.11\\times 10^{-47}$$\\end{document}</tex-math><mml:math id=\"M418\"><mml:mrow><mml:mn>1.11</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>47</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq208\"><alternatives><tex-math id=\"M419\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{6}$$\\end{document}</tex-math><mml:math id=\"M420\"><mml:msup><mml:mrow/><mml:mn>6</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq209\"><alternatives><tex-math id=\"M421\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M422\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq210\"><alternatives><tex-math id=\"M423\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{17}$$\\end{document}</tex-math><mml:math id=\"M424\"><mml:msub><mml:mi>R</mml:mi><mml:mn>17</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq211\"><alternatives><tex-math id=\"M425\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {O}_3+\\text {M} \\rightarrow \\text {O}_2 + \\text {O} + \\text {M}$$\\end{document}</tex-math><mml:math id=\"M426\"><mml:mrow><mml:msub><mml:mtext>O</mml:mtext><mml:mn>3</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext><mml:mo stretchy=\"false\">→</mml:mo><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mtext>O</mml:mtext><mml:mo>+</mml:mo><mml:mtext>M</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq212\"><alternatives><tex-math id=\"M427\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$1.16\\times 10^{-32}$$\\end{document}</tex-math><mml:math id=\"M428\"><mml:mrow><mml:mn>1.16</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>32</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq213\"><alternatives><tex-math id=\"M429\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{6}$$\\end{document}</tex-math><mml:math id=\"M430\"><mml:msup><mml:mrow/><mml:mn>6</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq214\"><alternatives><tex-math id=\"M431\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{1}$$\\end{document}</tex-math><mml:math id=\"M432\"><mml:msup><mml:mrow/><mml:mn>1</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq215\"><alternatives><tex-math id=\"M433\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$f({\\bar{\\varepsilon }})$$\\end{document}</tex-math><mml:math id=\"M434\"><mml:mrow><mml:mi>f</mml:mi><mml:mo stretchy=\"false\">(</mml:mo><mml:mover accent=\"true\"><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">¯</mml:mo></mml:mrow></mml:mover><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq216\"><alternatives><tex-math id=\"M435\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{17}$$\\end{document}</tex-math><mml:math id=\"M436\"><mml:msub><mml:mi>R</mml:mi><mml:mn>17</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq217\"><alternatives><tex-math id=\"M437\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R_{18}$$\\end{document}</tex-math><mml:math id=\"M438\"><mml:msub><mml:mi>R</mml:mi><mml:mn>18</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ4\"><label>4</label><alternatives><tex-math id=\"M439\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} S_i = \\sum _{j=1}^r \\left( h_j k_j \\prod _{m \\in R} n_m \\right) , \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M440\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>r</mml:mi></mml:munderover><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>h</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:munder><mml:mo>∏</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>∈</mml:mo><mml:mi>R</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq218\"><alternatives><tex-math id=\"M441\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k_j$$\\end{document}</tex-math><mml:math id=\"M442\"><mml:msub><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq219\"><alternatives><tex-math id=\"M443\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$j \\in r$$\\end{document}</tex-math><mml:math id=\"M444\"><mml:mrow><mml:mi>j</mml:mi><mml:mo>∈</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq220\"><alternatives><tex-math id=\"M445\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$h_j$$\\end{document}</tex-math><mml:math id=\"M446\"><mml:msub><mml:mi>h</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq221\"><alternatives><tex-math id=\"M447\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n_m$$\\end{document}</tex-math><mml:math id=\"M448\"><mml:msub><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq222\"><alternatives><tex-math id=\"M449\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M450\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq223\"><alternatives><tex-math id=\"M451\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M452\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq224\"><alternatives><tex-math id=\"M453\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{17}$$\\end{document}</tex-math><mml:math id=\"M454\"><mml:msub><mml:mrow/><mml:mn>17</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq225\"><alternatives><tex-math id=\"M455\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{18}$$\\end{document}</tex-math><mml:math id=\"M456\"><mml:msub><mml:mrow/><mml:mn>18</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ5\"><label>5</label><alternatives><tex-math id=\"M457\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\nabla ^2 S_{ph,j} - \\left( p_{\\text {O}_2}\\lambda _j\\right) ^2 S_{ph,j}=-\\left( A_j p_{\\text {O}_2}^2\\frac{p_q}{p+p_q}\\xi \\frac{\\nu _u}{\\nu _i}\\right) S_{ion}, \\nonumber \\\\ S_{ph} = \\sum _j S_{ph,j}, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M458\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msup><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>h</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msup><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>p</mml:mi><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub></mml:msub><mml:msub><mml:mi>λ</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>h</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mfenced close=\")\" open=\"(\"><mml:msub><mml:mi>A</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msubsup><mml:mi>p</mml:mi><mml:mrow><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mfrac><mml:msub><mml:mi>p</mml:mi><mml:mi>q</mml:mi></mml:msub><mml:mrow><mml:mi>p</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>q</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mi>ξ</mml:mi><mml:mfrac><mml:msub><mml:mi>ν</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:msub><mml:mi>ν</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfrac></mml:mfenced><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">ion</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:mrow/><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">ph</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:munder><mml:mo>∑</mml:mo><mml:mi>j</mml:mi></mml:munder><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>h</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq226\"><alternatives><tex-math id=\"M459\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p_{\\text {O}_2}$$\\end{document}</tex-math><mml:math id=\"M460\"><mml:msub><mml:mi>p</mml:mi><mml:msub><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn></mml:msub></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq227\"><alternatives><tex-math id=\"M461\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p_q$$\\end{document}</tex-math><mml:math id=\"M462\"><mml:msub><mml:mi>p</mml:mi><mml:mi>q</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq228\"><alternatives><tex-math id=\"M463\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$A_j$$\\end{document}</tex-math><mml:math id=\"M464\"><mml:msub><mml:mi>A</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq229\"><alternatives><tex-math id=\"M465\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda _j$$\\end{document}</tex-math><mml:math id=\"M466\"><mml:msub><mml:mi>λ</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq230\"><alternatives><tex-math id=\"M467\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\xi \\nu _u/\\nu _i$$\\end{document}</tex-math><mml:math id=\"M468\"><mml:mrow><mml:mi>ξ</mml:mi><mml:msub><mml:mi>ν</mml:mi><mml:mi>u</mml:mi></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:msub><mml:mi>ν</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq231\"><alternatives><tex-math id=\"M469\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$10^9$$\\end{document}</tex-math><mml:math id=\"M470\"><mml:msup><mml:mn>10</mml:mn><mml:mn>9</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq232\"><alternatives><tex-math id=\"M471\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{-3}$$\\end{document}</tex-math><mml:math id=\"M472\"><mml:msup><mml:mrow/><mml:mrow><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq233\"><alternatives><tex-math id=\"M473\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {N}_2^+$$\\end{document}</tex-math><mml:math id=\"M474\"><mml:msubsup><mml:mtext>N</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq234\"><alternatives><tex-math id=\"M475\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M476\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq235\"><alternatives><tex-math id=\"M477\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M478\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq236\"><alternatives><tex-math id=\"M479\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$10^{13}$$\\end{document}</tex-math><mml:math id=\"M480\"><mml:msup><mml:mn>10</mml:mn><mml:mn>13</mml:mn></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq237\"><alternatives><tex-math id=\"M481\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{-3}$$\\end{document}</tex-math><mml:math id=\"M482\"><mml:msup><mml:mrow/><mml:mrow><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq238\"><alternatives><tex-math id=\"M483\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\text {CO}^{+}_2$$\\end{document}</tex-math><mml:math id=\"M484\"><mml:msubsup><mml:mtext>CO</mml:mtext><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq239\"><alternatives><tex-math id=\"M485\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M486\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq240\"><alternatives><tex-math id=\"M487\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M488\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq241\"><alternatives><tex-math id=\"M489\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document}</tex-math><mml:math id=\"M490\"><mml:mi mathvariant=\"normal\">μ</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ6\"><label>6</label><alternatives><tex-math id=\"M491\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\partial _t n_\\varepsilon + \\nabla \\cdot \\mathbf {\\Gamma }_\\varepsilon = {\\bar{e}}\\mathbf {\\Gamma }_e \\cdot \\nabla \\varphi -\\sum _{j=1}^n \\left( \\Delta E_j k_j \\prod _{m \\in R} n_m \\right) , \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M492\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msub><mml:mi>∂</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:msub><mml:mi>n</mml:mi><mml:mi>ε</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mo>·</mml:mo><mml:msub><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mi>ε</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mover accent=\"true\"><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">¯</mml:mo></mml:mrow></mml:mover><mml:msub><mml:mi mathvariant=\"normal\">Γ</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>·</mml:mo><mml:mi mathvariant=\"normal\">∇</mml:mi><mml:mi>φ</mml:mi><mml:mo>-</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:munderover><mml:mfenced close=\")\" open=\"(\"><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>E</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:munder><mml:mo>∏</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>∈</mml:mo><mml:mi>R</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq242\"><alternatives><tex-math id=\"M493\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n_\\varepsilon$$\\end{document}</tex-math><mml:math id=\"M494\"><mml:msub><mml:mi>n</mml:mi><mml:mi>ε</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq243\"><alternatives><tex-math id=\"M495\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\varepsilon }$$\\end{document}</tex-math><mml:math id=\"M496\"><mml:mover accent=\"true\"><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">¯</mml:mo></mml:mrow></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq244\"><alternatives><tex-math id=\"M497\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\varepsilon }= n_\\varepsilon /n_e$$\\end{document}</tex-math><mml:math id=\"M498\"><mml:mrow><mml:mover accent=\"true\"><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">¯</mml:mo></mml:mrow></mml:mover><mml:mo>=</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mi>ε</mml:mi></mml:msub><mml:mo stretchy=\"false\">/</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq245\"><alternatives><tex-math id=\"M499\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$n_m$$\\end{document}</tex-math><mml:math id=\"M500\"><mml:msub><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq246\"><alternatives><tex-math id=\"M501\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${\\bar{e}}$$\\end{document}</tex-math><mml:math id=\"M502\"><mml:mover accent=\"true\"><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">¯</mml:mo></mml:mrow></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq247\"><alternatives><tex-math id=\"M503\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Delta E_j$$\\end{document}</tex-math><mml:math id=\"M504\"><mml:mrow><mml:mi mathvariant=\"normal\">Δ</mml:mi><mml:msub><mml:mi>E</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq248\"><alternatives><tex-math id=\"M505\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\varepsilon }$$\\end{document}</tex-math><mml:math id=\"M506\"><mml:mover accent=\"true\"><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">¯</mml:mo></mml:mrow></mml:mover></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq249\"><alternatives><tex-math id=\"M507\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document}</tex-math><mml:math id=\"M508\"><mml:mi mathvariant=\"normal\">μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq250\"><alternatives><tex-math id=\"M509\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document}</tex-math><mml:math id=\"M510\"><mml:mi mathvariant=\"normal\">μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq251\"><alternatives><tex-math id=\"M511\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document}</tex-math><mml:math id=\"M512\"><mml:mi mathvariant=\"normal\">μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq252\"><alternatives><tex-math id=\"M513\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$z = \\pm$$\\end{document}</tex-math><mml:math id=\"M514\"><mml:mrow><mml:mi>z</mml:mi><mml:mo>=</mml:mo><mml:mo>±</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq253\"><alternatives><tex-math id=\"M515\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document}</tex-math><mml:math id=\"M516\"><mml:mi mathvariant=\"normal\">μ</mml:mi></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ7\"><label>7</label><alternatives><tex-math id=\"M517\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} U_0(t) = \\frac{dU}{dt}t \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M518\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msub><mml:mi>U</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant=\"italic\">dU</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant=\"italic\">dt</mml:mi></mml:mrow></mml:mfrac><mml:mi>t</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq254\"><alternatives><tex-math id=\"M519\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document}</tex-math><mml:math id=\"M520\"><mml:mi mathvariant=\"normal\">μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq255\"><alternatives><tex-math id=\"M521\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M522\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq256\"><alternatives><tex-math id=\"M523\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M524\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq257\"><alternatives><tex-math id=\"M525\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M526\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq258\"><alternatives><tex-math id=\"M527\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M528\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq259\"><alternatives><tex-math id=\"M529\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$(dU/dt)^{-1}$$\\end{document}</tex-math><mml:math id=\"M530\"><mml:msup><mml:mrow><mml:mo stretchy=\"false\">(</mml:mo><mml:mi>d</mml:mi><mml:mi>U</mml:mi><mml:mo stretchy=\"false\">/</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy=\"false\">)</mml:mo></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq260\"><alternatives><tex-math id=\"M531\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M532\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<disp-formula id=\"Equ8\"><label>8</label><alternatives><tex-math id=\"M533\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} v_{avg}=\\frac{d}{t_c - t_i}, \\end{aligned}$$\\end{document}</tex-math><mml:math id=\"M534\" display=\"block\"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign=\"right\"><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant=\"italic\">avg</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>", "<inline-formula id=\"IEq261\"><alternatives><tex-math id=\"M535\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t_c$$\\end{document}</tex-math><mml:math id=\"M536\"><mml:msub><mml:mi>t</mml:mi><mml:mi>c</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq262\"><alternatives><tex-math id=\"M537\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$t_i$$\\end{document}</tex-math><mml:math id=\"M538\"><mml:msub><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq263\"><alternatives><tex-math id=\"M539\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M540\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq264\"><alternatives><tex-math id=\"M541\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M542\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq265\"><alternatives><tex-math id=\"M543\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M544\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq266\"><alternatives><tex-math id=\"M545\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M546\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq267\"><alternatives><tex-math id=\"M547\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M548\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq268\"><alternatives><tex-math id=\"M549\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M550\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq269\"><alternatives><tex-math id=\"M551\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M552\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq270\"><alternatives><tex-math id=\"M553\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M554\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq271\"><alternatives><tex-math id=\"M555\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M556\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq272\"><alternatives><tex-math id=\"M557\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M558\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq273\"><alternatives><tex-math id=\"M559\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M560\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq274\"><alternatives><tex-math id=\"M561\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M562\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq275\"><alternatives><tex-math id=\"M563\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M564\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq276\"><alternatives><tex-math id=\"M565\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M566\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq277\"><alternatives><tex-math id=\"M567\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M568\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq278\"><alternatives><tex-math id=\"M569\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lesssim \\bar{\\varepsilon } \\lesssim$$\\end{document}</tex-math><mml:math id=\"M570\"><mml:mrow><mml:mo>≲</mml:mo><mml:mover accent=\"true\"><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">¯</mml:mo></mml:mrow></mml:mover><mml:mo>≲</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq279\"><alternatives><tex-math id=\"M571\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M572\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq280\"><alternatives><tex-math id=\"M573\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M574\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq281\"><alternatives><tex-math id=\"M575\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\sim$$\\end{document}</tex-math><mml:math id=\"M576\"><mml:mo>∼</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq282\"><alternatives><tex-math id=\"M577\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\sim$$\\end{document}</tex-math><mml:math id=\"M578\"><mml:mo>∼</mml:mo></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq283\"><alternatives><tex-math id=\"M579\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M580\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq284\"><alternatives><tex-math id=\"M581\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M582\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq285\"><alternatives><tex-math id=\"M583\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M584\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq286\"><alternatives><tex-math id=\"M585\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document}</tex-math><mml:math id=\"M586\"><mml:mi mathvariant=\"normal\">μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq287\"><alternatives><tex-math id=\"M587\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M588\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq288\"><alternatives><tex-math id=\"M589\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M590\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq289\"><alternatives><tex-math id=\"M591\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\le {\\bar{\\varepsilon }} \\le$$\\end{document}</tex-math><mml:math id=\"M592\"><mml:mrow><mml:mo>≤</mml:mo><mml:mover accent=\"true\"><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy=\"false\">¯</mml:mo></mml:mrow></mml:mover><mml:mo>≤</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq290\"><alternatives><tex-math id=\"M593\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M594\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq291\"><alternatives><tex-math id=\"M595\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M596\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq292\"><alternatives><tex-math id=\"M597\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M598\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq293\"><alternatives><tex-math id=\"M599\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M600\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq294\"><alternatives><tex-math id=\"M601\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document}</tex-math><mml:math id=\"M602\"><mml:mi mathvariant=\"normal\">μ</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq295\"><alternatives><tex-math id=\"M603\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M604\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq296\"><alternatives><tex-math id=\"M605\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M606\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq297\"><alternatives><tex-math id=\"M607\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M608\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq298\"><alternatives><tex-math id=\"M609\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M610\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq299\"><alternatives><tex-math id=\"M611\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M612\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq300\"><alternatives><tex-math id=\"M613\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M614\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq301\"><alternatives><tex-math id=\"M615\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M616\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq302\"><alternatives><tex-math id=\"M617\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M618\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq303\"><alternatives><tex-math id=\"M619\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M620\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq304\"><alternatives><tex-math id=\"M621\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}</tex-math><mml:math id=\"M622\"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>M denotes and . BOLSIG+ represents tabulated data computed using bolsig<sup>##UREF##20##23##</sup>. indicates that the reaction rate is an empirical function of the local mean energy.</p></table-wrap-foot>", "<table-wrap-foot><p>BOLSIG+ represents tabulated data computed using bolsig<sup>##UREF##20##23##</sup>. indicates that the reaction rate is an empirical function of the local mean energy.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq1.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq4.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq5.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq6.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq7.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq8.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq9.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq10.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq11.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq12.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq13.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq14.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq15.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq16.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq17.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq18.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq19.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq20.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq21.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq22.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Article_Equ1.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq23.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq24.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq25.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq26.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq27.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Article_Equ2.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq28.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq29.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Article_Equ3.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq30.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq31.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq32.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq33.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq34.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq35.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq36.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq37.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq38.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq39.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq40.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq41.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq42.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq43.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq44.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq45.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq46.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq47.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq48.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq49.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq50.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq51.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq52.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq53.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq54.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq55.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq56.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq57.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq58.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq59.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq60.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq61.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq62.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq63.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq64.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq65.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq66.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq67.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq68.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq69.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq70.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq71.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq72.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq73.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq74.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq75.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq76.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq77.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq78.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq79.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq80.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq81.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq82.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq83.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq84.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq85.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq86.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq87.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq88.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq89.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq90.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq91.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq92.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq93.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq94.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq95.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq96.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq97.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq98.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq99.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq100.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq101.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq102.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq103.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq104.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq105.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq106.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq107.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq108.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq109.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq110.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq111.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq112.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq113.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq114.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq115.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq116.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq117.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq118.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq119.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq120.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq121.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq122.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq123.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq124.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq125.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq126.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq127.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq128.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq129.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq130.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq131.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq132.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq133.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq134.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq135.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq136.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq137.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq138.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq139.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq140.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq141.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq142.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq143.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq144.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq145.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq146.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq147.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq148.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq149.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq150.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq151.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq152.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq153.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq154.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq155.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq156.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq157.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq158.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq159.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq160.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq161.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq162.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq163.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq164.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq165.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq166.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq167.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq168.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq169.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq170.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq171.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq172.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq173.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq174.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq175.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq176.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq177.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq178.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq179.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq180.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq181.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq182.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq183.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq184.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq185.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq186.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq187.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq188.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq189.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq190.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq191.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq192.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq193.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq194.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq195.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq196.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq197.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq198.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq199.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq200.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq201.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq202.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq203.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq204.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq205.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq206.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq207.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq208.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq209.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq210.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq211.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq212.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq213.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq214.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq215.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq216.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq217.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Article_Equ4.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq218.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq219.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq220.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq221.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq222.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq223.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq224.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq225.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Article_Equ5.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq226.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq227.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq228.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq229.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq230.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq231.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq232.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq233.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq234.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq235.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq236.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq237.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq238.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq239.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq240.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq241.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Article_Equ6.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq242.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq243.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq244.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq245.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq246.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq247.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq248.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq249.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq250.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq251.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq252.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq253.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Fig1_HTML\" id=\"MO7\"/>", "<graphic xlink:href=\"41598_2024_51727_Article_Equ7.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq254.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq255.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq256.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq257.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Fig2_HTML\" id=\"MO9\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq258.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Fig3_HTML\" id=\"MO10\"/>", "<graphic xlink:href=\"41598_2024_51727_Fig4_HTML\" id=\"MO11\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq259.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Fig5_HTML\" id=\"MO12\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq260.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Article_Equ8.gif\" position=\"anchor\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq261.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq262.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq263.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq264.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq265.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq266.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq267.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq268.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq269.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Fig6_HTML\" id=\"MO14\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq270.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq271.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Fig7_HTML\" id=\"MO15\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq272.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Fig8_HTML\" id=\"MO16\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq273.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq274.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Fig9_HTML\" id=\"MO17\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq275.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq276.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq277.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq278.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq279.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq280.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq281.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq282.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq283.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq284.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq285.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq286.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq287.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Fig10_HTML\" id=\"MO18\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq288.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq289.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Fig11_HTML\" id=\"MO19\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq290.gif\"/>", "<graphic xlink:href=\"41598_2024_51727_Fig12_HTML\" id=\"MO20\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq291.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq292.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq293.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq294.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq295.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq296.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq297.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq298.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq299.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq300.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq301.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq302.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq303.gif\"/>", "<inline-graphic xlink:href=\"41598_2024_51727_Article_IEq304.gif\"/>" ]
[ "<media xlink:href=\"41598_2024_51727_MOESM1_ESM.pdf\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["1."], "surname": ["de Groot", "Webster", "Felnhofer", "Gusev"], "given-names": ["WA", "JR", "D", "EP"], "article-title": ["Review of device and reliability physics of dielectrics in electrostatically driven mems devices"], "source": ["IEEE Trans. Device Mater. Reliab."], "year": ["2009"], "volume": ["9"], "fpage": ["190"], "lpage": ["202"], "pub-id": ["10.1109/TDMR.2009.2020565"]}, {"label": ["2."], "surname": ["Yao"], "given-names": ["Y"], "article-title": ["Breakdown characteristics of plasma closing switch filled with air, n2, co2, and ar/o2"], "source": ["IEEE Trans. Plasma Sci."], "year": ["2018"], "volume": ["46"], "fpage": ["3574"], "lpage": ["3583"], "pub-id": ["10.1109/TPS.2018.2856306"]}, {"label": ["3."], "surname": ["Mermigkas"], "given-names": ["AC"], "article-title": ["Impulsive corona discharges for fine particles precipitation in a coaxial topology"], "source": ["IEEE Trans. Plasma Sci."], "year": ["2014"], "volume": ["42"], "fpage": ["3089"], "lpage": ["3094"], "pub-id": ["10.1109/TPS.2014.2301039"]}, {"label": ["4."], "surname": ["Ibrahimi"], "given-names": ["N"], "article-title": ["A subnanosecond pulsed electric field system for studying cells electropermeabilization"], "source": ["IEEE Trans. Plasma Sci."], "year": ["2020"], "volume": ["48"], "fpage": ["4242"], "lpage": ["4249"], "pub-id": ["10.1109/TPS.2020.3034286"]}, {"label": ["6."], "surname": ["Li"], "given-names": ["Y"], "article-title": ["Sub-microsecond streamer breakdown in transformer oil-filled short gaps"], "source": ["IEEE Trans. Dielectr. Electr. Insul."], "year": ["2014"], "volume": ["21"], "fpage": ["1616"], "lpage": ["1626"], "pub-id": ["10.1109/TDEI.2014.004237"]}, {"label": ["7."], "surname": ["Li"], "given-names": ["Y"], "article-title": ["Transformer oil breakdown dynamics stressed by fast impulse voltages: Experimental and modeling investigation"], "source": ["IEEE Trans. Plasma Sci."], "year": ["2014"], "volume": ["42"], "fpage": ["3004"], "lpage": ["3013"], "pub-id": ["10.1109/TPS.2014.2320751"]}, {"label": ["8."], "surname": ["Jadidian", "Zahn", "Lavesson", "Widlund", "Borg"], "given-names": ["J", "M", "N", "O", "K"], "article-title": ["Effects of impulse voltage polarity, peak amplitude, and rise time on streamers initiated from a needle electrode in transformer oil"], "source": ["IEEE Trans. Plasma Sci."], "year": ["2012"], "volume": ["40"], "fpage": ["909"], "lpage": ["918"], "pub-id": ["10.1109/TPS.2011.2181961"]}, {"label": ["9."], "mixed-citation": ["Hogg, M. G. "], "italic": ["et al", "2013 19th IEEE Pulsed Power Conference (PPC)"]}, {"label": ["10."], "surname": ["Hogg", "Timoshkin", "Mcgregor", "Wilson", "Given"], "given-names": ["MG", "IV", "SJ", "MP", "MJ"], "article-title": ["Polarity effects on breakdown of short gaps in a point-plane topology in air"], "source": ["IEEE Trans. Dielectr. Electr. Insul."], "year": ["2015"], "volume": ["22"], "fpage": ["1815"], "lpage": ["1822"], "pub-id": ["10.1109/TDEI.2015.005029"]}, {"label": ["11."], "surname": ["Liu", "Timoshkin", "Wilson", "Given", "MacGregor"], "given-names": ["T", "I", "MP", "MJ", "SJ"], "article-title": ["The nanosecond impulsive breakdown characteristics of air, n2 and co2 in a sub-mm gap"], "source": ["Plasma"], "year": ["2022"], "volume": ["5"], "fpage": ["12"], "lpage": ["29"], "pub-id": ["10.3390/plasma5010002"]}, {"label": ["12."], "surname": ["Kumar"], "given-names": ["S"], "article-title": ["Electrical breakdown study in co2 and co2-o2 mixtures in ac, dc and pulsed electric fields at 0.1\u20131 mpa pressure"], "source": ["IEEE Trans. Dielectr. Electr. Insul."], "year": ["2021"], "volume": ["28"], "fpage": ["158"], "lpage": ["166"], "pub-id": ["10.1109/TDEI.2020.009115"]}, {"label": ["13."], "surname": ["Balmelli"], "given-names": ["M"], "article-title": ["Breakdown of synthetic air under nanosecond pulsed voltages in quasi-uniform electric fields"], "source": ["IEEE Access"], "year": ["2022"], "volume": ["10"], "fpage": ["53454"], "lpage": ["53467"], "pub-id": ["10.1109/ACCESS.2022.3175460"]}, {"label": ["15."], "surname": ["Nechmi", "Beroual", "Girodet", "Vinson"], "given-names": ["HE", "A", "A", "P"], "article-title": ["Fluoronitriles/co2 gas mixture as promising substitute to sf6 for insulation in high voltage applications"], "source": ["IEEE Trans. Dielectr. Electr. Insul."], "year": ["2016"], "volume": ["23"], "fpage": ["2587"], "lpage": ["2593"], "pub-id": ["10.1109/TDEI.2016.7736816"]}, {"label": ["16."], "surname": ["Tian"], "given-names": ["S"], "article-title": ["Research status of replacement gases for SF6 in power industry"], "source": ["AIP Adv."], "year": ["2020"], "volume": ["10"], "fpage": ["25"], "pub-id": ["10.1063/1.5134727"]}, {"label": ["17."], "surname": ["Guo"], "given-names": ["Z"], "article-title": ["Study of the arc interruption performance of co2 gas in high-voltage circuit breaker"], "source": ["IEEE Trans. Plasma Sci."], "year": ["2019"], "volume": ["47"], "fpage": ["2742"], "lpage": ["2751"], "pub-id": ["10.1109/TPS.2019.2904981"]}, {"label": ["18."], "surname": ["Kolobov", "Arslanbekov"], "given-names": ["V", "R"], "article-title": ["Deterministic Boltzmann solver for electron kinetics in plasma reactors for microelectronics applications"], "source": ["Microelectron. Eng."], "year": ["2003"], "volume": ["69"], "fpage": ["606"], "lpage": ["615"], "pub-id": ["10.1016/S0167-9317(03)00352-6"]}, {"label": ["19."], "surname": ["Zhu"], "given-names": ["Y"], "article-title": ["Simulation of ionization-wave discharges: A direct comparison between the fluid model and e-fish measurements"], "source": ["Plasma Sources Sci. Technol."], "year": ["2021"], "volume": ["30"], "fpage": ["075025"], "pub-id": ["10.1088/1361-6595/ac0714"]}, {"label": ["20."], "surname": ["H\u00f6ft", "Becker", "Kolb", "Huiskamp"], "given-names": ["H", "MM", "JF", "T"], "article-title": ["Double-propagation mode in short-gap spark discharges driven by hv pulses with sub-ns rise time"], "source": ["Plasma Sources Sci. Technol."], "year": ["2020"], "volume": ["29"], "fpage": ["085002"], "pub-id": ["10.1088/1361-6595/aba112"]}, {"label": ["21."], "surname": ["Tardiveau"], "given-names": ["P"], "article-title": ["Sub-nanosecond time resolved light emission study for diffuse discharges in air under steep high voltage pulses"], "source": ["Plasma Sources Sci. Technol."], "year": ["2016"], "volume": ["25"], "fpage": ["054005"], "pub-id": ["10.1088/0963-0252/25/5/054005"]}, {"label": ["22."], "surname": ["Pancheshnyi", "Starikovskii"], "given-names": ["SV", "AY"], "article-title": ["Two-dimensional numerical modelling of the cathode-directed streamer development in a long gap at high voltage"], "source": ["J. Phys. D Appl. Phys."], "year": ["2003"], "volume": ["36"], "fpage": ["2683"], "pub-id": ["10.1088/0022-3727/36/21/014"]}, {"label": ["23."], "surname": ["Hagelaar", "Pitchford"], "given-names": ["GJM", "LC"], "article-title": ["Solving the Boltzmann equation to obtain electron transport coefficients and rate coefficients for fluid models"], "source": ["Plasma Sources Sci. Technol."], "year": ["2005"], "volume": ["14"], "fpage": ["722"], "pub-id": ["10.1088/0963-0252/14/4/011"]}, {"label": ["24."], "surname": ["Phelps", "Pitchford"], "given-names": ["AV", "LC"], "article-title": ["Anisotropic scattering of electrons by n"], "tex-math": ["\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$_{2}$$\\end{document}"], "{http://www.w3.org/1998/Math/MathML}mn": ["2"], "source": ["Phys. Rev. A"], "year": ["1985"], "volume": ["31"], "fpage": ["2932"], "pub-id": ["10.1103/physreva.31.2932"]}, {"label": ["25."], "surname": ["Zheleznyak", "Mnatsakanyan", "Sizykh"], "given-names": ["MB", "AK", "SV"], "article-title": ["Photo-ionization of nitrogen and oxygen mixtures by radiation from a gas-discharge"], "source": ["High Temp."], "year": ["1982"], "volume": ["20"], "fpage": ["357"], "lpage": ["362"]}, {"label": ["26."], "surname": ["Bagheri", "Teunissen"], "given-names": ["B", "J"], "article-title": ["The effect of the stochasticity of photoionization on 3d streamer simulations"], "source": ["Plasma Sources Sci. Technol."], "year": ["2019"], "volume": ["28"], "fpage": ["045013"], "pub-id": ["10.1088/1361-6595/ab1331"]}, {"label": ["27."], "surname": ["Bourdon"], "given-names": ["A"], "article-title": ["Efficient models for photoionization produced by non-thermal gas discharges in air based on radiative transfer and the helmholtz equations"], "source": ["Plasma Sources Sci. Technol."], "year": ["2007"], "volume": ["16"], "fpage": ["656"], "pub-id": ["10.1088/0963-0252/16/3/026"]}, {"label": ["28."], "surname": ["Bagheri"], "given-names": ["B"], "article-title": ["Comparison of six simulation codes for positive streamers in air"], "source": ["Plasma Sources Sci. Technol."], "year": ["2018"], "volume": ["27"], "fpage": ["095002"], "pub-id": ["10.1088/1361-6595/aad768"]}, {"label": ["29."], "surname": ["Nijdam", "Wormeester", "van Veldhuizen", "Ebert"], "given-names": ["S", "G", "EM", "U"], "article-title": ["Probing background ionization: Positive streamers with varying pulse repetition rate and with a radioactive admixture"], "source": ["J. Phys. D Appl. Phys."], "year": ["2011"], "volume": ["44"], "fpage": ["455201"], "pub-id": ["10.1088/0022-3727/44/45/455201"]}, {"label": ["30."], "surname": ["Bagheri", "Teunissen", "Ebert"], "given-names": ["B", "J", "U"], "article-title": ["Simulation of positive streamers in co2 and in air: The role of photoionization or other electron sources"], "source": ["Plasma Sources Sci. Technol."], "year": ["2020"], "volume": ["29"], "fpage": ["125021"], "pub-id": ["10.1088/1361-6595/abc93e"]}, {"label": ["31."], "surname": ["Grubert", "Becker", "Loffhagen"], "given-names": ["GK", "MM", "D"], "article-title": ["Why the local-mean-energy approximation should be used in hydrodynamic plasma descriptions instead of the local-field approximation"], "source": ["Phys. Rev. E"], "year": ["2009"], "volume": ["80"], "fpage": ["036405"], "pub-id": ["10.1103/PhysRevE.80.036405"]}, {"label": ["32."], "surname": ["Hagelaar", "de Hoog", "Kroesen"], "given-names": ["GJM", "FJ", "GMW"], "article-title": ["Boundary conditions in fluid models of gas discharges"], "source": ["Phys. Rev. E"], "year": ["2000"], "volume": ["62"], "fpage": ["1452"], "lpage": ["1454"], "pub-id": ["10.1103/PhysRevE.62.1452"]}, {"label": ["33."], "surname": ["Wong", "Timoshkin", "MacGregor", "Wilson", "Given"], "given-names": ["T", "I", "S", "M", "M"], "article-title": ["The design of a python library for the automatic definition and simulation of transient ionization fronts"], "source": ["IEEE Access"], "year": ["2023"], "volume": ["11"], "fpage": ["26577"], "lpage": ["26592"], "pub-id": ["10.1109/ACCESS.2023.3257724"]}, {"label": ["34."], "surname": ["Luque", "Ratushnaya", "Ebert"], "given-names": ["A", "V", "U"], "article-title": ["Positive and negative streamers in ambient air: Modelling evolution and velocities"], "source": ["J. Phys. D Appl. Phys."], "year": ["2008"], "volume": ["41"], "fpage": ["234005"], "pub-id": ["10.1088/0022-3727/41/23/234005"]}, {"label": ["35."], "surname": ["\u010cern\u00e1k"], "given-names": ["M"], "article-title": ["Formation and evolution of the cathode sheath on the streamer arrival"], "source": ["AIP Conf. Proc."], "year": ["1996"], "volume": ["363"], "fpage": ["136"], "lpage": ["145"], "pub-id": ["10.1063/1.50109"]}, {"label": ["36."], "surname": ["Yan", "Liu", "Sang", "Wang"], "given-names": ["W", "F", "C", "D"], "article-title": ["Two-dimensional modeling of the cathode sheath formation during the streamer-cathode interaction"], "source": ["Phys. Plasmas"], "year": ["2014"], "pub-id": ["10.1063/1.4861613"]}]
{ "acronym": [], "definition": [] }
36
CC BY
no
2024-01-14 23:40:18
Sci Rep. 2024 Jan 12; 14:1185
oa_package/54/92/PMC10786894.tar.gz
PMC10786895
38216573
[ "<title>Introduction</title>", "<p id=\"Par3\">Low-cost and sustainable energy storage systems are required to keep up with the increasing energy demands of today’s society<sup>##UREF##0##1##–##UREF##2##3##</sup>. In that context, battery chemistries based on metallic negative electrode (anode) and multivalent ion shuttle meets the criterion of high energy density and has generated substantial interest amongst researchers<sup>##UREF##3##4##,##UREF##4##5##</sup>. Li ion batteries (LIBs) are the benchmark for practical performance metrics<sup>##UREF##5##6##–##UREF##8##9##</sup> but multivalent systems have shown promise as viable candidates that could supplement the energy demands in the future by employing comparatively safe metal anodes<sup>##UREF##9##10##–##UREF##11##12##</sup>. Rechargeable magnesium batteries (RMBs), where Mg metal is used as the negative electrode due to its high volumetric capacity (3833 mAh L<sup>−</sup><sup>1</sup>) and low tendency to form dendrites, have attracted particular attention<sup>##UREF##12##13##–##UREF##13##15##</sup>. The low redox potential of Mg (−2.37 V vs SHE) and divalent charge carriers offer high theoretical energy densities<sup>##UREF##13##15##</sup>. However, research has shown that the knowledge gained from LIBs cannot be directly translated in a facile manner to RMB systems due to various properties associated with multivalent chemistries<sup>##UREF##13##15##,##UREF##14##16##</sup>.</p>", "<p id=\"Par4\">One major challenge is the lack of appropriate intercalation materials for positive electrode or cathode<sup>##UREF##15##17##</sup>. Contrary to the monovalent Li ions, the solid-state diffusion of Mg<sup>2+</sup> is sluggish due to the strong Coulombic interaction with the host material. In effect, solid-state diffusion is typically the rate-limiting step for redox reactions, thus rendering the conventional intercalation approach as a hurdle for RMBs. Different strategies have been employed to counter this bottleneck, the most popular being particle downsizing<sup>##UREF##14##16##,##UREF##15##17##</sup>. This approach is an effective way to shorten the diffusion path length, unlike the longer diffusion path in bigger particles which can restrict the intercalating ion to the particle surface and leave the core unreacted, as explained by the core-shell particle model<sup>##REF##24807043##18##</sup>.</p>", "<p id=\"Par5\">Vacancy-mediated diffusion mechanism showed improved kinetics in non-stoichiometric anatase TiO<sub>2</sub>, where Ti vacancies were synthetically generated by fluorine doping which in turn created additional charge storage sites<sup>##REF##28920941##19##</sup>. This strategy highlighted how defect engineering can be influential in promoting Mg ion intercalation. In a different work Li et al. demonstrated the strategy of intercalating solvated Mg<sup>2+</sup><sup>##REF##30504910##20##</sup>. In this approach, 1,2 dimethoxyethane (DME) coordinated Mg<sup>2+</sup> [Mg<sup>2+</sup>•3DME] enabled fast solid-state diffusion by lowering the charge density of the Mg ions. The strategy of cation-solvent co-intercalation greatly enhanced the reaction kinetics and indicated that the intercalation of two species in tandem can be a viable approach to promote fast kinetics in the positive electrode<sup>##REF##30504910##20##</sup>.</p>", "<p id=\"Par6\">In a similar direction, Li et al. demonstrated dual-cation co-intercalation in the Chevrel phase Mo<sub>6</sub>S<sub>8</sub> cathode by employing a Mg-Li dual salt electrolyte<sup>##UREF##16##21##,##UREF##17##22##</sup>. The working principle was based on the ‘rocking chair-type’ model, where both charge carriers (Li<sup>+</sup> and Mg<sup>2+</sup>) participated in the half-cell reactions, as illustrated in Fig. ##FIG##0##1##. It was observed that Mo<sub>6</sub>S<sub>8</sub> could accommodate both carrier ions in equal concentrations during discharge and seemingly co-deposited Mg and Li in a dendrite free manner during charge<sup>##UREF##16##21##</sup>. Co-intercalation of both carrier ions delivered a higher insertion voltage compared to the single carrier Mg analogue which could indicate improved insertion kinetics. First-principles calculations explained that the solid-state diffusion of both carrier ions was concomitant in nature, where the ions moved along the reaction path via a coordinated interaction<sup>##UREF##17##22##</sup>. According to the authors this type of coordinated motion greatly reduced the Mg<sup>2+</sup> migration barrier (~0.2 eV) compared to the individual hopping mechanism, which showed a much higher migration barrier (~0.55 eV) for Mg ions<sup>##UREF##17##22##</sup>. Consequently, by virtue of coordinated or concerted interaction between Mg and Li ions, the energy barrier along the diffusion path was reduced considerably, which facilitated faster solid-state diffusion in Mo<sub>6</sub>S<sub>8</sub>.</p>", "<p id=\"Par7\">However, after the successful demonstration in Mo<sub>6</sub>S<sub>8</sub>, the cation co-intercalation strategy was rarely reported in other host structures<sup>##REF##34844407##23##</sup>. As Chevrel phase Mo<sub>6</sub>S<sub>8</sub> is almost the only material that exhibits fast Mg<sup>2+</sup> mobility at room temperature (25 °C), the feasibility to transfer the cation co-intercalation concept to other materials remains unexplored. More importantly, it is still not clear whether co-intercalation with a monovalent ion could indeed improve the overall Mg ion storage capacity. Additionally, the storage mechanism, redox chemistry and other key factors governing Mg storage need to be clarified for better understanding and is necessary for further advancements.</p>", "<p id=\"Par8\">In this work we attempted to answer these questions by establishing a model system with a layered host (TiS<sub>2</sub>) as the positive electrode, an advanced dual salt electrolyte based on fluorinated alkoxyborate and Mg metal as the negative electrode. Based on that, a multimodal approach combining experimental and theoretical techniques was applied to understand how the size of different monovalent charge carriers (Li<sup>+</sup>/Na<sup>+</sup>) along with the thermodynamics and structural stability of the host compound affect the viability of cation co-intercalation. In order to assess the influence of monovalent ions on the reactivity of Mg ions, a holistic combination of elemental, structural and redox probes was used together with standard electrochemical techniques. The elemental analysis highlighted the direct impact of the size of the monovalent ion on the intercalation of the divalent Mg ions. Structural characterization of cycled TiS<sub>2</sub> along with density functional theory (DFT) studies demonstrated the importance of thermodynamic and structural stability of the host compound to reversibly accommodate more than one cationic charge carrier. Especially for layered materials which are susceptible to phase change due to the sliding of layers, phase transformation plays an active role in the co-intercalation of different carrier ions. Furthermore, spectroscopic probing through ex situ electron energy-loss spectroscopy (EELS) of cycled TiS<sub>2</sub> positive electrodes helped to clarify the redox mechanism.</p>" ]
[ "<title>Methods</title>", "<title>Electrolyte synthesis</title>", "<p id=\"Par49\">Li[B(hfip)<sub>4</sub>]: LiBH<sub>4</sub> powder (0.32 g, 14.8 mmol) was dissolved in DME (25 ml) in a Schlenk flask. To this solution, 4.1 equivalents of hexafluoroisopropanol (hfip) amounting to 10.3 g (6.4 ml, 60.7 mmol) was dropwise added while stirring. After stirring for 1 h, the flask was equipped with a Dimroth condenser and refluxed for 2 h at 85 °C under argon atmosphere. Afterwards, following cooling down the solvent was removed using a vacuum pump equipped with cooling traps. The resulting solid residue was further dried at gradually increasing temperatures from 30 °C to 60 °C under vacuum until a pressure of 0.1 Pa was achieved.</p>", "<p id=\"Par50\">Na[B(hfip<sub>4</sub>)]: 0.56 g of NaBH<sub>4</sub> (14.8 mmol) was dissolved in DME (28 ml) in a 100 ml Schlenk flask. 4.1 equivalents of hexafluoroisopropanol (10.3 g, 6.4 ml, 60.7 mmol) was slowly added in a dropwise manner while stirring. The mixture was refluxed at 85 °C for 2 h under argon atmosphere. When the mixture cooled down, the solvent was removed using a vacuum pump. The solid residue was further dried under vacuum at gradually increasing temperatures from 30 °C to 60 °C until 0.1 Pa was achieved.</p>", "<p id=\"Par51\">Mg[B(hfip<sub>4</sub>)]<sub>2</sub>: Mg(BH<sub>4</sub>)<sub>2</sub> powder (0.80 g, 14.8 mmol) was first dissolved into 50 ml DME in a Schlenk flask. 20.40 g (12.8 ml, 121.4 mmol) or 8.2 equivalents of hexfluoroisopropanol was added dropwise into the solution while being stirred. After stirring for 1 h, the flask was connected with a Dimroth condenser and refluxed at 85 °C under argon for 2 h. A nearly colourless clear solution was formed. After cooling down, the solvent was removed with a vacuum pump. The resulting solid was further dried at gradually elevated temperatures from 30 to 60 °C by vacuum<sup>##UREF##40##52##</sup>.</p>", "<title>Preparation of electrolytes</title>", "<p id=\"Par52\">All electrolyte salts were dissolved in 1,2 dimethoxyethane (DME). The solvent was dried with 3 Å molecular sieves for 72 h before usage and the water content observed via Karl Fischer titration was 1 ppm. [0.3 M Mg[B(hfip)<sub>4</sub>]<sub>2</sub> – 0.15 M Li[B(hfip)<sub>4</sub>] / DME] dual salt electrolyte was prepared by adding 2478 mg Mg[B(hfip)<sub>4</sub>]<sub>2</sub> and 616 mg Li[B(hfip)<sub>4</sub>] to DME in a 5 mL volumetric flask. [0.3 M Mg[B(hfip)<sub>4</sub>]<sub>2</sub> – 0.15 M Na[B(hfip)<sub>4</sub>] / DME] dual salt electrolyte was prepared by adding 991.5 mg Mg[B(hfip)<sub>4</sub>]<sub>2</sub> and 251.1 mg Na[B(hfip)<sub>4</sub>] to DME in a 2 mL volumetric flask. The single salt electrolyte solutions, 0.3 M Mg[B(hfip)<sub>4</sub>]<sub>2</sub> / DME, 0.15 M Li[B(hfip)<sub>4</sub>] / DME and 0.15 M Na[B(hfip)<sub>4</sub>] / DME, were prepared by adding 991.5 mg, 246.3 mg and 251.1 mg of corresponding salts to DME in 2 mL volumetric flasks, respectively. All electrolyte solutions were shaken and after waiting for 1 day, the supernatant was used. It should be noted that the dual salt electrolytes still had some residues, hence the concentrations (0.3 and 0.15 M) are not exact and the molarity values have been used for convenience.</p>", "<title>Electrochemical measurement</title>", "<p id=\"Par53\">Electrochemical measurements were carried out using two different configurations. Swagelok cell configuration was used to carry out galvanostatic measurements while PAT-Cell configuration from EL-CELL was used to conduct CV measurements. TiS<sub>2</sub> (99.9%, 200 mesh) was purchased from Aldrich and ball milled at 300 rpm with a milling time of 5 min followed by 10 min of rest, repeated for 16 times. The slurry was prepared by mixing 70% TiS<sub>2</sub> as the active material with 20% Super P carbon black (Timcal) and 10% Polyvinylidene difluoride (PVDF) from Solef in N-methyl-2-pyrrolidone (NMP). The slurry was then coated on 11.8 mm polished stainless steel current collectors. The areal active mass loading ranged between 0.8 and 1.2 mg cm<sup>–2</sup>. The cathodes were dried under vacuum at 80 °C for 15 h. The dual salt electrolyte solutions used in this work are [0.3 M Mg[B(hfip)<sub>4</sub>]<sub>2</sub> – 0.15 M Li[B(hfip)<sub>4</sub>]] / DME and [0.3 M Mg[B(hfip)<sub>4</sub>]<sub>2</sub> – 0.15 M Na[B(hfip)<sub>4</sub>]] / DME. The magnesium tetrakis (hexafluoroisopropyloxy) borate Mg[B(hfip)<sub>4</sub>]<sub>2</sub> was synthesized by reacting MgBH<sub>4</sub> and hexafluoroisopropanol in DME in a one-pot reaction following our previous work<sup>##UREF##40##52##</sup>. The Li[B(hfip)<sub>4</sub>] and Na[B(hfip)<sub>4</sub>] electrolytes were synthesized by following the same reaction steps, using LiBH<sub>4</sub> and NaBH<sub>4</sub> as precursors, respectively, as explained in the electrolyte synthesis section. The Swagelok cells were assembled in an Ar-filled glovebox with freshly polished 11 mm Mg disks (0.1 mm thick from Gelon LIB group) used as the anode and two 12 mm diameter glass fibre GF/C as the separator soaked with 80 μL electrolyte. Other electrolytes that were used in this work are 0.15 M Li[B(hfip)<sub>4</sub>] / DME and 0.15 M Na[B(hfip)<sub>4</sub>] / DME. For the RMB three-electrode configuration, we incorporated polished Mg foils of 14 mm diameter (0.1 mm thick) as the counter electrode while a Mg ring (EL-CELL) was used as the reference (Mg<sub>ref</sub>). Two 21 mm diameter GF/C separators soaked in 250 μL electrolyte were used. The three-electrode configuration of the lithium half-cell was constructed by incorporating polished 13 mm Li foil (0.75 mm thick) as the counter electrode with Li ring (EL-CELL) as the reference and a single GF/C separator soaked in 100 μL electrolyte. For all, three-electrode CV measurements, 11.8 mm TiS<sub>2</sub> electrodes were used as the working electrode. The BCS 805 battery cycler from Bio-Logic was used for the two-electrode galvanostatic measurements. The three-electrode CV measurments were carried out with the SP150 single channel potentiostat from Bio-Logic SAS. All electrochemical measurements were carried out at 25 °C in a controlled climate chamber.</p>", "<title>Characterization</title>", "<p id=\"Par54\">XRD was performed using a STOE-STADI P powder diffractometer operated in the Debye- Scherrer mode by applying Ag-Kα<sub>1</sub> radiation (λ = 0.559407 Å) with a step size of 2.04° and a step time of 120 s. Elemental analysis of the samples were carried out with ICP-OES in a Spectro Acros-SOP system. Ex situ Raman spectroscopy was done using an inVia<sup>TM</sup> confocal Raman microscope from Renishaw. The Raman spectra were collected over a single 30 µm × 30 µm area at spatial resolution of 1.0 µm per pixel. Laser power at the sample was 2.5 mW at 633 nm wavelength with a 30 s exposure time. A Leica™ 50× long working distance, 0.5 N.A. microscope objective was used. Parameters of the laser beam were carefully selected to obtain the maximal signal to noise ratio without sample heating which mask the native state of the electrode surface. The cosmic rays and the background of all the spectra were then removed using Renishaw WiRE<sup>TM</sup> 4.0 software. The modified Raman spectra were deconvoluted in individual spectral components using Lorentzian line-shape function in MATLAB platform to designate the positions, full widths at half maximum (FWHM), and intensities of Raman modes (see the Supporting Information for details). Transmission Electron Microscopy (TEM) characterization was performed on a double aberration-corrected microscope ThemisZ (ThermoFisher Scientific) at an acceleration voltage of 300 kV. The TEM is equipped with a high angle annular dark-field (HAADF) detector for scanning transmission electron microscopy (STEM) and a Super-X energy-dispersive X-ray spectroscopy (EDX) detector to acquire EDX elemental maps. EELS data were acquired with an energy resolution of ≈1 eV, estimated from the FWHM of the zero-loss peak using a Gatan image filter with K3 camera (Gatan Inc.). For all ex situ measurements including ICP-OES, XRD, Raman spectroscopy and STEM, the samples were collected from cathodes of cells at specified dis-/charge states. The cells were disassembled in an Ar atmosphere glovebox and the cathodes were washed several times with DME. Afterwards they were dried at 60 °C for 12 h under vacuum before the samples were collected for corresponding ex situ analysis. The ex situ XRD was performed under Ar atmosphere by sealing the powder sample scratched off the cathode in a 0.6 mm wide glass capillary. For ICP-OES, 3–4 mg of cathode material (including carbon super P and PVDF) was dissolved in aqua regia (HNO<sub>3</sub>:HCl in a 3:1 ratio) to prepare each sample. The resulting solution was diluted with deionized water, depending on the detection and calibration regime of the element of interest. Filtration was necessary in all cases as carbon super P did not dissolve in the solution. The Raman samples were prepared by sealing the powder cathode samples between two glass slides with UHV epoxy in an Ar glovebox. The TEM specimens were also prepared inside the glovebox by scratching the electrode material with a lacey carbon-coated copper grid. Afterwards, the grid was mounted into a Gatan 648 vacuum transfer holder, which can be used to transfer the specimen into the TEM under Ar protection.</p>", "<title>Statistical information</title>", "<p id=\"Par55\">A collection of 360 spectra were collected from the electrode surface, which contains Raman fingerprint of both active materials and additive conducting carbon. Spectrum from each pixel was crosschecked and only 90 spectra were selected which contained less carbon signature. The selected Raman spectra are deconvoluted into three different spectral portions <italic>E</italic><sub>g</sub>, <italic>A</italic><sub>1g</sub> and ‘Sh’ by using three Lorentzian line shape functions in a MATLAB script. The fitting parameters e.g., peak frequency or FWHM of a band and their relative occurring frequency is plotted in x and y axis respectively in a histogram plot. The statistical occurrence frequency plots are the fitted under normal distribution (Supplementary Fig. ##SUPPL##0##7##). The normal distributive nature of the histogram establishes a confidence on the sampling frequency which is 90 (90 selected spectra among 360 on the electrode surface).</p>", "<p id=\"Par56\">The comparisons among peak frequencies and respective FWHM from the different charge discharge states are presented in a box chart form. A box chart plot displays the five-number summary of a set of data. The five-number summaries are first quartile-third quartile (25–75%) enclosing box, the whisker selecting points in the ± 1.5 times of the quartile (IQR), the median line, the mean point and outliers (Supplementary Fig. ##SUPPL##0##9##). This also validates a statistical viewpoint which is essential in analyzing a relatively inhomogeneous surface.</p>", "<title>DFT calculations</title>", "<p id=\"Par57\">Density functional theory (DFT) was employed based on the generalized gradient approximation using the PBE<sup>##REF##10062328##57##</sup> functional and the projected augmented<sup>##UREF##42##58##</sup> wave (PAW) method<sup>##UREF##43##59##,##UREF##44##60##</sup> to describe ion-electron interactions as implemented in the Vienna ab initio simulation package (VASP)<sup>##UREF##45##61##</sup>. The underlying structural optimizations included the third-generation (D3) semi-empirical van der Waals corrections proposed by Grimme<sup>##REF##20423165##62##</sup>. The plane-wave cutoff energy was set to 520 eV, and the Brillouin zone was represented by Monkhorst-Pack (MP) k-point meshes of 2 × 2 × 2<sup>##UREF##46##63##</sup>. Activation barriers and minimum energy pathways for the charge carriers hopping were obtained using the climbing-image nudged elastic band method (cNEB)<sup>##UREF##47##64##,##UREF##48##65##</sup>. The diffusion path was first constructed by linear interpolation of the atomic coordinates in the initial and final states and then relaxed until the forces on all atoms were smaller than 0.05 eV Å<sup>–1</sup>. Large supercells were chosen to ensure that each ion is isolated from its periodic images (images of ions are no less than 6 Å apart). The configurations for the construction of the phase diagrams are taken from the Materials Project (MP) database<sup>##UREF##49##66##</sup>.</p>" ]
[ "<title>Results</title>", "<title>Establishing model systems for co-intercalation and the impact of monovalent ions</title>", "<p id=\"Par9\">To demonstrate the versatility of cation co-intercalation, a typical layered TiS<sub>2</sub> was selected as the host material for establishing model systems. In order to investigate the size effect of monovalent ions on co-intercalation, Mg electrolyte was mixed in stoichiometric amounts with the corresponding Li and Na counterparts, separately. For the convenience of the reader, the cell system with the dual salt electrolyte 0.3 M Mg[B(hfip)<sub>4</sub>]<sub>2</sub> – 0.15 M Li[B(hfip)<sub>4</sub>] / DME, ([B(hfip)<sub>4</sub>]<sup>–</sup> = hexafluoroisopro-pyloxy borate ion) has been referred to as the Mg-Li system and the cell system with 0.3 M Mg[B(hfip)<sub>4</sub>]<sub>2</sub> – 0.15 M Na[B(hfip)<sub>4</sub>] / DME as the Mg-Na system. In this section we have analyzed the two dual salt systems (Mg-Li and Mg-Na) looking into the co-intercalation of cationic charge carriers. In the process we individually validated both systems by combining electrochemical and elemental probes. The outcome of the investigations clarified the impact of two different monovalent ions on the degree of co-intercalation.</p>", "<p id=\"Par10\">Mg-Li system: The Mg-Li cell delivered a reasonably high initial discharge capacity of ~250 mAh g<sup>–1</sup> (Fig. ##FIG##1##2a##), which agreed closely with the theoretical capacity of TiS<sub>2</sub> (239 mAh g<sup>–1</sup>) for 1e<sup>–</sup> exchange. In contrast, for the single salt Mg cell, TiS<sub>2</sub> cathode delivered a much lower initial discharge capacity of ca. 90 mAh g<sup>–1</sup> (Fig. ##FIG##1##2c##). The poor performance of the single salt Mg cell did not match up with the findings reported by the Sun et al. <sup>##UREF##18##24##</sup> where an initial discharge capacity of ~ 250 mAh g<sup>–1</sup> was delivered. The reason behind this could be that the measurements were conducted at an elevated temperature of 60 °C<sup>##UREF##18##24##</sup>. Furthermore, the single salt Li system delivered ~200 mAh g<sup>–1</sup> (Supplementary Fig. ##SUPPL##0##1a##) in the voltage range (1.5 V – 2.9 V vs Li) corresponding to the intercalation regime<sup>##REF##29856638##25##</sup>. The Mg-Li system produced a slightly higher initial discharge capacity compared to the Li system. The corresponding charge capacities of the Mg-Li and the single ion Mg systems were 206 mAh g<sup>–1</sup> and 40 mAh g<sup>–1</sup>, respectively. The irreversible capacity loss observed after the first cycle in the Mg-Li cell (ca. 30 mAh g<sup>–1</sup>) was slightly reduced, compared to the Mg cell (ca. 40 mAh g<sup>–1</sup>). The irreversible capacity loss is a direct consequence of carrier ion entrapment in the TiS<sub>2</sub> crystal structure<sup>##UREF##18##24##,##UREF##19##26##</sup>. The Mg-Li system delivered a reversible capacity of ~140 mAh g<sup>–1</sup> after 100 cycles (Supplementary Fig. ##SUPPL##0##2b##) as opposed to 40 mAh g<sup>–1</sup> delivered by the Mg system (Supplementary Fig. ##SUPPL##0##2a##). In addition to improved specific capacity, the Mg-Li cell had a higher insertion voltage of ~1.25 V and a higher nominal voltage of ~1.1 V with a smooth plateau-like profile during the first discharge, similar to the Li system (Supplementary Fig. ##SUPPL##0##1a##). The Mg cell on the contrary showed a steep drop in the voltage profile (Fig. ##FIG##1##2c##) with a low nominal voltage of ~0.6 V. Moreover, the Mg-Li system exhibited reasonable rate performance by delivering a discharge capacity of ~157 mAh g<sup>–1</sup> at C/4, ~144 mAh g<sup>–1</sup> at C/2, ~131 mAh g<sup>–1</sup> at 1 C and ~115 mAh g<sup>–1</sup> at 2 C (Supplementary Fig. ##SUPPL##0##2c##). The above observations highlighted that the insertion kinetics was significantly improved in the dual salt Mg-Li system in comparison to the single salt Mg system, whereby the sluggishness of Mg<sup>2+</sup> affected the kinetics adversely.</p>", "<p id=\"Par11\">The redox activity of the Mg-Li system was further characterized by three-electrode cyclic voltammetry (CV), as shown in Fig. ##FIG##1##2d##, and the voltammogram showed a prominent reduction peak centered around 1.14 V vs Mg<sub>ref</sub>, which corroborated reasonably well with the nominal voltage. The prominence of the reduction peak in the Mg-Li system suggested that the intercalation kinetics improved significantly compared to the Mg system, which had a broad and asymmetric CV profile (Supplementary Fig. ##SUPPL##0##3a##) and in addition had low current density, characteristic of sluggish mobility of Mg<sup>2+</sup>. The corresponding anodic scan involved a two-step oxidation process (Fig. ##FIG##1##2d##) centered around ~1.0 V and ~1.4 V, which indicated that two types of charge carriers occupied the storage sites with different potentials through structural relaxation<sup>##UREF##17##22##,##UREF##20##27##</sup>. Furthermore, the voltammogram of the Li system (Supplementary Fig. ##SUPPL##0##3b##) had a completely different redox profile with the redox couple positioned around 2.33 V vs Li<sub>ref</sub> (1.66 V vs Mg). The fundamental differences in the profile shape and redox peak position between the two voltammograms could be explained by the co-intercalation of Li<sup>+</sup> and Mg<sup>2+</sup> in TiS<sub>2</sub> in the dual salt Mg-Li system and intercalation of only Li<sup>+</sup> in the single salt Li system. The evolution of the oxidation peaks with cycling (Fig. ##FIG##1##2d##) showed a trend, whereby the intensity increased for the peak at ~1.0 V, while the peak at ~1.4 V lost intensity. The electrochemical activity of the storage site corresponding to 1.4 V was observed to decrease during cycling. However, the precise nature of this phenomenon remains unclear and warrants further investigation in future studies.</p>", "<p id=\"Par12\">The improved electrochemical performance of TiS<sub>2</sub> in the Mg-Li system raised a question about the capacity share of each cationic charge carrier. Li ions being more mobile can either facilitate or hinder co-intercalation of sluggish Mg ions<sup>##UREF##16##21##,##UREF##17##22##,##UREF##21##28##</sup>. Hence, it was of importance that the individual charge compensations of the respective charge carriers (Mg<sup>2+</sup> and Li<sup>+</sup>) were evaluated in order to obtain a clear picture of the actual redox activity of Mg<sup>2+</sup>. This was done by estimating the concentration of the intercalated carrier ions with the help of inductive coupled plasma optical emission spectroscopy (ICP-OES). After the first discharge, a Mg/Ti atomic ratio of ~0.24 was observed along with a Li/Ti value of ~0.35 (Fig. ##FIG##1##2f## and Supplementary Table ##SUPPL##0##1##). In comparison, the Mg/Ti ratio after first discharge in the single salt Mg system was ~0.16 (Fig. ##FIG##1##2f##). The improvement in Mg intercalation was accompanied by a comparable amount of Li in the Mg-Li system. In terms of charge transfer, Mg<sup>2+</sup> and Li<sup>+</sup> contributed 0.48 e<sup>−</sup> and 0.35 e<sup>−</sup>, respectively, which underlined their equitable nature to charge distribution and capacity share. However, the first cycle showed significant Mg trapping, with an atomic fraction of ~0.17 Mg per formula unit of TiS<sub>2</sub> being irreversibly trapped (Fig. ##FIG##1##2f##). Qualitatively, scanning transmission electron microscopy electron dispersive X-ray (STEM-EDX) mapping also confirmed co-intercalation of Mg ions in the Mg-Li system, as shown by the uniform distribution of Mg in TiS<sub>2</sub> after the first discharge (Supplementary Fig. ##SUPPL##0##4d##). It should be noted that after the first charge, TiS<sub>2</sub> still exhibited significant Mg entrapment, as is apparent from the STEM-EDX map (Supplementary Fig. ##SUPPL##0##4h##), which was corroborated by the ICP-OES data. The initial irreversible Mg entrapment in the Mg-Li system is a drawback that was also observed in the Mg system (Fig. ##FIG##1##2f##) where a fraction of ~0.11 Mg remained in the TiS<sub>2</sub> structure. The issue of irreversible Mg trapping has been reported previously<sup>##UREF##18##24##</sup> and underlines the consequence of poor solid-state diffusion of Mg<sup>2+</sup>. Further investigation after the fifth cycle showed improved Mg<sup>2+</sup> insertion kinetics as a Mg/Ti atomic ratio of ~0.13 could be reversibly de-/intercalated in the Mg-Li system, whereas an atomic ratio of only ~0.08 was reversibly de-/intercalated in the single salt Mg system (Fig. ##FIG##1##2f##). Thus, the Mg-Li system showed superior insertion kinetics for divalent Mg ions enabled by dual cation co-intercalation compared to the single salt Mg system. All ICP-OES data of the above-mentioned samples are presented in Supplementary Table ##SUPPL##0##1##.</p>", "<p id=\"Par13\">Mg-Na system: In an attempt to examine the versatility of dual-cation co-intercalation, the concept was extended to Mg-Na dual salt system. The main difference between the systems is the larger ionic radius of Na<sup>+</sup> (102 pm), which can impact the storage site preference and interaction potential in TiS<sub>2</sub>. The electrochemical performance showed an initial discharge capacity of ~250 mAh g<sup>–1</sup> (Fig. ##FIG##1##2b##), similar to the Mg-Li system. For comparison, the single salt Na system delivered ~237 mAh g<sup>–1</sup> after the first discharge (Supplementary Fig. ##SUPPL##0##1b##). It is worth noting that the initial discharge capacity of the Mg-Na system also matched closely with the work by Bian et al. <sup>##UREF##22##29##</sup> However, differences between the voltage profiles exist and could be attributed to the chemical modification of TiS<sub>2</sub> cathode upon reacting with the borohydride-based dual salt electrolyte, while with the borate-based dual salt electrolyte, TiS<sub>2</sub> did not exhibit any chemical change. Following charging, the Mg-Na system provided a charge capacity of ~196 mAh g<sup>–1</sup>, which corresponds to a capacity loss of 54 mAh g<sup>–1</sup>. Irreversible charge carrier entrapment was the likely reason, similar to both Mg-Li and Mg systems. The discharge voltage profile of the Mg-Na system showed two distinct voltage plateaus at ~1.25 V and ~0.6 V, which indicated a two-phase intercalation process. In comparison, the voltage profile of the Mg-Li and Mg systems resembled a solid-solution type behavior without indication of phase transition. Cycling showed a drastic change in the shape of the discharge voltage profile, where the plateaus disappeared completely by the 5<sup>th</sup> cycle. The change in the shape of the voltage profile was likely due to structural degradation, which will be discussed later on.</p>", "<p id=\"Par14\">The CV profile (Fig. ##FIG##1##2e##) showed a sharp feature of a reduction process around 1.2 V and another low intensity broad peak around 0.6 V during the first cathodic sweep, which agreed well with the corresponding discharge voltage curve. The anodic sweep showed two main oxidation peaks at 0.85 V and 1.35 V, and another small peak at 1.1 V. These profiles hint at multiple phase transitions, which is a typical feature of Na<sup>+</sup> intercalation in layered materials. In the following cycles, the oxidation peak at 1.1 V became more prominent, while the peak at 1.35 V lowered in intensity. The cycling induced changes in the oxidation peaks (1.1 V and 1.35 V) exhibited a similar pattern to that observed in the Mg-Li system, thus warranting further perusal. Additionally, a new reduction peak emerged in the 5<sup>th</sup> cycle at 0.14 V which could be attributed to a probable irreversible conversion reaction which could lead to possible structural degradation. The degradation of the structure was also reported elsewhere for Na-ion batteries, where the more complicated phase transition and the presence of unstable intermediate Na<sub>x</sub>TiS<sub>2</sub> has been mentioned as a possible reason<sup>##UREF##23##30##</sup>.</p>", "<p id=\"Par15\">The elemental analysis of cycled TiS<sub>2</sub> from the Mg-Na system via ICP-OES data showed a strong divergence in the results compared to the Mg-Li system (inset of Fig. ##FIG##1##2f## and Supplementary Table ##SUPPL##0##2##). After full discharge the Mg/Ti ratio was ~0.13 while the Na/Ti value was ~0.81. The high Na content is a strong indicator of an un-equitable specific capacity distribution between Mg and Na ions, unlike the Mg-Li system. After the corresponding charge step it was found that almost all of the Mg (Mg/Ti ~0.125) was irreversibly trapped in the TiS<sub>2</sub> structure while the Na<sup>+</sup> showed much superior reversibility and only had ~0.09 atomic fraction trapped in the structure. The dominant effect of Na ions and the disproportionate nature of charge contribution from the two cations indicated that the size difference between the monovalent and multivalent ions could be a decisive parameter regarding the feasibility and degree of dual-cation co-intercalation in layered TiS<sub>2</sub>.</p>", "<title>Structural evolution of TiS<sub>2</sub> upon cycling</title>", "<p id=\"Par16\">The layered structure of TiS<sub>2</sub> gives rise to a discernible structural change as the concentration of intercalating ions increases<sup>##UREF##18##24##,##UREF##24##31##</sup>. The layers are held together by weak van der Waals forces which make them susceptible to slide along the 2D plane, changing the stacking order and stimulating phase transformation. Additionally, the layers also expand and contract along the <italic>c</italic>-direction with varying concentration of charge carriers. Co-intercalation of Mg and Li ions showed expansion of the crystal structure, evident from the ex situ XRD pattern shown in Fig. ##FIG##2##3a##, where the three most intense reflections at (001), (101) and (102) shifted toward lower angles after the first discharge which suggested increased lattice parameter values<sup>##UREF##18##24##,##UREF##25##32##</sup>. In this scenario, the (001) reflection at 5.6° in the pristine TiS<sub>2</sub> shifted to 5.15° upon discharge, which demonstrated a <italic>d</italic>-space expansion from 5.7 Å to 6.2 Å. In contrast, no clear shift of the reflections was observed when only Mg ions were intercalated into TiS<sub>2</sub> (Fig. ##FIG##2##3b##) in the Mg system. The likely reason for no obvious structural expansion can be attributed to low Mg concentration in the TiS<sub>2</sub> crystal structure as a direct consequence of limited Mg<sup>2+</sup> intercalation in the Mg system. TiS<sub>2</sub> showed reasonable structural reversibility in the Mg-Li system, whereby the diffraction pattern of pristine TiS<sub>2</sub> was recovered back upon charging. In addition to the structural reversibility, it was also observed that TiS<sub>2</sub> did not undergo any phase transformation during de-/intercalation. The crystal structure retained the space group (O1 phase) after intercalation and exhibited a solid-solution behavior which agreed well with the slope-like voltage profile (Fig. ##FIG##1##2a##). Absence of phase transformation ensured no drastic structural alteration and limited stress generation in the positive electrode. The XRD pattern also did not show any reflections that can be attributed to polysulfides and/or Ti metal, indicating that the conversion reaction did not occur and that the reversible capacity was delivered through  the intercalation redox mechanism.</p>", "<p id=\"Par17\">In stark contrast, the structural evolution of TiS<sub>2</sub> in the Mg-Na system is completely different from the aforementioned Mg-Li system, primarily due to the role played by the bigger Na ion (<italic>r</italic> = 104 pm)<sup>##UREF##24##31##</sup>. In order to track the evolution that the TiS<sub>2</sub> crystal structure underwent with increasing intercalant concentration, ex situ XRD was conducted at different stages of discharge as shown in Fig. ##FIG##3##4a, c##. The XRD patterns indicated a larger expansion of the crystal structure along the <italic>c</italic>-axis compared to the Mg-Li system. The (001) peak shifted to 4.55° and caused the <italic>d</italic>-space to expand to 7.2 Å upon discharge, significantly larger compared to when the smaller Mg ions (<italic>r</italic> = 72 pm) and Li ions (<italic>r</italic> = 76 pm) were co-intercalated. The interlayer expansion was accompanied by significant change in the crystal structure. The XRD pattern showed broadening upon discharging to 1.13 V accompanied with a low angle shift of the (001) reflection from 5.6° to 4.9°, suggesting the beginning of interlayer expansion. The (101) reflection of the pristine TiS<sub>2</sub> appeared broadened while the (102) reflection also dropped in intensity. This could be interpreted as the onset of the formation of a phase different from the pristine O1 phase. It is worth noting that at 1.13 V, TiS<sub>2</sub> had a sodium dominant composition of Mg<sub>0.11</sub>Na<sub>0.46</sub>TiS<sub>2</sub> (inset of Fig. ##FIG##1##2f## and Supplementary Table ##SUPPL##0##2##) which confirmed that the phase transition was driven by Na ion intercalation. Upon further discharge to 0.6 V (also see Fig. ##FIG##3##4b##), it was observed that the (001) reflection in the pristine O1 phase was replaced by the (003) reflection at 4.55° which corresponded to the prismatic P3 phase (R3m)<sup>##UREF##24##31##,##REF##31386342##33##</sup>.</p>", "<p id=\"Par18\">In conjunction, the appearance of another new reflection at 13.2° indexed as (015) along with the disappearance of the (102) reflection shown in Fig. ##FIG##3##4b## (also see Fig. ##FIG##3##4a##), confirmed the formation of the P3 phase. On full discharge (0.01 V), a new reflection (104) emerged at 12.6°, which is characteristic of the O3 phase () corresponding to ~1 Na per formula unit of TiS<sub>2</sub> (NaTiS<sub>2</sub>)<sup>##UREF##24##31##,##REF##31386342##33##</sup>. This agrees closely with the measured stoichiometry (Mg<sub>0.13</sub>Na<sub>0.81</sub>TiS<sub>2</sub>) (Fig. ##FIG##1##2f## and Supplementary Table ##SUPPL##0##2##) as ~0.81 mole fraction of Na<sup>+</sup> was intercalated along with a small fraction of Mg<sup>2+</sup>. Hence, a mixture of P3 and O3 phases was formed upon full discharge (see Fig. ##FIG##3##4b##). However, due to the inadequate resolution quality of the XRD patterns, refinement and phase quantification could not be accomplished.</p>", "<p id=\"Par19\">The low concentration of Mg in the structure could be explained by the stacking order change of layered TiS<sub>2</sub>, initiated by the intercalation of the Na ions. The phase transformation from O1 to P3 alters the co-ordination geometry of the charge storage site from octahedral to prismatic. The prismatic site prefers the storage of the bigger Na<sup>+</sup> as opposed to the smaller Mg<sup>2+</sup> and Li<sup>+</sup><sup>##UREF##26##34##</sup>. On the contrary, Mg<sup>2+</sup> finds it favorable to occupy the octahedral site<sup>##UREF##26##34##</sup>. This site preference mismatch, directly related to phase change, benefitted the storage of the bigger Na<sup>+</sup>. Thus, making it effectively the dominant charge carrier while suppressing the co-intercalation of Mg<sup>2+</sup> despite the larger interlayer spacing. It is worth noting that a reasonable reversibility of the structure was observed in the first cycle with the recovery of the pristine O1 () phase upon charging. Almost all of the intercalated Na ions were extracted as per ICP-OES (Supplementary Table ##SUPPL##0##2##). However, as discussed in the previous section, the Mg ions were completely trapped and that made the co-intercalation irreversible. Furthermore, the suppression of Mg co-intercalation could also be traced back to the metastable nature of the P3 phase.</p>", "<p id=\"Par20\">The metastability of the P3 phase and its impact on the co-intercalation of Mg will be discussed further with the help of DFT phase diagrams, which will be shown later. The additional investigation of the crystal structure conducted after the second and fifth discharge showed severe amorphization and onset of structural distortions with the eventual disappearance of the characteristic (003) reflection as shown in Supplementary Fig. ##SUPPL##0##5b##. This could be another possible reason for the suppressed co-intercalation of Mg ions. The degradation of the structure was corroborated with the drastic change observed in the voltage profile during cycling (Fig. ##FIG##1##2b##). In stark contrast, TiS<sub>2</sub> showed robust structural integrity in the Mg-Li system as the crystallinity and O1 phase were retained after multiple cycles as shown in Supplementary Fig. ##SUPPL##0##5a##. Based on these findings, a correlation can be established that structural stability could be one of the key parameters required for co-intercalation of two charge carriers.</p>", "<p id=\"Par21\">In conjunction to the bulk structure, it is also important to study the changes the structure undergoes locally upon intercalation of different charge carriers to develop a better understanding of the storage mechanism. Through a combination of ex situ Raman spectroscopy and ex situ transmission electron microscopy (TEM), the local structure of various cycled TiS<sub>2</sub> samples in relation to the aforementioned systems were probed. TiS<sub>2</sub> is a layered material which forms a trigonal structured crystal with a space group of where S-Ti-S slabs interact conventionally through weakly interacting van der Waals forces. On the other hand, single-crystal synchrotron X-ray diffraction measurement suggested the presence of partially covalent Ti-S intralayer interaction and a strong S…S interlayer electron sharing<sup>##REF##29434305##35##</sup>, dissimilar to the classical van der Waals force.</p>", "<p id=\"Par22\">The irreducible representation at Γ point is Γ = <italic>A</italic><sub>1g</sub> + <italic>E</italic><sub>g</sub> + 2<italic>A</italic><sub>2u</sub> + 2<italic>E</italic><sub>u</sub> and the Raman active vibrational modes are the in-plane <italic>E</italic><sub>g</sub> and out-of-plane <italic>A</italic><sub>1g</sub> symmetric stretching of sulfur atoms (Fig. ##FIG##4##5a##) The three primary modes of vibrations centered at ~214 cm<sup>−1</sup> (assigned to <italic>E</italic><sub>g</sub>), ~331 cm<sup>−1</sup> (assigned to <italic>A</italic><sub>1g</sub>) and a “shoulder peak” at ~362 cm<sup>−1</sup> (herein termed Sh) were measured by Raman spectroscopy of pristine TiS<sub>2</sub> electrode (Fig. ##FIG##4##5b##)<sup>##UREF##27##36##</sup>. The origin of the Sh mode of vibration is still under debate as it is linked to several processes such as, presence of excess interlayer titanium<sup>##UREF##28##37##</sup>, van der Waals forces between the interlayers<sup>##REF##31458996##38##</sup> or stress induced forbidden <italic>A</italic><sub>2u</sub> mode. The presence of <italic>E</italic><sub>g</sub>, <italic>A</italic><sub>1g</sub> and Sh suggested that the bulk TiS<sub>2</sub> was trigonal and contained multiple layers in agreement with existing reports<sup>##REF##31458996##38##,##UREF##29##39##</sup>. Monitoring the collective changes in the vibrational bands can shed light on the induced local structural and environmental changes in TiS<sub>2</sub> following intercalation of charge carriers.</p>", "<p id=\"Par23\">Raman spectra were acquired from the surfaces of pristine TiS<sub>2</sub>, Mg-TiS<sub>2</sub> (first discharge), Mg-Li-TiS<sub>2</sub> (first discharge) and Mg-Na-TiS<sub>2</sub> (first discharge) electrodes. No obvious phase change was observed in TiS<sub>2</sub> when Mg ions were intercalated in the single salt Mg system, as the Raman band features resembled closely to those of pristine TiS<sub>2</sub>. On the contrary, co-intercalation of Mg and Li ions broadened the main band features (Fig. ##FIG##4##5b##). The appearance of new or disappearance of existing vibrational modes was not observed. Obviously, no phase change had occurred. However, in the Mg-Na system after discharge, the Raman spectrum of TiS<sub>2</sub> showed significant changes as two new bands centered at ~463 cm<sup>−1</sup> and ~490 cm<sup>−1</sup> emerged. This supports that TiS<sub>2</sub> undergoes a phase transition during intercalation of the larger Na ions, in good agreement with the bulk XRD analysis. The new Raman band could not be identified however, and would require further investigation. As the Mg-Na system showed severely limited co-intercalation based on the ICP-OES, the focus was directed towards the co-intercalation favoring Mg-Li system.</p>", "<p id=\"Par24\">In Supplementary Fig. ##SUPPL##0##6## a juxtaposition of spectra from dis-/charged electrode surfaces are presented in a head to head fashion. Intercalation of Li and co-intercalation of Mg and Li ions in the interlayer reduced the intensity of the Raman bands, which suggested a lowering of the polarizability of the vibrating sulfur atoms. Hence it could be considered that the intercalated ions induced an electronic structure change. The measured Raman spectra were validated by a thorough statistical analysis of the peak frequencies (see methods for details) and the corresponding full-width-half-maxima (FWHM) of <italic>E</italic><sub>g</sub>, <italic>A</italic><sub>1g</sub> and Sh bands of a variety of cycled samples (Supplementary Fig. ##SUPPL##0##7##). The three vibrational modes were traced for the Mg-TiS<sub>2</sub> and the Mg-Li-TiS<sub>2</sub> dis-/charged samples along with partially lithiated (Li-TiS<sub>2</sub>-mid) and fully de-/lithiated Li-TiS<sub>2</sub> samples as control or reference systems.</p>", "<p id=\"Par25\">The two out-of-plane modes of vibrations corresponding to the <italic>A</italic><sub>1g</sub> and the Sh showed a similar trend where the wavenumbers (Raman frequencies) increased for the discharged samples (Fig. ##FIG##4##5d, e##). The fully lithiated TiS<sub>2</sub> (Li-TiS<sub>2</sub> first discharge) blue shifted the <italic>A</italic><sub>1g</sub> mode from 331 cm<sup>−1</sup> to 336 cm<sup>−1</sup> while the Mg and Li-ion co-intercalation (Mg-Li-TiS<sub>2</sub> first discharge) shifted <italic>A</italic><sub>1g</sub> by an additional ~7 cm<sup>−1</sup>. The Sh band also showed a blue shift of 21 cm<sup>–1</sup> (362 cm<sup>–1</sup> to 381 cm<sup>–1</sup>) post-lithiation, while a stronger blue shift of ~29 cm<sup>−1</sup> was observed after the first discharge in the Mg-Li system. A blue shift of <italic>A</italic><sub>1g</sub> band in layered materials has been reported for the case that the number of layers increases<sup>##REF##31458996##38##</sup>. For completeness, we have also provided the frequency distributions together with the outlier points in Supplementary Fig. ##SUPPL##0##8##.</p>", "<p id=\"Par26\">This general trend can be ascribed to the relative stiffening of the <italic>A</italic><sub>1g</sub> mode as the interlayer van der Waals interaction increases with intercalation, thus increasing the effective restoring forces acting on the sulfur layers. Furthermore, during intercalation, the interaction is not limited to weak van der Waals forces as intercalated ions induce local charge on the sulfur layers, which in turn inflict a long-range Coulombic interaction that further stiffens the <italic>A</italic><sub>1g</sub> mode<sup>##REF##20392077##40##,##UREF##30##41##</sup>. The stiffening of out-of-plane <italic>A</italic><sub>1g</sub> and Sh vibrational modes observed in the Mg-Li dual cation co-intercalation was similar to that during the Li ion intercalation, except that a stronger blue shift was observed in the Mg-Li system. This was likely due to the higher charge density of Mg<sup>2+</sup> which amplified the restoring force of the sulfur atoms in the Mg-Li system compared to the intercalation of only Li ions. After charging, the Sh bands in the Li and Mg-Li systems reverted back to Raman frequencies near pristine TiS<sub>2</sub>, which demonstrated reasonable reversibility. However, the corresponding <italic>A</italic><sub>1g</sub> bands showed a red shift with respect to pristine TiS<sub>2</sub> sample. This anomalous behavior can be attributed to the enhancement of interlayer separation at the surface level or exfoliation of TiS<sub>2</sub> to smaller fragments which are insensitive to a bulk structure characterization technique like XRD<sup>##REF##20392077##40##</sup>.</p>", "<p id=\"Par27\">The in-plane <italic>E</italic><sub>1g</sub> mode showed a red shift of ~10 cm<sup>–1</sup> (214 cm<sup>–1</sup> to 204 cm<sup>–1</sup>) and ~15 cm<sup>−1</sup> (214 cm<sup>−1</sup> to 199 cm<sup>−1</sup>) upon lithiation in the Li system and co-intercalation in the Mg-Li system, respectively as shown in Fig. ##FIG##4##5c##. This contradicted the typical outcome that is expected from the classical van der Waals interactions<sup>##REF##31458996##38##,##REF##20392077##40##</sup>. This divergent behavior between in-plane (<italic>E</italic><sub>g</sub>) and out-of-plane (<italic>A</italic><sub>1g</sub>) vibrational modes has been recorded previously in other layered materials, like MoS<sub>2</sub> or GaSe<sup>##REF##20392077##40##,##UREF##30##41##</sup>. Hence a non-negligible Coulombic interaction between the chalcogen atoms and metallic atoms has been proposed to explain such an observation<sup>##UREF##30##41##</sup>. This result reinforces our previous assumption of an intercalation induced local charge in the sulfur layer which could have assisted the in-plane vibration and caused the red shift. Fig. ##FIG##4##5f–h## presents line widths of the Raman modes as a function of dis-/charge of the different systems. It was observed that upon intercalation all the bands showed significant broadening. The implication being that the intercalated carrier ions were distributed in an inhomogeneous manner within the TiS<sub>2</sub> interlayer without short-range ordering.</p>", "<p id=\"Par28\">The local structural change of TiS<sub>2</sub> in the Mg-Li system was further examined by high-resolution transmission electron microscopy (HRTEM) and electron diffraction. The layered structure of TiS<sub>2</sub> was visible in the TEM images shown in Fig. ##FIG##5##6a–c##. The TEM images of cycled TiS<sub>2</sub> (Fig. ##FIG##5##6b, c##) showed that the layered structure was maintained following de-/intercalation. Different orientations were observed in the HRTEM (Fig. ##FIG##5##6d–f##) that can be attributed to the polycrystalline nature of TiS<sub>2</sub>. Interlayer expansion was observed upon co-intercalation of Mg and Li ions as shown in the HRTEM image in Fig. ##FIG##5##6e## where the interlayer distance increased from 5.82 Å to 6.06 Å upon co-intercalation. After de-intercalation, the interlayer distance contracted back to 5.8 Å as in pristine TiS<sub>2</sub>, which demonstrated good reversibility. The Fast Fourier Transformation (FFT) patterns (Fig. ##FIG##5##6g–i##) show ring patterns characteristic for polycrystalline materials. The structural change of TiS<sub>2</sub> that was observed in the Mg-Li system was further analyzed with the help of electron diffraction of cycled TiS<sub>2</sub>. By comparing the diffraction profiles (Fig. ##FIG##5##6j, k##) azimuthally averaged from the corresponding electron diffraction patterns, it was observed that the (001) reflection shifted from 1.72 nm<sup>–1</sup> to 1.65 nm<sup>–1</sup> which is equivalent to a d-space change from 5.8 Å to 6.07 Å upon co-intercalation of Mg and Li ions<sup>##REF##29856638##25##</sup>. Additionally, both (101) and (102) reflections shifted towards lower <italic>g</italic> values in conjunction with the (001) diffraction peak following the expansion of the lattice along <italic>c</italic> direction. After the corresponding de-intercalation process, the electron diffraction pattern changed back to the pristine pattern (Fig. ##FIG##5##6j##), further reinforcing that reversible co-intercalation of both Mg and Li ions occurred.</p>", "<p id=\"Par29\">On the contrary, in the Mg system the electron diffraction pattern showed no shift in the position of the reflections (Fig. ##FIG##5##6k##) as there was no significant structural change following the limited intercalation of Mg<sup>2+</sup>. Overall, the electron diffraction patterns of both Mg-Li and Mg systems were consistent with the XRD data, which means that the local structural change is consistent with the bulk structural change of TiS<sub>2</sub> upon de-/intercalation of the two charge carriers.</p>", "<title>DFT studies</title>", "<p id=\"Par30\">First-principles calculations in the framework of DFT studies were carried out to provide deeper insights into the thermodynamics and kinetics of the cation co-intercalation process. We begin by analyzing the Li, Na, and Mg ion diffusion in the bulk phase of TiS<sub>2</sub>. The sulfur atoms in Li<sub><italic>x</italic></sub>TiS<sub>2</sub> and Mg<sub>x</sub>TiS<sub>2</sub> (<italic>x</italic> ≤ 1.0) are stacked in an ABAB sequence, which is the same as the O1-TiS<sub>2</sub>, crystalized in the space group (see Fig. ##FIG##2##3c##). Li and Mg ions can potentially occupy either octahedral or tetrahedral sites in layered O1-TiS<sub>2</sub> (denoted as O<sub>h</sub> and T<sub>h</sub>, respectively). The intercalated atoms, however, have the propensity to occupy the O<sub>h</sub> sites<sup>##UREF##26##34##</sup>, where each atom is coordinated octahedrally to six S atoms from the two TiS<sub>6</sub> octahedra in each of the upper and lower layers of TiS<sub>2</sub>. The site occupation is more nuanced in thiospinel Ti<sub>2</sub>S<sub>4</sub> with Mg<sup>2+</sup> exhibiting mixed occupancy at non-dilute Mg concentrations<sup>##UREF##31##42##,##UREF##32##43##</sup>. In the layered TiS<sub>2</sub>, intercalated atoms typically migrate through the metastable T<sub>h</sub> sites when hopping from one O<sub>h</sub> site to a neighboring O<sub>h</sub> site which normally requires considerable activation energy to overcome the migration barriers. Fig. ##FIG##6##7a## shows the schematic representation of the diffusion path in O1-TiS<sub>2</sub>. Our calculated activation energies (E<sub>a</sub>) were 0.73 eV and 1.28 eV for Li and Mg ions, respectively, as depicted in Fig. ##FIG##6##7b## (left) and 1.07 eV for Na ions (Supplementary Fig. ##SUPPL##0##9##). These values can be used to compute the diffusion coefficient (D) for the ions at room temperature (25 °C) (k<sub>B</sub>T = 0.026 eV) using the established Arrhenius expression D ~ exp(-E<sub>a</sub>/k<sub>B</sub>T). Specifically, the calculated diffusion coefficients of Li and Mg ions at 25 °C are approximately 10<sup>–13</sup> and 10<sup>–21</sup> cm<sup>2</sup>/s, respectively. This translates to a D of Mg ions that is 10<sup>8</sup> times lower than that of Li ions which underlined the significant sluggishness of Mg ions. It should be mentioned that the migration barrier calculations were done without taking the temperature parameter into account (i.e. 0 K).</p>", "<p id=\"Par31\">The charge density differences were constructed by subtracting the total electron density of the system with a single intercalated ion from that of the isolated atom and pristine TiS<sub>2</sub> without changing the atomic positions. An isovalue of 0.004 eÅ<sup>‒3</sup> was used for all three ions. The distribution of the charge density difference of Li and Na intercalation at equilibrium are comparable, with the exception that the charge depletion zone around Na is more delocalized than that around Li (Fig. ##FIG##6##7d, e##). In line with earlier observations, the charge rehybridization or electronic redistribution upon Mg insertion appears to be higher than that of Li and Na. The divalent character of Mg ions strongly encourages charge rehybridization (Fig. ##FIG##6##7c##), explaining why Mg ions move slowly in layered TiS<sub>2</sub>, highlighting the necessity for new mitigating strategies. In this regard it was observed that the presence of Li in the interstices of TiS<sub>2</sub> crystal structure enabled improved solid-state diffusion of Mg. The variations in the energy profiles governing the diffusion of Mg and Li ions within Li<sub>0.5</sub>TiS<sub>2</sub> were examined as the interlayer spacing increased from its equilibrium state to a 4% expansion. As illustrated in Fig. ##FIG##6##7b## (right), we have determined the activation energies (E<sub>a</sub>) of Li and Mg ions in Li<sub>0.5</sub>TiS<sub>2</sub> to be 0.55 and 1.07 eV, respectively. The lowering of the migration barrier for Mg ions amounts to 0.20 eV and for Li ions it is 0.18 eV. This demonstrated a noteworthy reduction in the activation barrier of Mg ions together with its Li counterpart, resulting in a significant enhancement of its diffusion coefficient.</p>", "<p id=\"Par32\">We now shift our attention to the mobility of the Na and Mg ions in the TiS<sub>2</sub> crystal structure for the Mg-Na system. Two space groups that were observed experimentally matched well with the Na<sub>0.5</sub>TiS<sub>2</sub> and NaTiS<sub>2</sub> structures, namely R3m (P3) and (O3), respectively. In the O3-TiS<sub>2</sub> structure, there are O<sub>h</sub> and T<sub>h</sub> sites for the Na and Mg ions to reside. However, both Na and Mg ions tend to occupy the O<sub>h</sub> sites. Compared to the O1 structure, the T<sub>h</sub> sites in the O3 phase function as transition states for Na ions due to their larger radii while providing a local minimum for the smaller Mg ions as shown in Fig. ##FIG##7##8a##. The potential diffusion pathways between the two closest O<sub>h</sub> sites going through T<sub>h</sub> sites were examined to determine the activation energies. Our computed activation energies were 0.59 and 0.99 eV for Na and Mg ions, respectively (Fig. ##FIG##7##8a##), which indicated faster diffusion of Mg in the Mg-Na system. For the P3-TiS<sub>2</sub> structure, the ABBCCA sulfur stacking and four TiS<sub>2</sub> sheets per unit cell have prisms sharing a face with one TiS<sub>6</sub> octahedron and three edges with TiS<sub>6</sub> octahedra from the next layer, resulting in only one storage site called the prismatic site (see Fig. ##FIG##3##4d##). Facile migration of Na and Mg ions between two adjacent prismatic sites was obtained with the rectangular shared face as the transition state (Fig. ##FIG##7##8b##). Our computed activation energies were 0.18 and 0.31 eV for Na and Mg ions, respectively, which again suggested faster mobility. Calculated migration barriers of the O3 and P3 phases however did not align with the experimental finding of suppressed Mg co-intercalation. Therefore, the solid-state diffusion of Mg ions was probably not the determining factor for its limited co-intercalation with Na ions in bulk TiS<sub>2</sub>.</p>", "<p id=\"Par33\">In order to clarify this anomalous finding, we checked the thermodynamic stability of the different phases of TiS<sub>2</sub>. Layered sulfides exhibit mainly O1, O3, and P3 structures. As TiS<sub>2</sub> slabs glide over each other without breaking S links, transitions between them can happen quickly during de-/intercalation. While TiS<sub>2</sub> favors the O1 structure for Li and Mg storage, fully sodiated (~1 Na) TiS<sub>2</sub> is stable in the O3 phase, and at intermediate concentrations, the structure exhibits the metastable P3 (R3m) phase<sup>##UREF##24##31##</sup>.</p>", "<p id=\"Par34\">The calculated phase diagrams demonstrate that each ion can lead to a series of phase transformations upon changing its concentration, as shown in Fig. ##FIG##8##9##. The ternary phase diagrams were constructed by utilizing all DFT computed bulk energies of corresponding materials. No binary phase exists between the metallic phase of the intercalated ions (Li, Mg, and Na) and the titanium phase, which is obviously valid for all of the three phase diagrams. Considering the case of the Li-Ti-S phase diagram (Fig. ##FIG##8##9a##), we found two stable binary compounds between the lithium and sulfur phases, Li<sub>2</sub>S and LiS<sub>4</sub>. On the other hand, multiple stable binary compounds exist between the titanium and sulfur phases, showing a rich transition metal–sulfide chemistry. The ternary phases in this phase diagram exhibited both Li<sub>0.5</sub>TiS<sub>2</sub> and LiTiS<sub>2,</sub> as well as Li<sub>4</sub>TiS<sub>4</sub> and Li<sub>8</sub>TiS<sub>6</sub>. The Li intercalated TiS<sub>2</sub> showed the same O1 structure for Li-poor (Li<sub>0.5</sub>TiS<sub>2</sub>) to Li-rich (Li<sub>8</sub>TiS<sub>6</sub>) phases. Going from the Li to the Mg system (Fig. ##FIG##8##9b##), two stable binary compounds, MgS and MgS<sub>2</sub>, were found between the magnesium and sulfur phases in the phase diagram. No stable ternary phase was calculated in this phase diagram. Therefore, the co-intercalation approach with Li ions could be one way of introducing Mg ions into the TiS<sub>2</sub> structure.</p>", "<p id=\"Par35\">The Na system (Fig. ##FIG##9##10c##) has four binary phases between sodium and sulfur, Na<sub>2</sub>S, NaS, NaS<sub>2</sub> and Na<sub>2</sub>S<sub>5</sub>. The titanium and sulfur binary compounds were the same as in Li and Mg phase diagrams. However, only two phase stable ternary compounds exist, in the form of NaTiS<sub>2</sub> and Na<sub>0.3</sub>TiS<sub>2</sub> (dark green points) along with the metastable Na<sub>0.5</sub>TiS<sub>2</sub> phase (red point). The metastable nature of P3-Na<sub>0.5</sub>TiS<sub>2</sub> thermodynamically drives the transition towards phase stable O3-TiS<sub>2</sub>. In order to clarify the role that the stability of the structure played to inhibit the intercalation of Mg ions in the Mg-Na system, the structural stability of the P3 and O3 phase was calculated upon incorporation of Mg ions. The outcome was that significant distortions were induced in the crystal structure of both P3 and O3-TiS<sub>2</sub> (Fig. ##FIG##8##9d##). Furthermore, it was observed that the accommodation of Mg ions in O3-TiS<sub>2</sub> generated relatively stronger distortions compared to the metastable P3-TiS<sub>2</sub> (Supplementary Table ##SUPPL##0##3##). Thus, the transition of the metastable P3 phase to the thermodynamically stable O3 phase is likely to exacerbate the overall distortions in the crystal lattice, leading to severe structural destabilization. This phenomenon explained well the suppression of Mg<sup>2+</sup> co-intercalation, as well as the structural degradation observed with cycling (Supplementary Fig. ##SUPPL##0##5##). On the flipside, in the Mg-Li system the O1-TiS<sub>2</sub> phase is retained when storing the smaller Li ions. Therefore, no distortions were introduced while accommodating Mg ions in the lithiated O1 phase (Fig. ##FIG##8##9d##) due to  the similarity of the ionic radius.</p>", "<p id=\"Par36\">From the computational results, it can be inferred that the diffusion kinetics of Mg ions benefit from the thermodynamic and structural stability of TiS<sub>2</sub> as evidenced from the difference observed between the Mg-Li and the Mg-Na systems. This underlines the importance of the ionic radius of the co-intercalating monovalent ion for the strategy to succeed.</p>", "<title>Reaction mechanism of de-/intercalation</title>", "<p id=\"Par37\">The electrochemical reaction mechanism of TiS<sub>2</sub> was investigated thoroughly for the co-intercalating Mg-Li system by probing the local electronic structure using ex situ transmission electron microscopy-based electron energy loss spectroscopy (EELS). The high sensitivity of EELS for chemical state changes upon redox reaction was exploited to monitor the oxidation state of both Ti and S redox centers. As TiS<sub>2</sub> has a covalent character due to the orbital mixing of S 3p and Ti 3d, it has been reported that redox contribution from S is also likely together with Ti<sup>##REF##29856638##25##,##REF##35653701##44##</sup>.</p>", "<p id=\"Par38\">In order to clarify the exact nature of the redox reaction, both Ti L<sub>2,3</sub> and S L<sub>2,3</sub>-ionization edges were analyzed post discharge/charge. A detailed comparison of the Ti L<sub>2,3</sub> fine structure before and after the first cycle is shown in Fig. ##FIG##9##10a##. The Ti 3d character of the pristine sample was characterized by the presence of three-fold degenerate <italic>t</italic><sub><italic>2g</italic></sub> states (shoulder peaks) and two-fold degenerate <italic>e</italic><sub><italic>g</italic></sub> states (peaks at 459.2 eV and 464.9 eV). The crystal field splitting (<italic>t</italic><sub><italic>2g</italic></sub> – <italic>e</italic><sub><italic>g</italic></sub>) is reasonably resolved in TiS<sub>2</sub> as can be seen from the clear shoulder peaks at 457.4 eV and 463.1 eV. However, on discharging the Mg-Li system, the shoulder peaks disappeared. This indicates a reduction in the <italic>t</italic><sub><italic>2g</italic></sub> – <italic>e</italic><sub><italic>g</italic></sub> splitting of the Ti L<sub>2,3</sub> edge, which is characteristic for the reduction of Ti<sup>##UREF##33##45##–##UREF##36##48##</sup>. Furthermore, the Ti L<sub>2,3</sub> edge was shifted by ~0.7 eV to lower energies which confirmed the reduction of the Ti oxidation state. On charging, the Ti L<sub>2,3</sub> edge shifted back to its previous position and concurrently the shoulder peaks reappeared, which demonstrated a consistent reversible redox process, whereas the S L<sub>2,3</sub> edge (Fig. ##FIG##9##10b##) on the other hand showed no significant change in its feature or position upon discharge/charge, which indicated no obvious anionic sulfur redox reaction in TiS<sub>2</sub> upon reversible Mg<sup>2+</sup> and Li<sup>+</sup> co-intercalation. The Mg system on the other hand, showed no low energy shift of the Ti L<sub>2,3</sub> edge after discharge. This is consistent with the low capacity and incomplete reduction of TiS<sub>2</sub> due to the limited intercalation of Mg<sup>2+</sup> charge carriers. Additionally, the S L<sub>2,3</sub> edge (Fig. ##FIG##9##10d##) also showed no clear changes, suggesting no sulfur redox, similar to the Mg-Li system.</p>", "<p id=\"Par39\">Furthermore, the calculated density of states (DOS) alongside calculated EELS data also corroborated the above findings, as illustrated in Fig. ##FIG##9##10e##. For TiS<sub>2</sub>, the filled valence band (bonding states, <italic>σ</italic>), which extends from –5.5 eV to 0 eV, is predominantly of S-p character with some contribution from Ti-d orbitals. The Ti-d states relevant for the redox properties lie mostly above the Fermi level (anti-bonding states, <italic>σ</italic><sup>*</sup>) between 0 and 4 eV. Passing from TiS<sub>2</sub> to LiTiS<sub>2</sub>, the monovalent Li ions are introduced into the system and extra electrons fill up the <italic>σ</italic><sup>*</sup> states. Based on the DOS calculations, the Ti (<italic>σ</italic><sup>*</sup>) states were occupied. A detailed look at the spectral region of interest of the calculated EELS showed that the redox activity is related to peaks that lie in the energy window from 0 to 3 eV. The disappearance of the lower peak corresponding to the Ti-<italic>t</italic><sub><italic>2g</italic></sub> (<italic>σ</italic><sup>*</sup>) orbital after Li insertion agreed well with the measured EELS data of the Mg-Li system and further verified that Ti is the center of the redox reaction. The bonding/anti-bonding states were further analyzed using the Crystal Orbital Hamiltonian (COHP) analysis as can be seen in Supplementary Fig. ##SUPPL##0##10##. It can be observed that upon reduction, the continuum corresponding to the anti-bonding states (blue) near the Fermi level underwent broadening due to the delocalization of the electrons in the empty Ti-d states. Simultaneously, in the bonding continuum (red), which is primarily comprised of the S-p orbitals, the sharp peak vanishes as the bonding weakens likely due to slight lengthening of the Ti−S bond on Li<sup>+</sup> intercalation<sup>##REF##35653701##44##</sup>. These observations complement well with the DOS calculations and suggest that Ti is the dominant redox site.</p>", "<p id=\"Par40\">Moreover, charge analysis was also conducted to support the assertion that TiS<sub>2</sub> predominantly undergoes redox at the Ti site. It should be noted that from the study done by Zhang et al. and the subsequent Bader charge analysis, it was found that one titanium (Ti) atom and two sulfur (S) atoms gained electrons when lithium ions were intercalated in TiS<sub>2</sub><sup>##REF##29856638##25##</sup>. They predicted that both Ti and S contributed to the charge compensation mechanism, with S gaining more electrons than Ti upon intercalation of one Li<sup>+</sup> per formula unit. In our study, we found that the PBE (Perdew-Burke-Emzerhof) functional predicts incorrectly the charge compensation process in TiS<sub>2</sub> showing a shared mechanism between Ti and S with more contribution from S (Supplementary Table. ##SUPPL##0##4##). However, the Ti cations gain more electrons using the more accurate HSE06 hybrid functional<sup>##UREF##37##49##</sup> and the contribution of the S anions to the charge compensation process becomes relatively small (0.128 for Ti and 0.040 for S), following the charges listed in the VASP (Supplementary Table. ##SUPPL##0##5##).</p>", "<p id=\"Par41\">The conclusion that can be derived from the EELS fine structure analysis and the calculated DOS, COHP and charge analysis was that TiS<sub>2</sub> did not exhibit any obvious sulfur redox activity and Ti is the dominant redox active site when charge carriers are intercalated. The redox mechanism was more clearly observed for the co-intercalating Mg-Li system compared to the Mg system as a greater amount of charge was transferred to the Ti redox center due to the co-intercalation of two charge carriers.</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par42\">We have demonstrated herein a novel approach to offset the poor redox activity of Mg ions in model TiS<sub>2</sub> cathode by enabling dual cation co-intercalation with faster Li ions by using a fluorinated alkoxyborate-based dual salt electrolyte. The concept was then extended to an analogous system by incorporating Na ions instead of Li and the performance was similar, delivering an initial discharge capacity close to the theoretical value. Previously, dual salt electrolytes have been explored to mitigate the high migration barrier and associated kinetically sluggish transportation of Mg<sup>2+</sup>. However, the widely reported dual salt electrolytes are either corrosive due to the presence of chlorine, like APC–LiCl/LiBF<sub>4</sub>, where APC stands for All Phenyl Complex, or are highly reductive, in the case of borohydrides (Mg(BH<sub>4</sub>)<sub>2</sub>–NaBH<sub>4</sub>))<sup>##UREF##22##29##,##UREF##38##50##</sup>. Both these classes of electrolyte have limited anodic stability, which restricts them from high voltage applications. Yagi et al. reported self-discharge and spurious side reactions involving an APC-LiBF<sub>4</sub> / THF (tetrahydrofuran) dual salt and LiFePO<sub>4</sub> cathode during resting and charging, respectively<sup>##UREF##39##51##</sup>. Furthermore, borohydride based Mg(BH<sub>4</sub>)<sub>2</sub>–NaBH<sub>4</sub> / DGM (diglyme) has been shown to be chemically reactive by irreversibly modifying the pristine TiS<sub>2</sub> cathode<sup>##UREF##22##29##</sup> after the first discharge and lowered the anodic stability when the concentration of Mg(BH<sub>4</sub>)<sub>2</sub> was increased. In addition, there is strong association between anion and cation in both Cl-based and borohydride-based electrolytes, generating a high energy barrier for dissociation at cathode-electrolyte interface. The respective monovalent cation species (such as MgCl<sup>+</sup>) might even intercalate into the cathode as a whole, which makes it more complicated for exploring the cation co-intercalation strategy. In comparison, the dual salt electrolytes used in this work have superior anodic stability due to the strong C-F bond in [B(hfip<sub>4</sub>)]<sup>–</sup> which render it as an ideal electrolyte system for exploring the cation co-intercalation strategy<sup>##UREF##40##52##</sup>.</p>", "<p id=\"Par43\">Typically, the dual salt electrolyte approach has been tuned towards designing hybrid battery systems, where the positive electrode only accommodates the faster Li<sup>+</sup>/Na<sup>+</sup> (discharge) while the slower Mg<sup>2+</sup> plates on the metal negative electrode (charge). Effectively, the cathode operates as a Li<sup>+</sup>/Na<sup>+</sup> pass filter<sup>##UREF##38##50##</sup>. This strategy has been reported to be a viable way to circumvent the problematic kinetics of Mg<sup>2+</sup>. However, as the charge carriers (all Mg<sup>2+</sup> after discharge and all Li<sup>+</sup> after charge) are stored in the electrolyte solution, large amount of solvent is required, which consequently lowers the energy density. Not to mention, the cell design will need to be altered to safely hold larger quantities of electrolyte. On the contrary, dual cation co-intercalation enabled by a dual salt electrolyte is based on the ‘rocking chair’ principle<sup>##UREF##17##22##</sup>. The advantage of this approach is that the charge carriers are accommodated in the electrodes and not in the electrolyte, thus ensuring higher overall energy density.</p>", "<p id=\"Par44\">Co-intercalation approaches have been investigated as an alternative counter measure to combat the sluggishness of Mg<sup>2+</sup>. Water solvated Mg<sup>2+</sup> was first studied by Song et al. to shield the charge carrier and decrease its polarization<sup>##REF##25608277##53##</sup>. Although the capacity was much improved, the presence of water in the electrolyte passivated the Mg anode<sup>##UREF##41##54##</sup>. Along similar lines, V<sub>2</sub>O<sub>5</sub> xerogels with hydrated interlayers screened the intercalated Mg<sup>2+</sup> and reduced the polarization. However, it was later reported that the water molecules get extracted on charging along with Mg<sup>2+</sup>, causing the V<sub>2</sub>O<sub>5</sub> structure to collapse. A more effective solvent co-intercalation method was reported by Li et al. with DME solvated [Mg • 3DME]<sup>2+</sup> exhibiting fast kinetics in layered MoS<sub>2</sub> by shielding the high charge density of Mg<sup>2+</sup><sup>##REF##30504910##20##</sup>. A study done by Yoo et al. explored an alternative co-intercalation strategy and demonstrated fast kinetics in TiS<sub>2</sub> by intercalating monovalent [MgCl]<sup>+</sup>. This can be interpreted as the co-intercalation of Mg<sup>2+</sup> and Cl<sup>−</sup> ions<sup>##REF##28835681##55##</sup>. Nevertheless, the intercalation of such a bulky specie, either [Mg(solvent)<sub>x</sub>]<sup>2+</sup> or [MgCl]<sup>+</sup>, could cause steric hindrance and hence require artificial modification of the host structure. Furthermore, cation-solvent co-intercalation or cation-anion co-intercalation requires large amount of electrolyte as reservoir of solvents or anions which in turn will affect the energy density.</p>", "<p id=\"Par45\">The co-intercalation concept reported in this work corresponds to the simultaneous accommodation of two cations in the host crystal structure without the need for any artificial structural modification of the cathode due to the much smaller size of cationic charge carriers. Thus, ensuring greater structural integrity and stability. Additionally, dual cation co-intercalation strategy executed by the dual salt electrolyte approach also has the possibility to lower the de-solvation penalty at the cathode-electrolyte interface, thus enhancing the electrochemical performance<sup>##REF##34778645##56##</sup>. Furthermore, compared to the other co-intercalation methods, the electrolyte amount is not a rate limiting parameter for achieving higher energy densities. Finally, both cations are active charge carriers and enable obtaining high specific capacities.</p>", "<p id=\"Par46\">Investigation of the dual cation co-intercalation strategy requires a thorough examination of the capacity contributions from each charge carrier. This was conducted through elemental analysis, which revealed an interesting dichotomy underlining the influence of the ionic radius of the cations. While the Li ions enabled co-intercalation of Mg<sup>2+</sup>, the influence of the bigger Na ions was detrimental. Examining the reason behind the divergent behavior between two apparently similar systems highlighted the impact of phase transformation on the ability of TiS<sub>2</sub> to accommodate two different charge carriers with different valencies. The Mg-Li system exhibited no phase change of O1-TiS<sub>2</sub> upon co-intercalation of Mg and Li ions. The thermodynamic and structural stability of a variety of lithiated ternary Li<sub><italic>x</italic></sub>TiS<sub>2</sub> compositions along with interlayer expansion enabled improved solid-state diffusion of Mg<sup>2+</sup> with the migration barrier being reduced by more than 0.2 eV. On the other hand, TiS<sub>2</sub> underwent a phase change to a mixture of metastable P3 and O3 phases upon the first full discharge in the Mg-Na system. Despite greater interlayer expansion, the metastability of P3 phase and the unfavorable energetics of the prismatic site suppressed the co-intercalation of the smaller and densely charged Mg<sup>2+</sup>. In fact, calculations and experiments showed that the incorporation of Mg<sup>2+</sup> in P3 and O3 structures led to severe structural distortions which clarified the reason behind the low Mg concentration.</p>", "<p id=\"Par47\">A detailed mechanistic study of the Mg-Li system clarified the charge storage mechanism in TiS<sub>2</sub>. Post-mortem ex situ analysis of TiS<sub>2</sub> showed that the co-intercalation was reasonably reversible with interlayer expansion/contraction being observed after full dis-/charge. Raman spectroscopy showed the interaction of the intercalated ions with the surrounding sulfur atoms. Comparing the vibrational modes of the Mg-Li system with the half-discharged and fully discharge Li systems further highlighted that Mg and Li ions were co-intercalated into the structure. This was clarified as a stronger interaction was observed with the surrounding sulfur atoms in the Mg-Li system, comprising of 0.35 Li together with 0.24 Mg, in comparison to the half lithiated Li system (half-discharged). Moreover, when compared against the fully lithiated Li system, the Mg-Li system still exhibited a slightly stronger blue shift in the out-of-plane frequencies by 8 cm<sup>−1</sup> likely due to stronger Coulombic interaction due to the presence of divalent Mg<sup>2+</sup>. The above specified observations lend credence towards improved storage of Mg<sup>2+</sup> in tandem with Li<sup>+</sup> in the Mg-Li system, whereas the single ion Mg system suffered to sufficiently intercalate Mg<sup>2+</sup> and showed no obvious change in the Raman modes due to dilute Mg concentration in the TiS<sub>2</sub>. Furthermore, the redox mechanism investigation clarified that Ti is the dominant redox center and no discernible anionic redox is observed in TiS<sub>2</sub>.</p>", "<p id=\"Par48\">Overall, the co-intercalation method proved to be a viable strategy to mitigate the poor solid-state diffusion of divalent Mg ions which opens an alternative pathway to improve the performance of RMBs provided the right accompanying monovalent ion is employed. The conclusions drawn from the model systems provide guidelines to further explore co-intercalation chemistries, especially high-voltage cathode materials by designing suitable dual cation systems.</p>" ]
[]
[ "<p id=\"Par1\">The development of competitive rechargeable Mg batteries is hindered by the poor mobility of divalent Mg ions in cathode host materials. In this work, we explore the dual cation co-intercalation strategy to mitigate the sluggishness of Mg<sup>2+</sup> in model TiS<sub>2</sub> material. The strategy involves pairing Mg<sup>2+</sup> with Li<sup>+</sup> or Na<sup>+</sup> in dual-salt electrolytes in order to exploit the faster mobility of the latter with the aim to reach better electrochemical performance. A combination of experiments and theoretical calculations details the charge storage and redox mechanism of co-intercalating cationic charge carriers. Comparative evaluation reveals that the redox activity of Mg<sup>2+</sup> can be improved significantly with the help of the dual cation co-intercalation strategy, although the ionic radius of the accompanying monovalent ion plays a critical role on the viability of the strategy. More specifically, a significantly higher Mg<sup>2+</sup> quantity intercalates with Li<sup>+</sup> than with Na<sup>+</sup> in TiS<sub>2</sub>. The reason being the absence of phase transition in the former case, which enables improved Mg<sup>2+</sup> storage. Our results highlight dual cation co-intercalation strategy as an alternative approach to improve the electrochemical performance of rechargeable Mg batteries by opening the pathway to a rich playground of advanced cathode materials for multivalent battery applications.</p>", "<p id=\"Par2\">Rechargeable magnesium batteries suffer from poor mobility of Mg-ions, severely affecting the electrochemical performance. Here, authors demonstrate a strategy of co-intercalation of monovalent ions into the host lattice, which substantially improves Mg-ion mobility and battery performance.</p>", "<title>Subject terms</title>" ]
[ "<title>Supplementary information</title>", "<p>\n\n\n</p>" ]
[ "<title>Supplementary information</title>", "<p>The online version contains supplementary material available at 10.1038/s41467-023-44495-2.</p>", "<title>Acknowledgements</title>", "<p>The authors acknowledge the funding from the German Research Foundation (DFG) under Project ID 390874152 (POLiS Cluster of Excellence). This work contributes to the research performed at CELEST (Center for Electrochemical Energy Storage Ulm-Karlsruhe). Z.L. acknowledge the funding by the National Natural Science Foundation of China with grant No 52002350. The authors also acknowledge the computational time provided by the state of Baden-Württemberg through bwHPC and the German Research Foundation (DFG) through grant no INST 40/575-1 FUGG (JUSTUS 2 cluster). The authors would further like to acknowledge the ICP-OES operator, Jason Lelovas, for conducting the ICP-OES measurements.</p>", "<title>Author contributions</title>", "<p>A.R. prepared the electrolytes, fabricated the electrodes and conducted all electrochemical tests. A.R., M.S. also performed all ex situ XRD measurements and the associated analyses and A.G. did the DFT calculations and contributed to the theoretical part of the manuscript. S.D. was responsible for the ex situ Raman spectroscopy and related analysis. Y.T. and C.K. conducted the STEM and EELS measurements and all related analyses. A.R. wrote the manuscript with contributions from M.S., S.D., Y.T., and Z.L. The project was conceptualized and coordinated by M.F., Z.Z.-K., and Z.L. All authors have given approval to the final version of the manuscript.</p>", "<title>Peer review</title>", "<title>Peer review information</title>", "<p id=\"Par58\"><italic>Nature Communications</italic> thanks the anonymous reviewers for their contribution to the peer review of this work. A peer review file is available.</p>", "<title>Funding</title>", "<p>Open Access funding enabled and organized by Projekt DEAL.</p>", "<title>Data availability</title>", "<p>The experimental and theoretical data generated in this study have been deposited in the Zenodo database under accession code: 10.5281/zenodo.8355348.</p>", "<title>Competing interests</title>", "<p id=\"Par59\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><title>Schematic of the working principle.</title><p>Co-intercalation of divalent Mg and monovalent Li/Na-ions for the dual salt electrolyte system with Mg metal anode and TiS<sub>2</sub> cathode during (<bold>a</bold>) discharge and (<bold>b</bold>) charge.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><title>Comparing dual cation systems against the reference Mg system using electrochemical and elemental techniques as follows.</title><p>Two-electrode galvanostatic charge-discharge profiles of TiS<sub>2</sub> in (<bold>a</bold>) Mg-Li system, (<bold>b</bold>) Mg-Na system and (<bold>c</bold>) Mg system cycled between 0.01 V and 2.2 V vs Mg with a constant current of 20 mA g<sup>–1</sup>. Three-electrode cyclic voltammograms (CV) of TiS<sub>2</sub> for (<bold>d</bold>) Mg-Li system and (<bold>e</bold>) Mg-Na system operated between 0.01 V and 2.2 V vs Mg reference (Mg<sub>ref</sub>) scanned with 0.1 mV s<sup>–1</sup>. <bold>f</bold> Mg/Ti ratio in Mg-Li (red curve), Mg (blue curve) and Mg-Na (inset) cells calculated from ICP-OES data.</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><title>Bulk structure analysis of the cathode in the Mg-Li system upon cycling.</title><p>Ex situ XRD of TiS<sub>2</sub> comparing the (<bold>a</bold>) Mg-Li system and the reference (<bold>b</bold>) Mg system. <bold>c</bold> Atomic models representing the structural expansion of layered TiS<sub>2</sub> in the Mg-Li system upon co-intercalation with no phase transformation.</p></caption></fig>", "<fig id=\"Fig4\"><label>Fig. 4</label><caption><title>Structural evolution of TiS<sub>2</sub> during co-intercalation of Mg and Na ions.</title><p><bold>a</bold> Ex situ XRD at different states of charge. <bold>b</bold> Magnified XRD pattern at 0.6 V and 0.01 V shows the major P3 phase and the minor O3 phase. <bold>c</bold> Voltage profile showing the different states of charge. <bold>d</bold> Atomic model showing the phase transformation to the Na dominant P3 and O3 mixed phase along with the changes in the stacking sequence of the layers.</p></caption></fig>", "<fig id=\"Fig5\"><label>Fig. 5</label><caption><title>Ex situ Raman spectroscopy of TiS<sub>2</sub>.</title><p><bold>a</bold> Schematic of Raman active <italic>A</italic><sub><italic>1g</italic></sub>, Sh and <italic>E</italic><sub><italic>g</italic></sub> modes of vibration. <bold>b</bold> Raman spectra showing the <italic>A</italic><sub><italic>1g</italic></sub>, Sh and <italic>E</italic><sub><italic>g</italic></sub> vibrational frequencies of TiS<sub>2</sub> in pristine and discharged (Mg-TiS<sub>2</sub>, Mg-Li-TiS<sub>2</sub> and Mg-Na-TiS<sub>2</sub>) samples. Peak frequency distribution of pristine TiS<sub>2</sub> (blue), discharged TiS<sub>2</sub> (yellow) and charged TiS<sub>2</sub> (green) corresponding to (<bold>c</bold>) <italic>E</italic><sub><italic>g</italic></sub>, (<bold>d</bold>) <italic>A</italic><sub><italic>1g</italic></sub> and (<bold>e</bold>) Sh modes. Full width half maxima (FWHM) distribution of pristine TiS<sub>2</sub> (blue), discharged TiS<sub>2</sub> (yellow) and charged TiS<sub>2</sub> (green) corresponding to (<bold>f</bold>) <italic>E</italic><sub><italic>g</italic></sub>, (<bold>g</bold>) <italic>A</italic><sub><italic>1g</italic></sub> and (<bold>h</bold>) Sh modes of vibration.</p></caption></fig>", "<fig id=\"Fig6\"><label>Fig. 6</label><caption><title>Local structure analysis of TiS<sub>2</sub>.</title><p>Ex Situ TEM image of TiS2 corresponding to (<bold>a</bold>) pristine, (<bold>b</bold>) discharged and (<bold>c</bold>) charged samples. The corresponding HRTEM images cropped from the area marked with dashed red box correspond to (<bold>d</bold>−<bold>f</bold>). The interlayer distances of marked in the images. <bold>g</bold>–<bold>i</bold> Corresponds to the FFT of TEM images of pristine, discharged and charged samples, respectively. Background subtracted diffraction profiles azimuthally averaged from the corresponding electron diffraction patterns for (<bold>j</bold>) Mg-Li and (<bold>k</bold>) Mg systems. The peak in 0.359 nm is the carbon from the additives.</p></caption></fig>", "<fig id=\"Fig7\"><label>Fig. 7</label><caption><title>DFT calculations pertaining to the Mg and Mg-Li systems.</title><p><bold>a</bold> The O1-TiS<sub>2</sub> crystal structure with Li and Mg atoms intercalated in octahedral (O<sub>h</sub>) sites indicated by orange colour. Occupation of the tetrahedral (T<sub>h</sub>) site is metastable during the hopping process in the diffusion channel between nearby O<sub>h</sub> sites, which is indicated by green. <bold>b</bold> Migration barriers of Li and Mg ions in the bulk of TiS<sub>2</sub> and Li<sub>0.5</sub>TiS<sub>2</sub>, respectively. A significant reduction in the height of the activation barrier is observed when Li fills 50% of interlayer sites. <bold>c</bold>–<bold>e</bold> Show a comparison of the spatial distribution of the difference in charge density (with isovalue of 0.004 eÅ<sup>–3</sup>) for (<bold>c</bold>) Mg, (<bold>d</bold>) Na, and (<bold>e</bold>) Li atom in an O<sub>h</sub> site. The brown and green isosurfaces represent the charge accumulation and depletion regions, respectively.</p></caption></fig>", "<fig id=\"Fig8\"><label>Fig. 8</label><caption><title>DFT calculations pertaining to the Mg-Na system.</title><p>The calculated activation barriers of Na and Mg ion bulk diffusion in (<bold>a</bold>) O3- and (<bold>b</bold>) P3-TiS<sub>2</sub>. The activation barriers are significantly reduced in the P3 structure compared to the O3 structure due to the rectangular face-sharing transition state.</p></caption></fig>", "<fig id=\"Fig9\"><label>Fig. 9</label><caption><title>Phase and structural stability of TiS<sub>2</sub> and its effect on co-intercalation.</title><p>Ternary phase diagrams of the (<bold>a</bold>) Li–Ti–S, (<bold>b</bold>) Mg–Ti–S, (<bold>c</bold>) Na–Ti–S systems. <bold>d</bold> Simulated structures of P3, O3 and O1-TiS<sub>2</sub>. The labels and points (dark green) correspond to the stable crystalline phases (<bold>a</bold>–<bold>c</bold>) according to the convex hull analysis. The lines highlight the reaction vectors for the various elemental concentrations for the stable phases. The red point in (<bold>c</bold>) corresponds to the metastable half-sodiated P3-TiS<sub>2</sub> phase. The effect of the structural stability on interstitial Mg ion occupation is highlighted in the computed structures of P3, O3 and O1-TiS<sub>2</sub>, where O3 and P3-TiS<sub>2</sub> exhibit structural distortions unlike the O1-TiS<sub>2</sub>.</p></caption></fig>", "<fig id=\"Fig10\"><label>Fig. 10</label><caption><title>Reaction mechanism investigation by EELS spectra analysis.</title><p>EELS spectra of TiS<sub>2</sub> in the (<bold>a</bold>, <bold>b</bold>) Mg-Li and (<bold>c</bold>, <bold>d</bold>) Mg systems. The energy range of (<bold>a</bold>, <bold>c</bold>) Ti L<sub>2,3</sub> edge and (<bold>b</bold>, <bold>d</bold>) S L<sub>2,3</sub> edge. <bold>e</bold> The calculated density of states of (DOS) of TiS<sub>2</sub> (top) and LiTiS<sub>2</sub> (bottom) structures. The graphs show the total DOS (grey) and the projected DOS for S-p (red), Ti-<italic>t</italic><sub><italic>2g</italic></sub> (<italic>σ</italic>) / Ti-<italic>t</italic><sub><italic>2g</italic></sub> (<italic>σ</italic><sup>*</sup>) (green), Ti<italic>-e</italic><sub><italic>g</italic></sub>\n<italic>(σ</italic>) <italic>/</italic> Ti-<italic>e</italic><sub><italic>g</italic></sub> (<italic>σ</italic><sup>*</sup>) (yellow) bonding / anti-bonding states. The calculated EELS data is represented by dark blue colour.</p></caption></fig>" ]
[]
[ "<inline-formula id=\"IEq1\"><alternatives><tex-math id=\"M1\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{{{{\\rm{P}}}}}}\\bar{3}{{{{{\\rm{m}}}}}}1$$\\end{document}</tex-math><mml:math id=\"M2\"><mml:mi mathvariant=\"normal\">P</mml:mi><mml:mover accent=\"true\"><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:mo>¯</mml:mo></mml:mover><mml:mi mathvariant=\"normal\">m</mml:mi><mml:mn>1</mml:mn></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq2\"><alternatives><tex-math id=\"M3\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{{{{\\rm{R}}}}}}\\bar{3}{{{{{\\rm{m}}}}}}$$\\end{document}</tex-math><mml:math id=\"M4\"><mml:mi mathvariant=\"normal\">R</mml:mi><mml:mover accent=\"true\"><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:mo>¯</mml:mo></mml:mover><mml:mi mathvariant=\"normal\">m</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq3\"><alternatives><tex-math id=\"M5\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{{{{\\rm{P}}}}}}\\bar{3}{{{{{\\rm{m}}}}}}1$$\\end{document}</tex-math><mml:math id=\"M6\"><mml:mi mathvariant=\"normal\">P</mml:mi><mml:mover accent=\"true\"><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:mo>¯</mml:mo></mml:mover><mml:mi mathvariant=\"normal\">m</mml:mi><mml:mn>1</mml:mn></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq4\"><alternatives><tex-math id=\"M7\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{{{{\\rm{P}}}}}}\\bar{3}{{{{{\\rm{m}}}}}}1$$\\end{document}</tex-math><mml:math id=\"M8\"><mml:mi mathvariant=\"normal\">P</mml:mi><mml:mover accent=\"true\"><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:mo>¯</mml:mo></mml:mover><mml:mi mathvariant=\"normal\">m</mml:mi><mml:mn>1</mml:mn></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq5\"><alternatives><tex-math id=\"M9\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{{{{\\rm{P}}}}}}\\bar{3}{{{{{\\rm{m}}}}}}1$$\\end{document}</tex-math><mml:math id=\"M10\"><mml:mi mathvariant=\"normal\">P</mml:mi><mml:mover accent=\"true\"><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:mo>¯</mml:mo></mml:mover><mml:mi mathvariant=\"normal\">m</mml:mi><mml:mn>1</mml:mn></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq6\"><alternatives><tex-math id=\"M11\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${{{{{\\rm{R}}}}}}\\bar{3}{{{{{\\rm{m}}}}}}$$\\end{document}</tex-math><mml:math id=\"M12\"><mml:mi mathvariant=\"normal\">R</mml:mi><mml:mover accent=\"true\"><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:mo>¯</mml:mo></mml:mover><mml:mi mathvariant=\"normal\">m</mml:mi></mml:math></alternatives></inline-formula>", "<inline-formula id=\"IEq7\"><alternatives><tex-math id=\"M13\">\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$({{{{{\\rm{R}}}}}}\\bar{3}{{{{{\\rm{m}}}}}})$$\\end{document}</tex-math><mml:math id=\"M14\"><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant=\"normal\">R</mml:mi><mml:mover accent=\"true\"><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:mo>¯</mml:mo></mml:mover><mml:mi mathvariant=\"normal\">m</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>" ]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>", "<supplementary-material content-type=\"local-data\" id=\"MOESM2\"></supplementary-material>" ]
[ "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41467_2023_44495_Fig1_HTML\" id=\"d32e457\"/>", "<graphic xlink:href=\"41467_2023_44495_Fig2_HTML\" id=\"d32e639\"/>", "<inline-graphic xlink:href=\"41467_2023_44495_Article_IEq1.gif\"/>", "<graphic xlink:href=\"41467_2023_44495_Fig3_HTML\" id=\"d32e914\"/>", "<graphic xlink:href=\"41467_2023_44495_Fig4_HTML\" id=\"d32e994\"/>", "<inline-graphic xlink:href=\"41467_2023_44495_Article_IEq2.gif\"/>", "<inline-graphic xlink:href=\"41467_2023_44495_Article_IEq3.gif\"/>", "<inline-graphic xlink:href=\"41467_2023_44495_Article_IEq4.gif\"/>", "<graphic xlink:href=\"41467_2023_44495_Fig5_HTML\" id=\"d32e1330\"/>", "<graphic xlink:href=\"41467_2023_44495_Fig6_HTML\" id=\"d32e1623\"/>", "<inline-graphic xlink:href=\"41467_2023_44495_Article_IEq5.gif\"/>", "<graphic xlink:href=\"41467_2023_44495_Fig7_HTML\" id=\"d32e1792\"/>", "<inline-graphic xlink:href=\"41467_2023_44495_Article_IEq6.gif\"/>", "<graphic xlink:href=\"41467_2023_44495_Fig8_HTML\" id=\"d32e1905\"/>", "<inline-graphic xlink:href=\"41467_2023_44495_Article_IEq7.gif\"/>", "<graphic xlink:href=\"41467_2023_44495_Fig9_HTML\" id=\"d32e2031\"/>", "<graphic xlink:href=\"41467_2023_44495_Fig10_HTML\" id=\"d32e2176\"/>" ]
[ "<media xlink:href=\"41467_2023_44495_MOESM1_ESM.pdf\"><caption><p>Supplementary Information</p></caption></media>", "<media xlink:href=\"41467_2023_44495_MOESM2_ESM.pdf\"><caption><p>Peer Review File</p></caption></media>" ]
[{"label": ["1."], "surname": ["Ryu", "Sun", "Myung", "Yoon", "Sun"], "given-names": ["H-H", "HH", "S-T", "CS", "Y-K"], "article-title": ["Reducing cobalt from lithium-ion batteries for the electric vehicle era"], "source": ["Energy Environ. Sci."], "year": ["2021"], "volume": ["14"], "fpage": ["844"], "lpage": ["852"], "pub-id": ["10.1039/D0EE03581E"]}, {"label": ["2."], "surname": ["Duffner"], "given-names": ["F"], "article-title": ["Post-lithium-ion battery cell production and its compatibility with lithium-ion cell production infrastructure"], "source": ["Nat. Energy"], "year": ["2021"], "volume": ["6"], "fpage": ["123"], "lpage": ["134"], "pub-id": ["10.1038/s41560-020-00748-8"]}, {"label": ["3."], "surname": ["Schmuch", "Wagner", "H\u00f6rpel", "Placke", "Winter"], "given-names": ["R", "R", "G", "T", "M"], "article-title": ["Performance and cost of materials for lithium-based rechargeable automotive batteries"], "source": ["Nat. Energy"], "year": ["2018"], "volume": ["3"], "fpage": ["267"], "lpage": ["278"], "pub-id": ["10.1038/s41560-018-0107-2"]}, {"label": ["4."], "surname": ["Liang", "Dong", "Aurbach", "Yao"], "given-names": ["Y", "H", "D", "Y"], "article-title": ["Current status and future directions of multivalent metal-ion batteries"], "source": ["Nat. Energy"], "year": ["2020"], "volume": ["5"], "fpage": ["646"], "lpage": ["656"], "pub-id": ["10.1038/s41560-020-0655-0"]}, {"label": ["5."], "mixed-citation": ["Monti, D. et al. Multivalent Batteries\u2014Prospects for High Energy Density: Ca Batteries. "], "italic": ["Front. Chem."], "bold": ["7"]}, {"label": ["6."], "surname": ["Tobishima", "Takei", "Sakurai", "Yamaki"], "given-names": ["S-I", "K", "Y", "J-I"], "article-title": ["Lithium ion cell safety"], "source": ["J. Power Sources"], "year": ["2000"], "volume": ["90"], "fpage": ["188"], "lpage": ["195"], "pub-id": ["10.1016/S0378-7753(00)00409-2"]}, {"label": ["7."], "surname": ["Nykvist", "Nilsson"], "given-names": ["B", "M"], "article-title": ["Rapidly falling costs of battery packs for electric vehicles"], "source": ["Nat. Clim. Change"], "year": ["2015"], "volume": ["5"], "fpage": ["329"], "lpage": ["332"], "pub-id": ["10.1038/nclimate2564"]}, {"label": ["8."], "surname": ["Tsujikawa", "Yabuta", "Arakawa", "Hayashi"], "given-names": ["T", "K", "M", "K"], "article-title": ["Safety of large-capacity lithium-ion battery and evaluation of battery system for telecommunications"], "source": ["J. Power Sources"], "year": ["2013"], "volume": ["244"], "fpage": ["11"], "lpage": ["16"], "pub-id": ["10.1016/j.jpowsour.2013.01.155"]}, {"label": ["9."], "surname": ["Armand"], "given-names": ["M"], "article-title": ["Lithium-ion batteries \u2013 Current state of the art and anticipated developments"], "source": ["J. Power Sources"], "year": ["2020"], "volume": ["479"], "fpage": ["228708"], "pub-id": ["10.1016/j.jpowsour.2020.228708"]}, {"label": ["10."], "surname": ["Zhao-Karger"], "given-names": ["Z"], "article-title": ["Toward Highly Reversible Magnesium\u2013Sulfur Batteries with Efficient and Practical Mg[B(hfip)4]2 Electrolyte"], "source": ["ACS Energy Lett."], "year": ["2018"], "volume": ["3"], "fpage": ["2005"], "lpage": ["2013"], "pub-id": ["10.1021/acsenergylett.8b01061"]}, {"label": ["11."], "surname": ["Pan"], "given-names": ["B"], "article-title": ["Polyanthraquinone-Based Organic Cathode for High-Performance Rechargeable Magnesium-Ion Batteries"], "source": ["Adv. Energy Mater."], "year": ["2016"], "volume": ["6"], "fpage": ["1600140"], "pub-id": ["10.1002/aenm.201600140"]}, {"label": ["12."], "surname": ["Xiu"], "given-names": ["Y"], "article-title": ["Combining Quinone-Based Cathode with an Efficient Borate Electrolyte for High-Performance Magnesium Batteries"], "source": ["Batteries Supercaps"], "year": ["2021"], "volume": ["4"], "fpage": ["1850"], "lpage": ["1857"], "pub-id": ["10.1002/batt.202100163"]}, {"label": ["13."], "surname": ["Aurbach", "Cohen", "Moshkovich"], "given-names": ["D", "Y", "M"], "article-title": ["The study of reversible magnesium deposition by in situ scanning tunneling microscopy"], "source": ["Electrochem. Solid-State Lett."], "year": ["2001"], "volume": ["4"], "fpage": ["A113"], "pub-id": ["10.1149/1.1379828"]}, {"label": ["15."], "surname": ["Mohtadi", "Tutusaus", "Arthur", "Zhao-Karger", "Fichtner"], "given-names": ["R", "O", "TS", "Z", "M"], "article-title": ["The metamorphosis of rechargeable magnesium batteries"], "source": ["Joule"], "year": ["2021"], "volume": ["5"], "fpage": ["581"], "lpage": ["617"], "pub-id": ["10.1016/j.joule.2020.12.021"]}, {"label": ["16."], "surname": ["Yoo"], "given-names": ["HD"], "article-title": ["Mg rechargeable batteries: an on-going challenge"], "source": ["Energy Environ. Sci."], "year": ["2013"], "volume": ["6"], "fpage": ["2265"], "lpage": ["2279"], "pub-id": ["10.1039/c3ee40871j"]}, {"label": ["17."], "surname": ["Levi", "Gofer", "Aurbach"], "given-names": ["E", "Y", "D"], "article-title": ["On the Way to Rechargeable Mg Batteries: The Challenge of New Cathode Materials"], "source": ["Chem. Mater."], "year": ["2010"], "volume": ["22"], "fpage": ["860"], "lpage": ["868"], "pub-id": ["10.1021/cm9016497"]}, {"label": ["21."], "surname": ["Li", "Ichitsubo", "Yagi", "Matsubara"], "given-names": ["H", "T", "S", "E"], "article-title": ["Constructing metal-anode rechargeable batteries utilizing concomitant intercalation of Li\u2013Mg dual cations into Mo6S8"], "source": ["J. Mater. Chem. A"], "year": ["2017"], "volume": ["5"], "fpage": ["3534"], "lpage": ["3540"], "pub-id": ["10.1039/C6TA10663C"]}, {"label": ["22."], "surname": ["Li"], "given-names": ["H"], "article-title": ["Fast Diffusion of Multivalent Ions Facilitated by Concerted Interactions in Dual-Ion Battery Systems"], "source": ["Adv. Energy Mater."], "year": ["2018"], "volume": ["8"], "fpage": ["1801475"], "pub-id": ["10.1002/aenm.201801475"]}, {"label": ["24."], "surname": ["Sun", "Bonnick", "Nazar"], "given-names": ["X", "P", "LF"], "article-title": ["Layered TiS2 Positive Electrode for Mg Batteries"], "source": ["ACS Energy Lett."], "year": ["2016"], "volume": ["1"], "fpage": ["297"], "lpage": ["301"], "pub-id": ["10.1021/acsenergylett.6b00145"]}, {"label": ["26."], "surname": ["Roy"], "given-names": ["A"], "article-title": ["Investigation of the Anode-Electrolyte Interface in a Magnesium Full-Cell with Fluorinated Alkoxyborate-Based Electrolyte"], "source": ["Batteries Supercaps"], "year": ["2022"], "volume": ["5"], "fpage": ["e202100305"], "pub-id": ["10.1002/batt.202100305"]}, {"label": ["27."], "surname": ["Ichitsubo"], "given-names": ["T"], "article-title": ["A new aspect of Chevrel compounds as positive electrodes for magnesium batteries"], "source": ["J. Mater. Chem. A"], "year": ["2014"], "volume": ["2"], "fpage": ["14858"], "lpage": ["14866"], "pub-id": ["10.1039/C4TA03063J"]}, {"label": ["28."], "surname": ["Li", "Zheng", "Guo", "Zhao", "Li"], "given-names": ["Y", "Y", "K", "J", "C"], "article-title": ["Mg-Li Hybrid Batteries: The Combination of Fast Kinetics and Reduced Overpotential"], "source": ["Energy Mater. Adv."], "year": ["2022"], "volume": ["2022"], "fpage": ["9840837"], "pub-id": ["10.34133/2022/9840837"]}, {"label": ["29."], "surname": ["Bian"], "given-names": ["X"], "article-title": ["A long cycle-life and high safety Na+/Mg2+ hybrid-ion battery built by using a TiS2 derived titanium sulfide cathode"], "source": ["J. Mater. Chem. A"], "year": ["2017"], "volume": ["5"], "fpage": ["600"], "lpage": ["608"], "pub-id": ["10.1039/C6TA08505A"]}, {"label": ["30."], "surname": ["Park", "Kim", "Lim", "Cho", "Kang"], "given-names": ["J", "SJ", "K", "J", "K"], "article-title": ["Reconfiguring Sodium Intercalation Process of TiS2 Electrode for Sodium-Ion Batteries by a Partial Solvent Cointercalation"], "source": ["ACS Energy Lett."], "year": ["2022"], "volume": ["7"], "fpage": ["3718"], "lpage": ["3726"], "pub-id": ["10.1021/acsenergylett.2c01838"]}, {"label": ["31."], "surname": ["Lin"], "given-names": ["C-H"], "article-title": ["Operando structural and chemical evolutions of TiS2 in Na-ion batteries"], "source": ["J. Mater. Chem. A"], "year": ["2020"], "volume": ["8"], "fpage": ["12339"], "lpage": ["12350"], "pub-id": ["10.1039/D0TA00226G"]}, {"label": ["32."], "surname": ["Tchitchekova"], "given-names": ["DS"], "article-title": ["Electrochemical Intercalation of Calcium and Magnesium in TiS2: Fundamental Studies Related to Multivalent Battery Applications"], "source": ["Chem. Mat."], "year": ["2018"], "volume": ["30"], "fpage": ["847"], "lpage": ["856"], "pub-id": ["10.1021/acs.chemmater.7b04406"]}, {"label": ["34."], "surname": ["Radin", "Van der Ven"], "given-names": ["MD", "A"], "article-title": ["Stability of Prismatic and Octahedral Coordination in Layered Oxides and Sulfides Intercalated with Alkali and Alkaline-Earth Metals"], "source": ["Chem. Mat."], "year": ["2016"], "volume": ["28"], "fpage": ["7898"], "lpage": ["7904"], "pub-id": ["10.1021/acs.chemmater.6b03454"]}, {"label": ["36."], "surname": ["Du\u017cy\u0144ska"], "given-names": ["A"], "article-title": ["Temperature-induced phonon behavior in titanium disulfide (TiS2) nanosheets"], "source": ["J. Raman Spectrosc."], "year": ["2019"], "volume": ["50"], "fpage": ["1114"], "lpage": ["1119"], "pub-id": ["10.1002/jrs.5637"]}, {"label": ["37."], "surname": ["Chen"], "given-names": ["K"], "article-title": ["Defects controlled doping and electrical transport in TiS2 single crystals"], "source": ["Appl. Phys. Lett."], "year": ["2020"], "volume": ["116"], "fpage": ["121901"], "pub-id": ["10.1063/5.0005170"]}, {"label": ["39."], "surname": ["Dolui", "Sanvito"], "given-names": ["K", "S"], "article-title": ["Dimensionality-driven phonon softening and incipient charge density wave instability in TiS2"], "source": ["Europhys. Lett."], "year": ["2016"], "volume": ["115"], "fpage": ["47001"], "pub-id": ["10.1209/0295-5075/115/47001"]}, {"label": ["41."], "surname": ["Wieting", "Verble"], "given-names": ["TJ", "JL"], "article-title": ["Interlayer Bonding and the Lattice Vibrations of $\\ensuremath{\\beta}$-GaSe"], "source": ["Phys. Rev. B"], "year": ["1972"], "volume": ["5"], "fpage": ["1473"], "lpage": ["1479"], "pub-id": ["10.1103/PhysRevB.5.1473"]}, {"label": ["42."], "surname": ["Kolli", "Van der Ven"], "given-names": ["SK", "A"], "article-title": ["First-Principles Study of Spinel MgTiS2 as a Cathode Material"], "source": ["Chem. Mater."], "year": ["2018"], "volume": ["30"], "fpage": ["2436"], "lpage": ["2442"], "pub-id": ["10.1021/acs.chemmater.8b00552"]}, {"label": ["43."], "surname": ["Sun"], "given-names": ["X"], "article-title": ["A high capacity thiospinel cathode for Mg batteries"], "source": ["Energy Environ. Sci."], "year": ["2016"], "volume": ["9"], "fpage": ["2273"], "lpage": ["2277"], "pub-id": ["10.1039/C6EE00724D"]}, {"label": ["45."], "surname": ["Wang"], "given-names": ["CM"], "article-title": ["Crystal and electronic structure of lithiated nanosized rutile TiO2 by electron diffraction and electron energy-loss spectroscopy"], "source": ["Appl. Phys. Lett."], "year": ["2009"], "volume": ["94"], "fpage": ["233116"], "pub-id": ["10.1063/1.3152783"]}, {"label": ["46."], "surname": ["Masato", "Isao", "Kenji", "Hirohiko"], "given-names": ["Y", "T", "K", "A"], "article-title": ["First principles calculation of chemical shifts in ELNES/NEXAFS of titanium oxides"], "source": ["J. Phys.: Condens. Matter"], "year": ["1999"], "volume": ["11"], "fpage": ["3217"]}, {"label": ["47."], "surname": ["Weng", "Fisher", "Skowronski", "Salvador", "Maksimov"], "given-names": ["X", "P", "M", "PA", "O"], "article-title": ["Structural characterization of TiO2 films grown on LaAlO3 and SrTiO3 substrates using reactive molecular beam epitaxy"], "source": ["J. Cryst. Growth"], "year": ["2008"], "volume": ["310"], "fpage": ["545"], "lpage": ["550"], "pub-id": ["10.1016/j.jcrysgro.2007.10.084"]}, {"label": ["48."], "surname": ["Mitterbauer", "Kothleitner", "Hofer"], "given-names": ["C", "G", "F"], "article-title": ["Comparative Electron Energy-Loss Near-Edge Fine Structure Investigations Of Titanium Oxides"], "source": ["Microsc. Microanalysis"], "year": ["2003"], "volume": ["9"], "fpage": ["834"], "lpage": ["835"], "pub-id": ["10.1017/S1431927603444176"]}, {"label": ["49."], "mixed-citation": ["Krukau, A. V., Vydrov, O. A., Izmaylov, A. F. & Scuseria, G. E. Influence of the exchange screening parameter on the performance of screened hybrid functionals. "], "italic": ["J. Chem. Phys."], "bold": ["125"]}, {"label": ["50."], "surname": ["Gao"], "given-names": ["T"], "article-title": ["Hybrid Mg2+/Li+ Battery with Long Cycle Life and High Rate Capability"], "source": ["Adv. Energy Mater."], "year": ["2015"], "volume": ["5"], "fpage": ["1401507"], "pub-id": ["10.1002/aenm.201401507"]}, {"label": ["51."], "surname": ["Yagi"], "given-names": ["S"], "article-title": ["A concept of dual-salt polyvalent-metal storage battery"], "source": ["J. Mater. Chem. A"], "year": ["2014"], "volume": ["2"], "fpage": ["1144"], "lpage": ["1149"], "pub-id": ["10.1039/C3TA13668J"]}, {"label": ["52."], "surname": ["Zhao-Karger", "Gil Bardaji", "Fuhr", "Fichtner"], "given-names": ["Z", "ME", "O", "M"], "article-title": ["A new class of non-corrosive, highly efficient electrolytes for rechargeable magnesium batteries"], "source": ["J. Mater. Chem. A"], "year": ["2017"], "volume": ["5"], "fpage": ["10815"], "lpage": ["10820"], "pub-id": ["10.1039/C7TA02237A"]}, {"label": ["54."], "surname": ["Nov\u00e1k", "Desilvestro"], "given-names": ["P", "J"], "article-title": ["Electrochemical Insertion of Magnesium in Metal Oxides and Sulfides from Aprotic Electrolytes"], "source": ["J. Electrochem. Soc."], "year": ["1993"], "volume": ["140"], "fpage": ["140"], "pub-id": ["10.1149/1.2056075"]}, {"label": ["58."], "surname": ["Euchner", "Gro\u00df"], "given-names": ["H", "A"], "article-title": ["Atomistic modeling of Li- and post-Li-ion batteries"], "source": ["Phys. Rev. Mater."], "year": ["2022"], "volume": ["6"], "fpage": ["040302"], "pub-id": ["10.1103/PhysRevMaterials.6.040302"]}, {"label": ["59."], "surname": ["Kresse", "Joubert"], "given-names": ["G", "D"], "article-title": ["From ultrasoft pseudopotentials to the projector augmented-wave method"], "source": ["Phys. Rev. B"], "year": ["1999"], "volume": ["59"], "fpage": ["1758"], "lpage": ["1775"], "pub-id": ["10.1103/PhysRevB.59.1758"]}, {"label": ["60."], "surname": ["Bl\u00f6chl"], "given-names": ["PE"], "article-title": ["Projector augmented-wave method"], "source": ["Phys. Rev. B"], "year": ["1994"], "volume": ["50"], "fpage": ["17953"], "lpage": ["17979"], "pub-id": ["10.1103/PhysRevB.50.17953"]}, {"label": ["61."], "surname": ["Kresse", "Furthm\u00fcller"], "given-names": ["G", "J"], "article-title": ["Efficient iterative schemes for ab initio total-energy calculations using a plane-wave basis set"], "source": ["Phys. Rev. B"], "year": ["1996"], "volume": ["54"], "fpage": ["11169"], "lpage": ["11186"], "pub-id": ["10.1103/PhysRevB.54.11169"]}, {"label": ["63."], "surname": ["Monkhorst", "Pack"], "given-names": ["HJ", "JD"], "article-title": ["Special points for Brillouin-zone integrations"], "source": ["Phys. Rev. B"], "year": ["1976"], "volume": ["13"], "fpage": ["5188"], "lpage": ["5192"], "pub-id": ["10.1103/PhysRevB.13.5188"]}, {"label": ["64."], "surname": ["Henkelman", "J\u00f3nsson"], "given-names": ["G", "H"], "article-title": ["Improved tangent estimate in the nudged elastic band method for finding minimum energy paths and saddle points"], "source": ["J. Chem. Phys."], "year": ["2000"], "volume": ["113"], "fpage": ["9978"], "lpage": ["9985"], "pub-id": ["10.1063/1.1323224"]}, {"label": ["65."], "surname": ["Henkelman", "Uberuaga", "J\u00f3nsson"], "given-names": ["G", "BP", "H"], "article-title": ["A climbing image nudged elastic band method for finding saddle points and minimum energy paths"], "source": ["J. Chem. Phys."], "year": ["2000"], "volume": ["113"], "fpage": ["9901"], "lpage": ["9904"], "pub-id": ["10.1063/1.1329672"]}, {"label": ["66."], "surname": ["Jain"], "given-names": ["A"], "article-title": ["Commentary: The Materials Project: A materials genome approach to accelerating materials innovation"], "source": ["APL Mater."], "year": ["2013"], "volume": ["1"], "fpage": ["011002"], "pub-id": ["10.1063/1.4812323"]}]
{ "acronym": [], "definition": [] }
66
CC BY
no
2024-01-14 23:40:18
Nat Commun. 2024 Jan 12; 15:492
oa_package/e9/d2/PMC10786895.tar.gz
PMC10786896
38216580
[ "<title>Background &amp; Summary</title>", "<p id=\"Par2\">In arid regions of North America, middens created by packrats (<italic>Neotoma</italic> spp.; also referred to as wood rats or trade rats) are an important source of paleobotanical information. Packrats collect plant debris and other material, typically from within a 50 m radius of their den sites, which are commonly located in caves and rockshelters<sup>##UREF##0##1##</sup>. The animals build middens near their dens by combining the collected materials with their fecal pellets and viscous urine and then compacting the mixture into voids and rock crevices. Over time, urine-cemented middens crystallize into solid masses preserving the plant remains inside. If middens are protected from weather, especially moisture, they may persist for tens of thousands of years after deposition<sup>##UREF##1##2##–##UREF##3##4##</sup>. Plant macrofossils (e.g., leaves, twigs, fruits, seeds) preserved in packrat middens often can be identified to the species level, providing inventories of plant communities found near a midden site in the past, although these inventories are biased by packrat foraging ranges and dietary preferences<sup>##UREF##4##5##</sup>. When radiocarbon dated, midden assemblages of various ages from multiple sites provide records of the spatial and temporal patterns of paleovegetation change over late Pleistocene and Holocene time periods<sup>##UREF##1##2##,##UREF##5##6##–##UREF##6##8##</sup>. In addition to providing records of vegetation change, packrat midden data have also been used for paleoclimate reconstructions<sup>##UREF##7##9##</sup>, for paleogenomic studies<sup>##REF##32184999##10##</sup>, as a source of ancient DNA for investigating virus evolution<sup>##REF##29977605##11##</sup>, to examine linkages between vegetation change and fluvial-system aggradation<sup>##UREF##8##12##</sup>, and for species-distribution modeling<sup>##UREF##9##13##</sup>.</p>", "<p id=\"Par3\">One of the challenges in using paleobotanical midden data to investigate broad-scale patterns of climate and vegetation change is that a variety of different methods have been used to analyze plant macrofossil assemblages from middens and to classify the taxa they contain, making it difficult to compare and synthesize midden data. To address this issue, the U.S. Geological Survey (USGS) North American Packrat Midden Database was developed to provide researchers with access to standardized midden-derived paleobotanical data for investigating late Pleistocene and Holocene changes in plant species distributions in response to climate and environmental change. With support from the USGS and the National Oceanic and Atmospheric Administration (NOAA), the first online version of the midden database was released in 1998. In 2001, a data dictionary describing the structure of the 1998 database was published<sup>##UREF##10##14##</sup>, followed by an update to the online database in 2002. Version 3.0 of the database was released in 2006 and version 4.0 in 2016 with 3,205 packrat midden samples<sup>##UREF##11##15##</sup>. A timeline of database version releases, related publications, and conference presentations with abstracts are listed in Table ##TAB##0##1##.</p>", "<p id=\"Par4\">Here we describe version 5.0 of the USGS North American Packrat Midden Database with data available at 10.5066/P91UOARW<sup>##UREF##12##16##</sup>, including the methods used to compile the database and a description of the tables and variables included in the database. Version 5.0 contains original data from 3,331 packrat midden samples collected from permanently dry settings in caves and rock shelters in southwest Canada, the western United States, and northern Mexico (Fig. ##FIG##0##1##). Data, including location information, midden-sample ages, plant macrofossil taxon lists (from 2,336 midden samples), and taxon counts or relative-abundance data, were collected from published sources (e.g., journal articles, book chapters, theses, dissertations, government and private industry reports, and conference proceedings). Additional unpublished data were graciously contributed by researchers. The data were entered into a Microsoft Access relational database exactly as they were published or contributed without changing their original form unless noted. Taxon relative-abundance and count data were entered into the database with the intent to preserve the original sample count format. However, to facilitate the comparison and use of plant-macrofossil relative-abundance data from multiple sources, which are often published in a variety of formats, all relative-abundance and count data were also interpreted and translated into a simplified uniform-relative-abundance scheme. Compared to version 4.0, version 5.0 of the midden database has been expanded to include more precise midden-sample location data, calibration and evaluation of midden-sample age data, and assignment of plant functional types (PFTs) for the taxa in each midden sample. We have also assigned midden-sample sites to World Wildlife Fund (WWF) ecoregions and major habitat types (MHTs)<sup>##UREF##13##17##</sup> and interpolated modern climate and bioclimate data<sup>##UREF##14##18##,##UREF##15##19##</sup> to each midden-sample site location.</p>", "<p id=\"Par5\">The USGS North American Packrat Midden Database (version 5.0) consists of 20 data tables arranged in a hierarchical fashion (listed in Tables ##TAB##1##2##–##TAB##3##4##)<sup>##UREF##12##16##</sup>. We refer to these data tables in the following text as “Linked” tables, “Unlinked” tables, and “Lookup” tables to distinguish them from the numbered tables in this paper (i.e., Tables ##TAB##0##1##–##TAB##26##27##). There are 10 Linked data tables in the Access relational database (see Table ##TAB##1##2##). Figure ##FIG##1##2## displays the fields in each Linked data table and illustrates the relationships among the fields (these relationships may also be viewed within the relational database). Four Unlinked data tables (see Table ##TAB##2##3##) provide lists of: (1) synonymous taxon names (Unlinked Table 1) appearing in the Linked Table 4 MIDDEN TAXA table, (2) publications that contain midden-related information but did not contain midden-sample data suitable for inclusion in the database (Unlinked Table 2), (3) published abstracts related to packrat middens that did not contribute data to the database (Unlinked Table 3), (4) midden publications discussing middens located outside of North America that did not contribute data to the database (Unlinked Table 4). Six additional tables function as Lookup tables (see Table ##TAB##3##4##) which define: (1) use status codes indicating the completeness of the data provided for each midden sample (Lookup Table 1), (2) the 0-1-2 presence-absence relative-abundance codes (Lookup Table 2), (3) recommended age codes (Lookup Table 3), (4) taxon list codes (Lookup Table 4), (5) ecoregion codes (Lookup Table 5), and (6) PFT codes (Lookup Table 6).</p>" ]
[ "<title>Methods</title>", "<p id=\"Par6\">Below we describe the methods (adapted and updated from Strickland <italic>et al</italic>.<sup>##UREF##10##14##</sup>) used to create the data in each of the midden database tables. To the extent possible, we recorded midden data exactly as they were presented in their original source publications. However, in many cases we supplemented the published data with improved geographic location data and updated taxonomic classifications. In this version of the midden database (version 5.0), we have also calibrated the radiocarbon sample age data, added PFT data for midden taxa, and added ecoregion, climate, and bioclimate data for the midden sites.</p>", "<p id=\"Par7\">Not all midden samples in the midden database have complete data. Table fields that contain “99999” values indicate that published data were not available or that we were unable to generate the appropriate information (e.g., sample sites without location data could not be assigned to an ecoregion). Blank table cells may indicate that published data were not available (e.g., missing location data) or blank cells may appear in unused fields such as notes or comments fields, fields with flags, and secondary data fields. The abbreviation “n/a” (i.e., not applicable) was used when a field was not applicable to the record represented by the table cell.</p>", "<title>Linked Tables 1–10</title>", "<p id=\"Par8\">The 10 Linked data tables contain the midden macrofossil data fields displayed in Fig. ##FIG##1##2##. These data tables were used to create the relational database.</p>", "<title>Linked Table 1: REFERENCE</title>", "<p id=\"Par9\">The REFERENCE table lists the 336 published sources, including journal articles, book chapters, theses, dissertations, government and private industry reports, and conference proceedings, containing midden data that have been entered into the midden database. Each source publication is represented by a unique reference number (REFNUM). Various data elements in the midden database, such as midden ages, location data, and taxon lists, are tied to source publications using REFNUMs. The midden database also contains unpublished data that were contributed by various researchers. Sometimes a midden sample had data available from a published source, and additional contributed but unpublished data were added to the sample record in the MIDDEN SAMPLE table (Linked Table 2) or the AGEC14 table (Linked Table 3). Some data are from unpublished sources only, or data related to a particular sample are known to exist, but they are not published, and permission has not been granted to include these data in this database. All unpublished data sources are represented in the MIDDEN SAMPLE table (Linked Table 2) and AGEC14 table (Linked Table 3) source reference fields by the last name of the investigator(s) followed by “unpublished”. Further information about existing unpublished data not included in this database may be available from the noted investigator. Full references for all published data sources can be found in the FULL_REFERENCE field. The REFERENCE table consists of the four fields listed in Table ##TAB##4##5##.</p>", "<title>Linked Table 2: MIDDEN SAMPLE</title>", "<p id=\"Par10\">The MIDDEN SAMPLE table provides location information for 3,331 midden samples and contains 109 different fields (Table ##TAB##5##6##). Each midden sample is identified by a unique sample code (SAMCODE). Midden-sample site location information, including latitude, longitude, elevation (m), state or province, county or regional district, country, and general locality description (e.g., was the site located in a particular mountain range or stream valley), was recorded directly from the written reports describing the midden-sample locations. For some midden-sample sites, latitude and longitude, elevation, and general locality information were interpreted from site maps included in the written reports describing the midden samples or were estimated from topographic maps and these data are labelled as estimates in the source fields.</p>", "<p id=\"Par11\">In some cases, there may be multiple reference sources containing details about a specific midden sample. The REFERENCE1 field almost always lists the primary published source for information about a particular midden sample. The primary source is typically the earliest publication of the midden data, which usually includes the plant macrofossil taxon list. If a taxon list is available for a midden, its source publication is assigned as REFERENCE1, and thus REFERENCE1 is always the source of the taxon list. Additional sources of new or republished information for a midden are listed as additional references in the fields REFERENCE2 to REFERENCE17. References are followed by their corresponding REFNUMs found in the fields REFNUM1 to REFNUM17. REFNUMs are defined in the REFERENCE table (Linked Table 1) where complete references are provided. Sometimes macrofossil taxon lists have been published multiple times in different sources. In these instances, we compared subsequent taxon lists and noted in the COMMENTS field any unexplained discrepancies or corrections made to the original list by the author(s). If identifications, taxonomic names, and/or quantifications changed in subsequent publications, the original published macrofossil data from REFERENCE1 were edited to reflect these changes.</p>", "<p id=\"Par12\">There are 2,336 midden samples (approximately two-thirds of the samples) that have associated taxon lists in the midden database. A symbol in the MIDDEN SAMPLE table’s TAXON_LIST_CODE field indicates when a taxon list is available for the midden sample. These symbols are defined in the TAXON LIST CODE table (Lookup Table 4). The symbol “C” indicates that a complete published taxon list is available, and the symbol “P” indicates that only a partial taxon list is published and available. Sometimes midden analysts were looking for the presence of particular plant taxa, and only those taxa were reported. When a complete taxon list is published, we assume that all taxa in the midden sample were reported. The symbol “CU” indicates that a complete but unpublished taxon list exists, and the symbol “PU” indicates that a partial but unpublished taxon list exists, however these unpublished taxon lists are not included in the database because the author has not given permission to release these data. The TAXON_LIST_SOURCE field provides the REFNUM of the primary taxon list source publication and multiple sources may be listed if a taxon list has been updated in a subsequent publication.</p>", "<p id=\"Par13\">Most midden studies carried out prior to 2000 CE provided midden-site location coordinates as degrees, minutes, and seconds of latitude and longitude. More recent studies use the Global Positioning System (GPS) for locating sites, and site coordinates are commonly published using decimal degrees or UTM (Universal Transverse Mercator) coordinates. We record all midden locations by their original published latitude and longitude coordinates, which may be recorded as degrees, minutes, and seconds, decimal degrees, or both. Midden-sample location latitudes and longitudes reported only in decimal degrees were converted to degrees, minutes, and seconds in order to populate latitude and longitude set 1 fields [i.e., LATDEG(1), LATMIN(1), LATSEC(1), LONGDEG(1), LONGMIN(1), LONGSEC(1)]. All midden-sample locations reported as degrees, minutes, and seconds from set 1 were converted to decimal degrees using TOPO! Software<sup>##UREF##16##20##–##UREF##18##22##</sup> and recorded in the latitude and longitude decimal degree fields (LATDECDEGCON, LONGDECDEGCON). A midden’s location data, such as latitude and longitude coordinates and elevation values, may have been published in multiple sources. We recorded every occurrence of each location data element that we found in the scientific literature along with the corresponding publication source. Repeatedly published location data are not always consistent, and data values frequently change through time, sometimes because of improved knowledge or sometimes because of researcher errors. Recording all location data occurrences in the literature allows us to evaluate which data values are most consistent and therefore may be most reliable and accurate. Multiple fields can be found in the MIDDEN SAMPLE table showing up to five latitude and longitude coordinate value sets [e.g., LATDEG(1), LATMIN(1), LATSEC(1), LONGDEG(1), LONGMIN(1), LONGSEC(1) form one coordinate set] and up to five elevation values [e.g., ELEV(M)1], with their corresponding source publications [e.g., SOURCE(1) and SOURCE_EL(1)]. For latitude, longitude, and elevation, the first set of values (i.e., identified with a “1” in the variable name) are typically those that are published most frequently and consistently or are derived from the original publication describing the midden sample and we therefore consider these data most reliable. When multiple published location data exist for a sample, we suggest using the first set of latitude, longitude, and elevation values (i.e., those identified with a “1” in the variable name).</p>", "<p id=\"Par14\">Accurate location and elevation data are very important when conducting paleoenvironmental reconstructions and modeling exercises. Original published location data were not always precise, especially for locations described before the availability of GPS technology, which tended to have very general location data. In the MIDDEN SAMPLE table, we provide improved midden-location data for some samples based on original published coordinates, maps, and site descriptions. Improved location data (latitude, longitude, and elevation) were created by plotting the original published latitude and longitude coordinates using the geographic mapping software TOPO!<sup>##UREF##16##20##–##UREF##18##22##</sup>. The mapped midden locations were then compared to the published descriptions to assess whether the published coordinates accurately matched the published written description and/or location map. We checked each location for consistency, and in some cases, the plotted locations did not match the published description. When the coordinates significantly differed from detailed published accounts, we moved the point location within TOPO! to a new location that we considered an improved and better representation of the midden latitude, longitude, and elevation. Improved location estimates are represented in the “best location” (BEST_LATDEG, BEST_LATMIN, BEST_LATSEC, BEST_LONGDEG, BEST_LONGMIN, BEST_LONGSEC) and “best elevation” fields [BEST_ELEV(M)]. The BEST_SOURCE and BEST_LOCALITY_NOTES fields describe the resources used to improve the location estimate and the decisions made when altering the original location. When utilizing midden data for paleoecological reconstruction or modeling exercises, we recommend using these improved “best” location data instead of the original published location data. Note that if the sample site was considered a sensitive location at the time the site data were added to the database (e.g., Bechan Cave, Hoopers Hollow, Sandblast Cave) the location data were generalized (i.e., the latitude and longitude do not represent the exact site location) and this adjustment is noted in the MIDDEN SAMPLE table fields [e.g., LOCALITY_NOTES, BEST_LOCALITY_NOTES, SOURCE(1)] for the site.</p>", "<p id=\"Par15\">To assist database users, the USE_STATUS field contains a numeric code that describes the completeness of the age data and taxon list for each midden sample. A USE_STATUS value of 1 indicates that the age data and taxon list are complete for the midden sample. USE_STATUS codes not equal to 1 indicate that the age data and/or taxon list are not complete (see Table ##TAB##5##6## USE_STATUS code descriptions).</p>", "<title>Linked Table 3: AGEC14</title>", "<p id=\"Par16\">This table provides the radiocarbon (<sup>14</sup>C) ages for individual midden samples. It is linked to the MIDDEN SAMPLE table (Linked Table 2) by the sample code (SAMCODE) field. The radiocarbon age data include radiocarbon <sup>14</sup>C dates with standard deviations (s.d.), laboratory numbers, material dated, and calibrated radiocarbon ages. The AGEC14 table consists of the 19 fields listed in Table ##TAB##6##7##.</p>", "<p id=\"Par17\">Radiocarbon ages were calibrated using CALIB (rev. 7.0.4)<sup>##UREF##19##23##</sup> and the IntCal13.14c radiocarbon age calibration curve<sup>##UREF##20##24##</sup>, with the CALIB options for 2-sigma and Cal BP selected. This version of CALIB does not calibrate radiocarbon ages less than 71 <sup>14</sup>C years or greater than 46,401 <sup>14</sup>C years. Radiocarbon ages without reported standard deviations and infinite ages (for example, reported as greater than 30,000 years) were not calibrated. Infinite radiocarbon ages reported with a greater than sign (“&gt;”) cannot be entered as a numeric value into the AGEC14 field, therefore for infinite ages, we dropped the greater-than sign and added one year to the age (for example, an age of &gt;30,000 was input as 30,001), and an explanation of the change was added to the COMMENTS field. If a radiocarbon age is reported with a standard deviation where the positive value (“+”) is different from the negative value (“−”), we used the larger absolute value for the calibration. Middens reported or observed as modern but not dated are recorded in the database with a <sup>14</sup>C age of “0” and a standard deviation of “99999” and these ages were not calibrated. Middens with ages reported as post 1950 with percent modern carbon are recorded in the database as modern with a <sup>14</sup>C age of “0” and a standard deviation of “99999” and were not calibrated. Average ages created by investigators also were not calibrated. For radiocarbon ages that meet CALIB requirements, we used CALIB to generate the calendar year BP (before present) median probability, the absolute lower calendar age, the absolute upper calendar age, and the 95% (2-sigma) calendar age range. There are 2,859 midden samples for which we provide calibrated radiocarbon ages. The sample ages have a bimodal distribution, with large numbers of samples dated to the late Holocene and to the late Pleistocene (Fig. ##FIG##2##3##). Thompson <italic>et al</italic>.<sup>##UREF##21##25##</sup> discussed potential reasons that the midden calibrated ages might display this bimodal distribution, including paleoclimatic effects, differences in midden preservation over time, and preferential sampling of particular time periods by researchers. Note that CALIB (rev. 7.0.4)<sup>##UREF##19##23##</sup> used the IntCal13 curve for radiocarbon age calibration<sup>##UREF##20##24##</sup>. The more recent IntCal20 curve<sup>##UREF##22##26##</sup> may produce different calibrated ages, particularly during the late Pleistocene<sup>##UREF##23##27##</sup>, and database users interested in this time period may want to use the IntCal20 curve to calibrate the database’s radiocarbon ages. Differences in the calibration curves can be seen by visually comparing the curves (e.g., Fig. 4 in Reimer <italic>et al</italic>.<sup>##UREF##22##26##</sup>).</p>", "<p id=\"Par18\">In some cases, multiple subsamples from the same larger midden sample have been dated and such subsamples will have the same SAMCODE value in the AGEC14 table. If multiple ages on the same midden sample are within 2 standard deviations (2 sigma) of each other, we pooled the ages with CALIB. To calculate a single pooled age (PA), we used CALIB by first selecting from “Tools” and running: “Test Sample Significance”. If the results indicated that the samples were statistically the same at the 95% confidence level, we proceeded and created a pooled mean, by choosing: “Create Pooled Mean” and “Calibrate (GO)”. The output file “calout.csv” contained the pooled (averaged) <sup>14</sup>C year and calendar year age. There were some instances when multiple radiocarbon ages were within 2 standard deviations of each other, however CALIB determined that the samples were not statistically the same. In these cases, we calculated a pooled mean regardless of the fact that the samples failed CALIB’s significance test. We ran the create pooled mean/calibrate calculation as above, but we note when, according to CALIB, the samples were not statistically the same age, and the pooled age (PA) is labelled as “PA(FST)” where “FST” stands for “Failed Significance Test”.</p>", "<p id=\"Par19\">When multiple ages exist for a given midden sample, it may be confusing as to which age best represents the calendar age of the midden macrofossil assemblage. In the field called RECOMMENDED_AGE_OF_MIDDEN_ASSEMBLAGE we suggest a single age that best represents each sample/macrofossil assemblage by using a series of symbols [X, X1-PA, X1-PA(FST), X2]. When a midden sample has only a single age, that age is marked with an “X”, designating it as the recommended age of the midden. When multiple ages are listed and they are statistically the same, we recommend using a pooled age [PA or PA(FST)] as the primary preferred age to represent the sample/macrofossil assemblage. Pooled ages are designated with an “X1-PA” or “X1-PA(FST)” where “X1” indicates the primary preferred age. When multiple ages are present, instead of using a pooled age, a user may also choose one of the individual ages to represent the midden assemblage, such as an age on <italic>Neotoma</italic> spp. fecal pellets or an age on a specific plant taxon. We use the symbol “X2” to identify a secondary preferred age. When choosing a single age amongst multiple ages to represent an assemblage, rather than using a pooled age, the following rules apply: (1) when multiple uncalibrated radiocarbon age ranges overlap within 2 standard deviations, we recommend using the age with the smallest standard deviation and the corresponding calibrated age; (2) if the ages are reported as infinite, we recommend using the oldest age to represent the midden; (3) if the standard deviation is the same for multiple ages, we recommend using the oldest age; and (4) if one age is finite and one age is infinite, we recommend using the finite age. When recommending a preferred age to represent a midden assemblage, we provide justification for the decision within the RECOMMENDED_AGE_JUSTIFICATION field.</p>", "<p id=\"Par20\">When a midden has multiple ages and they are not within two standard deviations of each other, it is not possible to determine which age would best represent the midden assemblage. In this case, we use a “?” in the RECOMMENDED_AGE_OF_MIDDEN_ASSEMBLAGE field to indicate that the age of the assemblage is uncertain, and we are unable to assign a single age. We occasionally use “X?” to designate a recommended age, which indicates that there is some uncertainty about the age due to issues such as mixed assemblages or confusing changes in interpretation by the author, therefore midden assemblages with ages marked with “X?” should be used with caution.</p>", "<title>Linked Table 4: MIDDEN TAXA</title>", "<p id=\"Par21\">The MIDDEN TAXA table lists the 1,815 plant macrofossil taxa recorded from the midden samples. Each plant taxon in the MIDDEN TAXA table has a unique identifying variable number (VARNUM). The Latin botanical names for each taxon have generally been recorded in the VARNAME field in the same format as they were published by the midden macrofossil analysts. To maintain data consistency, because italics are not possible in .csv file formats, Latin genus and species names are not italicized in the database tables although use of italics is the correct style.</p>", "<p id=\"Par22\">If the nomenclature or syntax of the taxon name used by the midden analyst did not conform to the rules of this database, we modified the name to match the database rules if the modification did not alter the meaning or level of uncertainty of the taxon identification. Where we have modified the nomenclature or syntax of a botanical name, the original name and any changes applied will be described in the NOTES field. The MIDDEN TAXA table consists of the 12 fields described in Table ##TAB##7##8##.</p>", "<title>Rules of nomenclatural synonymy</title>", "<p id=\"Par23\">Botanical nomenclature is the formal system for naming plants, which is governed by the International Code of Botanical Nomenclature (ICBN)<sup>##UREF##24##28##</sup>. Plant taxa are often renamed when they are assigned to new families, genera, species, or infraspecific (varieties and subspecies) subdivisions of classification as our understanding of the inter-relationships of plant taxa changes. Consequently, taxonomic distinctions available to midden analysts decades ago frequently did not include many of the choices available today. The MIDDEN TAXA table VARNAME field lists the original Latin botanical names of plant macrofossil taxa as they were published by midden analysts. If the botanical nomenclature used by the analyst is no longer accepted as the taxon’s formal botanical name due to taxonomic changes, then the new currently accepted taxon name (synonym) is listed in the CURRENTLY_ACCEPTED_VARNAME field. Authorities and source references for old and new taxon names, as well as common names and family names are also included in the MIDDEN TAXA table.</p>", "<p id=\"Par24\">Botanical nomenclature in the midden database generally follows the Integrated Taxonomic Information System (ITIS, <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.itis.gov\">https://www.itis.gov</ext-link>, accessed 2014–2019). Common names and family names also follow ITIS. All original plant macrofossil taxon names were cross-checked with ITIS as well as with the Tropicos database (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.tropicos.org\">http://www.tropicos.org</ext-link>, accessed 2014–2015) and the USDA NRCS PLANTS Database (<ext-link ext-link-type=\"uri\" xlink:href=\"https://plants.sc.egov.usda.gov\">https://plants.sc.egov.usda.gov</ext-link>, accessed 2015) to verify correct spelling, authority names, and status of acceptance of the botanical name. Through this cross-checking process, we determined that ITIS was the most complete, consistent, and reliable source dataset for verifying plant macrofossil botanical names. We therefore used ITIS as the main source for current botanical nomenclature. However, if ITIS did not provide sufficient information on current nomenclature, we used the following additional sources for nomenclature verification: Anderson<sup>##UREF##25##29##,##UREF##26##30##</sup>, Calflora (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.calflora.org/\">https://www.calflora.org/</ext-link>), The Gymnosperm Database (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.conifers.org/\">https://www.conifers.org/</ext-link>, accessed 2011), eFloras (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.efloras.org\">http://www.efloras.org</ext-link>), Gentry<sup>##UREF##27##31##</sup>, Gleason &amp; Cronquist<sup>##UREF##28##32##</sup>, Guzmán <italic>et al</italic>.<sup>##UREF##29##33##</sup>,Tropicos.org (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.tropicos.org\">http://www.tropicos.org</ext-link>), USDA NRCS PLANTS Database (<ext-link ext-link-type=\"uri\" xlink:href=\"https://plants.sc.egov.usda.gov\">https://plants.sc.egov.usda.gov</ext-link>), Webb &amp; Starr<sup>##UREF##30##34##</sup>, and Wiggins<sup>##UREF##31##35##</sup>. The source reference used for verifying each taxon is listed in the NOMENCLATURAL_SOURCE field. Other nomenclatural resources consulted and mentioned in the NOTES field include: Bye<sup>##UREF##32##36##</sup>, de Laubenfels<sup>##UREF##33##37##</sup>, Farjon<sup>##UREF##34##38##</sup>, Felger<sup>##UREF##35##39##</sup>, Jepson eFlora (<ext-link ext-link-type=\"uri\" xlink:href=\"https://ucjeps.berkeley.edu/eflora/\">https://ucjeps.berkeley.edu/eflora/</ext-link>, accessed 2014), Kartesz<sup>##UREF##36##40##</sup>, McLaughlin<sup>##UREF##37##41##</sup>, Starr<sup>##UREF##38##42##</sup>, The Plant List<sup>##UREF##39##43##</sup>, Turner <italic>et al</italic>.<sup>##UREF##40##44##</sup>, USDA Agricultural Research Service National Plant Germplasm System (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ars-grin.gov/npgs/\">https://www.ars-grin.gov/npgs/</ext-link>, accessed 2015), Vanden Heuvel<sup>##UREF##41##45##</sup>, and Wilder <italic>et al</italic>.<sup>##UREF##42##46##</sup>.</p>", "<p id=\"Par25\">When a plant species is transferred to a new genus and species, sometimes the old species name is not directly synonymous with one of the new infraspecific taxa. Thus, ITIS specifies the autonym of the new taxon as the accepted name for the old taxon. The autonym is a botanical name with repeated species epithet and infraspecific name. For example, the taxon <italic>Ericameria viscidiflora</italic> is no longer recognized as an accepted botanical name, and its new accepted name or synonym is the autonym <italic>Chrysothamnus viscidiflorus</italic> ssp. <italic>viscidiflorus</italic>. Autonyms are automatically established when an infraspecific taxon is described and validly published. The autonym has no authority, and it shares the type material and morphological description of the original described species. For autonyms, ITIS places the species rank authority after the trinomial (genus, species, and infraspecific) names instead of after the binomial (genus and species) names. This placement is confusing and makes it appear that autonyms in the ITIS dataset have authorities, which they do not.</p>", "<p id=\"Par26\">In paleoecological studies, it is important to consider that a plant macrofossil taxon identified in a midden at the species rank, such as <italic>Ericameria viscidiflora</italic>, could potentially belong to any of the former subspecies of <italic>E. viscidiflora</italic> or their synonymous currently accepted subspecies of <italic>Chrysothamnus viscidiflorus</italic>. The midden analyst may have chosen not to identify the original <italic>Ericameria viscidiflora</italic> specimen to the infraspecific level or they were unable to do so. For macrofossil taxa such as <italic>Ericameria viscidiflora</italic>, for which the currently accepted name is an autonym (<italic>Chrysothamnus viscidiflorus</italic> ssp<italic>. viscidiflorus</italic>), it may be more useful to consider these taxa as synonymous with the species rank (<italic>Chrysothamnus viscidiflorus</italic>), which includes all of the species’ infraspecific taxa. A species includes all of its subordinate taxa, whereas the subspecies autonym excludes any other subspecies.</p>", "<p id=\"Par27\">Examples of nomenclatural synonymy from the database (currently accepted names in bold font) include:</p>", "<p id=\"Par28\">Family level synonymy<list list-type=\"order\"><list-item><p id=\"Par29\"><bold>Asteraceae</bold> = Compositae</p></list-item><list-item><p id=\"Par30\"><bold>Poaceae</bold> = Gramineae</p></list-item></list></p>", "<p id=\"Par31\">Genus level synonymy<list list-type=\"order\"><list-item><p id=\"Par32\"><bold><italic>Ambrosia dumosa</italic></bold> = <italic>Franseria dumosa</italic></p></list-item><list-item><p id=\"Par33\"><bold><italic>Forsellesia</italic></bold>\n<bold>sp</bold>. = <italic>Glossopetalon</italic> sp.</p></list-item></list></p>", "<p id=\"Par34\">Species level synonymy<list list-type=\"order\"><list-item><p id=\"Par35\"><bold><italic>Larrea tridentata</italic></bold> = <italic>Larrea divaricata</italic></p></list-item><list-item><p id=\"Par36\"><bold><italic>Lappula squarrosa</italic></bold> = <italic>Lappula fremontii</italic></p></list-item></list></p>", "<title>General rules of syntax</title>", "<p id=\"Par37\">Syntax rules apply to the non-Latin parts of botanical names. In the identification of plant macrofossils, syntax helps to convey the degree of certainty of the taxon identification. The midden database syntactic rules generally follow those defined by Birks &amp; Birks<sup>##UREF##43##47##</sup>, The North American Pollen Database Manual<sup>##UREF##44##48##</sup>, Sigovini <italic>et al</italic>.<sup>##UREF##45##49##</sup>, and Watts &amp; Winter<sup>##UREF##46##50##</sup>. Examples of syntax commonly used in the identification of plant macrofossils from packrat middens are listed below along with descriptions of the syntax used in this midden database. The following syntax, “cf.”, and “type” rules text is from Strickland <italic>et al</italic>.<sup>##UREF##10##14##</sup> (pp. 12–16), updated as needed for version 5.0 of the midden database.<list list-type=\"order\"><list-item><p id=\"Par38\">Family level use of syntax rules:<list list-type=\"simple\"><list-item><label>A.</label><p id=\"Par39\">If a specimen (or specimens) can only be identified to the family level, the following syntax is often used.</p><p id=\"Par40\">Family =&gt; Asteraceae*</p><p id=\"Par41\">Family sp. =&gt; Asteraceae sp.</p><p id=\"Par42\">*Use of the family name alone (Family =&gt; Asteraceae) is preferred. Data that do not conform to this syntax are modified. For example, Family sp. =&gt; Asteraceae sp. is changed to Family =&gt; Asteraceae.</p></list-item><list-item><label>B.</label><p id=\"Par43\">When multiple specimens are identified to the family level, and more than one morphological type is distinguished but the genera cannot or were not determined, the abbreviations “undiff.” (undifferentiated) or “spp.” (presence of multiple genera/species within a family) are commonly used and the abbreviation “undet.” (undetermined) is occasionally used.</p><p id=\"Par44\">Family undiff. (genera or species are undifferentiated) =&gt; Asteraceae undiff.*</p><p id=\"Par45\">Family spp. (multiple genera/species) =&gt; Asteraceae spp.</p><p id=\"Par46\">Family undet. (undetermined) =&gt; Asteraceae undet.</p><p id=\"Par47\">*This database uses Family undiff. rather than Family spp. or Family undet. Data that do not conform to this syntax have been modified.</p></list-item><list-item><label>C.</label><p id=\"Par48\">When a specimen(s) belongs to one of two similar families and assignment to a single family cannot be made, the following syntax is often used.</p></list-item></list></p><p id=\"Par49\">Family/Family =&gt; Chenopodiaceae/Amaranthaceae*</p><p id=\"Par50\">Family or Family =&gt; Chenopodiaceae or Amaranthaceae</p><p id=\"Par51\">Family – Family =&gt; Chenopodiaceae – Amaranthaceae</p><p id=\"Par52\">*If a distinction between two similar families cannot be made based on morphology alone, a slash should be used between multiple family names rather than using “or” or “–”. Data that do not conform to this syntax have been modified. Chenopodiaceae is no longer recognized as a separate family, and it is now synonymous with Amaranthaceae. However, Chenopodiaceae/Amaranthaceae was a common assignment previously used by midden analysts.</p></list-item><list-item><p id=\"Par53\">Genus and species level use of syntax rules:<list list-type=\"simple\"><list-item><label>A.</label><p id=\"Par54\">When the genus and species are known, the taxon should be written as:</p><p id=\"Par55\"><italic>Genus species</italic> =&gt; <italic>Quercus gambelii</italic></p></list-item><list-item><label>B.</label><p id=\"Par56\">When the genus is known and the species cannot be determined, the taxon should be written as:</p><p id=\"Par57\"><italic>Genus</italic> sp. =&gt; <italic>Quercus</italic> sp.</p></list-item><list-item><label>C.</label><p id=\"Par58\">When multiple specimens belong to the same genus, but multiple species may be present, the following syntax is commonly used.</p><p id=\"Par59\"><italic>Genus</italic> undiff. (undifferentiated) =&gt; <italic>Quercus</italic> undiff.*</p><p id=\"Par60\"><italic>Genus</italic> spp. (multiple species) =&gt; <italic>Quercus</italic> spp.</p><p id=\"Par61\">*The database uses <italic>Genus</italic> undiff. rather than <italic>Genus</italic> spp. Data that do not conform to this syntax have been modified.</p></list-item><list-item><label>D.</label><p id=\"Par62\">When a specimen(s) belongs to one of two similar genera, the following syntax is commonly used.</p><p id=\"Par63\"><italic>Genus</italic>/<italic>Genus</italic> =&gt; <italic>Rumex/Polygonum</italic>*</p><p id=\"Par64\"><italic>Genus</italic> or <italic>Genus</italic> =&gt; <italic>Rumex</italic> or <italic>Polygonum</italic></p><p id=\"Par65\"><italic>Genus</italic> – <italic>Genus</italic> =&gt; <italic>Rumex</italic> – <italic>Polygonum</italic></p><p id=\"Par66\">*If a distinction between two similar genera cannot be made based on morphology, a slash is used between multiple genus names, rather than “or” or “–”, and the abbreviation sp. (species) after the genus name is dropped. Data that do not conform to this syntax have been modified.</p></list-item><list-item><label>E.</label><p id=\"Par67\">If a distinction cannot be made between two species, the following syntax is often used.</p></list-item></list></p></list-item></list></p>", "<p id=\"Par68\"><italic>Genus species/Genus species</italic> =&gt; <italic>Rhus aromatica/Rhus virens*</italic></p>", "<p id=\"Par69\"><italic>Genus species/species</italic> =&gt; <italic>Rhus aromatica/virens</italic></p>", "<p id=\"Par70\"><italic>Genus species/G. species</italic> =&gt; <italic>Rhus aromatica/R. virens</italic></p>", "<p id=\"Par71\">*The database uses <italic>Genus species/Genus species</italic> and data that do not conform to this syntax have been modified.</p>", "<title><italic>Placement of “cf.” rules</italic></title>", "<p id=\"Par72\">If the family, genus, or species identification of a plant macrofossil is somewhat uncertain but the specimen resembles a specific family, genus, or species, the Latin abbreviation “cf.” (<italic>confer</italic>, compare) is used to indicate that a specimen has the form of a particular family, genus, or species. Use of “cf.” implies that there is some degree of uncertainty in the taxon identification that may be the result of a number of factors, including poor macrofossil preservation, inadequate reference material, or ill-defined morphology.<list list-type=\"order\"><list-item><p id=\"Par73\">If the species identification is uncertain, “cf.” should be placed before the species name.</p><p id=\"Par74\"><italic>Genus</italic> cf. <italic>species =&gt; Quercus</italic> cf. <italic>gambelii</italic></p><p id=\"Par75\">Abbreviating the genus name when using “cf.” is considered proper syntax, however this rule is not commonly followed by macrofossil analysts and thus in this database we do not abbreviate the genus when using “cf.”</p><p id=\"Par76\"><italic>Genus</italic> cf. <italic>G. species</italic> =&gt; <italic>Quercus</italic> cf. <italic>Q. gambelii</italic> =&gt; <italic>Quercus</italic> cf. <italic>gambelii</italic></p></list-item><list-item><p id=\"Par77\">If the genus or family identification is uncertain, “cf.” should be placed in front of the genus or family name:</p><p id=\"Par78\">cf. <italic>Genus</italic> =&gt; cf. <italic>Quercus</italic></p><p id=\"Par79\">cf. Family =&gt; cf. Asteraceae</p><p id=\"Par80\">Family cf. <italic>Genus</italic> =&gt; Asteraceae cf. <italic>Brickellia</italic></p></list-item><list-item><p id=\"Par81\">This database does not use parentheses around “cf.” placed after the genus or family name such as:</p></list-item></list></p>", "<p id=\"Par82\"><italic>Genus</italic> (cf.) =&gt; <italic>Quercus</italic> (cf.)</p>", "<p id=\"Par83\">Family (cf.) =&gt; Asteraceae (cf.)</p>", "<title>Use of “type” rules</title>", "<p id=\"Par84\">The term “type” is used when one macrofossil type is present in a midden-sample assemblage, and it could be assigned to three or more taxa. Analysts that use “type” in their specimen identification may or may not indicate which taxa are possible matches to the specimen. The term “type” should always be placed after the family, genus, or species name and preceded by a hyphen<sup>##UREF##44##48##</sup>. Taxon names not conforming to this syntax were modified. The following examples are accepted in the midden database.</p>", "<p id=\"Par85\">1. Family-type =&gt; Asteraceae-type</p>", "<p id=\"Par86\">2. <italic>Genus</italic>-type =&gt; <italic>Quercus</italic>-type</p>", "<p id=\"Par87\">Rather than:   <italic>Genus</italic> type =&gt; <italic>Quercus</italic> type   </p>", "<p id=\"Par88\"><italic>Genus</italic> (type) =&gt; <italic>Quercus</italic> (type)   </p>", "<p id=\"Par89\"><italic>Genus</italic> s.l. (<italic>sensu lato</italic>, in the broad sense) =&gt; <italic>Quercus</italic> s.l.</p>", "<p id=\"Par90\">3. <italic>Genus</italic>\n<italic>species</italic>-type =&gt; <italic>Quercus</italic>\n<italic>gambelii</italic>-type</p>", "<p id=\"Par91\">4. <italic>Genus</italic>/<italic>Genus</italic>-type =&gt; <italic>Avena</italic>/<italic>Festuca</italic>-type</p>", "<p id=\"Par92\">Rather than: <italic>Genus</italic>-type/<italic>Genus</italic>-type =&gt; <italic>Avena</italic>-type/<italic>Festuca</italic>-type</p>", "<title>Other syntax</title>", "<p id=\"Par93\">Other acceptable syntax to be placed in front of the appropriate variety, subspecies, subgenus, or subfamily name include:</p>", "<p id=\"Par94\">var. = variety</p>", "<p id=\"Par95\">ssp. = subspecies</p>", "<p id=\"Par96\">aff. = <italic>affinis</italic> in Latin, meaning the specimen has affinity with a known species</p>", "<p id=\"Par97\">subgenus (not abbreviated)</p>", "<p id=\"Par98\">subfamily (not abbreviated)</p>", "<p id=\"Par99\">The use of the abbreviation indet. (<italic>indeterminabilis</italic>, indeterminate) indicates that the specimen(s) was too poorly preserved, incomplete, or damaged to be identified to a lower taxonomic level. The level of taxonomic uncertainty is specified as follows:</p>", "<p id=\"Par100\">Family, genus indet. =&gt; Asteraceae, genus indet.</p>", "<p id=\"Par101\"><italic>Genus</italic>, species indet. =&gt; <italic>Quercus</italic>, species indet.</p>", "<title>Hybrid taxa syntax</title>", "<p id=\"Par102\">The syntax for officially named hybrid taxa is:</p>", "<p id=\"Par103\"><italic>Genus</italic> X <italic>species</italic> =&gt; <italic>Quercus</italic> X <italic>organensis</italic></p>", "<p id=\"Par104\">The syntax for suspected hybrid taxa is:</p>", "<p id=\"Par105\"><italic>Genus species</italic> X <italic>Genus species</italic> hybrid =&gt; <italic>Pinus monophylla</italic> X <italic>Pinus edulis</italic> hybrid</p>", "<title>Linked Table 5: MIDDEN TAXA PER SAMPLE</title>", "<p id=\"Par106\">The MIDDEN TAXA PER SAMPLE table consists of the 5 fields listed in Table ##TAB##8##9##, including the variable numbers (VARNUM) identifying the plant macrofossil taxa that were collected from each midden sample. Plant taxon lists for each midden sample were input directly from the midden sample’s source references. When a midden sample’s plant taxon list was published in multiple sources, the taxon list from the most recent source was typically entered into the database and assumed to be the most accurate taxon list. An effort was made to record discrepancies among taxon lists published at different times in the NOTES field as well as in the COMMENTS field of the MIDDEN SAMPLE table (Linked Table 2). The original published relative-abundance or count data for each macrofossil taxon were entered in the MCOUNT field and the plant organ(s) identified were included in the TYPE field. Original published MCOUNTs may have been represented by symbols or numbers. In some cases, authors included a symbol to denote when a taxon was considered an older or younger contaminant. Some authors included suspected contaminants in the taxon list and marked them with a symbol such as a “?”, while other authors removed possible contaminant taxa from their taxon list. Since authors do not deal with contaminant taxa in a consistent way, we made a concerted effort to document any contaminants discussed by the author in the NOTES field of the MIDDEN TAXA PER SAMPLE table.</p>", "<title>Linked Table 6: CODE TRANSLATION</title>", "<p id=\"Par107\">In addition to recording numbers of individual macrofossil specimens (raw counts), various counting methods have been used in packrat midden analyses to represent the relative abundance of plant macrofossil taxa collected from midden samples. Common counting schemes include the use of numeric codes or symbols to represent taxon relative abundance. The CODE TRANSLATION table describes the type of counting scheme used in the source publication for each midden-sample taxon list and consists of the 6 fields listed in Table ##TAB##9##10##.</p>", "<p id=\"Par108\">To allow comparison of taxon count and relative-abundance data for midden samples that were analyzed using different counting methods, the counting scheme for each midden sample was converted to a standardized 0-1-2 relative-abundance scale (see rules in next subsection). Each source reference contributing a macrofossil assemblage to the database is listed in the REFERENCE field of the CODE TRANSLATION table, and the original counting scheme (TYPE_OF_COUNT field), with an explanation (EXPLANATION field) of how the scheme is translated to the 0-1-2 code, is associated with each source reference. The translation from original scheme to 0-1-2 code is uniquely defined for each source publication, therefore each midden-sample taxon list is linked to a single source publication. The source publication citation for each midden-sample taxon list in the database is found in the REFERENCE1 field of the MIDDEN SAMPLE table (Linked Table 2). Individual midden-sample codes are linked by the REFERENCE1 field to the REFERENCE field in the CODE TRANSLATION table, allowing the taxa in each sample to be translated according to the rules defined in the CODE TRANSLATION table.</p>", "<title>Rules for Translating the MCOUNT Data into the 0-1-2 Presence-Absence Scale</title>", "<p id=\"Par109\">The following rules text is from Strickland <italic>et al</italic>.<sup>##UREF##10##14##</sup> (p. 18), updated as needed for version 5.0 of the midden database.<list list-type=\"order\"><list-item><p id=\"Par110\">Counting schemes using symbols (e.g., *, X, +): A single symbol is represented in the 0-1-2 code by the code number “1” (rare) and two or more symbols (for example ** or ***) are represented by the code number “2” (present).</p></list-item><list-item><p id=\"Par111\">Numeric relative-abundance scales: A value of 1 is represented in the 0-1-2 code by the code number “1” (rare) and values ≥ 2 are represented by the code number “2” (present).</p></list-item><list-item><p id=\"Par112\">Percent abundance scales and raw counts: Values ≤ 5% or ≤ 5 specimens are represented by the code number “1” (rare) and values &gt; 5% or &gt; 5 specimens are represented by the code number “2” (present).</p></list-item><list-item><p id=\"Par113\">Macrofossil weights in grams: Values ≤ 0.003 grams are represented by the code number “1” (rare) and values &gt; 0.003 grams are represented by the code number “2” (present).</p></list-item><list-item><p id=\"Par114\">Macrofossil abundance measured on a log<sub>10</sub> of number of plant fragments/kg of washed matrix scale: Values ≤ 0.70 are represented by the code number “1” (rare) and values &gt; 0.70 are represented by the code number “2” (present). The value 0.70 = log<sub>10</sub> 5 macrofossils/kg.</p></list-item><list-item><p id=\"Par115\">If authors list contaminants in the taxon list, those taxa are assigned code number “9” and should not be used as part of the assemblage.</p></list-item><list-item><p id=\"Par116\">Sometimes we are unable to translate an original macrofossil count because the author has not sufficiently defined the symbols used in the counting scheme, and those taxa are assigned code number “7”. Note that if macrofossil counts for taxa from one publication were assigned code number “7” in the CODE TRANSLATION table (Linked Table 6), but an alternate published dataset with a more complete taxon list, and with no macrofossil counts assigned code number “7”, was chosen to represent the macrofossil assemblage, then no taxa with a code number of “7” will appear in the MCOUNT TRANSLATION table (Linked Table 7). This happens when the same data are published in multiple reports, however only one source can be designated as REFERENCE1 in the MIDDEN SAMPLE table. In this version of the midden database (version 5.0) no code number “7”s appear in the MCOUNT TRANSLATION table (Linked Table 7) because they are supplanted by data from the more complete source designated as REFERENCE1.</p></list-item><list-item><p id=\"Par117\">Absences are not frequently recorded by midden analysts. If a taxon list is complete (i.e., all midden taxa were identified) usually only taxa present are recorded (represented by code numbers “1” or “2”) and unlisted taxa are assumed absent. If a taxon list is complete and absences have been recorded, these absences are represented by the code number “0”. More commonly, if a taxon list is only partial (i.e., only certain midden taxa were identified and other potentially identifiable taxa were ignored), an author sometimes records the absence of certain taxa that were being sought out and these absences are also represented by code number “0”.</p></list-item></list></p>", "<title>Linked Table 7: MCOUNT TRANSLATION</title>", "<p id=\"Par118\">This table is similar to the MIDDEN TAXA PER SAMPLE table (Linked Table 5). Both tables list the midden taxa from each sample assemblage by their variable numbers (VARNUM) and the original macrofossil count or relative-abundance value or symbol (MCOUNT) for each taxon is provided. The MCOUNT TRANSLATION table adds equivalent standard 0-1-2 codes for each macrofossil value or symbol in the MCOUNT field. The original macrofossil counts from the MIDDEN TAXA PER SAMPLE table (Linked Table 5) are translated into the standardized presence-absence 0-1-2 code using parameters defined in the CODE TRANSLATION table (Linked Table 6) and a make-table query. The MCOUNT TRANSLATION table consists of the four fields listed in Table ##TAB##10##11##.</p>", "<title>Linked Table 8: CLIMATE DATA</title>", "<p id=\"Par119\">The CLIMATE DATA table contains climate and bioclimate data for the 2,929 midden-sample sites with original published location data or for which we estimated “best” location data. The CLIMATE DATA table consists of the 72 fields listed in Table ##TAB##11##12##. We interpolated CRU CL 2.0 (1961–1990 30-year mean<sup>##UREF##14##18##</sup>, data available at <ext-link ext-link-type=\"uri\" xlink:href=\"https://crudata.uea.ac.uk/cru/data/hrg/\">https://crudata.uea.ac.uk/cru/data/hrg/</ext-link>) mean monthly temperature (°C), precipitation (mm), possible sunshine (% of daylength), and mean diurnal temperature range (°C) data to each midden-sample site location (latitude and longitude) and elevation (m) using lapse-rate adjusted bilinear interpolation<sup>##UREF##47##51##</sup>. The same approach was used to interpolate World WeatherDisc absolute minimum and maximum temperature (1951–1980) data<sup>##UREF##48##52##</sup> to the midden-sample site locations.</p>", "<p id=\"Par120\">The interpolated monthly climate data (1961–1990 30-year mean) were used to calculate a set of bioclimatic variables (Table ##TAB##11##12##) for each midden site location using SPLASH<sup>##UREF##15##19##</sup> (SPLASH code is available from <ext-link ext-link-type=\"uri\" xlink:href=\"https://bitbucket.org/labprentice/splash/src/master/\">https://bitbucket.org/labprentice/splash/src/master/</ext-link>). The monthly climate data were interpolated to a daily time step using a mean-preserving interpolation method<sup>##UREF##49##53##,##UREF##50##54##</sup>. Mean annual temperature (°C) was calculated as the month-length weighted average of monthly mean temperature. Chilling period was calculated as the number of days in the year with temperatures &lt;5 °C. SPLASH was modified to include snow-water accounting: snowfall snow water equivalent (SWE) was calculated using a threshold air temperature of −1.0 °C at which all precipitation falls as snow and a threshold air temperature of 4.0 °C at which no precipitation falls as snow<sup>##UREF##51##55##</sup>. Actual evapotranspiration (AET) was calculated by SPLASH using a soil moisture capacity of 150 mm for all midden-sample site locations. The annual Priestley-Taylor coefficient (α) was calculated as AET divided by equilibrium evapotranspiration (EET), an evaporation-ratio variable (AETPET) was calculated as AET divided by potential evapotranspiration (PET), and the annual moisture index, MI, was calculated as annual total precipitation (ANNP) divided by PET (Table ##TAB##11##12##).</p>", "<p id=\"Par121\">The midden-sample site latitudes, longitudes, and elevations used to estimate the climate data have various uncertainties associated with them that affect their locational accuracy. The BEST_LOCALITY_NOTES field in the MIDDEN SAMPLE table (Linked Table 2) describes many of the issues with these data and the steps that were taken to develop the “best” latitude, longitude, and elevation data for each site. Users of the climate data are encouraged to read through the BEST_LOCALITY_NOTES field information describing the adjustments to the site latitudes, longitudes, and elevations before using the climate data created for the midden-sample site locations.</p>", "<p id=\"Par122\">Packrat middens are typically found in protected locations such as caves and crevices, and the climate and bioclimate data in the CLIMATE DATA table do not represent the climatic conditions in these protected locations. Packrat midden sites may be in canyons, cliff faces, and other topographic positions where topographic shading, slope, aspect, cold-air drainage, local moisture sources (e.g., streams), substrate type, etc., may modify local climatic conditions, which in turn may affect the taxonomic composition of the local vegetation within a packrat’s foraging area<sup>##UREF##52##56##</sup>. The climate and bioclimate data provided for the individual midden-sample sites may not capture these unique local conditions but instead should be considered estimates of the conditions in unprotected, open areas around the packrat midden sites.</p>", "<title>Linked Table 9: ECOREGION</title>", "<p id=\"Par123\">All midden samples with either best location data (as estimated by us) or original published location data were plotted and classified according to ecoregion type. If specific latitude and longitude coordinates were not available, but the general location was known, the ecoregion could usually be deduced, however if the ecoregion could not be interpreted, we entered “99999”. Ecoregion classification follows the World Wildlife Fund ecoregions of North America scheme as described by Ricketts <italic>et al</italic>.<sup>##UREF##13##17##</sup>. We use the WWF major habitat types (MHTs) and ecoregion classifications, which we refer to as level II and level III categories, respectively. Ecoregions are grouped together to form MHTs, which “are not geographically defined units; rather, they refer to the dynamics of ecological systems and to the broad vegetative structures and patterns of species diversity that define them. In this way they are roughly equivalent to biomes.” (Ricketts <italic>et al</italic>.<sup>##UREF##13##17##</sup>, p. 13–14). An ecoregion is defined as “a relatively large area of land or water that contains a geographically distinct assemblage of natural communities. These communities (1) share a large majority of their species, dynamics, and environmental conditions and (2) function together effectively as a conservation unit at global and continental scales […]” (Ricketts <italic>et al</italic>.<sup>##UREF##13##17##</sup>, p. 7). Midden sites in this dataset occur within 6 different level II MHT categories and 24 level III ecoregion categories (Table ##TAB##12##13##). The ECOREGION table consists of the 5 fields listed in Table ##TAB##13##14##.</p>", "<title>Linked Table 10: PLANT FUNCTIONAL TYPE</title>", "<p id=\"Par124\">Plant functional types (PFTs) group plant taxa by characteristics such as their stature, leaf form, phenology, and climatic adaptations<sup>##UREF##53##57##–##UREF##56##60##</sup>. These categories of plant functionality may be grouped together to form biomes, which provide the foundation for modeling past and future vegetation change<sup>##UREF##57##61##–##UREF##59##63##</sup>. Each macrofossil plant taxon in the packrat midden database has been assigned to one or more of 24 PFT categories (because individual taxa can belong to multiple PFTs). For each VARNUM in the PLANT FUNCTIONAL TYPE table (Table ##TAB##14##15##), PFT categories (table columns B-Y) contain either a value of “0” or “1” indicating the PFTs to which each taxon belongs. A “1” indicates that the midden taxon is assigned to the PFT category and a “0” indicates that the taxon is not assigned to the PFT category. The PLANT FUNCTIONAL TYPE table consists of the 27 fields listed in Table ##TAB##14##15##.</p>", "<p id=\"Par125\">PFT categories were modified from those used to classify European pollen taxa for biome reconstruction<sup>##UREF##54##58##</sup>, and our PFT assignments and definitions are similar to those applied to pollen taxa in biome reconstruction studies for Canada, Beringia, and the eastern United States<sup>##UREF##60##64##,##UREF##61##65##</sup>. The PFT categories used here closely follow those used for midden taxa in Thompson &amp; Anderson<sup>##UREF##55##59##</sup> where 5 new PFTs (steppe shrub, woodland conifer, woodland shrub, desert shrub or succulent, and frost sensitive desert shrub or succulent) were created to accommodate plants from southwestern United States steppe, woodland, and desert plant communities. This expanded PFT classification successfully incorporates taxa common in packrat middens, however categories used for biomization are not always broad enough to capture the full climatic range of each midden taxon. For example, in the boreal climatic zone, PFTs do not include categories to represent broadleaved evergreens (<italic>Arctostaphylos</italic> sp.), succulents (Cactaceae such as <italic>Opuntia fragilis</italic>), or deciduous needleleaved plants (no representative taxa currently found in middens) which do occur there. However, these excluded PFT categories are not as characteristic of boreal climates as are needleleaved evergreen and broadleaved summergreen categories<sup>##UREF##54##58##,##UREF##62##66##</sup>. Some plant taxa found in the midden samples are difficult to assign to representative PFT categories, particularly taxa that may not be important components of PFTs, such as climatically widespread taxa (many forbs) or highly localized edaphic taxa (<italic>Salix</italic> spp. in riparian areas). In cases where there was not a good PFT match for a taxon, we assigned the taxon to a PFT in the climatic zone or biome where the taxon is most common.</p>", "<p id=\"Par126\">PFT assignments were made based on descriptions of plant community ecology for individual plant species found in North American floras including Benson<sup>##UREF##63##67##</sup>, Benson &amp; Darrow<sup>##UREF##64##68##</sup>, Carter<sup>##UREF##65##69##</sup>, Davis<sup>##UREF##66##70##</sup>, Great Plains Flora Association<sup>##UREF##67##71##</sup>, Harrington<sup>##UREF##68##72##</sup>, Hickman<sup>##UREF##69##73##</sup>, Hitchcock &amp; Cronquist<sup>##UREF##70##74##</sup>, Kartesz<sup>##UREF##71##75##</sup>, Kearney &amp; Peebles<sup>##UREF##72##76##</sup>, Munz &amp; Keck<sup>##UREF##73##77##</sup>, Powell<sup>##UREF##74##78##</sup>, Powell <italic>et al</italic>.<sup>##UREF##75##79##</sup>, Roberts<sup>##UREF##76##80##</sup>, Taylor <italic>et al</italic>.<sup>##UREF##77##81##</sup>, Turner <italic>et al</italic>.<sup>##UREF##40##44##</sup>, and Welsh<sup>##UREF##78##82##</sup>. Additional online resources that were consulted are listed in Table ##TAB##15##16##. Table ##TAB##16##17## describes the characteristics of plants included in each PFT category and lists representative midden taxa belonging to each category.</p>", "<title>Unlinked Tables 1–4</title>", "<p id=\"Par127\">Four Unlinked data tables provide additional information that was compiled when creating the midden database and that users of the database may find useful.</p>", "<title>Unlinked Table 1: SYNONYMS</title>", "<p id=\"Par128\">This table equates synonymous botanical names listed in the MIDDEN TAXA table (Linked Table 4) VARNAME field. Changes in botanical nomenclature may occur based on expert opinion and genetic studies that improve our understanding of the relationships between plant families, genera, and species. As a result, packrat midden analysts have used different botanical names to identify plant macrofossils belonging to the same plant taxon. For example, in the 1960s creosote bush was represented in North America by the taxon <italic>Larrea divaricata</italic> ssp. <italic>tridentata</italic>. During the 1970s, some scientists, including midden analysts, began to consider <italic>Larrea divaricata</italic> ssp. <italic>tridentata</italic> as a species distinct from <italic>Larrea divaricata</italic> and the new species was recognized as <italic>Larrea tridentata</italic><sup>##UREF##79##83##–##UREF##82##86##</sup>. The new species distinction was controversial for decades, but genetic studies later verified that <italic>Larrea tridentata</italic> and <italic>Larrea divaricata</italic> were distinct species<sup>##REF##11697924##87##</sup> with <italic>Larrea tridentata</italic> only found in North America and <italic>Larrea divaricata</italic> only present in South America. Both names (<italic>L. divaricata</italic> and <italic>L. tridentata</italic>) have been used by midden analysts to identify creosote bush macrofossils, and both names appear separately in the VARNAME field of the MIDDEN TAXA table (Linked Table 4), even though they are synonymous names representing the same plant species. All synonymous names for a taxon [up to 8 names if there are multiple older names (VARNAME through SYNONYM_VARNAME8 fields)] are listed in the SYNONYMS table and are displayed across a single table row alongside their corresponding variable numbers (VARNUM through VARNUM8 fields). The SYNONYMS table consists of the 18 fields listed in Table ##TAB##17##18##.</p>", "<p id=\"Par129\">Sometimes a plant taxon is identified with various degrees of certainty. A midden analyst may use syntax such as “cf.”, “-type”, “undiff.”, or two taxa separated by a slash to indicate various levels of certainty in an identification. We include names using such syntax as synonymous names, since there is potential for taxa identified with less certainty to be equivalent to the taxon of interest. Each database user should decide on the level of certainty of identification that is acceptable for their particular investigation. After each series of synonymous macrofossil taxon names, we also provide the currently accepted botanical name, however the macrofossil taxon may not be listed or identified by this name in the VARNAME field of the MIDDEN TAXA table (Linked Table 4). The currently accepted name is provided without any syntax indicating uncertainty (“cf.”, “-type”, “undiff.”, etc.) regardless of the syntax of the original botanical name used by the midden analyst.</p>", "<p id=\"Par130\">If a botanical name has been revised and a species has been transferred to a lower rank of ssp. or var. under a new species (for example, the accepted name for <italic>Andropogon hallii</italic> is now <italic>Andropogon gerardii</italic> ssp<italic>. hallii</italic>), we only equate the old name (<italic>Andropogon hallii</italic>) with the new subspecies (<italic>Andropogon gerardii</italic> ssp. <italic>hallii</italic>) and we do not equate <italic>A. hallii</italic> with the new species (<italic>A. gerardii</italic>), even though <italic>A. gerardii</italic> appears in the MIDDEN TAXA table (Linked Table 4). It is possible that macrofossils identified as <italic>A. gerardii</italic> could include plants now known as <italic>A. gerardii</italic> ssp. <italic>hallii</italic>, as well as other subspecies, because a species is the sum of its infraspecific taxa. However, it is unknown which varieties the midden analyst considered in the <italic>A. gerardii</italic> identification. Depending on what point in time the identification was made, the analyst may have considered <italic>A. gerardii</italic> ssp. <italic>hallii</italic> an infraspecific taxon of <italic>A. gerardii</italic> or considered it a separate species (<italic>A. hallii</italic>).</p>", "<p id=\"Par131\">Sometimes when a taxon is moved to a new genus or species, its accepted botanical name is the autonym of the new taxon, for example, the accepted name for <italic>Condalia lycioides</italic> is now <italic>Ziziphus obtusifolia</italic> var. <italic>obtusifolia</italic>. Considering that the macrofossil <italic>C. lycioides</italic> could potentially belong to a former variety of <italic>C. lycioides</italic> or a new variety of <italic>Ziziphus obtusifolia</italic>, we treat the old name <italic>C. lycioides</italic> as synonymous with both the autonym (<italic>Ziziphus obtusifolia</italic> var. <italic>obtusifolia</italic>) and the new species rank name (<italic>Ziziphus obtusifolia</italic>) if either name appears in the MIDDEN TAXA table (Linked Table 4). A note is included in the SYNONYMS table NOTES field to indicate when an autonym is the accepted botanical name, however it may be useful to also recognize the species-rank taxon, which includes all the species’ infraspecific taxa, as synonymous.</p>", "<title>Unlinked Table 2: MIDDEN RELATED PUBLICATIONS WITH NO SIGNIFICANT DATA</title>", "<p id=\"Par132\">This table lists selected references published from 1875 to 2019 that were assessed for midden plant macrofossil data. These publications did not contain significant midden data and no data from these sources were included in the database. The MIDDEN RELATED PUBLICATIONS WITH NO SIGNIFICANT DATA table consists of the three fields listed in Table ##TAB##18##19##.</p>", "<title>Unlinked Table 3: MIDDEN RELATED ABSTRACTS WITH NO SIGNIFICANT DATA</title>", "<p id=\"Par133\">This table lists references for a selection of oral and poster presentation abstracts published in conference proceedings (1974 to 2016) that are related to midden studies. These abstracts did not contain significant midden plant macrofossil data and no data from these sources were included in the database. The MIDDEN RELATED ABSTRACTS WITH NO SIGNIFICANT DATA table consists of the three fields listed in Table ##TAB##19##20##.</p>", "<title>Unlinked Table 4: MIDDEN PUBLICATIONS OUTSIDE NORTH AMERICA</title>", "<p id=\"Par134\">This table lists a selection of references published from 1983 to 2004 for midden studies located outside of North America. Midden data available in this database are derived only from sites located in North America. However, as data were collected for North America, we kept a list of midden publications encountered that represented other areas. No data from these sources were included in the midden database and the list of these sources (Unlinked Table 4) is not meant to be a complete bibliography of midden publications for sites outside of North America. The MIDDEN PUBLICATIONS OUTSIDE NORTH AMERICA table consists of the three fields listed in Table ##TAB##20##21##.</p>", "<title>Lookup Tables 1–6</title>", "<p id=\"Par135\">The six Lookup tables provide definitions of the various codes that are used in Linked Tables 2, 3, 6, 7, 9, 10 (Tables ##TAB##5##6##, ##TAB##6##7##, ##TAB##9##10##, ##TAB##10##11##, ##TAB##13##14##, ##TAB##14##15##).</p>", "<title>Lookup Table 1: USE STATUS CODE</title>", "<p id=\"Par136\">Use status codes are used to indicate the completeness of data available for each midden sample. Detailed definitions were previously described in the MIDDEN SAMPLE table (Linked Table 2) description. The USE STATUS CODE table consists of the two fields listed in Table ##TAB##21##22##.</p>", "<title>Lookup Table 2: 0-1-2 CODE</title>", "<p id=\"Par137\">This table defines the numeric codes used in the midden taxon 0-1-2 presence-absence scale. Relative-abundance or count data for each plant macrofossil taxon in a midden sample in the MIDDEN TAXA PER SAMPLE table (Linked Table 5, MCOUNT field) were translated into 0-1-2 code values using the code definitions in the CODE TRANSLATION table (Linked Table 6). The 0-1-2 CODE table consists of the two fields listed in Table ##TAB##22##23##.</p>", "<title>Lookup Table 3: RECOMMENDED AGE CODE</title>", "<p id=\"Par138\">This table defines the codes used in the AGEC14 table to indicate ages recommended to represent each midden sample/assemblage. Detailed definitions were previously described in the AGEC14 table (Linked Table 3) description. The RECOMMENDED AGE CODE table consists of the two fields listed in Table ##TAB##23##24##.</p>", "<title>Lookup Table 4: TAXON LIST CODE</title>", "<p id=\"Par139\">This table defines the taxon list codes that indicate whether a taxon list is available for a midden sample, if the taxon list is complete or partial, and whether the taxon list is published or unpublished. Detailed taxon list code definitions were previously described in the MIDDEN SAMPLE table (Linked Table 2) description. The TAXON LIST CODE table consists of the two fields listed in Table ##TAB##24##25##.</p>", "<title>Lookup Table 5: ECOREGION CODE</title>", "<p id=\"Par140\">This table defines abbreviations used in the ECOREGION table (Linked Table 9) to represent 6 WWF level II major habitat types (MHTs) and 24 WWF level III ecoregions. Detailed definitions can be found in the ECOREGION table (Linked Table 9) description. The ECOREGION CODE table consists of the four fields listed in Table ##TAB##25##26##.</p>", "<title>Lookup Table 6: PLANT FUNCTIONAL TYPE CODE</title>", "<p id=\"Par141\">Plant functional type codes were previously defined in the PLANT FUNCTIONAL TYPE table (Linked Table 10) description. The PLANT FUNCTIONAL TYPE CODE table consists of the two fields listed in Table ##TAB##26##27##.</p>" ]
[]
[]
[]
[ "<p id=\"Par1\">Plant macrofossils from packrat (<italic>Neotoma</italic> spp.) middens provide direct evidence of past vegetation changes in arid regions of North America. Here we describe the newest version (version 5.0) of the U.S. Geological Survey (USGS) North American Packrat Midden Database. The database contains published and contributed data from 3,331 midden samples collected in southwest Canada, the western United States, and northern Mexico, with samples ranging in age from 48 ka to the present. The database includes original midden-sample macrofossil counts and relative-abundance data along with a standardized relative-abundance scheme that makes it easier to compare macrofossil data across midden-sample sites. In addition to the midden-sample data, this version of the midden database includes calibrated radiocarbon (<sup>14</sup>C) ages for the midden samples and plant functional type (PFT) assignments for the midden taxa. We also provide World Wildlife Fund ecoregion assignments and climate and bioclimate data for each midden-sample site location. The data are provided in tabular (.xlsx), comma-separated values (.csv), and relational database (.mdb) files.</p>", "<title>Subject terms</title>" ]
[ "<title>Data Records</title>", "<p id=\"Par142\">The data described above are part of the USGS North American Packrat Midden Database version 5.0 data release<sup>##UREF##12##16##</sup> and are available at 10.5066/P91UOARW. The Linked, Unlinked, and Lookup tables are provided within a relational database (.mdb) and are also provided separately as tabular (.xlsx) and comma-separated values (.csv) files<sup>##UREF##12##16##</sup>. Tables in the relational database are linked by simple joins connecting common fields containing unique values (Fig. ##FIG##1##2##). Each individual publication, midden sample, and plant macrofossil taxon recorded in the database is distinguished by a unique code. Publications are represented by reference numbers (REFNUM), midden samples by sample codes (SAMCODE), and macrofossil plant taxa by variable numbers (VARNUM).</p>", "<p id=\"Par143\">An earlier version of the database (version 4.0, June 2016)<sup>##UREF##11##15##</sup> can be accessed at <ext-link ext-link-type=\"uri\" xlink:href=\"https://geochange.er.usgs.gov/midden/\">https://geochange.er.usgs.gov/midden/</ext-link>. This online version of the database contains data for only 3,205 midden samples and does not contain the PFT and ecoregion assignments, climate and bioclimate data, recommended age data, or calibrated age data described in this publication. It allows the user to use a web browser to query the original published data and standardized data in the midden database by publication (author and date of publication), taxon, geographic area (state and country), locality name, latitude, longitude, and <sup>14</sup>C age.</p>", "<p id=\"Par144\">The relational database filename in the Strickland <italic>et al</italic>.<sup>##UREF##12##16##</sup> midden database data release is: Strickland_and_others_2022_USGS_packrat_midden_Access_database_version_5.0.mdb</p>", "<p id=\"Par145\">The Linked, Unlinked, and Lookup table .xslx (.csv) filenames in the Strickland <italic>et al</italic>.<sup>##UREF##12##16##</sup> midden database data release are:</p>", "<p id=\"Par146\">Linked_Table_1_REFERENCE.xlsx (.csv)</p>", "<p id=\"Par147\">Linked_Table_2_MIDDEN_SAMPLE.xlsx (.csv)</p>", "<p id=\"Par148\">Linked_Table_3_AGEC14.xlsx (.csv)</p>", "<p id=\"Par149\">Linked_Table_4_MIDDEN_TAXA.xlsx (.csv)</p>", "<p id=\"Par150\">Linked_Table_5_MIDDEN_TAXA_PER_SAMPLE.xlsx (.csv)</p>", "<p id=\"Par151\">Linked_Table_6_CODE_TRANSLATION.xlsx (.csv)</p>", "<p id=\"Par152\">Linked_Table_7_MCOUNT_TRANSLATION.xlsx (.csv)</p>", "<p id=\"Par153\">Linked_Table_8_CLIMATE_DATA.xlsx (.csv)</p>", "<p id=\"Par154\">Linked_Table_9_ECOREGION.xlsx (.csv)</p>", "<p id=\"Par155\">Linked_Table_10_PLANT_FUNCTIONAL_TYPE.xlsx (.csv)</p>", "<p id=\"Par156\">Unlinked_Table_1_SYNONYMS.xlsx (.csv)</p>", "<p id=\"Par157\">Unlinked_Table_2_MIDDEN_RELATED_PUBLICATIONS_WITH_NO_SIGNIFICANT_DATA.xlsx (.csv)</p>", "<p id=\"Par158\">Unlinked_Table_3_MIDDEN_RELATED_ABSTRACTS_WITH_NO_SIGNIFICANT_DATA.xlsx (.csv)</p>", "<p id=\"Par159\">Unlinked_Table_4_MIDDEN_PUBLICATIONS_OUTSIDE_NORTH_AMERICA.xlsx (.csv)</p>", "<p id=\"Par160\">Lookup_Table_1_USE_STATUS_CODE.xlsx (.csv)</p>", "<p id=\"Par161\">Lookup_Table_2_0_1_2_CODE.xlsx (.csv)</p>", "<p id=\"Par162\">Lookup_Table_3_RECOMMENDED_AGE_CODE.xlsx (.csv)</p>", "<p id=\"Par163\">Lookup_Table_4_TAXON_LIST_CODE.xlsx (.csv)</p>", "<p id=\"Par164\">Lookup_Table_5_ECOREGION_CODE.xlsx (.csv)</p>", "<p id=\"Par165\">Lookup_Table_6_PLANT_FUNCTIONAL_TYPE_CODE.xlsx (.csv)</p>", "<title>Technical Validation</title>", "<p id=\"Par166\">Data in the midden database have been evaluated and reviewed starting with the first release of the database in 1998. For this version of the midden database (version 5.0), data validation steps are described above for each data table and are summarized here. Midden-sample site location (latitude and longitude) and elevation data were recorded from each publication that provided this information for each midden site. Data for individual samples were often repeatedly reported in multiple source references allowing us to compare reported location and elevation data and identify data errors that may have propagated from one publication to the next. Midden site location and elevation data were also validated against TOPO! Software<sup>##UREF##16##20##–##UREF##18##22##</sup> latitude, longitude, and elevation data, and adjustments were made to the midden-sample location data as described in the Methods section. Geographic names (e.g., the names of mountain ranges) were checked in the Geographic Names Information System (GNIS; <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.usgs.gov/us-board-on-geographic-names/domestic-names\">https://www.usgs.gov/us-board-on-geographic-names/domestic-names</ext-link>) for locations in the United States and the GEOnet Names Server (GNS; <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.nga.mil/resources/US_Board_on_Geographic_Names_.html\">https://www.nga.mil/resources/US_Board_on_Geographic_Names_.html</ext-link>) for locations in Canada and Mexico.</p>", "<p id=\"Par167\">Changes in identification of a midden sample’s taxa or the quantification of macrofossil taxa from one publication to the next were noted. Taxon list discrepancies among publications describing the same midden sample were also noted and the recorded plant taxon names were cross-checked with ITIS (<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.itis.gov\">https://www.itis.gov</ext-link>, accessed 2014–2019), Tropicos (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.tropicos.org\">http://www.tropicos.org</ext-link>, accessed 2014–2015), and USDA NRCS PLANTS Database (<ext-link ext-link-type=\"uri\" xlink:href=\"https://plants.sc.egov.usda.gov\">https://plants.sc.egov.usda.gov</ext-link>, accessed 2015) databases and other published data sources.</p>", "<p id=\"Par168\">Calibrated radiocarbon ages were plotted to check for data outliers (Fig. ##FIG##2##3##). Climate and bioclimate data were also checked for outliers. Names of geologic time periods used in the midden database conform to the usage approved by the USGS Geologic Names Committee<sup>##UREF##83##88##</sup>.</p>" ]
[ "<title>Acknowledgements</title>", "<p>Development of this database has been supported by the U.S. Geological Survey Climate Research and Development Program and the National Oceanic and Atmospheric Administration (NOAA). Anderson’s contributions to this project were supported by U.S. Geological Survey Cooperative Agreement G14AC00234. We thank Lisa A. Doner for reviewing the data tables, Lydia A. Pinkham for table editing, and Paul D. Henne and one anonymous reviewer for their helpful suggestions to improve the manuscript. We also thank the researchers who contributed unpublished data and supplemental data including Larry L. Coats, Camille A. Holmgren, Peter A. Koehler, and Janet Riddell. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.</p>", "<title>Author contributions</title>", "<p>L.E.S., K.H.A., and R.S.T. designed the database; L.E.S., R.S.T., K.H.A., R.T.P., R.R.S., and A.K.M. collected and validated the midden data; P.J.B. and S.L.S developed the climate and bioclimate data; L.E.S., R.S.T, S.L.S., P.J.B., and R.T.P. drafted the manuscript and all authors commented on the final version.</p>", "<title>Code availability</title>", "<p>Bioclimatic variables were calculated using SPLASH<sup>##UREF##15##19##</sup>. SPLASH code is available from bitbucket (<ext-link ext-link-type=\"uri\" xlink:href=\"https://bitbucket.org/labprentice/splash/src/master/\">https://bitbucket.org/labprentice/splash/src/master/</ext-link>).</p>", "<title>Competing interests</title>", "<p id=\"Par169\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Fig. 1</label><caption><p>Locations (, red circles) of midden-sample sites included in the midden database. Figure from Strickland <italic>et al</italic>.<sup>##UREF##12##16##</sup>.</p></caption></fig>", "<fig id=\"Fig2\"><label>Fig. 2</label><caption><p>Relationships among the Linked data tables in the midden database. Each box lists the Linked data table name (bold black text), the common data fields in each table (bold red, blue, green, orange, and purple text) that are used to join the tables in the relational database, and the other data fields in each table (regular black text). Common data fields that provide unique identifiers for each table entry (i.e., each table row) are in italicized text. Note that the common data fields do not need to have the same name to be joined. For example, the REFERENCE field in the CODE TRANSLATION table (Linked Table 6) can be joined with the REFERENCE1 field in the MIDDEN SAMPLE table (Linked Table 2).</p></caption></fig>", "<fig id=\"Fig3\"><label>Fig. 3</label><caption><p>Histogram of the 2,859 calibrated radiocarbon ages (ka) in the midden database. The number above each bar indicates the number of midden-sample calibrated radiocarbon ages that fall within each 1-kyr age bin. Calibrated age data are from the CALIB704_CALENDAR_YR_BP_MEDIAN_PROBABILITY field in the AGEC14 table (Linked Table 3).</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Timeline of midden database releases and related publications.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Database Version (Release Date)</th><th>Database Title, Authors, and Related Publications</th></tr></thead><tbody><tr><td rowspan=\"2\">Version 1.0 (1998)</td><td>USGS/NOAA North American Packrat Midden Database (R. R. Schumann, R. S. Thompson, K. H. Anderson). No longer available online.</td></tr><tr><td>Related publication: USGS/NOAA North American Packrat Midden Database Data Dictionary (2001)<sup>##UREF##10##14##</sup>.</td></tr><tr><td rowspan=\"2\">Version 2.0 (October 2002)</td><td>USGS/NOAA North American Packrat Midden Database (L. E. Strickland, R. R. Schumann, R. S. Thompson, K. H. Anderson). No longer available online.</td></tr><tr><td>Related publication: Standardized paleobotanical data derived from packrat middens in western North America. Geological Society of America Annual Meeting abstract (October 2002)<sup>##UREF##84##89##</sup>.</td></tr><tr><td rowspan=\"2\">Version 3.0 (October 2006)</td><td>USGS/NOAA North American Packrat Midden Database (L. E. Strickland, R. R. Schumann, R. S. Thompson, K. H. Anderson, R. T. Pelltier). No longer available online.</td></tr><tr><td>Related publication: Quaternary plant fossils from caves and rockshelters: A database of paleoecological records from Neotoma middens in western North America. Geological Society of America Annual Meeting abstract (October 2006)<sup>##UREF##85##90##</sup>.</td></tr><tr><td rowspan=\"2\">Version 4.0 (June 2016)</td><td>USGS/NOAA North American Packrat Midden Database (L. E. Strickland, R. R. Schumann, R. S. Thompson, K. H. Anderson, R. T. Pelltier)<sup>##UREF##11##15##</sup>. Currently available at: <ext-link ext-link-type=\"uri\" xlink:href=\"https://geochange.er.usgs.gov/midden/\">https://geochange.er.usgs.gov/midden/</ext-link>.</td></tr><tr><td>Related publication: Quaternary plant fossils from <italic>Neotoma</italic> middens in western North America: An update of the USGS/NOAA North American Packrat Midden Database. American Quaternary Association (AMQUA) abstract (June 28-July 2, 2016; L. E. Strickland, R. R. Schumann, R. S. Thompson, K. H. Anderson, R. T. Pelltier).</td></tr><tr><td rowspan=\"2\">Version 5.0 (October 2022)</td><td>USGS North American Packrat Midden Database (L. E. Strickland, R. S. Thompson, K. H. Anderson, R. T. Pelltier, S. L. Shafer, P. J. Bartlein, R. R. Schumann, A. K. McFadden)<sup>##UREF##12##16##</sup>. U.S. Geological Survey data release. Currently available at: 10.5066/P91UOARW.</td></tr><tr><td>Related publication: Paleobotanical data from the USGS/NOAA North American Packrat Midden Database, version 5: Primary data, quality-assessed standardized data, and information on sample climatic and ecological context. Geological Society of America Annual Meeting abstract (September 2019)<sup>##UREF##86##91##</sup>.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab2\"><label>Table 2</label><caption><p>Linked data tables and descriptions of their content.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Linked Data Tables</th><th>Content</th></tr></thead><tbody><tr><td>1. REFERENCE</td><td>List of data source publications.</td></tr><tr><td>2. MIDDEN SAMPLE</td><td>Sample codes and location information.</td></tr><tr><td>3. AGEC14</td><td>Radiocarbon ages, calibrated ages, and material dated.</td></tr><tr><td>4. MIDDEN TAXA</td><td>A comprehensive list of plant taxa recovered from midden samples included in this database.</td></tr><tr><td>5. MIDDEN TAXA PER SAMPLE</td><td>Lists plant taxon assemblages collected from each midden sample, original taxon-relative-abundance or count data, and organ type.</td></tr><tr><td>6. CODE TRANSLATION</td><td>Describes original macrofossil count data and macrofossil-relative-abundance schemes and explains how each count or scheme type was translated into a standard presence-absence scale.</td></tr><tr><td>7. MCOUNT TRANSLATION</td><td>Translates original macrofossil-relative-abundance or count data from the MIDDEN TAXA PER SAMPLE table (Linked Table 5) into a standard presence-absence scale (0-1-2 scale) using parameters defined in the CODE TRANSLATION table (Linked Table 6) and a make-table query.</td></tr><tr><td>8. CLIMATE DATA</td><td>Sixty-five climate and bioclimate variables, including monthly temperature and precipitation values interpolated to each midden-sample location.</td></tr><tr><td>9. ECOREGION</td><td>Midden-sample locations are assigned to one of 6 World Wildlife Fund (WWF) major habitat types (MHTs) and one of 24 WWF ecoregions<sup>##UREF##13##17##</sup>.</td></tr><tr><td>10. PLANT FUNCTIONAL TYPE</td><td>Midden taxa are assigned to 24 possible plant functional type (PFT) categories.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab3\"><label>Table 3</label><caption><p>Unlinked data tables and descriptions of their content.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Unlinked Data Tables</th><th>Content</th></tr></thead><tbody><tr><td>1. SYNONYMS</td><td>Synonymous taxon names appearing in the MIDDEN TAXA table (Linked Table 4).</td></tr><tr><td>2. MIDDEN RELATED PUBLICATIONS WITH NO SIGNIFICANT DATA</td><td>Midden-related publications with no significant data content.</td></tr><tr><td>3. MIDDEN RELATED ABSTRACTS WITH NO SIGNIFICANT DATA</td><td>Midden-related abstracts with no significant data content.</td></tr><tr><td>4. MIDDEN PUBLICATIONS OUTSIDE NORTH AMERICA</td><td>Midden publications with midden sites outside of North America.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab4\"><label>Table 4</label><caption><p>Lookup data tables and descriptions of their content.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Lookup Data Tables</th><th>Content</th></tr></thead><tbody><tr><td>1. USE STATUS CODE</td><td>A numeric scheme representing the completeness of available data used in the MIDDEN SAMPLE table (Linked Table 2).</td></tr><tr><td>2. 0-1-2 CODE</td><td>Defines the 0-1-2 presence-absence scale used in the CODE TRANSLATION and MCOUNT TRANSLATION tables (Linked Tables 6, 7).</td></tr><tr><td>3. RECOMMENDED AGE CODE</td><td>Defines symbols in the AGEC14 table (Linked Table 3) that indicate which age we consider best represents the midden sample/assemblage.</td></tr><tr><td>4. TAXON LIST CODE</td><td>Defines symbols in the MIDDEN SAMPLE table (Linked Table 2) that indicate when a taxon list is available and the completeness of the taxon list.</td></tr><tr><td>5. ECOREGION CODE</td><td>Defines abbreviations in the ECOREGION table (Linked Table 9) for the WWF MHTs and ecoregions<sup>##UREF##13##17##</sup>.</td></tr><tr><td>6. PLANT FUNCTIONAL TYPE CODE</td><td>Defines abbreviations in the PLANT FUNCTIONAL TYPE table (Linked Table 10) that represent the 24 plant functional type (PFT) categories.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab5\"><label>Table 5</label><caption><p>REFERENCE (Linked Table 1) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>REFNUM</td><td>Reference number. A unique number assigned to each source reference consisting of a number followed by the letter “m”.</td></tr><tr><td>B</td><td>YEAR_PUBLISHED</td><td>The year the source reference was published.</td></tr><tr><td>C</td><td>CITATION</td><td>Author(s) last name(s) and year of publication.</td></tr><tr><td>D</td><td>FULL_REFERENCE</td><td>Includes when available, the author(s) last name(s) and first initials, year of publication, title, journal or publication series, editor, publisher, page numbers, and URL.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab6\"><label>Table 6</label><caption><p>MIDDEN SAMPLE (Linked Table 2) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>SAMCODE</td><td>Sample code. A unique code assigned to each midden sample.</td></tr><tr><td>B</td><td>SITE</td><td>Name of midden site.</td></tr><tr><td>C</td><td>SAMPLE</td><td>Original midden-sample identifier.</td></tr><tr><td>D</td><td>TAXON_LIST_CODE</td><td>A symbol in this field means a list of plant macrofossil taxa collected from the midden is available in the MIDDEN TAXA PER SAMPLE table (Linked Table 5; C = Complete taxon list, P = Partial taxon list, CU = Complete taxon list but unpublished and not available, PU = Partial taxon list but unpublished and not available). Codes are also defined in the TAXON LIST CODE table (Lookup Table 4).</td></tr><tr><td>E</td><td>TAXON_LIST_SOURCE</td><td>Source publication REFNUM(s) for the plant macrofossil taxon list.</td></tr><tr><td>F</td><td>LATDEG(1)</td><td>Published degrees of north latitude (set 1).</td></tr><tr><td>G</td><td>LATMIN(1)</td><td>Published minutes of north latitude (set 1).</td></tr><tr><td>H</td><td>LATSEC(1)</td><td>Published seconds of north latitude (set 1).</td></tr><tr><td>I</td><td>LONGDEG(1)</td><td>Published degrees of west longitude (set 1).</td></tr><tr><td>J</td><td>LONGMIN(1)</td><td>Published minutes of west longitude (set 1).</td></tr><tr><td>K</td><td>LONGSEC(1)</td><td>Published seconds of west longitude (set 1).</td></tr><tr><td>L</td><td>LATDECDEG(1)</td><td>Latitude published in decimal degrees, sometimes used to convert to degrees, minutes, seconds and populate latitude (set 1) fields.</td></tr><tr><td>M</td><td>LONGDECDEG(1)</td><td>Longitude published in decimal degrees, sometimes used to convert to degrees, minutes, seconds and populate longitude (set 1) fields.</td></tr><tr><td>N</td><td>SOURCE(1)</td><td>Latitude and longitude (set 1) data source REFNUM.</td></tr><tr><td>O</td><td>LATDECDEGCON</td><td>Latitude degrees, minutes, seconds (set 1) converted to decimal degrees.</td></tr><tr><td>P</td><td>LONGDECDEGCON</td><td>Longitude degrees, minutes, seconds (set 1) converted to decimal degrees.</td></tr><tr><td>Q-AR</td><td>LATDEG(2–5)</td><td>Degrees of north latitude (sets 2–5).</td></tr><tr><td>Q-AR</td><td>LATMIN(2–5)</td><td>Minutes of north latitude (sets 2–5).</td></tr><tr><td>Q-AR</td><td>LATSEC(2–5)</td><td>Seconds of north latitude (sets 2–5).</td></tr><tr><td>Q-AR</td><td>LONGDEG(2–5)</td><td>Degrees of west longitude (sets 2–5).</td></tr><tr><td>Q-AR</td><td>LONGMIN(2–5)</td><td>Minutes of west longitude (sets 2–5).</td></tr><tr><td>Q-AR</td><td>LONGSEC(2–5)</td><td>Seconds of west longitude (sets 2–5).</td></tr><tr><td>Q-AR</td><td>SOURCE(2–5)</td><td>Latitude and longitude (sets 2–5) data source REFNUM.</td></tr><tr><td>AS</td><td>BEST_LATDEG</td><td>Improved degrees of north latitude estimate.</td></tr><tr><td>AT</td><td>BEST_LATMIN</td><td>Improved minutes of north latitude estimate.</td></tr><tr><td>AU</td><td>BEST_LATSEC</td><td>Improved seconds of north latitude estimate.</td></tr><tr><td>AV</td><td>BEST_LONGDEG</td><td>Improved degrees of west longitude estimate.</td></tr><tr><td>AW</td><td>BEST_LONGMIN</td><td>Improved minutes of west longitude estimate.</td></tr><tr><td>AX</td><td>BEST_LONGSEC</td><td>Improved seconds of west longitude estimate.</td></tr><tr><td>AY</td><td>BEST_SOURCE</td><td>Sources utilized to estimate best location coordinates.</td></tr><tr><td>AZ</td><td>BEST_OR_PUB_LATDECDEGCON</td><td>Degrees, minutes, seconds of latitude converted to decimal degrees using “BEST_” coordinates when available or published coordinates if “BEST_” coordinates are not provided.</td></tr><tr><td>BA</td><td>BEST_OR_PUB_LONGDECDEGCON</td><td>Degrees, minutes, seconds of longitude converted to decimal degrees using “BEST_” coordinates when available or published coordinates if “BEST_” coordinates are not provided.</td></tr><tr><td>BB</td><td>ELEV(M)1</td><td>Elevation (value 1) in meters.</td></tr><tr><td>BC</td><td>SOURCE_EL(1)</td><td>Elevation data source (value 1) REFNUM.</td></tr><tr><td>BD-BK</td><td>ELEV(M)2–5</td><td>Elevation (values 2–5) in meters.</td></tr><tr><td>BD-BK</td><td>SOURCE_EL(2–5)</td><td>Elevation data source (values 2–5) REFNUM.</td></tr><tr><td>BL</td><td>BEST_ELEV(M)</td><td>Improved elevation estimate, in meters.</td></tr><tr><td>BM</td><td>SOURCE_BEST_ELEV(M)</td><td>Sources utilized to estimate best elevation.</td></tr><tr><td>BN</td><td>REFERENCE1</td><td>Author and year of the primary reference, typically the earliest publication and usually includes the taxon list.</td></tr><tr><td>BO</td><td>REFNUM1</td><td>Reference number of primary reference (REFERENCE1).</td></tr><tr><td>BP-CU</td><td>REFERENCE2-17</td><td>Additional publications containing new or repeated publication of data pertaining to the midden.</td></tr><tr><td>BP-CU</td><td>REFNUM2-17</td><td>Reference numbers of secondary references (REFERENCE2 to REFERENCE17).</td></tr><tr><td>CV</td><td>COMMENTS</td><td>Miscellaneous comments.</td></tr><tr><td>CW</td><td>LOCALITY</td><td>General geographic region where midden sample was collected (e.g., mountain range or stream valley).</td></tr><tr><td>CX</td><td>LOCALITY_NOTES</td><td>Detailed information about the midden-sample collection location.</td></tr><tr><td>CY</td><td>BEST_LOCALITY_NOTES</td><td>Description of how the best location data were determined and how the original location data were altered.</td></tr><tr><td>CZ</td><td>SLOPE_EXPOSURE</td><td>Geographic direction midden faces (N = north, S = south, E = east, W = west).</td></tr><tr><td>DA</td><td>USE_STATUS</td><td>Describes the completeness of the data available using a numeric code which is defined below and in the USE STATUS CODE table [Lookup Table 1; 1 = Sample information, age data, complete taxon list published, 2 = Sample information and age data, no taxon list, 3 = Sample information and partial or complete taxon list, no age data, 4 = Sample information, no taxon list or age data (data may be unpublished), −9 = Sample information, age data, and partial taxon list published].</td></tr><tr><td>DB</td><td>STATE_OR_PROVINCE</td><td>State name for sites in the United States of America (USA) and Mexico, or province name for sites in Canada.</td></tr><tr><td>DC</td><td>COUNTY_OR_REGIONAL_DISTRICT</td><td>County name for sites in the USA or regional district name for sites in Canada.</td></tr><tr><td>DD</td><td>COUNTRY</td><td>Country name (USA, Mexico, or Canada).</td></tr><tr><td>DE</td><td>EARLIEST_PUBLICATION</td><td>Year of earliest publication.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab7\"><label>Table 7</label><caption><p>AGEC14 (Linked Table 3) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>RECOMMENDED_AGE_OF _ MIDDEN_ASSEMBLAGE</td><td><p>Symbols indicate the preferred age for representing the midden sample/assemblage. Symbols are defined below and in the RECOMMENDED AGE CODE table (Lookup Table 3).</p><p>X = Recommended age to represent the midden sample/assemblage.</p><p>X1-PA or X1-PA(FST) = Pooled Age (PA) or Pooled Age (Failed Significance Test). Primary preferred age when there are multiple ages on a sample.</p><p>X2 = Secondary preferred age when there are multiple ages on a sample. Age with the smaller standard deviation.</p><p>X? = Recommended age to represent the midden sample/assemblage but use with caution.</p><p>? = Multiple ages are not within two standard deviations of each other, and it is uncertain which age represents the midden sample/assemblage.</p></td></tr><tr><td>B</td><td>RECOMMENDED_AGE_JUSTIFICATION</td><td>Reasoning for age recommendation.</td></tr><tr><td>C</td><td>SAMCODE</td><td>Sample code. A unique code assigned to each midden sample.</td></tr><tr><td>D</td><td>AGEC14</td><td>Radiocarbon age in years before present.</td></tr><tr><td>E</td><td>STANDEV</td><td>Standard deviation (measure of analytical uncertainty).</td></tr><tr><td>F</td><td>CALIB704_CALENDAR_YR_BP_MEDIAN_PROBABILITY</td><td>Calibrated radiocarbon calendar age median probability generated using CALIB (rev. 7.0.4).</td></tr><tr><td>G</td><td>ABSOLUTE_LOWER_CALENDAR_AGE</td><td>2 sigma absolute youngest probable calendar age.</td></tr><tr><td>H</td><td>ABSOLUTE_UPPER_CALENDAR_AGE</td><td>2 sigma absolute oldest probable calendar age.</td></tr><tr><td>I</td><td>CALIB_95_PERCENT(2_SIGMA)_CALENDAR_AGE_RANGE</td><td>2 sigma probable calendar age range.</td></tr><tr><td>J</td><td>CALIBRATION_NOTES</td><td>Comments related to radiocarbon age calibration.</td></tr><tr><td>K</td><td>LABNO</td><td>A sample identification number assigned by the radiocarbon laboratory.</td></tr><tr><td>L</td><td>MATDATED</td><td>Material dated. May consist of various plant materials, dung pellets, or midden matrix. If the age is an average of multiple ages, the material used for each age is separated by a slash.</td></tr><tr><td>M</td><td>MDVARNUM1</td><td>Material dated variable number (corresponds to the VARNUM values in Linked Table 4), a unique number representing the first plant taxon dated in the sample.</td></tr><tr><td>N</td><td>MDVARNUM2</td><td>Material dated variable number (corresponds to the VARNUM values in Linked Table 4), a unique number representing the second plant taxon dated in the sample.</td></tr><tr><td>O</td><td>MDVARNUM3</td><td>Material dated variable number (corresponds to the VARNUM values in Linked Table 4), a unique number representing the third plant taxon dated in the sample.</td></tr><tr><td>P</td><td>MD_LISTED_IN_MIDDEN_TAXA_TABLE</td><td>Indicates whether the material dated is included in the midden taxon assemblage list.</td></tr><tr><td>Q</td><td>COMMENTS</td><td>Miscellaneous comments.</td></tr><tr><td>R</td><td>DATE_SUSPECT</td><td>An “X” indicates that the age may be in error, or the material dated may be an older or younger contaminant.</td></tr><tr><td>S</td><td>REFERENCE</td><td>Published source(s) for the age data.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab8\"><label>Table 8</label><caption><p>MIDDEN TAXA (Linked Table 4) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>VARNUM</td><td>Variable number. A unique number assigned to each midden taxon.</td></tr><tr><td>B</td><td>MAP_AVAILABILITY</td><td>A “1” indicates that a modern geographic distribution map for the midden taxon is available in the Thompson <italic>et al</italic>. Atlas<sup>##UREF##87##92##,##UREF##88##93##</sup>. A “0” indicates a map is not available in the Atlas. We did not indicate distribution map availability for midden taxa without species level identifications or for taxa with some degree of uncertainty in the species identification such as names containing “cf.” or “-type”. It is likely that midden taxa identified at the variety or subspecies level are included in species-level map coverages; however, we only list map coverage availability in association with species-level midden taxa and not for individual varieties or subspecies. Digital versions of species distribution maps from Thompson <italic>et al</italic>.<sup>##UREF##87##92##</sup> can be viewed online at 10.3133/pp1650G.</td></tr><tr><td>C</td><td>ATLAS_TAXON_NAME</td><td>Name of the Atlas taxon distribution map<sup>##UREF##87##92##,##UREF##88##93##</sup> that best represents the midden taxon. This name comes from the original mapped distribution source publication; therefore, the Atlas taxon name may not be the currently accepted name of the taxon.</td></tr><tr><td>D</td><td>CURRENTLY_ACCEPTED_ATLAS_TAXON_NAME</td><td>Currently accepted name of the mapped Atlas taxon<sup>##UREF##87##92##,##UREF##88##93##</sup>. This name is provided when the original map name has changed or when the original map distribution represents different taxa than the original name suggests.</td></tr><tr><td>E</td><td>VARNAME</td><td>Variable name. The original Latin botanical name and syntax for each taxon as used by the midden macrofossil analyst.</td></tr><tr><td>F</td><td>VARNAME_AUTHORITY</td><td>The name(s) identifying the person(s) who described and validly published the plant taxon name. Should the original taxon name have been revised, the name of the original authority is shown in parentheses followed by the name of the authority who created the existing taxon name. The names of authorities are abbreviated.</td></tr><tr><td>G</td><td>CURRENTLY_ACCEPTED_VARNAME</td><td>The currently accepted Latin botanical name for the taxon (“same” indicates that the currently accepted taxon name is the same as the VARNAME).</td></tr><tr><td>H</td><td>CURRENTLY_ACCEPTED_VARNAME_AUTHORITY</td><td>The name(s) identifying the person(s) who assigned the original taxon name (in parentheses) followed by the authority of the currently accepted taxon name who is responsible for defining the taxonomic name change (“same” indicates that the currently accepted authority is the same as the VARNAME_AUTHORITY).</td></tr><tr><td>I</td><td>NOMENCLATURAL_SOURCE</td><td>Source reference for nomenclatural information.</td></tr><tr><td>J</td><td>NOTES</td><td>Miscellaneous notes.</td></tr><tr><td>K</td><td>COMMON_NAME</td><td>Common name(s).</td></tr><tr><td>L</td><td>FAMILY</td><td>Latin name of the family of plants to which the taxon belongs.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab9\"><label>Table 9</label><caption><p>MIDDEN TAXA PER SAMPLE (Linked Table 5) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>SAMCODE</td><td>Sample code. A unique code assigned to each midden sample.</td></tr><tr><td>B</td><td>VARNUM</td><td>Variable number. A unique number assigned to each midden taxon.</td></tr><tr><td>C</td><td>MCOUNT</td><td>Macrofossil count. Original symbols or numbers used to represent plant macrofossil relative abundance or counts, defined in the CODE TRANSLATION table (Linked Table 6).</td></tr><tr><td>D</td><td>TYPE</td><td>Plant organs identified (needle, seed, leaf, etc.).</td></tr><tr><td>E</td><td>NOTES</td><td>Miscellaneous notes.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab10\"><label>Table 10</label><caption><p>CODE TRANSLATION (Linked Table ##TAB##5##6##) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>REFERENCE</td><td>Citation including author(s) and date of publication of taxon list source publication.</td></tr><tr><td>B</td><td>MCOUNT</td><td>Macrofossil count. Original symbols or numbers used to represent plant macrofossil relative abundance or counts, defined in the EXPLANATION field.</td></tr><tr><td>C</td><td>TYPE_OF_COUNT</td><td>General type of counting scheme used.</td></tr><tr><td>D</td><td>TAXA_COUNTED</td><td>Specifies whether the publication provides complete or partial taxon lists or if the taxon was added from material dated information.</td></tr><tr><td>E</td><td>EXPLANATION</td><td>Defines the symbols used to represent relative abundance in the source publication.</td></tr><tr><td>F</td><td>0_1_2_CODE</td><td>The original MCOUNT value or symbol translated into a standard 0-1-2 presence-absence scale (0 = Absent, 1 = Rare, 2 = Present, 7 = Cannot translate, 9 = Possible contaminant).</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab11\"><label>Table 11</label><caption><p>MCOUNT TRANSLATION (Linked Table 7) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>SAMCODE</td><td>Sample code. A unique code assigned to each midden sample.</td></tr><tr><td>B</td><td>VARNUM</td><td>Variable number. A unique number assigned to each midden taxon.</td></tr><tr><td>C</td><td>MCOUNT</td><td>Macrofossil count. Original symbols or numbers used to represent plant macrofossil relative abundance or counts, defined in the CODE TRANSLATION table (Linked Table 6).</td></tr><tr><td>D</td><td>0_1_2_CODE</td><td>The original macrofossil relative abundance or counts translated into a standard 0-1-2 presence-absence scale.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab12\"><label>Table 12</label><caption><p>CLIMATE DATA (Linked Table 8) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>SAMCODE</td><td>Sample code. A unique code assigned to each midden sample.</td></tr><tr><td>B</td><td>SITE</td><td>Name of midden site.</td></tr><tr><td>C</td><td>STATE_OR_PROVINCE</td><td>State name for sites in the USA and Mexico, or province name for sites in Canada.</td></tr><tr><td>D</td><td>COUNTRY</td><td>Country name (USA, Mexico, or Canada).</td></tr><tr><td>E</td><td>BEST_OR_PUB_LATDECDEGCON</td><td>Latitude (decimal degrees) used for climate interpolation. These latitude values are from the MIDDEN SAMPLE table (Linked Table 2).</td></tr><tr><td>F</td><td>BEST_OR_PUB_LONGDECDEGCON</td><td>Longitude (decimal degrees) used for climate interpolation. These longitude values are from the MIDDEN SAMPLE table (Linked Table 2).</td></tr><tr><td>G</td><td>BEST_OR_ELEV(M)1_ELEVATION</td><td>Elevation (meters) used for climate interpolation.</td></tr><tr><td>H-S</td><td>JANT – DECT</td><td>January to December monthly mean temperature (°C; 1961–1990 30-year mean).</td></tr><tr><td>T</td><td>MTCO<sup>a</sup></td><td>Mean temperature of the coldest month (°C; 1961–1990 30-year mean).</td></tr><tr><td>U</td><td>MTWA<sup>a</sup></td><td>Mean temperature of the warmest month (°C; 1961–1990 30-year mean).</td></tr><tr><td>V</td><td>ANNT<sup>a</sup></td><td>Mean annual temperature (°C; 1961–1990 30-year mean).</td></tr><tr><td>W</td><td>TMIN</td><td>Absolute minimum temperature (°C; 1951–1980).</td></tr><tr><td>X</td><td>TMAX</td><td>Absolute maximum temperature (°C; 1951–1980).</td></tr><tr><td>Y-AJ</td><td>JANP – DECP</td><td>January to December monthly mean total precipitation (mm; 1961–1990 30-year mean).</td></tr><tr><td>AK</td><td>ANNP<sup>a</sup></td><td>Mean annual total precipitation (mm; 1961–1990 30-year mean).</td></tr><tr><td>AL</td><td>RAIN<sup>a</sup></td><td>Rain (mm) component of mean annual total precipitation.</td></tr><tr><td>AM</td><td>SNOW<sup>a</sup></td><td>Snowfall snow water equivalent (mm) component of mean annual total precipitation.</td></tr><tr><td>AN</td><td>PET<sup>a</sup></td><td>Mean annual potential evapotranspiration (mm).</td></tr><tr><td>AO</td><td>EET<sup>a</sup></td><td>Mean annual equilibrium evapotranspiration (mm).</td></tr><tr><td>AP</td><td>AET<sup>a</sup></td><td>Mean annual actual evapotranspiration (mm).</td></tr><tr><td>AQ</td><td>ALPHA<sup>a</sup></td><td>Annual Priestley-Taylor coefficient (α) calculated as AET divided by EET (dimensionless)<sup>##UREF##89##94##</sup>.</td></tr><tr><td>AR</td><td>AETPET</td><td>Annual evaporation ratio calculated as AET divided by PET (dimensionless).</td></tr><tr><td>AS</td><td>MI</td><td>Annual moisture index calculated as ANNP divided by PET (dimensionless).</td></tr><tr><td>AT</td><td>CHILL<sup>a</sup></td><td>Chilling period (number of days with temperature &lt; 5 °C).</td></tr><tr><td>AU</td><td>GDD0<sup>a</sup></td><td>Growing-degree days on a 0 °C base.</td></tr><tr><td>AV</td><td>GDD5<sup>a</sup></td><td>Growing-degree days on a 5 °C base.</td></tr><tr><td>AW-BH</td><td>JANSUN – DECSUN</td><td>January to December mean monthly maximum possible sunshine (% of daylength; 1961–1990 30-year mean).</td></tr><tr><td>BI-BT</td><td>JANDTR – DECDTR</td><td>January to December mean monthly diurnal temperature range (°C; 1961–1990 30-year mean).</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab13\"><label>Table 13</label><caption><p>WWF ecoregion classification for packrat midden sites.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Level II Major Habitat Type</th><th>Level III Ecoregion</th></tr></thead><tbody><tr><td>Grasslands/Savanna/Shrub (GSS)</td><td><p>Montana Valley and Foothill Grasslands (MVFG)</p><p>Northern Short Grasslands (NSG)</p><p>Western Short Grasslands (WSG)</p></td></tr><tr><td>Temperate Coniferous Forests (TCF)</td><td><p>Arizona Mountains Forests (AMF)</p><p>Blue Mountains Forest (BMF)</p><p>Cascade Mountains Leeward Forest (CMLF)</p><p>Colorado Rockies Forests (CRF)</p><p>Eastern Cascades Forest (ECF)</p><p>Fraser Plateau and Basin complex Forests (FPBF)</p><p>Great Basin Montane Forests (GBMF)</p><p>Sierra Juarez and San Pedro Martir Pine Oak Forest (SSPOF)</p><p>Sierra Nevada Forests (SNF)</p><p>South Central Rockies Forests (SCRF)</p><p>Wasatch Uinta Montane Forests (WUMF)</p></td></tr><tr><td>Mediterranean Scrub and Savanna (MSS)</td><td>California Coastal Sage and Chaparral (CCSC).</td></tr><tr><td>Xeric Shrublands/Scrublands (XSS)</td><td><p>Snake/Columbia Shrub Steppe (SCSS)</p><p>Wyoming Basin Shrub Steppe (WBSS)</p><p>Great Basin Shrub Steppe (GBSS)</p><p>Colorado Plateau Shrubland (CPS)</p></td></tr><tr><td>Xeric Deserts (XD)</td><td><p>Baja California Desert (BCD)</p><p>Chihuahuan Desert (CD)</p><p>Mojave Desert (MD)</p><p>Sonoran Desert (SD)</p></td></tr><tr><td>Broadleaf and Mixed Forests (BMF)</td><td>Sierra Madre Occidental Pine Oak Forest (SMPOF)</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab14\"><label>Table 14</label><caption><p>ECOREGION (Linked Table 9) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>SAMCODE</td><td>Sample code. A unique code assigned to each midden sample.</td></tr><tr><td>B</td><td>WWF_LEVEL_II_MHT_CODE</td><td>Two- or three-letter code representing 1 of 6 possible level II MHT categories.</td></tr><tr><td>C</td><td>WWF_LEVEL_II_MHT_CATEGORY</td><td>Level II MHT category definition.</td></tr><tr><td>D</td><td>WWF_LEVEL_III_ECOREGION_CODE</td><td>Two-, three-, four-, or five-letter code representing 1 of 24 possible level III ecoregion categories.</td></tr><tr><td>E</td><td>WWF_LEVEL_III_ECOREGION_CATEGORY</td><td>Level III ecoregion category definition.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab15\"><label>Table 15</label><caption><p>PLANT FUNCTIONAL TYPE (Linked Table 10) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>VARNUM</td><td>Variable number. A unique number assigned to each midden taxon.</td></tr><tr><td>B</td><td>AA</td><td>Arctic/Alpine</td></tr><tr><td>C</td><td>BEC</td><td>Boreal Evergreen Conifer</td></tr><tr><td>D</td><td>BS</td><td>Boreal Summergreen</td></tr><tr><td>E</td><td>TS</td><td>Temperate Summergreen</td></tr><tr><td>F</td><td>CTC</td><td>Cool Temperate Conifer</td></tr><tr><td>G</td><td>CTE</td><td>Cool Temperate broadleaved Evergreen</td></tr><tr><td>H</td><td>TS1</td><td>cool Temperate Summergreen</td></tr><tr><td>I</td><td>TS2</td><td>intermediate Temperate Summergreen</td></tr><tr><td>J</td><td>WTC</td><td>Warm Temperate Conifer</td></tr><tr><td>K</td><td>WTE</td><td>Warm Temperate broadleaved Evergreen</td></tr><tr><td>L</td><td>WTE2</td><td>Warm Temperate broadleaved Evergreen sclerophyll</td></tr><tr><td>M</td><td>TS3</td><td>warm Temperate Summergreen</td></tr><tr><td>N</td><td>WC</td><td>Woodland Conifer</td></tr><tr><td>O</td><td>WS</td><td>Woodland broadleaved tree/Shrub</td></tr><tr><td>P</td><td>SS</td><td>Steppe tree/Shrub</td></tr><tr><td>Q</td><td>SF</td><td>Steppe Forb</td></tr><tr><td>R</td><td>DS</td><td>Desert tree/Shrub</td></tr><tr><td>S</td><td>DS2</td><td>Desert tree/Shrub frost sensitive</td></tr><tr><td>T</td><td>DF</td><td>Desert Forb</td></tr><tr><td>U</td><td>OF</td><td>Other Forb</td></tr><tr><td>V</td><td>G</td><td>Grass</td></tr><tr><td>W</td><td>H</td><td>Heath</td></tr><tr><td>X</td><td>S</td><td>Sedge</td></tr><tr><td>Y</td><td>FA</td><td>Ferns and Fern Allies</td></tr><tr><td>Z</td><td>GROWTH_FORM</td><td>Categorizes each taxon by growth form. If a taxon belongs to more than one category (for example, trees and shrubs) we assigned the taxon to the lowest category (tree). 0 = tree, 5 = shrub (includes subshrubs), 8 = forbs and grasses.</td></tr><tr><td>AA</td><td>PLANT_COMMUNITY_DESCRIPTION_AND_DISTRIBUTION_NOTES</td><td>Notes collected from various floras describing the geographic occurrence of the taxon and the plant communities in which the taxon is commonly found.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab16\"><label>Table 16</label><caption><p>Online resources consulted for plant functional type (PFT) evaluation and classification (accessed 2011–2020).</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Online Resource</th><th>URL</th></tr></thead><tbody><tr><td>Calflora, information on wild California plants.</td><td><ext-link ext-link-type=\"uri\" xlink:href=\"https://www.calflora.org/\">https://www.calflora.org/</ext-link></td></tr><tr><td>California Native Plant Society, CALSCAPE.</td><td><ext-link ext-link-type=\"uri\" xlink:href=\"https://calscape.org/\">https://calscape.org/</ext-link></td></tr><tr><td>Fire Effects Information System (FEIS). Fire effects information system (FEIS) online database, U.S. Department of Agriculture Forest Service, Rocky Mountain Research Station, Fire Sciences Laboratory.</td><td><ext-link ext-link-type=\"uri\" xlink:href=\"https://feis-crs.org/feis/\">https://feis-crs.org/feis/</ext-link></td></tr><tr><td>Flora of North America, eFloras: St. Louis, MO, Missouri Botanical Garden, and Cambridge, MA, Harvard University Herbaria.</td><td><ext-link ext-link-type=\"uri\" xlink:href=\"http://www.efloras.org\">http://www.efloras.org</ext-link></td></tr><tr><td>Southwest Environmental Information Network (SEINet). SEINet Data Portal.</td><td><ext-link ext-link-type=\"uri\" xlink:href=\"https://swbiodiversity.org/seinet/\">https://swbiodiversity.org/seinet/</ext-link></td></tr><tr><td>Texas Native Plants Database (Benny Simpson’s Texas native trees).</td><td><ext-link ext-link-type=\"uri\" xlink:href=\"https://aggie-horticulture.tamu.edu/ornamentals/natives/tamuhort.html\">https://aggie-horticulture.tamu.edu/ornamentals/natives/tamuhort.html</ext-link></td></tr><tr><td>The Biota of North America Program, BONAP.</td><td><ext-link ext-link-type=\"uri\" xlink:href=\"http://bonap.net/napa\">http://bonap.net/napa</ext-link></td></tr><tr><td>The Jepson Herbarium eFlora, University of California, Berkeley.</td><td><ext-link ext-link-type=\"uri\" xlink:href=\"http://ucjeps.berkeley.edu/eflora/\">http://ucjeps.berkeley.edu/eflora/</ext-link></td></tr><tr><td>U.S. Department of Agriculture Natural Resources Conservation Service (USDA NRCS). The PLANTS Database, National Plant Data Team, Greensboro, NC, USA.</td><td><ext-link ext-link-type=\"uri\" xlink:href=\"https://plants.sc.egov.usda.gov/home\">https://plants.sc.egov.usda.gov/ home</ext-link></td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab17\"><label>Table 17</label><caption><p>Plant functional type (PFT) category descriptions and representative taxa.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Climatic Zone or Biome</th><th>PFTs and Representative Taxa</th></tr></thead><tbody><tr><td>ARCTIC</td><td><bold>AA</bold> = Arctic/Alpine dwarf shrubs and perennial herbs: needleleaved, scale-leaved, or broadleaved; deciduous or evergreen. Includes midden database taxa: <italic>Juniperus communis</italic>, <italic>J. horizontalis</italic>, <italic>Phlox</italic> sp., and Polemoniaceae. <bold>OF</bold> = Other Forbs, arctic forbs are placed in this category.</td></tr><tr><td>BOREAL</td><td><p><bold>BEC</bold> = Boreal Evergreen Conifer trees/shrubs, needleleaved and scale-leaved. Includes midden database taxa: <italic>Juniperus communis</italic>, <italic>J. horizontalis, Pseudotsuga menziesii</italic>, Pinaceae<italic>, Picea</italic> sp., and <italic>Pinus</italic> sp.</p><p><bold>BS</bold> = Boreal Summergreen trees/shrubs, broadleaved. Includes midden database taxa: <italic>Alnus</italic> spp., <italic>Amelanchier alnifolia</italic>, <italic>Betula papyrifera</italic>-type, <italic>Ceanothus</italic> sp., <italic>Cornus</italic> spp., <italic>Fraxinus</italic> sp., <italic>Populus</italic> sp., <italic>Dasiphora fruticosa</italic>, <italic>Prunus</italic> sp., <italic>Rhamnus</italic> sp., <italic>Rhus</italic> sp., <italic>Ribes montigenum, Rosa woodsii, Rubus</italic> sp.<italic>, Salix lasiandra, Sambucus</italic> spp<italic>., Shepherdia canadensis</italic>, and <italic>Symphoricarpos</italic> spp.</p><p><bold>OF</bold> = Other Forbs, boreal forbs are placed in this category.</p></td></tr><tr><td>TEMPERATE</td><td><bold>TS</bold> = General category for Temperate Summergreen trees/shrubs (includes <bold>TS1,</bold>\n<bold>TS2</bold>, and <bold>TS3</bold> categories). Taxa assigned to the TS category are not always differentiated into <bold>TS1,</bold>\n<bold>TS2</bold>, or <bold>TS3</bold> categories.</td></tr><tr><td>Cool Temperate</td><td><p><bold>CTC</bold> = Cool Temperate Conifer trees/shrubs, evergreen. Includes midden database taxa: <italic>Abies</italic> spp., <italic>Juniperus</italic> spp., <italic>Picea</italic> spp., and <italic>Pinus</italic> spp.</p><p><bold>CTE</bold> = Cool Temperate broadleaved Evergreen trees/shrubs, includes succulents (<italic>Agave</italic> and Cactaceae). Includes midden database genera: <italic>Arctostaphylos, Artemisia, Berberis, Cercocarpus, Ericameria, Purshia, Quercus, Rhamnus</italic>, and <italic>Yucca</italic>.</p><p><bold>TS1</bold> = cool Temperate Summergreen trees/shrubs. Includes midden database genera: <italic>Acer, Amelanchier, Artemisia, Betula, Celtis, Populus, Prunus, Purshia, Quercus, Rhus, Ribes, Salix, Sambucus</italic>, and <italic>Symphoricarpos</italic>.</p></td></tr><tr><td>Intermediate Temperate</td><td><bold>TS2</bold> = intermediate Temperate Summergreen trees/shrubs.</td></tr><tr><td>Warm Temperate</td><td><p>Includes plants occurring in Mediterranean type chaparral, coastal sage scrub, and oak woodland within California (USA), in chaparral and oak woodland within Arizona (USA) and New Mexico (USA), and oak woodland within Texas (USA).</p><p><bold>WTC</bold> = Warm Temperate Conifer trees/shrubs, evergreen. Includes midden database taxa: <italic>Abies concolor</italic>, <italic>Calocedrus decurrens</italic>, <italic>Hesperocyparis</italic> spp., <italic>Pinus discolor</italic>, <italic>Pinus monophylla</italic>, and <italic>Torreya californica</italic>.</p><p><bold>WTE</bold> = Warm Temperate broadleaved Evergreen trees/shrubs, also semi-evergreen (drought deciduous) plants, includes succulents (<italic>Agave</italic> and Cactaceae). Includes midden database genera and families: <italic>Arctostaphylos</italic>, Cactaceae, <italic>Cercocarpus, Ephedra, Ericameria</italic>, <italic>Quercus, Rhamnus</italic>, and <italic>Yucca</italic>.</p><p><bold>WTE2</bold> = Warm Temperate broadleaved Evergreen sclerophyll trees/shrubs, plants with hard, leathery, evergreen foliage. Includes midden database genera: <italic>Arctostaphylos</italic>, <italic>Baccharis, Ceanothus, Quercus</italic>, and <italic>Vauquelinia</italic>.</p><p><bold>TS3</bold> = warm Temperate Summergreen trees/shrubs. Includes midden database genera: <italic>Bursera, Encelia, Eriogonum, Lycium, Nolina, Populus, Prosopis, Prunus, Rhus</italic>, and <italic>Sambucus</italic>.</p><p><bold>OF</bold> = Other Forbs, temperate forbs are placed in this category.</p></td></tr><tr><td>OPEN CONIFER WOODLAND (PINYON – JUNIPER WOODLAND)</td><td><p><bold>WC</bold> = Woodland Conifer trees/shrubs, evergreen, needleleaved and scale-leaved. Includes midden database taxa: <italic>Hesperocyparis</italic> spp., <italic>Juniperus ashei, J. communis</italic>, <italic>J. deppeana, J. horizontalis, J. osteosperma, J. pinchotii</italic>, <italic>J. scopulorum</italic>, <italic>Pinus cembroides, P. edulis</italic>, <italic>P. flexilis, P. monophylla</italic>, <italic>P. quadrifolia</italic>, and <italic>P. remota</italic>.</p><p><bold>WS</bold> = Woodland broadleaved trees/Shrubs, evergreen or summergreen, including succulents (Agavaceae and Cactaceae). Includes midden database genera: <italic>Agave, Artemisia, Atriplex, Brickellia, Echinocereus, Ephedra</italic>, <italic>Ericameria, Eriogonum, Forsellesia, Gutierrezia, Holodiscus, Lycium, Mortonia, Opuntia, Prunus, Psorothamnus, Quercus, Rosa, Salvia, Sclerocactus, Shepherdia, Symphoricarpos, Tetradymia</italic>, and <italic>Yucca</italic>.</p><p><bold>OF</bold> = Other Forbs, conifer woodland forbs are placed in this category.</p></td></tr><tr><td>STEPPE</td><td><p><bold>SS</bold> = Steppe trees/Shrubs, broadleaved (evergreen or summergreen). Includes subshrubs or suffrutescent shrubs with woody bases, and succulents (<italic>Agave</italic> and Cactaceae). Includes midden database genera and families: <italic>Agave</italic>, <italic>Amelanchier</italic>, <italic>Artemisia</italic>, <italic>Atriplex</italic>, <italic>Berberis</italic>, <italic>Brickellia</italic>, Cactaceae, <italic>Cercocarpus</italic>, <italic>Ephedra</italic>, <italic>Ericameria</italic>, <italic>Gutierrezia</italic>, <italic>Potentilla</italic>, <italic>Prosopis</italic>, <italic>Prunus</italic>, <italic>Purshia</italic>, <italic>Quercus</italic>, <italic>Rhus</italic>, <italic>Ribes</italic>, <italic>Salvia</italic>, <italic>Sambucus</italic>, <italic>Tetradymia</italic>, and <italic>Yucca</italic>.</p><p><bold>SF</bold> = Steppe herbaceous Forbs. Found in grassland or prairie environments.</p></td></tr><tr><td>DESERT</td><td><p><bold>DS</bold> = Desert trees/Shrubs, broadleaved (evergreen or summergreen), plants have a strategy for survival in desert climates such as stem photosynthesis, drought deciduousness, and succulence. Includes subshrubs or suffrutescent shrubs with woody bases, and succulents (<italic>Agave</italic> and Cactaceae). Includes midden database taxa: <italic>Agave</italic>, <italic>Ambrosia</italic>, <italic>Artemisia</italic>, <italic>Atriplex</italic>, <italic>Berberis</italic>, <italic>Brickellia</italic>, <italic>Buddleja</italic>, Cactaceae, <italic>Cercidium</italic>, <italic>Condalia</italic>, <italic>Dasylirion wheeleri</italic>, <italic>Ephedra</italic>, <italic>Fallugia paradoxa</italic>, <italic>Fouquieria</italic>, <italic>Fraxinus</italic>, <italic>Ericameria</italic>, <italic>Gutierrezia</italic>, <italic>Jatropha</italic>, <italic>Larrea tridentata</italic>, <italic>Mortonia</italic>, <italic>Olneya</italic>, <italic>Parkinsonia</italic>, <italic>Prosopis</italic>, <italic>Psorothamnus</italic>, <italic>Rhus</italic>, <italic>Sarcobatus</italic>, <italic>Senegalia</italic>, <italic>Vachellia</italic>, <italic>Viguiera</italic>, and <italic>Yucca</italic>.</p><p><bold>DS2</bold> = Desert trees/Shrubs, frost sensitive (not annuals or perennials that regenerate after frost). Includes midden database taxa: <italic>Bursera microphylla</italic>, <italic>Cereus giganteus</italic>, <italic>Olneya tesota</italic>, <italic>Pachycereus schottii</italic>, <italic>Parkinsonia</italic>, and <italic>Stenocereus thurberi</italic>. <bold>DF</bold> = Desert herbaceous Forbs.</p></td></tr><tr><td>OTHER</td><td><p><bold>G</bold> = Grass, all Poaceae. <bold>S</bold> = Sedge, all Cyperaceae. <bold>H</bold> = Heath, all Ericaceae.</p><p><bold>FA</bold> = Ferns and Fern Allies, non-vascular bryophytes (liverwort, hornwort, true moss) and seedless vascular plants: Lycophyta (club mosses), Psilotophyta (<italic>Psilotum</italic>), Pterophyta (ferns), and Sphenophyta (horsetails).</p><p><bold>OF</bold> = Other Forbs, includes weedy species, all forbs other than desert and steppe forbs such as arctic, boreal, temperate, and open conifer woodland forbs.</p></td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab18\"><label>Table 18</label><caption><p>SYNONYMS (Unlinked Table 1) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>VARNUM</td><td>Variable number. A unique number assigned to each midden taxon.</td></tr><tr><td>B</td><td>VARNAME</td><td>Variable name. The original Latin botanical name and syntax used by the midden macrofossil analyst.</td></tr><tr><td>C-O</td><td>VARNUM2-8</td><td>Variable numbers 2–8.</td></tr><tr><td>D-P</td><td>SYNONYM_VARNAME2–8</td><td>Synonymous variable names 2–8.</td></tr><tr><td>Q</td><td>CURRENTLY_ACCEPTED_VARNAME</td><td>The currently accepted Latin botanical name.</td></tr><tr><td>R</td><td>NOTES</td><td>Note indicates when an autonym is the accepted name.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab19\"><label>Table 19</label><caption><p>MIDDEN RELATED PUBLICATIONS WITH NO SIGNIFICANT DATA (Unlinked Table 2) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>YEAR_PUBLISHED</td><td>The year the source reference was published.</td></tr><tr><td>B</td><td>CITATION</td><td>Author(s) last name(s) and year of publication.</td></tr><tr><td>C</td><td>FULL_REFERENCE</td><td>Includes when available, the author(s) last name(s) and first initials, year of publication, title, journal or publication series, editor, publisher, page numbers, and URL.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab20\"><label>Table 20</label><caption><p>MIDDEN RELATED ABSTRACTS WITH NO SIGNIFICANT DATA (Unlinked Table 3) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>YEAR_PUBLISHED</td><td>The year the source reference was published.</td></tr><tr><td>B</td><td>CITATION</td><td>Author(s) last name(s) and year of publication.</td></tr><tr><td>C</td><td>FULL_REFERENCE</td><td>Includes when available, the author(s) last name(s) and first initials, year of publication, title, journal, program or abstract volume, page numbers, and URL.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab21\"><label>Table 21</label><caption><p>MIDDEN PUBLICATIONS OUTSIDE NORTH AMERICA (Unlinked Table 4) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>YEAR_PUBLISHED</td><td>The year the source reference was published.</td></tr><tr><td>B</td><td>CITATION</td><td>Author(s) last name(s) and year of publication.</td></tr><tr><td>C</td><td>FULL_REFERENCE</td><td>Includes when available, the author(s) last name(s) and first initials, year of publication, title, journal or publication series, editor, publisher, page numbers, and URL.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab22\"><label>Table 22</label><caption><p>USE STATUS CODE (Lookup Table 1) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>USE_STATUS_CODE</td><td>Status codes: −9, 1, 2, 3, 4.</td></tr><tr><td>B</td><td>CODE_DEFINITION</td><td>Definition for each use status code.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab23\"><label>Table 23</label><caption><p>0-1-2 CODE (Lookup Table 2) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>0_1_2_CODE</td><td>Codes: 0, 1, 2, 7, 9.</td></tr><tr><td>B</td><td>CODE_DEFINITION</td><td>Definition for each 0-1-2 code.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab24\"><label>Table 24</label><caption><p>RECOMMENDED AGE CODE (Lookup Table 3) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>AGE_CODE</td><td>Age codes: X, X?, X1-PA, X1-PA(FST), X2, ?.</td></tr><tr><td>B</td><td>CODE_DEFINITION</td><td>Definition for each age code.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab25\"><label>Table 25</label><caption><p>TAXON LIST CODE (Lookup Table 4) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>TAXON_LIST_CODE</td><td>Taxon list codes: C, CU, P, PU.</td></tr><tr><td>B</td><td>CODE_DEFINITION</td><td>Definition for each taxon list code.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab26\"><label>Table 26</label><caption><p>ECOREGION CODE (Lookup Table 5) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>WWF_LEVEL_III_ECOREGION_CODE</td><td>WWF level III ecoregion codes.</td></tr><tr><td>B</td><td>WWF_LEVEL_III_ECOREGION_CATEGORY</td><td>WWF level III ecoregion names.</td></tr><tr><td>C</td><td>WWF_LEVEL_II_MHT_CODE</td><td>WWF level II major habitat type (MHT) codes.</td></tr><tr><td>D</td><td>WWF_LEVEL_II_MHT_CATEGORY</td><td>WWF level II major habitat type (MHT) names.</td></tr></tbody></table></table-wrap>", "<table-wrap id=\"Tab27\"><label>Table 27</label><caption><p>PLANT FUNCTIONAL TYPE CODE (Lookup Table 6) field descriptions.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th>Column</th><th>Field Name</th><th>Description</th></tr></thead><tbody><tr><td>A</td><td>PLANT_FUNCTIONAL_TYPE_CATEGORY_ABBREVIATION</td><td>Plant functional type (PFT) category abbreviations.</td></tr><tr><td>B</td><td>PLANT_FUNCTIONAL_TYPE_CATEGORY</td><td>Plant functional type (PFT) category names.</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[]
[ "<table-wrap-foot><p>Data release files: Linked_Table_1_REFERENCE.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Linked_Table_2_MIDDEN_SAMPLE.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Linked_Table_3_AGEC14.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Linked_Table_4_MIDDEN_TAXA.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Linked_Table_5_MIDDEN_TAXA_PER_SAMPLE.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Linked_Table_6_CODE_TRANSLATION.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Linked_Table_7_MCOUNT_TRANSLATION.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Linked_Table_8_CLIMATE_DATA.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p><p><sup>a</sup>Variable calculated using SPLASH<sup>##UREF##15##19##</sup> (SPLASH code is available from <ext-link ext-link-type=\"uri\" xlink:href=\"https://bitbucket.org/labprentice/splash/src/master/\">https://bitbucket.org/labprentice/splash/src/master/</ext-link>).</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Linked_Table_9_ECOREGION.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Linked_Table_10_PLANT_FUNCTIONAL_TYPE.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Unlinked_Table_1_SYNONYMS.xls (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Unlinked_Table_2_MIDDEN_RELATED_PUBLICATIONS_WITH_NO_SIGNIFICANT_DATA.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Unlinked_Table_3_MIDDEN_RELATED_ABSTRACTS_WITH_NO_SIGNIFICANT_DATA.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Unlinked_Table_4_MIDDEN_PUBLICATIONS_OUTSIDE_NORTH_AMERICA.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Lookup_Table_1_USE_STATUS_CODE.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Lookup_Table_2_0_1_2_CODE.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Lookup_Table_3_RECOMMENDED_AGE_CODE.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release files: Lookup_Table_4_TAXON_LIST_CODE.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release file: Lookup_Table_5_ECOREGION_CODE.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<table-wrap-foot><p>Data release file: Lookup_Table_6_PLANT_FUNCTIONAL_TYPE_CODE.xlsx (.csv)<sup>##UREF##12##16##</sup>.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group>" ]
[ "<inline-graphic xlink:href=\"41597_2023_2616_Figa_HTML.gif\" id=\"d32e434\"/>", "<graphic xlink:href=\"41597_2023_2616_Fig1_HTML\" id=\"d32e444\"/>", "<graphic xlink:href=\"41597_2023_2616_Fig2_HTML\" id=\"d32e3273\"/>", "<graphic xlink:href=\"41597_2023_2616_Fig3_HTML\" id=\"d32e3405\"/>" ]
[]
[{"label": ["1."], "mixed-citation": ["Vaughan, T. A. Ecology of living packrats. In "], "italic": ["Packrat Middens: The Last 40,000 Years Of Biotic Change"]}, {"label": ["2."], "mixed-citation": ["Betancourt, J. L., Van Devender, T. R. & Martin, P. S. (eds.) "], "italic": ["Packrat Middens: The Last 40,000 Years Of Biotic Change"]}, {"label": ["3."], "mixed-citation": ["Finley, R. B. Jr. Woodrat ecology and behavior and the interpretation of paleomiddens. In "], "italic": ["Packrat Middens: The Last 40,000 Years Of Biotic Change"]}, {"label": ["4."], "mixed-citation": ["Spaulding, W. G., Betancourt, J. L., Croft, L. K. & Cole, K. L. Packrat middens: their composition and methods of analysis. In "], "italic": ["Packrat Middens: The Last 40,000 Years of Biotic Change"]}, {"label": ["5."], "surname": ["Beck", "Bryant", "Jenkins"], "given-names": ["CW", "VM", "DL"], "article-title": ["Comparison of "], "italic": ["Neotoma"], "source": ["Palynology"], "year": ["2020"], "volume": ["44"], "fpage": ["723"], "lpage": ["741"], "pub-id": ["10.1080/01916122.2019.1702118"]}, {"label": ["6."], "surname": ["Pearson", "Betancourt"], "given-names": ["S", "JL"], "article-title": ["Understanding arid environments using fossil rodent middens"], "source": ["J. Arid Environ."], "year": ["2002"], "volume": ["50"], "fpage": ["499"], "lpage": ["511"], "pub-id": ["10.1006/jare.2001.0901"]}, {"label": ["8."], "surname": ["Butterfield", "Anderson", "Holmgren", "Betancourt"], "given-names": ["BJ", "RS", "CA", "JL"], "article-title": ["Extinction debt and delayed colonization have had comparable but unique effects on plant community\u2013climate lags since the Last Glacial Maximum"], "source": ["Global Ecol. Biogeogr."], "year": ["2019"], "volume": ["28"], "issue": ["8"], "fpage": ["1067"], "lpage": ["1077"], "pub-id": ["10.1111/geb.12915"]}, {"label": ["9."], "surname": ["Harbert", "Nixon"], "given-names": ["RS", "KC"], "article-title": ["Quantitative Late Quaternary climate reconstruction from plant macrofossil communities in Western North America"], "source": ["Open Quaternary"], "year": ["2018"], "volume": ["4"], "fpage": ["1"], "lpage": ["13"], "pub-id": ["10.5334/oq.46"]}, {"label": ["12."], "surname": ["Pelletier"], "given-names": ["J"], "article-title": ["The linkages among hillslope-vegetation changes, elevation, and the timing of late-Quaternary fluvial-system aggradation in the Mojave Desert revisited"], "source": ["Earth Surf. Dynam."], "year": ["2014"], "volume": ["2"], "fpage": ["455"], "lpage": ["468"], "pub-id": ["10.5194/esurf-2-455-2014"]}, {"label": ["13."], "surname": ["Inman", "Franklin", "Esque", "Nussear"], "given-names": ["R", "J", "T", "K"], "article-title": ["Spatial sampling bias in the "], "italic": ["Neotoma"], "source": ["Quaternary Sci. Rev."], "year": ["2018"], "volume": ["198"], "fpage": ["115"], "lpage": ["125"], "pub-id": ["10.1016/j.quascirev.2018.08.015"]}, {"label": ["14."], "surname": ["Strickland", "Thompson", "Anderson"], "given-names": ["LE", "RS", "KH"], "source": ["USGS/NOAA North American Packrat Midden Database Data Dictionary, USGS Open File Report 2001-022"], "year": ["2001"], "pub-id": ["10.3133/ofr0122"]}, {"label": ["15."], "mixed-citation": ["Strickland, L. E., Schumann, R. R., Thompson, R. S., Anderson, K. H. & Pelltier, R. T. USGS/NOAA North American Packrat Midden Database, Version 4, "], "ext-link": ["https://geochange.er.usgs.gov/midden/"]}, {"label": ["16."], "surname": ["Strickland"], "given-names": ["LE"], "year": ["2023"], "data-title": ["USGS North American Packrat Midden Database, Version 5.0. U.S. Geological Survey data release"], "source": ["ScienceBase"], "pub-id": ["10.5066/P91UOARW"]}, {"label": ["17."], "mixed-citation": ["Ricketts, T. H. "], "italic": ["et al", "Terrestrial Ecoregions Of North America\u2014A Conservation Assessment"]}, {"label": ["18."], "surname": ["New", "Lister", "Hulme", "Makin"], "given-names": ["M", "D", "M", "I"], "article-title": ["A high-resolution data set of surface climate over global land areas"], "source": ["Clim. Res."], "year": ["2002"], "volume": ["21"], "fpage": ["1"], "lpage": ["25"], "pub-id": ["10.3354/cr021001"]}, {"label": ["19."], "surname": ["Davis"], "given-names": ["TW"], "article-title": ["Simple process-led algorithms for simulating habitats (SPLASH v.1.0): robust indices of radiation, evapotranspiration and plant-available moisture"], "source": ["Geosci. Model Dev."], "year": ["2017"], "volume": ["10"], "fpage": ["689"], "lpage": ["708"], "pub-id": ["10.5194/gmd-10-689-2017"]}, {"label": ["20."], "mixed-citation": ["National Geographic. TOPO! Wyoming [CD-ROM] (National Geographic Holdings Inc., 2000)."]}, {"label": ["21."], "mixed-citation": ["National Geographic. TOPO! Arizona, California, Colorado, Idaho, Nevada [CD-ROM] (National Geographic Holdings Inc., 2003)."]}, {"label": ["22."], "mixed-citation": ["National Geographic. TOPO! Montana, New Mexico, Oregon, Texas, Utah, Washington [CD-ROM] (National Geographic Holdings Inc., 2004)."]}, {"label": ["23."], "surname": ["Stuiver", "Reimer"], "given-names": ["M", "PJ"], "article-title": ["Extended "], "sup": ["14", "14"], "source": ["Radiocarbon"], "year": ["1993"], "volume": ["35"], "fpage": ["215"], "lpage": ["230"], "pub-id": ["10.1017/S0033822200013904"]}, {"label": ["24."], "surname": ["Reimer"], "given-names": ["PJ"], "article-title": ["IntCal13 and Marine13 radiocarbon age calibration curves 0\u221250,000 years cal BP"], "source": ["Radiocarbon"], "year": ["2013"], "volume": ["55"], "fpage": ["1869"], "lpage": ["1887"], "pub-id": ["10.2458/azu_js_rc.55.16947"]}, {"label": ["25."], "surname": ["Thompson", "Shafer", "Strickland", "Van de Water", "Anderson"], "given-names": ["RS", "SL", "LE", "PK", "KH"], "article-title": ["Quaternary vegetation and climate change in the western United States: Developments, perspectives, and prospects"], "source": ["Developments in Quaternary Science"], "year": ["2003"], "volume": ["1"], "fpage": ["403"], "lpage": ["426"], "pub-id": ["10.1016/S1571-0866(03)01018-2"]}, {"label": ["26."], "surname": ["Reimer"], "given-names": ["PJ"], "article-title": ["The IntCal20 Northern Hemisphere radiocarbon age calibration curve (0\u221255 cal kBP)"], "source": ["Radiocarbon"], "year": ["2020"], "volume": ["62"], "fpage": ["725"], "lpage": ["757"], "pub-id": ["10.1017/RDC.2020.41"]}, {"label": ["27."], "surname": ["Reimer"], "given-names": ["PJ"], "article-title": ["Evolution of radiocarbon calibration"], "source": ["Radiocarbon"], "year": ["2022"], "volume": ["64"], "fpage": ["523"], "lpage": ["539"], "pub-id": ["10.1017/RDC.2021.62"]}, {"label": ["28."], "mixed-citation": ["McNeill, J. International Code of Botanical Nomenclature (Vienna Code): Adopted By The Seventeenth International Botanical Congress, Vienna, Austria, July 2005. (International Association for Plant Taxonomy, 2006)."]}, {"label": ["29."], "surname": ["Anderson"], "given-names": ["LC"], "article-title": ["A new species of fossil "], "italic": ["Chrysothamnus"], "source": ["Great Basin Nat."], "year": ["1980"], "volume": ["40"], "fpage": ["351"], "lpage": ["352"]}, {"label": ["30."], "surname": ["Anderson"], "given-names": ["LC"], "article-title": ["The "], "italic": ["Chrysothamnus", "Ericameria"], "source": ["Great Basin Nat."], "year": ["1995"], "volume": ["55"], "fpage": ["84"], "lpage": ["88"]}, {"label": ["31."], "mixed-citation": ["Gentry, H. S. "], "italic": ["Agaves Of Continental North America"]}, {"label": ["32."], "mixed-citation": ["Gleason, H. A. & Cronquist, A. "], "italic": ["Manual Of Vascular Plants Of The Northeastern United States And Adjacent Canada"]}, {"label": ["33."], "mixed-citation": ["Guzm\u00e1n, U., Arias, S. & D\u00e1vila Aranda, P. D. "], "italic": ["Cat\u00e1logo De Cact\u00e1ceas Mexicanas"]}, {"label": ["34."], "surname": ["Webb", "Starr"], "given-names": ["RH", "G"], "article-title": ["Gentry revisited: The agaves of the peninsula of Baja California, M\u00e9xico"], "source": ["Haseltonia"], "year": ["2015"], "volume": ["20"], "fpage": ["64"], "lpage": ["108"], "pub-id": ["10.2985/026.020.0101"]}, {"label": ["35."], "mixed-citation": ["Wiggins, I. R. "], "italic": ["Flora Of Baja California"]}, {"label": ["36."], "surname": ["Bye"], "given-names": ["R"], "article-title": ["Vascular plants of Arizona: Solanaceae Potato Family. Part One. Datura L"], "source": ["Journal of the Arizona-Nevada Academy of Science"], "year": ["2001"], "volume": ["33"], "fpage": ["58"], "lpage": ["64"]}, {"label": ["37."], "surname": ["de Laubenfels"], "given-names": ["DJ"], "article-title": ["Further nomenclatural action for the Cypresses (Cupressaceae)"], "source": ["Novon"], "year": ["2012"], "volume": ["22"], "fpage": ["8"], "lpage": ["15"], "pub-id": ["10.3417/2010056"]}, {"label": ["38."], "mixed-citation": ["Farjon, A. "], "italic": ["World Checklist And Bibliography Of Conifers, Second Edition"]}, {"label": ["39."], "mixed-citation": ["Felger, R. S. "], "italic": ["Flora Of The Gran Desierto And Rio Colorado Of Northwestern Mexico"]}, {"label": ["40."], "mixed-citation": ["Kartesz, J. T. "], "italic": ["A Synonymized Checklist Of The Vascular Flora Of The United States, Canada, And Greenland, Second Edition, Volume 1, Checklist"]}, {"label": ["41."], "surname": ["McLaughlin"], "given-names": ["SP"], "article-title": ["Apocynaceae, A. L. Juss. Dogbane Family"], "source": ["Journal of the Arizona-Nevada Academy of Science"], "year": ["1994"], "volume": ["27"], "fpage": ["164"], "lpage": ["168"]}, {"label": ["42."], "mixed-citation": ["Starr, G. "], "italic": ["Agaves: Living Sculptures For Landscapes And Containers"]}, {"label": ["43."], "mixed-citation": ["The Plant List, Version 1.1. "], "ext-link": ["http://www.theplantlist.org/"]}, {"label": ["44."], "mixed-citation": ["Turner, R. M., Bowers, J. E. & Burgess, T. L. "], "italic": ["Sonoran Desert Plants\u2014An Ecological Atlas"]}, {"label": ["45."], "mixed-citation": ["Vanden Heuvel, B. D. "], "italic": ["Molecular Systematics Of Cercocarpus HBK (Rosaceae)"], "ext-link": ["http://hdl.handle.net/2152/1017"]}, {"label": ["46."], "surname": ["Wilder", "Felger", "Morales"], "given-names": ["BT", "RS", "HR"], "article-title": ["Succulent plant diversity of the Sonoran islands, Gulf of California, Mexico"], "source": ["Haseltonia"], "year": ["2008"], "volume": ["14"], "fpage": ["127"], "lpage": ["160"], "pub-id": ["10.2985/1070-0048-14.1.127"]}, {"label": ["47."], "mixed-citation": ["Birks, H. J. B. & Birks, H. H. Plant macrofossils. In "], "italic": ["Quaternary Palaeoecology"]}, {"label": ["48."], "mixed-citation": ["Grimm, E. C. "], "italic": ["North American Pollen Database Manual"], "ext-link": ["https://epic.awi.de/id/eprint/36566/1/pollen-database-manual-20071011.pdf"]}, {"label": ["49."], "surname": ["Sigovini", "Keppel", "Tagliapietra"], "given-names": ["M", "E", "D"], "article-title": ["Open Nomenclature in the biodiversity era"], "source": ["Methods Ecol. Evol."], "year": ["2016"], "volume": ["7"], "fpage": ["1217"], "lpage": ["1225"], "pub-id": ["10.1111/2041-210X.12594"]}, {"label": ["50."], "surname": ["Watts", "Winter"], "given-names": ["WA", "TC"], "article-title": ["Plant macrofossils from Kirchner Marsh, Minnesota \u2013 A paleoecological study"], "source": ["Geol. Soc. Am. Bull."], "year": ["1966"], "volume": ["77"], "fpage": ["1339"], "lpage": ["1359"], "pub-id": ["10.1130/0016-7606(1966)77[1339:PMFKMM]2.0.CO;2"]}, {"label": ["51."], "mixed-citation": ["Thompson, R. S., Anderson, K. H. & Bartlein, P. J. Atlas of relations between climatic parameters and distributions of important trees and shrubs in North America. "], "italic": ["U.S. Geological Survey Professional Paper"]}, {"label": ["52."], "mixed-citation": ["WeatherDisc Associates. World WeatherDisc, version 1.0 [CD-ROM]. (WeatherDisc Associates, 1989)."]}, {"label": ["53."], "mixed-citation": ["Epstein, E. S. On obtaining daily climatological values from monthly means. "], "italic": ["J. Climate"], "bold": ["4"]}, {"label": ["54."], "surname": ["Bartlein", "Shafer"], "given-names": ["PJ", "SL"], "article-title": ["Paleo calendar-effect adjustments in time-slice and transient climate-model simulations (PaleoCalAdjust v1.0): impact and strategies for data analysis"], "source": ["Geosci. Model Dev."], "year": ["2019"], "volume": ["12"], "fpage": ["3889"], "lpage": ["3913"], "pub-id": ["10.5194/gmd-12-3889-2019"]}, {"label": ["55."], "mixed-citation": ["Tarboton, D. G. & Luce, C. H. Utah Energy Balance Snow Accumulation and Melt Model (UEB) (Utah Water Research Laboratory, Utah State University, and USDA Forest Service, Intermountain Research Station, 1996)."]}, {"label": ["56."], "surname": ["Millar"], "given-names": ["CI"], "article-title": ["Do low-elevation ravines provide climate refugia for subalpine limber pine ("], "italic": ["Pinus flexilis"], "source": ["Can. J. For. Res."], "year": ["2018"], "volume": ["48"], "fpage": ["663"], "lpage": ["671"], "pub-id": ["10.1139/cjfr-2017-0374"]}, {"label": ["57."], "surname": ["Prentice"], "given-names": ["IC"], "article-title": ["A global biome model based on plant physiology and dominance, soil properties and climate"], "source": ["J. Biogeogr."], "year": ["1992"], "volume": ["19"], "fpage": ["117"], "lpage": ["134"], "pub-id": ["10.2307/2845499"]}, {"label": ["58."], "surname": ["Prentice", "Guiot", "Huntley", "Jolly", "Cheddadi"], "given-names": ["IC", "J", "B", "D", "R"], "article-title": ["Reconstructing biomes from palaeoecological data: A general method and its application to European pollen data at 0 and 6 ka"], "source": ["Clim. Dynam."], "year": ["1996"], "volume": ["12"], "fpage": ["185"], "lpage": ["194"], "pub-id": ["10.1007/BF00211617"]}, {"label": ["59."], "surname": ["Thompson", "Anderson"], "given-names": ["RS", "KH"], "article-title": ["Biomes of western North America at 18,000, 6000 and 0 "], "sup": ["14"], "source": ["J. Biogeogr."], "year": ["2000"], "volume": ["27"], "fpage": ["555"], "lpage": ["584"], "pub-id": ["10.1046/j.1365-2699.2000.00427.x"]}, {"label": ["60."], "surname": ["Harrison"], "given-names": ["SP"], "article-title": ["Ecophysiological and bioclimatic foundations for a global plant functional classification"], "source": ["J. Vegetation Sci."], "year": ["2010"], "volume": ["21"], "fpage": ["300"], "lpage": ["317"], "pub-id": ["10.1111/j.1654-1103.2009.01144.x"]}, {"label": ["61."], "surname": ["Harrison", "Kutzbach", "Prentice", "Behling", "Sykes"], "given-names": ["SP", "JE", "IC", "PJ", "MT"], "article-title": ["The response of northern hemisphere extratropical climate and vegetation to orbitally induced changes in insolation during the last interglaciation: Results of atmospheric general circulation model and biome simulations"], "source": ["Quaternary Res."], "year": ["1995"], "volume": ["43"], "fpage": ["174"], "lpage": ["184"], "pub-id": ["10.1006/qres.1995.1018"]}, {"label": ["62."], "surname": ["Kutzbach"], "given-names": ["JE"], "article-title": ["Climate and biome simulations for the past 21,000 years"], "source": ["Quaternary Sci. Rev."], "year": ["1998"], "volume": ["17"], "fpage": ["473"], "lpage": ["506"], "pub-id": ["10.1016/S0277-3791(98)00009-2"]}, {"label": ["63."], "mixed-citation": ["Neilson, R. P., Prentice, I. C. & Smith, B. Simulated changes in vegetation distribution under global warming. In "], "italic": ["Regional Impacts Of Climate Change: An Assessment of Vulnerability"]}, {"label": ["64."], "surname": ["Williams", "Webb", "Richard", "Newby"], "given-names": ["JW", "T", "PH", "P"], "suffix": ["III"], "article-title": ["Late Quaternary biomes of Canada and the eastern United States"], "source": ["J. Biogeogr."], "year": ["2000"], "volume": ["27"], "fpage": ["585"], "lpage": ["607"], "pub-id": ["10.1046/j.1365-2699.2000.00428.x"]}, {"label": ["65."], "surname": ["Edwards"], "given-names": ["ME"], "article-title": ["Pollen-based biomes for Beringia 18,000, 6000 and 0 "], "sup": ["14"], "source": ["J. Biogeogr."], "year": ["2000"], "volume": ["27"], "fpage": ["521"], "lpage": ["554"], "pub-id": ["10.1046/j.1365-2699.2000.00426.x"]}, {"label": ["66."], "surname": ["Ni", "Yu", "Harrison", "Prentice"], "given-names": ["J", "G", "SP", "IC"], "article-title": ["Palaeovegetation in China during the late Quaternary: Biome reconstructions based on a global scheme of plant functional types"], "source": ["Palaeogeogr., Palaeoclimatol., Palaeoecol."], "year": ["2010"], "volume": ["289"], "fpage": ["44"], "lpage": ["61"], "pub-id": ["10.1016/j.palaeo.2010.02.008"]}, {"label": ["67."], "mixed-citation": ["Benson, L. "], "italic": ["The Cacti Of The United States And Canada"]}, {"label": ["68."], "mixed-citation": ["Benson, L. & Darrow, R. A. "], "italic": ["Trees And Shrubs Of The Southwestern Deserts"]}, {"label": ["69."], "mixed-citation": ["Carter, J. L. "], "italic": ["Trees And Shrubs Of New Mexico"]}, {"label": ["70."], "mixed-citation": ["Davis, R. J. "], "italic": ["Flora Of Idaho"]}, {"label": ["71."], "mixed-citation": ["Great Plains Flora Association. "], "italic": ["Flora Of The Great Plains"]}, {"label": ["72."], "mixed-citation": ["Harrington, H. D. "], "italic": ["Manual Of The Plants Of Colorado"]}, {"label": ["73."], "mixed-citation": ["Hickman, J. C. (ed.) "], "italic": ["The Jepson Manual: Higher Plants Of California"]}, {"label": ["74."], "mixed-citation": ["Hitchcock, C. L. & Cronquist, A. "], "italic": ["Flora Of The Pacific Northwest An Illustrated Manual"]}, {"label": ["75."], "mixed-citation": ["Kartesz, J. T. "], "italic": ["A Flora Of Nevada Volumes I And II"]}, {"label": ["76."], "mixed-citation": ["Kearney, T. H. & Peebles, R. H. "], "italic": ["Arizona Flora, Second Edition"]}, {"label": ["77."], "mixed-citation": ["Munz, P. A. & Keck, D. D. "], "italic": ["A California Flora And Supplement"]}, {"label": ["78."], "mixed-citation": ["Powell, A. M. "], "italic": ["Trees And Shrubs Of The Trans-Pecos And Adjacent Areas"]}, {"label": ["79."], "mixed-citation": ["Powell, A. M., Weedin, J. F. & Powell, S. A. "], "italic": ["Cacti Of Texas: A Field Guide"]}, {"label": ["80."], "mixed-citation": ["Roberts, N. C. "], "italic": ["Baja California Plant Field Guide"]}, {"label": ["81."], "mixed-citation": ["Taylor, R. B., Rutledge, J. & Herrera, J. G. "], "italic": ["A Field Guide To Common South Texas Shrubs"]}, {"label": ["82."], "mixed-citation": ["Welsh, S. L., Atwood, N. D., Goodrich, S. & Higgins, L. C. (eds.) "], "italic": ["A Utah Flora"]}, {"label": ["83."], "mixed-citation": ["Hunziker, J. H., Palacios, R. A., De Valesi, A. G. & Poggio, L. Species disjunctions in Larrea: evidence from morphology, cytogenetics, phenolic compounds, and seed albumins. "], "italic": ["Ann. Missouri Botanical Garden"], "bold": ["59"]}, {"label": ["84."], "mixed-citation": ["Hunziker, J. H., Palacios, R. A., Poggio, L., Naranjo, C. A. & Yang, T. W. Geographic distribution, morphology, hybridization, cytogenetics, and evolution. In "], "italic": ["Creosote Bush: Biology And Chemistry Of Larrea In New World Deserts"]}, {"label": ["85."], "surname": ["Porter"], "given-names": ["DM"], "article-title": ["Disjunct distribution in the New World Zygophyllaceae"], "source": ["Taxon"], "year": ["1974"], "volume": ["23"], "fpage": ["339"], "lpage": ["346"], "pub-id": ["10.2307/1218714"]}, {"label": ["86."], "surname": ["Wells", "Hunziker"], "given-names": ["PV", "JH"], "article-title": ["Origin of the creosote bush (Larrea) deserts of southwestern North America"], "source": ["Ann. Missouri Botanical Garden"], "year": ["1976"], "volume": ["63"], "fpage": ["843"], "lpage": ["861"], "pub-id": ["10.2307/2395251"]}, {"label": ["88."], "mixed-citation": ["U.S. Geological Survey Geologic Names Committee. Divisions of geologic time\u2014Major chronostratigraphic and geochronologic units. "], "italic": ["U.S. Geological Survey Fact Sheet"]}, {"label": ["89."], "surname": ["Strickland", "Schumann", "Thompson", "Anderson"], "given-names": ["LE", "RR", "RS", "KH"], "article-title": ["Standardized paleobotanical data derived from packrat middens in western North America. Geological Society of America Annual Meeting, Denver, Colorado, October 2002"], "source": ["Geological Society of America Abstracts with Programs"], "year": ["2002"], "volume": ["34"], "fpage": ["200"]}, {"label": ["90."], "surname": ["Strickland", "Schumann", "Thompson", "Anderson", "Pelltier"], "given-names": ["LE", "RR", "RS", "KH", "RT"], "article-title": ["Quaternary plant fossils from caves and rockshelters: A database of paleoecological records from Neotoma middens in western North America. Geological Society of America Annual Meeting, Philadelphia, Pennsylvania, October 2006"], "source": ["Geological Society of America Abstracts with Programs"], "year": ["2006"], "volume": ["38"], "fpage": ["24"]}, {"label": ["91."], "mixed-citation": ["Strickland, L. E., Thompson, R. S., Anderson, K. H., Pelltier, R. T. & Schumann, R. R. Paleobotanical data from the USGS/NOAA North American Packrat Midden Database, version 5: Primary data, quality-assessed standardized data, and information on sample climatic and ecological context. Geological Society of America Annual Meeting, Phoenix, Arizona, September 2019. "], "italic": ["Geological Society of America Abstracts with Programs"], "bold": ["51"]}, {"label": ["92."], "mixed-citation": ["Thompson, R. S. "], "italic": ["et al", "U.S. Geological Survey Professional Paper"]}, {"label": ["93."], "surname": ["Thompson"], "given-names": ["RS"], "year": ["2023"], "data-title": ["A gridded database of the modern distributions of climate, woody plant taxa, and ecoregions for the continental United States and Canada. U.S. Geological Survey data release"], "source": ["ScienceBase"], "pub-id": ["10.5066/P9FPD80E"]}, {"label": ["94."], "mixed-citation": ["Priestley, C. H. B. & Taylor, R. J. On the assessment of surface heat flux and evaporation using large-scale parameters. "], "italic": ["Mon. Weather Rev"], "bold": ["100"]}]
{ "acronym": [], "definition": [] }
94
CC BY
no
2024-01-14 23:40:18
Sci Data. 2024 Jan 12; 11:68
oa_package/38/b3/PMC10786896.tar.gz
PMC10786897
38216664
[ "<title>Introduction</title>", "<p id=\"Par2\">Analyzing and interpreting radiological examinations and documenting findings in written form is the key aspect of radiological work that has to be conveyed to younger colleagues during their residency<sup>##UREF##0##1##–##UREF##2##3##</sup>. Hence, continuous theoretical and practical training is paramount. However, the way residents access theoretical radiological knowledge has changed tremendously within the last decade. While radiological textbooks were considered a cornerstone of radiological expertise, this paradigm is challenged by the ongoing digitalization. While only 50% of the residents used a computer for offline database search in the 1990s, current surveys show that 99% of radiology residents primarily rely on online databases<sup>##REF##2345094##4##–##UREF##3##6##</sup>.</p>", "<p id=\"Par3\">Despite the advance of new media in radiological self-education, the impact of digitalization on practical training has been minimal until now. Here, primary image review and reporting are performed by a resident. Afterwards, a board-certified radiologist reviews preliminary reports to correct potential errors and provide continuous feedback to the reporting residents. Within this workflow, the so-called “radiology readout”, a mutual image reading session with experienced radiologists, is still a globally recognized tool to swiftly convey radiological knowledge to residents<sup>##REF##33411612##7##</sup>. As the radiology report is a key clinical and legal component<sup>##REF##21788016##8##,##UREF##4##9##</sup> those read-out sessions are used to raise the quality of the residents' reports, too. Especially with regard to understandability, brevity, and overall impression of the reports, senior radiologists can share valuable insights with their younger colleagues<sup>##REF##12643556##10##</sup>.</p>", "<p id=\"Par4\">The acceptance of this teaching method, however, has continuously eroded due to an ever-increasing workload<sup>##UREF##5##11##</sup>. Additionally, the COVID-19 pandemic was an accelerator of this subtle process as it led to a gradual increase of radiologists working from home<sup>##REF##34245674##12##</sup>. As this was considered very popular among radiologists it is unlikely that there will be a return to traditional work models even after the pandemic<sup>##REF##32425711##13##</sup>. While greater availability of potential employees, improved work-life balance, and increased independence are advantages of remote working models, there are also significant drawbacks such as the challenges of integration into the clinical routine and communication with colleagues<sup>##REF##36577604##14##</sup>. Especially, the loss of training opportunities is seen as a potential risk<sup>##REF##36577604##14##,##UREF##6##15##</sup>. To counteract this, various concepts, such as the implementation of virtual read-out sessions for regular personal feedback or the provision of reporting curricula, have been introduced internationally and have been generally well-received<sup>##REF##24331275##16##–##REF##32386950##19##</sup>. Anyway, it is intriguing that young residents deliver a less positive of the virtual read-out compared to senior radiologists<sup>##REF##32507612##20##</sup>. This data suggests that young residents' have an urgent need for very regular feedback. Furthermore, it is difficult for residents to perceive subtle changes in approved reports. Thus, the opportunity to obtain skills in conveying individual opinions in ambiguous findings, a key aspect of radiological reporting, is endangered. Here, the manual comparison of preliminary and approved reports is not only time-consuming but also prone to errors and therefore not feasible in everyday clinical practice. To address this problem, we developed an in-house software (DiffTool), to track changes made to preliminary reports by board-certified radiologists. The goal of the present study was to evaluate the acceptance and effectiveness of this software solution for the radiological training of residents.</p>" ]
[ "<title>Methods</title>", "<title>Ethics statement</title>", "<p id=\"Par5\">The local institutional review board (Ethics Commission of the University Duisburg-Essen, Germany) waived the ethics approval and informed consent for this pseudonymized employee attitude survey.</p>", "<title>Study design &amp; questionnaire</title>", "<p id=\"Par6\">The DiffTool software was developed to improve the education of residents. Prior to the software launch in 05/2022, information about the study habits and educational needs of residents at our department was collected anonymously via a structured online questionnaire (t<sub>0</sub>). The base questionnaire at t<sub>0</sub> contained 17 questions. Primarily, the first eleven questions assessed the residents' sex, age, and radiological work experience in general and for each of the main three imaging modalities (radiography, CT, MRI) specifically. Questions 12–14 collected information on whether residents are tracking, understanding and learning (from) the changes made to their preliminary reports. With this data, we aimed to comprehensively evaluate the relevance of the report correction carried out by the board-certified radiologists. Questions 15 and 16 with a sub-set of five questions each analyzed the preferred modality to obtain radiological knowledge right now and their teaching needs regarding the remaining residency. Finally, the survey at t<sub>0</sub> featured a statement aimed at evaluating the requirement for a new software solution for monitoring changes made to preliminary reports. After two to four months of use, data collection was repeated via the same questionnaire, along with additional questions regarding the DiffTool (t<sub>2−4</sub>) to ensure optimal comparability and assess any changes in user perspectives. In the questionnaire at t<sub>2/4</sub>, the user experience as well as the significance of the DiffTool for the daily routine of the residents was evaluated with three additional questions to understand the impact of the new software in clinical care. (See s Supplement ##SUPPL##0##1## for the complete questionnaire).</p>", "<p id=\"Par7\">Responses were recorded using a six-point Likert scale ranging from 1 (strongly agree) to 6 (strongly disagree, see supplementary material ##SUPPL##0##1## for the complete questionnaire).</p>", "<title>Software</title>", "<p id=\"Par8\">The DiffTool is a web-based application developed in-house without disrupting established workflows in radiological departments that allows users to compare and analyze differences between versions of diagnostic reports.</p>", "<p id=\"Par9\">(Fig. ##FIG##0##1##).</p>", "<p id=\"Par10\">It was built using TypeScript, React, and Scala and is based on the local Smart Hospital Information Platform (SHIP), which uses the Fast Healthcare Interoperability Resources (FHIR) standard to store and transfer medical data. SHIP offers a Representational State Transfer Application-Program-Interface-Type (REST API) that returns data as JavaScript Object Notation (JSON) objects. Various applications, including the DiffTool, have been developed to support patient care and research at the hospital. To access and manipulate data in SHIP, users must authenticate themselves using an existing SHIP app called Ship-auth, which creates a JSON web token (JWT). The DiffTool uses this SHIP token to validate user permissions and display a list of diagnostic reports for the current date or a specified date range. In this overview, details on the report status and the extent of changes in percent are visualized. By clicking on a report, it is possible to get a detailed comparison between different versions of the report. The software provides a multi-level comparison possibility in which different variants of the report can be compared (e.g. in hybrid imaging where different adjustments are made by a board-certified radiologist and a nuclear medicine physician). Users can then select two versions of a diagnostic report to compare, and the tool uses the react-diff-viewer library to highlight differences, including whitespaces, commas, deleted, changed, or added text. Differences between the selected versions are highlighted to give users a quick overview. Here light colors (either red or green) indicate additions while dark colors represent removed text segments.</p>", "<p id=\"Par11\">The DiffTool retrieves the reports by sending GET requests to the SHIP-FHIR server with the report IDs and, in the case of the preliminary report, the keyword “history”. To retrieve the preliminary report, the last entry in the history should be selected. Users can also access the DiffTool by opening a case in the Radiology Information System (RIS) and clicking on a link to the DiffTool, which will then verify the user's credentials and search for the desired report. (Fig. ##FIG##1##2##).</p>", "<title>Statistics</title>", "<p id=\"Par12\">Since only a limited number of residents participated in the study (n = 18) only explorative and observational data analysis was performed using GraphPad Prism version 9.4.1 for MacOS (Dotmatics, Boston, MA, USA).</p>", "<title>Definitions</title>", "<p id=\"Par13\">To enhance reader comprehension, the number of specific responses was abbreviated according to the following scheme (R<sub>x</sub> = number of responses), where x corresponds to the response on the Likert scale. The term “new media” can be confusing because it covers a broad spectrum of digital content, which may lead to different interpretations. When referring to \"new media\" in this article, we include a wide range of digital content, including websites, videos, learning platforms, and online databases. However, it's important to note that we exclude purely digitized texts like books and journals.</p>" ]
[ "<title>Results</title>", "<p id=\"Par14\">The study population was composed of 18 radiology residents of the radiological department at the investigating hospital. Their radiological experience ranged from one year to five years (median: 2 years; IQR: 1.25–3). Six residents were female and 12 residents were male, with a median age of 29 years (IQR: 28–29). All residents completed both questionnaires, and no dropouts were observed.</p>", "<p id=\"Par15\">(Table ##TAB##0##1##).</p>", "<p id=\"Par16\">At t<sub>0</sub>, 22% (4/18) of the residents have primarily analyzed radiographs for the last four month while 72% (13/18) worked on CTs and 6% (1/18) on MRI. In line with this, we have also asked the residents about their confidence and level of knowledge with regard to the distinct imaging modalities. 78% (R<sub>1</sub> + R<sub>2</sub> = 14/18) agreed (strongly) on having acquired good knowledge with respect to the reporting of radiographs over the course of their residency, while 44% (R<sub>1</sub> + R<sub>2</sub> = 8/18) made the same statements about CT and 22% (R<sub>1</sub> + R<sub>2</sub> = 4/18) about MRI. Regarding the primary workplace of the last four month 72% (R<sub>1</sub> + R<sub>2</sub> = 13/18) (strongly) agreed on feeling confident in generating reports.</p>", "<p id=\"Par17\">Before the DiffTool was made available to the residents in 2022, we assessed the habits of the residents regarding their professional training. Residents unanimously (strongly) agreed on the significance of online databases on their radiological education (R<sub>1</sub> + R<sub>2</sub> = 18/18), while only 41% (R<sub>1</sub> + R<sub>2</sub> = 7/18) provided an identical response for medical textbooks and 22% (R<sub>1</sub> + R<sub>2</sub> = 4/18) echoed this for medical journals. However, internal training activities were still considered as important by 78% (R<sub>1</sub> + R<sub>2</sub> = 14/18) of residents. Additionally, 89% (R<sub>1</sub> + R<sub>2</sub> = 16/18) agreed on the importance of corrected radiology reports for their training. (Fig. ##FIG##2##3##).</p>", "<p id=\"Par18\">In addition to their habits, we investigated the desire for other teaching methods of residents regarding their professional training. 78% (R<sub>1</sub> = 14/18) strongly agreed with the statements that they would like to have access to online databases, internal training, and access to radiological conferences, respectively. 44% (R<sub>1</sub> = 8/18) strongly agreed with the statement that they would like to have more access to medical textbooks and medical journals, respectively.</p>", "<p id=\"Par19\">To evaluate the need for regular feedback in hands-on training, we evaluated the need and wish for a software tool to keep track of changes in finally approved reports. 61% (R<sub>1</sub> = 11/18) of the residents strongly agreed with the statement: “I wish I had a software tool to keep track of changes made in my reports by my supervisors”.</p>", "<p id=\"Par20\">(Fig. ##FIG##3##4##).</p>", "<p id=\"Par21\">To circumvent a potential bias by the previous item, we also analyzed whether residents were manually tracking corrections made by board-certified radiologists in the preliminary reports of the residents. Prior to the deployment of the DiffTool 39% (R<sub>1</sub> = 7/18) of residents reported to track corrections for every report. After the launch of the DiffTool, there was an increase from 39% (R<sub>1</sub> = 7/18) to 61% (R<sub>1</sub> = 11/18) of residents who strongly agreed on the statement that they tracked the changes made to every report. Although only a slight increase in residents strongly agreeing with the statement “I can understand the changes made by my supervisors in my reports” from 28% (R<sub>1</sub> = 5/18) to 33% (R<sub>1</sub> = 6/18) was observed, the software seems to facilitate the tracking of changes and therefore has a positive impact on residents. To evaluate whether the development of the DiffTool improved the radiology training we asked, whether residents used corrected reports for additional self-education. Two to four months after the deployment of the DiffTool 67% (R<sub>1</sub> = 12/18) of the residents strongly agreed on that statement compared to 50% (R<sub>1</sub> = 9/18) at t<sub>0</sub>. Additionally, we observed an increase from 33% (R<sub>1</sub> = 6/18) to 44% (R<sub>1</sub> = 8/18) of residents who strongly agreed with the statement “I profit from every corrected report”.</p>", "<p id=\"Par22\">(Fig. ##FIG##4##5##).</p>", "<p id=\"Par23\">The software itself was well received by the residents. A majority of 72% (R<sub>1</sub> + R<sub>2</sub> = 13/18) agreed on using the DiffTool regularly. A majority of 78% (R<sub>1</sub> + R<sub>2</sub> = 14/18) agreed with the statement “I am very satisfied with the functionality of the DiffTool”. 78% of the residents (R<sub>1</sub> + R<sub>2</sub> = 14/18) agreed with the statement “My training improved through the use of the DiffTool. (Fig. ##FIG##5##6##).</p>" ]
[ "<title>Discussion</title>", "<p id=\"Par24\">Established tools in radiological hands-on training, such as radiology read-outs, are under continuous pressure due to the ever-increasing workload as well as ongoing challenges such as the COVID-19 pandemic or evolution to decentralized workspaces<sup>##REF##34245674##12##,##REF##32425711##13##,##REF##32522010##21##–##REF##32925383##24##</sup>. To address the residents´ needs, a thorough investigation of the current situation is necessary. Furthermore, we assessed an in-house developed software, DiffTool, to improve practical training by establishing a workflow for residents to track changes made to preliminary reports by senior radiologists. Our investigation revealed four major findings. First, new media, especially online databases, are central to professional education. Second, tracking reports of changes made by supervising radiologists is the second most important way for residents to improve their radiological education as 89% (strongly) agree (R<sub>1</sub> + R<sub>2</sub> = 16/18 at t0) on that statement (Fig. ##FIG##2##3##), which underscores the importance of report correction for training that has been shown before<sup>##UREF##7##25##,##UREF##8##26##</sup>. Third, the launch of DiffTool encouraged more residents to track their reports and raised awareness for this way of self-education. Fourth, we observed a broad adoption of this new teaching tool due to a satisfactory user experience leading to an improvement in the residents’ education.</p>", "<p id=\"Par25\">On their way to the board examination, residents obtain radiological knowledge by self-study, lectures, or hands-on teaching. While most residents used medical textbooks for self-study in the past, we observed that in our cohort, online databases were considered the most important tool for residents to access radiological knowledge. These findings are in line with a recent survey by Derakhshani et al. revealing that new media, especially online databases, are the most important source of information for residents nowadays<sup>##REF##17707320##5##</sup>. The outstanding role of online databases is matched by their recent user data. For instance, the open-access online library radiopaedia.org founded in 2005 noted a continuous incline to 20 million page-views per month in 2020<sup>##UREF##9##27##</sup>.</p>", "<p id=\"Par26\">Although internal training courses or lectures were considered as less important than online databases, residents preferred these formats in direct comparison to textbooks or medical journals in our study. In accordance with these findings, the majority of residents expressed their wish to access online databases, congresses, and internal training to improve their radiological training. Here, the possibility to access online presentations at virtually any time from any place in the world might provide new teaching opportunities for residents, however, the benefit of these teaching concepts has to be elucidated in further studies. Despite the ever-growing importance of new media, access to medical books and journals is still considered relevant by the interviewed residents as 44% still strongly demand access to medical textbooks and journals, respectively. These findings are in line with the above-mentioned results from Derakhshani et al., who observed that medical journals were still considered an important secondary source in challenging cases<sup>##REF##17707320##5##</sup>.</p>", "<p id=\"Par27\">Although various options are available for radiological self-education thanks to the advancing digitalization in the early twenty-first century, direct hands-on teaching is fundamental and an internationally well-accepted method in radiological residency<sup>##REF##33411612##7##</sup>. However, since the radiological report is a legally significant and clinically guiding document<sup>##REF##21788016##8##</sup>, it is important to provide additional training in terms of structure, syntax, or brevity<sup>##REF##12643556##10##,##REF##27657361##28##,##REF##29683348##29##</sup>.</p>", "<p id=\"Par28\">As 89% of the residents (strongly) agreed with the statement “I profit from every corrected report”, regular, preferably daily feedback by an experienced radiologist is necessary. However, the possibility of providing such feedback in a common radiology readout session was minimized during the COVID-19 pandemic. Although these restrictions have been abolished, it is questionable whether the trend of remote reporting, which was kickstarted during the pandemic, will ever be fully reversed, given the positive feedback by radiologists<sup>##REF##32425711##13##,##REF##33745705##30##,##REF##32654757##31##</sup>. Leaving the positive effects of remote working like better work-life balance apart, there is an undeniable risk of reduced face-to-face contact between employees<sup>##REF##36577604##14##</sup>. Naturally, this also includes the interaction between board-certified and resident radiologists, which, in addition to the high workload, further diminishes one-on-one hands-on teaching opportunities<sup>##REF##36577604##14##,##UREF##6##15##</sup>. Various studies have investigated the possibility of employing virtual radiology read-out sessions with positive feedback<sup>##REF##33594906##17##–##REF##32386950##19##</sup>. However, Matalon et al. have elucidated that remote feedback mechanisms can pose a particular threat to the education of junior residents and suggest that they require more feedback<sup>##REF##32507612##20##</sup>. The results of our study indicate that such feedback does not exclusively have to be conveyed in a face-to-face conversation, as 61% of the residents demanded a software solution to track changes made by superiors as an addition to exsting feedback mechanisms. Indeed, the introduction of the software led to an increased awareness of corrections made in final radiology reports as a majority of 61% of the residents strongly agreed on tracking the corrections for every report, while only 39% did track those changes to that extent manually before. Additionally, a greater share of residents benefited from the implementation of the DiffTool as they improved their radiological knowledge with every corrected report (R<sub>1</sub> after = 44%; before: 33%). However, the introduction of the DiffTool resulted only a modest increase in strong agreement regarding residents' understanding of changes in their reports, with only 33% at t<sub>2/4</sub> (vs. t<sub>0</sub> = 28%). This underscores the limitations of the DiffTool, as it cannot facilitate comprehension of alterations made. For the time being, in-person interaction remains of great significance. Additionally, an add-on to the DiffTool with annotation functionality for board-certified radiologists is worth considering in the future. Still, as the primary intention of the software was not comprehension improvement but raising the awareness of made alterations, it's worth noting that an encouraging majority of 83% at t<sub>2/4</sub> (vs. t<sub>0</sub> = 78%) either strongly agreed or agreed on understanding changes made to their preliminary reports. As multiple aspects within a radiological report can be subject to corrections, ranging from image interpretation to minor adjustments in syntax that impact the statement's accuracy, it becomes crucial to investigate the impact of software solutions like the DiffTool on specific error subgroups in the future.</p>", "<p id=\"Par29\">These results support the findings of Sharpe and Kalaria et al. that indicated the potential of such software. At their department, residents checked for corrections made in their reports more frequently after the software launch and improved their radiological knowledge in that manner<sup>##UREF##7##25##,##UREF##8##26##</sup>. Unfortunately, their software solution could not be rolled out to other departments due to the lack of interoperability. Therefore, the DiffTool is based on international standards like FHIR to ensure an easy transfer to other institutions. Apart from the sole improvement to the training, the DiffTool software was well accepted among residents as 72% (strongly) agreed on using it regularly. Additionally, 78% were satisfied with the functionality of the DiffTool and stated that the software improved their radiological training significantly, a result echoing the positive evaluations reported by Kalaria et al<sup>##UREF##8##26##</sup>.</p>", "<p id=\"Par30\">However, there are a few limitations to address in the present investigation. First, only a limited number of residents from one department participated in the study. Moreover, the software and its functionality were adjusted towards the workflow in the department of the investigating hospital. Because of the missing long-term follow-up and the difficulty in measuring the gain of radiological knowledge, there is a risk of a temporary novelty effect. However, we tackled the issue of generalizability by using standardized interfaces such as FHIR for easy translation to other systems.</p>", "<p id=\"Par31\">In conclusion, the demand for direct feedback and hands-on teaching is still high despite new digital opportunities for radiological self-education. To satisfy this demand despite the ever-increasing number of home office workspaces kickstarted due to the COVID-19 pandemic, a novel software (DiffTool) was developed to track changes made to reports automatically. Thanks to the software, residents tracked reports more frequently and stated that the highly accepted, and considered this easy-to-use software a welcomed addition to their radiology training.</p>" ]
[]
[ "<p id=\"Par1\">A novel software, DiffTool, was developed in-house to keep track of changes made by board-certified radiologists to preliminary reports created by residents and evaluate its impact on radiological hands-on training. Before (t<sub>0</sub>) and after (t<sub>2−4</sub>) the deployment of the software, 18 residents (median age: 29 years; 33% female) completed a standardized questionnaire on professional training. At t<sub>2−4</sub> the participants were also requested to respond to three additional questions to evaluate the software. Responses were recorded via a six-point Likert scale ranging from 1 (“strongly agree”) to 6 (“strongly disagree”). Prior to the release of the software, 39% (7/18) of the residents strongly agreed with the statement that they manually tracked changes made by board-certified radiologists to each of their radiological reports while 61% were less inclined to agree with that statement. At t<sub>2−4</sub>, 61% (11/18) stated that they used DiffTool to track differences. Furthermore, we observed an increase from 33% (6/18) to 44% (8/18) of residents who agreed to the statement “I profit from every corrected report”. The DiffTool was well accepted among residents with a regular user base of 72% (13/18), while 78% (14/18) considered it a relevant improvement to their training. The results of this study demonstrate the importance of providing a time-efficient way to analyze changes made to preliminary reports as an additive for professional training.</p>", "<title>Subject terms</title>", "<p>Open Access funding enabled and organized by Projekt DEAL.</p>" ]
[ "<title>Supplementary Information</title>", "<p>\n</p>" ]
[ "<title>Supplementary Information</title>", "<p>The online version contains supplementary material available at 10.1038/s41598-024-51462-4.</p>", "<title>Acknowledgements</title>", "<p>The authors specifically thank the team of residents at the investigating hospital for their participation.</p>", "<title>Author contributions</title>", "<p>Study conception: L.S., J.H., F.N., R.H., B.M.S. Data acquisition and analysis: L.S., J.H., M.G., M.M., M.S., F.N., B.M.S. Data interpretation: L.S., J.H., M.M., F.N., B.M.S. Writing the original manuscript: L.S., J.H., F.N., B.M.S. Revising the work for important intellectual content: L.S., J.H., M.M., M.G., R.H., M.F., L.U., M.S., F.N., B.M.S. All authors contributed to the article and approved the submitted version.</p>", "<title>Funding</title>", "<p>Open Access funding enabled and organized by Projekt DEAL. JH was supported by a German Research Foundation (DFG)-initiated clinician scientist program FU 356/12–2.</p>", "<title>Data availability</title>", "<p>Data, material and all necessary codes can be made available upon request via the corresponding author.</p>", "<title>Competing interests</title>", "<p id=\"Par32\">The authors declare no competing interests.</p>" ]
[ "<fig id=\"Fig1\"><label>Figure 1</label><caption><p>Workflow in a radiology department and possible teaching points. RIS = Radiology Information System, HIS = Hospital Information System.</p></caption></fig>", "<fig id=\"Fig2\"><label>Figure 2</label><caption><p>Overview of the user interface of the DiffTool.</p></caption></fig>", "<fig id=\"Fig3\"><label>Figure 3</label><caption><p>Opinion of radiology residents on the significance of various methods for radiological self-education. The importance of each method was assessed using a six-point Likert scale ranging from 1 (strongly agree) to 6 (strongly disagree).</p></caption></fig>", "<fig id=\"Fig4\"><label>Figure 4</label><caption><p>Desires of radiological residents for further teaching methods. The importance of each method was assessed using a six-point Likert scale ranging from 1 (strongly agree) to 6 (strongly disagree).</p></caption></fig>", "<fig id=\"Fig5\"><label>Figure 5</label><caption><p>Impact of the DiffTool on tracking, understanding and learning from corrected reports. The importance of each statement was assessed using a six-point Likert scale ranging from 1 (strongly agree) to 6 (strongly disagree).</p></caption></fig>", "<fig id=\"Fig6\"><label>Figure 6</label><caption><p>Evaluation of the overall user experience of the DiffTool. The importance of each statement was assessed using a six-point Likert scale ranging from 1 (strongly agree) to 6 (strongly disagree).</p></caption></fig>" ]
[ "<table-wrap id=\"Tab1\"><label>Table 1</label><caption><p>Demographics Table at t<sub>0</sub>.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\">Variable</th><th align=\"left\">Study population <italic>(n</italic> = <italic>18)</italic></th></tr></thead><tbody><tr><td align=\"left\">Age, years*</td><td align=\"left\">29 (28–29)</td></tr><tr><td align=\"left\">Sex, female</td><td align=\"left\">6 (33%)</td></tr><tr><td align=\"left\">Experience in radiology, years*</td><td align=\"left\">2 (1.25–3)</td></tr><tr><td align=\"left\">Experience in radiograph evaluation, month*</td><td align=\"left\">10.6 (6–23.25)</td></tr><tr><td align=\"left\">Experience in CT evaluation, month*</td><td align=\"left\">10.5 (1–18.5)</td></tr><tr><td align=\"left\">Experience in MRI evaluation, month*</td><td align=\"left\">1.5 (0–4.5)</td></tr></tbody></table></table-wrap>" ]
[]
[]
[]
[]
[]
[ "<supplementary-material content-type=\"local-data\" id=\"MOESM1\"></supplementary-material>" ]
[ "<table-wrap-foot><p>* = Data are medians with interquartile range.</p></table-wrap-foot>", "<fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Luca Salhöfer and Johannes Haubold.</p></fn><fn><p>These authors jointly supervised this work: Felix Nensa and Benedikt Michael Schaarschmidt.</p></fn></fn-group>" ]
[ "<graphic xlink:href=\"41598_2024_51462_Fig1_HTML\" id=\"MO1\"/>", "<graphic xlink:href=\"41598_2024_51462_Fig2_HTML\" id=\"MO2\"/>", "<graphic xlink:href=\"41598_2024_51462_Fig3_HTML\" id=\"MO3\"/>", "<graphic xlink:href=\"41598_2024_51462_Fig4_HTML\" id=\"MO4\"/>", "<graphic xlink:href=\"41598_2024_51462_Fig5_HTML\" id=\"MO5\"/>", "<graphic xlink:href=\"41598_2024_51462_Fig6_HTML\" id=\"MO6\"/>" ]
[ "<media xlink:href=\"41598_2024_51462_MOESM1_ESM.docx\"><caption><p>Supplementary Information.</p></caption></media>" ]
[{"label": ["1."], "mixed-citation": ["Accreditation Council for Graduate Medical Education (2021) Diagnostic radiology case log categories and required minimum numbers"]}, {"label": ["2."], "mixed-citation": ["The Accreditation Council for Graduate Medical Education and The American Board of Radiology. (2012) Accreditation Council for Graduate Medical Education. The Diagnostic Radiology Milestone Project. A Joint Initiative of the Accreditation Council for Graduate Medical Education and The American Board of Radiology. "], "ext-link": ["https://www.acgme.org/globalassets/PDFs/Milestones/DiagnosticRadiologyMilestones.pdf"]}, {"label": ["3."], "mixed-citation": ["\u00c4rztekammer Nordrhein (2012) Weiterbildungsinhalte im 29. Gebiet Radiologie"]}, {"label": ["6."], "surname": ["Derakhshani", "Ding", "Vijayasarathi"], "given-names": ["A", "J", "A"], "article-title": ["On-call radiology 2020: Where trainees look for help in a high stakes and time sensitive environment"], "source": ["Clin. Imag."], "year": ["2021"], "volume": ["77"], "fpage": ["219"], "lpage": ["223"], "pub-id": ["10.1016/j.clinimag.2021.05.003"]}, {"label": ["9."], "surname": ["Brady"], "given-names": ["AP"], "article-title": ["Radiology reporting-from Hemingway to HAL?"], "source": ["Insights Imag."], "year": ["2018"], "volume": ["9"], "fpage": ["237"], "lpage": ["246"], "pub-id": ["10.1007/s13244-018-0596-3"]}, {"label": ["11."], "surname": ["Nekolla", "Schegerer", "Griebel", "Brix"], "given-names": ["EA", "AA", "J", "G"], "article-title": ["Frequency and doses of diagnostic and interventional X-ray applications : Trends between 2007 and 2014"], "source": ["Radiol"], "year": ["2017"], "volume": ["57"], "fpage": ["555"], "lpage": ["562"], "pub-id": ["10.1007/s00117-017-0242-y"]}, {"label": ["15."], "surname": ["Choudhury"], "given-names": ["P"], "article-title": ["Our work-from-anywhere future"], "source": ["Harv. Bus. Rev."], "year": ["2020"], "volume": ["98"], "issue": ["6"], "fpage": ["58"]}, {"label": ["25."], "surname": ["Sharpe", "Surrey", "Gorniak"], "given-names": ["RE", "D", "RJT"], "article-title": ["Radiology report comparator: A novel method to augment resident education"], "source": ["J. Digit. Imag."], "year": ["2012"], "volume": ["25"], "fpage": ["330"], "lpage": ["336"], "pub-id": ["10.1007/s10278-011-9419-5"]}, {"label": ["26."], "surname": ["Kalaria", "Filice"], "given-names": ["AD", "RW"], "article-title": ["Comparison-bot: An automated preliminary-final report comparison system"], "source": ["J. Digit. Imag."], "year": ["2016"], "volume": ["29"], "fpage": ["325"], "lpage": ["330"], "pub-id": ["10.1007/s10278-015-9840-2"]}, {"label": ["27."], "mixed-citation": ["Impact|Radiopaedia.org. "], "ext-link": ["https://radiopaedia.org/impact"]}]
{ "acronym": [], "definition": [] }
31
CC BY
no
2024-01-14 23:40:18
Sci Rep. 2024 Jan 12; 14:1172
oa_package/03/88/PMC10786897.tar.gz